PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Ortega-Madueno, I; Garcia-Montojo, M; Dominguez-Mozo, MI; Garcia-Martinez, A; Arias-Leal, AM; Casanova, I; Arroyo, R; Alvarez-Lafuente, R				Ortega-Madueno, Isabel; Garcia-Montojo, Marta; Inmaculada Dominguez-Mozo, Maria; Garcia-Martinez, Angel; Maria Arias-Leal, Ana; Casanova, Ignacio; Arroyo, Rafael; Alvarez-Lafuente, Roberto			Anti-Human Herpesvirus 6A/B IgG Correlates with Relapses and Progression in Multiple Sclerosis	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; INTERFERON-BETA TREATMENT; PLACEBO-CONTROLLED TRIAL; NEUTRALIZING ANTIBODIES; HUMAN-HERPESVIRUS-6; NATALIZUMAB; EXPRESSION; VARIANT; HHV-6A; RISK	Objective: To analyze the titers of the IgG and IgM antibodies against human herpesvirus 6A/B (HHV-6A/B) in multiple sclerosis (MS) patients treated with different disease modified therapies (DMTs) along two-years of follow-up. Methods: We collected 2163 serum samples from 596 MS; for 301 MS patients a 2-years follow-up was performed. Serum samples of 337 healthy controls were also analyzed. Anti-HHV-6A/B IgG and IgM were analyzed by ELISA (Panbio). Results: We found that 129/187 (69.0%) MS patients with a decrease of the anti-HHV-6A/B IgG titers after 2-years with DMTs were free of relapses and progression vs. 46/113 (40.7%) of MS patients with an increase of the anti-HHV-6A/B IgG titers (p = 0.0000015); the higher significance was found for natalizumab. Furthermore, we found that anti-HHV-6A/B IgG titers reached their highest value two weeks before the relapse (p = 0.0142), while the anti-HHV-6A/B IgM titers reached their highest value one month before the relapse (p = 0.0344). Conclusion: The measurement of the anti-HHV-6A/B IgG titers could be a good biomarker of clinical response to the different DMTs. The increase of the anti-HHV-6A/B IgG and IgM titers predicts the upcoming clinical relapses. However, further longitudinal studies are needed to validate these results.	[Ortega-Madueno, Isabel] Hosp Clin San Carlos IdISSC, Inst Invest Sanitaria, Hosp Clin San Carlos, Serv Anal Clin, Madrid, Spain; [Garcia-Montojo, Marta; Inmaculada Dominguez-Mozo, Maria; Garcia-Martinez, Angel; Maria Arias-Leal, Ana; Casanova, Ignacio; Arroyo, Rafael; Alvarez-Lafuente, Roberto] Hosp Clin San Carlos IdISSC, Inst Invest Sanitaria, Hosp Clin San Carlos, Serv Neurol, Madrid, Spain	Hospital Clinico San Carlos; Hospital Clinico San Carlos	Alvarez-Lafuente, R (corresponding author), Hosp Clin San Carlos IdISSC, Inst Invest Sanitaria, Hosp Clin San Carlos, Serv Neurol, Madrid, Spain.	ralvarezlafuente@yahoo.es	Alvarez-Lafuente, Roberto/AAJ-9980-2020	Garcia-Montojo, Marta/0000-0003-0664-3480; Alvarez-Lafuente, Roberto/0000-0002-3132-1486; Dominguez-Mozo, Maria Inmaculada/0000-0001-9236-5717	Instituto de Salud Carlos III-Fondo Europeo de Desarrollo Regional (Feder) [CP07/00273, FIS PI12/02349]; REEM: Red Espanola de Esclerosis Multiple [RETICS-REEM RD12/0032/0001]; Fundacion Mutua Madrilena; Fundacion LAIR	Instituto de Salud Carlos III-Fondo Europeo de Desarrollo Regional (Feder)(European Commission); REEM: Red Espanola de Esclerosis Multiple; Fundacion Mutua Madrilena(Instituto de Salud Carlos III); Fundacion LAIR	Roberto Alvarez-Lafuente is recipient of a research contract of the Instituto de Salud Carlos III-Fondo Europeo de Desarrollo Regional (Feder) (CP07/00273). Arias-Leal and Garcia-Martinez are recipients of a technician contract from "REEM: Red Espanola de Esclerosis Multiple'' (RETICS-REEM RD12/0032/0001; www.reem.es). This work was financially supported by grants from the Instituto de Salud Carlos III-Fondo Europeo de Desarrollo Regional (Feder) (FIS PI12/02349), "Fundacion Mutua Madrilena'', and "Fundacion LAIR''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhyani N, 2000, J INFECT DIS, V182, P1321, DOI 10.1086/315893; Alvarez-Lafuente R, 2006, BRAIN PATHOL, V16, P20, DOI 10.1111/j.1750-3639.2006.tb00558.x; Alvarez-Lafuente R, 2004, EUR NEUROL, V52, P87, DOI 10.1159/000079936; Alvarez-Lafuente R, 2010, EUR J NEUROL, V17, P129, DOI 10.1111/j.1468-1331.2009.02758.x; Ascherio A, 2001, JAMA-J AM MED ASSOC, V286, P3083, DOI 10.1001/jama.286.24.3083; Bertolotto A, 2004, J NEUROL, V251, P15, DOI 10.1007/s00415-004-1204-7; Borden EC, 2007, NAT REV DRUG DISCOV, V6, P975, DOI 10.1038/nrd2422; CHALLONER PB, 1995, P NATL ACAD SCI USA, V92, P7440, DOI 10.1073/pnas.92.16.7440; Comi G, 2009, LANCET, V374, P1503, DOI 10.1016/S0140-6736(09)61259-9; Garcia-Montojo M, 2011, EUR J NEUROL, V18, P1027, DOI 10.1111/j.1468-1331.2011.03410.x; Garcia-Montojo M, 2010, EUR J NEUROL, V17, P470, DOI 10.1111/j.1468-1331.2009.02890.x; Goodman AD, 2003, J INFECT DIS, V187, P1365, DOI 10.1086/368172; Hollsberg P, 2005, ACTA NEUROL SCAND, V112, P395, DOI 10.1111/j.1600-0404.2005.00516.x; Hong J, 2002, MULT SCLER J, V8, P237, DOI 10.1191/1352458502ms794oa; Hurwitz BJ, 2008, J NEUROL SCI, V272, P8, DOI 10.1016/j.jns.2008.05.004; JOHNSON KP, 1995, NEUROLOGY, V45, P1268, DOI 10.1212/WNL.45.7.1268; Johnson KP, 1997, J MOL MED, V75, P89, DOI 10.1007/s001090050093; Kappos L, 2009, LANCET NEUROL, V8, P987, DOI 10.1016/S1474-4422(09)70237-6; KAWADE Y, 1986, METHOD ENZYMOL, V119, P558; Levin LI, 2005, JAMA-J AM MED ASSOC, V293, P2496, DOI 10.1001/jama.293.20.2496; Noseworthy JH, 2000, NEW ENGL J MED, V343, P938, DOI 10.1056/NEJM200009283431307; Polman CH, 2006, NEW ENGL J MED, V354, P899, DOI 10.1056/NEJMoa044397; Racke MK, 2010, NEUROLOGY, V74, pS25, DOI 10.1212/WNL.0b013e3181c97e39; Rice GPA, 2005, NEUROLOGY, V64, P1336, DOI 10.1212/01.WNL.0000158329.30470.D0; Salvetti M, 2009, CURR OPIN NEUROL, V22, P201, DOI 10.1097/WCO.0b013e32832b4c8d; Selter RC, 2013, MULT SCLER J, V19, P1454, DOI 10.1177/1352458513477229; Simpson S, 2012, MULT SCLER J, V18, P799, DOI 10.1177/1352458511428081; Soldan SS, 2000, ANN NEUROL, V47, P306, DOI 10.1002/1531-8249(200003)47:3<306::AID-ANA5>3.0.CO;2-A; Soldan SS, 1997, NAT MED, V3, P1394, DOI 10.1038/nm1297-1394; Tselis A, 2011, SEMIN NEUROL, V31, P307, DOI 10.1055/s-0031-1287656	30	22	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2014	9	8							e104836	10.1371/journal.pone.0104836	http://dx.doi.org/10.1371/journal.pone.0104836			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WB	25110949	Green Submitted, Green Published, gold			2022-12-27	WOS:000341105100104
J	Karlson, AML; Gorokhova, E; Elmgren, R				Karlson, Agnes M. L.; Gorokhova, Elena; Elmgren, Ragnar			Nitrogen Fixed by Cyanobacteria Is Utilized by Deposit-Feeders	PLOS ONE			English	Article							AMPHIPODS MONOPOREIA-AFFINIS; BALTIC SEA; FOOD-WEB; APHANIZOMENON SP.; STABLE-ISOTOPES; CARBON; DYNAMICS; BLOOMS; PHYTODETRITUS; SEDIMENTATION	Benthic communities below the photic zone depend for food on allochthonous organic matter derived from seasonal phytoplankton blooms. In the Baltic Sea, the spring diatom bloom is considered the most important input of organic matter, whereas the contribution of the summer bloom dominated by diazotrophic cyanobacteria is less understood. The possible increase in cyanobacteria blooms as a consequence of eutrophication and climate change calls for evaluation of cyanobacteria effects on benthic community functioning and productivity. Here, we examine utilization of cyanobacterial nitrogen by deposit-feeding benthic macrofauna following a cyanobacteria bloom at three stations during two consecutive years and link these changes to isotopic niche and variations in body condition (assayed as C:N ratio) of the animals. Since nitrogen-fixing cyanobacteria have delta N-15 close to -2 parts per thousand, we expected the delta N-15 in the deposit-feeders to decrease after the bloom if their assimilation of cyanobacteria-derived nitrogen was substantial. We also expected the settled cyanobacteria with their associated microheterotrophic community and relatively high nitrogen content to increase the isotopic niche area, trophic diversity and dietary divergence between individuals (estimated as the nearest neighbour distance) in the benthic fauna after the bloom. The three surface-feeding species (Monoporeia affinis, Macoma balthica and Marenzelleria arctia) showed significantly lower delta N-15 values after the bloom, while the sub-surface feeder Pontoporeia femorata did not. The effect of the bloom on isotopic niche varied greatly between stations; populations which increased niche area after the bloom had better body condition than populations with reduced niche, regardless of species. Thus, cyanobacterial nitrogen is efficiently integrated into the benthic food webs in the Baltic, with likely consequences for their functioning, secondary production, transfer efficiency, trophic interactions, and intra- and interspecific competition.	[Karlson, Agnes M. L.; Gorokhova, Elena] Stockholm Univ, Dept Appl Environm Sci, S-10691 Stockholm, Sweden; [Gorokhova, Elena; Elmgren, Ragnar] Stockholm Univ, Dept Ecol Environm & Plant Sci, S-10691 Stockholm, Sweden	Stockholm University; Stockholm University	Karlson, AML (corresponding author), Stockholm Univ, Dept Appl Environm Sci, S-10691 Stockholm, Sweden.	agnes.karlsson@itm.su.se	Karlson, Agnes/ABG-3861-2020; Gorokhova, Elena/E-7105-2018; Karlson, Agnes/N-9230-2017	Karlson, Agnes/0000-0001-6493-9533; Gorokhova, Elena/0000-0002-4192-6956; Karlson, Agnes/0000-0001-6493-9533	BEAM (Baltic Ecosystem Adaptive Management); strategic marine research programme of Stockholm University; Swedish Research Council for Environment, Agriculture and Spatial Planning [217-2007-749, 215-2009-813]	BEAM (Baltic Ecosystem Adaptive Management); strategic marine research programme of Stockholm University; Swedish Research Council for Environment, Agriculture and Spatial Planning(Swedish Research Council Formas)	This research was funded by BEAM (Baltic Ecosystem Adaptive Management), the strategic marine research programme of Stockholm University and The Swedish Research Council for Environment, Agriculture and Spatial Planning (Contracts 217-2007-749 to EG and 215-2009-813 to RE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHLGREN G, 1992, J PHYCOL, V28, P37, DOI 10.1111/j.0022-3646.1992.00037.x; Basen T, 2013, CAN J FISH AQUAT SCI, V70, P198, DOI 10.1139/cjfas-2012-0188; Basen T, 2012, OECOLOGIA, V170, P57, DOI 10.1007/s00442-012-2294-z; Blank M, 2008, HELGOLAND MAR RES, V62, P129, DOI 10.1007/s10152-007-0081-8; Brind'Amour A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084198; Byren L, 2006, MAR ECOL PROG SER, V313, P135, DOI 10.3354/meps313135; Darimont CT, 2007, BIOL J LINN SOC, V90, P125, DOI 10.1111/j.1095-8312.2007.00716.x; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; Elmgren R., 1978, KIELER MEERESFORSCH, V4, P1; Fry B., 2006, STABLE ISOTOPE ECOLO; Goedkoop W, 1996, LIMNOL OCEANOGR, V41, P636, DOI 10.4319/lo.1996.41.4.0636; Goedkoop W, 2006, FRESHWATER BIOL, V51, P878, DOI 10.1111/j.1365-2427.2006.01539.x; Goedkoop W, 2007, CAN J FISH AQUAT SCI, V64, P425, DOI 10.1139/F07-016; GOERING J, 1990, ESTUAR COAST SHELF S, V30, P239, DOI 10.1016/0272-7714(90)90050-2; GRAF G, 1992, OCEANOGR MAR BIOL, V30, P149; Hansson S, 1997, ECOLOGY, V78, P2249, DOI 10.2307/2265961; HAYES JM, 1990, ORG GEOCHEM, V16, P1115, DOI 10.1016/0146-6380(90)90147-R; HILL C, 1992, LIMNOL OCEANOGR, V37, P1280, DOI 10.4319/lo.1992.37.6.1280; Jackson AL, 2011, J ANIM ECOL, V80, P595, DOI 10.1111/j.1365-2656.2011.01806.x; Karlson AML, 2011, HARMFUL ALGAE, V12, P77, DOI 10.1016/j.hal.2011.09.003; Karlson AML, 2011, OECOLOGIA, V166, P1055, DOI 10.1007/s00442-011-1936-x; Karlson AML, 2010, ECOLOGY, V91, P1414, DOI 10.1890/09-0660.1; Karlson AML, 2008, LIMNOL OCEANOGR, V53, P2754, DOI 10.4319/lo.2008.53.6.2754; Layman CA, 2007, ECOLOGY, V88, P42, DOI 10.1890/0012-9658(2007)88[42:CSIRPF]2.0.CO;2; Lehtonen KK, 1998, MAR ECOL PROG SER, V168, P71, DOI 10.3354/meps168071; Lesutiene J, 2014, ESTUAR COAST SHELF S, V138, P47, DOI 10.1016/j.ecss.2013.12.017; Levin LA, 1999, MAR ECOL PROG SER, V182, P37, DOI 10.3354/meps182037; Limen H, 2002, MAR BIOL, V140, P733, DOI 10.1007/s00227-001-0739-8; McGoldrick DJ, 2008, CAN J FISH AQUAT SCI, V65, P1983, DOI 10.1139/F08-109; Nascimento FJA, 2009, J EXP MAR BIOL ECOL, V368, P138, DOI 10.1016/j.jembe.2008.09.014; Nascimento FJA, 2008, LIMNOL OCEANOGR, V53, P2636, DOI 10.4319/lo.2008.53.6.2636; Nash Hugh, 1979, ENERGY CONTROVERSY S; Nordstrom M, 2009, MAR ECOL PROG SER, V378, P13, DOI 10.3354/meps07872; Olafsson E, 1997, ESTUAR COAST SHELF S, V45, P149, DOI 10.1006/ecss.1996.0195; Parnell A., 2008, SIAR STABLE ISOTOPE; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Ploug H, 2010, ISME J, V4, P1215, DOI 10.1038/ismej.2010.53; Post DM, 2007, OECOLOGIA, V152, P179, DOI 10.1007/s00442-006-0630-x; R Development Core Team, 2012, R LANG ENV STAT COMP; Raateoja M, 2005, AMBIO, V34, P188, DOI 10.1639/0044-7447(2005)034[0188:RCITSO]2.0.CO;2; Rolff C, 2000, MAR ECOL PROG SER, V203, P47, DOI 10.3354/meps203047; Rolff C, 1998, THESIS STOCKHOLM U S; RUDNICK DT, 1989, MAR ECOL PROG SER, V50, P231, DOI 10.3354/meps050231; Savage C, 2004, ECOL APPL, V14, P517, DOI 10.1890/02-5396; SEGERSTRALE S G, 1973, Commentationes Biologicae Societas Scientiarum Fennica, V67, P1; Suikkanen S, 2007, ESTUAR COAST SHELF S, V71, P580, DOI 10.1016/j.ecss.2006.09.004; Sylvander P, 2013, MICROB ECOL, V65, P566, DOI 10.1007/s00248-012-0156-1; Syvaranta J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056094; Tecchio S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063796; UITTO A, 1991, MAR BIOL, V111, P237, DOI 10.1007/BF01319705; Vehmaa A, 2013, ECOL EVOL, V3, P4548, DOI 10.1002/ece3.839; Walve J, 2007, AQUAT MICROB ECOL, V49, P57, DOI 10.3354/ame01130; Wannicke N, 2013, J MARINE SYST, V117, P1, DOI 10.1016/j.jmarsys.2013.03.005; Wolf N, 2009, FUNCT ECOL, V23, P17, DOI 10.1111/j.1365-2435.2009.01529.x; Zakrisson A, 2014, J PLANKTON RES, V36, P1368, DOI 10.1093/plankt/fbu053	55	21	21	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2014	9	8							e104460	10.1371/journal.pone.0104460	http://dx.doi.org/10.1371/journal.pone.0104460			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR0CG	25105967	Green Submitted, gold, Green Published			2022-12-27	WOS:000343231900060
J	Robb, ML; Shahrezaei, V				Robb, Matthew L.; Shahrezaei, Vahid			Stochastic Cellular Fate Decision Making by Multiple Infecting Lambda Phage	PLOS ONE			English	Article							BACTERIOPHAGE-LAMBDA; GENE-EXPRESSION; DOSAGE COMPENSATION; ESCHERICHIA-COLI; CHEMICAL-REACTIONS; BACTERIAL-VIRUSES; KINETIC-ANALYSIS; NOISE; CELLS; SIMULATION	Bacteriophage lambda is a classic system for the study of cellular decision making. Both experiments and mathematical models have demonstrated the importance of viral concentration in the lysis-lysogeny decision outcome in lambda phage. However, a recent experimental study using single cell and single phage resolution reported that cells with the same viral concentrations but different numbers of infecting phage (multiplicity of infection) can have markedly different rates of lysogeny. Thus the decision depends on not only viral concentration, but also directly on the number of infecting phage. Here, we attempt to provide a mechanistic explanation of these results using a simple stochastic model of the lambda phage genetic network. Several potential factors including intrinsic gene expression noise, spatial dynamics and cell-cycle effects are investigated. We find that interplay between the level of intrinsic noise and viral protein decision threshold is a major factor that produces dependence on multiplicity of infection. However, simulations suggest spatial segregation of phage particles does not play a significant role. Cellular image processing is used to re-analyse the original time-lapse movies from the recent study and it is found that higher numbers of infecting phage reduce the cell elongation rate. This could also contribute to the observed phenomena as cellular growth rate can affect transcription rates. Our model further predicts that rate of lysogeny is dependent on bacterial growth rate, which can be experimentally tested. Our study provides new insight on the mechanisms of individual phage decision making. More generally, our results are relevant for the understanding of gene-dosage compensation in cellular systems.	[Robb, Matthew L.; Shahrezaei, Vahid] Univ London Imperial Coll Sci Technol & Med, Dept Math, London, England	Imperial College London	Shahrezaei, V (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Math, London, England.	v.shahrezaei@imperial.ac.uk		Shahrezaei, Vahid/0000-0002-4013-5458	NERC	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	MLR is supported by a PhD studentship from NERC (http://www.nerc.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acar M, 2010, SCIENCE, V329, P1656, DOI 10.1126/science.1190544; ACKERS GK, 1982, P NATL ACAD SCI-BIOL, V79, P1129, DOI 10.1073/pnas.79.4.1129; Andrews SS, 2004, PHYS BIOL, V1, P137, DOI 10.1088/1478-3967/1/3/001; Arkin A, 1998, GENETICS, V149, P1633; Aurell E, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.051914; Avlund M, 2010, PLOS ONE, V5; Avlund M, 2009, J VIROL, V83, P11416, DOI 10.1128/JVI.01057-09; Balazsi G, 2011, CELL, V144, P910, DOI 10.1016/j.cell.2011.01.030; BETTER M, 1983, VIROLOGY, V126, P168, DOI 10.1016/0042-6822(83)90469-5; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; Cottrell D, 2012, P NATL ACAD SCI USA, V109, P9699, DOI 10.1073/pnas.1201103109; Court DL, 2007, J BACTERIOL, V189, P298, DOI 10.1128/JB.01215-06; Dodd IB, 2005, CURR OPIN GENET DEV, V15, P145, DOI 10.1016/j.gde.2005.02.001; Eden E, 2011, SCIENCE, V331, P764, DOI 10.1126/science.1199784; Edgar R, 2008, MOL MICROBIOL, V68, P1107, DOI 10.1111/j.1365-2958.2008.06205.x; Eldar A, 2010, NATURE, V467, P167, DOI 10.1038/nature09326; Galitski T, 1999, SCIENCE, V285, P251, DOI 10.1126/science.285.5425.251; Gibson MA, 2000, J PHYS CHEM A, V104, P1876, DOI 10.1021/jp993732q; Gilfillan GD, 2006, GENE DEV, V20, P858, DOI 10.1101/gad.1399406; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Golding I, 2011, ANNU REV BIOPHYS, V40, P63, DOI 10.1146/annurev-biophys-042910-155227; Joh RI, 2011, PLOS COMPUTATIONAL B, V7; Johnston IG, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002416; Kalmar T, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000149; Klumpp S, 2009, CELL, V139, P1366, DOI 10.1016/j.cell.2009.12.001; Kobiler O, 2005, P NATL ACAD SCI USA, V102, P4470, DOI 10.1073/pnas.0500670102; KOURILSKY P, 1973, MOL GEN GENET, V122, P183, DOI 10.1007/BF00435190; Kussell E, 2005, SCIENCE, V309, P2075, DOI 10.1126/science.1114383; Liang ST, 1999, J MOL BIOL, V292, P19, DOI 10.1006/jmbi.1999.3056; Little JW, 1999, EMBO J, V18, P4299, DOI 10.1093/emboj/18.15.4299; Marguerat S, 2012, TRENDS GENET, V28, P560, DOI 10.1016/j.tig.2012.07.003; Mehta P, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/2/026005; Milo R, 2010, NUCLEIC ACIDS RES, V38, pD750, DOI 10.1093/nar/gkp889; Morelli MJ, 2009, P NATL ACAD SCI USA, V106, P8101, DOI 10.1073/pnas.0810399106; Oppenheim AB, 2005, ANNU REV GENET, V39, P409, DOI 10.1146/annurev.genet.39.073003.113656; Parua PK, 2010, J GEN VIROL, V91, P306, DOI 10.1099/vir.0.015040-0; Ptashne M, 2004, GENETIC SWITCH PHAGE; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Rothenberg E, 2011, BIOPHYS J, V100, P2875, DOI 10.1016/j.bpj.2011.05.014; Shahrezaei V, 2008, MOL SYST BIOL, V4; Shahrezaei V, 2008, P NATL ACAD SCI USA, V105, P17256, DOI 10.1073/pnas.0803850105; SHEA MA, 1985, J MOL BIOL, V181, P211, DOI 10.1016/0022-2836(85)90086-5; Singh A, 2009, CURR OPIN MICROBIOL, V12, P460, DOI 10.1016/j.mib.2009.06.016; Siso-Nadal F, 2007, BMC SYST BIOL, V1; St-Pierre F, 2008, P NATL ACAD SCI USA, V105, P20705, DOI 10.1073/pnas.0808831105; STEWART FM, 1984, THEOR POPUL BIOL, V26, P93, DOI 10.1016/0040-5809(84)90026-1; Suel GM, 2007, SCIENCE, V315, P1716, DOI 10.1126/science.1137455; Veitia RA, 2013, TRENDS GENET, V29, P385, DOI 10.1016/j.tig.2013.04.004; Weitz JS, 2008, BIOPHYS J, V95, P2673, DOI 10.1529/biophysj.108.133694; Zeng LY, 2010, CELL, V141, P682, DOI 10.1016/j.cell.2010.03.034; Zong C, 2010, MOL SYSTEMS BIOL, V6	51	9	9	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2014	9	8							e103636	10.1371/journal.pone.0103636	http://dx.doi.org/10.1371/journal.pone.0103636			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR0CG	25105971	gold, Green Published, Green Submitted			2022-12-27	WOS:000343231900018
J	Briganti, S; Flori, E; Bellei, B; Picardo, M				Briganti, Stefania; Flori, Enrica; Bellei, Barbara; Picardo, Mauro			Modulation of PPAR gamma Provides New Insights in a Stress Induced Premature Senescence Model	PLOS ONE			English	Article							ACTIVATED RECEPTOR-GAMMA; INDUCED OXIDATIVE DAMAGE; TRANSCRIPTION FACTOR; CELLULAR SENESCENCE; INDUCED APOPTOSIS; SKIN FIBROBLASTS; UVA RADIATION; IN-VITRO; ACID; ULTRAVIOLET	Peroxisome proliferator-activated receptor gamma (PPAR gamma) may be involved in a key mechanism of the skin aging process, influencing several aspects related to the age-related degeneration of skin cells, including antioxidant unbalance. Therefore, we investigated whether the up-modulation of this nuclear receptor exerts a protective effect in a stress-induced premature senescence (SIPS) model based on a single exposure of human dermal fibroblasts to 8-methoxypsoralen plus + ultraviolet-A-irradiation (PUVA). Among possible PPAR gamma modulators, we selected 2,4,6-octatrienoic acid (Octa), a member of the parrodiene family, previously reported to promote melanogenesis and antioxidant defense in normal human melanocytes through a mechanism involving PPAR gamma activation. Exposure to PUVA induced an early and significant decrease in PPAR gamma expression and activity. PPAR gamma up-modulation counteracted the antioxidant imbalance induced by PUVA and reduced the expression of stress response genes with a synergistic increase of different components of the cell antioxidant network, such as catalase and reduced glutathione. PUVA-treated fibroblasts grown in the presence of Octa are partially but significantly rescued from the features of the cellular senescence-like phenotype, such as cytoplasmic enlargement, the expression of senescence-associated-beta-galactosidase, matrix-metalloproteinase-1, and cell cycle proteins. Moreover, the alterations in the cell membrane lipids, such as the decrease in the polyunsaturated fatty acid content of phospholipids and the increase in cholesterol levels, which are typical features of cell aging, were prevented. Our data suggest that PPAR gamma is one of the targets of PUVA-SIPS and that its pharmacological up-modulation may represent a novel therapeutic approach for the photooxidative skin damage.	[Briganti, Stefania; Flori, Enrica; Bellei, Barbara; Picardo, Mauro] Ist Ricovero & Cura Carattere Sci, San Gallicano Dermatol Inst, Lab Cutaneous Physiopathol, Rome, Italy	IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS San Gallicano Dermatological Institute (ISG)	Picardo, M (corresponding author), Ist Ricovero & Cura Carattere Sci, San Gallicano Dermatol Inst, Lab Cutaneous Physiopathol, Rome, Italy.	picardo@ifo.it	Briganti, Stefania/AAY-2136-2021; briganti, stefania/J-3185-2016; Flori, Enrica/H-4417-2014; Bellei, Barbara/K-5288-2016; Picardo, Mauro/A-6978-2011	Briganti, Stefania/0000-0003-2000-006X; briganti, stefania/0000-0003-2000-006X; Flori, Enrica/0000-0002-9275-1041; Bellei, Barbara/0000-0002-3883-5500; Picardo, Mauro/0000-0003-4899-6639	Giuliani Pharma, Milan, Italy	Giuliani Pharma, Milan, Italy	This work has been partly supported by a research grant provided by Giuliani Pharma, Milan, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional funding received for this study.	Afaq F, 2001, J PHOTOCH PHOTOBIO B, V63, P61, DOI 10.1016/S1011-1344(01)00217-2; Andre M, 2003, FEBS LETT, V546, P223, DOI 10.1016/S0014-5793(03)00576-3; Anticoli S, 2010, J CELL PHYSIOL, V222, P586, DOI 10.1002/jcp.21972; Armoni M, 2006, J BIOL CHEM, V281, P19881, DOI 10.1074/jbc.M600320200; BAYREUTHER K, 1992, ARCH GERONTOL GERIAT, P47, DOI 10.1016/S0167-4943(05)80006-8; Berneburg M, 1999, J BIOL CHEM, V274, P15345, DOI 10.1074/jbc.274.22.15345; Brenneisen P, 2002, ANN NY ACAD SCI, V973, P31, DOI 10.1111/j.1749-6632.2002.tb04602.x; Briganti S, 2008, FREE RADICAL BIO MED, V45, P636, DOI 10.1016/j.freeradbiomed.2008.05.006; Briganti S, 2013, EXP DERMATOL, V22, P41, DOI 10.1111/exd.12066; Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200; BRULS WAG, 1984, PHOTOCHEM PHOTOBIOL, V39, P63, DOI 10.1111/j.1751-1097.1984.tb03405.x; Camera E, 2001, J CHROMATOGR B, V757, P69, DOI 10.1016/S0378-4347(01)00081-0; Canton M, 2002, FEBS LETT, V522, P168, DOI 10.1016/S0014-5793(02)02926-5; Chen JH, 2007, NUCLEIC ACIDS RES, V35, P7417, DOI 10.1093/nar/gkm681; Chiba Y, 2005, J GERONTOL A-BIOL, V60, P1087, DOI 10.1093/gerona/60.9.1087; Claiborne A., 1985, CRC HDB METHODS OXYG, P283; CUNNINGHAM M L, 1985, Journal of Free Radicals in Biology and Medicine, V1, P381, DOI 10.1016/0748-5514(85)90150-3; Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; dos Santos DJVA, 2006, BIOPHYS J, V91, P2464, DOI 10.1529/biophysj.105.077156; Dowell P, 2003, J BIOL CHEM, V278, P45485, DOI 10.1074/jbc.M309069200; El-Domyati M, 2002, EXP DERMATOL, V11, P398, DOI 10.1034/j.1600-0625.2002.110502.x; Essers MAG, 2004, EMBO J, V23, P4802, DOI 10.1038/sj.emboj.7600476; Fan WQ, 2007, J BIOL CHEM, V282, P7329, DOI 10.1074/jbc.M610447200; Feingold KR, 2011, DERM-ENDOCRINOL, V3, P113, DOI 10.4161/derm.3.2.14996; Flori E, 2011, PIGM CELL MELANOMA R, V24, P618, DOI 10.1111/j.1755-148X.2011.00887.x; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; Grabacka M, 2008, PIGM CELL MELANOMA R, V21, P388, DOI 10.1111/j.1755-148X.2008.00460.x; Gruber F, 2010, FASEB J, V24, P39, DOI 10.1096/fj.09-133520; Halliday GA, 2005, MUTAT RES-FUND MOL M, V571, P107, DOI 10.1016/j.mrfmmm.2004.09.013; Ham SA, 2013, J INVEST DERMATOL, V133, P2593, DOI 10.1038/jid.2013.202; Hanson KM, 2002, PHOTOCHEM PHOTOBIOL, V76, P57, DOI 10.1562/0031-8655(2002)076<0057:OAQOUI>2.0.CO;2; Herbig U, 2006, SCIENCE, V311, P1257, DOI 10.1126/science.1122446; Herrmann G, 1998, J CELL SCI, V111, P759; Jurzak M, 2008, ACTA POL PHARM, V65, P85; Kim BH, 2003, TOXICOL LETT, V146, P65, DOI 10.1016/j.toxlet.2003.09.001; Koziel R, 2011, J INVEST DERMATOL, V131, P594, DOI 10.1038/jid.2010.383; Kurien BT, 2003, LIFE SCI, V73, P1655, DOI 10.1016/S0024-3205(03)00475-2; Kwak BR, 2002, DRUG NEWS PERSPECT, V15, P325, DOI 10.1358/dnp.2002.15.6.701652; Lee YH, 2010, CELL BIOCHEM FUNCT, V28, P490, DOI 10.1002/cbf.1681; Lehmann JCU, 2007, J INVEST DERMATOL, V127, P835, DOI 10.1038/sj.jid.5700686; Maeda M, 2009, LIFE SCI, V84, P119, DOI 10.1016/j.lfs.2008.11.009; McCarty MF, 2009, MED HYPOTHESES, V72, P29, DOI 10.1016/j.mehy.2008.07.043; McCubrey JA, 2006, ANTIOXID REDOX SIGN, V8, P1775, DOI 10.1089/ars.2006.8.1775; Mongan NP, 2007, DIFFERENTIATION, V75, P853, DOI 10.1111/j.1432-0436.2007.00206.x; Morelli R, 2003, DRUG EXP CLIN RES, V29, P95; Naru E, 2005, BRIT J DERMATOL, V153, P6, DOI 10.1111/j.1365-2133.2005.06964.x; Nejati Reza, 2013, Expert Rev Dermatol, V8, P581; Okuno Y, 2010, ENDOCR J, V57, P303, DOI 10.1507/endocrj.K09E-113; Palozza P, 2011, J NUTR BIOCHEM, V22, P259, DOI 10.1016/j.jnutbio.2010.02.003; Pamplona R, 2008, BBA-BIOENERGETICS, V1777, P1249, DOI 10.1016/j.bbabio.2008.07.003; Park H, 2008, EXP DERMATOL, V17, P829, DOI 10.1111/j.1600-0625.2008.00708.x; Park WY, 2000, J BIOL CHEM, V275, P20847, DOI 10.1074/jbc.M908162199; Picardo M, 1996, J INVEST DERMATOL, V107, P322, DOI 10.1111/1523-1747.ep12363163; Pini E, 2004, DRUG EXP CLIN RES, V30, P203; Pinnell SR, 2003, J AM ACAD DERMATOL, V48, P1, DOI 10.1067/mjd.2003.16; Polvani S, 2012, PPAR RES, V2012, DOI 10.1155/2012/641087; Raval CM, 2012, FREE RADICAL BIO MED, V52, P227, DOI 10.1016/j.freeradbiomed.2011.10.494; Rocchi S, 2001, MOL CELL, V8, P737, DOI 10.1016/S1097-2765(01)00353-7; Saito Y, 2007, FEBS LETT, V581, P4349, DOI 10.1016/j.febslet.2007.08.010; Santamaria AB, 2002, CELL DEATH DIFFER, V9, P549, DOI 10.1038/sj/cdd/4401007; Scharffetter-Kochanek K, 2000, EXP GERONTOL, V35, P307, DOI 10.1016/S0531-5565(00)00098-X; Schroepfer GJ, 2000, PHYSIOL REV, V80, P361, DOI 10.1152/physrev.2000.80.1.361; Shin MH, 2005, J INVEST DERMATOL, V125, P221, DOI 10.1111/j.0022-202X.2005.23823.x; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Slominski Andrzej T, 2012, Adv Anat Embryol Cell Biol, V212, P1; STOCKS J, 1971, BRIT J HAEMATOL, V20, P95, DOI 10.1111/j.1365-2141.1971.tb00790.x; Stradi R, 2001, COMP BIOCHEM PHYS B, V130, P57, DOI 10.1016/S1096-4959(01)00402-X; Suttner DM, 1999, FASEB J, V13, P1800, DOI 10.1096/fasebj.13.13.1800; Tanaka H, 2009, J INVEST DERM SYMP P, V14, P60, DOI 10.1038/jidsymp.2009.2; Thatcher JE, 2009, EXPERT OPIN DRUG MET, V5, P875, DOI 10.1517/17425250903032681; Tian FF, 2011, BIOSCI TRENDS, V5, P23, DOI 10.5582/bst.2011.v5.1.23; Varga T, 2011, BBA-MOL BASIS DIS, V1812, P1007, DOI 10.1016/j.bbadis.2011.02.014; VILE GF, 1995, FREE RADICAL BIO MED, V18, P721, DOI 10.1016/0891-5849(94)00192-M; Wada T, 2008, CELL DEATH DIFFER, V15, P89, DOI 10.1038/sj.cdd.4402222; WALDMAN T, 1995, CANCER RES, V55, P5187; WEISS JS, 1988, J AM ACAD DERMATOL, V19, P169, DOI 10.1016/S0190-9622(88)70161-9; Wenk J, 2001, CURR PROBL DERMATOL, V29, P83; Yasui H, 2003, EXP DERMATOL, V12, P655, DOI 10.1034/j.1600-0625.2003.00033.x; Zhong JL, 2010, PHOTOCH PHOTOBIO SCI, V9, P18, DOI 10.1039/b9pp00068b	80	18	18	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e104045	10.1371/journal.pone.0104045	http://dx.doi.org/10.1371/journal.pone.0104045			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25101957	Green Published, gold, Green Submitted			2022-12-27	WOS:000339993900033
J	Gustine, DD; Barboza, PS; Adams, LG; Wolf, NB				Gustine, David D.; Barboza, Perry S.; Adams, Layne G.; Wolf, Nathan B.			Environmental and Physiological Influences to Isotopic Ratios of N and Protein Status in a Montane Ungulate in Winter	PLOS ONE			English	Article							STABLE-ISOTOPES; MATERNAL CHARACTERISTICS; MILK-PRODUCTION; REPRODUCTIVE ALLOCATION; POPULATION-DYNAMICS; RANGIFER-TARANDUS; WOODLAND CARIBOU; BODY CONDITION; AMINO-ACIDS; BIRTH-DATE	Winter severity can influence large herbivore populations through a reduction in maternal proteins available for reproduction. Nitrogen (N) isotopes in blood fractions can be used to track the use of body proteins in northern and montane ungulates. We studied 113 adult female caribou for 13 years throughout a series of severe winters that reduced population size and offspring mass. After these severe winters, offspring mass increased but the size of the population remained low. We devised a conceptual model for routing of isotopic N in blood in the context of the severe environmental conditions experienced by this population. We measured delta N-15 in three blood fractions and predicted the relative mobilization of dietary and body proteins. The delta N-15 of the body protein pool varied by 4 parts per thousand and 46% of the variance was associated with year. Annual variation in delta N-15 of body protein likely reflected the fall/early winter diet and winter locations, yet 15% of the isotopic variation in amino acid N was due to body proteins. Consistent isotopic differences among blood N pools indicated that animals tolerated fluxes in diet and body stores. Conservation of body protein in caribou is the result of active exchange among diet and body N pools. Adult females were robust to historically severe winter conditions and prioritized body condition and survival over early investment in offspring. For a vagile ungulate residing at low densities in a predator-rich environment, protein restrictions in winter may not be the primary limiting factor for reproduction.	[Gustine, David D.; Adams, Layne G.] US Geol Survey, Alaska Sci Ctr, Anchorage, AK 99508 USA; [Barboza, Perry S.] Univ Alaska Fairbanks, Inst Arctic Biol, Dept Biol & Wildlife, Fairbanks, AK USA; [Wolf, Nathan B.] Univ Alaska Anchorage, Environm & Nat Resources Inst, Anchorage, AK USA	United States Department of the Interior; United States Geological Survey; University of Alaska System; University of Alaska Fairbanks; University of Alaska System; University of Alaska Anchorage	Gustine, DD (corresponding author), US Geol Survey, Alaska Sci Ctr, Anchorage, AK 99508 USA.	dgustine@usgs.gov		Barboza, Perry/0000-0002-1489-6448	United States Geological Survey; National Park Service	United States Geological Survey(United States Geological Survey); National Park Service	This work was funded by the United States Geological Survey and the National Park Service. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LG, 2010, ECOL APPL, V20, P251, DOI 10.1890/08-1437.1; Adams LG, 2005, J MAMMAL, V86, P506, DOI 10.1644/1545-1542(2005)86[506:EOMCAC]2.0.CO;2; ADAMS LG, 1995, J WILDLIFE MANAGE, V59, P584, DOI 10.2307/3802467; Adams LG, 2003, J WILDLIFE MANAGE, V67, P20, DOI 10.2307/3803057; Adams LG, 1998, J WILDLIFE MANAGE, V62, P1184, DOI 10.2307/3801982; Adams LG, 2006, ALASKA PARK SCI, V5, P36; Adams LG, 1995, OCCASIONAL PUBLICATI, P245; ALBON SD, 1987, J ANIM ECOL, V56, P69, DOI 10.2307/4800; Andersen R, 2000, J ANIM ECOL, V69, P672, DOI 10.1046/j.1365-2656.2000.00425.x; Barboza P. S., 2009, INT WILDL NUTR, P350, DOI 10. 1007/978-3-540-87885-8; Barboza PS, 2008, PHYSIOL BIOCHEM ZOOL, V81, P835, DOI 10.1086/590414; Barboza PS, 2006, PHYSIOL BIOCHEM ZOOL, V79, P628, DOI 10.1086/502811; Bardsen BJ, 2008, ECOLOGY, V89, P829, DOI 10.1890/07-0414.1; Bardsen BJ, 2011, OIKOS, V120, P245, DOI 10.1111/j.1600-0706.2010.18597.x; Bartz KK, 2005, ECOSYSTEMS, V8, P529, DOI 10.1007/s10021-005-0064-z; Ben-David M, 2001, ALCES-N AM MOOSE CON, V37, P421; Ben-David M, 2012, J MAMMAL, V93, P399, DOI 10.1644/11-MAMM-S-168.1; BOERTJE RD, 1984, ARCTIC, V37, P161; CHANMCLEOD ACA, 1994, CAN J ZOOL, V72, P938, DOI DOI 10.1139/z94-127; Clutton-Brock T.H., 1991, EVOLUTION PARENTAL C; Clutton-Brock TH., 1982, RED DEER BEHAV ECOLO; Cote SD, 2001, OECOLOGIA, V127, P230, DOI 10.1007/s004420000584; del Rio CM, 2009, BIOL REV, V84, P91, DOI 10.1111/j.1469-185X.2008.00064.x; DRENT RH, 1980, ARDEA, V68, P225; Festa-Bianchet M, 1998, AM NAT, V152, P367, DOI 10.1086/286175; Festa-Bianchet M, 1998, BEHAV ECOL, V9, P144, DOI 10.1093/beheco/9.2.144; Finstad GL, 2011, ARCT ANTARCT ALP RES, V43, P543, DOI 10.1657/1938-4246-43.4.543; Fischer LA, 2005, CAN J ZOOL, V83, P1162, DOI 10.1139/Z05-117; Forchhammer MC, 2002, POPUL ECOL, V44, P113, DOI 10.1007/s101440200013; Gannes LZ, 1997, ECOLOGY, V78, P1271, DOI 10.1890/0012-9658(1997)078[1271:SIIAEA]2.0.CO;2; Graham BS, 2010, ISOSCAPES: UNDERSTANDING MOVEMENT, PATTERN, AND PROCESS ON EARTH THROUGH ISOTOPE MAPPING, P299, DOI 10.1007/978-90-481-3354-3_14; Gustine DD, 2006, J WILDLIFE MANAGE, V70, P1601, DOI 10.2193/0022-541X(2006)70[1601:IRSADS]2.0.CO;2; Gustine DD, 2012, J MAMMAL, V93, P778, DOI 10.1644/11-MAMM-A-164.1; Gustine DD, 2011, J WILDLIFE MANAGE, V75, P178, DOI 10.1002/jwmg.11; Gustine DD, 2010, PHYSIOL BIOCHEM ZOOL, V83, P687, DOI 10.1086/652729; Hamel S, 2010, ECOLOGY, V91, P2034, DOI 10.1890/09-1311.1; Hamel S, 2009, ECOLOGY, V90, P1981, DOI 10.1890/08-0596.1; Hamel S, 2009, OECOLOGIA, V161, P421, DOI 10.1007/s00442-009-1377-y; Helle T, 2008, ECOGRAPHY, V31, P221, DOI 10.1111/j.0906-7590.2008.4912.x; Hilderbrand GV, 1996, CAN J ZOOL, V74, P2080, DOI 10.1139/z96-236; HOBSON KA, 1992, CONDOR, V94, P189, DOI 10.2307/1368808; Hobson KA, 2008, TERR ECOL SER, V2, P1, DOI 10.1016/S1936-7961(07)00001-2; Huber PJ, 2009, WILEY SERIES PROBABI; Joly K, 2007, CAN FIELD NAT, V121, P379, DOI 10.22621/cfn.v121i4.509; Karasov WH., 2007, PHYSL ECOLOGY ANIMAL, P741; Landete-Castillejos T, 2001, J ANIM SCI, V79, P1085; Lecomte N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021357; Lesage L, 2001, OECOLOGIA, V126, P30, DOI 10.1007/s004420000499; Lobley Gerald E., 1994, P147; Martin JGA, 2010, AM NAT, V176, P414, DOI 10.1086/656267; McClelland JW, 2002, ECOLOGY, V83, P2173, DOI 10.1890/0012-9658(2002)083[2173:TRATNI]2.0.CO;2; Milakovic B, 2011, J MAMMAL, V92, P295, DOI 10.1644/10-MAMM-A-038.1; MILLER FL, 1974, J WILDLIFE MANAGE, V38, P47, DOI 10.2307/3800199; Milner JM, 2003, CAN J ZOOL, V81, P1566, DOI [10.1139/z03-152, 10.1139/Z03-152]; Murray K, 2009, ECOLOGY, V90, P348, DOI 10.1890/07-1929.1; Newsome SD, 2010, MAR MAMMAL SCI, V26, P509, DOI 10.1111/j.1748-7692.2009.00354.x; NOLAN JV, 1972, BRIT J NUTR, V27, P177, DOI 10.1079/BJN19720081; O'Brien DM, 2005, PHYSIOL BIOCHEM ZOOL, V78, P819, DOI 10.1086/431191; O'Brien DM, 2002, P NATL ACAD SCI USA, V99, P4413, DOI 10.1073/pnas.072346699; Oftedal O.T., 1985, BIOENERGETICS WILD H, V10, P215; Parker KL, 2009, FUNCT ECOL, V23, P57, DOI 10.1111/j.1365-2435.2009.01528.x; Podlesak DW, 2006, PHYSIOL BIOCHEM ZOOL, V79, P534, DOI 10.1086/502813; Popp BN, 2007, TERR ECOL SER, V1, P173; Quillfeldt P, 2008, MAR BIOL, V155, P593, DOI 10.1007/s00227-008-1048-2; ROBBINS CT, 1981, J WILDLIFE MANAGE, V45, P172, DOI 10.2307/3807885; ROBBINS CT, 1979, AM NAT, V114, P101, DOI 10.1086/283456; Roth JD, 2000, CAN J ZOOL, V78, P848, DOI 10.1139/cjz-78-5-848; Russell DE, 1993, RANGIFER, V8, P1, DOI DOI 10.7557/2.13.5.1057; Stephens PA, 2014, ECOLOGY, V95, P882, DOI 10.1890/13-1434.1; Sweeting CJ, 2007, J EXP MAR BIOL ECOL, V340, P1, DOI 10.1016/j.jembe.2006.07.023; Taillon J, 2013, ECOLOGY, V94, P1815, DOI 10.1890/12-1424.1; Tyler NJC, 2008, ECOLOGY, V89, P1675, DOI 10.1890/07-0416.1; Wang GM, 2006, ECOLOGY, V87, P95, DOI 10.1890/05-0355; Waterlow JC, 1999, NUTR RES REV, V12, P25, DOI 10.1079/095442299108728857; White R.G., 1984, Symposia of the Zoological Society of London, P215; WHITE RG, 1983, OIKOS, V40, P377, DOI 10.2307/3544310; WHITTEN KR, 1995, J WILDLIFE MANAGE, V59, P273, DOI 10.2307/3808940; Zar JH, 1999, BIOSTATISTICAL ANAL	78	5	5	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e103471	10.1371/journal.pone.0103471	http://dx.doi.org/10.1371/journal.pone.0103471			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25102057	Green Submitted, Green Published, gold			2022-12-27	WOS:000339993900019
J	Michaud, L; Lo Giudice, A; Mysara, M; Monsieurs, P; Raffa, C; Leys, N; Amalfitano, S; Van Houdt, R				Michaud, Luigi; Lo Giudice, Angelina; Mysara, Mohamed; Monsieurs, Pieter; Raffa, Carmela; Leys, Natalie; Amalfitano, Stefano; Van Houdt, Rob			Snow Surface Microbiome on the High Antarctic Plateau (DOME C)	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; TARGETED OLIGONUCLEOTIDE PROBES; CATALYZED REPORTER DEPOSITION; GRAM-POSITIVE BACTERIA; DIVERSITY; IDENTIFICATION; MICROORGANISMS; SEQUENCES; COMMUNITY; PROTEOBACTERIA	The cryosphere is an integral part of the global climate system and one of the major habitable ecosystems of Earth's biosphere. These permanently frozen environments harbor diverse, viable and metabolically active microbial populations that represent almost all the major phylogenetic groups. In this study, we investigated the microbial diversity in the surface snow surrounding the Concordia Research Station on the High Antarctic Plateau through a polyphasic approach, including direct prokaryotic quantification by flow cytometry and catalyzed reporter deposition fluorescence in situ hybridization (CARD-FISH), and phylogenetic identification by 16S RNA gene clone library sequencing and 454 16S amplicon pyrosequencing. Although the microbial abundance was low (<10(3) cells/ml of snowmelt), concordant results were obtained with the different techniques. The microbial community was mainly composed of members of the Alpha-proteobacteria class (e.g. Kiloniellaceae and Rhodobacteraceae), which is one of the most well-represented bacterial groups in marine habitats, Bacteroidetes (e.g. Cryomorphaceae and Flavobacteriaceae) and Cyanobacteria. Based on our results, polar microorganisms could not only be considered as deposited airborne particles, but as an active component of the snowpack ecology of the High Antarctic Plateau.	[Michaud, Luigi; Lo Giudice, Angelina; Raffa, Carmela] Univ Messina, Dept Biol & Environm Sci, Messina, Italy; [Mysara, Mohamed; Monsieurs, Pieter; Leys, Natalie; Van Houdt, Rob] Belgian Nucl Res Ctr SCK CEN, Microbiol Unit, Mol, Belgium; [Mysara, Mohamed] Vrije Univ Brussel, Dept Biosci Engn, Brussels, Belgium; [Amalfitano, Stefano] Natl Res Council IRSA CNR, Water Res Inst, Rome, Italy	University of Messina; Belgian Nuclear Research Centre (SCK-CEN); Vrije Universiteit Brussel; Consiglio Nazionale delle Ricerche (CNR); Istituto di Ricerca sulle Acque (IRSA-CNR)	Lo Giudice, A (corresponding author), Univ Messina, Dept Biol & Environm Sci, Messina, Italy.	alogiudice@unime.it	Monsieurs, Pieter/A-2917-2009; Amalfitano, Stefano/C-6737-2012; Mysara, Mohamed/AAH-4242-2019; Monsieurs, Pieter/W-3916-2019; Leys, Natalie M.E.J./P-2761-2017; Van Houdt, Rob/B-8599-2011	Amalfitano, Stefano/0000-0002-6148-1472; Mysara, Mohamed/0000-0001-5746-4330; Monsieurs, Pieter/0000-0003-2214-6652; Van Houdt, Rob/0000-0002-7459-496X	European Space Agency (ESA-PRODEX); EXANAM project [C90359]	European Space Agency (ESA-PRODEX)(European Space Agency); EXANAM project	This work was supported by the European Space Agency (ESA-PRODEX) and the Belgian Science Policy (Belspo) through the EXANAM project (C90359). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aller JY, 2005, J AEROSOL SCI, V36, P801, DOI 10.1016/j.jaerosci.2004.10.012; AMANN RI, 1990, APPL ENVIRON MICROB, V56, P1919, DOI 10.1128/AEM.56.6.1919-1925.1990; Amato P, 2007, FEMS MICROBIOL ECOL, V59, P255, DOI 10.1111/j.1574-6941.2006.00198.x; Amoroso A, 2010, ENVIRON SCI TECHNOL, V44, P714, DOI 10.1021/es9027309; BOTTGER EC, 1990, CLIN CHEM, V36, P1258; Carpenter EJ, 2000, APPL ENVIRON MICROB, V66, P4514, DOI 10.1128/AEM.66.10.4514-4517.2000; Clarke A, 2013, PLOS ONE, V8, P1; Cowan DA, 2011, TRENDS MICROBIOL, V19, P540, DOI 10.1016/j.tim.2011.07.008; Daims H, 1999, SYST APPL MICROBIOL, V22, P434, DOI 10.1016/S0723-2020(99)80053-8; Donachie SP, 2005, INT J SYST EVOL MICR, V55, P1271, DOI 10.1099/ijs.0.63581-0; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Gantner S, 2011, J MICROBIOL METH, V84, P12, DOI 10.1016/j.mimet.2010.10.001; Giovannoni SJ, 2005, NATURE, V437, P343, DOI 10.1038/nature04158; Harding T, 2011, APPL ENVIRON MICROB, V77, P3234, DOI 10.1128/AEM.02611-10; HUGHES MS, 1994, J CLIN MICROBIOL, V32, P2007, DOI 10.1128/JCM.32.8.2007-2008.1994; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Junge K, 2004, APPL ENVIRON MICROB, V70, P550, DOI 10.1128/AEM.70.1.550-557.2004; La Cono V, 2013, ENVIRON MICROBIOL, V15, P1717, DOI 10.1111/1462-2920.12060; Larose C, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/3/035004; Liu YQ, 2006, CHINESE SCI BULL, V51, P1476, DOI 10.1007/s11434-006-1476-7; Liu YQ, 2009, EXTREMOPHILES, V13, P411, DOI 10.1007/s00792-009-0227-5; Lopatina A, 2013, RES MICROBIOL, V164, P949, DOI 10.1016/j.resmic.2013.08.005; Loy A, 2002, APPL ENVIRON MICROB, V68, P5064, DOI 10.1128/AEM.68.10.5064-5081.2002; Loy A, 2007, NUCLEIC ACIDS RES, V35, pD800, DOI 10.1093/nar/gkl856; Lugg D, 1999, ACTA ASTRONAUT, V44, P693, DOI 10.1016/S0094-5765(99)00068-5; MANZ W, 1992, SYST APPL MICROBIOL, V15, P593, DOI 10.1016/S0723-2020(11)80121-9; Manz W, 1996, MICROBIOL-SGM, V142, P1097, DOI 10.1099/13500872-142-5-1097; Margesin R, 2011, RES MICROBIOL, V162, P346, DOI 10.1016/j.resmic.2010.12.004; Meier H, 1999, SYST APPL MICROBIOL, V22, P186, DOI 10.1016/S0723-2020(99)80065-4; Michaud L, 2012, FEMS MICROBIOL ECOL, V82, P391, DOI 10.1111/j.1574-6941.2012.01394.x; Miteva V, 2007, GEOMICROBIOL J, V24, P451, DOI 10.1080/01490450701437693; Miteva Vanya, 2008, P31, DOI 10.1007/978-3-540-74335-4_3; Miteva VI, 2004, APPL ENVIRON MICROB, V70, P202, DOI 10.1128/AEM.70.1.202-213.2004; Neef A, 1997, THESIS MUNICH; Pernthaler A, 2002, APPL ENVIRON MICROB, V68, P3094, DOI 10.1128/AEM.68.6.3094-3101.2002; Pernthaler A, 2002, APPL ENVIRON MICROB, V68, P661, DOI 10.1128/AEM.68.2.661-667.2002; PORTER KG, 1980, LIMNOL OCEANOGR, V25, P943, DOI 10.4319/lo.1980.25.5.0943; Price PB, 2004, P NATL ACAD SCI USA, V101, P4631, DOI 10.1073/pnas.0400522101; Pyne SJ, 2007, SPACE POLICY, V23, P147, DOI 10.1016/j.spacepol.2007.06.006; Quesada A., 2012, ECOLOGY CYANOBACTERI, P387, DOI DOI 10.1007/978-94-007-3855-3_14; ROLLER C, 1994, MICROBIOL-UK, V140, P2849, DOI 10.1099/00221287-140-10-2849; Sattler B, 2001, GEOPHYS RES LETT, V28, P239, DOI 10.1029/2000GL011684; Scanlan DJ, 2009, MICROBIOL MOL BIOL R, V73, P249, DOI 10.1128/MMBR.00035-08; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schonhuber W, 1999, APPL ENVIRON MICROB, V65, P1259; Sowers T, 2001, J GEOPHYS RES-ATMOS, V106, P31903, DOI 10.1029/2000JD900707; Stahl D.A., 1991, NUCL ACID TECHNIQUES, P205; Teira E, 2004, APPL ENVIRON MICROB, V70, P4411, DOI 10.1128/AEM.70.7.4411-4414.2004; Tindall BJ, 2004, MICROB ECOL, V47, P271, DOI 10.1007/s00248-003-1050-7; Van Houdt R, 2013, EXTREMOPHILES, V17, P565, DOI 10.1007/s00792-013-0539-3; Velazquez D, 2011, POLAR BIOL, V34, P1045, DOI 10.1007/s00300-011-0964-7; Vincent Warwick F., 2007, V11; Vincent WF, 2000, ANTARCT SCI, V12, P374, DOI 10.1017/S0954102000000420; WALLNER G, 1993, CYTOMETRY, V14, P136, DOI 10.1002/cyto.990140205; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Yan PY, 2012, EXTREMOPHILES, V16, P345, DOI 10.1007/s00792-012-0434-3; Zhou JZ, 1996, APPL ENVIRON MICROB, V62, P316, DOI 10.1128/AEM.62.2.316-322.1996	60	26	27	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e104505	10.1371/journal.pone.0104505	http://dx.doi.org/10.1371/journal.pone.0104505			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25101779	gold, Green Published, Green Submitted			2022-12-27	WOS:000339993900071
J	Schmid, MR; Anderl, I; Vesala, L; Vanha-aho, LM; Deng, XJ; Ramet, M; Hultmark, D				Schmid, Martin R.; Anderl, Ines; Vesala, Laura; Vanha-aho, Leena-Maija; Deng, Xiao-Juan; Ramet, Mika; Hultmark, Dan			Control of Drosophila Blood Cell Activation via Toll Signaling in the Fat Body	PLOS ONE			English	Article							IMMUNE-RESPONSE; TUMOR-SUPPRESSOR; GENE-EXPRESSION; MELANOGASTER; PATHWAY; HEMATOPOIESIS; HEMOCYTES; PROTEIN; DORSAL; LEPTOPILINA	The Toll signaling pathway, first discovered in Drosophila, has a well-established role in immune responses in insects as well as in mammals. In Drosophila, the Toll-dependent induction of antimicrobial peptide production has been intensely studied as a model for innate immune responses in general. Besides this humoral immune response, Toll signaling is also known to activate blood cells in a reaction that is similar to the cellular immune response to parasite infections, but the mechanisms of this response are poorly understood. Here we have studied this response in detail, and found that Toll signaling in several different tissues can activate a cellular immune defense, and that this response does not require Toll signaling in the blood cells themselves. Like in the humoral immune response, we show that Toll signaling in the fat body (analogous to the liver in vertebrates) is of major importance in the Toll-dependent activation of blood cells. However, this Toll-dependent mechanism of blood cell activation contributes very little to the immune response against the parasitoid wasp, Leptopilina boulardi, probably because the wasp is able to suppress Toll induction. Other redundant pathways may be more important in the defense against this pathogen.	[Schmid, Martin R.; Anderl, Ines; Deng, Xiao-Juan; Hultmark, Dan] Umea Univ, Dept Mol Biol, Umea, Sweden; [Anderl, Ines; Vesala, Laura; Vanha-aho, Leena-Maija; Ramet, Mika; Hultmark, Dan] Univ Tampere, Inst Biomed Technol BioMediTech, FIN-33101 Tampere, Finland; [Deng, Xiao-Juan] South China Agr Univ, Coll Anim Sci, Guangzhou, Guangdong, Peoples R China; [Ramet, Mika] Tampere Univ Hosp, Dept Pediat, Tampere, Finland	Umea University; Tampere University; South China Agricultural University; Tampere University; Tampere University Hospital	Hultmark, D (corresponding author), Umea Univ, Dept Mol Biol, Umea, Sweden.	dan.hultmark@ucmp.umu.se	Hultmark, Dan/C-5058-2013; Schmid, Martin/M-3802-2014	Hultmark, Dan/0000-0002-6506-5855; Vanha-aho, Leena-Maija/0000-0001-7933-7711	Swedish Research Council; Swedish Cancer Society; Sigrid Juselius Foundation; Academy of Finland; Tampere University Hospital	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Academy of Finland(Academy of Finland); Tampere University Hospital	This work was supported by the Swedish Research Council, the Swedish Cancer Society and the Sigrid Juselius Foundation to DH, the Academy of Finland to DH and MR, and Competitive Research Funding of the Tampere University Hospital to MR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres A.J., 1994, DROSOPHILA MELANOGAS, P565; Asha H, 2003, GENETICS, V163, P203; BRAND AH, 1993, DEVELOPMENT, V118, P401; Bulet P, 2005, PROTEIN PEPTIDE LETT, V12, P3, DOI 10.2174/0929866053406011; Colinet D, 2009, DEV COMP IMMUNOL, V33, P681, DOI 10.1016/j.dci.2008.11.013; De Gregorio E, 2002, EMBO J, V21, P2568, DOI 10.1093/emboj/21.11.2568; DUNN OJ, 1961, J AM STAT ASSOC, V56, P52, DOI 10.2307/2282330; ERDELYI M, 1989, GENETICS, V122, P111; Fauvarque MO, 2011, J CELL SCI, V124, P1373, DOI 10.1242/jcs.064592; FEHLBAUM P, 1994, J BIOL CHEM, V269, P33159; Ferrandon D, 1998, EMBO J, V17, P1217, DOI 10.1093/emboj/17.5.1217; GERTTULA S, 1988, GENETICS, V119, P123; Gronke S, 2003, CURR BIOL, V13, P603, DOI 10.1016/S0960-9822(03)00175-1; Gueguen G, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003580; Hedengren M, 1999, MOL CELL, V4, P827, DOI 10.1016/S1097-2765(00)80392-5; Honti V, 2010, MOL IMMUNOL, V47, P1997, DOI 10.1016/j.molimm.2010.04.017; Hultmark D, 2003, CURR OPIN IMMUNOL, V15, P12, DOI 10.1016/S0952-7915(02)00005-5; Imler JL, 2014, DEV COMP IMMUNOL, V42, P3, DOI 10.1016/j.dci.2013.08.018; Irving P, 2005, CELL MICROBIOL, V7, P335, DOI 10.1111/j.1462-5822.2004.00462.x; Kleino A, 2014, DEV COMP IMMUNOL, V42, P25, DOI 10.1016/j.dci.2013.05.014; Kroeger PT, 2012, GENESIS, V50, P41, DOI 10.1002/dvg.20787; Lanot R, 2001, DEV BIOL, V230, P243, DOI 10.1006/dbio.2000.0123; LEMAITRE B, 1995, EMBO J, V14, P536, DOI 10.1002/j.1460-2075.1995.tb07029.x; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Lindsay SA, 2014, DEV COMP IMMUNOL, V42, P16, DOI 10.1016/j.dci.2013.04.011; Markus R, 2009, P NATL ACAD SCI USA, V106, P4805, DOI 10.1073/pnas.0801766106; Maxton-Kuchenmeister J, 1999, MECH DEVELOP, V83, P107, DOI 10.1016/S0925-4773(99)00041-6; Parisi F, 2014, CELL REP, V6, P855, DOI 10.1016/j.celrep.2014.01.039; Pearson AM, 2003, MICROBES INFECT, V5, P815, DOI 10.1016/S1286-4579(03)00157-6; Qiu P, 1998, DEVELOPMENT, V125, P1909; RIZKI TM, 1992, DEV COMP IMMUNOL, V16, P103, DOI 10.1016/0145-305X(92)90011-Z; Ryder E, 2004, GENETICS, V167, P797, DOI 10.1534/genetics.104.026658; Schlenke TA, 2007, PLOS PATHOG, V3, P1486, DOI 10.1371/journal.ppat.0030158; Shia AKH, 2009, J CELL SCI, V122, P4505, DOI 10.1242/jcs.049155; Sinenko SA, 2004, ONCOGENE, V23, P9120, DOI 10.1038/sj.onc.1208156; Sorrentino RP, 2007, DEV BIOL, V311, P311, DOI 10.1016/j.ydbio.2007.08.011; Sorrentino RP, 2004, GENETICS, V166, P1343, DOI 10.1534/genetics.166.3.1343; Tokusumi T, 2009, GENESIS, V47, P771, DOI 10.1002/dvg.20561; Valanne S, 2010, J IMMUNOL, V184, P6188, DOI 10.4049/jimmunol.1000261; Zettervall CJ, 2004, P NATL ACAD SCI USA, V101, P14192, DOI 10.1073/pnas.0403789101	41	48	48	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e102568	10.1371/journal.pone.0102568	http://dx.doi.org/10.1371/journal.pone.0102568			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25102059	Green Submitted, Green Published, gold			2022-12-27	WOS:000339993900003
J	Carreiras, JMB; Jones, J; Lucas, RM; Gabriel, C				Carreiras, Joao M. B.; Jones, Joshua; Lucas, Richard M.; Gabriel, Cristina			Land Use and Land Cover Change Dynamics across the Brazilian Amazon: Insights from Extensive Time-Series Analysis of Remote Sensing Data	PLOS ONE			English	Article							TAPAJOS NATIONAL FOREST; UPPER RIO NEGRO; TROPICAL FOREST; LANDSCAPE DYNAMICS; ABANDONED PASTURES; SECONDARY FORESTS; BIODIVERSITY LOSS; BURN AGRICULTURE; EASTERN AMAZONIA; CARBON-CYCLE	Throughout the Amazon region, the age of forests regenerating on previously deforested land is determined, in part, by the periods of active land use prior to abandonment and the frequency of reclearance of regrowth, both of which can be quantified by comparing time-series of Landsat sensor data. Using these time-series of near annual data from 1973-2011 for an area north of Manaus (in Amazonas state), from 1984-2010 for south of Santarem (Parastate) and 1984-2011 near Machadinho d'Oeste (Rondonia state), the changes in the area of primary forest, non-forest and secondary forest were documented from which the age of regenerating forests, periods of active land use and the frequency of forest reclearance were derived. At Manaus, and at the end of the time-series, over 50% of regenerating forests were older than 16 years, whilst at Santarem and Machadinho d'Oeste, 57% and 41% of forests respectively were aged 6-15 years, with the remainder being mostly younger forests. These differences were attributed to the time since deforestation commenced but also the greater frequencies of reclearance of forests at the latter two sites with short periods of use in the intervening periods. The majority of clearance for agriculture was also found outside of protected areas. The study suggested that a) the history of clearance and land use should be taken into account when protecting deforested land for the purpose of restoring both tree species diversity and biomass through natural regeneration and b) a greater proportion of the forested landscape should be placed under protection, including areas of regrowth.	[Carreiras, Joao M. B.; Gabriel, Cristina] Trop Res Inst IICT, Lisbon, Portugal; [Carreiras, Joao M. B.] Univ Sheffield, Ctr Terr Carbon Dynam, Natl Ctr Earth Observat, Sheffield, S Yorkshire, England; [Jones, Joshua; Lucas, Richard M.] Aberystwyth Univ, Dept Geog & Earth Sci, Aberystwyth, Ceredigion, Wales; [Lucas, Richard M.] Univ New S Wales, Sch Biol Earth & Environm Sci, Ctr Ecosyst Sci, Sydney, NSW, Australia	Universidade de Lisboa; University of Sheffield; Aberystwyth University; University of New South Wales Sydney	Carreiras, JMB (corresponding author), Trop Res Inst IICT, Lisbon, Portugal.	j.carreiras@sheffield.ac.uk	Carreiras, Joao M B/B-4520-2008; Jones, Joshua/U-1494-2017	Carreiras, Joao M B/0000-0003-2737-9420; Jones, Joshua/0000-0001-9047-9147; Lucas, Richard/0000-0003-3010-3302	"REGROWTH-BR - Remote sensing of regenerating tropical forests in Brazil: mapping and retrieving biophysical parameters" project [PTDC/AGR-CFL/114908/2009]; Foundation for Science and Technology (FCT), Portugal; NERC National Centre for Earth Observation [R8/H12/82]; NERC [nceo020005, earth010003] Funding Source: UKRI; Natural Environment Research Council [earth010003, nceo020005] Funding Source: researchfish	"REGROWTH-BR - Remote sensing of regenerating tropical forests in Brazil: mapping and retrieving biophysical parameters" project; Foundation for Science and Technology (FCT), Portugal(Portuguese Foundation for Science and Technology); NERC National Centre for Earth Observation(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This study was supported by the "REGROWTH-BR - Remote sensing of regenerating tropical forests in Brazil: mapping and retrieving biophysical parameters" project (Ref. PTDC/AGR-CFL/114908/2009), funded by the Foundation for Science and Technology (FCT, http://www.fct.pt/index.phtml.en), Portugal. J.M.B. Carreiras' work was partially funded by NERC National Centre for Earth Observation (Ref: R8/H12/82). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard F, 2002, SCIENCE, V297, P999, DOI 10.1126/science.1070656; Batistella Mateus, 2005, Acta Amaz., V35, P239, DOI 10.1590/S0044-59672005000200014; Bierregaard R., 2001, LESSONS AMAZONIA ECO; Brazil INPE (Instituto Nacional de Pesquisas Espaciais), 2013, PROJ PRODES MON FLOR; Brondizio ES, 2012, POPUL ENVIRON, V34, P69, DOI 10.1007/s11111-011-0159-8; BROWN S, 1990, J TROP ECOL, V6, P1, DOI 10.1017/S0266467400003989; BUSCHBACHER R, 1988, J ECOL, V76, P682, DOI 10.2307/2260567; Bacha CJC, 2007, ECOL ECON, V63, P70, DOI 10.1016/j.ecolecon.2006.09.024; Cardille JA, 2003, REMOTE SENS ENVIRON, V87, P551, DOI 10.1016/j.rse.2002.09.001; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Carreiras JMB, 2006, REMOTE SENS ENVIRON, V101, P283, DOI 10.1016/j.rse.2005.12.017; Chander G, 2009, REMOTE SENS ENVIRON, V113, P893, DOI 10.1016/j.rse.2009.01.007; Chazdon RL, 2003, PERSPECT PLANT ECOL, V6, P51, DOI 10.1078/1433-8319-00042; Chazdon RL, 2008, SCIENCE, V320, P1458, DOI 10.1126/science.1155365; Chazdon RL, 2007, PHILOS T R SOC B, V362, P273, DOI 10.1098/rstb.2006.1990; Cochrane MA, 1998, INT J REMOTE SENS, V19, P3433, DOI 10.1080/014311698214109; Davidson EA, 2012, NATURE, V481, P321, DOI 10.1038/nature10717; Espírito-Santo Fernando Del Bon, 2005, Acta Amaz., V35, P155, DOI 10.1590/S0044-59672005000200006; Ewers RM, 2013, ECOL LETT, V16, P1221, DOI 10.1111/ele.12160; Falkowski P, 2000, SCIENCE, V290, P291, DOI 10.1126/science.290.5490.291; Fearnside PM, 2006, ENVIRON MANAGE, V38, P705, DOI 10.1007/s00267-005-0295-y; Fearnside PM, 2005, CONSERV BIOL, V19, P680, DOI 10.1111/j.1523-1739.2005.00697.x; Fearnside PM, 1996, FOREST ECOL MANAG, V80, P21, DOI 10.1016/0378-1127(95)03647-4; Fearnside PM, 2000, CLIMATIC CHANGE, V46, P115, DOI 10.1023/A:1005569915357; Ferraz SFD, 2005, FOREST ECOL MANAG, V204, P67, DOI 10.1016/j.foreco.2004.07.073; Foody GM, 2009, INT J REMOTE SENS, V30, P5273, DOI 10.1080/01431160903130937; Gallego FJ, 2004, INT J REMOTE SENS, V25, P3019, DOI 10.1080/01431160310001619607; Gibson L, 2011, NATURE, V478, P378, DOI 10.1038/nature10425; Goulding M, 2003, SMITHSONIAN ATLAS AM; Hastie T., 2009, UNSUPERVISED LEARNIN; Heimann M, 2008, NATURE, V451, P289, DOI 10.1038/nature06591; Hooper DU, 2012, NATURE, V486, P105, DOI 10.1038/nature11118; Houghton RA, 2005, GLOBAL CHANGE BIOL, V11, P945, DOI 10.1111/j.1365-2486.2005.00955.x; Keller M, 2005, EARTH INTERACT, V9; Kimes DS, 1999, INT J REMOTE SENS, V20, P3625, DOI 10.1080/014311699211246; Kirby KR, 2006, FUTURES, V38, P432, DOI 10.1016/j.futures.2005.07.011; Kuplich TM, 2006, FOREST ECOL MANAG, V234, P1, DOI 10.1016/j.foreco.2006.05.066; Laurance SGW, 2010, J VEG SCI, V21, P96, DOI 10.1111/j.1654-1103.2009.01122.x; Laurance WF, 1999, FOREST ECOL MANAG, V118, P127, DOI 10.1016/S0378-1127(98)00494-0; Laurance WF, 2011, BIOL CONSERV, V144, P56, DOI 10.1016/j.biocon.2010.09.021; Lederer M, 2011, ECOL ECON, V70, P1900, DOI 10.1016/j.ecolecon.2011.02.003; Lillesand T.M., 2000, REMOTE SENSING IMAGE, V4th ed.; Lu DS, 2003, REMOTE SENS ENVIRON, V87, P456, DOI 10.1016/j.rse.2002.06.001; Lucas RM, 2000, INT J REMOTE SENS, V21, P2855, DOI 10.1080/01431160050121285; Lucas RM, 2002, INT J REMOTE SENS, V23, P965, DOI 10.1080/01431160110069791; Lucas RM, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL013375; Mesquita RCG, 2001, J ECOL, V89, P528, DOI 10.1046/j.1365-2745.2001.00583.x; Metzger JP, 2002, LANDSCAPE ECOL, V17, P419, DOI 10.1023/A:1021250306481; Miranda EE, 2013, SUSTENTABILIDADE AGR; Navulur K., 2007, MULTISPECTRAL IMAGE; Neeff T, 2006, ECOSYSTEMS, V9, P609, DOI 10.1007/s10021-006-0001-9; Nepstad DC, 2011, CONSERV BIOL, V25, P1113, DOI 10.1111/j.1523-1739.2011.01784.x; Nepstad DC, 1999, NATURE, V398, P505, DOI 10.1038/19066; Nolte C, 2013, P NATL ACAD SCI USA, V110, P4956, DOI 10.1073/pnas.1214786110; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Pacheco P, 2009, WORLD DEV, V37, P1337, DOI 10.1016/j.worlddev.2008.08.019; Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609; PEREIRA MC, 1993, INT J REMOTE SENS, V14, P2061, DOI 10.1080/01431169308954022; Perz SG, 2003, SOC SCI RES, V32, P25, DOI 10.1016/S0049-089X(02)00012-1; Prates-Clark CD, 2009, CAN J REMOTE SENS, V35, P534; Prates-Clark CC, 2004, THESIS U WALES ABERY; Puyravaud JP, 2003, FOREST ECOL MANAG, V177, P593, DOI 10.1016/S0378-1127(02)00335-3; Raupach MR, 2011, NAT CLIM CHANGE, V1, P148, DOI 10.1038/nclimate1123; Roberts DA, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD000374; Rosa IMD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077231; Saatchi SS, 2007, GLOBAL CHANGE BIOL, V13, P816, DOI 10.1111/j.1365-2486.2007.01323.x; SALDARRIAGA JG, 1988, J ECOL, V76, P938, DOI 10.2307/2260625; Scatena FN, 1996, ECOL ECON, V18, P29, DOI 10.1016/0921-8009(95)00055-0; SCHROEDER PE, 1995, FOREST ECOL MANAG, V75, P87, DOI 10.1016/0378-1127(95)03533-G; Silva JMN, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2011JD016056; Silver WL, 2000, ECOSYSTEMS, V3, P193, DOI 10.1007/s100210000019; STONE TA, 1994, PHOTOGRAMM ENG REM S, V60, P541; TENENBEI.A, 1972, TECHNOMETRICS, V14, P187, DOI 10.2307/1266930; UHL C, 1984, ECOLOGY, V65, P1476, DOI 10.2307/1939128; UHL C, 1981, J ECOL, V69, P631, DOI 10.2307/2259689; UHL C, 1987, J ECOL, V75, P377, DOI 10.2307/2260425; UHL C, 1988, J ECOL, V76, P663, DOI 10.2307/2260566; van Gardingen PR, 2006, FOREST ECOL MANAG, V231, P184, DOI 10.1016/j.foreco.2006.05.047; Vieira ICG, 2003, REMOTE SENS ENVIRON, V87, P470, DOI 10.1016/j.rse.2002.09.002; WALSH TA, 1993, REMOTE SENS ENVIRON, V46, P281, DOI 10.1016/0034-4257(93)90048-3; Zarin DJ, 2001, ECOSYSTEMS, V4, P658, DOI 10.1007/s10021-001-0035-y	81	41	43	1	114	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e104144	10.1371/journal.pone.0104144	http://dx.doi.org/10.1371/journal.pone.0104144			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM6SM	25099362	Green Published, gold, Green Accepted			2022-12-27	WOS:000339995100051
J	Fukushima, M; Jutagate, T; Grudpan, C; Phomikong, P; Nohara, S				Fukushima, Michio; Jutagate, Tuantong; Grudpan, Chaiwut; Phomikong, Pisit; Nohara, Seiichi			Potential Effects of Hydroelectric Dam Development in the Mekong River Basin on the Migration of Siamese Mud Carp (Henicorhynchus siamensis and H-lobatus) Elucidated by Otolith Microchemistry	PLOS ONE			English	Article							WESTSLOPE CUTTHROAT TROUT; DESCRIBE MOVEMENTS; FISH OTOLITHS; CHEMISTRY; WATER; TEMPERATURE; SIGNATURES; STRONTIUM; RESERVOIR; HISTORY	The migration of Siamese mud carp (Henicorhynchus siamensis and H. lobatus), two of the most economically important fish species in the Mekong River, was studied using an otolith microchemistry technique. Fish and river water samples were collected in seven regions throughout the whole basin in Thailand, Laos and Cambodia over a 4 year study period. There was coherence between the elements in the ambient water and on the surface of the otoliths, with strontium (Sr) and barium (Ba) showing the strongest correlation. The partition coefficients were 0.409-0.496 for Sr and 0.055 for Ba. Otolith Sr-Ba profiles indicated extensive synchronized migrations with similar natal origins among individuals within the same region. H. siamensis movement has been severely suppressed in a tributary system where a series of irrigation dams has blocked their migration. H. lobatus collected both below and above the Khone Falls in the mainstream Mekong exhibited statistically different otolith surface elemental signatures but similar core elemental signatures. This result suggests a population originating from a single natal origin but bypassing the waterfalls through a passable side channel where a major hydroelectric dam is planned. The potential effects of damming in the Mekong River are discussed.	[Fukushima, Michio; Nohara, Seiichi] Natl Inst Environm Studies, Tsukuba, Ibaraki, Japan; [Jutagate, Tuantong; Grudpan, Chaiwut; Phomikong, Pisit] Ubon Ratchathani Univ, Fac Agr, Dept Fisheries, Ubon Ratchathani, Thailand	National Institute for Environmental Studies - Japan; Ubon Ratchathani University	Fukushima, M (corresponding author), Natl Inst Environm Studies, Tsukuba, Ibaraki, Japan.	michio@nies.go.jp			Mitsui & Co., Ltd. Environment Fund [R08-B034]; Environment Research and Technology Development Fund of the Ministry of the Environment, Japan [4D-1202]; Royal Golden Jubilee Ph.D. Program of the Thailand Research Fund [Ph.D./0236/2551]	Mitsui & Co., Ltd. Environment Fund; Environment Research and Technology Development Fund of the Ministry of the Environment, Japan(Ministry of the Environment, Japan); Royal Golden Jubilee Ph.D. Program of the Thailand Research Fund(Thailand Research Fund (TRF))	This study was supported by the Mitsui & Co., Ltd. Environment Fund (R08-B034) to MF and TJ, the Environment Research and Technology Development Fund (4D-1202) of the Ministry of the Environment, Japan to MF, and the Royal Golden Jubilee Ph.D. Program of the Thailand Research Fund (Ph.D./0236/2551) to PP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson EAS, 2009, J FISH BIOL, V75, P1371, DOI 10.1111/j.1095-8649.2009.02369.x; Amarasinghe, 2009, STATUS RESERVOIR FIS, P96; [Anonymous], 2004, DISTRIBUTION ECOLOG; Baird Ian G., 2003, Natural History Bulletin of the Siam Society, V51, P5; Baird IG, 1996, CATCH CULTURE MEKONG, V2, P2; Baran E., 2010, ICEM 2010 MEKONG RIV; Baran E., 2001, FISH RESOURCE HYDROB; Baran E., 2006, FISH MIGRATION TRIGG; Baran E., 2005, FISHERIES BIOECOLOGY; Barlow C, 2008, CATCH CULTURE, V14, P16; Barthem R., 1997, CATFISH CONNECTION E; Bunn SE, 2002, ENVIRON MANAGE, V30, P492, DOI 10.1007/s00267-002-2737-0; Campana SE, 1999, MAR ECOL PROG SER, V188, P263, DOI 10.3354/meps188263; Campbell IC, 2009, AQUAT ECOL-SAN DIEGO, P251, DOI 10.1016/B978-0-12-374026-7.00010-3; Chheng P, 2005, BIOL REV IMPORTANT C; Clarke AD, 2007, J APPL ECOL, V44, P1156, DOI 10.1111/j.1365-2664.2007.01350.x; Coghlan SM, 2007, N AM J FISH MANAGE, V27, P531, DOI 10.1577/M06-118.1; Collingsworth PD, 2010, CAN J FISH AQUAT SCI, V67, P1187, DOI 10.1139/F10-050; Crook DA, 2006, RIVER RES APPL, V22, P871, DOI 10.1002/rra.941; Dugan PJ, 2010, AMBIO, V39, P344, DOI 10.1007/s13280-010-0036-1; Elsdon TS, 2008, OCEANOGR MAR BIOL, V46, P297, DOI 10.1201/9781420065756.ch7; Elsdon TS, 2003, MAR ECOL PROG SER, V260, P263, DOI 10.3354/meps260263; Ferguson JW, 2011, ENVIRON MANAGE, V47, P141, DOI 10.1007/s00267-010-9563-6; Fukushima M, 2012, J JAPAN SOC WATER EN, V35, P53; Gibson-Reinemer DK, 2009, CAN J FISH AQUAT SCI, V66, P513, DOI 10.1139/F09-015; Halden NM, 2008, MINERAL MAG, V72, P593, DOI 10.1180/minmag.2008.072.2.593; Hale R, 2008, MAR ECOL PROG SER, V354, P229, DOI 10.3354/meps07251; Hoff GR, 1997, T AM FISH SOC, V126, P488, DOI 10.1577/1548-8659(1997)126<0488:NOMAIV>2.3.CO;2; Hogan Z, 2007, J FISH BIOL, V71, P818, DOI 10.1111/j.1095-8649.2007.01549.x; Hortle KG, 2009, AQUAT ECOL-SAN DIEGO, P197, DOI 10.1016/B978-0-12-374026-7.00009-7; Hurwood DA, 2008, ECOL FRESHW FISH, V17, P272; Jackson D., 2001, DAMS; Jutagat T, 2005, FISHERIES MANAG ECOL, V12, P57, DOI 10.1111/j.1365-2400.2004.00419.x; Jutagate T, 2007, RIVER RES APPL, V23, P87, DOI 10.1002/rra.945; Lamberts D, 2001, FAO REGIONAL OFFICE; Lieng S, 1995, ASIAN FISH, V8, P255; Longerich HP, 1996, J ANAL ATOM SPECTROM, V11, P899, DOI 10.1039/ja9961100899; Martin GB, 2004, CAN J FISH AQUAT SCI, V61, P34, DOI 10.1139/F03-143; Miller JA, 2011, J EXP MAR BIOL ECOL, V405, P42, DOI 10.1016/j.jembe.2011.05.017; Milton DA, 2001, J EXP MAR BIOL ECOL, V264, P47, DOI 10.1016/S0022-0981(01)00301-X; MUGIYA Y, 1995, FISHERIES SCI, V61, P29, DOI 10.2331/fishsci.61.29; Muhlfeld CC, 2005, T AM FISH SOC, V134, P945, DOI 10.1577/T04-029.1; Muhlfeld CC, 2012, CAN J FISH AQUAT SCI, V69, P906, DOI 10.1139/F2012-033; Northcote TG, 1998, FISH MIGRATION AND FISH BYPASSES, P3; Pangle KL, 2010, CAN J FISH AQUAT SCI, V67, P1475, DOI 10.1139/F10-076; Phomikong P, 2014, RIVER RES A IN PRESS; Pongsri C, 2008, 10 DEP FISH; Puangchareon S, 2006, P 44 KAS U ANN C FIS, P21; Rainboth W.J., 1996, FAO SPECIES IDENTIFI; Roberts Tyson R., 1997, Natural History Bulletin of the Siam Society, V45, P171; Roberts Tyson R., 1995, Natural History Bulletin of the Siam Society, V43, P219; Sanchez-Jerez P, 2002, J FISH BIOL, V61, P801, DOI 10.1006/jfbi.2002.2109; Secor DH, 2000, FISH RES, V46, P359, DOI 10.1016/S0165-7836(00)00159-4; Suntornratana U, 2002, MRC C SERIES, P270; Suvarnaraksha A, 2011, J APPL ICHTHYOL, V27, P995, DOI 10.1111/j.1439-0426.2010.01619.x; Termvidchakorn A., 2013, 38 MRC; van Zalinge N., 2004, P 2 INT S MANAGEMENT, V1, P335; Welcomme R.L., 2001, FISHING NEW BOOKS, P358; Wells BK, 2003, T AM FISH SOC, V132, P409, DOI 10.1577/1548-8659(2003)132<0409:RBWOAS>2.0.CO;2; Yen NTH, 2009, J GREAT LAKES RES, V35, P169, DOI 10.1016/j.jglr.2008.11.014; Zimmerman CE, 2009, T AM FISH SOC, V138, P280, DOI 10.1577/T08-044.1	61	23	23	2	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e103722	10.1371/journal.pone.0103722	http://dx.doi.org/10.1371/journal.pone.0103722			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25099147	Green Submitted, gold, Green Published			2022-12-27	WOS:000339995100029
J	Nigro, D; Blanco, A; Anderson, OD; Gadaleta, A				Nigro, Domenica; Blanco, Antonio; Anderson, Olin D.; Gadaleta, Agata			Characterization of Ferredoxin-Dependent Glutamine-Oxoglutarate Amidotransferase (Fd-GOGAT) Genes and Their Relationship with Grain Protein Content QTL in Wheat	PLOS ONE			English	Article							AMMONIUM ASSIMILATION; SYNTHASE; NITROGEN; SYNTHETASE; METABOLISM; QUALITY; PLANTS; PHOTORESPIRATION; PURIFICATION; EXPRESSION	Background: In higher plants, inorganic nitrogen is assimilated via the glutamate synthase cycle or GS-GOGAT pathway. GOGAT enzyme occurs in two distinct forms that use NADH (NADH-GOGAT) or Fd (Fd-GOGAT) as electron carriers. The goal of the present study was to characterize wheat Fd-GOGAT genes and to assess the linkage with grain protein content (GPC), an important quantitative trait controlled by multiple genes. Results: We report the complete genomic sequences of the three homoeologous A, B and D Fd-GOGAT genes from hexaploid wheat (Triticum aestivum) and their localization and characterization. The gene is comprised of 33 exons and 32 introns for all the three homoeologues genes. The three genes show the same exon/intron number and size, with the only exception of a series of indels in intronic regions. The partial sequence of the Fd-GOGAT gene located on A genome was determined in two durum wheat (Triticum turgidum ssp. durum) cvs Ciccio and Svevo, characterized by different grain protein content. Genomic differences allowed the gene mapping in the centromeric region of chromosome 2A. QTL analysis was conducted in the Svevo xCiccio RIL mapping population, previously evaluated in 5 different environments. The study co-localized the Fd-GOGAT-A gene with the marker GWM-339, identifying a significant major QTL for GPC. Conclusions: The wheat Fd-GOGAT genes are highly conserved; both among the three homoeologous hexaploid wheat genes and in comparison with other plants. In durum wheat, an association was shown between the Fd-GOGAT allele of cv Svevo with increasing GPC - potentially useful in breeding programs.	[Nigro, Domenica; Blanco, Antonio; Gadaleta, Agata] Univ Bari Aldo Moro, Sect Genet & Plant Breeding, Dept Soil Plant & Food Sci, Bari, Italy; [Anderson, Olin D.] USDA ARS, Genom & Gene Discovery Res Unit, Western Reg Res Ctr, Albany, CA USA	Universita degli Studi di Bari Aldo Moro; United States Department of Agriculture (USDA)	Gadaleta, A (corresponding author), Univ Bari Aldo Moro, Sect Genet & Plant Breeding, Dept Soil Plant & Food Sci, Bari, Italy.	agata.gadaleta@uniba.it	Gadaleta, Agata/H-2627-2012	Gadaleta, Agata/0000-0002-6312-249X; BLANCO, ANTONIO/0000-0002-2222-1133	Ministero dell'Istruzione, dell'Universita' e della Ricerca ['PON01_01145-ISCOCEM]; USDA Agricultural Research Service	Ministero dell'Istruzione, dell'Universita' e della Ricerca(Ministry of Education, Universities and Research (MIUR)); USDA Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	The research project was supported by grants from Ministero dell'Istruzione, dell'Universita' e della Ricerca, projects 'PON01_01145-ISCOCEM' and 'PRIN-2010-2011, and by USDA Agricultural Research Service. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AVILA C, 1993, PLANTA, V189, P475, DOI 10.1007/BF00198209; Bernard SM, 2008, PLANT MOL BIOL, V67, P89, DOI 10.1007/s11103-008-9303-y; Blanco A, 2006, THEOR APPL GENET, V112, P1195, DOI 10.1007/s00122-006-0221-6; Blanco A, 2012, MOL BREEDING, V30, P79, DOI 10.1007/s11032-011-9600-z; Boisson M, 2005, THEOR APPL GENET, V110, P932, DOI 10.1007/s00122-004-1913-4; Bordes J, 2011, J CEREAL SCI, V54, P137, DOI 10.1016/j.jcs.2011.03.004; Campbell KG, 2001, CROP SCI, V41, P1275, DOI 10.2135/cropsci2001.4141275x; Canovas FM, 2007, J EXP BOT, V58, P2307, DOI 10.1093/jxb/erm051; Coschigano KT, 1998, PLANT CELL, V10, P741, DOI 10.1105/tpc.10.5.741; Endo TR, 1996, J HERED, V87, P295, DOI 10.1093/oxfordjournals.jhered.a023003; Ferrario-Mery S, 2002, PLANTA, V214, P877, DOI 10.1007/s00425-001-0692-2; Ferrario-Mery S, 2002, PLANT SCI, V163, P59, DOI 10.1016/S0168-9452(02)00058-4; Fontaine JX, 2009, THEOR APPL GENET, V119, P645, DOI 10.1007/s00122-009-1076-4; Forde BG, 2007, J EXP BOT, V58, P2339, DOI 10.1093/jxb/erm121; Gadaleta A, 2009, THEOR APPL GENET, V118, P1015, DOI 10.1007/s00122-008-0958-1; Gadaleta A, 2011, FUNCT INTEGR GENOMIC, V11, P665, DOI 10.1007/s10142-011-0235-2; Groos C, 2003, THEOR APPL GENET, V106, P1032, DOI 10.1007/s00122-002-1111-1; Habash DZ, 2007, THEOR APPL GENET, V114, P403, DOI 10.1007/s00122-006-0429-5; Halushka MK, 1999, NAT GENET, V22, P239, DOI 10.1038/10297; JOPPA LR, 1990, CROP SCI, V30, P1059, DOI 10.2135/cropsci1990.0011183X003000050021x; Khan IA, 2000, CROP SCI, V40, P518, DOI 10.2135/cropsci2000.402518x; Kosambi D. D., 1944, ANN EUGENICS, V12, P172; KRAMER T, 1979, EUPHYTICA, V28, P209, DOI 10.1007/BF00056577; Lancien M, 2002, PLANT J, V29, P347, DOI 10.1046/j.1365-313X.2002.01218.x; Lawlor DW, 2002, J EXP BOT, V53, P773, DOI 10.1093/jexbot/53.370.773; Lea PJ, 2003, PLANT PHYSIOL BIOCH, V41, P555, DOI 10.1016/S0981-9428(03)00060-3; LEEGOOD RC, 1995, J EXP BOT, V46, P1397, DOI 10.1093/jxb/46.special_issue.1397; Li HH, 2007, GENETICS, V175, P361, DOI 10.1534/genetics.106.066811; MARQUEZ AJ, 1988, PLANT PHYSIOL BIOCH, V26, P645; Miflin BJ, 1980, BIOCH PLANTS, V5; Nakayama T, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-35; Nigro D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073751; Prasad M, 1999, THEOR APPL GENET, V99, P341, DOI 10.1007/s001220051242; Prasad M, 2003, THEOR APPL GENET, V106, P659, DOI 10.1007/s00122-002-1114-y; Raman R, 2009, MOL BREEDING, V24, P153, DOI 10.1007/s11032-009-9280-0; SAKAKIBARA H, 1992, PLANT CELL PHYSIOL, V33, P49; Sears E. R., 1978, Proceedings of the fifth international wheat genetics symposium. Volume 1. Session IV. Cytogenetics., P389; Sears E. R., 1966, Chromosome manipulations and plant genetics., P29; Sears E.R., 1954, MISSOURI AGR EXPT ST, V572, P1; SHARP PJ, 1988, THEOR APPL GENET, V75, P286, DOI 10.1007/BF00303966; Sun YP, 2010, MOL BREEDING, V26, P493, DOI 10.1007/s11032-010-9390-8; Suprayogi Y, 2009, THEOR APPL GENET, V119, P437, DOI 10.1007/s00122-009-1050-1; Suzuki A, 2005, PHOTOSYNTH RES, V83, P191, DOI 10.1007/s11120-004-3478-0; Tabuchi M, 2007, J EXP BOT, V58, P2319, DOI 10.1093/jxb/erm016; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Till BJ, 2004, NUCLEIC ACIDS RES, V32, P2632, DOI 10.1093/nar/gkh599; Till BJ, 2004, BMC PLANT BIOL, P4; Tobin AK, 2001, J EXP BOT, V52, P591, DOI 10.1093/jexbot/52.356.591; Trepp GB, 1999, PLANT PHYSIOL, V119, P829, DOI 10.1104/pp.119.3.829; Triboi E, 2002, EUR J AGRON, V16, P163, DOI 10.1016/S1161-0301(01)00146-0; Voorrips, 2001, JOINMAP VERSION 3 0; Yaronskaya E, 2006, PLANTA, V224, P700, DOI 10.1007/s00425-006-0249-5; Zanetti S, 2001, PLANT BREEDING, V120, P13, DOI 10.1046/j.1439-0523.2001.00552.x; ZEHNACKER C, 1992, PLANTA, V187, P266, DOI 10.1007/BF00201950; Zhang L, 2008, PLANT SOIL, V303, P55, DOI 10.1007/s11104-007-9442-y	55	27	30	4	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e103869	10.1371/journal.pone.0103869	http://dx.doi.org/10.1371/journal.pone.0103869			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25099972	Green Published, gold, Green Submitted			2022-12-27	WOS:000339995100036
J	Aberg, CH; Haubek, D; Kwamin, F; Johansson, A; Claesson, R				Aberg, Carola Hoglund; Haubek, Dorte; Kwamin, Francis; Johansson, Anders; Claesson, Rolf			Leukotoxic Activity of Aggregatibacter actinomycetemcomitans and Periodontal Attachment Loss	PLOS ONE			English	Article							ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; JP2 CLONE; AGGRESSIVE PERIODONTITIS; LONGITUDINAL COHORT; EXPRESSION; STRAINS; SEROTYPE; GENE; ADOLESCENTS; GENOTYPE	Aggregatibacter actinomycetemcomitans is a Gram-negative periodontitis-associated bacterium that expresses a toxin that selectively affects leukocytes. This leukotoxin is encoded by an operon belonging to the core genome of this bacterial species. Variations in the expression of the leukotoxin have been reported, and a well-characterized specific clonal type (JP2) of this bacterium with enhanced leukotoxin expression has been isolated. In particular, the presence of the JP2 genotype significantly increases the risk for the progression of periodontal attachment loss (AL). Based on these findings we hypothesized that variations in the leukotoxicity are linked to disease progression in infected individuals. In the present study, the leukotoxicity of 239 clinical isolates of A. actinomycetemcomitans was analysed with different bioassays, and the genetic peculiarities of the isolates were related to their leukotoxicity based on examination with molecular techniques. The periodontal status of the individuals sampled for the presence of A. actinomycetemcomitans was examined longitudinally, and the importance of the observed variations in leukotoxicity was evaluated in relation to disease progression. Our data show that high leukotoxicity correlates with an enhanced risk for the progression of AL. The JP2 genotype isolates were all highly leukotoxic, while the isolates with an intact leukotoxin promoter (non-JP2 genotypes) showed substantial variation in leukotoxicity. Genetic characterization of the non-JP2 genotype isolates indicated the presence of highly leukotoxic genotypes of serotype b with similarities to the JP2 genotype. Based on these results, we conclude that A. actinomycetemcomitans harbours other highly virulent genotypes besides the previously described JP2 genotype. In addition, the results from the present study further highlight the importance of the leukotoxin as a key virulence factor in aggressive forms of periodontitis.	[Aberg, Carola Hoglund; Johansson, Anders] Umea Univ, Dept Odontol, Fac Med, Div Mol Periodontol, Umea, Sweden; [Haubek, Dorte] Aarhus Univ, Dept Dent, Sect Pediat Dent, Aarhus, Denmark; [Kwamin, Francis] Univ Ghana, Sch Dent, Accra, Ghana; [Claesson, Rolf] Umea Univ, Dept Odontol, Fac Med, Umea, Sweden	Umea University; Aarhus University; University of Ghana; Umea University	Claesson, R (corresponding author), Umea Univ, Dept Odontol, Fac Med, Umea, Sweden.	rolf.claesson@odont.umu.se			Swedish National Graduate School in Odontological Science; Research Fund (TUA); County of Vasterbotten, Sweden; Swedish Dental Association, Sweden; Ingeborg and Leo Dannins Foundation; Aarhus University Research Foundation [F-2009-SUN-1-57]; Danish Dental Association	Swedish National Graduate School in Odontological Science; Research Fund (TUA); County of Vasterbotten, Sweden; Swedish Dental Association, Sweden; Ingeborg and Leo Dannins Foundation; Aarhus University Research Foundation; Danish Dental Association	This study was supported by the Swedish National Graduate School in Odontological Science, the Research Fund (TUA), County of Vasterbotten, Sweden, the Swedish Dental Association, Sweden, Ingeborg and Leo Dannins Foundation, Aarhus University Research Foundation (F-2009-SUN-1-57), funds from the Danish Dental Association. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg CH, 2014, J CLIN PERIODONTOL, V41, P232, DOI 10.1111/jcpe.12209; Aberg CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065781; Aberg CH, 2012, J PERIODONTOL, V83, P1520, DOI 10.1902/jop.2012.110699; Balashova NV, 2006, INFECT IMMUN, V74, P2015, DOI 10.1128/IAI.74.4.2015-2021.2006; BROGAN JM, 1994, INFECT IMMUN, V62, P501, DOI 10.1128/IAI.62.2.501-508.1994; Claesson R, 2002, J PERIODONTAL RES, V37, P353, DOI 10.1034/j.1600-0765.2002.00365.x; Claesson R, 2011, J CLIN PERIODONTOL, V38, P115, DOI 10.1111/j.1600-051X.2010.01643.x; Dogan B, 1999, ORAL MICROBIOL IMMUN, V14, P98, DOI 10.1034/j.1399-302X.1999.140204.x; Eriksen KT, 2005, MICROBIOL-SGM, V151, P3371, DOI 10.1099/mic.0.28193-0; Feuerbacher LA, 2011, MICROB PATHOGENESIS, V51, P133, DOI 10.1016/j.micpath.2011.04.009; Fine DH, 2007, J CLIN MICROBIOL, V45, P3859, DOI 10.1128/JCM.00653-07; Guthmiller JM, 2001, CRIT REV ORAL BIOL M, V12, P116, DOI 10.1177/10454411010120020201; Haubek D, 1997, J CLIN MICROBIOL, V35, P3037, DOI 10.1128/JCM.35.12.3037-3042.1997; Haubek D, 2008, LANCET, V371, P237, DOI 10.1016/S0140-6736(08)60135-X; Haubek D, 2007, INFECT IMMUN, V75, P3080, DOI 10.1128/IAI.01734-06; Haubek D, 2010, APMIS, V118, P1, DOI 10.1111/j.1600-0463.2010.02665.x; He T, 1998, J PERIODONTOL, V69, P69, DOI 10.1902/jop.1998.69.1.69; He T, 1999, J PERIODONTOL, V70, P1261, DOI 10.1902/jop.1999.70.11.1261; Henderson B, 2010, PERIODONTOL 2000, V54, P78, DOI 10.1111/j.1600-0757.2009.00331.x; Inoue T, 2001, MICROBIOL-SGM, V147, P2749, DOI 10.1099/00221287-147-10-2749; Jentsch H, 2012, CLIN ORAL INVEST, V16, P1589, DOI 10.1007/s00784-012-0672-x; Johansson A, 2000, J PERIODONTAL RES, V35, P85, DOI 10.1034/j.1600-0765.2000.035002085.x; Johansson A, 2011, TOXINS, V3, P242, DOI 10.3390/toxins3030242; Kelk P, 2003, INFECT IMMUN, V71, P4448, DOI 10.1128/IAI.71.8.4448-4455.2003; Kelk P, 2008, INT J MED MICROBIOL, V298, P529, DOI 10.1016/j.ijmm.2007.06.005; Kolodrubetz D, 2003, RES MICROBIOL, V154, P645, DOI 10.1016/j.resmic.2003.09.001; KOLODRUBETZ D, 1989, INFECT IMMUN, V57, P1465, DOI 10.1128/IAI.57.5.1465-1469.1989; Kolodrubetz D, 1996, INFECT IMMUN, V64, P3451, DOI 10.1128/IAI.64.9.3451-3460.1996; KRAIG E, 1990, INFECT IMMUN, V58, P920, DOI 10.1128/IAI.58.4.920-929.1990; LALLY ET, 1989, BIOCHEM BIOPH RES CO, V159, P256, DOI 10.1016/0006-291X(89)92431-5; Macheleidt A, 1999, Clin Oral Investig, V3, P161, DOI 10.1007/s007840050096; Mitchell C, 2003, INFECT IMMUN, V71, P5640, DOI 10.1128/IAI.71.10.5640-5649.2003; Paju S, 1998, J CLIN MICROBIOL, V36, P2019, DOI 10.1128/JCM.36.7.2019-2022.1998; Paju S, 2000, J CLIN MICROBIOL, V38, P79; Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8; Poulsen K, 2003, J CLIN MICROBIOL, V41, P4829, DOI 10.1128/JCM.41.10.4829-4832.2003; Reinholdt J, 2013, BBA-PROTEINS PROTEOM, V1834, P546, DOI 10.1016/j.bbapap.2012.12.004; Repetto G, 2008, NAT PROTOC, V3, P1125, DOI 10.1038/nprot.2008.75; SPITZNAGEL J, 1991, INFECT IMMUN, V59, P1394, DOI 10.1128/IAI.59.4.1394-1401.1991; Van der Velden U, 2006, J CLIN PERIODONTOL, V33, P540, DOI 10.1111/j.1600-051X.2006.00953.x; Yang HW, 2004, J PERIODONTOL, V75, P592, DOI 10.1902/jop.2004.75.4.592; ZAMBON JJ, 1983, INFECT IMMUN, V41, P19, DOI 10.1128/IAI.41.1.19-27.1983	42	42	42	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e104095	10.1371/journal.pone.0104095	http://dx.doi.org/10.1371/journal.pone.0104095			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093857	Green Published, Green Submitted, gold			2022-12-27	WOS:000341357200065
J	Du, J; Sheth, V; He, Q; Carl, M; Chen, J; Corey-Bloom, J; Bydder, GM				Du, Jiang; Sheth, Vipul; He, Qun; Carl, Michael; Chen, Jun; Corey-Bloom, Jody; Bydder, Graeme M.			Measurement of T1 of the Ultrashort T2*Components in White Matter of the Brain at 3T	PLOS ONE			English	Article							MAGNETIZATION-TRANSFER; LONG-T-2 SUPPRESSION; MULTIPLE-SCLEROSIS; MYELIN; T-2; QUANTIFICATION; DESIGN; PULSES; NERVE; MODEL	Recent research demonstrates that white matter of the brain contains not only long T2 components, but a minority of ultrashort T2* components. Adiabatic inversion recovery prepared dual echo ultrashort echo time (IR-dUTE) sequences can be used to selectively image the ultrashort T2* components in white matter of the brain using a clinical whole body scanner. The T2*s of the ultrashort T2* components can be quantified using mono-exponential decay fitting of the IR-dUTE signal at a series of different TEs. However, accurate T1 measurement of the ultrashort T2* components is technically challenging. Efficient suppression of the signal from the majority of long T2 components is essential for robust T1 measurement. In this paper we describe a novel approach to this problem based on the use of IR-dUTE data acquisitions with different TR and TI combinations to selectively detect the signal recovery of the ultrashort T2* components. Exponential recovery curve fitting provides efficient T1 estimation, with minimized contamination from the majority of long T2 components. A rubber phantom and a piece of bovine cortical bone were used for validation of this approach. Six healthy volunteers were studied. An averaged T2* of 0.32 +/- 0.09 ms, and a short mean T1 of 226 +/- 46 ms were demonstrated for the healthy volunteers at 3T.	[Du, Jiang; Sheth, Vipul; He, Qun; Chen, Jun; Bydder, Graeme M.] Univ Calif San Diego, Dept Radiol, San Diego, CA 92103 USA; [Carl, Michael] GE Healthcare, Global Appl Sci Lab, San Diego, CA USA; [Corey-Bloom, Jody] Univ Calif San Diego, Dept Neurosci, San Diego, CA 92103 USA	University of California System; University of California San Diego; General Electric; University of California System; University of California San Diego	Du, J (corresponding author), Univ Calif San Diego, Dept Radiol, San Diego, CA 92103 USA.	jiangdu@ucsd.edu	Du, jiang/J-8286-2014; Sheth, Vipul/GLQ-9648-2022	Du, jiang/0000-0002-9203-2450; Sheth, Vipul/0000-0001-6130-4276	GE Healthcare;  [1R21 AR063894-01A1];  [1R01 AR062581-01A1]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR063894, R01AR062581] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS092650] Funding Source: NIH RePORTER	GE Healthcare(General ElectricGE Healthcare); ; ; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study received grant support from 1R21 AR063894-01A1 and 1R01 AR062581-01A1. GE Healthcare provided support in the form of salaries for author MC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the author contributions section.	BREGER RK, 1989, RADIOLOGY, V171, P273, DOI 10.1148/radiology.171.1.2928538; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Does MD, 2002, MAGNET RESON MED, V47, P274, DOI 10.1002/mrm.10060; Du J, 2007, P 15 ANN M ISMRM BER, P3368; Du J, 2014, NEUROIMAGE, V87, P32, DOI 10.1016/j.neuroimage.2013.10.053; Du J, 2011, MAGN RESON IMAGING, V29, P470, DOI 10.1016/j.mri.2010.11.003; Du JA, 2010, J MAGN RESON, V207, P304, DOI 10.1016/j.jmr.2010.09.013; Du YP, 2007, MAGN RESON MED, V58, P865, DOI 10.1002/mrm.21409; Frohman EM, 2006, NEW ENGL J MED, V354, P942, DOI 10.1056/NEJMra052130; Gareau PJ, 2000, J MAGN RESON IMAGING, V11, P586, DOI 10.1002/1522-2586(200006)11:6<586::AID-JMRI3>3.0.CO;2-V; Gurney PT, 2006, MAGN RESON MED, V55, P575, DOI 10.1002/mrm.20796; Horch RA, 2012, MAGN RESON MED, V68, P1774, DOI 10.1002/mrm.24186; Horch RA, 2011, MAGN RESON MED, V66, P24, DOI 10.1002/mrm.22980; Hwang D, 2010, NEUROIMAGE, V52, P198, DOI 10.1016/j.neuroimage.2010.04.023; Hwang D, 2009, J MAGN RESON IMAGING, V30, P203, DOI 10.1002/jmri.21783; KOENIG SH, 1990, MAGNET RESON MED, V14, P482, DOI 10.1002/mrm.1910140306; Lancaster JL, 2003, J MAGN RESON IMAGING, V17, P1, DOI 10.1002/jmri.10230; Larson PEZ, 2007, MAGN RESON MED, V58, P952, DOI 10.1002/mrm.21341; Larson PEZ, 2006, MAGN RESON MED, V56, P94, DOI 10.1002/mrm.20926; LECAR H, 1971, BIOPHYS J, V11, P140, DOI 10.1016/S0006-3495(71)86203-3; Lu AM, 2008, J MAGN RESON IMAGING, V28, P190, DOI 10.1002/jmri.21396; MACFALL JR, 1987, MAGN RESON IMAGING, V5, P209, DOI 10.1016/0730-725X(87)90022-1; MacKay A, 2006, MAGN RESON IMAGING, V24, P515, DOI 10.1016/j.mri.2005.12.037; MILLER AJ, 1993, MAGN RESON IMAGING, V11, P1051, DOI 10.1016/0730-725X(93)90225-3; Moore GRW, 2000, NEUROLOGY, V55, P1506, DOI 10.1212/WNL.55.10.1506; Nayak KS., 2000, P 8 ANN M ISMRM DENV, P509; Ou XW, 2008, MAGN RESON MED, V59, P835, DOI 10.1002/mrm.21550; Ramani A, 2003, MAGN RESON IMAGING, V21, P1039, DOI 10.1016/S0730-725X(03)00207-8; Reiter DA, 2009, MAGN RESON MED, V61, P803, DOI 10.1002/mrm.21926; Stanisz GJ, 1999, MAGN RESON MED, V42, P1128, DOI 10.1002/(SICI)1522-2594(199912)42:6<1128::AID-MRM18>3.0.CO;2-9; Sussman MS, 1998, MAGNET RESON MED, V40, P890, DOI 10.1002/mrm.1910400615; van der Knaap MS, 2005, MAGNETIC RESONANCE M, P1, DOI DOI 10.1007/3-540-27660-2_1; Waldman A, 2003, NEURORADIOLOGY, V45, P887, DOI 10.1007/s00234-003-1076-z; Whittall KP, 1997, MAGNET RESON MED, V37, P34, DOI 10.1002/mrm.1910370107; Wilhelm MJ, 2012, P NATL ACAD SCI USA, V109, P9605, DOI 10.1073/pnas.1115107109	35	33	36	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e103296	10.1371/journal.pone.0103296	http://dx.doi.org/10.1371/journal.pone.0103296			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093859	Green Published, gold, Green Submitted			2022-12-27	WOS:000341357200020
J	Gersten, M; Zhou, D; Azad, P; Haddad, GG; Subramaniam, S				Gersten, Merril; Zhou, Dan; Azad, Priti; Haddad, Gabriel G.; Subramaniam, Shankar			Wnt Pathway Activation Increases Hypoxia Tolerance during Development	PLOS ONE			English	Article							BETA-CATENIN; GENE-EXPRESSION; EXPERIMENTAL SELECTION; SIGNALING PATHWAYS; DROSOPHILA; NOTCH; ADAPTATION; ONTOLOGY; CELLS; STEM	Adaptation to hypoxia, defined as a condition of inadequate oxygen supply, has enabled humans to successfully colonize high altitude regions. The mechanisms attempted by organisms to cope with short-term hypoxia include increased ATP production via anaerobic respiration and stabilization of Hypoxia Inducible Factor 1 alpha (HIF-1 alpha). However, less is known about the means through which populations adapt to chronic hypoxia during the process of development within a life time or over generations. Here we show that signaling via the highly conserved Wnt pathway impacts the ability of Drosophila melanogaster to complete its life cycle under hypoxia. We identify this pathway through analyses of genome sequencing and gene expression of a Drosophila melanogaster population adapted over >180 generations to tolerate a concentration of 3.5-4% O-2 in air. We then show that genetic activation of the Wnt canonical pathway leads to increased rates of adult eclosion in low O-2. Our results indicate that a previously unsuspected major developmental pathway, Wnt, plays a significant role in hypoxia tolerance.	[Gersten, Merril; Subramaniam, Shankar] Univ Calif San Diego, Bioinformat & Syst Biol Grad Program, La Jolla, CA 92093 USA; [Zhou, Dan; Azad, Priti; Haddad, Gabriel G.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Haddad, Gabriel G.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Haddad, Gabriel G.] Rady Childrens Hosp, San Diego, CA USA; [Subramaniam, Shankar] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Subramaniam, Shankar] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Subramaniam, Shankar] Univ Calif San Diego, Dept Chem, La Jolla, CA 92093 USA; [Subramaniam, Shankar] Univ Calif San Diego, Dept Biochem, La Jolla, CA 92093 USA; [Subramaniam, Shankar] Univ Calif San Diego, Dept Nanoengn, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Rady Childrens Hospital San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Subramaniam, S (corresponding author), Univ Calif San Diego, Bioinformat & Syst Biol Grad Program, La Jolla, CA 92093 USA.	ghaddad@ucsd.edu; shankar@ucsd.edu	Zhou, Dan/T-7203-2017	Azad, Priti/0000-0002-7615-9507; Zhou, Dan/0000-0001-6401-9040	Eunice Kennedy Shriver National Institute of Child Health and Human Development Grant [5P01HD032573]; National Heart, Lung, and Blood Institute [1P01HL098053, 5 R33 HL087375-02]; National Institute of Neurological Disorders and Stroke [5R01NS037756]; American Heart Association [0835188N]; National Science Foundation (NSF) [DBI-0641037]; NSF Collaborative Grant [DBI-0835541]; National Institute of Health/National Institute of General Medical Sciences Grant [GM078005-05]; NSF [STC-0939370]; Div Of Biological Infrastructure [0835541] Funding Source: National Science Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD032573] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R33HL087375, P01HL098053] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037756] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development Grant; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); American Heart Association(American Heart Association); National Science Foundation (NSF)(National Science Foundation (NSF)); NSF Collaborative Grant; National Institute of Health/National Institute of General Medical Sciences Grant; NSF(National Science Foundation (NSF)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by Eunice Kennedy Shriver National Institute of Child Health and Human Development Grant 5P01HD032573 (GGH), National Heart, Lung, and Blood Institute Grant 1P01HL098053 (GGH), National Institute of Neurological Disorders and Stroke Grant 5R01NS037756 (GGH), American Heart Association Award 0835188N (DZ), National Heart, Lung and Blood Institute Grant 5 R33 HL087375-02 (S. S.), National Science Foundation (NSF) Grant DBI-0641037 (S. S.), NSF Collaborative Grant DBI-0835541 (S. S.), National Institute of Health/National Institute of General Medical Sciences Grant GM078005-05 (S. S.), and NSF Collaborative Grant STC-0939370 (S. S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdu U, 2002, CURR BIOL, V12, P1645, DOI 10.1016/S0960-9822(02)01165-X; Affymetrix, 2005, TECHN NOT GUID PROB; Anastas JN, 2013, NAT REV CANCER, V13, P11, DOI 10.1038/nrc3419; Archbold HC, 2011, ACTA PHYSL OXF; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ayyanan A, 2006, P NATL ACAD SCI USA, V103, P3799, DOI 10.1073/pnas.0600065103; Azad P, 2011, FREE RADICAL BIO MED, V51, P530, DOI 10.1016/j.freeradbiomed.2011.05.005; Costello JC, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r97; DasGupta R, 2005, SCIENCE, V308, P826, DOI 10.1126/science.1109374; De Strooper B, 2001, J CELL BIOL, V152, pF17, DOI 10.1083/jcb.152.4.F17; Duffy JB, 2002, GENESIS, V34, P1, DOI 10.1002/gene.10150; Ernst J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-191; Espinosa L, 2003, J BIOL CHEM, V278, P32227, DOI 10.1074/jbc.M304001200; Fauvarque MO, 2011, J CELL SCI, V124, P1373, DOI 10.1242/jcs.064592; Fernandez-Ayala DJM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008549; Flicek P, 2011, NUCLEIC ACIDS RES, V39, pD800, DOI 10.1093/nar/gkq1064; Hayward P, 2005, DEVELOPMENT, V132, P1819, DOI 10.1242/dev.01724; Hayward P, 2008, DEVELOPMENT, V135, P411, DOI 10.1242/dev.000505; Herbst Andreas, 2007, Methods Mol Biol, V361, P63; Hochachka PW, 2001, COMP BIOCHEM PHYS B, V130, P435, DOI 10.1016/S1096-4959(01)00408-0; Hsiao A, 2004, BIOINFORMATICS, V20, P3108, DOI 10.1093/bioinformatics/bth371; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hurlbut GD, 2007, CURR OPIN CELL BIOL, V19, P166, DOI 10.1016/j.ceb.2007.02.012; Irving P, 2005, CELL MICROBIOL, V7, P335, DOI 10.1111/j.1462-5822.2004.00462.x; Kaidi A, 2007, NAT CELL BIOL, V9, P210, DOI 10.1038/ncb1534; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kenneth NS, 2008, BIOCHEM J, V414, P19, DOI 10.1042/BJ20081055; Komiya Yuko, 2008, Organogenesis, V4, P68; Lal A, 2001, JNCI-J NATL CANCER I, V93, P1337, DOI 10.1093/jnci/93.17.1337; Lanot R, 2001, DEV BIOL, V230, P243, DOI 10.1006/dbio.2000.0123; Lawrie DS, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003527; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Liu LA, 2010, CLIN CANCER RES, V16, P2740, DOI 10.1158/1078-0432.CCR-09-2610; Luo JY, 2007, LAB INVEST, V87, P97, DOI 10.1038/labinvest.3700509; Mazumdar J, 2010, NAT CELL BIOL, V12, P1007, DOI 10.1038/ncb2102; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Mi HY, 2009, METHODS MOL BIOL, V563, P123, DOI 10.1007/978-1-60761-175-2_7; Mitani T, 2012, J BIOL CHEM, V287, P33594, DOI 10.1074/jbc.M112.388298; Morin PJ, 1999, BIOESSAYS, V21, P1021, DOI 10.1002/(SICI)1521-1878(199912)22:1<1021::AID-BIES6>3.0.CO;2-P; Munoz-Descalzo S., 2010, FLY AUSTIN, V4; Polakis P, 2000, GENE DEV, V14, P1837; R Core Team, 2012, R LANG ENV STAT COMP; Rademakers SE, 2008, MOL ONCOL, V2, P41, DOI 10.1016/j.molonc.2008.03.006; Ramirez JM, 2007, ANNU REV PHYSIOL, V69, P113, DOI 10.1146/annurev.physiol.69.031905.163111; Rao TP, 2010, CIRC RES, V106, P1798, DOI 10.1161/CIRCRESAHA.110.219840; Rius J, 2008, NATURE, V453, P807, DOI 10.1038/nature06905; Rodilla V, 2009, P NATL ACAD SCI USA, V106, P6315, DOI 10.1073/pnas.0813221106; Scherbakov AM, 2013, EXP CELL RES, V319, P3150, DOI 10.1016/j.yexcr.2013.08.019; Schlessinger K, 2009, GENE DEV, V23, P265, DOI 10.1101/gad.1760809; Scott BA, 2002, SCIENCE, V296, P2388, DOI 10.1126/science.1072302; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Simonson TS, 2010, SCIENCE, V329, P72, DOI 10.1126/science.1189406; Sinenko SA, 2009, DEV CELL, V16, P756, DOI 10.1016/j.devcel.2009.03.003; Streiner DL, 1996, CAN J PSYCHIAT, V41, P498, DOI 10.1177/070674379604100805; Takemaru K. -I., 2008, V186, P261, DOI 10.1007/978-3-540-72843-6_11; Tweedie S, 2009, NUCLEIC ACIDS RES, V37, pD555, DOI 10.1093/nar/gkn788; van Amerongen R, 2009, DEVELOPMENT, V136, P3205, DOI 10.1242/dev.033910; Weidemann A, 2008, CELL DEATH DIFFER, V15, P621, DOI 10.1038/cdd.2008.12; Williams MJ, 2007, J CELL SCI, V120, P502, DOI 10.1242/jcs.03341; Williams MJ, 2006, J CELL SCI, V119, P2015, DOI 10.1242/jcs.02920; Yi X, 2010, SCIENCE, V329, P75, DOI 10.1126/science.1190371; Zhang K, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00005; Zhou D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000490; Zhou D, 2011, P NATL ACAD SCI USA, V108, P2349, DOI 10.1073/pnas.1010643108; Zhou D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000221	67	7	7	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e103292	10.1371/journal.pone.0103292	http://dx.doi.org/10.1371/journal.pone.0103292			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093834	Green Submitted, Green Published, gold			2022-12-27	WOS:000341357200019
J	Kamiya, K; Hori, M; Miyajima, M; Nakajima, M; Suzuki, Y; Kamagata, K; Suzuki, M; Arai, H; Ohtomo, K; Aoki, S				Kamiya, Kouhei; Hori, Masaaki; Miyajima, Masakazu; Nakajima, Madoka; Suzuki, Yuriko; Kamagata, Koji; Suzuki, Michimasa; Arai, Hajime; Ohtomo, Kuni; Aoki, Shigeki			Axon Diameter and Intra-Axonal Volume Fraction of the Corticospinal Tract in Idiopathic Normal Pressure Hydrocephalus Measured by Q-Space Imaging	PLOS ONE			English	Article							DIFFUSION-WEIGHTED MRI; MULTIPLE-SCLEROSIS; ALZHEIMER-DISEASE; PYRAMIDAL TRACT; SPINAL-CORD; TENSOR; TRACTOGRAPHY; MICROSTRUCTURE; MANAGEMENT; DIAGNOSIS	Purpose: Previous studies suggest that compression and stretching of the corticospinal tract (CST) potentially cause treatable gait disturbance in patients with idiopathic normal pressure hydrocephalus (iNPH). Measurement of axon diameter with diffusion MRI has recently been used to investigate microstructural alterations in neurological diseases. In this study, we investigated alterations in the axon diameter and intra-axonal fraction of the CST in iNPH by q-space imaging (QSI) analysis. Methods: Nineteen patients with iNPH and 10 age-matched controls were recruited. QSI data were obtained with a 3-T system by using a single-shot echo planar imaging sequence with the diffusion gradient applied parallel to the anteroposterior axis. By using a two-component low-q fit model, the root mean square displacements of intra-axonal space (= axon diameter) and intra-axonal volume fraction of the CST were calculated at the levels of the internal capsule and body of the lateral ventricle, respectively. Results: Wilcoxon's rank-sum test revealed a significant increase in CST intra-axonal volume fraction at the paraventricular level in patients (p<0.001), whereas no significant difference was observed in the axon diameter. At the level of the internal capsule, neither axon diameter nor intra-axonal volume fraction differed significantly between the two groups. Conclusion: Our results suggest that in patients with iNPH, the CST does not undergo irreversible axonal damage but is rather compressed and/or stretched owing to pressure from the enlarged ventricle. These analyses of axon diameter and intra-axonal fraction yield insights into microstructural alterations of the CST in iNPH.	[Kamiya, Kouhei; Hori, Masaaki; Suzuki, Yuriko; Kamagata, Koji; Suzuki, Michimasa; Aoki, Shigeki] Juntendo Univ Grad Sch Med, Dept Radiol, Tokyo, Japan; [Miyajima, Masakazu; Nakajima, Madoka; Arai, Hajime] Juntendo Univ Grad Sch Med, Dept Neurosurg, Tokyo, Japan; [Suzuki, Yuriko] Philips Elect Japan Ltd, Tokyo, Japan; [Kamiya, Kouhei; Ohtomo, Kuni] Univ Tokyo, Dept Radiol, Grad Sch Med, Tokyo, Japan	Juntendo University; Juntendo University; Philips; University of Tokyo	Kamiya, K (corresponding author), Juntendo Univ Grad Sch Med, Dept Radiol, Tokyo, Japan.	kkamiya-tky@umin.ac.jp	Hori, Masaaki/G-1235-2010; Nakajima, Madoka/AAU-6505-2021	Hori, Masaaki/0000-0002-1791-8032; Kamagata, Koji/0000-0001-5028-218X; Suzuki, Yuriko/0000-0002-4851-7872	Ministry of Health, Labor and Welfare of Japan [2011-Nanchi-018]; Ministry of Education, Science, Sports, and Culture of Japan	Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was partly supported by a Research Grant from the Ministry of Health, Labor and Welfare of Japan (2011-Nanchi-018) and a Grant-in-Aid for Scientific Research on Innovative Areas (Comprehensive Brain Science Network) from the Ministry of Education, Science, Sports, and Culture of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABOITIZ F, 1992, BRAIN RES, V598, P143, DOI 10.1016/0006-8993(92)90178-C; ADAMS RD, 1965, NEW ENGL J MED, V273, P117, DOI 10.1056/NEJM196507152730301; AKAI K, 1987, ACTA PATHOL JAPON, V37, P97; Alexander DC, 2010, NEUROIMAGE, V52, P1374, DOI 10.1016/j.neuroimage.2010.05.043; Assaf Y, 2000, MAGNET RESON MED, V44, P713, DOI 10.1002/1522-2594(200011)44:5<713::AID-MRM9>3.0.CO;2-6; Assaf Y, 2006, AM J NEURORADIOL, V27, P1717; Assaf Y, 2002, MAGNET RESON MED, V47, P115, DOI 10.1002/mrm.10040; Assaf Y, 2008, MAGN RESON MED, V59, P1347, DOI 10.1002/mrm.21577; Assaf Y, 2013, NEUROIMAGE, V80, P273, DOI 10.1016/j.neuroimage.2013.05.055; Bar-Shir A, 2008, J MAGN RESON, V194, P230, DOI 10.1016/j.jmr.2008.07.009; Barazany D., 2011, PROC 19 ANN M ISMRM, P76; BRADLEY WG, 1991, AM J NEURORADIOL, V12, P31; Cluskey S, 2001, J CLIN PATHOL-MOL PA, V54, P386; Cohen Y, 2002, NMR BIOMED, V15, P516, DOI 10.1002/nbm.778; Conturo TE, 2008, J INT NEUROPSYCH SOC, V14, P933, DOI 10.1017/S1355617708081381; DELBIGIO MR, 1993, ACTA NEUROPATHOL, V85, P573, DOI 10.1007/BF00334666; DeLuca GC, 2004, BRAIN, V127, P1009, DOI 10.1093/brain/awh118; DIROCCO C, 1977, J NEUROL SCI, V33, P437, DOI 10.1016/0022-510X(77)90139-3; Dyrby TB, 2013, MAGN RESON MED, V70, P711, DOI 10.1002/mrm.24501; Farrell JAD, 2010, MAGN RESON MED, V63, P1323, DOI 10.1002/mrm.22389; Hakim S, 1976, Surg Neurol, V5, P187; Hattingen E, 2010, NEUROSURGERY, V66, P917, DOI 10.1227/01.NEU.0000367801.35654.EC; Hattori T, 2012, AM J NEURORADIOL, V33, P97, DOI 10.3174/ajnr.A2706; Hattori T, 2011, AM J NEURORADIOL, V32, P1681, DOI 10.3174/ajnr.A2570; Holodny AI, 2005, RADIOLOGY, V234, P649, DOI 10.1148/radiol.2343032087; Hori M, 2012, MAGN RESON MED SCI, V11, P221, DOI 10.2463/mrms.11.221; Inglese M, 2010, NMR BIOMED, V23, P865, DOI 10.1002/nbm.1515; Jang SH, 2011, J NEUROIMAGING, V21, P69, DOI 10.1111/j.1552-6569.2009.00394.x; Jensen JH, 2010, NMR BIOMED, V23, P698, DOI 10.1002/nbm.1518; Jurcoane A, 2013, NEURORADIOLOGY; Kim JS, 2005, NEUROLOGY, V64, P1438, DOI 10.1212/01.WNL.0000158656.09335.E7; Kim MJ, 2011, AM J NEURORADIOL, V32, P1496, DOI 10.3174/ajnr.A2531; Krauss JK, 1996, STROKE, V27, P24, DOI 10.1161/01.STR.27.1.24; Kunimatsu A, 2003, NEURORADIOLOGY, V45, P532, DOI 10.1007/s00234-003-0974-4; LAMANTIA AS, 1990, J COMP NEUROL, V291, P520, DOI 10.1002/cne.902910404; Marmarou A, 2005, J NEUROSURG, V102, P987, DOI 10.3171/jns.2005.102.6.0987; Mayzel-Oreg O, 2007, J NEUROL SCI, V257, P105, DOI 10.1016/j.jns.2007.01.048; McNab JA, 2013, NEUROIMAGE, V80, P234, DOI 10.1016/j.neuroimage.2013.05.074; Meier U, 2006, ACTA NEUROCHIR SUPPL, V96, P377; Mori E, 2012, NEUROL MED-CHIR, V52, P775, DOI 10.2176/nmc.52.775; Morozov D, 2013, NMR BIOMED, V26, P1787, DOI 10.1002/nbm.3018; Nakanishi A, 2013, NEURORADIOLOGY, V55, P971, DOI 10.1007/s00234-013-1201-6; Ong HH, 2010, NEUROIMAGE, V51, P1360, DOI 10.1016/j.neuroimage.2010.03.063; Relkin N, 2005, NEUROSURGERY, V57, P4, DOI 10.1227/01.NEU.0000168185.29659.C5; RITCHIE JM, 1982, PROC R SOC SER B-BIO, V217, P29, DOI 10.1098/rspb.1982.0092; Sasaki M, 2008, NEURORADIOLOGY, V50, P117, DOI 10.1007/s00234-007-0318-x; Schaefer PW, 2000, RADIOLOGY, V217, P331, DOI 10.1148/radiology.217.2.r00nv24331; Scheel M, 2012, ACTA NEUROCHIR, V154, P1699, DOI 10.1007/s00701-012-1377-2; Shemesh N, 2009, J MAGN RESON, V198, P15, DOI 10.1016/j.jmr.2009.01.004; Shizukuishi T, 2013, MAGN RESON MED SCI, V12, P153, DOI 10.2463/mrms.2012-0082; Wu EX, 2010, NMR BIOMED, V23, P836, DOI 10.1002/nbm.1506; Yamada K, 2007, J MAGN RESON IMAGING, V26, P519, DOI 10.1002/jmri.21006; Zolal A, 2012, ACTA NEUROCHIR, V154, P1097, DOI 10.1007/s00701-012-1326-0	53	13	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e103842	10.1371/journal.pone.0103842	http://dx.doi.org/10.1371/journal.pone.0103842			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093733	Green Published, gold, Green Submitted			2022-12-27	WOS:000341357200035
J	Qin, YJ; Chu, KO; Yip, YWY; Li, WY; Yang, YP; Chan, KP; Ren, JL; Chan, SO; Pang, CP				Qin, Yong Jie; Chu, Kai On; Yip, Yolanda Wong Ying; Li, Wai Ying; Yang, Ya Ping; Chan, Kwok Ping; Ren, Jia Lin; Chan, Sun On; Pang, Chi Pui			Green Tea Extract Treatment Alleviates Ocular Inflammation in a Rat Model of Endotoxin-Induced Uveitis	PLOS ONE			English	Article							EPIGALLOCATECHIN GALLATE; SIGNALING PATHWAYS; TNF-ALPHA; EXPRESSION; RECOGNITION; MECHANISMS; CYTOKINES; (-)-EPIGALLOCATECHIN-3-GALLATE; POLYPHENOLS; CATECHINS	Green tea extract (GTE) ingested by rats exerted anti-oxidative activities in various ocular tissues as shown in our previous studies. The present work investigated anti-inflammatory effects of GTE on endotoxin-induced uveitis (EIU). EIU was generated in adult rats by a footpad injection of 1 mg/kg lipopolysaccharide (LPS). Oral administration of GTE (550 mg/kg) was given one, two or four times after LPS injection. Twenty-four hours later, LPS produced severe hyperemia and edema in the iris. Immunocytochemical examinations showed an accumulation of infiltrating cells in the aqueous humor that were immunopositive for cluster of differentiation 43 (CD43) and CD68, markers for leucocytes and macrophages, respectively. Analyses of the aqueous humor showed an increase in pro-inflammatory mediators including tumor necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6) and monocyte chemoattractant protein-1 (MCP-1). GTE treatments improved the clinical manifestations and reduced infiltrating cells and protein exudation in the aqueous humor, which were not observed under half dose of GTE (275 mg/kg). The number of CD68 positive macrophages residing in the iris and ciliary was also reduced. GTE suppressed production of TNF-alpha, IL-6 and MCP-1 in the aqueous humor, which was associated with a down-regulation of LPS receptor complex subunits, Toll-like receptor 4 (TLR-4) and CD14, and suppression of nuclear factor-kappa Bp65 (NF-kappa Bp65) in the iris and ciliary body. Our findings show that GTE is a potent anti-inflammatory agent against the inflammation of EIU, and suggest a potential use in treatment of acute uveitis.	[Qin, Yong Jie; Chu, Kai On; Yip, Yolanda Wong Ying; Li, Wai Ying; Yang, Ya Ping; Chan, Kwok Ping; Pang, Chi Pui] Chinese Univ Hong Kong, Dept Ophthalmol & Visual Sci, Hong Kong, Hong Kong, Peoples R China; [Ren, Jia Lin; Chan, Sun On] Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong	Chan, SO (corresponding author), Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China.	sunonchan@cuhk.edu.hk; cppang@cuhk.edu.hk	Chan, Sun-On/R-6547-2018; Chan, Kwok Ping/E-6044-2016	Chan, Sun-On/0000-0002-3221-3786; Chan, Kwok Ping/0000-0003-2416-1995; Qin, Yong Jie/0000-0003-3117-0865	University Grants Committee Hong Kong, a GRF Grant [CUHK461612]; Lui Che Woo Institute of Innovative Medicine [8303107]; Endowment Fund for Lim Por-Yen Eye Genetics Research Centre, Hong Kong	University Grants Committee Hong Kong, a GRF Grant; Lui Che Woo Institute of Innovative Medicine; Endowment Fund for Lim Por-Yen Eye Genetics Research Centre, Hong Kong	This work was supported in part by a block grant of the University Grants Committee Hong Kong, a GRF Grant (Project No. CUHK461612), a seed grant from Lui Che Woo Institute of Innovative Medicine (Project No. 8303107) and the Endowment Fund for Lim Por-Yen Eye Genetics Research Centre, Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar N, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3368; BHATTACHERJEE P, 1983, INVEST OPHTH VIS SCI, V24, P196; Brito BE, 2004, EXP EYE RES, V79, P203, DOI 10.1016/j.exer.2004.03.012; Byun EH, 2010, J IMMUNOL, V185, P33, DOI 10.4049/jimmunol.0903742; Cavet ME, 2011, MOL VIS, V17, P533; Chertin B, 2003, EUR UROL, V44, P144, DOI 10.1016/S0302-2838(03)00190-8; Chu KO, 2010, J AGR FOOD CHEM, V58, P1523, DOI 10.1021/jf9032602; da Silva PS, 2011, MOL VIS, V17, P1310; de Visser L, 2009, INFECTIOUS UVEITIS N, P148; DEVOS AF, 1994, INVEST OPHTH VIS SCI, V35, P3873; Durrani OM, 2004, BRIT J OPHTHALMOL, V88, P1159, DOI 10.1136/bjo.2003.037226; GREWAL HP, 1994, AM J SURG, V167, P214, DOI 10.1016/0002-9610(94)90076-0; Gritz DC, 2004, OPHTHALMOLOGY, V111, P491, DOI 10.1016/j.ophtha.2003.06.014; Heiligenhaus A, 2010, GRAEF ARCH CLIN EXP, V248, P1531, DOI 10.1007/s00417-010-1485-8; Jimenez-Sainz MC, 2003, MOL PHARMACOL, V64, P773, DOI 10.1124/mol.64.3.773; Kalariya NM, 2011, INVEST OPHTH VIS SCI, V52, P5144, DOI 10.1167/iovs.10-7047; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Koizumi K, 2003, INVEST OPHTH VIS SCI, V44, P2184, DOI 10.1167/iovs.02-0589; Lee FF, 2010, EXPERT OPIN PHARMACO, V11, P1135, DOI 10.1517/14656561003713534; Lee HS, 2011, CORNEA, V30, P1465, DOI 10.1097/ICO.0b013e31821c9b5a; Lin S, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-46; Lin YL, 1997, MOL PHARMACOL, V52, P465, DOI 10.1124/mol.52.3.465; Masukawa Y, 2006, J CHROMATOGR B, V834, P26, DOI 10.1016/j.jchromb.2006.02.008; Nam S, 2001, J BIOL CHEM, V276, P13322, DOI 10.1074/jbc.M004209200; Nguyen QD, 2006, RETINA-J RET VIT DIS, P1; Nguyen QD, 2011, OPHTHALMOLOGY, V118, P184, DOI 10.1016/j.ophtha.2010.03.029; Ohgami K, 2005, INVEST OPHTH VIS SCI, V46, P275, DOI 10.1167/iovs.04-0715; OKUMURA A, 1990, INT OPHTHALMOL, V14, P31, DOI 10.1007/BF00131166; OKUMURA A, 1988, JPN J OPHTHALMOL, V32, P457; Ooi KGJ, 2006, CLIN MED RES, V4, P294, DOI 10.3121/cmr.4.4.294; Piazza M, 2009, J MED CHEM, V52, P1209, DOI 10.1021/jm801333m; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Pooran N, 2003, J CLIN GASTROENTEROL, V37, P263, DOI 10.1097/00004836-200309000-00013; Poulaki V, 2007, FASEB J, V21, P2113, DOI 10.1096/fj.06-7637com; Pouvreau I, 1998, J NEUROIMMUNOL, V86, P171, DOI 10.1016/S0165-5728(98)00042-3; ROSENBAUM JT, 1980, NATURE, V286, P611, DOI 10.1038/286611a0; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Serhan CN, 2010, AM J PATHOL, V177, P1576, DOI 10.2353/ajpath.2010.100322; Siddique SS, 2011, EXPERT OPIN INV DRUG, V20, P1497, DOI 10.1517/13543784.2011.617741; Smith JR, 1998, IMMUNOL CELL BIOL, V76, P497, DOI 10.1046/j.1440-1711.1998.00783.x; Stangl V, 2007, CARDIOVASC RES, V73, P348, DOI 10.1016/j.cardiores.2006.08.022; Su GL, 2002, AM J PHYSIOL-GASTR L, V283, pG256, DOI 10.1152/ajpgi.00550.2001; Suzuki J, 2011, INVEST OPHTH VIS SCI, V52, P6565, DOI 10.1167/iovs.11-7331; Triantafilou M, 2002, TRENDS IMMUNOL, V23, P301, DOI 10.1016/S1471-4906(02)02233-0; Triantafilou M, 2002, J CELL SCI, V115, P2603; Tuaillon N, 2002, INVEST OPHTH VIS SCI, V43, P1493; VANKESSEL KPM, 1991, J IMMUNOL, V147, P3862; Wakefield D, 2010, BRIT J OPHTHALMOL, V94, P271, DOI 10.1136/bjo.2008.146753; Yang XL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029155; Youn HS, 2006, BIOCHEM PHARMACOL, V72, P850, DOI 10.1016/j.bcp.2006.06.021	50	25	27	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e103995	10.1371/journal.pone.0103995	http://dx.doi.org/10.1371/journal.pone.0103995			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093862	Green Submitted, Green Published, gold			2022-12-27	WOS:000341357200056
J	Sang, TT; Cao, Q; Wang, YQ; Liu, F; Chen, SY				Sang, Tiantian; Cao, Qing; Wang, Yuqiang; Liu, Fang; Chen, Shuyan			Overexpression or Silencing of FOXO3a Affects Proliferation of Endothelial Progenitor Cells and Expression of Cell Cycle Regulatory Proteins	PLOS ONE			English	Article							ACTIVATION; INHIBITOR; THERAPY; CANCER; AKT; P27; SENESCENCE; P27(KIP1)	Endothelial dysfunction is involved in the pathogenesis of many cardiovascular diseases such as atherosclerosis. Endothelial progenitor cells (EPCs) have been considered to be of great significance in therapeutic angiogenesis. Furthermore, the Forkhead box O (FOXO) transcription factors are known to be important regulators of cell cycle. Therefore, we investigated the effects of changes in FOXO3a activity on cell proliferation and cell cycle regulatory proteins in EPCs. The constructed recombinant adenovirus vectors Ad-TM (triple mutant)-FOXO3a, Ad-shRNA-FOXO3a and the control Ad-GFP were transfected into EPCs derived from human umbilical cord blood. Assessment of transfection efficiency using an inverted fluorescence microscope and flow cytometry indicated a successful transfection. Additionally, the expression of FOXO3a was markedly increased in the Ad-TM-FOXO3a group but was inhibited in the Ad-shRNA-FOXO3a group as seen by western blotting. Overexpression of FOXO3a suppressed EPC proliferation and modulated expression of the cell cycle regulatory proteins including upregulation of the cell cycle inhibitor p27(kip1) and downregulation of cyclin-dependent kinase 2 (CDK2), cyclin D1 and proliferating cell nuclear antigen (PCNA). In the Ad-shRNA-FOXO3a group, the results were counterproductive. Furthermore, flow cytometry for cell cycle analysis suggested that the active mutant of FOXO3a caused a noticeable increase in G1- and S-phase frequencies, while a decrease was observed after FOXO3a silencing. In conclusion, these data demonstrated that FOXO3a could possibly inhibit EPC proliferation via cell cycle arrest involving upregulation of p27(kip1) and downregulation of CDK2, cyclin D1 and PCNA.	[Sang, Tiantian; Cao, Qing; Wang, Yuqiang; Liu, Fang; Chen, Shuyan] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Gerontol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Liu, F (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Gerontol, Shanghai 200030, Peoples R China.	Fangliucn@163.com; shuyanchencn@hotmail.com	Stefanadis, Christodoulos/ABH-2232-2020; Sang, Tiantian/GPT-0103-2022	Stefanadis, Christodoulos/0000-0001-5974-6454; 	National Natural Science Foundation of China [30973152, 81270205]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (Grant No. 30973152 and 81270205). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asahara T, 1999, CIRC RES, V85, P221, DOI 10.1161/01.RES.85.3.221; Assmus B, 2003, CIRC RES, V92, P1049, DOI 10.1161/01.RES.0000070067.64040.7C; Balestrieri ML, 2013, DIABETOLOGIA, V56, P162, DOI 10.1007/s00125-012-2749-0; Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; Brunet A, 2001, MOL CELL BIOL, V21, P952, DOI 10.1128/MCB.21.3.952-965.2001; Chang EI, 2007, CIRCULATION, V116, P2818, DOI 10.1161/CIRCULATIONAHA.107.715847; Chen SW, 2009, J ELECTRON MATER, V38, P1, DOI 10.1007/s11664-008-0572-7; Chiacchiera F, 2010, CELL CYCLE, V9, P1091, DOI 10.4161/cc.9.6.11035; Chu IM, 2008, NAT REV CANCER, V8, P253, DOI 10.1038/nrc2347; de Keizer PLJ, 2011, ANTIOXID REDOX SIGN, V14, P1093, DOI 10.1089/ars.2010.3403; Fillies T, 2007, ONCOL REP, V17, P355; Griese DP, 2003, CIRCULATION, V108, P2710, DOI 10.1161/01.CIR.0000096490.16596.A6; Jahn SC, 2013, BIOCHEMISTRY; Lau CJ, 2009, CANCER RES, V69, P5433, DOI 10.1158/0008-5472.CAN-08-4540; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Naryzhny SN, 2008, CELL MOL LIFE SCI, V65, P3789, DOI 10.1007/s00018-008-8305-x; Potente M, 2003, J BIOL CHEM, V278, P29619, DOI 10.1074/jbc.M305385200; Santamaria D, 2006, FRONT BIOSCI-LANDMRK, V11, P1164, DOI 10.2741/1871; Skurk C, 2004, J BIOL CHEM, V279, P1513, DOI 10.1074/jbc.M304736200; Tousoulis D, 2008, ATHEROSCLEROSIS, V201, P236, DOI 10.1016/j.atherosclerosis.2008.05.034; TOYOSHIMA H, 1994, CELL, V78, P67, DOI 10.1016/0092-8674(94)90573-8; Urbich C, 2004, CIRC RES, V95, P343, DOI 10.1161/01.RES.0000137877.89448.78; Wang F., 2013, MICROVASC RES; Wang JY, 2009, J CELL PHYSIOL, V219, P617, DOI 10.1002/jcp.21711; Werner N, 2005, NEW ENGL J MED, V353, P999, DOI 10.1056/NEJMoa043814; Zhang SW, 2013, J CELL BIOCHEM, V114, P354, DOI 10.1002/jcb.24371; Zhong S, 2013, CHEM-BIOL INTERACT, V206, P222, DOI 10.1016/j.cbi.2013.09.008; Zhu JH, 2006, J MOL CELL CARDIOL, V40, P648, DOI 10.1016/j.yjmcc.2006.01.011; Zhu SK, 2008, CIRCULATION, V118, P2156, DOI 10.1161/CIRCULATIONAHA.108.787200	29	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e101703	10.1371/journal.pone.0101703	http://dx.doi.org/10.1371/journal.pone.0101703			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093499	Green Published, gold, Green Submitted			2022-12-27	WOS:000341357200005
J	Vecoli, C; Novelli, M; Pippa, A; Giacopelli, D; Beffy, P; Masiello, P; L'Abbate, A; Neglia, D				Vecoli, Cecilia; Novelli, Michela; Pippa, Anna; Giacopelli, Daniela; Beffy, Pascale; Masiello, Pellegrino; L'Abbate, Antonio; Neglia, Danilo			Partial Deletion of eNOS Gene Causes Hyperinsulinemic State, Unbalance of Cardiac Insulin Signaling Pathways and Coronary Dysfunction Independently of High Fat Diet	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; MICE LACKING; ENDOTHELIAL DYSFUNCTION; ARTERY-DISEASE; RESISTANCE; HYPERTENSION; POLYMORPHISM; EXPRESSION; RISK; AKT	Abnormalities in eNOS gene, possibly interacting with high fat diet (HFD), affect peripheral vascular function and glucose metabolism. The relative role of eNOS gene, HFD and metabolic derangement on coronary function has not been fully elucidated. We test whether eNOS gene deficiency per se or in association with HFD modulates coronary function through mechanisms involving molecular pathways related to insulin signaling. Wild type (WT), eNOS(-/-) and eNOS(+/-) mice were studied. WT and eNOS(+/-) mice were fed with either standard or HF diet for 16 weeks and compared with standard diet fed eNOS(-/-). Glucose and insulin tolerance tests were performed during the last week of diet. Coronary resistance (CR) was measured at baseline and during infusions of acetylcholine (Ach) or sodium-nitroprusside (SNP) to evaluate endothelium-dependent or independent vasodilation, in the Langendorff isolated hearts. Cardiac expression of Akt and ERK genes as evaluation of two major insulin-regulated signaling pathways involved in the control of vascular tone were assessed by western blot. HFD-fed mice developed an overt diabetic state. Conversely, chow-fed genetically modified mice (in particular eNOS(-/-)) showed a metabolic pattern characterized by normoglycemia and hyperinsulinemia with a limited degree of insulin resistance. CR was significantly higher in animals with eNOS gene deletions than in WT, independently of diet. Percent decrease in CR, during Ach infusion, was significantly lower in both eNOS(-/-) and eNOS(+/-) mice than in WT, independently of diet. SNP reduced CR in all groups except eNOS(-/-). The cardiac ERK1-2/Akt ratio, increased in animals with eNOS gene deletions compared with WT, independently of diet. These results suggest that the eNOS genetic deficiency, associated or not with HFD, has a relevant effect on coronary vascular function, possibly mediated by increase in blood insulin levels and unbalance in insulin-dependent signaling in coronary vessels, consistent with a shift towards a vasoconstrictive pattern.	[Vecoli, Cecilia; Giacopelli, Daniela; Beffy, Pascale; L'Abbate, Antonio; Neglia, Danilo] Clin CNR, Ist Fisiol, Pisa, Italy; [Novelli, Michela; Masiello, Pellegrino] Univ Pisa, Dipartimento Ric Traslaz & Nuove Tecnol Med & Chi, Pisa, Italy; [Pippa, Anna; L'Abbate, Antonio] Scuola Super Sant Anna, Inst Life Sci, Pisa, Italy; [Neglia, Danilo] Fdn Toscana G Monasterio CNR, Pisa, Italy	University of Pisa; Scuola Superiore Sant'Anna	Neglia, D (corresponding author), Clin CNR, Ist Fisiol, Pisa, Italy.	dneglia@ifc.cnr.it	Vecoli, Cecilia/K-8613-2016; Neglia, Danilo/AAR-6384-2020	Vecoli, Cecilia/0000-0002-5921-3604; Neglia, Danilo/0000-0003-0016-9538	Scuola Superiore Sant'Anna; IFC-CNR	Scuola Superiore Sant'Anna; IFC-CNR(Consiglio Nazionale delle Ricerche (CNR))	Scuola Superiore Sant'Anna and IFC-CNR internal funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cai H, 1999, J MOL MED, V77, P511, DOI 10.1007/s001099900020; Cao J, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00160; Cardillo C, 1999, CIRCULATION, V100, P820, DOI 10.1161/01.CIR.100.8.820; Contreras C, 2011, ATHEROSCLEROSIS, V217, P331, DOI 10.1016/j.atherosclerosis.2011.03.036; Cook S, 2004, DIABETES, V53, P2067, DOI 10.2337/diabetes.53.8.2067; Cook S, 2003, SWISS MED WKLY, V133, P360; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Duplain H, 2001, CIRCULATION, V104, P342, DOI 10.1161/01.CIR.104.3.342; Godecke A, 1998, CIRC RES, V82, P186; HERBERT V, 1965, J CLIN ENDOCR METAB, V25, P1375, DOI 10.1210/jcem-25-10-1375; Hingorani AD, 1999, CIRCULATION, V100, P1515, DOI 10.1161/01.CIR.100.14.1515; Huang PL, 2009, TRENDS ENDOCRIN MET, V20, P295, DOI 10.1016/j.tem.2009.03.005; Huang PL, 2000, J AM SOC NEPHROL, V11, pS120; HUANG PL, 1995, NATURE, V377, P239, DOI 10.1038/377239a0; Kaneko YK, 2013, J PHARMACOL SCI, V123, P295, DOI 10.1254/jphs.13R10CP; Kapur S, 1997, DIABETES, V46, P1691, DOI 10.2337/diabetes.46.11.1691; Kim JA, 2006, CIRCULATION, V113, P1888, DOI 10.1161/CIRCULATIONAHA.105.563213; Kubis N, 2002, J HYPERTENS, V20, P1581, DOI 10.1097/00004872-200208000-00021; Kubis N, 2002, J HYPERTENS, V20, P273, DOI 10.1097/00004872-200202000-00017; L'Abbate A, 2007, AM J PHYSIOL-HEART C, V293, pH3532, DOI 10.1152/ajpheart.00826.2007; Lajoix AD, 2001, DIABETES, V50, P1311, DOI 10.2337/diabetes.50.6.1311; Leuwerke SM, 2002, AM J PHYSIOL-LUNG C, V282, pL1272, DOI 10.1152/ajplung.00490.2001; LUCAS CP, 1985, HYPERTENSION, V7, P702, DOI 10.1161/01.HYP.7.5.702; Mashimo H, 1999, AM J PHYSIOL-GASTR L, V277, pG745, DOI 10.1152/ajpgi.1999.277.4.G745; Matsa LS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070523; Miyamoto Y, 1998, HYPERTENSION, V32, P3, DOI 10.1161/01.HYP.32.1.3; MODAN M, 1985, J CLIN INVEST, V75, P809, DOI 10.1172/JCI111776; Montagnani M, 2001, J BIOL CHEM, V276, P30392, DOI 10.1074/jbc.M103702200; Monti LD, 2003, DIABETES, V52, P1270, DOI 10.2337/diabetes.52.5.1270; Nagareddy PR, 2005, AM J PHYSIOL-HEART C, V289, pH2144, DOI 10.1152/ajpheart.00591.2005; NATHAN C, 1994, CELL, V78, P915, DOI 10.1016/0092-8674(94)90266-6; Niu WQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024266; RADOMSKI MW, 1993, THROMB HAEMOSTASIS, V70, P36; Sartori C, 1999, J HYPERTENS, V17, P1517, DOI 10.1097/00004872-199917110-00003; Scherrer U, 2000, EUR J ENDOCRINOL, V142, P315, DOI 10.1530/eje.0.1420315; Shankar RR, 2000, DIABETES, V49, P684, DOI 10.2337/diabetes.49.5.684; Shesely EG, 1996, P NATL ACAD SCI USA, V93, P13176, DOI 10.1073/pnas.93.23.13176; Shimasaki Y, 1998, J AM COLL CARDIOL, V31, P1506, DOI 10.1016/S0735-1097(98)00167-3; Shoji M, 2000, LIFE SCI, V66, P2557, DOI 10.1016/S0024-3205(00)00589-0; Symons JD, 2009, CIRC RES, V104, P1085, DOI 10.1161/CIRCRESAHA.108.189316; Vecoli C, 2011, J CELL BIOCHEM, V112, P2616, DOI 10.1002/jcb.23188; Vecoli C, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-92; Wang XL, 2006, DIABETES, V55, P2301, DOI 10.2337/db05-1574; Wang XL, 1996, NAT MED, V2, P41, DOI 10.1038/nm0196-41; Wu GY, 2009, BIOFACTORS, V35, P21, DOI 10.1002/biof.3; Zeng GY, 2000, CIRCULATION, V101, P1539, DOI 10.1161/01.CIR.101.13.1539	46	13	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e104156	10.1371/journal.pone.0104156	http://dx.doi.org/10.1371/journal.pone.0104156			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093405	gold, Green Published, Green Submitted			2022-12-27	WOS:000341357200076
J	Xu, J; Barinas-Mitchell, E; Kuller, LH; Youk, AO; Catov, JM				Xu, Jia; Barinas-Mitchell, Emma; Kuller, Lewis H.; Youk, Ada O.; Catov, Janet M.			Maternal Hypertension after a Low-Birth-Weight Delivery Differs by Race/Ethnicity: Evidence from the National Health and Nutrition Examination Survey (NHANES) 1999-2006	PLOS ONE			English	Article							GESTATIONAL-AGE; PRETERM BIRTH; PREGNANCY COMPLICATIONS; RETROSPECTIVE COHORT; FETAL-GROWTH; DISEASE; MORTALITY; RISK	Studies have suggested an increase in maternal morbidity and mortality due to cardiovascular diseases in women with a prior low-birth-weight (LBW, <2,500 grams) delivery. This study evaluated blood pressure and hypertension in women who reported a prior preterm or small-for-gestational-age (SGA) LBW delivery in the National Health and Nutrition Examination Survey 1999-2006 (n = 6,307). This study also aimed to explore if race/ethnicity, menopause status, and years since last pregnancy modified the above associations. A total of 3,239 white, 1,350 black, and 1,718 Hispanics were assessed. Linear regression models were used to evaluate blood pressure by birth characteristics (preterm-LBW, SGA-LBW, and birthweight >= 2,500). Logistic regression models estimated the odds ratios (OR) of hypertension among women who reported a preterm-LBW or SGA-LBW delivery compared with women who reported an infant with birthweight >= 2,500 at delivery. Overall, there was a positive association between a preterm-LBW delivery and hypertension (adjusted OR = 1.39, 95% confidence interval (CI) 1.02-1.90). Prior SGA-LBW also increased the odds of hypertension, but the estimate did not reach statistical significance (adjusted OR = 1.21, 95% CI 0.76-1.92). Race/ethnicity modified the above associations. Only black women had increased risk of hypertension following SGA-LBW delivery (adjusted OR = 2.09, 95% CI 1.12-3.90). Black women were at marginally increased risk of hypertension after delivery of a preterm-LBW (adjusted OR = 1.49, 95% CI 0.93-2.38). Whites and Hispanics had increased, but not statistically significant, risk of hypertension after a preterm-LBW (whites: adjusted OR = 1.39, 95% CI 0.92-2.10; Hispanics: adjusted OR = 1.22, 95% CI 0.62-2.38). Stratified analysis indicated that the associations were stronger among women who were premenopausal and whose last pregnancy were more recent. The current study suggests that in a representative United States population, women with a history of preterm- or SGA-LBW deliveries have increased odds of hypertension and this risk appears to be higher for black women and younger women.	[Xu, Jia; Barinas-Mitchell, Emma; Kuller, Lewis H.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA USA; [Youk, Ada O.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Biostat, Pittsburgh, PA 15261 USA; [Catov, Janet M.] Univ Pittsburgh, Dept OB GYN, Pittsburgh, PA 15260 USA; [Catov, Janet M.] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Catov, JM (corresponding author), Univ Pittsburgh, Dept OB GYN, Pittsburgh, PA 15260 USA.	catovjm@mail.magee.edu		Youk, Ada/0000-0001-6912-9759; Barinas-Mitchell, Emma/0000-0002-7280-7781	National Institutes of Health's National Institute of Child Health and Human Development Building Interdisciplinary Research Careers in Women's Health (BIRCWH) Award [5K12 HD43441-09]; Women and Infant Study of Healthy Hearts (WISH) Fetal Growth Restriction and Maternal Cardiovascular Risk Grant [RO1HL76532-01A1]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD043441] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076532] Funding Source: NIH RePORTER	National Institutes of Health's National Institute of Child Health and Human Development Building Interdisciplinary Research Careers in Women's Health (BIRCWH) Award; Women and Infant Study of Healthy Hearts (WISH) Fetal Growth Restriction and Maternal Cardiovascular Risk Grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work is supported by The National Institutes of Health's National Institute of Child Health and Human Development Building Interdisciplinary Research Careers in Women's Health (BIRCWH) Award Grant 5K12 HD43441-09, and Women and Infant Study of Healthy Hearts (WISH) Fetal Growth Restriction and Maternal Cardiovascular Risk Grant RO1HL76532-01A1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adegboye ARA, 2008, BJOG-INT J OBSTET GY, V115, P886, DOI 10.1111/j.1471-0528.2008.01717.x; Ananth CV, 2008, CLIN PERINATOL, V35, P53, DOI 10.1016/j.clp.2007.11.001; Axt R., 1999, Clinical and Experimental Obstetrics and Gynecology, V26, P195; Bonamy AKE, 2011, CIRCULATION, V124, P2839, DOI 10.1161/CIRCULATIONAHA.111.034884; Brodsky Dara, 2004, J Intensive Care Med, V19, P307, DOI 10.1177/0885066604269663; Bukowski R, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0033047, 10.1371/journal.pone.0047149]; Catov JM, 2008, OBSTET GYNECOL, V112, P290, DOI 10.1097/AOG.0b013e31817f589b; Catov JM, 2007, INT J EPIDEMIOL, V36, P412, DOI 10.1093/ije/dyl271; Catov JM, 2011, OBSTET GYNECOL, V117, P225, DOI 10.1097/AOG.0b013e3182075626; Catov JM, 2010, ANN EPIDEMIOL, V20, P604, DOI 10.1016/j.annepidem.2010.05.007; Chaturvedi S, 2004, NATL MED J INDIA, V17, P227; Curtin Lester R, 2012, Vital Health Stat 2, P1; Egan BM, 2010, JAMA-J AM MED ASSOC, V303, P2043, DOI 10.1001/jama.2010.650; GIBBS RS, 1992, AM J OBSTET GYNECOL, V166, P1515, DOI 10.1016/0002-9378(92)91628-N; Goldenberg RL, 2000, NEW ENGL J MED, V342, P1500, DOI 10.1056/NEJM200005183422007; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Goldman N, 2003, J CLIN EPIDEMIOL, V56, P148, DOI 10.1016/S0895-4356(02)00580-2; HADLOCK FP, 1991, RADIOLOGY, V181, P129, DOI 10.1148/radiology.181.1.1887021; Hall WD, 1997, AM J MED SCI, V313, P195, DOI 10.1097/00000441-199704000-00002; Hamilton BE, 2013, PEDIATRICS, V131, P548, DOI 10.1542/peds.2012-3769; Hastie CE, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.06.080; Hauck FR, 2011, SEMIN PERINATOL, V35, P209, DOI 10.1053/j.semperi.2011.02.018; Klein RJ, 2001, HLTH PEOPLE 2010 STA, V20, P1; Lin CC, 1998, OBSTET GYNECOL, V92, P1044, DOI 10.1016/S0029-7844(98)00328-7; Magnussen EB, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2011.02.016; Martin Joyce A, 2010, Natl Vital Stat Rep, V59, P3; PANETH NS, 1995, FUTURE CHILD, V5, P19, DOI 10.2307/1602505; Pell JP, 2004, AM J EPIDEMIOL, V159, P336, DOI 10.1093/aje/kwh064; RAO JNK, 1984, ANN STAT, V12, P46, DOI 10.1214/aos/1176346391; Rich-Edwards JW, 2014, EPIDEMIOL REV, V36, P57, DOI 10.1093/epirev/mxt006; Romero R, 2006, BJOG-INT J OBSTET GY, V113, P118, DOI 10.1111/j.1471-0528.2006.01150.x; Smith GCS, 2001, LANCET, V357, P2002, DOI 10.1016/S0140-6736(00)05112-6; Smith GD, 2005, EPIDEMIOLOGY, V16, P563, DOI 10.1097/01.ede.0000164790.96316.c0; Smith GD, 2000, LANCET, V356, P2066, DOI 10.1016/S0140-6736(00)03406-1; Watson T, 2008, ANTIOXID REDOX SIGN, V10, P1079, DOI 10.1089/ars.2007.1998	35	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e104149	10.1371/journal.pone.0104149	http://dx.doi.org/10.1371/journal.pone.0104149			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093324	gold, Green Published, Green Accepted			2022-12-27	WOS:000341357200075
J	Zhang, JX; Li, Y; Chen, XT; Pan, YQ; Zhang, SW; Wang, YH				Zhang, Jingxiao; Li, Yan; Chen, Xuetong; Pan, Yanqiu; Zhang, Shuwei; Wang, Yonghua			Systems Pharmacology Dissection of Multi-Scale Mechanisms of Action for Herbal Medicines in Stroke Treatment and Prevention	PLOS ONE			English	Article							SALVIANOLIC ACID B; DRUG DISCOVERY; PLATELET-AGGREGATION; THERAPEUTIC TARGET; AQUEOUS SOLUBILITY; CEREBRAL-ISCHEMIA; FOCAL ISCHEMIA; GINKGO-BILOBA; BRAIN; INHIBITION	Annually, tens of millions of first-ever strokes occur in the world; however, currently there is lack of effective and widely applicable pharmacological treatments for stroke patients. Herbal medicines, characterized as multi-constituent, multi-target and multi-effect, have been acknowledged with conspicuous effects in treating stroke, and attract extensive interest of researchers although the mechanism of action is yet unclear. In this work, we introduce an innovative systems-pharmacology method that combines pharmacokinetic prescreening, target fishing and network analysis to decipher the mechanisms of action of 10 herbal medicines like Salvia miltiorrhizae, Ginkgo biloba and Ephedrae herba which are efficient in stroke treatment and prevention. Our systematic analysis results display that, in these anti-stroke herbal medicines, 168 out of 1285 constituents with the favorable pharmacokinetic profiles might be implicated in stroke therapy, and the systematic use of these compounds probably acts through multiple mechanisms to synergistically benefit patients with stroke, which can roughly be classified as preventing ischemic inflammatory response, scavenging free radicals and inhibiting neuronal apoptosis against ischemic cerebral damage, as well as exhibiting lipid-lowering, anti-diabetic, anti-thrombotic and antiplatelet effects to decrease recurrent strokes. Relying on systems biology-based analysis, we speculate that herbal medicines, being characterized as the classical combination therapies, might be not only engaged in multiple mechanisms of action to synergistically improve the stroke outcomes, but also might be participated in reducing the risk factors for recurrent strokes.	[Zhang, Jingxiao; Li, Yan; Pan, Yanqiu; Zhang, Shuwei] Dalian Univ Technol, Fac Chem Environm & Biol Sci & Technol, Key Lab Ind Ecol & Environm Engn, MOE, Dalian, Liaoning, Peoples R China; [Chen, Xuetong; Wang, Yonghua] Northwest A&F Univ, Coll Life Sci, Yangling, Shaanxi, Peoples R China; [Chen, Xuetong; Wang, Yonghua] Northwest A&F Univ, Ctr Bioinformat, Yangling, Shaanxi, Peoples R China	Dalian University of Technology; Northwest A&F University - China; Northwest A&F University - China	Li, Y (corresponding author), Dalian Univ Technol, Fac Chem Environm & Biol Sci & Technol, Key Lab Ind Ecol & Environm Engn, MOE, Dalian, Liaoning, Peoples R China.	yanli@dlut.edu.cn; yh_wang@nwsuaf.edu.cn	Li, Yang/GWM-7879-2022; Li, Yuan/GXV-1310-2022; li, yong/HDN-3885-2022		National Natural Science Foundation of China [11201049, 31170796, 81373892]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The research is financially supported by the National Natural Science Foundation of China (Grant No. 11201049, 31170796 and 81373892). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson C, 2003, STROKE, V34, P1333, DOI 10.1161/01.STR.0000069266.99057.BF; Arnott JA, 2012, EXPERT OPIN DRUG DIS, V7, P863, DOI 10.1517/17460441.2012.714363; Asahi M, 2000, J CEREBR BLOOD F MET, V20, P452, DOI 10.1097/00004647-200003000-00002; Broussalis E, 2012, DRUG DISCOV TODAY, V17, P296, DOI 10.1016/j.drudis.2011.11.005; Chang CP, 2007, NEUROPHARMACOLOGY, V52, P1024, DOI 10.1016/j.neuropharm.2006.10.018; CHEN CX, 1992, ACTA PHARM SINIC, V13, P126; Chen YH, 2000, ACTA PHARMACOL SIN, V21, P463; Choi MY, 2008, ARCH PHARM RES, V31, P1166, DOI 10.1007/s12272-001-1284-4; Culman J, 2007, TRENDS PHARMACOL SCI, V28, P244, DOI 10.1016/j.tips.2007.03.004; Di Napoli M, 2003, STROKE, V34, P2922, DOI 10.1161/01.STR.0000099124.84425.BB; Feigin VL, 2007, STROKE, V38, P1734, DOI 10.1161/STROKEAHA.107.487132; Gao DY, 2009, ARCH PHARM RES, V32, P773, DOI 10.1007/s12272-009-1517-2; Geraets L, 2007, J NUTR, V137, P2190, DOI 10.1093/jn/137.10.2190; Gim SangA, 2013, Laboratory Animal Research, V29, P63; Gong XD, 1999, TRENDS PHARMACOL SCI, V20, P191, DOI 10.1016/S0165-6147(98)01276-0; Ha SK, 2012, NEUROCHEM RES, V37, P1560, DOI 10.1007/s11064-012-0751-z; The HP, 2011, MOL INFORM, V30, P376, DOI 10.1002/minf.201000118; Hou TJ, 2002, J MOL MODEL, V8, P337, DOI 10.1007/s00894-002-0101-1; Huang C., 2013, BRIEF BIOINFORM; Iadecola C, 1997, TRENDS NEUROSCI, V20, P132, DOI 10.1016/S0166-2236(96)10074-6; Jeon SJ, 2011, NEUROSCI RES, V69, P214, DOI 10.1016/j.neures.2010.11.008; Jin DZ, 2006, EUR J PHARMACOL, V549, P166, DOI 10.1016/j.ejphar.2006.07.055; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; Jorgensen WL, 2002, ADV DRUG DELIVER REV, V54, P355, DOI 10.1016/S0169-409X(02)00008-X; Kam A, 2012, CURR MED CHEM, V19, P1830, DOI 10.2174/092986712800099794; Karmin O, 2001, LIFE SCI, V68, P903, DOI 10.1016/S0024-3205(00)00989-9; Kawai Mari, 2007, Allergol Int, V56, P113; Keiser MJ, 2007, NAT BIOTECHNOL, V25, P197, DOI 10.1038/nbt1284; Kilic E, 2006, FASEB J, V20, P1185, DOI 10.1096/fj.05-4829fje; Kim EJ, 2007, MOL PHARMACOL, V72, P62, DOI 10.1124/mol.107.034447; Kuhn M, 2012, NUCLEIC ACIDS RES, V40, pD876, DOI 10.1093/nar/gkr1011; Kuo PL, 2005, LIFE SCI, V77, P2964, DOI 10.1016/j.lfs.2005.05.026; Ladecola C, 2001, P NATL ACAD SCI USA, V98, P1294, DOI 10.1073/pnas.98.3.1294; Lee S, 2010, NEUROCHEM RES, V35, P1725, DOI 10.1007/s11064-010-0235-y; [李兰婷 LI Lanting], 2007, [中国药物化学杂志, Chinese Journal of Medicinal Chemistry], V17, P221; [李兰婷 LI Lanting], 2007, [分子科学学报, Journal of Molecular Science], V23, P286; Li M, 2004, CLIN HEMORHEOL MICRO, V31, P97; Li XX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043918; Lin Tsai-Hui, 2010, Chin Med, V5, P22, DOI 10.1186/1749-8546-5-22; Liu CL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001321; Liu H, 2013, J ETHNOPHARMACOL, V146, P773, DOI 10.1016/j.jep.2013.02.004; Lo EH, 2003, NAT REV NEUROSCI, V4, P399, DOI 10.1038/nrn1106; Lu C, 2011, J IMMUNOL, V187, P1458, DOI 10.4049/jimmunol.1003428; Mehta SL, 2007, BRAIN RES REV, V54, P34, DOI 10.1016/j.brainresrev.2006.11.003; MELDRUM BS, 1995, CURR OPIN NEUROL, V8, P15, DOI 10.1097/00019052-199502000-00004; Mendis S., 2011, GLOBAL ATLAS CARDIOV; Mueller M, 2008, J AGR FOOD CHEM, V56, P11621, DOI 10.1021/jf802298w; O'Collins VE, 2012, J CEREBR BLOOD F MET, V32, P585, DOI 10.1038/jcbfm.2011.203; Pang KS, 2003, DRUG METAB DISPOS, V31, P1507, DOI 10.1124/dmd.31.12.1507; SEIBERT K, 1995, AGENT ACTION SUPPL, V46, P41; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shi C, 2010, INT J MOL SCI, V11, P107, DOI 10.3390/ijms11010107; Shi JS, 2003, ACTA PHARMACOL SIN, V24, P97; Shuaib A, 2002, J CEREBR BLOOD F MET, V22, P215, DOI 10.1097/00004647-200202000-00009; Suh SJ, 2006, BIOCHEM PHARMACOL, V72, P1680, DOI 10.1016/j.bcp.2006.08.013; Suk K, 2002, LIFE SCI, V70, P2467, DOI 10.1016/S0024-3205(02)01534-5; Sumii T, 2002, STROKE, V33, P831, DOI 10.1161/hs0302.104542; Tavazoie S, 1999, NAT GENET, V22, P281, DOI 10.1038/10343; Tetko IV, 2004, J PHARM SCI-US, V93, P3103, DOI 10.1002/jps.20217; Tetko IV, 2001, J CHEM INF COMP SCI, V41, P1488, DOI 10.1021/ci000392t; van Wijk SJL, 2005, FREE RADICAL BIO MED, V39, P81, DOI 10.1016/j.freeadbiomed.2005.03.021; Wang JM, 2007, J CHEM INF MODEL, V47, P1395, DOI 10.1021/ci700096r; Wang X, 2013, INTEGR BIOL-UK, V5, P351, DOI 10.1039/c2ib20204b; Wang XH, 2007, MED RES REV, V27, P133, DOI 10.1002/med.20077; Whirl-Carrillo M, 2012, CLIN PHARMACOL THER, V92, P414, DOI 10.1038/clpt.2012.96; WU B, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD004295.PUB3; Wu B, 2007, STROKE, V38, P1973, DOI 10.1161/STROKEAHA.106.473165; Xu X, 2012, INT J MOL SCI, V13, P6964, DOI 10.3390/ijms13066964; Ye H, 2011, NUCLEIC ACIDS RES, V39, pD1055, DOI 10.1093/nar/gkq1165; Yu H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037608; Zeng X, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003691.pub2; Zhang FY, 2009, EXP BRAIN RES, V193, P109, DOI 10.1007/s00221-008-1600-9; Zhao S, 2012, ANNU REV PHARMACOL, V52, P505, DOI 10.1146/annurev-pharmtox-010611-134520; Zhou JY, 2012, FITOTERAPIA, V83, P617, DOI 10.1016/j.fitote.2012.02.010; Zhou JY, 2010, J ETHNOPHARMACOL, V132, P15, DOI 10.1016/j.jep.2010.08.041; Zhu F, 2012, NUCLEIC ACIDS RES, V40, pD1128, DOI 10.1093/nar/gkr797	76	35	43	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e102506	10.1371/journal.pone.0102506	http://dx.doi.org/10.1371/journal.pone.0102506			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093322	Green Submitted, Green Published, gold			2022-12-27	WOS:000341357200012
J	Bennett, TM; Mackay, DS; Siegfried, CJ; Shiels, A				Bennett, Thomas M.; Mackay, Donna S.; Siegfried, Carla J.; Shiels, Alan			Mutation of the Melastatin-Related Cation Channel, TRPM3, Underlies Inherited Cataract and Glaucoma	PLOS ONE			English	Article							ANTERIOR SEGMENT DYSGENESIS; STATIONARY NIGHT BLINDNESS; CONGENITAL CATARACT; GENE-EXPRESSION; N-TERMINUS; PROTEIN; MOUSE; DOMAIN; LOCUS; COMPLEX	Inherited forms of cataract are a clinically important and genetically heterogeneous cause of visual impairment that usually present at an early age with or without systemic and/or other ocular abnormalities. Here we have identified a new locus for inherited cataract and high-tension glaucoma with variable anterior segment defects, and characterized an underlying mutation in the gene coding for transient receptor potential cation channel, subfamily M, member-3 (TRPM3, melastatin-2). Genome-wide linkage analysis mapped the ocular disease locus to the pericentric region of human chromosome 9. Whole exome and custom-target next-generation sequencing detected a heterozygous A-to-G transition in exon-3 of TRPM3 that co-segregated with disease. As a consequence of alternative splicing this missense mutation was predicted to result in the substitution of isoleucine-to-methionine at codon 65 (c.195A>G; p.I65 M) of TRPM3 transcript variant 9, and at codon 8 (c.24A>G; p.18 M) of a novel TRPM3 transcript variant expressed in human lens. In both transcript variants the I-to-M substitution was predicted in silico to exert damaging effects on protein function. Furthermore, transient expression studies of a recombinant TRPM3-GFP reporter product predicted that the I-to-M substitution introduced an alternative translation start-site located 89 codons upstream from the native initiator methionine found in eight other TRPM3 transcript variants (1-8). Collectively, these studies have provided the first evidence that TRPM3 is associated with inherited ocular disease in humans, and further provide support for the important role of this cation channel in normal eye development.	[Bennett, Thomas M.; Mackay, Donna S.; Siegfried, Carla J.; Shiels, Alan] Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63130 USA	Washington University (WUSTL)	Shiels, A (corresponding author), Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63130 USA.	shiels@vision.wustl.edu		Mackay, Donna/0000-0002-2499-1203	National Institutes of Health/National Eye Institute (NIH/NEI) [EY012284, EY02687]; Research to Prevent Blindness (RPB); NATIONAL EYE INSTITUTE [R01EY012284, P30EY002687] Funding Source: NIH RePORTER	National Institutes of Health/National Eye Institute (NIH/NEI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness (RPB)(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health/National Eye Institute (NIH/NEI) grants EY012284 (to AS), and EY02687 (Core Grant for Vision Research), and by an unrestricted grant to the Department of Ophthalmology and Visual Sciences from Research to Prevent Blindness (RPB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Amaya L, 2003, SURV OPHTHALMOL, V48, P125, DOI 10.1016/S0039-6257(02)00462-9; Audo I, 2009, AM J HUM GENET, V85, P720, DOI 10.1016/j.ajhg.2009.10.013; Banka S, 2012, EUR J HUM GENET, V20, P381, DOI 10.1038/ejhg.2011.220; Bellone RR, 2008, GENETICS, V179, P1861, DOI 10.1534/genetics.108.088807; Bonaldo MDF, 1996, GENOME RES, V6, P791, DOI 10.1101/gr.6.9.791; Civan MM, 2004, EXP EYE RES, V78, P625, DOI 10.1016/j.exer.2003.09.021; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Conte I, 2010, P NATL ACAD SCI USA, V107, P15491, DOI 10.1073/pnas.0914785107; Deo M, 2006, DEV DYNAM, V235, P2538, DOI 10.1002/dvdy.20847; Everett KV, 2011, ADV EXP MED BIOL, V704, P1011, DOI 10.1007/978-94-007-0265-3_52; Forshew T, 2005, HUM GENET, V117, P452, DOI 10.1007/s00439-005-1309-9; Fruhwald J, 2012, J BIOL CHEM, V287, P36663, DOI 10.1074/jbc.M112.396663; Gilliam JC, 2011, VISION RES, V51, P2440, DOI 10.1016/j.visres.2011.10.009; Gould DB, 2002, HUM MOL GENET, V11, P1185, DOI 10.1093/hmg/11.10.1185; Heon E, 2001, AM J HUM GENET, V68, P772, DOI 10.1086/318798; HILL RE, 1991, NATURE, V354, P522, DOI 10.1038/354522a0; Hingorani M, 2012, EUR J HUM GENET, V20, P1011, DOI 10.1038/ejhg.2012.100; Holakovska B, 2012, J BIOL CHEM, V287, P16645, DOI 10.1074/jbc.M112.350686; Hughes S, 2012, EUR J NEUROSCI, V35, P34, DOI 10.1111/j.1460-9568.2011.07944.x; Jamieson RV, 2002, HUM MOL GENET, V11, P33, DOI 10.1093/hmg/11.1.33; Karali M, 2007, INVEST OPHTH VIS SCI, V48, P509, DOI 10.1167/iovs.06-0866; Kluijt I, 2000, Ophthalmic Genet, V21, P51, DOI 10.1076/1381-6810(200003)21:1;1-I;FT051; Kunert-Keil C, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-159; Kuniba H, 2009, J HUM GENET, V54, P304, DOI 10.1038/jhg.2009.30; Lachke SA, 2011, SCIENCE, V331, P1571, DOI 10.1126/science.1195970; Lambert SR, 2013, AM J OPHTHALMOL, V156, P355, DOI 10.1016/j.ajo.2013.03.013; Latorre R, 2009, Q REV BIOPHYS, V42, P201, DOI 10.1017/S0033583509990072; Lattin Jane E, 2008, Immunome Res, V4, P5, DOI 10.1186/1745-7580-4-5; Lee H, 2008, ACTA OPHTHALMOL, V86, P708, DOI 10.1111/j.1755-3768.2008.01427.x; Li Z, 2009, AM J HUM GENET, V85, P711, DOI 10.1016/j.ajhg.2009.10.003; Lin ZM, 2012, AM J HUM GENET, V90, P558, DOI 10.1016/j.ajhg.2012.02.006; Mackay DS, 2003, EUR J HUM GENET, V11, P784, DOI 10.1038/sj.ejhg.5201046; Moiseenkova-Bell V, 2011, ADV EXP MED BIOL, V704, P25, DOI 10.1007/978-94-007-0265-3_2; MONTELL C, 1989, NEURON, V2, P1313, DOI 10.1016/0896-6273(89)90069-X; Naylor J, 2010, CIRC RES, V106, P1507, DOI 10.1161/CIRCRESAHA.110.219329; Nilius B, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-218; Nilius B, 2010, PFLUG ARCH EUR J PHY, V460, P437, DOI 10.1007/s00424-010-0788-2; Oberwinkler J, 2005, J BIOL CHEM, V280, P22540, DOI 10.1074/jbc.M503092200; Pagnamenta AT, 2011, J NEURODEV DISORD, V3, P124, DOI 10.1007/s11689-011-9076-5; Park SH, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-S2-S13; Phelps CB, 2007, J BIOL CHEM, V282, P36474, DOI 10.1074/jbc.M707205200; Rahi JS, 2001, INVEST OPHTH VIS SCI, V42, P1444; Reis LM, 2011, CURR OPIN OPHTHALMOL, V22, P314, DOI 10.1097/ICU.0b013e328349412b; Rhodes JD, 2009, EXP EYE RES, V88, P226, DOI 10.1016/j.exer.2008.10.025; Sandmeyer LS, 2012, VET OPHTHALMOL, V15, P18, DOI 10.1111/j.1463-5224.2011.00903.x; Shaham O, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003357; Shiels A, 2013, CLIN GENET, V84, P120, DOI 10.1111/cge.12182; Shiels A, 2010, MOL VIS, V16, P2007; Sim NL, 2012, NUCLEIC ACIDS RES, V40, pW452, DOI 10.1093/nar/gks539; Toro CA, 2011, CURR PHARM BIOTECHNO, V12, P12; Trumler AA, 2011, CURR OPIN OPHTHALMOL, V22, P365, DOI 10.1097/ICU.0b013e32834994dc; van Genderen MM, 2009, AM J HUM GENET, V85, P730, DOI 10.1016/j.ajhg.2009.10.012; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Vriens J, 2011, NEURON, V70, P482, DOI 10.1016/j.neuron.2011.02.051; Wagner TFJ, 2008, NAT CELL BIOL, V10, P1421, DOI 10.1038/ncb1801; Wang FE, 2010, FASEB J, V24, P1552, DOI 10.1096/fj.08-125856; Wang Y, 2013, INVEST OPHTH VIS SCI, V54, P323, DOI 10.1167/iovs.12-10904; Wiederholt M, 2000, PROG RETIN EYE RES, V19, P271, DOI 10.1016/S1350-9462(99)00015-4; Wimmers S, 2007, PROG RETIN EYE RES, V26, P263, DOI 10.1016/j.preteyeres.2006.12.002; Xie Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054507; Xu XZS, 2001, P NATL ACAD SCI USA, V98, P10692, DOI 10.1073/pnas.191360198; Yashin AI, 2010, AGING-US, V2, P612, DOI 10.18632/aging.100191; Zetterstrom C, 2005, J CATARACT REFR SURG, V31, P824, DOI 10.1016/j.jcrs.2005.01.012	64	30	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e104000	10.1371/journal.pone.0104000	http://dx.doi.org/10.1371/journal.pone.0104000			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25090642	Green Published, gold, Green Submitted			2022-12-27	WOS:000339812700076
J	Sagnia, B; Fedeli, D; Casetti, R; Montesano, C; Falcioni, G; Colizzi, V				Sagnia, Bertrand; Fedeli, Donatella; Casetti, Rita; Montesano, Carla; Falcioni, Giancarlo; Colizzi, Vittorio			Antioxidant and Anti-Inflammatory Activities of Extracts from Cassia alata, Eleusine indica, Eremomastax speciosa, Carica papaya and Polyscias fulva Medicinal Plants Collected in Cameroon	PLOS ONE			English	Article							FREE-RADICALS; IN-VITRO; OXIDATIVE STRESS; DENDRITIC CELLS; AQUEOUS EXTRACT; ASSAY; ACID; GLUTATHIONE; TRITERPENE; LEAVES	Background: The vast majority of the population around the world has always used medicinal plants as first source of health care to fight infectious and non infectious diseases. Most of these medicinal plants may have scientific evidence to be considered in general practice. Objective: The aim of this work was to investigate the antioxidant capacities and anti-inflammatory activities of ethanol extracts of leaves of Cassia alata, Eleusine indica, Carica papaya, Eremomastax speciosa and the stem bark of Polyscias fulva, collected in Cameroon. Methods: Chemiluminescence was used to analyze the antioxidant activities of plant extracts against hydrogen peroxide or superoxide anion. Comet assays were used to analyze the protection against antioxidant-induced DNA damage induced in white blood cells after treating with hydrogen peroxide. Flow cytometry was used to measure gamma delta T cells proliferation and anti-inflammatory activity of gamma delta T cells and of immature dendritic cells (imDC) in the presence of different concentrations of plant extracts. Results: Ethanol extracts showed strong antioxidant properties against both hydrogen peroxide and superoxide anion. Cassia alata showed the highest antioxidant activity. The effect of plant extracts on gamma delta T cells and imDC was evidenced by the dose dependent reduction in TNF-alpha production in the presence of Cassia alata, Carica papaya, Eremomastax speciosa Eleusine indica, and Polyscias fulva. gamma delta T cells proliferation was affected to the greatest extent by Polyscias fulva. Conclusion: These results clearly show the antioxidant capacity and anti-inflammatory activities of plant extracts collected in Cameroon. These properties of leaves and stem bark extracts may contribute to the value for these plants in traditional medicine and in general medical practice.	[Sagnia, Bertrand] Chantal BIYA Int Reference Ctr Res Prevent & Mana, Lab Microbiol & Immunol, Yaounde, Cameroon; [Fedeli, Donatella; Falcioni, Giancarlo] Univ Camerino, Sch Pharm, I-62032 Camerino, MC, Italy; [Casetti, Rita; Colizzi, Vittorio] Natl Inst Infect Dis Lazzaro Spallanzani, Cellular Immunol Lab, Rome, Italy; [Montesano, Carla; Colizzi, Vittorio] Univ Roma Tor Vergata, Dept Biol, I-00173 Rome, Italy	University of Camerino; IRCCS Lazzaro Spallanzani; University of Rome Tor Vergata	Sagnia, B (corresponding author), Chantal BIYA Int Reference Ctr Res Prevent & Mana, Lab Microbiol & Immunol, Yaounde, Cameroon.	bertrandsagnia@yahoo.fr	Casetti, Rita/K-8631-2016	Casetti, Rita/0000-0002-7574-8780; Montesano, Carla/0000-0002-9865-6619	School of Advanced Studies, University of Camerino, Italy; University of Rome Tor Vergata, Italy	School of Advanced Studies, University of Camerino, Italy; University of Rome Tor Vergata, Italy	This work was supported by the School of Advanced Studies, University of Camerino, Italy, and the University of Rome Tor Vergata, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afolabi IS, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-262; Aruoma OI, 2010, TOXICOLOGY, V278, P6, DOI 10.1016/j.tox.2010.09.006; Bedir E, 2001, J NAT PROD, V64, P95, DOI 10.1021/np0003589; Birdi T, 2010, BMC COMPLEM ALTERN M, V10, DOI 10.1186/1472-6882-10-33; Brusotti G, 2013, J PHARM BIOMED ANAL; Cesari I, 2013, J ETHNOPHARMACOL, V146, P264, DOI 10.1016/j.jep.2012.12.041; Cheynier V, 2013, PLANT PHYSL BIOCH; Cunningham AL, 2013, ADV EXP MED BIOL, V762, P1, DOI 10.1007/978-1-4614-4433-6_1; De Melo GO, 2005, PLANTA MED, V71, P362, DOI 10.1055/s-2005-864104; Dunne MR, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/704941; Ettebong EO, 2012, ASIAN PAC J TROP MED, V5, P673, DOI 10.1016/S1995-7645(12)60105-9; Finkel T, 2003, CURR OPIN CELL BIOL, V15, P247, DOI 10.1016/S0955-0674(03)00002-4; FLOYD RA, 1990, FASEB J, V4, P2587, DOI 10.1096/fasebj.4.9.2189775; Focho DA, 2009, J ETHNOBIOL ETHNOMED, V5, DOI 10.1186/1746-4269-5-17; Gabbianelli R, 2004, COMP BIOCHEM PHYS C, V137, P355, DOI 10.1016/j.cca.2004.03.006; Gabbianelli R, 2003, ARCH ENVIRON CON TOX, V45, P350, DOI 10.1007/s00244-003-2171-1; Ghoti H, 2011, ANN HEMATOL, V90, P509, DOI 10.1007/s00277-010-1110-2; Huang LF, 2011, EUR J PHARMACOL, V672, P169, DOI 10.1016/j.ejphar.2011.09.175; Huang SS, 2013, J ETHNOPHARMACOL, V147, P395, DOI 10.1016/j.jep.2013.03.025; Iqbal Mohammad, 2012, Environmental Health and Preventive Medicine, V17, P307, DOI 10.1007/s12199-011-0255-5; Iweala EEJ, 2010, AFR J TRADIT COMPLEM, V7, P113; Khan M, 2012, J PHARMACEUT BIOMED, V59, P162, DOI 10.1016/j.jpba.2011.09.025; KIRKPATRICK D T, 1986, Journal of Biochemical Toxicology, V1, P93, DOI 10.1002/jbt.2570010110; Kisangau DP, 2007, AFR J TRADIT COMPLEM, V4, P510; Kumar H, 2012, CNS NEUROL DISORD-DR, V11, P1015; Mandas A, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/749575; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; Mitchelmore CL, 1998, MUTAT RES-FUND MOL M, V399, P135, DOI 10.1016/S0027-5107(97)00252-2; Mitchelmore CL, 1998, ECOTOX ENVIRON SAFE, V41, P51, DOI 10.1006/eesa.1998.1666; Momo CEN, 2006, ANN TROP MED PARASIT, V100, P69, DOI 10.1179/136485906X78517; Morris D, 2013, BBA-GEN SUBJECTS, V1830, P3329, DOI 10.1016/j.bbagen.2012.10.012; Njateng GSS, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-95; Nussbaumer O, 2011, BLOOD, V118, P2743, DOI 10.1182/blood-2011-01-328526; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Ouedraogo M, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/162651; Rao Chandana Venkateswara, 2007, Acta Pharmaceutica (Zagreb), V57, P491, DOI 10.2478/v10007-007-0039-z; RICEEVANS CA, 1995, FREE RADICAL RES, V22, P375, DOI 10.3109/10715769509145649; Sen TA, 2010, ANADOLU KARDIYOL DER, V10, P465, DOI 10.5152/akd.2010.149; Sripanidkulchai B, 2001, J ETHNOPHARMACOL, V75, P185, DOI 10.1016/S0378-8741(01)00173-8; Tan PV, 1996, J ETHNOPHARMACOL, V54, P139, DOI 10.1016/S0378-8741(96)01461-4; Thomas E, 2009, J ETHNOPHARMACOL, V122, P60, DOI 10.1016/j.jep.2008.11.021; Valko M, 2006, CHEM-BIOL INTERACT, V160, P1, DOI 10.1016/j.cbi.2005.12.009; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Varghese GK, 2013, PHARM BIOL, V51, P345, DOI 10.3109/13880209.2012.729066; World Health Organization, 2002, WHO TRAD MED STRAT 2	45	50	51	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103999	10.1371/journal.pone.0103999	http://dx.doi.org/10.1371/journal.pone.0103999			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25090613	Green Published, Green Submitted, gold			2022-12-27	WOS:000339812700075
J	Li, LH; Wu, P; Lee, JY; Li, PR; Hsieh, WY; Ho, CC; Ho, CL; Chen, WJ; Wang, CC; Yen, MY; Yang, SM; Chen, HW				Li, Lan-Hui; Wu, Ping; Lee, Jen-Yi; Li, Pei-Rong; Hsieh, Wan-Yu; Ho, Chao-Chi; Ho, Chen-Lung; Chen, Wan-Jiun; Wang, Chien-Chun; Yen, Muh-Yong; Yang, Shun-Min; Chen, Huei-Wen			Hinokitiol Induces DNA Damage and Autophagy followed by Cell Cycle Arrest and Senescence in Gefitinib-Resistant Lung Adenocarcinoma Cells	PLOS ONE			English	Article							IN-VITRO; CHEMICAL-CONSTITUENTS; BETA-THUJAPLICIN; CANCER CELLS; GROWTH; GAMMA-H2AX; ANTICANCER; APOPTOSIS; INHIBITORS; EXPRESSION	Despite good initial responses, drug resistance and disease recurrence remain major issues for lung adenocarcinoma patients with epidermal growth factor receptor (EGFR) mutations taking EGFR-tyrosine kinase inhibitors (TKI). To discover new strategies to overcome this issue, we investigated 40 essential oils from plants indigenous to Taiwan as alternative treatments for a wide range of illnesses. Here, we found that hinokitiol, a natural monoterpenoid from the heartwood of Calocedrus formosana, exhibited potent anticancer effects. In this study, we demonstrated that hinokitiol inhibited the proliferation and colony formation ability of lung adenocarcinoma cells as well as the EGFR-TKI-resistant lines PC9-IR and H1975. Transcriptomic analysis and pathway prediction algorithms indicated that the main implicated pathways included DNA damage, autophagy, and cell cycle. Further investigations confirmed that in lung cancer cells, hinokitiol inhibited cell proliferation by inducing the p53-independent DNA damage response, autophagy (not apoptosis), S-phase cell cycle arrest, and senescence. Furthermore, hinokitiol inhibited the growth of xenograft tumors in association with DNA damage and autophagy but exhibited fewer effects on lung stromal fibroblasts. In summary, we demonstrated novel mechanisms by which hinokitiol, an essential oil extract, acted as a promising anticancer agent to overcome EGFR-TKI resistance in lung cancer cells via inducing DNA damage, autophagy, cell cycle arrest, and senescence in vitro and in vivo.	[Li, Lan-Hui; Wu, Ping; Lee, Jen-Yi; Li, Pei-Rong; Hsieh, Wan-Yu; Chen, Wan-Jiun; Chen, Huei-Wen] Natl Taiwan Univ, Coll Med, Grad Inst Toxicol, Taipei, Taiwan; [Li, Lan-Hui] Taipei City Hosp, Kunming Branch, Dept Lab, Taipei, Taiwan; [Ho, Chao-Chi] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Ho, Chao-Chi] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan; [Ho, Chen-Lung] Taiwan Forestry Res Inst, Div Wood Cellulose, Taipei, Taiwan; [Chen, Wan-Jiun] Natl Taiwan Univ, Coll Med, Grad Inst Oncol, Taipei 10764, Taiwan; [Wang, Chien-Chun; Yen, Muh-Yong] Taipei City Hosp, Kunming Branch, Div Infect Dis, Taipei, Taiwan; [Yen, Muh-Yong] Natl Yang Ming Univ, Dept Med, Taipei 112, Taiwan; [Yang, Shun-Min] Natl Def Med Ctr, Triserv Gen Hosp, Dept Pathol, Taipei, Taiwan	National Taiwan University; Taipei City Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; Taipei City Hospital; National Yang Ming Chiao Tung University; National Defense Medical Center; Tri-Service General Hospital	Chen, HW (corresponding author), Natl Taiwan Univ, Coll Med, Grad Inst Toxicol, Taipei, Taiwan.	shwchen@ntu.edu.tw		CHEN, HUEI-WEN/0000-0001-5051-9896; HO, CHAO-CHI/0000-0002-8156-2413	Ministry of Science and Technology [102-2325-B-002-046-]; National Taiwan University Cutting-Edge Steering Research Project [NTU CESRP-10R71602C2, 100R705057]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Taiwan University Cutting-Edge Steering Research Project	This work was supported by the grants from Ministry of Science and Technology (102-2325-B-002-046-) and National Taiwan University Cutting-Edge Steering Research Project (NTU CESRP-10R71602C2 and 100R705057). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhalla Y, 2013, J SCI FOOD AGR; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Brand TM, 2013, RADIOTHER ONCOL, V108, P370, DOI 10.1016/j.radonc.2013.06.010; Broet P, 2011, CLIN CANCER RES, V17, P3542, DOI 10.1158/1078-0432.CCR-10-2185; Budihas SR, 2005, NUCLEIC ACIDS RES, V33, P1249, DOI 10.1093/nar/gki268; Cai LL, 2013, INT J ONCOL, V42, P1452, DOI 10.3892/ijo.2013.1816; Calderon-Montano JM, 2012, PHARMACOL REP, V64, P1515, DOI 10.1016/S1734-1140(12)70949-0; Caron P, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002460; Chang TH, 2011, AM J RESP CRIT CARE, V183, P1071, DOI 10.1164/rccm.201009-1440OC; Chen HW, 2008, CANCER RES, V68, P7428, DOI 10.1158/0008-5472.CAN-07-6734; Chen WJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4472; Chiu SJ, 2009, CHEM-BIOL INTERACT, V182, P173, DOI 10.1016/j.cbi.2009.08.019; Cho JY, 2004, EUR J PHARMACOL, V492, P85, DOI 10.1016/j.ejphar.2004.03.027; Chowdhury G, 2007, J AM CHEM SOC, V129, P12870, DOI 10.1021/ja074432m; da Silva EBP, 2013, NAT PROD COMMUN, V8, P277; Darmanin S, 2009, NAT PROD RES, V23, P561, DOI 10.1080/14786410802228579; Gonzalez-Rodriguez A, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.162; Hebar A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045015; Hisatomi T, 2011, BLOOD, V117, P3575, DOI 10.1182/blood-2010-02-270439; Hiyoshi H, 2012, BRIT J CANCER, V106, P1807, DOI 10.1038/bjc.2012.159; Huang MH, 2013, MOL ONCOL, V7, P112, DOI 10.1016/j.molonc.2012.09.002; Imai Norio, 2006, Journal of Toxicological Sciences, V31, P357, DOI 10.2131/jts.31.357; Kitagawa M, 2013, ARCH BIOCHEM BIOPHYS, V539, P92, DOI 10.1016/j.abb.2013.06.014; Komaki N, 2008, BIOL PHARM BULL, V31, P735, DOI 10.1248/bpb.31.735; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; La Monica S, 2009, BIOCHEM PHARMACOL, V78, P460, DOI 10.1016/j.bcp.2009.04.033; Lam M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040152; Lee H, 2013, ONCOL REP, V30, P863, DOI 10.3892/or.2013.2499; Lee J, 2011, CANCER PREV RES, V4, P1306, DOI 10.1158/1940-6207.CAPR-10-0364; Lee YS, 2013, J NAT PROD, V76, P2195, DOI 10.1021/np4005135; Liu CC, 2006, NUCLEIC ACIDS RES, V34, pW571, DOI 10.1093/nar/gkl279; Liu F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042138; Liu SC, 2006, BIOCHEM BIOPH RES CO, V351, P26, DOI 10.1016/j.bbrc.2006.09.166; Liu SC, 2009, CANCER LETT, V286, P240, DOI 10.1016/j.canlet.2009.05.038; Luo Y, 2011, EXP GERONTOL, V46, P860, DOI 10.1016/j.exger.2011.07.005; Ma L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020159; Mah LJ, 2010, LEUKEMIA, V24, P679, DOI 10.1038/leu.2010.6; Morita Y, 2004, BIOL PHARM BULL, V27, P899, DOI 10.1248/bpb.27.899; Patane S, 2006, CANCER RES, V66, P4750, DOI 10.1158/0008-5472.CAN-05-4422; Podhorecka M, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/920161; Polewska J, 2013, J PHARMACOL EXP THER, V346, P393, DOI 10.1124/jpet.113.203851; Roberts PJ, 2013, J CLIN ONCOL, V31, P1112, DOI 10.1200/JCO.2012.43.0454; Rodriguez-Rocha H, 2011, MUTAT RES-FUND MOL M, V711, P158, DOI 10.1016/j.mrfmmm.2011.03.007; Rogerio AP, 2009, BRIT J PHARMACOL, V158, P1074, DOI 10.1111/j.1476-5381.2009.00177.x; Schnekenburger M, 2011, BIOCHEM PHARMACOL, V81, P364, DOI 10.1016/j.bcp.2010.10.013; Seal S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047014; Shamim U, 2012, J CELL PHYSIOL, V227, P1493, DOI 10.1002/jcp.22865; Shih MF, 2012, INT J IMMUNOPATH PH, V25, P39, DOI 10.1177/039463201202500106; Shih YH, 2013, MICROBIOL RES, V168, P254, DOI 10.1016/j.micres.2012.12.007; Shimizu M, 1993, SEIKATSU EISEI, V37, P215; Su YC, 2012, NAT PROD COMMUN, V7, P1245; Sudo M, 2013, CANCER CHEMOTH PHARM, V71, P1325, DOI 10.1007/s00280-013-2132-y; Sugiyama A, 2003, CARCINOGENESIS, V24, P1549, DOI 10.1093/carcin/bgg113; Szmulewitz RZ, 2012, INT J CANCER, V130, P509, DOI 10.1002/ijc.26005; Tang YC, 2011, CELL, V144, P499, DOI 10.1016/j.cell.2011.01.017; Wang CF, 2009, AGING CELL, V8, P311, DOI 10.1111/j.1474-9726.2009.00481.x; Watrin E, 2009, EMBO J, V28, P2625, DOI 10.1038/emboj.2009.202; Weeks LD, 2013, MOL CANCER THER, V12, P2248, DOI 10.1158/1535-7163.MCT-13-0172; White E, 2009, GENE DEV, V23, P784, DOI 10.1101/gad.1795309; Yen TB, 2008, BIORESOURCE TECHNOL, V99, P4871, DOI 10.1016/j.biortech.2007.09.037; Young ARJ, 2009, GENE DEV, V23, P798, DOI 10.1101/gad.519709	61	41	51	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2014	9	8							e104203	10.1371/journal.pone.0104203	http://dx.doi.org/10.1371/journal.pone.0104203			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR0CG	25105411	Green Submitted, gold, Green Published			2022-12-27	WOS:000343231900041
J	Sang, P; Yang, LQ; Ji, XL; Fu, YX; Liu, SQ				Sang, Peng; Yang, Li-Quan; Ji, Xing-Lai; Fu, Yun-Xin; Liu, Shu-Qun			Insight Derived from Molecular Dynamics Simulations into Molecular Motions, Thermodynamics and Kinetics of HIV-1 gp120	PLOS ONE			English	Article							ENVELOPE GLYCOPROTEINS; PROTEIN DYNAMICS; CONFORMATIONAL STATES; STRUCTURAL BASIS; CD4 RECEPTOR; BINDING; ANTIBODY; ENTRY; CORE; NEUTRALIZATION	Although the crystal structures of the HIV-1 gp120 core bound and pre-bound by CD4 are known, the details of dynamics involved in conformational equilibrium and transition in relation to gp120 function have remained elusive. The homology models of gp120 comprising the N- and C-termini and loops V3 and V4 in the CD4-bound and CD4-unbound states were built and subjected to molecular dynamics (MD) simulations to investigate the differences in dynamic properties and molecular motions between them. The results indicate that the CD4-bound gp120 adopted a more compact and stable conformation than the unbound form during simulations. For both the unbound and bound gp120, the large concerted motions derived from essential dynamics (ED) analyses can influence the size/shape of the ligand-binding channel/cavity of gp120 and, therefore, were related to its functional properties. The differences in motion direction between certain structural components of these two forms of gp120 were related to the conformational interconversion between them. The free energy calculations based on the metadynamics simulations reveal a more rugged and complex free energy landscape (FEL) for the unbound than for the bound gp120, implying that gp120 has a richer conformational diversity in the unbound form. The estimated free energy difference of similar to-6.0 kJ/mol between the global minimum free energy states of the unbound and bound gp120 indicates that gp120 can transform spontaneously from the unbound to bound states, revealing that the bound state represents a high-probability "ground state" for gp120 and explaining why the unbound state resists crystallization. Our results provide insight into the dynamics-and-function relationship of gp120, and facilitate understandings of the thermodynamics, kinetics and conformational control mechanism of HIV-1 gp120.	[Sang, Peng; Yang, Li-Quan; Ji, Xing-Lai; Fu, Yun-Xin; Liu, Shu-Qun] Yunnan Univ, Lab Conservat & Utilizat Bioresources, Kunming, Peoples R China; [Sang, Peng; Yang, Li-Quan; Ji, Xing-Lai; Fu, Yun-Xin; Liu, Shu-Qun] Yunnan Univ, Key Lab Microbial Resources, Minist Educ, Kunming, Peoples R China; [Yang, Li-Quan] Dali Univ, Coll Agr & Biol Sci, Dali, Peoples R China; [Ji, Xing-Lai; Liu, Shu-Qun] Chinese Acad Sci, Kunming Branch, Southwest Biol Div Lab, Kunming, Peoples R China; [Ji, Xing-Lai; Liu, Shu-Qun] Yunnan Univ, Key Lab Anim Genet Div & Evolut High Educ Yunnan, Kunming, Peoples R China; [Fu, Yun-Xin] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Ctr Human Genet, Houston, TX 77030 USA	Yunnan University; Yunnan University; Dali University; Chinese Academy of Sciences; Yunnan University; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health	Liu, SQ (corresponding author), Yunnan Univ, Lab Conservat & Utilizat Bioresources, Kunming, Peoples R China.	shuqunliu@gmail.com			National Natural Science Foundation of China [31370715, 31160181, 30860011]; National Basic Research Program of China [2013CB127500]; Program of Innovation Group of Yunnan Province [2011CI123]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Program of Innovation Group of Yunnan Province	This work was supported by the National Natural Science Foundation of China (Grant Nos. 31370715, 31160181 and 30860011. URL: http://www.nsfc.gov.cn/), the National Basic Research Program of China (2013CB127500. URL: http://www.most.gov.cn/eng/), and the Program of Innovation Group of Yunnan Province (Grant No. 2011CI123. URL: http://www.ynstc.gov.cn/index.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; Balsera MA, 1996, J PHYS CHEM-US, V100, P2567, DOI 10.1021/jp9536920; Barducci A, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.020603; BARRESINOUSSI F, 1983, SCIENCE, V220, P868, DOI 10.1126/science.6189183; Berendsen H. J. C., 1981, INTERMOLECULAR FORCE, P331, DOI [10.1007/978-94-015-7658-1_21, DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658, DOI 10.1007/978-94-015-7658]; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; Bonomi M, 2009, COMPUT PHYS COMMUN, V180, P1961, DOI 10.1016/j.cpc.2009.05.011; Bowman GR, 2012, P NATL ACAD SCI USA, V109, P11681, DOI 10.1073/pnas.1209309109; Chan DC, 1998, CELL, V93, P681, DOI 10.1016/S0092-8674(00)81430-0; Chen L, 2009, SCIENCE, V326, P1123, DOI 10.1126/science.1175868; Chen XR, 2009, ACTA CRYSTALLOGR D, V65, P339, DOI 10.1107/S0907444909003539; Coakley E, 2005, CURR OPIN INFECT DIS, V18, P9, DOI 10.1097/00001432-200502000-00003; Colman PM, 2003, NAT REV MOL CELL BIO, V4, P309, DOI 10.1038/nrm1076; Cunningham AL, 2010, CURR OPIN MICROBIOL, V13, P524, DOI 10.1016/j.mib.2010.06.002; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Deshpande N, 2005, NUCLEIC ACIDS RES, V33, pD233; Do Kwon Y, 2012, P NATL ACAD SCI USA, V109, P5663, DOI 10.1073/pnas.1112391109; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; GALLO RC, 1984, SCIENCE, V224, P500, DOI 10.1126/science.6200936; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Hess B, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.031910; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Huang CC, 2005, SCIENCE, V310, P1025, DOI 10.1126/science.1118398; Huang CC, 2007, SCIENCE, V317, P1930, DOI 10.1126/science.1145373; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kong L, 2010, J VIROL, V84, P10311, DOI 10.1128/JVI.00688-10; Kumar S, 2000, PROTEIN SCI, V9, P10; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; Kwong PD, 2000, STRUCTURE, V8, P1329, DOI 10.1016/S0969-2126(00)00547-5; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Laio A, 2002, P NATL ACAD SCI USA, V99, P12562, DOI 10.1073/pnas.202427399; Laio A, 2008, REP PROG PHYS, V71, DOI 10.1088/0034-4885/71/12/126601; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lechtenberg BC, 2012, BIOL CHEM, V393, P889, DOI 10.1515/hsz-2012-0178; Li HM, 2014, SCI CHINA LIFE SCI, V57, P287, DOI 10.1007/s11427-014-4617-2; Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159; Liu S. Q., 2012, PROTEIN ENG, P207; Liu SQ, 2008, J MOL MODEL, V14, P857, DOI 10.1007/s00894-008-0327-7; Liu SQ, 2007, J MOL GRAPH MODEL, V26, P306, DOI 10.1016/j.jmgm.2006.12.007; Liu SQ, 2010, J MOL MODEL, V16, P17, DOI 10.1007/s00894-009-0518-x; Liu SQ, 2007, CHINESE SCI BULL, V52, P3074, DOI 10.1007/s11434-007-0478-4; Liu SQ, 2004, J MOL STRUC-THEOCHEM, V673, P133, DOI 10.1016/j.theochem.2003.12.009; Liu SQ, 2003, J MOL MODEL, V9, P329, DOI 10.1007/s00894-003-0154-9; Ma BY, 1999, PROTEIN ENG, V12, P713, DOI 10.1093/protein/12.9.713; Mereghetti P, 2010, J PHYS CHEM B, V114, P7609, DOI 10.1021/jp911523h; Myszka DG, 2000, P NATL ACAD SCI USA, V97, P9026, DOI 10.1073/pnas.97.16.9026; Pancera M, 2010, P NATL ACAD SCI USA, V107, P1166, DOI 10.1073/pnas.0911004107; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sattentau QJ, 1998, STRUCT FOLD DES, V6, P945, DOI 10.1016/S0969-2126(98)00096-3; Schrodinger LLC, 2013, PYMOL MOL GRAPH SYST; Schulz R, 2009, BIOPHYS J, V96, P3116, DOI 10.1016/j.bpj.2009.01.021; Sicard F, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4810884; Spiwok V, 2007, J PHYS CHEM B, V111, P3073, DOI 10.1021/jp068587c; VANAALTEN DMF, 1995, PROTEINS, V22, P45, DOI 10.1002/prot.340220107; Vandekerckhove L, 2009, J ANTIMICROB CHEMOTH, V63, P1087, DOI 10.1093/jac/dkp113; Wu CH, 2006, NUCLEIC ACIDS RES, V34, pD187, DOI 10.1093/nar/gkj161; Wu LJ, 1996, NATURE, V384, P179, DOI 10.1038/384179a0; Wu SR, 2010, P NATL ACAD SCI USA, V107, P18844, DOI 10.1073/pnas.1007227107; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Xie YH, 2013, J BIOMOL STRUCT DYN, V31, P98, DOI 10.1080/07391102.2013.786395; Yang LQ, 2014, J BIOMOL STRUCT DYN, V32, P372, DOI 10.1080/07391102.2013.770372; Yang LQ, 2013, J BIOMOL STRUCT DYN, V31, P982, DOI 10.1080/07391102.2012.748536; Yuan W, 2006, J VIROL, V80, P6725, DOI 10.1128/JVI.00118-06; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819	70	13	14	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2014	9	8							e104714	10.1371/journal.pone.0104714	http://dx.doi.org/10.1371/journal.pone.0104714			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR0CG	25105502	Green Published, gold, Green Submitted			2022-12-27	WOS:000343231900084
J	Mathews, WC; Agmas, W; Cachay, ER; Cosman, BC; Jackson, C				Mathews, William C.; Agmas, Wollelaw; Cachay, Edward R.; Cosman, Bard C.; Jackson, Christopher			Natural History of Anal Dysplasia in an HIV-Infected Clinical Care Cohort: Estimates Using Multi-State Markov Modeling	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS INFECTION; SQUAMOUS INTRAEPITHELIAL LESIONS; ACTIVE ANTIRETROVIRAL THERAPY; INFRARED COAGULATOR ABLATION; COST-EFFECTIVENESS; PANEL-DATA; NEOPLASTIC LESIONS; PUNCH BIOPSIES; CELL CARCINOMA; POSITIVE MEN	Objectives: (1) To model the natural history of anal neoplasia in HIV-infected patients using a 3-state Markov model of anal cancer pathogenesis, adjusting for cytology misclassification; and (2) to estimate the effects of selected time-varying covariates on transition probabilities. Design: A retrospective cytology-based inception screening cohort of HIV-infected adults was analyzed using a 3-state Markov model of clinical pathogenesis of anal neoplasia. Methods: Longitudinally ascertained cytology categories were adjusted for misclassification using estimates of cytology accuracy derived from the study cohort. Time-varying covariate effects were estimated as hazard ratios. Results: (1) There was a moderate to high probability of regression of the high grade squamous intraepithelial lesion (HSIL) state (27-62%) at 2 years after initial cytology screening; (2) the probability of developing invasive anal cancer (IAC) during the first 2 years after a baseline HSIL cytology is low (1.9-2.8%); (3) infrared coagulation (IRC) ablation of HSIL lesions is associated with a 2.2-4.2 fold increased probability of regression to <HSIL; and (4) antiretroviral therapy, suppressed HIV plasma viral load, and CD4 >= 350/ mm(3) are each associated with reduced probability of progression from <HSIL to HSIL. Conclusions: The finding of moderate to high rates of regression of the HSIL state accompanied by low rates of progression to IAC should inform both screening and precursor treatment guideline development. There appears to be a consistent and robust beneficial effect of antiretroviral therapy, suppressed viral load, and higher CD4 on the transition from the <HSIL state to the HSIL state.	[Mathews, William C.; Agmas, Wollelaw; Cachay, Edward R.] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA; [Cosman, Bard C.] Univ Calif San Diego, Dept Surg, San Diego, CA 92103 USA; [Jackson, Christopher] MRC, Biostat Unit, Cambridge Inst Publ Hlth, Cambridge CB2 2BW, England	University of California System; University of California San Diego; University of California System; University of California San Diego; MRC Biostatistics Unit; University of Cambridge	Mathews, WC (corresponding author), Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA.	cmathews@ucsd.edu	Mathews, William C/E-4451-2010	Mathews, William C/0000-0002-2352-0725; Jackson, Christopher/0000-0002-6656-8913	Clinical Investigation and Biostatistics Core of the UC San Diego Center for AIDS Research [AI036214]; CFAR Network of Integrated Clinical Systems-CNICS; NIH [R24 AI067039]; MRC [MC_U105260556] Funding Source: UKRI; Medical Research Council [MC_U105260556] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R24AI067039, P30AI036214] Funding Source: NIH RePORTER	Clinical Investigation and Biostatistics Core of the UC San Diego Center for AIDS Research; CFAR Network of Integrated Clinical Systems-CNICS; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the following: Clinical Investigation and Biostatistics Core of the UC San Diego Center for AIDS Research (AI036214) and CFAR Network of Integrated Clinical Systems-CNICS, an NIH funded program (R24 AI067039). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assoumou SA, 2013, SEX TRANSM DIS, V40, P298, DOI 10.1097/OLQ.0b013e31827f4fe9; Berry JM, 2013, INT J CANCER; Bertisch B, 2013, AM J EPIDEMIOL, V178, P877, DOI 10.1093/aje/kwt153; Blitz S, 2013, J INFECT DIS, V208, P454, DOI 10.1093/infdis/jit181; Byrom J, 2006, INT J GYNECOL CANCER, V16, P253, DOI 10.1111/j.1525-1438.2006.00344.x; Cachay ER, 2013, AIDS REV, V15, P122; Cachay ER, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038956; Chiao EY, 2013, JAIDS-J ACQ IMM DEF, V63, P631, DOI 10.1097/QAI.0b013e3182968fa7; Cranston RD, 2008, INT J STD AIDS, V19, P118, DOI 10.1258/ijsa.2007.005665; Crum-Cianflone NF, 2010, AIDS, V24, P535, DOI 10.1097/QAD.0b013e328331f6e2; Dalla Pria A, 2014, AIDS, V28, P861, DOI 10.1097/QAD.0000000000000160; Dalla Pria A, 2013, AIDS, V27, P1185, DOI 10.1097/QAD.0b013e32835c122e; Darragh TM, 2012, J LOW GENIT TRACT DI, V16, P205, DOI 10.1097/PGP.0b013e31826916c7; Darwich L, 2013, SEX TRANSM DIS, V40, P611, DOI 10.1097/01.OLQ.0000430798.61475.08; de Pokomandy A, 2011, CLIN INFECT DIS, V52, P1174, DOI 10.1093/cid/cir064; de Pokomandy A, 2009, J INFECT DIS, V199, P965, DOI 10.1086/597207; DETSKY AS, 1988, J GEN INTERN MED, V3, P260, DOI 10.1007/BF02596342; Fonseca-Moutinho Jose Alberto, 2011, ISRN Obstet Gynecol, V2011, P847684, DOI 10.5402/2011/847684; Gadducci A, 2011, GYNECOL ENDOCRINOL, V27, P597, DOI 10.3109/09513590.2011.558953; Gervaz P, 2006, BRIT J SURG, V93, P531, DOI 10.1002/bjs.5376; Goldie SJ, 2000, AM J MED, V108, P634, DOI 10.1016/S0002-9343(00)00349-1; Goldie SJ, 1999, JAMA-J AM MED ASSOC, V281, P1822, DOI 10.1001/jama.281.19.1822; Goldstone RN, 2011, DIS COLON RECTUM, V54, P1284, DOI 10.1097/DCR.0b013e318227833e; Goldstone S, 2013, AIDS, V27, P1194, DOI 10.1097/QAD.0b013e32835f1fec; Goldstone SE, 2007, DIS COLON RECTUM, V50, P565, DOI 10.1007/s10350-006-0874-x; Goldstone SE, 2014, DIS COLON RECTUM, V57, P316, DOI 10.1097/DCR.0000000000000058; Heselmeyer K, 1997, BRIT J CANCER, V76, P1271, DOI 10.1038/bjc.1997.547; Jackson C, 2014, MULTISTATE MODELLING; Jackson CH, 2011, J STAT SOFTW, V38, P1; Jay N, 2011, J ASSOC NURSE AIDS C, V22, P465, DOI 10.1016/j.jana.2011.08.006; Jit M, 2010, MED DECIS MAKING, V30, P84, DOI 10.1177/0272989X09336140; KALBFLEISCH JD, 1985, J AM STAT ASSOC, V80, P863, DOI 10.2307/2288545; Kang MH, 2007, BIOSTATISTICS, V8, P252, DOI 10.1093/biostatistics/kxl006; Kirby AJ, 1994, WILEY S PRO; Macaya Antonio, 2012, Cochrane Database Syst Rev, V12, pCD009244, DOI 10.1002/14651858.CD009244.pub2; Machalek DA, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-946; Machalek DA, 2012, LANCET ONCOL, V13, P487, DOI 10.1016/S1470-2045(12)70080-3; Mathews Christopher, 2007, Open AIDS J, V1, P11, DOI 10.2174/1874613600701010011; Mathews WC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012284; Mathews WC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024946; Myers ER, 2000, AM J EPIDEMIOL, V151, P1158, DOI 10.1093/oxfordjournals.aje.a010166; Palefsky JM, 2012, SEX TRANSM DIS, V39, P501, DOI 10.1097/OLQ.0b013e31825f7921; Park Ina U, 2010, Curr Infect Dis Rep, V12, P126, DOI 10.1007/s11908-010-0090-7; Piketty C, 2008, AIDS, V22, P1203, DOI 10.1097/QAD.0b013e3283023f78; Scholefield JH, 2005, BRIT J SURG, V92, P1133, DOI 10.1002/bjs.4994; Schwartz LM, 2013, J INFECT DIS, V208, P1768, DOI 10.1093/infdis/jit374; Seaberg EC, 2010, CANCER-AM CANCER SOC, V116, P5507, DOI 10.1002/cncr.25530; Sirera G, 2013, AIDS, V27, P951, DOI 10.1097/QAD.0b013e32835e06c1; Solomon D, 2006, BETHESDA SYSTEM REPO; Stelzer MK, 2010, CANCER PREV RES, V3, P1534, DOI 10.1158/1940-6207.CAPR-10-0086; Stier EA, 2008, JAIDS-J ACQ IMM DEF, V47, P56, DOI 10.1097/QAI.0b013e3181582d93; Tong WWY, 2014, HIV MED, V15, P65, DOI 10.1111/hiv.12080; Underwood M, 2012, BJOG-INT J OBSTET GY, V119, P1293, DOI 10.1111/j.1471-0528.2012.03444.x; van der Snoek EM, 2012, SEX TRANSM DIS, V39, P495, DOI 10.1097/OLQ.0b013e31825aa764; Videla S, 2013, SEX TRANSM DIS, V40, P3, DOI 10.1097/OLQ.0b013e31827e87bd; Weis SE, 2012, DIS COLON RECTUM, V55, P1236, DOI 10.1097/DCR.0b013e31826d5cb5; Wilkin TJ, 2004, J INFECT DIS, V190, P1685, DOI 10.1086/424599	57	25	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e104116	10.1371/journal.pone.0104116	http://dx.doi.org/10.1371/journal.pone.0104116			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25101757	gold, Green Published, Green Submitted			2022-12-27	WOS:000339993900039
J	Escobar-Nino, A; Luna, C; Luna, D; Marcos, AT; Canovas, D; Mellado, E				Escobar-Nino, Almudena; Luna, Carlos; Luna, Diego; Marcos, Ana T.; Canovas, David; Mellado, Encarnacion			Selection and Characterization of Biofuel-Producing Environmental Bacteria Isolated from Vegetable Oil-Rich Wastes	PLOS ONE			English	Article							SOLID BY-PRODUCT; BIODIESEL PRODUCTION; ENZYMATIC PRODUCTION; OLIVE OIL; SP NOV.; LIPASE; TRANSESTERIFICATION; TERRIBACILLUS; ALPERUJO; PROPOSAL	Fossil fuels are consumed so rapidly that it is expected that the planet resources will be soon exhausted. Therefore, it is imperative to develop alternative and inexpensive new technologies to produce sustainable fuels, for example biodiesel. In addition to hydrolytic and esterification reactions, lipases are capable of performing transesterification reactions useful for the production of biodiesel. However selection of the lipases capable of performing transesterification reactions is not easy and consequently very few biodiesel producing lipases are currently available. In this work we first isolated 1,016 lipolytic microorganisms by a qualitative plate assay. In a second step, lipolytic bacteria were analyzed using a colorimetric assay to detect the transesterification activity. Thirty of the initial lipolytic strains were selected for further characterization. Phylogenetic analysis revealed that 23 of the bacterial isolates were Gram negative and 7 were Gram positive, belonging to different clades. Biofuel production was analyzed and quantified by gas chromatography and revealed that 5 of the isolates produced biofuel with yields higher than 80% at benchtop scale. Chemical and viscosity analysis of the produced biofuel revealed that it differed from biodiesel. This bacterial-derived biofuel does not require any further downstream processing and it can be used directly in engines. The freeze-dried bacterial culture supernatants could be used at least five times for biofuel production without diminishing their activity. Therefore, these 5 isolates represent excellent candidates for testing biofuel production at industrial scale.	[Escobar-Nino, Almudena; Marcos, Ana T.; Canovas, David] Univ Seville, Fac Biol, Dept Genet, Seville, Spain; [Escobar-Nino, Almudena; Mellado, Encarnacion] Univ Seville, Fac Pharm, Dept Microbiol & Parasitol, Seville, Spain; [Luna, Carlos; Luna, Diego] Univ Cordoba, Dept Organ Chem, Cordoba, Spain	University of Sevilla; University of Sevilla; Universidad de Cordoba	Canovas, D (corresponding author), Univ Seville, Fac Biol, Dept Genet, Seville, Spain.	davidc@us.es; emellado@us.es	Cánovas, David/L-7628-2014; MELLADO, ENCARNACIÓN/K-8665-2014; NIÑO, ALMUDENA ESCOBAR/Y-3315-2019; Luna, Diego/I-1059-2015	Cánovas, David/0000-0002-7293-7332; MELLADO, ENCARNACIÓN/0000-0002-7135-1428; NIÑO, ALMUDENA ESCOBAR/0000-0001-5637-1474; Marcos, Ana Teresa/0000-0002-0263-7473; Luna, Diego/0000-0003-1478-7476	Junta de Andalucia [P08-RNM-03515, P11-CVI-7427 MO, P11-TEP-7723]; Spanish Ministry of Economy and Competitiveness [ENE 2011-27017]; FEDER funds	Junta de Andalucia(Junta de Andalucia); Spanish Ministry of Economy and Competitiveness(Spanish Government); FEDER funds(European Commission)	This work was supported by grants from Junta de Andalucia (P08-RNM-03515, P11-CVI-7427 MO and P11-TEP-7723), as well as Spanish Ministry of Economy and Competitiveness (Project ENE 2011-27017) and FEDER funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alburquerque JA, 2004, BIORESOURCE TECHNOL, V91, P195, DOI 10.1016/S0960-8524(03)00177-9; Alburquerque JA, 2006, CHEMOSPHERE, V64, P470, DOI 10.1016/j.chemosphere.2005.10.055; An SY, 2007, INT J SYST EVOL MICR, V57, P51, DOI 10.1099/ijs.0.64340-0; Bajaj A, 2010, J MOL CATAL B-ENZYM, V62, P9, DOI 10.1016/j.molcatb.2009.09.018; BRISOU J, 1954, ANN I PASTEUR PARIS, V86, P722; Cowan ST, 2004, MANUAL IDENTIFICATIO; de la Fuente C, 2008, ECOTOX ENVIRON SAFE, V70, P207, DOI 10.1016/j.ecoenv.2007.05.021; Elomari M, 1996, INT J SYST BACTERIOL, V46, P1138, DOI 10.1099/00207713-46-4-1138; Green M.R., 2012, MOL CLONING LAB MANU; Heyrman J, 2005, INT J SYST EVOL MICR, V55, P119, DOI 10.1099/ijs.0.63221-0; Hoffmann H, 2005, SYST APPL MICROBIOL, V28, P206, DOI 10.1016/j.syapm.2004.12.009; Ilham Z, 2010, BIORESOURCE TECHNOL, V101, P2735, DOI 10.1016/j.biortech.2009.10.053; JEFFRIES CD, 1957, J BACTERIOL, V73, P590, DOI 10.1128/JB.73.4.590-591.1957; Krishnamurthi S, 2008, INT J SYST EVOL MICR, V58, P2287, DOI 10.1099/ijs.0.65579-0; LINDSAY WL, 1978, SOIL SCI SOC AM J, V42, P421, DOI 10.2136/sssaj1978.03615995004200030009x; Lopez NI, 2009, CURR MICROBIOL, V59, P514, DOI 10.1007/s00284-009-9469-9; Luna C, 2013, ENERGIES, V6, P3879, DOI 10.3390/en6083879; Meher LC, 2006, RENEW SUST ENERG REV, V10, P248, DOI 10.1016/j.rser.2004.09.002; Meyer A, 1901, ZENTRALBL BAKTERIOL, V7, P680; Modi MK, 2007, BIORESOURCE TECHNOL, V98, P1260, DOI 10.1016/j.biortech.2006.05.006; Moreno MD, 2009, FEMS MICROBIOL ECOL, V68, P59, DOI 10.1111/j.1574-6941.2009.00651.x; MORGAN FJ, 1979, J APPL BACTERIOL, V46, P291, DOI 10.1111/j.1365-2672.1979.tb00823.x; MURPHY J, 1962, ANAL CHIM ACTA, V26, P31; Ognjanovic N, 2009, BIORESOURCE TECHNOL, V100, P5146, DOI 10.1016/j.biortech.2009.05.068; OLSEN STERLING R., 1954, U S DEPT AGRIC CIRC, V939, P1; Porta Casanellas J., 1986, TECNICAS EXPT EDAFOL; Ranganathan SV, 2008, BIORESOURCE TECHNOL, V99, P3975, DOI 10.1016/j.biortech.2007.04.060; Ribeiro Bernardo Dias, 2011, Enzyme Res, V2011, P615803, DOI 10.4061/2011/615803; Robles-Medina A, 2009, BIOTECHNOL ADV, V27, P398, DOI 10.1016/j.biotechadv.2008.10.008; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SILVERMAN MP, 1959, J BACTERIOL, V77, P642, DOI 10.1128/JB.77.5.642-647.1959; Sumner M. E., 1996, Methods of soil analysis. Part 3 - chemical methods., P1201; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Teng Y, 2007, ANAL BIOCHEM, V363, P297, DOI 10.1016/j.ab.2007.01.026; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Verdugo C, 2010, BIORESOURCE TECHNOL, V101, P6657, DOI 10.1016/j.biortech.2010.03.089; Zhang Y, 2003, BIORESOURCE TECHNOL, V89, P1, DOI 10.1016/S0960-8524(03)00040-3	38	14	14	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e104063	10.1371/journal.pone.0104063	http://dx.doi.org/10.1371/journal.pone.0104063			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25099150	Green Published, gold			2022-12-27	WOS:000339995100049
J	Lim, J; Sabandal, PR; Fernandez, A; Sabandal, JM; Lee, HG; Evans, P; Han, KA				Lim, Junghwa; Sabandal, Paul R.; Fernandez, Ana; Sabandal, John Martin; Lee, Hyun-Gwan; Evans, Peter; Han, Kyung-An			The Octopamine Receptor Oct beta 2R Regulates Ovulation in Drosophila melanogaster	PLOS ONE			English	Article							PROTEIN-KINASE-II; PHARMACOLOGICAL CHARACTERIZATION; FRUIT-FLY; EXPRESSION; OAMB; SYSTEM; ROLES; GENE; IMMUNOREACTIVITY; IDENTIFICATION	Oviposition is induced upon mating in most insects. Ovulation is a primary step in oviposition, representing an important target to control insect pests and vectors, but limited information is available on the underlying mechanism. Here we report that the beta adrenergic-like octopamine receptor Oct beta 2R serves as a key signaling molecule for ovulation and recruits protein kinase A and Ca2+/calmodulin-sensitive kinase II as downstream effectors for this activity. We found that the oct beta 2r homozygous mutant females are sterile. They displayed normal courtship, copulation, sperm storage and post-mating rejection behavior but were unable to lay eggs. We have previously shown that octopamine neurons in the abdominal ganglion innervate the oviduct epithelium. Consistently, restored expression of Oct beta 2R in oviduct epithelial cells was sufficient to reinstate ovulation and full fecundity in the oct beta 2r mutant females, demonstrating that the oviduct epithelium is a major site of Oct beta 2R's function in oviposition. We also found that overexpression of the protein kinase A catalytic subunit or Ca2+/calmodulin-sensitive protein kinase U led to partial rescue of oct beta 2r's sterility. This suggests that Oct beta 2R activates cAMP as well as additional effectors including Ca2+ /calmodulin-sensitive protein kinase II for oviposition. All three known beta adrenergic-like octopamine receptors stimulate cAMP production in vitro. Oct beta 1R, when ectopically expressed in the oct beta 2r's oviduct epithelium, fully reinstated ovulation and fecundity. Ectopically expressed Oct beta 3R, on the other hand, partly restored ovulation and fecundity while OAMB-K3 and OAMB-AS that increase Ca2+ levels yielded partial rescue of ovulation but not fecundity deficit. These observations suggest that Oct beta 2R have distinct signaling capacities in vivo and activate multiple signaling pathways to induce egg laying. The findings reported here narrow the knowledge gap and offer insight into novel strategies for insect control.	[Lim, Junghwa; Sabandal, Paul R.; Fernandez, Ana; Sabandal, John Martin; Lee, Hyun-Gwan; Han, Kyung-An] Univ Texas El Paso, Dept Biol Sci, Border Biomed Res Ctr Neurosci & Metab Disorders, El Paso, TX 79968 USA; [Evans, Peter] Babraham Inst, Inositide Lab, Cambridge, England	University of Texas System; University of Texas El Paso; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Han, KA (corresponding author), Univ Texas El Paso, Dept Biol Sci, Border Biomed Res Ctr Neurosci & Metab Disorders, El Paso, TX 79968 USA.	khan@utep.edu			United States Department of Agriculture [NIFA2010-65105-20625]; National Institute on Minority Health and Health Disparities [8G12MD007592]; Babraham Institute; Biotechnology and Biological Sciences Research Council [BBS/E/B/00001194, BBS/E/B/0000C194] Funding Source: researchfish; BBSRC [BBS/E/B/0000C194] Funding Source: UKRI; National Institute on Minority Health and Health Disparities [G12MD007592] Funding Source: NIH RePORTER	United States Department of Agriculture(United States Department of Agriculture (USDA)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); Babraham Institute(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by United States Department of Agriculture NIFA2010-65105-20625 (K.-A.H.) and National Institute on Minority Health and Health Disparities 8G12MD007592 (BBRC/K.-A.H.) grants, and BBSRC funding through the Babraham Institute (P.D.E.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnew AJ, 2012, BRIT J PHARMACOL, V166, P327, DOI 10.1111/j.1476-5381.2011.01761.x; AIGAKI T, 1991, NEURON, V7, P557, DOI 10.1016/0896-6273(91)90368-A; Akbari OS, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-8; Balfanz S, 2005, J NEUROCHEM, V93, P440, DOI 10.1111/j.1471-4159.2005.03034.x; BOOTH TF, 1989, EXP APPL ACAROL, V7, P259, DOI 10.1007/BF01197920; BRAND AH, 1993, DEVELOPMENT, V118, P401; Chen A, 2013, GENETICS, V193, P159, DOI 10.1534/genetics.112.142042; Chen X, 2010, INSECT BIOCHEM MOLEC, V40, P476, DOI 10.1016/j.ibmb.2010.04.007; Cole SH, 2005, J BIOL CHEM, V280, P14948, DOI 10.1074/jbc.M414197200; Cossio-Bayugar R, 2012, J INSECT PHYSIOL, V58, P628, DOI 10.1016/j.jinsphys.2012.01.006; Crocker A, 2010, NEURON, V65, P670, DOI 10.1016/j.neuron.2010.01.032; Daborn PJ, 2002, SCIENCE, V297, P2253, DOI 10.1126/science.1074170; Drazen DL, 1999, NITRIC OXIDE-BIOL CH, V3, P366, DOI 10.1006/niox.1999.0251; Evans Peter D., 2005, Invertebrate Neuroscience, V5, P111, DOI 10.1007/s10158-005-0001-z; Farooqui T, 2003, J NEUROSCI, V23, P5370; Gabler M, 2005, GENETICS, V169, P723, DOI 10.1534/genetics.103.020842; Gelbart W, 2003, NUCLEIC ACIDS RES, V31, P172, DOI 10.1093/nar/gkg094; Hasemeyer M, 2009, NEURON, V61, P511, DOI 10.1016/j.neuron.2009.01.009; Han KA, 1998, J NEUROSCI, V18, P3650; HELM G, 1982, ACTA PHYSIOL SCAND, V114, P425, DOI 10.1111/j.1748-1716.1982.tb07005.x; Isaac RE, 2010, P ROY SOC B-BIOL SCI, V277, P65, DOI 10.1098/rspb.2009.1236; Jones RJ, 2007, AM J PHYSIOL-HEART C, V292, pH2634, DOI 10.1152/ajpheart.01247.2006; Kapelnikov A, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-114; Khan I, 2005, PHARMACOLOGY, V74, P157, DOI 10.1159/000084615; Kiger JA, 1999, GENETICS, V152, P281; Kim YC, 2007, GENES BRAIN BEHAV, V6, P201, DOI 10.1111/j.1601-183X.2006.00241.x; Kim YC, 2013, J NEUROSCI, V33, P1672, DOI 10.1523/JNEUROSCI.3042-12.2013; Lee HG, 2003, DEV BIOL, V264, P179, DOI 10.1016/j.ydbio.2003.07.018; Lee HG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004716; Maqueira B, 2005, J NEUROCHEM, V94, P547, DOI 10.1111/j.1471-4159.2005.03251.x; Middleton CA, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-17; Monastirioti M, 1996, J NEUROSCI, V16, P3900; Monastirioti M, 2003, DEV BIOL, V264, P38, DOI 10.1016/j.ydbio.2003.07.019; MONASTIRIOTI M, 1995, J COMP NEUROL, V356, P275, DOI 10.1002/cne.903560210; Nykamp DA, 2000, J INSECT PHYSIOL, V46, P809, DOI 10.1016/S0022-1910(99)00170-5; Peng J, 2005, CURR BIOL, V15, P1690, DOI 10.1016/j.cub.2005.08.048; Rezaval C, 2012, CURR BIOL, V22, P1155, DOI 10.1016/j.cub.2012.04.062; Ribeiro C, 2010, CURR BIOL, V20, P1000, DOI 10.1016/j.cub.2010.03.061; Rodriguez-Valentin R, 2006, J CELL PHYSIOL, V209, P183, DOI 10.1002/jcp.20722; Roeder T, 2005, ANNU REV ENTOMOL, V50, P447, DOI 10.1146/annurev.ento.50.071803.130404; Schneider JC, 2003, AM J PHYSIOL-HEART C, V284, pH2311, DOI 10.1152/ajpheart.00932.2001; Schwaerzel M, 2003, J NEUROSCI, V23, P10495, DOI 10.1523/jneurosci.23-33-10495.2003; Sinakevitch I, 2006, J COMP NEUROL, V494, P460, DOI 10.1002/cne.20799; Tay JI, 1997, HUM REPROD, V12, P2451, DOI 10.1093/humrep/12.11.2451; Thibault ST, 2004, NAT GENET, V36, P283, DOI 10.1038/ng1314; Unoki S, 2005, EUR J NEUROSCI, V22, P1409, DOI 10.1111/j.1460-9568.2005.04318.x; Wu SF, 2012, J EXP BIOL, V215, P2646, DOI 10.1242/jeb.068932; Yamane T, 2010, J INSECT PHYSIOL, V56, P271, DOI 10.1016/j.jinsphys.2009.10.011; Yang CH, 2009, NEURON, V61, P519, DOI 10.1016/j.neuron.2008.12.021; Yapici N, 2008, NATURE, V451, P33, DOI 10.1038/nature06483; Zhou C, 2012, J NEUROSCI, V32, P14281, DOI 10.1523/JNEUROSCI.0517-12.2012	51	33	35	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e104441	10.1371/journal.pone.0104441	http://dx.doi.org/10.1371/journal.pone.0104441			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25099506	Green Published, gold, Green Submitted			2022-12-27	WOS:000339995100072
J	Carver, J; Dexheimer, TS; Hsu, D; Weng, MT; Smith, JL; Guha, R; Jadhav, A; Simeonov, A; Luo, J				Carver, Joseph; Dexheimer, Thomas S.; Hsu, Dennis; Weng, Meng-Tzu; Smith, Jordan L.; Guha, Rajarshi; Jadhav, Ajit; Simeonov, Anton; Luo, Ji			A High-Throughput Assay for Small Molecule Destabilizers of the KRAS Oncoprotein	PLOS ONE			English	Article							RAS ONCOGENES; IN-VITRO; K-RAS; INHIBITION; PROTEIN; DEGRADATION; CANCER; LOCALIZATION; TRAFFICKING; ACTIVATION	Mutations in the Ras family of small GTPases, particularly KRAS, occur at high frequencies in cancer and represent a major unmet therapeutic need due to the lack of effective targeted therapies. Past efforts directed at inhibiting the activity of the Ras oncoprotein have proved difficult. We propose an alternative approach to target Ras by eliminating Ras protein from cells with pharmacological means. In this study, we developed a cell-based, high-content screening platform to identify small molecules that could promote the degradation of the KRAS oncoprotein. We generated an EGFP-KRAS(G12V) fluorescence reporter system and implemented it for automated screening in 1536-well plates using high-throughput cellular imaging. We screened a library of clinically relevant compounds at wide dose range and identified Ponatinib and AMG-47a as two candidate compounds that selectively reduced the levels of EGFP-KRAS(G12V) protein but did not affect EGFP protein in cells. This proof-of-principle study demonstrates that it is feasible to use a high-throughput screen to identify compounds that promote the degradation of the Ras oncoprotein as a new approach to target Ras.	[Carver, Joseph; Hsu, Dennis; Weng, Meng-Tzu; Smith, Jordan L.; Luo, Ji] NCI, Lab Canc Biol & Genet, Ctr Canc Res, Bethesda, MD 20892 USA; [Dexheimer, Thomas S.; Guha, Rajarshi; Jadhav, Ajit; Simeonov, Anton] Natl Ctr Adv Translat Sci, Div Preclin Innovat, Natl Inst Hlth Chem Genom Ctr, Bethesda, MD 20894 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS)	Simeonov, A (corresponding author), Natl Ctr Adv Translat Sci, Div Preclin Innovat, Natl Inst Hlth Chem Genom Ctr, Bethesda, MD 20894 USA.	asimeono@mail.nih.gov; ji.luo@nih.gov	Smith, Jordan/GVU-3480-2022	Smith, Jordan/0000-0003-0460-0647; Jadhav, Ajit/0000-0001-7955-1451	National Cancer Institute (NCI) Center for Cancer Research-Johns Hopkins University Master in Biotechnology Fellowship; Howard Hughes Medical Institute-National Institutes of Health Research Scholar Fellowship; Liver Disease Prevention and Treatment Research Foundation (Taiwan) Fellowship; NCI Intramural Program; Division of Preclinical Innovation at the National Center for Advancing Translational Sciences; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [ZIBTR000004] Funding Source: NIH RePORTER	National Cancer Institute (NCI) Center for Cancer Research-Johns Hopkins University Master in Biotechnology Fellowship; Howard Hughes Medical Institute-National Institutes of Health Research Scholar Fellowship; Liver Disease Prevention and Treatment Research Foundation (Taiwan) Fellowship; NCI Intramural Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Division of Preclinical Innovation at the National Center for Advancing Translational Sciences; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by an National Cancer Institute (NCI) Center for Cancer Research-Johns Hopkins University Master in Biotechnology Fellowship to J.C.; by a Howard Hughes Medical Institute-National Institutes of Health Research Scholar Fellowship to D. H.; by a Liver Disease Prevention and Treatment Research Foundation (Taiwan) Fellowship to M. T. W.; by the NCI Intramural Program to J.L.; and by the Division of Preclinical Innovation at the National Center for Advancing Translational Sciences to T. S. D., R. G., A.J. and A. S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahearn IM, 2012, NAT REV MOL CELL BIO, V13, P39, DOI 10.1038/nrm3255; Cho KJ, 2012, J BIOL CHEM, V287, P43573, DOI 10.1074/jbc.M112.424457; Cox Adrienne D, 2010, Small GTPases, V1, P2; Friedland JC, 2014, INVEST NEW DRUG, V32, P14, DOI 10.1007/s10637-013-9971-6; Grade M, 2011, INT J CANCER, V128, P1069, DOI 10.1002/ijc.25453; Griner LAM, 2014, P NATL ACAD SCI USA, V111, P2349, DOI 10.1073/pnas.1311846111; Huo YL, 2012, BIOCHEM J, V444, P141, DOI 10.1042/BJ20112107; JOHN J, 1990, BIOCHEMISTRY-US, V29, P6058, DOI 10.1021/bi00477a025; Kanasty R, 2013, NAT MATER, V12, P967, DOI [10.1038/NMAT3765, 10.1038/nmat3765]; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; Khvalevsky EZ, 2013, P NATL ACAD SCI USA, V110, P20723, DOI 10.1073/pnas.1314307110; Ma YH, 2013, MOL CANCER THER, V12, P286, DOI 10.1158/1535-7163.MCT-12-0650; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; Maurer T, 2012, P NATL ACAD SCI USA, V109, P5299, DOI 10.1073/pnas.1116510109; Meerbrey KL, 2011, P NATL ACAD SCI USA, V108, P3665, DOI 10.1073/pnas.1019736108; O'Hare T, 2009, CANCER CELL, V16, P401, DOI 10.1016/j.ccr.2009.09.028; Ostrem JM, 2013, NATURE, V503, P548, DOI 10.1038/nature12796; Prior IA, 2012, SEMIN CELL DEV BIOL, V23, P145, DOI 10.1016/j.semcdb.2011.09.002; Pylayeva-Gupta Y, 2011, NAT REV CANCER, V11, P761, DOI 10.1038/nrc3106; Raina K, 2010, J BIOL CHEM, V285, P11057, DOI 10.1074/jbc.R109.078105; Regan PL, 2011, INT J ONCOL, V38, P105, DOI 10.3892/ijo_00000829; Rodriguez-Gonzalez A, 2008, ONCOGENE, V27, P7201, DOI 10.1038/onc.2008.320; Shima F, 2010, J BIOL CHEM, V285, P22696, DOI 10.1074/jbc.M110.125161; Sontag EM, 2014, CURR OPIN CELL BIOL, V26, P139, DOI 10.1016/j.ceb.2013.12.006; Stephen AG, 2014, CANCER CELL, V25, P272, DOI 10.1016/j.ccr.2014.02.017; Sun Q, 2012, ANGEW CHEM INT EDIT, V51, P6140, DOI 10.1002/anie.201201358; Sunaga N, 2011, MOL CANCER THER, V10, P336, DOI 10.1158/1535-7163.MCT-10-0750; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; ULSH LS, 1984, MOL CELL BIOL, V4, P1647, DOI 10.1128/MCB.4.8.1647; van der Hoeven D, 2013, MOL CELL BIOL, V33, P237, DOI 10.1128/MCB.00884-12; Wee S, 2009, CANCER RES, V69, P4286, DOI 10.1158/0008-5472.CAN-08-4765; Zhang XW, 2010, SCIENCE, V328, P240, DOI 10.1126/science.1183424; Zimmermann G, 2013, NATURE, V497, P638, DOI 10.1038/nature12205	33	15	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e103836	10.1371/journal.pone.0103836	http://dx.doi.org/10.1371/journal.pone.0103836			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093678	Green Submitted, Green Published, gold			2022-12-27	WOS:000341357200034
J	Chaurasia, A; Tarallo, A; Berna, L; Yagi, M; Agnisola, C; D'Onofrio, G				Chaurasia, Ankita; Tarallo, Andrea; Berna, Luisa; Yagi, Mitsuharu; Agnisola, Claudio; D'Onofrio, Giuseppe			Length and GC Content Variability of Introns among Teleostean Genomes in the Light of the Metabolic Rate Hypothesis	PLOS ONE			English	Article							HUMAN HOUSEKEEPING GENES; NONCODING RNAS; EXPRESSION PATTERN; EVOLUTION; SELECTION; SIZE; DNA; TRANSCRIPTOME; TEMPERATURE; VERTEBRATES	A comparative analysis of five teleostean genomes, namely zebrafish, medaka, three-spine stickleback, fugu and pufferfish was performed with the aim to highlight the nature of the forces driving both length and base composition of introns (i.e., bpi and GCi). An inter-genome approach using orthologous intronic sequences was carried out, analyzing independently both variables in pairwise comparisons. An average length shortening of introns was observed at increasing average GCi values. The result was not affected by masking transposable and repetitive elements harbored in the intronic sequences. The routine metabolic rate (mass specific temperature-corrected using the Boltzmann's factor) was measured for each species. A significant correlation held between average differences of metabolic rate, length and GC content, while environmental temperature of fish habitat was not correlated with bpi and GCi. Analyzing the concomitant effect of both variables, i.e., bpi and GCi, at increasing genomic GC content, a decrease of bpi and an increase of GCi was observed for the significant majority of the intronic sequences (from similar to 40% to similar to 90%, in each pairwise comparison). The opposite event, concomitant increase of bpi and decrease of GCi, was counter selected (from <1% to similar to 10%, in each pairwise comparison). The results further support the hypothesis that the metabolic rate plays a key role in shaping genome architecture and evolution of vertebrate genomes.	[Chaurasia, Ankita; Tarallo, Andrea; Berna, Luisa; D'Onofrio, Giuseppe] Stn Zool Anton Dohrn, Dept Anim Physiol & Evolut, Naples, Italy; [Chaurasia, Ankita] CRAG Bellaterra, Barcelona, Spain; [Berna, Luisa] Inst Pasteur Montevideo, Mol Biol Unit, Montevideo, Uruguay; [Yagi, Mitsuharu] Nagasaki Univ, Fac Fisheries, Bunkyo Ku, Nagasaki 852, Japan; [Agnisola, Claudio] Univ Naples Federico II, Dept Biol Sci, Naples, Italy	Stazione Zoologica Anton Dohrn di Napoli; Consejo Superior de Investigaciones Cientificas (CSIC); Centre de Recerca en Agrigenomica (CRAG); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur de Montevideo; Nagasaki University; University of Naples Federico II	D'Onofrio, G (corresponding author), Stn Zool Anton Dohrn, Dept Anim Physiol & Evolut, Naples, Italy.	donofrio@szn.it	Tarallo, Andrea/AAD-4820-2021; Berna, Luisa/L-5561-2013	Berna, Luisa/0000-0002-9358-3414; Yagi, Mitsuharu/0000-0002-1974-3280; AGNISOLA, Claudio/0000-0003-1382-3498; Tarallo, Andrea/0000-0002-2749-8588	National Ministry of Research and Education	National Ministry of Research and Education	Funding for this research was provided by the Public funding of the National Ministry of Research and Education for the Stazione Zoologica A. Dohrn of Naples. SZN supported the PhD fellowship of AC, AT and LB. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arhondakis S, 2004, GENE, V325, P165, DOI 10.1016/j.gene.2003.10.009; Benjamini Y, 1997, SCAND J STAT, V24, P407, DOI 10.1111/1467-9469.00072; Berna L, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-174; Bernardi G, 2004, SRUCTURAL EVOLUTIONA; Carmel L, 2009, GENOME BIOL EVOL, V1, P382, DOI 10.1093/gbe/evp038; Castillo-Davis CI, 2002, NAT GENET, V31, P415, DOI 10.1038/ng940; Chaurasia A, 2011, DOES HABITAT AFFECT; Comeron JM, 2004, GENETICS, V167, P1293, DOI 10.1534/genetics.104.026351; Costantini M, 2007, GENOMICS, V90, P364, DOI 10.1016/j.ygeno.2007.05.006; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; DURET L, 1995, J MOL EVOL, V40, P308, DOI 10.1007/BF00163235; Duret L, 1999, P NATL ACAD SCI USA, V96, P4482, DOI 10.1073/pnas.96.8.4482; Duret L, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000071; Eisenberg E, 2003, TRENDS GENET, V19, P362, DOI 10.1016/S0168-9525(03)00140-9; Federico C, 2006, CHROMOSOMA, V115, P123, DOI 10.1007/s00412-005-0039-z; Fedorova L, 2003, GENETICA, V118, P123, DOI 10.1023/A:1024145407467; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; Hildebrand F, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001107; Howe K, 2013, NATURE, V496, P498, DOI 10.1038/nature12111; HUGHES AL, 1995, NATURE, V377, P391, DOI 10.1038/377391a0; Jabbari K, 2004, GENE, V333, P179, DOI 10.1016/j.gene.2004.02.048; Kai W, 2011, GENOME BIOL EVOL, V3, P424, DOI 10.1093/gbe/evr041; Kandul NP, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-67; Kozlowski J, 2003, P NATL ACAD SCI USA, V100, P14080, DOI 10.1073/pnas.2334605100; Li SW, 2007, BIOCHEM BIOPH RES CO, V360, P586, DOI 10.1016/j.bbrc.2007.06.085; Loh YH, 2008, MOL BIOL EVOL, V25, P526, DOI 10.1093/molbev/msm278; Mattick JS, 2001, EMBO REP, V2, P986, DOI 10.1093/embo-reports/kve230; Mattick JS, 2001, MOL BIOL EVOL, V18, P1611, DOI 10.1093/oxfordjournals.molbev.a003951; Meunier J, 2004, MOL BIOL EVOL, V21, P984, DOI 10.1093/molbev/msh070; Oesterreich FC, 2011, TRENDS CELL BIOL, V21, P328, DOI 10.1016/j.tcb.2011.03.002; OHNO S, 1972, BROOKHAVEN SYM BIOL, P366; Ortiz V, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.238107; Pennisi E, 2012, SCIENCE, V337, P1159, DOI 10.1126/science.337.6099.1159; Rao YS, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-35; Rao YS, 2013, GENET SEL EVOL, V45, DOI 10.1186/1297-9686-45-9; Saccone Salvatore, 2001, Methods in Cell Science, V23, P7, DOI 10.1023/A:1013173011458; Shabalina SA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-4-105; Uliano E, 2010, MAR GENOM, V3, P29, DOI 10.1016/j.margen.2010.02.001; Urrutia AO, 2003, GENOME RES, V13, P2260, DOI 10.1101/gr.641103; Versteeg R, 2003, GENOME RES, V13, P1998, DOI 10.1101/gr.1649303; Vinogradov AE, 2005, NUCLEIC ACIDS RES, V33, P559, DOI 10.1093/nar/gki184; Vinogradov AE, 2004, TRENDS GENET, V20, P248, DOI 10.1016/j.tig.2004.03.006; Vinogradov AE, 1998, CYTOMETRY, V31, P100, DOI 10.1002/(SICI)1097-0320(19980201)31:2<100::AID-CYTO5>3.0.CO;2-Q; Vinogradov AE, 2001, MOL BIOL EVOL, V18, P2195, DOI 10.1093/oxfordjournals.molbev.a003766; Wang DP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017945; Ward LD, 2012, SCIENCE, V337, P1675, DOI 10.1126/science.1225057; Yagi M, 2010, P ROY SOC B-BIOL SCI, V277, P2793, DOI 10.1098/rspb.2010.0583; Zhang Q, 2012, GENOME BIOL EVOL, V4, P1033, DOI 10.1093/gbe/evs070	50	7	8	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e103889	10.1371/journal.pone.0103889	http://dx.doi.org/10.1371/journal.pone.0103889			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093416	Green Published, gold, Green Submitted			2022-12-27	WOS:000341357200040
J	Konda, K; Konishi, K; Yamochi, T; Ito, YM; Nozawa, H; Tojo, M; Shinmura, K; Kogo, M; Katagiri, A; Kubota, Y; Muramoto, T; Yano, Y; Kobayashi, Y; Kihara, T; Tagawa, T; Makino, R; Takimoto, M; Imawari, M; Yoshida, H				Konda, Kenichi; Konishi, Kazuo; Yamochi, Toshiko; Ito, Yoichi M.; Nozawa, Hisako; Tojo, Masayuki; Shinmura, Kensuke; Kogo, Mari; Katagiri, Atsushi; Kubota, Yutaro; Muramoto, Takashi; Yano, Yuichiro; Kobayashi, Yoshiya; Kihara, Toshihiro; Tagawa, Teppei; Makino, Reiko; Takimoto, Masafumi; Imawari, Michio; Yoshida, Hitoshi			Distinct Molecular Features of Different Macroscopic Subtypes of Colorectal Neoplasms	PLOS ONE			English	Article							ISLAND METHYLATOR PHENOTYPE; LATERALLY-SPREADING TUMORS; POPULATION-BASED SERIES; K-RAS; DNA METHYLATION; PIK3CA MUTATION; SERRATED PATHWAY; FLAT; ADENOMAS; CANCER	Background: Colorectal adenoma develops into cancer with the accumulation of genetic and epigenetic changes. We studied the underlying molecular and clinicopathological features to better understand the heterogeneity of colorectal neoplasms (CRNs). Methods: We evaluated both genetic (mutations of KRAS, BRAF, TP53, and PIK3CA, and microsatellite instability [MSI]) and epigenetic (methylation status of nine genes or sequences, including the CpG island methylator phenotype [CIMP] markers) alterations in 158 CRNs including 56 polypoid neoplasms (PNs), 25 granular type laterally spreading tumors (LST-Gs), 48 non-granular type LSTs (LST-NGs), 19 depressed neoplasms (DNs) and 10 small flat-elevated neoplasms (S-FNs) on the basis of macroscopic appearance. Results: S-FNs showed few molecular changes except SFRP1 methylation. Significant differences in the frequency of KRAS mutations were observed among subtypes (68% for LST-Gs, 36% for PNs, 16% for DNs and 6% for LST-NGs) (P<0.001). By contrast, the frequency of TP53 mutation was higher in DNs than PNs or LST-Gs (32% vs. 5% or 0%, respectively) (P<0.007). We also observed significant differences in the frequency of CIMP between LST-Gs and LST-NGs or PNs (32% vs. 6% or 5%, respectively) (P<0.005). Moreover, the methylation level of LINE-1 was significantly lower in DNs or LST-Gs than in PNs (58.3% or 60.5% vs. 63.2%, P<0.05). PIK3CA mutations were detected only in LSTs. Finally, multivariate analyses showed that macroscopic morphologies were significantly associated with an increased risk of molecular changes (PN or LST-G for KRAS mutation, odds ratio [OR] 9.11; LST-NG or DN for TP53 mutation, OR 5.30; LST-G for PIK3CA mutation, OR 26.53; LST-G or DN for LINE-1 hypomethylation, OR 3.41). Conclusion: We demonstrated that CRNs could be classified into five macroscopic subtypes according to clinicopathological and molecular differences, suggesting that different mechanisms are involved in the pathogenesis of colorectal tumorigenesis.	[Konda, Kenichi; Konishi, Kazuo; Nozawa, Hisako; Tojo, Masayuki; Shinmura, Kensuke; Katagiri, Atsushi; Kubota, Yutaro; Muramoto, Takashi; Yano, Yuichiro; Kobayashi, Yoshiya; Kihara, Toshihiro; Tagawa, Teppei; Imawari, Michio; Yoshida, Hitoshi] Showa Univ Sch Med, Dept Med, Div Gastroenterol, Tokyo, Japan; [Yamochi, Toshiko; Takimoto, Masafumi] Showa Univ Sch Med, Dept Pathol, Tokyo, Japan; [Makino, Reiko] Showa Univ Sch Med, Clin Collaborating Lab, Tokyo, Japan; [Kogo, Mari] Showa Univ Sch Pharm, Dept Hosp Pharmaceut, Tokyo, Japan; [Ito, Yoichi M.] Hokkaido Univ Grad Sch Med, Dept Biostat, Sapporo, Hokkaido, Japan	Showa University; Showa University; Showa University; Hokkaido University	Konishi, K (corresponding author), Showa Univ Sch Med, Dept Med, Div Gastroenterol, Tokyo, Japan.	konishimd@med.showa-u.ac.jp		Ito, Yoichi M./0000-0001-5073-0827	Japanese Ministry of Education, Culture, Sports, Science and Technology of Japan	Japanese Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grant-in-Aid for Scientific Research (C) and Supported Program for the Strategic Research Foundation at Private Universities from Japanese Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI M, 1991, DIS COLON RECTUM, V34, P981, DOI 10.1007/BF02049961; An B, 2010, INT J CANCER, V127, P2095, DOI 10.1002/ijc.25225; [Anonymous], 2003, GASTROINTEST ENDOSC, V58, pS3; Barault L, 2008, INT J CANCER, V122, P2255, DOI 10.1002/ijc.23388; BEDENNE L, 1992, CANCER, V69, P883, DOI 10.1002/1097-0142(19920215)69:4<883::AID-CNCR2820690408>3.0.CO;2-B; Beggs AD, 2013, J PATHOL, V229, P697, DOI 10.1002/path.4132; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990; FUJIMORI T, 1994, INT J CANCER, V57, P51, DOI 10.1002/ijc.2910570110; Hinoue T, 2012, GENOME RES, V22, P271, DOI 10.1101/gr.117523.110; Hiraoka S, 2006, GASTROENTEROLOGY, V131, P379, DOI 10.1053/j.gastro.2006.04.027; Issa JP, 2004, NAT REV CANCER, V4, P988, DOI 10.1038/nrc1507; Kaji E, 2011, J GASTROEN HEPATOL, V26, P599, DOI 10.1111/j.1440-1746.2010.06485.x; Kaneko K, 2000, GASTROINTEST ENDOSC, V51, P443, DOI 10.1016/S0016-5107(00)70446-9; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Konishi K, 2004, CLIN CANCER RES, V10, P3082, DOI 10.1158/1078-0432.CCR-03-0334; Konishi K, 2006, BRIT J CANCER, V94, P311, DOI 10.1038/sj.bjc.6602911; Konishi K, 2007, GASTROENTEROLOGY, V132, P1254, DOI 10.1053/j.gastro.2007.01.035; Konishi K, 2007, CANCER J, V13, P49, DOI 10.1097/PPO.0b013e31803c72fe; Konishi K, 2009, CANCER PREV RES, V2, P814, DOI 10.1158/1940-6207.CAPR-09-0054; KUDO S, 1993, ENDOSCOPY, V25, P455, DOI 10.1055/s-2007-1010367; Kudo S, 1997, WORLD J SURG, V21, P694, DOI 10.1007/s002689900293; Kudo S, 2000, WORLD J SURG, V24, P1081, DOI 10.1007/s002680010154; Kudo SE, 1996, GASTROINTEST ENDOSC, V44, P8, DOI 10.1016/S0016-5107(96)70222-5; Leggett B, 2010, GASTROENTEROLOGY, V138, P2088, DOI 10.1053/j.gastro.2009.12.066; Liao XY, 2012, NEW ENGL J MED, V367, P1596, DOI 10.1056/NEJMoa1207756; Matsuzaki K, 2005, CLIN CANCER RES, V11, P8564, DOI 10.1158/1078-0432.CCR-05-0859; MINAMOTO T, 1994, CANCER RES, V54, P2841; MINAMOTO T, 1994, GASTROENTEROLOGY, V106, P1436, DOI 10.1016/0016-5085(94)90395-6; Mollevi DG, 2007, CARCINOGENESIS, V28, P1241, DOI 10.1093/carcin/bgm012; Morita T, 2002, GASTROINTEST ENDOSC, V56, P663, DOI 10.1067/mge.2002.129087; MORSON BC, 1968, BRIT J SURG, V55, P725, DOI 10.1002/bjs.1800551003; Nosho K, 2008, NEOPLASIA, V10, P534, DOI 10.1593/neo.08336; O'Brien MJ, 2004, CLIN GASTROENTEROL H, V2, P905, DOI 10.1016/S1542-3565(04)00392-1; Ogino S, 2005, CLIN CANCER RES, V11, P6650, DOI 10.1158/1078-0432.CCR-05-0738; Ogino S, 2006, J MOL DIAGN, V8, P582, DOI 10.2353/jmoldx.2006.060082; Ogino S, 2013, JNCI-J NATL CANCER I, V105, P1789, DOI 10.1093/jnci/djt298; Peyssonnaux C, 2001, BIOL CELL, V93, P53, DOI 10.1016/S0248-4900(01)01125-X; Phipps AI, 2012, CANCER EPIDEM BIOMAR, V21, P1792, DOI 10.1158/1055-9965.EPI-12-0674; Rembacken BJ, 2000, LANCET, V355, P1211, DOI 10.1016/S0140-6736(00)02086-9; Richter H, 2003, AM J PATHOL, V163, P287, DOI 10.1016/S0002-9440(10)63652-8; Rodriguez J, 2006, CANCER RES, V66, P8462, DOI 10.1158/0008-5472.CAN-06-0293; Saito Y, 2001, ENDOSCOPY, V33, P682, DOI 10.1055/s-2001-16213; Shen LL, 2007, P NATL ACAD SCI USA, V104, P18654, DOI 10.1073/pnas.0704652104; Snover DC, 2011, HUM PATHOL, V42, P1, DOI 10.1016/j.humpath.2010.06.002; Sugimoto T, 2010, INT J CANCER, V127, P1562, DOI 10.1002/ijc.25180; Suzuki H, 2011, CANCER RES, V71, P5646, DOI 10.1158/0008-5472.CAN-11-1076; Takahashi T, 2007, MODERN PATHOL, V20, P139, DOI 10.1038/modpathol.3800722; Voorham QJM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041963; Yagi K, 2010, CLIN CANCER RES, V16, P21, DOI 10.1158/1078-0432.CCR-09-2006; YAMAGATA S, 1994, JPN J CANCER RES, V85, P147, DOI 10.1111/j.1349-7006.1994.tb02075.x; Yamamoto E, 2012, AM J PATHOL, V181, P1847, DOI 10.1016/j.ajpath.2012.08.007; Yamauchi M, 2012, GUT, V61, P847, DOI 10.1136/gutjnl-2011-300865; Yang AS, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh032; Yano Y, 2011, AM J GASTROENTEROL, V106, P1351, DOI 10.1038/ajg.2011.76; Young J, 2006, CANCER EPIDEM BIOMAR, V15, P1778, DOI 10.1158/1055-9965.EPI-06-0164	55	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e103822	10.1371/journal.pone.0103822	http://dx.doi.org/10.1371/journal.pone.0103822			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093594	gold, Green Published, Green Submitted			2022-12-27	WOS:000341357200033
J	Rezola, A; Pey, J; Rubio, A; Planes, FJ				Rezola, Alberto; Pey, Jon; Rubio, Angel; Planes, Francisco J.			In-Silico Prediction of Key Metabolic Differences between Two Non-Small Cell Lung Cancer Subtypes	PLOS ONE			English	Article							ELEMENTARY FLUX MODES; GLOBAL RECONSTRUCTION; BIOMARKERS; PATHWAYS	Metabolism expresses the phenotype of living cells and understanding it is crucial for different applications in biotechnology and health. With the increasing availability of metabolomic, proteomic and, to a larger extent, transcriptomic data, the elucidation of specific metabolic properties in different scenarios and cell types is a key topic in systems biology. Despite the potential of the elementary flux mode (EFM) concept for this purpose, its use has been limited so far, mainly because their computation has been infeasible for genome-scale metabolic networks. In a recent work, we determined a subset of EFMs in human metabolism and proposed a new protocol to integrate gene expression data, spotting key 'characteristic EFMs' in different scenarios. Our approach was successfully applied to identify metabolic differences among several human healthy tissues. In this article, we evaluated the performance of our approach in clinically interesting situation. In particular, we identified key EFMs and metabolites in adenocarcinoma and squamous-cell carcinoma subtypes of non-small cell lung cancers. Results are consistent with previous knowledge of these major subtypes of lung cancer in the medical literature. Therefore, this work constitutes the starting point to establish a new methodology that could lead to distinguish key metabolic processes among different clinical outcomes.	[Planes, Francisco J.] Univ Navarra, Dept Bioinformat, CEIT, San Sebastian, Spain; Univ Navarra, TECNUN, San Sebastian, Spain	University of Navarra; University of Navarra	Planes, FJ (corresponding author), Univ Navarra, Dept Bioinformat, CEIT, San Sebastian, Spain.	fplanes@tecnun.es	Rubio, Angel/M-7387-2019; Planes, Francisco J/H-3341-2013; Rubio, Angel/Y-8610-2019; Rubio, Angel/O-6348-2014; Rezola, Alberto/L-5631-2014	Rubio, Angel/0000-0002-3274-2450; Planes, Francisco J/0000-0003-1155-3105; Rubio, Angel/0000-0002-3274-2450; Rezola, Alberto/0000-0001-9942-5487	Asociacion de Amigos de la Universidad de Navarra; Basque Government	Asociacion de Amigos de la Universidad de Navarra; Basque Government(Basque Government)	Funds were received from Asociacion de Amigos de la Universidad de Navarra to Alberto Rezola and from the Basque Government to Jon Pey. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agren R, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002518; Barrett T, 2011, NUCLEIC ACIDS RES, V39, pD1005, DOI 10.1093/nar/gkq1184; Buszewski B, 2012, CLIN CHEM LAB MED, V50, P573, DOI 10.1515/CCLM.2011.769; Crouser ED, 2009, AM J RESP CRIT CARE, V179, P929, DOI 10.1164/rccm.200803-490OC; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; de Figueiredo LF, 2009, BIOINFORMATICS, V25, P3158, DOI 10.1093/bioinformatics/btp564; Duarte NC, 2007, P NATL ACAD SCI USA, V104, P1777, DOI 10.1073/pnas.0610772104; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Folger O, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.51; Hori S, 2011, LUNG CANCER, V74, P284, DOI 10.1016/j.lungcan.2011.02.008; Jerby L, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.56; Jin MJ, 2009, CANCER SCI, V100, P2325, DOI 10.1111/j.1349-7006.2009.01321.x; Kaleta C, 2009, GENOME RES, V19, P1872, DOI 10.1101/gr.090639.108; Kelloff GJ, 2012, NAT REV DRUG DISCOV, V11, P201, DOI 10.1038/nrd3651; Kuner R, 2009, LUNG CANCER, V63, P32, DOI 10.1016/j.lungcan.2008.03.033; McCall MN, 2011, NUCLEIC ACIDS RES, V39, pD1011, DOI 10.1093/nar/gkq1259; Qu BX, 1996, P NATL ACAD SCI USA, V93, P8995, DOI 10.1073/pnas.93.17.8995; Rezola A, 2011, BIOINFORMATICS, V27, P534, DOI 10.1093/bioinformatics/btq681; Rezola A, 2015, BRIEF BIOINFORM, V16, P265, DOI 10.1093/bib/bbu009; Rezola A, 2013, BIOINFORMATICS, V29, P2009, DOI 10.1093/bioinformatics/btt328; Schuster S, 2000, NAT BIOTECHNOL, V18, P326, DOI 10.1038/73786; Shlomi T, 2008, NAT BIOTECHNOL, V26, P1003, DOI 10.1038/nbt.1487; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Thiele I, 2013, NAT BIOTECHNOL, V31, P419, DOI 10.1038/nbt.2488; van Heijst JWJ, 2006, CANCER LETT, V241, P309, DOI 10.1016/j.canlet.2005.10.042; Vander Heiden MG, 2011, NAT REV DRUG DISCOV, V10, P671, DOI 10.1038/nrd3504; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Wagner C, 2005, BIOPHYS J, V89, P3837, DOI 10.1529/biophysj.104.055129; Wang XJ, 2012, MOL CELL PROTEOMICS, V11, P370, DOI 10.1074/mcp.M111.016006; Zhou XM, 2012, ANAL BIOANAL CHEM, V404, P3123, DOI 10.1007/s00216-012-6432-6	31	11	12	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e103998	10.1371/journal.pone.0103998	http://dx.doi.org/10.1371/journal.pone.0103998			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093336	Green Published, gold, Green Submitted			2022-12-27	WOS:000341357200057
J	Ye, Q; Hu, YF; Jin, CW				Ye, Qian; Hu, Yunfei; Jin, Changwen			Conformational Dynamics of Escherichia coli Flavodoxins in Apo- and Holo-States by Solution NMR Spectroscopy	PLOS ONE			English	Article							CLOSTRIDIUM-BEIJERINCKII FLAVODOXIN; TORSION ANGLE DYNAMICS; BACKBONE DYNAMICS; BIOTIN SYNTHASE; ANABAENA APOFLAVODOXIN; DIFFERENTIATING LOOP; VULGARIS FLAVODOXIN; OXIDIZED FLAVODOXIN; SECONDARY STRUCTURE; ELECTRON-TRANSFER	Flavodoxins are a family of small FMN-binding proteins that commonly exist in prokaryotes. They utilize a non-covalently bound FMN molecule to act as the redox center during the electron transfer processes in various important biological pathways. Although extensive investigations were performed, detailed molecular mechanisms of cofactor binding and electron transfer remain elusive. Herein we report the solution NMR studies on Escherichia coli flavodoxins FldA and YqcA, belonging to the long-chain and short-chain flavodoxin subfamilies respectively. Our structural studies demonstrate that both proteins show the typical flavodoxin fold, with extensive conformational exchanges observed near the FMN binding pocket in their apo-forms. Cofactor binding significantly stabilizes both proteins as revealed by the extension of secondary structures in the holo-forms, and the overall rigidity shown by the backbone dynamics data. However, the 50 s loops of both proteins in the holo-form still show conformational exchanges on the mu s-ms timescales, which appears to be a common feature in the flavodoxin family, and might play an important role in structural fine-tuning during the electron transfer reactions.	[Ye, Qian; Hu, Yunfei; Jin, Changwen] Peking Univ, Beijing Nucl Magnet Resonance Ctr, Beijing 100871, Peoples R China; [Ye, Qian; Jin, Changwen] Peking Univ, Coll Life Sci, Beijing 100871, Peoples R China; [Hu, Yunfei; Jin, Changwen] Peking Univ, Coll Chem & Mol Engn, Beijing 100871, Peoples R China; [Jin, Changwen] Peking Univ, Beijing Natl Lab Mol Sci, Beijing 100871, Peoples R China	Peking University; Peking University; Peking University; Chinese Academy of Sciences; Peking University	Hu, YF (corresponding author), Peking Univ, Beijing Nucl Magnet Resonance Ctr, Beijing 100871, Peoples R China.	yunfei@pku.edu.cn; changwen@pku.edu.cn			National Natural Science Foundation of China [31100525]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by Grant 31100525 from the National Natural Science Foundation of China to YH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astuti Y, 2004, J AM CHEM SOC, V126, P8001, DOI 10.1021/ja0496470; Barsukov I, 1997, J BIOMOL NMR, V10, P63, DOI 10.1023/A:1018313830207; BAX A, 1990, J MAGN RESON, V87, P620, DOI 10.1016/0022-2364(90)90320-9; BIANCHI V, 1993, BIOCHEM BIOPH RES CO, V197, P792, DOI 10.1006/bbrc.1993.2548; Birch OM, 2000, J BIOL CHEM, V275, P32277, DOI 10.1074/jbc.M004497200; BIRCH OM, 1995, J BIOL CHEM, V270, P19158, DOI 10.1074/jbc.270.32.19158; Bollen YJM, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2010; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chang FC, 1999, BIOCHEMISTRY-US, V38, P7168, DOI 10.1021/bi982203u; Chen HC, 2008, BIOCHEMISTRY-US, V47, P13788, DOI 10.1021/bi800954h; de la Pena TC, 2013, J APPL MICROBIOL, V115, P236, DOI 10.1111/jam.12224; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Cremades N, 2005, BIOPHYS CHEM, V115, P267, DOI 10.1016/j.bpc.2004.12.045; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Duggan BM, 2001, J BIOMOL NMR, V19, P321, DOI 10.1023/A:1011227824104; EDMONDSON DE, 1971, BIOCHEMISTRY-US, V10, P124; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Fischer MWF, 1998, P NATL ACAD SCI USA, V95, P8016, DOI 10.1073/pnas.95.14.8016; Fushman D, 1997, J MOL BIOL, V266, P173, DOI 10.1006/jmbi.1996.0771; Genzor CG, 1996, NAT STRUCT BIOL, V3, P329, DOI 10.1038/nsb0496-329; GRZESIEK S, 1993, J MAGN RESON SER B, V101, P114, DOI 10.1006/jmrb.1993.1019; GRZESIEK S, 1993, J BIOMOL NMR, V3, P185; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Hoover DM, 1997, PROTEIN SCI, V6, P2525; Hrovat A, 1997, J BIOMOL NMR, V10, P53, DOI 10.1023/A:1018380509735; Hu YF, 2006, J BIOL CHEM, V281, P35454, DOI 10.1074/jbc.M607336200; Inda LA, 2003, PHYTOCHEMISTRY, V63, P303, DOI 10.1016/S0031-9422(03)00160-2; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kasim M, 2000, BIOCHEMISTRY-US, V39, P15322, DOI 10.1021/bi001519a; Kasim M, 2001, BIOCHEMISTRY-US, V40, P13548, DOI 10.1021/bi011587c; KNIGHT E, 1967, J BIOL CHEM, V242, P1370; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Langdon GM, 2001, PROTEINS, V43, P476, DOI 10.1002/prot.1059; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; LIPARI G, 1982, J AM CHEM SOC, V104, P4559, DOI 10.1021/ja00381a010; Lopez-Llano J, 2004, J BIOL CHEM, V279, P47184, DOI 10.1074/jbc.M405791200; Lopez-Llano J, 2004, J BIOL CHEM, V279, P47177, DOI 10.1074/jbc.M405792200; Lostao A, 2003, J BIOL CHEM, V278, P24053, DOI 10.1074/jbc.M301049200; Lostao A, 2000, J BIOL CHEM, V275, P9518, DOI 10.1074/jbc.275.13.9518; MARION D, 1989, BIOCHEMISTRY-US, V28, P6150, DOI 10.1021/bi00441a004; Marley J, 2001, J BIOMOL NMR, V20, P71, DOI 10.1023/A:1011254402785; Martinez-Julvez M, 2007, PROTEINS, V69, P581, DOI 10.1002/prot.21410; Mayhew SG, 1996, BIOCHEM SOC T, V24, P122, DOI 10.1042/bst0240122; McIver L, 1998, EUR J BIOCHEM, V257, P577, DOI 10.1046/j.1432-1327.1998.2570577.x; O'Farrell PA, 1998, BIOCHEMISTRY-US, V37, P8405, DOI 10.1021/bi973193k; OSBORNE C, 1991, J BACTERIOL, V173, P1729, DOI 10.1128/jb.173.5.1729-1737.1991; Ponstingl H, 1997, EUR J BIOCHEM, V244, P384, DOI 10.1111/j.1432-1033.1997.00384.x; Sancho J, 2006, CELL MOL LIFE SCI, V63, P855, DOI 10.1007/s00018-005-5514-4; Sanyal I, 1996, ARCH BIOCHEM BIOPHYS, V326, P48, DOI 10.1006/abbi.1996.0045; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Sawers G, 1998, MOL MICROBIOL, V29, P945, DOI 10.1046/j.1365-2958.1998.00941.x; Sibille N, 2005, BIOCHEMISTRY-US, V44, P9086, DOI 10.1021/bi050437p; Steensma E, 1998, J MOL BIOL, V282, P653, DOI 10.1006/jmbi.1998.2045; Ye Q, 2013, BIOMOL NMR ASSIGN; Zhang PL, 1997, J MOL BIOL, V272, P443, DOI 10.1006/jmbi.1997.1266	56	8	8	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e103936	10.1371/journal.pone.0103936	http://dx.doi.org/10.1371/journal.pone.0103936			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093851	Green Published, gold, Green Submitted			2022-12-27	WOS:000341357200047
J	Strom, A; Yutzy, B; Kruip, C; Ooms, M; Schloot, NC; Roden, M; Scott, FW; Loewer, J; Holznagel, E				Strom, Alexander; Yutzy, Barbara; Kruip, Carina; Ooms, Mark; Schloot, Nanette C.; Roden, Michael; Scott, Fraser W.; Loewer, Johannes; Holznagel, Edgar			Foodborne Transmission of Bovine Spongiform Encephalopathy to Non-Human Primates Results in Preclinical Rapid-Onset Obesity	PLOS ONE			English	Article							CELLULAR PRION PROTEIN; VARIANT CJD; BRAIN; GUT; MICE; CATTLE; AGENT; CELLS; COMMUNICATION; INFECTION	Obesity has become one of the largest public health challenges worldwide. Recently, certain bacterial and viral pathogens have been implicated in the pathogenesis of obesity. In the present study, we retrospectively analyzed clinical data, plasma samples and post-mortem tissue specimens derived from a risk assessment study in bovine spongiform encephalopathy (BSE)-infected female cynomolgus monkeys (Macaca fascicularis). The original study design aimed to determine minimal infectious doses after oral or intracerebral (i.c.) infection of macaques to assess the risk for humans. High-dose exposures resulted in 100% attack rates and a median incubation time of 4.7 years as described previously. Retrospective analyses of clinical data from high-dosed macaques revealed that foodborne BSE transmission caused rapid weight gain within 1.5 years post infection (beta = 0.915; P<0.0001) which was not seen in age-and sex-matched control animals or i.c. infected animals. The rapid-onset obesity was not associated with impaired pancreatic islet function or glucose metabolism. In the early preclinical phase of oral transmission associated with body weight gain, prion accumulation was confined to the gastrointestinal tract. Intriguingly, immunohistochemical findings suggest that foodborne BSE transmission has a pathophysiological impact on gut endocrine cells which may explain rapid weight gain. To our knowledge, this is the first experimental model which clearly demonstrates that foodborne pathogens can induce obesity.	[Strom, Alexander; Ooms, Mark; Schloot, Nanette C.; Roden, Michael] Leibniz Ctr Diabet Res, German Diabet Ctr, Inst Clin Diabetol, Dusseldorf, Germany; [Yutzy, Barbara; Kruip, Carina; Loewer, Johannes; Holznagel, Edgar] Fed Agcy Vaccines & Biomed, Paul Ehrlich Inst, Langen, Germany; [Roden, Michael] Univ Dusseldorf, Dept Endocrinol & Diabetol, Dusseldorf, Germany; [Scott, Fraser W.] Ottawa Hosp, Res Inst, Chron Dis Program, Ottawa, ON, Canada	Deutsches Diabetes-Zentrum (DDZ); Paul Ehrlich Institute; Heinrich Heine University Dusseldorf; University of Ottawa; Ottawa Hospital Research Institute	Strom, A (corresponding author), Leibniz Ctr Diabet Res, German Diabet Ctr, Inst Clin Diabetol, Dusseldorf, Germany.	alexander.strom@ddz.uni-duesseldorf.de; Edgar.Holznagel@pei.de	Roden, Michael/AAD-3843-2019		European Union [QLK1-2002-01096]; German Ministry of Health, Bonn/Berlin	European Union(European Commission); German Ministry of Health, Bonn/Berlin	This study was performed in partial fulfillment of the study 'BSE in primates' supported by the European Union [QLK1-2002-01096] and by the German Ministry of Health, Bonn/Berlin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almgren M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041652; Amselgruber WM, 2006, HISTOCHEM CELL BIOL, V125, P441, DOI 10.1007/s00418-005-0089-6; Atkinson RL, 2005, INT J OBESITY, V29, P281, DOI 10.1038/sj.ijo.0802830; Beekes M, 2007, FEBS J, V274, P588, DOI 10.1111/j.1742-4658.2007.05631.x; BOLTON DC, 1982, SCIENCE, V218, P1309, DOI 10.1126/science.6815801; Brown KL, 2000, MICROSC RES TECHNIQ, V50, P40, DOI 10.1002/1097-0029(20000701)50:1<40::AID-JEMT7>3.0.CO;2-M; Bruce ME, 1997, NATURE, V389, P498, DOI 10.1038/39057; CARP RI, 1989, J GEN VIROL, V70, P827, DOI 10.1099/0022-1317-70-4-827; CARP RI, 1990, J INFECT DIS, V161, P462, DOI 10.1093/infdis/161.3.462; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; Cummings DE, 2007, J CLIN INVEST, V117, P13, DOI 10.1172/JCI30227; DAWSON M, 1990, VET REC, V126, P112; EISSELE R, 1992, EUR J CLIN INVEST, V22, P283, DOI 10.1111/j.1365-2362.1992.tb01464.x; Field BCT, 2010, NAT REV ENDOCRINOL, V6, P444, DOI 10.1038/nrendo.2010.93; Finan B, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007218; Holst JJ, 2013, INT J OBESITY, V37, P1161, DOI 10.1038/ijo.2012.208; Holznagel E, 2013, EMERG INFECT DIS, V19, P712, DOI 10.3201/eid1905.120274; Kaatz M, 2012, AM J PATHOL, V181, P515, DOI 10.1016/j.ajpath.2012.05.001; KIM YS, 1987, J INFECT DIS, V156, P402, DOI 10.1093/infdis/156.2.402; Kujala P, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002449; Lasmezas CI, 2005, LANCET, V365, P781, DOI 10.1016/S0140-6736(05)17985-9; Lawson VA, 2010, GUT, V59, P1643, DOI 10.1136/gut.2010.222620; Linden R, 2008, PHYSIOL REV, V88, P673, DOI 10.1152/physrev.00007.2007; LYONS MJ, 1982, SCIENCE, V216, P82, DOI 10.1126/science.7038878; Mayer EA, 2011, NAT REV NEUROSCI, V12, P453, DOI 10.1038/nrn3071; Miranda A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018422; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; SJOLUND K, 1983, GASTROENTEROLOGY, V85, P1120; Steinacker P, 2010, AM J PATHOL, V176, P1409, DOI 10.2353/ajpath.2010.090355; Stella R, 2010, MOL CELL BIOL, V30, P4864, DOI 10.1128/MCB.01040-09; Strom A, 2013, VET PATHOL, V50, P909, DOI 10.1177/0300985813476057; Strom A, 2007, LAB INVEST, V87, P139, DOI 10.1038/labinvest.3700500; Strom A, 2011, EUR J CELL BIOL, V90, P414, DOI 10.1016/j.ejcb.2010.11.015; Strom A, 2011, PANCREAS, V40, P229, DOI 10.1097/MPA.0b013e3181f7e547; Valleron AJ, 2001, SCIENCE, V294, P1726, DOI 10.1126/science.1066838; Weissmann C, 2004, NAT REV MICROBIOL, V2, P861, DOI 10.1038/nrmicro1025; Wells GAH, 2007, J GEN VIROL, V88, P1363, DOI 10.1099/vir.0.82421-0; WELLS GAH, 1987, VET REC, V121, P419, DOI 10.1136/vr.121.18.419; Will RG, 1996, LANCET, V347, P921, DOI 10.1016/S0140-6736(96)91412-9; Yi CX, 2012, DIS MODEL MECH, V5, P583, DOI 10.1242/dmm.009902; Yutzy B, 2007, J GEN VIROL, V88, P3469, DOI 10.1099/vir.0.83128-0; Zinn AR, 2010, AM J MED SCI, V340, P481, DOI 10.1097/MAJ.0b013e3181ccb980	42	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e104343	10.1371/journal.pone.0104343	http://dx.doi.org/10.1371/journal.pone.0104343			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25090610	Green Published, gold, Green Submitted			2022-12-27	WOS:000339812700118
J	Sue, YM; Chou, HC; Chang, CC; Yang, NJ; Chou, Y; Juan, SH				Sue, Yuh-Mou; Chou, Hsiu-Chu; Chang, Chih-Cheng; Yang, Nian-Jie; Chou, Ying; Juan, Shu-Hui			L-Carnitine Protects against Carboplatin-Mediated Renal Injury: AMPK- and PPAR alpha-Dependent Inactivation of NFAT3	PLOS ONE			English	Article							ACTIVATED RECEPTOR-ALPHA; SPONTANEOUSLY HYPERTENSIVE-RATS; PROPIONYL-L-CARNITINE; NF-KAPPA-B; GENE-EXPRESSION; MUSCLE-CELLS; INDUCTION; CISPLATIN; MECHANISM; APOPTOSIS	We have previously shown that carboplatin induces inflammation and apoptosis in renal tubular cells (RTCs) through the activation of the nuclear factor of activated T cells-3 (NFAT3) protein by reactive oxygen species (ROS), and that the ROS-mediated activation of NFAT3 is prevented by N-acetyl cysteine and heme oxygenase-1 treatment. In the current study, we investigated the underlying molecular mechanisms of the protective effect of L-carnitine on carboplatin-mediated renal injury. Balb/c mice and RTCs were used as model systems. Carboplatin-induced apoptosis in RTCs was examined using terminal-deoxynucleotidyl-transferase-mediated dUTP nick end labeling. We evaluated the effects of the overexpression of the peroxisome-proliferator-activated receptor alpha (PPAR alpha) protein, the knockdown of PPAR alpha gene, and the blockade of AMPK activation and PPAR alpha to investigate the underlying mechanisms of the protective effect of L-carnitine on carboplatin-mediated renal injury. Carboplatin reduced the nuclear translocation, phosphorylation, and peroxisome proliferator responsive element transactivational activity of PPAR alpha. These carboplatin-mediated effects were prevented by L-carnitine through a mechanism dependent on AMPK phosphorylation and subsequent PPAR alpha activation. The activation of PPAR alpha induced cyclooxygenase 2 (COX-2) and prostacyclin (PGI2) synthase expression that formed a positive feedback loop to further activate PPAR alpha. The coimmunoprecipitation of the nuclear factor (NF) kappa B proteins increased following the induction of PPAR alpha by L-carnitine, which reduced NF kappa B transactivational activity and cytokine expression. The in vivo study showed that the inactivation of AMPK suppressed the protective effect of L-carnitine in carboplatin-treated mice, indicating that AMPK phosphorylation is required for PPAR alpha activation in the L-carnitine-mediated protection of RTC apoptosis caused by carboplatin. The results of our study provide molecular evidence that L-carnitine prevents carboplatin-mediated apoptosis through AMPK-mediated PPAR alpha activation.	[Sue, Yuh-Mou] Taipei Med Univ, Wan Fang Hosp, Dept Nephrol, Taipei, Taiwan; [Chou, Hsiu-Chu] Taipei Med Univ, Coll Med, Sch Med, Dept Anat, Taipei, Taiwan; [Chang, Chih-Cheng; Yang, Nian-Jie; Chou, Ying; Juan, Shu-Hui] Taipei Med Univ, Grad Inst Med Sci, Taipei, Taiwan; [Chang, Chih-Cheng; Yang, Nian-Jie; Chou, Ying; Juan, Shu-Hui] Taipei Med Univ, Coll Med, Sch Med, Dept Physiol, Taipei, Taiwan	Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University; Taipei Medical University; Taipei Medical University	Juan, SH (corresponding author), Taipei Med Univ, Grad Inst Med Sci, Taipei, Taiwan.	juansh@tmu.edu.tw			Wan Fang Hospital; Taipei Medical University [100TMU-WFH-06, 101TMU-WFH-09]; National Science Council, Taiwan [NSC100-2320-B-038-016-MY2(1-2), NSC102-2320-B-038-030-MY3(1-3)]	Wan Fang Hospital; Taipei Medical University; National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This study was funded by grants from Wan Fang Hospital and Taipei Medical University (100TMU-WFH-06 and 101TMU-WFH-09) and the National Science Council, Taiwan (NSC100-2320-B-038-016-MY2(1-2) and NSC102-2320-B-038-030-MY3(1-3)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERTS DS, 1995, SEMIN ONCOL, V22, P88; Ardizzoni A, 2007, J NATL CANCER I, V99, P847, DOI 10.1093/jnci/djk196; Best CJM, 1999, IN VITRO CELL DEV-AN, V35, P205, DOI 10.1007/s11626-999-0028-2; Bueno R, 2005, LIFE SCI, V77, P2082, DOI 10.1016/j.lfs.2005.01.035; Caito S, 2008, ANTIOXID REDOX SIGN, V10, P253, DOI 10.1089/ars.2007.1889; Chen HH, 2009, AM J PHYSIOL-RENAL, V297, pF1109, DOI 10.1152/ajprenal.00057.2009; Chen HH, 2009, NEPHROL DIAL TRANSPL, V24, P3042, DOI 10.1093/ndt/gfp258; Cipolla MJ, 1999, J VASC SURG, V29, P1097, DOI 10.1016/S0741-5214(99)70251-X; DELARCO JE, 1978, J CELL PHYSIOL, V94, P335, DOI 10.1002/jcp.1040940311; Delerive P, 1999, J BIOL CHEM, V274, P32048, DOI 10.1074/jbc.274.45.32048; Delerive P, 2000, J BIOL CHEM, V275, P36703, DOI 10.1074/jbc.M004045200; Evans RM, 2004, NAT MED, V10, P355, DOI 10.1038/nm1025; Ferrari R, 2004, ANN NY ACAD SCI, V1033, P79, DOI 10.1196/annals.1320.007; Fujiwara K, 2003, GYNECOL ONCOL, V90, P637, DOI 10.1016/S0090-8258(03)00377-9; GARRELDS IM, 1994, BRIT J NUTR, V72, P785, DOI 10.1079/BJN19940080; Gilroy DW, 1999, NAT MED, V5, P698, DOI 10.1038/9550; Groeger AL, 2010, NAT CHEM BIOL, V6, P433, DOI 10.1038/nchembio.367; He TC, 1999, CELL, V99, P335, DOI 10.1016/S0092-8674(00)81664-5; Herrera MD, 2002, J PHARM PHARMACOL, V54, P1423, DOI 10.1211/002235702760345536; Husain K, 2001, HEARING RES, V151, P71, DOI 10.1016/S0300-2977(00)00081-4; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Juge-Aubry CE, 1999, J BIOL CHEM, V274, P10505, DOI 10.1074/jbc.274.15.10505; Kockx M, 1999, BLOOD, V93, P2991; Lee FP, 2010, J CELL PHYSIOL, V224, P837, DOI 10.1002/jcp.22192; Lee SK, 2011, J CELL BIOCHEM, V112, P1259, DOI 10.1002/jcb.23000; Lim H, 2002, ENDOCRINOLOGY, V143, P3207, DOI 10.1210/en.2002-220159; Lin H, 2010, BRIT J PHARMACOL, V161, P1661, DOI 10.1111/j.1476-5381.2010.00989.x; Lin H, 2010, AM J PATHOL, V177, P1697, DOI 10.2353/ajpath.2010.090789; MacAulay K, 2005, J BIOL CHEM, V280, P9509, DOI 10.1074/jbc.M411648200; Madej A, 1998, INT J CLIN PHARM TH, V36, P345; Marx N, 1999, CIRCULATION, V99, P3125, DOI 10.1161/01.CIR.99.24.3125; Miguel-Carrasco JL, 2010, EUR J PHARMACOL, V632, P65, DOI 10.1016/j.ejphar.2010.01.017; Neve BP, 2001, CIRCULATION, V103, P207; Ning WH, 2013, VASCUL PHARM; Odriozola L, 2007, J BIOL CHEM, V282, P23306, DOI 10.1074/jbc.M611240200; Pisano C, CLIN CANC RES, V16, P3944; Santana-Davila R, 2014, J THORAC ONCOL, V9, P702, DOI 10.1097/JTO.0000000000000146; Shalev A, 1996, ENDOCRINOLOGY, V137, P4499, DOI 10.1210/en.137.10.4499; Staels B, 1998, NATURE, V393, P790, DOI 10.1038/31701; Steiber Alison, 2004, Molecular Aspects of Medicine, V25, P455, DOI 10.1016/j.mam.2004.06.006; Sue YM, 2011, BRIT J PHARMACOL, V162, P1716, DOI 10.1111/j.1476-5381.2010.01189.x	41	10	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e104079	10.1371/journal.pone.0104079	http://dx.doi.org/10.1371/journal.pone.0104079			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25090113	gold, Green Published, Green Submitted			2022-12-27	WOS:000339812700094
J	Wang, ZL; Fang, Q; Han, ZL; Pan, JX; Li, XH; Li, N; Tang, HH; Wang, P; Zheng, T; Chang, XM; Wang, R				Wang, Zi-long; Fang, Quan; Han, Zheng-lan; Pan, Jia-xin; Li, Xu-hui; Li, Ning; Tang, Hong-hai; Wang, Pei; Zheng, Ting; Chang, Xue-mei; Wang, Rui			Opposite Effects of Neuropeptide FF on Central Antinociception Induced by Endomorphin-1 and Endomorphin-2 in Mice	PLOS ONE			English	Article							RAT DORSAL RAPHE; PHARMACOLOGICAL CHARACTERIZATION; DIFFERENTIAL MECHANISMS; SPINAL ANTINOCICEPTION; MAMMALIAN NEUROPEPTIDE; POSSIBLE INVOLVEMENT; MODULATING PEPTIDES; RECEPTOR ANTAGONIST; MORPHINE ANALGESIA; OPIOID ACTIVITIES	Neuropeptide FF (NPFF) is known to be an endogenous opioid-modulating peptide. Nevertheless, very few researches focused on the interaction between NPFF and endogenous opioid peptides. In the present study, we have investigated the effects of NPFF system on the supraspinal antinociceptive effects induced by the endogenous m-opioid receptor agonists, endomorphin-1 (EM-1) and endomorphin-2 (EM-2). In the mouse tail-flick assay, intracerebroventricular injection of EM-1 induced antinociception via mu-opioid receptor while the antinociception of intracerebroventricular injected EM-2 was mediated by both mu- and kappa-opioid receptors. In addition, central administration of NPFF significantly reduced EM-1-induced central antinociception, but enhanced EM-2-induced central antinociception. The results using the selective NPFF1 and NPFF2 receptor agonists indicated that the EM-1-modulating action of NPFF was mainly mediated by NPFF2 receptor, while NPFF potentiated EM-2-induecd antinociception via both NPFF1 and NPFF2 receptors. To further investigate the roles of mu- and kappa-opioid systems in the opposite effects of NPFF on central antinociception of endomprphins, the mu- and kappa-opioid receptors selective agonists DAMGO and U69593, respectively, were used. Our results showed that NPFF could reduce the central antinociception of DAMGO via NPFF2 receptor and enhance the central antinociception of U69593 via both NPFF1 and NPFF2 receptors. Taken together, our data demonstrate that NPFF exerts opposite effects on central antinociception of endomorphins and provide the first evidence that NPFF potentiate antinociception of EM-2, which might result from the interaction between NPFF and kappa-opioid systems.	[Wang, Rui] Lanzhou Univ, Sch Basic Med Sci, Key Lab Preclin Study New Drugs Gansu Prov, Lanzhou 730000, Peoples R China; Lanzhou Univ, Sch Basic Med Sci, Inst Physiol, Lanzhou 730000, Peoples R China	Lanzhou University; Lanzhou University	Wang, R (corresponding author), Lanzhou Univ, Sch Basic Med Sci, Key Lab Preclin Study New Drugs Gansu Prov, Lanzhou 730000, Peoples R China.	wangrui@lzu.edu.cn	Wang, Zilong/AAB-4143-2019; Wang, Zilong/AEY-8544-2022; Wang, Zilong/P-7047-2017; Li, Xuhui/V-2692-2019	Wang, Zilong/0000-0001-7473-0354; Wang, Zilong/0000-0001-7473-0354; Li, Xuhui/0000-0003-4376-6252; Fang, Quan/0000-0003-0381-6796	National Natural Science Foundation of China [81273355]; Key National S&T Program of the Ministry of Science and Technology [2012ZX09504001-003]; Program for Changjiang Scholars and Innovative Research Team in University [IRT1137]; Program for New Century Excellent Talents in University [NCET-13-0257]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key National S&T Program of the Ministry of Science and Technology; Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This study was supported by the grants from the National Natural Science Foundation of China (No. 81273355), the Key National S&T Program of the Ministry of Science and Technology (2012ZX09504001-003), Program for Changjiang Scholars and Innovative Research Team in University (IRT1137), and Program for New Century Excellent Talents in University (NCET-13-0257). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonini JA, 2000, J BIOL CHEM, V275, P39324, DOI 10.1074/jbc.M004385200; Brown RM, 2012, DRUG ALCOHOL DEPEN, V123, P264, DOI 10.1016/j.drugalcdep.2011.11.002; Desprat C, 1997, NEUROPEPTIDES, V31, P1, DOI 10.1016/S0143-4179(97)90010-X; Elshourbagy NA, 2000, J BIOL CHEM, V275, P25965, DOI 10.1074/jbc.M004515200; Fang Q, 2008, REGUL PEPTIDES, V147, P45, DOI 10.1016/j.regpep.2007.12.007; Fang Q, 2012, NEUROPHARMACOLOGY, V62, P855, DOI 10.1016/j.neuropharm.2011.09.013; Fang Q, 2011, PROTEIN PEPTIDE LETT, V18, P403, DOI 10.2174/092986611794654012; GICQUEL S, 1993, PEPTIDES, V14, P749, DOI 10.1016/0196-9781(93)90108-S; Goldberg IE, 1998, J PHARMACOL EXP THER, V286, P1007; Gouarderes C, 2007, NEUROPHARMACOLOGY, V52, P376, DOI 10.1016/j.neuropharm.2006.07.034; GOUARDERES C, 1993, EUR J PHARMACOL, V237, P73, DOI 10.1016/0014-2999(93)90095-Y; Han ZL, 2013, BEHAV BRAIN RES, V248, P51, DOI 10.1016/j.bbr.2013.03.046; Hinuma S, 2000, NAT CELL BIOL, V2, P703, DOI 10.1038/35036326; Kersante F, 2006, PEPTIDES, V27, P980, DOI 10.1016/j.peptides.2005.07.025; KONTINEN VK, 1995, PEPTIDES, V16, P973, DOI 10.1016/0196-9781(95)00068-U; Leitermann RJ, 2004, EUR J PHARMACOL, V504, P177, DOI 10.1016/j.ejphar.2004.10.006; Liu QY, 2001, J BIOL CHEM, V276, P36961, DOI 10.1074/jbc.M105308200; Mizoguchi H, 2006, J PHARMACOL EXP THER, V317, P362, DOI 10.1124/jpet.105.098293; Mollereau C, 2005, CURR TOP MED CHEM, V5, P341, DOI 10.2174/1568026053544515; Mollereau C, 2005, MOL PHARMACOL, V67, P965, DOI 10.1124/mol.104.004614; Mollereau C, 2002, EUR J PHARMACOL, V451, P245, DOI 10.1016/S0014-2999(02)02224-0; Mouledous L, 2010, BIOFACTORS, V36, P423, DOI 10.1002/biof.116; OBERLING P, 1993, PEPTIDES, V14, P919, DOI 10.1016/0196-9781(93)90067-Q; Ohsawa M, 2000, J PHARMACOL EXP THER, V294, P1106; Osikowicz M, 2008, PAIN, V139, P117, DOI 10.1016/j.pain.2008.03.017; Panula P, 1999, BRAIN RES, V848, P191, DOI 10.1016/S0006-8993(99)02044-2; Panula P, 1996, PROG NEUROBIOL, V48, P461, DOI 10.1016/0301-0082(96)00001-9; Perry SJ, 1997, FEBS LETT, V409, P426, DOI 10.1016/S0014-5793(97)00557-7; Picker MJ, 2011, BEHAV PHARMACOL, V22, P785, DOI 10.1097/FBP.0b013e32834d13a2; Quelven I, 2005, EUR J PHARMACOL, V508, P107, DOI 10.1016/j.ejphar.2004.12.002; RAFFA RB, 1989, PEPTIDES, V10, P873, DOI 10.1016/0196-9781(89)90127-7; Rebeyrolles S, 1996, NEUROREPORT, V7, P2979, DOI 10.1097/00001756-199611250-00036; Roumy M, 1999, BRAIN RES, V845, P208, DOI 10.1016/S0006-8993(99)01965-4; Roumy M, 1998, EUR J PHARMACOL, V345, P1, DOI 10.1016/S0014-2999(97)01604-X; Roumy M, 2003, NEUROSCI LETT, V348, P159, DOI 10.1016/S0304-3940(03)00791-2; Roumy M, 2007, J BIOL CHEM, V282, P8332, DOI 10.1074/jbc.M606946200; Roussin A, 2005, BIOCHEM BIOPH RES CO, V336, P197, DOI 10.1016/j.bbrc.2005.08.060; Sakurada S, 1999, EUR J PHARMACOL, V372, P25, DOI 10.1016/S0014-2999(99)00181-8; Sakurada S, 2008, PEPTIDES, V29, P1554, DOI 10.1016/j.peptides.2008.04.012; Simonin F, 2006, P NATL ACAD SCI USA, V103, P466, DOI 10.1073/pnas.0502090103; Spetea M, 1998, BIOCHEM BIOPH RES CO, V250, P720, DOI 10.1006/bbrc.1998.9395; Stone LS, 1997, NEUROREPORT, V8, P3131, DOI 10.1097/00001756-199709290-00025; Terashvili M, 2005, J PHARMACOL EXP THER, V312, P1257, DOI 10.1124/jpet.104.076224; Tseng LF, 2002, JPN J PHARMACOL, V89, P216, DOI 10.1254/jjp.89.216; Tseng LF, 2000, J PHARMACOL EXP THER, V292, P576; Vilim FS, 1999, MOL PHARMACOL, V55, P804; YANG HYT, 1985, P NATL ACAD SCI USA, V82, P7757, DOI 10.1073/pnas.82.22.7757; Zadina JE, 1997, NATURE, V386, P499, DOI 10.1038/386499a0	48	8	8	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103773	10.1371/journal.pone.0103773	http://dx.doi.org/10.1371/journal.pone.0103773			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25090615	Green Published, gold, Green Submitted			2022-12-27	WOS:000339812700053
J	Zhang, Y; Kim, JY; Horst, O; Nakano, Y; Zhu, L; Radlanski, RJ; Ho, S; Den Besten, PK				Zhang, Yan; Kim, Ji-Yeon; Horst, Orapin; Nakano, Yukiko; Zhu, Li; Radlanski, Ralf J.; Ho, Sunita; Den Besten, Pamela K.			Fluorosed Mouse Ameloblasts Have Increased SATB1 Retention and G alpha q Activity	PLOS ONE			English	Article							CELLS IN-VITRO; DEVELOPING DENTAL ENAMEL; SODIUM-FLUORIDE; BINDING PROTEIN; MATRIX; GENES; DIFFERENTIATION; AMELOGENESIS; MODULATION; MECHANISMS	Dental fluorosis is characterized by subsurface hypomineralization and increased porosity of enamel, associated with a delay in the removal of enamel matrix proteins. To investigate the effects of fluoride on ameloblasts, A/J mice were given 50 ppm sodium fluoride in drinking water for four weeks, resulting serum fluoride levels of 4.5 mu M, a four-fold increase over control mice with no fluoride added to drinking water. MicroCT analyses showed delayed and incomplete mineralization of fluorosed incisor enamel as compared to control enamel. A microarray analysis of secretory and maturation stage ameloblasts microdissected from control and fluorosed mouse incisors showed that genes clustered with Mmp20 appeared to be less downregulated in maturation stage ameloblasts of fluorosed incisors as compared to control maturation ameloblasts. One of these Mmp20 co-regulated genes was the global chromatin organizer, special AT-rich sequence-binding protein-1 (SATB1). Immunohistochemical analysis showed increased SATB1 protein present in fluorosed ameloblasts compared to controls. In vitro, exposure of human ameloblast-lineage cells to micromolar levels of both NaF and AlF3 led to a significantly increase in SATB1 protein content, but not levels of Satb1 mRNA, suggesting a fluoride-induced mechanism protecting SABT1 from degradation. Consistent with this possibility, we used immunohistochemistry and Western blot to show that fluoride exposed ameloblasts had increased phosphorylated PKC alpha both in vivo and in vitro. This kinase is known to phosphorylate SATB1, and phosphorylation is known to protect SATB1 from degradation by caspase-6. In addition, production of cellular diacylglycerol (DAG) was significantly increased in fluorosed ameloblasts, suggesting that the increased phosphorylation of SATB1 may be related to an effect of fluoride to enhance G alpha q activity of secretory ameloblasts.	[Zhang, Yan; Nakano, Yukiko; Zhu, Li; Den Besten, Pamela K.] Univ Calif San Francisco, Dept Orofacial Sci, San Francisco, CA 94143 USA; [Kim, Ji-Yeon] Pusan Natl Univ, Dent Res Inst, Dept Pediat Dent, Pusan 609735, South Korea; [Horst, Orapin; Ho, Sunita] Univ Calif San Francisco, Dept Prevent & Restorat Dent Sci, San Francisco, CA 94143 USA; [Radlanski, Ralf J.] Free Univ Berlin, Ctr Dent & Craniofacial Sci, Dept Craniofacial Dev Biol, Charite Campus Benjamin Franklin, Berlin, Germany	University of California System; University of California San Francisco; Pusan National University; University of California System; University of California San Francisco; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Den Besten, PK (corresponding author), Univ Calif San Francisco, Dept Orofacial Sci, San Francisco, CA 94143 USA.	Pamela.denbesten@ucsf.edu	Nakano, Yukiko/E-1019-2015; Ho, Sunita P/B-1084-2008	Radlanski, Ralf Johannes/0000-0001-7090-5225; Nakano, Yukiko/0000-0002-1799-1205	NIH/NIDCR [R56 DE13508]; Department of Orofacial Sciences at UCSF; NIH S10 Shared Instrumentation Grant [S10RR026645]; Departments of Preventive and Restorative Dental Sciences and Orofacial Sciences, School of Dentistry at UCSF; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026645] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [K08DE022377] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R56DE013508] Funding Source: NIH RePORTER	NIH/NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Department of Orofacial Sciences at UCSF; NIH S10 Shared Instrumentation Grant; Departments of Preventive and Restorative Dental Sciences and Orofacial Sciences, School of Dentistry at UCSF; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study was supported by NIH/NIDCR grants R56 DE13508 to Pamela K. Den Besten, and the funds from the Department of Orofacial Sciences at UCSF. The Micro-CT Imaging facility was supported by NIH S10 Shared Instrumentation Grant (S10RR026645) and Departments of Preventive and Restorative Dental Sciences and Orofacial Sciences, School of Dentistry at UCSF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez JD, 2000, GENE DEV, V14, P521; Bartlett JD, 1999, CRIT REV ORAL BIOL M, V10, P425, DOI 10.1177/10454411990100040101; Bartlett JD, 2005, J DENT RES, V84, P832, DOI 10.1177/154405910508400910; BAWDEN JW, 1989, J DENT RES, V68, P1169, DOI 10.1177/00220345890680070601; Bronckers ALJJ, 2009, J DENT RES, V88, P877, DOI 10.1177/0022034509343280; DenBesten P K, 1989, Adv Dent Res, V3, P199; DenBesten P, 2011, MONOGR ORAL SCI, V22, P81, DOI 10.1159/000327028; DenBesten PK, 2011, EUR J ORAL SCI, V119, P3, DOI 10.1111/j.1600-0722.2011.00903.x; DENBESTEN PK, 1985, J DENT RES, V64, P1365, DOI 10.1177/00220345850640120701; Everett ET, 2011, EUR J ORAL SCI, V119, P8, DOI 10.1111/j.1600-0722.2011.00868.x; Everett ET, 2002, J DENT RES, V81, P794, DOI 10.1177/0810794; Fessing MY, 2011, J CELL BIOL, V194, P825, DOI 10.1083/jcb.201101148; Fincham AG, 1999, J STRUCT BIOL, V126, P270, DOI 10.1006/jsbi.1999.4130; Galande S, 2001, MOL CELL BIOL, V21, P5591, DOI 10.1128/MCB.21.16.5591-5604.2001; He PP, 2010, MATRIX BIOL, V29, P411, DOI 10.1016/j.matbio.2010.03.001; Hurowitz EH, 2000, DNA RES, V7, P111, DOI 10.1093/dnares/7.2.111; KIERDORF U, 1993, ARCH ORAL BIOL, V38, P1071, DOI 10.1016/0003-9969(93)90169-M; Kubota K, 2005, J BIOL CHEM, V280, P23194, DOI 10.1074/jbc.M503288200; Li L, 2003, CRIT REV ORAL BIOL M, V14, P100, DOI 10.1177/154411130301400204; Li Y, 2005, ARCH ORAL BIOL, V50, P681, DOI 10.1016/j.archoralbio.2004.11.021; Matsuo S, 1996, ARCH TOXICOL, V70, P420, DOI 10.1007/s002040050294; Morris AJ, 1999, PHYSIOL REV, V79, P1373, DOI 10.1152/physrev.1999.79.4.1373; Ribeiro DA, 2006, J MOL HISTOL, V37, P361, DOI 10.1007/s10735-006-9065-2; Shimizu D, 2008, ANAT REC, V291, P175, DOI 10.1002/ar.20633; SIMMER JP, 1995, CRIT REV ORAL BIOL M, V6, P84, DOI 10.1177/10454411950060020701; SMID JR, 1990, ARCH ORAL BIOL, V35, P671, DOI 10.1016/0003-9969(90)90035-9; SMITH CE, 1993, ANAT RECORD, V237, P243, DOI 10.1002/ar.1092370212; Smith CE, 2011, EUR J ORAL SCI, V119, P125, DOI 10.1111/j.1600-0722.2011.00871.x; SUCKLING G, 1984, ARCH ORAL BIOL, V29, P165, DOI 10.1016/0003-9969(84)90050-5; Takano Y, 2006, EUR J ORAL SCI, V114, P52, DOI 10.1111/j.1600-0722.2006.00295.x; Tan J.A., MOL CELL BIOL, V30, P2823; Tan JAT, 2008, J BIOL CHEM, V283, P18124, DOI 10.1074/jbc.M800512200; Tan JAT, 2010, MOL CELL BIOL, V30, P2823, DOI 10.1128/MCB.01603-09; TAVES DR, 1968, TALANTA, V15, P1015, DOI 10.1016/0039-9140(68)80109-2; Toker A, 2004, PROTEIN KINASE C, P64; WALTON RE, 1974, ARCH ORAL BIOL, V19, P171, DOI 10.1016/0003-9969(74)90212-X; Yan Q, 2007, J DENT RES, V86, P336, DOI 10.1177/154405910708600407; Yan QM, 2006, EUR J ORAL SCI, V114, P154, DOI 10.1111/j.1600-0722.2006.00304.x; Yasui D, 2002, NATURE, V419, P641, DOI 10.1038/nature01084; Zhang Y, 2006, EUR J ORAL SCI, V114, P105, DOI 10.1111/j.1600-0722.2006.00303.x	40	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103994	10.1371/journal.pone.0103994	http://dx.doi.org/10.1371/journal.pone.0103994			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25090413	Green Published, Green Submitted, gold			2022-12-27	WOS:000339812700074
J	Gu, YX; Cheng, Y; Song, Y; Zhang, ZJ; Deng, M; Wang, CK; Zheng, GP; He, ZM				Gu, Yixue; Cheng, Ye; Song, Ying; Zhang, Zhijie; Deng, Min; Wang, Chengkun; Zheng, Guopei; He, Zhimin			MicroRNA-493 Suppresses Tumor Growth, Invasion and Metastasis of Lung Cancer by Regulating E2F1	PLOS ONE			English	Article							TRANSCRIPTION FACTOR E2F-1; BLADDER-CANCER; K-RAS; CELLS; PROGRESSION; EXPRESSION; MELANOMA; GENE; TRANSFORMATION; PROLIFERATION	miRNAs have been proposed to be key regulators of progression and metastasis in cancer. However, an understanding of their roles and molecular mechanisms is needed to provide deeper insights for better therapeutic opportunities. In this study we investigated the role and mechanism of miR-493 in the development and progression of nonsmall-cell lung cancer (NSCLC). Our data indicated that the expression of miR-493 was markedly reduced in pulmonary carcinoma. The ectopic expression of miR-493 impaired cell growth and invasion in vitro and in vivo. Mechanically, miR-493 commonly directly targeted E2F1, which resulted in a robust reduction of the expression of mRNA and protein. This effect, in turn, decreased the growth, invasion and metastasis of lung cancer cells. Our findings highlight the importance of miR-493 dysfunction in promoting tumor progression, and implicate miR-493 as a potential therapeutic target in lung cancer.	[Gu, Yixue; Cheng, Ye; Song, Ying; Zhang, Zhijie; Deng, Min; Wang, Chengkun; Zheng, Guopei; He, Zhimin] Guangzhou Med Univ, Canc Res Inst, Guangzhou, Guangdong, Peoples R China; [Gu, Yixue; Cheng, Ye; Song, Ying; Zhang, Zhijie; Deng, Min; Wang, Chengkun; Zheng, Guopei; He, Zhimin] Guangzhou Med Univ, Canc Hosp, Guangzhou, Guangdong, Peoples R China; [Gu, Yixue] Univ South China, Sch Med, Hengyang, Hunan, Peoples R China	Guangzhou Medical University; Guangzhou Medical University; University of South China	He, ZM (corresponding author), Guangzhou Med Univ, Canc Res Inst, Guangzhou, Guangdong, Peoples R China.	hezhimin2005@yahoo.com			China Postdoctoral Science Foundation [2012M521588]	China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	The study was financially supported by grants from the China Postdoctoral Science Foundation (Project Code: 2012M521588), http://jj.chinapostdoctor.org.cn/V1/Program1/Default.aspx. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alla V, 2010, JNCI-J NATL CANCER I, V102, P127, DOI 10.1093/jnci/djp458; Bae S, 2009, CELL TISSUE RES, V335, P565, DOI 10.1007/s00441-008-0729-y; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Calvo F, 2010, BIOESSAYS, V32, P412, DOI 10.1002/bies.200900155; Campbell PM, 2007, CANCER RES, V67, P2098, DOI 10.1158/0008-5472.CAN-06-3752; Chong JL, 2009, NATURE, V462, P930, DOI 10.1038/nature08677; DeGregori J, 2002, BBA-REV CANCER, V1602, P131, DOI 10.1016/S0304-419X(02)00051-3; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Engelmann D, 2012, CANCER RES, V72, P571, DOI 10.1158/0008-5472.CAN-11-2575; Eymin B, 2001, ONCOGENE, V20, P1678, DOI 10.1038/sj.onc.1204242; German MA, 2008, NAT BIOTECHNOL, V26, P941, DOI 10.1038/nbt1417; Gorgoulis VG, 2002, J PATHOL, V198, P142, DOI 10.1002/path.1121; Hallstrom TC, 2008, CANCER CELL, V13, P11, DOI 10.1016/j.ccr.2007.11.031; Han S, 2003, BREAST CANCER RES TR, V82, P11, DOI 10.1023/B:BREA.0000003843.53726.63; Hu ZB, 2008, J CLIN INVEST, V118, P2600, DOI 10.1172/JCI34934; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kasinski AL, 2012, CANCER RES, V72, P5576, DOI 10.1158/0008-5472.CAN-12-2001; Khromova N, 2012, ONCOGENE, V31, P1389, DOI 10.1038/onc.2011.330; Kumar MS, 2014, NATURE, V505, P212, DOI 10.1038/nature12785; Lee JS, 2010, J CLIN ONCOL, V28, P2660, DOI 10.1200/JCO.2009.25.0977; Muller H, 2000, BBA-REV CANCER, V1470, pM1, DOI 10.1016/S0304-419X(99)00030-X; Nelson MA, 2006, CANCER BIOL THER, V5, P407, DOI 10.4161/cbt.5.4.2512; Okamoto K, 2012, EMBO J, V31, P1752, DOI 10.1038/emboj.2012.25; Philippidou D, 2010, CANCER RES, V70, P4163, DOI 10.1158/0008-5472.CAN-09-4512; Rabbani F, 1999, J NATL CANCER I, V91, P874, DOI 10.1093/jnci/91.10.874; SAITO M, 1995, GENOMICS, V25, P130, DOI 10.1016/0888-7543(95)80118-6; Sakai H, 2014, CANCER SCI, V105, P425, DOI 10.1111/cas.12380; Sharma A, 2010, J CLIN INVEST, V120, P4478, DOI 10.1172/JCI44239; SINGH P, 1994, EMBO J, V13, P3329, DOI 10.1002/j.1460-2075.1994.tb06635.x; Tang HL, 2013, CLIN CANCER RES, V19, P5602, DOI 10.1158/1078-0432.CCR-13-1326; Ueno K, 2012, MOL CANCER THER, V11, P244, DOI 10.1158/1535-7163.MCT-11-0592; Xiong F, 2011, CANCER RES, V71, P5175, DOI 10.1158/0008-5472.CAN-10-4407; XU GF, 1995, P NATL ACAD SCI USA, V92, P1357, DOI 10.1073/pnas.92.5.1357; Yu YH, 2013, ONCOGENE, V32, P431, DOI 10.1038/onc.2012.74; Zhang CL, 2013, ACTA BIOCH BIOPH SIN, V45, P1055, DOI 10.1093/abbs/gmt109	35	53	62	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2014	9	8							e102602	10.1371/journal.pone.0102602	http://dx.doi.org/10.1371/journal.pone.0102602			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR0CG	25105419	Green Published, gold			2022-12-27	WOS:000343231900006
J	Wang, YX; Jonas, JB; Wang, NL; You, QS; Yang, DY; Xie, XB; Xu, L				Wang, Ya Xing; Jonas, Jost B.; Wang, Ningli; You, Qi Sheng; Yang, Diya; Xie, Xiao Bin; Xu, Liang			Intraocular Pressure and Estimated Cerebrospinal Fluid Pressure. The Beijing Eye Study 2011	PLOS ONE			English	Article							CENTRAL CORNEAL THICKNESS; RETINAL VEIN PULSATION; BODY-MASS INDEX; INTRACRANIAL-PRESSURE; SYSTEMIC FACTORS; BLOOD-PRESSURE; POPULATION; ASSOCIATION; ROTTERDAM; GLAUCOMA	Purpose: To examine a potential association between intraocular pressure (IOP) and cerebrospinal fluid pressure (CSFP) in a population-based setting. Methods: The population-based Beijing Eye Study 2011 included 3468 individuals with a mean age of 64.6 +/- 9.8 years (range: 50-93 years). A detailed ophthalmic examination was performed. Based on a previous study with lumbar cerebrospinal fluid pressure (CSFP) measurements, CSFP was calculated as CSFP [mm Hg] = 0.44xBody Mass Index [kg/m(2)]+ 0.16xDiastolic Blood Pressure [mm Hg]-0.18xAge [Years]. Results: In multivariate analysis, IOP was associated with higher estimated CSFP (P<0.001; standardized correlation coefficient beta: 0.27; regression coefficient B: 0.20; 95% confidence interval (CI): 0.16, 0.24), after adjusting for thinner central corneal thickness (P<0.001; beta: 0.45; B: 0.04;95%CI: 0.04,0.04), smaller corneal curvature radius (P<0.001; beta:-0.11; B:-1.13;95%CI:-1.61,-0.64), shallower anterior chamber depth (P = 0.01; beta:-0.05; B:-0.33;95%CI:-0.59,-0.08) and longer axial length (P = 0.002; beta: 0.08; B: 0.20; 95% CI: 0.08,0.32)), and after adjusting for the systemic parameters of higher pulse rate (P<0.001; beta: 0.08; B: 0.02;95%CI: 0.01,0.03), higher prevalence of arterial hypertension (P = 0.002; beta: 0.06; B: 0.32;95% CI: 0.12,0.53)), frequency of drinking alcohol (P = 0.02; beta: 0.04; B: 0.09;95%CI: 0.01,0.17), higher blood concentration of triglycerides (P = 0.001; beta: 0.06; B: 0.06;95%CI: 0.02,0.10) and cholesterol (P = 0.049; beta: 0.04; B: 0.08;95%CI: 0.00,0.17), and body mass index (P<0.001; beta:-0.13; B:-0.09;95%CI:-0.13,-0.06). In a parallel manner, estimated CSFP (mean: 10.8 +/- 3.7 mm Hg) was significantly associated with higher IOP (P<0.001; beta: 0.13; B: 0.18;95%CI: 0.13,0.23) after adjusting for rural region of habitation (P<0.001; beta:-0.37; B:-2.78;95%CI:-3.07,-2.48), higher systolic blood pressure (P<0.001; beta: 0.34; B: 0.06;95%CI: 0.05,0.07), higher pulse rate (P = 0.003; beta: 0.05; B: 0.02;95%CI: 0.01,0.03), taller body height (P<0.001; beta: 0.11; B: 0.05;95%CI: 0.03,0.07), higher blood concentration of cholesterol (P = 0.003; beta: 0.05; B: 0.17;95%CI: 0.06,0.28) and higher level of education (P = 0.003; beta: 0.09; B: 0.30;95%CI: 0.16,0.45). Conclusions: IOP was positively associated with estimated CSFP after adjusting for other ocular and systemic parameters. As a corollary, higher estimated CSFP was significantly associated with higher IOP in multivariate analysis. It fits with the notion that the arterial blood pressure, estimated CSFP and IOP are physiologically correlated with each other.	[Wang, Ya Xing; Jonas, Jost B.; You, Qi Sheng; Xu, Liang] Capital Med Univ, Beijing Tongren Hosp, Beijing Ophthalmol & Visual Sci Key Lab, Beijing Inst Ophthalmol,Beijing Tongren Eye Ctr, Beijing, Peoples R China; [Jonas, Jost B.] Heidelberg Univ, Med Fac Mannheim, Dept Ophthalmol, Heidelberg, Germany; [Wang, Ningli; Yang, Diya; Xie, Xiao Bin] Capital Med Univ, Beijing Tongren Hosp, Beijing Tongren Eye Ctr, Beijing Ophthalmol & Visual Sci Key Lab, Beijing, Peoples R China	Capital Medical University; Ruprecht Karls University Heidelberg; Capital Medical University	Jonas, JB (corresponding author), Capital Med Univ, Beijing Tongren Hosp, Beijing Ophthalmol & Visual Sci Key Lab, Beijing Inst Ophthalmol,Beijing Tongren Eye Ctr, Beijing, Peoples R China.	jost.jonas@medma.uni-heidelberg.de; xlbio1@gmail.com	wang, YA XING/K-9671-2016; You, Qisheng/AAG-7153-2020	wang, YA XING/0000-0003-2749-7793; You, Qisheng/0000-0003-0743-7320	National Natural Science Foundation of China [81770890]; National Key Technology R&D Program of the Ministry of Science and Technology [2012BAH05F05, 2013BAH19F04]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technology R&D Program of the Ministry of Science and Technology(National Key Technology R&D Program)	Supported by National Natural Science Foundation of China (grant #81770890) and by National Key Technology R&D Program of the Ministry of Science and Technology (No. 2012BAH05F05 and 2013BAH19F04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berdahl John P, 2013, J Glaucoma, V22 Suppl 5, pS17, DOI 10.1097/IJG.0b013e31829349fc; Berdahl JP, 2012, INVEST OPHTH VIS SCI, V53, P1422, DOI 10.1167/iovs.11-8220; DIELEMANS I, 1995, OPHTHALMOLOGY, V102, P54; Eysteinsson T, 2002, ACTA OPHTHALMOL SCAN, V80, P11, DOI 10.1034/j.1600-0420.2002.800103.x; Foster PJ, 2003, INVEST OPHTH VIS SCI, V44, P3885, DOI 10.1167/iovs.03-0012; Han Y, 2008, ANN NEUROL, V64, P221, DOI 10.1002/ana.21416; Jonas JB, 2014, AM J HYPERTENS; Jonas JB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096273; Jonas JB, 2014, INVEST OPHTH VIS SCI, V55, P1292, DOI 10.1167/iovs.13-13351; Jonas JB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086678; Jonas JB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082284; Jonas JB, 2012, INVEST OPHTH VIS SCI, V53, P6045, DOI 10.1167/iovs.12-10623; Jonas JB, 2011, J GLAUCOMA, V20, P405, DOI 10.1097/IJG.0b013e3181f7af9b; Kawase K, 2008, BRIT J OPHTHALMOL, V92, P1175, DOI 10.1136/bjo.2007.128819; Memarzadeh F, 2008, AM J OPHTHALMOL, V146, P69, DOI 10.1016/j.ajo.2008.03.015; Mitchell P, 2005, AM J OPHTHALMOL, V140, P131, DOI 10.1016/j.ajo.2004.12.088; Morgan WH, 2012, INVEST OPHTH VIS SCI, V53, P4676, DOI 10.1167/iovs.12-9837; Nomura H, 1999, OPHTHALMOLOGY, V106, P2016, DOI 10.1016/S0161-6420(99)90417-7; Ren RJ, 2012, GRAEF ARCH CLIN EXP, V250, P445, DOI 10.1007/s00417-011-1746-1; Ren RJ, 2010, OPHTHALMOLOGY, V117, P259, DOI 10.1016/j.ophtha.2009.06.058; Sajjadi SA, 2006, ANN NEUROL, V59, P867, DOI 10.1002/ana.20856; Samuels BC, 2012, INVEST OPHTH VIS SCI, V53, P7328, DOI 10.1167/iovs.12-10632; Wang Y, 2006, BRIT J OPHTHALMOL, V90, P353, DOI 10.1136/bjo.2005.081521; Wolfs RC, 1997, AM J OPHTHALMOL, V123, P767, DOI 10.1016/S0002-9394(14)71125-0; Xie XB, 2013, CRIT CARE, V17, DOI 10.1186/cc12841; Xu L, 2006, BRIT J OPHTHALMOL, V90, P1087, DOI 10.1136/bjo.2006.096123; Zhou Q, 2012, OPHTHAL EPIDEMIOL, V19, P278, DOI 10.3109/09286586.2012.708084	27	4	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2014	9	8							e104267	10.1371/journal.pone.0104267	http://dx.doi.org/10.1371/journal.pone.0104267			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR0CG	25105777	gold, Green Published, Green Submitted			2022-12-27	WOS:000343231900044
J	Yap, FC; Taylor, MS; Lin, MT				Yap, Fui C.; Taylor, Mark S.; Lin, Mike T.			Ovariectomy-Induced Reductions in Endothelial SK3 Channel Activity and Endothelium-Dependent Vasorelaxation in Murine Mesenteric Arteries	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; SMALL-CONDUCTANCE; MESSENGER-RNA; GENDER-DIFFERENCES; CA2+ SIGNALS; SEX-HORMONES; RAT ARTERIES; FEMALE RATS; EDHF; ESTROGEN	Mesenteric artery endothelium expresses both small (SK3)- and intermediate (IK1)-conductance Ca2+-activated K+ (K-Ca) channels whose activity modulates vascular tone via endothelium-dependent hyperpolarization (EDH). Two other major endothelium-dependent vasodilation pathways utilize nitric oxide (NO) and prostacyclin (PGI(2)). To examine how ovariectomy (ovx) affects the basal activity and acetylcholine (ACh)-induced activity of each of these three pathways to vasorelaxation, we used wire myograph and electrophysiological recordings. The results from functional studies using isolated murine mesenteric arteries show that ovx reduces ACh-induced endothelium-dependent vasodilation due to decreased EDH and NO contributions, although the contribution of PGI(2) is upregulated. Both endothelial SK3 and IK1 channels are functionally coupled to TRPV4 (transient receptor potential, vanilloid type 4) channels: the activation of TRPV4 channels activates SK3 and IK1 channels, leading to EDH-mediated vascular relaxation. The decreased EDH-mediated vasorelaxation in ovx vessels is due to reduced SK3 channel contribution to the pathway. Further, whole-cell recordings using dispersed endothelial cells also show reduced SK3 current density in ovx endothelial cells. Consequently, activation of TRPV4 channels induces smaller changes in whole-cell current density. Thus, ovariectomy leads to a reduction in endothelial SK3 channel activity thereby reducing the SK3 contribution to EDH vasorelaxation.	[Yap, Fui C.; Taylor, Mark S.; Lin, Mike T.] Univ S Alabama, Dept Physiol, Mobile, AL 36688 USA	University of South Alabama	Lin, MT (corresponding author), Univ S Alabama, Dept Physiol, Mobile, AL 36688 USA.	mlin@southalabama.edu			National Institutes of Health [R00 HL102056]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL102056, K99HL102056] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the National Institutes of Health, R00 HL102056 to MTL. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Absi M, 2007, BRIT J PHARMACOL, V151, P332, DOI 10.1038/sj.bjp.0707222; Alkayed NJ, 2000, STROKE, V31, P161, DOI 10.1161/01.STR.31.1.161; Balut CM, 2011, FASEB J, V25, P3938, DOI 10.1096/fj.11-187005; BARRETTCONNOR E, 1991, JAMA-J AM MED ASSOC, V265, P1861, DOI 10.1001/jama.265.14.1861; Bearden SE, 2004, J PHYSIOL-LONDON, V561, P535, DOI 10.1113/jphysiol.2004.068262; Bertuccio CA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092013; Bosch MA, 2002, ENDOCRINOLOGY, V143, P1097, DOI 10.1210/en.143.3.1097; Bosch MA, 2013, MOL CELL ENDOCRINOL, V367, P85, DOI 10.1016/j.mce.2012.12.021; Brahler S, 2009, CIRCULATION, V119, P2323, DOI 10.1161/CIRCULATIONAHA.108.846634; Brazer SCW, 2003, J BIOL CHEM, V278, P27208, DOI 10.1074/jbc.M301118200; Burger NZ, 2009, AM J PHYSIOL-ENDOC M, V296, pE503, DOI 10.1152/ajpendo.90517.2008; Chlebowski RT, 2009, NEW ENGL J MED, V360, P573, DOI 10.1056/NEJMoa0807684; Corriu C, 1996, BRIT J PHARMACOL, V119, P959, DOI 10.1111/j.1476-5381.1996.tb15765.x; Crane GJ, 2003, J PHYSIOL-LONDON, V553, P183, DOI 10.1113/jphysiol.2003.051896; Du J, 2012, J AM SOC NEPHROL, V23, P1172, DOI 10.1681/ASN.2011100972; Dubey RK, 2001, J APPL PHYSIOL, V91, P1868, DOI 10.1152/jappl.2001.91.4.1868; Dubey RK, 2002, CARDIOVASC RES, V53, P688, DOI 10.1016/S0008-6363(01)00527-2; Eichler I, 2003, BRIT J PHARMACOL, V138, P594, DOI 10.1038/sj.bjp.0705075; Feletou M, 2009, CLIN SCI, V117, P139, DOI 10.1042/CS20090096; Geary GG, 1998, AM J PHYSIOL-HEART C, V275, pH292, DOI 10.1152/ajpheart.1998.275.1.H292; Ghosh S, 1998, J BIOL CHEM, V273, P22267, DOI 10.1074/jbc.273.35.22267; Graziani A, 2004, CARDIOVASC RES, V64, P234, DOI 10.1016/j.cardiores.2004.06.026; Hickey M, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e763; Hilgers RHP, 2007, AM J PHYSIOL-HEART C, V292, pH2275, DOI 10.1152/ajpheart.00949.2006; Jacobson D, 2003, BIOCHEM BIOPH RES CO, V303, P660, DOI 10.1016/S0006-291X(03)00408-X; Jayachandran M, 2001, AM J PHYSIOL-HEART C, V281, pH1327, DOI 10.1152/ajpheart.2001.281.3.H1327; KANNEL WB, 1976, ANN INTERN MED, V85, P447, DOI 10.7326/0003-4819-85-4-447; Leo CH, 2011, BRIT J PHARMACOL, V162, P365, DOI 10.1111/j.1476-5381.2010.01023.x; Lin MT, 2012, AM J PHYSIOL-CELL PH, V303, pC318, DOI 10.1152/ajpcell.00058.2012; Lin MT, 2003, AM J PHYSIOL-HEART C, V285, pH701, DOI 10.1152/ajpheart.00138.2003; Linder AE, 2005, J CARDIOVASC PHARM, V46, P438, DOI 10.1097/01.fjc.0000175879.14994.63; Liu MY, 2001, BRIT J PHARMACOL, V132, P1035, DOI 10.1038/sj.bjp.0703899; Mack WJ, 2004, FERTIL STERIL, V82, P391, DOI 10.1016/j.fertnstert.2004.01.034; Nawate S, 2005, BRIT J PHARMACOL, V144, P178, DOI 10.1038/sj.bjp.0706091; Orshal JM, 2004, AM J PHYSIOL-REG I, V286, pR233, DOI 10.1152/ajpregu.00338.2003; Palacios J, 2004, AM J PHYSIOL-HEART C, V286, pH1793, DOI 10.1152/ajpheart.00990.2003; Parker JC, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.121; Qian X, 2014, ARTERIOSCL THROM VAS, V34, P127, DOI 10.1161/ATVBAHA.113.302506; Saliez J, 2008, CIRCULATION, V117, P1065, DOI 10.1161/CIRCULATIONAHA.107.731679; Sandow SL, 2006, J ANAT, V209, P689, DOI 10.1111/j.1469-7580.2006.00647.x; Sheng JZ, 2007, AM J PHYSIOL-CELL PH, V293, pC458, DOI 10.1152/ajpcell.00036.2007; Shimokawa H, 1996, J CARDIOVASC PHARM, V28, P703, DOI 10.1097/00005344-199611000-00014; Si H, 2006, CIRC RES, V99, P537, DOI 10.1161/01.RES.0000238377.08219.0c; Sonkusare SK, 2012, SCIENCE, V336, P597, DOI 10.1126/science.1216283; STAESSEN J, 1989, J HUM HYPERTENS, V3, P427; Taddei S, 2006, CURR HYPERTENS REP, V8, P84, DOI 10.1007/s11906-006-0045-4; Taylor MS, 2003, CIRC RES, V93, P124, DOI 10.1161/01.RES.0000081980.63146.69; Tran CHT, 2012, AM J PHYSIOL-CELL PH, V302, pC1226, DOI 10.1152/ajpcell.00418.2011; Vanhoutte PM, 1997, EUR HEART J, V18, pE19, DOI 10.1016/S0195-668X(97)90005-1; Xu J, 2009, CIRCULATION, V120, P1266, DOI 10.1161/CIRCULATIONAHA.108.835223	50	14	14	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2014	9	8							e104686	10.1371/journal.pone.0104686	http://dx.doi.org/10.1371/journal.pone.0104686			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR0CG	25105912	gold, Green Published, Green Submitted			2022-12-27	WOS:000343231900080
J	Minett, MS; Eijkelkamp, N; Wood, JN				Minett, Michael S.; Eijkelkamp, Niels; Wood, John N.			Significant Determinants of Mouse Pain Behaviour	PLOS ONE			English	Article							SENSORY NEURONS; MOLECULAR-BASIS; NOCICEPTION; COLD; DELETION; TRPA1; RECOMBINATION; HERITABILITY; HYPERALGESIA; EXPRESSION	Transgenic mouse behavioural analysis has furthered our understanding of the molecular and cellular mechanisms underlying damage sensing and pain. However, it is not unusual for conflicting data on the pain phenotypes of knockout mice to be generated by reputable groups. Here we focus on some technical aspects of measuring mouse pain behaviour that are often overlooked, which may help explain discrepancies in the pain literature. We examined touch perception using von Frey hairs and mechanical pain thresholds using the Randall-Selitto test. Thermal pain thresholds were measured using the Hargreaves apparatus and a thermal place preference test. Sodium channel Nav1.7 knockout mice show a mechanical deficit in the hairy skin, but not the paw, whilst shaving the abdominal hair abolished this phenotype. Nav1.7, Nav1.8 and Nav1.9 knockout mice show deficits in noxious mechanosensation in the tail, but not the paw. TRPA1 knockout mice, however, have a loss of noxious mechanosensation in the paw but not the tail. Studies of heat and cold sensitivity also show variability depending on the intensity of the stimulus. Deleting Nav1.7, Nav1.8 or Nav1.9 in Nav1.8-positive sensory neurons attenuates responses to slow noxious heat ramps, whilst responses to fast noxious heat ramps are only reduced when Nav1.7 is lost in large diameter sensory neurons. Deleting Nav1.7 from all sensory neurons attenuates responses to noxious cooling but not extreme cold. Finally, circadian rhythms dramatically influence behavioural outcome measures such as von Frey responses, which change by 80% over the day. These observations demonstrate that fully characterising the phenotype of a transgenic mouse strain requires a range of behavioural pain models. Failure to conduct behavioural tests at different anatomical locations, stimulus intensities, and at different points in the circadian cycle may lead to a pain behavioural phenotype being misinterpreted, or missed altogether.	[Minett, Michael S.; Eijkelkamp, Niels; Wood, John N.] UCL, Wolfson Inst Biomed Res, Mol Nocicept Grp, London, England; [Eijkelkamp, Niels] Univ Med Ctr Utrecht, Lab Neuroimmunol & Dev Origins Dis, Utrecht, Netherlands	University of London; University College London; Utrecht University; Utrecht University Medical Center	Wood, JN (corresponding author), UCL, Wolfson Inst Biomed Res, Mol Nocicept Grp, Gower St, London, England.	j.wood@ucl.ac.uk		Eijkelkamp, Niels/0000-0003-0039-7063	Medical Research Council [G0901905]; Wellcome Trust [101054/Z/13/Z]; Rubicon Trust; BBSRC [BB/F000227/1] Funding Source: UKRI; MRC [G0901905] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F000227/1] Funding Source: researchfish; Versus Arthritis [20200] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Rubicon Trust; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Versus Arthritis(Versus Arthritis)	This study was supported by JNW Medical Research Council G0901905, JNW MSM Wellcome Trust 101054/Z/13/Z, NE Rubicon Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsen B, 2008, SCIENCE, V321, P702, DOI 10.1126/science.1156916; Abraira VE, 2013, NEURON, V79, P618, DOI 10.1016/j.neuron.2013.07.051; Akopian AN, 1999, NAT NEUROSCI, V2, P541, DOI 10.1038/9195; Andersson DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046917; Bautista DM, 2007, NATURE, V448, P204, DOI 10.1038/nature05910; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Callahan BL, 2008, J PAIN, V9, P174, DOI 10.1016/j.jpain.2007.10.011; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chassard D, 2004, ANESTHESIOLOGY, V100, P413; Chesler EJ, 2002, NAT NEUROSCI, V5, P1101, DOI 10.1038/nn1102-1101; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; Dhaka A, 2007, NEURON, V54, P371, DOI 10.1016/j.neuron.2007.02.024; EDDY NB, 1953, J PHARMACOL EXP THER, V107, P385; FREDERICKSON RCA, 1977, SCIENCE, V198, P756, DOI 10.1126/science.561998; Gautron L, 2011, J COMP NEUROL, V519, P3085, DOI 10.1002/cne.22667; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Kusunose N, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-83; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; Li LS, 2011, CELL, V147, P1615, DOI 10.1016/j.cell.2011.11.027; Minett MS, 2014, CELL REP, V6, P301, DOI 10.1016/j.celrep.2013.12.033; Minett Michael S, 2011, Curr Protoc Mouse Biol, V1, P383, DOI 10.1002/9780470942390.mo110116; Minett MS, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1795; Mishra SK, 2011, EMBO J, V30, P582, DOI 10.1038/emboj.2010.325; Mogil JS, 2010, PAIN, V151, P12, DOI 10.1016/j.pain.2010.07.015; Mogil JS, 1999, PAIN, V80, P83, DOI 10.1016/S0304-3959(98)00196-1; Mogil JS, 1999, PAIN, V80, P67, DOI 10.1016/S0304-3959(98)00197-3; Nassar MA, 2004, P NATL ACAD SCI USA, V101, P12706, DOI 10.1073/pnas.0404915101; Nassar MA, 2006, MOL PAIN, V2, DOI 10.1186/1744-8069-2-33; Ostman JAR, 2008, J PHYSIOL-LONDON, V586, P1077, DOI 10.1113/jphysiol.2007.147942; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Petrus M, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-40; RANDALL LO, 1957, ARCH INT PHARMACOD T, V111, P409; SAUER B, 1987, MOL CELL BIOL, V7, P2087, DOI 10.1128/MCB.7.6.2087; SAUER B, 1988, P NATL ACAD SCI USA, V85, P5166, DOI 10.1073/pnas.85.14.5166; SELTZER Z, 1990, PAIN, V43, P205, DOI 10.1016/0304-3959(90)91074-S; Shields SD, 2012, PAIN, V153, P2017, DOI 10.1016/j.pain.2012.04.022; Stirling LC, 2005, PAIN, V113, P27, DOI 10.1016/j.pain.2004.08.015; Thompson SJ, 2012, NEUROSCI LETT, V520, P131, DOI 10.1016/j.neulet.2012.03.015; Zhou X, 2010, P NATL ACAD SCI USA, V107, P9424, DOI 10.1073/pnas.0914725107	39	68	68	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e104458	10.1371/journal.pone.0104458	http://dx.doi.org/10.1371/journal.pone.0104458			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25101983	Green Published, gold			2022-12-27	WOS:000339993900066
J	Swale, DR; Sun, BN; Tong, F; Bloomquist, JR				Swale, Daniel R.; Sun, Baonan; Tong, Fan; Bloomquist, Jeffrey R.			Neurotoxicity and Mode of Action of N,N-Diethyl-Meta-Toluamide (DEET)	PLOS ONE			English	Article							INSECT REPELLENT; ANOPHELES-GAMBIAE; FIREFLY LANTERN; NEURAL-CONTROL; AEDES-AEGYPTI; OCTOPAMINE; N,N-DIETHYL-M-TOLUAMIDE; CHOLINESTERASES; TRANSMITTER; PESTICIDES	Recent studies suggest that N,N-diethyl-meta-toluamide (DEET) is an acetylcholinesterase inhibitor and that this action may result in neurotoxicity and pose a risk to humans from its use as an insect repellent. We investigated the mode of action of DEET neurotoxicity in order to define the specific neuronal targets related to its acute toxicity in insects and mammals. Although toxic to mosquitoes (LD50 ca. 1.5 mu g/mg), DEET was a poor acetylcholinesterase inhibitor (<10% inhibition), even at a concentration of 10 mM. IC50 values for DEET against Drosophila melanogaster, Musca domestica, and human acetylcholinesterases were 6-12 mM. Neurophysiological recordings showed that DEET had excitatory effects on the housefly larval central nervous system (EC50: 120 mu M), but was over 300-fold less potent than propoxur, a standard anticholinesterase insecticide. Phentolamine, an octopamine receptor antagonist, completely blocked the central neuroexcitation by DEET and octopamine, but was essentially ineffective against hyperexcitation by propoxur and 4-aminopyridine, a potassium channel blocker. DEET was found to illuminate the firefly light organ, a tissue utilizing octopamine as the principal neurotransmitter. Additionally, DEET was shown to increase internal free calcium via the octopamine receptors of Sf21 cells, an effect blocked by phentolamine. DEET also blocked Na+ and K+ channels in patch clamped rat cortical neurons, with IC50 values in the micromolar range. These findings suggest DEET is likely targeting octopaminergic synapses to induce neuroexcitation and toxicity in insects, while acetylcholinesterase in both insects and mammals has low (mM) sensitivity to DEET. The ion channel blocking action of DEET in neurons may contribute to the numbness experienced after inadvertent application to the lips or mouth of humans.	[Swale, Daniel R.; Sun, Baonan; Tong, Fan; Bloomquist, Jeffrey R.] Univ Florida, Emerging Pathogens Inst, Dept Entomol & Nematol, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	Bloomquist, JR (corresponding author), Univ Florida, Emerging Pathogens Inst, Dept Entomol & Nematol, Gainesville, FL 32611 USA.	jbquist@epi.ufl.edu			Deployed War Fighter Research Program under USDA [58-0208-0-068]	Deployed War Fighter Research Program under USDA	This study was financially supported by the Deployed War Fighter Research Program under USDA Specific Cooperative Agreement 58-0208-0-068. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a; Bloomquist JR, 1996, TOXICON, V34, P1072, DOI 10.1016/0041-0101(96)00028-1; BLOOMQUIST JR, 1991, PESTIC SCI, V32, P463, DOI 10.1002/ps.2780320408; Bonnet J, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-17; BOOTH GM, 1971, B WORLD HEALTH ORGAN, V44, P91; Carlier PR, 2008, CHEM-BIOL INTERACT, V175, P368, DOI 10.1016/j.cbi.2008.04.037; CASIDA JE, 1970, J AGR FOOD CHEM, V18, P753, DOI 10.1021/jf60171a013; CLEM JR, 1993, ANN PHARMACOTHER, V27, P289, DOI 10.1177/106002809302700305; Coats JR., 1982, INSECTICIDE MODE ACT, P198; Colhoun E. H., 1963, P1; COPELAND J, 1982, COMP BIOCHEM PHYS C, V72, P125, DOI 10.1016/0306-4492(82)90217-9; Corbel V, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-47; Djogbenou L, 2007, J MED ENTOMOL, V44, P805, DOI 10.1603/0022-2585(2007)44[805:COIAAI]2.0.CO;2; Ellenhorn M.J, 1997, ELLENHORNS MED TOXIC, V2nd; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; HOLLINGWORTH RM, 1980, SCIENCE, V208, P74, DOI 10.1126/science.208.4439.74; Jaffe RA, 1996, ANESTHESIOLOGY, V84, P1455, DOI 10.1097/00000542-199606000-00022; Licciardi S, 2006, MED VET ENTOMOL, V20, P288, DOI 10.1111/j.1365-2915.2006.00630.x; LIPSCOMB JW, 1992, ANN EMERG MED, V21, P315, DOI 10.1016/S0196-0644(05)80896-0; Macko J, 1980, PHASE 6 ACUTE TOXICI; Moore Sarah J., 2007, P3; Moss JI, 1996, J ECON ENTOMOL, V89, P1151, DOI 10.1093/jee/89.5.1151; NATHANSON JA, 1979, J EXP ZOOL, V208, P255, DOI 10.1002/jez.1402080213; NATHANSON JA, 1979, SCIENCE, V203, P65, DOI 10.1126/science.214856; ORR N, 1992, INSECT BIOCHEM MOLEC, V22, P591, DOI 10.1016/0965-1748(92)90036-E; Pridgeon JW, 2008, J MED ENTOMOL, V45, P82, DOI 10.1603/0022-2585(2008)45[82:SOAACQ]2.0.CO;2; REUVENI H, 1982, ARCH DERMATOL, V118, P582, DOI 10.1001/archderm.118.8.582; ROBERTSON HA, 1976, J EXP ZOOL, V195, P159, DOI 10.1002/jez.1401950116; SALGADO VL, 1992, ARCH INSECT BIOCHEM, V21, P239, DOI 10.1002/arch.940210307; Scholz A, 2002, BRIT J ANAESTH, V89, P52, DOI 10.1093/bja/aef163; Scior TRF, 2009, J RECEPT LIGAND CH R, V2, P1; Shoichet BK, 2006, J MED CHEM, V49, P7274, DOI 10.1021/jm061103g; World Health Organization, 1981, 81805 WHOVBC; Yadouleton AWM, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-103	34	58	58	5	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e103713	10.1371/journal.pone.0103713	http://dx.doi.org/10.1371/journal.pone.0103713			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25101788	Green Published, gold			2022-12-27	WOS:000339993900023
J	Wang, Y; Zeng, XB; Yao, FJ; Wu, F; Su, C; Fan, ZG; Zhu, Z; Tao, J; Huang, YJ				Wang, Yan; Zeng, Xian-bo; Yao, Feng-juan; Wu, Fang; Su, Chen; Fan, Zhen-guo; Zhu, Zhu; Tao, Jun; Huang, Yi-jun			Endurance Capacity Is Not Correlated with Endothelial Function in Male University Students	PLOS ONE			English	Article							MICROPARTICLES CORRELATE; V+ MICROPARTICLES; PHYSICAL-ACTIVITY; PROGENITOR CELLS; OXYGEN-UPTAKE; DYSFUNCTION; YOUNG; INCREASES; MEN	Background: Endurance capacity, assessed by 1000-meter (1000 m) run of male university students, is an indicator of cardiovascular fitness in Chinese students physical fitness surveillance. Although cardiovascular fitness is related to endothelial function closely in patients with cardiovascular diseases, it remains unclear whether endurance capacity correlates with endothelial function, especially with circulating endothelial microparticles (EMPs), a new sensitive marker of endothelial dysfunction in young students. The present study aimed to investigate the relationship between endurance capacity and endothelial function in male university students. Methods: Forty-seven healthy male university students (mean age, 20.1 +/- 0.6 years; mean height, 172.4 +/- 6.3 cm; and mean weight, 60.0 +/- 8.2 kg) were recruited in this study. The measurement procedure of 1000 m run time was followed to Chinese national students Constitutional Health Criterion. Endothelium function was assessed by flow-mediated vasodilation (FMD) in the brachial artery measured by ultrasonic imaging, and the level of circulating EMPs was measured by flow cytometry. Cardiovascular fitness indicator - maximal oxygen uptake (VO2 max) - was also measured on a cycle ergometer using a portable gas analyzer. Results: 1000 m run time was correlated with VO(2)max (r = -0.399, p < 0.05). However, there were no correlations between VO(2)max and FMD or levels of circulating CD31+/CD42- microparticles. Similarly, no correlations were found between 1000 m run time and FMD, and levels of circulating CD31+/CD42- microparticles in these male university students (p > 0.05). Conclusion: The correlations between endurance capacity or cardiovascular fitness and endothelial function were not found in healthy Chinese male university students. These results suggest that endurance capacity may not reflect endothelial function in healthy young adults with well preserved FMD and low level of circulating CD31+/CD42-EMPs.	[Wang, Yan] Sun Yat Sen Univ, Affiliated Hosp 1, Phys Examinat Ctr, Guangzhou 510275, Guangdong, Peoples R China; [Zeng, Xian-bo; Fan, Zhen-guo] Sun Yat Sen Univ, Sch Educ, Guangzhou 510275, Guangdong, Peoples R China; [Yao, Feng-juan] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Med Ultrason, Guangzhou 510275, Guangdong, Peoples R China; [Wu, Fang; Su, Chen; Tao, Jun] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Hypertens & Vasc Dis, Guangzhou 510275, Guangdong, Peoples R China; [Zhu, Zhu; Huang, Yi-jun] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Pharmacol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Tao, J (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Hypertens & Vasc Dis, Guangzhou 510275, Guangdong, Peoples R China.	taojungz@yahoo.com; huangyj@mail.sysu.edu.cn			National Natural Scientific Foundation of China [81200095]; Guangdong National Science Foundation [S2011010004852]	National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong National Science Foundation	This study is financially supported by the grants from National Natural Scientific Foundation of China (81200095, http://isisn.nsfc.gov.cn/egrantweb/) and Guangdong National Science Foundation (S2011010004852, http://pro.gdstc.gov.cn/). The funders had no role in study design, data collection and analysis,	Agouni A, 2008, AM J PATHOL, V173, P1210, DOI 10.2353/ajpath.2008.080228; Babbitt DM, 2013, INT J HYPER IN PRESS; Boyle LJ, 2013, J APPL PHYSIOL, V115, P1519, DOI 10.1152/japplphysiol.00837.2013; Brodsky SV, 2004, AM J PHYSIOL-HEART C, V286, pH1910, DOI 10.1152/ajpheart.01172.2003; Bulut D, 2009, EUR J CLIN INVEST, V39, P17, DOI 10.1111/j.1365-2362.2008.02058.x; Bulut D, 2008, J CARD FAIL, V14, P336, DOI 10.1016/j.cardfail.2007.11.002; Buscemi S, 2013, ACTA DIABETOL, V50, P135, DOI 10.1007/s00592-010-0229-x; Cai H, 2000, CIRC RES, V87, P840, DOI 10.1161/01.RES.87.10.840; Cheng F, 2013, INT J CARDIOL, V167, P936, DOI 10.1016/j.ijcard.2012.03.090; Chinese National Survey on Students of Constitution and Health Association, 2012, REP 2010 PHYS FITN H; Chironi GN, 2009, CELL TISSUE RES, V335, P143, DOI 10.1007/s00441-008-0710-9; Dignat-George F, 2011, ARTERIOSCL THROM VAS, V31, P27, DOI 10.1161/ATVBAHA.110.218123; Duffield R, 2004, J SCI MED SPORT, V7, P11, DOI 10.1016/S1440-2440(04)80039-2; Fletcher GF, 2001, CIRCULATION, V104, P1694, DOI 10.1161/hc3901.095960; Franzoni F, 2005, AM J HYPERTENS, V18, P510, DOI 10.1016/j.amjhyper.2004.11.006; Guazzi M, 2007, EUR J CLIN INVEST, V37, P454, DOI 10.1111/j.1365-2362.2007.01805.x; Jenkins NT, 2011, J PHYSIOL-LONDON, V589, P5539, DOI 10.1113/jphysiol.2011.215277; Klinkner DB, 2006, SHOCK, V25, P575, DOI 10.1097/01.shk.0000209558.69575.80; Lee ST, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035713; Moe IT, 2005, VASC MED, V10, P97, DOI 10.1191/1358863x05vm592oa; Peterson D. Fred, 2003, Journal of the American Osteopathic Association, V103, P361; Rognmo O, 2008, J STRENGTH COND RES, V22, P535, DOI 10.1519/JSC.0b013e31816354b1; Schmidt JF, 2013, MED SCI SPORT EXER, V45, P2223, DOI 10.1249/MSS.0b013e31829ab43c; Sinning JM, 2011, EUR HEART J, V32, P2034, DOI 10.1093/eurheartj/ehq478; Sossdorf M, 2011, MED SCI SPORT EXER, V43, P1169, DOI 10.1249/MSS.0b013e3182068645; Strohacker K, 2012, APPL PHYSIOL NUTR ME, V37, P530, DOI [10.1139/h2012-034, 10.1139/H2012-034]; Tjonna AE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065382; Versari D, 2009, DIABETES CARE, V32, pS314, DOI 10.2337/dc09-S330; Wang JM, 2007, AM J HYPERTENS, V20, P957, DOI 10.1016/j.amjhyper.2007.04.005; Wang JM, 2009, EUR J PHARMACOL, V614, P77, DOI 10.1016/j.ejphar.2009.04.037; Wilkinson DM, 1999, J SPORT SCI, V17, P413, DOI 10.1080/026404199365939; Xia WH, 2012, AGING CELL, V11, P111, DOI 10.1111/j.1474-9726.2011.00758.x; Yang Z, 2007, J HUM HYPERTENS, V21, P452, DOI 10.1038/sj.jhh.1002171	33	0	0	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e103814	10.1371/journal.pone.0103814	http://dx.doi.org/10.1371/journal.pone.0103814			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25101975	Green Published, Green Submitted, gold			2022-12-27	WOS:000339993900025
J	Yamaguchi, S; Machida, J; Kamamoto, M; Kimura, M; Shibata, A; Tatematsu, T; Miyachi, H; Higashi, Y; Jezewski, P; Nakayama, A; Shimozato, K; Tokita, Y				Yamaguchi, Seishi; Machida, Junichiro; Kamamoto, Munefumi; Kimura, Masashi; Shibata, Akio; Tatematsu, Tadashi; Miyachi, Hitoshi; Higashi, Yujiro; Jezewski, Peter; Nakayama, Atsuo; Shimozato, Kazuo; Tokita, Yoshihito			Characterization of Novel MSX1 Mutations Identified in Japanese Patients with Nonsyndromic Tooth Agenesis	PLOS ONE			English	Article							AUTOSOMAL-DOMINANT HYPODONTIA; BONE MORPHOGENETIC PROTEIN; CLEFT-LIP; NONSENSE MUTATION; CRYSTAL-STRUCTURE; EXPRESSION; PAX9; HAPLOINSUFFICIENCY; DIFFERENTIATION; TRANSCRIPTION	Since MSX1 and PAX9 are linked to the pathogenesis of nonsyndromic tooth agenesis, we performed detailed mutational analysis of these two genes sampled from Japanese patients. We identified two novel MSX1 variants with an amino acid substitution within the homeodomain; Thr174Ile (T174I) from a sporadic hypodontia case and Leu205Arg (L205R) from a familial oligodontia case. Both the Thr174 and Leu205 residues in the MSX1 homeodomain are highly conserved among different species. To define possible roles of mutations at these amino acids in the pathogenesis of nonsyndromic tooth agenesis, we performed several functional analyses. It has been demonstrated that MSX1 plays a pivotal role in hard tissue development as a suppressor for mesenchymal cell differentiation. To evaluate the suppression activity of the variants in mesenchymal cells, we used the myoD-promoter, which is one of convenient reporter assay system for MSX1. Although the gene products of these MSX1 variants are stable and capable of normal nuclear localization, they do not suppress myoD-promoter activity in differentiated C2C12 cells. To clarify the molecular mechanisms underlying our results, we performed further analyses including electrophoretic mobility shift assays, and co-immunoprecipitation assays to survey the molecular interactions between the mutant MSX1 proteins and the oligonucleotide DNA with MSX1 consensus binding motif or EZH2 methyltransferase. Since EZH2 is reported to interact with MSX1 and regulate MSX1 mediated gene suppression, we hypothesized that the T174I and L205R substitutions would impair this interaction. We conclude from the results of our experiments that the DNA binding ability of MSX1 is abolished by these two amino acid substitutions. This illustrates a causative role of the T174I and L205R MSX1 homeodomain mutations in tooth agenesis, and suggests that they may influence cell proliferation and differentiation resulting in lesser tooth germ formation in vivo.	[Yamaguchi, Seishi; Machida, Junichiro; Kamamoto, Munefumi; Kimura, Masashi; Shibata, Akio; Tatematsu, Tadashi; Miyachi, Hitoshi; Shimozato, Kazuo; Tokita, Yoshihito] Aichi Gakuin Univ, Sch Dent, Dept Maxillofacial Surg, Nagoya, Aichi 464, Japan; [Yamaguchi, Seishi] Aichi Childrens Hlth & Med Ctr, Dept Dent & Oral Surg, Aichi, Japan; [Yamaguchi, Seishi; Kimura, Masashi; Shibata, Akio; Tatematsu, Tadashi; Higashi, Yujiro; Tokita, Yoshihito] Aichi Human Serv Ctr, Inst Dev Res, Dept Perinatol, Kasugai, Aichi, Japan; [Nakayama, Atsuo] Aichi Human Serv Ctr, Inst Dev Res, Dept Embryol, Kasugai, Aichi, Japan; [Kamamoto, Munefumi] Himeji Hosp, Japanese Red Cross Soc, Dept Oral & Maxillofacial Surg, Himeji, Hyogo, Japan; [Jezewski, Peter] Univ Alabama Birmingham, Birmingham Sch Dent, Inst Oral Hlth Res, Dept Periodontol, Birmingham, AL USA; [Machida, Junichiro] Toyota Mem Hosp, Dept Oral & Maxillofacial Surg, Toyota, Aichi, Japan	Aichi Gakuin University; University of Alabama System; University of Alabama Birmingham	Tokita, Y (corresponding author), Aichi Gakuin Univ, Sch Dent, Dept Maxillofacial Surg, 1-100 Kusumoto Cho, Nagoya, Aichi 464, Japan.	tokita@inst-hsc.jp			Institute for Developmental Research; Aichi-Human Service Center; Aichi-Gakuin University, School of Dentistry; Grants-in-Aid for Scientific Research [23591524] Funding Source: KAKEN	Institute for Developmental Research; Aichi-Human Service Center; Aichi-Gakuin University, School of Dentistry; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by grants from the Institute for Developmental Research, Aichi-Human Service Center (YT), and from the Aichi-Gakuin University, School of Dentistry (KS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen YP, 1996, DEVELOPMENT, V122, P3035; Das P, 2002, HUM GENET, V110, P371, DOI 10.1007/s00439-002-0699-1; Feng XY, 2013, EUR J ORAL SCI, V121, P412, DOI 10.1111/eos.12078; Finnerty JR, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-18; Frazier-Bowers SA, 2002, J DENT RES, V81, P129, DOI 10.1177/154405910208100209; HEWITT JE, 1991, GENOMICS, V11, P670, DOI 10.1016/0888-7543(91)90074-O; Honda T, 2010, MOL BIOL CELL, V21, P3269, DOI 10.1091/mbc.E10-02-0117; Hu GZ, 1998, MOL CELL BIOL, V18, P6044, DOI 10.1128/MCB.18.10.6044; ILER N, 1995, MECH DEVELOP, V53, P87, DOI 10.1016/0925-4773(95)00427-0; Jezewski PA, 2003, J MED GENET, V40, P399, DOI 10.1136/jmg.40.6.399; Jumlongras D, 2001, AM J HUM GENET, V69, P67, DOI 10.1086/321271; Kamamoto M, 2011, INT J ORAL MAX SURG, V40, P434, DOI 10.1016/j.ijom.2010.09.025; Kamamoto M, 2011, EUR J HUM GENET, V19, P844, DOI 10.1038/ejhg.2011.47; Kimura M, 2013, EUR J ORAL IN PRESS; KLEMM JD, 1994, CELL, V77, P21, DOI 10.1016/0092-8674(94)90231-3; Lee H, 2006, GENE DEV, V20, P784, DOI 10.1101/gad.1392006; Lee H, 2004, SCIENCE, V304, P1675, DOI 10.1126/science.1098096; Letra A, 2007, J DENT RES, V86, P986, DOI 10.1177/154405910708601013; LEWIS PN, 1973, BIOCHIM BIOPHYS ACTA, V303, P211, DOI 10.1016/0005-2795(73)90350-4; Li H, 1997, PROTEIN SCI, V6, P956, DOI 10.1002/pro.5560060502; Liang J, 2012, EUR J ORAL SCI, V120, P278, DOI 10.1111/j.1600-0722.2012.00965.x; Lidral AC, 1998, AM J HUM GENET, V63, P557, DOI 10.1086/301956; Mostowska A, 2013, CLIN GENET, V84, P429, DOI 10.1111/cge.12061; Mostowska A, 2012, ARCH ORAL BIOL, V57, P790, DOI 10.1016/j.archoralbio.2012.01.003; Murayama A, 2008, CELL, V133, P627, DOI 10.1016/j.cell.2008.03.030; Nakayama A, 2003, J BIOL CHEM, V278, P233, DOI 10.1074/jbc.M209574200; Padanilam B. J., 1992, Human Molecular Genetics, V1, P407, DOI 10.1093/hmg/1.6.407; QIAN YQ, 1989, CELL, V59, P573, DOI 10.1016/0092-8674(89)90040-8; Shi XM, 1999, J BIOL CHEM, V274, P13711, DOI 10.1074/jbc.274.19.13711; Stockton DW, 2000, NAT GENET, V24, P18, DOI 10.1038/71634; Suzuki Y, 2004, GENET MED, V6, P117, DOI 10.1097/01.GIM.0000127275.52925.05; Tokita Y, 2001, J NEUROSCI, V21, P1257; URIST MR, 1971, J DENT RES, V50, P1392, DOI 10.1177/00220345710500060601; van den Boogaard MJ, 2012, J MED GENET, V49, P327, DOI 10.1136/jmedgenet-2012-100750; van den Boogaard MJH, 2000, NAT GENET, V24, P342, DOI 10.1038/74155; Vastardis H, 1996, NAT GENET, V13, P417, DOI 10.1038/ng0896-417; Vieira AR, 2003, J DENT RES, V82, P289, DOI 10.1177/154405910308200409; Wang JQ, 2011, DEV CELL, V21, P575, DOI 10.1016/j.devcel.2011.07.003; Wang Y, 2011, J DENT RES, V90, P311, DOI 10.1177/0022034510387430; WOLBERGER C, 1991, CELL, V67, P517, DOI 10.1016/0092-8674(91)90526-5; WOLOSHIN P, 1995, CELL, V82, P611, DOI 10.1016/0092-8674(95)90033-0; Yumimoto K, 2013, J BIOL CHEM, V288, P28488, DOI 10.1074/jbc.M113.465179; Zhang HL, 1997, MOL CELL BIOL, V17, P2920, DOI 10.1128/MCB.17.5.2920	43	15	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e102944	10.1371/journal.pone.0102944	http://dx.doi.org/10.1371/journal.pone.0102944			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25101640	Green Published, gold, Green Submitted			2022-12-27	WOS:000339993900013
J	Zhang, ZY; Li, CY; Zug, C; Schluesener, HJ				Zhang, Zhi-Yuan; Li, Chaoyun; Zug, Caroline; Schluesener, Hermann J.			Icariin Ameliorates Neuropathological Changes, TGF-beta 1 Accumulation and Behavioral Deficits in a Mouse Model of Cerebral Amyloidosis	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; TRANSFORMING GROWTH-FACTOR-BETA-1; FUNCTIONAL RECOVERY; TRANSGENIC MICE; IV COLLAGEN; INFLAMMATION; NEUROINFLAMMATION; INHIBITOR; NEURONS; DIFFERENTIATION	Icariin, a major constituent of flavonoids from the Chinese medicinal herb Epimedium brevicornum, exhibits multiple biological properties, including anti-inflammatory, neuroregulatory and neuroprotective activities. Therefore, Icariin might be applied in treatment of neurodegenerative disorders, including Alzheimer's disease (AD), which is neuropathologically characterized by beta-amyloid aggregation, hyperphosphorylated tau and neuroinflammation. Potential therapeutic effects of Icariin were investigated in an animal model of cerebral amyloidosis for AD, transgenic APP/PS1 mouse. Icariin was suspended in carboxymethylcellulose and given orally to APP/PS1 mice. Therapeutic effects were monitored by behavioral tests, namely nesting assay, before and during the experimental treatment. Following an oral treatment of 10 days, Icariin significantly attenuated A beta deposition, microglial activation and TGF-beta 1 immunoreactivity at amyloid plaques in cortex and hippocampus of transgenic mice 5 months of age, and restored impaired nesting ability. Our results suggest that Icariin might be considered a promising therapeutic option for human AD.	[Zhang, Zhi-Yuan; Li, Chaoyun; Zug, Caroline; Schluesener, Hermann J.] Univ Tubingen, Inst Pathol & Neuropathol, Div Immunopathol Nervous Syst, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Zhang, ZY (corresponding author), Univ Tubingen, Inst Pathol & Neuropathol, Div Immunopathol Nervous Syst, Tubingen, Germany.	zhiyuan.zhang@medizin.uni-tuebingen.de	zhang, zhiyuan/GRS-2141-2022	Zhang, Zhi-Yuan/0000-0001-9067-0670	China Scholarship Council (CSC); Deutsche Forschungsgemeinschaft (German Research Foundation); Tuebingen University	China Scholarship Council (CSC)(China Scholarship Council); Deutsche Forschungsgemeinschaft (German Research Foundation)(German Research Foundation (DFG)); Tuebingen University	Chaoyun Li is supported and financed by the Chinese government scholarship from the China Scholarship Council (CSC). The authors also acknowledge support by Deutsche Forschungsgemeinschaft (German Research Foundation) and Open Access Publishing Fund of Tuebingen University, for the open access publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostinho P, 2010, CURR PHARM DESIGN, V16, P2766, DOI 10.2174/138161210793176572; Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Alexander G, 2011, BEHAV BRAIN RES, V216, P77, DOI 10.1016/j.bbr.2010.07.016; BRANDAN E, 1993, GEN PHARMACOL, V24, P1063, DOI 10.1016/0306-3623(93)90350-7; Chen SR, 2010, BIOL PHARM BULL, V33, P1307, DOI 10.1248/bpb.33.1307; Chen Y, 2011, MOLECULES, V16, P1336, DOI 10.3390/molecules16021336; Cheng YF, 2010, PSYCHOPHARMACOLOGY, V212, P181, DOI 10.1007/s00213-010-1943-3; Gengler S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009764; Grammas P, 2002, AM J PATHOL, V160, P1583, DOI 10.1016/S0002-9440(10)61105-4; GRAY CW, 1993, MOL BRAIN RES, V19, P251, DOI 10.1016/0169-328X(93)90037-P; Guo J, 2010, PHYTOMEDICINE, V17, P950, DOI 10.1016/j.phymed.2010.03.007; Herrmann N, 2011, CURRENT EMERGING DRU; Ho Christopher C K, 2011, Curr Urol Rep, V12, P470, DOI 10.1007/s11934-011-0217-x; Huang J, 2007, LIFE SCI, V81, P832, DOI 10.1016/j.lfs.2007.07.015; Kuroda M, 2000, PLANTA MED, V66, P575, DOI 10.1055/s-2000-8611; Lesne S, 2003, J BIOL CHEM, V278, P18408, DOI 10.1074/jbc.M300819200; Li L, 2005, CHINESE MED J-PEKING, V118, P1637; Li YC, 2013, CLIN EXP PHARMACOL P, V40, P635, DOI 10.1111/1440-1681.12143; Lippa CF, 1998, NEUROBIOL AGING, V19, P527, DOI 10.1016/S0197-4580(98)00089-X; Liu RM, 2010, FREE RADICAL BIO MED, V48, P1, DOI 10.1016/j.freeradbiomed.2009.09.026; Luo Y, 2007, CLIN EXP PHARMACOL P, V34, P792, DOI 10.1111/j.1440-1681.2007.04647.x; Martin-Moreno AM, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-8; Ming LG, 2013, J CELL PHYSIOL, V228, P513, DOI 10.1002/jcp.24158; Moehlmann T, 2002, P NATL ACAD SCI USA, V99, P8025, DOI 10.1073/pnas.112686799; Nie J, 2010, EUR J PHARMACOL, V626, P213, DOI 10.1016/j.ejphar.2009.09.039; Ning HX, 2006, UROLOGY, V68, P1350, DOI 10.1016/j.urology.2006.09.031; Ownby RL, 2010, CURR PSYCHIAT REP, V12, P39, DOI 10.1007/s11920-009-0082-1; Pan Y, 2005, PHARMACOL BIOCHEM BE, V82, P686, DOI 10.1016/j.pbb.2005.11.010; Pan Y, 2007, PHARMACOL BIOCHEM BE, V87, P130, DOI 10.1016/j.pbb.2007.04.009; PERESS NS, 1995, J NEUROPATH EXP NEUR, V54, P802, DOI 10.1097/00005072-199511000-00007; Pietropaolo S, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.09.012; Qi MY, 2011, J ETHNOPHARMACOL, V138, P731, DOI 10.1016/j.jep.2011.10.015; Radde R, 2006, EMBO REP, V7, P940, DOI 10.1038/sj.embor.7400784; Rangasamy T, 2004, J CLIN INVEST, V114, P1248, DOI 10.1172/JCI200421146; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Sha DJ, 2009, NEUROREPORT, V20, P1564, DOI 10.1097/WNR.0b013e328332d345; Sun PJ, 2013, PHYTOMEDICINE, V20, P975, DOI 10.1016/j.phymed.2013.04.019; Tweedie D, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-106; VANDERWAL EA, 1993, NEUROREPORT, V4, P69, DOI 10.1097/00001756-199301000-00018; Wang Z, 2007, NEUROSCIENCE, V145, P911, DOI 10.1016/j.neuroscience.2006.12.059; Wesson DW, 2011, BEHAV BRAIN RES, V216, P408, DOI 10.1016/j.bbr.2010.08.033; Wu JF, 2012, INT IMMUNOPHARMACOL, V12, P74, DOI 10.1016/j.intimp.2011.10.015; Wyss-Coray T, 2000, AM J PATHOL, V156, P139, DOI 10.1016/S0002-9440(10)64713-X; Wyss-Coray T, 2002, NEURON, V35, P419, DOI 10.1016/S0896-6273(02)00794-8; Wyss-Coray T, 2001, NAT MED, V7, P612, DOI 10.1038/87945; Wyss-Coray Tony, 2006, Current Alzheimer Research, V3, P191, DOI 10.2174/156720506777632916; WyssCoray T, 1997, NATURE, V389, P603, DOI 10.1038/39321; Xie J, 2007, NAT PROD RES, V21, P600, DOI 10.1080/14786410701369680; Xin ZC, 2003, ASIAN J ANDROL, V5, P15; Xu Y, 2009, INT IMMUNOPHARMACOL, V9, P360, DOI 10.1016/j.intimp.2009.01.002; Zeng KW, 2010, INT IMMUNOPHARMACOL, V10, P668, DOI 10.1016/j.intimp.2010.03.010; Zhang DW, 2012, BIOCHIMIE, V94, P2514, DOI 10.1016/j.biochi.2012.06.033; Zhang HY, 2012, MOL MED REP, V6, P967, DOI 10.3892/mmr.2012.1041; Zhang L, 2005, STROKE, V36, P847, DOI 10.1161/01.STR.0000158923.19956.73; Zhang RL, 2002, STROKE, V33, P2675, DOI 10.1161/01.STR.0000034399.95249.59; Zhang ZY, 2013, J NEUROPATH EXP NEUR, V72, P178, DOI 10.1097/NEN.0b013e318283114a; Zhang Z, 2008, EXP NEUROL, V210, P681, DOI 10.1016/j.expneurol.2007.12.025; Zhao J, 2010, NEUROPHARMACOLOGY, V58, P774, DOI 10.1016/j.neuropharm.2009.12.008	58	18	21	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e104616	10.1371/journal.pone.0104616	http://dx.doi.org/10.1371/journal.pone.0104616			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25101849	Green Published, gold, Green Submitted			2022-12-27	WOS:000339993900080
J	Blask, DE; Dauchy, RT; Dauchy, EM; Mao, L; Hill, SM; Greene, MW; Belancio, VP; Sauer, LA; Davidson, L				Blask, David E.; Dauchy, Robert T.; Dauchy, Erin M.; Mao, Lulu; Hill, Steven M.; Greene, Michael W.; Belancio, Victoria P.; Sauer, Leonard A.; Davidson, Leslie			Light Exposure at Night Disrupts Host/Cancer Circadian Regulatory Dynamics: Impact on the Warburg Effect, Lipid Signaling and Tumor Growth Prevention	PLOS ONE			English	Article							BREAST-CANCER XENOGRAFTS; HEPATOMA 7288CTC; CELL METABOLISM; MELATONIN; ACID; CLOCK; HIF-1-ALPHA; INHIBITION; EXPRESSION; DIETARY	The central circadian clock within the suprachiasmatic nucleus (SCN) plays an important role in temporally organizing and coordinating many of the processes governing cancer cell proliferation and tumor growth in synchrony with the daily light/dark cycle which may contribute to endogenous cancer prevention. Bioenergetic substrates and molecular intermediates required for building tumor biomass each day are derived from both aerobic glycolysis (Warburg effect) and lipid metabolism. Using tissue-isolated human breast cancer xenografts grown in nude rats, we determined that circulating systemic factors in the host and the Warburg effect, linoleic acid uptake/metabolism and growth signaling activities in the tumor are dynamically regulated, coordinated and integrated within circadian time structure over a 24-hour light/dark cycle by SCN-driven nocturnal pineal production of the anticancer hormone melatonin. Dim light at night (LAN)-induced melatonin suppression disrupts this circadian-regulated host/cancer balance among several important cancer preventative signaling mechanisms, leading to hyperglycemia and hyperinsulinemia in the host and runaway aerobic glycolysis, lipid signaling and proliferative activity in the tumor.	[Blask, David E.; Dauchy, Robert T.; Sauer, Leonard A.] Tulane Univ, Sch Med, Lab Chrononeuroendocrine Oncol, New Orleans, LA 70112 USA; [Blask, David E.; Dauchy, Robert T.; Dauchy, Erin M.; Mao, Lulu; Hill, Steven M.; Belancio, Victoria P.] Tulane Univ, Sch Med, Dept Struct & Cellular Biol, New Orleans, LA 70112 USA; [Blask, David E.; Dauchy, Robert T.; Dauchy, Erin M.; Mao, Lulu; Hill, Steven M.; Belancio, Victoria P.] Tulane Canc Ctr, New Orleans, LA USA; [Blask, David E.; Dauchy, Robert T.; Dauchy, Erin M.; Mao, Lulu; Hill, Steven M.; Belancio, Victoria P.] Louisiana Canc Res Consortium, New Orleans, LA USA; [Greene, Michael W.; Davidson, Leslie] Mary Imogene Bassett Hosp, Bassett Res Inst, Cooperstown, NY 13326 USA	Tulane University; Tulane University; Tulane University	Blask, DE (corresponding author), Tulane Univ, Sch Med, Lab Chrononeuroendocrine Oncol, 1430 Tulane Ave, New Orleans, LA 70112 USA.	dblask@tulane.edu	Greene, Michael/L-6174-2019	Greene, Michael/0000-0002-6443-8269	American Association for Laboratory Animal Science; National Institutes of Health [R21CA129875, R01CA054152]; Tulane University School of Medicine; Louisiana Cancer Research Consortium [631455]; NATIONAL CANCER INSTITUTE [R21CA129875, R01CA054152] Funding Source: NIH RePORTER	American Association for Laboratory Animal Science; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tulane University School of Medicine; Louisiana Cancer Research Consortium; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was generously supported by the American Association for Laboratory Animal Science (www.aalas.org) Grants for Laboratory Animal Science (GLAS) Award to RTD, National Institutes of Health (www.nih.gov) grant R21CA129875 to DEB, Tulane University School of Medicine (www.tulane.edu) and Louisiana Cancer Research Consortium (www.louisianacancercenter.org) Startup Grant 631455 to DEB and National Institutes of Health grant R01CA054152 to SMH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bass J, 2012, NATURE, V491, P348, DOI 10.1038/nature11704; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Blask DE, 2011, J PINEAL RES, V51, P259, DOI 10.1111/j.1600-079X.2011.00888.x; Blask DE, 1999, CANCER RES, V59, P4693; Blask DE, 2005, CANCER RES, V65, P11174, DOI 10.1158/0008-5472.CAN-05-1945; Canaple L, 2003, CANCER RES, V63, P7545; Cantor JR, 2012, CANCER DISCOV, V2, P881, DOI 10.1158/2159-8290.CD-12-0345; Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Dauchy RT, 2004, CANCER LETT, V209, P7, DOI 10.1016/j.canlet.2003.12.012; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Elstrom RL, 2004, CANCER RES, V64, P3892, DOI 10.1158/0008-5472.CAN-03-2904; GLASGOW WC, 1994, ARCH BIOCHEM BIOPHYS, V311, P286, DOI 10.1006/abbi.1994.1239; Glasgow WC, 1997, J BIOL CHEM, V272, P19269, DOI 10.1074/jbc.272.31.19269; Golombek DA, 2010, PHYSIOL REV, V90, P1063, DOI 10.1152/physrev.00009.2009; Gordan JD, 2007, CANCER CELL, V12, P108, DOI 10.1016/j.ccr.2007.07.006; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hrushesky WJM, 2001, J CONTROL RELEASE, V74, P27, DOI 10.1016/S0168-3659(01)00307-8; Hrushesky WJM, 2000, JPN J CLIN ONCOL, V30, P529, DOI 10.1093/jjco/hyd134; Hsi LC, 2002, J BIOL CHEM, V277, P40549, DOI 10.1074/jbc.M203522200; Hubbi ME, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003417; Kalsbeek A, 1998, PHYSIOL BEHAV, V63, P553, DOI 10.1016/S0031-9384(97)00493-9; Koshiji M, 2004, EMBO J, V23, P1949, DOI 10.1038/sj.emboj.7600196; Locasale JW, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-88; REITER RJ, 1994, LAB MED, V25, P438, DOI 10.1093/labmed/25.7.438; REITER RJ, 1991, MOL CELL ENDOCRINOL, V79, pC153, DOI 10.1016/0303-7207(91)90087-9; Reiter RJ, 2012, ANN MED, V44, P564, DOI 10.3109/07853890.2011.586365; Sauer LA, 1999, CANCER RES, V59, P4688; SAUER LA, 1992, BRIT J CANCER, V66, P297, DOI 10.1038/bjc.1992.260; Sauer LA, 1997, J NUTR, V127, P1412, DOI 10.1093/jn/127.7.1412; Shureiqi I, 1999, CARCINOGENESIS, V20, P1985, DOI 10.1093/carcin/20.10.1985; Stevens RG, 2005, EPIDEMIOLOGY, V16, P254, DOI 10.1097/01.ede.0000152525.21924.54; Stevens RG, 2009, INT J EPIDEMIOL, V38, P963, DOI 10.1093/ije/dyp178; Straif K, 2007, LANCET ONCOL, V8, P1065, DOI 10.1016/S1470-2045(07)70373-X; Warburg O., 1925, KLIN WOCHENSCHR, V4, P534, DOI DOI 10.1007/BF01726151; Wu JH, 2011, CANCER RES, V71, P2622, DOI 10.1158/0008-5472.CAN-10-3837; Xiang S, 2012, BREAST CANCER-BASIC, V6, P137, DOI 10.4137/BCBCR.S9673; Yang XM, 2009, BREAST CANCER RES TR, V117, P423, DOI 10.1007/s10549-008-0133-z; Zhao YH, 2011, FRONT BIOSCI-LANDMRK, V16, P1844, DOI 10.2741/3826	39	77	81	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e102776	10.1371/journal.pone.0102776	http://dx.doi.org/10.1371/journal.pone.0102776			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25099274	Green Published, Green Submitted, gold			2022-12-27	WOS:000339995100011
J	Ge, W; Kuang, HZ; Wei, B; Bo, L; Xu, ZC; Xu, XS; Geng, DQ; Sun, M				Ge, Wei; Kuang, Hanzhe; Wei, Bin; Bo, Le; Xu, Zhice; Xu, Xingshun; Geng, Deqin; Sun, Miao			A Novel Cysteine-Sparing NOTCH3 Mutation in a Chinese Family with CADASIL	PLOS ONE			English	Article							RECEPTOR; SPECTRUM	Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is an adult onset cerebral small vessel disorder caused by the mutations of the neurogenic locus notch homolog protein 3 (NOTCH3) gene. The extracellular part of NOTCH3 is composed of 34 epidermal growth factor-like (EGF-like) repeat domains. Each EGF-like domain is rich of cysteine and glycine to produce three loops that are essential for high-affinity binding to its ligand. Nearly all reported CADASIL-associated mutations result in gain or loss of a cysteine residue within the EGF-like domains. Only a few cysteine-sparing NOTCH3 mutations have been documented in the patients with CADASIL to date. Here we reported a Chinese CADASIL family with a cysteine-sparing NOTCH3 mutation. In this family, affected patients had dizziness, memory loss, gait instability, or hemiplegia. Brain magnetic resonance imaging (MRI) showed diffuse leukoencephalopathy with confluent signal abnormalities in the periventricular white matter, basal ganglia, and centrum semiovale bilaterally. By screening the entire coding region of NOTCH3, a novel missense mutation p.G149V (c.446G>T) as found. This mutation was not detected in 400 normal controls. Considering the critical position of glycine within the C-loop of EGF-like domain and its high conservation through evolution p.G149V mutation could be a potential pathogenic cause for CADASIL.	[Ge, Wei; Kuang, Hanzhe; Wei, Bin; Bo, Le; Xu, Zhice; Sun, Miao] Soochow Univ, Affiliated Hosp 1, Inst Fetol, Suzhou, Jiangsu, Peoples R China; [Ge, Wei; Geng, Deqin] Xuzhou Med Coll, Affiliated Hosp, Dept Neurol, Xuzhou, Jiangsu, Peoples R China; [Ge, Wei; Xu, Xingshun] Soochow Univ, Affiliated Hosp 2, Dept Neurol, Suzhou, Jiangsu, Peoples R China	Soochow University - China; Xuzhou Medical University; Soochow University - China	Geng, DQ (corresponding author), Xuzhou Med Coll, Affiliated Hosp, Dept Neurol, Xuzhou, Jiangsu, Peoples R China.	gengdeqin@hotmail.com; sunmiaosun@yahoo.com	miao, sun/E-2834-2018; Xu, Xingshun/AAF-8183-2020	Xu, Xingshun/0000-0003-0205-6342	National Natural Science Foundation of China [30871355]; Ministry of Science and Technology of China [2013CB945400]; FOGARTY INTERNATIONAL CENTER [D43TW006176] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work is supported by National Natural Science Foundation of China 30871355 and Ministry of Science and Technology of China 2013CB945400 (to MS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bersano A, 2012, FUNCT NEUROL, V27, P247; CAMPION SR, 1994, PROG NUCLEIC ACID RE, V49, P353; CHABRIAT H, 1995, LANCET, V346, P934, DOI 10.1016/S0140-6736(95)91557-5; Dichgans M, 1998, ANN NEUROL, V44, P731, DOI 10.1002/ana.410440506; Fouillade C, 2012, CARDIOVASC RES, V95, P138, DOI 10.1093/cvr/cvs019; Joutel A, 2000, J CLIN INVEST, V105, P597, DOI 10.1172/JCI8047; Joutel A, 1996, NATURE, V383, P707, DOI 10.1038/383707a0; Opherk C, 2004, BRAIN, V127, P2533, DOI 10.1093/brain/awh282; Scheid R, 2008, NEUROLOGY, V71, P774, DOI 10.1212/01.wnl.0000324928.44694.f7; TOURNIERLASSERVE E, 1993, NAT GENET, V3, P256, DOI 10.1038/ng0393-256; Wouters MA, 2005, PROTEIN SCI, V14, P1091, DOI 10.1110/ps.041207005	11	11	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e104533	10.1371/journal.pone.0104533	http://dx.doi.org/10.1371/journal.pone.0104533			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25098330	Green Submitted, gold, Green Published			2022-12-27	WOS:000339995100082
J	Olesh, EV; Yakovenko, S; Gritsenko, V				Olesh, Erienne V.; Yakovenko, Sergiy; Gritsenko, Valeriya			Automated Assessment of Upper Extremity Movement Impairment due to Stroke	PLOS ONE			English	Article							FUGL-MEYER ASSESSMENT; UPPER-LIMB FUNCTION; REACH-TO-GRASP; PHYSICAL REHABILITATION; MICROSOFT KINECT; MOTOR RECOVERY; TELEREHABILITATION; THERAPY; PERFORMANCE; SYSTEM	Current diagnosis and treatment of movement impairment post-stroke is based on the subjective assessment of select movements by a trained clinical specialist. However, modern low-cost motion capture technology allows for the development of automated quantitative assessment of motor impairment. Such outcome measures are crucial for advancing post-stroke treatment methods. We sought to develop an automated method of measuring the quality of movement in clinically-relevant terms from low-cost motion capture. Unconstrained movements of upper extremity were performed by people with chronic hemiparesis and recorded by standard and low-cost motion capture systems. Quantitative scores derived from motion capture were compared to qualitative clinical scores produced by trained human raters. A strong linear relationship was found between qualitative scores and quantitative scores derived from both standard and low-cost motion capture. Performance of the automated scoring algorithm was matched by averaged qualitative scores of three human raters. We conclude that low-cost motion capture combined with an automated scoring algorithm is a feasible method to assess objectively upper-arm impairment post stroke. The application of this technology may not only reduce the cost of assessment of post stroke movement impairment, but also promote the acceptance of objective impairment measures into routine medical practice.	[Olesh, Erienne V.; Gritsenko, Valeriya] W Virginia Univ, Sch Med, Div Phys Therapy, Morgantown, WV 26506 USA; [Yakovenko, Sergiy] W Virginia Univ, Sch Med, Div Exercise Physiol, Morgantown, WV 26506 USA	West Virginia University; West Virginia University	Gritsenko, V (corresponding author), W Virginia Univ, Sch Med, Div Phys Therapy, Morgantown, WV 26506 USA.	vgritsenko@hsc.wvu.edu	Gritsenko, Valeriya/G-9232-2012	Gritsenko, Valeriya/0000-0001-5302-4004; Gritsenko, Valeriya/0000-0002-6408-9433; Yakovenko, Sergiy/0000-0002-5946-6409	Departmental Start-up Fund from West Virginia University; West Virginia University; WVU/NSF ADVANCE program; National Institute of General Medical Sciences [T32 GM081741]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM081741] Funding Source: NIH RePORTER	Departmental Start-up Fund from West Virginia University; West Virginia University; WVU/NSF ADVANCE program(National Science Foundation (NSF)NSF - Office of the Director (OD)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Departmental Start-up Fund from West Virginia University (VG); Research Funding Development Grant from West Virginia University (VG); WVU/NSF ADVANCE program support (http://advance.wvu.edu) (VG); National Institute of General Medical Sciences grant T32 GM081741 stipend (EVO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERGLUND K, 1986, SCAND J REHABIL MED, V18, P155; Brennan DM, 2011, IEEE ENG MED BIO, P1819, DOI 10.1109/IEMBS.2011.6090518; Broeren J, 2006, STUD HEALTH TECHNOL, V124, P51; Caimmi M, 2008, NEUROREHAB NEURAL RE, V22, P31, DOI 10.1177/1545968307302923; Chang YJ, 2011, RES DEV DISABIL, V32, P2566, DOI 10.1016/j.ridd.2011.07.002; Chumbler NR, 2012, STROKE, V43, P2168, DOI 10.1161/STROKEAHA.111.646943; Clark RA, 2013, GAIT POSTURE, V38, P1064, DOI 10.1016/j.gaitpost.2013.03.029; Clark RA, 2013, J BIOMECH, V46, P2722, DOI 10.1016/j.jbiomech.2013.08.011; Clark RA, 2012, GAIT POSTURE, V36, P372, DOI 10.1016/j.gaitpost.2012.03.033; De Weerdt WJG., 1985, PHYSIOTHER CAN, V37, P65, DOI DOI 10.3138/PTC.37.2.065; Desrosiers J, 2006, DISABIL REHABIL, V28, P221, DOI 10.1080/09638280500158372; Duff M, 2013, NEUROREHAB NEURAL RE, V27, P306, DOI 10.1177/1545968312465195; Duncan P, 2003, STROKE, V34, P2173, DOI 10.1161/01.STR.0000083699.95351.F2; DUNCAN PW, 1983, PHYS THER, V63, P1606, DOI 10.1093/ptj/63.10.1606; Durfee W, 2009, IEEE ENG MED BIO, P2422, DOI 10.1109/IEMBS.2009.5334951; Fisher RA, 1925, STAT METHODS RES WOR, P1; FUGLMEYER AR, 1975, SCAND J REHABIL MED, V7, P13; GATSONIS C, 1989, PSYCHOL BULL, V106, P516, DOI 10.1037/0033-2909.106.3.516; Gladstone DJ, 2002, NEUROREHAB NEURAL RE, V16, P232, DOI 10.1177/154596802401105171; Go AS, 2013, CIRCULATION, DOI [10.1161/CIR.0b013e3182009701, DOI 10.1161/CIR.0B013E3182009701]; Gritsenko V, 2004, ARCH PHYS MED REHAB, V85, P881, DOI 10.1016/j.apmr.2003.08.094; Hsieh YW, 2009, STROKE, V40, P1386, DOI 10.1161/STROKEAHA.108.530584; Huijgen BCH, 2008, J TELEMED TELECARE, V14, P249, DOI 10.1258/jtt.2008.080104; Johnson MJ, 2011, BIOMED TECH, V56, P5, DOI 10.1515/BMT.2010.050; Kelly-Hayes Margaret, 2003, J Stroke Cerebrovasc Dis, V12, P119, DOI 10.1016/S1052-3057(03)00042-9; Kunkel A, 1999, ARCH PHYS MED REHAB, V80, P624, DOI 10.1016/S0003-9993(99)90163-6; Lai JCK, 2004, J TELEMED TELECARE, V10, P199, DOI 10.1258/1357633041424340; Langan J, 2013, J REHABIL MED, V45, P217, DOI 10.2340/16501977-1115; Lange B, 2011, IEEE ENG MED BIO, P1831, DOI 10.1109/IEMBS.2011.6090521; Lin KC, 2007, CLIN REHABIL, V21, P1075, DOI 10.1177/0269215507079843; Llorens R, 2012, STUD HEALTH TECHNOL, V181, P108, DOI 10.3233/978-1-61499-121-2-108; LYLE RC, 1981, INT J REHABIL RES, V4, P483, DOI 10.1097/00004356-198112000-00001; MacLellan MJ, 2013, PM&R, V5, P381, DOI 10.1016/j.pmrj.2013.02.003; Morris JH, 2013, DISABIL REHABIL, V35, P291, DOI 10.3109/09638288.2012.691942; Pastor I, 2012, IEEE ENG MED BIO, P1286, DOI 10.1109/EMBC.2012.6346173; Perry Joel C, 2011, IEEE Int Conf Rehabil Robot, V2011, P5975413, DOI 10.1109/ICORR.2011.5975413; Rodriguez-de-Pablo C, 2012, IEEE ENG MED BIO, P4571, DOI 10.1109/EMBC.2012.6346984; Rubin MN, 2013, CURR ATHEROSCLER REP, V15, DOI 10.1007/s11883-013-0343-7; Stone EE, 2011, IEEE ENG MED BIO, P6491, DOI 10.1109/IEMBS.2011.6091602; Taub E, 1997, Top Stroke Rehabil, V3, P38, DOI 10.1080/10749357.1997.11754128; TAUB E, 1993, ARCH PHYS MED REHAB, V74, P347; van der Lee JH, 2001, J REHABIL MED, V33, P110; van Kordelaar J, 2012, EXP BRAIN RES, V221, P251, DOI 10.1007/s00221-012-3169-6; Volpe BT, 2008, NEUROREHAB NEURAL RE, V22, P305, DOI 10.1177/1545968307311102; WOLF SL, 1989, EXP NEUROL, V104, P125, DOI 10.1016/S0014-4886(89)80005-6; Zheng H, 2005, MED BIOL ENG COMPUT, V43, P413, DOI 10.1007/BF02344720	46	54	56	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e104487	10.1371/journal.pone.0104487	http://dx.doi.org/10.1371/journal.pone.0104487			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM6SM	25100036	gold, Green Published, Green Submitted			2022-12-27	WOS:000339995100076
J	Cao, LL; Kawai, H; Sasatani, M; Iizuka, D; Masuda, Y; Inaba, T; Suzuki, K; Ootsuyama, A; Umata, T; Kamiya, K; Suzuki, F				Cao, Lili; Kawai, Hidehiko; Sasatani, Megumi; Iizuka, Daisuke; Masuda, Yuji; Inaba, Toshiya; Suzuki, Keiji; Ootsuyama, Akira; Umata, Toshiyuki; Kamiya, Kenji; Suzuki, Fumio			A Novel ATM/TP53/p21-Mediated Checkpoint Only Activated by Chronic gamma-Irradiation	PLOS ONE			English	Article							DNA-DAMAGE RESPONSE; CELLULAR SENESCENCE; DOSE RATE; IN-VIVO; P53; CELLS; RADIATION; INSTABILITY; GROWTH; CANCER	Different levels or types of DNA damage activate distinct signaling pathways that elicit various cellular responses, including cell-cycle arrest, DNA repair, senescence, and apoptosis. Whereas a range of DNA-damage responses have been characterized, mechanisms underlying subsequent cell-fate decision remain elusive. Here we exposed cultured cells and mice to different doses and dose rates of gamma-irradiation, which revealed cell-type-specific sensitivities to chronic, but not acute, gamma-irradiation. Among tested cell types, human fibroblasts were associated with the highest levels of growth inhibition in response to chronic gamma-irradiation. In this context, fibroblasts exhibited a reversible G1 cell-cycle arrest or an irreversible senescence-like growth arrest, depending on the irradiation dose rate or the rate of DNA damage. Remarkably, when the same dose of gamma-irradiation was delivered chronically or acutely, chronic delivery induced considerably more cellular senescence. A similar effect was observed with primary cells isolated from irradiated mice. We demonstrate a critical role for the ataxia telangiectasia mutated (ATM)/tumor protein p53 (TP53)/p21 pathway in regulating DNA-damage-associated cell fate. Indeed, blocking the ATM/TP53/p21 pathway deregulated DNA damage responses, leading to micronucleus formation in chronically irradiated cells. Together these results provide insights into the mechanisms governing cell-fate determination in response to different rates of DNA damage.	[Cao, Lili; Sasatani, Megumi; Iizuka, Daisuke; Masuda, Yuji; Kamiya, Kenji] Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Expt Oncol, Hiroshima, Japan; [Cao, Lili; Kawai, Hidehiko; Suzuki, Fumio] Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Mol Radiobiol, Hiroshima, Japan; [Masuda, Yuji] Nagoya Univ, Environm Med Res Inst, Dept Genome Dynam, Chikusa Ku, Nagoya, Aichi 464, Japan; [Inaba, Toshiya] Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Mol Oncol, Hiroshima, Japan; [Inaba, Toshiya] Hiroshima Univ, Res Inst Radiat Biol & Med, Leukemia Program Project, Hiroshima, Japan; [Suzuki, Keiji] Nagasaki Univ, Dept Radiat Med Sci, Atom Bomb Dis Inst, Nagasaki 852, Japan; [Ootsuyama, Akira] Univ Occupat & Environm Hlth, Sch Med, Dept Radiat Biol & Hlth, Kitakyushu, Fukuoka 807, Japan; [Umata, Toshiyuki] Univ Occupat & Environm Hlth, Radioisotope Res Ctr, Kitakyushu, Fukuoka 807, Japan	Hiroshima University; Hiroshima University; Nagoya University; Hiroshima University; Hiroshima University; Nagasaki University; University of Occupational & Environmental Health - Japan; University of Occupational & Environmental Health - Japan	Kawai, H (corresponding author), Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Mol Radiobiol, Hiroshima, Japan.	kawaih@hiroshima-u.ac.jp	Masuda, Yuji/I-6315-2014	Masuda, Yuji/0000-0002-6229-1988; IIZUKA, Daisuke/0000-0003-3990-4800; Kawai, Hidehiko/0000-0003-2213-7166	Ministry of Education, Science, Sports and Culture of Japan; Grants-in-Aid for Scientific Research [25281020, 26340024] Funding Source: KAKEN	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Funding was provided by the Ministry of Education, Science, Sports and Culture of Japan (to HK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashcroft M, 1999, ONCOGENE, V18, P7637, DOI 10.1038/sj.onc.1203012; Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191; di Fagagna FD, 2008, NAT REV CANCER, V8, P512, DOI 10.1038/nrc2440; GONDO Y, 1994, BIOCHEM BIOPH RES CO, V202, P830, DOI 10.1006/bbrc.1994.2005; Gudkov AV, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001180; Gudkov AV, 2003, NAT REV CANCER, V3, P117, DOI 10.1038/nrc992; HALL EJ, 1964, RADIAT RES, V22, P305, DOI 10.2307/3571661; HALL EJ, 1986, INT J RADIAT ONCOL, V12, P655, DOI 10.1016/0360-3016(86)90076-3; Harfouche G, 2010, MUTAT RES-REV MUTAT, V704, P167, DOI 10.1016/j.mrrev.2010.01.007; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Illa-Bochaca I, 2010, METHODS MOL BIOL, V621, P29, DOI 10.1007/978-1-60761-063-2_2; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Kawai H, 2003, J BIOL CHEM, V278, P45946, DOI 10.1074/jbc.M308295200; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Lu XB, 2007, CANCER CELL, V12, P342, DOI 10.1016/j.ccr.2007.08.033; MARIN G, 1966, EXP CELL RES, V43, P413, DOI 10.1016/0014-4827(66)90068-1; Martin M, 2012, MUTAT RES; MCMILLAN TJ, 1992, EUR J CANCER, V28A, P267, DOI 10.1016/0959-8049(92)90430-A; MICHALOWSKI A, 1981, RADIAT ENVIRON BIOPH, V19, P157, DOI 10.1007/BF01324183; Munoz-Espin D, 2013, CELL, V155, P1104, DOI 10.1016/j.cell.2013.10.019; Norimura T, 1996, NAT MED, V2, P577, DOI 10.1038/nm0596-577; Nussenzweig A, 2007, CELL CYCLE, V6, P2339, DOI 10.4161/cc.6.19.4995; Ojima M, 2004, J RADIAT RES, V45, P105, DOI 10.1269/jrr.45.105; Panganiban RAM, 2013, INT J MOL SCI, V14, P15931, DOI 10.3390/ijms140815931; Purvis JE, 2012, SCIENCE, V336, P1440, DOI 10.1126/science.1218351; Rubin H, 1997, MECH AGEING DEV, V98, P1, DOI 10.1016/S0047-6374(97)00067-5; Salama R, 2014, GENE DEV, V28, P99, DOI 10.1101/gad.235184.113; Santoro R, 2010, CELL CYCLE, V9, P4262, DOI 10.4161/cc.9.21.13853; Shiloh Y, 1997, ANNU REV GENET, V31, P635, DOI 10.1146/annurev.genet.31.1.635; Shreeram S, 2006, MOL CELL, V23, P757, DOI 10.1016/j.molcel.2006.07.010; Siliciano JD, 1997, GENE DEV, V11, P3471, DOI 10.1101/gad.11.24.3471; Smith LE, 2003, HEALTH PHYS, V85, P23, DOI 10.1097/00004032-200307000-00006; Storer M, 2013, CELL, V155, P1119, DOI 10.1016/j.cell.2013.10.041; SUZUKI F, 1992, RADIAT RES, V131, P290, DOI 10.2307/3578418; Tahara H, 2005, NAT METHODS, V2, P829, DOI 10.1038/NMETH797; Vilenchik MM, 2003, P NATL ACAD SCI USA, V100, P12871, DOI 10.1073/pnas.2135498100; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wagner J, 2005, IEE P SYST BIOL, V152, P109, DOI 10.1049/ip-syb:20050025; WU XW, 1993, GENE DEV, V7, P1126, DOI 10.1101/gad.7.7a.1126; Xu Y, 1996, GENE DEV, V10, P2401, DOI 10.1101/gad.10.19.2401	43	29	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e104279	10.1371/journal.pone.0104279	http://dx.doi.org/10.1371/journal.pone.0104279			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093836	Green Submitted, Green Published, gold			2022-12-27	WOS:000341357200091
J	de Freitas, FAD; Bernardo, V; Gomgnimbou, MK; Sola, C; Siqueira, HR; Pereira, MAS; Fandinho, FCO; Gomes, H; Araujo, MEI; Suffys, PN; Marques, EA; Albano, RM				de Freitas, Flavia A. D.; Bernardo, Vagner; Gomgnimbou, Michel K.; Sola, Christophe; Siqueira, Helio R.; Pereira, Marcia A. S.; Fandinho, Fatima C. O.; Gomes, HarrisonM.; Araujo, Marcelo E. I.; Suffys, Philip N.; Marques, Elizabeth A.; Albano, Rodolpho M.			Multidrug Resistant Mycobacterium tuberculosis: A Retrospective katG and rpoB Mutation Profile Analysis in Isolates from a Reference Center in Brazil	PLOS ONE			English	Article							DRUG-RESISTANCE; MOLECULAR EPIDEMIOLOGY; GENETIC DIVERSITY; RIFAMPICIN; STRAINS; SUBSTITUTION; PREVALENCE	Background: Multidrug resistance is a critical factor in tuberculosis control. To gain better understanding of multidrug resistant tuberculosis in Brazil, a retrospective study was performed to compare genotypic diversity and drug resistance associated mutations in Mycobacterium tuberculosis isolates from a national reference center. Methods and Findings: Ninety-nine multidrug resistant isolates from 12 Brazilian states were studied. Drug-resistance patterns were determined and the rpoB and katG genes were screened for mutations. Genotypic diversity was investigated by IS6110-RFLP and Luminex 47 spoligotyping. Mutations in rpoB and katG were seen in 91% and 93% of the isolates, respectively. Codon 315 katG mutations occurred in 82.8% of the isolates with a predominance of the Ser315Thr substitution. Twenty-five isolates were clustered in 11 groups with identical IS6110-RFLP patterns while 74 showed unique patterns with no association between mutation frequencies or susceptibility profiles. The most prevalent spoligotyping lineages were LAM (47%), T (17%) and Haarlen (12%). The Haarlen lineage showed a higher frequency of codon 516 rpoB mutations while codon 531 mutations prevailed in the other isolates. Conclusions: Our data suggest that there were no major multidrug resistant M. tuberculosis strains transmitted among patients referred to the reference center, indicating an independent acquisition of resistance. In addition, drug resistance associated mutation profiles were well established among the main spoligotyping lineages found in these Brazilian multidrug resistant isolates, providing useful data for patient management and treatment.	[de Freitas, Flavia A. D.; Bernardo, Vagner; Albano, Rodolpho M.] Univ Estado Rio de Janeiro, Dept Bioquim, BR-20550011 Rio De Janeiro, Brazil; [Gomgnimbou, Michel K.; Sola, Christophe] Univ Paris 11, CNRS, Inst Genet & Microbiol, Infect Genet Emerging Pathogens Evolut Team, F-91405 Orsay, France; [Siqueira, Helio R.; Marques, Elizabeth A.] Univ Estado Rio de Janeiro, Fac Ciencias Med, BR-20550011 Rio De Janeiro, Brazil; [Pereira, Marcia A. S.; Fandinho, Fatima C. O.] Fundacao Oswaldo Cruz, Ctr Referencia Prof Helio Fraga, Rio De Janeiro, Brazil; [Gomes, HarrisonM.; Araujo, Marcelo E. I.; Suffys, Philip N.] Fundacao Oswaldo Cruz, Lab Biol Mol Aplicada Micobacteria, Rio De Janeiro, Brazil	Universidade do Estado do Rio de Janeiro; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Universidade do Estado do Rio de Janeiro; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz	Albano, RM (corresponding author), Univ Estado Rio de Janeiro, Dept Bioquim, BR-20550011 Rio De Janeiro, Brazil.	albano@uerj.br	Sola, Christophe/A-7992-2016; Bernardo, Vagner G/H-7924-2012; Marques, Elizabeth/AAL-8002-2021; suffys, philip/E-3009-2013	Sola, Christophe/0000-0003-4672-2140; Bernardo, Vagner G/0000-0003-2844-0924; Albano, Rodolpho/0000-0002-0643-901X; Fandinho, Fatima Cristina Onofre/0000-0003-3896-3526	Fundacao Carlos Chagas de Amparo a Pesquisa (FAPERJ); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Fundacao Carlos Chagas de Amparo a Pesquisa (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Some of the authors received funding for this work. RMA received funding from the following Brazilian Agencies: Fundacao Carlos Chagas de Amparo a Pesquisa (FAPERJ), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) e Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afanas'ev MV, 2007, J ANTIMICROB CHEMOTH, V59, P1057, DOI 10.1093/jac/dkm086; da Silva PEA, 2011, FEMS IMMUNOL MED MIC, V63, P1, DOI 10.1111/j.1574-695X.2011.00831.x; Araya P, 2011, REV MED CHILE, V139, P467, DOI /S0034-98872011000400008; Baranov AA, 2009, INT J TUBERC LUNG D, V13, P1288; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; CANETTI G, 1963, Rev Tuberc Pneumol (Paris), V27, P217; Cardoso RF, 2004, ANTIMICROB AGENTS CH, V48, P3373, DOI 10.1128/AAC.48.9.3373-3381.2004; Cave MD, 2005, TUBERCULOSIS AND THE TUBERCLE BACILLUS, P33; Caws M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000034; Chan RCY, 2007, J ANTIMICROB CHEMOTH, V59, P866, DOI 10.1093/jac/dkm054; Dalcolmo MP, 2007, REV SAUDE PUBL, V41; Dalcomo M. P., 2012, PULMAO RJ, V21, P55; Dalla Costa ER, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-39; de Siqueira HR, 2009, J BRAS PNEUMOL, V35, P773, DOI 10.1590/S1806-37132009000800009; Doroudchi M, 2000, SCAND J INFECT DIS, V32, P663, DOI 10.1080/003655400459595; Durmaz R, 2007, INFECT GENET EVOL, V7, P513, DOI 10.1016/j.meegid.2007.03.003; Filliol I, 2003, J CLIN MICROBIOL, V41, P1963, DOI 10.1128/JCM.41.5.1963-1970.2003; Gomes HM, 2012, INFECT GENET EVOL, V12, P649, DOI 10.1016/j.meegid.2011.08.027; Gomgnimbou MK, 2012, J CLIN MICROBIOL, V50, P3172, DOI 10.1128/JCM.00976-12; Hofling CC, 2005, INT J TUBERC LUNG D, V9, P87; Jackson AD, 2009, INT J TUBERC LUNG D, V13, P486; Jou R, 2005, J CLIN MICROBIOL, V43, P1390, DOI 10.1128/JCM.43.3.1390-1394.2005; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P314; Kisa O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030331; Koch A, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.17; Kozhamkulov U, 2011, JPN J INFECT DIS, V64, P253; Lipin MY, 2007, CLIN MICROBIOL INFEC, V13, P620, DOI 10.1111/j.1469-0691.2007.01711.x; Marttila HJ, 1998, ANTIMICROB AGENTS CH, V42, P2443, DOI 10.1128/AAC.42.9.2443; Muller B, 2013, TRENDS GENET, V29, P160, DOI 10.1016/j.tig.2012.11.005; O'Sullivan DM, 2005, J ANTIMICROB CHEMOTH, V55, P674, DOI 10.1093/jac/dki069; Perizzolo PF, 2012, TUBERCULOSIS, V92, P56, DOI 10.1016/j.tube.2011.09.008; Portugal I, 1999, J CLIN MICROBIOL, V37, P3022, DOI 10.1128/JCM.37.9.3022-3024.1999; Rouse DA, 1996, MOL MICROBIOL, V22, P583, DOI 10.1046/j.1365-2958.1996.00133.x; Santos LC, 2010, INFECT GENET EVOL, V10, P1052, DOI 10.1016/j.meegid.2010.06.018; Siu GKH, 2011, DIAGN MICR INFEC DIS, V69, P51, DOI 10.1016/j.diagmicrobio.2010.08.021; Slayden RA, 2000, MICROBES INFECT, V2, P659, DOI 10.1016/S1286-4579(00)00359-2; Somoskovi A, 2001, RESP RES, V2, P164, DOI 10.1186/rr54; Toungoussova OS, 2003, CLIN INFECT DIS, V37, P665, DOI 10.1086/377205; Valim ARM, 2000, J CLIN MICROBIOL, V38, P3119, DOI 10.1128/JCM.38.8.3119-3122.2000; Valvatne H, 2009, J ANTIMICROB CHEMOTH, V64, P694, DOI 10.1093/jac/dkp292; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; VANSOOLINGEN D, 1991, J CLIN MICROBIOL, V29, P2578, DOI 10.1128/JCM.29.11.2578-2586.1991; World Health Organization, 2021, 10 THREATS GLOB HLTH; Yue J, 2003, J CLIN MICROBIOL, V41, P2209, DOI 10.1128/JCM.41.5.2209-2212.2003; Zumarraga MJ, 1999, J CLIN MICROBIOL, V37, P296	45	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e104100	10.1371/journal.pone.0104100	http://dx.doi.org/10.1371/journal.pone.0104100			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093512	Green Published, Green Submitted, gold			2022-12-27	WOS:000341357200068
J	Hartley, DEH; Isaiah, A				Hartley, Douglas E. H.; Isaiah, Amal			Envelope Enhancement Increases Cortical Sensitivity to Interaural Envelope Delays with Acoustic and Electric Hearing	PLOS ONE			English	Article							BILATERAL COCHLEAR IMPLANTS; SUPERIOR OLIVARY COMPLEX; HIGH-FREQUENCY NEURONS; INFERIOR COLLICULUS NEURONS; TIME DIFFERENCES; SOUND LOCALIZATION; AUDITORY-CORTEX; BINAURAL SENSITIVITY; TEMPORAL DISPARITIES; GUINEA-PIG	Evidence from human psychophysical and animal electrophysiological studies suggests that sensitivity to interaural time delay (ITD) in the modulating envelope of a high-frequency carrier can be enhanced using half-wave rectified stimuli. Recent evidence has shown potential benefits of equivalent electrical stimuli to deaf individuals with bilateral cochlear implants (CIs). In the current study we assessed the effects of envelope shape on ITD sensitivity in the primary auditory cortex of normal-hearing ferrets, and profoundly-deaf animals with bilateral CIs. In normal-hearing animals, cortical sensitivity to ITDs (+/- 1 ms in 0.1-ms steps) was assessed in response to dichotically-presented i) sinusoidal amplitude-modulated (SAM) and ii) half-wave rectified (HWR) tones (100-ms duration; 70 dB SPL) presented at the best-frequency of the unit over a range of modulation frequencies. In separate experiments, adult ferrets were deafened with neomycin administration and bilaterally-implanted with intra-cochlear electrode arrays. Electrically-evoked auditory brainstem responses (EABRs) were recorded in response to bipolar electrical stimulation of the apical pair of electrodes with singe biphasic current pulses (40 mu s per phase) over a range of current levels to measure hearing thresholds. Subsequently, we recorded cortical sensitivity to ITDs (+/- 800 mu s in 80-mu s steps) within the envelope of SAM and HWR biphasic-pulse trains (40 mu s per phase; 6000 pulses per second, 100-ms duration) over a range of modulation frequencies. In normal-hearing animals, nearly a third of cortical neurons were sensitive to envelope-ITDs in response to SAM tones. In deaf animals with bilateral CI, the proportion of ITD-sensitive cortical neurons was approximately a fifth in response to SAM pulse trains. In normal-hearing and deaf animals with bilateral CI the proportion of ITD sensitive units and neural sensitivity to ITDs increased in response to HWR, compared with SAM stimuli. Consequently, novel stimulation strategies based on envelope enhancement may prove beneficial to individuals with bilateral cochlear implants.	[Hartley, Douglas E. H.] NIHR Natl Biomed Res Unit Hearing, Nottingham, England; [Hartley, Douglas E. H.] Univ Nottingham, Dept Otolaryngol, Sch Clin Sci, Nottingham NG7 2RD, England; [Hartley, Douglas E. H.] MRC, Inst Hearing Res, Nottingham, England; [Hartley, Douglas E. H.; Isaiah, Amal] Univ Oxford, Dept Physiol Anat & Genet, Oxford, England	University of Nottingham; University of Nottingham; University of Oxford	Hartley, DEH (corresponding author), NIHR Natl Biomed Res Unit Hearing, Ropewalk House, Nottingham, England.	Douglas.Hartley@nottingham.ac.uk		Hartley, Douglas/0000-0001-9803-4169; Isaiah, Amal/0000-0003-3064-6964	National Institute for Health Research; Wellcome Trust; Rhodes Trust	National Institute for Health Research(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome TrustEuropean Commission); Rhodes Trust	This work was supported by the National Institute for Health Research, the Wellcome Trust through a Clinician Scientist Fellowship to DEHH and the Rhodes Trust through a Scholarship to AI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batra R, 1997, J NEUROPHYSIOL, V78, P1237, DOI 10.1152/jn.1997.78.3.1237; Batra R, 1997, J NEUROPHYSIOL, V78, P1222, DOI 10.1152/jn.1997.78.3.1222; BERNSTEIN LR, 1982, J ACOUST SOC AM, V71, P147, DOI 10.1121/1.387254; Bernstein LR, 2002, J ACOUST SOC AM, V112, P1026, DOI 10.1121/1.1497620; BERNSTEIN LR, 1994, J ACOUST SOC AM, V95, P3561, DOI 10.1121/1.409973; Bizley JK, 2005, CEREB CORTEX, V15, P1637, DOI 10.1093/cercor/bhi042; Coffey CS, 2006, HEARING RES, V221, P1, DOI 10.1016/j.heares.2006.06.005; Darwin C. J., 1995, P387, DOI 10.1016/B978-012505626-7/50013-3; de Cheveigne A, 2007, J NEUROSCI METH, V165, P297, DOI 10.1016/j.jneumeth.2007.06.003; DOMNITZ RH, 1976, J ACOUST SOC AM, V59, P598, DOI 10.1121/1.380904; Dreyer A, 2006, J NEUROPHYSIOL, V96, P2327, DOI 10.1152/jn.00326.2006; Fitzpatrick DC, 2001, J NEUROSCI, V21, P4844, DOI 10.1523/JNEUROSCI.21-13-04844.2001; Green T, 2004, J ACOUST SOC AM, V116, P2298, DOI 10.1121/1.1785611; Griffin SJ, 2005, J NEUROPHYSIOL, V93, P3463, DOI 10.1152/jn.00794.2004; Hancock KE, 2004, J NEUROSCI, V24, P7110, DOI 10.1523/JNEUROSCI.0762-04.2004; Hartley DEH, 2011, J NEUROPHYSIOL, V106, P30, DOI 10.1152/jn.01070.2010; Hartley DEH, 2010, J NEUROSCI METH, V190, P214, DOI 10.1016/j.jneumeth.2010.05.014; IRVINE DRF, 1995, HEARING RES, V85, P127, DOI 10.1016/0378-5955(95)00040-B; Ison JR, 2003, J ACOUST SOC AM, V114, P522, DOI 10.1121/1.1577553; Joris P, 2007, TRENDS NEUROSCI, V30, P70, DOI 10.1016/j.tins.2006.12.004; Joris PX, 1996, J NEUROPHYSIOL, V76, P2137, DOI 10.1152/jn.1996.76.4.2137; Joris PX, 1998, J NEUROPHYSIOL, V79, P253, DOI 10.1152/jn.1998.79.1.253; JORIS PX, 1995, J NEUROPHYSIOL, V73, P1043, DOI 10.1152/jn.1995.73.3.1043; Joris PX, 2003, J NEUROSCI, V23, P6345; KAVANAGH GL, 1987, J NEUROPHYSIOL, V57, P1746, DOI 10.1152/jn.1987.57.6.1746; KELLY JB, 1991, HEARING RES, V55, P39, DOI 10.1016/0378-5955(91)90089-R; Klein-Hennig M, 2011, J ACOUST SOC AM, V129, P3856, DOI 10.1121/1.3585847; Laback B, 2004, EAR HEARING, V25, P488, DOI 10.1097/01.aud.0000145124.85517.e8; Laback B, 2011, J ACOUST SOC AM, V130, P1515, DOI 10.1121/1.3613704; Long CJ, 2003, J ACOUST SOC AM, V114, P1565, DOI 10.1121/1.1603765; McAlpine D, 1996, HEARING RES, V97, P136, DOI 10.1016/0378-5955(96)00068-8; McAlpine D, 2001, NAT NEUROSCI, V4, P396, DOI 10.1038/86049; Monaghan JJM, 2013, J ACOUST SOC AM, V133, P2288, DOI 10.1121/1.4793270; Moore BCJ, 1997, INTRO PSYCHOL HEARIN, P213; PELIZZONE M, 1990, HEARING RES, V48, P287, DOI 10.1016/0378-5955(90)90069-2; Pind J, 1998, J ACOUST SOC AM, V103, P2117, DOI 10.1121/1.421357; REALE RA, 1990, J NEUROPHYSIOL, V64, P1247, DOI 10.1152/jn.1990.64.4.1247; Schlauch RS, 2001, J ACOUST SOC AM, V109, P2880, DOI 10.1121/1.1372913; Schnupp JWH, 2003, J ACOUST SOC AM, V113, P2021, DOI 10.1121/1.1547460; SHEPHERD RK, 1993, HEARING RES, V66, P108, DOI 10.1016/0378-5955(93)90265-3; Skottun BC, 2001, P NATL ACAD SCI USA, V98, P14050, DOI 10.1073/pnas.241513998; Smith ZM, 2008, J NEUROPHYSIOL, V99, P2390, DOI 10.1152/jn.00751.2007; Smith ZM, 2007, J NEUROSCI, V27, P6740, DOI 10.1523/JNEUROSCI.0052-07.2007; Smith ZM, 2007, JARO-J ASSOC RES OTO, V8, P134, DOI 10.1007/s10162-006-0069-0; Stecker GC, 2009, J ACOUST SOC AM, V125, P3914, DOI 10.1121/1.3124776; Tillein J, 2010, CEREB CORTEX, V20, P492, DOI 10.1093/cercor/bhp222; van Hoesel RJM, 2009, JARO-J ASSOC RES OTO, V10, P557, DOI 10.1007/s10162-009-0175-x; van Hoesel RJM, 2003, J ACOUST SOC AM, V113, P1617, DOI 10.1121/1.1539520; vandePar S, 1997, J ACOUST SOC AM, V101, P1671, DOI 10.1121/1.418151; Wang XQ, 2005, NATURE, V435, P341, DOI 10.1038/nature03565; YIN TCT, 1984, J ACOUST SOC AM, V76, P1401, DOI 10.1121/1.391457; YOST WA, 1971, J ACOUST SOC AM, V50, P1526, DOI 10.1121/1.1912806	52	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e104097	10.1371/journal.pone.0104097	http://dx.doi.org/10.1371/journal.pone.0104097			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093417	Green Published, Green Submitted, gold			2022-12-27	WOS:000341357200067
J	Rowan, F; Richards, M; Widya, M; Bayliss, R; Blagg, J				Rowan, Fiona; Richards, Meirion; Widya, Marcella; Bayliss, Richard; Blagg, Julian			Diverse Functionalization of Aurora-A Kinase at Specified Surface and Buried Sites by Native Chemical Modification	PLOS ONE			English	Article							UNNATURAL AMINO-ACIDS; CRYSTAL-STRUCTURE; GENERAL-METHOD; PROTEIN; CHEMISTRY; CYSTEINE; DEHYDROALANINE; CONVERSION; INSIGHTS; INSTALLATION	The ability to obtain a homogeneous sample of protein is invaluable when studying the effect of alterations such as post-translational modifications (PTMs). Selective functionalization of a protein to investigate the effect of PTMs on its structure or activity can be achieved by chemical modification of cysteine residues. We demonstrate here that one such technique, which involves conversion of cysteine to dehydroalanine followed by thiol nucleophile addition, is suitable for the site-specific installation of a wide range of chemical mimics of PTMs, including acetylated and dimethylated lysine, and other unnatural amino acids. These reactions, optimized for the clinically relevant kinase Aurora-A, readily proceed to completion as revealed by intact protein mass spectrometry. Moreover, these reactions proceed under non-denaturing conditions, which is desirable when working with large protein substrates. We have determined reactivity trends for a diverse range of thiol nucleophile addition reactions at two separate sites on Aurora-A, and we also highlight limitations when using thiol nucleophiles that contain basic functional groups. We show that chemical modification of cysteine residues is possible not only on a flexible surface-exposed loop, but also within a deep active site pocket at the conserved DFG motif, which reveals the potential use of this method in exploring enzyme function through modification of catalytic site residues.	[Rowan, Fiona; Richards, Meirion; Blagg, Julian] Inst Canc Res, Div Canc Therapeut, Canc Res UK Canc Therapeut Unit, London SW3 6JB, England; [Rowan, Fiona; Bayliss, Richard] Inst Canc Res, Div Struct Biol, London SW3 6JB, England; [Widya, Marcella] Inst Canc Res, Prote Core Facil, London SW3 6JB, England; [Bayliss, Richard] Univ Leicester, Dept Biochem, Leicester LE1 7RH, Leics, England	Cancer Research UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of Leicester	Rowan, F (corresponding author), Inst Canc Res, Div Canc Therapeut, Canc Res UK Canc Therapeut Unit, London SW3 6JB, England.	fiona.rowan@icr.ac.uk; julian.blagg@icr.ac.uk		Bayliss, Richard/0000-0003-0604-2773	Wellcome Trust [093986/Z/10/Z]; Cancer Research UK [C309/A11566, C24461/A12772]; Cancer Research UK [11566, 12772] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK)	FR is supported by The Wellcome Trust (www.wellcome.ac.uk) Ph.D. program in Mechanism-Based Drug Discovery at The Institute of Cancer Research, grant number 093986/Z/10/Z. MR and JB are supported by Cancer Research UK (www.cancerresearchuk.org) grant number C309/A11566. RB is a Royal Society Research Fellow and is supported by Cancer Research UK grant number C24461/A12772. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basle E, 2010, CHEM BIOL, V17, P213, DOI 10.1016/j.chembiol.2010.02.008; Bayliss R, 2003, MOL CELL, V12, P851, DOI 10.1016/S1097-2765(03)00392-7; Becker CFW, 2004, J MOL BIOL, V343, P747, DOI 10.1016/j.jmb.2004.08.062; Bernardes GJL, 2008, J AM CHEM SOC, V130, P5052, DOI 10.1021/ja800800p; Bukhtiyarova M, 2007, BIOCHEMISTRY-US, V46, P5687, DOI 10.1021/bi0622221; Chalker JM, 2012, ANGEW CHEM INT EDIT, V51, P1835, DOI 10.1002/anie.201106432; Chalker JM, 2011, CHEM SCI, V2, P1666, DOI 10.1039/c1sc00185j; Chalker JM, 2009, CHEM-ASIAN J, V4, P630, DOI 10.1002/asia.200800427; Chooi KP, 2014, J AM CHEM SOC, V136, P1698, DOI 10.1021/ja4095318; de Graaf AJ, 2009, BIOCONJUGATE CHEM, V20, P1281, DOI 10.1021/bc800294a; Dodson CA, 2010, BIOCHEM J, V427, P19, DOI 10.1042/BJ20091530; Fernandez-Gonzalez M, 2010, CHEM SCI, V1, P709, DOI 10.1039/c0sc00265h; Halkides CJ, 2000, BIOCHEMISTRY-US, V39, P5280, DOI 10.1021/bi9925524; Huang R, 2010, J AM CHEM SOC, V132, P9986, DOI 10.1021/ja103954u; Le DD, 2013, J AM CHEM SOC, V135, P2879, DOI 10.1021/ja3108214; Li FP, 2011, ANGEW CHEM INT EDIT, V50, P9611, DOI 10.1002/anie.201103754; Muir TW, 1998, P NATL ACAD SCI USA, V95, P6705, DOI 10.1073/pnas.95.12.6705; NOREN CJ, 1989, SCIENCE, V244, P182, DOI 10.1126/science.2649980; Rowan FC, 2013, ACS CHEM BIOL, V8, P2184, DOI 10.1021/cb400425t; Simard JR, 2009, J AM CHEM SOC, V131, P13286, DOI 10.1021/ja902010p; Simard JR, 2009, NAT CHEM BIOL, V5, P394, DOI 10.1038/nchembio.162; Simon MD, 2007, CELL, V128, P1003, DOI 10.1016/j.cell.2006.12.041; Sletten EM, 2009, ANGEW CHEM INT EDIT, V48, P6974, DOI 10.1002/anie.200900942; Smith MEB, 2010, J AM CHEM SOC, V132, P1960, DOI 10.1021/ja908610s; Valkevich EM, 2012, J AM CHEM SOC, V134, P6916, DOI 10.1021/ja300500a; Walsh CT, 2005, ANGEW CHEM INT EDIT, V44, P7342, DOI 10.1002/anie.200501023	26	10	10	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e103935	10.1371/journal.pone.0103935	http://dx.doi.org/10.1371/journal.pone.0103935			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093837	gold, Green Published, Green Submitted			2022-12-27	WOS:000341357200046
J	Yu, KR; Lee, JY; Kim, HS; Hong, IS; Choi, SW; Seo, Y; Kang, I; Kim, JJ; Lee, BC; Lee, S; Kurtz, A; Seo, KW; Kang, KS				Yu, Kyung-Rok; Lee, Jin Young; Kim, Hyung-Sik; Hong, In-Sun; Choi, Soon Won; Seo, Yoojin; Kang, Insung; Kim, Jae-Jun; Lee, Byung-Chul; Lee, SeungHee; Kurtz, Andreas; Seo, Kwang-Won; Kang, Kyung-Sun			A p38 MAPK-Mediated Alteration of COX-2/PGE(2) Regulates Immunomodulatory Properties in Human Mesenchymal Stem Cell Aging	PLOS ONE			English	Article							MARROW STROMAL CELLS; ACTIVATED PROTEIN-KINASE; IMMUNOSUPPRESSION; SENESCENCE; RESPONSES; COLITIS; PATHWAY; DISEASE; PROLIFERATION; MACROPHAGES	Because human mesenchymal stem cells (hMSC) have profound immunomodulatory effects, many attempts have been made to use hMSCs in preclinical and clinical trials. For hMSCs to be used in therapy, a large population of hMSCs must be generated by in vitro expansion. However, the immunomodulatory changes following the in vitro expansion of hMSCs have not been elucidated. In this study, we evaluated the effect of replicative senescence on the immunomodulatory ability of hMSCs in vitro and in vivo. Late-passage hMSCs showed impaired suppressive effect on mitogen-induced mononuclear cell proliferation. Strikingly, late-passage hMSCs had a significantly compromised protective effect against mouse experimental colitis, which was confirmed by gross and histologic examination. Among the anti-inflammatory cytokines, the production of prostaglandin E-2 (PGE(2)) and the expression of its primary enzyme, cyclooxygenase-2 (COX-2), were profoundly increased by pre-stimulation with interferon gamma (IFN-gamma) and tumor necrosis factor alpha (TNF-alpha), and this response was significantly decreased with consecutive passages. We demonstrated that the impaired phosphorylation activity of p38 MAP kinase (p38 MAPK) in late-passage hMSCs led to a compromised immunomodulatory ability through the regulation of COX-2. In conclusion, our data indicate that the immunomodulatory ability of hMSCs gradually declines with consecutive passages via a p38-mediated alteration of COX-2 and PGE(2) levels.	[Yu, Kyung-Rok; Lee, Jin Young; Kim, Hyung-Sik; Hong, In-Sun; Choi, Soon Won; Seo, Yoojin; Kang, Insung; Kim, Jae-Jun; Lee, Byung-Chul; Lee, SeungHee; Kurtz, Andreas; Seo, Kwang-Won; Kang, Kyung-Sun] Seoul Natl Univ, Coll Vet Med, Adult Stem Cell Res Ctr, Seoul, South Korea; [Yu, Kyung-Rok; Lee, Jin Young; Hong, In-Sun; Choi, Soon Won; Seo, Yoojin; Kang, Insung; Kim, Jae-Jun; Lee, Byung-Chul; Kurtz, Andreas; Kang, Kyung-Sun] Seoul Natl Univ, Coll Vet Med, Vet Med Res Inst, Seoul, South Korea; [Kim, Hyung-Sik; Lee, SeungHee; Seo, Kwang-Won] Seoul Natl Univ, Biotechnol Incubating Ctr, Inst Stem Cell & Regenerat Med Kangstem Biotech, Seoul, South Korea; [Kurtz, Andreas] Berlin Brandenburg Ctr Regenerat Therapies, Berlin, Germany	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Seo, KW (corresponding author), Seoul Natl Univ, Coll Vet Med, Adult Stem Cell Res Ctr, Seoul, South Korea.	kwang_wons@hotmail.com; kangpub@snu.ac.kr	Yu, Kyung-Rok/AAR-6227-2021; Kang, Kyung-Sun/G-6205-2013; Seo, Kwang Won/AAB-4821-2020; Choi, Soon Won/S-3052-2017	Yu, Kyung-Rok/0000-0002-4685-3223; Seo, Kwang Won/0000-0003-1025-6133; Choi, Soon Won/0000-0001-8642-6093; Kurtz, Andreas/0000-0003-3301-6546; Lee, Jin Young/0000-0001-8559-7077	National Research Foundation (NRF) - Korean government [2012M3A9C6049716]; Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [A120176]; Research Institute for Veterinary Science, Seoul National University	National Research Foundation (NRF) - Korean government(Korean Government); Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea; Research Institute for Veterinary Science, Seoul National University	This research was supported by the Bio & Medical Technology Development Program of the National Research Foundation (NRF) funded by the Korean government (No. 2012M3A9C6049716), a grant of the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (A120176), and the Research Institute for Veterinary Science, Seoul National University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; ANDRE C, 1981, GUT, V22, P571, DOI 10.1136/gut.22.7.571; Banfi A, 2002, TISSUE ENG, V8, P901, DOI 10.1089/107632702320934001; Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197; Chen BC, 1999, IMMUNOLOGY, V97, P124, DOI 10.1046/j.1365-2567.1999.00747.x; COOPER HS, 1993, LAB INVEST, V69, P238; Crisostomo PR, 2006, SHOCK, V26, P575, DOI 10.1097/01.shk.0000235087.45798.93; Dean JLE, 1999, J BIOL CHEM, V274, P264, DOI 10.1074/jbc.274.1.264; Greenhough A, 2009, CARCINOGENESIS, V30, P377, DOI 10.1093/carcin/bgp014; Gruber HE, 2012, BIOTECH HISTOCHEM, V87, P303, DOI 10.3109/10520295.2011.649785; Gu ZF, 2012, CELL SIGNAL, V24, P2307, DOI 10.1016/j.cellsig.2012.07.012; Jung JW, 2010, CELL MOL LIFE SCI, V67, P1165, DOI 10.1007/s00018-009-0242-9; Karp JM, 2009, CELL STEM CELL, V4, P206, DOI 10.1016/j.stem.2009.02.001; Kim H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011608; Kim HS, 2013, GASTROENTEROLOGY, V145, P1392, DOI 10.1053/j.gastro.2013.08.033; Lee S, 2009, CELL PROLIFERAT, V42, P711, DOI 10.1111/j.1365-2184.2009.00633.x; Lin CS, 2012, STEM CELLS DEV, V21, P2770, DOI 10.1089/scd.2012.0176; Liu H, 2012, J CELL SCI, V125, P200, DOI 10.1242/jcs.093070; Meisel R, 2004, BLOOD, V103, P4619, DOI 10.1182/blood-2003-11-3909; Nemeth K, 2009, NAT MED, V15, P42, DOI 10.1038/nm.1905; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Ren GW, 2008, CELL STEM CELL, V2, P141, DOI 10.1016/j.stem.2007.11.014; Ren GW, 2009, STEM CELLS, V27, P1954, DOI 10.1002/stem.118; Saklatvala J, 2004, CURR OPIN PHARMACOL, V4, P372, DOI 10.1016/j.coph.2004.03.009; Scruggs BA, 2013, STEM CELL TRANSL MED, V2, P797, DOI 10.5966/sctm.2013-0026; Shi YF, 2012, TRENDS IMMUNOL, V33, P136, DOI 10.1016/j.it.2011.11.004; Shi YF, 2010, CELL RES, V20, P510, DOI 10.1038/cr.2010.44; Spaggiari GM, 2008, BLOOD, V111, P1327, DOI 10.1182/blood-2007-02-074997; Spaggiari GM, 2009, BLOOD, V113, P6576, DOI 10.1182/blood-2009-02-203943; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; Wagner W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002213; Yang YB, 2007, J BIOL CHEM, V282, P36223, DOI 10.1074/jbc.M703079200; Yu KR, 2013, J CELL SCI, V126, P5422, DOI 10.1242/jcs.133314; Yu KR, 2013, GERONTOLOGY, V59, P557, DOI 10.1159/000353857; Yu KR, 2012, STEM CELLS, V30, P876, DOI 10.1002/stem.1052; Zaim M, 2012, ANN HEMATOL, V91, P1175, DOI 10.1007/s00277-012-1438-x	37	67	69	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e102426	10.1371/journal.pone.0102426	http://dx.doi.org/10.1371/journal.pone.0102426			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25090227	Green Published, Green Submitted, gold			2022-12-27	WOS:000339812700007
J	Khodakova, AS; Smith, RJ; Burgoyne, L; Abarno, D; Linacre, A				Khodakova, Anastasia S.; Smith, Renee J.; Burgoyne, Leigh; Abarno, Damien; Linacre, Adrian			Random Whole Metagenomic Sequencing for Forensic Discrimination of Soils	PLOS ONE			English	Article							MICROBIAL COMMUNITIES; DNA EXTRACTION; BACTERIAL; AMPLIFICATION; PCR; DIVERSITY; SEDIMENTS; POWER	Here we assess the ability of random whole metagenomic sequencing approaches to discriminate between similar soils from two geographically distinct urban sites for application in forensic science. Repeat samples from two parklands in residential areas separated by approximately 3 km were collected and the DNA was extracted. Shotgun, whole genome amplification (WGA) and single arbitrarily primed DNA amplification (AP-PCR) based sequencing techniques were then used to generate soil metagenomic profiles. Full and subsampled metagenomic datasets were then annotated against M5NR/M5RNA (taxonomic classification) and SEED Subsystems (metabolic classification) databases. Further comparative analyses were performed using a number of statistical tools including: hierarchical agglomerative clustering (CLUSTER); similarity profile analysis (SIMPROF); non-metric multidimensional scaling (NMDS); and canonical analysis of principal coordinates (CAP) at all major levels of taxonomic and metabolic classification. Our data showed that shotgun and WGA-based approaches generated highly similar metagenomic profiles for the soil samples such that the soil samples could not be distinguished accurately. An AP-PCR based approach was shown to be successful at obtaining reproducible site-specific metagenomic DNA profiles, which in turn were employed for successful discrimination of visually similar soil samples collected from two different locations.	[Khodakova, Anastasia S.; Smith, Renee J.; Burgoyne, Leigh; Abarno, Damien; Linacre, Adrian] Flinders Univ S Australia, Sch Biol Sci, Adelaide, SA 5001, Australia; [Abarno, Damien] Forens Sci South Australia, Adelaide, SA, Australia	Flinders University South Australia	Khodakova, AS (corresponding author), Flinders Univ S Australia, Sch Biol Sci, Adelaide, SA 5001, Australia.	anastasia.khodakova@flinders.edu.au	Linacre, Adrian/I-5377-2015; Abarno, Damien/ABD-7386-2020	Linacre, Adrian/0000-0001-5890-5548; 	Attorney General's Office of South Australia	Attorney General's Office of South Australia	Funding for this research was provided by the Attorney General's Office of South Australia. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson M.J., 2008, PERMANOVA PRIMER GUI; Anderson MJ, 2003, ECOLOGY, V84, P511, DOI 10.1890/0012-9658(2003)084[0511:CAOPCA]2.0.CO;2; Arroyo L, 2010, ENVIRON FORENSICS, V11, P315, DOI 10.1080/15275922.2010.494949; Atienzar FA, 2006, MUTAT RES-REV MUTAT, V613, P76, DOI 10.1016/j.mrrev.2006.06.001; Bates ST, 2013, ISME J, V7, P652, DOI 10.1038/ismej.2012.147; Binga EK, 2008, ISME J, V2, P233, DOI 10.1038/ismej.2008.10; CAETANOANOLLES G, 1993, PCR METH APPL, V3, P85; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Concheri G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020222; Cox RJ, 2000, FORENSIC SCI INT, V108, P107, DOI 10.1016/S0379-0738(99)00203-0; Dabrowski W, 2003, FEMS MICROBIOL LETT, V218, P51, DOI 10.1016/S0378-1097(02)01183-7; Dawson LA, 2010, SURF INTERFACE ANAL, V42, P363, DOI 10.1002/sia.3315; Delmont TO, 2012, ISME J, V6, P1625, DOI 10.1038/ismej.2012.55; Delmont TO, 2012, ISME J, V6, P1677, DOI 10.1038/ismej.2011.197; Fierer N, 2012, P NATL ACAD SCI USA, V109, P21390, DOI 10.1073/pnas.1215210110; Fierer N, 2012, ISME J, V6, P1007, DOI 10.1038/ismej.2011.159; Fitzpatrick RW, 2009, WILEY ENCY FORENSIC, P2377; Franklin RB, 1999, J MICROBIOL METH, V35, P225, DOI 10.1016/S0167-7012(99)00003-2; Fuhrman Jed A, 2012, F1000 Biol Rep, V4, P15, DOI 10.3410/B4-15; Gilbert JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015545; Gorley C.K., 2006, GETTING STARTED PRIM; Havelsrud OE, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-203; Horswell J, 2002, J FORENSIC SCI, V47, P350; Howe AC, 2014, P NATL ACAD SCI USA, V111, P4904, DOI 10.1073/pnas.1402564111; Jeffries TC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025173; Khodakova AS, 2013, FORENS SCI INT-GEN S, V4, pE39, DOI 10.1016/j.fsigss.2013.10.019; Lauber CL, 2013, ISME J, V7, P1641, DOI 10.1038/ismej.2013.50; Lenz EJ, 2010, J FORENSIC SCI, V55, P1437, DOI 10.1111/j.1556-4029.2010.01464.x; Lewis CT, 2011, OPEN APPL INFORM J, V5, P30, DOI DOI 10.2174/1874136301105010030; Logares R, 2012, J MICROBIOL METH, V91, P106, DOI 10.1016/j.mimet.2012.07.017; Loman NJ, 2012, NAT BIOTECHNOL, V30, P434, DOI 10.1038/nbt.2198; Macdonald CA, 2011, J FORENSIC SCI, V56, P61, DOI 10.1111/j.1556-4029.2010.01542.x; Mao DP, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-66; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Moreno LI, 2006, J FORENSIC SCI, V51, P1315, DOI 10.1111/j.1556-4029.2006.00264.x; Morrisson AR, 2009, CRIMINAL AND ENVIRONMENTAL SOIL FORENSICS, P75, DOI 10.1007/978-1-4020-9204-6_6; Pasternak Z, 2012, INT RES J MICROBIOL, V3, P363; Prakash T, 2012, BRIEF BIOINFORM, V13, P711, DOI 10.1093/bib/bbs033; Rincon-Florez V. A., 2013, Diversity, V5, P581, DOI 10.3390/d5030581; Roy S, 2004, TROP MED INT HEALTH, V9, P1203, DOI 10.1111/j.1365-3156.2004.01322.x; Ruffell A, 2004, FORENSIC SCI INT, V145, P13, DOI 10.1016/j.forsciint.2004.03.017; Sagar K, 2014, J MICROBIOL METH, V97, P68, DOI 10.1016/j.mimet.2013.11.008; Sensabaugh GF, 2009, CRIMINAL AND ENVIRONMENTAL SOIL FORENSICS, P49, DOI 10.1007/978-1-4020-9204-6_4; Shange R., 2013, Diversity, V5, P461, DOI 10.3390/d5030461; Shokralla S, 2012, MOL ECOL, V21, P1794, DOI 10.1111/j.1365-294X.2012.05538.x; Smith RJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081910; Suenaga H, 2012, ENVIRON MICROBIOL, V14, P13, DOI 10.1111/j.1462-2920.2011.02438.x; Terrat S, 2012, MICROB BIOTECHNOL, V5, P135, DOI 10.1111/j.1751-7915.2011.00307.x; Uroz S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055929; Wang J, 2013, BRIEF BIOINFORM, V14, P575, DOI 10.1093/bib/bbt032; Waters JM, 2012, ELECTROPHORESIS, V33, P492, DOI 10.1002/elps.201100359; WELSH J, 1990, NUCLEIC ACIDS RES, V18, P7213, DOI 10.1093/nar/18.24.7213; Xu ZF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093445; Young JM, 2014, SCI JUSTICE, V54, P238, DOI 10.1016/j.scijus.2014.02.006; Zarraonaindia I, 2013, BIOL PHILOS, V28, P261, DOI 10.1007/s10539-012-9357-8	55	34	37	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2014	9	8							e104996	10.1371/journal.pone.0104996	http://dx.doi.org/10.1371/journal.pone.0104996			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WB	25111003	Green Published, Green Submitted, gold			2022-12-27	WOS:000341105100118
J	Ding, T; Bergeron, M; Seely, P; Yang, XF; Diallo, TO; Plews, M; Sandstrom, P; Ball, TB; Meyers, AFA				Ding, Tao; Bergeron, Michele; Seely, Peggy; Yang, Xuefen; Diallo, Tamsir O.; Plews, Margot; Sandstrom, Paul; Ball, T. Blake; Meyers, Adrienne F. A.			Compatibility of Stabilized Whole Blood Products with CD4 Technologies and Their Suitability for Quality Assessment Programs	PLOS ONE			English	Article							T-CELL ENUMERATION; SETTINGS; SCHEME	Background: CD4 T cell enumeration is the most widely used prognostic marker for management of HIV disease. Internal quality control and external quality assessment (EQA) programs are critical to ensure reliability of clinical measurements. The utility of stabilized whole blood products (SWBP) as a test reagent for EQA programs such as Quality Assessment and Standardization for Immunological measures relevant to HIV/AIDS (QASI) program have been demonstrated previously. Since then, several new commercial SWBPs and alternative CD4 enumeration technologies have become available. Seven SWBPs were evaluated on seven different enumeration platforms to determine which product(s) are most suitable for EQA programs that support multiple analytical technologies. Method: Assessment of SWBPs was based on two criteria: (1) accuracy of CD4 T cell measurements and; (2) stability under sub optimal storage conditions. Results: Three SWBPs (Multi-Check, StatusFlow and CD4 Count) showed accurate CD4 T-cell absolute count and percentage values across six of the enumeration platforms. All products retain stability up to 18 days at 21-23 degrees C with the exception of Multi-Check-high on FacsCount and Multi-Check-Low and StatusFlow-Low on Pima. One of the products (CD4 Count) retained stability for three days on all platforms tested when stored at 37 degrees C. Conclusion: This study demonstrated that the characteristics of commercially available SWBPs vary across multiple CD4 platforms. The compatibility of testing panels for EQA programs with multiple analytical platforms needs to be carefully considered, especially in large multiplatform CD4 EQA programs. The selection of a suitable cross-platform SWBP is an increasing challenge as more reagents and platforms are introduced for CD4 T-cell enumeration.	[Ding, Tao; Bergeron, Michele; Seely, Peggy; Yang, Xuefen; Diallo, Tamsir O.; Sandstrom, Paul; Ball, T. Blake; Meyers, Adrienne F. A.] Publ Hlth Agcy Canada, Natl Lab HIV Immunol, Winnipeg, MB, Canada; [Ball, T. Blake; Meyers, Adrienne F. A.] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada; [Ball, T. Blake] Univ Manitoba, Dept Immunol, Winnipeg, MB, Canada; [Ball, T. Blake; Meyers, Adrienne F. A.] Univ Nairobi, Dept Med Microbiol, Nairobi, Kenya; [Yang, Xuefen; Diallo, Tamsir O.; Plews, Margot; Sandstrom, Paul; Ball, T. Blake; Meyers, Adrienne F. A.] Publ Hlth Agcy Canada, Natl Lab HIV Immunol, Winnipeg, MB, Canada	Public Health Agency of Canada; University of Manitoba; University of Manitoba; University of Nairobi; Public Health Agency of Canada	Plews, M (corresponding author), Publ Hlth Agcy Canada, Natl Lab HIV Immunol, Winnipeg, MB, Canada.	Margot.Plews@phac-aspc.gc.ca			PHAC (Public Health Agency of Canada)	PHAC (Public Health Agency of Canada)	Funding for this study was provided by PHAC (Public Health Agency of Canada). The agencies had no input in the study design, project methods, data generation and analysis or outcome, nor did they contribute to the preparation of this manuscript.	Barnett D, 1996, CYTOMETRY, V26, P216, DOI 10.1002/(SICI)1097-0320(19960915)26:3<216::AID-CYTO6>3.0.CO;2-C; Barnett D, 2008, NAT REV MICROBIOL, V6, pS7, DOI 10.1038/nrmicro1998; Bergeron M, 2002, CYTOMETRY, V50, P86, DOI 10.1002/cyto.10090; Bergeron M, 2002, CYTOMETRY, V50, P62, DOI 10.1002/cyto.10089; Bergeron M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041166; Bergeron M, 2010, CYTOM PART B-CLIN CY, V78B, P41, DOI 10.1002/cyto.b.20487; Glencross DK, 2008, CYTOM PART B-CLIN CY, V74B, pS69, DOI 10.1002/cyto.b.20397; Nicholson JKA, 1999, CYTOMETRY, V38, P268, DOI 10.1002/(SICI)1097-0320(19991215)38:6<268::AID-CYTO2>3.0.CO;2-K; Peter T, 2008, CYTOM PART B-CLIN CY, V74B, pS123, DOI 10.1002/cyto.b.20416; Stevens W, 2008, NAT REV MICROBIOL, V6, pS29, DOI 10.1038/nrmicro2000; UNAIDS, 2013, 2013 UNAIDS REP GLOB; US Department of Health and Human Services Health Resources and Services Administration HIV/AIDS Bureau, 2011, GUID HIV AIDS CLIN C; Westerman LE, 2010, AM J CLIN PATHOL, V134, P556, DOI 10.1309/AJCPP7MCHFYLX2FM; Whitby L, 2002, CYTOMETRY, V50, P102, DOI 10.1002/cyto.10094; WHO, 2010, ANT THER HIV INF AD; World Health Organization, 2013, SUMM STUD PROT MULT	16	7	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2014	9	8							e103391	10.1371/journal.pone.0103391	http://dx.doi.org/10.1371/journal.pone.0103391			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR0CG	25105290	Green Submitted, Green Published, gold			2022-12-27	WOS:000343231900012
J	Grisanti, S; Almici, C; Consoli, F; Buglione, M; Verardi, R; Bolzoni-Villaret, A; Bianchetti, A; Ciccarese, C; Mangoni, M; Ferrari, L; Biti, G; Marini, M; Ferrari, VD; Nicolai, P; Magrini, SM; Berruti, A				Grisanti, Salvatore; Almici, Camillo; Consoli, Francesca; Buglione, Michela; Verardi, Rosanna; Bolzoni-Villaret, Andrea; Bianchetti, Andrea; Ciccarese, Chiara; Mangoni, Monica; Ferrari, Laura; Biti, Gianpaolo; Marini, Mirella; Ferrari, Vittorio D.; Nicolai, Piero; Magrini, Stefano M.; Berruti, Alfredo			Circulating Tumor Cells in Patients with Recurrent or Metastatic Head and Neck Carcinoma: Prognostic and Predictive Significance	PLOS ONE			English	Article							CHEMOTHERAPY PLUS CETUXIMAB; FACTOR RECEPTOR EXPRESSION; LOCALLY ADVANCED HEAD; MESENCHYMAL TRANSITION; COLORECTAL-CANCER; PERIPHERAL-BLOOD; BREAST-CANCER; SURVIVAL; COMBINATION; PROGRESSION	Introduction: We investigated the frequency of detection and the prognostic and predictive significance of circulating tumor cells (CTCs) in patients with recurrent/metastatic (R/M) head and neck carcinoma (HNC) before starting systemic therapy. Patients and methods: Using the CellSearch technology, CTCs were assessed prospectively in peripheral blood of 53 R/M-HNC patients. We performed spiking experiments to test the diagnostic performance of the CellSearch platform in identifying squamous carcinoma cells. Results: CTCs were identified in 14 (26%) and 22 (41%) patients at baseline and at any time point, respectively. In univariate analysis >= 2 CTCs had a poorer prognostic role than 0-1 CTC. In multivariate analysis, the presence of one CTC or more was associated with a poor prognosis both in terms of progression-free survival (PFS) [Hazard Ratio (HR): 3.068, 95% confidence interval (CI): 1.53-6.13, p 0.002] and overall survival (OS) [HR: 3.0, 95% CI: 1.48-6.0, p 0.002]. A disease control after systemic therapy was obtained in 8% of CTC-positive patients as opposed to 45% in CTC-negative ones (p 0.03). The epidermal growth factor receptor (EGFR) expression was identified in 45% of CTC-positive patients. Discussion: In conclusion, CTCs are detected in one out of three patients with RM-HNC. CTC detection is a strong prognostic parameter and may be predictive of treatment efficacy. The frequency of EGFR expression in CTCs seems to be lower than that expected in the primary tumor.	[Grisanti, Salvatore; Consoli, Francesca; Ciccarese, Chiara; Ferrari, Laura; Ferrari, Vittorio D.; Berruti, Alfredo] Univ Brescia, Med Oncol Unit, Brescia, Italy; [Grisanti, Salvatore; Consoli, Francesca; Buglione, Michela; Bolzoni-Villaret, Andrea; Ciccarese, Chiara; Ferrari, Laura; Ferrari, Vittorio D.; Nicolai, Piero; Magrini, Stefano M.; Berruti, Alfredo] Spedali Civili Hosp, Brescia, Italy; [Almici, Camillo; Verardi, Rosanna; Bianchetti, Andrea; Marini, Mirella] Spedali Civili Hosp, Dept Transfus Med, Lab Stem Cell Manipulat & Cryopreservat, Brescia, Italy; [Buglione, Michela; Magrini, Stefano M.] Univ Brescia, Radiat Oncol Unit, Brescia, Italy; [Bolzoni-Villaret, Andrea; Nicolai, Piero] Univ Brescia, Otorhinolaryngol Head & Neck Surg Unit, Brescia, Italy; [Mangoni, Monica; Biti, Gianpaolo] Univ Florence, Dept Radiat Oncol, Florence, Italy	University of Brescia; Hospital Spedali Civili Brescia; Hospital Spedali Civili Brescia; University of Brescia; University of Brescia; University of Florence	Grisanti, S (corresponding author), Univ Brescia, Med Oncol Unit, Brescia, Italy.	salvatore.grisanti@tin.it	Buglione di Monale e Bastia, Michela/AAC-7240-2022; Magrini, Stefano Maria/S-5876-2019; Almici, Camillo/AAA-2141-2019; Berruti, Alfredo/AAC-2069-2019; mangoni, monica/K-8142-2016; Magrini, Stefano Maria/ABE-8820-2020; Ciccarese, Chiara/AAB-7602-2019; Bianchetti, Andrea/I-1168-2018	Magrini, Stefano Maria/0000-0002-4126-733X; Almici, Camillo/0000-0002-9438-2569; mangoni, monica/0000-0002-3422-6812; Magrini, Stefano Maria/0000-0002-4126-733X; Ciccarese, Chiara/0000-0002-3283-4339; Bianchetti, Andrea/0000-0002-1102-3043; Ferrari, Laura/0000-0001-9909-2918; BUGLIONE DI MONALE E BASTIA, Michela/0000-0002-5485-1260	Regione Lombardia Piano Sangue; Ministero dell'Istruzione dell'Universita e della Ricerca (MIUR)	Regione Lombardia Piano Sangue; Ministero dell'Istruzione dell'Universita e della Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR))	This work was supported in part by a grant from the Regione Lombardia Piano Sangue 2008-2010 and Piano Sangue 2010-2012, in part by a grant from the Ministero dell'Istruzione dell'Universita e della Ricerca (MIUR) 2009, and in part by a donation of Mrs Marilena Bortolotti in memory of Carlo Ridon. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aktas B, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2333; Allard WJ, 2004, CLIN CANCER RES, V10, P6897, DOI 10.1158/1078-0432.CCR-04-0378; Ang KK, 2002, CANCER RES, V62, P7350; Argiris A, 2004, CANCER, V101, P2222, DOI 10.1002/cncr.20640; Arnold DJ, 2004, SEMIN RADIAT ONCOL, V14, P190, DOI 10.1053/j.semradonc.2004.03.001; Bleijerveld OB, 2011, J PROTEOMICS, V74, P558, DOI 10.1016/j.jprot.2011.01.008; Bozec A, 2013, EUR ARCH OTO-RHINO-L, V270, P2745, DOI 10.1007/s00405-013-2399-y; Buglione M, 2012, EUR J CANCER, V48, P3019, DOI 10.1016/j.ejca.2012.05.007; Christiansen JJ, 2006, CANCER RES, V66, P8319, DOI 10.1158/0008-5472.CAN-06-0410; Cohen SJ, 2008, J CLIN ONCOL, V26, P3213, DOI 10.1200/JCO.2007.15.8923; Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766; de Bono JS, 2008, CLIN CANCER RES, V14, P6302, DOI 10.1158/1078-0432.CCR-08-0872; Gazzaniga P, 2008, INT J CANCER, V123, P1730, DOI 10.1002/ijc.23699; Grandis JR, 1998, JNCI-J NATL CANCER I, V90, P824, DOI 10.1093/jnci/90.11.824; Hristozova T, 2011, ANN ONCOL, V22, P1878, DOI 10.1093/annonc/mdr130; Jatana KR, 2010, ARCH OTOLARYNGOL, V136, P1274, DOI 10.1001/archoto.2010.223; Kim MY, 2009, CELL, V139, P1315, DOI 10.1016/j.cell.2009.11.025; Krebs MG, 2011, J CLIN ONCOL, V29, P1556, DOI 10.1200/JCO.2010.28.7045; Laimer K, 2008, ORAL ONCOL, V44, P72, DOI 10.1016/j.oraloncology.2007.01.008; Licitra L, 2011, ANN ONCOL, V22, P1078, DOI 10.1093/annonc/mdq588; Licitra L, 2013, EUR J CANCER, V49, P1161, DOI 10.1016/j.ejca.2012.11.018; McShane LM, 2005, JNCI-J NATL CANCER I, V97, P1180, DOI 10.1093/jnci/dji237; Mostert B, 2009, CANCER TREAT REV, V35, P463, DOI 10.1016/j.ctrv.2009.03.004; Nichols AC, 2012, HEAD NECK-J SCI SPEC, V34, P1440, DOI 10.1002/hed.21941; Partridge M, 2003, CLIN CANCER RES, V9, P5287; Pestrin M, 2009, BREAST CANCER RES TR, V118, P523, DOI 10.1007/s10549-009-0461-7; Pignon JP, 2007, INT J RADIAT ONCOL, V69, pS112, DOI 10.1016/j.ijrobp.2007.04.088; Tanaka F, 2009, CLIN CANCER RES, V15, P6980, DOI 10.1158/1078-0432.CCR-09-1095; Tong XD, 2007, CYTOM PART B-CLIN CY, V72B, P310, DOI 10.1002/cyto.b.20177; Vermorken JB, 2010, ANN ONCOL, V21, P252, DOI 10.1093/annonc/mdq453; Vermorken JB, 2008, NEW ENGL J MED, V359, P1116, DOI 10.1056/NEJMoa0802656; Went PT, 2004, HUM PATHOL, V35, P122, DOI 10.1016/j.humpath.2003.08.026; Wirtschafter A, 2002, ARCH OTOLARYNGOL, V128, P40, DOI 10.1001/archotol.128.1.40	33	56	61	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2014	9	8							e103918	10.1371/journal.pone.0103918	http://dx.doi.org/10.1371/journal.pone.0103918			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR0CG	25105871	Green Published, Green Submitted, gold			2022-12-27	WOS:000343231900031
J	Kurlovs, AH; Li, JZ; Cheng, D; Zhong, JM				Kurlovs, Andre H.; Li, Jinze; Cheng, Du; Zhong, Jianmin			Ixodes pacificus Ticks Maintain Embryogenesis and Hatching after Antibiotic Treatment of Rickettsia Endosymbiont	PLOS ONE			English	Article							BLACK-LEGGED TICK; AMBLYOMMA-AMERICANUM; SUSCEPTIBILITIES; REPRODUCTION; SYMBIONTS; EVOLUTION; FITNESS; ACARI; HOST; TRANSMISSION	Rickettsia is a genus of intracellular bacteria that causes a variety of diseases in humans and other mammals and associates with a diverse group of arthropods. Although Rickettsia appears to be common in ticks, most Rickettsia-tick relationships remain generally uncharacterized. The most intimate of these associations is Rickettsia species phylotype G021, a maternally and transstadially transmitted endosymbiont that resides in 100% of I. pacificus in California. We investigated the effects of this Rickettsia phylotype on I. pacificus reproductive fitness using selective antibiotic treatment. Ciprofloxacin was 10-fold more effective than tetracycline in eliminating Rickettsia from I. pacificus, and quantitative PCR results showed that eggs from the ciprofloxacin-treated ticks contained an average of 0.02 Rickettsia per egg cell as opposed to the average of 0.2 in the tetracycline-treated ticks. Ampicillin did not significantly affect the number of Rickettsia per tick cell in adults or eggs compared to the water-injected control ticks. We found no relationship between tick embryogenesis and rickettsial density in engorged I. pacificus females. Tetracycline treatment significantly delayed oviposition of I. pacificus ticks, but the antibiotic's effect was unlikely related to Rickettsia. We also demonstrated that Rickettsia-free eggs could successfully develop into larvae without any significant decrease in hatching compared to eggs containing Rickettsia. No significant differences in the incubation period, egg hatching rate, and the number of larvae were found between any of the antibiotic-treated groups and the water-injected tick control. We concluded that Rickettsia species phylotype G021 does not have an apparent effect on embryogenesis, oviposition, and egg hatching of I. pacificus.	[Kurlovs, Andre H.; Li, Jinze; Cheng, Du; Zhong, Jianmin] Humboldt State Univ, Dept Biol Sci, Arcata, CA 95521 USA	California State University System; California State Polytechnic University, Humboldt	Zhong, JM (corresponding author), Humboldt State Univ, Dept Biol Sci, Arcata, CA 95521 USA.	jz15@humboldt.edu	Zhong, Jianmin/AAO-9401-2020	Zhong, Jianmin/0000-0002-4746-8458; Cheng, Du/0000-0002-7851-1244	National Institute of Health [1R15AI082515-01]; NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R15AI082515] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institute of Health (http://www.nih.gov/) Grant #1R15AI082515-01. JZ received the NIH funding. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHRENS WH, 1990, WEED SCI, V38, P452, DOI 10.1017/S0043174500056824; ANDERSON TW, 1952, ANN MATH STAT, V23, P193, DOI 10.1214/aoms/1177729437; ARTHUR DR, 1968, PARASITOLOGY, V58, P893, DOI 10.1017/S0031182000069663; Baumann P, 2005, ANNU REV MICROBIOL, V59, P155, DOI 10.1146/annurev.micro.59.030804.121041; Blondeau JM, 2004, SURV OPHTHALMOL, V49, pS73, DOI 10.1016/j.survophthal.2004.01.005; Branger S, 2004, ANTIMICROB AGENTS CH, V48, P4822, DOI 10.1128/AAC.48.12.4822-4828.2004; Brumin M, 2011, INSECT SCI, V18, P57, DOI 10.1111/j.1744-7917.2010.01396.x; Carpi G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025604; Cheng D, 2013, TICKS TICK-BORNE DIS, V4, P421, DOI 10.1016/j.ttbdis.2013.04.006; Cheng D, 2013, TICKS TICK-BORNE DIS, V4, P280, DOI 10.1016/j.ttbdis.2012.12.005; Dale C, 2006, CELL, V126, P453, DOI 10.1016/j.cell.2006.07.014; Dennis DT, 1998, J MED ENTOMOL, V35, P629, DOI 10.1093/jmedent/35.5.629; Dobson SL, 2004, HEREDITY, V93, P135, DOI 10.1038/sj.hdy.6800458; Duron O, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-45; Durvasula RV, 1997, P NATL ACAD SCI USA, V94, P3274, DOI 10.1073/pnas.94.7.3274; Furman D.P., 1984, Bulletin of the California Insect Survey, V25, P1; Giordano R, 2010, ENVIRON ENTOMOL, V39, P1170, DOI 10.1603/EN10027; Giorgini M, 2010, APPL ENVIRON MICROB, V76, P2589, DOI 10.1128/AEM.03154-09; GUDIOL F, 1989, ANTIMICROB AGENTS CH, V33, P987, DOI 10.1128/AAC.33.6.987; Harrell Jr F, 2013, HMISC HARRELL MISCEL; Jasinskas A, 2007, APPL ENVIRON MICROB, V73, P334, DOI 10.1128/AEM.02009-06; Kagemann J, 2013, J MED ENTOMOL, V50, P155, DOI 10.1603/ME12086; Labruna MB, 2004, J MED ENTOMOL, V41, P1073, DOI 10.1603/0022-2585-41.6.1073; Levene H., 1960, CONTRIBUTIONS PROBAB, P278; Lukasik P, 2013, ECOL LETT, V16, P214, DOI 10.1111/ele.12031; Merhej V, 2009, CLIN MICROBIOL INFEC, V15, P336, DOI 10.1111/j.1469-0691.2008.02265.x; Merhej V, 2011, BIOL REV, V86, P379, DOI 10.1111/j.1469-185X.2010.00151.x; Moran NA, 2008, ANNU REV GENET, V42, P165, DOI 10.1146/annurev.genet.41.110306.130119; Niebylski ML, 1999, APPL ENVIRON MICROB, V65, P773; Pais R, 2008, APPL ENVIRON MICROB, V74, P5965, DOI 10.1128/AEM.00741-08; Parola P, 2005, CLIN MICROBIOL REV, V18, P719, DOI 10.1128/CMR.18.4.719-756.2005; Peavey CA, 1996, EXP APPL ACAROL, V20, P695, DOI 10.1007/BF00051555; PEAVEY CA, 1995, J PARASITOL, V81, P175, DOI 10.2307/3283916; Phan JN, 2011, VECTOR-BORNE ZOONOT, V11, P957, DOI 10.1089/vbz.2010.0077; R Core Team, 2021, R LANGUAGE ENV STAT; Rich JT, 2010, OTOLARYNG HEAD NECK, V143, P331, DOI 10.1016/j.otohns.2010.05.007; Rolain JM, 2002, ANTIMICROB AGENTS CH, V46, P2747, DOI 10.1128/AAC.46.9.2747-2751.2002; Rolain JM, 1998, ANTIMICROB AGENTS CH, V42, P1537, DOI 10.1128/AAC.42.7.1537; Ruan YM, 2006, ENTOMOL EXP APPL, V121, P159, DOI 10.1111/j.1570-8703.2006.00466.x; Sakurai M, 2005, APPL ENVIRON MICROB, V71, P4069, DOI 10.1128/AEM.71.7.4069-4075.2005; Shigenobu S, 2000, NATURE, V407, P81, DOI 10.1038/35024074; Socolovschi C, 2009, CLIN MICROBIOL INFEC, V15, P324, DOI 10.1111/j.1469-0691.2008.02259.x; Soneshine D., 1991, BIOL TICKS; Thaker M, 2010, CELL MOL LIFE SCI, V67, P419, DOI 10.1007/s00018-009-0172-6; Troughton DR, 2007, J MED ENTOMOL, V44, P732, DOI 10.1603/0022-2585(2007)44[732:LCOSIT]2.0.CO;2; Weinert LA, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-6; Yuan D. T, 2010, METAGENOMIC STUDY TI; Zhong JM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000405	48	18	19	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2014	9	8							e104815	10.1371/journal.pone.0104815	http://dx.doi.org/10.1371/journal.pone.0104815			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR0CG	25105893	Green Submitted, gold, Green Published			2022-12-27	WOS:000343231900087
J	Ramanantoanina, A; Ouhinou, A; Hui, C				Ramanantoanina, Andriamihaja; Ouhinou, Aziz; Hui, Cang			Spatial Assortment of Mixed Propagules Explains the Acceleration of Range Expansion	PLOS ONE			English	Article							DENSITY-DEPENDENT DISPERSAL; ECO-EVOLUTIONARY DYNAMICS; LONG-DISTANCE DISPERSAL; RAPID EVOLUTION; REIDS PARADOX; PRESSURE; INVASION; SPREAD; ESTABLISHMENT; POPULATION	Range expansion of spreading organisms has been found to follow three types: (i) linear expansion with a constant rate of spread; (ii) bi-phase expansion with a faster linear expansion following a slower linear expansion; and (iii) accelerating expansion with a continuously increasing rate of spread. To date, no overarching formula exists that can be applied to all three types of range expansion. We investigated how propagule pressure, i. e., the initial number of individuals and their composition in terms of dispersal ability, affects the spread of a population. A system of integrodifference equations was then used to model the spatiotemporal dynamics of the population. We studied the dynamics of dispersal ability as well as the instantaneous and asymptotic rate of spread. We found that individuals with different dispersal abilities were spatially sorted with the stronger dispersers situated at the expanding range front, causing the velocity of expansion to accelerate. The instantaneous rate of spread was found to be fully determined by the growth and dispersal abilities of the population at the advancing edge of the invasion. We derived a formula for the asymptotic rate of spread under different scenarios of propagule pressure. The results suggest that data collected from the core of the invasion may underestimate the spreading rate of the population. Aside from better managing of invasive species, the derived formula could conceivably also be applied to conservation management of relocated, endangered or extra-limital species.	[Ramanantoanina, Andriamihaja; Hui, Cang] Univ Stellenbosch, Ctr Invas Biol, Dept Math Sci, Matieland, South Africa; [Ramanantoanina, Andriamihaja; Hui, Cang] African Inst Math Sci, Muizenberg, South Africa; [Ouhinou, Aziz] Univ Sultan Moulay Slimane, Fac Sci & Technol, Dept Math, Beni Mellal, Morocco	Stellenbosch University; Sultan Moulay Slimane University of Beni Mellal	Ramanantoanina, A (corresponding author), Univ Stellenbosch, Ctr Invas Biol, Dept Math Sci, Matieland, South Africa.	ar@aims.ac.za	Hui, Cang/A-1781-2008; Ramanantoanina, Andriamihaja/HHR-9881-2022	Hui, Cang/0000-0002-3660-8160; Ramanantoanina, Andriamihaja/0000-0002-6909-3554	National Research Foundation of South Africa [76912, 81825, 89967]; South African Research Chair Initiative (SARChI); DST-NRF Centre of Excellence for Invasion Biology; African Institute for Mathematical Sciences, South Africa	National Research Foundation of South Africa(National Research Foundation - South Africa); South African Research Chair Initiative (SARChI); DST-NRF Centre of Excellence for Invasion Biology(Department of Science & Technology (India)); African Institute for Mathematical Sciences, South Africa	This work was supported by the National Research Foundation of South Africa (Grants 76912, 81825 and 89967) and the South African Research Chair Initiative (SARChI). Additional supports were provided by the DST-NRF Centre of Excellence for Invasion Biology and the African Institute for Mathematical Sciences, South Africa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen EJ, 1996, J MATH BIOL, V34, P455; Altwegg R, 2013, DIVERS DISTRIB, V19, P60, DOI 10.1111/j.1472-4642.2012.00943.x; Andersen MC, 2004, RISK ANAL, V24, P787, DOI 10.1111/j.0272-4332.2004.00478.x; Bell G, 2000, AM NAT, V155, P606, DOI 10.1086/303345; Benichou O, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.041908; Berthouly-Salazar C, 2013, MOL ECOL, V22, P5793, DOI 10.1111/mec.12538; Berthouly-Salazar C, 2012, CONSERV GENET RESOUR, V4, P621, DOI 10.1007/s12686-012-9607-8; Berthouly-Salazar C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038145; Blackburn TM, 2013, BIOL INVASIONS, V15, P1459, DOI 10.1007/s10530-013-0451-x; Bocedi G, 2012, AM NAT, V179, P606, DOI 10.1086/665004; Bouin E, 2012, CR MATH, V350, P761, DOI 10.1016/j.crma.2012.09.010; Boukal DS, 2002, J THEOR BIOL, V218, P375, DOI 10.1006/jtbi.2002.3084; Clark JS, 1998, BIOSCIENCE, V48, P13, DOI 10.2307/1313224; Cohen AN, 1998, SCIENCE, V279, P555, DOI 10.1126/science.279.5350.555; Colautti RI, 2006, BIOL INVASIONS, V8, P1023, DOI 10.1007/s10530-005-3735-y; Davies SJ, 2013, AUSTRAL ECOL, V38, P851, DOI 10.1111/aec.12022; Donaldson JE, 2014, GLOBAL CHANGE BIOL, V20, P1527, DOI 10.1111/gcb.12486; Dytham C, 2009, P ROY SOC B-BIOL SCI, V276, P1407, DOI 10.1098/rspb.2008.1535; Ellner SP, 2011, ECOL LETT, V14, P603, DOI 10.1111/j.1461-0248.2011.01616.x; Fisher RA, 1937, ANN EUGENIC, V7, P355, DOI 10.1111/j.1469-1809.1937.tb02153.x; Garcia Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082281; Gertzen EL, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00170.1; Gilbert M, 2004, J ANIM ECOL, V73, P459, DOI 10.1111/j.0021-8790.2004.00820.x; Hairston NG, 2005, ECOL LETT, V8, P1114, DOI 10.1111/j.1461-0248.2005.00812.x; Hanski I, 2011, ECOL LETT, V14, P1025, DOI 10.1111/j.1461-0248.2011.01671.x; HARRISON RG, 1980, ANNU REV ECOL SYST, V11, P95, DOI 10.1146/annurev.es.11.110180.000523; Hastings A, 2005, ECOL LETT, V8, P91, DOI 10.1111/j.1461-0248.2004.00687.x; Henry RC, 2014, PEERJ, V2, DOI 10.7717/peerj.228; Henry RC, 2013, J THEOR BIOL, V321, P1, DOI 10.1016/j.jtbi.2012.12.004; Hui C, 2012, ECOGRAPHY, V35, P1024, DOI 10.1111/j.1600-0587.2012.07697.x; Jenkins DG, 2007, GLOBAL ECOL BIOGEOGR, V16, P415, DOI 10.1111/j.1466-8238.2007.00312.x; Jones E., 2001, SCIPY OPEN SOURCE SC; Korsu Kai, 2009, Aquatic Invasions, V4, P619, DOI 10.3391/ai.2009.4.4.8; Kot M, 1996, ECOLOGY, V77, P2027, DOI 10.2307/2265698; Kubisch A, 2014, OIKOS, V123, P5, DOI 10.1111/j.1600-0706.2013.00706.x; LANDE R, 1993, AM NAT, V142, P911, DOI 10.1086/285580; Limpert E, 2001, BIOSCIENCE, V51, P341, DOI 10.1641/0006-3568(2001)051[0341:LNDATS]2.0.CO;2; Lockwood JL, 2005, TRENDS ECOL EVOL, V20, P223, DOI 10.1016/j.tree.2005.02.004; Lutscher F, 2007, B MATH BIOL, V69, P1615, DOI 10.1007/s11538-006-9182-9; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Matthysen E, 2005, ECOGRAPHY, V28, P403, DOI 10.1111/j.0906-7590.2005.04073.x; May R., 2007, THEORETICAL ECOLOGY, V3rd; Meynard CN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066445; Mikheyev AS, 2008, DIVERS DISTRIB, V14, P301, DOI 10.1111/j.1472-4642.2007.00463.x; MORSE DH, 1985, OECOLOGIA, V67, P372, DOI 10.1007/BF00384943; Murrell DJ, 2002, OIKOS, V97, P229, DOI 10.1034/j.1600-0706.2002.970209.x; Pennekamp F, 2014, EVOLUTION, V68, P2319, DOI 10.1111/evo.12428; Phillips BL, 2008, AM NAT, V172, pS34, DOI 10.1086/588255; Phillips BL, 2010, ECOLOGY, V91, P1617, DOI 10.1890/09-0910.1; Phillips BL, 2006, NATURE, V439, P803, DOI 10.1038/439803a; PRESTON FW, 1962, ECOLOGY, V43, P185, DOI 10.2307/1931976; Ramanantoanina A, 2011, ECOL MODEL, V222, P3524, DOI 10.1016/j.ecolmodel.2011.08.010; RICKER W. E., 1954, JOUR FISH RES BD CANADA, V11, P559; Roura-Pascual N, 2009, GLOBAL CHANGE BIOL, V15, P2101, DOI 10.1111/j.1365-2486.2009.01907.x; SHIGESADA N, 1995, AM NAT, V146, P229, DOI 10.1086/285796; Shigesada N., 1997, BIOL INVASIONS THEOR; Shine R, 2011, P NATL ACAD SCI USA, V108, P5708, DOI 10.1073/pnas.1018989108; Simberloff D, 2009, ANNU REV ECOL EVOL S, V40, P81, DOI 10.1146/annurev.ecolsys.110308.120304; Simmons AD, 2004, AM NAT, V164, P378, DOI 10.1086/423430; Skalski GT, 2000, ECOLOGY, V81, P1685, DOI 10.2307/177317; SKELLAM JG, 1951, BIOMETRIKA, V38, P196, DOI 10.2307/2332328; Suarez AV, 2001, P NATL ACAD SCI USA, V98, P1095, DOI 10.1073/pnas.98.3.1095; Talavera M, 2012, J ECOL, V100, P1194, DOI 10.1111/j.1365-2745.2012.01999.x; VANDENBOSCH F, 1992, J BIOGEOGR, V19, P135, DOI 10.2307/2845500; Vander Wall SB, 2008, ECOLOGY, V89, P1837, DOI 10.1890/07-0409.1; WEINBERGER HF, 1982, SIAM J MATH ANAL, V13, P353, DOI 10.1137/0513028; Wilson JRU, 2007, DIVERS DISTRIB, V13, P11, DOI 10.1111/j.1366-9516.2006.00302.x; Woodford DJ, 2013, ECOL APPL, V23, P1926, DOI 10.1890/12-1262.1; Yamamura K, 2002, POPUL ECOL, V44, P93, DOI 10.1007/s101440200011	70	13	14	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2014	9	8							e103409	10.1371/journal.pone.0103409	http://dx.doi.org/10.1371/journal.pone.0103409			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR0CG	25105414	Green Submitted, gold, Green Published			2022-12-27	WOS:000343231900013
J	Diez, MDA; Aleanzi, MC; Iglesias, AA; Ballicora, MA				Asencion Diez, Matias D.; Aleanzi, Mabel C.; Iglesias, Alberto A.; Ballicora, Miguel A.			A Novel Dual Allosteric Activation Mechanism of Escherichia coli ADP-Glucose Pyrophosphorylase: The Role of Pyruvate	PLOS ONE			English	Article							N-TERMINAL REGION; BACTERIAL GLYCOGEN; AGROBACTERIUM-TUMEFACIENS; BINDING-SITE; SCANNING MUTAGENESIS; REGULATORY ENZYME; BIOSYNTHESIS; INHIBITION; SYNTHASE; IDENTIFICATION	Fructose-1,6-bisphosphate activates ADP-glucose pyrophosphorylase and the synthesis of glycogen in Escherichia coli. Here, we show that although pyruvate is a weak activator by itself, it synergically enhances the fructose-1,6-bisphosphate activation. They increase the enzyme affinity for each other, and the combination increases V-max, substrate apparent affinity, and decreases AMP inhibition. Our results indicate that there are two distinct interacting allosteric sites for activation. Hence, pyruvate modulates E. coli glycogen metabolism by orchestrating a functional network of allosteric regulators. We postulate that this novel dual activator mechanism increases the evolvability of ADP-glucose pyrophosphorylase and its related metabolic control.	[Asencion Diez, Matias D.; Ballicora, Miguel A.] Loyola Univ, Dept Chem, Chicago, IL 60626 USA; [Asencion Diez, Matias D.; Aleanzi, Mabel C.; Iglesias, Alberto A.] UNL, CONICET, Inst Agrobiotecnol Litoral, Lab Enzimol Mol, Santa Fe, Argentina	Loyola University Chicago; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of the Littoral	Ballicora, MA (corresponding author), Loyola Univ, Dept Chem, 6525 N Sheridan Rd, Chicago, IL 60626 USA.	mballic@luc.edu		Ballicora, Miguel/0000-0002-5324-0724; Asencion Diez, Matias Damian/0000-0001-6495-387X; Iglesias, Alberto/0000-0001-9729-7338	CONICET [PIP 112-201101-00438]; UNL [CAI+D'11]; ANPCyT [PICT'12 2439]; National Science Foundation [MCB 1024945]	CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); UNL; ANPCyT(ANPCyT); National Science Foundation(National Science Foundation (NSF))	This work was supported by grants to AAI from CONICET [PIP 112-201101-00438 and external collaboration], UNL [CAI+D'11 and Orientado], and ANPCyT [PICT'12 2439]; and to MAB from the National Science Foundation [MCB 1024945]. MDAD is Post-Doctoral Fellow from CONICET. AAI is Principal Investigator from the same Institution. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Diez MDA, 2013, MOL MICROBIOL, V90, P1011, DOI 10.1111/mmi.12413; Diez MDA, 2013, INT J MOL SCI, V14, P9703, DOI 10.3390/ijms14059703; Diez MDA, 2012, J BACTERIOL, V194, P1485, DOI 10.1128/JB.06377-11; Ballicora MA, 2004, PHOTOSYNTH RES, V79, P1, DOI 10.1023/B:PRES.0000011916.67519.58; Ballicora MA, 2002, BIOCHEMISTRY-US, V41, P9431, DOI 10.1021/bi025793b; Ballicora MA, 2003, MICROBIOL MOL BIOL R, V67, P213, DOI 10.1128/MMBR.67.2.213-225.2003; Ballicora MA, 2007, J BACTERIOL, V189, P5325, DOI 10.1128/JB.00481-07; Bejar CM, 2006, J BIOL CHEM, V281, P40473, DOI 10.1074/jbc.M607088200; Bejar CM, 2004, FEBS LETT, V573, P99, DOI 10.1016/j.febslet.2004.07.060; Cupp-Vickery JR, 2008, BIOCHEMISTRY-US, V47, P4439, DOI 10.1021/bi701933q; EIDELS L, 1970, ARCH BIOCHEM BIOPHYS, V140, P60, DOI 10.1016/0003-9861(70)90010-X; Figueroa CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066824; Figueroa CM, 2011, BIOCHIMIE, V93, P1816, DOI 10.1016/j.biochi.2011.06.029; Frueauf JB, 2001, J BIOL CHEM, V276, P46319, DOI 10.1074/jbc.M107408200; FURLONG CE, 1969, J BIOL CHEM, V244, P2539; Fusari C, 2006, ANAL BIOCHEM, V352, P145, DOI 10.1016/j.ab.2006.01.024; GARDIOL A, 1990, ARCH BIOCHEM BIOPHYS, V280, P175, DOI 10.1016/0003-9861(90)90533-5; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Gomez-Casati DF, 2001, BIOCHEMISTRY-US, V40, P10169, DOI 10.1021/bi002615e; Hill MA, 1998, BIOCHEM BIOPH RES CO, V244, P573, DOI 10.1006/bbrc.1998.8301; Iglesias A.A., 1992, BIOCHEM EDUC, V20, P196, DOI 10.1016/0307-4412(92)90191-N; Jin XS, 2005, EMBO J, V24, P694, DOI 10.1038/sj.emboj.7600551; Kuhn ML, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-51; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Machtey M, 2012, J BACTERIOL, V194, P6056, DOI 10.1128/JB.00810-12; PARSONS TF, 1978, J BIOL CHEM, V253, P7638; PARSONS TF, 1978, J BIOL CHEM, V253, P6197; PREISS J, 1966, BIOCHEMISTRY-US, V5, P1833, DOI 10.1021/bi00870a008; PREISS J, 1965, BIOCHEM BIOPH RES CO, V18, P180, DOI 10.1016/0006-291X(65)90737-0; Preiss J, 1996, Biotechnol Annu Rev, V2, P259, DOI 10.1016/S1387-2656(08)70013-9; PREISS J, 1989, ADV MICROB PHYSIOL, V30, P183; Sheng J, 1996, BIOCHEMISTRY-US, V35, P3115, DOI 10.1021/bi952359j; Uttaro AD, 1998, ARCH BIOCHEM BIOPHYS, V357, P13, DOI 10.1006/abbi.1998.0786; Wu MX, 2001, ARCH BIOCHEM BIOPHYS, V389, P159, DOI 10.1006/abbi.2001.2327; Wu MX, 1998, ARCH BIOCHEM BIOPHYS, V358, P182, DOI 10.1006/abbi.1998.0846; Yang YT, 2001, METAB ENG, V3, P115, DOI 10.1006/mben.2000.0166	36	12	12	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e103888	10.1371/journal.pone.0103888	http://dx.doi.org/10.1371/journal.pone.0103888			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25102309	Green Published, Green Submitted, gold			2022-12-27	WOS:000339993900028
J	Darsalia, V; Hua, S; Larsson, M; Mallard, C; Nathanson, D; Nystrom, T; Sjoholm, A; Johansson, ME; Patrone, C				Darsalia, Vladimer; Hua, Sansan; Larsson, Martin; Mallard, Carina; Nathanson, David; Nystroem, Thomas; Sjoeholm, Ake; Johansson, Maria E.; Patrone, Cesare			Exendin-4 Reduces Ischemic Brain Injury in Normal and Aged Type 2 Diabetic Mice and Promotes Microglial M2 Polarization	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; CEREBRAL-ISCHEMIA; RECEPTOR STIMULATION; STROKE; NEUROPROTECTION; INFARCTION; MECHANISM; FAILURE; MOUSE	Exendin-4 is a glucagon-like receptor 1 agonist clinically used against type 2 diabetes that has also shown neuroprotective effects in experimental stroke models. However, while the neuroprotective efficacy of Exendin-4 has been thoroughly investigated if the pharmacological treatment starts before stroke, the therapeutic potential of the Exendin-4 if the treatment starts acutely after stroke has not been clearly determined. Further, a comparison of the neuroprotective efficacy in normal and aged diabetic mice has not been performed. Finally, the cellular mechanisms behind the efficacy of Exendin-4 have been only partially studied. The main objective of this study was to determine the neuroprotective efficacy of Exendin4 in normal and aged type 2 diabetic mice if the treatment started after stroke in a clinically relevant setting. Furthermore we characterized the Exendin-4 effects on stroke-induced neuroinflammation. Two-month-old healthy and 14-month-old type 2 diabetic/obese mice were subjected to middle cerebral artery occlusion. 5 or 50 mg/kg Exendin-4 was administered intraperitoneally at 1.5, 3 or 4.5 hours thereafter. The treatment was continued (0.2 mg/kg/day) for 1 week. The neuroprotective efficacy was assessed by stroke volume measurement and stereological counting of NeuN-positive neurons. Neuroinflammation was determined by gene expression analysis of M1/M2 microglia subtypes and proinflammatory cytokines. We show neuroprotective efficacy of 50 mg/kg Exendin-4 at 1.5 and 3 hours after stroke in both young healthy and aged diabetic/obese mice. The 5 mu g/kg dose was neuroprotective at 1.5 hour only. Proinflammatory markers and M1 phenotype were not impacted by Exendin-4 treatment while M2 markers were significantly up regulated. Our results support the use of Exendin-4 to reduce stroke-damage in the prehospital/early hospitalization setting irrespectively of age/diabetes. The results indicate the polarization of microglia/macrophages towards the M2 reparative phenotype as a potential mechanism of neuroprotection.	[Darsalia, Vladimer; Larsson, Martin; Nathanson, David; Nystroem, Thomas; Patrone, Cesare] Karolinska Inst, Dept Clin Sci & Educ, Stockholm, Sweden; [Hua, Sansan; Mallard, Carina; Johansson, Maria E.] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Physiol, Gothenburg, Sweden; [Sjoeholm, Ake] Univ S Alabama, Coll Med, Dept Biochem & Mol Biol, Mobile, AL USA; [Sjoeholm, Ake] Sodertalje Hosp, Diabet Res Unit, Dept Internal Med, Sodertalje, Sweden	Karolinska Institutet; University of Gothenburg; University of South Alabama	Darsalia, V (corresponding author), Karolinska Inst, Dept Clin Sci & Educ, Stockholm, Sweden.	vladimer.darsalia@ki.se; cesare.patrone@ki.se	Larsson, Martin/C-2314-2017; Darsalia, Vladimer/AAF-3608-2019	Larsson, Martin/0000-0002-3226-7397; Mallard, Carina/0000-0001-8953-919X; Darsalia, Vladimer/0000-0002-6693-934X; Johansson, Maria/0000-0002-2569-2977	Novo Nordisk foundation [5421]; Diabetesfonden [DIA2013-010]; European foundation [94174]; AFA Insurance [110067]; Diabetes Research and Wellness Foundation [0245/2010W]; Swedish Heart and Lung Foundation [20130523]; Konung Gustaf V:s och Drottning Victorias Frimurarestiftelse; Swedish Research Council; Swedish Society of Medicine; foundation Bergvalls; Syskonen Svensson; Thuring; Lagerman; Osterman; Stohne; Alen; STROKE Riksforbundet; Tornspiran; Gamla Tjanarinnor	Novo Nordisk foundation(Novo Nordisk FoundationNovocure Limited); Diabetesfonden; European foundation(European Science Foundation (ESF)); AFA Insurance; Diabetes Research and Wellness Foundation; Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Konung Gustaf V:s och Drottning Victorias Frimurarestiftelse; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Society of Medicine; foundation Bergvalls; Syskonen Svensson; Thuring; Lagerman; Osterman; Stohne; Alen; STROKE Riksforbundet; Tornspiran; Gamla Tjanarinnor	This study was supported by 1) Novo Nordisk foundation [Grant number 5421]. http://www.novonordiskfonden.dk/en/grantrecipients? field_date_ value%5Bvalue%5D&field_date_value_1%5Bvalue%5D&field_related_center_tid=All&keys=&page=1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.2) Diabetesfonden [Grant number DIA2013-010]. http://www.diabetesfonden.se/Forskning/Beviljade-projekt/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.3) European foundation for the study of diabetes [( EFSD/Lilly European Diabetes Research Programme) grant number: 94174]. www.EuropeanDiabetesFoundation.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.4) AFA Insurance [grant number 110067]. http://www.afaforsakring.se/Forskning/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.5) Diabetes Research and Wellness Foundation [grant number 0245/2010W]. http://diabeteswellness.se/Research/2010%C3%A5rsforskningsanslag/tabid/841/language/en-US/Default.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.6) the Swedish Heart and Lung Foundation [grant number: 20130523. http://www.hjart-lungfonden.se/Forskning/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.7) This work has also been supported by grants from: Konung Gustaf V:s och Drottning Victorias Frimurarestiftelse, The Swedish Research Council, the Swedish Society of Medicine and by the foundations Bergvalls, Syskonen Svensson, Thuring, Lagerman, Osterman, Stohne, Alen, STROKE Riksforbundet, Tornspiran, Gamla Tjanarinnor. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Briyal S, 2012, BRAIN RES, V1427, P23, DOI 10.1016/j.brainres.2011.10.026; Brott T, 1997, STROKE, V28, P1530, DOI 10.1161/01.STR.28.8.1530; Darsalia V, 2012, CLIN SCI, V122, P473, DOI 10.1042/CS20110374; Deacon CF, 2005, REGUL PEPTIDES, V128, P117, DOI 10.1016/j.regpep.2004.06.007; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Drucker DJ, 2006, LANCET, V368, P1696, DOI 10.1016/S0140-6736(06)69705-5; Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507; Fisher M, 2009, STROKE, V40, P2244, DOI 10.1161/STROKEAHA.108.541128; Gladstone DJ, 2002, STROKE, V33, P2123, DOI 10.1161/01.STR.0000025518.34157.51; HAMILTON A, 2009, NEUROREPORT; Hara H, 1996, J CEREBR BLOOD F MET, V16, P605, DOI 10.1097/00004647-199607000-00010; Harkavyi A, 2010, BRIT J PHARMACOL, V159, P495, DOI 10.1111/j.1476-5381.2009.00486.x; Holscher C., 2013, J ENDOCRINOL; Hu XM, 2012, STROKE, V43, P3063, DOI 10.1161/STROKEAHA.112.659656; Iwai T, 2006, NEUROSCI RES, V55, P352, DOI 10.1016/j.neures.2006.04.008; Jin R, 2010, J LEUKOCYTE BIOL, V87, P779, DOI 10.1189/jlb.1109766; Johnson SC, 2005, NEUROLOGY, V64, P654; Karapanayiotides T, 2004, NEUROLOGY, V62, P1558, DOI 10.1212/01.WNL.0000123252.55688.05; Kastin AJ, 2003, INT J OBESITY, V27, P313, DOI 10.1038/sj.ijo.0802206; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Lansberg MG, 2009, STROKE, V40, P2438, DOI 10.1161/STROKEAHA.109.552547; Lee CH, 2011, J NEUROSCI RES, V89, P1103, DOI 10.1002/jnr.22596; Li XL, 2004, EXP NEUROL, V187, P94, DOI 10.1016/j.expneurol.2004.01.004; Li YZ, 2009, P NATL ACAD SCI USA, V106, P1285, DOI 10.1073/pnas.0806720106; Manning NW, 2014, STROKE, V45, P640, DOI 10.1161/STROKEAHA.113.003798; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; Meretoja A, 2012, NEUROLOGY, V79, P306, DOI 10.1212/WNL.0b013e31825d6011; Rother J, 2008, STROKE, V39, P523, DOI 10.1161/STROKEAHA.107.494799; Salcedo I, 2012, BRIT J PHARMACOL, V166, P1586, DOI 10.1111/j.1476-5381.2012.01971.x; Sander D, 2009, J NEUROL, V256, P1603, DOI 10.1007/s00415-009-5143-1; Sena E, 2007, TRENDS NEUROSCI, V30, P433, DOI 10.1016/j.tins.2007.06.009; Shichita T, 2012, J NEUROCHEM, V123, P29, DOI 10.1111/j.1471-4159.2012.07941.x; Shyangdan DS, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006423.pub2; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Sohrabji F, 2013, NEUROCHEM INT, V63, P291, DOI 10.1016/j.neuint.2013.06.013; Steiner I, 2008, J NEUROL SCI, V267, P187, DOI 10.1016/j.jns.2007.10.021; Stridh L, 2013, J NEUROSCI, V33, P12041, DOI 10.1523/JNEUROSCI.0673-13.2013; Teramoto S., 2011, J CEREB BLOOD FLOW M; Turner RC, 2013, J NEUROSURG, V118, P1072, DOI 10.3171/2012.11.JNS12408; Wahlgren NG, 2004, CEREBROVASC DIS, V17, P153, DOI 10.1159/000074808	40	70	75	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e103114	10.1371/journal.pone.0103114	http://dx.doi.org/10.1371/journal.pone.0103114			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25101679	gold, Green Published, Green Submitted			2022-12-27	WOS:000339993900014
J	Heredia-Pi, I; Servan-Mori, EE; Wirtz, VJ; Avila-Burgos, L; Lozano, R				Heredia-Pi, Ileana; Servan-Mori, Edson E.; Wirtz, Veronika J.; Avila-Burgos, Leticia; Lozano, Rafael			Obstetric Care and Method of Delivery in Mexico: Results from the 2012 National Health and Nutrition Survey	PLOS ONE			English	Article							CESAREAN-SECTION RATE; RATES; PREGNANCY; PHYSICIANS; SERVICES; TRENDS; CHILE; WOMEN; LABOR	Objective: To identify the current clinical, socio-demographic and obstetric factors associated with the various types of delivery strategies in Mexico. Materials and Methods: This is a cross-sectional study based on the 2012 National Health and Nutrition Survey (ENSANUT) of 6,736 women aged 12 to 49 years. Delivery types discussed in this paper include vaginal delivery, emergency cesarean section and planned cesarean section. Using bivariate analyses, sub-population group differences were identified. Logistic regression models were applied, including both binary and multinomial outcome variables from the survey. The logistic regression results identify those covariates associated with the type of delivery. Results: 53.1% of institutional births in the period 2006 through 2012 were vaginal deliveries, 46.9% were either a planned or emergency cesarean sections. The highest rates of this procedure were among women who reported a complication during delivery (OR: 4.21; 95%CI: 3.66-4.84), between the ages of 35 and 49 at the time of their last child birth (OR: 2.54; 95%CI: 2.02-3.20) and women receiving care through private healthcare providers during delivery (OR: 2.36; 95%CI: 1.84-3.03). Conclusions: The existence of different socio-demographic and obstetric profiles among women who receive care for vaginal or cesarean delivery, are supported by the findings of the present study. The frequency of vaginal delivery is higher in indigenous women, when the care provider is public and, in women with two or more children at time of the most recent child birth. Planned cesarean deliveries are positively associated with years of schooling, a higher socioeconomic level, and higher age. The occurrence of emergency cesarean sections is elevated in women with a diagnosis of a health issue during pregnancy or delivery, and it is reduced in highly marginalized settings.	[Heredia-Pi, Ileana; Servan-Mori, Edson E.; Avila-Burgos, Leticia; Lozano, Rafael] Natl Inst Publ Hlth, Cuernavaca, Morelos, Mexico; [Wirtz, Veronika J.] Boston Univ, Ctr Global Hlth & Dev, Boston, MA 02215 USA; [Lozano, Rafael] Inst Hlth Metr & Evaluat, Seattle, WA USA	Instituto Nacional de Salud Publica; Boston University; Institute for Health Metrics & Evaluation	Servan-Mori, EE (corresponding author), Natl Inst Publ Hlth, Cuernavaca, Morelos, Mexico.	eservan@insp.mx	Wirtz, Veornika/AAG-9712-2019; Avila-Burgos, Leticia/AAR-1815-2021; Lozano, Rafael/T-5352-2018; Heredia-Pi, Ileana Beatriz/L-4247-2019	Lozano, Rafael/0000-0002-7356-8823; Heredia-Pi, Ileana Beatriz/0000-0002-9998-9239; Wirtz, Veronika J./0000-0002-0863-8768; Servan-Mori, Edson/0000-0001-9820-8325				Abenhaim HA, 2011, J OBSTET GYNAECOL CA, V33, P443, DOI 10.1016/S1701-2163(16)34876-9; ANDERSEN RM, 1995, J HEALTH SOC BEHAV, V36, P1, DOI 10.2307/2137284; [Anonymous], IND 2011; Atout MM, 2012, CANADIAN J SCI IND R, V3, P179; Badakhsh MH, 2012, ARCH IRAN MED, V15, P4, DOI 012151/AIM.004; Brown CJ, 2005, HEALTH POLICY, V72, P81, DOI 10.1016/j.healthpol.2004.06.008; Cameron AC, 2010, MICROECONOMETRICS US, P448; Campero L, 2007, SALUD PUBLICA MEXICO, V49, P118, DOI 10.1590/S0036-36342007000200007; Chalmers B, 2001, BIRTH-ISS PERINAT C, V28, P202, DOI 10.1046/j.1523-536x.2001.00202.x; Chigbu CO, 2008, INT J GYNECOL OBSTET, V103, P158, DOI 10.1016/j.ijgo.2008.06.006; Comision Nacional para el Desarrollo de los Pueblos Indigenas (CDI), 2009, HOG POBL IND; Consejo Nacional de Poblacion (CONAPO), IND MARG LOC; Cragin L, 2007, REPROD HEALTH MATTER, V15, P50, DOI 10.1016/S0968-8080(07)30332-7; D'Orsi Eleonora, 2006, Cad. Saúde Pública, V22, P2067, DOI 10.1590/S0102-311X2006001000012; DeMaria LM, 2012, HUM RESOUR HEALTH, V10, DOI 10.1186/1478-4491-10-6; Dodd JM, 2004, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD004224.pub2, DOI 10.1002/14651858.CD004224.PUB2]; Fondo de las Naciones Unidas para la Infancia (UNICEF), 2012, EST MUND INF 2012 NI; Freitas PF, 1999, THESIS LONDON SCH HY; Glei DA, 2003, SOC SCI MED, V57, P2447, DOI 10.1016/S0277-9536(03)00140-0; Gonzalez Perez G J, 2001, HLTH POLICY PLAN, V16, P62; Gonzalez Perez GJ, 1996, J EPIDEMIOL COMMUNIT, V52, P226; Gonzalez Perez GJ, 2011, CESAREAS MEXICO ASPE; Gutierrez JP, 2012, ENCUESTA NACL SALUD; Gyimah SO, 2006, SOC SCI MED, V62, P2930, DOI 10.1016/j.socscimed.2005.11.034; Hamilton Brady E, 2010, Natl Vital Stat Rep, V59, P1; Heredia-Pi I, 2013, SALUD PUBLICA MEXICO, V55, pS249; Hong X, 2007, TOHOKU J EXP MED, V212, P283, DOI 10.1620/tjem.212.283; Hosmer D, 2000, WILEY SERIES PROBABI, P260; Instituto Nacional de Estadistica y Geografia, 2010, ENC NAC DIN DEM 2009; LOCALIO AR, 1993, JAMA-J AM MED ASSOC, V269, P366, DOI 10.1001/jama.269.3.366; Lopez-Cevallos DF, 2010, HEALTH POLICY PLANN, V25, P209, DOI 10.1093/heapol/czp052; Main EK, 2011, CESAREAN DELIVERIES; Patah LEM, 2011, REV SAUDE PUBL, V45, P185, DOI 10.1590/S0034-89102011000100021; Murray SF, 1997, BIRTH-ISS PERINAT C, V24, P258, DOI 10.1111/j.1523-536X.1997.tb00600.x; Murray SF, 2000, BRIT MED J, V321, P1501, DOI 10.1136/bmj.321.7275.1501; Puentes Rosas E, 2004, SALUD PUBLICA MEXICO, V46, P16; Sahn DE, 2003, OXFORD B ECON STAT, V65, P241, DOI 10.1111/1468-0084.t01-2-00046; Stanton C., 2008, B WHO, V86; Stanton CK, 2005, B WORLD HEALTH ORGAN, V83, P449; Stata Corp. LP, 2011, STAT SE 12 1 WIND XP; Studdert DM, 2005, JAMA-J AM MED ASSOC, V293, P2609, DOI 10.1001/jama.293.21.2609; Suarez L, 2013, ELEVADA RECURRENCIA; Valdivia M, 2002, HEALTH POLICY PLANN, V17, P12, DOI 10.1093/heapol/17.suppl_1.12; Velasco Murillo Vitelio, 1997, Revista Medica del Instituto Mexicano del Seguro Social, V35, P207; Villanueva-Egan LA, 2004, REV FAC MED UNAM, V47, P246; Villar J, 2007, BRIT MED J, V335, P1025, DOI 10.1136/bmj.39363.706956.55; Villar J, 2006, LANCET, V367, P1819, DOI 10.1016/S0140-6736(06)68704-7; Vimercati A, 2000, J PERINAT MED, V28, P111, DOI 10.1515/JPM.2000.014; Weiss JL, 2004, AM J OBSTET GYNECOL, V190, P1091, DOI 10.1016/j.ajog.2003.09.058; Wolfe S, 2011, GUIDE AVOIDING UNNEC	50	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e104166	10.1371/journal.pone.0104166	http://dx.doi.org/10.1371/journal.pone.0104166			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM6SB	25101781	Green Submitted, Green Published, gold			2022-12-27	WOS:000339993900047
J	Liu, ZL; Liu, YP; Gao, R; Li, HX; Dunn, T; Wu, P; Smith, RG; Sarkar, PS; Fang, X				Liu, Zilong; Liu, Yongping; Gao, Rui; Li, Haixia; Dunn, Tiffany; Wu, Ping; Smith, Robert G.; Sarkar, Partha S.; Fang, Xiang			Ethanol Suppresses PGC-1 alpha Expression by Interfering with the cAMP-CREB Pathway in Neuronal Cells	PLOS ONE			English	Article							MITOCHONDRIAL DYSFUNCTION; ENERGY-METABOLISM; OXIDATIVE STRESS; SKELETAL-MUSCLE; GROWTH-FACTORS; RECEPTOR; PROTEIN; BRAIN; NEURODEGENERATION; MODULATION	Alcohol intoxication results in neuronal apoptosis, neurodegeneration and manifest with impaired balance, loss of muscle coordination and behavioral changes. One of the early events of alcohol intoxication is mitochondrial (Mt) dysfunction and disruption of intracellular redox homeostasis. The mechanisms by which alcohol causes Mt dysfunction, disrupts cellular redox homeostasis and triggers neurodegeneration remains to be further investigated. Proliferator-activated receptor gamma co-activator 1-alpha (PGC-1 alpha) plays critical roles in regulating Mt biogenesis and respiration, cellular antioxidant defense mechanism, and maintenance of neuronal integrity and function. In this study, we sought to investigate whether alcohol causes Mt dysfunction and triggers neurodegeneration by suppressing PGC-1 alpha expression. We report that ethanol suppresses PGC-1 alpha expression, and impairs mitochondrial function and enhances cellular toxicity in cultured neuronal cell line and also in human fetal brain neural stem cell-derived primary neurons. Moreover, we report that cells over-expressing exogenous PGC-1 alpha or treated with Rolipram, a selective phosphodiesterase-4 inhibitor, ameliorate alcohol-induced cellular toxicity. Further analysis show that ethanol decreases steady-state intracellular cAMP levels, and thus depletes phosphorylation of cAMP-response element binding protein (p-CREB), the key transcription factor that regulates transcription of PGC-1 alpha gene. Accordingly, we found PGC-1 alpha promoter activity and transcription was dramatically repressed in neuronal cells when exposed to ethanol, suggesting that ethanol blunts cAMP -> CREB signaling pathway to interfere with the transcription of PGC-1 alpha. Ethanol-mediated decrease in PGC-1 alpha activity results in the disruption of Mt respiration and function and higher cellular toxicity. This study might lead to potential therapeutic intervention to ameliorate alcohol-induced apoptosis and/or neurodegeneration by targeting PGC-1 alpha.	[Liu, Zilong; Liu, Yongping; Gao, Rui; Smith, Robert G.; Sarkar, Partha S.; Fang, Xiang] Univ Texas Med Branch, Dept Neurol, Galveston, TX 77555 USA; [Li, Haixia] Univ Texas Med Branch, Dept Internal Med Gastroenterol, Galveston, TX 77555 USA; [Dunn, Tiffany; Wu, Ping; Sarkar, Partha S.] Univ Texas Med Branch, Dept Neurosci & Cell Biol, Galveston, TX 77555 USA; [Liu, Zilong] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Forens Med, Wuhan 430074, Peoples R China	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; Huazhong University of Science & Technology	Fang, X (corresponding author), Univ Texas Med Branch, Dept Neurol, Galveston, TX 77555 USA.	xiang.fang01@gmail.com			NINDS grant [1K02NS081000-01A1]; University of Texas Medical Branch (UTMB) start-up fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K02NS081000] Funding Source: NIH RePORTER	NINDS grant; University of Texas Medical Branch (UTMB) start-up fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by NINDS grant 1K02NS081000-01A1), and University of Texas Medical Branch (UTMB) start-up fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADICKES ED, 1988, ALCOHOL ALCOHOLISM, V23, P377, DOI 10.1093/oxfordjournals.alcalc.a044832; Agrawal R, 2014, BBA-MOL BASIS DIS, V1842, P535, DOI 10.1016/j.bbadis.2013.12.004; Akimoto T, 2005, J BIOL CHEM, V280, P19587, DOI 10.1074/jbc.M408862200; Aksenova MV, 2005, CURR NEUROVASC RES, V2, P73, DOI 10.2174/1567202052773463; Antonio AM, 2008, BRAIN RES, V1204, P16, DOI 10.1016/j.brainres.2008.02.018; Bailey SM, 1998, HEPATOLOGY, V28, P1318, DOI 10.1002/hep.510280521; Castillo-Quan JI, 2011, DIS MODEL MECH, V4, P427, DOI 10.1242/dmm.008227; Chaung WW, 2008, INT J CLIN EXP MED, V1, P161; CORY AH, 1991, CANCER COMMUN, V3, P207, DOI 10.3727/095535491820873191; Crews FT, 2009, ALCOHOL ALCOHOLISM, V44, P115, DOI 10.1093/alcalc/agn079; Cui LB, 2006, CELL, V127, P59, DOI 10.1016/j.cell.2006.09.015; Dikranian K, 2005, DEV BRAIN RES, V155, P1, DOI 10.1016/j.devbrainres.2004.11.005; Echevarria DJ, 2011, REV NEUROSCIENCE, V22, P85, DOI 10.1515/RNS.2011.010; Fan M, 2004, GENE DEV, V18, P278, DOI 10.1101/gad.1152204; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; Garic-Stankovic A, 2005, ALCOHOL CLIN EXP RES, V29, P1237, DOI 10.1097/01.ALC.0000172460.05756.D9; Handschin C, 2003, P NATL ACAD SCI USA, V100, P7111, DOI 10.1073/pnas.1232352100; Heaton MB, 2004, DEV BRAIN RES, V150, P117, DOI 10.1016/j.devbrainres.2004.03.010; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Hulley P, 1995, EUR J NEUROSCI, V7, P2431, DOI 10.1111/j.1460-9568.1995.tb01041.x; Ichida M, 2002, J BIOL CHEM, V277, P50991, DOI 10.1074/jbc.M210262200; IVESTER P, 1995, ARCH BIOCHEM BIOPHYS, V322, P14, DOI 10.1006/abbi.1995.1430; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Knutti D, 2001, TRENDS ENDOCRIN MET, V12, P360, DOI 10.1016/S1043-2760(01)00457-X; Kranz K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092157; LEGRAND C, 1992, J BIOTECHNOL, V25, P231, DOI 10.1016/0168-1656(92)90158-6; Liang HY, 2006, ADV PHYSIOL EDUC, V30, P145, DOI 10.1152/advan.00052.2006; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Luo J, 1997, ALCOHOL CLIN EXP RES, V21, P1186, DOI 10.1111/j.1530-0277.1997.tb04436.x; MORGAN AJ, 1993, BIOCHEM PHARMACOL, V45, P2373, DOI 10.1016/0006-2952(93)90216-J; Naseer MI, 2010, SYNAPSE, V64, P467, DOI 10.1002/syn.20752; Naseer MI, 2010, SYNAPSE, V65, P562; Patel M, 2010, EXP BRAIN RES, V202, P431, DOI 10.1007/s00221-009-2150-5; Qin WP, 2009, ARCH NEUROL-CHICAGO, V66, P352, DOI 10.1001/archneurol.2008.588; Room R, 2005, LANCET, V365, P519, DOI 10.1016/S0140-6736(05)70276-2; Sakai R, 2005, J NEURAL TRANSM, V112, P1005, DOI 10.1007/s00702-004-0246-4; Sato O, 2002, J BIOL CHEM, V277, P15703, DOI 10.1074/jbc.M110158200; Seiler AEM, 2001, J NEUROCHEM, V76, P573, DOI 10.1046/j.1471-4159.2001.00025.x; Shin JH, 2011, CELL, V144, P689, DOI 10.1016/j.cell.2011.02.010; SMITH RA, 1991, VIRCHOWS ARCH B, V61, P209; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Svendsen CN, 1998, J NEUROSCI METH, V85, P141, DOI 10.1016/S0165-0270(98)00126-5; Tarasenko YI, 2004, J NEUROSCI RES, V78, P625, DOI 10.1002/jnr.20316; Thibault C, 2000, MOL PHARMACOL, V58, P1593, DOI 10.1124/mol.58.6.1593; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Wu ZD, 2006, P NATL ACAD SCI USA, V103, P14379, DOI 10.1073/pnas.0606714103; Yan D, 2010, BIOCHEM PHARMACOL, V80, P144, DOI 10.1016/j.bcp.2010.03.004; Yeo JE, 2008, CELL PHYSIOL BIOCHEM, V21, P225, DOI 10.1159/000113764; Zhang C, 2011, TOXICOLOGY, V287, P124, DOI 10.1016/j.tox.2011.06.006; Zheng B, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001059; Zhu L, 2009, IEEE PHOTONICS J, V1, P1, DOI 10.1109/JPHOT.2009.2020963	52	21	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e104247	10.1371/journal.pone.0104247	http://dx.doi.org/10.1371/journal.pone.0104247			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25099937	gold, Green Published			2022-12-27	WOS:000339995100055
J	Wang, CC; Wang, LX; Shrestha, R; Zhang, MF; Huang, XY; Hu, K; Jin, L; Li, H				Wang, Chuan-Chao; Wang, Ling-Xiang; Shrestha, Rukesh; Zhang, Manfei; Huang, Xiu-Yuan; Hu, Kang; Jin, Li; Li, Hui			Genetic Structure of Qiangic Populations Residing in the Western Sichuan Corridor	PLOS ONE			English	Article							MITOCHONDRIAL-DNA ANALYSIS; TIBETO-BURMAN POPULATIONS; CONTROL REGION SEQUENCES; Y-CHROMOSOME EVIDENCE; EAST-ASIA; SOUTHEAST-ASIA; MULTIPLE ORIGINS; NEOLITHIC EXPANSION; STATISTICAL TESTS; MIGRATION ROUTES	The Qiangic languages in western Sichuan (WSC) are believed to be the oldest branch of the Sino-Tibetan linguistic family, and therefore, all Sino-Tibetan populations might have originated in WSC. However, very few genetic investigations have been done on Qiangic populations and no genetic evidences for the origin of Sino-Tibetan populations have been provided. By using the informative Y chromosome and mitochondrial DNA (mtDNA) markers, we analyzed the genetic structure of Qiangic populations. Our results revealed a predominantly Northern Asian-specific component in Qiangic populations, especially in maternal lineages. The Qiangic populations are an admixture of the northward migrations of East Asian initial settlers with Y chromosome haplogroup D (D1-M15 and the later originated D3a-P47) in the late Paleolithic age, and the southward Di-Qiang people with dominant haplogroup O3a2c1*-M134 and O3a2c1a-M117 in the Neolithic Age.	[Wang, Chuan-Chao; Wang, Ling-Xiang; Shrestha, Rukesh; Zhang, Manfei; Huang, Xiu-Yuan; Jin, Li; Li, Hui] Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Wang, Chuan-Chao; Wang, Ling-Xiang; Shrestha, Rukesh; Zhang, Manfei; Huang, Xiu-Yuan; Jin, Li; Li, Hui] Fudan Univ, Sch Life Sci, MOE Key Lab Contemporary Anthropol, Shanghai 200433, Peoples R China; [Hu, Kang] Tibet Univ Nationalities, Sch Med, Key Lab High Altitude Environm & Genes Related Di, Xianyang, Shaanxi, Peoples R China; [Jin, Li] Chinese Acad Sci, SIBS, CAS MPG Partner Inst Computat Biol, Shanghai, Peoples R China	Fudan University; Fudan University; Xizang Minzu University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society	Li, H (corresponding author), Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China.	LHCA@FUDAN.edu.cn	Jin, Li/C-1468-2009; Wang, Chuan-Chao/B-2975-2011; Jin, Li/M-5063-2019; Wang, Chuan-Chao/AGY-2940-2022	Jin, Li/0000-0002-4546-2415; Wang, Chuan-Chao/0000-0001-9628-0307; Wang, Chuan-Chao/0000-0003-4630-5232	National Excellent Youth Science Foundation of China [31222030]; National Natural Science Foundation of China [91131002]; Shanghai Rising-Star Program [12QA1400300]; China Ministry of Education Scientific Research Major Project [311016, 113022A]; MOE University Doctoral Research Supervisor's Funds [20120071110021]; Shanghai Professional Development Funding [2010001]	National Excellent Youth Science Foundation of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Rising-Star Program; China Ministry of Education Scientific Research Major Project; MOE University Doctoral Research Supervisor's Funds; Shanghai Professional Development Funding	This work was supported by the National Excellent Youth Science Foundation of China (31222030), National Natural Science Foundation of China (91131002), Shanghai Rising-Star Program (12QA1400300), China Ministry of Education Scientific Research Major Project (311016,113022A), MOE University Doctoral Research Supervisor's Funds (20120071110021), and Shanghai Professional Development Funding (2010001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldenderfer M, 2004, J WORLD PREHIST, V18, P1, DOI 10.1023/B:JOWO.0000038657.79035.9e; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Black ML, 2006, ANN HUM BIOL, V33, P620, DOI 10.1080/03014460600882561; Brantingham PJ, 2001, ANTIQUITY, V75, P319, DOI 10.1017/S0003598X0006097X; Burgarella C, 2011, EUR J HUM GENET, V19, P70, DOI 10.1038/ejhg.2010.154; Cai XY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024282; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; Chandrasekar A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007447; Dancause KN, 2009, J HUM GENET, V54, P86, DOI 10.1038/jhg.2008.12; Deng QY, 2013, J SYST EVOL, V51, P263, DOI 10.1111/jse.12009; Derenko M, 2007, AM J HUM GENET, V81, P1025, DOI 10.1086/522933; Derenko MV, 2003, ANN HUM GENET, V67, P391, DOI 10.1046/j.1469-1809.2003.00035.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fornarino S, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-154; Forster P, 1996, AM J HUM GENET, V59, P935; Forster P, 2011, SCIENCE, V333, P1390, DOI 10.1126/science.1205331; FU YX, 1993, GENETICS, V133, P693; Fu YX, 1997, GENETICS, V147, P915; Fucharoen G, 2001, J HUM GENET, V46, P115, DOI 10.1007/s100380170098; Gan RJ, 2008, J HUM GENET, V53, P303, DOI 10.1007/s10038-008-0250-x; Gayden T, 2007, AM J HUM GENET, V80, P884, DOI 10.1086/516757; Gayden T, 2009, J HUM GENET, V54, P216, DOI 10.1038/jhg.2009.14; Gokcumen O, 2008, AM J PHYS ANTHROPOL, V136, P278, DOI 10.1002/ajpa.20802; Hammer MF, 2006, J HUM GENET, V51, P47, DOI 10.1007/s10038-005-0322-0; Hill C, 2007, AM J HUM GENET, V80, P29, DOI 10.1086/510412; Hill C, 2006, MOL BIOL EVOL, V23, P2480, DOI 10.1093/molbev/msl124; Irwin JA, 2008, INT J LEGAL MED, V122, P257, DOI 10.1007/s00414-007-0205-3; Irwin JA, 2010, INT J LEGAL MED, V124, P195, DOI 10.1007/s00414-009-0406-z; Jin HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004210; Kang LL, 2012, ANN HUM GENET, V76, P92, DOI 10.1111/j.1469-1809.2011.00690.x; Kang LL, 2010, J HUM GENET, V55, P270, DOI 10.1038/jhg.2010.21; Karafet TM, 2008, GENOME RES, V18, P830, DOI 10.1101/gr.7172008; Kong QP, 2011, MOL BIOL EVOL, V28, P513, DOI 10.1093/molbev/msq219; Lee H, 2006, INT J LEGAL MED, V120, P5, DOI 10.1007/s00414-005-0005-6; Lertrit P, 2008, AM J PHYS ANTHROPOL, V137, P425, DOI 10.1002/ajpa.20884; Li DN, 2013, J SYST EVOL, V51, P671, DOI 10.1111/jse.12024; Li DN, 2013, J SYST EVOL, V51, P287, DOI 10.1111/jse.12000; Li DN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002168; Li H, 2007, AM J PHYS ANTHROPOL, V134, P481, DOI 10.1002/ajpa.20690; Li H, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-146; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lu Y, 2013, J SYST EVOL, V51, P271, DOI 10.1111/jse.12003; Maruyama S, 2010, INT J LEGAL MED, V124, P165, DOI 10.1007/s00414-009-0355-6; MATISOFF JA, 1991, ANNU REV ANTHROPOL, V20, P469, DOI 10.1146/annurev.an.20.100191.002345; Mirabal S, 2009, EUR J HUM GENET, V17, P1260, DOI 10.1038/ejhg.2009.6; Mona S, 2009, MOL BIOL EVOL, V26, P1865, DOI 10.1093/molbev/msp097; Nohira C, 2010, INT J LEGAL MED, V124, P7, DOI 10.1007/s00414-008-0308-5; Nonaka I, 2007, ANN HUM GENET, V71, P480, DOI 10.1111/j.1469-1809.2006.00343.x; Oota H, 2002, AM J PHYS ANTHROPOL, V118, P146, DOI 10.1002/ajpa.10056; Pakendorf B, 2003, AM J PHYS ANTHROPOL, V120, P211, DOI 10.1002/ajpa.10145; Park MJ, 2012, INT J LEGAL MED, V126, P589, DOI 10.1007/s00414-012-0703-9; Peng MS, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-2; Peng MS, 2010, MOL BIOL EVOL, V27, P2417, DOI 10.1093/molbev/msq131; Qi XB, 2013, MOL BIOL EVOL, V30, P1761, DOI 10.1093/molbev/mst093; Qian YP, 2000, HUM GENET, V106, P453, DOI 10.1007/s004390000259; Qin ZD, 2010, AM J PHYS ANTHROPOL, V143, P555, DOI 10.1002/ajpa.21350; Reddy BM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001141; Roewer L, 2008, INT J LEGAL MED, V122, P219, DOI 10.1007/s00414-007-0222-2; Rootsi S, 2007, EUR J HUM GENET, V15, P204, DOI 10.1038/sj.ejhg.5201748; Saillard J, 2000, AM J HUM GENET, V67, P718, DOI 10.1086/303038; Sengupta S, 2006, AM J HUM GENET, V78, P202, DOI 10.1086/499411; Shi H, 2005, AM J HUM GENET, V77, P408, DOI 10.1086/444436; Shi H, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-45; Shi S., 2008, J SW U NATL, V29, P1; Shi WT, 2010, MOL BIOL EVOL, V27, P385, DOI 10.1093/molbev/msp243; Soares P, 2008, MOL BIOL EVOL, V25, P1209, DOI 10.1093/molbev/msn068; Soares P, 2009, AM J HUM GENET, V84, P740, DOI 10.1016/j.ajhg.2009.05.001; Su B, 2000, HUM GENET, V107, P582, DOI 10.1007/s004390000406; Sun H.K., 1983, YUNNAN MINZUXUEBAO, V3, P99; Tabbada KA, 2010, MOL BIOL EVOL, V27, P21, DOI 10.1093/molbev/msp215; Tajima A, 2004, J HUM GENET, V49, P187, DOI 10.1007/s10038-004-0131-x; TAJIMA F, 1989, GENETICS, V123, P585; Tan SJ, 2007, ANN HUM BIOL, V34, P573, DOI 10.1080/03014460701492237; Tanaka M, 2004, GENOME RES, V14, P1832, DOI 10.1101/gr.2286304; TORRONI A, 1994, AM J PHYS ANTHROPOL, V93, P189, DOI 10.1002/ajpa.1330930204; Trivedi R, 2006, J HUM GENET, V51, P217, DOI 10.1007/s10038-005-0349-2; Tsai LC, 2001, FORENSIC SCI INT, V119, P239, DOI 10.1016/S0379-0738(00)00439-4; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Wang C.-C., 2014, COMP Y CHROMOSOMAL L; Wang CC, 2013, J SYST EVOL, V51, P280, DOI 10.1111/j.1759-6831.2012.00244.x; Wang Chuan-Chao, 2013, Investig Genet, V4, P11, DOI 10.1186/2041-2223-4-11; Wang D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038848; WANG William S-Y, 1998, BRONZE AGE EARLY IRO, V1, P508; Wei L, 2008, COM C A, V2, pe11; Wei W, 2013, FORENSIC SCI INT-GEN, V7, P568, DOI 10.1016/j.fsigen.2013.03.014; Wen B, 2004, NATURE, V431, P302, DOI 10.1038/nature02878; Wen B, 2004, AM J HUM GENET, V74, P856, DOI 10.1086/386292; Wen B, 2005, MOL BIOL EVOL, V22, P725, DOI 10.1093/molbev/msi055; Wilson IJ, 2003, J R STAT SOC A STAT, V166, P155, DOI 10.1111/1467-985X.00264; Wong Hang Yee, 2007, Legal Medicine, V9, P33, DOI 10.1016/j.legalmed.2006.08.007; Xue YL, 2006, GENETICS, V172, P2431, DOI 10.1534/genetics.105.054270; Yan S, 2011, EUR J HUM GENET, V19, P1013, DOI 10.1038/ejhg.2011.64; Yang K, 2011, J HUM GENET, V56, P253, DOI 10.1038/jhg.2010.165; Yao YG, 2002, AM J HUM GENET, V70, P635, DOI 10.1086/338999; Yuan BY, 2007, CHINESE SCI BULL, V52, P2675, DOI 10.1007/s11434-007-0357-z; Zerjal T, 2003, AM J HUM GENET, V72, P717, DOI 10.1086/367774; Zhang DD, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL013749; Zhao M, 2009, P NATL ACAD SCI USA, V106, P21230, DOI 10.1073/pnas.0907844106; Zhivotovsky LA, 2004, AM J HUM GENET, V74, P50, DOI 10.1086/380911; Zhong H, 2011, MOL BIOL EVOL, V28, P717, DOI 10.1093/molbev/msq247; Zhong H, 2010, J HUM GENET, V55, P428, DOI 10.1038/jhg.2010.40; Zimmermann B, 2009, INT J LEGAL MED, V123, P495, DOI 10.1007/s00414-009-0373-4	102	31	35	5	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103772	10.1371/journal.pone.0103772	http://dx.doi.org/10.1371/journal.pone.0103772			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	AM4GX	25090432	Green Published, gold, Green Submitted			2022-12-27	WOS:000339812700052
J	Reavie, ED; Heathcote, AJ; Chraibi, VLS				Reavie, Euan D.; Heathcote, Adam J.; Chraibi, Victoria L. Shaw			Laurentian Great Lakes Phytoplankton and Their Water Quality Characteristics, Including a Diatom-Based Model for Paleoreconstruction of Phosphorus	PLOS ONE			English	Article							INDICATORS; TRENDS; ERIE; EUTROPHICATION; PROGRAM; HISTORY	Recent shifts in water quality and food web characteristics driven by anthropogenic impacts on the Laurentian Great Lakes warranted an examination of pelagic primary producers as tracers of environmental change. The distributions of the 263 common phytoplankton taxa were related to water quality variables to determine taxon-specific responses that may be useful in indicator models. A detailed checklist of taxa and their environmental optima are provided. Multivariate analyses indicated a strong relationship between total phosphorus (TP) and patterns in the diatom assemblages across the Great Lakes. Of the 118 common diatom taxa, 90 (76%) had a directional response along the TP gradient. We further evaluated a diatom-based transfer function for TP based on the weighted-average abundance of taxa, assuming unimodal distributions along the TP gradient. The r(2) between observed and inferred TP in the training dataset was 0.79. Substantial spatial and environmental autocorrelation within the training set of samples justified the need for further model validation. A randomization procedure indicated that the actual transfer function consistently performed better than functions based on reshuffled environmental data. Further, TP was minimally confounded by other environmental variables, as indicated by the relatively large amount of unique variance in the diatoms explained by TP. We demonstrated the effectiveness of the transfer function by hindcasting TP concentrations using fossil diatom assemblages in a Lake Superior sediment core. Passive, multivariate analysis of the fossil samples against the training set indicated that phosphorus was a strong determinant of historical diatom assemblages, verifying that the transfer function was suited to reconstruct past TP in Lake Superior. Collectively, these results showed that phytoplankton coefficients for water quality can be robust indicators of Great Lakes pelagic condition. The diatom-based transfer function can be used in lake management when retrospective data are needed for tracking long-term degradation, remediation and trajectories.	[Reavie, Euan D.] Univ Minnesota, Nat Resources Res Inst, Ctr Water & Environm, Duluth, MN 55811 USA; [Heathcote, Adam J.] Univ Quebec, Dept Sci Biol, Grp Rech Interuniv Limnol, Montreal, PQ H3C 3P8, Canada; [Chraibi, Victoria L. Shaw] Univ Nebraska, Dept Earth & Atmospher Sci, Lincoln, NE USA	University of Minnesota System; University of Minnesota Duluth; University of Quebec; University of Quebec Montreal; University of Nebraska System; University of Nebraska Lincoln	Reavie, ED (corresponding author), Univ Minnesota, Nat Resources Res Inst, Ctr Water & Environm, Duluth, MN 55811 USA.	ereavie@d.umn.edu	Heathcote, Adam J./I-9253-2019	Heathcote, Adam J./0000-0002-9633-9548; Reavie, Euan/0000-0001-8871-5809	U.S. Environmental Protection Agency [GL-00E23101, GL-00E00790-2]; Minnesota Sea Grant College Program; NOAA office of Sea Grant, United States Department of Commerce [R/CC-01-10]	U.S. Environmental Protection Agency(United States Environmental Protection Agency); Minnesota Sea Grant College Program; NOAA office of Sea Grant, United States Department of Commerce(National Oceanic Atmospheric Admin (NOAA) - USA)	This research was largely supported by grants to E. Reavie from the U.S. Environmental Protection Agency under Cooperative Agreements GL-00E23101 and GL-00E00790-2. This document has not been subjected to the Agency's required peer and policy review and therefore does not necessarily reflect the view of the Agency, and no official endorsement should be inferred. Sedimentary assemblages from Lake Superior were collected and assessed under research sponsored by the Minnesota Sea Grant College Program supported by the NOAA office of Sea Grant, United States Department of Commerce, under grant No. R/CC-01-10. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allinger LE, 2013, J GREAT LAKES RES, V39, P365, DOI 10.1016/j.jglr.2013.06.014; Barbiero RP, 2011, J GREAT LAKES RES, V37, P9, DOI 10.1016/j.jglr.2010.11.009; Barbiero RP, 2001, J GREAT LAKES RES, V27, P134, DOI 10.1016/S0380-1330(01)70628-4; Barbiero RP, 2000, VERH INT VEREIN LIMN, V27, P1788; Battarbee R. W., 2001, TRACKING ENV CHANGE, P155, DOI DOI 10.1007/0-306-47668-1_8; Bennion H, 1996, ENVIRON SCI TECHNOL, V30, P2004, DOI 10.1021/es9508030; Brazner JC, 2007, ECOL INDIC, V7, P610, DOI 10.1016/j.ecolind.2006.07.001; Chapra SC, 2012, J GREAT LAKES RES, V38, P550, DOI 10.1016/j.jglr.2012.06.010; CHARLES D F, 1990, Journal of Paleolimnology, V3, P175, DOI 10.1007/BF00414071; DIXIT SS, 1992, ENVIRON SCI TECHNOL, V26, P22, DOI 10.1021/es00025a002; DIXIT SS, 1994, ENVIRON MONIT ASSESS, V31, P275, DOI 10.1007/BF00577258; EFRON B, 1983, AM STAT, V37, P36, DOI 10.2307/2685844; Gauch Jr HG, 1982, MULTIVARIATE ANAL CO; Hastie T, 2019, GEN ADDITIVE MODELS; Holt E. A., 2011, NATURE ED KNOWLEDGE, V3, P8; Imbrie J, 1971, DEV MAR GEOL, V1, P523; Juggins S., 2012, RIOJA ANAL QUATERNAR, P7; Juggins S, 2013, J PALEOLIMNOL, V49, P373, DOI 10.1007/s10933-013-9678-x; Juggins Steve, 2012, P431; KELLY MG, 1995, J APPL PHYCOL, V7, P433, DOI 10.1007/BF00003802; Last WM, 2001, TRACKING ENV CHANGE, V3; LEAN DRS, 1983, J GREAT LAKES RES, V9, P83, DOI 10.1016/S0380-1330(83)71875-7; Line J. M., 1994, Journal of Paleolimnology, V10, P147, DOI 10.1007/BF00682511; MCCORMICK PV, 1994, J APPL PHYCOL, V6, P509, DOI 10.1007/BF02182405; Merilainen JJ, 2003, J PALEOLIMNOL, V30, P387, DOI 10.1023/B:JOPL.0000007229.46166.59; Michalak AM, 2013, P NATL ACAD SCI USA, V110, P6448, DOI 10.1073/pnas.1216006110; Millie DF, 2009, AQUAT ECOL, V43, P915, DOI 10.1007/s10452-009-9238-7; MUNAWAR M, 1982, CAN J BOT, V60, P1837, DOI 10.1139/b82-231; Oksanen J., 2020, VEGAN COMMUNITY ECOL; OVERPECK JT, 1985, QUATERNARY RES, V23, P87, DOI 10.1016/0033-5894(85)90074-2; Pebesma EJ, 2004, COMPUT GEOSCI-UK, V30, P683, DOI 10.1016/j.cageo.2004.03.012; R Core Team, 2021, R LANGUAGE ENV STAT; Ramstack JM, 2003, J PALEOLIMNOL, V29, P79, DOI 10.1023/A:1022869205291; Reavie ED, 2005, CAN J FISH AQUAT SCI, V62, P2586, DOI 10.1139/F05-170; Reavie ED, 2014, J GREAT LAK IN PRESS; Reavie ED, 2006, J GREAT LAKES RES, V32, P321, DOI 10.3394/0380-1330(2006)32[321:DWTFFG]2.0.CO;2; Reavie ED, 2011, AQUAT ECOL, V45, P529, DOI 10.1007/s10452-011-9373-9; Shaw Chraibi VL, 2014, J GREAT LAK IN PRESS; Shaw Chraibi VL, 2013, THESIS U MINNESOTA D; Siver PA, 2003, J PALEOLIMNOL, V29, P179, DOI 10.1023/A:1023246321517; Smol J. P., 2002, POLLUTION LAKES RIVE; STOERMER EF, 1978, T AM MICROSC SOC, V97, P2, DOI 10.2307/3225680; STOERMER EF, 1985, P ACAD NAT SCI PHILA, V137, P106; Szczepocka E, 2009, OCEANOL HYDROBIOL ST, V38, P17, DOI 10.2478/v10009-009-0012-x; Telford RJ, 2009, QUATERNARY SCI REV, V28, P1309, DOI 10.1016/j.quascirev.2008.12.020; Telford RJ, 2013, PALAEOSIG SIGNIFICAN; Tibby J, 2004, J PALEOLIMNOL, V31, P23, DOI 10.1023/B:JOPL.0000013272.25122.2a; U.S. Environmental Protection Agency, 2010, 905R05001 US EPA GRE; Uthermol H., 1958, MITTEILINGEN INTERNA, V9, P1, DOI [10.1080/0 5384680.1958.11904091, DOI 10.1080/05384680.1958.11904091]; Vanderploeg HA, 2012, J GREAT LAKES RES, V38, P336, DOI 10.1016/j.jglr.2012.02.005; Wood SN, 2006, GEN ADDITIVE MODELS; YEE TW, 1991, J VEG SCI, V2, P587, DOI 10.2307/3236170	52	34	35	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2014	9	8							e104705	10.1371/journal.pone.0104705	http://dx.doi.org/10.1371/journal.pone.0104705			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR0CG	25105416	Green Published, gold			2022-12-27	WOS:000343231900083
J	Zhang, D; Liu, J; Gao, JF; Shahzad, M; Han, ZQ; Wang, Z; Li, JK; Sjolinder, H				Zhang, Ding; Liu, Jingying; Gao, Jianfeng; Shahzad, Muhammad; Han, Zhaoqing; Wang, Zhi; Li, Jiakui; Sjolinder, Hong			Zinc Supplementation Protects against Cadmium Accumulation and Cytotoxicity in Madin-Darby Bovine Kidney Cells	PLOS ONE			English	Article							OXYGEN SPECIES ROS; REACTIVE OXYGEN; GLUTATHIONE METABOLISM; INDUCED APOPTOSIS; METAL TOXICITY; MESSENGER-RNA; METALLOTHIONEIN; EXPOSURE; HEPATOTOXICITY; TRANSCRIPTION	Cadmium ions (Cd2+) have been reported to accumulate in bovine tissues, although Cd2+ cytotoxicity has not been investigated thoroughly in this species. Zinc ions (Zn2+) have been shown to antagonize the toxic effects of heavy metals such as Cd2+ in some systems. The present study investigated Cd2+ cytotoxicity in Madin-Darby bovine kidney (MDBK) epithelial cells, and explored whether this was modified by Zn2+. Exposure to Cd2+ led to a dose-and time-dependent increase in apoptotic cell death, with increased intracellular levels of reactive oxygen species and mitochondrial damage. Zn2+ supplementation alleviated Cd2+-induced cytotoxicity and this protective effect was more obvious when cells were exposed to a lower concentration of Cd2+ (10 mu M), as compared to 50 mu M Cd2+. This indicated that high levels of Cd2+ accumulation might induce irreversible damage in bovine kidney cells. Metallothioneins (MTs) are metal-binding proteins that play an essential role in heavy metal ion detoxification. We found that co-exposure to Zn2+ and Cd2+ synergistically enhanced RNA and protein expression of MT-1, MT-2, and the metal-regulatory transcription factor 1 in MDBK cells. Notably, addition of Zn2+ reduced the amounts of cytosolic Cd2+ detected following MDBK exposure to 10 mu M Cd2+. These findings revealed a protective role of Zn2+ in counteracting Cd2+ uptake and toxicity in MDBK cells, indicating that this approach may provide a means to protect livestock from excessive Cd2+ accumulation.	[Zhang, Ding; Liu, Jingying; Gao, Jianfeng; Shahzad, Muhammad; Han, Zhaoqing; Wang, Zhi; Li, Jiakui] Huazhong Agr Univ, Coll Vet Med, Wuhan, Peoples R China; [Sjolinder, Hong] Stockholm Univ, Dept Mol Biosci, Wenner Gren Inst, S-10691 Stockholm, Sweden	Huazhong Agricultural University; Stockholm University	Li, JK (corresponding author), Huazhong Agr Univ, Coll Vet Med, Wuhan, Peoples R China.	lijk210@sina.com	Li, Jiakui/HDN-1674-2022	Li, Jiakui/0000-0002-6065-6648	Fundamental Research Funds for the Central Universities, Huazhong Agricultural University Scientific & Technological Self-innovation Foundation; Chinese Agricultural Research Systems [CARS-38]	Fundamental Research Funds for the Central Universities, Huazhong Agricultural University Scientific & Technological Self-innovation Foundation; Chinese Agricultural Research Systems	This study was supported by the Fundamental Research Funds for the Central Universities, Huazhong Agricultural University Scientific & Technological Self-innovation Foundation, and the Chinese Agricultural Research Systems (CARS-38). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiba I, 2008, MOL PHARMACOL, V74, P823, DOI 10.1124/mol.108.046862; Aimola P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033647; Belyaeva EA, 2008, TOXICOL APPL PHARM, V231, P34, DOI 10.1016/j.taap.2008.03.017; Bernhoft RA., 2013, THESCIENTIFICWORLDJO, V2013; Bhattacharyya MH, 2009, TOXICOL APPL PHARM, V238, P258, DOI 10.1016/j.taap.2009.05.015; Bishop GM, 2007, FREE RADICAL BIO MED, V42, P1222, DOI 10.1016/j.freeradbiomed.2007.01.022; Campagne MV, 2000, J NEUROSCI, V20, P5200, DOI 10.1523/JNEUROSCI.20-14-05200.2000; Cheuk WK, 2008, AQUAT TOXICOL, V89, P103, DOI 10.1016/j.aquatox.2008.06.006; Duprez J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046831; Formigare A, 2007, COMP BIOCHEM PHYS C, V146, P443, DOI 10.1016/j.cbpc.2007.07.010; Herrera B, 2001, FASEB J, V15, P741, DOI 10.1096/fj.00-0267com; Homma K, 2013, MOL CELL, V52, P75, DOI 10.1016/j.molcel.2013.08.038; Jozefczak M, 2012, INT J MOL SCI, V13, P3145, DOI 10.3390/ijms13033145; Kaur J, 2006, MOL CELL BIOCHEM, V283, P169, DOI 10.1007/s11010-006-2676-9; kesson A, 2009, TOXICOLOGY APPL PHAR, V238, P201; Kim J, 2006, J TOXICOL ENV HEAL A, V69, P1181, DOI 10.1080/15287390600631144; Klaassen CD, 2009, TOXICOL APPL PHARM, V238, P215, DOI 10.1016/j.taap.2009.03.026; Kondoh M, 2002, TOXICOLOGY, V170, P111, DOI 10.1016/S0300-483X(01)00536-4; Kowaltowski AJ, 2009, FREE RADICAL BIO MED, V47, P333, DOI 10.1016/j.freeradbiomed.2009.05.004; Lange A, 2002, COMP BIOCHEM PHYS C, V131, P231, DOI 10.1016/S1532-0456(02)00010-8; Lee WK, 2006, AM J PHYSIOL-RENAL, V291, pF823, DOI 10.1152/ajprenal.00276.2005; Lindert U, 2009, MOL CELL BIOL, V29, P6283, DOI 10.1128/MCB.00847-09; Omata Y, 2013, TOXICOL SCI, V133, P90, DOI 10.1093/toxsci/kft022; Peralta-Videa JR, 2009, INT J BIOCHEM CELL B, V41, P1665, DOI 10.1016/j.biocel.2009.03.005; Prozialeck WC, 2008, TOXICOL SCI, V102, P207, DOI 10.1093/toxsci/kfm263; Rogalska J, 2011, CHEM-BIOL INTERACT, V193, P191, DOI 10.1016/j.cbi.2011.05.008; Saydam N, 2002, J BIOL CHEM, V277, P20438, DOI 10.1074/jbc.M110631200; SEAGRAVE J, 1983, BIOCHEM PHARMACOL, V32, P3017, DOI 10.1016/0006-2952(83)90243-5; Shen CC, 2013, TOXICOL SCI, V136, P120, DOI 10.1093/toxsci/kft187; Sugawara T, 2002, FASEB J, V16, P1997, DOI 10.1096/fj.02-0251fje; Tang WF, 1998, TOXICOL APPL PHARM, V151, P276, DOI 10.1006/taap.1998.8465; Thevenod F, 2013, ARCH TOXICOL, V87, P1743, DOI 10.1007/s00204-013-1110-9; Vasak M, 2011, J BIOL INORG CHEM, V16, P1067, DOI 10.1007/s00775-011-0799-2; Xu S, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.7; Zasadowski A., 1999, Polish Journal of Environmental Studies, V8, P443	36	23	23	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2014	9	8							e103427	10.1371/journal.pone.0103427	http://dx.doi.org/10.1371/journal.pone.0103427			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR0CG	25105504	Green Submitted, Green Published, gold			2022-12-27	WOS:000343231900014
J	Zou, YC; Wang, GP; Grace, M; Lou, XN; Yu, XF; Lu, XG				Zou, Yuanchun; Wang, Guoping; Grace, Michael; Lou, Xiaonan; Yu, Xiaofei; Lu, Xianguo			Response of Two Dominant Boreal Freshwater Wetland Plants to Manipulated Warming and Altered Precipitation	PLOS ONE			English	Article							CLIMATE-CHANGE; TEMPERATURE; GROWTH; PHOTOSYNTHESIS; COMPETITION; DYNAMICS; CO2	This study characterized the morphological and photosynthetic responses of two wetland plant species when they were subject to 2-6 degrees C fluctuations in growth temperature and +/- 50% of precipitation, in order to predict the evolution of natural wetlands in Sanjiang Plain of North-eastern China. We investigated the morphological and photosynthetic responses of two dominant and competitive boreal freshwater wetland plants in Northeastern China to manipulation of warming (ambient, +2.0 degrees C, +4.0 degrees C, +6.0 degrees C) and altered precipitation (-50%, ambient, +50%) simultaneously by incubating the plants from seedling to senescence within climate-controlled environmental chambers. Post-harvest, secondary growth of C. angustifolia was observed to explore intergenerational effects. The results indicated that C. angustifolia demonstrated a greater acclimated capacity than G. spiculosa to respond to climate change due to higher resistance to temperature and precipitation manipulations. The accumulated effect on aboveground biomass of post-harvest secondary growth of C. angustifolia was significant. These results explain the expansion of C. angustifolia during last 40 years and indicate the further expansion in natural boreal wetlands under a warmer and wetter future. Stability of the natural surface water table is critical for the conservation and restoration of G. spiculosa populations reacting to encroachment stress from C. angustifolia expansion.	[Zou, Yuanchun; Wang, Guoping; Lou, Xiaonan; Yu, Xiaofei; Lu, Xianguo] Chinese Acad Sci, Key Lab Wetland Ecol & Environm, Northeast Inst Geog & Agroecol, Changchun, Peoples R China; [Grace, Michael] Monash Univ, Water Studies Ctr, Clayton, Vic, Australia; [Grace, Michael] Monash Univ, Sch Chem, Clayton, Vic, Australia	Chinese Academy of Sciences; Northeast Institute of Geography & Agroecology, CAS; Monash University; Monash University	Lu, XG (corresponding author), Chinese Acad Sci, Key Lab Wetland Ecol & Environm, Northeast Inst Geog & Agroecol, Changchun, Peoples R China.	luxg@iga.ac.cn	Zou, Yuanchun/B-6666-2008; Grace, Mike/AAE-3376-2021; Grace, Mike/AAE-3073-2022; Wang, Guoping/A-8140-2008	Zou, Yuanchun/0000-0003-1520-9678; Grace, Mike/0000-0002-0982-8133; Yu, Xiaofei/0000-0001-6623-0165; Wang, Guoping/0000-0002-8350-812X; lu, xian guo/0000-0001-7638-2787	National Basic Research Program of China [2010CB951301-2]; National Key Technology R D Program [2012BAC19B05]; National Natural Science Foundation of China [41271107, 41101195]	National Basic Research Program of China(National Basic Research Program of China); National Key Technology R D Program(National Key Technology R&D Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The research was supported by the National Basic Research Program of China (2010CB951301-2), the National Key Technology R & D Program (2012BAC19B05), and the National Natural Science Foundation of China (41271107, 41101195) in the study design, data collection and analysis and preparation of the manuscript.	Aerts R, 2012, OECOLOGIA, V170, P809, DOI 10.1007/s00442-012-2330-z; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; BARTLETT KB, 1993, CHEMOSPHERE, V26, P261, DOI 10.1016/0045-6535(93)90427-7; BERRY J, 1980, ANNU REV PLANT PHYS, V31, P491, DOI 10.1146/annurev.pp.31.060180.002423; Berry PM, 2002, GLOBAL ECOL BIOGEOGR, V11, P453, DOI 10.1111/j.1466-8238.2002.00304.x; Breeuwer A, 2008, OECOLOGIA, V156, P155, DOI 10.1007/s00442-008-0963-8; Bridgham SD, 1999, ECOL APPL, V9, P1345, DOI 10.1890/1051-0761(1999)009[1345:ECOTAE]2.0.CO;2; Brooker RW, 2006, NEW PHYTOL, V171, P271, DOI 10.1111/j.1469-8137.2006.01752.x; Charles H, 2009, ECOL APPL, V19, P1758, DOI 10.1890/08-0172.1; De Boeck HJ, 2008, BIOGEOSCIENCES, V5, P585, DOI 10.5194/bg-5-585-2008; Dise NB, 2009, SCIENCE, V326, P810, DOI 10.1126/science.1174268; Editorial Committee of Flora Republicae Popularis Sinicae, 2002, FLORA REPUBLICAE POP, V9, P327; Editorial Committee of Flora Republicae Popularis Sinicae, 1987, FLORA REPUBLICAE POP, V9, P221; Erwin KL, 2009, WETL ECOL MANAG, V17, P71, DOI 10.1007/s11273-008-9119-1; Essl F, 2012, BIODIVERS CONSERV, V21, P655, DOI 10.1007/s10531-011-0206-x; EVANS JR, 1989, OECOLOGIA, V78, P9, DOI 10.1007/BF00377192; FARQUHAR GD, 1982, ANNU REV PLANT PHYS, V33, P317, DOI 10.1146/annurev.pp.33.060182.001533; Fenner N, 2007, ENVIRON SCI TECHNOL, V41, P3146, DOI 10.1021/es061765v; Flanagan LB, 2011, GLOBAL CHANGE BIOL, V17, P2271, DOI 10.1111/j.1365-2486.2010.02378.x; Ge ZM, 2012, PHOTOSYNTHETICA, V50, P141, DOI 10.1007/s11099-012-0014-x; Gedan KB, 2010, OECOLOGIA, V164, P479, DOI 10.1007/s00442-010-1661-x; GORHAM E, 1991, ECOL APPL, V1, P182, DOI 10.2307/1941811; Gough L, 2012, OECOLOGIA, V169, P1053, DOI 10.1007/s00442-012-2264-5; Guo R, 2010, AGRON J, V102, P1252, DOI 10.2134/agronj2010.0022; He Q, 2013, ECOL LETT, V16, P695, DOI 10.1111/ele.12080; Hobbs RJ, 2009, TRENDS ECOL EVOL, V24, P599, DOI 10.1016/j.tree.2009.05.012; Hoeppner SS, 2012, GLOBAL CHANGE BIOL, V18, P1754, DOI 10.1111/j.1365-2486.2011.02626.x; Kardol P, 2010, ECOLOGY, V91, P767, DOI 10.1890/09-0135.1; Liancourt P, 2013, ECOLOGY, V94, P444, DOI 10.1890/12-0780.1; Lin DL, 2010, NEW PHYTOL, V188, P187, DOI 10.1111/j.1469-8137.2010.03347.x; Lou YJ, 2008, SPECIES BIODIVERSITY; Luo WB, 2009, HYDROBIOLOGIA, V624, P151, DOI 10.1007/s10750-008-9689-1; Mae T, 1997, PLANT SOIL, V196, P201, DOI 10.1023/A:1004293706242; Pastor J, 2002, AM NAT, V160, P553, DOI 10.1086/342814; Porra RJ, 2002, PHOTOSYNTH RES, V73, P149, DOI 10.1023/A:1020470224740; Qiu ZC, 2011, HYDROBIOLOGIA, V661, P251, DOI 10.1007/s10750-010-0530-2; [任国玉 Ren Guoyu], 2005, [气象学报, Acta Meteorologica Sinica], V63, P942; Rustad LE, 2001, OECOLOGIA, V126, P543, DOI 10.1007/s004420000544; Thompson RM, 2013, ECOL LETT, V16, P799, DOI 10.1111/ele.12095; Van Minnen JG, 2002, ENVIRON SCI POLICY, V5, P335, DOI DOI 10.1016/S1462-9011(02)00044-8; Weltzin JF, 2003, GLOBAL CHANGE BIOL, V9, P141, DOI 10.1046/j.1365-2486.2003.00571.x; Weltzin JF, 2000, ECOLOGY, V81, P3464, DOI 10.1890/0012-9658(2000)081[3464:ROBAFP]2.0.CO;2; WILSON SD, 1993, ECOLOGY, V74, P599, DOI 10.2307/1939319; Yin XM, 2013, SIMULATION STUDY CLI; Zou YC, 2011, GEODERMA, V164, P238, DOI 10.1016/j.geoderma.2011.06.017	45	5	6	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2014	9	8							e104454	10.1371/journal.pone.0104454	http://dx.doi.org/10.1371/journal.pone.0104454			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR0CG	25105764	Green Submitted, Green Published, gold			2022-12-27	WOS:000343231900058
J	Guo, N; Zhu, MX; Han, XJ; Sui, D; Wang, Y; Yang, Q				Guo, Na; Zhu, Meixuan; Han, Xuejiao; Sui, Dan; Wang, Yang; Yang, Qian			The Metabolism of Salidroside to Its Aglycone p-Tyrosol in Rats following the Administration of Salidroside	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; N-TYROSOL; IN-VIVO; GASTROINTESTINAL-TRACT; TISSUE DISTRIBUTION; DIETARY FLAVONOIDS; SMALL-INTESTINE; GLYCOSIDES; PLASMA; DEGLYCOSYLATION	Salidroside is one of the major phenolic glycosides in Rhodiola, which has been reported to possess various biological activities. In the present study the in vivo deglycosylation metabolism of salidroside was investigated and its aglycone p-tyrosol but not the original salidroside was identified as the main form in rat tissues following the administration of salidroside. After the i.v. administration of salidroside at a dose of 50 mg/kg in rats, salidroside was quantified only in the liver, kidney and heart tissues. The highest level of p-tyrosol was detected in the heart, followed by the spleen, kidney, liver and lungs, in order. Salidroside was detected only in the liver, in contrast, p-tyrosol was detectable in most tissues except the brain, and the kidney tissues contained a significant amount of p-tyrosol compared to the other tissues after the i.g. administration of 100 mg/kg salidroside. The excretion behaviour revealed that the administrated salidroside mainly eliminated in the form of salidroside but not its aglycone metabolite p-tyrosol through urine. After i.v. and i.g. administration in rats, 64.00% and 23.80% of the total dose was excreted through urine in the form of salidroside, respectively. In addition, 0.19% and 2.25% of the dose was excreted in the form of p-tyrosol through urine after i.v. and i.g. administration, respectively. The faecal salidroside and p-tyrosol concentrations were 0.3% and 1.48% of the total dose after i.v. administration, respectively. After the i.g. administration of salidroside, trace salidroside and p-tyrosol were quantified in faeces within 72 h. In addition, the biliary excretion levels of salidroside after i.v. and i.g. administration were 2.86% and 0.02% of the dose, respectively. The obtained results show that salidroside was extensively metabolised to its aglycone p-tyrosol and distributed to various organs and the orginal salidroside was cleared rapidly through urine following the administration of salidroside.	[Guo, Na; Yang, Qian] Harbin Inst Technol, Sch Municipal & Environm Engn, Harbin 150006, Peoples R China; [Guo, Na; Zhu, Meixuan; Han, Xuejiao; Wang, Yang] Northeast Forestry Univ, Alkali Soil Nat Environm Sci Ctr, Key Lab Saline Alkali Vegetat Ecol Restorat Oil F, Minist Educ, Harbin, Peoples R China; [Yang, Qian] Harbin Inst Technol, Sch Life Sci & Technol, Harbin 150006, Peoples R China; [Sui, Dan] Northeast Forestry Univ, Management Off Lab & Equipment, Ctr Anal & Testing, Harbin, Peoples R China	Harbin Institute of Technology; Northeast Forestry University - China; Harbin Institute of Technology; Northeast Forestry University - China	Yang, Q (corresponding author), Harbin Inst Technol, Sch Municipal & Environm Engn, Harbin 150006, Peoples R China.	ywang@nefu.edu.cn; yangq@hit.edu.cn						Chang YW, 2007, J CHROMATOGR B, V857, P164, DOI 10.1016/j.jchromb.2007.06.029; Chao PDL, 2006, BIOAVAILABILITY META; Chen J, 2003, J PHARMACOL EXP THER, V304, P1228, DOI 10.1124/jpet.102.046409; Chernyshova GA, 2007, B EXP BIOL MED+, V143, P689, DOI 10.1007/s10517-007-0215-7; Day AJ, 2000, FEBS LETT, V468, P166, DOI 10.1016/S0014-5793(00)01211-4; Day AJ, 1998, FEBS LETT, V436, P71, DOI 10.1016/S0014-5793(98)01101-6; Day AJ, 2001, BRIT J NUTR, V86, pS105, DOI 10.1079/BJN2001342; Di Benedetto R, 2007, NUTR METAB CARDIOVAS, V17, P535, DOI 10.1016/j.numecd.2006.03.005; Giovannini C, 1999, J NUTR, V129, P1269, DOI 10.1093/jn/129.7.1269; Guo N, 2012, MOLECULES, V17, P4733, DOI 10.3390/molecules17044733; ICH, 1995, FED REGISTER, V60, P11274; Jin Z, 2009, CHINA SURFACTANT DET, V39, P402; Kanupriya D, 2005, MOL CELL BIOCHEM, V275, P1, DOI 10.1007/s11010-005-7637-1; Li M., 2008, J MED COLL PLA, V23, P88, DOI [DOI 10.1016/S1000-1948(08)60028-3, 10.1016/s1000-1948(08)60028-3]; Liu Z, 2002, CHINESE CEREALS OILS, V17, P24; Manjunath K, 2005, J CONTROL RELEASE, V107, P215, DOI 10.1016/j.jconrel.2005.06.006; Nemeth K, 2003, EUR J NUTR, V42, P29, DOI 10.1007/s00394-003-0397-3; Plotnikov MB, 2007, B EXP BIOL MED+, V143, P61, DOI 10.1007/s10517-007-0017-y; Samuel SM, 2008, J AGR FOOD CHEM, V56, P9692, DOI 10.1021/jf802050h; Spencer JPE, 2008, BRIT J NUTR, V99, P12, DOI 10.1017/S0007114507798938; Spencer JPE, 2003, J NUTR, V133, p3255S, DOI 10.1093/jn/133.10.3255S; Spencer JPE, 2001, ANTIOXID REDOX SIGN, V3, P1023, DOI 10.1089/152308601317203558; Spencer JPE, 1999, FEBS LETT, V458, P224, DOI 10.1016/S0014-5793(99)01160-6; Tezuka Y, 1999, PHYTOMEDICINE, V6, P197, DOI 10.1016/S0944-7113(99)80009-9; Vivancos M, 2008, BRIT J NUTR, V99, P1199, DOI 10.1017/S0007114507876203; Wang DG, 2008, PHYTOMEDICINE, V15, P859, DOI 10.1016/j.phymed.2008.02.009; Wang HB, 2009, PHYTOMEDICINE, V16, P146, DOI 10.1016/j.phymed.2008.07.013; Williamson G, 2000, BIOCHEM SOC T, V28, P16, DOI 10.1042/bst0280016; Yang XJ, 2011, J CHROMATOGR B, V879, P2513, DOI 10.1016/j.jchromb.2011.07.002; YE YC, 1993, ACTA PHARM SINIC, V14, P424; Zhang JP, 2009, EUR J PHARMACOL, V607, P6, DOI 10.1016/j.ejphar.2009.01.046; Zheng W, 2001, J AGR FOOD CHEM, V49, P5165, DOI 10.1021/jf010697n	32	31	34	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e103648	10.1371/journal.pone.0103648	http://dx.doi.org/10.1371/journal.pone.0103648			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25101641	Green Published, Green Submitted, gold			2022-12-27	WOS:000339993900021
J	Hingsamer, P; Peeters, F; Hofmann, H				Hingsamer, Peter; Peeters, Frank; Hofmann, Hilmar			The Consequences of Internal Waves for Phytoplankton Focusing on the Distribution and Production of Planktothrix rubescens	PLOS ONE			English	Article							LAKE-AMMERSEE; VERTICAL-DISTRIBUTION; DEPTH; CYANOBACTERIA; DYNAMICS; PHOTOSYNTHESIS; ZOOPLANKTON; POPULATIONS; ABUNDANCE; TURNOVER	Consequences of internal wave motion for phytoplankton and in particular for the distribution and production of the harmful and buoyant cyanobacterium Planktothrix rubescens were investigated based on data from two field campaigns conducted in Lake Ammer during summer 2009 and 2011. In both years, P. rubescens dominated the phytoplankton community and formed a deep chlorophyll maximum (DCM) in the metalimnion. Internal wave motions caused vertical displacement of P. rubescens of up to 6 m and 10 m, respectively. Vertical displacements of isotherms and of isoconcentration lines of P. rubescens from the same depth range coincided, suggesting that P. rubescens did not or could not regulate its buoyancy to prevent wave-induced vertical displacements. Diatoms dominated the phytoplankton community in the epilimnion and were vertically separated from P. rubescens. The thickness of the diatom layer, but not the diatom concentrations within the layer, changed in phase with the changes in the thickness of the epilimnion caused by internal wave motions. Seiche induced vertical displacements of P. rubescens caused fluctuations in the light intensity available at the depth of the P. rubescens layer. The interplay between seiche induced vertical displacements of the P. rubescens layer and the daily cycle of incident light lead to differences in the daily mean available light intensity between lake ends by up to a factor of similar to 3. As a consequence, the daily mean specific oxygen production rate of P. rubescens differed by up to a factor of similar to 7 between lake ends. The horizontal differences in the specific oxygen production rate of P. rubescens were persistent over several days suggesting that the associated production of P. rubescens biomass may lead to phytoplankton patchiness. The effect of internal seiches on the spatial heterogeneity and the persistence of horizontal differences in production, however, depend on the timing and the synchronization between internal wave motion and the daily course of incident light intensity. Vertical displacements caused by internal waves could be distinguished from other factors influencing the distribution of P. rubescens (e. g. active buoyancy control, production, vertical mixing) by a temperature-based data transformation. This technique may be of general use for separating wave-induced transport from other processes (e. g. sedimentation, vertical mixing) that affect the distributions of dissolved substances and suspended particles.	[Hingsamer, Peter; Peeters, Frank; Hofmann, Hilmar] Univ Konstanz, Limnol Inst, Environm Phys Grp, Constance, Germany	University of Konstanz	Hingsamer, P (corresponding author), Univ Konstanz, Limnol Inst, Environm Phys Grp, Constance, Germany.	peter.hingsamer@uni-konstanz.de	Hofmann, Hilmar/G-8445-2011		German Research Foundation (DFG) [HO 4536/2-1]	German Research Foundation (DFG)(German Research Foundation (DFG))	This work was financially supported by the German Research Foundation (DFG) - grant HO 4536/2-1 (http://www.dfg.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beutler M, 2002, PHOTOSYNTH RES, V72, P39, DOI 10.1023/A:1016026607048; Bright DI, 2000, NEW PHYTOL, V146, P301, DOI 10.1046/j.1469-8137.2000.00640.x; Burgi H, 2002, HYDROBIOLOGIA, V469, P33, DOI 10.1023/A:1015575527280; Carraro E, 2012, HYDROBIOLOGIA, V698, P77, DOI 10.1007/s10750-012-1096-y; Cuypers Y, 2011, ISME J, V5, P580, DOI 10.1038/ismej.2010.154; da Silva JCB, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL013888; de Figueiredo DR, 2004, ECOTOX ENVIRON SAFE, V59, P151, DOI 10.1016/j.ecoenv.2004.04.006; Dokulil MT, 2012, HYDROBIOLOGIA, V698, P29, DOI 10.1007/s10750-012-1020-5; Ernst B, 2001, ENVIRON TOXICOL, V16, P483, DOI 10.1002/tox.10006.abs; Ernst B, 2009, HARMFUL ALGAE, V8, P329, DOI 10.1016/j.hal.2008.07.006; Evans MA, 2008, LIMNOL OCEANOGR, V53, P339, DOI 10.4319/lo.2008.53.1.0339; Franks PJS, 1997, ICES J MAR SCI, V54, P161, DOI 10.1006/jmsc.1996.0191; GAEDKE U, 1991, J PLANKTON RES, V13, P743, DOI 10.1093/plankt/13.4.743; Garneau ME, 2013, LIMNOL OCEANOGR, V58, P1892, DOI 10.4319/lo.2013.58.5.1892; Halstvedt CB, 2008, J PLANKTON RES, V30, P607, DOI 10.1093/plankt/fbn025; Halstvedt CB, 2007, J PLANKTON RES, V29, P471, DOI 10.1093/plankt/fbm036; Hofmann H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080913; Hossain MY, 2012, SAINS MALAYS, V41, P277; Huber AMR, 2011, LIMNOL OCEANOGR, V56, P695, DOI 10.4319/lo.2011.56.2.0695; Jacquet S, 2005, HARMFUL ALGAE, V4, P651, DOI 10.1016/j.hal.2003.12.006; Kaartvedt S, 2012, MAR ECOL PROG SER, V452, P1, DOI 10.3354/meps09688; Klausmeier CA, 2001, LIMNOL OCEANOGR, V46, P1998, DOI 10.4319/lo.2001.46.8.1998; Legnani Elena, 2005, Journal of Limnology, V64, P61; Lenard T, 2009, OCEANOL HYDROBIOL ST, V38, P45; MacIntyre S, 2001, HYDROBIOLOGIA, V466, P13, DOI 10.1023/A:1014563914112; McManus MA, 2012, J EXP BIOL, V215, P1008, DOI 10.1242/jeb.059014; MORTIMER CH, 1952, PHILOS T ROY SOC B, V236, P355, DOI 10.1098/rstb.1952.0005; Nixdorf B., 2004, DOKUMENTATION ZUSTAN; Paerl HW, 2009, ENV MICROBIOL REP, V1, P27, DOI 10.1111/j.1758-2229.2008.00004.x; Pannard A, 2011, LIMNOL OCEANOGR FLUI, V1, P91, DOI [DOI 10.1215/21573698-1303296, 10.1215/21573698-1303296]; Pannard A, 2008, CAN J FISH AQUAT SCI, V65, P47, DOI 10.1139/F07-149; PINELALLOUL B, 1995, HYDROBIOLOGIA, V300, P17; Posch T, 2012, NAT CLIM CHANGE, V2, P809, DOI [10.1038/nclimate1581, 10.1038/NCLIMATE1581]; Preusse M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041674; Rinke K, 2007, FRESHWATER BIOL, V52, P137, DOI 10.1111/j.1365-2427.2006.01687.x; Suda S, 2002, INT J SYST EVOL MICR, V52, P1577, DOI [10.1099/ijs.0.01834-0, 10.1099/00207713-52-5-1577]; Tsubo M, 2005, THEOR APPL CLIMATOL, V80, P17, DOI 10.1007/s00704-004-0080-5; Vetter M, 2012, FUND APPL LIMNOL, V180, P41, DOI 10.1127/1863-9135/2012/0123; WALSBY AE, 1994, MICROBIOL REV, V58, P94, DOI 10.1128/MMBR.58.1.94-144.1994; Walsby AE, 1998, J PLANKTON RES, V20, P1357, DOI 10.1093/plankt/20.7.1357; Walsby AE, 2004, NEW PHYTOL, V162, P133, DOI 10.1111/j.1469-8137.2004.01020.x; Walsby AE, 2001, AQUAT SCI, V63, P326, DOI 10.1007/PL00001358; Wetzel R.G., 2001, LIMNOLOGY LAKE RIVER, DOI DOI 10.1046/J.1529-8817.2001.37602.X	43	14	16	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e104359	10.1371/journal.pone.0104359	http://dx.doi.org/10.1371/journal.pone.0104359			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25102279	Green Published, gold, Green Submitted			2022-12-27	WOS:000339993900060
J	Lee, SJ; Shin, SJ; Lee, MH; Lee, MG; Kang, TH; Park, WS; Soh, BY; Park, JH; Shin, YK; Kim, HW; Yun, CH; Jung, ID; Park, YM				Lee, Seung Jun; Shin, Sung Jae; Lee, Moon Hee; Lee, Min-Goo; Kang, Tae Heung; Park, Won Sun; Soh, Byoung Yul; Park, Jung Hee; Shin, Yong Kyoo; Kim, Han Wool; Yun, Cheol-Heui; Jung, In Duk; Park, Yeong-Min			A Potential Protein Adjuvant Derived from Mycobacterium tuberculosis Rv0652 Enhances Dendritic Cells-Based Tumor Immunotherapy	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; CANCER-IMMUNOTHERAPY; CARCINOMA-CELLS; MELANOMA PATIENTS; IMMUNE-RESPONSES; INNATE IMMUNITY; T-CELLS; FUSIONS; ANTIGEN; MICE	A key factor in dendritic cell (DC)-based tumor immunotherapy is the identification of an immunoadjuvant capable of inducing DC maturation to enhance cellular immunity. The efficacy of a 50S ribosomal protein L7/L12 (rplL) from Mycobacterium tuberculosis Rv0652, as an immunoadjuvant for DC-based tumor immunotherapy, and its capacity for inducing DC maturation was investigated. In this study, we showed that Rv0652 is recognized by Toll-like receptor 4 (TLR4) to induce DC maturation, and pro-inflammatory cytokine production (TNF-alpha, IL-1beta, and IL-6) that is partially modulated by both MyD88 and TRIF signaling pathways. Rv0652-activated DCs could activate naive T cells, effectively polarize CD4(+) and CD8(+) T cells to secrete IFN-gamma, and induce T cell-mediated-cytotoxicity. Immunization of mice with Rv0652-stimulated ovalbumin (OVA)-pulsed DCs resulted in induction of a potent OVA-specific CD8(+) T cell response, slowed tumor growth, and promoted long-term survival in a murine OVA-expressing E. G7 thymoma model. These findings suggest that Rv0652 enhances the polarization of T effector cells toward a Th1 phenotype through DC maturation, and that Rv0652 may be an effective adjuvant for enhancing the therapeutic response to DC-based tumor immunotherapy.	[Lee, Seung Jun; Lee, Moon Hee; Kang, Tae Heung; Jung, In Duk; Park, Yeong-Min] Konkuk Univ, Sch Med, Dept Immunol, Lab Dendrit Cell Differentiat & Regulat, Chungju, South Korea; [Shin, Sung Jae] Yonsei Univ, Coll Med, Inst Immunol & Immunol Dis, Dept Microbiol,Brain Korea PLUS Project Med Sci 2, Seoul, South Korea; [Lee, Min-Goo] Korea Univ, Coll Med, Dept Physiol, Seoul 136705, South Korea; [Park, Won Sun] Kangwon Natl Univ, Sch Med, Dept Physiol, Chunchon, South Korea; [Soh, Byoung Yul] Seonam Univ, Coll Med, Dept Biochem, Namwon, Jeonbuk, South Korea; [Park, Jung Hee] Chonbuk Natl Univ, Coll Environm & Bioresources Sci, Adv Inst Environm & Biosci, Div Biotechnol, Iksan, South Korea; [Shin, Yong Kyoo] Chung Ang Univ, Coll Med, Dept Pharmacol, Seoul 156756, South Korea; [Kim, Han Wool; Yun, Cheol-Heui] Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea; [Kim, Han Wool; Yun, Cheol-Heui] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul, South Korea	Konkuk University; Konkuk University Medical Center; Yonsei University; Yonsei University Health System; Korea University; Korea University Medicine (KU Medicine); Kangwon National University; Seonam University; Jeonbuk National University; Chung Ang University; Chung Ang University Hospital; Seoul National University (SNU); Seoul National University (SNU)	Jung, ID (corresponding author), Konkuk Univ, Sch Med, Dept Immunol, Lab Dendrit Cell Differentiat & Regulat, Chungju, South Korea.	jungid@kku.ac.kr; immun3023@kku.ac.kr	LEE, Seung Jun/G-4846-2018; Lee, Moon Hee/K-8526-2014; YUN, Cheol-Heui/AAR-2775-2020	YUN, Cheol-Heui/0000-0002-0041-2887; Shin, Sung Jae/0000-0003-0854-4582	National Research Foundation of Korea (NRF) grant - Korean Government [NRF-2012R1A2A1A03008433, NRF-2012R1A1A4A01007325, NRF-2011-0028573]; National R&D Program for Cancer Control, Ministry for Health and Welfare, Republic of Korea [1120390]	National Research Foundation of Korea (NRF) grant - Korean Government; National R&D Program for Cancer Control, Ministry for Health and Welfare, Republic of Korea	This study was supported by a National Research Foundation of Korea (NRF) grant funded by the Korean Government (NRF-2012R1A2A1A03008433, NRF-2012R1A1A4A01007325, and NRF-2011-0028573), a grant from the National R&D Program for Cancer Control, Ministry for Health and Welfare, Republic of Korea (1120390). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal S, 2003, J IMMUNOL, V171, P4984, DOI 10.4049/jimmunol.171.10.4984; Andersen MH, 2001, INT J CANCER, V94, P820, DOI 10.1002/ijc.1536; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Banchereau J, 2005, NAT REV IMMUNOL, V5, P296, DOI 10.1038/nri1592; Bansal K, 2010, J IMMUNOL, V184, P3495, DOI 10.4049/jimmunol.0903299; Beutler B, 2002, CURR TOP MICROBIOL, V270, P109; CARTER WA, 1985, J BIOL RESP MODIF, V4, P495; de Vries IJM, 2003, CLIN CANCER RES, V9, P5091; Gilboa E, 2007, J CLIN INVEST, V117, P1195, DOI 10.1172/JCI31205; Gnjatic S, 2010, CANCER J, V16, P382, DOI 10.1097/PPO.0b013e3181eaca65; Gong JL, 1997, NAT MED, V3, P558, DOI 10.1038/nm0597-558; Gong JL, 2000, J IMMUNOL, V165, P1705, DOI 10.4049/jimmunol.165.3.1705; Gong JL, 1998, P NATL ACAD SCI USA, V95, P6279, DOI 10.1073/pnas.95.11.6279; Gorden KB, 2005, J IMMUNOL, V174, P1259, DOI 10.4049/jimmunol.174.3.1259; Grange JM, 2008, VACCINE, V26, P4984, DOI 10.1016/j.vaccine.2008.06.092; Gunzer M, 2001, CRIT REV IMMUNOL, V21, P133; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Homma S, 2006, CLIN EXP IMMUNOL, V144, P41, DOI 10.1111/j.1365-2249.2006.03029.x; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Jung ID, 2011, CANCER RES, V71, P2858, DOI 10.1158/0008-5472.CAN-10-3487; Jung ID, 2009, J IMMUNOL, V182, P3146, DOI 10.4049/jimmunol.0803104; Kim K, 2012, IMMUNOLOGY, V136, P231, DOI 10.1111/j.1365-2567.2012.03575.x; Kitaura H, 1999, SCAND J IMMUNOL, V50, P580, DOI 10.1046/j.1365-3083.1999.00630.x; Koido S, 2005, INT J CANCER, V117, P587, DOI 10.1002/ijc.21184; Koido S, 2004, CLIN IMMUNOL, V113, P261, DOI 10.1016/j.clim.2004.08.004; Koido S, 2002, J IMMUNOL, V168, P2111, DOI 10.4049/jimmunol.168.5.2111; Liu YJ, 2001, CELL, V106, P259, DOI 10.1016/S0092-8674(01)00456-1; Matijevic T, 2010, CURR PHARM DESIGN, V16, P1081, DOI 10.2174/138161210790963779; Means TK, 2001, J IMMUNOL, V166, P4074, DOI 10.4049/jimmunol.166.6.4074; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Morefield GL, 2007, CLIN VACCINE IMMUNOL, V14, P1499, DOI 10.1128/CVI.00153-07; Moser M, 2000, NAT IMMUNOL, V1, P199, DOI 10.1038/79734; OHARA N, 1993, NUCLEIC ACIDS RES, V21, P3579, DOI 10.1093/nar/21.15.3579; Pecora ND, 2006, J IMMUNOL, V177, P422, DOI 10.4049/jimmunol.177.1.422; Peng GY, 2005, SCIENCE, V309, P1380, DOI 10.1126/science.1113401; Przetak M, 2003, VACCINE, V21, P961, DOI 10.1016/S0264-410X(02)00737-5; Schuler G, 2003, CURR OPIN IMMUNOL, V15, P138, DOI 10.1016/S0952-7915(03)00015-3; Sun SQ, 1998, J EXP MED, V187, P1145, DOI 10.1084/jem.187.7.1145; Visintin A, 2001, J IMMUNOL, V166, P249, DOI 10.4049/jimmunol.166.1.249; Wahl MC, 2002, CURR PROTEIN PEPT SC, V3, P93, DOI 10.2174/1389203023380756; Willimann K, 1998, EUR J IMMUNOL, V28, P2025, DOI 10.1002/(SICI)1521-4141(199806)28:06<2025::AID-IMMU2025>3.0.CO;2-C; Wilson DN, 2005, CRIT REV BIOCHEM MOL, V40, P243, DOI 10.1080/10409230500256523; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262	43	45	45	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e104351	10.1371/journal.pone.0104351	http://dx.doi.org/10.1371/journal.pone.0104351			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25102137	Green Published, Green Submitted, gold			2022-12-27	WOS:000339993900059
J	Mazor, T; Possingham, HP; Edelist, D; Brokovich, E; Kark, S				Mazor, Tessa; Possingham, Hugh P.; Edelist, Dori; Brokovich, Eran; Kark, Salit			The Crowded Sea: Incorporating Multiple Marine Activities in Conservation Plans Can Significantly Alter Spatial Priorities	PLOS ONE			English	Article							GREAT-BARRIER-REEF; USE MANAGEMENT; TRADE-OFFS; OIL-SPILL; ISRAEL; AREAS; BIODIVERSITY; RESERVES; SCALE; IMPLEMENTATION	Successful implementation of marine conservation plans is largely inhibited by inadequate consideration of the broader social and economic context within which conservation operates. Marine waters and their biodiversity are shared by a host of stakeholders, such as commercial fishers, recreational users and offshore developers. Hence, to improve implementation success of conservation plans, we must incorporate other marine activities while explicitly examining trade-offs that may be required. In this study, we test how the inclusion of multiple marine activities can shape conservation plans. We used the entire Mediterranean territorial waters of Israel as a case study to compare four planning scenarios with increasing levels of complexity, where additional zones, threats and activities were added (e.g., commercial fisheries, hydrocarbon exploration interests, aquaculture, and shipping lanes). We applied the marine zoning decision support tool Marxan to each planning scenario and tested a) the ability of each scenario to reach biodiversity targets, b) the change in opportunity cost and c) the alteration of spatial conservation priorities. We found that by including increasing numbers of marine activities and zones in the planning process, greater compromises are required to reach conservation objectives. Complex plans with more activities incurred greater opportunity cost and did not reach biodiversity targets as easily as simplified plans with less marine activities. We discovered that including hydrocarbon data in the planning process significantly alters spatial priorities. For the territorial waters of Israel we found that in order to protect at least 10% of the range of 166 marine biodiversity features there would be a loss of similar to 15% of annual commercial fishery revenue and similar to 5% of prospective hydrocarbon revenue. This case study follows an illustrated framework for adopting a transparent systematic process to balance biodiversity goals and economic considerations within a country's territorial waters.	[Mazor, Tessa; Possingham, Hugh P.; Kark, Salit] Univ Queensland, Sch Biol Sci, ARC Ctr Excellence Environm Decis, Brisbane, Qld, Australia; [Possingham, Hugh P.] Univ London Imperial Coll Sci Technol & Med, Grand Challenges Ecosyst & Environm, London, England; [Edelist, Dori] Univ Haifa, Leon Recanati Inst Maritime Studies, Dept Maritime Civilizat, IL-31999 Haifa, Israel; [Brokovich, Eran] Hebrew Univ Jerusalem, Dept Geog, Jerusalem, Israel	University of Queensland; Imperial College London; University of Haifa; Hebrew University of Jerusalem	Mazor, T (corresponding author), Univ Queensland, Sch Biol Sci, ARC Ctr Excellence Environm Decis, Brisbane, Qld, Australia.	t.mazor@uq.edu.au	Kark, Salit/I-7123-2013; POSSINGHAM, HUGH/R-8310-2019; edelist, dor/HGD-5614-2022; Kark, Salit/C-6795-2016; Possingham, Hugh/B-1337-2008; Mazor, Tessa/G-2017-2012	Kark, Salit/0000-0002-7183-3988; POSSINGHAM, HUGH/0000-0001-7755-996X; Kark, Salit/0000-0002-7183-3988; Possingham, Hugh/0000-0001-7755-996X; Mazor, Tessa/0000-0001-7307-5693	Australian Research Council Centre of Excellence for Environmental Decisions; Australian Postgraduate Award; Australian-Israel Scientific Exchange Foundation (AISEF); University of Queensland	Australian Research Council Centre of Excellence for Environmental Decisions(Australian Research Council); Australian Postgraduate Award(Australian Government); Australian-Israel Scientific Exchange Foundation (AISEF); University of Queensland(University of Queensland)	This research was conducted with the support of funding from the Australian Research Council Centre of Excellence for Environmental Decisions. T. M was a recipient of a University of Queensland Library OA Award, was funded by an Australian Postgraduate Award and gratefully acknowledges the financial support of the Australian-Israel Scientific Exchange Foundation (AISEF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agardy T, 2010, OCEAN ZONING MAKING, P207; Agostini VN, 2010, MARINE ZONING SAINT, P39; Amante C., 2009, NOAA TECHNICAL MEMOR, V1, P1, DOI 10.7289/V5C8276M; [Anonymous], 2009, IOC MARINE SPATIAL P; Ball I. R., 2009, SPATIAL CONSERVATION, P185, DOI DOI 10.1111/EVA.12631; Barr LM, 2013, MAR POLICY, V42, P39, DOI 10.1016/j.marpol.2013.01.012; Biggs D, 2011, CONSERV LETT, V4, P169, DOI 10.1111/j.1755-263X.2011.00170.x; Boyes SJ, 2007, MAR POLICY, V31, P287, DOI 10.1016/j.marpol.2006.08.005; Butt N, 2013, SCIENCE, V342, P425, DOI 10.1126/science.1237261; Cao WZ, 2007, ENVIRON INT, V33, P985, DOI 10.1016/j.envint.2007.04.009; Casale P, 2011, FISH FISH, V12, P299, DOI 10.1111/j.1467-2979.2010.00394.x; Clark MR, 2010, MAR ECOL-EVOL PERSP, V31, P200, DOI 10.1111/j.1439-0485.2010.00392.x; Davies AJ, 2007, BIOL CONSERV, V138, P299, DOI 10.1016/j.biocon.2007.05.011; Day JC, 2002, OCEAN COAST MANAGE, V45, P139, DOI 10.1016/S0964-5691(02)00052-2; DIAMANT A, 1986, J EXP MAR BIOL ECOL, V97, P269, DOI 10.1016/0022-0981(86)90245-5; Douvere F, 2008, MAR POLICY, V32, P762, DOI 10.1016/j.marpol.2008.03.021; Douvere F, 2009, J ENVIRON MANAGE, V90, P77, DOI 10.1016/j.jenvman.2008.07.004; DSEWPC, 2013, COMM MAR RES; Edelist D, 2013, THESIS U HAIFA HAIFA; Edelist D, 2013, ACTA ADRIAT, V54, P253; EIA, 2013, OV OIL NAT GAS E MED; ESRI, 2008, ARCMAP 9 3 GEOGR INF; European Commission, 2011, EXPL POT MAR SPAT PL; Fenberg PB, 2012, MAR POLICY, V36, P1012, DOI 10.1016/j.marpol.2012.02.021; Fernandes L, 2005, CONSERV BIOL, V19, P1733, DOI 10.1111/j.1523-1739.2005.00302.x; Foley MM, 2010, MAR POLICY, V34, P955, DOI 10.1016/j.marpol.2010.02.001; Game ET, 2014, CONSERV LETT, V7, P271, DOI 10.1111/conl.12050; Gesteira JLG, 2003, MAR POLLUT BULL, V46, P562, DOI 10.1016/S0025-326X(03)00034-1; Golani D, 2007, MAR BIOL RES, V3, P333, DOI 10.1080/17451000701635110; Goren M, 2001, MAR ECOL-P S Z N I, V22, P369, DOI 10.1046/j.1439-0485.2001.01750.x; Grantham HS, 2013, MAR POLICY, V38, P184, DOI 10.1016/j.marpol.2012.05.035; Halpern BS, 2013, P NATL ACAD SCI USA, V110, P6229, DOI 10.1073/pnas.1217689110; Halpern BS, 2004, ECOL APPL, V14, P1248, DOI 10.1890/03-5136; Hirsch PD, 2011, CONSERV BIOL, V25, P259, DOI 10.1111/j.1523-1739.2010.01608.x; Inger R, 2009, J APPL ECOL, V46, P1145, DOI 10.1111/j.1365-2664.2009.01697.x; IUCN, 2013, IUCN RED LIST THREAT; Kark S, 2009, P NATL ACAD SCI USA, V106, P15368, DOI 10.1073/pnas.0901001106; Klein CJ, 2010, FRONT ECOL ENVIRON, V8, P349, DOI 10.1890/090047; Knight AT, 2008, CONSERV BIOL, V22, P610, DOI 10.1111/j.1523-1739.2008.00914.x; Knight AT, 2007, CONSERV BIOL, V21, P1124, DOI 10.1111/j.1523-1739.2007.00690.x; Lee LH, 2013, MAR POLLUT BULL, V73, P291, DOI 10.1016/j.marpolbul.2013.05.006; Levin N, MARINE ECOL IN PRESS; Levit Y, 2012, THESIS TEL AVIV U TE; Lipsky G, 2012, THESIS TEL AVIV U TE; Makino A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078986; Mazor T, 2014, ECOL APPL, V24, P1115, DOI 10.1890/13-1249.1; McDonald RI, 2009, P NATL ACAD SCI USA, V106, P15101, DOI 10.1073/pnas.0908125106; Naidoo R, 2006, TRENDS ECOL EVOL, V21, P681, DOI 10.1016/j.tree.2006.10.003; NOAA, 2009, SETT NEW COURS SHIPP, P6; Norse EA, 2008, EBM PERSPECTIVE OCEA; Pressey RL, 2008, CONSERV BIOL, V22, P1340, DOI 10.1111/j.1523-1739.2008.01032.x; Pressey RL, 2007, TRENDS ECOL EVOL, V22, P583, DOI 10.1016/j.tree.2007.10.001; Redfern JV, 2013, CONSERV BIOL, V27, P292, DOI 10.1111/cobi.12029; Roberts CM, 2005, PHILOS T R SOC B, V360, P123, DOI 10.1098/rstb.2004.1578; Rooker JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076080; Scheinin A, 2010, THESIS U HAIFA HAIFA; Shaffer B, 2011, ENERG POLICY, V39, P5379, DOI 10.1016/j.enpol.2011.05.026; Sivas DA, 2008, STANFORD ENV LAW J, V27, P209; SPANIER E, 1989, J FISH BIOL, V35, P641, DOI 10.1111/j.1095-8649.1989.tb03016.x; State of Israel Ministry of Energy and Water resources, 2012, OIL GAS SECT OWN PET; Stern N, 2010, THESIS TEL AVIV U TE; Tagliapietra S., 2013, NEW E MEDITERRANEAN; The Israel Nature and Parks Authority, 2012, DAT EC GEOGR INF CTR; Tognelli MF, 2005, BIOL CONSERV, V126, P420, DOI 10.1016/j.biocon.2005.06.021; Varshavsky A, 2012, CURRENT STATUS OFFSH; Warman LD, 2004, CONSERV BIOL, V18, P655, DOI 10.1111/j.1523-1739.2004.00538.x; Watts ME, 2009, ENVIRON MODELL SOFTW, V24, P1513, DOI 10.1016/j.envsoft.2009.06.005; Weeks R, 2010, CONSERV LETT, V3, P445, DOI 10.1111/j.1755-263X.2010.00131.x; Weeks R, 2010, BIOL CONSERV, V143, P1236, DOI 10.1016/j.biocon.2010.02.031; Wells R., 2010, MARXAN GOOD PRACTICE, P24; Yahel R., 2012, NATURE CONSERVATION	72	51	51	5	185	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e104489	10.1371/journal.pone.0104489	http://dx.doi.org/10.1371/journal.pone.0104489			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM6SB	25102177	gold, Green Published			2022-12-27	WOS:000339993900068
J	Plesner, A; ten Holder, JT; Verchere, CB				Plesner, Annette; ten Holder, Joris T.; Verchere, C. Bruce			Islet Remodeling in Female Mice with Spontaneous Autoimmune and Streptozotocin-Induced Diabetes	PLOS ONE			English	Article							PANCREATIC BETA-CELLS; NOD MICE; ALPHA-CELLS; ENDOCRINE PANCREAS; GLUCOSE-INFUSION; ADULT-RATS; REGENERATION; MOUSE; REVERSAL; PROLIFERATION	Islet alpha-and delta-cells are spared autoimmune destruction directed at beta-cells in type 1 diabetes resulting in an apparent increase of non-beta endocrine cells in the islet core. We determined how islet remodeling in autoimmune diabetes compares to streptozotocin (STZ)-induced diabetes. Islet cell mass, proliferation, and immune cell infiltration in pancreas sections from diabetic NOD mice and mice with STZ-induced diabetes was assessed using quantitative image analysis. Serial sections were stained for various beta-cell markers and Ngn3, typically restricted to embryonic tissue, was only upregulated in diabetic NOD mouse islets. Serum levels of insulin, glucagon and GLP-1 were measured to compare hormone levels with respect to disease state. Total pancreatic alpha-cell mass did not change as autoimmune diabetes developed in NOD mice despite the proportion of islet area comprised of alpha-and delta-cells increased. By contrast, alpha-and delta-cell mass was increased in mice with STZ-induced diabetes. Serum levels of glucagon reflected these changes in alpha-cell mass: glucagon levels remained constant in NOD mice over time but increased significantly in STZ-induced diabetes. Increased serum GLP-1 levels were found in both models of diabetes, likely due to alpha-cell expression of prohormone convertase 1/3. Alpha-or delta-cell mass in STZ-diabetic mice did not normalize by replacement of insulin via osmotic mini-pumps or islet transplantation. Hence, the inflammatory milieu in NOD mouse islets may restrict alpha-cell expansion highlighting important differences between these two diabetes models and raising the possibility that increased alpha-cell mass might contribute to the hyperglycemia observed in the STZ model.	[Plesner, Annette; ten Holder, Joris T.; Verchere, C. Bruce] Univ British Columbia, Dept Pathol, Child & Family Res Inst, Vancouver, BC V5Z 1M9, Canada; [Plesner, Annette; ten Holder, Joris T.; Verchere, C. Bruce] Univ British Columbia, Dept Lab Med, Child & Family Res Inst, Vancouver, BC V5Z 1M9, Canada; [Verchere, C. Bruce] Univ British Columbia, Dept Surg, Child & Family Res Inst, Vancouver, BC V5Z 1M9, Canada	Child & Family Research Institute; University of British Columbia; Child & Family Research Institute; University of British Columbia; Child & Family Research Institute; University of British Columbia	Plesner, A (corresponding author), Univ British Columbia, Dept Pathol, Child & Family Res Inst, Vancouver, BC V5Z 1M9, Canada.	apln@novonordisk.com		Plesner, Annette/0000-0002-2188-7056; Verchere, Cameron Bruce/0000-0002-9262-0586	Canadian Institutes of Health Research [MOP-64427]; British Columbia Children's Hospital Foundation; Dutch Diabetes Research Foundation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); British Columbia Children's Hospital Foundation; Dutch Diabetes Research Foundation	This work was supported by the Canadian Institutes of Health Research (MOP-64427; http://www.cihr-irsc.gc.ca/e/193.html) and British Columbia Children's Hospital Foundation (https://www.bcchf.ca/). JtH was funded by a studentship from the Dutch Diabetes Research Foundation (http://www.dcti.net/partners/diabetes-fonds. html). CBV is an investigator of the Child&Family Research Institute and holds the Irving K Barber Chair in Diabetes Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso LC, 2007, DIABETES, V56, P1792, DOI 10.2337/db06-1513; Anderson MS, 2005, ANNU REV IMMUNOL, V23, P447, DOI 10.1146/annurev.immunol.23.021704.115643; Ansaria MJI, 2008, CLIN IMMUNOL, V126, P140, DOI 10.1016/j.clim.2007.07.019; Azam A, 2004, EXPERT OPIN BIOL TH, V4, P1569, DOI 10.1517/14712598.4.10.1569; Bonner-Weir S, 2005, NAT BIOTECHNOL, V23, P857, DOI 10.1038/nbt1115; BONNERWEIR S, 1993, DIABETES, V42, P1715, DOI 10.2337/diabetes.42.12.1715; BONNERWEIR S, 1989, DIABETES, V38, P49, DOI 10.2337/diabetes.38.1.49; Chong AS, 2006, SCIENCE, V311, P1774, DOI 10.1126/science.1123510; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Dror V, 2007, DIABETOLOGIA, V50, P2504, DOI 10.1007/s00125-007-0835-5; DUMM CLAG, 1995, PANCREAS, V11, P396, DOI 10.1097/00006676-199511000-00012; Fernandes A, 1997, ENDOCRINOLOGY, V138, P1750, DOI 10.1210/en.138.4.1750; Gradwohl G, 2000, P NATL ACAD SCI USA, V97, P1607, DOI 10.1073/pnas.97.4.1607; Gu GQ, 2002, DEVELOPMENT, V129, P2447; Guleria I, 2007, CLIN IMMUNOL, V125, P16, DOI 10.1016/j.clim.2007.05.013; Guz Y, 2001, ENDOCRINOLOGY, V142, P4956, DOI 10.1210/en.142.11.4956; Hess D, 2003, NAT BIOTECHNOL, V21, P763, DOI 10.1038/nbt841; Holst JJ, 2010, RESULTS PROBL CELL D, V50, P121, DOI 10.1007/400_2009_35; Jorgensen MC, 2007, ENDOCR REV, V28, P685, DOI 10.1210/er.2007-0016; Kay TWH, 2000, TRENDS ENDOCRIN MET, V11, P11, DOI 10.1016/S1043-2760(99)00210-6; Kilimnik G, 2010, ISLETS, V2, P149, DOI 10.4161/isl.2.3.11396; Kodama S, 2003, SCIENCE, V302, P1223, DOI 10.1126/science.1088949; Li WC, 2010, J CELL SCI, V123, P2792, DOI 10.1242/jcs.065268; Li Z, 2000, J ENDOCRINOL, V165, P93, DOI 10.1677/joe.0.1650093; Lipsett M, 2002, DIABETES, V51, P1834, DOI 10.2337/diabetes.51.6.1834; Mandrup-Poulsen T, 2003, ANN NY ACAD SCI, V1005, P32, DOI 10.1196/annals.1288.005; Minami K, 2005, P NATL ACAD SCI USA, V102, P15116, DOI 10.1073/pnas.0507567102; Nishio J, 2006, SCIENCE, V311, P1775, DOI 10.1126/science.1124004; ORCI L, 1976, P NATL ACAD SCI USA, V73, P1338, DOI 10.1073/pnas.73.4.1338; Pechhold K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004827; Pechhold K, 2009, DIABETES, V58, P1175, DOI 10.2337/db08-0616; Plesner A, 2005, DIABETES, V54, P2533, DOI 10.2337/diabetes.54.9.2533; Plesner A, 1998, J AUTOIMMUN, V11, P335, DOI 10.1006/jaut.1998.0206; Rankin MM, 2009, DIABETES, V58, P1365, DOI 10.2337/db08-1198; Seaberg RM, 2004, NAT BIOTECHNOL, V22, P1115, DOI 10.1038/nbt1004; Sherry NA, 2006, DIABETES, V55, P3238, DOI 10.2337/db05-1034; Sreenan S, 1999, DIABETES, V48, P989, DOI 10.2337/diabetes.48.5.989; Suri A, 2006, SCIENCE, V311, P1778, DOI 10.1126/science.1123500; Talchai C, 2012, CELL, V150, P1223, DOI 10.1016/j.cell.2012.07.029; Teta M, 2005, DIABETES, V54, P2557, DOI 10.2337/diabetes.54.9.2557; Teta M, 2007, DEV CELL, V12, P817, DOI 10.1016/j.devcel.2007.04.011; Thorel F, 2010, NATURE, V464, P1149, DOI 10.1038/nature08894; Thyssen S, 2006, ENDOCRINOLOGY; Vergani A, 2010, DIABETES, V59, P2253, DOI 10.2337/db09-1264; von Herrath M, 2007, NAT REV IMMUNOL, V7, P988, DOI 10.1038/nri2192; Wideman RD, 2007, DIABETES, V56, P2744, DOI 10.2337/db07-0563	46	24	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e102843	10.1371/journal.pone.0102843	http://dx.doi.org/10.1371/journal.pone.0102843			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25101835	gold, Green Submitted, Green Published			2022-12-27	WOS:000339993900008
J	Shah, KB; Tripathy, S; Suganthi, H; Rudraiah, M				Shah, Kunal B.; Tripathy, Sudeshna; Suganthi, Hepziba; Rudraiah, Medhamurthy			Profiling of Luteal Transcriptome during Prostaglandin F2-Alpha Treatment in Buffalo Cows: Analysis of Signaling Pathways Associated with Luteolysis	PLOS ONE			English	Article							BOVINE CORPUS-LUTEUM; MESSENGER-RIBONUCLEIC-ACID; LUTEINIZING-HORMONE RECEPTOR; HUMAN CHORIONIC-GONADOTROPIN; GENE-EXPRESSION ANALYSIS; ACUTE REGULATORY PROTEIN; ESTROUS-CYCLE; BCL-2 EXPRESSION; GRANULOSA-CELLS; BREAST-CANCER	In several species including the buffalo cow, prostaglandin (PG) F-2 alpha is the key molecule responsible for regression of corpus luteum (CL). Experiments were carried out to characterize gene expression changes in the CL tissue at various time points after administration of luteolytic dose of PGF(2 alpha) in buffalo cows. Circulating progesterone levels decreased within 1 h of PGF(2 alpha) treatment and evidence of apoptosis was demonstrable at 18 h post treatment. Microarray analysis indicated expression changes in several of immediate early genes and transcription factors within 3 h of treatment. Also, changes in expression of genes associated with cell to cell signaling, cytokine signaling, steroidogenesis, PG synthesis and apoptosis were observed. Analysis of various components of LH/CGR signaling in CL tissues indicated decreased LH/CGR protein expression, pCREB levels and PKA activity post PGF(2 alpha) treatment. The novel finding of this study is the down regulation of CYP19A1 gene expression accompanied by decrease in expression of E-2 receptors and circulating and intra luteal E-2 post PGF(2 alpha) treatment. Mining of microarray data revealed several differentially expressed E-2 responsive genes. Since CYP19A1 gene expression is low in the bovine CL, mining of microarray data of PGF(2 alpha)-treated macaques, the species with high luteal CYP19A1 expression, showed good correlation between differentially expressed E-2 responsive genes between both the species. Taken together, the results of this study suggest that PGF(2 alpha) interferes with luteotrophic signaling, impairs intraluteal E-2 levels and regulates various signaling pathways before the effects on structural luteolysis are manifest.	[Shah, Kunal B.; Tripathy, Sudeshna; Suganthi, Hepziba; Rudraiah, Medhamurthy] Indian Inst Sci, Dept Mol Reprod Dev & Genet, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Rudraiah, M (corresponding author), Indian Inst Sci, Dept Mol Reprod Dev & Genet, Bangalore 560012, Karnataka, India.	rmm@mrdg.iisc.ernet.in	Tripathy, Sudeshna/ABB-9975-2021	Tripathy, Sudeshna/0000-0002-6257-1461	DBT, Government of India [350]	DBT, Government of India(Department of Biotechnology (DBT) India)	The work was supported by DBT(350), Government of India. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta TJ, 2002, BIOL REPROD, V66, P651, DOI 10.1095/biolreprod66.3.651; AGUDO LS, 1984, J ANIM SCI, V58, P955, DOI 10.2527/jas1984.584955x; Arvisais E, 2010, MOL ENDOCRINOL, V24, P632, DOI 10.1210/me.2009-0312; Atli MO, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.094870; AULETTA FJ, 1988, ENDOCR REV, V9, P88, DOI 10.1210/edrv-9-1-88; AZHAR S, 1989, BIOL REPROD, V40, P961, DOI 10.1095/biolreprod40.5.961; BALAPURE AK, 1989, BIOL REPROD, V41, P385, DOI 10.1095/biolreprod41.3.385; Barton M, 2012, STEROIDS, V77, P935, DOI 10.1016/j.steroids.2012.04.001; BATTYE KM, 1988, J REPROD FERTIL, V84, P425, DOI 10.1530/jrf.0.0840425; BEHRMAN HR, 1978, ENDOCRINOLOGY, V103, P349, DOI 10.1210/endo-103-2-349; Benyo DF, 1997, ENDOCRINOLOGY, V138, P3452, DOI 10.1210/en.138.8.3452; Berisha B, 2005, DOMEST ANIM ENDOCRIN, V29, P305, DOI 10.1016/j.domaniend.2005.02.035; Berisha B, 2002, ENDOCRINE, V17, P207, DOI 10.1385/ENDO:17:3:207; Berisha B, 2010, BIOL REPROD, V82, P940, DOI 10.1095/biolreprod.109.076752; Bjurulf E, 1996, BIOL REPROD, V54, P1350, DOI 10.1095/biolreprod54.6.1350; Bratton MR, 2010, INT J ONCOL, V37, P541, DOI 10.3892/ijo_00000703; BRYNER RW, 1990, DOMEST ANIM ENDOCRIN, V7, P181, DOI 10.1016/0739-7240(90)90024-T; Bulun SE, 2005, PHARMACOL REV, V57, P359, DOI 10.1124/pr.57.3.6; Casey OM, 2005, THERIOGENOLOGY, V64, P1963, DOI 10.1016/j.theriogenology.2005.04.015; Coleman KM, 2001, FRONT BIOSCI, V6, pD1379, DOI 10.2741/Coleman; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Dawson SJ, 2010, BRIT J CANCER, V103, P668, DOI 10.1038/sj.bjc.6605736; Devoto L, 2000, J REPROD FERTIL, P13; Diaz FJ, 2004, BIOL REPROD, V70, P1333, DOI 10.1095/biolreprod.103.020461; Diaz FJ, 2011, BIOL REPROD, V84, P26, DOI 10.1095/biolreprod.110.084368; Dong LA, 1999, J BIOL CHEM, V274, P32099, DOI 10.1074/jbc.274.45.32099; Du KY, 1998, J BIOL CHEM, V273, P32377, DOI 10.1074/jbc.273.49.32377; FITZ TA, 1982, BIOL REPROD, V27, P703, DOI 10.1095/biolreprod27.3.703; GARVERICK HA, 1985, J ANIM SCI, V61, P216, DOI 10.2527/jas1985.611216x; Ghosh S, 2005, ONCOGENE, V24, P2236, DOI 10.1038/sj.onc.1208415; GIBORI G, 1984, ENDOCRINOLOGY, V114, P609, DOI 10.1210/endo-114-2-609; Ginther OJ, 2011, DOMEST ANIM ENDOCRIN, V40, P119, DOI 10.1016/j.domaniend.2010.09.006; Ginther OJ, 2009, BIOL REPROD, V80, P641, DOI 10.1095/biolreprod.108.072769; Goodman SB, 1998, BIOL REPROD, V59, P820, DOI 10.1095/biolreprod59.4.820; Goravanahally MP, 2009, BIOL REPROD, V80, P980, DOI 10.1095/biolreprod.108.069518; GUY MK, 1995, ENDOCRINE, V3, P585, DOI 10.1007/BF02953023; HALL JE, 1991, J CLIN ENDOCR METAB, V72, P993, DOI 10.1210/jcem-72-5-993; HINSHELWOOD MM, 1995, BIOL REPROD, V53, P1151, DOI 10.1095/biolreprod53.5.1151; Hinshelwood MM, 1997, ENDOCRINOLOGY, V138, P3704, DOI 10.1210/en.138.9.3704; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; JACKSON JA, 1985, BIOL REPROD, V33, P451, DOI 10.1095/biolreprod33.2.451; Ji W, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh084; JUENGEL JL, 1993, ENDOCRINOLOGY, V132, P249, DOI 10.1210/en.132.1.249; JUENGEL JL, 1995, ENDOCRINOLOGY, V136, P5423, DOI 10.1210/en.136.12.5423; Jyotsna UR, 2009, ANIM REPROD SCI, V113, P71, DOI 10.1016/j.anireprosci.2008.08.001; Jyotsna UR, 2011, PLOS ONE, V6; KNICKERBOCKER JJ, 1988, DOMEST ANIM ENDOCRIN, V5, P91, DOI 10.1016/0739-7240(88)90011-2; Korzekwa AJ, 2008, REPROD DOMEST ANIM, V43, P464, DOI 10.1111/j.1439-0531.2007.00936.x; Kugu K, 1998, CELL DEATH DIFFER, V5, P67, DOI 10.1038/sj.cdd.4400316; Lahav M, 1989, J Reprod Fertil Suppl, V37, P233; Lee J, 2010, ENDOCRINOLOGY, V151, P3326, DOI 10.1210/en.2009-0948; Lenz S, 2004, MOL REPROD DEV, V67, P406, DOI 10.1002/mrd.20000; Lin CY, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r66; Liu HF, 2007, BIOINFORMATICS, V23, P2385, DOI 10.1093/bioinformatics/btm360; Luo WX, 2011, BIOL REPROD, V84, P369, DOI 10.1095/biolreprod.110.085274; MAAS S, 1992, J CLIN ENDOCR METAB, V74, P306, DOI 10.1210/jc.74.2.306; Maranesi M, 2010, DOMEST ANIM ENDOCRIN, V39, P116, DOI 10.1016/j.domaniend.2010.03.001; McCracken JA, 1999, PHYSIOL REV, V79, P263, DOI 10.1152/physrev.1999.79.2.263; MICHAEL AE, 1993, J REPROD FERTIL, V97, P425; MICHAEL AE, 1991, MOL CELL ENDOCRINOL, V82, P207, DOI 10.1016/0303-7207(91)90033-O; Minegishi K, 2002, AM J PHYSIOL-ENDOC M, V283, pE1308, DOI 10.1152/ajpendo.00240.2002; Miyamoto A, 2005, DOMEST ANIM ENDOCRIN, V29, P329, DOI 10.1016/j.domaniend.2005.03.011; Mondal M, 2011, PHYSIOL GENOMICS, V43, P447, DOI 10.1152/physiolgenomics.00155.2010; Nazar RN, 2010, MOL BIOTECHNOL, V44, P8, DOI 10.1007/s12033-009-9212-6; Nimz M, 2009, DOMEST ANIM ENDOCRIN, V37, P45, DOI 10.1016/j.domaniend.2009.02.002; Niswender GD, 2000, PHYSIOL REV, V80, P1, DOI 10.1152/physrev.2000.80.1.1; Noda Y, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.092999; Noseir Wael M B, 2003, Reprod Biol Endocrinol, V1, P50, DOI 10.1186/1477-7827-1-50; Okuda K, 2001, BIOL REPROD, V65, P1634, DOI 10.1095/biolreprod65.6.1634; Okuda K, 1999, REPROD FERT DEVELOP, V11, P147, DOI 10.1071/RD99027; Oshlack A, 2007, BIOINFORMATICS, V23, P1235, DOI 10.1093/bioinformatics/btm111; Pate JL, 1996, THERIOGENOLOGY, V45, P1381, DOI 10.1016/0093-691X(96)00102-1; Peluffo MC, 2006, REPRODUCTION, V132, P465, DOI 10.1530/rep.1.00910; Perillo B, 2000, MOL CELL BIOL, V20, P2890, DOI 10.1128/MCB.20.8.2890-2901.2000; Pescador N, 1996, BIOL REPROD, V55, P485, DOI 10.1095/biolreprod55.2.485; PETERS KE, 1994, BIOL REPROD, V51, P1248, DOI 10.1095/biolreprod51.6.1248; Pharriss B B, 1972, Recent Prog Horm Res, V28, P51; Priyanka S, 2007, MOL HUM REPROD, V13, P381, DOI 10.1093/molehr/gam015; Priyanka S, 2009, ENDOCRINOLOGY, V150, P1473, DOI 10.1210/en.2008-0840; Pugazhenthi S, 2000, J BIOL CHEM, V275, P10761, DOI 10.1074/jbc.275.15.10761; RAVINDRANATH N, 1992, J CLIN ENDOCR METAB, V74, P779, DOI 10.1210/jc.74.4.779; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Rena G, 1999, J BIOL CHEM, V274, P17179, DOI 10.1074/jbc.274.24.17179; RODGER FE, 1995, HUM REPROD, V10, P1566, DOI 10.1093/HUMREP/10.6.1566; Rueda BR, 1997, BIOL REPROD, V56, P186, DOI 10.1095/biolreprod56.1.186; RUEDA BR, 1995, BIOL REPROD, V52, P305, DOI 10.1095/biolreprod52.2.305; Sanders SL, 1997, BIOL REPROD, V56, P1077, DOI 10.1095/biolreprod56.5.1077; SCHALLENBERGER E, 1984, J REPROD FERTIL, V71, P493; Schams D, 2002, DOMEST ANIM ENDOCRIN, V23, P53, DOI 10.1016/S0739-7240(02)00145-5; Shibaya M, 2007, J REPROD DEVELOP, V53, P1059, DOI 10.1262/jrd.19065; Shirasuna K, 2008, REPRODUCTION, V135, P527, DOI 10.1530/REP-07-0496; Shirasuna K, 2010, J REPROD DEVELOP, V56, P428, DOI 10.1262/jrd.10-004O; Shirasuna K, 2010, J REPROD DEVELOP, V56, P124, DOI 10.1262/jrd.09-106O; SHUTT DA, 1975, STEROIDS, V26, P299, DOI 10.1016/0039-128X(75)90076-8; Simoncini T, 2000, NATURE, V407, P538, DOI 10.1038/35035131; Smith GW, 1996, BIOL REPROD, V54, P76, DOI 10.1095/biolreprod54.1.76; SNOOK RB, 1971, ENDOCRINOLOGY, V88, P678, DOI 10.1210/endo-88-3-678; SOTREL G, 1981, AM J OBSTET GYNECOL, V139, P134, DOI 10.1016/0002-9378(81)90434-8; Stevenson JS, 2010, THERIOGENOLOGY, V73, P1127, DOI 10.1016/j.theriogenology.2010.01.014; Stocco C, 2008, STEROIDS, V73, P473, DOI 10.1016/j.steroids.2008.01.017; Stocco C, 2007, ENDOCR REV, V28, P117, DOI 10.1210/er.2006-0022; Stouffer RL, 2013, REPROD BIOL, V13, P259, DOI 10.1016/j.repbio.2013.08.002; Sudeshna T, 2013, REPROD BIOL ENDOCRIN, V11, P1, DOI 10.1186/1477-7827-11-111; Sugino N, 2007, J REPROD DEVELOP, V53, P977, DOI 10.1262/jrd.19047; Suresh PS, 2013, SYST BIOL REPROD MED, V59, P1, DOI 10.3109/19396368.2012.729647; Tang ED, 1999, J BIOL CHEM, V274, P16741, DOI 10.1074/jbc.274.24.16741; Taniguchi H, 2009, MOL REPROD DEV, V76, P873, DOI 10.1002/mrd.21054; TILLY JL, 1993, J CELL PHYSIOL, V154, P519, DOI 10.1002/jcp.1041540310; Townson DH, 2006, INTEGR COMP BIOL, V46, P1055, DOI 10.1093/icb/icl021; TSUMAGARI S, 1993, J REPROD FERTIL, V98, P631, DOI 10.1530/jrf.0.0980631; Uma J, 2003, BIOL REPROD, V69, P1379, DOI 10.1095/biolreprod.103.017897; Utt MD, 2007, ANIM REPROD SCI, V97, P63, DOI 10.1016/j.anireprosci.2006.01.009; Vaillant F, 2013, CANCER CELL, V24, P120, DOI 10.1016/j.ccr.2013.06.002; Vanselow J, 2005, MOL CELL ENDOCRINOL, V233, P57, DOI 10.1016/j.mce.2005.01.007; Vanselow J, 2004, DOMEST ANIM ENDOCRIN, V27, P99, DOI 10.1016/j.domaniend.2004.01.008; Vanselow J, 2010, BIOL REPROD, V82, P289, DOI 10.1095/biolreprod.109.079251; Waclawik A, 2011, REPRODUCTION, V142, P389, DOI 10.1530/REP-11-0033; WARSHAW ML, 1986, ENDOCRINOLOGY, V119, P2642, DOI 10.1210/endo-119-6-2642; Webb R, 2002, DOMEST ANIM ENDOCRIN, V23, P277, DOI 10.1016/S0739-7240(02)00163-7; WEBLEY GE, 1991, J ENDOCRINOL, V128, P121, DOI 10.1677/joe.0.1280121; Weinbauer GF, 2008, TOXICOL PATHOL, V36, p7S, DOI 10.1177/0192623308327412; Wilson BE, 1996, MOL CELL BIOL, V16, P5546; Wiltbank MC, 2012, ANIM REPROD, V9, P242; WILTBANK MC, 1990, BIOL REPROD, V42, P239, DOI 10.1095/biolreprod42.2.239; Yadav VK, 2005, J BIOL CHEM, V280, P10357, DOI 10.1074/jbc.M409596200; Yadav VK, 2002, BIOL REPROD, V67, P752, DOI 10.1095/biolreprod.102.004077; Zalman Y, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.095067	127	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e104127	10.1371/journal.pone.0104127	http://dx.doi.org/10.1371/journal.pone.0104127			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25102061	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000339993900043
J	Zarrineh, P; Sanchez-Rodriguez, A; Hosseinkhan, N; Narimani, Z; Marchal, K; Masoudi-Nejad, A				Zarrineh, Peyman; Sanchez-Rodriguez, Aminael; Hosseinkhan, Nazanin; Narimani, Zahra; Marchal, Kathleen; Masoudi-Nejad, Ali			Genome-Scale Co-Expression Network Comparison across Escherichia coli and Salmonella enterica Serovar Typhimurium Reveals Significant Conservation at the Regulon Level of Local Regulators Despite Their Dissimilar Lifestyles	PLOS ONE			English	Article							ADAPTIVE MUTATIONS; GENE-EXPRESSION; SIGMA-FACTORS; IDENTIFICATION; EVOLUTION; TRANSCRIPTION; INFORMATION; DISCOVERY; BACTERIA; DATABASE	Availability of genome-wide gene expression datasets provides the opportunity to study gene expression across different organisms under a plethora of experimental conditions. In our previous work, we developed an algorithm called COMODO (COnserved MODules across Organisms) that identifies conserved expression modules between two species. In the present study, we expanded COMODO to detect the co-expression conservation across three organisms by adapting the statistics behind it. We applied COMODO to study expression conservation/divergence between Escherichia coli, Salmonella enterica, and Bacillus subtilis. We observed that some parts of the regulatory interaction networks were conserved between E. coli and S. enterica especially in the regulon of local regulators. However, such conservation was not observed between the regulatory interaction networks of B. subtilis and the two other species. We found co-expression conservation on a number of genes involved in quorum sensing, but almost no conservation for genes involved in pathogenicity across E. coli and S. enterica which could partially explain their different lifestyles. We concluded that despite their different lifestyles, no significant rewiring have occurred at the level of local regulons involved for instance, and notable conservation can be detected in signaling pathways and stress sensing in the phylogenetically close species S. enterica and E. coli. Moreover, conservation of local regulons seems to depend on the evolutionary time of divergence across species disappearing at larger distances as shown by the comparison with B. subtilis. Global regulons follow a different trend and show major rewiring even at the limited evolutionary distance that separates E. coli and S. enterica.	[Zarrineh, Peyman] Katholieke Univ Leuven, Dept Microbial & Mol Syst, Ctr Microbial & Plant Genet, Leuven, Belgium; [Sanchez-Rodriguez, Aminael] Univ Tecn Particula Loja, Dept Ciencias Nat, Loja, Ecuador; [Hosseinkhan, Nazanin; Narimani, Zahra; Masoudi-Nejad, Ali] Univ Tehran, Lab Syst Biol & Bioinformat LBB, Inst Biochem & Biophys, Tehran, Iran; [Marchal, Kathleen] Univ Ghent, Dept Informat Technol, IMinds, B-9000 Ghent, Belgium	KU Leuven; Universidad Tecnica Particular de Loja; University of Tehran; Ghent University; IMEC	Marchal, K (corresponding author), Univ Ghent, Dept Informat Technol, IMinds, B-9000 Ghent, Belgium.	kamar@psb.vib-ugent.be; amasoudin@ibb.ut.ac.ir	Marchal, Kathleen/B-5001-2013; Marchal, Kathleen/O-7936-2017; Zarrineh, Peyman/AAE-2533-2022; Hosseinkhan, Nazanin/AAC-3321-2021; Hosseinkhan, Nazanin/AAA-6288-2019; Masoudi-Nejad, Ali/ABH-2078-2021	Marchal, Kathleen/0000-0002-2169-4588; Marchal, Kathleen/0000-0002-2169-4588; Sanchez-Rodriguez, Aminael/0000-0002-9269-0621; Narimani, Zahra/0000-0003-2534-9201	KULeuven Research Council [GOA/08/011, CoE EF/05/007, CoE NATAR IOK-C1895-PF/10/010, CREA/ 08/023, ZKB8933/CREA/08/023/BOF]; Flemish Interuniversity Council-University Development Cooperation [VLIR-UOS]; Agency for Innovation by Science and Technology [SBO-BioFrame]; Interuniversity Attraction Poles [P6/25-BioMaGNet]; Research Foundation-Flanders [IOK-B9725-G.0329.09]; Human Frontier Science Program [RGY0079/2007C]	KULeuven Research Council(KU Leuven); Flemish Interuniversity Council-University Development Cooperation [VLIR-UOS]; Agency for Innovation by Science and Technology [SBO-BioFrame]; Interuniversity Attraction Poles(Belgian Federal Science Policy Office); Research Foundation-Flanders(FWO); Human Frontier Science Program(Human Frontier Science Program)	Funding from following source is acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. KULeuven Research Council [GOA AMBioRICS, GOA/08/011, CoE EF/05/007, SymBioSys, CoE NATAR IOK-C1895-PF/10/010, CREA/ 08/023, ZKB8933/CREA/08/023/BOF]; Flemish Interuniversity Council-University Development Cooperation [VLIR-UOS]; Agency for Innovation by Science and Technology [SBO-BioFrame]; Interuniversity Attraction Poles [P6/25-BioMaGNet]; Research Foundation-Flanders [IOK-B9725-G.0329.09]; Human Frontier Science Program [RGY0079/2007C]. Funding for the open access charge: Agency for Innovation by Science and Technology [SBO-BioFrame].	ANDREWS SC, 2006, BIOMETALS, V19, P143; Babu MM, 2006, J MOL BIOL, V358, P614, DOI 10.1016/j.jmb.2006.02.019; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bergmann S, 2004, PLOS BIOL, V2, P85, DOI 10.1371/journal.pbio.0020009; BROOS S, 2013, NUCL ACIDS RES; Carbon S, 2009, BIOINFORMATICS, V25, P288, DOI 10.1093/bioinformatics/btn615; Chadsey MS, 1998, GENE DEV, V12, P3123, DOI 10.1101/gad.12.19.3123; Chen Z, 2007, NUCLEIC ACIDS RES, V35, P6762, DOI 10.1093/nar/gkm631; Chikina MD, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001074; Dandekar T, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00164; Engelen K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020938; Erill I, 2007, FEMS MICROBIOL REV, V31, P637, DOI 10.1111/j.1574-6976.2007.00082.x; Fadda A, 2009, MOL BIOSYST, V5, P1840, DOI 10.1039/b907310h; GALAGAN JE, 2013, NATURE; Gama-Castro S, 2008, NUCLEIC ACIDS RES, V36, pD120, DOI 10.1093/nar/gkm994; Ihmels J, 2005, PLOS GENET, V1, P380, DOI 10.1371/journal.pgen.0010039; Karp PD, 2005, NUCLEIC ACIDS RES, V33, P6083, DOI 10.1093/nar/gki892; Keseler IM, 2009, NUCLEIC ACIDS RES, V37, pD464, DOI 10.1093/nar/gkn751; Kroger C, 2013, CELL HOST MICROBE, V14, P683, DOI 10.1016/j.chom.2013.11.010; Lai YC, 2003, J BACTERIOL, V185, P788, DOI 10.1128/JB.185.3.788-800.2003; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lemmens K, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r27; Lim A, 1999, BIOINFORMATICS, V15, P1068, DOI 10.1093/bioinformatics/15.12.1068; Lozada-Chavez I, 2006, NUCLEIC ACIDS RES, V34, P3434, DOI 10.1093/nar/gkl423; Makarova KS, 2001, GENOME BIOL, V2; Menard A, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-308; Meysman P, 2013, MOL BIOL EVOL, V30, P1302, DOI 10.1093/molbev/mst029; Okuda S, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-48; Oldham MC, 2006, P NATL ACAD SCI USA, V103, P17973, DOI 10.1073/pnas.0605938103; Osterberg S, 2011, ANNU REV MICROBIOL, V65, P37, DOI 10.1146/annurev.micro.112408.134219; Paget MSB, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-1-203; Perez JC, 2009, CELL, V138, P233, DOI 10.1016/j.cell.2009.07.002; Pesavento C, 2008, GENE DEV, V22, P2434, DOI 10.1101/gad.475808; Pons T, 2006, J MOL MODEL, V12, P973, DOI 10.1007/s00894-005-0096-5; Rhodius VA, 2006, PLOS BIOL, V4, P43, DOI 10.1371/journal.pbio.0040002; Rodionov DA, 2005, TRENDS GENET, V21, P385, DOI 10.1016/j.tig.2005.05.011; Rodionov DA, 2002, GENOME RES, V12, P1507, DOI 10.1101/gr.314502; Saldana Z, 2009, ENVIRON MICROBIOL, V11, P992, DOI 10.1111/j.1462-2920.2008.01824.x; Sierro N, 2008, NUCLEIC ACIDS RES, V36, pD93, DOI 10.1093/nar/gkm910; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Tirosh I, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r50; Wall Dennis P., 2007, V396, P95; Wall DP, 2003, BIOINFORMATICS, V19, P1710, DOI 10.1093/bioinformatics/btg213; Yang ZW, 2006, MUTAT RES-FUND MOL M, V595, P107, DOI 10.1016/j.mrfmmm.2005.10.013; Yang ZW, 2001, MUTAT RES-FUND MOL M, V484, P95, DOI 10.1016/S0027-5107(01)00257-3; Zarrineh P, 2011, NUCLEIC ACIDS RES, V39, pE41, DOI 10.1093/nar/gkq1275	46	11	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e102871	10.1371/journal.pone.0102871	http://dx.doi.org/10.1371/journal.pone.0102871			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25101984	gold, Green Published, Green Submitted			2022-12-27	WOS:000339993900010
J	Alvarez-Sandoval, BA; Manzanilla, LR; Montiel, R				Alvarez-Sandoval, Brenda A.; Manzanilla, Linda R.; Montiel, Rafael			Sex Determination in Highly Fragmented Human DNA by High-Resolution Melting (HRM) Analysis	PLOS ONE			English	Article							DISCRIMINANT FUNCTION-ANALYSIS; MEATUS ACUSTICUS INTERNUS; HUMAN Y-CHROMOSOME; AMELOGENIN GENE; HUMAN REMAINS; FORAMEN MAGNUM; HUMAN ENAMEL; RING FINGER; SHORT ARM; IDENTIFICATION	Sex identification in ancient human remains is a common problem especially if the skeletons are sub-adult, incomplete or damaged. In this paper propose a new method to identify sex, based on real-time PCR amplification of small fragments (61 and 64 bp) of the third exon within the amelogenin gene covering a 3-bp deletion on the AAAELX-allele, followed by a High Resolution Melting analysis (HRM). HRM is based on the melting curves of amplified fragments. The amelogenin gene is located on both chromosomes X and Y, showing dimorphism in length. This molecular tool is rapid, sensitive and reduces he risk of contamination from exogenous genetic material when used for ancient DNA studies. The accuracy of the new method described here has been corroborated by using control samples of known sex and by contrasting our results wit those obtained with other methods. Our method has proven to be useful even in heavily degraded samples, where other previously published methods failed. Stochastic problems such as the random allele drop-out phenomenon are expected cur in a less severe form, due to the smaller fragment size to be amplified. Thus, their negative effect could be easier overcome by a proper experimental design.	[Alvarez-Sandoval, Brenda A.; Montiel, Rafael] Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Unidad Genom Avanzada, Lab Nacl Genom Biodiversidad, Guanajuato, Mexico; [Manzanilla, Linda R.] Univ Nacl Autonoma Mexico, Inst Invest Antropol, Mexico City 04510, DF, Mexico	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico; Universidad Nacional Autonoma de Mexico	Montiel, R (corresponding author), Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Unidad Genom Avanzada, Lab Nacl Genom Biodiversidad, Guanajuato, Mexico.	montiel@langebio.cinvestav.mx	Montiel, Rafael/A-6774-2008	Montiel, Rafael/0000-0001-8052-0679	Consejo Nacional de Ciencia y Tecnologia (CONACYT) [CB-2008-01-105481]; CONACYT fellowship [300750]	Consejo Nacional de Ciencia y Tecnologia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CONACYT fellowship(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by Consejo Nacional de Ciencia y Tecnologia (CONACYT; www.conacyt.gob.mx) grant No. CB-2008-01-105481 to Dr. Rafael Montiel. M.Sc. Alvarez-Sandoval is supported by a CONACYT fellowship (Reg. No. 300750). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKANE A, 1992, FORENSIC SCI INT, V52, P143, DOI 10.1016/0379-0738(92)90102-3; AKANE A, 1991, FORENSIC SCI INT, V49, P81, DOI 10.1016/0379-0738(91)90174-H; Albanese J, 2003, J FORENSIC SCI, V48, P263; Alonso A, 2003, CROAT MED J, V44, P273; Andreasson H, 2003, J FORENSIC SCI, V48, P1280; Atamturk D, 2010, ANTHROPOL ANZ, V68, P21, DOI 10.1127/0003-5548/2010/0026; Aye VO, 2010, FORENSIC SCI INT, V199, DOI 10.1016/j.forsciint.2010.03.001; BAILEY DMD, 1992, GENOMICS, V14, P203, DOI 10.1016/S0888-7543(05)80310-6; BERRIZBEITIA EL, 1989, J FORENSIC SCI, V34, P1206; Bongiovanni R, 2012, FORENSIC SCI INT, V219, DOI 10.1016/j.forsciint.2011.11.034; Burris BG, 1998, J FORENSIC SCI, V43, P959; Case DT, 2007, J FORENSIC SCI, V52, P264, DOI 10.1111/j.1556-4029.2006.00365.x; Chang YM, 2003, J FORENSIC SCI, V48, P1309; Dabbs GR, 2010, J FORENSIC SCI, V55, P149, DOI 10.1111/j.1556-4029.2009.01232.x; Daskalaki E, 2011, J ARCHAEOL SCI, V38, P1326, DOI 10.1016/j.jas.2011.01.009; Faerman M, 1995, GENE, V167, P327, DOI 10.1016/0378-1119(95)00697-4; Francesquini Junior L, 2007, J Forensic Odontostomatol, V25, P7; Gagneux P, 1997, MOL ECOL, V6, P861, DOI 10.1111/j.1365-294X.1997.tb00140.x; Gapert R, 2009, INT J LEGAL MED, V123, P25, DOI 10.1007/s00414-008-0256-0; Gibbon V, 2009, FORENSIC SCI INT-GEN, V3, P74, DOI 10.1016/j.fsigen.2008.10.007; Giglio S, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng135; Goncalves D, 2013, J FORENSIC LEG MED, V20, P906, DOI 10.1016/j.jflm.2013.07.003; Gonzalez RA, 2012, J FORENSIC SCI, V57, P24, DOI 10.1111/j.1556-4029.2011.01920.x; Gotherstrom A, 1997, INT J OSTEOARCHAEOL, V7, P71, DOI 10.1002/(SICI)1099-1212(199701)7:1<71::AID-OA321>3.0.CO;2-K; Graw M, 2005, FORENSIC SCI INT, V147, P113, DOI 10.1016/j.forsciint.2004.08.006; Green RE, 2009, EMBO J, V28, P2494, DOI 10.1038/emboj.2009.222; HaasRochholz H, 1997, INT J LEGAL MED, V110, P312, DOI 10.1007/s004140050094; Harris SM, 2012, J FORENSIC SCI, V57, P295, DOI 10.1111/j.1556-4029.2011.02004.x; Herrmann MG, 2006, CLIN CHEM, V52, P494, DOI 10.1373/clinchem.2005.063438; HUMMEL S, 1991, NATURWISSENSCHAFTEN, V78, P266, DOI 10.1007/BF01134353; Introna F, 1998, FORENSIC SCI INT, V95, P39, DOI 10.1016/S0379-0738(98)00080-2; Jobling MA, 2007, HUM MOL GENET, V16, P307, DOI 10.1093/hmg/ddl465; Jowaheer V, 2011, J FORENSIC LEG MED, V18, P173, DOI 10.1016/j.jflm.2011.02.007; Kalmey JK, 1996, J FORENSIC SCI, V41, P865; Kanchan T, 2008, FORENSIC SCI INT, V181; Kanchan T, 2013, J FORENSIC LEG MED, V20, P855, DOI 10.1016/j.jflm.2013.06.016; Kanchan T, 2011, J FORENSIC LEG MED, V18, P14, DOI 10.1016/j.jflm.2010.11.013; Kanchan T, 2010, FORENSIC SCI MED PAT, V6, P255, DOI 10.1007/s12024-010-9156-y; Kanchan T, 2010, J FORENSIC LEG MED, V17, P243, DOI 10.1016/j.jflm.2010.02.009; Karsai A, 2002, BIOTECHNIQUES, V32, P790, DOI 10.2144/02324st05; Kim KY, 2013, INT J LEGAL MED, V127, P55, DOI 10.1007/s00414-011-0663-5; Kindschuh SC, 2010, AM J PHYS ANTHROPOL, V143, P279, DOI 10.1002/ajpa.21315; Krishan K, 2013, J FORENSIC LEG MED, V20, P471, DOI 10.1016/j.jflm.2013.03.004; Krishan K, 2012, J FORENSIC SCI, V57, P172, DOI 10.1111/j.1556-4029.2011.01960.x; Lain R, 2011, FORENSIC SCI INT, V205, P36, DOI 10.1016/j.forsciint.2010.06.008; Lassen C, 2000, Anthropol Anz, V58, P1; Lassen Cadja, 1996, ANCIENT BIOMOLECULES, V1, P25; Lattanzi W, 2005, HUM GENET, V116, P395, DOI 10.1007/s00439-004-1238-z; LAU EC, 1990, CLEFT PALATE J, V27, P121, DOI 10.1597/1545-1569(1990)027<0121:AOHEGI>2.3.CO;2; LAU EC, 1989, GENOMICS, V4, P162, DOI 10.1016/0888-7543(89)90295-4; Macaluso PJ, 2011, FORENSIC SCI MED PAT, V7, P233, DOI 10.1007/s12024-010-9204-7; Mall G, 2001, FORENSIC SCI INT, V117, P23, DOI 10.1016/S0379-0738(00)00445-X; Malmstrom H, 2007, MOL BIOL EVOL, V24, P998, DOI 10.1093/molbev/msm015; MANNUCCI A, 1994, INT J LEGAL MED, V106, P190, DOI 10.1007/BF01371335; Manzanilla LindaR., 2012, ESTUDIOS ARQUEOMETRI, P467; Masotti S, 2013, INT J LEGAL MED, V127, P1039, DOI 10.1007/s00414-013-0822-y; May H, 2011, INT J LEGAL MED, V125, P669, DOI 10.1007/s00414-010-0497-6; Meyer E, 2000, FORENSIC SCI INT, V113, P87, DOI 10.1016/S0379-0738(00)00220-6; Montiel R, 2001, HUM BIOL, V73, P689, DOI 10.1353/hub.2001.0069; Moudgil Rohan, 2008, J Forensic Leg Med, V15, P223, DOI 10.1016/j.jflm.2007.10.003; NAKAHORI Y, 1991, GENOMICS, V9, P264, DOI 10.1016/0888-7543(91)90251-9; NAKAHORI Y, 1991, AM J MED GENET, V39, P472, DOI 10.1002/ajmg.1320390420; Ozden H, 2005, FORENSIC SCI INT, V147, P181, DOI 10.1016/j.forsciint.2004.09.072; Pilli E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052524; Purkait R, 2005, FORENSIC SCI INT, V147, P135, DOI 10.1016/j.forsciint.2004.08.005; Ramadan SU, 2010, FORENSIC SCI INT, V197, DOI 10.1016/j.forsciint.2009.12.049; Ririe KM, 1997, ANAL BIOCHEM, V245, P154, DOI 10.1006/abio.1996.9916; Rissech C, 2008, FORENSIC SCI INT, V180, P1, DOI 10.1016/j.forsciint.2008.06.006; Rodriguez JV, 1994, INTRO ANTROPOLOGIA F; Rogers NL, 2000, J FORENSIC SCI, V45, P61; ROGERS T, 1994, J FORENSIC SCI, V39, P1047; Rogers TL, 2009, AM J PHYS ANTHROPOL, V140, P143, DOI 10.1002/ajpa.21060; SALIDO EC, 1992, AM J HUM GENET, V50, P303; Santos FR, 1998, NAT GENET, V18, P103, DOI 10.1038/ng0298-103; SASAKI S, 1995, INT J DEV BIOL, V39, P127; Schmidt D, 2003, AM J PHYS ANTHROPOL, V121, P337, DOI 10.1002/ajpa.10172; Scholtz Y, 2010, HOMO, V61, P253, DOI 10.1016/j.jchb.2010.01.048; Shinka T, 2001, J HUM GENET, V46, P263, DOI 10.1007/s100380170076; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; Skoglund P, 2013, J ARCHAEOL SCI, V40, P4477, DOI 10.1016/j.jas.2013.07.004; Slavkin HC, 1997, J AM DENT ASSOC, V128, P1021, DOI 10.14219/jada.archive.1997.0311; Spradley MK, 2011, J FORENSIC SCI, V56, P289, DOI 10.1111/j.1556-4029.2010.01635.x; Steinlechner M, 2002, INT J LEGAL MED, V116, P117, DOI 10.1007/s00414-001-0264-9; Steyn M, 2012, FORENSIC SCI INT, V214, DOI 10.1016/j.forsciint.2011.07.049; Stone AC, 1996, AM J PHYS ANTHROPOL, V99, P231; SULLIVAN KM, 1993, BIOTECHNIQUES, V15, P636; Taberlet P, 1996, NUCLEIC ACIDS RES, V24, P3189, DOI 10.1093/nar/24.16.3189; Teke HY, 2007, SURG RADIOL ANAT, V29, P9, DOI 10.1007/s00276-006-0157-1; Thangaraj K, 2002, INT J LEGAL MED, V116, P121, DOI 10.1007/s00414-001-0262-y; Tozzo P, 2013, J FORENSIC LEG MED, V20, P387, DOI 10.1016/j.jflm.2013.03.012; Tschentscher F, 2008, INT J LEGAL MED, V122, P333, DOI 10.1007/s00414-008-0228-4; Tvedebrink T, 2012, FORENSIC SCI INT-GEN, V6, P97, DOI 10.1016/j.fsigen.2011.03.001; Uthman AT, 2012, DENTOMAXILLOFAC RAD, V41, P197, DOI 10.1259/dmfr/21276789; Varga A, 2006, J VIROL METHODS, V132, P146, DOI 10.1016/j.jviromet.2005.10.004; Velarde-Felix JS, 2008, REV MEX PATOL CLIN, V55, P17; Wescott DJ, 2001, J FORENSIC SCI, V46, P1159; Wittwer CT, 1997, BIOTECHNIQUES, V22, P130, DOI 10.2144/97221bi01; Wittwer CT, 1997, BIOTECHNIQUES, V22, P176, DOI 10.2144/97221pf02; Zemskova E Iu, 2003, Sud Med Ekspert, V46, P19; Zeybek G, 2008, FORENSIC SCI INT, V181, DOI DOI 10.1016/J.FORSCIINT.2008.08.003	100	17	18	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e104629	10.1371/journal.pone.0104629	http://dx.doi.org/10.1371/journal.pone.0104629			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25098828	Green Published, Green Submitted, gold			2022-12-27	WOS:000339995100086
J	Calder, T; Kinch, LN; Fernandez, J; Salomon, D; Grishin, NV; Orth, K				Calder, Thomas; Kinch, Lisa N.; Fernandez, Jessie; Salomon, Dor; Grishin, Nick V.; Orth, Kim			Vibrio Type III Effector VPA1380 Is Related to the Cysteine Protease Domain of Large Bacterial Toxins	PLOS ONE			English	Article							ACTIN-BINDING; PARAHAEMOLYTICUS; ACTIVATION; PATHOGENS; KINASE; SEQUENCE	Vibrio parahaemolyticus is a Gram-negative halophilic bacterium and one of he leading causes of food-borne gastroenteritis. Its genome harbors two Type III Secretion Systems (T3SS1 and T3SS2), but only T3SS2 is required for enterotoxicity seen in animal models. Effector proteins secreted from T3SS2 have been previously shown to promote colonization of the intestinal epithelium, invasion of host cells, and destruction of the epithelial monolayer. In this study, we identify VPA1380, a T3SS2 effector protein that is toxic when expressed in yeast. Bioinformatic analyses revealed that VPA1380 is highly similar to the inositol hexakisphosphate (IP6)-inducible cysteine protease domains of several large bacterial toxins. Mutations in conserved catalytic residues and residues in the putative IP6-binding pocket abolished toxicity in yeast. Furthermore, VPA1380 was not toxic in IP6 deficient yeast cells Therefore, our findings that VPA1380 is a cysteine protease that requires IP6 as an activator.	[Calder, Thomas; Fernandez, Jessie; Salomon, Dor; Orth, Kim] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Kinch, Lisa N.; Grishin, Nick V.] Univ Texas SW Med Ctr Dallas, Dept Biophys & Biochem, Dallas, TX 75390 USA; [Grishin, Nick V.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Orth, K (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA.	kim.orth@utsouthwestern.edu	Fernandez, Jessie/AAR-3477-2021; Orth, Kim/AAV-4421-2021	Orth, Kim/0000-0002-0678-7620; Kinch, Lisa/0000-0003-3041-2615; Fernandez, Jessie/0000-0002-0897-2707; Salomon, Dor/0000-0002-2009-9453	NIH [GM094575, R01-AI056404]; Welch Foundation from the Welch Research Foundation [I-1505, I-1561];  [T32 AI007520]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007520, R01AI056404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094575] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation from the Welch Research Foundation(The Welch Foundation); ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project is supported in part by the NIH GM094575 and R01-AI056404, the Welch Foundation I-1505 and I-1561 from the Welch Research Foundation. DS is a Chilton Foundation Fellow. TC is supported by T32 AI007520. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Broberg CA, 2011, MICROBES INFECT, V13, P992, DOI 10.1016/j.micinf.2011.06.013; Buss C, 2009, CELL MICROBIOL, V11, P661, DOI 10.1111/j.1462-5822.2009.01284.x; Coaker G, 2005, SCIENCE, V308, P548, DOI 10.1126/science.1108633; Coaker G, 2006, MOL MICROBIOL, V61, P1485, DOI 10.1111/j.1365-2958.2006.05335.x; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Daniels NA, 2000, J INFECT DIS, V181, P1661, DOI 10.1086/315459; Egerer M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000942; Egerer M, 2009, J BIOL CHEM, V284, P3389, DOI 10.1074/jbc.M806002200; Fukazawa A, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000228; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; Gotoh K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013365; Hiyoshi H, 2011, CELL HOST MICROBE, V10, P401, DOI 10.1016/j.chom.2011.08.014; Juris SJ, 2000, P NATL ACAD SCI USA, V97, P9431, DOI 10.1073/pnas.170281997; Liverman ADB, 2007, P NATL ACAD SCI USA, V104, P17117, DOI 10.1073/pnas.0703196104; Lupardus PJ, 2008, SCIENCE, V322, P265, DOI 10.1126/science.1162403; Makino K, 2003, LANCET, V361, P743, DOI 10.1016/S0140-6736(03)12659-1; Nair GB, 2007, CLIN MICROBIOL REV, V20, P39, DOI 10.1128/CMR.00025-06; Okada R, 2013, CELL MICROBIOL; Park KS, 2004, INFECT IMMUN, V72, P6659, DOI 10.1128/IAI.72.11.6659-6665.2004; Park KS, 2004, MICROBIOL IMMUNOL, V48, P313, DOI 10.1111/j.1348-0421.2004.tb03512.x; Pei JM, 2014, METHODS MOL BIOL, V1079, P263, DOI 10.1007/978-1-62703-646-7_17; Pineyro P, 2010, INFECT IMMUN, V78, P4551, DOI 10.1128/IAI.00461-10; Prochazkova K, 2008, J BIOL CHEM, V283, P23656, DOI 10.1074/jbc.M803334200; Prochazkova K, 2009, J BIOL CHEM, V284, P26557, DOI 10.1074/jbc.M109.025510; Pruitt RN, 2009, J BIOL CHEM, V284, P21934, DOI 10.1074/jbc.M109.018929; Reineke J, 2007, NATURE, V446, P415, DOI 10.1038/nature05622; Ritchie JM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002593; Salomon D, 2010, J VIS EXP; Salomon D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3973; Salomon D, 2013, CELL HOST MICROBE, V14, P269, DOI 10.1016/j.chom.2013.07.008; Salomon D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061086; Salomon D, 2012, MICROBIOL-SGM, V158, P2859, DOI 10.1099/mic.0.062513-0; Salomon D, 2011, MOL PLANT MICROBE IN, V24, P305, DOI 10.1094/MPMI-09-10-0196; Shimohata T, 2010, J MED INVESTIG, V57, P179, DOI 10.2152/jmi.57.179; Slagowski NL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040009; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Su YC, 2007, FOOD MICROBIOL, V24, P549, DOI 10.1016/j.fm.2007.01.005; Trosky JE, 2004, J BIOL CHEM, V279, P51953, DOI 10.1074/jbc.M407001200; York JD, 1999, SCIENCE, V285, P96, DOI 10.1126/science.285.5424.96; Zhang LL, 2012, CELL REP, V1, P453, DOI 10.1016/j.celrep.2012.04.004; Zhou XH, 2013, CELL REP, V3, P1690, DOI 10.1016/j.celrep.2013.03.039; Zhou Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057558; Zurawski DV, 2009, MOL MICROBIOL, V71, P350, DOI 10.1111/j.1365-2958.2008.06524.x	44	16	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e104387	10.1371/journal.pone.0104387	http://dx.doi.org/10.1371/journal.pone.0104387			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25099122	Green Published, Green Submitted, gold			2022-12-27	WOS:000339995100068
J	Elston, TW; Pandian, A; Smith, GD; Holley, AJ; Gao, NJ; Lugo, JN				Elston, Thomas W.; Pandian, Ashvini; Smith, Gregory D.; Holley, Andrew J.; Gao, Nanjing; Lugo, Joaquin N.			Aniracetam Does Not Alter Cognitive and Affective Behavior in Adult C57BL/6J Mice	PLOS ONE			English	Article							MEMORY DEFICITS; RATS; TRANSMISSION; ENHANCEMENT; PERFORMANCE; SCOPOLAMINE; IMPAIRMENT; RECEPTORS; RESTORES; LESIONS	There a growing community of individuals who self-administer the nootropic aniracetam for its purported cognitive enhancing effects. Aniracetam is believed to be therapeutically useful for enhancing cognition, alleviating anxiety, and treating various neurodegenerative conditions. Physiologically, aniracetam enhances both glutamatergic neurotransmission and long-term potentiation. Previous studies of aniracetam have demonstrated the cognition-restoring effects of acute administration in different models of disease. No previous studies have explored the effects of aniracetam in healthy subjects. We investigated whether daily 50 mg/kg oral administration improves cognitive performance in naive C57BL/6J mice in a variety of aspects of cognitive behavior. We measured spatial learning in the Morris water maze test; associative learning in the fear conditioning test; motor learning in the accelerating rotarod test; and odor discrimination. We also measured locomotion in the open field test, anxiety through the elevated plus maze test and by measuring time in the center of the open field test. We measured repetitive behavior through the marble burying test. We detected no significant differences between the naive, placebo, and experimental groups across all measures. Despite several studies demonstrating efficacy in impaired subjects, our findings suggest that aniracetam does not alter behavior in normal healthy mice. This study is timely in light of the growing community of healthy humans self-administering nootropic drugs.	[Elston, Thomas W.; Pandian, Ashvini; Holley, Andrew J.; Gao, Nanjing; Lugo, Joaquin N.] Baylor Univ, Dept Psychol & Neurosci, Waco, TX 76798 USA; [Smith, Gregory D.; Lugo, Joaquin N.] Baylor Univ, Inst Biomed Studies, Waco, TX 76798 USA	Baylor University; Baylor University	Lugo, JN (corresponding author), Baylor Univ, Dept Psychol & Neurosci, Waco, TX 76798 USA.	Joaquin_lugo@baylor.edu		Holley, Andrew/0000-0003-3658-9569	Baylor Undergraduate Research and Scholarly Achievement Small Grant Program; Vice Provost	Baylor Undergraduate Research and Scholarly Achievement Small Grant Program; Vice Provost	This study was supported in part by funds from the Baylor Undergraduate Research and Scholarly Achievement Small Grant Program and the Vice Provost for Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartolini L, 1996, PHARMACOL BIOCHEM BE, V53, P277, DOI 10.1016/0091-3057(95)02021-7; Bogle Kristin E, 2009, Curr Drug Abuse Rev, V2, P157; CUMIN R, 1982, PSYCHOPHARMACOLOGY, V78, P104, DOI 10.1007/BF00432244; GOULIAEV AH, 1994, BRAIN RES REV, V19, P180, DOI 10.1016/0165-0173(94)90011-6; Ingvar M, 1997, EXP NEUROL, V146, P553, DOI 10.1006/exnr.1997.6581; Koliaki CC, 2012, CNS NEUROSCI THER, V18, P302, DOI 10.1111/j.1755-5949.2010.00244.x; Li Y, 2007, J NEURAL TRANSM, V114, P1407, DOI 10.1007/s00702-007-0760-2; Lu Y, 1997, BRAIN RES, V768, P197, DOI 10.1016/S0006-8993(97)00644-6; Lugo JN, 2012, LEARN MEMORY, V19, P182, DOI 10.1101/lm.023614.111; MARTIN JR, 1995, PHARMACOL RES, V31, P133, DOI 10.1016/1043-6618(95)80059-X; Masuoka T, 2008, PSYCHOPHARMACOLOGY, V197, P107, DOI 10.1007/s00213-007-1013-7; McCabe SE, 2005, ADDICT BEHAV, V30, P789, DOI 10.1016/j.addbeh.2004.08.024; McLaughlin L., 2011, ADDERALL WHOLE STORY; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Nakamura K, 2001, BRAIN RES, V897, P82, DOI 10.1016/S0006-8993(01)02096-0; Nakamura K, 2001, EUR J PHARMACOL, V420, P33, DOI 10.1016/S0014-2999(01)01005-6; Nakayama S, 1986, YAKURI TO CHIRYO, V14; Ogiso T, 1998, J PHARM SCI, V87, P594, DOI 10.1021/js970355p; Rao Y, 2001, NEUROSCI LETT, V298, P183, DOI 10.1016/S0304-3940(00)01744-4; Sara SJ, 1999, LEARN MEMORY, V6, P88; SPIGNOLI G, 1987, PHARMACOL BIOCHEM BE, V27, P491, DOI 10.1016/0091-3057(87)90353-4; UPCHURCH M, 1988, BEHAV GENET, V18, P55, DOI 10.1007/BF01067075; Vaglenova J, 2008, NEUROPSYCHOPHARMACOL, V33, P1071, DOI 10.1038/sj.npp.1301496; Wijayawardhane N, 2008, NEUROBIOL DIS, V29, P81, DOI 10.1016/j.nbd.2007.08.001; Wijayawardhane N, 2007, NEUROBIOL DIS, V26, P696, DOI 10.1016/j.nbd.2007.03.009; Yu SM, 2003, NEUROSCI LETT, V339, P187, DOI 10.1016/S0304-3940(03)00028-4; Zhang J, 2007, J CHROMATOGR B, V858, P129, DOI 10.1016/j.jchromb.2007.08.010	28	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e104443	10.1371/journal.pone.0104443	http://dx.doi.org/10.1371/journal.pone.0104443			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25099639	Green Published, Green Submitted, gold			2022-12-27	WOS:000339995100073
J	Gil, S; Le Bigot, L				Gil, Sandrine; Le Bigot, Ludovic			Seeing Life through Positive-Tinted Glasses: Color-Meaning Associations	PLOS ONE			English	Article							FACIAL EXPRESSIONS; EMOTION; RED; CONTEXT; RECOGNITION; FACES; PERFORMANCE; ATTRACTION; PERCEPTION; TASK	There is a growing body of literature to show that color can convey information, owing to its emotionally meaningful associations. Most research so far has focused on negative hue-meaning associations (e.g., red) with the exception of the positive aspects associated with green. We therefore set out to investigate the positive associations of colors (i.e., green and pink), using an emotional facial expression recognition task in which colors provided the emotional contextual information for the face processing. In two experiments, green and pink backgrounds enhanced happy face recognition and impaired sad face recognition, compared with a control color (gray). Our findings therefore suggest that because green and pink both convey positive information, they facilitate the processing of emotionally congruent facial expressions (i.e., faces expressing happiness) and interfere with that of incongruent facial expressions (i.e., faces expressing sadness). Data also revealed a positive association for white. Results are discussed within the theoretical framework of emotional cue processing and color meaning.	[Gil, Sandrine] Univ Poitiers, Poitiers, France; CNRS, CeRCA, UMR 7295, Poitiers, France	Universite de Poitiers; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Poitiers	Gil, S (corresponding author), Univ Poitiers, Poitiers, France.	sandrine.gil@univ-poitiers.fr	LE BIGOT, Ludovic/N-1320-2013	LE BIGOT, Ludovic/0000-0003-1951-8793	French National Research Agency (ANR) [EMCO-01-2011]	French National Research Agency (ANR)(French National Research Agency (ANR))	This research was supported by a grant from the French National Research Agency (ANR), within the framework of the Emotion(s), Cognition and Behavior call for projects (EMCO-01-2011). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 2002, CURR OPIN NEUROBIOL; Akers A, 2012, ENVIRON SCI TECHNOL, V46, P8661, DOI 10.1021/es301685g; [Anonymous], 2012, 2012 SAS GLOB FOR OR; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Bargh J. A., 1994, HDB SOCIAL COGNITION, V1, P1, DOI DOI 10.1007/S00572-005-0022-9; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Barrett LF, 2011, CURR DIR PSYCHOL SCI, V20, P286, DOI 10.1177/0963721411422522; Bonnardel N, 2011, DISPLAYS, V32, P69, DOI 10.1016/j.displa.2010.12.002; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; Calvo MG, 2008, J EXP PSYCHOL GEN, V137, P471, DOI 10.1037/a0012771; Coelho CM, 2010, J VISION, V10, DOI 10.1167/10.1.7; Darwin C., 1965, EXPRESS EMOT MAN; Egan M., 1974, AM ETHNOL, V1, P49, DOI [DOI 10.1525/AE.1974.1.1.02A00030, 10.1525/ae.1974.1.1.02a00030.]; EKMAN P, 1992, PSYCHOL SCI, V3, P34, DOI 10.1111/j.1467-9280.1992.tb00253.x; Ekman P., 1976, PICTURES FACIAL AFFE; Ekman P, 2011, EMOT REV, V3, P364, DOI 10.1177/1754073911410740; Elliot AJ, 2008, J PERS SOC PSYCHOL, V95, P1150, DOI 10.1037/0022-3514.95.5.1150; Elliot AJ, 2007, CURR DIR PSYCHOL SCI, V16, P250, DOI 10.1111/j.1467-8721.2007.00514.x; Elliot AJ, 2007, J EXP PSYCHOL GEN, V136, P154, DOI 10.1037/0096-3445.136.1.154; Elliot AJ, 2014, ANNU REV PSYCHOL, V65, P95, DOI 10.1146/annurev-psych-010213-115035; Elliot AJ, 2011, PSYCHOPHYSIOLOGY, V48, P1340, DOI 10.1111/j.1469-8986.2011.01216.x; Fetterman AK, 2012, COGNITION EMOTION, V26, P1445, DOI 10.1080/02699931.2012.673477; Fridlund A. J., 1997, PSYCHOL FACIAL EXPRE, P103, DOI [10.1017/CBO9780511659911.007, DOI 10.1017/CBO9780511659911.007]; Fridlund A.J., 1994, HUMAN FACIAL EXPRESS; Fruhholz S, 2011, COGNITION EMOTION, V25, P1045, DOI 10.1080/02699931.2010.516905; Gegenfurtner KR, 2003, NAT REV NEUROSCI, V4, P563, DOI 10.1038/nrn1138; Gendron M, 2012, EMOTION, V12, P314, DOI 10.1037/a0026007; Gerend MA, 2009, J EXP SOC PSYCHOL, V45, P999, DOI 10.1016/j.jesp.2009.04.002; Gnambs T, 2010, COMPUT HUM BEHAV, V26, P1625, DOI 10.1016/j.chb.2010.06.010; Goldstein K., 1942, OCCUP THER J RES, V21, P147, DOI DOI 10.4314/NJBAS.V21I2.9; Hemphill M, 1996, J GENET PSYCHOL, V157, P275, DOI 10.1080/00221325.1996.9914865; Ishihara S., 2009, ISHIHARA TEST COLOUR; Izard CE, 2011, EMOT REV, V3, P371, DOI 10.1177/1754073911410737; Jaeger TF, 2008, J MEM LANG, V59, P434, DOI 10.1016/j.jml.2007.11.007; Jalil NA, 2012, PROCD SOC BEHV, V35, P54, DOI 10.1016/j.sbspro.2012.02.062; Jiang F, 2014, J BEHAV DECIS MAKING, V27, P226, DOI 10.1002/bdm.1800; Keltner D, 1999, COGNITION EMOTION, V13, P505, DOI 10.1080/026999399379168; Kim H, 2004, J COGNITIVE NEUROSCI, V16, P1730, DOI 10.1162/0898929042947865; Ko SG, 2011, PSYCHOL AGING, V26, P48, DOI 10.1037/a0020222; Koller V, 2008, VISUAL COMMUN-US, V7, P395, DOI 10.1177/1470357208096209; Kuhbandner C, 2013, EMOTION, V13, P375, DOI 10.1037/a0031821; Lakens D, 2013, COGNITION EMOTION, V27, P1225, DOI 10.1080/02699931.2013.781501; Lang P.J., 2008, A8 U FLOR; Lee TH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032987; Lichtenfeld S, 2012, PERS SOC PSYCHOL B, V38, P784, DOI 10.1177/0146167212436611; Maier MA, 2008, PERS SOC PSYCHOL B, V34, P1530, DOI 10.1177/0146167208323104; Matsumoto D, 2000, J NONVERBAL BEHAV, V24, P179, DOI 10.1023/A:1006668120583; Meier BP, 2004, PSYCHOL SCI, V15, P82, DOI 10.1111/j.0963-7214.2004.01502002.x; Meier BP, 2007, EMOTION, V7, P366, DOI 10.1037/1528-3542.7.2.366; Meier BP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040333; Moller AC, 2009, EMOTION, V9, P898, DOI 10.1037/a0017811; Montagne B, 2007, PERCEPT MOTOR SKILL, V104, P589, DOI 10.2466/PMS.104.2.589-598; Morrot G, 2001, BRAIN LANG, V79, P309, DOI 10.1006/brln.2001.2493; Mumenthaler C, 2012, J PERS SOC PSYCHOL, V102, P1118, DOI 10.1037/a0026885; Neta M, 2011, EMOTION, V11, P1425, DOI 10.1037/a0022993; Ozturk E, 2012, COLOR RES APPL, V37, P359, DOI 10.1002/col.20697; Palmer SE, 2013, P NATL ACAD SCI USA, V110, P8836, DOI 10.1073/pnas.1212562110; Pazda AD, 2012, J EXP SOC PSYCHOL, V48, P787, DOI 10.1016/j.jesp.2011.12.009; Plutchik Robert, 1980, EMOTION THEORY RES E, V1, P3, DOI [10.1016/8978-0-12-558701-3.50007-7, DOI 10.1016/B978-0-12-558701-3.50007-7]; Porcherot C, 2012, FOOD QUAL PREFER, V23, P125, DOI 10.1016/j.foodqual.2011.07.006; Pravossoudovitch K, 2014, ERGONOMICS, V57, P503, DOI 10.1080/00140139.2014.889220; Righart R, 2008, COGN AFFECT BEHAV NE, V8, P264, DOI 10.3758/CABN.8.3.264; Righart R, 2008, SOC COGN AFFECT NEUR, V3, P270, DOI 10.1093/scan/nsn021; Righart R, 2006, CEREB CORTEX, V16, P1249, DOI 10.1093/cercor/bhj066; Schwarz KA, 2013, SOC COGN AFFECT NEUR, V8, P438, DOI 10.1093/scan/nss013; Shariff AF, 2011, CURR DIR PSYCHOL SCI, V20, P395, DOI 10.1177/0963721411424739; Shevell S. K., 2003, SCI COLOR; Smith ML, 2005, PSYCHOL SCI, V16, P184, DOI 10.1111/j.0956-7976.2005.00801.x; Song HJ, 2012, J EXP SOC PSYCHOL, V48, P450, DOI 10.1016/j.jesp.2011.10.003; Spence C, 2011, ATTEN PERCEPT PSYCHO, V73, P971, DOI 10.3758/s13414-010-0073-7; Tracy JL, 2008, EMOTION, V8, P81, DOI 10.1037/1528-3542.8.1.81; VALDEZ P, 1994, J EXP PSYCHOL GEN, V123, P394, DOI 10.1037/0096-3445.123.4.394; WELLER L, 1988, J GEN PSYCHOL, V115, P433, DOI 10.1080/00221309.1988.9710580; Wieser MJ, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00471; Yik MSM, 1999, J PERS SOC PSYCHOL, V77, P600, DOI 10.1037/0022-3514.77.3.600; Young SG, 2013, EMOTION, V13, P380, DOI 10.1037/a0032471	77	25	26	1	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e104291	10.1371/journal.pone.0104291	http://dx.doi.org/10.1371/journal.pone.0104291			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM6SM	25098167	Green Published, gold, Green Submitted			2022-12-27	WOS:000339995100060
J	Lim, JE; Kimm, H; Jee, SH				Lim, Jung-eun; Kimm, Heejin; Jee, Sun Ha			Combined Effects of Smoking and Bilirubin Levels on the Risk of Lung Cancer in Korea: The Severance Cohort Study	PLOS ONE			English	Article							STAGE RENAL-DISEASE; SERUM BILIRUBIN; KIDNEY-DISEASE; UNITED-STATES; MORTALITY; METAANALYSIS; ASSOCIATION; SURVIVAL; INDIVIDUALS; ANTIOXIDANT	Background: Smoking is a major risk factor for lung cancer. Bilirubin, an antioxidant, is inversely associated with the risk of diseases related to oxidative stress. This study was conducted to determine the influence of smoking and bilirubin levels on the risk of lung cancer in the Severance cohort study. Methods: This study included 68,676 Korean who received a health examination at Severance Health Promotion Center from 1994 to 2004. Serum bilirubin measurements within normal range were divided into tertiles whereas smoking states were divided as never-smokers, former smokers and current smokers. A diagnosis of lung cancer was coded as occurring based on the report from the National Cancer Registry. Hazard ratios (HRs) and 95% confidence intervals (95% CIs) were calculated using Cox proportional hazards model. Results: At the end of the study period, 240 patients (men: 181, women: 59) developed lung cancer. Compared to those with bilirubin levels >= 1.0 mg/dL, HRs (95% CI) for lung cancer were 2.8 (1.8-4.2) for subjects having bilirubin levels from 0.2 to 0.7 mg/dL in men. When we stratified our analysis by smoking status, bilirubin consistently showed a protective effect on the risk of lung cancer on both never- and current smokers. Current smokers having bilirubin levels from 0.2 to 0.7 mg/dL had a risk of lung cancer by 6.0-fold higher than never-smokers with bilirubin levels >= 1.0 mg/dL in men. Conclusion: In this large prospective study, higher baseline bilirubin level in the normal range was associated with low risk of lung cancer. Smoking and low bilirubin levels were cumulatively associated with a higher risk of lung cancer.	[Lim, Jung-eun; Kimm, Heejin; Jee, Sun Ha] Yonsei Univ, Grad Sch Publ Hlth, Inst Hlth Promot, Seoul 120749, South Korea; [Lim, Jung-eun; Kimm, Heejin; Jee, Sun Ha] Yonsei Univ, Grad Sch Publ Hlth, Dept Epidemiol & Hlth Promot, Seoul 120749, South Korea; [Lim, Jung-eun; Jee, Sun Ha] Yonsei Univ, Grad Sch, Dept Publ Hlth, Seoul 120749, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University	Jee, SH (corresponding author), Yonsei Univ, Grad Sch Publ Hlth, Inst Hlth Promot, Seoul 120749, South Korea.	jsunha@yuhs.ac		Jee, Sun Ha/0000-0001-9519-3068; Kimm, Heejin/0000-0003-4526-0570	National R&D Program for Cancer Control, Ministry for Health, Welfare and Family affairs, Republic of Korea [1220180]; Korea government (MEST) [2011-0029348]; Seoul R&BD Program, Republic of Korea [10526]	National R&D Program for Cancer Control, Ministry for Health, Welfare and Family affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Seoul R&BD Program, Republic of Korea(Seoul RBD program)	This study was supported by a grant from the National R&D Program for Cancer Control, Ministry for Health, Welfare and Family affairs, Republic of Korea (1220180). The National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST)(2011-0029348) and a grant of the Seoul R&BD Program, Republic of Korea (10526) also supported this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari B., 2009, Morbidity and Mortality Weekly Report, V58, P29; Bae JM, 2013, J KOREAN MED SCI, V28, P636, DOI 10.3346/jkms.2013.28.4.636; Castilho AF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042428; Chang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037241; Djousse L, 2001, AM J CARDIOL, V87, P1196, DOI 10.1016/S0002-9149(01)01494-1; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fox CS, 2012, LANCET, V380, P1662, DOI 10.1016/S0140-6736(12)61350-6; Prim JMG, 2008, MED CLIN-BARCELONA, V131, P601, DOI 10.1157/13127916; Hallan SI, 2012, JAMA-J AM MED ASSOC, V308, P2349, DOI 10.1001/jama.2012.16817; Horsfall LJ, 2011, JAMA-J AM MED ASSOC, V305, P691, DOI 10.1001/jama.2011.124; Huang SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042594; Inoguchi T, 2007, JAMA-J AM MED ASSOC, V298, P1398, DOI 10.1001/jama.298.12.1398-b; Jo Jaeseong, 2012, J Prev Med Public Health, V45, P105, DOI 10.3961/jpmph.2012.45.2.105; Jung KW, 2011, CANCER RES TREAT, V43, P1, DOI 10.4143/crt.2011.43.1.1; Keshavan P, 2004, INT J CANCER, V112, P433, DOI 10.1002/ijc.20418; Kimm H, 2009, STROKE, V40, P3422, DOI 10.1161/STROKEAHA.109.560649; Lee PN, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-385; Lin LY, 2009, ATHEROSCLEROSIS, V203, P563, DOI 10.1016/j.atherosclerosis.2008.07.021; Mahmoodi BK, 2012, LANCET, V380, P1649, DOI 10.1016/S0140-6736(12)61272-0; MICOZZI MS, 1989, AM J CLIN NUTR, V50, P1276, DOI 10.1093/ajcn/50.6.1276; Milman N, 2001, EUR J HAEMATOL, V67, P23, DOI 10.1034/j.1600-0609.2001.067001023.x; Milton JN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034741; Mok Y, 2012, J EPIDEMIOL, V22, P494, DOI 10.2188/jea.JE20110110; Mok Y, 2012, NEPHROL DIAL TRANSPL, V27, P1831, DOI 10.1093/ndt/gfr530; Rao P, 2006, BIOCHEM BIOPH RES CO, V342, P1279, DOI 10.1016/j.bbrc.2006.02.074; Riaz SP, 2011, J THORAC ONCOL, V6, P2005, DOI 10.1097/JTO.0b013e31822b02db; Rodrigues M, 1998, EUR J NUCL MED, V25, P265, DOI 10.1007/s002590050227; Ryter SW, 2007, AM J RESP CELL MOL, V36, P175, DOI 10.1165/rcmb.2006-0333TR; Schwertner HA, 1998, ATHEROSCLEROSIS, V136, P383, DOI 10.1016/S0021-9150(97)00232-3; Schwertner HA, 2008, ATHEROSCLEROSIS, V198, P1, DOI 10.1016/j.atherosclerosis.2008.01.001; Shin Hai-Rim, 2005, Cancer Res Treat, V37, P325, DOI 10.4143/crt.2005.37.6.325; Staempfli MR, 2009, NAT REV IMMUNOL, V9, P377, DOI 10.1038/nri2530; STOCKER R, 1987, SCIENCE, V235, P1043, DOI 10.1126/science.3029864; Van Hoydonck PGA, 2001, INT J EPIDEMIOL, V30, P1465; Zucker SD, 2004, HEPATOLOGY, V40, P827, DOI 10.1002/hep.20407	35	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e103972	10.1371/journal.pone.0103972	http://dx.doi.org/10.1371/journal.pone.0103972			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25100210	Green Submitted, Green Published, gold			2022-12-27	WOS:000339995100038
J	Nishida, K; Matsumura, S; Taniguchi, W; Uta, D; Furue, H; Ito, S				Nishida, Kazuhiko; Matsumura, Shinji; Taniguchi, Wataru; Uta, Daisuke; Furue, Hidemasa; Ito, Seiji			Three-Dimensional Distribution of Sensory Stimulation-Evoked Neuronal Activity of Spinal Dorsal Horn Neurons Analyzed by In Vivo Calcium Imaging	PLOS ONE			English	Article							SUBSTANTIA-GELATINOSA NEURONS; SUBNUCLEUS CAUDALIS NEURONS; PRIMARY AFFERENT NEURONS; AMINO-ACID ANTAGONISTS; RECEPTIVE-FIELD; RAT; CORD; EXPRESSION; ORGANIZATION; INTERNEURONS	The spinal dorsal horn comprises heterogeneous populations of interneurons and projection neurons, which form neuronal circuits crucial for processing of primary sensory information. Although electrophysiological analyses have uncovered sensory stimulation-evoked neuronal activity of various spinal dorsal horn neurons, monitoring these activities from large ensembles of neurons is needed to obtain a comprehensive view of the spinal dorsal horn circuitry. In the present study, we established in vivo calcium imaging of multiple spinal dorsal horn neurons by using a two-photon microscope and extracted three-dimensional neuronal activity maps of these neurons in response to cutaneous sensory stimulation. For calcium imaging, a fluorescence resonance energy transfer (FRET)-based calcium indicator protein, Yellow Cameleon, which is insensitive to motion artifacts of living animals was introduced into spinal dorsal horn neurons by in utero electroporation. In vivo calcium imaging following pinch, brush, and heat stimulation suggests that laminar distribution of sensory stimulation-evoked neuronal activity in the spinal dorsal horn largely corresponds to that of primary afferent inputs. In addition, cutaneous pinch stimulation elicited activities of neurons in the spinal cord at least until 2 spinal segments away from the central projection field of primary sensory neurons responsible for the stimulated skin point. These results provide a clue to understand neuronal processing of sensory information in the spinal dorsal horn.	[Nishida, Kazuhiko; Matsumura, Shinji; Ito, Seiji] Kansai Med Univ, Dept Med Chem, Hirakata, Osaka, Japan; [Taniguchi, Wataru] Kansai Univ Hlth Sci, Pain Res Ctr, Kumatori, Osaka, Japan; [Uta, Daisuke; Furue, Hidemasa] Natl Inst Physiol Sci, Dept Informat Physiol, Okazaki, Aichi 444, Japan	Kansai Medical University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS)	Ito, S (corresponding author), Kansai Med Univ, Dept Med Chem, Hirakata, Osaka, Japan.	ito@hirakata.kmu.ac.jp		ito, Seiji/0000-0002-0942-1624; Nishida, Kazuhiko/0000-0001-8825-8441; Taniguchi, Wataru/0000-0002-8333-7877	Japanese Ministry of Education, Culture, Sports, Science and Technology [24590736, 24590735, 23659322]; Grants-in-Aid for Scientific Research [25670289, 25860431, 26293132, 24590736] Funding Source: KAKEN	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research (http://www.jsps.go.jp/english/e-grants/index.html) from the Japanese Ministry of Education, Culture, Sports, Science and Technology, to KN (#24590736), SM (#24590735), and SI (#23659322). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albuquerque C, 1999, EUR J NEUROSCI, V11, P2758, DOI 10.1046/j.1460-9568.1999.00691.x; Avraham O, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-21; BULLITT E, 1991, J COMP NEUROL, V312, P279, DOI 10.1002/cne.903120210; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Cheng LP, 2004, NAT NEUROSCI, V7, P510, DOI 10.1038/nn1221; Dai JX, 2008, J COMP NEUROL, V509, P341, DOI 10.1002/cne.21759; Drdla R, 2009, SCIENCE, V325, P207, DOI 10.1126/science.1171759; Furue H, 1999, J PHYSIOL-LONDON, V521, P529, DOI 10.1111/j.1469-7793.1999.00529.x; Graham BA, 2004, J PHYSIOL-LONDON, V561, P749, DOI 10.1113/jphysiol.2004.072645; Grienberger C, 2012, NEURON, V73, P862, DOI 10.1016/j.neuron.2012.02.011; Grudt TJ, 2002, J PHYSIOL-LONDON, V540, P189, DOI 10.1113/jphysiol.2001.012890; Hatanaka Y, 2002, J COMP NEUROL, V454, P1, DOI 10.1002/cne.10421; Horikawa K, 2010, NAT METHODS, V7, P729, DOI 10.1038/nmeth.1488; Ikeda H, 2006, SCIENCE, V312, P1659, DOI 10.1126/science.1127233; Johannssen HC, 2013, EXP NEUROL, V242, P18, DOI 10.1016/j.expneurol.2012.07.014; Johannssen HC, 2010, J PHYSIOL-LONDON, V588, P3397, DOI 10.1113/jphysiol.2010.191833; Kato G, 2011, J NEUROSCI, V31, P17300, DOI 10.1523/JNEUROSCI.4474-11.2011; Kato G, 2009, J NEUROSCI, V29, P5088, DOI 10.1523/JNEUROSCI.6175-08.2009; Kobayashi K, 2005, J COMP NEUROL, V493, P596, DOI 10.1002/cne.20794; Laffray S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019928; Le Bars D, 2002, BRAIN RES REV, V40, P29, DOI 10.1016/S0165-0173(02)00186-8; Li LS, 2011, CELL, V147, P1615, DOI 10.1016/j.cell.2011.11.027; Light AR, 1999, J NEUROPHYSIOL, V82, P3316, DOI 10.1152/jn.1999.82.6.3316; LIGHT AR, 1979, J COMP NEUROL, V186, P133, DOI 10.1002/cne.901860203; Lorenzo LE, 2008, J COMP NEUROL, V508, P592, DOI 10.1002/cne.21691; Luu B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020940; Michael GJ, 1999, J NEUROSCI, V19, P1844; Narikawa K, 2000, J NEUROPHYSIOL, V84, P2171, DOI 10.1152/jn.2000.84.4.2171; Nishida K, 2011, MOL CELL NEUROSCI, V46, P662, DOI 10.1016/j.mcn.2011.01.007; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; REXED B, 1952, J COMP NEUROL, V96, P415, DOI 10.1002/cne.900960303; Ross SE, 2010, NEURON, V65, P886, DOI 10.1016/j.neuron.2010.02.025; Saba R, 2003, J NEUROSCI, V23, P1987; Sandkuhler J, 2009, PHYSIOL REV, V89, P707, DOI 10.1152/physrev.00025.2008; Sardella TCP, 2011, NEUROSCIENCE, V192, P708, DOI 10.1016/j.neuroscience.2011.07.011; SHERMAN SE, 1994, PAIN, V56, P17, DOI 10.1016/0304-3959(94)90146-5; Sorkin LS, 1998, PAIN, V77, P181, DOI 10.1016/S0304-3959(98)00094-3; SUGIURA Y, 1986, SCIENCE, V234, P358, DOI 10.1126/science.3764416; Takahashi Y, 2002, J COMP NEUROL, V445, P133, DOI 10.1002/cne.10158; Todd AJ, 2010, NAT REV NEUROSCI, V11, P823, DOI 10.1038/nrn2947; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Wang XD, 2013, NEURON, V78, P312, DOI 10.1016/j.neuron.2013.03.001; WOOLF CJ, 1983, J COMP NEUROL, V221, P313, DOI 10.1002/cne.902210307; Xu Y, 2013, J NEUROSCI, V33, P14738, DOI 10.1523/JNEUROSCI.5512-12.2013; YAKSH TL, 1989, PAIN, V37, P111, DOI 10.1016/0304-3959(89)90160-7; Yasaka T, 2010, PAIN, V151, P475, DOI 10.1016/j.pain.2010.08.008; YOKOTA T, 1979, BRAIN RES, V171, P369, DOI 10.1016/0006-8993(79)90345-7; YOKOTA T, 1979, BRAIN RES, V168, P430, DOI 10.1016/0006-8993(79)90188-4; Zhu Y, 2009, DEVELOPMENT, V136, P1919, DOI 10.1242/dev.032276	49	22	24	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e103321	10.1371/journal.pone.0103321	http://dx.doi.org/10.1371/journal.pone.0103321			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25100083	Green Submitted, gold, Green Published			2022-12-27	WOS:000339995100017
J	Pelosi, B; Migliarini, S; Pacini, G; Pratelli, M; Pasqualetti, M				Pelosi, Barbara; Migliarini, Sara; Pacini, Giulia; Pratelli, Marta; Pasqualetti, Massimo			Generation of Pet1(210)-Cre Transgenic Mouse Line Reveals Non-Serotonergic Expression Domains of Pet1 Both in CNS and Periphery	PLOS ONE			English	Article							NAIL-PATELLA SYNDROME; DORSAL RAPHE NUCLEUS; CENTRAL SEROTONERGIC NEURONS; TRANSCRIPTION FACTOR; BRAIN-DEVELOPMENT; GENE-EXPRESSION; EWING SARCOMA; IN-VIVO; LMX1B; SYSTEM	Neurons producing serotonin (5-hydroxytryptamine, 5-HT) constitute one of the most widely distributed neuronal networks in the mammalian central nervous system (CNS) and exhibit a profuse innervation throughout the CNS already at early stages of development. Serotonergic neuron specification is controlled by a combination of secreted molecules and transcription factors such as Shh, Fgf4/8, Nkx2.2, Lmx1b and Pet1. In the mouse, Pet1 mRNA expression appears between 10 and 11 days post coitum (dpc) in serotonergic post-mitotic precursors and persists in serotonergic neurons up to adulthood, where it promotes the expression of genes defining the mature serotonergic phenotype such as tryptophan hydroxylase 2 (Tph2) and serotonin transporter (SERT). Hence, the generation of genetic tools based on Pet1 specific expression represents a valuable approach to study the development and function of the serotonergic system. Here, we report the generation of a Pet1(210)-Cre transgenic mouse line in which the Cre recombinase is expressed under the control of a 210 kb fragment from the Pet1 genetic locus to ensure a reliable and faithful control of somatic recombination in Pet1 cell lineage. Besides Cre-mediated recombination accurately occurred in the serotonergic system as expected and according to previous studies, Pet1(270)-Cre transgenic mouse line allowed us to identify novel, so far uncharacterized, Pet1 expression domains. Indeed, we showed that in the raphe Pet1 is expressed also in a non-serotonergic neuronal population intermingled with Tph2-expressing cells and mostly localized in the B8 and B9 nuclei. Moreover, we detected Cre-mediated recombination also in the developing pancreas and in the ureteric bud derivatives of the kidney, where it reflected a specific Pet1 expression. Thus, Pet1270-Cre transgenic mouse line faithfully drives Cre-mediated recombination in all Pet1 expression domains representing a valuable tool to genetically manipulate serotonergic and non-serotonergic Pet1 cell lineages.	[Pelosi, Barbara; Migliarini, Sara; Pacini, Giulia; Pratelli, Marta; Pasqualetti, Massimo] Univ Pisa, Unit Cell & Dev Biol, Dept Biol, Pisa, Italy; [Pasqualetti, Massimo] Ist Italiano Tecnol, Ctr Neurosci & Cognit Syst UniTn, Rovereto, Italy	University of Pisa; Istituto Italiano di Tecnologia - IIT	Pasqualetti, M (corresponding author), Univ Pisa, Unit Cell & Dev Biol, Dept Biol, Pisa, Italy.	massimo.pasqualetti@unipi.it	Pratelli, Marta/GWQ-6324-2022	Pasqualetti, Massimo/0000-0002-0844-8139; Migliarini, Sara/0000-0003-2741-269X; Pelosi, Barbara/0000-0002-2829-2979	Italian Ministry of Education, University and Research (MIUR) [200894SYW2]; Toscana Life Sciences Foundation (Orphan_0108 program); University of Pisa; Regional Program; European Social Fund	Italian Ministry of Education, University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR)); Toscana Life Sciences Foundation (Orphan_0108 program); University of Pisa; Regional Program; European Social Fund(European Social Fund (ESF))	This work was supported by the Italian Ministry of Education, University and Research (MIUR) (Prin 2008, 200894SYW2) and Toscana Life Sciences Foundation (Orphan_0108 program) to MP. BP and GP were supported by a PhD program from the University of Pisa. SM was supported by the Regional Program and European Social Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade R, 2013, ACS CHEM NEUROSCI, V4, P22, DOI 10.1021/cn300224n; Awatramani R, 2003, NAT GENET, V35, P70, DOI 10.1038/ng1228; Aznar S, 2004, NEUROSCIENCE, V124, P573, DOI 10.1016/j.neuroscience.2003.12.020; Bang SJ, 2012, J COMP NEUROL, V520, P4157, DOI 10.1002/cne.23146; Bang SJ, 2012, EUR J NEUROSCI, V35, P85, DOI 10.1111/j.1460-9568.2011.07936.x; Berg T, 2009, CANCER GENET CYTOGEN, V194, P53, DOI 10.1016/j.cancergencyto.2009.06.002; Bonnin A, 2011, NATURE, V472, P347, DOI 10.1038/nature09972; Calizo LH, 2011, NEUROPHARMACOLOGY, V61, P524, DOI 10.1016/j.neuropharm.2011.04.008; Casanova E, 2001, GENESIS, V31, P37, DOI 10.1002/gene.1078; Chen H, 1998, NAT GENET, V19, P51, DOI 10.1038/ng0598-51; Cheng LP, 2003, J NEUROSCI, V23, P9961; Commons KG, 2003, NEUROPSYCHOPHARMACOL, V28, P206, DOI 10.1038/sj.npp.1300045; Copeland NG, 2001, NAT REV GENET, V2, P769, DOI 10.1038/35093556; Cote F, 2007, P NATL ACAD SCI USA, V104, P329, DOI 10.1073/pnas.0606722104; DAHLSTROM A, 1964, EXPERIENTIA, V20, P398, DOI 10.1007/BF02147990; Dahlstrom A, 1964, ACTA PHYSIOL SCAND S, V232, P1, DOI DOI 10.1007/BF00337069; DESCARRIES L, 1982, J COMP NEUROL, V207, P239, DOI 10.1002/cne.902070305; Ding YQ, 2003, NAT NEUROSCI, V6, P933, DOI 10.1038/nn1104; Dreyer SD, 1998, NAT GENET, V19, P47, DOI 10.1038/ng0598-47; Fyodorov D, 1998, J NEUROBIOL, V34, P151, DOI 10.1002/(SICI)1097-4695(19980205)34:2<151::AID-NEU5>3.0.CO;2-1; Gaspar P, 2003, NAT REV NEUROSCI, V4, P1002, DOI 10.1038/nrn1256; Giraldo P, 2001, TRANSGENIC RES, V10, P83, DOI 10.1023/A:1008918913249; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Gras C, 2002, J NEUROSCI, V22, P5442; Halberstadt AL, 2006, NEUROSCIENCE, V140, P1067, DOI 10.1016/j.neuroscience.2006.02.053; Heintz N, 2001, NAT REV NEUROSCI, V2, P861, DOI 10.1038/35104049; Hendricks T, 1999, J NEUROSCI, V19, P10348; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Hull EM, 2004, PHYSIOL BEHAV, V83, P291, DOI 10.1016/j.physbeh.2004.08.018; Jackson LN, 2009, CLIN CANCER RES, V15, P2747, DOI 10.1158/1078-0432.CCR-08-2346; Jacob J, 2009, DEVELOPMENT, V136, P2477, DOI 10.1242/dev.034546; Jankowski MP, 2004, J COMP NEUROL, V468, P518, DOI 10.1002/cne.10976; Jensen P, 2008, NAT NEUROSCI, V11, P417, DOI 10.1038/nn2050; Jensen Patricia, 2014, Methods Mol Biol, V1092, P437, DOI 10.1007/978-1-60327-292-6_26; Kiyasova V, 2011, EUR J NEUROSCI, V34, P1553, DOI 10.1111/j.1460-9568.2011.07910.x; KOHLER C, 1982, NEUROSCIENCE, V7, P951, DOI 10.1016/0306-4522(82)90054-9; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; LIDOV HGW, 1982, BRAIN RES BULL, V9, P559, DOI 10.1016/0361-9230(82)90164-2; Liu C, 2010, NAT NEUROSCI, V13, P1190, DOI 10.1038/nn.2623; McIntosh I, 1998, AM J HUM GENET, V63, P1651, DOI 10.1086/302165; Migliarini S, 2013, MOL PSYCHIATR, V18, P1106, DOI 10.1038/mp.2012.128; Morin LP, 1999, ANN MED, V31, P12, DOI 10.3109/07853899909019259; Narboux-Neme N, 2008, NEUROPHARMACOLOGY, V55, P994, DOI 10.1016/j.neuropharm.2008.08.020; Ng TL, 2007, J MOL DIAGN, V9, P459, DOI 10.2353/jmoldx.2007.070009; Ohta Y, 2011, DIABETES, V60, P3208, DOI 10.2337/db10-1192; Olivier B, 2005, NOVART FDN SYMP, V268, P242; OLIVIER B, 2005, NOVART FDN SYMP, V268, P183; Olivier Berend, 2005, Novartis Found Symp, V268, P171; Pattyn A, 2004, NAT NEUROSCI, V7, P589, DOI 10.1038/nn1247; Pattyn A, 2003, GENE DEV, V17, P729, DOI 10.1101/gad.255803; Peter M, 1997, ONCOGENE, V14, P1159, DOI 10.1038/sj.onc.1200933; Pfaar H, 2002, DEV GENES EVOL, V212, P43, DOI 10.1007/s00427-001-0208-x; Riccio O, 2009, MOL PSYCHIATR, V14, P280, DOI 10.1038/mp.2008.89; Robertson SD, 2013, NAT NEUROSCI, V16, P1016, DOI 10.1038/nn.3458; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Rohr C, 2002, J CLIN INVEST, V109, P1073, DOI 10.1172/JCI200213961; Ruhe HG, 2007, MOL PSYCHIATR, V12, P331, DOI 10.1038/sj.mp.4001949; SCHEDL A, 1993, NATURE, V362, P258, DOI 10.1038/362258a0; Schmidt-Ott KM, 2005, J AM SOC NEPHROL, V16, P1993, DOI 10.1681/ASN.2004121127; Scott MM, 2005, P NATL ACAD SCI USA, V102, P16472, DOI 10.1073/pnas.0504510102; Scott MM, 2005, J NEUROSCI, V25, P2628, DOI 10.1523/JNEUROSCI.4979-04.2005; Sodhi MSK, 2004, INT REV NEUROBIOL, V59, P111; Soiza-Reilly M, 2011, J CHEM NEUROANAT, V41, P247, DOI 10.1016/j.jchemneu.2011.04.004; Song NN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015998; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Thomson RB, 1998, GENOMICS, V51, P445, DOI 10.1006/geno.1998.5402; Valentino RJ, 2005, NEUROPEPTIDES, V39, P1, DOI 10.1016/j.npep.2004.09.005; WALLACE JA, 1983, BRAIN RES BULL, V10, P459, DOI 10.1016/0361-9230(83)90144-2; Weber T, 2009, FRONT MOL NEUROSCI, V2, DOI 10.3389/neuro.02.024.2009; Whitaker-Azmitia PM, 2001, BRAIN RES BULL, V56, P479, DOI 10.1016/S0361-9230(01)00615-3; Zhuang XX, 2005, J NEUROSCI METH, V143, P27, DOI 10.1016/j.jneumeth.2004.09.020	72	34	34	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e104318	10.1371/journal.pone.0104318	http://dx.doi.org/10.1371/journal.pone.0104318			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25098329	Green Published, Green Submitted, gold			2022-12-27	WOS:000339995100062
J	Vigneron, A; Cruaud, P; Roussel, EG; Pignet, P; Caprais, JC; Callac, N; Ciobanu, MC; Godfroy, A; Cragg, BA; Parkes, JR; Van Nostrand, JD; He, ZL; Zhou, JZ; Toffin, L				Vigneron, Adrien; Cruaud, Perrine; Roussel, Erwan G.; Pignet, Patricia; Caprais, Jean-Claude; Callac, Nolwenn; Ciobanu, Maria-Cristina; Godfroy, Anne; Cragg, Barry A.; Parkes, John R.; Van Nostrand, Joy D.; He, Zhili; Zhou, Jizhong; Toffin, Laurent			Phylogenetic and Functional Diversity of Microbial Communities Associated with Subsurface Sediments of the Sonora Margin, Guaymas Basin	PLOS ONE			English	Article							DEEP-SEA SEDIMENTS; SUBSEAFLOOR SEDIMENTS; MARINE-SEDIMENTS; ARCHAEAL COMMUNITIES; GROWTH-RATE; GULF; RNA; NITROGEN; BACTERIA; GEOCHIP	Subsurface sediments of the Sonora Margin (Guayma Basin), located in proximity of active cold seep sites were explored. The taxonomic and functional diversity of bacterial and archaeal communities were investigated from 1 to 10 meters below the seafloor. Microbial community structure and abundance and distribution of dominant populations were assessed using complementary molecular approaches (Ribosomal Intergenic Spacer Analysis, 16S rRNA libraries and quantitative PCR with an extensive primers set) and correlated to comprehensive geochemical data. Moreover the metabolic potentials and functional traits of the microbial community were also identified using the GeoChip functional gene microarray and metabolic rates. The active microbial community structure in the Sonora Margin sediments was related to deep subsurface ecosystems (Marine Benthic Groups B and D, Miscellaneous Crenarchaeotal Group, Chloroflexi and Candidate divisions) and remained relatively similar throughout the sediment section, despite defined biogeochemical gradients. However, relative abundances of bacterial and archaeal dominant lineages were significantly correlated with organic carbon quantity and origin. Consistently, metabolic pathways for the degradation and assimilation of this organic carbon as well as genetic potentials for the transformation of detrital organic matters, hydrocarbons and recalcitrant substrates were detected, suggesting that chemoorganotrophic microorganisms may dominate the microbial community of the Sonora Margin subsurface sediments.	[Vigneron, Adrien; Cruaud, Perrine; Pignet, Patricia; Callac, Nolwenn; Godfroy, Anne; Toffin, Laurent] IFREMER, Lab Microbiol Environm Extremes, UMR6197, Plouzane, France; [Vigneron, Adrien; Cruaud, Perrine; Pignet, Patricia; Callac, Nolwenn; Godfroy, Anne; Toffin, Laurent] Univ Bretagne Occidentale, Lab Microbiol Environm Extremes, UMR6197, Plouzane, France; [Vigneron, Adrien; Cruaud, Perrine; Pignet, Patricia; Callac, Nolwenn; Godfroy, Anne; Toffin, Laurent] CNRS, Lab Microbiol Environm Extremes, UMR6197, Plouzane, France; [Caprais, Jean-Claude] IFREMER, Lab Etud Environm Profonds, UMR6197, Plouzane, France; [Callac, Nolwenn] Univ Brest, Domaines Ocean IUEM, UMR6538, Plouzane, France; [Ciobanu, Maria-Cristina] IFREMER, Geosci Marines, Lab Environm Sedimentaires, Plouzane, France; [Roussel, Erwan G.; Cragg, Barry A.; Parkes, John R.] Cardiff Univ, Sch Earth & Ocean Sci, Cardiff CF10 3AX, S Glam, Wales; [Van Nostrand, Joy D.; He, Zhili; Zhou, Jizhong] Univ Oklahoma, Inst Environm Genom, Norman, OK 73019 USA; [Van Nostrand, Joy D.; He, Zhili; Zhou, Jizhong] Univ Oklahoma, Dept Microbiol & Plant Biol, Norman, OK 73019 USA; [Zhou, Jizhong] Tsinghua Univ, Sch Environm, State Key Joint Lab Environm Simulat & Pollut Con, Beijing 100084, Peoples R China; [Zhou, Jizhong] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Earth Sci, Berkeley, CA 94720 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Ifremer; Universite de Bretagne Occidentale; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Ifremer; Universite de Bretagne Occidentale; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Ifremer; Universite de Bretagne Occidentale; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Ifremer; Universite de Bretagne Occidentale; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite de Bretagne Occidentale; Institut Universitaire Europeen de la Mer (IUEM); Ifremer; Cardiff University; University of Oklahoma System; University of Oklahoma - Norman; University of Oklahoma System; University of Oklahoma - Norman; Tsinghua University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Vigneron, A (corresponding author), IFREMER, Lab Microbiol Environm Extremes, UMR6197, Plouzane, France.	avignero@gmail.com	Cruaud, Perrine/U-9631-2019; Cragg, Barry/D-2690-2009; He, Zhili/C-2879-2012; Van Nostrand, Joy D/F-1740-2016; Roussel, Erwan G/B-9992-2009; 吴, 昊/AAB-1620-2020; Anne, Godfroy/J-9897-2017; Godfroy, Anne/X-1992-2018; Callac, Nolwenn/O-3579-2016	Cruaud, Perrine/0000-0001-8628-3600; He, Zhili/0000-0001-8225-7333; Van Nostrand, Joy D/0000-0001-9548-6450; Roussel, Erwan G/0000-0002-8735-5597; Anne, Godfroy/0000-0003-0483-4160; Godfroy, Anne/0000-0003-0483-4160; Callac, Nolwenn/0000-0002-7578-3455; Ciobanu, Maria-Cristina/0000-0002-7504-2358	IFREMER; IFREMER PhD grant	IFREMER; IFREMER PhD grant	The oceanographic cruise and this study was funded by IFREMER and a IFREMER PhD grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARENSDORF JJ, 1995, APPL ENVIRON MICROB, V61, P443, DOI 10.1128/AEM.61.2.443-447.1995; Biddle JF, 2008, P NATL ACAD SCI USA, V105, P10583, DOI 10.1073/pnas.0709942105; Biddle JF, 2006, P NATL ACAD SCI USA, V103, P3846, DOI 10.1073/pnas.0600035103; Blazejak A, 2010, FEMS MICROBIOL ECOL, V72, P198, DOI 10.1111/j.1574-6941.2010.00838.x; Callac N, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00250; Carmona M, 2009, MICROBIOL MOL BIOL R, V73, P71, DOI 10.1128/MMBR.00021-08; Chan YK, 2013, P NATL ACAD SCI USA, V110, P8990, DOI 10.1073/pnas.1300643110; Cheshire H, 2005, J QUATERNARY SCI, V20, P457, DOI 10.1002/jqs.944; Ciobanu MC, 2012, BIOGEOSCIENCES DISCU, V9, P253; D'Hondt S, 2004, SCIENCE, V306, P2216, DOI 10.1126/science.1101155; Danovaro R, 1999, DEEP-SEA RES PT I, V46, P1077, DOI 10.1016/S0967-0637(98)00101-0; Dekas AE, 2009, SCIENCE, V326, P422, DOI 10.1126/science.1178223; Divins DL, 2003, TOTAL SEDIMENT TCHIC; Durbin AM, 2011, ENVIRON MICROBIOL, V13, P3219, DOI 10.1111/j.1462-2920.2011.02544.x; Fonselius S, 2007, METHODS SEAWATER ANA, P91, DOI DOI 10.1086/678125; Futagami T, 2009, APPL ENVIRON MICROB, V75, P6905, DOI 10.1128/AEM.01124-09; Govin A, 2012, GEOCHEM GEOPHY GEOSY, V13, DOI 10.1029/2011GC003785; Guy L, 2011, TRENDS MICROBIOL, V19, P580, DOI 10.1016/j.tim.2011.09.002; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; He ZL, 2010, ISME J, V4, P1167, DOI 10.1038/ismej.2010.46; Inagaki F, 2003, APPL ENVIRON MICROB, V69, P7224, DOI 10.1128/AEM.69.12.7224-7235.2003; Inagaki F, 2006, P NATL ACAD SCI USA, V103, P14164, DOI 10.1073/pnas.0606083103; Jorgensen BB, 2011, P NATL ACAD SCI USA, V108, P18193, DOI 10.1073/pnas.1115421108; Jorgensen SL, 2012, P NATL ACAD SCI USA, V109, pE2846, DOI 10.1073/pnas.1207574109; Kallmeyer J, 2012, P NATL ACAD SCI; KEMP PF, 1993, APPL ENVIRON MICROB, V59, P2594, DOI 10.1128/AEM.59.8.2594-2601.1993; KERKHOF L, 1993, APPL ENVIRON MICROB, V59, P1303, DOI 10.1128/AEM.59.5.1303-1309.1993; Knittel K, 2009, ANNU REV MICROBIOL, V63, P311, DOI 10.1146/annurev.micro.61.080706.093130; Kubo K, 2012, ISME J; Lazar CS, 2011, APPL ENVIRON MICROB, V77, P3120, DOI 10.1128/AEM.01296-10; Lazar CS, 2010, MICROB ECOL, V60, P516, DOI 10.1007/s00248-010-9654-1; Leigh JA, 2000, PROKARYOTIC NITROGEN FIXATION, P657; Lipp JS, 2008, NATURE, V454, P991, DOI 10.1038/nature07174; Lloyd KG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008738; Lloyd KG, 2013, NATURE; Loffler FE, 2012, INT J SYSTEMATIC EVO; Lomstein BA, 2012, NATURE, V484, P101, DOI 10.1038/nature10905; Lu ZM, 2012, ENVIRON SCI TECHNOL, V46, P5824, DOI 10.1021/es300478j; Meng J, 2013, ISME J; Meyerdierks A, 2010, ENVIRON MICROBIOL, V12, P422, DOI 10.1111/j.1462-2920.2009.02083.x; Morono Y, 2011, P NATL ACAD SCI USA, V108, P18295, DOI 10.1073/pnas.1107763108; Mussmann M, 2011, P NATL ACAD SCI USA, V108, P16771, DOI 10.1073/pnas.1106427108; NATH BN, 1989, MAR GEOL, V87, P301, DOI 10.1016/0025-3227(89)90067-4; Newberry CJ, 2004, ENVIRON MICROBIOL, V6, P274, DOI 10.1111/j.1462-2920.2004.00568.x; Orcutt BN, 2011, MICROBIOL MOL BIOL R, V75, P361, DOI 10.1128/MMBR.00039-10; Orsi WD, 2013, NATURE, V499, P205, DOI 10.1038/nature12230; Parkes RJ, 2007, ENVIRON MICROBIOL, V9, P1146, DOI 10.1111/j.1462-2920.2006.01237.x; Parkes RJ, 2000, HYDROGEOL J, V8, P11, DOI 10.1007/PL00010971; Parkes RJ, 2005, NATURE, V436, P390, DOI 10.1038/nature03796; Raymond J, 2004, MOL BIOL EVOL, V21, P541, DOI 10.1093/molbev/msh047; Roussel EG, 2008, SCIENCE, V320, P1046, DOI 10.1126/science.1154545; Roussel EG, 2009, ENVIRON MICROBIOL, V11, P2446, DOI 10.1111/j.1462-2920.2009.01976.x; Roy R, 2010, ESTUAR COAST SHELF S, V88, P311, DOI 10.1016/j.ecss.2010.04.011; Russ L, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00219; Sarradin P-M, 1996, ANAL COMMUN, V33; SIMONEIT BRT, 1979, DEEP-SEA RES, V26, P879, DOI 10.1016/0198-0149(79)90102-X; SIMONEIT BRT, 1990, APPL GEOCHEM, V5, P41, DOI 10.1016/0883-2927(90)90034-3; SOWERS KR, 1983, APPL ENVIRON MICROB, V45, P684, DOI 10.1128/AEM.45.2.684-690.1983; Teske A, 2008, ISME J, V2, P3, DOI 10.1038/ismej.2007.90; Vetriani C, 2003, APPL ENVIRON MICROB, V69, P6481, DOI 10.1128/AEM.69.11.6481-6488.2003; Vigneron A, 2013, ISME J; Vigneron A, 2014, ENV MICROBIOL; Webster G, 2004, APPL ENVIRON MICROB, V70, P5708, DOI 10.1128/AEM.70.9.5708-5713.2004; Zhou J, 2009, PHYTOPATHOLOGY, V99, pS164; Zhou JZ, 1996, APPL ENVIRON MICROB, V62, P316, DOI 10.1128/AEM.62.2.316-322.1996	65	21	22	1	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e104427	10.1371/journal.pone.0104427	http://dx.doi.org/10.1371/journal.pone.0104427			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25099369	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000339995100071
J	Marko, PB; Nance, HA; van den Hurk, P				Marko, Peter B.; Nance, Holly A.; van den Hurk, Peter			Seafood Substitutions Obscure Patterns of Mercury Contamination in Patagonian Toothfish (Dissostichus eleginoides) or "Chilean Sea Bass''	PLOS ONE			English	Article							FISH; EXPOSURE; OCEAN	Seafood mislabeling distorts the true abundance of fish in the sea, defrauds consumers, and can also cause unwanted exposure to harmful pollutants. By combining genetic data with analyses of total mercury content, we have investigated how species substitutions and fishery-stock substitutions obscure mercury contamination in Patagonian toothfish (Dissostichus eleginoides), also known as "Chilean sea bass''. Patagonian toothfish show wide variation in mercury concentrations such that consumers may be exposed to either acceptable or unacceptable levels of mercury depending on the geographic origins of the fish and the allowable limits of different countries. Most notably, stocks of Patagonian toothfish in Chile accumulate significantly more mercury than stocks closer to the South Pole, including the South Georgia/Shag Rocks stock, a fishery certified by the Marine Stewardship Council (MSC) as sustainably fished. Consistent with the documented geography of mercury contamination, our analysis showed that, on average, retail fish labeled as MSC-certified Patagonian toothfish had only half the mercury of uncertified fish. However, consideration of genetic data that were informative about seafood substitutions revealed a complex pattern of contamination hidden from consumers: species substitutions artificially inflated the expected difference in mercury levels between MSC-certified and uncertified fish whereas fishery stock substitutions artificially reduced the expected difference in mercury content between MSC-certified and uncertified fish that were actually D. eleginoides. Among MSC-certified fish that were actually D. eleginoides, several with exogenous mtDNA haplotypes (i.e., not known from the certified fishery) had mercury concentrations on par with uncertified fish from Chile. Overall, our analysis of mercury was consistent with inferences from the genetic data about the geographic origins of the fish, demonstrated the potential negative impact of seafood mislabeling on unwanted mercury exposure for consumers, and showed that fishery-stock substitutions may expose consumers to significantly greater mercury concentrations in retail-acquired fish than species substitutions.	[Marko, Peter B.] Univ Hawaii Manoa, Dept Biol, Honolulu, HI 96822 USA; [Nance, Holly A.] Indian River State Coll, Ft Pierce, FL USA; [van den Hurk, Peter] Clemson Univ, Dept Biol Sci, Clemson, SC 29634 USA	University of Hawaii System; University of Hawaii Manoa; Clemson University	Marko, PB (corresponding author), Univ Hawaii Manoa, Dept Biol, Honolulu, HI 96822 USA.	pmarko@hawaii.edu		van den Hurk, Peter/0000-0002-8131-0996	National Science Foundation [OCE-0961996]	National Science Foundation(National Science Foundation (NSF))	This work was supported by the National Science Foundation (OCE-0961996). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	COSTA LG, 1988, TOXICOLOGY, V49, P359, DOI 10.1016/0300-483X(88)90019-4; Guynn KD, 2008, POLAR BIOL, V31, P269, DOI 10.1007/s00300-007-0354-3; Hanchet SM, 2012, ANTARCT SCI, V24, P34, DOI 10.1017/S0954102011000654; Hanner R, 2011, MITOCHONDR DNA, V22, P27, DOI 10.3109/19401736.2011.596833; Hightower JM, 2003, ENVIRON HEALTH PERSP, V111, P604, DOI 10.1289/ehp.5837; Hillary RM, 2006, CCAMLR SCI, V13, P65; Karimi R, 2012, ENVIRON HEALTH PERSP, V120, P1512, DOI 10.1289/ehp.1205122; Lowenstein JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007866; Marko PB, 2004, NATURE, V430, P309, DOI 10.1038/430309b; Marko PB, 2011, CURR BIOL, V21, pR621, DOI 10.1016/j.cub.2011.07.006; McArthur T, 2003, POLAR BIOL, V27, P1, DOI 10.1007/s00300-003-0560-6; Mendez E, 2001, J FOOD COMPOS ANAL, V14, P547, DOI 10.1006/jfca.2001.1006; Miller DD, 2014, SEAFOOD, V8, P517, DOI DOI 10.1890/090212; Piraino MN, 2009, MAR ENVIRON RES, V67, P117, DOI 10.1016/j.marenvres.2008.12.006; Sackett DK, 2013, INT J ENV RES PUB HE, V10, P638, DOI 10.3390/ijerph10020638; Shaw PW, 2004, MOL ECOL, V13, P3293, DOI 10.1111/j.1365-294X.2004.02327.x; Staff, 2011, CONSUMER REPORTS DEC; Streit Bruno, 1998, EXS, V86, P353; Sunderland EM, 2007, ENVIRON HEALTH PERSP, V115, P235, DOI 10.1289/ehp.9377; US EPA, 1994, 2008 US EPA; [US FDA US EPA], 2004, WHAT YOU NEED KNOW M; US-EPA, 1996, SW 846 TEST METHOD 3; von der Heyden S, 2009, AFR J MAR SCI, V31, P263, DOI 10.2989/AJMS.2009.31.2.14.886	23	16	16	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e104140	10.1371/journal.pone.0104140	http://dx.doi.org/10.1371/journal.pone.0104140			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093736	Green Published, gold, Green Submitted			2022-12-27	WOS:000341357200071
J	Middleton, CH; Irving, W; Robertson, JFR; Murray, A; Parsy-Kowalska, CB; Macdonald, IK; McElveen, J; Allen, J; Healey, GF; Thomson, BJ; Ryder, SJ; Holdenrieder, S; Chapman, CJ				Middleton, Catrin H.; Irving, William; Robertson, John F. R.; Murray, Andrea; Parsy-Kowalska, Celine B.; Macdonald, Isabel K.; McElveen, Jane; Allen, Jared; Healey, Graham F.; Thomson, Brian J.; Ryder, Stephen J.; Holdenrieder, Stefan; Chapman, Caroline J.			Serum Autoantibody Measurement for the Detection of Hepatocellular Carcinoma	PLOS ONE			English	Article							TUMOR-ASSOCIATED ANTIGENS; BREAST-CANCER; LUNG; BIOMARKERS; VALIDATION; ANTIBODIES; ALPHA; AID; P53	Background: Individuals with liver disease, and especially those with Hepatitis B or C, are at an increased risk of developing hepatocellular carcinoma (HCC) which is the third most common cause of cancer-related death worldwide. Inadequate screening tests largely account for presentation of advanced tumours and high mortality rates. Early detection of HCC amongst high-risk groups is paramount in improving prognosis. This research aimed to further characterise the previously described humoral immune response raised to tumour-associated antigens (TAAs) in the serum of patients with HCC. Methods: Serum from 96 patients with confirmed HCC, 96 healthy controls matched for age and sex, 78 patients with confirmed liver cirrhosis and 91 patients with confirmed chronic liver disease were analysed for the presence of IgG autoantibodies raised to 41 recombinant TAAs/antigen fragments by ELISA. Results: Varying autoantibody specificities (97-100%) and sensitivities (0-10%) were observed to individual TAAs. A 21-antigen panel achieved a specificity of 92% and sensitivity of 45% for the detection of HCC. This same panel identified 21% of 169 high-risk controls as having elevated autoantibody levels. A reproducible panel of 10 antigens achieved a specificity of 91% and sensitivity of 41% in HCC. 15% of 152 high-risk controls gave positive results with this panel. Conclusions: This minimally invasive blood test has the potential to offer advantages over currently available tools for the identification of HCC amongst pre-disposed patients. Results are comparable to current gold standards in HCC (Ultrasonography) and to similar tests in other cancers (EarlyCDT-Lung).	[Middleton, Catrin H.; Robertson, John F. R.; Chapman, Caroline J.] Univ Nottingham, Sch Med, Ctr Excellence Autoimmun Canc, Nottingham, England; [Murray, Andrea; Parsy-Kowalska, Celine B.; Macdonald, Isabel K.; McElveen, Jane; Allen, Jared; Healey, Graham F.] Oncimmune Ltd, Nottingham, England; [Irving, William; Thomson, Brian J.; Ryder, Stephen J.] Queens Med Ctr, Nottingham Digest Dis Biomed Res Unit, Nottingham NG7 2UH, England; [Holdenrieder, Stefan] Univ Hosp Bonn, Inst Clin Chem & Clin Pharmacol, Bonn, Germany	University of Nottingham; University of Nottingham; University of Bonn	Chapman, CJ (corresponding author), Univ Nottingham, Sch Med, Ctr Excellence Autoimmun Canc, Nottingham, England.	caroline.chapman@nottingham.ac.uk		Thomson, Brian/0000-0001-8490-2332; Ryder, Stephen David/0000-0001-9649-4444; Allen, Jared/0000-0002-4061-3704; Irving, William/0000-0002-7268-3168	University of Nottingham; Oncimmune Ltd.	University of Nottingham; Oncimmune Ltd.	This work was supported by funding from the University of Nottingham and Oncimmune Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boyle P, 2011, ANN ONCOL, V22, P383, DOI 10.1093/annonc/mdq361; Bruix J, 2001, J HEPATOL, V35, P421, DOI 10.1016/S0168-8278(01)00130-1; Bruno S, 2011, HEPATIC MED-EVID RES, V3, P21, DOI 10.2147/HMER.S16991; Cancer Research UK, 2010, CANCERSTATS; Chan CC, 2010, INT J CANCER, V126, P1683, DOI 10.1002/ijc.24912; Chapman C, 2007, ANN ONCOL, V18, P868, DOI 10.1093/annonc/mdm007; Chapman CJ, 2008, THORAX, V63, P228, DOI 10.1136/thx.2007.083592; Chapman CJ, 2012, TUMOR BIOL, V33, P1319, DOI 10.1007/s13277-012-0379-2; Chapman CJ, 2011, CLIN CANCER RES, V17, P1474, DOI 10.1158/1078-0432.CCR-10-1363; Chapman CJ, 2010, CHEST, V138, p775A; Chen Y, 2010, CANCER LETT, V289, P32, DOI 10.1016/j.canlet.2009.07.016; Dutta J, 2008, J VIROL, V82, P10792, DOI 10.1128/JVI.00903-08; European Assoc Study Liver, 2012, EUR J CANCER, V48, P599, DOI 10.1016/j.ejca.2011.12.021; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Hollander M., 2014, NONPARAMETRIC STAT M, V3rd ed.; Kilic A, 2008, J THORAC CARDIOV SUR, V136, P199, DOI 10.1016/j.jtcvs.2008.01.012; Kridel SJ, 2004, CANCER RES, V64, P2070, DOI 10.1158/0008-5472.can-03-3645; Lafaro KJ, 2015, SURG ONCOL CLIN N AM, V24, P1, DOI 10.1016/j.soc.2014.09.001; Lam S, 2011, CANCER PREV RES, V4, P1126, DOI 10.1158/1940-6207.CAPR-10-0328; Le Naour F, 2002, MOL CELL PROTEOMICS, V1, P197, DOI 10.1074/mcp.M100029-MCP200; Li J, 2012, SCAND J IMMUNOL, V75, P342, DOI 10.1111/j.1365-3083.2011.02657.x; Liu H, 2012, CANCER EPIDEMIOL, V36, P82, DOI 10.1016/j.canep.2011.04.001; Looi KS, 2008, J PROTEOME RES, V7, P4004, DOI 10.1021/pr800273h; Lu HL, 2012, CANCER PREV RES, V5, P1036, DOI 10.1158/1940-6207.CAPR-11-0558; Macdonald IK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040759; Murray A, 2010, ANN ONCOL, V21, P1687, DOI 10.1093/annonc/mdp606; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pedersen JW, 2013, BRIT J CANCER, V108, P107, DOI 10.1038/bjc.2012.517; Piura B, 2009, J ONCOL, V2009, DOI 10.1155/2009/581939; Piura E, 2011, J ONCOL, V2011, DOI 10.1155/2011/982425; Robertson JFR, 2005, J CLIN ONCOL, V23, p16S; Robertson JFR, 2005, Tumour markers. European patent, Patent No. [EP-B 1078264, 1078264]; Shan Q, 2013, CANCER LETT, V328, P160, DOI 10.1016/j.canlet.2012.08.019; Storr SJ, 2006, EXPERT REV ANTICANC, V6, P1215, DOI 10.1586/14737140.6.8.1215; Wang KJ, 2009, CANCER LETT, V281, P144, DOI 10.1016/j.canlet.2009.02.037; Yi XY, 2013, CLIN CHIM ACTA, V425, P212, DOI 10.1016/j.cca.2013.08.005; Zayakin P, 2013, INT J CANCER, V132, P137, DOI 10.1002/ijc.27667; Zhang JY, 2007, J HEPATOL, V46, P107, DOI 10.1016/j.jhep.2006.08.010; Zhong L, 2006, J THORAC ONCOL, V1, P513, DOI 10.1097/01243894-200607000-00003	39	21	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e103867	10.1371/journal.pone.0103867	http://dx.doi.org/10.1371/journal.pone.0103867			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093332	Green Published, Green Submitted, gold			2022-12-27	WOS:000341357200039
J	Jenkins, RKB; Tognelli, MF; Bowles, P; Cox, N; Brown, JL; Chan, L; Andreone, F; Andriamazava, A; Andriantsimanarilafy, RR; Anjeriniaina, M; Bora, P; Brady, LD; Hantalalaina, EF; Glaw, F; Griffiths, RA; Hilton-Taylor, C; Hoffmann, M; Katariya, V; Rabibisoa, NH; Rafanomezantsoa, J; Rakotomalala, D; Rakotondravony, H; Rakotondrazafy, NA; Ralambonirainy, J; Ramanamanjato, JB; Randriamahazo, H; Randrianantoandro, JC; Randrianasolo, HH; Randrianirina, JE; Randrianizahana, H; Raselimanana, AP; Rasolohery, A; Ratsoavina, FM; Raxworthy, CJ; Robsomanitrandrasana, E; Rollande, F; van Dijk, PP; Yoder, AD; Vences, M				Jenkins, Richard K. B.; Tognelli, Marcelo F.; Bowles, Philip; Cox, Neil; Brown, Jason L.; Chan, Lauren; Andreone, Franco; Andriamazava, Alain; Andriantsimanarilafy, Raphali R.; Anjeriniaina, Mirana; Bora, Parfait; Brady, Lee D.; Hantalalaina, Elisoa F.; Glaw, Frank; Griffiths, Richard A.; Hilton-Taylor, Craig; Hoffmann, Michael; Katariya, Vineet; Rabibisoa, Nirhy H.; Rafanomezantsoa, Jeannot; Rakotomalala, Domoina; Rakotondravony, Hery; Rakotondrazafy, Ny A.; Ralambonirainy, Johans; Ramanamanjato, Jean-Baptiste; Randriamahazo, Herilala; Randrianantoandro, J. Christian; Randrianasolo, Hanson H.; Randrianirina, Jasmin E.; Randrianizahana, Hiarinirina; Raselimanana, Achille P.; Rasolohery, Andriambolantsoa; Ratsoavina, Fanomezana M.; Raxworthy, Christopher J.; Robsomanitrandrasana, Eric; Rollande, Finoana; van Dijk, Peter P.; Yoder, Anne D.; Vences, Miguel			Extinction Risks and the Conservation of Madagascar's Reptiles	PLOS ONE			English	Article							TORTOISE GEOCHELONE-YNIPHORA; RAIN-FORESTS; SCINCID LIZARDS; GLOBAL ANALYSIS; CLIMATE-CHANGE; NATIONAL-PARK; LIFE-HISTORY; GAP ANALYSIS; AMPHIBIANS; DIVERSITY	Background: An understanding of the conservation status of Madagascar's endemic reptile species is needed to underpin conservation planning and priority setting in this global biodiversity hotspot, and to complement existing information on the island's mammals, birds and amphibians. We report here on the first systematic assessment of the extinction risk of endemic and native non-marine Malagasy snakes, lizards, turtles and tortoises. Methodology/Principal Findings: Species range maps from The IUCN Red List of Threatened Species were analysed to determine patterns in the distribution of threatened reptile species. These data, in addition to information on threats, were used to identify priority areas and actions for conservation. Thirty-nine percent of the data-sufficient Malagasy reptiles in our analyses are threatened with extinction. Areas in the north, west and south-east were identified as having more threatened species than expected and are therefore conservation priorities. Habitat degradation caused by wood harvesting and non-timber crops was the most pervasive threat. The direct removal of reptiles for international trade and human consumption threatened relatively few species, but were the primary threats for tortoises. Nine threatened reptile species are endemic to recently created protected areas. Conclusions/Significance: With a few alarming exceptions, the threatened endemic reptiles of Madagascar occur within the national network of protected areas, including some taxa that are only found in new protected areas. Threats to these species, however, operate inside and outside protected area boundaries. This analysis has identified priority sites for reptile conservation and completes the conservation assessment of terrestrial vertebrates in Madagascar which will facilitate conservation planning, monitoring and wise-decision making. In sharp contrast with the amphibians, there is significant reptile diversity and regional endemism in the southern and western regions of Madagascar and this study highlights the importance of these arid regions to conserving the island's biodiversity.	[Jenkins, Richard K. B.; Hilton-Taylor, Craig; Katariya, Vineet] IUCN, Global Species Programme, Cambridge, England; [Tognelli, Marcelo F.; Bowles, Philip; Cox, Neil; Hoffmann, Michael; van Dijk, Peter P.] Conservat Int, Betty & Gordon Moore Ctr Sci & Oceans, IUCN CI Biodivers Assessment Unit, Arlington, VA USA; [Tognelli, Marcelo F.; Bowles, Philip; Cox, Neil] IUCN Global Species Programme, Gland, Switzerland; [Brown, Jason L.; Chan, Lauren; Yoder, Anne D.] Duke Univ, Dept Biol, Durham, NC USA; [Chan, Lauren] Pitzer Coll, WM Keck Sci Dept Claremont McKenna, Claremont, CA 91711 USA; [Chan, Lauren] Scripps Coll, WM Keck Sci Dept Claremont McKenna, Claremont, CA 91711 USA; [Andreone, Franco] Museo Regionale Sci Nat, Turin, Italy; [Andriamazava, Alain] Ligue Protect Nat Madagascar, Antananarivo, Madagascar; [Andriantsimanarilafy, Raphali R.; Randrianantoandro, J. Christian] Madagasikara Voakajy, Antananarivo, Madagascar; [Anjeriniaina, Mirana; Rakotomalala, Domoina] WWF Madagascar & West Indian Ocean Programme Off, Antananarivo, Madagascar; [Bora, Parfait; Hantalalaina, Elisoa F.; Rafanomezantsoa, Jeannot; Rakotondravony, Hery; Rakotondrazafy, Ny A.; Rasolohery, Andriambolantsoa; Ratsoavina, Fanomezana M.] Univ Antananarivo, Fac Sci, Dept Biol Anim, Antananarivo, Madagascar; [Brady, Lee D.] Calumma Ecol Serv, Faversham, Kent, England; [Glaw, Frank] Zool Staatssammlung Munchen, Munich, Germany; [Griffiths, Richard A.] Univ Kent, Durrell Inst Conservat & Ecol, Sch Anthropol & Conservat, Canterbury, Kent, England; [Hoffmann, Michael] IUCN Species Survival Commiss, Gland, Switzerland; [Hoffmann, Michael] World Conservat Monitoring Ctr, United Nations Environm Programme, Cambridge, England; [Rabibisoa, Nirhy H.] Fac Sci, Dept Zool & Ecol, Mahajanga, Madagascar; [Ralambonirainy, Johans; Randrianasolo, Hanson H.; Rollande, Finoana] Conservat Int, Antananarivo, Madagascar; [Ramanamanjato, Jean-Baptiste] Rio Tinto QMM, Ft Dauphin, Madagascar; [Randriamahazo, Herilala] Turtle Survival Alliance, Antananarivo, Madagascar; [Randrianirina, Jasmin E.] Parc Bot & Zool Tsimbazaza, Antananarivo, Madagascar; [Randrianizahana, Hiarinirina; Robsomanitrandrasana, Eric] Minist Environm & Forets, Antananarivo, Madagascar; [Raselimanana, Achille P.] Assoc Vahatra, Antananarivo, Madagascar; [Raxworthy, Christopher J.] Amer Museum Nat Hist, Herpetol Dept, New York, NY 10024 USA; [Ratsoavina, Fanomezana M.; Vences, Miguel] Tech Univ Carolo Wilhelmina Braunschweig, Inst Zool, Braunschweig, Germany	Conservation International; Duke University; Claremont Colleges; Pitzer College; Claremont Colleges; Scripps College; University Antananarivo; University of Kent; Rio Tinto; American Museum of Natural History (AMNH); Braunschweig University of Technology	Jenkins, RKB (corresponding author), IUCN, Global Species Programme, Cambridge, England.	richard.jenkins@iucn.org	Hoffmann, Michael/E-6419-2010; Tognelli, Marcelo/L-3958-2019; ANDREONE, FRANCO/H-4942-2012	Hoffmann, Michael/0000-0003-4785-2254; Tognelli, Marcelo/0000-0002-9761-4505; ANDREONE, FRANCO/0000-0001-9809-5818; Vences, Miguel/0000-0003-0747-0817; Raselimanana, Achille Philippe/0000-0003-1610-7307; Rasolohery, Andriambolantsoa/0000-0002-9686-262X; Andriantsimanarilafy, Rodlis Raphali/0000-0002-9897-9434	Darwin Initiative; Mohamed bin Zayed Species Conservation Fund; Humboldt Foundation; BIOPAT Foundation; Volkswagen Foundation; National Science Foundation [DEB-0641023, 0423286, 9984496, 0621279]; Gordon and Betty Moore Foundation; Earthwatch; MacArthur Foundation; European Association of Zoos and Aquaria; World Association of Zoos and Aquaria; Gondwana Resesarch and Conservation; Bundesministerium fur Bildung und Forschung; Deutsche Forschungsgemeinschaft; Deutscher Akademischer Austauschienst; NWO/WOTRO	Darwin Initiative; Mohamed bin Zayed Species Conservation Fund; Humboldt Foundation(Alexander von Humboldt Foundation); BIOPAT Foundation; Volkswagen Foundation(Volkswagen); National Science Foundation(National Science Foundation (NSF)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Earthwatch; MacArthur Foundation; European Association of Zoos and Aquaria; World Association of Zoos and Aquaria; Gondwana Resesarch and Conservation; Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutscher Akademischer Austauschienst(Deutscher Akademischer Austausch Dienst (DAAD)); NWO/WOTRO(Netherlands Organization for Scientific Research (NWO))	This study was made possible through the generous financial support of a number of donors: Darwin Initiative (www.darwin.defra.gov.uk/), Mohamed bin Zayed Species Conservation Fund (www.speciesconservation.org), Humboldt Foundation (www.humboldt-foundation.de), BIOPAT Foundation (www.biopat.de), Volkswagen Foundation (www.volkswagenstiftung.de), National Science Foundation (www.nsf.gov: DEB-0641023, 0423286, 9984496, 0621279), National Geographic Society (www.nationalgeographic.com), Gordon and Betty Moore Foundation (www. moore.org), Earthwatch (www.earthwatch.org), MacArthur Foundation (www. macfound.org), European Association of Zoos and Aquaria (www. eaza. net), World Association of Zoos and Aquaria (www.waza.org), Gondwana Resesarch and Conservation (www.gondwanaconservation.org), Bundesministerium fur Bildung und Forschung (www.bmbf.de), Deutsche Forschungsgemeinschaft, Deutscher Akademischer Austauschienst, and NWO/WOTRO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreone F, 2007, TROP ZOOL, V20, P19; Andreone F, 2005, TROP ZOOL, V18, P209, DOI 10.1080/03946975.2005.10531221; Andreone F, 2005, CONSERV BIOL, V19, P1790, DOI 10.1111/j.1523-1739.2005.00249.x; Andreone F, 2003, ITAL J ZOOL, V70, P53, DOI 10.1080/11250000309356496; Andreone F, 2003, J NAT HIST, V37, P2119, DOI 10.1080/00222930210130357; Andreone F, 2002, J ZOOL, V258, P139, DOI 10.1017/S0952836902001280; Andreone F, 2009, ITAL J ZOOL, V76, P92, DOI 10.1080/11250000802088603; Andreone F, 2001, ITAL J ZOOL, V68, P235, DOI 10.1080/11250000109356414; Andreone F, 2000, REV ECOL-TERRE VIE, V55, P215; Andreone F, 2000, BIODIVERS CONSERV, V9, P1587, DOI 10.1023/A:1026559728808; ANDREONE F, 1991, Museo Regionale di Scienze Naturali Bollettino (Turin), V9, P437; Andreone F, 2004, ITAL J ZOOL, V71, P229, DOI 10.1080/11250000409356640; Andreone F, 2008, PLOS BIOL, V6, P943, DOI 10.1371/journal.pbio.0060118; Andreone Franco, 2008, Museo Regionale di Scienze Naturali Monografie (Turin), V45, P419; Andreone Franco, 1997, Revue Francaise d'Aquariologie Herpetologie, V24, P95; Andreone Franco, 2006, Museo Regionale di Scienze Naturali Bollettino (Turin), V24, P179; BirdLife International, 2008, STAT WORLDS BIRDS IN; Blanc CP, 1987, OCCASIONAL PAPERS IU, V2, P117; Bohm M, 2013, BIOL CONSERV, V157, P372, DOI 10.1016/j.biocon.2012.07.015; Bora P, 2010, HERPETOL CONSERV BIO, V5, P111; Bora Parfait, 2007, Mitteilungen aus dem Museum fuer Naturkunde in Berlin Zoologische Reihe, V83, P170, DOI 10.1002/mmnz.200700007; Boumans L, 2007, MOL PHYLOGENET EVOL, V45, P822, DOI 10.1016/j.ympev.2007.05.028; Buhlmann KA, 2009, CHELONIAN CONSERV BI, V8, P116, DOI 10.2744/CCB-0774.1; Carpenter AI, 2005, BIOL CONSERV, V123, P279, DOI 10.1016/j.biocon.2004.11.015; Carpenter AI, 2004, BIOL CONSERV, V120, P291, DOI 10.1016/j.biocon.2004.03.002; Ceballos CP, 2004, WILDLIFE SOC B, V32, P881, DOI 10.2193/0091-7648(2004)032[0881:TTINAE]2.0.CO;2; Chen TH, 2009, CHELONIAN CONSERV BI, V8, P11, DOI 10.2744/CCB-0747.1; COX N, 2006, STATUS DISTRIBUTION; Crottini A, 2011, ZOOTAXA, V2982, P340; Crottini A, 2012, ZOOTAXA, P63; Crottini A, 2012, P NATL ACAD SCI USA, V109, P5358, DOI 10.1073/pnas.1112487109; D'Cruze N, 2011, ANIM CONSERV, V14, P542, DOI 10.1111/j.1469-1795.2011.00459.x; D'Cruze N, 2007, HERPETOL CONSERV BIO, V2, P87; D'Cruze Neil, 2009, Herpetological Review, V40, P19; Durbin Joanna, 1996, Oryx, V30, P113; DUTILLEUL P, 1993, BIOMETRICS, V49, P305, DOI 10.2307/2532625; Florio AM, 2012, J EVOLUTION BIOL, V25, P1399, DOI 10.1111/j.1420-9101.2012.02528.x; Funnell Sheila, 2012, Herpetology Notes, V5, P151; Ganzhorn Jorg U., 1997, Primate Report, V48, P1; Gehring PS, 2012, ECOL EVOL, V2, P1468, DOI 10.1002/ece3.269; Gehring PS, 2010, SALAMANDRA, V46, P214; Gehring PS, 2010, SALAMANDRA, V46, P167; Gibbons JW, 2000, BIOSCIENCE, V50, P653, DOI 10.1641/0006-3568(2000)050[0653:TGDORD]2.0.CO;2; Glaw F, 2007, FIELD GUIDE AMPHIBIA; GLAW F, 1994, FIELDGUIDE AMPHIBIAN; Glaw F, 2013, ZOOTAXA, V3630, P317, DOI 10.11646/zootaxa.3630.2.7; Glaw F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031314; Goodman SM, 1997, RECHERCHES DEV SB, V12, p[110, 1]; Goodman Steven M., 1994, Oryx, V28, P115; GREEN GM, 1990, SCIENCE, V248, P212, DOI 10.1126/science.248.4952.212; Hannah L, 2008, BIOL LETTERS, V4, P590, DOI 10.1098/rsbl.2008.0270; Hawkins BA, 2003, ECOLOGY, V84, P3105, DOI 10.1890/03-8006; Huey RB, 2009, P ROY SOC B-BIOL SCI, V276, P1939, DOI 10.1098/rspb.2008.1957; IUCN, 2011, GUID APPR US IUCN RE; Jenkins CN, 2009, BIOL CONSERV, V142, P2166, DOI 10.1016/j.biocon.2009.04.016; Jenkins RKB, 2003, BIOL CONSERV, V109, P407, DOI 10.1016/S0006-3207(02)00166-0; Jenkins RKB, 1999, ORYX, V33, P38, DOI 10.1017/S0030605300030222; Jennings MD, 2000, LANDSCAPE ECOL, V15, P5, DOI 10.1023/A:1008184408300; JUVIK JO, 1981, BIOL CONSERV, V19, P297, DOI 10.1016/0006-3207(81)90005-7; Karsten KB, 2008, P NATL ACAD SCI USA, V105, P8980, DOI 10.1073/pnas.0802468105; KIESTER AR, 1971, SYST ZOOL, V20, P127, DOI 10.2307/2412053; Kohler J, 2010, ORG DIVERS EVOL, V10, P147, DOI 10.1007/s13127-010-0011-5; Kremen C, 2008, SCIENCE, V320, P222, DOI 10.1126/science.1155193; KUCHLING G, 1988, BIOL CONSERV, V43, P107, DOI 10.1016/0006-3207(88)90085-7; KUCHLING G, 1988, Amphibia-Reptilia, V9, P175, DOI 10.1163/156853888X00576; Lambert Michael R.K., 2005, Applied Herpetology, V2, P99, DOI 10.1163/1570754043492108; Lehtinen Richard M., 2006, Applied Herpetology, V3, P95, DOI 10.1163/157075406776984248; Lehtinen RM, 2003, BIODIVERS CONSERV, V12, P1357, DOI 10.1023/A:1023673301850; Leuteritz TEJ, 2005, BIOL CONSERV, V124, P451, DOI 10.1016/j.biocon.2005.02.003; McCain CM, 2010, GLOBAL ECOL BIOGEOGR, V19, P541, DOI 10.1111/j.1466-8238.2010.00528.x; Measey GJ, 2006, EUR J SOIL BIOL, V42, pS103, DOI 10.1016/j.ejsobi.2006.07.034; Measey GJ, 2009, ORYX, V43, P284, DOI 10.1017/S0030605307002311; Ministere de l'Environnement malgache ONE ANGAP, 2001, CAMP CONS ASS MAN PL; Miralles A, 2012, ZOOSYSTEMA, V34, P701, DOI 10.5252/z2012n4a3; Mittermeier R. A., 1997, MEGADIVERSITY; Mori Akira, 2006, Herpetological Natural History, V10, P31; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nagy Zoltan T, 2012, PLoS One, V7, pe34506, DOI 10.1371/journal.pone.0034506; Nussbaum RA, 1999, FIELD ZOOL, P155; Nussbaum Ronald A., 2000, Amphibian and Reptile Conservation, V2, P6; O'Brien S, 2003, ORYX, V37, P338, DOI 10.1017/S0030605303000590; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Pearson RG, 2009, EVOLUTION, V63, P959, DOI 10.1111/j.1558-5646.2008.00596.x; Pedrono M, 2000, BIOL CONSERV, V95, P333, DOI 10.1016/S0006-3207(00)00023-9; Pedrono M, 2001, J HERPETOL, V35, P151, DOI 10.2307/1566041; Pedrono M., 2003, NATURAL HIST MADAGAS, P951; Pedrono M., 2008, TORTOISES TURTLES MA; Pedrono Miguel, 2000, P249; PIANKA ER, 1972, COPEIA, P127; Qian H, 2008, ECOL LETT, V11, P547, DOI 10.1111/j.1461-0248.2008.01168.x; Rakotomalala D, 2001, RECHERCHES DEV SERIE, V17, p[133, 1]; Rakotomalala Domoina, 2002, Boissiera, V59, P339; Rakotonirina Berthin, 1994, Oryx, V28, P51; Ramanamanjato J.B, 2000, BONN ZOOL MONOGR, P297; RAMANAMANJATO J. B, 2002, B RAP EVALUATION RAP, P98; Ramanamanjato JB, 2002, BIODIVERS CONSERV, V11, P1791, DOI 10.1023/A:1020325415489; Randrianantoandro JC, 2012, HERPETOL NOTES, V5, P165; Rangel TF, 2010, ECOGRAPHY, V33, P46, DOI 10.1111/j.1600-0587.2009.06299.x; Raselimanana A.P., 2008, MALAGASY NATURE, V1, P46; Raselimanana A. P., 1998, RECHERCHES DEV SB, V13, P43; RASELIMANANA A.P, 1998, RECHERCHES DEV SB, V14, p[183, 1]; Raselimanana Achille P., 2000, Fieldiana Zoology, V97, P157; Raselimanana AP, 1999, RECHERCHES DEV SB, V15, p[81, 1]; Raxworthy C.J., 2003, P934; Raxworthy C.J., 1994, RECHERCHES DEV SB, P41; Raxworthy CJ, 2008, GLOBAL CHANGE BIOL, V14, P1703, DOI 10.1111/j.1365-2486.2008.01596.x; Raxworthy CJ, 2007, SYST BIOL, V56, P907, DOI 10.1080/10635150701775111; Raxworthy Christopher J., 1996, Fieldiana Zoology, V85, P158; Raxworthy Christopher J., 2000, Amphibian and Reptile Conservation, V2, P15; Raxworthy Christopher J., 2002, Phelsuma, V10, P41; Raxworthy Christopher J., 1998, Fieldiana Zoology, V90, P79; Raxworthy CJ, 2003, NATURE, V426, P837, DOI 10.1038/nature02205; RAXWORTHY CJ, 1994, BIOL CONSERV, V69, P65, DOI 10.1016/0006-3207(94)90329-8; RAXWORTHY CJ, 1988, BIOL CONSERV, V43, P181, DOI 10.1016/0006-3207(88)90113-9; Raxworthy CJ, 1996, CONSERV BIOL, V10, P750, DOI 10.1046/j.1523-1739.1996.10030750.x; RAXWORTHY CJ, 1994, MISCELLANEOUS PUBLIC, V182, P1; Ribeiro R, 2009, ACTA OECOL, V35, P327, DOI 10.1016/j.actao.2008.12.003; Ricketts TH, 2005, P NATL ACAD SCI USA, V102, P18497, DOI 10.1073/pnas.0509060102; Rodrigues ASL, 2004, BIOSCIENCE, V54, P1092, DOI 10.1641/0006-3568(2004)054[1092:GGAPRF]2.0.CO;2; Samonds KE, 2012, P NATL ACAD SCI USA, V109, P5352, DOI 10.1073/pnas.1113993109; SCHALL JJ, 1978, SCIENCE, V201, P679, DOI 10.1126/science.201.4357.679; Schipper J, 2008, SCIENCE, V322, P225, DOI 10.1126/science.1165115; Schlaepfer MA, 2005, BIOSCIENCE, V55, P256, DOI 10.1641/0006-3568(2005)055[0256:CIETIO]2.0.CO;2; Scott DM, 2006, BIOL CONSERV, V127, P72, DOI 10.1016/j.biocon.2005.07.014; Sinervo B, 2010, SCIENCE, V328, P894, DOI 10.1126/science.1184695; Smith LL, 1999, BIOL CONSERV, V91, P23, DOI 10.1016/S0006-3207(99)00044-0; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Todd M, 2011, TRADE MALAGASY REPTI; Vences M, 2002, ITAL J ZOOL, V69, P263, DOI 10.1080/11250000209356469; Vences M, 2009, TRENDS ECOL EVOL, V24, P456, DOI 10.1016/j.tree.2009.03.011; Walker R, 2012, AMPHIBIA-REPTILIA, V33, P141, DOI 10.1163/156853811X621706; Walker RCJ, 2012, HERPETOL J, V22, P63; Wollenberg K. C., 2011, Journal of Ecotourism, V10, P101, DOI 10.1080/14724049.2010.511229	133	33	36	2	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2014	9	8							e100173	10.1371/journal.pone.0100173	http://dx.doi.org/10.1371/journal.pone.0100173			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WB	25111137	Green Published, Green Submitted, gold			2022-12-27	WOS:000341105100002
J	Pang, XY; Cui, WM; Liu, L; Zhang, SW; Lv, JP				Pang, Xiao-Yang; Cui, Wen-Ming; Liu, Lu; Zhang, Shu-Wen; Lv, Jia-Ping			Gene Knockout and Overexpression Analysis Revealed the Role of N-Acetylmuramidase in Autolysis of Lactobacillus delbrueckii subsp bulgaricus Ljj-6	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; CHEDDAR CHEESE; LACTOCOCCUS-LACTIS; PEPTIDOGLYCAN HYDROLASES; ENZYMES; PROPIONIBACTERIA; LYSOZYME; SYSTEMS; BUFFER	Autolysis of lactic acid bacteria (LAB) plays a vital role in dairy processing. During cheese making, autolysis of LAB affects cheese flavor development through release of intracellular enzymes and restricts the proliferation of cells in yogurt fermentation and probiotics production. In order to explore the mechanism of autolysis, the gene for the autolytic enzymes of L. bulgaricus, N-acetylmuramidase (mur), was cloned and sequenced (GenBank accession number: KF157911). Mur gene overexpression and gene knockout vectors were constructed based on pMG76e and pUC19 vectors. Recombinant plasmids were transformed into L. bulgaricus ljj-6 by electroporation, then three engineered strains with pMG76e-mur vector and fifteen engineered strains with pUC19-mur:: EryBII were screened. The autolysis of the mur knockout strain was significantly lower and autolysis of the mur overexpressed strain was significantly higher compared with that of the wild type strain ljj-6. This result suggested that the mur gene played an important role in autolysis of L. bulgaricus. On the other hand, autolytic activity in a low degree was still observed in the mur knockout strain, which implied that other enzymes but autolysin encoded by mur were also involved in autolysis of L. bulgaricus.	[Pang, Xiao-Yang; Cui, Wen-Ming; Liu, Lu; Zhang, Shu-Wen; Lv, Jia-Ping] Chinese Acad Agr Sci, Inst Agrofood Sci & Technol, Key Lab Agrofood Proc & Qual Control, Beijing 100193, Peoples R China	Chinese Academy of Agricultural Sciences	Lv, JP (corresponding author), Chinese Acad Agr Sci, Inst Agrofood Sci & Technol, Key Lab Agrofood Proc & Qual Control, Beijing 100193, Peoples R China.	lvjp586@vip.sina.com	Zhang, Shuwen/AAF-9086-2021	Zhang, Shuwen/0000-0002-0064-2236; pang, xiaoyang/0000-0003-1813-2039	China Postdoctoral Science Foundation [2013M541091]	China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	The authors acknowledge the financial support provided by the China Postdoctoral Science Foundation (2013M541091). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chung W, 2000, INT J FOOD MICROBIOL, V60, P25, DOI 10.1016/S0168-1605(00)00330-5; Collins YF, 2003, J DAIRY RES, V70, P105, DOI 10.1017/S0022029902005915; CROUX C, 1991, GENE, V104, P25, DOI 10.1016/0378-1119(91)90460-S; Crow VL, 1995, INT DAIRY J, V5, P855, DOI 10.1016/0958-6946(95)00036-4; CROW VL, 1995, INT DAIRY J, V5, P45, DOI 10.1016/0958-6946(94)P1598-8; Douillard FP, 2011, PLASMID, V66, P129, DOI 10.1016/j.plasmid.2011.07.001; Fox PF, 1996, ANTON LEEUW INT J G, V70, P271, DOI 10.1007/BF00395937; Hickey DK, 2007, J DAIRY RES, V74, P9, DOI 10.1017/S0022029906002032; HOLO H, 1989, APPL ENVIRON MICROB, V55, P3119, DOI 10.1128/AEM.55.12.3119-3123.1989; Jebava I, 2011, INT J FOOD MICROBIOL, V148, P1, DOI 10.1016/j.ijfoodmicro.2011.04.015; Kaleta P, 2009, J MICROBIOL METH, V79, P32, DOI 10.1016/j.mimet.2009.07.019; Kim SJ, 2009, FEMS IMMUNOL MED MIC, V57, P257, DOI 10.1111/j.1574-695X.2009.00605.x; Ledala N, 2006, INT J ANTIMICROB AG, V27, P518, DOI 10.1016/j.ijantimicag.2006.03.008; Mercier C, 2000, FEMS MICROBIOL LETT, V187, P47, DOI 10.1111/j.1574-6968.2000.tb09135.x; Mullaney EJ, 2003, BIOCHEM BIOPH RES CO, V312, P179, DOI 10.1016/j.bbrc.2003.09.176; Ostlie H, 1995, J DAIRY SCI, V78, P2315, DOI 10.3168/jds.S0022-0302(95)76858-8; Ostlie HM, 2007, INT J FOOD MICROBIOL, V117, P167, DOI 10.1016/j.ijfoodmicro.2007.03.006; Pillidge CJ, 2002, INT DAIRY J, V12, P133, DOI 10.1016/S0958-6946(01)00135-2; Sallami L, 2004, J DAIRY SCI, V87, P1585, DOI 10.3168/jds.S0022-0302(04)73312-3; Sheehan A, 2005, J APPL MICROBIOL, V99, P1007, DOI 10.1111/j.1365-2672.2005.02718.x; Sheehan A, 2006, J APPL MICROBIOL, V100, P893, DOI 10.1111/j.1365-2672.2005.02815.x; Sugahara K, 2007, GENE, V404, P41, DOI 10.1016/j.gene.2007.08.023; Zhang XM, 2013, MICROBIOL RES, V168, P305, DOI 10.1016/j.micres.2012.11.008; Zhang XH, 2012, INT DAIRY J, V25, P60, DOI 10.1016/j.idairyj.2012.02.003	24	15	16	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2014	9	8							e104829	10.1371/journal.pone.0104829	http://dx.doi.org/10.1371/journal.pone.0104829			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WB	25110891	Green Submitted, Green Published, gold			2022-12-27	WOS:000341105100103
J	Henriksen, RE; Torsheim, T; Thuen, F				Henriksen, Roger Ekeberg; Torsheim, Torbjorn; Thuen, Frode			Loneliness, Social Integration and Consumption of Sugar-Containing Beverages: Testing the Social Baseline Theory	PLOS ONE			English	Article							FOOD PREFERENCE; COMFORT FOOD; STRESS; APPETITE; GLUCOSE; SECRETION; ECONOMY; ABSENCE; HEALTH; BRAIN	Objective: Social Baseline Theory (SBT) proposes that close relationships aid in metabolic resource management and that individuals without significant relationships may experience more demands on their own neural metabolic resources on a daily basis when solving problems, remaining vigilant against potential threats and regulating emotional responses. This study tests a hypothesised consequence derived from SBT: relative social isolation leads to increased levels of sugar intake. Methods: Based on cross-sectional, self-reported data from the Norwegian Mother and Child Cohort Study (N = 90 084), information on social integration and the consumption of both sugar-sweetened and artificially sweetened sodas and juices was obtained from a large number of women in early pregnancy. Multiple regression analyses were conducted to assess whether loneliness, marital status, relationship satisfaction, advice from others than partner, and cohesion at work is associated with consumption of sodas and juices. Results: Perceived loneliness was associated with elevated intake of all sugary beverages, while relationship satisfaction was negatively associated with all sugary beverages. Being married or cohabitating, having supportive friends, and having a sense of togetherness at work were associated with lower intake of two out of three sugar-containing beverages. These associations were significant, even after controlling for factors such as body mass index, weight related self-image, depression, physical activity, educational level, age and income. In comparison, a statistically significant relationship emerged between relationship satisfaction and artificially sweetened cola. No other predictor variables were significantly associated with any type of artificially sweetened beverage. Conclusions: This study indicates that loneliness and social integration influence the level of consumption of sugary beverages. The results support the hypothesis derived from the Social Baseline Theory that relative social isolation leads to increased levels of sugar intake.	[Henriksen, Roger Ekeberg; Thuen, Frode] Bergen Univ Coll, Ctr Evidence Based Practice, Bergen, Norway; [Torsheim, Torbjorn] Univ Bergen, Fac Psychol, Dept Psychosocial Sci, Bergen, Norway	Western Norway University of Applied Sciences; University of Bergen	Henriksen, RE (corresponding author), Bergen Univ Coll, Ctr Evidence Based Practice, Bergen, Norway.	roger.ekeberg.henriksen@hib.no		Torsheim, Torbjorn/0000-0001-7825-4463	Norwegian Ministry of Health; Ministry of Education and Research (National Institutes of Health (NIH)/National Institute of Environmental Health Sciences) [NO1-ES-75558]; Ministry of Education and Research (NIH/National Institute of Neurological Disorders and Stroke) [1 UO1 NS 047537-01]; Ministry of Education and Research [2 UO1 NS047537-06A1]; Norwegian Research Council/FUGE [151918/S10]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS047537] Funding Source: NIH RePORTER	Norwegian Ministry of Health; Ministry of Education and Research (National Institutes of Health (NIH)/National Institute of Environmental Health Sciences); Ministry of Education and Research (NIH/National Institute of Neurological Disorders and Stroke); Ministry of Education and Research; Norwegian Research Council/FUGE(Research Council of Norway); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The Norwegian Mother and Child Cohort Study is supported by the Norwegian Ministry of Health and the Ministry of Education and Research (National Institutes of Health (NIH)/National Institute of Environmental Health Sciences contract no. NO1-ES-75558, NIH/National Institute of Neurological Disorders and Stroke grant no. 1 UO1 NS 047537-01 and grant no. 2 UO1 NS047537-06A1) and the Norwegian Research Council/FUGE (grant no. 151918/S10). However, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript, and the authors received no specific funding for this work.	Ahren B, 2000, DIABETOLOGIA, V43, P393, DOI 10.1007/s001250051322; Baumeister RF, 2005, J PERS SOC PSYCHOL, V88, P589, DOI 10.1037/0022-3514.88.4.589; Beckes L, 2011, SOC PERSONAL PSYCHOL, V5, P976, DOI 10.1111/j.1751-9004.2011.00400.x; Blum JS, 1999, J PERS, V67, P93, DOI 10.1111/1467-6494.00049; Born JM, 2010, INT J OBESITY, V34, P172, DOI 10.1038/ijo.2009.221; BOWEN DJ, 1992, APPETITE, V19, P233, DOI 10.1016/0195-6663(92)90164-2; Bugge BB, 2010, FORBIDDEN FRUIT TAST; Bye EK, 1999, BRUK DRIKKEVARER HVE, P88; Cacioppo JT, 2002, PSYCHOSOM MED, V64, P407, DOI 10.1097/00006842-200205000-00005; Christensen L, 2001, APPETITE, V36, P137, DOI 10.1006/appe.2001.0390; Christensen L, 2006, J PSYCHOL, V140, P293, DOI 10.3200/JRLP.140.4.293-306; Coan JA, 2006, PSYCHOL SCI, V17, P1032, DOI 10.1111/j.1467-9280.2006.01832.x; Coan JA, 2013, INT J PSYCHOPHYSIOL, V88, P224, DOI 10.1016/j.ijpsycho.2013.04.006; Coan JA, 2013, ATTACH HUM DEV, V15, P303, DOI 10.1080/14616734.2013.782656; Coan JA, 2010, J SOC PERS RELAT, V27, P210, DOI 10.1177/0265407509360900; Epel E, 2001, PSYCHONEUROENDOCRINO, V26, P37, DOI 10.1016/S0306-4530(00)00035-4; FERNSTROM MH, 1987, BIOL PSYCHIAT, V22, P529, DOI 10.1016/0006-3223(87)90180-6; Gailliot MT, 2007, J PERS SOC PSYCHOL, V92, P325, DOI 10.1037/0022-3514.92.2.325; George GC, 2005, J AM DIET ASSOC, V105, P916, DOI 10.1016/j.jada.2005.03.009; Glade MJ, 2010, NUTRITION, V26, P932, DOI 10.1016/j.nut.2010.08.004; Groesz LM, 2012, APPETITE, V58, P717, DOI 10.1016/j.appet.2011.11.028; Gross EB, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00772; Heininger K, 2002, INT REV NEUROBIOL, V51, P103, DOI 10.1016/S0074-7742(02)51004-7; HENDRICK SS, 1988, J MARRIAGE FAM, V50, P93, DOI 10.2307/352430; Hertz L, 2002, INT REV NEUROBIOL, V51, P1, DOI 10.1016/S0074-7742(02)51003-5; Hitze Britta, 2010, Front Neuroenergetics, V2, P7, DOI 10.3389/fnene.2010.00007; Kandiah J, 2006, NUTR RES, V26, P118, DOI 10.1016/j.nutres.2005.11.010; Kishore P, 2006, DIABETES, V55, P659, DOI 10.2337/diabetes.55.03.06.db05-0849; Lafay L, 2001, INT J EAT DISORDER, V29, P195, DOI 10.1002/1098-108X(200103)29:2&lt;195::AID-EAT1009&gt;3.0.CO;2-N; Laitinen J, 2002, PREV MED, V34, P29, DOI 10.1006/pmed.2001.0948; Lambillotte C, 1997, J CLIN INVEST, V99, P414, DOI 10.1172/JCI119175; Lemmens SG, 2011, PHYSIOL BEHAV, V103, P157, DOI 10.1016/j.physbeh.2011.01.009; Levin BE, 2002, INT REV NEUROBIOL, V51, P219, DOI 10.1016/S0074-7742(02)51007-2; Levine MP, 2012, J PSYCHOL, V146, P243, DOI 10.1080/00223980.2011.606435; Macht M, 2008, APPETITE, V50, P1, DOI 10.1016/j.appet.2007.07.002; Magnus P, 2006, INT J EPIDEMIOL, V35, P1146, DOI 10.1093/ije/dyl170; Masheb RM, 2006, INT J EAT DISORDER, V39, P141, DOI 10.1002/eat.20221; Mortensen O, 2012, FAM PROCESS, V51, P122, DOI 10.1111/j.1545-5300.2012.01384.x; Nilsen RM, 2009, PAEDIATR PERINAT EP, V23, P597, DOI 10.1111/j.1365-3016.2009.01062.x; Park S, 2011, NCHS DATA BRIEF; Peters A, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00074; Rosand GMB, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-161; Scholey AB, 2001, PHYSIOL BEHAV, V73, P585, DOI 10.1016/S0031-9384(01)00476-0; Smaldino PE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080753; Snyder D. K, 1997, MARITAL SATISFACTION; Stice E, 2001, J ABNORM PSYCHOL, V110, P124, DOI 10.1037//0021-843X.110.1.124; Tomiyama AJ, 2011, PSYCHONEUROENDOCRINO, V36, P1513, DOI 10.1016/j.psyneuen.2011.04.005; Wilcox Gisela, 2005, Clin Biochem Rev, V26, P19; Zellner DA, 2006, PHYSIOL BEHAV, V87, P789, DOI 10.1016/j.physbeh.2006.01.014	49	35	35	4	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2014	9	8							e104421	10.1371/journal.pone.0104421	http://dx.doi.org/10.1371/journal.pone.0104421			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR0CG	25105408	Green Published, gold, Green Submitted			2022-12-27	WOS:000343231900055
J	Verschoor, CP; Johnstone, J; Millar, J; Parsons, R; Lelic, A; Loeb, M; Bramson, JL; Bowdish, DME				Verschoor, Chris P.; Johnstone, Jennie; Millar, Jamie; Parsons, Robin; Lelic, Alina; Loeb, Mark; Bramson, Jonathan L.; Bowdish, Dawn M. E.			Alterations to the Frequency and Function of Peripheral Blood Monocytes and Associations with Chronic Disease in the Advanced-Age, Frail Elderly	PLOS ONE			English	Article							PLASMACYTOID DENDRITIC CELLS; FRACTALKINE; ACTIVATION; CX3CR1; ATHEROSCLEROSIS; SUBSETS; ANEMIA; OLD	Background: Circulating myeloid cells are important mediators of the inflammatory response, acting as a major source of resident tissue antigen presenting cells and serum cytokines. They represent a number of distinct subpopulations whose functional capacity and relative concentrations are known to change with age. Little is known of these changes in the very old and physically frail, a rapidly increasing proportion of the North American population. Design: In the following study the frequency and receptor expression of blood monocytes and dendritic cells (DCs) were characterized in a sample of advanced-age, frail elderly (81-100 yrs), and compared against that of adults (19-59 yrs), and community-dwelling seniors (61-76 yrs). Cytokine responses following TLR stimulation were also investigated, as well as associations between immunophenotyping parameters and chronic diseases. Results: The advanced-age, frail elderly had significantly fewer CD14(++) and CD14(+) CD16(+), but not CD14(++) CD16(+) monocytes, fewer plasmacytoid and myeloid DCs, and a lower frequency of monocytes expressing the chemokine receptors CCR2 and CX(3)CR1. At baseline and following stimulation with TLR-2 and -4 agonists, monocytes from the advanced-age, frail elderly produced more TNF than adults, although the overall induction was significantly lower. Finally, monocyte subset frequency and CX3CR1 expression was positively associated with dementia, while negatively associated with anemia and diabetes in the advanced-age, frail elderly. Conclusions: These data demonstrate that blood monocyte frequency and phenotype are altered in the advanced-age, frail elderly and that these changes correlate with certain chronic diseases. Whether these changes contribute to or are caused by these conditions warrants further investigation.	[Verschoor, Chris P.; Millar, Jamie; Parsons, Robin; Lelic, Alina; Loeb, Mark; Bramson, Jonathan L.; Bowdish, Dawn M. E.] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada; [Johnstone, Jennie; Loeb, Mark] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Loeb, Mark] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Loeb, Mark; Bramson, Jonathan L.; Bowdish, Dawn M. E.] McMaster Univ, Inst Infect Dis Res, Hamilton, ON, Canada	McMaster University; McMaster University; McMaster University; McMaster University	Bowdish, DME (corresponding author), McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada.	bowdish@mcmaster.ca		Bramson, Jonathan/0000-0003-2874-6886; Bowdish, Dawn/0000-0001-6823-2957	Canadian Institutes of Health Research [MOP123404]; Ontario Lung Association	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Lung Association	Funding provided by Canadian Institutes of Health Research: http://www.cihr-irsc.gc.ca/; MOP123404. Ontario Lung Association: www.on.lung.ca/; No grant number provided. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artz AS, 2004, J AM GERIATR SOC, V52, P423, DOI 10.1111/j.1532-5415.2004.52116.x; Balistreri CR, 2009, J CLIN IMMUNOL, V29, P406, DOI 10.1007/s10875-009-9297-5; Cipolletta C, 2005, DIABETES, V54, P2779, DOI 10.2337/diabetes.54.9.2779; Cros J, 2010, IMMUNITY, V33, P375, DOI 10.1016/j.immuni.2010.08.012; Della Bella S, 2007, CLIN IMMUNOL, V122, P220, DOI 10.1016/j.clim.2006.09.012; Ershler WB, 2003, J AM GERIATR SOC, V51, pS18; Fuhrmann M, 2010, NAT NEUROSCI, V13, P411, DOI 10.1038/nn.2511; Hearps AC, 2012, AGING CELL, V11, P867, DOI 10.1111/j.1474-9726.2012.00851.x; Ioannou M, 2013, J IMMUNOL, V190, P2631, DOI 10.4049/jimmunol.1201897; Jing Y, 2009, HUM IMMUNOL, V70, P777, DOI 10.1016/j.humimm.2009.07.005; Kim TS, 2008, NEUROSCI LETT, V436, P196, DOI 10.1016/j.neulet.2008.03.019; Korkosz M, 2012, BLOOD, V119, P5329, DOI 10.1182/blood-2012-02-412551; Larbi A, 2008, PHYSIOLOGY, V23, P64, DOI 10.1152/physiol.00040.2007; Lee S, 2010, AM J PATHOL, V177, P2549, DOI 10.2353/ajpath.2010.100265; Min DQ, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/649083; Nyugen J, 2010, J CLIN IMMUNOL, V30, P806, DOI 10.1007/s10875-010-9448-8; Perez-Cabezas B, 2007, EXP GERONTOL, V42, P1033, DOI 10.1016/j.exger.2007.05.010; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Renshaw M, 2002, J IMMUNOL, V169, P4697, DOI 10.4049/jimmunol.169.9.4697; Rockwood K, 2007, J AM MED DIR ASSOC, V8, P595, DOI 10.1016/j.jamda.2007.07.012; Rosenkranz D, 2007, J NEUROIMMUNOL, V188, P117, DOI 10.1016/j.jneuroim.2007.05.011; Sanchez-Torres C, 2001, INT IMMUNOL, V13, P1571, DOI 10.1093/intimm/13.12.1571; Seidler S, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-30; Shah R, 2011, DIABETES, V60, P1512, DOI 10.2337/db10-0956; Swirski FK, 2013, SCIENCE, V339, P161, DOI 10.1126/science.1230719; van den Biggelaar AHJ, 2004, EXP GERONTOL, V39, P1407, DOI 10.1016/j.exger.2004.06.009; Verschoor CP, 2013, J LEUKOCYTE BIOL, V93, P633, DOI 10.1189/jlb.0912461; Wikby A, 1998, MECH AGEING DEV, V102, P187, DOI 10.1016/S0047-6374(97)00151-6; Wong BWC, 2002, CARDIOVASC PATHOL, V11, P332, DOI 10.1016/S1054-8807(02)00111-4; Ziegler-Heitbrock L, 2010, BLOOD, V116, pE74, DOI 10.1182/blood-2010-02-258558	30	41	41	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2014	9	8							e104522	10.1371/journal.pone.0104522	http://dx.doi.org/10.1371/journal.pone.0104522			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR0CG	25105870	Green Submitted, Green Published, gold			2022-12-27	WOS:000343231900066
J	Weston, S; Czieso, S; White, IJ; Smith, SE; Kellam, P; Marsh, M				Weston, Stuart; Czieso, Stephanie; White, Ian J.; Smith, Sarah E.; Kellam, Paul; Marsh, Mark			A Membrane Topology Model for Human Interferon Inducible Transmembrane Protein 1	PLOS ONE			English	Article							IFITM PROTEINS; ANTIVIRAL ACTIVITY; S-PALMITOYLATION; VIRAL ENTRY; INFLUENZA; VIRUS; ANTIBODY; LOCALIZATION; AGGREGATION; RESISTANCE	InterFeron Inducible TransMembrane proteins 1-3 (IFITM1, IFITM2 and IFITM3) are a family of proteins capable of inhibiting the cellular entry of numerous human and animal viruses. IFITM1-3 are unique amongst the currently described viral restriction factors in their apparent ability to block viral entry. This restrictive property is dependant on the localisation of the proteins to plasma and endosomal membranes, which constitute the main portals of viral entry into cells. The topology of the IFITM proteins within cell membranes is an unresolved aspect of their biology. Here we present data from immunofluorescence microscopy, protease cleavage, biotin-labelling and immuno-electron microscopy assays, showing that human IFITM1 has a membrane topology in which the N-terminal domain resides in the cytoplasm, and the C-terminal domain is extracellular. Furthermore, we provide evidence that this topology is conserved for all of the human interferon-induced IFITM proteins. This model is consistent with that recently proposed for murine IFITM3, but differs from that proposed for murine IFITM1.	[Weston, Stuart; Czieso, Stephanie; White, Ian J.; Marsh, Mark] UCL, MRC, Mol Cell Biol Lab, London, England; [Smith, Sarah E.; Kellam, Paul] Wellcome Trust Sanger Inst, Hinxton, Cambs, England; [Kellam, Paul; Marsh, Mark] UCL, MRC, Ctr Med Mol Virol, Div Infect & Immun, London, England	University of London; University College London; Wellcome Trust Sanger Institute; University of London; University College London	Weston, S (corresponding author), UCL, MRC, Mol Cell Biol Lab, London, England.	stuart.weston.09@ucl.ac.uk; m.marsh@ucl.ac.uk	Marsh, Mark/B-4105-2009	Marsh, Mark/0000-0002-0213-3259; Weston, Stuart/0000-0001-9840-2953; Smith, Sarah/0000-0001-8699-7670; Kellam, Paul/0000-0003-3166-4734	MRC Laboratory for Molecular Cell Biology Graduate Programme; MRC; Wellcome Trust [098051]; Medical Research Council [G1000413]; MRC [MC_UU_12018/1] Funding Source: UKRI; Medical Research Council [1223252, 975284, MC_UU_12018/1] Funding Source: researchfish	MRC Laboratory for Molecular Cell Biology Graduate Programme(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	SW is supported by the MRC Laboratory for Molecular Cell Biology Graduate Programme. MM, SC, IW are supported by MRC core funding to the MRC LMCB, UCL University Unit. SS and PK are supported by the Wellcome Trust (098051) and the Medical Research Council (G1000413). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amini-Bavil-Olyaee S, 2013, CELL HOST MICROBE, V13, P452, DOI 10.1016/j.chom.2013.03.006; Bailey CC, 2013, J BIOL CHEM, V288, P32184, DOI 10.1074/jbc.M113.514356; Bailey CC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002909; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; CHEN YX, 1984, J IMMUNOL, V133, P2496; Denek M, 2007, J CELL BIOL, V177, P329, DOI 10.1083/jcb.200609050; Desai TM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004048; EVANS SS, 1990, BLOOD, V76, P2583; Everitt AR, 2012, NATURE, V484, P519, DOI 10.1038/nature10921; Feeley EM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002337; FRIEDMAN RL, 1984, CELL, V38, P745, DOI 10.1016/0092-8674(84)90270-8; Hach JC, 2013, J VIROL, V87, P9923, DOI 10.1128/JVI.00621-13; Huang IC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001258; Jia R, 2014, CELL MICROBIOL, V16, P1080, DOI 10.1111/cmi.12262; Jia R, 2012, J VIROL, V86, P13697, DOI 10.1128/JVI.01828-12; John SP, 2013, J VIROL, DOI [10.1128/JVI.00481-13, DOI 10.1128/ JVI.00481-13]; LEWIN AR, 1991, EUR J BIOCHEM, V199, P417, DOI 10.1111/j.1432-1033.1991.tb16139.x; Li K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003124; Lin TY, 2013, CELL REP, V5, P895, DOI 10.1016/j.celrep.2013.10.033; SLOT JW, 1991, J CELL BIOL, V113, P123, DOI 10.1083/jcb.113.1.123; Smith SE, 2014, CURR OPIN VIROL, V4, P71, DOI 10.1016/j.coviro.2013.11.004; Smith SE, 2013, J VIROL, V87, P12957, DOI 10.1128/JVI.01443-13; TAKAHASHI S, 1990, J IMMUNOL, V145, P2207; Warren CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096579; Yount JS, 2012, J BIOL CHEM, V287, P19631, DOI 10.1074/jbc.M112.362095; Yount JS, 2010, NAT CHEM BIOL, V6, P610, DOI [10.1038/NCHEMBIO.405, 10.1038/nchembio.405]; Zhao XS, 2014, P NATL ACAD SCI USA, V111, P6756, DOI 10.1073/pnas.1320856111	28	51	54	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2014	9	8							e104341	10.1371/journal.pone.0104341	http://dx.doi.org/10.1371/journal.pone.0104341			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR0CG	25105503	Green Published, Green Submitted, gold			2022-12-27	WOS:000343231900049
J	Agarwal, S; Jangir, DK; Mehrotra, R; Lohani, N; Rajeswari, MR				Agarwal, Shweta; Jangir, Deepak Kumar; Mehrotra, Ranjana; Lohani, Neelam; Rajeswari, M. R.			A Structural Insight into Major Groove Directed Binding of Nitrosourea Derivative Nimustine with DNA: A Spectroscopic Study	PLOS ONE			English	Article							CIRCULAR-DICHROISM; ECTEINASCIDIN 743; NUCLEIC-ACIDS; MINOR-GROOVE; C-FORM; QUADRUPLEXES; RADIOTHERAPY; ALKYLATION; TRANSITION; ENERGETICS	Nitrosourea therapeutics occupies a definite place in cancer therapy but its exact mechanism of action has yet to be established. Nimustine, a chloroethyl nitrosourea derivative, is used to treat various types of malignancy including gliomas. The present work focuses on the understanding of nimustine interaction with DNA to delineate its mechanism at molecular level. Attenuated total reflection-Fourier transform infrared (ATR-FTIR) has been used to determine the binding sites of nimustine on DNA. Circular dichroism (CD) spectroscopy has been used to confirm conformational variations in DNA molecule upon nimustine-DNA interaction. Thermodynamic parameters of nimustine-DNA reaction have been calculated by isothermal titration calorimetry. Results of the present study demonstrate that nimustine is not a simple alkylating agent rather it causes major grove-directed-alkylation. Spectroscopic data suggest binding of nimustine with nitrogenous bases guanine (C6 = O6) and thymine (C4 = O4) in DNA major groove. CD spectra of nimustine-DNA complexes point toward the perturbation of native B-conformation of DNA and its partial transition into C-form. Thermodynamically, nimustine-DNA interaction is an entropy driven endothermic reaction, which suggests hydrophobic interaction of nimustine in DNA-major groove pocket. Spectral results suggest base binding and local conformational changes in DNA upon nimustine interaction. Investigation of drug-DNA interaction is an essential part of rational drug designing that also provides information about the drug's action at molecular level. Results, demonstrated here, may contribute in the development of new nitrosourea therapeutics with better efficacy and fewer side effects.	[Agarwal, Shweta; Jangir, Deepak Kumar; Mehrotra, Ranjana] CSIR Natl Phys Lab, New Delhi, India; [Lohani, Neelam; Rajeswari, M. R.] All India Inst Med Sci, Dept Biochem, New Delhi 110029, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Physical Laboratory (NPL); All India Institute of Medical Sciences (AIIMS) New Delhi	Mehrotra, R (corresponding author), CSIR Natl Phys Lab, New Delhi, India.	ranjana@mail.nplindia.ernet.in		Jangir, Deepak Kumar/0000-0001-8838-3859	National Physical Laboratory, New Delhi	National Physical Laboratory, New Delhi	This work was supported by National Physical Laboratory, New Delhi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2012, J PHOTOCHEMISTRY P B; Agarwal S, 2013, J PHOTOCHEMISTRY P B; ALEX S, 1989, INORG CHIM ACTA, V157, P271, DOI 10.1016/S0020-1693(00)80552-6; Banyay M, 2003, BIOPHYS CHEM, V104, P477, DOI 10.1016/S0301-4622(03)00035-8; Barcelo F, 2002, NUCLEIC ACIDS RES, V30, P4567, DOI 10.1093/nar/gkf558; BOKMA JT, 1987, BIOPOLYMERS, V26, P893, DOI 10.1002/bip.360260609; Braun CS, 2003, BIOPHYS J, V84, P1114, DOI 10.1016/S0006-3495(03)74927-3; Chaires JB, 1997, BIOPOLYMERS, V44, P201, DOI 10.1002/(SICI)1097-0282(1997)44:3<201::AID-BIP2>3.0.CO;2-Z; Chaires JB, 1998, CURR OPIN STRUC BIOL, V8, P314, DOI 10.1016/S0959-440X(98)80064-X; CHAN A, 1979, BIOCHEMISTRY-US, V18, P84, DOI 10.1021/bi00568a013; Curtis-Johnson W., 1994, CD NUCL ACIDS CIRCUL, P523; GLASEL JA, 1995, BIOTECHNIQUES, V18, P62; HANSEN M, 1995, J AM CHEM SOC, V117, P2421, DOI 10.1021/ja00114a006; Haq I, 2002, ARCH BIOCHEM BIOPHYS, V403, P1, DOI 10.1016/S0003-9861(02)00202-3; Haq I, 2000, J MOL RECOGNIT, V13, P188, DOI 10.1002/1099-1352(200007/08)13:4<188::AID-JMR503>3.0.CO;2-1; Jangir DK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069933; KENNARD O, 1993, PURE APPL CHEM, V65, P1213, DOI 10.1351/pac199365061213; Kondo N, 2010, CANCER SCI, V101, P1881, DOI 10.1111/j.1349-7006.2010.01591.x; Kypr J, 2009, NUCLEIC ACIDS RES, V37, P1713, DOI 10.1093/nar/gkp026; MINEURA K, 1988, J NEUROL NEUROSUR PS, V51, P1391, DOI 10.1136/jnnp.51.11.1391; Miyagami M, 1990, Neurol Med Chir (Tokyo), V30, P582, DOI 10.2176/nmc.30.582; Miyahara T, 2013, J PHYS CHEM A, V117, P42, DOI 10.1021/jp3085556; Ouameur AA, 2004, J BIOL CHEM, V279, P42041, DOI 10.1074/jbc.M406053200; Pagano B, 2009, INT J MOL SCI, V10, P2935, DOI 10.3390/ijms10072935; Patil SD, 2000, NUCLEIC ACIDS RES, V28, P4125, DOI 10.1093/nar/28.21.4125; Pommier Y, 1996, BIOCHEMISTRY-US, V35, P13303, DOI 10.1021/bi960306b; PORTUGAL J, 1985, EMBO J, V4, P2403, DOI 10.1002/j.1460-2075.1985.tb03946.x; PULLMAN B, 1985, J BIOSCIENCE, V8, P681, DOI 10.1007/BF02702766; Puyo S, 2013, CRITICAL REV ONCOLOG; TAKAKURA K, 1986, J NEUROSURG, V64, P53, DOI 10.3171/jns.1986.64.1.0053; Tanaka M, 2001, JPN J CLIN ONCOL, V31, P246, DOI 10.1093/jjco/hye059; Tanaka S, 2003, INT J CANCER, V103, P67, DOI 10.1002/ijc.10757; Tyagi G, 2014, BBA-GEN SUBJECTS, V1840, P350, DOI 10.1016/j.bbagen.2013.09.007; Vijayalakshmi R, 2000, BIOCHEM BIOPH RES CO, V271, P731, DOI 10.1006/bbrc.2000.2707; Vorlickova M, 2012, CHIRALITY, V24, P691, DOI 10.1002/chir.22064; Xiong Y, 2001, PROTEIN NUCL ACID IN; Zerbe O, 2012, ANGEW CHEM INT EDIT, V51, P860, DOI 10.1002/anie.201107639; Zewail-Foote M, 1999, J MED CHEM, V42, P2493, DOI 10.1021/jm990241l; Zhang ZL, 2002, BIOPHYS CHEM, V97, P7, DOI 10.1016/S0301-4622(02)00006-6; Zhao CQ, 2012, NUCLEIC ACIDS RES, V40, P8186, DOI 10.1093/nar/gks524; Zuidam NJ, 1999, FEBS LETT, V457, P419, DOI 10.1016/S0014-5793(99)01053-4	42	22	22	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e104115	10.1371/journal.pone.0104115	http://dx.doi.org/10.1371/journal.pone.0104115			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25101667	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000339993900038
J	Du, CZ; Li, Z; Wang, S; Zhou, ZM; Wang, JK; Dong, J; Chen, CS				Du, Chengzhi; Li, Zhen; Wang, Shuang; Zhou, Zhongmei; Wang, Jingkun; Dong, Jian; Chen, Ceshi			Tongshu Capsule Down-Regulates the Expression of Estrogen Receptor alpha and Suppresses Human Breast Cancer Cell Proliferation	PLOS ONE			English	Article							TAMOXIFEN; BETA; PHOSPHORYLATION; ESTRADIOL; DISEASE	The Tongshu Capsule (TSC) is a prevalent form of traditional Chinese medicine widely used for its purported effects in treating mammary gland hyperplasia and inflammation. Though successful in several clinical studies, there is no clear evidence as to why TSC has a positive treatment effect, and little known about underlying mechanism that may account for it. In this study, we examined the effects of TSC and found that it has a comparatively strong growth inhibition on ER alpha positive breast cancer cells. TSC seems to cause G1 cell cycle arrest instead of apoptosis. Interestingly, TSC also down-regulated the expression of ER alpha and Cyclin D1. Consistently, TSC suppressed E2 mediated ER alpha downstream gene expression and cell proliferation in ER alpha positive breast cancer cell lines MCF7 and T47D. Depletion of ER alpha partially abolished the effects of TSC on the decrease of Cyclin D1 and cell viability. Our findings suggest that TSC may have therapeutic effects on ER alpha positive breast cancers and moreover that TSC may suppress breast epithelial cell proliferation by inhibiting the estrogen pathway.	[Du, Chengzhi; Wang, Shuang; Zhou, Zhongmei; Chen, Ceshi] Chinese Acad Sci & Yunnan Prov, Key Lab Anim Models & Human Dis Mech, Kunming Inst Zool, Kunming, Yunnan, Peoples R China; [Li, Zhen; Dong, Jian] Kunming Med Univ, Affiliated Hosp 1, Kunming, Yunnan, Peoples R China; [Wang, Jingkun] Kunming Med Univ, Affiliated Hosp 1, Kunming, Yunnan, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Zoology; Kunming Medical University; Kunming Medical University	Chen, CS (corresponding author), Chinese Acad Sci & Yunnan Prov, Key Lab Anim Models & Human Dis Mech, Kunming Inst Zool, Kunming, Yunnan, Peoples R China.	chenc@mail.kiz.ac.cn			Yunnan Institute of Materia Medica; National Nature Science Foundation of China [81120108019, U1132605, 81325016]; Yunnan Province High-Profile Scientist Program [2010CI114]	Yunnan Institute of Materia Medica; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Yunnan Province High-Profile Scientist Program	This study was partially funded by Yunnan Institute of Materia Medica, which is the manufacturer of Tongshu Capsule. This funder provided support in the form of salaries for author JW, but did not have any additional role in the study design, data collection and analysis, decision to publish, orpreparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. This study was also supported in part by National Nature Science Foundation of China (81120108019, U1132605, and 81325016), and a grant from the Yunnan Province High-Profile Scientist Program (2010CI114). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEGRA JC, 1979, CANCER, V44, P228, DOI 10.1002/1097-0142(197907)44:1<228::AID-CNCR2820440137>3.0.CO;2-0; Altucci L, 1996, ONCOGENE, V12, P2315; Callige M, 2005, MOL CELL BIOL, V25, P4349, DOI 10.1128/MCB.25.11.4349-4358.2005; Chen J, 2011, HEBEI MED J, V33, P623; Cheng L, 2012, J CLIN INVEST, V122, P2857, DOI 10.1172/JCI62676; Chu I, 2005, CANCER RES, V65, P18; Dorgan JF, 2002, JNCI-J NATL CANCER I, V94, P606; FISHER B, 1989, NEW ENGL J MED, V320, P479, DOI 10.1056/NEJM198902233200802; Foster JS, 1996, MOL ENDOCRINOL, V10, P488, DOI 10.1210/me.10.5.488; Hall JM, 2001, J BIOL CHEM, V276, P36869, DOI 10.1074/jbc.R100029200; Key TJ, 2003, J NATL CANCER I, V95, P1218, DOI 10.1093/jnci/djg022; Kontostolis E, 1997, GYNECOL ENDOCRINOL, V11, P393, DOI 10.3109/09513599709152566; Lagiou P, 2013, ANN ONCOLOGY; Li X, 2006, GUIDE CHINA MED, V4; MADDOX PR, 1989, WORLD J SURG, V13, P699, DOI 10.1007/BF01658417; Sabbah M, 1999, P NATL ACAD SCI USA, V96, P11217, DOI 10.1073/pnas.96.20.11217; Santen RJ, 2005, NEW ENGL J MED, V353, P275, DOI 10.1056/NEJMra035692; Sartippour MR, 2006, CARCINOGENESIS, V27, P2424, DOI 10.1093/carcin/bgl066; Sasaki Y, 2010, CANCER SCI, V101, P2286, DOI 10.1111/j.1349-7006.2010.01673.x; Shaw LE, 2006, J STEROID BIOCHEM, V99, P19, DOI 10.1016/j.jsbmb.2005.11.005	20	4	4	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e104261	10.1371/journal.pone.0104261	http://dx.doi.org/10.1371/journal.pone.0104261			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25101695	Green Submitted, gold, Green Published			2022-12-27	WOS:000339993900054
J	Muller, JR; Waldmann, TA; Dubois, S				Mueller, Juergen R.; Waldmann, Thomas A.; Dubois, Sigrid			Loss of Cytotoxicity and Gain of Cytokine Production in Murine Tumor-Activated NK Cells	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; PERIPHERAL-BLOOD; DIFFERENTIAL EXPRESSION; INHIBITORY RECEPTORS; DENDRITIC CELLS; CD56(BRIGHT); IL-15; SUBSETS; MOUSE; CANCER	NK cells are able to form a functional memory suggesting that some NK cells are surviving the activation process. We hypothesized that NK cell activation causes the development of a distinct NK cell subset and studied the fate of murine post-activation NK cells. Activation was achieved by in vivo and in vitro exposures to the melanoma tumor cell line B16 that was followed by differentiation in IL-2. When compared with control NK cells, post-activation CD25(+) NK cells expressed little granzyme B or perforin and had low lysis activity. Post-activation NK cells expressed CD27, CD90, CD127, and were low for CD11b suggesting that tumor-induced activation is restricted to an early NK cell subset. Activation of NK cells led to decreases of CD16, CD11c and increases of CD62L and the IL-18 receptor. In vivo activated but not control NK cells expressed a variety of cytokines that included IFN gamma, TNF alpha, GM-CSF and IL-10. These data suggest that the exposure of a subset of peripheral NK cells to the B16 tumor environment caused an exhaustion of their cytolytic capacity but also a gain in their ability to produce cytokines.	[Mueller, Juergen R.; Waldmann, Thomas A.; Dubois, Sigrid] NCI, Metab Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Dubois, S (corresponding author), NCI, Metab Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	duboiss@mail.nih.gov	Waldmann, Thomas/AAT-5972-2021	Waldmann, Thomas/0000-0003-4500-6660; Dubois, Sigrid/0000-0002-4543-5222	National Cancer Institute, NIH; NATIONAL CANCER INSTITUTE [ZIASC004002] Funding Source: NIH RePORTER	National Cancer Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research is supported by the intramural research program of the National Cancer Institute, NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANEGON I, 1988, J EXP MED, V167, P452, DOI 10.1084/jem.167.2.452; Anfossi N, 2006, IMMUNITY, V25, P331, DOI 10.1016/j.immuni.2006.06.013; Aranami T, 2006, J IMMUNOL, V177, P5659, DOI 10.4049/jimmunol.177.8.5659; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Bielekova B, 2006, P NATL ACAD SCI USA, V103, P5941, DOI 10.1073/pnas.0601335103; Chambers BJ, 1996, IMMUNITY, V5, P311, DOI 10.1016/S1074-7613(00)80257-5; Chiossone L, 2009, BLOOD, V113, P5488, DOI 10.1182/blood-2008-10-187179; Colucci F, 2003, NAT REV IMMUNOL, V3, P413, DOI 10.1038/nri1088; Cooper MA, 2001, TRENDS IMMUNOL, V22, P633, DOI 10.1016/S1471-4906(01)02060-9; Cooper MA, 2001, BLOOD, V97, P3146, DOI 10.1182/blood.V97.10.3146; Cousens LP, 2000, IMMUNOL REV, V174, P150, DOI 10.1034/j.1600-0528.2002.017407.x; Dalbeth N, 2004, J IMMUNOL, V173, P6418, DOI 10.4049/jimmunol.173.10.6418; Dalbeth N, 2002, ARTHRITIS RHEUM, V46, P1763, DOI 10.1002/art.10410; Di Santo JP, 2006, ANNU REV IMMUNOL, V24, P257, DOI 10.1146/annurev.immunol.24.021605.090700; Dubois S, 2008, J IMMUNOL, V180, P2099, DOI 10.4049/jimmunol.180.4.2099; Dubois SP, 2005, P NATL ACAD SCI USA, V102, P8662, DOI 10.1073/pnas.0503360102; Farag SS, 2006, BLOOD REV, V20, P123, DOI 10.1016/j.blre.2005.10.001; Fehniger TA, 1999, J IMMUNOL, V162, P4511; Ferlazzo G, 2004, J IMMUNOL, V172, P1333, DOI 10.4049/jimmunol.172.3.1333; Fernandez NC, 2005, BLOOD, V105, P4416, DOI 10.1182/blood-2004-08-3156; Freud AG, 2006, IMMUNOL REV, V214, P56, DOI 10.1111/j.1600-065X.2006.00451.x; Frey M, 1998, J IMMUNOL, V161, P400; Gasteiger G, 2013, J EXP MED, V210, P1179, DOI 10.1084/jem.20122571; Hayakawa Y, 2006, J IMMUNOL, V176, P1517, DOI 10.4049/jimmunol.176.3.1517; Hayakawa Y, 2006, IMMUNOL REV, V214, P47, DOI 10.1111/j.1600-065X.2006.00454.x; Kennedy MK, 2000, J EXP MED, V191, P771, DOI 10.1084/jem.191.5.771; KIESSLING R, 1975, EUR J IMMUNOL, V5, P112, DOI 10.1002/eji.1830050208; Kim S, 2005, NATURE, V436, P709, DOI 10.1038/nature03847; Kunikata T, 1998, CELL IMMUNOL, V189, P135, DOI 10.1006/cimm.1998.1376; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; LANIER LL, 1986, J IMMUNOL, V136, P4480; Laouar Y, 2005, NAT IMMUNOL, V6, P600, DOI 10.1038/ni1197; Lima M, 2002, BLOOD CELL MOL DIS, V28, P181, DOI 10.1006/bcmd.2002.0506; Lodolce JP, 1998, IMMUNITY, V9, P669, DOI 10.1016/S1074-7613(00)80664-0; Loza MJ, 2004, J IMMUNOL, V172, P88, DOI 10.4049/jimmunol.172.1.88; Lucas M, 2007, IMMUNITY, V26, P503, DOI 10.1016/j.immuni.2007.03.006; MAENPAA A, 1993, INT J CANCER, V53, P850, DOI 10.1002/ijc.2910530524; Moffett-King A, 2002, NAT REV IMMUNOL, V2, P656, DOI 10.1038/nri886; NAGLER A, 1990, J EXP MED, V171, P1527, DOI 10.1084/jem.171.5.1527; NAGLER A, 1989, J IMMUNOL, V143, P3183; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Rubinstein MP, 2006, P NATL ACAD SCI USA, V103, P9166, DOI 10.1073/pnas.0600240103; Saraste M, 2007, NEUROL SCI, V28, P121, DOI 10.1007/s10072-007-0803-3; Sedlmayr P, 1996, INT ARCH ALLERGY IMM, V110, P308, DOI 10.1159/000237321; Sun JC, 2009, NATURE, V457, P557, DOI 10.1038/nature07665	45	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e102793	10.1371/journal.pone.0102793	http://dx.doi.org/10.1371/journal.pone.0102793			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25101668	Green Published, Green Submitted, gold			2022-12-27	WOS:000339993900006
J	Cao, TW; Gao, Z; Gu, LY; Chen, ML; Yang, B; Cao, KJ; Huang, H; Li, MF				Cao, Tengwei; Gao, Zhen; Gu, Lingyun; Chen, Minglong; Yang, Bing; Cao, Kejiang; Huang, He; Li, Mingfang			AdipoR1/APPL1 Potentiates the Protective Effects of Globular Adiponectin on Angiotensin II-Induced Cardiac Hypertrophy and Fibrosis in Neonatal Rat Atrial Myocytes and Fibroblasts	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; VASCULAR ENDOTHELIAL-CELLS; KAPPA-B; FIBRILLATION; RECEPTORS; HEART; CARDIOMYOCYTES; MECHANISMS; DEATH; AKT	Atrial hypertrophy and fibrosis are essential pathological features of atrial fibrillation. Recently, adiponectin has become a protein of interest due to its beneficial effects on cardiovascular diseases. However, the molecular mechanism of atrial structural remodeling and signaling pathways evoked by adiponectin remain unclear. In the present study, we investigated the cardioprotective effect of globular adiponectin (gAcrp) on angiotensin II-induced atrial hypertrophy and fibrosis in neonatal Sprague-Dawley rat. To further investigate the molecular mechanisms underlying the preventive effect of gAcrp, transfection of cells with siRNA was used to suppress the mRNA expression of adiponectin receptor 1 (AdipoR1) and its downstream adaptor protein APPL1. Non-silencing-Cy-3 labelled siRNA was used to determine transfection efficiency using fluorescence microscopy. The expression of atrial natriuretic peptide and procollagen type1 alpha-1, hypertrophy marker and fibrosis one, respectively, was detected by real-time PCR. Furthermore, the expression of adenosine monophosphate-activated protein kinase (AMPK), phosphatidylinositol 3-kinase (PI3K) and Akt was detected by western blotting. In addition, nuclear p65 translocation activity was analyzed by EMSA supershift assay. Our results showed that AdipoR1 and the adaptor protein APPL1 mediated the protective effects of gAcrp. In addition, the function of adiponectin and phosphorylation of AMPK were prominently diminished by inhibition of PI3K. Furthermore, nuclear factor-kappa B (NF-kB) transcription was diminished by the specific inhibition of AMPK. Taken together, AMPK pivotally interacts with NF-kappa B and PI3K, mediating the cardioprotective effect of adiponectin, and may serve as a therapeutic target for preventing atrial hypertrophy and fibrosis. Our present study suggests that gAcrp could ameliorate AngII-induced cardiac hypertrophy and fibrosis in rat atrial cells, which is mediated by the activation of AMPK signaling pathways. APPL1 and AdipoR1 are the key factors involved in the downstream of gAcrp approach.	[Cao, Tengwei; Gao, Zhen; Huang, He] Nanjing Tech Univ, Coll Biotechnol & Pharmaceut Engn, Nanjing, Jiangsu, Peoples R China; [Gu, Lingyun] Southeast Univ, Jiangyin Hosp, Div Cardiol, Jiangyin, Peoples R China; [Chen, Minglong; Yang, Bing; Cao, Kejiang; Li, Mingfang] Nanjing Med Univ, Affiliated Hosp 1, Dept Med, Div Cardiol, Nanjing, Jiangsu, Peoples R China; [Huang, He] State Key Lab Mat Oriented Chem Engn, Nanjing, Jiangsu, Peoples R China	Nanjing Tech University; Southeast University - China; Nanjing Medical University	Huang, H (corresponding author), Nanjing Tech Univ, Coll Biotechnol & Pharmaceut Engn, Nanjing, Jiangsu, Peoples R China.	huangh@njtech.edu.cn; mingflee@hotmail.com			National Natural Science Foundation of China [81000083]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from National Natural Science Foundation of China (Young Project, No. 81000083). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allessie M, 2002, CARDIOVASC RES, V54, P230, DOI 10.1016/S0008-6363(02)00258-4; BARKALOW K, 1995, CURR BIOL, V5, P1000, DOI 10.1016/S0960-9822(95)00200-4; Benjamin EJ, 1998, CIRCULATION, V98, P946, DOI 10.1161/01.CIR.98.10.946; Chandrasekar B, 2008, J BIOL CHEM, V283, P24889, DOI 10.1074/jbc.M804236200; Chen H, 2003, J BIOL CHEM, V278, P45021, DOI 10.1074/jbc.M307878200; Chlopcikova Sarka, 2001, Biomedical Papers (Olomouc), V145, P49; Cnop M, 2003, DIABETOLOGIA, V46, P459, DOI 10.1007/s00125-003-1074-z; Diez JJ, 2003, EUR J ENDOCRINOL, V148, P293, DOI 10.1530/eje.0.1480293; Doughty RN, 2004, CIRCULATION, V109, P201, DOI 10.1161/01.CIR.0000108928.25690.94; Fang XP, 2010, AM J PHYSIOL-ENDOC M, V299, pE721, DOI 10.1152/ajpendo.00086.2010; Fujioka D, 2006, AM J PHYSIOL-HEART C, V290, pH2409, DOI 10.1152/ajpheart.00987.2005; Hattori Y, 2006, HYPERTENSION, V47, P1183, DOI 10.1161/01.HYP.0000221429.94591.72; Hu E, 1996, J BIOL CHEM, V271, P10697, DOI 10.1074/jbc.271.18.10697; Kadowaki T, 2005, ENDOCR REV, V26, P439, DOI 10.1210/er.2005-0005; KANNEL WB, 1982, NEW ENGL J MED, V306, P1018, DOI 10.1056/NEJM198204293061703; Li DS, 2001, CIRCULATION, V104, P2608, DOI 10.1161/hc4601.099402; Mao XM, 2006, NAT CELL BIOL, V8, P516, DOI 10.1038/ncb1404; Mehta PK, 2007, AM J PHYSIOL-CELL PH, V292, pC82, DOI 10.1152/ajpcell.00287.2006; Ouchi N, 2006, TRENDS CARDIOVAS MED, V16, P141, DOI 10.1016/j.tcm.2006.03.001; Park M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019143; Purcell NH, 2001, P NATL ACAD SCI USA, V98, P6668, DOI 10.1073/pnas.111155798; Sattar AA, 2012, BIOCHEM BIOPH RES CO, V424, P753, DOI 10.1016/j.bbrc.2012.07.027; Shibata R, 2004, J BIOL CHEM, V279, P28670, DOI 10.1074/jbc.M402558200; Shibata R, 2004, NAT MED, V10, P1384, DOI 10.1038/nm1137; Sugden PH, 1998, J MOL MED, V76, P725, DOI 10.1007/s001090050275; Tian L, 2012, ATHEROSCLEROSIS, V221, P66, DOI 10.1016/j.atherosclerosis.2011.12.014; Tsai CT, 2008, CIRCULATION, V117, P344, DOI 10.1161/CIRCULATIONAHA.107.695346; Wang C, 2010, J CELL PHYSIOL, V222, P149, DOI 10.1002/jcp.21931; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yang L, 2003, J BIOL CHEM, V278, P16820, DOI 10.1074/jbc.M213163200; Zhou LJ, 2009, J BIOL CHEM, V284, P22426, DOI 10.1074/jbc.M109.028357; Zhu WD, 2008, CLIN SCI, V114, P361, DOI 10.1042/CS20070347	33	31	37	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e103793	10.1371/journal.pone.0103793	http://dx.doi.org/10.1371/journal.pone.0103793			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25099270	gold, Green Submitted, Green Published			2022-12-27	WOS:000339995100031
J	Moarii, M; Pinheiro, A; Sigal-Zafrani, B; Fourquet, A; Caly, M; Servant, N; Stoven, V; Vert, JP; Reyal, F				Moarii, Matahi; Pinheiro, Alice; Sigal-Zafrani, Brigitte; Fourquet, Alain; Caly, Martial; Servant, Nicolas; Stoven, Veronique; Vert, Jean-Philippe; Reyal, Fabien			Epigenomic Alterations in Breast Carcinoma from Primary Tumor to Locoregional Recurrences	PLOS ONE			English	Article							DNA METHYLATION; COPY NUMBER; CONSERVING THERAPY; ALLELIC IMBALANCE; CANCER; SURVIVAL; IMPACT; RECOMMENDATIONS; METASTASES; PATTERNS	Introduction: Epigenetic modifications such as aberrant DNA methylation has long been associated with tumorogenesis. Little is known, however, about how these modifications appear in cancer progression. Comparing the methylome of breast carcinomas and locoregional evolutions could shed light on this process. Methods: The methylome profiles of 48 primary breast carcinomas (PT) and their matched axillary metastases (PT/AM pairs, 20 cases), local recurrences (PT/LR pairs, 17 cases) or contralateral breast carcinomas (PT/CL pairs, 11 cases) were analyzed. Univariate and multivariate analyzes were performed to determine differentially methylated probes (DMPs), and a similarity score was defined to compare methylation profiles. Correlation with copy-number based score was calculated and metastatic-free survival was compared between methods. Results: 49 DMPs were found for the PT/AM set, but none for the others (FDR < 5%). Hierarchical clustering clustered 75% of the PT/AM, 47% of the PT/LR, and none of the PT/CL pairs together. A methylation-based score (MS) was defined as a clonality measure. The PT/AM set contained a high proportion of clonal pairs while PT/LR pairs were evenly split between high and low MS score, suggesting two groups: true recurrences (TR) and new primary tumors (NP). CL were classified as new tumors. MS score was significantly correlated with copy-number based scores. There was no significant difference between the metastatic-free survival of groups of patients based on different classifications. Conclusion: Epigenomic alterations are well suited to study clonality and track cancer progression. Methylation-based classification of TR and NP performed as well as clinical and copy-number based methods suggesting that these phenomenons are tightly linked.	[Moarii, Matahi; Servant, Nicolas; Stoven, Veronique; Vert, Jean-Philippe] Mines ParisTech, Ctr Computat Biol, Fontainebleau, France; [Moarii, Matahi; Servant, Nicolas; Stoven, Veronique; Vert, Jean-Philippe] Inst Curie, Paris, France; [Moarii, Matahi; Servant, Nicolas; Stoven, Veronique; Vert, Jean-Philippe] INSERM, U900, Paris, France; [Pinheiro, Alice; Reyal, Fabien] Inst Curie, UMR144, Oncol Mol Team, Paris, France; [Pinheiro, Alice; Reyal, Fabien] Inst Curie, Residual Tumor & Response Treatment Team, Dept Translat Res, Paris, France; [Sigal-Zafrani, Brigitte; Caly, Martial] Inst Curie, Dept Tumor Biol, Paris, France; [Fourquet, Alain] Inst Curie, Dept Radiotherapy, Paris, France; [Reyal, Fabien] Inst Curie, Dept Surg, Paris, France	UDICE-French Research Universities; PSL Research University Paris; MINES ParisTech; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Reyal, F (corresponding author), Inst Curie, UMR144, Oncol Mol Team, Paris, France.	fabien.reyal@curie.fr		Servant, Nicolas/0000-0003-1678-7410; MOARII, Matahi/0000-0001-6011-9212; Vert, Jean-Philippe/0000-0001-9510-8441	French league against cancer; European Research Council [SMAC-ERC-280032]; hospital program for clinical research [AOM 06 149]	French league against cancer; European Research Council(European Research Council (ERC)European Commission); hospital program for clinical research	MM was supported by the French league against cancer (www.ligue-cancer.net). JPV was supported by the European Research Council (SMAC-ERC-280032, url: erc.europa.eu). AF was supported by the hospital program for clinical research (AOM 06 149, url: http://www.sante.gouv.fr/le-programme-hospitalier-de-recherche-clinique-phrc.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balaton A. J., 1995, Archives d'Anatomie et de Cytologie Pathologiques, V43, P93; Balaton AJ, 1996, ANN PATHOL, V16, P144; Bartelink H, 2007, J CLIN ONCOL, V25, P3259, DOI 10.1200/JCO.2007.11.4991; Baylin SB, 2001, HUM MOL GENET, V10, P687, DOI 10.1093/hmg/10.7.687; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bollet MA, 2008, JNCI-J NATL CANCER I, V100, P48, DOI 10.1093/jnci/djm266; BORG A, 1990, CANCER RES, V50, P4332; Brommesson S, 2008, BMC CLIN PATHOL, V8, DOI 10.1186/1472-6890-8-6; CARTER CL, 1989, CANCER-AM CANCER SOC, V63, P181, DOI 10.1002/1097-0142(19890101)63:1<181::AID-CNCR2820630129>3.0.CO;2-H; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Christensen BC, 2010, CANCER RES, V70, P5686, DOI 10.1158/0008-5472.CAN-10-0190; Cox D. R., 1984, ANAL SURVIVAL DATA; Das PM, 2004, J CLIN ONCOL, V22, P4632, DOI 10.1200/JCO.2004.07.151; Dawson LA, 1998, EUR J CANCER, V34, P2000, DOI 10.1016/S0959-8049(98)00208-1; Ehrlich M, 2002, ONCOGENE, V21, P5400, DOI 10.1038/sj.onc.1205651; Ellsworth RE, 2005, MOL CANCER RES, V3, P71, DOI 10.1158/1541-7786.MCR-04-0180; Feng YM, 2007, BREAST CANCER RES TR, V103, P319, DOI 10.1007/s10549-006-9385-7; FISHER ER, 1975, CANCER, V36, P1, DOI 10.1002/1097-0142(197507)36:1<1::AID-CNCR2820360102>3.0.CO;2-4; Haffty BG, 1996, J CLIN ONCOL, V14, P52, DOI 10.1200/JCO.1996.14.1.52; HEALEY EA, 1993, J CLIN ONCOL, V11, P1545, DOI 10.1200/JCO.1993.11.8.1545; Houseman EA, 2009, BIOINFORMATICS, V25, P1999, DOI 10.1093/bioinformatics/btp364; Imyanitov EN, 2002, INT J CANCER, V100, P557, DOI 10.1002/ijc.10530; Jatoi I, 1999, SURG CLIN N AM, V79, P1061, DOI 10.1016/S0039-6109(05)70061-X; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; LAIRD PW, 1994, HUM MOL GENET, V3, P1487, DOI 10.1093/hmg/3.suppl_1.1487; Lauss M, 2012, EPIGENETICS-US, V7, P858, DOI 10.4161/epi.20837; Metcalfe K, 2004, J CLIN ONCOL, V22, P2328, DOI 10.1200/JCO.2004.04.033; Ostrovnaya I, 2010, STAT MED, V29, P1608, DOI 10.1002/sim.3866; Poage GM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009651; RAZIN A, 1980, SCIENCE, V210, P604, DOI 10.1126/science.6254144; Sabbah C, 2011, BIOINFORMATICS, V27, P1693, DOI 10.1093/bioinformatics/btr187; Schermelleh L, 2007, NUCLEIC ACIDS RES, V35, P4301, DOI 10.1093/nar/gkm432; Shibata A, 1996, CLIN CANCER RES, V2, P743; Smith TE, 1999, INT J RAD COL, V48, P1281; TATE PH, 1993, CURR OPIN GENET DEV, V3, P226, DOI 10.1016/0959-437X(93)90027-M; van der Sijp JRM, 2002, J CLIN ONCOL, V20, P1105, DOI 10.1200/JCO.20.4.1105; van Dongen JA, 2000, JNCI-J NATL CANCER I, V92, P1143, DOI 10.1093/jnci/92.14.1143; VERONESI U, 1995, J NATL CANCER I, V87, P19, DOI 10.1093/jnci/87.1.19; Vichapat V, 2012, J CLIN ONCOL, V30, P3478, DOI 10.1200/JCO.2011.39.3645; Vicini FA, 2007, CANCER-AM CANCER SOC, V109, P1264, DOI 10.1002/cncr.22529; Weigelt B, 2005, BRIT J CANCER, V93, P924, DOI 10.1038/sj.bjc.6602794; Weisenberger DJ, 2008, TECHNICAL REPORT; West NR, 2011, BREAST CANCER-BASIC, V5, P105, DOI 10.4137/BCBCR.S7344; Wolff AC, 2013, J CLIN ONCOL, V31, P3997, DOI 10.1200/JCO.2013.50.9984	46	9	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e103986	10.1371/journal.pone.0103986	http://dx.doi.org/10.1371/journal.pone.0103986			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25098247	Green Published, gold, Green Submitted			2022-12-27	WOS:000339995100041
J	Schreiter, S; Sandmann, M; Smalla, K; Grosch, R				Schreiter, Susanne; Sandmann, Martin; Smalla, Kornelia; Grosch, Rita			Soil Type Dependent Rhizosphere Competence and Biocontrol of Two Bacterial Inoculant Strains and Their Effects on the Rhizosphere Microbial Community of Field-Grown Lettuce	PLOS ONE			English	Article							RHIZOCTONIA-SOLANI; ANTAGONISTIC BACTERIA; ANTIBIOTIC PRODUCTION; GENOTYPIC DIVERSITY; FUSARIUM-OXYSPORUM; BIOLOGICAL-CONTROL; ROOT COLONIZATION; PSEUDOMONAS; IDENTIFICATION; AMPLIFICATION	Rhizosphere competence of bacterial inoculants is assumed to be important for successful biocontrol. Knowledge of factors influencing rhizosphere competence under field conditions is largely lacking. The present study is aimed to unravel the effects of soil types on the rhizosphere competence and biocontrol activity of the two inoculant strains Pseudomonas jessenii RU47 and Serratia plymuthica 3Re4-18 in field-grown lettuce in soils inoculated with Rhizoctonia solani AG1-IB or not. Two independent experiments were carried out in 2011 on an experimental plot system with three soil types sharing the same cropping history and weather conditions for more than 10 years. Rifampicin resistant mutants of the inoculants were used to evaluate their colonization in the rhizosphere of lettuce. The rhizosphere bacterial community structure was analyzed by denaturing gradient gel electrophoresis of 16S rRNA gene fragments amplified from total community DNA to get insights into the effects of the inoculants and R. solani on the indigenous rhizosphere bacterial communities. Both inoculants showed a good colonization ability of the rhizosphere of lettuce with more than 10 6 colony forming units per g root dry mass two weeks after planting. An effect of the soil type on rhizosphere competence was observed for 3Re4-18 but not for RU47. In both experiments a comparable rhizosphere competence was observed and in the presence of the inoculants disease symptoms were either significantly reduced, or at least a non-significant trend was shown. Disease severity was highest in diluvial sand followed by alluvial loam and loess loam suggesting that the soil types differed in their conduciveness for bottom rot disease. Compared to effect of the soil type of the rhizosphere bacterial communities, the effects of the pathogen and the inoculants were less pronounced. The soil types had a surprisingly low influence on rhizosphere competence and biocontrol activity while they significantly affected the bottom rot disease severity.	[Schreiter, Susanne; Smalla, Kornelia] Julius Kuhn Inst Fed Res Ctr Cultivated Plants JK, Inst Epidemiol & Pathogen Diagnost, Braunschweig, Germany; [Schreiter, Susanne; Sandmann, Martin; Grosch, Rita] Leibniz Inst Vegetable & Ornamental Crops Grossbe, Dept Plant Hlth, Grossbeeren, Germany	Julius Kuhn-Institut; Leibniz Institut fur Gemuse- und Zierpflanzenbau (IGZ)	Grosch, R (corresponding author), Leibniz Inst Vegetable & Ornamental Crops Grossbe, Dept Plant Hlth, Grossbeeren, Germany.	grosch@igzev.de	Grosch, Rita/HHM-5490-2022; Smalla, Kornelia/H-4002-2011	Grosch, Rita/0000-0002-7179-5715	'German Research Foundation' (DFG) [SM 59/11-1, GR 1729/8-1]	'German Research Foundation' (DFG)(German Research Foundation (DFG))	The study was funded by 'German Research Foundation' (DFG), SM 59/11-1; GR 1729/8-1: KS RG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adesina MF, 2007, SOIL BIOL BIOCHEM, V39, P2818, DOI 10.1016/j.soilbio.2007.06.004; Adesina MF, 2009, FEMS MICROBIOL ECOL, V69, P62, DOI 10.1111/j.1574-6941.2009.00685.x; Alabouvette C, 2006, EUR J PLANT PATHOL, V114, P329, DOI 10.1007/s10658-005-0233-0; Barret M, 2011, BIOL FERT SOILS, V47, P729, DOI 10.1007/s00374-011-0605-x; Baudoin E, 2002, APPL SOIL ECOL, V19, P135, DOI 10.1016/S0929-1393(01)00185-8; Benizri E, 2007, SOIL BIOL BIOCHEM, V39, P1230, DOI 10.1016/j.soilbio.2006.12.026; Berg G, 2005, FEMS MICROBIOL ECOL, V51, P215, DOI 10.1016/j.femsec.2004.08.006; Bloemberg GV, 2001, CURR OPIN PLANT BIOL, V4, P343, DOI 10.1016/S1369-5266(00)00183-7; BULL CT, 1991, PHYTOPATHOLOGY, V81, P954, DOI 10.1094/Phyto-81-954; Capdevila S, 2004, MICROBIOL-SGM, V150, P3889, DOI 10.1099/mic.0.27362-0; Chowdhury SP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068818; Davis R M, 1997, COMPENDIUM LETTUCE D, P15; De Bellis P, 2001, APPL ENVIRON MICROB, V67, P1945, DOI 10.1128/AEM.67.4.1945-1948.2001; Dekkers LC, 2000, MOL PLANT MICROBE IN, V13, P1177, DOI 10.1094/MPMI.2000.13.11.1177; Ghirardi S, 2012, MICROB ECOL, V64, P725, DOI 10.1007/s00248-012-0065-3; Gomes NCM, 2005, FEMS MICROBIOL ECOL, V54, P21, DOI 10.1016/j.femsec.2005.02.005; Gotz M, 2006, FEMS MICROBIOL ECOL, V56, P207, DOI 10.1111/j.1574-6941.2006.00093.x; Grosch R, 2005, CAN J MICROBIOL, V51, P345, DOI 10.1139/W05-002; Grosch R, 2012, PLANT SOIL, V361, P343, DOI 10.1007/s11104-012-1239-y; Grosch R, 2011, J PHYTOPATHOL, V159, P35, DOI 10.1111/j.1439-0434.2010.01708.x; Gutezeit B, 1993, GEMUSE, V29, P106; Haas D, 2005, NAT REV MICROBIOL, V3, P307, DOI 10.1038/nrmicro1129; Henry S, 2008, ENVIRON MICROBIOL, V10, P3082, DOI 10.1111/j.1462-2920.2008.01599.x; Heuer H, 1997, APPL ENVIRON MICROB, V63, P3233, DOI 10.1128/AEM.63.8.3233-3241.1997; Heuer H., 2001, BACTERIAL COMMUNITY, P177; Kazempour M. N., 2004, Plant Pathology Journal, V3, P88; Kropfa S, 2004, J MICROBIOL METH, V57, P187, DOI 10.1016/j.mimet.2004.01.002; Leistra M, 2004, J ENVIRON SCI HEAL B, V39, P1, DOI 10.1081/PFC-120027435; LEMANCEAU P, 1993, BIOCONTROL SCI TECHN, V3, P219, DOI 10.1080/09583159309355278; Loper JE, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002784; Lottmann J, 2000, FEMS MICROBIOL ECOL, V33, P41, DOI 10.1111/j.1574-6941.2000.tb00725.x; Lugtenberg BJJ, 2001, ANNU REV PHYTOPATHOL, V39, P461, DOI 10.1146/annurev.phyto.39.1.461; Mark GL, 2006, FEMS MICROBIOL ECOL, V56, P167, DOI 10.1111/j.1574-6941.2006.00056.x; Mavrodi DV, 2011, J BACTERIOL, V193, P177, DOI 10.1128/JB.00895-10; Neumann G, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00002; Oerke EC, 2006, J AGR SCI, V144, P31, DOI 10.1017/S0021859605005708; Paterson E, 2007, NEW PHYTOL, V173, P600, DOI 10.1111/j.1469-8137.2006.01931.x; Patten CL, 2002, APPL ENVIRON MICROB, V68, P3795, DOI 10.1128/AEM.68.8.3795-3801.2002; Persello-Cartieaux F, 2003, PLANT CELL ENVIRON, V26, P189, DOI 10.1046/j.1365-3040.2003.00956.x; Pierson LS, 1996, FEMS MICROBIOL LETT, V136, P101, DOI 10.1111/j.1574-6968.1996.tb08034.x; Quinlan RJ, 2010, N AM BIOPESTICIDES M; Raaijmakers JM, 2001, APPL ENVIRON MICROB, V67, P2545, DOI 10.1128/AEM.67.6.2545-2554.2001; Raaijmakers JM, 2012, ANNU REV PHYTOPATHOL, V50, P403, DOI 10.1146/annurev-phyto-081211-172908; Raaijmakers JM, 2009, PLANT SOIL, V321, P341, DOI 10.1007/s11104-008-9568-6; Rodriguez-Navarro DN, 2007, FEMS MICROBIOL LETT, V272, P127, DOI 10.1111/j.1574-6968.2007.00761.x; Ruhlmann J, 2005, ARCH AGRON SOIL SCI, V51, P163, DOI DOI 10.1080/03650340400026651; Scherwinski K, 2008, FEMS MICROBIOL ECOL, V64, P106, DOI 10.1111/j.1574-6941.2007.00421.x; Schneider JHM, 1997, EUR J PLANT PATHOL, V103, P265, DOI 10.1023/A:1008643311984; SCHNIDER U, 1995, J BACTERIOL, V177, P5387, DOI 10.1128/jb.177.18.5387-5392.1995; Schreiter S, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00144; Steidle A, 2002, APPL ENVIRON MICROB, V68, P6371, DOI 10.1128/AEM.68.12.6371-6382.2002; Steinberg C., 2007, MODERN SOIL MICROBIO, P455; Tikhonovich IA, 2011, ANN APPL BIOL, V159, P155, DOI 10.1111/j.1744-7348.2011.00489.x; Wang YS, 2004, ECOTOX ENVIRON SAFE, V59, P127, DOI 10.1016/j.ecoenv.2004.01.008; Weinert N, 2009, APPL ENVIRON MICROB, V75, P3859, DOI 10.1128/AEM.00414-09; Weller DM, 2002, ANNU REV PHYTOPATHOL, V40, P309, DOI 10.1146/annurev.phyto.40.030402.110010; Wibberg D, 2013, J BIOTECHNOL, V167, P142, DOI 10.1016/j.jbiotec.2012.12.010	57	45	48	2	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e103726	10.1371/journal.pone.0103726	http://dx.doi.org/10.1371/journal.pone.0103726			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25099168	gold, Green Published, Green Submitted			2022-12-27	WOS:000339995100030
J	Wang, IH; Chen, HY; Wang, YH; Chang, KW; Chen, YC; Chang, CR				Wang, I-Hua; Chen, Hsin-Yi; Wang, Yu-Han; Chang, Ko-Wei; Chen, Ying-Chieh; Chang, Chuang-Rung			Resveratrol Modulates Mitochondria Dynamics in Replicative Senescent Yeast Cells	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; LIFE-SPAN; CELLULAR SENESCENCE; FUSION; FISSION; PROTEIN; GTPASE; FZO1P; DNM1P; MORPHOLOGY	Mitochondria form a reticulum network dynamically fuse and divide in the cell. The balance between mitochondria fusion and fission is correlated to the shape, activity and integrity of these pivotal organelles. Resveratrol is a polyphenol antioxidant that can extend life span in yeast and worm. This study examined mitochondria dynamics in replicative senescent yeast cells as well as the effects of resveratrol on mitochondria fusion and fission. Collecting cells by biotin-streptavidin sorting method revealed that majority of the replicative senescent cells bear fragmented mitochondrial network, indicating mitochondria dynamics favors fission. Resveratrol treatment resulted in a reduction in the ratio of senescent yeast cells with fragmented mitochondria. The readjustment of mitochondria dynamics induced by resveratrol likely derives from altered expression profiles of fusion and fission genes. Our results demonstrate that resveratrol serves not only as an antioxidant, but also a compound that can mitigate mitochondria fragmentation in replicative senescent yeast cells.	[Wang, I-Hua; Chen, Hsin-Yi; Wang, Yu-Han; Chang, Ko-Wei; Chen, Ying-Chieh; Chang, Chuang-Rung] Natl Tsing Hua Univ, Inst Biotechnol, Hsinchu, Taiwan; [Chang, Chuang-Rung] Natl Tsing Hua Univ, Dept Med Sci, Hsinchu, Taiwan	National Tsing Hua University; National Tsing Hua University	Chang, CR (corresponding author), Natl Tsing Hua Univ, Inst Biotechnol, Hsinchu, Taiwan.	crchang@life.nthu.edu.tw	Chang, Chuang-Rung/C-1815-2012	Chang, Chuang-Rung/0000-0002-6124-5429	Ministry of Science and Technology of Taiwan [101-2311-B-007-012-MY3, 102-2320-B-007-008-MY3]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by the Ministry of Science and Technology of Taiwan (http://web1.most.gov.tw/mp.aspx) under Grants 101-2311-B-007-012-MY3 and 102-2320-B-007-008-MY3 to CRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blackstone C, 2011, NAT CELL BIOL, V13, P521, DOI 10.1038/ncb0511-521; Bleazard W, 1999, NAT CELL BIOL, V1, P298, DOI 10.1038/13014; Braun RJ, 2011, BIOCHEM SOC T, V39, P1520, DOI 10.1042/BST0391520; Campello S, 2010, EMBO REP, V11, P678, DOI 10.1038/embor.2010.115; Chang CR, 2007, J BIOL CHEM, V282, P21583, DOI 10.1074/jbc.C700083200; Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026; Cho DH, 2009, SCIENCE, V324, P102, DOI 10.1126/science.1171091; CORRALDEBRINSKI M, 1992, MUTAT RES, V275, P169, DOI 10.1016/0921-8734(92)90021-G; Drose S, 2012, ADV EXP MED BIOL, V748, P145, DOI 10.1007/978-1-4614-3573-0_6; Escobar-Henriques M, 2006, J CELL BIOL, V173, P645, DOI 10.1083/jcb.200512079; Ferretta A, 2014, BIOCH BIOPHYS ACTA; Figueroa-Romero C, 2009, FASEB J, V23, P3917, DOI 10.1096/fj.09-136630; GADALETA MN, 1992, MUTAT RES, V275, P181, DOI 10.1016/0921-8734(92)90022-H; Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220; Griffin EE, 2005, J CELL BIOL, V170, P237, DOI 10.1083/jcb.200503148; Hermann GJ, 1998, J CELL BIOL, V143, P359, DOI 10.1083/jcb.143.2.359; Hoch HC, 2005, MYCOLOGIA, V97, P580, DOI 10.3852/mycologia.97.3.580; Horn SR, 2011, MOL BIOL CELL, V22, P1207, DOI 10.1091/mbc.E10-07-0567; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Hughes AL, 2012, NATURE, V492, P261, DOI 10.1038/nature11654; Iqbal S, 2013, MUSCLE NERVE, V48, P963, DOI 10.1002/mus.23838; Jayashankar V, 2014, CURR OPIN CELL BIOL, V26, P34, DOI 10.1016/j.ceb.2013.09.002; Jin SM, 2012, J CELL SCI, V125, P795, DOI 10.1242/jcs.093849; Kennedy BK, 1997, CELL, V89, P381, DOI 10.1016/S0092-8674(00)80219-6; Kennedy BK, 2013, TRANSL RES; Lam YT, 2011, FREE RADICAL BIO MED, V50, P963, DOI 10.1016/j.freeradbiomed.2011.01.013; Laun P, 2001, MOL MICROBIOL, V39, P1166, DOI 10.1046/j.1365-2958.2001.02317.x; Lee HC, 2012, ADV EXP MED BIOL, V942, P311, DOI 10.1007/978-94-007-2869-1_14; Lee S, 2007, J BIOL CHEM, V282, P22977, DOI 10.1074/jbc.M700679200; Lindstrom DL, 2009, GENETICS, V183, P413, DOI 10.1534/genetics.109.106229; Longo VD, 2012, CELL METAB, V16, P18, DOI 10.1016/j.cmet.2012.06.002; Mozdy AD, 2000, J CELL BIOL, V151, P367, DOI 10.1083/jcb.151.2.367; Okamoto K, 2005, ANNU REV GENET, V39, P503, DOI 10.1146/annurev.genet.38.072902.093019; Rafelski SM, 2012, SCIENCE, V338, P822, DOI 10.1126/science.1225720; Rapaport D, 1998, J BIOL CHEM, V273, P20150, DOI 10.1074/jbc.273.32.20150; Rolland SG, 2013, P NATL ACAD SCI USA, V110, pE2967, DOI 10.1073/pnas.1303872110; Rubinsztein DC, 2011, CELL, V146, P682, DOI 10.1016/j.cell.2011.07.030; Scorrano L, 2013, EUR J CLIN INVEST, V43, P886, DOI 10.1111/eci.12135; Scott I, 2010, ESSAYS BIOCHEM, V47, P85, DOI [10.1042/BSE0470085, 10.1042/bse0470085]; Sesaki H, 2004, J BIOL CHEM, V279, P28298, DOI 10.1074/jbc.M401363200; Sesaki H, 1999, J CELL BIOL, V147, P699, DOI 10.1083/jcb.147.4.699; Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6; Tieu Q, 2000, J CELL BIOL, V151, P353, DOI 10.1083/jcb.151.2.353; Um JH, 2010, DIABETES, V59, P554, DOI 10.2337/db09-0482; Viswanathan M, 2011, NATURE, V477, pE1, DOI 10.1038/nature10440; Wasiak S, 2007, J CELL BIOL, V177, P439, DOI 10.1083/jcb.200610042; Westermann B, 2000, YEAST, V16, P1421, DOI 10.1002/1097-0061(200011)16:15<1421::AID-YEA624>3.3.CO;2-L; Westermann B, 2010, SEMIN CELL DEV BIOL, V21, P542, DOI 10.1016/j.semcdb.2009.12.003; Wong ED, 2000, J CELL BIOL, V151, P341, DOI 10.1083/jcb.151.2.341; Wood JG, 2004, NATURE, V430, P686, DOI 10.1038/nature02789; Wu YT, 2013, BBA-MOL BASIS DIS, V1832, P216, DOI 10.1016/j.bbadis.2012.10.002; Yoon YS, 2006, J CELL PHYSIOL, V209, P468, DOI 10.1002/jcp.20753; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855; Zunino R, 2007, J CELL SCI, V120, P1178, DOI 10.1242/jcs.03418	54	12	13	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e104345	10.1371/journal.pone.0104345	http://dx.doi.org/10.1371/journal.pone.0104345			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25098588	Green Submitted, Green Published, gold			2022-12-27	WOS:000339995100064
J	Stevanovic, J; Pompen, M; Le, HH; Rozenbaum, MH; Tieleman, RG; Postma, MJ				Stevanovic, Jelena; Pompen, Marjolein; Le, Hoa H.; Rozenbaum, Mark H.; Tieleman, Robert G.; Postma, Maarten J.			Economic Evaluation of Apixaban for the Prevention of Stroke in Non-Valvular Atrial Fibrillation in the Netherlands	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; COST-EFFECTIVENESS; RISK-FACTORS; WARFARIN; DABIGATRAN; MANAGEMENT; FREQUENCY; EFFICACY; DISEASE; SAFETY	Background: Stroke prevention is the main goal of treating patients with atrial fibrillation (AF). Vitamin-K antagonists (VKAs) present an effective treatment in stroke prevention, however, the risk of bleeding and the requirement for regular coagulation monitoring are limiting their use. Apixaban is a novel oral anticoagulant associated with significantly lower hazard rates for stroke, major bleedings and treatment discontinuations, compared to VKAs. Objective: To estimate the cost-effectiveness of apixaban compared to VKAs in non-valvular AF patients in the Netherlands. Methods: Previously published lifetime Markov model using efficacy data from the ARISTOTLE and the AVERROES trial was modified to reflect the use of oral anticoagulants in the Netherlands. Dutch specific costs, baseline population stroke risk and coagulation monitoring levels were incorporated. Univariate, probabilistic sensitivity and scenario analyses on the impact of different coagulation monitoring levels were performed on the incremental cost-effectiveness ratio (ICER). Results: Treatment with apixaban compared to VKAs resulted in an ICER of (sic)10,576 per quality adjusted life year (QALY). Those findings correspond with lower number of strokes and bleedings associated with the use of apixaban compared to VKAs. Univariate sensitivity analyses revealed model sensitivity to the absolute stroke risk with apixaban and treatment discontinuations risks with apixaban and VKAs. The probability that apixaban is cost-effective at a willingness-to-pay threshold of (sic)20,000/QALY was 68%. Results of the scenario analyses on the impact of different coagulation monitoring levels were quite robust. Conclusions: In patients with non-valvular AF, apixaban is likely to be a cost-effective alternative to VKAs in the Netherlands.	[Stevanovic, Jelena; Le, Hoa H.; Postma, Maarten J.] Univ Groningen, Groningen, Netherlands; [Pompen, Marjolein] Bristol Myers Squibb Co, Woerden, Netherlands; [Rozenbaum, Mark H.] Pfizer Nederland, Capelle Aan Den Ijssel, Netherlands; [Tieleman, Robert G.] Martini Hosp, Groningen, Netherlands	University of Groningen; Bristol-Myers Squibb; Pfizer; Martini Hospital	Stevanovic, J (corresponding author), Univ Groningen, Groningen, Netherlands.	j.stevanovic@rug.nl		Postma, Maarten/0000-0002-6306-3653	GlaxoSmithKline; Sanofi Pasteur MSD; Sanofi; Shire; Pfizer; Novartis; Amgen; Astra Zeneca; Gilead; Boehringer Ingelheim	GlaxoSmithKline(GlaxoSmithKline); Sanofi Pasteur MSD; Sanofi(Sanofi-Aventis); Shire; Pfizer(Pfizer); Novartis(Novartis); Amgen(Amgen); Astra Zeneca(AstraZeneca); Gilead(Gilead Sciences); Boehringer Ingelheim(Boehringer Ingelheim)	Prof. Postma received grants, honoraria and travel stipend from GlaxoSmithKline, Sanofi Pasteur MSD, Sanofi, Shire, Pfizer, Novartis, Amgen, Astra Zeneca, Gilead and Boehringer Ingelheim. The funder provided support in the form of salaries for authors [MP and MHR], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, NEW ANT WELL DOS INT; [Anonymous], HANDLEIDING KOSTENON; Ansell J, 2012, CIRCULATION, V125, P165, DOI 10.1161/CIRCULATIONAHA.111.031153; Baeten Stefan A, 2010, Cost Eff Resour Alloc, V8, P21, DOI 10.1186/1478-7547-8-21; Benjamin EJ, 1998, CIRCULATION, V98, P946, DOI 10.1161/01.CIR.98.10.946; Camm AJ, 2012, EUROPACE, V14, P1385, DOI [10.1093/europace/eus305, 10.1093/eurheartj/ehs253]; Connolly SJ, 2011, NEW ENGL J MED, V364, P806, DOI 10.1056/NEJMoa1007432; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Dorian P, 2014, EUR HEART J IN PRESS; Gage BF, 1996, ARCH INTERN MED, V156, P1829, DOI 10.1001/archinte.156.16.1829; Goren A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071264; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Greving JP, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1672; Harrington AR, 2013, STROKE, V44, P1676, DOI 10.1161/STROKEAHA.111.000402; Heeringa J, 2006, EUR HEART J, V27, P949, DOI 10.1093/eurheartj/ehi825; Hu B, 2010, MED DECIS MAKING, V30, pE29, DOI 10.1177/0272989X10374508; Hylek EM, 2007, CIRCULATION, V115, P2689, DOI 10.1161/CIRCULATIONAHA.106.653048; Kamel H, 2012, NEUROLOGY, V79, P1428, DOI 10.1212/WNL.0b013e31826d5fe8; Lee S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047473; Leendertse AJ, 2008, ARCH INTERN MED, V168, P1890, DOI 10.1001/archinternmed.2008.3; Lip G, 2014, CLIN THER IN PRESS; Lopes RD, 2012, LANCET, V380, P1749, DOI 10.1016/S0140-6736(12)60986-6; Mohan KM, 2009, J NEUROL NEUROSUR PS, V80, P1012, DOI 10.1136/jnnp.2008.170456; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Pink J, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6333; Pisters R, 2010, EUROPACE, V12, P779, DOI 10.1093/europace/euq080; Ringborg A, 2008, EUROPACE, V10, P403, DOI 10.1093/europace/eun048; Soekhlal RR, 2013, NETH HEART J, V21, P230, DOI 10.1007/s12471-013-0386-y; Statistics Netherlands, POP SEX AG MAR STAT; Statistics Netherlands website, CONS PRIC; Statistics Netherlands website, CAUS DEATH MAIN PRIM; Steger C, 2004, EUR HEART J, V25, P1734, DOI 10.1016/j.ehj.2004.06.030; Sullivan PW, 2011, MED DECIS MAKING, V31, P800, DOI 10.1177/0272989X11401031; ten Cate-Hoek AJ, 2009, J THROMB HAEMOST, V7, P2042, DOI 10.1111/j.1538-7836.2009.03627.x; Tengs TO, 2003, PHARMACOECONOMICS, V21, P191, DOI 10.2165/00019053-200321030-00004; Vaartjes I, 2010, BMC CARDIOVASC DISOR, V10, DOI 10.1186/1471-2261-10-57; Wallentin L, 2013, CIRCULATION, V127, P2166, DOI 10.1161/CIRCULATIONAHA.112.142158; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983	38	22	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e103974	10.1371/journal.pone.0103974	http://dx.doi.org/10.1371/journal.pone.0103974			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093723	Green Published, gold, Green Submitted			2022-12-27	WOS:000341357200053
J	Chen, JB; Lu, J				Chen, Jiabo; Lu, Jun			Effects of Land Use, Topography and Socio-Economic Factors on River Water Quality in a Mountainous Watershed with Intensive Agricultural Production in East China	PLOS ONE			English	Article							CAO-E RIVER; NUTRIENT CONCENTRATIONS; STREAM; COVER; BASIN; POLLUTION; NITROGEN; SYSTEM; MANAGEMENT; IMPACTS	Understanding the primary effects of anthropogenic activities and natural factors on river water quality is important in the study and efficient management of water resources. In this study, analysis of Variance (ANOVA), Principal component analysis (PCA), Pearson correlations, Multiple regression analysis (MRA) and Redundancy analysis (RDA) were applied as an integrated approach in a GIS environment to explore the temporal and spatial variations in river water quality and to estimate the influence of watershed land use, topography and socio-economic factors on river water quality based on 3 years of water quality monitoring data for the Cao-E River system. The statistical analysis revealed that TN, pH and temperature were generally higher in the rainy season, whereas BOD5, DO and turbidity were higher in the dry season. Spatial variations in river water quality were related to numerous anthropogenic and natural factors. Urban land use was found to be the most important explanatory variable for BOD5, CODMn, TN, DN, NH4+-N, NO3--N, DO, pH and TP. The animal husbandry output per capita was an important predictor of TP and turbidity, and the gross domestic product per capita largely determined spatial variations in EC. The remaining unexplained variance was related to other factors, such as topography. Our results suggested that pollution control of animal waste discharge in rural settlements, agricultural runoff in cropland, industrial production pollution and domestic pollution in urban and industrial areas were important within the Cao-E River basin. Moreover, the percentage of the total overall river water quality variance explained by an individual variable and/or all environmental variables (according to RDA) can assist in quantitatively identifying the primary factors that control pollution at the watershed scale.	[Chen, Jiabo; Lu, Jun] Zhejiang Univ, Coll Environm & Nat Resources, Dept Nat Resources, Hangzhou 310003, Zhejiang, Peoples R China; [Lu, Jun] Zhejiang Univ, Key Lab Environm Remediat & Ecol Hlth, China Minist Educ, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Lu, J (corresponding author), Zhejiang Univ, Coll Environm & Nat Resources, Dept Nat Resources, Hangzhou 310003, Zhejiang, Peoples R China.	jlu@zju.edu.cn	Jun, Lu/GMX-2504-2022		Chinese National Key Technology RD Program [2012BAC17B01]	Chinese National Key Technology RD Program(National Key Technology R&D Program)	Chinese National Key Technology R&D Program (Grant No. 2012BAC17B01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahearn DS, 2005, J HYDROL, V313, P234, DOI 10.1016/j.jhydrol.2005.02.038; Astaraie-Imani M, 2012, J ENVIRON MANAGE, V112, P1, DOI 10.1016/j.jenvman.2012.06.039; Aubert AH, 2013, J HYDROL, V478, P29, DOI 10.1016/j.jhydrol.2012.11.027; Belsey DA, 1980, REGRESSION DIAGNOSTI; Brett MT, 2005, ENVIRON MANAGE, V35, P330, DOI 10.1007/s00267-003-0311-z; Chang H, 2008, WATER RES, V42, P3285, DOI 10.1016/j.watres.2008.04.006; Chang NB, 2005, STOCH ENV RES RISK A, V19, P97, DOI 10.1007/s00477-004-0217-1; Chen DJ, 2006, J ENVIRON SCI, V18, P680; Chen DJ, 2011, ENVIRON POLLUT, V159, P2989, DOI 10.1016/j.envpol.2011.04.023; Chen J, 2013, ENVIRON SCI POLLUT R, V4, P2496; Chen JS, 2000, J HAZARD MATER, V73, P107, DOI 10.1016/S0304-3894(99)00165-X; Costa-Cabral M, 2013, CLIMATIC CHANGE, V116, P1, DOI 10.1007/s10584-012-0630-2; Dodds WK, 2004, LIMNOL OCEANOGR-METH, V2, P333, DOI 10.4319/lom.2004.2.333; Heathcote AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053554; Hoorman J, 2008, WATER AIR SOIL POLL, V193, P309, DOI 10.1007/s11270-008-9692-1; Huang F, 2010, WATER RES, V44, P1562, DOI 10.1016/j.watres.2009.11.003; Jiang XY, 2011, ENERG POLICY, V39, P6073, DOI 10.1016/j.enpol.2011.07.007; Jin SQ, 2009, J ENVIRON SCI, V21, P429, DOI 10.1016/S1001-0742(08)62287-1; Kannel PR, 2008, J ENVIRON MANAGE, V86, P595, DOI 10.1016/j.jenvman.2006.12.021; Karaer F, 2006, ENVIRON MONIT ASSESS, V114, P391, DOI 10.1007/s10661-006-5029-y; Keatley Be, 2011, PLOS ONE, V6; Kolovos A, 2002, WATER RESOUR RES, V38, DOI 10.1029/2001WR000743; Miserendino ML, 2011, SCI TOTAL ENVIRON, V409, P612, DOI 10.1016/j.scitotenv.2010.10.034; Leps J, 2003, MULTIVARIATE ANAL EC; Li SH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0083037, 10.1371/journal.pone.0067928, 10.1371/journal.pone.0057604]; Li SY, 2008, CATENA, V75, P216, DOI 10.1016/j.catena.2008.06.005; Lindell L, 2010, APPL GEOCHEM, V25, P485, DOI 10.1016/j.apgeochem.2009.12.013; Liu WZ, 2012, ENVIRON SCI POLLUT R, V19, P858, DOI 10.1007/s11356-011-0616-z; Mehaffey MH, 2005, ENVIRON MONIT ASSESS, V107, P29, DOI 10.1007/s10661-005-2018-5; Myers R., 1990, CLASSICAL MODERN REG; Odokuma LO, 1997, ENVIRON MONIT ASSESS, V45, P43, DOI 10.1023/A:1005709709031; Olsen RL, 2012, WATER RES, V46, P3110, DOI 10.1016/j.watres.2012.03.028; Pratt B, 2012, J HAZARD MATER, V209, P48, DOI 10.1016/j.jhazmat.2011.12.068; RICHARD A. J., 2002, APPL MULTIVARIATE ST; Sepbc, 2002, WAT WAST AN METH; Shah VG, 2007, WATER RES, V41, P3655, DOI 10.1016/j.watres.2007.02.052; Shaoxing City Statistical Bureau, 2005, SHZOX STAT YB; Shen YN, 2011, PEDOSPHERE, V21, P115, DOI 10.1016/S1002-0160(10)60086-0; Sliva L, 2001, WATER RES, V35, P3462, DOI 10.1016/S0043-1354(01)00062-8; ter Braak CJF, 2002, CANOCO REFERENCE MAN; Tian C, 2013, ENVIRON MONIT ASSESS, V185, P2627, DOI 10.1007/s10661-012-2736-4; Tong L, 2009, CHEMOSPHERE, V74, P1090, DOI 10.1016/j.chemosphere.2008.10.051; Wei RC, 2011, CHEMOSPHERE, V82, P1408, DOI 10.1016/j.chemosphere.2010.11.067; Xianghao Z, 2008, J MT SCI-ENGL, V1, P4; Xiao B, 2010, AGR ECOSYST ENVIRON, V139, P653, DOI 10.1016/j.agee.2010.10.011; Yang XE, 2008, J ZHEJIANG UNIV-SC B, V9, P197, DOI 10.1631/jzus.B0710626; Ye L, 2009, ENVIRON GEOL, V58, P937, DOI 10.1007/s00254-008-1573-9; Zhang Y, 2009, ENVIRON MONIT ASSESS, V152, P105, DOI 10.1007/s10661-008-0300-z; Zhao J, 2011, J ENVIRON SCI, V23, P1460, DOI 10.1016/S1001-0742(10)60599-2; Zhou NQ, 2011, J HYDROL, V396, P267, DOI 10.1016/j.jhydrol.2010.11.019	50	61	66	8	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e102714	10.1371/journal.pone.0102714	http://dx.doi.org/10.1371/journal.pone.0102714			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25090375	Green Published, gold, Green Submitted			2022-12-27	WOS:000339812700008
J	Maughan-Brown, B; Spaull, N				Maughan-Brown, Brendan; Spaull, Nicholas			HIV-Related Discrimination among Grade Six Students in Nine Southern African Countries	PLOS ONE			English	Article							HIV/AIDS-RELATED STIGMA; CHILDRENS ATTITUDES; PROTECTIVE FACTORS; CAPE-TOWN; AIDS; FAMILIES; PEOPLE; RISK; STIGMATIZATION; TRANSMISSION	Background: HIV-related stigmatisation and discrimination by young children towards their peers have important consequences at the individual level and for our response to the epidemic, yet research on this area is limited. Methods: We used nationally representative data to examine discrimination of HIV-positive children by grade six students (n = 39,664) across nine countries in Southern Africa: Botswana, Lesotho, Malawi, Mozambique, Namibia, South Africa, Swaziland, Zambia and Zimbabwe. Descriptive statistics are used to compare discrimination by country, gender, geographic location and socioeconomic status. Multivariate logistic regression is employed to assess potential determinants of discrimination. Results: The levels and determinants of discrimination varied significantly between the nine countries. While one in ten students in Botswana, Malawi, South Africa and Swaziland would "avoid or shun" an HIV positive friend, the proportions in Lesotho, Mozambique, Zambia and Zimbabwe were twice as high (approximately 20%). A large proportion of students believed that HIV positive children should not be allowed to continue to attend school, particularly in Zambia (33%), Lesotho (37%) and Zimbabwe (42%). The corresponding figures for Malawi and Swaziland were significantly lower at 13% and 12% respectively. Small differences were found by gender. Children from rural areas and poorer schools were much more likely to discriminate than those from urban areas and wealthier schools. Importantly, we identified factors consistently associated with discrimination across the region: students with greater exposure to HIV information, better general HIV knowledge and fewer misconceptions about transmission of HIV via casual contact were less likely to report discrimination. Conclusions: Our study points toward the need for early interventions (grade six or before) to reduce stigma and discrimination among children, especially in schools situated in rural areas and poorer communities. In particular, interventions should focus on correcting misconceptions that HIV can be transmitted via casual contact.	[Maughan-Brown, Brendan] Univ Cape Town, Southern Africa Labour & Dev Res Unit, ZA-7925 Cape Town, Western Cape, South Africa; [Spaull, Nicholas] Univ Stellenbosch, Res Socioecon Policy Grp RESEP, ZA-7600 Stellenbosch, Western Cape, South Africa	University of Cape Town; Stellenbosch University	Maughan-Brown, B (corresponding author), Univ Cape Town, Southern Africa Labour & Dev Res Unit, ZA-7925 Cape Town, Western Cape, South Africa.	brendan.maughanbrown@gmail.com	Spaull, Nicholas/AAA-6478-2020; Maughan-Brown, Brendan/AAH-4254-2019	Spaull, Nicholas/0000-0002-2970-5229; 				Aggleton P, 2003, STIGMA DISCRIMINATIO; Bond V, 2002, EVAL PROGRAM PLANN, V25, P347, DOI 10.1016/S0149-7189(02)00046-0; Buseh A. G., 2006, Journal of HIV/AIDS Prevention in Children & Youth, V7, P97, DOI 10.1300/J499v07n01_06; Campbell C, 2010, SOC SCI MED, V71, P975, DOI 10.1016/j.socscimed.2010.05.028; Castle S, 2004, CULT HEALTH SEX, V6, P1, DOI 10.1080/13691050310001622460; Chi PL, 2014, AIDS BEHAV, V18, P1054, DOI 10.1007/s10461-013-0649-z; Cluver L, 2007, AIDS CARE, V19, P318, DOI 10.1080/09540120600986578; Cluver L, 2010, CHILD ABUSE NEGLECT, V34, P793, DOI 10.1016/j.chiabu.2010.04.002; Cluver L, 2009, SOC SCI MED, V69, P1186, DOI 10.1016/j.socscimed.2009.07.033; Cossman JS, 2004, SOCIOL SPECTRUM, V24, P319, DOI 10.1080/02732170490431322; Dahl B, 2012, AFR HIST REV, V44, P53, DOI 10.1080/17532523.2012.714160; Day J., 2012, SAIL WORLD AUSTR FIS; Deacon H., 2007, HIV AIDS STIGMA CHIL; Deacon H., 2005, UNDERSTANDING HIV AI; Deacon H, 2006, J COMMUNITY APPL SOC, V16, P418, DOI 10.1002/casp.900; Demmer C, 2011, AIDS CARE, V23, P873, DOI 10.1080/09540121.2010.542123; Dolata S, 2011, PUPIL TEACHER KNOWLE; Fielden SJ, 2006, AIDS CARE, V18, P1050, DOI 10.1080/09540120600581460; GILMORE N, 1994, SOC SCI MED, V39, P1339, DOI 10.1016/0277-9536(94)90365-4; Hamra M, 2006, TROP MED INT HEALTH, V11, P513, DOI 10.1111/j.1365-3156.2006.01583.x; Hungi N., 2010, SACMEQ 3 PROJECT RES; Joffe Helene, 1999, RISK OTHER; Kalish Charles W., 1999, CHILDRENS UNDERSTAND, P99, DOI DOI 10.1017/CB09780511659881.006; Kelly M, 2000, PLANNING ED CONTEXT; Letamo G, 2003, J HEALTH POPUL NUTR, V21, P347; Link BG, 2001, ANNU REV SOCIOL, V27, P363, DOI 10.1146/annurev.soc.27.1.363; Liu H, 2005, SEX TRANSM INFECT, V81, P511, DOI 10.1136/sti.2005.014977; Maughan-Brown B, 2014, AIDS BEHAV, V18, P958, DOI 10.1007/s10461-013-0636-4; Maughan-Brown BG, 2006, S AFR REV SOCIOL, V37, P165, DOI 10.1080/21528586.2006.10419153; Moloi MQ, 2005, SACMEQ 2 PROJECT S A; Murimba S., 2005, Q REV COMP ED, V35, P75; Onsomu Eldah, 2005, SACMEQ 2 PROJECT KEN; Pitpitan EV, 2012, ANN BEHAV MED, V43, P362, DOI 10.1007/s12160-012-9346-9; Ross K. R, 2005, SACMEQ 2 PROJECT KEN; Sambisa W, 2010, AIDS CARE, V22, P170, DOI 10.1080/09540120903038374; Stephenson R, 2009, AIDS CARE, V21, P403, DOI 10.1080/09540120802290365; Surkan PJ, 2010, AIDS CARE, V22, P803, DOI 10.1080/09540120903443392; Young SD, 2010, JAIDS-J ACQ IMM DEF, V55, P620, DOI 10.1097/QAI.0b013e3181fc6429	38	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2014	9	8							e102981	10.1371/journal.pone.0102981	http://dx.doi.org/10.1371/journal.pone.0102981			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR0CG	25105728	Green Published, gold			2022-12-27	WOS:000343231900008
J	Yirdaw, KD; Jerene, D; Gashu, Z; Edginton, ME; Kumar, AMV; Letamo, Y; Feleke, B; Teklu, AM; Zewdu, S; Weiss, B; Ruff, A				Yirdaw, Kesetebirhan Delele; Jerene, Degu; Gashu, Zewdu; Edginton, M. E.; Kumar, Ajay M. V.; Letamo, Yohannes; Feleke, Beniam; Teklu, Alula M.; Zewdu, Solomon; Weiss, Bill; Ruff, Andrea			Beneficial Effect of Isoniazid Preventive Therapy and Antiretroviral Therapy on the Incidence of Tuberculosis in People Living with HIV in Ethiopia	PLOS ONE			English	Article							ADULTS; IMPLEMENTATION	Background: IPT with or without concomitant administration of ART is a proven intervention to prevent tuberculosis among PLHIV. However, there are few data on the routine implementation of this intervention and its effectiveness in settings with limited resources. Objectives: To measure the level of uptake and effectiveness of IPT in reducing tuberculosis incidence in a cohort of PLHIV enrolled into HIV care between 2007 and 2010 in five hospitals in southern Ethiopia. Methods: A retrospective cohort analysis of electronic patient database was done. The independent effects of no intervention, "IPT-only," "IPT-before-ART," "IPT-and-ART started simultaneously," "ART-only," and "IPT-after-ART" on TB incidence were measured. Cox-proportional hazards regression was used to assess association of treatment categories with TB incidence. Results: Of 7,097 patients, 867 were excluded because they were transferred-in; a further 823 (12%) were excluded from the study because they were either identified to have TB through screening (292 patients) or were on TB treatment (531). Among the remaining 5,407 patients observed, IPT had been initiated for 39% of eligible patients. Children, male sex, advanced disease, and those in Pre-ART were less likely to be initiated on IPT. The overall TB incidence was 2.6 per 100 person-years. As compared to those with no intervention, use of "IPT-only" (aHR = 0.36, 95% CI = 0.19-0.66) and "ART-only" (aHR = 0.32, 95% CI = 0.24-0.43) were associated with significant reduction in TB incidence rate. Combining ART and IPT had a more profound effect. Starting IPT-before-ART (aHR = 0.18, 95% CI = 0.08-0.42) or simultaneously with ART (aHR = 0.20, 95% CI = 0.10-0.42) provided further reduction of TB at similar to 80%. Conclusions: IPT was found to be effective in reducing TB incidence, independently and with concomitant ART, under programme conditions in resource-limited settings. The level of IPT provision and effectiveness in reducing TB was encouraging in the study setting. Scaling up and strengthening IPT service in addition to ART can have beneficial effect in reducing TB burden among PLHIV in settings with high TB/HIV burden.	[Yirdaw, Kesetebirhan Delele; Jerene, Degu; Gashu, Zewdu] Johns Hopkins Univ, TSEHAI Project, Clin Dept, Addis Ababa, Ethiopia; [Edginton, M. E.] Int Union TB & Lung Dis, Ctr Operat Res, Paris, France; [Kumar, Ajay M. V.] Int Union TB & Lung Dis, South East Asia Reg Off, New Delhi, India; [Letamo, Yohannes] Southen Nations Natl & Peoples Reg Hlth Bur, Hlth Res & Technol Transfer Support Proc, Hawassa, Southern Nation, Ethiopia; [Feleke, Beniam] Ctr Dis Control & Prevent, TB HIV Unit, Care & Treatment Branch, Addis Ababa, Ethiopia; [Teklu, Alula M.] Johns Hopkins Univ, TSEHAI Project, PCM Dept, Addis Ababa, Ethiopia; [Zewdu, Solomon; Weiss, Bill; Ruff, Andrea] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Yirdaw, KD (corresponding author), Johns Hopkins Univ, TSEHAI Project, Clin Dept, Addis Ababa, Ethiopia.	kcgp2005@yahoo.com		Madhugiri Venkatachalaiah, Ajay Kumar/0000-0003-1011-8531; Weiss, William/0000-0003-3013-8599	Department for International Development, UK; National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP) [U2GPS000858] Funding Source: NIH RePORTER	Department for International Development, UK; National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Funding for the course was from an anonymous donor and the Department for International Development, UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auld AF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054665; Chehab JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057791; Durovni B, 2010, AIDS, V24, pS49, DOI 10.1097/01.aids.0000391022.95412.a6; Ethiopian Population Census Commission, 2008, SUMM STAT REP 2007 P; Ethiopian Statistical Agency, 2011, DEM HLTH SURV; Federal HIV/AIDS Prevention and Control Office, 2012, COUNTR PROGR REP HIV; Federal HIV/AIDS Prevention and Control Office & Federal Ministry of Health, 2008, GUID ANT THER ETH; Federal Ministry of Health, 2012, GUID CLIN PROGR MAN; Federal Ministry of Health, 2004, NAT TB HIV SURV PROG; Federal Ministry of Health, 2010, HLTH MAN INF SYST HM; Federal Ministry of Health Ethiopian Health and Nutrition Research Institute, 2011, 1 ETH NAT POP BAS TB; Getahun H, 2010, AIDS, V24, pS57, DOI 10.1097/01.aids.0000391023.03037.1f; Golub JE, 2007, AIDS, V21, P1441, DOI 10.1097/QAD.0b013e328216f441; Golub JE, 2009, AIDS, V23, P631, DOI 10.1097/QAD.0b013e328327964f; Granich R, 2011, CURR HIV RES, V9, P446, DOI 10.2174/157016211798038597; Gupta A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034156; Jerene Degu, 2006, AIDS Res Ther, V3, P10, DOI 10.1186/1742-6405-3-10; Kabali C, 2011, INT J TUBERC LUNG D, V15, P1515, DOI 10.5588/ijtld.10.0788; Kibret KT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064488; Lester R, 2010, AIDS, V24, pS45, DOI 10.1097/01.aids.0000391021.18284.12; Tegbaru B, 2006, CLIN VACCINE IMMUNOL, V13, P784, DOI 10.1128/CVI.00098-06; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, 2010, TREATMENT OF TUBERCULOSIS: GUIDELINES, FOURTH EDITION, P1; World Health Organization, 2011, GUID INT TB CAS FIND	24	48	48	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2014	9	8							e104557	10.1371/journal.pone.0104557	http://dx.doi.org/10.1371/journal.pone.0104557			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR0CG	25105417	Green Published, gold			2022-12-27	WOS:000343231900069
J	Akella, SVS; Kirk, WDJ; Lu, YB; Murai, T; Walters, KFA; Hamilton, JGC				Akella, Sudhakar V. S.; Kirk, William D. J.; Lu, Yao-bin; Murai, Tamotsu; Walters, Keith F. A.; Hamilton, James G. C.			Identification of the Aggregation Pheromone of the Melon Thrips, Thrips palmi	PLOS ONE			English	Article							WESTERN FLOWER THRIPS; FRANKLINIELLA-OCCIDENTALIS PERGANDE; THYSANOPTERA THRIPIDAE; SEX-PHEROMONE; ERADICATION; PEST	The objective of this study was to identify the aggregation pheromone of the melon thrips Thrips palmi, a major pest of vegetable and ornamental plants around the world. The species causes damage both through feeding activities and as a vector of tospoviruses, and is a threat to world trade and European horticulture. Improved methods of detecting and controlling this species are needed and the identification of an aggregation pheromone will contribute to this requirement. Bioassays with a Y-tube olfactometer showed that virgin female T. palmi were attracted to the odour of live males, but not to that of live females, and that mixed-age adults of both sexes were attracted to the odour of live males, indicating the presence of a male-produced aggregation pheromone. Examination of the headspace volatiles of adult male T. palmi revealed only one compound that was not found in adult females. It was identified by comparison of its mass spectrum and chromatographic details with those of similar compounds. This compound had a structure like that of the previously identified male-produced aggregation pheromone of the western flower thrips Frankliniella occidentalis. The compound was synthesised and tested in eggplant crops infested with T. palmi in Japan. Significantly greater numbers of both males and females were attracted to traps baited with the putative aggregation pheromone compared to unbaited traps. The aggregation pheromone of T. palmi is thus identified as (R)-lavandulyl 3-methyl-3-butenoate by spectroscopic, chromatographic and behavioural analysis.	[Akella, Sudhakar V. S.; Kirk, William D. J.; Hamilton, James G. C.] Keele Univ, Sch Life Sci, Ctr Appl Entomol & Parasitol, Keele ST5 5BG, Staffs, England; [Lu, Yao-bin] Zhejiang Acad Agr Sci, Inst Plant Protect & Microbiol, Hangzhou, Zhejiang, Peoples R China; [Murai, Tamotsu] Utsunomiya Univ, Fac Agr, Appl Entomol Lab, Utsunomiya, Tochigi 321, Japan; [Walters, Keith F. A.] Food & Environm Res Agcy, York, N Yorkshire, England	Keele University; Zhejiang Academy of Agricultural Sciences; Utsunomiya University; Food & Environment Research Agency	Hamilton, JGC (corresponding author), Keele Univ, Sch Life Sci, Ctr Appl Entomol & Parasitol, Huxley Bldg, Keele ST5 5BG, Staffs, England.	j.g.c.hamilton@keele.ac.uk	Walters, Keith/AAK-3562-2020; Hamilton, Gordon/AAA-6960-2022	hamilton, james/0000-0001-9196-8516; Kirk, William/0000-0001-8586-4518	European Union, Marie Curie, Incoming International Fellowship [252258]	European Union, Marie Curie, Incoming International Fellowship	This research was funded by a European Union, Marie Curie, Incoming International Fellowship scheme to Dr S. Akella (Project 252258) and as a subcontract of a project, The integrated control of Thrips palmi Karny, made to Central Science Laboratory by the United Kingdom government Department of Food Environment and Rural Affairs. The funders had no role in study design, data collection and analysis or preparation of the manuscript.	Austin AD, 2004, AUST J ENTOMOL, V43, P216, DOI 10.1111/j.1326-6756.2004.00448.x; Buckman RS, 2013, SYST ENTOMOL, V38, P123, DOI 10.1111/j.1365-3113.2012.00650.x; Cannon RJC, 2007, CROP PROT, V26, P1089, DOI 10.1016/j.cropro.2006.10.023; Cannon RJC, 2007, CROP PROT, V26, P1303, DOI 10.1016/j.cropro.2006.11.005; El-Ghariani I. M., 2008, Acta Phytopathologica et Entomologica Hungarica, V43, P257, DOI 10.1556/APhyt.43.2008.2.7; Gomez M., 2006, IOBC-WPRS Bulletin, V29, P153; Hamilton JGC, 2005, J CHEM ECOL, V31, P1369, DOI 10.1007/s10886-005-1351-z; Hamodi A.A., 2012, Arab Journal of Plant Protection, V30, P142; Hinkens DM, 2001, TETRAHEDRON LETT, V42, P1619, DOI 10.1016/S0040-4039(00)02347-9; Kawai A., 1986, B VEG ORNAM CROPS C, V9, P69; Kirk WDJ, 2004, J CHEM ECOL, V30, P167, DOI 10.1023/B:JOEC.0000013189.89576.8f; KIRK WDJ, 1985, ECOL ENTOMOL, V10, P433, DOI 10.1111/j.1365-2311.1985.tb00741.x; MacLeod A, 2004, CROP PROT, V23, P601, DOI 10.1016/j.cropro.2003.11.010; MATTESON NA, 1992, ENTOMOL EXP APPL, V63, P187, DOI 10.1007/BF00343578; Mound LA, 2009, ZOOTAXA, P29, DOI 10.11646/zootaxa.2129.1.2; Murai T., 1988, Bulletin of the Shimane Agricultural Experiment Station, P1; Murai T., 2002, P 7 INT S THYS 2 7 J, P19; OEPP/EPPO, 1989, B OEPP EPPO B, V19, P717; Olaniran OA, 2013, J CHEM ECOL, V39, P559, DOI 10.1007/s10886-013-0272-5; Palmer J.M., 1989, CIE GUIDES INSECTS I, P73; Sampson C., 2012, IOBC/WPRS Bulletin, V80, P313; Sampson C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080787; Song Jeong-Heub, 1997, RDA Journal of Crop Protection, V39, P53; Sudo M, 2002, P ARTHROPODAN EMBRYO, V37, P35; TERRY LI, 1990, J INSECT BEHAV, V3, P133, DOI 10.1007/BF01049200; Theodorou V, 2007, TETRAHEDRON LETT, V48, P8230, DOI 10.1016/j.tetlet.2007.09.074; Whitfield AE, 2005, ANNU REV PHYTOPATHOL, V43, P459, DOI 10.1146/annurev.phyto.43.040204.140017; Zada A, 2006, TETRAHEDRON-ASYMMETR, V17, P230, DOI 10.1016/j.tetasy.2005.12.021; Zhu Xiao-Yun, 2012, Acta Entomologica Sinica, V55, P376	29	29	36	1	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e103315	10.1371/journal.pone.0103315	http://dx.doi.org/10.1371/journal.pone.0103315			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25101871	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000339993900016
J	Peng, C; Zhu, J; Sun, HC; Huang, XP; Zhao, WA; Zheng, M; Liu, LJ; Tian, J				Peng, Chang; Zhu, Jing; Sun, Hui-Chao; Huang, Xu-Pei; Zhao, Wei-An; Zheng, Min; Liu, Ling-Juan; Tian, Jie			Inhibition of Histone H3K9 Acetylation by Anacardic Acid Can Correct the Over-Expression of Gata4 in the Hearts of Fetal Mice Exposed to Alcohol during Pregnancy	PLOS ONE			English	Article							EPIGENETIC REGULATION; CARDIAC MYOCYTES; DNA METHYLATION; TRANSCRIPTION; CHROMATIN; GCN5; DIFFERENTIATION; CARDIOMYOCYTES; CELLS	Background: Cardiovascular malformations can be caused by abnormalities in Gata4 expression during fetal development. In a previous study, we demonstrated that ethanol exposure could lead to histone hyperacetylation and Gata4 over-expression in fetal mouse hearts. However, the potential mechanisms of histone hyperacetylation and Gata4 over-expression induced by ethanol remain unclear. Methods and Results: Pregnant mice were gavaged with ethanol or saline. Fetal mouse hearts were collected for analysis. The results of ethanol fed groups showed that global HAT activity was unusually high in the hearts of fetal mice while global HDAC activity remained unchanged. Binding of P300, CBP, PCAF, SRC1, but not GCN5, were increased on the Gata4 promoter relative to the saline treated group. Increased acetylation of H3K9 and increased mRNA expression of Gata4, alpha-MHC, cTnT were observed in these hearts. Treatment with the pan-histone acetylase inhibitor, anacardic acid, reduced the binding of P300, PCAF to the Gata4 promoter and reversed H3K9 hyperacetylation in the presence of ethanol. Interestingly, anacardic acid attenuated over-expression of Gata4, alpha-MHC and cTnT in fetal mouse hearts exposed to ethanol. Conclusions: Our results suggest that P300 and PCAF may be critical regulatory factors that mediate Gata4 over-expression induced by ethanol exposure. Alternatively, P300, PCAF and Gata4 may coordinate over-expression of cardiac downstream genes in mouse hearts exposed to ethanol. Anacardic acid may thus protect against ethanol-induced Gata4, alpha-MHC, cTnT over-expression by inhibiting the binding of P300 and PCAF to the promoter region of these genes.	[Peng, Chang; Sun, Hui-Chao; Zhao, Wei-An; Zheng, Min; Liu, Ling-Juan; Tian, Jie] Chongqing Med Univ, Childrens Hosp, Ctr Heart, Chongqing, Peoples R China; [Zhu, Jing; Liu, Ling-Juan] Key Lab Pediat Chongqing, Chongqing, Peoples R China; [Peng, Chang] Minist Educ, Key Lab Child Dev & Disorders, Chongqing, Peoples R China; [Peng, Chang; Zhu, Jing] Chongqing Int Sci & Technol Cooperat Ctr Child De, Chongqing, Peoples R China; [Huang, Xu-Pei] Florida Atlantic Univ, Dept Biomed Sci, Charlie E Schmidt Coll Med, Boca Raton, FL 33431 USA	Chongqing Medical University; State University System of Florida; Florida Atlantic University	Tian, J (corresponding author), Chongqing Med Univ, Childrens Hosp, Ctr Heart, Chongqing, Peoples R China.	jietian@cqmu.edu.cn			National Natural Science Foundation of China [81270234]; Chongqing key laboratory, CSTC, China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chongqing key laboratory, CSTC, China	This study was financially supported by research grants from National Natural Science Foundation of China (Grant Number: 81270234) and the special fund of Chongqing key laboratory, CSTC, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borah JC, 2011, CHEM BIOL, V18, P531, DOI 10.1016/j.chembiol.2010.12.021; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Chen L, 2013, J BIOL CHEM, V288, P14510, DOI 10.1074/jbc.M113.458737; Colussi C, 2011, P NATL ACAD SCI USA, V108, P2795, DOI 10.1073/pnas.1013124108; Connelly JJ, 2013, HUM MOL GENET, V22, P5107, DOI 10.1093/hmg/ddt365; Downey M, 2013, CURR BIOL, V23, P1638, DOI 10.1016/j.cub.2013.06.050; Hon GC, 2013, NAT GENET, V45, P1198, DOI 10.1038/ng.2746; Kawamura T, 2005, J BIOL CHEM, V280, P19682, DOI 10.1074/jbc.M412428200; Klose RJ, 2007, NAT REV MOL CELL BIO, V8, P307, DOI 10.1038/nrm2143; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Misra C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002690; Nemer M, 2008, CARDIOVASC PATHOL, V17, P48, DOI 10.1016/j.carpath.2007.06.005; O'Leary CM, 2013, BIRTH DEFECTS RES A, V97, P497, DOI 10.1002/bdra.23142; Ohtani K, 2011, CARDIOVASC RES, V90, P404, DOI 10.1093/cvr/cvr019; Peng Yanyu, 2009, Journal of Pharmacological and Toxicological Methods, V59, P135, DOI 10.1016/j.vascn.2009.03.002; Rajagopal SK, 2007, J MOL CELL CARDIOL, V43, P677, DOI 10.1016/j.yjmcc.2007.06.004; Rando OJ, 2009, ANNU REV BIOCHEM, V78, P245, DOI 10.1146/annurev.biochem.78.071107.134639; Stashi E, 2013, MOL ENDOCRINOL, V27, P1776, DOI 10.1210/me.2013-1192; Sun YV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073480; Takaya T, 2008, J BIOL CHEM, V283, P9828, DOI 10.1074/jbc.M707391200; Tian Xiaohui, 2013, Virologica Sinica, V28, P216, DOI 10.1007/s12250-013-3344-3; van Berlo JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084591; van der Linde D, 2011, J AM COLL CARDIOL, V58, P2241, DOI 10.1016/j.jacc.2011.08.025; Wang E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062138; Wang LY, 2012, BIOCHEM BIOPH RES CO, V424, P593, DOI 10.1016/j.bbrc.2012.06.158; Yang XJ, 2007, ONCOGENE, V26, P5310, DOI 10.1038/sj.onc.1210599; Yoshida Y, 2010, CIRC J, V74, P156, DOI 10.1253/circj.CJ-09-0050; Yu CE, 2013, HUM MOL GENET, V22, P5036, DOI 10.1093/hmg/ddt354; Yuan Joshua S., 2008, Biotechnology Journal, V3, P112, DOI 10.1002/biot.200700169; Zhang YM, 2012, J MOL CELL BIOL, V4, P97, DOI 10.1093/jmcb/mjs002; Zhong LL, 2010, CARDIOVASC TOXICOL, V10, P268, DOI 10.1007/s12012-010-9081-z	32	25	29	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e104135	10.1371/journal.pone.0104135	http://dx.doi.org/10.1371/journal.pone.0104135			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25101666	gold, Green Submitted, Green Published			2022-12-27	WOS:000339993900046
J	Hsu, K; Chung, YM; Endoh, Y; Geczy, CL				Hsu, Kenneth; Chung, Yuen Ming; Endoh, Yasumi; Geczy, Carolyn L.			TLR9 Ligands Induce S100A8 in Macrophages via a STAT3-Dependent Pathway which Requires IL-10 and PGE(2)	PLOS ONE			English	Article							CALCIUM-BINDING PROTEINS; NF-KAPPA-B; CPG DNA; C/EBP-BETA; CYCLOOXYGENASE-2 EXPRESSION; CELL-DIFFERENTIATION; MESSENGER-RNA; BACTERIAL-DNA; TNF-ALPHA; INTERLEUKIN-10	S100A8 and S100A9 are highly-expressed calcium-binding proteins in neutrophils and monocytes, and in subsets of macrophages in inflammatory lesions. Unmethylated CpG motifs found in bacterial and viral DNA are potent activators of innate immunity via Toll-like receptor 9 (TLR9). S100A8, but not S100A9, mRNA and protein was directly induced by CpG-DNA in murine and human macrophages. Induction in murine macrophages peaked at 16 h. CpG-DNA-induced S100A8 required de novo protein synthesis; IL-10 and Prostaglandin E-2 (PGE(2)) synergistically enhanced expression and promoted earlier gene induction. Inhibitors of endogenous IL-10, PGE2, and the E prostanoid (EP) 4 receptor strongly suppressed S100A8 expression, particularly when combined. Thus, S100A8 induction by E. coli DNA required both IL-10 and PGE(2)/EP4 signaling. The MAPKs, PI3K and JAK pathways were essential, whereas ERK1/2 appeared to play a direct role. S100A8 induction by CpG-DNA was controlled at the transcriptional level. The promoter region responsible for activation, either directly, or indirectly via IL-10 and PGE(2), was located within a -178 to -34-bp region and required STAT3 binding. Because of the robust links connecting IL-10 and PGE(2) with an anti-inflammatory macrophage phenotype, the induction profile of S100A8 strongly indicates a role for this protein in resolution of	[Hsu, Kenneth; Chung, Yuen Ming; Endoh, Yasumi; Geczy, Carolyn L.] Univ New S Wales, Sch Med Sci, Inflammat & Infect Res Ctr, Sydney, NSW, Australia	University of New South Wales Sydney	Hsu, K (corresponding author), Univ New S Wales, Sch Med Sci, Inflammat & Infect Res Ctr, Sydney, NSW, Australia.	k.hsu@unsw.edu.au	Hsu, Kenneth/ABA-4079-2020		National Health and Medical Research Council (NHMRC) Australia [455406, 455307]	National Health and Medical Research Council (NHMRC) Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by project grants #455406 and #455307 from the National Health and Medical Research Council (NHMRC) Australia (http://www.nhmrc.gov.au/grants). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaogi J, 2004, J LEUKOCYTE BIOL, V76, P227, DOI 10.1189/jlb.1203627; Aochi S, 2011, J AM ACAD DERMATOL, V64, P879, DOI 10.1016/j.jaad.2010.02.049; Averill MM, 2011, CIRCULATION, V123, P1216, DOI 10.1161/CIRCULATIONAHA.110.985523; Barton GM, 2006, NAT IMMUNOL, V7, P49, DOI 10.1038/ni1280; Carl VS, 2004, J LEUKOCYTE BIOL, V76, P735, DOI 10.1189/jlb.1003526; CASSATELLA MA, 1994, J EXP MED, V179, P1695, DOI 10.1084/jem.179.5.1695; Chen YJ, 2001, INT IMMUNOL, V13, P1013, DOI 10.1093/intimm/13.8.1013; Cheng PY, 2008, J EXP MED, V205, P2235, DOI 10.1084/jem.20080132; Cornish CJ, 1996, J CELL PHYSIOL, V166, P427, DOI 10.1002/(SICI)1097-4652(199602)166:2<427::AID-JCP21>3.0.CO;2-6; Csoka B, 2007, BLOOD, V110, P2685, DOI 10.1182/blood-2007-01-065870; DiSepio D, 1997, J BIOL CHEM, V272, P25555, DOI 10.1074/jbc.272.41.25555; Endoh Y, 2009, J IMMUNOL, V182, P2258, DOI 10.4049/jimmunol.0802683; Fleming BD, 2011, EUR J IMMUNOL, V41, P2498, DOI 10.1002/eji.201141717; Gao JJ, 2001, J IMMUNOL, V166, P6855, DOI 10.4049/jimmunol.166.11.6855; Goldsmith M, 2009, MOL IMMUNOL, V46, P1979, DOI 10.1016/j.molimm.2009.03.009; Gomes LH, 2013, FREE RADICAL BIO MED, V58, P170, DOI 10.1016/j.freeradbiomed.2012.12.012; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Goyette J, 2009, J IMMUNOL, V183, P593, DOI 10.4049/jimmunol.0900373; Haas T, 2008, IMMUNITY, V28, P315, DOI 10.1016/j.immuni.2008.01.013; Hacker H, 2006, NATURE, V439, P204, DOI 10.1038/nature04369; Harris SG, 2002, TRENDS IMMUNOL, V23, P144, DOI 10.1016/S1471-4906(01)02154-8; Harrison CA, 1999, J BIOL CHEM, V274, P8561, DOI 10.1074/jbc.274.13.8561; Hiroshima Y, 2014, J IMMUNOL, V192, P2800, DOI 10.4049/jimmunol.1302556; Hornung V, 2002, J IMMUNOL, V168, P4531, DOI 10.4049/jimmunol.168.9.4531; Hoshino K, 2002, INT IMMUNOL, V14, P1225, DOI 10.1093/intimm/dxf089; Hsu K, 2005, J IMMUNOL, V174, P2318, DOI 10.4049/jimmunol.174.4.2318; Hsu Kenneth, 2009, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry, V8, P290; Hu SP, 1996, BLOOD, V87, P3919, DOI 10.1182/blood.V87.9.3919.bloodjournal8793919; Ishii KJ, 2002, J EXP MED, V196, P269, DOI 10.1084/jem.20020773; Jozsef L, 2006, J IMMUNOL, V176, P1195, DOI 10.4049/jimmunol.176.2.1195; Jung M, 2012, MOL CELL BIOL, V32, P3938, DOI 10.1128/MCB.00413-12; Kadowaki N, 2001, J EXP MED, V194, P863, DOI 10.1084/jem.194.6.863; Kalinski P, 2012, J IMMUNOL, V188, P21, DOI 10.4049/jimmunol.1101029; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Krieg AM, 2002, ANNU REV IMMUNOL, V20, P709, DOI 10.1146/annurev.immunol.20.100301.064842; Lim SY, 2008, J IMMUNOL, V181, P5627, DOI 10.4049/jimmunol.181.8.5627; Lim SY, 2011, ANTIOXID REDOX SIGN, V15, P2235, DOI 10.1089/ars.2010.3641; Liu YW, 2006, CELL SIGNAL, V18, P1492, DOI 10.1016/j.cellsig.2005.12.001; McCormick MM, 2005, J BIOL CHEM, V280, P41521, DOI 10.1074/jbc.M509442200; Medzhitov R, 2009, NAT REV IMMUNOL, V9, P692, DOI 10.1038/nri2634; Mosser DM, 2008, IMMUNOL REV, V226, P205, DOI 10.1111/j.1600-065X.2008.00706.x; Murray PJ, 2006, CURR OPIN PHARMACOL, V6, P379, DOI 10.1016/j.coph.2006.01.010; Murray PJ, 2012, NAT IMMUNOL, V13, P916, DOI 10.1038/ni.2391; Nacken W, 2003, MICROSC RES TECHNIQ, V60, P569, DOI 10.1002/jemt.10299; Nathan C, 2002, NATURE, V420, P846, DOI 10.1038/nature01320; Newton RA, 1998, J IMMUNOL, V160, P1427; Niu GL, 2002, ONCOGENE, V21, P2000, DOI 10.1038/sj.onc.1205260; ODINK K, 1987, NATURE, V330, P80, DOI 10.1038/330080a0; Ravasi T, 2004, GENOMICS, V84, P10, DOI 10.1016/j.ygeno.2004.02.002; Robb BW, 2002, SURGERY, V132, P226, DOI 10.1067/msy.2002.125354; Rodriguez M, 2014, MOL PHARMACOL, V85, P187, DOI 10.1124/mol.113.089573; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; SEIDEL HM, 1995, P NATL ACAD SCI USA, V92, P3041, DOI 10.1073/pnas.92.7.3041; Shackleford TJ, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2902; Smale ST, 2010, CELL, V140, P833, DOI 10.1016/j.cell.2010.01.037; Sun Y, 2013, MOL IMMUNOL, V53, P443, DOI 10.1016/j.molimm.2012.10.002; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tanaka N, 2005, AM J RESP CELL MOL, V33, P406, DOI 10.1165/rcmb.2005-0140OC; Turovskaya O, 2008, CARCINOGENESIS, V29, P2035, DOI 10.1093/carcin/bgn188; Vogl T, 2004, BLOOD, V104, P4260, DOI 10.1182/blood-2004-02-0446; Vogl T, 2007, NAT MED, V13, P1042, DOI 10.1038/nm1638; Xu K, 2000, J IMMUNOL, V164, P4916, DOI 10.4049/jimmunol.164.9.4916; Xu K, 2001, J IMMUNOL, V166, P6358, DOI 10.4049/jimmunol.166.10.6358; Yeo SJ, 2003, J BIOL CHEM, V278, P22563, DOI 10.1074/jbc.M302076200; Yeo SJ, 2003, J IMMUNOL, V170, P1052, DOI 10.4049/jimmunol.170.2.1052; Yi AK, 2002, J IMMUNOL, V168, P4711, DOI 10.4049/jimmunol.168.9.4711; Zhao J, 2011, ANTIOXID REDOX SIGN, V14, P1589, DOI 10.1089/ars.2010.3583; ZWADLO G, 1988, CLIN EXP IMMUNOL, V72, P510	68	26	26	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e103629	10.1371/journal.pone.0103629	http://dx.doi.org/10.1371/journal.pone.0103629			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25098409	gold, Green Submitted, Green Published			2022-12-27	WOS:000339995100023
J	Xu, ZY; Shen, XT; Pan, W				Xu, Zhiyuan; Shen, Xiaotong; Pan, Wei		Alzheimers Dis Neuroimaging Initia	Longitudinal Analysis Is More Powerful than Cross-Sectional Analysis in Detecting Genetic Association with Neuroimaging Phenotypes	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; ALZHEIMERS-DISEASE; APOLIPOPROTEIN-E; STATISTICAL-ANALYSIS; IMAGING PHENOTYPES; QUANTITATIVE TRAIT; TESTS; HIPPOCAMPAL; VARIANTS; IDENTIFICATION	Most existing genome-wide association analyses are cross-sectional, utilizing only phenotypic data at a single time point, e. g. baseline. On the other hand, longitudinal studies, such as Alzheimer's Disease Neuroimaging Initiative (ADNI), collect phenotypic information at multiple time points. In this article, as a case study, we conducted both longitudinal and cross-sectional analyses of the ADNI data with several brain imaging (not clinical diagnosis) phenotypes, demonstrating the power gains of longitudinal analysis over cross-sectional analysis. Specifically, we scanned genome-wide single nucleotide polymorphisms (SNPs) with 56 brain-wide imaging phenotypes processed by FreeSurfer on 638 subjects. At the genome-wide significance level (P < 1.8 x 10(-9)) or a less stringent level (e.g. P < 10(-7)), longitudinal analysis of the phenotypic data from the baseline to month 48 identified more SNP-phenotype associations than cross-sectional analysis of only the baseline data. In particular, at the genome-wide significance level, both SNP rs429358 in gene APOE and SNP rs2075650 in gene TOMM40 were confirmed to be associated with various imaging phenotypes in multiple regions of interests (ROIs) by both analyses, though longitudinal analysis detected more regional phenotypes associated with the two SNPs and indicated another significant SNP rs439401 in gene APOE. In light of the power advantage of longitudinal analysis, we advocate its use in current and future longitudinal neuroimaging studies.	[Xu, Zhiyuan; Pan, Wei] Univ Minnesota, Sch Publ Hlth, Div Biostat, Minneapolis, MN 55455 USA; [Shen, Xiaotong] Univ Minnesota, Sch Stat, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Pan, W (corresponding author), Univ Minnesota, Sch Publ Hlth, Div Biostat, Minneapolis, MN 55455 USA.	weip@biostat.umn.edu			NIH [R01HL65462, R01HL105397, R01HL116720, R01GM081535]; Minnesota Supercomputing Institute; Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health) [U01 AG024904]; DOD ADNI (Department of Defense) [W81XWH-12-2-0012]; Canadian Institutes of Health Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105397, R01HL065462, R01HL116720] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081535] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U24AG021886, U01AG024904] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Minnesota Supercomputing Institute; Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); DOD ADNI (Department of Defense); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by NIH grants R01HL65462, R01HL105397, R01HL116720 and R01GM081535, and by the Minnesota Supercomputing Institute. Data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904) and DOD ADNI (Department of Defense award number W81XWH-12-2-0012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The following institutions had no direct involvement in the funding of this present study, but are funders of ADNI: the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: Alzheimer's Association; Alzheimer's Drug Discovery Foundation; BioClinica, Inc.; Biogen Idec Inc.; Bristol-Myers Squibb Company; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; GE Healthcare; Innogenetics, N.V.; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Medpace, Inc.; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRx Research; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Synarc Inc.; and Takeda Pharmaceutical Company. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Disease Cooperative Study at the University of California, San Diego. ADNI data are disseminated (Abraham et al. 2008) by the Laboratory for Neuro Imaging at the University of Southern California.	Abraham R, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-44; Basu S, 2011, GENET EPIDEMIOL, V35, P606, DOI 10.1002/gepi.20609; Beecham GW, 2009, AM J HUM GENET, V84, P35, DOI 10.1016/j.ajhg.2008.12.008; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benke KS, 2013, GENET EPIDEMIOL, V37, P419, DOI 10.1002/gepi.21733; Chen LS, 2012, AM J HUM GENET, V91, P977, DOI 10.1016/j.ajhg.2012.09.017; Costanza MC, 2012, EUR J EPIDEMIOL, V27, P131, DOI 10.1007/s10654-012-9670-1; Dering C, 2011, GENET EPIDEMIOL, V35, pS12, DOI 10.1002/gepi.20643; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Fan RZ, 2013, GENET EPIDEMIOL, V37, P726, DOI 10.1002/gepi.21757; Fan RZ, 2012, GENET EPIDEMIOL, V36, P856, DOI 10.1002/gepi.21673; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.1997.03550160069041; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Ge T, 2012, NEUROIMAGE, V63, P858, DOI 10.1016/j.neuroimage.2012.07.012; Hartig M, 2012, UCSF FREESURFER OVER; Hibar DP, 2011, NEUROIMAGE, V56, P1875, DOI 10.1016/j.neuroimage.2011.03.077; Holland D, 2009, P NATL ACAD SCI USA, V106, P20954, DOI 10.1073/pnas.0906053106; Jack CR, 2008, J MAGN RESON IMAGING, V27, P685, DOI 10.1002/jmri.21049; Kohannim O, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00115; Kring SII, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015745; Lee S, 2012, AM J HUM GENET, V91, P224, DOI 10.1016/j.ajhg.2012.06.007; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Lindquist MA, 2008, STAT SCI, V23, P439, DOI 10.1214/09-STS282; Liu Y, 2010, J LIPID RES; Luo L, 2011, GENOME RES, V21, P1099, DOI 10.1101/gr.115998.110; Mei H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031470; Melville SA, 2012, ANN NEUROL, V72, P65, DOI 10.1002/ana.23644; Mueller Susanne G, 2005, Alzheimers Dement, V1, P55, DOI 10.1016/j.jalz.2005.06.003; Mukherjee B, 2012, STAT MED, V31, P2531, DOI 10.1002/sim.5315; Pan W, 2009, GENET EPIDEMIOL, V33, P497, DOI 10.1002/gepi.20402; Potkin SG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006501; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Reuter M, 2012, NEUROIMAGE, V61, P1402, DOI 10.1016/j.neuroimage.2012.02.084; SANAN DA, 1994, J CLIN INVEST, V94, P860, DOI 10.1172/JCI117407; Shen L, 2010, NEUROIMAGE, V53, P1051, DOI 10.1016/j.neuroimage.2010.01.042; Shete SS, 2001, GENET EPIDEMIOL, V21, pS849, DOI 10.1002/gepi.2001.21.s1.s849; Shiffman D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002895; Sikorska K, 2013, STAT MED, V32, P165, DOI 10.1002/sim.5517; Silver M, 2012, NEUROIMAGE, V63, P1681, DOI 10.1016/j.neuroimage.2012.08.002; Smith EN, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001094; Stein JL, 2012, NAT GENET, V44, P552, DOI 10.1038/ng.2250; Stein JL, 2010, NEUROIMAGE, V53, P1160, DOI 10.1016/j.neuroimage.2010.02.032; Stein JL, 2010, NEUROIMAGE, V51, P542, DOI 10.1016/j.neuroimage.2010.02.068; STRAM DO, 1994, BIOMETRICS, V50, P1171, DOI 10.2307/2533455; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P8098, DOI 10.1073/pnas.90.17.8098; Tzeng JY, 2007, AM J HUM GENET, V81, P927, DOI 10.1086/521558; Verbrugghe P, 2012, AM J MED GENET B, V159B, P392, DOI 10.1002/ajmg.b.32042; Wang H, 2012, BIOINFORMATICS, V28, pI619, DOI 10.1093/bioinformatics/bts411; Wei Z, 2008, ANN HUM GENET, V72, P821, DOI 10.1111/j.1469-1809.2008.00473.x; Wessel J, 2006, AM J HUM GENET, V79, P792, DOI 10.1086/508346; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Xie JC, 2011, BIOMETRIKA, V98, P273, DOI 10.1093/biomet/asr003; Zhao ZG, 2013, ANN APPL STAT, V7, P2229, DOI 10.1214/13-AOAS660; Ziegler A, 1998, BIOMETRICAL J, V40, P115, DOI 10.1002/(SICI)1521-4036(199806)40:2<115::AID-BIMJ115>3.0.CO;2-6	54	37	38	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e102312	10.1371/journal.pone.0102312	http://dx.doi.org/10.1371/journal.pone.0102312			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25098835	Green Published, Green Submitted, gold			2022-12-27	WOS:000339995100006
J	Huber, W; Hollthaler, J; Schuster, T; Umgelter, A; Franzen, M; Saugel, B; Cordemans, C; Schmid, RM; Malbrain, MLNG				Huber, Wolfgang; Hoellthaler, Josef; Schuster, Tibor; Umgelter, Andreas; Franzen, Michael; Saugel, Bernd; Cordemans, Colin; Schmid, Roland M.; Malbrain, Manu L. N. G.			Association between Different Indexations of Extravascular Lung Water (EVLW) and PaO2/FiO(2): A Two-Center Study in 231 Patients	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; PREDICTED BODY-WEIGHT; INTENSIVE-CARE-UNIT; CRITICALLY ILL PATIENTS; TRANSPULMONARY THERMODILUTION; BLOOD-VOLUME; SINGLE INDICATOR; MASS INDEX; MORTALITY; OBESITY	Background: Variability of body weight (BW) and height calls for indexation of volumetric hemodynamic parameters. Extravascular lung water (EVLW) has formerly been indexed to actual BW (BWact) termed EVLW-index (EVLWI). In overweight patients indexation to BWact might inappropriately lower indexed EVLWIact. Several studies suggest indexation of EVLWI to predicted BW (EVLWIpred). However, data regarding association of EVLWIact and EVLWpred to mortality and PaO2/FiO(2) are inconsistent. Two recent studies based on biometric database-analyses suggest indexation of EVLWI to height (EVLWIheight). Therefore, our study compared the association of un-indexed EVLW, EVLWIheight, EVLWpred and EVLWIact to PaO2/FiO(2) and Oxygenation index (OI = mean airway pressure*FiO(2)*/PaO2). Methods: A total of 2119 triplicate transpulmonary thermodilutions (TPTDs; PiCCO; Pulsion Medical-Systems, Germany) were performed in 50 patients from the evaluation, and 181 patients from the validation groups. Correlations of EVLW and EVLWI to PaO2/FiO(2), OI and ROC-AUC-analyses regarding PaO2/FiO(2)<200 mmHg (primary endpoint) and OI>10 were performed. Results: In the evaluation group, un-indexed EVLW (AUC 0.758; 95%-CI: 0.637-0.880) and EVLWIheight (AUC 0.746; 95%-CI: 0.622-0.869) provided the largest ROC-AUCs regarding PaO2/FiO(2),200 mmHg. The AUC for EVLWIpred was smaller (0.713). EVLWIact provided the smallest AUC (0.685). This was confirmed in the validation group: EVLWIheight provided the largest AUC (0.735), EVLWIact (0.710) the smallest. In the merged data-pool, AUC was significantly greater for EVLWIheight (0.729; 95%-CI: 0.674-0.784) compared to all other indexations including EVLWIact (ROC-AUC 0.683, p = 0.007) and EVLWIpred (ROCAUC 0.707, p = 0.015). The association of EVLW(I) was even stronger to OI compared to PaO2/FiO(2). In the merged data-pool, EVLWIheight provided the largest AUC regarding "OI>10'' (0.778; 95%-CI: 0.713-0.842) compared to 0.739 (95%-CI: 0.6690.810) for EVLWIact and 0.756 (95%-CI: 0.688-0.824) for EVLWIpred. Conclusions: Indexation of EVLW to height (EVLWIheight) improves the association of EVLW(I) to PaO2/FiO(2) and OI compared to all other indexations including EVLWIpred and EVLWIact. Also considering two recent biometric database analyses, EVLWI should be indexed to height.	[Huber, Wolfgang; Hoellthaler, Josef; Umgelter, Andreas; Franzen, Michael; Saugel, Bernd; Schmid, Roland M.] Tech Univ Munich, Klinikum Rechts Isar, Med Klin & Poliklin 2, D-80290 Munich, Germany; [Schuster, Tibor] Tech Univ Munich, Klinikum Rechts Isar, Inst Med Epidemiol & Stat, D-80290 Munich, Germany; [Cordemans, Colin; Malbrain, Manu L. N. G.] Ziekenhuis Netwerk Antwerpen, Dept Intens Care, Antwerp, Belgium	Technical University of Munich; University of Hamburg; University Medical Center Hamburg-Eppendorf; Technical University of Munich	Huber, W (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Med Klin & Poliklin 2, D-80290 Munich, Germany.	wolfgang.huber@lrz.tum.de	Saugel, Bernd/D-2841-2011; Malbrain, Manu LNG/B-3680-2017; Cordemans, Colin/AAR-5268-2020	Saugel, Bernd/0000-0001-6619-0722; Malbrain, Manu LNG/0000-0002-1816-5255; 	Medical Advisory Board of Pulsion Medical Systems, Feldkirchen, Germany	Medical Advisory Board of Pulsion Medical Systems, Feldkirchen, Germany	Wolfgang Huber, Bernd Saugel and Manu LNG Malbrain received lecture fees and are members of the Medical Advisory Board of Pulsion Medical Systems, Feldkirchen, Germany. All other authors have no conflict of interest. Hereby the authors confirm that this does not alter their adherence to PLOS ONE policies on sharing data and materials.	Akinnusi ME, 2008, CRIT CARE MED, V36, P151, DOI 10.1097/01.CCM.0000297885.60037.6E; BEDELL GN, 1958, J CLIN INVEST, V37, P1049, DOI 10.1172/JCI103686; Berkowitz DM, 2008, CRIT CARE MED, V36, P1803, DOI 10.1097/CCM.0b013e3181743eeb; Beutler S, 2004, CRIT CARE MED, V32, P1981, DOI 10.1097/01.CCM.0000139622.85728.C1; Brivet FG, 2012, CRIT CARE, V16, DOI 10.1186/cc11208; Camporota L, 2012, CRIT CARE, V16, DOI 10.1186/cc11187; Chew MS, 2012, CRIT CARE, V16, DOI 10.1186/cc10599; COOK CD, 1961, J PEDIATR-US, V59, P710, DOI 10.1016/S0022-3476(61)80007-3; Cordemans C, 2012, ANN INTENSIVE CARE, V2, DOI 10.1186/2110-5820-2-S1-S1; Cordemans C, 2012, ANN INTENSIVE CARE, V2, DOI 10.1186/2110-5820-2-S1-S15; Craig TR, 2010, CRIT CARE MED, V38, P114, DOI 10.1097/CCM.0b013e3181b43050; EISENBERG PR, 1987, AM REV RESPIR DIS, V136, P662, DOI 10.1164/ajrccm/136.3.662; Fernandez-Mondejar E, 2003, J CRIT CARE, V18, P253, DOI 10.1016/j.jcrc.2003.10.009; Groeneveld ABJ, 2006, INTENS CARE MED, V32, P1315, DOI 10.1007/s00134-006-0212-8; Huber W, 2013, INTENS CARE MED, V39, P146, DOI 10.1007/s00134-012-2745-3; Jones RL, 2006, CHEST, V130, P827, DOI 10.1378/chest.130.3.827; Jozwiak M, 2013, CRIT CARE MED, V41, P472, DOI 10.1097/CCM.0b013e31826ab377; Kirov MY, 2004, CRIT CARE, V8, pR451, DOI 10.1186/cc2974; Kuzkov VV, 2006, CRIT CARE MED, V34, P1647, DOI 10.1097/01.CCM.0000218817.24208.2E; Mallat J, 2012, J CRIT CARE, V27, P376, DOI 10.1016/j.jcrc.2012.03.009; Martin GS, 2005, CRIT CARE, V9, pR74, DOI 10.1186/cc3025; MILLER GJ, 1977, THORAX, V32, P486, DOI 10.1136/thx.32.4.486; MITCHELL JP, 1992, AM REV RESPIR DIS, V145, P990, DOI 10.1164/ajrccm/145.5.990; NAIMARK A, 1960, J APPL PHYSIOL, V15, P377, DOI 10.1152/jappl.1960.15.3.377; Neumann P, 1999, INTENS CARE MED, V25, P216, DOI 10.1007/s001340050819; O'Brien JM, 2006, CRIT CARE MED, V34, P738, DOI 10.1097/01.CCM.0000202207.87891.FC; OBRIEN RJ, 1983, AM REV RESPIR DIS, V128, P949; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Pai MP, 2000, ANN PHARMACOTHER, V34, P1066, DOI 10.1345/aph.19381; Phillips CR, 2008, CRIT CARE MED, V36, P69, DOI 10.1097/01.CCM.0000295314.01232.BE; POOL JB, 1989, RESP MED, V83, P123, DOI 10.1016/S0954-6111(89)80227-6; RAHMAN MA, 1990, RESP MED, V84, P47, DOI 10.1016/S0954-6111(08)80094-7; RAY CS, 1983, AM REV RESPIR DIS, V128, P501, DOI 10.1164/arrd.1983.128.3.501; Rossi P, 2006, CRIT CARE MED, V34, P1437, DOI 10.1097/01.CCM.0000215830.48977.29; Sakka SG, 2002, CHEST, V122, P2080, DOI 10.1378/chest.122.6.2080; Sakr Y, 2008, INTENS CARE MED, V34, P1999, DOI 10.1007/s00134-008-1243-0; SAVILLE DJ, 1990, AM STAT, V44, P174, DOI 10.2307/2684163; STOCKS J, 1995, EUR RESPIR J, V8, P492, DOI 10.1183/09031936.95.08030492; Tagami T, 2010, CRIT CARE, V14, DOI 10.1186/cc9250; Wanger J, 2005, EUR RESPIR J, V26, P511, DOI 10.1183/09031936.05.00035005; Wolf S, 2013, CRIT CARE MED, V41, P990, DOI 10.1097/CCM.0b013e318275cd75	41	25	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e103854	10.1371/journal.pone.0103854	http://dx.doi.org/10.1371/journal.pone.0103854			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093821	Green Published, gold			2022-12-27	WOS:000341357200036
J	Li, S; Pettersson, US; Hoorelbeke, B; Kolaczkowska, E; Schelfhout, K; Martens, E; Kubes, P; Van Damme, J; Phillipson, M; Opdenakker, G				Li, Sandra; Pettersson, Ulrika S.; Hoorelbeke, Bart; Kolaczkowska, Elzbieta; Schelfhout, Katrien; Martens, Erik; Kubes, Paul; Van Damme, Jo; Phillipson, Mia; Opdenakker, Ghislain			Interference with Glycosaminoglycan-Chemokine Interactions with a Probe to Alter Leukocyte Recruitment and Inflammation In Vivo	PLOS ONE			English	Article							GRANULOCYTE CHEMOTACTIC PROTEIN-2; HEPARAN-SULFATE; CXC CHEMOKINES; CC-CHEMOKINE; NEUTROPHIL; BINDING; INDUCTION; CELLS; IDENTIFICATION; FIBROBLASTS	In vivo leukocyte recruitment is not fully understood and may result from interactions of chemokines with glycosaminoglycans/GAGs. We previously showed that chlorite-oxidized oxyamylose/COAM binds the neutrophil chemokine GCP-2/CXCL6. Here, mouse chemokine binding by COAM was studied systematically and binding affinities of chemokines to COAM versus GAGs were compared. COAM and heparan sulphate bound the mouse CXC chemokines KC/CXCL1, MIP-2/CXCL2, IP-10/CXCL10 and I-TAC/CXCL11 and the CC chemokine RANTES/CCL5 with affinities in the nanomolar range, whereas no binding interactions were observed for mouse MCP-1/CCL2, MIP-1 alpha/CCL3 and MIP-1 beta/CCL4. The affinities of COAM-interacting chemokines were similar to or higher than those observed for heparan sulphate. Although COAM did not display chemotactic activity by itself, its co-administration with mouse GCP-2/CXCL6 and MIP-2/CXCL2 or its binding of endogenous chemokines resulted in fast and cooperative peritoneal neutrophil recruitment and in extravasation into the cremaster muscle in vivo. These local GAG mimetic features by COAM within tissues superseded systemic effects and were sufficient and applicable to reduce LPS-induced liver-specific neutrophil recruitment and activation. COAM mimics glycosaminoglycans and is a nontoxic probe for the study of leukocyte recruitment and inflammation in vivo.	[Li, Sandra; Kolaczkowska, Elzbieta; Schelfhout, Katrien; Martens, Erik; Opdenakker, Ghislain] Katholieke Univ Leuven, Immunobiol Lab, Rega Inst Med Res, Leuven, Belgium; [Pettersson, Ulrika S.; Phillipson, Mia] Uppsala Univ, Dept Med Cell Biol, Uppsala, Sweden; [Hoorelbeke, Bart] Katholieke Univ Leuven, Lab Virol & Chemotherapy, Rega Inst Med Res, Leuven, Belgium; [Kolaczkowska, Elzbieta] Jagiellonian Univ, Krakow, Poland; [Kolaczkowska, Elzbieta; Kubes, Paul] Univ Calgary, Snyder Inst Chron Dis, Calgary, AB, Canada; [Kolaczkowska, Elzbieta; Kubes, Paul] Univ Calgary, Dept Physiol & Pharmacol, Calgary, AB, Canada; [Van Damme, Jo] Katholieke Univ Leuven, Lab Mol Immunol, Rega Inst Med Res, Leuven, Belgium	KU Leuven; Uppsala University; KU Leuven; Jagiellonian University; University of Calgary; University of Calgary; KU Leuven	Opdenakker, G (corresponding author), Katholieke Univ Leuven, Immunobiol Lab, Rega Inst Med Res, Leuven, Belgium.	ghislain.opdenakker@rega.kuleuven.be	Opdenakker, Ghislain/V-8562-2019; Martens, Erik/F-9214-2015; Kolaczkowska, Elzbieta/AAC-1988-2021; Opdenakker, Ghislain/Q-3130-2017	Opdenakker, Ghislain/0000-0003-1714-2294; Martens, Erik/0000-0002-7947-6567; Kolaczkowska, Elzbieta/0000-0002-3573-3584; Opdenakker, Ghislain/0000-0003-1714-2294; Phillipson, Mia/0000-0002-2387-0266; Van Damme, Jo/0000-0002-6707-1167	Fund for Scientific Research of Flanders (FWO-Vlaanderen); Centre of Excellence [EF/05/015]; "Geconcerteerde OnderzoeksActies'' of the KU Leuven; Swedish Research Council [K2012-99x-20675-05-3]; Ragnar Soderberg Foundation; Knut and Alice Wallenberg Foundation; University of Leuven (KU Leuven), Belgium [273340]; University of Calgary, Canada [273340]	Fund for Scientific Research of Flanders (FWO-Vlaanderen)(FWO); Centre of Excellence; "Geconcerteerde OnderzoeksActies'' of the KU Leuven; Swedish Research Council(Swedish Research CouncilEuropean Commission); Ragnar Soderberg Foundation; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); University of Leuven (KU Leuven), Belgium; University of Calgary, Canada	This study was supported by grants from the Fund for Scientific Research of Flanders (FWO-Vlaanderen), the Centre of Excellence (EF/05/015) and the "Geconcerteerde OnderzoeksActies'' (GOA-15, 2007-2012) of the KU Leuven. The work performed in Uppsala was supported by the Swedish Research Council (K2012-99x-20675-05-3), the Ragnar Soderberg Foundation and the Knut and Alice Wallenberg Foundation. Elzbieta Kolaczkowska is a Marie Curie Fellow of the FP7 framework programme (FP7-PEOPLE-2010-IOF) under agreements between the University of Leuven (KU Leuven), Belgium, and the University of Calgary, Canada (grant No.273340). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berghmans N, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-243; Cara DC, 2001, J IMMUNOL, V167, P6552, DOI 10.4049/jimmunol.167.11.6552; CLAES P, 1970, J VIROL, V5, P313, DOI 10.1128/JVI.5.3.313-320.1970; De Filippo K, 2008, J IMMUNOL, V180, P4308, DOI 10.4049/jimmunol.180.6.4308; Ellyard JI, 2007, J BIOL CHEM, V282, P15238, DOI 10.1074/jbc.M608046200; Gouwy M, 2009, J LEUKOCYTE BIOL, V86, P671, DOI 10.1189/jlb.1008638; Hermanson GT, 1996, BIOCONJUGATE TECHNIQ, P390; Jenne CN, 2013, CELL HOST MICROBE, V13, P169, DOI 10.1016/j.chom.2013.01.005; Johnson Z, 2005, CYTOKINE GROWTH F R, V16, P625, DOI 10.1016/j.cytogfr.2005.04.006; Kuschert GSV, 1999, BIOCHEMISTRY-US, V38, P12959, DOI 10.1021/bi990711d; Lau EK, 2004, J BIOL CHEM, V279, P22294, DOI 10.1074/jbc.M311224200; Li S, 2008, BIOCHEM PHARMACOL, V76, P831, DOI 10.1016/j.bcp.2008.07.022; Li S, 2010, J LEUKOCYTE BIOL, V88, P1017, DOI 10.1189/jlb.1109724; Luster AD, 1998, NEW ENGL J MED, V338, P436, DOI 10.1056/NEJM199802123380706; Massena S, 2010, BLOOD, V116, P1924, DOI 10.1182/blood-2010-01-266072; McDonald B, 2012, CELL HOST MICROBE, V12, P324, DOI 10.1016/j.chom.2012.06.011; Moser B, 2001, NAT IMMUNOL, V2, P123, DOI 10.1038/84219; Phillipson M, 2006, J EXP MED, V203, P2569, DOI 10.1084/jem.20060925; Piccard H, 2012, INT J CANCER, V131, pE425, DOI 10.1002/ijc.26465; Piccinini AM, 2010, J BIOL CHEM, V285, P8782, DOI 10.1074/jbc.M109.043299; Proudfoot AEI, 2003, P NATL ACAD SCI USA, V100, P1885, DOI 10.1073/pnas.0334864100; Ramdin L, 1998, CLIN EXP ALLERGY, V28, P616; Rollins BJ, 1997, BLOOD, V90, P909, DOI 10.1182/blood.V90.3.909.909_909_928; Sadir R, 2004, J BIOL CHEM, V279, P43854, DOI 10.1074/jbc.M405392200; Scapini P, 2000, IMMUNOL REV, V177, P195, DOI 10.1034/j.1600-065X.2000.17706.x; Strieter RM, 2005, CYTOKINE GROWTH F R, V16, P593, DOI 10.1016/j.cytogfr.2005.04.007; Struyf S, 2005, EUR J IMMUNOL, V35, P1583, DOI 10.1002/eji.200425753; Tanino Y, 2010, J IMMUNOL, V184, P2677, DOI 10.4049/jimmunol.0903274; Visser CE, 1998, CLIN EXP IMMUNOL, V112, P270; Wang LC, 2005, NAT IMMUNOL, V6, P902, DOI 10.1038/ni1233; WEBB LMC, 1993, P NATL ACAD SCI USA, V90, P7158, DOI 10.1073/pnas.90.15.7158; Wengner AM, 2008, BLOOD, V111, P42, DOI 10.1182/blood-2007-07-099648; Witowski J, 2001, AM J PATHOL, V158, P1441, DOI 10.1016/S0002-9440(10)64095-3; Wuyts A, 1999, J IMMUNOL, V163, P6155; Wuyts A, 1996, J IMMUNOL, V157, P1736; Wuyts A, 1998, CYTOKINE HDB; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X	37	12	12	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e104107	10.1371/journal.pone.0104107	http://dx.doi.org/10.1371/journal.pone.0104107			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093679	Green Published, Green Submitted, gold			2022-12-27	WOS:000341357200070
J	Robinson, C; Alfonso, H; Woo, S; Walsh, A; Olsen, N; Musk, AW; Robinson, BWS; Nowak, AK; Lake, RA				Robinson, Cleo; Alfonso, Helman; Woo, Samantha; Walsh, Amy; Olsen, Nola; Musk, Arthur W.; Robinson, Bruce W. S.; Nowak, Anna K.; Lake, Richard A.			Statins Do Not Alter the Incidence of Mesothelioma in Asbestos Exposed Mice or Humans	PLOS ONE			English	Article							PROSTATE-CANCER; MALIGNANT MESOTHELIOMA; VITAMIN-A; CHEMOPREVENTION; APOPTOSIS; WITTENOOM; SELENIUM; ASPIRIN; RETINOL; MODEL	Mesothelioma is principally caused by asbestos and may be preventable because there is a long latent period between exposure and disease development. The most at-risk are a relatively well-defined population who were exposed as a consequence of their occupations. Although preventative agents investigated so far have not been promising, discovery of such an agent would have a significant benefit world-wide on healthcare costs and personal suffering. Statins are widely used for management of hypercholesterolemia and cardiovascular risk; they can induce apoptosis in mesothelioma cells and epidemiological data has linked their use to a lower incidence of cancer. We hypothesised that statins would inhibit the development of asbestos-induced mesothelioma in mice and humans. An autochthonous murine model of asbestos-induced mesothelioma was used to test this by providing atorvastatin daily in the feed at 100 mg/kg, 200 mg/kg and 400 mg/kg. Continuous administration of atorvastatin did not alter the rate of disease development nor increase the length of time that mice survived. Latency to first symptoms of disease and disease progression were also unaffected. In a parallel study, the relationship between the use of statins and development of mesothelioma was investigated in asbestos-exposed humans. In a cohort of 1,738 asbestos exposed people living or working at a crocidolite mine site in Wittenoom, Western Australia, individuals who reported use of statins did not have a lower incidence of mesothelioma (HR = 1.01; 95% CI = 0.44-2.29, p = 0.99). Some individuals reported use of both statins and non-steroidal anti-inflammatory drugs or COX-2 inhibitors, and these people also did not have an altered risk of mesothelioma development (HR = 1.01; 95% CI = 0.61-1.67, p = 0.97). We conclude that statins do not moderate the rate of development of mesothelioma in either a mouse model or a human cohort exposed to asbestos.	[Robinson, Cleo; Woo, Samantha; Walsh, Amy; Robinson, Bruce W. S.; Nowak, Anna K.; Lake, Richard A.] Univ Western Australia, Sch Med & Pharmacol, Natl Ctr Asbestos Related Dis, Harry Perkins Inst Med Res, Perth, WA 6009, Australia; [Robinson, Cleo] PathWest, Anat Pathol, Perth, WA, Australia; [Alfonso, Helman] Curtin Univ, Sch Publ Hlth, Perth, WA 6845, Australia; [Olsen, Nola; Musk, Arthur W.] Univ Western Australia, Sch Populat Hlth, Perth, WA 6009, Australia; [Musk, Arthur W.] Sir Charles Gairdner Hosp, Dept Resp Med, Perth, WA, Australia	Harry Perkins Institute of Medical Research; University of Western Australia; University of Western Australia; Curtin University; University of Western Australia; University of Western Australia	Robinson, C (corresponding author), Univ Western Australia, Sch Med & Pharmacol, Natl Ctr Asbestos Related Dis, Harry Perkins Inst Med Res, Perth, WA 6009, Australia.	cleo.robinson@uwa.edu.au	Robinson, Bruce/N-1900-2014; Nowak, Anna K/B-2487-2013	Nowak, Anna K/0000-0002-9317-9526	NHMRC Centre for Research Excellence [1001020]; Insurance Commission of Western Australia	NHMRC Centre for Research Excellence(National Health and Medical Research Council (NHMRC) of Australia); Insurance Commission of Western Australia	This work was funded by NHMRC Centre for Research Excellence grant ID 1001020 and a grant from Insurance Commission of Western Australia. Funding received by CR, BWSR, AKN, RAL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfonso HS, 2010, EUR J CANCER PREV, V19, P355, DOI 10.1097/CEJ.0b013e32833c1bcb; Algra AM, 2012, LANCET ONCOL, V13, P518, DOI 10.1016/S1470-2045(12)70112-2; Alpha-Tocopherol Beta Carotene Cancer Prevention Study Group, 1994, N Engl J Med, V330, P1029, DOI 10.1056/NEJM199404143301501; Beales ILP, 2012, EUR J GASTROEN HEPAT, V24, P917, DOI 10.1097/MEG.0b013e3283543f01; Bu DX, 2011, CURR OPIN LIPIDOL, V22, P165, DOI 10.1097/MOL.0b013e3283453e41; Coogan PF, 2010, PHARMACOEPIDEM DR S, V19, P752, DOI 10.1002/pds.1970; de Klerk NH, 1998, INT J CANCER, V75, P362, DOI 10.1002/(SICI)1097-0215(19980130)75:3&lt;362::AID-IJC6&gt;3.0.CO;2-0; Demierre MF, 2005, NAT REV CANCER, V5, P930, DOI 10.1038/nrc1751; Emberson JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029849; Gonzalez CA, 2006, BRIT J NUTR, V96, pS42, DOI 10.1079/BJN20061699; Graaf MR, 2004, CANCER TREAT REV, V30, P609, DOI 10.1016/j.ctrv.2004.06.010; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hoque A, 2008, CANCER EPIDEM BIOMAR, V17, P88, DOI 10.1158/1055-9965.EPI-07-0531; Liao JK, 2005, ANNU REV PHARMACOL, V45, P89, DOI 10.1146/annurev.pharmtox.45.120403.095748; Lippman SM, 2009, JAMA-J AM MED ASSOC, V301, P39, DOI 10.1001/jama.2008.864; Mamede AC, 2011, NUTR CANCER, V63, P479, DOI 10.1080/01635581.2011.539315; Mant A, 2007, BRIT J CLIN PHARMACO, V63, P125, DOI 10.1111/j.1365-2125.2006.02735.x; Musk AW, 2011, EUR RESPIR J, V38, P1420, DOI 10.1183/09031936.00000811; Musk AW, 1998, INT J CANCER, V75, P355, DOI 10.1002/(SICI)1097-0215(19980130)75:3&lt;355::AID-IJC5&gt;3.0.CO;2-1; Nicholson W J, 1995, Med Lav, V86, P393; Nielsen SF, 2012, NEW ENGL J MED, V367, P1792, DOI 10.1056/NEJMoa1201735; Olsen NJ, 2011, MED J AUSTRALIA, V195, P271, DOI 10.5694/mja11.10125; Poynter JN, 2005, NEW ENGL J MED, V352, P2184, DOI 10.1056/NEJMoa043792; Riganti C, 2006, INT J CANCER, V119, P17, DOI 10.1002/ijc.21832; Robinson BWS, 2005, NEW ENGL J MED, V353, P1591, DOI 10.1056/NEJMra050152; Robinson C, 2014, NUTR CANC; Robinson C, 2014, NSAIDS COX 2 I UNPUB; Robinson C, 2006, CANCER RES, V66, P10786, DOI 10.1158/0008-5472.CAN-05-4668; Robinson C, 2012, NUTR CANCER, V64, P315, DOI 10.1080/01635581.2012.649100; Robinson C, 2011, EUR J CANCER, V47, P151, DOI 10.1016/j.ejca.2010.08.015; Rubins JB, 1998, AM J RESP CRIT CARE, V157, P1616, DOI 10.1164/ajrccm.157.5.9709020; Shureiqi I, 2000, CRIT REV ONCOL HEMAT, V33, P157, DOI 10.1016/S1040-8428(99)00072-4; Strohmaier S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054242; Xiao H, 2008, INT J CANCER, V123, P983, DOI 10.1002/ijc.23718; Zhou P, 2012, EUR J CANCER PREV, V21, P231, DOI 10.1097/CEJ.0b013e32834dbbfd	35	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e103025	10.1371/journal.pone.0103025	http://dx.doi.org/10.1371/journal.pone.0103025			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093718	gold, Green Published, Green Submitted			2022-12-27	WOS:000341357200017
J	Bernard, MA; Han, XB; Inderbitzin, S; Agbim, I; Zhao, H; Koziel, H; Tachado, SD				Bernard, Mark A.; Han, Xinbing; Inderbitzin, Sonya; Agbim, Ifunanya; Zhao, Hui; Koziel, Henry; Tachado, Souvenir D.			HIV-Derived ssRNA Binds to TLR8 to Induce Inflammation-Driven Macrophage Foam Cell Formation	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; TNF-ALPHA RELEASE; ANTIRETROVIRAL THERAPY; INFECTED PATIENTS; ATHEROSCLEROSIS; DISEASE; IMMUNODEFICIENCY; MICRORNAS; DNA; STIMULATION	Even though combined anti-retroviral therapy (cART) dramatically improves patient survival, they remain at a higher risk of being afflicted with non-infectious complications such as cardiovascular disease (CVD). This increased risk is linked to persistent inflammation and chronic immune activation. In this study, we assessed whether this complication is related to HIV-derived ssRNAs inducing in macrophages increases in TNF alpha release through TLR8 activation leading to foam cell formation. HIV ssRNAs induced foam cell formation in monocyte-derived macrophages (MDMs) in a dose-dependent manner. This response was reduced when either endocytosis or endosomal acidification was inhibited by dynasore or chloroquine, respectively. Using a flow cytometry FRET assay, we demonstrated that ssRNAs bind to TLR8 in HEK cells. In MDMs, ssRNAs triggered a TLR8-mediated inflammatory response that ultimately lead to foam cell formation. Targeted silencing of the TLR8 and MYD88 genes reduced foam cell formation. Furthermore, foam cell formation induced by these ssRNAs was blocked by an anti-TNF alpha neutralizing antibody. Taken together in MDMs, HIV ssRNAs are internalized; bind TLR8 in the endosome followed by endosomal acidification. TLR8 signaling then triggers TNF alpha release and ultimately leads to foam cell formation. As this response was inhibited by a blocking anti-TNF alpha antibody, drug targeting HIV ssRNA-driven TLR8 activation may serve as a potential therapeutic target to reduce chronic immune activation and inflammation leading to CVD in HIV+ patients.	[Bernard, Mark A.; Han, Xinbing; Inderbitzin, Sonya; Agbim, Ifunanya; Zhao, Hui; Koziel, Henry; Tachado, Souvenir D.] Beth Israel Deaconess Med Ctr, Dept Med, Div Pulm Crit Care & Sleep Med, Boston, MA 02215 USA; [Bernard, Mark A.; Han, Xinbing; Inderbitzin, Sonya; Agbim, Ifunanya; Zhao, Hui; Koziel, Henry; Tachado, Souvenir D.] Harvard Univ, Sch Med, Boston, MA USA; [Zhao, Hui] Shanxi Med Univ, Hosp 2, Dept Resp Med, Taiyuan, Peoples R China	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Shanxi Medical University	Tachado, SD (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, Div Pulm Crit Care & Sleep Med, Boston, MA 02215 USA.	stachado@bidmc.harvard.edu		Tachado, Souvenir/0000-0002-8368-6102; Bernard, Mark/0000-0001-7141-2975	National Heart, Lung and Blood Institute of the National Institutes of Health [R01 HL92811, NIH NL 063655]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092811] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Heart, Lung and Blood Institute of the National Institutes of Health, Grant R01 HL92811 to SDT and NIH NL 063655 to Henry Koziel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Barbaro G, 2002, J CARDIOVASC RISK, V9, P295, DOI 10.1097/00043798-200210000-00011; BARBOLINI G, 1969, VIRCHOWS ARCH B, V3, P24; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Cao F, 2007, INFECT IMMUN, V75, P753, DOI 10.1128/IAI.01386-06; Crowe SM, 2010, J LEUKOCYTE BIOL, V87, P589, DOI 10.1189/jlb.0809580; Currier Judith S, 2008, Circulation, V118, pe29, DOI 10.1161/CIRCULATIONAHA.107.189624; Deeks SG, 2011, ANNU REV MED, V62, P141, DOI 10.1146/annurev-med-042909-093756; Edfeldt K, 2002, CIRCULATION, V105, P1158, DOI 10.1161/circ.105.10.1158; El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360; ENSOLI B, 1993, J VIROL, V67, P277, DOI 10.1128/JVI.67.1.277-287.1993; Fabbri M, 2012, CANCER RES, V72, P6333, DOI 10.1158/0008-5472.CAN-12-3229; Fabbri M, 2012, P NATL ACAD SCI USA, V109, pE2110, DOI 10.1073/pnas.1209414109; Francisci D, 2009, AIDS, V23, P589, DOI 10.1097/QAD.0b013e328325a87c; Fraser IP, 1998, SEMIN IMMUNOL, V10, P363, DOI 10.1006/smim.1998.0141; Fujii Y, 1996, FEBS LETT, V393, P93, DOI 10.1016/0014-5793(96)00859-9; FUNK JL, 1993, ATHEROSCLEROSIS, V98, P67, DOI 10.1016/0021-9150(93)90224-I; GERRITY RG, 1980, ARTERY, V8, P208; Han XB, 2012, J BIOL CHEM, V287, P13778, DOI 10.1074/jbc.M112.342683; Han XB, 2010, FASEB J, V24, P2869, DOI 10.1096/fj.09-148155; Han XB, 2009, J BIOL CHEM, V284, P32950, DOI 10.1074/jbc.M109.040899; Havlir DV, 2003, J VIROL, V77, P11212, DOI 10.1128/JVI.77.20.11212-11219.2003; He S, 2013, BLOOD, V121, P4663, DOI 10.1182/blood-2012-07-441360; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hsue PY, 2009, AIDS, V23, P1059, DOI 10.1097/QAD.0b013e32832b514b; Iloeje UH, 2005, HIV MED, V6, P37, DOI 10.1111/j.1468-1293.2005.00265.x; Kalayjian RC, 2003, J INFECT DIS, V187, P1924, DOI 10.1086/375372; Kim JS, 2009, BIOCHEM BIOPH RES CO, V390, P196, DOI 10.1016/j.bbrc.2009.09.009; LAFEUILLADE A, 1991, AIDS, V5, P1139, DOI 10.1097/00002030-199109000-00014; Lee JG, 2008, CELL SIGNAL, V20, P2266, DOI 10.1016/j.cellsig.2008.08.022; Lehmann SM, 2012, NAT NEUROSCI, V15, P827, DOI 10.1038/nn.3113; Lewis W, 2000, J MOL CELL CARDIOL, V32, P2115, DOI 10.1006/jmcc.2000.1271; Maria-Magdalena M, 2011, PROTEOMICS, V11, P2063, DOI 10.1002/pmic.201100028; Mehta NJ, 2003, ANGIOLOGY, V54, P269, DOI 10.1177/000331970305400302; Niessner A, 2007, CIRCULATION, V116, P2043, DOI 10.1161/CIRCULATIONAHA.107.697789; Ostrowski SR, 2005, J INFECT DIS, V191, P348, DOI 10.1086/427340; Rutz M, 2004, EUR J IMMUNOL, V34, P2541, DOI 10.1002/eji.200425218; Schopman NCT, 2012, NUCLEIC ACIDS RES, V40, P414, DOI 10.1093/nar/gkr719; Shrestha S, 2014, ARTERIOSCL THROM VAS, V34, P244, DOI 10.1161/ATVBAHA.113.302191; Smiley RD, 2007, P NATL ACAD SCI USA, V104, P4840, DOI 10.1073/pnas.0700342104; Tachado SD, 2005, AM J RESP CELL MOL, V33, P610, DOI 10.1165/rcmb.2004-0341OC; Tachado SD, 2010, BLOOD, V115, P3606, DOI 10.1182/blood-2009-10-250787; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Tanji H, 2013, SCIENCE, V339, P1426, DOI 10.1126/science.1229159; Vittecoq D, 2003, AIDS, V17, pS70, DOI 10.1097/00002030-200304001-00010; ZUCKERFRANKLIN D, 1978, LAB INVEST, V38, P620	47	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e104039	10.1371/journal.pone.0104039	http://dx.doi.org/10.1371/journal.pone.0104039			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25090652	Green Submitted, gold, Green Published			2022-12-27	WOS:000339812700087
J	Chen, SY; Shen, QY; Tang, YM; He, L; Li, Y; Li, H; Li, M; Peng, Y				Chen, Shuying; Shen, Qingyu; Tang, Yamei; He, Lei; Li, Yi; Li, Hui; Li, Mei; Peng, Ying			Efficacy and Safety of Adding Clopidogrel to Aspirin on Stroke Prevention among High Vascular Risk Patients: A Meta-Analysis of Randomized Controlled Trials	PLOS ONE			English	Article							DUAL ANTIPLATELET THERAPY; TRANSIENT ISCHEMIC ATTACK; MYOCARDIAL-INFARCTION; SECONDARY PREVENTION; RATIONALE; DESIGN; SURGERY	Objectives: Whether clopidogrel should be added to aspirin for stroke prevention remained controversial for the risk of hemorrhagic complications. This meta-analysis was aimed to assess the efficacy and safety of adding clopidogrel to aspirin on stroke prevention in high vascular risk patients, and to provide evidence for a suitable duration of dual antiplatelet therapy. Methods: We searched PubMed, EMBase, OVID and Cochrane Central Register of Controlled Trials (up to June, 2013) for randomized controlled trials evaluating the efficacy and safety of clopidogrel plus aspirin versus aspirin alone in high vascular risk patients. Comparisons of stroke and hemorrhagic complications between treatment groups were expressed by the pooled Relative Risks (RRs) with 95% Confidence Intervals (CIs). Results: Fifteen trials with a total of 97692 intention-to-treat participants were included with duration of follow-up ranging from 7 days to 3.6 years. Dual antiplatelet therapy reduced all stroke by 21% (RR: 0.79, 95% CI: 0.73-0.85) with no evidence of heterogeneity across the trials (P = 0.27, I-2 = 17%). The effects were consistent between short-term subgroup (<= 1 month, RR: 0.76, 95% CI: 0.67-0.85) and long-term subgroup (>= 3 months, RR: 0.81, 95% CI: 0.73-0.89). The risk of major bleeding was not significantly increased by dual antiplatelet therapy in short-term subgroup (RR: 1.11, 95% CI: 0.91-1.36), while significantly increased in long-term subgroup (RR: 1.52, 95% CI: 1.36-1.69). Long-term dual antiplatelet therapy substantially increased the risk of intracranial bleeding (RR: 1.76, 95% CI: 1.22-2.54). Conclusions: This meta-analysis demonstrates that short-term combination of clopidogrel and aspirin is effective and safe for stroke prevention in high vascular risk patients. Long-term combination therapy substantially increases the risk of major bleeding and intracranial bleeding.	[Chen, Shuying; Tang, Yamei; He, Lei; Li, Yi; Li, Mei; Peng, Ying] Sun Yat Sen Univ, Dept Neurol, Sun Yat Sen Mem Hosp, Guangzhou 510275, Guangdong, Peoples R China; [Shen, Qingyu] Sun Yat Sen Univ, Dept Neurol, Affiliated Boji Hosp, Guangzhou 510275, Guangdong, Peoples R China; [Li, Hui] Guangdong Gen Hosp, Dept Neurol, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Guangdong Academy of Medical Sciences & Guangdong General Hospital	Peng, Y (corresponding author), Sun Yat Sen Univ, Dept Neurol, Sun Yat Sen Mem Hosp, Guangzhou 510275, Guangdong, Peoples R China.	2353352460@qq.com		Tang, Yamei/0000-0002-6353-6107	Sub-Program of National "12-5'' Science & Technology Plan Project of China [2011BAI08B11]; International Collaboration Program of Universities in Guangdong Province [2012gjhz001]; National Natural Science Key Program Foundation of China of Sun Yat-Sen University [10ykjc26]	Sub-Program of National "12-5'' Science & Technology Plan Project of China; International Collaboration Program of Universities in Guangdong Province; National Natural Science Key Program Foundation of China of Sun Yat-Sen University	This study was supported by the Sub-Program of National "12-5'' Science & Technology Plan Project of China (NO. 2011BAI08B11 to Ying Peng), International Collaboration Program of Universities in Guangdong Province (NO. 2012gjhz001 to Ying Peng), and the culture funds for National Natural Science Key Program Foundation of China of Sun Yat-Sen University (No. 10ykjc26 to Ying Peng). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belch JJF, 2010, J VASC SURG, V52, P825, DOI 10.1016/j.jvs.2010.04.027; Benavente OR, 2012, NEW ENGL J MED, V367, P817, DOI 10.1056/NEJMoa1204133; Benavente OR, 2011, INT J STROKE, V6, P164, DOI 10.1111/j.1747-4949.2010.00573.x; Bhatt DL, 2006, NEW ENGL J MED, V354, P1706, DOI 10.1056/NEJMoa060989; Bhatt DL, 2004, AM HEART J, V148, P263, DOI 10.1016/j.ahj.2004.03.028; Chen ZM, 2005, LANCET, V366, P1607, DOI 10.1016/s0140-6736(05)67660-x; Connolly S, 2006, AM HEART J, V151, P1187, DOI 10.1016/j.ahj.2005.06.026; Connolly SJ, 2009, NEW ENGL J MED, V360, P2066, DOI 10.1056/NEJMoa0901301; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Gent M, 1996, LANCET, V348, P1329, DOI 10.1016/s0140-6736(96)09457-3; Gouya G, 2014, STROKE, V45, P492, DOI 10.1161/STROKEAHA.113.002590; Hankey GJ, 2011, INT J STROKE, V6, P3, DOI 10.1111/j.1747-4949.2010.00535.x; Kennedy J, 2007, LANCET NEUROL, V6, P961, DOI 10.1016/S1474-4422(07)70250-8; Kulik A, 2005, CURR CONTR TRIALS C, V6, DOI 10.1186/1468-6708-6-15; Kulik A, 2010, CIRCULATION, V122, P2680, DOI 10.1161/CIRCULATIONAHA.110.978007; Lee M, 2013, ANN INTERN MED, V159, P463, DOI 10.7326/0003-4819-159-7-201310010-00006; Liu LS, 2000, J CARDIOVASC RISK, V7, P435; Markus HS, 2005, CIRCULATION, V111, P2233, DOI 10.1161/01.CIR.0000163561.90680.1C; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Palacio S, 2013, INT J STROKE; Palacio S, 2012, STROKE, V43, P2157, DOI 10.1161/STROKEAHA.112.656173; Park SJ, 2010, NEW ENGL J MED, V362, P1374, DOI 10.1056/NEJMoa1001266; Sabatine MS, 2005, AM HEART J, V149, P227, DOI 10.1016/j.ahj.2004.11.006; Sabatine MS, 2005, NEW ENGL J MED, V352, P1179, DOI 10.1056/NEJMoa050522; Sun JCJ, 2010, AM HEART J, V160, P1178, DOI 10.1016/j.ahj.2010.07.035; Ussia GP, 2011, AM J CARDIOL, V108, P1772, DOI 10.1016/j.amjcard.2011.07.049; Wang YJ, 2013, NEW ENGL J MED, V369, P11, DOI 10.1056/NEJMoa1215340; Wang YJ, 2010, AM HEART J, V160, P380, DOI 10.1016/j.ahj.2010.05.017; Wong KSL, 2013, CIRCULATION, V128, P1656, DOI 10.1161/CIRCULATIONAHA.113.003187; Wong KSL, 2010, LANCET NEUROL, V9, P489, DOI 10.1016/S1474-4422(10)70060-0; Yusuf S, 2001, NEW ENGL J MED, V345, P494; Yusuf S, 2000, EUR HEART J, V21, P2033; Zhou YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031642	33	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2014	9	8							e104402	10.1371/journal.pone.0104402	http://dx.doi.org/10.1371/journal.pone.0104402			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WB	25110930	Green Submitted, gold, Green Published			2022-12-27	WOS:000341105100052
J	Sayers, KT; Brooks, AD; Sayers, TJ; Chertov, O				Sayers, Kevin T.; Brooks, Alan D.; Sayers, Thomas J.; Chertov, Oleg			Increased Secretory Leukocyte Protease Inhibitor (SLPI) Production by Highly Metastatic Mouse Breast Cancer Cells	PLOS ONE			English	Article							STIMULATES MIGRATION; EXTRACELLULAR-MATRIX; GROWTH-FACTOR; IN-VITRO; IDENTIFICATION; PROTEOMICS; CARCINOMA; PROMOTES; LINES	The precise molecular mechanisms enabling cancer cells to metastasize from the primary tumor to different tissue locations are still largely unknown. Secretion of some proteins by metastatic cells could facilitate metastasis formation. The comparison of secreted proteins from cancer cells with different metastatic capabilities in vivo might provide insight into proteins involved in the metastatic process. Comparison of the secreted proteins from the mouse breast cancer cell line 4T1 and its highly metastatic 4T1.2 clone revealed a prominent differentially secreted protein which was identified as SLPI (secretory leukocyte protease inhibitor). Western blotting indicated higher levels of the protein in both conditioned media and whole cell lysates of 4T1.2 cells. Additionally higher levels of SLPI were also observed in 4T1.2 breast tumors in vivo following immunohistochemical staining. A comparison of SLPI mRNA levels by gene profiling using microarrays and RTPCR did not detect major differences in SLPI gene expression between the 4T1 and 4T1.2 cells indicating that SLPI secretion is regulated at the protein level. Our results demonstrate that secretion of SLPI is drastically increased in highly metastatic cells, suggesting a possible role for SLPI in enhancing the metastatic behavior of breast cancer cell line 4T1.	[Sayers, Kevin T.; Chertov, Oleg] Leidos Biomed Res Inc, Canc Res Technol Program, Frederick Natl Lab Canc Res, Frederick, MD USA; [Brooks, Alan D.; Sayers, Thomas J.] Leidos Biomed Res Inc, Canc & Inflammat Program, Frederick Natl Lab Canc Res, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Sayers, TJ (corresponding author), Leidos Biomed Res Inc, Canc & Inflammat Program, Frederick Natl Lab Canc Res, Frederick, MD 21702 USA.	sayerst@mail.nih.gov	Sayers, Thomas J/G-4859-2015	Chertov, Oleg/0000-0002-0426-2521	Frederick National Laboratory for Cancer Research; National Institutes of Health [HHSN261200800001E]	Frederick National Laboratory for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This project has been funded in whole with federal funds from the Frederick National Laboratory for Cancer Research, National Institutes of Health, under contract HHSN261200800001E. All funding for this research was funded under contract HHSN261200800001E. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRIOZZO P, 1988, CANCER RES, V48, P3688; Chen ST, 2008, J PROTEOME RES, V7, P1379, DOI 10.1021/pr700745n; Chenau J, 2009, J PROTEOME RES, V8, P4579, DOI 10.1021/pr900383g; Czubayko F, 1997, NAT MED, V3, P1137, DOI 10.1038/nm1097-1137; Devoogdt N, 2003, P NATL ACAD SCI USA, V100, P5778, DOI 10.1073/pnas.1037154100; Devoogdt N, 2009, CANCER SCI, V100, P434, DOI 10.1111/j.1349-7006.2009.01076.x; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Fishman DA, 1997, CANCER-AM CANCER SOC, V80, P1457, DOI 10.1002/(SICI)1097-0142(19971015)80:8<1457::AID-CNCR13>3.0.CO;2-4; He ZH, 2003, J MOL MED-JMM, V81, P600, DOI 10.1007/s00109-003-0474-3; Lai TC, 2010, J PROTEOME RES, V9, P1302, DOI 10.1021/pr900825t; Lelekakis M, 1999, CLIN EXP METASTAS, V17, P163, DOI 10.1023/A:1006689719505; Liang XQ, 2009, PROTEOMICS, V9, P182, DOI 10.1002/pmic.200700957; Martin FT, 2010, BREAST CANCER RES TR, V124, P317, DOI 10.1007/s10549-010-0734-1; McKiernan PJ, 2011, BIOCHEM SOC T, V39, P1421, DOI 10.1042/BST0391421; Peng L, 2009, CARCINOGENESIS, V30, P1660, DOI 10.1093/carcin/bgp178; Piersma SR, 2010, J PROTEOME RES, V9, P1913, DOI 10.1021/pr901072h; Prest SJ, 2002, FASEB J, V16, P592, DOI 10.1096/fj.01-0498fje; Shevchenko A, 2000, METH MOL B, V146, P1, DOI 10.1385/1-59259-045-4:1; Tangkeangsirisin W, 2004, CARCINOGENESIS, V25, P1587, DOI 10.1093/carcin/bgh171; Tester AM, 2001, CLIN EXP METASTAS, V18, P553, DOI 10.1023/A:1011953118186; Wu CC, 2008, PROTEOMICS, V8, P316, DOI 10.1002/pmic.200700819; Wu CC, 2010, MOL CELL PROTEOMICS, V9, P1100, DOI 10.1074/mcp.M900398-MCP200	22	6	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2014	9	8							e104223	10.1371/journal.pone.0104223	http://dx.doi.org/10.1371/journal.pone.0104223			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WB	25110884	Green Submitted, gold, Green Published			2022-12-27	WOS:000341105100038
J	Levesque, S; Plante, PL; Mendis, N; Cantin, P; Marchand, G; Charest, H; Raymond, F; Huot, C; Goupil-Sormany, I; Desbiens, F; Faucher, SP; Corbeil, J; Tremblay, C				Levesque, Simon; Plante, Pier-Luc; Mendis, Nilmini; Cantin, Philippe; Marchand, Genevieve; Charest, Hugues; Raymond, Frederic; Huot, Caroline; Goupil-Sormany, Isabelle; Desbiens, Francois; Faucher, Sebastien P.; Corbeil, Jacques; Tremblay, Cecile			Genomic Characterization of a Large Outbreak of Legionella pneumophila Serogroup 1 Strains in Quebec City, 2012	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; SEQUENCE-BASED SCHEME; LEGIONNAIRES-DISEASE; PATHOGENESIS; WATER; PATHOGENICITY; PROTOZOA; AMEBAS; SPP.; PCR	During the summer of 2012, a major Legionella pneumophila serogroup 1 outbreak occurred in Quebec City, Canada, which caused 182 declared cases of Legionnaire's disease and included 13 fatalities. Legionella pneumophila serogroup 1 isolates from 23 patients as well as from 32 cooling towers located in the vicinity of the outbreak were recovered for analysis. In addition, 6 isolates from the 1996 Quebec City outbreak and 4 isolates from patients unrelated to both outbreaks were added to allow comparison. We characterized the isolates using pulsed-field gel electrophoresis, sequence-based typing, and whole genome sequencing. The comparison of patients-isolated strains to cooling tower isolates allowed the identification of the tower that was the source of the outbreak. Legionella pneumophila strain Quebec 2012 was identified as a ST-62 by sequence-based typing methodology. Two new Legionellaceae plasmids were found only in the epidemic strain. The LVH type IV secretion system was found in the 2012 outbreak isolates but not in the ones from the 1996 outbreak and only in half of the contemporary human isolates. The epidemic strains replicated more efficiently and were more cytotoxic to human macrophages than the environmental strains tested. At least four Icm/Dot effectors in the epidemic strains were absent in the environmental strains suggesting that some effectors could impact the intracellular replication in human macrophages. Sequence-based typing and pulsed-field gel electrophoresis combined with whole genome sequencing allowed the identification and the analysis of the causative strain including its likely environmental source.	[Levesque, Simon; Charest, Hugues; Tremblay, Cecile] Inst Natl Sante Publ Quebec, LSPQ, Quebec City, PQ, Canada; [Plante, Pier-Luc; Raymond, Frederic; Corbeil, Jacques] Univ Laval, Dept Mol Med, Quebec City, PQ, Canada; [Mendis, Nilmini; Faucher, Sebastien P.] McGill Univ, Fac Agr & Environm Sci, Dept Nat Resource Sci, Quebec City, PQ, Canada; [Cantin, Philippe] Ctr Expertise Anal Environm Quebec, Quebec City, PQ, Canada; [Marchand, Genevieve] Inst Rech Robert Sauve Sante & Securite Travail, Quebec City, PQ, Canada; [Huot, Caroline; Goupil-Sormany, Isabelle; Desbiens, Francois] Direct Reg Sante Publ Capitale Natl, Quebec City, PQ, Canada; [Charest, Hugues] Univ Montreal, Dept Microbiol Immunol & Infectiol, Quebec City, PQ, Canada; [Tremblay, Cecile] Univ Montreal, Ctr Hosp, Ctr Rech, Quebec City, PQ, Canada	Institut national de sante publique du Quebec (INSPQ); Laval University; McGill University; Universite de Montreal; Laval University; Universite de Montreal	Levesque, S (corresponding author), Inst Natl Sante Publ Quebec, LSPQ, Quebec City, PQ, Canada.	simon.levesque@inspq.qc.ca	Raymond, Frederic/I-4135-2019; Corbeil, Jacques/AAW-9739-2020	Raymond, Frederic/0000-0002-3606-4060; Corbeil, Jacques/0000-0002-9973-2740; Levesque, Simon/0000-0002-4356-9702; Goupil-Sormany, Isabelle/0000-0002-0086-3848; marchand, genevieve/0000-0002-4496-5459; Faucher, Sebastien/0000-0002-2721-7715	INSPQ; NSERC [418289-2012]	INSPQ; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by internal funding (INSPQ) to SL. A part of this work was supported by NSERC Discovery grant 418289-2012 to SF. JC is the holder of the Canada Research Chair in Medical Genomics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Kwaik Y, 1998, APPL ENVIRON MICROB, V64, P3127; Agence nationale de securite sanitaire de l'alimentation de l'environnement et du travail (ANSES), 2011, METH DET DEN LEG EA; Amemura-Maekawa J, 2005, MICROBIOL IMMUNOL, V49, P1027, DOI 10.1111/j.1348-0421.2005.tb03699.x; Angiuoli SV, 2011, BIOINFORMATICS, V27, P334, DOI 10.1093/bioinformatics/btq665; Aurell H, 2003, J CLIN MICROBIOL, V41, P3320, DOI 10.1128/JCM.41.7.3320-3322.2003; Bartram Jamie, 2007, P1; Boisvert S, 2010, J COMPUT BIOL, V17, P1519, DOI 10.1089/cmb.2009.0238; Bull M, 2012, EURO SURVEILL, V17, P203; Carlson HK, 2010, MOL MICROBIOL, V77, P930, DOI 10.1111/j.1365-2958.2010.07259.x; Cazalet C, 2004, NAT GENET, V36, P1165, DOI 10.1038/ng1447; Charpentier X, 2008, J BACTERIOL, V190, P8126, DOI 10.1128/JB.01035-08; Chen LH, 2012, NUCLEIC ACIDS RES, V40, pD641, DOI 10.1093/nar/gkr989; Chien MC, 2004, SCIENCE, V305, P1966, DOI 10.1126/science.1099776; Coscolla M, 2014, INT J MED MICROBIOL, V304, P307, DOI 10.1016/j.ijmm.2013.11.002; D'Auria G, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-181; Diederen BMW, 2008, J INFECTION, V56, P1, DOI 10.1016/j.jinf.2007.09.010; Dufresne SF, 2012, EPIDEMIOL INFECT, V140, P172, DOI 10.1017/S0950268811000355; Edelstein PH, 2007, MANAL CLIN MICROBIOL; Franco IS, 2009, CELL MICROBIOL, V11, P1435, DOI 10.1111/j.1462-5822.2009.01351.x; Gaia V, 2005, J CLIN MICROBIOL, V43, P2047, DOI 10.1128/JCM.43.5.2047-2052.2005; Ginevra C, 2009, J CLIN MICROBIOL, V47, P981, DOI 10.1128/JCM.02071-08; Gomez-Valero L., 2013, COLD SPRING HARB PER, V3; Gomez-Valero L, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-536; Gomez-Valero L, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00208; Guillemet TA, 2010, LETT APPL MICROBIOL, V51, P639, DOI 10.1111/j.1472-765X.2010.02947.x; HENKE M, 1986, ISRAEL J MED SCI, V22, P690; Lau HY, 2009, J APPL MICROBIOL, V107, P368, DOI 10.1111/j.1365-2672.2009.04208.x; Levi A, 2011, MBIO, V2, DOI 10.1128/mBio.00316-10; Lifshitz Z, 2013, P NATL ACAD SCI USA, V110, pE707, DOI 10.1073/pnas.1215278110; Luck Christian, 2013, Methods Mol Biol, V954, P119, DOI 10.1007/978-1-62703-161-5_6; Luo ZQ, 2012, CELL MICROBIOL, V14, P19, DOI 10.1111/j.1462-5822.2011.01713.x; MARRA A, 1990, J IMMUNOL, V144, P2738; Marrie TJ, 2010, CAN MED ASSOC J, V182, P1538, DOI 10.1503/cmaj.082030; Newton HJ, 2010, CLIN MICROBIOL REV, V23, P274, DOI 10.1128/CMR.00052-09; Paradis R, 1997, EPIDEMIE LEGIONELLOS; Ratzow S, 2007, J CLIN MICROBIOL, V45, P1965, DOI 10.1128/JCM.00261-07; Reimer AR, 2010, EUR J CLIN MICROBIOL, V29, P191, DOI 10.1007/s10096-009-0840-3; Reuter S, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002175; ROWBOTHAM TJ, 1980, J CLIN PATHOL, V33, P1179, DOI 10.1136/jcp.33.12.1179; SADOSKY AB, 1993, INFECT IMMUN, V61, P5361, DOI 10.1128/IAI.61.12.5361-5373.1993; Steinert M, 2007, INT J MED MICROBIOL, V297, P577, DOI 10.1016/j.ijmm.2007.03.009; Stewart CR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050560; Swanson MS, 2000, ANNU REV MICROBIOL, V54, P567, DOI 10.1146/annurev.micro.54.1.567; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Tijet N, 2010, EMERG INFECT DIS, V16, P447, DOI 10.3201/eid1603.081689; Le VTM, 2013, CURR OPIN CRIT CARE, V19, P432, DOI 10.1097/MCC.0b013e3283636b8c; WADOWSKY RM, 1991, APPL ENVIRON MICROB, V57, P1950, DOI 10.1128/AEM.57.7.1950-1955.1991; WHO, 2003, EM ISS WAT INF DIS; Zhou HJ, 2010, APPL ENVIRON MICROB, V76, P1334, DOI 10.1128/AEM.01455-09; Zhu WH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017638	51	45	45	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2014	9	8							e103852	10.1371/journal.pone.0103852	http://dx.doi.org/10.1371/journal.pone.0103852			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR0CG	25105285	Green Submitted, Green Published, gold			2022-12-27	WOS:000343231900026
J	Kennedy, DP; Adolphs, R				Kennedy, Daniel P.; Adolphs, Ralph			Violations of Personal Space by Individuals with Autism Spectrum Disorder	PLOS ONE			English	Article							SOCIAL-BEHAVIOR; DIAGNOSTIC INTERVIEW; ETHOLOGICAL APPROACH; AMYGDALA; CHILDREN; ADOLESCENTS; TRAITS; BRAIN	The ability to maintain an appropriate physical distance (i.e., interpersonal distance) from others is a critical aspect of social interaction and contributes importantly to real-life social functioning. In Study 1, using parent-report data that had been acquired on a large number of individuals (ages 4-18 years) for the Autism Genetic Resource Exchange and the Simons Simplex Collection, we found that those with Autism Spectrum Disorder (ASD; n = 766) more often violated the space of others compared to their unaffected siblings (n = 766). This abnormality held equally across ASD diagnostic categories, and correlated with clinical measures of communication and social functioning. In Study 2, laboratory experiments in a sample of high-functioning adults with ASD demonstrated an altered relationship between interpersonal distance and personal space, and documented a complete absence of personal space in 3 individuals with ASD. Furthermore, anecdotal self-report from several participants confirmed that violations of social distancing conventions continue to occur in real-world interactions through adulthood. We suggest that atypical social distancing behavior offers a practical and sensitive measure of social dysfunction in ASD, and one whose psychological and neurological substrates should be further investigated.	[Kennedy, Daniel P.] Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN 47405 USA; [Kennedy, Daniel P.; Adolphs, Ralph] CALTECH, Div Humanities & Social Sci, Pasadena, CA 91125 USA; [Adolphs, Ralph] CALTECH, Div Biol, Pasadena, CA 91125 USA	Indiana University System; Indiana University Bloomington; California Institute of Technology; California Institute of Technology	Kennedy, DP (corresponding author), Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN 47405 USA.	dpk@indiana.edu; radolphs@hss.caltech.edu		Kennedy, Daniel/0000-0002-5915-0893	Simons Foundation [SFARI-07-01]; National Institute of Mental Health [R01 MH080721]; Tamagawa University global Centers of Excellence program of the Japanese Ministry of Education, Culture, Sports and Technology; NATIONAL INSTITUTE OF MENTAL HEALTH [U24MH081810, R01MH080721] Funding Source: NIH RePORTER	Simons Foundation; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Tamagawa University global Centers of Excellence program of the Japanese Ministry of Education, Culture, Sports and Technology; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the Simons Foundation (SFARI-07-01 to R.A.), the National Institute of Mental Health (R01 MH080721 to R.A.), and the Tamagawa University global Centers of Excellence program of the Japanese Ministry of Education, Culture, Sports and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAUMAN M, 1985, NEUROLOGY, V35, P866, DOI 10.1212/WNL.35.6.866; Constantino J. N., 2005, SOCIAL RESPONSIVENES; Constantino JN, 2004, J CHILD PSYCHOL PSYC, V45, P719, DOI 10.1111/j.1469-7610.2004.00266.x; Constantino JN, 2003, J AUTISM DEV DISORD, V33, P427, DOI 10.1023/A:1025014929212; Dalton KM, 2005, NAT NEUROSCI, V8, P519, DOI 10.1038/nn1421; Dawson G, 2005, DEV NEUROPSYCHOL, V27, P403, DOI 10.1207/s15326942dn2703_6; DONNELLAN AM, 1984, J AUTISM DEV DISORD, V14, P205, DOI 10.1007/BF02409663; Frith U, 2001, NEURON, V32, P969, DOI 10.1016/S0896-6273(01)00552-9; Garfin DG, 1986, SOCIAL BEHAV AUTISM; Gessaroli E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074959; Hall E.T., 1966, HIDDEN DIMENSION, V609; HAYDUK LA, 1978, PSYCHOL BULL, V85, P117, DOI 10.1037/0033-2909.85.1.117; Howlin P, 1986, SOCIAL BEHAV AUTISM; Kennedy DP, 2009, NAT NEUROSCI, V12, P1226, DOI 10.1038/nn.2381; LECOUTEUR A, 1989, J AUTISM DEV DISORD, V19, P363, DOI 10.1007/BF02212936; LORD C, 1989, J AUTISM DEV DISORD, V19, P185, DOI 10.1007/BF02211841; LORD C, 1986, J AUTISM DEV DISORD, V16, P249, DOI 10.1007/BF01531658; McGee GG, 1997, J AUTISM DEV DISORD, V27, P353, DOI 10.1023/A:1025849220209; NESBITT PD, 1974, SOCIOMETRY, V37, P105, DOI 10.2307/2786470; Parsons S, 2004, J AUTISM DEV DISORD, V34, P449, DOI 10.1023/B:JADD.0000037421.98517.8d; PEDERSEN J, 1989, ACTA PSYCHIAT SCAND, V80, P346, DOI 10.1111/j.1600-0447.1989.tb02991.x; Pelphrey K, 2004, MENT RETARD DEV D R, V10, P259, DOI 10.1002/mrdd.20040; Schultz RT, 2005, INT J DEV NEUROSCI, V23, P125, DOI 10.1016/j.ijdevneu.2004.12.012; Schumann CM, 2004, J NEUROSCI, V24, P6392, DOI 10.1523/JNEUROSCI.1297-04.2004; Schumann CM, 2006, J NEUROSCI, V26, P7674, DOI 10.1523/JNEUROSCI.1285-06.2006; VANENGELAND H, 1985, J CHILD PSYCHOL PSYC, V26, P879	26	43	44	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e103369	10.1371/journal.pone.0103369	http://dx.doi.org/10.1371/journal.pone.0103369			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM6SM	25100326	Green Published, gold, Green Accepted			2022-12-27	WOS:000339995100019
J	Pereiro, P; Dios, S; Boltana, S; Coll, J; Estepa, A; Mackenzie, S; Novoa, B; Figueras, A				Pereiro, Patricia; Dios, Sonia; Boltana, Sebastian; Coll, Julio; Estepa, Amparo; Mackenzie, Simon; Novoa, Beatriz; Figueras, Antonio			Transcriptome Profiles Associated to VHSV Infection or DNA Vaccination in Turbot (Scophthalmus maximus)	PLOS ONE			English	Article							VIRAL HEMORRHAGIC SEPTICEMIA; TROUT ONCORHYNCHUS-MYKISS; MACROPHAGE MANNOSE RECEPTOR; TOLL-LIKE RECEPTORS; RAINBOW-TROUT; PARALICHTHYS-OLIVACEUS; JAPANESE FLOUNDER; IMMUNE-RESPONSES; DOWN-REGULATION; VIRUS	DNA vaccines encoding the viral G glycoprotein show the most successful protection capability against fish rhabdoviruses. Nowadays, the molecular mechanisms underlying the protective response remain still poorly understood. With the aim of shedding light on the protection conferred by the DNA vaccines based in the G glycoprotein of viral haemorrhagic septicaemia virus (VHSV) in turbot (Scophthalmus maximus) we have used a specific microarray highly enriched in antiviral sequences to carry out the transcriptomic study associated to VHSV DNA vaccination/infection. The differential gene expression pattern in response to empty plasmid (pMCV1.4) and DNA vaccine (pMCV1.4-G(860)) intramuscular administration with regard to non-stimulated turbot was analyzed in head kidney at 8, 24 and 72 hours post-vaccination. Moreover, the effect of VHSV infection one month after immunization was also analyzed in vaccinated and non-vaccinated fish at the same time points. Genes implicated in the Toll-like receptor signalling pathway, IFN inducible/regulatory proteins, numerous sequences implicated in apoptosis and cytotoxic pathways, MHC class I antigens, as well as complement and coagulation cascades among others were analyzed in the different experimental groups. Fish receiving the pMCV1.4-G(860) vaccine showed transcriptomic patterns very different to the ones observed in pMCV1.4-injected turbot after 72 h. On the other hand, VHSV challenge in vaccinated and non-vaccinated turbot induced a highly different response at the transcriptome level, indicating a very relevant role of the acquired immunity in vaccinated fish able to alter the typical innate immune response profile observed in non-vaccinated individuals. This exhaustive transcriptome study will serve as a complete overview for a better understanding of the crosstalk between the innate and adaptive immune response in fish after viral infection/vaccination. Moreover, it provides interesting dues about molecules with a potential use as vaccine adjuvants, antiviral treatments or markers for vaccine efficiency monitoring.	[Pereiro, Patricia; Dios, Sonia; Novoa, Beatriz; Figueras, Antonio] CSIC, Inst Invest Marinas, Vigo, Spain; [Boltana, Sebastian; Mackenzie, Simon] Univ Stirling, Inst Aquaculture, Stirling FK9 4LA, Scotland; [Coll, Julio] Inst Nacl Invest Agr, Dpto Biotecnol, Madrid, Spain; [Estepa, Amparo] Miguel Hernandez Univ, Inst Biol & Mol Celular, Elche, Spain; [Boltana, Sebastian; Mackenzie, Simon] Univ Autonoma Barcelona, Inst Biotecnol & Biomed, E-08193 Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Marinas (IIM); University of Stirling; Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA); Universidad Miguel Hernandez de Elche; Autonomous University of Barcelona	Novoa, B (corresponding author), CSIC, Inst Invest Marinas, Vigo, Spain.	virus@iim.csic.es	Figueras, Antonio/B-5133-2015; Boltana, Sebastian/AAC-8944-2019; Dios, Sonia/M-4201-2018; Pereiro, Patricia/AAS-9514-2020; Figueras, Antonio/AAB-8921-2019; MacKenzie, Simon/Q-2362-2019; Coll, julio/M-6071-2019; Novoa, Beatriz/K-3785-2014	Figueras, Antonio/0000-0002-0617-0030; Boltana, Sebastian/0000-0002-5195-0490; Dios, Sonia/0000-0002-2126-991X; Pereiro, Patricia/0000-0002-8734-3334; Figueras, Antonio/0000-0002-0617-0030; MacKenzie, Simon/0000-0003-1845-6826; Coll, julio/0000-0001-8496-3493; Novoa, Beatriz/0000-0003-4888-8419	Spanish Ministerio de Ciencia e Innovacion [AGL2011-28921-C03, CSD2007-00002]; Agencia Estatal Consejo Superior de Investigaciones Cientificas (CSIC) [201230E057]; Ministerio de Educacion [AP2010-2408]	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Agencia Estatal Consejo Superior de Investigaciones Cientificas (CSIC); Ministerio de Educacion	This work has been funded by the project CSD2007-00002 "Aquagenomics" and AGL2011-28921-C03 from the Spanish Ministerio de Ciencia e Innovacion. The authors' laboratory is also funded by the project 201230E057 from the Agencia Estatal Consejo Superior de Investigaciones Cientificas (CSIC). P. Pereiro gratefully acknowledges the Ministerio de Educacion for a FPU fellowship (AP2010-2408). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelmann M, 2008, VACCINE, V26, P837, DOI 10.1016/j.vaccine.2007.11.065; Aliprantis AO, 2000, EMBO J, V19, P3325, DOI 10.1093/emboj/19.13.3325; Amara U, 2010, J IMMUNOL, V185, P5628, DOI 10.4049/jimmunol.0903678; Barber GN, 2001, CELL DEATH DIFFER, V8, P113, DOI 10.1038/sj.cdd.4400823; BERNARD J, 1983, INFECT IMMUN, V39, P7, DOI 10.1128/IAI.39.1.7-14.1983; Boraschi D, 2006, EUR CYTOKINE NETW, V17, P224; Brode S, 2004, IMMUNOLOGY, V112, P345, DOI 10.1111/j.1365-2567.2004.01920.x; Byon JY, 2006, VACCINE, V24, P921, DOI 10.1016/j.vaccine.2005.08.087; Byon JY, 2005, FISH SHELLFISH IMMUN, V18, P135, DOI 10.1016/j.fsi.2004.06.008; Carroll MC, 2004, NAT IMMUNOL, V5, P981, DOI 10.1038/ni1113; CASTRIC J, 1980, J FISH DIS, V3, P21, DOI 10.1111/j.1365-2761.1980.tb00180.x; Chang LL, 2007, ANTIVIR RES, V75, P43, DOI 10.1016/j.antiviral.2006.11.009; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Dakhama A, 1998, CHEST, V114, P1681, DOI 10.1378/chest.114.6.1681; DEKINKELIN P, 1995, VET RES, V26, P379; DEKINKELIN P, 1980, J VIROL, V36, P652, DOI 10.1128/JVI.36.3.652-658.1980; Esmon CT, 2003, J THROMB HAEMOST, V1, P1343, DOI 10.1046/j.1538-7836.2003.00261.x; Fensterl V, 2011, J INTERF CYTOK RES, V31, P71, DOI 10.1089/jir.2010.0101; Glaros T, 2009, FRONT BIOSCI-LANDMRK, V14, P3988, DOI [10.2735/3506, 10.2741/3506]; Goodbourn S, 2000, J GEN VIROL, V81, P2341, DOI 10.1099/0022-1317-81-10-2341; Ha SJ, 2003, GENE THER, V10, P1592, DOI 10.1038/sj.gt.3302057; HARRIS N, 1992, BLOOD, V80, P2363; Hewitt EW, 2003, IMMUNOLOGY, V110, P163, DOI 10.1046/j.1365-2567.2003.01738.x; Hidmark A, 2012, J IMMUNOL, V189, P2717, DOI 10.4049/jimmunol.1200898; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Horlyck V., 1984, Bulletin of the European Association of Fish Pathologists, V4, P11; Iking-Konert C, 2002, CLIN EXP IMMUNOL, V130, P501, DOI 10.1046/j.1365-2249.2002.02008.x; Jorgensen JB, 2003, J VIROL, V77, P11471, DOI 10.1128/JVI.77.21.11471-11479.2003; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kim CH, 2000, J VIROL, V74, P7048, DOI 10.1128/JVI.74.15.7048-7054.2000; Klinman DM, 2004, IMMUNOL REV, V199, P201, DOI 10.1111/j.0105-2896.2004.00148.x; Krieg AM, 1998, TRENDS MICROBIOL, V6, P23, DOI 10.1016/S0966-842X(97)01145-1; LaPatra SE, 2001, VACCINE, V19, P4011, DOI 10.1016/S0264-410X(01)00113-X; Lecker SH, 2006, J AM SOC NEPHROL, V17, P1807, DOI 10.1681/ASN.2006010083; LECOCQXHONNEUX F, 1994, J GEN VIROL, V75, P1579, DOI 10.1099/0022-1317-75-7-1579; Leong J. C., 1993, Annual Review of Fish Diseases, V3, P225, DOI 10.1016/0959-8030(93)90036-B; Levi M, 2003, CARDIOVASC RES, V60, P26, DOI 10.1016/S0008-6363(02)00857-X; Lorenzen E, 2005, FISH SHELLFISH IMMUN, V19, P27, DOI 10.1016/j.fsi.2004.10.009; Lorenzen N, 2005, REV SCI TECH OIE, V24, P201, DOI 10.20506/rst.24.1.1565; LORENZEN N, 1990, J GEN VIROL, V71, P561, DOI 10.1099/0022-1317-71-3-561; Luo RF, 2010, HUM PATHOL, V41, P271, DOI 10.1016/j.humpath.2009.07.022; Manders P, 2000, INFLAMM RES, V49, P199, DOI 10.1007/s000110050580; Martinez-Alonso S, 2011, VACCINE, V29, P1289, DOI 10.1016/j.vaccine.2010.11.073; Mogensen TH, 2009, CLIN MICROBIOL REV, V22, P240, DOI 10.1128/CMR.00046-08; MORAHAN PS, 1985, BRIT MED BULL, V41, P15, DOI 10.1093/oxfordjournals.bmb.a072017; Morey JS, 2006, BIOL PROCED ONLINE, V8, P175, DOI 10.1251/bpo126; Nakanishi K, 2001, CYTOKINE GROWTH F R, V12, P53, DOI 10.1016/S1359-6101(00)00015-0; Pereiro P, 2014, DEV COMP IMMUNOL, V45, P233, DOI 10.1016/j.dci.2014.03.006; Pereiro P, 2012, FISH SHELLFISH IMMUN, V32, P1088, DOI 10.1016/j.fsi.2012.03.004; Pereiro P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035369; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Purcell MK, 2006, MOL IMMUNOL, V43, P2089, DOI 10.1016/j.molimm.2005.12.005; REED L. J., 1938, AMER JOUR HYG, V27, P493; Rittner GMG, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001519; Roder G, 2008, J VIROL, V82, P8246, DOI 10.1128/JVI.00207-08; Ross K., 1994, Bulletin of the European Association of Fish Pathologists, V14, P213; Rozen S, 2000, Methods Mol Biol, V132, P365; Schlotfeldt H.-J., 1991, Bulletin of the European Association of Fish Pathologists, V11, P105; Shi ZC, 2011, J BIOL CHEM, V286, P4517, DOI 10.1074/jbc.M110.159590; Sommerset I, 2003, VACCINE, V21, P4661, DOI 10.1016/S0264-410X(03)00526-7; STEIN M, 1992, J EXP MED, V176, P287, DOI 10.1084/jem.176.1.287; Tafalla C, 1998, VET IMMUNOL IMMUNOP, V62, P359, DOI 10.1016/S0165-2427(97)00167-0; Trapani JA, 2002, NAT REV IMMUNOL, V2, P735, DOI 10.1038/nri911; Uematsu S, 2007, J BIOL CHEM, V282, P15319, DOI 10.1074/jbc.R700009200; Wolf K., 1988, FISH VIRUSES FISH VI, P217, DOI [10.7591/9781501746383, DOI 10.7591/9781501746383]; WU LX, 1990, MICROB PATHOGENESIS, V9, P293, DOI 10.1016/0882-4010(90)90064-W; Xagorari Angeliki, 2008, Open Microbiol J, V2, P49, DOI 10.2174/1874285800802010049; Yasuike M, 2007, FISH SHELLFISH IMMUN, V23, P531, DOI 10.1016/j.fsi.2006.12.006; Yasuike M, 2011, COMP IMMUNOL MICROB, V34, P103, DOI 10.1016/j.cimid.2010.03.001; Zhou LJ, 1996, P NATL ACAD SCI USA, V93, P2588, DOI 10.1073/pnas.93.6.2588; Zou J, 2011, DEV COMP IMMUNOL, V35, P1376, DOI 10.1016/j.dci.2011.07.001	72	25	27	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e104509	10.1371/journal.pone.0104509	http://dx.doi.org/10.1371/journal.pone.0104509			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25098168	Green Published, Green Submitted, gold			2022-12-27	WOS:000339995100080
J	Sivera, M; Kvitek, L; Soukupova, J; Panacek, A; Prucek, R; Vecerova, R; Zboril, R				Sivera, Martin; Kvitek, Libor; Soukupova, Jana; Panacek, Ales; Prucek, Robert; Vecerova, Renata; Zboril, Radek			Silver Nanoparticles Modified by Gelatin with Extraordinary pH Stability and Long-Term Antibacterial Activity	PLOS ONE			English	Article							GREEN SYNTHESIS; REDUCING AGENT; CHITOSAN; BIONANOCOMPOSITES; POLYMERS; FACILE; SIZE	The potential for application of any nanoparticles, including silver nanoparticles (AgNPs), is strongly dependent on their stability against aggregation. Therefore, improvement of this parameter is a key task, especially in the case of AgNPs, because a correlation between size and biological activity has been demonstrated. In the present work, a natural stabilizer, gelatin, was investigated for the stabilization of AgNPs in an aqueous dispersion. The particles were prepared via a modified Tollens process, and the gelatin modifier was added prior to the reducing agent. The stability against aggregation of the AgNPs prepared by this method was more than one order of magnitude higher (on the basis of the critical coagulation concentration (CCC)) than that of AgNPs prepared via a similar method but without the assistance of gelatin. Their high stability against aggregation was confirmed over wide pH range (from 2 to 13) in which the particles did not exhibit rapid aggregation; such stability has not been previously reported for AgNPs. Additionally, gelatin not only fulfills the role of a unique stabilizer but also positively influences the modified Tollens process used to prepare the AgNPs. The diameter of the gelatin-modified AgNPs was substantially smaller in comparison to those prepared without gelatin. The polydispersity of the dispersion significantly narrowed. Moreover, the gelatin-stabilized AgNPs exhibited long-term stability against aggregation and maintained high antibacterial activity when stored for several months under ambient conditions.	[Sivera, Martin; Kvitek, Libor; Soukupova, Jana; Panacek, Ales; Prucek, Robert; Zboril, Radek] Palacky Univ, Fac Sci, Dept Phys Chem, CR-77147 Olomouc, Czech Republic; [Kvitek, Libor; Soukupova, Jana; Panacek, Ales; Prucek, Robert; Zboril, Radek] Palacky Univ, Fac Sci, Reg Ctr Adv Technol & Mat, CR-77147 Olomouc, Czech Republic; [Vecerova, Renata] Palacky Univ, Fac Med, Dept Microbiol, CR-77147 Olomouc, Czech Republic	Palacky University Olomouc; Palacky University Olomouc; Palacky University Olomouc	Kvitek, L (corresponding author), Palacky Univ, Fac Sci, Dept Phys Chem, CR-77147 Olomouc, Czech Republic.	libor.kvitek@upol.cz	Panacek, Ales/F-3867-2010; Zboril, Radek/F-5153-2015; Kvitek, Libor/L-1539-2018	Zboril, Radek/0000-0002-3147-2196; Kvitek, Libor/0000-0003-2005-560X; Vecerova, Renata/0000-0002-7546-530X	Operational Program Research and Development for Innovations - European Regional Development Fund of the Ministry of Education, Youth and Sports of the Czech Republic [CZ.1.05/2.1.00/03.0058]; Operational Program Education for Competitiveness European Social Fund of the Ministry of Education, Youth and Sports of the Czech Republic [CZ. 1.07/2.3.00/20.0056]; Technology Agency of the Czech Republic [TA03010799]; Internal Grant of Palacky University in Olomouc [PrF_2014_032]	Operational Program Research and Development for Innovations - European Regional Development Fund of the Ministry of Education, Youth and Sports of the Czech Republic; Operational Program Education for Competitiveness European Social Fund of the Ministry of Education, Youth and Sports of the Czech Republic; Technology Agency of the Czech Republic; Internal Grant of Palacky University in Olomouc	Operational Program Research and Development for Innovations - European Regional Development Fund, project CZ.1.05/2.1.00/03.0058 of the Ministry of Education, Youth and Sports of the Czech Republic; http://www.opvavpi.cz/ (LK AP RP RV RZ). Operational Program Education for Competitiveness European Social Fund, project CZ. 1.07/2.3.00/20.0056 of the Ministry of Education, Youth and Sports of the Czech Republic; http://www. op-vk.cz/ (LK JS AP RP). Technology Agency of the Czech Republic, project TA03010799; http://www.tacr.cz/ (MS LK RP RZ). Internal Grant of Palacky University in Olomouc, project PrF_2014_032; http://www.upol.cz/ (MS LK JS AP RP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arvizo RR, 2012, CHEM SOC REV, V41, P2943, DOI 10.1039/c2cs15355f; Bhaduri GA, 2013, J PHOTOCH PHOTOBIO A, V258, P1, DOI 10.1016/j.jphotochem.2013.02.015; Bin Ahmad M, 2012, CHEM CENT J, V6, DOI 10.1186/1752-153X-6-101; Bin Ahmad M, 2011, MOLECULES, V16, P7237, DOI 10.3390/molecules16097237; Chaloupka K, 2010, TRENDS BIOTECHNOL, V28, P580, DOI 10.1016/j.tibtech.2010.07.006; Chen X, 2008, TOXICOL LETT, V176, P1, DOI 10.1016/j.toxlet.2007.10.004; Csapo E, 2012, COLLOID SURFACE B, V98, P43, DOI 10.1016/j.colsurfb.2012.03.036; Darroudi M, 2012, MATER LETT, V66, P117, DOI 10.1016/j.matlet.2011.08.016; Farrugia CA, 1999, J PHARM PHARMACOL, V51, P643, DOI 10.1211/0022357991772925; Fortunati E, 2013, J FOOD ENG, V118, P117, DOI 10.1016/j.jfoodeng.2013.03.025; Gomes SIL, 2013, J HAZARD MATER, V254, P336, DOI 10.1016/j.jhazmat.2013.04.005; Inyang M, 2013, CHEM ENG J, V220, P221, DOI 10.1016/j.cej.2013.01.054; Jain P, 2005, BIOTECHNOL BIOENG, V90, P59, DOI 10.1002/bit.20368; Jia ZQ, 2013, COLLOID SURFACE A, V419, P174, DOI 10.1016/j.colsurfa.2012.12.003; Kvitek L, 2005, J MATER CHEM, V15, P1099, DOI 10.1039/b417007e; Kvitek L, 2008, J PHYS CHEM C, V112, P5825, DOI 10.1021/jp711616v; Lee C, 2013, J RAMAN SPECTROSC, V44, P823, DOI 10.1002/jrs.4304; Lee HJ, 2003, J MATER SCI, V38, P2199, DOI 10.1023/A:1023736416361; Long Y, 2013, MATER LETT, V112, P101, DOI 10.1016/j.matlet.2013.09.035; Maity D, 2011, J APPL POLYM SCI, V122, P2189, DOI 10.1002/app.34266; Marambio-Jones C, 2010, J NANOPART RES, V12, P1531, DOI 10.1007/s11051-010-9900-y; Moussa SH, 2013, J FOOD SCI, V78, pM1589, DOI 10.1111/1750-3841.12247; Oluwafemi OS, 2013, COLLOID SURFACE B, V102, P718, DOI 10.1016/j.colsurfb.2012.09.001; Panacek A, 2006, J PHYS CHEM B, V110, P16248, DOI 10.1021/jp063826h; Pokhrel LR, 2013, ENVIRON SCI TECHNOL, V47, P12877, DOI 10.1021/es403462j; Rai M, 2009, BIOTECHNOL ADV, V27, P76, DOI 10.1016/j.biotechadv.2008.09.002; Ravindra S, 2010, COLLOID SURFACE A, V367, P31, DOI 10.1016/j.colsurfa.2010.06.013; Roh J, 2013, KOREAN J CHEM ENG, V30, P671, DOI 10.1007/s11814-012-0172-3; Sharma VK, 2009, ADV COLLOID INTERFAC, V145, P83, DOI 10.1016/j.cis.2008.09.002; Teng HH, 2013, SEP SCI TECHNOL, V48, P1729, DOI 10.1080/01496395.2012.753905; Thakkar KN, 2010, NANOMED-NANOTECHNOL, V6, P257, DOI 10.1016/j.nano.2009.07.002; Tokarek K, 2013, EUR J INORG CHEM, V2013, P4940, DOI 10.1002/ejic.201300594; Xiong YL, 2012, APPL SURF SCI, V258, P5822, DOI 10.1016/j.apsusc.2012.02.108; Zaheer Z, 2013, COLLOID SURFACE B, V108, P90, DOI 10.1016/j.colsurfb.2013.02.023; Zamiri R, 2012, B MATER SCI, V35, P727, DOI 10.1007/s12034-012-0360-0	35	48	49	4	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e103675	10.1371/journal.pone.0103675	http://dx.doi.org/10.1371/journal.pone.0103675			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25098570	Green Submitted, gold, Green Published			2022-12-27	WOS:000339995100024
J	Pellier, AS; Wells, JA; Abram, NK; Gaveau, D; Meijaard, E				Pellier, Anne-Sophie; Wells, Jessie A.; Abram, Nicola K.; Gaveau, David; Meijaard, Erik			Through the Eyes of Children: Perceptions of Environmental Change in Tropical Forests	PLOS ONE			English	Article							BASE-LINE SYNDROME; CONSERVATION; BIODIVERSITY	This study seeks to understand children's perceptions of their present and future environments in the highly biodiverse and rapidly changing landscapes of Kalimantan, Indonesian Borneo. We analyzed drawings by children (target age 10-15 years) from 22 villages, which show how children perceive the present conditions of forests and wildlife surrounding their villages and how they expect conditions to change over the next 15 years. Analyses of picture elements and their relationships to current landscape variables indicate that children have a sophisticated understanding of their environment and how different environmental factors interact, either positively or negatively. Children appear to have landscape-dependent environmental perceptions, showing awareness of past environmental conditions and many aspects of recent trends, and translating these into predictions for future environmental conditions. The further removed their present landscape is from the originally forested one, the more environmental change they expect in the future, particularly declines in forest cover, rivers, animal diversity and increases in temperature and natural disasters. This suggests that loss of past perceptions and associated "shifting environmental baselines" do not feature strongly among children on Borneo, at least not for the perceptions we investigated here. Our findings that children have negative expectations of their future environmental conditions have important political implications. More than other generations, children have a stake in ensuring that future environmental conditions support their long-term well-being. Understanding what drives environmental views among children, and how they consider trade-offs between economic development and social and environmental change, should inform optimal policies on land use. Our study illuminates part of the complex interplay between perceptions of land cover and land use change. Capturing the views of children through artistic expressions provides a potentially powerful tool to influence public and political opinions, as well as a valuable approach for developing localized education and nature conservation programs.	[Pellier, Anne-Sophie; Gaveau, David; Meijaard, Erik] Ctr Int Forestry Res CIFOR, Bogor, Indonesia; [Wells, Jessie A.; Meijaard, Erik] Univ Queensland, Ctr Biodivers & Conservat Sci, ARC Ctr Excellence Environm Decis, Brisbane, Qld, Australia; [Abram, Nicola K.] Univ Kent, Durrell Inst Conservat & Ecol, Sch Anthropol & Conservat, Canterbury, Kent, England; [Pellier, Anne-Sophie; Wells, Jessie A.; Abram, Nicola K.; Gaveau, David; Meijaard, Erik] People & Nat Consulting Int, Borneo Futures Initiat, Jakarta, Indonesia	CGIAR; Center for International Forestry Research (CIFOR); University of Queensland; University of Kent; People & Nature Consulting International	Pellier, AS (corresponding author), Ctr Int Forestry Res CIFOR, Bogor, Indonesia.	pellier.annesophie@gmail.com	Wells, Jessie A/F-7318-2010; Meijaard, Erik/A-2687-2016; Abram, Nicola/K-2060-2014	Wells, Jessie A/0000-0002-3555-5108; Meijaard, Erik/0000-0001-8685-3685; Abram, Nicola/0000-0003-1886-7297	United States Agency for International Development (USAID); Arcus Foundation; The CGIAR Research Program on Forests, Trees and Agroforestry	United States Agency for International Development (USAID)(United States Agency for International Development (USAID)); Arcus Foundation; The CGIAR Research Program on Forests, Trees and Agroforestry	The study was financially supported by the United States Agency for International Development (USAID) (www.usaid.gov/) and the Arcus Foundation (http://www.arcusfoundation.org/). The CGIAR Research Program on Forests, Trees and Agroforestry, led by the Center for International Forestry Research (CIFOR), provided additional funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alerby E., 2000, ENVIRON EDUC RES, V6, P205, DOI [10.1080/13504620050076713, DOI 10.1080/13504620050076713]; ANDERSON S, 1993, INT J SCI EDUC, V15, P473, DOI 10.1080/0950069930150502; Barraza L, 1999, ENVIRON EDUC RES, V5, P49, DOI DOI 10.1080/1350462990050103; Bowker R., 2007, ENVIRON EDUC RES, V13, P75, DOI [10.1080/13504620601122731, DOI 10.1080/13504620601122731]; Bright EA, 2008, LANDSCAN 2007; Carlson KM, 2013, NAT CLIM CHANGE, V3, P283, DOI [10.1038/nclimate1702, 10.1038/NCLIMATE1702]; COLFER CJP, 1999, CRITERIA INDICATORS, V6; Dove J, 2012, INT RES GEOGR ENVIRO, V21, P59, DOI 10.1080/10382046.2012.639150; FAO, 2010, 163 FAO; Gaveau DLA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101654; KAHN PH, 1995, CHILD DEV, V66, P1403; Kareiva P, 2008, P NATL ACAD SCI USA, V105, P2757, DOI 10.1073/pnas.0800474105; Lehner B, 2006, HYDROSHEDS TECHNICAL; Liu JG, 2007, SCIENCE, V317, P1513, DOI 10.1126/science.1144004; Malchiodi C. A., 1998, UNDERSTANDING CHILDR; Meijaard E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073008; Meijaard E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027491; Meijaard E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018008; Miettinen J, 2011, GLOBAL CHANGE BIOL, V17, P2261, DOI 10.1111/j.1365-2486.2011.02398.x; Miller JR, 2005, TRENDS ECOL EVOL, V20, P430, DOI 10.1016/j.tree.2005.05.013; Papworth SK, 2009, CONSERV LETT, V2, P93, DOI 10.1111/j.1755-263X.2009.00049.x; PAULY D, 1995, TRENDS ECOL EVOL, V10, P430, DOI 10.1016/S0169-5347(00)89171-5; Pinnegar JK, 2008, REV FISH BIOL FISHER, V18, P1, DOI 10.1007/s11160-007-9058-6; Saenz-Arroyo A, 2005, P ROY SOC B-BIOL SCI, V272, P1957, DOI 10.1098/rspb.2005.3175; Simons DJ, 2005, TRENDS COGN SCI, V9, P16, DOI 10.1016/j.tics.2004.11.006; Snaddon JL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002579; Turvey ST, 2010, CONSERV BIOL, V24, P778, DOI 10.1111/j.1523-1739.2009.01395.x; Wells J.A., 2013, FORESTS FLOODS PEOPL; Whitten T, 2004, HOTSPOTS REVISITED A; Wich SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049142	30	26	27	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e103005	10.1371/journal.pone.0103005	http://dx.doi.org/10.1371/journal.pone.0103005			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093658	Green Published, gold, Green Submitted			2022-12-27	WOS:000341357200016
J	Yan, LM; Chen, SP; Xia, JY; Luo, YQ				Yan, Liming; Chen, Shiping; Xia, Jianyang; Luo, Yiqi			Precipitation Regime Shift Enhanced the Rain Pulse Effect on Soil Respiration in a Semi-Arid Steppe	PLOS ONE			English	Article							CO2 EFFLUX; DIFFERENTIAL RESPONSES; ECOSYSTEM RESPIRATION; TEMPORAL VARIATION; MICROBIAL BIOMASS; SONORAN DESERT; CLIMATE-CHANGE; ELEVATED CO2; CARBON; WATER	The effect of resource pulses, such as rainfall events, on soil respiration plays an important role in controlling grassland carbon balance, but how shifts in long-term precipitation regime regulate rain pulse effect on soil respiration is still unclear. We first quantified the influence of rainfall event on soil respiration based on a two-year (2006 and 2009) continuously measured soil respiration data set in a temperate steppe in northern China. In 2006 and 2009, soil carbon release induced by rainfall events contributed about 44.5% (83.3 g C m(-2)) and 39.6% (61.7 g C m(-2)) to the growing-season total soil respiration, respectively. The pulse effect of rainfall event on soil respiration can be accurately predicted by a water status index (WSI), which is the product of rainfall event size and the ratio between antecedent soil temperature to moisture at the depth of 10 cm (r(2)=0.92, P<0.001) through the growing season. It indicates the pulse effect can be enhanced by not only larger individual rainfall event, but also higher soil temperature/moisture ratio which is usually associated with longer dry spells. We then analyzed a long-term (1953-2009) precipitation record in the experimental area. We found both the extreme heavy rainfall events (>40 mm per event) and the long dry-spells (>5 days) during the growing seasons increased from 1953-2009. It suggests the shift in precipitation regime has increased the contribution of rain pulse effect to growing-season total soil respiration in this region. These findings highlight the importance of incorporating precipitation regime shift and its impacts on the rain pulse effect into the future predictions of grassland carbon cycle under climate change.	[Yan, Liming; Chen, Shiping] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China; [Yan, Liming] Fudan Univ, Sch Life Sci, Shanghai 200433, Peoples R China; [Xia, Jianyang; Luo, Yiqi] Univ Oklahoma, Dept Bot & Microbiol, Norman, OK 73019 USA	Chinese Academy of Sciences; Institute of Botany, CAS; Fudan University; University of Oklahoma System; University of Oklahoma - Norman	Chen, SP (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China.	spchen@ibcas.ac.cn	Chen, Shiping/AAH-9751-2019; Xia, Jianyang/S-9499-2019; Xia, Jianyang/A-7886-2008		"Strategic Priority Research Program" of the Chinese Academy of Sciences, Climate Change: Carbon Budget and Relevant Issues [XDA05050402]; National Natural Science Foundation of China [31170453]; National Basic Research Program of China (973 program) [2010CB833501]; Selected Young Scientist Program of the State Key Laboratory of Vegetation and Environment Change	"Strategic Priority Research Program" of the Chinese Academy of Sciences, Climate Change: Carbon Budget and Relevant Issues(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 program)(National Basic Research Program of China); Selected Young Scientist Program of the State Key Laboratory of Vegetation and Environment Change	This study was supported partly by the "Strategic Priority Research Program" of the Chinese Academy of Sciences, Climate Change: Carbon Budget and Relevant Issues (XDA05050402), the National Natural Science Foundation of China (31170453), the National Basic Research Program of China (973 program, 2010CB833501), and a Selected Young Scientist Program of the State Key Laboratory of Vegetation and Environment Change to SC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boot CM, 2013, SOIL BIOL BIOCHEM, V57, P356, DOI 10.1016/j.soilbio.2012.09.005; Borken W, 2002, GLOBAL CHANGE BIOL, V8, P1205, DOI 10.1046/j.1365-2486.2002.00547.x; Bowling DR, 2011, J GEOPHYS RES-BIOGEO, V116, DOI [10.1029/2011JG001722, 10.1029/2011JG001643]; Cable JM, 2008, ECOSYSTEMS, V11, P961, DOI 10.1007/s10021-008-9172-x; Carbone MS, 2011, OECOLOGIA, V167, P265, DOI 10.1007/s00442-011-1975-3; Chen SP, 2009, GLOBAL CHANGE BIOL, V15, P2450, DOI 10.1111/j.1365-2486.2009.01879.x; Chen SP, 2008, J PLANT ECOL, V1, P237, DOI 10.1093/jpe/rtn020; Daly E, 2008, ADV WATER RESOUR, V31, P987, DOI 10.1016/j.advwatres.2008.04.001; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; Dore MHI, 2005, ENVIRON INT, V31, P1167, DOI 10.1016/j.envint.2005.03.004; Fierer N, 2003, SOIL SCI SOC AM J, V67, P798, DOI 10.2136/sssaj2003.0798; Fierer N, 2002, SOIL BIOL BIOCHEM, V34, P777, DOI 10.1016/S0038-0717(02)00007-X; Gong DY, 2004, J ARID ENVIRON, V59, P771, DOI 10.1016/j.jaridenv.2004.02.006; GRIFFITHS E, 1961, NATURE, V189, P424, DOI 10.1038/189424a0; Harper CW, 2005, GLOBAL CHANGE BIOL, V11, P322, DOI 10.1111/j.1365-2486.2005.00899.x; Hogberg P, 2001, NATURE, V411, P789, DOI 10.1038/35081058; Huxman TE, 2004, OECOLOGIA, V141, P254, DOI 10.1007/s00442-004-1682-4; Inglima I, 2009, GLOBAL CHANGE BIOL, V15, P1289, DOI 10.1111/j.1365-2486.2008.01793.x; JAGER G, 1975, SOIL BIOL BIOCHEM, V7, P153, DOI 10.1016/0038-0717(75)90013-9; KIEFT TL, 1987, SOIL BIOL BIOCHEM, V19, P119, DOI 10.1016/0038-0717(87)90070-8; Kim DG, 2012, BIOGEOSCIENCES, V9, P2459, DOI 10.5194/bg-9-2459-2012; Kim DG, 2010, SOIL BIOL BIOCHEM, V42, P576, DOI 10.1016/j.soilbio.2009.12.005; Knapp AK, 2002, SCIENCE, V298, P2202, DOI 10.1126/science.1076347; Lee MS, 2002, ECOL RES, V17, P401, DOI 10.1046/j.1440-1703.2002.00498.x; Lee R, 2002, INT J REMOTE SENS, V23, P2505, DOI 10.1080/01431160110106087; Lee X, 2004, GLOBAL CHANGE BIOL, V10, P1017, DOI 10.1111/j.1529-8817.2003.00787.x; Liu BH, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD004864; Liu R, 2013, PLANT SOIL, V373, P799, DOI 10.1007/s11104-013-1839-1; Liu WX, 2009, GLOBAL CHANGE BIOL, V15, P184, DOI 10.1111/j.1365-2486.2008.01728.x; Liu XZ, 2002, PLANT SOIL, V240, P213, DOI 10.1023/A:1015744126533; Ma SY, 2012, AGR FOREST METEOROL, V154, P203, DOI 10.1016/j.agrformet.2011.11.007; Meehl GA, 2005, GEOPHYS RES LETT, V32; Miller AE, 2005, SOIL BIOL BIOCHEM, V37, P2195, DOI 10.1016/j.soilbio.2005.03.021; New M, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006289; Ni J, 2002, J ARID ENVIRON, V50, P205, DOI 10.1006/jare.2001.0902; Paulo AA, 2006, WATER INT, V31, P37, DOI 10.1080/02508060608691913; Reynolds JF, 2004, OECOLOGIA, V141, P194, DOI 10.1007/s00442-004-1524-4; Riveros-Iregui DA, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030938; Schimel J, 2007, ECOLOGY, V88, P1386, DOI 10.1890/06-0219; Schimel JP, 1999, SOIL BIOL BIOCHEM, V31, P831, DOI 10.1016/S0038-0717(98)00182-5; Schmidli J, 2005, INT J CLIMATOL, V25, P753, DOI 10.1002/joc.1179; Sharkhuu A, 2013, BIOGEOCHEMISTRY, V115, P333, DOI 10.1007/s10533-013-9839-z; Smart DR, 2005, APPL SOIL ECOL, V28, P247, DOI 10.1016/j.apsoil.2004.07.011; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Sponseller RA, 2007, GLOBAL CHANGE BIOL, V13, P426, DOI 10.1111/j.1365-2486.2006.01307.x; Tang JW, 2005, BIOGEOCHEMISTRY, V73, P183, DOI 10.1007/s10533-004-5889-6; Vargas R, 2011, GLOBAL CHANGE BIOL, V16, P1589; Vargas R, 2008, NEW PHYTOL, V179, P460, DOI 10.1111/j.1469-8137.2008.02481.x; Vargas R, 2012, GLOBAL CHANGE BIOL, V18, P1401, DOI 10.1111/j.1365-2486.2011.02628.x; Wan S, 2007, GLOBAL CHANGE BIOL, V13, P2411, DOI 10.1111/j.1365-2486.2007.01433.x; Wu HJ, 2011, PLANT SOIL, V338, P329, DOI 10.1007/s11104-010-0548-2; Xu LK, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002281; Yan LM, 2011, GLOBAL CHANGE BIOL, V17, P1990, DOI 10.1111/j.1365-2486.2010.02365.x; Yan LM, 2010, GLOBAL CHANGE BIOL, V16, P2345, DOI 10.1111/j.1365-2486.2009.02091.x; Yuste JC, 2005, BIOGEOCHEMISTRY, V73, P209, DOI 10.1007/s10533-004-7201-1	55	46	54	3	109	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e104217	10.1371/journal.pone.0104217	http://dx.doi.org/10.1371/journal.pone.0104217			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093573	gold, Green Published, Green Submitted			2022-12-27	WOS:000341357200087
J	Hara, A; Thijs, L; Asayama, K; Jacobs, L; Wang, JG; Staessen, JA				Hara, Azusa; Thijs, Lutgarde; Asayama, Kei; Jacobs, Lotte; Wang, Ji-Guang; Staessen, Jan A.			Randomised Double-Blind Comparison of Placebo and Active Drugs for Effects on Risks Associated with Blood Pressure Variability in the Systolic Hypertension in Europe Trial	PLOS ONE			English	Article							TO-VISIT VARIABILITY; CARDIOVASCULAR EVENTS; PROGNOSTIC-SIGNIFICANCE; MORTALITY; STROKE	Background: In the Systolic Hypertension in Europe trial (NCT02088450), we investigated whether systolic blood pressure variability determines prognosis over and beyond level. Methods: Using a computerised random function and a double-blind design, we randomly allocated 4695 patients (>= 60 years) with isolated systolic hypertension (160-219/<95 mm Hg) to active treatment or matching placebo. Active treatment consisted of nitrendipine (10-40 mg/day) with possible addition of enalapril (5-20 mg/day) and/or hydrochlorothiazide (12.5-25.0 mg/day). We assessed whether on-treatment systolic blood pressure level (SBP), visit-to-visit variability independent of the mean (VIM) or within-visit variability (WVV) predicted total (n = 286) or cardiovascular (n = 150) mortality or cardiovascular (n = 347), cerebrovascular (n = 133) or cardiac (n = 217) endpoints. Findings: At 2 years, mean between-group differences were 10.5 mm Hg (p<0.0001) for SBP, 0.29 units (p = 0.20) for VIM, and 0.07 mm Hg (p = 0.47) for WVV. Active treatment reduced (p <= 0.048) cardiovascular (-28%), cerebrovascular (-40%) and cardiac (-24%) endpoints. In analyses dichotomised by the median, patients with low vs. high VIM had similar event rates (p >= 0.14). Low vs. high WVV was not associated with event rates (p >= 0.095), except for total and cardiovascular mortality on active treatment, which were higher with low WVV (p <= 0.0003). In multivariable-adjusted Cox models, SBP predicted all endpoints (p <= 0.0043), whereas VIM did not predict any (p >= 0.058). Except for an inverse association with total mortality (p = 0.042), WVV was not predictive (p >= 0.15). Sensitivity analyses, from which we excluded blood pressure readings within 6 months after randomisation, 6 months prior to an event or both were confirmatory. Conclusions: The double-blind placebo-controlled Syst-Eur trial demonstrated that blood-pressure lowering treatment reduces cardiovascular complications by decreasing level but not variability of SBP. Higher blood pressure level, but not higher variability, predicted risk.	[Hara, Azusa; Thijs, Lutgarde; Asayama, Kei; Jacobs, Lotte; Staessen, Jan A.] Univ Leuven, KU Leuven Dept Cardiovasc Dis, Res Unit Hypertens & Cardiovasc Epidemiol, Studies Coordinating Ctr, Leuven, Belgium; [Asayama, Kei] Teikyo Univ, Sch Med, Dept Hyg & Publ Hlth, Tokyo 173, Japan; [Wang, Ji-Guang] Shanghai Jiao Tong Univ, Sch Med, Ctr Epidemiol Studies & Clin Trials, Ruijin Hosp, Shanghai 200030, Peoples R China; [Staessen, Jan A.] Maastricht Univ, Dept Epidemiol, Maastricht, Netherlands	KU Leuven; Teikyo University; Shanghai Jiao Tong University; Maastricht University	Staessen, JA (corresponding author), Univ Leuven, KU Leuven Dept Cardiovasc Dis, Res Unit Hypertens & Cardiovasc Epidemiol, Studies Coordinating Ctr, Leuven, Belgium.	jan.staessen@med.kuleuven.be	Staessen, Jan A/A-1065-2011; Asayama, Kei/H-5598-2011; Wang, Ji Guang/AAP-4045-2021	Staessen, Jan A/0000-0002-3026-1637; Asayama, Kei/0000-0003-3365-0547; Wang, Ji Guang/0000-0001-8511-1524; Thijs, Lutgarde/0000-0002-8108-2356	Bayer AG, Wuppertal, Germany; European Union (European Research Council) [2011-294713-EPLORE]; Japanese Heart Foundation	Bayer AG, Wuppertal, Germany; European Union (European Research Council)(European Research Council (ERC)European Commission); Japanese Heart Foundation	Bayer AG, Wuppertal, Germany funded the Systolic Hypertension in Europe Trial (1989-1997). The European Union (HEALTH-2011.2.4.2-2-EU-MASCARA, HEALTH-F7-305507 HOMAGE and the European Research Council Advanced Researcher Grant-2011-294713-EPLORE) and the Fonds voor Wetenschappelijk Onderzoek Vlaanderen, Ministry of the Flemish Community, Brussels, Belgium (G.0881.13 and G.088013) currently support the Studies Coordinating Centre in Leuven. A Hara received the Bayer Yakuhin Research Grant Abroad Fellowship from the Japanese Heart Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	41st World Medical Assembly, 1990, B PAN AM HLTH ORG, V24, P606; Amery A, 1991, Aging (Milano), V3, P287; Brunelli SM, 2008, AM J KIDNEY DIS, V52, P716, DOI 10.1053/j.ajkd.2008.04.032; Dahlof B, 2005, LANCET, V366, P895, DOI 10.1016/S0140-6736(05)67185-1; Franklin SS, 2001, CIRCULATION, V103, P1245; Grove JS, 1997, AM J EPIDEMIOL, V145, P771, DOI 10.1093/oxfordjournals.aje.a009169; Hsieh YT, 2012, EUR J CLIN INVEST, V42, P245, DOI 10.1111/j.1365-2362.2011.02574.x; Kilpatrick ES, 2010, DIABETES CARE, V33, P2442, DOI 10.2337/dc10-1000; Mancia G, 2013, EUR HEART J, V34, P2159, DOI 10.1093/eurheartj/eht151; Mancia G, 2012, CIRCULATION, V126, P569, DOI 10.1161/CIRCULATIONAHA.112.107565; Mena L, 2005, J HYPERTENS, V23, P505, DOI 10.1097/01.hjh.0000160205.81652.5a; Muntner P, 2013, BLOOD PRESS MONIT, V18, P232, DOI 10.1097/MBP.0b013e3283624b24; Muntner P, 2011, HYPERTENSION, V57, P160, DOI 10.1161/HYPERTENSIONAHA.110.162255; Parati G, 2013, NAT REV CARDIOL, V10, P143, DOI 10.1038/nrcardio.2013.1; Rossignol P, 2012, HYPERTENSION, V60, P339, DOI 10.1161/HYPERTENSIONAHA.111.190397; Rothwell PM, 2010, LANCET, V375, P938, DOI 10.1016/S0140-6736(10)60309-1; Rothwell PM, 2010, LANCET NEUROL, V9, P469, DOI 10.1016/S1474-4422(10)70066-1; Rothwell PM, 2010, LANCET, V375, P895, DOI 10.1016/S0140-6736(10)60308-X; Shimbo D, 2012, HYPERTENSION, V60, P625, DOI 10.1161/HYPERTENSIONAHA.112.193094; STAESSEN J, 1989, BMJ-BRIT MED J, V298, P1552, DOI 10.1136/bmj.298.6687.1552; Staessen JA, 1999, HYPERTENSION, V33, P1476, DOI 10.1161/01.HYP.33.6.1476; Staessen JA, 1997, LANCET, V350, P757, DOI 10.1016/S0140-6736(97)05381-6; Tozawa M, 1999, NEPHROL DIAL TRANSPL, V14, P1976, DOI 10.1093/ndt/14.8.1976; Webb AJS, 2010, LANCET, V375, P906, DOI 10.1016/S0140-6736(10)60235-8; Webb AJS, 2011, STROKE, V42, P2860, DOI 10.1161/STROKEAHA.110.611566; Wingfield D, 2002, BLOOD PRESS MONIT, V7, P169, DOI 10.1097/00126097-200206000-00005	26	31	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103169	10.1371/journal.pone.0103169	http://dx.doi.org/10.1371/journal.pone.0103169			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25090617	gold, Green Submitted, Green Published			2022-12-27	WOS:000339812700020
J	Mahende, C; Ngasala, B; Lusingu, J; Butichi, A; Lushino, P; Lemnge, M; Premji, Z				Mahende, Coline; Ngasala, Billy; Lusingu, John; Butichi, Allvan; Lushino, Paminus; Lemnge, Martha; Premji, Zul			Aetiology of Acute Febrile Episodes in Children Attending Korogwe District Hospital in North-Eastern Tanzania	PLOS ONE			English	Article							URINARY-TRACT-INFECTION; SEVERE MALARIA; VIRAL ETIOLOGY; DIAGNOSIS; TRANSMISSION; BACTERIAL; ILLNESS; FEVER; PREVALENCE; MORTALITY	Introduction: Although the burden of malaria in many parts of Tanzania has declined, the proportion of children with fever has not changed. This situation underscores the need to explore the possible causes of febrile episodes in patients presenting with symptoms at the Korogwe District Hospital (KDH). Methods: A hospital based cross-sectional study was conducted at KDH, north-eastern Tanzania. Patients aged 2 to 59 months presenting at the outpatient department with an acute medical condition and fever (measured axillary temperature >= 37.5 degrees C) were enrolled. Blood samples were examined for malaria parasites, human immunodeficiency virus (HIV) and bacterial infections. A urine culture was performed in selected cases to test for bacterial infection and a chest radiograph was requested if pneumonia was suspected. Diagnosis was based on both clinical and laboratory investigations. Results: A total of 867 patients with a median age of 15.1 months (Interquartile range 8.6-29.9) were enrolled from January 2013 to October 2013. Respiratory tract infections were the leading clinical diagnosis with 406/867 (46.8%) of patients diagnosed with upper respiratory tract infection and 130/867 (15.0%) with pneumonia. Gastroenteritis was diagnosed in 184/867 (21.2%) of patients. Malaria infection was confirmed in 72/867 (8.3%) of patients. Bacterial infection in blood and urine accounted for 26/808 (3.2%) infections in the former, and 66/373 (17.7%) infections in the latter. HIV infection was confirmed in 10/824 (1.2%) of patients. Respiratory tract infections and gastroenteritis were frequent in patients under 36 months of age (87.3% and 91.3% respectively). Co-infections were seen in 221/867 (25.5%) of patients. The cause of fever was not identified in 65/867 (7.5%) of these patients. Conclusions: The different proportions of infections found among febrile children reflect the causes of fever in the study area. These findings indicate the need to optimise patient management by developing malaria and non-malaria febrile illnesses management protocols.	[Mahende, Coline; Lusingu, John; Butichi, Allvan; Lushino, Paminus; Lemnge, Martha] Natl Inst Med Res, Korogwe Res Lab, Tanga, Tanzania; [Mahende, Coline; Ngasala, Billy; Premji, Zul] Muhimbili Univ Hlth & Allied Sci, Sch Publ Hlth, Dept Med Entomol & Parasitol, Dar Es Salaam, Tanzania	Muhimbili University of Health & Allied Sciences	Mahende, C (corresponding author), Natl Inst Med Res, Korogwe Res Lab, Tanga, Tanzania.	cbdmahende@yahoo.co.uk	Lusingu, John P. A./GSJ-3228-2022	Lusingu, John P. A./0000-0002-9407-0602	Swedish International Development Cooperation Agency (SIDA) through Muhimbili University of Health and Allied Sciences	Swedish International Development Cooperation Agency (SIDA) through Muhimbili University of Health and Allied Sciences	The study was sponsored by Swedish International Development Cooperation Agency (SIDA) through Muhimbili University of Health and Allied Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemu A, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-18; Archibald LK, 2001, EMERG INFECT DIS, V7, P302, DOI 10.3201/eid0702.010232; Aregawi MW, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-46; Baltzell K, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-37; Biggs HM, 2014, CLIN INFECT DIS, V58, P638, DOI 10.1093/cid/cit798; Bonkoungou IJO, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-36; Choi Soo-Han, 2013, Korean J Pediatr, V56, P196, DOI 10.3345/kjp.2013.56.5.196; Crump JA, 2011, TROP MED INT HEALTH, V16, P830, DOI 10.1111/j.1365-3156.2011.02774.x; D'Acremont V, 2014, NEW ENGL J MED, V370, P809, DOI 10.1056/NEJMoa1214482; D'Acremont V, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-240; Feikin DR, 2013, PEDIATR INFECT DIS J, V32, pE14, DOI 10.1097/INF.0b013e31826fd39b; Gething PW, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000301; Gwer S, 2007, AM J TROP MED HYG, V77, P6, DOI 10.4269/ajtmh.2007.77.6; Hamilton JL, 2013, AM FAM PHYSICIAN, V87, P254; Hertz JT, 2013, TROP MED INT HEALTH, V18, P1406, DOI 10.1111/tmi.12191; Kwon JH, 2012, AM J CLIN PATHOL, V137, P778, DOI 10.1309/AJCP4KVGQZEG1YDM; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Mmbando BP, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-216; Montini G, 2011, NEW ENGL J MED, V365, P239, DOI 10.1056/NEJMra1007755; Moon AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089814; Moyo SJ, 2011, BMC PEDIATR, V11, DOI 10.1186/1471-2431-11-19; Msaki BP, 2012, ARCH PUBLIC HEALTH, V70, DOI 10.1186/0778-7367-70-4; Mtove G, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-320; Mubi M, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-293; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; Nadjm B, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1350; National Aids Control Programme Ministry of Health and Social Welfare Tanzania, 2012, GUID HIV TEST; National Bureau of Statistics Ministry of Finance Tanzania, 2013, 2012 POP HOUS CENS; Niang MN, 2010, J MED VIROL, V82, P866, DOI 10.1002/jmv.21665; Osei-Kwakye K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058107; PETIT PLC, 1995, J TROP MED HYG, V98, P217; Petti CA, 2006, CLIN INFECT DIS, V42, P377, DOI 10.1086/499363; Reyburn H, 2004, BMJ-BRIT MED J, V329, P1212, DOI 10.1136/bmj.38251.658229.55; Rutta ASM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-152; Schmiegelow C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053794; Sire JM, 2013, PAEDIATR INT CHILD H, V33, P139, DOI 10.1179/2046905512Y.0000000046; Strom GEA, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-228; The United Republic of Tanzania MoHaSW, 2007, STAND TREATM GUID ST, P6; Thriemer K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030350; Urdea Mickey, 2006, Nature, V444 Suppl 1, P73, DOI 10.1038/nature05448; Were T, 2011, J CLIN MICROBIOL, V49, P671, DOI 10.1128/JCM.01864-10; WHO, 2005, INT MAN CHILDH ILLN; WHO, 2010, GUID TREATM MAL, V2nd; Ye Y, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-160	44	32	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e104197	10.1371/journal.pone.0104197	http://dx.doi.org/10.1371/journal.pone.0104197			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25090651	Green Published, gold			2022-12-27	WOS:000339812700109
J	Gray, RT; Vallely, A; Wilson, DP; Kaldor, J; MacLaren, D; Kelly-Hanku, A; Siba, P; Murray, JM				Gray, Richard T.; Vallely, Andrew; Wilson, David P.; Kaldor, John; MacLaren, David; Kelly-Hanku, Angela; Siba, Peter; Murray, John M.		Male Circumcision Acceptability	Impact of Male Circumcision on the HIV Epidemic in Papua New Guinea: A Country with Extensive Foreskin Cutting Practices	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED-DISEASES; SUB-SAHARAN AFRICA; PREVENTION; PREVALENCE; ACCEPTABILITY; INTERVENTION; INFECTIONS; REDUCTION; UGANDA; TRIAL	The degree to which adult medical male circumcision (MC) programs can reduce new HIV infections in a moderate HIV prevalence country like Papua New Guinea (PNG) are uncertain especially given the widespread prevalence of longitudinal foreskin cuts among adult males. We estimated the likely impact of a medical MC intervention in PNG using a mathematical model of HIV transmission. The model was age-structured and incorporated separate components for sex, rural/urban, men who have sex with men and female sex workers. Country-specific data of the prevalence of foreskin cuts, sexually transmitted infections, condom usage, and the acceptability of MC were obtained by our group through related studies. If longitudinal foreskin cutting has a protective efficacy of 20% compared to 60% for MC, then providing MC to 20% of uncut males from 2012 would require 376,000 procedures, avert 7,900 HIV infections by 2032, and require 143 MC per averted infection. Targeting uncut urban youths would achieve the most cost effective returns of 54 MC per HIV infection averted. These numbers of MC required to avert an HIV infection change little even with coverage up to 80% of men. The greater the protective efficacy of longitudinal foreskin cuts against HIV acquisition, the less impact MC interventions will have. Dependent on this efficacy, increasing condom use could have a much greater impact with a 10 percentage point increase averting 18,400 infections over this same period. MC programs could be effective in reducing HIV infections in PNG, particularly in high prevalence populations. However the overall impact is highly dependent on the protective efficacy of existing longitudinal foreskin cutting in preventing HIV.	[Gray, Richard T.; Vallely, Andrew; Wilson, David P.; Kaldor, John] Univ New S Wales, Kirby Inst, Sydney, NSW, Australia; [Vallely, Andrew; Kelly-Hanku, Angela; Siba, Peter] Papua New Guinea Inst Med Res, Sexual & Reprod Hlth Unit, Goroka, Eastern Highlan, Papua N Guinea; [MacLaren, David] James Cook Univ, Sch Med & Dent, Cairns, Qld, Australia; [Kelly-Hanku, Angela] Univ New S Wales, Sch Publ Hlth & Community Med, Int HIV Res Grp, Sydney, NSW, Australia; [Murray, John M.] Univ New S Wales, Sch Math & Stat, Sydney, NSW, Australia	University of New South Wales Sydney; Kirby Institute; PNG Institute Of Medical Research; James Cook University; University of New South Wales Sydney; University of New South Wales Sydney	Murray, JM (corresponding author), Univ New S Wales, Sch Math & Stat, Sydney, NSW, Australia.	J.Murray@unsw.edu.au	Murray, John/B-5481-2009	Murray, John/0000-0001-9314-2283; Vallely, Andrew/0000-0003-1558-4822; Kelly-Hanku, Angela/0000-0003-0152-2954; Gray, Richard/0000-0002-2885-0483	Australian Agency for International Development (AusAID) [ADRA 44743]; National Health and Medical Research Council [630495]; Australian Government, Department of Health and Ageing	Australian Agency for International Development (AusAID)(Australian Aid (AusAID)); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Government, Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing)	The Male Circumcision Acceptability and Impact Study (MCAIS) was funded by an Australian Agency for International Development (AusAID) Australian Development Research Award (ADRA 44743). RTG and DPW received funding from a National Health and Medical Research Council Project Grant (630495). The Kirby Institute is funded by the Australian Government, Department of Health and Ageing. The views expressed in this publication do not necessarily represent the position of the Australian Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, UNGASS 2008 COUNTR P; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Auvert B, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001509; Brown JE, 2001, SEX TRANSM DIS, V28, P608, DOI 10.1097/00007435-200110000-00007; Buchanan-Aruwafu H, 2010, BEHAV SURVEILLANCE R; Gray RH, 2007, AIDS, V21, P845, DOI 10.1097/QAD.0b013e3280187544; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Gray RT, 2011, PNG HIV MODEL SUMMAR; Hankins C, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001127; Hill PS, 2012, AIDS CARE, V24, P77, DOI 10.1080/09540121.2011.592812; Hoare A, 2008, THEOR BIOL MED MODEL, V5, DOI 10.1186/1742-4682-5-4; Kelly A., 2011, ASKIM SAVE ASK UNDER; Kelly A, 2013, QUAL HEALTH RES, V23, P180, DOI 10.1177/1049732312467234; Kelly A, 2012, BMC INT HEALTH HUM R, V12, DOI 10.1186/1472-698X-12-10; Kelly A, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-67; Londish GJ, 2008, INT J EPIDEMIOL, V37, P1246, DOI 10.1093/ije/dyn038; MacLaren D, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-818; Maughan-Brown B, 2011, JAIDS-J ACQ IMM DEF, V58, P499, DOI 10.1097/QAI.0b013e31823584c1; Millan J, 2006, HIV AIDS BEHAV SURVE; Murray JM, 2010, SEX TRANSM INFECT, V86, P161, DOI 10.1136/sti.2009.040329; National AIDS Council PNG, 2008, 2007 EST REP HIV EP, P1; National Department of Health Papua New Guinea, 2009, 2008 STI HIV AIDS AN; Njeuhmeli E, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001132; Reed JB, 2012, JAIDS-J ACQ IMM DEF, V60, pS88, DOI 10.1097/QAI.0b013e31825cac4e; Rottingen JA, 2001, SEX TRANSM DIS, V28, P579; Tobian AAR, 2009, NEW ENGL J MED, V360, P1298, DOI 10.1056/NEJMoa0802556; Tynan A., 2013, HEALTH POLICY PLANN, V29, P902; UNAIDS, 2011, HIV AIDS EST UNAIDS; UNAIDS, 2012, GLOBAL REPORT UNAIDS; UNAIDS/ WHO/ SACEMA expert group on modelling the impact and cost of male circumcision for HIV prevention, 2009, PLOS MED, V6; Vallely A, 2011, PAPUA NEW GUINEA MED, V54, P91; Vallely A, 2014, SEX HEALTH, V11, P58, DOI 10.1071/SH13197; Vallely A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015586; Weiss HA, 2007, CURR OPIN INFECT DIS, V20, P66, DOI 10.1097/QCO.0b013e328011ab73; WHO/UNAIDS, 2000, CONS STD INT PREV HI, P1; Williams BG, 2006, PLOS MED, V3, P1032, DOI 10.1371/journal.pmed.0030262	36	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2014	9	8							e104531	10.1371/journal.pone.0104531	http://dx.doi.org/10.1371/journal.pone.0104531			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WB	25111058	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000341105100067
J	do Vale, S; Selinger, L; Martins, JM; Gomes, AC; Bicho, M; do Carmo, I; Escera, C				do Vale, Sonia; Selinger, Lenka; Martins, Joao Martin; Gomes, Ana Coelho; Bicho, Manuel; do Carmo, Isabel; Escera, Carles			The Relationship between Dehydroepiandrosterone (DHEA), Working Memory and Distraction - A Behavioral and Electrophysiological Approach	PLOS ONE			English	Article							ACUTE PSYCHOSOCIAL STRESS; POSTMENOPAUSAL WOMEN; PLASMA DEHYDROEPIANDROSTERONE; SERUM-LEVELS; NEUROENDOCRINE REACTIVITY; INVOLUNTARY ATTENTION; OBJECTIVE PERFORMANCE; DECLARATIVE MEMORY; SALIVARY CORTISOL; NONHUMAN-PRIMATES	Dehydroepiandrosterone (DHEA) and dehydroepiandrosterone-sulphate (DHEAS) have been reported to have memory enhancement effects in humans. A neuro-stimulatory action and an anti-cortisol mechanism of action may contribute to that relation. In order to study DHEA, DHEAS and cortisol relations to working memory and distraction, we recorded the electroencephalogram of 23 young women performing a discrimination (no working memory load) or 1-back (working memory load) task in an audio-visual oddball paradigm. We measured salivary DHEA, DHEAS and cortisol both before each task and at 30 and 60 min. Under working memory load, a higher baseline cortisol/DHEA ratio was related to higher distraction as indexed by an enhanced novelty P3. This suggests that cortisol may lead to increased distraction whereas DHEA may hinder distraction by leading to less processing of the distractor. An increased DHEA production with consecutive cognitive tasks was found and higher DHEA responses attributed to working memory load were related to enhanced working memory processing as indexed by an enhanced visual P300. Overall, the results suggest that in women DHEA may oppose cortisol effects reducing distraction and that a higher DHEA response may enhance working memory at the electrophysiological level.	[do Vale, Sonia; Selinger, Lenka; Escera, Carles] Univ Barcelona, Inst Brain Cognit & Behav IR3C, Barcelona, Catalonia, Spain; [do Vale, Sonia; Selinger, Lenka; Escera, Carles] Univ Barcelona, Psychiat & Clin Psychobiol Dept, Cognit Neurosci Res Grp, Barcelona, Catalonia, Spain; [do Vale, Sonia; Martins, Joao Martin] Univ Lisbon, Lisbon Med Sch, Endocrinol Univ Clin, P-1699 Lisbon, Portugal; [do Vale, Sonia; Martins, Joao Martin; Gomes, Ana Coelho; do Carmo, Isabel] Santa Maria Univ Hosp, Dept Diabet Endocrinol & Metab, Lisbon, Portugal; [do Vale, Sonia; Martins, Joao Martin; Bicho, Manuel] Univ Lisbon, Lisbon Med Sch, Genet Lab, Metab & Endocrinol Ctr, P-1699 Lisbon, Portugal	University of Barcelona; University of Barcelona; Universidade de Lisboa; Universidade de Lisboa; Hospital Santa Maria; Universidade de Lisboa	do Vale, S (corresponding author), Univ Barcelona, Inst Brain Cognit & Behav IR3C, Barcelona, Catalonia, Spain.	soniavale@net.sapo.pt	2010, BRAINGLOT Consolider Ingenio/D-1235-2009; Escera, Carles/A-8658-2010; do Vale, Sónia/H-9663-2019	Escera, Carles/0000-0001-8203-2951; do Vale, Sónia/0000-0001-9287-4095; Bicho, Manuel/0000-0002-5773-5687	Spanish Ministry of Economy and Knowledge [CDS2007-00012]; Catalan Government [SGR2009-11]; ICREA Academia Distinguished Professorship; Portuguese Calouste Gulbenkian Foundation [116503]	Spanish Ministry of Economy and Knowledge(Spanish Government); Catalan Government; ICREA Academia Distinguished Professorship(ICREA); Portuguese Calouste Gulbenkian Foundation	This work was supported by the Spanish Ministry of Economy and Knowledge (CDS2007-00012), Catalan Government (SGR2009-11, http://www.gencat.cat/economia/ur/ambits/recerca/sistema_catala/index_en.html) and ICREA Academia Distinguished Professorship to Carles Escera (http://www.icrea.cat/web/home.aspx). Also, partial support was received from the Portuguese Calouste Gulbenkian Foundation (116503, 2011, http://www.gulbenkian.pt). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott DH, 2009, REV ENDOCR METAB DIS, V10, P33, DOI 10.1007/s11154-008-9099-8; Ahn RS, 2007, YONSEI MED J, V48, P379, DOI 10.3349/ymj.2007.48.3.379; Alhaj HA, 2006, PSYCHOPHARMACOLOGY, V188, P541, DOI 10.1007/s00213-005-0136-y; BARRETTCONNOR E, 1994, J AM GERIATR SOC, V42, P420, DOI 10.1111/j.1532-5415.1994.tb07491.x; Baulieu EE, 1998, P NATL ACAD SCI USA, V95, P4089, DOI 10.1073/pnas.95.8.4089; BELANGER B, 1989, J STEROID BIOCHEM, V32, P695, DOI 10.1016/0022-4731(89)90514-1; Berr C, 1996, P NATL ACAD SCI USA, V93, P13410, DOI 10.1073/pnas.93.23.13410; BERTAGNA X, 1994, J CLIN ENDOCR METAB, V79, P390, DOI 10.1210/jc.79.2.390; Brzoza Z, 2008, PSYCHOSOM MED, V70, P723, DOI 10.1097/PSY.0b013e31817bcc8d; Campeau S, 2011, STRESS, V14, P503, DOI 10.3109/10253890.2011.596864; COSTE J, 1994, BRIT J CLIN PHARMACO, V38, P474, DOI 10.1111/j.1365-2125.1994.tb04386.x; Davis SR, 2011, J CLIN ENDOCR METAB, V96, P1642, DOI 10.1210/jc.2010-2888; de Kloet ER, 2008, FRONT NEUROENDOCRIN, V29, P268, DOI 10.1016/j.yfrne.2007.10.002; do Vale S, 2011, NEUROENDOCRINOL LETT, V32, P442; Dong Y, 2012, J NEUROENDOCRINOL, V24, P215, DOI 10.1111/j.1365-2826.2011.02256.x; Engler-Chiurazzi E, 2011, NEUROBIOL AGING, V32, P680, DOI 10.1016/j.neurobiolaging.2009.09.005; Escera C, 2000, AUDIOL NEURO-OTOL, V5, P151, DOI 10.1159/000013877; Escera C, 2003, EUR J NEUROSCI, V18, P2408, DOI 10.1046/j.1460-9568.2003.02937.x; Escera C, 1998, J COGNITIVE NEUROSCI, V10, P590, DOI 10.1162/089892998562997; Escera C, 2007, J PSYCHOPHYSIOL, V21, P251, DOI 10.1027/0269-8803.21.34.251; Evans JG, 2006, COCHRANE DB SYST REV, V18; Friedman D, 2001, NEUROSCI BIOBEHAV R, V25, P355, DOI 10.1016/S0149-7634(01)00019-7; Gadinger MC, 2011, PSYCHOSOM MED, V73, P44, DOI 10.1097/PSY.0b013e3181fc6fe8; Gasbarri A, 2008, REV NEUROSCIENCE, V19, P129; Gibbs TT, 2006, PHARMACOL BIOCHEM BE, V84, P555, DOI 10.1016/j.pbb.2006.07.031; Goh C, 2010, PSYCHIAT DANUB, V22, P198; Gold PW, 2002, MOL PSYCHIATR, V7, P254, DOI 10.1038/sj.mp.4001032; Groeneweg FL, 2011, J ENDOCRINOL, V209, P153, DOI 10.1530/JOE-10-0472; Gruenewald DA, 2003, J AM GERIATR SOC, V51, P101, DOI 10.1034/j.1601-5215.2002.51018.x; Gruenewald TL, 2006, P NATL ACAD SCI USA, V103, P14158, DOI 10.1073/pnas.0606215103; HAUFFA BP, 1984, LANCET, V1, P1373; Herbert J, 1997, BRIT MED J, V315, P530, DOI 10.1136/bmj.315.7107.530; Hirshman E, 2004, HORM BEHAV, V45, P144, DOI 10.1016/j.yhbeh.2003.09.008; Hirshman E, 2003, PSYCHON B REV, V10, P125, DOI 10.3758/BF03196476; Imamura M, 1998, BIOCHEM BIOPH RES CO, V243, P771, DOI 10.1006/bbrc.1998.8177; Izawa S, 2012, PSYCHONEUROENDOCRINO, V37, P852, DOI 10.1016/j.psyneuen.2011.10.001; Kimonides VG, 1998, P NATL ACAD SCI USA, V95, P1852, DOI 10.1073/pnas.95.4.1852; Kirschbaum C, 1996, LIFE SCI, V58, P1475, DOI 10.1016/0024-3205(96)00118-X; Kok A, 2001, PSYCHOPHYSIOLOGY, V38, P557, DOI 10.1017/S0048577201990559; Komesaroff PA, 2008, ENDOCRINOLOGY, V149, P886, DOI 10.1210/en.2007-1787; Kremen WS, 2012, J GERONTOL A-BIOL, V67, P760, DOI 10.1093/gerona/gls125; Labrie F, 1997, J CLIN ENDOCR METAB, V82, P2403, DOI 10.1210/jc.82.8.2403; Labrie F, 2010, PROG BRAIN RES, V182, P97, DOI 10.1016/S0079-6123(10)82004-7; Lennartsson AK, 2013, PSYCHONEUROENDOCRINO, V38, P1650, DOI 10.1016/j.psyneuen.2013.01.010; Lennartsson AK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072460; Lennartsson AK, 2012, BIOL PSYCHOL, V90, P143, DOI 10.1016/j.biopsycho.2012.03.003; Lupien SJ, 1997, BRAIN RES REV, V24, P1, DOI 10.1016/S0165-0173(97)00004-0; Lupien SJ, 2005, PSYCHONEUROENDOCRINO, V30, P225, DOI 10.1016/j.psyneuen.2004.08.003; Maninger N, 2010, PSYCHONEUROENDOCRINO, V35, P1055, DOI 10.1016/j.psyneuen.2010.01.006; Maninger N, 2009, FRONT NEUROENDOCRIN, V30, P65, DOI 10.1016/j.yfrne.2008.11.002; Maras PM, 2012, TRENDS NEUROSCI, V35, P315, DOI 10.1016/j.tins.2012.01.005; Martins JM, 2004, PHYSIOL BEHAV, V82, P741, DOI 10.1016/j.physbeh.2004.06.015; Martins JM, 2002, BRAIN BEHAV IMMUN, V16, P383, DOI 10.1006/brbi.2001.0636; Martins JM, 2001, INT J OBESITY, V25, P24, DOI 10.1038/sj.ijo.0801500; McEwen BS, 2012, P NATL ACAD SCI USA, V109, P17180, DOI 10.1073/pnas.1121254109; Merritt P, 2012, BRAIN RES, V1483, P54, DOI 10.1016/j.brainres.2012.09.015; Monk CS, 2002, NEUROPSYCHOPHARMACOL, V26, P505, DOI 10.1016/S0893-133X(01)00384-0; Morgan CA, 2004, ARCH GEN PSYCHIAT, V61, P819, DOI 10.1001/archpsyc.61.8.819; Morgan CA, 2009, BIOL PSYCHIAT, V66, P334, DOI 10.1016/j.biopsych.2009.04.004; Jeckel CMM, 2010, NEUROIMMUNOMODULAT, V17, P9, DOI 10.1159/000243080; Morley JE, 2003, CLIN GERIATR MED, V19, P605, DOI 10.1016/S0749-0690(02)00106-4; NIESCHLAG E, 1973, J ENDOCRINOL, V57, P123, DOI 10.1677/joe.0.0570123; OHASHI M, 1986, GERONTOLOGY, V32, P43, DOI 10.1159/000212764; Park-Chung M, 1999, BRAIN RES, V830, P72, DOI 10.1016/S0006-8993(99)01381-5; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; ROSENFELD RS, 1975, J CLIN ENDOCR METAB, V40, P850, DOI 10.1210/jcem-40-5-850; Russo SJ, 2012, NAT NEUROSCI, V15, P1475, DOI 10.1038/nn.3234; SanMiguel I, 2008, J COGNITIVE NEUROSCI, V20, P1131, DOI 10.1162/jocn.2008.20078; Schroger E, 1998, NEUROREPORT, V9, P3355, DOI 10.1097/00001756-199810260-00003; Singh A, 1999, J CLIN ENDOCR METAB, V84, P1944, DOI 10.1210/jc.84.6.1944; SKLAR CA, 1980, J CLIN ENDOCR METAB, V51, P548, DOI 10.1210/jcem-51-3-548; Smith R, 1998, J CLIN ENDOCR METAB, V83, P2916, DOI 10.1210/jc.83.8.2916; Sorwell KG, 2010, AGE, V32, P61, DOI 10.1007/s11357-009-9113-4; Spielberger C., 1988, MANUAL STATE TRAIT A; Stangl B, 2011, BEHAV NEUROSCI, V125, P742, DOI 10.1037/a0025151; VINING RF, 1987, J STEROID BIOCHEM, V27, P81, DOI 10.1016/0022-4731(87)90297-4; Weill-Engerer S, 2002, J CLIN ENDOCR METAB, V87, P5138, DOI 10.1210/jc.2002-020878; Wemm S, 2010, BIOL PSYCHOL, V85, P53, DOI 10.1016/j.biopsycho.2010.05.003; Wolf OT, 1998, J GERONTOL A-BIOL, V53, pM385, DOI 10.1093/gerona/53A.5.M385; Wolf OT, 1998, PSYCHONEUROENDOCRINO, V23, P617; Yuen EY, 2012, NEURON, V73, P962, DOI 10.1016/j.neuron.2011.12.033; Yuen EY, 2009, P NATL ACAD SCI USA, V106, P14075, DOI 10.1073/pnas.0906791106	82	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2014	9	8							e104869	10.1371/journal.pone.0104869	http://dx.doi.org/10.1371/journal.pone.0104869			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR0CG	25105970	Green Published, gold, Green Submitted			2022-12-27	WOS:000343231900088
J	Tian, YH; Shen, LJ; Wu, J; Chen, WH; Yuan, J; Yang, HD; Wang, YJ; Liang, Y; Wu, TC				Tian, Yaohua; Shen, Lijun; Wu, Jing; Chen, Weihong; Yuan, Jing; Yang, Handong; Wang, Youjie; Liang, Yuan; Wu, Tangchun			Parity and the Risk of Diabetes Mellitus among Chinese Women: A Cross-Sectional Evidence from the Tongji-Dongfeng Cohort Study	PLOS ONE			English	Article							INSULIN-RESISTANCE; GLUCOSE-TOLERANCE; YOUNG-ADULTS; WEIGHT-GAIN; LIFE-STYLE; PREGNANCY; PREVALENCE; HEALTH; CHILDBEARING; ASSOCIATION	Objectives: Little is known about the long-term health impact of pregnancy on women. The objective of this study was to examine the association between parity and the risk of diabetes among a population of Chinese women. Study design: A total of 14,196 women (aged >= 45 years) from the Dongfeng-Tongji Cohort study who had experienced at least one live birth completed baseline questionnaires, medical examinations, and provided baseline blood samples. Participants were categorized into four groups according to parity (one, two, three, or four or more live births). Logistic regression models were used to investigate the association between parity and the risk of diabetes after controlling potential confounders. Results: The prevalence of diabetes in the study population was 18.0% (2,552/14,196). Fasting plasma glucose levels increased with the increasing number of live births (P<0.001) and parity had a positive graded association with diabetes without adjustment for any covariates (P for trend <0.001). After adjusting for potential confounders, women who had had two, three, and four or more live births had 1.35 times (95% CI, 1.20-1.52), 1.59 times (95% CI, 1.39-1.82) and 1.44 times (95% CI, 1.21-1.71), respectively, higher risk of diabetes compared with women who had had one live birth. Conclusion: Multiparity was associated with increasing risk of diabetes in this population of Chinese women. These findings suggested that multiparity may be a risk factor for the development of diabetes among Chinese women. Future studies are needed to examine the physiological changes during pregnancy for risk of diabetes in later life.	[Tian, Yaohua; Shen, Lijun; Wu, Jing; Chen, Weihong; Yuan, Jing; Wang, Youjie; Liang, Yuan; Wu, Tangchun] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, MOE Key Lab Environm & Hlth, Wuhan 430074, Peoples R China; [Shen, Lijun; Wu, Jing; Wang, Youjie] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Maternal & Child Hlth, Wuhan 430074, Peoples R China; [Yang, Handong] Dongfeng Motor Corp, Dongfeng Gen Hosp, Wuhan, Hubei, Peoples R China; [Yang, Handong] Hubei Univ Med, Wuhan, Hubei, Peoples R China; [Liang, Yuan] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Social Med, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Dongfeng Motor; Hubei University of Medicine; Huazhong University of Science & Technology	Wang, YJ (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, MOE Key Lab Environm & Hlth, Wuhan 430074, Peoples R China.	wangyoujie@mails.tjmu.edu.cn; liangyuan217@163.com	Chen, Weihong/D-2177-2011	Chen, Weihong/0000-0001-8689-7311	National Natural Science Foundation of China [81273083]; Fundamental Research Funds for the Central Universities [2012TS071]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This research was supported by National Natural Science Foundation of China, Project No. 81273083 and Fundamental Research Funds for the Central Universities (2012TS071). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Mamun A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075679; Araneta MRG, 2010, DIABETES CARE, V33, P385, DOI 10.2337/dc09-1477; BERNSTEIN L, 1985, J NATL CANCER I, V74, P741; Bonner-Weir S, 2000, ENDOCRINOLOGY, V141, P1926, DOI 10.1210/en.141.6.1926; BOYKO EJ, 1990, DIABETES CARE, V13, P848, DOI 10.2337/diacare.13.8.848; Chinese Diabetes Society, 2014, CHIN GUID TYP 2 DIAB; COLE P, 1976, LANCET, V2, P596; Dahlgren Jovanna, 2006, Metabolic Syndrome and Related Disorders, V4, P149, DOI 10.1089/met.2006.4.149; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Fowler-Brown AG, 2010, DIABETES CARE, V33, P1778, DOI 10.2337/dc10-0015; Fu C, 2013, STAT RES, V30, P68; Gunderson EP, 2004, INT J OBESITY, V28, P525, DOI 10.1038/sj.ijo.0802551; Gunderson EP, 2007, DIABETES, V56, P2990, DOI 10.2337/db07-1024; Hanley AJG, 2002, DIABETES CARE, V25, P690, DOI 10.2337/diacare.25.4.690; Hayashino Y, 2008, DIABETES CARE, V31, P732, DOI 10.2337/dc07-1905; Holroyd E, 1997, Health Care Women Int, V18, P301; Hu FB, 2001, NEW ENGL J MED, V345, P790, DOI 10.1056/NEJMoa010492; Jandeleit-Dahm K, 2002, CURR OPIN NEPHROL HY, V11, P221, DOI 10.1097/00041552-200203000-00014; Kirwan JP, 2002, DIABETES, V51, P2207, DOI 10.2337/diabetes.51.7.2207; Krane NK, 2007, AM J KIDNEY DIS, V49, P336, DOI 10.1053/j.ajkd.2006.10.029; KRITZSILVERSTEIN D, 1989, NEW ENGL J MED, V321, P1214, DOI 10.1056/NEJM198911023211802; KVALE G, 1994, INT J EPIDEMIOL, V23, P691, DOI 10.1093/ije/23.4.691; Lawlor DA, 2003, CIRCULATION, V107, P1260, DOI 10.1161/01.CIR.0000053441.43495.1A; Linne Y, 2002, Obes Rev, V3, P75, DOI 10.1046/j.1467-789X.2002.00061.x; Liu B, 2010, DIABETES CARE, V33, P1239, DOI 10.2337/dc10-0347; Liu JH, 2005, J BIOSOC SCI, V37, P55, DOI 10.1017/S0021932003006461; Lunt H, 1996, DIABETIC MED, V13, P1009, DOI 10.1002/(SICI)1096-9136(199612)13:12<1009::AID-DIA281>3.0.CO;2-U; Mamun AA, 2010, AM J CLIN NUTR, V91, P1336, DOI 10.3945/ajcn.2009.28950; MANSON JE, 1992, AM J MED, V93, P13, DOI 10.1016/0002-9343(92)90674-Z; McDonald SD, 2008, DIABETES CARE, V31, P1635, DOI 10.2337/dc08-0621; Mueller NT, 2013, BJOG-INT J OBSTET GY, V120, P1483, DOI 10.1111/1471-0528.12364; Narayan KMV, 2003, JAMA-J AM MED ASSOC, V290, P1884, DOI 10.1001/jama.290.14.1884; Nicholson WK, 2006, DIABETES CARE, V29, P2349, DOI 10.2337/dc06-0825; PATHAK DR, 1986, INT J CANCER, V37, P21, DOI 10.1002/ijc.2910370105; Ramachandran A, 2010, LANCET, V375, P408, DOI 10.1016/S0140-6736(09)60937-5; Rieck S, 2010, TRENDS ENDOCRIN MET, V21, P151, DOI 10.1016/j.tem.2009.11.001; RYAN EA, 1988, J CLIN ENDOCR METAB, V67, P341, DOI 10.1210/jcem-67-2-341; Wang F, 2013, INT J EPIDEMIOL, V42, P731, DOI 10.1093/ije/dys053; Wang Wen-peng, 2013, Zhonghua Fu Chan Ke Za Zhi, V48, P321; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Wilder RL, 1998, ANN NY ACAD SCI, V840, P45, DOI 10.1111/j.1749-6632.1998.tb09547.x; Wong W, 2000, J AM DIET ASSOC, V100, P791, DOI 10.1016/S0002-8223(00)00230-3; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690; Zocchetti C, 1997, INT J EPIDEMIOL, V26, P220, DOI 10.1093/ije/26.1.220	45	16	17	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2014	9	8							e104810	10.1371/journal.pone.0104810	http://dx.doi.org/10.1371/journal.pone.0104810			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR0CG	25105792	Green Submitted, Green Published, gold			2022-12-27	WOS:000343231900086
J	Kehoe, MA; Coutts, BA; Buirchell, BJ; Jones, RAC				Kehoe, Monica A.; Coutts, Brenda A.; Buirchell, Bevan J.; Jones, Roger A. C.			Plant Virology and Next Generation Sequencing: Experiences with a Potyvirus	PLOS ONE			English	Article							YELLOW-MOSAIC-VIRUS; NON-NECROTIC STRAINS; RESISTANCE; WILD; RNA	Next generation sequencing is quickly emerging as the go-to tool for plant virologists when sequencing whole virus genomes, and undertaking plant metagenomic studies for new virus discoveries. This study aims to compare the genomic and biological properties of Bean yellow mosaic virus (BYMV) (genus Potyvirus), isolates from Lupinus angustifolius plants with black pod syndrome (BPS), systemic necrosis or non-necrotic symptoms, and from two other plant species. When one Clover yellow vein virus (ClYVV) (genus Potyvirus) and 22 BYMV isolates were sequenced on the Illumina HiSeq2000, one new ClYVV and 23 new BYMV sequences were obtained. When the 23 new BYMV genomes were compared with 17 other BYMV genomes available on Genbank, phylogenetic analysis provided strong support for existence of nine phylogenetic groupings. Biological studies involving seven isolates of BYMV and one of ClYVV gave no symptoms or reactions that could be used to distinguish BYMV isolates from L. angustifolius plants with black pod syndrome from other isolates. Here, we propose that the current system of nomenclature based on biological properties be replaced by numbered groups (I-IX). This is because use of whole genomes revealed that the previous phylogenetic grouping system based on partial sequences of virus genomes and original isolation hosts was unsustainable. This study also demonstrated that, where next generation sequencing is used to obtain complete plant virus genomes, consideration needs to be given to issues regarding sample preparation, adequate levels of coverage across a genome and methods of assembly. It also provided important lessons that will be helpful to other plant virologists using next generation sequencing in the future.	[Kehoe, Monica A.; Coutts, Brenda A.; Buirchell, Bevan J.; Jones, Roger A. C.] Univ Western Australia, Fac Sci, Sch Plant Biol, Crawley, WA, Australia; [Kehoe, Monica A.; Coutts, Brenda A.; Buirchell, Bevan J.; Jones, Roger A. C.] Univ Western Australia, Fac Sci, Inst Agr, Crawley, WA, Australia; [Kehoe, Monica A.; Coutts, Brenda A.; Buirchell, Bevan J.; Jones, Roger A. C.] Dept Agr & Food Western Australia, Crop Protect Branch, Perth, WA, Australia; [Kehoe, Monica A.; Coutts, Brenda A.; Buirchell, Bevan J.; Jones, Roger A. C.] Dept Agr & Food Western Australia, Lupin Breeding Branch, Perth, WA, Australia	University of Western Australia; University of Western Australia	Kehoe, MA (corresponding author), Univ Western Australia, Fac Sci, Sch Plant Biol, Crawley, WA, Australia.	monica.kehoe@agric.wa.gov.au	Jones, Roger A.C./B-1200-2011	Jones, Roger A.C./0000-0003-3593-3102; Buirchell, Bevan/0000-0001-8247-3570	Australian Postgraduate Award (APA); Australian Grains Research and Development Corporation (GRDC) Studentship [GRS10039]	Australian Postgraduate Award (APA)(Australian Government); Australian Grains Research and Development Corporation (GRDC) Studentship(Grains R&D Corp)	This research was funded by an Australian Postgraduate Award (APA), and an Australian Grains Research and Development Corporation (GRDC) Studentship, Project number GRS10039. It was undertaken using the facilities at the Department of Agriculture and Food, Western Australia. This study forms part of a PhD project by the first author at the University of Western Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams IP, 2009, MOL PLANT PATHOL, V10, P537, DOI [10.1111/J.1364-3703.2009.00545.X, 10.1111/j.1364-3703.2009.00545.x]; Adams MJ, 2005, ARCH VIROL, V150, P459, DOI 10.1007/s00705-004-0440-6; Al Rwahnih M, 2011, ARCH VIROL, V156, P397, DOI 10.1007/s00705-010-0869-8; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Berlandier FA, 1997, ANN APPL BIOL, V131, P297, DOI 10.1111/j.1744-7348.1997.tb05158.x; Boonham N, 2014, VIRUS RES, V186, P20, DOI 10.1016/j.virusres.2013.12.007; Bos L, 1973, CMI AAB DESCRIPTIONS, P111; Buirchell B. J., 2008, Lupins for health and wealth. Proceedings of the 12th International Lupin Conference, Fremantle, Western Australia, 14-18 September 2008, P226; Cheng Y, 2000, ANN APPL BIOL, V136, P215, DOI 10.1111/j.1744-7348.2000.tb00028.x; Cheng Y, 1999, AUST J AGR RES, V50, P589, DOI 10.1071/A98116; CLARK MF, 1977, J GEN VIROL, V34, P475, DOI 10.1099/0022-1317-34-3-475; Edwardson JR, 1991, CRC HDB VIRUSES INFE, P137; Hollings M, 1974, CLOVER YELLOW VEIN V; Jones RAC, 2014, VIRUS RES, V186, P3, DOI 10.1016/j.virusres.2013.11.003; Jones R. A. C., 2001, Integrated Pest Management Reviews, V6, P15, DOI 10.1023/A:1020494604184; Jones RAC, 2005, ANN APPL BIOL, V146, P539, DOI 10.1111/j.1744-7348.2005.040148.x; Jones RAC, 2003, AUST J AGR RES, V54, P849, DOI 10.1071/AR03087; JONES RAC, 1989, ANN APPL BIOL, V114, P609, DOI 10.1111/j.1744-7348.1989.tb03376.x; Kehoe MA, 2014, PLANT DIS, V98, P739, DOI [10.1094/PDIS-11-13-1144-RE, 10.1094/PDIS-11-13-1144-]; Kehoe MA, 2014, VIRUS RES, V184, P87, DOI 10.1016/j.virusres.2014.02.012; Koboldt DC, 2013, CELL, V155, P27, DOI 10.1016/j.cell.2013.09.006; MacDiarmid R, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003337; Mardis ER, 2013, ANNU REV ANAL CHEM, V6, P287, DOI 10.1146/annurev-anchem-062012-092628; PROVVIDENTI R, 1987, J HERED, V78, P126, DOI 10.1093/oxfordjournals.jhered.a110334; Roossinck MJ, 2012, ANNU REV GENET, V46, P359, DOI 10.1146/annurev-genet-110711-155600; SCHROEDE.WT, 1971, PHYTOPATHOLOGY, V61, P846, DOI 10.1094/Phyto-61-846; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Torrance L, 1986, DEV APPL BIOL, V1, P103; UYEDA I, 1991, INTERVIROLOGY, V32, P234, DOI 10.1159/000150205; Wetterstrand KA, 2014, DNA SEQUENCING COSTS; Wylie SJ, 2008, PLANT DIS, V92, P1596, DOI 10.1094/PDIS-92-12-1596; Wylie SJ, 2014, ARCH VIROL, V159, P1521, DOI 10.1007/s00705-013-1969-z; Wylie SJ, 2012, ARCH VIROL, V157, P271, DOI 10.1007/s00705-011-1166-x	33	58	61	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e104580	10.1371/journal.pone.0104580	http://dx.doi.org/10.1371/journal.pone.0104580			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25102175	Green Published, gold, Green Submitted			2022-12-27	WOS:000339993900076
J	Shier, MK; El-Wetidy, MS; Ali, HH; Al-Qattan, MM				Shier, Medhat K.; El-Wetidy, Mohammad S.; Ali, Hebatallah H.; Al-Qattan, Mohammad M.			Characterization of Hepatitis C Virus Genotypes by Direct Sequencing of HCV 5 ' UTR Region of Isolates from Saudi Arabia	PLOS ONE			English	Article							MAJOR GENETIC GROUPS; PLUS RIBAVIRIN; WEST-AFRICA; INFECTION; VARIANTS; INTERFERON; DIVERSITY; THERAPY; CHINA; RECOMBINANTS	The current study was designed to determine the Hepatitis C Virus (HCV) genotypes in a representative sample of HCV chronically infected patients in Saudi Arabia. All HCV isolates were genotyped by sequencing of the 5'UTR region and newly identified HCV isolates were identified. Specific universal primers targeting 5'UTR region were used for both amplification and sequencing of all isolates that resulted in 244 bp fragment which represent about 80% of 5'UTR region. Most of HCV isolates in this study were genotype 4 (76.4%) where only few isolates were recognized as genotype 1 (19.6%). All results were compared to HCV reference sequences from LOS ALAMOS HCV database, considering only the complete full genomes for the main phylogenetic analysis. Sequences that showed maximum identity (98% - 100%) were selected. Most isolates were identical with HCV genotype 4 references. Some isolates were similar to different subtypes of HCV genotypes 4, 1 and 6. Phylogenetic analysis showed resemblance of most isolates to similar ones from the Far East, North America and Egypt. Using sequence Weblogo, Alignment analysis of isolated HCV genotypes 4 and 1 showed 92% and 95.5% nucleotide conservation, respectively. There was no predominant nucleotide in the varied sites, in both genotypes. All isolated sequences were submitted to GenBank database.	[Shier, Medhat K.; El-Wetidy, Mohammad S.; Ali, Hebatallah H.; Al-Qattan, Mohammad M.] King Saud Univ, Coll Med, Res Ctr, Riyadh 11461, Saudi Arabia; [Al-Qattan, Mohammad M.] King Saud Univ, Coll Med, Dept Surg, Riyadh 11461, Saudi Arabia	King Saud University; King Saud University	Shier, MK (corresponding author), King Saud Univ, Coll Med, Res Ctr, Riyadh 11461, Saudi Arabia.	mshier2010@gmail.com	El-Wetidy, mohammad/O-2210-2015	El-Wetidy, Mohammad/0000-0003-2725-4708	College of Medicine Research center, Deanship of Scientific Research, King Saud University, Riyadh, Saudi Arabia	College of Medicine Research center, Deanship of Scientific Research, King Saud University, Riyadh, Saudi Arabia(King Saud University)	This project was funded by the College of Medicine Research center, Deanship of Scientific Research, King Saud University, Riyadh, Saudi Arabia, MKS MMA. All work was done in the labs of College of Medicine Research Center, MSE HHA. All materials, chemicals and required instruments were supplied by College of Medicine Research Center, MKS HHA MSE MMA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Moneim AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029781; Abdo AA, 2004, J GASTROEN HEPATOL, V19, P1233, DOI 10.1111/j.1440-1746.2003.03325.x; Akbar Hisham Osman, 2004, Saudi J Gastroenterol, V10, P127; Antonishyn NA, 2005, J CLIN MICROBIOL, V43, P5158, DOI 10.1128/JCM.43.10.5158-5163.2005; Bhattacharya D, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-458; Candotti D, 2003, J VIROL, V77, P7914, DOI 10.1128/JVI.77.14.7914-7923.2003; Chakravarti A, 2011, INDIAN J MED RES, V133, P326; Colina R, 2004, J GEN VIROL, V85, P31, DOI 10.1099/vir.0.19472-0; de Bruijne J, 2009, J CLIN MICROBIOL, V47, P3832, DOI 10.1128/JCM.01146-09; Di Lello FA, 2013, J MED VIROL, V85, P1734, DOI 10.1002/jmv.23657; Fakeeh M, 1999, AM J TROP MED HYG, V61, P889, DOI 10.4269/ajtmh.1999.61.889; FRETZ C, 1995, J MED VIROL, V47, P435, DOI 10.1002/jmv.1890470423; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Gededzha MP, 2012, J MED VIROL, V84, P601, DOI 10.1002/jmv.23215; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Hoofnagle JH, 2002, HEPATOLOGY, V36, pS21, DOI 10.1053/jhep.2002.36227; Jeannel D, 1998, J MED VIROL, V55, P92, DOI 10.1002/(SICI)1096-9071(199806)55:2&lt;92::AID-JMV2&gt;3.0.CO;2-I; Kalinina O, 2002, J VIROL, V76, P4034, DOI 10.1128/JVI.76.8.4034-4043.2002; Kaplan DE, 2005, HEPATOLOGY, V41, P1365, DOI 10.1002/hep.20706; Koshy A, 2002, J CLIN GASTROENTEROL, V35, P82, DOI 10.1097/00004836-200207000-00017; Laperche S, 2005, J CLIN MICROBIOL, V43, P733, DOI 10.1128/JCM.43.2.733-739.2005; Legrand-Abravanel F, 2004, J INFECT DIS, V189, P1397, DOI 10.1086/382544; Legrand-Abravanel F, 2007, J VIROL, V81, P4357, DOI 10.1128/JVI.02639-06; Lemon SM, 2007, FIELDS VIROLOGY, V1, P1253; Lole KS, 2003, J CLIN MICROBIOL, V41, P5240, DOI 10.1128/JCM.41.11.5240-5244.2003; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Moreau I, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-95; Nakano T, 2006, J GEN VIROL, V87, P73, DOI 10.1099/vir.0.81360-0; Pawlotsky JM, 2003, CURR OPIN INFECT DIS, V16, P587, DOI 10.1097/00001432-200312000-00012; Pawlotsky JM, 2003, ANTIVIR RES, V59, P1, DOI 10.1016/S0166-3542(03)00088-3; Pineda JA, 2007, HEPATOLOGY, V46, P622, DOI 10.1002/hep.21757; RICE CM, 1996, FIELDS VIROLOGY, P931; Ruggieri A, 1996, J GEN VIROL, V77, P2073, DOI 10.1099/0022-1317-77-9-2073; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Shobokshi OA, 2003, SAUDI MED J, V24, pS87; Simmonds P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/hep.20819; Simmonds P, 2004, J GEN VIROL, V85, P3173, DOI 10.1099/vir.0.80401-0; Smyk-Pearson S, 2006, J INFECT DIS, V194, P454, DOI 10.1086/505714; Sy Theodore, 2006, Int J Med Sci, V3, P41; Tokita H, 1996, J GEN VIROL, V77, P293, DOI 10.1099/0022-1317-77-2-293; TOKITA H, 1995, J GEN VIROL, V76, P2329, DOI 10.1099/0022-1317-76-9-2329; TOKITA H, 1994, P NATL ACAD SCI USA, V91, P11022, DOI 10.1073/pnas.91.23.11022; TOKITA H, 1994, J GEN VIROL, V75, P931, DOI 10.1099/0022-1317-75-4-931; Verbeeck J, 2006, J VIROL, V80, P4220, DOI 10.1128/JVI.80.9.4220-4226.2006; Xia XS, 2008, J MED VIROL, V80, P1142, DOI 10.1002/jmv.21204; XU LZ, 1994, J GEN VIROL, V75, P2393, DOI 10.1099/0022-1317-75-9-2393; Zhou YQ, 2010, J CLIN VIROL, V49, P272, DOI 10.1016/j.jcv.2010.08.007	48	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e103160	10.1371/journal.pone.0103160	http://dx.doi.org/10.1371/journal.pone.0103160			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25099694	Green Published, Green Submitted, gold			2022-12-27	WOS:000339995100014
J	Siegel, KR; Ali, MK; Srinivasiah, A; Nugent, RA; Narayan, KMV				Siegel, Karen R.; Ali, Mohammed K.; Srinivasiah, Adithi; Nugent, Rachel A.; Narayan, K. M. Venkat			Do We Produce Enough Fruits and Vegetables to Meet Global Health Need?	PLOS ONE			English	Article							CONSUMPTION; DISEASE; RISK; OBESITY; POLICY	Background: Low fruit and vegetable (FV) intake is a leading risk factor for chronic disease globally, but much of the world's population does not consume the recommended servings of FV daily. It remains unknown whether global supply of FV is sufficient to meet current and growing population needs. We sought to determine whether supply of FV is sufficient to meet current and growing population needs, globally and in individual countries. Methods and Findings: We used global data on agricultural production and population size to compare supply of FV in 2009 with population need, globally and in individual countries. We found that the global supply of FV falls, on average, 22% short of population need according to nutrition recommendations (supply: need ratio: 0.78 [Range: 0.05-2.01]). This ratio varies widely by country income level, with a median supply: need ratio of 0.42 and 1.02 in low-income and high-income countries, respectively. A sensitivity analysis accounting for need-side food wastage showed similar insufficiency, to a slightly greater extent (global supply: need ratio: 0.66, varying from 0.37 [low-income countries] to 0.77 [high-income countries]). Using agricultural production and population projections, we also estimated supply and need for FV for 2025 and 2050. Assuming medium fertility and projected growth in agricultural production, the global supply: need ratio for FV increases slightly to 0.81 by 2025 and to 0.88 by 2050, with similar patterns seen across country income levels. In a sensitivity analysis assuming no change from current levels of FV production, the global supply: need ratio for FV decreases to 0.66 by 2025 and to 0.57 by 2050. Conclusion: The global nutrition and agricultural communities need to find innovative ways to increase FV production and consumption to meet population health needs, particularly in low-income countries.	[Siegel, Karen R.; Narayan, K. M. Venkat] Emory Univ, Laney Grad Sch, Atlanta, GA 30322 USA; [Siegel, Karen R.; Ali, Mohammed K.; Narayan, K. M. Venkat] Emory Univ, Hubert Dept Global Hlth, Atlanta, GA 30322 USA; [Srinivasiah, Adithi] Emory Univ, Emory Coll, Atlanta, GA 30322 USA; [Nugent, Rachel A.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA	Emory University; Emory University; Emory University; University of Washington; University of Washington Seattle	Siegel, KR (corresponding author), Emory Univ, Laney Grad Sch, Atlanta, GA 30322 USA.	krsiege@emory.edu	Narayan, K.M. Venkat/J-9819-2012; Ali, Mohammed K/N-9833-2013	Narayan, K.M. Venkat/0000-0001-8621-5405; Nugent, Rachel/0000-0001-6421-9077; Ali, Mohammed/0000-0001-7266-2503	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007734] Funding Source: NIH RePORTER; NIDDK NIH HHS [T32 DK007734] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AFT, 2010, 13 MIL MOR ACR; AFT, 2010, AM FARML TRUST SAYS; Alexandratos N., 2012, WORLD AGR 2030 2050, DOI DOI 10.22004/AG.ECON.288998; [Anonymous], 2004, GLOBAL TRADE PATTERN; Basu S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057873; Bellavia A, 2013, AM J CLIN NUTR, V98, P454, DOI 10.3945/ajcn.112.056119; CDC, 2011, STRAT PREV OB OTH CH; Dauchet L, 2006, J NUTR, V136, P2588, DOI 10.1093/jn/136.10.2588; FAO, 2009, FOOD AGR ORG FOOD BA; Franck C, 2013, AM J PREV MED, V45, P327, DOI 10.1016/j.amepre.2013.04.010; Hung HC, 2004, JNCI-J NATL CANCER I, V96, P1577, DOI 10.1093/jnci/djh296; Industry PMsCoTa, 2010, REP FOOD AGR IND MAN; Jackson RJ, 2009, J HUNGER ENVIRON NUT, V4, P393, DOI 10.1080/19320240903321367; Joffe M, 2001, PUBLIC HEALTH NUTR, V4, P893, DOI 10.1079/PHN2001126; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lock K, 2004, COMP QUANTIFICATION; Murray CJL, 2013, JAMA-J AM MED ASSOC, V310, P591, DOI 10.1001/jama.2013.13805; Nugent R., 2011, BRINGING AGR TABLE A; Pollan M, 2003, NY TIMES MAGAZINE; Pomerleau J, 2005, J NUTR, V135, P2486, DOI 10.1093/jn/135.10.2486; Sekula W, 1991, WHO Reg Publ Eur Ser, V34, P91; Siegel KR, 2012, DIABETES RES CLIN PR, V96, P76, DOI 10.1016/j.diabres.2011.11.014; Thow AM, 2010, B WORLD HEALTH ORGAN, V88, P609, DOI 10.2471/BLT.09.070987; UNDESA, 2012, WORLD POP PROSP 2012; WHO/FAO, 2003, DIET NUTR; WHO/FAO, 2003, WHO TECHN REP SER; Wolfenden L, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008552.pub2	27	99	100	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e104059	10.1371/journal.pone.0104059	http://dx.doi.org/10.1371/journal.pone.0104059			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25099121	Green Published, gold, Green Submitted			2022-12-27	WOS:000339995100048
J	Wu, ZH; Su, S				Wu, Zhenghua; Su, Sheng			A Dynamic Selection Method for Reference Electrode in SSVEP-Based BCI	PLOS ONE			English	Article							BRAIN-COMPUTER INTERFACES; VISUAL-EVOKED POTENTIALS; COMMUNICATION	In SSVEP-based Brain-Computer Interface (BCI), it is very important to get an evoked EEG with a high signal to noise ratio (SNR). The SNR of SSVEP is fundamentally related to the characteristics of stimulus, such as its intensity and frequency, and it is also related to both the reference electrode and the active electrode. In the past, with SSVEP-based BCI, often the potential at 'Cz', the average potential at all electrodes or the average mastoid potential, were statically selected as the reference. In conjunction, a certain electrode in the occipital area was statically selected as the active electrode for all stimuli. This work proposed a dynamic selection method for the reference electrode, in which all electrodes can be looked upon as active electrodes, while an electrode which can result in the maximum sum relative-power of a specific frequency SSVEP can be confirmed dynamically and considered as the optimum reference electrode for that specific frequency stimulus. Comparing this dynamic selection method with previous methods, in which "Cz', the average potential at all electrodes or the average mastoid potential were selected as the reference electrode, it is demonstrated that the SNR of SSVEP is improved significantly as is the accuracy of SSVEP detection.	[Wu, Zhenghua; Su, Sheng] Univ Elect Sci & Technol China, Sch Comp Sci & Engn, Chengdu 610054, Peoples R China; [Wu, Zhenghua] Univ Elect Sci & Technol China, Sch Life Sci & Technol, Minist Educ, Key Lab NeuroInformat, Chengdu 610054, Peoples R China	University of Electronic Science & Technology of China; University of Electronic Science & Technology of China	Wu, ZH (corresponding author), Univ Elect Sci & Technol China, Sch Comp Sci & Engn, Chengdu 610054, Peoples R China.	wzhzxwz@sina.com						Allison BZ, 2007, EXPERT REV MED DEVIC, V4, P463, DOI 10.1586/17434440.4.4.463; Birbaumer N, 2007, J PHYSIOL-LONDON, V579, P621, DOI 10.1113/jphysiol.2006.125633; Burkitt GR, 2000, CLIN NEUROPHYSIOL, V111, P246, DOI 10.1016/S1388-2457(99)00194-7; Cheng M, 2005, 2005 First International Conference on Neural Interface and Control Proceedings, P64; Cheng M, 2002, IEEE T BIO-MED ENG, V49, P1181, DOI 10.1109/TBME.2002.803536; DAVILA CE, 1994, IEEE T BIO-MED ENG, V41, P197, DOI 10.1109/10.284933; Friman O, 2007, IEEE T BIO-MED ENG, V54, P742, DOI 10.1109/TBME.2006.889160; Gao SK, 2014, IEEE T BIO-MED ENG, V61, P1436, DOI 10.1109/TBME.2014.2300164; Gao XR, 2003, IEEE T NEUR SYS REH, V11, P137, DOI 10.1109/TNSRE.2003.814449; Gary G.M., 2013, INT J AUTONOMOUS ADA, V6, P1; Ghaleb I, 1996, PROCEEDINGS OF THE 1996 FIFTEENTH SOUTHERN BIOMEDICAL ENGINEERING CONFERENCE, P121, DOI 10.1109/SBEC.1996.493128; Herrmann CS, 2001, EXP BRAIN RES, V137, P346, DOI 10.1007/s002210100682; Hwang HJ, 2012, J NEUROSCI METH, V208, P59, DOI 10.1016/j.jneumeth.2012.04.011; Kelly SP, 2005, IEEE T NEUR SYS REH, V13, P172, DOI 10.1109/TNSRE.2005.847369; Lee PL, 2010, ANN BIOMED ENG, V38, P2383, DOI 10.1007/s10439-010-9964-y; Lin ZL, 2007, IEEE T BIO-MED ENG, V54, P1172, DOI 10.1109/TBME.2006.889197; Lopez MA, 2009, NEURAL PROCESS LETT, V29, P179, DOI 10.1007/s11063-009-9102-8; Lopez-Gordo MA, 2010, NEURAL PROCESS LETT, V32, P1, DOI 10.1007/s11063-010-9139-8; Luo A, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/2/026010; McCullagh Paul, 2013, Universal Access in Human-Computer Interaction. Design Methods, Tools, and Interaction Techniques for eInclusion. 7th International Conference, UAHCI 2013 Held as Part of HCI International 2013. Proceedings. LNCS 8009, P530, DOI 10.1007/978-3-642-39188-0_57; Middendorf M, 2000, IEEE T REHABIL ENG, V8, P211, DOI 10.1109/86.847819; Muller-Putz GR, 2005, J NEURAL ENG, V2, P123, DOI 10.1088/1741-2560/2/4/008; Ortiz-Rosario A., 2013, REV NEUROSCIENCES, V24, P455; Ridder WH, 1998, INVEST OPHTH VIS SCI, V39, P2759; Sami S, 2004, BRAIN COMP INT 9 ANN, P475; Vialatte FB, 2010, PROG NEUROBIOL, V90, P418, DOI 10.1016/j.pneurobio.2009.11.005; Wang RP, 2005, 2005 FIRST INTERNATIONAL CONFERENCE ON NEURAL INTERFACE AND CONTROL PROCEEDINGS, P75; Wang YJ, 2004, P ANN INT IEEE EMBS, V26, P4507; Wolpaw JR, 2002, CLIN NEUROPHYSIOL, V113, P767, DOI 10.1016/S1388-2457(02)00057-3; Wu ZH, 2008, MED ENG PHYS, V30, P1079, DOI 10.1016/j.medengphy.2008.01.004; Wu ZH, 2008, J NEURAL ENG, V5, P36, DOI 10.1088/1741-2560/5/1/004; Yin EW, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/2/026012; Yuan H, 2014, IEEE T BIO-MED ENG, V61, P1425, DOI 10.1109/TBME.2014.2312397	33	10	10	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e104248	10.1371/journal.pone.0104248	http://dx.doi.org/10.1371/journal.pone.0104248			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25100038	Green Published, Green Submitted, gold			2022-12-27	WOS:000339995100056
J	Cui, FM; Li, M; Chen, YJ; Liu, YM; He, Y; Jiang, DW; Tong, J; Li, JX; Shen, XR				Cui, Fengmei; Li, Ming; Chen, Yuejin; Liu, Yuming; He, Yin; Jiang, Dingwen; Tong, Jian; Li, Jianxiang; Shen, Xianrong			Protective Effects of Polysaccharides from Sipunculus nudus on Beagle Dogs Exposed to gamma-Radiation	PLOS ONE			English	Article							PROTEIN COMPLEXES; IMMUNITY; AGENTS; MOUSE	The aim of the study is to investigate the radioprotective effect of polysaccharide extract from Sipunculus nudus (SNP). Beagle dogs were randomly divided into the following six groups. Group-1: Un-treated and un-irradiated controls. Group-2: Exposed to a single acute dose of 2 Gy gamma-radiation alone. Groups-3, 4 and 5: Oral administration of SNP at 50, 100 or 200 mg/kg body weight once a day for 7 days followed by a single acute whole body exposure to 2 Gy gamma-radiation. The same doses of SNP were administered for further 27 days. Group-6: Positive controls treated with 1.6 mg/kg Nilestriol by gavage after radiation. Blood parameters including white/red cells and platelet counts, as well as hemoglobin level, were assessed every other day for 34 days (7 days before and 27 days of experiment). Serum separated from aliquots of the same blood sample was used to estimate enzyme activity of antioxidant superoxide-dismutase, and to determine levels of free radical, nitric oxide, hydroxyl and superoxide anion. At the end of the experiment, all dogs were euthanized to weigh the organs for organ co-efficient calculation. Pathological changes were assessed in the bone marrow. The results showed that the dogs exposed to gamma-radiation alone exhibited a typical hematopoietic syndrome. In contrast, at the end of 27 days experiment, dogs received oral administration of SNP+gamma-radiation showed: (i) a much improved blood picture as indicated by shorter duration of leucopenia, neutropenia, thrombocytopenia (platelet counts), as well as hemoglobin levels, (ii) significantly improved hematopoietic activity in the bone marrow, (iii) substantial decrease in nitric oxide levels, and notable increase in activity of antioxidant superoxide dismutase. The results suggested that oral administration of SNP in Beagle dogs was effective in facilitating the recovery of hematopoietic bone marrow damage induced by gamma-radiation.	[Cui, Fengmei; Li, Ming] Soochow Univ, Coll Med, Sch Radiat Med & Protect, Dept Radiotoxicol, Suzhou, Peoples R China; [Chen, Yuejin; Tong, Jian; Li, Jianxiang] Soochow Univ, Coll Med, Sch Publ Hlth, Dept Hlth Toxicol, Suzhou, Peoples R China; [Liu, Yuming; He, Yin; Jiang, Dingwen; Shen, Xianrong] Naval Med Res Inst, Dept Protect Med, Shanghai, Peoples R China	Soochow University - China; Soochow University - China	Li, JX (corresponding author), Soochow Univ, Coll Med, Sch Publ Hlth, Dept Hlth Toxicol, Suzhou, Peoples R China.	aljxcr@suda.edu.cn; xianrong_sh@yahoo.com			National Natural Science Foundation of China [81172706, 81172707]; Province Natural Science Foundation [BK2012618]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Province Natural Science Foundation; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by the National Natural Science Foundation of China (No. 81172706, 81172707), the Province Natural Science Foundation (BK2012618) and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrea L, 1993, CANCER IMMUNOL IMMUN, V3, P123; Boice JD, 2012, J RADIOL PROT, V32, pN33, DOI 10.1088/0952-4746/32/1/N33; Borchers AT, 1999, P SOC EXP BIOL MED, V221, P281, DOI 10.1046/j.1525-1373.1999.d01-86.x; Coleman C. Norman, 2003, Radiation Research, V159, P812, DOI 10.1667/RR3021; Guan S. H., 2009, CHINESE MAT MED OCEA; Han SB, 2001, INT IMMUNOPHARMACOL, V1, P1969, DOI 10.1016/S1567-5769(01)00124-2; Hosseinimehr SJ, 2007, DRUG DISCOV TODAY, V12, P794, DOI 10.1016/j.drudis.2007.07.017; Joel S, 2009, IN VIVO, V23, P323; Kim HM, 1996, INT J IMMUNOPHARMACO, V18, P295, DOI 10.1016/0192-0561(96)00028-8; [李珂娴 Li Kexian], 2012, [中国海洋药物, Chinese Journal of Marine Drugs], V31, P46; Liu F, 1999, LIFE SCI, V64, P1005, DOI 10.1016/S0024-3205(99)00027-2; Liu F, 1996, LIFE SCI, V58, P1795, DOI 10.1016/0024-3205(96)00163-4; [刘玉明 Liu Yuming], 2012, [中国海洋药物, Chinese Journal of Marine Drugs], V31, P41; [刘玉明 LIU Yuming], 2011, [时珍国医国药, Lishizhen Medicine and Materia Medica Research], V22, P1454; Mao BZ, 2001, BASIS CLIN ACUTE RAD, P152; Mettler FA, 2002, NEW ENGL J MED, V346, P1554, DOI 10.1056/NEJMra000365; Ooi VEC, 2000, CURR MED CHEM, V7, P715; Ovodova RG, 1990, CHEM NAT COMPD, V26, P626; Pataje GS, 2012, TRANSL CANC RES, V1, P35; Peng XN, 2007, J GUANGDONG OCEAN U, V27, P54; Pillai TG, 2013, MUTAT RES-GEN TOX EN, V751, P109, DOI 10.1016/j.mrgentox.2012.12.005; Robbins MEC, 2004, INT J RADIAT BIOL, V80, P251, DOI 10.1080/09553000410001692726; Shen XR, 2004, CHINESE J MARINE DRU, V97, P30; Sokolov M, 2013, INT J MOL SCI, V14, P15695, DOI 10.3390/ijms140815695; Sonis ST, 2009, ORAL ONCOL, V45, P1015, DOI 10.1016/j.oraloncology.2009.08.006; Sowby D, 2003, J RADIOL PROT, V23, P157, DOI 10.1088/0952-4746/23/2/303; TSYBULSKY AV, 1990, VOP VIRUSOL+, V35, P194; Weiss JF, 2009, INT J RADIAT BIOL, V85, P539, DOI 10.1080/09553000902985144; Xia QF, 2009, SHANDONG MED J, V49, P35; ZAPOROZHETS TS, 1985, ANTIBIOT MED BIOTEK, V30, P43	30	16	18	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e104299	10.1371/journal.pone.0104299	http://dx.doi.org/10.1371/journal.pone.0104299			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093861	gold, Green Published, Green Submitted			2022-12-27	WOS:000341357200092
J	Liu, C; Wang, Y; Zhang, HL; Cheng, S; Charreyre, C; Audonnet, JC; Chen, P; He, QG				Liu, Chong; Wang, Yang; Zhang, Hengling; Cheng, Shuang; Charreyre, Catherine; Audonnet, Jean Christophe; Chen, Pin; He, Qigai			Porcine Coronin 1A Contributes to Nuclear Factor-Kappa B (NF-kappa B) Inactivation during Haemophilus parasuis Infection	PLOS ONE			English	Article							ACTIN-BINDING-PROTEIN; GENE-EXPRESSION; INNATE IMMUNITY; COAT PROTEIN; PK-15 CELLS; SEROVAR 5; MACROPHAGES; ACTIVATION; SURVIVAL; CYTOSKELETON	Haemophilus parasuis (H. parasuis) is the etiological agent of porcine polyserositis and arthritis (Glasser's disease) characterized by fibrinous polyserositis, meningitis and polyarthritis, causing severe economic losses to the swine industry. Currently, the molecular basis of this infection is largely unkonwn. Coronin 1A (Coro1A) plays important roles in host against bacterial infection, yet little is known about porcine Coro1A. In this study, we investigated the molecular characterization of porcine Coro1A, revealing that porcine Coro1A was widely expressed in different tissues. Coro1A could be induced by lipopolysaccharide (LPS), polyinosinic acid-polycytidylic acid [poly (I: C)] and H. parasuis in porcine kidney-15 (PK-15) cells. Functional analyses revealed that porcine Coro1A suppressed the NF-kappa B activation during H. parasuis infection by inhibiting the degradation of I kappa B alpha and nuclear translocation of p65. Overexpression of porcine Coro1A inhibited the transcription of NF-kappa B-mediated downstream genes [Interleukin-6 (IL-6), Interleukin-8 (IL-8) and COX-2] through down-regulation of NF-kappa B. The results indicated that porcine Coro1A is an important immunity related gene that helps to inhibit NF-kappa B activation during H. parasuis infection.	[Liu, Chong; Zhang, Hengling; Cheng, Shuang; Chen, Pin; He, Qigai] Huazhong Agr Univ, Coll Vet Med, State Key Lab Agr Microbiol, Div Anim Infect Dis, Wuhan, Peoples R China; [Wang, Yang] Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, Harbin, Peoples R China; [Charreyre, Catherine; Audonnet, Jean Christophe] Merial SAS, Lyon, France	Huazhong Agricultural University; Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS; Merial SASU	He, QG (corresponding author), Huazhong Agr Univ, Coll Vet Med, State Key Lab Agr Microbiol, Div Anim Infect Dis, Wuhan, Peoples R China.	he628@mail.hzau.edu.cn			China agriculture research system [CARS-36]; National Basic Research Program (973 Program) [2012CB518802]; Merial SAS, France	China agriculture research system; National Basic Research Program (973 Program)(National Basic Research Program of China); Merial SAS, France	This work was supported by the China agriculture research system (CARS-36), National Basic Research Program (973 Program, grant No. 2012CB518802) and Merial SAS, France (http://www.merial.com). The funders had no role in data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Allen LAH, 1999, BLOOD, V93, P3521, DOI 10.1182/blood.V93.10.3521.410k21_3521_3530; AMANO H, 1994, J VET MED SCI, V56, P639, DOI 10.1292/jvms.56.639; Bouchet B, 2008, VET RES, V39, DOI 10.1051/vetres:2008019; Bouchet B, 2009, MICROB PATHOGENESIS, V46, P108, DOI 10.1016/j.micpath.2008.10.008; Chen HB, 2011, DEV COMP IMMUNOL, V35, P490, DOI 10.1016/j.dci.2010.11.017; Chen YS, 2012, VET MICROBIOL, V160, P259, DOI 10.1016/j.vetmic.2012.05.021; Constantoulakis P, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-243; de Hostos EL, 1999, TRENDS CELL BIOL, V9, P345, DOI 10.1016/S0962-8924(99)01620-7; DEHOSTOS EL, 1991, EMBO J, V10, P4097, DOI 10.1002/j.1460-2075.1991.tb04986.x; Dinarello CA, 2010, CELL, V140, P935, DOI 10.1016/j.cell.2010.02.043; Engler A, 2005, J NEUROIMMUNOL, V162, P103, DOI 10.1016/j.jneuroim.2005.01.017; Ferrari G, 1999, CELL, V97, P435, DOI 10.1016/S0092-8674(00)80754-0; Foger N, 2006, SCIENCE, V313, P839, DOI 10.1126/science.1130563; Frandoloso R, 2012, VET MICROBIOL, V154, P347, DOI 10.1016/j.vetmic.2011.07.022; Gatfield J, 2005, MOL BIOL CELL, V16, P2786, DOI 10.1091/mbc.E05-01-0042; Grogan A, 1997, J CELL SCI, V110, P3071; Humphries CL, 2002, J CELL BIOL, V159, P993, DOI 10.1083/jcb.200206113; Jayachandran R, 2008, MOL BIOL CELL, V19, P1241, DOI 10.1091/mbc.E07-07-0640; Jayachandran R, 2007, CELL, V130, P37, DOI 10.1016/j.cell.2007.04.043; KIELSTEIN P, 1992, J CLIN MICROBIOL, V30, P862, DOI 10.1128/JCM.30.4.862-865.1992; Liu XD, 2011, J IMMUNOL, V186, P3031, DOI 10.4049/jimmunol.0902687; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Mueller P, 2008, NAT IMMUNOL, V9, P424, DOI 10.1038/ni1570; Mugnier B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003467; Nal B, 2004, INT IMMUNOL, V16, P231, DOI 10.1093/intimm/dxh022; Oliveira S, 2004, VET MICROBIOL, V99, P1, DOI 10.1016/j.vetmic.2003.12.001; Purcell MK, 2011, FISH SHELLFISH IMMUN, V30, P84, DOI 10.1016/j.fsi.2010.09.007; Roadcap David W., 2008, V48, P124, DOI 10.1007/978-0-387-09595-0_12; Rybakin V, 2005, BIOESSAYS, V27, P625, DOI 10.1002/bies.20235; Schiotz BL, 2008, VIRUS RES, V136, P65, DOI 10.1016/j.virusres.2008.04.019; Schmitz F, 2004, EUR J IMMUNOL, V34, P2863, DOI 10.1002/eji.200425228; Segales J, 1997, J VET DIAGN INVEST, V9, P237, DOI 10.1177/104063879700900303; Seto S, 2012, CELL MICROBIOL, V14, P710, DOI 10.1111/j.1462-5822.2012.01754.x; Shiow LR, 2008, NAT IMMUNOL, V9, P1307, DOI 10.1038/ni.1662; SUZUKI K, 1995, FEBS LETT, V364, P283, DOI 10.1016/0014-5793(95)00393-N; Tanigawa K, 2009, CLIN EXP IMMUNOL, V156, P495, DOI 10.1111/j.1365-2249.2009.03930.x; Uetrecht AC, 2006, TRENDS CELL BIOL, V16, P421, DOI 10.1016/j.tcb.2006.06.002; Wan FY, 2010, CELL RES, V20, P24, DOI 10.1038/cr.2009.137; Wang Y, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-68; Wilkinson JM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-455; Xavier Charks-Paer, 2008, V48, P98, DOI 10.1007/978-0-387-09595-0_9	42	7	8	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e103904	10.1371/journal.pone.0103904	http://dx.doi.org/10.1371/journal.pone.0103904			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093672	gold, Green Published, Green Submitted			2022-12-27	WOS:000341357200043
J	Spadacenta, S; Gallese, V; Fragola, M; Mirabella, G				Spadacenta, Silvia; Gallese, Vittorio; Fragola, Michele; Mirabella, Giovanni			Modulation of Arm Reaching Movements during Processing of Arm/Hand-Related Action Verbs with and without Emotional Connotation	PLOS ONE			English	Article							MOTOR SYSTEM; SEMANTIC RICHNESS; TIME-COURSE; LANGUAGE; EMBODIMENT; ATTENTION; RESPONSES; WORDS	The theory of embodied language states that language comprehension relies on an internal reenactment of the sensorimotor experience associated with the processed word or sentence. Most evidence in support of this hypothesis had been collected using linguistic material without any emotional connotation. For instance, it had been shown that processing of arm-related verbs, but not of those leg-related verbs, affects the planning and execution of reaching movements; however, at present it is unknown whether this effect is further modulated by verbs evoking an emotional experience. Showing such a modulation might shed light on a very debated issue, i. e. the way in which the emotional meaning of a word is processed. To this end, we assessed whether processing arm/hand-related verbs describing actions with negative connotations (e. g. to stab) affects reaching movements differently from arm/hand-related verbs describing actions with neutral connotation (e. g. to comb). We exploited a go/no-go paradigm in which healthy participants were required to perform arm-reaching movements toward a target when verbs expressing emotional hand actions, neutral hand actions or foot actions were shown, and to refrain from moving when no-effector-related verbs were presented. Reaction times and percentages of errors increased when the verb involved the same effector as used to give the response. However, we also found that the size of this interference decreased when the arm/hand-related verbs had a negative emotional connotation. Crucially, we show that such modulation only occurred when the verb semantics had to be retrieved. These results suggest that the comprehension of negatively valenced verbs might require the simultaneous reenactment of the neural circuitry associated with the processing of the emotion evoked by their meaning and of the neural circuitry associated with their motor features.	[Spadacenta, Silvia] Univ Roma La Sapienza, Dept Physiol & Pharmacol, PhD Program Neurophysiol, I-00185 Rome, Italy; [Gallese, Vittorio] Univ Parma, Dept Neurosci, I-43100 Parma, Italy; [Fragola, Michele; Mirabella, Giovanni] Univ Roma La Sapienza, Dept Physiol & Pharmacol, I-00185 Rome, Italy; [Spadacenta, Silvia; Mirabella, Giovanni] Ist Neurol Mediterraneo Neuromed, Pozzilli, IS, Italy	Sapienza University Rome; University of Parma; Sapienza University Rome; IRCCS Neuromed	Mirabella, G (corresponding author), Univ Roma La Sapienza, Dept Physiol & Pharmacol, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	giovanni.mirabella@uniroma1.it	ferraina, stefano/M-5230-2018; Gallese, Vittorio/ABD-5097-2021; Mirabella, Giovanni/AAB-2818-2019	ferraina, stefano/0000-0001-6100-2438; Gallese, Vittorio/0000-0003-4815-3607; Mirabella, Giovanni/0000-0002-4405-2609	Italian Ministry of Work, Health and Social Policies; Italian Ministry of University and Research [2008_RBFNLH_005]	Italian Ministry of Work, Health and Social Policies(Ministry of Health, Italy); Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR))	This research was supported by the Italian Ministry of Work, Health and Social Policies (Bando Giovani Ricercatori 2007 to G.M.) and by the Italian Ministry of University and Research (PRIN n.2008_RBFNLH_005 to G.M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barsalou LW, 1999, BEHAV BRAIN SCI, V22, P577, DOI 10.1017/S0140525X99532147; Bertinetto P. M., 2005, CORPUS LESSICO FREQU; Boulenger V, 2008, NEUROPSYCHOLOGIA, V46, P743, DOI 10.1016/j.neuropsychologia.2007.10.007; Bradley M., 1999, TECHNICAL REPORT, DOI DOI 10.1109/MIC.2008.114; Buccino G, 2005, COGNITIVE BRAIN RES, V24, P355, DOI 10.1016/j.cogbrainres.2005.02.020; Chen M, 1999, PERS SOC PSYCHOL B, V25, P215, DOI 10.1177/0146167299025002007; CLARK HH, 1973, J VERB LEARN VERB BE, V12, P335, DOI 10.1016/S0022-5371(73)80014-3; Cohen J.E., 1988, STAT POWER ANAL BEHA; Dehaene S, 2001, NAT NEUROSCI, V4, P752, DOI 10.1038/89551; Dijksterhuis A, 2003, PSYCHOL SCI, V14, P14, DOI 10.1111/1467-9280.t01-1-01412; Estes Z, 2008, COGNITION, V108, P557, DOI 10.1016/j.cognition.2008.03.003; Fadiga L, 2002, EUR J NEUROSCI, V15, P399, DOI 10.1046/j.0953-816x.2001.01874.x; Ferri F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054091; Fodor J. A, 1983, MODULARITY MIND; Foroni F, 2009, PSYCHOL SCI, V20, P974, DOI 10.1111/j.1467-9280.2009.02400.x; Fruhholz S, 2011, BIOL PSYCHOL, V87, P265, DOI 10.1016/j.biopsycho.2011.03.008; Gallese V, 2005, COGN NEUROPSYCHOL, V22, P455, DOI 10.1080/02643290442000310; Glenberg AM, 2008, Q J EXP PSYCHOL, V61, P905, DOI 10.1080/17470210701625550; Hauk O, 2006, NEUROIMAGE, V30, P1383, DOI 10.1016/j.neuroimage.2005.11.048; Hauk O, 2004, HUM BRAIN MAPP, V21, P191, DOI 10.1002/hbm.10157; Havas DA, 2007, PSYCHON B REV, V14, P436, DOI 10.3758/BF03194085; Kousta ST, 2011, J EXP PSYCHOL GEN, V140, P14, DOI 10.1037/a0021446; Kuperman V, 2014, J EXP PSYCHOL GEN, V143, P1065, DOI 10.1037/a0035669; Lakens D, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00863; Mahon BZ, 2005, COGN NEUROPSYCHOL, V22, P480, DOI 10.1080/02643290442000446; McKenna FP, 2004, J EXP PSYCHOL LEARN, V30, P382, DOI 10.1037/0278-7393.30.2.382; Meteyard L, 2012, CORTEX, V48, P788, DOI 10.1016/j.cortex.2010.11.002; Mirabella G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062793; Mirabella G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035403; Mirabella G, 2008, COGN NEUROPSYCHOL, V25, P996, DOI 10.1080/02643290802003216; Naccache L, 2005, P NATL ACAD SCI USA, V102, P7713, DOI 10.1073/pnas.0500542102; Nasrallah M, 2009, EMOTION, V9, P609, DOI 10.1037/a0016305; Neininger B, 2003, NEUROPSYCHOLOGIA, V41, P53, DOI 10.1016/S0028-3932(02)00126-4; Newcombe PI, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00275; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pexman PM, 2008, PSYCHON B REV, V15, P161, DOI 10.3758/PBR.15.1.161; Postle N, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00011; PRATTO F, 1991, J PERS SOC PSYCHOL, V61, P380, DOI 10.1037/0022-3514.61.3.380; Pulvermuller F, 2013, BRAIN LANG, V127, P86, DOI 10.1016/j.bandl.2013.05.015; Pulvermuller F, 2005, EUR J NEUROSCI, V21, P793, DOI 10.1111/j.1460-9568.2005.03900.x; Raaijmakers JGW, 2003, CAN J EXP PSYCHOL, V57, P141, DOI 10.1037/h0087421; Sato M, 2008, BRAIN LANG, V105, P83, DOI 10.1016/j.bandl.2007.10.001; Scorolli C, 2007, BRAIN RES, V1130, P119, DOI 10.1016/j.brainres.2006.10.033; Smith NK, 2003, NEUROPSYCHOLOGIA, V41, P171, DOI 10.1016/S0028-3932(02)00147-1; SOLARZ AK, 1960, J EXP PSYCHOL, V59, P239, DOI 10.1037/h0047274; Vigliocco G, 2014, CEREB CORTEX, V24, P1767, DOI 10.1093/cercor/bht025; Vigliocco G, 2009, LANG COGN, V1, P219, DOI 10.1515/LANGCOG.2009.011; Vigliocco G, 2011, NEUROSCI BIOBEHAV R, V35, P407, DOI 10.1016/j.neubiorev.2010.04.007; Yap MJ, 2011, PSYCHON B REV, V18, P742, DOI 10.3758/s13423-011-0092-y	49	20	20	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e104349	10.1371/journal.pone.0104349	http://dx.doi.org/10.1371/journal.pone.0104349			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO5BW	25093410	Green Published, gold			2022-12-27	WOS:000341357200103
J	Uraji, M; Arima, J; Inoue, Y; Harazono, K; Hatanaka, T				Uraji, Misugi; Arima, Jiro; Inoue, Yoshikazu; Harazono, Koichi; Hatanaka, Tadashi			Application of Two Newly Identified and Characterized Feruloyl Esterases from Streptomyces sp in the Enzymatic Production of Ferulic Acid from Agricultural Biomass	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; THERMOBIFIDA-FUSCA; OXIDATIVE STRESS; ETHYL-ESTER; PURIFICATION; EXPRESSION; RELEASE; GENE; BRAN	Ferulic acid (FA), a component of hemicellulose in plant cell walls, is a phenolic acid with several potential applications based on its antioxidant properties. Recent studies have shown that feruloyl esterase (FAE) is a key bacterial enzyme involved in FA production from agricultural biomass. In this study, we screened a library of 43 esterases from Streptomyces species and identified two enzymes, R18 and R43, that have FAE activity toward ethyl ferulate. In addition, we characterized their enzyme properties in detail. R18 and R43 showed esterase activity toward other hydroxycinnamic acid esters as well, such as methyl p-coumarate, methyl caffeate, and methyl sinapinate. The amino acid sequences of R18 and R43 were neither similar to each other, nor to other FAEs. We found that R18 and R43 individually showed the ability to produce FA from corn bran; however, combination with other Streptomyces enzymes, namely xylanase and a-L-arabinofuranosidase, increased FA production from biomass such as corn bran, defatted rice bran, and wheat bran. These results suggest that R18 and R43 are effective FAEs for the enzymatic production of FA from biomass.	[Uraji, Misugi; Hatanaka, Tadashi] Okayama Prefectural Technol Ctr Agr Forestry & Fi, RIBS, Okayama, Japan; [Arima, Jiro] Tottori Univ, Fac Agr, Dept Agr Biol & Environm Sci, Tottori 680, Japan; [Inoue, Yoshikazu] Satake Corp, Higashihiroshima, Hiroshima, Japan; [Harazono, Koichi] Nagase ChemteX Corp, Enzyme Div, Bio Chem Dept, Fukuchiyama, Kyoto, Japan	Tottori University	Hatanaka, T (corresponding author), Okayama Prefectural Technol Ctr Agr Forestry & Fi, RIBS, Okayama, Japan.	hatanaka@bio-ribs.com						Agger J, 2010, J AGR FOOD CHEM, V58, P6141, DOI 10.1021/jf100633f; Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; Buanafina MMD, 2009, MOL PLANT, V2, P861, DOI 10.1093/mp/ssp067; Crepin VF, 2004, APPL MICROBIOL BIOT, V63, P647, DOI 10.1007/s00253-003-1476-3; Di Domenico F, 2009, FREE RADICAL RES, V43, P365, DOI 10.1080/10715760902777329; Dobberstein D, 2010, J AGR FOOD CHEM, V58, P8927, DOI 10.1021/jf101514j; FAULDS CB, 1995, APPL MICROBIOL BIOT, V43, P1082, DOI 10.1007/BF00166929; FAULDS CB, 1991, J GEN MICROBIOL, V137, P2339, DOI 10.1099/00221287-137-10-2339; Hatanaka T, 2008, PROTEIN EXPRES PURIF, V62, P244, DOI 10.1016/j.pep.2008.09.001; Huang YC, 2011, BIORESOURCE TECHNOL, V102, P8117, DOI 10.1016/j.biortech.2011.05.062; Huang YC, 2010, BIOCHEM BIOPH RES CO, V400, P718, DOI 10.1016/j.bbrc.2010.08.136; Ikeda H, 2003, NAT BIOTECHNOL, V21, P526, DOI 10.1038/nbt820; Kheder F, 2009, CAN J MICROBIOL, V55, P729, DOI [10.1139/W09-027, 10.1139/w09-027]; Koseki T, 2005, BBA-GEN SUBJECTS, V1722, P200, DOI 10.1016/j.bbagen.2004.12.016; Koseki T, 1998, BIOSCI BIOTECH BIOCH, V62, P2032, DOI 10.1271/bbb.62.2032; Koseki T, 2009, APPL MICROBIOL BIOT, V84, P803, DOI 10.1007/s00253-009-2148-8; Mathew S, 2004, CRIT REV BIOTECHNOL, V24, P59, DOI 10.1080/07388550490491467; Priefert H, 2001, APPL MICROBIOL BIOT, V56, P296, DOI 10.1007/s002530100687; ROSAZZA JP, 1999, J IN DMICROBIOL, V15, P457; Rose DJ, 2010, J AGR FOOD CHEM, V58, P493, DOI 10.1021/jf9020416; Sultana R, 2005, J NEUROCHEM, V92, P749, DOI 10.1111/j.1471-4159.2004.02899.x; Topakas E, 2007, PROCESS BIOCHEM, V42, P497, DOI 10.1016/j.procbio.2007.01.007; Tsujibo H, 2002, BIOSCI BIOTECH BIOCH, V66, P434, DOI 10.1271/bbb.66.434; TSUJIBO H, 1992, APPL ENVIRON MICROB, V58, P371, DOI 10.1128/AEM.58.1.371-375.1992; Uraji M, 2013, APPL BIOCHEM BIOTECH, V171, P1085, DOI 10.1007/s12010-013-0190-6; Wong DWS, 2006, APPL BIOCHEM BIOTECH, V133, P87, DOI 10.1385/ABAB:133:2:87; Yan JJ, 2001, BRIT J PHARMACOL, V133, P89, DOI 10.1038/sj.bjp.0704047	27	23	23	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e104584	10.1371/journal.pone.0104584	http://dx.doi.org/10.1371/journal.pone.0104584			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093500	Green Submitted, Green Published, gold			2022-12-27	WOS:000341357200113
J	Wang, LG; Feng, XY; Zhao, H; Wang, LD; An, LZ; Qiu, QS				Wang, Liguang; Feng, Xueying; Zhao, Hong; Wang, Lidong; An, Lizhe; Qiu, Quan-Sheng			Functional Analysis of the Na+, K+/H+ Antiporter PeNHX3 from the Tree Halophyte Populus euphratica in Yeast by Model-Guided Mutagenesis	PLOS ONE			English	Article							SALT TOLERANCE; ARABIDOPSIS-THALIANA; PLASMA-MEMBRANE; ION HOMEOSTASIS; EXCHANGER NHX1P; MORNING GLORY; PLANT-GROWTH; PROTEIN; ROLES; SOS1	Na+, K+/H+ antiporters are H+-coupled cotransporters that are crucial for cellular homeostasis. Populus euphratica, a well-known tree halophyte, contains six Na+/H+ antiporter genes (PeNHX1-6) that have been shown to function in salt tolerance. However, the catalytic mechanisms governing their ion transport remain largely unknown. Using the crystal structure of the Na+/H+ antiporter from the Escherichia coli (EcNhaA) as a template, we built the three-dimensional structure of PeNHX3 from P. euphratica. The PeNHX3 model displays the typical TM4-TM11 assembly that is critical for ion binding and translocation. The PeNHX3 structure follows the ` positive-inside' rule and exhibits a typical physicochemical property of the transporter proteins. Four conserved residues, including Tyr149, Asn187, Asp188, and Arg356, are indentified in the TM4-TM11 assembly region of PeNHX3. Mutagenesis analysis showed that these reserved residues were essential for the function of PeNHX3: Asn187 and Asp188 (forming a ND motif) controlled ion binding and translocation, and Tyr149 and Arg356 compensated helix dipoles in the TM4-TM11 assembly. PeNHX3 mediated Na+, K+ and Li+ transport in a yeast growth assay. Domainswitch analysis shows that TM11 is crucial to Li+ transport. The novel features of PeNHX3 in ion binding and translocation are discussed.	[Wang, Liguang; Feng, Xueying; Zhao, Hong; Wang, Lidong; An, Lizhe; Qiu, Quan-Sheng] Lanzhou Univ, MOE Key Lab Cell Activ & Stress Adaptat, Sch Life Sci, Lanzhou 730000, Gansu, Peoples R China	Lanzhou University	Qiu, QS (corresponding author), Lanzhou Univ, MOE Key Lab Cell Activ & Stress Adaptat, Sch Life Sci, Lanzhou 730000, Gansu, Peoples R China.	qiuqsh@lzu.edu.cn	Yang, Xiaoming/GRJ-9483-2022	Yang, Xiaoming/0000-0002-1792-6921	National Basic Research Program of China (973 project) [2013CB429904]; National Natural Science Foundation of China (NSFC) [31371438, 31070222]; Research Fund for the Doctoral Program of Higher Education of China (RFDP) [20130211110001]; Fundamental Research Funds for the Central Universities [lzujbky-2013-k10]	National Basic Research Program of China (973 project)(National Basic Research Program of China); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China (RFDP)(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Basic Research Program of China (973 project, 2013CB429904 to QSQ), the National Natural Science Foundation of China (NSFC) (31371438, 31070222 to QSQ), the Research Fund for the Doctoral Program of Higher Education of China (RFDP) (20130211110001 to QSQ), and the Fundamental Research Funds for the Central Universities (lzujbky-2013-k10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali R, 2004, J BIOL CHEM, V279, P4498, DOI 10.1074/jbc.M307446200; Apse MP, 2003, PLANT J, V36, P229, DOI 10.1046/j.1365-313X.2003.01871.x; Apse MP, 1999, SCIENCE, V285, P1256, DOI 10.1126/science.285.5431.1256; Barragan V, 2012, PLANT CELL, V24, P1127, DOI 10.1105/tpc.111.095273; Bassil E, 2012, J EXP BOT, V63, P5727, DOI 10.1093/jxb/ers250; Bassil E, 2011, PLANT CELL, V23, P3482, DOI 10.1105/tpc.111.089581; Bassil E, 2011, PLANT CELL, V23, P224, DOI 10.1105/tpc.110.079426; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Blumwald E, 2000, CURR OPIN CELL BIOL, V12, P431, DOI 10.1016/S0955-0674(00)00112-5; Bowers K, 2000, MOL BIOL CELL, V11, P4277, DOI 10.1091/mbc.11.12.4277; Bressan R, 2009, MOL PLANT, V2, P1, DOI 10.1093/mp/ssn097; Brett CL, 2005, MOL BIOL CELL, V16, P1396, DOI 10.1091/mbc.E04-11-0999; Brett CL, 2005, AM J PHYSIOL-CELL PH, V288, pC223, DOI 10.1152/ajpcell.00360.2004; Brinker M, 2010, PLANT PHYSIOL, V154, P1697, DOI 10.1104/pp.110.164152; Chanroj S, 2011, J BIOL CHEM, V286, P33931, DOI 10.1074/jbc.M111.252650; Counillon L, 2000, J BIOL CHEM, V275, P1, DOI 10.1074/jbc.275.1.1; Fukada-Tanaka S, 2000, NATURE, V407, P581, DOI 10.1038/35036683; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Guo Y, 2004, PLANT CELL, V16, P435, DOI 10.1105/tpc.019174; Hunte C, 2005, NATURE, V435, P1197, DOI 10.1038/nature03692; Inan G, 2004, PLANT PHYSIOL, V135, P1718, DOI 10.1104/pp.104.041723; INOUE H, 1995, FEBS LETT, V363, P264, DOI 10.1016/0014-5793(95)00331-3; Jaroszewski L, 2005, NUCLEIC ACIDS RES, V33, pW284, DOI 10.1093/nar/gki418; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Landau M, 2007, J BIOL CHEM, V282, P37854, DOI 10.1074/jbc.M705460200; Lawrence SP, 2010, MOL BIOL CELL, V21, P3540, DOI 10.1091/mbc.E09-12-1053; Leidi EO, 2010, PLANT J, V61, P495, DOI 10.1111/j.1365-313X.2009.04073.x; Ma T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3797; Maresova L, 2005, MOL MICROBIOL, V55, P588, DOI 10.1111/j.1365-2958.2004.04410.x; Mitsui K, 2011, J BIOL CHEM, V286, P37625, DOI 10.1074/jbc.M111.260612; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Orsini F, 2010, J EXP BOT, V61, P3787, DOI 10.1093/jxb/erq188; Ottow EA, 2005, PLANT PHYSIOL, V139, P1762, DOI 10.1104/pp.105.069971; Padan E, 2001, BBA-BIOENERGETICS, V1505, P144, DOI 10.1016/S0005-2728(00)00284-X; Padan E, 2009, J EXP BIOL, V212, P1593, DOI 10.1242/jeb.026708; Pardo JM, 2006, J EXP BOT, V57, P1181, DOI 10.1093/jxb/erj114; Petrey D, 2005, MOL CELL, V20, P811, DOI 10.1016/j.molcel.2005.12.005; Pierri CL, 2010, BBA-PROTEINS PROTEOM, V1804, P1695, DOI 10.1016/j.bbapap.2010.04.008; Rodriguez-Rosales MP, 2008, NEW PHYTOL, V179, P366, DOI 10.1111/j.1469-8137.2008.02461.x; Qiu QS, 2004, J BIOL CHEM, V279, P207, DOI 10.1074/jbc.M307982200; Qiu QS, 2003, PLANT PHYSIOL, V132, P1041, DOI 10.1104/pp.102.010421; Qiu QS, 2002, P NATL ACAD SCI USA, V99, P8436, DOI 10.1073/pnas.122224699; Qiu QS, 2012, J GENET GENOMICS, V39, P167, DOI 10.1016/j.jgg.2012.02.001; Qiu QS, 2012, J INTEGR PLANT BIOL, V54, P66, DOI 10.1111/j.1744-7909.2012.01097.x; Qiu QS, 2010, J CELL SCI, V123, P3266, DOI 10.1242/jcs.067637; Quintero FJ, 2000, FEBS LETT, V471, P224, DOI 10.1016/S0014-5793(00)01412-5; Quintero FJ, 2011, P NATL ACAD SCI USA, V108, P2611, DOI 10.1073/pnas.1018921108; Schushan M, 2010, J MOL BIOL, V396, P1181, DOI 10.1016/j.jmb.2009.12.055; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; Shi HZ, 2000, P NATL ACAD SCI USA, V97, P6896, DOI 10.1073/pnas.120170197; Shi HZ, 2003, NAT BIOTECHNOL, V21, P81, DOI 10.1038/nbt766; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; Slepkov ER, 2007, BIOCHEM J, V401, P623, DOI 10.1042/BJ20061062; Sun J, 2009, PLANT PHYSIOL, V149, P1141, DOI 10.1104/pp.108.129494; Tester M, 2003, ANN BOT-LONDON, V91, P503, DOI 10.1093/aob/mcg058; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Venema K, 2002, J BIOL CHEM, V277, P2413, DOI 10.1074/jbc.M105043200; VONHEIJNE G, 1986, EMBO J, V5, P3021, DOI 10.1002/j.1460-2075.1986.tb04601.x; Wallin E, 1998, PROTEIN SCI, V7, P1029, DOI 10.1002/pro.5560070420; WALLIS JW, 1989, CELL, V58, P409, DOI 10.1016/0092-8674(89)90855-6; Wu SJ, 1996, PLANT CELL, V8, P617, DOI 10.1105/tpc.8.4.617; Yamaguchi T, 2005, P NATL ACAD SCI USA, V102, P16107, DOI 10.1073/pnas.0504437102; Ye CY, 2009, PHYSIOL PLANTARUM, V137, P166, DOI 10.1111/j.1399-3054.2009.01269.x; Yokoi S, 2002, PLANT J, V30, P529, DOI 10.1046/j.1365-313X.2002.01309.x; Yoshida K, 2005, PLANT CELL PHYSIOL, V46, P407, DOI 10.1093/pcp/pci057; Zhang HX, 2001, NAT BIOTECHNOL, V19, P765, DOI 10.1038/90824; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329	67	10	13	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e104147	10.1371/journal.pone.0104147	http://dx.doi.org/10.1371/journal.pone.0104147			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093858	gold, Green Published, Green Submitted			2022-12-27	WOS:000341357200074
J	Wang, WQ; Bielefeldt-Ohmann, H; Traub, RJ; Cuttell, L; Owen, H				Wang, Wenqi; Bielefeldt-Ohmann, Helle; Traub, Rebecca J.; Cuttell, Leigh; Owen, Helen			Location and Pathogenic Potential of Blastocystis in the Porcine Intestine	PLOS ONE			English	Article							IRRITABLE-BOWEL-SYNDROME; HOMINIS INFECTION; ZOO ANIMALS; IDENTIFICATION; PREDOMINANCE; DIVERSITY; DIAGNOSIS; CHILDREN; SUBTYPES; MODEL	Blastocystis is an ubiquitous, enteric protozoan of humans and many other species. Human infection has been associated with gastrointestinal disease such as irritable bowel syndrome, however, this remains unproven. A relevant animal model is needed to investigate the pathogenesis/pathogenicity of Blastocystis. We concluded previously that pigs are likely natural hosts of Blastocystis with a potentially zoonotic, host-adapted subtype (ST), ST5, and may make suitable animal models. In this study, we aimed to characterise the host-agent interaction of Blastocystis and the pig, including localising Blastocystis in porcine intestine using microscopy, PCR and histopathological examination of tissues. Intestines from pigs in three different management systems, i.e., a commercial piggery, a small family farm and a research herd (where the animals were immunosuppressed) were examined. This design was used to determine if environment or immune status influences intestinal colonisation of Blastocystis as immunocompromised individuals may potentially be more susceptible to blastocystosis and development of associated clinical signs. Intestines from all 28 pigs were positive for Blastocystis with all pigs harbouring ST5. In addition, the farm pigs had mixed infections with STs 1 and/or 3. Blastocystis organisms/DNA were predominantly found in the large intestine but were also detected in the small intestine of the immunosuppressed and some of the farm pigs, suggesting that immunosuppression and/or husbandry factors may influence Blastocystis colonisation of the small intestine. No obvious pathology was observed in the histological sections. Blastocystis was present as vacuolar/granular forms and these were found within luminal material or in close proximity to epithelial cells, with no evidence of attachment or invasion. These results concur with most human studies, in which Blastocystis is predominantly found in the large intestine in the absence of significant organic pathology. Our findings also support the use of pigs as animal models and may have implications for blastocystosis diagnosis/treatment.	[Wang, Wenqi; Bielefeldt-Ohmann, Helle; Cuttell, Leigh; Owen, Helen] Univ Queensland, Sch Vet Sci, Gatton, Qld, Australia; [Bielefeldt-Ohmann, Helle] Univ Queensland, Australian Infect Dis Res Ctr, St Lucia, Qld, Australia; [Traub, Rebecca J.] Univ Melbourne, Fac Vet Sci, Parkville, Vic 3052, Australia	University of Queensland; University of Queensland; University of Melbourne	Wang, WQ (corresponding author), Univ Queensland, Sch Vet Sci, Gatton, Qld, Australia.	w.wang3@uq.edu.au	Traub, Rebecca/A-4273-2013	Traub, Rebecca/0000-0002-7484-7592	William Peter Richards Trust; University of Queensland [2010000368]	William Peter Richards Trust; University of Queensland(University of Queensland)	Financial support for this project has been provided for by: 1) William Peter Richards Trust Award Grant (WW) and 2) The University of Queensland New Staff Start-up Grant, Research Master number: 2010000368 (HO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Hafeez EH, 2012, KOREAN J PARASITOL, V50, P57, DOI 10.3347/kjp.2012.50.1.57; Abramson Joseph H, 2011, Epidemiol Perspect Innov, V8, P1, DOI 10.1186/1742-5573-8-1; Aggarwal V, 1998, ARCH DIS CHILD, V78, P5, DOI 10.1136/adc.78.1.5; Agholi M, 2013, AIDS RES HUM RETROV, V29, P35, DOI [10.1089/aid.2012.0119, 10.1089/AID.2012.0119]; Alfellani MA, 2013, PROTIST, V164, P497, DOI 10.1016/j.protis.2013.05.003; Alfellani MA, 2013, ACTA TROP, V126, P11, DOI 10.1016/j.actatropica.2012.12.011; ALTAWIL YS, 1994, ARCH PEDIAT ADOL MED, V148, P882, DOI 10.1001/archpedi.1994.02170080112026; Boorom KF, 2008, PARASITE VECTOR, V1, DOI 10.1186/1756-3305-1-40; Carrascosa M, 1996, ANN INTERN MED, V124, P278, DOI 10.7326/0003-4819-124-2-199601150-00031; Chandramathi S, 2012, T ROY SOC TROP MED H, V106, P267, DOI 10.1016/j.trstmh.2011.12.008; Clark CG, 1997, MOL BIOCHEM PARASIT, V87, P79, DOI 10.1016/S0166-6851(97)00046-7; Day MJ, 2008, J COMP PATHOL, V138, pS1, DOI 10.1016/j.jcpa.2008.01.001; Fayer R, 2014, PARASITOL RES, V113, P1465, DOI 10.1007/s00436-014-3787-y; Giacometti A, 1999, EUR J CLIN MICROBIOL, V18, P436, DOI 10.1007/s100960050314; Idris NS, 2010, J INFECT DEV COUNTR, V4, P309, DOI 10.3855/jidc.275; Iguchi A, 2007, PARASITOL INT, V56, P107, DOI 10.1016/j.parint.2006.12.004; Janarthanan S, 2011, ENDOSCOPY, V43, pE185, DOI 10.1055/s-0030-1256322; JEDDY TA, 1991, J ROY SOC MED, V84, P623; JONES WR, 1946, ANN TROP MED PARASIT, V40, P130, DOI 10.1080/00034983.1946.11685270; Kraaij MD, 2011, MOL IMMUNOL, V49, P549, DOI 10.1016/j.molimm.2011.10.002; Laodim P, 2012, FOODBORNE PATHOG DIS, V9, P1077, DOI 10.1089/fpd.2012.1177; Leelayoova S, 2002, ANN TROP MED PARASIT, V96, P803, DOI 10.1179/000349802125002275; Li J, 2013, PARASITOL RES, V112, P3537, DOI 10.1007/s00436-013-3536-7; Marcos LA, 2013, CURR OPIN INFECT DIS, V26, P302, DOI [10.1097/QCO.0b013e3283630e85, 10.1097/QCO.0b013e3283630be3]; Moe KT, 1997, PARASITOL RES, V83, P319, DOI 10.1007/s004360050256; Mounsey K, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000756; PHILLIPS BP, 1976, EXP PARASITOL, V36, P358, DOI 10.1016/0014-4894(76)90039-4; Poirier P, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002545; Preacher K.J., 2001, CALCULATION CHI SQUA; Roelen DL, 2008, TRANSPL IMMUNOL, V19, P220, DOI 10.1016/j.trim.2008.06.004; Stark D, 2007, INT J PARASITOL, V37, P11, DOI 10.1016/j.ijpara.2006.09.009; Stensvold CR, 2007, DIAGN MICR INFEC DIS, V59, P303, DOI 10.1016/j.diagmicrobio.2007.06.003; Stensvold CR, 2009, INT J PARASITOL, V39, P473, DOI 10.1016/j.ijpara.2008.07.006; Stensvold R, 2006, J PARASITOL, V92, P1081, DOI 10.1645/GE-840R.1; Tai WP, 2011, PARASITOL RES, V108, P1207, DOI 10.1007/s00436-010-2164-8; Tan KSW, 2008, CLIN MICROBIOL REV, V21, P639, DOI 10.1128/CMR.00022-08; Tan Kevin S W, 2010, Curr Infect Dis Rep, V12, P28, DOI 10.1007/s11908-009-0073-8; Tan TC, 2006, PARASITOL RES, V98, P189, DOI 10.1007/s00436-005-0033-7; Wang WQ, 2014, VET PARASITOL, V203, P264, DOI 10.1016/j.vetpar.2014.04.006; Wang WQ, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-215; Wong KHS, 2008, PARASITOL RES, V102, P663, DOI 10.1007/s00436-007-0808-0; Yakoob J, 2004, AM J TROP MED HYG, V70, P383, DOI 10.4269/ajtmh.2004.70.383; Yoshikawa H, 2004, PARASITOL RES, V94, P391, DOI 10.1007/s00436-004-1230-5	43	21	23	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e103962	10.1371/journal.pone.0103962	http://dx.doi.org/10.1371/journal.pone.0103962			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093578	Green Published, gold			2022-12-27	WOS:000341357200051
J	Adeloye, D; Basquill, C				Adeloye, Davies; Basquill, Catriona			Estimating the Prevalence and Awareness Rates of Hypertension in Africa: A Systematic Analysis	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; SUB-SAHARAN AFRICA; POPULATION-BASED SURVEY; BLOOD-PRESSURE SURVEY; BODY-MASS INDEX; NONCOMMUNICABLE DISEASES; ARTERIAL-HYPERTENSION; OLDER-ADULTS; PROJECTED PREVALENCE; SEMIURBAN COMMUNITY	Background: The burden of hypertension is high in Africa, and due to rapid population growth and ageing, the exact burden on the continent is still far from being known. We aimed to estimate the prevalence and awareness rates of hypertension in Africa based on the cut off ">= 140/90 mm Hg". Methods: We conducted a systematic search of Medline, EMBASE and Global Health. Search date was set from January 1980 to December 2013. We included population-based studies on hypertension, conducted among people aged >= 15 years and providing numerical estimates on the prevalence of hypertension in Africa. Overall pooled prevalence of hypertension in mixed, rural and urban settings in Africa were estimated from reported crude prevalence rates. A meta-regression epidemiological modelling, using United Nations population demographics for the years 1990, 2000, 2010 and 2030, was applied to determine the prevalence rates and number of cases of hypertension in Africa separately for these four years. Results: Our search returned 7680 publications, 92 of which met the selection criteria. The overall pooled prevalence of hypertension in Africa was 19.7% in 1990, 27.4% in 2000 and 30.8% in 2010, each with a pooled awareness rate (expressed as percentage of hypertensive cases) of 16.9%, 29.2% and 33.7%, respectively. From the modelling, over 54.6 million cases of hypertension were estimated in 1990, 92.3 million cases in 2000, 130.2 million cases in 2010, and a projected increase to 216.8 million cases of hypertension by 2030; each with an age-adjusted prevalence of 19.1% (13.9, 25.5), 24.3% (23.3, 31.6), 25.9% (23.5, 34.0), and 25.3% (24.3, 39.7), respectively. Conclusion: Our findings suggest the prevalence of hypertension is increasing in Africa, and many hypertensive individuals are not aware of their condition. We hope this research will prompt appropriate policy response towards improving the awareness, control and overall management of hypertension in Africa.	[Adeloye, Davies; Basquill, Catriona] Univ Edinburgh, Sch Med, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland	University of Edinburgh	Adeloye, D (corresponding author), Univ Edinburgh, Sch Med, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland.	Davies.Adeloye@ed.ac.uk	Adeloye, Davies/AAB-6302-2022	Adeloye, Davies/0000-0003-1316-8139				Abegunde KA, 2013, ANN AFR MED, V12, P90, DOI 10.4103/1596-3519.112398; Addo J, 2007, HYPERTENSION, V50, P1012, DOI 10.1161/HYPERTENSIONAHA.107.093336; Addo J, 2006, ETHNIC DIS, V16, P894; Adedoyin R. A., 2012, Turk Silahli Kuvvetleri,  Koruyucu Hekimlik Bulteni, V11, P463; Adedoyin RA, 2008, EUR J CARDIOV PREV R, V15, P683, DOI 10.1097/HJR.0b013e32830edc32; Afridi I, 2003, J HYPERTENS, V21, P1983, DOI 10.1097/01.hjh.0000084751-37215.d2; Agyemang C, 2006, PUBLIC HEALTH, V120, P525, DOI 10.1016/j.puhe.2006.02.002; Ahaneku GI, 2011, ANN AFR MED, V10, P120, DOI 10.4103/1596-3519.82076; Alberts M, 2005, EUR J CARDIOV PREV R, V12, P347, DOI 10.1097/01.hjr.0000174792.24188.8e; Alikor CA, 2013, NIGER HLTH J, V13, P18; Allal-Elasmi M, 2012, PATHOL BIOL, V60, P174, DOI 10.1016/j.patbio.2011.03.007; Amira C. O., 2012, International Journal of Medicine and Biomedical Research, V1, P104; Amole IO, 2011, AFR J PRIM HEALTH CA, V3, DOI 10.4102/phcfm.v3i1.188; Anderson G H, 1999, Saudi J Kidney Dis Transpl, V10, P286; [Anonymous], WORLD BANK LIST EC; [Anonymous], HLTH PEOPL AFR REG H; Asekun-Olarinmoye EO, 2013, INT J GEN MED, V6, P317, DOI 10.2147/IJGM.S42905; ASTAGNEAU P, 1992, J HYPERTENS, V10, P1095; Awoke A, 2012, BMC CARDIOVASC DISOR, V12, DOI 10.1186/1471-2261-12-113; Balde M D, 2006, Mali Med, V21, P19; Balshem H, 2011, J CLIN EPIDEMIOL, V64, P401, DOI 10.1016/j.jclinepi.2010.07.015; Baragou S, 2012, CARDIOVASC J AFR, V23, P308, DOI 10.5830/CVJA-2011-071; Beaglehole R, 2011, LANCET, V378, P449, DOI 10.1016/S0140-6736(11)60879-9; Ben Romdhane Habiba, 2005, Tunis Med, V83 Suppl 5, P41; Ben Romdhane H, 2012, HYPERTENS RES, V35, P341, DOI 10.1038/hr.2011.198; Bovet P, 2002, INT J EPIDEMIOL, V31, P240, DOI 10.1093/ije/31.1.240; Bovet P, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-9; BUNKER CH, 1992, PREV MED, V21, P710, DOI 10.1016/0091-7435(92)90078-V; Burket BA, 2006, ETHNIC DIS, V16, P292; Capingana DP, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-732; Cappuccio FP, 2004, HYPERTENSION, V43, P1017, DOI 10.1161/01.HYP.0000126176.03319.d8; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; Cook-Huynh M, 2012, ETHNIC DIS, V22, P347; Cooper R, 1997, AM J PUBLIC HEALTH, V87, P160, DOI 10.2105/AJPH.87.2.160; Cruickshank JK, 2001, J HYPERTENS, V19, P41, DOI 10.1097/00004872-200101000-00006; Damasceno A, 2009, HYPERTENSION, V54, P77, DOI 10.1161/HYPERTENSIONAHA.109.132423; Danaei G, 2011, LANCET, V377, P568, DOI 10.1016/S0140-6736(10)62036-3; de Ramirez SS, 2010, J HUM HYPERTENS, V24, P786, DOI 10.1038/jhh.2010.14; de-Graft Aikins A, 2010, GLOBALIZATION HLTH, V6; Dewhurst MJ, 2013, J HUM HYPERTENS, V27, P374, DOI 10.1038/jhh.2012.59; Dionadji M., 2010, Revue Medecine Tropicale, V70, P414; Edwards R, 2000, J HYPERTENS, V18, P145, DOI 10.1097/00004872-200018020-00003; Ejim EC, 2011, J TROPICAL MED; Ekanem US, 2013, AFR HEALTH SCI, V13, P56, DOI 10.4314/ahs.v13i1.8; Ekwunife O. I., 2010, Health, V2, P731; ELBAGIR M, 1990, J HUM HYPERTENS, V4, P621; Erhun W. O., 2005, African Journal of Biomedical Research, V8, P15; Ezeji J, 2013, INT J BASIC APPL SCI, V13, P26; Fezeu L, 2010, J EPIDEMIOL COMMUN H, V64, P360, DOI 10.1136/jech.2008.086355; Gaziano TA, 2005, CIRCULATION, V112, P3569, DOI 10.1161/CIRCULATIONAHA.105.535922; Ghannem H., 1997, Eastern Mediterranean Health Journal, V3, P472; Giday Araya, 2011, Ethiop Med J, V49, P139; GILES WH, 1994, AM J MED SCI, V308, P271, DOI 10.1097/00000441-199411000-00003; Goma FM, 2011, INT ARCH MED, V4; Hajjar I, 2006, ANNU REV PUBL HEALTH, V27, P465, DOI 10.1146/annurev.publhealth.27.021405.102132; Hamida F, 2013, ANN CARDIOL ANGEIOL, V62, P172, DOI 10.1016/j.ancard.2013.04.008; Hammami S, 2011, BMC CARDIOVASC DISOR, V11, DOI 10.1186/1471-2261-11-65; Hendriks ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032638; Houinato DS, 2012, REV EPIDEMIOL SANTE, V60, P95, DOI 10.1016/j.respe.2011.09.010; IBRAHIM MM, 1995, HYPERTENSION, V26, P886, DOI 10.1161/01.HYP.26.6.886; Institute for Security Studies, 2010, REV RUR URB MIGR IND; Isezuo SA, 2011, J HUM HYPERTENS, V25, P224, DOI 10.1038/jhh.2010.56; Kamadjeu RM, 2006, J HUM HYPERTENS, V20, P91, DOI 10.1038/sj.jhh.1001936; Katchunga Philippe B, 2011, Presse Med, V40, pe315, DOI 10.1016/j.lpm.2010.10.036; Kayima J, 2013, BMC CARDIOVASC DISOR, V13, DOI 10.1186/1471-2261-13-54; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Kengne AP, 2012, CARDIOVASC J AFR, V23, P105, DOI 10.5830/CVJA-2011-042; Koopman JJE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046855; Laouani Kechrid Chadia, 2004, Tunis Med, V82, P1001; Latifa Boukli Hacene, 2007, Sante, V17, P153, DOI 10.1684/san.2007.0079; Lawes CMM, 2006, J HYPERTENS, V24, P413, DOI 10.1097/01.hjh.0000199801.72563.6f; Macia E, 2012, CARDIOVASC J AFR, V23, P265, DOI 10.5830/CVJA-2011-039; MacMahon S, 2008, LANCET, V371, P1480, DOI 10.1016/S0140-6736(08)60632-7; Maher D, 2011, J HYPERTENS, V29, P1061, DOI 10.1097/HJH.0b013e3283466e90; Malaza A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047761; Mathenge W, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-569; Mauny F, 2003, ANN TROP MED PARASIT, V97, P645, DOI 10.1179/000349803225001535; Mayega RW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047632; MBUYAMBAKABANGU JR, 1986, J HYPERTENS, V4, P485, DOI 10.1097/00004872-198608000-00015; Mezue K, 2013, PERSPECT PUBLIC HLTH; Mohamed M R, 2000, J Egypt Public Health Assoc, V75, P391; Mohan V, 2013, INT J HYPERTENS, V2013, DOI 10.1155/2013/409083; Msyamboza KP, 2012, INT HEALTH, V4, P246, DOI 10.1016/j.inhe.2012.09.005; Mufunda J, 2006, J HUM HYPERTENS, V20, P59, DOI 10.1038/sj.jhh.1001924; Musinguzi G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062236; N'Gouin-Claih AP, 2003, ARCH MAL COEUR VAISS, V96, P763; Negin J, 2011, TROP MED INT HEALTH, V16, P640, DOI 10.1111/j.1365-3156.2011.02739.x; Nejjari C, 2013, J HYPERTENS, V31, P49, DOI 10.1097/HJH.0b013e32835a6611; Niakara A, 2007, T ROY SOC TROP MED H, V101, P1136, DOI 10.1016/j.trstmh.2007.07.002; Nshisso LD, 2012, DIABETES METAB SYND, V6, P36, DOI 10.1016/j.dsx.2012.05.005; Odugbemi T O, 2012, Niger Postgrad Med J, V19, P1; Ogah OS, 2013, ETHNIC DIS, V23, P161; Oghagbon EK, 2008, NIGER J CLIN PRACT, V11, P342; Oladapo OO, 2010, CARDIOVASC J AFR, V21, P26; Omorogiuwa A, 2009, INT J BIOMED HLTH SC, V5, P103; Omuemu V O, 2007, Niger J Clin Pract, V10, P208; Opie LH, 2005, CIRCULATION, V112, P3536, DOI 10.1161/CIRCULATIONAHA.105.597765; Opie LH, 2005, CIRCULATION, V112, P3562, DOI 10.1161/CIRCULATIONAHA.105.539569; Organization WH, 2016, GLOBAL STATUS REPORT; Ozumba BC, 2004, J OBSTET GYN INDIA, V54, P575; Peltzer K, 2013, CARDIOVASC J AFR, V24, P66, DOI 10.5830/CVJA-2013-002; Perkovic V, 2007, HYPERTENSION, V50, P991, DOI 10.1161/HYPERTENSIONAHA.107.095497; Pires JE, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-90; Poulter NR, 2011, J HYPERTENS, V29, P1281, DOI 10.1097/HJH.0b013e328347f437; Seedat Y K, 2006, Cardiovasc J S Afr, V17, P47; Steyn K, 1996, E AFR MED J, V73, P758; Steyn K, 2004, ETHNIC DIS, V14, P233; STEYN K, 1986, S AFR MED J, V69, P165; Suhrcke M, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-2; Suleiman Ismail A., 2013, Pharmacy Practice (Internet), V11, P24, DOI 10.4321/s1886-36552013000100005; Tazi MA, 2003, J HYPERTENS, V21, P897, DOI 10.1097/00004872-200305000-00013; Temmar M, 2007, J HYPERTENS, V25, P2218, DOI 10.1097/HJH.0b013e3282dc7549; Tesfaye F, 2009, BMC CARDIOVASC DISOR, V9, DOI 10.1186/1471-2261-9-39; Thorogood M, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-326; Tran A, 2011, INT J HYPERTENS, V2011, DOI 10.4061/2011/193719; Twagirumukiza M, 2011, J HYPERTENS, V29, P1243, DOI 10.1097/HJH.0b013e328346995d; U.S. Department of Health and Human Services, 1997, 6 US DEP HLTH HUM SE; Ulasi II, 2011, INT J HYPERTENS, V2011, DOI 10.4061/2011/869675; Ulasi II, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-71; United Nations, 2013, WORLD POP AG 2013; van de Vijver SJM, 2013, J HYPERTENS, V31, P1018, DOI 10.1097/HJH.0b013e32835e3a56; van der Sande MAB, 2001, HEALTH POLICY PLANN, V16, P345, DOI 10.1093/heapol/16.4.345; van der Sande MAB, 2000, J HUM HYPERTENS, V14, P489, DOI 10.1038/sj.jhh.1001050; Wamala JF, 2009, AFR HEALTH SCI, V9, P153; WHO, 2013, WHODCOWHD20132; Williams EA, 2013, DIABETES METAB SYND, V7, P123, DOI 10.1016/j.dsx.2013.06.015; World Health Organisation. AFRO, 2005, REP REG DIR CARD DIS; World Heart Federation, 2008, AFR BURD CVD HYP WOR; Yayehd K, 2013, ANN CARDIOL ANGEIOL, V62, P43, DOI 10.1016/j.ancard.2012.09.006	129	131	132	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e104300	10.1371/journal.pone.0104300	http://dx.doi.org/10.1371/journal.pone.0104300			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM4GX	25090232	Green Published, gold, Green Submitted			2022-12-27	WOS:000339812700117
J	Lai, H; Mo, XW; Yang, Y; Xiao, J; He, K; Chen, JS; Lin, Y				Lai, Hao; Mo, Xianwei; Yang, Yang; Xiao, Jun; He, Ke; Chen, Jiansi; Lin, Yuan			Association between Duration of Carbon Dioxide Pneumoperitoneum during Laparoscopic Abdominal Surgery and Hepatic Injury: A Meta-Analysis	PLOS ONE			English	Article							LIVER-FUNCTION TESTS; BLOOD-FLOW; GASTRIC-CANCER; LOW-PRESSURE; CHOLECYSTECTOMY; ENZYMES; GASTRECTOMY; APPENDECTOMY; DYSFUNCTION	Background: The aim of this study is to accurately assess whether the duration of intraoperative carbon dioxide pneumoperitoneum (CDP) is associated with the induction of hepatic injury. Methods: We conducted a systematic review of PubMed, Embase, and Cochrane Library databases (through February 2014) to identify case-match studies that compared high-pressure CDP with low-pressure CDP or varied the duration of CDP in patients who underwent abdominal surgery. The outcome of interest was postoperative liver function (ALT, AST, TB). Results: Eleven comparative studies involving 2,235 participants were included. Overall, levels of ALT, AST, and TB (on postoperative days 1, 3, and 7) were significantly elevated in the study groups. However, the results of the subanalyses of those who underwent laparoscopic colorectal cancer resection (LCR) versus open colorectal cancer resection (OCR) and those who underwent laparoscopic gastric bypass (LGBP) versus open gastric bypass (OGBP) were inconsistent. Conclusions: The current evidence suggests that the duration of CDP during laparoscopic abdominal surgery may be associated with hepatic injury. Additional large-scale, randomized, controlled trials are urgently needed to further confirm this.	[Lai, Hao; Mo, Xianwei; Yang, Yang; Xiao, Jun; Chen, Jiansi; Lin, Yuan] Guangxi Med Univ, Affiliated Canc Hosp, Dept Gastrointestinal Surg, Nanning, Guangxi Autonom, Peoples R China; [He, Ke] Guangxi Med Univ, Affiliated Canc Hosp, Dept Neck & Head Surg, Nanning, Guangxi Autonom, Peoples R China	Guangxi Medical University; Guangxi Medical University	Chen, JS (corresponding author), Guangxi Med Univ, Affiliated Canc Hosp, Dept Gastrointestinal Surg, Nanning, Guangxi Autonom, Peoples R China.	Chenjiansi168@sina.cn; doctoryuanlin@sina.cn						Andrei VE, 1998, DIGEST SURG, V15, P256, DOI 10.1159/000018624; Atila K, 2009, J LAPAROENDOSC ADV S, V19, P39, DOI 10.1089/lap.2008.0085; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bickel A, 2008, J GASTROINTEST SURG, V12, P1418, DOI 10.1007/s11605-008-0557-0; Bohm B, 1999, VISZERALCHIRURGIE, V34, P20; Brundell SM, 2002, BRIT J SURG, V89, P617, DOI 10.1046/j.1365-2168.2002.02071.x; Chen K, 2013, WORLD J GASTROENTERO, V19, P5365, DOI 10.3748/wjg.v19.i32.5365; CLARKE RSJ, 1976, BRIT J ANAESTH, V48, P119, DOI 10.1093/bja/48.2.119; Dexter SPL, 1999, SURG ENDOSC, V13, P376, DOI 10.1007/s004649900993; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Eryilmaz HB, 2012, SCI WORLD J, DOI 10.1100/2012/172575; Etoh T, 2007, WORLD J SURG, V31, P1115, DOI 10.1007/s00268-007-0237-3; Glantzounis GK, 2001, SURG ENDOSC, V15, P1315, DOI 10.1007/s00464-001-0034-2; Guven HE, 2007, J GASTROINTEST LIVER, V16, P391; Gupta R, 2013, J LAPAROENDOSC ADV S, V23, P339, DOI 10.1089/lap.2012.0399; Gutt CN, 2004, DIGEST SURG, V21, P95, DOI 10.1159/000077038; HALEVY A, 1994, ANN SURG, V219, P362, DOI 10.1097/00000658-199404000-00006; Hasukic S, 2005, SURG ENDOSC, V19, P1451, DOI 10.1007/s00464-005-0061-5; Hasukic SK, 2005, MED PRIN PRACT, V14, P147, DOI 10.1159/000084630; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Jeong GA, 2011, WORLD J GASTROENTERO, V17, P372, DOI 10.3748/wjg.v17.i3.372; Kinjo Y, 2011, WORLD J SURG, V35, P2730, DOI 10.1007/s00268-011-1301-6; Li XH, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-129; Liang YC, 2011, ANZ J SURG, V81, P673, DOI 10.1111/j.1445-2197.2010.05599.x; Markar SR, 2012, J GASTROINTEST SURG, V16, P1993, DOI 10.1007/s11605-012-1962-y; Morino M, 1998, SURG ENDOSC-ULTRAS, V12, P968, DOI 10.1007/s004649900758; Nguyen NT, 2003, AM J SURG, V186, P40, DOI 10.1016/S0002-9610(03)00106-5; Omari A, 2007, J LAPAROENDOSC ADV S, V17, P419, DOI 10.1089/lap.2006.0160; Osman Yildirim, 2009, JPMA Journal of the Pakistan Medical Association, V59, P201; Richter S, 2001, ANESTH ANALG, V93, P872, DOI 10.1097/00000539-200110000-00014; Saber AA, 2000, AM SURGEON, V66, P699; Saber AA, 2007, J GASTROINTEST LIVER, V16, P427; Said-Ahmed HAEF, 2004, ACTA ANAESTHESIOLOGI, V55, P120; Sakorafas George, 2005, N Z Med J, V118, pU1317; Sato K, 2000, ANESTH ANALG, V90, P1198, DOI 10.1097/00000539-200005000-00037; Takagi S, 1998, SURG ENDOSC-ULTRAS, V12, P427, DOI 10.1007/s004649900696; Tan M, 2003, WORLD J GASTROENTERO, V9, P364, DOI 10.3748/wjg.v9.i2.364; Tunon MJ, 1999, SURG ENDOSC-ULTRAS, V13, P668, DOI 10.1007/s004649901070; Yoon HM, 2011, SURG ENDOSC, V25, P1761, DOI 10.1007/s00464-010-1449-4	39	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2014	9	8							e104067	10.1371/journal.pone.0104067	http://dx.doi.org/10.1371/journal.pone.0104067			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WB	25110982	Green Published, gold, Green Submitted			2022-12-27	WOS:000341105100027
J	Sousa, ACPD; Guerra, RO; Tu, MT; Phillips, SP; Guralnik, JM; Zunzunegui, MV				de Albuquerque Sousa, Ana Carolina Patricio; Guerra, Ricardo Oliveira; Tu, Mai Thanh; Phillips, Susan P.; Guralnik, Jack M.; Zunzunegui, Maria-Victoria			Lifecourse Adversity and Physical Performance across Countries among Men and Women Aged 65-74	PLOS ONE			English	Article							CHILDHOOD SOCIOECONOMIC-STATUS; LOWER-EXTREMITY FUNCTION; LIFE-COURSE; SUBSEQUENT DISABILITY; OLDER-PEOPLE; ASSOCIATION; MORTALITY; BATTERY; EPIDEMIOLOGY; INEQUALITIES	Background: This study examines the associations between lifecourse adversity and physical performance in old age in different societies of North and South America and Europe. Methods: We used data from the baseline survey of the International Study of Mobility in Aging, conducted in: Kingston (Canada), Saint-Hyacinthe (Canada), Natal (Brazil), Manizales (Colombia) and Tirana (Albania). The study population was composed of community dwelling people between 65 and 74 years of age, recruiting 200 men and 200 women at each site. Physical Performance was assessed with the Short Physical Performance Battery (SPPB). Economic and social adversity was estimated from childhood adverse events, low education, semi-skilled occupations during adulthood and living alone and insufficient income in old age. Results: A total of 1995 people were assessed. Low physical performance was associated with childhood social and economic adversity, semi-skilled occupations, living alone and insufficient income. Physical performance was lower in participants living in Colombia, Brazil and Albania than in Canada counterparts, despite adjustment for lifecourse adversity, age and sex. Conclusions: We show evidence of the early origins of social and economic inequalities in physical performance during old age in distinct populations and for the independent and cumulative disadvantage of low socioeconomic status during adulthood and poverty and living alone in later life.	[de Albuquerque Sousa, Ana Carolina Patricio] Univ Fed Rio Grande do Norte, CNPQ Programa Posgrad Ciencias Saude, BR-59072970 Natal, RN, Brazil; [Guerra, Ricardo Oliveira] Univ Fed Rio Grande do Norte, Dept Physiotherapy, BR-59072970 Natal, RN, Brazil; [Tu, Mai Thanh; Zunzunegui, Maria-Victoria] Univ Montreal, Ecole Sante Publ, Montreal, PQ, Canada; [Phillips, Susan P.] Queens Univ, Dept Family Med, Kingston, ON, Canada; [Guralnik, Jack M.] Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, Div Gerontol, Baltimore, MD 21201 USA; [Zunzunegui, Maria-Victoria] CRCHUM, Montreal, PQ, Canada	Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte; Universite de Montreal; Queens University - Canada; University System of Maryland; University of Maryland Baltimore; Universite de Montreal	Guerra, RO (corresponding author), Univ Fed Rio Grande do Norte, Dept Physiotherapy, BR-59072970 Natal, RN, Brazil.	roguerra@ufrnet.br	GUERRA, Ricardo/J-7586-2015	GUERRA, Ricardo/0000-0003-3824-3713; Zunzunegui, Maria-Victoria/0000-0003-0827-2804; Phillips, Susan/0000-0003-4798-1742	Canadian Institutes for Health Research, Mobility in Aging Initiative;  [AAM 108751]	Canadian Institutes for Health Research, Mobility in Aging Initiative; 	This work was supported by the Canadian Institutes for Health Research, Mobility in Aging Initiative. Funding Reference Number AAM 108751. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler N, 2012, P NATL ACAD SCI USA, V109, P17154, DOI 10.1073/pnas.1121399109; Barnes LL, 2012, NEUROLOGY, V79, P2321, DOI 10.1212/WNL.0b013e318278b607; Ben-Shlomo Y, 2002, INT J EPIDEMIOL, V31, P285, DOI 10.1093/ije/31.2.285; Birnie K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015564; Bruna G, 2006, ANN EPIDEMIOL, V16, P91; Brunner E, 2009, J GERONTOL A-BIOL, V64, P1082, DOI 10.1093/gerona/glp078; de Leon CFM, 1999, J GERONTOL B-PSYCHOL, V54, pS162, DOI 10.1093/geronb/54B.3.S162; de Yebenes MJG, 2003, INT J GERIATR PSYCH, V18, P925, DOI 10.1002/gps.947; Dube SR, 2010, PREV CHRONIC DIS, V7; Ferri CP, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001179; Freire AN, 2012, J AGING HEALTH, V24, P863, DOI 10.1177/0898264312438551; Fujiwara T, 2014, J GERONTOL A-BIOL, V69, P852, DOI 10.1093/gerona/glt189; Fuller-Thomson E, 2009, ARTHRIT RHEUM-ARTHR, V61, P1554, DOI 10.1002/art.24871; Grundy E, 2001, J EPIDEMIOL COMMUN H, V55, P895, DOI 10.1136/jech.55.12.895; Guerra RO, 2008, AGING CLIN EXP RES, V20, P53; Guralnik JM, 2006, J GERONTOL A-BIOL, V61, P694, DOI 10.1093/gerona/61.7.694; GURALNIK JM, 1995, NEW ENGL J MED, V332, P556, DOI 10.1056/NEJM199503023320902; GURALNIK JM, 1994, J GERONTOL, V49, pM85, DOI 10.1093/geronj/49.2.M85; Hairi FM, 2010, J EPIDEMIOL COMMUN H, V64, P829, DOI 10.1136/jech.2009.088476; Huisman M, 2003, SOC SCI MED, V57, P861, DOI 10.1016/S0277-9536(02)00454-9; Keeler E, 2010, J GERONTOL A-BIOL, V65, P727, DOI 10.1093/gerona/glq029; Kuh D, 2003, J EPIDEMIOL COMMUN H, V57, P778, DOI 10.1136/jech.57.10.778; Lawlor DA, 2006, AM J EPIDEMIOL, V164, P907, DOI 10.1093/aje/kwj319; Minkler M, 2006, NEW ENGL J MED, V355, P695, DOI 10.1056/NEJMsa044316; Richter M, 2013, INT J PUBLIC HEALTH, V58, P1, DOI 10.1007/s00038-012-0436-z; Schollgen I, 2010, EUR J AGEING, V7, P17, DOI 10.1007/s10433-010-0140-x; Seidel D, 2011, AGE AGEING, V40, P463, DOI 10.1093/ageing/afr054; Smith GD, 1997, BMJ-BRIT MED J, V314, P547, DOI 10.1136/bmj.314.7080.547; United Nations Development Programme (UNDP), 2014, HUM DEV REP 2013 RIS; Vasunilashorn S, 2009, J GERONTOL A-BIOL, V64, P223, DOI 10.1093/gerona/gln022; WHO, 2006, PREV CHILD MALTR GUI; Zunzunegui M V, 2005, Eur J Ageing, V2, P40, DOI 10.1007/s10433-005-0021-x	32	52	54	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e102299	10.1371/journal.pone.0102299	http://dx.doi.org/10.1371/journal.pone.0102299			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM6SB	25101981	gold, Green Published, Green Submitted			2022-12-27	WOS:000339993900002
J	Jeganathan, S; Fiorino, C; Naik, U; Sun, HS; Harrison, RE				Jeganathan, Sujeeve; Fiorino, Cara; Naik, Urja; Sun, He Song; Harrison, Rene E.			Modulation of Osteoclastogenesis with Macrophage M1-and M2-Inducing Stimuli	PLOS ONE			English	Article							FOREIGN-BODY REACTION; GIANT-CELL FORMATION; ACTIVATED MACROPHAGES; STABLE MICROTUBULES; BIOACTIVE GLASSES; ACTIN-FILAMENTS; STROMAL CELLS; CATHEPSIN-K; MYOSIN-II; IN-VITRO	Macrophages are generated through the differentiation of monocytes in tissues and they have important functions in innate and adaptive immunity. In addition to their roles as phagocytes, macrophages can be further differentiated, in the presence of receptor activator of nuclear factor kappa-B ligand (RANKL) and macrophage colony-stimulating factor (M-CSF), into osteoclasts (multinucleated giant cells that are responsible for bone resorption). In this work, we set out to characterize whether various inflammatory stimuli, known to induce macrophage polarization, can alter the type of multinucleated giant cell obtained from RANKL differentiation. Following a four-day differentiation protocol, along with lipopolysaccharide (LPS)/interferon gamma (IFN gamma) as one stimulus, and interleukin-4 (IL-4) as the other, three types of multinucleated cells were generated. Using various microscopy techniques (bright field, epifluorescence and scanning electron), functional assays, and western blotting for osteoclast markers, we found that, as expected, RANKL treatment alone resulted in osteoclasts, whereas the addition of LPS/IFN gamma to RANKL pre-treated macrophages generated Langhans-type giant cells, while IL-4 led to giant cells resembling foreign body giant cells with osteoclast-like characteristics. Finally, to gain insight into the modulation of osteoclastogenesis, we characterized the formation and morphology of RANKL and LPS/IFN gamma-induced multinucleated giant cells.	[Jeganathan, Sujeeve] Univ Hlth Network, Ontario Canc Inst, Toronto, ON, Canada; [Jeganathan, Sujeeve] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada; [Fiorino, Cara; Naik, Urja; Sun, He Song; Harrison, Rene E.] Univ Toronto Scarborough, Dept Biol Sci, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University Toronto Scarborough	Harrison, RE (corresponding author), Univ Toronto Scarborough, Dept Biol Sci, Toronto, ON, Canada.	harrison@utsc.utoronto.ca			Natural Science and Engineering Research Council (NSERC) [RGPIN 298538-09]; Canadian Institutes of Health Research	Natural Science and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by a Natural Science and Engineering Research Council (NSERC) grant (RGPIN 298538-09) to REH. REH is the recipient of an Ontario Early Researcher Award (ERA) and a Canadian Institutes of Health Research New Investigator Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Anderson JM, 2000, CURR OPIN HEMATOL, V7, P40, DOI 10.1097/00062752-200001000-00008; BOGDAN C, 1992, J LEUKOCYTE BIOL, V52, P119, DOI 10.1002/jlb.52.1.119; Bohm KJ, 1999, CELL BIOL INT, V23, P431, DOI 10.1006/cbir.1999.0382; Bosetti M, 2005, BIOMATERIALS, V26, P3873, DOI 10.1016/j.biomaterials.2004.09.059; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Brodbeck WG, 2009, CURR OPIN HEMATOL, V16, P53, DOI 10.1097/MOH.0b013e32831ac52e; Buhling F, 2001, J PATHOL, V195, P375; CAMBRAYDEAKIN MA, 1987, CELL MOTIL CYTOSKEL, V8, P284, DOI 10.1002/cm.970080309; Carboni J M, 1993, J Natl Cancer Inst Monogr, P95; Carter JD, 2009, RHEUM DIS CLIN N AM, V35, P21, DOI 10.1016/j.rdc.2009.03.010; CASELLA JF, 1981, NATURE, V293, P302, DOI 10.1038/293302a0; Cheng J, 2011, J CELL BIOCHEM, V112, P3385, DOI 10.1002/jcb.23269; Collin-Osdoby P, 2003, METH MOLEC MED, V80, P153; Eng EW, 2007, MOL BIOL CELL, V18, P2389, DOI 10.1091/mbc.e06-12-1128; Fujii T, 2012, BONE, V51, P771, DOI 10.1016/j.bone.2012.06.024; Goldenberg DL, 1998, LANCET, V351, P197, DOI 10.1016/S0140-6736(97)09522-6; Grevers L, 2012, ANN RHEUMATIC DIS; Guerriero C, 2007, AM J PHYSIOL-CELL PH, V292, P6; Hanania R, 2012, J BIOL CHEM, V287, P8468, DOI 10.1074/jbc.M111.290676; HOGG N, 1980, CELL TISSUE RES, V212, P509; Islam S, 2007, BIOCHEM BIOPH RES CO, V360, P346, DOI 10.1016/j.bbrc.2007.06.023; Isowa N, 2000, AM J PHYSIOL-LUNG C, V279, P82; Ivashkiv L, 2012, TRENDS IMMUNOLOGY; Ji JD, 2009, J IMMUNOL, V183, P7223, DOI 10.4049/jimmunol.0900072; Jiang J, 2006, J ENDODONT, V32, P742, DOI 10.1016/j.joen.2006.02.003; Jones JA, 2008, J BIOMED MATER RES A, V84A, P158, DOI 10.1002/jbm.a.31220; Karpov M, 2008, J BIOMED MATER RES A, V84A, P718, DOI 10.1002/jbm.a.31386; Kotake S, 2005, EUR J IMMUNOL, V35, P3353, DOI 10.1002/eji.200526141; Kovacs M, 2004, J BIOL CHEM, V279, P35557, DOI 10.1074/jbc.M405319200; KUPFER A, 1983, P NATL ACAD SCI-BIOL, V80, P7224, DOI 10.1073/pnas.80.23.7224; Lay G, 2007, J PATHOL, V211, P76, DOI 10.1002/path.2092; Lee JSH, 2005, MOL BIOL CELL, V16, P871, DOI 10.1091/mbc.e03-12-0910; Liu JZ, 2009, J BIOL CHEM, V284, P12512, DOI 10.1074/jbc.M809789200; Luttikhuizen DT, 2006, BIOMATERIALS, V27, P5763, DOI 10.1016/j.biomaterials.2006.07.004; Luttikhuizen DT, 2006, TISSUE ENG, V12, P1955, DOI 10.1089/ten.2006.12.1955; MacLauchlan S, 2009, J LEUKOCYTE BIOL, V85, P617, DOI 10.1189/jlb.1008588; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; McNally AK, 2005, EXP MOL PATHOL, V79, P126, DOI 10.1016/j.yexmp.2005.06.008; McNally AK, 2011, ADV EXP MED BIOL, V713, P97, DOI 10.1007/978-94-007-0763-4_7; Mitchison TJ, 1996, CELL, V84, P371, DOI 10.1016/S0092-8674(00)81281-7; Mosser David M, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1402s83; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Nakamura N, 1995, J CELL BIOL, V131, P1715, DOI 10.1083/jcb.131.6.1715; Patel PC, 2008, MOL BIOL CELL, V19, P4628, DOI 10.1091/mbc.E08-02-0223; Patel PC, 2009, MOL CELL PROTEOMICS, V8, P2500, DOI 10.1074/mcp.M900190-MCP200; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Saltel F, 2004, MOL BIOL CELL, V15, P5231, DOI 10.1091/mbc.E04-06-0522; Shashkin P, 2005, CURR PHARM DESIGN, V11, P3061, DOI 10.2174/1381612054865064; Small JV, 2002, TRENDS CELL BIOL, V12, P112, DOI 10.1016/S0962-8924(01)02237-1; Stumpe KDM, 2009, SEMIN NUCL MED, V39, P27, DOI 10.1053/j.semnuclmed.2008.08.003; Vaahtio M, 2006, J MATER SCI-MATER M, V17, P1113, DOI 10.1007/s10856-006-0538-3; VANDERRHEE HJ, 1978, ARCH DERMATOL RES, V263, P13, DOI 10.1007/BF00446849; VERKHOVSKY AB, 1995, J CELL BIOL, V131, P989, DOI 10.1083/jcb.131.4.989; Wijenayaka AKAR, 2009, J MATER SCI-MATER M, V20, P1467, DOI 10.1007/s10856-009-3718-0; Zenger S, 2007, BONE, V41, P820, DOI 10.1016/j.bone.2007.07.010; Zou W, 2002, J BONE MINER RES, V17, P1211, DOI 10.1359/jbmr.2002.17.7.1211	58	26	28	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e104498	10.1371/journal.pone.0104498	http://dx.doi.org/10.1371/journal.pone.0104498			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25101660	Green Published, Green Submitted, gold			2022-12-27	WOS:000339993900070
J	Masiulionis, VE; Rabeling, C; Licht, HHD; Schultz, T; Bacci, M; Bezerra, CMS; Pagnocca, FC				Masiulionis, Virginia E.; Rabeling, Christian; Licht, Henrik H. De Fine; Schultz, Ted; Bacci, Mauricio, Jr.; Santos Bezerra, Cintia M.; Pagnocca, Fernando C.			A Brazilian Population of the Asexual Fungus-Growing Ant Mycocepurus smithii (Formicidae, Myrmicinae, Attini) Cultivates Fungal Symbionts with Gongylidia-Like Structures	PLOS ONE			English	Article							ACROMYRMEX-OCTOSPINOSUS REICH; MULTIPLE SEQUENCE ALIGNMENT; NEST ARCHITECTURE; FARMING ANTS; HYMENOPTERA; ORIGIN; PHYLOGENY; EVOLUTION; DIVERSITY; NUTRIENTS	Attine ants cultivate fungi as their most important food source and in turn the fungus is nourished, protected against harmful microorganisms, and dispersed by the ants. This symbiosis evolved approximately 50-60 million years ago in the late Paleocene or early Eocene, and since its origin attine ants have acquired a variety of fungal mutualists in the Leucocoprineae and the distantly related Pterulaceae. The most specialized symbiotic interaction is referred to as "higher agriculture'' and includes leafcutter ant agriculture in which the ants cultivate the single species Leucoagaricus gongylophorus. Higher agriculture fungal cultivars are characterized by specialized hyphal tip swellings, so-called gongylidia, which are considered a unique, derived morphological adaptation of higher attine fungi thought to be absent in lower attine fungi. Rare reports of gongylidia-like structures in fungus gardens of lower attines exist, but it was never tested whether these represent rare switches of lower attines to L. gonglyphorus cultivars or whether lower attine cultivars occasionally produce gongylidia. Here we describe the occurrence of gongylidia-like structures in fungus gardens of the asexual lower attine ant Mycocepurus smithii. To test whether M. smithii cultivates leafcutter ant fungi or whether lower attine cultivars produce gongylidia, we identified the M. smithii fungus utilizing molecular and morphological methods. Results shows that the gongylidia-like structures of M. smithii gardens are morphologically similar to gongylidia of higher attine fungus gardens and can only be distinguished by their slightly smaller size. A molecular phylogenetic analysis of the fungal ITS sequence indicates that the gongylidia-bearing M. smithii cultivar belongs to the so-called "Clade 1'' of lower Attini cultivars. Given that M. smithii is capable of cultivating a morphologically and genetically diverse array of fungal symbionts, we discuss whether asexuality of the ant host maybe correlated with low partner fidelity and active symbiont choice between fungus and ant mutualists.	[Masiulionis, Virginia E.; Bacci, Mauricio, Jr.; Santos Bezerra, Cintia M.; Pagnocca, Fernando C.] Sao Paulo State Univ, Inst Biociencias, Rio Claro, SP, Brazil; [Rabeling, Christian] Harvard Univ, Museum Comparat Zool, Cambridge, MA 02138 USA; [Rabeling, Christian; Schultz, Ted] Smithsonian Inst, Natl Museum Nat Hist, Dept Entomol, Washington, DC 20560 USA; [Licht, Henrik H. De Fine] Univ Copenhagen, Sect Organismal Biol, Dept Plant & Environm Sci, Copenhagen, Denmark	Universidade Estadual Paulista; Harvard University; Smithsonian Institution; Smithsonian National Museum of Natural History; University of Copenhagen	Masiulionis, VE (corresponding author), Sao Paulo State Univ, Inst Biociencias, Rio Claro, SP, Brazil.	vemasiulionis@gmail.com	Masiulionis, Virginia Elena/L-6800-2013; de Fine Licht, Henrik Hjarvard/G-3307-2014; Bacci, Mauricio/C-4960-2013	Masiulionis, Virginia Elena/0000-0002-3619-5781; de Fine Licht, Henrik Hjarvard/0000-0003-3326-5729; Bacci, Mauricio/0000-0002-5619-1411	CNPq; Fapesp; CAPES/PEC-PG scholarship; Harvard Society of Fellows; HMS Milton Fund; U.S. National Science Foundation [DEB 0949689]; Smithsonian Institution Scholarly Studies Program; Smithsonian NMNH Small Grants Program; Danish Research Council; Carlsberg Foundation	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fapesp(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES/PEC-PG scholarship; Harvard Society of Fellows; HMS Milton Fund; U.S. National Science Foundation(National Science Foundation (NSF)); Smithsonian Institution Scholarly Studies Program; Smithsonian NMNH Small Grants Program; Danish Research Council(Det Frie Forskningsrad (DFF)); Carlsberg Foundation(Carlsberg Foundation)	FCP and MB are grateful to CNPq and Fapesp for their financial support. VEM is a recipient of a CAPES/PEC-PG scholarship. CR was financially supported by a Junior Fellowship from the Harvard Society of Fellows and the HMS Milton Fund. TS was supported by the U.S. National Science Foundation grant DEB 0949689, the Smithsonian Institution Scholarly Studies Program, and the Smithsonian NMNH Small Grants Program. HHDFL was supported by grants from the Danish Research Council and the Carlsberg Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGELIPAPA J, 1985, ANN SCI NAT BOT BIOL, V7, P103; Ayres M., 2007, BIOESTAT 5 0; BASS M, 1995, PHYSIOL ENTOMOL, V20, P1, DOI 10.1111/j.1365-3032.1995.tb00793.x; Bass M, 1996, FUNCT ECOL, V10, P55, DOI 10.2307/2390262; BENSON WW, 1975, EVOLUTION, V29, P659, DOI 10.1111/j.1558-5646.1975.tb00861.x; BLACKSTONE NW, 1995, EVOLUTION, V49, P785, DOI 10.1111/j.1558-5646.1995.tb02315.x; BRANDAO C R F, 1991, Revista Brasileira de Entomologia, V35, P319; Brown JM, 2010, SYST BIOL, V59, P145, DOI 10.1093/sysbio/syp081; CHAPELA IH, 1994, SCIENCE, V266, P1691, DOI 10.1126/science.266.5191.1691; Currie CR, 1999, P NATL ACAD SCI USA, V96, P7998, DOI 10.1073/pnas.96.14.7998; Currie CR, 2001, OECOLOGIA, V128, P99, DOI 10.1007/s004420100630; EHRLICH PR, 1964, EVOLUTION, V18, P586, DOI 10.2307/2406212; Fernandez-Marin H, 2005, J NAT HIST, V39, P1735, DOI 10.1080/00222930400027462; FURLETTI MEM, 1983, REV MICROBIOL, V14, P183; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Herre EA, 1996, J BIOGEOGR, V23, P521, DOI 10.1111/j.1365-2699.1996.tb00014.x; Himler AG, 2009, P ROY SOC B-BIOL SCI, V276, P2611, DOI 10.1098/rspb.2009.0313; HINKLE G, 1994, SCIENCE, V266, P1695, DOI 10.1126/science.7992052; Holldobler B., 1990, pi; Hu┬lldobler B., 2010, LEAFCUTTER ANTS CIVI; JANZEN DH, 1980, EVOLUTION, V34, P611, DOI 10.1111/j.1558-5646.1980.tb04849.x; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kellner K, 2013, J EVOLUTION BIOL, V26, P1353, DOI 10.1111/jeb.12140; KEMPF W W, 1972, Studia Entomologica, V15, P3; Kempf W. W., 1963, Studia Entomologica Petropolis (NS), V6, P417; Licht HHDF, 2013, P NATL ACAD SCI USA, V110, P583, DOI 10.1073/pnas.1212709110; LITTLEDYKE M, 1976, B ENTOMOL RES, V66, P205, DOI 10.1017/S0007485300006647; Maddison DR, 2000, MACCLADE V4 0; Manter DK, 2007, J MICROBIOL METH, V71, P7, DOI 10.1016/j.mimet.2007.06.016; MARTIN MM, 1969, ANN ENTOMOL SOC AM, V62, P11, DOI 10.1093/aesa/62.1.11; Martins J, 2007, INSECT MOL BIOL, V16, P777, DOI 10.1111/j.1365-2583.2007.00771.x; Mayhe-Nunes Antonio, 1998, Ecotropicos, V11, P45; Mehdiabadi NJ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1844; Mehdiabadi NJ, 2010, MYRMECOL NEWS, V13, P37; Mikheyev AS, 2010, AM NAT, V175, pE126, DOI 10.1086/652472; Moller A., 1893, BOT MITT TROP, V6, P1; Mueller UG, 2001, Q REV BIOL, V76, P169, DOI 10.1086/393867; Mueller UG, 1998, SCIENCE, V281, P2034, DOI 10.1126/science.281.5385.2034; Mueller UG, 2002, AM NAT, V160, pS67, DOI 10.1086/342084; Mueller UG, 2004, BEHAV ECOL, V15, P357, DOI 10.1093/beheco/arh020; Mueller UG, 2012, CURR OPIN MICROBIOL, V15, P269, DOI 10.1016/j.mib.2012.03.001; Murakami T, 1997, J ETHOL, V15, P17, DOI 10.1007/BF02767322; NEWTON MA, 1994, J R STAT SOC B, V56, P3; Pagnocca F. C., 2012, Psyche: A Journal of Entomology, V2012, P905109, DOI 10.1155/2012/905109; Pellmyr O, 1996, AM NAT, V148, P827, DOI 10.1086/285958; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; POWELL RJ, 1986, T BRIT MYCOL SOC, V87, P205, DOI 10.1016/S0007-1536(86)80022-5; QUINLAN RJ, 1979, ECOL ENTOMOL, V4, P151, DOI 10.1111/j.1365-2311.1979.tb00570.x; QUINLAN RJ, 1978, ECOL ENTOMOL, V3, P221, DOI 10.1111/j.1365-2311.1978.tb00922.x; QUINLAN RJ, 1977, ECOL ENTOMOL, V2, P161, DOI 10.1111/j.1365-2311.1977.tb00877.x; Rabeling C, 2007, J INSECT SCI, V7, DOI 10.1673/031.007.4001; Rabeling C, 2004, THESIS U TUBINGEN GE; Rabeling C, 2011, P NATL ACAD SCI USA, V108, P12366, DOI 10.1073/pnas.1105467108; Rabeling C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006781; Rambaut A., 2007, TRACER V1 5; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sachs JL, 2011, TRENDS ECOL EVOL, V26, P202, DOI 10.1016/j.tree.2011.01.010; Schultz Ted R., 2005, P149; Schultz TR, 2008, P NATL ACAD SCI USA, V105, P5435, DOI 10.1073/pnas.0711024105; Schultz TR, 2002, INSECT SOC, V49, P331, DOI 10.1007/PL00012657; Schultz TR, 1995, SYST ENTOMOL, V20, P337, DOI 10.1111/j.1365-3113.1995.tb00100.x; Schultz TR, 1993, NOTES UNDERGROUND, V8, P7; Silva A, 2003, J INSECT PHYSIOL, V49, P307, DOI 10.1016/S0022-1910(03)00004-0; Smith J M, 1998, MAJOR TRANSITIONS EV; Solomon SE, 2011, J INSECT SCI, V11, DOI 10.1673/031.011.0112; Sosa-Calvo J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080498; Spegazzini C, 1922, VER MUS LA PLATA, V26, P166; Suchard MA, 2001, MOL BIOL EVOL, V18, P1001, DOI 10.1093/oxfordjournals.molbev.a003872; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Timmis JN, 2004, NAT REV GENET, V5, P123, DOI 10.1038/nrg1271; Vo TL, 2009, MYCOLOGIA, V101, P206, DOI 10.3852/07-055; Ward PS, 2010, SYST BIOL, V59, P342, DOI 10.1093/sysbio/syq012; Weber N.A., 1972, Memoirs Am phil Soc, V92, P1; WEBER NA, 1966, SCIENCE, V153, P587, DOI 10.1126/science.153.3736.587; WEBER NA, 1957, ANAT REC, V128, P638; Wheeler WM, 1907, B AM MUS NAT HIST, V23, P669; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Zwickl D. J, 2006, GENETIC ALGORITHM AP	78	14	16	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e103800	10.1371/journal.pone.0103800	http://dx.doi.org/10.1371/journal.pone.0103800			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25101899	Green Published, gold, Green Submitted			2022-12-27	WOS:000339993900024
J	Xi, YY; Wu, XJ; Gao, LH; Shao, Y; Peng, H; Chen, HX; Chen, HP; Hu, XW; Yue, JJ				Xi, Yongyi; Wu, Xiaojie; Gao, Lihua; Shao, Yong; Peng, Hui; Chen, Hongxing; Chen, Huipeng; Hu, Xianwen; Yue, Junjie			Improving the Anti-Toxin Abilities of the CMG2-Fc Fusion Protein with the Aid of Computational Design	PLOS ONE			English	Article							CAPILLARY MORPHOGENESIS PROTEIN-2; ANTHRAX TOXIN RECEPTOR; CRYSTAL-STRUCTURE; RECOMBINANT ANTHRAX; STRUCTURAL BIOLOGY; ANTIBODIES; LIGAND	CMG2-Fc is a fusion protein composed of the extracellular domain of capillary morphogenesis protein 2 (CMG2) and the Fc region of human immunoglobulin G; CMG2-Fc neutralizes anthrax toxin and offers protection against Bacillus anthracis challenge. To enhance the efficacy of CMG2-Fc against anthrax toxin, we attempted to engineer a CMG2-Fc with an improved affinity for PA. Using the automatic design algorithm FoldX and visual inspection, we devised two CMG2-Fc variants that introduce mutations in the CMG2 binding interface and improve the computationally assessed binding affinity for PA. An experimental affinity assay revealed that the two variants showed increased binding affinity, and in vitro and in vivo toxin neutralization testing indicated that one of these mutants (CMG2-Fc(E117Q)) has superior activity against anthrax toxin and was suitable for further development as a therapeutic agent for anthrax infections. This study shows that the computational design of the PA binding interface of CMG2 to obtain CMG2-Fc variants with improving anti-toxin abilities is viable. Our results demonstrate that computational design can be further applied to generate other CMG2-Fc mutants with greatly improved therapeutic efficacy.	[Xi, Yongyi; Wu, Xiaojie; Gao, Lihua; Shao, Yong; Peng, Hui; Chen, Hongxing; Chen, Huipeng; Hu, Xianwen; Yue, Junjie] Beijing Inst Biotechnol, Beijing, Peoples R China		Chen, HP (corresponding author), Beijing Inst Biotechnol, Beijing, Peoples R China.	hpcamms@126.com; hu.xianwen@tsinghua.org.cn; yue_junjie@126.com		Yue, Junjie/0000-0002-2549-9261	National Science Foundation of China [3090592, 81202445]; Chinese National Science and Technology Major Project [2012ZX09102301-001, 2011ZX09102-001-30]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese National Science and Technology Major Project	This work was supported in part by grants from the National Science Foundation of China (No. 3090592 & 81202445) and the Chinese National Science and Technology Major Project (Nos. 2012ZX09102301-001 & 2011ZX09102-001-30). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrami L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000792; Andrianov V, 2010, PROTEIN EXPRES PURIF, V70, P158, DOI 10.1016/j.pep.2009.09.016; Bann JG, 2004, NATURE, V430, P843, DOI 10.1038/430843a; Barderas R, 2008, P NATL ACAD SCI USA, V105, P9029, DOI 10.1073/pnas.0801221105; Bouzianas DG, 2007, EXPERT REV ANTI-INFE, V5, P665, DOI 10.1586/14787210.5.4.665; Bradley KA, 2001, NATURE, V414, P225, DOI 10.1038/n35101999; Fleishman SJ, 2011, SCIENCE, V332, P816, DOI 10.1126/science.1202617; Gao M, 2006, BIOPHYS J, V90, P3267, DOI 10.1529/biophysj.105.079376; Hacker DL, 2009, BIOTECHNOL ADV, V27, P1023, DOI 10.1016/j.biotechadv.2009.05.008; Hocker B, 2012, NATURE, V491, P204, DOI 10.1038/491204a; Karanicolas J, 2009, CURR OPIN STRUC BIOL, V19, P458, DOI 10.1016/j.sbi.2009.07.005; Lacy DB, 2004, P NATL ACAD SCI USA, V101, P6367, DOI 10.1073/pnas.0401506101; Lacy DB, 2004, P NATL ACAD SCI USA, V101, P13147, DOI 10.1073/pnas.0405405101; Li GL, 2009, BIOCHEM BIOPH RES CO, V385, P591, DOI 10.1016/j.bbrc.2009.05.114; Liu SL, 2009, P NATL ACAD SCI USA, V106, P12424, DOI 10.1073/pnas.0905409106; Looger LL, 2003, NATURE, V423, P185, DOI 10.1038/nature01556; Petosa C, 1997, NATURE, V385, P833, DOI 10.1038/385833a0; Rich RL, 2007, ANAL BIOCHEM, V361, P1, DOI 10.1016/j.ab.2006.10.040; Samish I, 2011, ANNU REV PHYS CHEM, V62, P129, DOI 10.1146/annurev-physchem-032210-103509; Santelli E, 2004, NATURE, V430, P905, DOI 10.1038/nature02763; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Schymkowitz JWH, 2005, P NATL ACAD SCI USA, V102, P10147, DOI 10.1073/pnas.0501980102; Scobie HM, 2005, J INFECT DIS, V192, P1047, DOI 10.1086/432731; Scobie HM, 2003, P NATL ACAD SCI USA, V100, P5170, DOI 10.1073/pnas.0431098100; Sharma S, 2009, ANTIMICROB AGENTS CH, V53, P1210, DOI 10.1128/AAC.01294-08; St Croix B, 2000, SCIENCE, V289, P1197; Van der Sloot AM, 2006, P NATL ACAD SCI USA, V103, P8634, DOI 10.1073/pnas.0510187103; Van Durme J, 2011, BIOINFORMATICS, V27, P1711, DOI 10.1093/bioinformatics/btr254; Vuyisich M, 2008, PROTEIN J, V27, P292, DOI 10.1007/s10930-008-9137-0; Whittaker CA, 2002, MOL BIOL CELL, V13, P3369, DOI 10.1091/mbc.E02-05-0259; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Wycoff KL, 2011, ANTIMICROB AGENTS CH, V55, P132, DOI 10.1128/AAC.00592-10; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819	33	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e104674	10.1371/journal.pone.0104674	http://dx.doi.org/10.1371/journal.pone.0104674			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25101992	Green Submitted, Green Published, gold			2022-12-27	WOS:000339993900082
J	Xu, CL; Wang, YM; Sun, R; Qiao, XJ; Shang, XY; Niu, WN				Xu, Chunlan; Wang, Youming; Sun, Rui; Qiao, Xiangjin; Shang, Xiaoya; Niu, Weining			Modulatory Effects of Vasoactive Intestinal Peptide on Intestinal Mucosal Immunity and Microbial Community of Weaned Piglets Challenged by an Enterotoxigenic Escherichia coli (K88)	PLOS ONE			English	Article							CYCLASE-ACTIVATING POLYPEPTIDE; IN-VITRO; KAPPA-B; VIP; RECEPTORS; RESPONSES; SYSTEM; EXPRESSION; CYTOKINE; BARRIER	Toll-like receptors (TLRs) recognize microbial pathogens and trigger immune response, but their regulation by neuropeptide-vasoactive intestinal peptide (VIP) in weaned piglets infected by enterotoxigenic Escherichia coli (ETEC) K88 remains unexplored. Therefore, the study was conducted to investigate its role using a model of early weaned piglets infected by ETEC K88. Male DurocxLandracexYorkshire piglets (n = 24) were randomly divided into control, ETEC K88, VIP, and ETEC K88+VIP groups. On the first three days, ETEC K88 and ETEC K88+VIP groups were orally administrated with ETEC K88, other two groups were given sterile medium. Then each piglet from VIP and ETEC K88+VIP group received 10 nmol VIP intraperitoneally (i.p.) once daily, on day four and six. On the seventh day, the piglets were sacrificed. The results indicated that administration of VIP improved the growth performance, reduced diarrhea incidence of ETEC K88 challenged pigs, and mitigated the histopathological changes of intestine. Serum levels of IL-2, IL-6, IL-12p40, IFN-gamma and TNF-alpha in the ETEC K88+VIP group were significantly reduced compared with those in the ETEC group. VIP significantly increased IL-4, IL-10, TGF-beta and S-IgA production compared with the ETEC K88 group. Besides, VIP could inhibit the expression of TLR2, TLR4, MyD88, NF-kappa B p65 and the phosphorylation of I kappa B-alpha, p-ERK, p-JNK, and p-38 induced by ETEC K88. Moreover, VIP could upregulate the expression of occludin in the ileum mucosa compared with the ETEC K88 group. Colon and caecum content bacterial richness and diversity were lower for pigs in the ETEC group than the unchallenged groups. These results demonstrate that VIP is beneficial for the maturation of the intestinal mucosal immune system and elicited local immunomodulatory activities. The TLR2/4-MyD88 mediated NF-kappa B and MAPK signaling pathway may be critical to the mechanism underlying the modulatory effect of VIP on intestinal mucosal immune function and bacterial community.	[Xu, Chunlan; Sun, Rui; Qiao, Xiangjin; Shang, Xiaoya; Niu, Weining] Northwestern Polytech Univ, Sch Life Sci, Key Lab Space Biosci & Biotechnol, Xian 710072, Shaanxi, Peoples R China; [Wang, Youming] Zhejiang Univ, Coll Anim Sci, Inst Feed Sci, Hangzhou 310003, Zhejiang, Peoples R China	Northwestern Polytechnical University; Zhejiang University	Xu, CL (corresponding author), Northwestern Polytech Univ, Sch Life Sci, Key Lab Space Biosci & Biotechnol, Xian 710072, Shaanxi, Peoples R China.	clxu@nwpu.edu.cn			National Natural Science Foundation of China [31001012, 31101304]; Programs for Agricultural Science and Technology Development of Shanxi Province, China [2013K02-16]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Programs for Agricultural Science and Technology Development of Shanxi Province, China	The research was supported by National Natural Science Foundation of China, No.31001012 and No.31101304; and Programs for Agricultural Science and Technology Development of Shanxi Province, China, No.2013K02-16. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad C, 2003, GASTROENTEROLOGY, V124, P961, DOI 10.1053/gast.2003.50141; AISADI R, 2011, AM J PHYSIOL-GASTR L, V300, pG1054; Arranz A, 2008, PEPTIDES, V29, P948, DOI 10.1016/j.peptides.2008.01.019; Augustyniak D, 2012, CURR PROTEIN PEPT SC, V13, P723, DOI 10.2174/138920312804871139; Bailey M, 2005, P NUTR SOC, V64, P451, DOI 10.1079/PNS2005452; Bik W, 2004, NEUROIMMUNOMODULAT, V11, P358, DOI 10.1159/000080145; Brogden KA, 2005, NAT IMMUNOL, V6, P558, DOI 10.1038/ni1209; Campos-Salinas J, 2014, J BIOL CHEM, V289, P14583, DOI 10.1074/jbc.M114.560573; Capaldo CT, 2009, BBA-BIOMEMBRANES, V1788, P864, DOI 10.1016/j.bbamem.2008.08.027; Chorny A, 2008, AM J PATHOL, V172, P1297, DOI 10.2353/ajpath.2008.070969; Clarke TB, 2011, CELL HOST MICROBE, V9, P404, DOI 10.1016/j.chom.2011.04.012; Conlin VS, 2009, AM J PHYSIOL-GASTR L, V297, pG735, DOI 10.1152/ajpgi.90551.2008; Corthesy B, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00185; DelaFuente M, 1996, ADV NEUROIMMUNOL, V6, P75, DOI 10.1016/S0960-5428(96)00002-2; Delgado M, 2000, J NEUROIMMUNOL, V110, P97, DOI 10.1016/S0165-5728(00)00359-3; Delgado M, 2009, CELL DEATH DIFFER, V16, P406, DOI 10.1038/cdd.2008.161; Delgado M, 1999, J IMMUNOL, V162, P1707; Delgado M, 1999, J IMMUNOL, V162, P1200; Delgado M, 2002, J MOL MED, V80, P16, DOI 10.1007/s00109-001-0291-5; Delgado M, 2001, J IMMUNOL, V166, P2907, DOI 10.4049/jimmunol.166.5.2907; Delgado M, 2004, PHARMACOL REV, V56, P249, DOI 10.1124/pr.56.2.7; Delgado M, 2001, NAT MED, V7, P563, DOI 10.1038/87887; Delgado M, 2000, EUR J IMMUNOL, V30, P3236, DOI 10.1002/1521-4141(200011)30:11<3236::AID-IMMU3236>3.0.CO;2-L; Delgado M, 2003, BIOCHEM BIOPH RES CO, V302, P275, DOI 10.1016/S0006-291X(03)00149-9; DELGADO M, 1995, J NEUROIMMUNOL, V62, P137, DOI 10.1016/0165-5728(95)00105-6; Dokladny K, 2010, CELL STRESS CHAPERON, V15, P153, DOI 10.1007/s12192-009-0129-6; El Karim IA, 2008, J NEUROIMMUNOL, V200, P11, DOI 10.1016/j.jneuroim.2008.05.014; Fairbrother John M., 2005, Animal Health Research Reviews, V6, P17, DOI 10.1079/AHR2005105; Francis DH, 1998, INFECT IMMUN, V66, P4050; GAASTRA W, 1982, MICROBIOL REV, V46, P129, DOI 10.1128/MMBR.46.2.129-161.1982; Gomariz RP, 2007, PEPTIDES, V28, P1825, DOI 10.1016/j.peptides.2007.07.005; Gomariz RP, 2010, CURR PHARM DESIGN, V16, P1063, DOI 10.2174/138161210790963841; Gonzalez-Rey E, 2007, NAT REV IMMUNOL, V7, P52, DOI 10.1038/nri1984; Goyal RK, 1996, NEW ENGL J MED, V334, P1106, DOI 10.1056/NEJM199604253341707; Groschwitz KR, 2009, J ALLERGY CLIN IMMUN, V124, P3, DOI 10.1016/j.jaci.2009.05.038; Guo X, 2008, LETT APPL MICROBIOL, V47, P367, DOI 10.1111/j.1472-765X.2008.02408.x; Guzman JR, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/425146; Hwang MH, 2011, VET RES COMMUN, V35, P21, DOI 10.1007/s11259-010-9447-5; Janjatovic AK, 2012, EUR J HISTOCHEM, V56, P185, DOI 10.4081/ejh.2012.e30; Juarranz Y, 2005, ARTHRITIS RES THER, V7, pR1034, DOI 10.1186/ar1779; Keita AV, 2010, NEUROGASTROENT MOTIL, V22, P718, DOI 10.1111/j.1365-2982.2010.01498.x; Kiarie E, 2011, J ANIM SCI, V89, P1062, DOI 10.2527/jas.2010-3424; Kim JC, 2012, ANIM FEED SCI TECH, V173, P3, DOI 10.1016/j.anifeedsci.2011.12.022; KIMATA H, 1994, EUR J IMMUNOL, V24, P2262, DOI 10.1002/eji.1830240950; Kitazawa H., 2009, CURR OPIN IMMUNOL, V3, P87; Kitazawa H, 2008, ANIM SCI J, V79, P11, DOI [10.1111/j.1740-0929.2007.00492.x, 10.1111/j.1740-0929.2007.00491.x-i1]; Kojima M, 2005, PANCREAS, V30, P62; Konstantinov SR, 2004, ANIM RES, V53, P317, DOI 10.1051/animres:2004019; Laburthe M, 2002, REGUL PEPTIDES, V108, P165, DOI 10.1016/S0167-0115(02)00099-X; LABURTHE M, 1989, AM J PHYSIOL, V256, pG443, DOI 10.1152/ajpgi.1989.256.3.G443; Lalles JP, 2009, ANIMAL, V3, P1625, DOI 10.1017/S175173110900398X; Leser TD, 2002, APPL ENVIRON MICROB, V68, P673, DOI 10.1128/AEM.68.2.673-690.2002; Liu P, 2010, J ANIM SCI, V88, P3871, DOI 10.2527/jas.2009-2771; Long KZ, 2010, INFECT IMMUN, V78, P1221, DOI 10.1128/IAI.00767-09; MCCABE RD, 1988, ANN NY ACAD SCI, V527, P326; Mourad FH, 2000, GUT, V47, P382, DOI 10.1136/gut.47.3.382; Naiki Y, 2005, J BIOL CHEM, V280, P5491, DOI 10.1074/jbc.C400503200; Neunlist M, 2003, AM J PHYSIOL-GASTR L, V285, pG1028, DOI 10.1152/ajpgi.00066.2003; Nusrat A, 2000, AM J PHYSIOL-GASTR L, V279, pG851, DOI 10.1152/ajpgi.2000.279.5.G851; Nyachoti CM, 2012, J ANIM SCI, V90, P252, DOI 10.2527/jas.2010-3596; Nyachoti CM, 2006, J ANIM SCI, V84, P125, DOI 10.2527/2006.841125x; Owusu-Asiedu A, 2003, J ANIM SCI, V81, P1790; Pie S, 2004, J NUTR, V134, P641, DOI 10.1093/jn/134.3.641; Pozo D, 2007, PEPTIDES, V28, P1833, DOI 10.1016/j.peptides.2007.04.008; Prasse A, 2010, AM J RESP CRIT CARE, V182, P540, DOI 10.1164/rccm.200909-1451OC; Roselli M, 2005, ANIM RES, V54, P203, DOI 10.1051/animres:2005012; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Schmidt PT, 1999, GUT, V45, P679, DOI 10.1136/gut.45.5.679; Sherwood NM, 2000, ENDOCR REV, V21, P619, DOI 10.1210/er.21.6.619; Stokes CR, 2004, ANIM RES, V53, P325, DOI 10.1051/animres:2004020; Vaudry D, 2000, PHARMACOL REV, V52, P269; Westendorf AM, 2010, INT J MED MICROBIOL, V300, P11, DOI 10.1016/j.ijmm.2009.08.009; Wong V, 1997, J CELL BIOL, V136, P399, DOI 10.1083/jcb.136.2.399; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005	74	29	33	4	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e104183	10.1371/journal.pone.0104183	http://dx.doi.org/10.1371/journal.pone.0104183			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25101851	Green Published, Green Submitted, gold			2022-12-27	WOS:000339993900048
J	Goodchild, SC; Sheynis, T; Thompson, R; Tipping, KW; Xue, WF; Ranson, NA; Beales, PA; Hewitt, EW; Radford, SE				Goodchild, Sophia C.; Sheynis, Tania; Thompson, Rebecca; Tipping, Kevin W.; Xue, Wei-Feng; Ranson, Neil A.; Beales, Paul A.; Hewitt, Eric W.; Radford, Sheena E.			beta(2)-Microglobulin Amyloid Fibril-Induced Membrane Disruption Is Enhanced by Endosomal Lipids and Acidic pH	PLOS ONE			English	Article							BIS-PHOSPHATIDIC ACID; CULTURED BHK-CELLS; A-BETA; ALZHEIMERS-DISEASE; ALPHA-SYNUCLEIN; PORE FORMATION; NEUTRAL PH; IN-VITRO; GANGLIOSIDE GM1; BODY FORMATION	Although the molecular mechanisms underlying the pathology of amyloidoses are not well understood, the interaction between amyloid proteins and cell membranes is thought to play a role in several amlyloid diseases. Amyloid fibrils of beta(2)-microglobulin (beta(2)m), associated with dialysis-related amyloidosis (DRA), have been shown to cause disruption of anionic lipid bilayers in vitro. However, the effect of lipid composition and the chemical environment in which beta(2)-lipid interactions occur have not been investigated previously. Here we examine membrane damage resulting from the interaction of beta(2)m monomers and fibrils with lipid bilayers. Using dye release, tryptophan fluorescence quenching and fluorescence confocal microscopy assays we investigate the effect of anionic lipid composition and pH on the susceptibility of liposomes to fibril-induced membrane damage. We show that beta(2)m fibril-induced membrane disruption is modulated by anionic lipid composition and is enhanced by acidic pH. Most strikingly, the greatest degree of membrane disruption is observed for liposomes containing bis(monoacylglycero)phosphate (BMP) at acidic pH, conditions likely to reflect those encountered in the endocytic pathway. The results suggest that the interaction between beta(2)m fibrils and membranes of endosomal origin may play a role in the molecular mechanism of beta(2)m amyloid-associated osteoarticular tissue destruction in DRA.	[Goodchild, Sophia C.; Sheynis, Tania; Thompson, Rebecca; Tipping, Kevin W.; Xue, Wei-Feng; Ranson, Neil A.; Beales, Paul A.; Hewitt, Eric W.; Radford, Sheena E.] Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds, W Yorkshire, England; [Goodchild, Sophia C.; Sheynis, Tania; Thompson, Rebecca; Tipping, Kevin W.; Xue, Wei-Feng; Ranson, Neil A.; Hewitt, Eric W.; Radford, Sheena E.] Univ Leeds, Sch Mol & Cellular Biol, Leeds, W Yorkshire, England; [Beales, Paul A.] Univ Leeds, Sch Chem, Leeds LS2 9JT, W Yorkshire, England	University of Leeds; University of Leeds; University of Leeds	Radford, SE (corresponding author), Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds, W Yorkshire, England.	S.E.Radford@leeds.ac.uk	Beales, Paul/E-2194-2013; Goodchild, Sophia/AAB-1465-2021	Beales, Paul/0000-0001-9076-9793; Xue, Wei-Feng/0000-0002-6504-0404; Goodchild, Sophia/0000-0002-5091-7576; Ranson, Neil/0000-0002-3640-5275; Hewitt, Eric/0000-0002-6238-6303; Radford, Sheena/0000-0002-3079-8039; Thompson, Rebecca/0000-0002-4254-8854	Wellcome Trust [092896, 096685/z/11/z, 080707/z/06/z]; Marie Curie Intra-European Fellowship [276621]; European Research Council under the European Union's [322408]; Engineering and Physical Sciences Research Council [EP/K03135X/1] Funding Source: researchfish; Wellcome Trust [092896/Z/10/Z] Funding Source: researchfish; EPSRC [EP/K03135X/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Marie Curie Intra-European Fellowship(European Commission); European Research Council under the European Union's; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the Wellcome Trust grants 092896 MA, 096685/z/11/z (RT) and 080707/z/06/z (KWT), http://www.wellcome.ac.uk/, and Marie Curie Intra-European Fellowship 276621 (TS), http://ec.europa.eu/research/. EWH and SER acknowledge funding from the European Research Council under the European Union's Seventh Framework Programme, FP7/2007-2013, and grant agreement no322408 (EWH), http://erc.europa.eu/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambroggio EE, 2005, BIOPHYS J, V89, P1874, DOI 10.1529/biophysj.105.066589; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; BECKER JW, 1985, P NATL ACAD SCI USA, V82, P4225, DOI 10.1073/pnas.82.12.4225; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Bergstrom CL, 2013, P NATL ACAD SCI USA, V110, P6269, DOI 10.1073/pnas.1303819110; Berthelot K, 2013, BIOCHIMIE, V95, P12, DOI 10.1016/j.biochi.2012.07.011; Boland B, 2004, NEUROBIOL AGING, V25, P83, DOI 10.1016/S0197-4580(03)00034-4; Bostrom M, 2002, LANGMUIR, V18, P6010, DOI 10.1021/la0201220; BROTHERUS J, 1974, CHEM PHYS LIPIDS, V13, P11, DOI 10.1016/0009-3084(74)90038-3; BROTHERUS J, 1974, CHEM PHYS LIPIDS, V13, P178, DOI 10.1016/0009-3084(74)90034-6; Bucciantini M, 2012, FASEB J, V26, P818, DOI 10.1096/fj.11-189381; Cecchi C, 2009, BBA-BIOMEMBRANES, V1788, P2204, DOI 10.1016/j.bbamem.2009.07.019; Chebukati JN, 2010, BIOCHEM BIOPH RES CO, V394, P509, DOI 10.1016/j.bbrc.2010.02.180; CHEN RF, 1988, ANAL BIOCHEM, V172, P61, DOI 10.1016/0003-2697(88)90412-5; Cremades N, 2012, CELL, V149, P1048, DOI 10.1016/j.cell.2012.03.037; Demaurex N, 2002, NEWS PHYSIOL SCI, V17, P1; Ditaranto K, 2001, NEUROBIOL DIS, V8, P19, DOI 10.1006/nbdi.2000.0364; Duan MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047150; EFTINK MR, 1976, BIOCHEMISTRY-US, V15, P672, DOI 10.1021/bi00648a035; Eichner T, 2011, FEBS J, V278, P3868, DOI 10.1111/j.1742-4658.2011.08186.x; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; Engel MFM, 2012, J AM CHEM SOC, V134, P14781, DOI 10.1021/ja3031664; Ferrone F, 1999, METHOD ENZYMOL, V309, P256; Fogarty MP, 2010, NEUROBIOL AGING, V31, P1774, DOI 10.1016/j.neurobiolaging.2008.09.018; Franzin CM, 2001, BIOPHYS J, V81, P3346, DOI 10.1016/S0006-3495(01)75968-1; Frederick TE, 2010, CHEM PHYS LIPIDS, V163, P703, DOI 10.1016/j.chemphyslip.2010.06.002; Frederick TE, 2009, BIOPHYS J, V96, P1847, DOI 10.1016/j.bpj.2008.12.3892; Freeman D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062143; Gallala HD, 2011, NEUROCHEM RES, V36, P1594, DOI 10.1007/s11064-010-0337-6; Garcia-Garcia M, 1999, KIDNEY INT, V55, P899, DOI 10.1046/j.1523-1755.1999.055003899.x; Gasteiger E., 2005, PROTEIN IDENTIFICATI, DOI 10.1385/1592598900; GEJYO F, 1985, BIOCHEM BIOPH RES CO, V129, P701, DOI 10.1016/0006-291X(85)91948-5; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Hayakawa T, 2007, BIOPHYS J, V92, pL13, DOI 10.1529/biophysj.106.098657; Hirakura Y, 2001, AMYLOID, V8, P94, DOI 10.3109/13506120109007350; HUTERER S, 1979, J LIPID RES, V20, P966; Ivankin A, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.238103; Jahn TR, 2008, J BIOL CHEM, V283, P17279, DOI 10.1074/jbc.M710351200; Jahn TR, 2010, J MOL BIOL, V395, P717, DOI 10.1016/j.jmb.2009.09.039; Ji ZS, 2002, J BIOL CHEM, V277, P21821, DOI 10.1074/jbc.M112109200; Kad NM, 2001, J MOL BIOL, V313, P559, DOI 10.1006/jmbi.2001.5071; Knowles TP, 2007, SCIENCE, V318, P1900, DOI 10.1126/science.1150057; Knowles TPJ, 2009, SCIENCE, V326, P1533, DOI 10.1126/science.1178250; Kobayashi T, 1999, NAT CELL BIOL, V1, P113, DOI 10.1038/10084; Kobayashi T, 1998, NATURE, V392, P193, DOI 10.1038/32440; Kobayashi T, 2002, J BIOL CHEM, V277, P32157, DOI 10.1074/jbc.M202838200; Kobayashi T, 2001, BIOL CHEM, V382, P483, DOI 10.1515/BC.2001.059; Lee DE, 2013, CHEM PHYS LIPIDS, V166, P45, DOI 10.1016/j.chemphyslip.2012.11.004; Lee JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047580; Liguori N, 2013, BIOPHYS J, V105, P899, DOI 10.1016/j.bpj.2013.06.046; Luquain C, 2000, BIOCHEM J, V351, P795, DOI 10.1042/0264-6021:3510795; McParland VJ, 2000, BIOCHEMISTRY-US, V39, P8735, DOI 10.1021/bi000276j; Milanesi L, 2012, P NATL ACAD SCI USA, V109, P20455, DOI 10.1073/pnas.1206325109; Morten IJ, 2007, J BIOL CHEM, V282, P29691, DOI 10.1074/jbc.M705004200; Myers SL, 2006, BIOCHEMISTRY-US, V45, P2311, DOI 10.1021/bi052434i; Ohvo-Rekila H, 2002, PROG LIPID RES, V41, P66, DOI 10.1016/S0163-7827(01)00020-0; Ookoshi T, 2008, NEPHROL DIAL TRANSPL, V23, P3247, DOI 10.1093/ndt/gfn231; Pan JJ, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.198103; Parsegia Va., 1973, ANNU REV BIOPHYS BIO, V2, P221; Petelska AD, 2000, BIOPHYS J, V78, P812, DOI 10.1016/S0006-3495(00)76638-0; Pieri L, 2012, BIOPHYS J, V102, P2894, DOI 10.1016/j.bpj.2012.04.050; Pieri L, 2009, BIOPHYS J, V96, P3319, DOI 10.1016/j.bpj.2008.12.3958; Porter MY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027353; Rajendran L, 2012, TRAFFIC, V13, P759, DOI 10.1111/j.1600-0854.2012.01332.x; Reed B, 2014, JAMA NEUROL, V71, P195, DOI 10.1001/jamaneurol.2013.5390; Reynolds NP, 2011, J AM CHEM SOC, V133, P19366, DOI 10.1021/ja2029848; Sarell CJ, 2013, PRION, V7, P359, DOI 10.4161/pri.26415; Sciacca MFM, 2012, BIOCHEMISTRY-US, V51, P7676, DOI 10.1021/bi3009888; Sciacca MFM, 2012, BIOPHYS J, V103, P702, DOI 10.1016/j.bpj.2012.06.045; Sheynis T, 2013, BIOPHYS J, V105, P745, DOI 10.1016/j.bpj.2013.06.015; Smith A, 2006, AGENDA, V42, P9; Smith DP, 2003, J MOL BIOL, V330, P943, DOI 10.1016/S0022-2836(03)00687-9; Soura V, 2012, BIOCHEM J, V441, P579, DOI 10.1042/BJ20110749; Stefani M, 2010, FEBS J, V277, P4602, DOI 10.1111/j.1742-4658.2010.07889.x; Umeda T, 2011, J NEUROSCI RES, V89, P1031, DOI 10.1002/jnr.22640; Uversky VN, 2010, FEBS J, V277, P2940, DOI 10.1111/j.1742-4658.2010.07721.x; Valleix S, 2012, NEW ENGL J MED, V366, P2276, DOI 10.1056/NEJMoa1201356; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Villanueva J, 2004, PROTEIN SCI, V13, P797, DOI 10.1110/ps.03445704; WHERRETT JR, 1973, LIPIDS, V8, P531, DOI 10.1007/BF02531989; White HE, 2009, J MOL BIOL, V389, P48, DOI 10.1016/j.jmb.2009.03.066; Williams TL, 2011, FEBS J, V278, P3905, DOI 10.1111/j.1742-4658.2011.08228.x; Williams TL, 2011, BIOCHEM J, V439, P67, DOI 10.1042/BJ20110750; Wood WG, 2014, J NEUROCHEM, V129, P559, DOI 10.1111/jnc.12637; Xue WF, 2008, P NATL ACAD SCI USA, V105, P8926, DOI 10.1073/pnas.0711664105; Xue WF, 2013, BIOPHYS J, V105, P2811, DOI 10.1016/j.bpj.2013.10.034; Xue WF, 2010, PRION, V4, P20, DOI 10.4161/pri.4.1.11378; Xue WF, 2009, J BIOL CHEM, V284, P34272, DOI 10.1074/jbc.M109.049809; Xue WF, 2009, PROTEIN ENG DES SEL, V22, P489, DOI 10.1093/protein/gzp026; Yamamoto S, 2004, J AM SOC NEPHROL, V15, P126, DOI 10.1097/01.ASN.0000103228.81623.C7; Zimmerberg J, 2006, NAT REV MOL CELL BIO, V7, P9, DOI 10.1038/nrm1784	91	27	27	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e104492	10.1371/journal.pone.0104492	http://dx.doi.org/10.1371/journal.pone.0104492			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25100247	Green Accepted, Green Published, gold			2022-12-27	WOS:000339995100078
J	Huang, CH; Chang, CC; Kuo, CL; Huang, CS; Chiu, TW; Lin, CS; Liu, CS				Huang, Ching-Hui; Chang, Chia-Chu; Kuo, Chen-Ling; Huang, Ching-Shan; Chiu, Tzai-Wen; Lin, Chih-Sheng; Liu, Chin-San			Serum Iron Concentration, but Not Hemoglobin, Correlates with TIMI Risk Score and 6-Month Left Ventricular Performance after Primary Angioplasty for Acute Myocardial Infarction	PLOS ONE			English	Article							HEART-FAILURE; STANDARDS COMMITTEE; OF-ECHOCARDIOGRAPHY; PROGNOSTIC VALUE; MORTALITY; ANEMIA; TRIAL; RECOMMENDATIONS; QUANTIFICATION; INTERLEUKIN-6	Objective: Anemia is associated with high mortality and poor prognosis after acute coronary syndrome (A(S). Increased red cell distribution width (RDW) is a strong independent predictor for adverse outcomes in ACS. The common underlying mechanism for anemia and increased RDW value is iron deficiency. It is not clear whether serum iron deficiency without anemia affects left ventricular (LV) performance after primary angioplasty for acute myocardial infarction (AMI). We investigated the prognostic value of serum iron concentration on LV ejection fraction (EF) at 6 months and its relationship to thrombolysis in myocardial infarction (TIMI) risk score in post MI patients. Methods: We recruited 55 patients who were scheduled to undergo primary coronary balloon angioplasty after AM I and 54 age- and sex-matched volunteers. Serum iron concentration and interleukin-6 levels were measured before primary angioplasty. LVEF was measured by echocardiography at baseline and after 6 months. TIMI risk score was calculated for risk stratification. Results: Serum iron concentration was significantly lower in those in whom LVEF had not improved >= 10% from baseline (52.7 +/- 24.1 versus 80.8 +/- 50.8 mu g/dl, P = 0.016) regardless of hemoglobin level, and was significantly lower in the AMI group than in the control group (62.5 +/- 37.7 versus 103.0 +/- 38.1 mu g/dl, P<0.001). Trend analysis revealed that serum iron concentration decreased as TIMI risk score increased (P = 0.002). In addition, lower serum iron concentrations were associated with higher levels of inflammatory markers. Multiple linear regression showed that baseline serum iron concentration can predict LV systolic function 6 months after primary angioplasty for AMI even after adjusting for traditional prognostic factors. Conclusion: Hypoferremia is not only a marker of inflammation but also a potential prognostic factor for LV systolic function after revascularization therapy for AMI, and may be a novel biomarker for therapeutic intervention.	[Huang, Ching-Hui] Changhua Christian Hosp, Dept Internal Med, Div Cardiol, Changhua, Taiwan; [Huang, Ching-Hui; Chiu, Tzai-Wen; Lin, Chih-Sheng] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan; [Chang, Chia-Chu] Changhua Christian Hosp, Dept Internal Med, Div Nephrol, Changhua, Taiwan; [Chang, Chia-Chu] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Kuo, Chen-Ling; Huang, Ching-Shan; Liu, Chin-San] Changhua Christian Hosp, Vasc & Genom Res Ctr, Changhua, Taiwan; [Liu, Chin-San] Changhua Christian Hosp, Dept Neurol, Changhua, Taiwan; [Liu, Chin-San] China Med Univ, Grad Inst Integrat Med, Taichung, Taiwan	Changhua Christian Hospital; National Yang Ming Chiao Tung University; Changhua Christian Hospital; Chung Shan Medical University; Changhua Christian Hospital; Changhua Christian Hospital; China Medical University Taiwan	Lin, CS (corresponding author), Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan.	lincs@mail.nctu.edu.tw; liu48111@gmail.com			Changhua Christian hospital [100-CCH-IRP-08]	Changhua Christian hospital	The study was supported by a research grant of Changhua Christian hospital (100-CCH-IRP-08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anker SD, 2009, NEW ENGL J MED, V361, P2436, DOI 10.1056/NEJMoa0908355; Anker SD, 2009, EUR HEART J, V30, P1331, DOI 10.1093/eurheartj/ehp116; Aronson D, 2007, EUR HEART J, V28, P1289, DOI 10.1093/eurheartj/ehm013; Beard John L., 2001, Journal of Nutrition, V131, p568S; Cairo G, 2006, GENES NUTR, V1, P25, DOI 10.1007/BF02829934; Chan W, 2012, CIRC-CARDIOVASC INTE, V5, P270, DOI 10.1161/CIRCINTERVENTIONS.111.966226; Dabbah S, 2010, AM J CARDIOL, V105, P312, DOI 10.1016/j.amjcard.2009.09.027; ELLIS SG, 1990, CIRCULATION, V82, P1193, DOI 10.1161/01.CIR.82.4.1193; FEIGENBAUM H, 1990, AM J CARDIOL, V66, pH17, DOI 10.1016/0002-9149(90)90571-H; Gabriel Amon S, 2004, Eur J Intern Med, V15, P523, DOI 10.1016/j.ejim.2004.07.013; Gibson CM, 2000, CIRCULATION, V101, P125, DOI 10.1161/01.CIR.101.2.125; Hower V, 2009, MOL BIOSYST, V5, P422, DOI 10.1039/b816714c; Ilhan E, 2012, CORONARY ARTERY DIS, V23, P450, DOI 10.1097/MCA.0b013e3283587897; Investigators GA, 1993, NEW ENGL J MED, V329, P1615; Jankowska EA, 2013, EUR HEART J, V34, P816, DOI 10.1093/eurheartj/ehs224; Karpinski L, 2008, KARDIOL POL, V66, P1279; Kell DB, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-2; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Lee SD, 2006, CLIN CHIM ACTA, V370, P50, DOI 10.1016/j.cca.2006.01.012; Lenth R. V, 2010, JAVA APPLETS POWER S; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Maeder MT, 2011, J AM COLL CARDIOL, V58, P474, DOI 10.1016/j.jacc.2011.01.059; McMurray J, 2011, J AM COLL CARDIOL, V58, P481, DOI 10.1016/j.jacc.2011.02.066; Morrow DA, 2000, CIRCULATION, V102, P2031, DOI 10.1161/01.CIR.102.17.2031; Munoz M, 2011, J CLIN PATHOL, V64, P281, DOI 10.1136/jcp.2010.079046; Ndrepepa G, 2007, J AM COLL CARDIOL, V50, P149, DOI 10.1016/j.jacc.2007.03.034; Nemeth E, 2004, J CLIN INVEST, V113, P1271, DOI 10.1172/JCI200420945; Nikolsky E, 2004, J AM COLL CARDIOL, V44, P547, DOI 10.1016/j.jacc.2004.03.080; Quinones MA, 2002, J AM SOC ECHOCARDIOG, V15, P167, DOI 10.1067/mje.2002.120202; Rines AK, 2013, J MOL CELL CARDIOL, V55, P50, DOI 10.1016/j.yjmcc.2012.05.014; Schiller N B, 1989, J Am Soc Echocardiogr, V2, P358; SIMEL DL, 1988, ARCH INTERN MED, V148, P822, DOI 10.1001/archinte.148.4.822; Simonis G, 2010, PEPTIDES, V31, P1786, DOI 10.1016/j.peptides.2010.05.013; Suzuki H, 2009, TOHOKU J EXPT MED, V218; Tan J, 2009, HEART VESSELS, V24, P329, DOI 10.1007/s00380-008-1128-8; Thygesen K, 2007, J AM COLL CARDIOL, V50, P2173, DOI 10.1016/j.jacc.2007.09.011; Uyarel H, 2011, CORONARY ARTERY DIS, V22, P138, DOI 10.1097/MCA.0b013e328342c77b; Vasan RS, 2003, CIRCULATION, V107, P1486, DOI 10.1161/01.CIR.0000057810.48709.F6; Wiviott SD, 2004, J AM COLL CARDIOL, V44, P783, DOI 10.1016/j.jacc.2004.05.045; Zeben D, 1990, EUROPEAN J HAEMATOLO, V44, P106	40	16	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e104495	10.1371/journal.pone.0104495	http://dx.doi.org/10.1371/journal.pone.0104495			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25100442	Green Published, gold, Green Submitted			2022-12-27	WOS:000339995100079
J	Long, YM; Zheng, YB; Chen, MY; Zhang, B; Gao, C; Shan, FL; Yang, N; Fan, YX				Long, Youming; Zheng, Yangbo; Chen, Mengyu; Zhang, Bin; Gao, Cong; Shan, Fulan; Yang, Ning; Fan, Yongxiang			Serum Thyroid-Stimulating Hormone and Anti-Thyroglobulin Antibody Are Independently Associated with Lesions in Spinal Cord in Central Nervous System Demyelinating Diseases	PLOS ONE			English	Article							DEVICS-NEUROMYELITIS-OPTICA; MULTIPLE-SCLEROSIS; DIAGNOSTIC-CRITERIA; TRANSVERSE MYELITIS; AUTOIMMUNE-DISEASE; AQUAPORIN-4; PREVALENCE; COHORT; DISORDERS; MS	Transverse myelitis (TM) is associated with neuromyelitis optica (NMO) and multiple sclerosis (MS). Early recognition of useful parameters may be helpful to distinguish their difference. This retrospective study analyzed thyroid parameters from 243 serum samples (relapse = 128; remission = 115) of 178 patients with demyelinating diseases (NMO, n = 25; TM, n = 48; MS, n = 105). The relationship between thyroid and clinical parameters was analyzed. Patients with NMO and TM had a higher frequency of abnormal thyroid-stimulating hormone (TSH), anti-thyroglobulin antibodies (TG-Ab), and antithyroid peroxidase antibody (TPO-Ab) than MS patients (p<0.05). The level of TSH and TG-Ab returned to normal levels after administration of high-dose intravenous methylprednisolone (p<0.05). In 96 patients (NMO, n = 19; TM, n = 25; MS, n = 52) without treatment, serum levels of TSH, TG-Ab and TPO-Ab were significantly different between patients with and without myelitis (p<0.01). Patients positive for aquaporin-4 (AQP4) antibodies showed higher abnormalities of TSH (p = 0.001), TGAb (p = 0.004) and TPO-Ab (p<0.0001) levels than AQP4 antibodies negative patients. Logistic regression analyses revealed independent relationships between TSH (odds ratio [OR] = 33.994; p<0.0001), TG-Ab (OR = 7.703; p = 0.017) and myelitis occurrence in 96 patients at the active stage. In 52 MS patients experiencing their first attack, MS patients with myelitis were associated with TSH abnormalities (OR = 42.778; p<0.0001). This study showed increased abnormalities of thyroid parameters in patients with NMO and TM than in MS patients. MS patients with myelitis also had greater TSH abnormality than in MS patients without myelitis. Abnormal TSH and TG-Ab were independently associated with myelitis occurrence in central nervous system demyelinating disorders.	[Long, Youming; Zheng, Yangbo; Chen, Mengyu; Zhang, Bin; Gao, Cong; Shan, Fulan; Fan, Yongxiang] GuangZhou Med Univ, Key Lab Neurogenet & Channelopathies Guangdong Pr, Guangzhou, Guangdong, Peoples R China; [Long, Youming; Zheng, Yangbo; Chen, Mengyu; Zhang, Bin; Gao, Cong; Shan, Fulan; Fan, Yongxiang] GuangZhou Med Univ, Minist Educ China, Inst Neurosci, Guangzhou, Guangdong, Peoples R China; [Long, Youming; Zheng, Yangbo; Chen, Mengyu; Zhang, Bin; Gao, Cong; Shan, Fulan; Fan, Yongxiang] GuangZhou Med Univ, Affiliated Hosp 2, Guangzhou, Guangdong, Peoples R China; [Long, Youming; Zheng, Yangbo; Chen, Mengyu; Zhang, Bin; Gao, Cong; Shan, Fulan; Fan, Yongxiang] GuangZhou Med Univ, Affiliated Hosp 2, Dept Neurol, Guangzhou, Guangdong, Peoples R China; [Yang, Ning] GuangZhou Med Univ, Affiliated Hosp 5, Dept Neurol, Guangzhou, Guangdong, Peoples R China	Guangzhou Medical University; Guangzhou Medical University; Ministry of Education, China; Guangzhou Medical University; Guangzhou Medical University; Guangzhou Medical University	Gao, C (corresponding author), GuangZhou Med Univ, Key Lab Neurogenet & Channelopathies Guangdong Pr, Guangzhou, Guangdong, Peoples R China.	smilegaocong@126.com			China Postdoctoral Science Foundation [2012M521586]; Guangdong Natural Science Foundation [S2013010016262]; Science and Technology plan project of Guangdong Province [2012B031800240, 2012B061700042]; GuangZhou Medical University [2012C46]	China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Science and Technology plan project of Guangdong Province; GuangZhou Medical University	This project was supported by the plan of China Postdoctoral Science Foundation Grant (2012M521586), Guangdong Natural Science Foundation (S2013010016262), the Science and Technology plan project of Guangdong Province (2012B031800240, 2012B061700042), and the plan of GuangZhou Medical University (2012C46). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRABANT A, 1989, ACTA ENDOCRINOL-COP, V121, P95, DOI 10.1530/acta.0.1210095; Caraccio N, 2005, J CLIN ENDOCR METAB, V90, P4133, DOI 10.1210/jc.2004-2326; Cossburn M, 2011, NEUROLOGY, V77, P573, DOI 10.1212/WNL.0b013e318228bec5; DAWE K, 1993, SPRINGER SEMIN IMMUN, V14, P285; de Seze J, 2003, MULT SCLER J, V9, P521, DOI 10.1191/1352458503ms947oa; Durelli L, 1999, J NEUROL SCI, V162, P74, DOI 10.1016/S0022-510X(98)00299-8; Durelli L, 2001, J NEUROL SCI, V193, P17, DOI 10.1016/S0022-510X(01)00637-2; Hamnik Sheri E, 2008, Semin Ophthalmol, V23, P191, DOI 10.1080/08820530802049921; Jarius S, 2008, BRAIN, V131, P3072, DOI 10.1093/brain/awn240; Karni A, 1999, NEUROLOGY, V53, P883, DOI 10.1212/WNL.53.4.883; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Li R, 2011, J NEUROL, V258, P2206, DOI 10.1007/s00415-011-6093-y; Long YM, 2012, NEUROIMMUNOMODULAT, V19, P96, DOI 10.1159/000330240; Marrie RA, 2012, NEUROEPIDEMIOLOGY, V39, P135, DOI 10.1159/000339757; McKeon A, 2008, NEUROLOGY, V71, P93, DOI 10.1212/01.wnl.0000314832.24682.c6; Munteis E, 2007, EUR J NEUROL, V14, P1048, DOI 10.1111/j.1468-1331.2007.01882.x; Nagaishi A, 2011, J NEUROL NEUROSUR PS, V82, P1360, DOI 10.1136/jnnp-2011-300403; Niederwieser G, 2003, J NEUROL, V250, P672, DOI 10.1007/s00415-003-1053-9; Niu DF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040770; ORiordan JI, 1996, J NEUROL NEUROSUR PS, V60, P382, DOI 10.1136/jnnp.60.4.382; OTA K, 1990, NATURE, V346, P183, DOI 10.1038/346183a0; Pittock SJ, 2008, ARCH NEUROL-CHICAGO, V65, P78, DOI 10.1001/archneurol.2007.17; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Qiu W, 2010, MULT SCLER J, V16, P351, DOI 10.1177/1352458509355463; Ramagopolan SV, 2007, LANCET NEUROL, V6, P604, DOI 10.1016/S1474-4422(07)70132-1; Sakuma R, 1999, J NEUROL, V246, P449, DOI 10.1007/s004150050381; Scott TF, 2006, ARCH NEUROL-CHICAGO, V63, P1398, DOI 10.1001/archneur.63.10.1398; Sellner J, 2011, CLIN ENDOCRINOL, V75, P271, DOI 10.1111/j.1365-2265.2011.04024.x; STEFANEANU L, 1986, ACTA HISTOCHEM, V78, P7; TORRES SMF, 1991, AM J VET RES, V52, P416; Wingerchuk DM, 2006, NEUROLOGY, V66, P1485, DOI 10.1212/01.wnl.0000216139.44259.74; Wingerchuk DM, 2007, LANCET NEUROL, V6, P805, DOI 10.1016/S1474-4422(07)70216-8; 2002, NEUROLOGY, V59, P499	33	21	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e100672	10.1371/journal.pone.0100672	http://dx.doi.org/10.1371/journal.pone.0100672			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093326	gold, Green Published, Green Submitted			2022-12-27	WOS:000341357200003
J	Adam, MB; Dillmann, M; Chen, MK; Mbugua, S; Ndung'u, J; Mumbi, P; Waweru, E; Meissner, P				Adam, Mary B.; Dillmann, Maria; Chen, Mei-Kuang; Mbugua, Simon; Ndung'u, Joram; Mumbi, Priscilla; Waweru, Eunice; Meissner, Peter			Improving Maternal and Newborn Health: Effectiveness of a Community Health Worker Program in Rural Kenya	PLOS ONE			English	Article							WOMENS GROUPS; INTERVENTIONS; MORTALITY; SETTINGS; CARE	Background: Volunteer community health workers (CHWs) form an important element of many health systems, and in Kenya these volunteers are the foundation for promoting behavior change through health education, earlier case identification, and timely referral to trained health care providers. This study examines the effectiveness of a community health worker project conducted in rural Kenya that sought to promote improved knowledge of maternal newborn health and to increase deliveries under skilled attendance. Methods: The study utilized a quasi-experimental nonequivalent design that examined relevant demographic items and knowledge about maternal and newborn health combined with a comprehensive retrospective birth history of women's children using oral interviews of women who were exposed to health messages delivered by CHWs and those who were not exposed. The project trained CHWs in three geographically distinct areas. Results: Mean knowledge scores were higher in those women who reported being exposed to the health messages from CHWs, Eburru 32.3 versus 29.2, Kinale 21.8 vs 20.7, Nyakio 26.6 vs 23.8. The number of women delivering under skilled attendance was higher for those mothers who reported exposure to one or more health messages, compared to those who did not. The percentage of facility deliveries for women exposed to health messages by CHWs versus non-exposed was: Eburru 46% versus 19%; Kinale 94% versus 73%: and Nyakio 80% versus 78%. Conclusion: The delivery of health messages by CHWs increased knowledge of maternal and newborn care among women in the local community and encouraged deliveries under skilled attendance.	[Adam, Mary B.; Mbugua, Simon; Ndung'u, Joram; Mumbi, Priscilla; Waweru, Eunice] AIC Kijabe Med Ctr, Kijabe, Kenya; [Dillmann, Maria; Meissner, Peter] Univ Ulm, Dept Pediat & Adolescent Med, D-89069 Ulm, Germany; [Chen, Mei-Kuang] Univ Arizona, Tucson, AZ USA	Ulm University; University of Arizona	Adam, MB (corresponding author), AIC Kijabe Med Ctr, Kijabe, Kenya.	mary.b.adam@gmail.com		Chen, Mei-kuang/0000-0002-0407-6788	Intergreen Flower Farms Naivasha; foundation Stiching Roer; German Institute for Medical Mission; Agnes Phillipine Walters Foundation	Intergreen Flower Farms Naivasha; foundation Stiching Roer; German Institute for Medical Mission; Agnes Phillipine Walters Foundation	Funding for the research was received from Intergreen Flower Farms Naivasha and the foundation Stiching Roer. Funds to run the program were received from the German Institute for Medical Mission and the Agnes Phillipine Walters Foundation, however program funding did not include research funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, KENYA DEMOGRAPHIC HL; [Anonymous], 2011, COMMUNITY BASED NEWB, P1; Bahl R, 2010, SEMIN PERINATOL, V34, P477, DOI 10.1053/j.semperi.2010.09.001; Bhutta ZA, 2005, PEDIATRICS, V115, P519, DOI 10.1542/peds.2004-1441; Campbell C, 2011, GLOB PUBLIC HEALTH, V6, P125, DOI 10.1080/17441690903334232; Darmstadt GL, 2010, SEMIN PERINATOL, V34, P367, DOI 10.1053/j.semperi.2010.09.003; Darmstadt GL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009696; Darmstadt GL, 2005, LANCET, V365, P977, DOI 10.1016/S0140-6736(05)71088-6; Del Barco R. E., 2004, MONITORING BIRTH PRE; Hounton S, 2009, GLOBAL HEALTH ACTION, V2, DOI 10.3402/gha.v2i0.1947; Kawakatsu Yoshito, 2012, Prim Health Care Res Dev, V13, P294, DOI 10.1017/S1463423612000138; Kumar V, 2010, SEMIN PERINATOL, V34, P446, DOI 10.1053/j.semperi.2010.09.006; Lehmann U., 2007, COMMUNITY HLTH WORKE, P1; Lewin S, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004015.pub3; Mo Health, 2006, TAKING KENYA ESSENTI; Nair N, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000246; Neeloy AA, 2008, J PERINATOL, V28, pS2, DOI 10.1038/jp.2008.166; Olang'o CO, 2010, HEALTH POLICY, V97, P232, DOI 10.1016/j.healthpol.2010.05.004; Prost A, 2013, LANCET, V381, P1736, DOI 10.1016/S0140-6736(13)60685-6; Rosato M, 2010, MALAWI MED J, V22, P112; Shaddish W.R., 2001, EXPT QUASIEXPERIMENT; Souza JP, 2013, LANCET, V381, P1747, DOI 10.1016/S0140-6736(13)60686-8; Takasugi T, 2012, PUBLIC HEALTH, V126, P839, DOI 10.1016/j.puhe.2012.06.005; Tylleskar T, 2011, LANCET, V378, P420, DOI 10.1016/S0140-6736(11)60738-1	24	62	63	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e104027	10.1371/journal.pone.0104027	http://dx.doi.org/10.1371/journal.pone.0104027			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25090111	gold, Green Submitted, Green Published			2022-12-27	WOS:000339812700083
J	Viceconte, N; McKenna, T; Eriksson, M				Viceconte, Nikenza; McKenna, Tomas; Eriksson, Maria			Low Levels of the Reverse Transactivator Fail to Induce Target Transgene Expression in Vascular Smooth Muscle Cells	PLOS ONE			English	Article							HUTCHINSON-GILFORD-PROGERIA; GENE-EXPRESSION; MICE; ATHEROSCLEROSIS; MUTATION; DISEASE; TTA	Hutchinson-Gilford progeria syndrome (HGPS) is a genetic disease with multiple features that are suggestive of premature aging. Most patients with HGPS carry a mutation on one of their copies of the LMNA gene. The LMNA gene encodes the lamin A and lamin C proteins, which are the major proteins of the nuclear lamina. The organs of the cardiovascular system are amongst those that are most severely affected in HGPS, undergoing a progressive depletion of vascular smooth muscle cells, and most children with HGPS die in their early teens from cardio-vascular disease and other complications from atherosclerosis. In this study, we developed a transgenic mouse model based on the tet-ON system to increase the understanding of the molecular mechanisms leading to the most lethal aspect of HGPS. To induce the expression of the most common HGPS mutation, LMNA c.1824C>T; p.G608G, in the vascular smooth muscle cells of the aortic arch and thoracic aorta, we used the previously described reverse tetracycline-controlled transactivator, sm22 alpha-rtTA. However, the expression of the reverse sm22 alpha-transactivator was barely detectable in the arteries, and this low level of expression was not sufficient to induce the expression of the target human lamin A minigene. The results from this study are important because they suggest caution during the use of previously functional transgenic animal models and emphasize the importance of assessing transgene expression over time.	[Viceconte, Nikenza; McKenna, Tomas; Eriksson, Maria] Karolinska Inst, Novum, Ctr Biosci, Dept Biosci & Nutr, Huddinge, Sweden	Karolinska Institutet	Eriksson, M (corresponding author), Karolinska Inst, Novum, Ctr Biosci, Dept Biosci & Nutr, Huddinge, Sweden.	Maria.Eriksson.2@ki.se			Knut and Alice Wallenberg Foundation; Swedish Research Council and the Center for Biosciences; Swedish Research Council; OE & Edla Johansson foundation; Lars Hierta foundation; Svenska Lakare Sallskapet; Ake Wiberg foundation	Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Research Council and the Center for Biosciences; Swedish Research Council(Swedish Research CouncilEuropean Commission); OE & Edla Johansson foundation; Lars Hierta foundation; Svenska Lakare Sallskapet; Ake Wiberg foundation	This study was in part performed at the Live Cell Imaging unit, Department of Biosciences and Nutrition, Karolinska Institutet, Huddinge, Sweden, supported by grants from the Knut and Alice Wallenberg Foundation, the Swedish Research Council and the Center for Biosciences. This research was supported by grants to ME from the Swedish Research Council, the OE & Edla Johansson foundation, the in memory of Lars Hierta foundation, the Svenska Lakare Sallskapet, and the Ake Wiberg foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek J-H MT, 2012, GENETIC DISORDERS IN, P65; Bao-Cutrona M, 2009, GENETICS, V181, P1687, DOI 10.1534/genetics.108.097600; Bernal-Mizrachi C, 2005, NATURE, V435, P502, DOI 10.1038/nature03527; Boger H, 1999, MECH DEVELOP, V83, P141, DOI 10.1016/S0925-4773(99)00042-8; Bridger JM, 2004, EXP GERONTOL, V39, P717, DOI 10.1016/j.exger.2004.02.002; Capell BC, 2007, CIRC RES, V101, P13, DOI 10.1161/CIRCRESAHA.107.153692; Chen JS, 1998, MOL PHARMACOL, V54, P495, DOI 10.1124/mol.54.3.495; De Sandre-Giovannoli A, 2003, SCIENCE, V300, P2055, DOI 10.1126/science.1084125; DEBUSK FL, 1972, J PEDIATR-US, V80, P697, DOI 10.1016/S0022-3476(72)80229-4; Eriksson M, 2003, NATURE, V423, P293, DOI 10.1038/nature01629; Fedorov LM, 2001, GENESIS, V31, P78, DOI 10.1002/gene.10007; Goldman RD, 2004, ACCUMULATION MUTANT; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Lee S, 2006, J MOL CELL CARDIOL, V40, P148, DOI 10.1016/j.yjmcc.2005.09.015; Lee S, 2005, CIRC RES, V97, pE85; Li L, 1996, J CELL BIOL, V132, P849, DOI 10.1083/jcb.132.5.849; McKenna T, 2013, AGING CELL      1204, V4; Merideth MA, 2008, NEW ENGL J MED, V358, P592, DOI 10.1056/NEJMoa0706898; Osorio FG, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002847; Sagelius H, 2008, J CELL SCI, V121, P969, DOI 10.1242/jcs.022913; Schmidt E, 2012, J BIOL CHEM, V287, P33512, DOI 10.1074/jbc.M112.366450; Schmidt Eva, 2011, BMC Res Notes, V4, P282, DOI 10.1186/1756-0500-4-282; Schonig K, 2010, METHOD ENZYMOL, V477, P429, DOI 10.1016/S0076-6879(10)77022-1; Stehbens WE, 1999, CARDIOVASC PATHOL, V8, P29, DOI 10.1016/S1054-8807(98)00023-4; Varga R, 2006, P NATL ACAD SCI USA, V103, P3250, DOI 10.1073/pnas.0600012103; Zhang HY, 2013, AGING CELL, V12, P2, DOI 10.1111/acel.12021	26	1	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e104098	10.1371/journal.pone.0104098	http://dx.doi.org/10.1371/journal.pone.0104098			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25090270	gold, Green Published, Green Submitted			2022-12-27	WOS:000339812700095
J	Stiller-Reeve, MA; Spengler, T; Chu, PS				Stiller-Reeve, Mathew Alexander; Spengler, Thomas; Chu, Pao-Shin			Testing a Flexible Method to Reduce False Monsoon Onsets	PLOS ONE			English	Article							GRIDDED PRECIPITATION DATASET; SUMMER MONSOON; RAINY-SEASON; DENSE NETWORK; DEFINITION; DATES; ASIA; PREDICTABILITY; REGION; AMAZON	To generate information about the monsoon onset and withdrawal we have to choose a monsoon definition and apply it to data. One problem that arises is that false monsoon onsets can hamper our analysis, which is often alleviated by smoothing the data in time or space. Another problem is that local communities or stakeholder groups may define the monsoon differently. We therefore aim to develop a technique that reduces false onsets for high-resolution gridded data, while also being flexible for different requirements that can be tailored to particular end-users. In this study, we explain how we developed our technique and demonstrate how it successfully reduces false onsets and withdrawals. The presented results yield improved information about the monsoon length and its interannual variability. Due to this improvement, we are able to extract information from higher resolution data sets. This implies that we can potentially get a more detailed picture of local climate variations that can be used in more local climate application projects such as community-based adaptations.	[Stiller-Reeve, Mathew Alexander] Uni Res Climate, Bergen, Norway; [Stiller-Reeve, Mathew Alexander; Spengler, Thomas] Bjerknes Ctr Climate Res, Bergen, Norway; [Spengler, Thomas] Univ Bergen, Inst Geophys, N-5020 Bergen, Norway; [Chu, Pao-Shin] Univ Hawaii, Dept Meteorol, Honolulu, HI 96822 USA	Bjerknes Centre for Climate Research; University of Bergen; University of Hawaii System	Stiller-Reeve, MA (corresponding author), Uni Res Climate, Bergen, Norway.	Mathew.reeve@uni.no	Spengler, Thomas/AAB-5153-2021	Spengler, Thomas/0000-0002-1747-6385	Norwegian Ministry of Foreign Affairs; Uni Research AS; Norwegian Research School for Climate Dynamics	Norwegian Ministry of Foreign Affairs; Uni Research AS; Norwegian Research School for Climate Dynamics	This work was funded by the Norwegian Ministry of Foreign Affairs (www.regjeringen.no), internal funding at Uni Research AS (www.uni.no), and student travel grants from the Norwegian Research School for Climate Dynamics (www.resclim.no). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson GCD, 2013, CLIM DYNAM, V40, P2589, DOI 10.1007/s00382-012-1494-x; AHMED R, 1993, INT J CLIMATOL, V13, P727, DOI 10.1002/joc.3370130703; ANANTHAKRISHNAN R, 1989, INT J CLIMATOL, V9, P321, DOI 10.1002/joc.3370090308; Ashfaq M, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036500; Ayers J, 2009, ENVIRONMENT, V51, P22, DOI 10.3200/ENV.51.4.22-31; Dilling L, 2011, GLOBAL ENVIRON CHANG, V21, P680, DOI 10.1016/j.gloenvcha.2010.11.006; Ensor J., 2009, UNDERSTANDING CLIMAT; Fasullo J, 2003, J CLIMATE, V16, P3200, DOI 10.1175/1520-0442(2003)016&lt;3200a:AHDOIM&gt;2.0.CO;2; Flatau MK, 2001, J CLIMATE, V14, P4130, DOI 10.1175/1520-0442(2001)014<4130:TDODMO>2.0.CO;2; Fontaine B, 2008, INT J CLIMATOL, V28, P1787, DOI 10.1002/joc.1674; Gadgil S., 2006, ASIAN MONSOON, P651; Garcia SR, 2009, THEOR APPL CLIMATOL, V97, P361, DOI 10.1007/s00704-008-0080-y; Giorgi F., 2009, WORLD METEOROLOGICAL, V58, P175, DOI DOI 10.1109/ICASSP.2009.4960141; Jun Matsumoto, 1997, Advances in Atmospheric Sciences, V14, P231; Krishnamurti TN, 1987, REV RECENT RES E ASI, P6092; Lau K M, 1997, Advances in Atmospheric Sciences, V14, P141, DOI 10.1007/s00376-997-0016-y; Marengo JA, 2001, J CLIMATE, V14, P833, DOI 10.1175/1520-0442(2001)014<0833:OAEOTR>2.0.CO;2; Pai DS, 2009, J EARTH SYST SCI, V118, P123, DOI 10.1007/s12040-009-0020-y; Rajeevan M, 2006, CURR SCI INDIA, V91, P296; Ramage CS, 1995, FORECASTERS GUIDE TR; ROSENZWEIG MR, 1993, ECON J, V103, P56, DOI 10.2307/2234337; Stiller-Reeve A, 2014, B AM METEOROLOGICAL; TANAKA M, 1992, J METEOROL SOC JPN, V70, P613, DOI 10.2151/jmsj1965.70.1B_613; Wang B, 2004, J CLIMATE, V17, P699, DOI 10.1175/2932.1; Wang B, 2002, J CLIMATE, V15, P386, DOI 10.1175/1520-0442(2002)015<0386:RSOTAP>2.0.CO;2; Webster PJ, 1998, J GEOPHYS RES-OCEANS, V103, P14451, DOI 10.1029/97JC02719; 王斌, 1997, Advances in Atmospheric Sciences, V14, P177, DOI 10.1007/s00376-997-0018-9; Xie A, 1998, THEOR APPL CLIMATOL, V59, P201, DOI 10.1007/s007040050024; Yatagai A, 2012, B AM METEOROL SOC, V93, P1401, DOI 10.1175/BAMS-D-11-00122.1; Yatagai A, 2009, SOLA, V5, P137, DOI 10.2151/sola.2009-035; Zeng XB, 2004, J CLIMATE, V17, P2241, DOI 10.1175/1520-0442(2004)017<2241:GUMOAR>2.0.CO;2; Zhang YS, 2002, J CLIMATE, V15, P3206, DOI 10.1175/1520-0442(2002)015&lt;3206:OOTSMO&gt;2.0.CO;2; Zhang ZQ, 2004, INT J CLIMATOL, V24, P1461, DOI 10.1002/joc.1082	33	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2014	9	8							e104386	10.1371/journal.pone.0104386	http://dx.doi.org/10.1371/journal.pone.0104386			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR0CG	25105900	Green Published, gold			2022-12-27	WOS:000343231900052
J	Schuler, P; Speck, T; Buhrig-Polaczek, A; Fleck, C				Schueler, Paul; Speck, Thomas; Buehrig-Polaczek, Andreas; Fleck, Claudia			Structure-Function Relationships in Macadamia integrifolia Seed Coats - Fundamentals of the Hierarchical Microstructure	PLOS ONE			English	Article							MECHANICAL-BEHAVIOR; NUT; SHELL; MICROSCOPY; NUTSHELL; ORCHARDS; FEATURES	The shells/coats of nuts and seeds are often very hard to crack. This is particularly the case with Macadamia seed coats, known to exhibit astoundingly high strength and toughness. We performed an extensive materials science characterization of the complex hierarchical structure of these coats, using light and scanning electron microscopy in 2D as well as microCT for 3D characterization. We differentiate nine hierarchical levels that characterize the structure ranging from the whole fruit on the macroscopic scale down to the molecular scale. From a biological viewpoint, understanding the hierarchical structure may elucidate why it is advantageous for these seed coats to be so difficult to break. From an engineering viewpoint, microstructure characterization is important for identifying features that contribute to the high strength and cracking resistance of these objects. This is essential for revealing the underlying structure-function-relationships. Such information will help us develop engineering materials and lightweight-structures with improved fracture and puncture resistance.	[Schueler, Paul; Fleck, Claudia] Tech Univ Berlin, Berlin, Germany; [Speck, Thomas] Univ Freiburg, Fac Biol, Plant Biomech Grp Freiburg, D-79106 Freiburg, Germany; [Buehrig-Polaczek, Andreas] Rhein Westfal TH Aachen, Foundry Inst, D-52062 Aachen, Germany	Technical University of Berlin; University of Freiburg; RWTH Aachen University	Fleck, C (corresponding author), Tech Univ Berlin, Berlin, Germany.	claudia.fleck@tu-berlin.de		Fleck, Claudia/0000-0002-8160-2710	German Research Foundation (DFG) [SPP 1420]; DFG	German Research Foundation (DFG)(German Research Foundation (DFG)); DFG(German Research Foundation (DFG))	This work has been performed within the project "Impact resistant hierarchically structured materials based on fruit walls and nutshells'' funded by the German Research Foundation (DFG) within SPP 1420. The financial support of the DFG is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aktas T, 2007, J FOOD PROCESS ENG, V30, P773, DOI 10.1111/j.1745-4530.2007.00164.x; Braga GC, 1999, J AGR ENG RES, V72, P239, DOI 10.1006/jaer.1998.0369; Bresinsky A., 2008, STRASBURGER LEHRBUCH; Costello G, 2009, SO MACADAMIA SPECIES; Eldridge J., 2012, Australian Journal of Crop Science, V6, P1110; Elmouttie D, 2005, J ENVIRON MANAGE, V77, P79, DOI 10.1016/j.jenvman.2005.03.004; Esau K., 1977, ANATOMY SEED PLANTS; Fleck C, 2012, BIOINSPIR BIOMIM NAN, V1, P67, DOI 10.1680/bbn.11.00015; Guner M, 2003, BIOSYST ENG, V85, P485, DOI 10.1016/S1537-5110(03)00089-8; Hardner C. M., 2009, Horticultural Reviews, V35, P1; Hartung ME, 1939, J AGRIC RES, V59, P0397; Horskins K, 1999, CROP PROT, V18, P379, DOI 10.1016/S0261-2194(99)00038-1; Janick J., 2006, ENCY FRUIT NUTS; JENNINGS JS, 1986, J MATER SCI, V21, P1517, DOI 10.1007/BF01114704; Kaupp G, 2007, SCI RES ESSAYS, V2, P150; Kaupp G, 2011, J MATER CHEM, V21, P8389, DOI 10.1039/c0jm03713c; Ledbetter CA, 2008, BIORESOURCE TECHNOL, V99, P5567, DOI 10.1016/j.biortech.2007.10.059; Loprang RR, 2010, P WORLD C ENG, VII, P1586; Martone PT, 2010, INTEGR COMP BIOL, V50, P888, DOI 10.1093/icb/icq122; McConachie I, 1980, CALIFORNIA MACADAMIA, V26, P41; Menninger EA, 1977, EDIBLE NUTS WORLD; Naimi-Jamal MR, 2007, INT J MATER RES, V98, P438, DOI 10.3139/146.101490; Neves PC, 1993, ISHS ACT HORT 370 IN, P197; Peace C. P., 2005, South African Journal of Plant and Soil, V22, P71; Schopfer P, 2010, PFLANZENPHYSIOLOGIE; Schuler P, 2010, THESIS TU BERLIN; Sharifian Faroogh, 2008, Journal of Applied Sciences, V8, P886, DOI 10.3923/jas.2008.886.890; Speck O, 2011, SPRITZGIESSEN 2011, VVDI-Verlag, P25; Speck T, 2008, WIT TRANS ECOL ENVIR, V114, P3, DOI 10.2495/DN080011; Speck T, 2011, ANNU REV MATER RES, V41, P169, DOI 10.1146/annurev-matsci-062910-100425; Strohschen B, 1985, THESIS RHEINISCHE FR; Trueb LF, 1999, FRUCHTE NUSSE ALLER; VINCENT JFV, 1993, MATER RES SOC SYMP P, V292, P35; Walton DA, 2005, THESIS U SUNSHINE CO; WANG CH, 1994, INT J FRACTURE, V69, P67; Yan YY, 2011, ADV COLLOID INTERFAC, V169, P80, DOI 10.1016/j.cis.2011.08.005	36	32	32	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e102913	10.1371/journal.pone.0102913	http://dx.doi.org/10.1371/journal.pone.0102913			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25102155	Green Submitted, Green Published, gold			2022-12-27	WOS:000339993900012
J	Chen, MX; Zhang, H; Liu, WD; Zhang, WZ				Chen, Mingxing; Zhang, Hua; Liu, Weidong; Zhang, Wenzhong			The Global Pattern of Urbanization and Economic Growth: Evidence from the Last Three Decades	PLOS ONE			English	Article							DEVELOPING-COUNTRIES; CHINA URBANIZATION; CO2 EMISSIONS; AFRICA; GEOGRAPHY; CITIES; IMPACT; SIZE	The relationship between urbanization and economic growth has been perplexing. In this paper, we identify the pattern of global change and the correlation of urbanization and economic growth, using cross-sectional, panel estimation and geographic information systems (GIS) methods. The analysis has been carried out on a global geographical scale, while the timescale of the study spans the last 30 years. The data shows that urbanization levels have changed substantially during these three decades. Empirical findings from cross-sectional data and panel data support the general notion of close links between urbanization levels and GDP per capita. However, we also present significant evidence that there is no correlation between urbanization speed and economic growth rate at the global level. Hence, we conclude that a given country cannot obtain the expected economic benefits from accelerated urbanization, especially if it takes the form of government-led urbanization. In addition, only when all facets are taken into consideration can we fully assess the urbanization process.	[Chen, Mingxing; Liu, Weidong; Zhang, Wenzhong] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Key Lab Reg Sustainable Dev Modeling, Beijing, Peoples R China; [Zhang, Hua] Beijing Normal Univ, Sch Geog, Beijing 100875, Peoples R China	Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; Beijing Normal University	Chen, MX (corresponding author), Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Key Lab Reg Sustainable Dev Modeling, Beijing, Peoples R China.	chenmx@igsnrr.ac.cn	chen, mingxing/K-4097-2013; 张, 华/AFP-9479-2022	chen, mingxing/0000-0001-5224-9762; 	National Natural Science Foundation of China [41001080, 41125005, 41230632]; Key Project for the Strategic Science Plan in IGSNRR, CAS [2012ZD006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project for the Strategic Science Plan in IGSNRR, CAS	Support for this study was provided by the National Natural Science Foundation of China (Grant No. 41001080, 41125005, 41230632), and by the Key Project for the Strategic Science Plan in IGSNRR, CAS (Grant No. 2012ZD006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai XM, 2012, ENVIRON SCI TECHNOL, V46, P132, DOI 10.1021/es202329f; Bao C, 2007, ECOL ECON, V62, P508, DOI 10.1016/j.ecolecon.2006.07.013; Batty M, 2008, SCIENCE, V319, P769, DOI 10.1126/science.1151419; Batty M, 2012, CITIES, V29, pS9, DOI 10.1016/j.cities.2011.11.008; Bertinelli L, 2007, URBAN STUD, V44, P2499, DOI 10.1080/00420980701558442; Bloom DE, 2008, SCIENCE, V319, P772, DOI 10.1126/science.1153057; Bruckner M, 2012, J URBAN ECON, V71, P26, DOI 10.1016/j.jue.2011.08.004; Brulhart M, 2009, J URBAN ECON, V65, P48, DOI 10.1016/j.jue.2008.08.003; Chang G. H., 2006, ECON SYST, V30, P24, DOI DOI 10.1016/J.ECOSYS.2005.07.002; Chen MX, 2013, HABITAT INT, V38, P25, DOI 10.1016/j.habitatint.2012.09.007; CHENERY HB, 1968, REV ECON STAT, V50, P391, DOI 10.2307/1926806; Czech B, 2004, US FOR SERV T R NC, V265, P8; El Nour A H, 1989, GeoJournal, V18, P369; Frenken K, 2007, REG STUD, V41, P685, DOI 10.1080/00343400601120296; Friedmann J, 2006, INT J URBAN REGIONAL, V30, P440, DOI 10.1111/j.1468-2427.2006.00671.x; Gu K, 2007, SINGAPORE J TROP GEO, V28, P158, DOI 10.1111/j.1467-9493.2007.00288.x; Harvey D, 2009, DEV CHANGE, V40, P1269, DOI 10.1111/j.1467-7660.2009.01602.x; Henderson V, 2003, J ECON GROWTH, V8, P47, DOI 10.1023/A:1022860800744; Hope KR, 1998, J ASIAN AFR STUD, V33, P345; Martinez-Zarzoso I, 2011, ECOL ECON, V70, P1344, DOI 10.1016/j.ecolecon.2011.02.009; Moomaw R, 1993, J ECON, V19, P1; Moomaw RL, 1996, J URBAN ECON, V40, P13, DOI 10.1006/juec.1996.0021; Moore M, 2003, INT J HYG ENVIR HEAL, V206, P269, DOI 10.1078/1438-4639-00223; Naughton Barry, 2007, CHINESE EC TRANSITIO; Njoh AJ, 2003, CITIES, V20, P167, DOI 10.1016/S0264-2751(03)00010-6; Normile D, 2008, SCIENCE, V319, P740, DOI 10.1126/science.319.5864.740; Oo N, 1989, Sojourn, V4, P233; Perren R, 2001, ECON HIST REV, V54, P807; Portugali J., 1999, SELF ORG CITY; Portugali J, 2006, ENVIRON PLANN A, V38, P647, DOI 10.1068/a37260; Poumanyvong P, 2010, ECOL ECON, V70, P434, DOI 10.1016/j.ecolecon.2010.09.029; PUGH C, 1995, CITIES, V12, P381, DOI 10.1016/0264-2751(95)00083-X; Scott AJ, 2009, J ECON GEOGR, V9, P583, DOI 10.1093/jeg/lbp019; Shen Kailing, 2012, J COMP EC; Turok I, 2013, ENVIRON URBAN, V25, P465, DOI 10.1177/0956247813490908; Whalley J, 2010, CHINA ECON REV, V21, P123, DOI 10.1016/j.chieco.2009.11.004; Zhou LM, 2004, P NATL ACAD SCI USA, V101, P9540, DOI 10.1073/pnas.0400357101	37	116	125	21	106	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e103799	10.1371/journal.pone.0103799	http://dx.doi.org/10.1371/journal.pone.0103799			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM6SM	25099392	gold, Green Submitted, Green Published			2022-12-27	WOS:000339995100032
J	Jackson, SE; Steptoe, A; Beeken, RJ; Kivimaki, M; Wardle, J				Jackson, Sarah E.; Steptoe, Andrew; Beeken, Rebecca J.; Kivimaki, Mika; Wardle, Jane			Psychological Changes following Weight Loss in Overweight and Obese Adults: A Prospective Cohort Study	PLOS ONE			English	Article							DEPRESSIVE SYMPTOMS; LONG-TERM; RISK; METAANALYSIS; DISEASE; MEN	Background: Participation in weight loss programs is often associated with improved wellbeing alongside reduced cardio-metabolic risk. In contrast, population-based analyses have found no evidence of psychological benefits of weight loss, but this may be due to inclusion of healthy-weight individuals. We therefore examined cardio-metabolic and psychological changes following weight loss in a cohort of overweight/obese adults. Methods: Data were from 1,979 overweight and obese adults (BMI >= 25 kg/m(2); age >= 50 y), free of long-standing illness or clinical depression at baseline, from the English Longitudinal Study of Ageing. Participants were grouped according to four-year weight change into those losing >= 5% weight, those gaining >= 5%, and those whose weight was stable within 5%. Logistic regression examined changes in depressed mood (eight-item Center for Epidemiologic Studies Depression score >= 4), low wellbeing (Satisfaction With Life Scale score <20), hypertension (systolic blood pressure >= 140 mmHg or anti-hypertensives), and high triglycerides (>= 1.7 mmol/l), controlling for demographic variables, weight loss intention, and baseline characteristics. Results: The proportion of participants with depressed mood increased more in the weight loss than weight stable or weight gain groups (+289%, +86%, +62% respectively; odds ratio [OR] for weight loss vs. weight stable = 1.78 [95% CI 1.29- 2.471]). The proportion with low wellbeing also increased more in the weight loss group (+31%, +22%, -4%), but the difference was not statistically significant (OR= 1.16 [0.81-1.661]). Hypertension and high triglyceride prevalence decreased in weight losers and increased in weight gainers (-28%, 4%, +18%; OR = 0.61 [0.45-0.83]; -47%, -13%, +5%; OR = 0.41 [0.28-0.60]). All effects persisted in analyses adjusting for illness and life stress during the weight loss period. Conclusions: Weight loss over four years in initially healthy overweight/obese older adults was associated with reduction in cardio-metabolic risk but no psychological benefit, even when changes in health and life stresses were accounted for. These results highlight the need to investigate the emotional consequences of weight loss.	[Jackson, Sarah E.; Steptoe, Andrew; Beeken, Rebecca J.; Kivimaki, Mika; Wardle, Jane] UCL, Dept Epidemiol & Publ Hlth, London, England	University of London; University College London	Wardle, J (corresponding author), UCL, Dept Epidemiol & Publ Hlth, London, England.	j.wardle@ucl.ac.uk	Kivimaki, Mika/B-3607-2012; Jackson, Sarah/J-9046-2019; Steptoe, Andrew/Y-2440-2019	Kivimaki, Mika/0000-0002-4699-5627; Jackson, Sarah/0000-0001-5658-6168; Beeken, Rebecca/0000-0001-8287-9351	National Institute on Aging [2RO1AG7644-01A1, 2RO1AG017644]; UK Medical Research Council; UK Economic and Social Research Council; British Heart Foundation; US National Institutes of Health; Cancer Research UK; ESRC [ES/J023299/1] Funding Source: UKRI; MRC [MR/K013351/1] Funding Source: UKRI; Cancer Research UK [14133] Funding Source: researchfish; Economic and Social Research Council [ES/J023299/1] Funding Source: researchfish; Medical Research Council [MR/K013351/1] Funding Source: researchfish; NATIONAL INSTITUTE ON AGING [R01AG017644] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); British Heart Foundation(British Heart Foundation); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research UK(Cancer Research UK); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The English Longitudinal Study of Ageing was developed by a team of researchers based at University College London, the Institute of Fiscal Studies and the National Centre for Social Research. The funding is provided by the National Institute on Aging (grants 2RO1AG7644-01A1 and 2RO1AG017644) and a consortium of UK government departments coordinated by the Office for National Statistics. SEJ is supported by an interdisciplinary studentship from the UK Medical Research Council and the UK Economic and Social Research Council. AS is supported by the British Heart Foundation. MK is supported by the UK Medical Research Council and the US National Institutes of Health. RJB and JW are supported by Cancer Research UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT, V4th; Anderson JW, 2001, AM J CLIN NUTR, V74, P579; [Anonymous], [No title captured]; Banks J., 2006, RETIREMENT HLTH RELA; Banks J, 2003, HLTH WEALTH LIFESTYL; Berry JD, 2012, NEW ENGL J MED, V366, P321, DOI 10.1056/NEJMoa1012848; Blaine BE, 2007, J HEALTH PSYCHOL, V12, P66, DOI 10.1177/1359105307071741; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; de Leon CFM, 2007, J GERONTOL B-PSYCHOL, V62, pS198, DOI 10.1093/geronb/62.3.S198; Di Angelantonio E, 2009, JAMA-J AM MED ASSOC, V302, P1993, DOI 10.1001/jama.2009.1619; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Fabricatore AN, 2011, INT J OBESITY, V35, P1363, DOI 10.1038/ijo.2011.2; FITZGIBBON ML, 1993, HEALTH PSYCHOL, V12, P342, DOI 10.1037/0278-6133.12.5.342; Forman-Hoffman VL, 2007, J GERONTOL B-PSYCHOL, V62, pS43, DOI 10.1093/geronb/62.1.S43; Foster GD, 1994, OBESITY PATHOPHYSIOL, P140; Franco M, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1515; Gallo WT, 2006, J GERONTOL B-PSYCHOL, V61, pS221, DOI 10.1093/geronb/61.4.S221; Gilbert JA, 2009, APPETITE, V52, P809, DOI 10.1016/j.appet.2009.04.003; Haukkala A, 2001, INT J BEHAV MED, V8, P116, DOI 10.1207/S15327558IJBM0802_03; HOLMES TH, 1967, J PSYCHOSOM RES, V11, P213, DOI 10.1016/0022-3999(67)90010-4; Johnston DW, 2014, ECON HUM BIOL, V12, P132, DOI 10.1016/j.ehb.2013.02.004; Koster A, 2010, AM J GERIAT PSYCHIAT, V18, P236, DOI 10.1097/JGP.0b013e3181c65837; LEIBEL RL, 1995, NEW ENGL J MED, V332, P621, DOI 10.1056/NEJM199503093321001; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Lowe MR, 1999, OBES RES, V7, P51, DOI 10.1002/j.1550-8528.1999.tb00390.x; Moore LL, 2005, ARCH INTERN MED, V165, P1298, DOI 10.1001/archinte.165.11.1298; National Heart Lung and Blood Institute, 2005, AIM HLTH WEIGHT; Neter JE, 2003, HYPERTENSION, V42, P878, DOI 10.1161/01.HYP.0000094221.86888.AE; Nicklas JM, 2012, AM J PREV MED, V42, P481, DOI 10.1016/j.amepre.2012.01.005; Nordestgaard BG, 2007, JAMA-J AM MED ASSOC, V298, P299, DOI 10.1001/jama.298.3.299; Peltonen M, 2012, END ABSTR, V29, P527; Poobalan A, 2004, Obes Rev, V5, P43, DOI 10.1111/j.1467-789X.2004.00127.x; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Resnick HE, 2000, J EPIDEMIOL COMMUN H, V54, P596, DOI 10.1136/jech.54.8.596; Sarwar N, 2010, LANCET, V375, P1634, DOI 10.1016/S0140-6736(10)60545-4; Serretti A, 2010, J CLIN PSYCHIAT, V71, P1259, DOI 10.4088/JCP.09r05346blu; Steffick DE, 2000, DR005 HRS SURV RES C; Steptoe A, 2013, INT J EPIDEMIOL, V42, P1640, DOI 10.1093/ije/dys168; Turvey C L, 1999, Int Psychogeriatr, V11, P139, DOI 10.1017/S1041610299005694; van Gool CH, 2003, AGE AGEING, V32, P81, DOI 10.1093/ageing/32.1.81; Vohs KD, 2000, PSYCHOL SCI, V11, P249, DOI 10.1111/1467-9280.00250; World Cancer Research Fund, HLTH WEIGHT CANC PRE; Yaemsiri S, 2011, INT J OBESITY, V35, P1063, DOI 10.1038/ijo.2010.229	44	24	24	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e104552	10.1371/journal.pone.0104552	http://dx.doi.org/10.1371/journal.pone.0104552			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM6SM	25098417	Green Published, gold			2022-12-27	WOS:000339995100083
J	Kolodka, T; Charles, ML; Raghavan, A; Radichev, IA; Amatya, C; Ellefson, J; Savinov, AY; Nag, A; Williams, MS; Robbins, MS				Kolodka, Tadeusz; Charles, Matthew L.; Raghavan, Arvind; Radichev, Ilian A.; Amatya, Christina; Ellefson, Jacob; Savinov, Alexei Y.; Nag, Abhijeet; Williams, Mark S.; Robbins, Mark S.			Preclinical Characterization of Recombinant Human Tissue Kallikrein-1 as a Novel Treatment for Type 2 Diabetes Mellitus	PLOS ONE			English	Article							CONVERTING-ENZYME-INHIBITORS; BRADYKININ B-2 RECEPTOR; KININ SYSTEM; INSULIN-RESISTANCE; GLUT4 TRANSLOCATION; SKELETAL-MUSCLE; GLUCOSE; PROKALLIKREIN; HYPERTENSION; LIRAGLUTIDE	Modulation of the kallikrein-kinin system (KKS) has been shown to have beneficial effects on glucose homeostasis and several other physiological responses relevant to the progression of type 2 diabetes mellitus (T2D). The importance of bradykinin and its receptors in mediating these responses is well documented, but the role of tissue kallikrein-1, the protease that generates bradykinin in situ, is much less understood. We developed and tested DM 199, recombinant human tissue kallikrein-1 protein (rhKLK-1), as a potential novel therapeutic for T2D. Hyperinsulinemic-euglycemic clamp studies suggest that DM199 increases whole body glucose disposal in non-diabetic rats. Single dose administration of DM199 in obese db/db mice and ZDF rats, showed an acute, dose-dependent improvement in whole-body glucose utilization. Sub-acute dosing for a week in ZDF rates improved glucose utilization, with a concomitant rise in fasting insulin levels and HOMA1 %B scores. After cessation of sub-acute dosing, fasting blood glucose levels were significantly lower in ZDF rats during a drug wash-out period. Our studies show for the first time that DM199 administration results in acute anti-hyperglycemic effects in several preclinical models, and demonstrate the potential for further development of DM199 as a novel therapeutic for T2D.	[Kolodka, Tadeusz; Charles, Matthew L.; Raghavan, Arvind; Williams, Mark S.; Robbins, Mark S.] DiaMed USA Inc, Minneapolis, MN 55441 USA; [Radichev, Ilian A.; Amatya, Christina; Ellefson, Jacob; Savinov, Alexei Y.] Sanford Res, Sanford Project, Childrens Hlth Res Ctr, Sioux Falls, SD USA; [Nag, Abhijeet] Invitek Inc, Hayward, CA USA	Sanford Health	Raghavan, A (corresponding author), DiaMed USA Inc, Minneapolis, MN 55441 USA.	araghavan@diamedica.com		Raghavan, Arvind/0000-0002-2959-3626	Diamedica USA, Inc; Invitek, Inc.	Diamedica USA, Inc; Invitek, Inc.	All funding for the study and supply of the therapeutic test article, DM199, was provided by Diamedica USA, Inc. The funder and Invitek, Inc., provided support in the form of salaries for authors TK, MLC, AR, MSW, MSR, and AN but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aref ABM, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/429154; Barros CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040573; Beard KM, 2006, DIABETES, V55, P2678, DOI 10.2337/db05-1538; Biyashev D, 2006, AM J PHYSIOL-HEART C, V290, pH1244, DOI 10.1152/ajpheart.00934.2005; Brand CL, 2009, DIABETES OBES METAB, V11, P795, DOI 10.1111/j.1463-1326.2009.01049.x; Brubaker PL, 2010, ENDOCRINOLOGY, V151, P1984, DOI 10.1210/en.2010-0115; Burgess GM, 2000, BRIT J PHARMACOL, V129, P77, DOI 10.1038/sj.bjp.0703012; Busse R, 1996, DIABETES, V45, pS8, DOI 10.2337/diab.45.1.S8; Campbell DJ, 2001, CLIN EXP PHARMACOL P, V28, P1060, DOI 10.1046/j.1440-1681.2001.03564.x; CAMPBELL DJ, 1994, HYPERTENSION, V23, P439, DOI 10.1161/01.HYP.23.4.439; Chao JL, 2008, HYPERTENSION, V52, P715, DOI 10.1161/HYPERTENSIONAHA.108.114587; Chao J, 2010, BIOL CHEM, V391, P345, DOI 10.1515/BC.2010.042; Damas J, 2004, DIABETES-METAB RES, V20, P288, DOI 10.1002/dmrr.489; Damas J, 1999, EXP PHYSIOL, V84, P549, DOI 10.1111/j.1469-445X.1999.01812.x; Hecquet C, 2000, MOL PHARMACOL, V58, P828, DOI 10.1124/mol.58.4.828; Henriksen EJ, 1998, AM J PHYSIOL-REG I, V275, pR40, DOI 10.1152/ajpregu.1998.275.1.R40; Hillmeister P, 2012, ACTA PHYSIOL, V206, P215, DOI 10.1111/apha.12007; Houle S, 2003, HYPERTENSION, V41, P611, DOI 10.1161/01.HYP.0000054971.03046.9B; Isami S, 1996, DIABETOLOGIA, V39, P412, DOI 10.1007/s001250050460; Kishi K, 1998, DIABETES, V47, P550, DOI 10.2337/diabetes.47.4.550; KOHLMAN O, 1995, HYPERTENSION, V25, P1003, DOI 10.1161/01.HYP.25.5.1003; Lu HS, 1996, PROTEIN EXPRES PURIF, V8, P227, DOI 10.1006/prep.1996.0095; Lu HS, 1996, PROTEIN EXPRES PURIF, V8, P215, DOI 10.1006/prep.1996.0094; Madeddu P, 2007, NAT CLIN PRACT NEPHR, V3, P208, DOI 10.1038/ncpneph0444; Mayfield RK, 1996, DIABETES, V45, pS20, DOI 10.2337/diab.45.1.S20; Miyata T, 1998, EUR J ENDOCRINOL, V138, P344, DOI 10.1530/eje.0.1380344; Molitch ME, 2013, AM J MANAG CARE, V19; Montanari D, 2005, DIABETES, V54, P1573, DOI 10.2337/diabetes.54.5.1573; Pick A, 1998, DIABETES, V47, P358, DOI 10.2337/diabetes.47.3.358; RHALEB NE, 1992, EUR J PHARMACOL, V210, P115, DOI 10.1016/0014-2999(92)90661-M; Rhaleb NE, 2011, COMPR PHYSIOL, V1, P971, DOI 10.1002/cphy.c100053; Shiuchi T, 2002, HYPERTENSION, V40, P329, DOI 10.1161/01.HYP.0000028979.98877.0C; Sturis J, 2003, BRIT J PHARMACOL, V140, P123, DOI 10.1038/sj.bjp.0705397; Tomita H, 2012, KIDNEY INT, V81, P733, DOI 10.1038/ki.2011.499; WANG J, 1994, HYPERTENSION, V23, P236, DOI 10.1161/01.HYP.23.2.236; XIONG W, 1995, HYPERTENSION, V25, P715, DOI 10.1161/01.HYP.25.4.715; YANG C, 1995, AM J PHYSIOL-ENDOC M, V268, pE1027, DOI 10.1152/ajpendo.1995.268.5.E1027; Yang C, 1997, REGUL PEPTIDES, V71, P23, DOI 10.1016/S0167-0115(97)01011-2; Yu QJ, 2011, CARDIOVASC RES, V89, P516, DOI 10.1093/cvr/cvq349; Yuan G, 2007, ENDOCRINOLOGY, V148, P2016, DOI 10.1210/en.2006-0602; Zhao CX, 2003, HYPERTENSION, V42, P1026, DOI 10.1161/01.HYP.0000097603.55404.35	41	11	17	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e103981	10.1371/journal.pone.0103981	http://dx.doi.org/10.1371/journal.pone.0103981			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25100328	Green Published, Green Submitted, gold			2022-12-27	WOS:000339995100039
J	Adler, L; Alter, T; Sharbati, S; Golz, G				Adler, Linda; Alter, Thomas; Sharbati, Soroush; Goelz, Greta			Phenotypes of Campylobacter jejuni luxS Mutants Are Depending on Strain Background, Kind of Mutation and Experimental Conditions	PLOS ONE			English	Article							QUORUM-SENSING SIGNAL; SEROVAR TYPHIMURIUM; ESCHERICHIA-COLI; AUTOINDUCER-2; BACTERIA; MOLECULE; METABOLISM; VIRULENCE; EXPRESSION; BIOFILM	Since the discovery that Campylobacter (C.) jejuni produces Autoinducer 2 (AI-2), various studies have been conducted to explore the function and role of AI-2 in C. jejuni. However, the interpretation of these analyses has been complicated by differences in strain backgrounds, kind of mutation and culture conditions used. Furthermore, all research on AI-2 dependent phenotypes has been conducted with AI-2 synthase (luxS) mutants. This mutation also leads to a disruption of the activated-methyl-cycle. Most studies lack sufficient complementation resulting in not knowing whether phenotypes of luxS mutants depend on disrupted metabolism or lack of AI-2. Additionally, no AI-2 receptor has been found yet. All this contributes to an intensive discussion about the exact role of AI-2 in C. jejuni. Therefore, we examined the impact of different experiment settings on three different C. jejuni luxS mutants on growth and motility (37 degrees C and 42 degrees C). Our study showed that differing phenotypes of C. jejuni luxS mutants depend on strain background, mutation strategy and culture conditions. Furthermore, we complemented experiments with synthetic AI-2 or homocysteine as well as the combination of both. Complementation with AI-2 and AI-2+ homocysteine significantly increased the cell number of C. jejuni NCTC 11168 Delta luxS in stationary phase compared to the non-complemented C. jejuni NCTC 11168 Delta luxS mutant. Genetic complementation of both C. jejuni 81-176 luxS mutants resulted in wild type comparable growth curves. Also swarming ability could be partially complemented. While genetic complementation restored swarming abilities of C. jejuni 81-176 Delta luxS, it did not fully restore the phenotype of C. jejuni 81-176:: luxS, which indicates that compensatory mutations in other parts of the chromosome and/or potential polar effects may appear in this mutant strain. Also with neither synthetic complementation, the phenotype of the wild type-strains was achieved, suggesting yet another reason for differing phenotypes other than communication and methionine metabolism for C. jejuni luxS mutants.	[Adler, Linda; Alter, Thomas; Goelz, Greta] Free Univ Berlin, Inst Food Hyg, Berlin, Germany; [Sharbati, Soroush] Free Univ Berlin, Inst Vet Biochem, Berlin, Germany	Free University of Berlin; Free University of Berlin	Adler, L (corresponding author), Free Univ Berlin, Inst Food Hyg, Berlin, Germany.	lindaadler@fu-berlin.de	Alter, Thomas/J-4810-2014	Alter, Thomas/0000-0002-6048-5666; Sharbati, Soroush/0000-0003-3338-7654	German Federal Office for Agriculture and Food	German Federal Office for Agriculture and Food	GG was funded by the German Federal Office for Agriculture and Food within the project InnoStep (http://www.ble.de/DE/07_DieBLE/dieble_node.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassler BL, 1999, CURR OPIN MICROBIOL, V2, P582, DOI 10.1016/S1369-5274(99)00025-9; Bassler BL, 1997, J BACTERIOL, V179, P4043, DOI 10.1128/jb.179.12.4043-4045.1997; Chen X, 2002, NATURE, V415, P545, DOI 10.1038/415545a; Cloak OM, 2002, APPL ENVIRON MICROB, V68, P4666, DOI 10.1128/AEM.68.9.4666-4671.2002; Corcionivoschi N, 2009, INFECT IMMUN, V77, P1959, DOI 10.1128/IAI.01239-08; Davies DG, 1998, SCIENCE, V280, P295, DOI 10.1126/science.280.5361.295; Dingle KE, 2001, J CLIN MICROBIOL, V39, P3346, DOI 10.1128/JCM.39.9.3346-3349.2001; Dugar G, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003495; Elvers KT, 2002, MICROBIOL-SGM, V148, P1475, DOI 10.1099/00221287-148-5-1475; ENGEBRECHT J, 1983, CELL, V32, P773, DOI 10.1016/0092-8674(83)90063-6; Golz G, 2012, EUR J MICROBIOL IMMU, V2, P50, DOI 10.1556/EuJMI.2.2012.1.8; Guerry P, 2006, MOL MICROBIOL, V60, P299, DOI 10.1111/j.1365-2958.2006.05100.x; Haigh R, 2013, MOL MICROBIOL, V88, P951, DOI 10.1111/mmi.12237; He YP, 2008, FOODBORNE PATHOG DIS, V5, P399, DOI 10.1089/fpd.2008.0106; Hofreuter D, 2006, INFECT IMMUN, V74, P4694, DOI 10.1128/IAI.00210-06; Kavanaugh JS, 2011, ACTA CRYSTALLOGR F, V67, P1501, DOI 10.1107/S1744309111042953; Kint G, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-276; Miller MB, 2002, CELL, V110, P303, DOI 10.1016/S0092-8674(02)00829-2; Miller ST, 2004, MOL CELL, V15, P677, DOI 10.1016/j.molcel.2004.07.020; Neiditch MB, 2006, CELL, V126, P1095, DOI 10.1016/j.cell.2006.07.032; NG LK, 1985, J CLIN MICROBIOL, V21, P226, DOI 10.1128/JCM.21.2.226-230.1985; Pereira CS, 2008, MOL MICROBIOL, V70, P1223, DOI 10.1111/j.1365-2958.2008.06477.x; Plummer P, 2012, INFECT IMMUN, V80, P585, DOI 10.1128/IAI.05766-11; Plummer PJ, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00022; Quinones B, 2009, APPL ENVIRON MICROB, V75, P281, DOI 10.1128/AEM.01803-08; Rader BA, 2011, MICROBIOL-SGM, V157, P2445, DOI 10.1099/mic.0.049353-0; Rezzonico F, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-154; Schauder S, 2001, MOL MICROBIOL, V41, P463, DOI 10.1046/j.1365-2958.2001.02532.x; Tsuchikama K, 2011, J ORG CHEM, V76, P6981, DOI 10.1021/jo200882k; Udekwu KI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013449; Vendeville A, 2005, NAT REV MICROBIOL, V3, P383, DOI 10.1038/nrmicro1146; Wang L, 2005, J BACTERIOL, V187, P2066, DOI 10.1128/JB.187.6.2066-2076.2005; Winzer K, 2003, ADV APPL MICROBIOL, V53, P291, DOI 10.1016/S0065-2164(03)53009-X; Winzer K, 2002, MICROBIOL-SGM, V148, P909, DOI 10.1099/00221287-148-4-909	34	12	14	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e104399	10.1371/journal.pone.0104399	http://dx.doi.org/10.1371/journal.pone.0104399			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093839	Green Published, Green Submitted, gold			2022-12-27	WOS:000341357200109
J	Hung, HS; Chang, CH; Chang, CJ; Tang, CM; Kao, WC; Lin, SZ; Hsieh, HH; Chu, MY; Sun, WS; Hsu, SH				Hung, Huey-Shan; Chang, Chih-Hsuan; Chang, Chen-Jung; Tang, Cheng-Ming; Kao, Wei-Chien; Lin, Shinn-Zong; Hsieh, Hsien-Hsu; Chu, Mei-Yun; Sun, Wei-Shen; Hsu, Shan-hui			In Vitro Study of a Novel Nanogold-Collagen Composite to Enhance the Mesenchymal Stem Cell Behavior for Vascular Regeneration	PLOS ONE			English	Article							POLYURETHANE NANOCOMPOSITES; MECHANICAL-PROPERTIES; EXTRACELLULAR-MATRIX; ENDOTHELIAL-CELLS; TISSUE; GOLD; SCAFFOLDS; BINDING; NANOPARTICLES; PROLIFERATION	Novel nanocomposites based on type I collagen (Col) containing a small amount (17.4, 43.5, and 174 ppm) of gold nanoparticles (AuNPs, approximately 5 nm) were prepared in this study. The pure Col and Col-AuNP composites (Col-Au) were characterized by the UV-Vis spectroscopy (UV-Vis), surface-enhanced raman spectroscopy (SERS) and atomic force microscopy (AFM). The interaction between Col and AuNPs was confirmed by infrared (IR) spectra. The effect of AuNPs on the biocompatibility of Col, evaluated by the proliferation and reactive oxygen species (ROS) production of mesenchymal stem cells (MSCs) as well as the activation of monocytes and platelets, was investigated. Results showed that Col-Au had better biocompatibility than Col. Upon stimulation by vascular endothelial growth factor (VEGF) and stromal derived factor-1 alpha (SDF-1 alpha), MSCs expressed the highest levels of alpha v beta 3 integrin/CXCR4, focal adhesion kinase (FAK), matrix metalloproteinase-2 (MMP-2), and Akt/endothelial nitric oxide synthase (eNOS) proteins when grown on the Col-Au (43.5 ppm) nanocomposite. Taken together, Col-Au nanocomposites may promote the proliferation and migration of MSCs and stimulate the endothelial cell differentiation. These results suggest that Col-Au may be used to construct tissue engineering scaffolds for vascular regeneration.	[Hung, Huey-Shan; Chang, Chih-Hsuan; Kao, Wei-Chien; Chu, Mei-Yun; Sun, Wei-Shen] China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan; [Hung, Huey-Shan; Lin, Shinn-Zong] China Med Univ Hosp, Ctr Neuropsychiat, Taichung, Taiwan; [Chang, Chen-Jung] Cent Taiwan Univ Sci & Technol, Dept Med Imaging & Radiol Sci, Taichung, Taiwan; [Tang, Cheng-Ming] Chung Shan Med Univ, Inst Oral Sci, Taichung, Taiwan; [Lin, Shinn-Zong] China Med Univ, Beigang Hosp, Yunlin, Taiwan; [Lin, Shinn-Zong] China Med Univ, Grad Inst Immunol, Taichung, Taiwan; [Hsieh, Hsien-Hsu] Taichung Vet Gen Hosp, Blood Bank, Taichung, Taiwan; [Hsu, Shan-hui] Natl Taiwan Univ, Inst Polymer Sci & Engn, Taipei 10764, Taiwan; [Hsu, Shan-hui] Natl Taiwan Univ, Rehabil Engn Res Ctr, Taipei 10764, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Central Taiwan University Science & Technology; Chung Shan Medical University; China Medical University Taiwan; China Medical University Taiwan; Taichung Veterans General Hospital; National Taiwan University; National Taiwan University	Hsu, SH (corresponding author), Natl Taiwan Univ, Inst Polymer Sci & Engn, Taipei 10764, Taiwan.	shhsu@ntu.edu.tw	Lin, Shinn-Zong/AAX-2379-2020	Hsu, Shan-hui/0000-0003-3399-055X	National Science Council, Taiwan; Blood Bank, Taichung Veterans General Hospital	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Blood Bank, Taichung Veterans General Hospital	The work was supported by both National Science Council, Taiwan, and Blood Bank, Taichung Veterans General Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blit PH, 2011, BIOMATERIALS, V32, P5790, DOI 10.1016/j.biomaterials.2011.04.067; Buerck J, 2013, LANGMUIR, V29, P1562, DOI 10.1021/la3033258; Caplan A, 2009, J PATHOL, V217, P318, DOI 10.1002/path.2469; Caplan AI, 2008, CELL STEM CELL, V3, P229, DOI 10.1016/j.stem.2008.08.008; Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886; Cen L, 2008, PEDIATR RES, V63, P492, DOI 10.1203/PDR.0b013e31816c5bc3; CHAPUIS JF, 1992, J BIOMECH, V25, P115, DOI 10.1016/0021-9290(92)90250-5; Couet F, 2007, MACROMOL BIOSCI, V7, P701, DOI 10.1002/mabi.200700002; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Cummings CL, 2004, BIOMATERIALS, V25, P3699, DOI 10.1016/j.biomaterials.2003.10.073; Desimone MF, 2010, ACTA BIOMATER, V6, P3998, DOI 10.1016/j.actbio.2010.05.014; Di Lullo GA, 2002, J BIOL CHEM, V277, P4223, DOI 10.1074/jbc.M110709200; Ding DC, 2007, NEUROBIOL DIS, V27, P339, DOI 10.1016/j.nbd.2007.06.010; Fortini C, 2011, J CELL MOL MED, V15, P1726, DOI 10.1111/j.1582-4934.2010.01195.x; Garcia AJ, 1999, MOL BIOL CELL, V10, P785, DOI 10.1091/mbc.10.3.785; Glowacki J, 2008, BIOPOLYMERS, V89, P338, DOI 10.1002/bip.20871; Gu HY, 2004, BIOMATERIALS, V25, P3445, DOI 10.1016/j.biomaterials.2003.10.048; Ho TT, 2012, GOLD BULL, V45, P161, DOI 10.1007/s13404-012-0062-9; Holmes DF, 2001, MICRON, V32, P273, DOI 10.1016/S0968-4328(00)00040-8; Horovitz O, 2007, GOLD BULL, V40, P295, DOI 10.1007/BF03215603; HSU S, 1994, BIORHEOLOGY, V31, P21; Hsu SH, 2008, BIOMACROMOLECULES, V9, P241, DOI 10.1021/bm700471k; Hsu SH, 2008, ACTA BIOMATER, V4, P1797, DOI 10.1016/j.actbio.2008.06.015; Huang CY, 2013, J MED BIOL ENG, V33, P139, DOI 10.5405/jmbe.1109; Hung HS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065738; Hung HS, 2012, J BIOMED MATER RES A, V100A, P26, DOI 10.1002/jbm.a.33224; Hung HS, 2009, BIOMATERIALS, V30, P1502, DOI 10.1016/j.biomaterials.2008.12.003; Kirschner C, 2004, J AGR FOOD CHEM, V52, P3920, DOI 10.1021/jf0306136; Knetsch MLW, 2004, J BIOMED MATER RES A, V71A, P615, DOI 10.1002/jbm.a.30195; L'Heureux N, 2006, NAT MED, V12, P361, DOI 10.1038/nm1364; LEE JM, 1986, BIOMATERIALS, V7, P423; Liu LZ, 2011, STEM CELLS DEV, V20, P1961, DOI 10.1089/scd.2010.0453; Lynn AK, 2004, J BIOMED MATER RES B, V71B, P343, DOI 10.1002/jbm.b.30096; MacDonald RA, 2005, J BIOMED MATER RES A, V74A, P489, DOI 10.1002/jbm.a.30386; Madhavan K, 2010, ACTA BIOMATER, V6, P1413, DOI 10.1016/j.actbio.2009.09.028; Malda J, 2004, BIOTECHNOL BIOENG, V86, P9, DOI 10.1002/bit.20038; Meirelles LD, 2009, CYTOKINE GROWTH F R, V20, P419, DOI 10.1016/j.cytogfr.2009.10.002; Mekhfi H, 2012, NUTRITION, V28, P937, DOI 10.1016/j.nut.2011.11.032; Mironov V, 2008, TRENDS BIOTECHNOL, V26, P338, DOI 10.1016/j.tibtech.2008.03.001; Nimi N, 2011, GOLD BULL, V44, P15, DOI 10.1007/s13404-010-0001-6; Nudelman F, 2010, NAT MATER, V9, P1004, DOI 10.1038/NMAT2875; Roeder BA, 2002, J BIOMECH ENG-T ASME, V124, P214, DOI 10.1115/1.1449904; Salacinski HJ, 2001, J BIOMATER APPL, V15, P241, DOI 10.1106/NA5T-J57A-JTDD-FD04; Schlapp M, 2003, J PHARM SCI-US, V92, P2145, DOI 10.1002/jps.10460; Sedaghat A, 2013, CLIN RES CARDIOL, V102, P413, DOI 10.1007/s00392-013-0547-4; Smith ML, 2007, PLOS BIOL, V5, P2243, DOI 10.1371/journal.pbio.0050268; Sun WJ, 2007, GROWTH FACTORS, V25, P309, DOI 10.1080/08977190701803885; Tan W, 2001, TISSUE ENG, V7, P203, DOI 10.1089/107632701300062831; Tang JM, 2011, CARDIOVASC RES, V91, P402, DOI 10.1093/cvr/cvr053; Wang DB, 2014, J COLLOID INTERF SCI, V417, P244, DOI 10.1016/j.jcis.2013.11.019; Wu HC, 2007, BIOMATERIALS, V28, P1385, DOI 10.1016/j.biomaterials.2006.11.012; Xu HZ, 2012, INT J MOL SCI, V13, P3366, DOI 10.3390/ijms13033366; Yen HJ, 2009, SMALL, V5, P1553, DOI 10.1002/smll.200900126; Zaruba MM, 2010, EXPERT OPIN BIOL TH, V10, P321, DOI 10.1517/14712590903460286; Zhang L, 2010, APPL SPECTROSC, V64, P23, DOI 10.1366/000370210790571918; Zilla P, 2007, BIOMATERIALS, V28, P5009, DOI 10.1016/j.biomaterials.2007.07.017	56	38	39	1	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e104019	10.1371/journal.pone.0104019	http://dx.doi.org/10.1371/journal.pone.0104019			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093502	Green Submitted, gold, Green Published			2022-12-27	WOS:000341357200059
J	Monument, MJ; Johnson, KM; McIlvaine, E; Abegglen, L; Watkins, WS; Jorde, LB; Womer, RB; Beeler, N; Monovich, L; Lawlor, ER; Bridge, JA; Schiffman, JD; Krailo, MD; Randall, RL; Lessnick, SL				Monument, Michael J.; Johnson, Kirsten M.; McIlvaine, Elizabeth; Abegglen, Lisa; Watkins, W. Scott; Jorde, Lynn B.; Womer, Richard B.; Beeler, Natalie; Monovich, Laura; Lawlor, Elizabeth R.; Bridge, Julia A.; Schiffman, Joshua D.; Krailo, Mark D.; Randall, R. Lor; Lessnick, Stephen L.			Clinical and Biochemical Function of Polymorphic NR0B1 GGAA-Microsatellites in Ewing Sarcoma: A Report from the Children's Oncology Group	PLOS ONE			English	Article							ROUND-CELL TUMORS; EWS/FLI; INSTABILITY; GENE; SPECIFICITY; ONCOPROTEIN; EXPRESSION; SEQUENCES; ELEMENTS; FAMILY	Background: The genetics involved in Ewing sarcoma susceptibility and prognosis are poorly understood. EWS/FLI and related EWS/ETS chimeras upregulate numerous gene targets via promoter-based GGAA-microsatellite response elements. These microsatellites are highly polymorphic in humans, and preliminary evidence suggests EWS/FLI-mediated gene expression is highly dependent on the number of GGAA motifs within the microsatellite. Objectives: Here we sought to examine the polymorphic spectrum of a GGAA-microsatellite within the NR0B1 promoter (a critical EWS/FLI target) in primary Ewing sarcoma tumors, and characterize how this polymorphism influences gene expression and clinical outcomes. Results: A complex, bimodal pattern of EWS/FLI-mediated gene expression was observed across a wide range of GGAA motifs, with maximal expression observed in constructs containing 20-26 GGAA motifs. Relative to white European and African controls, the NR0B1 GGAA-microsatellite in tumor cells demonstrated a strong bias for haplotypes containing 21-25 GGAA motifs suggesting a relationship between microsatellite function and disease susceptibility. This selection bias was not a product of microsatellite instability in tumor samples, nor was there a correlation between NR0B1 GGAA-microsatellite polymorphisms and survival outcomes. Conclusions: These data suggest that GGAA-microsatellite polymorphisms observed in human populations modulate EWS/FLI-mediated gene expression and may influence disease susceptibility in Ewing sarcoma.	[Monument, Michael J.; Randall, R. Lor; Lessnick, Stephen L.] Univ Utah, Dept Orthoped Surg, Sarcoma Serv, Salt Lake City, UT 84112 USA; [Monument, Michael J.; Johnson, Kirsten M.; Abegglen, Lisa; Schiffman, Joshua D.; Randall, R. Lor; Lessnick, Stephen L.] Univ Utah, Ctr Childrens Canc Res, Huntsman Canc Inst, Salt Lake City, UT USA; [McIlvaine, Elizabeth; Krailo, Mark D.] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Watkins, W. Scott; Jorde, Lynn B.] Univ Utah, Dept Human Genet, Salt Lake City, UT USA; [Watkins, W. Scott; Jorde, Lynn B.] Univ Utah, Eccles Inst Human Genet, Salt Lake City, UT USA; [Womer, Richard B.] Univ Penn, Childrens Hosp Philadelphia, Div Oncol, Philadelphia, PA 19104 USA; [Beeler, Natalie; Monovich, Laura] Nationwide Childrens Hosp, Res Inst, Childrens Oncol Grp, Biopathol Ctr, Columbus, OH USA; [Lawlor, Elizabeth R.] Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA; [Lawlor, Elizabeth R.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Bridge, Julia A.] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Nebraska Med Ctr, Omaha, NE USA; [Schiffman, Joshua D.; Lessnick, Stephen L.] Univ Utah, Div Pediat Hematol Oncol, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; University of Southern California; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Children's Oncology Group (COG); University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Nebraska System; University of Nebraska Medical Center; Utah System of Higher Education; University of Utah	Lessnick, SL (corresponding author), Univ Utah, Dept Orthoped Surg, Sarcoma Serv, Salt Lake City, UT 84112 USA.	stephen.lessnick@hci.utah.edu		Johnson, Kirsten/0000-0003-2388-0621	Huntsman Cancer Institute [P30CA042014]; Terri Anne Perine Sarcoma fund; Orthopaedic Research and Education Fund (OREF); Nick Currey Fund; NIH/NCI [R01 CA140394, R01 CA161780]; Damon Runyon Cancer Research Foundation [56--<SUP>-</SUP>11]; NATIONAL CANCER INSTITUTE [U01CA114757, U54CA168512, R01CA161780, U10CA180899, U10CA180886, R01CA140394, U10CA098543, P30CA042014] Funding Source: NIH RePORTER	Huntsman Cancer Institute; Terri Anne Perine Sarcoma fund; Orthopaedic Research and Education Fund (OREF); Nick Currey Fund; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Damon Runyon Cancer Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	All listed authors acknowledge support from the Huntsman Cancer Institute via P30CA042014 and the Terri Anne Perine Sarcoma fund. MJM acknowledges support from the Orthopaedic Research and Education Fund (OREF); MDK and EM acknowledge support from the Nick Currey Fund; SLL acknowledges support from the NIH/NCI via R01 CA140394 and JDS acknowledges support from the Damon Runyon Cancer Research Foundation (CI#56--<SUP>-</SUP>11) and from the NIH/NCI via R01 CA161780. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arzimanoglou II, 1998, CANCER-AM CANCER SOC, V82, P1808, DOI 10.1002/(SICI)1097-0142(19980515)82:10<1808::AID-CNCR2>3.0.CO;2-J; Bamshad MJ, 2003, AM J HUM GENET, V72, P578, DOI 10.1086/368061; Batra S, 2004, CANCER RES, V64, P5415, DOI 10.1158/0008-5472.CAN-04-0377; Beck R, 2012, CANCER GENET-NY, V205, P304, DOI 10.1016/j.cancergen.2012.04.004; Borinstein SC, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00057; Braunreiter CL, 2006, CELL CYCLE, V5, P2753, DOI 10.4161/cc.5.23.3505; Dean FB, 2002, P NATL ACAD SCI USA, V99, P5261, DOI 10.1073/pnas.082089499; DELATTRE O, 1994, NEW ENGL J MED, V331, P294, DOI 10.1056/NEJM199408043310503; Dubois SG, 2011, PEDIAT BLOOD CANC; Eckert KA, 2002, MOL CARCINOGEN, V34, P140, DOI 10.1002/mc.10058; Eckert KA, 2009, MOL CARCINOGEN, V48, P379, DOI 10.1002/mc.20499; Ellegren H, 2004, NAT REV GENET, V5, P435, DOI 10.1038/nrg1348; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gangwal K, 2008, CELL CYCLE, V7, P3127, DOI 10.4161/cc.7.20.6892; Gangwal K, 2008, P NATL ACAD SCI USA, V105, P10149, DOI 10.1073/pnas.0801073105; Gangwal Kunal, 2010, Genes Cancer, V1, P177; Garcia-Aragoncillo E, 2008, ONCOGENE, V27, P6034, DOI 10.1038/onc.2008.203; Guillon N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004932; Hollenhorst PC, 2011, ANNU REV BIOCHEM, V80, P437, DOI 10.1146/annurev.biochem.79.081507.103945; Iglesias AR, 2004, GENE, V341, P149, DOI 10.1016/j.gene.2004.06.035; Jorde LB, 1997, P NATL ACAD SCI USA, V94, P3100, DOI 10.1073/pnas.94.7.3100; Kalbfleisch J.D., 2002, STAT ANAL FAILURE TI; Kinsey M, 2006, MOL CANCER RES, V4, P851, DOI 10.1158/1541-7786.MCR-06-0090; Kinsey M, 2009, CANCER RES, V69, P9047, DOI 10.1158/0008-5472.CAN-09-1540; Lessnick SL, 2002, CANCER CELL, V1, P393, DOI 10.1016/S1535-6108(02)00056-9; Lessnick SL, 2012, ANNU REV PATHOL-MECH, V7, P145, DOI 10.1146/annurev-pathol-011110-130237; Martin P, 2005, P NATL ACAD SCI USA, V102, P3800, DOI 10.1073/pnas.0406805102; Martin P, 2003, MOL MICROBIOL, V50, P245, DOI 10.1046/j.1365-2958.2003.03678.x; Martin SS, 1998, ANN SURG ONCOL, V5, P356, DOI 10.1007/BF02303500; Martinez-Ramirez A, 2003, CANCER GENET CYTOGEN, V141, P138, DOI 10.1016/S0165-4608(02)00670-2; May WA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080060; Ohali A, 2004, CANCER GENET CYTOGEN, V150, P50, DOI 10.1016/j.cancergencyto.2003.08.014; Patel M, 2011, GENOME RES; Postel-Vinay S, 2012, NATURE GENETICS; Prieur A, 2004, MOL CELL BIOL, V24, P7275, DOI 10.1128/MCB.24.16.7275-7283.2004; Riggi N, 2005, CANCER RES, V65, P11459, DOI 10.1158/0008-5472.CAN-05-1696; Sankar S, 2011, CANCER GENET-NY, V204, P351, DOI 10.1016/j.cancergen.2011.07.008; Sawaya S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054710; Smith R, 2006, CANCER CELL, V9, P405, DOI 10.1016/j.ccr.2006.04.004; STEPHENS MA, 1974, J AM STAT ASSOC, V69, P730, DOI 10.2307/2286009; Torchia EC, 2007, MOL CELL BIOL, V27, P7918, DOI 10.1128/MCB.00099-07; Weiss R, 2009, J COMP PATHOL, V141, P182, DOI 10.1016/j.jcpa.2008.11.008; WHANGPENG J, 1986, CANCER GENET CYTOGEN, V21, P185, DOI 10.1016/0165-4608(86)90001-4; Womer RB, 2012, J CLIN ONCOL, V30, P4148, DOI 10.1200/JCO.2011.41.5703; Worch J, 2010, CANCER-AM CANCER SOC, V116, P983, DOI 10.1002/cncr.24865; Yeny CT, 2005, CANCER RES, V65, P8698, DOI 10.1158/0008-5472.CAN-05-1704; Zucman-Rossi J, 1997, HUM GENET, V99, P357, DOI 10.1007/s004390050372	47	24	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e104378	10.1371/journal.pone.0104378	http://dx.doi.org/10.1371/journal.pone.0104378			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093581	Green Submitted, gold, Green Published			2022-12-27	WOS:000341357200105
J	Vizcaino, C; Nunez, LE; Moris, F; Portugal, J				Vizcaino, Carolina; Nunez, Luz-Elena; Moris, Francisco; Portugal, Jose			Genome-Wide Modulation of Gene Transcription in Ovarian Carcinoma Cells by a New Mithramycin Analogue	PLOS ONE			English	Article							PRODUCER STREPTOMYCES-ARGILLACEUS; ANTITUMOR-ACTIVITY; CANCER; EXPRESSION; BINDING; DNA; DRUG; SK; INHIBITION; RESISTANCE	Ovarian cancer has a poor prognosis due to intrinsic or acquired resistance to some cytotoxic drugs, raising the interest in new DNA-binding agents such as mithramycin analogues as potential chemotherapeutic agents in gynecological cancer. Using a genome-wide approach, we have analyzed gene expression in A2780 human ovarian carcinoma cells treated with the novel mithramycin analogue DIG-MSK (demycarosyl-3D-beta-D-digitoxosyl-mithramycin SK) that binds to C+G-rich DNA sequences. Nanomolar concentrations of DIG-MSK abrogated the expression of genes involved in a variety of cell processes including transcription regulation and tumor development, which resulted in cell death. Some of those genes have been associated with cell proliferation and poor prognosis in ovarian cancer. Sp1 transcription factor regulated most of the genes that were down-regulated by the drug, as well as the up-regulation of other genes mainly involved in response to cell stress. The effect of DIG-MSK in the control of gene expression by other transcription factors was also explored. Some of them, such as CREB, E2F and EGR1, also recognize C/G-rich regions in gene promoters, which encompass potential DIG-MSK binding sites. DIG-MSK affected several biological processes and molecular functions related to transcription and its cellular regulation in A2780 cells, including transcription factor activity. This new compound might be a promising drug for the treatment of ovarian cancer.	[Vizcaino, Carolina; Portugal, Jose] CSIC, Inst Biol Mol Barcelona, Barcelona, Spain; [Nunez, Luz-Elena; Moris, Francisco] EntreChem, Oviedo, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB)	Portugal, J (corresponding author), CSIC, Inst Biol Mol Barcelona, Barcelona, Spain.	jpmbmc@ibmb.csic.es	Portugal, José/K-4504-2014	Portugal, José/0000-0002-1923-9666	Spanish Ministry of Science and Innovation [BFU2010-15518]; FEDER program of the European Community; European Social Fund	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); FEDER program of the European Community(European Commission); European Social Fund(European Social Fund (ESF))	This work was supported by grant BFU2010-15518 from the Spanish Ministry of Science and Innovation, and the FEDER program of the European Community, and it was performed within the framework of the "Xarxa de Referencia en Biotecnologia'' of the Generalitat de Catalunya. Carolina Vizcaino is recipient of a JAE-Predoc2010 fellowship (CSIC), co-financed by the European Social Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertini V, 2006, NUCLEIC ACIDS RES, V34, P1721, DOI 10.1093/nar/gkl063; Albihn A, 2010, ADV CANCER RES, V107, P163, DOI 10.1016/S0065-230X(10)07006-5; Barakat BM, 2010, INT J CANCER, V127, P977, DOI 10.1002/ijc.25112; Barcelo F, 2007, NUCLEIC ACIDS RES, V35, P2215, DOI 10.1093/nar/gkm037; Barcelo F, 2010, BIOCHEMISTRY-US, V49, P10543, DOI 10.1021/bi101398s; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bataller M, 2008, MOL CANCER THER, V7, P2988, DOI 10.1158/1535-7163.MCT-08-0420; Cancer Genome Atlas Research Network, 2011, Nature, V474, P609, DOI 10.1038/nature10166; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Cole SW, 2005, BIOINFORMATICS, V21, P803, DOI 10.1093/bioinformatics/bti038; Crijns APG, 2009, PLOS MED, V6, P181, DOI 10.1371/journal.pmed.1000024; Davidson B, 2004, CANCER-AM CANCER SOC, V100, P2139, DOI 10.1002/cncr.20219; Duncan TJ, 2008, CLIN CANCER RES, V14, P3030, DOI 10.1158/1078-0432.CCR-07-1888; Fernandez-Guizan A, 2014, CHEM-BIOL INTERACT, V219, P123, DOI 10.1016/j.cbi.2014.05.019; Grivas PD, 2011, TRENDS MOL MED, V17, P537, DOI 10.1016/j.molmed.2011.06.005; Grohar PJ, 2011, JNCI-J NATL CANCER I, V103, P962, DOI 10.1093/jnci/djr156; Hall M, 2013, BRIT J CANCER, V108, P250, DOI 10.1038/bjc.2012.541; Hennessy BT, 2009, LANCET, V374, P1371, DOI 10.1016/S0140-6736(09)61338-6; Honda H, 2006, J BIOL CHEM, V281, P21433, DOI 10.1074/jbc.M603767200; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jia ZL, 2007, CANCER RES, V67, P4878, DOI 10.1158/0008-5472.CAN-06-3494; JONES DE, 1995, ONCOGENE, V10, P2323; Kaur M, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-144; Kelly ZL, 2011, J OVARIAN RES, V4, DOI 10.1186/1757-2215-4-16; Kigawa J, 2013, YONAGO ACTA MED, V56, P43; King PD, 2001, ONCOLOGIST, V6, P162, DOI 10.1634/theoncologist.6-2-162; Lombo F, 2006, APPL MICROBIOL BIOT, V73, P1, DOI 10.1007/s00253-006-0511-6; Malek A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035130; Mi HY, 2010, NUCLEIC ACIDS RES, V38, pD204, DOI 10.1093/nar/gkp1019; Minuzzo M, 2005, MOL PHARMACOL, V68, P1496, DOI 10.1124/mol.105.013615; Nunez LE, 2012, J MED CHEM, V55, P5813, DOI 10.1021/jm300234t; Oeggerli M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041664; Perez M, 2008, CHEMBIOCHEM, V9, P2295, DOI 10.1002/cbic.200800299; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Portugal J, 2011, RECENT RES DEV BIOCH, V8, P45; Previdi S, 2010, GYNECOL ONCOL, V118, P182, DOI 10.1016/j.ygyno.2010.03.020; Reimer D, 2010, CANCER RES, V70, P4613, DOI 10.1158/0008-5472.CAN-09-3551; Remsing LL, 2003, J AM CHEM SOC, V125, P5745, DOI 10.1021/ja034162h; Rice GE, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-62; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Safe S, 2005, EUR J CANCER, V41, P2438, DOI 10.1016/j.ejca.2005.08.006; Skubitz APN, 2006, TRANSL RES, V148, P223, DOI 10.1016/j.trsl.2006.06.001; Solar P, 2011, CANCER LETT, V309, P11, DOI 10.1016/j.canlet.2011.05.008; Villamarin S, 2003, EUR J BIOCHEM, V270, P764, DOI 10.1046/j.1432-1033.2003.03442.x; Vizcaino C, 2012, BIOCHEM PHARMACOL, V84, P1133, DOI 10.1016/j.bcp.2012.08.003; Yan CH, 2013, BBA-REV CANCER, V1835, P76, DOI 10.1016/j.bbcan.2012.11.002; Zabala D, 2013, METAB ENG, V20, P187, DOI 10.1016/j.ymben.2013.10.002	47	18	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2014	9	8							e104687	10.1371/journal.pone.0104687	http://dx.doi.org/10.1371/journal.pone.0104687			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WB	25110883	Green Published, gold, Green Submitted			2022-12-27	WOS:000341105100090
J	Fang, Y; Zhu, RL; Mishler, BD				Fang, Yuan; Zhu, Rui-Liang; Mishler, Brent D.			Evolution of Oleosin in Land Plants	PLOS ONE			English	Article							OIL BODIES; ARABIDOPSIS-THALIANA; NUCLEOTIDE-SEQUENCE; LIPID BODIES; GENE FAMILY; POLLEN COAT; BRASSICA; EXPRESSION; PROTEINS; CLONING	Oleosins form a steric barrier surface on lipid droplets in cytoplasm, preventing them from contacting and coalescing with adjacent droplets. Oleosin genes have been detected in numerous plant species. However, the presence of oleosin genes in the most basally diverging lineage of land plants, liverworts, has not been reported previously. Thus we explored whether liverworts have an oleosin gene. In Marchantia polymorpha L., a thalloid liverwort, one predicted sequence was found that could encode oleosin, possessing the hallmark of oleosin, a proline knot (-PX5SPX3P-) motif. The phylogeny of the oleosin gene family in land plants was reconstructed based on both nucleotide and amino acid sequences of oleosins, from 31 representative species covering almost all the main lineages of land plants. Based on our phylogenetic trees, oleosin genes were classified into three groups: M-oleosins (defined here as a novel group distinct from the two previously known groups), low molecular weight isoform (L-oleosin), and high molecular weight isoform (H-oleosin), according to their amino-acid organization, phylogenetic relationships, expression tissues, and immunological characteristics. In liverworts, mosses, lycophytes, and gymnosperms, only M-oleosins have been described. In angiosperms, however, while this isoform remains and is highly expressed in the gametophyte pollen tube, two other isoforms also occur, L-oleosins and H-oleosins. Phylogenetic analyses suggest that the M-oleosin isoform is the precursor to the ancestor of L-oleosins and H-oleosins. The later two isoforms evolved by successive gene duplications in ancestral angiosperms. At the genomic level, most oleosins possess no introns. If introns are present, in both the L-isoform and the M-isoform a single intron inserts behind the central region, while in the H-isoform, a single intron is located at the 5'-terminus. This study fills a major gap in understanding functional gene evolution of oleosin in land plants, shedding new light on evolutionary transitions of lipid storage strategies.	[Fang, Yuan; Zhu, Rui-Liang] E China Normal Univ, Sch Life Sci, Shanghai 200062, Peoples R China; [Fang, Yuan; Mishler, Brent D.] Univ Calif Berkeley, Univ & Jepson Herbaria, Berkeley, CA 94720 USA; [Fang, Yuan; Mishler, Brent D.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA	East China Normal University; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Zhu, RL (corresponding author), E China Normal Univ, Sch Life Sci, Shanghai 200062, Peoples R China.	lejeunea@163.com; bmishler@berkeley.edu			National Natural Science Foundation of China [31170190, 31370238]; 211 Project for the East China Normal University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 211 Project for the East China Normal University(Ministry of Education, China)	This research was sponsored by the National Natural Science Foundation of China (nos. 31170190, 31370238), and 211 Project for the East China Normal University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AALEN RB, 1995, PLANT MOL BIOL, V28, P583, DOI 10.1007/BF00020404; Albert VA, 2013, SCIENCE, V342, P1467, DOI 10.1126/science.1241089; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bartschat S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-106; CECH TR, 1988, GENE, V73, P259, DOI 10.1016/0378-1119(88)90492-1; Chen JCF, 1997, J BIOCHEM-TOKYO, V122, P819, DOI 10.1093/oxfordjournals.jbchem.a021828; Cove D, 2005, ANNU REV GENET, V39, P339, DOI 10.1146/annurev.genet.39.073003.110214; Davidi L, 2012, PLANTA, V236, P19, DOI 10.1007/s00425-011-1585-7; DUCKETT JG, 1995, ANN BOT-LONDON, V76, P405, DOI 10.1006/anbo.1995.1114; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Frandsen GI, 2001, PHYSIOL PLANTARUM, V112, P301, DOI 10.1034/j.1399-3054.2001.1120301.x; Giannoulia K, 2007, J PLANT PHYSIOL, V164, P104, DOI 10.1016/j.jplph.2006.03.016; Goremykin VV, 2005, PLANT SYST EVOL, V254, P93, DOI 10.1007/s00606-005-0337-1; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Guilloteau M, 2003, PLANT SCI, V164, P597, DOI 10.1016/S0168-9452(03)00011-6; He XL, 2013, CRIT REV PLANT SCI, V32, P293, DOI 10.1080/07352689.2013.765765; Herman E.M., 2017, SEED DEV GERMINATION, P195, DOI [10.1201/9780203740071, DOI 10.1201/9780203740071]; Hsieh K, 2004, PLANT PHYSIOL, V136, P3427, DOI 10.1104/pp.104.051060; HUANG AHC, 1992, ANNU REV PLANT PHYS, V43, P177, DOI 10.1146/annurev.pp.43.060192.001141; Huang AHC, 1996, PLANT PHYSIOL, V110, P1055, DOI 10.1104/pp.110.4.1055; Huang CY, 2009, PLANT PHYSIOL, V150, P1192, DOI 10.1104/pp.109.138123; Huang N-L, 2013, PLANT PHYSIOL, V161, P1; HUGHES DW, 1993, PLANT PHYSIOL, V101, P697, DOI 10.1104/pp.101.2.697; Jiang PL, 2007, PLANT CELL PHYSIOL, V48, P812, DOI 10.1093/pcp/pcm051; Jolivet P, 2011, J PLANT PHYSIOL, V168, P2015, DOI 10.1016/j.jplph.2011.06.007; Jolivet P, 2009, PROTEOMICS, V9, P3268, DOI 10.1002/pmic.200800449; KALINSKI A, 1991, PLANT MOL BIOL, V17, P1095, DOI 10.1007/BF00037150; KEDDIE JS, 1992, PLANT MOL BIOL, V19, P443, DOI 10.1007/BF00023392; Kim HU, 2002, J BIOL CHEM, V277, P22677, DOI 10.1074/jbc.M109298200; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LEE K, 1994, PLANTA, V193, P461, DOI 10.1007/BF00201827; LEE K, 1991, PLANT PHYSIOL, V96, P1395, DOI 10.1104/pp.96.4.1395; LEE KY, 1994, PLANT MOL BIOL, V26, P1981, DOI 10.1007/BF00019508; Liu P, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-132; Mayfield JA, 2001, SCIENCE, V292, P2482, DOI 10.1126/science.1060972; Moellering ER, 2010, EUKARYOT CELL, V9, P97, DOI 10.1128/EC.00203-09; MURPHY DJ, 1993, PROG LIPID RES, V32, P247, DOI 10.1016/0163-7827(93)90009-L; Murphy DJ, 2001, PROG LIPID RES, V40, P325, DOI 10.1016/S0163-7827(01)00013-3; Nishiyama T, 2003, P NATL ACAD SCI USA, V100, P8007, DOI 10.1073/pnas.0932694100; Nystedt B, 2013, NATURE, V497, P579, DOI 10.1038/nature12211; Ohsaki Y, 2009, BBA-MOL CELL BIOL L, V1791, P399, DOI 10.1016/j.bbalip.2008.10.002; Piffanelli P, 1998, SEX PLANT REPROD, V11, P65, DOI 10.1007/s004970050122; PIHAKASKI K, 1968, PROTOPLASMA, V66, P79, DOI 10.1007/BF01252526; Pons L, 1998, J CHROMATOGR B, V706, P131, DOI 10.1016/S0378-4347(97)00530-6; Popluechai S, 2011, PLANT PHYSIOL BIOCH, V49, P352, DOI 10.1016/j.plaphy.2010.12.003; QU R, 1990, J BIOL CHEM, V265, P2238; Ratnayake C, 1996, BIOCHEM J, V317, P956, DOI 10.1042/bj3170956; ROBERTS MR, 1995, PLANTA, V195, P469, DOI 10.1007/BF00202607; Ruiter RK, 1997, PLANT CELL, V9, P1621, DOI 10.1105/tpc.9.9.1621; Schuster R.M., 1992, J HATTORI BOT LAB, V72, P151; Sharp PA, 1997, CELL, V91, P875, DOI 10.1016/S0092-8674(00)80479-1; Shaw AJ, 2011, AM J BOT, V98, P352, DOI 10.3732/ajb.1000316; Simkin AJ, 2006, J PLANT PHYSIOL, V163, P691, DOI 10.1016/j.jplph.2005.11.008; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Tai SSK, 2002, BIOSCI BIOTECH BIOCH, V66, P2146, DOI 10.1271/bbb.66.2146; VANROOIJEN GJH, 1992, PLANT MOL BIOL, V18, P1177, DOI 10.1007/BF00047721; Welte MA, 2007, TRENDS CELL BIOL, V17, P363, DOI 10.1016/j.tcb.2007.06.004; Zou JT, 1996, PLANT MOL BIOL, V31, P429, DOI 10.1007/BF00021805	59	11	12	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2014	9	8							e103806	10.1371/journal.pone.0103806	http://dx.doi.org/10.1371/journal.pone.0103806			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR0CG	25105766	Green Published, Green Submitted, gold			2022-12-27	WOS:000343231900023
J	Luo, HY; Zeng, CQ; Fang, C; Seeruttun, SR; Lv, L; Wang, W				Luo, Huiyan; Zeng, Changqing; Fang, Cheng; Seeruttun, Sharvesh Raj; Lv, Lin; Wang, Wei			A New Strategy Using ALDH(high)-CD8+T Cells to Inhibit Tumorigenesis	PLOS ONE			English	Article							CANCER STEM-CELLS; PULSED DENDRITIC CELLS; LUNG-CANCER; INITIATING CELLS; PROSTATE-CANCER; HETEROGENEITY; VACCINATION; MARKER; MODEL; TRIAL	Background: Currently, many studies suggest that cancer stem cells (CSCs) are responsible for tumor initiation, tumorigenesis, metastasis and recurrence. CSCs have been identified from various human and murine tumors. The identification of CSCs allows us to develop strategies to target the CSCs. Methods and Results: In this study, we used ALDEFLUOR as a single marker to isolate the CSCs from the human lung cancer cell line H460. We then characterized the CSCs by testing their sphere formation ability and tumorigenicity. Furthermore, we used CSC lysate-pulsed dendritic cells to stimulate CD8+T cells as a treatment strategy. Our study demonstrated that ALDEFLUOR could be used as a single marker to identify CSCs from the human lung cancer cell line H460. The ALDH(high) cells could form more spheres and were more tumorigenic than the ALDH(low) cells. Further study demonstrated that ALDH(high)-CD8+T cells conferred more significant antitumor effects, resulting in the inhibition of tumor growth and prolonged survival. And the ALDH(high)-CD8+ T cells-mediated anti-tumor immunity might be due to the directly targeting against ALDH(high) cancer stem cells (CSCs). Conclusions: This study shows that ALDH(high)-CD8+ T cells mediate anti-tumor immunity by selectively targeting cancer stem cells, which result in inhibiting tumor growth and prolonging the survival of tumor-bearing mice, which provides a new strategy using ALDH(high)-CD8+ T cells to treat tumors.	[Luo, Huiyan] Third Peoples Hosp Chongqing, Dept Oncol, Chongqing, Peoples R China; [Zeng, Changqing] Fujian Prov Hosp, Dept Gastrointestinal Surg, Fuzhou, Peoples R China; [Zeng, Changqing] Fujian Med Univ, Prov Clin Med Coll, Fuzhou, Peoples R China; [Fang, Cheng; Seeruttun, Sharvesh Raj; Wang, Wei] Sun Yat Sen Univ, Dept Gastr & Pancreat Surg, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China; [Luo, Huiyan; Fang, Cheng; Seeruttun, Sharvesh Raj; Lv, Lin; Wang, Wei] State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China; [Luo, Huiyan; Fang, Cheng; Seeruttun, Sharvesh Raj; Lv, Lin; Wang, Wei] Collaborat Innovat Ctr Canc Med, Guangzhou, Guangdong, Peoples R China; [Lv, Lin] Guangzhou First Peoples Hosp, Dept Med Oncol, Guangzhou, Guangdong, Peoples R China	Fujian Provincial Hospital; Fujian Medical University; Sun Yat Sen University; State Key Lab Oncology South China; South China University of Technology	Lv, L (corresponding author), State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China.	lvlin@sysucc.org.cn; wangwei@sysucc.org.cn			National Natural Science Foundation of China [81201773]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20120171120114]; Science and technology project of Fujian Province [2014J01284]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Science and technology project of Fujian Province	This project was supported by the National Natural Science Foundation of China (grant no. 81201773), the Specialized Research Fund for the Doctoral Program of Higher Education of China (grant no. 20120171120114), and the Science and technology project of Fujian Province (2014J01284). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alamgeer M, 2013, RESPIROLOGY, V18, P757, DOI 10.1111/resp.12094; Carpentino JE, 2009, CANCER RES, V69, P8208, DOI 10.1158/0008-5472.CAN-09-1132; Chang AE, 2003, J CLIN ONCOL, V21, P884, DOI 10.1200/JCO.2003.08.023; Chang AE, 2002, CLIN CANCER RES, V8, P1021; Charafe-Jauffret E, 2009, CANCER RES, V69, P1302, DOI 10.1158/0008-5472.CAN-08-2741; Dougan M, 2009, ANNU REV IMMUNOL, V27, P83, DOI 10.1146/annurev.immunol.021908.132544; Duarte S, 2013, STEM CELLS, V31, P423, DOI 10.1002/stem.1292; Garcia-Hernandez MD, 2008, CANCER RES, V68, P861, DOI 10.1158/0008-5472.CAN-07-0445; Geissler C, 2012, IN VIVO, V26, P593; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Huang CP, 2013, CANCER LETT, V328, P144, DOI 10.1016/j.canlet.2012.08.021; Huang EH, 2009, CANCER RES, V69, P3382, DOI 10.1158/0008-5472.CAN-08-4418; Laga AC, 2010, ARCH PATHOL LAB MED, V134, P1750, DOI 10.1043/2009-0394-RAR.1; Liang D, 2012, MED ONCOL, V29, P633, DOI 10.1007/s12032-011-9933-9; Lu L, 2013, J IMMUNOTHER, V36, P451, DOI 10.1097/CJI.0b013e3182a802cf; Molina JR, 2008, MAYO CLIN PROC, V83, P584, DOI 10.4065/83.5.584; Ning N, 2012, CANCER RES, V72, P1853, DOI 10.1158/0008-5472.CAN-11-1400; OLDHAM RK, 1986, J CELL PHYSIOL, P91; Park SY, 2010, CLIN CANCER RES, V16, P876, DOI 10.1158/1078-0432.CCR-09-1532; Redman BG, 2008, J IMMUNOTHER, V31, P591, DOI 10.1097/CJI.0b013e31817fd90b; Shafee N, 2008, CANCER RES, V68, P3243, DOI 10.1158/0008-5472.CAN-07-5480; Sottoriva A, 2010, CANCER RES, V70, P46, DOI 10.1158/0008-5472.CAN-09-3663; Valent P, 2013, CANCER RES, V73, P1037, DOI 10.1158/0008-5472.CAN-12-3678; van den Hoogen C, 2010, CANCER RES, V70, P5163, DOI 10.1158/0008-5472.CAN-09-3806; Visus C, 2011, CLIN CANCER RES, V17, P6174, DOI 10.1158/1078-0432.CCR-11-1111; Yang Ping, 2009, V471, P469, DOI 10.1007/978-1-59745-416-2_24	26	22	22	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2014	9	8							e103193	10.1371/journal.pone.0103193	http://dx.doi.org/10.1371/journal.pone.0103193			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR0CG	25105957	gold, Green Submitted, Green Published			2022-12-27	WOS:000343231900010
J	Ye, XH; Yao, ZJ; Liu, WD; Fan, YP; Xu, Y; Chen, SD				Ye, Xiaohua; Yao, Zhenjiang; Liu, Weidong; Fan, Yanping; Xu, Ya; Chen, Sidong			Path Analysis to Identify Factors Influencing Health Skills and Behaviors in Adolescents: A Cross-Sectional Survey	PLOS ONE			English	Article							READING-COMPREHENSION; LITERACY; KNOWLEDGE	Background: Studies conducted in the past mostly rely on models of functional health literacy in adult populations. However, such models do not satisfy the need for health intervention in adolescents. The identification of key factors influencing adolescents' health literacy is essential in developing effective prevention and intervention measures. This study aimed to test a theoretical model of predictors on health skills and health behaviors in adolescents. Methods: A cross-sectional survey was conducted in Guangdong using a multi-stage stratified cluster sample design. A representative random sample of 3821 students aged 13-25 years was selected using multi-stage stratified cluster sampling. The path analysis was used to test a hypothesized model of health literacy. Results: The path analysis showed that knowledge of infectious disease (beta = 0.26), health skills (beta = 0.22), health concept (beta = 0.20), general health knowledge (beta = 0.15), gender (beta = 0.12), and school performance (beta = 0.06) had positive direct effect on health behaviors in adolescents. The explanatory variables accounted for 43% of the variance in explaining health behaviors. Knowledge of infectious disease (beta = 0.30), health concept (beta = 0.17), general health knowledge (beta = 0.13), and school performance (beta = 0.05) had positive indirect effect on health behaviors through the impacts on health skills. Conclusion: This study identified several direct and indirect factors influencing health skills and health behaviors in adolescents. These findings will assist health professionals designing effective health interventions that aim to improve health skills and health behaviors in adolescents.	[Ye, Xiaohua; Yao, Zhenjiang; Liu, Weidong; Fan, Yanping; Xu, Ya; Chen, Sidong] Guangdong Pharmaceut Univ, Sch Publ Hlth, Guangdong Key Lab Mol Epidemiol, Guangzhou, Guangdong, Peoples R China; [Ye, Xiaohua] Southern Med Univ, Sch Publ Hlth & Trop Med, Guangzhou, Guangdong, Peoples R China	Guangdong Pharmaceutical University; Southern Medical University - China	Xu, Y (corresponding author), Guangdong Pharmaceut Univ, Sch Publ Hlth, Guangdong Key Lab Mol Epidemiol, Guangzhou, Guangdong, Peoples R China.	yaoxuya@163.com; chensidong1@126.com	yao, zhenjiang/N-7450-2016	yao, zhenjiang/0000-0002-2156-7896	Guangdong key laboratory of molecular epidemiology [2010A060801015]	Guangdong key laboratory of molecular epidemiology	This work was supported by Guangdong key laboratory of molecular epidemiology (No. 2010A060801015). No funders were involved in any aspect of the analyses contained herein or in the preparation of this manuscript.	Brown SL, 2007, J SCHOOL HEALTH, V77, P7, DOI 10.1111/j.1746-1561.2007.00156.x; Carthery-Goulart MT, 2009, REV SAUDE PUBL, V43, P631, DOI 10.1590/S0034-89102009005000031; Chang LC, 2011, J CLIN NURS, V20, P190, DOI 10.1111/j.1365-2702.2009.03181.x; Davis TC, 1999, J ADOLESCENT HEALTH, V24, P403, DOI 10.1016/S1054-139X(98)00148-7; Davis TC, 2006, PEDIATRICS, V118, pE1707, DOI 10.1542/peds.2006-1139; DeWalt Darren A, 2009, Pediatrics, V124 Suppl 3, pS265, DOI 10.1542/peds.2009-1162B; Diamond JJ, 2007, NUTR J, V6, DOI 10.1186/1475-2891-6-5; Fortenberry JD, 2001, SEX TRANSM INFECT, V77, P206, DOI 10.1136/sti.77.3.206; Gray NJ, 2005, SOC SCI MED, V60, P1467, DOI 10.1016/j.socscimed.2004.08.010; Ishikawa H, 2008, DIABETES CARE, V31, P874, DOI 10.2337/dc07-1932; KEATING DP, 1990, THRESHOLD DEV ADOLES, P54; Kutner M, 2007, LITERACY EVERYDAY LI; Lee SYD, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-614; Levin-Zamir D, 2011, HEALTH EDUC RES, V26, P323, DOI 10.1093/her/cyr007; Lynn NB, 2004, HLTH LITERACY PRESCR; Macabasco-O'Connell A, 2011, J GEN INTERN MED, V26, P979, DOI 10.1007/s11606-011-1668-y; Manganello JA, 2008, HEALTH EDUC RES, V23, P840, DOI 10.1093/her/cym069; Martin LT, 2009, J GEN INTERN MED, V24, P1211, DOI 10.1007/s11606-009-1105-7; McCabe MP, 2001, ADOLESCENCE, V36, P225; McGee R, 2002, J CHILD PSYCHOL PSYC, V43, P1004, DOI 10.1111/1469-7610.00228; Mellard DF, 2010, J LEARN DISABIL-US, V43, P154, DOI 10.1177/0022219409359345; Miles SB, 2006, CHILD DEV, V77, P103, DOI 10.1111/j.1467-8624.2006.00859.x; Needham HE, 2010, J ADOLESCENT HEALTH, V46, P506, DOI 10.1016/j.jadohealth.2009.11.195; Olobatuyi M.E., 2006, USERS GUIDE PATH ANA; Owais A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-239; Paek HJ, 2011, HEALTH EDUC RES, V26, P131, DOI 10.1093/her/cyq082; Rivero-Mendez M, 2010, P R HEALTH SCI J, V29, P49; Schmidt CO, 2010, HEALTH EDUC RES, V25, P542, DOI 10.1093/her/cyq011; Sharma SV, 2009, J PHYS ACT HEALTH, V6, P606, DOI 10.1123/jpah.6.5.606; Shibuya A, 2011, BLOOD PRESS MONIT, V16, P224, DOI 10.1097/MBP.0b013e32834af7ba; Stein Aryeh D., 2005, Food and Nutrition Bulletin, V26, pS46; Swami V, 2011, BRIT J PSYCHOL, V102, P662, DOI 10.1111/j.2044-8295.2011.02036.x; Tabachnick B.G., 2007, USING MULTIVARIATE S, VVolume 5, P481; Ye Xiao-hua, 2011, Zhonghua Liu Xing Bing Xue Za Zhi, V32, P873	34	5	5	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2014	9	8							e104406	10.1371/journal.pone.0104406	http://dx.doi.org/10.1371/journal.pone.0104406			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR0CG	25105974	Green Published, gold, Green Submitted			2022-12-27	WOS:000343231900053
J	Cornelie, S; Rossignol, M; Seveno, M; Demettre, E; Mouchet, F; Djegbe, I; Marin, P; Chandre, F; Corbel, V; Remoue, F; Mathieu-Daude, F				Cornelie, Sylvie; Rossignol, Marie; Seveno, Martial; Demettre, Edith; Mouchet, Francois; Djegbe, Innocent; Marin, Philippe; Chandre, Fabrice; Corbel, Vincent; Remoue, Franck; Mathieu-Daude, Francoise			Salivary Gland Proteome Analysis Reveals Modulation of Anopheline Unique Proteins in Insensitive Acetylcholinesterase Resistant Anopheles gambiae Mosquitoes	PLOS ONE			English	Article							GLUTATHIONE S-TRANSFERASES; MALARIA VECTOR; INSECTICIDE RESISTANCE; TRANSMISSION; DDT; IDENTIFICATION; EVOLUTION; GENES; COSTS; MASS	Insensitive acetylcholinesterase resistance due to a mutation in the acetylcholinesterase (ace) encoding ace-1 gene confers cross-resistance to organophosphate and carbamate insecticides in Anopheles gambiae populations from Central and West Africa. This mutation is associated with a strong genetic cost revealed through alterations of some life history traits but little is known about the physiological and behavioural changes in insects bearing the ace-1 R allele. Comparative analysis of the salivary gland contents between An. gambiae susceptible and ace-1 R resistant strains was carried out to charaterize factors that could be involved in modifications of blood meal process, trophic behaviour or pathogen interaction in the insecticide-resistant mosquitoes. Differential analysis of the salivary gland protein profiles revealed differences in abundance for several proteins, two of them showing major differences between the two strains. These two proteins identified as saglin and TRIO are salivary gland-1 related proteins, a family unique to anopheline mosquitoes, one of them playing a crucial role in salivary gland invasion by Plasmodium falciparum sporozoites. Differential expression of two other proteins previously identified in the Anopheles sialome was also observed. The differentially regulated proteins are involved in pathogen invasion, blood feeding process, and protection against oxidation, relevant steps in the outcome of malaria infection. Further functional studies and insect behaviour experiments would confirm the impact of the modification of the sialome composition on blood feeding and pathogen transmission abilities of the resistant mosquitoes. The data supports the hypothesis of alterations linked to insecticide resistance in the biology of the primary vector of human malaria in Africa.	[Cornelie, Sylvie; Rossignol, Marie; Mouchet, Francois; Chandre, Fabrice; Mathieu-Daude, Francoise] UM1, UM2, CNRS 5290, MIVEGEC,IRD,UMR IRD 224, Montpellier, France; [Seveno, Martial; Demettre, Edith; Marin, Philippe] UM1, UM2, INSERM 661, IGF,UMR CNRS 5203, Montpellier, France; [Djegbe, Innocent; Corbel, Vincent; Remoue, Franck] UM1, UM2, CREC, IRD,CNRS 5290,MIVEGEC,UMR IRD 224, Cotonou, Benin	Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Entomological Research Center of Cotonou (CREC); Institut de Recherche pour le Developpement (IRD)	Mathieu-Daude, F (corresponding author), UM1, UM2, CNRS 5290, MIVEGEC,IRD,UMR IRD 224, Montpellier, France.	francoise.mathieu-daude@ird.fr	Chandre, Fabrice/Q-3429-2019; Corbel, VIncent/G-9576-2016	Chandre, Fabrice/0000-0002-1994-9705; Mathieu-Daude, Francoise/0000-0003-2994-3697; SEVENO, Martial/0000-0002-5000-8735; cornelie, sylvie/0000-0003-3662-1450; corbel, vincent/0000-0003-0995-3257; REMOUE, Franck/0000-0003-3220-5660	French Institut de Recherche pour le Developpement (IRD)	French Institut de Recherche pour le Developpement (IRD)	This work was supported by the French Institut de Recherche pour le Developpement (IRD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alout H, 2008, COMP BIOCHEM PHYS B, V150, P271, DOI 10.1016/j.cbpb.2008.03.008; Alout H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063849; Alvarenga PH, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000547; Arca B, 2002, INSECT MOL BIOL, V11, P47, DOI 10.1046/j.0962-1075.2001.00309.x; Arca B, 1999, P NATL ACAD SCI USA, V96, P1516, DOI 10.1073/pnas.96.4.1516; Baker DA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-296; Berticat C, 2002, GENET RES, V79, P41, DOI 10.1017/S001667230100547X; Berticat C, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-104; Bourguet D, 2004, EVOLUTION, V58, P128, DOI 10.1111/j.0014-3820.2004.tb01579.x; Brennan JDG, 2000, P NATL ACAD SCI USA, V97, P13859, DOI 10.1073/pnas.250472597; Calvo E, 2006, J BIOL CHEM, V281, P1935, DOI 10.1074/jbc.M510359200; Chen LQ, 2003, ACTA CRYSTALLOGR D, V59, P2211, DOI 10.1107/S0907444903018493; Choumet V, 2007, PROTEOMICS, V7, P3384, DOI 10.1002/pmic.200700334; Costantini Carlo, 2009, BMC Ecology, V9, P16, DOI 10.1186/1472-6785-9-16; Crawford JE, 2013, INFECT GENET EVOL, V16, P87, DOI 10.1016/j.meegid.2013.01.006; Djegbe I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017496; Djogbenou L, 2007, J MED ENTOMOL, V44, P805, DOI 10.1603/0022-2585(2007)44[805:COIAAI]2.0.CO;2; Djogbenou L, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-12; Djogbenou L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002172; Donovan MJ, 2007, INFECT IMMUN, V75, P2523, DOI 10.1128/IAI.01928-06; Fontaine A, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-187; Francischetti IMB, 2002, J EXP BIOL, V205, P2429; Gazave L, 2001, HEREDITY, V87, P441, DOI 10.1046/j.1365-2540.2001.00926.x; Ghosh AK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000265; Hemingway J, 2004, INSECT BIOCHEM MOLEC, V34, P653, DOI 10.1016/j.ibmb.2004.03.018; Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371; Hoffmann AA, 2008, ANNU REV ECOL EVOL S, V39, P21, DOI 10.1146/annurev.ecolsys.39.110707.173532; KARAS M, 1988, ANAL CHEM, V60, P2299, DOI 10.1021/ac00171a028; Lenormand T, 1999, NATURE, V400, P861, DOI 10.1038/23685; Mans BJ, 2007, J BIOL CHEM, V282, P36626, DOI 10.1074/jbc.M706410200; Marinotti O, 2005, INSECT MOL BIOL, V14, P365, DOI 10.1111/j.1365-2583.2005.00567.x; N'Guessan R, 2003, MED VET ENTOMOL, V17, P19, DOI 10.1046/j.1365-2915.2003.00406.x; Okulate MA, 2007, INSECT MOL BIOL, V16, P711, DOI 10.1111/j.1365-2583.2007.00765.x; Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200; Pates HV, 2001, B ENTOMOL RES, V91, P289, DOI 10.1079/BER200198; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; PETRARCA V, 1992, AM J TROP MED HYG, V46, P229, DOI 10.4269/ajtmh.1992.46.229; Pombi M, 2006, AM J TROP MED HYG, V75, P901, DOI 10.4269/ajtmh.2006.75.901; Prapanthadara La-Aied, 1993, Biochemical Society Transactions, V21, p304S; Ranson H, 1997, BIOCHEM J, V324, P97, DOI 10.1042/bj3240097; Ranson H, 2001, BIOCHEM J, V359, P295, DOI 10.1042/0264-6021:3590295; Schneider BS, 2008, T ROY SOC TROP MED H, V102, P400, DOI 10.1016/j.trstmh.2008.01.024; SHUTE G. T., 1956, ANN TROP MED AND PARASITOL, V50, P92; Sultan AA, 1997, CELL, V90, P511, DOI 10.1016/S0092-8674(00)80511-5; Valenzuela JG, 2002, INSECT MOL BIOL, V11, P149, DOI 10.1046/j.1365-2583.2002.00319.x; Wang YJ, 2008, J STRUCT BIOL, V164, P228, DOI 10.1016/j.jsb.2008.08.003; Weill M, 2004, CURR BIOL, V14, pR552, DOI 10.1016/j.cub.2004.07.008; WILCE MCJ, 1994, BBA-PROTEIN STRUCT M, V1205, P1, DOI 10.1016/0167-4838(94)90086-8; Wilkins MR, 1997, J THEOR BIOL, V186, P7, DOI 10.1006/jtbi.1996.0346; Wilm M, 1996, NATURE, V379, P466, DOI 10.1038/379466a0	50	7	7	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e103816	10.1371/journal.pone.0103816	http://dx.doi.org/10.1371/journal.pone.0103816			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25102176	Green Published, gold, Green Submitted			2022-12-27	WOS:000339993900027
J	Le Floc'h, N; Deblanc, C; Cariolet, R; Gautier-Bouchardon, AV; Merlot, E; Simon, G				Le Floc'h, Nathalie; Deblanc, Celine; Cariolet, Roland; Gautier-Bouchardon, Anne V.; Merlot, Elodie; Simon, Gaelle			Effect of Feed Restriction on Performance and Postprandial Nutrient Metabolism in Pigs Co-Infected with Mycoplasma hyopneumoniae and Swine Influenza Virus	PLOS ONE			English	Article							AMINO-ACID; IMMUNE-SYSTEM; GLUCOSE-METABOLISM; MUCIN SYNTHESIS; PRE-INFECTION; PROTEIN; PLASMA; INFLAMMATION; THREONINE; DISEASE	As nutritional status and inflammation are strongly connected, feeding and nutritional strategies could be effective to improve the ability of pigs to cope with disease. The aims of this study were to investigate the impact of a feed restriction on the ability of pigs to resist and be tolerant to a coinfection with Mycoplasma hyopneumoniae (Mhp) and the European H1N1 swine influenza virus, and the consequences for nutrient metabolism, with a focus on amino acids. Two groups of specific pathogen-free pigs were inoculated with Mhp and H1N1 21 days apart. One group was fed ad libitum, the other group was subjected to a two-week 40% feed restriction starting one week before H1N1 infection. The two respective mock control groups were included. Three days post-H1N1 infection, 200 g of feed was given to pigs previously fasted overnight and serial blood samples were taken over 4 hours to measure plasma nutrient concentrations. Throughout the study, clinical signs were observed and pathogens were detected in nasal swabs and lung tissues. Feed-restricted pigs presented shorter hyperthermia and a positive mean weight gain over the 3 days post-H1N1 infection whereas animals fed ad libitum lost weight. Both infection and feed restriction reduced postprandial glucose concentrations, indicating changes in glucose metabolism. Post-prandial plasma concentrations of the essential amino acids histidine, arginine and threonine were lower in co-infected pigs suggesting a greater use of those amino acids for metabolic purposes associated with the immune response. Altogether, these results indicate that modifying feeding practices could help to prepare animals to overcome an influenza infection. Connections with metabolism changes are discussed.	[Le Floc'h, Nathalie; Merlot, Elodie] INRA, PEGASE UMR1348, St Gilles, France; [Le Floc'h, Nathalie; Merlot, Elodie] Agrocampus Ouest, PEGASE UMR1348, Rennes, France; [Deblanc, Celine; Simon, Gaelle] Anses, Ploufragan Plouzane Lab, Swine Virol Immunol Unit, BP53, Ploufragan, France; [Deblanc, Celine; Cariolet, Roland; Gautier-Bouchardon, Anne V.; Simon, Gaelle] European Univ Brittany, Rennes, France; [Cariolet, Roland] Anses, Ploufragan Plouzane Lab, Prod Decontaminated Pigs & Testing, BP53, Ploufragan, France; [Gautier-Bouchardon, Anne V.] Anses, Ploufragan Plouzane Lab, Mycoplasmol Bacteriol Unit, BP53, Ploufragan, France	INRAE; Institut Agro; Agrocampus Ouest; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES)	Deblanc, C (corresponding author), Anses, Ploufragan Plouzane Lab, Swine Virol Immunol Unit, BP53, Ploufragan, France.	celine.deblanc@anses.fr	Simon, Gaelle/ABI-1479-2020; Merlot, Elodie/AAQ-8761-2020; le floc'h, nathalie/L-6049-2018	Simon, Gaelle/0000-0003-1099-5075; Le Floch, Nathalie/0000-0001-9858-1584; Merlot, Elodie/0000-0003-2300-0970	FARM'APRO; Conseil General des Cotes d'Armor	FARM'APRO; Conseil General des Cotes d'Armor(Region BretagneRegion Pays de la Loire)	This work received financial support from FARM'APRO. FARM'APRO participated in the study design but had no role in the data collection and analysis, decision to publish, or preparation of the manuscript. Remuneration of the Anses' personnel from the unit "Production of decontaminated pigs and testing'' was partially supported by the Conseil General des Cotes d'Armor. This funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BECHT H, 1971, J VIROL, V7, P204, DOI 10.1128/JVI.7.2.204-207.1971; Bruins MJ, 2003, CLIN SCI, V104, P127, DOI 10.1042/CS20020275; CALDER PC, 1995, P NUTR SOC, V54, P65, DOI 10.1079/PNS19950038; Calder PC, 2007, CURR OPIN CLIN NUTR, V10, P531, DOI 10.1097/MCO.0b013e3281e72ad4; CUARON JA, 1984, J ANIM SCI, V58, P631, DOI 10.2527/jas1984.583631x; Deblanc C, 2013, VET MICROBIOL, V162, P643, DOI 10.1016/j.vetmic.2012.11.028; Deblanc C, 2012, VET MICROBIOL, V157, P96, DOI 10.1016/j.vetmic.2011.12.027; Detilleux JC, 2011, GENET SEL EVOL, V43, DOI 10.1186/1297-9686-43-9; Fablet C, 2012, VET MICROBIOL, V157, P152, DOI 10.1016/j.vetmic.2011.12.015; Grimble RF, 1998, NUTRITION, V14, P634, DOI 10.1016/S0899-9007(98)00010-0; Heyer A, 2007, J ANIM SCI, V85, P769, DOI 10.2527/jas.2006-164; IMAMURA M, 1975, SURGERY, V77, P868; Jahoor F, 1999, J NUTR, V129, P693, DOI 10.1093/jn/129.3.693; Jonasson R, 2007, RES VET SCI, V82, P323, DOI 10.1016/j.rvsc.2006.08.005; Kagemann G, 2005, BIOL CHEM, V386, P1055, DOI 10.1515/BC.2005.121; Kaore SN, 2013, FUND CLIN PHARMACOL, V27, P35, DOI 10.1111/j.1472-8206.2012.01059.x; Kim CH, 2012, VET J, V192, P120, DOI 10.1016/j.tvjl.2011.04.023; Klasing KC, 1999, EAAP PUBLIC, P253; Konsman JP, 2001, NUTRITION, V17, P664, DOI 10.1016/S0899-9007(01)00602-5; KOONG LJ, 1982, J NUTR, V112, P1638, DOI 10.1093/jn/112.8.1638; Kuntz-Simon G, 2009, ZOONOSES PUBLIC HLTH, V56, P310, DOI 10.1111/j.1863-2378.2009.01236.x; Kuntz -Simon G., 2010, INFECT PARASITIC DIS, V1, P273; Le Floc'h N, 2005, BRIT J NUTR, V93, P447, DOI 10.1079/BJN20051375; Le Floc'h N, 2004, LIVEST PROD SCI, V87, P37, DOI 10.1016/j.livprodsci.2003.09.005; Le Floc'h N, 2011, AMINO ACIDS, V41, P1195, DOI 10.1007/s00726-010-0752-7; Li DF, 1999, ANIM FEED SCI TECH, V78, P179, DOI 10.1016/S0377-8401(99)00005-X; Lien KA, 1997, Z ERNAHRUNGSWISS, V36, P182, DOI 10.1007/BF01611398; Lkhagvadorj S, 2010, AM J PHYSIOL-REG I, V298, P25; LLOYD C, 1984, IN VITRO CELL DEV B, V20, P416, DOI 10.1007/BF02619588; Madec F, 1982, J RECH PORCINE FRANC, V14, P405; Marois C, 2010, J APPL MICROBIOL, V108, P1523, DOI 10.1111/j.1365-2672.2009.04556.x; Mata M, 2011, BIOCHEM PHARMACOL, V82, P548, DOI 10.1016/j.bcp.2011.05.014; Matsuzaki J, 2001, J NUTR, V131, P2139, DOI 10.1093/jn/131.8.2139; Melchior D, 2004, J ANIM SCI, V82, P1091; Mora JR, 2008, NAT REV IMMUNOL, V8, P685, DOI 10.1038/nri2378; Nafikov RA, 2007, J NUTR, V137, P702, DOI 10.1093/jn/137.3.702; Newsholme P, 2001, J NUTR, V131, p2515S, DOI 10.1093/jn/131.9.2515S; Noah L, 2000, AM J PHYSIOL-ENDOC M, V278, pE181, DOI 10.1152/ajpendo.2000.278.2.E181; Obled C, 2002, CAN J ANIM SCI, V82, P55; Opriessnig T., 2011, Animal Health Research Reviews, V12, P133, DOI 10.1017/S1466252311000120; Perrone LA, 2013, J INFECT DIS, V207, P1576, DOI 10.1093/infdis/jit062; Pithon-Curi TC, 2004, CELL BIOCHEM FUNCT, V22, P321, DOI 10.1002/cbf.1109; Pol F, 2011, J VIROL METHODS, V171, P241, DOI 10.1016/j.jviromet.2010.11.007; Rantzer D, 1996, ACTA AGR SCAND A-AN, V46, P219, DOI 10.1080/09064709609415874; REEDS PJ, 1994, J NUTR, V124, P906, DOI 10.1093/jn/124.6.906; Reeds PJ, 2001, CLIN NUTR, V20, P15, DOI 10.1054/clnu.2001.0402; Reeth VK, 2012, DIS SWINE, V10th, P557; Remond D, 2009, J NUTR, V139, P720, DOI 10.3945/jn.108.101675; Rose N, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-72; WANNEMACHER RW, 1977, AM J CLIN NUTR, V30, P1269, DOI 10.1093/ajcn/30.8.1269; Yoo SS, 1997, J NUTR, V127, P2253, DOI 10.1093/jn/127.11.2253; Zervas S, 2002, J ANIM SCI, V80, P3238	52	19	19	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e104605	10.1371/journal.pone.0104605	http://dx.doi.org/10.1371/journal.pone.0104605			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25101681	Green Published, Green Submitted, gold			2022-12-27	WOS:000339993900078
J	Richmond, RC; Skugarevsky, O; Yang, S; Kramer, MS; Wade, KH; Patel, R; Bogdanovich, N; Vilchuck, K; Sergeichick, N; Smith, GD; Oken, E; Martin, RM				Richmond, Rebecca C.; Skugarevsky, Oleg; Yang, Seungmi; Kramer, Michael S.; Wade, Kaitlin H.; Patel, Rita; Bogdanovich, Natalia; Vilchuck, Konstantin; Sergeichick, Natalia; Smith, George Davey; Oken, Emily; Martin, Richard M.			The Association of Early Childhood Cognitive Development and Behavioural Difficulties with Pre-Adolescent Problematic Eating Attitudes	PLOS ONE			English	Article							PSYCHOLOGICAL-FACTORS; WEIGHT PERCEPTION; BODY-IMAGE; ADOLESCENT; POPULATION; DISORDERS; GIRLS; PSYCHOPATHOLOGY; CHILDREN; SATISFACTION	Objectives: Few studies have prospectively investigated associations of child cognitive ability and behavioural difficulties with later eating attitudes. We investigated associations of intelligence quotient (IQ), academic performance and behavioural difficulties at 6.5 years with eating attitudes five years later. Methods: We conducted an observational cohort study nested within the Promotion of Breastfeeding Intervention Trial, Belarus. Of 17,046 infants enrolled at birth, 13,751 (80.7%) completed the Children's Eating Attitude Test (ChEAT) at 11.5 years, most with information on IQ (n = 12,667), academic performance (n = 9,954) and behavioural difficulties (n = 11,098) at 6.5 years. The main outcome was a ChEAT score >= 85th percentile, indicative of problematic eating attitudes. Results: Boys with higher IQ at 6.5 years reported fewer problematic eating attitudes, as assessed by ChEAT scores >= 85th percentile, at 11.5 years (OR per SD increase in full-scale IQ = 0.87; 0.79, 0.94). No such association was observed in girls (1.01; 0.93, 1.10) (p for sex-interaction = 0.016). In both boys and girls, teacher-assessed academic performance in non-verbal subjects was inversely associated with high ChEAT scores five years later (OR per unit increase in mathematics ability = 0.88; 0.82, 0.94; and OR per unit increase in ability for other non-verbal subjects = 0.86; 0.79, 0.94). Behavioural difficulties were positively associated with high ChEAT scores five years later (OR per SD increase in teacher-assessed rating = 1.13; 1.07, 1.19). Conclusion: Lower IQ, worse non-verbal academic performance and behavioural problems at early school age are positively associated with risk of problematic eating attitudes in early adolescence.	[Richmond, Rebecca C.; Wade, Kaitlin H.; Patel, Rita; Smith, George Davey; Martin, Richard M.] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Richmond, Rebecca C.; Wade, Kaitlin H.; Smith, George Davey; Martin, Richard M.] Univ Bristol, MRC Integrat Epidemiol Unit IEU, Bristol, Avon, England; [Skugarevsky, Oleg] Belarussian State Med Univ, Psychiat & Med Psychol Dept, Minsk, BELARUS; [Yang, Seungmi; Kramer, Michael S.] McGill Univ, Fac Med, Dept Pediat, Montreal, PQ, Canada; [Yang, Seungmi; Kramer, Michael S.] McGill Univ, Fac Med, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Bogdanovich, Natalia; Vilchuck, Konstantin; Sergeichick, Natalia] Natl Res & Appl Med Mother & Child Ctr, Minsk, BELARUS; [Oken, Emily] Harvard Univ, Sch Med, Dept Populat Med, Obes Prevent Program, Boston, MA USA; [Oken, Emily] Harvard Pilgrim Hlth Care Inst, Boston, MA USA; [Martin, Richard M.] Univ Hosp Bristol NHS Trust, NIHR, Bristol Biomed Res Unit Nutr, Bristol, Avon, England; [Martin, Richard M.] Univ Bristol, Bristol, Avon, England	University of Bristol; University of Bristol; McGill University; McGill University; Harvard University; Harvard Medical School; Harvard Pilgrim Health Care; University of Bristol	Martin, RM (corresponding author), Univ Bristol, Sch Social & Community Med, Bristol, Avon, England.	Richard.martin@bristol.ac.uk	Davey Smith, George/A-7407-2013	Davey Smith, George/0000-0002-1407-8314; Wade, Kaitlin/0000-0003-3362-6280; Richmond, Rebecca/0000-0003-0574-5071; Martin, Richard/0000-0002-7992-7719; s, hema/0000-0002-3440-9475; Venkatasubramanian, Siddharth/0000-0002-5860-0768	European Union Early Nutrition Programming Long-term Efficacy and Safety Trials [FOOD-DT-2005-007036]; Canadian Institutes of Health Research [MOP - 53155]; USA National Institutes of Health [R01 HD050758]; US National Institute of Child Health and Development [K24 HD069408]; MRC; University of Bristol; National Institute for Health Research; Wellcome Trust [WT083431MF, WT097097MF]; Medical Research Council [MC_UU_12013/1] Funding Source: researchfish; MRC [MC_UU_12013/1] Funding Source: UKRI; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K24HD069408, R01HD050758, R37HD034568] Funding Source: NIH RePORTER	European Union Early Nutrition Programming Long-term Efficacy and Safety Trials; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); USA National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Institute of Child Health and Development; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Bristol; National Institute for Health Research(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Support was provided by the European Union Early Nutrition Programming Long-term Efficacy and Safety Trials (grant no. FOOD-DT-2005-007036, http://www.metabolic-programming.org/researchprogramme.htm); Canadian Institutes of Health Research (MOP - 53155, http://www.cihr-irsc.gc.ca/e/193.html); and the USA National Institutes of Health (R01 HD050758, http://www.nih.gov/). Emily Oken was supported by US National Institute of Child Health and Development (K24 HD069408, http://www.nichd.nih.gov/). The Integrative Epidemiology Unit is supported by the MRC and the University of Bristol (http://www. bristol.ac.uk/integrative-epidemiology/). The Nutrition Biomedical Research Unit is supported by the National Institute for Health Research (http://www.nihr.ac.uk/ Pages/default.aspx). Rebecca C. Richmond and Kaitlin H. Wade were in receipt of 4-year PhD studentships from the Wellcome Trust (grant code: WT083431MF and WT097097MF, respectively, http://www.wellcome.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach T.M., 2001, MANUAL ASEBA SCH AGE; Berger U, 2005, PSYCHOTHER PSYCH MED, V55, P331, DOI 10.1055/s-2004-834745; BRYANTWAUGH R, 1995, J CHILD PSYCHOL PSYC, V36, P191, DOI 10.1111/j.1469-7610.1995.tb01820.x; Burklow KA, 1998, J PEDIATR GASTR NUTR, V27, P143, DOI 10.1097/00005176-199808000-00003; Colton PA, 2007, INT J EAT DISORDER, V40, P435, DOI 10.1002/eat.20386; Costarelli V, 2011, EUR EAT DISORD REV, V19, P322, DOI 10.1002/erv.1030; Dyer G, 1996, SEX ROLES, V34, P127, DOI 10.1007/BF01544800; Erickson Sarah J, 2007, Eat Behav, V8, P224, DOI 10.1016/j.eatbeh.2006.06.003; Fairburn CG, 2003, LANCET, V361, P407, DOI 10.1016/S0140-6736(03)12378-1; Fairburn CG., 2002, EATING DISORDERS OBE; Franko DL, 1999, J ADOLESCENCE, V22, P389, DOI 10.1006/jado.1999.0230; Gan WY, 2012, APPETITE, V59, P679, DOI 10.1016/j.appet.2012.08.002; Goodman R, 1998, EUR CHILD ADOLES PSY, V7, P125, DOI 10.1007/s007870050057; Hargreaves DA, 2006, J HEALTH PSYCHOL, V11, P567, DOI 10.1177/1359105306065017; Herpertz-Dahlmann B, 2008, EUR CHILD ADOLES PSY, V17, P82, DOI 10.1007/s00787-008-1009-9; Hoyland A, 2009, NUTR RES REV, V22, P220, DOI 10.1017/S0954422409990175; Jacobi C, 2008, INT J EAT DISORDER, V41, P626, DOI 10.1002/eat.20545; Jones JM, 2001, CAN MED ASSOC J, V165, P547; Kotler LA, 2001, J AM ACAD CHILD PSY, V40, P1434, DOI 10.1097/00004583-200112000-00014; Kramer MS, 2008, ARCH GEN PSYCHIAT, V65, P578, DOI 10.1001/archpsyc.65.5.578; Kramer MS, 2008, PEDIATRICS, V121, pE435, DOI 10.1542/peds.2007-1248; Kramer MS, 2001, JAMA-J AM MED ASSOC, V285, P413, DOI 10.1001/jama.285.4.413; Lena SM, 2004, NEUROPSYCHOL REV, V14, P99, DOI 10.1023/B:NERV.0000028081.40907.de; Leon GR, 1999, J YOUTH ADOLESCENCE, V28, P181, DOI 10.1023/A:1021649314458; LEVINE MP, 1992, S AP PSYC S, P59; Lopez C, 2010, ANN GEN PSYCHIATR, V9, DOI 10.1186/1744-859X-9-40; Makino Mariko, 2004, MedGenMed, V6, P49; MALONEY MJ, 1988, J AM ACAD CHILD PSY, V27, P541, DOI 10.1097/00004583-198809000-00004; MALONEY MJ, 1989, PEDIATRICS, V84, P482; MARCHI M, 1990, J AM ACAD CHILD PSY, V29, P112, DOI 10.1097/00004583-199001000-00017; McVey G, 2004, CAN MED ASSOC J, V170, P1559, DOI 10.1503/cmaj.1031247; Micali N, 2011, J DEV BEHAV PEDIATR, V32, P572, DOI 10.1097/DBP.0b013e31822bc7b7; Patel R, 2014, INT J EPIDEMIOL, V43, P679, DOI 10.1093/ije/dyt003; Patton GC, 1999, BRIT MED J, V318, P765, DOI 10.1136/bmj.318.7186.765; Rolland K, 1997, INT J EAT DISORDER, V21, P273, DOI 10.1002/(SICI)1098-108X(199704)21:3&lt;273::AID-EAT7&gt;3.0.CO;2-H; Sancho C, 2005, EUR EAT DISORD REV, V13, P338, DOI 10.1002/erv.643; Scrimshaw NS, 1998, NUTR RES, V18, P351, DOI 10.1016/S0271-5317(98)00027-X; Skugarevsky O, 2014, INT J EPIDEMIOL, V43, P1263, DOI 10.1093/ije/dyu072; SMOLAK L, 1994, INT J EAT DISORDER, V16, P275, DOI 10.1002/1098-108X(199411)16:3&lt;275::AID-EAT2260160308&gt;3.0.CO;2-U; Smolak L., 2002, BODY IMAGE EATING DI; Tchanturia K, 2005, INT J EAT DISORDER, V37, pS72, DOI 10.1002/eat.20119; Tchanturia K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028331; Wade KH, 2014, NUTR DIABETES, V4, DOI 10.1038/nutd.2013.40; Wechsler D., 2011, WASI 2 WECHSLER ABBR; Wechsler D., 2004, WISC 4 WECHSLER INTE, DOI 10.1037/t15174-000; Wichstrom L, 2000, INT J EAT DISORDER, V28, P33, DOI 10.1002/(SICI)1098-108X(200007)28:1<33::AID-EAT5>3.0.CO;2-H; Wong YC, 2011, J AM COLL NUTR, V30, P126, DOI 10.1080/07315724.2011.10719951; World Health Organization, 1989, UNICEF PROT PROM SUP; Xie B, 2006, AM J HEALTH BEHAV, V30, P115, DOI 10.5993/AJHB.30.2.1; Xie B, 2011, AM J HEALTH BEHAV, V35, P92; Zakzanis KK, 2010, J NEUROPSYCHOL, V4, P89, DOI 10.1348/174866409X459674	51	3	3	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e104132	10.1371/journal.pone.0104132	http://dx.doi.org/10.1371/journal.pone.0104132			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM6SB	25102171	Green Submitted, Green Published, gold			2022-12-27	WOS:000339993900044
J	Sasmono, RT; Aryati, A; Wardhani, P; Yohan, B; Trimarsanto, H; Fahri, S; Setianingsih, TY; Meutiawati, F				Sasmono, R. Tedjo; Aryati, Aryati; Wardhani, Puspa; Yohan, Benediktus; Trimarsanto, Hidayat; Fahri, Sukmal; Setianingsih, Tri Y.; Meutiawati, Febrina			Performance of Simplexa Dengue Molecular Assay Compared to Conventional and SYBR Green RT-PCR for Detection of Dengue Infection in Indonesia	PLOS ONE			English	Article							POLYMERASE CHAIN-REACTION; VIRUS-INFECTIONS; DIAGNOSIS; SEROTYPE; KINETICS; VIREMIA	Diagnostic tests based on detection of dengue virus (DENV) genome are available with varying sensitivities and specificities. The Simplexa Dengue assay (Focus Diagnostics) is a newly developed real-time RT-PCR method designed to detect and serotype DENV simultaneously. To assess the performance of the Simplexa Dengue assay, we performed comparison with conventional RT-PCR and SYBR Green real-time RT-PCR on patients sera isolated from eight cities across Indonesia, a dengue endemic country. A total of 184 sera that were confirmed using NS1 and/or IgM and IgG ELISA were examined. Using conventional and SYBR Green real-time RT-PCR, we detected DENV in 53 (28.8%) and 81 (44.0%) out of 184 sera, respectively. When the Simplexa Dengue assay was employed, the detection rate was increased to 76.6% (141 out of 184 samples). When tested in 40 sera that were confirmed by virus isolation as the gold standard, the conventional RT-PCR yielded 95% sensitivity while the sensitivity of SYBR Green real-time RT-PCR and Simplexa Dengue assay reached 97.5% and 100%, respectively. The specificities of all methods were 100% when tested in 43 non-dengue illness and 20 healthy human samples. Altogether, our data showed the higher detection rate of Simplexa Dengue compared to conventional and SYBR Green real-time RT-PCR in field/surveillance setting. In conclusion, Simplexa Dengue offers rapid and accurate detection and typing of dengue infection and is suitable for both routine diagnostic and surveillance.	[Sasmono, R. Tedjo; Yohan, Benediktus; Trimarsanto, Hidayat; Setianingsih, Tri Y.; Meutiawati, Febrina] Eijkman Inst Mol Biol, Jakarta, Indonesia; [Aryati, Aryati; Wardhani, Puspa] Airlangga Univ, Sch Med, Dept Clin Pathol, Surabaya, Indonesia; [Aryati, Aryati; Wardhani, Puspa] Airlangga Univ, Inst Trop Dis, Surabaya, Indonesia; [Trimarsanto, Hidayat] Agcy Assessment & Applicat Technol, Jakarta, Indonesia; [Fahri, Sukmal] Jambi Prov Hlth Off, Hlth Polytech, Kotabaru, Jambi, Indonesia; [Fahri, Sukmal] Diponegoro Univ, Grad Sch Med, Semarang, Indonesia	Eijkman Institute; Airlangga University; Airlangga University; Agency for the Assessment & Application of Technology (BPPT); Diponegoro University	Sasmono, RT (corresponding author), Eijkman Inst Mol Biol, Jakarta, Indonesia.	sasmono@eijkman.go.id	Meutiawati, Febrina/H-3419-2016; Aryati, Aryati/CAI-7894-2022; Yohan, Benediktus/J-9039-2019; Sasmono, Tedjo/H-5680-2016; Wardhani, Puspa/AAY-7389-2021	Yohan, Benediktus/0000-0003-2378-2386; Sasmono, Tedjo/0000-0003-0986-2590; Wardhani, Puspa/0000-0003-2202-8090; Trimarsanto, Hidayat/0000-0003-2436-8283	SINAS grant from the Ministry of Research and Technology of the Republic of Indonesia; PHKI grant from the Ministry of Education of the Republic of Indonesia	SINAS grant from the Ministry of Research and Technology of the Republic of Indonesia(Ministry of Research and Technology of the Republic of Indonesia (RISTEK)); PHKI grant from the Ministry of Education of the Republic of Indonesia(Ministry of Research and Technology of the Republic of Indonesia (RISTEK))	This study was funded by SINAS 2012 grant from the Ministry of Research and Technology of the Republic of Indonesia and PHKI grant from the Ministry of Education of the Republic of Indonesia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beranek M, 2005, KLIN BIOCH METAB, V13, P10; CHAN SY, 1994, J VIROL METHODS, V49, P315, DOI 10.1016/0166-0934(94)90146-5; Chen RB, 2011, VIRUSES-BASEL, V3, P1562, DOI 10.3390/v3091562; Chien LJ, 2006, J CLIN MICROBIOL, V44, P1295, DOI 10.1128/JCM.44.4.1295-1304.2006; Chinnawirotpisan P, 2008, ARCH VIROL, V153, P2225, DOI 10.1007/s00705-008-0249-9; Cuzzubbo AJ, 2000, J CLIN VIROL, V16, P135, DOI 10.1016/S1386-6532(99)00076-1; Araujo FMD, 2006, MEM I OSWALDO CRUZ, V101, P925, DOI 10.1590/S0074-02762006000800017; de Castro MG, 2012, MEM I OSWALDO CRUZ, V107, P940, DOI 10.1590/S0074-02762012000700017; de Figueiredo RMP, 2011, REV INST MED TROP SP, V53, P321, DOI 10.1590/S0036-46652011000600004; Domingo C, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000833; Santos Cecília Luiza Simões dos, 2003, Rev. Inst. Med. trop. S. Paulo, V45, P11; Duyen HTL, 2011, J INFECT DIS, V203, P1292, DOI 10.1093/infdis/jir014; Fahri S, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002354; Grant V, 2012, GOOD CLIN LAB PRACTI; GUBLER DJ, 1985, AM J TROP MED HYG, V34, P170, DOI 10.4269/ajtmh.1985.34.170; Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460; Guzman MG, 2004, INT J INFECT DIS, V8, P69, DOI 10.1016/j.ijid.2003.03.003; Harrell FE, 2013, RMS REGRESSION MODEL; Harrell FE, 2001, REGRESSION MODELING; Harris E, 1998, J CLIN MICROBIOL, V36, P2634, DOI 10.1128/JCM.36.9.2634-2639.1998; HENCHAL EA, 1991, AM J TROP MED HYG, V45, P418, DOI 10.4269/ajtmh.1991.45.418; Holmes EC, 2000, TRENDS MICROBIOL, V8, P74, DOI 10.1016/S0966-842X(99)01669-8; IGARASHI A, 1979, NATURE, V280, P690, DOI 10.1038/280690a0; Kien DTH, 2011, J VIROL METHODS, V177, P168, DOI 10.1016/j.jviromet.2011.08.002; Lai YL, 2007, J CLIN MICROBIOL, V45, P935, DOI 10.1128/JCM.01258-06; LAILLE M, 1991, J MED VIROL, V34, P51, DOI 10.1002/jmv.1890340109; LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992; Lorono-Pino MA, 1999, AM J TROP MED HYG, V61, P725, DOI 10.4269/ajtmh.1999.61.725; Martina BEE, 2009, CLIN MICROBIOL REV, V22, P564, DOI 10.1128/CMR.00035-09; Obuchowski N A, 1998, Stat Methods Med Res, V7, P371, DOI 10.1191/096228098678080061; Ong SH, 2008, INFECT GENET EVOL, V8, P191, DOI 10.1016/j.meegid.2007.12.005; Peeling RW, 2010, NAT REV MICROBIOL, pS30, DOI 10.1038/nrmicro2459; Peng WM, 2005, J CLIN VIROL, V32, P194, DOI 10.1016/j.jcv.2004.04.010; Poersch CD, 2005, J CLIN VIROL, V32, P272, DOI 10.1016/j.jcv.2004.08.008; Raengsakulrach B, 2002, J VIROL METHODS, V105, P219, DOI 10.1016/S0166-0934(02)00104-0; Shu PY, 2004, CLIN DIAGN LAB IMMUN, V11, P642, DOI 10.1128/CDLI.11.4.642-650.2004; Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265; Tang KF, 2012, EXPERT REV ANTI-INFE, V10, P895, DOI [10.1586/eri.12.76, 10.1586/ERI.12.76]; Tricou V, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001309; Twiddy SS, 2003, INFECT GENET EVOL, V3, P87, DOI 10.1016/S1567-1348(02)00153-3; Waggoner JJ, 2013, J CLIN MICROBIOL, V51, P2172, DOI 10.1128/JCM.00548-13	41	26	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e103815	10.1371/journal.pone.0103815	http://dx.doi.org/10.1371/journal.pone.0103815			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25102066	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000339993900026
J	Szatmari, A; Zvara, A; Moricz, AM; Besenyei, E; Szabo, E; Ott, PG; Puskas, LG; Bozso, Z				Szatmari, Agnes; Zvara, Agnes; Moricz, Agnes M.; Besenyei, Eszter; Szabo, Erika; Ott, Peter G.; Puskas, Laszlo G.; Bozso, Zoltan			Pattern Triggered Immunity (PTI) in Tobacco: Isolation of Activated Genes Suggests Role of the Phenylpropanoid Pathway in Inhibition of Bacterial Pathogens	PLOS ONE			English	Article							ARABIDOPSIS INNATE IMMUNITY; PSEUDOMONAS-SYRINGAE; DEFENSE RESPONSES; BASAL RESISTANCE; CELL-WALL; HYPERSENSITIVE REACTION; DISEASE RESISTANCE; PLANTS; CALCIUM; LEAVES	Background: Pattern Triggered Immunity (PTI) or Basal Resistance (BR) is a potent, symptomless form of plant resistance. Upon inoculation of a plant with non-pathogens or pathogenicity-mutant bacteria, the induced PTI will prevent bacterial proliferation. Developed PTI is also able to protect the plant from disease or HR (Hypersensitive Response) after a challenging infection with pathogenic bacteria. Our aim was to reveal those PTI-related genes of tobacco (Nicotiana tabacum) that could possibly play a role in the protection of the plant from disease. Methodology/Principal Findings: Leaves were infiltrated with Pseudomonas syringae pv. syringae hrcC-mutant bacteria to induce PTI, and samples were taken 6 and 48 hours later. Subtraction Suppressive Hybridization (SSH) resulted in 156 PTI-activated genes. A cDNA microarray was generated from the SSH clone library. Analysis of hybridization data showed that in the early (6 hpi) phase of PTI, among others, genes of peroxidases, signalling elements, heat shock proteins and secondary metabolites were upregulated, while at the late phase (48 hpi) the group of proteolysis genes was newly activated. Microarray data were verified by real time RT-PCR analysis. Almost all members of the phenyl-propanoid pathway (PPP) possibly leading to lignin biosynthesis were activated. Specific inhibition of cinnamic-acid-4-hydroxylase (C4H), rate limiting enzyme of the PPP, decreased the strength of PTI - as shown by the HR-inhibition and electrolyte leakage tests. Quantification of cinnamate and p-coumarate by thin-layer chromatography (TLC)-densitometry supported specific changes in the levels of these metabolites upon elicitation of PTI. Conclusions/Significance: We believe to provide first report on PTI-related changes in the levels of these PPP metabolites. Results implicated an actual role of the upregulation of the phenylpropanoid pathway in the inhibition of bacterial pathogenic activity during PTI.	[Szatmari, Agnes; Moricz, Agnes M.; Besenyei, Eszter; Szabo, Erika; Ott, Peter G.; Bozso, Zoltan] Hungarian Acad Sci, Agr Res Ctr, Inst Plant Protect, Dept Pathophysiol, Budapest, Hungary; [Zvara, Agnes; Puskas, Laszlo G.] Hungarian Acad Sci, Biol Res Ctr, Lab Funct Genom, Szeged, Hungary	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center	Szatmari, A (corresponding author), Hungarian Acad Sci, Agr Res Ctr, Inst Plant Protect, Dept Pathophysiol, Budapest, Hungary.	szatmari.agnes@agrar.mta.hu	Móricz, Ágnes M/E-2416-2018; Ott, Pėter/AAH-1208-2020	Móricz, Ágnes M/0000-0002-4330-9396; Ott, Peter G./0000-0002-2252-7482; Szatmari, Agnes/0000-0001-8768-8212	OTKA [68386, 109050, K101271]; Bolyai Fellowships from the Hungarian Academy of Sciences	OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Bolyai Fellowships from the Hungarian Academy of Sciences	This research was supported by the OTKA 68386, 109050 and K101271 grants. A A. Szatmari and A. M. Moricz were supported by Bolyai Fellowships from the Hungarian Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali R, 2007, PLANT CELL, V19, P1081, DOI 10.1105/tpc.106.045096; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Aslam SN, 2008, CURR BIOL, V18, P1078, DOI 10.1016/j.cub.2008.06.061; Bozso Z, 2005, J PHYTOPATHOL, V153, P596, DOI 10.1111/j.1439-0434.2005.01026.x; Bozso Z, 2009, PLANT MOL BIOL, V70, P627, DOI 10.1007/s11103-009-9496-8; Chakravarthy S, 2010, MOL PLANT MICROBE IN, V23, P715, DOI 10.1094/MPMI-23-6-0715; Collinge DB, 2009, J EXP BOT, V60, P351, DOI 10.1093/jxb/erp001; de Torres M, 2003, PLANT J, V33, P665, DOI 10.1046/j.1365-313X.2003.01653.x; Deng WL, 1998, J BACTERIOL, V180, P4523, DOI 10.1128/JB.180.17.4523-4531.1998; Denoux C, 2008, MOL PLANT, V1, P423, DOI 10.1093/mp/ssn019; Felix G, 1999, PLANT J, V18, P265, DOI 10.1046/j.1365-313X.1999.00265.x; Felix G, 2003, J BIOL CHEM, V278, P6201, DOI 10.1074/jbc.M209880200; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; Grant M, 2000, PLANT J, V23, P441, DOI 10.1046/j.1365-313x.2000.00804.x; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hauck P, 2003, P NATL ACAD SCI USA, V100, P8577, DOI 10.1073/pnas.1431173100; Hoffmann L, 2004, PLANT CELL, V16, P1446, DOI 10.1105/tpc.020297; Huang WE, 2006, PLANT J, V46, P1073, DOI 10.1111/j.1365-313X.2006.02758.x; Huckelhoven R, 2007, ANNU REV PHYTOPATHOL, V45, P101, DOI 10.1146/annurev.phyto.45.062806.094325; JAKOBEK JL, 1993, PLANT CELL, V5, P49, DOI 10.1105/tpc.5.1.49; JAKOBEK JL, 1993, PLANT CELL, V5, P57, DOI 10.1105/tpc.5.1.57; KING EO, 1954, J LAB CLIN MED, V44, P301; Klement Z, 2003, PEST MANAG SCI, V59, P465, DOI 10.1002/ps.694; Klement Z, 1999, J PHYTOPATHOL, V147, P467, DOI 10.1111/j.1439-0434.1999.tb03852.x; Klement Z., 1990, METHODS PHYTOBACTERI, P96; Kostyn K, 2012, PLANT SCI, V190, P103, DOI 10.1016/j.plantsci.2012.03.011; Kuntze G, 2004, PLANT CELL, V6, P3496; LOVREKOVICH L, 1965, NATURE, V205, P823, DOI 10.1038/205823a0; Ma W, 2007, CELL MICROBIOL, V9, P2571, DOI 10.1111/j.1462-5822.2007.01031.x; Maddox CE, 2010, CURR MICROBIOL, V60, P53, DOI 10.1007/s00284-009-9501-0; MAHER EA, 1994, P NATL ACAD SCI USA, V91, P7802, DOI 10.1073/pnas.91.16.7802; Meszaros T, 2007, PLANT SIGNAL BEHAV, V2, P30, DOI 10.4161/psb.2.1.3885; Navarro L, 2004, PLANT PHYSIOL, V135, P1113, DOI 10.1104/pp.103.036749; Ott PG, 2006, MOL PLANT MICROBE IN, V19, P161, DOI 10.1094/MPMI-19-0161; Park CJ, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00177; Puskas LG, 2002, BIOTECHNIQUES, V33, P898, DOI 10.2144/02334mt03; Rasmussen MW, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00169; Rodriguez MCS, 2010, ANNU REV PLANT BIOL, V61, P621, DOI 10.1146/annurev-arplant-042809-112252; Rotter A, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-10; Savatin DV, 2014, PLANT PHYSIOL, V2014; Schalk M, 1998, PLANT PHYSIOL, V118, P209, DOI 10.1104/pp.118.1.209; Shinya T, 2007, PLANT CELL PHYSIOL, V48, P1404, DOI 10.1093/pcp/pcm115; Silverstein KAT, 2005, PLANT PHYSIOL, V138, P600, DOI 10.1104/pp.105.060079; Szabo E, 2012, BIOL PLANTARUM, V56, P551, DOI 10.1007/s10535-011-0226-0; Szatmari A, 2006, PLANT CELL REP, V25, P728, DOI 10.1007/s00299-005-0110-5; Thilmony R, 2006, PLANT J, V46, P34, DOI 10.1111/j.1365-313X.2006.02725.x; Truman W, 2006, PLANT J, V46, P14, DOI 10.1111/j.1365-313X.2006.02672.x; Tsuda K, 2008, PLANT J, V53, P763, DOI 10.1111/j.1365-313X.2007.03369.x; Usadel B, 2005, PLANT PHYSIOL, V138, P1195, DOI 10.1104/pp.105.060459; Yuen T, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e48; Zhang J, 2010, MOL PLANT MICROBE IN, V23, P940, DOI 10.1094/MPMI-23-7-0940; Zipfel C, 2006, CELL, V125, P749, DOI 10.1016/j.cell.2006.03.037	53	11	14	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e102869	10.1371/journal.pone.0102869	http://dx.doi.org/10.1371/journal.pone.0102869			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25101956	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000339993900009
J	Tripathi, MK; Singh, R				Tripathi, Manish Kumar; Singh, Ramesh			Differential Suppressive Effects of Testosterone on Immune Function in Fresh Water Snake, Natrix piscator: An In Vitro Study	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; STEROID-HORMONES; SEX-HORMONES; PERITONEAL-MACROPHAGES; SURFACE-RECEPTORS; GONADAL-STEROIDS; WALL LIZARD; INFECTION; INTERLEUKIN-1; MODULATION	Reptiles represent the crucial phylogenetic group as they were the ancestors of both birds and mammals hence very important to study. The objectives of the present study were to investigate the potential roles of testosterone in the innate immune responses and splenic lymphocyte proliferation in fresh water snake, Natrix piscator. Animals were mildly anesthetized and spleens were taken out to study the splenic macrophage phagocytosis, super oxide production and nitrite release using in vitro testosterone. Splenic lymphocytes were isolated by density gradient centrifugation and were studied for mitogen induced proliferation in presence of in vitro testosterone. Testosterone suppressed the phagocytosis and nitrite release in a concentration dependent manner. Biphasic suppressive effect of testosterone was observed in superoxide production as judged by reduction of nitroblue tetrazolium salt where salt reduction was suppressed at lower and higher concentrations of testosterone. Mitogen induced splenic lymphocyte proliferation was also suppressed by testosterone. By suppressing immune responses, testosterone may, therefore, act as a physiological mechanism regulating the relative amount of energy invested into either reproductive effort or immunocompetence.	[Tripathi, Manish Kumar; Singh, Ramesh] Udai Pratap Autonomous Coll, Dept Zool, Varanasi, Uttar Pradesh, India	Udai Pratap College, Varanasi	Singh, R (corresponding author), Udai Pratap Autonomous Coll, Dept Zool, Varanasi, Uttar Pradesh, India.	upcrsingh@yahoo.com			Department of Science and Technology, New Delhi, Govt. of India [SR/SO/AS -15/2005]	Department of Science and Technology, New Delhi, Govt. of India(Department of Science & Technology (India))	This work was supported by a financial grant (SR/SO/AS -15/2005) from the Department of Science and Technology, New Delhi, Govt. of India to Ramesh Singh. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DO, 1992, NATURAL IMMUNE SYSTE, P75; Al-Afaleq AI, 1998, IMMUNOPHARM IMMUNOT, V20, P315, DOI 10.3109/08923979809038547; ALEXANDER J, 1988, PARASITOL TODAY, V4, P189, DOI 10.1016/0169-4758(88)90077-4; BAGASRA O, 1988, IMMUNOLOGY, V65, P405; Benten WPM, 2002, STEROIDS, V67, P647, DOI 10.1016/S0039-128X(02)00013-2; Berger J., 2003, COMP CLIN PATHOL, V12, P84, DOI [10.1007/s00580-003-0478-y, DOI 10.1007/S00580-003-0478-Y]; Berridge MV, 2005, BIOTECHNOL ANN REV, V11, P127, DOI 10.1016/S1387-2656(05)11004-7; Bilbo SD, 2001, AM J PHYSIOL-REG I, V280, pR207, DOI 10.1152/ajpregu.2001.280.1.R207; Billingham RE, 1986, REPRODUCTIVE IMMUNOL, P109; BOORMAN GA, 1980, J RETICULOENDOTH SOC, V28, P547; BUTTERWO.M, 1967, NATURE, V214, P1224, DOI 10.1038/2141224a0; Cannon JG, 1997, J PSYCHIAT RES, V31, P99, DOI 10.1016/S0022-3956(96)00055-6; CHAO TC, 1995, CELL IMMUNOL, V160, P43, DOI 10.1016/0008-8749(95)80007-6; DASILVA JAP, 1995, ANN RHEUM DIS, V54, P6, DOI 10.1136/ard.54.1.6; De Leon-Nava MA, 2009, J STEROID BIOCHEM, V113, P57, DOI 10.1016/j.jsbmb.2008.11.003; Demas GE, 1998, J COMP PHYSIOL B, V168, P419, DOI 10.1007/s003600050161; DING AH, 1988, J IMMUNOL, V141, P2407; Duffy DL, 2000, BEHAV ECOL, V11, P654, DOI 10.1093/beheco/11.6.654; EIDINGER D, 1972, J EXP MED, V136, P1098, DOI 10.1084/jem.136.5.1098; FLYNN A, 1986, LIFE SCI, V38, P2455, DOI 10.1016/0024-3205(86)90616-8; GROSSMAN CJ, 1985, SCIENCE, V227, P257, DOI 10.1126/science.3871252; GROSSMAN CJ, 1984, ENDOCR REV, V5, P435, DOI 10.1210/edrv-5-3-435; HALDAR C, 1989, GEN COMP ENDOCR, V76, P214, DOI 10.1016/0016-6480(89)90152-4; Hammar JA, 1929, Z MIKROSK ANAT FORSC, V16; HU SK, 1988, INT J IMMUNOPHARMACO, V10, P247; Hughes TK, 1995, INT J IMMUNOPHARMACO, V17, P857, DOI 10.1016/0192-0561(95)00078-X; KELLER R, 1993, RES IMMUNOL, V144, P271, DOI 10.1016/0923-2494(93)80105-8; Klein SL, 1997, HORM BEHAV, V32, P30, DOI 10.1006/hbeh.1997.1402; Klein SL, 1999, AM J PHYSIOL-REG I, V277, pR1362, DOI 10.1152/ajpregu.1999.277.5.R1362; Klein SL, 2000, NEUROSCI BIOBEHAV R, V24, P627, DOI 10.1016/S0149-7634(00)00027-0; LACHMAN LB, 1986, J IMMUNOL, V136, P3098; Mondal S, 2002, GEN COMP ENDOCR, V125, P264, DOI 10.1006/gcen.2001.7744; Mondal S, 2001, COMP BIOCHEM PHYS A, V129, P391, DOI 10.1016/S1095-6433(00)00356-1; Mondal S, 1999, GEN COMP ENDOCR, V116, P291, DOI 10.1006/gcen.1999.7370; Olsen NJ, 1996, ENDOCR REV, V17, P369, DOI 10.1210/edrv-17-4-369; PARK BH, 1968, LANCET, V2, P532; Pawlak J, 2005, MOL BRAIN RES, V138, P1, DOI 10.1016/j.molbrainres.2004.10.043; PHILIP R, 1986, NATURE, V323, P86, DOI 10.1038/323086a0; Poulin R, 1996, INT J PARASITOL, V26, P1311, DOI 10.1016/S0020-7519(96)00108-7; Rajput Z.I., 2005, Journal of Zhejiang University Science, V6B, P1057, DOI 10.1631/jzus.2005.B1057; Ramzan M, 2009, TROP ANIM HEALTH PRO, V41, P1225, DOI 10.1007/s11250-009-9304-0; Roden AC, 2004, J IMMUNOL, V173, P6098, DOI 10.4049/jimmunol.173.10.6098; SAAD AH, 1990, IMMUNOBIOLOGY, V180, P184, DOI 10.1016/S0171-2985(11)80327-X; Sano A, 1992, MYCOPATHOLOGIA, V14, P63; Savita, 1998, COMP BIOCHEM PHYS C, V119, P199, DOI 10.1016/S0742-8413(97)00207-7; SCHUURS AHWM, 1990, J STEROID BIOCHEM, V35, P157, DOI 10.1016/0022-4731(90)90270-3; Straub RH, 2001, ARTHRITIS RHEUM-US, V44, P493, DOI 10.1002/1529-0131(200103)44:3<493::AID-ANR95>3.0.CO;2-U; TIURIA R, 1995, PARASITE IMMUNOL, V17, P479, DOI 10.1111/j.1365-3024.1995.tb00918.x; VARAS A, 1992, DEV COMP IMMUNOL, V16, P165, DOI 10.1016/0145-305X(92)90016-6; VARAS A, 1991, THYMUS, V17, P129; VISELLI SM, 1995, IMMUNOLOGY, V84, P337; Zuk M, 1996, INT J PARASITOL, V26, P1009, DOI [10.1016/S0020-7519(96)00086-0, 10.1016/S0020-7519(96)80001-4]	52	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e104431	10.1371/journal.pone.0104431	http://dx.doi.org/10.1371/journal.pone.0104431			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25101765	Green Published, Green Submitted, gold			2022-12-27	WOS:000339993900063
J	Darimont, CT; Child, KR				Darimont, Chris T.; Child, K. Rosie			What Enables Size-Selective Trophy Hunting of Wildlife?	PLOS ONE			English	Article							HARVEST; AGE; EVOLUTION; SURVIVAL; BEHAVIOR; ORIGINS; SUCCESS; GENDER; HEALTH	Although rarely considered predators, wildlife hunters can function as important ecological and evolutionary agents. In part, their influence relates to targeting of large reproductive adults within prey populations. Despite known impacts of size-selective harvests, however, we know little about what enables hunters to kill these older, rarer, and presumably more wary individuals. In other mammalian predators, predatory performance varies with knowledge and physical condition, which accumulates and declines, respectively, with age. Moreover, some species evolved camouflage as a physical trait to aid in predatory performance. In this work, we tested whether knowledge-based faculty (use of a hunting guide with accumulated experience in specific areas), physical traits (relative body mass [RBM] and camouflage clothing), and age can predict predatory performance. We measured performance as do many hunters: size of killed cervid prey, using the number of antler tines as a proxy. Examining similar to 4300 online photographs of hunters posing with carcasses, we found that only the presence of guides increased the odds of killing larger prey. Accounting for this effect, modest evidence suggested that unguided hunters presumably handicapped with the highest RBM actually had greater odds of killing large prey. There was no association with hunter age, perhaps because of our coarse measure (presence of grey hair) and the performance trade-offs between knowledge accumulation and physical deterioration with age. Despite its prevalence among sampled hunters (80%), camouflage had no influence on size of killed prey. Should these patterns be representative of other areas and prey, and our interpretations correct, evolutionarily-enlightened harvest management might benefit from regulatory scrutiny on guided hunting. More broadly, we suggest that by being nutritionally and demographically de-coupled from prey and aided by efficient killing technology and road access, wildlife hunters in the developed world might have overcome many of the physical, but not knowledge-based, challenges of hunting.	[Darimont, Chris T.; Child, K. Rosie] Univ Victoria, Dept Geog, Victoria, BC, Canada; [Darimont, Chris T.; Child, K. Rosie] Raincoast Conservat Fdn, Sidney, BC, Canada	University of Victoria	Darimont, CT (corresponding author), Univ Victoria, Dept Geog, Victoria, BC, Canada.	darimont@uvic.ca			Natural Science and Engineering Research Council Discovery Grant [435683]	Natural Science and Engineering Research Council Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC))	CTD was supported by a Natural Science and Engineering Research Council Discovery Grant 435683 (http://www.nserc-crsng.gc.ca/index_eng.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth BE, 2000, COMPENDIUM PHYS ACTI; Allen WL, 2011, P ROY SOC B-BIOL SCI, V278, P1373, DOI 10.1098/rspb.2010.1734; Allendorf FW, 2009, P NATL ACAD SCI USA, V106, P9987, DOI 10.1073/pnas.0901069106; Autry JK, 2012, SHOOTING IND MAGAZIN; Bertoli A, 2003, ACTA DIABETOL, V40, pS130, DOI 10.1007/s00592-003-0045-7; Blurton Jones N, 1976, KALAHARI HUNTER GATH, P325; Brodie J, 2013, J APPL ECOL, V50, P295, DOI 10.1111/1365-2664.12044; BROWN PJ, 1987, ANN NY ACAD SCI, V499, P29, DOI 10.1111/j.1749-6632.1987.tb36195.x; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Caro T., 1994, CHEETAHS SERENGETI P; Churchill SE., 1993, ARCHEOL PAP AM ANTHR, V4, P11, DOI [10.1525/ap3a.1993.4.1.11, DOI 10.1525/AP3A.1993.4.1.11]; Ciuti S, 2012, P ROY SOC B-BIOL SCI, V279, P4407, DOI 10.1098/rspb.2012.1483; CLARK CW, 1994, BEHAV ECOL, V5, P159, DOI 10.1093/beheco/5.2.159; Coltman DW, 2003, NATURE, V426, P655, DOI 10.1038/nature02177; Cordain L, 2005, AM J CLIN NUTR, V81, P341, DOI 10.1093/ajcn.81.2.341; Coss RG, 2005, BEHAV PROCESS, V68, P145, DOI 10.1016/j.beproc.2004.12.004; Cott H.B., 1940, ADAPTIVE COLORATION; Darimont CT, 2009, P NATL ACAD SCI USA, V106, P952, DOI 10.1073/pnas.0809235106; Emery MR, 2005, ENVIRON PLANN A, V37, P981, DOI 10.1068/a36263; ESTES RD, 1967, J WILDLIFE MANAGE, V31, P52, DOI 10.2307/3798360; FANSHAWE JH, 1993, ANIM BEHAV, V45, P479, DOI 10.1006/anbe.1993.1059; Festa-Bianchet M, 2003, ANIMAL BEHAVIOR AND WILDLIFE CONSERVATION, P191; Garel M, 2007, ECOL APPL, V17, P1607, DOI 10.1890/06-0898.1; Gurven M, 2006, J HUM EVOL, V51, P454, DOI 10.1016/j.jhevol.2006.05.003; Hall JR, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0064; Hengeveld PE, 2011, J WILDLIFE MANAGE, V75, P189, DOI 10.1002/jwmg.14; Holekamp KE, 1997, J ZOOL, V242, P1, DOI 10.1111/j.1469-7998.1997.tb02925.x; Lecomte VJ, 2010, P NATL ACAD SCI USA, V107, P6370, DOI 10.1073/pnas.0911181107; Liebenberg L., 1990, ART TRACKING ORIGIN; Lieberman Daniel E., 2009, P77, DOI 10.1007/978-1-4020-9980-9_8; Loehr J, 2005, CAN J ZOOL, V83, P1602, DOI 10.1139/Z05-162; Loison A, 1999, ECOLOGY, V80, P2539, DOI 10.1890/0012-9658(1999)080[2539:ASSIFP]2.0.CO;2; MacNulty DR, 2009, ECOL LETT, V12, P1347, DOI 10.1111/j.1461-0248.2009.01385.x; Milner JM, 2007, CONSERV BIOL, V21, P36, DOI 10.1111/j.1523-1739.2006.00591.x; Mysterud A, 2011, J APPL ECOL, V48, P827, DOI 10.1111/j.1365-2664.2011.02006.x; POSNER MI, 1976, PSYCHOL REV, V83, P157, DOI 10.1037/0033-295X.83.2.157; Poudyal N., 2008, Human Dimensions of Wildlife, V13, P158, DOI 10.1080/10871200801922965; Poulton E.B., 1890, COLOURS ANIMALS THEI, DOI [10.1126/science.ns-16.407.286.a, DOI 10.1126/SCIENCE.NS-16.407.286.A]; Reither EN, 2009, DEMOGRAPHY, V46, P27, DOI 10.1353/dem.0.0037; Schmidt JI, 2007, WILDLIFE BIOL, V13, P53, DOI 10.2981/0909-6396(2007)13[53:ASOAMA]2.0.CO;2; Shackleton DM., 1999, HOOFED MAMMALS BRIT; SMITH JM, 1973, ECOLOGY, V54, P384, DOI 10.2307/1934346; Stedman R, 2004, J WILDLIFE MANAGE, V68, P762, DOI 10.2193/0022-541X(2004)068[0762:IWAHRM]2.0.CO;2; Stevens M, 2009, PHILOS T R SOC B, V364, P423, DOI 10.1098/rstb.2008.0217; Walker R, 2002, J HUM EVOL, V42, P639, DOI 10.1006/jhev.2001.0541; Wang Y, 2007, EPIDEMIOL REV, V29, P6, DOI 10.1093/epirev/mxm007; World Health Organization (WHO), 2013, GLOB DAT BOD MASS IN; Zimmer I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016098	48	4	4	0	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e103487	10.1371/journal.pone.0103487	http://dx.doi.org/10.1371/journal.pone.0103487			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM6SM	25098246	Green Published, gold, Green Submitted			2022-12-27	WOS:000339995100021
J	Longino, JT; Branstetter, MG; Colwell, RK				Longino, John T.; Branstetter, Michael G.; Colwell, Robert K.			How Ants Drop Out: Ant Abundance on Tropical Mountains	PLOS ONE			English	Article							DIVERSITY GRADIENTS; SPECIES RICHNESS; PRODUCTIVITY; TEMPERATURE; ENERGY	In tropical wet forests, ants are a large proportion of the animal biomass, but the factors determining abundance are not well understood. We characterized ant abundance in the litter layer of 41 mature wet forest sites spread throughout Central America (Chiapas, Guatemala, Honduras, Nicaragua, and Costa Rica) and examined the impact of elevation (as a proxy for temperature) and community species richness. Sites were intentionally chosen to minimize variation in precipitation and seasonality. From sea level to 1500 m ant abundance very gradually declined, community richness declined more rapidly than abundance, and the local frequency of the locally most common species increased. These results suggest that within this elevational zone, density compensation is acting, maintaining high ant abundance as richness declines. In contrast, in sites above 1500 m, ant abundance dropped abruptly to much lower levels. Among these high montane sites, community richness explained much more of the variation in abundance than elevation, and there was no evidence of density compensation. The relative stability of abundance below 1500 m may be caused by opposing effects of temperature on productivity and metabolism. Lower temperatures may decrease productivity and thus the amount of food available for consumers, but slower metabolisms of consumers may allow maintenance of higher biomass at lower resource supply rates. Ant communities at these lower elevations may be highly interactive, the result of continuous habitat presence over geological time. High montane sites may be ephemeral in geological time, resulting in non-interactive communities dominated by historical and stochastic processes. Abundance in these sites may be determined by the number of species that manage to colonize and/or avoid extinction on mountaintops.	[Longino, John T.] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Branstetter, Michael G.] Smithsonian Inst, Natl Museum Nat Hist, Dept Entomol, Washington, DC 20560 USA; [Colwell, Robert K.] Univ Connecticut, Dept Ecol & Evolutionary Biol, Storrs, CT USA; [Colwell, Robert K.] Univ Colorado, Museum Nat Hist, Boulder, CO 80309 USA	Utah System of Higher Education; University of Utah; Smithsonian Institution; Smithsonian National Museum of Natural History; University of Connecticut; University of Colorado System; University of Colorado Boulder	Longino, JT (corresponding author), Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA.	jacklongino@gmail.com	Colwell, Robert K/C-7276-2015		National Science Foundation [DEB-0072702, DEB-0640015/DEB-1157383, DEB-1354739]; National Geographic Society [7331-02, 7751-04]; Conservation International; Smithsonian Institution	National Science Foundation(National Science Foundation (NSF)); National Geographic Society(National Geographic Society); Conservation International; Smithsonian Institution(Smithsonian Institution)	This work was supported by National Science Foundation grants DEB-0072702 (Project ALAS), DEB-0640015/DEB-1157383 (Project LLAMA), DEB-1354739 (Project ADMAC), National Geographic Society grants 7331-02 and 7751-04, and Conservation International. MB was supported by a Buck Postdoctoral Fellowship from the Smithsonian Institution. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen AP, 2002, SCIENCE, V297, P1545, DOI 10.1126/science.1072380; Branstetter MG, 2013, ZOOKEYS, P1, DOI 10.3897/zookeys.295.4905; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Chao A, 2012, ECOLOGY, V93, P2533, DOI 10.1890/11-1952.1; CONNELL JH, 1964, AM NAT, V98, P399, DOI 10.1086/282335; Donoso DA, 2013, SOIL BIOL BIOCHEM, V61, P45, DOI 10.1016/j.soilbio.2013.02.004; Fan Y, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD008470; Fisher BL, 1999, ECOL APPL, V9, P714, DOI 10.1890/1051-0761(1999)009[0714:IIEACS]2.0.CO;2; Grace James B., 1999, Perspectives in Plant Ecology Evolution and Systematics, V2, P1, DOI 10.1078/1433-8319-00063; Groc S, 2010, BIOL CONSERV, V143, P2832, DOI 10.1016/j.biocon.2010.07.034; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hou C, 2010, P NATL ACAD SCI USA, V107, P3634, DOI 10.1073/pnas.0908071107; JORDAN CF, 1985, NUTR CYCLING TROPICA; Kaspari M, 2003, AM NAT, V161, P459, DOI 10.1086/367906; Kaspari M, 1996, OIKOS, V76, P443, DOI 10.2307/3546338; Kaspari M, 2000, AM NAT, V155, P280, DOI 10.1086/303313; Kaspari M, 2000, P ROY SOC B-BIOL SCI, V267, P485, DOI 10.1098/rspb.2000.1026; Kaspari M, 2001, GLOBAL ECOL BIOGEOGR, V10, P229, DOI 10.1046/j.1466-822X.2001.00214.x; Kaspari M, 2012, ECOGRAPHY, V35, P65, DOI 10.1111/j.1600-0587.2011.06971.x; Kaspari M, 2009, ECOLOGY, V90, P3342, DOI 10.1890/08-1795.1; Leith H., 1975, PRIMARY PRODUCTIVITY, DOI [10.1007/978-3-642-80913-2_12, DOI 10.1007/978-3-642-80913-2_12]; LEVINGS SC, 1984, BIOTROPICA, V16, P125, DOI 10.2307/2387844; LEVINGS SC, 1983, ECOL MONOGR, V53, P435, DOI 10.2307/1942647; Longino JT, 2012, ZOOTAXA, P1; Longino JT, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00200.1; Machac A, 2011, ECOGRAPHY, V34, P364, DOI 10.1111/j.1600-0587.2010.06629.x; McCain CM, 2007, GLOBAL ECOL BIOGEOGR, V16, P1, DOI 10.1111/j.1466-8238.2006.00263.x; McCain CM, 2010, GLOBAL ECOL BIOGEOGR, V19, P541, DOI 10.1111/j.1466-8238.2010.00528.x; McGlynn TP, 2009, BIOTROPICA, V41, P234, DOI 10.1111/j.1744-7429.2008.00465.x; *R COR DEV TEAM, 2012, R LANG ENV STAT COMP; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Sanders NJ, 2007, GLOBAL ECOL BIOGEOGR, V16, P640, DOI 10.1111/j.1466-8238.2007.00316.x	32	32	32	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e104030	10.1371/journal.pone.0104030	http://dx.doi.org/10.1371/journal.pone.0104030			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25098722	Green Published, gold, Green Submitted			2022-12-27	WOS:000339995100045
J	Marsicano, CA; Wilson, JA; Smith, RMH				Marsicano, Claudia A.; Wilson, Jeffrey A.; Smith, Roger M. H.			A Temnospondyl Trackway from the Early Mesozoic of Western Gondwana and Its Implications for Basal Tetrapod Locomotion	PLOS ONE			English	Article							TERRESTRIAL LOCOMOTION; ALLIGATOR-MISSISSIPPIENSIS; SOUTHERN AFRICA; TARICHA-TOROSA; EVOLUTION; LIMB; KINEMATICS; MECHANICS; WALKING; NEWT	Background: Temnospondyls are one of the earliest radiations of limbed vertebrates. Skeletal remains of more than 190 genera have been identified from late Paleozoic and early Mesozoic rocks. Paleozoic temnospondyls comprise mainly small to medium sized forms of diverse habits ranging from fully aquatic to fully terrestrial. Accordingly, their ichnological record includes tracks described from many Laurasian localities. Mesozoic temnospondyls, in contrast, include mostly medium to large aquatic or semi-aquatic forms. Exceedingly few fossil tracks or trackways have been attributed to Mesozoic temnospondyls, and as a consequence very little is known of their locomotor capabilities on land. Methodology/Principal Findings: We report a ca. 200 Ma trackway, Episcopopus ventrosus, from Lesotho, southern Africa that was made by a 3.5 m-long animal. This relatively long trackway records the trackmaker dragging its body along a wet substrate using only the tips of its digits, which in the manus left characteristic drag marks. Based on detailed mapping, casting, and laser scanning of the best-preserved part of the trackway, we identified synapomorphies (e.g., tetradactyl manus, pentadactyl pes) and symplesiomorphies (e.g., absence of claws) in the Episcopopus trackway that indicate a temnospondyl trackmaker. Conclusions/Significance: Our analysis shows that the Episcopopus trackmaker progressed with a sprawling posture, using a lateral-sequence walk. Its forelimbs were the major propulsive elements and there was little lateral bending of the trunk. We suggest this locomotor style, which differs dramatically from the hindlimb-driven locomotion of salamanders and other extant terrestrial tetrapods can be explained by the forwardly shifted center of mass resulting from the relatively large heads and heavily pectoral girdles of temnospondyls.	[Marsicano, Claudia A.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Ciencias Geol, Buenos Aires, DF, Argentina; [Wilson, Jeffrey A.] Univ Michigan, Museum Paleontol, Ann Arbor, MI 48109 USA; [Wilson, Jeffrey A.] Univ Michigan, Dept Earth & Environm Sci, Ann Arbor, MI 48109 USA; [Smith, Roger M. H.] Iziko South Africa Museum, Dept Karoo Paleontol, Cape Town, South Africa; [Smith, Roger M. H.] Univ Cape Town, Dept Geol Sci, ZA-7925 Cape Town, South Africa	University of Buenos Aires; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Cape Town	Marsicano, CA (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Ciencias Geol, Buenos Aires, DF, Argentina.	claumar@gl.fcen.uba.ar	Wilson, Jeffrey/C-2737-2008; Smith, Roger/AAF-7947-2019		Universidad de Buenos Aires Ciencia y Tecnica; Woodrow Wilson National Fellowship Foundation; Palaeontological Scientific Trust	Universidad de Buenos Aires Ciencia y Tecnica; Woodrow Wilson National Fellowship Foundation; Palaeontological Scientific Trust	This research was partially supported by grants Universidad de Buenos Aires Ciencia y Tecnica (to CAM), a Woodrow Wilson National Fellowship Foundation Career Enhancement Fellowship for Junior Faculty (to JAW), and Palaeontological Scientific Trust (to RMHS) which also supported our field work during 2005-2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen V, 2009, ANAT REC, V292, P1442, DOI 10.1002/ar.20973; [Anonymous], [No title captured]; [Anonymous], 1974, [No title captured]; Ashley-Ross MA, 2004, J EXP BIOL, V207, P461, DOI 10.1242/jeb.00769; Ashley-Ross MA, 2009, J EXP ZOOL PART A, V311A, P240, DOI 10.1002/jez.522; ASHLEYROSS MA, 1994, J EXP BIOL, V193, P255; BAIRD DONALD, 1952, JOUR PALEONTOL, V26, P832; Blob RW, 2001, J EXP BIOL, V204, P1099; Braddy SJ, 2003, PALAEONTOLOGY, V46, P671, DOI 10.1111/1475-4983.00315; Brand LR, 1996, J PALEONTOL, V70, P1004, DOI 10.1017/S0022336000038701; Carrano MT, 2001, PALEOBIOLOGY, V27, P564, DOI 10.1666/0094-8373(2001)027<0564:TDATTT>2.0.CO;2; Carroll RL., 2009, RISE AMPHIBIANS 365; Delvolve I, 1997, J NEUROPHYSIOL, V78, P638, DOI 10.1152/jn.1997.78.2.638; EDWARDS JL, 1989, AM ZOOL, V29, P235; Falcon-Lang HJ, 2010, PALAEOGEOGR PALAEOCL, V296, P1, DOI 10.1016/j.palaeo.2010.06.020; FROLICH LM, 1992, J EXP BIOL, V162, P107; FUGLEWICZ R, 1990, Acta Palaeontologica Polonica, V35, P109; Gray J, 1944, J EXP BIOL, V20, P88; HAUBOLD H, 1971, HDB PALAOHERPETOLOGI, V18, P1; Haubold H., 1971, PALAONTOLOGISCHE A A, V4, P395; Haubold H., 2005, PENNSYLVANIAN FOOTPR, P75; Horner AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096516; Hutchinson JR, 2000, PALEOBIOLOGY, V26, P734, DOI 10.1666/0094-8373(2000)026<0734:AAATEO>2.0.CO;2; Kawano SM, 2013, INTEGR COMP BIOL, V53, P283, DOI 10.1093/icb/ict051; King HM, 2011, P NATL ACAD SCI USA, V108, P21146, DOI 10.1073/pnas.1118669109; KITCHING J W, 1984, Palaeontologia Africana, V25, P111; Knoll F, 2005, B SOC GEOL FR, V176, P81, DOI 10.2113/176.1.81; Lehman J. P., 1971, Annls Paleont Vert, V57, P71; Lucas SG, 2010, ICHNOS, V17, P177, DOI 10.1080/10420940.2010.502492; Lucas Spencer G., 2009, Volumina Jurassica, V6, P99; Maddin HC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050743; Maddin HC, 2009, J ANAT, V214, P607, DOI 10.1111/j.1469-7580.2009.01052.x; Milan J, 2006, PALAEONTOLOGY, V49, P405, DOI 10.1111/j.1475-4983.2006.00543.x; Minter NJ, 2007, LETHAIA, V40, P365, DOI 10.1111/j.1502-3931.2007.00035.x; Noffke N, 2009, EARTH-SCI REV, V96, P173, DOI 10.1016/j.earscirev.2008.08.002; Olsen P.E., 1986, P321; OLSEN P E, 1984, Palaeontologia Africana, V25, P87; Pawley K, 2006, J PALEONTOL, V80, P561, DOI 10.1666/0022-3360(2006)80[561:TASOEM]2.0.CO;2; Peabody FE., 1948, B DEP GEOLOGICAL SCI, V27, P295; PEABODY FRANK, 1959, UNIV CALIFORNIA PUBL ZOOL, V63, P1; Pierce SE, 2013, INTEGR COMP BIOL, V53, P209, DOI 10.1093/icb/ict022; Pierce SE, 2012, NATURE, V486, P523, DOI 10.1038/nature11124; POHLING H, 1893, VERHANDLUNGEN NATURH, V50, P82; Porada H, 2008, PALAIOS, V23, P65, DOI 10.2110/palo.2006.p06-095r; Porchetti Simone D'Orazi, 2007, Ichnos, V14, P219, DOI 10.1080/10420940601049990; Prave AR, 2002, GEOLOGY, V30, P811, DOI 10.1130/0091-7613(2002)030<0811:LOLITP>2.0.CO;2; Ptaszynski T, 2004, ACTA PALAEONTOL POL, V49, P289; Reilly SM, 2006, P ROYAL SOC LONDON B; Requirand C, 2001, CATALOGUE PISTES STO; Ruta M, 2003, BIOL REV, V78, P251, DOI 10.1017/S1464793102006103; Ruta M, 2007, J SYST PALAEONTOL, V5, P69, DOI 10.1017/S1477201906002008; Sarjeant W, 1974, PALAEOGEOGR PALAEOCL, V23, P279; SCARBORO DD, 1995, PALAEOGEOGR PALAEOCL, V113, P335, DOI 10.1016/0031-0182(95)00068-W; Schaeffer B, 1941, B AM MUS NAT HIST, V48, P395; Schoch Rainer R., 1999, Stuttgarter Beitraege zur Naturkunde Serie B (Geologie und Palaeontologie), V278, P1; SCHOCH RR, 2000, STEREOSPONDYLI; Smith RMH, 2009, PALAIOS, V24, P672, DOI 10.2110/palo.2008.p08-115r; Spitz W., 1923, Palaeontologische Zeitschrift, V5, P380; TUREK V, 1989, PALAEONTOLOGY, V32, P623; Voigt S, 2011, GEOBIOS-LYON, V44, P399, DOI 10.1016/j.geobios.2010.11.008; WARREN AA, 1983, PHILOS T ROY SOC B, V303, P1, DOI 10.1098/rstb.1983.0080; Warren Anne, 2000, Amphibian Biology, V4, P1121; Warren Anne, 1999, Palaeontologia Africana, V35, P45; Watson D. M. S., 1958, Bulletin of the British Museum (Natural History) Geology, V3, P233; Welles S. P., 1965, University of California Publications in Geological Sciences, V54, P1; Willey JS, 2004, J EXP BIOL, V207, P553, DOI 10.1242/jeb.00774; Wilson JA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007331	67	18	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e103255	10.1371/journal.pone.0103255	http://dx.doi.org/10.1371/journal.pone.0103255			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25099971	Green Published, gold, Green Submitted			2022-12-27	WOS:000339995100016
J	Feretzaki, M; Hardison, SE; Wormley, FL; Heitman, J				Feretzaki, Marianna; Hardison, Sarah E.; Wormley, Floyd L., Jr.; Heitman, Joseph			Cryptococcus neoformans Hyperfilamentous Strain Is Hypervirulent in a Murine Model of Cryptococcal Meningoencephalitis	PLOS ONE			English	Article							MATING-TYPE; CANDIDA-ALBICANS; VAR. GRUBII; SEROTYPE-A; VIRULENCE; CAPSULE; ALPHA; GATTII; INFECTION; MICE	Cryptococcus neoformans is a human fungal pathogen that causes lethal infections of the lung and central nervous system in immunocompromised individuals. C. neoformans has a defined bipolar sexual life cycle with a and a mating types. During the sexual cycle, which can occur between cells of opposite mating types (bisexual reproduction) or cells of one mating type (unisexual reproduction), a dimorphic transition from yeast to hyphal growth occurs. Hyphal development and meiosis generate abundant spores that, following inhalation, penetrate deep into the lung to enter the alveoli, germinate, and establish a pulmonary infection growing as budding yeast cells. Unisexual reproduction has been directly observed only in the Cryptococcus var. neoformans (serotype D) lineage under laboratory conditions. However, hyphal development has been previously associated with reduced virulence and the serotype D lineage exhibits limited pathogenicity in the murine model. In this study we show that the serotype D hyperfilamentous strain XL280a is hypervirulent in an animal model. It can grow inside the lung of the host, establish a pulmonary infection, and then disseminate to the brain to cause cryptococcal meningoencephalitis. Surprisingly, this hyperfilamentous strain triggers an immune response polarized towards Th2-type immunity, which is usually observed in the highly virulent sibling species C. gattii, responsible for the Pacific Northwest outbreak. These studies provide a technological advance that will facilitate analysis of virulence genes and attributes in C. neoformans var. neoformans, and reveal the virulence potential of serotype D as broader and more dynamic than previously appreciated.	[Feretzaki, Marianna; Heitman, Joseph] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27708 USA; [Hardison, Sarah E.; Wormley, Floyd L., Jr.] Univ Texas San Antonio, Dept Biol, San Antonio, TX USA	Duke University; University of Texas System; University of Texas at San Antonio (UTSA)	Heitman, J (corresponding author), Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27708 USA.	heitm001@duke.edu	Hardison, Sarah E./AAC-7510-2019; Heitman, Joseph/ABC-6006-2021; Hardison, Sarah/ABB-1606-2021		Duke University Center for AIDS Research (CFAR) [National Institutes of Health (NIH)] [2P30 AI64518-07]; NIH/NIAID [AI50438-10, AI39115-16]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050438, P30AI064518, R37AI039115] Funding Source: NIH RePORTER	Duke University Center for AIDS Research (CFAR) [National Institutes of Health (NIH)]; NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the Duke University Center for AIDS Research (CFAR) [National Institutes of Health (NIH)-funded program (2P30 AI64518-07 to M.F.)] and NIH/NIAID R01 grant AI50438-10 and R37 MERIT award AI39115-16 to J.H. The funders had no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript.	Barchiesi F, 2005, J INFECTION, V51, P10, DOI 10.1016/j.jinf.2004.07.013; Bartlett Karen H, 2008, Curr Infect Dis Rep, V10, P58, DOI 10.1007/s11908-008-0011-1; Bartlett KH, 2012, MYCOPATHOLOGIA, V173, P311, DOI 10.1007/s11046-011-9475-x; Beenhouwer DO, 2001, INFECT IMMUN, V69, P6445, DOI 10.1128/IAI.69.10.6445-6455.2001; Botts MR, 2009, EUKARYOT CELL, V8, P595, DOI 10.1128/EC.00352-08; Bui T, 2008, EUKARYOT CELL, V7, P1771, DOI 10.1128/EC.00097-08; Byrnes EJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000850; Byrnes EJ, 2009, J INFECT DIS, V199, P1081, DOI 10.1086/597306; CHANG YC, 1994, MOL CELL BIOL, V14, P4912, DOI 10.1128/MCB.14.7.4912; Chang YC, 2001, P NATL ACAD SCI USA, V98, P3258, DOI 10.1073/pnas.061031998; Charlier C, 2005, AM J PATHOL, V166, P421, DOI 10.1016/S0002-9440(10)62265-1; Chen GH, 2008, INFECT IMMUN, V76, P2379, DOI 10.1128/IAI.01143-07; Chen S, 2000, CLIN INFECT DIS, V31, P499, DOI 10.1086/313992; Cheng PY, 2009, INFECT IMMUN, V77, P4284, DOI 10.1128/IAI.00628-09; Cherniak R, 1998, CLIN DIAGN LAB IMMUN, V5, P146; Chowdhary A, 2011, ENVIRON MICROBIOL, V13, P1875, DOI 10.1111/j.1462-2920.2011.02510.x; Clarke DL, 2001, MOL MICROBIOL, V40, P200, DOI 10.1046/j.1365-2958.2001.02375.x; Crabtree JN, 2012, INFECT IMMUN, V80, P3776, DOI 10.1128/IAI.00507-12; Dalle F, 2010, CELL MICROBIOL, V12, P248, DOI 10.1111/j.1462-5822.2009.01394.x; Davidson RC, 2003, MOL MICROBIOL, V49, P469, DOI 10.1046/j.1365-2958.2003.03563.x; DONG ZM, 1995, INFECT IMMUN, V63, P2632, DOI 10.1128/IAI.63.7.2632-2644.1995; Feretzaki M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003688; Gazzoni AF, 2010, REV INST MED TROP SP, V52, P145, DOI 10.1590/S0036-46652010000300006; Fraser JA, 2005, NATURE, V437, P1360, DOI 10.1038/nature04220; FREED ER, 1971, AM J CLIN PATHOL, V55, P30; FROMTLING RA, 1979, MYCOPATHOLOGIA, V68, P179, DOI 10.1007/BF00578527; FROMTLING RA, 1979, INFECT IMMUN, V24, P449, DOI 10.1128/IAI.24.2.449-453.1979; Galanis E, 2010, EMERG INFECT DIS, V16, P251, DOI [10.3201/eid1602.090900, 10.3201/eid1601.090900]; Garcia-Hermoso D, 2004, INFECT IMMUN, V72, P3359, DOI 10.1128/IAI.72.6.3359-3365.2004; Giles SS, 2009, INFECT IMMUN, V77, P3491, DOI 10.1128/IAI.00334-09; Gomez BL, 2003, CURR OPIN INFECT DIS, V16, P91, DOI 10.1097/00001432-200304000-00005; Guillot L, 2008, INFECT IMMUN, V76, P4745, DOI 10.1128/IAI.00341-08; Hardison SE, 2010, AM J PATHOL, V176, P774, DOI 10.2353/ajpath.2010.090634; Heitman J, 2011, CRYPTOCOCCUS: FROM HUMAN PATHOGEN TO MODEL YEAST, P1; Heitman J, 1999, FUNGAL GENET BIOL, V28, P1, DOI 10.1006/fgbi.1999.1155; Hiremath SS, 2008, MICROBIOL-SGM, V154, P1513, DOI 10.1099/mic.0.2007/015594-0; Huffnagle GB, 1998, J IMMUNOL, V160, P2393; Huffnagle GB, 1998, RES IMMUNOL, V149, P387, DOI 10.1016/S0923-2494(98)80762-1; Huffnagle GB, 1998, RES IMMUNOL, V149, P512; Idnurm A, 2005, NAT REV MICROBIOL, V3, P753, DOI 10.1038/nrmicro1245; Imwidthaya P, 2000, POSTGRAD MED J, V76, P85, DOI 10.1136/pmj.76.892.85; Jain AV, 2009, INFECT IMMUN, V77, P5389, DOI 10.1128/IAI.00809-09; Koguchi Yoshinobu, 2002, Int Rev Immunol, V21, P423, DOI 10.1080/08830180213274; KOZEL TR, 1995, TRENDS MICROBIOL, V3, P295, DOI 10.1016/S0966-842X(00)88957-X; KWONCHUNG KJ, 1992, INFECT IMMUN, V60, P602, DOI 10.1128/IAI.60.2.602-605.1992; Lee SC, 2012, EUKARYOT CELL, V11, P1391, DOI 10.1128/EC.00242-12; Lin XR, 2008, INFECT IMMUN, V76, P2923, DOI 10.1128/IAI.00168-08; Lin X, 2007, PLOS GENET, V3, P1975, DOI 10.1371/journal.pgen.0030186; Lin XR, 2006, PLOS GENET, V2, P1801, DOI 10.1371/journal.pgen.0020187; Lin XR, 2006, ANNU REV MICROBIOL, V60, P69, DOI 10.1146/annurev.micro.60.080805.142102; Lin XR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000953; Lin XR, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000283; Lin XR, 2005, NATURE, V434, P1017, DOI 10.1038/nature03448; Litvintseva AP, 2006, GENETICS, V172, P2223, DOI 10.1534/genetics.105.046672; Lo HJ, 1997, CELL, V90, P939, DOI 10.1016/S0092-8674(00)80358-X; Loftus BJ, 2005, SCIENCE, V307, P1321, DOI 10.1126/science.1103773; Lorenz MC, 2004, EUKARYOT CELL, V3, P1076, DOI 10.1128/EC.3.5.1076-1087.2004; Magditch DA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002936; McFadden DC, 2006, J BIOL CHEM, V281, P1868, DOI 10.1074/jbc.M509465200; Moyrand F, 2004, EUKARYOT CELL, V3, P1513, DOI 10.1128/EC.3.6.1513-1524.2004; NEILSON JB, 1978, INFECT IMMUN, V20, P262, DOI 10.1128/IAI.20.1.262-266.1978; Ngamskulrungroj Popchai, 2012, mBio, V3, DOI 10.1128/mBio.00103-12; Ni M, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001653; Nielsen K, 2005, GENETICS, V171, P975, DOI 10.1534/genetics.105.045039; Nielsen K, 2005, INFECT IMMUN, V73, P4922, DOI 10.1128/IAI.73.8.4922-4933.2005; Nielsen K, 2003, INFECT IMMUN, V71, P4831, DOI 10.1128/IAI.71.9.4831-4841.2003; Nielsen K, 2007, EUKARYOT CELL, V6, P949, DOI 10.1128/EC.00097-07; Noverr MC, 2003, INFECT IMMUN, V71, P1538, DOI 10.1128/IAI.71.3.1538-1547.2003; O'Meara TR, 2010, EUKARYOT CELL, V9, P1193, DOI 10.1128/EC.00098-10; Okagaki LH, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000953; Ren P, 2006, EUKARYOT CELL, V5, P1065, DOI 10.1128/EC.00009-06; Saul N, 2008, EUKARYOT CELL, V7, P727, DOI 10.1128/EC.00020-08; Shen G, 2008, EUKARYOT CELL, V7, P1540, DOI 10.1128/EC.00154-08; Sudbery PE, 2011, NAT REV MICROBIOL, V9, P737, DOI 10.1038/nrmicro2636; TODD RAMONA L., 1936, JOUR BACT, V32, P89; Tucker SC, 2002, P NATL ACAD SCI USA, V99, P3165, DOI 10.1073/pnas.052702799; Vecchiarelli A, 2003, J LEUKOCYTE BIOL, V74, P370, DOI 10.1189/jlb.1002476; Velagapudi R, 2009, INFECT IMMUN, V77, P4345, DOI 10.1128/IAI.00542-09; Wang LQ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002765; Wang P, 2004, EUKARYOT CELL, V3, P1028, DOI 10.1128/EC.3.4.1028-1035.2004; WANG YL, 1995, INFECT IMMUN, V63, P3131, DOI 10.1128/IAI.63.8.3131-3136.1995; Wickes BL, 1996, P NATL ACAD SCI USA, V93, P7327, DOI 10.1073/pnas.93.14.7327; Williams KL, 2011, CRYPTOCOCCUS: FROM HUMAN PATHOGEN TO MODEL YEAST, P451; Williamson JD, 1996, ACTA CYTOL, V40, P363, DOI 10.1159/000333769; Wright L, 2002, MICROBES INFECT, V4, P1427, DOI 10.1016/S1286-4579(02)00024-2; Xu JP, 2000, MOL ECOL, V9, P1471, DOI 10.1046/j.1365-294x.2000.01021.x; Zaragoza O, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000945; Zhai B, 2013, INFECT IMMUN, V81, P2626, DOI 10.1128/IAI.00259-13; Zhu WD, 2010, CELL MICROBIOL, V12, P273, DOI 10.1111/j.1462-5822.2009.01412.x	89	12	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e104432	10.1371/journal.pone.0104432	http://dx.doi.org/10.1371/journal.pone.0104432			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093333	Green Published, Green Submitted, gold			2022-12-27	WOS:000341357200111
J	Konrath, S; Meier, BP; Bushman, BJ				Konrath, Sara; Meier, Brian P.; Bushman, Brad J.			Development and Validation of the Single Item Narcissism Scale (SINS)	PLOS ONE			English	Article							SELF-ESTEEM; PERSONALITY-INVENTORY; PATHOLOGICAL NARCISSISM; THREATENED EGOTISM; AGGRESSION; RELIABILITY; DEPRESSION; VALIDITY; VIOLENCE; EMPATHY	Main Objectives: The narcissistic personality is characterized by grandiosity, entitlement, and low empathy. This paper describes the development and validation of the Single Item Narcissism Scale (SINS). Although the use of longer instruments is superior in most circumstances, we recommend the SINS in some circumstances (e. g. under serious time constraints, online studies). Methods: In 11 independent studies (total N = 2,250), we demonstrate the SINS' psychometric properties. Results: The SINS is significantly correlated with longer narcissism scales, but uncorrelated with self-esteem. It also has high test-retest reliability. We validate the SINS in a variety of samples (e. g., undergraduates, nationally representative adults), intrapersonal correlates (e. g., positive affect, depression), and interpersonal correlates (e. g., aggression, relationship quality, prosocial behavior). The SINS taps into the more fragile and less desirable components of narcissism. Significance: The SINS can be a useful tool for researchers, especially when it is important to measure narcissism with constraints preventing the use of longer measures.	[Konrath, Sara] Indiana Univ Purdue Univ, Lilly Family Sch Philanthropy, Indianapolis, IN 46202 USA; [Konrath, Sara] Univ Michigan, Inst Social Res, Ann Arbor, MI USA; [Konrath, Sara] Univ Rochester, Sch Med, Dept Psychiat, Rochester, NY USA; [Meier, Brian P.] Gettysburg Coll, Dept Psychol, Gettysburg, PA 17325 USA; [Bushman, Brad J.] Ohio State Univ, Sch Commun, Columbus, OH 43210 USA; [Bushman, Brad J.] Ohio State Univ, Dept Psychol, Columbus, OH 43210 USA; [Bushman, Brad J.] Vrije Univ Amsterdam, Amsterdam, Netherlands	Indiana University System; Indiana University-Purdue University Indianapolis; University of Michigan System; University of Michigan; University of Rochester; Gettysburg College; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Vrije Universiteit Amsterdam	Konrath, S (corresponding author), Indiana Univ Purdue Univ, Lilly Family Sch Philanthropy, Indianapolis, IN 46202 USA.	skonrath@iupui.edu	Bushman, Brad/AAN-6427-2021; Bushman, Brad/ABG-3412-2021	Bushman, Brad/0000-0002-1266-5101; Konrath, Sara/0000-0001-9182-0095	John Templeton Foundation, via Character Project (Wake Forest University); John Templeton Foundation [47993]	John Templeton Foundation, via Character Project (Wake Forest University); John Templeton Foundation	Sara Konrath was supported by two grants from the John Templeton Foundation while writing this manuscript, via the Character Project (Wake Forest University) and directly from the sponsor (Grant # 47993). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altemeyer B, 1989, ENEMIES FREEDOM UNDE; Ames DR, 2006, J RES PERS, V40, P440, DOI 10.1016/j.jrp.2005.03.002; APA, 1980, DIAGN STAT MAN MENT, DOI [10.1176/appi.books.9780890423349, DOI 10.1176/APPI.BOOKS.9780890423349]; Arble E. P., 2008, THESIS, P236; AUERBACH JS, 1984, J PERS ASSESS, V48, P649, DOI 10.1207/s15327752jpa4806_13; Baumeister RF, 1996, PSYCHOL REV, V103, P5, DOI 10.1037/0033-295X.103.1.5; Baumeister RF, 2000, CURR DIR PSYCHOL SCI, V9, P26, DOI 10.1111/1467-8721.00053; BECK AT, 1988, CLIN PSYCHOL REV, V8, P77, DOI 10.1016/0272-7358(88)90050-5; Borenstein M., 2009, INTRO METAANALYSIS; Brubaker R, 2017, ETHNIC RACIAL STUD, V40, P1191, DOI 10.1080/01419870.2017.1294700; Bushman B, 2014, PARTNER REJ IN PRESS; Bushman BJ, 2003, J PERS SOC PSYCHOL, V84, P1027, DOI 10.1037/0022-3514.84.5.1027; Bushman BJ, 1998, J PERS SOC PSYCHOL, V75, P219, DOI 10.1037/0022-3514.75.1.219; Bushman BJ, 2012, J PERS, V80, P1453, DOI 10.1111/j.1467-6494.2012.00781.x; Bushman BJ, 2011, J PERS, V79, P993, DOI 10.1111/j.1467-6494.2011.00712.x; Campbell WK, 2005, PERS SOC PSYCHOL B, V31, P1358, DOI 10.1177/0146167205274855; Campbell WK, 2002, PERS SOC PSYCHOL B, V28, P358, DOI 10.1177/0146167202286007; Campbell WK, 2004, J PERS ASSESS, V83, P29, DOI 10.1207/s15327752jpa8301_04; Campbell WK, 2004, J BEHAV DECIS MAKING, V17, P297, DOI 10.1002/bdm.475; Campbell WK, 1999, J PERS SOC PSYCHOL, V77, P1254, DOI 10.1037/0022-3514.77.6.1254; Campbell WK, 2002, J PERS SOC PSYCHOL, V83, P340, DOI [10.1037/0022-3514.83.2.340, 10.1037//0022-3514.83.2.340]; Carlson EN, 2013, SELF IDENTITY, V12, P259, DOI 10.1080/15298868.2012.659427; Corbitt EM, 2002, PERSONALITY DISORDER; Davey HM, 2007, J CLIN EPIDEMIOL, V60, P356, DOI 10.1016/j.jclinepi.2006.07.015; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; del Rosario PM, 2005, PERS INDIV DIFFER, V39, P1075, DOI 10.1016/j.paid.2005.08.001; Department for Education, 2010, IMP TEACH SCH WHIT P; EMMONS RA, 1987, J PERS SOC PSYCHOL, V52, P11, DOI 10.1037/0022-3514.52.1.11; EXNER JE, 1973, J PERS ASSESS, V37, P437, DOI 10.1080/00223891.1973.10119902; Foster JE, 2003, ECON THEOR, V22, P469, DOI 10.1007/s00199-002-0339-y; Foster JD, 2006, J SOC PERS RELAT, V23, P367, DOI 10.1177/0265407506064204; GIANCOLA PR, 1995, AGGRESSIVE BEHAV, V21, P199, DOI 10.1002/1098-2337(1995)21:3<199::AID-AB2480210303>3.0.CO;2-Q; Glover N, 2012, J PERS ASSESS, V94, P500, DOI 10.1080/00223891.2012.670680; Goldberg L.R., 1999, PERSONALITY PSYCHOL, V7, P7, DOI DOI 10.1016/J.JRP.2014.05.003; Goldstein RZ, 2010, J PSYCHOPHARMACOL, V24, P257, DOI 10.1177/0269881108096982; Grayden C, 1958, RELATIONSHIP NEUROTI; GUNDERSON JG, 1990, ARCH GEN PSYCHIAT, V47, P676; HARDER DW, 1979, J PERS ASSESS, V43, P23, DOI 10.1207/s15327752jpa4301_3; Hendin HM, 1997, J RES PERS, V31, P588, DOI 10.1006/jrpe.1997.2204; Horvath S, 2009, J EXP SOC PSYCHOL, V45, P1252, DOI 10.1016/j.jesp.2009.07.011; Jonason PK, 2010, PSYCHOL ASSESSMENT, V22, P420, DOI 10.1037/a0019265; KALICHMAN SC, 1995, J PERS ASSESS, V65, P586, DOI 10.1207/s15327752jpa6503_16; KERNIS MH, 1994, J RES PERS, V28, P4, DOI 10.1006/jrpe.1994.1002; Konrath S, 2006, PSYCHOL SCI, V17, P995, DOI 10.1111/j.1467-9280.2006.01818.x; Konrath S, 2009, J PERS, V77, P1197, DOI 10.1111/j.1467-6494.2009.00579.x; Kubarych TS, 2004, PERS INDIV DIFFER, V36, P857, DOI 10.1016/S0191-8869(03)00158-2; Leary M. R., 2007, INDIVIDUAL DIF UNPUB; Locke KD, 2009, J RES PERS, V43, P99, DOI 10.1016/j.jrp.2008.10.003; Morf CC, 2001, PSYCHOL INQ, V12, P177, DOI 10.1207/S15327965PLI1204_1; Nichols AL, 2013, PERSONALITY IN PRESS; Nunnally JC, 1994, PSYCHOMETRIC THEORY, V3rd, DOI DOI 10.1037/018882; Pincus AL, 2010, ANNU REV CLIN PSYCHO, V6, P421, DOI 10.1146/annurev.clinpsy.121208.131215; Pincus AL, 2009, PSYCHOL ASSESSMENT, V21, P365, DOI 10.1037/a0016530; Pond R, 2014, COMMUNICATION; RASKIN R, 1988, J PERS SOC PSYCHOL, V54, P890, DOI 10.1037/0022-3514.54.5.890; RASKIN R, 1981, J PERS ASSESS, V45, P159, DOI 10.1207/s15327752jpa4502_10; RASKIN R, 1988, J PERS, V56, P393, DOI 10.1111/j.1467-6494.1988.tb00892.x; RASKIN R, 1989, J PERS ASSESS, V53, P66, DOI 10.1207/s15327752jpa5301_8; RASKIN RN, 1980, PSYCHOL REP, V46, P55, DOI 10.2466/pr0.1980.46.1.55; Reed-Knight B., 2011, HDB NARCISSISM NARCI, Patent No. 020405; Rhodewalt F, 1998, PERS SOC PSYCHOL B, V24, P75, DOI 10.1177/0146167298241006; Robins RW, 2001, PERS SOC PSYCHOL B, V27, P151, DOI 10.1177/0146167201272002; Rose P, 2002, PERS INDIV DIFFER, V33, P379, DOI 10.1016/S0191-8869(01)00162-3; Rosenberg M., 1965, SOC ADOLESCENT SELF, DOI 10.1515/9781400876136; Sedikides C, 2004, J PERS SOC PSYCHOL, V87, P400, DOI 10.1037/0022-3514.87.3.400; SINGELIS TM, 1994, PERS SOC PSYCHOL B, V20, P580, DOI 10.1177/0146167294205014; Spector PE, 1992, SUMMATED RATING SCAL; Spielberger C. D., 1973, MANUAL STATE TRAIT I; STRAHAN R, 1972, J CLIN PSYCHOL, V28, P191, DOI 10.1002/1097-4679(197204)28:2<191::AID-JCLP2270280220>3.0.CO;2-G; TAYLOR SP, 1967, J PERS, V35, P297, DOI 10.1111/j.1467-6494.1967.tb01430.x; Triandis HC, 1995, INDIVIDUALISM COLLEC; Trull T, 2002, PERSONALITY DISORDER; Twenge JM, 2008, J PERS, V76, P875, DOI 10.1111/j.1467-6494.2008.00507.x; URIST J, 1977, J PERS ASSESS, V41, P3, DOI 10.1207/s15327752jpa4101_1; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; WATSON PJ, 1984, J PERS ASSESS, V48, P301, DOI 10.1207/s15327752jpa4803_12; WATSON PJ, 1988, PSYCHOTHER, V25, P125, DOI 10.1037/h0085308; WINK P, 1990, J PERS ASSESS, V54, P446, DOI 10.1207/s15327752jpa5403&4_2; WINK P, 1992, J PERS, V60, P7, DOI 10.1111/j.1467-6494.1992.tb00263.x; Wright AGC, 2010, ASSESSMENT, V17, P467, DOI 10.1177/1073191110373227	80	103	104	3	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e103469	10.1371/journal.pone.0103469	http://dx.doi.org/10.1371/journal.pone.0103469			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO5BW	25093508	Green Published, gold			2022-12-27	WOS:000341357200023
J	Tsugama, D; Liu, SK; Takano, T				Tsugama, Daisuke; Liu, Shenkui; Takano, Tetsuo			Analysis of Functions of VIP1 and Its Close Homologs in Osmosensory Responses of Arabidopsis thaliana	PLOS ONE			English	Article							BZIP TRANSCRIPTIONAL ACTIVATOR; REPRESSION OFSHOOT GROWTH; ABSCISIC-ACID; MOLECULAR CHARACTERIZATION; PROTEIN PHOSPHATASE; EXPRESSION PROFILES; HISTIDINE KINASE; GENE-EXPRESSION; DROUGHT; TRANSFORMATION	VIP1 is a bZIP protein in Arabidopsis thaliana. VIP1 accumulates in the nucleus under hypo-osmotic conditions and interacts with the promoters of hypo-osmolarity-responsive genes, CYP707A1 and CYP707A3 (CYP707A1/3), but neither overexpression of VIP1 nor truncation of its DNA-binding region affects the expression of CYP707A3 in vivo, raising the possibility that VIP and other proteins are functionally redundant. Here we show further analyses on VIP1 and its close homologs, namely, Arabidopsis group I bZIP proteins. The patterns of the signals of the GFP-fused group I bZIP proteins were similar in onion and Arabidopsis cells, suggesting that they have similar subcellular localization. In a yeast one-hybrid assay, the group I bZIP proteins caused reporter gene activation in the yeast reporter strain. VIP1 and other group I bZIP proteins showed positive results in a yeast two-hybrid assay and a bimolecular fluorescence complementation assay, suggesting that they physically interact. These results support the idea that they have somewhat similar functions. By gel shift assays, VIP1-binding sequences in the CYP707A1/3 promoters were confirmed to be AGCTGT/G. Their presence in the promoters of the genes that respond to hypo-osmotic conditions was evaluated using previously published microarray data. Interestingly, a significantly higher proportion of the promoters of the genes that were up-regulated by rehydration treatment and/or submergence treatment (treatment by a hypotonic solution) and a significantly lower proportion of the promoters of the genes that were down-regulated by such treatment shared AGCTGT/G. To further assess the physiological role of VIP1, constitutively nuclear-localized variants of VIP1 were generated. When overexpressed in Arabidopsis, some of them as well as VIP1 caused growth retardation under a mannitol-stressed condition, where VIP1 is localized mainly in the cytoplasm. This raises the possibility that the expression of VIP1 itself rather than its nuclear localization is responsible for regulating the mannitol responses.	[Tsugama, Daisuke; Takano, Tetsuo] Univ Tokyo, ANESC, Nishi Tokyo, Tokyo, Japan; [Tsugama, Daisuke] Univ Tokyo, Plant Mol Genet Lab, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo, Japan; [Liu, Shenkui] Northeast Forestry Univ, ASNESC, Harbin, Peoples R China	University of Tokyo; University of Tokyo; Northeast Forestry University - China	Takano, T (corresponding author), Univ Tokyo, ANESC, Nishi Tokyo, Tokyo, Japan.	takano@anesc.u-tokyo.ac.jp	Tsugama, Daisuke/N-6054-2014; Liu, Shenkui/AAC-5405-2019	Tsugama, Daisuke/0000-0002-4946-678X; Liu, Shenkui/0000-0001-5294-4765	JSPS [22-2144, 25-7247]	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by JSPS Grant-in-aid for Scientific Research (22-2144 and 25-7247) to DT. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso R, 2009, PLANT CELL, V21, P1747, DOI 10.1105/tpc.108.062968; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Chang-Qing Z, 2008, BMB REP, V41, P448, DOI 10.5483/BMBRep.2008.41.6.448; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Dai SH, 2004, P NATL ACAD SCI USA, V101, P687, DOI 10.1073/pnas.0307687100; Dai SH, 2003, J BIOL CHEM, V278, P36396, DOI 10.1074/jbc.M304862200; Deppmann CD, 2004, NUCLEIC ACIDS RES, V32, P3435, DOI 10.1093/nar/gkh653; Djamei A, 2007, SCIENCE, V318, P453, DOI 10.1126/science.1148110; Fukazawa J, 2000, PLANT CELL, V12, P901, DOI 10.1105/tpc.12.6.901; Fukazawa J, 2010, PLANT J, V62, P1035, DOI 10.1111/j.1365-313X.2010.04215.x; Furihata T, 2006, P NATL ACAD SCI USA, V103, P1988, DOI 10.1073/pnas.0505667103; Hsu FC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028888; Igarashi D, 2001, PLANT CELL, V13, P2483, DOI 10.1105/tpc.13.11.2483; Ishida S, 2004, PLANT CELL, V16, P2641, DOI 10.1105/tpc.104.024604; Iuchi S, 2001, PLANT J, V27, P325, DOI 10.1046/j.1365-313x.2001.01096.x; Jakoby M, 2002, TRENDS PLANT SCI, V7, P106, DOI 10.1016/S1360-1385(01)02223-3; Kumar MN, 2013, PLANT PHYSIOL, V161, P942, DOI 10.1104/pp.112.209791; Kushiro T, 2004, EMBO J, V23, P1647, DOI 10.1038/sj.emboj.7600121; Lee SC, 2011, NEW PHYTOL, V190, P457, DOI 10.1111/j.1469-8137.2010.03590.x; Li JX, 2005, P NATL ACAD SCI USA, V102, P5733, DOI 10.1073/pnas.0404118102; Moes D, 2008, PLANT J, V54, P806, DOI 10.1111/j.1365-313X.2008.03454.x; Narusaka M, 2006, PLANT BIOTECHNOL-NAR, V23, P321, DOI DOI 10.5511/plantbiotechnology.23.321; O'Rourke SM, 2002, TRENDS GENET, V18, P405, DOI 10.1016/S0168-9525(02)02723-3; Okamoto M, 2009, PLANT PHYSIOL, V149, P825, DOI 10.1104/pp.108.130823; Oono Y, 2003, PLANT J, V34, P868, DOI 10.1046/j.1365-313X.2003.01774.x; Pitzschke A, 2009, P NATL ACAD SCI USA, V106, P18414, DOI 10.1073/pnas.0905599106; Ringli C, 1998, PLANT MOL BIOL, V37, P977, DOI 10.1023/A:1006030007333; Seki M, 2002, SCIENCE, V296, P141, DOI 10.1126/science.1071006; Seki M, 2002, PLANT J, V31, P279, DOI 10.1046/j.1365-313X.2002.01359.x; Tan BC, 2003, PLANT J, V35, P44, DOI 10.1046/j.1365-313X.2003.01786.x; TorresSchumann S, 1996, PLANT J, V9, P283, DOI 10.1046/j.1365-313X.1996.09030283.x; Tran LSP, 2007, P NATL ACAD SCI USA, V104, P20623, DOI 10.1073/pnas.0706547105; Tsugama D, 2012, BIOCHEM BIOPH RES CO, V426, P626, DOI 10.1016/j.bbrc.2012.08.141; Tsugama D, 2012, PLANT PHYSIOL, V159, P144, DOI 10.1104/pp.112.197020; Tsugama D, 2012, FEBS LETT, V586, P693, DOI 10.1016/j.febslet.2012.02.019; Tzfira T, 2001, EMBO J, V20, P3596, DOI 10.1093/emboj/20.13.3596; Tzfira T, 2002, P NATL ACAD SCI USA, V99, P10435, DOI 10.1073/pnas.162304099; Umezawa T, 2006, PLANT J, V46, P171, DOI 10.1111/j.1365-313X.2006.02683.X; Urao T, 1999, PLANT CELL, V11, P1743, DOI 10.1105/tpc.11.9.1743; Wohlbach DJ, 2008, PLANT CELL, V20, P1101, DOI 10.1105/tpc.107.055871; Wu Y, 2010, J EXP BOT, V61, P3407, DOI 10.1093/jxb/erq161; Xue Y, 2008, MOL CELL PROTEOMICS, V7, P1598, DOI 10.1074/mcp.M700574-MCP200; Yamaji N, 2009, PLANT CELL, V21, P3339, DOI 10.1105/tpc.109.070771; Yin YH, 1997, EMBO J, V16, P5247, DOI 10.1093/emboj/16.17.5247	45	34	36	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e103930	10.1371/journal.pone.0103930	http://dx.doi.org/10.1371/journal.pone.0103930			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093810	Green Published, Green Submitted, gold			2022-12-27	WOS:000341357200045
J	Yang, M; Xu, YY; Liang, L; Fu, JF; Xiong, F; Liu, GL; Gong, CX; Luo, FH; Chen, SK; Xu, CX; Zhang, DD; Li, ZL; Zhang, S; Zhang, Y; Wang, H; Zhu, YM				Yang, Min; Xu, Yuyang; Liang, Li; Fu, Junfen; Xiong, Feng; Liu, Geli; Gong, Chunxiu; Luo, Feihong; Chen, Shaoke; Xu, Chunxiao; Zhang, Dandan; Li, Zhengli; Zhang, Shuai; Zhang, Yan; Wang, Hao; Zhu, Yimin			The Effects of Genetic Variation in FTO rs9939609 on Obesity and Dietary Preferences in Chinese Han Children and Adolescents	PLOS ONE			English	Article							BODY-MASS INDEX; EAST-ASIAN POPULATIONS; FAT MASS; METABOLIC SYNDROME; VARIANT RS9939609; CHILDHOOD OBESITY; ENERGY-INTAKE; DEVELOPING-COUNTRIES; JAPANESE POPULATION; TASTE PREFERENCES	The association of the rs9939609 single nucleotide polymorphism in FTO gene with obesity has been extensively investigated in studies of populations of European, African, and Asian ancestry. However, inconsistent results have been reported in Asian populations, and the relationship of FTO variation and dietary behaviors has only rarely been examined in Chinese children and adolescents. The aim of this study was to assess the association of rs9939609 with obesity and dietary preferences in childhood in a Chinese population. Epidemiological data including dietary preferences were collected in interviews using survey questionnaires, and rs9939609 genotype was determined by real-time PCR. The associations of rs9939609 genotypes with obesity and dietary preferences were analyzed by multivariate logistic regression using both additive and dominant models. The results showed that subjects with a TA or AA genotype had an increased risk of obesity compared with the TT participants; the odds ratios (ORs) were 1.47 (95% CI: 1.25-1.71, P = 1.73x10(-6)), and 3.32 (95% CI: 2.01-5.47, P = 2.68x10(-6)), respectively. After adjusting for age and gender, body mass index, waist circumference, hip circumference, systolic blood pressure, diastolic blood pressure, fasting blood glucose, triglycerides, and low-density lipoprotein cholesterol were higher, and high-density lipoprotein cholesterol was lower in TA and AA participants than in those with the TT genotype. After additionally controlling for body mass index, the association remained significant only for systolic blood pressure (P = 0.005). Compared with TT participants, those with the AA genotype were more likely to prefer a meat-based diet (OR = 2.81, 95% CI: 1.52-5.21). The combined OR for obesity in participants with TA/AA genotypes and preference for a meat-based diet was 4.04 (95% CI: 2.8-5.81) compared with the TT participants who preferred a plant-based diet. These findings indicate the genetic variation of rs9939609 is associated with obesity and dietary preferences in Chinese children and adolescents.	[Yang, Min] Zhejiang Univ, Sch Publ Hlth, Dept Nutr, Hangzhou 310003, Zhejiang, Peoples R China; [Xu, Yuyang; Xu, Chunxiao; Zhang, Dandan; Li, Zhengli; Zhang, Shuai; Zhang, Yan; Zhu, Yimin] Zhejiang Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Hangzhou 310003, Zhejiang, Peoples R China; [Xu, Yuyang] Hangzhou Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China; [Liang, Li] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Pediat, Hangzhou 310003, Zhejiang, Peoples R China; [Fu, Junfen] Zhejiang Univ, Coll Med, Childrens Hosp, Dept Endocrinol, Hangzhou 310003, Zhejiang, Peoples R China; [Xiong, Feng] Chongqing Med Univ, Childrens Hosp, Dept Endocrinol, Chongqing, Peoples R China; [Liu, Geli] Tianjin Med Univ, Gen Hosp, Dept Pediat, Tianjin, Peoples R China; [Gong, Chunxiu] Capital Med Univ, Beijing Childrens Hosp, Beijing, Peoples R China; [Luo, Feihong] Fudan Univ, Childrens Hosp, Dept Pediat Endocrinol & Inborn Metab Dis, Shanghai 200433, Peoples R China; [Chen, Shaoke; Wang, Hao] Maternal & Child Hlth Hosp Guangxi Zhuang Autonom, Dept Pediat Endocrinol, Nanning, Peoples R China; [Zhu, Yimin] Zhejiang Univ, Sch Med, Dept Pathol, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University; Zhejiang University; Chongqing Medical University; Tianjin Medical University; Capital Medical University; Fudan University; Zhejiang University	Zhu, YM (corresponding author), Zhejiang Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Hangzhou 310003, Zhejiang, Peoples R China.	zhuym@zju.edu.cn	Zhu, Yimin/D-6387-2017	Zhu, Yimin/0000-0001-8409-7636; Luo, Feihong/0000-0002-6433-7994	National Key Technology R&D Program of China [2012BAI02B03, 2009BAI80B02]; Zhejiang Provincial Program for the Cultivation of High-Level Innovative Health Talents; Fundamental Research Funds for the Central Universities; Program for Zhejiang Leading Team of Science and Technology Innovation	National Key Technology R&D Program of China(National Key Technology R&D Program); Zhejiang Provincial Program for the Cultivation of High-Level Innovative Health Talents; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Program for Zhejiang Leading Team of Science and Technology Innovation	This study has been supported by National Key Technology R&D Program of China (2012BAI02B03, 2009BAI80B02), Zhejiang Provincial Program for the Cultivation of High-Level Innovative Health Talents, Fundamental Research Funds for the Central Universities and Program for Zhejiang Leading Team of Science and Technology Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baik I, 2012, NUTR RES PRACT, V6, P78, DOI 10.4162/nrp.2012.6.1.78; Bradford NF, 2009, PRIMARY CARE, V36, P319, DOI 10.1016/j.pop.2009.01.002; Cecil JE, 2008, NEW ENGL J MED, V359, P2558, DOI 10.1056/NEJMoa0803839; Cha SW, 2008, OBESITY, V16, P2185, DOI 10.1038/oby.2008.314; Chang YC, 2008, DIABETES, V57, P2245, DOI 10.2337/db08-0377; Cheung Man-Ka Marcella, 2011, Front Endocrinol (Lausanne), V2, P4, DOI 10.3389/fendo.2011.00004; Cui ZH, 2010, INT J PEDIATR OBES, V5, P365, DOI 10.3109/17477166.2010.490262; den Hoed M, 2009, AM J CLIN NUTR, V90, P1426, DOI 10.3945/ajcn.2009.28053; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Dwivedi OP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047772; Ebbeling CB, 2002, LANCET, V360, P473, DOI 10.1016/S0140-6736(02)09678-2; Fang HY, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-136; Flynn MAT, 2006, OBES REV, V7, P7, DOI 10.1111/j.1467-789X.2006.00242.x; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Gonzalez-Sanchez JL, 2009, CLIN ENDOCRINOL, V70, P390, DOI 10.1111/j.1365-2265.2008.03335.x; Group of China Obesity Task Force, 2004, ZHONGHUA LIU XING BI, V25, P97; Hallman DM, 2012, INT J OBESITY, V36, P61, DOI 10.1038/ijo.2011.190; Hardy R, 2010, HUM MOL GENET, V19, P545, DOI 10.1093/hmg/ddp504; Haworth CMA, 2008, OBESITY, V16, P2663, DOI 10.1038/oby.2008.434; Horikoshi M, 2007, DIABETOLOGIA, V50, P2461, DOI 10.1007/s00125-007-0827-5; Hotta K, 2008, J HUM GENET, V53, P546, DOI 10.1007/s10038-008-0283-1; Ibba A, 2013, J PEDIATR ENDOCR MET, V26, P539, DOI 10.1515/jpem-2012-0417; Jess T, 2008, INT J OBESITY, V32, P1388, DOI 10.1038/ijo.2008.110; Johnson L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004594; Jonsson A, 2009, DIABETOLOGIA, V52, P1334, DOI 10.1007/s00125-009-1355-2; Jonsson A, 2009, NEW ENGL J MED, V360, P1571, DOI 10.1056/NEJMc090017; Karra E, 2013, J CLIN INVEST, V123, P3539, DOI 10.1172/JCI44403; Kotani K, 2012, J INVEST MED, V60, P514, DOI 10.2310/JIM.0b013e318240527c; Kuhne G, 2011, DEUT MED WOCHENSCHR, V136, P1613, DOI 10.1055/s-0031-1281565; Lanigan J, 2010, P NUTR SOC, V69, P204, DOI 10.1017/S0029665110000029; Lear SA, 2011, GENET RES, V93, P419, DOI 10.1017/S001667231100036X; Li H, 2012, DIABETOLOGIA, V55, P981, DOI 10.1007/s00125-011-2370-7; Li HX, 2008, DIABETES, V57, P264, DOI 10.2337/db07-1130; Li Min, 2010, Zhonghua Yixue Yichuanxue Zazhi, V27, P678, DOI 10.3760/cma.j.issn.1003-9406.2010.06.017; Liu Y, 2010, OBESITY, V18, P1619, DOI 10.1038/oby.2009.469; Loos RJF, 2008, OBES REV, V9, P246, DOI 10.1111/j.1467-789X.2008.00481.x; Low LCK, 2010, WORLD J PEDIATR, V6, P197, DOI 10.1007/s12519-010-0217-9; Matsushita Y, 2009, INT J OBESITY, V33, P1191, DOI 10.1038/ijo.2009.153; Moleres A, 2012, BRIT J NUTR, V107, P533, DOI 10.1017/S0007114511003424; Ng MCY, 2008, DIABETES, V57, P2226, DOI 10.2337/db07-1583; Okuda M, 2011, PEDIATR DIABETES, V12, P494, DOI 10.1111/j.1399-5448.2010.00727.x; Peng SH, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-71; Peters U, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003171; Prentice AM, 2006, INT J EPIDEMIOL, V35, P93, DOI 10.1093/ije/dyi272; Qi L, 2008, DIABETES, V57, P3145, DOI 10.2337/db08-0006; Rutters F, 2011, J CLIN ENDOCR METAB, V96, pE939, DOI 10.1210/jc.2010-2413; Salbe AD, 2004, AM J CLIN NUTR, V79, P372; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Sonestedt E, 2009, AM J CLIN NUTR, V90, P1418, DOI 10.3945/ajcn.2009.27958; Sovio U, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001307; Speakman JR, 2008, OBESITY, V16, P1961, DOI 10.1038/oby.2008.318; Speakman JR, 2010, NATURE, V464, pE1, DOI 10.1038/nature08807; Steemburgo T, 2013, J NUTRIGENET NUTRIGE, V6, P97, DOI 10.1159/000350741; Tan JT, 2008, DIABETES, V57, P2851, DOI 10.2337/db08-0214; Tanofsky-Kraff M, 2009, AM J CLIN NUTR, V90, P1483, DOI 10.3945/ajcn.2009.28439; Tercjak Magdalena, 2010, Pediatr Endocrinol Diabetes Metab, V16, P109; Timpson NJ, 2008, AM J CLIN NUTR, V88, P971, DOI 10.1093/ajcn/88.4.971; Binh TQ, 2013, GENE, V513, P31, DOI 10.1016/j.gene.2012.10.082; Vasan SK, 2012, OBESITY, V20, P2268, DOI 10.1038/oby.2012.64; Vasan SK, 2013, OBESITY; Velders FP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049131; Wahlen K, 2008, J LIPID RES, V49, P607, DOI 10.1194/jlr.M700448-JLR200; Wang HN, 2012, MOL BIOL REP, V39, P5691, DOI 10.1007/s11033-011-1377-y; Wardle J, 2009, INT J OBESITY, V33, P42, DOI 10.1038/ijo.2008.174; Wardle J, 2008, J CLIN ENDOCR METAB, V93, P3640, DOI 10.1210/jc.2008-0472; Xi B, 2013, MOL BIOL REP, V40, P773, DOI 10.1007/s11033-012-2113-y; Xi Bo, 2010, Zhonghua Liu Xing Bing Xue Za Zhi, V31, P737; Xi B, 2011, OBESITY, V19, P236, DOI 10.1038/oby.2010.139; Xi B, 2009, BIOMED ENVIRON SCI, V22, P449, DOI 10.1016/S0895-3988(10)60001-3; Yang J, 2012, NATURE, V490, P267, DOI 10.1038/nature11401; Zabena C, 2009, OBES SURG, V19, P87, DOI 10.1007/s11695-008-9727-0; Zhou DH, 2012, MOL BIOL REP, V39, P6555, DOI 10.1007/s11033-012-1484-4	72	25	27	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2014	9	8							e104574	10.1371/journal.pone.0104574	http://dx.doi.org/10.1371/journal.pone.0104574			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WB	25110886	Green Published, gold, Green Submitted			2022-12-27	WOS:000341105100077
J	Kido, M; Nakamura, Y; Nemoto, K; Takahashi, T; Aleksic, B; Furuichi, A; Nakamura, Y; Ikeda, M; Noguchi, K; Kaibuchi, K; Iwata, N; Ozaki, N; Suzuki, M				Kido, Mikio; Nakamura, Yukako; Nemoto, Kiyotaka; Takahashi, Tsutomu; Aleksic, Branko; Furuichi, Atsushi; Nakamura, Yumiko; Ikeda, Masashi; Noguchi, Kyo; Kaibuchi, Kozo; Iwata, Nakao; Ozaki, Norio; Suzuki, Michio			The Polymorphism of YWHAE, a Gene Encoding 14-3-3Epsilon, and Brain Morphology in Schizophrenia: A Voxel-Based Morphometric Study	PLOS ONE			English	Article							BASAL GANGLIA VOLUMES; 1ST-EPISODE SCHIZOPHRENIA; COMMON VARIANTS; INSULAR CORTEX; DISC1; MATTER; GRAY; RISK; HIPPOCAMPAL; METAANALYSIS	Background: YWHAE is a possible susceptibility gene for schizophrenia that encodes 14-3-3epsilon, a Disrupted-in-Schizophrenia 1 (DISC1)-interacting molecule, but the effect of variation in its genotype on brain morphology remains largely unknown. Methods: In this voxel-based morphometric magnetic resonance imaging study, we conducted whole-brain analyses regarding the effects of YWHAE single-nucleotide polymorphisms (SNPs) (rs28365859, rs11655548, and rs9393) and DISC1 SNP (rs821616) on gray matter volume in a Japanese sample of 72 schizophrenia patients and 86 healthy controls. On the basis of a previous animal study, we also examined the effect of rs28365859 genotype specifically on hippocampal volume. Results: Whole-brain analyses showed no significant genotype effect of these SNPs on gray matter volume in all subjects, but we found significant genotype-by-diagnosis interaction for rs28365859 in the left insula and right putamen. The protective C allele carriers of rs28365859 had a significantly larger left insula than the G homozygotes only for schizophrenia patients, while the controls with G allele homozygosity had a significantly larger right putamen than the C allele carriers. The C allele carriers had a larger right hippocampus than the G allele homozygotes in schizophrenia patients, but not in healthy controls. No significant interaction was found between rs28365859 and DISC1 SNP on gray matter volume. Conclusions: These different effects of the YWHAE (rs28365859) genotype on brain morphology in schizophrenia and healthy controls suggest that variation in its genotype might be, at least partly, related to the abnormal neurodevelopment, including in the limbic regions, reported in schizophrenia. Our results also suggest its specific role among YWHAE SNPs in the pathophysiology of schizophrenia.	[Kido, Mikio; Takahashi, Tsutomu; Furuichi, Atsushi; Nakamura, Yumiko; Suzuki, Michio] Toyama Univ, Dept Neuropsychiat, Toyama 930, Japan; [Nakamura, Yukako; Aleksic, Branko; Ozaki, Norio] Nagoya Univ, Dept Psychiat, Grad Sch Med, Nagoya, Aichi 4648601, Japan; [Nemoto, Kiyotaka] Univ Tsukuba, Fac Med, Div Clin Med, Dept Neuropsychiat, Ibaraki, Japan; [Ikeda, Masashi; Iwata, Nakao] Fujita Hlth Univ, Sch Med, Dept Psychiat, Toyoake, Aichi 47011, Japan; [Noguchi, Kyo] Toyama Univ, Dept Radiol, Toyama 930, Japan; [Kaibuchi, Kozo] Nagoya Univ, Dept Cell Pharmacol, Grad Sch Med, Nagoya, Aichi 4648601, Japan; [Takahashi, Tsutomu; Ikeda, Masashi; Kaibuchi, Kozo; Iwata, Nakao; Ozaki, Norio; Suzuki, Michio] Japan Sci & Technol Corp, Core Res Evolut Sci & Technol, Tokyo, Japan	University of Toyama; Nagoya University; University of Tsukuba; Fujita Health University; University of Toyama; Nagoya University; Japan Science & Technology Agency (JST)	Kido, M (corresponding author), Toyama Univ, Dept Neuropsychiat, Toyama 930, Japan.	mikiokid@med.u-toyama.ac.jp	Ozaki, Norio/M-8908-2014; Aleksic, Branko/G-1540-2011; Aleksic, Branko/L-7851-2019; Nemoto, Kiyotaka/C-4987-2013; nakamura, yukako/M-8889-2014; Kaibuchi, Kozo/M-4887-2014	Ozaki, Norio/0000-0002-7360-4898; Aleksic, Branko/0000-0001-8982-4580; Aleksic, Branko/0000-0001-8982-4580; Nemoto, Kiyotaka/0000-0001-8623-9829; nakamura, yukako/0000-0002-3306-7127; Kaibuchi, Kozo/0000-0003-0714-1992; IWATA, Nakao/0000-0003-3189-6076	Japanese Society for the Promotion of Science, Health and Labour Sciences Research [22591275, 24591699, 24390281]; JSPS; Ministry of Education, Culture, Sports, Science & Technology of Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan	Japanese Society for the Promotion of Science, Health and Labour Sciences Research; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science & Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was supported in part by Grants-in-Aid for Scientific Research (C) (No. 22591275, 24591699) and Grants-in-Aid for Scientific Research (B) (No. 24390281) from the Japanese Society for the Promotion of Science, Health and Labour Sciences Research Grants (Comprehensive Research on Disability, Health and Welfare, H23-Seishin-Ippan-002 and H23-Seishin-Ippan-009), a Research Grant from the JSPS Asian Core Program, and a Grant-in-Aid for Scientific Research on Innovative Areas (Comprehensive Brain Science Network) from the Ministry of Education, Culture, Sports, Science & Technology of Japan. It was also supported by Grant-in-Aid for "Integrated research on neuropsychiatric disorders" carried out under the Strategic Research Program for Brain Sciences by the Ministry of Education, Culture, Sports, Science and Technology of Japan and Grant-in-Aid for Scientific Research on Innovative Areas, "Glial assembly: a new regulatory machinery of brain function and disorders". The funding agencies had no further role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the paper for publication.	Anderson D, 2013, BIPOLAR DISORD, V15, P680, DOI 10.1111/bdi.12096; Andreasen N., 1984, SCALE ASSESSMENT POS; Andreasen N. C., 1984, SCALE ASSESSMENT POS; Andreasen NC, 2013, AM J PSYCHIAT, V170, P609, DOI 10.1176/appi.ajp.2013.12050674; ANDREASEN NC, 1992, ARCH GEN PSYCHIAT, V49, P615; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Augustine JR, 1996, BRAIN RES REV, V22, P229, DOI 10.1016/S0165-0173(96)00011-2; Ballmaier M, 2008, SCHIZOPHR RES, V106, P140, DOI 10.1016/j.schres.2008.08.025; Bis JC, 2012, NAT GENET, V44, P545, DOI 10.1038/ng.2237; Borgwardt S, 2012, PSYCHIAT RES-NEUROIM, V202, P273, DOI 10.1016/j.pscychresns.2011.12.005; Borgwardt SJ, 2007, BIOL PSYCHIAT, V61, P1148, DOI 10.1016/j.biopsych.2006.08.009; Borgwardt SJ, 2010, BIOL PSYCHIAT, V67, P956, DOI 10.1016/j.biopsych.2009.10.026; Callicott JH, 2005, P NATL ACAD SCI USA, V102, P8627, DOI 10.1073/pnas.0500515102; Chakravarty M Mallar, 2012, Front Psychiatry, V3, P57, DOI 10.3389/fpsyt.2012.00057; Duff BJ, 2013, SCHIZOPHR RES, V147, P1, DOI 10.1016/j.schres.2013.03.015; Ebdrup BH, 2011, INT J NEUROPSYCHOPH, V14, P69, DOI 10.1017/S1461145710000817; Glahn DC, 2008, BIOL PSYCHIAT, V64, P774, DOI 10.1016/j.biopsych.2008.03.031; Glenthoj A, 2007, PSYCHIAT RES-NEUROIM, V154, P199, DOI 10.1016/j.pscychresns.2006.10.002; GOLDMANRAKIC PS, 1994, J NEUROPSYCH CLIN N, V6, P348; Gottesman II, 2003, AM J PSYCHIAT, V160, P636, DOI 10.1176/appi.ajp.160.4.636; Gunduz H, 2002, BIOL PSYCHIAT, V51, P801, DOI 10.1016/S0006-3223(01)01345-2; Haijma SV, 2013, SCHIZOPHRENIA BULL, V39, P1129, DOI 10.1093/schbul/sbs118; Harrison PJ, 2005, MOL PSYCHIATR, V10, P40, DOI 10.1038/sj.mp.4001558; Hashimoto R, 2006, HUM MOL GENET, V15, P3024, DOI 10.1093/hmg/ddl244; Ikeda M, 2008, HUM MOL GENET, V17, P3212, DOI 10.1093/hmg/ddn217; Ishizuka K, 2006, BIOL PSYCHIAT, V59, P1189, DOI 10.1016/j.biopsych.2006.03.065; JAKOB H, 1986, J NEURAL TRANSM, V65, P303, DOI 10.1007/BF01249090; James R, 2004, MOL CELL NEUROSCI, V26, P112, DOI 10.1016/j.mcn.2004.01.013; Jones DK, 2005, NEUROIMAGE, V26, P546, DOI 10.1016/j.neuroimage.2005.02.013; Kamiya A, 2005, NAT CELL BIOL, V7, P1167, DOI 10.1038/ncb1328; Keshavan MS, 2007, INT REV PSYCHIATR, V19, P399, DOI 10.1080/09540260701486233; Kirkpatrick B, 2006, J COMP NEUROL, V497, P436, DOI 10.1002/cne.21007; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Lancaster JL, 1997, NEUROIMAGE, V5, pS633; Li M, 2012, PSYCHOL MED, V42, P1475, DOI 10.1017/S0033291711002157; Lieberman JA, 2005, ARCH GEN PSYCHIAT, V62, P361, DOI 10.1001/archpsyc.62.4.361; Lipina TV, 2010, GENES BRAIN BEHAV, V9, P777, DOI 10.1111/j.1601-183X.2010.00615.x; Lipska BK, 2006, HUM MOL GENET, V15, P1245, DOI 10.1093/hmg/ddl040; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Millar JK, 2000, HUM MOL GENET, V9, P1415, DOI 10.1093/hmg/9.9.1415; Ozeki Y, 2003, P NATL ACAD SCI USA, V100, P289, DOI 10.1073/pnas.0136913100; Palaniyappan L, 2012, J PSYCHIATR NEUROSCI, V37, P399, DOI 10.1503/jpn.110119; Pennington K, 2008, SCHIZOPHR RES, V106, P164, DOI 10.1016/j.schres.2008.08.022; Roberts RC, 2007, SCHIZOPHRENIA BULL, V33, P11, DOI 10.1093/schbul/sbl063; Salmond CH, 2002, NEUROIMAGE, V17, P1027, DOI 10.1006/nimg.2002.1153; Sawa A, 2002, SCIENCE, V296, P692, DOI 10.1126/science.1070532; Sekiguchi H, 2011, BRAIN RES, V1392, P47, DOI 10.1016/j.brainres.2011.03.058; Shenton ME, 2001, SCHIZOPHR RES, V49, P1, DOI 10.1016/S0920-9964(01)00163-3; Shepherd AM, 2012, BIOL PSYCHIAT, V72, P775, DOI 10.1016/j.biopsych.2012.04.020; STCLAIR D, 1990, LANCET, V336, P13, DOI 10.1016/0140-6736(90)91520-K; Stein JL, 2012, NAT GENET, V44, P552, DOI 10.1038/ng.2250; Sullivan PF, 2013, MOL PSYCHIATR, V18, P1050, DOI 10.1038/mp.2012.182; Suzuki M, 2002, SCHIZOPHR RES, V55, P41, DOI 10.1016/S0920-9964(01)00224-9; Takahashi T, 2009, SCHIZOPHR RES, V111, P94, DOI 10.1016/j.schres.2009.03.024; Takahashi T, 2009, PSYCHIAT RES-NEUROIM, V172, P128, DOI 10.1016/j.pscychresns.2009.01.005; Talairach J., 1988, COPLANAR STEREOTAXIC; Taya S, 2007, J NEUROSCI, V27, P15, DOI 10.1523/JNEUROSCI.3826-06.2006; Toru M., 2008, PSYCHOTROPIC MANUAL, V3rd ed.; Toyo-oka K, 2003, NAT GENET, V34, P274, DOI 10.1038/ng1169; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; WHO, 2012, ICD 10 CLASS MENT BE; Wylie KP, 2010, SCHIZOPHR RES, V123, P93, DOI 10.1016/j.schres.2010.08.027	63	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2014	9	8							e103571	10.1371/journal.pone.0103571	http://dx.doi.org/10.1371/journal.pone.0103571			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR0CG	25105667	Green Submitted, Green Published, gold			2022-12-27	WOS:000343231900015
J	Liu, ZY; Zhang, YC; Niu, YL; Li, K; Liu, X; Chen, HJ; Gao, CF				Liu, Zhongyu; Zhang, Yingchong; Niu, Yulong; Li, Ke; Liu, Xin; Chen, Huijuan; Gao, Chunfang			A Systematic Review and Meta-Analysis of Diagnostic and Prognostic Serum Biomarkers of Colorectal Cancer	PLOS ONE			English	Article							TUMOR-MARKERS; PUBLICATION BIAS; TEST ACCURACY; CARCINOEMBRYONIC ANTIGEN; ADJUVANT CHEMOTHERAPY; EUROPEAN GROUP; CA-19-9; SURVIVAL; TESTS; CEA	Background: Our systematic review summarizes the evidence concerning the accuracy of serum diagnostic and prognostic tests for colorectal cancer (CRC). Methods: The databases MEDLINE and EMBASE were searched iteratively to identify the relevant literature for serum markers of CRC published from 1950 to August 2012. The articles that provided adequate information to meet the requirements of the meta-analysis of diagnostic and prognostic markers were included. A 2-by-2 table of each diagnostic marker and its hazard ratio (HR) and the confidence interval (CI) of each prognostic marker was directly or indirectly extracted from the included papers, and the pooled sensitivity and specificity of the diagnostic marker and the pooled HR and the CI of the prognostic marker were subsequently calculated using the extracted data. Results: In total, 104 papers related to the diagnostic markers and 49 papers related to the prognostic serum markers of CRC were collected, and only 19 of 92 diagnostic markers were investigated in more than two studies, whereas 21 out of 44 prognostic markers were included in two or more studies. All of the pooled sensitivities of the diagnostic markers with >=3 repetitions were less than 50%, and the meta-analyses of the prognostic markers with more than 3 studies were performed, VEGF with highest (2.245, CI: 1.347-3.744) and MMP-7 with lowest (1.099, CI: 1.018-1.187)) pooled HRs are presented. Conclusions: The quality of studies addressing the diagnostic and prognostic accuracy of the tests was poor, and the results were highly heterogeneous. The poor characteristics indicate that these tests are of little value for clinical practice.	[Liu, Zhongyu; Li, Ke; Liu, Xin; Chen, Huijuan; Gao, Chunfang] Cent Hosp PLA, Anal Colorectal Surg Inst, Luoyang, Henan, Peoples R China; [Zhang, Yingchong] Chengdu Municipal Ctr Dis Control & Prevent, Chengdu, Peoples R China; [Niu, Yulong] Sichuan Univ, Coll Life Sci, Chengdu 610064, Peoples R China	Sichuan University	Liu, ZY (corresponding author), Cent Hosp PLA, Anal Colorectal Surg Inst, Luoyang, Henan, Peoples R China.	zhongyujohn@gmail.com; gaochunfang2010@163.com	Niu, Yulong/GQI-0688-2022	Niu, Yulong/0000-0002-1361-6272	China Postdoctoral Science Foundation [201150M1569, 2012T50893]; Luoyang application technology research and development projects [1401088A-5]	China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Luoyang application technology research and development projects	Funding for this work was provided by the China Postdoctoral Science Foundation (201150M1569 and 2012T50893 to ZL) and Luoyang application technology research and development projects (1401088A-5). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allegra C, 2003, J CLIN ONCOL, V21, P395, DOI 10.1200/JCO.2003.11.073; ALTMAN DG, 1995, BRIT J CANCER, V72, P511, DOI 10.1038/bjc.1995.364; Altman DG, 2005, NAT CLIN PRACT ONCOL, V2, P466, DOI 10.1038/ncponc0287; Altman DG, 1998, BRIT MED J, V317, P468; Altman DG, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001216; Bast RC, 1996, J CLIN ONCOL, V14, P2843; Bast RC, 2001, J CLIN ONCOL, V19, P1865, DOI 10.1200/JCO.2001.19.6.1865; BATES AS, 1993, J PEDIATR-US, V122, P585, DOI 10.1016/S0022-3476(05)83540-1; BEGG CB, 1983, BIOMETRICS, V39, P207, DOI 10.2307/2530820; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Behbehani AI, 2000, INT J BIOL MARKER, V15, P51, DOI 10.1177/172460080001500109; Cancer Res UK, 2003, CANC STAT LARGE BOWE, VUK4, P4; Carpelan-Holmstrom M, 2004, TUMOR BIOL, V25, P228, DOI 10.1159/000081385; Carpelan-Holmstrom M, 2002, ANTICANCER RES, V22, P2311; Centre for Reviews and Dissemination University of York, 2001, RES REPORT, V4; Clarke M, 2008, NEURORADIOLOGY, V50, P653, DOI 10.1007/s00234-008-0411-9; Deeks JJ, 2005, J CLIN EPIDEMIOL, V58, P882, DOI 10.1016/j.jclinepi.2005.01.016; Deeks JJ, 2001, SYSTEMATIC REV HLTH, P285, DOI DOI 10.1002/9780470693926.CH15; Duffy MJ, 2007, EUR J CANCER, V43, P1348, DOI 10.1016/j.ejca.2007.03.021; Duffy MJ, 1998, ANN CLIN BIOCHEM, V35, P364, DOI 10.1177/000456329803500304; Duffy MJ, 2001, CLIN CHEM, V47, P624; Duffy MJ, 2003, EUR J CANCER, V39, P718, DOI 10.1016/S0959-8049(02)00811-0; Duval S, 2000, J AM STAT ASSOC, V95, P89, DOI 10.2307/2669529; Egger E, 1997, LANCET, V350, P326, DOI 10.1016/S0140-6736(97)02419-7; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; FILELLA X, 1994, TUMOR BIOL, V15, P1, DOI 10.1159/000217867; Finlay IG, 1994, CURRENT MED, P51; FLETCHER RH, 1986, ANN INTERN MED, V104, P66, DOI 10.7326/0003-4819-104-1-66; Glasziou PP, 2002, STAT MED, V21, P1503, DOI 10.1002/sim.1183; Goldstein MJ, 2005, CANCER INVEST, V23, P338, DOI 10.1081/CNV-200058878; Graziano F, 2003, ANN ONCOL, V14, P1026, DOI 10.1093/annonc/mdg284; Grem Jean, 1997, Current Opinion in Oncology, V9, P380, DOI 10.1097/00001622-199709040-00012; Harbord RM, 2009, METAANALYSIS STATA U, P181; Hayden JA, 2006, ANN INTERN MED, V144, P427, DOI 10.7326/0003-4819-144-6-200603210-00010; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; Keough-Ryan T, 2002, AM J KIDNEY DIS, V39, P1196, DOI 10.1053/ajkd.2002.33391; Klapdor R, 1999, ANTICANCER RES, V119, P2811; Kyzas PA, 2005, JNCI-J NATL CANCER I, V97, P1043, DOI 10.1093/jnci/dji184; Lijmer JG, 1999, JAMA-J AM MED ASSOC, V282, P1061, DOI 10.1001/jama.282.11.1061; Lijmer JG, 2002, STAT MED, V21, P1525, DOI 10.1002/sim.1185; LINDMARK G, 1995, BRIT J CANCER, V71, P1090, DOI 10.1038/bjc.1995.211; Ling BS, 2001, J GEN INTERN MED, V16, P822, DOI 10.1046/j.1525-1497.2001.10337.x; Liu Z, 2013, BRIT J CANCER, V108, P2299, DOI 10.1038/bjc.2013.185; Locker GY, 2006, J CLIN ONCOL, V24, P5313, DOI 10.1200/JCO.2006.08.2644; Morikawa T, 2005, GASTROENTEROLOGY, V129, P422, DOI 10.1053/j.gastro.2005.05.056; Nakayama T, 1997, J SURG ONCOL, V66, P238; PARKIN DM, 1993, INT J CANCER, V54, P594, DOI 10.1002/ijc.2910540413; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Popat S, 2004, J CLIN ONCOL, V22, P529, DOI 10.1200/JCO.2004.05.064; RANSOHOFF DF, 1978, NEW ENGL J MED, V299, P926, DOI 10.1056/NEJM197810262991705; Reiter W, 2000, ANTICANCER RES, V20, P5195; Reitsma JB, 2005, J CLIN EPIDEMIOL, V58, P982, DOI 10.1016/j.jclinepi.2005.02.022; REX DK, 1993, AM J GASTROENTEROL, V88, P825; Rex DK, 2012, AM J GASTROENTEROL, V107, P1315, DOI 10.1038/ajg.2012.161; Riley R D, 2003, Health Technol Assess, V7, P1; Rothstein HR, 2005, PUBLICATION BIAS IN META-ANALYSIS: PREVENTION, ASSESSMENT AND ADJUSTMENTS, P1, DOI 10.1002/0470870168; Rothstein HR, 2005, PUBLICATION BIAS IN META-ANALYSIS: PREVENTION, ASSESSMENT AND ADJUSTMENTS, P1, DOI 10.1002/0470870168; Rutter CM, 2001, STAT MED, V20, P2865, DOI 10.1002/sim.942; Sica GT, 2006, RADIOLOGY, V238, P780, DOI 10.1148/radiol.2383041109; Simmonds MC, 2005, CLIN TRIALS, V2, P209, DOI 10.1191/1740774505cn087oa; Smith V, 2007, EUR J OBSTET GYN R B, V133, P134, DOI 10.1016/j.ejogrb.2007.03.005; Song FJ, 2002, INT J EPIDEMIOL, V31, P88, DOI 10.1093/ije/31.1.88; Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16; Tsuji T, 2003, CLIN CANCER RES, V9, P3700; van der Bij S, 2011, BRIT J CANCER, V104, P1325, DOI 10.1038/bjc.2011.104; VATN MH, 1982, CANCER, V49, P819, DOI 10.1002/1097-0142(19820215)49:4<819::AID-CNCR2820490435>3.0.CO;2-D; Whiting P, 2004, ANN INTERN MED, V140, P189, DOI 10.7326/0003-4819-140-3-200402030-00010; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25; Whiting PF, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-20; Winawer S J, 1988, Prog Clin Biol Res, V279, P35; Zamora Javier, 2006, BMC Med Res Methodol, V6, P31, DOI 10.1186/1471-2288-6-31; Zhou X H, 1998, Stat Methods Med Res, V7, P337, DOI 10.1191/096228098676485370	73	47	49	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2014	9	8							e103910	10.1371/journal.pone.0103910	http://dx.doi.org/10.1371/journal.pone.0103910			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR0CG	25105762	Green Submitted, gold, Green Published			2022-12-27	WOS:000343231900030
J	Wang, YQ; Luo, QQ; Li, YP; Wang, HQ; Deng, SL; Wei, SY; Li, XL				Wang, Yingqiang; Luo, Qianqian; Li, Youping; Wang, Haiqing; Deng, Shaolin; Wei, Shiyou; Li, Xianglian			Quality Assessment of Clinical Practice Guidelines on the Treatment of Hepatocellular Carcinoma or Metastatic Liver Cancer	PLOS ONE			English	Article							CONFLICTS-OF-INTEREST; JAPAN-SOCIETY; CONSENSUS GUIDELINES; MANAGEMENT; DIAGNOSIS; TRANSPLANTATION; HEPATOLOGY; RECOMMENDATIONS; CONCLUSIONS; THERAPIES	Objectives: To assess the quality of the currently available clinical practice guidelines (CPGs) for hepatocellular carcinoma, and provide a reference for clinicians in selecting the best available clinical protocols. Methods: The databases of PubMed, MEDLINE, Web of Science, Chinese Biomedical Literature database (CBM), China National Knowledge Infrastructure (CNKI), WanFang, and relevant CPGs websites were systematically searched through March 2014. CPGs quality was appraised using the Appraisal of Guidelines for Research & Evaluation (AGREE) II instrument, and data analysis was performed using SPSS 13.0 software. Results: A total of 20 evidence-based and 20 expert consensus-based guidelines were included. The mean percentage of the domain scores were: scope and purpose 83% (95% confidence interval (CI), 81% to 86%), clarity of presentation 79% (95% CI, 73% to 86%), stakeholder involvement 39% (95% CI, 30% to 49%), editorial independence 58% (95% CI, 52% to 64%), rigor of development 39% (95% CI, 31% to 46%), and applicability 16% (95% CI, 10% to 23%). Evidence-based guidelines were superior to those established by consensus for the domains of rigor of development (p<0.001), clarity of presentation (p = 0.01) and applicability (p = 0.021). Conclusions: The overall methodological quality of CPGs for hepatocellular carcinoma and metastatic liver cancer is moderate, with poor applicability and potential conflict of interest issues. The evidence-based guidelines has become mainstream for high quality CPGs development; however, there is still need to further increase the transparency and quality of evidence rating, as well as the recommendation process, and to address potential conflict of interest.	[Wang, Yingqiang; Li, Youping; Li, Xianglian] Sichuan Univ, West China Hosp, Chinese Cochrane Ctr, Chinese Evidence Based Med Ctr, Chengdu 610064, Peoples R China; [Wang, Yingqiang] 363 Hosp, Dept Med Adm, Chengdu, Peoples R China; [Luo, Qianqian] Sichuan Univ, West China Hosp, Natl Chengdu Ctr Safety Evaluat Drugs, Chengdu 610064, Peoples R China; [Wang, Haiqing] Yichun Univ, Inst Prevent Med, Yichun, Peoples R China; [Deng, Shaolin; Wei, Shiyou] Sichuan Univ, West China Hosp, West China Med Sch, Chengdu 610064, Peoples R China	Sichuan University; Sichuan University; Yichun University; Sichuan University	Li, YP (corresponding author), Sichuan Univ, West China Hosp, Chinese Cochrane Ctr, Chinese Evidence Based Med Ctr, Chengdu 610064, Peoples R China.	yzmylab@hotmail.com	Wang, Yingqiang/J-6654-2019		National Technology Support Program [2011BAI14B01]	National Technology Support Program	This paper was supported by National Technology Support Program (2011BAI14B01). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad A, 2007, CLIN TRANSL ONCOL, V9, P723, DOI 10.1007/s12094-007-0129-x; Abdalla EK, 2013, HPB, V15, P119, DOI 10.1111/j.1477-2574.2012.00597.x; Abdo AA, 2012, ANN SAUDI MED, V32, P174, DOI 10.5144/0256-4947.2012.174; AGREE Next Steps Consortium, 2009, AGREE 2 INTR EL VERS; Alonso-Coello P, 2010, QUAL SAF HEALTH CARE, V19, DOI 10.1136/qshc.2010.042077; Arii S, 2010, HEPATOL RES, V40, P667, DOI 10.1111/j.1872-034X.2010.00673.x; Benson AB, 2009, J NATL COMPR CANC NE, V7, P350, DOI 10.6004/jnccn.2009.0027; Bipat S, 2007, NETH J MED, V65, P5; Brouwers MC, 2010, CAN MED ASSOC J, V182, pE839, DOI 10.1503/cmaj.090449; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933; Bruix J, 2001, J HEPATOL, V35, P421, DOI 10.1016/S0168-8278(01)00130-1; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Burls A, 2010, LANCET, V376, P1128, DOI 10.1016/S0140-6736(10)61034-3; Campbell EG, 2010, ARCH INTERN MED, V170, P667, DOI 10.1001/archinternmed.2010.27; Chen YL, 2012, CHINESE MED J-PEKING, V125, P3660, DOI 10.3760/cma.j.issn.0366-6999.2012.20.011; Chinese Medical Association of Gastrointestinal and Colorectal Surgery Group Chinese Anti-Cancer Association of Colorectal Cancer, 2010, J GASTROINTEST SURG, V13, P457; Choudhry NK, 2002, JAMA-J AM MED ASSOC, V287, P612, DOI 10.1001/jama.287.5.612; Cluzeau Francoise, 2012, Proc Am Thorac Soc, V9, P269, DOI 10.1513/pats.201208-062ST; Devlin J, 1999, GUT, V45, P1; European Assoc Study Liver, 2012, EUR J CANCER, V48, P599, DOI 10.1016/j.ejca.2011.12.021; Ferenci P, 2010, J GASTROINTEST LIVER, V19, P311; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Ferlay JSH, 2008, IARC CANCERBASE; Field A. P, 2005, ENCY STAT BEHAV SCI, DOI DOI 10.1002/0470013192.BSA313; Field MJ, 1990, CLIN PRACTICE GUIDEL; Garden OJ, 2006, GUT, V55, P1, DOI 10.1136/gut.2006.098053; Giammarile F, 2011, EUR J NUCL MED MOL I, V38, P1393, DOI 10.1007/s00259-011-1812-2; Grilli R, 2000, LANCET, V355, P103, DOI 10.1016/S0140-6736(99)02171-6; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1311, DOI [10.1016/j.jclinepi.2011.03.017, 10.1016/j.jclinepi.2011.06.004]; Izumi N, 2010, ONCOLOGY-BASEL, V78, P78, DOI 10.1159/000315234; Jelic S, 2010, ANN ONCOL, V21, pv59, DOI 10.1093/annonc/mdq166; Kaneko S, 2012, HEPATOL RES, V42, P523, DOI 10.1111/j.1872-034X.2012.00981.x; Kennedy A, 2007, INT J RADIAT ONCOL, V68, P13, DOI 10.1016/j.ijrobp.2006.11.060; Knox J, 2008, SORAFENIB ADV HEPATO; Kudo M, 2007, ONCOLOGY-BASEL, V72, P2, DOI 10.1159/000111702; Kudo M, 2011, DIGEST DIS, V29, P339, DOI 10.1159/000327577; Kudo M, 2010, ONCOLOGY-BASEL, V78, P180, DOI 10.1159/000315740; Lang K, 2009, J HEPATOL, V50, P89, DOI 10.1016/j.jhep.2008.07.029; Makuuchi M, 2008, HEPATOL RES, V38, P37, DOI 10.1111/j.1872-034X.2007.00216.x; McAlister FA, 2007, PLOS MED, V4, P1325, DOI 10.1371/journal.pmed.0040250; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Murray KF, 2005, HEPATOLOGY, V41, P1407, DOI 10.1002/hep.20704; National Institute for Health and Clinical Excellence, 2012, NICE TECHN APPR GUID; Neuman J, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d5621; O'Grady J, 2005, HIV MED, V6, P149, DOI 10.1111/j.1468-1293.2005.00303.x; Omata M, 2010, HEPATOL INT, V4, P439, DOI 10.1007/s12072-010-9165-7; Parikh P, 2008, ANN ONCOL, V19, P27, DOI 10.1093/annonc/mdn114; Pavel M, 2012, NEUROENDOCRINOLOGY, V95, P157, DOI 10.1159/000335597; Peck-Radosavljevic M, 2012, WIEN KLIN WOCHENSCHR, V124, P104, DOI 10.1007/s00508-011-0056-2; Poon D, 2009, LANCET ONCOL, V10, P1111, DOI 10.1016/S1470-2045(09)70241-4; Prasad KR, 2011, LIVER TRANSPLANT, V17, pS81, DOI 10.1002/lt.22380; Rosenfeld RM, 2013, OTOLARYNG HEAD NECK, V148, pS1, DOI 10.1177/0194599812467004; Ryder SD, 2003, GUT, V52, pIII1, DOI 10.1136/gut.52.suppl_3.iii1; Samuel D, 2011, LIVER TRANSPLANT, V17, pS6, DOI 10.1002/lt.22423; Schmidt S, 2011, J GASTROEN HEPATOL, V26, P1779, DOI 10.1111/j.1440-1746.2011.06891.x; Schwarz RE, 2013, HPB, V15, P106, DOI 10.1111/j.1477-2574.2012.00558.x; Scott IA, 2011, MED J AUSTRALIA, V195, P29, DOI 10.5694/j.1326-5377.2011.tb03184.x; Steinmuller T, 2008, NEUROENDOCRINOLOGY, V87, P47, DOI 10.1159/000111037; Van Vlierberghe H, 2004, ACTA GASTRO-ENT BELG, V67, P14; White LA, 2012, CLIN GASTROENTEROL H, V10, P547, DOI 10.1016/j.cgh.2011.12.031; Woolf SH, 1999, BRIT MED J, V318, P527, DOI 10.1136/bmj.318.7182.527; Xu JM, 2011, J CANCER RES CLIN, V137, P1379, DOI 10.1007/s00432-011-0999-8; Ye Sheng-long, 2009, Zhonghua Gan Zang Bing Za Zhi, V17, P403; Zheng ZH, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-218	64	6	9	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2014	9	8							e103939	10.1371/journal.pone.0103939	http://dx.doi.org/10.1371/journal.pone.0103939			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR0CG	25105961	gold, Green Published, Green Submitted			2022-12-27	WOS:000343231900032
J	Witek, ME; Snook, AE; Lin, JE; Blomain, ES; Xiang, B; Magee, M; Waldman, SA				Witek, Matthew E.; Snook, Adam E.; Lin, Jieru E.; Blomain, Erik S.; Xiang, Bo; Magee, Michael; Waldman, Scott A.			A Novel CDX2 Isoform Regulates Alternative Splicing	PLOS ONE			English	Article							RNA-RECOGNITION MOTIF; MESSENGER-RNA; TRANSCRIPTION FACTORS; SUBNUCLEAR LOCALIZATION; TUMOR-SUPPRESSOR; SR PROTEINS; GENE; EXPRESSION; BINDING; PROMOTER	Gene expression is a dynamic and coordinated process coupling transcription with pre-mRNA processing. This regulation enables tissue-specific transcription factors to induce expression of specific transcripts that are subsequently amplified by alternative splicing allowing for increased proteome complexity and functional diversity. The intestine-specific transcription factor CDX2 regulates development and maintenance of the intestinal epithelium by inducing expression of genes characteristic of the mature enterocyte phenotype. Here, sequence analysis of CDX2 mRNA from colonic mucosa-derived tissues revealed an alternatively spliced transcript (CDX2/AS) that encodes a protein with a truncated homeodomain and a novel carboxy-terminal domain enriched in serine and arginine residues (RS domain). CDX2 and CDX2/AS exhibited distinct nuclear expression patterns with minimal areas of co-localization. CDX2/AS did not activate the CDX2-dependent promoter of guanylyl cyclase C nor inhibit transcriptional activity of CDX2. Unlike CDX2, CDX2/AS co-localized with the putative splicing factors ASF/SF2 and SC35. CDX2/AS altered splicing patterns of CD44v5 and Tra2-beta 1 minigenes in Lovo colon cancer cells independent of CDX2 expression. These data demonstrate unique dual functions of the CDX2 gene enabling it to regulate gene expression through both transcription (CDX2) and pre-mRNA processing (CDX2/AS).	[Witek, Matthew E.] Thomas Jefferson Univ, Kimmel Canc Ctr, Dept Radiat Oncol, Philadelphia, PA 19107 USA; [Witek, Matthew E.] Thomas Jefferson Univ, Jefferson Med Coll, Philadelphia, PA 19107 USA; [Snook, Adam E.; Lin, Jieru E.; Blomain, Erik S.; Xiang, Bo; Magee, Michael; Waldman, Scott A.] Thomas Jefferson Univ, Dept Pharmacol & Expt Therapeut, Philadelphia, PA 19107 USA	Jefferson University; Jefferson University; Jefferson University	Waldman, SA (corresponding author), Thomas Jefferson Univ, Dept Pharmacol & Expt Therapeut, Philadelphia, PA 19107 USA.	scott.waldman@jefferson.edu	Snook, Adam E./P-2585-2015; Magee, Michael/L-8354-2013	Snook, Adam E./0000-0001-9216-4560; Waldman, Scott/0000-0001-6619-175X; Magee, Michael/0000-0002-0480-4618	National Institutes of Health [R01 CA75123, R01 CA95026, RC1 CA146033, P30 CA56036, R01 CA170533, T32 GM08562, F30 CA180500]; Pennsylvania Department of Health [SAP] [4100059197, 4100051723]; Targeted Diagnostic and Therapeutics, Inc.; Measey Foundation Fellowship; NATIONAL CANCER INSTITUTE [R01CA095026, F30CA180500, RC1CA146033, R01CA170533, R01CA075123, P30CA056036] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008562] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania Department of Health [SAP]; Targeted Diagnostic and Therapeutics, Inc.; Measey Foundation Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health [R01 CA75123, R01 CA95026, RC1 CA146033, P30 CA56036, R01 CA170533, T32 GM08562 to JEL, F30 CA180500 to ESB]; the Pennsylvania Department of Health [SAP #4100059197, SAP #4100051723]; and Targeted Diagnostic and Therapeutics, Inc. The Pennsylvania Department of Health specifically disclaims responsibility for any analyses, interpretations or conclusions. AES is the recipient of the Measey Foundation Fellowship. SAW is the Samuel MV Hamilton Professor of Thomas Jefferson University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAM SA, 1986, MOL CELL BIOL, V6, P2932, DOI 10.1128/MCB.6.8.2932; Aftab S, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-226; Aoki K, 2003, NAT GENET, V35, P323, DOI 10.1038/ng1265; Bentley DL, 2005, CURR OPIN CELL BIOL, V17, P251, DOI 10.1016/j.ceb.2005.04.006; BIRNEY E, 1993, NUCLEIC ACIDS RES, V21, P5803, DOI 10.1093/nar/21.25.5803; Charlieu JP, 1995, J CELL SCI, P95; Chawengsaksophak K, 1997, NATURE, V386, P84, DOI 10.1038/386084a0; Chun SY, 2007, ONCOGENE, V26, P4725, DOI 10.1038/sj.onc.1210258; Dang LH, 2006, ONCOGENE, V25, P2264, DOI 10.1038/sj.onc.1209247; Das R, 2007, MOL CELL, V26, P867, DOI 10.1016/j.molcel.2007.05.036; Drummond F, 1997, ANN HUM GENET, V61, P393, DOI 10.1017/S0003480097006465; DRUMMOND IA, 1994, MOL CELL BIOL, V14, P3800, DOI 10.1128/MCB.14.6.3800; Englert C, 1995, P NATL ACAD SCI USA, V92, P11960, DOI 10.1073/pnas.92.26.11960; Escobar Andres J. Gutierrez, 2006, In Silico Biology, V6, P347; Fang RX, 2000, GASTROENTEROLOGY, V118, P115, DOI 10.1016/S0016-5085(00)70420-3; Grosso AR, 2008, NUCLEIC ACIDS RES, V36, P4823, DOI 10.1093/nar/gkn463; Hinoi T, 2001, AM J PATHOL, V159, P2239, DOI 10.1016/S0002-9440(10)63074-X; Hinoi T, 2002, GASTROENTEROLOGY, V123, P1565, DOI 10.1053/gast.2002.36598; IANNELLO RC, 1993, J BIOL CHEM, V268, P22581; Jin DK, 1999, RENAL FAILURE, V21, P685, DOI 10.3109/08860229909094162; Kaitaniemi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054151; Kim YD, 2011, NUCLEIC ACIDS RES, V39, P4300, DOI 10.1093/nar/gkq1267; Lambert M, 1996, EUR J BIOCHEM, V236, P778, DOI 10.1111/j.1432-1033.1996.00778.x; Lamond AI, 1998, SCIENCE, V280, P547, DOI 10.1126/science.280.5363.547; LARSSON SH, 1995, CELL, V81, P391, DOI 10.1016/0092-8674(95)90392-5; Li P, 2007, AM J PATHOL, V171, P1847, DOI 10.2353/ajpath.2007.070198; Li QP, 2012, SIGNALS COMMUN TECHN, P1, DOI 10.1007/978-3-642-23731-7; Lin JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031686; Lin JE, 2010, GASTROENTEROLOGY, V138, P241, DOI 10.1053/j.gastro.2009.08.064; Magnani E, 2008, PLANT CELL, V20, P875, DOI 10.1105/tpc.108.058495; Mangs AH, 2006, NUCLEIC ACIDS RES, V34, P4976, DOI 10.1093/nar/gkl660; Maris C, 2005, FEBS J, V272, P2118, DOI 10.1111/j.1742-4658.2005.04653.x; Molkentin JD, 2000, J BIOL CHEM, V275, P38949, DOI 10.1074/jbc.R000029200; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Noh SJ, 2006, DNA RES, V13, P229, DOI 10.1093/dnares/dsl011; Noro B, 2006, GENE DEV, V20, P1636, DOI 10.1101/gad.1412606; Park J, 2000, GASTROENTEROLOGY, V119, P89, DOI 10.1053/gast.2000.8520; Phatnani HP, 2006, GENE DEV, V20, P2922, DOI 10.1101/gad.1477006; Salari K, 2012, P NATL ACAD SCI USA, V109, pE3196, DOI 10.1073/pnas.1206004109; Siehl JM, 2004, ANN HEMATOL, V83, P745, DOI 10.1007/s00277-004-0941-0; Silberg DG, 2000, GASTROENTEROLOGY, V119, P961, DOI 10.1053/gast.2000.18142; Strumpf D, 2005, DEVELOPMENT, V132, P2093, DOI 10.1242/dev.01801; Suh E, 1996, MOL CELL BIOL, V16, P619; SUH E, 1994, MOL CELL BIOL, V14, P7340, DOI 10.1128/MCB.14.11.7340; SWANSON MS, 1987, MOL CELL BIOL, V7, P1731, DOI 10.1128/MCB.7.5.1731; Tamai Y, 1999, CANCER RES, V59, P2965; Traber PG, 1996, ANNU REV PHYSIOL, V58, P275, DOI 10.1146/annurev.physiol.58.1.275; Uesaka T, 2002, AM J PHYSIOL-GASTR L, V283, pG840, DOI 10.1152/ajpgi.00075.2002; Ule J, 2005, NAT GENET, V37, P844, DOI 10.1038/ng1610; Witek ME, 2005, CLIN CANCER RES, V11, P8549, DOI 10.1158/1078-0432.CCR-05-1624; Yang Y, 2000, J BIOL CHEM, V275, P20734, DOI 10.1074/jbc.M908382199; ZAHLER AM, 1992, GENE DEV, V6, P837, DOI 10.1101/gad.6.5.837	52	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e104293	10.1371/journal.pone.0104293	http://dx.doi.org/10.1371/journal.pone.0104293			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25101906	Green Published, gold, Green Submitted			2022-12-27	WOS:000339993900056
J	Lin, HT; Wu, XH				Lin, Haotian; Wu, Xiaohang			Intervention Strategies for Improving Patient Adherence to Follow-Up in the Era of Mobile Information Technology: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; SHORT MESSAGE SERVICE; PRIMARY-CARE; CLINICAL-RESEARCH; SMS REMINDERS; OUTPATIENT CLINICS; ATTENDANCE; IMPACT; PHONE; APPOINTMENTS	Background: Patient adherence to follow-up plays a key role in the medical surveillance of chronic diseases and affects the implementation of clinical research by influencing cost and validity. We previously reported a randomized controlled trial (RCT) on short message service (SMS) reminders, which significantly improved follow-up adherence in pediatric cataract treatment. Methods: RCTs published in English that reported the impact of SMS or telephone reminders on increasing or decreasing the follow-up rate (FUR) were selected from Medline, EMBASE, PubMed, and the Cochrane Library through February 2014. The impacts of SMS and telephone reminders on the FUR of patients were systematically evaluated by meta-analysis and bias was assessed. Results: We identified 13 RCTs reporting on 3276 patients with and 3402 patients without SMS reminders and 8 RCTs reporting on 2666 patients with and 3439 patients without telephone reminders. For the SMS reminders, the majority of the studies (>50%) were at low risk of bias, considering adequate sequence generation, allocation concealment, blinding, evaluation of incomplete outcome data, and lack of selective reporting. For the studies on the telephone reminders, only the evaluation of incomplete outcome data accounted for more than 50% of studies being at low risk of bias. The pooled odds ratio (OR) for the improvement of follow-up adherence in the SMS group compared with the control group was 1.76 (95% CI [1.37, 2.26]; P<0.01), and the pooled OR for the improvement of follow-up adherence in the telephone group compared with the control group was 2.09 (95% CI [1.85, 2.36]; P<0.01); both sets showed no evidence of publication bias. Conclusions: SMS and telephone reminders could both significantly improve the FUR. Telephone reminders were more effective but had a higher risk of bias than SMS reminders.	[Lin, Haotian; Wu, Xiaohang] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Lin, HT (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China.	gddlht@aliyun.com			Pearl River Science and Technology New Star Project of Guangzhou City [2014J2200060]; Cultivation Projects for Young Teaching Staff of Sun Yat-sen University of the Fundamental Research Funds [12ykpy61]	Pearl River Science and Technology New Star Project of Guangzhou City; Cultivation Projects for Young Teaching Staff of Sun Yat-sen University of the Fundamental Research Funds	This study was funded by the Pearl River Science and Technology New Star (Haotian Lin, 2014J2200060) Project of Guangzhou City and the Cultivation Projects for Young Teaching Staff of Sun Yat-sen University (12ykpy61) of the Fundamental Research Funds for the Central Universities. The sponsors of the study had no role in the design of the study protocol, the data collection, the data analysis, the data interpretation, the writing of the report, or the decision to submit the manuscript for publication.	Anderson RM, 2003, ETHNIC DIS, V13, P40; Baren JM, 2006, CHEST, V129, P257, DOI 10.1378/chest.129.2.257; Bos A, 2005, AM J ORTHOD DENTOFAC, V127, P355, DOI 10.1016/j.ajodo.2004.11.014; Chen X, 2008, MED PHYSL, P4; Chen Yu-tan, 2013, Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, V48, P511; Chen ZW, 2008, J ZHEJIANG UNIV-SC B, V9, P34, DOI 10.1631/jzus.B071464; Clough BA, 2014, BEHAV COGN PSYCHOTH, P1; Cooley ME, 2003, CANCER NURS, V26, P376, DOI 10.1097/00002820-200310000-00006; Downing SG, 2013, SEX TRANSM INFECT, V89, P16, DOI 10.1136/sextrans-2011-050454; Fairhurst K, 2008, QUAL SAF HEALTH CARE, V17, P373, DOI 10.1136/qshc.2006.020768; FERSON MJ, 1995, PUBLIC HEALTH, V109, P25, DOI 10.1016/S0033-3506(95)80072-7; Free C, 2013, PLOS MED, V10, DOI [10.1371/journal.pmed.1001363, 10.1371/journal.pmed.1001362]; Goelen G, 2010, ONCOL NURS FORUM, V37, P419, DOI 10.1188/10.ONF.E312-E317; Guy R, 2012, HEALTH SERV RES, V47, P614, DOI 10.1111/j.1475-6773.2011.01342.x; Hertz RP, 2005, CLIN THER, V27, P1064, DOI 10.1016/j.clinthera.2005.07.009; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Ho M, 2013, JAMA PEDIATR, V167, P759, DOI 10.1001/jamapediatrics.2013.1453; Holtzer-Goor KM, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-312; Hoofnagle JH, 2007, HEPATOLOGY, V45, P1056, DOI 10.1002/hep.21627; Huang GF, 2012, OPHTHAL EPIDEMIOL, V19, P67, DOI 10.3109/09286586.2011.628777; Isaaz K, 2013, J INVASIVE CARDIOL, V25, P323; Iturriaga Hernan, 2012, Binocul Vis Strabolog Q Simms Romano, V27, P195; Jin Jing, 2008, Ther Clin Risk Manag, V4, P269; Koshy E, 2008, BMC OPHTHALMOL, V8, DOI 10.1186/1471-2415-8-9; Leong KC, 2006, FAM PRACT, V23, P699, DOI 10.1093/fampra/cml044; Liew SM, 2009, BRIT J GEN PRACT, V59, P916, DOI 10.3399/bjgp09X472250; Lin HT, 2012, OPHTHALMOLOGY, V119, P2463, DOI 10.1016/j.ophtha.2012.06.046; Ma Rui-Hua, 2008, Zhonghua Yi Xue Za Zhi, V88, P2618; Mahtani KR, 2011, COCHRANE DB SYST REV, pD5025; Milne RG, 2006, HEALTH CARE MANAGE R, V31, P130, DOI 10.1097/00004010-200604000-00006; Nadel MR, 2005, ANN INTERN MED, V142, P86, DOI 10.7326/0003-4819-142-2-200501180-00007; Narring F, 2013, J EPIDEMIOL COMMUN H, V67, P888, DOI 10.1136/jech-2013-202510; Odeny TA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043832; Page SJ, 2013, AM J OCCUP THER, V67, P154, DOI 10.5014/ajot.2013.006197; Plotnikoff RC, 2010, AM J HEALTH PROMOT, V24, P255, DOI 10.4278/ajhp.08032830; Pop-Eleches C, 2011, AIDS, V25, P825, DOI 10.1097/QAD.0b013e32834380c1; Prasad S, 2012, INT DENT J, V62, P21, DOI 10.1111/j.1875-595X.2011.00081.x; Roberts Nicola, 2007, J Health Serv Res Policy, V12, P69, DOI 10.1258/135581907780279567; Robiner WN, 2005, CONTEMP CLIN TRIALS, V26, P59, DOI 10.1016/j.cct.2004.11.015; Roter DL, 1998, MED CARE, V36, P1138, DOI 10.1097/00005650-199808000-00004; Sawyer SM, 2002, J PAEDIATR CHILD H, V38, P79, DOI 10.1046/j.1440-1754.2002.00766.x; Schwartz Gail F, 2005, Curr Opin Ophthalmol, V16, P114, DOI 10.1097/01.icu.0000156139.05323.26; Taylor NF, 2012, ARCH PHYS MED REHAB, V93, P21, DOI 10.1016/j.apmr.2011.08.007; Toenders W, 1992, Int J Risk Saf Med, V3, P338, DOI 10.3233/JRS-1992-35-615; Vervloet M, 2012, J AM MED INFORM ASSN, V19, P696, DOI 10.1136/amiajnl-2011-000748; Vivier PM, 2000, ARCH PEDIAT ADOL MED, V154, P1243, DOI 10.1001/archpedi.154.12.1243; Wang KJ, 2014, INT ARCH ALLERGY IMM, V163, P51, DOI 10.1159/000356317; [吴一帆 Wu Yifan], 2012, [中国全科医学, Chinese General Practice], V15, P1198	49	35	35	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e104266	10.1371/journal.pone.0104266	http://dx.doi.org/10.1371/journal.pone.0104266			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM6SM	25100267	Green Published, gold, Green Submitted			2022-12-27	WOS:000339995100058
J	Pan, LL; North, HA; Sahni, V; Jeong, SJ; Mcguire, TL; Berns, EJ; Stupp, SI; Kessler, JA				Pan, Liuliu; North, Hilary A.; Sahni, Vibhu; Jeong, Su Ji; Mcguire, Tammy L.; Berns, Eric J.; Stupp, Samuel I.; Kessler, John A.			beta 1-Integrin and Integrin Linked Kinase Regulate Astrocytic Differentiation of Neural Stem Cells	PLOS ONE			English	Article							ALTERNATIVELY SPLICED REGION; SPINAL-CORD-INJURY; NEURITE OUTGROWTH; SYNTHETIC PEPTIDE; SCAR FORMATION; GLIAL SCAR; A-CHAIN; ACTIVATION; TENASCIN; ADHESION	Astrogiiosis with glial scar formation after damage to the nervous system is a major impediment to axonal regeneration and functional recovery. The present study examined the role of beta 1-integrin signaling in regulating astrocytic differentiation of neural stem cell. In the adult spinal cord beta 1-integrin is expressed predominantly in the ependymal region where ependymal stem cell (ESCs) reside. beta 1-integrin signaling suppressed astrocytic differentiation of both cultured ESCs and subventricular zone (SVZ) progenitor cells. Conditional knockout of beta 1-integrin enhanced astrogliogenesis both by cultured ECS and by SVZ progenitor cells. Previous studies have shown that injection into the injured spinal cord of a self-assembling peptide amphiphile that display an IKVA epitope (IKVAV-PA) limits glial scar formation and enhances functional recovery. Here we find that injection of IKVAV-PA induced high levels of beta 1-integrin in ESCs in vivo, and that conditional knockout of beta 1-integrin abolished the astroglial suppressive effects of IKVAV-PA in vitro, Injection into an injured spinal cord of PAs expressing two other epitopes known to interact with beta 1-integrin, a Tenascin C epitope and the fibronectin epitope RGD, improved functional recovery comparable to the effects of IKVAV-PA. Finally we found that the effects of beta 1-integrin signaling on astrogliosis are mediated by integrin linked kinase (ILK). These observations demonstrate an important role for beta 1-integrin/ILK signaling in regulating astrogliosis from ESCs and suggest ILK as a potential target for limiting glial scar formation after nervous system injury.	[Pan, Liuliu; North, Hilary A.; Sahni, Vibhu; Jeong, Su Ji; Mcguire, Tammy L.; Kessler, John A.] Northwestern Univ, Dept Neurol, Chicago, IL 60611 USA; [Berns, Eric J.] Northwestern Univ, Dept Biomed Engn, Evanston, IL 60611 USA; [Stupp, Samuel I.] Northwestern Univ, Dept Mat Sci & Engn, Evanston, IL 60611 USA; [Stupp, Samuel I.] Northwestern Univ, Dept Chem, Evanston, IL 60611 USA; [Stupp, Samuel I.] Northwestern Univ, Dept Med, Chicago, IL 60611 USA; [Stupp, Samuel I.] Northwestern Univ, Inst BioNanotechnol Med, Chicago, IL 60611 USA	Northwestern University; Northwestern University; Northwestern University; Northwestern University; Northwestern University; Northwestern University	Pan, LL (corresponding author), Northwestern Univ, Dept Neurol, Chicago, IL 60611 USA.	liuliupan2012@u.northwestern.edu	Stupp, Samuel/AGV-1942-2022; Stupp, Samuel/B-6737-2009	Berns, Eric/0000-0002-2203-0847	National Institutes of Health [R01 NS 20013, R01 NS 20778]; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB003806] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS020013, R01NS020778] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This project was supported by National Institutes of Health Grants R01 NS 20013 and R01 NS 20778. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthis NJ, 2011, TRENDS BIOCHEM SCI, V36, P191, DOI 10.1016/j.tibs.2010.11.002; Barnabe-Heider F, 2010, CELL STEM CELL, V7, P470, DOI 10.1016/j.stem.2010.07.014; Basso DM, 1996, J NEUROTRAUM, V13, P343, DOI 10.1089/neu.1996.13.343; Bonaguidi MA, 2005, DEVELOPMENT, V132, P5503, DOI 10.1242/dev.02166; Brakebusch C, 2005, CANCER METAST REV, V24, P403, DOI 10.1007/s10555-005-5132-5; Brozzi F, 2009, J BIOL CHEM, V284, P8788, DOI 10.1074/jbc.M805897200; Campbell I.D., 2011, COLD SPRING HARB PER, V3; Campos LS, 2004, DEVELOPMENT, V131, P3433, DOI 10.1242/dev.01199; Casar B, 2012, ONCOGENE; DUSART I, 1991, NEUROSCIENCE, V45, P541, DOI 10.1016/0306-4522(91)90269-T; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; Giancotti FG, 1997, CURR OPIN CELL BIOL, V9, P691, DOI 10.1016/S0955-0674(97)80123-8; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; HALL DE, 1990, J CELL BIOL, V110, P2175, DOI 10.1083/jcb.110.6.2175; Hall PE, 2006, STEM CELLS, V24, P2078, DOI 10.1634/stemcells.2005-0595; Hannigan G, 2005, NAT REV CANCER, V5, P51, DOI 10.1038/nrc1524; Hannigan GE, 1996, NATURE, V379, P91, DOI 10.1038/379091a0; Herrmann JE, 2008, J NEUROSCI, V28, P7231, DOI 10.1523/JNEUROSCI.1709-08.2008; Hill MM, 2002, CURR BIOL, V12, P1251, DOI 10.1016/S0960-9822(02)00973-9; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Joshi M, 2002, J NEUROTRAUM, V19, P175, DOI 10.1089/08977150252806947; Lee KK, 2006, GLIA, V53, P836, DOI 10.1002/glia.20343; Lee SL, 2011, J MED CHEM, V54, P6364, DOI 10.1021/jm2007744; Legate KR, 2006, NAT REV MOL CELL BIO, V7, P20, DOI 10.1038/nrm1789; Leone DP, 2005, J CELL SCI, V118, P2589, DOI 10.1242/jcs.02396; Leung-Hagesteijn C, 2005, MOL CELL BIOL, V25, P3648, DOI 10.1128/MCB.25.9.3648-3657.2005; Liberto CM, 2004, J NEUROCHEM, V89, P1092, DOI 10.1111/j.1471-4159.2004.02420.x; Liu SC, 2000, J CELL SCI, V113, P3563; Luque A, 1996, J BIOL CHEM, V271, P11067, DOI 10.1074/jbc.271.19.11067; Mehler MF, 2000, DEV NEUROSCI-BASEL, V22, P74, DOI 10.1159/000017429; Meiners S, 2001, J NEUROSCI, V21, P7215, DOI 10.1523/JNEUROSCI.21-18-07215.2001; Meletis K, 2008, PLOS BIOL, V6, P1494, DOI 10.1371/journal.pbio.0060182; Mercado MLT, 2004, J NEUROSCI, V24, P238, DOI 10.1523/JNEUROSCI.4519-03.2004; Milner R, 2002, J NEUROSCI RES, V69, P286, DOI 10.1002/jnr.10321; Naska S, 2006, J NEUROSCI, V26, P13344, DOI 10.1523/JNEUROSCI.4462-06.2006; NOMIZU M, 1995, FEBS LETT, V365, P227, DOI 10.1016/0014-5793(95)00475-O; Okada S, 2006, NAT MED, V12, P829, DOI 10.1038/nm1425; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; PFAFF M, 1994, EUR J BIOCHEM, V225, P975, DOI 10.1111/j.1432-1033.1994.0975b.x; Pruszak J, 2009, STEM CELLS, V27, P2928, DOI 10.1002/stem.211; Relvas JB, 2001, CURR BIOL, V11, P1039, DOI 10.1016/S0960-9822(01)00292-5; Robel S, 2011, NAT REV NEUROSCI, V12, P88, DOI 10.1038/nrn2978; Robel S, 2009, GLIA, V57, P1630, DOI 10.1002/glia.20876; Sahni V, 2010, J NEUROSCI, V30, P1839, DOI 10.1523/JNEUROSCI.4459-09.2010; SanchezMateos P, 1996, SEMIN CANCER BIOL, V7, P99, DOI 10.1006/scbi.1996.0015; SEPHEL GC, 1989, BIOCHEM BIOPH RES CO, V162, P821, DOI 10.1016/0006-291X(89)92384-X; Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Smeeton J, 2010, DEVELOPMENT, V137, P3233, DOI 10.1242/dev.052845; Stirling DP, 2009, J NEUROSCI, V29, P753, DOI 10.1523/JNEUROSCI.4918-08.2009; Tabe Y, 2007, CANCER RES, V67, P684, DOI 10.1158/0008-5472.CAN-06-3166; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; TASHIRO K, 1989, J BIOL CHEM, V264, P16174; Tysseling-Mattiace VM, 2008, J NEUROSCI, V28, P3814, DOI 10.1523/JNEUROSCI.0143-08.2008; Yokosaki Y, 1996, J BIOL CHEM, V271, P24144, DOI 10.1074/jbc.271.39.24144; Zhu Y, 1999, NEURON, V23, P473, DOI 10.1016/S0896-6273(00)80801-6	56	51	51	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e104335	10.1371/journal.pone.0104335	http://dx.doi.org/10.1371/journal.pone.0104335			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25098415	Green Published, gold, Green Submitted			2022-12-27	WOS:000339995100063
J	Suzuki, S; Kakuta, M; Ishida, T; Akiyama, Y				Suzuki, Shuji; Kakuta, Masanori; Ishida, Takashi; Akiyama, Yutaka			GHOSTX: An Improved Sequence Homology Search Algorithm Using a Query Suffix Array and a Database Suffix Array	PLOS ONE			English	Article							LOCAL ALIGNMENT SEARCH; PROTEIN; BLAST; GENERATION; KEGG; TOOL	DNA sequences are translated into protein coding sequences and then further assigned to protein families in metagenomic analyses, because of the need for sensitivity. However, huge amounts of sequence data create the problem that even general homology search analyses using BLASTX become difficult in terms of computational cost. We designed a new homology search algorithm that finds seed sequences based on the suffix arrays of a query and a database, and have implemented it as GHOSTX. GHOSTX achieved approximately 131-165 times acceleration over a BLASTX search at similar levels of sensitivity. GHOSTX is distributed under the BSD 2-clause license and is available for download at http://www.bi.cs.titech.ac.jp/ghostx/. Currently, sequencing technology continues to improve, and sequencers are increasingly producing larger and larger quantities of data. This explosion of sequence data makes computational analysis with contemporary tools more difficult. We offer this tool as a potential solution to this problem.	[Suzuki, Shuji; Kakuta, Masanori; Ishida, Takashi; Akiyama, Yutaka] Tokyo Inst Technol, Grad Sch Informat Sci & Engn, Meguro Ku, Tokyo 152, Japan	Tokyo Institute of Technology	Akiyama, Y (corresponding author), Tokyo Inst Technol, Grad Sch Informat Sci & Engn, Meguro Ku, Tokyo 152, Japan.	akiyama@cs.titech.ac.jp	Kakuta, Masanori/D-2096-2015; Kakuta, Masanori/AAA-5810-2020; Ishida, Takashi/D-2017-2015; Akiyama, Yutaka/D-2048-2015	Ishida, Takashi/0000-0002-9478-3223; Akiyama, Yutaka/0000-0003-2863-8703	JSPS [248766]; MEXT of Japan; National Cancer Center, Japan	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Cancer Center, Japan(National Cancer Center - Japan)	This research was supported by a Grant-in-Aid for JSPS Fellows (248766) and HPCI Strategic Program Computational Life Science, Application in Drug Discovery and Medical Development by MEXT of Japan, Cancer Research Development funding by National Cancer Center, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 2005, FEBS J, V272, P5101, DOI 10.1111/j.1742-4658.2005.04945.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ghodsi M, 2009, IEEE INT C BIOINFORM, P83, DOI 10.1109/BIBM.2009.25; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kurokawa K, 2007, DNA RES, V14, P169, DOI 10.1093/dnares/dsm018; Manber U, 1990, P 1 ANN ACM SIAM S D, P319; PEARSON WR, 1991, GENOMICS, V11, P635, DOI 10.1016/0888-7543(91)90071-L; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Vouzis PD, 2011, BIOINFORMATICS, V27, P182, DOI 10.1093/bioinformatics/btq644; Ye YZ, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-159; Zhao YA, 2012, BIOINFORMATICS, V28, P125, DOI 10.1093/bioinformatics/btr595	15	49	50	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e103833	10.1371/journal.pone.0103833	http://dx.doi.org/10.1371/journal.pone.0103833			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25099887	gold, Green Submitted, Green Published			2022-12-27	WOS:000339995100035
J	De Batista, PR; Palacios, R; Martin, A; Hernanz, R; Medici, CT; Silva, MASC; Rossi, EM; Aguado, A; Vassallo, DV; Salaices, M; Alonso, MJ				De Batista, Priscila R.; Palacios, Roberto; Martin, Angela; Hernanz, Raquel; Medici, Cindy T.; Silva, Marito A. S. C.; Rossi, Emilly M.; Aguado, Andrea; Vassallo, Dalton V.; Salaices, Mercedes; Alonso, Maria J.			Toll-Like Receptor 4 Upregulation by Angiotensin II Contributes to Hypertension and Vascular Dysfunction through Reactive Oxygen Species Production	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; ENDOTHELIAL DYSFUNCTION; BLOOD-PRESSURE; RESISTANCE ARTERIES; OXIDATIVE STRESS; IMMUNE-SYSTEM; EXPRESSION; INFLAMMATION; LIPOPOLYSACCHARIDE; ACTIVATION	Hypertension is considered as a low-grade inflammatory disease, with adaptive immunity being an important mediator of this pathology. TLR4 may have a role in the development of several cardiovascular diseases; however, little is known about its participation in hypertension. We aimed to investigate whether TLR4 activation due to increased activity of the renin-angiotensin system (RAS) contributes to hypertension and its associated endothelial dysfunction. For this, we used aortic segments from Wistar rats treated with a non-specific IgG (1 mu g/day) and SHRs treated with losartan (15 mg/kg? day), the non-specific IgG or the neutralizing antibody anti-TLR4 (1 mg/day), as well as cultured vascular smooth muscle cells (VSMC) from Wistar and SHRs. TLR4 mRNA levels were greater in the VSMC and aortas from SHRs compared with Wistar rats; losartan treatment reduced those levels in the SHRs. Treatment of the SHRs with the anti-TLR4 antibody: 1) reduced the increased blood pressure, heart rate and phenylephrine-induced contraction while it improved the impaired acetylcholine-induced relaxation; 2) increased the potentiation of phenylephrine contraction after endothelium removal; and 3) abolished the inhibitory effects of tiron, apocynin and catalase on the phenylephrine-induced response as well as its enhancing effect of acetylcholine-induced relaxation. In SHR VSMCs, angiotensin II increased TLR4 mRNA levels, and losartan reduced that increase. CLI-095, a TLR4 inhibitor, mitigated the increases in NAD(P) H oxidase activity, superoxide anion production, migration and proliferation that were induced by angiotensin II. In conclusion, TLR4 pathway activation due to increased RAS activity is involved in hypertension, and by inducing oxidative stress, this pathway contributes to the endothelial dysfunction associated with this pathology. These results suggest that TLR4 and innate immunity may play a role in hypertension and its associated end-organ damage.	[De Batista, Priscila R.; Palacios, Roberto; Martin, Angela; Hernanz, Raquel; Alonso, Maria J.] Univ Rey Juan Carlos, Dept Biochem Physiol & Mol Genet, Alcorcon, Spain; [De Batista, Priscila R.; Medici, Cindy T.; Silva, Marito A. S. C.; Rossi, Emilly M.; Vassallo, Dalton V.] Univ Fed Espirito Santo, Dept Physiol Sci, Vitoria, Brazil; [Aguado, Andrea; Salaices, Mercedes] Univ Autonoma Madrid, Dept Pharmacol, Madrid, Spain	Universidad Rey Juan Carlos; Universidade Federal do Espirito Santo; Autonomous University of Madrid	Salaices, M (corresponding author), Univ Autonoma Madrid, Dept Pharmacol, Madrid, Spain.	mercedes.salaices@uam.es; mariajesus.alonso@urjc.es	Martin, Angela/AAB-4185-2019; Palacios, Roberto/H-9905-2015; HERNANZ, RAQUEL/H-8943-2015; Palacios, Roberto/GYU-6427-2022; Alonso, María/AAB-4309-2019; Palacios, Roberto/K-7889-2019; Vassallo, Dalton/K-8289-2016	Martin, Angela/0000-0002-4368-6300; Palacios, Roberto/0000-0002-0867-1277; HERNANZ, RAQUEL/0000-0002-2624-9387; Palacios, Roberto/0000-0002-0867-1277; Alonso, María/0000-0003-4912-1121; Vassallo, Dalton/0000-0002-4463-4174; Salaices Sanchez, Mercedes/0000-0003-3323-1692; Silva, Marito/0000-0003-0515-2540	MINECO [SAF2012-36400]; ISCIII [RD12/0042/0024]; MEC [PHB2011-0001-PC]; URJC [PRIN13_CS12]; CAPES; PRONEX-FAPES/CNPq	MINECO(Spanish Government); ISCIII(Instituto de Salud Carlos III); MEC(European Commission); URJC; CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); PRONEX-FAPES/CNPq	This work was supported by MINECO (SAF2012-36400), ISCIII (RD12/0042/0024), MEC (PHB2011-0001-PC), URJC (PRIN13_CS12), CAPES and PRONEX-FAPES/CNPq. PRB was a fellow of CAPES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez Y, 2007, J PHARMACOL EXP THER, V321, P381, DOI 10.1124/jpet.106.115287; Asehnoune K, 2004, J IMMUNOL, V172, P2522, DOI 10.4049/jimmunol.172.4.2522; Garcia-Redondo AB, 2009, J PHARMACOL EXP THER, V328, P19, DOI 10.1124/jpet.108.144295; Bhagat K, 1997, CIRCULATION, V96, P3042, DOI 10.1161/01.CIR.96.9.3042; Bomfim GF, 2012, CLIN SCI, V122, P535, DOI 10.1042/CS20110523; Brandes RP, 1999, HYPERTENSION, V33, P1243, DOI 10.1161/01.HYP.33.5.1243; Briones AM, 2000, BRIT J PHARMACOL, V131, P185, DOI 10.1038/sj.bjp.0703552; Briones AM, 1999, BRIT J PHARMACOL, V126, P111, DOI 10.1038/sj.bjp.0702281; Cai H, 2000, CIRC RES, V87, P840, DOI 10.1161/01.RES.87.10.840; Dange RB, 2014, CARDIOVASC RES, V103, P17, DOI 10.1093/cvr/cvu067; Dasu MR, 2010, DIABETES CARE, V33, P861, DOI 10.2337/dc09-1799; Dasu MR, 2009, ATHEROSCLEROSIS, V202, P76, DOI 10.1016/j.atherosclerosis.2008.04.010; de Graaf R, 2006, MICROBES INFECT, V8, P1859, DOI 10.1016/j.micinf.2006.02.024; Devaraj S, 2008, J CLIN ENDOCR METAB, V93, P578, DOI 10.1210/jc.2007-2185; Eissler R, 2011, HYPERTENS RES, V34, P551, DOI 10.1038/hr.2010.270; Freitas MG, 2003, J HYPERTENS, V21, P1505, DOI 10.1097/00004872-200308000-00014; Hernanz R, 2004, AM J PHYSIOL-HEART C, V287, pH225, DOI 10.1152/ajpheart.00548.2003; Ji YY, 2009, LAB INVEST, V89, P887, DOI 10.1038/labinvest.2009.45; Ji YY, 2009, CELL PHYSIOL BIOCHEM, V23, P265, DOI 10.1159/000218173; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kim YM, 2005, AM J OBSTET GYNECOL, V193, P921, DOI 10.1016/j.ajog.2005.06.053; Liang CF, 2013, ARTERIOSCL THROM VAS, V33, P777, DOI 10.1161/ATVBAHA.112.301087; Lv JL, 2009, BIOCHEM BIOPH RES CO, V380, P81, DOI 10.1016/j.bbrc.2009.01.035; Marketou ME, 2012, J CLIN HYPERTENS, V14, P330, DOI 10.1111/j.1751-7176.2012.00620.x; Martin A, 2012, J HYPERTENS, V30, P315, DOI 10.1097/HJH.0b013e32834f043b; Martinez-Revelles S, 2013, ANTIOXID REDOX SIGN, V18, P51, DOI 10.1089/ars.2011.4335; McCarthy CG, 2014, AM J PHYSIOL-HEART C, V306, pH184, DOI 10.1152/ajpheart.00328.2013; Mehta PK, 2007, AM J PHYSIOL-CELL PH, V292, pC82, DOI 10.1152/ajpcell.00287.2006; Ogawa K, 2011, J CARDIOVASC PHARM, V58, P543, DOI 10.1097/FJC.0b013e31822e6b40; Otsui K, 2007, HEART VESSELS, V22, P416, DOI 10.1007/s00380-007-1001-1; Pacquelet S, 2007, BIOCHEM J, V403, P451, DOI 10.1042/BJ20061184; Park HS, 2006, CARDIOVASC RES, V72, P447, DOI 10.1016/j.cardiores.2006.09.012; Perticone F, 2001, CIRCULATION, V104, P191, DOI 10.1161/01.CIR.104.2.191; Pi Y, 2013, LAB INVEST, V93, P880, DOI 10.1038/labinvest.2013.79; Pineda A, 2011, ARCH MED RES, V42, P382, DOI 10.1016/j.arcmed.2011.08.003; Pleiner J, 2002, CIRCULATION, V106, P1460, DOI 10.1161/01.CIR.0000030184.70207.FF; Ryan KA, 2004, INFECT IMMUN, V72, P2123, DOI 10.1128/IAI.72.4.2123-2130.2004; Sanchez-Lemus E, 2008, ENDOCRINOLOGY, V149, P5177, DOI 10.1210/en.2008-0242; Sanchez-Lemus E, 2009, AM J PHYSIOL-REG I, V296, pR1376, DOI 10.1152/ajpregu.90962.2008; Savoia C, 2007, CLIN SCI, V112, P375, DOI 10.1042/CS20060247; Schiffrin EL, 2014, CLIN SCI, V126, P267, DOI 10.1042/CS20130407; Schiffrin EL, 2013, CAN J CARDIOL, V29, P543, DOI 10.1016/j.cjca.2012.06.009; Schulz E, 2011, HYPERTENS RES, V34, P665, DOI 10.1038/hr.2011.39; Sollinger D, 2014, CARDIOVASC RES, V101, P464, DOI 10.1093/cvr/cvt265; Touyz RM, 2011, HYPERTENS RES, V34, P5, DOI 10.1038/hr.2010.201; Tsan MF, 2004, J LEUKOCYTE BIOL, V76, P514, DOI 10.1189/jlb.0304127; Virdis A, 2011, INT J HYPERTENS, V2011, DOI 10.4061/2011/916310; Wolf G, 2006, J AM SOC NEPHROL, V17, P1585, DOI 10.1681/ASN.2005070699; Wu J, 2009, INFLAMM RES, V58, P473, DOI 10.1007/s00011-009-0012-z; Xavier FE, 2003, VASC PHARMACOL, V40, P67, DOI 10.1016/S1537-1891(02)00315-4; Xie BG, 2014, EXP THER MED, V7, P236, DOI 10.3892/etm.2013.1360; Yang J, 2009, MOL CELL BIOCHEM, V330, P39, DOI 10.1007/s11010-009-0098-1; Yuen CY, 2012, CIRC RES, V111, pE55, DOI 10.1161/CIRCRESAHA.112.271361; Zhang Z, 2011, INFLAMM RES, V60, P37, DOI 10.1007/s00011-010-0232-2	54	70	73	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e104020	10.1371/journal.pone.0104020	http://dx.doi.org/10.1371/journal.pone.0104020			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093580	Green Published, Green Submitted, gold			2022-12-27	WOS:000341357200060
J	Kalbouneh, H; Schlicksupp, A; Kirsch, J; Kuhse, J				Kalbouneh, Heba; Schlicksupp, Andrea; Kirsch, Joachim; Kuhse, Jochen			Cyclin-Dependent Kinase 5 Is Involved in the Phosphorylation of Gephyrin and Clustering of GABA(A) Receptors at Inhibitory Synapses of Hippocampal Neurons	PLOS ONE			English	Article							GLYCINE-RECEPTOR; TYROSINE PHOSPHORYLATION; CDK5; EXPRESSION; COLLYBISTIN; SUBUNIT; DOMAIN; P35	CDK5 has been implicated in neural functions including growth, neuronal migration, synaptic transmission and plasticity of excitatory chemical synapses. Here we report robust effects of CDK5 on phosphorylation of the postsynaptic scaffold protein gephyrin and clustering of inhibitory GABA(A) receptors in hippocampal neurons. shRNA-mediated knockdown of CDK5 and pharmacological inhibition of cyclin-dependent kinases reduced phosphorylated gephyrin clusters and postsynaptic gamma 2-containing GABA(A) receptors. Phosphorylation of S270 is antagonized by PP1/PP2a phosphatase and site-directed mutagenesis and in vitro phosphorylation experiments indicate that S270 is a putative CDK5 phosphorylation site of gephyrin. Our data suggest that CDK5 plays an essential role for the stability of gephyrin-dependent GABA(A) receptor clusters in hippocampal neurons.	[Kalbouneh, Heba; Schlicksupp, Andrea; Kirsch, Joachim; Kuhse, Jochen] Heidelberg Univ, Dept Anat & Cell Biol, Heidelberg, Germany	Ruprecht Karls University Heidelberg	Kuhse, J (corresponding author), Heidelberg Univ, Dept Anat & Cell Biol, Heidelberg, Germany.	jochen.kuhse@urz.uni-heidelberg.de	Kalbouneh, Heba/P-4801-2015; Kuhse, Jochen/T-3864-2019	Kalbouneh, Heba/0000-0002-0956-9223; 				Bausen M, 2010, MOL CELL NEUROSCI, V44, P201, DOI 10.1016/j.mcn.2010.02.007; Charrier C, 2010, NAT NEUROSCI, V13, P1388, DOI 10.1038/nn.2645; Cheung ZH, 2007, PLOS BIOL, V5, P865, DOI 10.1371/journal.pbio.0050063; Cheung ZH, 2012, TRENDS CELL BIOL, V22, P169, DOI 10.1016/j.tcb.2011.11.003; Dresbach T, 2003, MOL CELL NEUROSCI, V23, P279, DOI 10.1016/S1044-7431(03)00015-0; Essrich C, 1998, NAT NEUROSCI, V1, P563, DOI 10.1038/2798; Feng GP, 1998, SCIENCE, V282, P1321, DOI 10.1126/science.282.5392.1321; Guan JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025735; Harvey K, 2004, J NEUROSCI, V24, P5816, DOI 10.1523/JNEUROSCI.1184-04.2004; Herweg J, 2012, J BIOL CHEM, V287, P12645, DOI 10.1074/jbc.M112.341826; Hirasawa M, 2004, P NATL ACAD SCI USA, V101, P6249, DOI 10.1073/pnas.0307322101; Kins S, 2000, NAT NEUROSCI, V3, P22, DOI 10.1038/71096; Kirsch J, 1998, NATURE, V392, P717, DOI 10.1038/33694; Kneussel M, 2001, MOL CELL NEUROSCI, V17, P973, DOI 10.1006/mcne.2001.0983; Kneussel M, 2000, J PHYSIOL-LONDON, V525, P1, DOI 10.1111/j.1469-7793.2000.t01-4-00001.x; Korber C, 2012, MOL CELL NEUROSCI, V50, P250, DOI 10.1016/j.mcn.2012.05.006; Kuhse J, 2012, J BIOL CHEM, V287, P30952, DOI 10.1074/jbc.M112.349597; LANGOSCH D, 1992, FEBS LETT, V298, P113, DOI 10.1016/0014-5793(92)80034-E; LEW J, 1994, NATURE, V371, P423, DOI 10.1038/371423a0; Li BS, 2001, P NATL ACAD SCI USA, V98, P12742, DOI 10.1073/pnas.211428098; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; MEYERSON M, 1992, EMBO J, V11, P2909, DOI 10.1002/j.1460-2075.1992.tb05360.x; Morabito MA, 2004, J NEUROSCI, V24, P865, DOI 10.1523/JNEUROSCI.4582-03.2004; Nani F, 2013, J NEUROSCI, V33, P12718, DOI 10.1523/JNEUROSCI.0388-13.2013; Nawrotzki R, 2012, HISTOCHEM CELL BIOL, V137, P471, DOI 10.1007/s00418-012-0914-7; Ohshima T, 1996, P NATL ACAD SCI USA, V93, P11173, DOI 10.1073/pnas.93.20.11173; Ou CY, 2010, CELL, V141, P846, DOI 10.1016/j.cell.2010.04.011; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; Pawson AJ, 2014, NUCLEIC ACIDS RES, V42, pD1098, DOI 10.1093/nar/gkt1143; PFEIFFER F, 1984, P NATL ACAD SCI-BIOL, V81, P7224, DOI 10.1073/pnas.81.22.7224; Saiyed T, 2007, J BIOL CHEM, V282, P5625, DOI 10.1074/jbc.M610290200; Saliba RS, 2012, EMBO J, V31, P2937, DOI 10.1038/emboj.2012.109; Specht CG, 2011, EMBO J, V30, P3842, DOI 10.1038/emboj.2011.276; TSAI LH, 1994, NATURE, V371, P419, DOI 10.1038/371419a0; Tyagarajan SK, 2013, J BIOL CHEM, V288, P9634, DOI 10.1074/jbc.M112.442616; Tyagarajan SK, 2011, P NATL ACAD SCI USA, V108, P379, DOI 10.1073/pnas.1011824108; Vithlani M, 2009, BIOCHEM SOC T, V37, P1355, DOI 10.1042/BST0371355; Wuchter J, 2012, J NEUROSCI, V32, P14821, DOI 10.1523/JNEUROSCI.1261-12.2012; Zhang S, 2008, J NEUROSCI, V28, P415, DOI 10.1523/JNEUROSCI.1900-07.2008; Zita MM, 2007, EMBO J, V26, P1761, DOI 10.1038/sj.emboj.7601625; Zukerberg LR, 2000, NEURON, V26, P633, DOI 10.1016/S0896-6273(00)81200-3	41	16	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e104256	10.1371/journal.pone.0104256	http://dx.doi.org/10.1371/journal.pone.0104256			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093719	Green Published, Green Submitted, gold			2022-12-27	WOS:000341357200089
J	Kempton, CE; Heninger, JR; Johnson, SM				Kempton, Colton E.; Heninger, Justin R.; Johnson, Steven M.			Reproducibility and Consistency of In Vitro Nucleosome Reconstitutions Demonstrated by Invitrosome Isolation and Sequencing	PLOS ONE			English	Article							BASE-PAIR RESOLUTION; CORE PARTICLE; C. ELEGANS; POSITIONS; LANDSCAPE; CHROMATIN; GENOME; YEAST; MAP	Nucleosomes and their positions in the eukaryotic genome play an important role in regulating gene expression by influencing accessibility to DNA. Many factors influence a nucleosome's final position in the chromatin landscape including the underlying genomic sequence. One of the primary reasons for performing in vitro nucleosome reconstitution experiments is to identify how the underlying DNA sequence will influence a nucleosome's position in the absence of other compounding cellular factors. However, concerns have been raised about the reproducibility of data generated from these kinds of experiments. Here we present data for in vitro nucleosome reconstitution experiments performed on linear plasmid DNA that demonstrate that, when coverage is deep enough, these reconstitution experiments are exquisitely reproducible and highly consistent. Our data also suggests that a coverage depth of 35X be maintained for maximal confidence when assaying nucleosome positions, but lower coverage levels may be generally sufficient. These coverage depth recommendations are sufficient in the experimental system and conditions used in this study, but may vary depending on the exact parameters used in other systems.	[Kempton, Colton E.; Heninger, Justin R.; Johnson, Steven M.] Brigham Young Univ, Dept Microbiol & Mol Biol, Provo, UT 84602 USA	Brigham Young University	Johnson, SM (corresponding author), Brigham Young Univ, Dept Microbiol & Mol Biol, Provo, UT 84602 USA.	stevenj@byu.edu	Johnson, Steven M/B-3940-2013	Johnson, Steven/0000-0002-7399-8153	Brigham Young University's Office of Research & Creative Activities; Department of Microbiology and Molecular Biology; College of Life Sciences at Brigham Young University	Brigham Young University's Office of Research & Creative Activities; Department of Microbiology and Molecular Biology; College of Life Sciences at Brigham Young University	SMJ and CEK were supported by Mentoring Environment Grants from Brigham Young University's Office of Research & Creative Activities and other funding from the Department of Microbiology and Molecular Biology and the College of Life Sciences at Brigham Young University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brogaard K, 2012, NATURE, V486, P496, DOI 10.1038/nature11142; Flaus A, 1998, J MOL BIOL, V275, P427, DOI 10.1006/jmbi.1997.1464; Flaus A, 1999, METH MOL B, V119, P45; Johnson SM, 2006, GENOME RES, V16, P1505, DOI 10.1101/gr.5560806; Johnson SM, 2010, J BIOMOL STRUCT DYN, V27, P795, DOI 10.1080/073911010010524946; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; KORNBERG R, 1981, NATURE, V292, P579, DOI 10.1038/292579a0; KORNBERG RD, 1988, NUCLEIC ACIDS RES, V16, P6677, DOI 10.1093/nar/16.14.6677; Locke G, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-284; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; LU Q, 1994, J CELL BIOCHEM, V55, P83, DOI 10.1002/jcb.240550110; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Luger K, 1999, METH MOL B, V119, P1; Mavrich TN, 2008, GENOME RES, V18, P1073, DOI 10.1101/gr.078261.108; MEERSSEMAN G, 1992, EMBO J, V11, P2951, DOI 10.1002/j.1460-2075.1992.tb05365.x; SIMPSON RT, 1983, P NATL ACAD SCI-BIOL, V80, P51, DOI 10.1073/pnas.80.1.51; Struhl K, 2013, NAT STRUCT MOL BIOL, V20, P267, DOI 10.1038/nsmb.2506; Thastrom A, 1999, J MOL BIOL, V288, P213, DOI 10.1006/jmbi.1999.2686; Valouev A., 2011, NATURE; Valouev A, 2008, GENOME RES, V18, P1051, DOI 10.1101/gr.076463.108; Zhang Y, 2009, NAT STRUCT MOL BIOL, V16, P847, DOI 10.1038/nsmb.1636	21	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e103752	10.1371/journal.pone.0103752	http://dx.doi.org/10.1371/journal.pone.0103752			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093869	Green Published, Green Submitted, gold			2022-12-27	WOS:000341357200029
J	Leasi, F; Norenburg, JL				Leasi, Francesca; Norenburg, Jon L.			The Necessity of DNA Taxonomy to Reveal Cryptic Diversity and Spatial Distribution of Meiofauna, with a Focus on Nemertea	PLOS ONE			English	Article							MONOCELIS-LINEATA PROSERIATA; SPECIES COMPLEX; PHYLOGENETIC-RELATIONSHIPS; GENETIC-STRUCTURE; PHYLUM NEMERTEA; PHYLOGEOGRAPHY; OTOTYPHLONEMERTES; HOPLONEMERTEA; COSMOPOLITAN; MORPHOLOGY	Meiofauna represent one of the most abundant and diverse communities in marine benthic ecosystems. However, an accurate assessment of diversity at the level of species has been and remains challenging for these microscopic organisms. Therefore, for many taxa, especially the soft body forms such as nemerteans, which often lack clear diagnostic morphological traits, DNA taxonomy is an effective means to assess species diversity. Morphological taxonomy of Nemertea is well documented as complicated by scarcity of unambiguous character states and compromised by diagnoses of a majority of species (and higher clades) being inadequate or based on ambiguous characters and character states. Therefore, recent studies have advocated for the primacy of molecular tools to solve the taxonomy of this group. DNA taxonomy uncovers possible hidden cryptic species, provides a coherent means to systematize taxa in definite clades, and also reveals possible biogeographic patterns. Here, we analyze diversity of nemertean species by considering the barcode region of the mitochondrial gene Cytochrome Oxidase subunit I (COI) and different species delineation approaches in order to infer evolutionarily significant units. In the aim to uncover actual diversity of meiofaunal nemerteans across different sites in Central America, COI sequences were obtained for specimens assigned here to the genera Cephalothrix, Ototyphlonemertes, and Tetrastemma-like worms, each commonly encountered in our sampling. Additional genetic, taxonomic, and geographic data of other specimens belonging to these genera were added from GenBank. Results are consistent across different DNA taxonomy approaches, and revealed (i) the presence of several hidden cryptic species and (ii) numerous potential misidentifications due to traditional taxonomy. (iii) We additionally test a possible biogeographic pattern of taxonomic units revealed by this study, and, except for a few cases, the putative species seem not to be widely distributed, in contrast to what traditional taxonomy would suggest for the recognized morphotypes.	[Leasi, Francesca; Norenburg, Jon L.] Smithsonian Natl Museum Nat Hist, Dept Invertebrate Zool, Washington, DC 20560 USA	Smithsonian Institution; Smithsonian National Museum of Natural History	Leasi, F (corresponding author), Smithsonian Natl Museum Nat Hist, Dept Invertebrate Zool, Washington, DC 20560 USA.	leasif@si.edu	Leasi, Francesca/E-4361-2017; Norenburg, Jon L/K-3481-2015	Leasi, Francesca/0000-0001-6995-0934; Norenburg, Jon L/0000-0001-7776-1527	Smithsonian Marine Networks grant; Encyclopedia of Life Synthesis award; LAB (Laboratory of Analytical Biology) (LAB, Smithsonian National Museum of Natural History)	Smithsonian Marine Networks grant; Encyclopedia of Life Synthesis award; LAB (Laboratory of Analytical Biology) (LAB, Smithsonian National Museum of Natural History)	The workshops were partially funded by a Smithsonian Marine Networks grant, an Encyclopedia of Life Synthesis award and laboratory work was partially subsidized by LAB (Laboratory of Analytical Biology) (LAB, Smithsonian National Museum of Natural History). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade SCS, 2011, MAR BIOL, V158, P2109, DOI 10.1007/s00227-011-1718-3; Fernandez-Alvarez FA, 2013, HELGOLAND MAR RES, V67, P599, DOI 10.1007/s10152-013-0346-3; Artois T, 2011, BIOGEOGRAPHY MICROSC; Baker JM, 2007, MAR BIOL, V151, P2183, DOI 10.1007/s00227-007-0654-8; Brown JH, 2014, J BIOGEOGR, V41, P8, DOI 10.1111/jbi.12228; Casu M, 2004, MAR BIOL, V145, P669, DOI 10.1007/s00227-004-1367-x; Casu M, 2014, J ZOOL SYST EVOL RES, V52, P190, DOI 10.1111/jzs.12058; Chen G, 2011, MOL ECOL, V20, P2425, DOI 10.1111/j.1365-294X.2011.05079.x; Chen HL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0009318, 10.1371/journal.pone.0012885]; Curini-Galletti M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033801; Derycke S, 2008, MOL ECOL, V17, P3306, DOI 10.1111/j.1365-294X.2008.03846.x; Derycke S, 2008, ZOOL J LINN SOC-LOND, V152, P1, DOI 10.1111/j.1096-3642.2007.00365.x; Derycke S, 2005, MAR ECOL PROG SER, V300, P91, DOI 10.3354/meps300091; Derycke S, 2010, ZOOL SCR, V39, P276, DOI 10.1111/j.1463-6409.2009.00420.x; Di Domenico M, 2014, MOL PHYLOGENET EVOL, V75, P202, DOI 10.1016/j.ympev.2014.02.003; Envall M, 1998, ZOOL J LINN SOC-LOND, V123, P105, DOI 10.1006/zjls.1996.0130; Envall M, 2001, HYDROBIOLOGIA, V456, P145, DOI 10.1023/A:1013029310452; Foissner W, 2006, ACTA PROTOZOOL, V45, P111; Fontaneto D, 2011, BIOGEOGRAPHY MICROSC; Fontaneto D, 2007, HYDROBIOLOGIA, V583, P297, DOI 10.1007/s10750-007-0573-1; Fontaneto D, 2007, PLOS BIOL, V5, P914, DOI 10.1371/journal.pbio.0050087; Fontaneto D, 2014, INT REV HYDROBIOL, V99, P178, DOI 10.1002/iroh.201301719; Fontaneto D, 2009, MOL PHYLOGENET EVOL, V53, P182, DOI 10.1016/j.ympev.2009.04.011; Fujisawa T, 2013, SYST BIOL, V62, P707, DOI 10.1093/sysbio/syt033; Giere O., 2009, MEIOB MICR MOT FAUN, V2, DOI DOI 10.1007/b106489; Gomez A, 2002, EVOLUTION, V56, P1431; Guil N, 2011, BIOGEOGRAPHY MICROSC, P244; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Higgins R.P., 1988, P1; Kajihara H, 2013, ZOO SCI, V30, P895; Keane TM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-29; Kieneke A, 2012, MOL ECOL, V21, P1239, DOI 10.1111/j.1365-294X.2011.05421.x; Leasi F, 2013, ZOOL J LINN SOC-LOND, V168, P17, DOI 10.1111/zoj.12020; Leasi F, 2009, MAR BIOL, V156, P1335, DOI 10.1007/s00227-009-1175-4; Lee CE, 2000, EVOLUTION, V54, P2014, DOI 10.1111/j.0014-3820.2000.tb01245.x; Meyer CP, 2004, MALACOLOGIA, V46, P127; Norenburg J.L., 1988, P287; NORENBURG JL, 1988, HYDROBIOLOGIA, V156, P87, DOI 10.1007/BF00027981; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Provan J, 2008, TRENDS ECOL EVOL, V23, P564, DOI 10.1016/j.tree.2008.06.010; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; R Core Team, 2021, R LANGUAGE ENV STAT; Reygel P, 2014, MAR BIODIVERS, V44, P279, DOI 10.1007/s12526-014-0205-8; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sanderson MJ, 2002, MOL BIOL EVOL, V19, P101, DOI 10.1093/oxfordjournals.molbev.a003974; Sanna D, 2009, GENET MOL BIOL, V32, P864, DOI 10.1590/S1415-47572009005000076; Ceccarelli FS, 2012, MOL PHYLOGENET EVOL, V62, P485, DOI 10.1016/j.ympev.2011.10.018; Schmidt H, 2000, ZOOL SCR, V29, P17, DOI 10.1046/j.1463-6409.2000.00026.x; Strand M, 2005, MOL PHYLOGENET EVOL, V37, P144, DOI 10.1016/j.ympev.2005.02.006; Strand M, 2005, BIOL J LINN SOC, V86, P201, DOI 10.1111/j.1095-8312.2005.00535.x; Strand M, 2011, MAR BIOL RES, V7, P63, DOI 10.1080/17451001003713563; Sundberg P, 2010, J ZOOL SYST EVOL RES, V48, P283, DOI 10.1111/j.1439-0469.2010.00568.x; Sundberg P, 2009, ZOOL J LINN SOC-LOND, V157, P264, DOI 10.1111/j.1096-3642.2008.00514.x; Tang CQ, 2012, P NATL ACAD SCI USA, V109, P16208, DOI 10.1073/pnas.1209160109; Thollesson M, 2003, P ROY SOC B-BIOL SCI, V270, P407, DOI 10.1098/rspb.2002.2254; Tulchinsky AY, 2012, MAR BIOL, V159, P661, DOI 10.1007/s00227-011-1844-y; Walczynska A, 2014, EVOL ECOL, V28, P131, DOI 10.1007/s10682-013-9664-9; Westheide W, 2003, HELGOLAND MAR RES, V57, P1, DOI 10.1007/s10152-002-0114-2; Willett CS, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-139; Zhang JJ, 2013, BIOINFORMATICS, V29, P2869, DOI 10.1093/bioinformatics/btt499	61	50	53	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e104385	10.1371/journal.pone.0104385	http://dx.doi.org/10.1371/journal.pone.0104385			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093815	Green Published, Green Submitted, gold			2022-12-27	WOS:000341357200108
J	Mei, M; Xie, D; Zhang, Y; Jin, J; You, F; Li, Y; Dai, JG; Chen, XG				Mei, Mei; Xie, Dan; Zhang, Yi; Jin, Jing; You, Feng; Li, Yan; Dai, Jungui; Chen, Xiaoguang			A New 2 alpha,5 alpha,10 beta,14 beta-tetraacetoxy-4(20), 11-taxadiene (SIA) Derivative Overcomes Paclitaxel Resistance by Inhibiting MAPK Signaling and Increasing Paclitaxel Accumulation in Breast Cancer Cells	PLOS ONE			English	Article							PROTEIN-KINASE KINASE; MULTIDRUG-RESISTANCE; P-GLYCOPROTEIN; DRUG-RESISTANCE; IN-VIVO; REVERSAL AGENTS; TUMOR-CELLS; NUDE-MICE; PATHWAY; APOPTOSIS	Tumor resistance due to multiple mechanisms seriously hinders the efficacy of chemotherapy drugs such as paclitaxel. The most widely studied P-glycoprotein inhibitors still have limited ability to reverse resistance in the clinic. In this study, NPB304, a novel Sinenxan A (SIA) derivative, was found to significantly sensitize resistant breast cancer cells to paclitaxel in vitro and in vivo. Treatment with NPB304 increased paclitaxel-induced apoptosis in a p53-dependent manner through PARP cleavage. Importantly, NPB304 enhanced the antitumor effect of paclitaxel in resistant breast tumor xenografts in nude mice without significantly affecting weight loss. NPB304 regulated cell resistance through inhibition of MAPK pathway components, including p-ERK and p-p38. Moreover, NPB304 increased paclitaxel accumulation by affecting P-gp function. In addition to increasing Rhodamine 123 accumulation, NPB304 promoted bidirectional permeability but decreased the efflux ratio of paclitaxel in a Caco-2 monolayer model, thereby increasing the intracellular concentration of paclitaxel. Similarly, NPB304 increased the concentration of paclitaxel in the resistant tumor tissue. Hence, NPB304 is a novel compound that promotes the sensitization of resistant cells to paclitaxel through multiple mechanisms and has the potential for use in combination therapies to treat resistant breast cancer.	[Mei, Mei; Xie, Dan; Zhang, Yi; Jin, Jing; You, Feng; Li, Yan; Dai, Jungui; Chen, Xiaoguang] Chinese Acad Med Sci, Inst Mat Med, State Key Lab Bioact Subst & Funct Nat Med, Beijing 100050, Peoples R China; [Mei, Mei; Xie, Dan; Zhang, Yi; Jin, Jing; You, Feng; Li, Yan; Dai, Jungui; Chen, Xiaoguang] Peking Union Med Coll, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Materia Medica - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Chen, XG (corresponding author), Chinese Acad Med Sci, Inst Mat Med, State Key Lab Bioact Subst & Funct Nat Med, Beijing 100050, Peoples R China.	chxg@imm.ac.cn		ZHANG, YI/0000-0001-8373-017X	National Natural Science Foundation of China [81102469]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Grant Number 81102469). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiri-Kordestani L, 2012, DRUG RESIST UPDATE, V15, P50, DOI 10.1016/j.drup.2012.02.002; Baguley BC, 2010, MOL BIOTECHNOL, V46, P308, DOI 10.1007/s12033-010-9321-2; Banerjee M, 2010, FEBS J, V277, P3437, DOI 10.1111/j.1742-4658.2010.07750.x; Barancik M, 2001, EUR J PHARM SCI, V14, P29, DOI 10.1016/S0928-0987(01)00139-7; Bello E, 2013, MOL CANCER THER, V12, P131, DOI 10.1158/1535-7163.MCT-12-0275-T; Blagosklonny MV, 1999, INT J CANCER, V83, P151, DOI 10.1002/(SICI)1097-0215(19991008)83:2<151::AID-IJC1>3.0.CO;2-5; Boldt S, 2002, CARCINOGENESIS, V23, P1831, DOI 10.1093/carcin/23.11.1831; Brooks T, 2003, MOL CANCER THER, V2, P1195; Chou TC, 2005, CANCER CHEMOTH PHARM, V56, P379, DOI 10.1007/s00280-005-1019-y; Cossa G, 2013, CURR PHARM DESIGN, V19, P883, DOI 10.2174/138161213804547187; Dai JG, 2009, CURR TOP MED CHEM, V9, P1625, DOI 10.2174/156802609789941924; Dent P, 1998, LEUKEMIA, V12, P1843, DOI 10.1038/sj.leu.2401222; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Geney R, 2002, CLIN CHEM LAB MED, V40, P918, DOI 10.1515/CCLM.2002.161; Haass NK, 2008, CLIN CANCER RES, V14, P230, DOI 10.1158/1078-0432.CCR-07-1440; He D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054181; Higgins CF, 2007, NATURE, V446, P749, DOI 10.1038/nature05630; Horwitz S. B., 1994, ANN ONCOL, V5, pS3, DOI DOI 10.1093/ANN0NC/5.SUPPL_4.S3; Huang M, 2010, BIOORG MED CHEM LETT, V20, P5418, DOI 10.1016/j.bmcl.2010.07.099; Jazirehi AR, 2004, CANCER RES, V64, P7117, DOI 10.1158/0008-5472.CAN-03-3500; Kim KH, 2010, BIOMAT PROP PROD DEV, P149; Kohno M, 2006, ANN MED, V38, P200, DOI 10.1080/07853890600551037; Lage H, 2008, CELL MOL LIFE SCI, V65, P3145, DOI 10.1007/s00018-008-8111-5; Li Y, 2011, MOL MED REP, V4, P739, DOI 10.3892/mmr.2011.494; Liu KJ, 2013, INT J CANCER, V132, P224, DOI 10.1002/ijc.27649; MacKeigan JP, 2000, J BIOL CHEM, V275, P38953, DOI 10.1074/jbc.C000684200; Makin G, 2001, BREAST CANCER RES, V3, P150, DOI 10.1186/bcr289; Marengo B, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.118; McCubrey JA, 2007, BBA-MOL CELL RES, V1773, P1263, DOI 10.1016/j.bbamcr.2006.10.001; McCubrey JA, 2012, ONCOTARGET, V3, P1068, DOI 10.18632/oncotarget.659; McDaid HM, 2005, CANCER RES, V65, P2854, DOI 10.1158/0008-5472.CAN-04-4391; McDaid HM, 2001, MOL PHARMACOL, V60, P290, DOI 10.1124/mol.60.2.290; Mekhail Tarek M, 2002, Expert Opin Pharmacother, V3, P755; Milone MR, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.165; Milross CG, 1996, JNCI-J NATL CANCER I, V88, P1308, DOI 10.1093/jnci/88.18.1308; Ojima I, 2005, J MED CHEM, V48, P2218, DOI 10.1021/jm049483y; Oren M, 2003, CELL DEATH DIFFER, V10, P431, DOI 10.1038/sj.cdd.4401183; Penson RT, 2004, GYNECOL ONCOL, V93, P98, DOI 10.1016/j.ygyno.2003.11.053; Perez-Tomas R, 2006, CURR MED CHEM, V13, P1859, DOI 10.2174/092986706777585077; Redmond KM, 2008, FRONT BIOSCI-LANDMRK, V13, P5138, DOI 10.2741/3070; Santarpia L, 2012, EXPERT OPIN THER TAR, V16, P103, DOI 10.1517/14728222.2011.645805; Sauvant C, 2008, INT J CANCER, V123, P2532, DOI 10.1002/ijc.23818; Sebolt-Leopold JS, 2004, NAT REV CANCER, V4, P937, DOI 10.1038/nrc1503; Sparreboom A, 2003, DRUG RESIST UPDATE, V6, P71, DOI 10.1016/S1368-7646(03)00005-0; Steelman LS, 2011, LEUKEMIA, V25, P1080, DOI 10.1038/leu.2011.66; Thews O, 2013, ADV EXP MED BIOL, V765, P279, DOI 10.1007/978-1-4614-4989-8_39; Thews O, 2010, EUR J NUCL MED MOL I, V37, P1935, DOI 10.1007/s00259-010-1504-3; Thomas Hilary, 2003, Cancer Control, V10, P159; Torres K, 1998, CANCER RES, V58, P3620; Tortora G, 2007, DRUG RESIST UPDATE, V10, P81, DOI 10.1016/j.drup.2007.03.003; Trock BJ, 1997, J NATL CANCER I, V89, P917, DOI 10.1093/jnci/89.13.917; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Xie D, 2011, CHEM PHARM BULL, V59, P1038, DOI 10.1248/cpb.59.1038; You F, 2013, CANCER CHEMOTH PHARM, V71, P1453, DOI 10.1007/s00280-013-2144-7; Yu M, 2013, CANCER METAST REV, V32, P211, DOI 10.1007/s10555-012-9402-8; Zhang Y, 2010, CANCER CHEMOTH PHARM, V66, P851, DOI 10.1007/s00280-009-1229-9; Zhou Q, 2012, BIOL PHARM BULL, V35, P2170, DOI 10.1248/bpb.b12-00513; Zhou WJ, 2012, BRIT J PHARMACOL, V166, P1669, DOI 10.1111/j.1476-5381.2012.01849.x	58	8	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e104317	10.1371/journal.pone.0104317	http://dx.doi.org/10.1371/journal.pone.0104317			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093335	Green Published, Green Submitted, gold			2022-12-27	WOS:000341357200093
J	Mutsaerts, HJMM; Steketee, RME; Heijtel, DFR; Kuijer, JPA; van Osch, MJP; Majoie, CBLM; Smits, M; Nederveen, AJ				Mutsaerts, Henri J. M. M.; Steketee, Rebecca M. E.; Heijtel, Dennis F. R.; Kuijer, Joost P. A.; van Osch, Matthias J. P.; Majoie, Charles B. L. M.; Smits, Marion; Nederveen, Aart J.			Inter-Vendor Reproducibility of Pseudo-Continuous Arterial Spin Labeling at 3 Tesla	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; PERFUSION MRI; BRAIN; RELIABILITY; SENSITIVITY; EFFICIENCY; PRECISION; INVERSION; PET	Purpose: Prior to the implementation of arterial spin labeling (ASL) in clinical multi-center studies, it is important to establish its status quo inter-vendor reproducibility. This study evaluates and compares the intra-and inter-vendor reproducibility of pseudo-continuous ASL (pCASL) as clinically implemented by GE and Philips. Material and Methods: 22 healthy volunteers were scanned twice on both a 3T GE and a 3T Philips scanner. The main difference in implementation between the vendors was the readout module: spiral 3D fast spin echo vs. 2D gradient-echo echo-planar imaging respectively. Mean and variation of cerebral blood flow (CBF) were compared for the total gray matter (GM) and white matter (WM), and on a voxel-level. Results: Whereas the mean GM CBF of both vendors was almost equal (p = 1.0), the mean WM CBF was significantly different (p<0.01). The inter-vendor GM variation did not differ from the intra-vendor GM variation (p = 0.3 and p = 0.5 for GE and Philips respectively). Spatial inter-vendor CBF and variation differences were observed in several GM regions and in the WM. Conclusion: These results show that total GM CBF-values can be exchanged between vendors. For the inter-vendor comparison of GM regions or WM, these results encourage further standardization of ASL implementation among vendors.	[Mutsaerts, Henri J. M. M.; Heijtel, Dennis F. R.; Majoie, Charles B. L. M.; Nederveen, Aart J.] Univ Amsterdam, Acad Med Ctr, Dept Radiol, NL-1105 AZ Amsterdam, Netherlands; [Steketee, Rebecca M. E.; Smits, Marion] Erasmus MC Univ Med Ctr Rotterdam, Dept Radiol, Rotterdam, Netherlands; [Kuijer, Joost P. A.] Vrije Univ Amsterdam Med Ctr, Dept Phys & Med Technol, Amsterdam, Netherlands; [van Osch, Matthias J. P.] Leiden Univ, Med Ctr, C J Gorter Ctr High Field MRI, Dept Radiol, Leiden, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Erasmus University Rotterdam; Erasmus MC; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Mutsaerts, HJMM (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Radiol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	henkjanmutsaerts@gmail.com	Van Osch, Matthias/AAV-3876-2021; Kuijer, Joost/K-8985-2013; Steketee, Rebecca/AAA-4081-2020; Smits, Marion/AAB-3985-2019; Mutsaerts, Henk JMM/T-8656-2017; Smits, Marion/E-4795-2011	Van Osch, Matthias/0000-0001-7034-8959; Kuijer, Joost/0000-0002-4181-0427; Smits, Marion/0000-0001-5563-2871; Mutsaerts, Henk JMM/0000-0003-0894-0307; Nederveen, Aart/0000-0002-5477-973X; Steketee, Rebecca/0000-0003-2689-5490	Dutch non-governmental organization Stichting Coolsingel [179]; Dutch non-governmental organization NutsOhra [1002-031]	Dutch non-governmental organization Stichting Coolsingel; Dutch non-governmental organization NutsOhra	This work was financially supported by the Dutch non-governmental organizations Stichting Coolsingel (grant 179) and NutsOhra (grant 1002-031). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsop DC, 2015, MAGN RESON MED, V73, P102, DOI 10.1002/mrm.25197; Alsop DC, 1996, J CEREBR BLOOD F MET, V16, P1236, DOI 10.1097/00004647-199611000-00019; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Aslan S, 2010, MAGN RESON MED, V63, P765, DOI 10.1002/mrm.22245; Binnewijzend MAA, 2013, RADIOLOGY, V267, P221, DOI 10.1148/radiol.12120928; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; Chalela JA, 2000, STROKE, V31, P680, DOI 10.1161/01.STR.31.3.680; Chen Y, 2011, NEUROLOGY, V77, P1977, DOI 10.1212/WNL.0b013e31823a0ef7; Chen YF, 2011, J MAGN RESON IMAGING, V33, P940, DOI 10.1002/jmri.22345; Deichmann R, 2002, NEUROIMAGE, V15, P120, DOI 10.1006/nimg.2001.0985; Detre JA, 2012, J MAGN RESON IMAGING, V35, P1026, DOI 10.1002/jmri.23581; Donahue MJ, 2013, J MAGN RESON IMAGING, V38, P1129, DOI 10.1002/jmri.24070; Floyd TF, 2003, J MAGN RESON IMAGING, V18, P649, DOI 10.1002/jmri.10416; Garcia DM, 2005, MAGN RESON MED, V54, P366, DOI 10.1002/mrm.20556; Gevers S, 2011, J CEREBR BLOOD F MET, V31, P1706, DOI 10.1038/jcbfm.2011.10; Golay X, 2009, P INT SOC MAG RESON, V17; Golay Xavier, 2004, Top Magn Reson Imaging, V15, P10, DOI 10.1097/00002142-200402000-00003; Heijtel DFR, 2014, NEUROIMAGE, V92, P182, DOI 10.1016/j.neuroimage.2014.02.011; Hendrikse J, 2012, NEUROIMAG CLIN N AM, V22, P259, DOI 10.1016/j.nic.2012.02.003; HERSCOVITCH P, 1985, J CEREBR BLOOD F MET, V5, P65, DOI 10.1038/jcbfm.1985.9; howard levene, 1960, CONTRIBUTIONS PROBAB; Jahng GH, 2005, RADIOLOGY, V234, P909, DOI 10.1148/radiol.2343031499; Kilroy E, 2014, J MAGN RESON IMAGING, V39, P931, DOI 10.1002/jmri.24246; Lawrence KSS, 2005, MAGN RESON MED, V53, P425, DOI 10.1002/mrm.20364; Liu T, 2008, P INT SOC MAG RESON, V16, P3338; Lu HZ, 2005, J MAGN RESON IMAGING, V22, P13, DOI 10.1002/jmri.20356; Lu HZ, 2004, MAGN RESON MED, V52, P679, DOI 10.1002/mrm.20178; Parkes LM, 2004, MAGN RESON MED, V51, P736, DOI 10.1002/mrm.20023; Petersen ET, 2010, NEUROIMAGE, V49, P104, DOI 10.1016/j.neuroimage.2009.07.068; Timmann D, 2009, NEUROSCIENCE, V162, P836, DOI 10.1016/j.neuroscience.2009.01.040; van Gelderen P, 2008, MAGN RESON MED, V59, P788, DOI 10.1002/mrm.21515; Vidorreta M, 2013, NEUROIMAGE, V66, P662, DOI 10.1016/j.neuroimage.2012.10.087; Walther S, 2011, PSYCHIAT RES-NEUROIM, V192, P117, DOI 10.1016/j.pscychresns.2010.12.002; WILLIAMS DS, 1992, P NATL ACAD SCI USA, V89, P212, DOI 10.1073/pnas.89.1.212; Wolf RC, 2012, EUR ARCH PSY CLIN N, V262, P677, DOI 10.1007/s00406-012-0303-1; Xu GF, 2010, NMR BIOMED, V23, P286, DOI 10.1002/nbm.1462	36	56	56	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e104108	10.1371/journal.pone.0104108	http://dx.doi.org/10.1371/journal.pone.0104108			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25090654	Green Submitted, Green Published, gold			2022-12-27	WOS:000339812700098
J	Jungandreas, A; Costa, BS; Jakob, T; von Bergen, M; Baumann, S; Wilhelm, C				Jungandreas, Anne; Costa, Benjamin Schellenberger; Jakob, Torsten; von Bergen, Martin; Baumann, Sven; Wilhelm, Christian			The Acclimation of Phaeodactylum tricornutum to Blue and Red Light Does Not Influence the Photosynthetic Light Reaction but Strongly Disturbs the Carbon Allocation Pattern	PLOS ONE			English	Article							FTIR SPECTROSCOPY; XANTHOPHYLL CYCLE; HASLEA-OSTREARIA; CELL-DIVISION; 2 DIATOMS; FLUORESCENCE; EVOLUTION; GREEN; STATE; GROWTH	Diatoms are major contributors to the aquatic primary productivity and show an efficient acclimation ability to changing light intensities. Here, we investigated the acclimation of Phaeodactylum tricornutum to different light quality with respect to growth rate, photosynthesis rate, macromolecular composition and the metabolic profile by shifting the light quality from red light (RL) to blue light (BL) and vice versa. Our results show that cultures pre-acclimated to BL and RL exhibited similar growth performance, photosynthesis rates and metabolite profiles. However, light shift experiments revealed rapid and severe changes in the metabolite profile within 15 min as the initial reaction of light acclimation. Thus, during the shift from RL to BL, increased concentrations of amino acids and TCA cycle intermediates were observed whereas during the BL to RL shift the levels of amino acids were decreased and intermediates of glycolysis accumulated. Accordingly, on the time scale of hours the RL to BL shift led to a redirection of carbon into the synthesis of proteins, whereas during the BL to RL shift an accumulation of carbohydrates occurred. Thus, a vast metabolic reorganization of the cells was observed as the initial reaction to changes in light quality. The results are discussed with respect to a putative direct regulation of cellular enzymes by light quality and by transcriptional regulation. Interestingly, the short-term changes in the metabolome were accompanied by changes in the degree of reduction of the plastoquinone pool. Surprisingly, the RL to BL shift led to a severe inhibition of growth within the first 48 h which was not observed during the BL to RL shift. Furthermore, during the phase of growth arrest the photosynthetic performance did not change. We propose arguments that the growth arrest could have been caused by the reorganization of intracellular carbon partitioning.	[Jungandreas, Anne; Costa, Benjamin Schellenberger; Jakob, Torsten; Wilhelm, Christian] Univ Leipzig, Fac Biosci Pharm & Psychol, Inst Biol, Dept Plant Physiol, D-04109 Leipzig, Germany; [Jungandreas, Anne] UFZ Helmholtz Ctr Environm Res, Dept Computat Landscape Ecol, Leipzig, Germany; [von Bergen, Martin; Baumann, Sven] UFZ Helmholtz Ctr Environm Res, Dept Metabol, Leipzig, Germany; [von Bergen, Martin] UFZ Helmholtz Ctr Environm Res, Dept Prote, Leipzig, Germany; [von Bergen, Martin] Aalborg Univ, Dept Biotechnol Chem & Environm Engn, Aalborg, Denmark; [Baumann, Sven] Univ Leipzig, Fac Biosci Pharm & Psychol, Inst Pharm, D-04109 Leipzig, Germany	Leipzig University; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Aalborg University; Leipzig University	Wilhelm, C (corresponding author), Univ Leipzig, Fac Biosci Pharm & Psychol, Inst Biol, Dept Plant Physiol, D-04109 Leipzig, Germany.	cwilhelm@rz.uni-leipzig.de	von Bergen, Martin/D-7960-2011; Baumann, Sven/M-2177-2013	von Bergen, Martin/0000-0003-2732-2977; Baumann, Sven/0000-0002-3453-5308	DFG [Wi 764/19-2]	DFG(German Research Foundation (DFG))	The work was supported by the DFG FG 1261 "Specific Light-Driven Reactions in Unicellular Model Algae'' Wi 764/19-2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alric J, 2010, PHOTOSYNTH RES, V106, P47, DOI 10.1007/s11120-010-9566-4; Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; AZUARA MP, 1983, PLANT PHYSIOL, V71, P286, DOI 10.1104/pp.71.2.286; Bailleul B, 2010, P NATL ACAD SCI USA, V107, P18214, DOI 10.1073/pnas.1007703107; Bellafiore S, 2005, NATURE, V433, P892, DOI 10.1038/nature03286; BILGER W, 1990, PHOTOSYNTH RES, V25, P173, DOI 10.1007/BF00033159; Bowler C, 2008, NATURE, V456, P239, DOI 10.1038/nature07410; Bowler C, 2010, ANNU REV MAR SCI, V2, P333, DOI 10.1146/annurev-marine-120308-081051; Bromke MA, 2013, METABOLITES, V3, P294, DOI 10.3390/metabo3020294; Chaves I, 2011, ANNU REV PLANT BIOL, V62, P335, DOI 10.1146/annurev-arplant-042110-103759; Coesel S, 2009, EMBO REP, V10, P655, DOI 10.1038/embor.2009.59; Costa BS, 2013, J EXP BOT, V64, P483, DOI 10.1093/jxb/ers340; Cruz S, 2011, J EXP BOT, V62, P509, DOI 10.1093/jxb/erq284; Depauw FA, 2012, J EXP BOT, V63, P1575, DOI 10.1093/jxb/ers005; Dijkman NA, 2002, J PHOTOCH PHOTOBIO B, V66, P179, DOI 10.1016/S1011-1344(02)00236-1; Eberhard S, 2008, ANNU REV GENET, V42, P463, DOI 10.1146/annurev.genet.42.110807.091452; Eberhardt AT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070382; Furukawa T, 1998, PROTOPLASMA, V203, P214, DOI 10.1007/BF01279479; Gilbert M, 2000, J PLANT PHYSIOL, V157, P307, DOI 10.1016/S0176-1617(00)80052-8; Grouneva I, 2009, BBA-BIOENERGETICS, V1787, P929, DOI 10.1016/j.bbabio.2009.02.004; GUILLARD RR, 1972, J PHYCOL, V8, P10, DOI 10.1111/j.0022-3646.1972.00010.x; HOLDSWORTH ES, 1985, MAR BIOL, V86, P253, DOI 10.1007/BF00397512; Huysman MJJ, 2013, PLANT CELL, V25, P215, DOI 10.1105/tpc.112.106377; Ishikawa M, 2009, PLANTA, V230, P543, DOI 10.1007/s00425-009-0967-6; Jakob T, 1999, PLANT BIOLOGY, V1, P76, DOI 10.1055/s-2007-978491; JEFFREY SW, 1975, BIOCHEM PHYSIOL PFL, V167, P191, DOI 10.1016/s0015-3796(17)30778-3; Jungandreas A, 2012, PLANT CELL PHYSIOL, V53, P2153, DOI 10.1093/pcp/pcs144; Kirk JTO, 1994, LIGHT PHOTOSYNTHESIS; KOWALLIK W, 1982, ANNU REV PLANT PHYS, V33, P51, DOI 10.1146/annurev.pp.33.060182.000411; Kroon BMA, 2006, J PHYCOL, V42, P593, DOI 10.1111/j.1529-8817.2006.00221.x; Lepetit B, 2013, PLANT PHYSIOL, V161, P853, DOI 10.1104/pp.112.207811; Li ZR, 2009, ANNU REV PLANT BIOL, V60, P239, DOI 10.1146/annurev.arplant.58.032806.103844; Lomas MW, 1999, LIMNOL OCEANOGR, V44, P556, DOI 10.4319/lo.1999.44.3.0556; Mercado JM, 2004, AQUAT BOT, V78, P265, DOI 10.1016/j.aquabot.2003.11.004; Mouget JL, 2004, J PHOTOCH PHOTOBIO B, V75, P1, DOI 10.1016/j.jphotobiol.2004.04.002; MUNZNER P, 1992, PLANT PHYSIOL, V99, P1370, DOI 10.1104/pp.99.4.1370; NELSON DM, 1995, GLOBAL BIOGEOCHEM CY, V9, P359, DOI 10.1029/95GB01070; Nymark M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007743; Pfannschmidt T, 2012, PROTOPLASMA, V249, P125, DOI 10.1007/s00709-012-0398-2; Romisch-Margl W, 2012, METABOLOMICS, V8, P133, DOI 10.1007/s11306-011-0293-4; SAAVEDRA MDS, 1994, COMP BIOCHEM PHYS B, V107, P39, DOI 10.1016/0305-0491(94)90222-4; Shikata T, 2011, PHOTOCHEM PHOTOBIOL, V87, P590, DOI 10.1111/j.1751-1097.2011.00914.x; Sims PA, 2006, PHYCOLOGIA, V45, P361, DOI 10.2216/05-22.1; Smith SR, 2012, ALGAL RES, V1, P2, DOI 10.1016/j.algal.2012.04.003; Stirbet A, 2011, J PHOTOCH PHOTOBIO B, V104, P236, DOI 10.1016/j.jphotobiol.2010.12.010; Su WW, 2012, J PHYCOL, V48, P336, DOI 10.1111/j.1529-8817.2012.01128.x; Suetsugu N, 2013, PLANT CELL PHYSIOL, V54, P8, DOI 10.1093/pcp/pcs165; Takahashi F, 2007, P NATL ACAD SCI USA, V104, P19625, DOI 10.1073/pnas.0707692104; Toth SZ, 2007, PHOTOSYNTH RES, V93, P193, DOI 10.1007/s11120-007-9179-8; Tremblin G, 2000, J APPL PHYCOL, V12, P557, DOI 10.1023/A:1026502713075; Vergara JJ, 1998, J PHYCOL, V34, P952, DOI 10.1046/j.1529-8817.1998.340952.x; VOSKRESENSKAYA NP, 1972, ANN REV PLANT PHYSIO, V23, P219, DOI 10.1146/annurev.pp.23.060172.001251; Wagner H, 2006, NEW PHYTOL, V169, P95, DOI 10.1111/j.1469-8137.2005.01550.x; Wagner H, 2010, J BIOPHOTONICS, V3, P557, DOI 10.1002/jbio.201000019; Wu HY, 2011, PLANT PHYSIOL, V156, P2184, DOI 10.1104/pp.111.178772	55	56	58	3	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2014	9	8							e99727	10.1371/journal.pone.0099727	http://dx.doi.org/10.1371/journal.pone.0099727			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WB	25111046	Green Published, gold, Green Submitted			2022-12-27	WOS:000341105100001
J	Sluijter, M; van der Sluis, TC; van der Velden, PA; Versluis, M; West, BL; van der Burg, SH; van Hall, T				Sluijter, Marjolein; van der Sluis, Tetje C.; van der Velden, Pieter A.; Versluis, Mieke; West, Brian L.; van der Burg, Sjoerd H.; van Hall, Thorbald			Inhibition of CSF-1R Supports T-Cell Mediated Melanoma Therapy	PLOS ONE			English	Article							SUPPRESSOR-CELLS; MACROPHAGES; PROGRESSION; TUMORS	Tumor associated macrophages (TAM) can promote angiogenesis, invasiveness and immunosuppression. The cytokine CSF-1 (or M-CSF) is an important factor of TAM recruitment and differentiation and several pharmacological agents targeting the CSF-1 receptor (CSF-1R) have been developed to regulate TAM in solid cancers. We show that the kinase inhibitor PLX3397 strongly dampened the systemic and local accumulation of macrophages driven by B16F10 melanomas, without affecting Gr-1(+) myeloid derived suppressor cells. Removal of intratumoral macrophages was remarkably efficient and a modest, but statistically significant, delay in melanoma outgrowth was observed. Importantly, CSF-1R inhibition strongly enhanced tumor control by immunotherapy using tumor-specific CD8 T cells. Elevated IFN gamma production by T cells was observed in mice treated with the combination of PLX3397 and immunotherapy. These results support the combined use of CSF-1R inhibition with CD8 T cell immunotherapy, especially for macrophage-stimulating tumors.	[Sluijter, Marjolein; van der Burg, Sjoerd H.; van Hall, Thorbald] Leiden Univ, Med Ctr, Dept Clin Oncol, Leiden, Netherlands; [van der Sluis, Tetje C.] Leiden Univ, Med Ctr, Dept Immunohematol & Bloodtransfus, Leiden, Netherlands; [van der Velden, Pieter A.; Versluis, Mieke] Leiden Univ, Med Ctr, Dept Ophthalmol, Leiden, Netherlands; [West, Brian L.] Plexxikon Inc, Berkeley, CA USA	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Plexxikon	van Hall, T (corresponding author), Leiden Univ, Med Ctr, Dept Clin Oncol, Leiden, Netherlands.	T.van_Hall@lumc.nl	van der Burg, Sjoerd H/T-1875-2017; van Hall, Thorbald/Y-5651-2018	van der Burg, Sjoerd H/0000-0002-6556-0354; van Hall, Thorbald/0000-0002-9115-558X; van der Velden, Pieter/0000-0002-5710-9256; West, Brian/0000-0002-5320-3691; van der Sluis, Tetje/0000-0003-1804-1647	department of Clinical Oncology; Dutch Cancer Society [UL2009-4400]; Plexxikon Inc.	department of Clinical Oncology; Dutch Cancer Society(KWF Kankerbestrijding); Plexxikon Inc.	This work was supported by the department of Clinical Oncology and the Dutch Cancer Society (www.kwf.nl; grant UL2009-4400, SvdB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Co-author Brian L. West is employed by a commercial company Plexxikon Inc. Plexxikon Inc. provided support in the form of salary, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	Carlin LM, 2013, CELL, V153, P362, DOI 10.1016/j.cell.2013.03.010; DeNardo DG, 2011, CANCER DISCOV, V1, P54, DOI 10.1158/2159-8274.CD-10-0028; Dunn GP, 2006, NAT REV IMMUNOL, V6, P836, DOI 10.1038/nri1961; Fend L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073310; Gabrilovich DI, 2012, NAT REV IMMUNOL, V12, P253, DOI 10.1038/nri3175; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Heusinkveld M, 2011, J IMMUNOL, V187, P1157, DOI 10.4049/jimmunol.1100889; Hume DA, 2012, BLOOD, V119, P1810, DOI 10.1182/blood-2011-09-379214; Ly LV, 2013, J IMMUNOL, V190, P489, DOI 10.4049/jimmunol.1200135; Ly LV, 2010, CANCER RES, V70, P8339, DOI 10.1158/0008-5472.CAN-10-2288; Ly LV, 2010, J IMMUNOL, V185, P3481, DOI 10.4049/jimmunol.0903479; Manthey CL, 2009, MOL CANCER THER, V8, P3151, DOI 10.1158/1535-7163.MCT-09-0255; Mantovani A, 2010, CURR OPIN IMMUNOL, V22, P231, DOI 10.1016/j.coi.2010.01.009; Mok S, 2014, CANCER RES, V74, P153, DOI 10.1158/0008-5472.CAN-13-1816; Nagaraj S, 2013, J IMMUNOL, V191, P17, DOI 10.4049/jimmunol.1300654; Pyonteck SM, 2013, NAT MED, V19, P1264, DOI 10.1038/nm.3337; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Ryder M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054302; Sica A, 2007, J CLIN INVEST, V117, P1155, DOI 10.1172/JCI31422; Strachan DC, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.26968	22	39	42	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2014	9	8							e104230	10.1371/journal.pone.0104230	http://dx.doi.org/10.1371/journal.pone.0104230			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WB	25110953	Green Published, Green Submitted, gold			2022-12-27	WOS:000341105100039
J	Aydin-Schmidt, B; Xu, WP; Gonzalez, IJ; Polley, SD; Bell, D; Shakely, D; Msellem, MI; Bjorkman, A; Martensson, A				Aydin-Schmidt, Berit; Xu, Weiping; Gonzalez, Iveth J.; Polley, Spencer D.; Bell, David; Shakely, Deler; Msellem, Mwinyi I.; Bjorkman, Anders; Martensson, Andreas			Loop Mediated Isothermal Amplification (LAMP) Accurately Detects Malaria DNA from Filter Paper Blood Samples of Low Density Parasitaemias	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; PCR; DIAGNOSIS; SENSITIVITY; ELIMINATION; INFECTIONS; POINT; ASSAY	Background: Loop mediated isothermal amplification (LAMP) provides an opportunity for improved, field-friendly detection of malaria infections in endemic areas. However data on the diagnostic accuracy of LAMP for active case detection, particularly low-density parasitaemias, are lacking. We therefore evaluated the performance of a new LAMP kit compared with PCR using DNA from filter paper blood spots. Methods and Findings: Samples from 865 fever patients and 465 asymptomatic individuals collected in Zanzibar were analysed for Pan (all species) and Pf (P. falciparum) DNA with the Loopamp MALARIA Pan/Pf kit. Samples were amplified at 65 degrees C for 40 minutes in a real-time turbidimeter and results were compared with nested PCR. Samples with discordant results between LAMP and nested PCR were analysed with real-time PCR. The real-time PCR corrected nested PCR result was defined as gold standard. Among the 117 (13.5%) PCR detected P. falciparum infections from fever patients (mean parasite density 7491/mu L, range 6-782,400) 115, 115 and 111 were positive by Pan-LAMP, Pf-LAMP and nested PCR, respectively. The sensitivities were 98.3% (95% CI 94-99.8) for both Pan and Pf-LAMP. Among the 54 (11.6%) PCR positive samples from asymptomatic individuals (mean parasite density 10/mu L, range 0-4972) Pf-LAMP had a sensitivity of 92.7% (95%CI 80.1-98.5) for detection of the 41 P. falciparum infections. Pan-LAMP had sensitivities of 97% (95%CI 84.2-99.9) and 76.9% (95%CI 46.2-95) for detection of P. falciparum and P. malariae, respectively. The specificities for both Pan and Pf-LAMP were 100% (95% CI 99.1-100) in both study groups. Conclusion: Both components of the Loopamp MALARIA Pan/Pf detection kit revealed high diagnostic accuracy for parasite detection among fever patients and importantly also among asymptomatic individuals of low parasite densities from minute blood volumes preserved on filter paper. These data support LAMPs potential role for improved detection of low-density malaria infections in pre-elimination settings.	[Aydin-Schmidt, Berit; Xu, Weiping; Shakely, Deler; Bjorkman, Anders] Karolinska Inst, Dept Microbiol Tumor & Cellbiol, Stockholm, Sweden; [Gonzalez, Iveth J.] Fdn Innovat New Diagnost, Dept Clin Parasitol, Geneva, Switzerland; [Polley, Spencer D.] Univ Coll London Hosp, Hosp Trop Dis, London, England; [Polley, Spencer D.] Univ Coll London Hosp NHS Fdn Trust, NIHR Biomed Res Ctr, London, England; [Polley, Spencer D.] UCL, London, England; [Bell, David] Global Good Fund, Bellevue, WA USA; [Martensson, Andreas] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden; [Msellem, Mwinyi I.] Minist Hlth, Zanzibar Malaria Eliminat Program, Zanzibar, Tanzania; [Aydin-Schmidt, Berit] Karolinska Univ Hosp, Infect Dis Unit, Stockholm, Sweden; [Martensson, Andreas] Sormland Cty Council, Clin Res Ctr, Sormland, Sweden	Karolinska Institutet; Foundation For Innovative New Diagnostics; University College London Hospitals NHS Foundation Trust; University of London; London School of Hygiene & Tropical Medicine; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; University College London; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Aydin-Schmidt, B (corresponding author), Karolinska Inst, Dept Microbiol Tumor & Cellbiol, Stockholm, Sweden.	berit.schmidt@ki.se			Swedish Research Council; Swedish Civil Contingencies Agency (MSB); Stockholm County Council; German Federal Ministry of Education and Research (BMBF) through KfW Entwicklungsbank	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Civil Contingencies Agency (MSB); Stockholm County Council(Stockholm County Council); German Federal Ministry of Education and Research (BMBF) through KfW Entwicklungsbank(Federal Ministry of Education & Research (BMBF))	This study was funded by Swedish Research Council, Swedish Civil Contingencies Agency (MSB) and Stockholm County Council. FIND funding for this work was received from the German Federal Ministry of Education and Research (BMBF) through the KfW Entwicklungsbank. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Ghani R, 2012, ACTA TROP, V122, P233, DOI 10.1016/j.actatropica.2012.02.004; [Anonymous], 2013, J INFECT DIS; [Anonymous], 2012, MAN STAND OP PROC MA; [Anonymous], 2011, PLOS MED, V8; Bossuyt PM, 2003, BRIT MED J, V326, P41, DOI 10.1136/bmj.326.7379.41; Dahlstrom S, 2008, INFECT GENET EVOL, V8, P340, DOI 10.1016/j.meegid.2008.02.002; Han ET, 2007, J CLIN MICROBIOL, V45, P2521, DOI 10.1128/JCM.02117-06; Hanscheid T, 2002, TRENDS PARASITOL, V18, P395, DOI 10.1016/S1471-4922(02)02348-6; Helsinki WMADo, 2008, ETHICAL PRINCIPLES M; Hsiang MS, 2010, J CLIN MICROBIOL, V48, P3539, DOI 10.1128/JCM.00522-10; Kamau E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071539; Lucchi NW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013733; Manjurano A, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-370; McMorrow ML, 2011, CLIN MICROBIOL INFEC, V17, P1624, DOI 10.1111/j.1469-0691.2011.03639.x; Mills CD, 1999, B WORLD HEALTH ORGAN, V77, P553; Moonen B, 2010, LANCET, V376, P1592, DOI 10.1016/S0140-6736(10)61269-X; Njiru ZK, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001572; Okell LC, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2241; Patel JC, 2014, J INFECT DIS; Polley SD, 2013, J INFECT DIS; Polley SD, 2010, J CLIN MICROBIOL, V48, P2866, DOI 10.1128/JCM.00355-10; Poon LLM, 2006, CLIN CHEM, V52, P303; Shakely D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072912; Shokoples SE, 2009, J CLIN MICROBIOL, V47, P975, DOI 10.1128/JCM.01858-08; Steenkeste N, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-86; WOODEN J, 1993, PARASITOL TODAY, V9, P303, DOI 10.1016/0169-4758(93)90131-X	26	58	60	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2014	9	8							e103905	10.1371/journal.pone.0103905	http://dx.doi.org/10.1371/journal.pone.0103905			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR0CG	25105591	Green Submitted, gold, Green Published			2022-12-27	WOS:000343231900029
J	Baens, M; Bonsignore, L; Somers, R; Vanderheydt, C; Weeks, SD; Gunnarsson, J; Nilsson, E; Roth, RG; Thome, M; Marynen, P				Baens, Mathijs; Bonsignore, Luca; Somers, Riet; Vanderheydt, Charlotte; Weeks, Stephen D.; Gunnarsson, Jenny; Nilsson, Ewa; Roth, Robert G.; Thome, Margot; Marynen, Peter			MALT1 Auto-Proteolysis Is Essential for NF-kappa B-Dependent Gene Transcription in Activated Lymphocytes	PLOS ONE			English	Article							T-CELL; CHROMOSOMAL TRANSLOCATION; PARACASPASE MALT1; PROTEASE ACTIVITY; UBIQUITIN LIGASE; LYMPHOMA; CARMA1; BCL10; CLEAVAGE; KINASE	Mucosa-associated lymphoid tissue 1 (MALT1) controls antigen receptor-mediated signalling to nuclear factor kappa B (NF-kappa B) through both its adaptor and protease function. Upon antigen stimulation, MALT1 forms a complex with BCL10 and CARMA1, which is essential for initial I kappa B alpha phosphorylation and NF-kappa B nuclear translocation. Parallel induction of MALT1 protease activity serves to inactivate negative regulators of NF-kappa B signalling, such as A20 and RELB. Here we demonstrate a key role for auto-proteolytic MALT1 cleavage in B- and T-cell receptor signalling. MALT1 cleavage occurred after Arginine 149, between the N-terminal death domain and the first immunoglobulin-like region, and did not affect its proteolytic activity. Jurkat T cells expressing an un-cleavable MALT1-R149A mutant showed unaltered initial I kappa B alpha phosphorylation and normal nuclear accumulation of NF-kappa B subunits. Nevertheless, MALT1 cleavage was required for optimal activation of NF-kappa B reporter genes and expression of the NF-kappa B targets IL-2 and CSF2. Transcriptome analysis confirmed that MALT1 cleavage after R14(was required to induce NF-kappa B transcriptional activity in Jurkat T cells. Collectively, these data demonstrate that auto-proteolytic MALT1 cleavage controls antigen receptor-induced expression of NF-kappa B target genes downstream of nuclear NF-kappa B accumulation.	[Baens, Mathijs; Somers, Riet; Vanderheydt, Charlotte] VIB Ctr Biol Dis, Human Genome Lab, Leuven, Belgium; [Baens, Mathijs; Somers, Riet; Vanderheydt, Charlotte; Marynen, Peter] Katholieke Univ Leuven, Ctr Human Genet, Human Genome Lab, Leuven, Belgium; [Bonsignore, Luca; Thome, Margot] Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland; [Weeks, Stephen D.] Katholieke Univ Leuven, Dept Pharmaceut & Pharmacol Sci, Lab Biocrystallog, Leuven, Belgium; [Gunnarsson, Jenny; Nilsson, Ewa; Roth, Robert G.] AstraZeneca R&D, Discovery Sci, Reagent & Assay Dev, Innovat Med, Molndal, Sweden	Flanders Institute for Biotechnology (VIB); KU Leuven; University of Lausanne; KU Leuven; AstraZeneca	Baens, M (corresponding author), VIB Ctr Biol Dis, Human Genome Lab, Leuven, Belgium.	thijs.baens@med.kuleuven.be	Weeks, Stephen/N-4813-2019; Weeks, Stephen D/G-6150-2017; Thome, Margot/F-8167-2011	Weeks, Stephen/0000-0002-1360-0852; Weeks, Stephen D/0000-0002-1360-0852; Thome, Margot/0000-0002-5656-2139	FWO [G.0534.12]; 'Belgian Foundation against Cancer' [190-2008]; 'Concerted Research Actions' (GOA) [GOA/11/010]; Swiss National Science Foundation; Oncosuisse; Helmut Horten Foundation	FWO(FWO); 'Belgian Foundation against Cancer'; 'Concerted Research Actions' (GOA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Oncosuisse; Helmut Horten Foundation	Work in Mathijs Baens'/Peter Marynen's laboratory is supported by research grants from the FWO (G.0534.12), the 'Belgian Foundation against Cancer' (190-2008) and the 'Concerted Research Actions' (GOA grant GOA/11/010). The Thome laboratory is supported by grants from the Swiss National Science Foundation and Oncosuisse. The Helmut Horten Foundation supports Luca Bonsignore and Margot Thome. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE M, 1988, CANCER, V61, P483, DOI 10.1002/1097-0142(19880201)61:3<483::AID-CNCR2820610313>3.0.CO;2-L; Baens M, 2006, CANCER RES, V66, P5270, DOI 10.1158/0008-5472.CAN-05-4590; Boatright KM, 2003, MOL CELL, V11, P529, DOI 10.1016/S1097-2765(03)00051-0; Cabalzar K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072051; Che TJ, 2004, J BIOL CHEM, V279, P15870, DOI 10.1074/jbc.M310599200; Coornaert B, 2008, NAT IMMUNOL, V9, P263, DOI 10.1038/ni1561; Davis RE, 2001, J EXP MED, V194, P1861, DOI 10.1084/jem.194.12.1861; de Boer E, 2003, P NATL ACAD SCI USA, V100, P7480, DOI 10.1073/pnas.1332608100; Dierlamm J, 1999, BLOOD, V93, P3601, DOI 10.1182/blood.V93.11.3601; Egawa T, 2003, CURR BIOL, V13, P1252, DOI 10.1016/S0960-9822(03)00491-3; Ferch U, 2009, J EXP MED, V206, P2313, DOI 10.1084/jem.20091167; Fontan L, 2012, CANCER CELL, V22, P812, DOI 10.1016/j.ccr.2012.11.003; Gaide O, 2002, NAT IMMUNOL, V3, P836, DOI 10.1038/ni830; Hachmann J, 2012, BIOCHEM J, V443, P287, DOI 10.1042/BJ20120035; Hailfinger S, 2011, P NATL ACAD SCI USA, V108, P14596, DOI 10.1073/pnas.1105020108; Hailfinger S, 2009, P NATL ACAD SCI USA, V106, P19946, DOI 10.1073/pnas.0907511106; Hara H, 2004, J EXP MED, V200, P1167, DOI 10.1084/jem.20032246; Hara H, 2003, IMMUNITY, V18, P763, DOI 10.1016/S1074-7613(03)00148-1; Jun JE, 2003, IMMUNITY, V18, P751, DOI 10.1016/S1074-7613(03)00141-9; Kabouridis PS, 2006, MOL MEMBR BIOL, V23, P49, DOI 10.1080/09687860500453673; KLEIN G, 1974, P NATL ACAD SCI USA, V71, P3283, DOI 10.1073/pnas.71.8.3283; Lenz G, 2008, SCIENCE, V319, P1676, DOI 10.1126/science.1153629; Lucas PC, 2001, J BIOL CHEM, V276, P19012, DOI 10.1074/jbc.M009984200; Matsumoto R, 2005, IMMUNITY, V23, P575, DOI 10.1016/j.immuni.2005.10.007; McCall EJ, 2005, PROTEIN EXPRES PURIF, V42, P29, DOI 10.1016/j.pep.2005.03.021; Nakagawa M, 2005, BLOOD, V106, P4210, DOI 10.1182/blood-2004-12-4785; Newton K, 2003, CURR BIOL, V13, P1247, DOI 10.1016/S0960-9822(03)00458-5; Ngo VN, 2006, NATURE, V441, P106, DOI 10.1038/nature04687; Noels H, 2007, J BIOL CHEM, V282, P10180, DOI 10.1074/jbc.M611038200; Oeckinghaus A, 2007, EMBO J, V26, P4634, DOI 10.1038/sj.emboj.7601897; Pelzer C, 2013, NAT IMMUNOL, V14, P337, DOI 10.1038/ni.2540; Qiao Q, 2013, MOL CELL, V51, P766, DOI 10.1016/j.molcel.2013.08.032; Qiu L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023220; Rebeaud F, 2008, NAT IMMUNOL, V9, P272, DOI 10.1038/ni1568; Resh MD, 1999, BBA-MOL CELL RES, V1451, P1, DOI 10.1016/S0167-4889(99)00075-0; Rosebeck S, 2011, SCIENCE, V331, P468, DOI 10.1126/science.1198946; Ruefli-Brasse AA, 2003, SCIENCE, V302, P1581, DOI 10.1126/science.1090769; Ruland J, 2003, IMMUNITY, V19, P749, DOI 10.1016/S1074-7613(03)00293-0; Ruland J, 2001, CELL, V104, P33, DOI 10.1016/S0092-8674(01)00189-1; Sanchez-Izquierdo D, 2003, BLOOD, V101, P4539, DOI 10.1182/blood-2002-10-3236; SCHNEIDER U, 1977, INT J CANCER, V19, P621, DOI 10.1002/ijc.2910190505; Sideras P, 1989, Int Immunol, V1, P631, DOI 10.1093/intimm/1.6.631; Sommer K, 2005, IMMUNITY, V23, P561, DOI 10.1016/j.immuni.2005.09.014; Staal J, 2011, EMBO J, V30, P1742, DOI 10.1038/emboj.2011.85; Streubel B, 2003, BLOOD, V101, P2335, DOI 10.1182/blood-2002-09-2963; Sun LJ, 2004, MOL CELL, V14, P289, DOI 10.1016/S1097-2765(04)00236-9; Thome M, 2008, NAT REV IMMUNOL, V8, P495, DOI 10.1038/nri2338; TWEEDDALE ME, 1987, BLOOD, V69, P1307; Uehata T, 2013, CELL, V153, P1036, DOI 10.1016/j.cell.2013.04.034; Uren AG, 2000, MOL CELL, V6, P961, DOI 10.1016/S1097-2765(05)00086-9; Wang DH, 2004, MOL CELL BIOL, V24, P164, DOI 10.1128/MCB.24.1.164-171.2003; Wang DH, 2002, NAT IMMUNOL, V3, P830, DOI 10.1038/ni824; Weih F, 1996, ONCOGENE, V12, P445; Willis TG, 1999, CELL, V96, P35, DOI 10.1016/S0092-8674(00)80957-5; Wu CJ, 2008, P NATL ACAD SCI USA, V105, P3023, DOI 10.1073/pnas.0712313105; Wu CJ, 2006, NAT CELL BIOL, V8, P398, DOI 10.1038/ncb1384; Zhang QG, 1999, NAT GENET, V22, P63, DOI 10.1038/8767; Zhou HL, 2005, CANCER CELL, V7, P425, DOI 10.1016/j.ccr.2005.04.012; Zhou HL, 2004, NATURE, V427, P167, DOI 10.1038/nature02273	59	54	56	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2014	9	8							e103774	10.1371/journal.pone.0103774	http://dx.doi.org/10.1371/journal.pone.0103774			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR0CG	25105596	Green Published, Green Submitted, gold			2022-12-27	WOS:000343231900022
J	Dhamgaye, S; Devaux, F; Vandeputte, P; Khandelwal, NK; Sanglard, D; Mukhopadhyay, G; Prasad, R				Dhamgaye, Sanjiveeni; Devaux, Frederic; Vandeputte, Patrick; Khandelwal, Nitesh Kumar; Sanglard, Dominique; Mukhopadhyay, Gauranga; Prasad, Rajendra			Molecular Mechanisms of Action of Herbal Antifungal Alkaloid Berberine, in Candida albicans	PLOS ONE			English	Article							FLUCONAZOLE RESISTANCE; CANCER CELLS; APOPTOSIS; CURCUMIN; SUSCEPTIBILITIES; TRANSPORTERS; CONTRIBUTE; REGULATOR; TARGETS; AGENTS	Candida albicans causes superficial to systemic infections in immuno-compromised individuals. The concomitant use of fungistatic drugs and the lack of cidal drugs frequently result in strains that could withstand commonly used antifungals, and display multidrug resistance (MDR). In search of novel fungicidals, in this study, we have explored a plant alkaloid berberine (BER) for its antifungal potential. For this, we screened an in-house transcription factor (TF) mutant library of C. albicans strains towards their susceptibility to BER. Our screen of TF mutant strains identified a heat shock factor (HSF1), which has a central role in thermal adaptation, to be most responsive to BER treatment. Interestingly, HSF1 mutant was not only highly susceptible to BER but also displayed collateral susceptibility towards drugs targeting cell wall (CW) and ergosterol biosynthesis. Notably, BER treatment alone could affect the CW integrity as was evident from the growth retardation of MAP kinase and calcineurin pathway null mutant strains and transmission electron microscopy. However, unlike BER, HSF1 effect on CW appeared to be independent of MAP kinase and Calcineurin pathway genes. Additionally, unlike hsf1 null strain, BER treatment of Candida cells resulted in dysfunctional mitochondria, which was evident from its slow growth in non-fermentative carbon source and poor labeling with mitochondrial membrane potential sensitive probe. This phenotype was reinforced with an enhanced ROS levels coinciding with the up-regulated oxidative stress genes in BER-treated cells. Together, our study not only describes the molecular mechanism of BER fungicidal activity but also unravels a new role of evolutionary conserved HSF1, in MDR of Candida.	[Dhamgaye, Sanjiveeni; Khandelwal, Nitesh Kumar; Prasad, Rajendra] Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India; [Dhamgaye, Sanjiveeni; Mukhopadhyay, Gauranga] Jawaharlal Nehru Univ, Special Ctr Mol Med, New Delhi 110067, India; [Devaux, Frederic] Univ Paris 06, Sorbonne Univ, UMR 7238, Lab Genom Microorganisms, Paris, France; [Vandeputte, Patrick; Sanglard, Dominique] Univ Lausanne, Inst Microbiol, Lausanne, Switzerland; [Vandeputte, Patrick; Sanglard, Dominique] Univ Hosp Ctr, Lausanne, Switzerland	Jawaharlal Nehru University, New Delhi; Jawaharlal Nehru University, New Delhi; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; University of Lausanne	Prasad, R (corresponding author), Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India.	rp47jnu@gmail.com	Sanglard, Dominique/K-6032-2017; DEVAUX, Frédéric/N-2288-2019; Khandelwal, Nitesh Kumar/AAX-6273-2021	Sanglard, Dominique/0000-0002-5244-4178; DEVAUX, Frédéric/0000-0002-0039-9096; Khandelwal, Nitesh Kumar/0000-0002-6319-8048; Vandeputte, Patrick/0000-0002-9425-9253	Dept. of Biotechnology, Govt. of India [BT/01/CEIB/10/III/02]; Swiss-Indo collaboration grant [ISJRP 122917, 14879/BRB 10/885/2010]	Dept. of Biotechnology, Govt. of India(Department of Biotechnology (DBT) India); Swiss-Indo collaboration grant	Dept. of Biotechnology, Govt. of India (BT/01/CEIB/10/III/02) and (BT/PR 14879/BRB 10/885/2010, Swiss-Indo collaboration grant ISJRP 122917. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bambach A, 2009, EUKARYOT CELL, V8, P1706, DOI 10.1128/EC.00066-09; Bauer C, 2001, MICROSC MICROANAL, V7, P530, DOI 10.1007/s10005-001-0020-4; Binder U, 2010, MOL MICROBIOL, V75, P294, DOI 10.1111/j.1365-2958.2009.06936.x; Birdsall T. C., 1997, Alternative Medicine Review, V2, P94; Blokhina O, 2003, ANN BOT-LONDON, V91, P179, DOI 10.1093/aob/mcf118; Chauhan N, 2008, INFECT IMMUN, V76, P4795, DOI 10.1128/IAI.00834-08; CLSI, 2008, M27A3 CLSI; Coste AT, 2004, EUKARYOT CELL, V3, P1639, DOI 10.1128/EC.3.6.1639-1652.2004; Cruz MC, 2002, EMBO J, V21, P546, DOI 10.1093/emboj/21.4.546; Davis DA, 2002, GENETICS, V162, P1573; Dhamgaye S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-396; Dhamgaye S, 2012, ANTIMICROB AGENTS CH, V56, P495, DOI 10.1128/AAC.00574-11; Ellis D, 2002, J ANTIMICROB CHEMOTH, V49, P7, DOI 10.1093/jac/49.suppl_1.7; Ferrari S, 2011, ANTIMICROB AGENTS CH, V55, P1852, DOI 10.1128/AAC.01271-10; Franz R, 1999, MYCOSES, V42, P453, DOI 10.1046/j.1439-0507.1999.00498.x; Franz R, 1998, ANTIMICROB AGENTS CH, V42, P3065, DOI 10.1128/AAC.42.12.3065; Ghannoum MA, 1999, CLIN MICROBIOL REV, V12, P501, DOI 10.1128/CMR.12.4.501; Gomes-de-Elvas AR, 2012, GYNECOL OBSTET INVES, V74, P120, DOI 10.1159/000338899; Hajjeh RA, 2004, J CLIN MICROBIOL, V42, P1519, DOI 10.1128/JCM.42.4.1519-1527.2004; Hameed S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018684; Iwazaki RS, 2010, ANTON LEEUW INT J G, V97, P201, DOI 10.1007/s10482-009-9394-8; Jantova S, 2003, J PHARM PHARMACOL, V55, P1143, DOI 10.1211/002235703322277186; Kumar A, 2014, ANTIMICROB AGENTS CH, V58, P167, DOI 10.1128/AAC.01385-13; Letscher-Bru V, 2003, J ANTIMICROB CHEMOTH, V51, P513, DOI 10.1093/jac/dkg117; Li DD, 2013, ANTIMICROB AGENTS CH, V57, P6016, DOI 10.1128/AAC.00499-13; Lin CC, 2007, ANTICANCER RES, V27, P3371; Martins CVB, 2009, J ANTIMICROB CHEMOTH, V63, P337, DOI 10.1093/jac/dkn488; Meeran SM, 2008, TOXICOL APPL PHARM, V229, P33, DOI 10.1016/j.taap.2007.12.027; Menezes RA, 2008, BIOCHEM J, V414, P301, DOI 10.1042/BJ20071537; Morschhauser J, 2010, FUNGAL GENET BIOL, V47, P94, DOI 10.1016/j.fgb.2009.08.002; Mukhopadhyay K, 2002, ANTIMICROB AGENTS CH, V46, P3695, DOI 10.1128/AAC.46.12.3695-3705.2002; Nicholls S, 2009, MOL MICROBIOL, V74, P844, DOI 10.1111/j.1365-2958.2009.06883.x; Odds FC, 2003, TRENDS MICROBIOL, V11, P272, DOI 10.1016/S0966-842X(03)00117-3; Ostrosky-Zeichner L, 2003, ANTIMICROB AGENTS CH, V47, P3149, DOI 10.1128/AAC.47.10.3149-3154.2003; Pereira GC, 2007, J PHARMACOL EXP THER, V323, P636, DOI 10.1124/jpet.107.128017; Prasad R, 2013, CURR GENET, V59, P243, DOI 10.1007/s00294-013-0402-1; Sharma M, 2009, ANTIMICROB AGENTS CH, V53, P3256, DOI 10.1128/AAC.01497-08; Singh A, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030947, 10.1371/journal.pone.0044728, 10.1371/journal.pone.0039812, 10.1371/journal.pone.0044931]; Steverding D, 2012, MED MYCOL, V50, P333, DOI 10.3109/13693786.2011.609186; Sucher AJ, 2009, ANN PHARMACOTHER, V43, P1647, DOI 10.1345/aph.1M237; Sun N, 2013, ANTIMICROB AGENTS CH, V57, P532, DOI 10.1128/AAC.01520-12; Tan Wen, 2011, Int J Nanomedicine, V6, P1773, DOI 10.2147/IJN.S22683; Vanden Bossche H, 1997, Rev Iberoam Micol, V14, P44; Warrilow AGS, 2010, ANTIMICROB AGENTS CH, V54, P4235, DOI 10.1128/AAC.00587-10; White TC, 1998, CLIN MICROBIOL REV, V11, P382, DOI 10.1128/CMR.11.2.382; Zhang H, 2009, YAKUGAKU ZASSHI, V129, P623, DOI 10.1248/yakushi.129.623; Znaidi S, 2008, EUKARYOT CELL, V7, P836, DOI 10.1128/EC.00070-08	47	56	59	3	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2014	9	8							e104554	10.1371/journal.pone.0104554	http://dx.doi.org/10.1371/journal.pone.0104554			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR0CG	25105295	gold, Green Published			2022-12-27	WOS:000343231900068
J	Jarrett, CW; Caskey, CF; Gore, JC				Jarrett, Christopher W.; Caskey, Charles F.; Gore, John C.			Detection of a Novel Mechanism of Acousto-Optic Modulation of Incoherent Light	PLOS ONE			English	Article							OPTICAL-PROPERTIES; ULTRASONIC MODULATION; SHEAR-WAVES; TOMOGRAPHY; SCATTERING; TISSUES; OBJECTS; MEDIA	A novel form of acoustic modulation of light from an incoherent source has been detected in water as well as in turbid media. We demonstrate that patterns of modulated light intensity appear to propagate as the optical shadow of the density variations caused by ultrasound within an illuminated ultrasonic focal zone. This pattern differs from previous reports of acousto-optical interactions that produce diffraction effects that rely on phase shifts and changes in light directions caused by the acoustic modulation. Moreover, previous studies of acousto-optic interactions have mainly reported the effects of sound on coherent light sources via photon tagging, and/or the production of diffraction phenomena from phase effects that give rise to discrete sidebands. We aimed to assess whether the effects of ultrasound modulation of the intensity of light from an incoherent light source could be detected directly, and how the acoustically modulated (AOM) light signal depended on experimental parameters. Our observations suggest that ultrasound at moderate intensities can induce sufficiently large density variations within a uniform medium to cause measurable modulation of the intensity of an incoherent light source by absorption. Light passing through a region of high intensity ultrasound then produces a pattern that is the projection of the density variations within the region of their interaction. The patterns exhibit distinct maxima and minima that are observed at locations much different from those predicted by Raman-Nath, Bragg, or other diffraction theory. The observed patterns scaled appropriately with the geometrical magnification and sound wavelength. We conclude that these observed patterns are simple projections of the ultrasound induced density changes which cause spatial and temporal variations of the optical absorption within the illuminated sound field. These effects potentially provide a novel method for visualizing sound fields and may assist the interpretation of other hybrid imaging methods.	[Jarrett, Christopher W.; Caskey, Charles F.; Gore, John C.] Vanderbilt Univ, Inst Imaging Sci, Nashville, TN 37235 USA; [Jarrett, Christopher W.; Gore, John C.] Vanderbilt Univ, Program Chem & Phys Biol, Nashville, TN 37235 USA; [Caskey, Charles F.; Gore, John C.] Vanderbilt Univ, Dept Radiol & Radiol Sci, Nashville, TN 37235 USA; [Caskey, Charles F.; Gore, John C.] Vanderbilt Univ, Dept Biomed Engn, Nashville, TN 37235 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Jarrett, CW (corresponding author), Vanderbilt Univ, Inst Imaging Sci, 221 Kirkland Hall, Nashville, TN 37235 USA.	christopher.w.jarrett@vanderbilt.edu			National Cancer Institute [R25CA136440]; NATIONAL CANCER INSTITUTE [R25CA136440] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Christopher Jarrett and this work was supported by the National Cancer Institute under grant number R25CA136440. The funder's URL is: http://www.cancer.gov. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berry MV, 1966, DIFFRACTION LIGHT UL; Bossy E, 2007, P SOC PHOTO-OPT INS, V6437; Bossy E, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2733604; Bragg WL, 1914, P CAMB PHILOS SOC, V17, P43; Brillouin L., 1922, ANN PHYS-NEW YORK, V9, P88, DOI 10.1051/anphys/192209170088; Brillouin L, 1933, ACTUAL SCI IND, V59; Cobbold R. S. C., 2007, FDN BIOMEDICAL ULTRA; Debye P, 1932, P NATL ACAD SCI USA, V18, P409, DOI 10.1073/pnas.18.6.409; Frisvad JR, 2007, ACM T GRAPHIC, V26, DOI [10.1145/1239451.1239511, 10.1145/1276377.1276452]; Gamelin J, 2009, OPT EXPRESS, V17, P10489, DOI 10.1364/OE.17.010489; Huynh NT, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.2.020505; Jacques SL, 2013, PHYS MED BIOL, V58, pR37, DOI 10.1088/0031-9155/58/11/R37; Jensen HW, 2001, COMP GRAPH, P511, DOI 10.1145/383259.383319; Karu TI, 2003, LOW POWER LASER THER; KLEIN WR, 1967, IEEE T SON ULTRASON, VSU14, P123, DOI 10.1109/T-SU.1967.29423; Kobayashi M, 2007, P SPIE OSA BIOMEDICA, P6633; Kobayashi M, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2364600; Korpel A, 1988, ACOUSTO OPTICS; Krishnan K, 2005, P SOC PHOTO-OPT INS, V6900; LEUTZ W, 1995, PHYSICA B, V204, P14, DOI 10.1016/0921-4526(94)00238-Q; Leveque S, 1999, OPT LETT, V24, P181, DOI 10.1364/OL.24.000181; Li R, 2011, OPT EXPRESS, V19, P7299, DOI 10.1364/OE.19.007299; Li SN, 2014, OPT LETT, V39, P1597, DOI 10.1364/OL.39.001597; Lucas R, 1932, J PHYS-PARIS, V3, P464, DOI 10.1051/jphysrad:01932003010046400; Mahan GD, 1998, P NATL ACAD SCI USA, V95, P14015, DOI 10.1073/pnas.95.24.14015; MARKS FA, 1993, P SOC PHOTO-OPT INS, V1888, P500, DOI 10.1117/12.154670; Raman C, 1936, P INDIAN ACAD SCI  A, VA2, P406; Raman C.V., 1935, P INDIAN ACAD SCI, V2, P413, DOI [10.1007/BF03035841, DOI 10.1007/BF03035841]; Raman CV, 1936, P INDIAN ACAD SCI  A, V3, P119; Raman CV, 1936, P INDIAN ACAD SCI  A, V3, P75; Raman CV, 1936, P INDIAN ACAD SCI  A, V3, P459; Resink SG, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.4.040901; Sandell JL, 2011, J BIOPHOTONICS, V4, P773, DOI 10.1002/jbio.201100062; SCHIEBENER P, 1990, J PHYS CHEM REF DATA, V19, P677, DOI 10.1063/1.555859; SMITH RC, 1981, APPL OPTICS, V20, P177, DOI 10.1364/AO.20.000177; Wang LH, 1997, APPL OPTICS, V36, P7277, DOI 10.1364/AO.36.007277; WANG LH, 1995, OPT LETT, V20, P629, DOI 10.1364/OL.20.000629; Wang LHV, 2003, DIS MARKERS, V19, P123; Wang LHV, 2001, OPT LETT, V26, P1191, DOI 10.1364/OL.26.001191; Wang LHV, 2012, SCIENCE, V335, P1458, DOI 10.1126/science.1216210; Wang LV, 2001, PHYS REV LETT, V87; Yuan B, 2010, J BIOMED OPT, V15; Yuan BH, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3333546; Yuan BH, 2008, J APPL PHYS, V104, DOI 10.1063/1.3021088; Yuan BH, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3120493; Zackrisson S, 2014, CANCER RES, V74, P979, DOI 10.1158/0008-5472.CAN-13-2387	46	12	12	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2014	9	8							e104268	10.1371/journal.pone.0104268	http://dx.doi.org/10.1371/journal.pone.0104268			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR0CG	25105880	Green Published, gold, Green Submitted			2022-12-27	WOS:000343231900045
J	Xi, JX; Si, XHA; Kim, J; Mckee, E; Lin, EB				Xi, Jinxiang; Si, Xiuhua A.; Kim, JongWon; Mckee, Edward; Lin, En-Bing			Exhaled Aerosol Pattern Discloses Lung Structural Abnormality: A Sensitivity Study Using Computational Modeling and Fractal Analysis	PLOS ONE			English	Article							DRIFT FLUX MODEL; PARTICLE DEPOSITION; AIRWAY MORPHOMETRY; BREATH CONDENSATE; OXIDATIVE STRESS; BOLUS DISPERSION; NANOPARTICLE; INHALATION; BIOMARKERS; RESISTANCE	Background: Exhaled aerosol patterns, also called aerosol fingerprints, provide clues to the health of the lung and can be used to detect disease-modified airway structures. The key is how to decode the exhaled aerosol fingerprints and retrieve the lung structural information for a non-invasive identification of respiratory diseases. Objective and Methods: In this study, a CFD-fractal analysis method was developed to quantify exhaled aerosol fingerprints and applied it to one benign and three malign conditions: a tracheal carina tumor, a bronchial tumor, and asthma. Respirations of tracer aerosols of 1 mm at a flow rate of 30 L/min were simulated, with exhaled distributions recorded at the mouth. Large eddy simulations and a Lagrangian tracking approach were used to simulate respiratory airflows and aerosol dynamics. Aerosol morphometric measures such as concentration disparity, spatial distributions, and fractal analysis were applied to distinguish various exhaled aerosol patterns. Findings: Utilizing physiology-based modeling, we demonstrated substantial differences in exhaled aerosol distributions among normal and pathological airways, which were suggestive of the disease location and extent. With fractal analysis, we also demonstrated that exhaled aerosol patterns exhibited fractal behavior in both the entire image and selected regions of interest. Each exhaled aerosol fingerprint exhibited distinct pattern parameters such as spatial probability, fractal dimension, lacunarity, and multifractal spectrum. Furthermore, a correlation of the diseased location and exhaled aerosol spatial distribution was established for asthma. Conclusion: Aerosol-fingerprint-based breath tests disclose clues about the site and severity of lung diseases and appear to be sensitive enough to be a practical tool for diagnosis and prognosis of respiratory diseases with structural abnormalities.	[Xi, Jinxiang; Kim, JongWon] Cent Michigan Univ, Sch Engn & Technol, Mt Pleasant, MI 48859 USA; [Si, Xiuhua A.] Calvin Coll, Div Sci, Grand Rapids, MI 49506 USA; [Mckee, Edward] Cent Michigan Univ, Coll Med, Mt Pleasant, MI 48859 USA; [Lin, En-Bing] Cent Michigan Univ, Dept Math, Mt Pleasant, MI 48859 USA	Central Michigan University; Calvin University; Central Michigan University; Central Michigan University	Xi, JX (corresponding author), Cent Michigan Univ, Sch Engn & Technol, Mt Pleasant, MI 48859 USA.	xi1j@cmich.edu	Xi, Jinxiang/Y-1161-2019	McKee, Edward/0000-0002-4467-7668	Central Michigan University [P421071, P622911]; Calvin Summer Research Grant	Central Michigan University; Calvin Summer Research Grant	This work was funded by Central Michigan University Innovative Research Grant P421071 and Early Career Grant P622911. XS was supported by Calvin Summer Research Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN MD, 1985, AEROSOL SCI TECH, V4, P269, DOI 10.1080/02786828508959055; ANDERSON PJ, 1994, J AEROSOL MED, V7, P77, DOI 10.1089/jam.1994.7.77; Bassett DS, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000748; Blanchard JD, 1996, J AEROSOL MED, V9, P453, DOI 10.1089/jam.1996.9.453; Blanchard JD, 1996, J AEROSOL MED, V9, P183, DOI 10.1089/jam.1996.9.183; Boser SR, 2005, AM J RESP CRIT CARE, V172, P817, DOI 10.1164/rccm.200411-1463OC; Burges CJC, 1998, DATA MIN KNOWL DISC, V2, P121, DOI 10.1023/A:1009715923555; Canals M, 2000, BIOL RES, V33, P31; Chan HP, 2009, J THORAC ONCOL, V4, P172, DOI 10.1097/JTO.0b013e3181949eb9; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Choi J, 2009, PHYS FLUIDS, V21, DOI 10.1063/1.3247170; CIMBALA JM, 1988, EXP FLUIDS, V6, P547; Colombo C, 2011, INT J IMMUNOPATH PH, V24, P423, DOI 10.1177/039463201102400215; Fratini M, 2010, NATURE, V466, P841, DOI 10.1038/nature09260; Gould DJ, 2011, MICROCIRCULATION, V18, P136, DOI 10.1111/j.1549-8719.2010.00075.x; Gronlund A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033960; HOCHRAINER D, 1992, J AEROSOL MED, V5, P201, DOI 10.1089/jam.1992.5.201; HORSFILED K, 1990, Journal of Applied Physiology, V68, P457; Horvath I, 2009, EUR RESPIR J, V34, P261, DOI 10.1183/09031936.00142508; Hubbard MO, 2012, J THORAC CARDIOV SUR, V143, P1307, DOI 10.1016/j.jtcvs.2012.01.078; Jang M, 2008, AEROSOL SCI TECH, V42, P409, DOI 10.1080/02786820802154861; Karperien A, 2013, FRACTAL DIMENSION LA; Karperien A, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00003; Kim JW, 2013, INT J NUMER METH BIO, V29, P17, DOI 10.1002/cnm.2490; Kostikas K, 2008, CLIN EXP ALLERGY, V38, P557, DOI 10.1111/j.1365-2222.2008.02940.x; Krause A, 2012, Z RHEUMATOL, V71, P542; KRUMMEL JR, 1987, OIKOS, V48, P321, DOI 10.2307/3565520; Li Z, 2012, J BIONIC ENG, V9, P252, DOI 10.1016/S1672-6529(11)60106-6; Longest PW, 2008, J AEROSOL SCI, V39, P48, DOI 10.1016/j.jaerosci.2007.10.001; Lopes R, 2009, MED IMAGE ANAL, V13, P634, DOI 10.1016/j.media.2009.05.003; Loukides S, 2011, CURR DRUG TARGETS, V12, P469, DOI 10.2174/138945011794751573; Mandelbrot B. B., 1982, FRACTAL GEOMETRY NAT, DOI DOI 10.1002/ESP3290080415; McRobbie DW, 2005, J AEROSOL MED, V18, P325, DOI 10.1089/jam.2005.18.325; Miekisch W, 2004, CLIN CHIM ACTA, V347, P25, DOI 10.1016/j.cccn.2004.04.023; MORSI SA, 1972, J FLUID MECH, V55, P193, DOI 10.1017/S0022112072001806; Nicoud F, 1999, FLOW TURBUL COMBUST, V62, P183, DOI 10.1023/A:1009995426001; Phillips M, 2003, CHEST, V123, P2115, DOI 10.1378/chest.123.6.2115; Posadas AND, 2003, SOIL SCI SOC AM J, V67, P1361, DOI 10.2136/sssaj2003.1361; Provata A, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.066210; Ritchie N.W., 2011, MICROSCOPY MICROANAL, P179; Scheinherr A, 2012, Comput Methods Biomech Biomed Engin, V15 Suppl 1, P69; Segal RA, 2000, J THEORETICAL MED, V2, P199; Si XHA, 2013, RESP PHYSIOL NEUROBI, V186, P22, DOI 10.1016/j.resp.2012.12.005; SREENIVASAN KR, 1991, ANNU REV FLUID MECH, V23, P539; WEIBEL ER, 1962, SCIENCE, V137, P577, DOI 10.1126/science.137.3530.577; WILSON TA, 1967, NATURE, V213, P668, DOI 10.1038/213668a0; Longest PW, 2007, AEROSOL SCI TECH, V41, P380, DOI 10.1080/02786820701203223; Xi JX, 2008, ANN BIOMED ENG, V36, P1714, DOI 10.1007/s10439-008-9552-6; Xi JX, 2008, J APPL PHYSIOL, V104, P1761, DOI 10.1152/japplphysiol.01233.2007; Xi JX, 2007, ANN BIOMED ENG, V35, P560, DOI 10.1007/s10439-006-9245-y; Xi JX, 2014, INHAL TOXICOL, V26, P492, DOI 10.3109/08958378.2014.925992; Xi Jinxiang, 2014, Pharmaceutics, V6, P26, DOI 10.3390/pharmaceutics6010026; Xi JX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086593; Xi JX, 2013, J AEROSOL SCI, V64, P24, DOI 10.1016/j.jaerosci.2013.06.003; Xi JX, 2013, J ENVIRON SCI HEAL A, V48, P1790, DOI 10.1080/10934529.2013.823333; Xi JX, 2012, ANN BIOMED ENG, V40, P2579, DOI 10.1007/s10439-012-0603-7; Xi JX, 2011, J AEROSOL SCI, V42, P156, DOI 10.1016/j.jaerosci.2010.12.004; Xi JX, 2009, AEROSOL SCI TECH, V43, P808, DOI 10.1080/02786820902950887; Xi JX, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2838039; Xu YD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029956; Zhou Y, 2013, J AEROSOL MED, V26, P1	62	13	13	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2014	9	8							e104682	10.1371/journal.pone.0104682	http://dx.doi.org/10.1371/journal.pone.0104682			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR0CG	25105680	Green Submitted, Green Published, gold			2022-12-27	WOS:000343231900078
J	Bunimovich, YL; Nair-Gill, E; Riedinger, M; McCracken, MN; Cheng, DH; McLaughlin, J; Radu, CG; Witte, ON				Bunimovich, Yuri L.; Nair-Gill, Evan; Riedinger, Mireille; McCracken, Melissa N.; Cheng, Donghui; McLaughlin, Jami; Radu, Caius G.; Witte, Owen N.			Deoxycytidine Kinase Augments ATM-Mediated DNA Repair and Contributes to Radiation Resistance	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; RIBONUCLEOTIDE REDUCTASE; ATAXIA-TELANGIECTASIA; CELL LINE; NUCLEOTIDE-METABOLISM; PHOSPHORYLATION SITES; NUCLEOSIDE ANALOGS; CARCINOMA CELLS; GAMMA-DELTA; IN-VITRO	Efficient and adequate generation of deoxyribonucleotides is critical to successful DNA repair. We show that ataxia telangiectasia mutated (ATM) integrates the DNA damage response with DNA metabolism by regulating the salvage of deoxyribonucleosides. Specifically, ATM phosphorylates and activates deoxycytidine kinase (dCK) at serine 74 in response to ionizing radiation (IR). Activation of dCK shifts its substrate specificity toward deoxycytidine, increases intracellular dCTP pools post IR, and enhances the rate of DNA repair. Mutation of a single serine 74 residue has profound effects on murine T and B lymphocyte development, suggesting that post-translational regulation of dCK may be important in maintaining genomic stability during hematopoiesis. Using [F-18]-FAC, a dCK-specific positron emission tomography (PET) probe, we visualized and quantified dCK activation in tumor xenografts after IR, indicating that dCK activation could serve as a biomarker for ATM function and DNA damage response in vivo. In addition, dCK-deficient leukemia cell lines and murine embryonic fibroblasts exhibited increased sensitivity to IR, indicating that pharmacologic inhibition of dCK may be an effective radiosensitization strategy.	[Bunimovich, Yuri L.; Nair-Gill, Evan; Riedinger, Mireille; McCracken, Melissa N.; Radu, Caius G.; Witte, Owen N.] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Bunimovich, Yuri L.; Radu, Caius G.] Univ Calif Los Angeles, Crump Inst Mol Imaging, Los Angeles, CA USA; [Radu, Caius G.] Univ Calif Los Angeles, David Geffen Sch Med, Ahmanson Translat Imaging Div, Los Angeles, CA 90095 USA; [Cheng, Donghui; Witte, Owen N.] Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90024 USA; [Witte, Owen N.] Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA USA; [McLaughlin, Jami; Witte, Owen N.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Bunimovich, YL (corresponding author), Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA.	bunimovichyl@upmc.edu; OwenWitte@mednet.ucla.edu	; Radu, Caius/D-3936-2013	Bunimovich, Yuri/0000-0002-7920-8781; Radu, Caius/0000-0002-9338-5397; Nair-Gill, Evan/0000-0002-9876-7853	NIH grant [R25T CA098010]; NIAID UCLA CMCR seed grant [U19AI067769, NIH 5T32 AI06567, CIRM TG2-01169]; Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research; NATIONAL CANCER INSTITUTE [R25CA098010, P30CA016042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI067769] Funding Source: NIH RePORTER	NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID UCLA CMCR seed grant; Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grant R25T CA098010 [to YLB] and NIAID UCLA CMCR seed grant U19AI067769 [to YLB and ONW], NIH 5T32 AI06567 [to EN-G], CIRM TG2-01169 [to MNM]. ONW is an Investigator of the Howard Hughes Medical Institute and partially supported by the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aude-Garcia C, 2011, CELL MOL LIFE SCI, V68, P687, DOI 10.1007/s00018-010-0477-5; Austin WR, 2012, J EXP MED, V209, P2215, DOI 10.1084/jem.20121061; Barlow C, 1996, CELL, V86, P159, DOI 10.1016/S0092-8674(00)80086-0; Bassing CH, 2004, DNA REPAIR, V3, P781, DOI 10.1016/j.dnarep.2004.06.001; Bensimon A, 2011, FEBS LETT, V585, P1625, DOI 10.1016/j.febslet.2011.05.013; Bredemeyer AL, 2006, NATURE, V442, P466, DOI 10.1038/nature04866; Burkhalter MD, 2009, DNA REPAIR, V8, P1258, DOI 10.1016/j.dnarep.2009.07.009; Cardoen S, 2001, CLIN CANCER RES, V7, P3559; Chang LF, 2008, P NATL ACAD SCI USA, V105, P18519, DOI 10.1073/pnas.0803313105; Cheema AK, 2011, J PROTEOME RES, V10, P2651, DOI 10.1021/pr101243j; CHOTTINER EG, 1991, P NATL ACAD SCI USA, V88, P1531, DOI 10.1073/pnas.88.4.1531; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Ciofani M, 2010, NAT REV IMMUNOL, V10, P657, DOI 10.1038/nri2820; Cosentino C, 2011, EMBO J, V30, P546, DOI 10.1038/emboj.2010.330; Csapo Z, 2003, BIOCHEM PHARMACOL, V65, P2031, DOI 10.1016/S0006-2952(03)00182-5; Csapo Z, 1998, ADV EXP MED BIOL, V431, P525; Eaton JS, 2007, J CLIN INVEST, V117, P2723, DOI 10.1172/JCI31604; Falk I, 1996, J EXP MED, V184, P2327, DOI 10.1084/jem.184.6.2327; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Griffith DA, 1996, BBA-REV BIOMEMBRANES, V1286, P153, DOI 10.1016/S0304-4157(96)00008-1; Guo Z, 2010, SCIENCE, V330, P517, DOI 10.1126/science.1192912; Hakansson P, 2006, J BIOL CHEM, V281, P7834, DOI 10.1074/jbc.M512894200; HAMACHER K, 1986, J NUCL MED, V27, P235; Hardy RR, 2007, IMMUNITY, V26, P703, DOI 10.1016/j.immuni.2007.05.013; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; Haveman J, 2006, ONCOL REP, V16, P901; HAWLEY RG, 1994, GENE THER, V1, P136; Hazra S, 2011, BIOCHEMISTRY-US, V50, P2870, DOI 10.1021/bi2001032; Hesse JE, 2009, EXP GERONTOL, V44, P676, DOI 10.1016/j.exger.2009.06.009; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Jordheim LP, 2004, CLIN CANCER RES, V10, P5614, DOI 10.1158/1078-0432.CCR-04-0506; Keszler G, 2006, NUCLEOS NUCLEOT NUCL, V25, P1147, DOI 10.1080/15257770600894345; Keszler G, 2004, BIOCHEM PHARMACOL, V67, P947, DOI 10.1016/j.bcp.2003.10.019; Kim SH, 1998, INT J RADIAT ONCOL, V42, P789, DOI 10.1016/S0360-3016(98)00338-1; Kunos CA, 2011, RADIAT RES, V176, P425, DOI 10.1667/RR2556.1; Kunos CA, 2010, RADIAT RES, V174, P574, DOI 10.1667/RR2273.1; Laing RE, 2009, P NATL ACAD SCI USA, V106, P2847, DOI 10.1073/pnas.0812890106; Lavin MF, 2008, NAT REV MOL CELL BIO, V9, P759, DOI 10.1038/nrm2514; Leahy JJJ, 2004, BIOORG MED CHEM LETT, V14, P6083, DOI 10.1016/j.bmcl.2004.09.060; Lee MW, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-223; Ljungman M, 2009, CHEM REV, V109, P2929, DOI 10.1021/cr900047g; Loening AM, 2001, J NUCL MED, V42, p192P; Luo LZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030541; Mathews CK, 2006, FASEB J, V20, P1300, DOI 10.1096/fj.06-5730rev; Mathews CK, 2009, METHODS MOL BIOL, V554, P371, DOI 10.1007/978-1-59745-521-3_22; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; McSorley T, 2008, FEBS LETT, V582, P720, DOI 10.1016/j.febslet.2008.01.048; Munch-Petersen B, 2010, NUCLEOS NUCLEOT NUCL, V29, P363, DOI 10.1080/15257771003729591; O'Driscoll M, 2003, NAT GENET, V33, P497, DOI 10.1038/ng1129; Piao C, 2009, ONCOGENE, V28, P2173, DOI 10.1038/onc.2009.84; Radu CG, 2008, NAT MED, V14, P783, DOI 10.1038/nm1724; REICHARD P, 1988, ANNU REV BIOCHEM, V57, P349, DOI 10.1146/annurev.bi.57.070188.002025; Sabini E, 2003, NAT STRUCT BIOL, V10, P513, DOI 10.1038/nsb942; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Secretan MB, 2004, MUTAT RES-FUND MOL M, V554, P351, DOI 10.1016/j.mrfmmm.2004.05.016; Shewach DS, 1996, INVEST NEW DRUG, V14, P257, DOI 10.1007/BF00194528; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Shiloh Y, 2013, NAT REV MOL CELL BIO, V14, P197, DOI 10.1038/nrm3546; Shu CJ, 2010, J NUCL MED, V51, P1092, DOI 10.2967/jnumed.109.073361; Smal C, 2006, NUCLEOS NUCLEOT NUCL, V25, P1141, DOI 10.1080/15257770600890194; Smal C, 2006, J BIOL CHEM, V281, P4887, DOI 10.1074/jbc.M512129200; Smal C, 2004, NUCLEOS NUCLEOT NUCL, V23, P1363, DOI 10.1081/NCN-200027620; Smal C, 2004, BIOCHEM PHARMACOL, V68, P95, DOI 10.1016/j.bcp.2004.02.031; Smal C, 2007, CANCER LETT, V253, P68, DOI 10.1016/j.canlet.2007.01.013; Smal C, 2007, BIOCHEM PHARMACOL, V73, P351, DOI 10.1016/j.bcp.2006.10.012; Spasokoukotskaja T, 1999, EUR J CANCER, V35, P1862, DOI 10.1016/S0959-8049(99)00223-3; Spitz DR, 2004, CANCER METAST REV, V23, P311, DOI 10.1023/B:CANC.0000031769.14728.bc; Staub M, 1998, ANN ONCOL, V9, P113; Stiff T, 2006, EMBO J, V25, P5775, DOI 10.1038/sj.emboj.7601446; Stout DB, 2005, MOL IMAGING BIOL, V7, P393, DOI 10.1007/s11307-005-0015-2; Stuschke M, 1997, INT J RADIAT ONCOL, V37, P259, DOI 10.1016/S0360-3016(96)00511-1; Taghon T, 2006, IMMUNITY, V24, P53, DOI 10.1016/j.immuni.2005.11.012; Toy G, 2010, P NATL ACAD SCI USA, V107, P5551, DOI 10.1073/pnas.0913900107; Uziel T, 2003, EMBO J, V22, P5612, DOI 10.1093/emboj/cdg541; Van den Neste E, 2003, BIOCHEM PHARMACOL, V65, P573, DOI 10.1016/S0006-2952(02)01559-9; Warren LA, 2009, MECH AGEING DEV, V130, P46, DOI 10.1016/j.mad.2008.03.010; Wei S, 1999, INT J RADIAT BIOL, V75, P1005, DOI 10.1080/095530099139764; Wong S, 2004, P NATL ACAD SCI USA, V101, P17456, DOI 10.1073/pnas.0407061101; Yang CY, 2012, NUCLEIC ACIDS RES, V40, P9621, DOI 10.1093/nar/gks707; Young H, 1999, EUR J CANCER, V35, P1773, DOI 10.1016/S0959-8049(99)00229-4; Yu XC, 2010, J BIOMOL SCREEN, V15, P72, DOI 10.1177/1087057109353604	81	21	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e104125	10.1371/journal.pone.0104125	http://dx.doi.org/10.1371/journal.pone.0104125			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25101980	Green Published, gold, Green Submitted			2022-12-27	WOS:000339993900042
J	Jia, MY; Yang, BY; Li, ZY; Shen, HL; Song, XX; Gu, W				Jia, Minyue; Yang, Boyun; Li, Zhongyi; Shen, Huiling; Song, Xiaoxiao; Gu, Wei			Computational Analysis of Functional Single Nucleotide Polymorphisms Associated with the CYP11B2 Gene	PLOS ONE			English	Article							ALDOSTERONE SYNTHASE GENE; PROTEIN FUNCTION; SNPS; IDENTIFICATION; MUTATIONS; SEQUENCES; VARIANTS; DATABASE; DISEASE; REGIONS	Single nucleotide polymorphisms (SNPs) are the most common type of genetic variations in humans and play a major role in the genetics of human phenotype variation and the genetic basis of human complex diseases. Recently, there is considerable interest in understanding the possible role of the CYP11B2 gene with corticosterone methyl oxidase deficiency, primary aldosteronism, and cardio-cerebro-vascular diseases. Hence, the elucidation of the function and molecular dynamic behavior of CYP11B2 mutations is crucial in current genomics. In this study, we investigated the pathogenic effect of 51 nsSNPs and 26 UTR SNPs in the CYP11B2 gene through computational platforms. Using a combination of SIFT, PolyPhen, I-Mutant Suite, and ConSurf server, four nsSNPs (F487V, V129M, T498A, and V403E) were identified to potentially affect the structure, function, and activity of the CYP11B2 protein. Furthermore, molecular dynamics simulation and structure analyses also confirmed the impact of these nsSNPs on the stability and secondary properties of the CYP11B2 protein. Additionally, utilizing the UTRscan, MirSNP, PolymiRTS and miRNASNP, three SNPs in the 3'UTR region were predicted to exhibit a pattern change in the upstream open reading frames (uORF), and eight microRNA binding sites were found to be highly affected due to 3'UTR SNPs. This cataloguing of deleterious SNPs is essential for narrowing down the number of CYP11B2 mutations to be screened in genetic association studies and for a better understanding of the functional and structural aspects of the CYP11B2 protein.	[Jia, Minyue; Yang, Boyun; Shen, Huiling; Song, Xiaoxiao; Gu, Wei] Zhejiang Univ, Affiliated Hosp 2, Sch Med, Dept Endocrinol & Metab, Hangzhou 310003, Zhejiang, Peoples R China; [Li, Zhongyi] Zhejiang Univ, Hangzhou Binjiang Hosp, Affiliated Hosp 2, Dept Urol,Binjiang Branch, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Gu, W (corresponding author), Zhejiang Univ, Affiliated Hosp 2, Sch Med, Dept Endocrinol & Metab, Hangzhou 310003, Zhejiang, Peoples R China.	xsong103@gmail.com; guwei_1957@126.com		Yang, boyun/0000-0001-6221-2461	Science Technology Department of Zhejiang Province of China [2011C23018]; Research Fund for the Doctoral Program of Higher Education of China [20130101120038]	Science Technology Department of Zhejiang Province of China; Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by grants from Science Technology Department of Zhejiang Province of China [grant number 2011C23018], and grants from Research Fund for the Doctoral Program of Higher Education of China [grant number 20130101120038]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Androulakis E, 2013, INT J CARDIOL, V168, P1605, DOI 10.1016/j.ijcard.2013.01.035; Bhattacharya A, 2014, NUCLEIC ACIDS RES, V42, pD86, DOI 10.1093/nar/gkt1028; Brand E, 1998, HYPERTENSION, V32, P198, DOI 10.1161/01.HYP.32.2.198; Cao Fei-fei, 2009, Zhonghua Liu Xing Bing Xue Za Zhi, V30, P1069; Capriotti E, 2006, BIOINFORMATICS, V22, P2729, DOI 10.1093/bioinformatics/btl423; Cazzola M, 2000, BLOOD, V95, P3280, DOI 10.1182/blood.V95.11.3280.011k41_3280_3288; Chasman D, 2001, J MOL BIOL, V307, P683, DOI 10.1006/jmbi.2001.4510; Chen X, 2003, PHARMACOGENOMICS J, V3, P77, DOI 10.1038/sj.tpj.6500167; Conne B, 2000, NAT MED, V6, P637, DOI 10.1038/76211; Feng HJ, 2014, BRAZ J MED BIOL RES; Ferrer-Costa C, 2004, PROTEINS, V57, P811, DOI 10.1002/prot.20252; Flynt AS, 2008, NAT REV GENET, V9, P831, DOI 10.1038/nrg2455; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; Gong J, 2012, HUM MUTAT, V33, P254, DOI 10.1002/humu.21641; Grillo G, 2010, NUCLEIC ACIDS RES, V38, pD75, DOI 10.1093/nar/gkp902; Huang H, 2011, EUR HEART J, V32, P355; Hui E, 2014, BMC ENDOCR DISORD, V14, DOI 10.1186/1472-6823-14-29; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ji P, 2013, GENET TEST MOL BIOMA, V17, P548, DOI 10.1089/gtmb.2013.0026; Jia M, 2013, ENDOCR J, V60, P861, DOI 10.1507/endocrj.EJ12-0455; Jordan DM, 2010, CURR OPIN STRUC BIOL, V20, P342, DOI 10.1016/j.sbi.2010.03.006; Kayes-Wandover KM, 2001, J CLIN ENDOCR METAB, V86, P1008, DOI 10.1210/jc.86.3.1008; Ke X, 2008, EUR J HUM GENET, V16, P506, DOI 10.1038/sj.ejhg.5201987; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Liu CX, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-661; Mayosi BM, 2003, EUR J HUM GENET, V11, P395, DOI 10.1038/sj.ejhg.5200967; Mayrose I, 2004, MOL BIOL EVOL, V21, P1781, DOI 10.1093/molbev/msh194; Mignone F, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-3-reviews0004; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Nicod J, 2002, TRANSPLANTATION, V73, P960, DOI 10.1097/00007890-200203270-00023; PASCOE L, 1992, P NATL ACAD SCI USA, V89, P4996, DOI 10.1073/pnas.89.11.4996; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pupko T, 2002, BIOINFORMATICS, V18, P1116, DOI 10.1093/bioinformatics/18.8.1116; Quinkler M, 2010, HORM METAB RES, V42, P429, DOI 10.1055/s-0029-1243257; Rajith B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024607; Reynolds PR, 2002, ARCH DIS CHILD, V86, P322, DOI 10.1136/adc.86.5.322; Saunders CT, 2002, J MOL BIOL, V322, P891, DOI 10.1016/S0022-2836(02)00813-6; Scheper GC, 2007, NAT REV GENET, V8, P711, DOI 10.1038/nrg2142; Shastry BS, 2002, J HUM GENET, V47, P561, DOI 10.1007/s100380200086; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; SHRAKE A, 1973, J MOL BIOL, V79, P351, DOI 10.1016/0022-2836(73)90011-9; Strushkevich N, 2013, MOL ENDOCRINOL, V27, P315, DOI 10.1210/me.2012-1287; Tousoulis D, 2013, AM J HYPERTENS, V26, P683, DOI 10.1093/ajh/hps089; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Wu JX, 2013, SCI WORLD J, DOI 10.1155/2013/675851; Xu H, 2005, BIOINFORMATICS, V21, P4181, DOI 10.1093/bioinformatics/bti682; Yue P, 2005, J MOL BIOL, V353, P459, DOI 10.1016/j.jmb.2005.08.020; Zhu MJ, 2007, INT J BIOL SCI, V3, P420	50	27	27	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e104311	10.1371/journal.pone.0104311	http://dx.doi.org/10.1371/journal.pone.0104311			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25102047	Green Submitted, Green Published, gold			2022-12-27	WOS:000339993900058
J	Mondal, SP; Yamage, M				Mondal, Shankar P.; Yamage, Mat			A Retrospective Study on the Epidemiology of Anthrax, Foot and Mouth Disease, Haemorrhagic Septicaemia, Peste des Petits Ruminants and Rabies in Bangladesh, 2010-2012	PLOS ONE			English	Article							SOUTH-EAST-ASIA; CUTANEOUS ANTHRAX; WEST-BENGAL; VIRUS; OUTBREAKS; INDIA; PREVALENCE; MORBIDITY; MORTALITY; CATTLE	Anthrax, foot and mouth disease (FMD), haemorrhagic septicaemia (HS), peste des petits ruminants (PPR) and rabies are considered to be endemic in Bangladesh. This retrospective study was conducted to understand the geographic and seasonal distribution of these major infectious diseases in livestock based on data collected through passive surveillance from 1 January 2010 to 31 December 2012. Data analysis for this period revealed 5,937 cases of anthrax, 300,333 of FMD, 13,436 of HS, 247,783 of PPR and 14,085 cases of dog bite/rabies. While diseases were reported in almost every district of the country, the highest frequency of occurrence corresponded to the susceptible livestock population in the respective districts. There was no significant difference in the disease occurrences between districts bordering India/Myanmar and non-border districts (p>0.05). Significantly higher (p<0.01) numbers of anthrax (84.5%), FMD (88.3%), HS (84.9%) and dog bite/rabies (64.3%) cases were reported in cattle than any other species. PPR cases were reported mostly (94.8%) in goats with only isolated cases (5.2%) in sheep. The diseases occur throughout the year with peak numbers reported during June through September and lowest during December through April, with significant differences (p<0.01) between the months. The annual usages of vaccines for anthrax, FMD, HS and PPR were only 7.31%, 0.61%, 0.84% and 11.59% of the susceptible livestock population, respectively. Prophylactic vaccination against rabies was 21.16% of cases. There were significant differences (p<0.01) in the administration of anthrax, FMD and HS vaccines between border and non-border districts, but not PPR or rabies vaccines. We recommend that surveillance and reporting of these diseases need to be improved throughout the country. Furthermore, all suspected clinical cases should be confirmed by laboratory examination. The findings of this study can be used in the formulation of more effective disease management and control strategies, including appropriate vaccination policies in Bangladesh.	[Mondal, Shankar P.; Yamage, Mat] Food & Agr Org United Nations, Dhaka, Bangladesh	Food & Agriculture Organization of the United Nations (FAO)	Mondal, SP (corresponding author), Univ Kentucky, Maxwell H Gluck Equine Res Ctr, Dept Vet Sci, Lexington, KY 40506 USA.	shankarpm@yahoo.com			United States Agency for International Development	United States Agency for International Development(United States Agency for International Development (USAID))	The study was supported by the United States Agency for International Development. The views expressed in this manuscript do not necessarily represent the position of the US Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abubakar M, 2009, TROP ANIM HEALTH PRO, V41, P1197, DOI 10.1007/s11250-008-9300-9; Ahmed S, 1996, ASIAN LIVESTOCK J, V21, P112; [Anonymous], 2009, BANGL EC REV; Balamurugan V, 2012, J VET SCI, V13, P279, DOI 10.4142/jvs.2012.13.3.279; Bangladesh Bureau of Statistics, 2010, AGR CENS 2005; Banyard AC, 2010, J GEN VIROL, V91, P2885, DOI 10.1099/vir.0.025841-0; BARC Bangladesh, 2010, AGR RES PRIOR VIS 20; Benkirane A, 2002, VET MED-CZECH, V47, P234, DOI 10.17221/5830-VETMED; Bhattacharya S, 2005, REV SCI TECH OIE, V24, P945, DOI 10.20506/rst.24.3.1622; Biswas PK, 2012, EPIDEMIOL INFECT, V140, P1888, DOI 10.1017/S0950268811002408; Chakraborty A, 2012, AM J TROP MED HYG, V86, P703, DOI 10.4269/ajtmh.2012.11-0234; Chhetri BK, 2010, TROP ANIM HEALTH PRO, V42, P1441, DOI 10.1007/s11250-010-9573-7; Chowdhury S. M. Z. H., 1993, Asian-Australasian Journal of Animal Sciences, V6, P423; Coleman PG, 1996, VACCINE, V14, P185, DOI 10.1016/0264-410X(95)00197-9; Davies G, 2002, RES VET SCI, V73, P195, DOI 10.1016/S0034-5288(02)00105-4; DEALWIS MCL, 1990, TROP ANIM HEALTH PRO, V22, P185, DOI 10.1007/BF02241015; DEBNATH NC, 1990, PREV VET MED, V9, P1, DOI 10.1016/0167-5877(90)90037-I; Dhar P, 2002, VET MICROBIOL, V88, P153, DOI 10.1016/S0378-1135(02)00102-5; DOHMS JE, 1991, VET IMMUNOL IMMUNOP, V30, P89, DOI 10.1016/0165-2427(91)90011-Z; Dukpa K, 2011, TROP ANIM HEALTH PRO, V43, P495, DOI 10.1007/s11250-010-9722-z; FAO, 2011, P INT WORKSH FAO ROM; FAO/OIE, 2012, FAO OIE GLOB C FOOT; Food and Agriculture Organization (FAO) of the United Nations, 2001, ANTHR AN; GIBBS EPJ, 1979, INTERVIROLOGY, V11, P268, DOI 10.1159/000149044; Gleeson LJ, 2002, REV SCI TECH OIE, V21, P465, DOI 10.20506/rst.21.3.1346; Gongal Gyanendra, 2011, Adv Prev Med, V2011, P383870, DOI 10.4061/2011/383870; Grubman MJ, 2004, CLIN MICROBIOL REV, V17, P465, DOI 10.1128/CMR.17.2.465-493.2004; Hossain M, 2013, PREV VET MED, V111, P134, DOI 10.1016/j.prevetmed.2013.03.008; Hossain M, 2011, VACCINE, V29, P1036, DOI 10.1016/j.vaccine.2010.11.052; HOWLADER MMR, 2004, J BIOL SCI, V4, P581; Islam M. R., 2001, Bangladesh Veterinarian, V18, P14; Jamil KM, 2012, EMERG INFECT DIS, V18, P2021, DOI 10.3201/eid1812.120061; Khounsy S, 2008, REV SCI TECH OIE, V27, P839, DOI 10.20506/rst.27.3.1840; Khounsy S, 2009, VET MICROBIOL, V137, P178, DOI 10.1016/j.vetmic.2008.12.008; Kitching RP, 2002, REV SCI TECH OIE, V21, P499, DOI 10.20506/rst.21.3.1343; Lefevre PC, 1990, OFFICE INT EPIZOOTIE, V9, P951, DOI DOI 10.20506/rst.9.4.532; Livestock Research Institute, 2010, ANN REP PROD DISTR B; Loth L, 2011, TRANSBOUND EMERG DIS, V58, P240, DOI 10.1111/j.1865-1682.2011.01206.x; Madin B, 2011, PREV VET MED, V102, P230, DOI 10.1016/j.prevetmed.2011.07.010; MALAGA H, 1979, INT J EPIDEMIOL, V8, P243, DOI 10.1093/ije/8.3.243; Mannan MA, 2009, J BANGLADESH AGR U, V7, P317; Mumford JA, 2007, REV SCI TECH OIE, V26, P69, DOI 10.20506/rst.26.1.1730; Nandi SP, 2015, TRANSBOUND EMERG DIS, V62, P328, DOI 10.1111/tbed.12113; Ozkul A, 2002, EMERG INFECT DIS, V8, P708; Perry BD, 2002, REV SCI TECH OIE, V21, P663, DOI 10.20506/rst.21.3.1354; PHARO HJ, 1987, TROP ANIM HEALTH PRO, V19, P136, DOI 10.1007/BF02239707; Plotkin SA, 2000, CLIN INFECT DIS, V30, P4, DOI 10.1086/313632; Chakma S., 2012, Bangladesh Veterinarian, V29, P1, DOI 10.3329/bvet.v29i1.11883; Rahman MS, 2010, INT J BIORES, V2, P17; Ray TK, 2009, EMERG INFECT DIS, V15, P497, DOI 10.3201/eid1503.080972; Rosenberger G., 1979, CLIN EXAMINATION CAT; Samad MA, 2000, LEP PUB, V07; Sarker S, 2011, WAYAMBA J ANI S 0310; Sarker S, 2011, VET WORLD, V4, P546, DOI 10.5455/vetworld.2011.546-549; Siddiqui Muhammad Afsar, 2012, BMC Res Notes, V5, P464, DOI 10.1186/1756-0500-5-464; Sil BK, 1995, ANN C BANGL SOC VET; Singh RP, 2004, REV SCI TECH OIE, V23, P807, DOI 10.20506/rst.23.3.1522; Sumption K, 2008, TRANSBOUND EMERG DIS, V55, P5, DOI 10.1111/j.1865-1682.2007.01017.x; Thiptara A, 2011, AM J TROP MED HYG, V85, P138, DOI 10.4269/ajtmh.2011.10-0535; UN, 2011, WORLD POPULATION PRO; Verma A. K., 2008, Asian Journal of Epidemiology, V1, P40, DOI 10.3923/aje.2008.40.46; *WORLD ORG AN HLTH, 2010, WORLD AN HLTH INF DA; Zhang ZD, 2001, J COMP PATHOL, V124, P89, DOI 10.1053/jcpa.2000.0431	63	29	29	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e104435	10.1371/journal.pone.0104435	http://dx.doi.org/10.1371/journal.pone.0104435			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25101836	Green Submitted, Green Published, gold			2022-12-27	WOS:000339993900064
J	Son, JY; Lee, HY; Lee, KS; Kim, JH; Han, J; Jeong, JY; Kwon, OJ; Shim, YM				Son, Ji Ye; Lee, Ho Yun; Lee, Kyung Soo; Kim, Jae-Hun; Han, Joungho; Jeong, Ji Yun; Kwon, O. Jung; Shim, Young Mog			Quantitative CT Analysis of Pulmonary Ground-Glass Opacity Nodules for the Distinction of Invasive Adenocarcinoma from Pre-Invasive or Minimally Invasive Adenocarcinoma	PLOS ONE			English	Article							PROGNOSTIC-SIGNIFICANCE; LUNG ADENOCARCINOMA; HISTOGRAM ANALYSIS; TEXTURE ANALYSIS; PATHOLOGY; CANCER; CELL; HISTOPATHOLOGY; DIAGNOSIS; SUBTYPE	Objectives: We aimed to analyze the CT findings of ground-glass opacity nodules diagnosed pathologically as adenocarcinoma in situ (AIS), minimally invasive adenocarcinoma (MIA), and invasive adenocarcinoma in order to investigate whether quantitative CT parameters enable distinction of invasive adenocarcinoma from pre-invasive or minimally invasive adenocarcinoma. Methods: We reviewed CT images and pathologic specimens from 191 resected ground-glass opacity nodules with little or no solid component at CT. Nodule size, volume, density, mass, skewness/kurtosis, and CT attenuation values at the 2.5th-97.5th percentiles on histogram, and texture parameters (uniformity and entropy) were assessed from CT datasets. Results: Of 191 tumors, 38 were AISs (20%), 61 were MIAs (32%), and 92 (48%) were invasive adenocarcinomas. Multivariate logistic regression analysis helped identify the 75th percentile CT attenuation value (P = 0.04) and entropy (P<0.01) as independent predictors for invasive adenocarcinoma, with an area under the receiver operating characteristic curve of 0.780. Conclusion: Quantitative analysis of preoperative CT imaging metrics can help distinguish invasive adenocarcinoma from pre-invasive or minimally invasive adenocarcinoma.	[Son, Ji Ye; Lee, Ho Yun; Lee, Kyung Soo; Kim, Jae-Hun] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Radiol, Seoul, South Korea; [Son, Ji Ye; Lee, Ho Yun; Lee, Kyung Soo; Kim, Jae-Hun] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Ctr Imaging Sci, Seoul, South Korea; [Han, Joungho; Jeong, Ji Yun] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pathol, Seoul, South Korea; [Kwon, O. Jung] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Internal Med,Div Resp & Crit Med, Seoul, South Korea; [Shim, Young Mog] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Thorac Surg, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Lee, HY (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Radiol, Seoul, South Korea.	hoyunlee96@gmail.com	Lee, Ho Yun/D-6086-2012	Kim, Jae-Hun/0000-0003-3064-6948				Borezuk AC, 2009, AM J SURG PATHOL, V33, P462, DOI 10.1097/PAS.0b013e318190157c; Chandarana H, 2012, RADIOLOGY, V265, P790, DOI 10.1148/radiol.12111281; Ganeshan B, 2010, CANCER IMAGING, V10, P137, DOI 10.1102/1470-7330.2010.0021; Goh V, 2011, RADIOLOGY, V261, P165, DOI 10.1148/radiol.11110264; Hashizume T, 2008, CHEST, V133, P441, DOI 10.1378/chest.07-1533; Honda T, 2013, CLIN RADIOL, V68, pE21, DOI 10.1016/j.crad.2012.09.002; Ikeda K, 2007, CHEST, V132, P984, DOI 10.1378/chest.07-0793; Ikeda N, 2004, ANN THORAC SURG, V78, P1011, DOI 10.1016/j.athoracsur.2004.03.048; Kato F, 2012, LUNG CANCER, V77, P495, DOI 10.1016/j.lungcan.2012.05.109; Kayser G, 2013, ACTA HISTOCHEM; Kim HK, 2009, J THORAC ONCOL, V4, P1242, DOI 10.1097/JTO.0b013e3181b3fee3; Lee HY, 2014, AM J ROENTGENOL, V202, pW224, DOI 10.2214/AJR.13.11819; Lee HY, 2011, J THORAC IMAG, V26, P106, DOI 10.1097/RTI.0b013e3181fbaa64; Lim HJ, 2013, CHEST, V144, P1291, DOI 10.1378/chest.12-2987; Miles KA, 2009, RADIOLOGY, V250, P444, DOI 10.1148/radiol.2502071879; Min JH, 2010, LUNG CANCER, V69, P123, DOI 10.1016/j.lungcan.2010.04.022; Neltner JH, 2012, J NEUROPATH EXP NEUR, V71, P1075, DOI 10.1097/NEN.0b013e3182768de4; NOGUCHI M, 1995, CANCER-AM CANCER SOC, V75, P2844, DOI 10.1002/1097-0142(19950615)75:12<2844::AID-CNCR2820751209>3.0.CO;2-#; Onozato Maristela L, 2012, Stud Health Technol Inform, V179, P250; Ozluk Y, 2012, CLIN TRANSPLANT, V26, P336, DOI 10.1111/j.1399-0012.2011.01506.x; Sakurai H, 2004, AM J SURG PATHOL, V28, P198, DOI 10.1097/00000478-200402000-00007; Shimizu K, 2005, CHEST, V127, P871, DOI 10.1378/chest.127.3.871; Suzuki K, 2002, ANN THORAC SURG, V74, P1635, DOI 10.1016/S0003-4975(02)03895-X; Thunnissen E, 2012, MODERN PATHOL, V25, P1574, DOI 10.1038/modpathol.2012.106; Travis WD, 2005, J CLIN ONCOL, V23, P3279, DOI 10.1200/JCO.2005.15.776; Travis WD, 2011, J THORAC ONCOL, V6, P244, DOI 10.1097/JTO.0b013e318206a221; Wang SM, 2012, RADIOLOGY, V262, P584, DOI 10.1148/radiol.11110576; Xu X, 2010, J THORAC ONCOL, V5, P39, DOI 10.1097/JTO.0b013e3181c09f9c	28	108	126	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e104066	10.1371/journal.pone.0104066	http://dx.doi.org/10.1371/journal.pone.0104066			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25102064	Green Published, gold, Green Submitted			2022-12-27	WOS:000339993900035
J	Zhou, RP; Li, ZK; He, CY; Li, RL; Xia, HB; Li, CY; Xiao, J; Chen, ZY				Zhou, Ruiping; Li, Zhuokun; He, Chengyi; Li, Ronglin; Xia, Hongbin; Li, Chunyang; Xiao, Jia; Chen, Zhi-Ying			Human Umbilical Cord Mesenchymal Stem Cells and Derived Hepatocyte-Like Cells Exhibit Similar Therapeutic Effects on an Acute Liver Failure Mouse Model	PLOS ONE			English	Article							METASTASIS; PROMOTE	Mesenchymal stem cells (MSCs) have exhibited therapeutic effects in multiple animal models so that are promising liver substitute for transplantation treatment of end-stage liver diseases. However, it has been shown that over-manipulation of these cells increased their tumorigenic potential, and that reducing the in vitro culture time could minimize the risk. In this study, we used a D-galactosamine plus lipopolysaccharide (Gal/LPS)-induced acute liver failure mouse model, which caused death of about 50% of the mice with necrosis of more than 50% hepatocytes, to compare the therapeutic effects of human umbilical cord MSCs (hUCMSCs) before and after induction of differentiation into hepatocyte (i-Heps). Induction of hUCMSCs to become i-Heps was achieved by treatment of the cells with a group of growth factors within 4 weeks. The resulted i-Heps exhibited a panel of human hepatocyte biomarkers including cytokeratin (hCK-18), alpha-fetoprotein (hAFP), albumin (hALB), and hepatocyte-specific functions glycogen storage and urea metabolism. We demonstrated that transplantation of both cell types through tail vein injection rescued almost all of the Gal/LPS-intoxicated mice. Although both cell types exhibited similar ability in homing at the mouse livers, the populations of the hUCMSCs-derived cells, as judged by expressing hAFP, hCK-18 and human hepatocyte growth factor (hHGF), were small. These observations let us to conclude that the hUCMSCs was as effective as the i-Heps in treatment of the mouse acute liver failure, and that the therapeutic effects of hUCMSCs were mediated largely via stimulation of host hepatocyte regeneration, and that delivery of the cells through intravenous injection was effective.	[Zhou, Ruiping; Li, Zhuokun; He, Chengyi; Xia, Hongbin; Chen, Zhi-Ying] Chinese Acad Sci, Shenzhen Inst Adv Technol, Lab Gene & Cell Therapy, Shenzhen, Peoples R China; [Xiao, Jia] Jinan Univ, Inst Tissue Transplantat & Immunol, Dept Immunobiol, Guangzhou, Guangdong, Peoples R China; [Zhou, Ruiping; Li, Ronglin; Chen, Zhi-Ying] Sun Yat Sen Univ, Guanghua Sch Stomatol, Guangzhou 510275, Guangdong, Peoples R China; [Li, Chunyang] Sun Yat Sen Univ, Affiliated Hosp 5, Dept Stomatol, Zhuhai, Peoples R China; [Xiao, Jia] Univ Hong Kong, Dept Anat, Hong Kong, Hong Kong, Peoples R China; [Zhou, Ruiping] Shenzhen Seventh Yantian Dist Peoples Hosp, Dept Stomatol, Shenzhen, Peoples R China	Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS; Jinan University; Sun Yat Sen University; Sun Yat Sen University; University of Hong Kong	Xiao, J (corresponding author), Jinan Univ, Inst Tissue Transplantat & Immunol, Dept Immunobiol, Guangzhou, Guangdong, Peoples R China.	tjxiao@jnu.edu.cn; zy.chen1@siat.ac.cn		LI, Zhuokun/0000-0001-7297-6916	National Natural Science Foundation of China [31300813]; Science and Technology Foundation of Shenzhen, China [FGW2012.566, KCW2012.237]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Foundation of Shenzhen, China	This study was funded by the National Natural Science Foundation of China (Grant No. 31300813, http://www.nsfc.gov.cn/) and Science and Technology Foundation of Shenzhen, China (Grant No. FGW2012.566 and KCW2012.237, www.szsti.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banas A, 2009, J GASTROEN HEPATOL, V24, P70, DOI 10.1111/j.1440-1746.2008.05496.x; Bernal W, 2010, LANCET, V376, P190, DOI 10.1016/S0140-6736(10)60274-7; Burra P, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-88; Campard D, 2008, GASTROENTEROLOGY, V134, P833, DOI 10.1053/j.gastro.2007.12.024; DECKER K, 1974, REV PHYSIOL BIOCH P, V71, P77, DOI 10.1007/BFb0027661; Gomez-Aristizabal A, 2009, MOL THER, V17, P1504, DOI 10.1038/mt.2009.158; Houghton J, 2004, SCIENCE, V306, P1568, DOI 10.1126/science.1099513; Ito R, 2012, CELL MOL IMMUNOL, V9, P208, DOI 10.1038/cmi.2012.2; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Kuo TK, 2008, GASTROENTEROLOGY, V134, P2111, DOI 10.1053/j.gastro.2008.03.015; Larson AM, 2005, HEPATOLOGY, V42, P1364, DOI 10.1002/hep.20948; Lee JH, 2012, ARCH PLAST SURG-APS, V39, P593, DOI 10.5999/aps.2012.39.6.593; Li J, 2010, SCI CHINA LIFE SCI, V53, P1073, DOI 10.1007/s11427-010-4055-8; Li TR, 2013, EUR J MED RES, V18, DOI 10.1186/2047-783X-18-34; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mohseny AB, 2009, J PATHOL, V219, P294, DOI 10.1002/path.2603; Moslem M, 2013, CELL TRANSPLANT; O'Grady JG, 2008, LIVER TRANSPLANT, V14, pS97, DOI 10.1002/lt.21640; Parekkadan B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000941; Qiao L, 2008, CELL RES, V18, P500, DOI 10.1038/cr.2008.40; Rabani V, 2010, CELL BIOL INT, V34, P601, DOI 10.1042/CBI20090386; Rosland GV, 2009, CANCER RES, V69, P5331, DOI 10.1158/0008-5472.CAN-08-4630; Song PY, 2012, STEM CELL REV REP, V8, P1155, DOI 10.1007/s12015-012-9406-3; van Poll D, 2008, HEPATOLOGY, V47, P1634, DOI 10.1002/hep.22236; Xu WT, 2009, CANCER LETT, V281, P32, DOI 10.1016/j.canlet.2009.02.022; Yagi H, 2009, TISSUE ENG PT A, V15, P3377, DOI [10.1089/ten.tea.2008.0681, 10.1089/ten.TEA.2008.0681]; Zhu Y, 2009, LEUKEMIA, V23, P925, DOI 10.1038/leu.2008.384	27	28	30	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e104392	10.1371/journal.pone.0104392	http://dx.doi.org/10.1371/journal.pone.0104392			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25101638	Green Submitted, gold, Green Published			2022-12-27	WOS:000339993900061
J	Chang, KL; Ho, PC				Chang, Kai Lun; Ho, Paul C.			Gas Chromatography Time-Of-Flight Mass Spectrometry (GC-TOF-MS)-Based Metabolomics for Comparison of Caffeinated and Decaffeinated Coffee and Its Implications for Alzheimer's Disease	PLOS ONE			English	Article							ANTIOXIDANT ACTIVITY; ANTIRADICAL ACTIVITY; ACIDS; DEMENTIA; RATS; POPULATION; COGNITION; MICE	Findings from epidemiology, preclinical and clinical studies indicate that consumption of coffee could have beneficial effects against dementia and Alzheimer's disease (AD). The benefits appear to come from caffeinated coffee, but no decaffeinated coffee or pure caffeine itself. Therefore, the objective of this study was to use metabolomics approach to delineate the discriminant metabolites between caffeinated and decaffeinated coffee, which could have contributed to the observed therapeutic benefits. Gas chromatography time-of-flight mass spectrometry (GC-TOF-MS)-based metabolomics approach was employed to characterize the metabolic differences between caffeinated and decaffeinated coffee. Orthogonal partial least squares discriminant analysis (OPLS-DA) showed distinct separation between the two types of coffee (cumulative Q(2) = 0.998). A total of 69 discriminant metabolites were identified based on the OPLS-DA model, with 37 and 32 metabolites detected to be higher in caffeinated and decaffeinated coffee, respectively. These metabolites include several benzoate and cinnamate-derived phenolic compounds, organic acids, sugar, fatty acids, and amino acids. Our study successfully established GC-TOF-MS based metabolomics approach as a highly robust tool in discriminant analysis between caffeinated and decaffeinated coffee samples. Discriminant metabolites identified in this study are biologically relevant and provide valuable insights into therapeutic research of coffee against AD. Our data also hint at possible involvement of gut microbial metabolism to enhance therapeutic potential of coffee components, which represents an interesting area for future research.	[Chang, Kai Lun; Ho, Paul C.] Natl Univ Singapore, Fac Sci, Dept Pharm, Singapore 117548, Singapore	National University of Singapore	Ho, PC (corresponding author), Natl Univ Singapore, Fac Sci, Dept Pharm, Singapore 117548, Singapore.	phahocl@nus.edu.sg	Ho, Paul C/O-9652-2014	Ho, Paul C/0000-0001-9213-7116	National University of Singapore; National University of Singapore, Academic Research Funding [R148-000-180-112]; National Medical Research Council, Singapore [R148-000-158-275]	National University of Singapore(National University of Singapore); National University of Singapore, Academic Research Funding(Ministry of Education, SingaporeNational University of Singapore); National Medical Research Council, Singapore(National Medical Research Council, Singapore)	Kai Lun Chang is the recipient of the NUS Research Scholarship from the National University of Singapore. This work was supported by research grants from the National University of Singapore, Academic Research Funding (R148-000-180-112) and National Medical Research Council, Singapore (R148-000-158-275). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves RC, 2010, J AGR FOOD CHEM, V58, P12221, DOI 10.1021/jf1031229; BARRIE SA, 1987, AGENTS ACTIONS, V21, P222, DOI 10.1007/BF01974946; Becerra-Moreno A, 2012, J AGR FOOD CHEM, V60, P11378, DOI 10.1021/jf303252v; Brewer GJ, 2012, BIOFACTORS, V38, P107, DOI 10.1002/biof.1005; Cao CH, 2012, J ALZHEIMERS DIS, V30, P559, DOI 10.3233/JAD-2012-111781; Cao CH, 2011, J ALZHEIMERS DIS, V25, P323, DOI 10.3233/JAD-2011-110110; Chang KL, 2011, J PROTEOME RES, V10, P2079, DOI 10.1021/pr2000336; Choi MY, 2010, FOOD CHEM, V121, P1260, DOI 10.1016/j.foodchem.2010.01.035; Chu YF, 2012, FOOD CHEM, V135, P2095, DOI 10.1016/j.foodchem.2012.04.148; Chu YF, 2012, FOOD CHEM, V131, P564, DOI 10.1016/j.foodchem.2011.09.024; Silverio ADD, 2013, PLANT FOOD HUM NUTR, V68, P268, DOI 10.1007/s11130-013-0365-x; Di Paolo G, 2011, NAT REV NEUROSCI, V12, P284, DOI 10.1038/nrn3012; Eskelinen MH, 2009, J ALZHEIMERS DIS, V16, P85, DOI 10.3233/JAD-2009-0920; Farah A, 2006, J AGR FOOD CHEM, V54, P374, DOI 10.1021/jf0518305; Gold R, 2012, CLIN IMMUNOL, V142, P44, DOI 10.1016/j.clim.2011.02.017; GUNERAL F, 1994, CLIN CHEM, V40, P862; HALL IH, 1993, ARCH PHARM, V326, P15, DOI 10.1002/ardp.19933260105; Ho L, 2012, NUTR NEUROSCI, V15, P37, DOI 10.1179/1476830511Y.0000000027; Jeong SM, 2004, J AGR FOOD CHEM, V52, P3389, DOI 10.1021/jf049899k; Jumhawan U, 2013, J AGR FOOD CHEM, V61, P7994, DOI 10.1021/jf401819s; Karegoudar TB, 2000, J MICROBIOL, V38, P53; Katz SN, 1987, DECAFFEINATION COFFE; Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213; Viana ALM, 2012, PLANT FOOD HUM NUTR, V67, P82, DOI 10.1007/s11130-011-0267-8; Natella F, 1999, J AGR FOOD CHEM, V47, P1453, DOI 10.1021/jf980737w; Olthof MR, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-10; Santos C, 2010, J ALZHEIMERS DIS, V20, pS187, DOI 10.3233/JAD-2010-091387; Shukitt-Hale B, 2013, AGE, V35, P2183, DOI 10.1007/s11357-012-9509-4; Sroka Z, 2003, FOOD CHEM TOXICOL, V41, P753, DOI 10.1016/S0278-6915(02)00329-0; Vogt JA, 2004, AM J CLIN NUTR, V80, P89; Wei FF, 2012, J AGR FOOD CHEM, V60, P10118, DOI 10.1021/jf3033057; Zhou JY, 2013, FUND CLIN PHARMACOL, V27, P279, DOI 10.1111/j.1472-8206.2011.01022.x	32	22	23	1	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e104621	10.1371/journal.pone.0104621	http://dx.doi.org/10.1371/journal.pone.0104621			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25098597	gold, Green Published, Green Submitted			2022-12-27	WOS:000339995100084
J	Ghannam, K; Martinez-Gamboa, L; Spengler, L; Krause, S; Smiljanovic, B; Bonin, M; Bhattarai, S; Grutzkau, A; Burmester, GR; Haupl, T; Feist, E				Ghannam, Khetam; Martinez-Gamboa, Lorena; Spengler, Lydia; Krause, Sabine; Smiljanovic, Biljana; Bonin, Marc; Bhattarai, Salyan; Gruetzkau, Andreas; Burmester, Gerd-R.; Haeupl, Thomas; Feist, Eugen			Upregulation of Immunoproteasome Subunits in Myositis Indicates Active Inflammation with Involvement of Antigen Presenting Cells, CD8 T-Cells and IFN gamma	PLOS ONE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; INCLUSION-BODY MYOSITIS; INTERFERON-GAMMA; CLASS-I; 20S PROTEASOME; SELECTIVE INHIBITOR; AUTOIMMUNE-DISEASES; CYTOKINE PRODUCTION; MUSCLE; POLYMYOSITIS	Objective: In idiopathic inflammatory myopathies (IIM) infiltration of immune cells into muscle and upregulation of MHC-I expression implies increased antigen presentation and involvement of the proteasome system. To decipher the role of immunoproteasomes in myositis, we investigated individual cell types and muscle tissues and focused on possible immune triggers. Methods: Expression of constitutive (PSMB5, -6, -7) and corresponding immunoproteasomal subunits (PSMB8, -9, -10) was analyzed by real-time RT-PCR in muscle biopsies and sorted peripheral blood cells of patients with IIM, non-inflammatory myopathies (NIM) and healthy donors (HD). Protein analysis in muscle biopsies was performed by western blot. Affymetrix HG-U133 platform derived transcriptome data from biopsies of different muscle diseases and from immune cell types as well as monocyte stimulation experiments were used for validation, coregulation and coexpression analyses. Results: Real-time RT-PCR revealed significantly increased expression of immunoproteasomal subunits (PSMB8/-9/-10) in DC, monocytes and CD8+ T-cells in IIM. In muscle biopsies, the immunosubunits were elevated in IIM compared to NIM and exceeded levels of matched blood samples. Proteins of PSMB8 and -9 were found only in IIM but not NIM muscle biopsies. Reanalysis of 78 myositis and 20 healthy muscle transcriptomes confirmed these results and revealed involvement of the antigen processing and presentation pathway. Comparison with reference profiles of sorted immune cells and healthy muscle confirmed upregulation of PSMB8 and -9 in myositis biopsies beyond infiltration related changes. This upregulation correlated highest with STAT1, IRF1 and IFN gamma expression. Elevation of T-cell specific transcripts in active IIM muscles was accompanied by increased expression of DC and monocyte marker genes and thus reflects the cell type specific involvement observed in peripheral blood. Conclusions: Immunoproteasomes seem to indicate IIM activity and suggest that dominant involvement of antigen processing and presentation may qualify these diseases exemplarily for the evolving therapeutic concepts of immunoproteasome specific inhibition.	[Ghannam, Khetam; Martinez-Gamboa, Lorena; Spengler, Lydia; Smiljanovic, Biljana; Bonin, Marc; Bhattarai, Salyan; Burmester, Gerd-R.; Haeupl, Thomas; Feist, Eugen] Charite, Dept Rheumatol & Clin Immunol, Berlin, Germany; [Krause, Sabine] Univ Munich, Friedrich Baur Inst, Munich, Germany; [Gruetzkau, Andreas] German Arthrit Res Ctr, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Munich	Haupl, T (corresponding author), Charite, Dept Rheumatol & Clin Immunol, Berlin, Germany.	thomas.haeupl@charite.de	Krause, Sabine/AAJ-1163-2020; Burmester, Gerd R./AAY-7514-2020	Krause, Sabine/0000-0002-3141-886X; Martinez-Gamboa, Lorena/0000-0002-1120-4178	German Research Foundation [DFG FE470/3-1, DFG GRK1631]; EU [115142-2]; European Science Foundation, grant EUMYONET	German Research Foundation(German Research Foundation (DFG)); EU(European Commission); European Science Foundation, grant EUMYONET	German Research Foundation grant DFG FE470/3-1; German Research Foundation grant DFG GRK1631 (MyoGrad); EU IMI grant BeTheCure, contract no 115142-2; European Science Foundation, grant EUMYONET. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal AK, 2010, AM J HUM GENET, V87, P866, DOI 10.1016/j.ajhg.2010.10.031; AHN JY, 1995, FEBS LETT, V366, P37, DOI 10.1016/0014-5793(95)00492-R; AKI M, 1994, J BIOCHEM, V115, P257, DOI 10.1093/oxfordjournals.jbchem.a124327; Arima K, 2011, P NATL ACAD SCI USA, V108, P14914, DOI 10.1073/pnas.1106015108; Bakay M, 2006, BRAIN, V129, P996, DOI 10.1093/brain/awl023; Basler M, 2010, J IMMUNOL, V185, P634, DOI 10.4049/jimmunol.0903182; BOES B, 1994, J EXP MED, V179, P901, DOI 10.1084/jem.179.3.901; BOHAN A, 1975, NEW ENGL J MED, V292, P403, DOI 10.1056/NEJM197502202920807; BOHAN A, 1975, NEW ENGL J MED, V292, P344, DOI 10.1056/NEJM197502132920706; Brucet M, 2004, GENES IMMUN, V5, P26, DOI 10.1038/sj.gene.6364035; Brychcy M, 2006, ARTHRITIS RHEUM, V54, P2175, DOI 10.1002/art.21970; Chen WS, 2001, J EXP MED, V193, P1319, DOI 10.1084/jem.193.11.1319; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; Dalakas MC, 2003, LANCET, V362, P971, DOI 10.1016/S0140-6736(03)14368-1; Dalakas MC, 2006, NAT CLIN PRACT RHEUM, V2, P219, DOI 10.1038/ncprheum0140; Dalakas MC, 2004, CURR OPIN NEUROL, V17, P561, DOI 10.1097/00019052-200410000-00006; Egerer K, 2002, J RHEUMATOL, V29, P2045; Feist E, 1996, J EXP MED, V184, P1313, DOI 10.1084/jem.184.4.1313; Ferrer I, 2004, J NEUROPATH EXP NEUR, V63, P484, DOI 10.1093/jnen/63.5.484; Fredriksson K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003686; Greenberg SA, 2012, GENES IMMUN, V13, P207, DOI 10.1038/gene.2011.61; Groettrup M, 1996, IMMUNOL TODAY, V17, P429, DOI 10.1016/0167-5699(96)10051-7; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Huber EM, 2012, CELL, V148, P727, DOI 10.1016/j.cell.2011.12.030; Ivanidze J, 2011, AM J PATHOL, V179, P1347, DOI 10.1016/j.ajpath.2011.05.055; Jain A, 2007, ARCH PATHOL LAB MED, V131, P1070; KALOVIDOURIS AE, 1992, J LAB CLIN MED, V120, P244; Kitamura A, 2011, J CLIN INVEST, V121, P4150, DOI 10.1172/JCI58414; Kloetzel PM, 2004, CURR OPIN IMMUNOL, V16, P76, DOI 10.1016/j.coi.2003.11.004; Krause S, 2006, ANN RHEUM DIS, V65, P1021, DOI 10.1136/ard.2005.045930; KUCKELKORN U, 1995, EUR J IMMUNOL, V25, P2605, DOI 10.1002/eji.1830250930; Kumamoto T, 2000, ACTA NEUROPATHOL, V100, P595, DOI 10.1007/s004010000229; Liu Y, 2012, ARTHRITIS RHEUM-US, V64, P895, DOI 10.1002/art.33368; Lundberg Ingrid E., 1998, Current Opinion in Rheumatology, V10, P521, DOI 10.1097/00002281-199811000-00004; Menssen A, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-98; Mitch WE, 1996, NEW ENGL J MED, V335, P1897, DOI 10.1056/NEJM199612193352507; Morawietz L, 2009, J RHEUMATOL, V36, P2694, DOI 10.3899/jrheum.081098; Mortensen OH, 2008, J PHYSIOL-LONDON, V586, P3551, DOI 10.1113/jphysiol.2008.153551; Muchamuel T, 2009, NAT MED, V15, P781, DOI 10.1038/nm.1978; Muratani M, 2003, NAT REV MOL CELL BIO, V4, P192, DOI 10.1038/nrm1049; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; RECHSTEINER M, 1993, J BIOL CHEM, V268, P6065; Rockwell CE, 2012, PHARMACOLOGY, V89, P117, DOI 10.1159/000336335; Seifert U, 2010, CELL, V142, P613, DOI 10.1016/j.cell.2010.07.036; Smiljanovic B, 2012, J MOL MED, V90, P1295, DOI 10.1007/s00109-012-0907-y; Smiljanovic B, 2010, J MOL MED, V88, P1065, DOI 10.1007/s00109-010-0648-8; Verbrugge SE, 2012, J PHARMACOL EXP THER, V341, P174, DOI 10.1124/jpet.111.187542; Zaiss DMW, 2011, J IMMUNOL, V187, P2302, DOI 10.4049/jimmunol.1101003; Zanker D, 2013, J IMMUNOL, V191, P52, DOI 10.4049/jimmunol.1300802	49	26	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e104048	10.1371/journal.pone.0104048	http://dx.doi.org/10.1371/journal.pone.0104048			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25098831	Green Published, gold, Green Submitted			2022-12-27	WOS:000339995100046
J	Kotzerke, J; Punzet, R; Runge, R; Ferl, S; Oehme, L; Wunderlich, G; Freudenberg, R				Kotzerke, Joerg; Punzet, Robert; Runge, Roswitha; Ferl, Sandra; Oehme, Liane; Wunderlich, Gerd; Freudenberg, Robert			(99)mTc-Labeled HYNIC-DAPI Causes Plasmid DNA Damage with High Efficiency	PLOS ONE			English	Article							STRAND BREAKS; INTRACELLULAR UPTAKE; CLONOGENIC SURVIVAL; POSITIONAL CHANGES; IN-VITRO; TC-99M; CELLS; I-125; REDUCTION; SITES	Tc-99m is the standard radionuclide used for nuclear medicine imaging. In addition to gamma irradiation, Tc-99m emits low-energy Auger and conversion electrons that deposit their energy within nanometers of the decay site. To study the potential for DNA damage, direct DNA binding is required. Plasmid DNA enables the investigation of the unprotected interactions between molecules and DNA that result in single-strand breaks (SSBs) or double-strand breaks (DSBs); the resulting DNA fragments can be separated by gel electrophoresis and quantified by fluorescent staining. This study aimed to compare the plasmid DNA damage potential of a Tc-99m-labeled HYNIC-DAPI compound with that of Tc-99m pertechnetate ((TcO4-)-Tc-99m). pUC19 plasmid DNA was irradiated for 2 or 24 hours. Direct and radical-induced DNA damage were evaluated in the presence or absence of the radical scavenger DMSO. For both compounds, an increase in applied activity enhanced plasmid DNA damage, which was evidenced by an increase in the open circular and linear DNA fractions and a reduction in the supercoiled DNA fraction. The number of SSBs elicited by Tc-99m-HYNIC-DAPI (1.03) was twice that caused by (TcO4-)-Tc-99m (0.51), and the number of DSBs increased fivefold in the Tc-99m-HYNIC-DAPI-treated sample compared with the (TcO4-)-Tc-99m treated sample (0.02 to 0.10). In the presence of DMSO, the numbers of SSBs and DSBs decreased to 0.03 and 0.00, respectively, in the (TcO4-)-Tc-99m treated samples, whereas the numbers of SSBs and DSBs were slightly reduced to 0.95 and 0.06, respectively, in the Tc-99m-HYNIC-DAPI-treated samples. These results indicated that Tc-99m-HYNIC-DAPI induced SSBs and DSBs via a direct interaction of the Tc-99m-labeled compound with DNA. In contrast to these results, (TcO4-)-Tc-99m induced SSBs via radical formation, and DSBs were formed by two nearby SSBs. The biological effectiveness of Tc-99m-HYNIC-DAPI increased by approximately 4-fold in terms of inducing SSBs and by approximately 10-fold in terms of inducing DSBs.	[Kotzerke, Joerg; Punzet, Robert; Runge, Roswitha; Ferl, Sandra; Oehme, Liane; Wunderlich, Gerd; Freudenberg, Robert] Tech Univ Dresden, Univ Hosp, Dept Nucl Med, Fac Med Carl Gustav Carus, D-01062 Dresden, Germany	Technische Universitat Dresden; Carl Gustav Carus University Hospital	Freudenberg, R (corresponding author), Tech Univ Dresden, Univ Hosp, Dept Nucl Med, Fac Med Carl Gustav Carus, D-01062 Dresden, Germany.	robert.freudenberg@uniklinikum-dresden.de			Deutsche Forschungsgemeinschaft (DFG) [KO 1695/4-1]; Europaischer Sozialfonds (ESF) [080951832]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Europaischer Sozialfonds (ESF)(European Commission)	The research (JK, GW) was partly supported by the Deutsche Forschungsgemeinschaft (DFG, http://www.dfg.de/, Grant No. KO 1695/4-1). Sandra Ferl (SF) was supported by the Europaischer Sozialfonds (ESF, http://www.esf.de/portal/generator/8/startseite.html, grant code 080951832). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelstein SJ, 1996, ACTA ONCOL, V35, P797, DOI 10.3109/02841869609104029; BABICH JW, 1993, J NUCL MED, V34, P1964; Balagurumoorthy P, 2008, RADIAT RES, V170, P70, DOI 10.1667/RR1072.1; Balagurumoorthy P, 2012, INT J RADIAT BIOL, V88, P998, DOI 10.3109/09553002.2012.706360; Balagurumoorthy P, 2008, INT J RADIAT BIOL, V84, P976, DOI 10.1080/09553000802512568; Cambien B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092729; COWAN R, 1987, J THEOR BIOL, V127, P229, DOI 10.1016/S0022-5193(87)80133-9; Freudenberg R, 2012, INT J RADIAT BIOL, V88, P991, DOI 10.3109/09553002.2012.728303; Hafliger P, 2005, CHEMBIOCHEM, V6, P414, DOI 10.1002/cbic.200400210; HOWELL RW, 1992, MED PHYS, V19, P1371, DOI 10.1118/1.596927; HUMM JL, 1989, INT J RADIAT ONCOL, V17, P351, DOI 10.1016/0360-3016(89)90450-1; KASSIS AI, 1989, RADIAT RES, V118, P283, DOI 10.2307/3577443; Kassis AI, 1999, RADIAT RES, V152, P530, DOI 10.2307/3580150; Kotzerke J, 2012, NUKLEARMED-NUCL MED, V51, P170, DOI 10.3413/Nukmed-0506-12-05; Kriehuber R, 2004, INT J RADIAT BIOL, V80, P875, DOI 10.1080/09553000400017705; Pomplun E, 2004, INT J RADIAT BIOL, V80, P855, DOI 10.1080/09553000400017614; Pomplun E, 2002, RADIAT PROT DOSIM, V99, P81, DOI 10.1093/oxfordjournals.rpd.a006844; Santos-Cuevas CL, 2011, NUCL MED COMMUN, V32, P303, DOI 10.1097/MNM.0b013e328341b27f; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schipper ML, 2007, EUR J NUCL MED MOL I, V34, P638, DOI 10.1007/s00259-006-0254-8; TANIOUS FA, 1992, BIOCHEMISTRY-US, V31, P3103, DOI 10.1021/bi00127a010; Walicka MA, 2000, RADIAT RES, V154, P326, DOI 10.1667/0033-7587(2000)154[0326:TODIIQ]2.0.CO;2; Wendisch M, 2010, NUKLEARMED-NUCL MED, V49, P154, DOI 10.3413/nukmed-0300; Wunderlich G, 2012, NUKLEARMED-NUCL MED, V51, P179, DOI 10.3413/Nukmed-0450-11-12; Yasui LS, 2007, RADIAT RES, V167, P167, DOI 10.1667/RR0584.1	25	15	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e104653	10.1371/journal.pone.0104653	http://dx.doi.org/10.1371/journal.pone.0104653			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25098953	gold, Green Published, Green Submitted			2022-12-27	WOS:000339995100087
J	Niang, EA; Konate, L; Diallo, M; Faye, O; Dia, I				Niang, El Hadji Amadou; Konate, Lassana; Diallo, Mawlouth; Faye, Ousmane; Dia, Ibrahima			Reproductive Isolation among Sympatric Molecular Forms of An. gambiae from Inland Areas of South-Eastern Senegal	PLOS ONE			English	Article							ANOPHELES-GAMBIAE; INCIPIENT SPECIATION; MALARIA VECTORS; PLASMODIUM-FALCIPARUM; POPULATION-STRUCTURE; CHROMOSOMAL FORMS; WEST-AFRICA; ARABIENSIS; COMPLEX; CULICIDAE	The Anopheles gambiae species complex includes at least seven morphologically indistinguishable species, one of which, Anopheles gambiae sensu stricto, is the primary mosquito vector responsible for the transmission of malaria across sub-Saharan Africa. Sympatric ecological diversification of An. gambiae s.s. is in progress within this complex, leading to the emergence of at least two incipient species (the M and S molecular forms now recognized as good species and named An. coluzzii and An. gambiae respectively) that show heterogeneous levels of divergence in most parts of Africa. However, this process seems to have broken down in coastal areas of West Africa at the extreme edge of the distribution. We undertook a longitudinal study to describe An. gambiae s.s. populations collected from two inland transects with different ecological characteristics in south-eastern Senegal. Analysis of samples collected from 20 sites across these two transects showed the M and S molecular forms coexisted at almost all sampled sites. Overall, similar hybridization rates (2.16% and 1.86%) were recorded in the two transects; sites with relatively high frequencies of M/S hybrids (up to 7%) were clustered toward the north-western part of both transects, often near urban settings. Estimated inbreeding indices for this putative speciation event varied spatially (range: 0.52-1), with hybridization rates being generally lower than expected under panmictic conditions. Such observations suggest substantial reproductive isolation between the M and S molecular forms, and further support the ongoing process of speciation in these inland areas. According to a recent reclassification of the An. gambiae complex, the M and S molecular forms from this zone correspond to An. coluzzii and An. gambiae, respectively. There is considerable evidence that these molecular forms differ in their behavioural and ecological characteristics. Detailed study of these characteristics will allow the development and implementation of better insect control strategies for combating malaria.	[Niang, El Hadji Amadou; Diallo, Mawlouth; Dia, Ibrahima] Inst Pasteur, Unite Entomol Med, Dakar, Senegal; [Niang, El Hadji Amadou; Konate, Lassana; Faye, Ousmane] Univ Cheikh Anta Diop Dakar, Lab Ecol Vectorielle & Parasitaire, Dakar, Senegal	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar; University Cheikh Anta Diop Dakar	Dia, I (corresponding author), Inst Pasteur, Unite Entomol Med, Dakar, Senegal.	dia@pasteur.sn	Niang, E.A./X-3152-2018	Niang, E.A./0000-0001-5611-1998	EU project INFRAVEC (Research capacity for the implementation of genetic control of Mosquitoes); European Commission's [228421]	EU project INFRAVEC (Research capacity for the implementation of genetic control of Mosquitoes); European Commission's(European CommissionEuropean Commission Joint Research Centre)	This study was funded by the EU project INFRAVEC (Research capacity for the implementation of genetic control of Mosquitoes); funded by the European Commission's Seventh Framework Research Programme under the grant agreement 228421). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1968, ANOPHELINAE AFR S SA; Bogh C, 2003, B ENTOMOL RES, V93, P279, DOI 10.1079/BER2003239; Caputo B, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-182; Coetzee M, 2013, ZOOTAXA, V3619, P246, DOI 10.11646/zootaxa.3619.3.2; Collins F.H., 1988, Parassitologia (Rome), V30, P231; COLUZZI M, 1985, B ZOOL, V52, P45, DOI 10.1080/11250008509440343; Costantini Carlo, 2009, BMC Ecology, V9, P16, DOI 10.1186/1472-6785-9-16; de Souza D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009927; della Torre A, 2001, INSECT MOL BIOL, V10, P9, DOI 10.1046/j.1365-2583.2001.00235.x; della Torre A, 2002, SCIENCE, V298, P115, DOI 10.1126/science.1078170; della Torre A, 2005, INSECT BIOCHEM MOLEC, V35, P755, DOI 10.1016/j.ibmb.2005.02.006; Dia I, 2003, J MED ENTOMOL, V40, P279, DOI 10.1603/0022-2585-40.3.279; Diabate A, 2005, J MED ENTOMOL, V42, P548, DOI 10.1603/0022-2585(2005)042[0548:LDOTMF]2.0.CO;2; Djogbenou L, 2010, ACTA TROP, V114, P116, DOI 10.1016/j.actatropica.2010.02.001; Edillo FE, 2002, J MED ENTOMOL, V39, P70, DOI 10.1603/0022-2585-39.1.70; Fanello C, 2002, MED VET ENTOMOL, V16, P461, DOI 10.1046/j.1365-2915.2002.00393.x; Favia G, 2001, INSECT MOL BIOL, V10, P19, DOI 10.1046/j.1365-2583.2001.00236.x; Favia G, 1997, INSECT MOL BIOL, V6, P377, DOI 10.1046/j.1365-2583.1997.00189.x; FONTENILLE D, 1993, ANN PARASIT HUM COMP, V68, P239; GETIS A, 1992, GEOGR ANAL, V24, P189, DOI 10.1111/j.1538-4632.1992.tb00261.x; Gimonneau G, 2012, MED VET ENTOMOL, V26, P9, DOI 10.1111/j.1365-2915.2011.00957.x; Kamdem C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039453; Kristan M, 2003, MED VET ENTOMOL, V17, P326, DOI 10.1046/j.1365-2915.2003.00449.x; Lee Y, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-75; Lindsay SW, 1998, B WORLD HEALTH ORGAN, V76, P33; MORAN PAP, 1948, J ROY STAT SOC B, V10, P243; Ndiath MO, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-136; Nwakanma DC, 2013, GENETICS, V193, P1221, DOI 10.1534/genetics.112.148718; Oliveira E, 2008, J MED ENTOMOL, V45, P1057, DOI 10.1603/0022-2585(2008)45[1057:HLOHBM]2.0.CO;2; Onyabe DY, 2001, MEM I OSWALDO CRUZ, V96, P1081, DOI 10.1590/S0074-02762001000800009; Pinto J, 2013, EVOL APPL, V6, P910, DOI 10.1111/eva.12075; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Simard Frederic, 2009, BMC Ecology, V9, P17, DOI 10.1186/1472-6785-9-17; Slotman MA, 2007, MOL ECOL, V16, P639, DOI 10.1111/j.1365-294X.2006.03172.x; Toure Y. T., 1998, Parassitologia (Rome), V40, P477; Turner TL, 2007, MOL BIOL EVOL, V24, P2132, DOI 10.1093/molbev/msm143; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x	37	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e104622	10.1371/journal.pone.0104622	http://dx.doi.org/10.1371/journal.pone.0104622			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25098711	Green Published, Green Submitted, gold			2022-12-27	WOS:000339995100085
J	Triest, L; Sierens, T				Triest, Ludwig; Sierens, Tim			Seagrass Radiation after Messinian Salinity Crisis Reflected by Strong Genetic Structuring and Out-of-Africa Scenario (Ruppiaceae)	PLOS ONE			English	Article							PHYLOGENETIC ANALYSES; POPULATION-GENETICS; POSIDONIA-OCEANICA; MEDITERRANEAN SEA; RAPID RADIATION; DISPERSAL; DIVERSITY; ZOSTERA; RBCL; EVOLUTIONARY	Many aquatic plant and seagrass species are widespread and the origin of their continent-wide ranges might result from high gene flow levels. The response of species when extending northwards since the Last Glacial Maximum can be opposed to the structuring of their populations that survived glaciation cycles in southern regions. The peri-Mediterranean is a complex series of sea basins, coastlines, islands and river deltas with a unique history since the Messinian Crisis that potentially influenced allopatric processes of aquatic life. We tested whether vast ranges across Europe and the peri-Mediterranean of a global seagrass group (Ruppia species complexes) can be explained by either overall high levels of gene flow or vicariance through linking population genetics, phylogeography and shallow phylogenetics. A multigene approach identified haplogroup lineages of two species complexes, of ancient and recent hybrids with most of the diversity residing in the South. High levels of connectivity over long distances were only observed at recently colonized northern ranges and in recently-filled seas following the last glaciation. A strong substructure in the southern Mediterranean explained an isolation-by-distance model across Europe. The oldest lineages of the southern Mediterranean Ruppia dated back to the period between the end of the Messinian and Late Pliocene. An imprint of ancient allopatric origin was left at basin level, including basal African lineages. Thus both vicariance in the South and high levels of connectivity in the North explained vast species ranges. Our findings highlight the need for interpreting global distributions of these seagrass and euryhaline species in the context of their origin and evolutionary significant units for setting up appropriate conservation strategies.	[Triest, Ludwig; Sierens, Tim] Vrije Univ Brussel, Brussels, Belgium	Vrije Universiteit Brussel	Triest, L (corresponding author), Vrije Univ Brussel, Brussels, Belgium.	ltriest@vub.ac.be		Triest, Ludwig/0000-0002-4946-9614	Fund for Scientific Research Flanders [G.0076.05]; Vrije Universiteit Brussel [OZR 1189BOF, BAS42]	Fund for Scientific Research Flanders(FWO); Vrije Universiteit Brussel	This project was financed by the Fund for Scientific Research Flanders (G.0076.05, Sabbatical leave contract for Ludwig Triest) and by the Vrije Universiteit Brussel (OZR 1189BOF, Sabbatical leave research funding for Ludwig Triest; BAS42). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberto F, 2008, J BIOGEOGR, V35, P1279, DOI 10.1111/j.1365-2699.2007.01876.x; Arnaud-Haond S, 2007, J BIOGEOGR, V34, P963, DOI 10.1111/j.1365-2699.2006.01671.x; Arranz SE, 2013, MOL ECOL RESOUR, V13, P546, DOI 10.1111/1755-0998.12095; BRASIER M D, 1975, Palaeontology (Oxford), V18, P681; Bremer K, 2000, P NATL ACAD SCI USA, V97, P4707, DOI 10.1073/pnas.080421597; Carreras-Carbonell J, 2005, MOL PHYLOGENET EVOL, V37, P751, DOI 10.1016/j.ympev.2005.04.021; Chen JM, 2008, MOL PHYLOGENET EVOL, V48, P168, DOI 10.1016/j.ympev.2008.03.008; Clauzon G, 1996, GEOLOGY, V24, P363, DOI 10.1130/0091-7613(1996)024<0363:AIOTMS>2.3.CO;2; Coyer JA, 2008, ANN BOT-LONDON, V101, P73, DOI 10.1093/aob/mcm288; Coyer JA, 2013, SYST BIODIVERS, V11, P271, DOI 10.1080/14772000.2013.821187; Coyer JA, 2004, MAR ECOL PROG SER, V281, P51, DOI 10.3354/meps281051; Den Hartog C., 1970, SEA GRASSES WORLD; Doadrio I, 2004, GENETICS, V15, P398; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Feliner GN, 2007, MOL PHYLOGENET EVOL, V44, P911, DOI 10.1016/j.ympev.2007.01.013; Friis E. M., 2011, EARLY FLOWERS ANGIOS; Glenn TC, 2005, METHOD ENZYMOL, V395, P202, DOI 10.1016/S0076-6879(05)95013-1; Godwin H., 1956, HIST BRIT FLORA FACT; Green P., 2003, WORLD ATLAS SEAGRASS; Hampe A, 2005, ECOL LETT, V8, P461, DOI 10.1111/j.1461-0248.2005.00739.x; HASEBE M, 1994, P NATL ACAD SCI USA, V91, P5730, DOI 10.1073/pnas.91.12.5730; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; HSU KJ, 1977, NATURE, V267, P399, DOI 10.1038/267399a0; Ignatius H., 1981, BALTIC SEA, P54; Ito Y, 2013, J PLANT RES, V126, P753, DOI 10.1007/s10265-013-0570-6; Ito Y, 2010, AM J BOT, V97, P1156, DOI 10.3732/ajb.0900168; Janssen T, 2004, BOT J LINN SOC, V146, P385, DOI 10.1111/j.1095-8339.2004.00345.x; Johannesson K, 2006, MOL ECOL, V15, P2013, DOI 10.1111/j.1365-294X.2006.02919.x; Kato Y, 2003, GENES GENET SYST, V78, P329, DOI 10.1266/ggs.78.329; van Dijk JK, 2010, AQUAT BOT, V92, P63, DOI 10.1016/j.aquabot.2009.10.005; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Krijgsman W, 1999, NATURE, V400, P652, DOI 10.1038/23231; Larkum AWD, 1989, BIOL SEAGRASSES TREA, P112; Les DH, 1997, SYST BOT, V22, P443, DOI 10.2307/2419820; Lucas C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029987; Mannino AM, 2014, AQUAT BOT UNPUB; Masucci AP, 2012, EPJ DATA SCI, V1, DOI 10.1140/epjds11; MCCULLOCH MT, 1989, NATURE, V342, P62, DOI 10.1038/342062a0; Micheli F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079889; Muller K, 2006, MOL PHYLOGENET EVOL, V38, P667, DOI 10.1016/j.ympev.2005.07.011; Olsen JL, 2004, MOL ECOL, V13, P1923, DOI 10.1111/j.1365-294X.2004.02205.x; Orth RJ, 2006, BIOSCIENCE, V56, P987, DOI 10.1641/0006-3568(2006)56[987:AGCFSE]2.0.CO;2; Papenbrock J, 2012, ISRN BOT, V2012, DOI [DOI 10.5402/2012/103892, 10.5402/2012/103892]; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Petit RJ, 2003, SCIENCE, V300, P1563, DOI 10.1126/science.1083264; Pons O, 1996, GENETICS, V144, P1237; Procaccini G, 1999, AQUAT BOT, V62, P269, DOI 10.1016/S0304-3770(98)00099-0; Reynolds LK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038397; Ruggiero MV, 2004, J MOL EVOL, V58, P115, DOI 10.1007/s00239-003-2536-0; Ruggiero MV, 2002, CONSERV GENET, V3, P71; RUSSELL G, 1985, BRIT PHYCOL J, V20, P87, DOI 10.1080/00071618500650111; Sanna D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067372; Santamaria L, 2002, ACTA OECOL, V23, P137, DOI 10.1016/S1146-609X(02)01146-3; Serra IA, 2010, MOL ECOL, V19, P557, DOI 10.1111/j.1365-294X.2009.04462.x; Short F, 2007, J EXP MAR BIOL ECOL, V350, P3, DOI 10.1016/j.jembe.2007.06.012; SLATKIN M, 1995, GENETICS, V139, P457; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tanaka N, 2003, J PLANT RES, V116, P273, DOI 10.1007/s10265-003-0090-x; Tay PL, 2002, MAR GEOL, V186, P167, DOI 10.1016/S0025-3227(02)00178-0; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Triest L, 1991, OPERA BOT BELG, V4; Triest L, 2013, AQUAT BOT, V104, P176, DOI 10.1016/j.aquabot.2011.09.009; Triest L, 2010, AQUAT BOT, V93, P68, DOI 10.1016/j.aquabot.2010.03.007; Tsigenopoulos CS, 2003, BIOL J LINN SOC, V80, P207, DOI 10.1046/j.1095-8312.2003.00237.x; Veith M, 2003, MOL PHYLOGENET EVOL, V26, P310, DOI 10.1016/S1055-7903(02)00324-X; Waycott M, 2009, P NATL ACAD SCI USA, V106, P12377, DOI 10.1073/pnas.0905620106; Weising K, 1999, GENOME, V42, P9, DOI 10.1139/gen-42-1-9; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Wissler L, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-8; Yu S, 2014, J SYST EVOL, V52, P231, DOI 10.1111/jse.12069; Zhao LC, 2008, J SYST EVOL, V46, P467, DOI 10.3724/SP.J.1002.2008.07070	71	25	25	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e104264	10.1371/journal.pone.0104264	http://dx.doi.org/10.1371/journal.pone.0104264			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25100173	gold, Green Published, Green Submitted			2022-12-27	WOS:000339995100057
J	Wang, F; Song, YF; Yin, J; Liu, ZH; Mo, XD; Wang, DG; Gao, LP; Jing, YH				Wang, Fang; Song, Yan-Feng; Yin, Jie; Liu, Zi-Hua; Mo, Xiao-Dan; Wang, De-Gui; Gao, Li-Ping; Jing, Yu-Hong			Spatial Memory Impairment Is Associated with Hippocampal Insulin Signals in Ovariectomized Rats	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-ALPHA; ALZHEIMERS-DISEASE; COGNITIVE FUNCTION; WORKING-MEMORY; BETA; ESTRADIOL; BRAIN; TRANSMISSION; PERFORMANCE; EXPRESSION	Estrogen influences memory formation and insulin sensitivity. Meanwhile, glucose utilization directly affects learning and memory, which are modulated by insulin signals. Therefore, this study investigated whether or not the effect of estrogen on memory is associated with the regulatory effect of this hormone on glucose metabolism. The relative expression of estrogen receptor beta (ER beta) and glucose transporter type 4 (GLUT4) in the hippocampus of rats were evaluated by western blot. Insulin level was assessed by ELISA and quantitative RT-PCR, and spatial memory as tested by the Morris water maze. Glucose utilization in the hippocampus was measured by 2-NBDG uptake analysis. Results showed that ovariectomy impaired the spatial memory of rats. These impairments are similar as the female rats treated with the ER beta antagonist tamoxifen (TAM). Estrogen blockade by ovariectomy or TAM treatment obviously decreased glucose utilization. This phenomenon was accompanied by decreased insulin level and GLUT4 expression in the hippocampus. The female rats were neutralized with hippocampal insulin with insulin antibody, which also impaired memory and local glucose consumption These results indicated that estrogen blockade impaired the spatial memory of the female rats. The mechanisms by which estrogen blockade impaired memory partially contributed to the decline in hippocampal insulin signals, which diminished glucose consumption.	[Wang, Fang; Song, Yan-Feng; Yin, Jie; Liu, Zi-Hua; Mo, Xiao-Dan; Wang, De-Gui; Jing, Yu-Hong] Lanzhou Univ, Sch Basic Med Sci, Inst Anat & Embryol, Lanzhou 730000, Peoples R China; [Gao, Li-Ping] Lanzhou Univ, Sch Basic Med Sci, Inst Biochem & Mol Biol, Lanzhou 730000, Peoples R China; [Gao, Li-Ping; Jing, Yu-Hong] Lanzhou Univ, Key Lab Preclin Study New Drugs Gansu Prov, Lanzhou 730000, Peoples R China; [Wang, Fang] Maternal & Child Hlth Hosp Gansu Prov, Lanzhou, Peoples R China	Lanzhou University; Lanzhou University; Lanzhou University	Jing, YH (corresponding author), Lanzhou Univ, Sch Basic Med Sci, Inst Anat & Embryol, Lanzhou 730000, Peoples R China.	jingyh@lzu.edu.cn			National Natural Science Foundation of China [30872731, 81370448]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (No. 30872731 and No. 81370448) to Yu-Hong Jing. The funders had no role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Azizi-Malekabadi H, 2012, ARQ NEURO-PSIQUIAT, V70, P447, DOI 10.1590/S0004-282X2012000600012; CRAMER JH, 1981, AM J OBSTET GYNECOL, V139, P285, DOI 10.1016/0002-9378(81)90011-9; Davey DA, 2013, WOMENS HEALTH, V9, P279, DOI [10.2217/whe.13.22, 10.2217/WHE.13.22]; Eberling JL, 2004, NEUROIMAGE, V21, P364, DOI 10.1016/j.neuroimage.2003.08.037; Emmanuel Y, 2013, BRAIN BEHAV, V3, P134, DOI 10.1002/brb3.124; Fester L, 2013, J STEROID BIOCHEM, V138, P455, DOI 10.1016/j.jsbmb.2013.09.004; Foster TC, 2012, HIPPOCAMPUS, V22, P656, DOI 10.1002/hipo.20935; Fox EM, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3449; Fugger HN, 2000, BRAIN RES, V883, P258, DOI 10.1016/S0006-8993(00)02993-0; Galea LAM, 2001, BEHAV BRAIN RES, V126, P115, DOI 10.1016/S0166-4328(01)00255-8; Grillo CA, 2009, BRAIN RES, V1296, P35, DOI 10.1016/j.brainres.2009.08.005; Holmes MM, 2002, BEHAV NEUROSCI, V116, P928, DOI 10.1037//0735-7044.116.5.928; Jin G Y, 1989, Sheng Li Ke Xue Jin Zhan, V20, P148; Lu YH, 2012, PHYSIOL BEHAV, V106, P631, DOI 10.1016/j.physbeh.2012.04.019; Mauvais-Jarvis F, 2013, ENDOCR REV, V34, P309, DOI 10.1210/er.2012-1055; McClellan KM, 2006, FRONT NEUROENDOCRIN, V27, P193, DOI 10.1016/j.yfrne.2006.02.002; Mendoza-Garces L, 2011, ANAT REC, V294, P1913, DOI 10.1002/ar.21247; Messier C, 1996, BEHAV BRAIN RES, V75, P1, DOI 10.1016/0166-4328(95)00153-0; Mitra SW, 2003, ENDOCRINOLOGY, V144, P2055, DOI 10.1210/en.2002-221069; Mitterling KL, 2010, J COMP NEUROL, V518, P2729, DOI 10.1002/cne.22361; Newhouse P, 2013, NEUROPSYCHOPHARMACOL, V38, P2632, DOI 10.1038/npp.2013.172; Palmer Jaime L, 2008, J Cancer Surviv, V2, P275, DOI 10.1007/s11764-008-0070-1; Qu N, 2013, INT J NEUROPSYCHOPH, V16, P1071, DOI 10.1017/S1461145712000958; Rettberg JR, 2014, FRONT NEUROENDOCRIN, V35, P8, DOI 10.1016/j.yfrne.2013.08.001; Smith CC, 2005, J NEUROSCI, V25, P7780, DOI 10.1523/JNEUROSCI.0762-05.2005; Touraine P, 2003, ANN MED INTERNE, V154, P103; Vearncombe KJ, 2009, MENOPAUSE, V16, P188, DOI 10.1097/gme.0b013e3181775eb4; Walker CL, 2002, RECENT PROG HORM RES, V57, P277, DOI 10.1210/rp.57.1.277; Wu WW, 2013, J NEUROSCI, V33, P16158, DOI 10.1523/JNEUROSCI.2001-13.2013; Zbarsky V, 2005, FREE RADICAL RES, V39, P1119, DOI 10.1080/10715760500233113; Zhao LQ, 2013, J ALZHEIMERS DIS, V37, P403, DOI 10.3233/JAD-122341	31	15	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e104450	10.1371/journal.pone.0104450	http://dx.doi.org/10.1371/journal.pone.0104450			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25099767	gold, Green Submitted, Green Published			2022-12-27	WOS:000339995100074
J	Charbonneau, ME; Gonzalez-Hernandez, MJ; Showalter, HD; Donato, NJ; Wobus, CE; O'Riordan, MXD				Charbonneau, Marie-Eve; Gonzalez-Hernandez, Marta J.; Showalter, Hollis D.; Donato, Nicholas J.; Wobus, Christiane E.; O'Riordan, Mary X. D.			Small Molecule Deubiquitinase Inhibitors Promote Macrophage Anti-Infective Capacity	PLOS ONE			English	Article							INFECTIOUS-DISEASES SOCIETY; NORWALK VIRUS-RNA; LISTERIA-MONOCYTOGENES; UBIQUITIN SYSTEM; UNITED-STATES; ENZYMES; CELLS; REPLICATION; NOROVIRUSES; PROTEASOME	The global spread of anti-microbial resistance requires urgent attention, and diverse alternative strategies have been suggested to address this public health concern. Host-directed immunomodulatory therapies represent one approach that could reduce selection for resistant bacterial strains. Recently, the small molecule deubiquitinase inhibitor WP1130 was reported as a potential anti-infective drug against important human food-borne pathogens, notably Listeria monocytogenes and noroviruses. Utilization of WP1130 itself is limited due to poor solubility, but given the potential of this new compound, we initiated an iterative rational design approach to synthesize new derivatives with increased solubility that retained antii-nfective activity. Here, we test a small library of novel synthetic molecules based on the structure of the parent compound, WP1130, for anti-infective activity in vitro. Our studies identify a promising candidate, compound 9, which reduced intracellular growth of L. monocytogenes at concentrations that caused minimal cellular toxicity. Compound 9 itself had no bactericidal activity and only modestly slowed Listeria growth rate in liquid broth culture, suggesting that this drug acts as an anti-infective compound by modulating host-cell function. Moreover, this new compound also showed anti-infective activity against murine norovirus (MNV-1(and human norovirus, using the Norwalk virus replicon system. This small molecule inhibitor may provide a chemical platform for further development of therapeutic deubiquitinase inhibitors with broad-spectrum anti-infective activity.	[Charbonneau, Marie-Eve; Gonzalez-Hernandez, Marta J.; Wobus, Christiane E.; O'Riordan, Mary X. D.] Univ Michigan, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Donato, Nicholas J.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Showalter, Hollis D.] Univ Michigan, Coll Pharm, Dept Med Chem, Vahlteich Med Chem Core, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	O'Riordan, MXD (corresponding author), Univ Michigan, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA.	oriordan@umich.edu		Wobus, Christiane/0000-0001-5286-0924; O'Riordan, Mary/0000-0001-6014-4637	National Institutes of Health [1 R21 AI 102106]; Leukemia Lymphoma Society; University Of Michigan College Of Pharmacy Ella and Hans Vahlteich Research Fund; University of Michigan Institute for Clinical and Health Research MICHR [U024225]; Fond de recherche sante Quebec [27881]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI102106] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia Lymphoma Society(Leukemia and Lymphoma Society); University Of Michigan College Of Pharmacy Ella and Hans Vahlteich Research Fund; University of Michigan Institute for Clinical and Health Research MICHR; Fond de recherche sante Quebec; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	These studies were funded by National Institutes of Health grant 1 R21 AI 102106 to M. O. R. and C. E. W. These studies were partially supported by a grant from the Leukemia Lymphoma Society to N. J. D. and H. D. S., the University Of Michigan College Of Pharmacy Ella and Hans Vahlteich Research Fund to H. D. S., and the University of Michigan Institute for Clinical and Health Research MICHR U024225 to N. J. D. and H. D. S. M-E. C. was supported in part by a fellowship from the Fond de recherche sante Quebec (Fellowship #27881). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrose PG, 2011, NAT MED, V17, P772, DOI 10.1038/nm0711-772; Boucher HW, 2013, CLIN INFECT DIS, V56, P1685, DOI 10.1093/cid/cit152; Burkholder KM, 2011, INFECT IMMUN, V79, P4850, DOI 10.1128/IAI.05456-11; Caminero JA, 2010, LANCET INFECT DIS, V10, P621, DOI 10.1016/S1473-3099(10)70139-0; Chang KO, 2006, VIROLOGY, V353, P463, DOI 10.1016/j.virol.2006.06.006; Cohen P, 2010, CELL, V143, P686, DOI 10.1016/j.cell.2010.11.016; Colland F, 2009, MOL CANCER THER, V8, P2286, DOI 10.1158/1535-7163.MCT-09-0097; Duizer E, 2004, J GEN VIROL, V85, P79, DOI 10.1099/vir.0.19478-0; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Freitag NE, 2009, NAT REV MICROBIOL, V7, P623, DOI 10.1038/nrmicro2171; Glomski IJ, 2003, INFECT IMMUN, V71, P6754, DOI 10.1128/IAI.71.12.6754-6765.2003; Gonzalez-Hernandez MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094491; Guix S, 2007, J VIROL, V81, P12238, DOI 10.1128/JVI.01489-07; Hall AJ, 2013, EMERG INFECT DIS, V19, P1198, DOI 10.3201/eid1908.130465; Hancock REW, 2013, CURR OPIN MICROBIOL, V16, P519, DOI 10.1016/j.mib.2013.08.004; Hancock REW, 2012, NAT REV MICROBIOL, V10, P243, DOI 10.1038/nrmicro2745; Harhaj EW, 2011, CELL RES, V21, P22, DOI 10.1038/cr.2010.166; Hussain S, 2009, CELL CYCLE, V8, P1688, DOI 10.4161/cc.8.11.8739; Kapuria V, 2010, CANCER RES, V70, P9265, DOI 10.1158/0008-5472.CAN-10-1530; Lee BH, 2010, NATURE, V467, P179, DOI 10.1038/nature09299; McKenna M, 2013, NATURE, V499, P394, DOI 10.1038/499394a; Meray RK, 2007, J BIOL CHEM, V282, P10567, DOI 10.1074/jbc.M611153200; Mostowy S, 2012, ADV IMMUNOL, V113, P19, DOI 10.1016/B978-0-12-394590-7.00007-5; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Nijnik A, 2013, CURR OPIN MICROBIOL, V16, P590, DOI 10.1016/j.mib.2013.06.011; Perry JW, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002783; Petroski MD, 2008, BMC BIOCHEM, V9, DOI 10.1186/1471-2091-9-S1-S7; Pham LV, 2010, MOL CANCER THER, V9, P2026, DOI 10.1158/1535-7163.MCT-10-0238; Randow F, 2012, TRENDS IMMUNOL, V33, P475, DOI 10.1016/j.it.2012.06.003; Rasko DA, 2010, NAT REV DRUG DISCOV, V9, P117, DOI 10.1038/nrd3013; Ratia K, 2008, P NATL ACAD SCI USA, V105, P16119, DOI 10.1073/pnas.0805240105; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Rytkonen A, 2007, CELL HOST MICROBE, V1, P13, DOI 10.1016/j.chom.2007.02.003; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Shembade N, 2012, CELL MOL IMMUNOL, V9, P123, DOI 10.1038/cmi.2011.59; Spellberg B, 2008, CLIN INFECT DIS, V46, P155, DOI 10.1086/524891; Stevenson LF, 2007, EMBO J, V26, P976, DOI 10.1038/sj.emboj.7601567; Thackray LB, 2007, J VIROL, V81, P10460, DOI 10.1128/JVI.00783-07; Wobus CE, 2004, PLOS BIOL, V2, P2076, DOI 10.1371/journal.pbio.0020432	39	10	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e104096	10.1371/journal.pone.0104096	http://dx.doi.org/10.1371/journal.pone.0104096			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093325	gold, Green Published, Green Submitted			2022-12-27	WOS:000341357200066
J	Duan, JY; Lou, J; Zhang, Q; Ke, JT; Qi, YQ; Shen, N; Zhu, BB; Zhong, R; Wang, ZL; Liu, LF; Wu, J; Wang, W; Gong, FQ; Miao, XP				Duan, Jiayu; Lou, Jiao; Zhang, Qing; Ke, Juntao; Qi, Yanqi; Shen, Na; Zhu, Beibei; Zhong, Rong; Wang, Zhenling; Liu, Lifeng; Wu, Jing; Wang, Wei; Gong, Fangqi; Miao, Xiaoping			A Genetic Variant rs1801274 in FCGR2A as a Potential Risk Marker for Kawasaki Disease: A Case-Control Study and Meta-Analysis	PLOS ONE			English	Article							C-REACTIVE PROTEIN; GENOME-WIDE ASSOCIATION; CORONARY-ARTERY-DISEASE; FC-GAMMA-RIIA; EPIDEMIOLOGIC FEATURES; SUSCEPTIBILITY LOCI; IDENTIFIES 3; CHILDREN; PHAGOCYTOSIS; POLYMORPHISM	Objectives: Recent genome-wide association study found rs1801274, a functional single nucleotide polymorphism (SNP) in IgG receptor gene FCGR2A, was associated with increased risk of Kawasaki disease (KD). However, subsequent studies on the role of this SNP were limited and controversial. Methods: A case-control study was conducted in a Chinese Han population including 428 KD patients and 493 controls to examine the association between rs1801274 and KD susceptibility. A meta-analysis was performed in combination with the relevant published studies to further clarify such an association. Results: Our case-control study found that rs1801274 was significantly associated with increased risk of KD in the Chinese Han population, with an odds ratio (OR) of 1.58 (95% CI = 0.96-2.62) for the GA genotype and 1.93 (95% CI = 1.16-3.19) for the AA genotype compared with the GG genotype. The result of meta-analysis further demonstrated that the A allele of rs1801274 was significantly correlated with KD risk under the allelic model (OR = 1.35, 95% CI = 1.27-1.44) without heterogeneity by fixed-effects model analysis (Q = 17.30, p = 0.139). Moreover, sensitivity analysis supported the robustness of this meta-analysis. Conclusion: These results further confirm that rs1801274 in the FCGR2A gene is significantly associated with increased risk of KD.	[Duan, Jiayu; Lou, Jiao; Ke, Juntao; Shen, Na; Zhu, Beibei; Zhong, Rong; Wang, Zhenling; Liu, Lifeng; Wu, Jing; Miao, Xiaoping] Huazhong Univ Sci & Technol, Dept Epidemiol & Biostat, Wuhan, Hubei, Peoples R China; [Duan, Jiayu; Lou, Jiao; Ke, Juntao; Shen, Na; Zhu, Beibei; Zhong, Rong; Wang, Zhenling; Liu, Lifeng; Wu, Jing; Miao, Xiaoping] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, State Key Lab Environm Hlth,Minist Educ,Key Lab E, Wuhan, Hubei, Peoples R China; [Zhang, Qing; Qi, Yanqi; Wang, Wei; Gong, Fangqi] Zhejiang Univ, Sch Med, Childrens Hosp, Hangzhou 310003, Zhejiang, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Zhejiang University	Miao, XP (corresponding author), Huazhong Univ Sci & Technol, Dept Epidemiol & Biostat, Wuhan, Hubei, Peoples R China.	wanghz930@gmail.com; gongfangqi63@gmail.com; miaoxp@mail.hust.edu.cn	Duan, Jiayu/HCI-7247-2022; miao, xiaoping/C-4336-2011; Zhong, Rong/Q-1813-2019	miao, xiaoping/0000-0002-6818-9722; Duan, Jiayu/0000-0001-6311-5938	The National Natural Science Foundation of China [81270177]; Ministry of Health Research Foundation of China [201339378]; The Health Bureau of Zhejiang Province [2009A124, 2009CA072]; population and family planning commission of Zhejiang province [JSW2013-A15]	The National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Health Research Foundation of China; The Health Bureau of Zhejiang Province; population and family planning commission of Zhejiang province	This work is supported, in part, by grants from The National Natural Science Foundation of China (81270177), Ministry of Health Research Foundation of China (201339378), The Health Bureau of Zhejiang Province (2009A124, 2009CA072), and population and family planning commission of Zhejiang province (JSW2013-A15). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAGI T, 1992, J PEDIATR-US, V121, P689, DOI 10.1016/S0022-3476(05)81894-3; ARJUNAN K, 1986, J AM COLL CARDIOL, V8, P1119, DOI 10.1016/S0735-1097(86)80390-4; Asano K, 2009, NAT GENET, V41, P1325, DOI 10.1038/ng.482; Ayusawa M, 2005, PEDIATR INT, V47, P232, DOI 10.1111/j.1442-200x.2005.02033.x; Biezeveld M, 2007, CLIN EXP IMMUNOL, V147, P106, DOI 10.1111/j.1365-2249.2006.03266.x; Burgner D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000319; Burns JC, 2012, CIRC-CARDIOVASC GENE, V5, P277, DOI 10.1161/CIRCGENETICS.112.963710; Burns JC, 2004, LANCET, V364, P533, DOI 10.1016/S0140-6736(04)16814-1; DAJANI AS, 1993, CIRCULATION, V87, P1776, DOI 10.1161/01.CIR.87.5.1776; Deffert C, 2011, J ALLERGY CLIN IMMUN, V128, P677, DOI 10.1016/j.jaci.2011.04.027; Fimbres AM, 2008, PEDIATR REV, V29, P308, DOI 10.1542/pir.29-9-308; FUJITA Y, 1989, PEDIATRICS, V84, P666; Gerber JS, 2001, MICROBES INFECT, V3, P131, DOI 10.1016/S1286-4579(00)01360-5; Harley JB, 2008, NAT GENET, V40, P204, DOI 10.1038/ng.81; Holman RC, 2005, PEDIATR INFECT DIS J, V24, P429, DOI 10.1097/01.inf.0000160946.05295.91; Huang WC, 2009, PEDIATRICS, V123, pe401, DOI 10.1542/peds.2008-2187; Ji Yu-Xiao, 2013, Zhongguo Dang Dai Er Ke Za Zhi, V15, P196; Kawasaki T, 1967, Arerugi, V16, P178; Kazeem GR, 2005, ANN HUM GENET, V69, P329, DOI 10.1046/j.1529-8817.2005.00156.x; Khor CC, 2011, NAT GENET, V43, P1241, DOI 10.1038/ng.981; KILPATRICK JM, 1985, J IMMUNOL, V134, P3364; Kim JJ, 2011, HUM GENET, V129, P487, DOI 10.1007/s00439-010-0937-x; KINDMARK CO, 1971, CLIN EXP IMMUNOL, V8, P941; Lee YC, 2012, NAT GENET, V44, P522, DOI 10.1038/ng.2227; Lindahl B, 2000, NEW ENGL J MED, V343, P1139, DOI 10.1056/NEJM200010193431602; MARNELL LL, 1995, J IMMUNOL, V155, P2185; MORTENSEN RF, 1976, J IMMUNOL, V117, P774; Nakamura Y, 2008, PEDIATR INT, V50, P287, DOI 10.1111/j.1442-200X.2008.02572.x; Nakamura Y, 2012, J EPIDEMIOL, V22, P216, DOI 10.2188/jea.JE20110126; Newburger JW, 2004, CIRCULATION, V110, P2747, DOI 10.1161/01.CIR.0000145143.19711.78; NEWBURGER JW, 1991, NEW ENGL J MED, V324, P1633, DOI 10.1056/NEJM199106063242305; Nicodemus KK, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-130; Nimmerjahn F, 2006, SPRINGER SEMIN IMMUN, V28, P305, DOI 10.1007/s00281-006-0052-1; Onouchi Y, 2012, NAT GENET, V44, P517, DOI 10.1038/ng.2220; Park YW, 2011, PEDIATR INT, V53, P36, DOI 10.1111/j.1442-200X.2010.03178.x; PETERMAN RM, 1995, TRENDS ECOL EVOL, V10, P460, DOI 10.1016/S0169-5347(00)89180-6; Pleass RJ, 2001, TRENDS PARASITOL, V17, P545, DOI 10.1016/S1471-4922(01)02086-4; Retterstol L, 2002, ATHEROSCLEROSIS, V160, P433, DOI 10.1016/S0021-9150(01)00595-0; Ridker PM, 2002, NEW ENGL J MED, V347, P1557, DOI 10.1056/NEJMoa021993; Rowley AH, 2008, NAT REV MICROBIOL, V6, P394, DOI 10.1038/nrmicro1853; Schneider MP, 2011, ATHEROSCLEROSIS, V218, P411, DOI 10.1016/j.atherosclerosis.2011.07.009; Stein MP, 2000, J CLIN INVEST, V105, P369, DOI 10.1172/JCI7817; Taniuchi S, 2005, J CLIN IMMUNOL, V25, P309, DOI 10.1007/s10875-005-4697-7; Thakkinstian A, 2005, STAT MED, V24, P1291, DOI 10.1002/sim.2010; Tsai FJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016853; Tse SML, 2002, J PEDIATR-US, V140, P450, DOI 10.1067/mpd.2002.122469; Uehara R, 2003, ACTA PAEDIATR, V92, P694, DOI 10.1080/08035320310002768; Uehara R, 2012, J EPIDEMIOL, V22, P79, DOI 10.2188/jea.JE20110131; WARMERDAM PAM, 1991, J IMMUNOL, V147, P1338; Yan Y, 2013, HUM GENET, P1; Zebrack JS, 2002, J AM COLL CARDIOL, V39, P632, DOI 10.1016/S0735-1097(01)01804-6	51	24	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e103329	10.1371/journal.pone.0103329	http://dx.doi.org/10.1371/journal.pone.0103329			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093412	Green Published, gold, Green Submitted			2022-12-27	WOS:000341357200022
J	Goldsby, HJ; Knoester, DB; Kerr, B; Ofria, C				Goldsby, Heather J.; Knoester, David B.; Kerr, Benjamin; Ofria, Charles			The Effect of Conflicting Pressures on the Evolution of Division of Labor	PLOS ONE			English	Article							GROUP SELECTION CONTROVERSY; ARTIFICIAL SELECTION; SOCIAL-BEHAVIOR; COOPERATION	Within nature, many groups exhibit division of labor. Individuals in these groups are under seemingly antagonistic pressures to perform the task most directly beneficial to themselves and to potentially perform a less desirable task to ensure the success of the group. Performing experiments to study how these pressures interact in an evolutionary context is challenging with organic systems because of long generation times and difficulties related to group propagation and fine-grained control of within-group and between-group pressures. Here, we use groups of digital organisms (i.e., self-replicating computer programs) to explore how populations respond to antagonistic multilevel selection pressures. Specifically, we impose a within-group pressure to perform a highly-rewarded role and a between-group pressure to perform a diverse suite of roles. Thus, individuals specializing on highly-rewarded roles will have a within-group advantage, but groups of such specialists have a between-group disadvantage. We find that digital groups could evolve to be either single-lineage or multi-lineage, depending on experimental parameters. These group compositions are reminiscent of different kinds of major evolutionary transitions that occur within nature, where either relatives divide labor (fraternal transitions) or multiple different organisms coordinate activities to form a higher-level individual (egalitarian transitions). Regardless of group composition, organisms embraced phenotypic plasticity as a means for genetically similar individuals to perform different roles. Additionally, in multi-lineage groups, organisms from lineages performing highly-rewarded roles also employed reproductive restraint to ensure successful coexistence with organisms from other lineages.	[Goldsby, Heather J.; Kerr, Benjamin] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Knoester, David B.] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA; [Ofria, Charles] Michigan State Univ, Dept Comp Sci & Engn, E Lansing, MI 48824 USA; [Goldsby, Heather J.; Knoester, David B.; Kerr, Benjamin; Ofria, Charles] Michigan State Univ, BEACON Ctr Evolut Act, E Lansing, MI 48824 USA	University of Washington; University of Washington Seattle; Michigan State University; Michigan State University; Michigan State University	Goldsby, HJ (corresponding author), Univ Washington, Dept Biol, Seattle, WA 98195 USA.	goldsby@uw.edu		Ofria, Charles/0000-0003-2924-1732	BEACON Center for the Study of Evolution in Action (NSF) [DBI-0939454]; NSF [DEB0952825, OCI-1122620, OCI-1122617, CCF-0643952, CCF-0820220]; Office of Advanced Cyberinfrastructure (OAC) [1122620] Funding Source: National Science Foundation	BEACON Center for the Study of Evolution in Action (NSF); NSF(National Science Foundation (NSF)); Office of Advanced Cyberinfrastructure (OAC)(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This work was supported by the BEACON Center for the Study of Evolution in Action (NSF Cooperative Agreement DBI-0939454), an NSF CAREER award to B. K. (DEB0952825), NSF FELLOWSHIP award to H. G (OCI-1122620) and D. K (OCI-1122617), and NSF Grants (CCF-0643952, CCF-0820220). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1966, SOVIET PHYS DOKLADY; Axelrod R, 2006, P NATL ACAD SCI USA, V103, P13474, DOI 10.1073/pnas.0606053103; Bourke AFG, 2011, OX ECOL EV, P1, DOI 10.1093/acprof:oso/9780199231157.001.0001; Buss L., 1987, EVOLUTION INDIVIDUAL; Clune J, 2011, P ROY SOC B-BIOL SCI, V278, P666, DOI 10.1098/rspb.2010.1557; Crespi BJ, 2001, TRENDS ECOL EVOL, V16, P178, DOI 10.1016/S0169-5347(01)02115-2; Darwin C, 1859, ORIGIN SPECIES MEANS; Duffy JE, 2003, GENES BEHAV EVOLUTIO; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Fujii S, 2011, P NATL ACAD SCI USA, V108, P1723, DOI 10.1073/pnas.1007667108; Gintis H., 2005, MORAL SENTIMENTS MAT; Goings S, 2004, ARTIFICIAL LIFE IX, P303; Goldsby HJ, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001858; Goldsby HJ, 2012, P NATL ACAD SCI USA, V109, P13686, DOI 10.1073/pnas.1202233109; Goldsby HJ, 2012, ARTIF LIFE, V13, P178, DOI DOI 10.7551/978-0-262-31050-5-ch025; Goodnight CJ, 1997, AM NAT, V150, pS59, DOI 10.1086/286050; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Hamilton WD, 1963, AM NATURALIST, V97; Jablonka E, 2009, Q REV BIOL, V84, P131, DOI 10.1086/598822; Jandt JM, 2009, ANIM BEHAV, V77, P641, DOI 10.1016/j.anbehav.2008.11.019; Johnson AE, 2014, P GEN EV COMP C GECC; Johnson AE, 2014, ALIFE 2014: THE FOURTEENTH INTERNATIONAL CONFERENCE ON THE SYNTHESIS AND SIMULATION OF LIVING SYSTEMS, P120, DOI 10.7551/978-0-262-32621-6-ch020; Kerr B, 2011, MAJOR TRANSITIONS RE; Knoester DB, 2011, ARTIF LIFE, V17, P1, DOI 10.1162/artl_a_00014; Knoester DB, 2009, INT CONF SELF SELF, P223, DOI 10.1109/SASO.2009.29; Lenski RE, 2003, NATURE, V423, P139, DOI 10.1038/nature01568; McKinley PK, 2008, IEEE COMPUTER, V41; Ofria C, 2004, ARTIF LIFE, V10, P191, DOI 10.1162/106454604773563612; Ofria C, 2002, IEEE T EVOLUT COMPUT, V6, P420, DOI 10.1109/TEVC.2002.802442; Ofria C, 1999, P DIMACS WORKSH EV C; Okasha S, 2001, BRIT J PHILOS SCI, V52, P25, DOI 10.1093/bjps/52.1.25; Penn A, 2004, Artificial Life IX, P352; Penn A, 2003, LECT NOTES ARTIF INT, V2801, P659; Queller DC, 2003, CURR BIOL, V13, pR861, DOI 10.1016/j.cub.2003.10.043; Queller DC, 2000, PHILOS T R SOC B, V355, P1647, DOI 10.1098/rstb.2000.0727; Queller DC., 1997, Q REV BIOL, V72, P184, DOI [10.1086/419766, DOI 10.1086/419766]; Smith Adam, 1976, WEALTH NATIONS; Smith J. M., 1997, MAJOR TRANSITIONS EV; Sober E., 1998, OTHERS EVOLUTION PSY; Sundstrom L, 2001, HEREDITY, V86, P515, DOI 10.1046/j.1365-2540.2001.00884.x; Swenson W, 2000, ENVIRON MICROBIOL, V2, P564, DOI 10.1046/j.1462-2920.2000.00140.x; Swenson W, 2000, P NATL ACAD SCI USA, V97, P9110, DOI 10.1073/pnas.150237597; Traulsen A, 2006, P NATL ACAD SCI USA, V103, P10952, DOI 10.1073/pnas.0602530103; WADE MJ, 1980, ECOLOGY, V61, P1056, DOI 10.2307/1936824; WADE MJ, 1977, EVOLUTION, V31, P134, DOI 10.1111/j.1558-5646.1977.tb00991.x; Williams HTP, 2007, P NATL ACAD SCI USA, V104, P8918, DOI 10.1073/pnas.0610038104; WILSON DS, 1983, ANNU REV ECOL SYST, V14, P159, DOI 10.1146/annurev.es.14.110183.001111; WILSON EO, 1980, BEHAV ECOL SOCIOBIOL, V7, P143, DOI 10.1007/BF00299520	48	4	4	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e102713	10.1371/journal.pone.0102713	http://dx.doi.org/10.1371/journal.pone.0102713			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093399	Green Published, Green Submitted, gold			2022-12-27	WOS:000341357200013
J	Sang, A; Zheng, YY; Yin, YM; Dozmorov, I; Li, H; Hsu, HC; Mountz, JD; Morel, L				Sang, Allison; Zheng, Ying-Yi; Yin, Yiming; Dozmorov, Igor; Li, Hao; Hsu, Hui-Chen; Mountz, John D.; Morel, Laurence			Dysregulated Cytokine Production by Dendritic Cells Modulates B Cell Responses in the NZM2410 Mouse Model of Lupus	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; I INTERFERON; AUTOIMMUNE-DISEASE; TISSUE-DAMAGE; ERYTHEMATOSUS; ACTIVATION; MICE; DIFFERENTIATION; IL-6; INTERLEUKIN-6	The breakdown in tolerance of autoreactive B cells in the lupus-prone NZM2410-derived B6.Sle1.Sle2.Sle3 (TC) mice results in the secretion of autoantibodies. TC dendritic cells (DCs) enhance B cell proliferation and antibody secretion in a cytokine-dependent manner. However, the specific cytokine milieu by which TC DCs activate B cells was not known. In this study, we compared TC and C57BL/6 (B6) control for the distribution of DC subsets and for their production of cytokines affecting B cell responses. We show that TC DCs enhanced B cell proliferation through the production of IL-6 and IFN-gamma, while antibody secretion was only dependent on IL-6. Pre-disease TC mice showed an expanded PDCA1(+) cells prior to disease onset that was localized to the marginal zone and further expanded with age. The presence of PDCA1(+) cells in the marginal zone correlated with a Type I Interferon (IFN) signature in marginal zone B cells, and this response was higher in TC than B6 mice. In vivo administration of anti-chromatin immune complexes upregulated IL-6 and IFN-gamma production by splenic DCs from TC but not B6 mice. The production of BAFF and APRIL was decreased upon TC DC stimulation both in vitro and in vivo, indicating that these B cell survival factors do not play a role in B cell modulation by TC DCs. Finally, TC B cells were defective at downregulating IL-6 expression in response to anti-inflammatory apoptotic cell exposure. Overall, these results show that the TC autoimmune genetic background induces the production of B cell-modulating inflammatory cytokines by DCs, which are regulated by the microenvironment as well as the interplay between DC.	[Sang, Allison; Zheng, Ying-Yi; Yin, Yiming; Morel, Laurence] Univ Florida, Dept Pathol Immunol & Lab Med, Gainesville, FL 32611 USA; [Dozmorov, Igor] Univ Texas SW Med Ctr Dallas, Dept Immunol, Dallas, TX 75390 USA; [Li, Hao; Hsu, Hui-Chen; Mountz, John D.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA	State University System of Florida; University of Florida; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Alabama System; University of Alabama Birmingham	Morel, L (corresponding author), Univ Florida, Dept Pathol Immunol & Lab Med, Gainesville, FL 32611 USA.	morel@ufl.edu	Li, Hao/N-7406-2015	Li, Hao/0000-0002-2171-8826	VA Merit Review Grant [1I01BX000600-01]; National Institutes of Health/National Institute of Allergy and Infectious Diseases [1AI 071110]; Rheumatology Education Foundation; NIH/NIAID [1RO1AI083705]; Lupus Research Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI074491, R01AI083705, R01AI071110] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048311] Funding Source: NIH RePORTER	VA Merit Review Grant(US Department of Veterans Affairs); National Institutes of Health/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Rheumatology Education Foundation; NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Lupus Research Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	JDM is supported by VA Merit Review Grant (1I01BX000600-01), National Institutes of Health/National Institute of Allergy and Infectious Diseases (1AI 071110), and Rheumatology Education Foundation. HCH is supported by NIH/NIAID (1RO1AI083705) and Lupus Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asselin-Paturel C, 2005, J EXP MED, V201, P1157, DOI 10.1084/jem.20041930; Bermejo DA, 2013, NAT IMMUNOL, V14, P514, DOI 10.1038/ni.2569; Bierly AL, 2008, J IMMUNOL, V181, P8485, DOI 10.4049/jimmunol.181.12.8485; Blenman KRM, 2006, LAB INVEST, V86, P1136, DOI 10.1038/labinvest.3700468; Boule MW, 2004, J EXP MED, V199, P1631, DOI 10.1084/jem.20031942; Brawand P, 2002, J IMMUNOL, V169, P6711, DOI 10.4049/jimmunol.169.12.6711; Cassese G, 2003, J IMMUNOL, V171, P1684, DOI 10.4049/jimmunol.171.4.1684; Chan YH, 2009, J IMMUNOL, V183, P7039, DOI 10.4049/jimmunol.0901543; Chappell CP, 2012, J EXP MED, V209, P1825, DOI 10.1084/jem.20120774; Cuda CM, 2012, J IMMUNOL, V188, P604, DOI 10.4049/jimmunol.1002362; Dubois B, 1998, J IMMUNOL, V161, P2223; Elkon KB, 2012, CURR OPIN RHEUMATOL, V24, P499, DOI 10.1097/BOR.0b013e3283562c3e; Esposito P, 2009, LUPUS, V18, P1329, DOI 10.1177/0961203309106183; FINCK BK, 1994, J CLIN INVEST, V94, P585, DOI 10.1172/JCI117373; Ganguly D, 2013, NAT REV IMMUNOL, V13, P566, DOI 10.1038/nri3477; Gateva V, 2009, NAT GENET, V41, P1228, DOI 10.1038/ng.468; Gerl V, 2010, ANN RHEUM DIS, V69, P1370, DOI 10.1136/ard.2009.111021; Hannum LG, 1996, J EXP MED, V184, P1269, DOI 10.1084/jem.184.4.1269; Herlands RA, 2007, EUR J IMMUNOL, V37, P3339, DOI 10.1002/eji.200737752; Hirano T, 1989, Prog Growth Factor Res, V1, P133, DOI 10.1016/0955-2235(89)90007-0; Hofmann SR, 2012, CLIN IMMUNOL, V143, P116, DOI 10.1016/j.clim.2012.02.005; Honda K, 2005, NATURE, V434, P1035, DOI 10.1038/nature03547; Hou B, 2008, IMMUNITY, V29, P272, DOI 10.1016/j.immuni.2008.05.016; Jego G, 2003, IMMUNITY, V19, P225, DOI 10.1016/S1074-7613(03)00208-5; Jego Gaetan, 2005, V8, P124; Kadowaki N, 2001, J EXP MED, V194, P863, DOI 10.1084/jem.194.6.863; Kaneko T, 2012, J IMMUNOL, V188, P5397, DOI 10.4049/jimmunol.1103210; Kiefer K, 2012, IMMUNOL CELL BIOL, V90, P498, DOI 10.1038/icb.2012.10; Kim SJ, 2011, J EXP MED, V208, P2193, DOI 10.1084/jem.20110658; Kimura A, 2010, EUR J IMMUNOL, V40, P1830, DOI 10.1002/eji.201040391; Kutzner H, 2009, AM J SURG PATHOL, V33, P1307, DOI 10.1097/PAS.0b013e3181a6ae1e; Lande R, 2010, ANN NY ACAD SCI, V1183, P89, DOI 10.1111/j.1749-6632.2009.05152.x; Lantow M, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4208; Ling GS, 2011, RHEUMATOLOGY, V50, P1773, DOI 10.1093/rheumatology/ker198; LINKERISRAELI M, 1991, J IMMUNOL, V147, P117; Liu P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069547; LOSMAN MJ, 1992, J IMMUNOL, V148, P1561; Marshak-Rothstein A, 2007, ANNU REV IMMUNOL, V25, P419, DOI 10.1146/annurev.immunol.22.012703.104514; Mauri C, 2010, NAT REV RHEUMATOL, V6, P636, DOI 10.1038/nrrheum.2010.140; Means TK, 2005, J CLIN INVEST, V115, P407, DOI 10.1172/JCI200523025; Merad M, 2013, ANNU REV IMMUNOL, V31, P563, DOI 10.1146/annurev-immunol-020711-074950; Mihara M, 1998, CLIN EXP IMMUNOL, V112, P397; Miles K, 2012, P NATL ACAD SCI USA, V109, P887, DOI 10.1073/pnas.1109173109; Mohan C, 1998, J CLIN INVEST, V101, P1362; Morel L, 2000, P NATL ACAD SCI USA, V97, P6670, DOI 10.1073/pnas.97.12.6670; Negishi H, 2005, P NATL ACAD SCI USA, V102, P15989, DOI 10.1073/pnas.0508327102; Petri M, 2008, ARTHRITIS RHEUM, V58, P2453, DOI 10.1002/art.23678; Ramanujam M, 2010, ARTHRITIS RHEUM-US, V62, P1457, DOI 10.1002/art.27368; Sakurai D, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003870; Satpathy AT, 2012, NAT IMMUNOL, V13, P1145, DOI 10.1038/ni.2467; Sriram U, 2012, J IMMUNOL, V189, P80, DOI 10.4049/jimmunol.1101686; Teichmann LL, 2013, IMMUNITY, V38, P528, DOI 10.1016/j.immuni.2012.11.017; Teichmann LL, 2010, IMMUNITY, V33, P967, DOI 10.1016/j.immuni.2010.11.025; Vremec D, 2007, BLOOD, V109, P1165, DOI 10.1182/blood-2006-05-015354; Wan SG, 2008, ARTHRITIS RHEUM, V58, P1741, DOI 10.1002/art.23515; Wan SG, 2007, J IMMUNOL, V178, P271, DOI 10.4049/jimmunol.178.1.271; Wang B, 2013, GENE, V519, P209, DOI 10.1016/j.gene.2013.01.026; Wang JH, 2011, ARTHRITIS RHEUM-US, V63, P1054, DOI 10.1002/art.30231; Wang JH, 2010, J IMMUNOL, V184, P442, DOI 10.4049/jimmunol.0900870; Xiao S, 2012, P NATL ACAD SCI USA, V109, P12105, DOI 10.1073/pnas.1120914109; Xu ZW, 2011, J IMMUNOL, V186, P4130, DOI 10.4049/jimmunol.1003512	61	24	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e102151	10.1371/journal.pone.0102151	http://dx.doi.org/10.1371/journal.pone.0102151			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093822	Green Published, Green Submitted, gold			2022-12-27	WOS:000341357200009
J	Kienapfel, K; Link, Y; van Borstel, UK				Kienapfel, Kathrin; Link, Yvonne; van Borstel, Uta Konig			Prevalence of Different Head-Neck Positions in Horses Shown at Dressage Competitions and Their Relation to Conflict Behaviour and Performance Marks	PLOS ONE			English	Article							TEMPERATURE; VARIABILITY	Much controversy exists among riders, and in particular among those practicing dressage, regarding what can be considered an "appropriate" Head-Neck-Position (HNP). The objective was to assess the prevalence of different HNPs in the field, the behavioural reactions of horses during warm-up and competition rides in relation to HNP and the relation between HNP and marks achieved in the competition. Horses (n = 171) were selected during dressage competitions according to their HNP (3 categories based on the degree of flexion), and their behaviour was recorded during 3 minutes each of riding in the warm-up area and in the competition. Scans were carried out on an additional 355 horses every 15 minutes to determine the proportion of each HNP in the warm-up area. Sixty-nine percent of the 355 horses were ridden with their nasal planes behind the vertical in the warm-up area, 19% were ridden at or behind the vertical and only 12% were ridden with their nasal plane in front of the vertical. Horses carrying their nasal plane behind the vertical exhibited significantly (P<0.0001) more conflict behaviours than horses with their nose held in front of the vertical. Horses were commonly presented with a less flexed HNP during competition compared to warm-up (P<0.05). A HNP behind the vertical was penalised with lower marks in the lower (P = 0.0434) but not in the higher (P = 0.9629) competition levels. Horses in higher classes showed more (P = 0.0015) conflict behaviour than those in lower classes. In conclusion, dressage horses are commonly ridden during warm-up for competitions with their nasal plane behind the vertical, and this posture seems to cause significantly more conflict behaviour than HNPs in front of the vertical.	[Kienapfel, Kathrin] Ruhr Univ Bochum, Dept Anim Ecol Evolut & Biodivers, Bochum, Germany; [Link, Yvonne] Univ Kiel, Inst Anim Breeding & Husb, Kiel, Germany; [van Borstel, Uta Konig] Univ Gottingen, Dept Anim Breeding & Genet, D-37073 Gottingen, Germany	Ruhr University Bochum; University of Kiel; University of Gottingen	Kienapfel, K (corresponding author), Ruhr Univ Bochum, Dept Anim Ecol Evolut & Biodivers, Univ Str 150, Bochum, Germany.	Kathrin.Kienapfel@rub.de	von Borstel, Uta U. König/H-6747-2012	Konig von Borstel, Uta/0000-0002-7313-1197	German Research Foundation; Open Access Publication Funds of the Gottingen University	German Research Foundation(German Research Foundation (DFG)); Open Access Publication Funds of the Gottingen University	The authors acknowledge support by German Research Foundation and the Open Access Publication Funds of the Gottingen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker-Birck M, 2013, J ANIM PHYSIOL AN N, V97, P322, DOI 10.1111/j.1439-0396.2012.01274.x; Caanitz H, 1996, THESIS TIERARZDICHE; Cavendish William, 1667, NEW METHOD EXTRAORDI; Doherty O, 2013, 9 INT EQ SCI C P NEW, P38; Gomez Alvarez C B, 2006, Equine Vet J Suppl, P445; Hawson LA, 2010, J VET BEHAV, V5, P170, DOI 10.1016/j.jveb.2009.12.010; HDV, 1937, HEER; Hutchings K, 2013, 9 INT EQ SCI C P NEW, P79; Kienapfel K, 2014, J ANIMAL PH IN PRESS, P10; Kienapfel K, 2011, PFERDEHEILKUNDE, V27, P372, DOI 10.21836/PEM20110402; Kienapfel K, 2010, PFERDEHEILKUNDE, V26, P178, DOI 10.21836/PEM20100210; Konig von Borstel U, 2011, P 7 INT EQ SCI C 26, P75; Lesimple C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010257; Ludewig AK, 2011, P 7 INT EQ SCI C HOO; MCDONNELL SM, 1990, APPL ANIM BEHAV SCI, V27, P1, DOI 10.1016/0168-1591(90)90002-U; McGreevy P., 2004, EQUINE BEHAV GUIDE V, DOI 10.1016/B978-0-7020-2634-8.50006-X; McGreevy P, 2012, J VET BEHAV, V7, P142, DOI 10.1016/j.jveb.2011.08.001; McGreevy PD, 2010, J VET BEHAV, V5, P180, DOI 10.1016/j.jveb.2010.03.004; McGrogan C, 2008, APPL ANIM BEHAV SCI, V113, P206, DOI 10.1016/j.applanim.2007.10.006; McLean AN, 2010, J VET BEHAV, V5, P187, DOI 10.1016/j.jveb.2010.04.002; Murray R. C., 2006, Equine and Comparative Exercise Physiology, V3, P185, DOI 10.1017/S1478061506339242; Pfeil-Rotermund S, 1994, KTBL SCHRIFT 281 ARB, P231; Plewa D., 2006, Pferdeheilkunde, V22, P700; van Dierendonck M, 2012, 8 INT EQ SCI C ED, P62; von Borstel UK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087285; von Borstel UK, 2012, APPL ANIM BEHAV SCI, V139, P251, DOI 10.1016/j.applanim.2012.04.007; von Borstel UU, 2009, APPL ANIM BEHAV SCI, V116, P228, DOI 10.1016/j.applanim.2008.10.001; Waldern NM, 2009, EQUINE VET J, V41, P268, DOI 10.2746/042516409X397389; Weishaupt M A, 2006, Equine Vet J Suppl, P387; Wijnberg ID, 2010, EQUINE VET J, V42, P261, DOI 10.1111/j.2042-3306.2010.00224.x; Zeitler-Feicht M., 2008, HDB PFERDEVERHALTEN	31	24	25	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103140	10.1371/journal.pone.0103140	http://dx.doi.org/10.1371/journal.pone.0103140			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25090242	gold, Green Published			2022-12-27	WOS:000339812700018
J	Pardo, C; Lopez, L; Pena, V; Hernandez-Kantun, J; Le Gall, L; Barbara, I; Barreiro, R				Pardo, Cristina; Lopez, Lua; Pena, Viviana; Hernandez-Kantun, Jazmin; Le Gall, Line; Barbara, Ignacio; Barreiro, Rodolfo			A Multilocus Species Delimitation Reveals a Striking Number of Species of Coralline Algae Forming Maerl in the OSPAR Maritime Area	PLOS ONE			English	Article							DNA; RHODOPHYTA; DIVERSITY; MODELS; BEDS; FLORIDEOPHYCEAE; BIODIVERSITY; GIGARTINALES; REPRODUCTION; DISCOVERY	Maerl beds are sensitive biogenic habitats built by an accumulation of loose-lying, non-geniculate coralline algae. While these habitats are considered hot-spots of marine biodiversity, the number and distribution of maerl-forming species is uncertain because homoplasy and plasticity of morphological characters are common. As a result, species discrimination based on morphological features is notoriously challenging, making these coralline algae the ideal candidates for a DNA barcoding study. Here, mitochondrial (COI-5P DNA barcode fragment) and plastidial (psbA gene) sequence data were used in a two-step approach to delimit species in 224 collections of maerl sampled from Svalbard (78 degrees 96'N) to the Canary Islands (28 degrees 64'N) that represented 10 morphospecies from four genera and two families. First, the COI-5P dataset was analyzed with two methods based on distinct criteria (ABGD and GMYC) to delineate 16 primary species hypotheses (PSHs) arranged into four major lineages. Second, chloroplast (psbA) sequence data served to consolidate these PSHs into 13 secondary species hypotheses (SSHs) that showed biologically plausible ranges. Using several lines of evidence (e.g. morphological characters, known species distributions, sequences from type and topotype material), six SSHs were assigned to available species names that included the geographically widespread Phymatolithon calcareum, Lithothamnion corallioides, and L. glaciale; possible identities of other SSHs are discussed. Concordance between SSHs and morphospecies was minimal, highlighting the convenience of DNA barcoding for an accurate identification of maerl specimens. Our survey indicated that a majority of maerl forming species have small distribution ranges and revealed a gradual replacement of species with latitude.	[Pardo, Cristina; Lopez, Lua; Pena, Viviana; Barbara, Ignacio; Barreiro, Rodolfo] Univ A Coruna, Fac Ciencias, Dept Biol Anim Biol Vegetal & Ecol, La Coruna, Spain; [Pena, Viviana] Univ Ghent, Phycol Res Grp, B-9000 Ghent, Belgium; [Pena, Viviana; Le Gall, Line] Museum Natl Hist Nat, Unite Mixte Rech 7205, Equipe Explorat Especes & Evolut, F-75231 Paris, France; [Hernandez-Kantun, Jazmin] Natl Univ Ireland, Irish Seaweed Res Grp, Galway, Ireland	Universidade da Coruna; Ghent University; Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Ollscoil na Gaillimhe-University of Galway	Barreiro, R (corresponding author), Univ A Coruna, Fac Ciencias, Dept Biol Anim Biol Vegetal & Ecol, La Coruna, Spain.	rodolfo.barreiro@udc.es	Barreiro, Rodolfo/B-1005-2008; Le Gall, Line/AAI-1603-2020; Lopez, Lua/A-9710-2016; Peña, Viviana/A-6095-2014; Le Gall, Line/E-1884-2014; Pardo, Cristina/K-2929-2013	Barreiro, Rodolfo/0000-0002-6049-5215; Le Gall, Line/0000-0001-7807-4569; Lopez, Lua/0000-0002-3619-763X; Peña, Viviana/0000-0001-7003-3850; Le Gall, Line/0000-0001-7807-4569; Barbara, Ignacio/0000-0003-1779-0224; Hernandez, Jazmin/0000-0002-2284-8059; Pardo, Cristina/0000-0002-2534-3961	Ministerio de Ciencia e Innovacion of Spain [CTM2010-18787]; Xunta de Galicia [10MMA103003PR]; European Community-Research Infrastructure Action under the FP7 "Capacities'' Specific Programme (ASSEMBLE grant) [227799]; Xunta de Galicia Axudas a etapa predoutoral do Plan [I2C-2011]; Spain's Ministerio de Educacion Programa FPU; Universidade da Coruna Contratos Predoutorais; Xunta de Galicia Axudas posdoutorais do Plan [I2C-2012]; Action Transversale du Museum National d'Histoire Naturelle; project "Taxonomie moleculaire: DNA Barcode et gestion durable des collections"; FEDER, Fondo Europeo de Desarrollo Regional	Ministerio de Ciencia e Innovacion of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Xunta de Galicia(Xunta de GaliciaEuropean Commission); European Community-Research Infrastructure Action under the FP7 "Capacities'' Specific Programme (ASSEMBLE grant); Xunta de Galicia Axudas a etapa predoutoral do Plan; Spain's Ministerio de Educacion Programa FPU; Universidade da Coruna Contratos Predoutorais; Xunta de Galicia Axudas posdoutorais do Plan(Xunta de Galicia); Action Transversale du Museum National d'Histoire Naturelle; project "Taxonomie moleculaire: DNA Barcode et gestion durable des collections"; FEDER, Fondo Europeo de Desarrollo Regional(European Commission)	This work was funded by Ministerio de Ciencia e Innovacion of Spain (grant CTM2010-18787, partially co-founded by FEDER, Fondo Europeo de Desarrollo Regional), and Xunta de Galicia (grant 10MMA103003PR). Samples from French Brittany were collected with the support of a European Community-Research Infrastructure Action under the FP7 "Capacities'' Specific Programme (ASSEMBLE grant agreement no. 227799). Several authors were supported by fellowships: CP (Xunta de Galicia Axudas a etapa predoutoral do Plan I2C-2011, and Spain's Ministerio de Educacion Programa FPU-2010), LL (Universidade da Coruna Contratos Predoutorais-2012), and VP (Xunta de Galicia Axudas posdoutorais do Plan I2C-2012). VP acknowledges support for examining type material (Action Transversale du Museum National d'Histoire Naturelle, project "Taxonomie moleculaire: DNA Barcode et gestion durable des collections"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADEY W H, 1973, British Phycological Journal, V8, P343; Adey WH, 2005, J PHYCOL, V41, P1010, DOI 10.1111/j.1529-8817.2005.00123.x; ADEY WH, 1970, BOT MAR, V13, P100, DOI 10.1515/botm.1970.13.2.100; ADEY WH, 1971, SARSIA, P41; AFONSO-CARRILLO J, 1982, Collectanea Botanica (Barcelona), V13, P703; Barbera C, 2003, AQUAT CONSERV, V13, pS65, DOI 10.1002/aqc.569; Bartsch I, 2012, SEAWEED BIOL, P383, DOI DOI 10.1007/978-3-642-28451-9_18; Bittner L, 2011, MOL PHYLOGENET EVOL, V61, P697, DOI 10.1016/j.ympev.2011.07.019; Bittner L, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-47; CABIOCH J, 1969, CAH BIOL MAR, V10, P139; Cabioch J, 1974, B SOC PHYCOL FRANCE, V19, P74; Carro B, 2014, PHYTOTAXA IN PRESS; CHAMBERLAIN YM, 1991, BRIT PHYCOL J, V26, P219, DOI 10.1080/00071619100650201; Clarkston BE, 2010, BOTANY, V88, P119, DOI 10.1139/B09-101; Crouan P, 1867, FLORULE FINISTERE; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; DeSalle R, 2006, CONSERV BIOL, V20, P1545, DOI 10.1111/j.1523-1739.2006.00543.x; Dupuis JR, 2012, MOL ECOL, V21, P4422, DOI 10.1111/j.1365-294X.2012.05642.x; Foslie M, 1895, NORWEGIAN FORMS LITH, P29; Foslie M, 1929, CONTRIBUTIONS MONOGR; Foslie M, 1900, KONGELIGE NORSKE VID, P1; Foslie M, 1906, KGL NORSKE VIDENSKAB, V1906, P37; Foslie M, 1905, KGL NORSKE VIDENSKAB, V1905, P25; Foslie M, 1899, IR NAT, V8, P175; Fujisawa T, 2013, SYST BIOL, V62, P707, DOI 10.1093/sysbio/syt033; Gaston KJ, 1996, TRENDS ECOL EVOL, V11, P197, DOI 10.1016/0169-5347(96)10027-6; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guiry MD, 1978, CONSENSUS BIBLIO IRI; Gunnarsson K, 1977, HAFRANNSOKNIR, V10, P1; Hall-Spencer JM, 2000, ICES J MAR SCI, V57, P1407, DOI 10.1006/jmsc.2000.0918; Hall-Spencer JM, 2010, OSPAR COMMISSION BIO, P1; Hamilton CA, 2014, MOL PHYLOGENET EVOL, V71, P79, DOI 10.1016/j.ympev.2013.11.007; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, P313, DOI 10.1098/rspb.2002.2218; Hind KR, 2013, MOL PHYLOGENET EVOL, V67, P529, DOI 10.1016/j.ympev.2013.02.022; Hind KR, 2013, J PHYCOL, V49, P103, DOI 10.1111/jpy.12019; Hughey JR, 2001, J PHYCOL, V37, P1091, DOI 10.1046/j.1529-8817.2001.01048.x; Irvine LM, 1994, SEAWEEDS BRIT ISL 2B, V1; Kaleb S, 2012, BOT MAR, V55, P377, DOI 10.1515/bot-2012-0141; Kjellman FR, 1883, NORRA ISHAFVETS ALGF, P1; Kucera H, 2012, J PHYCOL, V48, P869, DOI 10.1111/j.1529-8817.2012.01193.x; Le Gall L, 2010, CRYPTOGAMIE ALGOL, V31, P403; Le Gall L, 2010, J PHYCOL, V46, P374, DOI 10.1111/j.1529-8817.2010.00807.x; Lemoine MP, 1910, ANN I OCEANOGR I, VI, P27; Lemoine MP, 1913, NOUV ARCHS MUS NAT 5, V5, P121; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Mamoozadeh NR, 2012, BOT MAR, V55, P317, DOI 10.1515/bot-2012-0147; Mendoza ML, 1998, CAN J BOT, V76, P1433, DOI 10.1139/b98-116; Milstein D, 2012, PHYCOLOGIA, V51, P247, DOI 10.2216/11-40.1; Monaghan MT, 2009, SYST BIOL, V58, P298, DOI 10.1093/sysbio/syp027; Pachauri R.K, 2007, CONTRIBUTION WORKING, P104, DOI DOI 10.1017/CBO9780511546013; Payo DA, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2660; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Pena V, 2014, MAR BIODIVERS, V44, P533, DOI 10.1007/s12526-014-0214-7; Pena V., 2004, ANALES BIOL, V26, P21; Pena V, 2014, CRYPTOGAMIE ALGOL, V35, P15, DOI 10.7872/crya.v35.iss1.2014.15; Pena V, 2011, J PHYCOL, V47, P911, DOI 10.1111/j.1529-8817.2011.01015.x; Pena V, 2009, CAH BIOL MAR, V50, P353; Pena V, 2008, BOT MAR, V51, P493, DOI 10.1515/BOT.2008.057; Perestenko LP, 1994, KRASNYE VODOROSLI DA; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Puillandre N, 2012, MOL ECOL, V21, P2671, DOI 10.1111/j.1365-294X.2012.05559.x; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Robba L, 2006, AM J BOT, V93, P1101, DOI 10.3732/ajb.93.8.1101; Rosas-Alquicira EF, 2009, CAH BIOL MAR, V50, P143; Rosenvinge MLK, 1894, ANN SCI NAT, V19, P53; Rueness J, 2010, CRYPTOGAMIE ALGOL, V31, P377; Saunders GW, 2008, BOTANY, V86, P773, DOI 10.1139/B08-001; Saunders Gary W, 2012, Methods Mol Biol, V858, P207, DOI 10.1007/978-1-61779-591-6_10; Saunders GW, 2010, BOTANY, V88, P639, DOI 10.1139/B10-038; Saunders GW, 2005, PHILOS T R SOC B, V360, P1879, DOI 10.1098/rstb.2005.1719; Sauriau P-G, 2012, ANN SOC SCI NAT CHAR, V10, P281; Sherwood AR, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-258; STENECK RS, 1986, ANNU REV ECOL SYST, V17, P273, DOI 10.1146/annurev.es.17.110186.001421; Stromfelt HFG, 1886, ALGVEGETATIONEN VID; SUNESON SVANTE, 1958, BOT NOTISER, V111, P195; Teichert S, 2012, PHYCOLOGIA, V51, P371, DOI 10.2216/11-76.1; Unger F., 1858, DENKSCHRIFTEN KAI MN, V14, P13; Walker RH, 2009, J PHYCOL, V45, P287, DOI 10.1111/j.1529-8817.2008.00637.x; Wheeler Q. D., 2008, NEW TAXONOMY; Wiemers M, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-8; Wilson S, 2004, BIOL CONSERV, V120, P279, DOI 10.1016/j.biocon.2004.03.001; WOELKERLING WJ, 1986, BRIT PHYCOL J, V21, P55, DOI 10.1080/00071618600650071; WOELKERLING WJ, 1985, BRIT PHYCOL J, V20, P123, DOI 10.1080/00071618500650151; Woelkerling WJ, 1998, NONGENICULATE CORALL; Yoon HS, 2002, P NATL ACAD SCI USA, V99, P11724, DOI 10.1073/pnas.172234799; Zhakova LV, 1985, NOVIT SYST PLANT NON, V22, P46	86	72	72	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2014	9	8							e104073	10.1371/journal.pone.0104073	http://dx.doi.org/10.1371/journal.pone.0104073			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WB	25111057	Green Published, gold, Green Submitted			2022-12-27	WOS:000341105100028
J	Xu, Y; Hu, CY; Dai, Y; Liang, J				Xu, Yun; Hu, Changyu; Dai, Yang; Liang, Jie			On Simplified Global Nonlinear Function for Fitness Landscape: A Case Study of Inverse Protein Folding	PLOS ONE			English	Article							COMPUTATIONAL DESIGN; ENERGY FUNCTIONS; SCORING FUNCTION; SECONDARY STRUCTURES; SEQUENCE DESIGN; POTENTIALS; RECOGNITION; SPECIFICITY; SELECTION; MODELS	The construction of fitness landscape has broad implication in understanding molecular evolution, cellular epigenetic state, and protein structures. We studied the problem of constructing fitness landscape of inverse protein folding or protein design, with the aim to generate amino acid sequences that would fold into an a priori determined structural fold which would enable engineering novel or enhanced biochemistry. For this task, an effective fitness function should allow identification of correct sequences that would fold into the desired structure. In this study, we showed that nonlinear fitness function for protein design can be constructed using a rectangular kernel with a basis set of proteins and decoys chosen a priori. The full landscape for a large number of protein folds can be captured using only 480 native proteins and 3,200 non-protein decoys via a finite Newton method. A blind test of a simplified version of fitness function for sequence design was carried out to discriminate simultaneously 428 native sequences not homologous to any training proteins from 11 million challenging protein-like decoys. This simplified function correctly classified 408 native sequences (20 misclassifications, 95% correct rate), which outperforms several other statistical linear scoring function and optimized linear function. Our results further suggested that for the task of global sequence design of 428 selected proteins, the search space of protein shape and sequence can be effectively parametrized with just about 3,680 carefully chosen basis set of proteins and decoys, and we showed in addition that the overall landscape is not overly sensitive to the specific choice of this set. Our results can be generalized to construct other types of fitness landscape.	[Xu, Yun; Hu, Changyu; Dai, Yang; Liang, Jie] Univ Illinois, Dept Bioengn, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Liang, J (corresponding author), Univ Illinois, Dept Bioengn, Chicago, IL 60607 USA.	jliang@uic.edu			NSF [DBI 1062328, DMS-0800257]; NIH [GM079804, GM086145]; Chicago Biomedical Consortium; Searle Funds at the Chicago Community Trust; UIC Research Open Access Article Publishing (ROAAP) Fund; Div Of Biological Infrastructure [1062328] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM086145, R01GM079804] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chicago Biomedical Consortium; Searle Funds at the Chicago Community Trust; UIC Research Open Access Article Publishing (ROAAP) Fund; Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NSF grants DBI 1062328 and DMS-0800257, and NIH grants GM079804 and GM086145. This work was also funded by the Chicago Biomedical Consortium with support from the Searle Funds at the Chicago Community Trust and the UIC Research Open Access Article Publishing (ROAAP) Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson E., 1999, LAPACK USERS GUIDE; [Anonymous], 2001, P 2001 SIAM INT C DA, DOI DOI 10.1137/1.9781611972719.13; Bastolla U, 2001, PROTEINS, V44, P79, DOI 10.1002/prot.1075; Bastolla U, 2000, P NATL ACAD SCI USA, V97, P3977, DOI 10.1073/pnas.97.8.3977; Bolon DN, 2001, P NATL ACAD SCI USA, V98, P14274, DOI 10.1073/pnas.251555398; Burges CJC, 1998, DATA MIN KNOWL DISC, V2, P121, DOI 10.1023/A:1009715923555; Dahiyat BI, 1997, SCIENCE, V278, P82, DOI 10.1126/science.278.5335.82; DESMET J, 1992, NATURE, V356, P539, DOI 10.1038/356539a0; Deutsch JM, 1996, PHYS REV LETT, V76, P323, DOI 10.1103/PhysRevLett.76.323; DREXLER KE, 1981, P NATL ACAD SCI USA, V78, P5275, DOI 10.1073/pnas.78.9.5275; Edelsbrunner H., 1993, P 9 ANN S COMP GEOM, P218; Edelsbrunner H., 1987, ALGORITHMS COMBINATO; Fung G, 2003, NEUROCOMPUTING, V55, P39, DOI 10.1016/S0925-2312(03)00379-5; Hill RB, 2000, ACCOUNTS CHEM RES, V33, P745, DOI 10.1021/ar970004h; HOLM L, 1992, PROTEIN SCI, V1, P1691, DOI 10.1002/pro.5560011217; Hu C, 2003, DESIGN OPTIMAL NONLI; Hu CY, 2004, BIOINFORMATICS, V20, P3080, DOI 10.1093/bioinformatics/bth369; Huang SY, 2008, PROTEINS, V72, P557, DOI 10.1002/prot.21949; Huang SY, 2006, J COMPUT CHEM, V27, P1866, DOI 10.1002/jcc.20504; Huang SY, 2010, PHYS CHEM CHEM PHYS, V12, P12899, DOI 10.1039/c0cp00151a; Jacak R, 2012, PROTEINS, V80, P825, DOI 10.1002/prot.23241; Jiang L, 2008, SCIENCE, V319, P1387, DOI 10.1126/science.1152692; Joachimiak LA, 2006, J MOL BIOL, V361, P195, DOI 10.1016/j.jmb.2006.05.022; Kleinberg JM, 1999, J COMPUT BIOL, V6, P387, DOI 10.1089/106652799318346; Lazar GA, 2006, P NATL ACAD SCI USA, V103, P4005, DOI 10.1073/pnas.0508123103; Li H, 1996, SCIENCE, V273, P666, DOI 10.1126/science.273.5275.666; Li X, 2003, PROTEINS, V53, P792, DOI 10.1002/prot.10442; Li ZX, 2013, ANNU REV BIOPHYS, V42, P315, DOI 10.1146/annurev-biophys-083012-130315; Liang J, 1998, PROTEINS STRUCTURE F; Liang SD, 2004, PROTEINS, V54, P271, DOI 10.1002/prot.10560; Lu H, 2001, PROTEINS, V44, P223, DOI 10.1002/prot.1087; MAIOROV VN, 1992, J MOL BIOL, V227, P876, DOI 10.1016/0022-2836(92)90228-C; Majek P, 2009, PROTEINS, V76, P822, DOI 10.1002/prot.22388; Mangasarian O.L., 1969, NONLINEAR PROGRAMMIN; Mintseris J, 2003, PROTEINS, V53, P629, DOI 10.1002/prot.10432; Miyazawa S, 1996, J MOL BIOL, V256, P623, DOI 10.1006/jmbi.1996.0114; MIYAZAWA S, 1985, MACROMOLECULES, V18, P534, DOI 10.1021/ma00145a039; Pokala N, 2005, J MOL BIOL, V347, P203, DOI 10.1016/j.jmb.2004.12.019; Ravikant DVS, 2010, PROTEINS, V78, P400, DOI 10.1002/prot.22550; Rost B, 1999, PROTEIN ENG, V12, P85, DOI 10.1093/protein/12.2.85; Rothlisberger D, 2008, NATURE, V453, P190, DOI 10.1038/nature06879; SHAKHNOVICH EI, 1993, P NATL ACAD SCI USA, V90, P7195, DOI 10.1073/pnas.90.15.7195; Shifman JM, 2006, P NATL ACAD SCI USA, V103, P13968, DOI 10.1073/pnas.0606433103; Siegel JB, 2010, SCIENCE, V329, P309, DOI 10.1126/science.1190239; TANAKA S, 1976, MACROMOLECULES, V9, P945, DOI 10.1021/ma60054a013; Tobi D, 2000, PROTEINS, V40, P71, DOI 10.1002/(SICI)1097-0134(20000701)40:1<71::AID-PROT90>3.0.CO;2-3; Vapnik V., 1999, NATURE STAT LEARNING; Vapnik V.N., 1974, THEORY PATTERN RECOG; Vendruscolo M, 1998, J CHEM PHYS, V109, P11101, DOI 10.1063/1.477748; Vendruscolo M, 2000, PROTEINS, V38, P134, DOI 10.1002/(SICI)1097-0134(20000201)38:2<134::AID-PROT3>3.0.CO;2-A; Wagner M, 2004, MATH PROGRAMMING, V101; Wang GL, 2003, BIOINFORMATICS, V19, P1589, DOI 10.1093/bioinformatics/btg224; Wright S, 1999, NUMERICAL OPTIMIZATI, V35, P7; Yang YD, 2008, PROTEINS, V72, P793, DOI 10.1002/prot.21968; Yang YD, 2008, PROTEIN SCI, V17, P1212, DOI 10.1110/ps.033480.107; YUE K, 1992, P NATL ACAD SCI USA, V89, P4163, DOI 10.1073/pnas.89.9.4163	58	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2014	9	8							e104403	10.1371/journal.pone.0104403	http://dx.doi.org/10.1371/journal.pone.0104403			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WB	25110986	gold, Green Published, Green Submitted			2022-12-27	WOS:000341105100053
J	Lee, H; Yun, S; Kim, IS; Lee, IS; Shin, JE; Park, SC; Kim, WJ; Park, KI				Lee, Haejin; Yun, Seokhwan; Kim, Il-Sun; Lee, Il-Shin; Shin, Jeong Eun; Park, Soo Chul; Kim, Won-Joo; Park, Kook In			Human Fetal Brain-Derived Neural Stem/Progenitor Cells Grafted into the Adult Epileptic Brain Restrain Seizures in Rat Models of Temporal Lobe Epilepsy	PLOS ONE			English	Article							MEDIAL GANGLIONIC EMINENCE; EMBRYONIC STEM-CELLS; CORTICAL INTERNEURONS; FUNCTIONAL MATURATION; BEHAVIORAL SEIZURES; PILOCARPINE MODEL; MUTANT MICE; WATER MAZE; HIPPOCAMPUS; TRANSPLANTATION	Cell transplantation has been suggested as an alternative therapy for temporal lobe epilepsy (TLE) because this can suppress spontaneous recurrent seizures in animal models. To evaluate the therapeutic potential of human neural stem/progenitor cells (huNSPCs) for treating TLE, we transplanted huNSPCs, derived from an aborted fetal telencephalon at 13 weeks of gestation and expanded in culture as neurospheres over a long time period, into the epileptic hippocampus of fully kindled and pilocarpine-treated adult rats exhibiting TLE. In vitro, huNSPCs not only produced all three central nervous system neural cell types, but also differentiated into ganglionic eminences-derived gamma-aminobutyric acid (GABA)-ergic interneurons and released GABA in response to the depolarization induced by a high K+ medium. NSPC grafting reduced behavioral seizure duration, afterdischarge duration on electroencephalograms, and seizure stage in the kindling model, as well as the frequency and the duration of spontaneous recurrent motor seizures in pilocarpine-induced animals. However, NSPC grafting neither improved spatial learning or memory function in pilocarpine-treated animals. Following transplantation, grafted cells showed extensive migration around the injection site, robust engraftment, and long-term survival, along with differentiation into beta-tubulin III+ neurons (similar to 34%), APC-CC1(+) oligodendrocytes (similar to 28%), and GFAP(+) astrocytes (similar to 8%). Furthermore, among donor-derived cells, similar to 24% produced GABA. Additionally, to explain the effect of seizure suppression after NSPC grafting, we examined the anticonvulsant glial cell-derived neurotrophic factor (GDNF) levels in host hippocampal astrocytes and mossy fiber sprouting into the supragranular layer of the dentate gyrus in the epileptic brain. Grafted cells restored the expression of GDNF in host astrocytes but did not reverse the mossy fiber sprouting, eliminating the latter as potential mechanism. These results suggest that human fetal brain-derived NSPCs possess some therapeutic effect for TLE treatments although further studies to both increase the yield of NSPC grafts-derived functionally integrated GABAergic neurons and improve cognitive deficits are still needed.	[Lee, Haejin; Yun, Seokhwan; Park, Kook In] Yonsei Univ, Coll Med, Brain Korea Plus Project Med Sci 21, Seoul, South Korea; [Kim, Il-Sun; Lee, Il-Shin; Shin, Jeong Eun; Park, Kook In] Yonsei Univ, Coll Med, Dept Pediat, Severance Childrens Hosp, Seoul, South Korea; [Park, Soo Chul; Kim, Won-Joo] Yonsei Univ, Coll Med, Dept Neurol, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Park, KI (corresponding author), Yonsei Univ, Coll Med, Brain Korea Plus Project Med Sci 21, Seoul, South Korea.	kipark@yuhs.ac		Yun, Seokhwan/0000-0002-9504-5230; Kim, Won-Joo/0000-0002-5850-010X; Kim, Il-Sun/0000-0003-4033-4323	Korea Healthcare Technology R&D Project, Ministry for Health and Welfare [A121943]; National Research Foundation [2013M3A9B4076545]; Yonsei University College of Medicine [6-2006-0017]	Korea Healthcare Technology R&D Project, Ministry for Health and Welfare; National Research Foundation; Yonsei University College of Medicine(General Electric)	This work was supported by grants from Korea Healthcare Technology R&D Project (A121943), Ministry for Health and Welfare, National Research Foundation (2013M3A9B4076545), and Faculty Grant of Yonsei University College of Medicine (6-2006-0017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERCROMBIE M, 1946, ANAT REC, V94, P239, DOI 10.1002/ar.1090940210; Alvarez-Dolado M, 2006, J NEUROSCI, V26, P7380, DOI 10.1523/JNEUROSCI.1540-06.2006; Banerjee PN, 2009, EPILEPSY RES, V85, P31, DOI 10.1016/j.eplepsyres.2009.03.003; Baraban SC, 2009, P NATL ACAD SCI USA, V106, P15472, DOI 10.1073/pnas.0900141106; Bosch M, 2004, EXP NEUROL, V190, P42, DOI 10.1016/j.expneurol.2004.06.027; Carpentino JE, 2008, J NEUROSCI RES, V86, P512, DOI 10.1002/jnr.21514; Chu K, 2004, BRAIN RES, V1023, P213, DOI 10.1016/j.brainres.2004.07.045; Cossart R, 2001, NAT NEUROSCI, V4, P52, DOI 10.1038/82900; Curia G, 2008, J NEUROSCI METH, V172, P143, DOI 10.1016/j.jneumeth.2008.04.019; D'Hooge R, 2001, BRAIN RES REV, V36, P60, DOI 10.1016/S0165-0173(01)00067-4; de Lanerolle NC, 2010, NEUROTHERAPEUTICS, V7, P424, DOI 10.1016/j.nurt.2010.08.002; Fisher PD, 1998, BRAIN DEV-JPN, V20, P563, DOI 10.1016/S0387-7604(98)00069-2; Gernert M, 2002, EXP NEUROL, V176, P183, DOI 10.1006/exnr.2002.7914; GILBERT ME, 1994, EPILEPSY RES, V17, P145, DOI 10.1016/0920-1211(94)90014-0; Groticke I, 2007, EXP NEUROL, V207, P329, DOI 10.1016/j.expneurol.2007.06.021; Hansen DV, 2013, NAT NEUROSCI, V16, P1576, DOI 10.1038/nn.3541; Hattiangady B, 2008, EXP NEUROL, V212, P468, DOI 10.1016/j.expneurol.2008.04.040; Heller AC, 2009, SURG NEUROL, V71, P631, DOI 10.1016/j.surneu.2008.03.023; Hermann B, 2008, LANCET NEUROL, V7, P151, DOI 10.1016/S1474-4422(08)70018-8; Hunt RF, 2013, NAT NEUROSCI, V16, P692, DOI 10.1038/nn.3392; Kanatani S, 2008, J NEUROSCI, V28, P13582, DOI 10.1523/JNEUROSCI.2132-08.2008; Kanter-Schlifke I, 2007, MOL THER, V15, P1106, DOI 10.1038/sj.mt.6300148; Kanter-Schlifle I, 2009, EXP NEUROL, V216, P413, DOI 10.1016/j.expneurol.2008.12.021; Kim TG, 2014, STEM CELLS, V32, P1789, DOI 10.1002/stem.1704; Kim YT, 2006, EXP NEUROL, V199, P222, DOI 10.1016/j.expneurol.2006.03.015; Kitano Y, 2005, EPILEPSIA, V46, P1561, DOI 10.1111/j.1528-1167.2005.00261.x; Kobayashi M, 2003, J NEUROSCI, V23, P2440; Lee CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038789; Loscher W, 2008, TRENDS NEUROSCI, V31, P62, DOI 10.1016/j.tins.2007.11.012; LOSCHER W, 1989, EUR J PHARMACOL, V163, P1, DOI 10.1016/0014-2999(89)90389-0; Loscher W., 2012, JASPERS BASIC MECH E, Vfourth; Magloczky Z, 2005, TRENDS NEUROSCI, V28, P334, DOI 10.1016/j.tins.2005.04.002; Magloczky Z, 2010, EPILEPSY RES, V89, P52, DOI 10.1016/j.eplepsyres.2010.01.002; Maisano X, 2012, J NEUROSCI, V32, P46, DOI 10.1523/JNEUROSCI.2683-11.2012; Marin O, 2013, CELL STEM CELL, V12, P497, DOI 10.1016/j.stem.2013.04.017; Maroof AM, 2013, CELL STEM CELL, V12, P559, DOI 10.1016/j.stem.2013.04.008; McIntyre DC, 2002, EPILEPSY RES, V50, P79, DOI 10.1016/S0920-1211(02)00071-2; Miyoshi G, 2010, J NEUROSCI, V30, P1582, DOI 10.1523/JNEUROSCI.4515-09.2010; Morimoto K, 2004, PROG NEUROBIOL, V73, P1, DOI 10.1016/j.pneurobio.2004.03.009; Nicholas CR, 2013, CELL STEM CELL, V12, P573, DOI 10.1016/j.stem.2013.04.005; Nolen R Scott, 2011, J Am Vet Med Assoc, V239, P1269; Park S, 2009, EXP MOL MED, V41, P487, DOI 10.3858/emm.2009.41.7.054; PINEL JPJ, 1978, EXP NEUROL, V58, P190, DOI 10.1016/0014-4886(78)90133-4; Raedt R, 2007, SEIZURE-EUR J EPILEP, V16, P565, DOI 10.1016/j.seizure.2007.05.003; Rao MS, 2007, NEUROBIOL DIS, V27, P117, DOI 10.1016/j.nbd.2007.03.016; Roper SN, 2013, EXP NEUROL, V244, P59, DOI 10.1016/j.expneurol.2012.01.004; Ruschenschmidt T, 2005, EPILEPSIA, V46, P174, DOI 10.1111/j.1528-1167.2005.01028.x; Sharma AK, 2007, TOXICOL PATHOL, V35, P984, DOI 10.1080/01926230701748305; Shetty AK, 2001, EXP NEUROL, V169, P276, DOI 10.1006/exnr.2001.7668; Shetty AK, 2000, J NEUROSCI, V20, P8788; Shetty AK, 2011, NEUROTHERAPEUTICS, V8, P721, DOI 10.1007/s13311-011-0064-y; Shin SY, 2009, J BIOL CHEM, V284, P30583, DOI 10.1074/jbc.M109.010678; Shindo A, 2010, NEUROL MED-CHIR, V50, P98, DOI 10.2176/nmc.50.98; Sorensen AT, 2013, EPILEPSIA, V54, P1, DOI 10.1111/epi.12000; Spandidos A, 2010, NUCLEIC ACIDS RES, V38, pD792, DOI 10.1093/nar/gkp1005; Stoltenberg M, 2004, J MOL HISTOL, V35, P141; Sundstrom LE, 2001, BRAIN, V124, P688, DOI 10.1093/brain/124.4.688; Sunnen CN, 2011, EPILEPSIA, V52, P2065, DOI 10.1111/j.1528-1167.2011.03280.x; Sussel L, 1999, DEVELOPMENT, V126, P3359; Tanabe K, 2012, BRAIN RES, V1463, P21, DOI 10.1016/j.brainres.2012.04.057; TAO W, 1992, NEURON, V8, P957, DOI 10.1016/0896-6273(92)90210-5; Thompson K, 2000, EXP NEUROL, V161, P481, DOI 10.1006/exnr.1999.7305; Waldau B, 2010, STEM CELLS, V28, P1153, DOI 10.1002/stem.446; Wichterle H, 1999, NAT NEUROSCI, V2, P461, DOI 10.1038/8131; Wonders CP, 2008, DEV BIOL, V314, P127, DOI 10.1016/j.ydbio.2007.11.018; Xie CC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024966; Xu Q, 2004, J NEUROSCI, V24, P2612, DOI 10.1523/JNEUROSCI.5667-03.2004; Zhang TY, 2007, PSYCHOPHARMACOLOGY, V191, P171, DOI 10.1007/s00213-006-0548-3	68	14	17	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2014	9	8							e104092	10.1371/journal.pone.0104092	http://dx.doi.org/10.1371/journal.pone.0104092			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR0CG	25105891	Green Submitted, Green Published, gold			2022-12-27	WOS:000343231900038
J	Park, ES; Lee, JH; Hong, JH; Park, YK; Lee, JW; Lee, WJ; Lee, JW; Kim, KP; Kim, KH				Park, Eun-Sook; Lee, Jeong Hwa; Hong, Ji Hye; Park, Yong Kwang; Lee, Joon Won; Lee, Won-Jae; Lee, Jae Won; Kim, Kwang Pyo; Kim, Kyun-Hwan			Phosphatidylcholine Alteration Identified Using MALDI Imaging MS in HBV-Infected Mouse Livers and Virus-Mediated Regeneration Defects	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; PARTIAL-HEPATECTOMY; PLASMA-MEMBRANE; RAT-LIVER; CELL-CYCLE; VIRAL-DNA; PROTEIN; METABOLISM; PROLIFERATION; REQUIREMENT	In this study, we investigated whether hepatitis B virus (HBV) causes the alteration of lipid metabolism and composition during acute infection and liver regeneration in a mouse model. The liver controls lipid biogenesis and bile acid homeostasis. Infection of HBV causes various liver diseases and impairs liver regeneration. As there are very few reports available in the literature on lipid alterations by HBV infection or HBV-mediated liver injury, we have analyzed phospholipids that have important roles in liver regeneration by using matrix-assisted laser desorption/ionization (MALDI)-imaging mass spectrometry (IMS) in the livers of HBV model mice. As a result, we identified different phosphatidylcholines (PCs) showing significant changes in their composition as well as cationized ion adduct formation in HBV-infected mouse livers which are associated with virus-mediated regeneration defects. To find the factor of altered PCs, the expression kinetics of enzymes was also examined that regulate PC biosynthesis during liver regeneration. It is noteworthy that the expression of choline-phosphate cytidylyltransferase A (PCYT1A) was significantly delayed in wild type HBV-expressing livers. Moreover, the amount of hepatic total PC was also significantly decreased in wt HBV-expressing mice. These results suggest that infection of HBV alters the composition of PCs which may involve in HBV-mediated regeneration defects and liver disease.	[Park, Eun-Sook; Park, Yong Kwang; Lee, Won-Jae; Kim, Kyun-Hwan] Konkuk Univ, Dept Pharmacol, Seoul, South Korea; [Park, Eun-Sook; Park, Yong Kwang; Lee, Won-Jae; Kim, Kyun-Hwan] Konkuk Univ, Ctr Canc Res & Diagnost Med, IBST, Sch Med, Seoul, South Korea; [Park, Eun-Sook; Kim, Kyun-Hwan] Konkuk Univ, KU Open Innovat Ctr, Seoul, South Korea; [Kim, Kyun-Hwan] Konkuk Univ, Res Inst Med Sci, Seoul, South Korea; [Lee, Jeong Hwa; Hong, Ji Hye; Lee, Joon Won; Lee, Jae Won; Kim, Kwang Pyo] Kyung Hee Univ, Dept Appl Chem, Yongin, Gyeonggi, South Korea	Konkuk University; Konkuk University; Konkuk University Medical Center; Konkuk University; Konkuk University; Kyung Hee University	Kim, KP (corresponding author), Kyung Hee Univ, Dept Appl Chem, Yongin, Gyeonggi, South Korea.	kimkp@khu.ac.kr; khkim10@kku.ac.kr	Kim, Kwang Pyo/AAG-1815-2020	Park, Eun-Sook/0000-0002-6652-9404; Kim, Kyun-Hwan/0000-0001-5266-072X; Kim, Kwang Pyo/0000-0003-0095-3787	Proteogenomic Research Program; Bio- and Medical Technology Development Program [2012M3A9B6055305]; Basic Science Research Program through the National Research Foundation of the Ministry of Science, ICT & Future Planning [NRF-2013R1A1A3008681]	Proteogenomic Research Program; Bio- and Medical Technology Development Program; Basic Science Research Program through the National Research Foundation of the Ministry of Science, ICT & Future Planning	This work was supported by Proteogenomic Research Program, the Bio- and Medical Technology Development Program (Project No. 2012M3A9B6055305), and Basic Science Research Program (NRF-2013R1A1A3008681) through the National Research Foundation of the Ministry of Science, ICT & Future Planning. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brechot C, 2000, SEMIN CANCER BIOL, V10, P211, DOI 10.1006/scbi.2000.0321; BRUSCALUPI G, 1980, BIOCHIM BIOPHYS ACTA, V597, P263, DOI 10.1016/0005-2736(80)90104-2; CORNELL R, 1977, EXP CELL RES, V109, P299, DOI 10.1016/0014-4827(77)90009-X; Cui Z, 1996, J BIOL CHEM, V271, P14668, DOI 10.1074/jbc.271.25.14668; DELAHUNTY TJ, 1970, J LIPID RES, V11, P536; DELICONSTANTINOS G, 1983, BIOCHEM J, V212, P445, DOI 10.1042/bj2120445; Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969; Fausto N, 2012, J HEPATOL, V57, P692, DOI 10.1016/j.jhep.2012.04.016; Feitelson MA, 1999, J CELL PHYSIOL, V181, P188; FEX G, 1970, BIOCHEM J, V119, P743, DOI 10.1042/bj1190743; GLENDE EA, 1968, EXP MOL PATHOL, V8, P190, DOI 10.1016/0014-4800(68)90015-4; Hodgson AJ, 2008, CANCER RES, V68, P10341, DOI 10.1158/0008-5472.CAN-08-2695; HOUWELING M, 1991, BIOCHEM J, V278, P347, DOI 10.1042/bj2780347; Kang HS, 2011, BMC CANCER, V11, P747; Kang S, 2011, INT J GYNECOL CANCER, V21, P1566, DOI 10.1097/IGC.0b013e318226c5f5; Lee GK, 2012, LUNG CANCER, V76, P197, DOI 10.1016/j.lungcan.2011.10.016; Michalopoulos GK, 2007, J CELL PHYSIOL, V213, P286, DOI 10.1002/jcp.21172; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; MICHALOPOULOS GK, 1990, FASEB J, V4, P176, DOI 10.1096/fasebj.4.2.2404819; Mitchell C, 2008, NAT PROTOC, V3, P1167, DOI 10.1038/nprot.2008.80; Miyamura N, 2011, BIOCHEM BIOPH RES CO, V408, P120, DOI 10.1016/j.bbrc.2011.03.133; Moustafa T, 2012, GASTROENTEROLOGY, V142, P140, DOI 10.1053/j.gastro.2011.09.051; MURRAY AB, 1981, J CELL SCI, V50, P433; Park ES, 2013, HEPATOLOGY, V58, P762, DOI 10.1002/hep.26379; Park YS, 2011, CLIN CHIM ACTA, V412, P1978, DOI 10.1016/j.cca.2011.07.008; Quetier I, 2013, J HEPATOL, V59, P285, DOI 10.1016/j.jhep.2013.03.021; Seeger C, 2000, MICROBIOL MOL BIOL R, V64, P51, DOI 10.1128/MMBR.64.1.51-68.2000; Shanta SR, 2012, J LIPID RES, V53, P1823, DOI 10.1194/jlr.M022558; Shanta SR, 2011, ANAL CHEM, V83, P1252, DOI 10.1021/ac1029659; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Sir D, 2010, P NATL ACAD SCI USA, V107, P4383, DOI 10.1073/pnas.0911373107; SUMMERS RM, 1991, INVEST RADIOL, V26, P233, DOI 10.1097/00004424-199103000-00007; Tang H, 2009, HEPATOLOGY, V49, P60, DOI 10.1002/hep.22581; Taub R, 2004, NAT REV MOL CELL BIO, V5, P836, DOI 10.1038/nrm1489; TERCE F, 1994, J LIPID RES, V35, P2130; Tralhao JG, 2002, P NATL ACAD SCI USA, V99, P6991, DOI 10.1073/pnas.092657699; Vance DE, 2008, N COMP BIOC, P213, DOI 10.1016/B978-044453219-0.50010-6; VANHOEVEN RP, 1979, BIOCHIM BIOPHYS ACTA, V551, P44, DOI 10.1016/0005-2736(79)90351-1; WRIGHT GH, 1977, BIOCHIM BIOPHYS ACTA, V470, P368, DOI 10.1016/0005-2736(77)90128-6; Wu BK, 2006, BIOCHEM BIOPH RES CO, V340, P916, DOI 10.1016/j.bbrc.2005.12.089; Yang PL, 2002, P NATL ACAD SCI USA, V99, P13825, DOI 10.1073/pnas.202398599	41	24	25	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e103955	10.1371/journal.pone.0103955	http://dx.doi.org/10.1371/journal.pone.0103955			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25101682	gold, Green Published, Green Submitted			2022-12-27	WOS:000339993900030
J	Fackler, PL; Pacifici, K; Martin, J; McIntyre, C				Fackler, Paul L.; Pacifici, Krishna; Martin, Julien; McIntyre, Carol			Efficient Use of Information in Adaptive Management with an Application to Managing Recreation near Golden Eagle Nesting Sites	PLOS ONE			English	Article							CONSERVATION; MODELS	It is generally the case that a significant degree of uncertainty exists concerning the behavior of ecological systems. Adaptive management has been developed to address such structural uncertainty, while recognizing that decisions must be made without full knowledge of how a system behaves. This paradigm attempts to use new information that develops during the course of management to learn how the system works. To date, however, adaptive management has used a very limited information set to characterize the learning that is possible. This paper uses an extension of the Partial Observable Markov Decision Process (POMDP) framework to expand the information set used to update belief in competing models. This feature can potentially increase the speed of learning through adaptive management, and lead to better management in the future. We apply this framework to a case study wherein interest lies in managing recreational restrictions around golden eagle (Aquila chrysaetos) nesting sites. The ultimate management objective is to maintain an abundant eagle population in Denali National Park while minimizing the regulatory burden on park visitors. In order to capture this objective, we developed a utility function that trades off expected breeding success with hiker access. Our work is relevant to the management of human activities in protected areas, but more generally demonstrates some of the benefits of POMDP in the context of adaptive management.	[Fackler, Paul L.] N Carolina State Univ, Raleigh, NC 27695 USA; [Pacifici, Krishna] N Carolina State Univ, Dept Appl Ecol, Raleigh, NC 27695 USA; [Martin, Julien] US Geol Survey, Patuxent Wildlife Res Ctr, Laurel, MD USA; [Martin, Julien] Florida Fish & Wildlife Conservat Commiss, Fish & Wildlife Res Inst, St Petersburg, FL USA; [McIntyre, Carol] Natl Pk Serv, Fairbanks, AK USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; United States Department of the Interior; United States Geological Survey; Florida Fish & Wildlife Conservation Commission; United States Department of the Interior	Fackler, PL (corresponding author), N Carolina State Univ, Raleigh, NC 27695 USA.	paul_fackler@ncsu.edu	Pacifici, Krishna/AAF-5171-2020; Nieuwkerk, Pythia/S-4084-2017	Nieuwkerk, Pythia/0000-0002-2616-1414; Martin, Julien/0000-0002-7375-129X; Pichler, Mario/0000-0002-5027-809X; Pacifici, Krishna/0000-0002-7518-7186	U.S. Geological Survey Status and Trends of Biological Resource Program; National Park Service Vital Signs Monitoring Program; Denali National Park and Preserve; United States Department of Agriculture Hatch Project [NC0228]; NCSU Department of Applied Ecology	U.S. Geological Survey Status and Trends of Biological Resource Program(United States Geological Survey); National Park Service Vital Signs Monitoring Program; Denali National Park and Preserve; United States Department of Agriculture Hatch Project; NCSU Department of Applied Ecology	This work was supported by the U.S. Geological Survey Status and Trends of Biological Resource Program, the National Park Service Vital Signs Monitoring Program, and Denali National Park and Preserve. P.L. Fackler's contribution to this paper was supported in part from United States Department of Agriculture Hatch Project NC0228. The authors would like to acknowledge the NCSU Department of Applied Ecology for financial assistance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araya-Lopez M., 2010, 22 INT C TOOLS ART I; Blumstein DT, 2005, J APPL ECOL, V42, P943, DOI 10.1111/j.1365-2664.2005.01071.x; Chades I., 2012, P 26 AAAI C ARTIFICI, P267; Fackler P, 2014, J ENVIRON MANAGE, V133, P27, DOI 10.1016/j.jenvman.2013.11.004; Fackler PL, 2012, METHODS ECOL EVOL, V3, P555, DOI 10.1111/j.2041-210X.2012.00191.x; Fackler PL, 2014, RESOURCE EN IN PRESS; Gill JA, 2007, IBIS, V149, P9, DOI 10.1111/j.1474-919X.2007.00642.x; Gonzalez LM, 2006, ANIM CONSERV, V9, P85, DOI 10.1111/j.1469-1795.2005.00016.x; Holling C.S., 1978, ADAPTIVE ENV ASSESSM; Kaelbling LP, 1998, ARTIF INTELL, V101, P99, DOI 10.1016/S0004-3702(98)00023-X; Kaisanlahti-Jokimaki ML, 2008, ORNIS FENNICA, V85, P2; Margalida A, 2011, ANIM CONSERV, V14, P167, DOI 10.1111/j.1469-1795.2010.00412.x; Martin J, 2011, CONSERV BIOL, V25, P316, DOI 10.1111/j.1523-1739.2010.01644.x; Martin J, 2009, BIOL CONSERV, V142, P2726, DOI 10.1016/j.biocon.2009.06.027; MONAHAN GE, 1982, MANAGE SCI, V28, P1, DOI 10.1287/mnsc.28.1.1; Ong S. C. W, 2009, P ROBOTICS SCI SYSTE; Puterman ML, 2005, MARKOV DECISION PROC; Walters C., 1986, ADAPTIVE MANAGEMENT; Williams BK, 2011, ECOL MODEL, V222, P1092, DOI 10.1016/j.ecolmodel.2010.12.015; Young J, 2005, BIODIVERS CONSERV, V14, P1641, DOI 10.1007/s10531-004-0536-z	20	26	26	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e102434	10.1371/journal.pone.0102434	http://dx.doi.org/10.1371/journal.pone.0102434			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25098955	gold, Green Published, Green Submitted			2022-12-27	WOS:000339995100007
J	Penna, C; Pasqua, T; Amelio, D; Perrelli, MG; Angotti, C; Tullio, F; Mahata, SK; Tota, B; Pagliaro, P; Cerra, MC; Angelone, T				Penna, Claudia; Pasqua, Teresa; Amelio, Daniela; Perrelli, Maria-Giulia; Angotti, Carmelina; Tullio, Francesca; Mahata, Sushil K.; Tota, Bruno; Pagliaro, Pasquale; Cerra, Maria C.; Angelone, Tommaso			Catestatin Increases the Expression of Anti-Apoptotic and Pro-Angiogenetic Factors in the Post-Ischemic Hypertrophied Heart of SHR	PLOS ONE			English	Article							SPONTANEOUSLY HYPERTENSIVE-RATS; INHIBITORY PEPTIDE CATESTATIN; PERMEABILITY TRANSITION PORE; PROTEIN-KINASE-C; K-ATP CHANNELS; CARDIAC-HYPERTROPHY; S-NITROSYLATION; CHROMOGRANIN-A; ISCHEMIA/REPERFUSION INJURY; SKELETAL-MUSCLE	Background: In the presence of comorbidities the effectiveness of many cardioprotective strategies is blunted. The goal of this study was to assess in a hypertensive rat model if the early reperfusion with anti-hypertensive and pro-angiogenic Chromogranin A-derived peptide, Catestatin (CST:hCgA(352-372); CST-Post), protects the heart via Reperfusion-Injury-Salvage-Kinases (RISK)-pathway activation, limiting infarct-size and apoptosis, and promoting angiogenetic factors (e.g., hypoxia inducible factor, HIF-1 alpha, and endothelial nitric oxide synthase, eNOS, expression). Methods and Results: The effects of CST-Post on infarct-size, apoptosis and pro-angiogenetic factors were studied in isolated hearts of spontaneously hypertensive rats (SHR), which underwent the following protocols: (a) 30-min ischemia and 120-min reperfusion (I/R); (b) 30-min ischemia and 20-min reperfusion (I/R-short), both with and without CST-Post (75 nM for 20-min at the beginning of reperfusion). In unprotected Wistar-Kyoto hearts, used as normal counterpart, infarct-size resulted smaller than in SHR. CST-Post reduced significantly infarct-size and improved post-ischemic cardiac function in both strains. After 20-min reperfusion, CST-Post induced S-nitrosylation of calcium channels and phosphorylation of RISK-pathway in WKY and SHR hearts. Yet specific inhibitors of the RISK pathway blocked the CST-Post protective effects against infarct in the 120-min reperfusion groups. Moreover, apoptosis (evaluated by TUNEL, ARC and cleaved caspase) was reduced by CST-Post. Importantly, CST-Post increased expression of pro-angiogenetic factors (i.e., HIF-1 alpha and eNOS expression) after two-hour reperfusion. Conclusions: CST-Post limits reperfusion damages and reverses the hypertension-induced increase of I/R susceptibility. Moreover, CST-Post triggers antiapoptotic and pro-angiogenetic factors suggesting that CST-Post can be used as an anti-maladaptive remodeling treatment.	[Penna, Claudia; Perrelli, Maria-Giulia; Angotti, Carmelina; Tullio, Francesca; Pagliaro, Pasquale] Univ Turin, Dept Clin & Biol Sci, Turin, Italy; [Pasqua, Teresa; Amelio, Daniela; Tota, Bruno; Cerra, Maria C.; Angelone, Tommaso] Univ Calabria, Dept Biol Ecol & Earth Sci, Arcavacata Di Rende, Italy; [Mahata, Sushil K.] Univ Calif San Diego, VA San Diego Healthcare Syst, San Diego, CA 92103 USA; [Tota, Bruno; Pagliaro, Pasquale; Cerra, Maria C.; Angelone, Tommaso] Natl Inst Cardiovasc Res, Bologna, Italy	University of Turin; University of Calabria; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System	Pagliaro, P (corresponding author), Univ Turin, Dept Clin & Biol Sci, Turin, Italy.	pasquale.pagliaro@unito.it; maria_carmela.cerra@unical.it	Angelone, Tommaso/AAM-1230-2020; Pasqua, Teresa/AAA-9067-2022; Pagliaro, Pasquale/E-5239-2010; Mahata, Sushil/AAF-8781-2021; Penna, Claudia/J-5103-2018	Angelone, Tommaso/0000-0001-7797-7862; Pagliaro, Pasquale/0000-0002-4386-1383; Amelio, Daniela/0000-0002-5543-8531; Cerra, Maria Carmela/0000-0002-2091-928X	National Institutes of Cardiovascular Research; MIUR; Research Career Scientist Award of the VA	National Institutes of Cardiovascular Research; MIUR(Ministry of Education, Universities and Research (MIUR)); Research Career Scientist Award of the VA	This work was supported by National Institutes of Cardiovascular Research [INRC-2010, to PP, BT, MCC, TA]; ex-60% [to CP, DA, MCC, PP, TA]; and MIUR [PRIN-2008 to BT, CP, DA, TA]. SKM is supported by a Research Career Scientist Award of the VA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amelio D, 2013, NITRIC OXIDE-BIOL CH, V32, P1, DOI 10.1016/j.niox.2013.03.005; Amelio D, 2008, NITRIC OXIDE-BIOL CH, V18, P1, DOI 10.1016/j.niox.2007.10.004; Angelone T, 2012, CURR MED CHEM, V19, P4042, DOI 10.2174/092986712802430009; Angelone T, 2008, ENDOCRINOLOGY, V149, P4780, DOI 10.1210/en.2008-0318; Angelone T, 2012, AM J PHYSIOL-HEART C, V302, pH431, DOI 10.1152/ajpheart.00491.2011; Bassino E, 2011, CARDIOVASC RES, V91, P617, DOI 10.1093/cvr/cvr129; Biswas N, 2010, CELL TISSUE RES, V342, P353, DOI 10.1007/s00441-010-1059-4; Boengler K, 2008, CIRC RES, V102, P131, DOI 10.1161/CIRCRESAHA.107.164699; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Braz JC, 2009, EUR J HEART FAIL, V11, P739, DOI 10.1093/eurjhf/hfp094; De Francesco EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069322; Faghihi M, 2012, PEPTIDES, V37, P314, DOI 10.1016/j.peptides.2012.08.001; Fantinelli JC, 2013, INT J CARDIOL, V166, P173, DOI 10.1016/j.ijcard.2011.10.103; Ferdinandy P, 2007, PHARMACOL REV, V59, P418, DOI 10.1124/pr.107.06002; Heusch G, 2012, CARDIOVASC RES, V96, P214, DOI 10.1093/cvr/cvs145; Hua YN, 2011, BASIC RES CARDIOL, V106, P1173, DOI 10.1007/s00395-011-0222-8; Jugdutt Bodh I, 2002, Heart Fail Rev, V7, P391, DOI 10.1023/A:1020718619155; Kin H, 2005, CARDIOVASC RES, V67, P124, DOI 10.1016/j.cardiores.2005.02.015; Koseki T, 1998, P NATL ACAD SCI USA, V95, P5156, DOI 10.1073/pnas.95.9.5156; Li YZ, 2009, APOPTOSIS, V14, P164, DOI 10.1007/s10495-008-0296-4; Lim SY, 2011, J CELL MOL MED, V15, P2443, DOI 10.1111/j.1582-4934.2010.01235.x; Mahata SK, 2000, MOL ENDOCRINOL, V14, P1525, DOI 10.1210/me.14.10.1525; Murphy E, 2012, J MOL CELL CARDIOL, V52, P568, DOI 10.1016/j.yjmcc.2011.08.021; O'Connor DT, 2002, J HYPERTENS, V20, P1335, DOI 10.1097/00004872-200207000-00020; Oikawa M, 2008, CIRC J, V72, P2081, DOI 10.1253/circj.CJ-08-0098; Ong SG, 2012, PHARMACOL THERAPEUT, V136, P69, DOI 10.1016/j.pharmthera.2012.07.005; Pagliaro P, 2003, FREE RADICAL BIO MED, V34, P33, DOI 10.1016/S0891-5849(02)01179-6; Pagliaro P, 2011, ANTIOXID REDOX SIGN, V14, P833, DOI 10.1089/ars.2010.3245; Pasqua T, 2013, ENDOCRINOLOGY, V154, P3353, DOI 10.1210/en.2012-2210; Penna C, 2005, AM J PHYSIOL-HEART C, V288, pH2512, DOI 10.1152/ajpheart.00599.2004; Penna C, 2011, BASIC RES CARDIOL, V106, P409, DOI 10.1007/s00395-010-0143-y; Penna C, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0272-6; Penna C, 2011, PFLUG ARCH EUR J PHY, V462, P219, DOI 10.1007/s00424-011-0970-1; Penna C, 2010, CELL MOL NEUROBIOL, V30, P1171, DOI 10.1007/s10571-010-9598-5; Penna C, 2010, BASIC RES CARDIOL, V105, P181, DOI 10.1007/s00395-009-0075-6; Penna C, 2009, BBA-BIOENERGETICS, V1787, P794, DOI 10.1016/j.bbabio.2009.03.013; Perrelli MG, 2013, PFLUG ARCH EUR J PHY, V465, P1031, DOI 10.1007/s00424-013-1217-0; Quadrilatero J, 2010, BIOCHEM BIOPH RES CO, V391, P1437, DOI 10.1016/j.bbrc.2009.12.084; Salloum FN, 2012, AM J PHYSIOL-HEART C, V302, pH1347, DOI 10.1152/ajpheart.00544.2011; SEN S, 1974, CIRC RES, V35, P775, DOI 10.1161/01.RES.35.5.775; Shiojima I, 2005, J CLIN INVEST, V115, P2108, DOI 10.1172/JCI24682; Sumi S, 2010, AM J PHYSIOL-HEART C, V299, pH1174, DOI 10.1152/ajpheart.00116.2010; Sun JH, 2006, CIRC RES, V98, P403, DOI 10.1161/01.RES.0000202707.79018.0a; Theurl M, 2010, CIRC RES, V107, P1326, DOI 10.1161/CIRCRESAHA.110.219493; Tsang A, 2004, CIRC RES, V95, P230, DOI 10.1161/01.RES.0000138303.76488.fe; Rueda JOV, 2012, J APPL PHYSIOL, V112, P2110, DOI 10.1152/japplphysiol.01383.2011; Wagner C, 2013, J CARDIOVASC PHARM, V61, P35, DOI 10.1097/FJC.0b013e3182760c4d; Zhao HX, 2010, BASIC RES CARDIOL, V105, P109, DOI 10.1007/s00395-009-0044-0; Zorov DB, 2009, CARDIOVASC RES, V83, P213, DOI 10.1093/cvr/cvp151	49	27	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e102536	10.1371/journal.pone.0102536	http://dx.doi.org/10.1371/journal.pone.0102536			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25099124	Green Published, Green Submitted, gold			2022-12-27	WOS:000339995100008
J	Baumgartner, FA; Pavia, H; Toth, GB				Baumgartner, Finn A.; Pavia, Henrik; Toth, Gunilla B.			Individual Specialization to Non-Optimal Hosts in a Polyphagous Marine Invertebrate Herbivore	PLOS ONE			English	Article							SACOGLOSSA MOLLUSCA; CHEMICAL DEFENSES; FOOD; OPISTHOBRANCHIA; ASCOGLOSSA; PHOTOSYNTHESIS; EVOLUTION; KLEPTOPLASTS; MAINTENANCE; SPECIFICITY	Factors determining the degree of dietary generalism versus specialism are central in ecology. Species that are generalists at the population level may in fact be composed of specialized individuals. The optimal diet theory assumes that individuals choose diets that maximize fitness, and individual specialization may occur if individuals' ability to locate, recognize, and handle different food types differ. We investigate if individuals of the marine herbivorous slug Elysia viridis, which co-occur at different densities on several green macroalgal species in the field, are specialized to different algal hosts. Individual slugs were collected from three original algal host species (Cladophora sericea, Cladophora rupestris and Codium fragile) in the field, and short-term habitat choice and consumption, as well as long-term growth (proxy for fitness), on four algal diet species (the original algal host species and Chaetomorpha melagonium) were studied in laboratory experiments. Nutritional (protein, nitrogen, and carbon content) and morphological (dry weight, and cell/utricle volume) algal traits were also measured to investigate if they correlated with the growth value of the different algal diets. E. viridis individuals tended to choose and consume algal species that were similar to their original algal host. Long-term growth of E. viridis, however, was mostly independent of original algal host, as all individuals reached a larger size on the non-host C. melagonium. E. viridis growth was positively correlated to algal cell/utricle volume but not to any of the other measured algal traits. Because E. viridis feeds by piercing individual algal cells, the results indicate that slugs may receive more cytoplasm, and thus more energy per unit time, on algal species with large cells/utricles. We conclude that E. viridis individuals are specialized on different hosts, but host choice in natural E. viridis populations is not determined by the energetic value of seaweed diets as predicted by the ODT.	[Baumgartner, Finn A.; Pavia, Henrik; Toth, Gunilla B.] Univ Gothenburg, Dept Biol & Environm Sci Tjarno, Stromstad, Sweden	University of Gothenburg	Toth, GB (corresponding author), Univ Gothenburg, Dept Biol & Environm Sci Tjarno, Stromstad, Sweden.	gunilla.toth@bioenv.gu.se	Toth, Gunilla B/E-8737-2013	Toth, Gunilla/0000-0002-1225-7773	Colliander foundation; Faculty of Natural Sciences at the University of Gothenburg through the Center for Marine Chemical Ecology (CeMaCE); Swedish National Science Foundation [621-2007-5874, 621-2011-5630]	Colliander foundation; Faculty of Natural Sciences at the University of Gothenburg through the Center for Marine Chemical Ecology (CeMaCE); Swedish National Science Foundation	This work was financially supported via grants from the Colliander foundation to FAB, the Faculty of Natural Sciences at the University of Gothenburg through the Center for Marine Chemical Ecology (CeMaCE) to HP and GBT, and the Swedish National Science Foundation grants 621-2007-5874 to GBT and 621-2011-5630 to HP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo MS, 2011, ECOL LETT, V14, P948, DOI 10.1111/j.1461-0248.2011.01662.x; Baumgartner FA, 2014, PLOS ONE IN PRESS; Becerro MA, 2001, J CHEM ECOL, V27, P2287, DOI 10.1023/A:1012287105923; Bolnick DI, 2003, AM NAT, V161, P1, DOI 10.1086/343878; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Casalduero FG, 2008, J EXP MAR BIOL ECOL, V357, P181, DOI 10.1016/j.jembe.2008.01.020; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; CLARK KB, 1990, VELIGER, V33, P339; CLARK KB, 1978, J MOLLUS STUD, V44, P272; Clark Kerry B., 1992, P515; Conover WJ., 1999, PRACTICAL NONPARAMET, V3rd; Cruz S, 2014, J MOLLUS STUD, V80, P475, DOI 10.1093/mollus/eyu021; DAVIS EM, 1988, AM BIOTECHNOL LAB, V6, P28; Duffy JE, 2007, ECOL LETT, V10, P522, DOI 10.1111/j.1461-0248.2007.01037.x; DUFFY JE, 1991, ECOLOGY, V72, P1286, DOI 10.2307/1941102; Evertsen J, 2007, MAR BIOL, V151, P2159, DOI 10.1007/s00227-007-0648-6; FUTUYMA DJ, 1988, ANNU REV ECOL SYST, V19, P207, DOI 10.1146/annurev.es.19.110188.001231; Futuyma DJ, 2009, P NATL ACAD SCI USA, V106, P18054, DOI 10.1073/pnas.0904106106; GAVAGNIN M, 1994, J EXP MAR BIOL ECOL, V175, P197, DOI 10.1016/0022-0981(94)90026-4; Green BJ, 2000, PLANT PHYSIOL, V124, P331, DOI 10.1104/pp.124.1.331; Handeler K, 2010, MOL ECOL RESOUR, V10, P968, DOI 10.1111/j.1755-0998.2010.02853.x; Hay Mark E., 1992, P371; HAY ME, 1990, LIMNOL OCEANOGR, V35, P1734, DOI 10.4319/lo.1990.35.8.1734; HINDE R, 1975, BIOL J LINN SOC, V7, P161, DOI 10.1111/j.1095-8312.1975.tb00738.x; JENSEN KR, 1994, ETHOL ECOL EVOL, V6, P87, DOI 10.1080/08927014.1994.9523011; JENSEN KR, 1989, J MOLLUS STUD, V55, P79, DOI 10.1093/mollus/55.1.79; JENSEN KR, 1993, BIOL J LINN SOC, V48, P135, DOI 10.1111/j.1095-8312.1993.tb00883.x; Jensen KR, 1997, EVOL ECOL, V11, P301, DOI 10.1023/A:1018468420368; Jormalainen V, 2001, OIKOS, V93, P77, DOI 10.1034/j.1600-0706.2001.930108.x; Loxdale HD, 2011, BIOL J LINN SOC, V103, P1, DOI 10.1111/j.1095-8312.2011.01627.x; Marin A, 2004, SCI MAR, V68, P227, DOI 10.3989/scimar.2004.68s1227; MORAN JAG, 1994, J EXP MAR BIOL ECOL, V182, P111, DOI 10.1016/0022-0981(94)90214-3; PAUL VJ, 1988, J EXP MAR BIOL ECOL, V119, P15, DOI 10.1016/0022-0981(88)90149-9; Poore AGB, 2006, MAR BIOL, V149, P1403, DOI 10.1007/s00227-006-0307-3; Raven JA, 2009, J EXP BOT, V60, P3975, DOI 10.1093/jxb/erp282; ROUGHGARDEN J, 1974, AM NAT, V108, P429, DOI 10.1086/282924; Stachowicz JJ, 1999, ECOLOGY, V80, P495, DOI 10.1890/0012-9658(1999)080[0495:RPTCMC]2.0.CO;2; Stephens D.W., 1986, pi; Svanback R, 2005, EVOL ECOL RES, V7, P993; Teugels B, 2008, AQUAT BIOL, V4, P15, DOI 10.3354/ab00092; TROWBRIDGE CD, 1991, ECOLOGY, V72, P1880, DOI 10.2307/1940985; Trowbridge CD, 2000, J MAR BIOL ASSOC UK, V80, P1087, DOI 10.1017/S0025315400003155; Trowbridge CD, 2008, J MAR BIOL ASSOC UK, V88, P771, DOI 10.1017/S0025315408001690; Vesakoski O, 2008, J EXP MAR BIOL ECOL, V367, P118, DOI 10.1016/j.jembe.2008.09.006; Warfe DM, 2004, OECOLOGIA, V141, P171, DOI 10.1007/s00442-004-1644-x; Williamson JE, 2004, ECOLOGY, V85, P1355, DOI 10.1890/02-4083	46	9	9	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e102752	10.1371/journal.pone.0102752	http://dx.doi.org/10.1371/journal.pone.0102752			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25090601	Green Published, gold, Green Submitted			2022-12-27	WOS:000339812700009
J	Cho, SH; Oh, SY; Lane, AP; Lee, J; Oh, MH; Lee, S; Zheng, T; Zhu, Z				Cho, Seok Hyun; Oh, Sun Young; Lane, Andrew P.; Lee, Joan; Oh, Min-Hee; Lee, Seakwoo; Zheng, Tao; Zhu, Zhou			Regulation of Nasal Airway Homeostasis and Inflammation in Mice by SHP-1 and Th2/Th1 Signaling Pathways	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; ALLERGIC RHINITIS PATIENTS; INTERFERON-GAMMA; MOTH-EATEN; IMMUNODEFICIENT MUTANT; CYTOKINE PRODUCTION; GENE-EXPRESSION; NECROSIS-FACTOR; MESSENGER-RNA; MOUSE MODEL	Allergic rhinitis is a chronic inflammatory disease orchestrated by Th2 lymphocytes. Src homology 2 domain-containing protein tyrosine phosphatase (SHP)-1 is known to be a negative regulator in the IL-4 alpha/STAT-6 signaling pathway of the lung. However, the role of SHP-1 enzyme and its functional relationship with Th2 and Th1 cytokines are not known in the nasal airway. In this study, we aimed to study the nasal inflammation as a result of SHP-1 deficiency in viable motheaten (mev) mice and to investigate the molecular mechanisms involved. Cytology, histology, and expression of cytokines and chemokines were analyzed to define the nature of the nasal inflammation. Targeted gene depletion of Th1 (IFN-gamma) and Th2 (IL-4 and IL-13) cytokines was used to identify the critical pathways involved. Matrix metalloproteinases (MMPs) were studied to demonstrate the clearance mechanism of recruited inflammatory cells into the nasal airway. We showed here that mev mice had a spontaneous allergic rhinitis-like inflammation with eosinophilia, mucus metaplasia, up-regulation of Th2 cytokines (IL-4 and IL-13), chemokines (eotaxin), and MMPs. All of these inflammatory mediators were clearly counter-regulated by Th2 and Th1 cytokines. Deletion of IFN-gamma gene induced a strong Th2-skewed inflammation with transepithelial migration of the inflammatory cells. These findings suggest that SHP-1 enzyme and Th2/Th1 paradigm may play a critical role in the maintenance of nasal immune homeostasis and in the regulation of allergic rhinitis.	[Cho, Seok Hyun; Lane, Andrew P.; Lee, Joan] Johns Hopkins Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21205 USA; [Oh, Sun Young; Oh, Min-Hee; Zheng, Tao; Zhu, Zhou] Johns Hopkins Univ, Sch Med, Div Allergy & Clin Immunol, Baltimore, MD 21218 USA; [Lee, Seakwoo] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Cho, Seok Hyun] Hanyang Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Seoul 133791, South Korea	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Hanyang University	Zhu, Z (corresponding author), Johns Hopkins Univ, Sch Med, Div Allergy & Clin Immunol, Baltimore, MD 21218 USA.	zhou.zhu@yale.edu	Cho, Seok Hyun/F-6753-2017	Cho, Seok Hyun/0000-0001-8218-5894; Oh, Min-Hee/0000-0003-1581-4288	NIH [HL079349, HL107151, AI075025, AI072502]; AAAAI Women's Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107151, R01HL079349] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI075025, R01AI072502] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AAAAI Women's Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grants HL079349 and HL107151 to ZZ; NIH AI075025 grant and the AAAAI Women's Award Grant to TZ; and NIH Grant AI072502 to APL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariano R, 2003, ALLERGY ASTHMA PROC, V24, P179; Beisswenger C, 2006, J IMMUNOL, V177, P1833, DOI 10.4049/jimmunol.177.3.1833; Blanchard C, 2009, ADV IMMUNOL, V101, P81, DOI 10.1016/S0065-2776(08)01003-1; Broide DH, 2010, ALLERGY ASTHMA PROC, V31, P370, DOI 10.2500/aap.2010.31.3388; Cataldo D, 2000, INT ARCH ALLERGY IMM, V123, P259, DOI 10.1159/000024452; Cho SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035114; Cho YS, 2008, AM J RESP CELL MOL, V39, P412, DOI 10.1165/rcmb.2007-0229OC; Christodoulopoulos P, 2000, J ALLERGY CLIN IMMUN, V105, P211, DOI 10.1016/S0091-6749(00)90068-X; CLARK EA, 1981, IMMUNOGENETICS, V12, P601, DOI 10.1007/BF01561700; Cohn L, 1999, J EXP MED, V190, P1309, DOI 10.1084/jem.190.9.1309; Commins SP, 2010, J ALLERGY CLIN IMMUN, V125, pS53, DOI 10.1016/j.jaci.2009.07.008; Corry DB, 2004, FASEB J, V18, P995, DOI 10.1096/fj.03-1412fje; Corry DB, 2002, NAT IMMUNOL, V3, P347, DOI 10.1038/ni773; Fulkerson PC, 2004, J IMMUNOL, V173, P7565, DOI 10.4049/jimmunol.173.12.7565; GREEN MC, 1975, J HERED, V66, P250, DOI 10.1093/oxfordjournals.jhered.a108625; Humbles AA, 2004, SCIENCE, V305, P1776, DOI 10.1126/science.1100283; Jyonouchi H, 2003, ARCH OTOLARYNGOL, V129, P563, DOI 10.1001/archotol.129.5.563; Jyonouchi H, 2001, ARCH OTOLARYNGOL, V127, P1488, DOI 10.1001/archotol.127.12.1488; Kaiko GE, 2011, CURR OPIN ALLERGY CL, V11, P39, DOI 10.1097/ACI.0b013e328342322f; Kim SW, 2007, ANN OTO RHINOL LARYN, V116, P76, DOI 10.1177/000348940711600113; Kim TH, 2010, CLIN EXP ALLERGY, V40, P1742, DOI 10.1111/j.1365-2222.2010.03612.x; Krakowiak A, 2008, INT J OCCUP MED ENV, V21, P165, DOI 10.2478/v10001-008-0015-y; Lee KS, 2004, CLIN EXP ALLERGY, V34, P276, DOI 10.1111/j.1365-2222.2004.01849.x; Lee SN, 2013, EUR RESPIR J, V42, P1379, DOI 10.1183/09031936.00100412; Leonard C, 1997, AM J RESP CELL MOL, V17, P368, DOI 10.1165/ajrcmb.17.3.2797; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McKenzie GJ, 1998, IMMUNITY, V9, P423, DOI 10.1016/S1074-7613(00)80625-1; Meltzer Eli O, 2004, J Allergy Clin Immunol, V114, P155, DOI 10.1016/j.jaci.2004.09.029; MING WJ, 1987, J IMMUNOL, V138, P1469; Mo JH, 2011, ALLERGY, V66, P279, DOI 10.1111/j.1398-9995.2010.02476.x; Nelms K, 1999, ANNU REV IMMUNOL, V17, P701, DOI 10.1146/annurev.immunol.17.1.701; Nieminen K, 2009, INT ARCH ALLERGY IMM, V150, P370, DOI 10.1159/000226238; Oh SY, 2009, AM J RESP CELL MOL, V40, P568, DOI 10.1165/rcmb.2008-0225OC; Okano M, 2013, INT ARCH ALLERGY IMM, V160, P275, DOI 10.1159/000341668; Ouyang Yuhui, 2010, Allergol Int, V59, P313, DOI 10.2332/allergolint.10-SC-0172; OWEN WF, 1987, J EXP MED, V166, P129, DOI 10.1084/jem.166.1.129; Pease JE, 2011, BIOCHEM J, V434, P11, DOI 10.1042/BJ20101132; PERNIS A, 1995, SCIENCE, V269, P245, DOI 10.1126/science.7618088; Piirila P, 2009, ALLERGY; Romagnani S, 1998, ALLERGY, V53, P12, DOI 10.1111/j.1398-9995.1998.tb04951.x; ROSSI GA, 1985, AM REV RESPIR DIS, V131, P150; Sannohe S, 2003, EUR RESPIR J, V21, P925, DOI 10.1183/09031936.03.00028103a; Savolainen J, 2004, CLIN EXP ALLERGY, V34, P413, DOI 10.1111/j.1365-2222.2004.01823.x; SHULTZ LD, 1984, AM J PATHOL, V116, P179; SHULTZ LD, 1976, J IMMUNOL, V116, P936; SHULTZ LD, 1993, CELL, V73, P1445, DOI 10.1016/0092-8674(93)90369-2; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Takahashi Y, 2009, INT IMMUNOPHARMACOL, V9, P734, DOI 10.1016/j.intimp.2009.02.011; Teixeira LK, 2005, MEM I OSWALDO CRUZ, V100, P137, DOI 10.1590/S0074-02762005000900024; Temann UA, 1997, AM J RESP CELL MOL, V16, P471, DOI 10.1165/ajrcmb.16.4.9115759; Verhaeghe B, 2002, ALLERGY, V57, P825, DOI 10.1034/j.1398-9995.2002.23539.x; Wang HY, 2007, EUR J PHARMACOL, V577, P162, DOI 10.1016/j.ejphar.2007.08.023; WARD JM, 1978, VET PATHOL, V15, P170, DOI 10.1177/030098587801500203; Wenzel SE, 2003, J ALLERGY CLIN IMMUN, V111, P1345, DOI 10.1067/mai.2003.1464	54	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103685	10.1371/journal.pone.0103685	http://dx.doi.org/10.1371/journal.pone.0103685			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25090641	Green Published, gold, Green Submitted			2022-12-27	WOS:000339812700043
J	Dorri, F; Mahini, H; Sharifi-Zarchi, A; Totonchi, M; Tusserkani, R; Pezeshk, H; Sadeghi, M				Dorri, Faezeh; Mahini, Hamid; Sharifi-Zarchi, Ali; Totonchi, Mehdi; Tusserkani, Ruzbeh; Pezeshk, Hamid; Sadeghi, Mehdi			Natural Biased Coin Encoded in the Genome Determines Cell Strategy	PLOS ONE			English	Article							BACTERIOPHAGE-LAMBDA; GENE-REGULATION; DECISION-MAKING; RIGHT OPERATOR; EVOLUTION; LYSOGENIZATION; NETWORKS; BISTABILITY; EQUILIBRIA; EXPRESSION	Decision making at a cellular level determines different fates for isogenic cells. However, it is not yet clear how rational decisions are encoded in the genome, how they are transmitted to their offspring, and whether they evolve and become optimized throughout generations. In this paper, we use a game theoretic approach to explain how rational decisions are made in the presence of cooperators and competitors. Our results suggest the existence of an internal switch that operates as a biased coin. The biased coin is, in fact, a biochemical bistable network of interacting genes that can flip to one of its stable states in response to different environmental stimuli. We present a framework to describe how the positions of attractors in such a gene regulatory network correspond to the behavior of a rational player in a competing environment. We evaluate our model by considering lysis/lysogeny decision making of bacteriophage lambda in E. coli.	[Dorri, Faezeh; Sharifi-Zarchi, Ali] Univ Tehran, Inst Biochem & Biophys, Tehran, Iran; [Mahini, Hamid] Univ Maryland, Dept Comp Sci, College Pk, MD 20742 USA; [Sharifi-Zarchi, Ali; Totonchi, Mehdi] ACECR, Royan Inst Stem Cell Biol & Technol, Dept Stem Cells & Dev Biol, Cell Sci Res Ctr, Tehran, Iran; [Totonchi, Mehdi] Royan Inst Reprod Biomedicine, ACECR, Reprod Biomed Res Ctr, Dept Genet, Tehran, Iran; [Tusserkani, Ruzbeh] Inst Res Fundamental Sci, Sch Comp Sci, Tehran, Iran; [Pezeshk, Hamid] Univ Tehran, Coll Sci, Sch Math Stat & Comp Sci, Tehran, Iran; [Pezeshk, Hamid] Inst Res Fundamental Sci, Sch Biol Sci, Tehran, Iran; [Sadeghi, Mehdi] Natl Inst Genet Engn & Biotechnol, Tehran, Iran	University of Tehran; University System of Maryland; University of Maryland College Park; Academic Center for Education, Culture & Research (ACECR); Academic Center for Education, Culture & Research (ACECR); University of Tehran	Sadeghi, M (corresponding author), Natl Inst Genet Engn & Biotechnol, Tehran, Iran.	sadeghi@nigeb.ac.ir	Sharifi-Zarchi, Ali/ABB-7910-2020	Sharifi-Zarchi, Ali/0000-0002-0087-7596; Totonchi, Mehdi/0000-0002-7285-3155				Abramowitz M., 1964, HDB MATH FUNCTIONS F; Alon U, 2007, INTRO SYSTEMS BIOL D; Avery SV, 2006, NAT REV MICROBIOL, V4, P577, DOI 10.1038/nrmicro1460; Avlund M, 2009, J VIROL, V83, P11416, DOI 10.1128/JVI.01057-09; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; BLUME LE, 1993, GAME ECON BEHAV, V5, P387, DOI 10.1006/game.1993.1023; Cao JG, 2012, METHODS MOL BIOL, V802, P185, DOI 10.1007/978-1-61779-400-1_12; Cao YF, 2010, P NATL ACAD SCI USA, V107, P18445, DOI 10.1073/pnas.1001455107; Chettaoui C, 2006, LECT NOTES COMPUT SC, V4210, P257; COHEN D, 1966, J THEOR BIOL, V12, P119, DOI 10.1016/0022-5193(66)90188-3; COVER T. M., 2012, ELEMENTS INFORM THEO, DOI 10.1002/0471200611; Davidson E, 2005, P NATL ACAD SCI USA, V102, P4935, DOI 10.1073/pnas.0502024102; Davidson EH, 2010, REGULATORY GENOME GE; Dubnau D, 2006, MOL MICROBIOL, V61, P564, DOI 10.1111/j.1365-2958.2006.05249.x; ELLISON G, 1993, ECONOMETRICA, V61, P1047, DOI 10.2307/2951493; Ferrell JE, 2012, CURR BIOL, V22, pR458, DOI 10.1016/j.cub.2012.03.045; Frank SA, 1996, Q REV BIOL, V71, P37, DOI 10.1086/419267; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; Gupta R, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-52; HAMILTON WD, 1967, SCIENCE, V156, P477, DOI 10.1126/science.156.3774.477; Harmer GP, 2001, CHAOS, V11, P705, DOI 10.1063/1.1395623; JOHNSON AD, 1981, NATURE, V294, P217, DOI 10.1038/294217a0; KANDORI M, 1993, ECONOMETRICA, V61, P29, DOI 10.2307/2951777; KOURILSKY P, 1974, BIOCHIMIE, V56, P1511; KOURILSKY P, 1973, MOL GEN GENET, V122, P183, DOI 10.1007/BF00435190; KOURILSKY P, 1974, BIOCHIMIE, V56, P1517; Kussell E, 2005, SCIENCE, V309, P2075, DOI 10.1126/science.1114383; Lachmann M, 1996, J THEOR BIOL, V181, P1, DOI 10.1006/jtbi.1996.0109; Levins R., 1968, EVOLUTION CHANGING E; MAURER R, 1980, J MOL BIOL, V139, P147, DOI 10.1016/0022-2836(80)90302-2; McFadden D., 1973, FRONTIERS ECONOMETRI, P105, DOI DOI 10.1108/EB028592; MCKELVEY RD, 1995, GAME ECON BEHAV, V10, P6, DOI 10.1006/game.1995.1023; MEYER BJ, 1980, J MOL BIOL, V139, P163, DOI 10.1016/0022-2836(80)90303-4; MEYER BJ, 1980, J MOL BIOL, V139, P195, DOI 10.1016/0022-2836(80)90304-6; Montanari A, 2010, P NATL ACAD SCI USA, V107, P20196, DOI 10.1073/pnas.1004098107; MOOKHERJEE D, 1994, GAME ECON BEHAV, V7, P62, DOI 10.1006/game.1994.1037; Oppenheim AB, 2005, ANNU REV GENET, V39, P409, DOI 10.1146/annurev.genet.39.073003.113656; Papoulis A., 2002, PROBABILITY RANDOM V; Perkins TJ, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.83; Pfeiffer T, 2005, TRENDS BIOCHEM SCI, V30, P20, DOI 10.1016/j.tibs.2004.11.006; Polynikis A, 2009, J THEOR BIOL, V261, P511, DOI 10.1016/j.jtbi.2009.07.040; Refardt D, 2010, EVOLUTION, V64, P1086, DOI 10.1111/j.1558-5646.2009.00882.x; Sandholm WH., 2010, POPULATION GAMES EVO; SCHAFFER WM, 1974, AM NAT, V108, P783, DOI 10.1086/282954; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI DOI 10.1002/J.1538-7305.1948.TB01338.X; Shmulevich I, 2002, BIOINFORMATICS, V18, P261, DOI 10.1093/bioinformatics/18.2.261; SMITH JM, 1973, NATURE, V246, P15, DOI 10.1038/246015a0; St-Pierre F, 2008, P NATL ACAD SCI USA, V105, P20705, DOI 10.1073/pnas.0808831105; STEARNS SC, 1976, Q REV BIOL, V51, P3, DOI 10.1086/409052; Thattai M, 2004, GENETICS, V167, P523, DOI 10.1534/genetics.167.1.523; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Waddington C. H., 1957, STRATEGY GENES, P11; Weitz JS, 2008, BIOPHYS J, V95, P2673, DOI 10.1529/biophysj.108.133694; Zeng LY, 2010, CELL, V141, P682, DOI 10.1016/j.cell.2010.03.034	54	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103569	10.1371/journal.pone.0103569	http://dx.doi.org/10.1371/journal.pone.0103569			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25090629	Green Published, gold, Green Submitted			2022-12-27	WOS:000339812700031
J	Fang, ZJ; Zhao, M; Zhen, H; Chen, LF; Shi, P; Huang, ZW				Fang, Zhijia; Zhao, Min; Zhen, Hong; Chen, Lifeng; Shi, Ping; Huang, Zhiwei			Genotoxicity of Tri- and Hexavalent Chromium Compounds In Vivo and Their Modes of Action on DNA Damage In Vitro	PLOS ONE			English	Article							TRIVALENT CHROMIUM; LUNG-CANCER; CROSS-LINKS; COMPLEXES; ACID; CYTOTOXICITY; MECHANISMS; TOXICITY; GLUCOSE; BINDING	Chromium occurs mostly in tri- and hexavalent states in the environment. Hexavalent chromium [Cr(VI)] compounds are extensively used in diverse industries, and trivalent chromium [Cr(III)] salts are used as micronutrients and dietary supplements. In the present work, we report that they both induce genetic mutations in yeast cells. They both also cause DNA damage in both yeast and Jurkat cells and the effect of Cr(III) is greater than that of Cr(VI). We further show that Cr(III) and Cr(VI) cause DNA damage through different mechanisms. Cr(VI) intercalates DNA and Cr(III) interferes base pair stacking. Based on our results, we conclude that Cr(III) can directly cause genotoxicity in vivo.	[Fang, Zhijia; Zhao, Min; Huang, Zhiwei] Donghua Univ, Coll Chem Chem Engn & Biotechnol, Shanghai, Peoples R China; [Zhen, Hong; Chen, Lifeng; Shi, Ping] E China Univ Sci & Technol, State Key Lab Bioreactor Engn, Shanghai 200237, Peoples R China	Donghua University; East China University of Science & Technology	Shi, P (corresponding author), E China Univ Sci & Technol, State Key Lab Bioreactor Engn, Shanghai 200237, Peoples R China.	ship@ecust.edu.cn; zhiweih@dhu.edu.cn			National Natural Science Foundation of China [31100549]; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry; Fundamental Research Funds for the Central Universities [2232014A3-03, 222201313010]; National Special Fund for State Key Laboratory of Bioreactor Engineering [2060204]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry(Scientific Research Foundation for the Returned Overseas Chinese Scholars); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Special Fund for State Key Laboratory of Bioreactor Engineering	This work was sponsored by grants from the National Natural Science Foundation of China (31100549, PS), Scientific Research Foundation for the Returned Overseas Chinese Scholars(PS, ZH), State Education Ministry and Fundamental Research Funds for the Central Universities (2232014A3-03, ZH and 222201313010, PS), the National Special Fund for State Key Laboratory of Bioreactor Engineering (2060204, PS). The funders had a role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Althuis MD, 2002, AM J CLIN NUTR, V76, P148, DOI 10.1093/ajcn/76.1.148; Anderson RA, 2003, NUTR RES REV, V16, P267, DOI 10.1079/NRR200366; Anderson RA, 1998, J AM COLL NUTR, V17, P548, DOI 10.1080/07315724.1998.10718802; Arakawa H, 2000, J BIOL CHEM, V275, P10150, DOI 10.1074/jbc.275.14.10150; Arakawa H, 2006, CARCINOGENESIS, V27, P639, DOI 10.1093/carcin/bgi249; Bagchi D, 2002, TOXICOLOGY, V180, P5, DOI 10.1016/S0300-483X(02)00378-5; BORGES KM, 1989, CARCINOGENESIS, V10, P2165, DOI 10.1093/carcin/10.11.2165; BRIDGEWATER LC, 1994, MOL CARCINOGEN, V9, P122, DOI 10.1002/mc.2940090304; BRIDGEWATER LC, 1994, CARCINOGENESIS, V15, P2421, DOI 10.1093/carcin/15.11.2421; Cefalu WT, 2004, DIABETES CARE, V27, P2741, DOI 10.2337/diacare.27.11.2741; Costa M, 2006, CRIT REV TOXICOL, V36, P155, DOI 10.1080/10408440500534032; De Flora S, 1989, LIFE CHEM REPORTS, V7, P169; FARRELL RP, 1989, CHEM RES TOXICOL, V2, P227, DOI 10.1021/tx00010a002; FORNACE AJ, 1981, CHEM-BIOL INTERACT, V36, P345, DOI 10.1016/0009-2797(81)90077-6; Gibb HJ, 2000, AM J IND MED, V38, P115, DOI 10.1002/1097-0274(200008)38:2<115::AID-AJIM1>3.3.CO;2-P; Goupil P, 2009, J PLANT PHYSIOL, V166, P1446, DOI 10.1016/j.jplph.2009.01.015; Hininger I, 2007, FREE RADICAL BIO MED, V42, P1759, DOI 10.1016/j.freeradbiomed.2007.02.034; Huang ZW, 2014, CURR MICROBIOL, V68, P448, DOI 10.1007/s00284-013-0496-1; Khorsandi K, 2013, MUTAT RES-GEN TOX EN, V750, P105, DOI 10.1016/j.mrgentox.2012.10.002; LANGARD S, 1990, AM J IND MED, V17, P189, DOI 10.1002/ajim.4700170205; Lay PA, 1998, J AM CHEM SOC, V120, P6704, DOI 10.1021/ja974240z; LEONARD A, 1993, ENVIRON HEALTH PERSP, V101, P127, DOI 10.2307/3431713; McMillin DR, 1998, CHEM REV, V98, P1201, DOI 10.1021/cr9601167; Mudrak SV, 2009, MOL CELL BIOL, V29, P5316, DOI 10.1128/MCB.00422-09; O'Brien T, 2002, BIOCHEMISTRY-US, V41, P12529, DOI 10.1021/bi020452j; O'Brien TJ, 2005, MOL CELL BIOCHEM, V279, P85, DOI 10.1007/s11010-005-8225-0; Park RM, 2004, RISK ANAL, V24, P1099, DOI 10.1111/j.0272-4332.2004.00512.x; Raspor P., 2000, Acta Microbiologica et Immunologica Hungarica, V47, P143; Rudolf Emil, 2003, Acta Medica (Hradec Kralove), V46, P139; SALNIKOW K, 1992, CARCINOGENESIS, V13, P2341, DOI 10.1093/carcin/13.12.2341; Salnikow K, 2008, CHEM RES TOXICOL, V21, P28, DOI 10.1021/tx700198a; Shanker AK, 2005, ENVIRON INT, V31, P739, DOI 10.1016/j.envint.2005.02.003; Slade PG, 2005, CHEM RES TOXICOL, V18, P1140, DOI 10.1021/tx050033y; SNOW ET, 1991, ENVIRON HEALTH PERSP, V92, P75, DOI 10.2307/3431140; TAMINO G, 1981, CHEM-BIOL INTERACT, V37, P309, DOI 10.1016/0009-2797(81)90117-4; Thompson CM, 2012, PLOS ONE, V7, P1932; TSAPAKOS MJ, 1983, CANCER RES, V43, P5662; TSAPAKOS MJ, 1983, CARCINOGENESIS, V4, P959, DOI 10.1093/carcin/4.8.959; TSAPAKOS MJ, 1983, CHEM-BIOL INTERACT, V46, P265, DOI 10.1016/0009-2797(83)90034-0; Vijayalakshmi R, 2002, J BIOMOL STRUCT DYN, V19, P1063, DOI 10.1080/07391102.2002.10506809; Wang JF, 1997, CARCINOGENESIS, V18, P371, DOI 10.1093/carcin/18.2.371; WARING MJ, 1981, ANNU REV BIOCHEM, V50, P159, DOI 10.1146/annurev.bi.50.070181.001111; XU J, 1994, CARCINOGENESIS, V15, P1443, DOI 10.1093/carcin/15.7.1443; Zhitkovich A, 1996, BIOCHEMISTRY-US, V35, P7275, DOI 10.1021/bi960147w; Zhitkovich A, 2000, CHEM RES TOXICOL, V13, P1114, DOI 10.1021/tx0001169	45	54	60	3	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2014	9	8							e103194	10.1371/journal.pone.0103194	http://dx.doi.org/10.1371/journal.pone.0103194			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WB	25111056	Green Published, gold, Green Submitted			2022-12-27	WOS:000341105100014
J	Grafals, M; Smith, B; Murakami, N; Trabucco, A; Hamill, K; Marangos, E; Gilligan, H; Pomfret, EA; Pomposelli, JJ; Simpson, MA; Azzi, J; Najafian, N; Riella, LV				Grafals, Monica; Smith, Brian; Murakami, Naoka; Trabucco, Agnes; Hamill, Katherine; Marangos, Erick; Gilligan, Hannah; Pomfret, Elizabeth A.; Pomposelli, James J.; Simpson, Mary A.; Azzi, Jamil; Najafian, Nader; Riella, Leonardo V.			Immunophenotyping and Efficacy of Low Dose ATG in Non-Sensitized Kidney Recipients Undergoing Early Steroid Withdrawal: A Randomized Pilot Study	PLOS ONE			English	Article							INDUCTION IMMUNOSUPPRESSIVE THERAPY; ANTITHYMOCYTE GLOBULIN INDUCTION; TRANSPLANT RECIPIENTS; LONG-TERM; THYMOGLOBULIN; ALEMTUZUMAB; TRIAL; ASSOCIATION; MULTICENTER	Rabbit antithymocyte globulin (ATG) is commonly used as an induction therapy in renal transplant recipients, but the ideal dosage in tacrolimus-based early steroid withdrawal protocols has not been established. The purpose of this pilot study was to determine the immunophenotyping and efficacy of lower dose ATG in low immunological-risk kidney transplant recipients. In this prospective study, 45 patients were randomized (1:1) to our standard dose ATG (total dose 3.75 mg/kg)(sATG) vs. lower dose 2.25 mg/kg (lowATG). All patients underwent early steroid withdrawal within 7 days. The primary end point was biopsy-proven acute rejection at 12 months. Prospective immunophenotyping of freshly isolated PBMCs was performed at baseline, 3, 6, 12 months post-transplant. The rate of acute rejection was 17% and 10% in the sATG and lowATG, respectively. Effector memory T cells, Tregs and recent thymic emigrants T cells had similar kinetics post-transplant in both groups. No statistically significant differences were found in graft survival, patient survival or infections between the two groups, though there was a non-significant increase in leukopenia (43% v s. 30%), CMV (8% vs. 0) and BK (4% vs. 0) infections in sATG group vs. lowATG. In sum, in low immunological risk kidney recipients undergoing steroid withdrawal, low dose ATG seems to be efficacious in preventing acute rejection and depleting T cells with potentially lower infectious complications. A larger study is warranted to confirm these findings.	[Grafals, Monica; Trabucco, Agnes; Hamill, Katherine; Marangos, Erick; Gilligan, Hannah; Pomfret, Elizabeth A.; Pomposelli, James J.; Simpson, Mary A.] Lahey Clin Fdn, Med Ctr, Dept Transplant Surg, Burlington, MA USA; [Grafals, Monica] Georgetown Univ, Dept Med, Washington, DC USA; [Smith, Brian; Azzi, Jamil; Najafian, Nader; Riella, Leonardo V.] Harvard Univ, Brigham & Womens Hosp, Transplantat Res Ctr, Renal Div,Med Sch, Boston, MA 02115 USA; [Murakami, Naoka] Beth Israel Deaconess Med Ctr, Dept Med, New York, NY 10003 USA; [Najafian, Nader] Cleveland Clin Florida, Dept Nephrol, Weston, FL USA	Lahey Hospital & Medical Center; Georgetown University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Cleveland Clinic Foundation	Riella, LV (corresponding author), Harvard Univ, Brigham & Womens Hosp, Transplantat Res Ctr, Renal Div,Med Sch, Boston, MA 02115 USA.	leonardoriella@gmail.com	Riella, Leonardo V./AAC-8182-2019; Riella, Leonardo V./AAD-5246-2019	Riella, Leonardo V./0000-0002-7636-3196; 	Robert Weiss Grant; American Heart Association	Robert Weiss Grant; American Heart Association(American Heart Association)	Funding for this study was provided by the Robert Weiss Grant (MG) and American Heart Association (LVR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brennan DC, 2006, NEW ENGL J MED, V355, P1967, DOI 10.1056/NEJMoa060068; Brennan DC, 1999, TRANSPLANTATION, V67, P1011, DOI 10.1097/00007890-199904150-00013; D'Addio F, 2013, PLOS ONE, P8; Farney AC, 2009, TRANSPLANTATION, V88, P810, DOI 10.1097/TP.0b013e3181b4acfb; Fink PJ, 2013, ANNU REV IMMUNOL, V31, P31, DOI 10.1146/annurev-immunol-032712-100010; Gaber AO, 2012, TRANSPLANTATION, V94, P331, DOI 10.1097/TP.0b013e31825a7d1f; Goggins WC, 2003, TRANSPLANTATION, V76, P798, DOI 10.1097/01.TP.0000081042.67285.91; Gurkan S, 2010, AM J TRANSPLANT, V10, P2132, DOI 10.1111/j.1600-6143.2010.03210.x; Halloran PF, 2004, NEW ENGL J MED, V351, P2715, DOI 10.1056/NEJMra033540; Hanaway MJ, 2011, NEW ENGL J MED, V364, P1909, DOI 10.1056/NEJMoa1009546; Hardinger KL, 2008, TRANSPLANTATION, V86, P947, DOI 10.1097/TP.0b013e318187bc67; Hardinger KL, 2013, TRANSPL INT, V26, P662, DOI 10.1111/tri.12043; Hardinger KL, 2010, J TRANSPLANT, V2010, DOI 10.1155/2010/957549; Karen LH, 2004, TRANSPLANTATION, P78; Kirk AD, 2003, TRANSPLANTATION, V76, P120, DOI 10.1097/01.TP.0000071362.99021.D9; Kirk AD, 2006, TRANSPLANTATION, V82, P593, DOI 10.1097/01.tp.0000234905.56926.7f; Krystufkova E, 2012, NEPHROL DIAL TRANSPL, V27, P2576, DOI 10.1093/ndt/gfr693; Lancaster GA, 2004, J EVAL CLIN PRACT, V10, P307, DOI 10.1111/j..2002.384.doc.x; Matas AJ, 2013, AM J TRANSPLANT, V13, P11, DOI 10.1111/ajt.12019; Meier-Kriesche HU, 2006, AM J TRANSPLANT, V6, P1111, DOI 10.1111/j.1600-6143.2006.01270.x; Meier-Kriesche HU, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133769; Opelz G, 2006, TRANSPLANTATION, V81, P1227, DOI 10.1097/01.tp.0000219817.18049.36; Rizzari MD, 2012, CLIN J AM SOC NEPHRO, V7, P494, DOI 10.2215/CJN.08630811; Tchao NK, 2012, AM J TRANSPLANT, V12, P1079, DOI 10.1111/j.1600-6143.2012.04008.x; Thibaudin D, 2005, TRANSPLANTATION, V80, P1514, DOI 10.1097/01.tp.0000181193.98026.3f; Thiyagarajan UM, 2013, AM J NEPHROL, V37, P586, DOI 10.1159/000351643; Todeschini M, 2013, J IMMUNOL, V191, P2818, DOI 10.4049/jimmunol.1203261; Vincenti F, 2008, AM J TRANSPLANT, V8, P307, DOI 10.1111/j.1600-6143.2007.02057.x; Wong WC, 2006, TRANSPL INT, V19, P629, DOI 10.1111/j.1432-2277.2006.00270.x; Woodle ES, 2008, ANN SURG, V248, P564, DOI 10.1097/SLA.0b013e318187d1da; Zheng XX, 2003, IMMUNOL REV, V196, P75, DOI 10.1046/j.1600-065X.2003.00089.x	31	26	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2014	9	8							e104408	10.1371/journal.pone.0104408	http://dx.doi.org/10.1371/journal.pone.0104408			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WB	25111080	Green Published, Green Submitted, gold			2022-12-27	WOS:000341105100054
J	Moschen, S; Luoni, SB; Paniego, NB; Hopp, HE; Dosio, GAA; Fernandez, P; Heinz, RA				Moschen, Sebastian; Bengoa Luoni, Sofia; Paniego, Norma B.; Esteban Hopp, H.; Dosio, Guillermo A. A.; Fernandez, Paula; Heinz, Ruth A.			Identification of Candidate Genes Associated with Leaf Senescence in Cultivated Sunflower (Helianthus annuus L.)	PLOS ONE			English	Article							NAC TRANSCRIPTION FACTOR; GENOME-WIDE ANALYSIS; FACTOR FAMILY; SIGNALING PATHWAYS; STRESS RESPONSES; COMPREHENSIVE ANALYSIS; REGULATORY NETWORK; SOLAR-RADIATION; EXPRESSION; ETHYLENE	Cultivated sunflower (Helianthus annuus L.), an important source of edible vegetable oil, shows rapid onset of senescence, which limits production by reducing photosynthetic capacity under specific growing conditions. Carbon for grain filling depends strongly on light interception by green leaf area, which diminishes during grain filling due to leaf senescence. Transcription factors (TFs) regulate the progression of leaf senescence in plants and have been well explored in model systems, but information for many agronomic crops remains limited. Here, we characterize the expression profiles of a set of putative senescence associated genes (SAGs) identified by a candidate gene approach and sunflower microarray expression studies. We examined a time course of sunflower leaves undergoing natural senescence and used quantitative PCR (qPCR) to measure the expression of 11 candidate genes representing the NAC, WRKY, MYB and NF-Y TF families. In addition, we measured physiological parameters such as chlorophyll, total soluble sugars and nitrogen content. The expression of Ha-NAC01, Ha-NAC03, Ha-NAC04, Ha-NAC05 and Ha-MYB01 TFs increased before the remobilization rate increased and therefore, before the appearance of the first physiological symptoms of senescence, whereas Ha-NAC02 expression decreased. In addition, we also examined the trifurcate feed-forward pathway (involving ORE1, miR164, and ETHYLENE INSENSITIVE 2) previously reported for Arabidopsis. We measured transcription of Ha-NAC01 (the sunflower homolog of ORE1) and Ha-EIN2, along with the levels of miR164, in two leaves from different stem positions, and identified differences in transcription between basal and upper leaves. Interestingly, Ha-NAC01 and Ha-EIN2 transcription profiles showed an earlier up-regulation in upper leaves of plants close to maturity, compared with basal leaves of plants at pre-anthesis stages. These results suggest that the H. annuus TFs characterized in this work could play important roles as potential triggers of leaf senescence and thus can be considered putative candidate genes for senescence in sunflower.	[Moschen, Sebastian; Paniego, Norma B.; Esteban Hopp, H.; Fernandez, Paula; Heinz, Ruth A.] Inst Nacl Tecnol Agr, Inst Biotecnol, Ctr Invest Ciencias Agron & Vet, Buenos Aires, DF, Argentina; [Moschen, Sebastian; Paniego, Norma B.; Dosio, Guillermo A. A.; Fernandez, Paula; Heinz, Ruth A.] Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina; [Bengoa Luoni, Sofia] Univ Nacl San Martin, Escuela Ciencia & Tecnol, Buenos Aires, DF, Argentina; [Esteban Hopp, H.; Heinz, Ruth A.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Buenos Aires, DF, Argentina; [Dosio, Guillermo A. A.] Univ Nacl Mar Plata, Lab Fisiol Vegetal, Unidad Integrada, Estn Expt Agr INTA Balcarce, Buenos Aires, DF, Argentina	Instituto Nacional de Tecnologia Agropecuaria (INTA); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Instituto Nacional de Tecnologia Agropecuaria (INTA); National University of Mar del Plata	Heinz, RA (corresponding author), Inst Nacl Tecnol Agr, Inst Biotecnol, Ctr Invest Ciencias Agron & Vet, Buenos Aires, DF, Argentina.	rheinz@cnia.inta.gov.ar	Paniego, Norma/AAK-6140-2021	Hopp, H. Esteban/0000-0002-2230-641X; Dosio, Guillermo/0000-0003-1274-5862; Paniego, Norma/0000-0003-3906-5330; Moschen, Sebastian/0000-0002-9127-7958	ANPCyT/FONCYT; Prestamo BID [PICT 15-32905, PAE 37100-PICT 019]; UNMdP [AGR212, AGR260];  [INTA-PE AEBIO 241001];  [INTA-PE AEBIO 245001];  [INTA-PE AEBIO 245711];  [INTA-AEBIO 243532];  [INTA PN CER 1336]	ANPCyT/FONCYT(ANPCyTFONCyT); Prestamo BID; UNMdP; ; ; ; ; 	This research was supported by ANPCyT/FONCYT, Prestamo BID PICT 15-32905 and PAE 37100-PICT 019, INTA-PE AEBIO 241001 and 245001, INTA-PE AEBIO 245711, INTA-AEBIO 243532, INTA PN CER 1336 and UNMdP, AGR212, AGR260. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguera E, 2010, PHYSIOL PLANTARUM, V138, P256, DOI 10.1111/j.1399-3054.2009.01336.x; Aguera E, 2012, METABOLIC REGULATION; Aguirrezabal LAN, 2003, CROP SCI, V43, P152, DOI 10.2135/cropsci2003.0152; Al-Shahrour F, 2005, NUCLEIC ACIDS RES, V33, pW460, DOI 10.1093/nar/gki456; Al-Shahrour F, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-114; Alonso JM, 1999, SCIENCE, V284, P2148, DOI 10.1126/science.284.5423.2148; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bachlava E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029814; Balazadeh S, 2011, MOL PLANT, V4, P346, DOI 10.1093/mp/ssq080; Balazadeh S, 2010, PLANT J, V62, P250, DOI 10.1111/j.1365-313X.2010.04151.x; Barozai MYK, 2012, MOL BIOL REP, V39, P2523, DOI 10.1007/s11033-011-1004-y; Bazin J, 2011, PLANT CELL, V23, P2196, DOI 10.1105/tpc.111.086694; Bisson MMA, 2009, BIOCHEM J, V424, P1, DOI 10.1042/BJ20091102; Breeze E, 2011, PLANT CELL, V23, P873, DOI 10.1105/tpc.111.083345; Buchanan-Wollaston V, 2005, PLANT J, V42, P567, DOI 10.1111/j.1365-313X.2005.02399.x; Buchanan-Wollaston V, 2003, PLANT BIOTECHNOL J, V1, P3, DOI 10.1046/j.1467-7652.2003.00004.x; Cabello P, 2006, PHYSIOL PLANTARUM, V128, P175, DOI 10.1111/j.1399-3054.2006.00722.x; Chan RL, 2009, PHYTON-INT J EXP BOT, V78, P5; De La Mata L, 2013, PHOTOSYNTHETICA, V51, P85, DOI 10.1007/s11099-013-0001-x; de la Vega AJ, 2011, FIELD CROP RES, V121, P175, DOI 10.1016/j.fcr.2010.12.015; de Zelicourt A, 2012, PLANT J, V70, P220, DOI 10.1111/j.1365-313X.2011.04859.x; Devaiah BN, 2009, MOL PLANT, V2, P43, DOI 10.1093/mp/ssn081; Di Rienzo JA, 2009, FACULTAD CIENCIAS AG; Dosio GAA, 2000, CROP SCI, V40, P1637, DOI 10.2135/cropsci2000.4061637x; Dosio GAA, 2010, AVANCES ECOFISIOLOGI, P237; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Dumas A, 1826, ANN CHIMIE, V33, P342; Fernandez P, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-40; Fernandez P, 2012, FUNCTIONAL APPROACHE; Fernandez P, 2012, PLOS ONE, V7; Fernandez P, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-11; Fernandez P, 2011, PLANT CELL REP, V30, P63, DOI 10.1007/s00299-010-0944-3; Fowler S, 2002, PLANT CELL, V14, P1675, DOI 10.1105/tpc.003483; Guo YF, 2006, PLANT J, V46, P601, DOI 10.1111/j.1365-313X.2006.02723.x; He XJ, 2005, PLANT J, V44, P903, DOI 10.1111/j.1365-313X.2005.02575.x; He YH, 2001, PLANT PHYSIOL, V126, P707, DOI 10.1104/pp.126.2.707; Hewezi T, 2008, ANN BOT-LONDON, V102, P127, DOI 10.1093/aob/mcn071; Hickman R, 2013, PLANT J, V75, P26, DOI 10.1111/tpj.12194; Hu RB, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-145; Huang H, 2012, PLANT SCI, V193, P18, DOI 10.1016/j.plantsci.2012.05.004; INSKEEP WP, 1985, PLANT PHYSIOL, V77, P483, DOI 10.1104/pp.77.2.483; Jensen MK, 2010, BIOCHEM J, V426, P183, DOI 10.1042/BJ20091234; Kane NC, 2011, BOTANY, V89, P429, DOI [10.1139/B11-032, 10.1139/b11-032]; Kim JH, 2009, SCIENCE, V323, P1053, DOI 10.1126/science.1166386; KINIRY JR, 1992, FIELD CROP RES, V30, P403, DOI 10.1016/0378-4290(92)90008-W; Kusaba M, 2013, PHOTOSYNTH RES; Lai Z, 2012, AM J BOT, V99, P209, DOI 10.3732/ajb.1100313; Lee D, 2005, NEW PHYTOL, V165, P429, DOI 10.1111/j.1469-8137.2004.01238.x; Manavella PA, 2008, PLANT J, V56, P376, DOI 10.1111/j.1365-313X.2008.03604.x; Manavella PA, 2008, J EXP BOT, V59, P3143, DOI 10.1093/jxb/ern170; Manavella PA, 2006, PLANT J, V48, P125, DOI 10.1111/j.1365-313X.2006.02865.x; Mao XG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084359; Matallana-Ramirez LP, 2013, MOL PLANT, V6, P1438, DOI 10.1093/mp/sst012; Moschen S, 2014, SUNFLOWERS GROWTH DE, P131; Nooden L.D., 1988, SENESCENCE AGING PLA, P392; Nooden LD, 1997, PHYSIOL PLANTARUM, V101, P746, DOI 10.1111/j.1399-3054.1997.tb01059.x; Nuruzzaman M, 2010, GENE, V465, P30, DOI 10.1016/j.gene.2010.06.008; Paniego N., 2007, Oilseeds, P153; Peluffo L, 2010, PHYTOCHEMISTRY, V71, P70, DOI 10.1016/j.phytochem.2009.09.018; Pereira ML, 2000, FIELD CROP RES, V67, P215, DOI 10.1016/S0378-4290(00)00096-4; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pinheiro J., 2021, NLME LINEAR NONLINEA; Rousseaux MC, 1996, PHYSIOL PLANTARUM, V96, P217, DOI 10.1111/j.1399-3054.1996.tb00205.x; Rozen S, 2000, Methods Mol Biol, V132, P365; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Sadras VO, 2000, ANN BOT-LONDON, V86, P1007, DOI 10.1006/anbo.2000.1267; Sadras VO, 2000, ANN BOT-LONDON, V85, P187, DOI 10.1006/anbo.1999.1013; Sato Y, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-10; Schafleitner R, 2007, PLANT PHYSIOL BIOCH, V45, P673, DOI 10.1016/j.plaphy.2007.06.003; Schuster I, 2004, ESTATISTICA GENOMICA, P568; Shah ST, 2013, GENE, V531, P220, DOI 10.1016/j.gene.2013.09.007; Singh AK, 2013, DNA RES, V20, P403, DOI 10.1093/dnares/dst019; Sohn KH, 2006, PLANT MOL BIOL, V61, P897, DOI 10.1007/s11103-006-0057-0; Srivalli B, 2004, BIOCHEM BIOPH RES CO, V325, P198, DOI 10.1016/j.bbrc.2004.09.221; Su HY, 2013, PLANT PHYSIOL BIOCH, V71, P11, DOI 10.1016/j.plaphy.2013.06.022; Thomas H, 2013, NEW PHYTOL, V197, P696, DOI 10.1111/nph.12047; van Doorn WG, 2008, J EXP BOT, V59, P1963, DOI 10.1093/jxb/ern076; Wang YX, 2013, MOL BIOL REP, V40, P6451, DOI 10.1007/s11033-013-2760-7; Wingler A, 2009, J EXP BOT, V60, P1063, DOI 10.1093/jxb/erp067; Woo HR, 2010, J EXP BOT, V61, P3947, DOI 10.1093/jxb/erq206; Wu AH, 2012, PLANT CELL, V24, P482, DOI 10.1105/tpc.111.090894; Ying L, 2014, PLANT PHYSIOL BIOCH, V79, P77, DOI 10.1016/j.plaphy.2014.03.004; Zhou Y, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-132	83	16	17	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2014	9	8							e104379	10.1371/journal.pone.0104379	http://dx.doi.org/10.1371/journal.pone.0104379			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WB	25110882	Green Published, Green Submitted, gold			2022-12-27	WOS:000341105100051
J	Voutouri, C; Mpekris, F; Papageorgis, P; Odysseos, AD; Stylianopoulos, T				Voutouri, Chrysovalantis; Mpekris, Fotios; Papageorgis, Panagiotis; Odysseos, Andreani D.; Stylianopoulos, Triantafyllos			Role of Constitutive Behavior and Tumor-Host Mechanical Interactions in the State of Stress and Growth of Solid Tumors	PLOS ONE			English	Article							INTERSTITIAL FLOW; RESIDUAL-STRESS; FLUID PRESSURE; CANCER-CELLS; MICROENVIRONMENT; FIBROBLASTS; PROGRESSION; MULTISCALE; FORCES	Mechanical forces play a crucial role in tumor patho-physiology. Compression of cancer cells inhibits their proliferation rate, induces apoptosis and enhances their invasive and metastatic potential. Additionally, compression of intratumor blood vessels reduces the supply of oxygen, nutrients and drugs, affecting tumor progression and treatment. Despite the great importance of the mechanical microenvironment to the pathology of cancer, there are limited studies for the constitutive modeling and the mechanical properties of tumors and on how these parameters affect tumor growth. Also, the contribution of the host tissue to the growth and state of stress of the tumor remains unclear. To this end, we performed unconfined compression experiments in two tumor types and found that the experimental stress-strain response is better fitted to an exponential constitutive equation compared to the widely used neo-Hookean and Blatz-Ko models. Subsequently, we incorporated the constitutive equations along with the corresponding values of the mechanical properties - calculated by the fit - to a biomechanical model of tumor growth. Interestingly, we found that the evolution of stress and the growth rate of the tumor are independent from the selection of the constitutive equation, but depend strongly on the mechanical interactions with the surrounding host tissue. Particularly, model predictions - in agreement with experimental studies - suggest that the stiffness of solid tumors should exceed a critical value compared with that of the surrounding tissue in order to be able to displace the tissue and grow in size. With the use of the model, we estimated this critical value to be on the order of 1.5. Our results suggest that the direct effect of solid stress on tumor growth involves not only the inhibitory effect of stress on cancer cell proliferation and the induction of apoptosis, but also the resistance of the surrounding tissue to tumor expansion.	[Voutouri, Chrysovalantis; Mpekris, Fotios; Papageorgis, Panagiotis; Stylianopoulos, Triantafyllos] Univ Cyprus, Dept Mech & Mfg Engn, Canc Biophys Lab, Nicosia, Cyprus; [Odysseos, Andreani D.] EPOS Iasis R&D, Div Biomed Res, Nicosia, Cyprus; [Odysseos, Andreani D.] Univ Cyprus, Dept Elect & Comp Engn, Biomed Imaging Lab, Nicosia, Cyprus	University of Cyprus; University of Cyprus	Stylianopoulos, T (corresponding author), Univ Cyprus, Dept Mech & Mfg Engn, Canc Biophys Lab, Nicosia, Cyprus.	tstylian@ucy.ac.cy	Stylianopoulos, Triantafyllos/AGF-9544-2022; Papageorgis, Panagiotis/J-5711-2019	Stylianopoulos, Triantafyllos/0000-0002-3093-1696; Papageorgis, Panagiotis/0000-0002-7595-5616; Voutouri, Chrysovalantis/0000-0003-3172-9489; Mpekris, Fotios/0000-0002-7125-4062	European Research Council under the European Union's Seventh Framework Programme (FP7)/ERC [336839, 286125]	European Research Council under the European Union's Seventh Framework Programme (FP7)/ERC(European Research Council (ERC))	The research leading to these results has received funding from the European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC grant agreement no 336839-ReEngineeringCancer to TS and FP7-PEOPLE-2011-IAPP grant agreement no 286125-NANORESISTANCE to ADO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. URLs: http://erc.europa.eu/; http://ucy.ac.cy/en/; http://ec.europa.eu/index_en.htm.	Ambrosi D, 2002, INT J ENG SCI, V40, P1297, DOI 10.1016/S0020-7225(02)00014-9; Ambrosi D, 2009, BIOMECH MODEL MECHAN, V8, P397, DOI 10.1007/s10237-008-0145-y; BOUCHER Y, 1990, CANCER RES, V50, P4478; Branton MH, 1999, MICROBES INFECT, V1, P1349, DOI 10.1016/S1286-4579(99)00250-6; Butcher DT, 2009, NAT REV CANCER, V9, P108, DOI 10.1038/nrc2544; Byrne H, 2003, MATH MED BIOL, V20, P341; Chauhan VP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3516; Cheng G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004632; Ciarletta P, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.158102; Demou ZN, 2010, ANN BIOMED ENG, V38, P3509, DOI 10.1007/s10439-010-0097-0; Egeblad M, 2010, CURR OPIN CELL BIOL, V22, P697, DOI 10.1016/j.ceb.2010.08.015; Fung Y.C., 1993, BIOMECHANICS MECH PR; Hagendoorn J, 2006, CANCER RES, V66, P3360, DOI 10.1158/0008-5472.CAN-05-2655; Helmlinger G, 1997, NAT BIOTECHNOL, V15, P778, DOI 10.1038/nbt0897-778; Jain RK, 2014, ANNU REV BIOMED ENG, V16, P321, DOI 10.1146/annurev-bioeng-071813-105259; Jain RK, 2010, NAT REV CLIN ONCOL, V7, P653, DOI 10.1038/nrclinonc.2010.139; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Karagiannis GS, 2012, MOL CANCER RES, V10, P1403, DOI 10.1158/1541-7786.MCR-12-0307; Kaufman LJ, 2005, BIOPHYS J, V89, P635, DOI 10.1529/biophysj.105.061994; Kim Y, 2011, PROG BIOPHYS MOL BIO, V106, P353, DOI 10.1016/j.pbiomolbio.2011.06.006; Levental I, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/19/194120; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; MacLaurin J, 2012, P ROY SOC A-MATH PHY, V468, P4123, DOI 10.1098/rspa.2012.0418; Nagy JA, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006544; Netti PA, 2000, CANCER RES, V60, P2497; Omens JH, 1998, J BIOMECH ENG-T ASME, V120, P715, DOI 10.1115/1.2834884; Padera TP, 2004, NATURE, V427, P695, DOI 10.1038/427695a; Plodinec M, 2012, NAT NANOTECHNOL, V7, P757, DOI [10.1038/nnano.2012.167, 10.1038/NNANO.2012.167]; Provenzano PP, 2012, CANCER CELL, V21, P418, DOI 10.1016/j.ccr.2012.01.007; RODRIGUEZ EK, 1994, J BIOMECH, V27, P455, DOI 10.1016/0021-9290(94)90021-3; Roose T, 2003, MICROVASC RES, V66, P204, DOI 10.1016/S0026-2862(03)00057-8; Roy S, 2005, AM J PHYSIOL-HEART C, V289, pH1567, DOI 10.1152/ajpheart.00564.2004; Sander EA, 2009, IEEE ENG MED BIOL, V28, P10, DOI 10.1109/MEMB.2009.932486; Santner SJ, 2001, BREAST CANCER RES TR, V65, P101, DOI 10.1023/A:1006461422273; Sarntinoranont M, 2003, ANN BIOMED ENG, V31, P327, DOI 10.1114/1.1554923; Shieh AC, 2011, ANN BIOMED ENG, V39, P1379, DOI 10.1007/s10439-011-0252-2; Stylianopoulos T, 2007, J BIOMECH ENG-T ASME, V129, P611, DOI 10.1115/1.2746387; Stylianopoulos T, 2013, P NATL ACAD SCI USA, V110, P18632, DOI 10.1073/pnas.1318415110; Stylianopoulos T, 2013, CANCER RES, V73, P3833, DOI 10.1158/0008-5472.CAN-12-4521; Stylianopoulos T, 2012, P NATL ACAD SCI USA, V109, P15101, DOI 10.1073/pnas.1213353109; Swartz MA, 2007, ANNU REV BIOMED ENG, V9, P229, DOI 10.1146/annurev.bioeng.9.060906.151850; Swartz MA, 2012, NAT REV CANCER, V12, P210, DOI 10.1038/nrc3186; Taber LA, 2008, BIOMECH MODEL MECHAN, V7, P427, DOI 10.1007/s10237-007-0106-x; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Tse JM, 2012, P NATL ACAD SCI USA, V109, P911, DOI 10.1073/pnas.1118910109; Wipff PJ, 2007, J CELL BIOL, V179, P1311, DOI 10.1083/jcb.200704042; Wirtz D, 2011, NAT REV CANCER, V11, P512, DOI 10.1038/nrc3080; Xu G, 2009, BIOMECH MODEL MECHAN, V8, P253, DOI 10.1007/s10237-008-0131-4	48	64	64	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2014	9	8							e104717	10.1371/journal.pone.0104717	http://dx.doi.org/10.1371/journal.pone.0104717			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WB	25111061	Green Published, gold, Green Submitted			2022-12-27	WOS:000341105100092
J	Possidonio, ACB; Soares, CP; Portilho, DM; Midlej, V; Benchimol, M; Butler-Browne, G; Costa, ML; Mermelstein, C				Batista Possidonio, Ana Claudia; Soares, Carolina Pontes; Portilho, Debora Morueco; Midlej, Victor; Benchimol, Marlene; Butler-Browne, Gillian; Costa, Manoel Luis; Mermelstein, Claudia			Differences in the Expression and Distribution of Flotillin-2 in Chick, Mice and Human Muscle Cells	PLOS ONE			English	Article							CHOLESTEROL DEPLETION; MYOTUBE FORMATION; SURFACE PROTEINS; MYOBLAST FUSION; DIFFERENTIATION; CULTURES; DESMIN; RICH	Myoblasts undergo a series of changes in the composition and dynamics of their plasma membranes during the initial steps of skeletal muscle differentiation. These changes are crucial requirements for myoblast fusion and allow the formation of striated muscle fibers. Membrane microdomains, or lipid rafts, have been implicated in myoblast fusion. Flotillins are scaffold proteins that are essential for the formation and dynamics of lipid rafts. Flotillins have been widely studied over the last few years, but still little is known about their role during skeletal muscle differentiation. In the present study, we analyzed the expression and distribution of flotillin-2 in chick, mice and human muscle cells grown in vitro. Primary cultures of chick myogenic cells showed a decrease in the expression of flotillin-2 during the first 72 hours of muscle differentiation. Interestingly, flotillin-2 was found to be highly expressed in chick myogenic fibroblasts and weakly expressed in chick myoblasts and multinucleated myotubes. Flotillin-2 was distributed in vesicle-like structures within the cytoplasm of chick myogenic fibroblasts, in the mouse C2C12 myogenic cell line, and in neonatal human muscle cells. Cryo-immunogold labeling revealed the presence of flotillin-2 in vesicles and in Golgi stacks in chick myogenic fibroblasts. Further, brefeldin A induced a major reduction in the number of flotillin-2 containing vesicles which correlates to a decrease in myoblast fusion. These results suggest the involvement of flotillin-2 during the initial steps of skeletal myogenesis.	[Batista Possidonio, Ana Claudia; Soares, Carolina Pontes; Costa, Manoel Luis; Mermelstein, Claudia] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Lab Diferenciacao Muscular & Citoesqueleto, Rio De Janeiro, Brazil; [Portilho, Debora Morueco; Butler-Browne, Gillian] Univ Paris 06, Paris, France; [Midlej, Victor; Benchimol, Marlene] Univ Santa Ursula, Lab Ultraestrutura Celular, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; UDICE-French Research Universities; Sorbonne Universite	Mermelstein, C (corresponding author), Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Lab Diferenciacao Muscular & Citoesqueleto, Rio De Janeiro, Brazil.	mermelstein@ufrj.br	Mouly, Gillian/G-6595-2017; mermelstein, Claudia S/C-1464-2010; Costa, Manoel/B-5009-2010; Midlej, Victor/AFU-1569-2022	mermelstein, Claudia S/0000-0002-8897-8526; Costa, Manoel/0000-0002-9037-0085; butler-browne, gillian/0000-0002-3431-242X; do Valle Pereira Midlej, Victor/0000-0001-9294-6597	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao Carlos Chagas Filho de Apoio a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Fundacao do Cancer/Programa de Oncobiologia	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Carlos Chagas Filho de Apoio a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Fundacao do Cancer/Programa de Oncobiologia	This work was supported by Brazilian grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Fundacao Carlos Chagas Filho de Apoio a Pesquisa do Estado do Rio de Janeiro (FAPERJ), and Fundacao do Cancer/Programa de Oncobiologia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banning A, 2011, CURR PROTEIN PEPT SC, V12, P725, DOI 10.2174/138920311798841708; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Costa ML, 2004, BRAZ J MED BIOL RES, V37, P1819, DOI 10.1590/S0100-879X2004001200007; Draeger A, 2003, DEV BIOL, V262, P324, DOI 10.1016/S0012-1606(03)00398-1; Edom-Vovard F, 1999, J CELL SCI, V112, P191; Gagescu R, 2000, MOL BIOL CELL, V11, P2775, DOI 10.1091/mbc.11.8.2775; ICHIKAWA K, 1993, EXP CELL RES, V209, P333, DOI 10.1006/excr.1993.1318; Langhorst MF, 2008, EUR J CELL BIOL, V87, P211, DOI 10.1016/j.ejcb.2007.12.001; Mermelstein CS, 2005, CELL TISSUE RES, V319, P289, DOI 10.1007/s00441-004-1004-5; Portilho DM, 2012, EUR J PHARMACOL, V694, P1, DOI 10.1016/j.ejphar.2012.07.035; Reuter A, 2004, CELL MOL LIFE SCI, V61, P2092, DOI 10.1007/s00018-004-4193-x; Royle SJ, 2003, BIOESSAYS, V25, P39, DOI 10.1002/bies.10200; Schulte T, 1997, DEVELOPMENT, V124, P577; Sciaky N, 1997, J CELL BIOL, V139, P1137, DOI 10.1083/jcb.139.5.1137; TOKUYASU KT, 1986, J MICROSC-OXFORD, V143, P139, DOI 10.1111/j.1365-2818.1986.tb02772.x; van den Eijnde SM, 2001, J CELL SCI, V114, P3631; Volonte D, 1999, J BIOL CHEM, V274, P12702, DOI 10.1074/jbc.274.18.12702; Volonte D, 2003, MOL BIOL CELL, V14, P4075, DOI 10.1091/mbc.E03-03-0161; Yablonka-Reuveni Z, 2001, J HISTOCHEM CYTOCHEM, V49, P455, DOI 10.1177/002215540104900405; ZESCHNIGK M, 1995, J CELL SCI, V108, P2973	20	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2014	9	8							e103990	10.1371/journal.pone.0103990	http://dx.doi.org/10.1371/journal.pone.0103990			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR0CG	25105415	Green Published, Green Submitted, gold			2022-12-27	WOS:000343231900034
J	Hoeft, F; Dai, L; Haas, BW; Sheau, K; Mimura, M; Mills, D; Galaburda, A; Bellugi, U; Korenberg, JR; Reiss, AL				Hoeft, Fumiko; Dai, Li; Haas, Brian W.; Sheau, Kristen; Mimura, Masaru; Mills, Debra; Galaburda, Albert; Bellugi, Ursula; Korenberg, Julie R.; Reiss, Allan L.			Mapping Genetically Controlled Neural Circuits of Social Behavior and Visuo-Motor Integration by a Preliminary Examination of Atypical Deletions with Williams Syndrome	PLOS ONE			English	Article							FUSIFORM FACE AREA; FRAGILE-X-SYNDROME; BEUREN-SYNDROME; CHROMOSOME 7Q11.23; SPATIAL-PATTERNS; COGNITION; GENE; AMYGDALA; PHENOTYPES; GTF2IRD1	In this study of eight rare atypical deletion cases with Williams-Beuren syndrome (WS; also known as 7q11.23 deletion syndrome) consisting of three different patterns of deletions, compared to typical WS and typically developing (TD) individuals, we show preliminary evidence of dissociable genetic contributions to brain structure and human cognition. Univariate and multivariate pattern classification results of morphometric brain patterns complemented by behavior implicate a possible role for the chromosomal region that includes: 1) GTF2I/GTF2IRD1 in visuo-spatial/motor integration, intraparietal as well as overall gray matter structures, 2) the region spanning ABHD11 through RFC2 including LIMK1, in social cognition, in particular approachability, as well as orbitofrontal, amygdala and fusiform anatomy, and 3) the regions including STX1A, and/or CYLN2 in overall white matter structure. This knowledge contributes to our understanding of the role of genetics on human brain structure, cognition and pathophysiology of altered cognition in WS. The current study builds on ongoing research designed to characterize the impact of multiple genes, gene-gene interactions and changes in gene expression on the human brain.	[Hoeft, Fumiko; Haas, Brian W.; Sheau, Kristen; Reiss, Allan L.] Stanford Univ, Sch Med, Ctr Interdisciplinary Brain Sci Res, Stanford, CA 94305 USA; [Hoeft, Fumiko; Mimura, Masaru] Keio Univ, Sch Med, Dept Neuropsychiat, Tokyo, Japan; [Dai, Li; Korenberg, Julie R.] Univ Utah, Dept Pediat, Salt Lake City, UT 84132 USA; [Dai, Li; Korenberg, Julie R.] Univ Utah, Inst Brain, Ctr Integrated Neurosci & Human Behav, Salt Lake City, UT USA; [Haas, Brian W.] Univ Georgia, Dept Psychol, Athens, GA 30602 USA; [Mills, Debra] Bangor Univ, Sch Psychol, Bangor, Gwynedd, Wales; [Galaburda, Albert] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Neurol, Cambridge, MA 02138 USA; [Bellugi, Ursula] Salk Inst Biol Studies, Cognit Neurosci Lab, La Jolla, CA 92037 USA; [Reiss, Allan L.] Stanford Univ, Sch Med, Dept Radiol, Stanford, CA 94305 USA; [Reiss, Allan L.] Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA	Stanford University; Keio University; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University System of Georgia; University of Georgia; Bangor University; Harvard University; Beth Israel Deaconess Medical Center; Salk Institute; Stanford University; Stanford University	Korenberg, JR (corresponding author), Univ Utah, Dept Pediat, Salt Lake City, UT 84132 USA.	Julie.korenberg@hsc.utah.edu; reiss@stanford.edu			NICHD [P01 HD033113, R01 HD049653-S1, K23 HD054720]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD033113, K23HD054720, R01HD049653] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH019908] Funding Source: NIH RePORTER	NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was funded by NICHD P01 HD033113 and NICHD R01 HD049653-S1. FH was funded by NICHD K23 HD054720. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 1998, NATURE, V393, P470, DOI 10.1038/30982; Antonell A, 2010, J MED GENET, V47, P312, DOI 10.1136/jmg.2009.071712; Bar-On R, 2003, BRAIN, V126, P1790, DOI 10.1093/brain/awg177; Beery  K., 1997, DEV TEST VISUAL MOTO; Benton A.L., 1994, CONTRIBUTIONS NEUROP; BERNARD O, 1994, CELL GROWTH DIFFER, V5, P1159; Blair RJR, 2001, J NEUROL NEUROSUR PS, V71, P727, DOI 10.1136/jnnp.71.6.727; Caraveo G, 2006, SCIENCE, V314, P122, DOI 10.1126/science.1127815; Dai L, 2009, AM J MED GENET A, V149A, P302, DOI 10.1002/ajmg.a.32652; Davidson RJ, 2000, SCIENCE, V289, P591, DOI 10.1126/science.289.5479.591; De Martino F, 2008, NEUROIMAGE, V43, P44, DOI 10.1016/j.neuroimage.2008.06.037; Edelmann L, 2007, J MED GENET, V44, P136, DOI 10.1136/jmg.2006.044537; Etkin A, 2010, AM J PSYCHIAT, V167, P545, DOI 10.1176/appi.ajp.2009.09070931; Fine C, 2001, BRAIN, V124, P287, DOI 10.1093/brain/124.2.287; Formisano E, 2008, SCIENCE, V322, P970, DOI 10.1126/science.1164318; Frangiskakis JM, 1996, CELL, V86, P59, DOI 10.1016/S0092-8674(00)80077-X; Fujiwara T, 2006, J NEUROSCI, V26, P5767, DOI 10.1523/JNEUROSCI.0289-06.2006; Golarai G, 2010, J NEUROSCI, V30, P6700, DOI 10.1523/JNEUROSCI.4268-09.2010; Gothelf D, 2011, J PSYCHIATR RES, V45, P322, DOI 10.1016/j.jpsychires.2010.07.008; Gray V, 2006, NEUROPSYCHOLOGIA, V44, P679, DOI 10.1016/j.neuropsychologia.2005.08.007; Haas BW, 2012, GENES BRAIN BEHAV, V11, P62, DOI 10.1111/j.1601-183X.2011.00733.x; Haas BW, 2009, J NEUROSCI, V29, P1132, DOI 10.1523/JNEUROSCI.5324-08.2009; Hillier LW, 2003, NATURE, V424, P157, DOI 10.1038/nature01782; Hirota H, 2003, GENET MED, V5, P311, DOI 10.1097/01.GIM.0000076975.10224.67; Hocking DR, 2007, NEUROSCI BIOBEHAV RE; Hoeft F, 2008, ARCH GEN PSYCHIAT, V65, P1087, DOI 10.1001/archpsyc.65.9.1087; Hoeft F, 2011, ARCH GEN PSYCHIAT, V68, P295, DOI 10.1001/archgenpsychiatry.2010.153; Hoeft F, 2011, P NATL ACAD SCI USA, V108, P361, DOI 10.1073/pnas.1008950108; Hoogenraad CC, 1998, GENOMICS, V53, P348, DOI 10.1006/geno.1998.5529; Jabbi M, 2012, P NATL ACAD SCI USA, V109, pE860, DOI 10.1073/pnas.1114774109; Jackson SR, 2006, NEUROPSYCHOLOGIA, V44, P2589, DOI 10.1016/j.neuropsychologia.2006.08.002; Kanwisher N, 2006, PHILOS T R SOC B, V361, P2109, DOI 10.1098/rstb.2006.1934; Karmiloff-Smith A, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00168; Korbel JO, 2009, P NATL ACAD SCI USA, V106, P12031, DOI 10.1073/pnas.0813248106; Korenberg J.R., 2008, INBORN ERRORS DEV MO, P1544; Korenberg JR, 2000, J COGNITIVE NEUROSCI, V12, P89, DOI 10.1162/089892900562002; Li HH, 2009, EMBO MOL MED, V1, P50, DOI 10.1002/emmm.200900003; Marenco S, 2007, P NATL ACAD SCI USA, V104, P15117, DOI 10.1073/pnas.0704311104; Marzelli MJ, 2011, NEUROIMAGE, V55, P439, DOI 10.1016/j.neuroimage.2010.12.054; Meng YH, 2002, NEURON, V35, P121, DOI 10.1016/S0896-6273(02)00758-4; Meyer-Lindenberg A, 2006, NAT REV NEUROSCI, V7, P380, DOI 10.1038/nrn1906; Meyer-Lindenberg A, 2005, NAT NEUROSCI, V8, P991, DOI 10.1038/nn1494; Meyer-Lindenberg A, 2004, NEURON, V43, P623, DOI 10.1016/j.neuron.2004.08.014; Meyer-Lindenberg A, 2006, NAT REV NEUROSCI, V7, P818, DOI 10.1038/nrn1993; Mills DL, DEV NEUROPSYCHOLOGY; Osborne LR, 1999, GENOMICS, V57, P279, DOI 10.1006/geno.1999.5784; Palmer SJ, 2007, GENE EXPR PATTERNS, V7, P396, DOI 10.1016/j.modgep.2006.11.008; Pober BR, 2010, NEW ENGL J MED, V362, P239, DOI 10.1056/NEJMra0903074; PROSCHEL C, 1995, ONCOGENE, V11, P1271; Reiss AL, 2004, J NEUROSCI, V24, P5009, DOI 10.1523/JNEUROSCI.5272-03.2004; Sakurai T, 2011, AUTISM RES, V4, P28, DOI 10.1002/aur.169; Sparrow N, 2012, J NEUROSCI, V32, P5284, DOI 10.1523/JNEUROSCI.6207-11.2012; Tanaka H, 2011, PSYCHOL SCI, V22, P1442, DOI 10.1177/0956797611419521; Tassabehji M, 1999, AM J HUM GENET, V64, P118, DOI 10.1086/302214; Wang YK, 1998, GENOMICS, V48, P163, DOI 10.1006/geno.1997.5182; Wang YK, 1999, GENOMICS, V57, P235, DOI 10.1006/geno.1999.5773; Wechsler D., 1991, WISC 3 WECHSLER INTE; Wechsler D., 1997, WECHSLER ADULT INTEL; Young EJ, 2007, GENES BRAIN BEHAV	59	17	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2014	9	8							e104088	10.1371/journal.pone.0104088	http://dx.doi.org/10.1371/journal.pone.0104088			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR0CG	25105779	Green Published, Green Submitted, gold			2022-12-27	WOS:000343231900037
J	Kleessen, S; Klie, S; Nikoloski, Z				Kleessen, Sabrina; Klie, Sebastian; Nikoloski, Zoran			Concurrent Conditional Clustering of Multiple Networks: COCONETS	PLOS ONE			English	Article							COMMUNITY STRUCTURE; GENETIC INTERACTIONS; ESCHERICHIA-COLI; COMPLEX NETWORKS; MODULARITY; TRANSCRIPTION	The accumulation of high-throughput data from different experiments has facilitated the extraction of condition-specific networks over the same set of biological entities. Comparing and contrasting of such multiple biological networks is in the center of differential network biology, aiming at determining general and condition-specific responses captured in the network structure (i.e., included associations between the network components). We provide a novel way for comparison of multiple networks based on determining network clustering (i.e., partition into communities) which is optimal across the set of networks with respect to a given cluster quality measure. To this end, we formulate the optimization-based problem of concurrent conditional clustering of multiple networks, termed COCONETS, based on the modularity. The solution to this problem is a clustering which depends on all considered networks and pinpoints their preserved substructures. We present theoretical results for special classes of networks to demonstrate the implications of conditionality captured by the COCONETS formulation. As the problem can be shown to be intractable, we extend an existing efficient greedy heuristic and applied it to determine concurrent conditional clusters on coexpression networks extracted from publically available time-resolved transcriptomics data of Escherichia coli under five stresses as well as on metabolite correlation networks from metabolomics data set from Arabidopsis thaliana exposed to eight environmental conditions. We demonstrate that the investigation of the differences between the clustering based on all networks with that obtained from a subset of networks can be used to quantify the specificity of biological responses. While a comparison of the Escherichia coli coexpression networks based on seminal properties does not pinpoint biologically relevant differences, the common network substructures extracted by COCONETS are supported by existing experimental evidence. Therefore, the comparison of multiple networks based on concurrent conditional clustering offers a novel venue for detection and investigation of preserved network substructures.	[Kleessen, Sabrina; Nikoloski, Zoran] Max Planck Inst Mol Plant Physiol, Syst Biol & Math Modeling Grp, Potsdam, Germany; [Klie, Sebastian] Max Planck Inst Mol Plant Physiol, Genes & Small Mol Grp, Potsdam, Germany	Max Planck Society; Max Planck Society	Nikoloski, Z (corresponding author), Max Planck Inst Mol Plant Physiol, Syst Biol & Math Modeling Grp, Potsdam, Germany.	nikoloski@mpimp-golm.mpg.de		Nikoloski, Zoran/0000-0003-2671-6763	Max Planck Society	Max Planck Society(Max Planck SocietyFoundation CELLEX)	This work was supported by the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barker MM, 2001, J MOL BIOL, V305, P673, DOI 10.1006/jmbi.2000.4327; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Boone C, 2007, NAT REV GENET, V8, P437, DOI 10.1038/nrg2085; Brandes U, 2008, IEEE T KNOWL DATA EN, V20, P172, DOI 10.1109/TKDE.2007.190689; Caldana C, 2011, PLANT J, V67, P869, DOI 10.1111/j.1365-313X.2011.04640.x; Duch J, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.027104; Fisher D. H., 1987, Machine Learning, V2, P139, DOI 10.1007/BF00114265; Fred A., 2001, Multiple Classifier Systems. Second International Workshop, MCS 2001. Proceedings (Lecture Notes in Computer Science Vol.2096), P309; Gaertler M, 2005, LECT NOTES COMPUT SC, V3418, P178; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Guimera R, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.025101; Harrison R, 2007, P NATL ACAD SCI USA, V104, P2307, DOI 10.1073/pnas.0607153104; Ideker T, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2011.99; Ji HK, 2010, NAT BIOTECHNOL, V28, P337, DOI 10.1038/nbt.1619; Jozefczuk S, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.18; Kannan R, 2004, J ACM, V51, P497, DOI 10.1145/990308.990313; Klie S, 2012, MOL BIOSYST, V8, P2233, DOI 10.1039/c2mb25089f; Lemuth K, 2008, APPL ENVIRON MICROB, V74, P7002, DOI 10.1128/AEM.01327-08; Mucha PJ, 2010, SCIENCE, V328, P876, DOI 10.1126/science.1184819; Narayanan M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000742; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman MEJ, 2012, NAT PHYS, V8, P25, DOI 10.1038/nphys2162; Newman MEJ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066133; RAND WM, 1971, J AM STAT ASSOC, V66, P846, DOI 10.2307/2284239; Reed JL, 2008, NATURE REV GENETICS, V7, P130; Reichardt J, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.016110; Rivals I, 2007, BIOINFORMATICS, V23, P401, DOI 10.1093/bioinformatics/btl633; Topchy A, 2003, THIRD IEEE INTERNATIONAL CONFERENCE ON DATA MINING, PROCEEDINGS, P331; Vinh NX, 2010, J MACH LEARN RES, V11, P2837; Wang L, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-147; Weber H, 2005, J BACTERIOL, V187, P1591, DOI 10.1128/JB.187.5.1591-1603.2005; White S., 2005, P SIAM INT C DAT MIN, P76	34	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2014	9	8							e103637	10.1371/journal.pone.0103637	http://dx.doi.org/10.1371/journal.pone.0103637			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR0CG	25105292	Green Published, gold, Green Submitted			2022-12-27	WOS:000343231900019
J	Semple, BD; Noble-Haeusslein, LJ; Kwon, YJ; Sam, PN; Gibson, AM; Grissom, S; Brown, S; Adahman, Z; Hollingsworth, CA; Kwakye, A; Gimlin, K; Wilde, EA; Hanten, G; Levin, HS; Schenk, AK				Semple, Bridgette D.; Noble-Haeusslein, Linda J.; Kwon, Yong Jun; Sam, Pingdewinde N.; Gibson, A. Matt; Grissom, Sarah; Brown, Sienna; Adahman, Zahra; Hollingsworth, Christopher A.; Kwakye, Alexander; Gimlin, Kayleen; Wilde, Elisabeth A.; Hanten, Gerri; Levin, Harvey S.; Schenk, A. Katrin			Sociosexual and Communication Deficits after Traumatic Injury to the Developing Murine Brain	PLOS ONE			English	Article							MOUSE ULTRASONIC VOCALIZATIONS; SCENT MARKING BEHAVIOR; MICE MUS-DOMESTICUS; SOCIAL COGNITION; C57BL/6J MICE; HOUSE MICE; VOCAL COMMUNICATION; COPULATORY-BEHAVIOR; CORPUS-CALLOSUM; SEXUAL-BEHAVIOR	Despite the life-long implications of social and communication dysfunction after pediatric traumatic brain injury, there is a poor understanding of these deficits in terms of their developmental trajectory and underlying mechanisms. In a well-characterized murine model of pediatric brain injury, we recently demonstrated that pronounced deficits in social interactions emerge across maturation to adulthood after injury at postnatal day (p) 21, approximating a toddler-aged child. Extending these findings, we here hypothesized that these social deficits are dependent upon brain maturation at the time of injury, and coincide with abnormal sociosexual behaviors and communication. Age-dependent vulnerability of the developing brain to social deficits was addressed by comparing behavioral and neuroanatomical outcomes in mice injured at either a pediatric age (p21) or during adolescence (p35). Sociosexual behaviors including social investigation and mounting were evaluated in a resident-intruder paradigm at adulthood. These outcomes were complemented by assays of urine scent marking and ultrasonic vocalizations as indices of social communication. We provide evidence of sociosexual deficits after brain injury at p21, which manifest as reduced mounting behavior and scent marking towards an unfamiliar female at adulthood. In contrast, with the exception of the loss of social recognition in a three-chamber social approach task, mice that received TBI at adolescence were remarkably resilient to social deficits at adulthood. Increased emission of ultrasonic vocalizations (USVs) as well as preferential emission of high frequency USVs after injury was dependent upon both the stimulus and prior social experience. Contrary to the hypothesis that changes in white matter volume may underlie social dysfunction, injury at both p21 and p35 resulted in a similar degree of atrophy of the corpus callosum by adulthood. However, loss of hippocampal tissue was greater after p21 compared to p35 injury, suggesting that a longer period of lesion progression or differences in the kinetics of secondary pathogenesis after p21 injury may contribute to observed behavioral differences. Together, these findings indicate vulnerability of the developing brain to social dysfunction, and suggest that a younger age-at-insult results in poorer social and sociosexual outcomes.	[Semple, Bridgette D.; Noble-Haeusslein, Linda J.; Sam, Pingdewinde N.; Gimlin, Kayleen] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; [Semple, Bridgette D.] Univ Melbourne, Dept Med, Melbourne Brain Ctr, Royal Melbourne Hosp, Parkville, Vic 3052, Australia; [Noble-Haeusslein, Linda J.] Univ Calif San Francisco, Dept Phys Therapy & Rehabil, San Francisco, CA 94143 USA; [Kwon, Yong Jun; Gibson, A. Matt; Grissom, Sarah; Brown, Sienna; Adahman, Zahra; Hollingsworth, Christopher A.; Kwakye, Alexander; Schenk, A. Katrin] Randolph Coll, Dept Phys, Lynchburg, VA USA; [Sam, Pingdewinde N.] San Francisco State Univ, San Francisco, CA 94132 USA; [Wilde, Elisabeth A.; Hanten, Gerri; Levin, Harvey S.] Baylor Coll Med, Phys Med & Rehabil Alliance, Houston, TX 77030 USA; [Wilde, Elisabeth A.; Hanten, Gerri; Levin, Harvey S.] Univ Texas Houston, Sch Med, Houston, TX USA; [Wilde, Elisabeth A.; Levin, Harvey S.] Michael E DeBakey VA Med Ctr, Houston, TX USA	University of California System; University of California San Francisco; Royal Melbourne Hospital; University of Melbourne; University of California System; University of California San Francisco; California State University System; San Francisco State University; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine	Semple, BD (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA.	Bridgette.Semple@ucsf.edu	Tercovich, Kayleen/I-8941-2018	Tercovich, Kayleen/0000-0003-0450-8912; Semple, Bridgette/0000-0002-2535-0491; Adahman, Zahra/0000-0001-6306-6486	National Institutes of Health/National Institute of Neurological Disorders and Stroke [NS050159, NS077767]; National Health and Medical Research Council of Australia [1052505]; Randolph College start-up funds; Division Of Human Resource Development [1302873] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T34GM008574, R25GM059298] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS077767, R01NS050159] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Randolph College start-up funds; Division Of Human Resource Development(National Science Foundation (NSF)NSF- Directorate for Education & Human Resources (EHR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding was provided by National Institutes of Health/National Institute of Neurological Disorders and Stroke (http://www.ninds.nih.gov/), R01 #NS050159 and #NS077767 (awarded to LJNH), a CJ Martin Overseas Biomedical Postdoctoral Fellowship from the National Health and Medical Research Council of Australia (https://www.nhmrc.gov.au/) #1052505(awarded to BDS), and Randolph College start-up funds (AKS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acerini CL, 2007, PITUITARY, V10, P373, DOI 10.1007/s11102-007-0052-8; Anderson V, 1995, CHILD NEUROPSYCHOL, V1, P187, DOI 10.1080/09297049508400224; Anderson V, 2010, J NEUROTRAUM, V27, P863, DOI 10.1089/neu.2009.1169; Arakawa H, 2008, BEHAV BRAIN RES, V190, P97, DOI 10.1016/j.bbr.2008.02.009; Arakawa H, 2007, BEHAV BRAIN RES, V182, P73, DOI 10.1016/j.bbr.2007.05.007; Arriaga G, 2013, BRAIN LANG, V124, P96, DOI 10.1016/j.bandl.2012.10.002; BEAN NJ, 1982, PHYSIOL BEHAV, V28, P31, DOI 10.1016/0031-9384(82)90097-X; BEAN NJ, 1981, BRAIN RES BULL, V6, P109, DOI 10.1016/S0361-9230(81)80033-0; Beauchamp MH, 2013, CORTEX, V49, P591, DOI 10.1016/j.cortex.2012.08.015; Beauchamp MH, 2010, PSYCHOL BULL, V136, P39, DOI 10.1037/a0017768; Beauchamp MH, 2009, J NEUROTRAUM, V26, P1645, DOI [10.1089/neu.2009.0916, 10.1089/neu.2009-0916]; Bigler ED, 2013, NEUROREHABILITATION, V32, P707, DOI 10.3233/NRE-130896; Blakemore SJ, 2008, NAT REV NEUROSCI, V9, P267, DOI 10.1038/nrn2353; Bramlett HM, 2002, ACTA NEUROPATHOL, V103, P607, DOI 10.1007/s00401-001-0510-8; Broadbent NJ, 2004, P NATL ACAD SCI USA, V101, P14515, DOI 10.1073/pnas.0406344101; Bruell JH, 2006, ANN NY ACAD SCI, V159, P825; Catroppa C, 2012, J NEUROTRAUM, V29, P2539, DOI 10.1089/neu.2012.2403; Cattelani R, 1998, BRAIN INJURY, V12, P283, DOI 10.1080/026990598122584; Chabout J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029401; Chang EF, 2005, J CEREBR BLOOD F MET, V25, P1401, DOI 10.1038/sj.jcbfm.9600147; Chen CY, 2013, DEV NEUROSCI-BASEL, V35, P474, DOI 10.1159/000355874; Claus CP, 2010, DEV NEUROSCI-BASEL, V32, P454, DOI 10.1159/000316805; Crawley JN, 2007, BRAIN PATHOL, V17, P448, DOI 10.1111/j.1750-3639.2007.00096.x; Didus E, 1999, Pediatr Rehabil, V3, P177; Downing MG, 2013, J HEAD TRAUMA REHAB, V28, P171, DOI 10.1097/HTR.0b013e31828b4f63; Duvoisin RM, 2011, BEHAV BRAIN RES, V221, P50, DOI 10.1016/j.bbr.2011.02.049; Ewing-Cobbs L, 1997, J Int Neuropsychol Soc, V3, P581; Ewing-Cobbs L, 2008, NEUROIMAGE, V42, P1305, DOI 10.1016/j.neuroimage.2008.06.031; Ewing-Cobbs L, 2012, INT J DEV NEUROSCI, V30, P247, DOI 10.1016/j.ijdevneu.2011.07.004; Fairless AH, 2012, BEHAV BRAIN RES, V228, P299, DOI 10.1016/j.bbr.2011.12.001; Fan P, 2003, J NEUROTRAUM, V20, P437, DOI 10.1089/089771503765355513; Fischer J, 2011, GENES BRAIN BEHAV, V10, P17, DOI 10.1111/j.1601-183X.2010.00610.x; Frith CD, 2007, PHILOS T R SOC B, V362, P671, DOI 10.1098/rstb.2006.2003; Fyrberg A, 2007, INT J REHABIL RES, V30, P153; GEYER LA, 1978, J COMP PHYSIOL PSYCH, V92, P447, DOI 10.1037/h0077487; Giannantoni A, 2011, ARCH PHYS MED REHAB, V92, P1134, DOI 10.1016/j.apmr.2011.02.013; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Giordano Giulio, 2005, Pituitary, V8, P227, DOI 10.1007/s11102-006-6045-1; Hall CS, 1934, J COMP PSYCHOL, V18, P385, DOI 10.1037/h0071444; Hammerschmidt K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041133; Hanson JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040782; Heyes S. B., 2012, DEV SOCIAL NEUROSCIE, P325; Hoang TX, 2006, J NEUROSCI, V26, P8672, DOI 10.1523/JNEUROSCI.1259-06.2006; Hoofien D, 2001, BRAIN INJURY, V15, P189; Hurst JL, 2004, BIOESSAYS, V26, P1288, DOI 10.1002/bies.20147; Johnson MH, 2005, DEV PSYCHOPATHOL, V17, P599, DOI 10.1017/S0954579405050297; JORDAN FM, 1994, BRAIN INJURY, V8, P501, DOI 10.3109/02699059409151002; Karver CL, 2012, REHABIL PSYCHOL, V57, P256, DOI 10.1037/a0029522; Keightley ML, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00139; Kennedy BC, 2011, BEHAV PHARMACOL, V22, P147, DOI 10.1097/FBP.0b013e328343d7dd; Kennedy Sidney H, 2008, Dialogues Clin Neurosci, V10, P271; Kim S, 2012, NMR BIOMED, V25, P104, DOI 10.1002/nbm.1722; Kimura A, 2010, ANN NEUROL, V67, P794, DOI 10.1002/ana.22023; Kogan JH, 2000, HIPPOCAMPUS, V10, P47, DOI 10.1002/(SICI)1098-1063(2000)10:1<47::AID-HIPO5>3.0.CO;2-6; Kumar M, 2012, BRAIN RES, V1455, P56, DOI 10.1016/j.brainres.2012.03.041; Lehmann ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069822; Levin HS, 2004, J INT NEUROPSYCH SOC, V10, P305, DOI 10.1017/S1355617704102129; Leypold BG, 2002, P NATL ACAD SCI USA, V99, P6376, DOI 10.1073/pnas.082127599; MAGGIO JC, 1983, PHYSIOL BEHAV, V31, P269, DOI 10.1016/0031-9384(83)90186-5; Mahrt EJ, 2013, J NEUROSCI, V33, P5573, DOI 10.1523/JNEUROSCI.5054-12.2013; Manzo J, 2002, PHYSIOL BEHAV, V75; Matsumoto YK, 2012, NEUROREPORT, V23, P676, DOI 10.1097/WNR.0b013e3283557eea; McCall C, 2012, NAT NEUROSCI, V15, P681, DOI 10.1038/nn.3084; McDonald S., 2012, DEV SOCIAL NEUROSCIE, P325; McDonald S, 2008, ARCH PHYS MED REHAB, V89, P1648, DOI 10.1016/j.apmr.2008.02.029; McDonald S, 2013, J INT NEUROPSYCH SOC, V19, P528, DOI 10.1017/S1355617713000039; McFarlane HG, 2008, GENES BRAIN BEHAV, V7, P152, DOI 10.1111/j.1601-183X.2007.00330.x; McKinlay A, 2010, CHILD CARE HLTH DEV, V36, P22, DOI 10.1111/j.1365-2214.2009.00947.x; McKinlay A, 2013, J HEAD TRAUMA REHABI; Moreau OK, 2012, J NEUROTRAUM, V29, P81, DOI 10.1089/neu.2011.2048; Moy SS, 2008, MOL PSYCHIATR, V13, P4, DOI 10.1038/sj.mp.4002082; Moy SS, 2004, GENES BRAIN BEHAV, V3, P287, DOI 10.1111/j.1601-1848.2004.00076.x; Muscara F, 2009, NEUROPSYCHOL REHABIL, V19, P541, DOI 10.1080/09602010802365223; Musolf K, 2010, ANIM BEHAV, V79, P757, DOI 10.1016/j.anbehav.2009.12.034; NYBY J, 1976, BEHAV BIOL, V18, P285, DOI 10.1016/S0091-6773(76)92198-2; NYBY J, 1983, BEHAV NEURAL BIOL, V38, P32, DOI 10.1016/S0163-1047(83)90354-0; NYBY J, 1992, HORM BEHAV, V26, P24, DOI 10.1016/0018-506X(92)90029-U; NYBY J, 1978, NEUROSCI BIOBEHAV R, V2, P1, DOI 10.1016/0149-7634(78)90003-9; Pandey DK, 2009, BEHAV BRAIN RES, V205, P436, DOI 10.1016/j.bbr.2009.07.027; Paul LK, 2007, NAT REV NEUROSCI, V8, P287, DOI 10.1038/nrn2107; Pobbe RLH, 2012, PHYSIOL BEHAV, V107, P641, DOI 10.1016/j.physbeh.2012.02.024; Pobbe RLH, 2012, HORM BEHAV, V61, P436, DOI 10.1016/j.yhbeh.2011.10.010; POMERANTZ SM, 1983, PHYSIOL BEHAV, V31, P91, DOI 10.1016/0031-9384(83)90101-4; Ponsford J, 2003, NEUROPSYCHOL REHABIL, V13, P275, DOI 10.1080/09602010244000363; Ponsford JL, 2013, J HEAD TRAUMA REHAB, V28, P195, DOI 10.1097/HTR.0b013e31828b4f7b; Portfors CV, 2007, J AM ASSOC LAB ANIM, V46, P28; Pullela R, 2006, DEV NEUROSCI-BASEL, V28, P396, DOI 10.1159/000094166; Richmond E, 2014, ENDOCRINE, V45, P3, DOI 10.1007/s12020-013-0049-1; Rose SR, 2012, PITUITARY, V15, P267, DOI 10.1007/s11102-011-0360-x; Rosema S, 2014, J NEUROTRAUM, V13, P13; Rosema S, 2012, J NEUROTRAUM, V29, P1277, DOI 10.1089/neu.2011.2144; Roullet FI, 2011, BEHAV BRAIN RES, V216; Ryan NP, 2014, J NEUROTRAUM, V31, P649, DOI 10.1089/neu.2013.3153; Ryan NP, 2013, INT J DEV NEUROSCI, V31, P811, DOI 10.1016/j.ijdevneu.2013.10.002; SALES GD, 1972, ANIM BEHAV, V20, P88, DOI 10.1016/S0003-3472(72)80177-5; Sander AM, 2012, ARCH PHYS MED REHAB, V93, P1331, DOI 10.1016/j.apmr.2012.03.037; Scattoni ML, 2011, GENES BRAIN BEHAV, V10, P44, DOI 10.1111/j.1601-183X.2010.00623.x; Scattoni ML, 2009, NEUROSCI BIOBEHAV R, V33, P508, DOI 10.1016/j.neubiorev.2008.08.003; Schmidt AT, 2010, NEUROPSYCHOLOGIA, V48, P2869, DOI 10.1016/j.neuropsychologia.2010.05.029; Semple BD, 2013, PROG NEUROBIOL, V106, P1, DOI 10.1016/j.pneurobio.2013.04.001; Semple BD, 2012, J NEUROTRAUM, V29, P2672, DOI 10.1089/neu.2012.2595; Sigurdardottir S, 2013, J REHABIL MED, V45, P808, DOI 10.2340/16501977-1156; Simpson GK, 2013, J HEAD TRAUMA REHAB, V28, P202, DOI 10.1097/HTR.0b013e31828dc5ae; SIPOS ML, 1992, BEHAV NEURAL BIOL, V58, P138, DOI 10.1016/0163-1047(92)90375-E; Slifer KJ, 2009, DEV DISABIL RES REV, V15, P144, DOI 10.1002/ddrr.60; Spikman JM, 2012, J NEUROTRAUM, V29, P101, DOI 10.1089/neu.2011.2084; Sullivan JR, 2010, APPL NEUROPSYCHOL, V17, P93, DOI 10.1080/09084281003708852; Terranova ML, 2005, CURR PROT TOXICOL; THOMSEN IV, 1975, J NEUROL NEUROSUR PS, V38, P713, DOI 10.1136/jnnp.38.7.713; Tlustos SJ, 2011, J INT NEUROPSYCH SOC, V17, P1132, DOI 10.1017/S1355617711001202; Tong W, 2002, EXP NEUROL, V176, P105, DOI 10.1006/exnr.2002.7941; van der Kooij MA, 2012, NEUROSCI BIOBEHAV R, V36, P1763, DOI 10.1016/j.neubiorev.2011.10.006; Veenema AH, 2012, HORM BEHAV, V61, P304, DOI 10.1016/j.yhbeh.2011.12.002; Wei L, 2011, J NEUROSCI, V31, P14335, DOI 10.1523/JNEUROSCI.1333-11.2011; Wells R, 2009, DEV NEUROREHABIL, V12, P12, DOI 10.1080/17518420902773109; White NR, 1998, PHYSIOL BEHAV, V63, P467, DOI 10.1016/S0031-9384(97)00484-8; WHITNEY G, 1973, J COMP PHYSIOL PSYCH, V84, P445, DOI 10.1037/h0034899; Whitney G, 1979, AM ZOOL, V19; Wilde EA, 2005, J NEUROTRAUM, V22, P333, DOI 10.1089/neu.2005.22.333; Willott JF, 2001, HDB MOUSE AUDITORY R; Wohr M, 2011, GENES BRAIN BEHAV, V10, P35, DOI 10.1111/j.1601-183X.2010.00582.x; Wohr M, 2013, BEHAV BRAIN RES, V251, P5, DOI 10.1016/j.bbr.2013.05.047; Wohr M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020631; Wu TC, 2010, DEV NEUROSCI-BASEL, V32, P361, DOI 10.1159/000317058; Yang M, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00159; Yang M, 2012, J NEUROSCI, V32, P6525, DOI 10.1523/JNEUROSCI.6107-11.2012; Yang Mu, 2011, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0826s56; Yang M, 2009, EUR J NEUROSCI, V29, P1663, DOI 10.1111/j.1460-9568.2009.06714.x; Yeates KO, 2007, PSYCHOL BULL, V133, P535, DOI 10.1037/0033-2909.133.3.535; Yeates KO, 2013, J INT NEUROPSYCH SOC, V19, P518, DOI 10.1017/S1355617712001531; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093; Ylvisaker Mark, 2007, Phys Med Rehabil Clin N Am, V18, P133, DOI 10.1016/j.pmr.2006.11.007; Young DM, 2010, P NATL ACAD SCI USA, V107, P11074, DOI 10.1073/pnas.1005620107	133	26	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2014	9	8							e103386	10.1371/journal.pone.0103386	http://dx.doi.org/10.1371/journal.pone.0103386			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR0CG	25106033	Green Published, gold			2022-12-27	WOS:000343231900011
J	Ohmomo, H; Hachiya, T; Shiwa, Y; Furukawa, R; Ono, K; Ito, S; Ishida, Y; Satoh, M; Hitomi, J; Sobue, K; Shimizu, A				Ohmomo, Hideki; Hachiya, Tsuyoshi; Shiwa, Yu; Furukawa, Ryohei; Ono, Kanako; Ito, Shigeki; Ishida, Yoji; Satoh, Mamoru; Hitomi, Jiro; Sobue, Kenji; Shimizu, Atsushi			Reduction of Systematic Bias in Transcriptome Data from Human Peripheral Blood Mononuclear Cells for Transportation and Biobanking	PLOS ONE			English	Article							GREAT EAST JAPAN; EXPRESSION; COLLECTION; EARTHQUAKE; PROFILES; TSUNAMI	Transportation of samples is essential for large-scale biobank projects. However, RNA degradation during pre-analytical operations prior to transportation can cause systematic bias in transcriptome data, which may prevent subsequent biomarker identification. Therefore, to collect high-quality biobank samples for expression analysis, specimens must be transported under stable conditions. In this study, we examined the effectiveness of RNA-stabilizing reagents to prevent RNA degradation during pre-analytical operations with an emphasis on RNA from peripheral blood mononuclear cells (PBMCs) to establish a protocol for reducing systematic bias. To this end, we obtained PBMCs from 11 healthy volunteers and analyzed the purity, yield, and integrity of extracted RNA after performing pre-analytical operations for freezing PBMCs at -80 degrees C. We randomly chose 7 samples from 11 samples individually, and systematic bias in expression levels was examined by real-time quantitative reverse transcription polymerase chain reaction (qRT-PCR), RNA sequencing (RNA-Seq) experiments and data analysis. Our data demonstrated that omission of stabilizing reagents significantly lowered RNA integrity, suggesting substantial degradation of RNA molecules due to pre-analytical freezing. qRT-PCR experiments for 19 selected transcripts revealed systematic bias in the expression levels of five transcripts. RNA-Seq for 25,223 transcripts also suggested that about 40% of transcripts were systematically biased. These results indicated that appropriate reduction in systematic bias is essential in protocols for collection of RNA from PBMCs for large-scale biobank projects. Among the seven commercially available stabilizing reagents examined in this study, qRT-PCR and RNA-Seq experiments consistently suggested that RNALock, RNA/DNA Stabilization Reagent for Blood and Bone Marrow, and 1-Thioglycerol/Homogenization solution could reduce systematic bias. On the basis of the results of this study, we established a protocol to reduce systematic bias in the expression levels of RNA transcripts isolated from PBMCs. We believe that these data provide a novel methodology for collection of high-quality RNA from PBMCs for biobank researchers.	[Ohmomo, Hideki; Hachiya, Tsuyoshi; Shiwa, Yu; Furukawa, Ryohei; Ono, Kanako; Satoh, Mamoru] Iwate Med Univ, Iwate Tohoku Med Megabank Org, Div Biobank & Data Management, Morioka, Iwate 020, Japan; [Hachiya, Tsuyoshi; Satoh, Mamoru; Shimizu, Atsushi] Iwate Med Univ, Iwate Tohoku Med Megabank Org, Div Biomed Informat Anal, Morioka, Iwate 020, Japan; [Ito, Shigeki; Ishida, Yoji] Iwate Med Univ, Sch Med, Dept Internal Med, Div Hematol & Oncol, Morioka, Iwate 020, Japan; [Satoh, Mamoru] Iwate Med Univ, Sch Med, Dept Internal Med, Div Cardioangiol, Morioka, Iwate 020, Japan; [Satoh, Mamoru] Iwate Med Univ, Sch Med, Mem Heart Ctr, Morioka, Iwate 020, Japan; [Hitomi, Jiro] Iwate Med Univ, Sch Med, Dept Anat, Morioka, Iwate 020, Japan; [Hitomi, Jiro; Sobue, Kenji] Iwate Med Univ, Iwate Tohoku Med Megabank Org, Morioka, Iwate 020, Japan; [Sobue, Kenji] Iwate Med Univ, Inst Biomed Sci, Dept Neurosci, Morioka, Iwate 020, Japan	Iwate Medical University; Iwate Medical University; Iwate Medical University; Iwate Medical University; Iwate Medical University; Iwate Medical University; Iwate Medical University; Iwate Medical University	Shimizu, A (corresponding author), Iwate Med Univ, Iwate Tohoku Med Megabank Org, Div Biomed Informat Anal, Morioka, Iwate 020, Japan.	ashimizu@iwate-med.ac.jp	Hachiya, Tsuyoshi/AAM-8691-2021	Hachiya, Tsuyoshi/0000-0002-5274-3266; Ohmomo, Hideki/0000-0002-3524-6524	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of the Japan	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of the Japan	This work was supported by a grant of the Tohoku Medical Megabank Project from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of the Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Al-Soud W, 2000, J CLIN MICROBIOL, V38, P4463; Aoki T, 2012, EUR HEART J, V33, P2796, DOI 10.1093/eurheartj/ehs288; Asare AL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-474; Baine MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017014; Bayatti N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087508; Burczynski ME, 2005, CLIN CANCER RES, V11, P1181; Debey S, 2004, PHARMACOGENOMICS J, V4, P193, DOI 10.1038/sj.tpj.6500240; Debey S, 2006, GENOMICS, V87, P653, DOI 10.1016/j.ygeno.2005.11.010; Elliott P, 2008, INT J EPIDEMIOL, V37, P234, DOI 10.1093/ije/dym276; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Nakamura M, 2012, AM J CARDIOL, V110, P1856, DOI 10.1016/j.amjcard.2012.08.020; Nederhand RJ, 2003, J THROMB HAEMOST, V1, P987, DOI 10.1046/j.1538-7836.2003.00216.x; Omama S, 2013, STROKE, V44, P1518, DOI 10.1161/STROKEAHA.111.000442; PAWLOWSKI NA, 1983, J EXP MED, V158, P393, DOI 10.1084/jem.158.2.393; Rainen L, 2002, CLIN CHEM, V48, P1883; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Steinberg K, 2002, EPIDEMIOLOGY, V13, P246, DOI 10.1097/00001648-200205000-00003; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Usami M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050721; Vartanian K, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-2; Wahlberg K, 2012, BIOPRESERV BIOBANK, V10, P266, DOI 10.1089/bio.2012.0004; Wright C, 2008, CLIN CHEM, V54, P396, DOI 10.1373/clinchem.2007.093419	25	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e104283	10.1371/journal.pone.0104283	http://dx.doi.org/10.1371/journal.pone.0104283			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25101803	Green Published, Green Submitted, gold			2022-12-27	WOS:000339993900055
J	Pavlova, V; Nabe-Nielsen, J; Dietz, R; Svenning, JC; Vorkamp, K; Riget, FF; Sonne, C; Letcher, RJ; Grimm, V				Pavlova, Viola; Nabe-Nielsen, Jacob; Dietz, Rune; Svenning, Jens-Christian; Vorkamp, Katrin; Riget, Frank Farso; Sonne, Christian; Letcher, Robert J.; Grimm, Volker			Field Metabolic Rate and PCB Adipose Tissue Deposition Efficiency in East Greenland Polar Bears Derived from Contaminant Monitoring Data	PLOS ONE			English	Article							DIGESTIVE-TRACT ABSORPTION; DOUBLY LABELED WATER; URSUS-MARITIMUS; RINGED SEALS; POLYCHLORINATED-BIPHENYLS; TEMPORAL TRENDS; PHOCA-HISPIDA; ICE; MASS; REQUIREMENTS	Climate change will increasingly affect the natural habitat and diet of polar bears (Ursus maritimus). Understanding the energetic needs of polar bears is therefore important. We developed a theoretical method for estimating polar bear food consumption based on using the highly recalcitrant polychlorinated biphenyl (PCB) congener, 2,2',4,4',55-hexaCB (CB153) in bear adipose tissue as an indicator of food intake. By comparing the CB153 tissue concentrations in wild polar bears with estimates from a purposely designed individual-based model, we identified the possible combinations of field metabolic rates (FMR) and CB153 deposition efficiencies in East Greenland polar bears. Our simulations indicate that if 30% of the CB153 consumed by polar bear individuals were deposited into their adipose tissue, the corresponding FMR would be only two times the basal metabolic rate. In contrast, if the modelled CB153 deposition efficiency were 10%, adult polar bears would require six times more energy than that needed to cover basal metabolism. This is considerably higher than what has been assumed for polar bears in previous studies though it is similar to FMRs found in other marine mammals. An implication of this result is that even relatively small reductions in future feeding opportunities could impact the survival of East Greenland polar bears.	[Pavlova, Viola; Nabe-Nielsen, Jacob; Dietz, Rune; Riget, Frank Farso; Sonne, Christian] Aarhus Univ, Dept Biosci, Sect Marine Mammal Res, Roskilde, Denmark; [Nabe-Nielsen, Jacob; Dietz, Rune; Vorkamp, Katrin; Sonne, Christian] Aarhus Univ, Arctic Res Ctr, Aarhus, Denmark; [Svenning, Jens-Christian] Aarhus Univ, Dept Biosci, Sect Ecoinformat & Biodivers, Aarhus, Denmark; [Vorkamp, Katrin] Aarhus Univ, Dept Environm Sci, Sect Environm Chem & Toxicol, Roskilde, Denmark; [Grimm, Volker] UFZ Helmholtz Ctr Environm Res, Dept Ecol Modelling, Leipzig, Germany; [Grimm, Volker] Univ Potsdam, Inst Biochem & Biol, Potsdam, Germany; [Letcher, Robert J.] Carleton Univ, Natl Wildlife Res Ctr, Environm Canada, Ecotoxicol & Wildlife Div,Sci & Technol Branch, Ottawa, ON K1S 5B6, Canada	Aarhus University; Aarhus University; Aarhus University; Aarhus University; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); University of Potsdam; Carleton University; Environment & Climate Change Canada; Canadian Wildlife Service; National Wildlife Research Centre - Canada	Pavlova, V (corresponding author), Aarhus Univ, Dept Biosci, Sect Marine Mammal Res, Roskilde, Denmark.	vpa@dmu.dk	Dietz, Rune/F-9154-2015; Svenning, Jens-Christian/C-8977-2012; Pavlova, Viola/P-2714-2017; Nabe-Nielsen, Jacob/A-5891-2010; Sonne, Christian/I-7532-2013	Dietz, Rune/0000-0001-9652-317X; Svenning, Jens-Christian/0000-0002-3415-0862; Nabe-Nielsen, Jacob/0000-0002-0716-9525; Sonne, Christian/0000-0001-5723-5263; Vorkamp, Katrin/0000-0002-1131-5687	European Union [PITN-GA-2009-238148]; Danish Environmental Protection Agency within the Danish Cooperation for Environment in the Arctic (DANCEA); Greenland Institute of Natural Resources (Nuuk); Aage V. Jensens Foundation; DANCEA (Danish Cooperation for Environment in the Arctic) programme; KVUG (The Commission for Scientific Research in Greenland); The Center for Informatics Research on Complexity in Ecology (CIRCE); Aarhus University; Aarhus University Research Foundation	European Union(European Commission); Danish Environmental Protection Agency within the Danish Cooperation for Environment in the Arctic (DANCEA); Greenland Institute of Natural Resources (Nuuk); Aage V. Jensens Foundation; DANCEA (Danish Cooperation for Environment in the Arctic) programme; KVUG (The Commission for Scientific Research in Greenland); The Center for Informatics Research on Complexity in Ecology (CIRCE); Aarhus University; Aarhus University Research Foundation	This study was financially supported by the European Union under the 7th Framework Programme (project acronym CREAM, contract number PITN-GA-2009-238148) http://ec.europa.eu/research/fp7/index_en.cfm, VP JNN VG. The research on contamination of ringed seals was funded by the Danish Environmental Protection Agency within the Danish Cooperation for Environment in the Arctic (DANCEA). The early sampling of polar bears in Greenland was funded by the Greenland Institute of Natural Resources (Nuuk), Aage V. Jensens Foundation. Samplings since 1999 and all chemical analyses were funded by a number of projects under the DANCEA (Danish Cooperation for Environment in the Arctic) programme including the CORE programme and the large scale IPY programme "BearHealth'', which was also supported by KVUG (The Commission for Scientific Research in Greenland) and The Prince Albert II Foundation for the POP time trend analysis; KV CS RD RJL FF. The Center for Informatics Research on Complexity in Ecology (CIRCE, Aarhus University and Aarhus University Research Foundation for funding CIRCE under the AU IDEAS program, JCS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acquarone Mario, 2006, Aquatic Mammals, V32, P363, DOI 10.1578/AM.32.3.2006.363; ARNOULD JPY, 1994, CAN J ZOOL, V72, P1365, DOI 10.1139/z94-180; Bentzen TW, 2008, SCI TOTAL ENVIRON, V406, P352, DOI 10.1016/j.scitotenv.2008.07.030; BEST RC, 1985, CAN J ZOOL, V63, P1033, DOI 10.1139/z85-155; Best RC, 1976, THESIS U GUELPH GUEL; Butler PJ, 2004, FUNCT ECOL, V18, P168, DOI 10.1111/j.0269-8463.2004.00821.x; Christensen JR, 2009, ENVIRON TOXICOL CHEM, V28, P2206, DOI 10.1897/08-582.1; Costa DP, 2000, BIOL MARINE MAMMALS, P176; Derocher AE, 2004, INTEGR COMP BIOL, V44, P163, DOI 10.1093/icb/44.2.163; Derocher AE, 2002, J ZOOL, V256, P343, DOI 10.1017/S0952836902000377; Derocher AE, 1996, CAN J ZOOL, V74, P1246, DOI 10.1139/z96-138; DEROCHER AE, 1994, J ZOOL, V234, P527, DOI 10.1111/j.1469-7998.1994.tb04863.x; Derocher AE, 2013, CONSERV LETT, V6, P368, DOI 10.1111/conl.12009; Dietz R, 2004, SCI TOTAL ENVIRON, V331, P107, DOI 10.1016/j.scitotenv.2004.03.025; Dietz R, 2013, ENVIRON INT, V59, P485, DOI 10.1016/j.envint.2012.09.004; Durner GM, 2011, POLAR BIOL, V34, P975, DOI 10.1007/s00300-010-0953-2; European Pet Food Industry Federation (FEDIAF), 2011, NUTR GUID COMPL COMP; Farley SD, 1995, CAN J ZOOL, V73, P2216, DOI 10.1139/z95-262; Fisk AT, 2001, ENVIRON SCI TECHNOL, V35, P732, DOI 10.1021/es001459w; Ginsberg G, 2002, TOXICOL SCI, V66, P185, DOI 10.1093/toxsci/66.2.185; Grimm V, 2006, ECOL MODEL, V198, P115, DOI 10.1016/j.ecolmodel.2006.04.023; Grimm V, 2010, ECOL MODEL, V221, P2760, DOI 10.1016/j.ecolmodel.2010.08.019; Henriksen EO, 2001, J ENVIRON MONITOR, V3, P493, DOI 10.1039/b102683f; Hickie BE, 1999, ENVIRON TOXICOL CHEM, V18, P2622, DOI [10.1897/1551-5028(1999)018&lt;2622:LPMFHC&gt;2.3.CO;2, 10.1002/etc.5620181132]; HURST RJ, 1982, ACTA PHYSIOL SCAND, V115, P391, DOI 10.1111/j.1748-1716.1982.tb07096.x; Iversen M, 2013, POLAR BIOL, V36, P561, DOI 10.1007/s00300-012-1284-2; Jakoby O, 2014, ECOL MODEL, V275, P78, DOI 10.1016/j.ecolmodel.2013.12.009; Kleiber M., 1975, FIRE LIFE INTRO ANIM; Knott KK, 2012, CHEMOSPHERE, V88, P395, DOI 10.1016/j.chemosphere.2012.02.053; Krafft BA, 2006, ICES J MAR SCI, V63, P1136, DOI 10.1016/j.icesjms.2006.04.001; Letcher RJ, 2009, ENVIRON INT, V35, P1118, DOI 10.1016/j.envint.2009.07.006; Lintzenich BA, 2006, POLAR BEAR NUTR GUID; Mathewson PD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072863; Mauritzen M, 2003, ANIM BEHAV, V66, P107, DOI 10.1006/anbe.2003.2171; McKinney MA, 2014, ECOL EVOL, V4, P516, DOI 10.1002/ece3.956; McKinney MA, 2013, GLOBAL CHANGE BIOL, V19, P2360, DOI 10.1111/gcb.12241; McKinney MA, 2011, ENVIRON INT, V37, P365, DOI 10.1016/j.envint.2010.10.008; Mckinney MA, 2009, ENVIRON SCI TECHNOL, V43, P4334, DOI 10.1021/es900471g; MCLACHLAN MS, 1993, TOXICOL APPL PHARM, V123, P68, DOI 10.1006/taap.1993.1222; MCLAREN IA, 1993, BIOL REV, V68, P1, DOI 10.1111/j.1469-185X.1993.tb00731.x; Molnar PK, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1183; NAGY KA, 1987, ECOL MONOGR, V57, P111, DOI 10.2307/1942620; Noren DP, 2011, MAR MAMMAL SCI, V27, P60, DOI 10.1111/j.1748-7692.2010.00386.x; Pilfold NW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041429; Polischuk SC, 1999, THESIS U SASKATCHEWA; Regehr EV, 2007, J WILDLIFE MANAGE, V71, P2673, DOI 10.2193/2006-180; Regehr EV, 2010, J ANIM ECOL, V79, P117, DOI 10.1111/j.1365-2656.2009.01603.x; Riget F, 2008, J ENVIRON MONITOR, V10, P935, DOI 10.1039/b807017b; Riget F, 2006, J ENVIRON MONITOR, V8, P1000, DOI 10.1039/b609522d; Schliebe S, 2008, IUCN 2012 IUCN RED L; Schlummer M, 1998, TOXICOL APPL PHARM, V152, P128, DOI 10.1006/taap.1998.8487; Schmidt-Nielsen K, 1997, ANIMAL PHYSL ADAPTAT; SMITH TG, 1980, CAN J ZOOL, V58, P2201, DOI 10.1139/z80-302; Sonne C, 2009, CHEMOSPHERE, V77, P1558, DOI 10.1016/j.chemosphere.2009.09.044; STIRLING I, 1977, J FISH RES BOARD CAN, V34, P1126, DOI 10.1139/f77-169; STIRLING I, 1993, ARCTIC, V46, P240; Stirling I, 1995, CAN J FISH AQUAT SCI, V52, P2594, DOI 10.1139/f95-849; STIRLING I, 1975, CAN J ZOOL, V53, P1021, DOI 10.1139/z75-117; STIRLING I, 1974, CAN J ZOOL, V52, P1191, DOI 10.1139/z74-157; Thiemann GW, 2008, ECOL MONOGR, V78, P591, DOI 10.1890/07-1050.1; Trites Andrew W., 1997, Journal of Northwest Atlantic Fishery Science, V22, P173; Vorkamp K, 2011, ENVIRON SCI TECHNOL, V45, P1243, DOI 10.1021/es102755x; WATTS PD, 1991, COMP BIOCHEM PHYS A, V98, P191, DOI 10.1016/0300-9629(91)90518-H; Wiegand T, 2003, OIKOS, V100, P209, DOI 10.1034/j.1600-0706.2003.12027.x; Wilensky U., 1999, NETLOGO CTR CONNECTE; Winship AJ, 2002, MAR ECOL PROG SER, V229, P291, DOI 10.3354/meps229291	66	8	8	1	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e104037	10.1371/journal.pone.0104037	http://dx.doi.org/10.1371/journal.pone.0104037			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25101837	Green Published, gold, Green Submitted			2022-12-27	WOS:000339993900032
J	Wang, PJ; Tam, N; Wang, HC; Zheng, HW; Chen, P; Wu, LW; He, XS				Wang, Peijie; Tam, Ngalei; Wang, Haochen; Zheng, Huanwei; Chen, Philip; Wu, Linwei; He, Xiaoshun			Is Hepatitis B Immunoglobulin Necessary in Prophylaxis of Hepatitis B Recurrence after Liver Transplantation? A Meta-Analysis	PLOS ONE			English	Article							ADEFOVIR DIPIVOXIL; IMMUNE GLOBULIN; LAMIVUDINE; VIRUS; REINFECTION; PREVENTION; ANALOGS; COMBINATION; EXPERIENCE; WITHDRAWAL	Background & Aims: Application of nucleoside analogues and hepatitis B immunoglobulin (HBIG) has reduced hepatitis B virus (HBV) recurrence rate after liver transplantation (LT) dramatically. Recent data suggests therapy without HBIG is also effective. We sought to evaluate the necessity of HBIG in prophylaxis of HBV recurrence after LT. Methods: A meta-analysis was performed. PubMed/MEDLINE, Web of Knowledge and other databases were searched for eligible literatures. The major end points were recurrence rate, patient survival, and YMDD mutant. Risk difference (RD) or risk ratio (RR) was calculated to synthesize the results. Results: Nineteen studies with a total of 1484 patients were included in this analysis. Application of HBIG was helpful to reduce HBV recurrence [P<0.001; RD = 0.16; 95% confidence interval (CI)(0.12, 0.20)] and virus mutants [P<0.001; RR = 3.13; 95%CI (1.86-5.26)], it also improved patients' 1-year [P = 0.03; RD = 0.08; 95%CI (0.01, 0.15)] and 3-year survival rates [P = 0.005; RD = 0.17; 95%CI(0.05, 0.28)]. No significant difference was found for patients' 5-year survival [P = 0.46; RD = 20.06; 95%CI (-0.21, 0.10)]. Sub-group analysis showed that in patients with positive pre-operative HBV DNA status, HBIG was necessary to reduce HBV recurrence rate (P<0.001; RD = 0.42; 95%CI (0.32, 0.52)). In patients with negative HBV DNA, combined therapy gained no significant advantages (P = 0.18; RD = 0.06; 95%CI (-0.03, 0.14)). Non-Lamivudine (non-LAM) antiviral drugs performed as well as combination therapy in prophylaxis of HBV recurrence after LT (P = 0.37; RD = 0.06; 95%CI (-0.02, 0.14)). Conclusions: HBIG with nucleoside analogues is helpful to reduce HBV recurrence and virus mutants. The necessity of HBIG in prophylaxis of HBV recurrence after LT when using new potent nucleoside analogues, especially for patients with negative pre-transplant HBV DNA status remains to be evaluated.	[Wang, Peijie; Tam, Ngalei; Wang, Haochen; Wu, Linwei; He, Xiaoshun] Sun Yat Sen Univ, Affiliated Hosp 1, Organ Transplant Ctr, Guangzhou 510275, Guangdong, Peoples R China; [Wang, Peijie] Sun Yat Sen Univ, Zhongshan Sch Med, Guangzhou 510275, Guangdong, Peoples R China; [Tam, Ngalei] Univ Hong Kong, Shenzhen Hosp, Hepatobiliary Surg Dept, Shenzhen, Guangdong, Peoples R China; [Zheng, Huanwei] Shijiazhuang Fifth Hosp, Liver Dis Dept, Shijiazhuang, Hebei, Peoples R China; [Zheng, Huanwei] Univ Texas SW Med Ctr Dallas, Clin Ctr Liver Dis, Dallas, TX 75390 USA; [Chen, Philip] Univ Texas SW Med Ctr Dallas, Dept Nephrol, Dallas, TX 75390 USA	Sun Yat Sen University; Sun Yat Sen University; University of Hong Kong; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Wu, LW (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Organ Transplant Ctr, Guangzhou 510275, Guangdong, Peoples R China.	lw97002@163.com	Wang, Peijie/Q-9388-2016	Wang, Peijie/0000-0001-8588-8464	National Natural Science Foundation of China [81102245]; Science and Technology Planning Project of Guangdong Province, China [2011B0318000099]; Sun Yat-Sen University [12ykpy21]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Planning Project of Guangdong Province, China; Sun Yat-Sen University	This study was supported by the National Natural Science Foundation of China (No. 81102245) and Science and Technology Planning Project of Guangdong Province, China (No. 2011B0318000099) and Youth teachers cultivation project of Sun Yat-Sen University (No. 12ykpy21). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angus PW, 2008, HEPATOLOGY, V48, P1460, DOI 10.1002/hep.22524; Anselmo DM, 2002, ANN SURG, V235, P611, DOI 10.1097/00000658-200205000-00002; Brock GN, 2011, TRANSPL INT, V24, P570, DOI 10.1111/j.1432-2277.2011.01236.x; Buti M, 2007, TRANSPLANTATION, V84, P650, DOI 10.1097/01.tp.0000277289.23677.0a; Cholongitas E, 2012, TRANSPL INFECT DIS, V14, P479, DOI 10.1111/j.1399-3062.2012.00741.x; [戴军 DAI Jun], 2009, [中华肝胆外科杂志, Chinese Journal of Hepatobiliary Surgery], V15, P106; FREEMAN RB, 1991, TRANSPLANTATION, V51, P793, DOI 10.1097/00007890-199104000-00011; Freshwater DA, 2008, TRANSPLANTATION, V85, P1105, DOI 10.1097/TP.0b013e31816a342a; Fung J, 2013, AM J GASTROENTEROL, V108, P942, DOI 10.1038/ajg.2013.111; Fung J, 2011, GASTROENTEROLOGY, V141, P1212, DOI 10.1053/j.gastro.2011.06.083; Grellier L, 1996, LANCET, V348, P1212, DOI 10.1016/S0140-6736(96)04444-3; Honaker M R, 2002, Transpl Infect Dis, V4, P137, DOI 10.1034/j.1399-3062.2002.01012.x; Jiao ZY, 2007, TRANSPL P, V39, P1533, DOI 10.1016/j.transproceed.2007.03.062; Lai CL, 2003, LANCET, V362, P2089, DOI 10.1016/S0140-6736(03)15108-2; Lo CM, 2005, LIVER TRANSPLANT, V11, P807, DOI 10.1002/lt.20416; Lo CM, 2003, TRANSPLANTATION, V75, pS41, DOI 10.1097/01.TP.0000047027.68167.07; Ma Yi, 2009, Zhonghua Wai Ke Za Zhi, V47, P1209; Neff GW, 2004, LIVER TRANSPLANT, V10, P1372, DOI 10.1002/lt.20277; OGRADY JG, 1992, J HEPATOL, V14, P104, DOI 10.1016/0168-8278(92)90138-F; Perrillo R, 1999, Ochsner J, V1, P33; Popescu I, 2010, CHIRURGIA-BUCHAREST, V105, P177; Qiang X, 2004, CHINESE J ORGAN TRAN, V25, P53; Rao WS, 2009, TRANSPL INT, V22, P387, DOI 10.1111/j.1432-2277.2008.00784.x; Saab S, 2000, GASTROENTEROLOGY, V119, P1382, DOI 10.1053/gast.2000.19279; Saab S, 2010, LIVER TRANSPLANT, V16, P300, DOI 10.1002/lt.21998; Samuel D, 2009, Dig Liver Dis, V41 Suppl 2, pS185, DOI 10.1016/S1590-8658(09)60442-4; Schiff E, 2007, LIVER TRANSPLANT, V13, P349, DOI 10.1002/lt.20981; Slim K, 2003, ANZ J SURG, V73, P712, DOI 10.1046/j.1445-2197.2003.02748.x; STARZL TE, 1989, NEW ENGL J MED, V321, P1014, DOI 10.1056/NEJM198910123211505; Teperman LW, 2013, LIVER TRANSPLANT, V19, P594, DOI 10.1002/lt.23628; Wesdorp DJW, 2013, J CLIN VIROL, V58, P67, DOI 10.1016/j.jcv.2013.06.035; Wong TCL, 2013, HEPATOB PANCREAT DIS, V12, P465, DOI 10.1016/S1499-3872(13)60074-0; Xia Jie, 2007, Chinese Journal of Digestive Surgery, V6, P348; Xia N, 2006, WORLD CHINESE J DIGE, V14, P1288; Yamamoto M, 2009, EXPERT REV ANTI-INFE, V7, P321, DOI [10.1586/eri.09.2, 10.1586/ERI.09.2]; Yang Yang, 2008, Nan Fang Yi Ke Da Xue Xue Bao, V28, P1810; Yoshida H, 2007, CLIN TRANSPLANT, V21, P166, DOI 10.1111/j.1399-0012.2006.00557.x; Yuan CH, 2013, HEPATOB PANCREAT DIS, V12, P149, DOI 10.1016/S1499-3872(13)60024-7; Yuan Guiyu, 2002, Zhonghua Gan Zang Bing Za Zhi, V10, P14; Zheng SS, 2006, LIVER TRANSPLANT, V12, P253, DOI 10.1002/lt.20701; Zhu Jian-Ping, 2003, Hepatobiliary Pancreat Dis Int, V2, P500	41	19	23	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e104480	10.1371/journal.pone.0104480	http://dx.doi.org/10.1371/journal.pone.0104480			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25102072	Green Published, Green Submitted, gold			2022-12-27	WOS:000339993900067
J	Christensen, HB				Christensen, Hilary B.			Similar Associations of Tooth Microwear and Morphology Indicate Similar Diet across Marsupial and Placental Mammals	PLOS ONE			English	Article							DENTAL MICROWEAR; MOLAR MICROWEAR; LATE MIOCENE; HERBIVOROUS MAMMALS; TEXTURE ANALYSIS; FEEDING ECOLOGY; INGESTA PASSAGE; JAW MOVEMENTS; ERROR RATES; FOOD-INTAKE	Low-magnification microwear techniques have been used effectively to infer diets within many unrelated mammalian orders, but the extent to which patterns are comparable among such different groups, including long extinct mammal lineages, is unknown. Microwear patterns between ecologically equivalent placental and marsupial mammals are found to be statistically indistinguishable, indicating that microwear can be used to infer diet across the mammals. Microwear data were compared to body size and molar shearing crest length in order to develop a system to distinguish the diet of mammals. Insectivores and carnivores were difficult to distinguish from herbivores using microwear alone, but combining microwear data with body size estimates and tooth morphology provides robust dietary inferences. This approach is a powerful tool for dietary assessment of fossils from extinct lineages and from museum specimens of living species where field study would be difficult owing to the animal's behavior, habitat, or conservation status.	[Christensen, Hilary B.] Univ Chicago, Dept Geophys Sci, Chicago, IL 60637 USA; [Christensen, Hilary B.] Bates Coll, Dept Geol, Lewiston, ME 04240 USA	University of Chicago	Christensen, HB (corresponding author), Univ Chicago, Dept Geophys Sci, 5734 S Ellis Ave, Chicago, IL 60637 USA.	hchriste@bates.edu			Evolving Earth Foundation; Sigma Xi; University of Chicago's Hinds Fund	Evolving Earth Foundation; Sigma Xi; University of Chicago's Hinds Fund	The Evolving Earth Foundation, Sigma Xi, and the University of Chicago's Hinds Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTHONY MRL, 1993, AM J SCI, V293A, P356, DOI 10.2475/ajs.293.A.356; BAKER G, 1959, NATURE, V184, P1583, DOI 10.1038/1841583b0; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; Calandra I, 2012, J HUM EVOL, V63, P85, DOI 10.1016/j.jhevol.2012.05.001; Charles C, 2007, NATURWISSENSCHAFTEN, V94, P71, DOI 10.1007/s00114-006-0161-7; Christensen H, 2012, THESIS; Clauss M, 2005, MAMMAL REV, V35, P174, DOI 10.1111/j.1365-2907.2005.00062.x; Clauss M, 2003, OECOLOGIA, V136, P14, DOI 10.1007/s00442-003-1254-z; Clauss Marcus, 2008, V195, P47, DOI 10.1007/978-3-540-72422-3_3; Clauss M, 2008, COMP BIOCHEM PHYS A, V150, P274, DOI 10.1016/j.cbpa.2008.03.012; Clauss M, 2007, OIKOS, V116, P209, DOI [10.1111/j.2006.0030-1299.15461.x, 10.1111/j.0030-1299.2007.15461.x]; Clissold FJ, 2007, ADV INSECT PHYSIOL, V34, P317, DOI 10.1016/S0065-2806(07)34006-X; Cope E. D., 1887, American Naturalist, Vxxi, P985; Crompton AW, 2008, COMP BIOCHEM PHYS A, V150, P109, DOI 10.1016/j.cbpa.2007.10.015; Crompton AW, 2011, INTEGR COMP BIOL, V51, P271, DOI 10.1093/icb/icr028; Crompton Alfred W., 2008, P83, DOI 10.1007/978-0-387-76585-3_5; Crompton AW, 2010, J EXP ZOOL PART A, V313A, P564, DOI 10.1002/jez.628; Cuozzo FP, 2012, AM J PHYS ANTHROPOL, V148, P159, DOI 10.1002/ajpa.22082; Damuth J., 1990, P1; Danielson DR, 1998, AM J PHYS ANTHROPOL, V107, P297, DOI 10.1002/(SICI)1096-8644(199811)107:3<297::AID-AJPA6>3.0.CO;2-M; Demment MW, 2009, AM NAT, P641; DeSantis L, 2013, PLOS ONE, DOI [10.1371/journal.pone.0071428.s006, DOI 10.1371/JOURNAL.PONE.0071428.S006]; DeSantis LRG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052453; Dewar E, 2004, J VERTEBR PALEONTOL, V24, p52A; Evans AR, 2007, NATURE, V445, P78, DOI 10.1038/nature05433; Evans AR, 2003, BIOL J LINN SOC, V78, P173, DOI 10.1046/j.1095-8312.2003.00146.x; FORTELLIUS M, 1990, NETH J ZOOL, V40, P312; Friscia AR, 2007, J ZOOL, V272, P82, DOI 10.1111/j.1469-7998.2006.00246.x; Fritz J, 2009, OIKOS, V118, P1623, DOI 10.1111/j.1600-0706.2009.17807.x; Galbany J, 2005, SCANNING, V27, P23; Galbany J, 2009, PRIMATES, V50, P221, DOI 10.1007/s10329-009-0139-0; Godfrey LR, 2005, INT J PRIMATOL, V26, P825, DOI 10.1007/s10764-005-5325-3; Godfrey LR, 2004, J HUM EVOL, V47, P145, DOI 10.1016/j.jhevol.2004.06.003; Goillot C, 2009, PALAEOGEOGR PALAEOCL, V271, P13, DOI 10.1016/j.palaeo.2008.09.004; GORDON KD, 1988, SCANNING MICROSCOPY, V2, P1139; Green JL, 2009, ZOOL J LINN SOC-LOND, V156, P201, DOI 10.1111/j.1096-3642.2008.00486.x; Green JL, 2005, PALAEOGEOGR PALAEOCL, V223, P34, DOI 10.1016/j.palaeo.2005.03.026; GRINE FE, 1981, S AFR J SCI, V77, P203; Grine FE, 2002, SCANNING, V24, P144, DOI 10.1002/sca.4950240307; Grine FE, 2012, AM J PHYS ANTHROPOL, V148, P285, DOI 10.1002/ajpa.22086; HERRING SW, 1993, AM ZOOL, V33, P289; HIIEMAE K, 1972, NATURE, V240, P486, DOI 10.1038/240486a0; Hogue AS, 2010, AUST J ZOOL, V58, P56, DOI 10.1071/ZO09084; JANIS CM, 1988, BIOL REV, V63, P197, DOI 10.1111/j.1469-185X.1988.tb00630.x; Jernvall J, 1996, SCIENCE, V274, P1489, DOI 10.1126/science.274.5292.1489; KAY RF, 1975, AM J PHYS ANTHROPOL, V43, P195, DOI 10.1002/ajpa.1330430207; KAY RF, 1978, AM J PHYS ANTHROPOL, V49, P119, DOI 10.1002/ajpa.1330490118; Krueger KL, 2008, AM J PHYS ANTHROPOL, V137, P485, DOI 10.1002/ajpa.20928; Legendre S., 1986, Palaeovertebrata (Montpellier), V16, P191; Lucas PW, 2000, ANN BOT-LONDON, V86, P913, DOI 10.1006/anbo.2000.1261; Lucas PW, 2002, FOOD QUAL PREFER, V13, P203, DOI 10.1016/S0950-3293(00)00036-7; Lucas PW, 2012, J R SOC INTERFACE, V10, DOI [10.1007/s10856-010-3988-6, DOI 10.1007/S10856-010-3988-6]; Lucas PW., 2004, DENT FUNCTIONAL MORP, DOI [10.1017/CBO9780511735011, DOI 10.1017/CB09780511735011]; Mainland I, 2006, J ARCHAEOL SCI, V33, P238, DOI 10.1016/j.jas.2005.07.013; Mainland IL, 2003, J ARCHAEOL SCI, V30, P1513, DOI 10.1016/S0305-4403(03)00055-4; Mainland IL, 2000, INT J OSTEOARCHAEOL, V10, P93, DOI 10.1002/(SICI)1099-1212(200003/04)10:2<93::AID-OA513>3.3.CO;2-L; McNab B.K., 2002, PHYSL ECOLOGY VERTEB, P576; Merceron G, 2005, PALAIOS, V20, P551, DOI 10.2110/palo.2004.p04-17; Merceron G, 2004, PALAEOGEOGR PALAEOCL, V207, P143, DOI 10.1016/j.palaeo.2004.02.008; Merceron G, 2004, SMALL RUMINANT RES, V53, P125, DOI [10.1016/j.smallrumres.2003.10.002, 10.1016/j.smallrumers.2003.10.002]; Merceron G, 2007, GEODIVERSITAS, V29, P421; Merceron G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009542; Mihlbachler Matthew C., 2006, Journal of Mammalian Evolution, V13, P11, DOI 10.1007/s10914-005-9001-3; Mihlbachler Matthew C., 2012, Palaeontologia Electronica, V15, P1; Nelson Sherry, 2005, Palaeontologia Electronica, V8, P1; Nowak R.M., 1999, WALKERS MAMMALS WORL, P1936; Prideaux GJ, 2009, P NATL ACAD SCI USA, V106, P11646, DOI 10.1073/pnas.0900956106; Purnell MA, 2013, J ZOOL, V291, P249, DOI 10.1111/jzo.12068; Purnell MA, 2012, J R SOC INTERFACE, V9, P2225, DOI 10.1098/rsif.2012.0140; Rafferty KL, 2002, J HUM EVOL, V43, P645, DOI 10.1006/jhev.2002.0592; Ramdarshan A, 2010, J HUM EVOL, V59, P96, DOI 10.1016/j.jhevol.2010.04.007; RENSBERGER JM, 1984, PALEOBIOLOGY, V10, P439, DOI 10.1017/S0094837300008447; Rivals F, 2008, PALAEOGEOGR PALAEOCL, V265, P134, DOI 10.1016/j.palaeo.2008.05.001; Rivals Florent, 2007, Journal of Mammalian Evolution, V14, P182, DOI 10.1007/s10914-007-9044-8; Rivals F, 2012, QUATERN INT, V255, P188, DOI 10.1016/j.quaint.2011.05.036; Rivals F, 2011, QUATERN INT, V245, P279, DOI 10.1016/j.quaint.2010.08.001; Rodrigues HG, 2009, NATURWISSENSCHAFTEN, V96, P537, DOI 10.1007/s00114-008-0501-x; Ross CF, 2007, J EXP BIOL, V210, P1046, DOI 10.1242/jeb.02733; Sacco T, 2004, J ZOOL, V263, P41, DOI 10.1017/S0952836904004856; SANSON GD, 1989, KANGAROOS, WALLABIES AND RAT-KANGAROOS, VOLS 1 AND 2, P151; Sanson GD, 2007, J ARCHAEOL SCI, V34, P526, DOI 10.1016/j.jas.2006.06.009; Santana SE, 2011, FUNCT ECOL, V25, P839, DOI 10.1111/j.1365-2435.2011.01832.x; Schubert BW, 2010, J ZOOL, V280, P257, DOI 10.1111/j.1469-7998.2009.00656.x; Schulz E, 2013, WEAR, V300, P169, DOI 10.1016/j.wear.2013.01.115; Schulz E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056167; Scott RS, 2006, J HUM EVOL, V51, P339, DOI 10.1016/j.jhevol.2006.04.006; Scott RS, 2005, NATURE, V436, P693, DOI 10.1038/nature03822; Semprebon GM, 2011, J MAMM EVOL, V18, P33, DOI 10.1007/s10914-010-9149-3; Semprebon GM, 2004, J HUM EVOL, V47, P115, DOI 10.1016/j.jhevol.2004.06.004; Smith FA, 2003, ECOLOGY, V84, P3403, DOI 10.1890/02-9003; Solounias N, 2002, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2002)366<0001:AITROU>2.0.CO;2; Strait DS, 2012, J HUM EVOL, V62, P165, DOI 10.1016/j.jhevol.2011.10.006; STRAIT SG, 1993, J MAMMAL, V74, P391, DOI 10.2307/1382395; STRAIT SG, 1993, AM J PHYS ANTHROPOL, V92, P63, DOI 10.1002/ajpa.1330920106; Strait SG, 2001, J VERTEBR PALEONTOL, V21, P322, DOI 10.1671/0272-4634(2001)021[0322:DROSBO]2.0.CO;2; STRAIT SG, 1993, J HUM EVOL, V25, P471, DOI 10.1006/jhev.1993.1062; Strait Suzanne G., 1997, Evolutionary Anthropology, V5, P199, DOI 10.1002/(SICI)1520-6505(1997)5:6<199::AID-EVAN2>3.0.CO;2-8; Teaford MF, 1996, AM J PHYS ANTHROPOL, V101, P527; TEAFORD MF, 1991, AM J PHYS ANTHROPOL, V85, P313, DOI 10.1002/ajpa.1330850310; TEAFORD MF, 1992, AM J PHYS ANTHROPOL, V88, P347, DOI 10.1002/ajpa.1330880308; TEAFORD MF, 1989, AM J PHYS ANTHROPOL, V80, P447, DOI 10.1002/ajpa.1330800405; TEAFORD MF, 1988, SCANNING MICROSCOPY, V2, P1149; TEAFORD MF, 1984, AM J PHYS ANTHROPOL, V64, P191, DOI 10.1002/ajpa.1330640213; Townsend KEB, 2008, J MAMMAL, V89, P730, DOI 10.1644/06-MAMM-A-336R1.1; Ungar PS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002044; Ungar PS, 2010, MAMMALIA, V74, P219, DOI 10.1515/MAMM.2010.015; UNGAR PS, 1995, P NATL ACAD SCI USA, V92, P5479, DOI 10.1073/pnas.92.12.5479; Ungar PS, 2006, J HUM EVOL, V50, P78, DOI 10.1016/j.jhevol.2005.08.007; UNGAR PS, 1995, AM J PHYS ANTHROPOL, V97, P93, DOI 10.1002/ajpa.1330970202; UNGAR PS, 1995, SCANNING, V17, P57; Ungar PS, 2010, MAMMAL TEETH ORIGIN, P304; Van Valkenburgh B., 1989, CARNIVORE BEHAV ECOL, P410, DOI DOI 10.1007/978-1-4757-4716-4; VANVALKENBURGH B, 1990, J ZOOL, V222, P319; VINCENT JFV, 1990, ADV BOT RES, V17, P235, DOI 10.1016/S0065-2296(08)60135-4; WALKER A, 1978, SCIENCE, V201, P908, DOI 10.1126/science.684415; Wilson GP, 2012, NATURE, V483, P457, DOI 10.1038/nature10880; Wright W, 1996, BIOL REV, V71, P401, DOI 10.1111/j.1469-185X.1996.tb01280.x	117	12	13	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e102789	10.1371/journal.pone.0102789	http://dx.doi.org/10.1371/journal.pone.0102789			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM6SM	25099537	Green Published, gold, Green Submitted			2022-12-27	WOS:000339995100013
J	Davis, CM; Roma, PG; Armour, E; Gooden, VL; Brady, JV; Weed, MR; Hienz, RD				Davis, Catherine M.; Roma, Peter G.; Armour, Elwood; Gooden, Virginia L.; Brady, Joseph V.; Weed, Michael R.; Hienz, Robert D.			Effects of X-Ray Radiation on Complex Visual Discrimination Learning and Social Recognition Memory in Rats	PLOS ONE			English	Article							SCHEDULE-CONTROLLED PERFORMANCE; IONIZING-RADIATION; INDUCED DISRUPTION; LITHIUM-CHLORIDE; FE-56 PARTICLES; EXPOSURE; NEUROGENESIS; ACQUISITION; DEFICITS; LESIONS	The present report describes an animal model for examining the effects of radiation on a range of neurocognitive functions in rodents that are similar to a number of basic human cognitive functions. Fourteen male Long-Evans rats were trained to perform an automated intra-dimensional set shifting task that consisted of their learning a basic discrimination between two stimulus shapes followed by more complex discrimination stages (e.g., a discrimination reversal, a compound discrimination, a compound reversal, a new shape discrimination, and an intra-dimensional stimulus discrimination reversal) One group of rats was exposed to head-only X-ray radiation (2.3 Gy at a dose rate of 1.9 Gy/min), while a second group received a sham-radiation exposure using the same anesthesia protocol. The irradiated group responded less, had elevated numbers of omitted trials, increased errors, and greater response latencies compared to the sham-irradiated control group. Additionally, social odor recognition memory was tested after radiation exposure by assessing the degree to which rats explored wooden beads impregnated with either their own odors or with the odors of novel, unfamiliar rats however, no significant effects of radiation on social odor recognition memory were observed. These data suggest that rodent tasks assessing higher-level human cognitive domains are useful in examining the effects of radiation on the CNS, and may be applicable in approximating CNS risks from radiation exposure in clinical populations receiving whole brain irradiation.	[Davis, Catherine M.; Roma, Peter G.; Gooden, Virginia L.; Brady, Joseph V.; Weed, Michael R.; Hienz, Robert D.] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Div Behav Biol, Baltimore, MD 21205 USA; [Armour, Elwood] Johns Hopkins Univ, Sch Med, Dept Radiat Oncol & Mol Radiat Sci, Baltimore, MD 21205 USA; [Roma, Peter G.; Brady, Joseph V.; Hienz, Robert D.] Inst Behav Resources, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University	Davis, CM (corresponding author), Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Div Behav Biol, Baltimore, MD 21205 USA.	cdavis91@jhmi.edu		Davis-Takacs, Catherine/0000-0002-2591-6352	National Space Biomedical Research Institute (NSBRI) through NASA [NCC 9-58, NBPF01604, NBPF02802, PF02602]	National Space Biomedical Research Institute (NSBRI) through NASA	This study was supported by the National Space Biomedical Research Institute (NSBRI) through NASA cooperative agreement NCC 9-58, grants NBPF01604 (R.D.H.), NBPF02802 (R.D.H.), and PF02602 (C.M.D.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ator AA, 1991, EXPT ANAL BEHAV 1, P1; BOGO V, 1989, RADIAT RES, V118, P341, DOI 10.2307/3577448; Brown MW, 2001, NAT REV NEUROSCI, V2, P51, DOI 10.1038/35049064; Burghardt NS, 2012, HIPPOCAMPUS, V22, P1795, DOI 10.1002/hipo.22013; Davis CM, 2014, RADIAT RES, V181, P258, DOI 10.1667/RR13359.1; Davis CM, 2013, NASA HUM RES PERF IN; Davis CM, 2012, NASA HUM RES PERF IN; Fan Y, 2007, EUR J NEUROSCI, V25, P38, DOI 10.1111/j.1460-9568.2006.05269.x; Feinberg LM, 2012, NEUROBIOL LEARN MEM, V97, P7, DOI 10.1016/j.nlm.2011.08.008; Greene-Schloesser D, 2013, CLIN CANCER RES, V19, P2294, DOI 10.1158/1078-0432.CCR-11-2903; Greene-Schloesser D, 2012, NEURO-ONCOLOGY, V14, P37, DOI 10.1093/neuonc/nos196; Hienz RD, 2008, RADIAT RES, V170, P292, DOI 10.1667/RR1222.1; Lonart G, 2012, RADIAT RES, V178, P289, DOI 10.1667/RR2862.1; MELE PC, 1995, NEUROTOXICOLOGY, V16, P497; MELE PC, 1988, PHARMACOL BIOCHEM BE, V30, P1007, DOI 10.1016/0091-3057(88)90133-5; MELE PC, 1990, NEUROTOXICOL TERATOL, V12, P367, DOI 10.1016/0892-0362(90)90056-I; Mizumatsu S, 2003, CANCER RES, V63, P4021; Ng T, 2014, EXPERT OPIN DRUG SAF, V13, P83, DOI 10.1517/14740338.2013.828034; RABIN BM, 1989, RADIAT RES, V119, P113, DOI 10.2307/3577371; RABIN BM, 1994, ADV SPACE RES, V14, P457, DOI 10.1016/0273-1177(94)90500-2; Rabin BM, 2005, RADIAT RES, V164, P552, DOI 10.1667/RR3349.1; Rabin BM, 2005, BRAIN RES, V1036, P122, DOI 10.1016/j.brainres.2004.12.041; Rabin BM, 2004, ADV SPACE RES, V33, P1330, DOI 10.1016/j.asr.2003.09.051; Rabin BM, 2002, J RADIAT RES, V43, pS225; Rabin BM, 2001, PHYS MEDICA, V17, P196; RABIN BM, 1992, BEHAV NEURAL BIOL, V58, P83, DOI 10.1016/0163-1047(92)90291-B; RABIN BM, 1988, PHARMACOL BIOCHEM BE, V31, P909, DOI 10.1016/0091-3057(88)90404-2; RABIN BM, 1992, AVIAT SPACE ENVIR MD, V63, P702; RABIN BM, 1986, NEUROSCI BIOBEHAV R, V10, P55, DOI 10.1016/0149-7634(86)90033-3; ROBERTS AC, 1994, J NEUROSCI, V14, P2531; Roberts AC, 1996, COGNITIVE BRAIN RES, V3, P319, DOI 10.1016/0926-6410(96)00017-1; Samuels BA, 2011, EUR J NEUROSCI, V33, P1152, DOI 10.1111/j.1460-9568.2011.07614.x; Shukitt-Hale B, 2000, RADIAT RES, V154, P28, DOI 10.1667/0033-7587(2000)154[0028:SLAMDI]2.0.CO;2; Shukitt-Hale B, 2003, ADV SPACE RES-SERIES, V31, P119, DOI 10.1016/S0273-1177(02)00878-5; Skinner B.F, 1938, BEHAV ORGANISMS EXPT; STEBBINS WC, 1964, J EXP ANAL BEHAV, V7, P309, DOI 10.1901/jeab.1964.7-309; WINSAUER PJ, 1995, NEUROTOXICOLOGY, V16, P257; WINSAUER PJ, 1993, PHARMACOL BIOCHEM BE, V44, P809, DOI 10.1016/0091-3057(93)90010-Q; Wong J, 2008, INT J RADIAT ONCOL, V71, P1591, DOI 10.1016/j.ijrobp.2008.04.025	39	12	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e104393	10.1371/journal.pone.0104393	http://dx.doi.org/10.1371/journal.pone.0104393			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25099152	gold, Green Submitted, Green Published			2022-12-27	WOS:000339995100069
J	Dileo, MV; Bostock, RM; Rizzo, DM				Dileo, Matthew V.; Bostock, Richard M.; Rizzo, David M.			Microclimate Impacts Survival and Prevalence of Phytophthora ramorum in Umbellularia californica, a Key Reservoir Host of Sudden Oak Death in Northern California Forests	PLOS ONE			English	Article							TEMPERATURE; TRANSMISSION; SPORULATION; PATHOGEN; EXPOSURE	Phytophthora ramorum, an invasive pathogen and the causal agent of Sudden Oak Death, has become established in mixed-evergreen and redwood forests in coastal northern California. While oak and tanoak mortality is the most visible indication of P. ramorum's presence, epidemics are largely driven by the presence of bay laurel (Umbellularia californica), a reservoir host that supports both prolific sporulation in the winter wet season and survival during the summer dry season. In order to better understand how over-summer survival of the pathogen contributes to variability in the severity of annual epidemics, we monitored the viability of P. ramorum leaf infections over three years along with coincident microclimate. The proportion of symptomatic bay laurel leaves that contained viable infections decreased during the first summer dry season and remained low for the following two years, likely due to the absence of conducive wet season weather during the study period. Over-summer survival of P. ramorum was positively correlated with high percent canopy cover, less negative bay leaf water potential and few days exceeding 30 degrees C but was not significantly different between mixed-evergreen and redwood forest ecosystems. Decreased summer survival of P. ramorum in exposed locations and during unusually hot summers likely contributes to the observed spatiotemporal heterogeneity of P. ramorum epidemics.	[Dileo, Matthew V.; Bostock, Richard M.; Rizzo, David M.] Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA	University of California System; University of California Davis	Rizzo, DM (corresponding author), Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA.	dmrizzo@ucdavis.edu			USDA Forest Service Pacific Southwest Research Station; Gordon and Betty Moore Foundation; Department of Homeland Security	USDA Forest Service Pacific Southwest Research Station(United States Department of Agriculture (USDA)United States Forest Service); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Department of Homeland Security(United States Department of Homeland Security (DHS))	This research was supported by the USDA Forest Service Pacific Southwest Research Station, the Gordon and Betty Moore Foundation, and the Department of Homeland Security. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansari AQ, 1959, LEAF TEMPERATURES, P713; Beh MM, 2012, NEW PHYTOL, V196, P1145, DOI 10.1111/j.1469-8137.2012.04352.x; Browning M, 2008, MYCOLOGIA, V100, P236, DOI 10.3852/mycologia.100.2.236; Buffo J, 1972, PNWRP142; Chimento A, 2012, FOREST PATHOL, V42, P14, DOI 10.1111/j.1439-0329.2011.00717.x; Condeso TE, 2007, J ECOL, V95, P364, DOI 10.1111/j.1365-2745.2006.01206.x; Davidson JM, 2008, PHYTOPATHOLOGY, V98, P860, DOI 10.1094/PHYTO-98-8-0860; Davidson JM, 2011, PHYTOPATHOLOGY, V101, P492, DOI 10.1094/PHYTO-03-10-0064; Davidson JM, 2005, PHYTOPATHOLOGY, V95, P587, DOI 10.1094/PHYTO-95-0587; DiLeo MV, 2009, PHYTOPATHOLOGY, V99, P1307, DOI 10.1094/PHYTO-99-11-1307; DiLeo MV, 2006, PHYTOPATHOLOGY; Duniway JM, 1983, PHYTOPHTHORA ITS BIO, P175; Englander L, 2006, MYCOLOGIA, V98, P365, DOI 10.3852/mycologia.98.3.365; Erwin DC, 1996, PHYTOPHTHORA DIS WOR; Fichtner EJ, 2007, PHYTOPATHOLOGY, V97, P1366, DOI 10.1094/PHYTO-97-10-1366; Fichtner EJ, 2009, PHYTOPATHOLOGY, V99, P608, DOI 10.1094/PHYTO-99-5-0608; FUCHS M, 1990, THEOR APPL CLIMATOL, V42, P253, DOI 10.1007/BF00865986; Huberli D, 2012, PLANT PATHOL, V61, P579, DOI 10.1111/j.1365-3059.2011.02535.x; Konzanitas M, 2012, 5 SUDD OAK DEATH SCI; Littell R. C., 2006, SAS SYSTEMS MIXED MO, V2nd; MCCUTCHAN H, 1992, J AM SOC HORTIC SCI, V117, P607, DOI 10.21273/JASHS.117.4.607; McPherson BA, 2005, FOREST ECOL MANAG, V213, P71, DOI 10.1016/j.foreco.2005.03.048; Rizzo DM, 2005, ANNU REV PHYTOPATHOL, V43, P309, DOI 10.1146/annurev.phyto.42.040803.140418; Rizzo DM, 2002, PLANT DIS, V86, P205, DOI 10.1094/PDIS.2002.86.3.205; Tooley PW, 2008, PLANT DIS, V92, P431, DOI 10.1094/PDIS-92-3-0431	25	12	12	4	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e98195	10.1371/journal.pone.0098195	http://dx.doi.org/10.1371/journal.pone.0098195			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25098281	Green Published, gold			2022-12-27	WOS:000339995100001
J	Richards, MA; Cassen, V; Heavner, BD; Ajami, NE; Herrmann, A; Simeonidis, E; Price, ND				Richards, Matthew A.; Cassen, Victor; Heavner, Benjamin D.; Ajami, Nassim E.; Herrmann, Andrea; Simeonidis, Evangelos; Price, Nathan D.			MediaDB: A Database of Microbial Growth Conditions in Defined Media	PLOS ONE			English	Article							MARINE-BACTERIA; DILUTION CULTURE; SOIL BACTERIA; PURE CULTURE; CULTIVATION; MICROORGANISMS; CULTURABILITY; INCUBATION; STRATEGIES; PROJECT	Isolating pure microbial cultures and cultivating them in the laboratory on defined media is used to more fully characterize the metabolism and physiology of organisms. However, identifying an appropriate growth medium for a novel isolate remains a challenging task. Even organisms with sequenced and annotated genomes can be difficult to grow, despite our ability to build genome-scale metabolic networks that connect genomic data with metabolic function. The scientific literature is scattered with information about defined growth media used successfully for cultivating a wide variety of organisms, but to date there exists no centralized repository to inform efforts to cultivate less characterized organisms by bridging the gap between genomic data and compound composition for growth media. Here we present MediaDB, a manually curated database of defined media that have been used for cultivating organisms with sequenced genomes, with an emphasis on organisms with metabolic network models. The database is accessible online, can be queried by keyword searches or downloaded in its entirety, and can generate exportable individual media formulation files. The data assembled in MediaDB facilitate comparative studies of organism growth media, serve as a starting point for formulating novel growth media, and contribute to formulating media for in silico investigation of metabolic networks. MediaDB is freely available for public use at https://mediadb.systemsbiology.net.	[Richards, Matthew A.; Ajami, Nassim E.; Herrmann, Andrea] Univ Illinois, Dept Chem & Biomol Engn, Urbana, IL USA; [Richards, Matthew A.; Cassen, Victor; Heavner, Benjamin D.; Simeonidis, Evangelos; Price, Nathan D.] Inst Syst Biol, Seattle, WA 98109 USA; [Simeonidis, Evangelos] Univ Luxembourg, Luxembourg Ctr Syst Biomed, Luxembourg, Luxembourg	University of Illinois System; University of Illinois Urbana-Champaign; Institute for Systems Biology (ISB); University of Luxembourg	Price, ND (corresponding author), Inst Syst Biol, Seattle, WA 98109 USA.	nprice@systemsbiology.org		Heavner, Benjamin/0000-0003-2898-9044; Simeonidis, Vangelis/0000-0001-6153-4493; Price, Nathan/0000-0002-4157-0267	Camille Dreyfus Teacher-Scholar Award; Department of Energy Genomic Sciences Program [DE-FG02-10ER64999]; National Institutes of Health Center for Systems Biology [2P50 GM076547]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM076547] Funding Source: NIH RePORTER	Camille Dreyfus Teacher-Scholar Award; Department of Energy Genomic Sciences Program(United States Department of Energy (DOE)); National Institutes of Health Center for Systems Biology(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded in part by a Camille Dreyfus Teacher-Scholar Award (http://www.dreyfus.org/), a Department of Energy Genomic Sciences Program (DE-FG02-10ER64999, http://genomicscience.energy.gov/), and National Institutes of Health Center for Systems Biology (2P50 GM076547, http://www.nih.gov/). Nathan D. Price received the funding from these sources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alain K, 2009, EXTREMOPHILES, V13, P583, DOI 10.1007/s00792-009-0261-3; Amann R, 2000, SYST APPL MICROBIOL, V23, P1; Benedict MN, 2012, J BACTERIOL, V194, P855, DOI 10.1128/JB.06040-11; Bollmann A, 2007, APPL ENVIRON MICROB, V73, P6386, DOI 10.1128/AEM.01309-07; Bolton EE, 2010, ANN REP COMP CHEM, V4, P217, DOI 10.1016/S1574-1400(08)00012-1; Bruns A, 2003, APPL ENVIRON MICROB, V69, P1980, DOI 10.1128/AEM.69.4.1980-1989.2003; Bruns A, 2002, APPL ENVIRON MICROB, V68, P3978, DOI 10.1128/AEM.68.8.3978-3987.2002; BUTTON DK, 1993, APPL ENVIRON MICROB, V59, P881, DOI 10.1128/AEM.59.3.881-891.1993; Carini P, 2013, ISME J, V7, P592, DOI 10.1038/ismej.2012.122; Connon SA, 2002, APPL ENVIRON MICROB, V68, P3878, DOI 10.1128/AEM.68.8.3878-3885.2002; Covert MW, 2003, BIOTECHNOL BIOENG, V84, P763, DOI 10.1002/bit.10849; D'Onofrio A, 2010, CHEM BIOL, V17, P254, DOI 10.1016/j.chembiol.2010.02.010; Davis KER, 2005, APPL ENVIRON MICROB, V71, P826, DOI 10.1128/AEM.71.2.826-834.2005; Feist AM, 2009, NAT REV MICROBIOL, V7, P129, DOI 10.1038/nrmicro1949; Felsenstein J., 1993, PHYLIP PHYLOGENETIC; Ferrari BC, 2005, APPL ENVIRON MICROB, V71, P8714, DOI 10.1128/AEM.71.12.8714-8720.2005; Hastings J, 2013, NUCLEIC ACIDS RES, V41, pD456, DOI 10.1093/nar/gks1146; Henry CS, 2010, NAT BIOTECHNOL, V28, P977, DOI 10.1038/nbt.1672; Imanishi T, 2009, NUCLEIC ACIDS RES, V37, pW17, DOI 10.1093/nar/gkp355; Ingham CJ, 2007, P NATL ACAD SCI USA, V104, P18217, DOI 10.1073/pnas.0701693104; Janssen PH, 2002, APPL ENVIRON MICROB, V68, P2391, DOI 10.1128/AEM.68.5.2391-2396.2002; Janssen PH, 1997, APPL ENVIRON MICROB, V63, P1382, DOI 10.1128/AEM.63.4.1382-1388.1997; Joint I, 2010, MICROB BIOTECHNOL, V3, P564, DOI 10.1111/j.1751-7915.2010.00188.x; Kaeberlein T, 2002, SCIENCE, V296, P1127, DOI 10.1126/science.1070633; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kauffman KJ, 2003, CURR OPIN BIOTECH, V14, P491, DOI 10.1016/j.copbio.2003.08.001; Keller M, 2004, NAT REV MICROBIOL, V2, P141, DOI 10.1038/nrmicro819; Nichols D, 2008, APPL ENVIRON MICROB, V74, P4889, DOI 10.1128/AEM.00393-08; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Pham VH, 2012, TRENDS BIOTECHNOLOGY; Prakash O, 2013, APPL MICROBIOL BIOT, V97, P51, DOI 10.1007/s00253-012-4533-y; Price ND, 2004, NAT REV MICROBIOL, V2, P886, DOI 10.1038/nrmicro1023; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Rappe MS, 2002, NATURE, V418, P630, DOI 10.1038/nature00917; Reed JL, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r54; Sait M, 2002, ENVIRON MICROBIOL, V4, P654, DOI 10.1046/j.1462-2920.2002.00352.x; Sangwan P, 2005, APPL ENVIRON MICROB, V71, P8402, DOI 10.1128/AEM.71.12.8402-8410.2005; Schellenberger J, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-213; Song H, 2008, APPL MICROBIOL BIOT, V79, P263, DOI 10.1007/s00253-008-1425-2; Stevenson BS, 2004, APPL ENVIRON MICROB, V70, P4748, DOI 10.1128/AEM.70.8.4748-4755.2004; Stott MB, 2008, ENVIRON MICROBIOL, V10, P2030, DOI 10.1111/j.1462-2920.2008.01621.x; Subramaniam S, 1998, PROTEINS, V32, P1; Thiele I, 2010, NAT PROTOC, V5, P93, DOI 10.1038/nprot.2009.203; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vartoukian SR, 2010, FEMS MICROBIOL LETT, V309, P1, DOI 10.1111/j.1574-6968.2010.02000.x; Watve M, 2000, CURR SCI INDIA, V78, P1535; Yasumoto-Hirose M, 2006, MAR BIOTECHNOL, V8, P227, DOI 10.1007/s10126-005-5015-3; Zengler K, 2002, P NATL ACAD SCI USA, V99, P15681, DOI 10.1073/pnas.252630999; Zengler K, 2005, METHOD ENZYMOL, V397, P124, DOI 10.1016/S0076-6879(05)97007-9	49	29	29	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e103548	10.1371/journal.pone.0103548	http://dx.doi.org/10.1371/journal.pone.0103548			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25098325	Green Submitted, Green Published, gold			2022-12-27	WOS:000339995100022
J	Gea, J; Munoz, MA; Costa, I; Ciria, LF; Miranda, JGV; Montoya, P				Gea, Juan; Munoz, Miguel A.; Costa, Isis; Ciria, Luis F.; Miranda, Jose G. V.; Montoya, Pedro			Viewing Pain and Happy Faces Elicited Similar Changes in Postural Body Sway	PLOS ONE			English	Article							FACIAL EXPRESSIONS; EMOTION; FEAR; MOTIVATION; PICTURES; THREAT	Affective facial expressions are potent social cues that can induce relevant physiological changes, as well as behavioral dispositions in the observer. Previous studies have revealed that angry faces induced significant reductions in body sway as compared with neutral and happy faces, reflecting an avoidance behavioral tendency as freezing. The expression of pain is usually considered an unpleasant stimulus, but also a relevant cue for delivering effective care and social support. Nevertheless, there are few data about behavioral dispositions elicited by the observation of pain expressions in others. The aim of the present research was to evaluate approach-avoidance tendencies by using video recordings of postural body sway when participants were standing and observing facial expressions of pain, happy and neutral. We hypothesized that although pain faces would be rated as more unpleasant than the other faces, they would provoke significant changes in postural body sway as compared to neutral facial expressions. Forty healthy female volunteers (mean age 25) participated in the study. Amplitude of forward movements and backward movements in the anterior-posterior and medial-lateral axes were obtained. Statistical analyses revealed that pain faces were the most unpleasant stimuli, and that both happy and pain faces were more arousing than neutral ones. Happy and pain faces also elicited greater amplitude of body sway in the anterior-posterior axes as compared with neutral faces. In addition, significant positive correlations were found between body sway elicited by pain faces and pleasantness and empathic ratings, suggesting that changes in postural body sway elicited by pain faces might be associated with approach and cooperative behavioral responses.	[Gea, Juan; Costa, Isis; Montoya, Pedro] Univ Balearic Isl, Res Inst Hlth Sci IUNICS, Palma De Mallorca, Spain; [Munoz, Miguel A.; Ciria, Luis F.] Univ Granada, Dept Personal, Granada, Spain; [Miranda, Jose G. V.] Univ Fed Bahia, Dept Phys Earth & Environm, Salvador, BA, Brazil	Universitat de les Illes Balears; University of Granada; Universidade Federal da Bahia	Montoya, P (corresponding author), Univ Balearic Isl, Res Inst Hlth Sci IUNICS, Palma De Mallorca, Spain.	pedro.montoya@uib.es	Miranda, Jose/HCI-6099-2022; Ciria, Luis/AAA-7528-2020; Montoya, Pedro/A-4666-2009; Muñoz, Miguel Angel/A-8067-2017	Montoya, Pedro/0000-0001-8652-948X; Muñoz, Miguel Angel/0000-0002-8361-7297; Ciria, Luis/0000-0001-7067-5060	Spanish Ministry of Science and Innovation [PSI2010-19372]; European Regional Development Funds	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Regional Development Funds(European Commission)	Research was funded by grant #PSI2010-19372 from Spanish Ministry of Science and Innovation and European Regional Development Funds (http://www.idi.mineco.gob.es/portal/site/MICINN/menuitem.dbc68b34d11ccbd5d52ffeb801432ea0/?vgnextoid = 17aba53632295210VgnVCM1000001d04140aRCRD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azevedo TM, 2005, PSYCHOPHYSIOLOGY, V42, P255, DOI 10.1111/j.1469-8986.2005.00287.x; Bradley MM, 2001, EMOTION, V1, P276, DOI 10.1037//1528-3542.1.3.276; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; Davis JR, 2009, GAIT POSTURE, V29, P275, DOI 10.1016/j.gaitpost.2008.09.006; Eerland A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031291; Elliot AJ, 2001, EDUC PSYCHOL REV, V13, P73, DOI 10.1023/A:1009009018235; Facchinetti LD, 2006, NEUROSCI LETT, V410, P52, DOI 10.1016/j.neulet.2006.09.063; Frank MG, 2001, J PERS SOC PSYCHOL, V80, P75, DOI 10.1037/0022-3514.80.1.75; Goldin PR, 2008, BIOL PSYCHIAT, V63, P577, DOI 10.1016/j.biopsych.2007.05.031; Gonzalez-Roldan AM, 2013, ALTERED PSYCHOPHYSIO; Gonzalez-Roldan AM, 2011, PAIN, V152, P853, DOI 10.1016/j.pain.2010.12.037; Hillman CH, 2004, BIOL PSYCHOL, V66, P51, DOI 10.1016/j.biopsycho.2003.07.005; Horslen BC, 2011, EXP BRAIN RES, V215, P27, DOI 10.1007/s00221-011-2867-9; Horstmann G, 2003, EMOTION, V3, P150, DOI 10.1037/1528-3542.3.2.150; Kret ME, 2011, NEUROIMAGE, V54, P1755, DOI 10.1016/j.neuroimage.2010.08.012; LANG PJ, 1995, AM PSYCHOL, V50, P372, DOI 10.1037/0003-066X.50.5.372; Lang PJ, 1997, ATTENTION ORIENTING; Latash ML, 2003, EXP BRAIN RES, V150, P314, DOI 10.1007/s00221-003-1419-3; Lopes FL, 2009, DEPRESS ANXIETY, V26, P917, DOI 10.1002/da.20593; LUNDQVIST LO, 1995, SCAND J PSYCHOL, V36, P130, DOI 10.1111/j.1467-9450.1995.tb00974.x; Marsh AA, 2005, EMOTION, V5, P119, DOI 10.1037/1528-3542.5.1.119; Peña Norberto, 2013, Rev. Bras. Ensino Fís., V35, P1, DOI 10.1590/S1806-11172013000300024; Roelofs K, 2010, PSYCHOL SCI, V21, P1575, DOI 10.1177/0956797610384746; Rotteveel M, 2004, EMOTION, V4, P156, DOI 10.1037/1528-3542.4.2.156; Rutherford HJV, 2011, EMOT REV, V3, P333, DOI 10.1177/1754073911402392; Sato W, 2008, INT J PSYCHOPHYSIOL, V70, P70, DOI 10.1016/j.ijpsycho.2008.06.001; Seidel EM, 2010, J EXP PSYCHOL HUMAN, V36, P500, DOI 10.1037/a0018169; Simon D, 2008, PAIN, V135, P55, DOI 10.1016/j.pain.2007.05.008; Stins JF, 2011, EXP BRAIN RES, V212, P603, DOI 10.1007/s00221-011-2767-z; Stins JF, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-83; Teasdale N, 2001, GAIT POSTURE, V14, P203, DOI 10.1016/S0966-6362(01)00134-5; Vuillerme N, 2007, PSYCHOL RES-PSYCH FO, V71, P192, DOI 10.1007/s00426-005-0018-2; Whitney SL, 2011, GAIT POSTURE, V33, P594, DOI 10.1016/j.gaitpost.2011.01.015; Williams LM, 2004, COGNITIVE BRAIN RES, V21, P114, DOI 10.1016/j.cogbrainres.2004.06.005	34	13	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e104381	10.1371/journal.pone.0104381	http://dx.doi.org/10.1371/journal.pone.0104381			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO5BW	25093727	Green Published, Green Submitted, gold			2022-12-27	WOS:000341357200107
J	Ishida, M; Ishida, T; Tashiro, S; Uchida, H; Sakai, C; Hironobe, N; Miura, K; Hashimoto, Y; Arihiro, K; Chayama, K; Kihara, Y; Yoshizumi, M				Ishida, Mari; Ishida, Takafumi; Tashiro, Satoshi; Uchida, Hitomi; Sakai, Chiemi; Hironobe, Naoya; Miura, Katsuya; Hashimoto, Yu; Arihiro, Koji; Chayama, Kazuaki; Kihara, Yasuki; Yoshizumi, Masao			Smoking Cessation Reverses DNA Double-Strand Breaks in Human Mononuclear Cells	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; LUNG-CANCER PATIENTS; CIGARETTE-SMOKING; CARBON-MONOXIDE; ANGIOTENSIN-II; TOBACCO-SMOKE; DAMAGE; REPAIR; ATHEROSCLEROSIS; SENESCENCE	Objective: Cigarette smoking is a major risk factor for atherosclerotic cardiovascular disease, which is responsible for a significant proportion of smoking-related deaths. However, the precise mechanism whereby smoking induces this pathology has not been fully delineated. Based on observation of DNA double-strand breaks (DSBs), the most harmful type of DNA damage, in atherosclerotic lesions, we hypothesized that there is a direct association between smoking and DSBs. The goal of this study was to investigate whether smoking induces DSBs and smoking cessation reverses DSBs in vivo through examination of peripheral mononuclear cells (MNCs). Approach and Results: Immunoreactivity of oxidative modification of DNA and DSBs were increased in human atherosclerotic lesions but not in the adjacent normal area. DSBs in human MNCs isolated from the blood of volunteers can be detected as cytologically visible "foci'' using an antibody against the phosphorylated form of the histone H2AX (gamma-H2AX). Young healthy active smokers (n = 15) showed increased gamma-H2AX foci number when compared with non-smokers (n = 12) (foci number/cell: median, 0.37/cell; interquartile range [IQR], 0.31-0.58 vs. 4.36/cell; IQR, 3.09-7.39, p<0.0001). Smoking cessation for 1 month reduced the gamma-H2AX foci number (median, 4.44/cell; IQR, 4.36-5.24 to 0.28/cell; IQR, 0.12-0.53, p<0.05). A positive correlation was noted between gamma-H2AX foci number and exhaled carbon monoxide levels (r = 0.75, p<0.01). Conclusions: Smoking induces DSBs in human MNCs in vivo, and importantly, smoking cessation for 1 month resulted in a decrease in DSBs to a level comparable to that seen in non-smokers. These data reinforce the notion that the cigarette smoking induces DSBs and highlight the importance of smoking cessation.	[Ishida, Mari; Uchida, Hitomi; Sakai, Chiemi; Miura, Katsuya; Yoshizumi, Masao] Hiroshima Univ, Dept Cardiovasc Physiol & Med, Grad Sch Biomed & Hlth Sci, Hiroshima, Japan; [Ishida, Takafumi; Hironobe, Naoya; Hashimoto, Yu; Kihara, Yasuki] Hiroshima Univ, Dept Cardiovasc Med, Grad Sch Biomed & Hlth Sci, Hiroshima, Japan; [Tashiro, Satoshi] Hiroshima Univ, Dept Cellular Biol, Res Inst Radiat Biol & Med, Hiroshima, Japan; [Arihiro, Koji] Hiroshima Univ Hosp, Dept Anat Pathol, Hiroshima, Japan; [Chayama, Kazuaki] Hiroshima Univ, Dept Gastroenterol & Metab, Grad Sch Biomed & Hlth Sci, Hiroshima, Japan	Hiroshima University; Hiroshima University; Hiroshima University; Hiroshima University; Hiroshima University	Ishida, T (corresponding author), Hiroshima Univ, Dept Cardiovasc Med, Grad Sch Biomed & Hlth Sci, Hiroshima, Japan.	ishidat@hiroshima-u.ac.jp	Ishida, Mari/L-8208-2016; Chayama, Kazuaki/B-2493-2016	Chayama, Kazuaki/0000-0002-5530-5341	Ministry of Education, Culture, Sports, Science and Technology of Japan [22590528]; Takeda Science Foundation; Kurozumi Medical Foundation; SENSHIN Medical Research Foundation	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Kurozumi Medical Foundation(Kurozumi Medical Foundation); SENSHIN Medical Research Foundation(SENSHIN Medical Research Foundation)	This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan, #22590528 (http://www.jsps.go.jp/english/e-grants/index.html) to MI and TI, research grants from the Takeda Science Foundation (http://www.takeda-sci.or.jp/index.html), the Kurozumi Medical Foundation (http://www.kmf.or.jp/), and the SENSHIN Medical Research Foundation (http://www.mt-pharma.co.jp/zaidan/) to MI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albino AP, 2009, MUTAT RES-GEN TOX EN, V678, P43, DOI 10.1016/j.mrgentox.2009.06.009; Albino AP, 2004, CELL CYCLE, V3, P1062; Asami S, 1996, CANCER RES, V56, P2546; Babizhayev MA, 2011, FUND CLIN PHARMACOL, V25, P425, DOI 10.1111/j.1472-8206.2010.00866.x; Bekker-Jensen S, 2010, DNA REPAIR, V9, P1219, DOI 10.1016/j.dnarep.2010.09.010; BURR ML, 1992, EUR HEART J, V13, P166, DOI 10.1093/oxfordjournals.eurheartj.a060141; Chen YY, 2007, CELL METAB, V6, P164, DOI 10.1016/j.cmet.2007.07.001; Clarke MCH, 2006, NAT MED, V12, P1075, DOI 10.1038/nm1459; Darby SC, 2013, NEW ENGL J MED, V368, P987, DOI 10.1056/NEJMoa1209825; Ding SL, 2008, CLIN INTERV AGING, V3, P431, DOI 10.2147/CIA.S1957; Hou SM, 1999, CARCINOGENESIS, V20, P437, DOI 10.1093/carcin/20.3.437; Ishida M, 1998, CIRC RES, V82, P7; Jorgensen ED, 2010, CELL CYCLE, V9, P2170, DOI 10.4161/cc.9.11.11842; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Kinner A, 2008, NUCLEIC ACIDS RES, V36, P5678, DOI 10.1093/nar/gkn550; Kunieda T, 2006, CIRCULATION, V114, P953, DOI 10.1161/CIRCULATIONAHA.106.626606; Lodovici M, 2009, INT J ENV RES PUB HE, V6, P874, DOI 10.3390/ijerph6030874; Lukas J, 2011, NAT CELL BIOL, V13, P1161, DOI 10.1038/ncb2344; Mahmoudi M, 2008, CIRC RES, V103, P717, DOI 10.1161/CIRCRESAHA.108.182899; Meyers DG, 2008, AM J CARDIOL, V102, P1421, DOI 10.1016/j.amjcard.2008.06.065; Middleton ET, 2000, CHEST, V117, P758, DOI 10.1378/chest.117.3.758; Minamino T, 2003, CIRCULATION, V108, P2264, DOI 10.1161/01.CIR.0000093274.82929.22; Moreno H, 1998, AM J PHYSIOL-HEART C, V275, pH1040, DOI 10.1152/ajpheart.1998.275.3.H1040; Nowosielska A, 2008, DNA REPAIR, V7, P48, DOI 10.1016/j.dnarep.2007.07.015; Peluso M, 2000, CARCINOGENESIS, V21, P183, DOI 10.1093/carcin/21.2.183; Rahman AA, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/189129; Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909; Skosareva LV, 2012, BIOCHEMISTRY-MOSCOW+, V77, P524, DOI 10.1134/S0006297912050136; Slatter TL, 2014, HUM PATHOL, V45, P17, DOI 10.1016/j.humpath.2013.07.024; Thorne D, 2009, MUTAT RES-GEN TOX EN, V673, P3, DOI 10.1016/j.mrgentox.2008.11.008; Thorp E, 2009, ARTERIOSCL THROM VAS, V29, P169, DOI 10.1161/ATVBAHA.108.176495; Vamvakas S, 1997, CRIT REV TOXICOL, V27, P155, DOI 10.3109/10408449709021617; van Zeeland AA, 1999, MUTAT RES-GEN TOX EN, V439, P249, DOI 10.1016/S1383-5718(98)00192-2; Varkonyi A, 2006, CANCER LETT, V236, P24, DOI 10.1016/j.canlet.2005.04.034; WALD NJ, 1981, THORAX, V36, P366, DOI 10.1136/thx.36.5.366; Wang JC, 2012, CIRC RES, V111, P245, DOI 10.1161/CIRCRESAHA.111.261388	36	24	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e103993	10.1371/journal.pone.0103993	http://dx.doi.org/10.1371/journal.pone.0103993			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093845	Green Published, gold, Green Submitted			2022-12-27	WOS:000341357200055
J	Topf, A; Griffin, HR; Glen, E; Soemedi, R; Brown, DL; Hall, D; Rahman, TJ; Eloranta, JJ; Jungst, C; Stuart, AG; O'Sullivan, J; Keavney, BD; Goodship, JA				Toepf, Ana; Griffin, Helen R.; Glen, Elise; Soemedi, Rachel; Brown, Danielle L.; Hall, Darroch; Rahman, Thahira J.; Eloranta, Jyrki J.; Juengst, Christoph; Stuart, A. Graham; O'Sullivan, John; Keavney, Bernard D.; Goodship, Judith A.			Functionally Significant, Rare Transcription Factor Variants in Tetralogy of Fallot	PLOS ONE			English	Article							CONGENITAL HEART-DISEASE; MISSENSE MUTATIONS; MENTAL-RETARDATION; NKX2.5 MUTATIONS; GENETIC SYNDROME; SEPTAL-DEFECT; FOXC1; GATA4; TBX1; EXPRESSION	Objective: Rare variants in certain transcription factors involved in cardiac development cause Mendelian forms of congenital heart disease. The purpose of this study was to systematically assess the frequency of rare transcription factor variants in sporadic patients with the cardiac outflow tract malformation tetralogy of Fallot (TOF). Methods and Results: We sequenced the coding, 5'UTR, and 3'UTR regions of twelve transcription factor genes implicated in cardiac outflow tract development (NKX2.5, GATA4, ISL1, TBX20, MEF2C, BOP/SMYD1, HAND2, FOXC1, FOXC2, FOXH, FOXA2 and TBX1) in 93 non-syndromic, non-Mendelian TOF cases. We also analysed Illumina Human 660W-Quad SNP Array data for copy number variants in these genes; none were detected. Four of the rare variants detected have previously been shown to affect transactivation in in vitro reporter assays: FOXC1 p.P297S, FOXC2 p.Q444R, FOXH1 p.S113T and TBX1 p.P43_G61del PPPPRYDPCAAAAPGAPGP. Two further rare variants, HAND2 p.A25_A26insAA and FOXC1 p.G378_G380delGGG, A488_491delAAAA, affected transactivation in in vitro reporter assays. Each of these six functionally significant variants was present in a single patient in the heterozygous state; each of the four for which parental samples were available were maternally inherited. Thus in the 93 TOF cases we identified six functionally significant mutations in the secondary heart field transcriptional network. Significance: This study indicates that rare genetic variants in the secondary heart field transcriptional network with functional effects on protein function occur in 3-13% of patients with TOF. This is the first report of a functionally significant HAND2 mutation in a patient with congenital heart disease.	[Toepf, Ana; Griffin, Helen R.; Glen, Elise; Soemedi, Rachel; Brown, Danielle L.; Hall, Darroch; Rahman, Thahira J.; Keavney, Bernard D.; Goodship, Judith A.] Newcastle Univ, Inst Med Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Eloranta, Jyrki J.; Juengst, Christoph] Univ Zurich Hosp, Dept Clin Pharmacol & Toxicol, CH-8091 Zurich, Switzerland; [Juengst, Christoph] Univ Saarland, Med Ctr, Dept Med 2, Homburg, Germany; [Stuart, A. Graham] Bristol Royal Hosp Children, Bristol, Avon, England; [O'Sullivan, John] Freeman Hosp Newcastle Tyne Hosp NHS Fdn Trust, Newcastle Upon Tyne, Tyne & Wear, England; [Keavney, Bernard D.] Univ Manchester, Inst Cardiovasc Sci, Manchester, Lancs, England	Newcastle University - UK; University of Zurich; University Zurich Hospital; Saarland University; Bristol Royal Hospital For Children; Newcastle Upon Tyne Hospitals NHS Foundation Trust; University of Manchester	Keavney, BD (corresponding author), Newcastle Univ, Inst Med Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	bernard.keavney@manchester.ac.uk; judith.goodship@ncl.ac.uk		Keavney, Bernard/0000-0001-9573-0812; Griffin, Helen R/0000-0002-5288-3322; Jungst, Christoph/0000-0001-5048-390X; Stuart, Alan Graham/0000-0003-2789-2216	British Heart Foundation; British Heart Foundation [RG/08/012/25941] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); British Heart Foundation(British Heart Foundation)	This study was funded by a British Heart Foundation Programme Grant. BDK holds a BHF Personal Chair. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht A, 2005, CURR OPIN GENET DEV, V15, P285, DOI 10.1016/j.gde.2005.04.003; Bienvenu T, 2002, HUM MOL GENET, V11, P981, DOI 10.1093/hmg/11.8.981; Bourgeois CF, 1999, MOL CELL BIOL, V19, P7347; Brais B, 1998, NAT GENET, V18, P164, DOI 10.1038/ng0298-164; Brice G, 2002, J MED GENET, V39, P478, DOI 10.1136/jmg.39.7.478; Buckingham M, 2005, NAT REV GENET, V6, P826, DOI 10.1038/nrg1710; Cunningham ET, 1998, ARCH OPHTHALMOL-CHIC, V116, P78, DOI 10.1001/archopht.116.1.78; Fetterman CD, 2009, CLIN GENET, V76, P296, DOI 10.1111/j.1399-0004.2009.01210.x; Garg V, 2003, NATURE, V424, P443, DOI 10.1038/nature01827; Goldmuntz E, 2001, CIRCULATION, V104, P2565, DOI 10.1161/hc4601.098427; Granados-Riveron JT, 2012, CONGENIT HEART DIS, V7, P151, DOI 10.1111/j.1747-0803.2011.00573.x; Griffin HR, 2010, HEART, V96, P1651, DOI 10.1136/hrt.2010.200121; Grosso S, 2002, AM J MED GENET, V111, P182, DOI 10.1002/ajmg.10493; Hirayama-Yamada K, 2005, AM J MED GENET A, V135A, P47, DOI 10.1002/ajmg.a.30684; Kirk EP, 2007, AM J HUM GENET, V81, P280, DOI 10.1086/519530; Posch MG, 2010, J MED GENET, V47, P230, DOI 10.1136/jmg.2009.069997; Roessler E, 2008, AM J HUM GENET, V83, P18, DOI 10.1016/j.ajhg.2008.05.012; Saleem RA, 2001, AM J HUM GENET, V68, P627, DOI 10.1086/318792; Shen L, 2010, CHINESE MED J-PEKING, V123, P1623, DOI 10.3760/cma.j.issn.0366-6999.2010.13.002; Singh R, 2009, CIRC RES, V105, P442, DOI 10.1161/CIRCRESAHA.109.196063; Soemedi R, 2012, AM J HUM GENET, V91, P489, DOI 10.1016/j.ajhg.2012.08.003; Strehle EM, 2012, AM J MED GENET A, V158A, P2139, DOI 10.1002/ajmg.a.35502; Tamura M, 2013, HUM MOL GENET, V22, P2471, DOI 10.1093/hmg/ddt099; Thattaliyath BD, 2002, J MOL CELL CARDIOL, V34, P1335, DOI 10.1006/jmcc.2002.2085; Tumer Z, 2009, EUR J HUM GENET, V17, P1527, DOI 10.1038/ejhg.2009.93; van Steensel MAM, 2009, HUM MUTAT, V30, pE1002, DOI 10.1002/humu.21127; Vavricka SR, 2004, J HEPATOL, V40, P212, DOI 10.1016/j.jhep.2003.10.008; Wendl T, 2007, DEVELOPMENT, V134, P2871, DOI 10.1242/dev.02872; Yagi H, 2003, LANCET, V362, P1366, DOI 10.1016/S0140-6736(03)14632-6; Zidere V, 2006, ULTRASOUND OBST GYN, V28, P876, DOI 10.1002/uog.3841; Zweier C, 2007, AM J HUM GENET, V80, P510, DOI 10.1086/511993; Zweier M, 2010, HUM MUTAT, V31, P722, DOI 10.1002/humu.21253	32	44	45	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e95453	10.1371/journal.pone.0095453	http://dx.doi.org/10.1371/journal.pone.0095453			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093829	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000341357200001
J	Zhou, WW; Zhang, BL; Chen, HM; Jin, JQ; Yang, JX; Wang, YY; Jiang, K; Murphy, RW; Zhang, YP; Che, J				Zhou, Wei-wei; Zhang, Bao-lin; Chen, Hong-man; Jin, Jie-qiong; Yang, Jun-xiao; Wang, Yun-yu; Jiang, Ke; Murphy, Robert W.; Zhang, Ya-ping; Che, Jing			DNA Barcodes and Species Distribution Models Evaluate Threats of Global Climate Changes to Genetic Diversity: A Case Study from Nanorana parkeri (Anura: Dicroglossidae)	PLOS ONE			English	Article							POPULATION-GROWTH; SYSTEM; CONSERVATISM; ECOLOGY; HISTORY	Anthropogenic global climate changes are one of the greatest threats to biodiversity. Distribution modeling can predict the effects of climate changes and potentially their effects on genetic diversity. DNA barcoding quickly identifies patterns of genetic diversity. As a case study, we use DNA barcodes and distribution models to predict threats under climate changes in the frog Nanorana parkeri, which is endemic to the Qinghai-Tibetan Plateau. Barcoding identifies major lineages W and E. Lineage W has a single origin in a refugium and Lineage E derives from three refugia. All refugia locate in river valleys and each greatly contributes to the current level of intraspecific genetic diversity. Species distribution models suggest that global climate changes will greatly influence N. parkeri, especially in the level of genetic diversity, because two former refugia will fail to provide suitable habitat. Our pipeline provides a novel application of DNA barcoding and has important implications for the conservation of biodiversity in southern areas of the Qinghai-Tibetan Plateau.	[Zhou, Wei-wei; Zhang, Bao-lin; Chen, Hong-man; Jin, Jie-qiong; Yang, Jun-xiao; Wang, Yun-yu; Jiang, Ke; Murphy, Robert W.; Che, Jing] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China; [Zhou, Wei-wei; Zhang, Bao-lin; Chen, Hong-man; Jin, Jie-qiong; Yang, Jun-xiao; Wang, Yun-yu; Jiang, Ke; Murphy, Robert W.; Che, Jing] Chinese Acad Sci, Kunming Inst Zool, Yunnan Lab Mol Biol Domest Anim, Kunming, Peoples R China; [Zhang, Bao-lin; Zhang, Ya-ping] Yunnan Univ, Lab Conservat & Utilizat Bioresources, Kunming, Peoples R China; [Murphy, Robert W.] Royal Ontario Museum, Ctr Biodivers & Conservat Biol, Toronto, ON M5S 2C6, Canada	Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; Kunming Institute of Zoology; Yunnan University; Royal Ontario Museum	Zhang, YP (corresponding author), Yunnan Univ, Lab Conservat & Utilizat Bioresources, Kunming, Peoples R China.	zhangyp@mail.kiz.ac.cn; chej@mail.kiz.ac.cn			Strategic Priority Research Program (B) [XDB03030113]; Ministry of Science and Technology of China (MOST) [2014FY210200]; Chinese Academy of Sciences (CAS); CAS [KJZD-EW-L07]; National Natural Science Foundation of China [31090250]; MOST [2011FY120200]; Bureau of Science and Technology of Yunnan, China [2010CI045]; Major Innovation Program of CAS [KSCX2-EW-Z-2]; Natural Sciences and Engineering Research Council of Canada [3148]	Strategic Priority Research Program (B)(Chinese Academy of Sciences); Ministry of Science and Technology of China (MOST)(Ministry of Science and Technology, China); Chinese Academy of Sciences (CAS)(Chinese Academy of Sciences); CAS(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); MOST; Bureau of Science and Technology of Yunnan, China; Major Innovation Program of CAS; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by grants of the Strategic Priority Research Program (B) (XDB03030113), the Ministry of Science and Technology of China (MOST) (2014FY210200), and the "Western Light" Talents Training Program of the Chinese Academy of Sciences (CAS) to ZWW; the Key Research Program (KJZD-EW-L07) of CAS, the National Natural Science Foundation of China (31090250), MOST (2011FY120200), and the Bureau of Science and Technology of Yunnan, China (2010CI045) to JC; and the Major Innovation Program of CAS (KSCX2-EW-Z-2) to ZYP. Research also was supported by Discovery Grant 3148 from the Natural Sciences and Engineering Research Council of Canada to RWM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baele G, 2012, MOL BIOL EVOL, V29, P2157, DOI 10.1093/molbev/mss084; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Beebee TJC, 2005, HEREDITY, V95, P423, DOI 10.1038/sj.hdy.6800736; Brandley MC, 2005, SYST BIOL, V54, P373, DOI 10.1080/10635150590946808; Brown JM, 2007, SYSTEMATIC BIOL, V56, P643, DOI 10.1080/10635150701546249; Che J, 2012, MOL ECOL RESOUR, V12, P247, DOI 10.1111/j.1755-0998.2011.03090.x; Che J, 2010, P NATL ACAD SCI USA, V107, P13765, DOI 10.1073/pnas.1008415107; Che J, 2009, MOL PHYLOGENET EVOL, V50, P59, DOI 10.1016/j.ympev.2008.10.007; Collins WD, 2006, J CLIMATE, V19, P2122, DOI 10.1175/JCLI3761.1; Crandall KA, 2000, TRENDS ECOL EVOL, V15, P290, DOI 10.1016/S0169-5347(00)01876-0; Dellicour S, 2013, MOL ECOL RE IN PRESS; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fei L, 2005, ILLUSTRATED KEY CHIN; Fu YX, 1997, GENETICS, V147, P915; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Guisan A, 2013, ECOL LETT, V16, P1424, DOI 10.1111/ele.12189; Hasumi H, 2004, K 1 COUPLED GCM MIRC; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Holt RD, 2003, EVOL ECOL RES, V5, P159; Jia DR, 2011, BIOL J LINN SOC, V102, P37, DOI 10.1111/j.1095-8312.2010.01553.x; [李生辰 Li Shengzhen], 2007, [中国沙漠, Journal of Desert Research], V27, P307; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Merow C, 2013, ECOGRAPHY, V36, P1058, DOI 10.1111/j.1600-0587.2013.07872.x; MORITZ C, 1994, TRENDS ECOL EVOL, V9, P373, DOI 10.1016/0169-5347(94)90057-4; Nylander J.A.A., 2004, MRMODELTEST V2 PROGR; Nylander JAA, 2008, BIOINFORMATICS, V24, P581, DOI 10.1093/bioinformatics/btm388; Peterson AT, 1999, SCIENCE, V285, P1265, DOI 10.1126/science.285.5431.1265; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Polzin T, 2003, OPER RES LETT, V31, P12, DOI 10.1016/S0167-6377(02)00185-2; Rambaut A., 2007, TRACER V1 4; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rosenzweig C, 2008, NATURE, V453, P353, DOI 10.1038/nature06937; Sambrook J., 2001, MOL CLONING LAB MANU; Smith AB, 2013, DIVERS DISTRIB, V19, P867, DOI 10.1111/ddi.12031; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Swofford DL., 2003, PAUP PHYLOGENETIC AN; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Wang H, 2010, MOL ECOL, V19, P2964, DOI 10.1111/j.1365-294X.2010.04729.x; Wang L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025896; Wang LY, 2009, MOL ECOL, V18, P709, DOI 10.1111/j.1365-294X.2008.04055.x; Wiens JJ, 2005, ANNU REV ECOL EVOL S, V36, P519, DOI 10.1146/annurev.ecolsys.36.102803.095431; Yang FS, 2008, MOL ECOL, V17, P5135, DOI 10.1111/j.1365-294X.2008.03976.x; Yao T, 2000, CHINESE SCI BULL, V45, P98; [赵井东 ZHAO Jingdong], 2011, [地理学报, Acta Geographica Sinica], V66, P867; Zheng D, 1996, SCI CHINA SER D, V39, P410; Zhou WW, 2013, MOL ECOL, V22, P130, DOI 10.1111/mec.12087	57	10	13	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e103899	10.1371/journal.pone.0103899	http://dx.doi.org/10.1371/journal.pone.0103899			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093586	Green Submitted, Green Published, gold			2022-12-27	WOS:000341357200042
J	Lee, J; Jain, A; Kim, P; Lee, T; Kuller, A; Princen, F; In-Gudo; Kim, SH; Park, JO; Park, YS; Singh, S; Kim, HC				Lee, Jeeyun; Jain, Anjali; Kim, Phillip; Lee, Tani; Kuller, Anne; Princen, Fred; In-Gudo; Kim, Suk Hyeong; Park, Joon Oh; Park, Young Suk; Singh, Sharat; Kim, Hee Cheol			Activated cMET and IGF1R-Driven PI3K Signaling Predicts Poor Survival in Colorectal Cancers Independent of KRAS Mutational Status	PLOS ONE			English	Article							1ST-LINE TREATMENT; CETUXIMAB; RAS; FLUOROURACIL; CHEMOTHERAPY; PANITUMUMAB; OXALIPLATIN; COMBINATION; LEUCOVORIN; INHIBITORS	Background: Oncogenic mutational analysis provides predictive guidance for therapeutics such as anti-EGFR antibodies, but it is successful only for a subset of colorectal cancer (CRC) patients. Method: A comprehensive molecular profiling of 120 CRC patients, including 116 primary, 15 liver metastasis, and 1 peritoneal seeding tissue samples was performed to identify the relationship between v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (KRAS) WT and mutant CRC tumors and clinical outcomes. This included determination of the protein activation patterns of human epidermal receptor 1 (HER1), HER2, HER3, c-MET, insulin-like growth factor 1 receptor (IGF1R), phosphatidylinositide 3-kinase (PI3K), Src homology 2 domain containing (Shc), protein kinase B (AKT), and extracellular signal-regulated kinase (ERK) kinases using multiplexed collaborative enzyme enhanced reactive (CEER) immunoassay. Results: KRAS WT and mutated CRCs were not different with respect to the expression of the various signaling molecules. Poor prognosis in terms of early relapse (<2 years) and shorter disease-free survival (DFS) correlated with enhanced activation of PI3K signaling relative to the HER kinase pathway signaling, but not with the KRAS mutational status. KRAS WT CRCs were identified as a mixed prognosis population depending on their level of PI3K signaling. KRAS WT CRCs with high HER1/c-MET index ratio demonstrated a better DFS post-surgery. c-MET and IGF1R activities relative to HER axis activity were considerably higher in early relapse CRCs, suggesting a role for these alternative receptor tyrosine kinases (RTKs) in driving high PI3K signaling. Conclusions: The presented data subclassified CRCs based on their activated signaling pathways and identify a role for c-MET and IGF1R-driven PI3K signaling in CRCs, which is superior to KRAS mutational tests alone. The results from this study can be utilized to identify aggressive CRCs, explain failure of currently approved therapeutics in specific CRC subsets, and, most importantly, generate hypotheses for pathway-guided therapeutic strategies that can be tested clinically.	[Lee, Jeeyun; Park, Joon Oh; Park, Young Suk] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Hematol Oncol,Dept Med, Seoul, South Korea; [Kim, Hee Cheol] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Surg, Seoul, South Korea; [Jain, Anjali; Kim, Phillip; Lee, Tani; Kuller, Anne; Princen, Fred; Singh, Sharat] Prometheus Labs, San Diego, CA USA; [In-Gudo; Kim, Suk Hyeong] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Kim, HC (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Surg, Seoul, South Korea.	hckim@skku.edu	Lee, Jeeyun/I-7171-2015; Lee, Jee Yun/C-9646-2011		Samsung Biomedical Research Institute [SS1-B3-011-1]; Korea Health Industry Development Institute(KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI13C1951]	Samsung Biomedical Research Institute(Samsung); Korea Health Industry Development Institute(KHIDI) - Ministry of Health & Welfare, Republic of Korea	This study was partially supported by Samsung Biomedical Research Institute grant #SS1-B3-011-1. This research was suppoorted by a grant of the Korea Health technology R&D Project through the Korea Health Industry Development Institute(KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea. (Grant Number: HI13C1951). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allegra CJ, 2009, J CLIN ONCOL, V27, P2091, DOI 10.1200/JCO.2009.21.9170; Bardelli A, 2010, J CLIN ONCOL, V28, P1254, DOI 10.1200/JCO.2009.24.6116; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; Coffee EM, 2013, CLIN CANCER RES, V19, P2688, DOI 10.1158/1078-0432.CCR-12-2556; De Roock W, 2010, JAMA-J AM MED ASSOC, V304, P1812, DOI 10.1001/jama.2010.1535; De Roock W, 2010, LANCET ONCOL, V11, P753, DOI 10.1016/S1470-2045(10)70130-3; Douillard JY, 2010, J CLIN ONCOL, V28, P4697, DOI 10.1200/JCO.2009.27.4860; Ebi H, 2011, J CLIN INVEST, V121, P4311, DOI 10.1172/JCI57909; Elkabets M, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005747; Gupta S, 2007, CELL, V129, P957, DOI 10.1016/j.cell.2007.03.051; Juric D, 2012, J CLIN ONCOL, V30, P765, DOI 10.1200/JCO.2011.39.6390; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Kim P, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-75; Knijn N, 2011, BRIT J CANCER, V104, P1020, DOI 10.1038/bjc.2011.26; Martin-Fernandez C, 2009, MOL CANCER RES, V7, P955, DOI 10.1158/1541-7786.MCR-08-0445; Morlan J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004584; Phipps AI, 2013, BRIT J CANCER, V108, P1757, DOI 10.1038/bjc.2013.118; Poehlmann A, 2007, PATHOL RES PRACT, V203, P489, DOI 10.1016/j.prp.2007.06.001; Raponi M, 2008, CURR OPIN PHARMACOL, V8, P413, DOI 10.1016/j.coph.2008.06.006; Roper J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025132; Starling Naureen, 2005, Clin Colorectal Cancer, V5 Suppl 1, pS28, DOI 10.3816/CCC.2005.s.004; Tabernero J, 2007, J CLIN ONCOL, V25, P5225, DOI 10.1200/JCO.2007.13.2183; Vakiani E, 2012, J CLIN ONCOL, V30, P2956, DOI 10.1200/JCO.2011.38.2994; Van Cutsem E, 2009, NEW ENGL J MED, V360, P1408, DOI 10.1056/NEJMoa0805019; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; Ward TM, 2013, ONCOGENE, V32, P2463, DOI 10.1038/onc.2012.256	26	14	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103551	10.1371/journal.pone.0103551	http://dx.doi.org/10.1371/journal.pone.0103551			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25090459	Green Submitted, Green Published, gold			2022-12-27	WOS:000339812700030
J	Grychtol, B; Elke, G; Meybohm, P; Weiler, N; Frerichs, I; Adler, A				Grychtol, Bartlomiej; Elke, Gunnar; Meybohm, Patrick; Weiler, Norbert; Frerichs, Inez; Adler, Andy			Functional Validation and Comparison Framework for EIT Lung Imaging	PLOS ONE			English	Article							ELECTRICAL-IMPEDANCE TOMOGRAPHY; RECONSTRUCTION ALGORITHM; VENTILATION DISTRIBUTION; REGIONAL VENTILATION; COMPUTED-TOMOGRAPHY; CONDUCTIVITY; IMPLEMENTATION; ATELECTASIS; AERATION; PREVENTS	Introduction: Electrical impedance tomography (EIT) is an emerging clinical tool for monitoring ventilation distribution in mechanically ventilated patients, for which many image reconstruction algorithms have been suggested. We propose an experimental framework to assess such algorithms with respect to their ability to correctly represent well-defined physiological changes. We defined a set of clinically relevant ventilation conditions and induced them experimentally in 8 pigs by controlling three ventilator settings (tidal volume, positive end-expiratory pressure and the fraction of inspired oxygen). In this way, large and discrete shifts in global and regional lung air content were elicited. Methods: We use the framework to compare twelve 2D EIT reconstruction algorithms, including backprojection (the original and still most frequently used algorithm), GREIT (a more recent consensus algorithm for lung imaging), truncated singular value decomposition (TSVD), several variants of the one-step Gauss-Newton approach and two iterative algorithms. We consider the effects of using a 3D finite element model, assuming non-uniform background conductivity, noise modeling, reconstructing for electrode movement, total variation (TV) reconstruction, robust error norms, smoothing priors, and using difference vs. normalized difference data. Results and Conclusions: Our results indicate that, while variation in appearance of images reconstructed from the same data is not negligible, clinically relevant parameters do not vary considerably among the advanced algorithms. Among the analysed algorithms, several advanced algorithms perform well, while some others are significantly worse. Given its vintage and ad-hoc formulation backprojection works surprisingly well, supporting the validity of previous studies in lung EIT.	[Grychtol, Bartlomiej] German Canc Res Ctr, Dept Med Phys Radiol, Heidelberg, Germany; [Grychtol, Bartlomiej] Fraunhofer Project Grp Automat Med & Biotechnol, Mannheim, Germany; [Elke, Gunnar; Weiler, Norbert; Frerichs, Inez] Univ Med Ctr Schleswig Holstein, Dept Anesthesiol & Intens Care Med, Kiel, Germany; [Meybohm, Patrick] Univ Hosp Frankfurt, Dept Anesthesiol Intens Care Med & Pain Therapy, Frankfurt, Germany; [Adler, Andy] Carleton Univ, Ottawa, ON K1S 5B6, Canada	Helmholtz Association; German Cancer Research Center (DKFZ); University of Kiel; Schleswig Holstein University Hospital; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Carleton University	Adler, A (corresponding author), Carleton Univ, Ottawa, ON K1S 5B6, Canada.	adler@sce.carleton.ca	Elke, Gunnar/S-8579-2016; Meybohm, Patrick/K-4066-2017; Frerichs, I./AAT-3685-2021; Grychtol, Bartek/A-6592-2016	Elke, Gunnar/0000-0002-4948-1605; Meybohm, Patrick/0000-0002-2666-8696; Frerichs, I./0000-0002-7712-6539; Grychtol, Bartek/0000-0002-8855-8046	Alexander von Humboldt Fellowship	Alexander von Humboldt Fellowship(Alexander von Humboldt Foundation)	BG was supported by the Alexander von Humboldt Fellowship. Experiments were supported with departamental funding. No external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler A, 2006, PHYSIOL MEAS, V27, pS25, DOI 10.1088/0967-3334/27/5/S03; Adler A, 1996, IEEE T BIO-MED ENG, V43, P414, DOI 10.1109/10.486261; Adler A, 1996, IEEE T MED IMAGING, V15, P170, DOI 10.1109/42.491418; Adler A, 2012, PHYSIOL MEAS, V33, P679, DOI 10.1088/0967-3334/33/5/679; Adler A, 2011, PHYSIOL MEAS, V32, DOI 10.1088/0967-3334/32/7/S07; Adler A, 2009, PHYSIOL MEAS, V30, pS35, DOI 10.1088/0967-3334/30/6/S03; Amato MBP, 1998, NEW ENGL J MED, V338, P347, DOI 10.1056/NEJM199802053380602; Aykroyd RG, 2006, MEAS SCI TECHNOL, V17, P2405, DOI 10.1088/0957-0233/17/9/006; BARBER CC, 1983, ELECTRON LETT, V19, P933, DOI 10.1049/el:19830637; BARBER DC, 1984, J PHYS E SCI INSTRUM, V17, P723, DOI 10.1088/0022-3735/17/9/002; Bikker IG, 2011, CRIT CARE, V15, DOI 10.1186/cc10354; Borsic A, 2012, INVERSE PROBL, V28, DOI 10.1088/0266-5611/28/9/095011; Borsic A, 2010, IEEE T MED IMAGING, V29, P44, DOI 10.1109/TMI.2009.2022540; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Brown B H, 1987, Clin Phys Physiol Meas, V8 Suppl A, P91, DOI 10.1088/0143-0815/8/4A/012; Bruhl M, 2000, INVERSE PROBL, V16, P1029, DOI 10.1088/0266-5611/16/4/310; Cheney M., 1990, International Journal of Imaging Systems and Technology, V2, P66, DOI 10.1002/ima.1850020203; Dai T, 2008, MED BIOL ENG COMPUT, V46, P889, DOI 10.1007/s11517-008-0371-6; Lima CR, 2007, MEAS SCI TECHNOL, V18, P2847, DOI 10.1088/0957-0233/18/9/014; Ferrario D, 2012, IEEE T BIO-MED ENG, V59, P3000, DOI 10.1109/TBME.2012.2209116; Frerichs I, 2003, INTENS CARE MED, V29, P2312, DOI 10.1007/s00134-003-2029-z; Frerichs I, 2002, J APPL PHYSIOL, V93, P660, DOI 10.1152/japplphysiol.00081.2002; Graham BM, 2006, PHYSIOL MEAS, V27, pS65, DOI 10.1088/0967-3334/27/5/S06; Grychtol B, 2013, PHYSIOL MEAS, V34, P579, DOI 10.1088/0967-3334/34/6/579; Grychtol B, 2012, IEEE T MED IMAGING, V31, P1754, DOI 10.1109/TMI.2012.2200904; Hartinger AE, 2009, IEEE T BIO-MED ENG, V56, P369, DOI 10.1109/TBME.2008.2003103; Hinz J, 2003, CHEST, V124, P314, DOI 10.1378/chest.124.1.314; Isaacson D, 2006, PHYSIOL MEAS, V27, pS43, DOI 10.1088/0967-3334/27/5/S04; JOYCE CJ, 1993, J APPL PHYSIOL, V74, P1107, DOI 10.1152/jappl.1993.74.3.1107; Kaipio JP, 2000, INVERSE PROBL, V16, P1487, DOI 10.1088/0266-5611/16/5/321; Kolehmainen V, 1999, INVERSE PROBL, V15, P1375, DOI 10.1088/0266-5611/15/5/318; Kunst PWA, 1998, PHYSIOL MEAS, V19, P481, DOI 10.1088/0967-3334/19/4/003; Lionheart WRB, 2004, PHYSIOL MEAS, V25, P125, DOI 10.1088/0967-3334/25/1/021; Lionheart WRB, 1998, INVERSE PROBL, V14, P139, DOI 10.1088/0266-5611/14/1/012; Magnusson L, 2003, BRIT J ANAESTH, V91, P61, DOI 10.1093/bja/aeg085; Marini JJ, 2004, CRIT CARE MED, V32, P250, DOI 10.1097/01.CCM.0000104946.66723.A8; Meier T, 2008, INTENS CARE MED, V34, P543, DOI 10.1007/s00134-007-0786-9; Moerer O, 2011, CURR OPIN CRIT CARE, V17, P260, DOI 10.1097/MCC.0b013e3283463c9c; MURAI T, 1985, IEEE T BIO-MED ENG, V32, P177, DOI 10.1109/TBME.1985.325526; Neumann P, 1999, ACTA ANAESTH SCAND, V43, P295, DOI 10.1034/j.1399-6576.1999.430309.x; Pham TMT, 2011, EUR RESPIR J, V37, P919, DOI 10.1183/09031936.00034310; PLONSEY R, 1963, IEEE T BIO-MED ENG, VBM10, P9, DOI 10.1109/TBMEL.1963.4322775; Polydorides N, 2002, MEAS SCI TECHNOL, V13, P1871, DOI 10.1088/0957-0233/13/12/310; Pulletz S, 2006, PHYSIOL MEAS, V27, pS115, DOI 10.1088/0967-3334/27/5/S10; Pulletz S, 2012, MULTIDISCIP RESP MED, V7, DOI 10.1186/2049-6958-7-44; Radke OC, 2012, ANESTHESIOLOGY, V116, P1227, DOI 10.1097/ALN.0b013e318256ee08; Rahmati P, 2012, PHYSIOL MEAS, V33, P739, DOI 10.1088/0967-3334/33/5/739; Ricard Jean-Damien, 2002, Curr Opin Crit Care, V8, P12, DOI 10.1097/00075198-200202000-00003; Richard JC, 2009, CRIT CARE, V13, DOI 10.1186/cc7900; Riedel T, 2009, INTENS CARE MED, V35, P144, DOI 10.1007/s00134-008-1299-x; SANTOSA F, 1990, SIAM J APPL MATH, V50, P216, DOI 10.1137/0150014; Schoberl J., 1997, Computing and Visualization in Science, V1, P41, DOI 10.1007/s007910050004; Siltanen S, 2000, INVERSE PROBL, V16, P681, DOI 10.1088/0266-5611/16/3/310; Soleimani M, 2006, INVERSE PROBL SCI EN, V14, P193, DOI 10.1080/17415970500264152; Soleimani M, 2006, PHYSIOL MEAS, V27, pS103, DOI 10.1088/0967-3334/27/5/S09; Vauhkonen M, 1998, IEEE T MED IMAGING, V17, P285, DOI 10.1109/42.700740; Victorino JA, 2004, AM J RESP CRIT CARE, V169, P791, DOI 10.1164/rccm.200301-133OC; Vogt B, 2012, J APPL PHYSIOL, V113, P1154, DOI 10.1152/japplphysiol.01630.2011; Wolf GK, 2013, CRIT CARE MED, V41, P1296, DOI 10.1097/CCM.0b013e3182771516; Wolf GK, 2010, PEDIATR CRIT CARE ME, V11, P610, DOI 10.1097/PCC.0b013e3181c51690; Wrigge H, 2008, CRIT CARE MED, V36, P903, DOI 10.1097/CCM.0B013E3181652EDD; Yasin M, 2011, PHYSIOL MEAS, V32, DOI 10.1088/0967-3334/32/7/S09; Zick G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072675	63	17	17	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2014	9	8							e103045	10.1371/journal.pone.0103045	http://dx.doi.org/10.1371/journal.pone.0103045			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WB	25110887	Green Published, gold, Green Submitted			2022-12-27	WOS:000341105100012
J	Kaas, RS; Leekitcharoenphon, P; Aarestrup, FM; Lund, O				Kaas, Rolf S.; Leekitcharoenphon, Pimlapas; Aarestrup, Frank M.; Lund, Ole			Solving the Problem of Comparing Whole Bacterial Genomes across Different Sequencing Platforms	PLOS ONE			English	Article							SURVEILLANCE; TREES	Whole genome sequencing (WGS) shows great potential for real-time monitoring and identification of infectious disease outbreaks. However, rapid and reliable comparison of data generated in multiple laboratories and using multiple technologies is essential. So far studies have focused on using one technology because each technology has a systematic bias making integration of data generated from different platforms difficult. We developed two different procedures for identifying variable sites and inferring phylogenies in WGS data across multiple platforms. The methods were evaluated on three bacterial data sets and sequenced on three different platforms (Illumina, 454, Ion Torrent). We show that the methods are able to overcome the systematic biases caused by the sequencers and infer the expected phylogenies. It is concluded that the cause of the success of these new procedures is due to a validation of all informative sites that are included in the analysis. The procedures are available as web tools.	[Kaas, Rolf S.; Leekitcharoenphon, Pimlapas; Aarestrup, Frank M.] Tech Univ Denmark, Natl Food Inst, DK-2800 Lyngby, Denmark; [Lund, Ole] Tech Univ Denmark, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark	Technical University of Denmark; Technical University of Denmark	Kaas, RS (corresponding author), Tech Univ Denmark, Natl Food Inst, DK-2800 Lyngby, Denmark.	rkmo@food.dtu.dk	Leekitcharoenphon, Pimlapas/AAB-5487-2021; Lund, Ole/F-4437-2014	Lund, Ole/0000-0003-1108-0491; Kaas, Rolf Sommer/0000-0002-5050-8668; Aarestrup, Frank/0000-0002-7116-2723; Leekitcharoenphon, Pimlapas/0000-0002-5674-0142	Center for Genomic Epidemiology from the Danish Council for Strategic Research [09-067103/DSF]	Center for Genomic Epidemiology from the Danish Council for Strategic Research	This study was supported by the Center for Genomic Epidemiology (www.genomicepidemiology.org) grant 09-067103/DSF from the Danish Council for Strategic Research. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarestrup Frank M, 2012, Emerg Infect Dis, V18, pe1, DOI 10.3201/eid/1811.120453; Allard MW, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-32; Didelot X, 2012, NAT REV GENET, V13, P601, DOI 10.1038/nrg3226; Harismendy O, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r32; Harris SR, 2013, LANCET INFECT DIS, V13, P130, DOI 10.1016/S1473-3099(12)70268-2; Hendriksen RS, 2011, MBIO, V2, DOI [10.1128/mBio.00157-11, 10.1128/mBio.00305-11]; Joensen KG, 2014, J CLIN MICROBIOL, V52, P1501, DOI 10.1128/JCM.03617-13; Junemann S, 2013, NAT BIOTECHNOL, V31, P294, DOI 10.1038/nbt.2522; Koser CU, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002824; Lam HYK, 2012, NAT BIOTECHNOL, V30, P78, DOI 10.1038/nbt.2065; Leekitcharoenphon P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087991; Leekitcharoenphon P, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S7-S6; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Mellmann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022751; Price LB, 2012, MBIO, V3, DOI 10.1128/mBio.00305-11; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ratan A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055089; Rieber N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066621; Suzuki S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019534; Walker TM, 2013, LANCET INFECT DIS, V13, P137, DOI 10.1016/S1473-3099(12)70277-3; Young B, 2012, EVOLUTIONARY DYNAMIC; Zankari E, 2013, J ANTIMICROB CHEMOTH, V68, P771, DOI 10.1093/jac/dks496	23	432	438	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2014	9	8							e104984	10.1371/journal.pone.0104984	http://dx.doi.org/10.1371/journal.pone.0104984			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WB	25110940	Green Published, gold, Green Submitted			2022-12-27	WOS:000341105100117
J	Louis, JM; Aniana, A; Lohith, K; Sayer, JM; Roche, J; Bewley, CA; Clore, GM				Louis, John M.; Aniana, Annie; Lohith, Katheryn; Sayer, Jane M.; Roche, Julien; Bewley, Carole A.; Clore, G. Marius			Binding of HIV-1 gp41-Directed Neutralizing and Non-Neutralizing Fragment Antibody Binding Domain (Fab) and Single Chain Variable Fragment (ScFv) Antibodies to the Ectodomain of gp41 in the Pre-Hairpin and Six-Helix Bundle Conformations	PLOS ONE			English	Article							HUMAN MONOCLONAL-ANTIBODY; MEDIATED CELL-FUSION; TRIMERIC COILED-COIL; 44 KDA ECTODOMAIN; IMMUNODEFICIENCY-VIRUS; ENVELOPE GLYCOPROTEIN; PHAGE LIBRARY; POTENT INHIBITORS; ATOMIC-STRUCTURE; STRUCTURAL BASIS	We previously reported a series of antibodies, in fragment antigen binding domain (Fab) formats, selected from a human non-immune phage library, directed against the internal trimeric coiled-coil of the N-heptad repeat (N-HR) of HIV-1 gp41. Broadly neutralizing antibodies from that series bind to both the fully exposed N-HR trimer, representing the pre-hairpin intermediate state of gp41, and to partially-exposed N-HR helices within the context of the gp41 six-helix bundle. While the affinities of the Fabs for pre-hairpin intermediate mimetics vary by only 2 to 20-fold between neutralizing and non-neutralizing antibodies, differences in inhibition of viral entry exceed three orders of magnitude. Here we compare the binding of neutralizing (8066) and non-neutralizing (8062) antibodies, differing in only four positions within the CDR-H2 binding loop, in Fab and single chain variable fragment (ScFv) formats, to several pre-hairpin intermediate and six-helix bundle constructs of gp41. Residues 56 and 58 of the mini-antibodies are shown to be crucial for neutralization activity. There is a large differential (>= 150-fold) in binding affinity between neutralizing and non-neutralizing antibodies to the six-helix bundle of gp41 and binding to the six-helix bundle does not involve displacement of the outer C-terminal helices of the bundle. The binding stoichiometry is one six-helix bundle to one Fab or three ScFvs. We postulate that neutralization by the 8066 antibody is achieved by binding to a continuum of states along the fusion pathway from the pre-hairpin intermediate all the way to the formation of the six-helix bundle, but prior to irreversible fusion between viral and cellular membranes.	[Louis, John M.; Aniana, Annie; Sayer, Jane M.; Roche, Julien; Clore, G. Marius] NIDDK, Labs Chem Phys, NIH, Bethesda, MD 20892 USA; [Lohith, Katheryn; Bewley, Carole A.] NIDDK, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Louis, JM (corresponding author), NIDDK, Labs Chem Phys, NIH, Bethesda, MD 20892 USA.	johnl@niddk.nih.gov; mariusc@mail.nih.gov	Roche, Julien/O-3204-2013; Clore, G Marius/L-2546-2018	Roche, Julien/0000-0003-3892-0200; Clore, G Marius/0000-0003-3809-1027; Bewley, Carole/0000-0003-2203-0852; Louis, John M/0000-0002-0052-1899	Intramural Research Program of the NIDDK, National Institutes of Health; Intramural AIDS-Targeted Antiviral Program of the Office of the Director, NIH; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK032103, ZIADK029023] Funding Source: NIH RePORTER	Intramural Research Program of the NIDDK, National Institutes of Health; Intramural AIDS-Targeted Antiviral Program of the Office of the Director, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by the Intramural Research Program of the NIDDK, National Institutes of Health and the Intramural AIDS-Targeted Antiviral Program of the Office of the Director, NIH (to G. M. C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Bewley CA, 2002, J BIOL CHEM, V277, P14238, DOI 10.1074/jbc.M201453200; Bianchi E, 2005, P NATL ACAD SCI USA, V102, P12903, DOI 10.1073/pnas.0502449102; Blumenthal R, 2012, J BIOL CHEM, V287, P40841, DOI 10.1074/jbc.R112.406272; Caffrey M, 1998, EMBO J, V17, P4572, DOI 10.1093/emboj/17.16.4572; Caffrey M, 1997, J MOL BIOL, V271, P819, DOI 10.1006/jmbi.1997.1217; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Chan DC, 1998, P NATL ACAD SCI USA, V95, P15613, DOI 10.1073/pnas.95.26.15613; Chan DC, 1998, CELL, V93, P681, DOI 10.1016/S0092-8674(00)81430-0; Choudhry V, 2007, VIROLOGY, V363, P79, DOI 10.1016/j.virol.2007.01.015; Eckert DM, 2001, ANNU REV BIOCHEM, V70, P777, DOI 10.1146/annurev.biochem.70.1.777; FREED EO, 1995, J BIOL CHEM, V270, P23883, DOI 10.1074/jbc.270.41.23883; Furuta RA, 1998, NAT STRUCT BIOL, V5, P276, DOI 10.1038/nsb0498-276; Gallo SA, 2003, BBA-BIOMEMBRANES, V1614, P36, DOI 10.1016/S0005-2736(03)00161-5; Gustchina E, 2005, J MED CHEM, V48, P3036, DOI 10.1021/jm049026h; Gustchina E, 2008, J VIROL, V82, P10032, DOI 10.1128/JVI.01050-08; Gustchina E, 2007, J VIROL, V81, P12946, DOI 10.1128/JVI.01260-07; Gustchina E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078187; Gustchina E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001182; Gustchina E, 2009, VIROLOGY, V393, P112, DOI 10.1016/j.virol.2009.07.019; Julien JP, 2013, SCIENCE, V342, P1477, DOI 10.1126/science.1245625; Knappik A, 2000, J MOL BIOL, V296, P57, DOI 10.1006/jmbi.1999.3444; Kurucz I, 1995, MOL IMMUNOL, V32, P1443, DOI 10.1016/0161-5890(95)00105-0; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Li Y, 2006, J VIROL, V80, P1414, DOI 10.1128/JVI.80.3.1414-1426.2006; Louis JM, 2005, J MOL BIOL, V353, P945, DOI 10.1016/j.jmb.2005.09.044; Louis JM, 2003, J BIOL CHEM, V278, P20278, DOI 10.1074/jbc.M301627200; Louis JM, 2001, J BIOL CHEM, V276, P29485, DOI 10.1074/jbc.C100317200; Luftig MA, 2006, NAT STRUCT MOL BIOL, V13, P740, DOI 10.1038/nsmb1127; Lyumkis D, 2013, SCIENCE, V342, P1484, DOI 10.1126/science.1245627; Melikyan GB, 2000, J CELL BIOL, V151, P413, DOI 10.1083/jcb.151.2.413; Miller MD, 2005, P NATL ACAD SCI USA, V102, P14759, DOI 10.1073/pnas.0506927102; Miyauchi K, 2009, CELL, V137, P433, DOI 10.1016/j.cell.2009.02.046; Moore JP, 1997, CURR OPIN IMMUNOL, V9, P551, DOI 10.1016/S0952-7915(97)80110-0; Nelson JK, 2008, IEEE T DIELECT EL IN, V15, P1, DOI 10.1109/T-DEI.2008.4446730; Rezacova P, 2001, STRUCTURE, V9, P887, DOI 10.1016/S0969-2126(01)00654-2; Root MJ, 2001, SCIENCE, V291, P884, DOI 10.1126/science.1057453; Rothe C, 2008, J MOL BIOL, V376, P1182, DOI 10.1016/j.jmb.2007.12.018; Sayer JM, 2012, J MOL BIOL, V422, P230, DOI 10.1016/j.jmb.2012.05.024; Tan KM, 1997, P NATL ACAD SCI USA, V94, P12303, DOI 10.1073/pnas.94.23.12303; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; WILD CT, 1994, P NATL ACAD SCI USA, V91, P9770, DOI 10.1073/pnas.91.21.9770; Zhang MY, 2008, J VIROL, V82, P6869, DOI 10.1128/JVI.00033-08	43	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2014	9	8							e104683	10.1371/journal.pone.0104683	http://dx.doi.org/10.1371/journal.pone.0104683			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR0CG	25105806	Green Submitted, Green Published, gold			2022-12-27	WOS:000343231900079
J	Shrivastava, SK; Gupta, RK; Mahanta, J; Dubey, ML				Shrivastava, Sandeep Kumar; Gupta, Ravi Kumar; Mahanta, Jagdish; Dubey, Mohan Lal			Correlation of Molecular Markers, Pfmdr1-N86Y and Pfcrt-K76T, with In Vitro Chloroquine Resistant Plasmodium falciparum, Isolated in the Malaria Endemic States of Assam and Arunachal Pradesh, Northeast India	PLOS ONE			English	Article							DRUG-RESISTANCE; TRANSPORTER PFCRT; POINT MUTATIONS; GENE; ASSOCIATION; PREVALENCE; POLYMORPHISMS; ALLELES; LOCI	The mechanism of chloroquine (CQ) resistance in Plasmodium falciparum is not clearly understood. However, CQ resistance has been shown to be associated with point mutations in Pfcrt and Pfmdr1. These genes encode for digestive vacuole transmembrane proteins Pfcrt and Pgh1, respectively. The present study was carried out to analyze the association of Pfcrt-K76T and Pfmdr1-N86Y mutations with CQ resistance in Northeast Indian P. falciparum isolates. 115 P. falciparum isolates were subjected to in vitro CQ sensitivity testing and PCR-RFLP analysis for the Pfmdr1-N86Y and Pfcrt-K76T mutations. 100 isolates of P. falciparum were found to be resistant to CQ by the in vitro susceptibility test (geometric mean EC50 2.21 mu M/L blood) while 15 were found to be CQ sensitive (geometric mean EC50 0.32 mu M/L blood). All the CQ resistant isolates showed the presence of Pfmdr1 and Pfcrt mutations. CQ sensitive isolates were negative for these mutations. Strong linkage disequilibrium was observed between the alleles at these two loci (Pfmdr1-N86Y and Pfcrt-K76T). The results indicate that Pfmdr1-N86Y and Pfcrt-K76T mutations can be used as molecular markers to identify CQ resistance in P. falciparum. The result necessitates the evaluation of CQ in vivo therapeutic efficacy in endemic areas for more effective malaria control strategies.	[Shrivastava, Sandeep Kumar; Dubey, Mohan Lal] Post Grad Inst Med Educ & Res, Dept Parasitol, Chandigarh, India; [Shrivastava, Sandeep Kumar] Inst Pasteur, Ctr Infect & Immun Lille, Basic & Clin Immunol Parasit Dis, Lille, France; [Gupta, Ravi Kumar] Cent Res Inst, Kasauli, HP, India; [Mahanta, Jagdish] Reg Med Res Ctr ICMR, Dibrugarh, Assam, India	Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille	Shrivastava, SK (corresponding author), Post Grad Inst Med Educ & Res, Dept Parasitol, Chandigarh, India.	sskpgi@gmail.com						Adagu IS, 1996, T ROY SOC TROP MED H, V90, P90, DOI 10.1016/S0035-9203(96)90491-5; Adagu IS, 2001, PARASITOLOGY, V123, P219, DOI 10.1017/S0031182001008344; Al-Mekhlafi AM, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-94; Alam MT, 2011, J INFECT DIS, V203, P220, DOI 10.1093/infdis/jiq038; Atroosh WM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-251; Basco LK, 1995, MOL BIOCHEM PARASIT, V74, P157, DOI 10.1016/0166-6851(95)02492-1; Bhattacharya PR, 1999, ANN TROP MED PARASIT, V93, P679, DOI 10.1080/00034989957916; Bin Dajem SM, 2010, ANN SAUDI MED, V30, P187, DOI 10.4103/0256-4947.62826; Chaijaroenkul W, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-42; CHOI K, 1988, CELL, V53, P519, DOI 10.1016/0092-8674(88)90568-5; Costanzo MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019636; COXSINGH J, 1995, T ROY SOC TROP MED H, V89, P436, DOI 10.1016/0035-9203(95)90045-4; Djimde A, 2001, NEW ENGL J MED, V344, P257, DOI 10.1056/NEJM200101253440403; Duraisingh MT, 1997, PARASITOLOGY, V114, P205, DOI 10.1017/S0031182096008487; Fidock DA, 2000, MOL CELL, V6, P861, DOI 10.1016/S1097-2765(05)00077-8; Figueiredo P, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-236; FITCH CD, 1970, SCIENCE, V169, P289, DOI 10.1126/science.169.3942.289; FOLEY M, 1992, MOL BIOCHEM PARASIT, V53, P241, DOI 10.1016/0166-6851(92)90026-G; FOOTE SJ, 1990, NATURE, V345, P255, DOI 10.1038/345255a0; Ghanchi NK, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-18; HILL WG, 1968, GENETICS, V60, P615; LEBRAS J, 1983, EXP PARASITOL, V56, P9, DOI 10.1016/0014-4894(83)90091-7; Lekana-Douki JB, 2011, INFECT GENET EVOL, V11, P512, DOI 10.1016/j.meegid.2011.01.003; Ministerio del Medio Ambiente, 2013, DECR 40 APR REGL SIS, P1; MOORE DV, 1961, AM J TROP MED HYG, V10, P5, DOI 10.4269/ajtmh.1961.10.5; Murambiwa P, 2011, ACTA TROP, V118, P71, DOI 10.1016/j.actatropica.2011.03.005; Ojurongbe O, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-41; Pickard AL, 2003, ANTIMICROB AGENTS CH, V47, P2418, DOI 10.1128/AAC.47.8.2418-2423.2003; Ranjitkar S, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-75; Sanchez CP, 2010, INT J PARASITOL, V40, P1109, DOI 10.1016/j.ijpara.2010.04.001; SEHGAL P N, 1973, Journal of Communicable Diseases, V5, P175; Sidhu ABS, 2002, SCIENCE, V298, P210, DOI 10.1126/science.1074045; Smith JM, 1968, EVOLUTIONARY GENETIC; Vathsala PG, 2004, AM J TROP MED HYG, V70, P256; Veiga MI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020212; Walliker D, 2005, ACTA TROP, V94, P251, DOI 10.1016/j.actatropica.2005.04.005; Wernsdorfer WH, 1995, MITT OESTERR GES TRO, V17, P221; WHO, 2001, IN VITR MICR MARK 3	38	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2014	9	8							e103848	10.1371/journal.pone.0103848	http://dx.doi.org/10.1371/journal.pone.0103848			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR0CG	25105963	gold, Green Published, Green Submitted			2022-12-27	WOS:000343231900025
J	Zhao, XF; Dai, JP; Xiao, XJ; Wu, LQ; Zeng, J; Sheng, JT; Su, JH; Chen, XX; Wang, GF; Li, KS				Zhao, Xiangfeng; Dai, Jianping; Xiao, Xuejun; Wu, Liqi; Zeng, Jun; Sheng, Jiangtao; Su, Jinghua; Chen, Xiaoxuan; Wang, Gefei; Li, Kangsheng			PI3K/Akt Signaling Pathway Modulates Influenza Virus Induced Mouse Alveolar Macrophage Polarization to M1/M2b	PLOS ONE			English	Article							INNATE IMMUNE-RESPONSE; EPITHELIAL-CELLS; BACTERIAL FLAGELLIN; RESPIRATORY-TRACT; ACTIVATION; INFECTION; REPLICATION; NEUTROPHILS; CHEMOKINES; APOPTOSIS	Macrophages polarized to M1 (pro-inflammation) or M2 (anti-inflammation) phenotypes in response to environmental signals. In this study, we examined the polarization of alveolar macrophage (AM), following induction by different influenza virus strains (ST169 (H1N1), ST602 (H3N2) and HKG9 (H9N2)). Macrophages from other tissues or cell line exert alternative responding pattern, and AM is necessary for investigating the respiratory system. AM polarized toward the M1 phenotype after 4 hours of infection by all three virus strains, and AM to presented M2b phenotype after 8 hours induction, and immunosuppressive phenotype after 24 hours of induction. Protein expression assay showed similar results as the gene expression analysis for phenotype verification. The ELISA assay showed that TNF-alpha secretion was up-regulated after 4 and 8 hours of infection by influenza viruses, and it returned to basal levels after 24 hours of infection. IL-10 expression was elevated after 8 and 24 hours of infection. Immunofluorescence showed that iNOS expression was up-regulated but not Arg1 expression. Influenza virus notably increased phospho-Akt but not phospho-Erk1/2 or phospho-p38, and the AM polarization pattern have been changed by LY294002 (PI3K inhibitor). In conclusion, our results demonstrate the dynamic polarization of AM induced by influenza viruses, and suggested that PI3K/Akt signaling pathway modulates AM polarization to M1/M2b.	[Zhao, Xiangfeng; Dai, Jianping; Wu, Liqi; Zeng, Jun; Sheng, Jiangtao; Su, Jinghua; Chen, Xiaoxuan; Wang, Gefei; Li, Kangsheng] Shantou Univ, Coll Med, Dept Microbiol & Immunol, Shantou, Guangdong, Peoples R China; [Xiao, Xuejun] Guilin Med Univ, Dept Nursing, Guilin, Guangxi, Peoples R China	Shantou University; Guilin Medical University	Wang, GF (corresponding author), Shantou Univ, Coll Med, Dept Microbiol & Immunol, Shantou, Guangdong, Peoples R China.	silvermask007@163.com; kslistuedu@sohu.com		Sheng, Jiangtao/0000-0003-2438-7345; Li, Kangsheng/0000-0002-6981-9263; Zeng, Jun/0000-0002-4317-2182	National Natural Science Foundation of China [81301447, 81374040, 30972766, 31170852, 81001322, 81172795]; Guangdong Natural Science Foundation [9451503102003499]; Specialized Research Fund for the Doctoral Program of Higher Education [20094402110004]; State Key Lab of Agriculture Microbiology Open Foundation [AML200910]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); State Key Lab of Agriculture Microbiology Open Foundation	This study was supported by grants from National Natural Science Foundation of China (81301447, 81374040, 30972766, 31170852, 81001322, 81172795), Guangdong Natural Science Foundation (9451503102003499), Specialized Research Fund for the Doctoral Program of Higher Education (20094402110004), State Key Lab of Agriculture Microbiology Open Foundation (AML200910). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS DO, 1989, IMMUNOL TODAY, V10, P33, DOI 10.1016/0167-5699(89)90298-3; Aliprantis AO, 2000, EMBO J, V19, P3325, DOI 10.1093/emboj/19.13.3325; Arora S, 2011, INFECT IMMUN, V79, P1915, DOI 10.1128/IAI.01270-10; Arranz A, 2012, P NATL ACAD SCI USA, V109, P9517, DOI 10.1073/pnas.1119038109; Baitsch D, 2011, ARTERIOSCL THROM VAS, V31, P1160, DOI 10.1161/ATVBAHA.111.222745; Brown JN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003664; Cassol E, 2010, J LEUKOCYTE BIOL, V87, P599, DOI 10.1189/jlb.1009673; Chen WH, 2012, IMMUNOL LETT, V141, P227, DOI 10.1016/j.imlet.2011.10.009; Cox NJ, 1999, LANCET, V354, P1277, DOI 10.1016/S0140-6736(99)01241-6; Dai JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061026; Dai JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042706; Di YP, 2014, METHODS MOL BIOL, V1105, P33, DOI 10.1007/978-1-62703-739-6_3; Gewirtz AT, 2001, J IMMUNOL, V167, P1882, DOI 10.4049/jimmunol.167.4.1882; Goerdt S, 1999, IMMUNITY, V10, P137, DOI 10.1016/S1074-7613(00)80014-X; Gordon SB, 2002, BRIT MED BULL, V61, P45, DOI 10.1093/bmb/61.1.45; Hardison SE, 2010, AM J PATHOL, V176, P774, DOI 10.2353/ajpath.2010.090634; Hashimoto Y, 2007, J IMMUNOL, V178, P2448, DOI 10.4049/jimmunol.178.4.2448; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Herold S, 2006, J IMMUNOL, V177, P1817, DOI 10.4049/jimmunol.177.3.1817; Hesse M, 2001, J IMMUNOL, V167, P6533, DOI 10.4049/jimmunol.167.11.6533; Hoeve MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029443; HOLT PG, 1986, CLIN EXP IMMUNOL, V63, P261; Joshi AD, 2008, J LEUKOCYTE BIOL, V83, P314, DOI 10.1189/jlb.1007689; Kim HM, 2008, J VIROL, V82, P4265, DOI 10.1128/JVI.02602-07; Kobasa D, 2007, NATURE, V445, P319, DOI 10.1038/nature05495; Lambrecht BN, 2006, IMMUNITY, V24, P366, DOI 10.1016/j.immuni.2006.03.008; Lefevre L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012828; LEHRER RI, 1985, J VIROL, V54, P467, DOI 10.1128/JVI.54.2.467-472.1985; Liao XD, 2011, J CLIN INVEST, V121, P2736, DOI 10.1172/JCI45444; Lopez M, 2003, J IMMUNOL, V170, P2409, DOI 10.4049/jimmunol.170.5.2409; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; McGill J, 2009, J LEUKOCYTE BIOL, V86, P803, DOI 10.1189/jlb.0509368; Mok CKP, 2007, J GEN VIROL, V88, P1275, DOI 10.1099/vir.0.82423-0; MOSSER DM, 1992, J LEUKOCYTE BIOL, V52, P369, DOI 10.1002/jlb.52.4.369; Narasaraju T, 2010, AM J RESP CELL MOL, V42, P732, DOI 10.1165/rcmb.2008-0423OC; NICKERSON CL, 1990, INFECT IMMUN, V58, P2809, DOI 10.1128/IAI.58.9.2809-2814.1990; Perrone LA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000115; RODGERS B, 1981, INFECT IMMUN, V31, P751, DOI 10.1128/IAI.31.2.751-757.1981; RODGERS BC, 1982, J MED VIROL, V9, P177, DOI 10.1002/jmv.1890090304; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Serkedjieva Julia, 2007, Antiviral Chemistry & Chemotherapy, V18, P75; Small CL, 2010, J IMMUNOL, V184, P2048, DOI 10.4049/jimmunol.0902772; Snelgrove RJ, 2011, TRENDS IMMUNOL, V32, P328, DOI 10.1016/j.it.2011.04.006; Tamura Y, 2010, J ATHEROSCLER THROMB, V17, P219, DOI 10.5551/jat.3368; Tate MD, 2011, VIRAL IMMUNOL, V24, P77, DOI 10.1089/vim.2010.0118; Teijaro JR, 2011, CELL, V146, P980, DOI 10.1016/j.cell.2011.08.015; Tumpey TM, 2005, J VIROL, V79, P14933, DOI 10.1128/JVI.79.23.14933-14944.2005; Watanabe Y, 2005, BIOCHEM BIOPH RES CO, V337, P881, DOI 10.1016/j.bbrc.2005.09.133; Yu WCL, 2011, J VIROL, V85, P6844, DOI 10.1128/JVI.02200-10; Zhang WJ, 2011, J IMMUNOL, V187, P1764, DOI 10.4049/jimmunol.1002315; Zhao XF, 2012, MOL CELLS, V34, P263, DOI 10.1007/s10059-012-0089-z; Zhao XF, 2011, COMP IMMUNOL MICROB, V34, P123, DOI 10.1016/j.cimid.2010.04.002; Zhou JF, 2006, J INFECT DIS, V194, P61, DOI 10.1086/504690	56	31	31	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2014	9	8							e104506	10.1371/journal.pone.0104506	http://dx.doi.org/10.1371/journal.pone.0104506			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR0CG	25105760	Green Published, gold, Green Submitted			2022-12-27	WOS:000343231900065
J	Arellano-Garcia, ME; Misuno, K; Tran, SD; Hu, S				Arellano-Garcia, Martha E.; Misuno, Kaori; Tran, Simon D.; Hu, Shen			Interferon-gamma Induces Immunoproteasomes and the Presentation of MHC I-Associated Peptides on Human Salivary Gland Cells	PLOS ONE			English	Article							SJOGRENS-SYNDROME; EPITHELIAL-CELLS; PROTEASOME; EXPRESSION; 20S; DEGRADATION; PROPEPTIDES; LACTACYSTIN; BIOMARKERS; APOPTOSIS	A prominent histopathological feature of Sjogren's syndrome, an autoimmune disease, is the presence of lymphocytic infiltrates in the salivary and lachrymal glands. Such infiltrates are comprised of activated lymphocytes and macrophages, and known to produce multiple cytokines including interferon-gamma (IFN-gamma). In this study, we have demonstrated that IFN-gamma strongly induces the expression of immunoproteasome beta subunits (beta 1i, beta 2i and beta 5i) and immunoproteasome activity but conversely inhibits the expression of proteasome beta subunits (beta 1, beta 2 and beta 5) in human salivary gland (HSG) cells. Mass spectrometric analysis has revealed potential MHC I-associated peptides on the HSG cells, including a tryptic peptide derived from salivary amylase, due to IFN-gamma stimulation. These results suggest that IFN-gamma induces immunoproteasomes in HSG cells, leading to enhanced presentation of MHC I-associated peptides on cell surface. These peptide-presenting salivary gland cells may be recognized and targeted by auto-reactive T lymphocytes. We have also found that lactacystin, a proteasome inhibitor, inhibits the expression of beta 1 subunit in HSG cells and blocks the IFN-gamma-induced expression of beta 1i and immunoproteasome activity. However, the expression of beta 2i and beta 5i in HSG cells is not affected by lactacystin. These results may add new insight into the mechanism regarding how lactacystin blocks the action of proteasomes or immunoproteasomes.	[Arellano-Garcia, Martha E.; Misuno, Kaori; Hu, Shen] Univ Calif Los Angeles, Sch Dent, Los Angeles, CA 90024 USA; [Arellano-Garcia, Martha E.; Misuno, Kaori; Hu, Shen] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USA; [Tran, Simon D.] McGill Univ, Fac Dent, Montreal, PQ, Canada	University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; McGill University	Hu, S (corresponding author), Univ Calif Los Angeles, Sch Dent, Los Angeles, CA 90024 USA.	shenhu@ucla.edu	Hu, Steve/B-3799-2011		Sjogren's Syndrome Foundation	Sjogren's Syndrome Foundation	This study was supported by the Sjogren's Syndrome Foundation (SH). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baturone R, 2009, SCAND J RHEUMATOL, V38, P386, DOI 10.1080/03009740902973821; Cha S, 2004, SCAND J IMMUNOL, V60, P552, DOI 10.1111/j.0300-9475.2004.01508.x; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; Craiu A, 1997, J BIOL CHEM, V272, P13437, DOI 10.1074/jbc.272.20.13437; Das A, 2007, AM J PHYSIOL-LUNG C, V292, pL74, DOI 10.1152/ajplung.00103.2006; De M, 2003, J BIOL CHEM, V278, P6153, DOI 10.1074/jbc.M209292200; Fenteany G, 1998, J BIOL CHEM, V273, P8545, DOI 10.1074/jbc.273.15.8545; Fox PC, 2007, ANN NY ACAD SCI, V1098, P15, DOI 10.1196/annals.1384.003; Fox RI, 2005, LANCET, V366, P321, DOI 10.1016/S0140-6736(05)66990-5; FOX RI, 1994, J IMMUNOL, V152, P5532; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Hirano Y, 2005, NATURE, V437, P1381, DOI 10.1038/nature04106; Hu S, 2007, ARTHRITIS RHEUM-US, V56, P3588, DOI 10.1002/art.22954; Hu S, 2010, ARTHRIT CARE RES, V62, P1633, DOI 10.1002/acr.20289; Hussong SA, 2010, J NEUROCHEM, V113, P1481, DOI 10.1111/j.1471-4159.2010.06688.x; Jager S, 1999, J MOL BIOL, V291, P997, DOI 10.1006/jmbi.1999.2995; Kesmir C, 2003, IMMUNOGENETICS, V55, P437, DOI 10.1007/s00251-003-0585-6; Krause S, 2006, ANN RHEUM DIS, V65, P1021, DOI 10.1136/ard.2005.045930; Lundegaard C, 2008, NUCLEIC ACIDS RES, V36, pW509, DOI 10.1093/nar/gkn202; Matsumura R, 2000, CLIN EXP RHEUMATOL, V18, P311; Morawietz L, 2009, J RHEUMATOL, V36, P2694, DOI 10.3899/jrheum.081098; Ping L, 2005, ARTHRITIS RHEUM-US, V52, P573, DOI 10.1002/art.20789; Rosenzweig R, 2008, BIOCHEM SOC T, V36, P807, DOI 10.1042/BST0360807; SHIRASUNA K, 1981, CANCER, V48, P745, DOI 10.1002/1097-0142(19810801)48:3<745::AID-CNCR2820480314>3.0.CO;2-7; Tanaka K, 1998, IMMUNOL REV, V163, P161; Thomas E, 2006, ARTHRITIS RHEUM, V54, P1501; Tran SD, 2007, ANN RHEUM DIS, V66, P812, DOI 10.1136/ard.2006.064030; VALENTE G, 1992, EUR J IMMUNOL, V22, P2403, DOI 10.1002/eji.1830220933; Vigneron N, 2012, CURR OPIN IMMUNOL, V24, P84, DOI 10.1016/j.coi.2011.12.002; Visekruna A, 2006, J CLIN INVEST, V116, P3195, DOI 10.1172/JCI28804; Wu AJ, 1996, J CELL PHYSIOL, V167, P297, DOI 10.1002/(SICI)1097-4652(199605)167:2<297::AID-JCP14>3.0.CO;2-5; Yin HE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018003; Yuan C, 2013, JSM OPHTHALMOL, V1, P1001; Zhou F, 2009, INT REV IMMUNOL, V28, P239, DOI 10.1080/08830180902978120	34	20	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e102878	10.1371/journal.pone.0102878	http://dx.doi.org/10.1371/journal.pone.0102878			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25102056	Green Published, Green Submitted, gold			2022-12-27	WOS:000339993900011
J	Lee, J; Napadow, V; Kim, J; Lee, S; Choi, W; Kaptchuk, TJ; Park, K				Lee, Jeungchan; Napadow, Vitaly; Kim, Jieun; Lee, Seunggi; Choi, Woojin; Kaptchuk, Ted J.; Park, Kyungmo			Phantom Acupuncture: Dissociating Somatosensory and Cognitive/Affective Components of Acupuncture Stimulation with a Novel Form of Placebo Acupuncture	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; AUTONOMIC NERVOUS-SYSTEM; PAIN; RESPONSES; HEART; ACTIVATION; EMOTION; HUMANS; MEMORY; BRAIN	In a clinical setting, acupuncture treatment consists of multiple components including somatosensory stimulation, treatment context, and attention to needle-based procedures. In order to dissociate somatosensory versus contextual and attentional aspects of acupuncture, we devised a novel form of placebo acupuncture, a visual manipulation dubbed phantom acupuncture, which reproduces the acupuncture needling ritual without somatosensory tactile stimulation. Subjects (N = 20) received both real (REAL) and phantom (PHNT) acupuncture. Subjects were retrospectively classified into two groups based on PHNT credibility (PHNTc, who found phantom acupuncture credible; and PHNTnc, who did not). Autonomic and psychophysical responses were monitored. We found that PHNT can be delivered in a credible manner. Acupuncture needling, a complex, ritualistic somatosensory intervention, induces sympathetic activation (phasic skin conductance [SC] response), which may be specific to the somatosensory component of acupuncture. In contrast, contextual effects, such as needling credibility, are instead associated with a shift toward relative cardiovagal activation (decreased heart rate) during needling and sympathetic inhibition (decreased SC) and parasympathetic activation (decreased pupil size) following acupuncture needling. Visual stimulation characterizing the needling ritual is an important factor for phasic autonomic responses to acupuncture and may undelie the needling orienting response. Our study suggests that phantom acupuncture can be a viable sham control for acupuncture as it completely excludes the somatosensory component of real needling while maintaining the credibility of the acupuncture treatment context in many subjects.	[Lee, Jeungchan; Napadow, Vitaly; Park, Kyungmo] Kyung Hee Univ, Dept Biomed Engn, Yongin, Gyeonggi, South Korea; [Napadow, Vitaly; Kim, Jieun] Massachusetts Gen Hosp, Dept Radiol, Martinos Ctr Biomed Imaging, Charlestown, MA USA; [Lee, Seunggi; Choi, Woojin] Sangji Univ, Coll Korean Med, Dept Neuropsychiat, Wonju, Gangwon, South Korea; [Kaptchuk, Ted J.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Program Placebo Studies, Boston, MA 02215 USA	Kyung Hee University; Harvard University; Massachusetts General Hospital; Sangji University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Park, K (corresponding author), Kyung Hee Univ, Dept Biomed Engn, Yongin, Gyeonggi, South Korea.	saenim@khu.ac.kr	Lee, Jeungchan/AAA-9955-2021	park, kyungmo/0000-0002-7689-8967; Napadow, Vitaly/0000-0003-1941-1750; LEE, JEUNGCHAN/0000-0002-4424-175X	Ministry of Science, ICT and Future Planning [NRF-2011-0028968, NRF-2009-0076345]; Ministry of Health & Welfare and Seoul Metropolitan Government (Traditional Korean Medicine RD Project) [HI13C0700]; National Center for Complementary and Alternative Medicine (NCCAM), at the United States of America National Institutes of Health (NIH) [P01-AT006663, R01-AT007550, R01-AT004714, K24-AT004095]; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [R01AT004714] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [K24AT004095, R01AT007550, P01AT006663] Funding Source: NIH RePORTER	Ministry of Science, ICT and Future Planning(Ministry of Science, ICT & Future Planning, Republic of Korea); Ministry of Health & Welfare and Seoul Metropolitan Government (Traditional Korean Medicine RD Project); National Center for Complementary and Alternative Medicine (NCCAM), at the United States of America National Institutes of Health (NIH); NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors would like to thank the Korean National Research Foundation funded by the Ministry of Science, ICT and Future Planning (NRF-2011-0028968, NRF-2009-0076345), and the Ministry of Health & Welfare and Seoul Metropolitan Government (Traditional Korean Medicine R&D Project, HI13C0700). The study was also supported by the National Center for Complementary and Alternative Medicine (NCCAM), at the United States of America National Institutes of Health (NIH) (P01-AT006663, R01-AT007550, R01-AT004714 to VN, K24-AT004095 to TJK). The content is the sole responsibility of the authors and does not necessarily represent the official views of our funding agencies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abercrombie HC, 2008, NEUROBIOL LEARN MEM, V90, P644, DOI 10.1016/j.nlm.2008.08.001; Almeida TF, 2004, BRAIN RES, V1000, P40, DOI 10.1016/j.brainres.2003.10.073; Anderson AK, 2006, LEARN MEMORY, V13, P711, DOI 10.1101/lm.388906; Beissner F, 2013, J NEUROSCI, V33, P10503, DOI 10.1523/JNEUROSCI.1103-13.2013; Beissner F, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/591304; Beissner F, 2012, NEUROIMAGE, V60, P653, DOI 10.1016/j.neuroimage.2011.12.045; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Bradley MM, 2009, PSYCHOPHYSIOLOGY, V46, P1, DOI 10.1111/j.1469-8986.2008.00702.x; CAO XD, 1983, ACUPUNCTURE ELECTRO, V8, P25, DOI 10.3727/036012983816715028; Critchley HD, 2003, BRAIN, V126, P2139, DOI 10.1093/brain/awg216; Dennehy EB, 2002, J ALTERN COMPLEM MED, V8, P421, DOI 10.1089/107555302760253612; Finniss DG, 2010, LANCET, V375, P686, DOI 10.1016/S0140-6736(09)61706-2; Haker E, 2000, J AUTONOM NERV SYST, V79, P52, DOI 10.1016/S0165-1838(99)00090-9; Hempel S., 2014, EVIDENCE MAP ACUPUNC; Jensen KB, 2012, P NATL ACAD SCI USA, V109, P15959, DOI 10.1073/pnas.1202056109; Kaptchuk TJ, 2006, BMJ-BRIT MED J, V332, P391, DOI 10.1136/bmj.38726.603310.55; Kaptchuk TJ, 2000, J CLIN EPIDEMIOL, V53, P786, DOI 10.1016/S0895-4356(00)00206-7; Kim J, 2004, P ANN INT IEEE EMBS, V26, P1451; Knardahl S, 1998, PAIN, V75, P19, DOI 10.1016/S0304-3959(97)00197-8; Kong J, 2007, J ALTERN COMPLEM MED, V13, P1059, DOI 10.1089/acm.2007.0524; Lang PJ, 2010, BIOL PSYCHOL, V84, P437, DOI 10.1016/j.biopsycho.2009.10.007; Langevin HM, 2011, EVID-BASED COMPL ALT, V2011, DOI 10.1155/2011/180805; Lanotte M, 2005, BRAIN BEHAV IMMUN, V19, P500, DOI 10.1016/j.bbi.2005.06.004; Lee S, 2010, AUTON NEUROSCI-BASIC, V155, P5, DOI 10.1016/j.autneu.2010.02.003; Linde K, 2005, JAMA-J AM MED ASSOC, V293, P2118, DOI 10.1001/jama.293.17.2118; Lundeberg T, 2012, ACUPUNCT RELAT THER, V1, P2, DOI 10.1016/j.arthe.2012.12.001; Madsen MV, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3115; McGlone F, 2010, NEUROSCI BIOBEHAV R, V34, P148, DOI 10.1016/j.neubiorev.2009.08.004; Meissner K, 2011, PHILOS T R SOC B, V366, P1808, DOI 10.1098/rstb.2010.0403; Mori H, 2002, NEUROSCI LETT, V320, P21, DOI 10.1016/S0304-3940(02)00012-5; Napadow V, 2013, HUM BRAIN MAPP, V34, P2592, DOI 10.1002/hbm.22091; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Park J, 1999, ACUPUNCT MED, V17, P110, DOI DOI 10.1136/AIM.17.2.110; Piche M, 2010, PAIN, V149, P453, DOI 10.1016/j.pain.2010.01.005; Pollo A, 2003, PAIN, V102, P125, DOI 10.1016/S0304-3959(02)00345-7; Shalev AY, 1998, ARCH GEN PSYCHIAT, V55, P553, DOI 10.1001/archpsyc.55.6.553; Sokolov E, 1997, ATTENTION ORIENTING; Sparrow K, 2007, MED ACUPUNCT, V19, P37, DOI 10.1089/acu.2006.0000; Streitberger K, 1998, LANCET, V25, P271; White P, 2003, PAIN, V106, P401, DOI 10.1016/j.pain.2003.08.013; Yao E, 2012, PM&R, V4, P367, DOI 10.1016/j.pmrj.2012.01.008; YAO T, 1982, BRAIN RES, V240, P77, DOI 10.1016/0006-8993(82)90645-X; Zubieta JK, 2009, ANN NY ACAD SCI, V1156, P198, DOI 10.1111/j.1749-6632.2009.04424.x	43	21	23	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e104582	10.1371/journal.pone.0104582	http://dx.doi.org/10.1371/journal.pone.0104582			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM6SB	25101637	Green Published, Green Submitted, gold			2022-12-27	WOS:000339993900077
J	Liu, YB; Lu, LG; Jin, HS; Chen, XM; Zhang, ZL; Liu, ZY; Liang, CH				Liu, Yubao; Lu, Ligong; Jin, Haosheng; Chen, Xiaoming; Zhang, Zhonglin; Liu, Zaiyi; Liang, Changhong			Radiofrequency Ablation of Liver VX2 Tumor: Experimental Results with MR Diffusion-Weighted Imaging at 3.0T	PLOS ONE			English	Article							STAGE HEPATOCELLULAR-CARCINOMA; FOLLOW-UP; RF ABLATION; PROGRESSION; SONOGRAPHY; ELECTRODES; MODEL	Purpose: To evaluate the value of DWI in detecting the lesions of pre- and post-radiofrequency ablation (RFA) of the rabbit liver VX2 tumors. Materials and Methods: Twenty-two New Zealand White rabbits were tested. The protocol was approved by the Committee on the Ethics of Animal Experiments. Twenty separate tumor fragments were implanted into the livers of 20 rabbits, the liver was exposed by performing midline laparotomy. 3.0T MR DWI (b = 0, 200, 400, 600, 800,1000 s/mm(2)) were performed 14-21 days after tumor implantation (mean, 17 days) in the 18 tumor-bearing animals. Then RFA was performed in the 18 tumor-bearing animals and in the two healthy animals. 3.0T MR DWI was performed 7-10 days after RFA (mean, 8 days). Pathology exam was performed immediately after the completion of post-RFA MR imaging. Analyzing the features of MRI and ADC values in the pre- and post-RFA lesions of the VX2 tumors, and histopathologic results were compared with imaging findings. Results: The difference of ADC value between viable tumor and normal liver parenchyma was significant (P<.001). After RFA, when b = 200, 400, 600, 800, 1000 s/mm(2), the differences of ADC values of viable tumor, granulation tissue, necrosis, normal liver parenchyma were significant (P,. 001). At the time the animals were sacrificed after RFA and MR imaging, histopathologic results of local viable tumors were found in 9 (50%) of the 18 treated tumors. Macroscopic viable tumors were found at the RFA sites in 3 (17%), all 3 macroscopic viable tumors were visualized at the periphery of the RFA areas. Conclusions: 3.0T MR DWI can be used to follow up the progress of the RFA lesion, it is useful in detecting different tissues after RFA, and it is valuable in the further clinical research.	[Liu, Yubao; Zhang, Zhonglin; Liu, Zaiyi; Liang, Changhong] Guangdong Acad Med Sci, Guangdong Gen Hosp, Dept Radiol, Guangzhou, Guangdong, Peoples R China; [Lu, Ligong; Chen, Xiaoming] Guangdong Acad Med Sci, Guangdong Gen Hosp, Dept Intervent Therapy, Guangzhou, Guangdong, Peoples R China; [Jin, Haosheng] Guangdong Acad Med Sci, Guangdong Gen Hosp, Dept Gen Surg, Guangzhou, Guangdong, Peoples R China	Guangdong Academy of Medical Sciences & Guangdong General Hospital; Guangdong Academy of Medical Sciences & Guangdong General Hospital; Guangdong Academy of Medical Sciences & Guangdong General Hospital	Liang, CH (corresponding author), Guangdong Acad Med Sci, Guangdong Gen Hosp, Dept Radiol, Guangzhou, Guangdong, Peoples R China.	cjr.lchh@vip.163.com	Liang, Chang Hong/L-1885-2016		National Natural Science Foundation of China [30970798, 81271654]; Key Research Program of Joint Fund for National Natural Science Foundation of China (NSFC)-Guangdong [U1301258]; Science and Technology Planning Project of Guangzhou [2010J-E481]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Research Program of Joint Fund for National Natural Science Foundation of China (NSFC)-Guangdong(National Natural Science Foundation of China (NSFC)); Science and Technology Planning Project of Guangzhou	This work was supported by grants from the National Natural Science Foundation of China (30970798, 81271654), Key Research Program of Joint Fund for National Natural Science Foundation of China (NSFC)-Guangdong (U1301258), Science and Technology Planning Project of Guangzhou (2010J-E481). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altekruse SF, 2012, HEPATOLOGY, V55, P476, DOI 10.1002/hep.24710; Cho YK, 2010, HEPATOLOGY, V51, P1284, DOI 10.1002/hep.23466; Cho YK, 2009, HEPATOLOGY, V49, P453, DOI 10.1002/hep.22648; Curley SA, 2000, ANN SURG, V232, P381, DOI 10.1097/00000658-200009000-00010; Deng J, 2006, INVEST RADIOL, V41, P410, DOI 10.1097/01.rli.0000201232.14903.da; Dromain C, 2002, RADIOLOGY, V223, P255, DOI 10.1148/radiol.2231010780; Goldberg SN, 2003, RADIOLOGY, V228, P335, DOI 10.1148/radiol.2282021787; Kei SK, 2008, AM J ROENTGENOL, V190, P1544, DOI 10.2214/AJR.07.2798; Koda M, 2004, AM J ROENTGENOL, V183, P583, DOI 10.2214/ajr.183.3.1830583; Kuehl H, 2008, EUR J RADIOL, V67, P362, DOI 10.1016/j.ejrad.2007.11.017; Kuszyk BS, 2000, RADIOLOGY, V217, P477, DOI 10.1148/radiology.217.2.r00nv41477; Kwee TC, 2008, J MAGN RESON IMAGING, V28, P1141, DOI 10.1002/jmri.21569; Lencioni R, 2005, RADIOLOGY, V234, P961, DOI 10.1148/radiol.2343040350; Lim HK, 2001, RADIOLOGY, V221, P447, DOI 10.1148/radiol.2212010446; Lin SM, 2004, GASTROENTEROLOGY, V127, P1714, DOI 10.1053/j.gastro.2004.09.003; Livraghi T, 2000, RADIOLOGY, V214, P761, DOI 10.1148/radiology.214.3.r00mr02761; Lu DSK, 2005, RADIOLOGY, V234, P954, DOI 10.1148/radiol.2343040153; McGahan JP, 2001, AM J ROENTGENOL, V176, P3, DOI 10.2214/ajr.176.1.1760003; Meloni MF, 2001, AM J ROENTGENOL, V177, P375, DOI 10.2214/ajr.177.2.1770375; Morimoto M, 2002, HEPATOLOGY, V35, P1467, DOI 10.1053/jhep.2002.33635; PRAT F, 1995, HEPATOLOGY, V21, P832, DOI 10.1002/hep.1840210333; Rhim H, 2008, AM J ROENTGENOL, V190, P1324, DOI 10.2214/AJR.07.2970; Rodriguez-Sanjuan JC, 2010, HEPATOLOGY, V51, P723, DOI 10.1002/hep.23454; Seror O, 2008, RADIOLOGY, V248, P288, DOI 10.1148/radiol.2481071101; Sofocleous CT, 2008, RADIOLOGY, V249, P364, DOI 10.1148/radiol.2491071752; Tateishi R, 2005, CANCER-AM CANCER SOC, V103, P1201, DOI 10.1002/cncr.20892; Teratani T, 2006, HEPATOLOGY, V43, P1101, DOI 10.1002/hep.21164; Youn BJ, 2008, ACAD RADIOL, V15, P593, DOI 10.1016/j.acra.2007.10.022; Yuan YH, 2005, WORLD J GASTROENTERO, V11, P3070, DOI 10.3748/wjg.v11.i20.3070	29	6	9	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e104239	10.1371/journal.pone.0104239	http://dx.doi.org/10.1371/journal.pone.0104239			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25102074	Green Published, gold, Green Submitted			2022-12-27	WOS:000339993900051
J	Zhang, N; Xu, YH; Zhang, B; Zhang, TX; Yang, HJ; Zhang, B; Feng, ZF; Zhong, DX				Zhang, Nan; Xu, Yuehong; Zhang, Bo; Zhang, Tianxiao; Yang, Haojie; Zhang, Bao; Feng, Zufei; Zhong, Dexing			Analysis of Interleukin-8 Gene Variants Reveals Their Relative Importance as Genetic Susceptibility Factors for Chronic Periodontitis in the Han Population	PLOS ONE			English	Article							RED-COMPLEX PERIODONTOPATHOGENS; SINGLE-NUCLEOTIDE POLYMORPHISM; GINGIVAL CREVICULAR FLUID; SCHIZOPHRENIA SUSCEPTIBILITY; RISK-FACTORS; ASSOCIATION; DISEASE; HAPLOTYPES; PROMOTER; SMOKING	Interleukin (IL)-8, an important chemokine that regulates the inflammatory response, plays an important role in periodontitis. Previous studies indicate that certain IL-8 gene polymorphisms are associated with periodontitis susceptibility in some populations. However, the literature is somewhat contradictory, and not all IL-8 polymorphisms have been examined, particularly in Han Chinese individuals. The aim of this study was to investigate the association of every IL-8 SNP with chronic periodontitis in Han Chinese individuals. We analyzed 23 SNPs with minor allele frequency (MAF)>= 0.01, which were selected from 219 SNPs in the NCBI dbSNP and preliminary HapMap data analyses from a cohort of 400 cases and 750 controls from genetically independent Han Chinese individuals. Single SNP, haplotype and gender-specific associations were performed. We found that rs4073 and rs2227307 were significantly associated with chronic periodontitis. Further haplotype analysis indicated that a haplotype block (rs4073-rs2227307-rs2227306) that spans the promoter and exon1 of IL-8 was highly associated with chronic periodontitis. Additionally, the ATC haplotype in this block was increased 1.5-fold in these cases. However, when analyzing the samples by gender, no significant gender-specific associations in IL-8 were observed, similar to the results of haplotype association analyses in female and male subgroups. Our results provide further evidence that IL-8 is associated with chronic periodontitis in Han Chinese individuals. Furthermore, our results confirm previous reports suggesting the intriguing possibilities that IL-8 plays a role in the pathogenesis of chronic periodontitis and that this gene may be involved in the etiology of this condition.	[Zhang, Nan] Xi An Jiao Tong Univ, Affiliated Hosp 1, Coll Med, Dept Dent, Xian 710049, Peoples R China; [Xu, Yuehong] Xi An Jiao Tong Univ, Coll Med, Key Lab Environm & Genes Related Dis, Xian 710049, Peoples R China; [Zhang, Bo] Xi An Jiao Tong Univ, Sch Life Sci & Technol, Xian 710049, Peoples R China; [Zhong, Dexing] Xi An Jiao Tong Univ, Sch Elect & Informat Engn, Xian 710049, Peoples R China; [Zhang, Tianxiao] Washington Univ, Dept Psychiat, St Louis, MO USA; [Zhang, Bao; Feng, Zufei] Xi An Jiao Tong Univ, Natl Minist Hlth Forens Sci, Coll Med, Key Lab, Xian 710049, Peoples R China; [Yang, Haojie] Xi An Jiao Tong Univ, Affiliated Hosp 2, Coll Med, Dept Orthoped 2, Xian 710049, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University; Xi'an Jiaotong University; Xi'an Jiaotong University; Washington University (WUSTL); Xi'an Jiaotong University; Xi'an Jiaotong University	Zhang, N (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 1, Coll Med, Dept Dent, Xian 710049, Peoples R China.	111-zhangnan@163.com	Xu, yue/HGE-1737-2022		China Postdoctoral Science Foundation [T70927, M532029]; Shaanxi Province Postdoctoral Science Foundation [201318420005]; Ph.D. Programs Foundation of Ministry of Education of China [2013021120078]; Fundamental Research Funds for the Central Universities [08142024, 08143003]; National Natural Science Foundation of China [61105021]	China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Shaanxi Province Postdoctoral Science Foundation; Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was totally supported by China Postdoctoral Science Foundation Funded Project (No. T70927 and M532029), Shaanxi Province Postdoctoral Science Foundation Funded Project (No. 201318420005), Ph.D. Programs Foundation of Ministry of Education of China (No. 2013021120078), Fundamental Research Funds for the Central Universities (No. 08142024 and 08143003) and National Natural Science Foundation of China (No. 61105021). The funding sources had no role in the design of this study, the collection, analysis and interpretation of data, the writing of the report, or the decision to submit the paper for publication.	Albandar JM, 2002, PERIODONTOL 2000, V29, P207, DOI 10.1034/j.1600-0757.2002.290110.x; Amaya MP, 2013, INT ENDOD J, V46, P71, DOI 10.1111/j.1365-2591.2012.02097.x; Andia DC, 2012, ARCH ORAL BIOL; Andia DC, 2011, J PERIODONTOL, V82, P893, DOI 10.1902/jop.2010.100513; Apatzidou DA, 2005, J CLIN PERIODONTOL, V32, P973, DOI 10.1111/j.1600-051X.2005.00788.x; Armitage G C, 1999, Ann Periodontol, V4, P1, DOI 10.1902/annals.1999.4.1.1; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bartold PM, 2006, PERIODONTOL 2000, V40, P7, DOI 10.1111/j.1600-0757.2005.00147.x; Bergstrom Jan, 2004, Odontology, V92, P1; Borrell LN, 2005, J CLIN PERIODONTOL, V32, P132, DOI 10.1111/j.1600-051X.2005.00799.x; Campa D, 2005, CANCER EPIDEM BIOMAR, V14, P2457, DOI 10.1158/1055-9965.EPI-05-0446; Cipollone F, 2004, JAMA-J AM MED ASSOC, V291, P2221, DOI 10.1001/jama.291.18.2221; Corbi SCT, 2012, ARCH ORAL BIOL, V57, P1355, DOI 10.1016/j.archoralbio.2012.07.003; Curtis D, 2006, ANN HUM GENET, V70, P277, DOI 10.1111/j.1529-8817.2005.00225.x; DEFORGE LE, 1992, J CLIN INVEST, V90, P2123, DOI 10.1172/JCI116097; Dutra WO, 2009, CYTOKINE GROWTH F R, V20, P223, DOI 10.1016/j.cytogfr.2009.05.005; Erdemir EO, 2004, J CLIN PERIODONTOL, V31, P99, DOI 10.1111/j.0303-6979.2004.00454.x; Fan WH, 2011, ORAL DIS, V17, P270, DOI 10.1111/j.1601-0825.2010.01736.x; Ferreira SB, 2008, INFECT IMMUN, V76, P3725, DOI 10.1128/IAI.00546-08; Gautam D K, 2011, J Indian Soc Periodontol, V15, P383, DOI 10.4103/0972-124X.92575; Gera Istvan, 2009, Fogorv Sz, V102, P131; GROSSI SG, 1995, J PERIODONTOL, V66, P23, DOI 10.1902/jop.1995.66.1.23; Guan FL, 2014, SCHIZOPHR RES, V152, P97, DOI 10.1016/j.schres.2013.11.004; Guan FL, 2013, J PSYCHIATR RES, V47, P712, DOI 10.1016/j.jpsychires.2013.01.025; Guan FL, 2012, HUM GENET, V131, P1047, DOI 10.1007/s00439-011-1120-8; Guan FL, 2012, SCHIZOPHR RES, V138, P63, DOI 10.1016/j.schres.2012.03.030; Highfield J, 2009, AUST DENT J, V54, pS11, DOI 10.1111/j.1834-7819.2009.01140.x; Kamma JJ, 2004, J CLIN PERIODONTOL, V31, P894, DOI 10.1111/j.1600-051X.2004.00585.x; Kim YJ, 2009, DNA CELL BIOL, V28, P185, DOI 10.1089/dna.2008.0816; Kim YJ, 2010, CLIN CHIM ACTA, V411, P1264, DOI 10.1016/j.cca.2010.05.014; Kinane DF, 2006, PERIODONTOL 2000, V40, P107, DOI 10.1111/j.1600-0757.2005.00136.x; Kinane DF, 2003, CRIT REV ORAL BIOL M, V14, P430, DOI 10.1177/154411130301400605; Kornman K S, 1998, Ann Periodontol, V3, P327, DOI 10.1902/annals.1998.3.1.327; Kornman Kenneth S, 2005, J Dent Educ, V69, P498; Korostishevsky M, 2004, BIOL PSYCHIAT, V56, P169, DOI 10.1016/j.biopsych.2004.04.006; Laine ML, 2010, INT J DENT, V2010, DOI 10.1155/2010/324719; Lee WP, 2005, CLIN CANCER RES, V11, P6431, DOI 10.1158/1078-0432.CCR-05-0942; Li GY, 2012, CYTOKINE, V60, P552, DOI 10.1016/j.cyto.2012.06.239; Loos BG, 2005, J CLIN PERIODONTOL, V32, P159, DOI 10.1111/j.1600-051X.2005.00806.x; Marshall JC, 2005, CRIT CARE MED, V33, pS502, DOI 10.1097/01.CCM.0000186266.34541.5F; Menashe I, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-36; Moreira PR, 2005, J PERIODONTAL RES, V40, P306, DOI 10.1111/j.1600-0765.2005.00801.x; Nibali L, 2011, ORAL DIS, V17, P232, DOI 10.1111/j.1601-0825.2010.01731.x; Nikolopoulos GK, 2008, J CLIN PERIODONTOL, V35, P754, DOI 10.1111/j.1600-051X.2008.01298.x; Palmer RM, 2005, J CLIN PERIODONTOL, V32, P180, DOI 10.1111/j.1600-051X.2005.00786.x; PAPAPANOU PN, 1991, J CLIN PERIODONTOL, V18, P611, DOI 10.1111/j.1600-051X.1991.tb00098.x; Remick DG, 2005, CRIT CARE MED, V33, pS466, DOI 10.1097/01.CCM.0000186783.34908.18; Scarel-Caminaga RM, 2011, BIOCHEM GENET, V49, P292, DOI 10.1007/s10528-010-9407-3; Scarel-Caminaga RM, 2004, J CLIN PERIODONTOL, V31, P443, DOI 10.1111/j.1600-051X.2004.00500.x; Schenkein HA, 2006, PERIODONTOL 2000, V40, P77, DOI 10.1111/j.1600-0757.2005.00144.x; Stern DL, 2000, NATURE, V408, P529, DOI 10.1038/35046183; Taguchi A, 2005, CANCER EPIDEM BIOMAR, V14, P2487, DOI 10.1158/1055-9965.EPI-05-0326; Trombone APF, 2009, J PERIODONTAL RES, V44, P598, DOI 10.1111/j.1600-0765.2008.01166.x; TSAI CC, 1995, J PERIODONTOL, V66, P852, DOI 10.1902/jop.1995.66.10.852; Zhao JH, 2004, BIOINFORMATICS, V20, P1325, DOI 10.1093/bioinformatics/bth071; Zhao JH, 2002, BIOINFORMATICS, V18, P1694, DOI 10.1093/bioinformatics/18.12.1694	56	11	14	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e104436	10.1371/journal.pone.0104436	http://dx.doi.org/10.1371/journal.pone.0104436			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25101955	gold, Green Published, Green Submitted			2022-12-27	WOS:000339993900065
J	Borie, A; Mok, HK; Chao, NL; Fine, ML				Borie, Alfredo; Mok, Hin-Kiu; Chao, Ning L.; Fine, Michael L.			Spatiotemporal Variability and Sound Characterization in Silver Croaker Plagioscion squamosissimus (Sciaenidae) in the Central Amazon	PLOS ONE			English	Article							PASSIVE ACOUSTICS; POGONIAS-CROMIS; SONIC MUSCLE; WEAKFISH; LOCALIZATION; MORPHOLOGY; HECKEL; WATERS; RIVER	Background: The fish family Sciaenidae has numerous species that produce sounds with superfast muscles that vibrate the swimbladder. These muscles form post embryonically and undergo seasonal hypertrophy-atrophy cycles. The family has been the focus of numerous passive acoustic studies to localize spatial and temporal occurrence of spawning aggregations. Fishes produce disturbance calls when hand-held, and males form aggregations in late afternoon and produce advertisement calls to attract females for mating. Previous studies on five continents have been confined to temperate species. Here we examine the calls of the silver croaker Plagioscion squamosissimus, a freshwater equatorial species, which experiences constant photoperiod, minimal temperature variation but seasonal changes in water depth and color, pH and conductivity. Methods and Principal Findings: Dissections indicate that sonic muscles are present exclusively in males and that muscles are thicker and redder during the mating season. Disturbance calls were recorded in hand-held fish during the low-water mating season and high-water period outside of the mating season. Advertisement calls were recorded from wild fish that formed aggregations in both periods but only during the mating season from fish in large cages. Disturbance calls consist of a series of short individual pulses in mature males. Advertisement calls start with single and paired pulses followed by greater amplitude multi-pulse bursts with higher peak frequencies than in disturbance calls. Advertisement-like calls also occur in aggregations during the off season, but bursts are shorter with fewer pulses. Conclusions and Significance: Silver croaker produce complex advertisement calls that vary in amplitude, number of cycles per burst and burst duration of their calls. Unlike temperate sciaenids, which only call during the spawning season, silver croaker produce advertisement calls in both seasons. Sonic muscles are thinner, and bursts are shorter than at the spawning peak, but males still produce complex calls outside of the mating season.	[Borie, Alfredo] Amazon Fed Univ, Dept Fishery, Manaus, Amazonas, Brazil; [Mok, Hin-Kiu] Natl Sun Yat Sen Univ, Dept Oceanog, Kaohsiung, Taiwan; [Mok, Hin-Kiu] Natl Sun Yat Sen Univ, Asia Pacific Ocean Res Ctr, Kaohsiung, Taiwan; [Chao, Ning L.] Natl Museum Marine Biol & Aquarium, Checheng, Pingtung, Taiwan; [Fine, Michael L.] Virginia Commonwealth Univ, Dept Biol, Richmond, VA 23284 USA	National Sun Yat Sen University; National Sun Yat Sen University; National Museum of Marine Biology & Aquarium; Virginia Commonwealth University	Fine, ML (corresponding author), Virginia Commonwealth Univ, Dept Biol, Richmond, VA 23284 USA.	mfine@vcu.edu	Fine, Michael/I-2656-2019	Fine, Michael/0000-0001-9665-1462	Bio-Amazon Conservation; Brazilian Research and Technology National Council (CNPq)	Bio-Amazon Conservation; Brazilian Research and Technology National Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The authors acknowledge the Bio-Amazon Conservation for the financial support and the Brazilian Research and Technology National Council (CNPq) for the MSc. scholarship during the study. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aucour AM, 2003, CHEM GEOL, V197, P271, DOI 10.1016/S0009-2541(02)00398-4; Barbosa ND, 2012, J APPL ICHTHYOL, V28, P800, DOI 10.1111/j.1439-0426.2012.02040.x; Borie A, 2014, B I PESCA IN PRESS; Casatti L, 2005, ZOOTAXA, P39; Casatti Lilian, 2002, Zootaxa, V26, P1; Chao NL, 1978, NMFS TECHNICAL REPOR, V415, P1; CONNAUGHTON MA, 1995, ENVIRON BIOL FISH, V42, P233, DOI 10.1007/BF00004916; Connaughton MA, 1996, COPEIA, P195; Connaughton MA, 1997, J EXP BIOL, V200, P2449; CONNAUGHTON MA, 1995, GEN COMP ENDOCR, V100, P238, DOI 10.1006/gcen.1995.1153; Fine ML, 2001, J COMP PHYSIOL A, V187, P371, DOI 10.1007/s003590100209; Fine ML, 2004, J ACOUST SOC AM, V116, P1271, DOI 10.1121/1.1736271; Fine ML, 2004, COPEIA, P235, DOI 10.1643/CP-03-073R1; FINE ML, 1978, OECOLOGIA, V36, P45, DOI 10.1007/BF00344570; HILL GL, 1987, COPEIA, P708; KONHAUSER KO, 1994, CHEM GEOL, V111, P155, DOI 10.1016/0009-2541(94)90088-4; Ladich Friedrich, 2006, P3; Lagardere JP, 2006, J FISH BIOL, V69, P1697, DOI 10.1111/j.1095-8649.2006.01237.x; Lin YC, 2007, J ACOUST SOC AM, V121, P586, DOI 10.1121/1.2384844; Locascio JV, 2011, J ACOUST SOC AM, V130, P1868, DOI 10.1121/1.3621514; Luczkovich JJ, 2008, T AM FISH SOC, V137, P533, DOI 10.1577/T06-258.1; Mitchell S, 2008, ANIM BEHAV, V76, P1011, DOI 10.1016/j.anbehav.2008.03.024; Mok HK, 2009, ZOOL STUD, V48, P325; MOK HK, 1983, B I ZOOL ACAD SINICA, V22, P157; ONO RD, 1982, CAN J ZOOL, V60, P1955, DOI 10.1139/z82-253; Parsons MJG, 2012, J ACOUST SOC AM, V132, P3559, DOI 10.1121/1.4756927; Picculin M, 2012, BIOACOUSTICS, P1; RICHEY JE, 1990, LIMNOL OCEANOGR, V35, P352, DOI 10.4319/lo.1990.35.2.0352; Rountree RA, 2006, FISHERIES, V31, P433, DOI 10.1577/1548-8446(2006)31[433:LTF]2.0.CO;2; SANTOS S.B., 2003, REV CIENCIA AGRONOMI, V34, P5; Siqueira-Souza FK, 2006, PEIXES MEDIO RIO NEG; Tellechea J, 2010, J EXP ZOOL PART A, V313A, P1, DOI DOI 10.1002/JEZ.551; Tellechea JS, 2011, BIOACOUSTICS, V20, P159, DOI 10.1080/09524622.2011.9753641; Devincenti CV, 2012, INT J MORPHOL, V30, P1442, DOI 10.4067/S0717-95022012000400027; WORTHMANN HO, 1992, AMAZONIANA, V12, P17	35	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e99326	10.1371/journal.pone.0099326	http://dx.doi.org/10.1371/journal.pone.0099326			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25098347	Green Submitted, Green Published, gold			2022-12-27	WOS:000339995100002
J	Roughan, JV; Coulter, CA; Flecknell, PA; Thomas, HD; Sufka, KJ				Roughan, John V.; Coulter, Claire A.; Flecknell, Paul A.; Thomas, Huw D.; Sufka, Kenneth J.			The Conditioned Place Preference Test for Assessing Welfare Consequences and Potential Refinements in a Mouse Bladder Cancer Model	PLOS ONE			English	Article							POSTOPERATIVE PAIN; THERMAL NOCICEPTION; SEX-DIFFERENCES; TUMOR-GROWTH; 2 STRAINS; MORPHINE; BEHAVIOR; BUPRENORPHINE; LAPAROTOMY; SURGERY	Most pre-clinical analgesic efficacy assays still involve nociceptive testing in rodents. This is despite concerns as to the relevance of these tests for evaluating the pain-preventative properties of drugs. More appropriate methods would target pain rather than nociception, but these are currently not available, so it remains unknown whether animal pain equates to the negatively affective and subjective/emotional state it causes in humans. Mouse cancer models are common despite the likelihood of substantial pain. We used Conditioned Place Preference (CPP) testing, assessments of thermal hyperalgesia and behaviour to determine the likelihood that MBT-2 bladder cancer impacts negatively on mouse welfare, such as by causing pain. There was no CPP to saline, but morphine preference in tumour bearing mice exceeded that seen in tumour-free controls. This occurred up to 10 days before the study end-point alongside reduced body weight, development of hyperalgesia and behaviour changes. These effects indicated mice experienced a negative welfare state caused by malaise (if not pain) before euthanasia. Due to the complexity of the assessments needed to demonstrate this, it is unlikely that this approach could be used for routine welfare assessment on a study-by-study basis. However, our results show mice in sufficiently similar studies are likely to benefit from more intensive severity assessment and re-evaluation of end-points with a view to implementing appropriate refinements. In this particular case, a refinement would have been to have euthanased mice at least 7 days earlier or possibly by provision of end-stage pain relief. CPP testing was found to be a helpful method to investigate the responses of mice to analgesics, possibly on a subjective level. These findings and those of other recent studies show it could be a valuable method of screening candidate analgesics for efficacy against cancer pain and possibly other pain or disease models.	[Roughan, John V.; Coulter, Claire A.; Flecknell, Paul A.] Univ Newcastle, Sch Med, Comparat Biol Ctr, Newcastle Upon Tyne, Tyne & Wear, England; [Thomas, Huw D.] Univ Newcastle, Sch Med, Northern Inst Canc Res, Newcastle Upon Tyne, Tyne & Wear, England; [Sufka, Kenneth J.] Univ Mississippi, Pharmaceut Sci Res Inst, Oxford, MS USA; [Sufka, Kenneth J.] Univ Mississippi, Dept Psychol, Oxford, MS USA; [Sufka, Kenneth J.] Univ Mississippi, Dept Pharmacol, Oxford, MS USA	Newcastle University - UK; Newcastle University - UK; University of Mississippi; University of Mississippi; University of Mississippi	Roughan, JV (corresponding author), Univ Newcastle, Sch Med, Comparat Biol Ctr, Newcastle Upon Tyne, Tyne & Wear, England.	j.v.roughan@ncl.ac.uk	Roughan, John Vincent/AAF-3586-2021	Roughan, John Vincent/0000-0002-0031-3918; Flecknell, Paul/0000-0002-1075-1129	UK National Centre for the 3Rs (NC3Rs) [G0900763]; National Centre for the Replacement [G0900763/1] Funding Source: researchfish	UK National Centre for the 3Rs (NC3Rs); National Centre for the Replacement	The study was funded by the UK National Centre for the 3Rs (NC3Rs): http://www.nc3rs.org.uk/, Grant Number G0900763, PI: JV Roughan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asai H, 2005, PAIN, V117, P19, DOI 10.1016/j.pain.2005.05.010; Bardo MT, 2000, PSYCHOPHARMACOLOGY, V153, P31, DOI 10.1007/s002130000569; BATESON P, 1991, ANIM BEHAV, V42, P827, DOI 10.1016/S0003-3472(05)80127-7; BATESON PPG, 1973, SCIENCE, V181, P576, DOI 10.1126/science.181.4099.576; Betourne A, 2008, NEUROSCIENCE, V157, P12, DOI 10.1016/j.neuroscience.2008.08.045; Calixto-Campos C, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/624815; Cesarovic N, 2014, APPL ANIM BEHAV SCI; CHIN J, 1991, J UROLOGY, V145, P1297, DOI 10.1016/S0022-5347(17)38618-4; COWAN A, 1977, BRIT J PHARMACOL, V60, P547, DOI 10.1111/j.1476-5381.1977.tb07533.x; Craft RM, 1995, J PHARMACOL EXP THER, V275, P1535; Dashti-Rahmatabadi MH, 2007, J ETHNOPHARMACOL, V109, P226, DOI 10.1016/j.jep.2006.07.035; Davoody L, 2011, J PAIN, V12, P868, DOI 10.1016/j.jpain.2011.01.010; DENNIS SG, 1979, ADV PAIN RES THER, V3, P747; Dickinson AL, 2009, LAB ANIM-UK, V43, P357, DOI 10.1258/la.2009.009005; Dimitrijevic M, 2001, BRAIN BEHAV IMMUN, V15, P255, DOI 10.1006/brbi.2000.0599; Duncan IJH, 1996, ACTA AGR SCAND A-AN, P29; Everdingen MHJVDBV, 2007, ANN ONCOL, V18, P1437, DOI 10.1093/annonc/mdm056; Flecknell P, 2011, PAIN, V152, P963, DOI 10.1016/j.pain.2011.01.030; Fox A, 2004, PAIN, V107, P33, DOI 10.1016/j.pain.2003.09.003; Franchi S, 2007, BRAIN BEHAV IMMUN, V21, P767, DOI 10.1016/j.bbi.2007.01.001; Hang LH, 2013, BASIC CLIN PHARMACOL, V113, P325, DOI 10.1111/bcpt.12099; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Hasegawa H, 2002, JPN J CANCER RES, V93, P729, DOI 10.1111/j.1349-7006.2002.tb01313.x; Hayes JH, 1999, LAB ANIM-UK, V33, P16, DOI 10.1258/002367799780578534; Hayes KE, 2000, CONTEMP TOP LAB ANIM, V39, P18; HMSO, 2012, STAT SCI PROC LIV AN; Kalueff AV, 2004, BRAIN RES PROTOC, V13, P151, DOI 10.1016/j.brainresprot.2004.04.002; Kilkenny C, 2010, J PHARMACOL PHARMACO, V1, P94, DOI 10.4103/0976-500X.72351; King T, 2009, NAT NEUROSCI, V12, P1364, DOI 10.1038/nn.2407; Langford DJ, 2010, NAT METHODS, V7, P447, DOI [10.1038/NMETH.1455, 10.1038/nmeth.1455]; Leach MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035656; Leach MC, 2009, RES VET SCI, V87, P336, DOI 10.1016/j.rvsc.2009.02.001; Lee BH, 2005, YONSEI MED J, V46, P252, DOI 10.3349/ymj.2005.46.2.252; LILES JH, 1993, LAB ANIM, V27, P374, DOI 10.1258/002367793780745552; LILES JH, 1993, BRIT VET J, V149, P515, DOI 10.1016/S0007-1935(05)80036-3; Liu M, 2013, PAIN, V154, P1551, DOI 10.1016/j.pain.2013.04.022; Mao JR, 2012, TRENDS PHARMACOL SCI, V33, P568, DOI 10.1016/j.tips.2012.08.001; Martucci C, 2004, PAIN, V110, P385, DOI 10.1016/j.pain.2004.04.020; Matsumiya LC, 2012, J AM ASSOC LAB ANIM, V51, P42; McNabb CT, 2012, NEUROSCI LETT, V507, P57, DOI 10.1016/j.neulet.2011.11.051; Medhurst S, 2001, BRIT J PHARMACOL, V134; Mendl M, 2009, APPL ANIM BEHAV SCI, V118, P161, DOI 10.1016/j.applanim.2009.02.023; Miller AL, 2012, LAB ANIM-UK, V46, P304, DOI 10.1258/la.2012.012078; Miller AL, 2011, APPL ANIM BEHAV SCI, V131, P138, DOI 10.1016/j.applanim.2011.02.007; Mogil JS, 2012, NAT REV NEUROSCI, V13, P859, DOI 10.1038/nrn3360; Mogil JS, 2006, HAND CLINIC, V81, P325, DOI 10.1016/S0072-9752(06)80027-8; Mogil JS, 2004, PAIN, V112, P12, DOI 10.1016/j.pain.2004.09.028; Mogil JS, 1999, PAIN, V80, P67, DOI 10.1016/S0304-3959(98)00197-3; Mogil JS, 2000, NEUROSCI BIOBEHAV R, V24, P375, DOI 10.1016/S0149-7634(00)00015-4; Nagahata S, 2007, EUR J PAIN, V11, P69; Okun A, 2012, PAIN, V153, P924, DOI 10.1016/j.pain.2012.01.022; Park HJ, 2013, ANESTH ANALG, V116, P224, DOI 10.1213/ANE.0b013e31826e1007; Qu CL, 2011, PAIN, V152, P1641, DOI 10.1016/j.pain.2011.03.002; Roughan JV, 2009, LAB ANIM-UK, V43, P17, DOI 10.1258/la.2008.007156; Roughan JV, 2006, APPL ANIM BEHAV SCI, V96, P327, DOI 10.1016/j.applanim.2005.06.012; Roughan JV, 2004, BEHAV PHARMACOL, V15, P461, DOI 10.1097/00008877-200411000-00002; Roughan JV, 2004, LAB ANIM-UK, V38, P286, DOI 10.1258/002367704323133673; Roughan JV, 2003, EUR J PAIN, V7, P397, DOI 10.1016/S1090-3801(02)00140-4; Roughan JV, 2000, RES VET SCI, V69, P283, DOI 10.1053/rvsc.2000.0430; Roughan JV, 2001, PAIN, V90, P65, DOI 10.1016/S0304-3959(00)00387-0; Roughan JV, 2003, 8 WORLD C VET AN KNO, P143; Roughan JV, 2003, VET ANAESTH ANALG, V30, P54; Rutten K, 2011, EUR J PAIN, V15, P299, DOI 10.1016/j.ejpain.2010.07.011; Sasamura T, 2002, EUR J PHARMACOL, V441, P185, DOI 10.1016/S0014-2999(02)01450-4; Sorge RE, 2011, J NEUROSCI, V31, P15450, DOI 10.1523/JNEUROSCI.3859-11.2011; Stevenson GW, 2006, J PAIN, V7, P408, DOI 10.1016/j.jpain.2006.01.447; Sufka KJ, 2011, PAIN, V152, P1942, DOI 10.1016/j.pain.2011.04.028; Sufka KJ, 1996, PAIN, V66, P99, DOI 10.1016/0304-3959(96)02990-9; SUFKA KJ, 1994, PAIN, V58, P355, DOI 10.1016/0304-3959(94)90130-9; Suzuki T, 1996, J PHARMACOL EXP THER, V279, P177; Urban R, 2011, PAIN, V152, P990, DOI 10.1016/j.pain.2010.12.003; Valeberg BT, 2008, EUR J PAIN, V12, P582, DOI 10.1016/j.ejpain.2007.09.004; Vermeirsch H, 2004, PHARMACOL BIOCHEM BE, V79, P243, DOI 10.1016/j.pbb.2004.07.011; Workman P, 2010, BRIT J CANCER, V102, P1555, DOI 10.1038/sj.bjc.6605642; Workman P, 1998, BRIT J CANCER, V77, P1; Wright-Williams S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075948; Wright-Williams SL, 2007, PAIN, V130, P108, DOI 10.1016/j.pain.2006.11.003; Zhang HW, 2003, J PHARMACOL SCI, V91, P167; Zhao J, 2013, NEUROSCIENCE, V253, P172, DOI 10.1016/j.neuroscience.2013.08.026	79	29	29	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e103362	10.1371/journal.pone.0103362	http://dx.doi.org/10.1371/journal.pone.0103362			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25100208	Green Published, gold, Green Submitted			2022-12-27	WOS:000339995100018
J	Wehner, K; Scheu, S; Maraun, M				Wehner, Katja; Scheu, Stefan; Maraun, Mark			Resource Availability as Driving Factor of the Reproductive Mode in Soil Microarthropods (Acari, Oribatida)	PLOS ONE			English	Article							SEXUAL REPRODUCTION; MITES ACARI; PARTHENOGENESIS; DIVERSITY; DENSITY; BEECH; COLONIZATION; COMMUNITY; SELECTION; PATTERNS	The availability of high quality resources is an important factor driving community structure and reproductive mode of animals. Parthenogenetic reproduction prevails when resources are available in excess, whereas sexuality correlates with resource shortage. We investigated the effect of resource availability on the community structure of oribatid mites in a laboratory experiment. Availability of food resources was increased by addition of glucose to leaf litter and reduced by leaching of nutrients from leaf litter. Experimental systems were incubated at three different temperatures to establish different regimes of resource exploitation. Community structure of oribatids and numbers of eggs per female were measured over a period of ten months. We expected the density of oribatid mites to decline in the reduced litter quality treatment but to increase in the glucose treatment. Both effects were assumed to be more pronounced at higher temperatures. We hypothesized sexual species to be less affected than parthenogenetic species by reduced resource quality due to higher genetic diversity allowing more efficient exploitation of limited resources, but to be outnumbered by parthenogenetic species in case of resource addition due to faster reproduction. In contrast to our hypotheses, both sexual and parthenogenetic oribatid mite species responded similarly with their densities declining uniformly during incubation. The parthenogenetic Brachychthoniidae and Tectocepheus dominated early in the experiment but were replaced later by parthenogenetic Desmonomata and Rhysotritia. In parthenogenetic species the number of eggs per female increased during the experiment while the number of eggs in sexual females remained constant or decreased slightly; in general, egg numbers were higher in sexual than in parthenogenetic species. The results indicate that for sustaining oribatid mite populations other resources than litter and associated saprotrophic microorganisms are needed. They also indicate that there are two groups of parthenogenetically reproducing species: exploiters of easily available resources and consumers of leaf litter associated resources.	[Wehner, Katja] Univ Technol, Inst Zool, Darmstadt, Germany; [Scheu, Stefan; Maraun, Mark] Univ Gottingen, Inst Zool & Anthropol, D-37073 Gottingen, Germany	Technical University of Darmstadt; University of Gottingen	Maraun, M (corresponding author), Univ Gottingen, Inst Zool & Anthropol, D-37073 Gottingen, Germany.	mmaraun@gwdg.de	Scheu, Stefan/H-7049-2015		German Research Foundation [SCHE 376/19-1]	German Research Foundation(German Research Foundation (DFG))	This work was supported by the German Research Foundation SCHE 376/19-1. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bardgett RD, 2005, TRENDS ECOL EVOL, V20, P634, DOI 10.1016/j.tree.2005.08.005; Bell G, 1982, MASTERPIECE NATURE E; Chahartaghi M, 2009, PEDOBIOLOGIA, V52, P181, DOI 10.1016/j.pedobi.2008.08.003; Cianciolo JM, 2006, EXP APPL ACAROL, V40, P1, DOI 10.1007/s10493-006-9016-3; DeBarro PJ, 1995, P ROY SOC B-BIOL SCI, V262, P321, DOI 10.1098/rspb.1995.0212; Domes K, 2007, PEDOBIOLOGIA, V51, P1, DOI 10.1016/j.pedobi.2006.11.001; Eissfeller V, 2013, SOIL BIOL BIOCHEM, V62, P76, DOI 10.1016/j.soilbio.2013.03.002; Erdmann G, 2006, PEDOBIOLOGIA, V50, P433, DOI 10.1016/j.pedobi.2006.08.004; Fioretto A, 2003, BIOL FERT SOILS, V39, P37, DOI 10.1007/s00374-003-0675-5; Fujikawa T., 1988, Edaphologia, P1; FUJIKAWA T, 1988, ACAROLOGIA, V29, P307; Ghiselin M.T., 1974, EC NATURE EVOLUTION; GLESENER RR, 1978, AM NAT, V112, P659, DOI 10.1086/283308; Grandjean F, 1941, CR HEBD ACAD SCI, V212, P463; HAMILTON WD, 1980, OIKOS, V35, P282, DOI 10.2307/3544435; Hammer M., 1979, Kongelige Danske Videnskabernes Selskab Biologiske Skrifter, V22, P1; Heethoff M, 2007, J EVOLUTION BIOL, V20, P392, DOI 10.1111/j.1420-9101.2006.01183.x; Judson Olivia P., 1996, Trends in Ecology and Evolution, V11, P41, DOI 10.1016/0169-5347(96)81040-8; Kempson D., 1963, Pedobiologia, V3, P1; KORPELAINEN H, 1990, BIOL REV, V65, P147, DOI 10.1111/j.1469-185X.1990.tb01187.x; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P1, DOI 10.1007/BF02289565; LUXTON M, 1981, PEDOBIOLOGIA, V21, P312; Lynch Michael, 1994, P109; MACFADYEN A, 1970, Soil Biology and Biochemistry, V2, P9, DOI 10.1016/0038-0717(70)90020-9; MACFADYEN A, 1961, J ANIM ECOL, V30, P171, DOI 10.2307/2120; Maraun M, 2000, ECOGRAPHY, V23, P374, DOI 10.1111/j.1600-0587.2000.tb00294.x; Maraun M, 2003, SOIL BIOL BIOCHEM, V35, P1387, DOI 10.1016/S0038-0717(03)00218-9; Maraun M, 2011, SOIL BIOL BIOCHEM, V43, P877, DOI 10.1016/j.soilbio.2011.01.003; Maraun M, 2013, PEDOBIOLOGIA, V56, P185, DOI 10.1016/j.pedobi.2013.07.001; Maraun M, 2012, EVOL ECOL RES, V14, P311; Martens K, 2003, P ROY SOC B-BIOL SCI, V270, P723, DOI 10.1098/rspb.2002.2270; MCNAUGHTON SJ, 1989, NATURE, V341, P142, DOI 10.1038/341142a0; NICOLAI V, 1986, OECOLOGIA, V69, P148, DOI 10.1007/BF00399052; Norton R.A., 1991, P107; NORTON RA, 1988, J PALEONTOL, V62, P259, DOI 10.1017/S0022336000029905; Norton Roy A., 1993, P8; PALMER SC, 1992, BIOCHEM SYST ECOL, V20, P219, DOI 10.1016/0305-1978(92)90056-J; Pollierer MM, 2007, ECOL LETT, V10, P729, DOI 10.1111/j.1461-0248.2007.01064.x; Redfield RJ, 1999, J EVOLUTION BIOL, V12, P1043; RHOMBERG LR, 1985, CAN J GENET CYTOL, V27, P224, DOI 10.1139/g85-033; Schaefer M., 1991, P51; Scheiner SM, 2001, DESIGN ANAL ECOLOGIC; Scheu S, 2007, P ROY SOC B-BIOL SCI, V274, P1225, DOI 10.1098/rspb.2007.0040; Scheu S, 1996, BIODIVERS CONSERV, V5, P235, DOI 10.1007/BF00055833; Schneider K, 2004, SOIL BIOL BIOCHEM, V36, P1769, DOI 10.1016/j.soilbio.2004.04.033; Schneider K, 2007, BASIC APPL ECOL, V8, P26, DOI 10.1016/j.baae.2006.03.004; SHEAR WA, 1984, SCIENCE, V224, P492, DOI 10.1126/science.224.4648.492; SMITH JM, 1978, EVOLUTION SEX; Song Y, 2012, J EVOLUTION BIOL, V25, P556, DOI 10.1111/j.1420-9101.2012.02454.x; Song Y, 2011, OIKOS, V120, P1601, DOI 10.1111/j.1600-0706.2011.19698.x; Sovik G, 2003, CAN J ZOOL, V81, P1579, DOI [10.1139/z03-113, 10.1139/Z03-113]; TABERLY G, 1988, ACAROLOGIA, V29, P95; Ter Braak C.J.F., 1998, CANOCO RELEASE 4 REF; Trave J., 1996, ACARIENS ORIBATES; Welch DM, 2000, SCIENCE, V288, P1211, DOI 10.1126/science.288.5469.1211; Williams G.C., 1975, Journal Cell Biol, VNo. 8, pi; YOUNG JPW, 1979, GENETICS, V92, P953	57	11	14	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e104243	10.1371/journal.pone.0104243	http://dx.doi.org/10.1371/journal.pone.0104243			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25099762	Green Submitted, gold, Green Published			2022-12-27	WOS:000339995100054
J	Kumar, S; Dansereau, E				Kumar, Santosh; Dansereau, Emily			Supply-Side Barriers to Maternity-Care in India: A Facility-Based Analysis	PLOS ONE			English	Article							CONTEXTUAL INFLUENCES; HEALTH-SERVICES; DEMAND-SIDE; RURAL INDIA; ACCESS; COUNTRIES; PRADESH	Background: Health facilities in many low-and middle-income countries face several types of barriers in delivering quality health services. Availability of resources at the facility may significantly affect the volume and quality of services provided. This study investigates the effect of supply-side determinants of maternity-care provision in India. Methods: Health facility data from the District-Level Household Survey collected in 2007-2008 were analyzed to explore the effects of supply-side factors on the volume of delivery care provided at Indian health facilities. A negative binomial regression model was applied to the data due to the count and over-dispersion property of the outcome variable (number of deliveries performed at the facility). Results: Availability of a labor room (Incidence Rate Ratio [IRR]: 1.81; 95% Confidence Interval [CI]: 1.68-1.95) and facility opening hours (IRR: 1.43; CI: 1.35-1.51) were the most significant predictors of the volume of delivery care at the health facilities. Medical and paramedical staff were found to be positively associated with institutional deliveries. The volume of deliveries was also higher if adequate beds, essential obstetric drugs, medical equipment, electricity, and communication infrastructures were available at the facility. Findings were robust to the inclusion of facility's catchment area population and district-level education, health insurance coverage, religion, wealth, and fertility. Separate analyses were performed for facilities with and without a labor room and results were qualitatively similar across these two types of facilities. Conclusions: Our study highlights the importance of supply-side barriers to maternity-care India. To meet Millennium Development Goals 4 and 5, policymakers should make additional investments in improving the availability of medical drugs and equipment at primary health centers (PHCs) in India.	[Kumar, Santosh] Sam Houston State Univ, Dept Econ & Int Business, Huntsville, TX 77340 USA; [Kumar, Santosh; Dansereau, Emily] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA	Texas State University System; Sam Houston State University; Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle	Kumar, S (corresponding author), Sam Houston State Univ, Dept Econ & Int Business, Huntsville, TX 77340 USA.	skumar@shsu.edu			Disease Control Priorities Network grant from the Bill & Melinda Gates Foundation	Disease Control Priorities Network grant from the Bill & Melinda Gates Foundation	This project was funded by the Disease Control Priorities Network grant to the Institute for Health Metrics and Evaluation from the Bill & Melinda Gates Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson PC, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-30; Adsul Neha, 2013, Indian J Community Med, V38, P223, DOI 10.4103/0970-0218.120157; Annual Health Survey, 2011, ANN HLTH SURV; Borah BJ, 2006, HEALTH ECON, V15, P915, DOI 10.1002/hec.1166; Cameron A. C., 2013, REGRESSION ANAL COUN, V53, DOI [10.1017/CBO9781139013567, DOI 10.1017/CBO9781139013567]; Department of Health and Family Welfare, 2010, ANN REPORT; Ensor T, 2004, HEALTH POLICY PLANN, V19, P69, DOI 10.1093/heapol/czh009; Hanson K, 2003, J INT DEV, V15, P1, DOI DOI 10.1002/JID.963; Hong R, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-79; International Institute for Population Sciences, 2010, DISTR LEV HOUS FAC S; Jacobs B, 2012, HEALTH POLICY PLANN, V27, P288, DOI 10.1093/heapol/czr038; Jat TR, 2011, INT J EQUITY HEALTH, V10, DOI 10.1186/1475-9276-10-59; Jones AM, 2000, HANDB ECON, V17, P265; Kesterton AJ, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-30; Lim SS, 2010, LANCET, V375, P2009, DOI 10.1016/S0140-6736(10)60744-1; Mbonye Anthony K, 2010, Int J Adolesc Med Health, V22, P249, DOI 10.1515/IJAMH.2010.22.2.249; Metcalfe R, 2013, INT HEALTH, V5, P96, DOI 10.1093/inthealth/ihs001; National Health Mission Directorate General of Health Services Ministry of Health and Family Welfare Government of India, 2012, IND PUBL HLTH STAND; O'Donnell O, 2007, CAD SAUDE PUBLICA, V23, P2820, DOI 10.1590/S0102-311X2007001200003; Olsen OE, 2005, HUM RESOUR HEALTH, V29, P3; Pandian Jayanthi, 2013, J Family Med Prim Care, V2, P329, DOI 10.4103/2249-4863.123781; Peabody JW, 1998, HEALTH POLICY, V43, P1, DOI 10.1016/S0168-8510(97)00085-7; Rai Sanjay K, 2011, Indian J Public Health, V55, P252, DOI 10.4103/0019-557X.92400; Sarma S, 2009, APPL HEALTH ECON HEA, V7, P265, DOI 10.2165/10899650-000000000-00000; Sharma M P, 2009, Indian J Public Health, V53, P177; Stephenson R, 2002, STUD FAMILY PLANN, V33, P309, DOI 10.1111/j.1728-4465.2002.00309.x; Stephenson R, 2008, HEALTH PLACE, V14, P841, DOI 10.1016/j.healthplace.2008.01.005; Winkelmann R, 1997, ECONOMETRIC ANAL COU, DOI 10.1007/978-3-662-03465-1; World Bank, 2012, WORLD DEV REP 2012 G; World Health Organization, 1999, RED MAT MORT; World Health Organization (WHO), 2012, TRENDS MAT MORT 1990	31	25	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e103927	10.1371/journal.pone.0103927	http://dx.doi.org/10.1371/journal.pone.0103927			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO5BW	25093729	Green Submitted, gold, Green Published			2022-12-27	WOS:000341357200044
J	Oh, JJ; Park, S; Lee, SE; Hong, SK; Lee, S; Choe, G; Yoon, S; Byun, SS				Oh, Jong Jin; Park, Seunghyun; Lee, Sang Eun; Hong, Sung Kyu; Lee, Sangchul; Choe, Gheeyoung; Yoon, Sungroh; Byun, Seok-soo			The Use of Exome Genotyping to Predict Pathological Gleason Score Upgrade after Radical Prostatectomy in Low-Risk Prostate Cancer Patients	PLOS ONE			English	Article							ACTIVE SURVEILLANCE; EPSTEIN CRITERIA; AFRICAN-AMERICAN; URINE ASSAY; MEN; OUTCOMES; CANDIDATES; PCA3	Background: Active surveillance (AS) is a promising option for patients with low-risk prostate cancer (PCa), however current criteria could not select the patients correctly, many patients who fulfilled recent AS criteria experienced pathological Gleason score upgrade (PGU) after radical prostatectomy (RP). In this study, we aimed to develop an accurate model for predicting PGU among low-risk PCa patients by using exome genotyping. Methods: We genotyped 242,221 single nucleotide polymorphisms (SNP)s on a custom HumanExome BeadChip v1.0 (Illuminam Inc.) in blood DNA from 257 low risk PCa patients (PSA <10 ng/ml, biopsy Gleason score (GS) <= 6 and clinical stage <= T2a) who underwent radical prostatectomy. Genetic data were analyzed using an unconditional logistic regression to calculate an odds ratio as an estimate of relative risk of PGU, which defined pathologic GS above 7. Among them, we selected persistent SNPs after multiple testing using FDR method, and we compared accuracies from the multivariate logistic model incorporating clinical factors between included and excluded selected SNP information. Results: After analysis of exome genotyping, 15 SNPs were significant to predict PGU in low risk PCa patients. Among them, one SNP - rs33999879 remained significant after multiple testing. When a multivariate model incorporating factors in Epstein definition - PSA density, biopsy GS, positive core number, tumor per core ratio and age was devised for the prediction of PGU, the predictive accuracy of the multivariate model was 78.4% (95% CI: 0.726-0.834). By addition the factor of rs33999879 in aforementioned multivariate model, the predictive accuracy was 82.9%, which was significantly increased (p = 0.0196). Conclusion: The rs33999879 SNP is a predictor for PGU. The addition of genetic information from the exome sequencing effectively enhanced the predictive accuracy of the multivariate model to establish suitable active surveillance criteria.	[Oh, Jong Jin; Lee, Sang Eun; Hong, Sung Kyu; Lee, Sangchul; Byun, Seok-soo] Seoul Natl Univ, Dept Urol, Bundang Hosp, Songnam, South Korea; [Park, Seunghyun; Yoon, Sungroh] Seoul Natl Univ, Dept Elect & Comp Engn, Seoul, South Korea; [Park, Seunghyun] Korea Univ, Sch Elect Engn, Seoul, South Korea; [Choe, Gheeyoung] Seoul Natl Univ, Dept Pathol, Bundang Hosp, Songnam, South Korea	Seoul National University (SNU); Seoul National University (SNU); Korea University; Seoul National University (SNU)	Yoon, S (corresponding author), Seoul Natl Univ, Dept Elect & Comp Engn, Seoul, South Korea.	sryoon@gmail.com; ssbyun@snubh.org		Park, Seunghyun/0000-0002-8509-9163	SNUBH (Seoul National University Bundang Hospital) Research Fund [12-2013-015]; National Research Foundation of Korea (NRF) - Korea government (Ministry of Science, ICT and Future Planning) [2011-0009963]	SNUBH (Seoul National University Bundang Hospital) Research Fund; National Research Foundation of Korea (NRF) - Korea government (Ministry of Science, ICT and Future Planning)	This work was supported by grant no. 12-2013-015 from the SNUBH (Seoul National University Bundang Hospital) Research Fund and supported in part by the National Research Foundation of Korea (NRF) grant funded by the Korea government (Ministry of Science, ICT and Future Planning) (No. 2011-0009963). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barocas DA, 2008, J UROLOGY, V180, P1330, DOI 10.1016/j.juro.2008.06.019; Bastian PJ, 2009, EUR UROL, V55, P1321, DOI 10.1016/j.eururo.2009.02.028; Bastian PJ, 2004, CANCER-AM CANCER SOC, V101, P2001, DOI 10.1002/cncr.20586; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Chun FKH, 2008, CANCER-AM CANCER SOC, V113, P701, DOI 10.1002/cncr.23610; Conti SL, 2009, J UROLOGY, V181, P1628, DOI 10.1016/j.juro.2008.11.107; Conti SL, 2009, J UROLOGY, V181, P1633; Dall'Era MA, 2012, EUR UROL, V62, P976, DOI 10.1016/j.eururo.2012.05.072; Deras IL, 2008, J UROLOGY, V179, P1587, DOI 10.1016/j.juro.2007.11.038; Eeles RA, 2013, NAT GENET, V45, P385, DOI 10.1038/ng.2560; EPSTEIN JI, 1994, JAMA-J AM MED ASSOC, V271, P368, DOI 10.1001/jama.271.5.368; Haese A, 2008, EUR UROL, V54, P1081, DOI 10.1016/j.eururo.2008.06.071; HEDRICK PW, 1987, GENETICS, V117, P331; Jeldres C, 2008, EUR UROL, V54, P1306, DOI 10.1016/j.eururo.2007.11.057; Kattan MW, 2003, J NATL CANCER I, V95, P634, DOI 10.1093/jnci/95.9.634; Klotz L, 2005, J CLIN ONCOL, V23, P8165, DOI 10.1200/JCO.2005.03.3134; Lee SE, 2010, BJU INT, V105, P1526, DOI 10.1111/j.1464-410X.2009.09070.x; MCNEAL JE, 1988, AM J SURG PATHOL, V12, P897, DOI 10.1097/00000478-198812000-00001; Mitsuzuka K, 2013, BJU INT, V111, P914, DOI 10.1111/j.1464-410X.2012.11658.x; Nelson WG, 2003, NEW ENGL J MED, V349, P366, DOI 10.1056/NEJMra021562; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; Roemeling S, 2007, EUR UROL, V51, P1244, DOI 10.1016/j.eururo.2006.11.053; Schumacher FR, 2011, HUM MOL GENET, V20, P3867, DOI 10.1093/hmg/ddr295; Song C, 2006, UROLOGY, V68, P820, DOI 10.1016/j.urology.2006.04.029; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Sundi D, 2013, J CLIN ONCOL, V31, P2991, DOI 10.1200/JCO.2012.47.0302; Thaxton CS, 2010, UROLOGY, V75, P414, DOI 10.1016/j.urology.2009.07.1353; van Houten ME, 2000, ASIAN J ANDROL, V2, P13; Warlick C, 2006, JNCI-J NATL CANCER I, V98, P355, DOI 10.1093/jnci/djj072; Wu AH, 2001, CANCER EPIDEM BIOMAR, V10, P533; Zhou B, 2012, ONCOL REP, V28, P1263, DOI 10.3892/or.2012.1929	31	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e104146	10.1371/journal.pone.0104146	http://dx.doi.org/10.1371/journal.pone.0104146			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093842	Green Published, Green Submitted, gold			2022-12-27	WOS:000341357200073
J	Athanassiou, CG; Kavallieratos, NG; Throne, JE; Nakas, CT				Athanassiou, Christos G.; Kavallieratos, Nickolas G.; Throne, James E.; Nakas, Christos T.			Competition among Species of Stored-Product Psocids (Psocoptera) in Stored Grain	PLOS ONE			English	Article							LIPOSCELIS-BOSTRYCHOPHILA PSOCOPTERA; CALLOSOBRUCHUS-MACULATUS F; POPULATION-GROWTH; INTRASPECIFIC COMPETITION; LEPINOTUS-RETICULATUS; BAMBARA GROUNDNUT; PAETA PSOCOPTERA; MAIZE; WHEAT; REPRODUCTION	We evaluated the competition among stored-product psocid species by conducting two series of laboratory experiments. In the first series, three species of Liposcelididae were used: Liposcelis bostrychophila, Liposcelis decolor, and Liposcelis paeta. Five adult females of these species were placed in vials containing wheat, either alone or in all possible combinations of two species. The number of adults in the vials was counted after 35, 70, 105, 140, and 175 days. These tests were performed at 25 and 30 degrees C. At 25 degrees C, there were no differences in numbers of L. bostrychophila when this species was reared either alone or with each of the other two species. At 30 degrees C, L. bostrychophila was the dominant species. The presence of L. bostrychophila had a negative effect on the growth of populations of L. decolor and L. paeta. The presence of L. paeta did not affect growth of populations of L. decolor, although the presence of L. decolor occasionally reduced growth of populations of L. paeta. In the second series of tests, L. bostrychophila adult females were placed in vials of wheat either alone or with adult females of Lepinotus reticulatus, at the ratios of (L. bostrychophila:L. reticulatus) 10:0, 9:1, 7:3, 5:5, 3:7, 1:9, and 0:10. These tests were carried out only at 30 degrees C, and the observation periods were the same as for the first series of tests. Liposcelis bostrychophila was the dominant species in this case as well, regardless of the ratio of the parental females. At the end of the experimental period, L. reticulatus was present only in vials that contained this species alone. Our results showed that L. bostrychophila outcompetes the other stored-product psocid species tested.	[Athanassiou, Christos G.] Univ Thessaly, Dept Agr Crop Prod & Rural Dev, Lab Entomol & Agr Zool, Nea Ionia Magnissia, Greece; [Kavallieratos, Nickolas G.] Benaki Phytopathol Inst, Dept Entomol & Agr Zool, Lab Agr Entomol, Kifisia, Attica, Greece; [Athanassiou, Christos G.; Kavallieratos, Nickolas G.; Throne, James E.] USDA ARS, Ctr Grain & Anim Hlth Res, Manhattan, KS USA; [Throne, James E.] USDA ARS, San Joaquin Valley Agr Sci Ctr, Parlier, CA USA; [Nakas, Christos T.] Univ Thessaly, Dept Agr Crop Prod & Rural Dev, Lab Biometry, Nea Ionia Magnissia, Greece	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Kavallieratos, NG (corresponding author), Benaki Phytopathol Inst, Dept Entomol & Agr Zool, Lab Agr Entomol, Kifisia, Attica, Greece.	nick_kaval@hotmail.com	Kavallieratos, Nickolas G./AAB-7500-2022; Nakas, Christos T/F-3052-2011; Athanassiou, Christos/ABE-8867-2020	Kavallieratos, Nickolas G./0000-0001-5851-5013; Nakas, Christos T/0000-0003-4155-722X; Kavallieratos, Nickolas/0000-0003-4342-1289				Arbogast RT, 1997, J STORED PROD RES, V33, P187, DOI 10.1016/S0022-474X(97)00006-4; Athanassiou CG, 2006, J ECON ENTOMOL, V99, P2191, DOI 10.1603/0022-0493-99.6.2191; Athanassiou CG, 2005, J ECON ENTOMOL, V98, P1058, DOI 10.1603/0022-0493-98.3.1058; Athanassiou CG, 2010, J ECON ENTOMOL, V103, P985, DOI 10.1603/EC09280; Athanassiou CG, 2009, PEST MANAG SCI, V65, P1140, DOI 10.1002/ps.1804; Ayerst G., 1986, Water, fungi and plants, P359; BIRCH LC, 1954, AUST J ZOOL, V2, P66, DOI 10.1071/ZO9540066; Cameron TC, 2007, J ANIM ECOL, V76, P83, DOI 10.1111/j.1365-2656.2006.01185.x; DEHOFF TW, 1984, T ASAE, V27, P259; Gelman A., 2007, DATA ANAL USING REGR; GIGA DP, 1993, J STORED PROD RES, V29, P63, DOI 10.1016/0022-474X(93)90023-W; GIGA DP, 1991, J APPL ECOL, V28, P918, DOI 10.2307/2404217; GORDON DM, 1988, J ANIM ECOL, V57, P645, DOI 10.2307/4930; HODGES RJ, 1992, TROP PEST MANAGE, V38, P391; JONES AE, 1990, FUNCT ECOL, V4, P629, DOI 10.2307/2389730; Kalinovic I., 2006, Proceedings of the 9th International Working Conference on Stored-Product Protection, ABRAPOS, Passo Fundo, RS, Brazil, 15-18 October 2006, P1087; Kleih U., 1995, Tropical Science, V35, P280; Kucerova Z, 2009, J STORED PROD RES, V45, P54, DOI 10.1016/j.jspr.2008.08.002; Kucerova Zuzana, 2002, Plant Protection Science, V38, P103; Laca A, 2006, J FOOD ENG, V72, P332, DOI 10.1016/j.jfoodeng.2004.12.012; Lale NES, 2003, J STORED PROD RES, V39, P459, DOI 10.1016/S0022-474X(01)00028-5; Lale NES, 2001, J STORED PROD RES, V37, P329, DOI 10.1016/S0022-474X(00)00032-1; LEFKOVIT.LP, 1968, J STORED PROD RES, V4, P1, DOI 10.1016/0022-474X(68)90023-4; Mbata GN, 2004, ANN ENTOMOL SOC AM, V97, P353, DOI 10.1603/0013-8746(2004)097[0353:SCUBPC]2.0.CO;2; McFarlane. J. A, 1982, Tropical Stored Products Information, P3; MILLS JT, 1992, J ECON ENTOMOL, V85, P1453, DOI 10.1093/jee/85.4.1453; Mockford E.L., 1987, P196; Mockford E.L., 1991, AGR HDB, V2, P371; Mockford EL, 2008, ZOOTAXA, P53, DOI 10.11646/zootaxa.1766.1.3; Nansen C, 2009, J STORED PROD RES, V45, P254, DOI 10.1016/j.jspr.2009.04.005; Nayak MK, 2014, ANNU REV ENTOMOL, V59, P279, DOI 10.1146/annurev-ento-011613-161947; Nayak MK, 1998, J ECON ENTOMOL, V91, P1208, DOI 10.1093/jee/91.5.1208; NICHOLSON AJ, 1954, AUST J ZOOL, V2, P9, DOI 10.1071/ZO9540009; OBR S, 1978, ACTA ENTOMOL BOHEMOS, V75, P226; Opit GP, 2008, J ECON ENTOMOL, V101, P616, DOI 10.1603/0022-0493(2008)101[616:EODOPG]2.0.CO;2; Opit GP, 2008, J ECON ENTOMOL, V101, P605, DOI 10.1603/0022-0493(2008)101[605:PGADOP]2.0.CO;2; Opit GP, 2009, J ECON ENTOMOL, V102, P1369, DOI 10.1603/029.102.0365; REES D, 1994, STORED PRODUCT PROTECTION, VOLS 1 AND 2, P1214; REES D, 1994, STORED PRODUCT PROTECTION, VOLS 1 AND 2, P583; REES DP, 1990, B ENTOMOL RES, V80, P353, DOI 10.1017/S0007485300050562; ROESLI R, 1994, STORED PRODUCT PROTECTION, VOLS 1 AND 2, P448; SHAZALI MEH, 1987, J STORED PROD RES, V23, P233, DOI 10.1016/0022-474X(87)90007-5; Sidik M, 1986, AUSTR CTR INT AGR RE, P37; Sinha R. N., 1992, The fungal community: its organization and role in the ecosystem., P797; Sokal RR, 1995, BIOMETRY; SOKOLOFF A., 1966, Journal of Stored Products Research, V1, P313, DOI 10.1016/0022-474X(66)90028-2; Tang PA, 2008, ANN ENTOMOL SOC AM, V101, P1017, DOI 10.1603/0013-8746-101.6.1017; Tilman D., 1982, Monographs in Population Biology, pi; TURNER B, 1986, NEW SCI, V110, P43; TURNER BD, 1994, INT J PEST MANAGE, V40, P179, DOI 10.1080/09670879409371879; Turner BD., 1996, ORG COMMITTEE ICIPUE, P7; Wang JJ, 2009, J ECON ENTOMOL, V102, P1705, DOI 10.1603/029.102.0439; Wang JJ, 2000, ANN ENTOMOL SOC AM, V93, P261, DOI 10.1603/0013-8746(2000)093[0261:DAROTP]2.0.CO;2; WHITE NDG, 1995, B ENTOMOL RES, V85, P425, DOI 10.1017/S0007485300036154; WHITE NDG, 1995, BOOK SOIL P, P123; WICKLOW DT, 1995, BOOK SOIL P, P197	56	22	21	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2014	9	8							e102867	10.1371/journal.pone.0102867	http://dx.doi.org/10.1371/journal.pone.0102867			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR0CG	25105507	gold, Green Published			2022-12-27	WOS:000343231900007
J	Baroukh, C; Munoz-Tamayo, R; Steyer, JP; Bernard, O				Baroukh, Caroline; Munoz-Tamayo, Rafael; Steyer, Jean-Philippe; Bernard, Olivier			DRUM: A New Framework for Metabolic Modeling under Non-Balanced Growth. Application to the Carbon Metabolism of Unicellular Microalgae	PLOS ONE			English	Article							ELEMENTARY FLUX MODES; PATHWAY ANALYSIS; BALANCE ANALYSIS; NETWORK; ACCUMULATION; BIODIESEL; IDENTIFICATION; MOBILIZATION; PREDICTION; ENERGETICS	Metabolic modeling is a powerful tool to understand, predict and optimize bioprocesses, particularly when they imply intracellular molecules of interest. Unfortunately, the use of metabolic models for time varying metabolic fluxes is hampered by the lack of experimental data required to define and calibrate the kinetic reaction rates of the metabolic pathways. For this reason, metabolic models are often used under the balanced growth hypothesis. However, for some processes such as the photoautotrophic metabolism of microalgae, the balanced-growth assumption appears to be unreasonable because of the synchronization of their circadian cycle on the daily light. Yet, understanding microalgae metabolism is necessary to optimize the production yield of bioprocesses based on this microorganism, as for example production of third-generation biofuels. In this paper, we propose DRUM, a new dynamic metabolic modeling framework that handles the non-balanced growth condition and hence accumulation of intracellular metabolites. The first stage of the approach consists in splitting the metabolic network into sub-networks describing reactions which are spatially close, and which are assumed to satisfy balanced growth condition. The left metabolites interconnecting the sub-networks behave dynamically. Then, thanks to Elementary Flux Mode analysis, each sub-network is reduced to macroscopic reactions, for which simple kinetics are assumed. Finally, an Ordinary Differential Equation system is obtained to describe substrate consumption, biomass production, products excretion and accumulation of some internal metabolites. DRUM was applied to the accumulation of lipids and carbohydrates of the microalgae Tisochrysis lutea under day/night cycles. The resulting model describes accurately experimental data obtained in day/night conditions. It efficiently predicts the accumulation and consumption of lipids and carbohydrates.	[Baroukh, Caroline; Steyer, Jean-Philippe] INRA, UR050, Lab Biotechnol Environm, Narbonne, France; [Baroukh, Caroline; Munoz-Tamayo, Rafael; Bernard, Olivier] INRIA BIOCORE, Sophia Antipolis, France; [Bernard, Olivier] LOV UPMC CNRS, UMR 7093, Villefranche Sur Mer, France	INRAE; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite	Baroukh, C (corresponding author), INRA, UR050, Lab Biotechnol Environm, Narbonne, France.	caroline.baroukh@supagro.inra.fr	Muñoz-Tamayo, Rafael/C-2483-2011; Muñoz-Tamayo, Rafael/K-1884-2019; Bernard, Olivier/J-1133-2014	Muñoz-Tamayo, Rafael/0000-0002-9266-4132; Muñoz-Tamayo, Rafael/0000-0002-9266-4132; Bernard, Olivier/0000-0003-2539-9014; Baroukh, Caroline/0000-0002-1041-1730; Steyer, Jean-Philippe/0000-0003-0467-8081	Contrat Jeune Scientifique (CJS) INRA-INRIA fellowship; ANR Facteur 4 project	Contrat Jeune Scientifique (CJS) INRA-INRIA fellowship; ANR Facteur 4 project(French National Research Agency (ANR))	Caroline Baroukh was supported by a Contrat Jeune Scientifique (CJS) INRA-INRIA fellowship. Rafael Munoz-Tamayo benefited from the support of the ANR Facteur 4 project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Bastin G, 1990, ON LINE ESTIMATION A, V1; Bendif E, 2013, J APPL PHYCOL, V25, P1763, DOI 10.1007/s10811-013-0037-0; Bernard O, 2005, BIOPROC BIOSYST ENG, V27, P293, DOI 10.1007/s00449-005-0407-3; Bernard O, 2005, MATH BIOSCI, V193, P51, DOI 10.1016/j.mbs.2004.10.004; Bernard O, 2011, J PROCESS CONTR, V21, P1378, DOI 10.1016/j.jprocont.2011.07.012; Boyle NR, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-4; Burgard AP, 2003, BIOTECHNOL BIOENG, V84, P647, DOI 10.1002/bit.10803; Burgard AP, 2004, GENOME RES, V14, P301, DOI 10.1101/gr.1926504; Chang RL, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.52; Cheung CYM, 2013, PLANT J, V75, P1050, DOI 10.1111/tpj.12252; Chisti Y, 2007, BIOTECHNOL ADV, V25, P294, DOI 10.1016/j.biotechadv.2007.02.001; Cogne G, 2011, BIOTECHNOL PROGR, V27, P631, DOI 10.1002/btpr.596; Curien G, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.29; Dal'Molin CGD, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S4-S5; Edwards JS, 2001, NAT BIOTECHNOL, V19, P125, DOI 10.1038/84379; Fleck-Schneider P, 2007, J BIOTECHNOL, V132, P134, DOI 10.1016/j.jbiotec.2007.05.030; Guest JS, 2013, ENVIRON SCI TECHNOL, V47, P3258, DOI 10.1021/es304980y; Heijnen JJ, 2013, BIOTECHNOL J, V8, P768, DOI 10.1002/biot.201300105; Kim J, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-53; Klamt S, 2003, TRENDS BIOTECHNOL, V21, P64, DOI 10.1016/S0167-7799(02)00034-3; Kliphuis AMJ, 2012, J APPL PHYCOL, V24, P253, DOI 10.1007/s10811-011-9674-3; Knoop H, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003081; Koutinas M, 2011, METAB ENG, V13, P401, DOI 10.1016/j.ymben.2011.02.001; Krumholz EW, 2012, J EXP BOT, V63, P2353, DOI 10.1093/jxb/err407; Lacour T, 2012, J PHYCOL, V48, P966, DOI 10.1111/j.1529-8817.2012.01177.x; Lardon L, 2009, ENVIRON SCI TECHNOL, V43, P6475, DOI 10.1021/es900705j; Larhlimi A, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-57; Liu BS, 2013, CURR OPIN BIOTECH, V24, P300, DOI 10.1016/j.copbio.2012.08.008; Mahadevan R, 2002, BIOPHYS J, V83, P1331, DOI 10.1016/S0006-3495(02)73903-9; Mairet F, 2011, P 18 IFAC WORLD C, V1, P1; Mairet F, 2011, BIORESOURCE TECHNOL, V102, P142, DOI 10.1016/j.biortech.2010.06.138; Manichaikul A, 2009, NAT METHODS, V6, P589, DOI [10.1038/NMETH.1348, 10.1038/nmeth.1348]; Mocquet C, 2013, J PHYCOL, V49, P371, DOI 10.1111/jpy.12045; NELDER JA, 1965, COMPUT J, V7, P308, DOI 10.1093/comjnl/7.4.308; Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614; Ovadi J, 2004, MOL CELL BIOCHEM, V256, P5, DOI 10.1023/B:MCBI.0000009855.14648.2c; Packer A, 2011, BIORESOURCE TECHNOL, V102, P111, DOI 10.1016/j.biortech.2010.06.029; Perry JJ, 2004, BIOSYNTHESE MONOMERE, P206; Pharkya P, 2004, GENOME RES, V14, P2367, DOI 10.1101/gr.2872004; Provost A, 2006, BIOPROC BIOSYST ENG, V29, P349, DOI 10.1007/s00449-006-0083-y; Quinn J, 2011, BIORESOURCE TECHNOL, V102, P5083, DOI 10.1016/j.biortech.2011.01.019; Ramkrishna D, 2012, AICHE J, V58, P986, DOI 10.1002/aic.13734; Ross ON, 2009, MAR ECOL PROG SER, V383, P53, DOI 10.3354/meps07961; Rugen M, 2012, METAB ENG, V14, P458, DOI 10.1016/j.ymben.2012.01.009; Schuster S, 1999, TRENDS BIOTECHNOL, V17, P53, DOI 10.1016/S0167-7799(98)01290-6; Schuster S, 2002, BIOINFORMATICS, V18, P351, DOI 10.1093/bioinformatics/18.2.351; Segre D, 2002, P NATL ACAD SCI USA, V99, P15112, DOI 10.1073/pnas.232349399; Shlomi T, 2005, PNAS, V102, P7698; Song HS, 2012, METAB ENG, V14, P69, DOI 10.1016/j.ymben.2012.02.003; Song HS, 2010, BIOTECHNOL BIOENG, V106, P271, DOI 10.1002/bit.22692; Song HS, 2009, IND ENG CHEM RES, V48, P7976, DOI 10.1021/ie900075f; Song HS, 2009, BIOTECHNOL BIOENG, V103, P984, DOI 10.1002/bit.22332; Song HS, 2009, BIOTECHNOL BIOENG, V102, P554, DOI 10.1002/bit.22062; Stephanopoulos G., 1998, METAB ENG; Terzer M, 2008, BIOINFORMATICS, V24, P2229, DOI 10.1093/bioinformatics/btn401; Tevatia R, 2012, BIORESOURCE TECHNOL, V119, P419, DOI 10.1016/j.biortech.2012.05.124; Verwoerd WS, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-25; Wijffels RH, 2010, SCIENCE, V329, P796, DOI 10.1126/science.1189003; Willey J, 2008, METABOLISM ENERGY EN, P167; Williams PJL, 2010, ENERG ENVIRON SCI, V3, P554, DOI 10.1039/b924978h; Yang C, 2000, BIOCHEM ENG J, V6, P87, DOI 10.1016/S1369-703X(00)00080-2; Yang JS, 2011, BIORESOURCE TECHNOL, V102, P3077, DOI 10.1016/j.biortech.2010.10.049; Young JD, 2007, BIOTECHNOL PROGR, V23, P83, DOI 10.1021/bp060176q; Zamorano F, 2013, J BIOTECHNOL, V164, P409, DOI 10.1016/j.jbiotec.2012.05.005; Zamorano F, 2010, J BIOTECHNOL, V150, P497, DOI 10.1016/j.jbiotec.2010.09.944; Zanghellini J, 2013, BIOTECHNOL J, V8, P1009, DOI 10.1002/biot.201200269; Zomorrodi AR, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002363	69	44	45	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2014	9	8							e104499	10.1371/journal.pone.0104499	http://dx.doi.org/10.1371/journal.pone.0104499			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR0CG	25105494	Green Published, gold, Green Submitted			2022-12-27	WOS:000343231900063
J	Chen, W; Howell, ML; Li, Y; Li, R; Chen, GX				Chen, Wei; Howell, Meredith L.; Li, Yang; Li, Rui; Chen, Guoxun			Vitamin A and Feeding Statuses Modulate the Insulin-Regulated Gene Expression in Zucker Lean and Fatty Primary Rat Hepatocytes	PLOS ONE			English	Article							RETINOIC ACID; LIVER; RECEPTOR; BINDING; PATHWAY; INHIBITION; METABOLISM; INDUCTION; OBESITY	Unattended hepatic insulin resistance predisposes individuals to dyslipidemia, type 2 diabetes and many other metabolic complications. The mechanism of hepatic insulin resistance at the gene expression level remains unrevealed. To examine the effects of vitamin A (VA), total energy intake and feeding conditions on the insulin-regulated gene expression in primary hepatocytes of Zucker lean (ZL) and fatty (ZF) rats, we analyze the expression levels of hepatic model genes in response to the treatments of insulin and retinoic acid (RA). We report that the insulin-and RA-regulated glucokinase, sterol regulatory element-binding protein-1c and cytosolic form of phosphoenolpyruvate carboxykinase expressions are impaired in hepatocytes of ZF rats fed chow or a VA sufficient (VAS) diet ad libitum. The impairments are partially corrected when ZF rats are fed a VA deficient (VAD) diet ad libitum or pair-fed a VAS diet to the intake of their VAD counterparts in non-fasting conditions. Interestingly in the pair-fed ZL and ZF rats, transient overeating on the last day of pair-feeding regimen changes the expression levels of some VA catabolic genes, and impairs the insulin-and RA-regulated gene expression in hepatocytes. These results demonstrate that VA and feeding statuses modulate the hepatic insulin sensitivity at the gene expression level.	[Chen, Wei; Howell, Meredith L.; Li, Yang; Li, Rui; Chen, Guoxun] Univ Tennessee, Dept Nutr, Knoxville, TN 37996 USA	University of Tennessee System; University of Tennessee Knoxville	Chen, GX (corresponding author), Univ Tennessee, Dept Nutr, Knoxville, TN 37996 USA.	gchen6@utk.edu		Chen, Guoxun/0000-0001-6226-4050; Chen, Wei/0000-0002-6383-7540	Allen Foundation Inc; University of Tennessee at Knoxville; American Heart Association [09SDG2140003]; China Scholarship Council	Allen Foundation Inc; University of Tennessee at Knoxville; American Heart Association(American Heart Association); China Scholarship Council(China Scholarship Council)	This work was financially supported by research grant from Allen Foundation Inc (to G. C.), start-up fund from the University of Tennessee at Knoxville (to G. C.), and Scientist Development Grant from American Heart Association (09SDG2140003, to G. C.). W. C., Y.L. and R. L. received financial support from the China Scholarship Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alapatt P, 2013, J BIOL CHEM, V288, P1250, DOI 10.1074/jbc.M112.369132; Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; ANZANO MA, 1979, J NUTR, V109, P1419, DOI 10.1093/jn/109.8.1419; Brown MS, 2008, CELL METAB, V7, P95, DOI 10.1016/j.cmet.2007.12.009; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Cahill F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074215; Chen Guoxun, 2013, ISRN Hepatol, V2013, P534972, DOI 10.1155/2013/534972; Chen GX, 2009, BIOCHEM J, V419, P645, DOI 10.1042/BJ20082368; CLARK JB, 1982, DIABETES, V31, P867, DOI 10.2337/diabetes.31.10.867; Elizondo G, 2000, J BIOL CHEM, V275, P39747, DOI 10.1074/jbc.M004987200; Elizondo G, 2009, BIOCHEM PHARMACOL, V77, P248, DOI 10.1016/j.bcp.2008.10.011; Heilbronn LK, 2013, OBESITY, V21, pE649, DOI 10.1002/oby.20508; Iynedjian P, 2009, CELL MOL LIFE SCI, V66, P27, DOI 10.1007/s00018-008-8322-9; Johnson AMF, 2013, CELL, V152, P673, DOI 10.1016/j.cell.2013.01.041; Lecoultre V, 2013, OBESITY, V21, P782, DOI 10.1002/oby.20377; Lefebvre P, 2005, VITAM HORM, V70, P199, DOI 10.1016/S0083-6729(05)70007-8; Li R, 2011, BIOCHEM BIOPH RES CO, V406, P268, DOI 10.1016/j.bbrc.2011.02.031; Li SJ, 2010, P NATL ACAD SCI USA, V107, P3441, DOI 10.1073/pnas.0914798107; Li Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045210; Magkos F, 2014, OBESITY, V22, P435, DOI 10.1002/oby.20562; MAYER J, 1948, YALE J BIOL MED, V20, P403; Moon YA, 2012, CELL METAB, V15, P240, DOI 10.1016/j.cmet.2011.12.017; Napoli JL, 2012, BBA-MOL CELL BIOL L, V1821, P152, DOI 10.1016/j.bbalip.2011.05.004; OBrien RM, 1996, PHYSIOL REV, V76, P1109, DOI 10.1152/physrev.1996.76.4.1109; Phillips MS, 1996, NAT GENET, V13, P18, DOI 10.1038/ng0596-18; Wadden D, 2013, NUTR METAB, V10, DOI 10.1186/1743-7075-10-33; Wang YP, 2002, ARCH BIOCHEM BIOPHYS, V401, P235, DOI 10.1016/S0003-9861(02)00043-7; Zhang Y, 2012, BIOCHEM CELL BIOL, V90, P548, DOI [10.1139/O2012-012, 10.1139/o2012-012]; Zhang Y, 2011, MOL CELL BIOCHEM, V355, P1, DOI 10.1007/s11010-011-0831-4; Zhang YJ, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0021342, 10.1371/journal.pone.0020596]; ZUCKER LM, 1972, ENDOCRINOLOGY, V90, P1320, DOI 10.1210/endo-90-5-1320	31	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2014	9	8							e100868	10.1371/journal.pone.0100868	http://dx.doi.org/10.1371/journal.pone.0100868			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR0CG	25105869	Green Submitted, Green Published, gold			2022-12-27	WOS:000343231900003
J	Shimizu, F; Sawai, S; Sano, Y; Beppu, M; Misawa, S; Nishihara, H; Koga, M; Kuwabara, S; Kanda, T				Shimizu, Fumitaka; Sawai, Setsu; Sano, Yasuteru; Beppu, Minako; Misawa, Sonoko; Nishihara, Hideaki; Koga, Michiaki; Kuwabara, Satoshi; Kanda, Takashi			Severity and Patterns of Blood-Nerve Barrier Breakdown in Patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy: Correlations with Clinical Subtypes	PLOS ONE			English	Article							LEWIS-SUMNER-SYNDROME; JOINT TASK-FORCE; NEUROLOGICAL-SOCIETIES; EUROPEAN-FEDERATION; MOTOR NEUROPATHY; FOLLOW-UP; ANTI-MAG; POLYNEUROPATHY; MANAGEMENT; GUIDELINE	Objective: Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is currently classified into clinical subtypes, including typical and atypical forms (multifocal acquired demyelinating sensory and motor neuropathy (MADSAM) and distal acquired demyelinating symmetric neuropathy (DADS)). The aim of this study was to elucidate the patterns and severity of breakdown of the blood-nerve barrier (BNB) in each CIDP subtype. Methods: We evaluated the effects of sera obtained from patients with typical CIDP, MADSAM and DADS and control subjects on the expression levels of tight junction proteins and transendothelial electrical resistance (TEER) value in human peripheral nerve microvascular endothelial cells (PnMECs). Results: The sera obtained from the patients with the three clinical phenotypes of CIDP decreased the amount of claudin-5 protein levels and TEER values in the PnMECs. In addition, the sera obtained from typical CIDP patients more prominently reduced claudin-5 protein levels and TEER values in the PnMECs than did that obtained from the MADSAM and DADS patients. Furthermore, the severity of BNB disruption after exposure to the sera was associated with higher Hughes grade, lower MRC score, more pronounced slowing of motor nerve conduction in the median nerve and higher frequency of abnormal temporal dispersion. Conclusions: Sera derived from typical CIDP patients destroy the BNB more severely than those from MADSAM or DADS patients. The extent of BNB disruption in the setting of CIDP is associated with clinical disability and demyelination in the nerve trunk. These observations may explain the phenotypical differences between CIDP subtypes.	[Shimizu, Fumitaka; Sano, Yasuteru; Nishihara, Hideaki; Koga, Michiaki; Kanda, Takashi] Yamaguchi Univ, Grad Sch Med, Dept Neurol & Clin Neurosci, Ube, Yamaguchi 755, Japan; [Sawai, Setsu; Beppu, Minako; Misawa, Sonoko; Kuwabara, Satoshi] Chiba Univ, Grad Sch Med, Dept Neurol, Chiba, Japan	Yamaguchi University; Chiba University	Kanda, T (corresponding author), Yamaguchi Univ, Grad Sch Med, Dept Neurol & Clin Neurosci, Ube, Yamaguchi 755, Japan.	tkanda@yamaguchi-u.ac.jp	Nishihara, Hideaki/AAJ-7563-2021; Koga, Michiaki/L-4825-2019	Nishihara, Hideaki/0000-0002-2990-835X; Koga, Michiaki/0000-0002-1356-955X; Kuwabara, Satoshi/0000-0002-4716-8578	Japan Society for the Promotion of Science, Tokyo, Japan [24790886, 22790821, 23659457]; Health and Labor Sciences Research Grants for research on intractable diseases (Neuroimmunological Disease Research Committee) from the Ministry of Health, Labor and Welfare of Japan [K2002528]; National Center of Neurology and Psychiatry [25-4]; Yamaguchi University Hospital; Grants-in-Aid for Scientific Research [26670443] Funding Source: KAKEN	Japan Society for the Promotion of Science, Tokyo, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Health and Labor Sciences Research Grants for research on intractable diseases (Neuroimmunological Disease Research Committee) from the Ministry of Health, Labor and Welfare of Japan; National Center of Neurology and Psychiatry(National Center for Neurology & Psychiatry - Japan); Yamaguchi University Hospital; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by research grants (Nos. 24790886, Nos. 22790821, and Nos. 23659457) from the Japan Society for the Promotion of Science, Tokyo, Japan, by research grant (K2002528) from Health and Labor Sciences Research Grants for research on intractable diseases (Neuroimmunological Disease Research Committee) from the Ministry of Health, Labor and Welfare of Japan, by Intramural Research Grant (25-4) for Neurological and Psychiatrical Disorders of National Center of Neurology and Psychiatry and also by the Translational Research Promotion Grant from Yamaguchi University Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2012, CELL STRUCT FUNCT, V37, P89, DOI 10.1247/csf.11042; [Anonymous], 1991, NEUROLOGY, V41, P617; BAROHN RJ, 1989, ARCH NEUROL-CHICAGO, V46, P878, DOI 10.1001/archneur.1989.00520440064022; Chassande B, 1998, MUSCLE NERVE, V21, P55, DOI 10.1002/(SICI)1097-4598(199801)21:1<55::AID-MUS8>3.0.CO;2-F; Hadden RDM, 2006, EUR J NEUROL, V13, P809, DOI 10.1111/j.1468-1331.2006.01467.x; HUGHES RAC, 1978, LANCET, V2, P750, DOI 10.1016/s0140-6736(78)92644-2; Hughes R, 2010, J CLIN IMMUNOL, V30, pS70, DOI 10.1007/s10875-010-9399-0; Kanda T, 2004, J NEUROL NEUROSUR PS, V75, P765, DOI 10.1136/jnnp.2003.025692; Kanda T, 2013, J NEUROL NEUROSUR PS, V84, P208, DOI 10.1136/jnnp-2012-302312; Katz Jonathan S., 2001, Curr Treat Options Neurol, V3, P119, DOI 10.1007/s11940-001-0046-1; Katz JS, 2000, NEUROLOGY, V54, P615, DOI 10.1212/WNL.54.3.615; Kuwabara S, 2006, J NEUROL NEUROSUR PS, V77, P66, DOI 10.1136/jnnp.2005.065441; Kuwabara S, 2002, J NEUROL NEUROSUR PS, V72, P37, DOI 10.1136/jnnp.72.1.37; Kuwabara S, 2011, CLIN EXP NEUROIMMUNO, V2, P41, DOI DOI 10.1111/J.1759-1961.2011.00020.X; Larue S, 2011, EUR J NEUROL, V18, P899, DOI 10.1111/j.1468-1331.2010.03312.x; Magda Paul, 2005, J Clin Neuromuscul Dis, V7, P10, DOI 10.1097/01.cnd.0000176973.53512.e4; Mygland A, 2003, ARCH NEUROL-CHICAGO, V60, P260, DOI 10.1001/archneur.60.2.260; Saperstein DS, 1999, MUSCLE NERVE, V22, P560, DOI 10.1002/(SICI)1097-4598(199905)22:5<560::AID-MUS2>3.0.CO;2-Q; Saperstein DS, 2001, MUSCLE NERVE, V24, P311, DOI 10.1002/1097-4598(200103)24:3<311::AID-MUS1001>3.3.CO;2-1; Shimizu F, 2014, J NEUROL NEUROSUR PS, V85, P526, DOI 10.1136/jnnp-2013-305405; Ubogu EE, 2013, J VASC RES, V50, P289, DOI 10.1159/000353293; Vallat JM, 2010, LANCET NEUROL, V9, P402, DOI 10.1016/S1474-4422(10)70041-7; Van den Bergh PYK, 2010, EUR J NEUROL, V17, P356, DOI 10.1111/j.1468-1331.2009.02930.x; vandenBerg LH, 1996, MUSCLE NERVE, V19, P637, DOI 10.1002/(SICI)1097-4598(199605)19:5<637::AID-MUS12>3.0.CO;2-K; Viala K, 2004, BRAIN, V127, P2010, DOI 10.1093/brain/awh222	25	31	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2014	9	8							e104205	10.1371/journal.pone.0104205	http://dx.doi.org/10.1371/journal.pone.0104205			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR0CG	25105500	Green Published, Green Submitted, gold			2022-12-27	WOS:000343231900042
J	Vanhommerig, E; Moons, P; Pirici, D; Lammens, C; Hernalsteens, JP; De Greve, H; Kumar-Singh, S; Goossens, H; Malhotra-Kumar, S				Vanhommerig, Evelyn; Moons, Pieter; Pirici, Daniel; Lammens, Christine; Hernalsteens, Jean-Pierre; De Greve, Henri; Kumar-Singh, Samir; Goossens, Herman; Malhotra-Kumar, Surbhi			Comparison of Biofilm Formation between Major Clonal Lineages of Methicillin Resistant Staphylococcus aureus	PLOS ONE			English	Article							CASSETTE CHROMOSOME MEC; VIRULENCE; EVOLUTION; EPIDEMIOLOGY	Objectives: Epidemic methicillin-resistant S. aureus (MRSA) clones cause infections in both hospital and community settings. As a biofilm phenotype further facilitates evasion of the host immune system and antibiotics, we compared the biofilm-forming capacities of various MRSA clones. Methods: Seventy-six MRSA classified into 13 clones (USA300, EMRSA-15, Hungarian/Brazilian etc.), and isolated from infections or from carriers were studied for biofilm formation under static and dynamic conditions. Static biofilms in microtitre plates were quantified colorimetrically. Dynamic biofilms (Bioflux 200, Fluxion, USA) were studied by confocal laser-scanning and time-lapse microscopy, and the total volume occupied by live/dead bacteria quantified by Volocity 5.4.1 (Improvision, UK). Results: MRSA harbouring SCCmec IV produced significantly more biomass under static conditions than SCCmec I-III (P = 0.003), and those harbouring SCCmec II significantly less than those harbouring SCCmec I or III (P < 0.001). In the dynamic model, SCCmec I-III harbouring MRSA were significantly better biofilm formers than SCCmec IV (P = 0.036). Only 16 strains successfully formed biofilms under both conditions, of which 13 harboured SCCmec IV and included all tested USA300 strains (n = 3). However, USA300 demonstrated remarkably lower percentages of cell-occupied space (6.6%) compared to the other clones (EMRSA-15 = 19.0%) under dynamic conditions. Time-lapse microscopy of dynamic biofilms demonstrated that USA300 formed long viscoelastic tethers that stretched far from the point of attachment, while EMRSA-15 consisted of micro-colonies attached densely to the surface. Conclusions: MRSA harbouring SCCmec types IV and I-III demonstrate distinct biofilm forming capacities, possibly owing to their adaptation to the community and hospital settings, respectively. USA300 demonstrated abundant biofilm formation under both conditions, which probably confers a competitive advantage, contributing to its remarkable success as a pathogen.	[Vanhommerig, Evelyn; Moons, Pieter; Lammens, Christine; Goossens, Herman; Malhotra-Kumar, Surbhi] Univ Antwerp, Dept Med Microbiol, B-2020 Antwerp, Belgium; [Vanhommerig, Evelyn; Moons, Pieter; Lammens, Christine; Kumar-Singh, Samir; Goossens, Herman; Malhotra-Kumar, Surbhi] Univ Antwerp, Vaccine & Infect Dis Inst, B-2020 Antwerp, Belgium; [Pirici, Daniel; Kumar-Singh, Samir] Univ Antwerp, Mol Pathol Grp, B-2020 Antwerp, Belgium; [Pirici, Daniel] Univ Med & Pharm Craiova, Dept Res Methodol, Craiova, Romania; [Hernalsteens, Jean-Pierre] Vrije Univ Brussel, Viral Genet Res Grp, Brussels, Belgium; [De Greve, Henri] Vrije Univ Brussel, Struct Biol Brussels, Brussels, Belgium; [De Greve, Henri] VIB, Struct Biol Res Ctr, Brussels, Belgium	University of Antwerp; University of Antwerp; University of Antwerp; University of Medicine & Pharmacy of Craiova; Vrije Universiteit Brussel; Vrije Universiteit Brussel; Flanders Institute for Biotechnology (VIB)	Malhotra-Kumar, S (corresponding author), Univ Antwerp, Dept Med Microbiol, B-2020 Antwerp, Belgium.	surbhi.malhotra@uantwerpen.be	Pirici, Daniel/C-5760-2012; Kumar-Singh, Samir/G-6280-2012	Pirici, Daniel/0000-0001-9192-7319; Kumar-Singh, Samir/0000-0001-9466-6732; Hernalsteens, Jean-Pierre/0000-0003-2146-0586; Pirici, Daniel/0000-0002-0196-0949; moons, pieter/0000-0002-9830-0444	Research Foundation Flanders [FWO G.0983.10N, 1522412N]; University of Antwerp Research funds [BOF-GOA 41/FA020000/2/5139]	Research Foundation Flanders(FWO); University of Antwerp Research funds	This work is supported by funding from Research Foundation Flanders (FWO G.0983.10N and Research grant no. 1522412N) and University of Antwerp Research funds (BOF-GOA 41/FA020000/2/5139). The sponsors of the study had no role in study design, data collection, data analysis, data interpretation, or writing the report. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication.	Aoyagi T., 2014, CLIN MICROBIOL INFEC; Benoit MR, 2010, APPL ENVIRON MICROB, V76, P4136, DOI 10.1128/AEM.03065-09; David MZ, 2010, CLIN MICROBIOL REV, V23, P616, DOI 10.1128/CMR.00081-09; Deurenberg RH, 2008, INFECT GENET EVOL, V8, P747, DOI 10.1016/j.meegid.2008.07.007; Diep BA, 2008, J INFECT DIS, V197, P1523, DOI 10.1086/587907; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Francois P, 2004, J CLIN MICROBIOL, V42, P3309, DOI 10.1128/JCM.42.7.3309-3312.2004; Gill SR, 2005, J BACTERIOL, V187, P2426, DOI 10.1128/JB.187.7.2426-2438.2005; Hoiby N, 2011, INT J ORAL SCI, V3, P55, DOI 10.4248/IJOS11026; Jansen WTM, 2006, ANTIMICROB AGENTS CH, V50, P2072, DOI 10.1128/AAC.01539-05; Jevons, 1961, BRIT MED J, V1, P1; Kaito C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001267; Kirby WMM, 1944, SCIENCE, V99, P452, DOI 10.1126/science.99.2579.452; McDougal LK, 2003, J CLIN MICROBIOL, V41, P5113, DOI 10.1128/JCM.41.11.5113-5120.2003; Mediavilla JR, 2012, CURR OPIN MICROBIOL, V15, P588, DOI 10.1016/j.mib.2012.08.003; Oliveira DC, 2001, MICROB DRUG RESIST, V7, P349, DOI 10.1089/10766290152773365; Otto M, 2008, CURR TOP MICROBIOL, V322, P207; Periasamy S, 2012, P NATL ACAD SCI USA, V109, P1281, DOI 10.1073/pnas.1115006109; Peschel A, 2013, NAT REV MICROBIOL, V11, P667, DOI 10.1038/nrmicro3110; Planet PJ, 2013, MBIO, V4, DOI 10.1128/mBio.00889-13; Pournaras S, 2013, FUTURE MICROBIOL, V8, P1365, DOI 10.2217/fmb.13.118; Smith K, 2008, J MED MICROBIOL, V57, P1018, DOI 10.1099/jmm.0.2008/000968-0; Watkins RR, 2012, J MED MICROBIOL, V61, P1179, DOI 10.1099/jmm.0.043513-0	23	36	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2014	9	8							e104561	10.1371/journal.pone.0104561	http://dx.doi.org/10.1371/journal.pone.0104561			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR0CG	25105505	gold, Green Submitted, Green Published			2022-12-27	WOS:000343231900070
J	Yang, F; Wang, GF; Wang, ZX; Sun, M; Cao, MD; Zhu, ZX; Fu, Q; Mao, J; Shi, Y; Yang, T				Yang, Fan; Wang, Guofeng; Wang, Zhixiao; Sun, Min; Cao, Mengdie; Zhu, Zhenxin; Fu, Qi; Mao, Jia; Shi, Yun; Yang, Tao			Visceral Adiposity Index May Be a Surrogate Marker for the Assessment of the Effects of Obesity on Arterial Stiffness	PLOS ONE			English	Article							PULSE-WAVE VELOCITY; BODY-MASS INDEX; HEALTHY NONOBESE WOMEN; BETA-CELL FUNCTION; CARDIOVASCULAR-DISEASE; METABOLICALLY HEALTHY; INSULIN-RESISTANCE; AORTIC STIFFNESS; CARDIOMETABOLIC RISK; ABDOMINAL ADIPOSITY	Objective: The relationship between obesity and cardiovascular disease (CVD) remains unclear. This study aims to describe the relationship between arterial stiffness and obesity in order to investigate the effects of obesity on CVD. Methods: We collected data from 5,158 individuals over 40 years of age from a cross-sectional study in Nanjing, China. Anthropometric, demographic, hemodynamic measurements and arterial stiffness measured through brachial-ankle pulse wave velocity (baPWV) were obtained. Subjects were grouped by body mass index (BMI), waist circumference (WC) and visceral adiposity index (VAI), a sex-specific index based on BMI, WC, triglyceride (TG) and high-density lipoprotein cholesterol (HDL-C). Results: The multivariate regression analysis revealed a negative but weak effect of BMI (beta = -0.047, P < 0.001) on baPWV, but failed to demonstrate any significant effect of WC on baPWV while VAI was a positive independent indicator of baPWV (beta = 0.023, P = 0.022). The unadjusted baPWV significantly increased across groups with higher obesity categories (P < 0.01). Although the positive association was lost after adjustments for confounding factors in the BMI or WC categories (P > 0.05), it was still obtained between baPWV and VAI quartile (P < 0.01). No differences were observed among the metabolically healthy groups or the metabolically abnormal groups in the BMI and WC categories (P > 0.05). However, baPWV significantly increased across groups with higher VAI categories even in the same metabolic category (P < 0.01). Conclusions: This study supports the concept of heterogeneity of metabolic status among individuals within the same obesity range. Obese individuals are at an increased risk of arterial stiffness regardless of their metabolic conditions. VAI may be a surrogate marker for the assessment of obesity and the effects of obesity on arterial stiffness.	[Yang, Fan; Wang, Guofeng; Wang, Zhixiao; Sun, Min; Cao, Mengdie; Zhu, Zhenxin; Fu, Qi; Mao, Jia; Shi, Yun; Yang, Tao] Nanjing Med Univ, Affiliated Hosp 1, Dept Endocrinol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University	Yang, T (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Endocrinol, Nanjing, Jiangsu, Peoples R China.	yangt@njmu.edu.cn			Chinese Society of Endocrinology; National Natural Science Foundation of China [81270897, 30971405]; Priority Academic Program Development of Jiangsu Higher Education Institutions	Chinese Society of Endocrinology; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions	This study is supported by the grants from the Chinese Society of Endocrinology, the National Natural Science Foundation of China (No. 81270897, 30971405), and the Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KF, 2006, NEW ENGL J MED, V355, P763, DOI 10.1056/NEJMoa055643; Aguilar-Salinas CA, 2008, J CLIN ENDOCR METAB, V93, P4075, DOI 10.1210/jc.2007-2724; Amato MC, 2010, DIABETES CARE, V33, P920, DOI 10.2337/dc09-1825; Appleton SL, 2013, DIABETES CARE, V36, P2388, DOI 10.2337/dc12-1971; Arnlov J, 2010, CIRCULATION, V121, P230, DOI 10.1161/CIRCULATIONAHA.109.887521; Chinese Joint Committee for Developing Chinese Guidelines (JCDCG) and the Working Group on Obesity in China (WGOC), 2002, CHINESE J EPIDEMIOL, V23, P5; Dahlen EM, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-55; DeNino WF, 2001, DIABETES CARE, V24, P925, DOI 10.2337/diacare.24.5.925; Despres J P, 2006, J Endocrinol Invest, V29, P77; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Hamer M, 2012, J CLIN ENDOCR METAB, V97, P2482, DOI 10.1210/jc.2011-3475; Hansen TW, 2004, J HUM HYPERTENS, V18, P1, DOI 10.1038/sj.jhh.1001620; Jee SH, 2006, NEW ENGL J MED, V355, P779, DOI 10.1056/NEJMoa054017; Karelis AD, 2005, J CLIN ENDOCR METAB, V90, P4145, DOI 10.1210/jc.2005-0482; Katzmarzyk P T, 2003, Obes Rev, V4, P257, DOI 10.1046/j.1467-789X.2003.00120.x; Kelly T, 2008, INT J OBESITY, V32, P1431, DOI 10.1038/ijo.2008.102; Kramer CK, 2013, ANN INTERN MED, V159, P758, DOI 10.7326/0003-4819-159-11-201312030-00008; Kubo T, 2008, J PAEDIATR CHILD H, V44, P33, DOI 10.1111/j.1440-1754.2007.01166.x; Lavie CJ, 2009, J AM COLL CARDIOL, V53, P1925, DOI 10.1016/j.jacc.2008.12.068; Marini MA, 2012, DIABETES CARE, V35, P1144, DOI 10.2337/dc11-2032; Marini MA, 2007, DIABETES CARE, V30, P2145, DOI 10.2337/dc07-0419; Mathieu P, 2008, INT J BIOCHEM CELL B, V40, P821, DOI 10.1016/j.biocel.2007.12.001; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Meigs JB, 2006, J CLIN ENDOCR METAB, V91, P2906, DOI 10.1210/jc.2006-0594; Oflaz H, 2003, DIABETES NUTR METAB, V16, P176; Pischon T, 2008, NEW ENGL J MED, V359, P2105, DOI 10.1056/NEJMoa0801891; POULIOT MC, 1994, AM J CARDIOL, V73, P460, DOI 10.1016/0002-9149(94)90676-9; Rader DJ, 2007, AM J MED, V120, pS12, DOI 10.1016/j.amjmed.2007.01.003; Rodrigues SL, 2012, AM J HYPERTENS, V25, P1064, DOI 10.1038/ajh.2012.91; Shoelson SE, 2007, GASTROENTEROLOGY, V132, P2169, DOI 10.1053/j.gastro.2007.03.059; Sironi AM, 2004, HYPERTENSION, V44, P127, DOI 10.1161/01.HYP.0000137982.10191.0a; Sugawara J, 2005, J HUM HYPERTENS, V19, P401, DOI 10.1038/sj.jhh.1001838; Sutton-Tyrrell K, 2005, CIRCULATION, V111, P3384, DOI 10.1161/CIRCULATIONAHA.104.483628; Sutton-Tyrrell K, 2001, HYPERTENSION, V38, P429, DOI 10.1161/01.HYP.38.3.429; Tanaka H, 2009, J HYPERTENS, V27, P2022, DOI 10.1097/HJH.0b013e32832e94e7; Tokita A, 2009, ATHEROSCLEROSIS, V206, P168, DOI 10.1016/j.atherosclerosis.2009.01.046; Webb DR, 2010, DIABETOLOGIA, V53, P1190, DOI 10.1007/s00125-010-1689-9; Wildman RP, 2009, CURR OPIN CLIN NUTR, V12, P438, DOI 10.1097/MCO.0b013e32832c6db7; Wing R, 2013, NEW ENGL J MED, V369, P145, DOI 10.1056/NEJMoa1212914	40	41	45	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2014	9	8							e104365	10.1371/journal.pone.0104365	http://dx.doi.org/10.1371/journal.pone.0104365			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR0CG	25105797	Green Published, gold, Green Submitted			2022-12-27	WOS:000343231900051
J	Bozue, J; Cote, CK; Chance, T; Kugelman, J; Kern, SJ; Kijek, TK; Jenkins, A; Mou, S; Moody, K; Fritz, D; Robinson, CG; Bell, T; Worsham, P				Bozue, Joel; Cote, Christopher K.; Chance, Taylor; Kugelman, Jeffrey; Kern, Steven J.; Kijek, Todd K.; Jenkins, Amy; Mou, Sherry; Moody, Krishna; Fritz, David; Robinson, Camenzind G.; Bell, Todd; Worsham, Patricia			A Yersinia pestis tat Mutant Is Attenuated in Bubonic and Small-Aerosol Pneumonic Challenge Models of Infection but Not As Attenuated by Intranasal Challenge	PLOS ONE			English	Article							ARGININE TRANSLOCATION SYSTEM; PROTEIN-TRANSPORT SYSTEM; ESCHERICHIA-COLI; SIGNAL PEPTIDE; V-ANTIGEN; PLASMINOGEN-ACTIVATOR; PSEUDOMONAS-SYRINGAE; REGULATORY PROTEIN; BIOFILM FORMATION; PLAGUE VACCINE	Bacterial proteins destined for the Tat pathway are folded before crossing the inner membrane and are typically identified by an N-terminal signal peptide containing a twin arginine motif. Translocation by the Tat pathway is dependent on the products of genes which encode proteins possessing the binding site of the signal peptide and mediating the actual translocation event. In the fully virulent CO92 strain of Yersinia pestis, the tatA gene was deleted. The mutant was assayed for loss of virulence through various in vitro and in vivo assays. Deletion of the tatA gene resulted in several consequences for the mutant as compared to wild-type. Cell morphology of the mutant bacteria was altered and demonstrated a more elongated form. In addition, while cultures of the mutant strain were able to produce a biofilm, we observed a loss of adhesion of the mutant biofilm structure compared to the biofilm produced by the wild-type strain. Immuno-electron microscopy revealed a partial disruption of the F1 antigen on the surface of the mutant. The virulence of the Delta tatA mutant was assessed in various murine models of plague. The mutant was severely attenuated in the bubonic model with full virulence restored by complementation with the native gene. After small-particle aerosol challenge in a pneumonic model of infection, the mutant was also shown to be attenuated. In contrast, when mice were challenged intranasally with the mutant, very little difference in the LD50 was observed between wild-type and mutant strains. However, an increased time-to- death and delay in bacterial dissemination was observed in mice infected with the Delta tatA mutant as compared to the parent strain. Collectively, these findings demonstrate an essential role for the Tat pathway in the virulence of Y. pestis in bubonic and small-aerosol pneumonic infection but less important role for intranasal challenge.	[Bozue, Joel; Cote, Christopher K.; Kijek, Todd K.; Jenkins, Amy; Mou, Sherry; Moody, Krishna; Fritz, David; Worsham, Patricia] US Army, Med Res Inst Infect Dis, Bacteriol Div, Ft Detrick, MD 21702 USA; [Chance, Taylor; Robinson, Camenzind G.; Bell, Todd] US Army, Med Res Inst Infect Dis, Div Pathol, Ft Detrick, MD 21702 USA; [Kugelman, Jeffrey] US Army, Med Res Inst Infect Dis, Ctr Genome Sci, Ft Detrick, MD 21702 USA; [Kern, Steven J.] US Army, Med Res Inst Infect Dis, Off Res Support, Ft Detrick, MD 21702 USA		Bozue, J (corresponding author), US Army, Med Res Inst Infect Dis, Bacteriol Div, Ft Detrick, MD 21702 USA.	joel.a.bozue@us.army.mil	Bozue, Joel/AAE-4357-2022; Robinson, Camenzind G/O-5097-2018; Bozue, Joel/AAE-4363-2022	Bozue, Joel/0000-0001-6959-8176; Robinson, Camenzind G/0000-0002-7277-692X; Bozue, Joel/0000-0001-6959-8176	Defense Threat Reduction Agency JSTO-CBD [923698]	Defense Threat Reduction Agency JSTO-CBD(United States Department of DefenseDefense Threat Reduction Agency)	The research described herein was sponsored by the Defense Threat Reduction Agency JSTO-CBD (project number 923698). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DM, 2009, AM J PATHOL, V174, P910, DOI 10.2353/ajpath.2009.071168; Anderson GW, 1996, INFECT IMMUN, V64, P4580, DOI 10.1128/IAI.64.11.4580-4585.1996; Anderson GW, 1997, AM J TROP MED HYG, V56, P471, DOI 10.4269/ajtmh.1997.56.471; Anisimov AP, 2009, J MED MICROBIOL, V58, P26, DOI 10.1099/jmm.0.005678-0; Baglieri J, 2012, J BIOL CHEM, V287, P7335, DOI 10.1074/jbc.M111.326355; Bendtsen JD, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-58; Benoit SL, 2014, MBIO, V5, DOI 10.1128/mBio.01016-13; Berks BC, 2000, MOL MICROBIOL, V35, P260, DOI 10.1046/j.1365-2958.2000.01719.x; Berks BC, 1996, MOL MICROBIOL, V22, P393, DOI 10.1046/j.1365-2958.1996.00114.x; Bozue J, 2012, FEMS MICROBIOL LETT, V332, P113, DOI 10.1111/j.1574-6968.2012.02583.x; Bozue J, 2011, MICROB PATHOGENESIS, V50, P314, DOI 10.1016/j.micpath.2011.02.005; Bronstein PA, 2005, J BACTERIOL, V187, P8450, DOI 10.1128/JB.187.24.8450-8461.2005; Buchanan G, 2002, MOL MICROBIOL, V43, P1457, DOI 10.1046/j.1365-2958.2002.02853.x; Buchrieser C, 1998, MOL MICROBIOL, V30, P965, DOI 10.1046/j.1365-2958.1998.01124.x; Caldelari I, 2006, MOL PLANT MICROBE IN, V19, P200, DOI 10.1094/MPMI-19-0200; Cathelyn JS, 2006, P NATL ACAD SCI USA, V103, P13514, DOI 10.1073/pnas.0603456103; Chen L, 2009, ARCH MICROBIOL, V191, P163, DOI 10.1007/s00203-008-0440-0; CHEN TH, 1977, INFECT IMMUN, V15, P972, DOI 10.1128/IAI.15.3.972-977.1977; CONCHAS RF, 1990, GENE, V87, P133, DOI 10.1016/0378-1119(90)90505-L; CORNELIS GR, 1989, MOL MICROBIOL, V3, P1455, DOI 10.1111/j.1365-2958.1989.tb00129.x; Cornelius CA, 2009, INFECT IMMUN, V77, P1807, DOI 10.1128/IAI.01162-08; DALY JA, 1985, J CLIN MICROBIOL, V21, P919, DOI 10.1128/JCM.21.6.919-921.1985; Davis KJ, 1996, ARCH PATHOL LAB MED, V120, P156; Davis KJ, 1997, ARCH PATHOL LAB MED, V121, P865; De Buck E, 2005, BIOCHEM BIOPH RES CO, V331, P1413, DOI 10.1016/j.bbrc.2005.04.060; de Leeuw E, 2002, J MOL BIOL, V322, P1135, DOI 10.1016/S0022-2836(02)00820-3; De Leeuw E, 2001, FEBS LETT, V506, P143, DOI 10.1016/S0014-5793(01)02904-0; Deghmane AE, 2002, MOL MICROBIOL, V43, P1555, DOI 10.1046/j.1365-2958.2002.02838.x; Dilks K, 2003, J BACTERIOL, V185, P1478, DOI 10.1128/JB.185.4.1478-1483.2003; DiMezzo TL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006281; Ding ZY, 2003, J BACTERIOL, V185, P760, DOI 10.1128/JB.185.3.760-771.2003; DOLL JM, 1994, AM J TROP MED HYG, V51, P109, DOI 10.4269/ajtmh.1994.51.109; DONNENBERG MS, 1991, INFECT IMMUN, V59, P4310, DOI 10.1128/IAI.59.12.4310-4317.1991; DROZDOV IG, 1995, J MED MICROBIOL, V42, P264, DOI 10.1099/00222615-42-4-264; Felek S, 2011, MICROBIOL-SGM, V157, P805, DOI 10.1099/mic.0.044826-0; Ferrandez Y, 2008, MOL MICROBIOL, V69, P1349, DOI 10.1111/j.1365-2958.2008.06366.x; FETHERSTON JD, 1992, MOL MICROBIOL, V6, P2693, DOI 10.1111/j.1365-2958.1992.tb01446.x; FETHERSTON JD, 1994, MOL MICROBIOL, V13, P697, DOI 10.1111/j.1365-2958.1994.tb00463.x; Fisher ML, 2007, INFECT IMMUN, V75, P429, DOI 10.1128/IAI.01287-06; FRIEDLANDER AM, 1995, CLIN INFECT DIS, V21, pS178, DOI 10.1093/clinids/21.Supplement_2.S178; GALYOV EE, 1991, FEBS LETT, V286, P79, DOI 10.1016/0014-5793(91)80945-Y; Glornski IJ, 2008, MICROBES INFECT, V10, P1398, DOI 10.1016/j.micinf.2008.07.042; Glynn A, 2005, INFECT IMMUN, V73, P5256, DOI 10.1128/IAI.73.8.5256-5261.2005; Gohlke U, 2005, P NATL ACAD SCI USA, V102, P10482, DOI 10.1073/pnas.0503558102; Guarner J, 2002, AM J CLIN PATHOL, V117, P205; HALLETT AF, 1973, INFECT IMMUN, V8, P876, DOI 10.1128/IAI.8.6.876-881.1973; He HH, 2011, CURR MICROBIOL, V62, P1193, DOI 10.1007/s00284-010-9844-6; Hennequin C, 2009, INFECT IMMUN, V77, P5449, DOI 10.1128/IAI.00837-09; Hinchliffe SJ, 2003, GENOME RES, V13, P2018, DOI 10.1101/gr.1507303; Hinsley AP, 2001, FEBS LETT, V497, P45, DOI 10.1016/S0014-5793(01)02428-0; KARLYSHEV AV, 1992, FEBS LETT, V297, P77, DOI 10.1016/0014-5793(92)80331-A; KATO JI, 1988, J BACTERIOL, V170, P3967, DOI 10.1128/jb.170.9.3967-3977.1988; Kolkman MAB, 2008, APPL ENVIRON MICROB, V74, P7507, DOI 10.1128/AEM.01401-08; Koskiniemi S, 1998, FEMS IMMUNOL MED MIC, V21, P159, DOI 10.1111/j.1574-695X.1998.tb01162.x; Kostecki JS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009225; Lathem WW, 2005, P NATL ACAD SCI USA, V102, P17786, DOI 10.1073/pnas.0506840102; Lathem WW, 2007, SCIENCE, V315, P509, DOI 10.1126/science.1137195; Lavander M, 2006, INFECT IMMUN, V74, P1768, DOI 10.1128/IAI.74.3.1768-1776.2006; MEHIGH RJ, 1993, INFECT IMMUN, V61, P13, DOI 10.1128/IAI.61.1.13-22.1993; Mori H, 2001, TRENDS MICROBIOL, V9, P494, DOI 10.1016/S0966-842X(01)02174-6; Ochsner UA, 2002, P NATL ACAD SCI USA, V99, P8312, DOI 10.1073/pnas.082238299; Parkhill J, 2001, NATURE, V413, P523, DOI 10.1038/35097083; Perry RD, 1997, CLIN MICROBIOL REV, V10, P35, DOI 10.1128/CMR.10.1.35; Pettersson J, 1999, MOL MICROBIOL, V32, P961, DOI 10.1046/j.1365-2958.1999.01408.x; Porcelli I, 2002, BIOCHEMISTRY-US, V41, P13690, DOI 10.1021/bi026142i; PRICE SB, 1991, J BACTERIOL, V173, P2649, DOI 10.1128/jb.173.8.2649-2657.1991; Quenee LE, 2008, INFECT IMMUN, V76, P2025, DOI 10.1128/IAI.00105-08; Rodriguez-Sanz M, 2010, FEMS MICROBIOL LETT, V302, P151, DOI 10.1111/j.1574-6968.2009.01844.x; Rossier O, 2005, INFECT IMMUN, V73, P2020, DOI 10.1128/IAI.73.4.2020-2032.2005; Runco LM, 2008, J BACTERIOL, V190, P3381, DOI 10.1128/JB.01840-07; Sarker MR, 1998, J BACTERIOL, V180, P1207, DOI 10.1128/JB.180.5.1207-1214.1998; Sarker MR, 1998, INFECT IMMUN, V66, P2976, DOI 10.1128/IAI.66.6.2976-2979.1998; Sebbane F, 2009, INFECT IMMUN, V77, P1222, DOI 10.1128/IAI.00950-08; SIMPSON WJ, 1990, AM J TROP MED HYG, V43, P389, DOI 10.4269/ajtmh.1990.43.389; Stanley NR, 2000, J BIOL CHEM, V275, P11591, DOI 10.1074/jbc.275.16.11591; Stanley NR, 2001, J BACTERIOL, V183, P139, DOI 10.1128/JB.183.1.139-144.2001; STRALEY SC, 1991, MICROB PATHOGENESIS, V10, P87, DOI 10.1016/0882-4010(91)90069-M; Sun YC, 2008, P NATL ACAD SCI USA, V105, P8097, DOI 10.1073/pnas.0803525105; SURGALLA MJ, 1969, APPL MICROBIOL, V18, P834, DOI 10.1128/AEM.18.5.834-837.1969; Swedin L, 2010, INT ARCH ALLERGY IMM, V153, P249, DOI 10.1159/000314365; van Mourik A, 2008, MICROBIOL-SGM, V154, P584, DOI 10.1099/mic.0.2007/012120-0; Voulhoux R, 2001, EMBO J, V20, P6735, DOI 10.1093/emboj/20.23.6735; Wagley S, 2014, J BACTERIOL, V196, P407, DOI 10.1128/JB.01046-13; WANG RF, 1991, GENE, V100, P195, DOI 10.1016/0378-1119(91)90366-J; Warawa JM, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00141; Weening EH, 2011, INFECT IMMUN, V79, P644, DOI 10.1128/IAI.00981-10; Welkos S, 2002, VACCINE, V20, P2206, DOI 10.1016/S0264-410X(02)00119-6; Welkos SL, 1997, MICROB PATHOGENESIS, V23, P211, DOI 10.1006/mpat.1997.0154; Welkos SL, 1995, CONTRIB TO MICROBIOL, V13, P299; Wexler M, 2000, J BIOL CHEM, V275, P16717, DOI 10.1074/jbc.M000800200; Worsham PL, 2003, ADV EXP MED BIOL, V529, P129; Worsham PL, 1995, CONTRIB TO MICROBIOL, V13, P325; WORSHAM PL, 2007, MED ASPECTS BIOL WAR, P91; Zhang LJ, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-114	94	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e104524	10.1371/journal.pone.0104524	http://dx.doi.org/10.1371/journal.pone.0104524			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25101850	Green Published, Green Submitted, gold			2022-12-27	WOS:000339993900072
J	Tsuji, S; Kawamura, F; Kubiura, M; Hayashi, A; Ohbayashi, T; Kazuki, Y; Chesne, C; Oshimura, M; Tada, M				Tsuji, Saori; Kawamura, Fumihiko; Kubiura, Musashi; Hayashi, Ayaka; Ohbayashi, Tetsuya; Kazuki, Yasuhiro; Chesne, Christophe; Oshimura, Mitsuo; Tada, Masako			Dual-Color Fluorescence Imaging to Monitor CYP3A4 and CYP3A7 Expression in Human Hepatic Carcinoma HepG2 and HepaRG Cells	PLOS ONE			English	Article							PREGNANE X RECEPTOR; NUCLEAR RECEPTOR; GENE-EXPRESSION; TRANSCRIPTIONAL ACTIVATION; LIVER MATURATION; INDUCTION; FETAL; HEPATOCYTES; PXR; RIFAMPICIN	Human adult hepatocytes expressing CYP3A4, a major cytochrome P450 enzyme, are required for cell-based assays to evaluate the potential risk of drug-drug interactions caused by transcriptional induction of P450 enzymes in early-phase drug discovery and development. However, CYP3A7 is preferentially expressed in premature hepatoblasts and major hepatic carcinoma cell lines. The human hepatocellular carcinoma cell line HepaRG possesses a high self-renewal capacity and can differentiate into hepatic cells similar to human adult hepatocytes in vitro. Transgenic HepaRG cells, in which the expression of fluorescent reporters is regulated by 35 kb regulatory elements of CYP3A4, have a distinct advantage over human hepatocytes isolated by collagenase perfusion, which are unstable in culture. Thus, we created transgenic HepaRG and HepG2 cells by replacing the protein-coding regions of human CYP3A4 and CYP3A7 with enhanced green fluorescent protein (EGFP) and DsRed reporters, respectively, in a bacterial artificial chromosome vector that included whole regulatory elements. The intensity of DsRed fluorescence was initially high during the proliferation of transgenic HepaRG cells. However, most EGFP-positive cells were derived from those in which DsRed fluorescence was extinguished. Comparative analyses in these transgenic clones showed that changes in the total fluorescence intensity of EGFP reflected fold changes in the mRNA level of endogenous CYP3A4. Moreover, CYP3A4 induction was monitored by the increase in EGFP fluorescence. Thus, this assay provides a real-time evaluation system for quality assurance of hepatic differentiation into CYP3A4-expressing cells, unfavourable CYP3A4 induction, and fluorescence-activated cell sorting-mediated enrichment of CYP3A4-expressing hepatocytes based on the total fluorescence intensities of fluorescent reporters, without the need for many time-consuming steps.	[Tsuji, Saori] Org Tottori Ind Promot, Bio Frontier Project Promot Sect, Yonago, Tottori, Japan; [Kawamura, Fumihiko; Kubiura, Musashi; Hayashi, Ayaka; Kazuki, Yasuhiro] Tottori Univ, Grad Sch Med Sci, Inst Regenerat Med & Biofunct, Dept Biomed Sci,Div Mol Genet & Biofunct, Yonago, Tottori, Japan; [Ohbayashi, Tetsuya] Tottori Univ, Res Ctr Biosci & Technol, Div Lab Anim Sci, Yonago, Tottori, Japan; [Kazuki, Yasuhiro; Oshimura, Mitsuo; Tada, Masako] Tottori Univ, Chromosome Engn Res Ctr, Yonago, Tottori, Japan; [Chesne, Christophe] Biopred Int, Rennes, France	Tottori University; Tottori University; Tottori University	Tada, M (corresponding author), Tottori Univ, Chromosome Engn Res Ctr, Yonago, Tottori, Japan.	matada@med.tottori-u.ac.jp	Sharma, Ashwani/AAK-3879-2020	Sharma, Ashwani/0000-0001-9835-1973	Regional Innovation Cluster Program, MEXT, Japan; A-STEP FS, JST, Japan; Cosmetology Research Foundation, Japan	Regional Innovation Cluster Program, MEXT, Japan; A-STEP FS, JST, Japan; Cosmetology Research Foundation, Japan	This study was supported by grants from the Regional Innovation Cluster Program 2010, MEXT, Japan; A-STEP FS 2013, JST, Japan; and The Cosmetology Research Foundation 2013, Japan. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antherieu S, 2010, DRUG METAB DISPOS, V38, P516, DOI 10.1124/dmd.109.030197; Barwick JL, 1996, MOL PHARMACOL, V50, P10; Bertilsson G, 2001, BIOCHEM BIOPH RES CO, V280, P139, DOI 10.1006/bbrc.2000.4066; BISGAARD HC, 1994, J CELL PHYSIOL, V159, P475, DOI 10.1002/jcp.1041590312; Blumberg B, 1998, GENE DEV, V12, P3195, DOI 10.1101/gad.12.20.3195; Cerec V, 2007, HEPATOLOGY, V45, P957, DOI 10.1002/hep.21536; Goodwin B, 1999, MOL PHARMACOL, V56, P1329, DOI 10.1124/mol.56.6.1329; Greuet J, 1996, BIOCHEM BIOPH RES CO, V225, P689, DOI 10.1006/bbrc.1996.1231; Gripon P, 2002, P NATL ACAD SCI USA, V99, P15655, DOI 10.1073/pnas.232137699; Hart SN, 2009, DRUG METAB DISPOS, V37, P116, DOI 10.1124/dmd.108.023812; Jones SA, 2000, MOL ENDOCRINOL, V14, P27, DOI 10.1210/me.14.1.27; Kubiura M, 2012, CHROMOSOME RES, V20, P837, DOI 10.1007/s10577-012-9317-9; Lacroix D, 1997, EUR J BIOCHEM, V247, P625, DOI 10.1111/j.1432-1033.1997.00625.x; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; Lehmann JM, 1998, J CLIN INVEST, V102, P1016, DOI 10.1172/JCI3703; Li Y, 2009, MOL PHARMACOL, V75, P1171, DOI 10.1124/mol.108.052993; Maruyama M, 2007, BIOL PHARM BULL, V30, P2091, DOI 10.1248/bpb.30.2091; Matsunaga T, 2004, BIOCHEM BIOPH RES CO, V318, P428, DOI 10.1016/j.bbrc.2004.04.041; Robertson GR, 2003, MOL PHARMACOL, V64, P42, DOI 10.1124/mol.64.1.42; Schmelzer E, 2007, J EXP MED, V204, P1973, DOI 10.1084/jem.20061603; Stevens JC, 2003, J PHARMACOL EXP THER, V307, P573, DOI 10.1124/jpet.103.054841; Sueyoshi T, 2001, ANNU REV PHARMACOL, V41, P123, DOI 10.1146/annurev.pharmtox.41.1.123; Takiguchi M., 2012, ACS SYNTH BIOL; Tirona RG, 2003, NAT MED, V9, P220, DOI 10.1038/nm815; Usui T, 2003, BIOL PHARM BULL, V26, P510; Waxman DJ, 1999, ARCH BIOCHEM BIOPHYS, V369, P11, DOI 10.1006/abbi.1999.1351; Wilkinson GR, 2005, NEW ENGL J MED, V352, P2211, DOI 10.1056/NEJMra032424; Yamaguchi S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017267; Zhang WS, 2003, DRUG METAB DISPOS, V31, P1054, DOI 10.1124/dmd.31.8.1054	29	11	11	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e104123	10.1371/journal.pone.0104123	http://dx.doi.org/10.1371/journal.pone.0104123			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25101946	Green Published, Green Submitted, gold			2022-12-27	WOS:000339993900041
J	Wang, FY; Fu, WC; Wang, IL; Yan, HY; Wang, TY				Wang, Feng-Yu; Fu, Wen-Chun; Wang, I-Li; Yan, Hong Young; Wang, Tzi-Yuan			The Giant Mottled Eel, Anguilla marmorata, Uses Blue-Shifted Rod Photoreceptors during Upstream Migration	PLOS ONE			English	Article							CONE VISUAL PIGMENTS; TUNING SPECTRAL SENSITIVITY; OPSIN GENE-EXPRESSION; COLOR-VISION; FRESH-WATER; HABITAT USE; MOLECULAR EVOLUTION; TROPICAL EEL; EUROPEAN EEL; TOKAY-GECKO	Catadromous fishes migrate between ocean and freshwater during particular phases of their life cycle. The dramatic environmental changes shape their physiological features, e. g. visual sensitivity, olfactory ability, and salinity tolerance. Anguilla marmorata, a catadromous eel, migrates upstream on dark nights, following the lunar cycle. Such behavior may be correlated with ontogenetic changes in sensory systems. Therefore, this study was designed to identify changes in spectral sensitivity and opsin gene expression of A. marmorata during upstream migration. Microspectrophotometry analysis revealed that the tropical eel possesses a duplex retina with rod and cone photoreceptors. The lambda(max) of rod cells are 493, 489, and 489 nm in glass, yellow, and wild eels, while those of cone cells are 508, and 517 nm in yellow, and wild eels, respectively. Unlike European and American eels, Asian eels exhibited a blue-shifted pattern of rod photoreceptors during upstream migration. Quantitative gene expression analyses of four cloned opsin genes (Rh1f, Rh1d, Rh2, and SWS2) revealed that Rh1f expression is dominant at all three stages, while Rh1d is expressed only in older yellow eel. Furthermore, sequence comparison and protein modeling studies implied that a blue shift in Rh1d opsin may be induced by two known (N83, S292) and four putative (S124, V189, V286, I290) tuning sites adjacent to the retinal binding sites. Finally, expression of blue-shifted Rh1d opsin resulted in a spectral shift in rod photoreceptors. Our observations indicate that the giant mottled eel is color-blind, and its blue-shifted scotopic vision may influence its upstream migration behavior and habitat choice.	[Wang, Feng-Yu] Taiwan Ocean Res Inst, Natl Appl Res Labs, Kaohsiung, Taiwan; [Fu, Wen-Chun; Yan, Hong Young] Acad Sinica, Sensory Physiol Lab, Marine Res Stn, Jiaoshi, I Lan County, Taiwan; [Wang, I-Li] Acad Sinica, Inst Biol Chem, Taiwan Int Grad Program, Chem Biol & Mol Biophys, Taipei, Taiwan; [Wang, I-Li] Natl Taiwan Univ, Inst Biochem Sci, Taipei 10764, Taiwan; [Yan, Hong Young] Hanse Wissenschaftskolleg Inst Adv Study, Delmenhorst, Germany; [Wang, Tzi-Yuan] Acad Sinica, Biodivers Res Ctr, Taipei 115, Taiwan	National Applied Research Laboratories - Taiwan; Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Taiwan University; Academia Sinica - Taiwan	Yan, HY (corresponding author), Acad Sinica, Sensory Physiol Lab, Marine Res Stn, Jiaoshi, I Lan County, Taiwan.	hyyan@gate.sinica.edu.tw; tziyuan@gmail.com	Wang, Tzi-Yuan/C-2874-2014	Wang, Tzi-Yuan/0000-0002-1562-0144	Academia Sinca, Taiwan; National Science Council [NSC 100-2311-B-001-001-MY2, NSC 102-2311-B-001-019, NSC 102-2311-B-001-010]	Academia Sinca, Taiwan; National Science Council(Ministry of Science and Technology, Taiwan)	This study was supported by intramural grants from Academia Sinca, Taiwan, and by the National Science Council grants (NSC 100-2311-B-001-001-MY2, NSC 102-2311-B-001-019 and NSC 102-2311-B-001-010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai T, 2012, J FISH BIOL, V81, P442, DOI 10.1111/j.1095-8649.2012.03353.x; Archer S, 1995, P ROY SOC B-BIOL SCI, V262, P289, DOI 10.1098/rspb.1995.0208; Aubin-Horth N, 2009, MOL ECOL, V18, P3763, DOI 10.1111/j.1365-294X.2009.04313.x; BEATTY DD, 1975, VISION RES, V15, P771, DOI 10.1016/0042-6989(75)90254-0; Bowmaker JK, 2008, VISION RES, V48, P2022, DOI 10.1016/j.visres.2008.03.025; Bowmaker JK, 2008, VISUAL NEUROSCI, V25, P249, DOI 10.1017/S0952523808080152; Bowmaker JK, 1995, PROG RETIN EYE RES, V15, P1; Bridges CDB, 1972, HDB SENSORY PHYSIOLO, P417, DOI DOI 10.1007/978-3-642-65066-6_11; Briones AA, 2007, RAFFLES B ZOOL, P141; Carleton KL, 2001, MOL BIOL EVOL, V18, P1540, DOI 10.1093/oxfordjournals.molbev.a003940; Cheng CL, 2004, NATURE, V428, P279, DOI 10.1038/428279a; Chinen A, 2005, MOL BIOL EVOL, V22, P1001, DOI 10.1093/molbev/msi086; Chinen A, 2005, J BIOL CHEM, V280, P9460, DOI 10.1074/jbc.M413001200; Chinen A, 2003, GENETICS, V163, P663; Chino N, 2010, ECOL FRESHW FISH, V19, P19, DOI 10.1111/j.1600-0633.2009.00385.x; Chino N, 2010, ENVIRON BIOL FISH, V89, P571, DOI 10.1007/s10641-010-9677-y; Cottrill PB, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-71; Damjanovic I, 2005, ANN NY ACAD SCI, V1048, P69, DOI 10.1196/annals.1342.007; Endler JA, 2001, AM NAT, V158, P36, DOI 10.1086/320862; Fasick JI, 1998, BIOCHEMISTRY-US, V37, P433, DOI 10.1021/bi972500j; Govardovskii VI, 2000, VISUAL NEUROSCI, V17, P509, DOI 10.1017/S0952523800174036; Hope AJ, 1998, P ROY SOC B-BIOL SCI, V265, P869, DOI 10.1098/rspb.1998.0372; Hunt DM, 2001, J EXP BIOL, V204, P3333; Hunt DM, 1996, VISION RES, V36, P1217, DOI 10.1016/0042-6989(95)00228-6; Jessop BM, 2002, MAR ECOL PROG SER, V233, P217, DOI 10.3354/meps233217; JOHNSON RL, 1993, BIOCHEMISTRY-US, V32, P208, DOI 10.1021/bi00052a027; Jokela M, 2003, J EXPT BIOL, V206; Kusmic C, 2000, MICRON, V31, P183, DOI 10.1016/S0968-4328(99)00081-5; Kuwayama S, 2002, BIOCHEMISTRY-US, V41, P15245, DOI 10.1021/bi026444k; LEVINE JS, 1979, SENS PROCESS, V3, P95; LIPETZ LE, 1988, VISION RES, V28, P1083, DOI 10.1016/0042-6989(88)90135-6; LOEW ER, 1994, VISION RES, V34, P1427, DOI 10.1016/0042-6989(94)90143-0; Marshall N. J., 2006, COMMUNICATION FISHES, V2, P393; Matsumoto Y, 2006, GENE, V371, P268, DOI 10.1016/j.gene.2005.12.005; Minamoto T, 2005, COMP BIOCHEM PHYS B, V140, P197, DOI 10.1016/j.cbpc.2004.09.028; NAWROCKI L, 1985, VISION RES, V25, P1569, DOI 10.1016/0042-6989(85)90127-0; Neafsey DE, 2005, GENE, V350, P161, DOI 10.1016/j.gene.2005.02.011; Palacios AG, 1998, VISION RES, V38, P2135, DOI 10.1016/S0042-6989(97)00411-2; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Parry JWL, 2005, CURR BIOL, V15, P1734, DOI 10.1016/j.cub.2005.08.010; PARTRIDGE JC, 1988, J COMP PHYSIOL A, V162, P543, DOI 10.1007/BF00612519; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Price TD, 2003, P ROY SOC B-BIOL SCI, V270, P1433, DOI 10.1098/rspb.2003.2372; Roesler CS, 1998, LIMNOL OCEANOGR, V43, P1649, DOI 10.4319/lo.1998.43.7.1649; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sandstrom Alfred, 1999, Fiskeriverket Rapport, V2, P45; Seehausen O, 2008, NATURE, V455, P620, DOI 10.1038/nature07285; Shand J, 2002, J EXP BIOL, V205, P3661; SHAPLEY R, 1980, PROC R SOC SER B-BIO, V209, P317, DOI 10.1098/rspb.1980.0097; Shiao JC, 2003, MAR ECOL PROG SER, V261, P233, DOI 10.3354/meps261233; Sillman AJ, 1999, J EXP BIOL, V202, P1931; SILLMAN AJ, 2001, J EXPT ZOOLOGY, V290, P259; Swofford D. L., 2011, PAUP PHYLOGENETIC AN; Takahashi Y, 2003, BIOCHEMISTRY-US, V42, P6025, DOI 10.1021/bi020629+; Takenaka N, 2007, GENE, V399, P26, DOI 10.1016/j.gene.2007.04.036; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tsukamoto K, 2002, CAN J FISH AQUAT SCI, V59, P1989, DOI 10.1139/F02-165; Tsukamoto K, 2001, MAR ECOL PROG SER, V220, P265, DOI 10.3354/meps220265; Tzeng WN, 1997, MAR ECOL PROG SER, V149, P73, DOI 10.3354/meps149073; Wang FY, 2008, VISION RES, V48, P1695, DOI 10.1016/j.visres.2008.04.026; Wang FY, 2011, VISION RES, V51, P1099, DOI 10.1016/j.visres.2011.02.025; Wang FY, 2009, VISION RES, V49, P1860, DOI 10.1016/j.visres.2009.04.023; WOOD P, 1992, J FISH BIOL, V41, P601, DOI 10.1111/j.1095-8649.1992.tb02686.x; WOOD P, 1993, P ROY SOC B-BIOL SCI, V254, P227, DOI 10.1098/rspb.1993.0150; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yokoyama S, 2000, PROG RETIN EYE RES, V19, P385, DOI 10.1016/S1350-9462(00)00002-1; Yokoyama S, 2002, GENE, V300, P69, DOI 10.1016/S0378-1119(02)00845-4; Yokoyama S, 2003, GENE, V306, P91, DOI 10.1016/S0378-1119(03)00424-4; Yokoyama S, 2008, ANNU REV GENOM HUM G, V9, P259, DOI 10.1146/annurev.genom.9.081307.164228; Yokoyama S, 2008, P NATL ACAD SCI USA, V105, P13480, DOI 10.1073/pnas.0802426105; Zhang H, 2000, FEBS LETT, V469, P39, DOI 10.1016/S0014-5793(00)01233-3	71	14	16	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e103953	10.1371/journal.pone.0103953	http://dx.doi.org/10.1371/journal.pone.0103953			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25101636	Green Published, gold, Green Submitted			2022-12-27	WOS:000339993900029
J	Liguori, M; Qualtieri, A; Tortorella, C; Direnzo, V; Bagala, A; Mastrapasqua, M; Spadafora, P; Trojano, M				Liguori, Maria; Qualtieri, Antonio; Tortorella, Carla; Direnzo, Vita; Bagala, Angelo; Mastrapasqua, Mariangela; Spadafora, Patrizia; Trojano, Maria			Proteomic Profiling in Multiple Sclerosis Clinical Courses Reveals Potential Biomarkers of Neurodegeneration	PLOS ONE			English	Article							CREUTZFELDT-JAKOB-DISEASE; CEREBROSPINAL-FLUID; DIAGNOSTIC-CRITERIA; NEUROMYELITIS-OPTICA; MASS-SPECTROMETRY; THYMOSIN BETA-4; AXONAL DAMAGE; GUIDELINES; PROTEIN; MS	The aim of our project was to perform an exploratory analysis of the cerebrospinal fluid (CSF) proteomic profiles of Multiple Sclerosis (MS) patients, collected in different phases of their clinical course, in order to investigate the existence of peculiar profiles characterizing the different MS phenotypes. The study was carried out on 24 Clinically Isolated Syndrome (CIS), 16 Relapsing Remitting (RR) MS, 11 progressive (Pr) MS patients. The CSF samples were analysed using the Matrix Assisted Laser Desorption lonisation Time Of Flight (MALDI-TOF) mass spectrometer in linear mode geometry and in delayed extraction mode (m/z range: 1000-25000 Da). Peak lists were imported for normalization and statistical analysis. CSF data were correlated with demographic, clinical and MRI parameters. The evaluation of MALDI-TOF spectra revealed 348 peak signals with relative intensity >= 1% in the study range. The peak intensity of the signals corresponding to Secretogranin II and Protein 7B2 were significantly upregulated in RRMS patients compared to PrMS (p<0.05), whereas the signals of Fibrinogen and Fibrinopeptide A were significantly downregulated in CIS compared to PrMS patients (p<0.04). Additionally, the intensity of the Tymosin beta 4 peak was the only signal to be significantly discriminated between the CIS and RRMS patients (p = 0.013). Although with caution due to the relatively small size of the study populations, and considering that not all the findings remained significant after adjustment for multiple comparisons, in our opinion this mass spectrometry evaluation confirms that this technique may provide useful and important information to improve our understanding of the complex pathogenesis of MS.	[Liguori, Maria] Natl Res Council Italy, Inst Biomed Technol, Bari, Italy; [Qualtieri, Antonio; Bagala, Angelo; Spadafora, Patrizia] Natl Res Council Italy, Inst Neurol Sci, Mangone, CS, Italy; [Tortorella, Carla; Direnzo, Vita; Mastrapasqua, Mariangela; Trojano, Maria] Univ Bari, Dept Basic Med Sci Neurosci & Sense Organs, Bari, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze Neurologiche (ISN-CNR); Universita degli Studi di Bari Aldo Moro	Liguori, M (corresponding author), Natl Res Council Italy, Inst Biomed Technol, Bari, Italy.	maria.liguori@cnr.it	Liguori, Maria/D-4390-2016; tortorella, carla/J-2557-2012	Liguori, Maria/0000-0003-4338-0392; tortorella, carla/0000-0001-9037-7300; SPADAFORA, PATRIZIA/0000-0001-5890-4561; Trojano, Maria/0000-0002-6329-8946	Pilot Research Award from the National ultiple Sclerosis Society (USA) [PP1896]	Pilot Research Award from the National ultiple Sclerosis Society (USA)	This investigation was fully supported by a Pilot Research Award from the National ultiple Sclerosis Society (USA) (Grant #PP1896). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DR, 2001, WILDLIFE SOC B, V29, P311; Bender R, 2001, J CLIN EPIDEMIOL, V54, P343, DOI 10.1016/S0895-4356(00)00314-0; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Comabella M, 2010, BRAIN, V133, P1082, DOI 10.1093/brain/awq035; Comi G, 2013, MULT SCLER J, V19, P1074, DOI 10.1177/1352458512469695; Dagley LF, 2013, PROTEOM CLIN APPL, V7, P91, DOI 10.1002/prca.201200104; Davalos D, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2230; Dhaunchak AS, 2012, ANN NEUROL, V71, P601, DOI 10.1002/ana.22693; Disanto G, 2013, MULT SCLER J, V19, P1679, DOI 10.1177/1352458513494494; Filippi M, 2012, LANCET NEUROL, V11, P349, DOI 10.1016/S1474-4422(12)70003-0; Fischer-Colbrie R, 2005, CURR PROTEIN PEPT SC, V6, P373, DOI 10.2174/1389203054546334; Gveric D, 2001, BRAIN, V124, P1978, DOI 10.1093/brain/124.10.1978; Helwig M, 2013, J BIOL CHEM, V288, P1114, DOI 10.1074/jbc.M112.417071; Jennewein C, 2011, MOL MED, V17, P568, DOI 10.2119/molmed.2010.00146; Kappos L, 2005, J NEUROL, V252, P21, DOI 10.1007/s00415-005-2013-3; Komori M, 2012, ANN NEUROL, V71, P614, DOI 10.1002/ana.22633; Lassmann H, 2001, TRENDS MOL MED, V7, P115, DOI 10.1016/S1471-4914(00)01909-2; Le Pera M, 2012, ARCH NEUROL-CHICAGO, V69, P868, DOI 10.1001/archneurol.2011.3558; Lublin FD, 1996, NEUROLOGY, V46, P907, DOI 10.1212/WNL.46.4.907; Mai W, 2011, J INT MED RES, V39, P2402, DOI 10.1177/147323001103900641; Mattsson N, 2007, J NEUROCHEM, V103, P1932, DOI 10.1111/j.1471-4159.2007.04985.x; Mattsson N, 2010, J ALZHEIMERS DIS, V20, P1039, DOI 10.3233/JAD-2010-091651; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Mollinari C, 2009, J CELL SCI, V122, P4195, DOI 10.1242/jcs.056895; Morris DC, 2012, ANN NY ACAD SCI, V1269, P110, DOI 10.1111/j.1749-6632.2012.06651.x; Nagtegaal GJA, 2014, MULT SCLER J, V20, P234, DOI 10.1177/1352458513494491; Patsopoulos NA, 2011, ANN NEUROL, V70, P897, DOI 10.1002/ana.22609; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; Qualtieri A, 2010, EXPERT REV PROTEOMIC, V7, P907, DOI 10.1586/EPR.10.80; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Scalfari A, 2014, J NEUROL NEUROSUR PS, V85, P67, DOI 10.1136/jnnp-2012-304333; Schutzer SE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066117; Stoop MP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012442; Teunissen CE, 2011, MULT SCLER J, V17, P838, DOI 10.1177/1352458511399614; Teunissen CE, 2009, NEUROLOGY, V73, P1914, DOI 10.1212/WNL.0b013e3181c47cc2; Teunissen C, 2013, MULT SCLER J, V19, P1802, DOI 10.1177/1352458513488232; Tortorella C, 2011, J NEUROL NEUROSUR PS, V82, P1355, DOI 10.1136/jnnp.2011.241836; Trojano M, 2011, NEUROL CLIN, V29, P309, DOI 10.1016/j.ncl.2010.12.008; Urso E, 2010, ANAL BIOCHEM, V402, P13, DOI 10.1016/j.ab.2010.03.029; Valis M, 2008, NEUROENDOCRINOL LETT, V29, P971; Verheul F, 2013, ACTA NEUROL SCAND, V127, P301, DOI 10.1111/ane.12007; Wirsching HG, 2014, BRAIN, V137, P433, DOI 10.1093/brain/awt333; Zastepa E, 2014, NEUROLOGY, V82, P681, DOI 10.1212/WNL.0000000000000146; Zhang J, 2009, NEUROSCIENCE, V164, P1887, DOI 10.1016/j.neuroscience.2009.09.054	46	25	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e103984	10.1371/journal.pone.0103984	http://dx.doi.org/10.1371/journal.pone.0103984			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25098164	Green Published, Green Submitted, gold			2022-12-27	WOS:000339995100040
J	Liu, YJ; Jiao, HS; Ji, X; Liu, CL; Zhong, XP; Zhang, HX; Ding, XH; Cao, XC				Liu, Yujie; Jiao, Hongsheng; Ji, Xiang; Liu, Chunlei; Zhong, Xiaopen; Zhang, Hongxun; Ding, Xiaohen; Cao, Xuecheng			A Comparative Study of Four Types of Free Flaps from the Ipsilateral Extremity for Finger Reconstruction	PLOS ONE			English	Article							ARTERIALIZED VENOUS FLAPS; SUPERFICIAL PALMAR BRANCH; ARTERY PERFORATOR FLAP; PULP RECONSTRUCTION; DIGITAL ARTERY; SKIN DEFECTS; HAND; THUMB; EXPERIENCE; INJURIES	Aim: To compare the outcomes of finger reconstruction using arterialized venous flap (AVF), superficial palmar branch of the radial artery (SPBRA) flap, posterior interosseous perforator flap (PIPF), and ulnar artery perforator free (UAPF) flap harvested from the ipsilateral extremity. Methods: We retrospectively reviewed the outcomes for 41 free flaps from the ipsilateral extremity in the reconstruction of finger defects in 41 patients with small/moderate skin defects, including 11 AVFs, 10 SPBRA flaps, 10 PIPFs, and 10 UAPF flaps. Standardized assessment of outcomes was performed, including duration of operation, objective sensory recovery, cold intolerance, time of returning to work, active total range of motion (ROM) of the injured fingers, and the cosmetic appearance of the donor/recipient sites. Results: All flaps survived completely, and the follow-up duration was 13.5 months. The mean duration of the complete surgical procedure for AVFs was distinctly shorter than that of the other flaps (p<0.05). AVFs were employed to reconstruct skin defects and extensor tendon defects using a vascularized palmaris longus graft in 4 fingers. Digital blood supply was reestablished in 4 fingers by flow-through technique when using AVFs. Optimal sensory recovery was better with AVFs and SPBRA flaps as compared with UAPF flaps and PIPFs (p<0.05). No significant differences were noted in ROM or cold intolerance between the 4 groups. Optimal cosmetic satisfaction was noted for the recipient sites of AVFs and the donor sites of SPBRA flaps. The number of second-stage defatting operations required for AVFs was considerably lesser than that for the other flaps. Conclusion: All 4 types of free flaps from the ipsilateral extremity are a practical choice in finger reconstruction for small/moderate-sized skin defects. AVFs play an important role in such operations due to the wider indications, and better sensory recovery and cosmetic appearance associated with this method.	[Liu, Yujie; Cao, Xuecheng] Gen Hosp Jinan Mil Command, Dept Orthoped & Traumat Surg, Jinan, Peoples R China; [Liu, Yujie; Jiao, Hongsheng; Ji, Xiang; Liu, Chunlei; Zhong, Xiaopen; Zhang, Hongxun; Ding, Xiaohen] 401st Hosp CPLA, Hand Surg Ctr Chinese Peoples Liberat Army, Qingdao, Peoples R China		Cao, XC (corresponding author), Gen Hosp Jinan Mil Command, Dept Orthoped & Traumat Surg, Jinan, Peoples R China.	caoxchengjn@126.com	Cao, Xuecheng/L-5141-2019					Brunelli G. A., 1995, Annals Academy of Medicine Singapore, V24, P108; CHEN CL, 1994, MICROSURG, V15, P886, DOI 10.1002/micr.1920151212; CHEN HC, 1991, J TRAUMA, V31, P1286, DOI 10.1097/00005373-199109000-00014; Chi ZL, 2012, J HAND SURG-AM, V37A, P1042, DOI 10.1016/j.jhsa.2012.02.010; Foucher G, 1999, BRIT J PLAST SURG, V52, P64, DOI 10.1054/bjps.1997.3005; FOUCHER G, 1991, WORLD J SURG, V15, P458, DOI 10.1007/BF01675641; Gillies H, 1957, PRINCIPLES ART PLAST; Gu JX, 2014, AESTHET PLAST SURG, V38, P156, DOI 10.1007/s00266-013-0260-8; Hamdi M, 1996, MICROSURG, V17, P375, DOI 10.1002/(SICI)1098-2752(1996)17:7<375::AID-MICR6>3.0.CO;2-F; Hsieh Jung-Hsien, 2009, J Trauma, V67, pE48, DOI 10.1097/TA.0b013e318047bfeb; Huang SH, 2010, MICROSURG, V30, P118, DOI 10.1002/micr.20718; Inada Y, 2004, PLAST RECONSTR SURG, V114, P411, DOI 10.1097/01.PRS.0000131881.42438.93; Ishiko Toshihiro, 2009, J Plast Reconstr Aesthet Surg, V62, pe211, DOI 10.1016/j.bjps.2009.01.065; Iwuagwu FC, 2013, PLAST RECONSTR SURG, V131, p308E, DOI 10.1097/PRS.0b013e318278fb22; Kappel D A, 1985, Hand Clin, V1, P677; Kim SW, 2013, ANN PLAS SURG, V71, P72, DOI 10.1097/SAP.0b013e31824681cc; KLEINERT HE, 1974, J TRAUMA, V14, P756, DOI 10.1097/00005373-197409000-00003; Kushima H, 2002, SCAND J PLAST RECONS, V36, P362, DOI 10.1080/028443102321096366; Lai CH, 2010, ANN PLAS SURG, V65, P535, DOI 10.1097/SAP.0b013e3181d376df; Lee HB, 1998, PLAST RECONSTR SURG, V101, P999, DOI 10.1097/00006534-199804040-00017; Li YF, 2005, J HAND SURG-AM, V30A, P1305, DOI 10.1016/j.jhsa.2005.05.012; Lin CH, 2007, PLAST RECONSTR SURG, V120, P1315, DOI 10.1097/01.prs.0000279476.29055.5f; Moschella F, 2006, PLAST RECONSTR SURG, V117, P920, DOI 10.1097/01.prs.0000200665.73624.6d; Oezaksar K, 2010, J HAND SURG-EUR VOL, V35E, P125, DOI 10.1177/1753193409337957; Omokawa S, 1997, PLAST RECONSTR SURG, V99, P116, DOI 10.1097/00006534-199701000-00018; Toia F, 2013, SURG RADIOL ANAT, V35, P737, DOI 10.1007/s00276-013-1091-7; Verdan C, 1975, HAND SURG; WARIS T, 1983, PLAST RECONSTR SURG, V72, P439, DOI 10.1097/00006534-198310000-00001; Woo SH, 2007, PLAST RECONSTR SURG, V119, P1823, DOI 10.1097/01.prs.0000259094.68803.3d; Woo SH, 1996, J HAND SURG-BRIT EUR, V21B, P222, DOI 10.1016/S0266-7681(96)80103-3; Woo SH, 2001, BRIT J PLAST SURG, V54, P390, DOI 10.1054/bjps.2001.3597; Yan HD, 2013, ANN PLAS SURG, V70, P666, DOI 10.1097/SAP.0b013e3182433575; Yan HD, 2012, J PLAST RECONSTR AES, V65, P1220, DOI 10.1016/j.bjps.2012.03.036; Yang JW, 2010, J RECONSTR MICROSURG, V26, P529, DOI 10.1055/s-0030-1262953; Yokoyama T, 2006, ANN PLAS SURG, V57, P552, DOI 10.1097/01.sap.0000227522.57422.6d; YOSHIMURA M, 1987, PLAST RECONSTR SURG, V79, P243, DOI 10.1097/00006534-198702000-00016	36	5	8	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e104014	10.1371/journal.pone.0104014	http://dx.doi.org/10.1371/journal.pone.0104014			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25098605	Green Published, gold, Green Submitted			2022-12-27	WOS:000339995100044
J	Marra, DM; Chambers, JQ; Higuchi, N; Trumbore, SE; Ribeiro, GHPM; dos Santos, J; Negron-Juarez, RI; Reu, B; Wirth, C				Marra, Daniel Magnabosco; Chambers, Jeffrey Q.; Higuchi, Niro; Trumbore, Susan E.; Ribeiro, Gabriel H. P. M.; dos Santos, Joaquim; Negron-Juarez, Robinson I.; Reu, Bjoern; Wirth, Christian			Large-Scale Wind Disturbances Promote Tree Diversity in a Central Amazon Forest	PLOS ONE			English	Article							BARRO-COLORADO-ISLAND; TROPICAL RAIN-FOREST; WOOD DENSITY; SPECIES-RICHNESS; GAP DISTURBANCES; LARGE BLOWDOWNS; HURRICANE HUGO; PATTERNS; BIOMASS; DAMAGE	Canopy gaps created by wind-throw events, or blowdowns, create a complex mosaic of forest patches varying in disturbance intensity and recovery in the Central Amazon. Using field and remote sensing data, we investigated the shortterm (four-year) effects of large (>2000 m(2)) blowdown gaps created during a single storm event in January 2005 near Manaus, Brazil, to study (i) how forest structure and composition vary with disturbance gradients and (ii) whether tree diversity is promoted by niche differentiation related to wind-throw events at the landscape scale. In the forest area affected by the blowdown, tree mortality ranged from 0 to 70%, and was highest on plateaus and slopes. Less impacted areas in the region affected by the blowdown had overlapping characteristics with a nearby unaffected forest in tree density (583 +/- 46 trees ha(-1)) (mean +/- 699% Confidence Interval) and basal area (26.7 +/- 2.4 m(2) ha(-1)). Highly impacted areas had tree density and basal area as low as 120 trees ha(-1) and 14.9 m 2 ha(-1), respectively. In general, these structural measures correlated negatively with an index of tree mortality intensity derived from satellite imagery. Four years after the blowdown event, differences in size-distribution, fraction of resprouters, floristic composition and species diversity still correlated with disturbance measures such as tree mortality and gap size. Our results suggest that the gradients of wind disturbance intensity encompassed in large blowdown gaps (>2000 m(2)) promote tree diversity. Specialists for particular disturbance intensities existed along the entire gradient. The existence of species or genera taking an intermediate position between undisturbed and gap specialists led to a peak of rarefied richness and diversity at intermediate disturbance levels. A diverse set of species differing widely in requirements and recruitment strategies forms the initial post-disturbance cohort, thus lending a high resilience towards wind disturbances at the community level.	[Marra, Daniel Magnabosco; Reu, Bjoern; Wirth, Christian] Univ Leipzig, D-04109 Leipzig, Germany; [Marra, Daniel Magnabosco; Trumbore, Susan E.; Wirth, Christian] Max Planck Inst Biogeochem, BGC Prozesse, D-07745 Jena, Germany; [Marra, Daniel Magnabosco; Chambers, Jeffrey Q.; Higuchi, Niro; Trumbore, Susan E.; Ribeiro, Gabriel H. P. M.; dos Santos, Joaquim] Inst Nacl de Pesquisas da Amazonia, Lab Manejo Florestal, Manaus, Amazonas, Brazil; [Chambers, Jeffrey Q.] Univ Calif Berkeley, Dept Geog, Berkeley, CA 94720 USA; [Chambers, Jeffrey Q.; Negron-Juarez, Robinson I.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Climate Sci Dept, Berkeley, CA 94720 USA; [Chambers, Jeffrey Q.; Negron-Juarez, Robinson I.] Tulane Univ, Dept Ecol & Evolutionary Biol, New Orleans, LA 70118 USA; [Wirth, Christian] German Ctr Integrat Biodivers Res iDiv, Leipzig, Germany	Leipzig University; Max Planck Society; Institute Nacional de Pesquisas da Amazonia; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Tulane University	Marra, DM (corresponding author), Univ Leipzig, D-04109 Leipzig, Germany.	daniel.marra@uni-leipzig.de	Trumbore, Susan/B-1948-2013; Marra, Daniel Magnabosco/ABE-4452-2020; Higuchi, Niro/ABC-9134-2020; Chambers, Jeffrey Q/J-9021-2014; Wirth, Christian/A-4446-2016; Santos, Joaquim dos/ABG-1455-2020; Ribeiro, Gabriel Henrique Pires de Mello/H-8948-2019; Reu, Björn/HDM-4363-2022; Higuchi, Niro/ABC-8890-2020; Chambers, Jeffrey Q/AAU-7097-2021; Higuchi, Niro/J-1287-2016; Negron-Juarez, Robinson/I-6289-2016	Marra, Daniel Magnabosco/0000-0003-1216-2982; Higuchi, Niro/0000-0002-1203-4502; Chambers, Jeffrey Q/0000-0003-3983-7847; Santos, Joaquim dos/0000-0002-4789-6110; Ribeiro, Gabriel Henrique Pires de Mello/0000-0002-3343-3043; Higuchi, Niro/0000-0002-1203-4502; Negron-Juarez, Robinson/0000-0002-4691-2692; Reu, Bjorn/0000-0001-5271-6420	Brazilian Council for Scientific and Technological Development (CNPq); National Aeronautics and Space Administration's Biodiversity Program [08-BIODIV-10]; Max-Planck-Institute for Biogeochemistry (BGC-Processes, Jena); Coordination for the Improvement of Higher Level Personal (CAPES)	Brazilian Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); National Aeronautics and Space Administration's Biodiversity Program; Max-Planck-Institute for Biogeochemistry (BGC-Processes, Jena); Coordination for the Improvement of Higher Level Personal (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was financed by the Brazilian Council for Scientific and Technological Development (CNPq) [Projeto SAWI (Chamada Universal MCTI/No 14/2012, Proc. 473357/2012-7) and INCT - Madeiras da Amazonia], by the National Aeronautics and Space Administration's Biodiversity Program (Project 08-BIODIV-10), and by the Max-Planck-Institute for Biogeochemistry (BGC-Processes, Jena). The presented results are part of the first author's PhD thesis, which incorporate data from his Master thesis, undertaken at the INPA/CFT, with fellowship funded by the Coordination for the Improvement of Higher Level Personal (CAPES). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JB, 1995, REMOTE SENS ENVIRON, V52, P137, DOI 10.1016/0034-4257(94)00098-8; ADAMS JB, 2006, REMOTE SENSING LANDS; Anderson MJ, 2011, ECOL LETT, V14, P19, DOI 10.1111/j.1461-0248.2010.01552.x; [Anonymous], [No title captured]; BELLINGHAM PJ, 1995, ECOLOGY, V76, P2562, DOI 10.2307/2265828; Boose ER, 2004, ECOL MONOGR, V74, P335, DOI 10.1890/02-4057; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Braga PIS, 1979, ACTA AMAZONICA S, V9, P53, DOI [10.1590/1809-43921979094s053, DOI 10.1590/1809-43921979094S053]; BROKAW NVL, 1991, BIOTROPICA, V23, P442, DOI 10.2307/2388264; BROKAW NVL, 1991, BIOTROPICA, V23, P386, DOI 10.2307/2388256; BROKAW NVL, 1985, ECOLOGY, V66, P682, DOI 10.2307/1940529; Burslem DFRP, 2000, J ECOL, V88, P1063, DOI 10.1046/j.1365-2745.2000.00517.x; Canham CD, 2010, BIOTROPICA, V42, P87, DOI 10.1111/j.1744-7429.2009.00545.x; Carlotto MJ, 1999, INT J REMOTE SENS, V20, P3333, DOI 10.1080/014311699211363; Carneiro V, 2005, VIS PORT 5 C FLOR NA; Chambers JQ, 2013, P NATL ACAD SCI USA, V110, P3949, DOI 10.1073/pnas.1202894110; Chambers JQ, 2009, ECOL LETT, V12, pE22, DOI 10.1111/j.1461-0248.2009.01398.x; Chambers JQ, 2009, OECOLOGIA, V160, P107, DOI 10.1007/s00442-008-1274-9; Chambers JQ, 2004, OECOLOGIA, V141, P596, DOI 10.1007/s00442-004-1676-2; CHAUVEL A, 1987, EXPERIENTIA, V43, P234, DOI 10.1007/BF01945546; Chave J, 2006, ECOL APPL, V16, P2356, DOI 10.1890/1051-0761(2006)016[2356:RAPVOW]2.0.CO;2; Chave J, 2008, PLOS BIOL, V6, P455, DOI 10.1371/journal.pbio.0060045; Clark DA, 2001, ECOLOGY, V82, P1460, DOI 10.1890/0012-9658(2001)082[1460:GTTCTH]2.0.CO;2; CLARK DB, 1991, J ECOL, V79, P447, DOI 10.2307/2260725; Clements FE, 1936, J ECOL, V24, P252, DOI 10.2307/2256278; Coley PD, 2014, SCIENCE, V343, P35, DOI 10.1126/science.1248110; Costa FRC, 2009, J VEG SCI, V20, P69, DOI 10.1111/j.1654-1103.2009.05314.x; CURTIS JT, 1950, ECOLOGY, V31, P434, DOI 10.2307/1931497; da Silva RP, 2002, FOREST ECOL MANAG, V166, P295, DOI 10.1016/S0378-1127(01)00678-8; Dalling JW, 2004, FUNCT ECOL, V18, P725, DOI 10.1111/j.0269-8463.2004.00868.x; de Castilho CV, 2006, FOREST ECOL MANAG, V234, P85, DOI 10.1016/j.foreco.2006.06.024; de Oliveira AA, 2001, FOREST ECOL MANAG, V146, P169, DOI 10.1016/S0378-1127(00)00458-8; De Oliveira AA, 1999, BIODIVERS CONSERV, V8, P1219, DOI 10.1023/A:1008908615271; de Toledo JJ, 2013, J VEG SCI, V24, P651, DOI 10.1111/j.1654-1103.2012.01491.x; de Toledo JJ, 2012, FOREST ECOL MANAG, V263, P253, DOI 10.1016/j.foreco.2011.09.017; Denslow JS, 1998, J ECOL, V86, P597, DOI 10.1046/j.1365-2745.1998.00295.x; DENSLOW JS, 1980, OECOLOGIA, V46, P18, DOI 10.1007/BF00346960; DENSLOW JS, 1987, ANNU REV ECOL SYST, V18, P431, DOI 10.1146/annurev.es.18.110187.002243; Di Vittorio AV, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/3/034010; Espirito-Santo FDB, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043146; Espirito-Santo FDB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4434; Fearnside PM, 1997, FOREST ECOL MANAG, V90, P59, DOI 10.1016/S0378-1127(96)03840-6; Fisher JI, 2008, ECOL LETT, V11, P554, DOI 10.1111/j.1461-0248.2008.01169.x; Foster DR, 1998, ECOSYSTEMS, V1, P497, DOI 10.1007/s100219900046; Garstang M, 1998, METEOROL ATMOS PHYS, V67, P199, DOI 10.1007/BF01277510; Gloor M, 2009, GLOBAL CHANGE BIOL, V15, P2418, DOI 10.1111/j.1365-2486.2009.01891.x; Gravel D, 2006, ECOL LETT, V9, P399, DOI 10.1111/j.1461-0248.2006.00884.x; GRUBB PJ, 1977, BIOL REV, V52, P107, DOI 10.1111/j.1469-185X.1977.tb01347.x; GUILLAUMET JL, 1987, EXPERIENTIA, V43, P241, DOI 10.1007/BF01945547; Haston E, 2009, BOT J LINN SOC, V161, P128, DOI 10.1111/j.1095-8339.2009.00996.x; Higuchi N., 2004, Floresta, V34, P295; Higuchi N., 2011, Floresta, V41, P427; Higuchi N., 1998, PESQUISAS FLORESTAIS, P51; Hijmans R., 2012, RASTER GEOGRAPHIC DA; Hubbell SP, 1999, SCIENCE, V283, P554, DOI 10.1126/science.283.5401.554; KAHN F, 1986, BIOTROPICA, V18, P214, DOI 10.2307/2388487; Kellner JR, 2009, ECOL LETT, V12, P887, DOI 10.1111/j.1461-0248.2009.01345.x; Lewin-Koh N, 2013, MAPTOOLS TOOLS READI; Lewis SL, 2004, J ECOL, V92, P929, DOI 10.1111/j.0022-0477.2004.00923.x; Lugo AE, 2008, AUSTRAL ECOL, V33, P368, DOI 10.1111/j.1442-9993.2008.01894.x; Marengo JA, 2008, J CLIMATE, V21, P495, DOI 10.1175/2007JCLI1600.1; Massoca P. E. dos S., 2012, Boletim do Museu Paraense Emilio Goeldi, Ciencias Naturais, V7, P235; Mesquita RCG, 2001, J ECOL, V89, P528, DOI 10.1046/j.1365-2745.2001.00583.x; Muller-Landau HC, 2004, BIOTROPICA, V36, P20, DOI 10.1111/j.1744-7429.2004.tb00292.x; Negron-Juarez R, 2014, REMOTE SENS ENVIRON, V140, P679, DOI 10.1016/j.rse.2013.09.028; Negron-Juarez RI, 2011, REMOTE SENS ENVIRON, V115, P3322, DOI 10.1016/j.rse.2011.07.015; Negron-Juarez RI, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043733; NELSON BW, 1994, ECOLOGY, V75, P853, DOI 10.2307/1941742; Nogueira EM, 2005, FOREST ECOL MANAG, V208, P261, DOI 10.1016/j.foreco.2004.12.007; Nogueira EM, 2007, FOREST ECOL MANAG, V248, P119, DOI 10.1016/j.foreco.2007.04.047; Lima Adriano José Nogueira, 2007, Acta Amaz., V37, P49, DOI 10.1590/S0044-59672007000100005; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Phillips OL, 2009, SCIENCE, V323, P1344, DOI 10.1126/science.1164033; Ribeiro GHPD, 2014, JARQ-JPN AGR RES Q, V48, P213; Poorter L, 2006, ECOLOGY, V87, P1733, DOI 10.1890/0012-9658(2006)87[1733:LTAGPO]2.0.CO;2; PRANCE G T, 1976, Acta Amazonica, V6, P9; PUTZ FE, 1989, ECOLOGY, V70, P508, DOI 10.2307/1937555; PUTZ FE, 1983, ECOLOGY, V64, P1069, DOI 10.2307/1937815; R Core Team, 2021, R LANGUAGE ENV STAT; RANZANI G, 1980, Acta Amazonica, V10, P7; Ribeiro J.E.L. da S., 1999, FLORA RESERVA DUCKE; Ruger N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025330; SALDARRIAGA JG, 1988, J ECOL, V76, P938, DOI 10.2307/2260625; Scariot A, 2000, BIOTROPICA, V32, P662, DOI 10.1646/0006-3606(2000)032[0662:SMBLIA]2.0.CO;2; Schnitzer SA, 2000, J ECOL, V88, P655, DOI 10.1046/j.1365-2745.2000.00489.x; SCHUPP EW, 1989, ECOLOGY, V70, P562, DOI 10.2307/1940206; Sombroek W, 2001, AMBIO, V30, P388, DOI 10.1639/0044-7447(2001)030[0388:SATPOA]2.0.CO;2; SOUSA WP, 1984, ANNU REV ECOL SYST, V15, P353, DOI 10.1146/annurev.es.15.110184.002033; Stevens P. F., 2012, ANGIOSPERM PHYLOGENY; SWAINE MD, 1988, VEGETATIO, V75, P81, DOI 10.1007/BF00044629; ter Steege H, 2013, SCIENCE, V342, P325, DOI 10.1126/science.1243092; The Angiosperm Phylogeny Group II, 2003, BOT J LINN SOC, V141, P399, DOI [DOI 10.1046/J.1095-8339.2003.T01-1-00158.X, 10.1046/j.1095-8339.2003.t01-1-00158.x]; Thompson J, 2002, ECOL APPL, V12, P1344, DOI 10.1890/1051-0761(2002)012[1344:LUHEAT]2.0.CO;2; Turner MG, 1998, ECOSYSTEMS, V1, P511, DOI 10.1007/s100219900047; UHL C, 1988, ECOLOGY, V69, P751, DOI 10.2307/1941024; Uriarte M, 2005, J ECOL, V93, P291, DOI 10.1111/j.0022-0477.2005.00984.x; Vandecar KL, 2011, BIOTROPICA, V43, P676, DOI 10.1111/j.1744-7429.2011.00756.x; Vandermeer J, 2000, SCIENCE, V290, P788, DOI 10.1126/science.290.5492.788; Vieira S, 2004, OECOLOGIA, V140, P468, DOI 10.1007/s00442-004-1598-z; Violle C, 2009, J PLANT ECOL-UK, V2, P87, DOI 10.1093/jpe/rtp007; VITOUSEK PM, 1986, J ECOL, V74, P1167, DOI 10.2307/2260241; WALKER LR, 1991, BIOTROPICA, V23, P379, DOI 10.2307/2388255; Wright SJ, 2003, ECOLOGY, V84, P3174, DOI 10.1890/02-0038; Xi WM, 2008, FORESTRY, V81, P317, DOI 10.1093/forestry/cpn020; ZIMMERMAN JK, 1994, J ECOL, V82, P911, DOI 10.2307/2261454	105	50	50	2	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e103711	10.1371/journal.pone.0103711	http://dx.doi.org/10.1371/journal.pone.0103711			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25099118	Green Published, gold			2022-12-27	WOS:000339995100028
J	Csato, V; Peto, A; Koller, A; Edes, I; Toth, A; Papp, Z				Csato, Viktoria; Peto, Attila; Koller, Akos; Edes, Istvan; Toth, Attila; Papp, Zoltan			Hydrogen Peroxide Elicits Constriction of Skeletal Muscle Arterioles by Activating the Arachidonic Acid Pathway	PLOS ONE			English	Article							ENDOTHELIUM-DEPENDENT CONTRACTIONS; PORCINE CORONARY-ARTERIES; SMOOTH-MUSCLE; HYPERPOLARIZING FACTOR; OXIDATIVE STRESS; MOLECULAR-MECHANISMS; HYPERTENSIVE-RATS; THROMBOXANE A(2); FREE-RADICALS; NITRIC-OXIDE	Aims: The molecular mechanisms of the vasoconstrictor responses evoked by hydrogen peroxide (H2O2) have not been clearly elucidated in skeletal muscle arterioles. Methods and Results: Changes in diameter of isolated, cannulated and pressurized gracilis muscle arterioles (GAs) of Wistar-Kyoto rats were determined under various test conditions. H2O2 (10-100 mu M) evoked concentration-dependent constrictions in the GAs, which were inhibited by endothelium removal, or by antagonists of phospholipase A (PLA; 100 mu M 7,7-dimethyl-(5Z, 8Z)-eicosadienoic acid), protein kinase C (PKC; 10 mu M chelerythrine), phospholipase C (PLC; 10 mu M U-73122), or Src family tyrosine kinase (Src kinase; 1 mu M Src Inhibitor-1). Antagonists of thromboxane A2 (TXA2; 1 mu M SQ-29548) or the non-specific cyclooxygenase (COX) inhibitor indomethacin (10 mu M) converted constrictions to dilations. The COX-1 inhibitor (SC-560, 1 mu M) demonstrated a greater reduction in constriction and conversion to dilation than that of COX-2 (celecoxib, 3 mu M). H2O2 did not elicit significant changes in arteriolar Ca2+ levels measured with Fura-2. Conclusions: These data suggest that H2O2 activates the endothelial Src kinase/PLC/PKC/PLA pathway, ultimately leading to the synthesis and release of TXA2 by COX-1, thereby increasing the Ca2+ sensitivity of the vascular smooth muscle cells and eliciting constriction in rat skeletal muscle arterioles.	[Csato, Viktoria; Peto, Attila; Edes, Istvan; Toth, Attila; Papp, Zoltan] Univ Debrecen, Div Clin Physiol, Inst Cardiol, H-4012 Debrecen, Hungary; [Csato, Viktoria; Peto, Attila; Edes, Istvan; Toth, Attila; Papp, Zoltan] Univ Debrecen, Res Ctr Mol Med, H-4012 Debrecen, Hungary; [Koller, Akos] Univ Pecs, Dept Pathophysiol & Gerontol, Pecs, Hungary; [Koller, Akos] Semmelweis Univ, Dept Pathophysiol, H-1085 Budapest, Hungary; [Koller, Akos] New York Med Coll, Dept Physiol, Valhalla, NY 10595 USA	University of Debrecen; University of Debrecen; University of Pecs; Semmelweis University; New York Medical College	Papp, Z (corresponding author), Univ Debrecen, Div Clin Physiol, Inst Cardiol, H-4012 Debrecen, Hungary.	pappz@med.unideb.hu	Papp, Zoltán/HDO-3347-2022; Tóth, Attila/F-4859-2010; Ákos, Koller/Q-4672-2019	Tóth, Attila/0000-0001-6503-3653; 	Hungarian Scientific Research Fund (OTKA) [K 108444, K 84300, K 109083]; Social Renewal Operational Programme [TAMOP-4.2.A-11/1KONV-2012-0045];  [SROP-4.2.2.A-11/1/KONV-2012-0024];  [SROP-4.2.2.A-11/1/KONV-2012-0017]	Hungarian Scientific Research Fund (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Social Renewal Operational Programme; ; 	Funding by grants from Hungarian Scientific Research Fund (OTKA): K 108444 (to AK), K 84300 (to AT), K 109083 (to ZP); by the Social Renewal Operational Programme TAMOP-4.2.A-11/1KONV-2012-0045; by grants SROP-4.2.2.A-11/1/KONV-2012-0024 and SROP-4.2.2.A-11/1/KONV-2012-0017. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiba S, 2004, BIOL PHARM BULL, V27, P1174, DOI 10.1248/bpb.27.1174; Ardanaz N, 2007, VASC PHARMACOL, V47, P288, DOI 10.1016/j.vph.2007.08.007; Barlow RS, 1998, AM J PHYSIOL-HEART C, V275, pH1283, DOI 10.1152/ajpheart.1998.275.4.H1283; Brandes RP, 2005, CARDIOVASC RES, V65, P16, DOI 10.1016/j.cardiores.2004.08.007; Briones AM, 2010, CURR HYPERTENS REP, V12, P135, DOI 10.1007/s11906-010-0100-z; Cai H, 2005, CARDIOVASC RES, V68, P26, DOI 10.1016/j.cardiores.2005.06.021; Cai H, 2003, TRENDS PHARMACOL SCI, V24, P471, DOI 10.1016/S0165-6147(03)00233-5; Cai H, 2005, CIRC RES, V96, P818, DOI 10.1161/01.RES.0000163631.07205.fb; Cseko C, 2004, J APPL PHYSIOL, V97, P1130, DOI 10.1152/japplphysiol.00106.2004; Czikora A, 2012, BRIT J PHARMACOL, V165, P1801, DOI 10.1111/j.1476-5381.2011.01645.x; Erdei N, 2007, AM J PHYSIOL-HEART C, V292, pH649, DOI 10.1152/ajpheart.00596.2006; Feher A, 2010, CARDIOVASC RES, V87, P732, DOI 10.1093/cvr/cvq088; Gao YJ, 2005, BRIT J PHARMACOL, V146, P1061, DOI 10.1038/sj.bjp.0706423; Gao YJ, 2003, BRIT J PHARMACOL, V138, P1085, DOI 10.1038/sj.bjp.0705147; Gao YJ, 2001, BRIT J PHARMACOL, V134, P1639, DOI 10.1038/sj.bjp.0704420; GAO YS, 1993, J APPL PHYSIOL, V74, P2105, DOI 10.1152/jappl.1993.74.5.2105; Gil-Longo J, 2005, VASC PHARMACOL, V43, P128, DOI 10.1016/j.vph.2005.06.001; HALLIWELL B, 1984, BIOCHEM J, V219, P1, DOI 10.1042/bj2190001; Hayabuchi Y, 1998, HEART VESSELS, V13, P9, DOI 10.1007/BF02750638; Hulsmans M, 2012, CURR ATHEROSCLER REP, V14, P264, DOI 10.1007/s11883-012-0237-0; Iida Y, 2000, STROKE, V31, P2224, DOI 10.1161/01.STR.31.9.2224; Kandasamy K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063465; KATUSIC ZS, 1993, AM J PHYSIOL, V264, pH859, DOI 10.1152/ajpheart.1993.264.3.H859; Koller A, 2004, AM J PHYSIOL-HEART C, V287, pH2461, DOI 10.1152/ajpheart.00295.2004; Lacy F, 2000, HYPERTENSION, V36, P878, DOI 10.1161/01.HYP.36.5.878; Liu XP, 2001, FREE RADICAL BIO MED, V31, P894, DOI 10.1016/S0891-5849(01)00665-7; Liu YP, 2011, CIRC RES, V108, P566, DOI 10.1161/CIRCRESAHA.110.237636; Liu YP, 2003, CIRC RES, V93, P573, DOI 10.1161/01.RES.0000091261.19387.AE; Matoba T, 2003, ARTERIOSCL THROM VAS, V23, P1224, DOI 10.1161/01.ATV.0000078601.79536.6C; Matoba T, 2002, BIOCHEM BIOPH RES CO, V290, P909, DOI 10.1006/bbrc.2001.6278; Matoba T, 2000, J CLIN INVEST, V106, P1521, DOI 10.1172/JCI10506; Meier M, 2000, VASC MED, V5, P173, DOI 10.1177/1358836X0000500307; Miura H, 2003, CIRC RES, V92, pE31, DOI 10.1161/01.RES.0000054200.44505.AB; Montezano AC, 2012, CAN J CARDIOL, V28, P288, DOI 10.1016/j.cjca.2012.01.017; Mueller CFH, 2005, ARTERIOSCL THROM VAS, V25, P274, DOI 10.1161/01.ATV.0000149143.04821.eb; Nakahata N, 2008, PHARMACOL THERAPEUT, V118, P18, DOI 10.1016/j.pharmthera.2008.01.001; Nedeljkovic ZS, 2003, POSTGRAD MED J, V79, P195, DOI 10.1136/pmj.79.930.195; Oeckler RA, 2003, CIRC RES, V92, P23, DOI 10.1161/01.RES.0000051860.84509.CE; OFFERMANNS S, 1994, P NATL ACAD SCI USA, V91, P504, DOI 10.1073/pnas.91.2.504; Pelaez NJ, 2000, AM J PHYSIOL-HEART C, V279, pH1185, DOI 10.1152/ajpheart.2000.279.3.H1185; Rodriguez-Martinez MA, 1998, BRIT J PHARMACOL, V125, P1329, DOI 10.1038/sj.bjp.0702200; Rogers PA, 2007, AM J PHYSIOL-HEART C, V292, pH1404, DOI 10.1152/ajpheart.00696.2006; Rogers PA, 2006, AM J PHYSIOL-HEART C, V291, pH2473, DOI 10.1152/ajpheart.00172.2006; ROOT RK, 1977, J CLIN INVEST, V60, P1266, DOI 10.1172/JCI108886; Sellers MM, 2008, AM J PHYSIOL-HEART C, V294, pH1978, DOI 10.1152/ajpheart.01318.2007; SHEEHAN DW, 1993, AM J PHYSIOL, V264, pH1542, DOI 10.1152/ajpheart.1993.264.5.H1542; Shi Y, 2007, BRIT J PHARMACOL, V152, P1033, DOI 10.1038/sj.bjp.0707439; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; Taniyama Y, 2003, HYPERTENSION, V42, P1075, DOI 10.1161/01.HYP.0000100443.09293.4F; Thengchaisri N, 2003, AM J PHYSIOL-HEART C, V285, pH2255, DOI 10.1152/ajpheart.00487.2003; Touyz RM, 2004, HYPERTENSION, V44, P248, DOI 10.1161/01.HYP.0000138070.47616.9d; Wagenfeld L, 2013, GRAEF ARCH CLIN EXP, V251, P2339, DOI 10.1007/s00417-013-2387-3; Walsh MP, 2013, J CEREBR BLOOD F MET, V33, P1, DOI 10.1038/jcbfm.2012.144; Wang XT, 2001, J BIOL CHEM, V276, P28364, DOI 10.1074/jbc.M102693200; Wilson DP, 2005, BIOCHEM J, V389, P763, DOI 10.1042/BJ20050237; Wong MSK, 2010, ACTA PHARMACOL SIN, V31, P1095, DOI 10.1038/aps.2010.127; Yada T, 2003, CIRCULATION, V107, P1040, DOI 10.1161/01.CIR.0000050145.25589.65; Yang Z, 1998, BRAIN RES BULL, V47, P257, DOI 10.1016/S0361-9230(98)00120-8; Yang ZW, 1999, N-S ARCH PHARMACOL, V360, P646, DOI 10.1007/s002109900128; Yang ZW, 1998, EUR J PHARMACOL, V344, P169, DOI 10.1016/S0014-2999(97)01576-8; ZEMBOWICZ A, 1993, BRIT J PHARMACOL, V110, P151, DOI 10.1111/j.1476-5381.1993.tb13785.x; Zhang DX, 2007, AM J PHYSIOL-HEART C, V292, pH2023, DOI 10.1152/ajpheart.01283.2006; Zhang DX, 2012, CIRC RES, V110, P471, DOI 10.1161/CIRCRESAHA.111.258871	63	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e103858	10.1371/journal.pone.0103858	http://dx.doi.org/10.1371/journal.pone.0103858			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093847	Green Submitted, Green Published, gold			2022-12-27	WOS:000341357200037
J	Zhang, J; Kong, YY; Ruan, Z; Huang, J; Song, TJ; Song, JJ; Jiang, Y; Yu, YS; Xie, XY				Zhang, Jun; Kong, Yingying; Ruan, Zhi; Huang, Jun; Song, Tiejun; Song, Jingjuan; Jiang, Yan; Yu, Yunsong; Xie, Xinyou			Correlation between Ureaplasma Subgroup 2 and Genitourinary Tract Disease Outcomes Revealed by an Expanded Multilocus Sequence Typing (eMLST) Scheme	PLOS ONE			English	Article							CHRONIC LUNG-DISEASE; UREALYTICUM; PARVUM; IDENTIFICATION; VIRULENCE; SEROVARS	The multilocus sequence typing (MLST) scheme of Ureaplasma based on four housekeeping genes (ftsH, rpL22, valS, and thrS) was described in our previous study; here we introduced an expanded MLST (eMLST) scheme with improved discriminatory power, which was developed by adding two putative virulence genes (ureG and mba-np1) to the original MLST scheme. To evaluate the discriminatory power of eMLST, a total of 14 reference strains of Ureaplasma serovars and 269 clinical strains (134 isolated from symptomatic patients and 135 obtained from asymptomatic persons) were investigated. Our study confirmed that all 14 serotype strains could successfully be differentiated into 14 eMLST STs (eSTs), while some of them could not even be differentiated by the MLST, and a total of 136 eSTs were identified among the clinical isolates we investigated. In addition, phylogenetic analysis indicated that two genetically significantly distant clusters (cluster I and II) were revealed and most clinical isolates were located in cluster I. These findings were in accordance with and further support for the concept of two well-known genetic lineages (Ureaplasma parvum and Ureaplasma urealyticum) in our previous study. Interestingly, although both clusters were associated with clinical manifestation, the sub-group 2 of cluster II had pronounced and adverse effect on patients and might be a potential risk factor for clinical outcomes. In conclusion, the eMLST scheme offers investigators a highly discriminative typing tool that is capable for precise epidemiological investigations and clinical relevance of Ureaplasma.	[Zhang, Jun; Kong, Yingying; Huang, Jun; Song, Tiejun; Song, Jingjuan; Xie, Xinyou] Zhejiang Univ, Coll Med, Sir Run Run Shaw Hosp, Dept Clin Lab, Hangzhou 310003, Zhejiang, Peoples R China; [Zhang, Jun; Kong, Yingying; Ruan, Zhi; Song, Jingjuan; Jiang, Yan; Yu, Yunsong; Xie, Xinyou] Zhejiang Univ, Coll Med, Sir Run Run Shaw Hosp, Biomed Res Ctr, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Xie, XY (corresponding author), Zhejiang Univ, Coll Med, Sir Run Run Shaw Hosp, Dept Clin Lab, Hangzhou 310003, Zhejiang, Peoples R China.	scottxie@mail.hz.zj.cn	Ruan, Zhi/P-3987-2015; Kong, Yingying/GQP-9865-2022	Ruan, Zhi/0000-0001-8648-4592; 	National Natural Science Foundation of China [81171629]; Zhejiang Provincial Natural Science Foundation [Y2080234]; Zhejiang Provincial Health Bureau Foundation [2012KYA115, 2013KYA216, 2014PYA011]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation(Natural Science Foundation of Zhejiang Province); Zhejiang Provincial Health Bureau Foundation	This study was supported by grants from the National Natural Science Foundation of China (grant no. 81171629), Zhejiang Provincial Natural Science Foundation (grant no. Y2080234), and Zhejiang Provincial Health Bureau Foundation (grant no. 2012KYA115, 2013KYA216 and 2014PYA011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbeleHorn M, 1997, J CLIN MICROBIOL, V35, P1199, DOI 10.1128/JCM.35.5.1199-1202.1997; Cooper JE, 2004, TRENDS MICROBIOL, V12, P373, DOI 10.1016/j.tim.2004.06.003; Feavers IM, 1999, J CLIN MICROBIOL, V37, P3883, DOI 10.1128/JCM.37.12.3883-3887.1999; Glass JI, 2000, NATURE, V407, P757, DOI 10.1038/35037619; Heggie AD, 2001, PEDIATR INFECT DIS J, V20, P854, DOI 10.1097/00006454-200109000-00006; Hunjak B, 2014, ARCH GYNECOL OBSTET, V289, P407, DOI 10.1007/s00404-013-2980-z; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Jolley KA, 2001, BIOINFORMATICS, V17, P1230, DOI 10.1093/bioinformatics/17.12.1230; Katz B, 2005, J CLIN MICROBIOL, V43, P4852, DOI 10.1128/JCM.43.9.4852-4854.2005; Knox CL, 2010, BIOL REPROD, V83, P415, DOI 10.1095/biolreprod.109.083121; Kong FR, 2000, J CLIN MICROBIOL, V38, P1175, DOI 10.1128/JCM.38.3.1175-1179.2000; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; LIGON JV, 1991, INFECT IMMUN, V59, P1170, DOI 10.1128/IAI.59.3.1170-1171.1991; Maiden MCJ, 2006, ANNU REV MICROBIOL, V60, P561, DOI 10.1146/annurev.micro.59.030804.121325; McDowell A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041480; Mohamad KY, 2008, INFECT GENET EVOL, V8, P764, DOI 10.1016/j.meegid.2008.06.009; Paralanov V, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-88; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320; Robertson JA, 2002, INT J SYST EVOL MICR, V52, P587, DOI 10.1099/00207713-52-2-587; Robinson JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062746; Ruan Z, 2013, INT J ANTIMICROB AG, V42, P322, DOI 10.1016/j.ijantimicag.2013.06.019; Salmeri M, 2012, J CHEMOTHERAPY, V24, P81, DOI 10.1179/1120009X12Z.00000000021; SANCHEZ PJ, 1987, PEDIATR INFECT DIS J, V6, P825, DOI 10.1097/00006454-198709000-00006; Scheffler K, 2006, BIOINFORMATICS, V22, P2493, DOI 10.1093/bioinformatics/btl427; Shariat N, 2013, FOOD MICROBIOL, V34, P164, DOI 10.1016/j.fm.2012.11.012; SMITH DGE, 1993, J BACTERIOL, V175, P3253, DOI 10.1128/jb.175.11.3253-3258.1993; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Teh CSJ, 2011, INFECT GENET EVOL, V11, P1121, DOI 10.1016/j.meegid.2011.04.005; Viscardi RM, 2009, PEDIATR RES, V65, p84R, DOI 10.1203/PDR.0b013e31819dc2f9; Waites KB, 2005, CLIN MICROBIOL REV, V18, P757, DOI 10.1128/CMR.18.4.757-789.2005; Xiao L, 2011, J CLIN MICROBIOL, V49, P3325, DOI 10.1128/JCM.01235-11; Xiao L, 2010, J CLIN MICROBIOL, V48, P2715, DOI 10.1128/JCM.01877-09; Zhang J, 2014, EUR J CLIN MICROBIOL, V33, P537, DOI 10.1007/s10096-013-1981-y; Zhang W, 2004, APPL ENVIRON MICROB, V70, P913, DOI 10.1128/AEM.70.2.913-920.2004	35	14	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e104347	10.1371/journal.pone.0104347	http://dx.doi.org/10.1371/journal.pone.0104347			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093900	gold, Green Submitted, Green Published			2022-12-27	WOS:000341357200101
J	Zgheib, S; Mequinion, M; Lucas, S; Leterme, D; Ghali, O; Tolle, V; Zizzari, P; Bellefontaine, N; Legroux-Gerot, I; Hardouin, P; Broux, O; Viltart, O; Chauveau, C				Zgheib, Sara; Mequinion, Mathieu; Lucas, Stephanie; Leterme, Damien; Ghali, Olfa; Tolle, Virginie; Zizzari, Philippe; Bellefontaine, Nicole; Legroux-Gerot, Isabelle; Hardouin, Pierre; Broux, Odile; Viltart, Odile; Chauveau, Christophe			Long-Term Physiological Alterations and Recovery in a Mouse Model of Separation Associated with Time-Restricted Feeding: A Tool to Study Anorexia Nervosa Related Consequences	PLOS ONE			English	Article							WHITE ADIPOSE-TISSUE; CALORIC RESTRICTION; GROWTH-HORMONE; BROWN ADIPOCYTES; EATING-DISORDERS; LEPTIN LEVELS; WEIGHT-LOSS; FOOD RESTRICTION; BONE METABOLISM; SERUM LEPTIN	Background: Anorexia nervosa is a primary psychiatric disorder, with non-negligible rates of mortality and morbidity. Some of the related alterations could participate in a vicious cycle limiting the recovery. Animal models mimicking various physiological alterations related to anorexia nervosa are necessary to provide better strategies of treatment. Aim: To explore physiological alterations and recovery in a long-term mouse model mimicking numerous consequences of severe anorexia nervosa. Methods: C57Bl/6 female mice were submitted to a separation-based anorexia protocol combining separation and time-restricted feeding for 10 weeks. Thereafter, mice were housed in standard conditions for 10 weeks. Body weight, food intake, body composition, plasma levels of leptin, adiponectin, IGF-1, blood levels of GH, reproductive function and glucose tolerance were followed. Gene expression of several markers of lipid and energy metabolism was assayed in adipose tissues. Results: Mimicking what is observed in anorexia nervosa patients, and despite a food intake close to that of control mice, separation-based anorexia mice displayed marked alterations in body weight, fat mass, lean mass, bone mass acquisition, reproductive function, GH/IGF-1 axis, and leptinemia. mRNA levels of markers of lipogenesis, lipolysis, and the brown-like adipocyte lineage in subcutaneous adipose tissue were also changed. All these alterations were corrected during the recovery phase, except for the hypoleptinemia that persisted despite the full recovery of fat mass. Conclusion: This study strongly supports the separation-based anorexia protocol as a valuable model of long-term negative energy balance state that closely mimics various symptoms observed in anorexia nervosa, including metabolic adaptations. Interestingly, during a recovery phase, mice showed a high capacity to normalize these parameters with the exception of plasma leptin levels. It will be interesting therefore to explore further the central and peripheral effects of the uncorrected hypoleptinemia during recovery from separation-based anorexia.	[Zgheib, Sara; Mequinion, Mathieu; Lucas, Stephanie; Leterme, Damien; Ghali, Olfa; Bellefontaine, Nicole; Legroux-Gerot, Isabelle; Hardouin, Pierre; Broux, Odile; Viltart, Odile; Chauveau, Christophe] Univ Lille Nord France, Boulogne Sur Mer, France; [Mequinion, Mathieu; Bellefontaine, Nicole; Viltart, Odile] UMR INSERM 837, Lille, France; [Tolle, Virginie; Zizzari, Philippe] Univ Paris 05, Ctr Psychiat & Neurosci, UMR S INSERM 894, Sorbonne Paris Cite, Paris, France; [Legroux-Gerot, Isabelle] CHU Lille, Hop Roger Salengro, Serv Rhumatol, Lille, France; [Viltart, Odile] Univ Lille 1, F-59655 Villeneuve Dascq, France	Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; Universite de Lille	Chauveau, C (corresponding author), Univ Lille Nord France, Boulogne Sur Mer, France.	chauveau@univ-littoral.fr	Tolle, Virginie S/H-5264-2015	Tolle, Virginie S/0000-0003-4456-0002; Zizzari, Philippe/0000-0001-8838-0762; LUCAS, Stephanie/0000-0001-7530-7486; Chauveau, Christophe/0000-0003-4668-9272; Hardouin, Pierre/0000-0002-1928-6382				Austad S N, 2001, Sci Aging Knowledge Environ, V2001, ppe3, DOI 10.1126/sageke.2001.6.pe3; Barbatelli G, 2010, AM J PHYSIOL-ENDOC M, V298, pE1244, DOI 10.1152/ajpendo.00600.2009; Boakes RA, 2001, BEHAV NEUROSCI, V115, P718, DOI 10.1037/0735-7044.115.3.718; Bray MS, 2013, INT J OBESITY, V37, P843, DOI 10.1038/ijo.2012.137; Bruss MD, 2010, AM J PHYSIOL-ENDOC M, V298, pE108, DOI 10.1152/ajpendo.00524.2009; Caligioni CS, 2009, CURR PROTOC NEUROSCI, V4, p4I, DOI DOI 10.1002/0471142301.NSA04IS48; Cerqueira FM, 2011, FREE RADICAL BIO MED, V51, P1454, DOI 10.1016/j.freeradbiomed.2011.07.006; Cerqueira FM, 2010, AGEING RES REV, V9, P424, DOI 10.1016/j.arr.2010.05.002; COUSIN B, 1992, J CELL SCI, V103, P931; Devlin MJ, 2010, J BONE MINER RES, V25, P2078, DOI 10.1002/jbmr.82; Dhahbi JM, 2004, P NATL ACAD SCI USA, V101, P5524, DOI 10.1073/pnas.0305300101; Estour B, 2010, J CLIN ENDOCR METAB, V95, P2203, DOI 10.1210/jc.2009-2608; Faje AT, 2014, INT J EAT DISORDER, V47, P458, DOI 10.1002/eat.22248; Ferguson M, 2007, MECH AGEING DEV, V128, P539, DOI 10.1016/j.mad.2007.07.005; Gahete MD, 2013, ENDOCRINOLOGY, V154, P263, DOI 10.1210/en.2012-1849; Gairdner SE, 2012, APPL PHYSIOL NUTR ME, V37, P1063, DOI [10.1139/h2012-092, 10.1139/H2012-092]; Gendall KA, 1999, BIOL PSYCHIAT, V46, P292, DOI 10.1016/S0006-3223(98)00292-3; Hao SZ, 2001, PHARMACOL BIOCHEM BE, V68, P273, DOI 10.1016/S0091-3057(00)00448-2; Hatori M, 2012, CELL METAB, V15, P848, DOI 10.1016/j.cmet.2012.04.019; Hebebrand J, 2003, PHYSIOL BEHAV, V79, P25, DOI 10.1016/S0031-9384(03)00102-1; Hebebrand J, 1997, MOL PSYCHIATR, V2, P330, DOI 10.1038/sj.mp.4000282; HERESI G, 1980, J NUTR, V110, P1888, DOI 10.1093/jn/110.9.1888; Higami Y, 2003, FASEB J, V17, P415, DOI 10.1096/fj.03-0678fje; Hoek HW, 2006, CURR OPIN PSYCHIATR, V19, P389, DOI 10.1097/01.yco.0000228759.95237.78; Holtkamp K, 2004, PSYCHONEUROENDOCRINO, V29, P791, DOI 10.1016/S0306-4530(03)00143-4; Holtkamp K, 2003, J PSYCHIATR RES, V37, P165, DOI 10.1016/S0022-3956(02)00100-0; Jappe LM, 2014, INT J EAT DISORDER, V47, P181, DOI 10.1002/eat.22211; Lawson EA, 2008, NAT CLIN PRACT ENDOC, V4, P407, DOI 10.1038/ncpendmet0872; Legroux-Gerot I, 2012, OSTEOPOROSIS INT, V23, P2855, DOI 10.1007/s00198-012-1919-8; Legroux-Gerot I, 2010, OSTEOPOROSIS INT, V21, P1715, DOI 10.1007/s00198-009-1120-x; Legroux-Gerot I, 2007, CALCIFIED TISSUE INT, V81, P174, DOI 10.1007/s00223-007-9038-9; Mequinion Mathieu, 2013, Front Endocrinol (Lausanne), V4, P15, DOI 10.3389/fendo.2013.00015; Misra M, 2003, J CLIN ENDOCR METAB, V88, P5615, DOI 10.1210/jc.2003-030532; Okita N, 2012, MECH AGEING DEV, V133, P255, DOI 10.1016/j.mad.2012.02.003; Park S, 2006, EXP GERONTOL, V41, P837, DOI 10.1016/j.exger.2006.06.055; PIRKE KM, 1993, NEUROSCI BIOBEHAV R, V17, P287, DOI 10.1016/S0149-7634(05)80012-0; Rogers NH, 2012, AGING CELL, V11, P1074, DOI 10.1111/acel.12010; Rojo L, 2006, PSYCHOSOM MED, V68, P628, DOI 10.1097/01.psy.0000227749.58726.41; ROUTTENBERG A, 1967, J COMP PHYSIOL PSYCH, V64, P414, DOI 10.1037/h0025205; Speakman JR, 2011, MOL ASPECTS MED, V32, P159, DOI 10.1016/j.mam.2011.07.001; Steyn FJ, 2011, ENDOCRINOLOGY, V152, P3165, DOI 10.1210/en.2011-0253; Tatsumi S, 2008, ENDOCRINOLOGY, V149, P634, DOI 10.1210/en.2007-1089; Tropp J, 2001, PHYSIOL BEHAV, V73, P553, DOI 10.1016/S0031-9384(01)00487-5; vanLeeuwen SD, 1997, PHYSIOL BEHAV, V62, P77, DOI 10.1016/S0031-9384(97)00144-3; Veyrat-Durebex C, 2009, AM J PHYSIOL-ENDOC M, V296, pE1120, DOI 10.1152/ajpendo.90592.2008; ZAMIRI MJ, 1978, AUST J BIOL SCI, V31, P629; Zhao TJ, 2010, P NATL ACAD SCI USA, V107, P7467, DOI 10.1073/pnas.1002271107; Zipfel S, 2001, J CLIN ENDOCR METAB, V86, P5227, DOI 10.1210/jc.86.11.5227	48	23	23	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103775	10.1371/journal.pone.0103775	http://dx.doi.org/10.1371/journal.pone.0103775			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25090643	Green Published, gold, Green Submitted			2022-12-27	WOS:000339812700054
J	Harvey, RM; Hughes, CE; Paton, AW; Trappetti, C; Tweten, RK; Paton, JC				Harvey, Richard M.; Hughes, Catherine E.; Paton, Adrienne W.; Trappetti, Claudia; Tweten, Rodney K.; Paton, James C.			The Impact of Pneumolysin on the Macrophage Response to Streptococcus pneumoniae is Strain-Dependent	PLOS ONE			English	Article							CAPSULAR POLYSACCHARIDE BIOSYNTHESIS; PNEUMOCOCCAL LUNG INFECTION; NECROSIS-FACTOR-ALPHA; EPITHELIAL-CELLS; IMMUNE-RESPONSE; VIRULENCE; MICE; IMMUNIZATION; PROTECTION; OUTBREAK	Streptococcus pneumoniae is the world's leading cause of pneumonia, bacteremia, meningitis and otitis media. A major pneumococcal virulence factor is the cholesterol-dependent cytolysin, which has the defining property of forming pores in cholesterol-containing membranes. In recent times a clinically significant and internationally successful serotype 1 ST306 clone has been found to express a non-cytolytic variant of Ply (Ply(306)). However, while the pneumococcus is a naturally transformable organism, strains of the ST306 clonal group have to date been virtually impossible to transform, severely restricting efforts to understand the role of non-cytolytic Ply in the success of this clone. In this study isogenic Ply mutants were constructed in the D39 background and for the first time in the ST306 background (A0229467) to enable direct comparisons between Ply variants for their impact on the immune response in a macrophage-like cell line. Strains that expressed cytolytic Ply were found to induce a significant increase in IL-1 beta release from macrophage-like cells compared to the non-cytolytic and Ply-deficient strains in a background-independent manner, confirming the requirement for pore formation in the Ply-dependent activation of the NLRP3 inflammasome. However, cytolytic activity in the D39 background was found to induce increased expression of the genes encoding GM-CSF (CSF2), p19 subunit of IL-23 (IL23A) and IFN beta (IFNB1) compared to non-cytolytic and Ply-deficient D39 mutants, but had no effect in the A0229467 background. The impact of Ply on the immune response to the pneumococcus is highly dependent on the strain background, thus emphasising the importance of the interaction between specific virulence factors and other components of the genetic background of this organism.	[Harvey, Richard M.; Hughes, Catherine E.; Paton, Adrienne W.; Trappetti, Claudia; Paton, James C.] Univ Adelaide, Sch Mol & Biomed Sci, Res Ctr Infect Dis, Adelaide, SA, Australia; [Tweten, Rodney K.] Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, Oklahoma City, OK 73190 USA	University of Adelaide; University of Oklahoma System; University of Oklahoma Health Sciences Center	Paton, JC (corresponding author), Univ Adelaide, Sch Mol & Biomed Sci, Res Ctr Infect Dis, Adelaide, SA, Australia.	james.paton@adelaide.edu.au		Trappetti, Claudia/0000-0001-8272-0068	National Health and Medical Research Council (NHMRC) of Australia [565526, 627142]; National Institutes of Allergy and Infectious Diseases [AI037567]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI037657] Funding Source: NIH RePORTER	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Institutes of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was funded by Program Grant 565526 (to JCP and AWP) and Project Grant 627142 (to JCP) from the National Health and Medical Research Council (NHMRC) of Australia and the National Institutes of Allergy and Infectious Diseases (AI037567) to RKT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER JE, 1994, INFECT IMMUN, V62, P5683, DOI 10.1128/IAI.62.12.5683-5688.1994; Antonio M, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-198; Arevalo MT, 2009, FEMS IMMUNOL MED MIC, V55, P346, DOI 10.1111/j.1574-695X.2008.00518.x; Avery OT, 1944, J EXP MED, V79, P137, DOI 10.1084/jem.79.2.137; BERRY AM, 1989, INFECT IMMUN, V57, P2037, DOI 10.1128/IAI.57.7.2037-2042.1989; BERRY AM, 1995, INFECT IMMUN, V63, P1969, DOI 10.1128/IAI.63.5.1969-1974.1995; Brasier AR, 1998, J BIOL CHEM, V273, P3551, DOI 10.1074/jbc.273.6.3551; Braun JS, 1999, INFECT IMMUN, V67, P3750, DOI 10.1128/IAI.67.8.3750-3756.1999; Brueggemann AB, 2003, J INFECT DIS, V187, P1424, DOI 10.1086/374624; Calbo E, 2010, INT J ANTIMICROB AG, V35, P107, DOI 10.1016/j.ijantimicag.2009.10.002; CANVIN JR, 1995, J INFECT DIS, V172, P119, DOI 10.1093/infdis/172.1.119; Cockeran R, 2001, J INFECT DIS, V183, P604, DOI 10.1086/318536; Daigneault M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008668; Duarte C, 2013, REV PANAM SALUD PUBL, V33, P422; Farrand AJ, 2010, P NATL ACAD SCI USA, V107, P4341, DOI 10.1073/pnas.0911581107; Giammarinaro P, 2002, INFECT IMMUN, V70, P5454, DOI 10.1128/IAI.70.10.5454-5461.2002; Hamilton JA, 2008, NAT REV IMMUNOL, V8, P533, DOI 10.1038/nri2356; Harvey RM, 2011, INFECT IMMUN, V79, P4122, DOI 10.1128/IAI.05418-11; Harvey RM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019650; HORTON RM, 1993, METHOD ENZYMOL, V217, P270; HOULDSWORTH S, 1994, INFECT IMMUN, V62, P1501, DOI 10.1128/IAI.62.4.1501-1503.1994; Kadioglu A, 2004, TRENDS IMMUNOL, V25, P143, DOI 10.1016/j.it.2003.12.006; Kadioglu A, 2000, INFECT IMMUN, V68, P492, DOI 10.1128/IAI.68.2.492-501.2000; KASAHARA T, 1991, IMMUNOLOGY, V74, P60; Kirkham LAS, 2006, J CLIN MICROBIOL, V44, P151, DOI 10.1128/JCM.44.1.151-159.2006; Kirkham LAS, 2006, INFECT IMMUN, V74, P586, DOI 10.1128/IAI.74.1.586-593.2006; Koppe U, 2012, J IMMUNOL, V188, P811, DOI 10.4049/jimmunol.1004143; LACKS S, 1960, BIOCHIM BIOPHYS ACTA, V39, P508, DOI 10.1016/0006-3002(60)90205-5; Lai JYR, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-409; Le Hello S, 2010, J CLIN MICROBIOL, V48, P2968, DOI 10.1128/JCM.01615-09; Leimkugel J, 2005, J INFECT DIS, V192, P192, DOI 10.1086/431151; Malley R, 2003, P NATL ACAD SCI USA, V100, P1966, DOI 10.1073/pnas.0435928100; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Marimon JM, 2009, CLIN MICROBIOL INFEC, V15, P875, DOI 10.1111/j.1469-0691.2009.02883.x; Martin B, 1995, DEV BIOL STAND, V85, P293; McNeela EA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001191; Morona JK, 2004, J INFECT DIS, V189, P1905, DOI 10.1086/383352; Morona JK, 2000, MOL MICROBIOL, V35, P1431, DOI 10.1046/j.1365-2958.2000.01808.x; Ogunniyi AD, 2000, INFECT IMMUN, V68, P3028, DOI 10.1128/IAI.68.5.3028-3033.2000; PATON JC, 1983, INFECT IMMUN, V40, P548, DOI 10.1128/IAI.40.2.548-552.1983; PATON JC, 1984, INFECT IMMUN, V43, P1085, DOI 10.1128/IAI.43.3.1085-1087.1984; PATON JC, 1991, INFECT IMMUN, V59, P2297, DOI 10.1128/IAI.59.7.2297-2304.1991; Riendeau CJ, 2003, INFECT IMMUN, V71, P254, DOI 10.1128/IAI.71.1.254-259.2003; Sandgren A, 2004, J INFECT DIS, V189, P785, DOI 10.1086/381686; Shak JR, 2013, MBIO, V4, DOI 10.1128/mBio.00655-13; Sjostrom K, 2006, CLIN INFECT DIS, V42, P451, DOI 10.1086/499242; Sonoda Y, 1997, J BIOL CHEM, V272, P15366, DOI 10.1074/jbc.272.24.15366; Stockinger B, 2007, CURR OPIN IMMUNOL, V19, P281, DOI 10.1016/j.coi.2007.04.005; Sung CK, 2001, APPL ENVIRON MICROB, V67, P5190, DOI 10.1128/AEM.67.11.5190-5196.2001; Trzcinski K, 2008, INFECT IMMUN, V76, P2678, DOI 10.1128/IAI.00141-08; WEISER JN, 1994, INFECT IMMUN, V62, P2582, DOI 10.1128/IAI.62.6.2582-2589.1994; Witzenrath M, 2011, J IMMUNOL, V187, P434, DOI 10.4049/jimmunol.1003143; Yaro S, 2006, CLIN INFECT DIS, V43, P693, DOI 10.1086/506940; Zhang Z, 2009, J CLIN INVEST, V119, P1899, DOI 10.1172/JCI36731	54	29	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2014	9	8							e103625	10.1371/journal.pone.0103625	http://dx.doi.org/10.1371/journal.pone.0103625			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR0CG	25105894	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000343231900017
J	Albertson, LK; Cardinale, BJ; Sklar, LS				Albertson, Lindsey K.; Cardinale, Bradley J.; Sklar, Leonard S.			Non-Additive Increases in Sediment Stability Are Generated by Macroinvertebrate Species Interactions in Laboratory Streams	PLOS ONE			English	Article							NET-SPINNING CADDISFLIES; BED MATERIAL TRANSPORT; LARVAE TRICHOPTERA; SIERRA-NEVADA; SHEAR-STRESS; ECOSYSTEM; DIVERSITY; BIODIVERSITY; HYDROPSYCHE; RIVER	Previous studies have shown that biological structures such as plant roots can have large impacts on landscape morphodynamics, and that physical models that do not incorporate biology can generate qualitatively incorrect predictions of sediment transport. However, work to date has focused almost entirely on the impacts of single, usually dominant, species. Here we ask whether multiple, coexisting species of hydropsychid caddisfly larvae have different impacts on sediment mobility compared to single-species systems due to competitive interactions and niche differences. We manipulated the presence of two common species of net-spinning caddisfly (Ceratopsyche oslari, Arctopsyche californica) in laboratory mesocosms and measured how their silk filtration nets influence the critical shear stress required to initiate sediment grain motion when they were in monoculture versus polyculture. We found that critical shear stress increases non-additively in polycultures where species were allowed to interact. Critical shear stress was 26% higher in multi-species assemblages compared to the average single-species monoculture, and 21% greater than levels of stability achieved by the species having the largest impact on sediment motion in monoculture. Supplementary behavioral experiments suggest the non-additive increase in critical shear stress may have occurred as competition among species led to shifts in the spatial distribution of the two populations and complementary habitat use. To explore the implications of these results for field conditions, we used results from the laboratory study to parameterize a common model of sediment transport. We then used this model to estimate potential bed movement in a natural stream for which we had measurements of channel geometry, grain size, and daily discharge. Although this extrapolation is speculative, it illustrates that multi-species impacts could be sufficiently large to reduce bedload sediment flux over annual time scales in streams where multiple species of caddisfly are present.	[Albertson, Lindsey K.] Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA; [Cardinale, Bradley J.] Univ Michigan, Sch Nat Resources & Environm, Ann Arbor, MI 48109 USA; [Sklar, Leonard S.] San Francisco State Univ, Dept Earth & Climate Sci, San Francisco, CA 94132 USA	University of California System; University of California Santa Barbara; University of Michigan System; University of Michigan; California State University System; San Francisco State University	Albertson, LK (corresponding author), Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA.	lalbertson@stroudcenter.org	Cardinale, Bradley J/I-7076-2013	Sklar, Leonard/0000-0001-9626-733X	National Science Foundation [1110571]; Valentine Eastern Sierra Reserve; Dawdy Fund for Hydrologic Science at SFSU; UCSB's Ecology, Evolution, and Marine Biology Department	National Science Foundation(National Science Foundation (NSF)); Valentine Eastern Sierra Reserve; Dawdy Fund for Hydrologic Science at SFSU; UCSB's Ecology, Evolution, and Marine Biology Department	This work was supported by grants from the National Science Foundation (1110571), the Valentine Eastern Sierra Reserve, the Dawdy Fund for Hydrologic Science at SFSU, and UCSB's Ecology, Evolution, and Marine Biology Department. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertson LK, 2011, RESTOR ECOL, V19, P627, DOI 10.1111/j.1526-100X.2010.00672.x; Allen DC, 2011, ECOLOGY, V92, P1013, DOI 10.1890/i0012-9658-92-5-1013; Andrews ED, 2000, WATER RESOUR RES, V36, P585, DOI 10.1029/1999WR900257; Braudrick CA, 2009, P NATL ACAD SCI USA, V106, P16936, DOI 10.1073/pnas.0909417106; Brown SA, 2004, J N AM BENTHOL SOC, V23, P771, DOI 10.1899/0887-3593(2004)023<0771:PPOHST>2.0.CO;2; Buffington JM, 1997, WATER RESOUR RES, V33, P1993, DOI 10.1029/96WR03190; Cardinale BJ, 2004, FUNCT ECOL, V18, P381, DOI 10.1111/j.0269-8463.2004.00865.x; Cardinale BJ, 2002, ECOLOGY, V83, P1915; Cardinale BJ, 2002, NATURE, V415, P426, DOI 10.1038/415426a; Church M, 2006, ANNU REV EARTH PL SC, V34, P325, DOI 10.1146/annurev.earth.33.092203.122721; Clements FE, 1936, J ECOL, V24, P252, DOI 10.2307/2256278; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; DIETRICH WE, 1989, NATURE, V340, P215, DOI 10.1038/340215a0; Dingman S. L, 2009, FLUVIAL HYDRAULICS; ENGLUND G, 1990, ANIM BEHAV, V39, P55, DOI 10.1016/S0003-3472(05)80725-0; Fuller BM, 2012, GEOMORPHOLOGY, V126, P732; GEORGIAN T, 1992, ECOLOGY, V73, P229, DOI 10.2307/1938734; Gordon ND, 2004, STREAM HYDROLOGY INT; Harding JS, 1997, HYDROBIOLOGIA, V350, P25, DOI 10.1023/A:1003012512998; Herbst D., 2004, General Technical Report - Pacific Southwest Research Station, USDA Forest Service, P133; Herbst DB, 2010, J N AM BENTHOL SOC, V29, P1354, DOI 10.1899/09-185.1; HILDREW AG, 1979, J ANIM ECOL, V48, P557, DOI 10.2307/4180; HOBBIE SE, 1992, TRENDS ECOL EVOL, V7, P336, DOI 10.1016/0169-5347(92)90126-V; Hughes AR, 2004, P NATL ACAD SCI USA, V101, P8998, DOI 10.1073/pnas.0402642101; Johnson MF, 2009, EARTH SURF PROC LAND, V34, P413, DOI 10.1002/esp.1750; JONES CG, 1994, OIKOS, V69, P373, DOI 10.2307/3545850; Kouwen N, 2000, J HYDRAUL ENG-ASCE, V126, P732, DOI 10.1061/(ASCE)0733-9429(2000)126:10(732); Kump LR, 2008, NATURE, V451, P277, DOI 10.1038/nature06587; Lake PS, 2000, J N AM BENTHOL SOC, V19, P573, DOI 10.2307/1468118; LELAND HV, 1986, GREAT BASIN NAT, V46, P595; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; LOUDON C, 1992, CAN J ZOOL, V70, P1166, DOI 10.1139/z92-163; MACKAY RJ, 1979, ANNU REV ENTOMOL, V24, P185, DOI 10.1146/annurev.en.24.010179.001153; Meyer-Peter E., 1948, P IAHSR 2 M STOCKH, P39; MILLER JC, 1984, OIKOS, V43, P117, DOI 10.2307/3544253; Nunokawa M, 2008, LANDSC ECOL ENG, V4, P125, DOI 10.1007/s11355-008-0044-5; OSBORNE L L, 1987, Journal of the North American Benthological Society, V6, P115, DOI 10.2307/1467221; Parker G, 2007, J GEOPHYS RES-EARTH, V112, DOI 10.1029/2006JF000549; PETERSEN LBM, 1983, FRESHWATER BIOL, V13, P185, DOI 10.1111/j.1365-2427.1983.tb00670.x; POFF NL, 1995, ECOLOGY, V76, P606, DOI 10.2307/1941217; Quinn GP, 2003, EXPT DESIGN DATA ANA; Reinhardt L, 2010, EARTH SURF PROC LAND, V35, P78, DOI 10.1002/esp.1912; Renschler CS, 2007, GEOMORPHOLOGY, V89, P1, DOI 10.1016/j.geomorph.2006.07.011; Rixen C, 2005, OECOLOGIA, V146, P287, DOI 10.1007/s00442-005-0196-z; Statzner B, 1999, WATER RESOUR RES, V35, P3495, DOI 10.1029/1999WR900196; Statzner B, 2008, GEOMORPHOLOGY, V93, P267, DOI 10.1016/j.geomorph.2007.02.019; TACHET H, 1992, J N AM BENTHOL SOC, V11, P350, DOI 10.2307/1467557; Takao A, 2006, J N AM BENTHOL SOC, V25, P545, DOI 10.1899/0887-3593(2006)25[545:PIOANC]2.0.CO;2; Tal M, 2007, GEOLOGY, V35, P347, DOI 10.1130/G23260A.1; Tilman D., 1982, Monographs in Population Biology, pi; WIBERG PL, 1987, WATER RESOUR RES, V23, P1471, DOI 10.1029/90WR02770; Wiggins GB, 1977, LARVAE N AM CADDISFL; Wilcock PR, 1996, WATER RESOUR RES, V32, P3361, DOI 10.1029/96WR02277; Wong MG, 2006, J HYDRAUL ENG, V132, P1159, DOI 10.1061/(ASCE)0733-9429(2006)132:11(1159)	54	21	21	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e103417	10.1371/journal.pone.0103417	http://dx.doi.org/10.1371/journal.pone.0103417			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25101964	Green Published, gold, Green Submitted			2022-12-27	WOS:000339993900017
J	Bosch, MK; Nerbonne, JM; Ornitz, DM				Bosch, Marie K.; Nerbonne, Jeanne M.; Ornitz, David M.			Dual Transgene Expression in Murine Cerebellar Purkinje Neurons by Viral Transduction In Vivo	PLOS ONE			English	Article							RAT SUBSTANTIA-NIGRA; LENTIVIRAL VECTORS; GENE-EXPRESSION; FIBROBLAST-GROWTH-FACTOR-14 GENE; SPINOCEREBELLAR ATAXIA; MULTIPLE PROTEINS; INITIAL SEGMENT; NERVOUS-SYSTEM; CULTURED-CELLS; MUTATION	Viral-vector mediated gene transfer to cerebellar Purkinje neurons in vivo is a promising avenue for gene therapy of cerebellar ataxias and for genetic manipulation in functional studies of animal models of cerebellar disease. Here, we report the results of experiments designed to identify efficient methods for viral transduction of adult murine Purkinje neurons in vivo. For these analyses, several lentiviral and an adeno-associated virus (AAV), serotype 1, vector with various promoter combinations were generated and compared for in situ transduction efficiency, assayed by fluorescent reporter protein expression in Purkinje neurons. Additional experiments were also conducted to identify the optimal experimental strategy for co-expression of two proteins in individual Purkinje neurons. Of the viruses tested, AAV1 with a CAG promoter exhibited the highest specificity for Purkinje neurons. To deliver two proteins to the same Purkinje neuron, several methods were tested, including: an internal ribosome entry site (IRES), a 2A sequence, a dual promoter vector, and co-injection of two viruses. Efficient expression of both proteins in the same Purkinje neuron was only achieved by co-injecting two AAV1-CAG viruses. We found that use of an AAV1-CAG virus outperformed similar lentivirus vectors and that co-injection of two AAV1-CAG viruses could be used to efficiently deliver two proteins to the same Purkinje neuron in adult mice. AAV1 with a CAG promoter is highly efficient and selective at transducing adult cerebellar Purkinje neurons and two AAV-CAG viruses can be used to efficiently express two proteins in the same neuron in vivo.	[Bosch, Marie K.; Nerbonne, Jeanne M.; Ornitz, David M.] Washington Univ, Sch Med, St Louis, MO 63130 USA	Washington University (WUSTL)	Ornitz, DM (corresponding author), Washington Univ, Sch Med, St Louis, MO 63130 USA.	dornitz@wustl.edu		Ornitz, David/0000-0003-1592-7629	NIH [R01NS065761, T32 GM007200, T32 HL007275, P30 NS057105]; Genome Institute at Washington University; Children's Discovery Institute [CDI-LI-2010-94]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007275] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007200] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065761, P30NS057105] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Genome Institute at Washington University; Children's Discovery Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH Grant# R01NS065761 (DMO, JMN). MKB was supported by NIH Grant# T32 GM007200 and NIH Grant# T32 HL007275. The Hope Center Viral Vectors Core is supported by a Neuroscience Blueprint Core Grant# P30 NS057105 from NIH to Washington University. The Washington University RNAi Core is supported by the Genome Institute at Washington University and the Children's Discovery Institute (CDI-LI-2010-94). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alisky JM, 2000, NEUROREPORT, V11, P2669, DOI 10.1097/00001756-200008210-00013; Apps R, 2005, NAT REV NEUROSCI, V6, P297, DOI 10.1038/nrn1646; Borman AM, 1997, NUCLEIC ACIDS RES, V25, P925, DOI 10.1093/nar/25.5.925; Brusse E, 2006, MOVEMENT DISORD, V21, P396, DOI 10.1002/mds.20708; CELIO MR, 1990, NEUROSCIENCE, V35, P375, DOI 10.1016/0306-4522(90)90091-H; CHALLITA PM, 1995, J VIROL, V69, P748, DOI 10.1128/JVI.69.2.748-755.1995; Croci C, 2006, DEV NEUROSCI-BASEL, V28, P216, DOI 10.1159/000091919; Dalski A, 2005, EUR J HUM GENET, V13, P118, DOI 10.1038/sj.ejhg.5201286; de Felipe P, 2006, TRENDS BIOTECHNOL, V24, P68, DOI 10.1016/j.tibtech.2005.12.006; de Felipe P, 2010, BIOTECHNOL J, V5, P213, DOI 10.1002/biot.200900134; Delzor A, 2012, HUM GENE THER METHOD; Dittgen T, 2004, P NATL ACAD SCI USA, V101, P18206, DOI 10.1073/pnas.0407976101; Dodge JC, 2005, P NATL ACAD SCI USA, V102, P17822, DOI 10.1073/pnas.0509062102; Donnelly MLL, 2001, J GEN VIROL, V82, P1027, DOI 10.1099/0022-1317-82-5-1027; Donnelly MLL, 2001, J GEN VIROL, V82, P1013, DOI 10.1099/0022-1317-82-5-1013; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; EMERMAN M, 1984, CELL, V39, P459, DOI 10.1016/0092-8674(84)90453-7; Furler S, 2001, GENE THER, V8, P864, DOI 10.1038/sj.gt.3301469; Gascon S, 2008, J NEUROSCI METH, V168, P104, DOI 10.1016/j.jneumeth.2007.09.023; Goenawan H, 2012, J NEUROVIROL, V18, P521, DOI 10.1007/s13365-012-0134-x; Jakobsson J, 2003, J NEUROSCI RES, V73, P876, DOI 10.1002/jnr.10719; Kaemmerer WF, 2000, MOL THER, V2, P446, DOI 10.1006/mthe.2000.0134; Kim JY, 2013, EUR J NEUROSCI, V37, P1203, DOI 10.1111/ejn.12126; Kim JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018556; Klein RL, 2002, HUM GENE THER, V13, P605, DOI 10.1089/10430340252837206; Kobayashi H, 2005, MOL THER, V11, P776, DOI 10.1016/j.ymthe.2004.10.006; KORDELI E, 1995, J BIOL CHEM, V270, P2352, DOI 10.1074/jbc.270.5.2352; Kuroda H, 2008, J GENE MED, V10, P1163, DOI 10.1002/jgm.1249; Laezza F, 2007, J NEUROSCI, V27, P12033, DOI 10.1523/JNEUROSCI.2282-07.2007; Li MJ, 2010, J NEUROSCI METH, V189, P56, DOI 10.1016/j.jneumeth.2010.03.019; Li MJ, 2007, CSH PROTOC 2007 PDB, V2007; Lou JY, 2005, J PHYSIOL-LONDON, V569, P179, DOI 10.1113/jphysiol.2005.097220; Manoonkitiwongsa PS, 2002, HISTOCHEM J, V34, P365; Manto M, 2009, CURR OPIN NEUROL, V22, P419, DOI 10.1097/WCO.0b013e32832b9897; McEwen DP, 2004, J BIOL CHEM, V279, P16044, DOI 10.1074/jbc.M400856200; Misceo D, 2009, NEUROGENETICS; Mizuguchi H, 2000, MOL THER, V1, P376, DOI 10.1006/mthe.2000.0050; Ngoi SM, 2004, CURR GENE THER, V4, P15, DOI 10.2174/1566523044578095; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Ohashi Y, 2011, MOL CELL NEUROSCI, V46, P136, DOI 10.1016/j.mcn.2010.08.013; Okubo Y, 2001, NEURON, V32, P113, DOI 10.1016/S0896-6273(01)00464-0; Ramesh N, 1996, NUCLEIC ACIDS RES, V24, P2697, DOI 10.1093/nar/24.14.2697; Ramezani A, 2000, MOL THER, V2, P458, DOI 10.1006/mthe.2000.0190; Rendahl KG, 1998, NAT BIOTECHNOL, V16, P757, DOI 10.1038/nbt0898-757; Rothwell DG, 2010, HUM GENE THER, V21, P1631, DOI 10.1089/hum.2009.197; Shakkottai VG, 2009, NEUROBIOL DIS, V33, P81, DOI 10.1016/j.nbd.2008.09.019; Shearwin KE, 2005, TRENDS GENET, V21, P339, DOI 10.1016/j.tig.2005.04.009; Stegmeier F, 2005, P NATL ACAD SCI USA, V102, P13212, DOI 10.1073/pnas.0506306102; Szymczak-Workman Andrea L, 2012, Cold Spring Harb Protoc, V2012, P199, DOI 10.1101/pdb.ip067876; Takayama K, 2008, NEUROSCI LETT, V443, P7, DOI 10.1016/j.neulet.2008.07.058; Tang W, 2009, J NEUROSCI, V29, P8621, DOI 10.1523/JNEUROSCI.0359-09.2009; Torashima T, 2006, BRAIN RES, V1082, P11, DOI 10.1016/j.brainres.2006.01.104; Torashima T, 2006, EUR J NEUROSCI, V24, P371, DOI 10.1111/j.1460-9568.2006.04927.x; van Swieten JC, 2003, AM J HUM GENET, V72, P191, DOI 10.1086/345488; Wang Q, 2000, MECH DEVELOP, V90, P283, DOI 10.1016/S0925-4773(99)00241-5; Wang Q, 2002, NEURON, V35, P25, DOI 10.1016/S0896-6273(02)00744-4; Xia HB, 2004, NAT MED, V10, P816, DOI 10.1038/nm1076; Xiao ML, 2013, MOL CELL NEUROSCI, V56, P393, DOI 10.1016/j.mcn.2013.07.008; Yang S, 2008, GENE THER, V15, P1411, DOI 10.1038/gt.2008.90; Yu XB, 2003, MOL THER, V7, P827, DOI 10.1016/S1525-0016(03)00104-7; Zhang X, 2001, HISTOCHEM CELL BIOL, V115, P455; Zolotukhin S, 2002, METHODS, V28, P158, DOI 10.1016/S1046-2023(02)00220-7	62	13	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e104062	10.1371/journal.pone.0104062	http://dx.doi.org/10.1371/journal.pone.0104062			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093726	Green Submitted, Green Published, gold			2022-12-27	WOS:000341357200062
J	Chakraborty, A; Pasek, DA; Huang, TQ; Gomez, AC; Yamaguchi, N; Anderson, ME; Meissner, G				Chakraborty, Asima; Pasek, Daniel A.; Huang, Tai-Qin; Gomez, Angela C.; Yamaguchi, Naohiro; Anderson, Mark E.; Meissner, Gerhard			Inhibition of CaMKII Does Not Attenuate Cardiac Hypertrophy in Mice with Dysfunctional Ryanodine Receptor	PLOS ONE			English	Article							PROTEIN-KINASE-II; HEART-FAILURE; CALMODULIN; PHOSPHORYLATION; DELTA; ISOFORM; SITE	In cardiac muscle, the release of calcium ions from the sarcoplasmic reticulum through ryanodine receptor ion channels (RyR2s) leads to muscle contraction. RyR2 is negatively regulated by calmodulin (CaM) and by phosphorylation of Ca2+/CaM-dependent protein kinase II (CaMKII). Substitution of three amino acid residues in the CaM binding domain of RyR2 (RyR2-W3587A/L3591D/F3603A, RyR2(ADA)) impairs inhibition of RyR2 by CaM and results in cardiac hypertrophy and early death of mice carrying the RyR2(ADA) mutation. To test the cellular function of CaMKII in cardiac hypertrophy, mutant mice were crossed with mice expressing the CaMKII inhibitory AC3-I peptide or the control AC3-C peptide in the myocardium. Inhibition of CaMKII by AC3-I modestly reduced CaMKII-dependent phosphorylation of RyR2 at Ser-2815 and markedly reduced CaMKII-dependent phosphorylation of SERCA2a regulatory subunit phospholamban at Thr-17. However the average life span and heart-to-body weight ratio of Ryr2(ADA/ADA) mice expressing the inhibitory peptide were not altered compared to control mice. In Ryr2(ADA/ADA) homozygous mice, AC3-I did not alter cardiac morphology, enhance cardiac function, improve sarcoplasmic reticulum Ca2+ handling, or suppress the expression of genes implicated in cardiac remodeling. The results suggest that CaMKII was not required for the rapid development of cardiac hypertrophy in Ryr2(ADA/ADA) mice.	[Chakraborty, Asima; Pasek, Daniel A.; Huang, Tai-Qin; Meissner, Gerhard] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27514 USA; [Gomez, Angela C.; Yamaguchi, Naohiro] Med Univ S Carolina, Dept Regenerat Med & Cell Biol, Charleston, SC 29425 USA; [Anderson, Mark E.] Univ Iowa, Dept Internal Med, Div Cardiovasc Med, Iowa City, IA 52242 USA; [Anderson, Mark E.] Univ Iowa, Dept Mol Physiol & Biophys, Div Cardiovasc Med, Iowa City, IA USA	University of North Carolina; University of North Carolina Chapel Hill; Medical University of South Carolina; University of Iowa; University of Iowa	Meissner, G (corresponding author), Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27514 USA.	meissner@med.unc.edu	Huang, Taiqin/J-7827-2019	Gomez, Angela/0000-0001-7019-9607	National Institutes of Health [HL070250, HL079031, HL096652, HL113001, AR061030]; American Heart Association [10SDG3500001]; National Science Foundation [EPS0903795, HL073051]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096652, R01HL079031, R01HL113001, R01HL070250] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR061030] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); National Science Foundation(National Science Foundation (NSF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Support of National Institutes of Health grants HL070250, HL079031, HL096652, HL113001 (to MEA), AR061030, American Heart Association grant 10SDG3500001 and National Science Foundation grant EPS0903795 (to NY), and HL073051 (to GM) are gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson ME, 2011, J MOL CELL CARDIOL, V51, P468, DOI 10.1016/j.yjmcc.2011.01.012; Anderson ME, 2004, TRENDS CARDIOVAS MED, V14, P152, DOI 10.1016/j.tcm.2004.02.005; Backs J, 2006, J CLIN INVEST, V116, P1853, DOI 10.1172/JCI27438; Backs J, 2009, P NATL ACAD SCI USA, V106, P2342, DOI 10.1073/pnas.0813013106; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Bossuyt J, 2008, CIRC RES, V102, P695, DOI 10.1161/CIRCRESAHA.107.169755; Caron KMI, 2004, P NATL ACAD SCI USA, V101, P3106, DOI 10.1073/pnas.0307333101; Chu GX, 2000, J BIOL CHEM, V275, P38938, DOI 10.1074/jbc.M004079200; Fischer TH, 2013, CIRCULATION, V128, P970, DOI 10.1161/CIRCULATIONAHA.113.001746; Halling DB, 2005, SCI STKE, V20, pre15; Khoo MSC, 2005, HEART RHYTHM, V2, P634, DOI 10.1016/j.hrthm.2005.03.019; Kim HS, 2002, P NATL ACAD SCI USA, V99, P4602, DOI 10.1073/pnas.072083799; Li BL, 2006, BBA-MOL CELL RES, V1763, P1275, DOI 10.1016/j.bbamcr.2006.09.029; Li N, 2012, CIRC RES, V110, P465, DOI 10.1161/CIRCRESAHA.111.253229; Ling HY, 2009, J CLIN INVEST, V119, P1230, DOI 10.1172/JCI38022; Maier LS, 2007, CARDIOVASC RES, V73, P631, DOI 10.1016/j.cardiores.2006.11.005; Mattiazzi A, 2011, HEART RHYTHM, V8, P784, DOI 10.1016/j.hrthm.2010.11.035; McCauley MD, 2011, TRENDS CARDIOVAS MED, V21, P48, DOI 10.1016/j.tcm.2012.02.004; Respress JL, 2012, CIRC RES, V110, P1474, DOI 10.1161/CIRCRESAHA.112.268094; Rokita AG, 2012, CIRCULATION, V126, P2125, DOI 10.1161/CIRCULATIONAHA.112.124990; Rozengurt E, 2005, J BIOL CHEM, V280, P13205, DOI 10.1074/jbc.R500002200; Said M, 2011, J MOL CELL CARDIOL, V51, P936, DOI 10.1016/j.yjmcc.2011.08.010; Singh MV, 2009, J CLIN INVEST, V119, P986, DOI 10.1172/JCI35814; Sossalla S, 2010, CIRC RES, V107, P1150, DOI 10.1161/CIRCRESAHA.110.220418; Steinberg SF, 2012, MOL PHARMACOL, V81, P284, DOI 10.1124/mol.111.075986; Sutko JL, 1997, PHARMACOL REV, V49, P53; Swaminathan PD, 2012, CIRC RES, V110, P1661, DOI 10.1161/CIRCRESAHA.111.243956; van Oort RJ, 2010, CIRCULATION, V122, P2669, DOI 10.1161/CIRCULATIONAHA.110.982298; Vega RB, 2004, MOL CELL BIOL, V24, P8374, DOI 10.1128/MCB.24.19.8374-8385.2004; Wehrens XHT, 2004, CIRC RES, V94, pE61, DOI 10.1161/01.RES.0000125626.33738.E2; WITCHER DR, 1991, J BIOL CHEM, V266, P11144; Yamaguchi N, 2007, J CLIN INVEST, V117, P1344, DOI 10.1172/JCI29515; Yamaguchi N, 2013, AM J PHYSIOL-HEART C, V305, pH86, DOI 10.1152/ajpheart.00144.2013; Yamaguchi N, 2011, AM J PHYSIOL-HEART C, V300, pH2187, DOI 10.1152/ajpheart.00719.2010; Yang YB, 2006, AM J PHYSIOL-HEART C, V291, pH3065, DOI 10.1152/ajpheart.00353.2006; Zhang R, 2005, NAT MED, V11, P409, DOI 10.1038/nm1215; Zhang T, 2004, CARDIOVASC RES, V63, P476, DOI 10.1016/j.cardiores.2004.04.026; Zhang T, 2002, J BIOL CHEM, V277, P1261, DOI 10.1074/jbc.M108525200; Zhang T, 2007, J BIOL CHEM, V282, P35078, DOI 10.1074/jbc.M707083200	39	6	6	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e104338	10.1371/journal.pone.0104338	http://dx.doi.org/10.1371/journal.pone.0104338			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093823	Green Published, gold, Green Submitted			2022-12-27	WOS:000341357200099
J	Chen, J; Zhao, J; Ma, R; Lin, H; Liang, X; Cai, XJ				Chen, Jiang; Zhao, Jie; Ma, Rui; Lin, Hui; Liang, Xiao; Cai, Xiujun			Prognostic Significance of E-Cadherin Expression in Hepatocellular Carcinoma: A Meta-Analysis	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; BETA-CATENIN EXPRESSION; PRIMARY LIVER-CANCER; POOR-PROGNOSIS; ALPHA-CATENIN; METASTASIS; ACTIVATION; MORTALITY; IMPACT; HYPERMETHYLATION	Backgrounds: Hepatocellular Carcinoma (HCC) is one of the most common malignancy of liver and HCC-related morbidity and mortality remains at high level. Researchers had investigated whether and how reduced E-cadherin expression impacted the prognosis of patients with HCC but the results reported by different teams remain inconclusive. Methods: A systematic literature search was performed in all available databases to retrieve eligible studies and identify all relevant data, which could be used to evaluate the correlation between reduced E-cadherin expression and clinicopathological features and prognosis for HCC patients. A fixed or random effects model was used in this meta-analysis to calculate the pooled odds ratios (OR) and weighted mean differences (WMD) with 95% confidence intervals (CI). Results: Total 2439 patients in thirty studies matched the selection criteria. Aggregation of the data suggested that reduced E-cadherin expression in HCC patients correlated with poor 1-, 3- and 5-year overall survival. The combined ORs were 0.50 (n = 13 studies, 95% CI: 0.37-0.67, Z = 4.49, P<0.00001), 0.39 (n = 13 studies, 95% CI: 0.28-0.56, Z = 5.12, P<0.00001), 0.40 (n = 11 studies, 95% CI: 0.25-0.64, Z = 3.82, P = 0.0001), respectively. Additionally, the pooled analysis denoted that reduced E-cadherin expression negatively impacts recurrence-free survival (RSF) with no significant heterogeneity. The pooled ORs for 1-, 3- and 5-year RSF affected by down-regulated E-cadherin were 0.73 (n = 6 studies, 95% CI: 0.54-1.00, Z = 1.95, P = 0.05), 0.70 (n = 6 studies, 95% CI: 0.52-0.95, Z = 2.32, P = 0.02), 0.66 (n = 5 studies, 95% CI: 0.48-0.90, Z = 2.64, P = 0.008). And what's more, reduced E-cadherin expression tended to be significantly associated with metastasis (OR = 0.31, 95% CI: 0.16-0.60, Z = 3.50, P = 0.0005), vascular invasion (OR = 0.76, 95% CI: 0.59-0.98, Z = 2.14, P = 0.03), advanced differentiation grade (OR = 0.31, 95% CI: 0.21-0.45, Z = 6.04, P<0.00001) and advanced TMN stage (T3/T4 versus T1/T2) (OR = 0.61,95% CI: 0.38-0.98, Z = 2.05, P = 0.04). Conclusions: Reduced E-cadherin expression indicates a poor prognosis for patients with HCC, and it may have predictive potential for prognosis of HCC patients.	[Chen, Jiang; Zhao, Jie; Lin, Hui; Liang, Xiao; Cai, Xiujun] Zhejiang Univ, Coll Med, Sir Run Run Shaw Hosp, Dept Gen Surg,Inst Minimally Invas Surg, Hangzhou 310003, Zhejiang, Peoples R China; [Ma, Rui] Zhejiang Univ, Zhejiang Univ Hosp, Dept Surg, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Cai, XJ (corresponding author), Zhejiang Univ, Coll Med, Sir Run Run Shaw Hosp, Dept Gen Surg,Inst Minimally Invas Surg, Hangzhou 310003, Zhejiang, Peoples R China.	cxjzu@hotmail.com		Ma, Rui/0000-0001-8226-6571				Altekruse SF, 2014, AM J GASTROENTEROL, V109, P542, DOI 10.1038/ajg.2014.11; Arias AM, 2001, CELL, V105, P425, DOI 10.1016/S0092-8674(01)00365-8; Asayama Y, 2002, LIVER, V22, P43, DOI 10.1046/j.0106-9543.2001.01580.x; Breier G, 2014, CELL TISSUE RES, V355, P523, DOI 10.1007/s00441-014-1851-7; Chen J, 2014, J CANCER RES CLIN, V140, P1205, DOI 10.1007/s00432-014-1644-0; Chen ZG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063854; Cho SB, 2008, PATHOL INT, V58, P635, DOI 10.1111/j.1440-1827.2008.02282.x; Ding SM, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-164; Du GS, 2009, ANN SURG ONCOL, V16, P1578, DOI 10.1245/s10434-009-0423-7; Endo K, 2000, HUM PATHOL, V31, P558, DOI 10.1053/hp.2000.6683; Fan CC, 2013, J CANCER RES CLIN, V139, P1735, DOI 10.1007/s00432-013-1499-9; Fox R, 2014, BRIT J CANCER, V110, P2090, DOI 10.1038/bjc.2014.130; Gao J, 2013, EUR J CANCER PREV, V22, P448, DOI 10.1097/CEJ.0b013e32835de82a; Guo C, 2008, HEPATOB PANCREAT DIS, V7, P490; Hashiguchi M, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-572; He X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070858; Herath NI, 2004, J GASTROEN HEPATOL, V19, P676, DOI 10.1111/j.1440-1746.2004.03361.x; Higashi Y, 2007, J SURG RES, V139, P68, DOI 10.1016/j.jss.2006.08.038; Ihara A, 1996, HEPATOLOGY, V23, P1441, DOI 10.1053/jhep.1996.v23.pm0008675162; Jiang XM, 2012, ASIAN PAC J CANCER P, V13, P6455, DOI 10.7314/APJCP.2012.13.12.6455; Jung SP, 2013, J BREAST CANCER, V16, P16, DOI 10.4048/jbc.2013.16.1.16; Katanoda K, 2013, JPN J CLIN ONCOL, V43, P492, DOI 10.1093/jjco/hyt038; Korita PV, 2008, HUM PATHOL, V39, P1777, DOI 10.1016/j.humpath.2008.05.006; Kwon GY, 2005, J KOREAN MED SCI, V20, P242, DOI 10.3346/jkms.2005.20.2.242; Ladep NG, 2014, WORLD J GASTROENTERO, V20, P1544, DOI 10.3748/wjg.v20.i6.1544; Lee HJ, 2014, GUT LIVER, V8, P177, DOI 10.5009/gnl.2014.8.2.177; Lee S, 2003, AM J PATHOL, V163, P1371, DOI 10.1016/S0002-9440(10)63495-5; Lee SC, 2014, WORLD J GASTROENTERO, V20, P3112, DOI 10.3748/wjg.v20.i12.3112; Li WQ, 2014, HEPATOLOGY; Liu J, 2006, ONCOGENE, V25, P1008, DOI 10.1038/sj.onc.1209138; Liu TA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057968; Luo SL, 2014, TUMOR BIOL; Matsumura T, 2001, CLIN CANCER RES, V7, P594; Ozaki K, 2014, J CANCER, V5, P221, DOI 10.7150/jca.7691; Pan JJ, 2013, J CANCER RES CLIN, V139, P1043, DOI 10.1007/s00432-013-1415-3; Pectasides E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094273; Pryczynicz A, 2014, TUMOR BIOL; Satoshi I, 2002, CLIN CANCER RES, V8, P450; Sekar P, 2014, J ONCOL, V2014, DOI 10.1155/2014/702527; Tanaka Y, 2013, CANCER BIOL THER, V14, P13, DOI 10.4161/cbt.22625; Wei Y, 2002, HEPATOLOGY, V36, P692, DOI 10.1053/jhep.2002.35342; Woo Hyun Young, 2011, Korean J Hepatol, V17, P12, DOI 10.3350/kjhep.2011.17.1.12; Wu LQ, 2008, CLIN CHEM LAB MED, V46, P1122, DOI 10.1515/CCLM.2008.231; Xia HP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044206; Xia LM, 2013, HEPATOLOGY, V57, P610, DOI 10.1002/hep.26029; Xing XB, 2013, INT J CANCER, V132, P2589, DOI 10.1002/ijc.27947; Xu XL, 2014, DIS ESOPHAGUS, V27, P79, DOI 10.1111/dote.12024; Yamaoka H, 2006, ONCOL REP, V15, P551; YAMAOKA K, 1995, J HEPATOL, V22, P536, DOI 10.1016/0168-8278(95)80447-1; Yip B, 2014, DIGEST DIS SCI, V59, P192, DOI 10.1007/s10620-013-2948-7; Zhai B, 2008, WORLD J GASTROENTERO, V14, P5665, DOI 10.3748/wjg.14.5665; Zhan Ping, 2014, Hepatobiliary Surg Nutr, V3, P11, DOI 10.3978/j.issn.2304-3881.2014.01.03; Zhang CH, 2012, J SURG RES, V174, P120, DOI 10.1016/j.jss.2010.10.030; Zhang L, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-108; Zhao XL, 2011, J CELL MOL MED, V15, P691, DOI 10.1111/j.1582-4934.2010.01052.x	55	24	25	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e103952	10.1371/journal.pone.0103952	http://dx.doi.org/10.1371/journal.pone.0103952			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093414	Green Published, Green Submitted, gold			2022-12-27	WOS:000341357200049
J	Huang, CL; Iqbal, U; Nguyen, PA; Chen, ZF; Clinciu, DL; Hsu, YHE; Hsu, CH; Jian, WS				Huang, Chen-Ling; Iqbal, Usman; Phung-Anh Nguyen; Chen, Zih-Fang; Clinciu, Daniel L.; Hsu, Yi-Hsin Elsa; Hsu, Chung-Huei; Jian, Wen-Shan			Using Hemoglobin A1C as a Predicting Model for Time Interval from Pre-Diabetes Progressing to Diabetes	PLOS ONE			English	Article							IDENTIFYING DYSGLYCEMIC STATES; GLYCATED HEMOGLOBIN; GLUCOSE; DIAGNOSIS; HBA(1C); INDIVIDUALS; MARKER	Objective: The early identification of subjects at high risk for diabetes is essential, thus, random rather than fasting plasma glucose is more useful. We aim to evaluate the time interval between pre-diabetes to diabetes with anti-diabetic drugs by using HbA1C as a diagnostic tool, and predicting it using a mathematic model. Methods: We used the Taipei Medical University Affiliated Hospital Patient Profile Database (AHPPD) from January-2007 to June-2011. The patients who progressed and were prescribed anti-diabetic drugs were selected from AHPPD. The mathematical model used to predict the time interval of HbA1C value ranged from 5.7% to 6.5% for diabetes progression. Results: We predicted an average overall time interval for all participants in between 5.7% to 6.5% during a total of 907 days (standard error, 103 days). For each group found among 5.7% to 6.5% we determined 1169.3 days for the low risk group (i.e 3.2 years), 1080.5 days (i.e 2.96 years) for the increased risk group and 729.4 days (i.e 1.99 years) for the diabetes group. This indicates the patients will take an average of 2.49 years to reach 6.5%. Conclusion: This prediction model is very useful to help prioritize the diagnosis at an early stage for targeting individuals with risk of diabetes. Using patients' HbA1C before anti-diabetes drugs are used we predicted the time interval from prediabetes progression to diabetes is 2.49 years without any influence of age and gender. Additional studies are needed to support this model for a long term prediction.	[Huang, Chen-Ling] Taipei Med Univ Hosp, Div Endocrinol & Metab, Dept Internal Med, Taipei, Taiwan; [Iqbal, Usman; Phung-Anh Nguyen] Taipei Med Univ, Grad Inst Biomed Informat, Coll Med Sci & Technol, Taipei, Taiwan; [Chen, Zih-Fang; Hsu, Yi-Hsin Elsa; Jian, Wen-Shan] Taipei Med Univ, Sch Hlth Care Adm, Taipei, Taiwan; [Clinciu, Daniel L.] Taipei Med Univ, Coll Med Sci & Technol, Translat Med Program, Taipei, Taiwan; [Hsu, Chung-Huei] Taipei Med Univ Hosp, Dept Nucl Med, Taipei, Taiwan	Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital	Jian, WS (corresponding author), Taipei Med Univ, Sch Hlth Care Adm, Taipei, Taiwan.	jjtmutw@gmail.com	Iqbal, Usman/L-2467-2016	Jian, Wen-Shan/0000-0002-1739-4398	Department of Health, Executive Yuan, Taiwan [DOH101-TD -C-111-008]	Department of Health, Executive Yuan, Taiwan	This research is sponsored in part by Department of Health, Executive Yuan, Taiwan under grants DOH101-TD -C-111-008. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamska E, 2012, ADV MED SCI-POLAND, V57, P296, DOI 10.2478/v10039-012-0030-x; [Anonymous], 2013, Diabetes Care, V36 Suppl 1, pS1, DOI 10.2337/dc13-S001; Bao YQ, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2249; Barak V, 2011, ANTICANCER RES, V31, P345; Basevi V, 2011, DIABETES CARE, V34, P1887, DOI 10.2337/dc11-s011; Bonora E, 2011, DIABETES CARE, V34, pS184, DOI 10.2337/dc11-s216; Borg R, 2010, DIABETIC MED, V27, P906, DOI 10.1111/j.1464-5491.2010.03034.x; Chang T-J, 2012, J FORMOSAN MED ASS; Cheng PY, 2011, DIABETES CARE, V34, P610, DOI 10.2337/dc10-0625; d'Emden MC, 2012, MED J AUSTRALIA, V197, P220, DOI 10.5694/mja12.10988; Droumaguet C, 2006, DIABETES CARE, V29, P1619, DOI 10.2337/dc05-2525; Drzewoski J, 2010, POL ARCH MED WEWN, V120, P109, DOI 10.20452/pamw.901; Edwards R., 1948, TECHNICAL ANAL STOCK; Ehrenberg R., 2011, MODERN LABOR EC THEO; Geiss LS, 2010, AM J PREV MED, V38, P403, DOI 10.1016/j.amepre.2009.12.029; Gillies CL, 2007, BMJ-BRIT MED J, V334, P299, DOI 10.1136/bmj.39063.689375.55; Goodall Ian, 2005, Clin Biochem Rev, V26, P5; Harris MI, 1998, DIABETES CARE, V21, pC11, DOI 10.2337/diacare.21.3.C11; Herman William H, 2009, J Diabetes Sci Technol, V3, P656; Jakob S, 2000, COMPUT METH PROG BIO, V63, P203, DOI 10.1016/S0169-2607(00)00110-3; Khovanova N, 2012, COMPUTER METHODS PRO; Ko GTC, 2000, DIABETES CARE, V23, P1770, DOI 10.2337/diacare.23.12.1770; KOENIG RJ, 1976, NEW ENGL J MED, V295, P417, DOI 10.1056/NEJM197608192950804; Krugman P., 1988, INT EC THEORY POLICY; Laidler, 1993, DEMAND MONEY THEORIE; Lipska KJ, 2010, J CLIN ENDOCR METAB, V95, P5289, DOI 10.1210/jc.2010-1171; Lorenzo C, 2010, DIABETES CARE, V33, P2104, DOI 10.2337/dc10-0679; Lu ZX, 2010, DIABETES CARE, V33, P817, DOI 10.2337/dc09-1763; Manley S, 2003, CLIN CHEM LAB MED, V41, P1182, DOI 10.1515/CCLM.2003.182; McCabe RM, 2008, ADV PATIENT SAFETY N; Mellitus D., 2011, DIABETES CARE, V27, pS5; Meyer M, 2012, INT J MED ROBOT COMP, V8, P448, DOI 10.1002/rcs.1455; Mohan V, 2010, DIABETES CARE, V33, P515, DOI 10.2337/dc09-1694; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; Sacks DB, 2002, CLIN CHEM, V48, P436; Saudek CD, 2008, J CLIN ENDOCR METAB, V93, P2447, DOI 10.1210/jc.2007-2174; Selvin E, 2011, DIABETES CARE, V34, P84, DOI 10.2337/dc10-1235; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; van 't Riet E, 2010, DIABETES CARE, V33, P61, DOI 10.2337/dc09-0677; World Health Organization-WHO, 2011, US GLYC HAEM HBALC D	40	5	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e104263	10.1371/journal.pone.0104263	http://dx.doi.org/10.1371/journal.pone.0104263			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093755	Green Published, Green Submitted, gold			2022-12-27	WOS:000341357200090
J	Lopez, S; Garcia, O; Yurrebaso, I; Flores, C; Acosta-Herrera, M; Chen, H; Gardeazabal, J; Careaga, JM; Boyano, MD; Sanchez, A; Raton-Nieto, JA; Sevilla, A; Smith-Zubiaga, I; de Galdeano, AG; Martinez-Cadenas, C; Izagirre, N; de la Rua, C; Alonso, S				Lopez, Saioa; Garcia, Oscar; Yurrebaso, Inaki; Flores, Carlos; Acosta-Herrera, Marialbert; Chen, Hua; Gardeazabal, Jesus; Maria Careaga, Jesus; Dolores Boyano, Maria; Sanchez, Ana; Antonio Raton-Nieto, Juan; Sevilla, Arrate; Smith-Zubiaga, Isabel; Garcia de Galdeano, Alicia; Martinez-Cadenas, Conrado; Izagirre, Neskuts; de la Rua, Concepcion; Alonso, Santos			The Interplay between Natural Selection and Susceptibility to Melanoma on Allele 374F of SLC45A2 Gene in a South European Population	PLOS ONE			English	Article							RECENT POSITIVE SELECTION; SKIN PIGMENTATION; MATP GENE; VITAMIN-D; GENOME; EVOLUTION; VARIANTS; POLYMORPHISM; ASSOCIATION; COLOR	We aimed to study the selective pressures interacting on SLC45A2 to investigate the interplay between selection and susceptibility to disease. Thus, we enrolled 500 volunteers from a geographically limited population (Basques from the North of Spain) and by resequencing the whole coding region and intron 5 of the 34 most and the 34 least pigmented individuals according to the reflectance distribution, we observed that the polymorphism Leu374Phe (L374F, rs16891982) was statistically associated with skin color variability within this sample. In particular, allele 374F was significantly more frequent among the individuals with lighter skin. Further genotyping an independent set of 558 individuals of a geographically wider population with known ancestry in the Spanish population also revealed that the frequency of L374F was significantly correlated with the incident UV radiation intensity. Selection tests suggest that allele 374F is being positively selected in South Europeans, thus indicating that depigmentation is an adaptive process. Interestingly, by genotyping 119 melanoma samples, we show that this variant is also associated with an increased susceptibility to melanoma in our populations. The ultimate driving force for this adaptation is unknown, but it is compatible with the vitamin D hypothesis. This shows that molecular evolution analysis can be used as a useful technology to predict phenotypic and biomedical consequences in humans.	[Lopez, Saioa; Sevilla, Arrate; Izagirre, Neskuts; de la Rua, Concepcion; Alonso, Santos] Univ Basque Country UPV EHU, Dept Genet Phys Anthropol & Anim Physiol, Leioa, Bizkaia, Spain; [Garcia, Oscar; Yurrebaso, Inaki] Ertzaintza Forens Unit, Erandio, Bizkaia, Spain; [Flores, Carlos; Acosta-Herrera, Marialbert] Inst Salud Carlos III, CIBER Enfermedades Resp, Madrid, Spain; [Flores, Carlos; Acosta-Herrera, Marialbert] Hosp Univ NS Candelaria, Res Unit, Tenerife, Spain; [Flores, Carlos] Univ La Laguna, Inst Univ Enfermedades Trop & Salud Publ Canarias, Genet Lab, G2A, Tenerife, Spain; [Acosta-Herrera, Marialbert] Univ Hosp Dr Negrin, Res Unit, Las Palmas Gan Canaria, Spain; [Chen, Hua] Temple Univ, Ctr Computat Genet & Genom, Philadelphia, PA 19122 USA; [Gardeazabal, Jesus; Antonio Raton-Nieto, Juan] Cruces Univ Hosp, BioCruces Hlth Res Inst, Dermatol Serv, Cruces Barakaldo, Bizkaia, Spain; [Maria Careaga, Jesus; Sanchez, Ana] Basurto Univ Hosp, BioCruces Hlth Res Inst, Dermatol Serv, Bilbao, Bizkaia, Spain; [Dolores Boyano, Maria; Garcia de Galdeano, Alicia] Univ Basque Country UPV EHU, Dept Cell Biol & Histol, Leioa, Bizkaia, Spain; [Smith-Zubiaga, Isabel] Univ Basque Country UPV EHU, Dept Zool & Anim Cell Biol, Leioa, Bizkaia, Spain; [Martinez-Cadenas, Conrado] Jaume I Univ Castellon, Dept Med, Castellon de La Plana, Spain	University of Basque Country; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III; Universidad de la Laguna; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Hospital Universitario Cruces; Basurto Hospital; University of Basque Country; University of Basque Country; Universitat Jaume I	Lopez, S (corresponding author), Univ Basque Country UPV EHU, Dept Genet Phys Anthropol & Anim Physiol, Leioa, Bizkaia, Spain.	saioa.lopez@ehu.es	BOYANO LOPEZ, MARIA DOLORES/ABF-6668-2021; Flores, Carlos/R-1159-2019; Alonso, Santos/L-8316-2014; Martinez-Cadenas, Conrado/AAB-3266-2021; Smith-Zubiaga, Isabel/L-5176-2014	BOYANO LOPEZ, MARIA DOLORES/0000-0001-6051-1054; Alonso, Santos/0000-0003-0221-4048; Martinez-Cadenas, Conrado/0000-0002-5252-563X; DE LA RUA VACA, CONCEPCION/0000-0003-4599-0020; Smith Zubiaga, Isabel/0000-0002-4509-9492; Lopez, Saioa/0000-0003-2936-4070; Flores, Carlos/0000-0001-5352-069X; Sevilla Mambrilla, Arrate/0000-0002-4860-3359; IZAGIRRE ARRIBALZAGA, NESKUTS/0000-0002-3345-9825; Chen, Hua/0000-0002-9829-6561	Spanish Ministerio de Ciencia e Innovacion [CGL2008-04066/BOS]; Dpt. Educacion, Universidades e Investigacion of the Basque Government [IT542-10]; University of the Basque Country [UFI11/09]; Dept. Educacion, Universidades e Investigacion of the Basque Government [BFI09.248]; Programa de Investigacion Cientifica de la Universidad de La Laguna [boc-a-2010-255-7177]; Health Institute "Carlos III" [FIS PI11/00623]; European Regional Development Funds, "A way of making Europe" from the European Union; Instituto de Salud Carlos III [FI11/00074]	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Dpt. Educacion, Universidades e Investigacion of the Basque Government; University of the Basque Country; Dept. Educacion, Universidades e Investigacion of the Basque Government; Programa de Investigacion Cientifica de la Universidad de La Laguna; Health Institute "Carlos III"(Instituto de Salud Carlos III); European Regional Development Funds, "A way of making Europe" from the European Union; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	This work was supported by the former Spanish Ministerio de Ciencia e Innovacion, project CGL2008-04066/BOS to S.A.; by the Dpt. Educacion, Universidades e Investigacion of the Basque Government, project IT542-10 to C.R.; the University of the Basque Country program UFI11/09; a predoctoral fellowship from the Dept. Educacion, Universidades e Investigacion of the Basque Government to S.L. (BFI09.248); "Programa de Investigacion Cientifica de la Universidad de La Laguna" (boc-a-2010-255-7177) the Health Institute "Carlos III" (FIS PI11/00623) to C.F. and co-financed by the European Regional Development Funds, "A way of making Europe" from the European Union. M.A.H. was supported by a fellowship from the Instituto de Salud Carlos III (FI11/00074). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; American Cancer Society, 2012, CANC FACTS FIG; Amigo J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-428; Beleza S, 2013, MOL BIOL EVOL, V30, P24, DOI 10.1093/molbev/mss207; Bonilla C, 2005, HUM GENET, V116, P402, DOI 10.1007/s00439-004-1251-2; Botigue LR, 2013, P NATL ACAD SCI USA, V110, P11791, DOI 10.1073/pnas.1306223110; Box NF, 1997, HUM MOL GENET, V6, P1891, DOI 10.1093/hmg/6.11.1891; Branicki W, 2008, J HUM GENET, V53, P966, DOI 10.1007/s10038-008-0338-3; Bryc K, 2010, P NATL ACAD SCI USA, V107, P786, DOI 10.1073/pnas.0909559107; Chaplin G, 2009, AM J PHYS ANTHROPOL, V139, P451, DOI 10.1002/ajpa.21079; Chen H, 2013, G3-GENES GENOM GENET, V3, P1429, DOI 10.1534/g3.113.006197; de Gruijter Johanna Maria, 2011, Investig Genet, V2, P24, DOI 10.1186/2041-2223-2-24; de Vries E, 2005, BRIT MED J, V331, P698, DOI 10.1136/bmj.331.7518.698; Delaneau O, 2012, NAT METHODS, V9, P179, DOI [10.1038/NMETH.1785, 10.1038/nmeth.1785]; Donnelly MP, 2012, HUM GENET, V131, P683, DOI 10.1007/s00439-011-1110-x; Dooley CM, 2012, PIGM CELL MELANOMA R, V26, P205, DOI DOI 10.1111/PCMR; Edwards M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000867; Falush D, 2003, GENETICS, V164, P1567; Fernandez L, 2008, HUM MUTAT, V29, P1161, DOI 10.1002/humu.20804; FITZPATRICK TB, 1988, ARCH DERMATOL, V124, P869, DOI 10.1001/archderm.124.6.869; Garbe C, 2009, CLIN DERMATOL, V27, P3, DOI 10.1016/j.clindermatol.2008.09.001; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Gonzalez JR, 2007, BIOINFORMATICS, V23, P644, DOI 10.1093/bioinformatics/btm025; Graf J, 2005, HUM MUTAT, V25, P278, DOI 10.1002/humu.20143; Guedj M, 2008, HUM MUTAT, V29, P1154, DOI 10.1002/humu.20823; Gutenkunst RN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000695; Han JL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000074; Hellenthal G, 2007, BIOINFORMATICS, V23, P520, DOI 10.1093/bioinformatics/btl622; Henn BM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002397; Hunter-Zinck H, 2010, AM J HUM GENET, V87, P17, DOI 10.1016/j.ajhg.2010.05.018; Ibarrola-Villava M, 2012, EUR J CANCER, V48, P2183, DOI 10.1016/j.ejca.2012.03.006; Jablonski NG, 2012, J ROY COLL PHYS EDIN, V42, P58, DOI 10.4997/JRCPE.2012.114; Jablonski NG, 2000, J HUM EVOL, V39, P57, DOI 10.1006/jhev.2000.0403; Kanetsky PA, 2002, AM J HUM GENET, V70, P770, DOI 10.1086/339076; Lamason RL, 2005, SCIENCE, V310, P1782, DOI 10.1126/science.1116238; Lewis PO, 2002, GENETIC DATA ANAL CO; Li W. H, 1997, MOL EVOLUTION; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; LOOMIS WF, 1967, SCIENCE, V157, P501, DOI 10.1126/science.157.3788.501; Lucotte G, 2013, BIOCHEM GENET, V51, P655, DOI 10.1007/s10528-013-9595-8; Lucotte G, 2010, BIOCHEM GENET, V48, P26, DOI 10.1007/s10528-009-9289-4; Martinez-Cadenas C, 2013, MOL BIOL EVOL, V30, P2654, DOI 10.1093/molbev/mst158; Nakayama K, 2002, J HUM GENET, V47, P92, DOI 10.1007/s100380200007; Nan HM, 2009, INT J CANCER, V125, P909, DOI 10.1002/ijc.24327; Newton JM, 2001, AM J HUM GENET, V69, P981, DOI 10.1086/324340; Norton HL, 2007, MOL BIOL EVOL, V24, P710, DOI 10.1093/molbev/msl203; Parkin DM, 1997, CANC INCIDENCE 5 CON, VVII; Pino-Yanes M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018389; Prado-Martinez J, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-363; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Reissmann M, 2013, SEMIN CELL DEV BIOL, V24, P576, DOI 10.1016/j.semcdb.2013.03.014; Relethford JH, 2002, AM J PHYS ANTHROPOL, V118, P393, DOI 10.1002/ajpa.10079; Robbins AH, 1991, BIOL PERSPECTIVES HU; Rosenberg NA, 2005, PLOS GENET, V1, P660, DOI 10.1371/journal.pgen.0010070; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Shriver MD, 2003, HUM GENET, V112, P387, DOI 10.1007/s00439-002-0896-y; SILVERS WK (ED), 1979, COAT COLORS MICE MOD; Soejima M, 2006, MOL BIOL EVOL, V23, P179, DOI 10.1093/molbev/msj018; Stokowski RP, 2007, AM J HUM GENET, V81, P1119, DOI 10.1086/522235; TAJIMA F, 1989, GENETICS, V123, P597; THOMSON ML, 1951, J PHYSIOL-LONDON, V112, P31, DOI 10.1113/jphysiol.1951.sp004506; Tsetskhladze ZR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047398; VALVERDE P, 1995, NAT GENET, V11, P328, DOI 10.1038/ng1195-328; Wickham H, 2011, J STAT SOFTW, V40, P1, DOI 10.18637/jss.v040.i01; Wickham H, 2007, J STAT SOFTW, V21, P1; Yuasa I, 2007, BIOCHEM GENET, V45, P535, DOI 10.1007/s10528-007-9095-9; Yuasa I, 2006, ANN HUM GENET, V70, P802, DOI 10.1111/j.1469-1809.2006.00261.x; Yuasa I, 2004, INT J LEGAL MED, V118, P364, DOI 10.1007/s00414-004-0490-z; Zeng K, 2007, MOL BIOL EVOL, V24, P1898, DOI 10.1093/molbev/msm119	72	12	12	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e104367	10.1371/journal.pone.0104367	http://dx.doi.org/10.1371/journal.pone.0104367			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093503	gold, Green Published			2022-12-27	WOS:000341357200104
J	Paldurai, A; Xiao, S; Kim, SH; Kumar, S; Nayak, B; Samal, S; Collins, PL; Samal, SK				Paldurai, Anandan; Xiao, Sa; Kim, Shin-Hee; Kumar, Sachin; Nayak, Baibaswata; Samal, Sweety; Collins, Peter L.; Samal, Siba K.			Effects of Naturally Occurring Six- and Twelve-Nucleotide Inserts on Newcastle Disease Virus Replication and Pathogenesis	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; COMPLETE NUCLEOTIDE-SEQUENCE; LIVE-BIRD MARKETS; PARAMYXOVIRUS TYPE-1; GENETIC DIVERSITY; STRAIN; EXISTENCE; VIRULENCE; WEST; SUBGROUPS	Newcastle disease virus (NDV) isolates contain genomes of 15,186, 15,192 or 15,198 nucleotides (nt). The length differences reflect a 6-nt insert in the 5' (downstream) non-translated region (NTR) of the N gene (15,192-nt genome) or a 12-nt insert in the ORF encoding the P and V proteins (causing a 4-amino acid insert; 15,198-nt genome). We evaluated the role of these inserts in the N and P genes on viral replication and pathogenicity by inserting them into genomes of two NDV strains that have natural genome lengths of 15,186 nt and represent two different pathotypes, namely the mesogenic strain Beaudette C (BC) and the velogenic strain GB Texas (GBT). Our results showed that the 6-nt and 12-nt inserts did not detectably affect N gene expression or P protein function. The inserts had no effect on the replication or virulence of the highly virulent GBT strain but showed modest degree of attenuation in mesogenic strain BC. We also deleted a naturally-occurring 6-nt insertion in the N gene from a highly virulent 15,192-nt genome-length virus, strain Banjarmasin. This resulted in reduced replication in vitro and reduced virulence in vivo. Thus, although these inserts had no evident effect on gene expression, protein function, or replication in vivo, they did affect virulence in two of the three tested strains.	[Paldurai, Anandan; Xiao, Sa; Kim, Shin-Hee; Kumar, Sachin; Nayak, Baibaswata; Samal, Sweety; Samal, Siba K.] Univ Maryland, Virginia Maryland Reg Coll Vet Med, College Pk, MD 20742 USA; [Collins, Peter L.] Natl Inst Allergy & Infect Dis, Infect Dis Lab, Bethesda, MD USA	University System of Maryland; University of Maryland College Park; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Samal, SK (corresponding author), Univ Maryland, Virginia Maryland Reg Coll Vet Med, College Pk, MD 20742 USA.	ssamal@umd.edu	Nayak, Baibaswata/L-6156-2016; SAMAL, SWEETY/GQS-6704-2022		NIAID [N01A060009]; NIAID NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000938] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by NIAID contract N01A060009 (85% support) and the NIAID NIH Intramural Research Program (15% support). The views expressed herein do not necessarily reflect the official policies of the Department of Health and Human Services, and the mention of trade names, commercial practices, or organizations does not imply endorsement by the U. S. Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldous EW, 2003, AVIAN PATHOL, V32, P239, DOI 10.1080/030794503100009783; Alexander D.J., 1989, LAB MANUAL ISOLATION; Alexander DJ, 2003, J DIS POULTRY, V11th, P63, DOI DOI 10.1007/S11262-007-0078-Z; CALAIN P, 1993, J VIROL, V67, P4822, DOI 10.1128/JVI.67.8.4822-4830.1993; de Almeida RS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076413; de Almeida RS, 2009, VACCINE, V27, P3127, DOI 10.1016/j.vaccine.2009.03.076; de Leeuw O, 1999, J GEN VIROL, V80, P131, DOI 10.1099/0022-1317-80-1-131; Diel DG, 2012, INFECT GENET EVOL, V12, P1770, DOI 10.1016/j.meegid.2012.07.012; Dortmans JCFM, 2009, J GEN VIROL, V90, P2746, DOI 10.1099/vir.0.014118-0; Huang Y, 2004, ARCH VIROL, V149, P1445, DOI 10.1007/s00705-004-0297-8; Kim LM, 2007, J VIROL, V81, P12641, DOI 10.1128/JVI.00843-07; Kim LM, 2007, J CLIN MICROBIOL, V45, P1310, DOI 10.1128/JCM.02594-06; Kim SH, 2012, J VIROL, V86, P11394, DOI 10.1128/JVI.01922-12; Krishnamurthy S, 1998, J GEN VIROL, V79, P2419, DOI 10.1099/0022-1317-79-10-2419; Krishnamurthy S, 2000, VIROLOGY, V278, P168, DOI 10.1006/viro.2000.0618; Kumar S, 2010, VIRUS RES, V149, P78, DOI 10.1016/j.virusres.2009.12.015; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Liu HL, 2010, VIRUS GENES, V40, P365, DOI 10.1007/s11262-010-0452-0; Lyles D. S., 2007, FIELDS VIROLOGY, V1, P1364; Mayo M A, 2002, Arch Virol, V147, P1071, DOI 10.1007/s007050200036; Miller PJ, 2010, INFECT GENET EVOL, V10, P26, DOI 10.1016/j.meegid.2009.09.012; Miller PJ, 2009, VIROLOGY, V391, P64, DOI 10.1016/j.virol.2009.05.033; Paldurai A, 2010, VIRUS GENES, V41, P67, DOI 10.1007/s11262-010-0486-3; Parthiban M, 2013, GENOME ANNOUNC, V1; REED L. J., 1938, AMER JOUR HYG, V27, P493; Romer-Oberdorfer A, 1999, J GEN VIROL, V80, P2987, DOI 10.1099/0022-1317-80-11-2987; Samal SK, 2011, BIOLOGY OF PARAMYXOVIRUSES, P69; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Seal BS, 2005, VET MICROBIOL, V106, P7, DOI 10.1016/j.vetmic.2004.11.013; Snoeck CJ, 2013, APPL ENVIRON MICROB, V79, P7867, DOI 10.1128/AEM.02716-13; Snoeck CJ, 2013, J CLIN MICROBIOL, V51, P2250, DOI 10.1128/JCM.00684-13; Subbiah M, 2010, VIRUS RES, V152, P85, DOI 10.1016/j.virusres.2010.06.009; Ujvari D, 2006, VIRUS GENES, V32, P49, DOI 10.1007/s11262-005-5845-0; Xiao S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052751; Xiao S, 2012, J VIROL, V86, P5969, DOI 10.1128/JVI.00546-12; Xiao S, 2010, VIRUS RES, V150, P61, DOI 10.1016/j.virusres.2010.02.015	36	5	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e103951	10.1371/journal.pone.0103951	http://dx.doi.org/10.1371/journal.pone.0103951			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093330	Green Published, Green Submitted, gold			2022-12-27	WOS:000341357200048
J	Franklin, TR; Wetherill, RR; Jagannathan, K; Johnson, B; Mumma, J; Hager, N; Rao, H; Childress, AR				Franklin, Teresa R.; Wetherill, Reagan R.; Jagannathan, Kanchana; Johnson, Barbara; Mumma, Joel; Hager, Nathan; Rao, Hengyi; Childress, Anna Rose			The Effects of Chronic Cigarette Smoking on Gray Matter Volume: Influence of Sex	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; OBSESSIVE-COMPULSIVE DISORDER; CEREBRAL-BLOOD-FLOW; ADULT HUMAN BRAINS; ORBITOFRONTAL CORTEX; FUNCTIONAL NEUROANATOMY; NICOTINE DEPENDENCE; NEURAL SYSTEMS; SMOKERS; METAANALYSIS	Cigarette smoke contains nicotine and toxic chemicals and may cause significant neurochemical and anatomical brain changes. Voxel-based morphometry studies have examined the effects of smoking on the brain by comparing gray matter volume (GMV) in nicotine dependent individuals (NDs) to nonsmoking individuals with inconsistent results. Although sex differences in neural and behavioral features of nicotine dependence are reported, sex differences in regional GMV remain unknown. The current study examined sex differences in GMV in a large sample of 80 NDs (41 males) and 80 healthy controls (41 males) using voxel-based morphometry. Within NDs, we explored whether GMV was correlated with measures of cigarette use and nicotine dependence. High-resolution T1 structural scans were obtained from all participants. Segmentation and registration were performed in SPM8 using the optimized DARTEL approach. Covariates included age and an estimate of total global GMV. Differences were considered significant at p <= 0.001, with a whole brain FWE-corrected cluster probability of p<0.025. Among NDs compared to Controls less GMV was observed in the thalamus and bilateral cerebellum and greater GMV was observed in the bilateral putamen and right parahippocampus. Lower thalamic GMV was observed in both female and male NDs compared to Controls. Female NDs also had lower GMV in the left cerebellum and in the ventral medial and orbitofrontal cortices with no areas of greater GMV. Male NDs had lower GMV in bilateral cerebellum and greater GMV in bilateral parahippocampus and left putamen. Within male NDs, GMV in the left putamen was correlated with number of pack years. This study, conducted in a large cohort, contributes to our knowledge of brain morphology in nicotine addiction and provides additional evidence of sex-specific effects on GMV in NDs. Identifying brain vulnerabilities with respect to sex provides a methodological framework for personalized therapies to improve relapse rates for both sexes.	[Franklin, Teresa R.; Wetherill, Reagan R.; Jagannathan, Kanchana; Johnson, Barbara; Mumma, Joel; Hager, Nathan; Childress, Anna Rose] Univ Penn, Perelman Sch Med, Dept Psychiat, Philadelphia, PA 19104 USA; [Rao, Hengyi] Univ Penn, Ctr Funct Neuroimaging, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Franklin, TR (corresponding author), Univ Penn, Perelman Sch Med, Dept Psychiat, Philadelphia, PA 19104 USA.	teresafr@mail.med.upenn.edu	Rao, Hengyi/AAQ-4919-2020; Wetherill, Reagan/AAA-4215-2022; Rao, Hengyi/K-5152-2019; Rao, Hengyi/A-7064-2009	Rao, Hengyi/0000-0003-2735-2500; Rao, Hengyi/0000-0003-2735-2500; Wetherill, Reagan/0000-0002-1991-6292	National Institutes of Health [R21 DA032022, R21 DA25882, R03 DA027098, R01 HL102119, R01 DA029845, R01 DA030394-01A1]; Pfizer Pharma; Institute for Translational Medicine and Therapeutics (ITMAT) of the University of Pennsylvania; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL102119] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015893] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS045839] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA032022, R01DA029845, R21DA025882, R01DA030394, R03DA027098] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pfizer Pharma(Pfizer); Institute for Translational Medicine and Therapeutics (ITMAT) of the University of Pennsylvania; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by grants received from National Institutes of Health (R21 DA032022 (HR), R21 DA25882 (TF), R03 DA027098 (HR), R01 HL102119 (HR), R01 DA029845 (TF), R01 DA030394-01A1 (TF)) and Pfizer Pharma (Investigator-initiated Award) (TF) and a pilot grant from the Institute for Translational Medicine and Therapeutics (ITMAT) of the University of Pennsylvania (HR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; BAILLIE AJ, 1995, AUST J PUBLIC HEALTH, V19, P129; Becker JB, 2008, FRONT NEUROENDOCRIN, V29, P36, DOI 10.1016/j.yfrne.2007.07.003; Bergen AW, 2009, NEUROPSYCHOPHARMACOL, V34, P2252, DOI 10.1038/npp.2009.52; Breese CR, 1997, J PHARMACOL EXP THER, V282, P7; Brody AL, 2004, BIOL PSYCHIAT, V55, P77, DOI 10.1016/S0006-3223(03)00610-3; BUIST AS, 1993, CHEST, V103, P1863, DOI 10.1378/chest.103.6.1863; Cahill L, 2006, NAT REV NEUROSCI, V7, P477, DOI 10.1038/nrn1909; Centers for Disease Control and Prevention, 2008, SMOK ATTR MORT YEARS; Chase HW, 2011, BIOL PSYCHIAT, V70, P785, DOI 10.1016/j.biopsych.2011.05.025; Cosgrove KP, 2007, BIOL PSYCHIAT, V62, P847, DOI 10.1016/j.biopsych.2007.03.001; Court JA, 1998, NEUROSCIENCE, V87, P63, DOI 10.1016/S0306-4522(98)00088-8; CZERNIN J, 1995, CIRCULATION, V91, P2891, DOI 10.1161/01.CIR.91.12.2891; Department of Health and Human Services National Toxicology Program, 2011, REP CARC; Domino EF, 2004, PROG NEURO-PSYCHOPH, V28, P319, DOI 10.1016/j.pnpbp.2003.10.011; Drum ML, 2009, J GERONTOL B-PSYCHOL, V64, pI119, DOI 10.1093/geronb/gbn017; Dwyer JB, 2009, PHARMACOL THERAPEUT, V122, P125, DOI 10.1016/j.pharmthera.2009.02.003; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; FAGERSTROM KO, 1989, J BEHAV MED, V12, P159, DOI 10.1007/BF00846549; Franklin TR, 2011, ADDICT BIOL, V16, P308, DOI 10.1111/j.1369-1600.2010.00277.x; Franklin TR, 2012, BRAIN STRUCTURE FUNC; Gallinat J, 2006, EUR J NEUROSCI, V24, P1744, DOI 10.1111/j.1460-9568.2006.05050.x; Goldstein RZ, 2007, NEUROSCIENCE, V144, P1153, DOI 10.1016/j.neuroscience.2006.11.024; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Good CD, 2001, NEUROIMAGE, V14, P685, DOI 10.1006/nimg.2001.0857; Hollander E, 2005, BIOL PSYCHIAT, V58, P226, DOI 10.1016/j.biopsych.2005.03.040; Hughes JR, 2003, TOB CONTROL, V12, P21, DOI 10.1136/tc.12.1.21; Kandel D B, 2000, Nicotine Tob Res, V2, P263; Koob GF, 2010, NEUROPSYCHOPHARMACOL, V35, P217, DOI 10.1038/npp.2009.110; Kringelbach ML, 2004, PROG NEUROBIOL, V72, P341, DOI 10.1016/j.pneurobio.2004.03.006; Kuhn S, 2012, BRAIN STRUCT FUNCT, V217, P517, DOI 10.1007/s00429-011-0346-5; Liao YH, 2012, ADDICT BIOL, V17, P977, DOI 10.1111/j.1369-1600.2010.00250.x; Longstreth WT, 2001, NEUROLOGY, V56, P368, DOI 10.1212/WNL.56.3.368; Lynch WJ, 2010, EXP CLIN PSYCHOPHARM, V18, P451, DOI 10.1037/a0021265; Mackiewicz KL, 2006, P NATL ACAD SCI USA, V103, P14200, DOI 10.1073/pnas.0601648103; Mak HKF, 2011, J ALZHEIMERS DIS, V23, P655, DOI 10.3233/JAD-2010-101659; Morales AM, 2012, DRUG ALCOHOL DEPEN, V125, P230, DOI 10.1016/j.drugalcdep.2012.02.017; Paterson D, 2000, PROG NEUROBIOL, V61, P75, DOI 10.1016/S0301-0082(99)00045-3; Pfefferbaum A, 2001, AM J PSYCHIAT, V158, P188, DOI 10.1176/appi.ajp.158.2.188; Picard F, 2013, NEUROIMAGE, V79, P42, DOI 10.1016/j.neuroimage.2013.04.074; Piefke M, 2005, HUM BRAIN MAPP, V24, P313, DOI 10.1002/hbm.20092; Radua J, 2009, BRIT J PSYCHIAT, V195, P393, DOI 10.1192/bjp.bp.108.055046; Rando K, 2013, ADDICT BIOL, V18, P147, DOI 10.1111/adb.12008; Rolls ET, 2004, BRAIN COGNITION, V55, P11, DOI 10.1016/s0278-2626(03)00277-x; Rose JE, 2003, AM J PSYCHIAT, V160, P323, DOI 10.1176/appi.ajp.160.2.323; Salgado-Pineda P, 2006, BRIT J CLIN PHARMACO, V62, P546, DOI 10.1111/j.1365-2125.2006.02695.x; SCARONE S, 1992, PSYCHIAT RES-NEUROIM, V45, P115, DOI 10.1016/0925-4927(92)90005-O; Seidlitz L, 1998, J PERS SOC PSYCHOL, V74, P262, DOI 10.1037/0022-3514.74.1.262; Slotkin TA, 2002, NEUROTOXICOL TERATOL, V24, P369, DOI 10.1016/S0892-0362(02)00199-X; Swan GE, 2007, NEUROPSYCHOL REV, V17, P259, DOI 10.1007/s11065-007-9035-9; Trauth JA, 1999, BRAIN RES, V851, P9, DOI 10.1016/S0006-8993(99)01994-0; Volkow ND, 2000, CEREB CORTEX, V10, P318, DOI 10.1093/cercor/10.3.318; Wetherill R.R., 2012, ADDICTION BIOL; Wetherill RR, 2014, ADDICT BEHAV, V39, P789, DOI 10.1016/j.addbeh.2014.01.006; Wetherill RR, 2013, BIOL SEX DIFFER, V4, DOI 10.1186/2042-6410-4-9; Yamasue H, 2007, ANN NEUROL, V61, P37, DOI 10.1002/ana.21024; Yu R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021255; Zhang XC, 2011, NEUROIMAGE, V54, P42, DOI 10.1016/j.neuroimage.2010.08.008; Zhang XC, 2011, NEUROIMAGE, V54, P131, DOI 10.1016/j.neuroimage.2010.07.063; Zubieta JK, 2005, AM J PSYCHIAT, V162, P567, DOI 10.1176/appi.ajp.162.3.567	61	66	66	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e104102	10.1371/journal.pone.0104102	http://dx.doi.org/10.1371/journal.pone.0104102			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM4GX	25090480	gold, Green Submitted, Green Published			2022-12-27	WOS:000339812700096
J	Naranjo-Diaz, N; Altamiranda, M; Luckhart, S; Conn, JE; Correa, MM				Naranjo-Diaz, Nelson; Altamiranda, Mariano; Luckhart, Shirley; Conn, Jan E.; Correa, Margarita M.			Malaria Vectors in Ecologically Heterogeneous Localities of the Colombian Pacific Region	PLOS ONE			English	Article							ANOPHELES-DARLINGI ROOT; DIPTERA-CULICIDAE; PLASMODIUM-FALCIPARUM; NATURAL INFECTIVITY; BITING BEHAVIOR; TRANSMISSION; NEIVAI; PUNCTIMACULA; ANTIOQUIA; ABUNDANCE	The Colombian Pacific region is second nationally in number of malaria cases reported. This zone presents great ecological heterogeneity and Anopheles species diversity. However, little is known about the current spatial and temporal distribution of vector species. This study, conducted in three ecologically different localities of the Pacific region, aimed to evaluate the composition and distribution of Anopheles species and characterize transmission intensity. A total of 4,016 Anopheles mosquitoes were collected representing seven species. The composition and dominant species differed in each locality. Three species were infected with malaria parasites: Anopheles darlingi and An. calderoni were infected with Plasmodium falciparum and An. nuneztovari with Plasmodium vivax VK210 and VK247. Annual EIRs varied from 3.5-7.2 infective bites per year. These results confirm the importance of the primary vector An. nuneztovari in areas disturbed by human interventions, of An. darlingi in deforested margins of humid tropical rainforest and An. albimanus and the suspected vector An. calderoni in areas impacted by urbanization and large-scale palm oil agriculture close to the coast. This constitutes the first report in the Colombia Pacific region of naturally infected An. darlingi, and in Colombia of naturally infected An. calderoni. Further studies should evaluate the epidemiological importance of An. calderoni in the Pacific region.	[Naranjo-Diaz, Nelson; Altamiranda, Mariano; Correa, Margarita M.] Univ Antioquia UdeA, Escuela Microbiol, Grp Microbiol Mol, Medellin, Colombia; [Luckhart, Shirley] Univ Calif Davis, Dept Med Microbiol & Immunol, Davis, CA 95616 USA; [Conn, Jan E.] New York State Dept Hlth, Wadsworth Ctr, Griffin Lab, New York, NY USA; [Conn, Jan E.] SUNY Albany, Sch Publ Hlth, Dept Biomed Sci, Albany, NY USA	Universidad de Antioquia; University of California System; University of California Davis; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Correa, MM (corresponding author), Univ Antioquia UdeA, Escuela Microbiol, Grp Microbiol Mol, Medellin, Colombia.	margaritcorrea@gmail.com		Naranjo, Nelson/0000-0001-8307-2859; Conn, Jan/0000-0002-5301-7020	National Institutes of Health-United States of America [R03-AI076710]; Estrategia para la Sostenibilidad de Grupos; Universidad de Antioquia [E01719]; Comite para el Desarrollo de la Investigacion, UdeA [8700-074]; Departamento Administrativo de Ciencia, Tecnologia e Innovacion-COLCIENCIAS, Colombia [Convocatoria 511-2010]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI076710] Funding Source: NIH RePORTER	National Institutes of Health-United States of America(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Estrategia para la Sostenibilidad de Grupos; Universidad de Antioquia; Comite para el Desarrollo de la Investigacion, UdeA; Departamento Administrativo de Ciencia, Tecnologia e Innovacion-COLCIENCIAS, Colombia(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work received funding from the National Institutes of Health-United States of America, Grant No. R03-AI076710 to MMC. Additional support was received from Estrategia para la Sostenibilidad de Grupos 2013-2014, Universidad de Antioquia-Grant No. E01719 and Comite para el Desarrollo de la Investigacion, UdeA, Grant No. 8700-074. NND received financial support for his doctoral studies from Departamento Administrativo de Ciencia, Tecnologia e Innovacion-COLCIENCIAS, Convocatoria 511-2010, Colombia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], REV PERU EPIDEMOLOGI; [Anonymous], 1987, COLOMB MED; [Anonymous], REV BIOMEDICA; [Anonymous], 2018, SANTIAGO CALI U VALL, DOI DOI 10.25100/PEU.309; FARAN M E, 1980, Contributions of the American Entomological Institute, V15, P1; Brochero Helena, 2006, Biomed., V26, P269; CARVAJAL H, 1989, T ROY SOC TROP MED H, V83, P609, DOI 10.1016/0035-9203(89)90372-6; Cienfuegos AV, 2011, ACTA TROP, V118, P128, DOI 10.1016/j.actatropica.2011.02.004; Cruz G Carmen, 2004, Rev. perú. med. exp. salud publica, V21, P223; Escovar JE, 2013, MEM I OSWALDO CRUZ, V108, P1057, DOI 10.1590/0074-0276130256; ELLIOTT R, 1972, AM J TROP MED HYG, V21, P755, DOI 10.4269/ajtmh.1972.21.755; Fajardo P, 1987, COLOMB MEDICA, V18, P14; FARAN M E, 1981, Mosquito Systematics, V13, P1; Ferro Vargas C. A., 1979, Revista de la Escuela Nacional de Salud Publica, V5, P11; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Frederickson E, 1993, BIONOMIA CONTROL ANO; Girod R, 2008, MEM I OSWALDO CRUZ, V103, P702, DOI 10.1590/S0074-02762008000700013; Githeko AK, 2000, B WORLD HEALTH ORGAN, V78, P1136; Gomez G, 2013, MOL ECOL RESOUR, V13, P1082, DOI 10.1111/1755-0998.12126; Gonzalez R, 2007, INTRODUCCION ESTUDIO; Gonzalez R, 2010, MEM I OSWALDO CRUZ, V105, P1001, DOI 10.1590/S0074-02762010000800009; Gutierrez LA, 2008, ACTA TROP, V107, P99, DOI 10.1016/j.actatropica.2008.04.019; Gutierrez LA, 2009, MEM I OSWALDO CRUZ, V104, P1117, DOI 10.1590/S0074-02762009000800008; Harbach RE, 2004, B ENTOMOL RES, V94, P537, DOI 10.1079/BER2004321; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hiwat H, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-177; HUDSON JE, 1984, B ENTOMOL RES, V74, P129, DOI 10.1017/S0007485300010002; HUFFAKER CB, 1945, AM J HYG, V42, P107, DOI 10.1093/oxfordjournals.aje.a119027; Instituto Geografico Agustin Codazzi, 2002, ATL COL; Instituto Nacional de Salud, 2011, B EP SEM EST SIST VI; Instituto Nacional de Salud, 2012, B EP SEM EST SIST VI; Instituto Nacional de Salud, 2010, B EP SEM EST SIST VI; Kovats RS, 2003, LANCET, V362, P1481, DOI 10.1016/S0140-6736(03)14695-8; Kroeger A, 1993, MALARIA ECUADOR PERU, P316; Lindblade KA, 2000, TROP MED INT HEALTH, V5, P263, DOI 10.1046/j.1365-3156.2000.00551.x; Lucumi-Aragon D, 2011, REV COLOMB ENTOMOL, V37, P256; Moreno JE, 2007, MED VET ENTOMOL, V21, P339, DOI 10.1111/j.1365-2915.2007.00704.x; Morrone JJ, 2006, ANNU REV ENTOMOL, V51, P467, DOI 10.1146/annurev.ento.50.071803.130447; Naranjo-Diaz N, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-61; Ochoa Johanna, 2006, Biomed., V26, P278; Olano V, 1997, Rev Panam Salud Publica, V1, P287, DOI 10.1590/S1020-49891997000400005; Olano VA, 2001, BIOMEDICA, V21, P402; Organizacion Panamericana de la Salud, 2011, INF SIT PAL AM; Poveda G, 2001, ENVIRON HEALTH PERSP, V109, P489, DOI 10.2307/3454707; Povoa MM, 2001, MEM I OSWALDO CRUZ, V96, P179, DOI 10.1590/S0074-02762001000200008; Rosero DA, 2013, ISRN PARASITOL, V2013, P10; Rosero DA, 2010, REV COLOMB ENTOMOL, V36, P260; ROZENDAAL J A, 1987, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V25, P33; ROZENDAAL JA, 1992, MED VET ENTOMOL, V6, P16, DOI 10.1111/j.1365-2915.1992.tb00029.x; Rubio-Palis Yasmin, 2005, ENTOMOTROPICA, V20, P29; Servicio de Erradicacion de la Malaria, 1957, PLAN ERR MAL COL; Solarte Y, 1996, MEM I OSWALDO CRUZ, V91, P141, DOI 10.1590/S0074-02761996000200002; Souza-Santos Reinaldo, 2002, Cad. Saúde Pública, V18, P1813, DOI 10.1590/S0102-311X2002000600039; SUAREZ MF, 1990, J AM MOSQUITO CONTR, V6, P72; Tadei Wanderli Pedro, 2000, Revista do Instituto de Medicina Tropical de Sao Paulo, V42, P87, DOI 10.1590/S0036-46652000000200005; Ulloa A, 2006, J AM MOSQUITO CONTR, V22, P648, DOI 10.2987/8756-971X(2006)22[648:HSAGCL]2.0.CO;2; Vittor AY, 2009, AM J TROP MED HYG, V81, P5; WHO, 2010, WORLD MALARIA REPORT 2010, P1; WILKERSON R C, 1991, Mosquito Systematics, V23, P25; WILKERSON RC, 1990, J MED ENTOMOL, V27, P225, DOI 10.1093/jmedent/27.2.225; WIRTZ RA, 1987, B WORLD HEALTH ORGAN, V65, P39; WIRTZ RA, 1992, J MED ENTOMOL, V29, P854, DOI 10.1093/jmedent/29.5.854; Zapata MA, 2007, AM J TROP MED HYG, V77, P67, DOI 10.4269/ajtmh.2007.77.67	63	26	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103769	10.1371/journal.pone.0103769	http://dx.doi.org/10.1371/journal.pone.0103769			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25090233	Green Submitted, Green Published, gold			2022-12-27	WOS:000339812700051
J	Zhang, YY; Hu, Y; Guan, SC; Hong, XL; Wang, ZX; Li, XC				Zhang, Yangyang; Hu, Yang; Guan, Shuchen; Hong, Xiaolong; Wang, Zhaoxin; Li, Xianchun			Neural Substrate of Initiation of Cross-Modal Working Memory Retrieval	PLOS ONE			English	Article							POSTERIOR PARIETAL CORTEX; MULTISENSORY INTEGRATION; PREFRONTAL CORTEX; NEURONAL-ACTIVITY; MANIPULATION; PRIMATE; MAINTENANCE; ASSOCIATION; REPRESENTATION; DISSOCIATIONS	Cross-modal working memory requires integrating stimuli from different modalities and it is associated with co-activation of distributed networks in the brain. However, how brain initiates cross-modal working memory retrieval remains not clear yet. In the present study, we developed a cued matching task, in which the necessity for cross-modal/unimodal memory retrieval and its initiation time were controlled by a task cue appeared in the delay period. Using functional magnetic resonance imaging (fMRI), significantly larger brain activations were observed in the left lateral prefrontal cortex (l-LPFC), left superior parietal lobe (l-SPL), and thalamus in the cued cross-modal matching trials (CCMT) compared to those in the cued unimodal matching trials (CUMT). However, no significant differences in the brain activations prior to task cue were observed for sensory stimulation in the l-LPFC and l-SPL areas. Although thalamus displayed differential responses to the sensory stimulation between two conditions, the differential responses were not the same with responses to the task cues. These results revealed that the frontoparietal-thalamus network participated in the initiation of cross-modal working memory retrieval. Secondly, the l-SPL and thalamus showed differential activations between maintenance and working memory retrieval, which might be associated with the enhanced demand for cognitive resources.	[Zhang, Yangyang; Guan, Shuchen; Hong, Xiaolong; Li, Xianchun] E China Normal Univ, Sch Psychol & Cognit Sci, Shanghai 200062, Peoples R China; [Hu, Yang; Wang, Zhaoxin] E China Normal Univ, Inst Cognit Neurosci, Shanghai 200062, Peoples R China	East China Normal University; East China Normal University	Li, XC (corresponding author), E China Normal Univ, Sch Psychol & Cognit Sci, Shanghai 200062, Peoples R China.	xcli@psy.ecnu.edu.cn	zhang, yangyang/GZG-7467-2022	Guan, Shuchen/0000-0001-6281-8623	National Natural Science Foundation of China [31000501]; Shanghai Pujiang Program [11PJC044]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Pujiang Program(Shanghai Pujiang Program)	This work was supported by (1) National Natural Science Foundation of China (No. 31000501, http://www.nsfc.gov.cn/) and (2) Shanghai Pujiang Program (No. 11PJC044, http://www.stcsm.gov.cn/gk/ywgz/bssx/kyjh/76.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asaad WF, 1998, NEURON, V21, P1399, DOI 10.1016/S0896-6273(00)80658-3; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Barone P., 2012, NEURAL BASES MULTISE; Blau V, 2009, CURR BIOL, V19, P503, DOI 10.1016/j.cub.2009.01.065; Cappe C, 2009, CEREB CORTEX, V19, P2025, DOI 10.1093/cercor/bhn228; Chiu YC, 2011, J COGNITIVE NEUROSCI, V23, P1198, DOI 10.1162/jocn.2010.21503; Cole MW, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00142; Constantinidis C, 1996, J NEUROPHYSIOL, V76, P1352, DOI 10.1152/jn.1996.76.2.1352; Curtis CE, 2003, TRENDS COGN SCI, V7, P415, DOI 10.1016/S1364-6613(03)00197-9; D'Esposito M, 1999, BRAIN COGNITION, V41, P66, DOI 10.1006/brcg.1999.1096; Foss-Feig JH, 2010, EXP BRAIN RES, V203, P381, DOI 10.1007/s00221-010-2240-4; FUNAHASHI S, 1989, J NEUROPHYSIOL, V61, P331, DOI 10.1152/jn.1989.61.2.331; Fuster JM, 2000, NATURE, V405, P347, DOI 10.1038/35012613; FUSTER JM, 1982, J NEUROSCI, V2, P361; FUSTER JM, 1971, SCIENCE, V173, P652, DOI 10.1126/science.173.3997.652; GATTASS R, 1979, BRAIN RES, V160, P413, DOI 10.1016/0006-8993(79)91070-9; Glahn DC, 2002, NEUROIMAGE, V17, P201, DOI 10.1006/nimg.2002.1161; Hikosaka O, 2007, ANN NY ACAD SCI, V1104, P229, DOI 10.1196/annals.1390.012; Hill SK, 2010, PSYCHOL MED, V40, P1979, DOI 10.1017/S003329171000019X; Komura Y, 2005, NAT NEUROSCI, V8, P1203, DOI 10.1038/nn1528; Linden DEJ, 2007, NEUROSCIENTIST, V13, P257, DOI 10.1177/1073858406298480; Lloyd D, 2006, J NEUROPHYSIOL, V95, P205, DOI 10.1152/jn.00614.2005; Meck WH, 2013, BEHAV NEUROSCI, V127, P655, DOI 10.1037/a0034188; Mohr HM, 2006, J NEUROSCI, V26, P4465, DOI 10.1523/JNEUROSCI.5232-05.2006; Molholm S, 2006, J NEUROPHYSIOL, V96, P721, DOI 10.1152/jn.00285.2006; Moran RJ, 2008, EUR J NEUROSCI, V27, P2303, DOI 10.1111/j.1460-9568.2008.06187.x; Nakashita S, 2008, BRAIN RES BULL, V75, P513, DOI 10.1016/j.brainresbull.2007.09.004; Naya Y, 1996, P NATL ACAD SCI USA, V93, P2664, DOI 10.1073/pnas.93.7.2664; Rainer G, 1998, NATURE, V393, P577, DOI 10.1038/31235; Ramirez S, 2014, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00226; Sherman SM, 2011, J NEUROPHYSIOL, V106, P1068, DOI 10.1152/jn.00429.2011; Shomstein S, 2004, J NEUROSCI, V24, P10702, DOI 10.1523/JNEUROSCI.2939-04.2004; STEIN BE, 1988, BRAIN RES, V448, P355, DOI 10.1016/0006-8993(88)91276-0; Tanabe HC, 2005, J NEUROSCI, V25, P6409, DOI 10.1523/JNEUROSCI.0636-05.2005; Travis SG, 2014, NEUROPSYCHOLOGIA, V53, P233, DOI 10.1016/j.neuropsychologia.2013.11.016; Viaene AN, 2011, J NEUROPHYSIOL, V105, P279, DOI 10.1152/jn.00747.2010; Wang LP, 2012, J COGNITIVE NEUROSCI, V24, P664, DOI 10.1162/jocn_a_00169; Warden MR, 2007, CEREB CORTEX, V17, pI41, DOI 10.1093/cercor/bhm070; Watanabe Y, 2004, J NEUROPHYSIOL, V92, P1756, DOI 10.1152/jn.00995.2003; Woolgar A, 2011, NEUROIMAGE, V56, P744, DOI 10.1016/j.neuroimage.2010.04.035; YIRMIYA R, 1987, BRAIN RES, V402, P93, DOI 10.1016/0006-8993(87)91051-1; Zangenehpour S, 2010, NEUROPSYCHOLOGIA, V48, P591, DOI 10.1016/j.neuropsychologia.2009.10.022	42	4	4	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103991	10.1371/journal.pone.0103991	http://dx.doi.org/10.1371/journal.pone.0103991			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25090230	Green Published, Green Submitted, gold			2022-12-27	WOS:000339812700073
J	Camacho, C; Palacios, S; Saez, P; Sanchez, S; Potti, J				Camacho, Carlos; Palacios, Sebastian; Saez, Pedro; Sanchez, Sonia; Potti, Jaime			Human-Induced Changes in Landscape Configuration Influence Individual Movement Routines: Lessons from a Versatile, Highly Mobile Species	PLOS ONE			English	Article							HABITAT USE; FORAGING HABITAT; HOME-RANGE; CONSERVATION; ABUNDANCE; EXTINCTION; BEHAVIOR; HETEROGENEITY; POPULATIONS; RESOURCES	Landscape conversion by humans may have detrimental effects on animal populations inhabiting managed ecosystems, but human-altered areas may also provide suitable environments for tolerant species. We investigated the spatial ecology of a highly mobile nocturnal avian species-the red-necked nightjar (Caprimulgus ruficollis)-in two contrastingly managed areas in Southwestern Spain to provide management recommendations for species having multiple habitat requirements. Based on habitat use by radiotagged nightjars, we created maps of functional heterogeneity in both areas so that the movements of breeding individuals could be modeled using least-cost path analyses. In both the natural and the managed area, nightjars used remnants of native shrublands as nesting sites, while pinewood patches (either newly planted or natural mature) and roads were selected as roosting and foraging habitats, respectively. Although the fraction of functional habitat was held relatively constant (60.9% vs. 74.1% in the natural and the managed area, respectively), landscape configuration changed noticeably. As a result, least-cost routes (summed linear distances) from nest locations to the nearest roost and foraging sites were three times larger in the natural than in the managed area (mean +/- SE: 1356 +/- 76 m vs. 439 +/- 32 m). It seems likely that the increased proximity of functional habitats in the managed area relative to the natural one is underlying the significantly higher abundances of nightjars observed therein, where breeders should travel shorter distances to link together essential resources, thus likely reducing their energy expenditure and mortality risks. Our results suggest that landscape configuration, but not habitat availability, is responsible for the observed differences between the natural and the managed area in the abundance and movements of breeding nightjars, although no effect on body condition was detected. Agricultural landscapes could be moderately managed to preserve small native remnants and to favor the juxtaposition of functional habitats to benefit those farm species relying on patchy resources.	[Camacho, Carlos; Sanchez, Sonia; Potti, Jaime] CSIC, Dept Evolutionary Ecol, Estn Biol Donana, E-41080 Seville, Spain; [Palacios, Sebastian] CSIC, Dept Conservat Biol, Estn Biol Donana, E-41080 Seville, Spain; [Saez, Pedro] Univ Huelva, Dept Environm Biol & Publ Hlth, Huelva, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Universidad de Huelva	Camacho, C (corresponding author), CSIC, Dept Evolutionary Ecol, Estn Biol Donana, E-41080 Seville, Spain.	ccamacho@ebd.csic.es	Sáez-Gómez, Pedro/E-9715-2016; Camacho, Carlos/AAC-7877-2019; Potti, Jaime/H-3113-2019; Sáez-Gómez, Pedro/P-6195-2019	Sáez-Gómez, Pedro/0000-0001-5105-3960; Camacho, Carlos/0000-0002-9704-5816; Potti, Jaime/0000-0002-2284-0022; Sáez-Gómez, Pedro/0000-0001-5105-3960; Palacios Ojeda, Sebastian/0000-0001-5745-6453	SEO/Birdlife	SEO/Birdlife	SEO/Birdlife (http://www.seo.org/) provided financial support to acquire the radio transmitters through a research initiation grant to CC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AEBISCHER NJ, 1993, ECOLOGY, V74, P1313, DOI 10.2307/1940062; Agresti A, 1998, AM STAT, V52, P119, DOI 10.2307/2685469; Aragones Juan, 2001, Ardeola, V48, P11; Baayen RH, 2011, LANGUAGER DATA SETS; Baker MB, 2004, ECOLOGY, V85, P1039, DOI 10.1890/02-0507; Bates D., 2011, PACKAGE LME4 LINEAR, V1; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Brotons L, 2005, BIOL CONSERV, V124, P407, DOI 10.1016/j.biocon.2005.01.046; Brown AF, 1998, BIRD STUDY, V45, P293, DOI 10.1080/00063659809461100; Caccamo C, 2011, IBIS, V153, P707, DOI 10.1111/j.1474-919X.2011.01153.x; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Camacho C, 2013, CONDOR, V115, P830, DOI 10.1525/cond.2013.120192; Camacho C, 2013, BIRD STUDY, V60, P124, DOI 10.1080/00063657.2012.753400; Cardador L, 2011, ANIM CONSERV, V14, P382, DOI 10.1111/j.1469-1795.2011.00449.x; Chamberlain DE, 2000, J APPL ECOL, V37, P771, DOI 10.1046/j.1365-2664.2000.00548.x; Cleere N, 2010, NIGHTJARS POTOOS FRO; Crook DA, 2001, OECOLOGIA, V129, P525, DOI 10.1007/s004420100750; De Solla SR, 1999, J ANIM ECOL, V68, P221, DOI 10.1046/j.1365-2656.1999.00279.x; Doucette LI, 2010, J ORNITHOL, V151, P673, DOI 10.1007/s10336-010-0497-9; DUNNING JB, 1992, OIKOS, V65, P169, DOI 10.2307/3544901; Fahrig L, 2007, FUNCT ECOL, V21, P1003, DOI 10.1111/j.1365-2435.2007.01326.x; Fahrig L, 2011, ECOL LETT, V14, P101, DOI 10.1111/j.1461-0248.2010.01559.x; Flather CH, 2002, AM NAT, V159, P40, DOI 10.1086/324120; FORD HA, 1995, TRZS NSW, P128; FORERO MG, 1995, J ORNITHOL, V136, P447, DOI 10.1007/BF01651592; Jackson H.D., 1984, Bokmakierie, V36, P86; Jackson HD, 2003, OSTRICH, V74, P187, DOI 10.2989/00306520309485392; LAURANCE WF, 1991, CONSERV BIOL, V5, P79, DOI 10.1111/j.1523-1739.1991.tb00390.x; Law BS, 1998, BIODIVERS CONSERV, V7, P323, DOI 10.1023/A:1008877611726; Lentini PE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048201; Lozano J, 2003, BIODIVERS CONSERV, V12, P921, DOI 10.1023/A:1022821708594; Masse RJ, 2013, BEHAV ECOL, V24, P1348, DOI 10.1093/beheco/art073; MCINTYRE S, 1992, CONSERV BIOL, V6, P146, DOI 10.1046/j.1523-1739.1992.610146.x; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.1093/biomet/37.1-2.17; Moreno-Mateos D, 2009, BIODIVERS CONSERV, V18, P811, DOI 10.1007/s10531-008-9472-7; Morris AJ, 2001, BIOL CONSERV, V101, P197, DOI 10.1016/S0006-3207(01)00067-2; Morris DW, 1995, MOSAIC LANDSCAPES EC, P110; Newton I, 2004, IBIS, V146, P579, DOI 10.1111/j.1474-919X.2004.00375.x; Owen-Smith N, 2004, LANDSCAPE ECOL, V19, P761, DOI 10.1007/s10980-005-0247-2; Pagen RW, 2000, CONDOR, V102, P738, DOI 10.1650/0010-5422(2000)102[0738:BAPBHU]2.0.CO;2; Palomo I, 2014, REG ENVIRON CHANGE, V14, P237, DOI 10.1007/s10113-013-0488-5; Penteriani V, 2002, J ZOOL, V257, P365, DOI 10.1017/S0952836902000961; PETTERSSON J, 1985, Ringing and Migration, V6, P66; Pope SE, 2000, ECOLOGY, V81, P2498; Poulin R. G., 1999, PRAIRIE NATURALIST, V30, P85; RAPPORT DJ, 1985, AM NAT, V125, P617, DOI 10.1086/284368; Revelle W, 2014, PACKAGE PSYCH R PACK; Rodriguez A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050336; SAUNDERS DA, 1991, CONSERV BIOL, V5, P18, DOI 10.1111/j.1523-1739.1991.tb00384.x; Scalercio S, 2007, BIODIVERS CONSERV, V16, P3463, DOI 10.1007/s10531-006-9015-z; Scott JM, 2001, ECOL APPL, V11, P999, DOI 10.1890/1051-0761(2001)011[0999:NRDTCT]2.0.CO;2; Sebastian-Gonzalez E, 2010, EUR J WILDLIFE RES, V56, P11, DOI 10.1007/s10344-009-0288-x; Senar JC, 1997, ARDEA, V85, P269; Sergio F, 2005, ANIM CONSERV, V8, P17, DOI 10.1017/S1367943004001623; SHORT J, 1994, CONSERV BIOL, V8, P439, DOI 10.1046/j.1523-1739.1994.08020439.x; Sierro A, 2001, BIOL CONSERV, V98, P325, DOI 10.1016/S0006-3207(00)00175-0; Silverman B.W., 1986, DENSITY ESTIMATION S; Stevenson CD, 2013, ECOL EVOL, V3, P2350, DOI 10.1002/ece3.638; Tella JL, 2005, ORYX, V39, P90, DOI 10.1017/S0030605305000165; Uezu A, 2005, BIOL CONSERV, V123, P507, DOI 10.1016/j.biocon.2005.01.001; Ursua E, 2005, BIOL CONSERV, V122, P643, DOI 10.1016/j.biocon.2004.10.002; Vallecillo S, 2008, BIODIVERS CONSERV, V17, P103, DOI 10.1007/s10531-007-9233-z; Vitz AC, 2007, AUK, V124, P494, DOI 10.1642/0004-8038(2007)124[494:VAFRAD]2.0.CO;2; Wand MP., 1994, KERNEL SMOOTHING; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423; Zhang TL, 2007, COMPUT STAT DATA AN, V51, P6123, DOI 10.1016/j.csda.2006.12.032; Zorrilla-Miras P, 2014, LANDSCAPE URBAN PLAN, V122, P160, DOI 10.1016/j.landurbplan.2013.09.013	67	23	23	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2014	9	8							e104974	10.1371/journal.pone.0104974	http://dx.doi.org/10.1371/journal.pone.0104974			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WB	25110888	Green Published, gold			2022-12-27	WOS:000341105100116
J	Levine, YA; Koopman, FA; Faltys, M; Caravaca, A; Bendele, A; Zitnik, R; Vervoordeldonk, MJ; Tak, PP				Levine, Yaakov A.; Koopman, Frieda A.; Faltys, Michael; Caravaca, April; Bendele, Alison; Zitnik, Ralph; Vervoordeldonk, Margriet J.; Tak, Paul Peter			Neurostimulation of the Cholinergic Anti-Inflammatory Pathway Ameliorates Disease in Rat Collagen-Induced Arthritis	PLOS ONE			English	Article							VAGUS NERVE-STIMULATION; INTERLEUKIN-1 RECEPTOR ANTAGONIST; NICOTINIC ACETYLCHOLINE-RECEPTOR; SYSTEMIC BONE LOSS; RHEUMATOID-ARTHRITIS; NEURAL SIGNALS; TNF-ALPHA; INFLAMMATION; MODELS; PARAMETERS	Introduction: The inflammatory reflex is a physiological mechanism through which the nervous system maintains immunologic homeostasis by modulating innate and adaptive immunity. We postulated that the reflex might be harnessed therapeutically to reduce pathological levels of inflammation in rheumatoid arthritis by activating its prototypical efferent arm, termed the cholinergic anti-inflammatory pathway. To explore this, we determined whether electrical neurostimulation of the cholinergic anti-inflammatory pathway reduced disease severity in the collagen-induced arthritis model. Methods: Rats implanted with vagus nerve cuff electrodes had collagen-induced arthritis induced and were followed for 15 days. Animals underwent active or sham electrical stimulation once daily from day 9 through the conclusion of the study. Joint swelling, histology, and levels of cytokines and bone metabolism mediators were assessed. Results: Compared with sham treatment, active neurostimulation of the cholinergic anti-inflammatory pathway resulted in a 52% reduction in ankle diameter (p = 0.02), a 57% reduction in ankle diameter (area under curve; p = 0.02) and 46% reduction overall histological arthritis score (p = 0.01) with significant improvements in inflammation, pannus formation, cartilage destruction, and bone erosion (p = 0.02), accompanied by numerical reductions in systemic cytokine levels, not reaching statistical significance. Bone erosion improvement was associated with a decrease in serum levels of receptor activator of NF-kappa B ligand (RANKL) from 132 +/- 13 to 6 +/- 2 pg/mL (mean +/- SEM, p = 0.01). Conclusions: The severity of collagen-induced arthritis is reduced by neurostimulation of the cholinergic anti-inflammatory pathway delivered using an implanted electrical vagus nerve stimulation cuff electrode, and supports the rationale for testing this approach in human inflammatory disorders.	[Levine, Yaakov A.; Faltys, Michael; Caravaca, April; Zitnik, Ralph] SetPoint Med Corp, Valencia, CA USA; [Koopman, Frieda A.; Vervoordeldonk, Margriet J.; Tak, Paul Peter] Univ Amsterdam, Acad Med Ctr, Div Clin Immunol & Rheumatol, NL-1105 AZ Amsterdam, Netherlands; [Bendele, Alison] Bolder BioPATH Inc, Boulder, CO USA; [Vervoordeldonk, Margriet J.] Arthrogen BV, Amsterdam, Netherlands; [Tak, Paul Peter] GlaxoSmithKline, Stevenage, Herts, England; [Tak, Paul Peter] Univ Cambridge, Cambridge, England	University of Amsterdam; Academic Medical Center Amsterdam; GlaxoSmithKline; University of Cambridge	Tak, PP (corresponding author), Univ Amsterdam, Acad Med Ctr, Div Clin Immunol & Rheumatol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	P.P.Tak@amc.uva.nl	Levine, Yaakov/AAA-2578-2020	Caravaca, April S/0000-0001-6921-8700; Levine, Yaakov/0000-0002-3313-6858	SetPoint Medical Corporation	SetPoint Medical Corporation	YAL, MF, AC and RZ are employees of SetPoint Medical Corporation and received funding in the form of salaries for this study, therefore the funder had a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Andersson U, 2012, ANNU REV IMMUNOL, V30, P313, DOI 10.1146/annurev-immunol-020711-075015; Bajayo A, 2012, P NATL ACAD SCI USA, V109, P15455, DOI 10.1073/pnas.1206061109; Beekwilder JP, 2010, J CLIN NEUROPHYSIOL, V27, P130, DOI 10.1097/WNP.0b013e3181d64d8a; Bendele A, 1998, PHARM RES-DORDR, V15, P1557, DOI 10.1023/A:1011903100188; Bendele AM, 2000, ARTHRITIS RHEUM-US, V43, P2648, DOI 10.1002/1529-0131(200012)43:12<2648::AID-ANR4>3.0.CO;2-M; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; de Jonge WJ, 2005, NAT IMMUNOL, V6, P844, DOI 10.1038/ni1229; Dore RK, 2010, ANN RHEUM DIS, V69, P872, DOI 10.1136/ard.2009.112920; Famm K, 2013, NATURE, V496, P159, DOI 10.1038/496159a; Galitovskiy V, 2011, J IMMUNOL, V187, P2677, DOI 10.4049/jimmunol.1002711; GEORGE R, 1995, NEUROLOGY, V45, P224, DOI 10.1212/wnl.45.2.224; Ghia JE, 2006, GASTROENTEROLOGY, V131, P1122, DOI 10.1053/j.gastro.2006.08.016; Ghia JE, 2007, AM J PHYSIOL-GASTR L, V293, pG560, DOI 10.1152/ajpgi.00098.2007; Heck C, 2002, NEUROLOGY, V59, pS31, DOI 10.1212/WNL.59.6_suppl_4.S31; Huston JM, 2007, CRIT CARE MED, V35, P2762, DOI 10.1097/01.CCM.0000288102.15975.BA; Huston JM, 2006, J EXP MED, V203, P1623, DOI 10.1084/jem.20052362; Huston JM, 2009, J IMMUNOL, V183, P552, DOI 10.4049/jimmunol.0802684; Karimi K, 2010, BRAIN BEHAV IMMUN, V24, P316, DOI 10.1016/j.bbi.2009.10.016; Koo B, 2001, J CLIN NEUROPHYSIOL, V18, P429, DOI 10.1097/00004691-200109000-00007; Lacey DL, 2012, NAT REV DRUG DISCOV, V11, P401, DOI 10.1038/nrd3705; Levine YA, 2013, GASTROENTEROLOGY, V144, pS67; Mina-Osorio P, 2012, MOL MED, V18, P618, DOI 10.2119/molmed.2012.00027; National Research Council, 2011, GUIDE CARE USE LAB A; Redlich K, 2012, NAT REV DRUG DISCOV, V11, P234, DOI 10.1038/nrd3669; Rosas-Ballina M, 2011, SCIENCE, V334, P98, DOI 10.1126/science.1209985; Saeed RW, 2005, J EXP MED, V201, P1113, DOI 10.1084/jem.20040463; Saidenberg-Kermanac'h N, 2004, BONE, V35, P1200, DOI 10.1016/j.bone.2004.07.004; Stolina M, 2005, J BONE MINER RES, V20, P1756, DOI 10.1359/JBMR.050601; Stolina M, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2879; van Maanen MA, 2010, ANN RHEUM DIS, V69, P1717, DOI 10.1136/ard.2009.118554; van Maanen MA, 2009, NAT REV RHEUMATOL, V5, P229, DOI 10.1038/nrrheum.2009.31; van Maanen MA, 2009, ARTHRITIS RHEUM-US, V60, P1272, DOI 10.1002/art.24470; van Maanen MA, 2009, ARTHRITIS RHEUM-US, V60, P114, DOI 10.1002/art.24177; Waldburger JM, 2008, ARTHRITIS RHEUM, V58, P3439, DOI 10.1002/art.23987; Zhang P, 2008, INFLAMM RES, V57, P322, DOI 10.1007/s00011-008-8070-1	35	105	107	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2014	9	8							e104530	10.1371/journal.pone.0104530	http://dx.doi.org/10.1371/journal.pone.0104530			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WB	25110981	Green Published, Green Submitted, gold			2022-12-27	WOS:000341105100066
J	Andresen, H; Strasser, M; van der Meer, J				Andresen, Henrike; Strasser, Matthias; van der Meer, Jaap			Estimation of Density-Dependent Mortality of Juvenile Bivalves in the Wadden Sea	PLOS ONE			English	Article							MACOMA-BALTHICA; SEVERE WINTER; LONG-TERM; OBSERVATION ERROR; PROCESS NOISE; TIDAL FLATS; RECRUITMENT; POPULATION; LIMITATION; SCALE	We investigated density-dependent mortality within the early months of life of the bivalves Macoma balthica (Baltic tellin) and Cerastoderma edule (common cockle) in the Wadden Sea. Mortality is thought to be density-dependent in juvenile bivalves, because there is no proportional relationship between the size of the reproductive adult stocks and the numbers of recruits for both species. It is not known however, when exactly density dependence in the pre-recruitment phase occurs and how prevalent it is. The magnitude of recruitment determines year class strength in bivalves. Thus, understanding pre-recruit mortality will improve the understanding of population dynamics. We analyzed count data from three years of temporal sampling during the first months after bivalve settlement at ten transects in the Sylt-Romo-Bay in the northern German Wadden Sea. Analyses of density dependence are sensitive to bias through measurement error. Measurement error was estimated by bootstrapping, and residual deviances were adjusted by adding process error. With simulations the effect of these two types of error on the estimate of the density-dependent mortality coefficient was investigated. In three out of eight time intervals density dependence was detected for M. balthica, and in zero out of six time intervals for C. edule. Biological or environmental stochastic processes dominated over density dependence at the investigated scale.	[Andresen, Henrike; van der Meer, Jaap] Royal Netherlands Inst Sea Res, Dept Marine Ecol, Den Burg, Netherlands; [Strasser, Matthias] Alfred Wegener Inst, Div Coastal Ecol, Wadden Sea Stn Sylt, List Auf Sylt, Germany; [van der Meer, Jaap] Vrije Univ Amsterdam, Dept Theoret Biol, Amsterdam, Netherlands	Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Vrije Universiteit Amsterdam	Andresen, H (corresponding author), Royal Netherlands Inst Sea Res, Dept Marine Ecol, Den Burg, Netherlands.	henrikea@gmx.de	Andresen, Henrike/C-3977-2017		Netherlands Organization for Scientific Research (NWO); Netherlands-Bremen Oceanography II (NEBROC)	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Netherlands-Bremen Oceanography II (NEBROC)	This research was funded by the Netherlands Organization for Scientific Research (NWO) and Netherlands-Bremen Oceanography II (NEBROC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andresen H, 2013, THESIS VU U AMSTERDA; BEUKEMA JJ, 1982, NETH J SEA RES, V16, P37, DOI 10.1016/0077-7579(82)90015-1; Beukema JJ, 1996, ICES J MAR SCI, V53, P964, DOI 10.1006/jmsc.1996.0119; BEVERTON RJH, 1992, NETH J SEA RES, V29, P61, DOI 10.1016/0077-7579(92)90008-3; Bos OG, 2005, THESIS U GRONINGEN; Bos OG, 2007, MAR ECOL PROG SER, V330, P155, DOI 10.3354/meps330155; COOK JR, 1994, J AM STAT ASSOC, V89, P1314, DOI 10.2307/2290994; De Valpine P, 2002, ECOL MONOGR, V72, P57, DOI 10.1890/0012-9615(2002)072[0057:FPMIPN]2.0.CO;2; Dekker R, 2007, MAR ECOL PROG SER, V337, P117, DOI 10.3354/meps337117; Dennis B, 2006, ECOL MONOGR, V76, P323, DOI 10.1890/0012-9615(2006)76[323:EDDPNA]2.0.CO;2; Forrester GE, 2008, ECOLOGY, V89, P2980, DOI 10.1890/07-1546.1; Freckleton RP, 2006, J ANIM ECOL, V75, P837, DOI 10.1111/j.1365-2656.2006.01121.x; Fuiman L.A., 2002, FISHERY SCI UNIQUE C; Gascoigne J, 2004, MAR ECOL PROG SER, V269, P49, DOI 10.3354/meps269049; Hewitt JE, 1997, J EXP MAR BIOL ECOL, V216, P77, DOI 10.1016/S0022-0981(97)00091-9; Hiddink JG, 2002, MAR BIOL, V140, P1149, DOI 10.1007/s00227-002-0794-9; Hiddink JG, 2002, THESIS U GRONINGEN; KAMERMANS P, 1992, J EXP MAR BIOL ECOL, V162, P113, DOI 10.1016/0022-0981(92)90127-V; Kammermans P, 1994, MAR ECOL PROG SER, V104, P63; Kraan C, 2009, MAR ECOL PROG SER, V383, P211, DOI 10.3354/meps07994; LEVINTON J, 1972, AM NAT, V106, P472, DOI 10.1086/282788; Luttikhuizen PC, 2011, J EXP MAR BIOL ECOL, V396, P156, DOI 10.1016/j.jembe.2010.10.017; MYERS RA, 1993, CAN J FISH AQUAT SCI, V50, P1576, DOI 10.1139/f93-179; OATEN A, 1975, AM NAT, V109, P299, DOI 10.1086/282999; OLAFSSON EB, 1994, OCEANOGR MAR BIOL, V32, P65; OLAFSSON EB, 1986, J ANIM ECOL, V55, P517, DOI 10.2307/4735; Planes S, 1998, OIKOS, V83, P293, DOI 10.2307/3546840; Powers SP, 2000, LIMNOL OCEANOGR, V45, P727, DOI 10.4319/lo.2000.45.3.0727; Ruesink JL, 2000, ECOLOGY, V81, P3377; Sale PF, 2000, OECOLOGIA, V124, P166, DOI 10.1007/s004420050003; SOLOMON ME, 1949, J ANIM ECOL, V18, P1, DOI 10.2307/1578; STEWARTOATEN A, 1990, J ANIM ECOL, V59, P1027, DOI 10.2307/5029; Strasser M, 2003, J SEA RES, V49, P47, DOI 10.1016/S1385-1101(02)00198-3; Strasser M, 2002, MAR ECOL PROG SER, V241, P113, DOI 10.3354/meps241113; Strasser M, 2001, J SEA RES, V46, P57, DOI 10.1016/S1385-1101(01)00063-6; Strasser M, 2001, HELGOLAND MAR RES, V55, P182, DOI 10.1007/s101520100080; Strasser M, 2000, THESIS U HAMBURG, P377; TAYLOR LR, 1982, J ANIM ECOL, V51, P879, DOI 10.2307/4012; van Beusekom JEE, 2009, J SEA RES, V61, P26, DOI 10.1016/j.seares.2008.06.005; van der Meer J, 2001, ECOL STU AN, V151, P317; Van der Meer J, 2001, J ANIM ECOL, V70, P159, DOI 10.1046/j.1365-2656.2001.00469.x; van der Veer HW, 2000, MAR ECOL PROG SER, V199, P255, DOI 10.3354/meps199255; van Gils JA, 2009, BIOL LETTERS, V5, P5, DOI 10.1098/rsbl.2008.0452	43	4	4	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2014	9	8							e102491	10.1371/journal.pone.0102491	http://dx.doi.org/10.1371/journal.pone.0102491			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR0CG	25105293	gold, Green Published			2022-12-27	WOS:000343231900005
J	Hutten, M; Dhanasingh, A; Hessler, R; Stover, T; Esser, KH; Moller, M; Lenarz, T; Jolly, C; Groll, J; Scheper, V				Huetten, Mareike; Dhanasingh, Anandhan; Hessler, Roland; Stoever, Timo; Esser, Karl-Heinz; Moeller, Martin; Lenarz, Thomas; Jolly, Claude; Groll, Juergen; Scheper, Verena			In Vitro and In Vivo Evaluation of a Hydrogel Reservoir as a Continuous Drug Delivery System for Inner Ear Treatment	PLOS ONE			English	Article							CROSS-LINKED STAR; CONSERVES HEARING; RESIDUAL HEARING; DEXAMETHASONE; TRAUMA; MODEL	Fibrous tissue growth and loss of residual hearing after cochlear implantation can be reduced by application of the glucocorticoid dexamethasone-21-phosphate-disodium-salt (DEX). To date, sustained delivery of this agent to the cochlea using a number of pharmaceutical technologies has not been entirely successful. In this study we examine a novel way of continuous local drug application into the inner ear using a refillable hydrogel functionalized silicone reservoir. A PEG-based hydrogel made of reactive NCO-sP(EO-stat-PO) prepolymers was evaluated as a drug conveying and delivery system in vitro and in vivo. Encapsulating the free form hydrogel into a silicone tube with a small opening for the drug diffusion resulted in delayed drug release but unaffected diffusion of DEX through the gel compared to the free form hydrogel. Additionally, controlled DEX release over several weeks could be demonstrated using the hydrogel filled reservoir. Using a guinea-pig cochlear trauma model the reservoir delivery of DEX significantly protected residual hearing and reduced fibrosis. As well as being used as a device in its own right or in combination with cochlear implants, the hydrogel-filled reservoir represents a new drug delivery system that feasibly could be replenished with therapeutic agents to provide sustained treatment of the inner ear.	[Huetten, Mareike; Lenarz, Thomas; Scheper, Verena] Hannover Med Sch, Dept Otolaryngol, Hannover, Germany; [Huetten, Mareike; Esser, Karl-Heinz] Univ Vet Med Hannover, Inst Zool, Hannover, Germany; [Dhanasingh, Anandhan; Hessler, Roland; Jolly, Claude] MED EL Innsbruck, Res & Dev, Innsbruck, Austria; [Dhanasingh, Anandhan; Moeller, Martin; Groll, Juergen] Rhein Westfal TH Aachen, Interact Mat Research DWI eV, Aachen, Germany; [Dhanasingh, Anandhan; Moeller, Martin; Groll, Juergen] Rhein Westfal TH Aachen, Inst Tech & Macromol Chem, Aachen, Germany; [Stoever, Timo] JW Goethe Univ Hosp, Frankfurt, Germany; [Stoever, Timo] Fac Med, Dept Otolaryngol, Frankfurt, Germany; [Groll, Juergen] Univ Wurzburg, Dept Funct Mat Med & Dent, D-97070 Wurzburg, Germany; [Scheper, Verena] Hannover Med Sch, Inst Audioneurotechnol, Hannover, Germany	Hannover Medical School; University of Veterinary Medicine Hannover, Foundation; RWTH Aachen University; RWTH Aachen University; Goethe University Frankfurt; Goethe University Frankfurt Hospital; University of Wurzburg; Hannover Medical School	Groll, J (corresponding author), Rhein Westfal TH Aachen, Interact Mat Research DWI eV, Aachen, Germany.	juergen.groll@fmz.uni-wuerzburg.de; scheper.verena@mh-hannover.de	Scheper, Verena/J-4298-2019; Groll, Jürgen/F-4202-2012; Möller, Martin/F-7860-2015	Scheper, Verena/0000-0001-8618-8793; Groll, Jürgen/0000-0003-3167-8466; Möller, Martin/0000-0002-5955-4185	DFG [SPP 1259]; European Community 6th Framework Programme on Research, Technological Development and Demonstration (Nanotechnology based Drug Delivery., Project acronym: NANOEAR; Hannover Medical School, MED-EL, RWTH Aachen) [NMP4-CT-2006-026556]	DFG(German Research Foundation (DFG)); European Community 6th Framework Programme on Research, Technological Development and Demonstration (Nanotechnology based Drug Delivery., Project acronym: NANOEAR; Hannover Medical School, MED-EL, RWTH Aachen)	This study was supported by the DFG within the SPP 1259 "Intelligent hydrogels" (RWTH Aachen) and the European Community 6th Framework Programme on Research, Technological Development and Demonstration (Nanotechnology based Drug Delivery. Contract Number: NMP4-CT-2006-026556, Project acronym: NANOEAR; Hannover Medical School, MED-EL, RWTH Aachen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abi-Hachem Ralph N, 2010, Recent Pat CNS Drug Discov, V5, P147; Birman CS, 2014, OTOL NEUROTOL, V35, P1385, DOI 10.1097/MAO.0000000000000362; Borenstein JT, 2011, EXPERT OPIN DRUG DEL, V8, P1161, DOI 10.1517/17425247.2011.588207; Braun S, 2011, ORL-J OTO-RHIN-LARYN, V73, P219, DOI 10.1159/000329791; Burghard A, 2014, HEARING RES, V312, P21, DOI 10.1016/j.heares.2014.02.002; Chandrasekhar SS, 2000, OTOLARYNG HEAD NECK, V122, P521, DOI 10.1016/S0194-5998(00)70094-5; Dalton PD, 2008, MACROMOL BIOSCI, V8, P923, DOI 10.1002/mabi.200800080; Dhanasingh A, 2012, SOFT MATTER, V8, P1643, DOI 10.1039/c1sm06603j; Dhanasingh A, 2010, SOFT MATTER, V6, P618, DOI 10.1039/b917113d; ELKAFRAWY AH, 1974, J DENT RES, V53, P15, DOI 10.1177/00220345740530012001; Eshraghi AA, 2007, OTOL NEUROTOL, V28, P842, DOI 10.1097/MAO.0b013e31805778fc; Gotz H, 2002, MACROMOL MATER ENG, V287, P223, DOI 10.1002/1439-2054(20020401)287:4<223::AID-MAME223>3.0.CO;2-Z; Groll J, 2004, J AM CHEM SOC, V126, P4234, DOI 10.1021/ja0318028; Hoffman AS, 2012, ADV DRUG DELIVER REV, V64, P18, DOI 10.1016/j.addr.2012.09.010; Ito M, 2001, United States Patent, Patent No. [US 6,214,048 B1, 6214048]; James DP, 2008, AUDIOL NEURO-OTOL, V13, P86, DOI 10.1159/000111780; Jolly C, 2010, ADV OTO-RHINO-LARYNG, V67, P28, DOI 10.1159/000262594; Kim HH, 2007, LARYNGOSCOPE, V117, P1209, DOI 10.1097/MLG.0b013e318058195f; Kim P, 2005, NANOTECHNOLOGY, V16, P2420, DOI 10.1088/0957-4484/16/10/072; Lenarz Thomas, 1998, Acta Oto-Rhino-Laryngologica Belgica, V52, P183; LERVIK T, 1978, ORAL SURG ORAL MED O, V45, P123, DOI 10.1016/0030-4220(78)90235-9; Luttikhuizen DT, 2006, TISSUE ENG, V12, P1955, DOI 10.1089/ten.2006.12.1955; Meltser I, 2011, HEARING RES, V281, P47, DOI 10.1016/j.heares.2011.06.003; MERRILL EW, 1993, J BIOMAT SCI-POLYM E, V5, P1; Messmer UK, 2001, BRIT J PHARMACOL, V133, P467, DOI 10.1038/sj.bjp.0704093; Nadol JB, 2004, OTOL NEUROTOL, V25, P257, DOI 10.1097/00129492-200405000-00010; NADOL JB, 1991, ANN OTO RHINOL LARYN, V100, P712, DOI 10.1177/000348949110000904; O'Leary SJ, 2013, HEARING RES, V298, P27, DOI 10.1016/j.heares.2013.01.012; Paasche G, 2006, OTOL NEUROTOL, V27, P639, DOI 10.1097/01.mao.0000227662.88840.61; Peppas NA, 1999, J CONTROL RELEASE, V62, P81, DOI 10.1016/S0168-3659(99)00027-9; Ruben R.J., 1967, ACTA OTO-LARYNGOL, DOI DOI 10.3109/00016486709127790; Scheper V, 2009, NANOMEDICINE-UK, V4, P623, DOI 10.2217/NNM.09.41; Scheper V, 2009, J NEUROSCI RES, V87, P1389, DOI 10.1002/jnr.21964; Seltzer S, 1976, J Endod, V2, P208, DOI 10.1016/S0099-2399(76)80135-5; Takemura K, 2004, HEARING RES, V196, P58, DOI 10.1016/j.heares.2004.06.003; Tizard I.R., 2004, VET IMMUNOLOGY INTRO, P67; Vivero RJ, 2008, LARYNGOSCOPE, V118, P2028, DOI 10.1097/MLG.0b013e31818173ec	37	31	32	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2014	9	8							e104564	10.1371/journal.pone.0104564	http://dx.doi.org/10.1371/journal.pone.0104564			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR0CG	25105670	Green Published, gold, Green Submitted			2022-12-27	WOS:000343231900071
J	Kelso, JK; Milne, GJ				Kelso, Joel K.; Milne, George J.			A Spatial Simulation Model for the Dispersal of the Bluetongue Vector Culicoides brevitarsis in Australia	PLOS ONE			English	Article							KIEFFER DIPTERA-CERATOPOGONIDAE; SOUTHERN LIMITS; INFECTIOUS-DISEASES; SEASONAL ABUNDANCE; ARBOVIRUS VECTOR; DIFFUSION-MODEL; MOUTH EPIDEMIC; BITING-MIDGES; VIRUS; TRANSMISSION	Background: The spread of Bluetongue virus (BTV) among ruminants is caused by movement of infected host animals or by movement of infected Culicoides midges, the vector of BTV. Biologically plausible models of Culicoides dispersal are necessary for predicting the spread of BTV and are important for planning control and eradication strategies. Methods: A spatially-explicit simulation model which captures the two underlying population mechanisms, population dynamics and movement, was developed using extensive data from a trapping program for C. brevitarsis on the east coast of Australia. A realistic midge flight sub-model was developed and the annual incursion and population establishment of C. brevitarsis was simulated. Data from the literature was used to parameterise the model. Results: The model was shown to reproduce the spread of C. brevitarsis southwards along the east Australian coastline in spring, from an endemic population to the north. Such incursions were shown to be reliant on wind-dispersal; Culicoides midge active flight on its own was not capable of achieving known rates of southern spread, nor was re-emergence of southern populations due to overwintering larvae. Data from midge trapping programmes were used to qualitatively validate the resulting simulation model. Conclusions: The model described in this paper is intended to form the vector component of an extended model that will also include BTV transmission. A model of midge movement and population dynamics has been developed in sufficient detail such that the extended model may be used to evaluate the timing and extent of BTV outbreaks. This extended model could then be used as a platform for addressing the effectiveness of spatially targeted vaccination strategies or animal movement bans as BTV spread mitigation measures, or the impact of climate change on the risk and extent of outbreaks. These questions involving incursive Culicoides spread cannot be simply addressed with non-spatial models.	[Kelso, Joel K.; Milne, George J.] Univ Western Australia, Sch Comp Sci & Software Engn, Crawley, WA, Australia	University of Western Australia	Milne, GJ (corresponding author), Univ Western Australia, Sch Comp Sci & Software Engn, Crawley, WA, Australia.	george.milne@uwa.edu.au	Milne, George/C-6839-2013	Kelso, Joel/0000-0001-9814-6435; Milne, George/0000-0002-9796-0600	Meat and Livestock Australia [B.AHE.0037]	Meat and Livestock Australia(Meat and Livestock Australia)	Research was funded by Meat and Livestock Australia (project number B.AHE.0037). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKEY DH, 1978, ANN ENTOMOL SOC AM, V71, P411, DOI 10.1093/aesa/71.3.411; Backer JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023066; Beebe NW, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002361; Bishop AL, 2000, PREV VET MED, V47, P243, DOI 10.1016/S0167-5877(00)00175-6; Bishop AL, 1996, AUST J ENTOMOL, V35, P361, DOI 10.1111/j.1440-6055.1996.tb01419.x; BISHOP AL, 1994, J AUST ENTOMOL SOC, V33, P159; BISHOP AL, 1995, AUST VET J, V72, P53, DOI 10.1111/j.1751-0813.1995.tb15330.x; BISHOP AL, 1995, J AUST ENTOMOL SOC, V34, P289; Burgin LE, 2013, TRANSBOUND EMERG DIS, V60, P263, DOI 10.1111/j.1865-1682.2012.01345.x; CAMPBELL MM, 1975, AUST J ZOOL, V23, P203, DOI 10.1071/ZO9750203; CAMPBELL MM, 1976, AUST J ZOOL, V24, P75, DOI 10.1071/ZO9760075; Caron M, 2012, CLIN INFECT DIS, V55, pE45, DOI 10.1093/cid/cis530; Carpenter S, 2009, TRENDS MICROBIOL, V17, P172, DOI 10.1016/j.tim.2009.01.001; Congalton R.G., 2019, ASSESSING ACCURACY R, VThird, DOI 10.1201/9780429052729; Davies T, 2005, Q J ROY METEOR SOC, V131, P1759, DOI 10.1256/qj.04.101; de Koeijer AA, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-53; Ducheyne E, 2007, GEOSPATIAL HEALTH, V1, P177, DOI 10.4081/gh.2007.266; Ducheyne E, 2011, PREV VET MED, V99, P48, DOI 10.1016/j.prevetmed.2011.01.003; Eagles D, 2013, PREV VET MED, V110, P312, DOI 10.1016/j.prevetmed.2013.02.022; Eagles D, 2012, MED VET ENTOMOL, V26, P334, DOI 10.1111/j.1365-2915.2011.01005.x; Ferguson NM, 2001, SCIENCE, V292, P1155, DOI 10.1126/science.1061020; Fu SC, 2004, LECT NOTES COMPUT SC, V3305, P642; Garner MG, 2006, ENVIRON MODEL ASSESS, V11, P195, DOI 10.1007/s10666-005-9023-5; Gerry AC, 2000, J MED ENTOMOL, V37, P675, DOI 10.1603/0022-2585-37.5.675; Gorman BM, 1990, BLUETONGUE VIRUSES; Gubbins S, 2008, J R SOC INTERFACE, V5, P363, DOI 10.1098/rsif.2007.1110; Jones DA, 2000, AUST METEOROL MAG, V49, P261; KAREIVA PM, 1983, OECOLOGIA, V57, P322, DOI 10.1007/BF00377175; Keeling MJ, 2001, SCIENCE, V294, P813, DOI 10.1126/science.1065973; Kelso JK, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-117; KETTLE DS, 1951, B ENTOMOL RES, V42, P239, DOI 10.1017/S0007485300025323; Kirkeby C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061269; Klingseisen B, 2011, SURV SPAT SCI BIENN; KOCH SE, 1983, J CLIM APPL METEOROL, V22, P1487, DOI 10.1175/1520-0450(1983)022<1487:AIBOMA>2.0.CO;2; LILLIE TH, 1981, CAN ENTOMOL, V113, P419, DOI 10.4039/Ent113419-5; Mellor PS, 2000, ANNU REV ENTOMOL, V45, P307, DOI 10.1146/annurev.ento.45.1.307; Meroc E, 2009, TRANSBOUND EMERG DIS, V56, P39, DOI 10.1111/j.1865-1682.2008.01063.x; Milne G, 2008, VET RES, V39, DOI 10.1051/vetres:2008029; Milne G, 2010, J R SOC INTERFACE, V7, P573, DOI 10.1098/rsif.2009.0312; Milne GJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004005; Mintiens K, 2008, PREV VET MED, V87, P145, DOI 10.1016/j.prevetmed.2008.06.010; MURRAY MD, 1987, AUST J ZOOL, V35, P575, DOI 10.1071/ZO9870575; MURRAY MD, 1975, AUST VET J, V51, P216, DOI 10.1111/j.1751-0813.1975.tb00060.x; MURRAY MD, 1987, AUST J ZOOL, V35, P559, DOI 10.1071/ZO9870559; MURRAY MD, 1991, AUST J ZOOL, V39, P333, DOI 10.1071/ZO9910333; Pioz M, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-60; Purse BV, 2005, NAT REV MICROBIOL, V3, P171, DOI 10.1038/nrmicro1090; Ritchie SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068137; Ross R., 1911, PREVENTION MALARIA; Ross S.M., 1996, STOCHASTIC PROCESSES; RUDD WG, 1985, J ECON ENTOMOL, V78, P295, DOI 10.1093/jee/78.2.295; Schley D, 2009, J R SOC INTERFACE, V6, P455, DOI 10.1098/rsif.2008.0306; Sedda L, 2012, P ROY SOC B-BIOL SCI, V279, P2354, DOI 10.1098/rspb.2011.2555; Szmaragd C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007741; Talbalaghi A, 2010, MED VET ENTOMOL, V24, P83, DOI 10.1111/j.1365-2915.2009.00853.x; Vazquez-Prokopec GM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000920; Verhulst, 1845, NOUVEAUX MEMOIRES AC, V18, P1; WARD MP, 1995, PREV VET MED, V24, P129, DOI 10.1016/0167-5877(94)00458-U; Wilson A, 2007, VET REC, V161, P487, DOI 10.1136/vr.161.14.487; Wilson E. O., 1971, PRIMER POPULATION BI; Wolfram S., 2002, NEW KIND SCI; Zeigler B.P., 1976, THEORY MODELING SIMU	62	11	11	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2014	9	8							e104646	10.1371/journal.pone.0104646	http://dx.doi.org/10.1371/journal.pone.0104646			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR0CG	25105418	Green Published, Green Submitted, gold			2022-12-27	WOS:000343231900076
J	Moerdyk-Schauwecker, M; Hwang, SI; Grdzelishvili, VZ				Moerdyk-Schauwecker, Megan; Hwang, Sun-Il; Grdzelishvili, Valery Z.			Cellular Proteins Associated with the Interior and Exterior of Vesicular Stomatitis Virus Virions	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; COMPLEMENT-MEDIATED DESTRUCTION; HUMAN CYTOMEGALOVIRUS HCMV; LARGE GENE LISTS; PROTEOMIC ANALYSIS; HOST PROTEINS; MASS-SPECTROMETRY; VACCINIA VIRUS; INTRACELLULAR MATURE; ENVELOPED VIRUSES	Virus particles (virions) often contain not only virus-encoded but also host-encoded proteins. Some of these host proteins are enclosed within the virion structure, while others, in the case of enveloped viruses, are embedded in the host-derived membrane. While many of these host protein incorporations are likely accidental, some may play a role in virus infectivity, replication and/or immunoreactivity in the next host. Host protein incorporations may be especially important in therapeutic applications where large numbers of virus particles are administered. Vesicular stomatitis virus (VSV) is the prototypic rhabdovirus and a candidate vaccine, gene therapy and oncolytic vector. Using mass spectrometry, we previously examined cell type dependent host protein content of VSV virions using intact ("whole") virions purified from three cell lines originating from different species. Here we aimed to determine the localization of host proteins within the VSV virions by analyzing: i) whole VSV virions; and ii) whole VSV virions treated with Proteinase K to remove all proteins outside the viral envelope. A total of 257 proteins were identified, with 181 identified in whole virions and 183 identified in Proteinase K treated virions. Most of these proteins have not been previously shown to be associated with VSV. Functional enrichment analysis indicated the most overrepresented categories were proteins associated with vesicles, vesicle-mediated transport and protein localization. Using western blotting, the presence of several host proteins, including some not previously shown in association with VSV (such as Yes1, Prl1 and Ddx3y), was confirmed and their relative quantities in various virion fractions determined. Our study provides a valuable inventory of virion-associated host proteins for further investigation of their roles in the replication cycle, pathogenesis and immunoreactivity of VSV.	[Moerdyk-Schauwecker, Megan; Grdzelishvili, Valery Z.] Univ N Carolina, Dept Biol Sci, Charlotte, NC 28223 USA; [Moerdyk-Schauwecker, Megan; Grdzelishvili, Valery Z.] Univ N Carolina, Ctr Biomed Engn & Sci, Charlotte, NC 28223 USA; [Hwang, Sun-Il] Carolinas HealthCare Syst, Prote Lab Clin & Translat Res, Charlotte, NC USA	University of North Carolina; University of North Carolina Charlotte; University of North Carolina; University of North Carolina Charlotte; Carolinas HealthCare System	Grdzelishvili, VZ (corresponding author), Univ N Carolina, Dept Biol Sci, Charlotte, NC 28223 USA.	vzgrdzel@uncc.edu	Grdzelishvili, Valery Z./AFL-6027-2022	Hwang, Sunil/0000-0003-0600-3694; Grdzelishvili, Valery/0000-0001-8715-3840				Amet T, 2012, HEPATOLOGY, V55, P354, DOI 10.1002/hep.24686; Barber GN, 2004, VIRAL IMMUNOL, V17, P516, DOI 10.1089/vim.2004.17.516; Bortz E, 2003, J VIROL, V77, P13425, DOI 10.1128/JVI.77.24.13425-13432.2003; Bounou S, 2002, J VIROL, V76, P1004, DOI 10.1128/JVI.76.3.1004-1014.2002; BROUILLETTE CG, 1982, J BIOL CHEM, V257, P12; Bukreyev A, 2006, J VIROL, V80, P10293, DOI 10.1128/JVI.00919-06; Cantin R, 2005, J VIROL, V79, P6577, DOI 10.1128/JVI.79.11.6577-6587.2005; Chan R, 2008, J VIROL, V82, P11228, DOI 10.1128/JVI.00981-08; Chen BJ, 2008, VIROLOGY, V372, P221, DOI 10.1016/j.virol.2007.11.008; Chertova E, 2006, J VIROL, V80, P9039, DOI 10.1128/JVI.01013-06; Chung CS, 2006, J VIROL, V80, P2127, DOI 10.1128/JVI.80.5.2127-2140.2006; Das SC, 2006, J VIROL, V80, P6368, DOI 10.1128/JVI.00211-06; DE BP, 1984, J VIROL, V51, P628, DOI 10.1128/JVI.51.3.628-634.1984; Dry I, 2008, J VIROL, V82, P5390, DOI 10.1128/JVI.00094-08; Finke S, 2005, CURR TOP MICROBIOL, V292, P165; Fortin JF, 2000, VIROLOGY, V268, P493, DOI 10.1006/viro.2000.0190; Fortin JF, 1997, J VIROL, V71, P3588, DOI 10.1128/JVI.71.5.3588-3596.1997; Grdzelishvili VZ, 2005, J VIROL, V79, P7327, DOI 10.1128/JVI.79.12.7327-7337.2005; Harty RN, 1999, J VIROL, V73, P2921, DOI 10.1128/JVI.73.4.2921-2929.1999; Harty RN, 2001, J VIROL, V75, P10623, DOI 10.1128/JVI.75.22.10623-10629.2001; Hastie E, 2012, J GEN VIROL; Hioe CE, 1998, AIDS RES HUM RETROV, V14, pS247; Hu WG, 2010, J IMMUNOL, V184, P359, DOI 10.4049/jimmunol.0902278; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hwang SI, 2006, MOL CELL PROTEOMICS, V5, P1131, DOI 10.1074/mcp.M500162-MCP200; Irie T, 2004, J VIROL, V78, P2657, DOI 10.1128/JVI.78.6.2657-2665.2004; Jayakar HR, 2004, VIRUS RES, V106, P117, DOI 10.1016/j.virusres.2004.08.009; Johannsen E, 2004, P NATL ACAD SCI USA, V101, P16286, DOI 10.1073/pnas.0407320101; Johnson JB, 2009, J VIROL, V83, P7602, DOI 10.1128/JVI.00713-09; Kalvodova L, 2009, J VIROL, V83, P7996, DOI 10.1128/JVI.00635-09; Kariithi HM, 2013, J GEN VIROL, V94, P193, DOI 10.1099/vir.0.047423-0; Kattenhorn LM, 2004, J VIROL, V78, P11187, DOI 10.1128/JVI.78.20.11187-11197.2004; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kondo N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044827; Kong QM, 2010, PROTEOME SCI, V8, DOI 10.1186/1477-5956-8-29; Kramer T, 2011, J VIROL, V85, P6427, DOI 10.1128/JVI.02253-10; LAWSON ND, 1995, P NATL ACAD SCI USA, V92, P4477, DOI 10.1073/pnas.92.10.4477; Leser GP, 2005, VIROLOGY, V342, P215, DOI 10.1016/j.virol.2005.09.049; Loret S, 2008, J VIROL, V82, P8605, DOI 10.1128/JVI.00904-08; Losier M, 2003, CLIN IMMUNOL, V108, P111, DOI 10.1016/S1521-6616(03)00093-7; Lundgren DH, 2010, EXPERT REV PROTEOMIC, V7, P39, DOI 10.1586/EPR.09.69; Lyles D, 2007, FIELDS VIROLOGY, P1364; Manes NP, 2008, J PROTEOME RES, V7, P960, DOI 10.1021/pr070432+; Martin-Serrano J, 2005, J CELL BIOL, V168, P89, DOI 10.1083/jcb.200408155; MCCOMBS RM, 1966, J BACTERIOL, V91, P803, DOI 10.1128/JB.91.2.803-812.1966; METSIKKO K, 1989, J VIROL, V63, P5111; Moerdyk-Schauwecker M, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-166; Neuman BW, 2008, J VIROL, V82, P5279, DOI 10.1128/JVI.02631-07; Nguyen DH, 2000, J VIROL, V74, P3264, DOI 10.1128/JVI.74.7.3264-3272.2000; ORENSTEIN J, 1976, VIROLOGY, V71, P291, DOI 10.1016/0042-6822(76)90113-6; Ott DE, 1996, J VIROL, V70, P7734, DOI 10.1128/JVI.70.11.7734-7743.1996; Paquette JS, 1998, J VIROL, V72, P9329, DOI 10.1128/JVI.72.11.9329-9336.1998; Radhakrishnan A, 2010, MOL CELL PROTEOMICS, V9, P1829, DOI 10.1074/mcp.M110.001651; Ren XP, 2012, PROTEOME SCI, V10, DOI 10.1186/1477-5956-10-32; Resch W, 2007, VIROLOGY, V358, P233, DOI 10.1016/j.virol.2006.08.025; Rizzuto CD, 1997, J VIROL, V71, P4847, DOI 10.1128/JVI.71.6.4847-4851.1997; Sadygov RG, 2002, J PROTEOME RES, V1, P211, DOI 10.1021/pr015514r; Saifuddin M, 1997, J GEN VIROL, V78, P1907, DOI 10.1099/0022-1317-78-8-1907; Saphire ACS, 2006, J PROTEOME RES, V5, P530, DOI 10.1021/pr050276b; Schnell MJ, 1996, P NATL ACAD SCI USA, V93, P11359, DOI 10.1073/pnas.93.21.11359; Segura MM, 2008, J VIROL, V82, P1107, DOI 10.1128/JVI.01909-07; Shaw ML, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000085; SPEAR GT, 1995, J IMMUNOL, V155, P4376; Stegen C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053276; Stephenson ST, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-107; Swinteck BD, 2008, J VIROL, V82, P5536, DOI 10.1128/JVI.02407-07; Taylor GM, 2007, J VIROL, V81, P13631, DOI 10.1128/JVI.01688-07; Vanderplasschen A, 1998, P NATL ACAD SCI USA, V95, P7544, DOI 10.1073/pnas.95.13.7544; Varnum SM, 2004, J VIROL, V78, P10960, DOI 10.1128/JVI.78.20.10960-10966.2004; Wang RR, 2010, J VIROL, V84, P7233, DOI 10.1128/JVI.00040-10; YATES JR, 1995, ANAL CHEM, V67, P3202, DOI 10.1021/ac00114a016; Yates JR, 1996, ANALYST, V121, pR65, DOI 10.1039/an996210065r; Zhang CW, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-242; Zhu FX, 2005, J VIROL, V79, P800, DOI 10.1128/JVI.79.2.800-811.2005	75	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2014	9	8							e104688	10.1371/journal.pone.0104688	http://dx.doi.org/10.1371/journal.pone.0104688			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR0CG	25105980	Green Published, gold			2022-12-27	WOS:000343231900081
J	Niu, J; Zhu, BQ; Cai, J; Li, PX; Wang, LB; Dai, HT; Qiu, L; Yu, HY; Ha, DL; Zhao, HY; Zhang, ZX; Lin, SZ				Niu, Jun; Zhu, Baoqing; Cai, Jian; Li, Peixue; Wang, Libing; Dai, Huitang; Qiu, Lin; Yu, Haiyan; Ha, Denglong; Zhao, Haiyan; Zhang, Zhixiang; Lin, Shanzhi			Selection of Reference Genes for Gene Expression Studies in Siberian Apricot (Prunus sibirica L.) Germplasm Using Quantitative Real-Time PCR	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; RT-PCR; HOUSEKEEPING GENES; INTERNAL CONTROLS; NORMALIZATION; VALIDATION; IDENTIFICATION; RNA; GUIDELINES; VARIETIES	Quantitative real time reverse transcription polymerase chain reaction has been applied in a vast range of studies of gene expression analysis. However, real-time PCR data must be normalized with one or more reference genes. In this study, eleven putative consistently expressed genes (ACT, TUA, TUB, CYP, DNAj, ELFA, F-box27, RPL12, GAPDH, UBC and UBQ) in nine Siberian Apricot Germplasms (including much variability) were evaluated for their potential as references for the normalization of gene expression by NormFinder and geNorm programs. From our studies, ACT, UBC, CYP, UBQ and RPL12 as suitable for normalization were identified by geNorm, while UBC and CYP as the best pair by NormFinder. Moreover, UBC was selected as the most stably expressed gene by both algorithms in different Siberian Apricot seed samples. We also detected that a set of three genes (ACT, CYP and UBC) by geNorm as control for normalization could lead to accurate results. Furthermore, the expression levels of oleosin gene were analyzed to validate the suitability of the selected reference genes. These obtained experimental results could make an important contribution to normalize real-time PCR data for gene expression analysis in Siberian Apricot Germplasm.	[Niu, Jun; Zhu, Baoqing; Cai, Jian; Zhang, Zhixiang; Lin, Shanzhi] Beijing Forestry Univ, Minist Educ, Coll Nat Conservat,Coll Biol Sci & Biotechnol, Natl Engn Lab Tree Breeding,Key Lab Genet & Breed, Beijing, Peoples R China; [Li, Peixue; Dai, Huitang; Qiu, Lin; Ha, Denglong; Zhao, Haiyan] Jigongshan Natl Nat Reserve, Xingyang, Peoples R China; [Wang, Libing; Yu, Haiyan] Chinese Acad Forestry, Res Inst Forestry, Beijing, Peoples R China	Beijing Forestry University; Chinese Academy of Forestry; Research Institute of Forestry, CAF	Lin, SZ (corresponding author), Beijing Forestry Univ, Minist Educ, Coll Nat Conservat,Coll Biol Sci & Biotechnol, Natl Engn Lab Tree Breeding,Key Lab Genet & Breed, Beijing, Peoples R China.	szlin@bjfu.edu.cn	Zhu, Baoqing/L-3326-2019	Zhu, Baoqing/0000-0002-9767-6888	National Natural Sciences Foundation of China [J1103516]; Central Public-Interest Scientific Institution Basal Research Fund [RIF2013-02, 201004001]; Chinese Key Technology Research and Development Program of Twelfth Five-Year Plan [2011BAD22B08]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Central Public-Interest Scientific Institution Basal Research Fund; Chinese Key Technology Research and Development Program of Twelfth Five-Year Plan	This research was supported by the National Natural Sciences Foundation of China (No. J1103516), the Central Public-Interest Scientific Institution Basal Research Fund (RIF2013-02) (No. 201004001) and the Chinese Key Technology Research and Development Program of Twelfth Five-Year Plan (No. 2011BAD22B08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Artico S, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-49; Brulle F, 2014, ECOTOXICOLOGY, V23, P459, DOI 10.1007/s10646-014-1209-7; Brunner Amy M., 2004, BMC Plant Biology, V4, P14, DOI 10.1186/1471-2229-4-14; Bustin SA, 2005, J MOL ENDOCRINOL, V34, P597, DOI 10.1677/jme.1.01755; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Bustin SA, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-74; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cao SN, 2012, BIOCHEM BIOPH RES CO, V424, P118, DOI 10.1016/j.bbrc.2012.06.086; Chang EM, 2013, PLOS ONE, V7; D'haene B, 2010, METHODS, V50, P262, DOI 10.1016/j.ymeth.2009.12.007; de Vega-Bartol JJ, 2013, PLANT CELL REP, V32, P715, DOI 10.1007/s00299-013-1407-4; Dragovic-Uzelac V, 2007, FOOD CHEM, V102, P966, DOI 10.1016/j.foodchem.2006.04.001; Du YS, 2013, FISH SHELLFISH IMMUN, V34, P939, DOI 10.1016/j.fsi.2012.12.007; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Jain M, 2006, BIOCHEM BIOPH RES CO, V345, P646, DOI 10.1016/j.bbrc.2006.04.140; Jian B, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-59; Jiang PL, 2010, PLANT SIGNAL BEHAV, V5, P447, DOI 10.4161/psb.5.4.10874; Kumar P, 2012, REPROD DOMEST ANIM, V47, pe88, DOI 10.1111/j.1439-0531.2012.01998.x; Lee JM, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-8; Li-bing W, 2010, FOREST RES, V3, P020; Lovdal T, 2014, MOL BIOTECHNOL, V56, P210, DOI 10.1007/s12033-013-9697-x; Lovdal T, 2009, ANAL BIOCHEM, V387, P238, DOI 10.1016/j.ab.2009.01.024; Mallona I, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-4; Manzoor M, 2012, GRASAS ACEITES, V63, P193, DOI 10.3989/gya.095011; Marty I, 2005, J EXP BOT, V56, P1877, DOI 10.1093/jxb/eri177; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Suzuki T, 2000, BIOTECHNIQUES, V29, P332, DOI 10.2144/00292rv02; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Tong ZG, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-71; Tricarico C, 2002, ANAL BIOCHEM, V309, P293, DOI 10.1016/S0003-2697(02)00311-1; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang LB., 2011, FOREST RESOURCES MAN, V5, P65; Wood SH, 2008, VET IMMUNOL IMMUNOP, V126, P392, DOI 10.1016/j.vetimm.2008.08.006; Yin ZY, 2013, WORLD J MICROB BIOT, V29, P1563, DOI 10.1007/s11274-013-1320-6; Zhang J, 2011, FOOD CHEM TOXICOL, V49, P3136, DOI 10.1016/j.fct.2011.08.015	38	21	27	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2014	9	8							e103900	10.1371/journal.pone.0103900	http://dx.doi.org/10.1371/journal.pone.0103900			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR0CG	25105495	Green Published, gold, Green Submitted			2022-12-27	WOS:000343231900028
J	Smith, MS; Fridley, JD; Goebel, M; Bauerle, TL				Smith, Maria S.; Fridley, Jason D.; Goebel, Marc; Bauerle, Taryn L.			Links between Belowground and Aboveground Resource-Related Traits Reveal Species Growth Strategies that Promote Invasive Advantages	PLOS ONE			English	Article							FINE-ROOT DYNAMICS; LIFE-SPAN; BIOMASS ALLOCATION; LEAF PHENOLOGY; PLANT INVASION; USE EFFICIENCY; BRANCH ORDER; SOIL; FOREST; CARBON	Belowground processes are rarely considered in comparison studies of native verses invasive species. We examined relationships between belowground fine root production and lifespan, leaf phenology, and seasonal nitrogen dynamics of Lonicera japonica (non-native) versus L. sempervirens (native) and Frangula alnus (non-native) versus Rhamnus alnifolia (native), over time. First and second order fine roots were monitored from 2010 to 2012 using minirhizotron technology and rhizotron windows. N-15 uptake of fine roots was measured across spring and fall seasons. Significant differences in fine root production across seasons were seen between Lonicera species, but not between Frangula and Rhamnus, with both groups having notable asynchrony in regards to the timing of leaf production. Root order and the number of root neighbors at the time of root death were the strongest predictors of root lifespan of both species pairs. Seasonal N-15 uptake was higher in spring than in the fall, which did not support the need for higher root activity to correspond with extended leaf phenology. We found higher spring N-15 uptake in non-native L. japonica compared to native L. sempervirens, although there was no difference in N-15 uptake between Frangula and Rhamnus species. Our findings indicate the potential for fast-growing non-native Lonicera japonica and Frangula alnus to outcompete native counterparts through differences in biomass allocation, root turnover, and nitrogen uptake, however evidence that this is a general strategy of invader dominance is limited.	[Smith, Maria S.; Bauerle, Taryn L.] Cornell Univ, Dept Hort, Ithaca, NY 14850 USA; [Fridley, Jason D.] Syracuse Univ, Dept Biol, Syracuse, NY 13244 USA; [Goebel, Marc] Cornell Univ, Dept Nat Resources, Ithaca, NY 14853 USA	Cornell University; Syracuse University; Cornell University	Bauerle, TL (corresponding author), Cornell Univ, Dept Hort, 134A Plant Sci Bldg, Ithaca, NY 14850 USA.	bauerle@cornell.edu						Allison P. D., 2010, SURVIVAL ANAL USING, VSecond; Allison SD, 2004, OECOLOGIA, V141, P612, DOI 10.1007/s00442-004-1679-z; Brassard BW, 2009, CRIT REV PLANT SCI, V28, P179, DOI 10.1080/07352680902776572; BURKE MK, 1994, PLANT SOIL, V162, P135, DOI 10.1007/BF01416099; Burton AJ, 2000, OECOLOGIA, V125, P389, DOI 10.1007/s004420000455; Burton AJ, 2012, GLOBAL CHANGE BIOL, V18, P258, DOI 10.1111/j.1365-2486.2011.02527.x; Chen HYH, 2013, CRIT REV PLANT SCI, V32, P151, DOI 10.1080/07352689.2012.734742; Cleland EE, 2007, TRENDS ECOL EVOL, V22, P357, DOI 10.1016/j.tree.2007.04.003; Comas LH, 2004, FUNCT ECOL, V18, P388, DOI 10.1111/j.0269-8463.2004.00835.x; COX DR, 1972, J R STAT SOC B, V34, P187; Daehler CC, 2003, ANNU REV ECOL EVOL S, V34, P183, DOI 10.1146/annurev.ecolsys.34.011802.132403; Davis MA, 2000, J ECOL, V88, P528, DOI 10.1046/j.1365-2745.2000.00473.x; Dawson W, 2011, GLOBAL ECOL BIOGEOGR, V20, P299, DOI 10.1111/j.1466-8238.2010.00599.x; Drenovsky RE, 2012, ANN BOT-LONDON, V110, P141, DOI 10.1093/aob/mcs100; Ehrenfeld JG, 2003, ECOSYSTEMS, V6, P503, DOI 10.1007/s10021-002-0151-3; Ehrenfeld JG, 2001, ECOL APPL, V11, P1287, DOI 10.2307/3060920; Eissenstat DM, 1997, ADV ECOL RES, V27, P1, DOI 10.1016/S0065-2504(08)60005-7; Fan PP, 2010, OECOLOGIA, V163, P509, DOI 10.1007/s00442-009-1541-4; Fitter AH, 1999, OECOLOGIA, V120, P575, DOI 10.1007/s004420050892; FITTER AH, 1987, NEW PHYTOL, V106, P61, DOI 10.1111/j.1469-8137.1987.tb04683.x; Fridley JD, 2012, NATURE, V485, P359, DOI 10.1038/nature11056; Funk JL, 2008, J ECOL, V96, P1162, DOI 10.1111/j.1365-2745.2008.01435.x; Funk JL, 2007, NATURE, V446, P1079, DOI 10.1038/nature05719; GARTNER BL, 1991, ECOLOGY, V72, P2005, DOI 10.2307/1941555; Goebel M, 2011, ECOL MONOGR, V81, P89, DOI 10.1890/09-2390.1; Guo DL, 2008, NEW PHYTOL, V180, P673, DOI 10.1111/j.1469-8137.2008.02573.x; Guo DL, 2008, J ECOL, V96, P737, DOI 10.1111/j.1365-2745.2008.01385.x; Guo DL, 2004, OECOLOGIA, V140, P450, DOI 10.1007/s00442-004-1596-1; Harner MJ, 2010, BIOL INVASIONS, V12, P1481, DOI 10.1007/s10530-009-9559-4; Heberling JM, 2013, NEW PHYTOL, V200, P523, DOI 10.1111/nph.12388; Hendrick RL, 1997, ECOSCIENCE, V4, P99, DOI 10.1080/11956860.1997.11682383; HENDRICK RL, 1993, CAN J FOREST RES, V23, P2507, DOI 10.1139/x93-312; Herron PM, 2007, DIVERS DISTRIB, V13, P633, DOI 10.1111/j.1472-4642.2007.00381.x; Isnard S, 2009, AM J BOT, V96, P1205, DOI 10.3732/ajb.0900045; Joslin JD, 2001, PLANT SOIL, V228, P201, DOI 10.1023/A:1004866705021; Kattge J, 2011, GLOBAL CHANGE BIOL, V17, P2905, DOI 10.1111/j.1365-2486.2011.02451.x; Kikuzawa K, 1995, VEGETATIO, V121, P89, DOI 10.1007/BF00044675; King JS, 2002, NEW PHYTOL, V154, P389, DOI 10.1046/j.1469-8137.2002.00393.x; Kourtev PS, 2003, SOIL BIOL BIOCHEM, V35, P895, DOI 10.1016/S0038-0717(03)00120-2; Kourtev PS, 2002, ECOLOGY, V83, P3152, DOI 10.1890/0012-9658(2002)083[3152:EPSATM]2.0.CO;2; Kurten EL, 2008, BIOL INVASIONS, V10, P19, DOI 10.1007/s10530-007-9101-5; Leishman MR, 2007, NEW PHYTOL, V176, P635, DOI 10.1111/j.1469-8137.2007.02189.x; Lyr H., 1967, Int. Rev. For Res., N. Y., V2, P181; Martina JP, 2012, ENVIRON EXP BOT, V82, P43, DOI 10.1016/j.envexpbot.2012.03.010; Matzek V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048821; McCormack ML, 2012, NEW PHYTOL, V195, P823, DOI 10.1111/j.1469-8137.2012.04198.x; Munzenberger B, 1995, WATER AIR SOIL POLL, V85, P1191, DOI 10.1007/BF00477143; NAEEM S, 1994, NATURE, V368, P734, DOI 10.1038/368734a0; Osunkoya OO, 2010, ANN BOT-LONDON, V106, P371, DOI 10.1093/aob/mcq119; Pregitzer KS, 2000, NEW PHYTOL, V147, P105, DOI 10.1046/j.1469-8137.2000.00689.x; Pregitzer KS, 2002, NEW PHYTOL, V154, P267, DOI 10.1046/j.1469-8137.2002.00413_1.x; Pregitzer KS, 2002, ECOL MONOGR, V72, P293, DOI 10.1890/0012-9615(2002)072[0293:FRAONN]2.0.CO;2; Pregitzer KS, 1998, TREE PHYSIOL, V18, P665; Pysek Petr, 2007, V193, P97; Ruiz-Robleto J, 2005, PLANT BIOLOGY, V7, P484, DOI 10.1055/s-2005-865905; Sanford NL, 2003, FOREST ECOL MANAG, V183, P377, DOI 10.1016/S0378-1127(03)00141-5; SCHIERENBECK KA, 1994, ECOLOGY, V75, P1661, DOI 10.2307/1939626; Steinaker DF, 2008, J ECOL, V96, P1222, DOI 10.1111/j.1365-2745.2008.01439.x; Tecco PA, 2010, J ECOL, V98, P17, DOI 10.1111/j.1365-2745.2009.01592.x; Thomas MM, 2008, FUNCT PLANT BIOL, V35, P462, DOI 10.1071/FP08112; Tierney GL, 2003, GLOBAL CHANGE BIOL, V9, P670, DOI 10.1046/j.1365-2486.2003.00622.x; Trammell TLE, 2012, BIOL INVASIONS, V14, P529, DOI 10.1007/s10530-011-0093-9; van Kleunen M, 2010, ECOL LETT, V13, P235, DOI 10.1111/j.1461-0248.2009.01418.x; Vitousek P.M., 1988, P181; VITOUSEK PM, 1990, OIKOS, V57, P7, DOI 10.2307/3565731; Volder A, 2005, NEW PHYTOL, V165, P493, DOI 10.1111/j.1469-8137.2004.01222.x; Volder A, 2009, FUNCT PLANT BIOL, V36, P621, DOI 10.1071/FP08330; Walters MB, 1999, NEW PHYTOL, V143, P143, DOI 10.1046/j.1469-8137.1999.00425.x; Wells CE, 2001, ECOLOGY, V82, P882, DOI 10.1890/0012-9658(2001)082[0882:MDISAA]2.0.CO;2; Withington JM, 2006, ECOL MONOGR, V76, P381, DOI 10.1890/0012-9615(2006)076[0381:COSALS]2.0.CO;2; Wolfe BE, 2005, BIOSCIENCE, V55, P477, DOI 10.1641/0006-3568(2005)055[0477:BNGSCA]2.0.CO;2; Wright IJ, 2004, FUNCT PLANT BIOL, V31, P551, DOI 10.1071/FP03212; Xu CY, 2007, OECOLOGIA, V154, P11, DOI 10.1007/s00442-007-0807-y	73	20	21	4	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2014	9	8							e104189	10.1371/journal.pone.0104189	http://dx.doi.org/10.1371/journal.pone.0104189			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR0CG	25105975	gold, Green Published, Green Submitted			2022-12-27	WOS:000343231900039
J	Zhou, X; Wu, XC; An, YY; Fu, F				Zhou, Xiao; Wu, Xinchun; An, Yuanyuan; Fu, Fang			Longitudinal Relationships between Posttraumatic Stress Symptoms and Sleep Problems in Adolescent Survivors following the Wenchuan Earthquake in China	PLOS ONE			English	Article							ATTEMPTED THOUGHT SUPPRESSION; EXPOSURE THERAPY; PTSD SYMPTOMS; REM-SLEEP; DISORDER; CHILDREN; INSOMNIA; QUALITY; PSYCHOPATHOLOGY; VALIDATION	Purpose: To examine the longitudinal relationships between Posttraumatic Stress Disorder (PTSD) and sleep problems among adolescent survivors in the Wenchuan earthquake, China. Methods: 350 adolescent survivors were randomly selected from several primary and secondary schools in the counties of Wenchuan and Maoxian, the two areas most severely affected by the Wenchuan earthquake. Participants completed Revised Child PTSD Symptom Scale and Sleep Problems Subscale of Self-generated Child Behavior Problems Questionnaire at one year (T1), one-and-a-half years (T2), two years (T3) after the earthquake, respectively. Results: There was a bidirectional relationship between intrusive symptom clusters of PTSD and sleep problems from T1 to T2, and this relationship became non-significant from T2 to T3. There was a one-way predictive relationship of avoidance symptom clusters of PTSD onto sleep problems from T1 to T3. The hyperarousal symptom clusters of PTSD had effects on sleep problems from T1 to T2 but not from T2 to T3, while sleep problems have no significant effect on hyperarousal symptom clusters of PTSD from T1 to T3. In addition, the relationships between three symptom clusters of PTSD and sleep problems weakened with time change. Conclusions: From 1 year to 1.5 years after the earthquake, all the three symptom clusters of PTSD could be important predictive factors for the development and maintenance of sleep problems, while sleep problems could only be risk factors for the intrusive symptom clusters of PTSD. From 1.5 years to 2 years, only the avoidance symptom clusters of PTSD were risk factors for sleep problems, and sleep problems had no significant effects on any symptom clusters of PTSD. Overall, the relationship between PTSD and sleep problems weakened with time change.	[Zhou, Xiao; Wu, Xinchun] Beijing Normal Univ, Sch Psychol, Beijing 100875, Peoples R China; [An, Yuanyuan] Nanjing Normal Univ, Sch Psychol, Nanjing, Jiangsu, Peoples R China; [Fu, Fang] Fudan Univ, Sch Social Dev & Publ Policy, Shanghai 200433, Peoples R China	Beijing Normal University; Nanjing Normal University; Fudan University	Wu, XC (corresponding author), Beijing Normal Univ, Sch Psychol, Beijing 100875, Peoples R China.	xcwu@bnu.edu.cn			Ministry of Education, China [11JJD190006]	Ministry of Education, China(Ministry of Education, China)	Supported was provided by the "Key Projects of Humanities and Social Sciences Key Research Base, Ministry of Education, China (Grant No. 11JJD190006). http://www.sinoss.net/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Amir M, 1997, PERS INDIV DIFFER, V23, P399, DOI 10.1016/S0191-8869(97)80005-0; Arbuckle J. L., 2006, AMOS 7 0; Babson K, 2011, J ANXIETY DISORD, V25, P706, DOI 10.1016/j.janxdis.2011.03.007; Babson KA, 2012, J TRAUMA STRESS, V25, P503, DOI 10.1002/jts.21739; Babson KA, 2010, J ANXIETY DISORD, V24, P1, DOI 10.1016/j.janxdis.2009.08.002; Bader K, 2007, SOMNOLOGIE, V11, P101, DOI [10.1007/s11818-007-0299-3, DOI 10.1007/S11818-007-0299-3]; Badour CL, 2012, BEHAV RES THER, V50, P610, DOI 10.1016/j.brat.2012.06.006; BRENER ND, 1995, AM J EPIDEMIOL, V141, P575, DOI 10.1093/oxfordjournals.aje.a117473; Brown TH, 2011, J TRAUMA STRESS, V24, P575, DOI 10.1002/jts.20680; CARSKADON M A, 1990, Pediatrician, V17, P5; Chang PP, 1997, AM J EPIDEMIOL, V146, P105; Charuvastra A, 2009, CHILD ADOL PSYCH CL, V18, P877, DOI 10.1016/j.chc.2009.04.002; Copeland WE, 2007, ARCH GEN PSYCHIAT, V64, P577, DOI 10.1001/archpsyc.64.5.577; DAGAN Y, 1991, BIOL PSYCHIAT, V30, P618, DOI 10.1016/0006-3223(91)90031-G; Dahl RE, 1996, DEV PSYCHOPATHOL, V8, P3, DOI 10.1017/S0954579400006945; Foa E.B., 1998, TREATING TRAUMA RAPE; FOA EB, 1989, BEHAV THER, V20, P155, DOI 10.1016/S0005-7894(89)80067-X; Foa EB, 2001, J CLIN CHILD PSYCHOL, V30, P376, DOI 10.1207/S15374424JCCP3003_9; Foa EB, 1998, PSYCHOL ASSESSMENT, V10, P206, DOI 10.1037/1040-3590.10.3.206; Germain A, 2004, J TRAUMA STRESS, V17, P477, DOI 10.1007/s10960-004-5796-6; Halper JMD, 2008, EXCEPTIONAL PARENT; Harvey AG, 1998, BEHAV RES THER, V36, P583, DOI 10.1016/S0005-7967(98)00052-7; Harvey AG, 2003, CLIN PSYCHOL REV, V23, P377, DOI 10.1016/S0272-7358(03)00032-1; Harvey AG, 2002, BEHAV RES THER, V40, P869, DOI 10.1016/S0005-7967(01)00061-4; Harvey AG, 1999, COGNITIVE THER RES, V23, P39, DOI 10.1023/A:1018758623889; Huntley ED, 2014, J TRAUMA STRESS, V27, P103, DOI 10.1002/jts.21882; Iwadare Y, 2014, SLEEP BIOL RHYTHMS, V12, P53, DOI 10.1111/sbr.12047; Koren D, 2002, AM J PSYCHIAT, V159, P855, DOI 10.1176/appi.ajp.159.5.855; Kovachy B, 2013, J CLIN SLEEP MED, V9, P503, DOI 10.5664/jcsm.2678; Krakow B, 2001, J TRAUMA STRESS, V14, P647, DOI 10.1023/A:1013029819358; Mellman TA, 2002, AM J PSYCHIAT, V159, P1696, DOI 10.1176/appi.ajp.159.10.1696; Mellman TA, 1997, ANN NY ACAD SCI, V821, P142, DOI 10.1111/j.1749-6632.1997.tb48275.x; Mellman TA, 2008, SLEEP MED REV, V12, P165, DOI 10.1016/j.smrv.2008.02.001; Mellman TA, 2007, J TRAUMA STRESS, V20, P893, DOI 10.1002/jts.20246; Pillar G, 2000, SLEEP MED REV, V4, P183, DOI 10.1053/smrv.1999.0095; Rothbaum BO, 2001, J TRAUMA STRESS, V14, P481, DOI 10.1023/A:1011104521887; Schneier FR, 2012, AM J PSYCHIAT, V169, P80, DOI 10.1176/appi.ajp.2011.11020321; SOUTHWICK SM, 1994, PSYCHIAT CLIN N AM, V17, P251; Spoormaker VI, 2008, SLEEP MED REV, V12, P169, DOI 10.1016/j.smrv.2007.08.008; Taylor S., 2009, CLIN GUIDE PTSD COGN; Tull MT, 2007, ANXIETY STRESS COPIN, V20, P337, DOI 10.1080/10615800701379249; Usami M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065398; [温忠麟 Wen Zhonglin], 2004, [心理学报, Acta Psychologica Sinica], V36, P186; Wittmann L, 2010, J TRAUMA STRESS, V23, P232, DOI 10.1002/jts.20514; WOODWARD SH, 2000, SLEEP, V23, P356; Zeng EJ, 2011, SCHOOL PSYCHOL INT, V32, P498, DOI 10.1177/0143034311402921	47	24	24	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2014	9	8							e104470	10.1371/journal.pone.0104470	http://dx.doi.org/10.1371/journal.pone.0104470			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR0CG	25105288	Green Published, gold, Green Submitted			2022-12-27	WOS:000343231900061
J	Chen, S; Wang, Q; Wu, ZY; Wu, QJ; Li, P; Li, Y; Li, J; Deng, CW; Wu, CY; Gao, L; Zhang, FC; Li, YZ				Chen, Si; Wang, Qian; Wu, Ziyan; Wu, Qingjun; Li, Ping; Li, Yuan; Li, Jing; Deng, Chuiwen; Wu, Chanyuan; Gao, Lei; Zhang, Fengchun; Li, Yongzhe			Associations between TNF-alpha-308A/G Polymorphism and Susceptibility with Dermatomyositis: A Meta-Analysis	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; IDIOPATHIC INFLAMMATORY MYOPATHIES; MAJOR HISTOCOMPATIBILITY COMPLEX; TNF-ALPHA; JUVENILE DERMATOMYOSITIS; PROMOTER POLYMORPHISM; GENETIC ASSOCIATION; ADULT DERMATOMYOSITIS; MUSCLE-FIBERS; POLYMYOSITIS	Background: Some surveys had inspected the effects of the tumor necrosis factor-alpha (TNF-alpha)-308A/G polymorphism on susceptibility to dermatomyositis (DM), and showed mixed results. To briefly review these consequences, a comprehensive meta-analysis was carried out to estimate the relationship between them much more accurately. Methods: Relevant documents dated to February 2014 were acquired from the PUBMED, MEDLINE, and EMBASE databases. The number of the genotypes and/or alleles for the TNF-alpha-308A/G in the DM and control subjects was extracted and statistical analysis was conducted using STATA 11.2 software. Summary odds ratios (ORs) with their 95% confidence intervals (95% CIs) were used to calculate the risk of DM with TNF-alpha-308A/G. Stratified analysis based on ethnicity and control population source was also performed. Results: 555 patients with DM and 1005 controls from eight published investigations were finally involved in this meta-analysis. Combined analysis revealed that the overall ORs for the TNF-alpha-308A allele were 2.041 (95% CIs 1.528-2.725, P< 0.0001) in DM. Stratification by ethnicity indicated the TNF-alpha-308A allele polymorphism was found to be significantly associated with DM in Europeans (OR = 1.977, 95% CI 1.413-2.765, P<0.0001). The only study conducted on TNF-alpha-308A/G polymorphism in Asians could not be used in ethnicity-stratified meta-analysis. Meta-analysis of the AA+AG vs. GG (dominant model) and AA vs. GG (additive model) of this polymorphism revealed a significant association with DM in overall populations and Europeans. Conclusions: Our meta-analysis demonstrated that the TNF-alpha-308A/G polymorphism in the TNF gene might contribute to DM susceptibility, especially in European population. However, further studies with large sample sizes and among different ethnicity populations should be required to verify the association.	[Chen, Si; Wang, Qian; Wu, Ziyan; Wu, Qingjun; Li, Ping; Li, Yuan; Li, Jing; Deng, Chuiwen; Wu, Chanyuan; Zhang, Fengchun; Li, Yongzhe] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Rheumatol & Clin Immunol, Beijing, Peoples R China; [Chen, Si; Wang, Qian; Wu, Ziyan; Wu, Qingjun; Li, Ping; Li, Yuan; Li, Jing; Deng, Chuiwen; Wu, Chanyuan; Zhang, Fengchun; Li, Yongzhe] Peking Union Med Coll, Minist Educ, Key Lab Rheumatol & Clin Immunol, Beijing 100021, Peoples R China; [Gao, Lei] Chinese Acad Sci, Inst Psychol, Key Lab Mental Hlth, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Sciences; Institute of Psychology, CAS	Li, YZ (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Rheumatol & Clin Immunol, Beijing, Peoples R China.	yongzhelipumch@126.com		Li, Jing/0000-0003-2504-1629	Research Special Fund for Public Welfare Industry of Health [201202004]; National Natural Science Foundation of China [81072486, 81172857, 81373188]	Research Special Fund for Public Welfare Industry of Health; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by funding from the Research Special Fund for Public Welfare Industry of Health No. 201202004 (to F-C. Z.), and the National Natural Science Foundation of China Grants 81072486, 81172857, 81373188 (to Y-Z. L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham LJ, 1999, J LEUKOCYTE BIOL, V66, P562, DOI 10.1002/jlb.66.4.562; Allen RD, 1999, MOL IMMUNOL, V36, P1017, DOI 10.1016/S0161-5890(99)00127-3; BENBASSAT J, 1980, ISRAEL J MED SCI, V16, P197; Bernatsky S, 2009, ANN RHEUM DIS, V68, P1192, DOI 10.1136/ard.2008.093161; Brittain EH, 2012, BIOSTATISTICS, V13, P637, DOI 10.1093/biostatistics/kxs006; CARROLL MC, 1987, P NATL ACAD SCI USA, V84, P8535, DOI 10.1073/pnas.84.23.8535; Chinoy H, 2007, RHEUMATOLOGY, V46, P1411, DOI 10.1093/rheumatology/kem145; Chinoy H, 2004, CURR OPIN RHEUMATOL, V16, P707, DOI 10.1097/01.bor.0000142339.24380.b7; Chinoy H, 2012, RHEUMATOLOGY, V51, P794, DOI 10.1093/rheumatology/ker379; Chinoy H, 2009, CURR OPIN RHEUMATOL, V21, P588, DOI 10.1097/BOR.0b013e3283315a22; Chootrakool H, 2011, STAT MED, V30, P1183, DOI 10.1002/sim.4143; DALFONSO S, 1994, IMMUNOGENETICS, V39, P150; Dourmishev L, 2012, INT J DERMATOL, V51, P1467, DOI 10.1111/j.1365-4632.2012.05522.x; Fedczyna TO, 2001, CLIN IMMUNOL, V100, P236, DOI 10.1006/clim.2001.5063; Furuya T, 2004, J RHEUMATOL, V31, P1768; Hassan AB, 2004, ARTHRITIS RHEUM, V50, P1013, DOI 10.1002/art.20208; Hassan AB, 2006, J AUTOIMMUN, V27, P62, DOI 10.1016/j.jaut.2006.06.003; Hengstman GJD, 2000, ANN RHEUM DIS, V59, P141, DOI 10.1136/ard.59.2.141; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hirakata Michito, 2007, Nihon Rinsho Meneki Gakkai Kaishi, V30, P444; HOLDEN DJ, 1985, CAN MED ASSOC J, V132, P649; Hristova M, 2012, ACTA DERMATOVENER CR, V20, P148; Ioannidis JPA, 2001, NAT GENET, V29, P306, DOI 10.1038/ng749; Jin X, 2012, J DERMATOL SCI, V68, P127, DOI 10.1016/j.jdermsci.2012.09.003; Kim TG, 2003, ARCH DERMATOL RES, V295, P8, DOI 10.1007/s00403-003-0392-9; Kok CC, 1999, IMMUNOGENETICS, V49, P508, DOI 10.1007/s002510050528; Kroeger KM, 1997, MOL IMMUNOL, V34, P391, DOI 10.1016/S0161-5890(97)00052-7; Kuru S, 2003, ACTA NEUROPATHOL, V105, P217, DOI 10.1007/s00401-002-0632-4; Lee YH, 2006, EUR J HUM GENET, V14, P364, DOI 10.1038/sj.ejhg.5201566; Liu JF, 2007, J DERMATOL, V34, P353, DOI 10.1111/j.1346-8138.2007.00287.x; Louis E, 1998, CLIN EXP IMMUNOL, V113, P401; Lundberg I, 1997, ARTHRITIS RHEUM, V40, P865, DOI 10.1002/art.1780400514; Lutz J, 2002, CLIN IMMUNOL, V103, P260, DOI 10.1006/clim.2001.5212; Mamyrova G, 2008, ARTHRITIS RHEUM-US, V58, P3941, DOI 10.1002/art.24039; MEDSGER TA, 1970, AM J MED, V48, P715, DOI 10.1016/S0002-9343(70)80006-7; MESSER G, 1991, J EXP MED, V173, P209, DOI 10.1084/jem.173.1.209; Munafo MR, 2004, PSYCHIAT RES, V129, P39, DOI 10.1016/j.psychres.2004.06.011; NEDWIN GE, 1985, NUCLEIC ACIDS RES, V13, P6361, DOI 10.1093/nar/13.17.6361; Niewold TB, 2010, J PEDIATR-US, V157, P653, DOI 10.1016/j.jpeds.2010.04.034; Niewold TB, 2009, ARTHRITIS RHEUM, V60, P1815, DOI 10.1002/art.24555; Ohta A, 2013, MOD RHEUMATOL; Pachman LM, 2000, ARTHRITIS RHEUM, V43, P2368, DOI 10.1002/1529-0131(200010)43:10<2368::AID-ANR26>3.0.CO;2-8; Reed AM, 1998, J RHEUMATOL, V25, P1000; Shamim EA, 2000, CURR OPIN RHEUMATOL, V12, P482, DOI 10.1097/00002281-200011000-00002; Sterne JAC, 2001, BMJ-BRIT MED J, V323, P101, DOI 10.1136/bmj.323.7304.101; Werth VP, 2002, J INVEST DERMATOL, V119, P1394, DOI 10.1046/j.1523-1747.2002.19608.x; Werth VP, 2002, J INVEST DERMATOL, V119, P617, DOI 10.1046/j.1523-1747.2002.01869.x; Wilson AG, 1997, P NATL ACAD SCI USA, V94, P3195, DOI 10.1073/pnas.94.7.3195; Zhuang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068827	49	1	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e102841	10.1371/journal.pone.0102841	http://dx.doi.org/10.1371/journal.pone.0102841			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25101759	Green Published, gold, Green Submitted			2022-12-27	WOS:000339993900007
J	Huang, QY; Swatantran, A; Dubayah, R; Goetz, SJ				Huang, Qiongyu; Swatantran, Anu; Dubayah, Ralph; Goetz, Scott J.			The Influence of Vegetation Height Heterogeneity on Forest and Woodland Bird Species Richness across the United States	PLOS ONE			English	Article							CAPTURE PROBABILITIES VARY; HABITAT HETEROGENEITY; AVIAN BIODIVERSITY; SCALE PATTERNS; IMAGE TEXTURE; ENERGY; POPULATION; FRAGMENTATION; DISTRIBUTIONS; PRODUCTIVITY	Avian diversity is under increasing pressures. It is thus critical to understand the ecological variables that contribute to large scale spatial distribution of avian species diversity. Traditionally, studies have relied primarily on two-dimensional habitat structure to model broad scale species richness. Vegetation vertical structure is increasingly used at local scales. However, the spatial arrangement of vegetation height has never been taken into consideration. Our goal was to examine the efficacies of three-dimensional forest structure, particularly the spatial heterogeneity of vegetation height in improving avian richness models across forested ecoregions in the U.S. We developed novel habitat metrics to characterize the spatial arrangement of vegetation height using the National Biomass and Carbon Dataset for the year 2000 (NBCD). The height-structured metrics were compared with other habitat metrics for statistical association with richness of three forest breeding bird guilds across Breeding Bird Survey (BBS) routes: a broadly grouped woodland guild, and two forest breeding guilds with preferences for forest edge and for interior forest. Parametric and non-parametric models were built to examine the improvement of predictability. Height-structured metrics had the strongest associations with species richness, yielding improved predictive ability for the woodland guild richness models (r(2) = similar to 0.53 for the parametric models, 0.63 the non-parametric models) and the forest edge guild models (r(2) = similar to 0.34 for the parametric models, 0.47 the non-parametric models). All but one of the linear models incorporating height-structured metrics showed significantly higher adjusted-r(2) values than their counterparts without additional metrics. The interior forest guild richness showed a consistent low association with height-structured metrics. Our results suggest that height heterogeneity, beyond canopy height alone, supplements habitat characterization and richness models of forest bird species. The metrics and models derived in this study demonstrate practical examples of utilizing three-dimensional vegetation data for improved characterization of spatial patterns in species richness.	[Huang, Qiongyu; Swatantran, Anu; Dubayah, Ralph] Univ Maryland, Dept Geog Sci, College Pk, MD 20742 USA; [Goetz, Scott J.] Woods Hole Res Ctr, Falmouth, MA USA	University System of Maryland; University of Maryland College Park; Woods Hole Research Center	Huang, QY (corresponding author), Univ Maryland, Dept Geog Sci, College Pk, MD 20742 USA.	qhuang@umd.edu	Swatantran, Anu/B-8786-2016; Goetz, Scott J/A-3393-2015	Goetz, Scott J/0000-0002-6326-4308; Huang, Qiongyu/0000-0002-1450-3587	NASA [NNX09AK20G]	NASA(National Aeronautics & Space Administration (NASA))	The research received support from the NASA Applied Sciences programs on Ecological Forecasting and Biological Diversity (http://www.nasa.gov/applied-sciences/eco-forecasting.html) (grant # NNX09AK20G to SJG and RD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baatz M., 2003, ECOGNITION USER GUID; Baccini A, 2012, NAT CLIM CHANGE, V2, P182, DOI [10.1038/NCLIMATE1354, 10.1038/nclimate1354]; Bailey RG, 1995, DESCRIPITON ECOREGIO; Bergen KM, 2009, J GEOPHYS RES-BIOGEO, V114, DOI 10.1029/2008JG000883; Bergen KM, 2007, ECOL INFORM, V2, P9, DOI 10.1016/j.ecoinf.2007.01.001; Biau G, 2012, J MACH LEARN RES, V13, P1063; Boulinier T, 1998, P NATL ACAD SCI USA, V95, P7497, DOI 10.1073/pnas.95.13.7497; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Broughton RK, 2006, IBIS, V148, P744, DOI 10.1111/j.1474-919X.2006.00583.x; BURNHAM KP, 1978, BIOMETRIKA, V65, P625, DOI 10.2307/2335915; BURNHAM KP, 1979, ECOLOGY, V60, P927, DOI 10.2307/1936861; Duro D, 2007, PROG PHYS GEOG, V31, P235, DOI 10.1177/0309133307079054; Coburn CA, 2004, INT J REMOTE SENS, V25, P4287, DOI 10.1080/0143116042000192367; Cody M.L, 1974, COMPETITION STRUCTUR; Colwell RK, 2004, AM NAT, V163, pE1, DOI 10.1086/382056; Culbert PD, 2013, AUK, V130, P656, DOI 10.1525/auk.2013.13007; Culbert PD, 2012, REMOTE SENS ENVIRON, V118, P140, DOI 10.1016/j.rse.2011.11.004; Currie DJ, 2004, ECOL LETT, V7, P1121, DOI 10.1111/j.1461-0248.2004.00671.x; Davies RG, 2007, P ROY SOC B-BIOL SCI, V274, P1189, DOI 10.1098/rspb.2006.0061; Donovan TM, 2002, ECOL APPL, V12, P364, DOI 10.1890/1051-0761(2002)012[0364:RANAST]2.0.CO;2; EFRON B, 1987, J AM STAT ASSOC, V82, P171, DOI 10.2307/2289144; Evans KL, 2005, BIOL REV, V80, P1, DOI 10.1017/S1464793104006517; Fagan WE, 1999, AM NAT, V153, P165, DOI 10.1086/303162; Franklin SE, 2000, INT J REMOTE SENS, V21, P61, DOI 10.1080/014311600210993; Gaston Kevin J., 2004, BIODIVERSITY INTRO; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; Gaston KJ, 2003, P ROY SOC B-BIOL SCI, V270, P1293, DOI 10.1098/rspb.2002.2303; Girvetz EH, 2007, LANDSCAPE ECOL, V22, P1131, DOI 10.1007/s10980-007-9104-8; Goetz S, 2007, REMOTE SENS ENVIRON, V108, P254, DOI 10.1016/j.rse.2006.11.016; Goetz SJ, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/3/034013; Goetz SJ, 2010, ECOLOGY, V91, P1569, DOI 10.1890/09-1670.1; Griffith EH, 2010, AUK, V127, P387, DOI 10.1525/auk.2009.09056; Griffiths GH, 2000, INT J REMOTE SENS, V21, P2685, DOI 10.1080/01431160050110232; Guegan JF, 1998, NATURE, V391, P382, DOI 10.1038/34899; Hagan JM, 1996, CONSERV BIOL, V10, P188, DOI 10.1046/j.1523-1739.1996.10010188.x; Halaj J, 2000, OIKOS, V90, P139, DOI 10.1034/j.1600-0706.2000.900114.x; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Hawkins BA, 2003, ECOLOGY, V84, P3105, DOI 10.1890/03-8006; Hawkins BA, 2007, AM NAT, V170, pS16, DOI 10.1086/519009; Helzer CJ, 1999, ECOL APPL, V9, P1448; Hill RA, 2004, INT J REMOTE SENS, V25, P4851, DOI 10.1080/0143116031000139962; Hines JE, 1999, BIRD STUDY, V46, P209; Hinsley SA, 2009, COMMUNITY ECOL, V10, P99, DOI 10.1556/ComEc.10.2009.1.12; Hurlbert AH, 2003, AM NAT, V161, P83, DOI 10.1086/345459; Imhoff ML, 1997, REMOTE SENS ENVIRON, V60, P217, DOI 10.1016/S0034-4257(96)00116-2; Keller CME, 1999, CONDOR, V101, P50, DOI 10.2307/1370445; Kellndorfer J, 2011, NATL BIOMASS CARBON; Kellndorfer JM, 2010, J GEOPHYS RES-BIOGEO, V115, DOI 10.1029/2009JG000997; KELLY JP, 1993, CONDOR, V95, P83, DOI 10.2307/1369389; Kendall WL, 1996, AUK, V113, P823, DOI 10.2307/4088860; Kerr JT, 1997, NATURE, V385, P252, DOI 10.1038/385252a0; Kerr JT, 2001, P NATL ACAD SCI USA, V98, P11365, DOI 10.1073/pnas.201398398; Kery M, 2004, BASIC APPL ECOL, V5, P65, DOI 10.1078/1439-1791-00194; Koh CN, 2006, DIVERS DISTRIB, V12, P546, DOI 10.1111/j.1366-9516.2006.00238.x; Lefsky MA, 2002, BIOSCIENCE, V52, P19, DOI 10.1641/0006-3568(2002)052[0019:LRSFES]2.0.CO;2; MACARTHUR R, 1961, ECOLOGY, V42, P594, DOI 10.2307/1932254; MORGAN K, 1985, Canadian Field-Naturalist, V100, P506; North MP, 1999, FOREST SCI, V45, P520; PALMER MW, 1994, FOLIA GEOBOT PHYTOTX, V29, P511, DOI 10.1007/BF02883148; Phillips LB, 2008, REMOTE SENS ENVIRON, V112, P3538, DOI [10.1016/j.rse.2008.04.012, 10.1016/j.rse.2008.08.002]; Pidgeon AM, 2007, ECOL APPL, V17, P1989, DOI 10.1890/06-1489.1; R Core Team, 2021, R LANGUAGE ENV STAT; Rahbek C, 2001, P NATL ACAD SCI USA, V98, P4534, DOI 10.1073/pnas.071034898; Rahbek C, 2007, P ROY SOC B-BIOL SCI, V274, P165, DOI 10.1098/rspb.2006.3700; RICHERSON PJ, 1980, AM NAT, V116, P504, DOI 10.1086/283645; Rittenhouse CD, 2012, CONSERV BIOL, V26, P821, DOI 10.1111/j.1523-1739.2012.01867.x; ROBBINS CS, 1989, WILDLIFE MONOGR, P1; Robbins CS, 1986, BREEDING BIRD SURVEY; ROBINSON SK, 1984, AUK, V101, P672, DOI 10.2307/4086894; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Saatchi SS, 2011, P NATL ACAD SCI USA, V108, P9899, DOI 10.1073/pnas.1019576108; SAUER JR, 2011, N AM BREEDING BIRD S; Schiewe J., 2002, ISPRS S GEOSP THEOR, V34; Seto KC, 2004, INT J REMOTE SENS, V25, P4309, DOI 10.1080/0143116042000192358; St-Louis V, 2006, REMOTE SENS ENVIRON, V105, P299, DOI 10.1016/j.rse.2006.07.003; St-Louis V, 2009, ECOGRAPHY, V32, P468, DOI 10.1111/j.1600-0587.2008.05512.x; STRELKE WK, 1980, J WILDLIFE MANAGE, V44, P559, DOI 10.2307/3808003; Swatantran A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028922; TURNER JRG, 1988, NATURE, V335, P539, DOI 10.1038/335539a0; U.S. Geological Survey, 2012, LIST SPEC GROUP; Vavrek MJ, 2011, PALAEONTOL ELECTRON, V14; Waide RB, 1999, ANNU REV ECOL SYST, V30, P257, DOI 10.1146/annurev.ecolsys.30.1.257; Walker WS, 2007, REMOTE SENS ENVIRON, V109, P482, DOI 10.1016/j.rse.2007.02.001; Whitehurst AS, 2013, REMOTE SENS-BASEL, V5, P2014, DOI 10.3390/rs5042014; Whittaker RJ, 2001, J BIOGEOGR, V28, P453, DOI 10.1046/j.1365-2699.2001.00563.x; Willig MR, 2003, ANNU REV ECOL EVOL S, V34, P273, DOI 10.1146/annurev.ecolsys.34.012103.144032; Zellweger F, 2013, FOREST ECOL MANAG, V307, P303, DOI [10.1016/j.foreco.2013.07.023, 10.1016/j.]	87	32	32	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e103236	10.1371/journal.pone.0103236	http://dx.doi.org/10.1371/journal.pone.0103236			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25101782	Green Submitted, Green Published, gold			2022-12-27	WOS:000339993900015
J	Kim, DS; Wang, Y; Oh, HJ; Lee, K; Hahn, Y				Kim, Dong Seon; Wang, Yao; Oh, Hye Ji; Lee, Kangseok; Hahn, Yoonsoo			Frequent Loss and Alteration of the MOXD2 Gene in Catarrhines and Whales: A Possible Connection with the Evolution of Olfaction	PLOS ONE			English	Article							DOPAMINE-BETA-HYDROXYLASE; GENOME SEQUENCE; MULTIGENE FAMILY; INSIGHTS; VERTEBRATES; COMPONENT; RESOURCE; ACCURACY; PROVIDE; TRPC2	The MOXD2 gene encodes a membrane-bound monooxygenase similar to dopamine-beta-hydroxylase, and has been proposed to be associated with olfaction. In this study, we analyzed MOXD2 genes from 64 mammalian species, and identified loss-of-function mutations in apes (humans, Sumatran and Bornean orangutans, and five gibbon species from the four major gibbon genera), toothed whales (killer whales, bottlenose dolphins, finless porpoises, baijis, and sperm whales), and baleen whales (minke whales and fin whales). We also identified a shared 13-nt deletion in the last exon of Old World cercopithecine monkeys that results in conversion of a membrane-bound protein to a soluble form. We hypothesize that the frequent inactivation and alteration of MOXD2 genes in catarrhines and whales may be associated with the evolution of olfaction in these clades.	[Kim, Dong Seon; Wang, Yao; Oh, Hye Ji; Lee, Kangseok; Hahn, Yoonsoo] Chung Ang Univ, Res Ctr Biomol & Biosyst, Dept Life Sci, Seoul 156756, South Korea	Chung Ang University	Hahn, Y (corresponding author), Chung Ang Univ, Res Ctr Biomol & Biosyst, Dept Life Sci, Seoul 156756, South Korea.	yoonsoo.hahn@gmail.com		HAHN, YOONSOO/0000-0003-4273-9842	National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology, Republic of Korea [NRF-2012R1A1B3001513, 2011-0028553]	National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology, Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of Korea)	This study was supported by the National Research Foundation of Korea (NRF) grants (NRF-2012R1A1B3001513 and 2011-0028553) funded by the Ministry of Education, Science and Technology, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnarsson I, 2011, PLOS CURR-TREE LIFE, DOI 10.1371/currents.RRN1212; Archibald AL, 2010, ANIM GENET, V41, P449, DOI 10.1111/j.1365-2052.2010.02100.x; Barton RA, 2006, AM J PRIMATOL, V68, P545, DOI 10.1002/ajp.20251; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Dong D, 2009, GENOME BIOL EVOL, V1, P258, DOI 10.1093/gbe/evp026; Dong Y, 2013, NAT BIOTECHNOL, V31, P135, DOI 10.1038/nbt.2478; dos Reis M, 2012, P ROY SOC B-BIOL SCI, V279, P3491, DOI 10.1098/rspb.2012.0683; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elsik CG, 2009, SCIENCE, V324, P522, DOI 10.1126/science.1169588; Fan Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2416; Florea L, 1998, GENOME RES, V8, P967, DOI 10.1101/gr.8.9.967; Gatesy J, 2013, MOL PHYLOGENET EVOL, V66, P479, DOI 10.1016/j.ympev.2012.10.012; Ge RL, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2860; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Gibbs RA, 2007, SCIENCE, V316, P222, DOI 10.1126/science.1139247; Godfrey SJ, 2013, ANAT REC, V296, P257, DOI 10.1002/ar.22637; Groenen MAM, 2012, NATURE, V491, P393, DOI 10.1038/nature11622; Hahn Y, 2007, MOL BIOL EVOL, V24, P2203, DOI 10.1093/molbev/msm146; Hayden S, 2010, GENOME RES, V20, P1, DOI 10.1101/gr.099416.109; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Perez SI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068029; Jiang PH, 2012, P NATL ACAD SCI USA, V109, P4956, DOI 10.1073/pnas.1118360109; Jirimutu, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2192; Kim CH, 2002, AM J MED GENET, V108, P140, DOI 10.1002/ajmg.10196; Kishida T, 2007, BIOLOGY LETT, V3, P428, DOI 10.1098/rsbl.2007.0191; LAMOUROUX A, 1987, EMBO J, V6, P3931, DOI 10.1002/j.1460-2075.1987.tb02734.x; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Liman ER, 2006, PFLUG ARCH EUR J PHY, V453, P125, DOI 10.1007/s00424-006-0120-3; Liman ER, 2003, P NATL ACAD SCI USA, V100, P3328, DOI 10.1073/pnas.0636123100; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Lindblad-Toh K, 2011, NATURE, V478, P476, DOI 10.1038/nature10530; Locke DP, 2011, NATURE, V469, P529, DOI 10.1038/nature09687; Lucas P, 2003, NEURON, V40, P551, DOI 10.1016/S0896-6273(03)00675-5; Matsui A, 2010, MOL BIOL EVOL, V27, P1192, DOI 10.1093/molbev/msq003; McGowen MR, 2008, SYST BIOL, V57, P574, DOI 10.1080/10635150802304787; Meredith RW, 2011, P ROY SOC B-BIOL SCI, V278, P993, DOI 10.1098/rspb.2010.1280; Mikkelsen TS, 2007, NATURE, V447, P167, DOI 10.1038/nature05805; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; Mirceta S, 2013, SCIENCE, V340, DOI 10.1126/science.1234192; Murchison EP, 2012, CELL, V148, P780, DOI 10.1016/j.cell.2011.11.065; Niimura Y, 2012, CURR GENOMICS, V13, P103, DOI 10.2174/138920212799860706; Partridge MA, 2007, DNA SEQUENCE, V18, P341, DOI 10.1080/10425170601101287; Perry GH, 2013, P NATL ACAD SCI USA, V110, P5823, DOI 10.1073/pnas.1211990110; Perry GH, 2012, GENOME BIOL EVOL, V4, P126, DOI 10.1093/gbe/evr132; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pierleoni A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-392; Pipes L, 2013, NUCLEIC ACIDS RES, V41, pD906, DOI 10.1093/nar/gks1268; Pontius JU, 2007, GENOME RES, V17, P1675, DOI 10.1101/gr.6380007; Prufer K, 2012, NATURE, V486, P527, DOI 10.1038/nature11128; Ruedi M, 2013, MOL PHYLOGENET EVOL, V69, P437, DOI 10.1016/j.ympev.2013.08.011; Scally A, 2012, NATURE, V483, P169, DOI 10.1038/nature10842; Schwartz S, 2000, GENOME RES, V10, P577, DOI 10.1101/gr.10.4.577; Seim I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3212; Smith Timothy D., 2004, Anatomical Record Part B:The New Anatomist, V279, P24, DOI 10.1002/ar.b.20026; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Thewissen JGM, 2011, MAR MAMMAL SCI, V27, P282, DOI 10.1111/j.1748-7692.2010.00406.x; Thinh VN, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-74; Wade CM, 2009, SCIENCE, V326, P865, DOI 10.1126/science.1178158; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Xin XN, 2004, J BIOL CHEM, V279, P48159, DOI 10.1074/jbc.M407486200; Yan Guangmei, 2011, Nat Biotechnol, V29, P1019, DOI 10.1038/nbt.1992; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yim HS, 2014, NAT GENET, V46, P88, DOI 10.1038/ng.2835; Yu L, 2010, MOL BIOL EVOL, V27, P1467, DOI 10.1093/molbev/msq027; Zhang GJ, 2013, SCIENCE, V339, P456, DOI 10.1126/science.1230835; Zhou XM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3708	68	5	5	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e104085	10.1371/journal.pone.0104085	http://dx.doi.org/10.1371/journal.pone.0104085			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25102179	Green Submitted, Green Published, gold			2022-12-27	WOS:000339993900036
J	Zhang, Y; Zhang, GZ; Huang, X; Han, RC				Zhang, Yi; Zhang, Guozhi; Huang, Xiu; Han, Richou			Proteomic Analysis of Apis cerana and Apis mellifera Larvae Fed with Heterospecific Royal Jelly and by CSBV Challenge	PLOS ONE			English	Article							HONEY-BEE; CRYSTAL-STRUCTURE; OXIDATIVE STRESS; SACBROOD VIRUS; EXPRESSION; PROTEIN; IMMUNE; IDENTIFICATION; INFECTION; GENE	Chinese honeybee Apis cerana (Ac) is one of the major Asian honeybee species for local apiculture. However, Ac is frequently damaged by Chinese sacbrood virus (CSBV), whereas Apis mellifera (Am) is usually resistant to it. Heterospecific royal jelly (RJ) breeding in two honeybee species may result in morphological and genetic modification. Nevertheless, knowledge on the resistant mechanism of Am to this deadly disease is still unknown. In the present study, heterospecific RJ breeding was conducted to determine the effects of food change on the larval mortality after CSBV infection at early larval stage. 2-DE and MALDI-TOF/TOF MS proteomic technology was employed to unravel the molecular event of the bees under heterospecific RJ breeding and CSBV challenge. The change of Ac larval food from RJC to RJM could enhance the bee resistance to CSBV. The mortality rate of Ac larvae after CSBV infection was much higher when the larvae were fed with RJC compared with the larvae fed with RJM. There were 101 proteins with altered expressions after heterospecific RJ breeding and viral infection. In Ac larvae, 6 differential expression proteins were identified from heterospecific RJ breeding only, 21 differential expression proteins from CSBV challenge only and 7 differential expression proteins from heterospecific RJ breeding plus CSBV challenge. In Am larvae, 17 differential expression proteins were identified from heterospecific RJ breeding only, 26 differential expression proteins from CSBV challenge only and 24 differential expression proteins from heterospecific RJ breeding plus CSBV challenge. The RJM may protect Ac larvae from CSBV infection, probably by activating the genes in energy metabolism pathways, antioxidation and ubiquitin-proteasome system. The present results, for the first time, comprehensively descript the molecular events of the viral infection of Ac and Am after heterospecific RJ breeding and are potentially useful for establishing CSBV resistant populations of Ac for apiculture.	[Zhang, Yi; Zhang, Guozhi; Huang, Xiu; Han, Richou] Guangdong Entomol Inst, Guangzhou, Guangdong, Peoples R China	Guangdong Academy of Sciences; Institute of Zoology, Guangdong Academy of Sciences	Han, RC (corresponding author), Guangdong Entomol Inst, Guangzhou, Guangdong, Peoples R China.	richou-han@163.net			Guangdong Department of Science and Technology [2011B01050002]; Guangzhou Agricultural Bureau [[2011]584]; Guangdong Academy of Sciences [Sf201208]; National Natural Science Foundation of China [31301924]	Guangdong Department of Science and Technology; Guangzhou Agricultural Bureau; Guangdong Academy of Sciences; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Guangdong Department of Science and Technology (2011B01050002), Guangzhou Agricultural Bureau ([2011]584), Guangdong Academy of Sciences (Sf201208), and National Natural Science Foundation of China (31301924). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai HX, 2012, J INVERTEBR PATHOL, V109, P160, DOI 10.1016/j.jip.2011.10.006; Antunez K, 2009, ENVIRON MICROBIOL, V11, P2284, DOI 10.1111/j.1462-2920.2009.01953.x; Asai M, 2009, J MOL CELL CARDIOL, V46, P452, DOI 10.1016/j.yjmcc.2008.11.001; Azzami K, 2012, ARCH VIROL, V157, P689, DOI 10.1007/s00705-012-1223-0; Bateman RL, 2001, J BIOL CHEM, V276, P15284, DOI 10.1074/jbc.M007621200; Begna D, 2012, J PROTEOME RES, V11, P1317, DOI 10.1021/pr200974a; Burmester T, 1999, EUR J ENTOMOL, V96, P213; Chaimanee V, 2012, J INSECT PHYSIOL, V58, P1090, DOI 10.1016/j.jinsphys.2012.04.016; Chan QWT, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-387; Chen YP, 2004, J INVERTEBR PATHOL, V87, P84, DOI 10.1016/j.jip.2004.07.005; Choe SE, 2012, VIROLOGY, V432, P155, DOI 10.1016/j.virol.2012.06.008; da Fonseca PCA, 2012, MOL CELL, V46, P54, DOI 10.1016/j.molcel.2012.03.026; Drapeau MD, 2006, GENOME RES, V16, P1385, DOI 10.1101/gr.5012006; Fang Y, 2010, J PROTEOME RES, V9, P2207, DOI 10.1021/pr900979h; Francklyn C, 2003, P NATL ACAD SCI USA, V100, P9650, DOI 10.1073/pnas.1934245100; Francklyn CS, 2008, BIOCHEMISTRY-US, V47, P11695, DOI 10.1021/bi801500z; Gallai N, 2009, ECOL ECON, V68, P810, DOI 10.1016/j.ecolecon.2008.06.014; Garibaldi LA, 2011, ECOL LETT, V14, P1062, DOI 10.1111/j.1461-0248.2011.01669.x; Ghosh RC, 1999, J GEN VIROL, V80, P1541, DOI 10.1099/0022-1317-80-6-1541; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; GORG A, 1988, ELECTROPHORESIS, V9, P681, DOI 10.1002/elps.1150091103; Gregorc A, 2012, J INSECT PHYSIOL, V58, P1042, DOI 10.1016/j.jinsphys.2012.03.015; Grune T, 2011, FREE RADICAL BIO MED, V51, P1355, DOI 10.1016/j.freeradbiomed.2011.06.015; Guo XQ, 2010, DEV MOL MECH QUEEN W; Han B, 2013, J PROTEOME RES, V12, P1881, DOI 10.1021/pr301226d; He XJ, 2010, J BEE, V6, P3; He XuJiang, 2010, Acta Agriculturae Universitatis Jiangxiensis, V32, P1245; Hofer MD, 2006, ARCH PATHOL LAB MED, V130, P989; Huang L, 1999, SCIENCE, V286, P1321, DOI 10.1126/science.286.5443.1321; Ikeda T, 2011, J INSECT SCI, V11, DOI 10.1673/031.011.7401; Kamakura M, 2011, NATURE, V473, P478, DOI 10.1038/nature10093; Kaplan N, 2006, GENOME RES, V16, P1431, DOI 10.1101/gr.4916306; Kaul G, 2011, CELL BIOCHEM FUNCT, V29, P227, DOI 10.1002/cbf.1740; Keene KM, 2004, P NATL ACAD SCI USA, V101, P17240, DOI 10.1073/pnas.0406983101; Kubota H, 2002, VITAM HORM, V65, P313, DOI 10.1016/S0083-6729(02)65069-1; Li J, 2009, INSECT MOL BIOL, V18, P1, DOI 10.1111/j.1365-2583.2008.00849.x; Li ZL, 2006, GUANGXI J ANIMAL HUS, V22, P276; Liu XJ, 2010, CURR MICROBIOL, V61, P422, DOI 10.1007/s00284-010-9633-2; Lourenco AP, 2013, INSECT BIOCHEM MOLEC, V43, P474, DOI 10.1016/j.ibmb.2013.03.001; Ma MX, 2011, COMP FUNCT GENOM, DOI 10.1155/2011/409386; Mathe C, 2006, ANTIVIR RES, V71, P276, DOI 10.1016/j.antiviral.2006.04.017; Mazurek S, 2011, INT J BIOCHEM CELL B, V43, P969, DOI 10.1016/j.biocel.2010.02.005; Misra RC, 2012, EXP PARASITOL, V132, P257, DOI 10.1016/j.exppara.2012.07.012; Mofeed J, 2013, ECOTOX ENVIRON SAFE, V95, P234, DOI 10.1016/j.ecoenv.2013.05.023; OstoaSaloma P, 1997, EUR J BIOCHEM, V244, P700, DOI 10.1111/j.1432-1033.1997.00700.x; Qiu XH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043114; Rabut G, 2012, SEMIN CELL DEV BIOL, V23, P481, DOI 10.1016/j.semcdb.2012.06.006; Ross SJ, 2000, MOL BIOL CELL, V11, P2631, DOI 10.1091/mbc.11.8.2631; Scharlaken B, 2007, ARCH INSECT BIOCHEM, V65, P223, DOI 10.1002/arch.20179; Schwarz RS, 2013, DEV COMP IMMUNOL, V40, P300, DOI 10.1016/j.dci.2013.03.010; Senthil-Kumar M, 2012, PLANT CELL ENVIRON, V35, P1329, DOI 10.1111/j.1365-3040.2012.02492.x; Shi QL, 2011, J NEUROCHEM, V118, P440, DOI 10.1111/j.1471-4159.2011.07333.x; Shi YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043727; Shin KH, 2008, MOL CELLS, V26, P554; Signor D, 1999, J CELL BIOL, V147, P519, DOI 10.1083/jcb.147.3.519; Sun YN, 2007, J PROTEOME RES, V6, P4478, DOI 10.1021/pr0705183; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Tan SL, 2007, NAT BIOTECHNOL, V25, P1383, DOI 10.1038/nbt1207-1383; van Rij RP, 2006, GENE DEV, V20, P2985, DOI 10.1101/gad.1482006; Wang HG, 2011, GENET MOL BIOL, V34, P396, DOI 10.1590/S1415-47572011005000018; Wenzel DM, 2011, BIOCHEM J, V433, P31, DOI 10.1042/BJ20100985; Worrall LJ, 2010, PROTEIN SCI, V19, P1091, DOI 10.1002/pro.382; Xie XianBing, 2008, Scientia Agricultura Sinica, V41, P1530; Xie XianBing, 2005, Acta Agriculturae Universitatis Jiangxiensis, V27, P607; Yan X, 2009, SOCIOBIOLOGY, V53, P687; Zanelli CF, 2006, BIOCHEM BIOPH RES CO, V348, P1358, DOI 10.1016/j.bbrc.2006.07.195; Zeng Zhi-jiang, 2005, Acta Agriculturae Universitatis Jiangxiensis, V27, P454; Zeng ZhiJiang, 2006, Journal of Shanghai Jiaotong University - Agricultural Science, V24, P75; Zeng ZJ, 2009, APICULTURE; Zhang GZ, 2008, CHINA J BIOL CONTROL, V24, P130; Zhang JQ, 2001, SCI CHINA SER C, V44, P443, DOI 10.1007/BF02879612; Zhang Q, 2012, J PROTEOME RES, V11, P1042, DOI 10.1021/pr200796a; Zhang Y, 2010, J INSECT PHYSIOL, V56, P1207, DOI 10.1016/j.jinsphys.2010.03.019; Zhao XF, 2006, J PROTEOME RES, V5, P164, DOI 10.1021/pr0502424	74	9	10	3	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e102663	10.1371/journal.pone.0102663	http://dx.doi.org/10.1371/journal.pone.0102663			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25102167	Green Published, gold, Green Submitted			2022-12-27	WOS:000339993900004
J	Kotoula, V; Bobos, M; Alexopoulou, Z; Papadimitriou, C; Papadopoulou, K; Charalambous, E; Tsolaki, E; Xepapadakis, G; Nicolaou, I; Papaspirou, I; Aravantinos, G; Christodoulou, C; Efstratiou, I; Gogas, H; Fountzilas, G				Kotoula, Vassiliki; Bobos, Mattheos; Alexopoulou, Zoi; Papadimitriou, Christos; Papadopoulou, Kyriaki; Charalambous, Elpida; Tsolaki, Eleftheria; Xepapadakis, Grigorios; Nicolaou, Irene; Papaspirou, Irene; Aravantinos, Gerasimos; Christodoulou, Christos; Efstratiou, Ioannis; Gogas, Helen; Fountzilas, George			Adjusting Breast Cancer Patient Prognosis with Non-HER2-Gene Patterns on Chromosome 17	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; COMPARATIVE GENOMIC HYBRIDIZATION; DENSE SEQUENTIAL CHEMOTHERAPY; RANDOMIZED PHASE-III; RETROSPECTIVE ANALYSIS; GENE AMPLIFICATION; PROTEIN EXPRESSION; HER2 AMPLICON; POLYSOMY 17; INSTABILITY	Background: HER2 and TOP2A gene status are assessed for diagnostic and research purposes in breast cancer with fluorescence in situ hybridization (FISH). However, FISH probes do not target only the annotated gene, while chromosome 17 (chr17) is among the most unstable chromosomes in breast cancer. Here we asked whether the status of specifically targeted genes on chr17 might help in refining prognosis of early high-risk breast cancer patients. Methods: Copy numbers (CN) for 14 genes on chr17, 4 of which were within and 10 outside the core HER2 amplicon (HER2 and non-HER2-genes, respectively) were assessed with qPCR in 485 paraffin-embedded tumor tissue samples from breast cancer patients treated with adjuvant chemotherapy in the frame of two randomized phase III trials. Principal Findings: HER2-genes CN strongly correlated to each other (Spearman's rho.0.6) and were concordant with FISH HER2 status (Kappa 0.6697 for ERBB2 CN). TOP2A CN were not concordant with TOP2A FISH status (Kappa 0.1154). CN hierarchical clustering revealed distinct patterns of gains, losses and complex alterations in HER2-and non-HER2-genes associated with IHC4 breast cancer subtypes. Upon multivariate analysis, non-HER2-gene gains independently predicted for shorter disease-free survival (DFS) and overall survival (OS) in patients with triple-negative cancer, as compared to luminal and HER2-positive tumors (interaction p = 0.007 for DFS and p = 0.011 for OS). Similarly, non-HER2-gene gains were associated with worse prognosis in patients who had undergone breast-conserving surgery as compared to modified radical mastectomy (p = 0.004 for both DFS and OS). Non-HER2-gene losses were unfavorable prognosticators in patients with 1-3 metastatic nodes, as compared to those with 4 or more nodes (p = 0.017 for DFS and p = 0.001 for OS). Conclusions: TOP2A FISH and qPCR may not identify the same pathology on chr17q. Non-HER2 chr17 CN patterns may further predict outcome in breast cancer patients with known favorable and unfavorable prognosis.	[Kotoula, Vassiliki] Aristotle Univ Thessaloniki, Dept Pathol, Sch Med, GR-54006 Thessaloniki, Greece; [Kotoula, Vassiliki; Bobos, Mattheos; Papadopoulou, Kyriaki; Charalambous, Elpida; Tsolaki, Eleftheria; Fountzilas, George] Aristotle Univ Thessaloniki, Mol Oncol Lab, Sch Med, Hellenic Fdn Canc Res, GR-54006 Thessaloniki, Greece; [Alexopoulou, Zoi] Hlth Data Specialists Ltd, Dept Biostat, Athens, Greece; [Papadimitriou, Christos] Univ Athens, Sch Med, Dept Clin Therapeut, Alexandra Hosp, GR-11527 Athens, Greece; [Xepapadakis, Grigorios] REA Hosp, Breast Clin, Piraeus, Greece; [Nicolaou, Irene] Agii Anagriri Canc Hosp, Dept Histopathol, Athens, Greece; [Papaspirou, Irene] Alexandra Hosp, Dept Pathol, Athens, Greece; [Aravantinos, Gerasimos] Agii Anargiri Canc Hosp, Dept Med Oncol 2, Athens, Greece; [Christodoulou, Christos] Metropolitan Hosp, Dept Med Oncol 2, Piraeus, Greece; [Efstratiou, Ioannis] Papageorgiou Hosp, Dept Pathol, Thessaloniki, Greece; [Gogas, Helen] Univ Athens, Sch Med, Laiko Gen Hosp, Dept Med 1, GR-11527 Athens, Greece; [Fountzilas, George] Aristotle Univ Thessaloniki, Dept Med Oncol, Papageorgiou Hosp, Sch Med, GR-54006 Thessaloniki, Greece	Aristotle University of Thessaloniki; Aristotle University of Thessaloniki; Alexandra Hospital; Athens Medical School; National & Kapodistrian University of Athens; Alexandra Hospital; Papageorgiou Hospital; Athens Medical School; Laiko General Hospital; National & Kapodistrian University of Athens; Aristotle University of Thessaloniki; Papageorgiou Hospital	Kotoula, V (corresponding author), Aristotle Univ Thessaloniki, Dept Pathol, Sch Med, GR-54006 Thessaloniki, Greece.	vkotoula@auth.gr	Dimopoulos, Meletios Athanasios/AAD-4130-2019; Bobos, Mattheos/L-5702-2019; Fountzilas, George/ABF-2139-2020	Bobos, Mattheos/0000-0001-5662-9201; Fountzilas, George/0000-0001-8045-2186; Aravantinos, Gerasimos/0000-0002-2106-1713; Papadopoulou, Kyriaki/0000-0003-0389-4209	Hellenic Cooperative Oncology Group internal research grant [HER_11P/05]	Hellenic Cooperative Oncology Group internal research grant	The study was supported by a Hellenic Cooperative Oncology Group internal research grant (HER_11P/05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	A'Hern RP, 2013, NAT REV CLIN ONCOL, V10, P357, DOI 10.1038/nrclinonc.2013.67; Agarwal S, 2014, JAMA SURG; Altman DG, 2012, BMC MED, V10, DOI [10.1186/1741-7015-10-51, 10.1371/journal.pmed.1001216]; Arriola E, 2008, LAB INVEST, V88, P491, DOI 10.1038/labinvest.2008.19; Baumann J, 2013, BBA-MOL CELL BIOL L, V1831, P1509, DOI 10.1016/j.bbalip.2013.03.011; Bonnet F, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-54; Brase JC, 2010, CLIN CANCER RES, V16, P2391, DOI 10.1158/1078-0432.CCR-09-2471; Burrell RA, 2010, J CELL BIOCHEM, V111, P782, DOI 10.1002/jcb.22781; Cheang MCU, 2009, JNCI-J NATL CANCER I, V101, P736, DOI 10.1093/jnci/djp082; Fountzilas G, 2008, ANN ONCOL, V19, P853, DOI [10.1093/annonc/mdm539, 10.1093/annonc/mdm464]; Fountzilas G, 2005, ANN ONCOL, V16, P1762, DOI 10.1093/annonc/mdi366; Fountzilas G, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-163; Fountzilas G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037946; Fountzilas G, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-10; Fuchs EM, 2013, INT J CANC; Glynn RW, 2011, ONCOLOGIST, V16, P949, DOI 10.1634/theoncologist.2011-0071; Gogas H, 2012, BREAST CANCER RES TR, V132, P609, DOI 10.1007/s10549-011-1913-4; Hammond MEH, 2010, J CLIN ONCOL, V28, P2784, DOI 10.1200/JCO.2009.25.6529; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hanna WM, 2014, MODERN PATHOL, V27, P4, DOI 10.1038/modpathol.2013.103; Hennig G, 2010, CLIN CHEM, V56, P1845, DOI 10.1373/clinchem.2010.151233; Iwamoto T, 2011, J NATL CANCER I, V103, P264, DOI 10.1093/jnci/djq524; Jacobson KK, 2004, GENE CHROMOSOME CANC, V40, P19, DOI 10.1002/gcc.20019; Jacot W, 2013, BBA-REV CANCER, V1836, P146, DOI 10.1016/j.bbcan.2013.04.004; Jacquemier J, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-351; Jornayvaz FR, 2012, ENDOCRINOLOGY, V153, P583, DOI 10.1210/en.2011-1793; KALLIONIEMI OP, 1992, P NATL ACAD SCI USA, V89, P5321, DOI 10.1073/pnas.89.12.5321; Kauraniemi P, 2006, ENDOCR-RELAT CANCER, V13, P39, DOI 10.1677/erc.1.01147; Knoop AS, 2005, J CLIN ONCOL, V23, P7483, DOI 10.1200/JCO.2005.11.007; Kytola S, 2000, GENE CHROMOSOME CANC, V28, P308, DOI 10.1002/1098-2264(200007)28:3<308::AID-GCC9>3.0.CO;2-B; Lambros MBK, 2006, LAB INVEST, V86, P398, DOI 10.1038/labinvest.3700390; Lamy PJ, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2824; Marchio C, 2009, J PATHOL, V219, P16, DOI 10.1002/path.2574; McGranahan N, 2012, EMBO REP, V13, P528, DOI 10.1038/embor.2012.61; Moelans CB, 2010, BREAST CANCER RES TR, V120, P1, DOI 10.1007/s10549-009-0539-2; Montemurro F, 2014, MOL ONCOL, V8, P20, DOI 10.1016/j.molonc.2013.08.013; Munch-Petersen HD, 2013, APMIS; Munro AF, 2012, BRIT J CANCER, V107, P71, DOI 10.1038/bjc.2012.232; Murthy SK, 2005, ARCH PATHOL LAB MED, V129, P39; Nielsen KV, 2010, MOL ONCOL, V4, P161, DOI 10.1016/j.molonc.2009.11.001; Press MF, 2011, J CLIN ONCOL, V29, P859, DOI 10.1200/JCO.2009.27.5644; Roylance R, 2011, CANCER EPIDEM BIOMAR, V20, P2183, DOI 10.1158/1055-9965.EPI-11-0343; Sahlberg KK, 2013, MOL ONCOL, V7, P392, DOI 10.1016/j.molonc.2012.10.012; Smid M, 2011, BREAST CANCER RES TR, V128, P23, DOI 10.1007/s10549-010-1026-5; Staaf J, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2568; Sung JS, 2010, CANCER GENET CYTOGEN, V198, P27, DOI 10.1016/j.cancergencyto.2009.12.001; Tse CH, 2011, J CLIN ONCOL, V29, P4168, DOI 10.1200/JCO.2011.36.0107; Vanden Bempt I, 2008, J CLIN ONCOL, V26, P4869, DOI 10.1200/JCO.2007.13.4296; Varga Z, 2012, BREAST CANCER RES TR, V133, P929, DOI 10.1007/s10549-011-1873-8; Vincent-Salomon A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076496; Watari H, 1997, P NATL ACAD SCI USA, V94, P8462, DOI 10.1073/pnas.94.16.8462; Wolff AC, 2013, ARCH PATHOL LAB MED; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; Yeh IT, 2009, MODERN PATHOL, V22, P1169, DOI 10.1038/modpathol.2009.78; Zaczek AJ, 2012, ONCOLOGIST, V17, P1246, DOI 10.1634/theoncologist.2012-0023	55	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e103707	10.1371/journal.pone.0103707	http://dx.doi.org/10.1371/journal.pone.0103707			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25098819	gold, Green Published, Green Submitted			2022-12-27	WOS:000339995100026
J	Leyva-Flores, R; Servan-Mori, E; Infante-Xibille, C; Pelcastre-Villafuerte, BE; Gonzalez, T				Leyva-Flores, Rene; Servan-Mori, Edson; Infante-Xibille, Cesar; Estela Pelcastre-Villafuerte, Blanca; Gonzalez, Tonatiuh			Primary Health Care Utilization by the Mexican Indigenous Population: The Role of the Seguro Popular in Socially Inequitable Contexts	PLOS ONE			English	Article							PROPENSITY SCORE; SERVICES; INSURANCE; DEMAND; IMPACT; MODEL	Objective: To analyze the relationship between primary health care utilization and extended health insurance coverage under the Seguro Popular (SP) among Mexican indigenous people. Methodology: A cross-sectional analysis was conducted using data from the Mexican National Nutrition Survey 2012 (n = 194,758). Quasi-experimental matching methods and nonlinear regression probit models were used to estimate the influence of SP on primary health care utilization. Results: 25% of the Mexican population reported having no health insurance coverage, while 59% of indigenous versus 35% of non-indigenous reported having SP coverage. Health problems were reported by 13.9% of indigenous vs. 10.5% of non-indigenous; of these, 52.8% and 57.7% respectively, received primary health care (p<0.05). Economic barriers were the most frequent reasons for not using primary health care services. The probability of utilizing primary health care services was 11.5 percentage points higher (p<0.01) for indigenous SP affiliates in comparison with non-indigenous, in similar socioeconomic conditions. Conclusion: Socioeconomic conditions, not ethnicity per-se, determine whether people utilize primary health care services. Therefore, SP can be conceived as a public policy strategy which acts as a social buffer by enhancing health care utilization regardless of ethnicity. Further analysis is required to explore the potential gaps as a result of SP coverage among socially vulnerable groups.	[Leyva-Flores, Rene; Servan-Mori, Edson; Infante-Xibille, Cesar; Estela Pelcastre-Villafuerte, Blanca; Gonzalez, Tonatiuh] Natl Inst Publ Hlth, Ctr Hlth Syst Res, Cuernavaca, Morelos, Mexico	Instituto Nacional de Salud Publica	Servan-Mori, E (corresponding author), Natl Inst Publ Hlth, Ctr Hlth Syst Res, Cuernavaca, Morelos, Mexico.	eservan@insp.mx	LEYVA, RENE/AAE-9368-2020; INFANTE, CESAR/AAF-1896-2021; Pelcastre, Blanca/AFD-6340-2022	LEYVA, RENE/0000-0002-5973-4549; INFANTE, CESAR/0000-0002-5367-8611; Servan-Mori, Edson/0000-0001-9820-8325; Pelcastre-Villafuerte, Blanca Estela/0000-0003-4755-1881				ANDERSEN RM, 1995, J HEALTH SOC BEHAV, V36, P1, DOI 10.2307/2137284; Gonzalez-Block MA, 2010, SALUD PUBLICA MEXICO, V52, P416, DOI 10.1590/S0036-36342010000500009; Berrio L, 2008, COALICION SALUD MUJE; Brown CJ, 2005, HEALTH POLICY, V72, P81, DOI 10.1016/j.healthpol.2004.06.008; Caliendo M, 2008, J ECON SURV, V22, P31, DOI 10.1111/j.1467-6419.2007.00527.x; Cameron A. C., 2010, MICROECONOMETRICS US; Céspedes-Londoño Juan Eduardo, 2002, Cad. Saúde Pública, V18, P1003, DOI 10.1590/S0102-311X2002000400008; Comision Nacional de Proteccion Social en Salud, 2013, HIST SEG POP; Comision Nacional para el Desarrollo de los Pueblos Indigenas (CDI), 2012, HOG POBL IND; Comision Nacional para el Desarrollo de los Pueblos Indigenas Programa de Naciones Unidas para el Desarrollo, 2006, REG IND MEX; CONAPO (Consejo Nacional de Poblacion MX), 2012, IND MARG LOC; CONEVAL (Consejo Nacional de Evaluacion de la Politica de Desarrollo Social), 2013, INF EV ESP DES 2012; Consejo Nacional de Poblacion (CONAPO), 2013, REP MEX IND DEM POBL; Danese-dlSantos LG, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-771; Dehejia RH, 2002, REV ECON STAT, V84, P151, DOI 10.1162/003465302317331982; Galarraga O, 2010, EUR J HEALTH ECON, V11, P437, DOI 10.1007/s10198-009-0180-3; Grogger J, 2012, IDENTIFICACION UNPUB; Gutierrez JP, 2012, ENCUESTA NACL SALUD; Hall G, 2006, INDIGENOUS PEOPLES P; Handa A, 2007, RACIAL ETHNIC DISPAR, P65; Instituto Nacional de Estadistica Geografia e Informatica., 2010, PRINC RES CENS POBL; International Fund for Agricultural Development (IFAD), 2007, STAT KEY FACTS IND P; King G, 2009, LANCET, V373, P1447, DOI 10.1016/S0140-6736(09)60239-7; Knaul FM, 2006, LANCET, V368, P1828, DOI 10.1016/S0140-6736(06)69565-2; Laurell Asa Cristina, 2013, IMPACTO SEGURO POPUL; Leyva-Flores R, 2013, SALUD PUBLICA MEXICO, V55; Lopez-Cevallos DF, 2010, HEALTH POLICY PLANN, V25, P209, DOI 10.1093/heapol/czp052; Knaul FM, 2012, LANCET, V380, P1259, DOI 10.1016/S0140-6736(12)61068-X; Martinez G, 2009, MEXICAN HLTH CARE SY; OMS, 2012, SOC PROT SHAR INT VU, V4; Gutierrez JP, 2013, SALUD PUBLICA MEXICO, V55, pS83; Partridge WL, 1998, WORLD B LAT AMER CAR, P229; Plant R, 1998, ISSUES INDIGENOUS PO; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Sahn DE, 2003, OXFORD B ECON STAT, V65, P241, DOI 10.1111/1468-0084.t01-2-00046; Sistema de Proteccion Social en Salud, 2013, INF RES SPSS EN DIC; Sosa-Rubi SG, 2011, SALUD PUBLICA MEXICO, V53, pS425; Sosa-Rubi SG, 2009, J HEALTH ECON, V28, P20, DOI 10.1016/j.jhealeco.2008.08.002; Stata Corp LP, 2009, STAT SE 13 0 WIND XP; The World Bank (WB), 2012, MEX PAN PROT SOC; Valdivia M, 2002, HEALTH POLICY PLANN, V17, P12, DOI 10.1093/heapol/17.suppl_1.12; Wirtz V, 2013, SALUD PUBLICA MEXICO, V55; Wirtz VJ, 2012, VALUE HEALTH, V15, P593, DOI 10.1016/j.jval.2012.01.006	43	11	11	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e102781	10.1371/journal.pone.0102781	http://dx.doi.org/10.1371/journal.pone.0102781			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM6SM	25099399	Green Published, gold, Green Submitted			2022-12-27	WOS:000339995100012
J	Zhou, P; Cowled, C; Mansell, A; Monaghan, P; Green, D; Wu, LJ; Shi, ZL; Wang, LF; Baker, ML				Zhou, Peng; Cowled, Chris; Mansell, Ashley; Monaghan, Paul; Green, Diane; Wu, Lijun; Shi, Zhengli; Wang, Lin-Fa; Baker, Michelle L.			IRF7 in the Australian Black Flying Fox, Pteropus alecto: Evidence for a Unique Expression Pattern and Functional Conservation	PLOS ONE			English	Article							REGULATORY FACTOR FAMILY; TOLL-LIKE RECEPTORS; MOLECULAR CHARACTERIZATION; POSITIVE FEEDBACK; FRUIT BATS; INTERFERON; VIRUS; INDUCTION; GENE; TRANSCRIPTION	As the only flying mammal, bats harbor a number of emerging and re-emerging viruses, may of which cause severe diseases in humans and other mammals yet results in no clinical symptoms in bats. As the master regulator of the interferon (IFN)-dependent immune response, IFN regulatory factor 7 (IRF7) plays a central role in innate antiviral immunity. To explore the role of bat IRF7 in the regulation of IFN response, we performed sequence and functional analysis of IRF7 from the pteropid bat, Pteropus alecto. Our results demonstrate that bat IRF7 retains the ability to bind to MyD88 and activate the IFN response despite unique changes in the MyD88 binding domain. We also demonstrate that bat IRF7 has a unique expression pattern across noth immune and non-immune related tissues and is inducible by double-strand RNA. The broad tissue compared to other mammals. The importance of IRF7 in antiviral activity against the bat reovirus, pulau virus ws confirmed by siRNA knockdown of IRF7 in bat cells resulting in enhanced viral replication. Our results highlight the importance of IRF7 in innate antiviral immunity in bats.	[Zhou, Peng; Cowled, Chris; Monaghan, Paul; Green, Diane; Wang, Lin-Fa; Baker, Michelle L.] CSIRO, Australian Anim Hlth Lab, Geelong, Vic, Australia; [Mansell, Ashley] Monash Univ, Prince Henry Inst Med Res, Monash Inst Med Res, Ctr Innate Immun & Infect Dis, Clayton, Vic, Australia; [Wu, Lijun; Shi, Zhengli] Chinese Acad Sci, Wuhan Inst Virol, Ctr Emerging Infect Dis, Wuhan, Peoples R China; [Wang, Lin-Fa] Duke Natl Univ Singapore, Grad Sch Med, Program Emerging Infect Dis, Singapore, Singapore	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Monash University; Prince Henry's Institute of Medical Research; Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; National University of Singapore	Baker, ML (corresponding author), CSIRO, Australian Anim Hlth Lab, Geelong, Vic, Australia.	Michelle.Baker@csiro.au	Baker, Michelle/AAX-9171-2020; Zhou, Peng/I-8578-2015; Cowled, Christopher JE/H-5308-2013; wang, lin/HHM-2225-2022; Monaghan, Paul/H-1973-2013; wang, lin/GSE-3040-2022; wang, lili/HDL-7210-2022; Baker, Michelle L/C-9694-2013; Mansell, Ashley/B-9553-2008; Shi, Zheng-Li/A-1013-2013	Baker, Michelle/0000-0002-7993-9971; Zhou, Peng/0000-0003-1938-8255; Cowled, Christopher JE/0000-0002-1969-9371; Baker, Michelle L/0000-0002-7993-9971; Mansell, Ashley/0000-0002-6540-1281; Shi, Zheng-Li/0000-0001-8089-163X; Wang, Lin-Fa/0000-0003-2752-0535	Australian Research Council Future Fellowship [FT110100234]; CSIRO OCE Science Leaders award; Victorian Government's Operational Infrastructure Support Program	Australian Research Council Future Fellowship(Australian Research Council); CSIRO OCE Science Leaders award; Victorian Government's Operational Infrastructure Support Program	This work was supported by funding from the Australian Research Council Future Fellowship (FT110100234) to M. L. B. and a CSIRO OCE Science Leaders award to L. -F. W. and support from the Victorian Government's Operational Infrastructure Support Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker ML, 2013, ZOONOSES PUBLIC HLTH, V60, P104, DOI 10.1111/j.1863-2378.2012.01528.x; Bergan V, 2010, MOL IMMUNOL, V47, P2005, DOI 10.1016/j.molimm.2010.04.015; Bermingham A, 2012, EUROSURVEILLANCE, V17, P6; Bidwell BN, 2012, NAT MED, V18, P1224, DOI 10.1038/nm.2830; Calisher CH, 2006, CLIN MICROBIOL REV, V19, P531, DOI 10.1128/CMR.00017-06; Chua KB, 2000, SCIENCE, V288, P1432, DOI 10.1126/science.288.5470.1432; Civas A, 2002, BIOCHIMIE, V84, P643, DOI 10.1016/S0300-9084(02)01431-1; Cowled C, 2012, DEV COMP IMMUNOL, V36, P657, DOI 10.1016/j.dci.2011.11.008; Cowled C, 2011, DEV COMP IMMUNOL, V35, P7, DOI 10.1016/j.dci.2010.07.006; Crameri G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008266; FUJITA T, 1988, EMBO J, V7, P3397, DOI 10.1002/j.1460-2075.1988.tb03213.x; Ge XY, 2013, NATURE, V503, P535, DOI 10.1038/nature12711; Genin P, 2009, CYTOKINE GROWTH F R, V20, P283, DOI 10.1016/j.cytogfr.2009.07.005; Halpin K, 2000, J GEN VIROL, V81, P1927, DOI 10.1099/0022-1317-81-8-1927; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Honda K, 2004, P NATL ACAD SCI USA, V101, P15416, DOI 10.1073/pnas.0406933101; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Hoshino K, 2006, NATURE, V440, P949, DOI 10.1038/nature04641; Hu GB, 2010, FISH SHELLFISH IMMUN, V29, P963, DOI 10.1016/j.fsi.2010.08.002; Ikeda F, 2007, EMBO J, V26, P3451, DOI 10.1038/sj.emboj.7601773; Into T, 2010, J BIOL CHEM, V285, P35759, DOI 10.1074/jbc.M110.126904; Jia WZ, 2008, MOL IMMUNOL, V45, P2419, DOI 10.1016/j.molimm.2007.11.011; Kawai T, 2004, NAT IMMUNOL, V5, P1061, DOI 10.1038/ni1118; Leroy EM, 2005, NATURE, V438, P575, DOI 10.1038/438575a; Lin RT, 2000, J BIOL CHEM, V275, P34320, DOI 10.1074/jbc.M002814200; Lu RQ, 2000, J BIOL CHEM, V275, P31805, DOI 10.1074/jbc.M005288200; Mansell A, 2006, NAT IMMUNOL, V7, P148, DOI 10.1038/ni1299; Marie I, 1998, EMBO J, V17, P6660, DOI 10.1093/emboj/17.22.6660; Marie I, 2000, MOL CELL BIOL, V20, P8803, DOI 10.1128/MCB.20.23.8803-8814.2000; Ning S, 2011, GENES IMMUN, V12, P399, DOI 10.1038/gene.2011.21; Nishiya T, 2007, FEBS LETT, V581, P3223, DOI 10.1016/j.febslet.2007.06.008; Osterlund PI, 2007, J IMMUNOL, V179, P3434, DOI 10.4049/jimmunol.179.6.3434; Papenfuss AT, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-261; Paun A, 2007, BIOCHIMIE, V89, P744, DOI 10.1016/j.biochi.2007.01.014; Pritchard LI, 2006, ARCH VIROL, V151, P229, DOI 10.1007/s00705-005-0644-4; Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0; Sato M, 1998, FEBS LETT, V441, P106, DOI 10.1016/S0014-5793(98)01514-2; Strahle L, 2006, VIROLOGY, V351, P101, DOI 10.1016/j.virol.2006.03.022; Sun BJ, 2007, VET IMMUNOL IMMUNOP, V116, P26, DOI 10.1016/j.vetimm.2007.01.001; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; van der Poel WHM, 2006, VECTOR-BORNE ZOONOT, V6, P315, DOI 10.1089/vbz.2006.6.315; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; Zhang GJ, 2013, SCIENCE, V339, P456, DOI 10.1126/science.1230835; Zhang LW, 1997, MOL CELL BIOL, V17, P5748, DOI 10.1128/MCB.17.10.5748; Zhang YB, 2003, FISH SHELLFISH IMMUN, V15, P453, DOI 10.1016/S1050-4648(03)00025-1; Zhou P, 2013, DEV COMP IMMUNOL, V40, P240, DOI 10.1016/j.dci.2013.03.006; Zhou P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025385; Zhou P, 2011, J IMMUNOL, V186, P3138, DOI 10.4049/jimmunol.1003115	48	33	35	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e103875	10.1371/journal.pone.0103875	http://dx.doi.org/10.1371/journal.pone.0103875			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25100081	Green Published, Green Submitted, gold			2022-12-27	WOS:000339995100037
J	Britze, A; Birkler, RID; Gregersen, N; Ovesen, T; Palmfeldt, J				Britze, Anders; Birkler, Rune Isak Dupont; Gregersen, Niels; Ovesen, Therese; Palmfeldt, Johan			Large-Scale Proteomics Differentiates Cholesteatoma from Surrounding Tissues and Identifies Novel Proteins Related to the Pathogenesis	PLOS ONE			English	Article							MIDDLE-EAR CHOLESTEATOMA; ACQUIRED CHOLESTEATOMA; CYTOKERATIN EXPRESSION; GENE-EXPRESSION; STEROID SULFATASE; BASEMENT-MEMBRANE; PSORIASIN S100A7; NIDOGEN-2 GENE; BREAST-CANCER; SKIN	Cholesteatoma is the growth of keratinizing squamous epithelium in the middle ear. It is associated with severe complications and has a poorly understood etiopathogenesis. Here, we present the results from extensive bioinformatics analyses of the first large-scale proteomic investigation of cholesteatoma. The purpose of this study was to take an unbiased approach to identifying alterations in protein expression and in biological processes, in order to explain the characteristic phenotype of this skin-derived tumor. Five different human tissue types (cholesteatoma, neck of cholesteatoma, tympanic membrane, external auditory canal skin, and middle ear mucosa) were analyzed. More than 2,400 unique proteins were identified using nanoLC-MS/MS based proteomics (data deposited to the ProteomeXchange), and 295 proteins were found to be differentially regulated in cholesteatoma. Validation analyses were performed by SRM mass spectrometry. Proteins found to be up- or down-regulated in cholesteatoma were analyzed using Ingenuity Pathway Analysis and clustered into functional groups, for which activation state and associations to disease processes were predicted. Cholesteatoma contained high levels of pro-inflammatory S100 proteins, such as S100A7A and S100A7. Several proteases, such as ELANE, were up-regulated, whereas extracellular matrix proteins, such as COL18A1 and NID2, were under-represented. This may lead to alterations in integrity and differentiation of the tissue (as suggested by the up-regulation of KRT4 in the cholesteatoma). The presented data on the differential protein composition in cholesteatoma corroborate previous studies, highlight novel protein functionalities involved in the pathogenesis, and identify new areas for targeted research that hold therapeutic potential for the disease.	[Britze, Anders; Ovesen, Therese] Aarhus Univ Hosp, Dept Otorhinolaryngol Head & Neck Surg, DK-8000 Aarhus, Denmark; [Birkler, Rune Isak Dupont; Gregersen, Niels; Palmfeldt, Johan] Aarhus Univ Hosp, Res Unit Mol Med, DK-8000 Aarhus, Denmark	Aarhus University; Aarhus University	Britze, A (corresponding author), Aarhus Univ Hosp, Dept Otorhinolaryngol Head & Neck Surg, DK-8000 Aarhus, Denmark.	andersbritze@gmail.com		Ovesen, Therese/0000-0003-0864-7987; Britze, Anders/0000-0002-2481-0425; Palmfeldt, Johan/0000-0001-5585-639X	Hans Skoubys og Hustru Emma Skoubys Foundation; John and Birthe Meyer Foundation; Aarhus University Hospital - Institute of Clinical Medicin	Hans Skoubys og Hustru Emma Skoubys Foundation; John and Birthe Meyer Foundation; Aarhus University Hospital - Institute of Clinical Medicin	The work was supported by external sources: *Hans Skoubys og Hustru Emma Skoubys Foundation - http://www.audioweb.dk/Skouby/index.htm *John and Birthe Meyer Foundation *Danaflex - www.danaflex.com; Internal source: Aarhus University Hospital - Institute of Clinical Medicin - http://clin.au.dk/en/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERG B, 1993, ARCH OTOLARYNGOL, V119, P272; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Baiges I, 2010, MOL CELL PROTEOMICS, V9, P1499, DOI 10.1074/mcp.M000055-MCP201; Baysal E, 2013, EUR ARCH OTO-RHINO-L, V270, P1203, DOI 10.1007/s00405-012-2070-z; Bloksgaard M, 2012, OTOL NEUROTOL, V33, P177, DOI 10.1097/MAO.0b013e318241be63; Britze A, 2014, ACTA OTO-LARYNGOL, V134, P41, DOI 10.3109/00016489.2013.844360; BROEKAERT D, 1992, ANN OTO RHINOL LARYN, V101, P931, DOI 10.1177/000348949210101109; Bujia J, 1996, EUR ARCH OTO-RHINO-L, V253, P21; Bujia J, 1996, ORL J OTO-RHINO-LARY, V58, P23, DOI 10.1159/000276789; BUJIA J, 1993, ACTA OTO-LARYNGOL, V113, P364, DOI 10.3109/00016489309135826; Cameron S, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-74; Canfield AE, 2007, BIOCHEM SOC T, V35, P669, DOI 10.1042/BST0350669; Chole RA, 2002, ARCH OTOLARYNGOL, V128, P1129, DOI 10.1001/archotol.128.10.1129; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; DALLARI S, 1994, ACTA OTO-LARYNGOL, V114, P188, DOI 10.3109/00016489409126040; Das D, 2012, J AM COLL CARDIOL, V60, P775, DOI 10.1016/j.jacc.2012.04.027; Djurhuus BD, 2010, DAN MED BULL, V57; Eckert RL, 2004, J INVEST DERMATOL, V123, P23, DOI 10.1111/j.0022-202X.2004.22719.x; Fleming JM, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-266; Fujimoto N, 2006, EXP DERMATOL, V15, P300, DOI 10.1111/j.0906-6705.2006.00409.x; Garca MF, 2013, J MEMBRANE BIOL, V246, P519, DOI 10.1007/s00232-013-9561-8; Grau S, 2005, P NATL ACAD SCI USA, V102, P6021, DOI 10.1073/pnas.0501823102; Grau S, 2006, J BIOL CHEM, V281, P6124, DOI 10.1074/jbc.M500361200; Hansen J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026634; Harder J, 2010, J INVEST DERMATOL, V130, P1355, DOI 10.1038/jid.2009.432; Haruyama T, 2010, ORL-J OTO-RHIN-LARYN, V72, P325, DOI 10.1159/000319897; Harvey CJ, 2009, FREE RADICAL BIO MED, V46, P443, DOI 10.1016/j.freeradbiomed.2008.10.040; Hegyi Z, 2012, J INVEST DERMATOL, V132, P1416, DOI 10.1038/jid.2011.486; Henry J, 2011, FASEB J, V25, P1567, DOI 10.1096/fj.10-168658; Ho KY, 2013, INT J MOL SCI, V14, P14439, DOI 10.3390/ijms140714439; Ho KY, 2012, LARYNGOSCOPE, V122, P2818, DOI 10.1002/lary.23547; HOLLY A, 1995, LARYNGO RHINO OTOL, V74, P33, DOI 10.1055/s-2007-997682; Huisman MA, 2003, ACTA OTO-LARYNGOL, V123, P377, DOI 10.1080/00016480310001376; Hussein MRA, 2010, EXP MOL PATHOL, V88, P316, DOI 10.1016/j.yexmp.2009.12.006; JACKSON DG, 1978, ACTA OTO-LARYNGOL, V86, P71, DOI 10.3109/00016487809124722; Jeong JH, 2006, LARYNGOSCOPE, V116, P1180, DOI 10.1097/01.mlg.0000224345.59291.da; KAKOI H, 1995, ACTA OTO-LARYNGOL, V115, P804, DOI 10.3109/00016489509139405; Kemppainen HO, 1999, ACTA OTO-LARYNGOL, V119, P568; Kim HJ, 2010, AM J PHYSIOL-RENAL, V298, pF662, DOI 10.1152/ajprenal.00421.2009; Kim JL, 2004, ACTA OTO-LARYNGOL, V124, P783, DOI 10.1080/00016480410017882; Kim KH, 2009, ACTA OTO-LARYNGOL, V129, P1067, DOI 10.1080/00016480802455291; Klenke C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052718; Korkmaz B, 2010, PHARMACOL REV, V62, P726, DOI 10.1124/pr.110.002733; Kwon KH, 2006, ACTA OTO-LARYNGOL, V126, P691, DOI 10.1080/00016480500475633; Louw L, 2010, J LARYNGOL OTOL, V124, P587, DOI 10.1017/S0022215109992763; Ma CY, 2011, ONCOL REP, V26, P813, DOI 10.3892/or.2011.1365; Macias JD, 2013, LARYNGOSCOPE, V123, pS1, DOI 10.1002/lary.24176; Malhotra D, 2008, AM J RESP CRIT CARE, V178, P592, DOI 10.1164/rccm.200803-380OC; Moll R, 2008, HISTOCHEM CELL BIOL, V129, P705, DOI 10.1007/s00418-008-0435-6; Mouneimne G, 2012, CANCER CELL, V22, P615, DOI 10.1016/j.ccr.2012.09.027; Olszewska E, 2007, HISTOL HISTOPATHOL, V22, P37, DOI 10.14670/HH-22.37; Olszewska E, 2005, EUR ARCH OTO-RHINO-L, V262, P731, DOI 10.1007/s00405-004-0875-0; Olszewska E, 2004, EUR ARCH OTO-RHINO-L, V261, P6, DOI 10.1007/s00405-003-0623-x; Olszewska E, 2006, MED SCI MONITOR, V12, pCR337; Olszewska E, 2006, EUR ARCH OTO-RHINO-L, V263, P409, DOI 10.1007/s00405-005-1026-y; Pelc P, 2003, HISTOPATHOLOGY, V42, P387, DOI 10.1046/j.1365-2559.2003.01588.x; Raffa S, 2012, HISTOCHEM CELL BIOL, V138, P251, DOI 10.1007/s00418-012-0947-y; Reed MJ, 2005, ENDOCR REV, V26, P171, DOI 10.1210/er.2004-0003; Revadi G, 2011, OTOL NEUROTOL, V32, P504, DOI 10.1097/MAO.0b013e31820d97e2; Ricciardiello F, 2009, ACTA OTORHINOLARYNGO, V29, P197; Sanjuan M, 2007, OTOL NEUROTOL, V28, P504, DOI 10.1097/mao.0b013e3180321352; Sarra M, 2011, J IMMUNOL, V186, P5435, DOI 10.4049/jimmunol.1003326; Schymeinsky J, 2002, MOL CELL BIOL, V22, P6820, DOI 10.1128/MCB.22.19.6820-6830.2002; SHINODA H, 1995, LARYNGOSCOPE, V105, P1232, DOI 10.1288/00005537-199511000-00018; Shunyu NB, 2011, OTOLARYNG HEAD NECK, V145, P628, DOI 10.1177/0194599811409303; Strott CA, 2003, J LIPID RES, V44, P1268, DOI 10.1194/jlr.R300005-JLR200; Sudhoff H, 1996, ANN OTO RHINOL LARYN, V105, P804; Sudhoff H, 2000, AM J OTOL, V21, P786; Sudhoff H, 2000, AM J OTOL, V21, P793; Sudhoff H, 2007, EUR ARCH OTO-RHINO-L, V264, P1137, DOI 10.1007/s00405-007-0340-y; Szczepanski M, 2006, EUR ARCH OTO-RHINO-L, V263, P603, DOI 10.1007/s00405-006-0030-1; Takaishi M, 2005, J BIOL CHEM, V280, P4696, DOI 10.1074/jbc.M409026200; Tokuriki M, 2003, LARYNGOSCOPE, V113, P808, DOI 10.1097/00005537-200305000-00008; Ulazzi L, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-17; Vennix PPCA, 1996, ARCH OTOLARYNGOL, V122, P825; VENNIX PPCA, 1994, ARCH OTOLARYNGOL, V120, P1102; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; Waters Katrina M., 2006, Briefings in Functional Genomics & Proteomics, V5, P261, DOI 10.1093/bfgp/ell019; WEINBERGER J, 1990, J OTOLARYNGOL, V19, P83; Wolf R, 2009, CANCER LETT, V277, P101, DOI 10.1016/j.canlet.2008.11.032; Xiong GP, 2012, NEOPLASMA, V59, P409, DOI 10.4149/neo_2012_053	82	8	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e104103	10.1371/journal.pone.0104103	http://dx.doi.org/10.1371/journal.pone.0104103			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093596	Green Published, Green Submitted, gold			2022-12-27	WOS:000341357200069
J	Gu, SP; Wu, WJ; Liu, C; Yang, L; Sun, C; Ye, WD; Li, XH; Chen, JQ; Long, FX; Chen, YP				Gu, Shuping; Wu, Weijie; Liu, Chao; Yang, Ling; Sun, Cheng; Ye, Wenduo; Li, Xihai; Chen, Jianquan; Long, Fanxin; Chen, YiPing			BMPRIA Mediated Signaling Is Essential for Temporomandibular Joint Development in Mice	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; CONDYLAR CARTILAGE; EXPRESSION PATTERNS; DOUBLE MUTATIONS; GENE-EXPRESSION; SYNOVIAL JOINT; CELL LINEAGE; MOUSE; DIFFERENTIATION; CHONDROGENESIS	The central importance of BMP signaling in the development and homeostasis of synovial joint of appendicular skeleton has been well documented, but its role in the development of temporomandibular joint (TMJ), also classified as a synovial joint, remains completely unknown. In this study, we investigated the function of BMPRIA mediated signaling in TMJ development in mice by transgenic loss-of-and gain-of-function approaches. We found that BMPRIA is expressed in the cranial neural crest (CNC)-derived developing condyle and glenoid fossa, major components of TMJ, as well as the interzone mesenchymal cells. Wnt1-Cre mediated tissue specific inactivation of BmprIa in CNC lineage led to defective TMJ development, including failure of articular disc separation from a hypoplastic condyle, persistence of interzone cells, and failed formation of a functional fibrocartilage layer on the articular surface of the glenoid fossa and condyle, which could be at least partially attributed to the down-regulation of Ihh in the developing condyle and inhibition of apoptosis in the interzone. On the other hand, augmented BMPRIA signaling by Wnt1-Cre driven expression of a constitutively active form of BmprIa (caBmprIa) inhibited osteogenesis of the glenoid fossa and converted the condylar primordium from secondary cartilage to primary cartilage associated with ectopic activation of Smad-dependent pathway but inhibition of JNK pathway, leading to TMJ agenesis. Our results present unambiguous evidence for an essential role of finely tuned BMPRIA mediated signaling in TMJ development.	[Gu, Shuping; Wu, Weijie; Liu, Chao; Yang, Ling; Sun, Cheng; Ye, Wenduo; Li, Xihai; Chen, YiPing] Tulane Univ, Dept Cell & Mol Biol, New Orleans, LA 70118 USA; [Wu, Weijie] Fudan Univ, ZhongShan Hosp, Dept Dent, Shanghai 200433, Peoples R China; [Yang, Ling] Sun Yat Sen Univ, Guanghua Sch Stomatol, Guangzhou 510275, Guangdong, Peoples R China; [Li, Xihai] Fujian Univ Tradit Chinese Med, Acad Integrat Med, Fuzhou, Fujian, Peoples R China; [Chen, Jianquan; Long, Fanxin] Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA	Tulane University; Fudan University; Sun Yat Sen University; Fujian University of Traditional Chinese Medicine; Washington University (WUSTL)	Chen, YP (corresponding author), Tulane Univ, Dept Cell & Mol Biol, New Orleans, LA 70118 USA.	ychen@tulane.edu			ZhongShan Hospital, FuDan University; China Scholarship Council [201208440191]; National Institutes of Health [R01 DE14044, DE17792]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE017792, R01DE014044] Funding Source: NIH RePORTER	ZhongShan Hospital, FuDan University; China Scholarship Council(China Scholarship Council); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	WW was supported by a fellowship from ZhongShan Hospital, FuDan University. LY was supported by a scholarship from the China Scholarship Council (No. 201208440191). This work was supported by the National Institutes of Health grants (R01 DE14044, DE17792) to YC. The funders had no role in this design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbuHijleh G, 1997, CLIN ANAT, V10, P183, DOI 10.1002/(SICI)1098-2353(1997)10:3<183::AID-CA4>3.0.CO;2-V; Alappat SR, 2005, DEV BIOL, V277, P102, DOI 10.1016/j.ydbio.2004.09.010; Brunet LJ, 1998, SCIENCE, V280, P1455, DOI 10.1126/science.280.5368.1455; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; DEWULF N, 1995, ENDOCRINOLOGY, V136, P2652, DOI 10.1210/en.136.6.2652; Dixon AD, 1997, FUNDAMENTALS CRANIOF, P99; Francis-West PH, 1999, CELL TISSUE RES, V296, P111, DOI 10.1007/s004410051272; FROMMER J, 1964, ANAT RECORD, V150, P449, DOI 10.1002/ar.1091500414; Fukada K, 1999, J ANAT, V195, P321, DOI 10.1046/j.1469-7580.1999.19530321.x; Fukuoka H, 2007, J ANAT, V211, P8, DOI 10.1111/j.1469-7580.2007.00739.x; Gu SP, 2008, MECH DEVELOP, V125, P729, DOI 10.1016/j.mod.2008.04.003; Gu SP, 2013, STEM CELLS IN CRANIOFACIAL DEVELOPMENT AND REGENERATION, P71; Hall B.K., 2015, BONES CARTILAGE DEV; He FL, 2010, DEV BIOL, V347, P109, DOI 10.1016/j.ydbio.2010.08.014; KERMACK KA, 1972, P ROY SOC MED, V65, P389, DOI 10.1177/003591577206500439; Kimura S, 1996, J MORPHOL, V229, P337, DOI 10.1002/(SICI)1097-4687(199609)229:3<337::AID-JMOR8>3.0.CO;2-V; Komatsu Y, 2013, J BONE MINER RES, V28, P1422, DOI 10.1002/jbmr.1857; Kuboki T, 2003, ARCH ORAL BIOL, V48, P519, DOI 10.1016/S0003-9969(03)00088-8; Li L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066107; Li L, 2011, DEV BIOL, V349, P451, DOI 10.1016/j.ydbio.2010.10.023; Lories RJU, 2005, CYTOKINE GROWTH F R, V16, P287, DOI 10.1016/j.cytogfr.2005.02.009; Marcelino J, 1999, NAT GENET, V23, P319, DOI 10.1038/15496; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Matsuda S, 1997, ANAT EMBRYOL, V196, P383, DOI 10.1007/s004290050106; Minina E, 2002, DEV CELL, V3, P439, DOI 10.1016/S1534-5807(02)00261-7; Minina E, 2001, DEVELOPMENT, V128, P4523; Mishina Y, 1995, GENE DEV, V9, P3027, DOI 10.1101/gad.9.24.3027; MITROVIC D, 1978, AM J ANAT, V151, P475, DOI 10.1002/aja.1001510403; MITROVIC DR, 1977, AM J ANAT, V150, P333, DOI 10.1002/aja.1001500207; Miyake T, 1997, J ANAT, V190, P239, DOI 10.1046/j.1469-7580.1997.19020239.x; Mori-Akiyama Y, 2003, P NATL ACAD SCI USA, V100, P9360, DOI 10.1073/pnas.1631288100; Morikawa Y, 2009, DEVELOPMENT, V136, P3575, DOI 10.1242/dev.038133; Morikawa Y, 2008, CIRC RES, V103, P1422, DOI 10.1161/CIRCRESAHA.108.180083; NALIN AM, 1995, DEV DYNAM, V203, P352, DOI 10.1002/aja.1002030307; Ochiai T, 2010, J DENT RES, V89, P349, DOI 10.1177/0022034510363078; Oka K, 2008, DEV BIOL, V321, P303, DOI 10.1016/j.ydbio.2008.03.046; Oka K, 2007, DEV BIOL, V303, P391, DOI 10.1016/j.ydbio.2006.11.025; Pacifici Maurizio, 2005, Birth Defects Research, V75, P237, DOI 10.1002/bdrc.20050; Pathi S, 1999, DEV BIOL, V209, P239, DOI 10.1006/dbio.1998.9181; PRESNELL JK, 1997, HUMASONS ANIMAL TISS; Purcell P, 2012, J DENT RES, V91, P387, DOI 10.1177/0022034512438401; Purcell P, 2009, P NATL ACAD SCI USA, V106, P18297, DOI 10.1073/pnas.0908836106; Rountree R, 2004, PLOS BIOL, V11, pe255; Seki K, 2004, J BIOL CHEM, V279, P18544, DOI 10.1074/jbc.M311592200; Settle SH, 2003, DEV BIOL, V254, P116, DOI 10.1016/S0012-1606(02)00022-2; Shibata S, 2006, J ANAT, V208, P169, DOI 10.1111/j.1469-7580.2006.00525.x; Shibata S, 2004, ANAT EMBRYOL, V208, P273, DOI 10.1007/s00429-004-0393-2; Shibukawa Y, 2007, DEV DYNAM, V236, P426, DOI 10.1002/dvdy.21036; Sperber G.H., 2001, CRANIOFACIAL DEV; St Amand TR, 2000, DEV BIOL, V217, P323, DOI 10.1006/dbio.1999.9547; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; STORM EE, 1994, NATURE, V368, P639, DOI 10.1038/368639a0; Storm EE, 1996, DEVELOPMENT, V122, P3969; Stottmann RW, 2004, DEVELOPMENT, V131, P2205, DOI 10.1242/dev.01086; SWANN DA, 1985, BIOCHEM J, V225, P195, DOI 10.1042/bj2250195; Wang Y, 2011, DEV DYNAM, V240, P2466, DOI 10.1002/dvdy.22748; Wolfman NM, 1997, J CLIN INVEST, V100, P321, DOI 10.1172/JCI119537; Yoon BS, 2005, P NATL ACAD SCI USA, V102, P5062, DOI 10.1073/pnas.0500031102; Yoon BS, 2006, DEVELOPMENT, V133, P4667, DOI 10.1242/dev.02680; Zhang ZY, 2002, DEVELOPMENT, V129, P4135; Zou HY, 1996, SCIENCE, V272, P738, DOI 10.1126/science.272.5262.738; Zou HY, 1997, GENE DEV, V11, P2191, DOI 10.1101/gad.11.17.2191	62	25	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e101000	10.1371/journal.pone.0101000	http://dx.doi.org/10.1371/journal.pone.0101000			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093411	Green Published, gold, Green Submitted			2022-12-27	WOS:000341357200004
J	Ud-Dean, SMM; Gunawan, R				Ud-Dean, S. M. Minhaz; Gunawan, Rudiyanto			Ensemble Inference and Inferability of Gene Regulatory Networks	PLOS ONE			English	Article							BIOLOGICAL NETWORKS	The inference of gene regulatory network (GRN) from gene expression data is an unsolved problem of great importance. This inference has been stated, though not proven, to be underdetermined implying that there could be many equivalent (indistinguishable) solutions. Motivated by this fundamental limitation, we have developed new framework and algorithm, called TRaCE, for the ensemble inference of GRNs. The ensemble corresponds to the inherent uncertainty associated with discriminating direct and indirect gene regulations from steady-state data of gene knock-out (KO) experiments. We applied TRaCE to analyze the inferability of random GRNs and the GRNs of E. coli and yeast from single-and double-gene KO experiments. The results showed that, with the exception of networks with very few edges, GRNs are typically not inferable even when the data are ideal (unbiased and noise-free). Finally, we compared the performance of TRaCE with top performing methods of DREAM4 in silico network inference challenge.	[Ud-Dean, S. M. Minhaz; Gunawan, Rudiyanto] ETH, Inst Chem & Bioengn, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Gunawan, R (corresponding author), ETH, Inst Chem & Bioengn, Zurich, Switzerland.	rudi.gunawan@chem.ethz.ch	Gunawan, Rudiyanto/D-4650-2009; UD-DEAN, S M MINHAZ/A-8135-2010	Gunawan, Rudiyanto/0000-0002-6480-7976; UD-DEAN, S M MINHAZ/0000-0002-7428-3432	Swiss National Science Foundation [137614]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The work was supported by funding from the Swiss National Science Foundation (grant 137614, http://www.snf.ch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aho A. V., 1972, SIAM Journal on Computing, V1, P131, DOI 10.1137/0201008; Albert R, 2005, J CELL SCI, V118, P4947, DOI 10.1242/jcs.02714; Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Alper H, 2009, NAT REV MICROBIOL, V7, P715, DOI 10.1038/nrmicro2186; Apic G, 2005, FEBS LETT, V579, P1872, DOI 10.1016/j.febslet.2005.02.023; Chis OT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027755; De Smet R, 2010, NAT REV MICROBIOL, V8, P717, DOI 10.1038/nrmicro2419; Gadkar KG, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-155; Haury AC, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-145; Hecker M, 2009, BIOSYSTEMS, V96, P86, DOI 10.1016/j.biosystems.2008.12.004; Huynh-Thu VA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012776; Jackson SL, 2011, RES METHODS STAT CRI; Jia G, 2012, METABOLITES, V2, P891, DOI 10.3390/metabo2040891; Kuepfer L, 2007, NAT BIOTECHNOL, V25, P1001, DOI 10.1038/nbt1330; Marbach D, 2012, NAT METHODS, V9, P796, DOI [10.1038/nmeth.2016, 10.1038/NMETH.2016]; Marbach D, 2010, P NATL ACAD SCI USA, V107, P6286, DOI 10.1073/pnas.0913357107; Margolin AA, 2007, ANN NY ACAD SCI, V1115, P51, DOI 10.1196/annals.1407.019; Miskovic L, 2011, BIOTECHNOL BIOENG, V108, P413, DOI 10.1002/bit.22932; Oberhardt MA, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.77; Pinna A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012912; Schaffter T, 2011, BIOINFORMATICS, V27, P2263, DOI 10.1093/bioinformatics/btr373; Siegenthaler C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090481; Srinath S, 2010, J BIOTECHNOL, V149, P132, DOI 10.1016/j.jbiotec.2010.02.019; Stolovitzky G, 2009, ANN NY ACAD SCI, V1158, P159, DOI 10.1111/j.1749-6632.2009.04497.x; Szederkenyi G, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-177; Tan YK, 2012, BIOTECHNOL J, V7, P343, DOI 10.1002/biot.201100186; Tsamardinos I, 2006, MACH LEARN, V65, P31, DOI 10.1007/s10994-006-6889-7; Wagner A, 2001, BIOINFORMATICS, V17, P1183, DOI 10.1093/bioinformatics/17.12.1183; Zhao XM, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002323; [No title captured]	30	21	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e103812	10.1371/journal.pone.0103812	http://dx.doi.org/10.1371/journal.pone.0103812			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093509	Green Published, Green Submitted, gold			2022-12-27	WOS:000341357200032
J	Budka, M; Osiejuk, TS				Budka, Michal; Osiejuk, Tomasz S.			Individually Specific Call Feature Is Not Used to Neighbour-Stranger Discrimination: The Corncrake Case	PLOS ONE			English	Article							KING PENGUIN; RECOGNITION; MALES; SONG; VOCALIZATIONS; SYSTEM; PARENT; SIGNAL; FROGS	In various contexts, animals rely on acoustic signals to differentiate between conspecifics. Currently, studies examining vocal signatures use two main approaches. In the first approach, researchers search for acoustic characteristics that have the potential to be individual specific. This approach yields information on variation in signal parameters both within and between individuals and generates practical tools that can be used in population monitoring. In the second approach, playback experiments with natural calls are conducted to discern whether animals are capable of discriminating among the vocal signatures of different individuals. However, both approaches do not reveal the exact signal characteristics that are being used in the discrimination process. In this study, we tested whether an individual-specific call characteristic - namely the length of the intervals between successive maximal amplitude peaks within syllables (PPD) - is crucial in neighbour-stranger discrimination by males of the nocturnal and highly secretive bird species, the corncrake (Crex crex). We conducted paired playback experiments in which corncrakes (n = 47) were exposed to artificial calls with PPD characteristics of neighbour and stranger birds. These artificial calls differed only in PPD structure. The calls were broadcast from a speaker, and we recorded the birds' behavioural responses. Although corncrakes have previously been experimentally shown to discriminate between neighbours and strangers, we found no difference in the responses to the artificial calls representing neighbours versus strangers. This finding demonstrates that even if vocal signatures are individual specific within a species, it does not automatically mean that said signatures are being crucial in discrimination among individuals. At the same time, the birds' aggressive responses to the artificial calls indicated that the information transmitted by PPDs is important in species-specific call recognition and may be used by males and/or females to evaluate sender quality, similarly like sound frequency in some insect species.	[Budka, Michal; Osiejuk, Tomasz S.] Adam Mickiewicz Univ, Fac Biol, Inst Environm Biol, Dept Behav Ecol, Poznan, Poland	Adam Mickiewicz University	Budka, M (corresponding author), Adam Mickiewicz Univ, Fac Biol, Inst Environm Biol, Dept Behav Ecol, Poznan, Poland.	m.budka@amu.edu.pl	Budka, Michał/R-5812-2019; Osiejuk, Tomasz S/A-1230-2008	Budka, Michał/0000-0002-1244-013X; Osiejuk, Tomasz/0000-0001-5980-7421	Department of Behavioural Ecology, Adam Mickiewicz University in Poznan	Department of Behavioural Ecology, Adam Mickiewicz University in Poznan	The study was funded by Department of Behavioural Ecology, Adam Mickiewicz University in Poznan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akcay C, 2013, BEHAV ECOL, V24, P898, DOI 10.1093/beheco/art018; Aubin T, 2000, P ROY SOC B-BIOL SCI, V267, P1081, DOI 10.1098/rspb.2000.1112; Beckers OM, 2011, ANIM BEHAV, V81, P519, DOI 10.1016/j.anbehav.2010.11.022; Bradbury J. W., 2011, PRINCIPLES ANIMAL CO; Brenowitz E.A., 1991, Seminars in the Neurosciences, V3, P399, DOI 10.1016/1044-5765(91)90030-R; Briefer E, 2008, J EXP BIOL, V211, P317, DOI 10.1242/jeb.013359; Briefer EF, 2012, P ROY SOC B-BIOL SCI, V279, P3749, DOI 10.1098/rspb.2012.0986; Budka M, 2013, ETHOLOGY, V119, P960, DOI 10.1111/eth.12141; Budka M, 2013, J ORNITHOL, V154, P685, DOI 10.1007/s10336-013-0933-8; Budka M, 2013, AGR ECOSYST ENVIRON, V171, P33, DOI 10.1016/j.agee.2013.03.007; Clark JA, 2006, ANIM BEHAV, V72, P1141, DOI 10.1016/j.anbehav.2006.04.002; Dentressangle F, 2012, ANIM BEHAV, V84, P413, DOI 10.1016/j.anbehav.2012.05.012; Dooling R., 2004, NATURES MUSIC SCI BI, P209; Dragonetti M, 2007, BIOACOUSTICS, V16, P147, DOI 10.1080/09524622.2007.9753573; Feng AS, 2009, ETHOLOGY, V115, P851, DOI 10.1111/j.1439-0310.2009.01666.x; Fisher J., 1954, P71; Frommolt KH, 2003, ANIM BEHAV, V65, P509, DOI 10.1006/anbe.2003.2064; Gamba M, 2012, J ETHOL, V30, P191, DOI 10.1007/s10164-011-0291-z; Gentner TQ, 1998, ANIM BEHAV, V56, P579, DOI 10.1006/anbe.1998.0810; Grava T, 2008, IBIS, V150, P279, DOI 10.1111/j.1474-919X.2007.00776.x; Green Rhys E., 1997, Vogelwelt, V118, P117; Hodl W, 2004, J COMP PHYSIOL A, V190, P823, DOI 10.1007/s00359-004-0536-1; Hoodless AN, 2008, IBIS, V150, P80; Hopp SL, 2001, ANIM BEHAV, V62, P297, DOI 10.1006/anbe.2001.1745; Jouventin P, 1999, ANIM BEHAV, V57, P1175, DOI 10.1006/anbe.1999.1086; Judge KA, 2011, ANIM BEHAV, V81, P185, DOI 10.1016/j.anbehav.2010.09.032; Kilkenny C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007824; Knudsen DP, 2010, BRAIN LANG, V115, P59, DOI 10.1016/j.bandl.2009.09.008; Lengagne T, 2001, J EXP BIOL, V204, P663; Marino L, 2007, PLOS BIOL, V5, P966, DOI 10.1371/journal.pbio.0050139; Mikkelsen G, 2013, J ORNITHOL, V154, P751, DOI 10.1007/s10336-013-0939-2; Osiejuk TS, 2004, ANIM BIOL, V54, P207, DOI 10.1163/1570756041445218; Peake TM, 1998, IBIS, V140, P120, DOI 10.1111/j.1474-919X.1998.tb04548.x; Pettitt BA, 2013, ETHOLOGY, V119, P244, DOI 10.1111/eth.12058; Price JJ, 2004, J AVIAN BIOL, V35, P135; Rek P, 2013, ANIM BEHAV, V86, P451, DOI 10.1016/j.anbehav.2013.05.042; Rek P, 2013, BEHAV ECOL, V24, P547, DOI 10.1093/beheco/ars196; Rek P, 2011, BEHAV ECOL, V22, P657, DOI 10.1093/beheco/arr027; Rek P, 2011, BEHAV PROCESS, V86, P323, DOI 10.1016/j.beproc.2011.01.011; Rek P, 2010, BEHAV ECOL, V21, P1203, DOI 10.1093/beheco/arq143; Schaeffer Norbert, 1999, Oekologie der Voegel, V21, P1; Skierczynski M, 2007, J AVIAN BIOL, V38, P415, DOI 10.1111/j.2007.0908-8857.04123.x; Smith AS, 2009, AM J PRIMATOL, V71, P324, DOI 10.1002/ajp.20656; Specht R, 2007, AVISOFT SASLAB PROVE; Stoddard Philip Kraft, 1996, P356; STODDARD PK, 1991, BEHAV ECOL SOCIOBIOL, V29, P211, DOI 10.1007/BF00166403; Terry AMR, 2002, ANIM CONSERV, V5, P103, DOI 10.1017/S1367943002002147; Terry Andrew M.R., 2005, Frontiers in Zoology, V2, P1; Vignal C, 2008, BEHAV PROCESS, V77, P191, DOI 10.1016/j.beproc.2007.09.003; Wilk T., 2010, IMPORTANT BIRD AREAS; Xia C, 2013, PLOS ONE, V7	51	5	6	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e104031	10.1371/journal.pone.0104031	http://dx.doi.org/10.1371/journal.pone.0104031			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25090457	Green Published, gold, Green Submitted			2022-12-27	WOS:000339812700085
J	Laurent, AJ; Bindslev, N; Johansson, B; Berg, L				Laurent, Agneta J.; Bindslev, Niels; Johansson, Bjorn; Berg, Louise			Synergistic Effects of Ethanol and Isopentenyl Pyrophosphate on Expansion of gamma delta T Cells in Synovial Fluid from Patients with Arthritis	PLOS ONE			English	Article							JUVENILE IDIOPATHIC ARTHRITIS; RHEUMATOID-ARTHRITIS; ALCOHOL-CONSUMPTION; RISK-FACTORS; RECOGNITION; SUBSETS; STIMULATION; RESPONSES; MEMORY; PROLIFERATION	Low to moderate ethanol consumption has been associated with protective effects in autoimmune diseases such as rheumatoid arthritis, RA. An expansion of gamma delta T cells induced by isopentenyl pyrophosphate, IPP, likewise seems to have a protective role in arthritis. The aim of this project was to test the hypothesis that low doses of ethanol can enhance IPP-induced expansion of synovial fluid gamma delta T cells from patients with arthritis and may thereby potentially account for the beneficial effects of ethanol on symptoms of the arthritic process. Thus, mononuclear cells from synovial fluid (SF) from 15 patients with arthritis and from peripheral blood (PB) from 15 healthy donors were stimulated with low concentrations of ethanol and IPP for 7 days in vitro. IPP in combination with ethanol 0.015%, 2.5 mM, equivalent to the decrease per hour in blood ethanol concentration due to metabolism, gave a significantly higher fractional expansion of SF gamma delta T cells compared with IPP alone after 7 days (ratio 10.1+/24.0, p<0.0008, n = 12) in patients with arthritis. Similar results were obtained for PB gamma delta T cells from healthy controls (ratio 2.0+/20.4, p< 0.011, n = 15). The augmented expansion of gamma delta T cells in SF is explained by a higher proliferation (p = 0.0034, n = 11) and an increased survival (p<0.005, n = 11) in SF cultures stimulated with IPP plus ethanol compared to IPP alone. The synergistic effects of IPP and ethanol indicate a possible allosteric effect of ethanol. Similar effects could be seen when stimulating PB with ethanol in presence of risedronate, which has the ability to increase endogenous levels of IPP. We conclude that expansion of gamma delta T cells by combinatorial drug effects, possibly in fixed-dose combination, FDC, of ethanol in the presence of IPP might give a protective role in diseases such as arthritis.	[Laurent, Agneta J.; Berg, Louise] Karolinska Inst, Dept Med, Rheumatol Unit, Stockholm, Sweden; [Bindslev, Niels] Univ Copenhagen, Fac Hlth & Med Sci, Dept Biomed Sci, Copenhagen, Denmark; [Laurent, Agneta J.; Johansson, Bjorn] Karolinska Inst, Dept Mol Med & Surg, Neurogenet Unit, Stockholm, Sweden	Karolinska Institutet; University of Copenhagen; Karolinska Institutet	Laurent, AJ (corresponding author), Karolinska Inst, Dept Med, Rheumatol Unit, Stockholm, Sweden.	agneta.laurent@comhem.se		Berg, Louise/0000-0001-6538-2837	Borje Dahlin's Foundation; Polysackaridforskning i Uppsala AB	Borje Dahlin's Foundation; Polysackaridforskning i Uppsala AB	This study was financed by Borje Dahlin's Foundation and Polysackaridforskning i Uppsala AB. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHO K, 1993, ANN RHEUM DIS, V52, P897, DOI 10.1136/ard.52.12.897-b; Ali Z, 2007, J IMMUNOL, V179, P8287, DOI 10.4049/jimmunol.179.12.8287; Angelini DF, 2004, BLOOD, V104, P1801, DOI 10.1182/blood-2004-01-0331; ATKINSON JP, 1977, J CLIN INVEST, V60, P284, DOI 10.1172/JCI108776; Bank I, 2002, ANN RHEUM DIS, V61, P438, DOI 10.1136/ard.61.5.438; Bendersky A, 2012, J IMMUNOL, V188, P4349, DOI 10.4049/jimmunol.1102403; Bendersky A, 2010, IMMUNOBIOLOGY, V215, P380, DOI 10.1016/j.imbio.2009.05.012; Berkun Y, 2011, J RHEUMATOL, V38, P1123, DOI 10.3899/jrheum.100938; Bindslev Niels, 2004, BMC Pharmacology, V4, P11, DOI 10.1186/1471-2210-4-11; Bindslev N, 2013, BMC PHARMACOL TOXICO, V14, DOI 10.1186/2050-6511-14-4; Bottini N, 2013, NAT REV RHEUMATOL, V9, P24, DOI 10.1038/nrrheum.2012.190; BUKOWSKI JF, 1994, J IMMUNOL, V153, P5133; Cerhan JR, 2002, J RHEUMATOL, V29, P246; Das H, 2001, BLOOD, V98, P1616, DOI 10.1182/blood.V98.5.1616; Deenick EK, 2003, J IMMUNOL, V170, P4963, DOI 10.4049/jimmunol.170.10.4963; Di Giuseppe D, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e4230; Dieli F, 2003, J EXP MED, V198, P391, DOI 10.1084/jem.20030235; EMERY P, 1984, CLIN EXP IMMUNOL, V57, P123; Gerits N, 2008, CELL SIGNAL, V20, P1592, DOI 10.1016/j.cellsig.2008.02.022; Hamann D, 1997, J EXP MED, V186, P1407, DOI 10.1084/jem.186.9.1407; Harris RA, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.128re7; Hayday AC, 2000, ANNU REV IMMUNOL, V18, P975, DOI 10.1146/annurev.immunol.18.1.975; HAZES JMW, 1990, ANN RHEUM DIS, V49, P980, DOI 10.1136/ard.49.12.980; HERMANN E, 1992, CLIN EXP IMMUNOL, V89, P427; HOLOSHITZ J, 1989, NATURE, V339, P226, DOI 10.1038/339226a0; Hu CY, 2012, CELL MOL IMMUNOL, V9, P245, DOI 10.1038/cmi.2011.50; Jonsson IM, 2007, P NATL ACAD SCI USA, V104, P258, DOI 10.1073/pnas.0608620104; Kabelitz Dieter, 1997, Frontiers in Bioscience (online), V2, pD61; Kallberg H, 2009, ANN RHEUM DIS, V68, P222, DOI 10.1136/ard.2007.086314; Klareskog L, 2009, LANCET, V373, P659, DOI 10.1016/S0140-6736(09)60008-8; Lee W, 1843, BRANWIN SALT LAKEMED; Lentner C., 1981, GEIGY SCI TABLES, P165; LUNARDI C, 1992, BRIT J RHEUMATOL, V31, P527; Martinet L, 2010, BIOCHEM PHARMACOL, V80, P838, DOI 10.1016/j.bcp.2010.05.002; Martinet L, 2009, EUR J IMMUNOL, V39, P752, DOI 10.1002/eji.200838812; Maxwell JR, 2010, RHEUMATOLOGY, V49, P2140, DOI 10.1093/rheumatology/keq202; Monkkonen H, 2006, BRIT J PHARMACOL, V147, P437, DOI 10.1038/sj.bjp.0706628; Morita CT, 2007, IMMUNOL REV, V215, P59, DOI 10.1111/j.1600-065X.2006.00479.x; Myllykangas-Luosujarvi R, 2000, ANN RHEUM DIS, V59, P75, DOI 10.1136/ard.59.1.75; Nedellec S, 2010, SEMIN IMMUNOL, V22, P199, DOI 10.1016/j.smim.2010.04.004; Noss EH, 2008, IMMUNOL REV, V223, P252, DOI 10.1111/j.1600-065X.2008.00648.x; Pedersen M, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2022; Ronksley PE, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d671; Saisho Y, 1997, ANAL BIOCHEM, V252, P89, DOI 10.1006/abio.1997.2314; Scott IC, 2013, RHEUMATOLOGY, V52, P856, DOI 10.1093/rheumatology/kes376; Siegel J., 2000, ENCY FORENSIC SCI; Siegers GM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016700; SZABO G, 1993, J LEUKOCYTE BIOL, V54, P534, DOI 10.1002/jlb.54.6.534; Szabo G, 2007, J IMMUNOL, V178, P1243, DOI 10.4049/jimmunol.178.3.1243; TANAKA Y, 1994, P NATL ACAD SCI USA, V91, P8175, DOI 10.1073/pnas.91.17.8175; VANDEPUTTE LBA, 1976, ANN RHEUM DIS, V35, P451, DOI 10.1136/ard.35.5.451; VOIGT LF, 1994, EPIDEMIOLOGY, V5, P525; Wang H, 2011, J IMMUNOL, V187, P5099, DOI 10.4049/jimmunol.1002697; Yoshimura M, 1999, ALCOHOL CLIN EXP RES, V23, P1457, DOI 10.1097/00000374-199909000-00006; Young JL, 1997, IMMUNOLOGY, V91, P503, DOI 10.1046/j.1365-2567.1997.00289.x	55	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103683	10.1371/journal.pone.0103683	http://dx.doi.org/10.1371/journal.pone.0103683			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25090614	Green Published, Green Submitted, gold			2022-12-27	WOS:000339812700042
J	Lee, HY; Chae, KO; Lee, CH; Choi, SM; Lee, J; Park, YS; Lee, SM; Yoo, CG; Kim, YW; Han, SK; Yim, JJ				Lee, Ha Youn; Chae, Kyoung Ok; Lee, Chang Hoon; Choi, Sun Mi; Lee, Jinwoo; Park, Young Sik; Lee, Sang-Min; Yoo, Chul-Gyu; Kim, Young Whan; Han, Sung Koo; Yim, Jae-Joon			Culture Conversion Rate at 2 Months of Treatment According to Diagnostic Methods among Patients with Culture-Positive Pulmonary Tuberculosis	PLOS ONE			English	Article							SHORT-COURSE CHEMOTHERAPY; MYCOBACTERIUM-TUBERCULOSIS; SPUTUM-SMEAR; 4-MONTH; TIME; THERAPY	Introduction: The culture-negative conversion rate of sputum after 2 months of treatment in patients with pulmonary tuberculosis (TB) is used as a reliable surrogate marker for relapse after completion of treatment. We hypothesized that culture conversion of sputum at 2 months of anti-TB treatment and the time to culture conversion are different among pulmonary TB patients who are diagnosed using different methods. Methods: Culture-confirmed pulmonary TB patients who were diagnosed between 1 January, 2011 and 31 December, 2012 were classified into three groups based on the diagnostic method that prompted treatment initiation: positive acid-fast bacilli (AFB) staining of sputum (smear-positive group), negative AFB staining, but Mycobacterium tuberculosis was cultured from sputum (culture-positive group), and positive AFB staining, positive polymerase chain reaction (PCR) for M. tuberculosis, or culture of M. tuberculosis from a bronchoscopic specimen (bronchoscopy group). Rates of negative mycobacterial culture conversion at 2 months of anti-TB treatment and the time to negative culture conversion of sputum were compared among the three groups. Results: A total of 203 patients with culture-confirmed pulmonary TB were included in the final analysis. TB patients in the culture-positive group (94.1%) and the bronchoscopy group (97.6%) showed a higher culture conversion rate at 2 months of treatment than those in the smear-positive group (78.7%, P = 0.001). Additionally, the time to culture conversion was longer in the smear-positive group (median, 40 days) than in the culture-positive (median, 19 days; P = 0.009) and bronchoscopy groups (median, 29 days; P = 0.004). Conclusions: The higher culture conversion rate at 2 months and the shorter time to culture conversion among pulmonary TB patients with a negative AFB smear suggests the feasibility of shortening treatment duration and isolation in these patients.	[Lee, Ha Youn; Chae, Kyoung Ok; Lee, Chang Hoon; Choi, Sun Mi; Lee, Jinwoo; Park, Young Sik; Lee, Sang-Min; Yoo, Chul-Gyu; Kim, Young Whan; Han, Sung Koo; Yim, Jae-Joon] Seoul Natl Univ, Coll Med, Dept Internal Med, Div Pulm & Crit Care Med, Seoul 151, South Korea	Seoul National University (SNU)	Yim, JJ (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, Div Pulm & Crit Care Med, Seoul 151, South Korea.	yimjj@snu.ac.kr	Lee, Chang-Hoon/AAC-7650-2021	Lee, Ha Youn/0000-0002-7664-3120; Yim, Jae-Joon/0000-0002-9605-0074	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HI13C0844]	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea	This study was supported by a grant of the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (HI13C0844). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, AM J RESP CRIT CARE, V167, P603; Mota PC, 2012, REV PORT PNEUMOL, V18, P72, DOI 10.1016/j.rppneu.2011.12.005; COHN DL, 1990, ANN INTERN MED, V112, P407, DOI 10.7326/0003-4819-76-3-112-6-407; COMBS DL, 1990, ANN INTERN MED, V112, P397, DOI 10.7326/0003-4819-76-3-112-6-397; DUTT AK, 1989, AM REV RESPIR DIS, V139, P867, DOI 10.1164/ajrccm/139.4.867; Dutt AK, 1994, SMEAR NEGATIVE PULMO, P113; El-Sadr WM, 2001, CLIN INFECT DIS, V32, P623, DOI 10.1086/318706; Epstein MD, 1998, CHEST, V113, P379, DOI 10.1378/chest.113.2.379; GIRLING DJ, 1989, AM REV RESPIR DIS, V139, P871; Hanna BA, 1999, J CLIN MICROBIOL, V37, P748, DOI 10.1128/JCM.37.3.748-752.1999; Lee J, 2012, INT J TUBERC LUNG D, V16, P1344, DOI 10.5588/ijtld.12.0113; Maciel EL, 2013, INT J TUBERC LUNG D, V17, P225, DOI 10.5588/ijtld.12.0426; Migliori GB, 2012, EUR RESPIR J, V39, P807, DOI 10.1183/09031936.00203811; Parikh Raunak, 2012, J Assoc Physicians India, V60, P22; Park SW, 2012, EUR J CLIN MICROBIOL, V31, P1305, DOI 10.1007/s10096-011-1443-3; Ritchie SR, 2007, EUR RESPIR J, V30, P501, DOI 10.1183/09031936.00131406; SNIDER DE, 1982, AM REV RESPIR DIS, V125, P265; Telzak EE, 1997, CLIN INFECT DIS, V25, P666, DOI 10.1086/513772; Teo SK, 2002, ANN ACAD MED SINGAP, V31, P175; Wada M, 2001, Kekkaku, V76, P33; Wallis RS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071116; Wallis RS, 2010, LANCET INFECT DIS, V10, P70, DOI 10.1016/S1473-3099(10)70002-5; WHO, 2010, TREATMENT OF TUBERCULOSIS: GUIDELINES, FOURTH EDITION, P1; World Health Organization, GLOB TUB REP 2013	24	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2014	9	8							e103768	10.1371/journal.pone.0103768	http://dx.doi.org/10.1371/journal.pone.0103768			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR0CG	25105410	gold, Green Submitted, Green Published			2022-12-27	WOS:000343231900020
J	Mika, J; Popiolek-Barczyk, K; Rojewska, E; Makuch, W; Starowicz, K; Przewlocka, B				Mika, Joanna; Popiolek-Barczyk, Katarzyna; Rojewska, Ewelina; Makuch, Wioletta; Starowicz, Katarzyna; Przewlocka, Barbara			Delta-Opioid Receptor Analgesia Is Independent of Microglial Activation in a Rat Model of Neuropathic Pain	PLOS ONE			English	Article							ATTENUATES MECHANICAL ALLODYNIA; PERIPHERAL-NERVE INJURY; ROOT GANGLION NEURONS; SPINAL-CORD; PROINFLAMMATORY CYTOKINES; KNOCKOUT MICE; HETEROLOGOUS DESENSITIZATION; CHRONIC INFLAMMATION; CHEMOKINE RECEPTORS; MORPHINE-TOLERANCE	The analgesic effect of delta-opioid receptor (DOR) ligands in neuropathic pain is not diminished in contrast to other opioid receptor ligands, which lose their effectiveness as analgesics. In this study, we examine whether this effect is related to nerve injury-induced microglial activation. We therefore investigated the influence of minocycline-induced inhibition of microglial activation on the analgesic effects of opioid receptor agonists: morphine, DAMGO, U50,488H, DPDPE, Deltorphin II and SNC80 after chronic constriction injury (CCI) to the sciatic nerve in rats. Pre-emptive and repeated administration of minocycline (30 mg/kg, i.p.) over 7 days significantly reduced allodynia and hyperalgesia as measured on day 7 after CCI. The antiallodynic and antihyperalgesic effects of intrathecally (i.t.) administered morphine (10-20 mu g), DAMGO (1-2 mu g) and U50,488H (25-50 mu g) were significantly potentiated in rats after minocycline, but no such changes were observed after DPDPE (10-20 mu g), deltorphin II (1.5-15 mu g) and SNC80 (10-20 mu g) administration. Additionally, nerve injury-induced down-regulation of all types of opioid receptors in the spinal cord and dorsal root ganglia was not influenced by minocycline, which indicates that the effects of opioid ligands are dependent on other changes, presumably neuroimmune interactions. Our study of rat primary microglial cell culture using qRT-PCR, Western blotting and immunocytochemistry confirmed the presence of mu-opioid receptors (MOR) and kappa-opioid receptors (KOR), further we provide the first evidence for the lack of DOR on microglial cells. In summary, DOR analgesia is different from analgesia induced by MOR and KOR receptors because it does not dependent on injury-induced microglial activation. DOR agonists appear to be the best candidates for new drugs to treat neuropathic pain.	[Mika, Joanna; Popiolek-Barczyk, Katarzyna; Rojewska, Ewelina; Makuch, Wioletta; Starowicz, Katarzyna; Przewlocka, Barbara] Polish Acad Sci, Inst Pharmacol, Dept Pain Pharmacol, Krakow, Poland	Polish Academy of Sciences	Mika, J (corresponding author), Polish Acad Sci, Inst Pharmacol, Dept Pain Pharmacol, Krakow, Poland.	joamika@if-pan.krakow.pl; przebar@if-pan.krakow.pl	Starowicz, Katarzyna/AAB-8595-2022	Popiolek-Barczyk, Katarzyna/0000-0003-4366-6577; Mika, Joanna/0000-0003-1986-7205; Rojewska, Ewelina/0000-0001-8383-7356; PRZEWLOCKA, BARBARA/0000-0002-6672-1906; Starowicz, Katarzyna/0000-0003-0091-0066; Makuch, Wioletta/0000-0002-1579-3643	MNiSzW/NCN [NN405375937]; grant OPUS NCN [2011/03/B/NZ4/00042]; grant PRELUDIUM NCN [2012/07/N/NZ3/00379]; grant MAESTRO NCN [2012/06/A/NZ4/00028]; KNOW - Ministry of Science and Higher Education, Republic of Poland	MNiSzW/NCN; grant OPUS NCN; grant PRELUDIUM NCN; grant MAESTRO NCN; KNOW - Ministry of Science and Higher Education, Republic of Poland	This work was supported by MNiSzW/NCN grant NN405375937, grant OPUS NCN 2011/03/B/NZ4/00042, grant PRELUDIUM NCN 2012/07/N/NZ3/00379, grant MAESTRO NCN 2012/06/A/NZ4/00028 and statutory funds. Katarzyna Popiolek-Barczyk is a Ph.D. student and has a scholarship from the KNOW sponsored by the Ministry of Science and Higher Education, Republic of Poland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin AR, 1996, P NATL ACAD SCI USA, V93, P14014, DOI 10.1073/pnas.93.24.14014; BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; Bie BH, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-37; Cahill CM, 2007, TRENDS PHARMACOL SCI, V28, P23, DOI 10.1016/j.tips.2006.11.003; Cahill CM, 2003, PAIN, V101, P199, DOI 10.1016/S0304-3959(02)00333-0; Chang AC, 1996, J MED CHEM, V39, P1729, DOI 10.1021/jm950813b; Chang YW, 2010, J PAIN, V11, P1146, DOI 10.1016/j.jpain.2010.02.010; Chao CC, 1997, J PHARMACOL EXP THER, V281, P998; Chao CC, 1996, P NATL ACAD SCI USA, V93, P8051, DOI 10.1073/pnas.93.15.8051; CHEN Y, 1993, BIOCHEM J, V295, P625, DOI 10.1042/bj2950625; Cheng PY, 1997, BRAIN RES, V778, P367, DOI 10.1016/S0006-8993(97)00891-3; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Colovic M, 2003, J CHROMATOGR B, V791, P337, DOI 10.1016/S1570-0232(03)00247-2; Commons KG, 1996, BRAIN RES, V738, P181, DOI 10.1016/S0006-8993(96)00774-3; Cui Y, 2008, BRAIN BEHAV IMMUN, V22, P114, DOI 10.1016/j.bbi.2007.07.014; Cunningham CL, 2013, J NEUROSCI, V33, P4216, DOI 10.1523/JNEUROSCI.3441-12.2013; Eisenberg E, 2005, JAMA-J AM MED ASSOC, V293, P3043, DOI 10.1001/jama.293.24.3043; El-Hage N, 2013, AIDS, V27, P2181, DOI 10.1097/QAD.0b013e3283639804; EVANS CJ, 1992, SCIENCE, V258, P1952, DOI 10.1126/science.1335167; Fenalti G, 2014, NATURE, V506, P191, DOI 10.1038/nature12944; Fillpovic R, 2008, EXP NEUROL, V211, P41, DOI 10.1016/j.expneurol.2007.12.024; Fraser GL, 2000, BRIT J PHARMACOL, V129, P1668, DOI 10.1038/sj.bjp.0703248; Gallantine EL, 2005, BASIC CLIN PHARMACOL, V97, P39, DOI 10.1111/j.1742-7843.2005.pto_97107.x; Gaveriaux-Ruff C, 2008, EUR J NEUROSCI, V27, P2558, DOI 10.1111/j.1460-9568.2008.06223.x; Gaveriaux-Ruff C, 2011, BEHAV PHARMACOL, V22, P405, DOI 10.1097/FBP.0b013e32834a1f2c; George SR, 2000, J BIOL CHEM, V275, P26128, DOI 10.1074/jbc.M000345200; Gilron I, 2005, NEW ENGL J MED, V352, P1324, DOI 10.1056/NEJMoa042580; Gomes I, 2004, P NATL ACAD SCI USA, V101, P5135, DOI 10.1073/pnas.0307601101; Gomes I, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-22-j0007.2000; Gonzalez JC, 2007, EUR J NEUROSCI, V26, P2481, DOI 10.1111/j.1460-9568.2007.05873.x; Hains BC, 2006, J NEUROSCI, V26, P4308, DOI 10.1523/JNEUROSCI.0003-06.2006; Happel C, 2008, J LEUKOCYTE BIOL, V83, P956, DOI 10.1189/jlb.1007685; Herradon G, 2008, NEUROSCI LETT, V438, P186, DOI 10.1016/j.neulet.2008.03.095; Hirsch SJ, 2014, NEUROSCI LETT, V562, P97, DOI 10.1016/j.neulet.2013.10.007; Holdridge SV, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-7; Holdridge SV, 2007, EUR J PAIN, V11, P685, DOI 10.1016/j.ejpain.2006.10.008; Horvath RJ, 2010, PAIN, V150, P401, DOI 10.1016/j.pain.2010.02.042; Horvath RJ, 2009, J NEUROSCI, V29, P998, DOI 10.1523/JNEUROSCI.4595-08.2009; Hua XY, 2005, EUR J NEUROSCI, V22, P2431, DOI 10.1111/j.1460-9568.2005.04451.x; Hurley RW, 2000, J NEUROSCI, V20, P1249, DOI 10.1523/JNEUROSCI.20-03-01249.2000; Hutchinson MR, 2008, BRAIN BEHAV IMMUN, V22, P1178, DOI 10.1016/j.bbi.2008.05.004; Jin SX, 2003, J NEUROSCI, V23, P4017; Kabli N, 2007, PAIN, V127, P84, DOI 10.1016/j.pain.2006.08.003; Kerros C, 2010, J NEUROIMMUNOL, V220, P69, DOI 10.1016/j.jneuroim.2010.01.010; KIEFFER BL, 1992, P NATL ACAD SCI USA, V89, P12048, DOI 10.1073/pnas.89.24.12048; Kieffer BL, 2002, PROG NEUROBIOL, V66, P285, DOI 10.1016/S0301-0082(02)00008-4; Kim TH, 2011, BRAIN RES, V1370, P34, DOI 10.1016/j.brainres.2010.11.038; Ko JL, 1999, MOL BRAIN RES, V69, P171, DOI 10.1016/S0169-328X(99)00094-7; Kobayashi K, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.54; Ledeboer A, 2005, PAIN, V115, P71, DOI 10.1016/j.pain.2005.02.009; LEE YW, 1995, NEUROSCI LETT, V199, P111, DOI 10.1016/0304-3940(95)12034-2; Liu XQ, 2013, NEUROSCI LETT, V542, P30, DOI 10.1016/j.neulet.2013.03.011; Machado LS, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-56; Makuch W, 2013, NEUROPHARMACOLOGY, V75, P445, DOI 10.1016/j.neuropharm.2013.08.031; MANSSON E, 1994, BIOCHEM BIOPH RES CO, V202, P1431, DOI 10.1006/bbrc.1994.2091; Garcia-Martinez EM, 2010, BIOCHEM PHARMACOL, V79, P239, DOI 10.1016/j.bcp.2009.07.028; Mayer DJ, 1999, P NATL ACAD SCI USA, V96, P7731, DOI 10.1073/pnas.96.14.7731; McQuay HJ, 2002, EUR J PAIN-LONDON, V6, P11, DOI 10.1053/eujp.2001.0316; Merighi S, 2013, BIOCHEM PHARMACOL, V86, P487, DOI 10.1016/j.bcp.2013.05.027; Mika J, 2010, NEUROSCIENCE, V165, P1420, DOI 10.1016/j.neuroscience.2009.11.064; Mika J, 2001, EUR J PHARMACOL, V415, P31, DOI 10.1016/S0014-2999(01)00814-7; Mika J, 2008, PAIN, V138, P587, DOI 10.1016/j.pain.2008.02.015; Mika J, 2007, EUR J PHARMACOL, V560, P142, DOI 10.1016/j.ejphar.2007.01.013; Mika J, 2013, EUR J PHARMACOL, V716, P106, DOI 10.1016/j.ejphar.2013.01.072; Mika J, 2011, NEUROPEPTIDES, V45, P247, DOI 10.1016/j.npep.2011.03.002; Mika J, 2009, BRAIN BEHAV IMMUN, V23, P75, DOI 10.1016/j.bbi.2008.07.005; MINAMI M, 1993, NEUROSCI LETT, V162, P161, DOI 10.1016/0304-3940(93)90585-9; Nadal X, 2006, EUR J NEUROSCI, V23, P830, DOI 10.1111/j.1460-9568.2006.04569.x; Niimi N, 2013, NEUROPATHOLOGY, V33, P612, DOI 10.1111/neup.12039; Nozaki C, 2012, J PHARMACOL EXP THER, V342, P799, DOI 10.1124/jpet.111.188987; Obara I, 2009, PAIN, V141, P283, DOI 10.1016/j.pain.2008.12.006; Osikowicz M, 2008, PAIN, V139, P117, DOI 10.1016/j.pain.2008.03.017; Osikowicz M, 2013, EXP PHYSIOL, V98, P372, DOI 10.1113/expphysiol.2012.069922; OSSIPOV MH, 1995, NEUROSCI LETT, V199, P87, DOI 10.1016/0304-3940(95)12022-V; Pinkernelle J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073422; Pol O, 2006, NEUROPHARMACOLOGY, V50, P123, DOI 10.1016/j.neuropharm.2005.11.002; Porreca F, 1998, BRAIN RES, V795, P197, DOI 10.1016/S0006-8993(98)00292-3; Pradhan AA, 2011, TRENDS PHARMACOL SCI, V32, P581, DOI 10.1016/j.tips.2011.06.008; Przanowski P, 2014, J MOL MED, V92, P239, DOI 10.1007/s00109-013-1090-5; Przewlocka B, 1999, EUR J PHARMACOL, V367, P189, DOI 10.1016/S0014-2999(98)00956-X; Przewlocki R, 2005, CURR PHARM DESIGN, V11, P3013, DOI 10.2174/1381612054865055; Przewlocki R, 2001, EUR J PHARMACOL, V429, P79, DOI 10.1016/S0014-2999(01)01308-5; Quock RM, 1999, PHARMACOL REV, V51, P503; Radad K, 2010, CAN J NEUROL SCI, V37, P81, DOI 10.1017/S0317167100009690; Raghavendra V, 2003, PAIN, V104, P655, DOI 10.1016/S0304-3959(03)00138-6; Raghavendra V, 2002, J NEUROSCI, V22, P9980, DOI 10.1523/jneurosci.22-22-09980.2002; Rowbotham MC, 2003, NEW ENGL J MED, V348, P1223, DOI 10.1056/NEJMoa021420; Scherrer G, 2006, P NATL ACAD SCI USA, V103, P9691, DOI 10.1073/pnas.0603359103; Scherrer G, 2009, CELL, V137, P1148, DOI 10.1016/j.cell.2009.04.019; Sluka KA, 2002, J PHARMACOL EXP THER, V302, P1146, DOI 10.1124/jpet.102.033167; Somvanshi RK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085193; Steele AD, 2002, CYTOKINE GROWTH F R, V13, P209, DOI 10.1016/S1359-6101(02)00007-2; Stone LS, 2004, NEUROSCI LETT, V361, P208, DOI 10.1016/j.neulet.2003.12.067; Szabo I, 2002, P NATL ACAD SCI USA, V99, P10276, DOI 10.1073/pnas.102327699; Thorlin T, 1999, GLIA, V25, P370, DOI 10.1002/(SICI)1098-1136(19990215)25:4<370::AID-GLIA6>3.0.CO;2-J; Tikka T, 2001, J NEUROSCI, V21, P2580, DOI 10.1523/JNEUROSCI.21-08-02580.2001; Turchan-Cholewo J, 2008, J NEUROSCI RES, V86, P2100, DOI 10.1002/jnr.21653; Watkins LR, 2003, NAT REV DRUG DISCOV, V2, P973, DOI 10.1038/nrd1251; Wieseler-Frank J, 2005, NEUROSIGNALS, V14, P166, DOI 10.1159/000087655; YAKSH TL, 1976, PHYSIOL BEHAV, V17, P1031, DOI 10.1016/0031-9384(76)90029-9; Zawadzka M, 2005, GLIA, V49, P36, DOI 10.1002/glia.20092; Zhang X, 2006, TRENDS PHARMACOL SCI, V27, P324, DOI 10.1016/j.tips.2006.04.005; Zhuang ZY, 2006, J NEUROSCI, V26, P3551, DOI 10.1523/JNEUROSCI.5290-05.2006; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4; Zychowska M, 2013, J NEUROIMMUNOL, V262, P35, DOI 10.1016/j.jneuroim.2013.06.005	105	51	52	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2014	9	8							e104420	10.1371/journal.pone.0104420	http://dx.doi.org/10.1371/journal.pone.0104420			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR0CG	25105291	Green Published, Green Submitted, gold			2022-12-27	WOS:000343231900054
J	Yoshida, S; Ikari, K; Furuya, T; Toyama, Y; Taniguchi, A; Yamanaka, H; Momohara, S				Yoshida, Shinji; Ikari, Katsunori; Furuya, Takefumi; Toyama, Yoshiaki; Taniguchi, Atsuo; Yamanaka, Hisashi; Momohara, Shigeki			An Osteoprotegerin Gene Polymorphism Is Associated with an Increased Risk of Hip Fracture in Japanese Patients with Rheumatoid Arthritis: Results from the IORRA Observational Cohort Study	PLOS ONE			English	Article							BONE-MINERAL DENSITY; POPULATION; LOCI; WOMEN	Introduction: Patients with rheumatoid arthritis (RA) have a higher prevalence of osteoporosis and hip fracture than healthy individuals. Multiple genetic loci for osteoporotic fracture were identified in recent genome-wide association studies. The purpose of this study was to identify genetic variants associated with the occurrence of hip fracture in Japanese patients with RA. Methods: DNA samples from 2,282 Japanese patients with RA were obtained from the DNA collection of the Institute of Rheumatology Rheumatoid Arthritis cohort (IORRA) study. Six single nucleotide polymorphisms (SNPs) that have been reported to be associated with fractures in recent studies were selected and genotyped. Forty hip fractures were identified with a maximum follow-up of 10 years. The genetic risk for hip fracture was examined using a multivariate Cox proportional hazards regression model. Results: The risk analyses revealed that patients who are homozygous for the major allele of SNP rs6993813, in the OPG locus, have a higher risk for hip fracture (hazard ratio [95% CI] = 2.53 [1.29-4.95], P = 0.0067). No association was found for the other SNPs. Conclusions: Our results indicate that an OPG allele is associated with increased risk for hip fracture in Japanese patients with RA.	[Yoshida, Shinji; Ikari, Katsunori; Furuya, Takefumi; Taniguchi, Atsuo; Yamanaka, Hisashi; Momohara, Shigeki] Tokyo Womens Med Univ, Inst Rheumatol, Tokyo, Japan; [Yoshida, Shinji; Toyama, Yoshiaki] Keio Univ, Sch Med, Dept Orthopaed Surg, Tokyo, Japan	Tokyo Women's Medical University; Keio University	Ikari, K (corresponding author), Tokyo Womens Med Univ, Inst Rheumatol, Tokyo, Japan.	kikari@ior.twmu.ac.jp			Japanese Ministry of Education, Culture, Sports, Science and Technology; Japanese Ministry of Health, Labour and Welfare; Grants-in-Aid for Scientific Research [24390360] Funding Source: KAKEN	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants provided by the Japanese Ministry of Education, Culture, Sports, Science and Technology Grant-in-Aid for Scientific Research (KI, SM), the Japanese Ministry of Health, Labour and Welfare (SM, HY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong C, 2005, ANN RHEUM DIS, V64, P1602, DOI 10.1136/ard.2004.031195; Boyce BF, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2165; Cummings SR, 2009, NEW ENGL J MED, V361, P756, DOI 10.1056/NEJMoa0809493; Estrada K, 2012, NAT GENET, V44, P491, DOI 10.1038/ng.2249; Furuya T, 2013, OSTEOPOROSIS INT, V24, P1257, DOI 10.1007/s00198-012-2080-0; Hayashibara M, 2010, OSTEOPOROSIS INT, V21, P1825, DOI 10.1007/s00198-009-1150-4; Huusko TM, 2001, ANN RHEUM DIS, V60, P521, DOI 10.1136/ard.60.5.521; Kanis JA, 2008, OSTEOPOROSIS INT, V19, P385, DOI 10.1007/s00198-007-0543-5; Kim SY, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3107; Kobayashi S, 2008, ARTHRITIS RHEUM, V58, P1940, DOI 10.1002/art.23494; Okada Y, 2014, NATURE, V506, P376, DOI 10.1038/nature12873; Okada Y, 2012, NAT GENET, V44, P511, DOI 10.1038/ng.2231; Orstavik RE, 2004, ANN RHEUM DIS, V63, P177, DOI 10.1136/ard.2003.005850; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Smulders E, 2009, ANN RHEUM DIS, V68, P1795, DOI 10.1136/ard.2009.109009; Styrkarsdottir U, 2008, NEW ENGL J MED, V358, P2355, DOI 10.1056/NEJMoa0801197; Yamanaka H, MOD RHEUMATOL, V23, P1; Yoshida S, ARTHRITIS RES THER, V16, pR75	18	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2014	9	8							e104587	10.1371/journal.pone.0104587	http://dx.doi.org/10.1371/journal.pone.0104587			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR0CG	25105978	Green Submitted, Green Published, gold			2022-12-27	WOS:000343231900074
J	Jung, YR; Kim, DH; Kim, SR; An, HJ; Lee, EK; Tanaka, T; Kim, ND; Yokozawa, T; Park, JN; Chung, HY				Jung, Yu Ri; Kim, Dae Hyun; Kim, So Ra; An, Hye Jin; Lee, Eun Kyeong; Tanaka, Takashi; Kim, Nam Deuk; Yokozawa, Takako; Park, Jin Nam; Chung, Hae Young			Anti-Wrinkle Effect of Magnesium Lithospermate B from Salvia miltiorrhiza BUNGE: Inhibition of MMPs via NF-kB Signaling	PLOS ONE			English	Article							MATRIX METALLOPROTEINASES; COX-2 EXPRESSION; KAPPA-B; SKIN; CONTRIBUTES; IRRADIATION; PROTEIN	Skin is in direct contact with the environment and therefore undergoes aging as a consequence of environmentally induce damage. Wrinkle formation is a striking feature of intrinsic and photo-induced skin aging, which are both associated with oxidative stress and inflammatory response. The present study was undertaken to identify the mechanisms responsible for the anti-wrinkle effects of MLB, and thus, we investigated whether magnesium lithospermate B (MLB) from Salvia miltiorrhiza BUNGE associated with wrinkle formation caused by intrinsic and extrinsic skin aging using Sprague-Dawley rats aged 5 and 20 months and ultraviolet B (UVB)-irradiated human skin fibroblasts cells, respectively. The results obtained showed that the oral administration of MLB significantly upregulated the level of type I procollagen and downregulated the activities and expressions of matrix-metalloproteinases (MMPs) in rat skin. In fibroblasts, MLB suppressed the transactivation of nuclear factor-kB (NF-kB) and activator protein 1(AP-1), which are the two transcription factors responsible for MMP expression, by suppressing oxidative stress and the mitogen activated protein kinase (MAPK) pathway. Our results show that the antioxidant effect of MLB is due to the direct scavenging of reactive oxygen species (ROS) and its inhibitory effects on NF-kB-dependent inflammation genes, such as, cyclooxygenase-2 and inducible nitric oxide synthase. MLB was found to reverse both age- and UVB-related reductions in skin procollagen levels by suppressing the expressions and activities of NFkB and AP-1-dependent MMPs by modulating ROS generation and the MAPK signaling pathway. We suggest that MLB potentially has anti-wrinkle and anti-skin aging effects.	[Jung, Yu Ri; Kim, Dae Hyun; Kim, So Ra; An, Hye Jin; Lee, Eun Kyeong; Kim, Nam Deuk; Chung, Hae Young] Pusan Natl Univ, Coll Pharm, Mol Inflammat Res Ctr Aging Intervent MRCA, Pusan, South Korea; [Yokozawa, Takako] Toyama Univ, Grad Sch Sci & Engn Res, Toyama 930, Japan; [Tanaka, Takashi] Nagasaki Univ, Fac Pharmaceut Sci, Nagasaki 852, Japan; [Park, Jin Nam] DrSkin, Pusan, South Korea	Pusan National University; University of Toyama; Nagasaki University	Chung, HY (corresponding author), Pusan Natl Univ, Coll Pharm, Mol Inflammat Res Ctr Aging Intervent MRCA, Pusan, South Korea.	hyjung@pusan.ac.kr		Tanaka, Takashi/0000-0001-7762-7432	Cooperative Research Program for Agriculture Science & Technology Development, Rural Development Administration, Republic of Korea [PJ006522132013]; National Research Foundation of Korea (NRF) grant - Korea government (MSIP) [2009-0083538]	Cooperative Research Program for Agriculture Science & Technology Development, Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea); National Research Foundation of Korea (NRF) grant - Korea government (MSIP)	This work was carried out with the support of "Cooperative Research Program for Agriculture Science & Technology Development (Project No. PJ006522132013)" Rural Development Administration, Republic of Korea. This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (No. 2009-0083538). The authors also take this opportunity to thank the Aging Tissue Bank (Busan, Korea) for supplying research materials. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bohm M, 1999, ANN NY ACAD SCI, V885, P277; Brenneisen P, 2002, ANN NY ACAD SCI, V973, P31, DOI 10.1111/j.1749-6632.2002.tb04602.x; Chung JH, 2001, J INVEST DERMATOL, V117, P1218, DOI 10.1046/j.0022-202x.2001.01544.x; Egbert M, 2014, J DERMATOL SCI, V73, P40, DOI 10.1016/j.jdermsci.2013.08.010; Farage M. A., 2008, International Journal of Cosmetic Science, V30, P87, DOI 10.1111/j.1468-2494.2007.00415.x; Fisher GJ, 2002, ARCH DERMATOL, V138, P1462, DOI 10.1001/archderm.138.11.1462; Fisher GJ, 1996, NATURE, V379, P335, DOI 10.1038/379335a0; Fisher GJ, 2001, J INVEST DERMATOL, V117, P219, DOI 10.1046/j.0022-202x.2001.01432.x; HABIB A, 1993, J BIOL CHEM, V268, P23448; Halliday GA, 2005, MUTAT RES-FUND MOL M, V571, P107, DOI 10.1016/j.mrfmmm.2004.09.013; Helfrich Yolanda Rosi, 2008, Dermatol Nurs, V20, P177; Khan AQ, 2012, FOOD CHEM TOXICOL, V50, P175, DOI 10.1016/j.fct.2011.10.043; Kim JK, 2007, FREE RADICAL RES, V41, P603, DOI 10.1080/10715760701209896; Kim SR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073877; Mehta PK, 2007, AM J PHYSIOL-CELL PH, V292, pC82, DOI 10.1152/ajpcell.00287.2006; ONITSUKA M, 1983, CHEM PHARM BULL, V31, P1670; Park JE, 2014, PHOTODERMAT IN PRESS; Quan TH, 2009, J INVEST DERM SYMP P, V14, P20, DOI 10.1038/jidsymp.2009.8; Richard SF, 2013, HEPATOLOGY, V57, P1838; Rittie L, 2002, AGEING RES REV, V1, P705, DOI 10.1016/S1568-1637(02)00024-7; Soung DY, 2003, J PHARM PHARMACOL, V55, P1427, DOI 10.1211/0022357021891; Taddese S, 2010, BBA-PROTEINS PROTEOM, V1804, P731, DOI 10.1016/j.bbapap.2009.11.014; TALWAR HS, 1995, J INVEST DERMATOL, V105, P285, DOI 10.1111/1523-1747.ep12318471; TANAKA T, 1989, CHEM PHARM BULL, V37, P340; Tang S, 2013, J DERMATOL SCI, V70, P42, DOI 10.1016/j.jdermsci.2013.01.008; Tang W, 1992, CHINESE DRUGS PLANT, P891; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; YOKOZAWA T, 1990, J NAT PROD, V53, P662, DOI 10.1021/np50069a019	28	34	35	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e102689	10.1371/journal.pone.0102689	http://dx.doi.org/10.1371/journal.pone.0102689			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25099178	gold, Green Published, Green Submitted			2022-12-27	WOS:000339995100010
J	Kobayashi, DR; Farman, R; Polovina, JJ; Parker, DM; Rice, M; Balazs, GH				Kobayashi, Donald R.; Farman, Richard; Polovina, Jeffrey J.; Parker, Denise M.; Rice, Marc; Balazs, George H.			"Going with the Flow'' or Not: Evidence of Positive Rheotaxis in Oceanic Juvenile Loggerhead Turtles (Caretta caretta) in the South Pacific Ocean Using Satellite Tags and Ocean Circulation Data	PLOS ONE			English	Article							CENTRAL NORTH PACIFIC; OLIVACEA SEA-TURTLES; ORIENTATION; MOVEMENT; BEHAVIOR; HABITAT	The movement of juvenile loggerhead turtles (n = 42) out-fitted with satellite tags and released in oceanic waters off New Caledonia was examined and compared with ocean circulation data. Merging of the daily turtle movement data with drifter buoy movements, OSCAR (Ocean Surface Current Analyses - Real time) circulation data, and three different vertical strata (05 m, 0-40 m, 0-100 m) of HYCOM (HYbrid Coordinate Ocean Model) circulation data indicated the turtles were swimming against the prevailing current in a statistically significant pattern. This was not an artifact of prevailing directions of current and swimming, nor was it an artifact of frictional slippage. Generalized additive modeling was used to decompose the pattern of swimming into spatial and temporal components. The findings are indicative of a positive rheotaxis whereby an organism is able to detect the current flow and orient itself to swim into the current flow direction or otherwise slow down its movement. Potential mechanisms for the means and adaptive significance of rheotaxis in oceanic juvenile loggerhead turtles are discussed.	[Kobayashi, Donald R.; Polovina, Jeffrey J.; Balazs, George H.] NOAA, Pacific Islands Fisheries Sci Ctr, Natl Marine Fisheries Serv, Honolulu, HI 96813 USA; [Farman, Richard] Aquarium Lagons, Noumea, New Caledonia; [Parker, Denise M.] Univ Hawaii, Joint Inst Marine & Atmospher Res, Newport, OR USA; [Rice, Marc] Hawaii Preparatory Acad, Kamuela, HI USA	National Aeronautics & Space Administration (NASA); National Oceanic Atmospheric Admin (NOAA) - USA	Kobayashi, DR (corresponding author), NOAA, Pacific Islands Fisheries Sci Ctr, Natl Marine Fisheries Serv, Honolulu, HI 96813 USA.	Donald.Kobayashi@noaa.gov		Kobayashi, Donald/0000-0002-1582-1544	United States government to National Oceanic and Atmospheric Administration	United States government to National Oceanic and Atmospheric Administration	The funders were base funding and add-on funding from the United States government to National Oceanic and Atmospheric Administration and had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecassis M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073274; Akesson S, 2007, BIOSCIENCE, V57, P123, DOI 10.1641/B570207; Balazs G.H., 1996, P 15 ANN S SEA TURTL, P21; Batschelet E, 1981, CIRCULAR STAT BIOL; Bolten A.B., 2003, LOGGERHEAD SEA TURTL, P63; Chapman JW, 2011, CURR BIOL, V21, pR861, DOI 10.1016/j.cub.2011.08.014; Conant TA., 2009, LOGGERHEAD SEA TURTL; Cressie N, 1991, STAT SPATIAL DATA; Dale MRT, 2002, ECOSCIENCE, V9, P162, DOI 10.1080/11956860.2002.11682702; DODD KC., 1988, SYNOPSIS BIOL DATA L; DURAND D, 1958, J GEOL, V66, P229, DOI 10.1086/626501; Edwards KP, 2006, J ATMOS OCEAN TECH, V23, P1614, DOI 10.1175/JTECH1933.1; Fossette S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013908; Galli S, 2012, ANIM BEHAV, V84, P1491, DOI 10.1016/j.anbehav.2012.09.022; Girard C, 2006, MAR ECOL PROG SER, V322, P281, DOI 10.3354/meps322281; Hedges LV, 2007, J EDUC BEHAV STAT, V32, P151, DOI 10.3102/1076998606298040; Howell EA, 2010, MAR BIOL, V157, P1011, DOI 10.1007/s00227-009-1381-0; HURLBERT SH, 1984, ECOL MONOGR, V54, P187, DOI 10.2307/1942661; Jones TT, 2013, METHODS ECOLOGY EVOL; Jonsen ID, 2007, MAR ECOL PROG SER, V337, P255, DOI 10.3354/meps337255; Jonsen ID, 2005, ECOLOGY, V86, P2874, DOI 10.1890/04-1852; Kobayashi DR, 2008, J EXP MAR BIOL ECOL, V356, P96, DOI 10.1016/j.jembe.2007.12.019; Kobayashi DR, 2011, ICES J MAR SCI, V68, P707, DOI 10.1093/icesjms/fsq185; Krauss W, 1996, J GEOPHYS RES-OCEANS, V101, P1309, DOI 10.1029/95JC02686; LOHMANN KJ, 1994, J EXP BIOL, V190, P1; LOHMANN KJ, 1995, J EXP BIOL, V198, P1079; Margaritoulis D., 2003, LOGGERHEAD SEA TURTL, P175; MONAHAN EC, 1973, LIMNOL OCEANOGR, V18, P981, DOI 10.4319/lo.1973.18.6.0981; Palacios DM, 2006, DEEP-SEA RES PT II, V53, P250, DOI 10.1016/j.dsr2.2006.03.004; Polovina J, 2006, DEEP-SEA RES PT II, V53, P326, DOI 10.1016/j.dsr2.2006.01.006; Polovina JJ, 2000, FISH OCEANOGR, V9, P71, DOI 10.1046/j.1365-2419.2000.00123.x; Polovina JJ, 2004, FISH OCEANOGR, V13, P36, DOI 10.1046/j.1365-2419.2003.00270.x; Polovina JJ, 2003, FISH B-NOAA, V101, P189; Putman NF, 2012, J EXP BIOL, V215, P1863, DOI 10.1242/jeb.067587; Roberts A, 2009, J EXP BIOL, V212, P914, DOI 10.1242/jeb.027250; Rowat D, 2007, FISH RES, V84, P32, DOI 10.1016/j.fishres.2006.11.009; Salumae T, 2012, IEEE INT CONF ROBOT, P4210, DOI 10.1109/ICRA.2012.6225023; SATTERTHWAITE FE, 1946, BIOMETRICS BULL, V2, P110, DOI 10.2307/3002019; Shillinger GL, 2008, PLOS BIOL, V6, P1408, DOI 10.1371/journal.pbio.0060171; Vandenabeele SP, 2012, MAR BIOL, V159, P1, DOI 10.1007/s00227-011-1784-6; Wessel P, 1991, EOS T AM GEOPHYS UN, V72, P445, DOI [10.1029/90EO00319, DOI 10.1029/90EO00319, DOI 10.1029/90E000319]; Wolf JB, 2011, GENETICS, V189, P1069, DOI 10.1534/genetics.111.130591; Wyneken J., 2001, ANATOMY SEA TURTLES; Zar J.H., 1999, ZAR KUHR 5 2019, V4th	45	21	21	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e103701	10.1371/journal.pone.0103701	http://dx.doi.org/10.1371/journal.pone.0103701			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25098694	Green Published, gold			2022-12-27	WOS:000339995100025
J	Wolf, S; McMahon, DP; Lim, KS; Pull, CD; Clark, SJ; Paxton, RJ; Osborne, JL				Wolf, Stephan; McMahon, Dino P.; Lim, Ka S.; Pull, Christopher D.; Clark, Suzanne J.; Paxton, Robert J.; Osborne, Juliet L.			So Near and Yet So Far: Harmonic Radar Reveals Reduced Homing Ability of Nosema Infected Honeybees	PLOS ONE			English	Article							DECREASES FORAGING SUCCESS; APIS-MELLIFERA; MICROSPORIDIAN PARASITE; FLIGHT PATHS; CERANAE; BEE; POLLINATORS; SCALE; HYMENOPTERA; TEMPERATURE	Pathogens may gain a fitness advantages through manipulation of the behaviour of their hosts. Likewise, host behavioural changes can be a defence mechanism, counteracting the impact of pathogens on host fitness. We apply harmonic radar technology to characterize the impact of an emerging pathogen - Nosema ceranae (Microsporidia) - on honeybee (Apis mellifera) flight and orientation in the field. Honeybees are the most important commercial pollinators. Emerging diseases have been proposed to play a prominent role in colony decline, partly through sub-lethal behavioural manipulation of their hosts. We found that homing success was significantly reduced in diseased (65.8%) versus healthy foragers (92.5%). Although lost bees had significantly reduced continuous flight times and prolonged resting times, other flight characteristics and navigational abilities showed no significant difference between infected and non-infected bees. Our results suggest that infected bees express normal flight characteristics but are constrained in their homing ability, potentially compromising the colony by reducing its response inputs, but also counteracting the intra-colony spread of infection. We provide the first high-resolution analysis of sub-lethal effects of an emerging disease on insect flight behaviour. The potential causes and the implications for both host and parasite are discussed.	[Wolf, Stephan; Lim, Ka S.; Pull, Christopher D.; Osborne, Juliet L.] Rothamsted Res, Dept Agroecol, Harpenden, Herts, England; [Wolf, Stephan] Queen Mary Univ London, Sch Biol & Chem Sci, London, England; [McMahon, Dino P.; Paxton, Robert J.] Queens Univ Belfast, Sch Biol Sci, Belfast, Antrim, North Ireland; [McMahon, Dino P.; Paxton, Robert J.] Univ Halle Wittenberg, Inst Biol, D-06108 Halle, Germany; [Pull, Christopher D.] IST Austria, Klosterneuburg, Austria; [Clark, Suzanne J.] Rothamsted Res, Dept Computat & Syst Biol, Harpenden, Herts, England; [Osborne, Juliet L.] Univ Exeter, Environm & Sustainabil Inst, Falmouth, Cornwall, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; University of London; Queen Mary University London; Queens University Belfast; Martin Luther University Halle Wittenberg; Institute of Science & Technology - Austria; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; University of Exeter	Wolf, S (corresponding author), Rothamsted Res, Dept Agroecol, Harpenden, Herts, England.	s.wolf@qmul.ac.uk	Lim, Ka Sing/B-4480-2012; Osborne, Juliet L/I-6776-2012; Paxton, Robert John/D-7082-2015; McMahon, Dino/S-2620-2019; McMahon, Dino P/F-7006-2012; Wolf, Stephan/C-1106-2009	Lim, Ka Sing/0000-0002-9166-2928; Paxton, Robert John/0000-0003-2517-1351; McMahon, Dino/0000-0003-1119-5299; McMahon, Dino P/0000-0003-1119-5299; Wolf, Stephan/0000-0002-7349-7113	BBSRC; Defra; NERC; Scottish Government; Wellcome Trust [BB/I00097/1, BB/I000100/1)]; UK Biotechnology and Biological Sciences Research Council (BBSRC); Biotechnology and Biological Sciences Research Council [BB/I000097/1, BB/I000100/1, BB/I000097/2] Funding Source: researchfish; BBSRC [BB/I000097/2, BB/I000100/1, BB/I000097/1] Funding Source: UKRI	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Defra(Department for Environment, Food & Rural Affairs (DEFRA)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Scottish Government; Wellcome Trust(Wellcome TrustEuropean Commission); UK Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was funded jointly by a grant from BBSRC, Defra, NERC, the Scottish Government and the Wellcome Trust, under the Insect Pollinators Initiative (grant numbers BB/I00097/1 and BB/I000100/1). Rothamsted Research is a national institute of bioscience strategically funded by the UK Biotechnology and Biological Sciences Research Council (BBSRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizen MA, 2009, CURR BIOL, V19, P915, DOI 10.1016/j.cub.2009.03.071; Aizen MA, 2009, ANN BOT-LONDON, V103, P1579, DOI 10.1093/aob/mcp076; Becher MA, 2013, J APPL ECOL, V50, P868, DOI 10.1111/1365-2664.12112; Becher MA, 2009, J COMP PHYSIOL A, V195, P673, DOI 10.1007/s00359-009-0442-7; Beekman M, 2000, FUNCT ECOL, V14, P490, DOI 10.1046/j.1365-2435.2000.00443.x; Bollan KA, 2013, PARASITOL RES, V112, P751, DOI 10.1007/s00436-012-3195-0; Bryden J, 2013, ECOL LETT, V16, P1463, DOI 10.1111/ele.12188; Cant ET, 2005, P ROY SOC B-BIOL SCI, V272, P785, DOI 10.1098/rspb.2004.3002; Capaldi EA, 2000, NATURE, V403, P537, DOI 10.1038/35000564; Cresswell JE, 2012, SCIENCE, V337, DOI 10.1126/science.1224618; DURRER S, 1994, P ROY SOC B-BIOL SCI, V258, P299, DOI 10.1098/rspb.1994.0176; Dussaubat C, 2013, J INVERTEBR PATHOL, V113, P42, DOI 10.1016/j.jip.2013.01.002; Dyer FC, 1996, J EXP BIOL, V199, P147; Dyer Fred C., 1994, P66; Fischer J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091364; Forsgren E, 2010, VET PARASITOL, V170, P212, DOI 10.1016/j.vetpar.2010.02.010; Fries I, 1996, EUR J PROTISTOL, V32, P356, DOI 10.1016/S0932-4739(96)80059-9; Fries I., 2013, J APICULT RES, V52, P1, DOI [10.3896/ IBRA. 1.52.1.14, DOI 10.3896/IBRA.1.52.1.14]; Fries I, 2010, J INVERTEBR PATHOL, V103, pS73, DOI 10.1016/j.jip.2009.06.017; Furst MA, 2014, NATURE, V506, P364, DOI 10.1038/nature12977; Gallai N, 2009, ECOL ECON, V68, P810, DOI 10.1016/j.ecolecon.2008.06.014; Garibaldi LA, 2013, SCIENCE, V339, P1608, DOI 10.1126/science.1230200; Goulson D, 2009, CONTEMP TOP ENTOMOL, P97; Hansen H, 1999, BEE WORLD, V80, P5, DOI 10.1080/0005772X.1999.11099415; Henry M, 2012, SCIENCE, V336, P348, DOI 10.1126/science.1215039; Higes M, 2006, J INVERTEBR PATHOL, V92, P93, DOI 10.1016/j.jip.2006.02.005; Higes M, 2008, ENVIRON MICROBIOL, V10, P2659, DOI 10.1111/j.1462-2920.2008.01687.x; Higes M, 2007, J INVERTEBR PATHOL, V94, P211, DOI 10.1016/j.jip.2006.11.001; Klee J, 2007, J INVERTEBR PATHOL, V96, P1, DOI 10.1016/j.jip.2007.02.014; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Kralj J, 2010, APIDOLOGIE, V41, P21, DOI 10.1051/apido/2009046; Lane PW, 2011, GENSTAT RELEASE 14 R; Lihoreau M, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001392; Mayack C, 2009, J INVERTEBR PATHOL, V100, P185, DOI 10.1016/j.jip.2008.12.001; Menzel R, 2005, P NATL ACAD SCI USA, V102, P3040, DOI 10.1073/pnas.0408550102; Menzel R, 2012, APIDOLOGIE, V43, P229, DOI 10.1007/s13592-012-0127-z; Menzel R, 2011, CURR BIOL, V21, P645, DOI 10.1016/j.cub.2011.02.039; Moritz RFA, 2010, APIDOLOGIE, V41, P227, DOI 10.1051/apido/2010010; MULLER CB, 1993, NATURE, V363, P65, DOI 10.1038/363065a0; Naug D, 2009, APIDOLOGIE, V40, P595, DOI 10.1051/apido/2009039; Neumann P, 2010, J APICULT RES, V49, P1, DOI 10.3896/IBRA.1.49.1.01; Oldroyd BP, 2007, PLOS BIOL, V5, P1195, DOI 10.1371/journal.pbio.0050168; Osborne JL, 1999, J APPL ECOL, V36, P519, DOI 10.1046/j.1365-2664.1999.00428.x; Osborne JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078681; Ovaskainen O, 2008, P NATL ACAD SCI USA, V105, P19090, DOI 10.1073/pnas.0802066105; Pahl M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019669; Paxton RJ, 2007, APIDOLOGIE, V38, P558, DOI 10.1051/apido:2007037; Paxton RJ, 2010, J APICULT RES, V49, P80, DOI 10.3896/IBRA.1.49.1.11; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Rader R, 2009, J APPL ECOL, V46, P1080, DOI 10.1111/j.1365-2664.2009.01700.x; Ratnieks FLW, 2010, SCIENCE, V327, P152, DOI 10.1126/science.1185563; Reynolds AM, 2007, J EXP BIOL, V210, P3763, DOI 10.1242/jeb.009563; Reynolds AM, 2007, ECOLOGY, V88, P1955, DOI 10.1890/06-1916.1; Reynolds AM, 2009, BEHAV ECOL SOCIOBIOL, V64, P19, DOI 10.1007/s00265-009-0813-7; Riley JR, 2005, NATURE, V435, P205, DOI 10.1038/nature03526; Riley JR, 2002, COMPUT ELECTRON AGR, V35, P151, DOI 10.1016/S0168-1699(02)00016-9; Riley JR, 1996, NATURE, V379, P29, DOI 10.1038/379029b0; Schmid-Hempel P., 1998, Parasites in social insects.; SCHMIDHEMPEL P, 1985, BEHAV ECOL SOCIOBIOL, V17, P61, DOI 10.1007/BF00299430; Sherman PW, 1998, AM NAT, V151, P392, DOI 10.1086/286127; SOUTHWICK EE, 1992, J ECON ENTOMOL, V85, P621, DOI 10.1093/jee/85.3.621; Steffan-Dewenter I, 2003, P ROY SOC B-BIOL SCI, V270, P569, DOI 10.1098/rspb.2002.2292; Vanbergen AJ, 2013, FRONT ECOL ENVIRON, V11, P251, DOI 10.1890/120126; Vanengelsdorp D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004071; Winfree R, 2011, ANNU REV ECOL EVOL S, V42, P1, DOI 10.1146/annurev-ecolsys-102710-145042	65	87	87	1	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e103989	10.1371/journal.pone.0103989	http://dx.doi.org/10.1371/journal.pone.0103989			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25098331	Green Published, gold, Green Submitted			2022-12-27	WOS:000339995100042
J	Adelfinger, M; Gentschev, I; de Guibert, JG; Weibel, S; Langbein-Laugwitz, J; Hartl, B; Escobar, HM; Nolte, I; Chen, NHG; Aguilar, RJ; Yu, YA; Zhang, Q; Frentzen, A; Szalay, AA				Adelfinger, Marion; Gentschev, Ivaylo; de Guibert, Julio Grimm; Weibel, Stephanie; Langbein-Laugwitz, Johanna; Haertl, Barbara; Escobar, Hugo Murua; Nolte, Ingo; Chen, Nanhai G.; Aguilar, Richard J.; Yu, Yong A.; Zhang, Qian; Frentzen, Alexa; Szalay, Aladar A.			Evaluation of a New Recombinant Oncolytic Vaccinia Virus Strain GLV-5b451 for Feline Mammary Carcinoma Therapy	PLOS ONE			English	Article							GROWTH-FACTOR EXPRESSION; MICROVASCULAR DENSITY; VEGF; CANINE; ANGIOGENESIS; COMBINATION; VIROTHERAPY; NEOPLASMS; TUMORS; DOGS	Virotherapy on the basis of oncolytic vaccinia virus (VACV) infection is a promising approach for cancer therapy. In this study we describe the establishment of a new preclinical model of feline mammary carcinoma (FMC) using a recently established cancer cell line, DT09/06. In addition, we evaluated a recombinant vaccinia virus strain, GLV-5b451, expressing the anti-vascular endothelial growth factor (VEGF) single-chain antibody (scAb) GLAF-2 as an oncolytic agent against FMC. Cell culture data demonstrate that GLV-5b451 virus efficiently infected, replicated in and destroyed DT09/06 cancer cells. In the selected xenografts of FMC, a single systemic administration of GLV-5b451 led to significant inhibition of tumor growth in comparison to untreated tumor-bearing mice. Furthermore, tumor-specific virus infection led to overproduction of functional scAb GLAF-2, which caused drastic reduction of intratumoral VEGF levels and inhibition of angiogenesis. In summary, here we have shown, for the first time, that the vaccinia virus strains and especially GLV-5b451 have great potential for effective treatment of FMC in animal model.	[Adelfinger, Marion; Gentschev, Ivaylo; de Guibert, Julio Grimm; Weibel, Stephanie; Langbein-Laugwitz, Johanna; Haertl, Barbara; Szalay, Aladar A.] Univ Wurzburg, Dept Biochem, D-97070 Wurzburg, Germany; [Gentschev, Ivaylo; Chen, Nanhai G.; Aguilar, Richard J.; Yu, Yong A.; Zhang, Qian; Frentzen, Alexa; Szalay, Aladar A.] Genelux Corp, San Diego Sci Ctr, San Diego, CA USA; [Haertl, Barbara] Genelux GmbH, Bernried, Germany; [Escobar, Hugo Murua; Nolte, Ingo] Univ Vet Med, Small Anim Clin, Hannover, Germany; [Escobar, Hugo Murua; Szalay, Aladar A.] Univ Rostock, Div Med Clin 3, D-18055 Rostock, Germany; [Chen, Nanhai G.; Yu, Yong A.; Zhang, Qian; Szalay, Aladar A.] Univ Calif San Diego, Dept Radiat Med & Appl Sci, Rebecca & John Moores Comprehens Canc Ctr, La Jolla, CA 92093 USA; [Szalay, Aladar A.] Univ Wurzburg, Rudolf Virchow Ctr Expt Biomed, D-97070 Wurzburg, Germany; [Szalay, Aladar A.] Univ Wurzburg, Inst Mol Infect Biol, D-97070 Wurzburg, Germany	University of Wurzburg; University of Veterinary Medicine Hannover, Foundation; University of Rostock; University of California System; University of California San Diego; University of Wurzburg; University of Wurzburg	Szalay, AA (corresponding author), Univ Wurzburg, Dept Biochem, D-97070 Wurzburg, Germany.	aaszalay@genelux.com	Gentschev, Ivaylo/AAJ-5819-2021		Research and Development Division of Genelux Corporation, San Diego, USA; Service Grant - Genelux Corp.; Genelux Corporation; Genelux GmbH	Research and Development Division of Genelux Corporation, San Diego, USA; Service Grant - Genelux Corp.; Genelux Corporation; Genelux GmbH	This work was supported by the Research and Development Division of Genelux Corporation, San Diego, USA, and a Service Grant to the University of Wuerzburg, Germany funded by Genelux Corp. MA and SW received postdoctoral fellowship. The funder, Genelux Corporation, and Genelux GmbH provided support in the form of salaries for authors IG NGC RJA YAY QA AF, AAS, and BH retrospectively, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Angarita FA, 2013, TRENDS MOL MED, V19, P378, DOI 10.1016/j.molmed.2013.02.008; BOSTOCK DE, 1986, BRIT VET J, V142, P506, DOI 10.1016/0007-1935(86)90107-7; Braghiroli MI, 2012, EXPERT REV ANTICANC, V12, P567, DOI [10.1586/ERA.12.13, 10.1586/era.12.13]; Breitbach CJ, 2007, MOL THER, V15, P1686, DOI 10.1038/sj.mt.6300215; Buckel L, 2013, INT J CANCER, V133, P2989, DOI 10.1002/ijc.28296; Chen NG, 2012, ADV VIROL, V2012, DOI 10.1155/2012/320206; de Queiroz GF, 2010, J VET DIAGN INVEST, V22, P105, DOI 10.1177/104063871002200121; DORN CR, 1968, JNCI-J NATL CANCER I, V40, P307; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; Frentzen A, 2009, P NATL ACAD SCI USA, V106, P12915, DOI 10.1073/pnas.0900660106; Fridlender ZG, 2009, CANCER CELL, V16, P183, DOI 10.1016/j.ccr.2009.06.017; Garber K, 2006, J NATL CANCER I, V98, P298, DOI 10.1093/jnci/djj111; Gentschev I, 2014, VIRUSES-BASEL, V6, P2122, DOI 10.3390/v6052122; Gentschev I, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/489759; Gentschev I, 2013, BIOENGINEERED, V4, P84, DOI 10.4161/bioe.22462; Gentschev I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037239; Gentschev I, 2010, J ONCOL, V2010, DOI 10.1155/2010/736907; HAYDEN DW, 1971, J SMALL ANIM PRACT, V12, P687, DOI 10.1111/j.1748-5827.1971.tb06197.x; HAYES HM, 1981, VET REC, V108, P476, DOI 10.1136/vr.108.22.476; Islam MS, 2012, VET J, V192, P338, DOI 10.1016/j.tvjl.2011.08.032; John LB, 2012, CANCER RES, V72, P1651, DOI 10.1158/0008-5472.CAN-11-2788; Jourdier TM, 2003, GENE THER, V10, P2126, DOI 10.1038/sj.gt.3302124; Kamstock D, 2007, CANCER IMMUNOL IMMUN, V56, P1299, DOI 10.1007/s00262-007-0282-7; MacNeill AL, 2012, RES VET SCI, V93, P1036, DOI 10.1016/j.rvsc.2011.10.016; Martin I, 2007, J ANIM SCI, V85, P2734, DOI 10.2527/jas.2007-0048; Millanta F, 2002, VET PATHOL, V39, P690, DOI 10.1354/vp.39-6-690; NELSONRE.WA, 1972, P SOC EXP BIOL MED, V139, P6; Patil SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047472; PATNAIK AK, 1975, JNCI-J NATL CANCER I, V54, P855; Patruno R, 2009, J CELL MOL MED, V13, P555, DOI 10.1111/j.1582-4934.2008.00355.x; Sterenczak KA, 2009, GENE, V434, P35, DOI 10.1016/j.gene.2008.10.027; Weibel S, 2008, CELL MICROBIOL, V10, P1235, DOI 10.1111/j.1462-5822.2008.01122.x; Weibel S, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-106; WEIJER K, 1983, J NATL CANCER I, V70, P709; Zizzo N, 2010, LEUKEMIA LYMPHOMA, V51, P291, DOI 10.3109/10428190903452818	37	12	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e104337	10.1371/journal.pone.0104337	http://dx.doi.org/10.1371/journal.pone.0104337			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093734	gold, Green Published, Green Submitted			2022-12-27	WOS:000341357200098
J	Li, Q; Yan, H; Liu, WT; Zhen, HC; Yang, YF; Cao, BW				Li, Qin; Yan, Han; Liu, Wenting; Zhen, Hongchao; Yang, Yifan; Cao, Bangwei			Efficacy and Safety of Gemcitabine-Fluorouracil Combination Therapy in the Management of Advanced Pancreatic Cancer: A Meta-Analysis of Randomized Controlled Trials	PLOS ONE			English	Article							PHASE-II TRIAL; PLUS CAPECITABINE; ONCOLOGY-GROUP; S-1; MULTICENTER; SURVIVAL; ADENOCARCINOMA; CHEMOTHERAPY; 5-FU	Background: Gemcitabine (GEM) is the standard first-line chemotherapy that provides limited clinical benefits for patients with locally advanced/metastatic pancreatic adenocarcinoma (LA/MPC). However, the fluorouracil derivatives (CAP and S-1) show promising efficacy in these patients. This study compared the efficacy and safety of GEM with GEM plus fluorouracil drugs in the treatment of LA/MPC. Methods: Pubmed, EMBASE and Cochrane Library databases were searched for relevant randomized controlled trials published on or before January 2014. The Cochrane Collaboration's tool was used to assess the risk of bias in randomized trials. The primary end point was overall survival (OS); the secondary end points were one-year survival rate, objective response rate (ORR) and toxicity rates (TRs). Results: A total of 8 randomized controlled trials involving 2,126 patients were included in the systematic evaluation. The results showed that OS was significantly improved (HR 0.83, P<0.01; HR 0.87, P=0.03; HR 0.80, P=0.01; respectively) and ORR was significantly increased (OR 0.51, P<0.01; OR 0.66, P=0.03; OR 0.35, P<0.01; respectively) in the GEM+5-FU/CAP/S-1, GEM+CAP and GEM+S-1 groups compared to the GEM alone group. In addition, the one-year survival rate was significantly increased (OR 0.78 P=0.01; OR 0.47, P=0.04; respectively) in the GEM+5-FU/CAP/S-1 and GEM+S-1 groups compared to the GEM alone group. The frequency of grade 3/4 TRs were higher in GEM+5-FU/CAP/S-1 group, the significant increase of grade 3/4 neutropenia, thrombocytopenia and diarrhea were observed. Conclusions: GEM combined with fluorouracil drugs significantly improved OS and increased one-year survival rate and ORR compared to GEM alone in LA/MPC patients. GEM combined with fluorouracil drugs may be considered as an acceptable alternative treatment for LA/MPC patients.	[Li, Qin; Yan, Han; Liu, Wenting; Zhen, Hongchao; Yang, Yifan; Cao, Bangwei] Capital Med Univ, Beijing Friendship Hosp, Dept Oncol, Beijing, Peoples R China; [Liu, Wenting; Zhen, Hongchao; Yang, Yifan; Cao, Bangwei] Capital Med Univ, Beijing Friendship Hosp, Beijing Key Lab Precancerous Lesion Digest Dis, Beijing, Peoples R China; [Liu, Wenting; Zhen, Hongchao; Yang, Yifan; Cao, Bangwei] Capital Med Univ, Beijing Friendship Hosp, Beijing Digest Dis Ctr, Beijing, Peoples R China	Capital Medical University; Capital Medical University; Capital Medical University	Cao, BW (corresponding author), Capital Med Univ, Beijing Friendship Hosp, Dept Oncol, Beijing, Peoples R China.	oncologychina@163.com			Beijing Municipal Health System High-level Health Person Foundation Project [2011-3-007]; National Nature Science Foundation of China [81272615, 81301912]; Capital Medical University Sciences-clinical Research Cooperation Foundation [12JL33]	Beijing Municipal Health System High-level Health Person Foundation Project; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Capital Medical University Sciences-clinical Research Cooperation Foundation	This work was supported by grants from Beijing Municipal Health System High-level Health Person Foundation Project (No. 2011-3-007 to Bangwei Cao), National Nature Science Foundation of China (No. 81272615; No. 81301912) and Capital Medical University Sciences-clinical Research Cooperation Foundation (No. 12JL33). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berlin JD, 2002, J CLIN ONCOL, V20, P3270, DOI 10.1200/JCO.2002.11.149; Bria E, 2007, CANCER-AM CANCER SOC, V110, P525, DOI 10.1002/cncr.22809; Burris HA, 1997, J CLIN ONCOL, V15, P2403, DOI 10.1200/JCO.1997.15.6.2403; Cartwright TH, 2002, J CLIN ONCOL, V20, P160, DOI 10.1200/JCO.20.1.160; Chau I, 2006, BRIT J CANCER, V94, P1107, DOI 10.1038/sj.bjc.6603058; Choi Jae-Hyuk, 2008, Cancer Res Treat, V40, P22, DOI 10.4143/crt.2008.40.1.22; Choi JG, 2012, CANCER RES TREAT, V44, P127, DOI 10.4143/crt.2012.44.2.127; Ciliberto D, 2013, EUR J CANCER, V49, P593, DOI 10.1016/j.ejca.2012.08.019; Cunningham D, 2009, J CLIN ONCOL, V27, P5513, DOI 10.1200/JCO.2009.24.2446; Di Costanzo F, 2005, BRIT J CANCER, V93, P185, DOI 10.1038/sj.bjc.6602640; Goulart BHL, 2009, J HEMATOL ONCOL, V2, DOI 10.1186/1756-8722-2-13; Gourgou-Bourgade S, 2013, J CLIN ONCOL, V31, P23, DOI 10.1200/JCO.2012.44.4869; Herrmann R, 2007, J CLIN ONCOL, V25, P2212, DOI 10.1200/JCO.2006.09.0886; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Hu J, 2011, J HEMATOL ONCOL, V4, DOI 10.1186/1756-8722-4-11; Hubner RA, 2013, PANCREAS, V42, P511, DOI 10.1097/MPA.0b013e31826c6aee; Ling W, 2011, J CANCER RES CLIN, V137, P927, DOI 10.1007/s00432-010-0954-0; Maisey N, 2002, J CLIN ONCOL, V20, P3130, DOI 10.1200/JCO.2002.09.029; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Moore MJ, 2007, J CLIN ONCOL, V25, P1960, DOI 10.1200/JCO.2006.07.9525; Nakai Y, 2012, BRIT J CANCER, V106, P1934, DOI 10.1038/bjc.2012.183; Nakamura K, 2006, BRIT J CANCER, V94, P1575, DOI 10.1038/sj.bjc.6603168; Ozaka M, 2012, CANCER CHEMOTH PHARM, V69, P1197, DOI 10.1007/s00280-012-1822-1; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Saif MW, 2009, EXPERT OPIN INV DRUG, V18, P335, DOI [10.1517/13543780902729412, 10.1517/13543780902729412 ]; Scheithauer W, 2003, ANN ONCOL, V14, P97, DOI 10.1093/annonc/mdg029; Shirasaka T, 2009, JPN J CLIN ONCOL, V39, P2, DOI 10.1093/jjco/hyn127; Sun C, 2012, WORLD J GASTROENTERO, V18, P4944, DOI 10.3748/wjg.v18.i35.4944; Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16; Ueno H, 2013, J CLIN ONCOL, V31, P1640, DOI 10.1200/JCO.2012.43.3680; Von Hoff DD, 2013, NEW ENGL J MED, V369, P1691, DOI 10.1056/NEJMoa1304369; Xie DR, 2006, WORLD J GASTROENTERO, V12, P6973, DOI 10.3748/wjg.v12.i43.6973; Xie DR, 2010, JPN J CLIN ONCOL, V40, P432, DOI 10.1093/jjco/hyp198	33	37	37	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e104346	10.1371/journal.pone.0104346	http://dx.doi.org/10.1371/journal.pone.0104346			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093849	gold, Green Submitted, Green Published			2022-12-27	WOS:000341357200100
J	Lillie, M; Shine, R; Belov, K				Lillie, Mette; Shine, Richard; Belov, Katherine			Characterisation of Major Histocompatibility Complex Class I in the Australian Cane Toad, Rhinella marina	PLOS ONE			English	Article							MHC CLASS-I; BUFO-MARINUS; EVOLUTION; PARASITES; GENES; LOCUS; ORGANIZATION; POPULATIONS; VERTEBRATES; DIVERSITY	The Major Histocompatibility Complex (MHC) class I is a highly variable gene family that encodes cell-surface receptors vital for recognition of intracellular pathogens and initiation of immune responses. The MHC class I has yet to be characterised in bufonid toads (Order: Anura; Suborder: Neobatrachia; Family: Bufonidae), a large and diverse family of anurans. Here we describe the characterisation of a classical MHC class I gene in the Australian cane toad, Rhinella marina. From 25 individuals sampled from the Australian population, we found only 3 alleles at this classical class I locus. We also found large number of class I alpha 1 alleles, implying an expansion of class I loci in this species. The low classical class I genetic diversity is likely the result of repeated bottleneck events, which arose as a result of the cane toad's complex history of introductions as a biocontrol agent and its subsequent invasion across Australia.	[Lillie, Mette; Belov, Katherine] Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia; [Shine, Richard] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney	Belov, K (corresponding author), Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia.	kathy.belov@sydney.edu.au		Lillie, Mette/0000-0001-8714-0812; Belov, Katherine/0000-0002-9762-5554	University of Sydney; Australian Research Council; ARC	University of Sydney(University of Sydney); Australian Research Council(Australian Research Council); ARC(Australian Research Council)	This work was supported by the University of Sydney and the Australian Research Council. KB is supported by an ARC Future Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bahram S, 2000, Adv Immunol, V76, P1; Barton DP, 1997, AUST J ECOL, V22, P316, DOI 10.1111/j.1442-9993.1997.tb00677.x; BJORKMAN PJ, 1987, NATURE, V329, P512, DOI 10.1038/329512a0; Bonneaud C, 2004, IMMUNOGENETICS, V55, P855, DOI 10.1007/s00251-004-0648-3; Borg AA, 2011, ECOL EVOL, V1, P145, DOI 10.1002/ece3.13; Braud VM, 1999, CURR OPIN IMMUNOL, V11, P100, DOI 10.1016/S0952-7915(99)80018-1; Brown GP, 2007, P NATL ACAD SCI USA, V104, P17698, DOI 10.1073/pnas.0705057104; Dubey S, 2008, MOL ECOL, V17, P4418, DOI 10.1111/j.1365-294X.2008.03922.x; EASTEAL S, 1981, BIOL J LINN SOC, V16, P93, DOI 10.1111/j.1095-8312.1981.tb01645.x; Edwards SV, 1998, TRENDS ECOL EVOL, V13, P305, DOI 10.1016/S0169-5347(98)01416-5; Flajnik MF, 1999, J IMMUNOL, V163, P3826; FLAJNIK MF, 1993, EMBO J, V12, P4385, DOI 10.1002/j.1460-2075.1993.tb06123.x; FLAJNIK MF, 1991, P NATL ACAD SCI USA, V88, P537, DOI 10.1073/pnas.88.2.537; Frost DR, 2006, B AM MUS NAT HIST, P8, DOI 10.1206/0003-0090(2006)297[0001:TATOL]2.0.CO;2; Goyos A, 2011, J IMMUNOL, V186, P372, DOI 10.4049/jimmunol.1001467; Grimholt U, 2002, IMMUNOGENETICS, V54, P570, DOI 10.1007/s00251-002-0499-8; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Keane TM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-29; Kelehear C, 2009, PARASITOLOGY, V136, P919, DOI 10.1017/S0031182009006325; Kiemnec-Tyburczy KM, 2012, HEREDITY, V109, P146, DOI 10.1038/hdy.2012.22; KLEIN J, 1986, NATURAL HIST MAJOR H; Llewellyn D, 2012, BIOL INVASIONS, V14, P999, DOI 10.1007/s10530-011-0135-3; McClelland EK, 2011, FISH SHELLFISH IMMUN, V31, P507, DOI 10.1016/j.fsi.2011.06.012; Nei M, 2005, ANNU REV GENET, V39, P121, DOI 10.1146/annurev.genet.39.073003.112240; Ohta Y, 2006, J IMMUNOL, V176, P3674, DOI 10.4049/jimmunol.176.6.3674; Okamura K, 1997, IMMUNITY, V7, P777, DOI 10.1016/S1074-7613(00)80396-9; Phillips BL, 2010, ECOLOGY, V91, P872, DOI 10.1890/09-0530.1; Piertney SB, 2006, HEREDITY, V96, P7, DOI 10.1038/sj.hdy.6800724; Roelants K, 2007, P NATL ACAD SCI USA, V104, P887, DOI 10.1073/pnas.0608378104; Salter-Cid L, 1998, J IMMUNOL, V160, P2853; Schut E, 2011, IMMUNOGENETICS, V63, P531, DOI 10.1007/s00251-011-0532-x; SHUM BP, 1993, J IMMUNOL, V151, P5376; Slade RW, 1998, P ROY SOC B-BIOL SCI, V265, P769, DOI 10.1098/rspb.1998.0359; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Teacher AGF, 2009, PLOS ONE, V4; Urban MC, 2007, P ROY SOC B-BIOL SCI, V274, P1413, DOI 10.1098/rspb.2007.0114	37	17	17	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e102824	10.1371/journal.pone.0102824	http://dx.doi.org/10.1371/journal.pone.0102824			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093458	gold, Green Submitted, Green Published			2022-12-27	WOS:000341357200014
J	Van Nuil, JI; Mutwa, P; Asiimwe-Kateera, B; Kestelyn, E; Vyankandondera, J; Pool, R; Ruhirimbura, J; Kanakuze, C; Reiss, P; Geelen, SPM; van de Wijgert, JH; Boer, KR				Van Nuil, Jennifer Ilo; Mutwa, Philippe; Asiimwe-Kateera, Brenda; Kestelyn, Evelyne; Vyankandondera, Joseph; Pool, Robert; Ruhirimbura, John; Kanakuze, Chantal; Reiss, Peter; Geelen, Sibyl P. M.; van de Wijgert, Janneke H.; Boer, Kimberly R.			"Let's Talk about Sex": A Qualitative Study of Rwandan Adolescents' Views on Sex and HIV	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; PARENT-CHILD COMMUNICATION; PERINATALLY ACQUIRED HIV; INFECTED-ADOLESCENTS; YOUNG-ADULTS; ANTIRETROVIRAL THERAPY; SEXUALITY EDUCATION; HIV/AIDS; NEEDS; INTENTIONS	Objective: This qualitative study explored the views and experiences of adolescents with perinatally acquired HIV in Kigali, Rwanda, regarding sex, love, marriage, children and hope for the future. Design: The study enrolled 42 adolescents who had received combination antiretroviral therapy for at least 12 months, and a selection of their primary caregivers. Study methods included 3 multiple day workshops consisting of role-playing and focus group discussions (FGDs) with adolescents, 8 in-depth interviews with adolescents, and one FGD with caregivers. Results: The adolescents reported experiencing similar sexual needs and dilemmas as most other adolescents, but with an added layer of complexity due to fears related to HIV transmission and/or rejection by partners. They desired more advice from their parents/caregivers on these topics. Although they struggled with aspects of sex, love, marriage and having children, most agreed that they would find love, be married and have children in the future. The two most discussed HIV-related anxieties were how and when to disclose to a (potential) sex/marriage partner and whether to have children. However, most adolescents felt that they had a right to love and be loved, and were aware of prevention-of-mother-to-child-transmission (PMTCT) options in Rwanda. Adolescents generally spoke about their future role in society in a positive manner. Conclusion: Strengthening the life skills of HIV-positive adolescents, especially around HIV disclosure and reduction of HIV transmission, as well as the support skills of parents/caregivers, may not only reduce onward HIV transmission but also improve quality of life by reducing anxiety.	[Van Nuil, Jennifer Ilo; Kestelyn, Evelyne; Vyankandondera, Joseph; van de Wijgert, Janneke H.] Rinda Ubuzima, Kigali, Rwanda; [Mutwa, Philippe; Asiimwe-Kateera, Brenda; Kestelyn, Evelyne; Reiss, Peter; Geelen, Sibyl P. M.; van de Wijgert, Janneke H.; Boer, Kimberly R.] Univ Amsterdam, Acad Med Ctr, Dept Global Hlth, NL-1105 AZ Amsterdam, Netherlands; [Mutwa, Philippe; Asiimwe-Kateera, Brenda; Kestelyn, Evelyne; Reiss, Peter; Geelen, Sibyl P. M.; van de Wijgert, Janneke H.; Boer, Kimberly R.] Univ Amsterdam, Acad Med Ctr, Amsterdam Inst Global Hlth & Dev, NL-1105 AZ Amsterdam, Netherlands; [Mutwa, Philippe] Kigali Univ, Teaching Hosp, Dept Pediat, Kigali, Rwanda; [Vyankandondera, Joseph] King Faisal Hosp, Dept Obstet & Gynecol, Kigali, Rwanda; [Pool, Robert] Univ Amsterdam, Ctr Social Sci & Global Hlth, Amsterdam, Netherlands; [Ruhirimbura, John; Kanakuze, Chantal] Treatment & Res HIV AIDS Ctr, Kigali, Rwanda; [Geelen, Sibyl P. M.; Boer, Kimberly R.] Univ Utrecht, Childrens Hosp, Univ Med Ctr Utrecht, Utrecht, Netherlands; [Boer, Kimberly R.] Royal Trop Inst, Epidemiol Unit, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Utrecht University; Utrecht University Medical Center	Van Nuil, JI (corresponding author), Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 3BX, Merseyside, England.	Jennifer.Van-Nuil@liverpool.ac.uk	Asiimwe-Kateera, Brenda/H-3378-2019; Kestelyn, Evelyne/AAD-6052-2019	Kestelyn, Evelyne/0000-0002-5728-0918; van de Wijgert, Janneke H.H.M./0000-0003-2728-4560; Asiimwe Kateera, Brenda/0000-0001-6134-1042	The Netherlands-African partnership for Capacity development and Clinical interventions against Poverty-related diseases (NACCAP); European Developing Countries Clinical Trials Partnership (EDCTP)	The Netherlands-African partnership for Capacity development and Clinical interventions against Poverty-related diseases (NACCAP); European Developing Countries Clinical Trials Partnership (EDCTP)	This study was funded by The Netherlands-African partnership for Capacity development and Clinical interventions against Poverty-related diseases (NACCAP) and the European Developing Countries Clinical Trials Partnership (EDCTP). NACCAP: http://www.nwo.nl/en/research-and-results/programmes/NACCAP. EDCTP: http://www.edctp.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atienzo EE, 2009, EUR J CONTRACEP REPR, V14, P111, DOI 10.1080/13625180802691848; Bakeera-Kitaka S, 2008, AIDS CARE, V20, P426, DOI 10.1080/09540120701867099; Baryamutuma R, 2011, AFR HEALTH SCI, V11, P211; Bastien S, 2011, REPROD HEALTH, V8, DOI 10.1186/1742-4755-8-25; Battles HB, 2002, J ADOLESCENT HEALTH, V30, P161, DOI 10.1016/S1054-139X(01)00341-X; Binagwaho A, 2012, AIDS CARE, V24, P936, DOI 10.1080/09540121.2011.648159; Birungi H, 2009, J ADOLESCENT HEALTH, V44, P184, DOI 10.1016/j.jadohealth.2008.06.004; Birungi H, 2009, AIDS CARE, V21, P725, DOI 10.1080/09540120802511901; Byakika-Tusiime J, 2009, AIDS BEHAV, V13, pS82, DOI 10.1007/s10461-009-9546-x; Domek GJ, 2006, LANCET, V367, P1367, DOI 10.1016/S0140-6736(06)68584-X; Edmonds A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001044; Evans D, 2013, AIDS RES HUM RETROV, V29, P892, DOI [10.1089/aid.2012.0215, 10.1089/AID.2012.0215]; Ezeanolue EE, 2006, J ADOLESCENT HEALTH, V38, P719, DOI 10.1016/j.jadohealth.2005.06.015; Fair C, 2012, AIDS PATIENT CARE ST, V26, P746, DOI 10.1089/apc.2012.0290; Fernet M, 2011, AIDS CARE, V23, P393, DOI 10.1080/09540121.2010.516332; Greenhalgh C, 2013, AIDS CARE, V25, P447, DOI 10.1080/09540121.2012.712671; Izugbara CO, 2008, YOUTH SOC, V39, P575, DOI 10.1177/0044118X07302061; Janssen N, 2010, ARCH DIS CHILD, V95, P414, DOI 10.1136/adc.2009.169367; Ketting E, 2013, BUNDESGESUNDHEITSBLA, V56, P250, DOI 10.1007/s00103-012-1599-8; Kisaakye VNK, 2009, INT AIDS SOC C; Krueger R., 2008, FOCUS GROUPS PRACTIC; Mavhu W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070254; Mburu G, 2013, REPROD HEALTH MATTER, V21, P176, DOI 10.1016/S0968-8080(13)41701-9; Mergui A, 2011, ARCH PEDIATRIE, V18, P797, DOI 10.1016/j.arcped.2011.04.015; Mukasa Mbooga B, 2012, INT AIDS SOC C; Mutwa PR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060073; Nambambi Ndishishi M, 2011, Afr J Reprod Health, V15, P120; Namisi FS, 2009, SCAND J PUBLIC HEALT, V37, P65, DOI 10.1177/1403494808086986; Nugent Nicole R, 2010, J Int Assoc Physicians AIDS Care (Chic), V9, P113, DOI 10.1177/1545109709357472; Obare F, 2010, POP STUD-J DEMOG, V64, P97, DOI 10.1080/00324720903427575; Poulsen MN, 2010, AIDS BEHAV, V14, P1083, DOI 10.1007/s10461-009-9612-4; Reddi Anand, 2007, BMC Pediatr, V7, P13, DOI 10.1186/1471-2431-7-13; Socar P, 2008, THESIS STANFORD U; Tukei VJ, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-42; Wiener LS, 2006, J ADOLESCENT HEALTH, V38, P307, DOI 10.1016/j.jadohealth.2005.03.024; World Health Organization, 2013, CONS ARV GUID	36	8	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e102933	10.1371/journal.pone.0102933	http://dx.doi.org/10.1371/journal.pone.0102933			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO5BW	25093572	Green Published, gold, Green Submitted			2022-12-27	WOS:000341357200015
J	Leet, JK; Lindberg, CD; Bassett, LA; Isales, GM; Yozzo, KL; Raftery, TD; Volz, DC				Leet, Jessica K.; Lindberg, Casey D.; Bassett, Luke A.; Isales, Gregory M.; Yozzo, Krystle L.; Raftery, Tara D.; Volz, David C.			High-Content Screening in Zebrafish Embryos Identifies Butafenacil as a Potent Inducer of Anemia	PLOS ONE			English	Article							RISK-ASSESSMENT; ASSAY; HAZARD; MODEL	Using transgenic zebrafish (fli1:egfp) that stably express enhanced green fluorescent protein (eGFP) within vascular endothelial cells, we recently developed and optimized a 384-well high-content screening (HCS) assay that enables us to screen and identify chemicals affecting cardiovascular development and function at non-teratogenic concentrations. Within this assay, automated image acquisition procedures and custom image analysis protocols are used to quantify body length, heart rate, circulation, pericardial area, and intersegmental vessel area within individual live embryos exposed from 5 to 72 hours post-fertilization. After ranking developmental toxicity data generated from the U.S. Environmental Protection Agency's (EPA's) zebrafish teratogenesis assay, we screened 26 of the most acutely toxic chemicals within EPA's ToxCast Phase-I library in concentration-response format (0.05-50 mu M) using this HCS assay. Based on this screen, we identified butafenacil as a potent inducer of anemia, as exposure from 0.39 to 3.125 mu M butafenacil completely abolished arterial circulation in the absence of effects on all other endpoints evaluated. Butafenacil is an herbicide that inhibits protoporphyrinogen oxidase (PPO)-an enzyme necessary for heme production in vertebrates. Using o-dianisidine staining, we then revealed that severe butafenacil-induced anemia in zebrafish was due to a complete loss of hemoglobin following exposure during early development. Therefore, six additional PPO inhibitors within the ToxCast Phase-I library were screened to determine whether anemia represents a common adverse outcome for these herbicides. Embryonic exposure to only one of these PPO inhibitors - flumioxazin - resulted in a similar phenotype as butafenacil, albeit not as severe as butafenacil. Overall, this study highlights the potential utility of this assay for (1) screening chemicals for cardiovascular toxicity and (2) prioritizing chemicals for future hypothesis-driven and mechanism-focused investigations within zebrafish and mammalian models.	[Leet, Jessica K.; Lindberg, Casey D.; Bassett, Luke A.; Isales, Gregory M.; Yozzo, Krystle L.; Raftery, Tara D.; Volz, David C.] Univ S Carolina, Dept Environm Hlth Sci, Arnold Sch Publ Hlth, Columbia, SC 29208 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Volz, DC (corresponding author), Univ S Carolina, Dept Environm Hlth Sci, Arnold Sch Publ Hlth, Columbia, SC 29208 USA.	volz@mailbox.sc.edu	Catron, Tara/J-2009-2019	Catron, Tara/0000-0003-1193-9366	U.S. Environmental Protection Agency (EPA) Science to Achieve Results (STAR) Grant [R835169]	U.S. Environmental Protection Agency (EPA) Science to Achieve Results (STAR) Grant	Funding was provided by a U.S. Environmental Protection Agency (EPA) Science to Achieve Results (STAR) Grant No. R835169 to DCV. The contents of this manuscript are solely the responsibility of DCV and do not necessarily represent the official views of the U.S. EPA. Further, the U.S. EPA does not endorse the purchase of any commercial products or services mentioned in the publication. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belanger SE, 2010, AQUAT TOXICOL, V97, P88, DOI 10.1016/j.aquatox.2009.11.020; Collins FS, 2008, SCIENCE, V319, P906, DOI 10.1126/science.1154619; Dix DJ, 2007, TOXICOL SCI, V95, P5, DOI 10.1093/toxsci/kfl103; Dooley KA, 2008, EXP HEMATOL, V36, P1132, DOI 10.1016/j.exphem.2008.04.008; Embry MR, 2010, AQUAT TOXICOL, V97, P79, DOI 10.1016/j.aquatox.2009.12.008; Halder Marlies, 2010, Integrated Environmental Assessment and Management, V6, P484, DOI 10.1002/ieam.48; Hanaoka R, 2007, DNA SEQUENCE, V18, P54, DOI 10.1080/10425170601060848; Jacob E, 2002, AM J PHYSIOL-REG I, V283, pR911, DOI 10.1152/ajpregu.00673.2001; Kawamura S, 1996, TOXICOL APPL PHARM, V141, P520, DOI 10.1006/taap.1996.0317; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Letamendia A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036690; Truong L, 2014, TOXICOL SCI, V137, P212, DOI 10.1093/toxsci/kft235; National Research Council, 2007, TOXICITY TESTING 21; NIH, 2007, GUID US ZEBR NIH INT; NRA, 2002, EV NEW ACT BUT PROD; Padilla S, 2012, REPROD TOXICOL, V33, P174, DOI 10.1016/j.reprotox.2011.10.018; Paffett-Lugassy NN, 2004, METH MOLEC MED, V105, P171; Pelster B, 1996, CIRC RES, V79, P358, DOI 10.1161/01.RES.79.2.358; Programs OoP, 2003, BUT PEST TOL, P54818; Ransom DG, 1996, DEVELOPMENT, V123, P311; Scholz S, 2008, ENVIRON SCI POLLUT R, V15, P394, DOI 10.1007/s11356-008-0018-z; Tran TC, 2007, CANCER RES, V67, P11386, DOI 10.1158/0008-5472.CAN-07-3126; Van den Bulck K, 2011, REPROD TOXICOL, V32, P213, DOI 10.1016/j.reprotox.2011.06.119; Vogt A, 2009, DEV DYNAM, V238, P656, DOI 10.1002/dvdy.21892; Weinstein BM, 1996, DEVELOPMENT, V123, P303; Yozzo KL, 2013, ENVIRON SCI TECHNOL, V47, P11302, DOI 10.1021/es403360y	27	35	36	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e104190	10.1371/journal.pone.0104190	http://dx.doi.org/10.1371/journal.pone.0104190			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25090246	Green Submitted, Green Published, gold			2022-12-27	WOS:000339812700106
J	Noseda, R; Kainz, V; Borsook, D; Burstein, R				Noseda, Rodrigo; Kainz, Vanessa; Borsook, David; Burstein, Rami			Neurochemical Pathways That Converge on Thalamic Trigeminovascular Neurons: Potential Substrate for Modulation of Migraine by Sleep, Food Intake, Stress and Anxiety	PLOS ONE			English	Article							MELANIN-CONCENTRATING HORMONE; LATERAL GENICULATE-NUCLEUS; LOCUS-COERULEUS STIMULATION; OREXIN NEURONS; VENTROPOSTEROMEDIAL NUCLEUS; NORADRENERGIC MODULATION; SYNAPTIC ORGANIZATION; DOPAMINE INNERVATION; VENTROBASAL THALAMUS; CEREBRAL-CORTEX	Dynamic thalamic regulation of sensory signals allows the cortex to adjust better to rapidly changing behavioral, physiological and environmental demands. To fulfill this role, thalamic neurons must themselves be subjected to constantly changing modulatory inputs that originate in multiple neurochemical pathways involved in autonomic, affective and cognitive functions. Our overall goal is to define an anatomical framework for conceptualizing how a 'decision' is made on whether a trigeminovascular thalamic neuron fires, for how long, and at what frequency. To begin answering this question, we determine which neuropeptides/neurotransmitters are in a position to modulate thalamic trigeminovascular neurons. Using a combination of in-vivo single-unit recording, juxtacellular labeling with tetramethylrhodamine dextran (TMR) and in-vitro immunohistochemistry, we found that thalamic trigeminovascular neurons were surrounded by high density of axons containing biomarkers of glutamate, GABA, dopamine and serotonin; moderate density of axons containing noradrenaline and histamine; low density of axons containing orexin and melanin concentrating hormone (MCH); but not axons containing CGRP, serotonin 1D receptor, oxytocin or vasopressin. In the context of migraine, the findings suggest that the transmission of headache-related nociceptive signals from the thalamus to the cortex may be modulated by opposing forces (i.e., facilitatory, inhibitory) that are governed by continuous adjustments needed to keep physiological, behavioral, cognitive and emotional homeostasis.	[Noseda, Rodrigo; Kainz, Vanessa; Burstein, Rami] Harvard Univ, Beth Israel Deaconess Med Ctr, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02215 USA; [Borsook, David] Harvard Univ, Boston Childrens Hosp, Dept Anesthesiol Perioperat & Pain Med, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Boston Children's Hospital	Noseda, R (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02215 USA.	rnoseda@bidmc.harvard.edu	Noseda, Rodrigo/AAN-1761-2020	Noseda, Rodrigo/0000-0002-9641-4691	National Institutes of Health [NS-069847, NS-079687]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS069847, R37NS079678] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by National Institutes of Health Grants NS-069847 and NS-079687 (R.B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamantidis A, 2009, PEPTIDES, V30, P2066, DOI 10.1016/j.peptides.2009.06.024; AEBELHOLTKRABBE A, 1980, PAIN, V8, P253, DOI 10.1016/0304-3959(88)90012-7; Astrand A, 2004, AM J PHYSIOL-REG I, V287, pR749, DOI 10.1152/ajpregu.00134.2004; Barroso-Chinea P, 2008, J CHEM NEUROANAT, V35, P101, DOI 10.1016/j.jchemneu.2007.08.001; Bergerot A, 2007, ANN NEUROL, V61, P251, DOI 10.1002/ana.21077; Berridge CW, 2012, SLEEP MED REV, V16, P187, DOI 10.1016/j.smrv.2011.12.003; Berridge CW, 2003, BRAIN RES REV, V42, P33, DOI 10.1016/S0165-0173(03)00143-7; Bittencourt JC, 1998, BRAIN RES, V804, P140, DOI 10.1016/S0006-8993(98)00662-3; Broberger C, 1998, J COMP NEUROL, V402, P460; Brown RE, 2001, PROG NEUROBIOL, V63, P637, DOI 10.1016/S0301-0082(00)00039-3; Burdakov D, 2005, J NEUROSCI, V25, P2429, DOI 10.1523/JNEUROSCI.4925-04.2005; CONSOLAZIONE A, 1984, BRAIN RES, V322, P233, DOI 10.1016/0006-8993(84)90113-6; Date Y, 1999, P NATL ACAD SCI USA, V96, P748, DOI 10.1073/pnas.96.2.748; DELIMA AD, 1987, J COMP NEUROL, V259, P92, DOI 10.1002/cne.902590107; DESCHENES M, 1990, BRAIN RES, V513, P339, DOI 10.1016/0006-8993(90)90478-T; Devilbiss DM, 2004, J NEUROSCI, V24, P10773, DOI 10.1523/JNEUROSCI.1573-04.2004; Di Chiara G, 2002, BEHAV BRAIN RES, V137, P75, DOI 10.1016/S0166-4328(02)00286-3; Di Chiara G, 2007, CURR OPIN PHARMACOL, V7, P69, DOI 10.1016/j.coph.2006.11.003; EATON SA, 1989, NEUROSCIENCE, V33, P285, DOI 10.1016/0306-4522(89)90208-X; Ego-Stengel V, 2002, NEUROSCIENCE, V111, P275, DOI 10.1016/S0306-4522(02)00011-8; Elias CF, 1998, J COMP NEUROL, V402, P442, DOI 10.1002/(SICI)1096-9861(19981228)402:4<442::AID-CNE2>3.0.CO;2-R; Elias CF, 2001, J COMP NEUROL, V432, P1, DOI 10.1002/cne.1085; Fremeau RT, 2001, NEURON, V31, P247, DOI 10.1016/S0896-6273(01)00344-0; Fremeau RT, 2004, SCIENCE, V304, P1815, DOI 10.1126/science.1097468; Garcia-Cabezas MA, 2007, NEUROIMAGE, V34, P965, DOI 10.1016/j.neuroimage.2006.07.032; Garcia-Cabezas MA, 2009, CEREB CORTEX, V19, P424, DOI 10.1093/cercor/bhn093; Ge SN, 2010, J COMP NEUROL, V518, P3149, DOI 10.1002/cne.22389; Girault EM, 2012, PROG BRAIN RES, V198, P47, DOI 10.1016/B978-0-444-59489-1.00005-7; Gonzalez MI, 1996, PEPTIDES, V17, P171, DOI 10.1016/0196-9781(95)02092-6; Govindaiah G, 2006, NEUROPHARMACOLOGY, V51, P414, DOI 10.1016/j.neuropharm.2006.03.030; Govindaiah G, 2010, NEUROSCIENCE, V170, P981, DOI 10.1016/j.neuroscience.2010.08.043; Graziano A, 2008, J COMP NEUROL, V507, P1258, DOI 10.1002/cne.21592; Green AR, 2006, BRIT J PHARMACOL, V147, pS145; GROENEWEGEN HJ, 1988, NEUROSCIENCE, V24, P379, DOI 10.1016/0306-4522(88)90339-9; Guillery RW, 2002, NEURON, V33, P163, DOI 10.1016/S0896-6273(01)00582-7; Hassani OK, 2009, P NATL ACAD SCI USA, V106, P2418, DOI 10.1073/pnas.0811400106; HEGERL U, 1993, BIOL PSYCHIAT, V33, P173, DOI 10.1016/0006-3223(93)90137-3; Hervieu GJ, 2000, EUR J NEUROSCI, V12, P1194, DOI 10.1046/j.1460-9568.2000.00008.x; Herzog E, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-22-j0001.2001; Ho TW, 2010, NAT REV NEUROL, V6, P573, DOI 10.1038/nrneurol.2010.127; Homberg JR, 2012, NEUROSCI BIOBEHAV R, V36, P218, DOI 10.1016/j.neubiorev.2011.06.001; Iversen SD, 2007, TRENDS NEUROSCI, V30, P188, DOI 10.1016/j.tins.2007.03.002; Kagan R, 2013, NEUROSCIENCE, V248, P359, DOI 10.1016/j.neuroscience.2013.06.014; KANEKO T, 1988, J COMP NEUROL, V267, P590, DOI 10.1002/cne.902670411; KAYAMA Y, 1982, NEUROSCIENCE, V7, P655, DOI 10.1016/0306-4522(82)90071-9; KAYAMA Y, 1985, VISION RES, V25, P339, DOI 10.1016/0042-6989(85)90058-6; Kelz MB, 2008, P NATL ACAD SCI USA, V105, P1309, DOI 10.1073/pnas.0707146105; Koob GF, 2010, NEUROPSYCHOPHARMACOL, V35, P217, DOI 10.1038/npp.2009.110; Leinninger GM, 2011, PHYSIOL BEHAV, V104, P572, DOI 10.1016/j.physbeh.2011.04.060; Levy D, 2004, P NATL ACAD SCI USA, V101, P4274, DOI 10.1073/pnas.0306147101; LIN JS, 1988, NEUROPHARMACOLOGY, V27, P111, DOI 10.1016/0028-3908(88)90159-1; LINDVALL O, 1974, J COMP NEUROL, V154, P317, DOI 10.1002/cne.901540307; Lopez JF, 1999, BIOL PSYCHIAT, V46, P1461, DOI 10.1016/S0006-3223(99)00266-8; Luthi A, 1998, NEURON, V21, P9, DOI 10.1016/S0896-6273(00)80509-7; Luthi A, 1998, NEURON, V20, P553, DOI 10.1016/S0896-6273(00)80994-0; Marsh DJ, 2002, P NATL ACAD SCI USA, V99, P3240, DOI 10.1073/pnas.052706899; MCCARLEY RW, 1983, J NEUROPHYSIOL, V50, P798, DOI 10.1152/jn.1983.50.4.798; McCormick DA, 1997, ANNU REV NEUROSCI, V20, P185, DOI 10.1146/annurev.neuro.20.1.185; MCCORMICK DA, 1992, PROG NEUROBIOL, V39, P337, DOI 10.1016/0301-0082(92)90012-4; MCCORMICK DA, 1991, J NEUROSCI, V11, P3188; MCCORMICK DA, 1992, P NATL ACAD SCI USA, V89, P2774, DOI 10.1073/pnas.89.7.2774; MELTZER H, 1989, BRIT J PSYCHIAT, V155, P25, DOI 10.1192/S0007125000291733; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; MONTI JM, 1993, LIFE SCI, V53, P1331, DOI 10.1016/0024-3205(93)90592-Q; MOORE RY, 1978, J COMP NEUROL, V180, P417, DOI 10.1002/cne.901800302; MORRISON JH, 1986, J COMP NEUROL, V243, P117, DOI 10.1002/cne.902430110; Nambu T, 1999, BRAIN RES, V827, P243, DOI 10.1016/S0006-8993(99)01336-0; Nathan DE, 2012, IEEE ENG MED BIO, P5445, DOI 10.1109/EMBC.2012.6347226; Nielsen K, 2006, SYNAPSE, V59, P270, DOI 10.1002/syn.20240; Noseda R, 2011, J NEUROSCI, V31, P14204, DOI 10.1523/JNEUROSCI.3285-11.2011; NOTHIAS F, 1988, NEUROSCI LETT, V95, P59, DOI 10.1016/0304-3940(88)90632-5; PANULA P, 1989, NEUROSCIENCE, V28, P585, DOI 10.1016/0306-4522(89)90007-9; PAPADOPOULOS GC, 1990, J COMP NEUROL, V294, P345, DOI 10.1002/cne.902940304; PAPADOPOULOS GC, 1990, J COMP NEUROL, V294, P356, DOI 10.1002/cne.902940305; PAPE HC, 1989, NATURE, V340, P715, DOI 10.1038/340715a0; Paxinos G, 2008, RAT BRAIN STEREOTAXI; Peyron C, 1998, J NEUROSCI, V18, P9996; Pinault D, 1996, J NEUROSCI METH, V65, P113, DOI 10.1016/0165-0270(95)00144-1; Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734; ROGAWSKI MA, 1980, NATURE, V287, P731, DOI 10.1038/287731a0; ROGAWSKI MA, 1980, EXP NEUROL, V69, P678, DOI 10.1016/0014-4886(80)90060-6; Rondou P, 2010, CELL MOL LIFE SCI, V67, P1971, DOI 10.1007/s00018-010-0293-y; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Sakurai T, 2007, NAT REV NEUROSCI, V8, P171, DOI 10.1038/nrn2092; SALT TE, 1989, EXP BRAIN RES, V77, P646; Sanchez-Gonzalez MA, 2005, J NEUROSCI, V25, P6076, DOI 10.1523/JNEUROSCI.0968-05.2005; SCHWARTZ JC, 1991, PHYSIOL REV, V71, P1, DOI 10.1152/physrev.1991.71.1.1; Segal-Lieberman G, 2003, P NATL ACAD SCI USA, V100, P10085, DOI 10.1073/pnas.1633636100; Sherman SM, 1996, J NEUROPHYSIOL, V76, P1367, DOI 10.1152/jn.1996.76.3.1367; Sherman SM, 2005, PROG BRAIN RES, V149, P107, DOI 10.1016/S0079-6123(05)49009-3; Sherman SM, 1998, P NATL ACAD SCI USA, V95, P7121, DOI 10.1073/pnas.95.12.7121; Shields KG, 2006, NEUROBIOL DIS, V23, P491, DOI 10.1016/j.nbd.2006.04.003; Shields KG, 2005, BRAIN, V128, P86, DOI 10.1093/brain/awh298; SICUTERI F, 1972, HEADACHE, V12, P69, DOI 10.1111/j.1526-4610.1972.hed1202069.x; SICUTERI F, 1977, HEADACHE, V17, P129, DOI 10.1111/j.1526-4610.1977.hed1703129.x; SKAGERBERG G, 1985, BRAIN RES, V342, P340, DOI 10.1016/0006-8993(85)91134-5; STERIADE M, 1984, BRAIN RES REV, V8, P1, DOI 10.1016/0165-0173(84)90017-1; STERIADE M, 1986, J NEUROSCI, V6, P68; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Summ O, 2010, BRAIN, V133, P2540, DOI 10.1093/brain/awq224; TAKADA M, 1988, BRAIN RES, V455, P346, DOI 10.1016/0006-8993(88)90093-5; Takahashi H, 2006, BIOL PSYCHIAT, V59, P919, DOI 10.1016/j.biopsych.2006.01.022; Tomasi D, 2011, CEREB CORTEX, V21, P2003, DOI 10.1093/cercor/bhq268; Varoqui H, 2002, J NEUROSCI, V22, P142, DOI 10.1523/JNEUROSCI.22-01-00142.2002; Wang ZQ, 2012, EUR J RADIOL, V81, P277, DOI 10.1016/j.ejrad.2010.12.044; WELCH KMA, 1993, NEW ENGL J MED, V329, P1476; WESTLUND KN, 1990, J COMP NEUROL, V295, P197, DOI 10.1002/cne.902950204; Yamanaka A, 2003, NEURON, V38, P701, DOI 10.1016/S0896-6273(03)00331-3; Yeo GSH, 2012, NAT NEUROSCI, V15, P1343, DOI 10.1038/nn.3211	109	51	53	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103929	10.1371/journal.pone.0103929	http://dx.doi.org/10.1371/journal.pone.0103929			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25090640	Green Submitted, Green Published, gold			2022-12-27	WOS:000339812700065
J	Zhang, ZQ; He, LP; Xie, XY; Ling, WH; Deng, J; Su, YX; Chen, YM				Zhang, Zhe-qing; He, Li-ping; Xie, Xiao-yan; Ling, Wen-hua; Deng, Juan; Su, Yi-xiang; Chen, Yu-ming			Association of Simple Anthropometric Indices and Body Fat with Early Atherosclerosis and Lipid Profiles in Chinese Adults	PLOS ONE			English	Article							INTIMA-MEDIA THICKNESS; CARDIOVASCULAR RISK-FACTORS; CORONARY-HEART-DISEASE; TO-HEIGHT RATIO; WAIST CIRCUMFERENCE; CAROTID-ARTERY; CARDIOMETABOLIC RISK; METABOLIC SYNDROME; ABDOMINAL OBESITY; MYOCARDIAL-INFARCTION	Objective: The discriminatory capability of different adiposity indices for atherosclerosis and lipid abnormalities remains uncertain. This study aimed to identify the best adiposity index for predicting early atherosclerosis and abnormal lipid profiles among anthropometric parameters and body fat measures in middle-aged and elderly Chinese. Method: A total of 2,063 women and 814 men (57.6 +/- 5.2 y) were recruited for this community-based cross-sectional study. Body mass index (BMI), waist circumference (WC), hip circumference (HC), waist-to-hip ratio (WHR) and waist-to-height ratio (WHtR) were assessed. Body fat mass and its percentage values for the whole body and trunk were measured by bioelectrical impedance analysis (BIA). The intima-media thicknesses (IMTs) of the common carotid arteries (CCA), internal carotid arteries (ICA) and bifurcation (BIF) were determined via B-mode ultrasound. The fasting lipid profiles were assessed. Results: With per SD increase of adiposity indices, the magnitude of the changes of IMT values and lipid profiles was more substantial for WC, WHR and WHtR in both genders. A multivariate logistic regression analysis indicated that WC, WHR and WHtR were more sensitive in predicting the presence of intima-media thickening at the three segments as well as the lipids disturbances in women and men. In general, BIA-derived measures have no added predictive value for IMT-thickening as opposed to those three traditional abdominal measures. Conclusion: Our findings suggest that abdominal anthropometric measures including WC, WHR and WHtR are sensitive for discriminating carotid atherosclerosis and lipids abnormalities. WC is the best index because of its simplicity in routine use.	[Zhang, Zhe-qing; He, Li-ping; Ling, Wen-hua; Deng, Juan; Su, Yi-xiang; Chen, Yu-ming] Sun Yat Sen Univ, Sch Publ Hlth, Guangdong Prov Key Lab Food, Guangzhou 510275, Guangdong, Peoples R China; [Xie, Xiao-yan] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Med Ultrasound, Guangzhou 510275, Guangdong, Peoples R China; [He, Li-ping] Guangzhou Panyu Cent Hosp, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Su, YX (corresponding author), Sun Yat Sen Univ, Sch Publ Hlth, Guangdong Prov Key Lab Food, Guangzhou 510275, Guangdong, Peoples R China.	suyx@mail.sysu.edu.cn; chenyum@mail.sysu.edu.cn	Chen, Yu/Y-3292-2019; Chen, Yi/HIR-2608-2022		5010 Program for Clinical Researches by Sun Yat-sen University, Guangzhou, China [2007032]; State Key Program of National Natural Science of China [81130052]	5010 Program for Clinical Researches by Sun Yat-sen University, Guangzhou, China; State Key Program of National Natural Science of China(National Natural Science Foundation of China (NSFC))	This study was jointly supported by the 5010 Program for Clinical Researches by Sun Yat-sen University, Guangzhou, China (No. 2007032), and the State Key Program of National Natural Science of China (No. 81130052). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashwell M, 2012, OBES REV, V13, P275, DOI 10.1111/j.1467-789X.2011.00952.x; Balkau B, 2007, CIRCULATION, V116, P1942, DOI 10.1161/CIRCULATIONAHA.106.676379; Beni MH, 2012, ASIA PAC J CLIN NUTR, V21, P220; Browning LM, 2010, OBESITY, V18, P2385, DOI 10.1038/oby.2010.71; Canoy D, 2007, CIRCULATION, V116, P2933, DOI 10.1161/CIRCULATIONAHA.106.673756; Chen MM, 2001, OBES RES, V9, P651, DOI 10.1038/oby.2001.87; Cornier MA, 2011, CIRCULATION, V124, P1996, DOI 10.1161/CIR.0b013e318233bc6a; Czernichow S, 2005, INT J OBESITY, V29, P826, DOI 10.1038/sj.ijo.0802986; de Koning L, 2007, EUR HEART J, V28, P850, DOI 10.1093/eurheartj/ehm026; De Michele M, 2002, STROKE, V33, P2923, DOI 10.1161/01.STR.0000038989.90931.BE; Despres JP, 2008, ANN MED, V40, P514, DOI 10.1080/07853890802004959; Despres JP, 2008, ARTERIOSCL THROM VAS, V28, P1039, DOI 10.1161/ATVBAHA.107.159228; Ebrahim S, 1999, STROKE, V30, P841, DOI 10.1161/01.STR.30.4.841; Gonzalez AS, 2007, NUTRITION, V23, P36, DOI 10.1016/j.nut.2006.08.019; Ho JS, 2009, AM J CARDIOL, V104, P943, DOI 10.1016/j.amjcard.2009.05.047; Ho SY, 2003, ANN EPIDEMIOL, V13, P683, DOI 10.1016/S1047-2797(03)00067-X; HOWARD G, 1993, STROKE, V24, P1297, DOI 10.1161/01.STR.24.9.1297; Hsieh SD, 2003, INT J OBESITY, V27, P610, DOI 10.1038/sj.ijo.0802259; Kawamoto R, 2008, INTERNAL MED, V47, P143, DOI 10.2169/internalmedicine.47.0478; Kay SJ, 2006, OBES REV, V7, P183, DOI 10.1111/j.1467-789X.2006.00250.x; Kotler Donald P., 1996, American Journal of Clinical Nutrition, V64, p489S, DOI 10.1093/ajcn/64.3.489S; Lee K, 2008, OBESITY, V16, P834, DOI 10.1038/oby.2007.109; Lorenz MW, 2007, CIRCULATION, V115, P459, DOI 10.1161/CIRCULATIONAHA.106.628875; Maher V, 2009, INT J OBESITY, V33, P136, DOI 10.1038/ijo.2008.254; O'Leary DH, 1999, NEW ENGL J MED, V340, P14, DOI 10.1056/NEJM199901073400103; POULIOT MC, 1994, AM J CARDIOL, V73, P460, DOI 10.1016/0002-9149(94)90676-9; Salonen JT, 1997, CIRCULATION, V95, P840; Simon A, 2002, J HYPERTENS, V20, P159, DOI 10.1097/00004872-200202000-00001; Takami R, 2001, DIABETES CARE, V24, P1248, DOI 10.2337/diacare.24.7.1248; Taylor AE, 2010, AM J CLIN NUTR, V91, P547, DOI 10.3945/ajcn.2009.28757; Urbina EM, 2002, AM J CARDIOL, V90, P953, DOI 10.1016/S0002-9149(02)02660-7; Wang P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032736; Wannamethee SG, 2005, AM J CLIN NUTR, V81, P1313; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Xu L, 2011, J CLIN DENSITOM, V14, P458, DOI 10.1016/j.jocd.2011.04.001; Yan RT, 2009, ATHEROSCLEROSIS, V207, P232, DOI 10.1016/j.atherosclerosis.2009.03.053; Yang Y., 2002, CHINA FOOD COMPOSITI, V2002nd ed.; Yu RHY, 2008, MENOPAUSE, V15, P185, DOI 10.1097/gme.0b013e31806458c9; Yusuf S, 2005, LANCET, V366, P1640, DOI 10.1016/S0140-6736(05)67663-5; Zhang CX, 2009, ASIA PAC J CLIN NUTR, V18, P240; Zhang C, 2008, CIRCULATION, V117, P1658, DOI 10.1161/CIRCULATIONAHA.107.739714; Zhang Z.G., 2013, PLOS ONE, P8; 2001, JAMA, V285, P2486	43	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e104361	10.1371/journal.pone.0104361	http://dx.doi.org/10.1371/journal.pone.0104361			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25090639	Green Submitted, gold, Green Published			2022-12-27	WOS:000339812700119
J	Pedersen, MG; Salunkhe, VA; Svedin, E; Edlund, A; Eliasson, L				Pedersen, Morten Gram; Salunkhe, Vishal Ashok; Svedin, Emma; Edlund, Anna; Eliasson, Lena			Calcium Current Inactivation Rather than Pool Depletion Explains Reduced Exocytotic Rate with Prolonged Stimulation in Insulin-Secreting INS-1 832/13 Cells	PLOS ONE			English	Article							PANCREATIC BETA-CELLS; ADRENAL CHROMAFFIN CELLS; B-CELLS; CA2+ CHANNELS; NEUROENDOCRINE CELLS; GRANULE EXOCYTOSIS; RAPID EXOCYTOSIS; COMMON VARIANT; MOUSE ISLETS; ALPHA-CELL	Impairment in beta-cell exocytosis is associated with reduced insulin secretion and diabetes. Here we aimed to investigate the dynamics of Ca2+-dependent insulin exocytosis with respect to pool depletion and Ca2+-current inactivation. We studied exocytosis, measured as increase in membrane capacitance (Delta C-m), as a function of calcium entry (Q) in insulin secreting INS-1 832/13 cells using patch clamp and mixed-effects statistical analysis. The observed linear relationship between Delta C-m and Q suggests that Ca2+-channel inactivation rather than granule pool restrictions is responsible for the decline in exocytosis observed at longer depolarizations. INS-1 832/13 cells possess an immediately releasable pool (IRP) of similar to 10 granules and most exocytosis of granules occurs from a large pool. The latter is attenuated by the calcium-buffer EGTA, while IRP is unaffected. These findings suggest that most insulin release occurs away from Ca2+-channels, and that pool depletion plays a minor role in the decline of exocytosis upon prolonged stimulation.	[Pedersen, Morten Gram; Salunkhe, Vishal Ashok; Edlund, Anna; Eliasson, Lena] Lund Univ, Dept Clin Sci Malmo, Ctr Diabet, Malmo, Sweden; [Svedin, Emma] Huddinge Univ Hosp, Karolinska Inst, Dept Med, Ctr Infect Med, Stockholm, Sweden	Lund University; Karolinska Institutet	Pedersen, MG (corresponding author), Univ Padua, Dept Informat Engn, Padua, Italy.	pedersen@dei.unipd.it	Eliasson, Lena/E-9294-2012; Pedersen, Morten/F-4134-2012; Pedersen, Morten Gram/P-5247-2019	Eliasson, Lena/0000-0002-6467-5029; Pedersen, Morten/0000-0002-2639-2394; Pedersen, Morten Gram/0000-0002-2639-2394	EU; Swedish Research Council; Albert Pahlsson foundation; The Swedish diabetes foundation	EU(European Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission); Albert Pahlsson foundation; The Swedish diabetes foundation	MGP held a Marie Curie Intra-European Fellowship from the EU. LE is a senior researcher at the Swedish Research Council. This work was supported by the Swedish Research Council, Albert Pahlsson foundation and The Swedish diabetes foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMMALA C, 1993, J PHYSIOL-LONDON, V472, P665, DOI 10.1113/jphysiol.1993.sp019966; Andersson SA, 2012, MOL CELL ENDOCRINOL, V364, P36, DOI 10.1016/j.mce.2012.08.009; Andersson SA, 2011, PFLUG ARCH EUR J PHY, V462, P443, DOI 10.1007/s00424-011-0979-5; Barg S, 2002, DIABETES, V51, pS74, DOI 10.2337/diabetes.51.2007.S74; Barg S, 2002, NEURON, V33, P287, DOI 10.1016/S0896-6273(02)00563-9; Barg S, 2001, BIOPHYS J, V81, P3308, DOI 10.1016/S0006-3495(01)75964-4; Bers DM, 2010, METHOD CELL BIOL, V99, P1, DOI [10.1016/S0091-679X(10)99001-8, 10.1016/B978-0-12-374841-6.00001-3]; Braun M, 2008, DIABETES, V57, P1618, DOI 10.2337/db07-0991; Braun M, 2009, ANN NY ACAD SCI, V1152, P187, DOI 10.1111/j.1749-6632.2008.03992.x; Cabrera O, 2006, P NATL ACAD SCI USA, V103, P2334, DOI 10.1073/pnas.0510790103; Dai XQ, 2011, DIABETES, V60, P838, DOI 10.2337/db10-0440; De Marinis YZ, 2010, CELL METAB, V11, P543; Del Guerra S, 2005, DIABETES, V54, P727, DOI 10.2337/diabetes.54.3.727; Eliasson L, 2003, J GEN PHYSIOL, V121, P181, DOI 10.1085/jgp.20028707; Eliasson L, 2008, J PHYSIOL-LONDON, V586, P3313, DOI 10.1113/jphysiol.2008.155317; Engisch KL, 1996, J NEUROSCI, V16, P1359; Fink M, 2009, 19 NC3RS; Fonseca SG, 2010, J CLIN INVEST, V120, P744, DOI 10.1172/JCI39678; GILLIS KD, 1992, PFLUG ARCH EUR J PHY, V420, P121, DOI 10.1007/BF00378654; Gillis KD, 1996, NEURON, V16, P1209, DOI 10.1016/S0896-6273(00)80147-6; Goehring I, 2012, J BIOL CHEM, V287, P15706, DOI 10.1074/jbc.M111.314567; Gromada J, 1999, J PHYSIOL-LONDON, V518, P745, DOI 10.1111/j.1469-7793.1999.0745p.x; Henquin JC, 2002, DIABETES, V51, pS60, DOI 10.2337/diabetes.51.2007.S60; Henquin JC, 2006, DIABETES, V55, P3470, DOI 10.2337/db06-0868; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; HORRIGAN FT, 1994, NEURON, V13, P1119, DOI 10.1016/0896-6273(94)90050-7; Ivarsson R, 2004, TRAFFIC, V5, P750, DOI 10.1111/j.1600-0854.2004.00216.x; Kasai K, 2008, TRAFFIC, V9, P1191, DOI 10.1111/j.1600-0854.2008.00744.x; Kennedy ED, 1996, J CLIN INVEST, V98, P2524, DOI 10.1172/JCI119071; Klingauf J, 1997, BIOPHYS J, V72, P674, DOI 10.1016/S0006-3495(97)78704-6; Koeck T, 2011, CELL METAB, V13, P80, DOI 10.1016/j.cmet.2010.12.007; LINDAU M, 1988, PFLUG ARCH EUR J PHY, V411, P137, DOI 10.1007/BF00582306; Lyssenko V, 2009, NAT GENET, V41, P82, DOI 10.1038/ng.288; MacDonald PE, 2005, DIABETES, V54, P736, DOI 10.2337/diabetes.54.3.736; Matveev V, 2011, BRAIN RES, V1398, P126, DOI 10.1016/j.brainres.2011.05.011; Mica OI, 2004, BIOCHEM J, V381, P13, DOI 10.1042/BJ20040434; Michael DJ, 2007, DIABETES, V56, P1277, DOI 10.2337/db06-0367; MISLER S, 1992, DIABETES, V41, P1221, DOI 10.2337/diabetes.41.10.1221; Ohara-Imaizumi M, 2002, J BIOL CHEM, V277, P3805, DOI 10.1074/jbc.C100712200; Olofsson CS, 2002, PFLUG ARCH EUR J PHY, V444, P43, DOI 10.1007/s00424-002-0781-5; Ostenson CG, 2006, DIABETES, V55, P435, DOI 10.2337/diabetes.55.02.06.db04-1575; Parekh AB, 2008, J PHYSIOL-LONDON, V586, P3043, DOI 10.1113/jphysiol.2008.153460; Pedersen MG, 2011, PROG BIOPHYS MOL BIO, V107, P257, DOI 10.1016/j.pbiomolbio.2011.07.012; Pedersen MG, 2011, BIOPHYS J, V101, P793, DOI 10.1016/j.bpj.2011.06.061; Pedersen MG, 2010, BIOPHYS J, V99, P3200, DOI 10.1016/j.bpj.2010.09.004; Pedersen MG, 2009, P NATL ACAD SCI USA, V106, P7432, DOI 10.1073/pnas.0901202106; Persaud SJ, 2010, ISLETS, V2, P236, DOI 10.4161/isl.2.4.12557; Pinheiro J, 2001, MIXED EFFECTS MODELS; PINHEIRO JC, 2011, NLME LINEAR NONLINEA, V3, P1, DOI DOI 10.1371/J0URNAL.P0NE.0018860; Quesada I, 2006, DIABETES, V55, P2463, DOI 10.2337/db06-0272; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Riz M, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003389; Rorsman P, 2013, ANNU REV PHYSIOL, V75, P155, DOI 10.1146/annurev-physiol-030212-183754; Rorsman P, 2011, PROG BIOPHYS MOL BIO, V107, P224, DOI 10.1016/j.pbiomolbio.2011.06.009; Rose T, 2007, J GEN PHYSIOL, V129, P493, DOI 10.1085/jgp.200609604; Rosengren A, 2002, PFLUG ARCH EUR J PHY, V444, P556, DOI 10.1007/s00424-002-0866-1; Rosengren AH, 2012, DIABETES, V61, P1726, DOI 10.2337/db11-1516; Shibasaki T, 2007, P NATL ACAD SCI USA, V104, P19333, DOI 10.1073/pnas.0707054104; Spegel P, 2013, BIOCHEM J, V450, P595, DOI 10.1042/BJ20121349; Vikman J, 2006, J MOL ENDOCRINOL, V36, P503, DOI 10.1677/jme.1.01978; Vikman J, 2009, AM J PHYSIOL-ENDOC M, V297, pE452, DOI 10.1152/ajpendo.90585.2008; Xavier GD, 2009, DIABETES, V58, P894, DOI 10.2337/db08-1187; Xie L, 2012, DIABETOLOGIA, V55, P2693, DOI 10.1007/s00125-012-2640-z; Yang Y, 2004, J GEN PHYSIOL, V124, P641, DOI 10.1085/jgp.200409081; Zhao Y, 2010, J PHYSIOL-LONDON, V588, P3485, DOI 10.1113/jphysiol.2010.190090; Zhu D, 2013, DIABETOLOGIA, V56, P359, DOI 10.1007/s00125-012-2757-0	66	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2014	9	8							e103874	10.1371/journal.pone.0103874	http://dx.doi.org/10.1371/journal.pone.0103874			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR0CG	25105407	Green Published, gold, Green Submitted			2022-12-27	WOS:000343231900027
J	Ricotta, C; Bacaro, G; Moretti, M				Ricotta, Carlo; Bacaro, Giovanni; Moretti, Marco			A New Measure of Functional Evenness and Some of Its Properties	PLOS ONE			English	Article							DIVERSITY INDEXES; PLANT; BIODIVERSITY; COMMUNITIES; REDUNDANCY; FRAMEWORK	Functional evenness is increasingly considered an important facet of functional diversity that sheds light on the complex relationships between community assembly and ecosystem functioning. Nonetheless, in spite of its relevant role for ecosystem functioning, only a few measures of functional evenness have been proposed. In this paper we introduce a new measure of functional evenness that reflects the regularity in the distribution of species abundances, together with the evenness in their pairwise functional dissimilarities. To show how the proposed measure works, we focus on changes in functional evenness calculated from Grime's classification of plant strategies as competitors (C), stress-tolerators (S) and ruderals (R) along a post-fire successional gradient in temperate chestnut forests of southern Switzerland.	[Ricotta, Carlo] Univ Roma La Sapienza, Dept Environm Biol, I-00185 Rome, Italy; [Bacaro, Giovanni] CNR, Ist Ric Protez Idrogeol, Perugia, Italy; [Bacaro, Giovanni] Univ Siena, Dept Life Sci, Biodivers & Conservat Network, BIOCONNET, I-53100 Siena, Italy; [Moretti, Marco] Swiss Fed Res Inst WSL, Birmensdorf, Switzerland	Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); Istituto di Ricerca per la Protezione Idrogeologica (IRPI-CNR); University of Siena; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research	Ricotta, C (corresponding author), Univ Roma La Sapienza, Dept Environm Biol, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	carlo.ricotta@uniroma1.it	Bacaro, Giovanni/AAA-5509-2022	Bacaro, Giovanni/0000-0003-0946-4496; Moretti, Marco/0000-0002-5845-3198; RICOTTA, Carlo/0000-0003-0818-3959	University of Rome 'La Sapienza'	University of Rome 'La Sapienza'	Funding was provided by the University of Rome 'La Sapienza'. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Braun-Blanquet J., 1964, PFLANZENSOZIOLOGIE; BULLA L, 1994, OIKOS, V70, P167, DOI 10.2307/3545713; de Bello F, 2013, ECOGRAPHY, V36, P393, DOI 10.1111/j.1600-0587.2012.07438.x; GOWER JC, 1986, J CLASSIF, V3, P5, DOI 10.1007/BF01896809; GRASSLE JF, 1979, ECOLOGICAL DIVERSITY; GREGORIUS HR, 1990, AM NAT, V136, P701, DOI 10.1086/285124; Grime JP, 1998, J ECOL, V86, P902, DOI 10.1046/j.1365-2745.1998.00306.x; GRIME JP, 1974, NATURE, V250, P26, DOI 10.1038/250026a0; Grime JP, 1996, COMP PLANT ECOLOGY F; Hillebrand H, 2008, ECOLOGY, V89, P1510, DOI 10.1890/07-1053.1; Hodgson JG, 1999, OIKOS, V85, P282, DOI 10.2307/3546494; JOST L, 2010, DIVERSITY-BASEL, V2, P207, DOI [DOI 10.3390/d2020207, 10.3390/d2020207]; Lavorel S, 2008, FUNCT ECOL, V22, P134, DOI 10.1111/j.1365-2435.2007.01339.x; Loreau M, 2004, OIKOS, V104, P606, DOI 10.1111/j.0030-1299.2004.12685.x; Magurran A.E., 2010, BIOL DIVERSITY FRONT; Mason NWH, 2005, OIKOS, V111, P112, DOI 10.1111/j.0030-1299.2005.13886.x; Moretti M, 2002, J APPL ECOL, V39, P321, DOI 10.1046/j.1365-2664.2002.00701.x; Moretti M, 2006, OECOLOGIA, V149, P312, DOI 10.1007/s00442-006-0450-z; Moretti M, 2009, ECOGRAPHY, V32, P299, DOI 10.1111/j.1600-0587.2008.05524.x; Mouchet MA, 2010, FUNCT ECOL, V24, P867, DOI 10.1111/j.1365-2435.2010.01695.x; Pavoine S, 2009, OIKOS, V118, P391, DOI 10.1111/j.1600-0706.2008.16668.x; Petchey OL, 2006, ECOL LETT, V9, P741, DOI 10.1111/j.1461-0248.2006.00924.x; Pielou E. C., 1975, ECOLOGICAL DIVERSITY; Podani J, 2013, COMMUNITY ECOL, V14, P180, DOI 10.1556/ComEc.14.2013.2.8; Podani J., 2000, INTRO EXPLORATION MU; Podani J, 2006, OIKOS, V115, P179, DOI 10.1111/j.2006.0030-1299.15048.x; Podani J, 2013, ECOL COMPLEX, V15, P52, DOI 10.1016/j.ecocom.2013.03.002; Poos MS, 2009, ECOLOGY, V90, P341, DOI 10.1890/08-1638.1; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; RAO CR, 1982, THEOR POPUL BIOL, V21, P24, DOI 10.1016/0040-5809(82)90004-1; Ricotta C, 2005, BASIC APPL ECOL, V6, P479, DOI 10.1016/j.baae.2005.02.008; Ricotta C, 2004, ACTA BIOTHEOR, V52, P95, DOI 10.1023/B:ACBI.0000043438.41888.ac; Ricotta C, 2003, J THEOR BIOL, V222, P189, DOI 10.1016/S0022-5193(03)00026-2; Ricotta C, 2013, FOLIA GEOBOT, V48, P437, DOI 10.1007/s12224-013-9152-6; Ricotta C, 2011, OECOLOGIA, V167, P181, DOI 10.1007/s00442-011-1965-5; ROUTLEDGE RD, 1983, OIKOS, V40, P149, DOI 10.2307/3544211; Ruika M., 1958, BIOL BRATISLAV, V13, P647; Smith B, 1996, OIKOS, V76, P70, DOI 10.2307/3545749; Taillie C., 1979, Statistical Ecology Series, V6, P51; Tuomisto H, 2012, OIKOS, V121, P1203, DOI 10.1111/j.1600-0706.2011.19897.x; Villeger S, 2008, ECOLOGY, V89, P2290, DOI 10.1890/07-1206.1; Violle C, 2007, OIKOS, V116, P882, DOI 10.1111/j.2007.0030-1299.15559.x; Warwick RM, 1995, MAR ECOL PROG SER, V129, P301, DOI 10.3354/meps129301; Wilson JB, 1999, J VEG SCI, V10, P463, DOI 10.2307/3237181	44	20	20	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2014	9	8							e104060	10.1371/journal.pone.0104060	http://dx.doi.org/10.1371/journal.pone.0104060			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR0CG	25105659	Green Published, gold, Green Submitted			2022-12-27	WOS:000343231900036
J	Hjorth, MF; Chaput, JP; Damsgaard, CT; Dalskov, SM; Andersen, R; Astrup, A; Michaelsen, KF; Tetens, I; Ritz, C; Sjodin, A				Hjorth, Mads F.; Chaput, Jean-Philippe; Damsgaard, Camilla T.; Dalskov, Stine-Mathilde; Andersen, Rikke; Astrup, Arne; Michaelsen, Kim F.; Tetens, Inge; Ritz, Christian; Sjodin, Anders			Low Physical Activity Level and Short Sleep Duration Are Associated with an Increased Cardio-Metabolic Risk Profile: A Longitudinal Study in 8-11 Year Old Danish Children	PLOS ONE			English	Article							POPULATION-BASED SAMPLE; SEDENTARY BEHAVIOR; INSULIN-RESISTANCE; CARDIORESPIRATORY FITNESS; BLOOD-PRESSURE; LIPID PROFILE; TIME; OVERWEIGHT; MODERATE; ACCELEROMETER	Background: As cardio-metabolic risk tracks from childhood to adulthood, a better understanding of the relationship between movement behaviors (physical activity, sedentary behavior and sleep) and cardio-metabolic risk in childhood may aid in preventing metabolic syndrome (MetS) in adulthood. Objective: To examine independent and combined cross-sectional and longitudinal associations between movement behaviors and the MetS score in 8-11 year old Danish children. Design: Physical activity, sedentary time and sleep duration (seven days and eight nights) were assessed by accelerometer and fat mass index (fat mass/height(2)) was assessed using Dual-energy X-ray absorptiometry. The MetS-score was based on z-scores of waist circumference, mean arterial blood pressure, homeostatic model assessment of insulin resistance, triglycerides and high density lipoprotein cholesterol. All measurements were taken at three time points separated by 100 days. Average of the three measurements was used as habitual behavior in the cross-sectional analysis and changes from first to third measurement was used in the longitudinal analysis. Results: 723 children were included. In the cross-sectional analysis, physical activity was negatively associated with the MetS-score (P<0.03). In the longitudinal analysis, low physical activity and high sedentary time were associated with an increased MetS-score (all P<0.005); however, after mutual adjustments for movement behaviors, physical activity and sleep duration, but not sedentary time, were associated with the MetS-score (all P<0.03). Further adjusting for fat mass index while removing waist circumference from the MetS-score rendered the associations no longer statistically significant (all P. 0.17). Children in the most favorable tertiles of changes in moderate-to-vigorous physical activity, sleep duration and sedentary time during the 200-day follow-up period had an improved MetS-score relative to children in the opposite tertiles (P = 0.005). Conclusion: The present findings indicate that physical activity, sedentary time and sleep duration should all be targeted to improve cardio-metabolic risk markers in childhood; this is possibly mediated by adiposity.	[Hjorth, Mads F.; Damsgaard, Camilla T.; Dalskov, Stine-Mathilde; Astrup, Arne; Michaelsen, Kim F.; Ritz, Christian; Sjodin, Anders] Univ Copenhagen, Fac Sci, Dept Nutr Exercise & Sports, Copenhagen, Denmark; [Chaput, Jean-Philippe] Childrens Hosp Eastern Ontario, Res Inst, Healthy Active Living & Obes Res Grp, Ottawa, ON K1H 8L1, Canada; [Andersen, Rikke; Tetens, Inge] Tech Univ Denmark, Div Nutr, Natl Food Inst, Soborg, Denmark	University of Copenhagen; University of Ottawa; Children's Hospital of Eastern Ontario; Technical University of Denmark	Hjorth, MF (corresponding author), Univ Copenhagen, Fac Sci, Dept Nutr Exercise & Sports, Copenhagen, Denmark.	madsfiil@life.ku.dk	Damsgaard, Camilla T/B-4866-2015; Sjödin, Anders/B-6975-2015; Andersen, Rikke/GRS-3064-2022; Chaput, Jean-Philippe/ABE-6307-2020; Tetens, Inge/B-8965-2017; Ritz, Christian/P-6159-2014; Astrup, Arne/B-1407-2015; Hjorth, Mads/A-1760-2015	Sjödin, Anders/0000-0002-6451-3847; Chaput, Jean-Philippe/0000-0002-5607-5736; Tetens, Inge/0000-0002-2495-2511; Ritz, Christian/0000-0002-5095-0624; Michaelsen, Kim F/0000-0003-0449-0839; Astrup, Arne/0000-0001-8968-8996; Hjorth, Mads/0000-0001-9440-2737; Damsgaard, Camilla T/0000-0002-5013-0562; Andersen, Rikke/0000-0002-5091-6995	Nordea Foundation	Nordea Foundation	The study is part of the OPUS project 'Optimal well-being, development and health for Danish children through a healthy New Nordic Diet' which is supported by a grant from the Nordea Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aeberli I, 2009, INT J VITAM NUTR RES, V79, P14, DOI 10.1024/0300-9831.79.1.14; Andersen LB, 2006, LANCET, V368, P1326, DOI 10.1016/S0140-6736(06)69554-8; Andersen LB, 2006, LANCET, V368, P299, DOI 10.1016/S0140-6736(06)69075-2; Atkin AJ, 2013, MED SCI SPORT EXER, V45, P1097, DOI 10.1249/MSS.0b013e318282190e; Biltoft-Jensen A, 2014, J HUM NUTR DIET, V27, P43, DOI 10.1111/j.1365-277X.2012.01257.x; Biltoft-Jensen A, 2013, BRIT J NUTR, V110, P186, DOI 10.1017/S0007114512004746; Black AE, 2000, EUR J CLIN NUTR, V54, P395, DOI 10.1038/sj.ejcn.1600971; Buchan DS, 2011, SCAND J MED SCI SPOR, V21, pE341, DOI 10.1111/j.1600-0838.2011.01303.x; Chaput JP, 2011, OBES REV, V12, pe12, DOI 10.1111/j.1467-789X.2010.00772.x; Chaput JP, 2013, APPL PHYSIOL NUTR ME, V38, P477, DOI 10.1139/apnm-2012-0382; Chaput JP, 2011, CAN J PUBLIC HEALTH, V102, P369, DOI 10.1007/BF03404179; Cliff DP, 2013, OBESITY, V21, P382, DOI 10.1002/oby.20005; Cole TJ, 2007, BMJ-BRIT MED J, V335, P194, DOI 10.1136/bmj.39238.399444.55; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Colley RC, 2013, BMC PUBLIC HEALTH, V13, DOI [10.1186/1471-2458-13-200, 10.1186/1471-2458-13-554]; Cutfield Wayne S, 2003, Pediatr Diabetes, V4, P119, DOI 10.1034/j.1399-5448.2003.t01-1-00022.x; Damsgaard CT, 2013, BRIT J NUTR, V110, P1304, DOI 10.1017/S0007114513000585; Damsgaard CT, 2012, SCAND J PUBLIC HEALT, V40, P693, DOI 10.1177/1403494812463173; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; Dulloo AG, 2010, INT J OBESITY, V34, pS4, DOI 10.1038/ijo.2010.234; Eisenmann JC, 2008, CARDIOVASC DIABETOL, V7, DOI 10.1186/1475-2840-7-17; Ekelund U, 2006, PLOS MED, V3, P2449, DOI 10.1371/journal.pmed.0030488; Ekelund U, 2012, JAMA-J AM MED ASSOC, V307, P704, DOI 10.1001/jama.2012.156; Flint J, 2007, J PEDIATR-US, V150, P364, DOI 10.1016/j.jpeds.2006.08.063; Henderson M, 2012, DIABETES CARE, V35, P1272, DOI 10.2337/dc11-1785; Hjorth MF, 2014, INT J OBESITY, V38, P959, DOI 10.1038/ijo.2013.229; Hjorth MF, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-808; Hjorth MF, 2012, SLEEP BIOL RHYTHMS, V10, P328, DOI 10.1111/j.1479-8425.2012.00578.x; Javaheri S, 2008, CIRCULATION, V118, P1034, DOI 10.1161/CIRCULATIONAHA.108.766410; Javaheri S, 2011, J PEDIATR-US, V158, P617, DOI 10.1016/j.jpeds.2010.09.080; Klingenberg L, 2013, SLEEP, V36, P1085, DOI 10.5665/sleep.2816; Koren D, 2011, DIABETES CARE, V34, P2442, DOI 10.2337/dc11-1093; Kristensen PL, 2008, SCAND J MED SCI SPOR, V18, P171, DOI 10.1111/j.1600-0838.2006.00622.x; Lambert M, 2008, CAN J CARDIOL, V24, P575, DOI 10.1016/S0828-282X(08)70639-1; Martikainen S, 2011, HYPERTENSION, V58, P16, DOI 10.1161/HYPERTENSIONAHA.111.172395; Matthews KA, 2012, SLEEP, V35, P1353, DOI 10.5665/sleep.2112; Mensink RP, 2003, AM J CLIN NUTR, V77, P1146, DOI 10.1093/ajcn/77.5.1146; MORRIS NM, 1980, J YOUTH ADOLESCENCE, V9, P271, DOI 10.1007/BF02088471; Morrison JA, 2008, J PEDIATR-US, V152, P201, DOI 10.1016/j.jpeds.2007.09.010; National Sleep Foundation, 2013, CHILDR SLEEP; Natl High Blood Pressure Educ Prog, 2004, PEDIATRICS, V114, P555; Owens JA, 2000, SLEEP, V23, P1043; Ried-Larsen M, 2014, BRIT J SPORT MED, V48, P1502, DOI 10.1136/bjsports-2012-091958; SADEH A, 1994, SLEEP, V17, P201, DOI 10.1093/sleep/17.3.201; Sardinha LB, 2008, DIABETES CARE, V31, P569, DOI 10.2337/dc07-1286; Spruyt K, 2011, PEDIATRICS, V127, pE345, DOI 10.1542/peds.2010-0497; Steele RM, 2008, J APPL PHYSIOL, V105, P342, DOI 10.1152/japplphysiol.00072.2008; Steele RM, 2009, AM J CLIN NUTR, V90, P1185, DOI 10.3945/ajcn.2009.28153; Sung V, 2011, SLEEP, V34, P891, DOI 10.5665/SLEEP.1122; Tremblay MS, 2011, APPL PHYSIOL NUTR ME, V36, P65, DOI 10.1139/H11-013; Tresaco B, 2005, J PHYSIOL BIOCHEM, V61, P381, DOI 10.1007/BF03167055; Trost SG, 2011, MED SCI SPORT EXER, V43, P1360, DOI 10.1249/MSS.0b013e318206476e; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; Zorba E, 2011, J SPORT MED PHYS FIT, V51, P664	54	90	90	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e104677	10.1371/journal.pone.0104677	http://dx.doi.org/10.1371/journal.pone.0104677			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25102157	Green Published, Green Submitted, gold			2022-12-27	WOS:000339993900084
J	Munir, RI; Schellenberg, J; Henrissat, B; Verbeke, TJ; Sparling, R; Levin, DB				Munir, Riffat I.; Schellenberg, John; Henrissat, Bernard; Verbeke, Tobin J.; Sparling, Richard; Levin, David B.			Comparative Analysis of Carbohydrate Active Enzymes in Clostridium termitidis CT1112 Reveals Complex Carbohydrate Degradation Ability	PLOS ONE			English	Article							SCAFFOLDING PROTEIN CIPA; BINDING MODULES; CELLULOSE DEGRADATION; GENE-CLUSTER; SEQUENCE-ANALYSIS; CRYSTAL-STRUCTURE; THERMOCELLUM; PURIFICATION; COMPONENT; GENOME	Clostridium termitidis strain CT1112 is an anaerobic, gram positive, mesophilic, cellulolytic bacillus isolated from the gut of the wood-feeding termite, Nasutitermes lujae. It produces biofuels such as hydrogen and ethanol from cellulose, cellobiose, xylan, xylose, glucose, and other sugars, and therefore could be used for biofuel production from biomass through consolidated bioprocessing. The first step in the production of biofuel from biomass by microorganisms is the hydrolysis of complex carbohydrates present in biomass. This is achieved through the presence of a repertoire of secreted or complexed carbohydrate active enzymes (CAZymes), sometimes organized in an extracellular organelle called cellulosome. To assess the ability and understand the mechanism of polysaccharide hydrolysis in C. termitidis, the recently sequenced strain CT1112 of C. termitidis was analyzed for both CAZymes and cellulosomal components, and compared to other cellulolytic bacteria. A total of 355 CAZyme sequences were identified in C. termitidis, significantly higher than other Clostridial species. Of these, high numbers of glycoside hydrolases (199) and carbohydrate binding modules (95) were identified. The presence of a variety of CAZymes involved with polysaccharide utilization/degradation ability suggests hydrolysis potential for a wide range of polysaccharides. In addition, dockerin-bearing enzymes, cohesion domains and a cellulosomal gene cluster were identified, indicating the presence of potential cellulosome assembly.	[Munir, Riffat I.; Levin, David B.] Univ Manitoba, Dept Biosyst Engn, Winnipeg, MB, Canada; [Schellenberg, John; Verbeke, Tobin J.; Sparling, Richard] Univ Manitoba, Dept Microbiol, Winnipeg, MB R3T 2N2, Canada; [Henrissat, Bernard] CNRS, Marseille, France; [Henrissat, Bernard] Univ Aix Marseille, Marseille, France	University of Manitoba; University of Manitoba; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Levin, DB (corresponding author), Univ Manitoba, Dept Biosyst Engn, Winnipeg, MB, Canada.	david.levin@umanitoba.ca	Henrissat, Bernard/J-2475-2012	Henrissat, Bernard/0000-0002-3434-8588; Verbeke, Tobin/0000-0002-0900-3254; Schellenberg, John/0000-0003-3970-1608; Sparling, Richard/0000-0002-0500-5877	Genome Canada, through the Applied Genomics Research in Bioproducts or Crops (ABC) program; Province of Manitoba, Agricultural and Rural Development Initiative (ARDI)	Genome Canada, through the Applied Genomics Research in Bioproducts or Crops (ABC) program; Province of Manitoba, Agricultural and Rural Development Initiative (ARDI)	This work was supported by funds provided by Genome Canada, through the Applied Genomics Research in Bioproducts or Crops (ABC) program, for the grant titled, "Microbial Genomics for Biofuels and CoProducts from Biorefining Processes'', and by the Province of Manitoba, Agricultural and Rural Development Initiative (ARDI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aspeborg H, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-186; BAGNARATARDIF C, 1992, GENE, V119, P17, DOI 10.1016/0378-1119(92)90062-T; Bayer EA, 2008, CHEM REC, V8, P364, DOI 10.1002/tcr.20160; BEGUIN P, 1992, FEMS MICROBIOL LETT, V100, P523, DOI 10.1016/0378-1097(92)90256-N; Bolam DN, 2004, J BIOL CHEM, V279, P22953, DOI 10.1074/jbc.M313317200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bronnenmeier K, 1996, BIOSEPARATION, V6, P41; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Carere CR, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-295; CORNET P, 1983, BIO-TECHNOL, V1, P589, DOI 10.1038/nbt0983-589; Cuskin F, 2012, P NATL ACAD SCI USA, V109, P20889, DOI 10.1073/pnas.1212034109; Demain AL, 2005, MICROBIOL MOL BIOL R, V69, P124, DOI 10.1128/MMBR.69.1.124-154.2005; Ding SY, 2001, J BACTERIOL, V183, P1945, DOI 10.1128/JB.183.6.1945-1953.2001; DOI RH, 1994, CRIT REV MICROBIOL, V20, P87, DOI 10.3109/10408419409113548; Doi RH, 2003, CELLULOSOMES MESOPHI, V185; FIEROBE HP, 1993, EUR J BIOCHEM, V217, P557, DOI 10.1111/j.1432-1033.1993.tb18277.x; Floudas D, 2012, SCIENCE, V336, P1715, DOI 10.1126/science.1221748; Fontes CMGA, 2010, ANNU REV BIOCHEM, V79, P655, DOI 10.1146/annurev-biochem-091208-085603; FUJINO T, 1993, J FERMENT BIOENG, V76, P243, DOI 10.1016/0922-338X(93)90188-E; FUJINO T, 1993, J BACTERIOL, V175, P1891, DOI 10.1128/JB.175.7.1891-1899.1993; Gal L, 1997, APPL ENVIRON MICROB, V63, P903, DOI 10.1128/AEM.63.3.903-909.1997; GERNGROSS UT, 1993, MOL MICROBIOL, V8, P325, DOI 10.1111/j.1365-2958.1993.tb01576.x; Goh SH, 1997, J CLIN MICROBIOL, V35, P3116, DOI 10.1128/JCM.35.12.3116-3121.1997; Guillen D, 2010, APPL MICROBIOL BIOT, V85, P1241, DOI 10.1007/s00253-009-2331-y; Guimaraes BG, 2002, J MOL BIOL, V320, P587, DOI 10.1016/S0022-2836(02)00497-7; HETHENER P, 1992, SYST APPL MICROBIOL, V15, P52, DOI 10.1016/S0723-2020(11)80138-4; Hill JE, 2004, GENOME RES, V14, P1669, DOI 10.1101/gr.2649204; Jian WY, 2001, INT J SYST EVOL MICR, V51, P1633, DOI 10.1099/00207713-51-5-1633; Kakiuchi M, 1998, J BACTERIOL, V180, P4303, DOI 10.1128/JB.180.16.4303-4308.1998; Kataeva I, 1999, J BACTERIOL, V181, P5288, DOI 10.1128/JB.181.17.5288-5295.1999; Kataeva I, 1998, GENETICS BIOCH ECOLO, P456; Kataeva IA, 2002, APPL ENVIRON MICROB, V68, P4292, DOI 10.1128/AEM.68.9.4292-4300.2002; Kosugi A, 2002, J BACTERIOL, V184, P884, DOI 10.1128/jb.184.4.884-888.2002; LAMED R, 1983, J BACTERIOL, V156, P828, DOI 10.1128/JB.156.2.828-836.1983; Lel S, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00281-13; LEMAIRE M, 1993, J BACTERIOL, V175, P3353, DOI 10.1128/jb.175.11.3353-3360.1993; Levasseur A, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-41; Levin DB, 2007, BIORESOURCE TECHNOL, V98, P654, DOI 10.1016/j.biortech.2006.02.027; Lynd LR, 2005, CURR OPIN BIOTECH, V16, P577, DOI 10.1016/j.copbio.2005.08.009; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; Marchler-Bauer Aron, 2011, Nucleic Acids Res, V39, pD225, DOI 10.1093/nar/gkq1189; Markowitz VM, 2009, BIOINFORMATICS, V25, P2271, DOI 10.1093/bioinformatics/btp393; McLean BW, 2002, J BIOL CHEM, V277, P50245, DOI 10.1074/jbc.M204433200; MISHRA SC, 1981, MATER ORGANISMEN, V16, P157; Montanier C, 2009, P NATL ACAD SCI USA, V106, P3065, DOI 10.1073/pnas.0808972106; Notenboom V, 2002, BIOCHEMISTRY-US, V41, P4246, DOI 10.1021/bi015865j; OBAYASHI T, 1995, LANCET, V345, P17, DOI 10.1016/S0140-6736(95)91152-9; Parsiegla G, 2002, BIOCHEMISTRY-US, V41, P11134, DOI 10.1021/bi025816m; Ramachandran U, 2008, INT J HYDROGEN ENERG, V33, P7006, DOI 10.1016/j.ijhydene.2008.09.022; ReverbelLeroy C, 1997, J BACTERIOL, V179, P46, DOI 10.1128/jb.179.1.46-52.1997; Rincon MT, 2005, J BACTERIOL, V187, P7569, DOI 10.1128/JB.187.22.7569-7578.2005; Sabathe F, 2002, FEMS MICROBIOL LETT, V217, P15, DOI 10.1016/S0378-1097(02)00991-6; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Scheller HV, 2010, ANNU REV PLANT BIOL, V61, P263, DOI 10.1146/annurev-arplant-042809-112315; Schwarz WH, 2001, APPL MICROBIOL BIOT, V56, P634, DOI 10.1007/s002530100710; SLEAT R, 1984, APPL ENVIRON MICROB, V48, P88, DOI 10.1128/AEM.48.1.88-93.1984; Sun JL, 1998, J FERMENT BIOENG, V85, P63, DOI 10.1016/S0922-338X(97)80355-8; Tamaru Y, 2011, MICROB BIOTECHNOL, V4, P64, DOI 10.1111/j.1751-7915.2010.00210.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THAYER DW, 1978, J GEN MICROBIOL, V106, P13, DOI 10.1099/00221287-106-1-13; Verbeke TJ, 2011, SYST APPL MICROBIOL, V34, P171, DOI 10.1016/j.syapm.2010.11.019; Wang ZW, 2009, APPL MICROBIOL BIOT, V83, P1, DOI 10.1007/s00253-009-1940-9; Xu Q, 2004, J BACTERIOL, V186, P968, DOI 10.1128/JB.186.4.968-977.2004; Xu Q, 2003, J BACTERIOL, V185, P4548, DOI 10.1128/JB.185.15.4548-4557.2003; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249; Zhang XZ, 2010, APPL MICROBIOL BIOT, V86, P525, DOI 10.1007/s00253-009-2231-1	66	25	26	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e104260	10.1371/journal.pone.0104260	http://dx.doi.org/10.1371/journal.pone.0104260			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25101643	Green Submitted, Green Published, gold			2022-12-27	WOS:000339993900053
J	Vatsyayan, R; Kothari, H; Mackman, N; Pendurthi, UR; Rao, LVM				Vatsyayan, Rit; Kothari, Hema; Mackman, Nigel; Pendurthi, Usha R.; Rao, L. Vijaya Mohan			Inactivation of Factor VIIa by Antithrombin In Vitro, Ex Vivo and In Vivo: Role of Tissue Factor and Endothelial Cell Protein C Receptor	PLOS ONE			English	Article							FACTOR PATHWAY INHIBITOR; III-HEPARIN; PLASMA; COMPLEXES; HEMOSTASIS; BINDING; COAGULATION; EXPRESSION; THROMBOSIS; ARTERIAL	Recent studies have suggested that antithrombin (AT) could act as a significant physiologic regulator of FVIIa. However, in vitro studies showed that AT could inhibit FVIIa effectively only when it was bound to tissue factor (TF). Circulating blood is known to contain only traces of TF, at best. FVIIa also binds endothelial cell protein C receptor (EPCR), but the role of EPCR on FVIIa inactivation by AT is unknown. The present study was designed to investigate the role of TF and EPCR in inactivation of FVIIa by AT in vivo. Low human TF mice (low TF, similar to 1% expression of the mouse TF level) and high human TF mice (HTF, similar to 100% of the mouse TF level) were injected with human rFVIIa (120 mu g kg(-1) body weight) via the tail vein. At varying time intervals following rFVIIa administration, blood was collected to measure FVIIa-AT complex and rFVIIa antigen levels in the plasma. Despite the large difference in TF expression in the mice, HTF mice generated only 40-50% more of FVIIa-AT complex as compared to low TF mice. Increasing the concentration of TF in vivo in HTF mice by LPS injection increased the levels of FVIIa-AT complexes by about 25%. No significant differences were found in FVIIa-AT levels among wild-type, EPCR-deficient, and EPCR-overexpressing mice. The levels of FVIIa-AT complex formed in vitro and ex vivo were much lower than that was found in vivo. In summary, our results suggest that traces of TF that may be present in circulating blood or extravascular TF that is transiently exposed during normal vessel damage contributes to inactivation of FVIIa by AT in circulation. However, TF's role in AT inactivation of FVIIa appears to be minor and other factor(s) present in plasma, on blood cells or vascular endothelium may play a predominant role in this process.	[Vatsyayan, Rit; Kothari, Hema; Pendurthi, Usha R.; Rao, L. Vijaya Mohan] Univ Texas Tyler, Hlth Sci Ctr Tyler, Dept Cellular & Mol Biol, Tyler, TX 75799 USA; [Mackman, Nigel] Univ N Carolina, Dept Med, McAllister Heart Inst, Div Hematol & Oncol, Chapel Hill, NC USA	University of Texas System; University of Texas at Tyler; University of Texas-Health Sciences Center at Tyler (UTHSCT); University of North Carolina; University of North Carolina Chapel Hill	Rao, LVM (corresponding author), Univ Texas Tyler, Hlth Sci Ctr Tyler, Dept Cellular & Mol Biol, Tyler, TX 75799 USA.	Vijay.rao@uthct.edu			National Institutes of Health [HL107483]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107483] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The work was supported by National Institutes of Health grant HL107483. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agerso H, 2011, J THROMB HAEMOST, V9, P333, DOI 10.1111/j.1538-7836.2010.04152.x; Agerso H, 2011, EUR J PHARM SCI, V42, P578, DOI 10.1016/j.ejps.2011.02.013; BROZE GJ, 1993, BLOOD, V82, P1679; BROZE GJ, 1995, BLOOD COAGUL FIBRIN, V6, pS7, DOI 10.1097/00001721-199506001-00002; Butenas S, 2005, BLOOD, V105, P2764, DOI 10.1182/blood-2004-09-3567; Clark CA, 2012, J THROMB HAEMOST, V10, P2383, DOI 10.1111/j.1538-7836.2012.04917.x; Geddings JE, 2013, BLOOD, V122, P1873, DOI 10.1182/blood-2013-04-460139; Ghosh S, 2007, J BIOL CHEM, V282, P11849, DOI 10.1074/jbc.M609283200; Giesen PLA, 1999, P NATL ACAD SCI USA, V96, P2311, DOI 10.1073/pnas.96.5.2311; Gopalakrishnan R, 2012, J THROMB HAEMOST, V10, P971, DOI 10.1111/j.1538-7836.2012.04670.x; Gopalakrishnan R, 2010, J THROMB HAEMOST, V8, P2318, DOI 10.1111/j.1538-7836.2010.04010.x; Gopalakrishnan R, 2010, J THROMB HAEMOST, V8, P301, DOI 10.1111/j.1538-7836.2009.03696.x; Hamamoto T, 1996, INT J HEMATOL, V63, P51; HAMAMOTO T, 1993, J BIOL CHEM, V268, P8704; Kothari H, 2010, BLOOD, V115, P4273, DOI 10.1182/blood-2009-09-241356; LAWSON JH, 1993, J BIOL CHEM, V268, P767; Li W, 2005, J THROMB HAEMOST, V3, P1351, DOI 10.1111/j.1538-7836.2005.01385.x; Li WH, 2005, BLOOD, V106, P2716, DOI 10.1182/blood-2005-01-0406; Lopez-Sagaseta J, 2007, J THROMB HAEMOST, V5, P1817, DOI 10.1111/j.1538-7836.2007.02648.x; Mackman N, 2008, J THROMB HAEMOST, V6, P303, DOI 10.1111/j.1538-7836.2007.02873.x; Mackman N, 2004, ARTERIOSCL THROM VAS, V24, P1015, DOI 10.1161/01.ATV.0000130465.23430.74; Nayak RC, 2009, BLOOD, V114, P1974, DOI 10.1182/blood-2009-03-208900; Parry GCN, 1998, J CLIN INVEST, V101, P560, DOI 10.1172/JCI814; Pawlinski R, 2007, J THROMB HAEMOST, V5, P1693, DOI 10.1111/j.1538-7836.2007.02649.x; Petersen LC, 2011, BRIT J HAEMATOL, V152, P99, DOI 10.1111/j.1365-2141.2010.08432.x; Petersen LC, 2009, THROMB HAEMOSTASIS, V101, P818, DOI 10.1160/TH08-10-0699; Preston RJS, 2006, J BIOL CHEM, V281, P28850, DOI 10.1074/jbc.M604966200; RAO LVM, 1993, BLOOD, V81, P2600; RAO LVM, 1995, BLOOD, V85, P121, DOI 10.1182/blood.V85.1.121.bloodjournal851121; RAPAPORT SI, 1995, THROMB HAEMOSTASIS, V74, P7; RAPAPORT SI, 1992, ARTERIOSCLER THROMB, V12, P1111, DOI 10.1161/01.ATV.12.10.1111; Sen P, 2012, THROMB HAEMOSTASIS, V107, P951, DOI 10.1160/TH11-09-0672; Sen P, 2011, BLOOD, V117, P3199, DOI 10.1182/blood-2010-09-310706; SHIGEMATSU Y, 1992, J BIOL CHEM, V267, P21329; Silveira A, 2012, THROMB RES, V130, P221, DOI 10.1016/j.thromres.2011.08.029; Simioni P, 2011, THROMB RES, V128, P507, DOI 10.1016/j.thromres.2011.09.020; Smith SA, 2007, J THROMB HAEMOST, V5; Spiezia L, 2011, THROMB RES, V128, P303, DOI 10.1016/j.thromres.2011.05.020; Spiezia L, 2010, THROMB HAEMOSTASIS, V103, P1188, DOI 10.1160/TH09-08-0606; Sundaram J, 2014, J THROMB HAEMOST, V12, P690, DOI 10.1111/jth.12532; TAKAHASHI H, 1994, AM J HEMATOL, V46, P333, DOI 10.1002/ajh.2830460414; Wang JG, 2009, J THROMB HAEMOST, V7, P1092, DOI 10.1111/j.1538-7836.2009.03448.x; WARR TA, 1990, BLOOD, V75, P1481	43	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e103505	10.1371/journal.pone.0103505	http://dx.doi.org/10.1371/journal.pone.0103505			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25102166	Green Published, Green Submitted, gold			2022-12-27	WOS:000339993900020
J	Zhou, YY; Wang, SN; Li, H; Zha, WF; Wang, XL; Liu, YY; Sun, J; Peng, QQ; Li, SL; Chen, Y; Jin, L				Zhou, Youyou; Wang, San-nan; Li, Hong; Zha, Weifeng; Wang, Xuli; Liu, Yuanyuan; Sun, Jian; Peng, Qianqian; Li, Shilin; Chen, Ying; Jin, Li			Association of UGT1A1 Variants and Hyperbilirubinemia in Breast-Fed Full-Term Chinese Infants	PLOS ONE			English	Article							BILIRUBIN UDP-GLUCURONOSYLTRANSFERASE; NEONATAL HYPERBILIRUBINEMIA; GILBERTS-SYNDROME; SERUM BILIRUBIN; POLYMORPHISM; GENES; TRANSFERASE; POPULATIONS; METABOLISM; HAPLOTYPES	A retrospective case control study of breast-fed full-term infants was carried out to determine whether variants in Uridine Diphosphate Glucuronosyl Transferase 1A1 (UGT1A1) and Heme Oxygenase-1 (HMOX1) were associated with neonatal hyperbilirubinemia. Eight genetic variants of UGT1A1 and 3 genetic variants of HMOX1 were genotyped in 170 hyperbilirubinemic newborns and 779 controls. Five significant associations with breast-fed hyperbilirubinemia were detected after adjusting for gender, birth season, birth weight, delivery mode, gestational age and False Discovery Rate (FDR) correction: the dominant effect of rs887829 (c-364t) (Odds Ratio (OR): 0.55; 95% Confidence Interval (CI): 0.34-0.89; p = 0.014), the additive effect of (TA)(n) repeat (OR: 0.59; 95%CI: 0.38-0.91; p = 0.017), the dominant effect of rs4148323 (Gly71Arg, G211A) (OR: 2.02; 95%CI: 1.44-2.85; p = 5.0x10(-5)), the recessive effect of rs6717546 (g+914a) (OR: 0.30; 95%CI: 0.11-0.83; p = 0.021) and rs6719561 (t+2558c) (OR: 0.38; 95%CI: 0.20-0.75; p = 0.005). Neonates carrying the minor allele of rs887829 (TA)(n) repeat had significantly lower peak bilirubin than wild types, while the minor allele carriers of rs4148323 had significantly higher peak bilirubin than wild types. No association was found in HMOX1. Our findings added to the understanding of the significance of UGT1A1 in association with neonatal hyperbilirubinemia in East Asian population. Additional studies were required to investigate the mechanisms of the protective effects.	[Zhou, Youyou; Peng, Qianqian; Li, Shilin; Jin, Li] Fudan Univ, Sch Life Sci, Inst Biomed Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Zhou, Youyou; Peng, Qianqian; Li, Shilin; Jin, Li] Fudan Univ, Sch Life Sci, MOE Key Lab Contemporary Anthropol, Shanghai 200433, Peoples R China; [Wang, San-nan; Zha, Weifeng; Wang, Xuli; Liu, Yuanyuan] Nanjing Med Univ, Affiliated Suzhou Hosp, Dept Neonatol, Suzhou, Peoples R China; [Li, Hong; Sun, Jian; Chen, Ying] Nanjing Med Univ, Affiliated Suzhou Hosp, Ctr Reprod & Genet, Suzhou, Peoples R China; [Li, Hong; Sun, Jian; Chen, Ying] Nanjing Med Univ, Affiliated Suzhou Hosp, Suzhou Maternal Child Med Ctr, Suzhou, Peoples R China	Fudan University; Fudan University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Jin, L (corresponding author), Fudan Univ, Sch Life Sci, Inst Biomed Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China.	lijin@fudan.edu.cn	liu, yuanyuan/GWZ-5838-2022; Jin, Li/M-5063-2019; Jin, Li/C-1468-2009	Jin, Li/0000-0002-4546-2415; chen, ying/0000-0001-5148-6504; Peng, Qianqian/0000-0002-2018-5706	Ministry of Science and Technology [2011BAI09B00]; National Basic Research Program [2012CB944600]; Ministry of Health [201002007]; "Twelfth Five'' Key Medical Talent's Project in Science and Education of Jiangsu Province [RC2011036]; Suzhou Science and Technology Development Project [SYSD2011101]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Basic Research Program(National Basic Research Program of China); Ministry of Health; "Twelfth Five'' Key Medical Talent's Project in Science and Education of Jiangsu Province; Suzhou Science and Technology Development Project	LJ was supported by grants from the Ministry of Science and Technology (2011BAI09B00), National Basic Research Program (2012CB944600), and Ministry of Health (201002007); YC was partially supported by the "Twelfth Five'' Key Medical Talent's Project in Science and Education of Jiangsu Province (RC2011036), Suzhou Science and Technology Development Project (SYSD2011101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AONO S, 1995, LANCET, V345, P958, DOI 10.1016/S0140-6736(95)90702-5; AONO S, 1993, BIOCHEM BIOPH RES CO, V197, P1239, DOI 10.1006/bbrc.1993.2610; Bancroft JD, 1998, J PEDIATR-US, V132, P656, DOI 10.1016/S0022-3476(98)70356-7; Beutler E, 1998, P NATL ACAD SCI USA, V95, P8170, DOI 10.1073/pnas.95.14.8170; BOSMA PJ, 1995, NEW ENGL J MED, V333, P1171, DOI 10.1056/NEJM199511023331802; Chang PF, 2011, J PEDIATR-US, V159, P561, DOI 10.1016/j.jpeds.2011.03.042; Chou HC, 2011, PEDIATR RES, V69, P170, DOI 10.1203/PDR.0b013e31820263d2; De Luca D, 2009, ARCH PEDIAT ADOL MED, V163, P1054, DOI 10.1001/archpediatrics.2009.187; Dennery PA, 2001, NEW ENGL J MED, V344, P581, DOI 10.1056/NEJM200102223440807; Eidelman AI, 2012, PEDIATRICS, V129, pE827, DOI 10.1542/peds.2011-3552; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Hanchard NA, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-57; Horsfall LJ, 2011, ANN HUM GENET, V75, P236, DOI 10.1111/j.1469-1809.2010.00638.x; Hu Y, 1996, PRACTICAL PEDIAT; Huang CS, 2002, PEDIATR RES, V52, P601, DOI 10.1203/01.PDR.0000028058.44773.24; Jin H, 1997, PRACTICAL NEONATOLOG; Johnson L, 2011, SEMIN PERINATOL, V35, P101, DOI 10.1053/j.semperi.2011.02.003; Kaplan M, 1997, P NATL ACAD SCI USA, V94, P12128, DOI 10.1073/pnas.94.22.12128; Lin R, 2009, HUM MUTAT, V30, P609, DOI 10.1002/humu.20895; Long J, 2011, PEDIATR INT, V53, P530, DOI 10.1111/j.1442-200X.2011.03337.x; Maisels MJ, 2004, PEDIATRICS, V114, P297; Maruo Y, 1999, PEDIATRICS, V103, P1224, DOI 10.1542/peds.103.6.1224; Sai K, 2004, CLIN PHARMACOL THER, V75, P501, DOI 10.1016/j.clpt.2004.01.010; Sato H, 2013, J HUM GENET, V58, P7, DOI 10.1038/jhg.2012.116; Sole X, 2006, BIOINFORMATICS, V22, P1928, DOI 10.1093/bioinformatics/btl268; Sun G, 2007, ACTA PAEDIATR, V96, P1622, DOI 10.1111/j.1651-2227.2007.00501.x; Watchko JF, 2010, SEMIN FETAL NEONAT M, V15, P169, DOI 10.1016/j.siny.2009.11.003; Wei K, 2000, PEDIAT NEONATES NEON, P117; Yamada N, 2000, AM J HUM GENET, V66, P187, DOI 10.1086/302729; [杨琳 Yang Lin], 2010, [中国循证儿科杂志, Chinese JOurnal of Evidence Based Pediatrics], V5, P335; Yu ZB, 2011, EUR J PEDIATR, V170, P185, DOI 10.1007/s00431-010-1281-9; Zhou YY, 2009, NEONATOLOGY, V96, P150, DOI 10.1159/000209851	32	15	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e104251	10.1371/journal.pone.0104251	http://dx.doi.org/10.1371/journal.pone.0104251			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25102181	Green Published, Green Submitted, gold			2022-12-27	WOS:000339993900052
J	Dutta, S; Das, S; Mitra, U; Jain, P; Roy, I; Ganguly, SS; Ray, U; Dutta, P; Paul, DK				Dutta, Shanta; Das, Surojit; Mitra, Utpala; Jain, Priyanka; Roy, Indranil; Ganguly, Shelley S.; Ray, Ujjwayini; Dutta, Phalguni; Paul, Dilip Kumar			Antimicrobial Resistance, Virulence Profiles and Molecular Subtypes of Salmonella enterica Serovars Typhi and Paratyphi A Blood Isolates from Kolkata, India during 2009-2013	PLOS ONE			English	Article							MULTIDRUG-RESISTANT; SEROTYPE TYPHI; CIPROFLOXACIN RESISTANCE; ANTIBIOTIC-RESISTANCE; GENETIC DIVERSITY; CHROMOSOMAL DNA; UNITED-STATES; S. PARATYPHI; FEVER; AZITHROMYCIN	Enteric fever, caused by Salmonella enterica, remains an unresolved public health problem in India and antimicrobial therapy is the main mode of treatment. The objective of this study was to characterize the Salmonella enterica isolates from Kolkata with respect to their antimicrobial resistance (AMR), virulence profiles and molecular subtypes. Salmonella enterica blood isolates were collected from clinically suspected enteric fever patients attending various hospitals in Kolkata, India from January 2009 to June 2013 and were tested for AMR profiles by standard protocols; for resistance gene transfer by conjugation; for resistance and virulence genes profiles by PCR; and for molecular subtypes by Pulsed Field Gel Electrophoresis (PFGE). A total of 77 Salmonella enterica serovar Typhi (S. Typhi) and 25 Salmonella enterica serovar Paratyphi A (S. Paratyphi A) from Kolkata were included in this study. Although multidrug resistance (resistance to chloramphenicol, ampicillin, co-trimoxazole) was decreasing in S. Typhi (18.2%) and absent in S. Paratyphi A, increased resistance to fluoroquinolone, the current drug of choice, caused growing concern for typhoid treatment. A single, non-conjugative non-IncHI1 plasmid of 180 kb was found in 71.4% multidrug resistant (MDR) S. Typhi; the remaining 28.6% isolates were without plasmid. Various AMR markers (bla(TEM-1), catA, sul1, sul2, dfrA15, strA-strB) and class 1 integron with dfrA7 gene were detected in MDR S. Typhi by PCR and sequencing. Most of the study isolates were likely to be virulent due to the presence of virulence markers. Major diversity was not noticed among S. Typhi and S. Paratyphi A from Kolkata by PFGE. The observed association between AMR profiles and S. Typhi pulsotypes might be useful in controlling the spread of the organism by appropriate intervention. The study reiterated the importance of continuous monitoring of AMR and molecular subtypes of Salmonella isolates from endemic regions for better understanding of the disease epidemiology.	[Dutta, Shanta; Das, Surojit; Mitra, Utpala; Jain, Priyanka; Dutta, Phalguni] Natl Inst Cholera & Enter Dis, Kolkata, India; [Roy, Indranil] Calcutta Med Res Inst, Kolkata, India; [Ganguly, Shelley S.] Adv Med Res Inst, Kolkata, India; [Ray, Ujjwayini] Apollo Gleneagles Hosp, Kolkata, India; [Paul, Dilip Kumar] Dr BC Roy Post Grad Inst Pediat Sci, Kolkata, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED)	Dutta, S (corresponding author), Natl Inst Cholera & Enter Dis, Kolkata, India.	shanta1232001@yahoo.co.in		Das, Surojit/0000-0003-1299-2855	Indian Council of Medical Research (ICMR) intramural fund; Indian Council of Medical Research	Indian Council of Medical Research (ICMR) intramural fund; Indian Council of Medical Research(Indian Council of Medical Research (ICMR))	The study was funded by the Indian Council of Medical Research (ICMR) intramural fund. Senior Research Fellowships from Indian Council of Medical Research to Mr. S. Das and Ms. P. Jain are gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish or preparation of manuscript.	Al Naiemi N, 2008, J CLIN MICROBIOL, V46, P2794, DOI 10.1128/JCM.00676-08; Bhattacharya SS, 2011, INDIAN J MED RES, V133, P431; Capoor MR, 2009, EPIDEMIOL INFECT, V137, P871, DOI 10.1017/S0950268808001076; Capoor MR, 2007, J MED MICROBIOL, V56, P1490, DOI 10.1099/jmm.0.47353-0; Carattoli A, 2005, J MICROBIOL METH, V63, P219, DOI 10.1016/j.mimet.2005.03.018; Center for Desease Control and Prevention, 2013, STAND OP PROC PULS P; Chandel DS, 2001, EMERG INFECT DIS, V7, P762; CLSI, 2013, PERFORMANCE STANDARD; Crump JA, 2004, B WORLD HEALTH ORGAN, V82, P346; Crump JA, 2008, ANTIMICROB AGENTS CH, V52, P1278, DOI 10.1128/AAC.01509-07; Dutta S, 2005, ANTIMICROB AGENTS CH, V49, P1662, DOI 10.1128/AAC.49.4.1662-1663.2005; Dutta S, 2008, INT J ANTIMICROB AG, V31, P387, DOI 10.1016/j.ijantimicag.2007.12.004; Effa EE, 2008, COCHRANE DB SYST REV, V4; European Centre for Disease Prevention and Control, 2013, 4 EXT QUAL ASS SCHEM; Gaind R, 2006, J ANTIMICROB CHEMOTH, V58, P1139, DOI 10.1093/jac/dkl391; Gebreyes WA, 2005, ANTIMICROB AGENTS CH, V49, P503, DOI 10.1128/AAC.49.2.503-511.2005; Gebreyes WA, 2002, J CLIN MICROBIOL, V40, P2813, DOI 10.1128/JCM.40.8.2813-2822.2002; Goh YL, 2002, J APPL MICROBIOL, V92, P1167, DOI 10.1046/j.1365-2672.2002.01655.x; Hampton MD, 1998, EMERG INFECT DIS, V4, P317, DOI 10.3201/eid0402.980223; Holt KE, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001245; KADO CI, 1981, J BACTERIOL, V145, P1365, DOI 10.1128/JB.145.3.1365-1373.1981; Kumar S, 2008, J MED MICROBIOL, V57, P1247, DOI 10.1099/jmm.0.2008/001719-0; Le TAH, 2007, J CLIN MICROBIOL, V45, P3485, DOI 10.1128/JCM.00948-07; Manchanda V, 2006, Indian J Med Microbiol, V24, P101; Matsumoto M, 2000, Kansenshogaku Zasshi, V74, P143; Medalla F, 2011, EMERG INFECT DIS, V17, P1095, DOI [10.3201/eid1706.100594, 10.3201/eid/1706.100594]; Menezes GA, 2012, CLIN MICROBIOL INFEC, V18, P239, DOI 10.1111/j.1469-0691.2011.03546.x; Mirza S, 2000, J CLIN MICROBIOL, V38, P1449, DOI 10.1128/JCM.38.4.1449-1452.2000; Mohanty S, 2006, EPIDEMIOL INFECT, V134, P961, DOI 10.1017/S0950268805005844; Molloy A, 2010, J CLIN MICROBIOL, V48, P4655, DOI 10.1128/JCM.00648-10; Ochiai RL, 2008, B WORLD HEALTH ORGAN, V86, P260, DOI 10.2471/BLT.06.039818; Parvathi A, 2011, CURR MICROBIOL, V62, P21, DOI 10.1007/s00284-010-9665-7; PILLAI PK, 1993, INDIAN J MED RES-A, V97, P154; Ploy MC, 2003, ANTIMICROB AGENTS CH, V47, P1427, DOI 10.1128/AAC.47.4.1427-1429.2003; Pokharel BM, 2006, INT J INFECT DIS, V10, P434, DOI 10.1016/j.ijid.2006.07.001; Rai S, 2012, INDIAN J MED MICROBI, V30, P30, DOI 10.4103/0255-0857.93017; Rotimi VO, 2008, J MED MICROBIOL, V57, P881, DOI 10.1099/jmm.0.47509-0; Saenz Y, 2004, ANTIMICROB AGENTS CH, V48, P3996, DOI 10.1128/AAC.48.10.3996-4001.2004; SAHA MR, 1992, INDIAN J MED RES-A, V95, P179; Shanahan PMA, 1998, J CLIN MICROBIOL, V36, P1595, DOI 10.1128/JCM.36.6.1595-1600.1998; Sjolund-Karlsson M, 2011, ANTIMICROB AGENTS CH, V55, P3985, DOI 10.1128/AAC.00590-11; Soto SM, 2006, J MED MICROBIOL, V55, P365, DOI 10.1099/jmm.0.46257-0; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Thong KL, 1998, EMERG INFECT DIS, V4, P507, DOI 10.3201/eid0403.980348; Thong KL, 2000, Int J Infect Dis, V4, P194, DOI 10.1016/S1201-9712(00)90108-5; Threlfall EJ, 2006, LANCET, V367, P1576, DOI 10.1016/S0140-6736(06)68691-1; Verma S, 2010, INDIAN J MED MICROBI, V28, P51, DOI 10.4103/0255-0857.58730; Vlieghe ER, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001933; Wain J, 2003, ANTIMICROB AGENTS CH, V47, P2732, DOI 10.1128/AAC.47.9.2732-2739.2003; World Health Organization, 1983, CDD833 WHO; World Health Organization: Indian Network for Surveillance of Antimicrobial Resistance, 2012, WHO S E ASIA J PUBLI, V1, P182, DOI DOI 10.4103/2224-3151.206930; Wu WY, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-32	52	47	52	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e101347	10.1371/journal.pone.0101347	http://dx.doi.org/10.1371/journal.pone.0101347			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25098613	gold, Green Published, Green Submitted			2022-12-27	WOS:000339995100004
J	Pearson, DE; Icasatti, NS; Hierro, JL; Bird, BJ				Pearson, Dean E.; Icasatti, Nadia S.; Hierro, Jose L.; Bird, Benjamin J.			Are Local Filters Blind to Provenance? Ant Seed Predation Suppresses Exotic Plants More than Natives	PLOS ONE			English	Article							FEEDING-PREFERENCE EXPERIMENTS; HARVESTER ANTS; BIOTIC RESISTANCE; INVASIONS; COMMUNITY; DESERT; DESIGN; SIZE; INVASIVENESS; MYRMECOCHORY	The question of whether species' origins influence invasion outcomes has been a point of substantial debate in invasion ecology. Theoretically, colonization outcomes can be predicted based on how species' traits interact with community filters, a process presumably blind to species' origins. Yet, exotic plant introductions commonly result in monospecific plant densities not commonly seen in native assemblages, suggesting that exotic species may respond to community filters differently than natives. Here, we tested whether exotic and native species differed in their responses to a local community filter by examining how ant seed predation affected recruitment of eighteen native and exotic plant species in central Argentina. Ant seed predation proved to be an important local filter that strongly suppressed plant recruitment, but ants suppressed exotic recruitment far more than natives (89% of exotic species vs. 22% of natives). Seed size predicted ant impacts on recruitment independent of origins, with ant preference for smaller seeds resulting in smaller seeded plant species being heavily suppressed. The disproportionate effects of provenance arose because exotics had generally smaller seeds than natives. Exotics also exhibited greater emergence and earlier peak emergence than natives in the absence of ants. However, when ants had access to seeds, these potential advantages of exotics were negated due to the filtering bias against exotics. The differences in traits we observed between exotics and natives suggest that higher-order introduction filters or regional processes preselected for certain exotic traits that then interacted with the local seed predation filter. Our results suggest that the interactions between local filters and species traits can predict invasion outcomes, but understanding the role of provenance will require quantifying filtering processes at multiple hierarchical scales and evaluating interactions between filters.	[Pearson, Dean E.] Forest Serv, Rocky Mt Res Stn, USDA, Missoula, MT 59808 USA; [Pearson, Dean E.] Univ Montana, Div Biol Sci, Missoula, MT 59812 USA; [Hierro, Jose L.] Univ Nacl La Pampa, Consejo Nacl Invest Cient & Tecn, Inst Ciencias Tierra & Ambientales La Pampa, Santa Rosa, La Pampa, Argentina; [Hierro, Jose L.] Univ Nacl La Pampa, Fac Ciencias Exactas & Nat, Santa Rosa, La Pampa, Argentina; [Icasatti, Nadia S.; Bird, Benjamin J.] Forest Serv, Rocky Mt Res Stn, USDA, Ft Collins, CO USA	United States Department of Agriculture (USDA); United States Forest Service; University of Montana System; University of Montana; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); United States Department of Agriculture (USDA); United States Forest Service	Pearson, DE (corresponding author), Forest Serv, Rocky Mt Res Stn, USDA, Missoula, MT 59808 USA.	dpearson@fs.fed.us			PECASE (President's Early Career Award in Science and Engineering); Rocky Mountain Research Station, USDA Forest Service	PECASE (President's Early Career Award in Science and Engineering); Rocky Mountain Research Station, USDA Forest Service(United States Department of Agriculture (USDA)United States Forest Service)	This project was supported by funding from PECASE (President's Early Career Award in Science and Engineering) and the Rocky Mountain Research Station, USDA Forest Service to DEP. ANPCyT (Agencia Nacional para la Promocion de la Cienciay la Tecnologi a), FCEyN (Facultad de Ciencias Exactas y Naturales), and CIN (Interuniversity National Council of Argentina) Consejo Interuniversitario Nacional to JLH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alba-Lynn C, 2010, PLANT ECOL, V210, P291, DOI 10.1007/s11258-010-9757-2; Allington GRH, 2013, ECOL LETT, V16, P158, DOI 10.1111/ele.12023; ANDERSEN AN, 1987, OIKOS, V48, P171, DOI 10.2307/3565852; Bazzaz F.A., 1990, PERSPECTIVES PLANT C, P240; Beattie Andrew J., 2002, P211; Blackburn TM, 2004, SCIENCE, V305, P1955, DOI 10.1126/science.1101617; BROWN JH, 1990, SCIENCE, V250, P1705, DOI 10.1126/science.250.4988.1705; Cadotte MW, 2001, ECOSCIENCE, V8, P230, DOI 10.1080/11956860.2001.11682649; Callaway RM, 2004, FRONT ECOL ENVIRON, V2, P436, DOI 10.1890/1540-9295(2004)002[0436:NWISAT]2.0.CO;2; Catford JA, 2009, DIVERS DISTRIB, V15, P22, DOI 10.1111/j.1472-4642.2008.00521.x; Connolly B, 2014, ECOLOGY IN PRESS; COTTRELL HJ, 1947, NATURE, V159, P748, DOI 10.1038/159748a0; Davis M, 2011, NATURE, V474, P153, DOI 10.1038/474153a; Ferreira AV, 2011, OIKOS, V120, P1013, DOI 10.1111/j.1600-0706.2010.19052.x; Gurevitch J, 2011, ECOL LETT, V14, P407, DOI 10.1111/j.1461-0248.2011.01594.x; Heredia A, 2005, BEHAV PROCESS, V70, P289, DOI 10.1016/j.beproc.2005.08.001; Hierro JL, 2005, J ECOL, V93, P5, DOI 10.1111/j.0022-0477.2004.00953.x; HUGHES L, 1994, FUNCT ECOL, V8, P358, DOI 10.2307/2389829; HUGHES L, 1992, ECOLOGY, V73, P1300, DOI 10.2307/1940677; Jensen JM, 2006, ENVIRON ENTOMOL, V35, P326, DOI 10.1603/0046-225X-35.2.326; JOHNSON DH, 1980, ECOLOGY, V61, P65, DOI 10.2307/1937156; Kaspari M, 1996, OECOLOGIA, V105, P397, DOI 10.1007/BF00328743; Leffler AJ, 2014, ECOLOGY, V95, P298, DOI 10.1890/13-0102.1; Lengyel S, 2010, PERSPECT PLANT ECOL, V12, P43, DOI 10.1016/j.ppees.2009.08.001; MacMahon JA, 2000, ANNU REV ECOL SYST, V31, P265, DOI 10.1146/annurev.ecolsys.31.1.265; MANLY BFJ, 1993, OECOLOGIA, V93, P149, DOI 10.1007/BF00321205; Maron JL, 2014, ECOL LETT, V17, P499, DOI 10.1111/ele.12250; Maron JL, 2012, J ECOL, V100, P1492, DOI 10.1111/j.1365-2745.2012.02027.x; Moore RJ, 1974, RES BRANCH CANADA DE, V10, P54; Moravcova L, 2010, PRESLIA, V82, P365; Nunez MA, 2008, BIOL INVASIONS, V10, P1389, DOI 10.1007/s10530-007-9214-x; O'Dowd DJ, 2003, ECOL LETT, V6, P812, DOI 10.1046/j.1461-0248.2003.00512.x; Pearson DE, 2014, BIOL INVASIONS, V16, P1185, DOI 10.1007/s10530-013-0573-1; Pearson DE, 2012, J ECOL, V100, P1383, DOI 10.1111/j.1365-2745.2012.02025.x; Pearson DE, 2012, BIOL INVASIONS, V14, P901, DOI 10.1007/s10530-011-0126-4; Pearson DE, 2011, ECOLOGY, V92, P1748, DOI 10.1890/11-0164.1; PEMBERTON RW, 1990, WEED SCI, V38, P615, DOI 10.1017/S0043174500051584; Peters HA, 2005, OIKOS, V109, P351, DOI 10.1111/j.0030-1299.2005.13282.x; Pirk GI, 2009, INSECT SOC, V56, P277, DOI 10.1007/s00040-009-0021-5; Prince JS, 2004, OECOLOGIA, V138, P1, DOI 10.1007/s00442-003-1413-2; Pysek Petr, 2007, V193, P97; R Development Core Team, 2006, R LANG ENV STAT COMP; Ricciardi A, 1998, CAN J FISH AQUAT SCI, V55, P1759, DOI 10.1139/cjfas-55-7-1759; Richardson David M., 2000, Diversity and Distributions, V6, P93, DOI 10.1046/j.1472-4642.2000.00083.x; ROA R, 1992, OECOLOGIA, V89, P509, DOI 10.1007/BF00317157; SAMSON DA, 1992, OIKOS, V65, P61, DOI 10.2307/3544888; Simberloff D, 2014, OIKOS, V123, P408, DOI 10.1111/j.1600-0706.2013.01228.x; Simberloff D, 2011, NATURE, V475, P36, DOI 10.1038/475036a; Smithson M, 2006, PSYCHOL METHODS, V11, P54, DOI 10.1037/1082-989X.11.1.54; Strauss SY, 2006, P NATL ACAD SCI USA, V103, P5841, DOI 10.1073/pnas.0508073103; Tizón F. Rodrigo, 2009, Rev. Soc. Entomol. Argent., V68, P365; Torchin ME, 2004, FRONT ECOL ENVIRON, V2, P183, DOI 10.1890/1540-9295(2004)002[0183:PPAIBP]2.0.CO;2; Weiher E., 1999, ECOLOGICAL ASSEMBLY, DOI DOI 10.1017/CBO9780511542237	54	25	25	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e103824	10.1371/journal.pone.0103824	http://dx.doi.org/10.1371/journal.pone.0103824			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25099535	Green Published, gold			2022-12-27	WOS:000339995100033
J	Tzamali, E; Grekas, G; Marias, K; Sakkalis, V				Tzamali, Eleftheria; Grekas, Georgios; Marias, Konstantinos; Sakkalis, Vangelis			Exploring the Competition between Proliferative and Invasive Cancer Phenotypes in a Continuous Spatial Model	PLOS ONE			English	Article							NONLINEAR TUMOR-GROWTH; HYPOXIA; MIGRATION; CELLS; GLIOMAS; HETEROGENEITY; MECHANISMS; MORPHOLOGY; EVOLUTION; DRIVEN	Tumor is characterized by extensive heterogeneity with respect to its microenvironment and its genetic composition. We extend a previously developed monoclonal continuous spatial model of tumor growth to account for polyclonal cell populations and investigate the interplay between a more proliferative and a more invasive phenotype under different conditions. The model simulations demonstrate a transition from the dominance of the proliferative to the dominance of the invasive phenotype resembling malignant tumor progression and show a time period where both subpopulations are abundant. As the dominant phenotype switches from proliferative to invasive, the geometry of tumor changes from a compact and almost spherical shape to a more diffusive and fingered morphology with the proliferative phenotype to be restricted in the tumor bulk and the invasive to dominate at tumor edges. Different micro-environmental conditions and different phenotypic properties can promote or inhibit invasion demonstrating their mutual importance. The model provides a computational framework to investigate tumor heterogeneity and the constant interplay between the environment and the specific characteristics of phenotypes that should be taken into account for the prediction of tumor evolution, morphology and effective treatment.	[Tzamali, Eleftheria; Grekas, Georgios; Marias, Konstantinos; Sakkalis, Vangelis] Fdn Res & Technol Hellas, Inst Comp Sci, Computat Med Lab, Iraklion, Greece	Foundation for Research & Technology - Hellas (FORTH)	Tzamali, E (corresponding author), Fdn Res & Technol Hellas, Inst Comp Sci, Computat Med Lab, Iraklion, Greece.	etzamali@gmail.com	Marias, Kostas/AAM-2330-2021; Sakkalis, Vangelis/M-3815-2019; Sakkalis, Vangelis/P-6883-2015	Marias, Kostas/0000-0003-3783-5223; Sakkalis, Vangelis/0000-0003-4701-850X; Grekas, Georgios/0000-0002-0267-0150	European Commission under the Transatlantic Tumor Model Repositories - TUMOR [FP7-ICT-2009.5.4-247754]; Computational Horizons In Cancer - CHIC [FP7-ICT-2011.5.2-600841]	European Commission under the Transatlantic Tumor Model Repositories - TUMOR; Computational Horizons In Cancer - CHIC	This work was supported in part by the European Commission under the Transatlantic Tumor Model Repositories - TUMOR (FP7-ICT-2009.5.4-247754) and the Computational Horizons In Cancer - CHIC (FP7-ICT-2011.5.2-600841) projects. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson ARA, 2008, NAT REV CANCER, V8, P227, DOI 10.1038/nrc2329; Anderson ARA, 2006, CELL, V127, P905, DOI 10.1016/j.cell.2006.09.042; Anderson ARA, 2005, MATH MED BIOL, V22, P163, DOI 10.1093/imammb/dqi005; Axelrod R, 2006, P NATL ACAD SCI USA, V103, P13474, DOI 10.1073/pnas.0606053103; Brown JM, 2004, NAT REV CANCER, V4, P437, DOI 10.1038/nrc1367; Cronin PA, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-225; Demuth T, 2004, J NEURO-ONCOL, V70, P217, DOI 10.1007/s11060-004-2751-6; Douglas J., 1962, NUMER MATH, V4, P41, DOI DOI 10.1007/BF01386295; Eckerich C, 2007, INT J CANCER, V121, P276, DOI 10.1002/ijc.22679; Fedotov S, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.118101; Frieboes HB, 2010, J THEOR BIOL, V264, P1254, DOI 10.1016/j.jtbi.2010.02.036; Giese A, 1996, INT J CANCER, V67, P275, DOI 10.1002/(SICI)1097-0215(19960717)67:2<275::AID-IJC20>3.0.CO;2-9; Giese A, 2003, J CLIN ONCOL, V21, P1624, DOI 10.1200/JCO.2003.05.063; Hadeler K.P., 2009, SPATIAL ECOLOGY; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hatzikirou H, 2012, MATH MED BIOL, V29, P49, DOI 10.1093/imammb/dqq011; Hinow P, 2009, MATH BIOSCI ENG, V6, P521, DOI 10.3934/mbe.2009.6.521; Kitano H, 2004, NAT REV CANCER, V4, P227, DOI 10.1038/nrc1300; Loeb LA, 2011, NAT REV CANCER, V11, P450, DOI 10.1038/nrc3063; Mansury Y, 2006, J THEOR BIOL, V238, P146, DOI 10.1016/j.jtbi.2005.05.027; Marusyk A, 2012, NAT REV CANCER, V12, P323, DOI 10.1038/nrc3261; Marusyk A, 2010, BBA-REV CANCER, V1805, P105, DOI 10.1016/j.bbcan.2009.11.002; Nagelkerke A, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3373; Pennacchietti S, 2003, CANCER CELL, V3, P347, DOI 10.1016/S1535-6108(03)00085-0; Pham K, 2012, J BIOL DYNAM, V6, P54, DOI 10.1080/17513758.2011.590610; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Roniotis A, 2012, IEEE T INF TECHNOL B, V16, P299, DOI 10.1109/TITB.2012.2185704; Sakkalis V, 2010, IEEE ENG MED BIO, P6809, DOI 10.1109/IEMBS.2010.5625961; Sanga S, 2007, NEUROIMAGE, V37, pS120, DOI 10.1016/j.neuroimage.2007.05.043; Sottoriva A, 2013, P NATL ACAD SCI USA, V110, P4009, DOI 10.1073/pnas.1219747110; Sullivan R, 2007, CANCER METAST REV, V26, P319, DOI 10.1007/s10555-007-9062-2; Swanson KR, 2008, CLIN ONCOL-UK, V20, P301, DOI 10.1016/j.clon.2008.01.006; Swanson KR, 2003, J NEUROL SCI, V216, P1, DOI 10.1016/j.jns.2003.06.001; Swanson KR, 2011, CANCER RES, V71, P7366, DOI 10.1158/0008-5472.CAN-11-1399; Tektonidis M, 2011, J THEOR BIOL, V287, P131, DOI 10.1016/j.jtbi.2011.07.012; WACHSPRESS EL, 1960, J SOC IND APPL MATH, V8, P403, DOI 10.1137/0108027; Wise SM, 2008, J THEOR BIOL, V253, P524, DOI 10.1016/j.jtbi.2008.03.027; Zaman MH, 2006, P NATL ACAD SCI USA, V103, P10889, DOI 10.1073/pnas.0604460103	38	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e103191	10.1371/journal.pone.0103191	http://dx.doi.org/10.1371/journal.pone.0103191			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25099885	Green Published, gold, Green Submitted			2022-12-27	WOS:000339995100015
J	Zhao, M; He, MX; Huang, XD; Wang, Q				Zhao, Mi; He, Maoxian; Huang, Xiande; Wang, Qi			A Homeodomain Transcription Factor Gene, PfMSX, Activates Expression of Pif Gene in the Pearl Oyster Pinctada fucata	PLOS ONE			English	Article							ACIDIC MATRIX PROTEIN; MSX HOMEOBOX GENES; DNA-BINDING; KEY MACROMOLECULE; EVOLUTION; IDENTIFICATION; CONSERVATION; REGENERATION; PLANARIAN; MUTATION	We reported pearl oyster Pinctada fucata cDNA and genomic characterization of a new homeobox-containing protein, PfMSX. The PfMSX gene encodes a transcription factor that was localized to the nucleus. Analyses of PfMSX mRNA in tissues and developmental stages showed high expressions in mantle or D-shaped larvae. In electrophoretic mobility shift assays (EMSAs) PfMSX binded to MSX consensus binding sites in the 59 flanking region of the Pif promoter. In co-transfection experiment PfMSX transactivated reporter constructs containing Pif promoter sequences, and mutation of the MSX-binding sites attenuated transactivation. A knockdown experiment using PfMSX dsRNA showed decreased Pif mRNA and unregular crystallization of the nacreous layer using scanning electron microscopy. Our results suggested that PfMSX was a conserved homeodomain transcription factor gene, which can activate Pif gene expression through MSX binding site, and was then involved in the mineralization process in pearl oyster Pinctada fucata. Our data provided important clues about mechanisms regulating biomineralization in pearl oyster.	[Zhao, Mi; He, Maoxian; Huang, Xiande; Wang, Qi] Chinese Acad Sci, South China Sea Inst Oceanol, CAS Key Lab Trop Marine Bioresources & Ecol, Guangzhou, Guangdong, Peoples R China; [Zhao, Mi; Wang, Qi] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; South China Sea Institute of Oceanology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	He, MX (corresponding author), Chinese Acad Sci, South China Sea Inst Oceanol, CAS Key Lab Trop Marine Bioresources & Ecol, Guangzhou, Guangdong, Peoples R China.	hmx@scsio.ac.cn			National Natural Science Foundation of China [41376159]; National Science and technology program of China [2012AA10A410]; Funds of Knowledge Innovation Program of Chinese Academy of Sciences [ZCX2-EW-Q21]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and technology program of China; Funds of Knowledge Innovation Program of Chinese Academy of Sciences	National Natural Science Foundation of China (41376159) http://www.nsfc.gov.cn/; the National Science and technology program of China (2012AA10A410) and the Funds of Knowledge Innovation Program of Chinese Academy of Sciences (ZCX2-EW-Q21). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aioub M, 2007, BONE, V41, P851, DOI 10.1016/j.bone.2007.07.023; AKIMENKO MA, 1995, DEVELOPMENT, V121, P347; Aniello F, 1999, MECH DEVELOP, V88, P123, DOI 10.1016/S0925-4773(99)00178-1; Bensoussan-Trigano V, 2011, DEV DYNAM, V240, P1190, DOI 10.1002/dvdy.22619; Berger MF, 2008, CELL, V133, P1266, DOI 10.1016/j.cell.2008.05.024; Carroll SB, 2005, PLOS BIOL, V3, P1159, DOI 10.1371/journal.pbio.0030245; CATRON KM, 1993, MOL CELL BIOL, V13, P2354, DOI 10.1128/MCB.13.4.2354; de Jong DM, 2006, DEV BIOL, V298, P632, DOI 10.1016/j.ydbio.2006.07.034; Dobias SL, 1997, MECH DEVELOP, V61, P37, DOI 10.1016/S0925-4773(96)00617-X; Ekker M, 1997, MOL BIOL EVOL, V14, P1008, DOI 10.1093/oxfordjournals.molbev.a025707; Fang D, 2012, J BIOL CHEM, V287, P15776, DOI 10.1074/jbc.M112.341594; Fang D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021860; Galle S, 2005, INT J DEV BIOL, V49, P961, DOI 10.1387/ijdb.052009sg; Garvie CW, 2001, MOL CELL, V8, P937, DOI 10.1016/S1097-2765(01)00392-6; Haerry TE, 1997, DEV BIOL, V186, P1, DOI 10.1006/dbio.1997.8582; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Holland PWH, 2005, BRAIN RES BULL, V66, P484, DOI 10.1016/j.brainresbull.2005.06.003; Hovde S, 2001, BIOCHEMISTRY-US, V40, P12013, DOI 10.1021/bi0108148; Hu GZ, 2001, DEVELOPMENT, V128, P2373; Huang XD, 2013, MAR BIOTECHNOL, V15, P253, DOI 10.1007/s10126-012-9484-x; Kapustin Y, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-20; Lallemand Y, 2005, DEVELOPMENT, V132, P3003, DOI 10.1242/dev.01877; Lallemand Y, 2009, DEV BIOL, V331, P189, DOI 10.1016/j.ydbio.2009.04.038; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; Liang J, 2012, EUR J ORAL SCI, V120, P278, DOI 10.1111/j.1600-0722.2012.00965.x; Liu Y, 1999, OPT EXPRESS, V4, P177, DOI 10.1364/OE.4.000177; Luscombe NM, 2002, J MOL BIOL, V320, P991, DOI 10.1016/S0022-2836(02)00571-5; Ma L, 1996, HUM MOL GENET, V5, P1915, DOI 10.1093/hmg/5.12.1915; Mannini L, 2008, INT J DEV BIOL, V52, P943, DOI 10.1387/ijdb.072476lm; Montagnani C, 2011, CHEMBIOCHEM, V12, P2033, DOI 10.1002/cbic.201100216; Pan C, 2014, J BIOL CHEM, V289, P2776, DOI 10.1074/jbc.M113.504027; Saadi I, 2013, DEVELOPMENT, V140, P2697, DOI 10.1242/dev.088393; Satokata I, 2000, NAT GENET, V24, P391, DOI 10.1038/74231; Schierwater B, 2002, MOL PHYLOGENET EVOL, V24, P374, DOI 10.1016/S1055-7903(02)00238-5; Sikes JM, 2013, NATURE, V500, P77, DOI 10.1038/nature12403; Suzuki M, 2009, SCIENCE, V325, P1388, DOI 10.1126/science.1173793; Takahashi H, 2008, MOL BIOL EVOL, V25, P69, DOI 10.1093/molbev/msm228; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TOWLER DA, 1994, MOL ENDOCRINOL, V8, P1484, DOI 10.1210/me.8.11.1484; Wang RZ, 2001, J MATER RES, V16, P2485, DOI 10.1557/JMR.2001.0340; WEINER S, 1984, PHILOS T ROY SOC B, V304, P425, DOI 10.1098/rstb.1984.0036; Weirauch MT, 2010, TRENDS GENET, V26, P66, DOI 10.1016/j.tig.2009.12.002; Wilson KA, 2005, EVOL DEV, V7, P416, DOI 10.1111/j.1525-142X.2005.05046.x; Zhang C, 2006, MAR BIOTECHNOL, V8, P572, DOI 10.1007/s10126-005-6029-6; Zhang GF, 2012, NATURE, V490, P49, DOI 10.1038/nature11413	45	17	17	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e103830	10.1371/journal.pone.0103830	http://dx.doi.org/10.1371/journal.pone.0103830			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25099698	gold, Green Submitted, Green Published			2022-12-27	WOS:000339995100034
J	Gahring, LC; Myers, E; Palumbos, S; Rogers, SW				Gahring, Lorise C.; Myers, Elizabeth; Palumbos, Sierra; Rogers, Scott W.			Nicotinic Receptor Alpha7 Expression during Mouse Adrenal Gland Development	PLOS ONE			English	Article							BOVINE CHROMAFFIN CELLS; MEDIATED INTERCELLULAR COMMUNICATION; TRANSCRIPTION FACTOR EGR-1; ACETYLCHOLINE-RECEPTOR; NERVOUS-SYSTEM; CATECHOLAMINE RELEASE; IMMUNE-SYSTEM; RAT; MEDULLA; INFLAMMATION	The nicotinic acetylcholine receptor alpha 7 (alpha 7) is a ligand-activated ion channel that contributes to a diversity of cellular processes involved in development, neurotransmission and inflammation. In this report the expression of a7 was examined in the mouse developing and adult adrenal gland that expresses a green fluorescent protein (GFP) reporter as a bi-cistronic extension of the endogenous alpha 7 transcript (alpha 7(G)). At embryonic day 12.5 (E12.5) alpha 7(G) expression was associated with the suprarenal ganglion and precursor cells of the adrenal gland. The a7 G cells are catecholaminergic chromaffin cells as reflected by their progressive increase in the co-expression of tyrosine hydroxylase (TH) and dopamine-beta-hydroxylase (DBH) that is complete by E18.5. In the adult, alpha 7(G) expression is limited to a subset of chromaffin cells in the adrenal medulla that cluster near the border with the adrenal cortex. These chromaffin cells co-express alpha 7(G), TH and DBH, but they lack phenylethanolamine N-methyltransferase (PNMT) consistent with only norepinephrine (NE) synthesis. These cell groups appear to be preferentially innervated by pre-ganglionic afferents identified by the neurotrophin receptor p75. No afferents identified by beta-III tubulin, neurofilament proteins or p75 co-expressed alpha 7(G). Occasional alpha 7(G) cells in the pre-E14.5 embryos express neuronal markers consistent with intrinsic ganglion cells and in the adult some alpha 7(G) cells co-express glutamic acid decarboxylase. The transient expression of alpha 7 during adrenal gland development and its prominent co-expression by a subset of NE chromaffin cells in the adult suggests that the alpha 7 receptor contributes to multiple aspects of adrenal gland development and function that persist into adulthood.	[Gahring, Lorise C.; Rogers, Scott W.] Salt Lake City VA Geriatr Res Educ & Clin Ctr, Salt Lake City, UT 84112 USA; [Gahring, Lorise C.; Myers, Elizabeth] Univ Utah, Dept Internal Med, Div Geriatr, Salt Lake City, UT 84112 USA; [Palumbos, Sierra; Rogers, Scott W.] Univ Utah, Dept Neurobiol & Anat, Salt Lake City, UT USA	Geriatric Research Education & Clinical Center; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Rogers, SW (corresponding author), Salt Lake City VA Geriatr Res Educ & Clin Ctr, Salt Lake City, UT 84112 USA.	Scott.Rogers@hsc.utah.edu		Palumbos, Sierra/0000-0002-3595-984X	National Institutes of Health (NIH) [DA025057, AG029838]; NATIONAL INSTITUTE ON AGING [R01AG029838] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA025057] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health (NIH) grants DA025057 and AG029838. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; ANDERSON DJ, 1986, CELL, V47, P1079, DOI 10.1016/0092-8674(86)90823-8; Bitner RS, 2002, BRAIN RES, V938, P45, DOI 10.1016/S0006-8993(02)02485-X; Buttigieg J, 2009, J NEUROSCI, V29, P7137, DOI 10.1523/JNEUROSCI.0544-09.2009; CamposCaro A, 1997, J NEUROCHEM, V68, P488; Carrasco-Serrano C, 2004, FEBS LETT, V566, P247, DOI 10.1016/j.febslet; Castro E, 2003, J NEUROSCI RES, V71, P375, DOI 10.1002/jnr.10488; Colomer C, 2008, J NEUROSCI, V28, P6616, DOI 10.1523/JNEUROSCI.5597-07.2008; Colomer C, 2012, BBA-BIOMEMBRANES, V1818, P1937, DOI 10.1016/j.bbamem.2011.07.034; Colomer C, 2010, J NEUROSCI, V30, P6732, DOI 10.1523/JNEUROSCI.4997-09.2010; Colomer C, 2009, MOL NEUROBIOL, V40, P87, DOI 10.1007/s12035-009-8073-0; Colomer C, 2008, ANN NY ACAD SCI, V1148, P106, DOI 10.1196/annals.1410.040; Conejero-Goldberg C, 2008, NEUROSCI BIOBEHAV R, V32, P693, DOI 10.1016/j.neubiorev.2007.10.007; Criado M, 1997, J NEUROSCI, V17, P6554; De Biasi M, 2002, J NEUROBIOL, V53, P568, DOI 10.1002/neu.10145; de Jonge WJ, 2007, BRIT J PHARMACOL, V151, P915, DOI 10.1038/sj.bjp.0707264; del Barrio L, 2011, BRIT J PHARMACOL, V162, P94, DOI 10.1111/j.1476-5381.2010.01034.x; Franceschini D, 2000, BEHAV BRAIN RES, V113, P3, DOI 10.1016/S0166-4328(00)00195-9; Fu YT, 1999, J PHARMACOL EXP THER, V289, P133; Gahring LC, 2005, AAPS J, V7, pE885, DOI 10.1208/aapsj070486; Gahring LC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057481; Garcia AG, 2006, PHYSIOL REV, V86, P1093, DOI 10.1152/physrev.00039.2005; GARCIAGUZMAN M, 1995, EUR J NEUROSCI, V7, P647, DOI 10.1111/j.1460-9568.1995.tb00668.x; Grando SA, 1997, JOURNAL OF INVESTIGATIVE DERMATOLOGY SYMPOSIUM PROCEEDINGS, VOL 2, NO 1, AUGUST 1997, P41, DOI 10.1038/jidsymp.1997.10; GUILLEMOT F, 1993, MECH DEVELOP, V42, P171, DOI 10.1016/0925-4773(93)90006-J; Gut P, 2005, DEVELOPMENT, V132, P4611, DOI 10.1242/dev.02052; Habecker BA, 2008, AUTON NEUROSCI-BASIC, V140, P40, DOI 10.1016/j.autneu.2008.03.002; HIGGINS LS, 1988, J NEUROSCI, V8, P1436; Huber K, 2006, GENE EXPRESSION, V13, P133, DOI 10.3727/000000006783991854; Huber K, 2006, DEV BIOL, V298, P335, DOI 10.1016/j.ydbio.2006.07.010; Hunter RG, 2010, BRAIN RES, V1325, P141, DOI 10.1016/j.brainres.2010.02.014; Iwasa K, 1999, J VET MED SCI, V61, P631, DOI 10.1292/jvms.61.631; Jones IW, 2005, TRENDS NEUROSCI, V28, P343, DOI 10.1016/j.tins.2005.04.010; KATAOKA Y, 1984, P NATL ACAD SCI-BIOL, V81, P3218, DOI 10.1073/pnas.81.10.3218; Kurzen H, 2007, HORM METAB RES, V39, P125, DOI 10.1055/s-2007-961816; Leslie FM, 2013, MOL PHARMACOL, V83, P753, DOI 10.1124/mol.112.083659; Lopez MG, 1998, P NATL ACAD SCI USA, V95, P14184, DOI 10.1073/pnas.95.24.14184; MADDEN KS, 1995, ANNU REV PHARMACOL, V35, P417, DOI 10.1146/annurev.pharmtox.35.1.417; Martin AO, 2005, J CELL BIOL, V169, P503, DOI 10.1083/jcb.200411054; Martin AO, 2003, J NEUROSCI, V23, P3669; Martin AO, 2001, J NEUROSCI, V21, P5397, DOI 10.1523/JNEUROSCI.21-15-05397.2001; Metz CN, 2005, NAT IMMUNOL, V6, P756, DOI 10.1038/ni0805-756; MICHELSOHN AM, 1992, NEURON, V8, P589, DOI 10.1016/0896-6273(92)90285-L; Mousavi M, 2001, LIFE SCI, V70, P577, DOI 10.1016/S0024-3205(01)01427-8; Nagavarapu U, 2001, J BIOL CHEM, V276, P16749, DOI 10.1074/jbc.M009712200; Nance DM, 2007, BRAIN BEHAV IMMUN, V21, P736, DOI 10.1016/j.bbi.2007.03.008; OOMORI Y, 1991, ANAT REC, V229, P407, DOI 10.1002/ar.1092290313; OSETGASQUE MJ, 1990, J NEUROSCI RES, V26, P181, DOI 10.1002/jnr.490260207; PARKER TL, 1993, J ANAT, V183, P265; Perez-Alvarez A, 2007, J NEUROCHEM, V103, P2281, DOI 10.1111/j.1471-4159.2007.04932.x; Perez-Alvarez A, 2012, BRIT J PHARMACOL, V165, P908, DOI 10.1111/j.1476-5381.2011.01596.x; Perez-Alvarez A, 2012, FASEB J, V26, P346, DOI 10.1096/fj.11-190223; Rogers SW, 2012, BRAIN BEHAV, V2, P628, DOI 10.1002/brb3.84; Rogers SW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036467; Rogers SW, 2012, AM J MED GENET A, V158A, P1135, DOI 10.1002/ajmg.a.35372; ROSENTHAL RN, 1977, BRIT J PHARMACOL, V60, P59, DOI 10.1111/j.1476-5381.1977.tb16747.x; Rosol TJ, 2001, TOXICOL PATHOL, V29, P41, DOI 10.1080/019262301301418847; Sala F, 2008, ACTA PHYSIOL, V192, P203, DOI 10.1111/j.1748-1716.2007.01804.x; Sanders VM, 2002, INT REV NEUROBIOL, V52, P17; SCHATTEMAN GC, 1993, SOMATOSENS MOT RES, V10, P415, DOI 10.3109/08990229309028847; Schober A, 1998, J NEUROSCI, V18, P7272; Tsoyi K, 2011, ANTIOXID REDOX SIGN, V14, P2057, DOI 10.1089/ars.2010.3555; UNSICKER K, 1978, P NATL ACAD SCI USA, V75, P3498, DOI 10.1073/pnas.75.7.3498; UNSICKER K, 1993, J ANAT, V183, P207; Vida G, 2011, J IMMUNOL, V186, P4340, DOI 10.4049/jimmunol.1003722; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; WILSON SP, 1977, J NEUROCHEM, V28, P687, DOI 10.1111/j.1471-4159.1977.tb10615.x; Young JB, 2002, TRENDS ENDOCRIN MET, V13, P381, DOI 10.1016/S1043-2760(02)00661-6; Zaika OL, 2004, ARCH BIOCHEM BIOPHYS, V424, P23, DOI 10.1016/j.abb.2004.01.012	69	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e103861	10.1371/journal.pone.0103861	http://dx.doi.org/10.1371/journal.pone.0103861			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093893	gold, Green Submitted, Green Published			2022-12-27	WOS:000341357200038
J	Holfeld, J; Tepekoylu, C; Blunder, S; Lobenwein, D; Kirchmair, E; Dietl, M; Kozaryn, R; Lener, D; Theurl, M; Paulus, P; Kirchmair, R; Grimm, M				Holfeld, Johannes; Tepekoeylue, Can; Blunder, Stefan; Lobenwein, Daniela; Kirchmair, Elke; Dietl, Marion; Kozaryn, Radoslaw; Lener, Daniela; Theurl, Markus; Paulus, Patrick; Kirchmair, Rudolf; Grimm, Michael			Low Energy Shock Wave Therapy Induces Angiogenesis in Acute Hind-Limb Ischemia via VEGF Receptor 2 Phosphorylation	PLOS ONE			English	Article							MYOCARDIAL VIABILITY ASSESSMENT; HEART-FAILURE; ENDOTHELIAL-CELLS; GENE-THERAPY; INFARCTION; MODEL; DYSFUNCTION; EXPRESSION; CHALLENGES	Objectives: Low energy shock waves have been shown to induce angiogenesis, improve left ventricular ejection fraction and decrease angina symptoms in patients suffering from chronic ischemic heart disease. Whether there is as well an effect in acute ischemia was not yet investigated. Methods: Hind-limb ischemia was induced in 10-12 weeks old male C57/Bl6 wild-type mice by excision of the left femoral artery. Animals were randomly divided in a treatment group (SWT, 300 shock waves at 0.1 mJ/mm(2), 5 Hz) and untreated controls (CTR), n = 10 per group. The treatment group received shock wave therapy immediately after surgery. Results: Higher gene expression and protein levels of angiogenic factors VEGF-A and PlGF, as well as their receptors Flt-1 and KDR have been found. This resulted in significantly more vessels per high-power field in SWT compared to controls. Improvement of blood perfusion in treatment animals was confirmed by laser Doppler perfusion imaging. Receptor tyrosine kinase profiler revealed significant phosphorylation of VEGF receptor 2 as an underlying mechanism of action. The effect of VEGF signaling was abolished upon incubation with a VEGFR2 inhibitor indicating that the effect is indeed VEGFR 2 dependent. Conclusions: Low energy shock wave treatment induces angiogenesis in acute ischemia via VEGF receptor 2 stimulation and shows the same promising effects as known from chronic myocardial ischemia. It may therefore develop as an adjunct to the treatment armentarium of acute muscle ischemia in limbs and myocardium.	[Holfeld, Johannes; Tepekoeylue, Can; Lobenwein, Daniela; Kirchmair, Elke; Dietl, Marion; Kozaryn, Radoslaw; Grimm, Michael] Med Univ Innsbruck, Univ Hosp Cardiac Surg, A-6020 Innsbruck, Austria; [Tepekoeylue, Can] Med Univ Innsbruck, Div Clin & Funct Anat, Dept Anat Histol & Embryol, A-6020 Innsbruck, Austria; [Blunder, Stefan] Med Univ Innsbruck, Univ Hosp Dermatol & Venerol, A-6020 Innsbruck, Austria; [Lener, Daniela; Theurl, Markus; Kirchmair, Rudolf] Med Univ Innsbruck, Univ Hosp Internal Med 3, Dept Cardiol & Angiol, A-6020 Innsbruck, Austria; [Paulus, Patrick] Goethe Univ Hosp, Clin Anaesthesiol Intens Care Med & Pain Therapy, Frankfurt, Germany	Medical University of Innsbruck; Medical University of Innsbruck; Medical University of Innsbruck; Medical University of Innsbruck; Goethe University Frankfurt; Goethe University Frankfurt Hospital	Holfeld, J (corresponding author), Med Univ Innsbruck, Univ Hosp Cardiac Surg, A-6020 Innsbruck, Austria.	johannes.holfeld@i-med.ac.at		Dietl, Marion/0000-0001-6171-577X; Gollmann-Tepekoylu, Can/0000-0001-6584-3488; Holfeld, Johannes/0000-0001-6623-0595; Theurl, Markus/0000-0002-3609-9730	Medizinischer Forschungsfonds Tirol (MFF) [220]; CRT - Cardiac Regeneration Technologies LLC., Woodstock, Georgia, USA	Medizinischer Forschungsfonds Tirol (MFF); CRT - Cardiac Regeneration Technologies LLC., Woodstock, Georgia, USA	This work was in part supported by a research grant of Medizinischer Forschungsfonds Tirol (MFF), project no. 220 and by a research grant provided by CRT - Cardiac Regeneration Technologies LLC., Woodstock, Georgia, USA, both to J.H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht-Schgoer K, 2012, CIRCULATION, V126, P2491, DOI 10.1161/CIRCULATIONAHA.111.076950; Baker M, 2012, NAT PROTOC, V7, P89, DOI 10.1038/nprot.2011.435; Blunder S, 2012, ATHEROSCLEROSIS, V220, P355, DOI 10.1016/j.atherosclerosis.2011.11.035; Carluccio E, 2012, ECHOCARDIOGR-J CARD, V29, P298, DOI 10.1111/j.1540-8175.2011.01575.x; Carmeliet P, 2000, NAT MED, V6, P1102, DOI 10.1038/80430; Couffinhal T, 1998, AM J PATHOL, V152, P1667; Cunningham JJ, 2012, NAT BIOTECHNOL, V30, P849, DOI 10.1038/nbt.2329; Di Carli MF, 1998, J THORAC CARDIOV SUR, V116, P997, DOI 10.1016/S0022-5223(98)70052-2; DREYFUS GD, 1994, ANN THORAC SURG, V57, P1402, DOI 10.1016/0003-4975(94)90091-4; Elster EA, 2010, J ORTHOP TRAUMA, V24, P133, DOI 10.1097/BOT.0b013e3181b26470; Fukumoto Y, 2006, CORONARY ARTERY DIS, V17, P63, DOI 10.1097/00019501-200602000-00011; Holfeld J, 2016, J TISSUE ENG REGEN M, V10, P1057, DOI 10.1002/term.1890; Holfeld J, 2014, JOVE-J VIS EXP, DOI 10.3791/51076; Isner JM, 2002, NATURE, V415, P234, DOI 10.1038/415234a; Koudstaal S, 2013, STEM CELL TRANSL MED, V2, P434, DOI 10.5966/sctm.2013-0001; Leibowitz D, 2013, INT J CARDIOL, V167, P3033, DOI 10.1016/j.ijcard.2012.11.099; Marwick TH, 1999, J AM COLL CARDIOL, V33, P750, DOI 10.1016/S0735-1097(98)00642-1; Meirer R, 2007, J RECONSTR MICROSURG, V23, P231, DOI 10.1055/s-2007-981506; Mittermayr R, 2012, WOUND REPAIR REGEN, V20, P456, DOI 10.1111/j.1524-475X.2012.00796.x; Mittermayr R, 2011, ANN SURG, V253, P1024, DOI 10.1097/SLA.0b013e3182121d6e; Nishida T, 2004, CIRCULATION, V110, P3055, DOI 10.1161/01.CIR.0000148849.51177.97; Ottomann C, 2012, ANN SURG, V255, P23, DOI 10.1097/SLA.0b013e318227b3c0; Pearle MS, 2012, NEW ENGL J MED, V367, P50, DOI 10.1056/NEJMct1103074; Pleger ST, 2013, CIRC RES, V113, P792, DOI 10.1161/CIRCRESAHA.113.300269; Post MJ, 2001, CARDIOVASC RES, V49, P522, DOI 10.1016/S0008-6363(00)00216-9; Pourrajab F, 2014, INT J CARDIOL, V173, P12, DOI 10.1016/j.ijcard.2014.02.006; Sanganalmath SK, 2013, CIRC RES, V113, P810, DOI 10.1161/CIRCRESAHA.113.300219; Sems A, 2006, J AM ACAD ORTHOP SUR, V14, P195, DOI 10.5435/00124635-200604000-00001; Shah BN, 2013, EUR HEART J, V34, P1323, DOI 10.1093/eurheartj/eht018; Siow RCM, 2012, METHODS MOL BIOL, V806, P265, DOI 10.1007/978-1-61779-367-7_18; Telukuntla KS, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000338; Tepekoylu C, 2013, J THORAC CARDIOV SUR, V146, P971, DOI 10.1016/j.jtcvs.2013.01.017; Theurl M, 2010, CIRC RES, V107, P1326, DOI 10.1161/CIRCRESAHA.110.219493; Uwatoku T, 2007, CORONARY ARTERY DIS, V18, P397, DOI 10.1097/MCA.0b013e328089f19b; Wang Y, 2010, CLIN CARDIOL, V33, P693, DOI 10.1002/clc.20811; Zhao HQ, 2013, CORONARY ARTERY DIS, V24, P493, DOI 10.1097/MCA.0b013e328363244b; Zimpfer D, 2009, J THORAC CARDIOV SUR, V137, P963, DOI 10.1016/j.jtcvs.2008.11.006	37	41	43	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e103982	10.1371/journal.pone.0103982	http://dx.doi.org/10.1371/journal.pone.0103982			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093816	Green Submitted, Green Published, gold			2022-12-27	WOS:000341357200054
J	Kong, XM; Zhang, XL; Zhao, Q; He, J; Chen, L; Zhao, ZG; Li, Q; Ge, JP; Chen, G; Guo, XH; Lu, JM; Weng, JP; Jia, WP; Ji, LN; Xiao, JZ; Shan, ZY; Liu, J; Tian, HM; Ji, QH; Zhu, DL; Zhou, ZG; Shan, GL; Yang, WY				Kong, Xiaomu; Zhang, Xuelian; Zhao, Qi; He, Jiang; Chen, Li; Zhao, Zhigang; Li, Qiang; Ge, Jiapu; Chen, Gang; Guo, Xiaohui; Lu, Juming; Weng, Jianping; Jia, Weiping; Ji, Linong; Xiao, Jianzhong; Shan, Zhongyan; Liu, Jie; Tian, Haoming; Ji, Qiuhe; Zhu, Dalong; Zhou, Zhiguang; Shan, Guangliang; Yang, Wenying			Obesity-Related Genomic Loci Are Associated with Type 2 Diabetes in a Han Chinese Population	PLOS ONE			English	Article							BODY-MASS INDEX; WIDE ASSOCIATION; GENETIC-VARIANTS; SUSCEPTIBILITY LOCI; WAIST CIRCUMFERENCE; ASIAN POPULATIONS; COMMON VARIANTS; MC4R GENE; RISK; WOMEN	Background and Aims: Obesity is a well-known risk factor for type 2 diabetes. Genome-wide association studies have identified a number of genetic loci associated with obesity. The aim of this study is to examine the contribution of obesity-related genomic loci to type 2 diabetes in a Chinese population. Methods: We successfully genotyped 18 obesity-related single nucleotide polymorphisms among 5338 type 2 diabetic patients and 4663 controls. Both individual and joint effects of these single nucleotide polymorphisms on type 2 diabetes and quantitative glycemic traits (assessing beta-cell function and insulin resistance) were analyzed using logistic and linear regression models, respectively. Results: Two single nucleotide polymorphisms near MC4R and GNPDA2 genes were significantly associated with type 2 diabetes before adjusting for body mass index and waist circumference (OR (95% CI) = 1.14 (1.06, 1.22) for the A allele of rs12970134, P = 4.75x10(-4); OR (95% CI) = 1.10 (1.03, 1.17) for the G allele of rs10938397, P = 4.54x10(-3)). When body mass index and waist circumference were further adjusted, the association of MC4R with type 2 diabetes remained significant (P = 1.81x10(-2)) and that of GNPDA2 was attenuated (P = 1.26x10(-1)), suggesting the effect of the locus including GNPDA2 on type 2 diabetes may be mediated through obesity. Single nucleotide polymorphism rs2260000 within BAT2 was significantly associated with type 2 diabetes after adjusting for body mass index and waist circumference (P = 1.04x10(-2)). In addition, four single nucleotide polymorphisms (near or within SEC16B, BDNF, MAF and PRL genes) showed significant associations with quantitative glycemic traits in controls even after adjusting for body mass index and waist circumference (all P values<0.05). Conclusions: This study indicates that obesity-related genomic loci were associated with type 2 diabetes and glycemic traits in the Han Chinese population.	[Kong, Xiaomu; Xiao, Jianzhong; Yang, Wenying] China Japan Friendship Hosp, Key Lab Diabet Prevent & Control, Dept Endocrinol, Beijing, Peoples R China; [Zhao, Qi; He, Jiang] Tulane Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA USA; [Chen, Li] Shandong Univ, Qilu Hosp, Dept Endocrinol, Jinan, Shandong, Peoples R China; [Zhao, Zhigang] Henan Prov Peoples Hosp, Dept Endocrinol, Zhengzhou, Henan, Peoples R China; [Li, Qiang] Harbin Med Univ, Affiliated Hosp 2, Dept Endocrinol, Harbin, Heilongjiang, Peoples R China; [Ge, Jiapu] Xinjiang Uygur Autonomous Reg Hosp, Dept Endocrinol, Urumqi, Xinjiang, Peoples R China; [Chen, Gang] Fujian Prov Hosp, Dept Endocrinol, Fuzhou, Fujian, Peoples R China; [Guo, Xiaohui] Peking Univ, Hosp 1, Dept Endocrinol, Beijing 100871, Peoples R China; [Lu, Juming] Chinese Peoples Liberat Army Gen Hosp, Dept Endocrinol, Beijing, Peoples R China; [Weng, Jianping] Sun Yat Sen Univ, Hosp 3, Dept Endocrinol, Guangzhou 510275, Guangdong, Peoples R China; [Jia, Weiping] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Endocrinol, Shanghai 200030, Peoples R China; [Ji, Linong] Peking Univ, Peoples Hosp, Dept Endocrinol, Beijing 100871, Peoples R China; [Shan, Zhongyan] Chinese Med Univ, Affiliated Hosp 1, Dept Endocrinol, Shenyang, Liaoning, Peoples R China; [Liu, Jie] Shanxi Prov Peoples Hosp, Dept Endocrinol, Taiyuan, Shanxi, Peoples R China; [Tian, Haoming] Sichuan Univ, Dept Endocrinol, West China Hosp, Chengdu 610064, Sichuan, Peoples R China; [Ji, Qiuhe] Fourth Mil Med Univ, Xijing Hosp, Dept Endocrinol, Xian 710032, Shaanxi, Peoples R China; [Zhu, Dalong] Nanjing Univ, Sch Med, Dept Endocrinol, Affiliated Drum Tower Hosp, Nanjing 210008, Jiangsu, Peoples R China; [Zhou, Zhiguang] Xiangya Second Hosp, Dept Endocrinol, Changsha, Hunan, Peoples R China; [Shan, Guangliang] Peking Union Med Coll, Dept Epidemiol, Beijing 100021, Peoples R China	China-Japan Friendship Hospital; Tulane University; Shandong University; Zhengzhou University; Harbin Medical University; Fujian Provincial Hospital; Peking University; Chinese People's Liberation Army General Hospital; Sun Yat Sen University; Shanghai Jiao Tong University; Peking University; China Medical University; Shanxi People's Hospital; Sichuan University; Air Force Military Medical University; Nanjing University; Central South University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Kong, XM (corresponding author), China Japan Friendship Hosp, Key Lab Diabet Prevent & Control, Dept Endocrinol, Beijing, Peoples R China.	ywying_1010@163.com	Jia, Weiping/B-7483-2012; Linong, Ji/AAB-6543-2020; Zhao, Qi/Y-9866-2019; He, Jiang/AAF-5303-2020	He, Jiang/0000-0002-8286-9652; Weng, Jianping/0000-0002-7889-1697; Kong, Xiaomu/0000-0002-5920-4759; Zhou, Zhiguang/0000-0002-0374-1838	Chinese Medical Association Foundation; Sanofi (China) Investment Company Limited; National 973 Program [2011CB504001]; China Postdoctoral Science Foundation [2012M520200]; Fogarty International Center of the National Institutes of Health [D43TW009107]; Eunice Kennedy Shriver National Institute of Child Health & Human Development [K12HD043451]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD043451] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [D43TW009107] Funding Source: NIH RePORTER	Chinese Medical Association Foundation; Sanofi (China) Investment Company Limited; National 973 Program(National Basic Research Program of China); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Fogarty International Center of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Eunice Kennedy Shriver National Institute of Child Health & Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	The Chinese National Diabetes and Metabolic Disorders Study was supported by grants from the Chinese Medical Association Foundation (http://en.cma.org.cn), Sanofi (China) Investment Company Limited (http://www.sanofi.cn/l/cn/zh/index.jsp) and the National 973 Program (2011CB504001) (http://www.973.gov.cn). XK was supported by Award Number 2012M520200 from China Postdoctoral Science Foundation Grant (http://res.chinapostdoctor.org.cn) and the Award Number D43TW009107 from Fogarty International Center of the National Institutes of Health (http://www.fic.nih.gov). QZ was supported by Award Number K12HD043451 from the Eunice Kennedy Shriver National Institute of Child Health & Human Development (http://www.nichd.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali O, 2013, WORLD J DIABETES, V4, P114, DOI 10.4239/wjd.v4.i4.114; Boffetta P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019930; Cauchi S, 2012, DIABETES METAB, V38, P316, DOI 10.1016/j.diabet.2012.02.003; Cauchi S, 2009, J MOL MED, V87, P537, DOI 10.1007/s00109-009-0451-6; Chambers JC, 2008, NAT GENET, V40, P716, DOI 10.1038/ng.156; Chan JCN, 2009, JAMA-J AM MED ASSOC, V301, P2129, DOI 10.1001/jama.2009.726; Cho YS, 2012, CURR DIABETES REP, V12, P686, DOI 10.1007/s11892-012-0326-z; Dwivedi OP, 2013, J HUM GENET, V58, P27, DOI 10.1038/jhg.2012.129; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Han X, 2013, PLOS ONE, V8; Hashimoto M, 1999, HUM GENET, V105, P197, DOI 10.1007/s004390051089; Huang W, 2011, ENDOCRINE, V39, P69, DOI 10.1007/s12020-010-9413-6; Jablonski KA, 2010, DIABETES, V59, P2672, DOI 10.2337/db10-0543; Janipalli CS, 2012, DIABETIC MED, V29, P121, DOI 10.1111/j.1464-5491.2011.03438.x; Li S, 2011, DIABETOLOGIA, V54, P776, DOI 10.1007/s00125-011-2044-5; Liu YJ, 2008, HUM MOL GENET, V17, P1803, DOI 10.1093/hmg/ddn072; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; Loos RJF, 2011, EUR J PHARMACOL, V660, P156, DOI 10.1016/j.ejphar.2011.01.033; Lu YC, 2013, GENOME MED, V5, DOI 10.1186/gm459; Ma RCW, 2013, ANN NY ACAD SCI, V1281, P64, DOI 10.1111/nyas.12098; Mutombo PB, 2013, ENDOCR RES IN PRESS; Ng MCY, 2010, J CLIN ENDOCR METAB, V95, P2418, DOI 10.1210/jc.2009-2077; Qi L, 2008, HUM MOL GENET, V17, P3502, DOI 10.1093/hmg/ddn242; Rees SD, 2011, DIABETIC MED, V28, P673, DOI 10.1111/j.1464-5491.2011.03257.x; Renstrom F, 2009, HUM MOL GENET, V18, P1489, DOI 10.1093/hmg/ddp041; Robiou-du-Pont S, 2013, INT J OBESITY, V37, P980, DOI 10.1038/ijo.2012.175; Sandholt CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023531; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Shi JJ, 2010, AM J EPIDEMIOL, V172, P244, DOI 10.1093/aje/kwq129; Stevens J, 2008, AM J EPIDEMIOL, V167, P1365, DOI 10.1093/aje/kwn060; Takeuchi F, 2011, DIABETOLOGIA, V54, P1350, DOI 10.1007/s00125-011-2086-8; Tao LM, 2012, MOL BIOL REP, V39, P6487, DOI 10.1007/s11033-012-1476-4; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Wen J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009153; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Xi B, 2012, DIABETOLOGIA, V55, P2660, DOI 10.1007/s00125-012-2655-5; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Yoon KH, 2006, LANCET, V368, P1681, DOI 10.1016/S0140-6736(06)69703-1; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364; Zobel DP, 2009, DIABETES, V58, P757, DOI 10.2337/db08-0620	40	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e104486	10.1371/journal.pone.0104486	http://dx.doi.org/10.1371/journal.pone.0104486			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093408	Green Published, Green Submitted, gold			2022-12-27	WOS:000341357200112
J	Nascimento, F; Pousinha, PA; Correia, AM; Gomes, R; Sebastiao, AM; Ribeiro, JA				Nascimento, Filipe; Pousinha, Paula A.; Correia, Alexandra M.; Gomes, Rui; Sebastiao, Ana M.; Ribeiro, Joaquim A.			Adenosine A(2A) Receptors Activation Facilitates Neuromuscular Transmission in the Pre-Symptomatic Phase of the SOD1(G93A) ALS Mice, but Not in the Symptomatic Phase	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; TRANSMITTER RELEASE; A(2A)-ADENOSINE RECEPTOR; ENDOGENOUS ADENOSINE; NERVE ENDINGS; MOUSE MODEL; RAT; NEUROTROPHINS; MODULATION; PARADIGM	Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease leading to motor neuron dysfunction resulting in impairment of neuromuscular transmission. A(2A) adenosine receptors have already been considered as a potential therapeutical target for ALS but their neuromodulatory role at the neuromuscular junction in ALS remains to be clarified. In the present work, we evaluated the effects of A(2A) receptors on neuromuscular transmission of an animal model of ALS: SOD1(G93A) mice either in the pre-symptomatic (4-6 weeks old) or in the symptomatic (12-14 weeks old) stage. Electrophysiological experiments were performed obtaining intracellular recordings in Mg2+ paralyzed phrenic nerve-hemidiaphragm preparations. Endplate potentials (EPPs), quantal content (q. c.) of EPPs, miniature endplate potentials (MEPPs) and giant miniature endplate potential (GMEPPs) were recorded. In the pre-symptomatic phase of the disease (4-6 weeks old mice), the selective A(2A) receptor agonist, CGS 21680, significantly enhanced (p<0.05 Unpaired t-test) the mean amplitude and q. c. of EPPs, and the frequency of MEPPs and GMEPPs at SOD1(G93A) neuromuscular junctions, the effect being of higher magnitude (p<0.05, Unpaired t-test) than age-matched control littermates. On the contrary, in symptomatic mice (12-14 weeks old), CGS 21680 was devoid of effect on both the amplitude and q. c. of EPPs and the frequency of MEPPs and GMEPPs (p<0.05 Paired t-test). The results herein reported clearly document that at the neuromuscular junction of SOD1(G93A) mice there is an exacerbation of A(2A) receptor-mediated excitatory effects at the pre-symptomatic phase, whereas in the symptomatic phase A(2A) receptor activation is absent. The results thus suggest that A(2A) receptors function changes with ALS progression.	[Nascimento, Filipe; Pousinha, Paula A.; Sebastiao, Ana M.; Ribeiro, Joaquim A.] Univ Lisbon, Inst Pharmacol & Neurosci, Fac Med, P-1699 Lisbon, Portugal; [Nascimento, Filipe; Pousinha, Paula A.; Correia, Alexandra M.; Gomes, Rui; Sebastiao, Ana M.; Ribeiro, Joaquim A.] Univ Lisbon, Unit Neurosci, Inst Med Mol, P-1699 Lisbon, Portugal; [Correia, Alexandra M.] Univ Lisbon, Natl Museum Nat Hist & Sci, P-1699 Lisbon, Portugal; [Gomes, Rui] Univ Lisbon, Fac Sci, P-1699 Lisbon, Portugal	Universidade de Lisboa; Universidade de Lisboa; Universidade de Lisboa; Universidade de Lisboa	Ribeiro, JA (corresponding author), Univ Lisbon, Inst Pharmacol & Neurosci, Fac Med, P-1699 Lisbon, Portugal.	jaribeiro@medicina.ulisboa.pt	Correia, Alexandra Marcal/W-8107-2018; Gomes, Rui APL/M-1803-2015; Gomes, Rui/AAE-9130-2022	Correia, Alexandra Marcal/0000-0002-4999-0477; Gomes, Rui APL/0000-0002-7242-6540; Gomes, Rui/0000-0002-7242-6540; Sebastiao, Ana M/0000-0001-9030-6115; Pousinha, Paula/0000-0002-5992-9418	Fundacao do Ministerio da Ciencia e Tecnologia de Portugal [PTDC/SAU-FAR/118787/2010]	Fundacao do Ministerio da Ciencia e Tecnologia de Portugal	This work was supported by Fundacao do Ministerio da Ciencia e Tecnologia de Portugal [Grant PTDC/SAU-FAR/118787/2010] (http://www.fct.pt/index.phtml.pt). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beghi E, 2011, AM J EPIDEMIOL, V174, P1002, DOI 10.1093/aje/kwr229; Belluardo N, 2001, MOL CELL NEUROSCI, V18, P56, DOI 10.1006/mcne.2001.1001; Boulanger L, 1999, NAT NEUROSCI, V2, P346, DOI 10.1038/7258; Catterall WA, 2008, NEURON, V59, P882, DOI 10.1016/j.neuron.2008.09.005; Correia-de-Sa P, 2000, J NEUROCHEM, V74, P2462, DOI 10.1046/j.1471-4159.2000.0742462.x; CORREIADESA P, 1994, N-S ARCH PHARMACOL, V350, P514; CORREIADESA P, 1991, BRIT J PHARMACOL, V103, P1614, DOI 10.1111/j.1476-5381.1991.tb09836.x; CORREIADESA P, 1994, EUR J PHARMACOL, V271, P349, DOI 10.1016/0014-2999(94)90793-5; CORREIADESA P, 1994, BRIT J PHARMACOL, V111, P582, DOI 10.1111/j.1476-5381.1994.tb14777.x; CorreiadeSa P, 1996, J NEUROPHYSIOL, V76, P3910, DOI 10.1152/jn.1996.76.6.3910; Fratantoni SA, 2000, MUSCLE NERVE, V23, P543, DOI 10.1002/(SICI)1097-4598(200004)23:4<543::AID-MUS13>3.0.CO;2-S; Fredholm BB, 1998, J NEUROCHEM, V70, P1210; Fuchs A, 2013, J PHYSIOL-LONDON, V591, P2723, DOI 10.1113/jphysiol.2012.247981; Gonzalez M, 1999, NEURON, V24, P567, DOI 10.1016/S0896-6273(00)81113-7; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Hasko G, 2008, NAT REV DRUG DISCOV, V7, P759, DOI 10.1038/nrd2638; Hu JH, 2003, J NEUROCHEM, V85, P432, DOI 10.1046/j.1471-4159.2003.01670.x; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; JARVIS MF, 1989, J PHARMACOL EXP THER, V251, P888; Kim YI, 1997, P IEEE EMBS, V18, P1773, DOI 10.1109/IEMBS.1996.647655; Krebs HA, 1932, H-S Z PHYSIOL CHEM, V210, P33, DOI 10.1515/bchm2.1932.210.1-2.33; Kust BM, 2002, EXP NEUROL, V177, P419, DOI 10.1006/exnr.2002.8011; Li N, 2012, EUR J IMMUNOL, V42, P1140, DOI 10.1002/eji.201142088; Lopes LV, 1999, J NEUROCHEM, V73, P1733, DOI 10.1046/j.1471-4159.1999.731733.x; Mantilla CB, 2004, MUSCLE NERVE, V29, P381, DOI 10.1002/mus.10558; Naumenko N, 2011, FRONT CELL NEUROSCI, V5, DOI 10.3389/fncel.2011.00026; Noronha-Matos JB, 2011, J NEUROCHEM, V117, P797, DOI 10.1111/j.1471-4159.2011.07216.x; NORRIS FH, 1955, ELECTROEN CLIN NEURO, V7, P115, DOI 10.1016/0013-4694(55)90064-X; Oliveira L, 2004, J PHYSIOL-LONDON, V560, P157, DOI 10.1113/jphysiol.2004.067595; Palma AG, 2011, NEUROSCIENCE, V172, P164, DOI 10.1016/j.neuroscience.2010.10.015; Phani S, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00150; Potenza RL, 2013, J NEUROSCI RES, V91, P585, DOI 10.1002/jnr.23185; Pousinha PA, 2006, NEUROSCI LETT, V404, P143, DOI 10.1016/j.neulet.2006.05.036; Pousinha PA, 2012, NEUROBIOL AGING, V33, P2869, DOI 10.1016/j.neurobiolaging.2012.01.008; Pousinha PA, 2010, J PHARMACOL EXP THER, V332, P153, DOI 10.1124/jpet.109.157255; RIBEIRO JA, 1975, BRIT J PHARMACOL, V54, P213, DOI 10.1111/j.1476-5381.1975.tb06931.x; RIBEIRO JA, 1987, J PHYSIOL-LONDON, V384, P571, DOI 10.1113/jphysiol.1987.sp016470; Ribeiro JA, 1996, PROG BRAIN RES, V109, P231; Robberecht W, 2013, NAT REV NEUROSCI, V14, P248, DOI 10.1038/nrn3430; Rocha MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073846; ROSEN DR, 1993, NATURE, V364, P362, DOI 10.1038/364362c0; Sebastiao Ana M, 2009, Handb Exp Pharmacol, P471, DOI 10.1007/978-3-540-89615-9_16; Sellin LC, 1996, PFLUG ARCH EUR J PHY, V431, P325, DOI 10.1007/BF02207269; Todd KJ, 2006, PFLUG ARCH EUR J PHY, V452, P608, DOI 10.1007/s00424-006-0068-3; Tsentsevitsky A, 2013, NEUROSCIENCE, V248, P699, DOI 10.1016/j.neuroscience.2013.05.065; Turner MR, 2013, LANCET NEUROL, V12, P310, DOI 10.1016/S1474-4422(13)70036-X; UCHITEL OD, 1988, P NATL ACAD SCI USA, V85, P7371, DOI 10.1073/pnas.85.19.7371; Vincenzi F, 2013, AMYOTROPH LAT SCL FR, V14, P406, DOI 10.3109/21678421.2013.793358; WEINSTEIN SP, 1980, J PHYSIOL-LONDON, V307, P453, DOI 10.1113/jphysiol.1980.sp013446; Yanpallewar SU, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039946; Ydens E, 2013, NEUROBIOL DIS, V55, P95, DOI 10.1016/j.nbd.2013.03.005	51	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e104081	10.1371/journal.pone.0104081	http://dx.doi.org/10.1371/journal.pone.0104081			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093813	gold, Green Published, Green Submitted			2022-12-27	WOS:000341357200063
J	Schoelinck, C; Hinsinger, DD; Dettai, A; Cruaud, C; Justine, JL				Schoelinck, Charlotte; Hinsinger, Damien D.; Dettai, Agnes; Cruaud, Corinne; Justine, Jean-Lou			A Phylogenetic Re-Analysis of Groupers with Applications for Ciguatera Fish Poisoning	PLOS ONE			English	Article							MARKET SUBSTITUTION; MOLECULAR PHYLOGENY; DNA BARCODE; TELEOSTEI; IDENTIFICATION; MITOCHONDRIAL; ACANTHOMORPHA; EPIDEMIOLOGY; VARIABILITY; PERFORMANCE	Background: Ciguatera fish poisoning (CFP) is a significant public health problem due to dinoflagellates. It is responsible for one of the highest reported incidence of seafood-borne illness and Groupers are commonly reported as a source of CFP due to their position in the food chain. With the role of recent climate change on harmful algal blooms, CFP cases might become more frequent and more geographically widespread. Since there is no appropriate treatment for CFP, the most efficient solution is to regulate fish consumption. Such a strategy can only work if the fish sold are correctly identified, and it has been repeatedly shown that misidentifications and species substitutions occur in fish markets. Methods: We provide here both a DNA-barcoding reference for groupers, and a new phylogenetic reconstruction based on five genes and a comprehensive taxonomical sampling. We analyse the correlation between geographic range of species and their susceptibility to ciguatera accumulation, and the co-occurrence of ciguatoxins in closely related species, using both character mapping and statistical methods. Results: Misidentifications were encountered in public databases, precluding accurate species identifications. Epinephelinae now includes only twelve genera (vs. 15 previously). Comparisons with the ciguatera incidences show that in some genera most species are ciguateric, but statistical tests display only a moderate correlation with the phylogeny. Atlantic species were rarely contaminated, with ciguatera occurrences being restricted to the South Pacific. Conclusions: The recent changes in classification based on the reanalyses of the relationships within Epinephelidae have an impact on the interpretation of the ciguatera distribution in the genera. In this context and to improve the monitoring of fish trade and safety, we need to obtain extensive data on contamination at the species level. Accurate species identifications through DNA barcoding are thus an essential tool in controlling CFP since meal remnants in CFP cases can be easily identified with molecular tools.	[Schoelinck, Charlotte; Hinsinger, Damien D.; Dettai, Agnes; Justine, Jean-Lou] Museum Natl Hist Nat, Dept Systemat & Evolut, UMR Systemat Adaptat Evolut 7138, F-75231 Paris, France; [Schoelinck, Charlotte] Fisheries & Oceans Canada, Mol Biol, Aquat Anim Hlth, Moncton, NB, Canada; [Cruaud, Corinne] Ctr Natl Sequencage, Evry, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Fisheries & Oceans Canada; UDICE-French Research Universities; Universite Paris Saclay	Schoelinck, C (corresponding author), Museum Natl Hist Nat, Dept Systemat & Evolut, UMR Systemat Adaptat Evolut 7138, F-75231 Paris, France.	schoelinck@mnhn.fr	Dettai, Agnes/Q-6743-2019; Hinsinger, Damien/V-5892-2019; Justine, Jean-Lou/B-1298-2010	Hinsinger, Damien/0000-0001-7459-7610; Justine, Jean-Lou/0000-0002-7155-4540; Cruaud, Corinne/0000-0002-4752-7278	MNHN ATM Barcode; MNHN ATM Biodiversite Actuelle et Fossile; MNHN BQR; Consortium National de Recherche en Genomique; "Service de Systematique Moleculaire" of Museum National d'Histoire Naturelle [CNRS UMS 2700]	MNHN ATM Barcode; MNHN ATM Biodiversite Actuelle et Fossile; MNHN BQR; Consortium National de Recherche en Genomique; "Service de Systematique Moleculaire" of Museum National d'Histoire Naturelle	This study was funded by MNHN ATM Barcode (2010, 2011), MNHN ATM Biodiversite Actuelle et Fossile (2010) and MNHN BQR (2011), awarded to CS and JLJ. This work was supported by the "Consortium National de Recherche en Genomique", and the "Service de Systematique Moleculaire" of the Museum National d'Histoire Naturelle (CNRS UMS 2700). It is part of the agreement no2005/67 between the Genoscope and the Museum National d'Histoire Naturelle on the project "Macrophylogeny of life" directed by Guillaume Lecointre. This work is part of the project @ SPEED-ID "Accurate SPEciEs Delimitation and IDentification of eukaryotic biodiversity using DNA markers'' proposed by F-BoL, the French Barcode of life initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumann F, 2010, TOXICON, V56, P662, DOI 10.1016/j.toxicon.2009.10.015; Buhay JE, 2009, J CRUSTACEAN BIOL, V29, P96, DOI 10.1651/08-3020.1; Carvalho DC, 2011, MITOCHONDR DNA, V22, P97, DOI 10.3109/19401736.2011.588219; Centers for disease control and prevention, 2013, JAMA-J AM MED ASSOC, V309, P1102; Chateau-Degat ML, 2007, AM J TROP MED HYG, V77, P842, DOI 10.4269/ajtmh.2007.77.842; Chateau-Degat ML, 2005, HARMFUL ALGAE, V4, P1053, DOI 10.1016/j.hal.2005.03.003; Chen WJ, 2003, MOL PHYLOGENET EVOL, V26, P262, DOI 10.1016/S1055-7903(02)00371-8; Cline E, 2012, FOOD RES INT, V45, P388, DOI 10.1016/j.foodres.2011.10.043; Clua E, 2011, TOXICON, V58, P591, DOI 10.1016/j.toxicon.2011.08.020; Collins R. A., 2012, PLOS ONE, Ve7; Craig M. T., 2012, GROUPERS WORLD FIELD; Craig MT, 2007, ICHTHYOL RES, V54, P1, DOI 10.1007/s10228-006-0367-x; De Fouw JC, 2001, CIGUATERA FISH POISO; Dettai A, 2012, MAR GENOM, V8, P49, DOI 10.1016/j.margen.2012.02.003; Dickey RW, 2010, TOXICON, V56, P123, DOI 10.1016/j.toxicon.2009.09.008; Ekrem T, 2007, MOL PHYLOGENET EVOL, V43, P530, DOI 10.1016/j.ympev.2006.11.021; *FAO, 2010, CAPT PROD 1950 2008; Fricke Ronald, 2011, Stuttgarter Beitraege zur Naturkunde Serie A (Biologie), V4, P341; Friedman MA, 2008, MAR DRUGS, V6, P456, DOI [10.3390/md20080022, 10.3390/md6030456]; FROESE R., 2012, FISHBASE; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hanner R, 2011, MITOCHONDR DNA, V22, P27, DOI 10.3109/19401736.2011.596833; Harikrishnan R, 2010, AQUACULTURE, V309, P1, DOI 10.1016/j.aquaculture.2010.09.011; Hassanin A, 2010, MITOCHONDR DNA, V21, P68, DOI 10.3109/19401736.2010.490583; Heemstra P. C., 1993, FAO FISH SYNOPSIS, V125, P382; Kipping R, 2006, J PUBLIC HEALTH, V28, P343, DOI 10.1093/pubmed/fdl064; Laboute P, 2000, POISSONS NOUVELLE CA; Lakra WS, 2011, MOL ECOL RESOUR, V11, P60, DOI 10.1111/j.1755-0998.2010.02894.x; Laurent D., 2005, CIGUATERA FIELD REFE; Lautredou AC, 2010, POLAR SCI, V4, P333, DOI 10.1016/j.polar.2010.04.006; Lautredou AC, 2013, MOL PHYLOGENET EVOL, V67, P140, DOI 10.1016/j.ympev.2012.12.020; Leache AD, 2002, SYST BIOL, V51, P44, DOI 10.1080/106351502753475871; Lehane L, 2000, INT J FOOD MICROBIOL, V61, P91, DOI 10.1016/S0168-1605(00)00382-2; LEWIS ND, 1986, MAR FISH REV, V48, P6; Lewis RJ, 2006, TOXICON, V48, P799, DOI 10.1016/j.toxicon.2006.07.019; Lewis RJ, 1997, TOXICON, V35, P159, DOI 10.1016/S0041-0101(96)00132-8; Lewis RJ, 2001, TOXICON, V39, P97, DOI 10.1016/S0041-0101(00)00161-6; Maddison WP, 2009, MESQUITE MODULAR SYS; Mariani S, 2014, CONSERVATION LETT; Meusnier I, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-214; de Mitcheson YS, 2013, FISH FISH, V14, P119, DOI 10.1111/j.1467-2979.2011.00455.x; Moore SK, 2008, ENVIRON HEALTH-GLOB, V7, DOI 10.1186/1476-069X-7-S2-S4; Mueller RL, 2006, SYST BIOL, V55, P289, DOI 10.1080/10635150500541672; Nelson JS, 2006, FISHES WORLD, DOI DOI 10.1002/9781119174844; OLSEN DA, 1984, MAR FISH REV, V46, P13; Oshiro N, 2010, TOXICON, V56, P656, DOI 10.1016/j.toxicon.2009.05.036; Ottolenghi F., 2004, FATTENING EELS GROUP; Palumbi Stephen R., 1996, P205; Parker J, 2008, INFECT GENET EVOL, V8, P239, DOI 10.1016/j.meegid.2007.08.001; Perez-Arellano JL, 2005, EMERG INFECT DIS, V11, P1981, DOI 10.3201/eid1112.050393; Pierre S, 2008, AQUAT CONSERV, V18, P297, DOI 10.1002/aqc.840; Posada D, 2001, P NATL ACAD SCI USA, V98, P13757, DOI 10.1073/pnas.241370698; Quod JP, 1996, TOXICON, V34, P779, DOI 10.1016/0041-0101(95)00164-6; R Core Team, 2021, R LANGUAGE ENV STAT; Rambaut A., 2007, TRACER V1 4; Randall John E., 1991, Indo-Pacific Fishes, V20, P1; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Richlen ML, 2008, HARMFUL ALGAE, V7, P614, DOI 10.1016/j.hal.2007.12.020; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schlaich C, 2012, J TRAVEL MED, V19, P238, DOI 10.1111/j.1708-8305.2012.00619.x; Skinner MP, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001416; Smith WL, 2007, COPEIA, P35, DOI 10.1643/0045-8511(2007)7[35:CTPNWT]2.0.CO;2; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Steinke D, 2011, MITOCHONDR DNA, V22, P10, DOI 10.3109/19401736.2010.536538; Stewart I, 2010, TOXICON, V56, P804, DOI 10.1016/j.toxicon.2009.07.028; Streelman JT, 1997, P ROY SOC B-BIOL SCI, V264, P1011, DOI 10.1098/rspb.1997.0140; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Tester Patricia A., 2009, Smithsonian Contributions to the Marine Sciences, P301; Vernooy R, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000417; Vilgalys R, 2003, NEW PHYTOL, V160, P4, DOI 10.1046/j.1469-8137.2003.00894.x; Villareal TA, 2007, HARMFUL ALGAE, V6, P253, DOI 10.1016/j.hal.2006.08.008; Ward RD, 2009, J FISH BIOL, V74, P329, DOI 10.1111/j.1095-8649.2008.02080.x; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Ward RD, 2009, MOL ECOL RESOUR, V9, P1077, DOI 10.1111/j.1755-0998.2009.02541.x; Wong CK, 2008, BIOMED ENVIRON SCI, V21, P521, DOI 10.1016/S0895-3988(09)60012-X; Wong CK, 2005, TOXICON, V46, P563, DOI 10.1016/j.toxicon.2005.06.023; Wong EHK, 2008, FOOD RES INT, V41, P828, DOI 10.1016/j.foodres.2008.07.005	78	21	26	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e98198	10.1371/journal.pone.0098198	http://dx.doi.org/10.1371/journal.pone.0098198			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093850	Green Submitted, Green Published, gold			2022-12-27	WOS:000341357200002
J	Xiao, DF; Wang, YF; Liu, G; He, JH; Qiu, W; Hu, XG; Feng, ZM; Ran, ML; Nyachoti, CM; Kim, SW; Tang, ZR; Yin, YL				Xiao, Dingfu; Wang, Yongfei; Liu, Gang; He, Jianhua; Qiu, Wei; Hu, Xionggui; Feng, Zemeng; Ran, Maoliang; Nyachoti, Charles M.; Kim, Sung Woo; Tang, Zhiru; Yin, Yulong			Effects of Chitosan on Intestinal Inflammation in Weaned Pigs Challenged by Enterotoxigenic Escherichia coli	PLOS ONE			English	Article							FECAL CALPROTECTIN; BOWEL-DISEASE; ANTIINFLAMMATORY ACTIVITY; GROWTH-PERFORMANCE; SIGNALING PATHWAY; OXIDATIVE STRESS; DIETARY CHITOSAN; OLIGOSACCHARIDE; SUPPLEMENTATION; PIGLETS	The aim of this study was to investigate whether supplementation with chitosan (COS) could reduce diarrhea and to explore how COS alleviates intestinal inflammation in weaned pigs. Thirty pigs (Duroc6Landrace6Yorkshire, initial BW of 5.65 +/- 0.27) weaned at age 21 d were challenged with enterotoxigenic Escherichia coli during a preliminary trial period, and then divided into three treatment groups. Pigs in individual pens were fed a corn-soybean meal diet, that contained either 0 (control), 50 mg/kg chlortetracycline, or 300 mg/kg COS for 21 days. The post-weaning diarrhea frequency, calprotectin levels and TLR4 protein expression were decreased (P < 0.05) in both the COS and chlortetracycline groups compared with control. Simultaneously, supplemental COS and chlortetracycline had no effect on the mRNA expression of TNF-alpha in the jejunal mucosa, or on the concentrations of IL-1 beta, IL-6 and TNF-alpha in serum. However, COS supplementation improved (P < 0.05) the mRNA expression of IL-1 beta and IL-6 in the jejunal mucosa. The results indicate that supplementation with COS at 300 mg/kg was effective for alleviating intestinal inflammation and enhancing the cell-mediated immune response. As feed additives, chitosan and chlortetracycline may influence different mechanisms for alleviating inflammation in piglets.	[Xiao, Dingfu; He, Jianhua; Ran, Maoliang] Hunan Agr Univ, Coll Anim Sci & Technol, Changsha, Hunan, Peoples R China; [Wang, Yongfei; Feng, Zemeng] Twins Grp Co Ltd, Ctr Res & Dev, Nanchang, Jiangxi, Peoples R China; [Liu, Gang; Yin, Yulong] Chinese Acad Sci, Inst Subtrop Agr, Hunan Engn & Res Ctr Anim & Poultry Sci, Changsha, Hunan, Peoples R China; [Liu, Gang; Yin, Yulong] Chinese Acad Sci, Inst Subtrop Agr, Key Lab Agro ecol Processes Subtrop Reg, Changsha, Hunan, Peoples R China; [Qiu, Wei] Hunan New Wellful Co LTD, Changsha, Hunan, Peoples R China; [Hu, Xionggui] Hunan Inst Anim & Vet Sci, Changsha, Peoples R China; [Nyachoti, Charles M.] Univ Manitoba, Fac Agr & Food Sci, Dept Anim Sci, Winnipeg, MB, Canada; [Kim, Sung Woo] N Carolina State Univ, Dept Anim Sci, Raleigh, NC USA; [Tang, Zhiru] Southwest Univ, Coll Anim Sci & Technol, Chongqing, Peoples R China	Hunan Agricultural University; Chinese Academy of Sciences; Institute of Subtropical Agriculture, CAS; Chinese Academy of Sciences; Institute of Subtropical Agriculture, CAS; University of Manitoba; University of North Carolina; North Carolina State University; Southwest University - China	Tang, ZR (corresponding author), Southwest Univ, Coll Anim Sci & Technol, Chongqing, Peoples R China.	tangzhiru2326@sina.com; yinyulong@isa.ac.cn	JIANHUA, HE/G-3340-2014; Liu, Gang/G-5283-2017; Kim, Sung Woo/AFQ-7580-2022	JIANHUA, HE/0000-0002-9289-4405; Liu, Gang/0000-0002-9475-5134; Kim, Sung Woo/0000-0003-4591-1943	National Natural Science Foundation of China [31330075, 31301985]; Scientific Research Fund of Hunan Provincial Education Department Project of China [12B058]; National Program on Key Basic Research Project of China [2013CB127303]; Natural Science Foundation Project of CQ CSTC [cstc2012jjA80001]; Chinese Academy of Sciences [ISACX-LYQY-QN-1205, 2013T2S0014, 2013T2S0015, 2013T2S0012, 2013T1S0010, 2011T2S15]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Fund of Hunan Provincial Education Department Project of China; National Program on Key Basic Research Project of China(National Basic Research Program of China); Natural Science Foundation Project of CQ CSTC(Natural Science Foundation Project of CQ CSTC); Chinese Academy of Sciences(Chinese Academy of Sciences)	This study was supported by National Natural Science Foundation of China (31330075, 31301985), Scientific Research Fund of Hunan Provincial Education Department Project of China (12B058), the National Program on Key Basic Research Project of China (2013CB127303), Natural Science Foundation Project of CQ CSTC (cstc2012jjA80001) and Chinese Academy of Sciences (ISACX-LYQY-QN-1205) and Chinese Academy of Sciences visiting professorship for senior international scientists (Grant no. 2013T2S0014, 2013T2S0015, 2013T2S0012, 2013T1S0010 and 2011T2S15). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anandan R, 2012, INT J BIOL MACROMOL, V51, P783, DOI 10.1016/j.ijbiomac.2012.07.016; Beser OF, 2014, ALLERGY ASTHMA IMMUN, V6, P33, DOI 10.4168/aair.2014.6.1.33; Byun EB, 2013, INT IMMUNOPHARMACOL, V15, P450, DOI 10.1016/j.intimp.2012.11.021; Chen CL, 2008, BIOMATERIALS, V29, P2173, DOI 10.1016/j.biomaterials.2008.01.023; Choi HK, 2013, YONSEI MED J, V54, P1336, DOI 10.3349/ymj.2013.54.6.1336; Costa F, 2003, DIGEST LIVER DIS, V35, P642, DOI 10.1016/S1590-8658(03)00381-5; Dou W, 2013, BRIT J NUTR, V110, P599, DOI 10.1017/S0007114512005594; Fairbrother John M., 2005, Animal Health Research Reviews, V6, P17, DOI 10.1079/AHR2005105; Fernandes JC, 2010, MAR DRUGS, V8, P1763, DOI 10.3390/md8061763; Heimesaat MM, 2007, GUT, V56, P941, DOI 10.1136/gut.2006.104497; Hormannsperger G, 2010, INT J MED MICROBIOL, V300, P63, DOI 10.1016/j.ijmm.2009.08.006; Kobayashi S, 2002, BRIT POULTRY SCI, V43, P270, DOI 10.1080/00071660120121490; Konikoff MR, 2006, INFLAMM BOWEL DIS, V12, P524, DOI 10.1097/00054725-200606000-00013; Lee SH, 2009, BIOORG MED CHEM LETT, V19, P6655, DOI 10.1016/j.bmcl.2009.10.007; Liu P, 2008, J ANIM SCI, V86, P2609, DOI 10.2527/jas.2007-0668; Liu P, 2010, J ANIM SCI, V88, P3871, DOI 10.2527/jas.2009-2771; Liu YL, 2013, J NUTR, V143, P1799, DOI 10.3945/jn.113.179960; Mollen KP, 2006, SHOCK, V26, P430, DOI 10.1097/01.shk.0000228797.41044.08; Pangestuti R, 2011, INT J BIOL MACROMOL, V49, P599, DOI 10.1016/j.ijbiomac.2011.06.014; Qiao Y, 2011, INT IMMUNOPHARMACOL, V11, P121, DOI 10.1016/j.intimp.2010.10.016; Rabea EI, 2003, BIOMACROMOLECULES, V4, P1457, DOI 10.1021/bm034130m; Reino DC, 2012, SHOCK, V38, P107, DOI 10.1097/SHK.0b013e318257123a; Sahlander K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031646; Shimazu T, 2012, INFECT IMMUN, V80, P276, DOI 10.1128/IAI.05729-11; Splichal I, 2005, IMMUNOBIOLOGY, V209, P681, DOI 10.1016/j.imbio.2004.09.009; Tang ZR, 2005, DOMEST ANIM ENDOCRIN, V28, P430, DOI 10.1016/j.domaniend.2005.02.003; van der Fels-Klerx HJ, 2011, J ANIM SCI, V89, P1922, DOI 10.2527/jas.2010-3046; van Kralingen C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084269; von Roon AC, 2007, AM J GASTROENTEROL, V102, P803, DOI 10.1111/j.1572-0241.2007.01126.x; Xiao DF, 2013, INT IMMUNOPHARMACOL, V17, P670, DOI 10.1016/j.intimp.2013.07.023; Yin YL, 2008, ASIAN AUSTRAL J ANIM, V21, P723, DOI 10.5713/ajas.2008.70408; Yoon HJ, 2007, BIOCHEM BIOPH RES CO, V358, P954, DOI 10.1016/j.bbrc.2007.05.042	32	54	59	3	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e104192	10.1371/journal.pone.0104192	http://dx.doi.org/10.1371/journal.pone.0104192			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25090447	Green Published, gold, Green Submitted			2022-12-27	WOS:000339812700107
J	Unger, NR; Ritter, E; Borrego, R; Goodman, J; Osiyemi, OO				Unger, Nathan R.; Ritter, Erich; Borrego, Robert; Goodman, Jay; Osiyemi, Olayemi O.			Antibiotic Susceptibilities of Bacteria Isolated within the Oral Flora of Florida Blacktip Sharks: Guidance for Empiric Antibiotic Therapy	PLOS ONE			English	Article							GREAT WHITE SHARK; CARCHARHINUS-LIMBATUS; FOOD-HABITS; PATTERNS; ECOLOGY; ATTACK; DIET; INFECTIONS; RESISTANCE; BAY	Sharks possess a variety of pathogenic bacteria in their oral cavity that may potentially be transferred into humans during a bite. The aim of the presented study focused on the identification of the bacteria present in the mouths of live blacktip sharks, Carcharhinus limbatus, and the extent that these bacteria possess multi-drug resistance. Swabs were taken from the oral cavity of nineteen live blacktip sharks, which were subsequently released. The average fork length was 146 cm (611), suggesting the blacktip sharks were mature adults at least 8 years old. All swabs underwent standard microbiological work-up with identification of organisms and reporting of antibiotic susceptibilities using an automated microbiology system. The oral samples revealed an average of 2.72 (+/- 1.4) bacterial isolates per shark. Gram-negative bacteria, making up 61% of all bacterial isolates, were significantly (p<0.001) more common than gram-positive bacteria (39%). The most common organisms were Vibrio spp. (28%), various coagulase-negative Staphylococcus spp. (16%), and Pasteurella spp. (12%). The overall resistance rate was 12% for all antibiotics tested with nearly 43% of bacteria resistant to at least one antibiotic. Multi-drug resistance was seen in 4% of bacteria. No association between shark gender or fork length with bacterial density or antibiotic resistance was observed. Antibiotics with the highest overall susceptibility rates included fluoroquinolones, 3rd generation cephalosporins and sulfamethoxazole/trimethoprim. Recommended empiric antimicrobial therapy for adult blacktip shark bites should encompass either a fluoroquinolone or combination of a 3rd generation cephalosporin plus doxycycline.	[Unger, Nathan R.] Nova SE Univ, Coll Pharm, Dept Pharm Practice, Palm Beach Gardens, FL 33410 USA; [Ritter, Erich] Univ W Florida, Dept Math & Stat, Pensacola, FL 32514 USA; [Ritter, Erich] Shark Res Inst, Princeton, NJ USA; [Borrego, Robert] St Marys Hosp, Div Trauma, W Palm Beach, FL USA; [Goodman, Jay] St Marys Hosp, Div Lab Serv, W Palm Beach, FL USA; [Osiyemi, Olayemi O.] PA, Triple O Med Serv, W Palm Beach, FL USA	Nova Southeastern University; State University System of Florida; University of West Florida	Unger, NR (corresponding author), Nova SE Univ, Coll Pharm, Dept Pharm Practice, Palm Beach Gardens, FL 33410 USA.	nunger@nova.edu	Unger, Nathan/I-3957-2013	Unger, Nathan/0000-0002-5648-6711	Nova Southeastern University's Health Profession Division Research Grant; St. Mary's Medical Center	Nova Southeastern University's Health Profession Division Research Grant; St. Mary's Medical Center	The research was supported by Nova Southeastern University's Health Profession Division Research Grant and St. Mary's Medical Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Bahry S, 2009, MAR POLLUT BULL, V58, P720, DOI 10.1016/j.marpolbul.2008.12.018; Amin R, 2012, MAR FRESHW BEHAV PHY, V45, P185, DOI 10.1080/10236244.2012.715742; Auerbach PS, 2011, INJURIES NONVENOMOUS, P1562; Barry KP, 2008, J FISH BIOL, V73, P650, DOI 10.1111/j.1095-8649.2008.01963.x; Bethea DM, 2007, MAR BIOL, V152, P1009, DOI 10.1007/s00227-007-0728-7; Bethea DM, 2004, MAR ECOL PROG SER, V268, P245, DOI 10.3354/meps268245; Blackburn JK, 2010, J ZOO WILDLIFE MED, V41, P7, DOI 10.1638/2007-0061.1; Bogomolni AL, 2008, DIS AQUAT ORGAN, V81, P13, DOI 10.3354/dao01936; BUCK JD, 1984, J CLIN MICROBIOL, V20, P849, DOI 10.1128/JCM.20.5.849-851.1984; Caldicott DGE, 2001, INJURY, V32, P445, DOI 10.1016/S0020-1383(01)00041-9; Carlson JK, 2006, ENVIRON BIOL FISH, V77, P279, DOI 10.1007/s10641-006-9129-x; Castro JI, 1996, B MAR SCI, V59, P508; CLIFF G, 1989, S AFR J MARINE SCI, V8, P131, DOI 10.2989/02577618909504556; Courtney DL, 2012, J FISH BIOL, V80, P1508, DOI 10.1111/j.1095-8649.2012.03261.x; DAVIES D H, 1962, J R Nav Med Serv, V48, P110; Florida Museum of Natural History Ichthyology Department, 2013, SHARK SPEC INV UNPR; Florida Museum of Natural History Ichthyology Department, 2014, ISAF STAT WORLD LOC, VInternational Shark Attack File; Foti M, 2009, MAR POLLUT BULL, V58, P1363, DOI 10.1016/j.marpolbul.2009.04.020; Heupel MR, 2002, MAR FRESHWATER RES, V53, P543, DOI 10.1071/MF01132; Hoffmayer ER, 2003, SOUTHEAST NAT, V2, P271, DOI 10.1656/1528-7092(2003)002[0271:FHOTSS]2.0.CO;2; Hussy NE, 2012, GLOBAL PERSPECTIVE B, P121; Interaminense JA, 2010, J MED MICROBIOL, V59, P941, DOI 10.1099/jmm.0.020453-0; LEWIS RJ, 1992, TOXICON, V30, P915, DOI 10.1016/0041-0101(92)90390-Q; Lockwood SK, 2006, J ZOO WILDLIFE MED, V37, P281, DOI 10.1638/05-035.1; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; McElroy WD, 2006, ENVIRON BIOL FISH, V76, P81, DOI 10.1007/s10641-006-9010-y; Miranda CD, 2001, MAR POLLUT BULL, V42, P1096, DOI 10.1016/S0025-326X(01)00093-5; Noonburg GE, 2005, J AM ACAD ORTHOP SUR, V13, P243, DOI 10.5435/00124635-200507000-00004; PAVIA AT, 1989, ANN INTERN MED, V111, P85, DOI 10.7326/0003-4819-111-1-85; Pottier I, 2003, TOXICON, V42, P663, DOI 10.1016/j.toxicon.2003.09.004; Ritter EK, 2005, AM J FOREN MED PATH, V26, P136, DOI 10.1097/01.paf.0000164231.99750.2b; Ritter EK, 2002, ENVIRON BIOL FISH, V65, P111, DOI 10.1023/A:1019642221755; Rose JM, 2009, FEMS MICROBIOL ECOL, V67, P421, DOI 10.1111/j.1574-6941.2009.00648.x; Royle JA, 1997, PEDIATR INFECT DIS J, V16, P531, DOI 10.1097/00006454-199705000-00019; Rtshiladze MA, 2011, ANZ J SURG, V81, P345, DOI 10.1111/j.1445-2197.2010.05640.x; Schaefer AM, 2009, ECOHEALTH, V6, P33, DOI 10.1007/s10393-009-0221-5; Shark Research Institute, 2014, GLOB SHARK ATT FIL I; Simpfendorfer CA, 2001, ENVIRON BIOL FISH, V61, P37, DOI 10.1023/A:1011021710183; TRICAS T C, 1984, Proceedings of the California Academy of Sciences, V43, P221; Woolgar JD, 2001, J TRAUMA, V50, P887, DOI 10.1097/00005373-200105000-00019	40	10	10	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2014	9	8							e104577	10.1371/journal.pone.0104577	http://dx.doi.org/10.1371/journal.pone.0104577			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WB	25110948	Green Published, Green Submitted, gold			2022-12-27	WOS:000341105100078
J	Ghestem, M; Cao, KF; Ma, WZ; Rowe, N; Leclerc, R; Gadenne, C; Stokes, A				Ghestem, Murielle; Cao, Kunfang; Ma, Wenzhang; Rowe, Nick; Leclerc, Raphaelle; Gadenne, Clement; Stokes, Alexia			A Framework for Identifying Plant Species to Be Used as 'Ecological Engineers' for Fixing Soil on Unstable Slopes	PLOS ONE			English	Article							ROOT-REINFORCEMENT; LAND CONVERSION; GULLY EROSION; GROWTH HABIT; TREE ROOTS; STABILITY; CHINA; REHABILITATION; RESISTANCE; STRENGTH	Major reforestation programs have been initiated on hillsides prone to erosion and landslides in China, but no framework exists to guide managers in the choice of plant species. We developed such a framework based on the suitability of given plant traits for fixing soil on steep slopes in western Yunnan, China. We examined the utility of 55 native and exotic species with regard to the services they provided. We then chose nine species differing in life form. Plant root system architecture, root mechanical and physiological traits were then measured at two adjacent field sites. One site was highly unstable, with severe soil slippage and erosion. The second site had been replanted 8 years previously and appeared to be physically stable. How root traits differed between sites, season, depth in soil and distance from the plant stem were determined. Root system morphology was analysed by considering architectural traits (root angle, depth, diameter and volume) both up-and downslope. Significant differences between all factors were found, depending on species. We estimated the most useful architectural and mechanical traits for physically fixing soil in place. We then combined these results with those concerning root physiological traits, which were used as a proxy for root metabolic activity. Scores were assigned to each species based on traits. No one species possessed a suite of highly desirable traits, therefore mixtures of species should be used on vulnerable slopes. We also propose a conceptual model describing how to position plants on an unstable site, based on root system traits.	[Ghestem, Murielle] AgroParis Tech, UMR AMAP, Montpellier, France; [Cao, Kunfang] Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Mengla, Yunnan, Peoples R China; [Ma, Wenzhang] Kunming Inst Bot, Kunming, Yunnan, Peoples R China; [Rowe, Nick] CNRS, UMR AMAP, Montpellier, France; [Leclerc, Raphaelle] CNRS, UMR CEFE, Montpellier, France; [Gadenne, Clement] AgroParisTech, Ctr Nancy, Nancy, France; [Stokes, Alexia] INRA, UMR AMAP, F-34060 Montpellier, France	AgroParisTech; CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS; Chinese Academy of Sciences; Kunming Institute of Botany, CAS; CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; AgroParisTech; CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; INRAE	Ghestem, M (corresponding author), DALETT, CETE SO, Toulouse, France.	yellownosed@gmail.com	Cao, Kun-Fang/D-2157-2009	Cao, Kun-Fang/0000-0002-2253-7189	French Government; AgroParisTech; CNRS; BMU International Climate Initiative	French Government; AgroParisTech; CNRS(Centre National de la Recherche Scientifique (CNRS)); BMU International Climate Initiative	Funding was provided by a PhD bursary (Murielle Ghestem) from the French Government and AgroParisTech, the CNRS funded project 'EcoPente,' an INRA 'Jeune Equipe' and the BMU International Climate Initiative funded project 'Ecosystems Protecting Infrastructure and Communities' (EPIC), coordinated by IUCN and ProAct Network. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achten WMJ, 2007, COMMUNICATIONS AGR A, V72, P1; Association francaise de normalisation, 1996, QUAL SOLS REC NORM F; Baigorria GA, 2007, ENVIRON MODELL SOFTW, V22, P1175, DOI 10.1016/j.envsoft.2006.06.012; Baize D, 2000, GUIDE ANAL PEDOLOGIE; Baize D, 1995, REFERENTIEL PEDOLOGI; Bennett MT, 2008, ECOL ECON, V65, P699, DOI 10.1016/j.ecolecon.2007.09.017; Burylo M, 2009, PLANT SOIL, V324, P31, DOI 10.1007/s11104-009-9920-5; Burylo M, 2010, THESIS U J FOURIER G; Cofie P, 2001, THESIS U WAGENINGEN; De Baets S, 2009, EARTH SURF PROC LAND, V34, P1374, DOI 10.1002/esp.1826; Docker BB, 2008, GEOMORPHOLOGY, V100, P401, DOI 10.1016/j.geomorph.2008.01.009; Eissenstat DM, 2000, NEW PHYTOL, V147, P33, DOI 10.1046/j.1469-8137.2000.00686.x; Ekanayake JC, 1999, CAN GEOTECH J, V36, P1172, DOI 10.1139/cgj-36-6-1172; Fattet M, 2011, CATENA, V87, P60, DOI 10.1016/j.catena.2011.05.006; Genet M, 2005, PLANT SOIL, V278, P1, DOI 10.1007/s11104-005-8768-6; Genet M, 2007, THESIS U BORDEAUX BO; Genet M, 2008, FOREST ECOL MANAG, V256, P1517, DOI 10.1016/j.foreco.2008.05.050; Genet M, 2010, ECOL ENG, V36, P265, DOI 10.1016/j.ecoleng.2009.05.018; Ghestem M, 2009, P 6 PLANT BIOM C CAV, P450; Ghestem M, 2012, THESIS AGROPARIS TEC; Ghestem M, 2014, PLANT SOIL, V377, P43, DOI 10.1007/s11104-012-1572-1; Ghestem M, 2011, BIOSCIENCE, V61, P869, DOI 10.1525/bio.2011.61.11.6; Greenway D.R., 1987, SLOPE STABILITY, P187; HATHAWAY R L, 1975, New Zealand Journal of Botany, V13, P333; Heller J, 1996, PHYS NUT JATROPHA CU; Hong DY, 2011, FLORA CHINA, V10; Huang JK, 2004, PROC SPIE, V5544, P135, DOI 10.1117/12.563268; HUGHES KA, 1995, PLANT SOIL, V175, P301, DOI 10.1007/BF00011366; Irish G, 2000, AGAVES YUCCAS RELATE; Isnard S, 2003, ANN BOT-LONDON, V91, P407, DOI 10.1093/aob/mcg044; Jessome AP, 1971, DEP ENV CANADIAN FOR, V1305, P1; Kalra YP, 1991, NORX319 NO FOR CTR; Kohler L, 2000, PLANTA, V210, P691, DOI 10.1007/s004250050669; Mao Z, 2013, PLANT SOIL, V363, P357, DOI 10.1007/s11104-012-1324-2; McGill BJ, 2006, TRENDS ECOL EVOL, V21, P178, DOI 10.1016/j.tree.2006.02.002; Mitsch WJ, 2012, ECOL ENG, V45, P5, DOI 10.1016/j.ecoleng.2012.04.013; Munsell AH, 1947, COLOR NOTATION; Nakamura H, 2007, DEV PLANT SOIL SCI, V103, P81; Oppelt AL, 2005, AGROFOREST SYST, V64, P1, DOI 10.1007/s10457-005-2402-8; Packard GC, 2011, J COMP PHYSIOL B, V181, P841, DOI 10.1007/s00360-011-0565-3; Petrone A, 2008, HYDROL EARTH SYST SC, V5, P379; Phillips CJ, 1994, STRUCTURAL TREE ROOT; Poesen J, 2003, CATENA, V50, P91, DOI 10.1016/S0341-8162(02)00143-1; Pohl M, 2009, PLANT SOIL, V324, P91, DOI 10.1007/s11104-009-9906-3; Pollen N, 2005, WATER RESOUR RES, V41, DOI 10.1029/2004WR003801; Reubens B, 2011, J ARID ENVIRON, V75, P201, DOI 10.1016/j.jaridenv.2010.09.011; Reubens B, 2011, AGROFOREST SYST, V82, P303, DOI 10.1007/s10457-011-9381-8; Rowe NP, 1996, INT J PLANT SCI, V157, P406, DOI 10.1086/297357; Schuppener B, 1999, RECOMMENDATION ISSMG, P87; Schwarz M, 2010, EARTH SURF PROC LAND, V35, P354, DOI 10.1002/esp.1927; Sidle R.C., 2011, WATER RESOUR RES, V47, P864, DOI [10.1029/WM018, DOI 10.1029/WM018]; SIDLE RC, 1991, J SOIL WATER CONSERV, V46, P268; Sidle RC, 2012, NAT GEOSCI, V5, P437, DOI 10.1038/ngeo1512; Smets T, 2008, EARTH-SCI REV, V89, P1, DOI 10.1016/j.earscirev.2008.04.001; Stokes A, 2010, ECOL ENG, V36, P247, DOI 10.1016/j.ecoleng.2009.07.008; Stokes A, 2009, PLANT SOIL, V324, P1, DOI 10.1007/s11104-009-0159-y; Trac CJ, 2007, J MT SCI-ENGL, V4, P275, DOI 10.1007/S11629-007-0275-1; van Beek LPH, 2005, PLANT SOIL, V278, P55, DOI 10.1007/s11104-005-7247-4; VANSOEST PJ, 1963, J ASSOC OFF AGR CHEM, V46, P829; WALDRON LJ, 1977, SOIL SCI SOC AM J, V41, P843, DOI 10.2136/sssaj1977.03615995004100050005x; Wang XH, 2007, LAND USE POLICY, V24, P417, DOI 10.1016/j.landusepol.2006.05.005; Weyerhaeuser H, 2005, AGR SYST, V85, P234, DOI 10.1016/j.agsy.2005.06.008; WU TH, 1979, CAN GEOTECH J, V16, P19, DOI 10.1139/t79-003; Wu TH, 1998, CAN GEOTECH J, V35, P579, DOI 10.1139/cgj-35-4-579; Xu JT, 2006, ECOL ECON, V57, P595, DOI 10.1016/j.ecolecon.2005.05.008; Yin Y, 2008, PARALLEL SESSION VOL, P693; Zhou Y, 1998, FOREST ECOL MANAG, V103, P107, DOI 10.1016/S0378-1127(97)00216-8; Ziemer RR, 1977, ROOT STRENGTH CHANGE; Zobel RW, 2008, COMPUT ELECTRON AGR, V60, P178, DOI 10.1016/j.compag.2007.08.002	69	59	62	7	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2014	9	8							e95876	10.1371/journal.pone.0095876	http://dx.doi.org/10.1371/journal.pone.0095876			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR0CG	25105571	Green Published, gold, Green Submitted			2022-12-27	WOS:000343231900001
J	Ishihara, M; Seo, N; Mitsui, J; Muraoka, D; Tanaka, M; Mineno, J; Ikeda, H; Shiku, H				Ishihara, Mikiya; Seo, Naohiro; Mitsui, Jun; Muraoka, Daisuke; Tanaka, Maki; Mineno, Junichi; Ikeda, Hiroaki; Shiku, Hiroshi			Systemic CD8(+) T Cell-Mediated Tumoricidal Effects by Intratumoral Treatment of Oncolytic Herpes Simplex Virus with the Agonistic Monoclonal Antibody for Murine Glucocorticoid-Induced Tumor Necrosis Factor Receptor	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; CLINICAL-TRIAL; VIRAL THERAPY; HSV TYPE-1; CANCER; HF10; POXVIRUS; JX-594; SAFETY; IPILIMUMAB	Oncolytic virotherapy combined with immunomodulators is a novel noninvasive strategy for cancer treatment. In this study, we examined the tumoricidal effects of oncolytic HF10, a naturally occurring mutant of herpes simplex virus type-1, combined with an agonistic DTA-1 monoclonal antibody specific for the glucocorticoid-induced tumor necrosis factor receptor. Two murine tumor models were used to evaluate the therapeutic efficacies of HF10 virotherapy combined with DTA-1. The kinetics and immunological mechanisms of DTA-1 in HF10 infection were examined using flow cytometry and immunohistochemistry. Intratumoral administration of HF10 in combination with DTA-1 at a low dose resulted in a more vigorous attenuation of growth of the untreated contralateral as well as the treated tumors than treatment with either HF10 or DTA-1 alone. An accumulation of CD8(+) T cells, including tumor- and herpes simplex virus type-1-specific populations, and a decrease in the number of CD4(+) Foxp3(+) T regulatory cells were seen in both HF10- and DTA-1-treated tumors. Studies using Fc-digested DTA-1 and Fc gamma receptor knockout mice demonstrated the direct participation of DTA-1 in regulatory T cell depletion by antibody-dependent cellular cytotoxicity primarily via macrophages. These results indicated the potential therapeutic efficacy of a glucocorticoid-induced tumor necrosis factor receptor-specific monoclonal antibody in oncolytic virotherapy at local tumor sites.	[Ishihara, Mikiya; Seo, Naohiro; Muraoka, Daisuke; Ikeda, Hiroaki; Shiku, Hiroshi] Mie Univ, Grad Sch Med, Dept Immunogene Therapy, Tsu, Mie, Japan; [Mitsui, Jun] Hokkaido Univ, Grad Sch Med, Dept Gastroenterol Surg 2, Sapporo, Hokkaido 060, Japan; [Tanaka, Maki; Mineno, Junichi] Takara Bio Inc, Gene Med Business Unit, Tokyo, Shiga, Japan	Mie University; Hokkaido University; Takara Bio Inc.	Seo, N (corresponding author), Mie Univ, Grad Sch Med, Dept Immunogene Therapy, Tsu, Mie, Japan.	seo-naohiro@clin.medic.mie-u.ac.jp; shiku@clin.medic.mie-u.ac.jp	Shiku, Hiroshi/U-7321-2019	Shiku, Hiroshi/0000-0002-0362-755X; ISHIHARA, Mikiya/0000-0002-7581-2615	Ministry of Education, Culture, Sports, Science and Technology of Japan [24390300, 24800033]; Grants-in-Aid for Scientific Research [24390300] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from Ministry of Education, Culture, Sports, Science and Technology of Japan (24390300 and 24800033). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Breitbach CJ, 2011, NATURE, V477, P99, DOI 10.1038/nature10358; Breitbach CJ, 2010, CYTOKINE GROWTH F R, V21, P85, DOI 10.1016/j.cytogfr.2010.02.001; Campadelli-Fiume G, 2011, REV MED VIROL, V21, P213, DOI 10.1002/rmv.691; Cohen AD, 2006, CANCER RES, V66, P4904, DOI 10.1158/0008-5472.CAN-05-2813; Cohen AD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010436; Cote AL, 2011, J IMMUNOL, V186, P275, DOI 10.4049/jimmunol.1001308; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Eager RM, 2011, CANCER GENE THER, V18, P305, DOI 10.1038/cgt.2011.7; Francisco LM, 2009, J EXP MED, V206, P3015, DOI 10.1084/jem.20090847; Fujimoto Y, 2006, ACTA OTO-LARYNGOL, V126, P1115, DOI 10.1080/00016480600702100; Goshima F, 2014, INT J CANCER, V134, P2865, DOI 10.1002/ijc.28631; Hamid O, 2013, NEW ENGL J MED, V369, P134, DOI 10.1056/NEJMoa1305133; Hans R, 2013, J CLIN ONCOL, V31; Huang AYC, 1996, P NATL ACAD SCI USA, V93, P9730, DOI 10.1073/pnas.93.18.9730; Hwang TH, 2011, MOL THER, V19, P1913, DOI 10.1038/mt.2011.132; Ikeda H, 1997, P NATL ACAD SCI USA, V94, P6375, DOI 10.1073/pnas.94.12.6375; Imai N, 2009, CANCER SCI, V100, P1317, DOI 10.1111/j.1349-7006.2009.01179.x; Kaufman HL, 2010, FUTURE ONCOL, V6, P941, DOI 10.2217/FON.10.66; Kaufman HL, 2010, ANN SURG ONCOL, V17, P718, DOI 10.1245/s10434-009-0809-6; Kim JH, 2006, MOL THER, V14, P361, DOI 10.1016/j.ymthe.2006.05.008; Kimata H, 2006, ANN SURG ONCOL, V13, P1078, DOI 10.1245/ASO.2006.08.035; Ko K, 2005, J EXP MED, V202, P885, DOI 10.1084/jem.20050940; Kohno SI, 2007, CANCER GENE THER, V14, P918, DOI 10.1038/sj.cgt.7701070; La S, 2005, EXP MOL MED, V37, P193, DOI 10.1038/emm.2005.26; LERNER WA, 1983, INT J CANCER, V31, P463, DOI 10.1002/ijc.2910310411; Li YJ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0080475, 10.1371/journal.pone.0070390]; Liu BL, 2003, GENE THER, V10, P292, DOI 10.1038/sj.gt.3301885; McHugh RS, 2002, IMMUNITY, V16, P311, DOI 10.1016/S1074-7613(02)00280-7; Merrick AE, 2009, CURR OPIN INVEST DR, V10, P1372; Mitsui J, 2010, CLIN CANCER RES, V16, P2781, DOI 10.1158/1078-0432.CCR-09-3243; Mori I, 2005, MICROBES INFECT, V7, P1492, DOI 10.1016/j.micinf.2005.05.007; Muraoka D, 2010, J IMMUNOL, V185, P3768, DOI 10.4049/jimmunol.0903649; Nakao A, 2004, ANN ONCOL, V15, P988, DOI 10.1093/annonc/mdh225; Nakao A, 2011, CANCER GENE THER, V18, P167, DOI 10.1038/cgt.2010.65; Nishikawa H, 2008, CANCER RES, V68, P5948, DOI 10.1158/0008-5472.CAN-07-5839; NISHIYAMA Y, 1991, J VIROL, V65, P4520, DOI 10.1128/JVI.65.8.4520-4524.1991; Nocentini G, 1997, P NATL ACAD SCI USA, V94, P6216, DOI 10.1073/pnas.94.12.6216; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Park BH, 2008, LANCET ONCOL, V9, P533, DOI 10.1016/S1470-2045(08)70107-4; Postow MA, 2013, ONCOLOGIST, V18, P726, DOI 10.1634/theoncologist.2012-0464; Ribas A, 2013, J CLIN ONCOL, V31, P616, DOI 10.1200/JCO.2012.44.6112; Robert C, 2011, NEW ENGL J MED, V364, P2517, DOI 10.1056/NEJMoa1104621; Rosenzweig M, 2010, J CLIN ONCOL, V28, DOI 10.1200/jco.2010.28.15_suppl.e13028; Shimizu J, 2002, NAT IMMUNOL, V3, P135, DOI 10.1038/ni759; Simpson TR, 2013, J EXP MED, V210, P1695, DOI 10.1084/jem.20130579; TAKAI T, 1994, CELL, V76, P519, DOI 10.1016/0092-8674(94)90115-5; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Vaha-Koskela MJV, 2007, CANCER LETT, V254, P178, DOI 10.1016/j.canlet.2007.02.002; Wang W, 2012, INT J CANCER, V131, pE928, DOI 10.1002/ijc.27613; Weber JS, 2013, CANCER-AM CANCER SOC, V119, P1675, DOI 10.1002/cncr.27969; Wolf D, 2005, CLIN CANCER RES, V11, P8326, DOI 10.1158/1078-0432.CCR-05-1244	52	8	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2014	9	8							e104669	10.1371/journal.pone.0104669	http://dx.doi.org/10.1371/journal.pone.0104669			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR0CG	25105508	gold, Green Submitted, Green Published			2022-12-27	WOS:000343231900077
J	Krag, LA; Herrmann, B; Iversen, SA; Engas, A; Nordrum, S; Krafft, BA				Krag, Ludvig A.; Herrmann, Bent; Iversen, Svein A.; Engas, Arill; Nordrum, Sigve; Krafft, Bjorn A.			Size Selection of Antarctic Krill (Euphausia superba) in Trawls	PLOS ONE			English	Article							COD	Trawlers involved in the Antarctic krill (Euphausia superba) fishery use different trawl designs, and very little is known about the size selectivity of the various gears. Size selectivity quantifies a given trawl's ability to catch different sizes of a harvested entity, and this information is crucial for the management of a sustainable fishery. We established a morphological description of krill and used it in a mathematical model (FISHSELECT) to predict the selective potential of diamond meshes measuring 5-40 mm with mesh opening angles (oa) ranging from 10 to 90 degrees. We expected the majority of krill to encounter the trawl netting in random orientations due to high towing speeds and the assumed swimming capabilities of krill. However, our results indicated that size selectivity of krill is a well-defined process in which individuals encounter meshes at an optimal orientation for escapement. The simulation-based results were supported by data from experimental trawl hauls and underwater video images of the mesh geometry during fishing. Herein we present predictions for the size selectivity of a range of netting configurations relevant to the krill fishery. The methods developed and results described are important tools for selecting optimal trawl designs for krill fishing.	[Krag, Ludvig A.] Tech Univ Denmark, DTU Aqua, Hirtshals, Denmark; [Herrmann, Bent] SINTEF Fisheries & Aquaculture, Fishing Gear Technol, Hirtshals, Denmark; [Iversen, Svein A.; Engas, Arill; Krafft, Bjorn A.] Inst Marine Res, N-5024 Bergen, Norway; [Nordrum, Sigve] Aker BioMarine Antarctic AS, Oslo, Norway	Technical University of Denmark; SINTEF; Institute of Marine Research - Norway	Krag, LA (corresponding author), Tech Univ Denmark, DTU Aqua, Hirtshals, Denmark.	lak@aqua.dtu.dk		Herrmann, Bent/0000-0003-1325-6198; Krag, Ludvig Ahm/0000-0002-1531-1499	Research Council of Norway [216574]	Research Council of Norway(Research Council of Norway)	This study is financed by the Research Council of Norway. The grant number (project number) is: 216574. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H., 1973, P 2 INT S INF THEOR, P267, DOI 10.1007/978-1-4612-1694-0; Atkinson A, 2008, MAR ECOL PROG SER, V362, P1, DOI 10.3354/meps07498; CCAMLR, 2009, 28 M SCI COMM HOB AU; CCAMLR, 2009, 28 M COMM HOB AUSTR; Frandsen RP, 2010, FISH RES, V101, P156, DOI 10.1016/j.fishres.2009.09.017; Herrmann Bent, 2012, Journal of Northwest Atlantic Fishery Science, V44, P1, DOI 10.2960/J.v44.m680; Herrmann B, 2013, FISH RES, V146, P59, DOI 10.1016/j.fishres.2013.04.004; Herrmann B, 2009, FISH RES, V97, P59, DOI 10.1016/j.fishres.2009.01.002; Hewitt RP, 2004, DEEP-SEA RES PT II, V51, P1215, DOI 10.1016/j.dsr2.2004.06.011; ICES, 2005, 8 ICES COOP, P8, DOI [10.17895/ices.pub, DOI 10.17895/ICES.PUB]; Krafft BA, 2010, POLAR BIOL, V33, P957, DOI 10.1007/s00300-010-0774-3; Krag LA, 2011, FISH RES, V110, P225, DOI 10.1016/j.fishres.2011.03.009; LOCHHEAD J. H, 1961, PHYSL CRUSTACEA, V2, P313; Marr J.W.S., 1962, DISCOVERY REP, VXXXII, P33; NEWLAND PL, 1989, FISH RES, V8, P63, DOI 10.1016/0165-7836(89)90041-6; Nicol S, 1999, AQUAT LIVING RESOUR, V12, P105, DOI 10.1016/S0990-7440(99)80020-5; Pshenichnov L., 2009, WGEMM0911 CCAMLR; Science Committee-Commission for the Conservation of Antarctic Marine Living Resources (SC-CAMLR), 2010, 29 M SCI COMM SC CAM; Siegel V, 2007, WGEMM0728 CCAMLR; Sistiaga M, 2011, CAN J FISH AQUAT SCI, V68, P927, DOI 10.1139/F2011-017; Wardle C.S., 1993, Fish and Fisheries Series, V7, P609; Wileman D.A., 1996, 1126 ICES COOP	22	38	40	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2014	9	8							e102168	10.1371/journal.pone.0102168	http://dx.doi.org/10.1371/journal.pone.0102168			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR0CG	25105960	Green Submitted, Green Published, gold			2022-12-27	WOS:000343231900004
J	Santos, G; Valenzuela-Fernandez, A; Torres, NV				Santos, Guido; Valenzuela-Fernandez, Agustin; Torres, Nestor V.			Quantitative Analysis of the Processes and Signaling Events Involved in Early HIV-1 Infection of T Cells	PLOS ONE			English	Article							PREFERENTIAL REPLICATION; CORECEPTOR ACTIVITY; VIRAL-INFECTION; CORTICAL ACTIN; MEMORY; VIRUS; RECEPTORS; INDEPENDENCE; LYMPHOCYTES; ACTIVATION	Lymphocyte invasion by HIV-1 is a complex, highly regulated process involving many different types of molecules that is prompted by the virus's association with viral receptors located at the cell-surface membrane that culminates in the formation of a fusion pore through which the virus enters the cell. A great deal of work has been done to identify the key actors in the process and determine the regulatory interactions; however, there have been no reports to date of attempts being made to fully understand the system dynamics through a systemic, quantitative modeling approach. In this paper, we introduce a dynamic mathematical model that integrates the available information on the molecular events involved in lymphocyte invasion. Our model shows that moesin activation is induced by virus signaling, while filamin-A is mobilized by the receptor capping. Actin disaggregation from the cap is facilitated by cofilin. Cofilin is inactivated by HIV-1 signaling in activated lymphocytes, while in resting lymphocytes another signal is required to activate cofilin in the later stages in order to accelerate the decay of the aggregated actin as a restriction factor for the viral entry. Furthermore, stopping the activation signaling of moesin is sufficient to liberate the actin filaments from the cap. The model also shows the positive effect of gelsolin on actin capping by means of the nucleation effect. These findings allow us to propose novel approaches in the search for new therapeutic strategies. In particular, gelsolin inhibition is seen as a promising target for preventing HIV-1 entry into lymphocytes, due to its role in facilitating the capping needed for the invasion. Also it is shown that HIV-1 should overcome the cortical actin barrier during early infection and predicts the different susceptibility of CD4+ T cells to be infected in terms of actin cytoskeleton dynamics driven by associated cellular factors.	[Santos, Guido; Torres, Nestor V.] Univ La Laguna, Fac Biol, Dept Bioquim Microbiol Biol Celular & Genet, Grp Biol Sistemas & Modelizac Matemat, Tenerife, Spain; [Valenzuela-Fernandez, Agustin] Univ La Laguna, Fac Med, Lab Inmunol Celular & Viral, Dept Med Fis & Farmacol, Tenerife, Spain; [Santos, Guido; Torres, Nestor V.] Univ La Laguna, Inst Tecnol Biomed, Tenerife, Spain	Universidad de la Laguna; Universidad de la Laguna; Universidad de la Laguna	Valenzuela-Fernandez, A (corresponding author), Univ La Laguna, Fac Med, Lab Inmunol Celular & Viral, Dept Med Fis & Farmacol, Tenerife, Spain.	avalenzu@ull.edu.es; ntorres@ull.edu.es	Santos, Guido/AAB-4695-2019; Torres, Nestor/K-2529-2014; Valenzuela-Fernández, Agustín/P-1638-2019; Valenzuela-Fernández, Agustín/B-6219-2014	Santos, Guido/0000-0002-4231-5946; Torres, Nestor/0000-0002-7594-9515; Valenzuela-Fernández, Agustín/0000-0002-2585-8703; Valenzuela-Fernández, Agustín/0000-0002-2585-8703	Spanish MICINN [BIO2011-29233-C02-02]; Agencia Canaria de Investigacion, Innovacion y Sociedad de la Informacion [PIL2071001]; European Regional Development Fund [SAF2011-24671, 24-0740-09, ProID20100020]; RIS-RETIC (Red Nacional de Investigacion en SIDA, ISCIII, Spain) [RD12/0017/0034]	Spanish MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Agencia Canaria de Investigacion, Innovacion y Sociedad de la Informacion; European Regional Development Fund(European Commission); RIS-RETIC (Red Nacional de Investigacion en SIDA, ISCIII, Spain)	This work was funded by research grants from the Spanish MICINN, Ref. No. BIO2011-29233-C02-02 and the Agencia Canaria de Investigacion, Innovacion y Sociedad de la Informacion, Ref. No. PIL2071001. AV-F is supported by the European Regional Development Fund, SAF2011-24671 (Ministerio de Ciencia e Innovacion, Spain), 24-0740-09 (Fundacion para la Investigacion y la Prevencion del SIDA en Espana (FIPSE), Spain), ProID20100020 (Agencia Canaria de Investigacion, Innovacion y Sociedad de la Informacion, Canary Island Government, Spain), and RIS-RETIC (Red Nacional de Investigacion en SIDA, ISCIII, Spain) associated RD12/0017/0034 grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkhatib G, 1997, VIROLOGY, V234, P340, DOI 10.1006/viro.1997.8673; Amieva MR, 1999, J CELL SCI, V112, P111; Aramori I, 1997, EMBO J, V16, P4606, DOI 10.1093/emboj/16.15.4606; Barrero-Villar M, 2009, J CELL SCI, V122, P103, DOI 10.1242/jcs.035873; Burtnick LD, 1997, CELL, V90, P661, DOI 10.1016/S0092-8674(00)80527-9; Cameron PU, 2010, P NATL ACAD SCI USA, V107, P16934, DOI 10.1073/pnas.1002894107; CAYOTA A, 1990, LANCET, V336, P941, DOI 10.1016/0140-6736(90)92311-5; Chomont N, 2009, NAT MED, V15, P893, DOI 10.1038/nm.1972; Doranz BJ, 1999, J VIROL, V73, P2752, DOI 10.1128/JVI.73.4.2752-2761.1999; Dunia R, 2013, J MATH BIOL, V67, P1425, DOI 10.1007/s00285-012-0593-y; Frank PM, 1978, INTRO SYSTEM SENSITI; Garcia Exposito L, 2013, RETROVIROLOGY, V10, P39; Gordon-Alonso M, 2013, J BIOL CHEM, V288, P28382, DOI 10.1074/jbc.M113.494906; Gordon-Alonso M, 2012, MOL BIOL CELL, V23, P2253, DOI 10.1091/mbc.E11-12-1003; Gosling J, 1997, P NATL ACAD SCI USA, V94, P5061, DOI 10.1073/pnas.94.10.5061; Guo J, 2011, J VIROL, V85, P9824, DOI 10.1128/JVI.05170-11; Helbert MR, 1997, CLIN EXP IMMUNOL, V107, P300, DOI 10.1111/j.1365-2249.1997.280-ce1170.x; Hormiga J, 2010, MOL BIOSYST, V6, P699, DOI 10.1039/b913063b; Iyengar S, 1998, J VIROL, V72, P5251, DOI 10.1128/JVI.72.6.5251-5255.1998; Jimenez-Baranda S, 2007, NAT CELL BIOL, V9, P838, DOI 10.1038/ncb1610; Konnyu B, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003103; Komano J, 2004, MOL BIOL CELL, V15, P5197, DOI 10.1091/mbc.E04-04-0279; Liu Y, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.266pe23; Mangeat P, 1999, TRENDS CELL BIOL, V9, P289, DOI 10.1016/S0962-8924(99)01607-4; Mark S, 2012, RETROVIROLOGY, V9, P45; Marsick BM, 2012, J NEUROSCI, V32, P282, DOI 10.1523/JNEUROSCI.4794-11.2012; Meberg PJ, 2000, MOL NEUROBIOL, V21, P97, DOI 10.1385/MN:21:1-2:097; Naghavi MH, 2007, EMBO J, V26, P41, DOI 10.1038/sj.emboj.7601475; Nampala H, 2013, MATH BIOSCI, V242, P77, DOI 10.1016/j.mbs.2012.12.005; Pan XY, 2013, CELL RES, V23, P876, DOI 10.1038/cr.2013.74; Permanyer M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079221; Phillips AN, 1996, SCIENCE, V271, P497, DOI 10.1126/science.271.5248.497; Pontow SE, 2004, J VIROL, V78, P7138, DOI 10.1128/JVI.78.13.7138-7147.2004; Rasaiyaah J, 2013, NATURE, V503, P402, DOI 10.1038/nature12769; Roederer M, 1997, J CLIN INVEST, V99, P1555, DOI 10.1172/JCI119318; Santos G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059968; Santos G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034533; Savageau M, 1976, BIOCH SYSTEMS ANAL S; SCHNITTMAN SM, 1990, P NATL ACAD SCI USA, V87, P6058, DOI 10.1073/pnas.87.16.6058; Siljak DD, 1969, NONLINEAR SYSTEM PAR; Spear M, 2012, COLD SPRING HARB NY; Spear M, 2014, J BIOL CHEM, V289, P6949, DOI 10.1074/jbc.M113.492132; Spear M, 2013, IMMUNOL REV, V256, P300, DOI 10.1111/imr.12106; Spina CA, 1997, J CLIN INVEST, V99, P1774, DOI 10.1172/JCI119342; Vera J, 2011, SYSTEMS BIOL APPROAC; Voit E. O., 2000, COMPUTATIONAL ANAL B; Vorster PJ, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.182238; Wang WF, 2012, J BIOL CHEM, V287, P35455, DOI 10.1074/jbc.M112.362400; Xu Xuehua, 2012, Commun Integr Biol, V5, P381, DOI 10.4161/cib.20165; Yoder A, 2008, CELL, V134, P782, DOI 10.1016/j.cell.2008.06.036	50	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2014	9	8							e103845	10.1371/journal.pone.0103845	http://dx.doi.org/10.1371/journal.pone.0103845			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR0CG	25105875	gold, Green Published, Green Submitted			2022-12-27	WOS:000343231900024
J	Luo, SL; Han, LF; Zeng, P; Chen, F; Pan, LM; Wang, S; Zhang, TM				Luo, Senlin; Han, Longfei; Zeng, Ping; Chen, Feng; Pan, Limin; Wang, Shu; Zhang, Tiemei			A Risk Assessment Model for Type 2 Diabetes in Chinese	PLOS ONE			English	Article							ASSESSMENT TOOLS; LIFE-STYLE; SCORE; INFORMATION; POPULATION; HEALTH	Aims: To develop a risk assessment model for persons at risk from type 2 diabetes in Chinese. Materials and Methods: The model was generated from the cross-sectional data of 16246 persons aged from 20 years old and over. C4.5 algorithm and multivariate logistic regression were used for variable selection. Relative risk value combined with expert decision constructed a comprehensive risk assessment for evaluating the individual risk category. The validity of the model was tested by cross validation and a survey performed six years later with some participants. Results: Nine variables were selected as risk variables. A mathematical model was established to calculate the average probability of diabetes in each cluster's group divided by sex and age. A series of criteria combined with relative RR value (2.2) and level of risk variables stratified individuals into four risk groups (non, low, medium and high risk). The overall accuracy reached 90.99% evaluated by cross-validation inside the model population. The incidence of diabetes for each risk group increased from 1.5 (non-risk group) to 28.2(high-risk group) per one thousand persons per year with six years follow-up. Discussion: The model could determine the individual risk for type 2 diabetes by four risk degrees. This model could be used as a technique tool not only to support screening persons at different risk, but also to evaluate the result of the intervention.	[Luo, Senlin; Han, Longfei; Pan, Limin] Beijing Inst Technol, Informat Syst & Secur & Countermeasures Expt Ctr, Beijing 100081, Peoples R China; [Zeng, Ping; Wang, Shu; Zhang, Tiemei] Beijing Hosp, Minist Hlth, Beijing Inst Geriatr, Beijing, Peoples R China; [Chen, Feng] Nanjing Med Univ, Coll Publ Hlth, Nanjing, Jiangsu, Peoples R China	Beijing Institute of Technology; Beijing Hospital; Nanjing Medical University	Zhang, TM (corresponding author), Beijing Hosp, Minist Hlth, Beijing Inst Geriatr, Beijing, Peoples R China.	tmzhang126@126.com		Luo, Sen Lin/0000-0002-3310-8312	National Natural Science Foundation of China [30971395, 60671008]; National Science and Technology [2001BA702B01, 2006BAI02B08, 2012BAI10B01]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology	This work was funded by National Natural Science Foundation of China (Approval No: 30971395 and 60671008) and the 10th to 12th 5-year National Science and Technology Supporting Project (Approval No: 2001BA702B01, 2006BAI02B08, 2012BAI10B01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aekplakorn W, 2006, DIABETES CARE, V29, P1872, DOI 10.2337/dc05-2141; Brown N, 2012, DIABETES RES CLIN PR, V98, P369, DOI 10.1016/j.diabres.2012.09.005; Buijsse B, 2011, EPIDEMIOL REV, V33, P46, DOI 10.1093/epirev/mxq019; Chen L, 2010, MED J AUSTRALIA, V192, P197, DOI 10.5694/j.1326-5377.2010.tb03478.x; Chen SJ, 2014, BIO-MED MATER ENG, V24, P1359, DOI 10.3233/BME-130939; Gao WG, 2010, DIABETIC MED, V27, P274, DOI 10.1111/j.1464-5491.2010.02943.x; Glumer C, 2004, DIABETES CARE, V27, P727, DOI 10.2337/diacare.27.3.727; Grabczewski K, 2005, HIS 2005: 5TH INTERNATIONAL CONFERENCE ON HYBRID INTELLIGENT SYSTEMS, PROCEEDINGS, P212; Griffin SJ, 2000, DIABETES-METAB RES, V16, P164, DOI 10.1002/1520-7560(200005/06)16:3<164::AID-DMRR103>3.0.CO;2-R; Grunsky EC, 2002, COMPUT GEOSCI-UK, V28, P1219, DOI 10.1016/S0098-3004(02)00034-1; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; Heikes KE, 2008, DIABETES CARE, V31, P1040, DOI 10.2337/dc07-1150; Luo Sen-lin, 2007, Journal of Beijing Institute of Technology, V16, P310; Nelson KM, 2003, DIABETES CARE, V26, P2058, DOI 10.2337/diacare.26.7.2058; Rolka DB, 2001, DIABETES CARE, V24, P1899, DOI 10.2337/diacare.24.11.1899; Soriguer F, 2012, MED CLIN-BARCELONA, V138, P371, DOI 10.1016/j.medcli.2011.05.025; Sun WX, 2007, MECH SYST SIGNAL PR, V21, P1300, DOI 10.1016/j.ymssp.2006.06.010; Taylor J, 2013, DIABETIC MED, V30, P16, DOI 10.1111/dme.12027; Thoopputra T, 2012, DIABETES-METAB RES, V28, P485, DOI 10.1002/dmrr.2296; Tian Ye, 2011, Wei Sheng Yan Jiu, V40, P771; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Wirfalt AKE, 1997, J AM DIET ASSOC, V97, P272, DOI 10.1016/S0002-8223(97)00071-0; Xin Z, 2010, J CLIN EPIDEMIOL, V63, P1030, DOI 10.1016/j.jclinepi.2009.11.012; Zhang TM, 2011, CHINESE MED J-PEKING, V124, P189, DOI 10.3760/cma.j.issn.0366-6999.2011.02.006	24	8	9	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e104046	10.1371/journal.pone.0104046	http://dx.doi.org/10.1371/journal.pone.0104046			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25101994	Green Submitted, gold, Green Published			2022-12-27	WOS:000339993900034
J	Fu, K; Cheng, Q; Liu, ZW; Chen, Z; Wang, Y; Ruan, HG; Zhou, L; Xiong, J; Xiao, RJ; Liu, SW; Zhang, QP; Yang, DC				Fu, Kai; Cheng, Qin; Liu, Zhenwei; Chen, Zhen; Wang, Yan; Ruan, Honggang; Zhou, Lu; Xiong, Jie; Xiao, Ruijing; Liu, Shengwu; Zhang, Qiuping; Yang, Daichang			Immunotoxicity Assessment of Rice-Derived Recombinant Human Serum Albumin Using Human Peripheral Blood Mononuclear Cells	PLOS ONE			English	Article							MONOCLONAL-ANTIBODY TGN1412; PROTEIN O-GLYCOSYLATION; SACCHAROMYCES-CEREVISIAE; IMMUNE-RESPONSES; CYTOKINE STORM; EXPRESSION; SECRETION; SAFETY; YEAST; PURIFICATION	Human serum albumin (HSA) is extensively used in clinics to treat a variety of diseases, such as hypoproteinemia, hemorrhagic shock, serious burn injuries, cirrhotic ascites and fetal erythroblastosis. To address supply shortages and high safety risks from limited human donors, we recently developed recombinant technology to produce HSA from rice endosperm. To assess he risk potential of HSA derived from Oryza sativa (OsrHSA) before a First-in-human (FIH) trial, we compared OsrHSA and plasma-derived HSA (pHSA), evaluating the potential for an immune reaction and toxicity using human peripheral blood mononuclear cells (PBMCs). The results indicated that neither OsrHSA nor pHSA stimulated T cell proliferation at 1x and 5x dosages. We also found no significant differences in the profiles of the CD4(+) and CD8(+) T cell subsets between OsrHSA- and pHSA-treated cells. Furthermore, the results showed that there were no significant differences between OsrHSA and pHSA in the production of cytokines such as interferon-gamma (IFN-gamma), tumor necrosis factor-alpha (TNF-alpha), interleukin (IL)-10 and IL-4. Our results demonstrated that OsrHSA has equivalent immunotoxicity to pHSA when using the PBMC model. Moreover, this ex vivo system could provide an alternative approach to predict potential risks in novel biopharmaceutical development.	[Fu, Kai; Cheng, Qin; Liu, Zhenwei; Chen, Zhen; Yang, Daichang] Wuhan Univ, State Key Lab Hybrid Rice, Wuhan 430072, Peoples R China; [Fu, Kai; Cheng, Qin; Liu, Zhenwei; Chen, Zhen; Yang, Daichang] Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China; [Ruan, Honggang; Zhou, Lu; Xiong, Jie; Xiao, Ruijing; Liu, Shengwu; Zhang, Qiuping] Wuhan Univ, Dept Immunol, Coll Basic Med Sci, Wuhan 430072, Peoples R China; [Wang, Yan] Chinese Acad Sci, Inst Hydrobiol, Anal & Testing Ctr, Wuhan, Peoples R China	Wuhan University; Wuhan University; Wuhan University; Chinese Academy of Sciences; Institute of Hydrobiology, CAS	Yang, DC (corresponding author), Wuhan Univ, State Key Lab Hybrid Rice, Wuhan 430072, Peoples R China.	dyang@whu.edu.cn	zhang, qiu/GXG-5600-2022		National Essential New Drug Research and Development of China [2013ZX09102038]; National High-Tech R&D Program 863 of China [2011AA100604]	National Essential New Drug Research and Development of China; National High-Tech R&D Program 863 of China(National High Technology Research and Development Program of China)	Major Projects of National Essential New Drug Research and Development of China (2013ZX09102038) and National High-Tech R&D Program 863 of China (2011AA100604). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER MR, 1979, JAMA-J AM MED ASSOC, V241, P2527, DOI 10.1001/jama.241.23.2527; An N, 2013, INT J MOL SCI, V14, P3556, DOI 10.3390/ijms14023556; [Anonymous], 2011, ROITTS ESSENTIAL IMM; BARASH I, 1993, TRANSGENIC RES, V2, P266, DOI 10.1007/BF01968839; Baroncelli S, 1997, VET IMMUNOL IMMUNOP, V59, P141, DOI 10.1016/S0165-2427(97)00040-8; Cavagnaro JA, 2008, PRECLINICAL SAFETY E; Czyz CN, 2012, DERMATOL SURG, V38, P445, DOI 10.1111/j.1524-4725.2011.02215.x; Farran I, 2002, TRANSGENIC RES, V11, P337, DOI 10.1023/A:1016356510770; Fernandez-San Millan A, 2003, PLANT BIOTECHNOL J, V1, P71, DOI 10.1046/j.1467-7652.2003.00008.x; Finco D, 2014, CYTOKINE, V66, P143, DOI 10.1016/j.cyto.2013.12.009; Fischer R, 2012, BIOTECHNOL ADV, V30, P434, DOI 10.1016/j.biotechadv.2011.08.007; FLEER R, 1991, BIO-TECHNOL, V9, P968, DOI 10.1038/nbt1091-968; Foster JR, 2001, INT J EXP PATHOL, V82, P171, DOI 10.1046/j.1365-2613.2001.00192.x; Frantz S, 2007, NAT REV DRUG DISCOV, V6, P5, DOI 10.1038/nrd2230; Hastings G E, 1992, Arch Fam Med, V1, P281, DOI 10.1001/archfami.1.2.281; He Y, 2011, P NATL ACAD SCI USA, V108, P19078, DOI 10.1073/pnas.1109736108; Herzyk DJ, 2008, IMMUNOTOXICOLOGY STR; House RV, 1999, METHODS, V19, P17, DOI 10.1006/meth.1999.0823; Huang LF, 2005, TRANSGENIC RES, V14, P569, DOI 10.1007/s11248-004-6481-5; Joubert MK, 2012, J BIOL CHEM, V287, P25266, DOI 10.1074/jbc.M111.330902; Kasahara A, 2008, J GASTROENTEROL, V43, P464, DOI 10.1007/s00535-008-2178-5; Kishimoto T, 1999, ARCH BIOCHEM BIOPHYS, V370, P271, DOI 10.1006/abbi.1999.1406; Kobayashi K, 2000, J BIOSCI BIOENG, V89, P55, DOI 10.1016/S1389-1723(00)88050-0; Kooijman R, 2010, TOXICOL IN VITRO, V24, P1782, DOI 10.1016/j.tiv.2010.07.007; LATTA M, 1987, BIO-TECHNOL, V5, P1309, DOI 10.1038/nbt1287-1309; LUSSIER M, 1995, J BIOL CHEM, V270, P2770, DOI 10.1074/jbc.270.6.2770; MOOLENAAR WH, 1991, ADV CANCER RES, V57, P87; MOOLENAAR WH, 1990, CIBA F SYMP, V150, P99; Obembe OO, 2011, BIOTECHNOL ADV, V29, P210, DOI 10.1016/j.biotechadv.2010.11.004; Ogwang C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057726; Okamura K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054817; Olsen SC, 2012, CLIN VACCINE IMMUNOL, V19, P642, DOI 10.1128/CVI.00033-12; Oszvald M, 2008, MOL BIOTECHNOL, V40, P261, DOI 10.1007/s12033-008-9083-2; Ou JQ, 2014, PLANT CELL REP, V33, P585, DOI 10.1007/s00299-013-1559-2; Schindel F, 2003, J CLIN PHARMACOL, V43, P1032; SIJMONS PC, 1990, BIO-TECHNOL, V8, P217, DOI 10.1038/nbt0390-217; SLEEP D, 1990, BIO-TECHNOL, V8, P42, DOI 10.1038/nbt0190-42; Stebbings R, 2007, J IMMUNOL, V179, P3325, DOI 10.4049/jimmunol.179.5.3325; Stebbings R, 2009, CURR OPIN BIOTECH, V20, P673, DOI 10.1016/j.copbio.2009.10.002; Stolevik SB, 2011, TOXICOL IN VITRO, V25, P555, DOI 10.1016/j.tiv.2010.11.021; STRAHLBOLSINGER S, 1993, P NATL ACAD SCI USA, V90, P8164, DOI 10.1073/pnas.90.17.8164; Suntharalingam G, 2006, NEW ENGL J MED, V355, P1018, DOI 10.1056/NEJMoa063842; Takahashi M, 2002, ATHEROSCLEROSIS, V161, P387, DOI 10.1016/S0021-9150(01)00674-8; TIGYI G, 1994, P NATL ACAD SCI USA, V91, P1908, DOI 10.1073/pnas.91.5.1908; Tomita Michiyo, 2004, Lipids Health Dis, V3, P1, DOI 10.1186/1476-511X-3-1; Vidal Jean-Marc, 2010, Cytokine, V51, P213, DOI 10.1016/j.cyto.2010.04.008; Walker MR, 2011, INT IMMUNOPHARMACOL, V11, P1697, DOI 10.1016/j.intimp.2011.06.001; Whelan KT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005934; Wongtangtintharn S, 2005, LIPIDS HLTH DIS, V4, P1476; WU AM, 1994, MOL CELL BIOCHEM, V137, P39, DOI 10.1007/BF00926038; Yoshida A, 1997, J BIOL CHEM, V272, P16884, DOI 10.1074/jbc.272.27.16884; Zhang DS, 2010, PROTEIN EXPRES PURIF, V74, P69, DOI 10.1016/j.pep.2010.04.019; Zhang LP, 2013, J BIOTECHNOL, V164, P300, DOI 10.1016/j.jbiotec.2013.01.008	53	7	8	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e104426	10.1371/journal.pone.0104426	http://dx.doi.org/10.1371/journal.pone.0104426			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25099245	Green Published, Green Submitted, gold			2022-12-27	WOS:000339995100070
J	Martinez-Maza, C; Alberdi, MT; Nieto-Diaz, M; Prado, JL				Martinez-Maza, Cayetana; Teresa Alberdi, Maria; Nieto-Diaz, Manuel; Luis Prado, Jose			Life-History Traits of the Miocene Hipparion concudense (Spain) Inferred from Bone Histological Structure	PLOS ONE			English	Article							GROWTH-PATTERNS; SEXUAL-MATURITY; ARRESTED GROWTH; DINOSAURS; MAMMALS; SKELETOCHRONOLOGY; PHYSIOLOGY; DYNAMICS; LIGHT; LINES	Histological analyses of fossil bones have provided clues on the growth patterns and life history traits of several extinct vertebrates that would be unavailable for classical morphological studies. We analyzed the bone histology of Hipparion to infer features of its life history traits and growth pattern. Microscope analysis of thin sections of a large sample of humeri, femora, tibiae and metapodials of Hipparion concudense from the upper Miocene site of Los Valles de Fuentiduena (Segovia, Spain) has shown that the number of growth marks is similar among the different limb bones, suggesting that equivalent skeletochronological inferences for this Hipparion population might be achieved by means of any of the elements studied. Considering their abundance, we conducted a skeletechronological study based on the large sample of third metapodials from Los Valles de Fuentiduena together with another large sample from the Upper Miocene locality of Concud (Teruel, Spain). The data obtained enabled us to distinguish four age groups in both samples and to determine that Hipparion concudense tended to reach skeletal maturity during its third year of life. Integration of bone microstructure and skeletochronological data allowed us to identify ontogenetic changes in bone structure and growth rate and to distinguish three histologic ontogenetic stages corresponding to immature, subadult and adult individuals. Data on secondary osteon density revealed an increase in bone remodeling throughout the ontogenetic stages and a lesser degree thereof in the Concud population, which indicates different biomechanical stresses in the two populations, likely due to environmental differences. Several individuals showed atypical growth patterns in the Concud sample, which may also reflect environmental differences between the two localities. Finally, classification of the specimens' age within groups enabled us to characterize the age structure of both samples, which is typical of attritional assemblages.	[Martinez-Maza, Cayetana; Teresa Alberdi, Maria] CSIC, Museo Nacl Ciencias Nat, Dept Paleobiol, E-28006 Madrid, Spain; [Nieto-Diaz, Manuel] Hosp Nacl Paraplej Toledo, Mol Neuroprotect Grp, Toledo, Castilla La Man, Spain; [Luis Prado, Jose] CONICET UNICEN Univ Olavarria, UE INCUAPA, Olavarria, Argentina	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); Hospital Nacional de Paraplejicos	Martinez-Maza, C (corresponding author), CSIC, Museo Nacl Ciencias Nat, Dept Paleobiol, E-28006 Madrid, Spain.	cayetana@mncn.csic.es	Alberdi, Maria Teresa/ABG-8623-2020; Nieto-Diaz, Manuel/R-5163-2017; Prado, Jose Luis/N-2001-2019; Díaz, Manuel Nieto/ABD-7144-2020	Alberdi, Maria Teresa/0000-0002-7071-360X; Nieto-Diaz, Manuel/0000-0002-7244-794X; Prado, Jose Luis/0000-0003-0579-8747; 	Ministerio de Economia y Competitividad, Spain [CGL2010-19116/BOS]; JAE-DOC postdoctoral contract (CSIC); European Social Fund	Ministerio de Economia y Competitividad, Spain; JAE-DOC postdoctoral contract (CSIC); European Social Fund(European Social Fund (ESF))	This study was funded by the research project CGL2010-19116/BOS (Ministerio de Economia y Competitividad, Spain). CMM was supported by a JAE-DOC postdoctoral contract (CSIC) co-funded by the European Social Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberdi M.T., 1981, Estudios Geologicos (Madrid), V37, P503; Alcala L., 1999, Publicaciones del Seminario de Paleontologia de Zaragoza, V4, P117; Alcala L, 1994, MACROMAMIFEROS NEOGE, P554; Alcala L., 1998, 4 REUN NAC COM PATR, P29; Amprino R., 1947, ARCH BIOL SCI, V58, P315; [Anonymous], 1999, WALKERS MAMMALS WORL; Bennett D, 2008, TIMING RATE SKLETAL; Brown-Douglas C., 2011, Equine reproduction, Volume 1, P280; Brown-Douglas CG, 2004, EQUINE VET J, V36, P499, DOI 10.2746/0425164044877422; Castanet J, 2006, CR PALEVOL, V5, P629, DOI 10.1016/j.crpv.2005.10.006; Castanet J, 2004, J ZOOL, V263, P31, DOI 10.1017/S0952836904004844; Castanet J, 2000, CR ACAD SCI III-VIE, V323, P543, DOI 10.1016/S0764-4469(00)00181-5; Castanet J., 1993, BONE, P245; Chinsamy A., 1992, Palaeontologia Africana, V29, P39; Chinsamy A, 2008, S AFR J SCI, V104, P311; Chinsamy-Turan A., 2005, MICROSTRUCTURE DINOS; Cubit TA, 2004, THESIS VIRGINIA POLY; de Boef M, 2007, CAN J ZOOL, V85, P63, DOI 10.1139/Z06-195; de Margerie E, 2002, CR BIOL, V325, P221, DOI 10.1016/S1631-0691(02)01429-4; de Ricqles A., 1991, BONE, V3, P255; Enlow D. H., 1957, Texas Journal of Science, V9, P186; Erickson GM, 2005, TRENDS ECOL EVOL, V20, P677, DOI 10.1016/j.tree.2005.08.012; Erickson GM, 2007, BIOL LETTERS, V3, P558, DOI 10.1098/rsbl.2007.0254; ESTES RD, 1991, BEHAV GUIDE AFRICAN; Fernandez P, 2006, J ARCHAEOL SCI, V33, P176, DOI 10.1016/j.jas.2005.07.005; Francillon-Vieillot H., 1990, P471; GUNDERSEN HJG, 1988, APMIS, V96, P379, DOI 10.1111/j.1699-0463.1988.tb05320.x; Horner JR, 2009, J VERTEBR PALEONTOL, V29, P734, DOI 10.1671/039.029.0312; Horner JR, 2000, J VERTEBR PALEONTOL, V20, P115, DOI 10.1671/0272-4634(2000)020[0115:LBHOTH]2.0.CO;2; Horner JR, 1999, PALEOBIOLOGY, V25, P295, DOI 10.1017/S0094837300021308; KLEIN R G, 1982, Annals of the South African Museum, V90, P49; Klevezal G., 1996, RECORDING STRUCTURES; Kohler M, 2012, NATURE, V487, P358, DOI 10.1038/nature11264; Kohler M, 2009, P NATL ACAD SCI USA, V106, P20354, DOI 10.1073/pnas.0813385106; Lamm ET, 2013, BONE HISTOLOGY OF FOSSIL TETRAPODS: ADVANCING METHODS, ANALYSIS, AND INTERPRETATION, P55; Lee AH, 2008, P NATL ACAD SCI USA, V105, P582, DOI 10.1073/pnas.0708903105; Lee AH, 2013, BONE HISTOLOGY OF FOSSIL TETRAPODS: ADVANCING METHODS, ANALYSIS, AND INTERPRETATION, P217; Marin-Moratalla N, 2013, MAMM BIOL, V78, P422, DOI 10.1016/j.mambio.2013.07.079; Marin-Moratalla N, 2011, CR PALEVOL, V10, P469, DOI 10.1016/j.crpv.2011.03.007; Martin RB, 1996, J BIOMECH, V29, P1515, DOI 10.1016/0021-9290(96)00082-6; Martin-Rosset W, 2005, EAAP PUBLIC, P15; MCFADDEN BJ, 1992, FOSSIL HORSES SYSTEM; MILLAR JS, 1983, ECOLOGY, V64, P631, DOI 10.2307/1937181; Nunez C. M. V., 2011, Equine reproduction, Volume 2, P2851; Padian K, 2013, BONE HISTOLOGY OF FOSSIL TETRAPODS: ADVANCING METHODS, ANALYSIS, AND INTERPRETATION, P35; Padian K, 2013, BONE HISTOLOGY OF FOSSIL TETRAPODS: ADVANCING METHODS, ANALYSIS, AND INTERPRETATION, P1; Pesquero MD, 2012, ESTUD GEOL-MADRID, V68, P47; Redelstorff R, 2012, ACTA PALAEONTOLOGICA, DOI org/10.4202/app.2012.0073; Ricklefs R. E., 2007, EC NATURE; Sander PM, 2006, PALAEONTOGR ABT A, V277, P143; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Skedros JG, 2009, BONE, V44, P392, DOI 10.1016/j.bone.2008.10.053; Stearns S.C., 1992, pi; Stein M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068590; STOVER SM, 1992, J ANAT, V181, P455; Warren LK, 1997, PROCEEDINGS OF THE FIFTEENTH EQUINE NUTRITION & PHYSIOLOGY SYMPOSIUM, P65; Werning S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033539; WESTERN D, 1979, AFR J ECOL, V17, P185, DOI 10.1111/j.1365-2028.1979.tb00256.x; Wilson James W., 1994, P205; Woodward HN, 2013, BONE HISTOLOGY OF FOSSIL TETRAPODS: ADVANCING METHODS, ANALYSIS, AND INTERPRETATION, P195	60	22	22	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e103708	10.1371/journal.pone.0103708	http://dx.doi.org/10.1371/journal.pone.0103708			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25098950	Green Submitted, gold, Green Published			2022-12-27	WOS:000339995100027
J	Burrow, CJ; Rudkin, D				Burrow, Carole J.; Rudkin, David			Oldest Near-Complete Acanthodian: The First Vertebrate from the Silurian Bertie Formation Konservat-Lagerstatte, Ontario	PLOS ONE			English	Article							NORTH-AMERICA; FISHES; CHELICERATA; EURYPTERIDA; PLACODERM; CANADA; BONES	Background: The relationships between early jawed vertebrates have been much debated, with cladistic analyses yielding little consensus on the position (or positions) of acanthodians with respect to other groups. Whereas one recent analysis showed various acanthodians (classically known as 'spiny sharks') as stem osteichthyans (bony fishes) and others as stem chondrichthyans, another shows the acanthodians as a paraphyletic group of stem chondrichthyans, and the latest analysis shows acanthodians as the monophyletic sister group of the Chondrichthyes. Methodology/Principal Findings: A small specimen of the ischnacanthiform acanthodian Nerepisacanthus denisoni is the first vertebrate fossil collected from the Late Silurian Bertie Formation Konservat-Lagerstatte of southern Ontario, Canada, a deposit well-known for its spectacular eurypterid fossils. The fish is the only near complete acanthodian from pre-Devonian strata worldwide, and confirms that Nerepisacanthus has dentigerous jaw bones, body scales with superposed crown growth zones formed of ondontocytic mesodentine, and a patch of chondrichthyan-like scales posterior to the jaw joint. Conclusions/Significance: The combination of features found in Nerepisacanthus supports the hypothesis that acanthodians could be a group, or even a clade, on the chondrichthyan stem. Cladistic analyses of early jawed vertebrates incorporating Nerepisacanthus, and updated data on other acanthodians based on publications in press, should help clarify their relationships.	[Burrow, Carole J.] Queensland Museum, Brisbane, Qld 4101, Australia; [Rudkin, David] Royal Ontario Museum, Dept Nat Hist Palaeobiol, Toronto, ON M5S 2C6, Canada	Queensland Museum; Royal Ontario Museum	Burrow, CJ (corresponding author), Queensland Museum, POB 300, Brisbane, Qld 4101, Australia.	carole.burrow@gmail.com	Burrow, Carole J./AAG-4327-2021					Braddy SJ, 2001, PALAEOGEOGR PALAEOCL, V172, P115, DOI 10.1016/S0031-0182(01)00274-7; Brazeau MD, 2009, NATURE, V457, P305, DOI 10.1038/nature07436; Brett CE, 1998, GEOLOGICAL SOCIETY O, V16, P32; Burrow CJ, 2013, ALCHERINGA, V37, P392, DOI 10.1080/03115518.2013.765656; Burrow CJ, 2011, CAN J EARTH SCI, V48, P1329, DOI 10.1139/E11-023; Burrow CJ, 2011, PALAEONTOLOGY, V54, P207, DOI 10.1111/j.1475-4983.2010.01003.x; Caron JB, 2004, J PALEONTOL, V78, P1138, DOI 10.1666/0022-3360(2004)078<1138:ANLSPN>2.0.CO;2; Cramer BD, 2011, LETHAIA, V44, P185, DOI 10.1111/j.1502-3931.2010.00234.x; Davis SP, 2012, NATURE, V486, P247, DOI 10.1038/nature11080; Denison R. H., 1979, HDB PALEOICHTHYOLO 5; Dupret V, 2014, NATURE, V507, P500, DOI 10.1038/nature12980; Edwards D, 2004, BOT J LINN SOC, V146, P399, DOI 10.1111/j.1095-8339.2004.00332.x; Fritsch A., 1907, MISCELLANEA PALAEONT; Hermus Chelsea R., 2001, Journal of Vertebrate Paleontology, V21, p61A; Miles R. S., 1973, ZOOLOGICAL J LINNEAN, P63; MILES RS, 1966, ARK ZOOL, V18, P147; MILES RS, 1970, LETHAIA, V3, P343, DOI 10.1111/j.1502-3931.1970.tb00828.x; NUDDS JR, 2008, FOSSIL ECOSYSTEMS N; Tetlie O. Erik, 2007, Bulletin of the Peabody Museum of Natural History, V48, P139, DOI 10.3374/0079-032X(2007)48[139:ERAELC]2.0.CO;2; Tetlie OE, 2008, PALAEOGEOGR PALAEOCL, V265, P182, DOI 10.1016/j.palaeo.2008.05.008; Upeniece Ieva, 1996, Modern Geology, V20, P383; Valiukevicius J., 1992, FOSSIL FISHES LIVING, P193; Valiukevicius Juozas, 2003, Geodiversitas, V25, P131; Valiukevicus J, 2005, ACTA PALAEONTOL POL, V50, P635; Wells J. W., 1944, PALAEONTOGRAPH AMER, V3, P99; Williams ME, 1998, J VERTEBR PALEONTOL, V18, P251, DOI 10.1080/02724634.1998.10011054; Zhu M, 2013, NATURE, V502, P188, DOI 10.1038/nature12617; ZIDEK J, 1985, Palaeontologische Zeitschrift, V59, P147	28	25	25	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e104171	10.1371/journal.pone.0104171	http://dx.doi.org/10.1371/journal.pone.0104171			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093877	Green Published, gold, Green Submitted			2022-12-27	WOS:000341357200083
J	Chandon, M; Bonnet, A; Burg, Y; Barnichon, C; DesMesnards-Smaja, V; Sitbon, B; Foiret, C; Dreyfus, JF; Rahmani, J; Laloe, PA; Fischler, M; Le Guen, M				Chandon, Michel; Bonnet, Agnes; Burg, Yannick; Barnichon, Carole; DesMesnards-Smaja, Veronique; Sitbon, Brigitte; Foiret, Christine; Dreyfus, Jean-Francois; Rahmani, Jamil; Laloe, Pierre-Antoine; Fischler, Marc; Le Guen, Morgan			Ultrasound-Guided Transversus Abdominis Plane Block versus Continuous Wound Infusion for Post-Caesarean Analgesia: A Randomized Trial	PLOS ONE			English	Article							POSTOPERATIVE ANALGESIA; CESAREAN DELIVERY; INFILTRATION	Objective: To compare the analgesic effect of ultrasound-guided Transversus Abdominis Plane (TAP) block versus Continuous Wound Infusion (CWI) with levobupivacaine after caesarean delivery. Methods: We recruited parturients undergoing elective caesareans for this multicenter study. Following written informed consent, they received a spinal anaesthetic without intrathecal morphine for their caesarean section. The postoperative analgesia was randomized to either a bilateral ultrasound guided TAP block (levobupivicaine = 150 mg) or a CWI through an elastomeric pump for 48 hours (levobupivacaine = 150 mg the first day and 12.5 mg/h thereafter). Every woman received regular analgesics along with oral morphine if required. The primary outcome was comparison of the 48-hour area under the curve (AUC) pain scores. Secondary outcomes included morphine consumption, adverse events, and persistent pain one month postoperatively. Results: Recruitment of 120 women was planned but the study was prematurely terminated due to the occurrence of generalized seizures in one patient of the TAP group. By then, 36 patients with TAP and 29 with CWI had completed the study. AUC of pain at rest and during mobilization were not significantly different: 50 [22.5-80] in TAP versus 50 [27.5-130] in CWI (P = 0.4) and 190 [130-240] versus 160 [112.5-247.5] (P = 0.5), respectively. Morphine consumption (0 [0-20] mg in the TAP group and 10 [0-32.5] mg in the CWI group (P = 0.09)) and persistent pain at one month were similar in both groups (respectively 29.6% and 26.6% (P = 0.73)). Conclusion: In cases of morphine-free spinal anesthesia for cesarean delivery, no difference between TAP block and CWI for postoperative analgesia was suggested. TAP block may induce seizures in this specific context. Consequently, such a technique after a caesarean section cannot be recommended.	[Chandon, Michel; Burg, Yannick; DesMesnards-Smaja, Veronique; Foiret, Christine; Fischler, Marc; Le Guen, Morgan] Hop Foch, Dept Anesthesiol, Suresnes, France; [Bonnet, Agnes; Barnichon, Carole; Sitbon, Brigitte; Rahmani, Jamil] Inst Hosp Francobritann, Dept Anesthesiol, Levallois Perret, France; [Dreyfus, Jean-Francois] Hop Foch, Dept Clin Res & Innovat, Suresnes, France; [Laloe, Pierre-Antoine] Bradford Teaching Hosp, Dept Hlth Educ, Leeds, W Yorkshire, England	Hospital Foch; Hospital Foch	Le Guen, M (corresponding author), Hop Foch, Dept Anesthesiol, Suresnes, France.	m.leguen@hopital-foch.org						Abdallah FW, 2012, REGION ANESTH PAIN M, V37, P193, DOI 10.1097/AAP.0b013e3182429531; Angst MS, 2006, ANESTHESIOLOGY, V104, P570, DOI 10.1097/00000542-200603000-00025; Bamigboye AA, 2010, SAMJ S AFR MED J, V100, P313, DOI 10.7196/SAMJ.3716; Bouhassira D, 2005, PAIN, V114, P29, DOI 10.1016/j.pain.2004.12.010; Carvalho B, 2005, ANESTH ANALG, V101, P1182, DOI 10.1213/01.ane.0000167774.36833.99; Charlton S, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007705.pub2; Corsini T, 2013, ANN FR ANESTH, V32, P25, DOI 10.1016/j.annfar.2012.10.035; Gupta A, 2011, ACTA ANAESTH SCAND, V55, P785, DOI 10.1111/j.1399-6576.2011.02463.x; Hebbard P, 2007, ANAESTH INTENS CARE, V35, P616; Hebbard PD, 2010, REGION ANESTH PAIN M, V35, P436, DOI 10.1097/AAP.0b013e3181e66702; Johns N, 2012, COLORECTAL DIS, V14, pE635, DOI 10.1111/j.1463-1318.2012.03104.x; Lavand'homme P, 2006, CURR OPIN ANESTHESIO, V19, P244, DOI 10.1097/01.aco.0000192815.22989.61; Lavand'homme PM, 2007, ANESTHESIOLOGY, V106, P1220, DOI 10.1097/01.anes.0000267606.17387.1d; Loane H, 2012, INT J OBSTET ANESTH, V21, P112, DOI 10.1016/j.ijoa.2012.02.005; MATTHEWS JNS, 1990, BRIT MED J, V300, P230, DOI 10.1136/bmj.300.6719.230; Mishriky BM, 2012, CAN J ANESTH, V59, P766, DOI 10.1007/s12630-012-9729-1; Nikolajsen L, 2004, ACTA ANAESTH SCAND, V48, P111, DOI 10.1111/j.1399-6576.2004.00271.x; Rackelboom T, 2010, OBSTET GYNECOL, V116, P893, DOI 10.1097/AOG.0b013e3181f38ac6; Sakai Toshiko, 2010, Masui, V59, P1502	19	42	44	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e103971	10.1371/journal.pone.0103971	http://dx.doi.org/10.1371/journal.pone.0103971			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093663	Green Published, gold, Green Submitted			2022-12-27	WOS:000341357200052
J	Ghiglione, Y; Falivene, J; Ruiz, MJ; Laufer, N; Socias, ME; Cahn, P; Giavedoni, L; Sued, O; Gherardi, MM; Salomon, H; Turk, G				Ghiglione, Yanina; Falivene, Juliana; Julia Ruiz, Maria; Laufer, Natalia; Eugenia Socias, Maria; Cahn, Pedro; Giavedoni, Luis; Sued, Omar; Magdalena Gherardi, Maria; Salomon, Horacio; Turk, Gabriela			Early Skewed Distribution of Total and HIV-Specific CD8(+) T-Cell Memory Phenotypes during Primary HIV Infection Is Related to Reduced Antiviral Activity and Faster Disease Progression	PLOS ONE			English	Article							PROGRAMMED DEATH-1; FUNCTIONAL PROFILE; VIRAL LOAD; PD-1 EXPRESSION; EX-VIVO; RESPONSES; DIFFERENTIATION; ASSOCIATION; EXHAUSTION; CAPACITY	The important role of the CD8(+) T-cells on HIV control is well established. However, correlates of immune protection remain elusive. Although the importance of CD8(+) T-cell specificity and functionality in virus control has been underscored, further unraveling the link between CD8(+) T-cell differentiation and viral control is needed. Here, an immunophenotypic analysis (in terms of memory markers and Programmed cell death 1 (PD-1) expression) of the CD8(+) T-cell subset found in primary HIV infection (PHI) was performed. The aim was to seek for associations with functional properties of the CD8(+) T-cell subsets, viral control and subsequent disease progression. Also, results were compared with samples from Chronics and Elite Controllers. It was found that normal maturation of total and HIV-specific CD8(+) T-cells into memory subsets is skewed in PHI, but not at the dramatic level observed in Chronics. Within the HIV-specific compartment, this alteration was evidenced by an accumulation of effector memory CD8(+) T (T-EM) cells over fully differentiated terminal effector CD8(+) T (T-TE) cells. Furthermore, higher proportions of total and HIV-specific CD8(+) T-EM cells and higher HIV-specific T-EM/(T-EM+T-TE) ratio correlated with markers of faster progression. Analysis of PD-1 expression on total and HIV-specific CD8(+) T-cells from PHI subjects revealed not only an association with disease progression but also with skewed memory CD8(+) T-cell differentiation. Most notably, significant direct correlations were obtained between the functional capacity of CD8(+) T-cells to inhibit viral replication in vitro with higher proportions of fully-differentiated HIV-specific CD8(+) T-TE cells, both at baseline and at 12 months post-infection. Thus, a relationship between preservation of CD8(+) T-cell differentiation pathway and cell functionality was established. This report presents evidence concerning the link among CD8(+) T-cell function, phenotype and virus control, hence supporting the instauration of early interventions to prevent irreversible immune damage.	[Ghiglione, Yanina; Falivene, Juliana; Julia Ruiz, Maria; Laufer, Natalia; Magdalena Gherardi, Maria; Salomon, Horacio; Turk, Gabriela] Univ Buenos Aires, CONICET, Inst Invest Biomed Retrovirus & SIDA INBIRS, Buenos Aires, DF, Argentina; [Eugenia Socias, Maria; Cahn, Pedro; Sued, Omar] Fdn Huesped, Buenos Aires, DF, Argentina; [Laufer, Natalia; Eugenia Socias, Maria; Cahn, Pedro; Sued, Omar] Hosp JA Fernandez, Buenos Aires, DF, Argentina; [Giavedoni, Luis] Texas Biomed, Res Inst, Southwest Natl Primate Res Ctr, Dept Virol & Immunol, San Antonio, TX USA	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Texas Biomedical Research Institute	Turk, G (corresponding author), Univ Buenos Aires, CONICET, Inst Invest Biomed Retrovirus & SIDA INBIRS, Buenos Aires, DF, Argentina.	gturk@fmed.uba.ar	Sued, Omar/H-3325-2019; Laufer, Natalia/AAB-7472-2022	Sued, Omar/0000-0001-5818-770X; Laufer, Natalia/0000-0002-5690-9454; Falivene, Juliana/0000-0003-3437-4863	Agencia Nacional de Promocion Cientifica y Tecnologica, ANPCYT [2008/0549, 2011/1658, 2011/0271]; Universidad de Buenos Aires [UBACyT 2013-201620020120200263BA]	Agencia Nacional de Promocion Cientifica y Tecnologica, ANPCYT(ANPCyT); Universidad de Buenos Aires(University of Buenos Aires)	This research was funded by grants from the Agencia Nacional de Promocion Cientifica y Tecnologica, ANPCYT, Grants #2008/0549 and #2011/1658 to MMG, Grant #2011/0271 to HS and a grant from Universidad de Buenos Aires (UBACyT 2013-201620020120200263BA) to GT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo MM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000321; Almeida JR, 2007, J EXP MED, V204, P2473, DOI 10.1084/jem.20070784; Barbour JD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004408; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Breton G, 2013, J IMMUNOL, V191, P2194, DOI 10.4049/jimmunol.1200646; Buckheit RW, 2012, J VIROL, V86, P13679, DOI 10.1128/JVI.02439-12; Bull M, 2007, J IMMUNOL METHODS, V322, P57, DOI 10.1016/j.jim.2007.02.003; Burgers WA, 2009, J IMMUNOL, V182, P4751, DOI 10.4049/jimmunol.0803801; Cao W, 2009, JAIDS-J ACQ IMM DEF, V50, P137, DOI 10.1097/QAI.0b013e3181926c28; Champagne P, 2001, NATURE, V410, P106, DOI 10.1038/35065118; Chun TW, 2004, P NATL ACAD SCI USA, V101, P2464, DOI 10.1073/pnas.0307328101; Currier JR, 2002, J IMMUNOL METHODS, V260, P157, DOI 10.1016/S0022-1759(01)00535-X; Day CL, 2007, J VIROL, V81, P434, DOI 10.1128/JVI.01754-06; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; de Silva TI, 2013, BLOOD, V121, P4330, DOI 10.1182/blood-2012-12-472787; Deeks SG, 2004, BLOOD, V104, P942, DOI 10.1182/blood-2003-09-3333; Demers KR, 2013, IMMUNOL REV, V254, P190, DOI 10.1111/imr.12069; Emu B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085613; Socias ME, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-40; Ferrando-Martinez S, 2012, J VIROL, V86, P3667, DOI 10.1128/JVI.07034-11; Fiebig EW, 2003, AIDS, V17, P1871, DOI 10.1097/00002030-200309050-00005; Freel SA, 2011, IMMUNOL RES, V49, P135, DOI 10.1007/s12026-010-8177-7; Freel SA, 2010, J VIROL, V84, P4998, DOI 10.1128/JVI.00138-10; Ganesan A, 2010, J INFECT DIS, V201, P272, DOI 10.1086/649430; Giavedoni LD, 2005, J IMMUNOL METHODS, V301, P89, DOI 10.1016/j.jim.2005.03.015; Hong JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060186; Janetzki Sylvia, 2005, Methods Mol Biol, V302, P51; Julg B, 2010, J VIROL, V84, P5540, DOI 10.1128/JVI.02031-09; Killian MS, 2011, J VIROL, V85, P1696, DOI 10.1128/JVI.01120-10; Maecker HT, 2005, BMC IMMUNOL, V6, DOI 10.1186/1471-2172-6-13; Mahnke YD, 2013, EUR J IMMUNOL, V43, P2797, DOI 10.1002/eji.201343751; Mahnke YD, 2013, AIDS, V27, P697, DOI 10.1097/QAD.0b013e32835ce2e9; Malhotra U, 2007, J VIROL, V81, P5225, DOI 10.1128/JVI.02564-06; Masemola A, 2004, J VIROL, V78, P3233, DOI 10.1128/JVI.78.7.3233-3243.2004; McDermott AB, 2012, AIDS, V26, P1281, DOI 10.1097/QAD.0b013e328353bcaf; McMichael AJ, 2010, NAT REV IMMUNOL, V10, P11, DOI 10.1038/nri2674; Meyer-Olson D, 2010, BLOOD, V116, P396, DOI 10.1182/blood-2009-11-254136; Northfield JW, 2007, J VIROL, V81, P5759, DOI 10.1128/JVI.00045-07; Passaes CP, 2014, VIROLOGY, V454, P340, DOI 10.1016/j.virol.2014.02.021; Patrick C, 2001, NATURE, P410; Peretz Y, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002840; Petrovas C, 2009, J IMMUNOL, V183, P1120, DOI 10.4049/jimmunol.0900182; Pires A, 2004, JAIDS-J ACQ IMM DEF, V36, P783, DOI 10.1097/00126334-200407010-00004; Riou C, 2014, J VIROL, V88, P1819, DOI 10.1128/JVI.02968-13; Riou C, 2012, J IMMUNOL, V189, P3838, DOI 10.4049/jimmunol.1201488; Saez-Cirion A, 2007, P NATL ACAD SCI USA, V104, P6776, DOI 10.1073/pnas.0611244104; Saez-Cirion A, 2009, J IMMUNOL, V182, P7828, DOI 10.4049/jimmunol.0803928; Sauce D, 2007, AIDS, V21, P2005, DOI 10.1097/QAD.0b013e3282eee548; Simon V, 2006, LANCET, V368, P489, DOI 10.1016/S0140-6736(06)69157-5; Streeck H, 2008, PLOS MED, V5, P790, DOI 10.1371/journal.pmed.0050100; Streeck H, 2010, J INFECT DIS, V202, pS302, DOI 10.1086/655652; Trautmann L, 2006, NAT MED, V12, P1198, DOI 10.1038/nm1482; Trautmann L, 2012, BLOOD, V120, P3466, DOI 10.1182/blood-2012-04-422550; Turk G, 2008, J VIROL, V82, P2853, DOI 10.1128/JVI.02260-07; Turk G, 2013, J VIROL, V87, P7445, DOI 10.1128/JVI.00865-13; Wei F, 2013, P NATL ACAD SCI USA, V110, pE2480, DOI 10.1073/pnas.1305394110; Westrop SJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005474; Yamamoto T, 2012, J VIROL, V86, P5877, DOI 10.1128/JVI.00315-12; Yamamoto T, 2011, BLOOD, V117, P4805, DOI 10.1182/blood-2010-11-317297; Zelinskyy G, 2011, J IMMUNOL, V187, P3730, DOI 10.4049/jimmunol.1101612; Zhang JY, 2007, BLOOD, V109, P4671, DOI 10.1182/blood-2006-09-044826; Zimmerli SC, 2005, P NATL ACAD SCI USA, V102, P7239, DOI 10.1073/pnas.0502393102	62	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e104235	10.1371/journal.pone.0104235	http://dx.doi.org/10.1371/journal.pone.0104235			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093660	Green Published, gold, Green Submitted			2022-12-27	WOS:000341357200088
J	Paterson, C; Law, AJ				Paterson, Clare; Law, Amanda J.			Transient Overexposure of Neuregulin 3 during Early Postnatal Development Impacts Selective Behaviors in Adulthood	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; DEVELOPING NEOCORTEX; RECOGNITION MEMORY; PREFRONTAL CORTEX; ANIMAL-MODEL; SCHIZOPHRENIA; MICE; RECEPTOR; SUSCEPTIBILITY; INTERNEURONS	Neuregulin 3 (NRG3), a specific ligand for ErbB4 and a neuronal-enriched neurotrophin is implicated in the genetic predisposition to a broad spectrum of neurodevelopmental, neurocognitive and neuropsychiatric disorders, including Alzheimer's disease, autism and schizophrenia. Genetic studies in schizophrenia demonstrate that risk variants in NRG3 are associated with cognitive and psychotic symptom severity, accompanied by increased expression of prefrontal cortical NRG3. Despite our expanding knowledge of genetic involvement of NRG3 in neurological disorders, little is known about the neurodevelopmental mechanisms of risk. Here we exploited the fact that a paralog of NRG3, NRG1, readily penetrates the murine blood brain barrier (BBB). In this study we synthesized the bioactive epidermal growth factor (EGF) domain of NRG3, and using previously validated in-vivo peripheral injection methodologies in neonatal mice, demonstrate that NRG3 successfully crosses the BBB, where it activates its receptor ErbB4 and downstream Akt signaling at levels of bioactivity comparable to NRG1. To determine the impact of NRG3 overexpression during one critical developmental window, C57BL/6 male mice were subcutaneously injected daily with NRG1-EGF, NRG3-EGF or vehicle from postnatal days 2-10. Mice were tested in adulthood using a comprehensive battery of behavioral tasks relevant to neurocognitive and psychiatric disorders. In agreement with previous studies, developmental overexposure to NRG1 induced multiple non-CNS mediated peripheral effects as well as severely disrupting performance of prepulse inhibition of the startle response. In contrast, NRG3 had no effect on any peripheral measures investigated or sensorimotor gating. Specifically, developmental NRG3 overexposure produced an anxiogenic-like phenotype and deficits in social behavior in adulthood. These results provide primary data to support a role for NRG3 in brain development and function, which appears to be distinct from its paralog NRG1. Furthermore we demonstrate how perturbations in NRG3 expression at distinct developmental stages may contribute to the neurological deficits observed in brain disorders such as schizophrenia and autism.	[Paterson, Clare; Law, Amanda J.] Univ Colorado, Sch Med, Dept Psychiat, Aurora, CO 80045 USA; [Law, Amanda J.] Univ Colorado, Sch Med, Dept Cell & Dev Biol, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Law, AJ (corresponding author), Univ Colorado, Sch Med, Dept Psychiat, Aurora, CO 80045 USA.	amanda.law@ucdenver.edu	Law, Amanda J/G-6372-2012	Law, Amanda J/0000-0002-2574-1564; Paterson, Clare/0000-0001-7454-560X	National Institute of Mental Health; Brain Behavior Research Foundations, Sidney R. Baer Jr. Award for Schizophrenia Research	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Brain Behavior Research Foundations, Sidney R. Baer Jr. Award for Schizophrenia Research	This work was supported by funds from the Intramural Research Program, National Institute of Mental Health, and from the Brain Behavior Research Foundations, Sidney R. Baer Jr. Award for Schizophrenia Research, awarded to Amanda J. Law at the University of Colorado, Denver, School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 1998, J BIOL CHEM, V273, P11150, DOI 10.1074/jbc.273.18.11150; Abe Y, 2011, J NEUROSCI, V31, P5699, DOI 10.1523/JNEUROSCI.3477-10.2011; Assimacopoulos S, 2003, J NEUROSCI, V23, P6399; Balciuniene J, 2007, AM J HUM GENET, V80, P938, DOI 10.1086/513607; Barker GRI, 2007, J NEUROSCI, V27, P2948, DOI 10.1523/JNEUROSCI.5289-06.2007; Barker GRI, 2011, J NEUROSCI, V31, P10721, DOI 10.1523/JNEUROSCI.6413-10.2011; Bortolato M, 2013, NEUROPHARMACOLOGY, V75, P223, DOI 10.1016/j.neuropharm.2013.07.003; Brasnjevic I, 2009, PROG NEUROBIOL, V87, P212, DOI 10.1016/j.pneurobio.2008.12.002; Carlsson T, 2011, J NEUROCHEM, V117, P1066, DOI 10.1111/j.1471-4159.2011.07284.x; Carteron C, 2006, J CELL SCI, V119, P898, DOI 10.1242/jcs.02799; Chen PL, 2009, AM J HUM GENET, V84, P21, DOI 10.1016/j.ajhg.2008.12.005; Chen YJJ, 2008, J NEUROSCI, V28, P6872, DOI 10.1523/JNEUROSCI.1815-08.2008; Deakin IH, 2012, CEREB CORTEX, V22, P1520, DOI 10.1093/cercor/bhr223; Deakin IH, 2009, NEUROREPORT, V20, P1523, DOI 10.1097/WNR.0b013e328330f6e7; Dean B, 2008, SCHIZOPHR RES, V99, P341, DOI 10.1016/j.schres.2007.10.013; del Pino I, 2013, NEURON, V79, P1152, DOI 10.1016/j.neuron.2013.07.010; Duffy L, 2010, NEUROSCIENCE, V170, P800, DOI 10.1016/j.neuroscience.2010.07.042; Elia J, 2010, MOL PSYCHIATR, V15, P637, DOI 10.1038/mp.2009.57; Fallin MD, 2003, AM J HUM GENET, V73, P601, DOI 10.1086/378158; Falls DL, 2003, EXP CELL RES, V284, P14, DOI 10.1016/S0014-4827(02)00102-7; Faraone SV, 2006, AM J PSYCHIAT, V163, P1760, DOI 10.1176/appi.ajp.163.10.1760; Futamura T, 2003, MOL PSYCHIATR, V8, P19, DOI 10.1038/sj.mp.4001138; Grant E, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00053; Guilmatre A, 2009, ARCH GEN PSYCHIAT, V66, P947, DOI 10.1001/archgenpsychiatry.2009.80; Hatzimanolis A, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.33; Henck JW, 2001, TOXICOL SCI, V62, P80, DOI 10.1093/toxsci/62.1.80; Hobbs SS, 2002, ONCOGENE, V21, P8442, DOI 10.1038/sj.onc.1205960; Kao WT, 2010, P NATL ACAD SCI USA, V107, P15619, DOI 10.1073/pnas.1005410107; Kastin AJ, 2004, J NEUROCHEM, V88, P965, DOI 10.1046/j.1471-4159.2003.02224.x; Kato T, 2011, MOL PSYCHIATR, V16, P307, DOI 10.1038/mp.2010.10; Law AJ, 2012, P NATL ACAD SCI USA, V109, P12165, DOI 10.1073/pnas.1206118109; LIPSKA BK, 1993, NEUROPSYCHOPHARMACOL, V9, P67, DOI 10.1038/npp.1993.44; Longart M, 2004, J COMP NEUROL, V472, P156, DOI 10.1002/cne.20016; Loos M, 2014, BIOL PSYCHIAT; Mahar I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026610; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; Mefford HC, 2009, GENOME RES, V19, P1579, DOI 10.1101/gr.094987.109; Meier S, 2013, INT J NEUROPSYCHOPH, V16, P549, DOI 10.1017/S1461145712000697; Mizuno M, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.29; Morar B, 2011, MOL PSYCHIATR, V16, P860, DOI 10.1038/mp.2010.70; Moy SS, 2004, GENES BRAIN BEHAV, V3, P287, DOI 10.1111/j.1601-1848.2004.00076.x; Ogiso H, 2002, CELL, V110, P775, DOI 10.1016/S0092-8674(02)00963-7; Papaleo F, 2008, J NEUROSCI, V28, P8709, DOI 10.1523/JNEUROSCI.2077-08.2008; Portera-Cailliau C, 2005, PLOS BIOL, V3, P1473, DOI 10.1371/journal.pbio.0030272; Sanchez MM, 2001, DEV PSYCHOPATHOL, V13, P419, DOI 10.1017/S0954579401003029; Saunders RC, 1998, NATURE, V393, P169, DOI 10.1038/30245; Shamir A, 2012, J NEUROSCI, V32, P2988, DOI 10.1523/JNEUROSCI.1899-11.2012; Tost H, 2014, J NEUROSCI, V34, P1051, DOI 10.1523/JNEUROSCI.3496-13.2014; Turner J.R., 2013, MOL PSYCHIAT; Vullhorst D, 2009, J NEUROSCI, V29, P12255, DOI 10.1523/JNEUROSCI.2454-09.2009; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Wang YC, 2008, BIOL PSYCHIAT, V64, P1093, DOI 10.1016/j.biopsych.2008.07.012; Yin DM, 2013, NEURON, V78, P644, DOI 10.1016/j.neuron.2013.03.028; Zhang DX, 1997, P NATL ACAD SCI USA, V94, P9562, DOI 10.1073/pnas.94.18.9562	54	27	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e104172	10.1371/journal.pone.0104172	http://dx.doi.org/10.1371/journal.pone.0104172			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093331	Green Published, gold, Green Submitted			2022-12-27	WOS:000341357200084
J	Pradier, C; Sakarovitch, C; Le Duff, F; Layese, R; Metelkina, A; Anthony, S; Tifratene, K; Robert, P				Pradier, Christian; Sakarovitch, Charlotte; Le Duff, Franck; Layese, Richard; Metelkina, Asya; Anthony, Sabine; Tifratene, Karim; Robert, Philippe			The Mini Mental State Examination at the Time of Alzheimer's Disease and Related Disorders Diagnosis, According to Age, Education, Gender and Place of Residence: A Cross-Sectional Study among the French National Alzheimer Database	PLOS ONE			English	Article							LATENT PROCESS; RESERVE; BRAIN; NORMS; MODEL	The aim of this study: was firstly to describe the MMSE (Mini- Mental State Examination) score upon initial diagnosis of Alzheimer's disease and related disorders among the French population, according to age. Secondly, education, gender and place of residence were studied as factors potentially associated with delayed Alzheimer's disease diagnosis. Design: we conducted a cross sectional analysis of the French National Alzheimer database (BNA). Data from 2008 to 2012 were extracted. Patients were selected at the moment of their first diagnosis of AD (n = 39,451). Results: The MMSE score at initial diagnosis dropped significantly with increasing age. The test score increased with the degree of educational background regardless of age. Gender and place of residence were significantly related to the MMSE score, women and persons living in medical institutions having lower MMSE scores under the age of 90 years and at all educational levels. Conclusions: Health care professionals should be aware of these risk factors in order to maximize chances of earliest possible diagnosis of Alzheimer's disease and related disorders.	[Pradier, Christian; Le Duff, Franck; Metelkina, Asya; Anthony, Sabine; Tifratene, Karim] Nice Univ Hosp, Dept Publ Hlth, Nice, France; [Pradier, Christian; Le Duff, Franck; Metelkina, Asya; Anthony, Sabine; Tifratene, Karim] Univ Nice Sophia Antipolis, F-06189 Nice, France; [Sakarovitch, Charlotte; Layese, Richard] Nice Univ Hosp Nice, Dept Clin Res, Nice, France; [Tifratene, Karim; Robert, Philippe] Univ Nice Sophia Antipolis, CoBTeK Res Unit, F-06189 Nice, France; [Robert, Philippe] Nice Univ Hosp, Memory Ctr CMRR, Nice, France	CHU Nice; UDICE-French Research Universities; Universite Cote d'Azur; CHU Nice; UDICE-French Research Universities; Universite Cote d'Azur; CHU Nice	Pradier, C (corresponding author), Nice Univ Hosp, Dept Publ Hlth, Nice, France.	pradier.c@chu-nice.fr	Pradier, Christian/AAE-9669-2022; Pradier, Christian/AFE-8255-2022; LAYESE, Richard/R-4395-2018	LAYESE, Richard/0000-0002-2855-4908; LE DUFF, Franck/0000-0002-7899-491X	French Ministry of Health	French Ministry of Health	The BNA is funded by the French Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo A, 2007, J CLIN EXP NEUROPSYC, V29, P530, DOI 10.1080/13803390600814740; Barnes LL, 2005, ARCH GEN PSYCHIAT, V62, P685, DOI 10.1001/archpsyc.62.6.685; Callahan MJ, 2001, AM J PATHOL, V158, P1173, DOI 10.1016/S0002-9440(10)64064-3; Chene G, 2013, ALZHEIMER DEMENT; COMMENGES D, 1992, J NERV MENT DIS, V180, P28, DOI 10.1097/00005053-199201000-00007; CRUM RM, 1993, JAMA-J AM MED ASSOC, V269, P2386, DOI 10.1001/jama.269.18.2386; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GANGULI M, 1991, NEUROEPIDEMIOLOGY, V10, P42, DOI 10.1159/000110246; Jacqmin-Gadda H, 2010, STAT MED, V29, P2723, DOI 10.1002/sim.4035; JacqminGadda H, 1997, AM J EPIDEMIOL, V145, P498; Le Duff F, 2012, J ALZHEIMERS DIS, V29, P891, DOI 10.3233/JAD-2012-111943; Mungas D, 1996, NEUROLOGY, V46, P700, DOI 10.1212/WNL.46.3.700; Perneczky R, 2007, INT J GERIATR PSYCH, V22, P1135, DOI 10.1002/gps.1803; Perneczky R, 2007, J NEUROL, V254, P1395, DOI 10.1007/s00415-007-0558-z; Placanica L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005088; Proust C, 2006, BIOMETRICS, V62, P1014, DOI 10.1111/j.1541-0420.2006.00573.x; Roberts RO, 2012, NEUROLOGY, V78, P342, DOI 10.1212/WNL.0b013e3182452862; Roselli F, 2009, CLIN NEUROL NEUROSUR, V111, P327, DOI 10.1016/j.clineuro.2008.10.006; ROYSTON P, 1994, J R STAT SOC C-APPL, V43, P429, DOI 10.2307/2986270; Sinforiani E, 2010, DEMENT GERIATR COGN, V30, P147, DOI 10.1159/000318842; TOMBAUGH TN, 1992, J AM GERIATR SOC, V40, P922, DOI 10.1111/j.1532-5415.1992.tb01992.x; Yue M, 2011, NEUROBIOL AGING, V32, P590, DOI 10.1016/j.neurobiolaging.2009.04.006	22	40	41	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e103630	10.1371/journal.pone.0103630	http://dx.doi.org/10.1371/journal.pone.0103630			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093735	Green Published, gold, Green Submitted			2022-12-27	WOS:000341357200026
J	Sabater-Lleal, M; Malarstig, A; Folkersen, L; Artigas, MS; Baldassarre, D; Kavousi, M; Almgren, P; Veglia, F; Brusselle, G; Hofman, A; Engstrom, G; Franco, OH; Melander, O; Paulsson-Berne, G; Watkins, H; Eriksson, P; Humphries, SE; Tremoli, E; de Faire, U; Tobin, MD; Hamsten, A				Sabater-Lleal, Maria; Maelarstig, Anders; Folkersen, Lasse; Artigas, Maria Soler; Baldassarre, Damiano; Kavousi, Maryam; Almgren, Peter; Veglia, Fabrizio; Brusselle, Guy; Hofman, Albert; Engstrom, Gunnar; Franco, Oscar H.; Melander, Olle; Paulsson-Berne, Gabrielle; Watkins, Hugh; Eriksson, Per; Humphries, Steve E.; Tremoli, Elena; de Faire, Ulf; Tobin, Martin D.; Hamsten, Anders			Common Genetic Determinants of Lung Function, Subclinical Atherosclerosis and Risk of Coronary Artery Disease	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; INTIMA-MEDIA THICKNESS; GENOME-WIDE ASSOCIATION; CARDIOVASCULAR RISK; GLOBAL BURDEN; INFLAMMATION; VARIANTS; IDENTIFICATION; COPD; TOOL	Chronic obstructive pulmonary disease (COPD) independently associates with an increased risk of coronary artery disease (CAD), but it has not been fully investigated whether this co-morbidity involves shared pathophysiological mechanisms. To identify potential common pathways across the two diseases, we tested all recently published single nucleotide polymorphisms (SNPs) associated with human lung function (spirometry) for association with carotid intima-media thickness (cIMT) in 3,378 subjects with multiple CAD risk factors, and for association with CAD in a case-control study of 5,775 CAD cases and 7,265 controls. SNPs rs2865531, located in the CFDP1 gene, and rs9978142, located in the KCNE2 gene, were significantly associated with CAD. In addition, SNP rs9978142 and SNP rs3995090 located in the HTR4 gene, were associated with average and maximal cIMT measures. Genetic risk scores combining the most robustly spirometry-associated SNPs from the literature were modestly associated with CAD, (odds ratio (OR) (95% confidence interval (CI95) = 1.06 (1.03, 1.09); P-value = 1.5x10(-4), per allele). In conclusion, our study suggests that some genetic loci implicated in determining human lung function also influence cIMT and susceptibility to CAD. The present results should help elucidate the molecular underpinnings of the co-morbidity observed across COPD and CAD.	[Sabater-Lleal, Maria; Folkersen, Lasse; Eriksson, Per; Hamsten, Anders] Karolinska Inst, Karolinska Univ Hosp, Dept Med, Atherosclerosis Res Unit, Stockholm, Sweden; [Maelarstig, Anders] Pfizer Worldwide Res & Dev, Cambridge, England; [Artigas, Maria Soler; Tobin, Martin D.] Univ Leicester, Genet Epidemiol Grp, Dept Hlth Sci, Leicester, Leics, England; [Artigas, Maria Soler; Tobin, Martin D.] Glenfield Hosp, Natl Inst Hlth Res, Leicester Resp Biomed Res Unit, Leicester, Leics, England; [Baldassarre, Damiano; Tremoli, Elena] Univ Milan, Dipartimento Sci Farmacol & Biomol, Milan, Italy; [Baldassarre, Damiano; Veglia, Fabrizio; Tremoli, Elena] Ist Ricovero & Cura Cattere Sci, Ctr Cardiol Monzino, Milan, Italy; [Kavousi, Maryam; Brusselle, Guy; Hofman, Albert; Franco, Oscar H.] Univ Med Ctr Rotterdam, Dept Epidemiol, Erasmus Med Ctr, Rotterdam, Netherlands; [Almgren, Peter; Engstrom, Gunnar; Melander, Olle] Lund Univ, Dept Clin Sci, Malmo, Sweden; [Brusselle, Guy] Univ Med Ctr Rotterdam, Dept Internal Med, Erasmus Med Ctr, Rotterdam, Netherlands; [Brusselle, Guy] Inspectorate Hlth Care, The Hague, Netherlands; [Melander, Olle] Skane Univ Hosp, Dept Internal Med, Malmo, Sweden; [Paulsson-Berne, Gabrielle] Karolinska Inst, Karolinska Univ Hosp, Dept Med, Cardiovasc Res Unit, Stockholm, Sweden; [Watkins, Hugh] Univ Oxford, Dept Cardiovasc Med, Oxford, England; [Watkins, Hugh] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Humphries, Steve E.] UCL, Inst Cardiovasc Sci, Ctr Cardiovasc Genet, London, England; [de Faire, Ulf] Karolinska Inst, Inst Environm Med, Div Cardiovasc Epidemiol, S-10401 Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Pfizer; University of Leicester; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; University of Milan; IRCCS Centro Cardiologico Monzino; Erasmus University Rotterdam; Erasmus MC; Lund University; Erasmus University Rotterdam; Erasmus MC; Lund University; Skane University Hospital; Karolinska Institutet; Karolinska University Hospital; University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; University of London; University College London; Karolinska Institutet	Sabater-Lleal, M (corresponding author), Karolinska Inst, Karolinska Univ Hosp, Dept Med, Atherosclerosis Res Unit, Stockholm, Sweden.	maria.sabater.lleal@ki.se	Artigas, María Soler/L-6529-2013; Franco, Óscar H/ABE-2305-2020; Baldassarre, Damiano/J-3295-2016; Lleal, Maria Sabater/I-5832-2013; Veglia, Fabrizio/K-1958-2016; Kavousi, Maryam/F-1174-2018; TREMOLI, ELENA/I-8126-2018	Artigas, María Soler/0000-0002-3213-1107; Franco, Óscar H/0000-0002-4606-4929; Baldassarre, Damiano/0000-0002-2766-8882; Lleal, Maria Sabater/0000-0002-0128-379X; Veglia, Fabrizio/0000-0002-9378-8874; Kavousi, Maryam/0000-0001-5976-6519; Folkersen, Lasse/0000-0003-0708-9530; Watkins, Hugh/0000-0002-5287-9016; Malarstig, Anders/0000-0003-2608-1358; Melander, Olle/0000-0002-2581-484X; Eriksson, Per/0000-0002-5635-2692; Engstrom, Gunnar/0000-0002-8618-9152; Brusselle, Guy/0000-0001-7021-8505; TREMOLI, ELENA/0000-0002-0929-6106; Humphries, Stephen E/0000-0002-8221-6547; Tobin, Martin/0000-0002-3596-7874	Pfizer; MRC [G0902313] Funding Source: UKRI; British Heart Foundation [RG/08/008/25291] Funding Source: researchfish; Medical Research Council [G0902313] Funding Source: researchfish	Pfizer(Pfizer); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	On behalf of all the authors, Dr. Sabater-Lleal would like to state that the authors received no specific funding for this work, however Pfizer provided support in the form of salary for author Dr. Malarstig, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	Abbott GW, 1999, CELL, V97, P175, DOI 10.1016/S0092-8674(00)80728-X; Artigas MS, 2011, AM J RESP CRIT CARE, V184, P786, DOI 10.1164/rccm.201102-0192OC; Baldassarre D, ARTERIOSCLER THROMB, V33, P2273; Baldassarre D, 2012, J AM COLL CARDIOL, V60, P1489, DOI 10.1016/j.jacc.2012.06.034; Bhatt SP, 2013, TRANSL RES; Castaldi PJ, 2011, AM J RESP CELL MOL, V45, P1147, DOI 10.1165/rcmb.2011-0055OC; Cho MH, 2010, NAT GENET, V42, P200, DOI 10.1038/ng.535; Clarke R, 2009, NEW ENGL J MED, V361, P2518, DOI 10.1056/NEJMoa0902604; Crawford DC, 2004, AM J HUM GENET, V74, P610, DOI 10.1086/382227; Ebrahim S, 1999, STROKE, V30, P841, DOI 10.1161/01.STR.30.4.841; Eisner MD, 2010, AM J RESP CRIT CARE, V182, P693, DOI 10.1164/rccm.200811-1757ST; Folkersen L, 2010, CIRC-CARDIOVASC GENE, V3, P365, DOI 10.1161/CIRCGENETICS.110.948935; Gan WQ, 2004, THORAX, V59, P574, DOI 10.1136/thx.2003.019588; Gertow K, 2012, CIRC-CARDIOVASC GENE, V5, P656, DOI 10.1161/CIRCGENETICS.112.963660; Hancock DB, 2010, NAT GENET, V42, P45, DOI 10.1038/ng.500; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; Lokke A, 2006, THORAX, V61, P935, DOI 10.1136/thx.2006.062802; Maclay JD, 2007, RESPIROLOGY, V12, P634, DOI 10.1111/j.1440-1843.2007.01136.x; Mullerova H, 2013, CHEST, V144, P1163, DOI 10.1378/chest.12-2847; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; Peden JF, 2011, NAT GENET, V43, P339, DOI 10.1038/ng.782; Pillai SG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000421; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Repapi E, 2010, NAT GENET, V42, P36, DOI 10.1038/ng.501; Schroeder EB, 2005, ATHEROSCLEROSIS, V180, P367, DOI 10.1016/j.atherosclerosis.2004.12.012; Silverman Edwin K, 2006, Proc Am Thorac Soc, V3, P405, DOI 10.1513/pats.200603-092AW; Silverman EK, 1996, MED CLIN N AM, V80, P501, DOI 10.1016/S0025-7125(05)70451-X; Soler Artigas M, 2011, NAT GENET, V43, P1082, DOI 10.1038/ng.941; Tang DD, 2009, J CARDIOVASC PHARM T, V14, P89, DOI 10.1177/1074248409333490; Tikhmyanova N, 2010, CELL MOL LIFE SCI, V67, P1025, DOI 10.1007/s00018-009-0213-1; Wilk JB, 2012, AM J RESP CRIT CARE, V186, P622, DOI 10.1164/rccm.201202-0366OC; Wilk JB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000429; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; WRIGHT JL, 1988, LUNG, V166, P277, DOI 10.1007/BF02714058	35	32	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e104082	10.1371/journal.pone.0104082	http://dx.doi.org/10.1371/journal.pone.0104082			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093840	Green Published, Green Submitted, gold			2022-12-27	WOS:000341357200064
J	Kanagaratham, C; Marino, R; Camateros, P; Ren, J; Houle, D; Sladek, R; Vidal, SM; Radzioch, D				Kanagaratham, Cynthia; Marino, Rafael; Camateros, Pierre; Ren, John; Houle, Daniel; Sladek, Robert; Vidal, Silvia M.; Radzioch, Danuta			Mapping of a Chromosome 12 Region Associated with Airway Hyperresponsiveness in a Recombinant Congenic Mouse Strain and Selection of Potential Candidate Genes by Expression and Sequence Variation Analyses	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; GENOME-WIDE; SUSCEPTIBILITY; ASTHMA; MICE; RESPONSIVENESS; FOXA1; A/J; IDENTIFICATION; ACTIVATION	In a previous study we determined that BcA86 mice, a strain belonging to a panel of AcB/BcA recombinant congenic strains, have an airway responsiveness phenotype resembling mice from the airway hyperresponsive A/J strain. The majority of the BcA86 genome is however from the hyporesponsive C57BL/6J strain. The aim of this study was to identify candidate regions and genes associated with airway hyperresponsiveness (AHR) by quantitative trait locus (QTL) analysis using the BcA86 strain. Airway responsiveness of 205 F2 mice generated from backcrossing BcA86 strain to C57BL/6J strain was measured and used for QTL analysis to identify genomic regions in linkage with AHR. Consomic mice for the QTL containing chromosomes were phenotyped to study the contribution of each chromosome to lung responsiveness. Candidate genes within the QTL were selected based on expression differences in mRNA from whole lungs, and the presence of coding non-synonymous mutations that were predicted to have a functional effect by amino acid substitution prediction tools. One QTL for AHR was identified on Chromosome 12 with its 95% confidence interval ranging from 54.6 to 82.6 Mbp and a maximum LOD score of 5.11 (p = 3.68x10(-3)). We confirmed that the genotype of mouse Chromosome 12 is an important determinant of lung responsiveness using a Chromosome 12 substitution strain. Mice with an A/J Chromosome 12 on a C57BL/6J background have an AHR phenotype similar to hyperresponsive strains A/J and BcA86. Within the QTL, genes with deleterious coding variants, such as Foxa1, and genes with expression differences, such as Mettl21d and Snapc1, were selected as possible candidates for the AHR phenotype. Overall, through QTL analysis of a recombinant congenic strain, microarray analysis and coding variant analysis we identified Chromosome 12 and three potential candidate genes to be in linkage with airway responsiveness.	[Kanagaratham, Cynthia; Sladek, Robert; Vidal, Silvia M.; Radzioch, Danuta] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [Marino, Rafael; Camateros, Pierre; Sladek, Robert; Radzioch, Danuta] McGill Univ, Fac Med, Div Expt Med, Montreal, PQ, Canada; [Ren, John; Vidal, Silvia M.] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ, Canada; [Houle, Daniel] McGill Univ, Ctr Hlth, Res Inst, Montreal, PQ, Canada; [Sladek, Robert] McGill Univ, Montreal, PQ, Canada; [Sladek, Robert] Genome Quebec Innovat Ctr, Montreal, PQ, Canada	McGill University; McGill University; McGill University; McGill University; McGill University	Kanagaratham, C (corresponding author), McGill Univ, Dept Human Genet, Montreal, PQ, Canada.	danuta.radzioch@mcgill.ca	Sladek, Robert/R-2391-2019	Sladek, Robert/0000-0002-2730-1204; Radzioch, Danuta/0000-0002-1601-2757	American Asthma Foundation; Canadian Institutes of Health Research [MOP-106544, MOP-89821]; CIHR; Natural Sciences and Engineering Research Council of Canada (NSERC); Fonds de recherche Sante Quebec (FRQ-S); AllerGen Network of Centers of Excellence; AllerGen; FRQ-S; Canada Research Chair	American Asthma Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); CIHR(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Fonds de recherche Sante Quebec (FRQ-S); AllerGen Network of Centers of Excellence; AllerGen; FRQ-S; Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs)	This work was supported by grants from American Asthma Foundation and the Canadian Institutes of Health Research awarded to DR (Canadian Institutes of Health Research, MOP-106544) and SMV and RS (Canadian Institutes of Health Research, MOP-89821). PC, CK, and RM are recipients of doctoral scholarships from the CIHR. PC is a recipient of Postgraduate Scholarship from the Natural Sciences and Engineering Research Council of Canada (NSERC). CK is a recipient of doctoral awards from the Fonds de recherche Sante Quebec (FRQ-S) and the AllerGen Network of Centers of Excellence. JR is a recipient of a summer studentship from AllerGen. RS is a recipient of a New Investigator Award from the CIHR and a Chercheur-boursier Junior 2 award from the FRQ-S. SMV is a recipient of a Canada Research Chair. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman KG, 2005, PHYSIOL GENOMICS, V21, P105, DOI 10.1152/physiolgenomics.00267.2004; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Ali S, 2013, J IMMUNOL, V190, P3949, DOI 10.4049/jimmunol.1201015; Baillat D, 2012, MOL CELL BIOL, V32, P4642, DOI 10.1128/MCB.00906-12; Bates J, 2004, AM J RESP CELL MOL, V31, P373, DOI 10.1165/ajrcmb.31.3.1; Besnard V, 2004, GENE EXPR PATTERNS, V5, P193, DOI 10.1016/j.modgep.2004.08.006; Blazejczyk M., 2007, FLEXARRAY STAT DATA; Boivin GA, 2012, J IMMUNOL, V188, P3949, DOI 10.4049/jimmunol.1103320; Camateros P, 2010, MAMM GENOME, V21, P28, DOI 10.1007/s00335-009-9236-z; Carlsson P, 2002, DEV BIOL, V250, P1, DOI 10.1006/dbio.2002.0780; Chen S, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0048747, 10.1371/journal.pone.0046703, 10.1371/journal.pone.0029579, 10.1371/journal.pone.0050850]; Choi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046688; Daley D, 2012, J ALLERGY CLIN IMMUN, V130, P1284, DOI 10.1016/j.jaci.2012.07.051; De Sanctis GT, 1999, AM J PHYSIOL-LUNG C, V277, pL1118, DOI 10.1152/ajplung.1999.277.6.L1118; DESANCTIS GT, 1995, NAT GENET, V11, P150, DOI 10.1038/ng1095-150; Ewart SL, 1996, AM J RESP CELL MOL, V14, P487, DOI 10.1165/ajrcmb.14.5.8624254; Firszt R, 2013, EUR RESP J; Fortin A, 2001, P NATL ACAD SCI USA, V98, P10793, DOI 10.1073/pnas.191288998; Fortin A, 2001, GENOMICS, V74, P21, DOI 10.1006/geno.2001.6528; Gao N, 2003, MOL ENDOCRINOL, V17, P1484, DOI 10.1210/me.2003-0020; Gill K, 2005, MAMM GENOME, V16, P319, DOI 10.1007/s00335-004-2239-x; Gill KJ, 2005, BEHAV BRAIN RES, V161, P113, DOI 10.1016/j.bbr.2005.01.013; Hansel NN, 2013, HUM GENET, V132, P79, DOI 10.1007/s00439-012-1219-6; Hinds DA, 2013, NAT GENET, V45, P907, DOI 10.1038/ng.2686; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jackson Brian C., 2010, Human Genomics, V4, P345; Kaneko Y, 2013, INT J CHRONIC OBSTR, V8, P65, DOI 10.2147/COPD.S39617; Kernstock S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2041; Leme AS, 2010, MOL GENET GENOMICS, V283, P317, DOI 10.1007/s00438-010-0515-x; LEVITT RC, 1989, J APPL PHYSIOL, V67, P1125, DOI 10.1152/jappl.1989.67.3.1125; Nicolaides NC, 1997, P NATL ACAD SCI USA, V94, P13175, DOI 10.1073/pnas.94.24.13175; PANI L, 1992, MOL CELL BIOL, V12, P3723, DOI 10.1128/MCB.12.9.3723; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Roy MF, 2006, GENES IMMUN, V7, P655, DOI 10.1038/sj.gene.6364344; Tomaru Y, 2003, BIOCHEM BIOPH RES CO, V310, P667, DOI 10.1016/j.bbrc.2003.08.148; Wan HJ, 2005, J BIOL CHEM, V280, P13809, DOI 10.1074/jbc.M414122200; Wolf I, 2007, INT J CANCER, V120, P1013, DOI 10.1002/ijc.22389	37	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2014	9	8							e104234	10.1371/journal.pone.0104234	http://dx.doi.org/10.1371/journal.pone.0104234			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WB	25111050	Green Published, Green Submitted, gold			2022-12-27	WOS:000341105100040
J	Li, HX; Pang, LJ; Wang, ZQ				Li, Huixian; Pang, Liaojun; Wang, Zhangquan			Two-Level Incremental Checkpoint Recovery Scheme for Reducing System Total Overheads	PLOS ONE			English	Article								Long-running applications are often subject to failures. Once failures occur, it will lead to unacceptable system overheads. The checkpoint technology is used to reduce the losses in the event of a failure. For the two-level checkpoint recovery scheme used in the long-running tasks, it is unavoidable for the system to periodically transfer huge memory context to a remote stable storage. Therefore, the overheads of setting checkpoints and the re-computing time become a critical issue which directly impacts the system total overheads. Motivated by these concerns, this paper presents a new model by introducing i-checkpoints into the existing two-level checkpoint recovery scheme to deal with the more probable failures with the smaller cost and the faster speed. The proposed scheme is independent of the specific failure distribution type and can be applied to different failure distribution types. We respectively make analyses between the two-level incremental and two-level checkpoint recovery schemes with the Weibull distribution and exponential distribution, both of which fit with the actual failure distribution best. The comparison results show that the total overheads of setting checkpoints, the total re-computing time and the system total overheads in the two-level incremental checkpoint recovery scheme are all significantly smaller than those in the two-level checkpoint recovery scheme. At last, limitations of our study are discussed, and at the same time, open questions and possible future work are given.	[Li, Huixian] Northwestern Polytech Univ, Sch Comp Sci & Engn, Xian 710072, Peoples R China; [Li, Huixian; Pang, Liaojun] Wayne State Univ, Dept Comp Sci, Detroit, MI 48202 USA; [Pang, Liaojun; Wang, Zhangquan] Xidian Univ, Sch Life Sci & Technol, Xian, Peoples R China	Northwestern Polytechnical University; Wayne State University; Xidian University	Li, HX (corresponding author), Northwestern Polytech Univ, Sch Comp Sci & Engn, Xian 710072, Peoples R China.	huixian.li@wayne.edu			National Natural Science Foundation of China [61103178, 60803151]; Basic Science Research Fund in Xidian University [K5051310006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Basic Science Research Fund in Xidian University	This work was supported by the National Natural Science Foundation of China under grant numbers 61103178 and 60803151; Basic Science Research Fund in Xidian University under grant number K5051310006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S., 2004, PROC 18 ANN INT C SU, P277, DOI [10.1145/1006209.1006248, DOI 10.1145/1006209.1006248]; Akkary H, 2003, 36TH INTERNATIONAL SYMPOSIUM ON MICROARCHITECTURE, PROCEEDINGS, P423; Arunagiri S, 2009, LECT NOTES COMPUT SC, V5513, P386, DOI 10.1007/978-3-642-02205-0_27; Bautista Gomez Leonardo Arturo, 2010, Proceedings 2010 10th IEEE/ACM International Conference on Cluster, Cloud and Grid Computing (CCGrid), P63, DOI 10.1109/CCGRID.2010.40; Bessho Noriaki, 2012, Algorithms and Architectures for Parallel Processing. Proceedings of the 12th International Conference, ICA3PP 2012, P531, DOI 10.1007/978-3-642-33078-0_38; Bronevetsky G., 2006, Proceedings. 20th International Parallel and Distributed Processing Symposium (IEEE Cat. No.06TH8860); Chiu GM, 2011, IEEE T DEPEND SECURE, V8, P481, DOI 10.1109/TDSC.2010.76; Cores I., 2012, 2012 IEEE 10th International Symposium on Parallel and Distributed Processing with Applications (ISPA), P371, DOI 10.1109/ISPA.2012.55; Cores I, 2013, NEW GENERAT COMPUT, V31, P163, DOI 10.1007/s00354-013-0302-4; Daly JT, 2006, FUTURE GENER COMP SY, V22, P303, DOI 10.1016/j.future.2004.11.016; Elnozahy E. N., 1992, Proceedings 11th Symposium on Reliable Distributed Systems (Cat. No.92CH3187-2), P39, DOI 10.1109/RELDIS.1992.235144; Henkel J., 2013, P 50 ANN DES AUT C, P99, DOI [10.1145/2463209.2488857, DOI 10.1145/2463209.2488857]; Hilton A, 2009, INT CONFER PARA, P159, DOI 10.1109/PACT.2009.42; Khunteta A, 2012, GLOBAL J COMPUTER SC, V12; Kwak SW, 2012, J COMPUT SCI TECH-CH, V27, P105, DOI 10.1007/s11390-012-1209-0; Li T, 2013, P 50 ANN DES AUT C A, P62, DOI [10.1145/2463209.2488809., DOI 10.1145/2463209.2488809]; Li T, 2013, DES AUT TEST EUROPE, P707; Li YW, 2008, I C DEPEND SYS NETWO, P217, DOI 10.1109/DSN.2008.4630090; Ling YB, 2001, IEEE T COMPUT, V50, P699, DOI 10.1109/12.936236; Liu Y, 2007, THESIS LOUISIANA TU; Liu Y, 2008, 2008 IEEE INTERNATIONAL CONFERENCE ON MULTIMEDIA AND EXPO, VOLS 1-4, P17, DOI 10.1109/IPDPS.2008.4536279; Moody A., 2010, SC 2010 P 2010 ACMIE, P1, DOI [10.1109/SC.2010.18, DOI 10.1109/SC.2010.18]; Naksinehaboon N, 2008, IEEE ACM INT SYMP, P783, DOI 10.1109/CCGRID.2008.109; Oliner A. J., 2006, PROC 20 ANN INT C SU, P14, DOI [10.1145/1183401.1183406, DOI 10.1145/1183401.1183406]; Ozaki T, 2009, PERFORM EVALUATION, V66, P311, DOI 10.1016/j.peva.2008.11.003; Park E, 2011, ACM SIGPLAN NOTICES, V46, P75, DOI 10.1145/2007477.1952694; Paun M, 2010, INT J FOUND COMPUT S, V21, P329, DOI 10.1142/S0129054110007283; Rehman S., 2011, 2011 IEEE/ACM/IFIP International Conference on Hardware/Software Codesign and System Synthesis (CODES+ISSS), P237; Rodriguez G, 2011, COMPUT J, V54, P1821, DOI 10.1093/comjnl/bxr018; Rusu C, 2008, DELTA 2008: FOURTH IEEE INTERNATIONAL SYMPOSIUM ON ELECTRONIC DESIGN, TEST AND APPLICATIONS, PROCEEDINGS, P32, DOI 10.1109/DELTA.2008.75; Sahoo RK, 2004, 2004 INTERNATIONAL CONFERENCE ON DEPENDABLE SYSTEMS AND NETWORKS, PROCEEDINGS, P772; Sahoo RK, 2003, P 9 ACM SIGKDD INT C, P426, DOI [DOI 10.1145/956750.956799, 10.1145/956750.956799.]; Schroeder B, 2010, IEEE T DEPEND SECURE, V7, P337, DOI 10.1109/TDSC.2009.4; Vaidya NH, 1998, IEEE T COMPUT, V47, P656, DOI 10.1109/12.689645; Wei Z, 2005, PROCEEDINGS OF THE 2ND INTERNATIONAL YELLOW RIVER FORUM ON KEEPING HEALTHY LIFE OF THE RIVER, VOL V, P8; Xinhai Xu, 2012, 2012 4th International Conference on Computational Intelligence and Communication Networks (CICN 2012), P582, DOI 10.1109/CICN.2012.59; YOUNG JW, 1974, COMMUN ACM, V17, P530, DOI 10.1145/361147.361115	37	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2014	9	8							e104591	10.1371/journal.pone.0104591	http://dx.doi.org/10.1371/journal.pone.0104591			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WB	25111048	gold, Green Published, Green Submitted			2022-12-27	WOS:000341105100079
J	Hoenigl, M; Wagner, J; Raggam, RB; Prueller, F; Prattes, J; Eigl, S; Leitner, E; Honigl, K; Valentin, T; Zollner-Schwetz, I; Grisold, AJ; Krause, R				Hoenigl, Martin; Wagner, Jasmin; Raggam, Reinhard B.; Prueller, Florian; Prattes, Juergen; Eigl, Susanne; Leitner, Eva; Hoenigl, Katharina; Valentin, Thomas; Zollner-Schwetz, Ines; Grisold, Andrea J.; Krause, Robert			Characteristics of Hospital-Acquired and Community-Onset Blood Stream Infections, South-East Austria	PLOS ONE			English	Article							ANTIFUNGAL THERAPY; EPIDEMIOLOGY; BACTEREMIA; CARE; PROCALCITONIN	Purpose: The objective of this study was to compare epidemiology, causative pathogens, outcome, and levels of laboratory markers of inflammation of community-onset (i.e. community-acquired and healthcare-associated) and hospital-acquired bloodstream infection (BSI) in South-East Austria. Methods: In this prospective cohort study, 672 patients fulfilling criteria of systemic inflammatory response syndrome with positive peripheral blood cultures (277 community-onset [192 community-acquired, 85 healthcare-associated BSI], 395 hospital-acquired) were enrolled at the Medical University of Graz, Austria from 2011 throughout 2012. Clinical, microbiological, demographic as well as outcome and laboratory data was collected. Results: Escherichia coli followed by Staphylococcus aureus were the most frequently isolated pathogens. While Streptococcus spp. and Escherichia coli were isolated more frequently in patients with community-onset BSI, Enterococcus spp., Candida spp., Pseudomonas spp., Enterobacter spp., and coagulase-negative staphylococci were isolated more frequently among those with hospital-acquired BSI. With regard to the outcome, 30-day (82/395 vs. 31/277; p = 0.001) and 90-day mortality (106/395 vs. 35/277; p<0.001) was significantly higher among patients with hospital-acquired BSI even though these patients were significantly younger. Also, hospital-acquired BSI remained a significant predictor of mortality in multivariable analysis. At the time the blood cultures were drawn, patients with community-onset BSI had significantly higher leukocyte counts, neutrophil-leucocyte ratios as well as C-reactive protein, procalcitonin, interleukin-6 and serum creatinine levels when compared to those with hospital-acquired BSI. Patients with healthcare-associated BSI presented with significantly higher PCT and creatinine levels than those with community-acquired BSI. Conclusions: Hospital-acquired BSI was associated with significantly higher 30- and 90-day mortality rates. Hospital-acquired BSI therefore poses an important target for the most aggressive strategies for prevention and infection control.	[Hoenigl, Martin; Wagner, Jasmin; Prattes, Juergen; Eigl, Susanne; Hoenigl, Katharina; Valentin, Thomas; Zollner-Schwetz, Ines; Krause, Robert] Med Univ Graz, Sect Infect Dis & Trop Med, Graz, Austria; [Hoenigl, Martin; Eigl, Susanne] Med Univ Graz, Div Pulmonol, Graz, Austria; [Hoenigl, Martin] Univ Calif San Diego, Div Infect Dis, San Diego, CA 92103 USA; [Raggam, Reinhard B.; Prueller, Florian] Med Univ Graz, Clin Inst Med & Chem Lab Diagnost, Graz, Austria; [Leitner, Eva; Grisold, Andrea J.] Med Univ Graz, Inst Hyg Microbiol & Environm Med, Graz, Austria	Medical University of Graz; Medical University of Graz; University of California System; University of California San Diego; Medical University of Graz; Medical University of Graz	Hoenigl, M (corresponding author), Med Univ Graz, Sect Infect Dis & Trop Med, Graz, Austria.	martin.hoenigl@medunigraz.at; robert.krause@medunigraz.at	Leitner, Eva/AAG-8045-2019; Prüller, Florian J./P-5326-2014; Hoenigl, Martin/E-8802-2010; Prattes, Juergen/A-9355-2014	Leitner, Eva/0000-0001-8748-2249; Prüller, Florian J./0000-0002-3388-0089; Hoenigl, Martin/0000-0002-1653-2824; Prattes, Juergen/0000-0001-5751-9311; Grisold, Andrea/0000-0002-6937-521X	Merck; Pfizer	Merck(Merck & Company); Pfizer(Pfizer)	M. Hoenigl received a research grant from Merck and Pfizer. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials. All other authors have no conflict.	Al-Hasan MN, 2012, EUR J CLIN MICROBIOL, V31, P1163, DOI 10.1007/s10096-011-1424-6; Al-Hasan MN, 2012, CLIN MICROBIOL INFEC; Anderson DJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091713; [Anonymous], 2009, CHEST; Arendrup MC, 2009, ANTIMICROB AGENTS CH, V53, P2704, DOI 10.1128/AAC.01411-08; de Jager CPC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046561; de Jager CPC, 2010, CRIT CARE, V14, DOI 10.1186/cc9309; de Kraker MEA, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001104; DEKRAKER ME, 2012, CLIN MICROBIOL INFEC; Diekema DJ, 2003, J CLIN MICROBIOL, V41, P3655, DOI 10.1128/JCM.41.8.3655-3660.2003; Frederiksen MS, 2007, PEDIATR INFECT DIS J, V26, P398, DOI 10.1097/01.inf.0000261112.53035.4c; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; Goncalves-Pereira J, 2013, CLIN MICROBIOL INFEC, V19, P242, DOI 10.1111/j.1469-0691.2012.03776.x; Goto M, 2013, CLIN MICROBIOL INFEC, V19, P501, DOI 10.1111/1469-0691.12195; Ho KM, 2009, ANAESTH INTENS CARE, V37, P234, DOI 10.1177/0310057X0903700217; Hoenigl M, 2011, MYCOSES, V54, P454, DOI 10.1111/j.1439-0507.2010.01881.x; Hoenigl M, 2013, CLIN BIOCHEM, V46, P225, DOI 10.1016/j.clinbiochem.2012.11.004; Kollef MH, 2011, J INFECTION, V62, P130, DOI 10.1016/j.jinf.2010.12.009; Laupland KB, 2013, EPIDEMIOL INFECT, V141, P2149, DOI 10.1017/S0950268812002725; Laupland KB, 2004, CRIT CARE MED, V32, P992, DOI 10.1097/01.CCM.0000119424.31648.1E; Laupland KB, 2012, CAN J INFECT DIS MED, V23, P170, DOI 10.1155/2012/931737; Leal J, 2010, INFECT CONT HOSP EP, V31, P740, DOI 10.1086/653207; Presterl E, 2007, CLIN MICROBIOL INFEC, V13, P1072, DOI 10.1111/J.1469-0691.2007.01812.x; Raggam RB, 2014, J INTERN MED, V276, P651, DOI 10.1111/joim.12238; Rahkonen M, 2012, EUR J CLIN MICROBIOL, V31, P2639, DOI 10.1007/s10096-012-1607-9; Ratzinger F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082946; Riedel S, 2011, AM J CLIN PATHOL, V135, P182, DOI 10.1309/AJCP1MFYINQLECV2; Rodriguez-Bano J, 2010, CLIN MICROBIOL INFEC, V16, P1408, DOI [10.1111/j.1469-0691.2010.03089.x, 10.1111/j.1469-0691.2009.03089.x]; Rodriguez-Bano J, 2010, J CLIN MICROBIOL, V48, P1726, DOI 10.1128/JCM.02353-09; Rowther FB, 2009, J CLIN MICROBIOL, V47, P2964, DOI 10.1128/JCM.00418-07; Safdar A, 2006, EUR J CLIN MICROBIOL, V25, P522, DOI 10.1007/s10096-006-0173-4; Weinstein MP, 1997, CLIN INFECT DIS, V24, P584, DOI 10.1093/clind/24.4.584; Zirkel J, 2012, MED MYCOL, V50, P50, DOI 10.3109/13693786.2011.587211	33	16	18	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2014	9	8							e104702	10.1371/journal.pone.0104702	http://dx.doi.org/10.1371/journal.pone.0104702			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR0CG	25105287	Green Published, gold			2022-12-27	WOS:000343231900082
J	Leiria, LB; Dora, JM; Wajner, SM; Estivalet, AAF; Crispim, D; Maia, AL				Leiria, Leonardo B.; Dora, Jose M.; Wajner, Simone M.; Estivalet, Aline A. F.; Crispim, Daisy; Maia, Ana Luiza			The rs225017 Polymorphism in the 3 ' UTR of the Human DIO2 Gene Is Associated with Increased Insulin Resistance	PLOS ONE			English	Article							HUMAN TYPE-2 DEIODINASE; HOMEOSTASIS MODEL ASSESSMENT; THYROID-HORMONE EXCESS; IODOTHYRONINE DEIODINASE; THR92ALA POLYMORPHISM; DIABETES-MELLITUS; SKELETAL-MUSCLE; HYPOTHYROIDISM; VARIANT; SENSITIVITY	The Thr92Ala (rs225014) polymorphism in the type 2 deiodinase (DIO2) gene has been associated with insulin resistance (IR) and decreased enzyme activity in human tissues but kinetic studies failed to detect changes in the mutant enzyme, suggesting that this variant might be a marker of abnormal DIO2 expression. Thus, we aimed to investigate whether other DIO2 polymorphisms, individually or in combination with the Thr92Ala, may contribute to IR. The entire coding-region of DIO2 gene was sequenced in 12 patients with type 2 diabetes mellitus (T2DM). Potentially informative variants were evaluated in 1077 T2DM patients and 516 nondiabetic subjects. IR was evaluated using the homeostasis model assessment (HOMA-IR) index. DIO2 gene sequencing revealed no new mutation but 5 previously described single nucleotide polymorphisms (SNPs). We observed that all T2DM patients displaying high HOMA-IR index (n = 6) were homozygous for the rs225017 (T/A) polymorphism. Further analysis showed that the median fasting plasma insulin and HOMA-IR of T2DM patients carrying the T/T genotype were higher than in patients carrying the A allele (P = 0.013 and P = 0.002, respectively). These associations were magnified in the presence of the Ala92Ala genotype of the Thr92Ala polymorphism. Moreover, the rs225017 and the Thr92Ala polymorphisms were in partial linkage disequilibrium (vertical bar D'vertical bar = 0.811; r(2) = 0.365). In conclusion, the rs225017 polymorphism is associated with greater IR in T2DM and it seems to interact with the Thr92Ala polymorphism in the modulation of IR.	[Leiria, Leonardo B.; Dora, Jose M.; Wajner, Simone M.; Estivalet, Aline A. F.; Crispim, Daisy; Maia, Ana Luiza] Univ Fed Rio Grande do Sul, Hosp Clin Porto Alegre, Div Endocrine, Thyroid Sect, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul	Crispim, D (corresponding author), Univ Fed Rio Grande do Sul, Hosp Clin Porto Alegre, Div Endocrine, Thyroid Sect, Porto Alegre, RS, Brazil.	dcmoreira@hcpa.ufrgs.br	Wajner, Simone/CAF-3858-2022; Maia, Ana Luiza/F-9201-2012; Wajner, S/E-7240-2013; Crispim, Daisy/R-5170-2019; Dora, Jose/AAR-4324-2020	Maia, Ana Luiza/0000-0002-4186-5532; Wajner, S/0000-0002-8942-244X; Crispim, Daisy/0000-0001-5095-9269; Barbosa Leiria, Leonardo/0000-0002-7866-1939	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundo de Incentivo a Pesquisa (FIPE), Brazil	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundo de Incentivo a Pesquisa (FIPE), Brazil	This study was supported by grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and Fundo de Incentivo a Pesquisa (FIPE), Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DR, 2012, HUM MUTAT, V33, P599, DOI 10.1002/humu.22035; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bonora E, 2000, DIABETES CARE, V23, P57, DOI 10.2337/diacare.23.1.57; Canani LH, 2005, DIABETIC MED, V22, P1167, DOI 10.1111/j.1464-5491.2005.01622.x; Canani LH, 2005, J CLIN ENDOCR METAB, V90, P3472, DOI 10.1210/jc.2004-1977; Chidakel A, 2005, THYROID, V15, P899, DOI 10.1089/thy.2005.15.899; Cooper DN, 2010, HUM MUTAT, V31, P631, DOI 10.1002/humu.21260; Coppotelli G, 2006, THYROID, V16, P625, DOI 10.1089/thy.2006.16.625; Croteau W, 1996, J CLIN INVEST, V98, P405, DOI 10.1172/JCI118806; Dimitriadis G, 2005, HORM METAB RES, V37, P15, DOI 10.1055/s-2005-861026; DIMITRIADIS G, 1985, AM J PHYSIOL, V248, pE593, DOI 10.1152/ajpendo.1985.248.5.E593; Dora JM, 2010, EUR J ENDOCRINOL, V163, P427, DOI 10.1530/EJE-10-0419; DUBANIEWICZ A, 1989, BIOCHEM J, V263, P243, DOI 10.1042/bj2630243; Emoto M, 1999, DIABETES CARE, V22, P818, DOI 10.2337/diacare.22.5.818; Estivalet AA, 2010, OBESITY SILVER SPRIN, V19, P825; Frojdo S, 2009, BBA-MOL BASIS DIS, V1792, P83, DOI 10.1016/j.bbadis.2008.10.019; Gereben B, 2000, MOL ENDOCRINOL, V14, P1697, DOI 10.1210/me.14.11.1697; Grarup N, 2007, J CLIN ENDOCR METAB, V92, P363, DOI 10.1210/jc.2006-1958; Grozovsky R, 2009, ENDOCRINOLOGY, V150, P1976, DOI 10.1210/en.2008-0938; Guay C, 2013, NAT REV ENDOCRINOL, V9, P513, DOI 10.1038/nrendo.2013.86; Guay C, 2011, TRANSL RES, V157, P253, DOI 10.1016/j.trsl.2011.01.009; HEDRICK PW, 1987, GENETICS, V117, P331; Heemstra KA, 2009, J CLIN ENDOCR METAB, V94, P2144, DOI 10.1210/jc.2008-2520; Irvin MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024052; ITAGAKI Y, 1990, J CLIN ENDOCR METAB, V71, P340, DOI 10.1210/jcem-71-2-340; Kim SR, 2002, MED HYPOTHESES, V59, P660, DOI 10.1016/S0306-9877(02)00211-6; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Maia AL, 2005, J CLIN INVEST, V115, P2524, DOI 10.1172/JCI25083; Maia AL, 2007, THYROID, V17, P199, DOI 10.1089/thy.2006.0298; Maia AL, 2011, J ENDOCRINOL, V209, P283, DOI 10.1530/JOE-10-0481; Marsili A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020832; Mentuccia D, 2005, THYROID, V15, P1223, DOI 10.1089/thy.2005.15.1223; Mentuccia D, 2002, DIABETES, V51, P880, DOI 10.2337/diabetes.51.3.880; Mix H, 2007, NUCLEIC ACIDS RES, V35, P414, DOI 10.1093/nar/gkl1060; Nair S, 2012, THYROID, V22, P80, DOI 10.1089/thy.2010.0455; North KE, 2005, OBES RES, V13, P1877, DOI 10.1038/oby.2005.230; North KE, 2003, OBES RES, V11, P1444, DOI 10.1038/oby.2003.193; Peeters RP, 2003, J CLIN ENDOCR METAB, V88, P2880, DOI 10.1210/jc.2002-021592; Rochon C, 2003, CLIN SCI, V104, P7, DOI 10.1042/CS20020154; Ryan K, 2008, INT J BIOCHEM CELL B, V40, P2384, DOI 10.1016/j.biocel.2008.03.016; Salvatore D, 1996, J CLIN INVEST, V98, P962, DOI 10.1172/JCI118880; Seligman BGS, 2000, DIABETES CARE, V23, P1395, DOI 10.2337/diacare.23.9.1395; Steinsapir J, 2000, ENDOCRINOLOGY, V141, P1127, DOI 10.1210/en.141.3.1127; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Torrance CJ, 1997, ENDOCRINOLOGY, V138, P1204, DOI 10.1210/en.138.3.1204; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; WEINSTEIN SP, 1994, DIABETES, V43, P1185, DOI 10.2337/diabetes.43.10.1185; Yen PM, 2001, PHYSIOL REV, V81, P1097, DOI 10.1152/physrev.2001.81.3.1097	50	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2014	9	8							e103960	10.1371/journal.pone.0103960	http://dx.doi.org/10.1371/journal.pone.0103960			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR0CG	25105294	gold, Green Submitted, Green Published			2022-12-27	WOS:000343231900033
J	Szpakowicz, A; Kiliszek, M; Pepinski, W; Waszkiewicz, E; Franaszczyk, M; Skawronska, M; Ploski, R; Niemcunowicz-Janica, A; Dobrzycki, S; Opolski, G; Musial, WJ; Kaminski, KA				Szpakowicz, Anna; Kiliszek, Marek; Pepinski, Witold; Waszkiewicz, Ewa; Franaszczyk, Maria; Skawronska, Malgorzata; Ploski, Rafal; Niemcunowicz-Janica, Anna; Dobrzycki, Slawomir; Opolski, Grzegorz; Musial, Wlodzimierz Jerzy; Kaminski, Karol Adam			Polymorphism of 9p21.3 Locus Is Associated with 5-Year Survival in High-Risk Patients with Myocardial Infarction	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CORONARY-ARTERY-DISEASE; CHROMOSOME 9P21; GENETIC-VARIANTS; ONSET; ATHEROSCLEROSIS; PREDICTION; DEATH; ANRIL; WHITE	Objective: The rs10757278, rs1333049 and rs4977574 are single nucleotide polymorphisms (SNPs) of chromosome 9p21 locus associated with a prevalence of acute coronary syndromes (ACS). Reports concerning their association with long-term outcome after an ACS are equivocal. The aim of our study was to investigate the association of the 9p21.3 locus with 5-year overall mortality in patients with ST-elevation myocardial infarction (STEMI). Materials and methods: We performed a retrospective analysis of data collected prospectively in 2 independent registries of consecutive patients with STEMI (derivation and validation group). Genotyping was performed with the TaqMan method. The analyzed end-point was total mortality. Results: The derivation group comprised 589 patients: 25.3% female (n = 149), mean age 62.4 +/- 12.0 years, total 5-year mortality 16.6% (n = 98). When all the study group was analyzed, no significant differences in mortality were found between the genotypes. However, in high-risk patients (GRACE risk score >= 155 points, n = 238), homozygotes associated with higher risk for ACS had significantly better 5-year survival compared to other genotypes. The hazard ratio associated with the high-risk genotype (a homozygote of high risk for ACS or a heterozygote) was: HR = 2.2 (1.15-4.2) for the rs10757278 polymorphism, HR = 2.7 (95% CI 1.3-5.4) for the rs4977574 one and HR = 2.3 (1.2-4.5) for the rs1333049 one (Cox proportional hazards model). Survival analysis in the validation group (n = 365) showed a clear trend towards better prognosis in GG homozygotes of the rs10757278 SNP, which confirms our initial results (p = 0.09, log-rank test). Conclusions: The 9p21.3 locus is associated with 5-year mortality in high-risk patients with STEMI. The genotypes associated with higher risk for ACS show a protective effect in terms of further survival (instead of a deteriorating prognosis, as reported previously). This finding, due to the very high size of the effect, could potentially be applied to clinical practice, if appropriate methods are elaborated.	[Szpakowicz, Anna; Waszkiewicz, Ewa; Musial, Wlodzimierz Jerzy; Kaminski, Karol Adam] Med Univ Bialystok, Dept Cardiol, Bialystok, Poland; [Kiliszek, Marek; Opolski, Grzegorz] Med Univ Warsaw, Dept Cardiol, Warsaw, Poland; [Pepinski, Witold; Skawronska, Malgorzata; Niemcunowicz-Janica, Anna] Med Univ Bialystok, Dept Forens Med, Bialystok, Poland; [Franaszczyk, Maria] Inst Cardiol, Mol Biol Lab, Warsaw, Poland; [Ploski, Rafal] Med Univ Warsaw, Dept Med Genet, Warsaw, Poland; [Dobrzycki, Slawomir] Med Univ Bialystok, Dept Invas Cardiol, Bialystok, Poland	Medical University of Bialystok; Medical University of Warsaw; Medical University of Bialystok; Institute of Cardiology - Poland; Medical University of Warsaw; Medical University of Bialystok	Kaminski, KA (corresponding author), Med Univ Bialystok, Dept Cardiol, Bialystok, Poland.	fizklin@wp.pl	Niemcunowicz-Janica, Anna/ABH-1454-2021; Tarasiuk, Ewa/Y-1757-2018; Pepiński, Witold/U-9250-2018; Skawrońska, Małgorzata/U-9251-2018; Szpakowicz, Anna/T-4059-2018; Kaminski, Karol A./J-4515-2014	Niemcunowicz-Janica, Anna/0000-0003-2807-8312; Tarasiuk, Ewa/0000-0002-0614-1352; Pepiński, Witold/0000-0003-1244-2247; Skawrońska, Małgorzata/0000-0002-1237-4240; Szpakowicz, Anna/0000-0002-4665-5227; Kaminski, Karol A./0000-0002-9465-2581; Opolski, Grzegorz/0000-0003-4744-2554; Ploski, Rafal/0000-0001-6286-5526	National Science Center, Poland [N N 402 529139]	National Science Center, Poland(National Science Centre, Poland)	This work was supported by National Science Center, Poland (N N 402 529139). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardissino D, 2011, J AM COLL CARDIOL, V58, P426, DOI 10.1016/j.jacc.2010.11.075; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Butterworth AS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002260; Buysschaert I, 2010, EUR HEART J, V31, P1132, DOI 10.1093/eurheartj/ehq053; CALDAS C, 1994, NAT GENET, V8, P27, DOI 10.1038/ng0994-27; CANNONALBRIGHT LA, 1992, SCIENCE, V258, P1148, DOI 10.1126/science.1439824; Congrains A, 2012, BIOCHEM BIOPH RES CO, V419, P612, DOI 10.1016/j.bbrc.2012.02.050; Congrains A, 2012, ATHEROSCLEROSIS, V220, P449, DOI 10.1016/j.atherosclerosis.2011.11.017; Cugino D, 2012, NUTR METAB CARDIOVAS, V22, P619, DOI 10.1016/j.numecd.2010.11.010; Eagle KA, 2004, JAMA-J AM MED ASSOC, V291, P2727, DOI 10.1001/jama.291.22.2727; Ellis KL, 2010, CIRC-CARDIOVASC GENE, V3, P286, DOI 10.1161/CIRCGENETICS.109.917443; Fox KAA, 2006, BMJ-BRIT MED J, V333, P1091, DOI 10.1136/bmj.38985.646481.55; Goncalves PDA, 2005, EUR HEART J, V26, P865, DOI 10.1093/eurheartj/ehi187; Gong Y, 2011, CIRC-CARDIOVASC GENE, V4, P169, DOI 10.1161/CIRCGENETICS.110.959296; Granger CB, 2003, ARCH INTERN MED, V163, P2345, DOI 10.1001/archinte.163.19.2345; Hamm CW, 2011, EUR HEART J, V32, P2999, DOI 10.1093/eurheartj/ehr236; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; Horne BD, 2008, CIRC-CARDIOVASC GENE, V1, P85, DOI 10.1161/CIRCGENETICS.108.793158; Kalinina N, 2004, ARTERIOSCL THROM VAS, V24, P1391, DOI 10.1161/01.ATV.0000133605.89421.79; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; Koch W, 2011, ATHEROSCLEROSIS, V217, P220, DOI 10.1016/j.atherosclerosis.2011.03.014; Lee JY, 2013, J HUM GENET, V58, P120, DOI 10.1038/jhg.2012.124; Nambi V, 2012, ATHEROSCLEROSIS, V222, P135, DOI 10.1016/j.atherosclerosis.2012.01.028; O'Donnell CJ, 2011, CIRCULATION, V124, P2855, DOI 10.1161/CIRCULATIONAHA.110.974899; Patel RS, 2011, CIRC-CARDIOVASC GENE, V4, pE11, DOI 10.1161/CIRCGENETICS.111.960641; Patel RS, 2010, EUR HEART J, V31, P3017, DOI 10.1093/eurheartj/ehq272; Peng WH, 2009, CLIN CHEM LAB MED, V47, P917, DOI 10.1515/CCLM.2009.215; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scheffold T, 2011, BMC CARDIOVASC DISOR, V11, DOI 10.1186/1471-2261-11-9; Schmid M, 2000, ONCOGENE, V19, P5747, DOI 10.1038/sj.onc.1203942; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Szpakowicz A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072333; Takeuchi F, 2012, EUR J HUM GENET, V20, P333, DOI 10.1038/ejhg.2011.184; Wang W, 2011, CHINESE MED J-PEKING, V124, P66, DOI [10.3760/cma.j.issn.0366-6999.2011.01.013, 10.3901/JME.2011.08.066]; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	36	14	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2014	9	8							e104635	10.1371/journal.pone.0104635	http://dx.doi.org/10.1371/journal.pone.0104635			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR0CG	25105296	Green Published, gold			2022-12-27	WOS:000343231900075
J	Ushijima, T; Okazaki, K; Tsushima, H; Ishihara, K; Doi, T; Iwamoto, Y				Ushijima, Takahiro; Okazaki, Ken; Tsushima, Hidetoshi; Ishihara, Kohei; Doi, Toshio; Iwamoto, Yukihide			CCAAT/Enhancer Binding Protein beta Regulates Expression of Indian Hedgehog during Chondrocytes Differentiation	PLOS ONE			English	Article							HUMAN ARTICULAR CHONDROCYTES; C/EBP-BETA; TARGETED DISRUPTION; GENE-TRANSCRIPTION; CARTILAGE; RUNX2; PROLIFERATION; ACTIVATION; REPRESSION; ARREST	Background: CCAAT/enhancer binding protein beta (C/EBP beta) is a transcription factor that promotes hypertrophic differentiation of chondrocytes. Indian hedgehog (Ihh) also stimulates the hypertrophic transition of chondrocytes. Furthermore, runt-related transcription factor-2 (RUNX2) was reported to regulate chondrocyte maturation during skeletal development and to directly regulate transcriptional activity of Ihh. In this study, we investigated whether the interaction of C/EBP beta and RUNX2 regulates the expression of Ihh during chondrocyte differentiation. Methodology/Results: Immunohistochemistry of embryonic growth plate revealed that both C/EBP beta and Ihh were strongly expressed in pre-hypertrophic and hypertrophic chondrocytes. Overexpression of C/EBP beta by adenovirus vector in ATDC5 cells caused marked stimulation of Ihh and Runx2. Conversely, knockdown of C/EBP beta by lentivirus expressing shRNA significantly repressed Ihh and Runx2 in ATDC5 cells. A reporter assay revealed that C/EBP beta stimulated transcriptional activity of Ihh. Deletion and mutation analysis showed that the C/EBP beta responsive element was located between -214 and -210 bp in the Ihh promoter. An electrophoretic mobility shift assay (EMSA) and a chromatin immunoprecipitation (ChIP) assay also revealed the direct binding of C/EBP beta to this region. Moreover, reporter assays demonstrated that RUNX2 failed to stimulate the transcriptional activity of the Ihh promoter harboring a mutation at the C/EBP beta binding site. EMSA and ChIP assays showed that RUNX2 interacted to this element with C/EBP beta. Immunoprecipitation revealed that RUNX2 and C/EBP beta formed heterodimer complex with each other in the nuclei of chondrocytes. These data suggested that the C/EBP beta binding element is also important for RUNX2 to regulate the expression of Ihh. Ex vivo organ culture of mouse limbs transfected with C/EBP beta showed that the expression of Ihh and RUNX2 was increased upon ectopic C/EBP beta expression. Conclusions: C/EBP beta and RUNX2 cooperatively stimulate expression of Ihh through direct interactions with a C/EBP beta binding element, which further promotes hypertrophic differentiation of chondrocytes during the chondrocyte differentiation process.	[Ushijima, Takahiro; Okazaki, Ken; Tsushima, Hidetoshi; Ishihara, Kohei; Doi, Toshio; Iwamoto, Yukihide] Kyushu Univ, Grad Sch Med Sci, Dept Orthopaed Surg, Fukuoka 812, Japan	Kyushu University	Okazaki, K (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Orthopaed Surg, Fukuoka 812, Japan.	okazaki@med.kyushu-u.ac.jp		Okazaki, Ken/0000-0003-1274-8406	Japan Society for the Promotion of Science [23592218]; Ministry of Health and Welfare; Ministry of Education, Culture, Sports, Science and Technology of Japan [08061012]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health and Welfare(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a Grant-in-Aid for Scientific Research (Basic Research(C), No. 23592218) from the Japan Society for the Promotion of Science and a Research Grant for Intractable Disease from the Ministry of Health and Welfare and a Grant for Translational Research Network Program (No. 08061012) from The Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIRA S, 1990, EMBO J, V9, P1897, DOI 10.1002/j.1460-2075.1990.tb08316.x; Amano K, 2009, MOL BIOL CELL, V20, P4541, DOI 10.1091/mbc.E09-03-0227; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Chang JK, 2009, ARTHRITIS RHEUM-US, V60, P3049, DOI 10.1002/art.24843; DESCOMBES P, 1991, CELL, V67, P569, DOI 10.1016/0092-8674(91)90531-3; Gutierrez S, 2002, J BIOL CHEM, V277, P1316, DOI 10.1074/jbc.M106611200; Harada H, 1999, J BIOL CHEM, V274, P6972, DOI 10.1074/jbc.274.11.6972; Hayashida M, 2009, ARTHRITIS RHEUM-US, V60, P708, DOI 10.1002/art.24332; Hirata M, 2012, HUM MOL GENET, V21, P1111, DOI 10.1093/hmg/ddr540; Hirata M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004543; Johnson PF, 2005, J CELL SCI, V118, P2545, DOI 10.1242/jcs.02459; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Lin AC, 2009, NAT MED, V15, P1421, DOI 10.1038/nm.2055; Mak KK, 2008, DEVELOPMENT, V135, P1947, DOI 10.1242/dev.018044; Minina E, 2001, DEVELOPMENT, V128, P4523; Nerlov C, 2007, TRENDS CELL BIOL, V17, P318, DOI 10.1016/j.tcb.2007.07.004; Okazaki K, 2004, CLIN ORTHOP RELAT R, pS123, DOI 10.1097/01.blo.0000144478.51284.f3; Okazaki K, 2002, J BIOL CHEM, V277, P31526, DOI 10.1074/jbc.M202815200; Olive M, 1996, J BIOL CHEM, V271, P2040, DOI 10.1074/jbc.271.4.2040; Sakaue H, 2002, GENE DEV, V16, P908, DOI 10.1101/gad.983202; Sandell LJ, 2001, ARTHRITIS RES, V3, P107, DOI 10.1186/ar148; Shukunami C, 1996, J CELL BIOL, V133, P457, DOI 10.1083/jcb.133.2.457; TANAKA T, 1995, CELL, V80, P353, DOI 10.1016/0092-8674(95)90418-2; Tominaga H, 2008, MOL BIOL CELL, V19, P5373, DOI 10.1091/mbc.E08-03-0329; Tsuchimochi K, 2010, J BIOL CHEM, V285, P8395, DOI 10.1074/jbc.M109.038638; Tsushima H, 2012, ANN RHEUM DIS, V71, P99, DOI 10.1136/annrheumdis-2011-200061; Ushijima T, 2014, J BIOL CHEM, V289, P2852, DOI 10.1074/jbc.M113.492843; Vortkamp A, 1996, SCIENCE, V273, P613, DOI 10.1126/science.273.5275.613; Wang WG, 2009, DEVELOPMENT, V136, P4143, DOI 10.1242/dev.043281; Wei F, 2012, OSTEOARTHR CARTILAGE, V20, P755, DOI 10.1016/j.joca.2012.03.010; Yoshida CA, 2004, GENE DEV, V18, P952, DOI 10.1101/gad.1174704	32	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2014	9	8							e104547	10.1371/journal.pone.0104547	http://dx.doi.org/10.1371/journal.pone.0104547			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR0CG	25105964	Green Published, Green Submitted, gold			2022-12-27	WOS:000343231900067
J	Chen, YR; Hung, KW; Tsai, JC; Chu, H; Chung, MH; Chen, SR; Liao, YM; Ou, KL; Chang, YC; Chou, KR				Chen, Ying-Ren; Hung, Kuo-Wei; Tsai, Jui-Chen; Chu, Hsin; Chung, Min-Huey; Chen, Su-Ru; Liao, Yuan-Mei; Ou, Keng-Liang; Chang, Yue-Cune; Chou, Kuei-Ru			Efficacy of Eye-Movement Desensitization and Reprocessing for Patients with Posttraumatic-Stress Disorder: A Meta-Analysis of Randomized Controlled Trials	PLOS ONE			English	Article							PROLONGED EXPOSURE; EMDR TREATMENT; PTSD; THERAPY; RELAXATION; CHILDREN; ANXIETY; TRAUMA	Background: We performed the first meta-analysis of clinical studies by investigating the effects of eye-movement desensitization and reprocessing (EMDR) therapy on the symptoms of posttraumatic stress disorder (PTSD), depression, anxiety, and subjective distress in PTSD patients treated during the past 2 decades. Methods: We performed a quantitative meta-analysis on the findings of 26 randomized controlled trials of EMDR therapy for PTSD published between 1991 and 2013, which were identified through the ISI Web of Science, Embase, Cochrane Library, MEDLINE, PubMed, Scopus, PsycINFO, and the Cumulative Index to Nursing and Allied Health Literature electronic databases, among which 22, 20, 16, and 11 of the studies assessed the effects of EMDR on the symptoms of PTSD, depression, anxiety, and subjective distress, respectively, as the primary clinical outcome. Results: The meta-analysis revealed that the EMDR treatments significantly reduced the symptoms of PTSD (g = -0.662; 95% confidence interval (CI): -0.887 to -0.436), depression (g = -0.643; 95% CI: -0.864 to -0.422), anxiety (g = -0.640; 95% CI: -0.890 to -0.390), and subjective distress (g = -0.956; 95% CI: -1.388 to -0.525) in PTSD patients. Conclusion: This study confirmed that EMDR therapy significantly reduces the symptoms of PTSD, depression, anxiety, and subjective distress in PTSD patients. The subgroup analysis indicated that a treatment duration of more than 60 min per session was a major contributing factor in the amelioration of anxiety and depression, and that a therapist with experience in conducting PTSD group therapy was a major contributing factor in the reduction of PTSD symptoms.	[Chen, Ying-Ren; Chung, Min-Huey; Liao, Yuan-Mei; Chou, Kuei-Ru] Taipei Med Univ, Grad Inst Nursing, Coll Nursing, Taipei, Taiwan; [Chen, Ying-Ren; Chung, Min-Huey; Liao, Yuan-Mei; Chou, Kuei-Ru] Taoyuan Armed Forces Gen Hosp, Longtan, Taiwan; [Hung, Kuo-Wei] Yuans Gen Hosp, Div Neurol, Dept Internal Med, Kaohsiung, Taiwan; [Tsai, Jui-Chen; Chou, Kuei-Ru] Taipei Med Univ, Dept Nursing, Shuang Ho Hosp, Taipei, Taiwan; [Chu, Hsin] Natl Def Med Ctr, Inst Aerosp & Undersea Med, Sch Med, Taipei, Taiwan; [Chu, Hsin] Triserv Gen Hosp, Dept Neurol, Natl Def Med Ctr, Taipei, Taiwan; [Chen, Su-Ru] Taipei Med Univ, Sch Nursing, Coll Nursing, Taipei, Taiwan; [Ou, Keng-Liang] Taipei Med Univ, Grad Inst Biomed Mat & Tissue Engn, Coll Oral Med, Taipei, Taiwan; [Ou, Keng-Liang] Taipei Med Univ, Res Ctr Biomed Devices & Prototyping Prod, Taipei, Taiwan; [Ou, Keng-Liang] Taipei Med Univ, Res Ctr Biomed Implants & Microsurgery Devices, Taipei, Taiwan; [Ou, Keng-Liang] Taipei Med Univ, Shuang Ho Hosp, Dept Dent, Taipei, Taiwan; [Chang, Yue-Cune] Tamkang Univ, Dept Math, Tamsui, Taiwan; [Chou, Kuei-Ru] Taipei Med Univ Hosp, Psychiat Res Ctr, Taipei, Taiwan	Taipei Medical University; Taipei Medical University; Shuang Ho Hospital; National Defense Medical Center; National Defense Medical Center; Tri-Service General Hospital; Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University; Shuang Ho Hospital; Tamkang University; Taipei Medical University; Taipei Medical University Hospital	Chou, KR (corresponding author), Taipei Med Univ, Grad Inst Nursing, Coll Nursing, Taipei, Taiwan.	kueiru@tmu.edu.tw		Chen, Su-Ru/0000-0001-9765-0517; chou, kueiru/0000-0002-4882-3503	Taiwan National Science Council [NSC102-2314-B-038-036]; Yuan's General Hospital [103YGH-TMU-03]	Taiwan National Science Council(Ministry of Science and Technology, Taiwan); Yuan's General Hospital	This work was supported by the Taiwan National Science Council (project no. NSC102-2314-B-038-036) and Yuan's General Hospital (103YGH-TMU-03). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasnejad MMK, 2007, PSYCHOL RES, V9, P104; Ahmad A, 2007, NORD J PSYCHIAT, V61, P349, DOI 10.1080/08039480701643464; Bisson JI, 2007, BMJ-BRIT MED J, V334, P789, DOI 10.1136/bmj.39162.538553.80; Borenstein M., 2007, INTRO METAANALYSIS; Brodaty H, 2003, J AM GERIATR SOC, V51, P657, DOI 10.1034/j.1600-0579.2003.00210.x; Carlson JG, 1998, J TRAUMA STRESS, V11, P3, DOI 10.1023/A:1024448814268; Chemtob CM, 2002, J CLIN PSYCHOL, V58, P99, DOI 10.1002/jclp.1131; Cohen J.E., 1988, STAT POWER ANAL BEHA; Davidson PR, 2001, J CONSULT CLIN PSYCH, V69, P305, DOI 10.1037/0022-006X.69.2.305; DeRubeis RJ, 2005, ARCH GEN PSYCHIAT, V62, P409, DOI 10.1001/archpsyc.62.4.409; Devilly GJ, 1998, BEHAV THER, V29, P435, DOI 10.1016/S0005-7894(98)80042-7; Devilly GJ, 1999, J ANXIETY DISORD, V13, P131, DOI 10.1016/S0887-6185(98)00044-9; Dunn TM, 1996, J BEHAV THER EXP PSY, V27, P231, DOI 10.1016/S0005-7916(96)00034-1; Egger M, 1987, BMJ-BRIT MED J, V315, P629; Grainger RD, 1997, J TRAUMA STRESS, V10, P665, DOI 10.1023/A:1024806105473; Haby MM, 2006, AUST NZ J PSYCHIAT, V40, P9, DOI 10.1080/j.1440-1614.2006.01736.x; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Hogberg G, 2007, NORD J PSYCHIAT, V61, P54, DOI 10.1080/08039480601129408; Ironson G, 2002, J CLIN PSYCHOL, V58, P113, DOI 10.1002/jclp.1132; Jaberghaderi N, 2004, CLIN PSYCHOL PSYCHOT, V11, P358, DOI 10.1002/cpp.395; JENSEN JA, 1994, BEHAV THER, V25, P311, DOI 10.1016/S0005-7894(05)80290-4; Karatzias T, 2011, J NERV MENT DIS, V199, P372, DOI 10.1097/NMD.0b013e31821cd262; Kemp Michael, 2010, Clin Child Psychol Psychiatry, V15, P5, DOI 10.1177/1359104509339086; Lee C, 2002, J CLIN PSYCHOL, V58, P1071, DOI 10.1002/jclp.10039; Light Richard J., 1984, SUMMING SCI REV RES; Lytle RA, 2002, J ANXIETY DISORD, V16, P273, DOI 10.1016/S0887-6185(02)00099-3; Marcus SV, 1997, PSYCHOTHERAPY, V34, P307, DOI 10.1037/h0087791; Power K, 2002, CLIN PSYCHOL PSYCHOT, V9, P299, DOI 10.1002/cpp.341; Rodenburg R, 2009, CLIN PSYCHOL REV, V29, P599, DOI 10.1016/j.cpr.2009.06.008; Rogers S, 1999, J ANXIETY DISORD, V13, P119, DOI 10.1016/S0887-6185(98)00043-7; Rothbaum BO, 2005, J TRAUMA STRESS, V18, P607, DOI 10.1002/jts.20069; Rothbaum BO, 1997, B MENNINGER CLIN, V61, P317; Scheck MM, 1998, J TRAUMA STRESS, V11, P25, DOI 10.1023/A:1024400931106; Shapiro F., 2001, EYE MOVEMENT DESENSI; Taylor S, 2003, J CONSULT CLIN PSYCH, V71, P330, DOI 10.1037/0022-006X.71.2.330; van der Kolk BA, 2007, J CLIN PSYCHIAT, V68, P37, DOI 10.4088/JCP.v68n0105; VAUGHAN K, 1994, J BEHAV THER EXP PSY, V25, P283, DOI 10.1016/0005-7916(94)90036-1; WILSON SA, 1995, J CONSULT CLIN PSYCH, V63, P928, DOI 10.1037/0022-006X.63.6.928; Wilson SA, 2001, INT J STRESS MANAGE, V8, P179, DOI 10.1023/A:1011366408693	40	102	103	1	123	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e103676	10.1371/journal.pone.0103676	http://dx.doi.org/10.1371/journal.pone.0103676			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM6SB	25101684	gold, Green Published, Green Submitted			2022-12-27	WOS:000339993900022
J	Fernandez-Aranda, F; Sauchelli, S; Pastor, A; Gonzalez, ML; de la Torre, R; Granero, R; Jimenez-Murcia, S; Banos, R; Botella, C; Fernandez-Real, JM; Fernandez-Garcia, JC; Fruhbeck, G; Gomez-Ambrosi, J; Rodriguez, R; Tinahones, FJ; Arcelus, J; Fagundo, AB; Aguera, Z; Miro, J; Casanueva, FF				Fernandez-Aranda, Fernando; Sauchelli, Sarah; Pastor, Antoni; Gonzalez, Marcela L.; de la Torre, Rafael; Granero, Roser; Jimenez-Murcia, Susana; Banos, Rosa; Botella, Cristina; Fernandez-Real, Jose M.; Fernandez-Garcia, Jose C.; Fruehbeck, Gema; Gomez-Ambrosi, Javier; Rodriguez, Roser; Tinahones, Francisco J.; Arcelus, Jon; Fagundo, Ana B.; Agueera, Zaida; Miro, Jordi; Casanueva, Felipe F.			Moderate-Vigorous Physical Activity across Body Mass Index in Females: Moderating Effect of Endocannabinoids and Temperament	PLOS ONE			English	Article							EATING-DISORDERS; WAIST CIRCUMFERENCE; SYSTEM; OBESITY; PERSONALITY; WEIGHT; ACCELEROMETER; OLEOYLETHANOLAMIDE; PREVALENCE; MODULATION	Background: Endocannabinoids and temperament traits have been linked to both physical activity and body mass index (BMI) however no study has explored how these factors interact in females. The aims of this cross-sectional study were to 1) examine differences among distinct BMI groups on daytime physical activity and time spent in moderate-vigorous physical activity (MVPA), temperament traits and plasma endocannabinoid concentrations; and 2) explore the association and interaction between MVPA, temperament, endocannabinoids and BMI. Methods: Physical activity was measured with the wrist-worn accelerometer Actiwatch AW7, in a sample of 189 female participants (43 morbid obese, 30 obese, and 116 healthy-weight controls). The Temperament and Character Inventory-Revised questionnaire was used to assess personality traits. BMI was calculated by bioelectrical impedance analysis via the TANITA digital scale. Blood analyses were conducted to measure levels of endocannabinoids and endocannabinoid-related compounds. Path-analysis was performed to examine the association between predictive variables and MVPA. Results: Obese groups showed lower MVPA and dysfunctional temperament traits compared to healthy-weight controls. Plasma concentrations of 2-arachidonoylglyceryl (2-AG) were greater in obese groups. Path-analysis identified a direct effect between greater MVPA and low BMI (b = -0.13, p = .039) and high MVPA levels were associated with elevated anandamide (AEA) levels (b = 0.16, p = .049) and N-oleylethanolamide (OEA) levels (b = 0.22, p = .004), as well as high Novelty seeking (b = 0.18, p < .001) and low Harm avoidance (b = -0.16, p < .001). Conclusions: Obese individuals showed a distinct temperament profile and circulating endocannabinoids compared to controls. Temperament and endocannabinoids may act as moderators of the low MVPA in obesity.	[Fernandez-Aranda, Fernando; Sauchelli, Sarah; Jimenez-Murcia, Susana; Fagundo, Ana B.; Agueera, Zaida] Univ Hosp Bellvitge IDIBELL, Dept Psychiat, Barcelona, Spain; [Fernandez-Aranda, Fernando; Pastor, Antoni; de la Torre, Rafael; Granero, Roser; Jimenez-Murcia, Susana; Banos, Rosa; Botella, Cristina; Fernandez-Real, Jose M.; Fernandez-Garcia, Jose C.; Fruehbeck, Gema; Gomez-Ambrosi, Javier; Rodriguez, Roser; Tinahones, Francisco J.; Fagundo, Ana B.; Agueera, Zaida; Casanueva, Felipe F.] Inst Salud Carlos III, CIBER Fisiopatol Obesidad Nutr CIBERobn, Madrid, Spain; [Fernandez-Aranda, Fernando; Jimenez-Murcia, Susana] Univ Barcelona, Sch Med, Dept Clin Sci, Barcelona, Spain; [Pastor, Antoni] Univ Autonoma Barcelona, Sch Med, Dept Pharmacol, E-08193 Barcelona, Spain; [Pastor, Antoni; de la Torre, Rafael] Hosp Mar, Med Res Inst, IMIM, Human Pharmacol & Clin Neurosci Res Grp,Neurosci, Barcelona, Spain; [Gonzalez, Marcela L.] Univ Rovira & Virgili, Dept Psychol, E-43007 Tarragona, Spain; [Miro, Jordi] Univ Pompeu Fabra, Dept Expt & Hlth Sci, Barcelona, Spain; [Granero, Roser] Univ Autonoma Barcelona, Dept Psicobiol & Metodol, E-08193 Barcelona, Spain; [Banos, Rosa] Univ Valencia, Dept Psychol Personal Evaluat & Treatment, Valencia, Spain; [Botella, Cristina] Univ Jaume 1, Dept Basic Psychol Clin & Psychobiol, Castellon de La Plana, Spain; [Fernandez-Garcia, Jose C.; Rodriguez, Roser] Hosp Dr Josep Trueta, Inst Invest Biomed Girona IdlBGi, Dept Diabet Endocrinol & Nutr, Girona, Spain; [Fernandez-Garcia, Jose C.; Tinahones, Francisco J.] Univ Virgen Victoria, Hosp Clin, Dept Diabet Endocrinol & Nutr, Malaga, Spain; [Fruehbeck, Gema; Gomez-Ambrosi, Javier] Univ Navarra, Clin Univ Navarra, Dept Endocrinol & Nutr, E-31080 Pamplona, Spain; [Arcelus, Jon] Glenfield Univ Hosp, Eating Disorders Serv, Leicester, Leics, England; [Casanueva, Felipe F.] Univ Santiago Compostela, Complejo Hosp Univ, Dept Med, Div Endocrinol, Santiago De Compostela, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; University of Barcelona; Autonomous University of Barcelona; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Universitat Rovira i Virgili; Pompeu Fabra University; Autonomous University of Barcelona; University of Valencia; Universitat Jaume I; Universitat de Girona; Girona University Hospital Dr. Josep Trueta; University of Navarra; Complexo Hospitalario Universitario de Santiago de Compostela; Universidade de Santiago de Compostela	Fernandez-Aranda, F (corresponding author), Univ Hosp Bellvitge IDIBELL, Dept Psychiat, Barcelona, Spain.	ffernandez@bellvitgehospital.cat; felipe.casanueva@usc.es	Pastor, Antoni/AAD-4638-2020; AGÜERA, ZAIDA/K-9771-2014; Granero, Roser/F-9492-2016; Botella, Cristina/F-9230-2010; FERNANDEZ-ARANDA, FERNANDO/AGY-1597-2022; Gómez-Ambrosi, Javier/D-2984-2017; Tinahones, Francisco José/AAB-2882-2020; Granero, Roser/S-3529-2019; Fernandez-Real, Jose Manuel/L-5897-2014; Fernandez-Aranda, Fernando/L-9762-2014; JIMENEZ-MURCIA, SUSANA/L-9786-2014; de la Torre, Rafael/D-3561-2018; Fernandez-Garcia, Jose Carlos/B-5312-2013; Arcelus, Jon/J-9937-2014; BAÑOS, ROSA MARIA/C-6077-2011; Miró, Jordi/F-9080-2019	Pastor, Antoni/0000-0003-3692-0696; AGÜERA, ZAIDA/0000-0003-4453-4939; Granero, Roser/0000-0001-6308-3198; Botella, Cristina/0000-0001-8783-6959; FERNANDEZ-ARANDA, FERNANDO/0000-0002-2968-9898; Gómez-Ambrosi, Javier/0000-0001-5601-1604; Fernandez-Aranda, Fernando/0000-0002-2968-9898; JIMENEZ-MURCIA, SUSANA/0000-0002-3596-8033; de la Torre, Rafael/0000-0002-6765-1866; Fernandez-Garcia, Jose Carlos/0000-0003-2229-8488; BAÑOS, ROSA MARIA/0000-0003-0626-7665; Miró, Jordi/0000-0002-1998-6653; Tinahones, Francisco J/0000-0001-6871-4403; Fernandez-Real, Jose Manuel/0000-0002-7442-9323; Fagundo, Ana Beatriz/0000-0003-1703-9457; Arcelus, Jon/0000-0002-3805-0180; Sauchelli, Sarah/0000-0003-3620-7671	Instituto Salud Carlos III [FIS PI11/210]; DIUE de la Generalitat de Catalunya, Spain [2009 SGR 718]; IDIBELL [2013-17]; 'Instituto de Salud Carlos III', Madrid, Spain [CM12/00059]	Instituto Salud Carlos III(Instituto de Salud Carlos III); DIUE de la Generalitat de Catalunya, Spain; IDIBELL; 'Instituto de Salud Carlos III', Madrid, Spain(Instituto de Salud Carlos III)	This manuscript was supported by grants from Instituto Salud Carlos III (FIS PI11/210 and CIBERobn) and DIUE de la Generalitat de Catalunya (2009 SGR 718), Spain. CIBERObn is an initiative of ISCIII. Sarah Sauchelli is recipient of a pre-doctoral Grant (2013-17) by IDIBELL. Jose C. Fernandez-Garcia is recipient of a 'Rio Hortega' contract from 'Instituto de Salud Carlos III', Madrid, Spain (CM12/00059). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade AM, 2010, PATIENT EDUC COUNS, V79, P320, DOI 10.1016/j.pec.2010.01.006; Arnone M, 1997, PSYCHOPHARMACOLOGY, V132, P104, DOI 10.1007/s002130050326; Avraham Y, 2005, BRAIN RES BULL, V65, P117, DOI 10.1016/j.brainresbull.2004.12.002; Ayabe M, 2013, INT J SPORTS MED, V34, P62, DOI 10.1055/s-0032-1314814; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Bauman A, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-21; Bentler PM, 2000, J APPL PSYCHOL, V85, P125, DOI 10.1037/0021-9010.85.1.125; Bermudez-Silva FJ, 2010, PHARMACOL BIOCHEM BE, V95, P375, DOI 10.1016/j.pbb.2010.03.012; Bilbao A, 2013, ADDICT BIOL, V18, P78, DOI 10.1111/adb.12006; Bluher M, 2006, DIABETES, V55, P3053, DOI 10.2337/db06-0812; Brunes A, 2013, SOC PSYCH PSYCH EPID, V48, P745, DOI 10.1007/s00127-012-0594-6; Busquets-Garcia A, 2011, BIOL PSYCHIAT, V70, P479, DOI 10.1016/j.biopsych.2011.04.022; Caraceni P, 2010, LIVER INT, V30, P816, DOI 10.1111/j.1478-3231.2009.02137.x; Carrard I, 2012, EUR EAT DISORD REV, V20, P350, DOI 10.1002/erv.2174; CLONINGER CR, 1993, ARCH GEN PSYCHIAT, V50, P975, DOI 10.1001/archpsyc.1993.01820240059008; CLONINGER CR, 1994, CURR OPIN NEUROBIOL, V4, P266, DOI 10.1016/0959-4388(94)90083-3; Cloninger CR., 1999, TEMPERAMENT CHARACTE; Corder K, 2007, CURR OPIN CLIN NUTR, V10, P597, DOI 10.1097/MCO.0b013e328285d883; Dalle Grave R, 2013, PSYCHIAT RES, V207, P86, DOI 10.1016/j.psychres.2012.09.001; de Fonseca FR, 2001, NATURE, V414, P209, DOI 10.1038/35102582; de Wit L, 2010, PSYCHIAT RES, V178, P230, DOI 10.1016/j.psychres.2009.04.015; Di Marzo V, 2009, DIABETOLOGIA, V52, P213, DOI 10.1007/s00125-008-1178-6; Di Marzo V, 2008, DIABETOLOGIA, V51, P1356, DOI 10.1007/s00125-008-1048-2; Dubreucq S, 2013, BIOL PSYCHIAT, V73, P895, DOI 10.1016/j.biopsych.2012.10.025; Dubreucq S, 2010, EXP NEUROL, V224, P106, DOI 10.1016/j.expneurol.2010.01.017; Engeli S, 2005, DIABETES, V54, P2838, DOI 10.2337/diabetes.54.10.2838; Fernandez-Aranda F, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-166; Ferreira-Vieira TH, 2014, HIPPOCAMPUS, V24, P79, DOI 10.1002/hipo.22206; Feuerecker M, 2012, EUR J APPL PHYSIOL, V112, P2777, DOI 10.1007/s00421-011-2237-0; First M. B., 1997, STRUCTURED CLIN INTE; Fu J, 2005, NEUROPHARMACOLOGY, V48, P1147, DOI 10.1016/j.neuropharm.2005.02.013; Gasperi V, 2014, MED SCI SPORT EXER, V46, P24, DOI 10.1249/MSS.0b013e3182a10ce6; Goldberg DP, 1981, MANUAL GEN HLTH QUES; Gomez R, 2002, J NEUROSCI, V22, P9612; Gutierrez-Zotes JA, 2004, ACTAS ESP PSIQUIATRI, V32, P8; Hamer M, 2013, OBESITY, V21, pE755, DOI 10.1002/oby.20446; Heil DP, 2006, RES Q EXERCISE SPORT, V77, P64, DOI 10.5641/027013606X13080769703920; Heyman E, 2012, OBES REV, V13, P1110, DOI 10.1111/j.1467-789X.2012.01026.x; Heyman E, 2012, PSYCHONEUROENDOCRINO, V37, P844, DOI 10.1016/j.psyneuen.2011.09.017; Hill MN, 2010, PROG NEURO-PSYCHOPH, V34, P791, DOI 10.1016/j.pnpbp.2009.11.001; Kelly T, 2008, INT J OBESITY, V32, P1431, DOI 10.1038/ijo.2008.102; Kirkham TC, 2002, BRIT J PHARMACOL, V136, P550, DOI 10.1038/sj.bjp.0704767; Kirkham TC, 2001, PSYCHOPHARMACOLOGY, V153, P267, DOI 10.1007/s002130000596; Kirkham TC, 2009, INT REV PSYCHIATR, V21, P163, DOI 10.1080/09540260902782810; Kjelsas E, 2004, SCAND J MED SCI SPOR, V14, P258, DOI 10.1111/j.1600-0838.2003.00343.x; Kline R.B., 2010, PRINCIPLES PRACTICE; Kumahara H, 2004, INT J OBESITY, V28, P1105, DOI 10.1038/sj.ijo.0802712; Lakerveld J, 2011, PREV MED, V53, P299, DOI 10.1016/j.ypmed.2011.07.012; LLERENA A, 1993, ACTA PSYCHIAT SCAND, V87, P23, DOI 10.1111/j.1600-0447.1993.tb03325.x; Masse LC, 2005, MED SCI SPORT EXER, V37, pS544, DOI 10.1249/01.mss.0000185674.09066.8a; Monteleone P, 2013, PSYCHONEUROENDOCRINO, V38, P312, DOI 10.1016/j.psyneuen.2012.10.021; Muller A, 2012, EUR EAT DISORD REV, V20, pe91, DOI 10.1002/erv.1126; Navarrete F, 2012, BRIT J PHARMACOL, V165, P260, DOI 10.1111/j.1476-5381.2011.01542.x; Pesonen AK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022958; Prince SA, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-56; Rhodes RE, 2006, BRIT J SPORT MED, V40, P958, DOI 10.1136/bjsm.2006.028860; Routen AC, 2012, J HUM KINET, V31, P17, DOI 10.2478/v10078-012-0002-z; Snider NT, 2008, J PHARMACOL EXP THER, V327, P538, DOI 10.1124/jpet.108.141796; Sparling PB, 2003, NEUROREPORT, V14, P2209, DOI 10.1097/00001756-200312020-00015; Strain GW, 2008, OBESITY, V16, P1953, DOI 10.1038/oby.2008.321; Tellez LA, 2013, SCIENCE, V341, P800, DOI 10.1126/science.1239275; Tudor-Locke C, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-60; van der Pas SC, 2011, ARCH PHYS MED REHAB, V92, P1437, DOI 10.1016/j.apmr.2011.02.021; Van Laere K, 2009, ARCH GEN PSYCHIAT, V66, P196, DOI 10.1001/archgenpsychiatry.2008.530; Villarejo C, 2012, EUR EAT DISORD REV, V20, P250, DOI 10.1002/erv.2166; Williams CM, 1999, PSYCHOPHARMACOLOGY, V143, P315, DOI 10.1007/s002130050953; You TJ, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-194; Zanettini C, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00057; Ziv M, 2010, HUM BRAIN MAPP, V31, P326, DOI 10.1002/hbm.20867	69	32	32	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e104534	10.1371/journal.pone.0104534	http://dx.doi.org/10.1371/journal.pone.0104534			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM6SB	25101961	Green Submitted, Green Published, gold			2022-12-27	WOS:000339993900073
J	Fu, LH; Hu, KD; Hu, LY; Li, YH; Hu, LB; Yan, H; Liu, YS; Zhang, H				Fu, Liu-Hui; Hu, Kang-Di; Hu, Lan-Ying; Li, Yan-Hong; Hu, Liang-Bin; Yan, Hong; Liu, Yong-Sheng; Zhang, Hua			An Antifungal Role of Hydrogen Sulfide on the Postharvest Pathogens Aspergillus niger and Penicillium italicum	PLOS ONE			English	Article							NITRIC-OXIDE; ANTIOXIDATIVE ROLE; SPORE GERMINATION; OXIDATIVE DAMAGE; IN-VITRO; FRUIT; H2S; SENESCENCE; STRAWBERRY; DEFENSE	In this research, the antifungal role of hydrogen sulfide (H2S) on the postharvest pathogens Aspergillus niger and Penicillium italicum growing on fruits and under culture conditions on defined media was investigated. Our results show that H2S, released by sodium hydrosulfide (NaHS) effectively reduced the postharvest decay of fruits induced by A. niger and P. italicum. Furthermore, H2S inhibited spore germination, germ tube elongation, mycelial growth, and produced abnormal mycelial contractions when the fungi were grown on defined media in Petri plates. Further studies showed that H2S could cause an increase in intracellular reactive oxygen species (ROS) in A. niger. In accordance with this observation we show that enzyme activities and the expression of superoxide dismutase (SOD) and catalase (CAT) genes in A. niger treated with H2S were lower than those in control. Moreover, H2S also significantly inhibited the growth of Saccharomyces cerevisiae, Rhizopus oryzae, the human pathogen Candida albicans, and several food-borne bacteria. We also found that short time exposure of H2S showed a microbicidal role rather than just inhibiting the growth of microbes. Taken together, this study suggests the potential value of H2S in reducing postharvest loss and food spoilage caused by microbe propagation.	[Fu, Liu-Hui; Hu, Kang-Di; Hu, Lan-Ying; Li, Yan-Hong; Liu, Yong-Sheng; Zhang, Hua] Hefei Univ Technol, Sch Biotechnol & Food Engn, Hefei, Peoples R China; [Hu, Liang-Bin] Henan Inst Sci & Technol, Sch Food Sci, Xinxiang, Peoples R China; [Yan, Hong] Harbin Univ Sci & Technol, Coll Chem & Environm Engn, Key Lab Green Chem Technol, Coll Heilongjiang Prov, Harbin, Peoples R China	Hefei University of Technology; Henan Institute of Science & Technology; Harbin University of Science & Technology	Zhang, H (corresponding author), Hefei Univ Technol, Sch Biotechnol & Food Engn, Hefei, Peoples R China.	hzhanglab@gmail.com	li, yan/GTI-4638-2022		Natural Science Foundation of China [31271803, 31301820, 31300133]; Scientific Research Foundation for the Returned Overseas Chinese Scholars (SRF for ROCS, SEM); Natural Science Foundations of Anhui Province [11040606M85]; Anhui Provincial Education Department [2012AJZR0028]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Foundation for the Returned Overseas Chinese Scholars (SRF for ROCS, SEM)(Scientific Research Foundation for the Returned Overseas Chinese Scholars); Natural Science Foundations of Anhui Province; Anhui Provincial Education Department	This work was supported by the Natural Science Foundation of China (31271803 to LYH, 31301820 to HZ, 31300133 to KDH) http://www.nsfc.gov.cn/, the Scientific Research Foundation for the Returned Overseas Chinese Scholars (SRF for ROCS, SEM to HZ), the Natural Science Foundations of Anhui Province (11040606M85 to HZ) and the Anhui Provincial Education Department (2012AJZR0028 to HZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attene-Ramos MS, 2007, MOL CANCER RES, V5, P455, DOI 10.1158/1541-7786.MCR-06-0439; BEERS RF, 1952, J BIOL CHEM, V195, P133; Bloem E, 2004, J EXP BOT, V55, P2305, DOI 10.1093/jxb/erh236; Bloem E, 2012, J AGR FOOD CHEM, V60, P7588, DOI 10.1021/jf301912h; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Deng Jing, 2013, Journal of Chemical and Pharmaceutical Research, V5, P443; Eghbal MA, 2004, TOXICOLOGY, V203, P69, DOI 10.1016/j.tox.2004.05.020; Gao SP, 2013, HORTSCIENCE, V48, P1385, DOI 10.21273/HORTSCI.48.11.1385; Garcia-Cela E, 2014, INT J FOOD MICROBIOL, V173, P89, DOI 10.1016/j.ijfoodmicro.2013.12.012; GIANNOPOLITIS CN, 1977, PLANT PHYSIOL, V59, P315, DOI 10.1104/pp.59.2.309; Hernandez-Montiel LG, 2010, POSTHARVEST BIOL TEC, V56, P181, DOI 10.1016/j.postharvbio.2009.12.010; Haneklaus S., 2007, MINERAL NUTR PLANT D, P101; Heydari A., 2010, Journal of Biological Sciences, V10, P273; Hodges RJ, 2011, J AGR SCI, V149, P37, DOI 10.1017/S0021859610000936; Hu HL, 2014, INT J FOOD SCI TECH, V49, P399, DOI 10.1111/ijfs.12313; Hu KD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085524; Hu LY, 2012, J AGR FOOD CHEM, V60, P8684, DOI 10.1021/jf300728h; Jin ZP, 2013, PLANT PHYSIOL BIOCH, V62, P41, DOI 10.1016/j.plaphy.2012.10.017; Jin ZP, 2011, BIOCHEM BIOPH RES CO, V414, P481, DOI 10.1016/j.bbrc.2011.09.090; Joyner-Matos J, 2010, PHYSIOL BIOCHEM ZOOL, V83, P356, DOI 10.1086/597529; Kreiner M, 2002, ENZYME MICROB TECH, V30, P346, DOI 10.1016/S0141-0229(01)00517-8; Lai TF, 2011, CURR MICROBIOL, V62, P229, DOI 10.1007/s00284-010-9695-1; Lazar EE, 2008, LETT APPL MICROBIOL, V46, P688, DOI 10.1111/j.1472-765X.2008.02373.x; Li SP, 2014, J AGR FOOD CHEM, V62, P1119, DOI 10.1021/jf4047122; Lisjak M, 2013, PLANT CELL ENVIRON, V36, P1607, DOI 10.1111/pce.12073; Liu XP, 2007, INT J FOOD MICROBIOL, V119, P223, DOI 10.1016/j.ijfoodmicro.2007.07.054; Majumdar T, 2013, J ELECTROCHEM SOC, V160, pG75, DOI 10.1149/2.026306jes; Manjunatha G, 2010, BIOTECHNOL ADV, V28, P489, DOI 10.1016/j.biotechadv.2010.03.001; MARSH R. W., 1929, JOUR POMOLOGY & HORT SCI, V7, P237; Reynolds A, 2010, COMMUN DIS INTELL, V34, P329; Savi GD, 2013, INT J FOOD SCI TECH, V48, P1834, DOI 10.1111/ijfs.12158; Senthilkumar M, 2007, CURR MICROBIOL, V55, P25, DOI 10.1007/s00284-006-0500-0; Shatalin K, 2011, SCIENCE, V334, P986, DOI 10.1126/science.1209855; Strawn LK, 2013, APPL ENVIRON MICROB, V79, P588, DOI 10.1128/AEM.02491-12; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Tian J, 2011, FOOD CONTROL, V22, P1992, DOI 10.1016/j.foodcont.2011.05.018; Tripathi P, 2004, POSTHARVEST BIOL TEC, V32, P235, DOI 10.1016/j.postharvbio.2003.11.005; Wang R, 2012, PHYSIOL REV, V92, P791, DOI 10.1152/physrev.00017.2011; Yu T, 2009, PHYTOPATHOLOGY, V99, P258, DOI 10.1094/PHYTO-99-3-0258; Zhang H, 2008, J INTEGR PLANT BIOL, V50, P1518, DOI 10.1111/j.1744-7909.2008.00769.x	40	50	58	6	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e104206	10.1371/journal.pone.0104206	http://dx.doi.org/10.1371/journal.pone.0104206			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25101960	gold, Green Submitted, Green Published			2022-12-27	WOS:000339993900049
J	Parhira, S; Yang, ZF; Zhu, GY; Chen, QL; Zhou, BX; Wang, YT; Liu, L; Bai, LP; Jiang, ZH				Parhira, Supawadee; Yang, Zi-Feng; Zhu, Guo-Yuan; Chen, Qiao-Lian; Zhou, Bei-Xian; Wang, Yu-Tao; Liu, Liang; Bai, Li-Ping; Jiang, Zhi-Hong			In Vitro Anti-Influenza Virus Activities of a New Lignan Glycoside from the Latex of Calotropis gigantea	PLOS ONE			English	Article							NF-KAPPA-B; A H7N9 VIRUS; INFLUENZA-VIRUS; INHIBITION; PROPAGATION; ACTIVATION; RESISTANCE; INFECTION; EXPRESSION; LEAVES	A new lignan glycoside, (+)-pinoresinol 4-O-[6"-O-vanilloyl]-beta-D-glucopyranoside (1) and two known phenolic compounds, 6'-O-vanilloyltachioside (2) and 6'-O-vanilloylisotachioside (3) were isolated from the latex of Calotropis gigantea (Asclepiadaceae). The structure of the new compound was elucidated by using spectroscopic and chemical methods. Three isolates (1-3) and one authentic compound, (+)-pinoresinol 4-O-beta-D-glucopyranoside, were screened for A/PR/8/34 (H1N1) inhibitory activity by cytopathic effect (CPE) inhibition assay on MDCK cells. Compound 1 showed inhibitory activity against A/PR/8/34 (H1N1). In sharp contrast, the other three compounds (2, 3 and (+)-pinoresinol 4-O-beta-D-glucopyranoside) did not show such activity. An analysis of structure-activity relationship between 1 and (+)-pinoresinol 4-O-beta-D-glucopyranoside revealed that the presence of a vanilloyl group in the sugar moiety of 1 is crucial for its anti-influenza virus activity. Compound 1 was further evaluated for in vitro inhibitory activities against a panel of human and avian influenza viruses by CPE inhibition assay. It showed inhibitory effect against human influenza viruses in both subtypes A and B (IC50 values around 13.4-39.8 mu M with SI values of 3.7-11.4), while had no effect on avian influenza viruses. Its antiviral activity against human influenza viruses subtype A was further confirmed by plaque reduction assay. The time course assay indicated that 1 exerts its antiviral activity at the early stage of viral replication. A mechanistic study showed that 1 efficiently inhibited influenza virus-induced activation of NF-kappa B pathway in a dose-dependent manner, but had no effect on virus-induced activation of Raf/MEK/ERK pathway. Further studies demonstrated that nuclear translocation of transcription factor NF-kappa B induced by influenza virus was significantly blocked by 1, meanwhile, nuclear export of viral ribonucleoproteins was also effectively inhibited. These findings suggest that this new lignan glycoside from Calotropis gigantea, may have therapeutic potential in influenza virus infection through inhibition of NF-kappa B pathway and viral ribonucleoproteins nuclear export.	[Parhira, Supawadee; Zhu, Guo-Yuan; Liu, Liang; Bai, Li-Ping; Jiang, Zhi-Hong] Macau Univ Sci & Technol, Macau Inst Appl Res Med & Hlth, State Key Lab Qual Res Chinese Med, Taipa, Macau, Peoples R China; [Yang, Zi-Feng; Chen, Qiao-Lian; Zhou, Bei-Xian; Wang, Yu-Tao] Guangzhou Med Univ, Affiliated Hosp 1, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China	Macau University of Science & Technology; Guangzhou Medical University; State Key Laboratory of Respiratory Disease	Bai, LP (corresponding author), Macau Univ Sci & Technol, Macau Inst Appl Res Med & Hlth, State Key Lab Qual Res Chinese Med, Taipa, Macau, Peoples R China.	lpbai@must.edu.mo; zhjiang@must.edu.mo	BAI, Li-Ping/O-5691-2016; Zhu, Guo-Yuan/AAG-7914-2019	BAI, Li-Ping/0000-0002-2806-6883; Zhu, Guo-Yuan/0000-0002-4355-894X; Parhira, Supawadee/0000-0002-2077-5888; Jiang, Zhi-Hong/0000-0002-7956-2481	Macao Science and Technology Development Fund, MSAR [063/2011/A3, 040/2012/A]	Macao Science and Technology Development Fund, MSAR	This work was financially supported by Macao Science and Technology Development Fund, MSAR (063/2011/A3 to LPB), and partly supported by Macao Science and Technology Development Fund, MSAR (040/2012/A to ZFY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai LP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053962; Bhaskara RMP, 1943, P INDIAN ACAD SCI A, VA18, P145; Silva MCC, 2010, ASIAN PAC J TROP MED, V3, P332, DOI 10.1016/S1995-7645(10)60081-8; DEYAMA T, 1983, CHEM PHARM BULL, V31, P2993; Deyde VM, 2007, J INFECT DIS, V196, P249, DOI 10.1086/518936; Du J, 2012, DRUG DISCOV TODAY, V17, P1111, DOI 10.1016/j.drudis.2012.06.002; eFloras, 2013, CAL GIG; Ehrhardt C, 2007, ANTIVIR RES, V76, P38, DOI 10.1016/j.antiviral.2007.05.002; Gao GF, 2014, SCIENCE, V344, P235, DOI 10.1126/science.1254664; Gao HN, 2013, NEW ENGL J MED, V368, P2277, DOI 10.1056/NEJMoa1305584; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; He H, 2012, BIOORG MED CHEM LETT, V22, P1582, DOI 10.1016/j.bmcl.2011.12.143; Hsieh CF, 2012, J ETHNOPHARMACOL, V143, P57, DOI 10.1016/j.jep.2012.05.061; Hu YW, 2013, LANCET, V381, P2273, DOI 10.1016/S0140-6736(13)61125-3; Jiang ZH, 2005, CHEM PHARM BULL, V53, P339, DOI 10.1248/cpb.53.339; Jiang ZH, 2002, CHEM PHARM BULL, V50, P137, DOI 10.1248/cpb.50.137; Kim M, 2012, ANTIVIR RES, V93, P253, DOI 10.1016/j.antiviral.2011.12.006; Kiyohara H, 2012, PHYTOMEDICINE, V19, P111, DOI 10.1016/j.phymed.2011.07.004; Lhinhatrakool T, 2006, J NAT PROD, V69, P1249, DOI 10.1021/np060249f; Marjuki H, 2006, J BIOL CHEM, V281, P16707, DOI 10.1074/jbc.M510233200; Mazur I, 2007, CELL MICROBIOL, V9, P1683, DOI 10.1111/j.1462-5822.2007.00902.x; Parhira S, 2014, SCI REP-UK, V4, DOI 10.1038/srep04748; Pari K, 1998, J NAT PROD, V61, P102, DOI 10.1021/np970255z; Pauli EK, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000196; Pinto R, 2011, ANTIVIR RES, V92, P45, DOI 10.1016/j.antiviral.2011.05.009; Pleschka S, 2001, NAT CELL BIOL, V3, P301, DOI 10.1038/35060098; REED L. J., 1938, AMER JOUR HYG, V27, P493; Sriwilaijaroen N, 2012, ANTIVIR RES, V94, P139, DOI 10.1016/j.antiviral.2012.02.013; Wei L, 2006, J BIOL CHEM, V281, P11678, DOI 10.1074/jbc.M513286200; World Health Organization, 2013, OV EM CHAR AV INFL A; Wright PF, 2007, FIELDS VIROLOGY, V2, P1692; Wurzer WJ, 2004, J BIOL CHEM, V279, P30931, DOI 10.1074/jbc.M403258200; Wurzer WJ, 2003, EMBO J, V22, P2717, DOI 10.1093/emboj/cdg279; Yang XW, 2007, PLANTA MED, V73, P1415, DOI 10.1055/s-2007-990235; Yang ZF, 2014, FITOTERAPIA, V93, P47, DOI 10.1016/j.fitote.2013.12.011; Yingsakmongkon S, 2008, BIOL PHARM BULL, V31, P511, DOI 10.1248/bpb.31.511	36	29	31	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e104544	10.1371/journal.pone.0104544	http://dx.doi.org/10.1371/journal.pone.0104544			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25102000	Green Published, Green Submitted, gold			2022-12-27	WOS:000339993900074
J	Mah, WC; Thurnherr, T; Chow, PKH; Chung, AYF; Ooi, LLPJ; Toh, HC; Teh, BT; Saunthararajah, Y; Lee, CGL				Mah, Way-Champ; Thurnherr, Thomas; Chow, Pierce K. H.; Chung, Alexander Y. F.; Ooi, London L. P. J.; Toh, Han Chong; Teh, Bin Tean; Saunthararajah, Yogen; Lee, Caroline G. L.			Methylation Profiles Reveal Distinct Subgroup of Hepatocellular Carcinoma Patients with Poor Prognosis	PLOS ONE			English	Article							DNA METHYLATION; HEPATITIS-B; CLASS DISCOVERY; BETA-CATENIN; P53 GENE; CANCER; HYPERMETHYLATION; LIVER; PATTERNS; INFLAMMATION	Hepatocellular Carcinoma (HCC) is one of the leading causes of cancer-associated mortality worldwide. However, the role of epigenetic changes such as aberrant DNA methylation in hepatocarcinogenesis remains largely unclear. In this study, we examined the methylation profiles of 59 HCC patients. Using consensus hierarchical clustering with feature selection, we identified three tumor subgroups based on their methylation profiles and correlated these subgroups with clinicopathological parameters. Interestingly, one tumor subgroup is different from the other 2 subgroups and the methylation profile of this subgroup is the most distinctly different from the non-tumorous liver tissues. Significantly, this subgroup of patients was found to be associated with poor overall as well as disease-free survival. To further understand the pathways modulated by the deregulation of methylation in HCC patients, we integrated data from both the methylation as well as the gene expression profiles of these 59 HCC patients. In these patients, while 4416 CpG sites were differentially methylated between the tumors compared to the adjacent non-tumorous tissues, only 536 of these CpG sites were associated with differences in the expression of their associated genes. Pathway analysis revealed that forty-four percent of the most significant upstream regulators of these 536 genes were involved in inflammation-related NF kappa B pathway. These data suggest that inflammation via the NF kappa B pathway play an important role in modulating gene expression of HCC patients through methylation. Overall, our analysis provides an understanding on aberrant methylation profile in HCC patients.	[Lee, Caroline G. L.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117595, Singapore; [Mah, Way-Champ; Teh, Bin Tean; Lee, Caroline G. L.] Natl Canc Ctr Singapore, Humphrey Oei Inst Canc Res, Div Med Sci, Singapore, Singapore; [Mah, Way-Champ; Thurnherr, Thomas; Lee, Caroline G. L.] Natl Univ Singapore, NUS Grad Sch Integrat Sci & Engn, Singapore 117548, Singapore; [Thurnherr, Thomas; Chow, Pierce K. H.; Teh, Bin Tean; Lee, Caroline G. L.] Duke NUS Grad Med Sch, Singapore, Singapore; [Chow, Pierce K. H.; Chung, Alexander Y. F.; Ooi, London L. P. J.] Singapore Gen Hosp, Dept Surg, Singapore, Singapore; [Ooi, London L. P. J.] Natl Canc Ctr Singapore, Dept Surg Oncol, Singapore, Singapore; [Toh, Han Chong] Natl Canc Ctr Singapore, Dept Med Oncol, Singapore, Singapore; [Teh, Bin Tean] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117548, Singapore; [Saunthararajah, Yogen] Cleveland Clin, Taussig Canc Inst, Dept Hematol Oncol & Blood Disorders, Cleveland, OH 44106 USA	National University of Singapore; National Cancer Centre Singapore (NCCS); National University of Singapore; National University of Singapore; Singapore General Hospital; National Cancer Centre Singapore (NCCS); National Cancer Centre Singapore (NCCS); National University of Singapore; Cleveland Clinic Foundation	Lee, CGL (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117595, Singapore.	caroline_lee@nuhs.edu.sg	Lee, Caroline G/M-8918-2019; Ooi, London Lucien/AGK-1395-2022	Lee, Caroline G/0000-0002-4323-3635; Teh, Bin Tean/0000-0003-1514-1124; Chow, Pierce/0000-0003-0584-2584	National Medical Research Council (NMRC) [NMRC/1131/2007, NMRC/1238/2009]; BioMedical Research Council (BMRC) of Singapore [BMRC06/1/21/19/449]; National Cancer Centre, SINGAPORE; DUKE-NUS Graduate Medical School; Singapore Millennium Foundation (SMF); NATIONAL CANCER INSTITUTE [P50CA150964] Funding Source: NIH RePORTER	National Medical Research Council (NMRC)(National Medical Research Council, Singapore); BioMedical Research Council (BMRC) of Singapore(Agency for Science Technology & Research (A*STAR)); National Cancer Centre, SINGAPORE; DUKE-NUS Graduate Medical School(National University of Singapore); Singapore Millennium Foundation (SMF)(Singapore Millennium Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported by grants from the National Medical Research Council (NMRC) (NMRC/1131/2007 and NMRC/1238/2009), the BioMedical Research Council (BMRC) (BMRC06/1/21/19/449) of Singapore and the Singapore Millennium Foundation (SMF), as well as block funding from the National Cancer Centre, SINGAPORE and the DUKE-NUS Graduate Medical School to A/Prof Caroline Lee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammerpohl O, 2012, INT J CANCER, V130, P1319, DOI 10.1002/ijc.26136; Archer KJ, 2010, MOL GENET GENOMICS, V283, P341, DOI 10.1007/s00438-010-0522-y; Berasain C, 2009, ANN NY ACAD SCI, V1155, P206, DOI 10.1111/j.1749-6632.2009.03704.x; BRESSAC B, 1991, NATURE, V350, P429, DOI 10.1038/350429a0; Carlson M, LUMIHUMANALL DB ME H; Carlson M, HGUG4112A DB AGILENT; Di Bisceglie AM, 2009, HEPATOLOGY, V49, pS56, DOI 10.1002/hep.22962; Du P, LUMIHUMANIDMAPPING I; Ebert MPA, 2006, GASTROENTEROLOGY, V131, P1418, DOI 10.1053/j.gastro.2006.08.034; Edamoto Y, 2003, INT J CANCER, V106, P334, DOI 10.1002/ijc.11254; Fang F, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001875; Fatemi M, 2014, CANCER-AM CANCER SOC, V120, P172, DOI 10.1002/cncr.28316; Fukai K, 2003, CANCER RES, V63, P8674; Gao W, 2008, CARCINOGENESIS, V29, P1901, DOI 10.1093/carcin/bgn170; Guichard C, 2012, NAT GENET, V44, P694, DOI 10.1038/ng.2256; Herbst A, 2011, AM J GASTROENTEROL, V106, P1110, DOI 10.1038/ajg.2011.6; Hernandez-Vargas H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009749; Hiranuma C, 2004, INT J MOL MED, V13, P413; Ishizaki Y, 2004, INT J ONCOL, V24, P1077; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Karin M, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000141; Lee CM, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-255; Lee HP, 2013, SINGAPORE CANC REGIS, P9; Lee S, 2003, AM J PATHOL, V163, P1371, DOI 10.1016/S0002-9440(10)63495-5; Lei ZD, 2013, GASTROENTEROLOGY, V145, P554, DOI 10.1053/j.gastro.2013.05.010; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mah WC, 2014, BIOMARK RES, V2, DOI 10.1186/2050-7771-2-5; Minouchi K, 2002, J HEPATOL, V37, P231, DOI 10.1016/S0168-8278(02)00144-7; Monti S, 2003, MACH LEARN, V52, P91, DOI 10.1023/A:1023949509487; Nishida N, 2011, CURR GENOMICS, V12, P130, DOI 10.2174/138920211795564359; Noushmehr Houtan, 2010, Cancer Cell, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Okamoto Y, 2014, GASTROENTEROLOGY, V146, P562, DOI 10.1053/j.gastro.2013.10.056; Satoh S, 2000, NAT GENET, V24, P245, DOI 10.1038/73448; Selamat SA, 2012, GENOME RES, V22, P1197, DOI 10.1101/gr.132662.111; Shen J, 2013, EPIGENETICS-US, V8, P34, DOI 10.4161/epi.23062; Shen J, 2012, HEPATOLOGY, V55, P1799, DOI 10.1002/hep.25569; Shim YH, 2003, CANCER LETT, V190, P213, DOI 10.1016/S0304-3835(02)00613-4; Shitani M, 2012, TUMOR BIOL, V33, P1307, DOI 10.1007/s13277-012-0378-3; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Song MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055761; Stefanska B, 2011, CANCER RES, V71, P5891, DOI 10.1158/0008-5472.CAN-10-3823; Sung WK, 2009, J BIOL CHEM, V284, P21941, DOI 10.1074/jbc.M109.014563; Suzuki H, 2009, METHODS MOL BIOL, V512, P55, DOI 10.1007/978-1-60327-530-9_5; Taniguchi K, 2002, ONCOGENE, V21, P4863, DOI 10.1038/sj.onc.1205591; Tao R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019862; Tung EKK, 2009, INT J CANCER, V124, P1811, DOI 10.1002/ijc.24115; Um TH, 2011, J HEPATOL, V54, P939, DOI 10.1016/j.jhep.2010.08.021; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Wilkerson MD, 2010, BIOINFORMATICS, V26, P1572, DOI 10.1093/bioinformatics/btq170; Yang B, 2003, AM J PATHOL, V163, P1101, DOI 10.1016/S0002-9440(10)63469-4; Yu J, 2003, CELL RES, V13, P319, DOI 10.1038/sj.cr.7290177; Yuen MF, 2009, J GASTROEN HEPATOL, V24, P346, DOI 10.1111/j.1440-1746.2009.05784.x; Zhang YJ, 2005, CANCER LETT, V221, P135, DOI 10.1016/j.canlet.2004.08.028; Zouridis H, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004504	55	47	50	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e104158	10.1371/journal.pone.0104158	http://dx.doi.org/10.1371/journal.pone.0104158			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093504	Green Published, Green Submitted, gold			2022-12-27	WOS:000341357200077
J	Roix, JJ; Harrison, SD; Rainbolt, EA; Meshaw, KR; McMurry, AS; Cheung, P; Saha, S				Roix, Jeffrey J.; Harrison, S. D.; Rainbolt, Elizabeth A.; Meshaw, Kathryn R.; McMurry, Avery S.; Cheung, Peter; Saha, Saurabh			Systematic Repurposing Screening in Xenograft Models Identifies Approved Drugs with Novel Anti-Cancer Activity	PLOS ONE			English	Article							TEMOZOLOMIDE; TERBINAFINE; INHIBITION; SUNITINIB	Approved drugs target approximately 400 different mechanisms of action, of which as few as 60 are currently used as anticancer therapies. Given that on average it takes 10-15 years for a new cancer therapeutic to be approved, and the recent success of drug repurposing for agents such as thalidomide, we hypothesized that effective, safe cancer treatments may be found by testing approved drugs in new therapeutic settings. Here, we report in-vivo testing of a broad compound collection in cancer xenograft models. Using 182 compounds that target 125 unique target mechanisms, we identified 3 drugs that displayed reproducible activity in combination with the chemotherapeutic temozolomide. Candidate drugs appear effective at dose equivalents that exceed current prescription levels, suggesting that additional pre-clinical efforts will be needed before these drugs can be tested for efficacy in clinical trials. In total, we suggest drug repurposing is a relatively resource-intensive method that can identify approved medicines with a narrow margin of anti-cancer activity.	[Roix, Jeffrey J.; Cheung, Peter; Saha, Saurabh] BioMed Valley Discoveries Inc, Kansas City, MO 64111 USA; [Harrison, S. D.; Rainbolt, Elizabeth A.; Meshaw, Kathryn R.; McMurry, Avery S.] Charles River Discovery Res Serv, Morrisville, NC USA		Roix, JJ (corresponding author), BioMed Valley Discoveries Inc, Kansas City, MO 64111 USA.	jroix@biomed-valley.com			BioMed Valley Discoveries, Inc.	BioMed Valley Discoveries, Inc.	All studies were sponsored and funded by BioMed Valley Discoveries, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], AT PRESCR INF; [Anonymous], LAM TABL PRESCR INF; Ashburn TT, 2004, NAT REV DRUG DISCOV, V3, P673, DOI 10.1038/nrd1468; Chauhan VP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3516; Chilcott Warner, ACT PRESCR INF; Friedman HS, 2000, CLIN CANCER RES, V6, P2585; Haber DA, 2011, CELL, V145, P19, DOI 10.1016/j.cell.2011.03.026; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; KAN VL, 1988, ANTIMICROB AGENTS CH, V32, P1619, DOI 10.1128/AAC.32.11.1619; Knox C, 2011, NUCLEIC ACIDS RES, V39, pD1035, DOI 10.1093/nar/gkq1126; Leaf C, 2004, WHY WERE LOSING WAR; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Saporito B, 2013, CONSPIRACY END CANC; Walzer PD, 2002, ANTIMICROB AGENTS CH, V46, P514, DOI 10.1128/AAC.46.2.514-516.2002; Williams MM, 2011, J VET PHARMACOL THER, V34, P232, DOI 10.1111/j.1365-2885.2010.01213.x; Zhou QY, 2008, CLIN CANCER RES, V14, P1540, DOI 10.1158/1078-0432.CCR-07-4544; Zhou QY, 2009, NEURO-ONCOLOGY, V11, P301, DOI 10.1215/15228517-2008-088; Zhu F, 2012, NUCLEIC ACIDS RES, V40, pD1128, DOI 10.1093/nar/gkr797	19	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e101708	10.1371/journal.pone.0101708	http://dx.doi.org/10.1371/journal.pone.0101708			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093583	Green Published, Green Submitted, gold			2022-12-27	WOS:000341357200006
J	Sasse, LK; Gamer, M; Buchel, C; Brassen, S				Sasse, Laura K.; Gamer, Matthias; Buechel, Christian; Brassen, Stefanie			Selective Control of Attention Supports the Positivity Effect in Aging	PLOS ONE			English	Article							LATE-LIFE DEPRESSION; MEDIAL PREFRONTAL CORTEX; OLDER EMOTIONAL FACES; AGE-GROUP DIFFERENCES; OWN-AGE; COGNITIVE CONTROL; NEGATIVE INFORMATION; VISUAL-ATTENTION; MEMORY; ADULTS	There is emerging evidence for a positivity effect in healthy aging, which describes an age-specific increased focus on positive compared to negative information. Life-span researchers have attributed this effect to the selective allocation of cognitive resources in the service of prioritized emotional goals. We explored the basic principles of this assumption by assessing selective attention and memory for visual stimuli, differing in emotional content and self-relevance, in young and old participants. To specifically address the impact of cognitive control, voluntary attentional selection during the presentation of multiple-item displays was analyzed and linked to participants' general ability of cognitive control. Results revealed a positivity effect in older adults' selective attention and memory, which was particularly pronounced for self-relevant stimuli. Focusing on positive and ignoring negative information was most evident in older participants with a generally higher ability to exert top-down control during visual search. Our findings highlight the role of controlled selectivity in the occurrence of a positivity effect in aging. Since the effect has been related to well-being in later life, we suggest that the ability to selectively allocate top-down control might represent a resilience factor for emotional health in aging.	[Sasse, Laura K.; Gamer, Matthias; Buechel, Christian; Brassen, Stefanie] Univ Med Ctr Hamburg Eppendorf, Dept Syst Neurosci, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf	Sasse, LK (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Syst Neurosci, Hamburg, Germany.	lsasse@uke.de	Gamer, Matthias/E-7967-2010	Gamer, Matthias/0000-0002-9676-9038; Brassen, Stefanie/0000-0002-8884-7593	German research foundation (DFG) [BR2877/2-2]	German research foundation (DFG)(German Research Foundation (DFG))	This work was supported by the German research foundation (DFG, BR2877/2-2) to SB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addis DR, 2010, CORTEX, V46, P425, DOI 10.1016/j.cortex.2009.04.011; Ashley V, 2009, BEHAV BRAIN FUNCT, V5, DOI 10.1186/1744-9081-5-14; Brassen S, 2008, BIOL PSYCHIAT, V64, P349, DOI 10.1016/j.biopsych.2008.03.022; Brassen S, 2012, SCIENCE, V336, P612, DOI 10.1126/science.1217516; Brassen S, 2011, BIOL PSYCHIAT, V70, P131, DOI 10.1016/j.biopsych.2010.10.013; Broomfield NM, 2007, INT J GERIATR PSYCH, V22, P175, DOI 10.1002/gps.1655; Brummer L, 2014, BEHAV COGN PSYCHOTH, V42, P668, DOI 10.1017/S1352465813000453; Cabeza R., 2013, PRINCIPLES FRONTAL L; Cacioppo JT., 2011, SOCIAL NEUROSCIENCE, P249, DOI [DOI 10.1093/ACPROF:OSO/9780195316872.003.0017, 10.1093/acprof:oso/9780195316872.003.0017]; Carstensen LL, 2006, SCIENCE, V312, P1913, DOI 10.1126/science.1127488; Carstensen LL, 2005, CURR DIR PSYCHOL SCI, V14, P117, DOI 10.1111/j.0963-7214.2005.00348.x; Carstensen LL, 1998, HEALTH PSYCHOL, V17, P494, DOI 10.1037/0278-6133.17.6.494; Carstensen LL, 1999, AM PSYCHOL, V54, P165, DOI 10.1037/0003-066X.54.3.165; Charles ST, 2003, J EXP PSYCHOL GEN, V132, P310, DOI 10.1037/0096-3445.132.2.310; Colcombe AM, 2003, ACTA PSYCHOL, V113, P205, DOI 10.1016/S0001-6918(03)00019-2; Costello MC, 2010, EXP AGING RES, V36, P249, DOI 10.1080/0361073X.2010.484719; Ebner NC, 2013, NEUROIMAGE, V78, P363, DOI 10.1016/j.neuroimage.2013.04.029; Ebner NC, 2011, COGNITION EMOTION, V25, P983, DOI 10.1080/02699931.2010.540817; Ebner NC, 2011, NEUROCASE, V17, P260, DOI 10.1080/13554794.2010.536953; Ebner NC, 2010, COGNITION EMOTION, V24, P1095, DOI 10.1080/02699930903128395; Ebner NC, 2009, EMOTION, V9, P329, DOI 10.1037/a0015179; Etkin A, 2011, TRENDS COGN SCI, V15, P85, DOI 10.1016/j.tics.2010.11.004; Fjell AM, 2009, CEREB CORTEX, V19, P2001, DOI 10.1093/cercor/bhn232; Germain CM, 2007, AGING NEUROPSYCHOL C, V14, P462, DOI 10.1080/13825580600611302; Golkar A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048107; GREENHOUSE SW, 1959, PSYCHOMETRIKA, V24, P95, DOI 10.1007/BF02289823; Guerreiro MJS, 2010, PSYCHOL BULL, V136, P975, DOI 10.1037/a0020731; Gutchess AH, 2007, SOC NEUROSCI-UK, V2, P117, DOI 10.1080/17470910701399029; Hahn S, 2006, ACTA PSYCHOL, V123, P312, DOI 10.1016/j.actpsy.2006.01.008; Hamami A, 2011, PSYCHOL AGING, V26, P636, DOI 10.1037/a0022626; Harvey PO, 2007, J COGNITIVE NEUROSCI, V19, P351, DOI 10.1162/jocn.2007.19.2.351; He Y, 2011, SOC COGNITION, V29, P97, DOI 10.1521/soco.2011.29.1.97; Isaacowitz DM, 2008, PSYCHOL SCI, V19, P848, DOI 10.1111/j.1467-9280.2008.02167.x; Isaacowitz DM, 2006, EMOTION, V6, P511, DOI 10.1037/1528-3542.6.3.511; Isaacowitz DM, 2009, J GERONTOL B-PSYCHOL, V64, P188, DOI 10.1093/geronb/gbn036; Isaacowitz DM, 2006, PSYCHOL AGING, V21, P40, DOI 10.1037/0882-7974.21.1.40; Itti L, 1998, IEEE T PATTERN ANAL, V20, P1254, DOI 10.1109/34.730558; Kalisch R, 2009, NEUROSCI BIOBEHAV R, V33, P1215, DOI 10.1016/j.neubiorev.2009.06.003; Katz R, 2010, AM J GERIAT PSYCHIAT, V18, P1017, DOI 10.1097/JGP.0b013e3181d695f2; Kennedy Q, 2004, PSYCHOL SCI, V15, P208, DOI 10.1111/j.0956-7976.2004.01503011.x; Kensinger EA, 2008, J COGNITIVE NEUROSCI, V20, P1161, DOI 10.1162/jocn.2008.20080; Kensinger EA, 2009, EUR J COGN PSYCHOL, V21, P192, DOI 10.1080/09541440801937116; Knight M, 2007, EMOTION, V7, P705, DOI 10.1037/1528-3542.7.4.705; Kryla-Lighthall N., 2009, HDB THEORIES AGING, P323; Lang P, 1980, TECHNOLOGY MENTAL HL, P119, DOI DOI 10.1016/J.LINDIF.2013.01.005; Lang P.J., 2008, A8 U FLOR; LAWTON MP, 1992, PSYCHOL AGING, V7, P171, DOI 10.1037/0882-7974.7.2.171; Leclerc CM, 2008, COGN AFFECT BEHAV NE, V8, P153, DOI 10.3758/CABN.8.2.153; Lee LO, 2009, PSYCHOL AGING, V24, P741, DOI 10.1037/a0016409; Lien MC, 2011, PSYCHOL AGING, V26, P188, DOI 10.1037/a0021073; Mather M, 2005, TRENDS COGN SCI, V9, P496, DOI 10.1016/j.tics.2005.08.005; Mather M, 2003, PSYCHOL SCI, V14, P409, DOI 10.1111/1467-9280.01455; Mather M, 2005, PSYCHOL AGING, V20, P554, DOI 10.1037/0882-7974.20.4.554; Mather M, 2012, ANN NY ACAD SCI, V1251, P33, DOI 10.1111/j.1749-6632.2012.06471.x; Monti JM, 2010, NEUROPSYCHOLOGIA, V48, P1697, DOI 10.1016/j.neuropsychologia.2010.02.017; Murphy NA, 2008, PSYCHOL AGING, V23, P263, DOI 10.1037/0882-7974.23.2.263; Nashiro K, 2012, GERONTOLOGY, V58, P156, DOI 10.1159/000328465; Ochsner K. N., 2007, SOCIAL PSYCHOL HDB B, P39; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; Opitz PC, 2012, NEUROBIOL AGING, V33, P645, DOI 10.1016/j.neurobiolaging.2010.06.004; Orgeta V, 2011, EXP AGING RES, V37, P449, DOI 10.1080/0361073X.2011.590759; Orgeta V, 2009, AGING MENT HEALTH, V13, P818, DOI 10.1080/13607860902989661; Petrican R, 2008, PSYCHOL AGING, V23, P585, DOI 10.1037/a0013176; Phillips LH, 2008, J GERONTOL B-PSYCHOL, V63, pP138, DOI 10.1093/geronb/63.3.P138; Price RB, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.46; Reed AE, 2014, PSYCHOL AGING, V29, P1, DOI 10.1037/a0035194; Reed AE, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00339; Rhodes MG, 2012, PSYCHOL BULL, V138, P146, DOI 10.1037/a0025750; Ritchey M, 2011, NEUROPSYCHOLOGIA, V49, P640, DOI 10.1016/j.neuropsychologia.2010.09.009; Samanez-Larkin GR, 2009, PSYCHOL AGING, V24, P519, DOI 10.1037/a0016952; Sheline YI, 2006, BIOL PSYCHIAT, V60, P58, DOI 10.1016/j.biopsych.2005.09.019; Tomaszczyk JC, 2008, PSYCHON B REV, V15, P191, DOI 10.3758/PBR.15.1.191; Wangelin BC, 2012, BIOL PSYCHOL, V91, P103, DOI 10.1016/j.biopsycho.2012.05.002; WELSH K, 1991, ARCH NEUROL-CHICAGO, V48, P278, DOI 10.1001/archneur.1991.00530150046016; Whiting WL, 2007, PSYCHOL AGING, V22, P223, DOI 10.1037/0882-7974.22.2.223; Wieser MJ, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00471	76	30	33	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e104180	10.1371/journal.pone.0104180	http://dx.doi.org/10.1371/journal.pone.0104180			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO5BW	25093459	Green Published, gold, Green Submitted			2022-12-27	WOS:000341357200086
J	Young, C; Wong, KY; Cheung, LK				Young, Cecilia; Wong, Kin Yau; Cheung, Lim K.			Effectiveness of Educational Poster on Knowledge of Emergency Management of Dental Trauma - Part 2: Cluster Randomised Controlled Trial for Secondary School Students	PLOS ONE			English	Article							AVULSED TEETH; 1ST AID; TEACHERS KNOWLEDGE; LAY KNOWLEDGE; ORAL-HEALTH; INJURIES; AWARENESS; PROFESSIONALS; ATTITUDES; URBAN	Objective: To investigate the effectiveness of educational poster on improving secondary school students' knowledge of emergency management of dental trauma. Methods: A cluster randomised controlled trial was conducted. 16 schools with total 671 secondary students who can read Chinese or English were randomised into intervention (poster, 8 schools, 364 students) and control groups (8 schools, 305 students) at the school level. Baseline knowledge of dental trauma was obtained by a questionnaire. Poster containing information of dental trauma management was displayed in a classroom for 2 weeks in each school in the intervention group whereas in the control group there was no display of such posters. Students of both groups completed the same questionnarie after 2 weeks. Results: Two-week display of posters improved the knowledge score by 1.25 (p-value = 0.0407) on average. Conclusion: Educational poster on dental trauma management significantly improved the level of knowledge of secondary school students in Hong Kong.	[Wong, Kin Yau] Univ N Carolina, Dept Biostat, Chapel Hill, NC USA; [Cheung, Lim K.] Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China	University of North Carolina; University of North Carolina Chapel Hill; University of Hong Kong		ceciliatyp@yahoo.com.hk	; Young, Cecilia/K-1699-2018	, Kin Yau/0000-0001-9066-1619; Young, Cecilia/0000-0003-1698-7738				Al-Asfour A, 2008, DENT TRAUMATOL, V24, P515, DOI 10.1111/j.1600-9657.2008.00651.x; Al-Asfour A, 2008, DENT TRAUMATOL, V24, P43, DOI 10.1111/j.1600-9657.2006.00476.x; Al-Jundi SH, 2005, DENT TRAUMATOL, V21, P183, DOI 10.1111/j.1600-9657.2005.00307.x; Al-Obaida M, 2010, DENT TRAUMATOL, V26, P338, DOI 10.1111/j.1600-9657.2010.00894.x; Andersson L, 2006, DENT TRAUMATOL, V22, P57, DOI 10.1111/j.1600-9657.2006.00338.x; Andreasen JO, 2002, DENT TRAUMATOL, V18, P116, DOI 10.1034/j.1600-9657.2002.00079.x; Arikan V, 2012, DENT TRAUMATOL, V28, P101, DOI 10.1111/j.1600-9657.2011.01042.x; Bayrak S, 2012, ORAL HLTH PREV DENT, V10, P253; Biagi R, 2010, EUR J PAEDIATR DENT, V11, P66; Caglar E, 2005, DENT TRAUMATOL, V21, P258, DOI 10.1111/j.1600-9657.2005.00321.x; Castilho LR, 2009, DENT TRAUMATOL, V25, P429, DOI 10.1111/j.1600-9657.2008.00756.x; de Lima Ludgero A, 2012, INDIAN J DENT RES, V23, P585, DOI DOI 10.4103/0970-9290.107331; Diaz J, 2009, DENT TRAUMATOL, V25, P611, DOI 10.1111/j.1600-9657.2009.00835.x; Draper N.R., 1981, APPL REGRESSION ANAL, Vsecond, DOI DOI 10.1002/9781118625590; Froud R, 2012, COMMUNITY DENT ORAL, V40, P3, DOI 10.1111/j.1600-0528.2011.00660.x; Fux-Noy A, 2011, DENT TRAUMATOL, V27, P252, DOI 10.1111/j.1600-9657.2010.00970.x; Glendor U, 2008, DENT TRAUMATOL, V24, P603, DOI 10.1111/j.1600-9657.2008.00696.x; Hamilton FA, 1997, ENDOD DENT TRAUMATOL, V13, P19; Hashim R, 2011, EUR J PAEDIATR DENT, V12, P99; Holan G, 2006, DENT TRAUMATOL, V22, P323, DOI 10.1111/j.1600-9657.2005.00387.x; Hugar SM, 2013, INT EMERG NURS, V21, P252, DOI 10.1016/j.ienj.2012.12.001; Kahabuka F K, 2001, SADJ, V56, P284; Levin L, 2010, DENT TRAUMATOL, V26, P86, DOI 10.1111/j.1600-9657.2009.00847.x; Lieger O, 2009, DENT TRAUMATOL, V25, P406, DOI 10.1111/j.1600-9657.2009.00798.x; McIntyre JD, 2008, DENT TRAUMATOL, V24, P289, DOI 10.1111/j.1600-9657.2007.00542.x; McIntyre JD, 2008, DENT TRAUMATOL, V24, P146, DOI 10.1111/j.1600-9657.2008.00573.x; Mesgarzadeh AH, 2009, ORAL HLTH PREV DENT, V7, P297; Mohandas U, 2009, J Indian Soc Pedod Prev Dent, V27, P242, DOI 10.4103/0970-4388.57660; Mori GG, 2007, J APPL ORAL SCI, V15, P534, DOI 10.1590/S1678-77572007000600015; Ozer Sezin, 2012, Eur J Dent, V6, P370; Pujita Chada, 2013, J Conserv Dent, V16, P21, DOI 10.4103/0972-0707.105293; RAPHAEL SL, 1990, AUST DENT J, V35, P130, DOI 10.1111/j.1834-7819.1990.tb05878.x; Sanu O O, 2005, Niger Postgrad Med J, V12, P115; Skapetis T, 2012, BMC MED EDUC, V12, DOI 10.1186/1472-6920-12-103; Skapetis T, 2012, AUSTRALAS EMERG NURS, V15, P14, DOI 10.1016/j.aenj.2011.12.003; Skeie MS, 2010, DENT TRAUMATOL, V26, P243, DOI 10.1111/j.1600-9657.2010.00897.x; Santos MESM, 2009, DENT TRAUMATOL, V25, P203, DOI 10.1111/j.1600-9657.2008.00620.x; STOKES AN, 1992, ENDOD DENT TRAUMATOL, V8, P160; Underwood M, 1998, BRIT J GEN PRACT, V48, P1089; Frujeri MDV, 2009, DENT TRAUMATOL, V25, P262, DOI 10.1111/j.1600-9657.2008.00760.x; Walker A, 2000, Accid Emerg Nurs, V8, P66, DOI 10.1054/aaen.1999.0115; Young C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084406; Young C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074833; Young C, 2012, HONG KONG MED J, V18, P362	44	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e101972	10.1371/journal.pone.0101972	http://dx.doi.org/10.1371/journal.pone.0101972			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093728	Green Published, gold, Green Submitted			2022-12-27	WOS:000341357200008
J	Khatun, J; Huda, MM; Hossain, MS; Presber, W; Ghosh, D; Kroeger, A; Matlashewski, G; Mondal, D				Khatun, Jahanara; Huda, M. Mamun; Hossain, Md. Shakhawat; Presber, Wolfgang; Ghosh, Debashis; Kroeger, Axel; Matlashewski, Greg; Mondal, Dinesh			Accelerated Active Case Detection of Visceral Leishmaniasis Patients in Endemic Villages of Bangladesh	PLOS ONE			English	Article							INDIA; FEASIBILITY	Background: The visceral leishmaniasis (VL) elimination program in Bangladesh is in its attack phase. The primary goal of this phase is to decrease the burden of VL as much as possible. Active case detection (ACD) by the fever camp method and an approach using past VL cases in the last 6-12 months have been found useful for detection of VL patients in the community. We aimed to explore the yield of Accelerated Active Case Detection (AACD) of non-self reporting VL as well as the factors that are associated with non-self reporting to hospitals in endemic communities of Bangladesh. Methods: Our study was conducted in the Trishal sub-district of Mymensingh, a highly VL endemic region of Bangladesh. We used a two-stage sampling strategy from 12 VL endemic unions of Trishal. Two villages from each union were selected at random. We looked for VL patients who had self-reported to the hospital and were under treatment from these villages. Then we conducted AACD for VL cases in those villages using house-to-house visit. Suspected VL cases were referred to the Trishal hospital where diagnosis and treatment of VL was done following National Guidelines for VL case management. We collected socio-demographic information from patients or a patient guardian using a structured questionnaire. Results: The total number of VL cases was 51. Nineteen of 51 (37.3%) were identified by AACD. Poverty, female gender and poor knowledge about VL were independent factors associated with non self-reporting to the hospital. Conclusion: Our primary finding is that AACD is a useful method for early detection of VL cases that would otherwise go unreported to the hospital in later stage due to poverty, poor knowledge about VL and gender inequity. We recommend that the National VL Program should consider AACD to strengthen its early VL case detection strategy.	[Khatun, Jahanara] Free Univ Berlin, Charite Med Sch, Berlin, Germany; [Khatun, Jahanara] Humboldt Univ, D-10099 Berlin, Germany; [Huda, M. Mamun; Ghosh, Debashis] Ctr Communicable Dis, Parasitol Lab, Dhaka, Bangladesh; [Hossain, Md. Shakhawat; Mondal, Dinesh] Ctr Nutr & Food Secur, Parasitol Lab, Dhaka, Bangladesh; [Presber, Wolfgang] Charite, Inst Mikrobiol, D-13353 Berlin, Germany; [Kroeger, Axel] WHO World Bank, Special Program Trop Dis Res TDR, Geneva, Switzerland; [Matlashewski, Greg] McGill Univ, Dept Microbiol & Immunol, Quebec City, PQ, Canada	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Humboldt University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; McGill University	Mondal, D (corresponding author), Ctr Nutr & Food Secur, Parasitol Lab, Dhaka, Bangladesh.	din63d@icddrb.org	Huda, M Mamun/AAA-2152-2020	Huda, M Mamun/0000-0003-1069-3472; Kroeger, Axel/0000-0001-8438-2904	Special Programme for Research and Training in Tropical Diseases (TDR/WHO/World bank) [A60443, A60482]	Special Programme for Research and Training in Tropical Diseases (TDR/WHO/World bank)	The Special Programme for Research and Training in Tropical Diseases (TDR/WHO/World bank) provided financial support (Project ID: A60443 & A60482). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahluwalia IB, 2003, AM J TROP MED HYG, V69, P624, DOI 10.4269/ajtmh.2003.69.624; Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Bern C, 2006, INDIAN J MED RES, V123, P275; Hirve S, 2010, AM J TROP MED HYG, V83, P507, DOI 10.4269/ajtmh.2010.09-0685; Huda MM, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1001; Joshi A., 2008, Journal of Vector Borne Diseases, V45, P105; Kleinbaum DG, 1998, APPL REGRESSION ANAL; Mondal D, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000355; Singh SP, 2011, PLOS NEGLECT TROP D, V5, pe960, DOI DOI 10.1371/journal.pntd.0000960; *WHO, 2008, SEACD182 WHO; WHO Regional Technical Advisory Group on Kala-azar Elimination, 2005, 1 M MAN HAR 20 23 DE	11	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103678	10.1371/journal.pone.0103678	http://dx.doi.org/10.1371/journal.pone.0103678			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25090412	Green Published, gold, Green Submitted			2022-12-27	WOS:000339812700041
J	Wu, XY; Cai, H; Kallianpur, A; Gao, YT; Yang, G; Chow, WH; Li, HL; Zheng, W; Shu, XO				Wu, Xiaoyan; Cai, Hui; Kallianpur, Asha; Gao, Yu-Tang; Yang, Gong; Chow, Wong-Ho; Li, Hong-Lan; Zheng, Wei; Shu, Xiao-Ou			Age at Menarche and Natural Menopause and Number of Reproductive Years in Association with Mortality: Results from a Median Follow-Up of 11.2 Years among 31,955 Naturally Menopausal Chinese Women	PLOS ONE			English	Article							ALL-CAUSE MORTALITY; CARDIOVASCULAR-DISEASE MORTALITY; ISCHEMIC-HEART-DISEASE; LUNG-CANCER; POSTMENOPAUSAL WOMEN; ADVENTIST HEALTH; NORWEGIAN WOMEN; KANGWHA COHORT; RISK; STROKE	Background: Studies conducted in Western countries suggest that early age at menarche and early age at menopause are both associated with increased total mortality, but limited data are available for Asian populations. We examined associations of age at menarche and natural menopause and duration of the reproductive span with mortality in a population-based cohort study of Chinese women. Methods: We evaluated the effects of age at menarche, age at natural menopause, and number of reproductive years on total and cause-specific mortality among 31,955 naturally menopausal Chinese women who participated in the Shanghai Women's Health Study, a population-based, prospective cohort study. Results: A total of 3,158 deaths occurred during a median follow-up of 11.2 years. Results from Cox proportional hazards models showed that younger age at menopause (<46.64 years) was associated with higher risk of total mortality (P-trend = 0.02). Younger age at menarche (<14 years) was associated with higher risk of mortality from stroke (P-trend = 0.03) and diabetes (P-trend = 0.02) but lower risk of mortality from respiratory system cancer (P-trend = 0.01). Women with a shorter reproductive span had lower risk of mortality from gynecological cancers (P-trend = 0.03). Conclusions: Our study found that menstrual characteristics are important predictors of mortality, suggesting an important role of sex hormones in biological aging.	[Wu, Xiaoyan; Cai, Hui; Kallianpur, Asha; Yang, Gong; Zheng, Wei; Shu, Xiao-Ou] Vanderbilt Univ, Sch Med, Vanderbilt Epidemiol Ctr, Div Epidemiol,Dept Med, Nashville, TN 37212 USA; [Wu, Xiaoyan; Cai, Hui; Kallianpur, Asha; Yang, Gong; Zheng, Wei; Shu, Xiao-Ou] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Nashville, TN 37212 USA; [Gao, Yu-Tang; Li, Hong-Lan] Shanghai Canc Inst, Dept Epidemiol, Shanghai, Peoples R China; [Chow, Wong-Ho] NCI, Occupat Epidemiol Branch, NIH, Bethesda, MD 20892 USA	Vanderbilt University; Vanderbilt University; Shanghai Jiao Tong University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Shu, XO (corresponding author), Vanderbilt Univ, Sch Med, Vanderbilt Epidemiol Ctr, Div Epidemiol,Dept Med, Nashville, TN 37212 USA.	Xiao-ou.shu@vanderbilt.edu	Gao, Y./GWZ-3665-2022; Zheng, Wei/O-3351-2013; zhang, weihua/GXV-1334-2022; Gao, Yu/HGE-1937-2022; gao, yi/HCI-8298-2022	Zheng, Wei/0000-0003-1226-070X; 	United States National Cancer Institute at the US National Institutes of Health [R37 CA070867]; NATIONAL CANCER INSTITUTE [R37CA070867] Funding Source: NIH RePORTER	United States National Cancer Institute at the US National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a grant from the United States National Cancer Institute at the US National Institutes of Health [grant number R37 CA070867, PI: W. Zheng]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belsky J, 2010, DEV PSYCHOL, V46, P120, DOI 10.1037/a0015549; Brenner AV, 2003, J EPIDEMIOL, V13, P22, DOI 10.2188/jea.13.22; Chang HS, 2011, MENOPAUSE, V18, P1205, DOI 10.1097/gme.0b013e31821adb43; Cooper GS, 1998, ANN EPIDEMIOL, V8, P229, DOI 10.1016/S1047-2797(97)00207-X; Cui R, 2006, J EPIDEMIOL, V16, P177, DOI 10.2188/jea.16.177; DEGRAAFF J, 1978, EUR J OBSTET GYN R B, V8, P187, DOI 10.1016/0028-2243(78)90014-X; Delbari A, 2011, INT J STROKE, V6, P195, DOI 10.1111/j.1747-4949.2010.00562.x; Gaudineau A, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-175; Giles LC, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-341; Hong JS, 2007, MATURITAS, V56, P411, DOI 10.1016/j.maturitas.2006.11.004; Hsieh YC, 2010, INT J GERONTOL, V4, P16, DOI 10.1016/S1873-9598(10)70017-X; Hu FB, 1999, ARCH INTERN MED, V159, P1061, DOI 10.1001/archinte.159.10.1061; Jacobsen BK, 2009, INT J EPIDEMIOL, V38, P245, DOI 10.1093/ije/dyn251; Jacobsen BK, 2007, AM J EPIDEMIOL, V166, P1431, DOI 10.1093/aje/kwm237; Jacobsen BK, 2004, STROKE, V35, P1548, DOI 10.1161/01.STR.0000131746.49082.5c; Jacobsen BK, 2003, AM J EPIDEMIOL, V157, P923, DOI 10.1093/aje/kwg066; Jacobsen BK, 1999, J CLIN EPIDEMIOL, V52, P303, DOI 10.1016/S0895-4356(98)00170-X; Kreuzer M, 2003, INT J EPIDEMIOL, V32, P263, DOI 10.1093/ije/dyg064; Lakshman R, 2008, DIABETOLOGIA, V51, P781, DOI 10.1007/s00125-008-0948-5; Lakshman R, 2009, J CLIN ENDOCR METAB, V94, P4953, DOI 10.1210/jc.2009-1789; Liu Y, 2005, INT J CANCER, V117, P662, DOI 10.1002/ijc.21229; Macsali F, 2011, AM J RESP CRIT CARE, V183, P8, DOI 10.1164/rccm.200912-1886OC; Matthews CE, 2003, AM J EPIDEMIOL, V158, P1114, DOI 10.1093/aje/kwg255; Mondul AM, 2005, AM J EPIDEMIOL, V162, P1089, DOI 10.1093/aje/kwi324; Mueller NT, 2012, ANN EPIDEMIOL, V22, P717, DOI 10.1016/j.annepidem.2012.08.002; Ossewaarde ME, 2005, EPIDEMIOLOGY, V16, P556, DOI 10.1097/01.ede.0000165392.35273.d4; Schouw YTvd, 1996, LANCET, V347, P714; Seow A, 2009, CANCER EPIDEM BIOMAR, V18, P821, DOI 10.1158/1055-9965.EPI-08-0892; SLEE VN, 1978, ANN INTERN MED, V88, P424, DOI 10.7326/0003-4819-88-3-424; SNOWDON DA, 1989, AM J PUBLIC HEALTH, V79, P709, DOI 10.2105/AJPH.79.6.709; Tamakoshi K, 2011, EUR J EPIDEMIOL, V26, P771, DOI 10.1007/s10654-011-9623-0; Thomas F, 2001, HUM BIOL, V73, P271, DOI 10.1353/hub.2001.0029; Yang L, 2009, STROKE, V40, P1050, DOI 10.1161/STROKEAHA.108.531913; Yi SW, 2009, STROKE, V40, P3428, DOI 10.1161/STROKEAHA.109.555144; Zheng W, 2005, AM J EPIDEMIOL, V162, P1123, DOI 10.1093/aje/kwi322	35	53	55	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103673	10.1371/journal.pone.0103673	http://dx.doi.org/10.1371/journal.pone.0103673			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25090234	Green Published, Green Submitted, gold			2022-12-27	WOS:000339812700040
J	Gibson, RM; Weber, J; Winner, D; Miller, MD; Quinones-Mateu, ME				Gibson, Richard M.; Weber, Jan; Winner, Dane; Miller, Michael D.; Quinones-Mateu, Miguel E.			Contribution of Human Immunodeficiency Virus Type 1 Minority Variants to Reduced Drug Susceptibility in Patients on an Integrase Strand Transfer Inhibitor-Based Therapy	PLOS ONE			English	Article							TREATMENT-NAIVE PATIENTS; HIV-1 GENOTYPING ASSAY; REVERSE-TRANSCRIPTASE; RESISTANCE MUTATIONS; CORECEPTOR USAGE; SUBTYPE-C; FITNESS; PROTEASE; ERA; QUANTIFICATION	The role of HIV-1 minority variants on transmission, pathogenesis, and virologic failure to antiretroviral regimens has been explored; however, most studies of low-level HIV-1 drug-resistant variants have focused in single target regions. Here we used a novel HIV-1 genotypic assay based on deep sequencing, DEEPGEN (Gibson et al 2014 Antimicrob Agents Chemother 58: 2167) to simultaneously analyze the presence of minority variants carrying mutations associated with reduced susceptibility to protease (PR), reverse transcriptase (RT), and integrase strand transfer integrase inhibitors (INSTIs), as well as HIV-1 coreceptor tropism. gag-p2/NCp7/p1/p6/pol-PR/RT/INT and env/C2V3 PCR products were obtained from twelve heavily treatment-experienced patients experiencing virologic failure while participating in a 48-week dose-ranging study of elvitegravir (GS-US-183-0105). Deep sequencing results were compared with (i) virological response to treatment, (ii) genotyping based on population sequencing, (iii) phenotyping data using PhenoSense and VIRALARTS, and (iv) HIV-1 coreceptor tropism based on the phenotypic test VERITROP. Most patients failed the antiretroviral regimen with numerous pre-existing mutations in the PR and RT, and additionally newly acquired INSTI-resistance mutations as determined by population sequencing (mean 9.4, 5.3, and 1.4 PI- RTI-, and INSTI-resistance mutations, respectively). Interestingly, since DEEPGEN allows the accurate detection of amino acid substitutions at frequencies as low as 1% of the population, a series of additional drug resistance mutations were detected by deep sequencing (mean 2.5, 1.5, and 0.9, respectively). The presence of these low-abundance HIV-1 variants was associated with drug susceptibility, replicative fitness, and coreceptor tropism determined using sensitive phenotypic assays, enhancing the overall burden of resistance to all four antiretroviral drug classes. Further longitudinal studies based on deep sequencing tests will help to clarify (i) the potential impact of minority HIV-1 drug resistant variants in response to antiretroviral therapy and (ii) the importance of the detection of HIV minority variants in the clinical practice.	[Gibson, Richard M.; Winner, Dane; Quinones-Mateu, Miguel E.] Univ Hosp Case Med Ctr, Univ Hosp Translat Lab, Cleveland, OH 44106 USA; [Weber, Jan] Acad Sci Czech Republ, Inst Organ Chem & Biochem, Prague, Czech Republic; [Miller, Michael D.] Gilead Sci Inc, Foster City, CA 94404 USA; [Quinones-Mateu, Miguel E.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University Hospital; Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences; Gilead Sciences; Case Western Reserve University	Quinones-Mateu, ME (corresponding author), Univ Hosp Case Med Ctr, Univ Hosp Translat Lab, Cleveland, OH 44106 USA.	meq@case.edu	Weber, Jan/B-5405-2013; Quinones-Mateu, Miguel/H-3846-2019	Weber, Jan/0000-0002-2799-7352; Quinones-Mateu, Miguel/0000-0001-9170-5601	Ministry of Education, Youth and Sports of the Czech Republic [LK11207];  [NIH-AI-71747]	Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); 	J.W. was supported by a research grant from the Ministry of Education, Youth and Sports of the Czech Republic (LK11207). M.E.Q.-M. was supported by research grant NIH-AI-71747. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archin NM, 2014, CURR OPIN INFECT DIS, V27, P29, DOI 10.1097/QCO.0000000000000026; Avidor B, 2013, J CLIN MICROBIOL, V51, P880, DOI 10.1128/JCM.02652-12; Bellecave P, 2013, AIDS RES HUM RETROV; Blanco JL, 2011, J INFECT DIS, V203, P1204, DOI 10.1093/infdis/jir025; Bunnik EM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002106; Castagna A, 2014, J INFECT DIS, V210, P354, DOI 10.1093/infdis/jiu051; Chang MW, 2013, J VIROL METHODS, V189, P232, DOI 10.1016/j.jviromet.2013.01.019; Church JD, 2006, J MOL DIAGN, V8, P430, DOI 10.2353/jmoldx.2006.050148; Codoner FM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019461; D'Aquila RT, 2011, AIDS RES HUM RETROV, V27, P201, DOI 10.1089/aid.2010.0077; De Wolf H, 2011, J VIROL METHODS, V175, P129, DOI 10.1016/j.jviromet.2011.04.023; Deeks SG, 2003, LANCET, V362, P2002, DOI 10.1016/S0140-6736(03)15022-2; Domingo E, 1997, Prog Drug Res, V48, P99; Domingo E, 1996, FASEB J, V10, P859, DOI 10.1096/fasebj.10.8.8666162; Dudley DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036494; Dudley DM, 2009, BIOTECHNIQUES, V46, P458, DOI 10.2144/000113119; Dunne AL, 2001, AIDS, V15, P1471, DOI 10.1097/00002030-200108170-00003; EIGEN M, 1993, SCI AM, V269, P42, DOI 10.1038/scientificamerican0793-42; Fast PE, 2013, LANCET, V382, P1778, DOI 10.1016/S0140-6736(13)62539-8; Fisher R, 2012, J VIROL, V86, P6231, DOI 10.1128/JVI.06541-11; Gianella S, 2010, J INFECT DIS, V202, P657, DOI 10.1086/655397; Gibson RM, 2014, ANTIMICROB AGENTS CH, V58, P2167, DOI 10.1128/AAC.02710-13; Gonzalez S, 2013, CURR HIV RES, V11, P43; Goodman DD, 2011, AIDS, V25, P325, DOI 10.1097/QAD.0b013e3283427dcb; Grant RM, 2003, J CLIN MICROBIOL, V41, P1586, DOI 10.1128/JCM.41.4.1586-1593.2003; Halvas EK, 2006, J CLIN MICROBIOL, V44, P2612, DOI 10.1128/JCM.00449-06; HARRIGAN PR, 2009, OPTIMIZATION CLIN CU; Holland AU, 2004, VIROLOGY, V319, P343, DOI 10.1016/j.virol.2003.11.012; Ibanez A, 2000, J GEN VIROL, V81, P85, DOI 10.1099/0022-1317-81-1-85; Ji HZ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009263; Johnson Victoria A, 2013, Top Antivir Med, V21, P6; Kitrinos KM, 2005, J VIROL, V79, P10627, DOI 10.1128/JVI.79.16.10627-10637.2005; Kobayashi M, 2011, ANTIMICROB AGENTS CH, V55, P813, DOI 10.1128/AAC.01209-10; Lalonde MS, 2007, J CLIN MICROBIOL, V45, P2604, DOI 10.1128/JCM.00431-07; LARDER BA, 1993, NATURE, V365, P671, DOI 10.1038/365671a0; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lataillade M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030118; Le T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006079; Lee GQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046181; LEITNER T, 1993, BIOTECHNIQUES, V15, P120; Lewin SR, 2011, AIDS, V25, P885, DOI 10.1097/QAD.0b013e3283467041; Li JZ, 2013, CLIN INFECT DIS, V56, P1667, DOI 10.1093/cid/cit125; Li JZ, 2013, J INFECT DIS, V207, P893, DOI 10.1093/infdis/jis925; Li JZ, 2012, AIDS, V26, P185, DOI 10.1097/QAD.0b013e32834e9d7d; Li JZ, 2011, JAMA-J AM MED ASSOC, V305, P1327, DOI 10.1001/jama.2011.375; Lobritz MA, 2007, J VIROL, V81, P8258, DOI 10.1128/JVI.02739-06; MANSKY LM, 1995, J VIROL, V69, P5087, DOI 10.1128/JVI.69.8.5087-5094.1995; McColl DJ, 2007, ANTIVIR THER, V12, pS11; McColl DJ, 2010, ANTIVIR RES, V85, P101, DOI 10.1016/j.antiviral.2009.11.004; Menendez-Arias L, 2013, ANTIVIR RES, V98, P93, DOI 10.1016/j.antiviral.2013.01.007; Messiaen P, 2012, VIROLOGY, V426, P7, DOI 10.1016/j.virol.2012.01.002; Mitsuya Y, 2008, J VIROL, V82, P10747, DOI 10.1128/JVI.01827-07; Palmer S, 2006, AIDS, V20, P701, DOI 10.1097/01.aids.0000216370.69066.7f; Paredes R, 2010, ANTIVIR RES, V85, P245, DOI 10.1016/j.antiviral.2009.09.015; Paredes R, 2010, J INFECT DIS, V201, P662, DOI 10.1086/650543; Preston BD, 1996, TRENDS MICROBIOL, V4, P16, DOI 10.1016/0966-842X(96)81500-9; Quinones-Mateu ME, 2000, J VIROL, V74, P9222, DOI 10.1128/JVI.74.19.9222-9233.2000; Quinones-Mateu ME, 2006, CURR TOP MICROBIOL, V299, P83; Quinones-Mateu ME, 2002, DRUG RESIST UPDATE, V5, P224, DOI 10.1016/S1368-7646(02)00123-1; Quinones-Mateu ME, 1999, AIDS RES HUM RETROV, V15, P73, DOI 10.1089/088922299311745; Quinones-Mateu ME, 2001, HIV SEQUENCE COMPEND, P134; Raffi F, 2013, LANCET, V381, P735, DOI 10.1016/S0140-6736(12)61853-4; Recordon-Pinson P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036549; REED L. J., 1938, AMER JOUR HYG, V27, P493; Richardson ET, 2013, ANTIVIRAL RES; Sato M, 2006, J MED CHEM, V49, P1506, DOI 10.1021/jm0600139; Simen BB, 2009, J INFECT DIS, V199, P693, DOI 10.1086/596736; Sing T, 2007, ANTIVIR THER, V12, P1097; Stekler JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028952; Summa V, 2008, J MED CHEM, V51, P5843, DOI 10.1021/jm800245z; Swenson LC, 2011, CLIN INFECT DIS, V53, P732, DOI 10.1093/cid/cir493; Swenson LC, 2011, J INFECT DIS, V203, P237, DOI 10.1093/infdis/jiq030; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang JW, 2004, J CLIN VIROL, V30, P1, DOI 10.1016/j.jcv.2003.12.002; Vandenhende MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086771; Wang CL, 2007, GENOME RES, V17, P1195, DOI 10.1101/gr.6468307; Weber J, 2007, ANTIVIR THER, V12, pS155; Weber J, 2003, J GEN VIROL, V84, P2217, DOI 10.1099/vir.0.19123-0; Weber J, 2006, J VIROL METHODS, V136, P102, DOI 10.1016/j.jviromet.2006.04.004; Weber J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065631; Weber J, 2013, J CLIN MICROBIOL, V51, P1517, DOI 10.1128/JCM.00092-13; Weber J, 2011, ANTIMICROB AGENTS CH, V55, P3729, DOI 10.1128/AAC.00396-11; WEI XP, 1995, NATURE, V373, P117, DOI 10.1038/373117a0; Zolopa A, 2012, J INT AIDS SOC, V15, P23, DOI 10.7448/IAS.15.6.18219; Zolopa AR, 2010, ANTIVIR RES, V85, P241, DOI 10.1016/j.antiviral.2009.10.018; Zolopa AR, 2010, J INFECT DIS, V201, P814, DOI 10.1086/650698	86	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2014	9	8							e104512	10.1371/journal.pone.0104512	http://dx.doi.org/10.1371/journal.pone.0104512			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WB	25110880	gold, Green Published, Green Submitted			2022-12-27	WOS:000341105100064
J	Li, GS; Wang, YM; Liu, B; Zhang, GA				Li, Guangsheng; Wang, Yongmo; Liu, Biao; Zhang, Guoan			Transgenic Bacillus thuringiensis (Bt) Rice Is Safer to Aquatic Ecosystems than Its Non-Transgenic Counterpart	PLOS ONE			English	Article							DAPHNIA-MAGNA; CORN LITTER; WASTE-WATER; TOXIN; MAIZE; FIELD; ZOOPLANKTON; COMMUNITIES; CRY1AB/1AC; INDICATOR	Rice lines genetically modified with the crystal toxin genes from Bacillus thuringiensis (Bt) have experienced rapid development, with biosafety certificates for two Bt rice lines issued in 2009. There has still been no commercial release of these lines yet due to public concerns about human health and environmental risks. Some studies confirmed that Bt rice was as safe as conventional rice to non-target organisms when pesticides were not applied, however, pesticides are still required in Bt rice to control non-lepidopteran pests. In this study, we assessed the environmental effects of two Bt rice lines expressing either the cry1Ab/1Ac or cry2A genes, respectively, by using zooplanktons as indicator species under normal field management practices using pesticides when required. In the whole rice growing season, non-Bt rice was sprayed 5 times while Bt rice was sprayed 2 times, which ensured both rice achieved a normal yield. Field investigations showed that rice type (Bt and non-Bt) significantly influenced zooplankton abundance and diversity, which were up to 95% and 80% lower in non-Bt rice fields than Bt rice fields. Laboratory rearing showed that water from non-Bt rice fields was significantly less suitable for the survival and reproduction of Daphnia magna and Paramecium caudatum in comparison with water from Bt rice fields. Higher pesticide residues were detected in the water from non-Bt than Bt rice fields, accounting for the bad performance of zooplankton in non-Bt field water. Our results demonstrate that Bt rice is safer to aquatic ecosystems than non-Bt rice, and its commercialization will be beneficial for biodiversity restoration in rice-based ecosystems.	[Li, Guangsheng; Wang, Yongmo; Zhang, Guoan] Huazhong Agr Univ, Coll Plant Sci & Technol, Hubei Insect Resources Utilizat & Sustainable Pes, Wuhan, Hubei, Peoples R China; [Liu, Biao] Minist Environm Protect Peoples Republ China, Nanjing Inst Environm Sci, Nanjing, Jiangsu, Peoples R China	Huazhong Agricultural University	Wang, YM (corresponding author), Huazhong Agr Univ, Coll Plant Sci & Technol, Hubei Insect Resources Utilizat & Sustainable Pes, Wuhan, Hubei, Peoples R China.	ymwang@mail.hzau.edu.cn			Major Projects of National Genetically Modified Organisms Breeding [2014ZX08012005]; National Natural Science Funds [31370544]	Major Projects of National Genetically Modified Organisms Breeding; National Natural Science Funds(National Natural Science Foundation of China (NSFC))	This study was supported by the Major Projects of National Genetically Modified Organisms Breeding (NO. 2014ZX08012005) and the National Natural Science Funds (31370544). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALI AB, 1990, HYDROBIOLOGIA, V206, P139, DOI 10.1007/BF00018640; Bai YY, 2006, ENVIRON ENTOMOL, V35, P1130, DOI 10.1603/0046-225X-35.4.1130; Bai YY, 2005, J PEST SCI, V78, P123, DOI 10.1007/s10340-004-0078-x; Beachy RN, 2008, P NATL ACAD SCI USA, V105, pE9, DOI DOI 10.1073/PNAS.0711431105; Benbrook Charles M., 2012, Environmental Sciences Europe, V24, P24, DOI 10.1186/2190-4715-24-24; BIESINGER KE, 1972, J FISH RES BOARD CAN, V29, P1691, DOI 10.1139/f72-269; Bohn T, 2008, ARCH ENVIRON CON TOX, V55, P584, DOI 10.1007/s00244-008-9150-5; Carstens K, 2012, TRANSGENIC RES, V21, P813, DOI 10.1007/s11248-011-9569-8; Chen H, 2005, THEOR APPL GENET, V111, P1330, DOI 10.1007/s00122-005-0062-8; Chen M, 2009, ECOTOXICOLOGY, V18, P230, DOI 10.1007/s10646-008-0276-z; Chen Mao, 2006, Insect Science, V13, P409, DOI 10.1111/j.1744-7917.2006.00110.x; Chen M, 2011, ANNU REV ENTOMOL, V56, P81, DOI 10.1146/annurev-ento-120709-144810; Clark BW, 2006, ENVIRON TOXICOL CHEM, V25, P2653, DOI 10.1897/05-471R.1; Emmanuel B. E., 2007, Turkish Journal of Fisheries and Aquatic Sciences, V7, P105; Griffiths BS, 2006, J ENVIRON QUAL, V35, P734, DOI 10.2134/jeq2005.0344; Halwart Matthias, 2008, BIODIVERSITY-OTTAWA, V9, P36; Hanazato T, 2001, ENVIRON POLLUT, V112, P1, DOI 10.1016/S0269-7491(00)00110-X; Heckmann LH, 2006, ENVIRON POLLUT, V142, P212, DOI 10.1016/j.envpol.2005.10.008; Huang JK, 2005, SCIENCE, V308, P688, DOI 10.1126/science.1108972; Ishikawa T, 2006, J EXP BIOL, V209, P4452, DOI 10.1242/jeb.02537; James C., 2009, GLOBAL STATUS COMMER; Jiang Y, 2003, ACTA ENTOMOL SINICA, V47, P124; Khush GS, 1997, PLANT MOL BIOL, V35, P25, DOI 10.1023/A:1005810616885; LI KM, 1988, AQUACULTURE, V71, P173; Liess M, 2005, ENVIRON TOXICOL CHEM, V24, P954, DOI 10.1897/03-652.1; Liu Z, 2001, ACTA PHYTOPHYLACICA, V29, P138; Lovern SB, 2007, ENVIRON SCI TECHNOL, V41, P4465, DOI 10.1021/es062146p; Lu Changming, 2010, GM Crops, V1, P113, DOI 10.4161/gmcr.1.3.12377; Miyoshi N, 2003, J HEALTH SCI, V49, P429, DOI 10.1248/jhs.49.429; Niu S, 2013, CHINA POST      0308; O'Sullivan P, 2008, LAKES HDB LIMNOLOGY; PATHAK MD, 1994, INSECT PESTS RICE IN; Redona ED, 2004, NABC REP, V16, P201; Rosi-Marshall EJ, 2007, P NATL ACAD SCI USA, V104, P16204, DOI 10.1073/pnas.0707177104; Saxena D, 2001, SOIL BIOL BIOCHEM, V33, P1225, DOI 10.1016/S0038-0717(01)00027-X; Shiny KJ, 2005, BIORESOURCE TECHNOL, V96, P55, DOI 10.1016/j.biortech.2004.01.008; Simpson I. C., 1995, Impact of pesticides on farmer health and the rice environment., P249; Stein J., 1973, HDB PHYCOLOGICAL MET; Tian JC, 2008, J ENV ENTOMOL, V003; Tu JM, 2000, NAT BIOTECHNOL, V18, P1101, DOI 10.1038/80310; Vandysh OI, 2004, RUSS J ECOL+, V35, P110, DOI 10.1023/B:RUSE.0000018936.56649.20; Vanni MJ, 2002, ANNU REV ECOL SYST, V33, P341, DOI 10.1146/annurev.ecolsys.33.010802.150519; Villegas-Navarro A, 1999, ENVIRON INT, V25, P619, DOI 10.1016/S0160-4120(99)00034-3; Wang YM, 2013, SOIL BIOL BIOCHEM, V58, P107, DOI 10.1016/j.soilbio.2012.11.007; Wang YM, 2013, ECOTOX ENVIRON SAFE, V92, P87, DOI 10.1016/j.ecoenv.2013.02.018; Wang YM, 2010, CROP PROT, V29, P128, DOI 10.1016/j.cropro.2009.10.004; Zwahlen C, 2003, MOL ECOL, V12, P1077, DOI 10.1046/j.1365-294X.2003.01799.x	47	16	20	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2014	9	8							e104270	10.1371/journal.pone.0104270	http://dx.doi.org/10.1371/journal.pone.0104270			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR0CG	25105299	Green Submitted, gold, Green Published			2022-12-27	WOS:000343231900047
J	Yan, JJ; Thomson, JK; Wu, XM; Zhao, WW; Pollard, AE; Ai, X				Yan, Jiajie; Thomson, Justin K.; Wu, Xiaomin; Zhao, Weiwei; Pollard, Andrew E.; Ai, Xun			Novel Methods of Automated Quantification of Gap Junction Distribution and Interstitial Collagen Quantity from Animal and Human Atrial Tissue Sections	PLOS ONE			English	Article							HEART-FAILURE; N-CADHERIN; CONDUCTION PROPERTIES; CONNEXIN EXPRESSION; MOLECULAR-BASIS; FIBRILLATION; PROTEINS; DEPHOSPHORYLATION; OVEREXPRESSION; VULNERABILITY	Background: Gap junctions (GJs) are the principal membrane structures that conduct electrical impulses between cardiac myocytes while interstitial collagen (IC) can physically separate adjacent myocytes and limit cell-cell communication. Emerging evidence suggests that both GJ and interstitial structural remodeling are linked to cardiac arrhythmia development. However, automated quantitative identification of GJ distribution and IC deposition from microscopic histological images has proven to be challenging. Such quantification is required to improve the understanding of functional consequences of GJ and structural remodeling in cardiac electrophysiology studies. Methods and Results: Separate approaches were employed for GJ and IC identification in images from histologically stained tissue sections obtained from rabbit and human atria. For GJ identification, we recognized N-Cadherin (N-Cad) as part of the gap junction connexin 43 (Cx43) molecular complex. Because N-Cad anchors Cx43 on intercalated discs (ID) to form functional GJ channels on cell membranes, we computationally dilated N-Cad pixels to create N-Cad units that covered all ID-associated Cx43 pixels on Cx43/N-Cad double immunostained confocal images. This approach allowed segmentation between ID-associated and non-ID-associated Cx43. Additionally, use of N-Cad as a unique internal reference with Z-stack layer-by-layer confocal images potentially limits sample processing related artifacts in Cx43 quantification. For IC quantification, color map thresholding of Masson's Trichrome blue stained sections allowed straightforward and automated segmentation of collagen from non-collagen pixels. Our results strongly demonstrate that the two novel image-processing approaches can minimize potential overestimation or underestimation of gap junction and structural remodeling in healthy and pathological hearts. The results of using the two novel methods will significantly improve our understanding of the molecular and structural remodeling associated functional changes in cardiac arrhythmia development in aged and diseased hearts.	[Yan, Jiajie; Thomson, Justin K.; Wu, Xiaomin; Zhao, Weiwei; Ai, Xun] Loyola Univ Chicago, Dept Cell & Mol Physiol, Maywood, IL 90270 USA; [Pollard, Andrew E.] Univ Alabama Birmingham, Dept Biomed Engn, Birmingham, AL 35294 USA	Loyola University Chicago; University of Alabama System; University of Alabama Birmingham	Ai, X (corresponding author), Loyola Univ Chicago, Dept Cell & Mol Physiol, Maywood, IL 90270 USA.	xai1@luc.edu	Wu, Xiaomin/Q-1526-2015; Yan, Jiajie/AAA-1974-2021	Yan, Jiajie/0000-0003-2434-7175	American Heart Association [10GRNT3770030, 12GRNT12050478]; National Institutes of Health [HL113640, HL092049]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092049, R01HL113640] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by American Heart Association (10GRNT3770030 & 12GRNT12050478 to XA) and National Institutes of Health (HL113640 to XA; HL092049 to AEP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai X, 2005, CIRC RES, V96, P54, DOI 10.1161/01.RES.0000152325.07495.5a; Ai X, 2011, CARDIOVASC RES, V92, P106, DOI 10.1093/cvr/cvr163; Ai X, 2010, CARDIOVASC RES, V85, P751, DOI 10.1093/cvr/cvp353; Anyukhovsky EP, 2002, CARDIOVASC RES, V54, P462, DOI 10.1016/S0008-6363(02)00271-7; Bruzzone R, 1996, EUR J BIOCHEM, V238, P1, DOI 10.1111/j.1432-1033.1996.0001q.x; Chung SS, 2005, ENVIRON MANAGE, V35, P468, DOI 10.1007/s00267-003-0085-3; Elvan A, 1997, CIRCULATION, V96, P1675, DOI 10.1161/01.CIR.96.5.1675; FUJIMURA O, 1990, J AM COLL CARDIOL, V15, P1082, DOI 10.1016/0735-1097(90)90244-J; Giepmans BNG, 2004, CARDIOVASC RES, V62, P233, DOI 10.1016/j.cardiores.2003.12.009; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; Hayashi H, 2002, J CARDIOVASC ELECTR, V13, P801, DOI 10.1046/j.1540-8167.2002.00801.x; Hertig C, 1996, J GEN VIROL, V77, P631, DOI 10.1099/0022-1317-77-4-631; Hertig CM, 1996, J CELL SCI, V109, P1; Igarashi T, 2012, CIRCULATION, V125, P216, DOI 10.1161/CIRCULATIONAHA.111.053272; Kanagaratnam P, 2002, J AM COLL CARDIOL, V39, P116, DOI 10.1016/S0735-1097(01)01710-7; Koura T, 2002, CIRCULATION, V105, P2092, DOI 10.1161/01.CIR.0000015506.36371.0D; Li DS, 1999, CIRCULATION, V100, P87, DOI 10.1161/01.CIR.100.1.87; Li JF, 2008, J MOL CELL CARDIOL, V44, P597, DOI 10.1016/j.yjmcc.2007.11.013; Liu IH, 2005, OPHTHALMOLOGICA, V219, P171, DOI 10.1159/000085250; Moolenaar WH, 2004, BIOESSAYS, V26, P870, DOI 10.1002/bies.20081; Otsu N, 1979, IEEE T SYST MAN CYB, V9, P4; Papageorgiou P, 1996, CIRCULATION, V94, P384, DOI 10.1161/01.CIR.94.3.384; Platonov PG, 2011, J AM COLL CARDIOL, V58, P2225, DOI 10.1016/j.jacc.2011.05.061; Polontchouk L, 2001, J AM COLL CARDIOL, V38, P883, DOI 10.1016/S0735-1097(01)01443-7; Remo BF, 2011, CIRC RES, V108, P1459, DOI 10.1161/CIRCRESAHA.111.244046; Ripplinger CM, 2007, CIRC RES, V101, P1049, DOI 10.1161/CIRCRESAHA.107.161240; SAFFITZ JE, 1995, J CARDIOVASC ELECTR, V6, P498, DOI 10.1111/j.1540-8167.1995.tb00423.x; Severs NJ, 2008, CARDIOVASC RES, V80, P9, DOI 10.1093/cvr/cvn133; Severs NJ, 2004, BBA-BIOMEMBRANES, V1662, P138, DOI 10.1016/j.bbamem.2003.10.019; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shaw RM, 2007, CELL, V128, P547, DOI 10.1016/j.cell.2006.12.037; Tieleman RG, 2000, CARDIOVASC RES, V46, P364, DOI 10.1016/S0008-6363(00)00067-5; van der Velden HMW, 2000, CARDIOVASC RES, V46, P476, DOI 10.1016/S0008-6363(00)00026-2; van der Velden HMW, 1998, J CARDIOVASC ELECTR, V9, P596; Verheule S, 1997, CIRC RES, V80, P673, DOI 10.1161/01.RES.80.5.673; Verheule S, 2004, CIRC RES, V94, P1458, DOI 10.1161/01.RES.0000129579.59664.9d; Wei CJ, 2005, J BIOL CHEM, V280, P19925, DOI 10.1074/jbc.M412921200	37	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2014	9	8							e104357	10.1371/journal.pone.0104357	http://dx.doi.org/10.1371/journal.pone.0104357			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR0CG	25105669	Green Published, gold, Green Submitted			2022-12-27	WOS:000343231900050
J	Alwahsh, SM; Xu, M; Schultze, FC; Wilting, J; Mihm, S; Raddatz, D; Ramadori, G				Alwahsh, Salamah Mohammad; Xu, Min; Schultze, Frank Christian; Wilting, Joerg; Mihm, Sabine; Raddatz, Dirk; Ramadori, Giuliano			Combination of Alcohol and Fructose Exacerbates Metabolic Imbalance in Terms of Hepatic Damage, Dyslipidemia, and Insulin Resistance in Rats	PLOS ONE			English	Article							FATTY LIVER-DISEASE; SERUM ALANINE AMINOTRANSFERASE; FAST-FOOD CONSUMPTION; ETHANOL ELIMINATION; WEIGHT-GAIN; CORN SYRUP; MICE; DIET; RISK; CARBOHYDRATE	Although both alcohol and fructose are particularly steatogenic, their long-term effect in the development of a metabolic syndrome has not been studied in vivo. Consumption of fructose generally leads to obesity, whereas ethanol can induce liver damage in the absence of overweight. Here, Sprague-Dawley rats were fed ad libitum for 28 days on five diets: chow (control), liquid Lieber-DeCarli (LDC) diet, LDC +30%J of ethanol (L-Et) or fructose (L-Fr), and LDC combined with 30%J ethanol and 30%J fructose (L-EF). Body weight (BW) and liver weight (LW) were measured. Blood and liver samples were harvested and subjected to biochemical tests, histopathological examinations, and RT-PCR. Alcohol-containing diets substantially reduced the food intake and BW (<= 3rd week), whereas fructose-fed animals had higher LW than controls ( P < 0.05). Additionally, leukocytes, plasma AST and leptin levels were the highest in the fructose-administered rats. Compared to the chow and LDC diets, the L-EF diet significantly elevated blood glucose, insulin, and total-cholesterol levels (also vs. the L-Et group). The albumin and Quick-test levels were the lowest, whereas ALT activity was the highest in the L-EF group. Moreover, the L-EF diet aggravated plasma triglyceride and reduced HDL-cholesterol levels more than 2.7-fold compared to the sum of the effects of the L-Et and L-Fr diets. The decreased hepatic insulin clearance in the L-EF group vs. control and LDC groups was reflected by a significantly decreased C-peptide: insulin ratio. All diets except the control caused hepatosteatosis, as evidenced by Nile red and H&E staining. Hepatic transcription of insulin receptor substrate-1/2 was mainly suppressed by the L-Fr and L-EF diets. The L-EF diet did not enhance the mitochondrial beta-oxidation of fatty acids (Cpt1 alpha and Ppar-alpha expressions) compared to the L-Et or L-Fr diet. Together, our data provide evidence for the coaction of ethanol and fructose with a high-fat-diet on dyslipidemia and insulin resistance-accompanied liver damage.	[Alwahsh, Salamah Mohammad; Schultze, Frank Christian; Mihm, Sabine; Raddatz, Dirk; Ramadori, Giuliano] Univ Med Ctr Goettingen, Dept Gastroenterol & Endocrinol, Gottingen, Germany; [Xu, Min] Univ Med Ctr Goettingen, Dept Gen Visceral & Pediat Surg, Gottingen, Germany; [Wilting, Joerg] Univ Med Ctr Goettingen, Inst Anat & Cell Biol, Gottingen, Germany	University of Gottingen; University of Gottingen; University of Gottingen	Alwahsh, SM (corresponding author), Univ Med Ctr Goettingen, Dept Gastroenterol & Endocrinol, Gottingen, Germany.	alwahsh.salamah@gmail.com			UMG	UMG	This study was financed by UMG budget resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adias TC, 2013, INT J GEN MED, V6, P489, DOI 10.2147/IJGM.S43472; Ahmad S, 2014, SHOCK, V41, P337, DOI 10.1097/SHK.0000000000000107; Akash MSH, 2013, CURR DIABETES REV, V9, P387, DOI 10.2174/15733998113099990069; Alwahsh SM, 2014, WORLD J GASTROENTERO, V20, P1807, DOI 10.3748/wjg.v20.i7.1807; Berman PAM, 2003, S AFR J SCI, V99, P47; Bray GA, 2004, AM J CLIN NUTR, V79, P537; Bugianesi E, 2010, CURR PHARM DESIGN, V16, P1941, DOI 10.2174/138161210791208875; Bykov I, 2007, CLIN IMMUNOL, V124, P213, DOI 10.1016/j.clim.2007.05.008; Cha JC, 2011, MOL MED REP, V4, P1053, DOI 10.3892/mmr.2011.562; Chalasani N, 2012, HEPATOLOGY, V55, P2005, DOI 10.1002/hep.25762; Cheung O, 2010, CURR OPIN GASTROEN, V26, P202, DOI 10.1097/MOG.0b013e328337b0c4; Chitturi S, 2002, HEPATOLOGY, V35, P373, DOI 10.1053/jhep.2002.30692; Collison KS, 2010, OBESITY, V18, P1122, DOI 10.1038/oby.2009.502; Dam-Larsen S, 2004, GUT, V53, P750, DOI 10.1136/gut.2003.019984; DIEHL AM, 1988, GASTROENTEROLOGY, V95, P1056, DOI 10.1016/0016-5085(88)90183-7; Dowman JK, 2014, AM J PATHOL, V184, P1550, DOI 10.1016/j.ajpath.2014.01.034; Drewnowski A, 2005, J NUTR, V135, P900, DOI 10.1093/jn/135.4.900; Faeh D, 2005, DIABETES, V54, P1907, DOI 10.2337/diabetes.54.7.1907; Fiebig R, 1998, J NUTR, V128, P810, DOI 10.1093/jn/128.5.810; GREENSPAN P, 1985, J CELL BIOL, V100, P965, DOI 10.1083/jcb.100.3.965; Hamaguchi M, 2012, WORLD J GASTROENTERO, V18, P156, DOI 10.3748/wjg.v18.i2.156; Hirsova P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070599; Hu FB, 2000, AM J CLIN NUTR, V72, P912; Ishimoto T, 2013, HEPATOLOGY, V58, P1632, DOI 10.1002/hep.26594; Kechagias S, 2008, GUT, V57, P649, DOI 10.1136/gut.2007.131797; Kerr WC, 2005, ALCOHOL CLIN EXP RES, V29, P2015, DOI 10.1097/01.alc.0000187596.92804.bd; Lisander B, 2006, ALCOHOL ALCOHOLISM, V41, P39, DOI 10.1093/alcalc/agh188; Lustig RH, 2010, J AM DIET ASSOC, V110, P1307, DOI 10.1016/j.jada.2010.06.008; Malik IA, 2012, HISTOCHEM CELL BIOL, V137, P279, DOI 10.1007/s00418-011-0899-7; Malik VS, 2006, AM J CLIN NUTR, V84, P274; McCullough Arthur J, 2004, Clin Liver Dis, V8, P521, DOI 10.1016/j.cld.2004.04.004; Michael MD, 2000, MOL CELL, V6, P87, DOI 10.1016/S1097-2765(00)00010-1; POLONSKY KS, 1984, DIABETES, V33, P486, DOI 10.2337/diabetes.33.5.486; Pravdova E, 2009, Endocr Regul, V43, P117; Raddatz D, 2007, Z GASTROENTEROL, V45, P51, DOI 10.1055/s-2006-927394; Rejitha S, 2012, BRIT J NUTR, V108, P1256, DOI 10.1017/S0007114511006568; Ritze Y, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0101702, 10.1371/journal.pone.0080169]; Rosenheck R, 2008, OBES REV, V9, P535, DOI 10.1111/j.1467-789X.2008.00477.x; Rouault TA, 2003, ALCOHOL, V30, P103, DOI 10.1016/S0741-8329(03)00102-2; Ryan MC, 2007, DIABETES CARE, V30, P1075, DOI 10.2337/dc06-2169; Santamarina-Fojo S, 2004, ARTERIOSCL THROM VAS, V24, P1750, DOI 10.1161/01.ATV.0000140818.00570.2d; Savard C, 2013, HEPATOLOGY, V57, P81, DOI 10.1002/hep.25789; Schroder H, 2007, BRIT J NUTR, V98, P1274, DOI 10.1017/S0007114507781436; Shimano H, 2007, J MOL MED, V85, P437, DOI 10.1007/s00109-007-0158-5; Shimomura T, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-104; Shulga N, 2014, J CELL SCI, V127, P896, DOI 10.1242/jcs.140764; Strbak V, 1998, METABOLISM, V47, P1269, DOI 10.1016/S0026-0495(98)90335-3; Tetri LH, 2008, AM J PHYSIOL-GASTR L, V295, pG987, DOI 10.1152/ajpgi.90272.2008; Thirunavukkarasu V, 2004, EXP DIABESITY RES, V5, P195, DOI 10.1080/15438600490486778; Van de Wiel A, 2012, INT J VASC MED, V2012, DOI 10.1155/2012/862504; Wei XQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095399; Xiao GZ, 2013, J BIOL CHEM, V288, P25350, DOI 10.1074/jbc.M113.470526; Zelber-Sagi S, 2011, WORLD J GASTROENTERO, V17, P3377, DOI 10.3748/wjg.v17.i29.3377; Zhong W, 2012, AM J PATHOL, V180, P998, DOI 10.1016/j.ajpath.2011.11.017; Zhong Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091308; Zhu Z, 2014, ALCOHOL CLIN EXP RES; Zivkovic AM, 2007, AM J CLIN NUTR, V86, P285, DOI 10.1093/ajcn/86.2.285	57	55	55	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e104220	10.1371/journal.pone.0104220	http://dx.doi.org/10.1371/journal.pone.0104220			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25101998	Green Published, gold			2022-12-27	WOS:000339993900050
J	Camargos, HS; Moreira, RA; Mendanha, SA; Fernandes, KS; Dorta, ML; Alonso, A				Camargos, Heverton Silva; Moreira, Rodrigo Alves; Mendanha, Sebastiao Antonio; Fernandes, Kelly Souza; Dorta, Miriam Leandro; Alonso, Antonio			Terpenes Increase the Lipid Dynamics in the Leishmania Plasma Membrane at Concentrations Similar to Their IC50 Values	PLOS ONE			English	Article							SPIN-LABELED LIPIDS; STRATUM-CORNEUM; CANCER CHEMOPREVENTION; ERYTHROCYTE-MEMBRANE; PROTEIN DYNAMICS; MILTEFOSINE; AMAZONENSIS; COMPONENTS; MONOTERPENES; BREAST	Although many terpenes have shown antitumor, antibacterial, antifungal, and antiparasitic activity, the mechanism of action is not well established. Electron paramagnetic resonance (EPR) spectroscopy of the spin-labeled 5-doxyl stearic acid revealed remarkable fluidity increases in the plasma membrane of terpene-treated Leishmania amazonensis promastigotes. For an antiproliferative activity assay using 5x10(6) parasites/mL, the sesquiterpene nerolidol and the monoterpenes(+)-limonene, alpha-terpineol and 1,8-cineole inhibited the growth of the parasites with IC50 values of 0.008, 0.549, 0.678 and 4.697 mM, respectively. The IC50 values of these terpenes increased as the parasite concentration used in the cytotoxicity assay increased, and this behavior was examined using a theoretical treatment of the experimental data. Cytotoxicity tests with the same parasite concentration as in the EPR experiments revealed a correlation between the IC50 values of the terpenes and the concentrations at which they altered the membrane fluidity. In addition, the terpenes induced small amounts of cell lysis (4-9%) at their respective IC50 values. For assays with high cell concentrations (2 x 10(9) parasites/mL), the incorporation of terpene into the cell membrane was very fast, and the IC50 values observed for 24 h and 5 min-incubation periods were not significantly different. Taken together, these results suggest that terpene cytotoxicity is associated with the attack on the plasma membrane of the parasite. The in vitro cytotoxicity of nerolidol was similar to that of miltefosine, and nerolidol has high hydrophobicity; thus, nerolidol might be used in drug delivery systems, such as lipid nanoparticles to treat leishmaniasis.	[Camargos, Heverton Silva; Moreira, Rodrigo Alves; Mendanha, Sebastiao Antonio; Fernandes, Kelly Souza; Alonso, Antonio] Univ Fed Goias, Inst Fis, Goiania, Go, Brazil; [Camargos, Heverton Silva] Fundacao Univ Fed Tocantins, Palmas, TO, Brazil; [Dorta, Miriam Leandro] Univ Fed Goias, Dept Imunol & Patol Geral, Inst Patol Trop & Saude Publ, Goiania, Go, Brazil	Universidade Federal de Goias; Universidade Federal do Tocantins (UFT); Universidade Federal de Goias	Alonso, A (corresponding author), Univ Fed Goias, Inst Fis, Goiania, Go, Brazil.	alonso@ufg.br	Mendanha, Sebastião A/E-4523-2013; Alonso, Antonio/I-8969-2012	Mendanha, Sebastião A/0000-0002-9545-5248; Alonso, Antonio/0000-0003-4768-6372	Brazilian research funding agency CNPq; Brazilian research funding agency CAPES; Brazilian research funding agency FAPEG; CAPES; CNPq	Brazilian research funding agency CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian research funding agency CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Brazilian research funding agency FAPEG; CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was financially supported by grants from the Brazilian research funding agencies CNPq, CAPES and FAPEG. Rodrigo A. Moreira, Sebastiao Antonio Mendanha and Kelly Souza Fernandes are recipients of fellowships from CAPES. Antonio Alonso is the recipient of a research grant from CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso A, 1997, BBA-BIOMEMBRANES, V1323, P75, DOI 10.1016/S0005-2736(96)00177-0; Alonso L, 2012, INT J PHARMACEUT, V434, P391, DOI 10.1016/j.ijpharm.2012.06.006; Arruda DC, 2005, ANTIMICROB AGENTS CH, V49, P1679, DOI 10.1128/AAC.49.5.1679-1687.2005; Arruda DC, 2009, BIOMED PHARMACOTHER, V63, P643, DOI 10.1016/j.biopha.2009.02.004; Bardon S, 2002, CANCER LETT, V181, P187, DOI 10.1016/S0304-3835(02)00047-2; Budil DE, 1996, J MAGN RESON SER A, V120, P155, DOI 10.1006/jmra.1996.0113; Camargos HS, 2013, QUIM NOVA, V36, P815, DOI 10.1590/S0100-40422013000600013; Camargos HS, 2010, LIPIDS, V45, P419, DOI 10.1007/s11745-010-3407-2; Chappuis F, 2007, NAT REV MICROBIOL, V5, P873, DOI 10.1038/nrmicro1748; Croft SL, 2003, TRENDS PARASITOL, V19, P502, DOI 10.1016/j.pt.2003.09.008; Crowell PL, 1999, J NUTR, V129, p775S, DOI 10.1093/jn/129.3.775S; Desoti VC, 2012, MAR DRUGS, V10, P1631, DOI 10.3390/md10081631; Dorlo TPC, 2012, J ANTIMICROB CHEMOTH, V67, P2576, DOI 10.1093/jac/dks275; dos Anjos JLV, 2007, INT J PHARMACEUT, V345, P81, DOI 10.1016/j.ijpharm.2007.05.041; dos Santos AO, 2013, MEM I OSWALDO CRUZ, V108, P59, DOI 10.1590/S0074-02762013000100010; Gould MN, 1997, ENVIRON HEALTH PERSP, V105, P977, DOI 10.2307/3433313; Greay SJ, 2010, CANCER CHEMOTH PHARM, V65, P877, DOI 10.1007/s00280-009-1093-7; Guerin PJ, 2002, LANCET INFECT DIS, V2, P494, DOI 10.1016/S1473-3099(02)00347-X; Laxmi Y, 2007, CANCER LETT, V257, P216, DOI 10.1016/j.canlet.2007.07.020; Maciel-Rezende CM, 2013, BIOORGAN MED CHEM, V21, P3114, DOI 10.1016/j.bmc.2013.03.045; MCGARVEY DJ, 1995, PLANT CELL, V7, P1015, DOI 10.1105/tpc.7.7.1015; Mendanha SA, 2013, TOXICOL IN VITRO, V27, P323, DOI 10.1016/j.tiv.2012.08.022; Miguel DC, 2007, J ANTIMICROB CHEMOTH, V60, P526, DOI 10.1093/jac/dkm219; Moreira RA, 2014, ANTIMICROB AGENTS CH, V58, P3021, DOI 10.1128/AAC.01332-13; Moreira RA, 2013, J PHARM SCI-US, V102, P1661, DOI 10.1002/jps.23496; Olagnier D, 2007, BIOORG MED CHEM LETT, V17, P6075, DOI 10.1016/j.bmcl.2007.09.056; Oliva B, 2003, LETT APPL MICROBIOL, V37, P185, DOI 10.1046/j.1472-765X.2003.01375.x; de Oliveira MAP, 2010, REV INST MED TROP SP, V52, P83, DOI 10.1590/S0036-46652010000200004; Rabi T, 2009, BREAST CANCER RES TR, V115, P223, DOI 10.1007/s10549-008-0118-y; Sharma M, 2013, J MED CHEM, V56, P4374, DOI 10.1021/jm400053v; Thoppil RJ, 2011, WORLD J HEPATOL, V3, P228, DOI 10.4254/wjh.v3.i9.228; Tiuman TS, 2011, INT J INFECT DIS, V15, pE525, DOI 10.1016/j.ijid.2011.03.021; Anjos JLV, 2011, COLLOID SURFACE B, V88, P463, DOI 10.1016/j.colsurfb.2011.07.030; Dos Anjos JLV, 2008, INT J PHARMACEUT, V350, P103, DOI 10.1016/j.ijpharm.2007.08.024; dos Anjos JLV, 2007, EUR J PHARM BIOPHARM, V67, P406, DOI 10.1016/j.ejpb.2007.02.004; Wu CS, 2012, EVID-BASED COMPL ALT, V2012, P1, DOI 10.1155/2012/818261; Yang HJ, 2010, CURR DRUG TARGETS, V11, P733, DOI 10.2174/138945010791170842	37	49	52	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e104429	10.1371/journal.pone.0104429	http://dx.doi.org/10.1371/journal.pone.0104429			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25101672	Green Published, gold, Green Submitted			2022-12-27	WOS:000339993900062
J	Cao, HW; Jin, KB; Li, CY; Yan, HM				Cao, Hong-Wen; Jin, Kai-Bin; Li, Chao-Yi; Yan, Hong-Mei			Attentional Blink Is Hierarchically Modulated by Phonological, Morphological, Semantic and Lexical Connections between Two Chinese Characters	PLOS ONE			English	Article							SERIAL VISUAL PRESENTATION; T1 DIFFICULTY; TIME-COURSE; TASK; IDENTIFICATION; ACTIVATION; MASKING; PERCEPTION; TARGETS; WORDS	The ability to identify the second of two targets (T2) is impaired if that target is presented less than similar to 500 ms after the first (T1). This transient deficit is known as attentional blink (AB). Previous studies have suggested that the magnitude of the AB effect can be modulated by manipulating the allocation of attentional resources to T1 or T2. However, few experiments have used Chinese characters and words to explore this phenomenon. The existence of lexical, semantic, phonological and morphological connections between Chinese characters has been well established, and understanding these connections may improve our knowledge of reading Chinese. In this study, we employed varying connections between T1 and T2 and examined how these connections modulate the AB effect. We found that the strongest AB was observed when the two Chinese characters were completely unrelated, while the AB was reduced when T1 and T2 were phonologically, orthographically or semantically related and was almost completely eliminated when T1 and T2 were united in a lexical phrase. The order of activation between Chinese characters was identified as follows: (a) lexical phrases, (b) semantic connection, (c) morphological connection, (d) phonological connection and (e) unrelated words.	[Cao, Hong-Wen; Jin, Kai-Bin; Li, Chao-Yi; Yan, Hong-Mei] Univ Elect Sci & Technol China, Minist Educ, Key Lab NeuroInformat, Chengdu 610054, Peoples R China; [Li, Chao-Yi] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai, Peoples R China	University of Electronic Science & Technology of China; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Yan, HM (corresponding author), Univ Elect Sci & Technol China, Minist Educ, Key Lab NeuroInformat, Chengdu 610054, Peoples R China.	hmyan@uestc.edu.cn		Cao, Hongwen/0000-0002-8549-2109	973 project [2013CB329401]; Natural Science Foundations of China [60972108, 91120013, 61375115, 31000492]	973 project(National Basic Research Program of China); Natural Science Foundations of China(National Natural Science Foundation of China (NSFC))	This work was supported by the 973 project (2013CB329401), the Natural Science Foundations of China (60972108, 91120013, 61375115, 31000492). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1990, DICT MODERN CHINESE; Barnard PJ, 2004, PSYCHOL SCI, V15, P179, DOI 10.1111/j.0956-7976.2004.01503006.x; BROADBENT DE, 1987, PERCEPT PSYCHOPHYS, V42, P105, DOI 10.3758/BF03210498; CHENG CM, 1981, ACTA PSYCHOL TAIWAN, V23, P137; CHUN MM, 1995, J EXP PSYCHOL HUMAN, V21, P109; Di Lollo V, 2005, PSYCHOL RES-PSYCH FO, V69, P191, DOI 10.1007/s00426-004-0173-x; Duncan J, 1997, NATURE, V387, P808, DOI 10.1038/42947; Dux PE, 2009, ATTEN PERCEPT PSYCHO, V71, P1683, DOI 10.3758/APP.71.8.1683; Evans KK, 2005, J EXP PSYCHOL HUMAN, V31, P1476, DOI 10.1037/0096-1523.31.6.1476; Giesbrecht B, 2009, VISION RES, V49, P1378, DOI 10.1016/j.visres.2008.02.013; Hillstrom AP, 2002, PERCEPT PSYCHOPHYS, V64, P1068, DOI 10.3758/BF03194757; Horvath J, 2011, ATTEN PERCEPT PSYCHO, V73, P695, DOI 10.3758/s13414-010-0077-3; Isaak MI, 1999, J EXP PSYCHOL HUMAN, V25, P1774, DOI 10.1037/0096-1523.25.6.1774; Jolicoeur P, 1999, PSYCHOL RES-PSYCH FO, V62, P154, DOI 10.1007/s004260050048; Language Teaching and Research Institute of Beijing Language and Culture University, 1986, DICT MOD CHIN FREQ; Liu BL, 2011, BRAIN RES, V1372, P81, DOI 10.1016/j.brainres.2010.11.068; Luck SJ, 1996, NATURE, V383, P616, DOI 10.1038/383616a0; Marois R, 2004, NEURON, V41, P465, DOI 10.1016/S0896-6273(04)00012-1; Marois R, 2000, NEURON, V25, P717, DOI 10.1016/S0896-6273(00)81073-9; Martens S, 2006, ACTA PSYCHOL, V123, P204, DOI 10.1016/j.actpsy.2006.01.001; Martens S, 2010, NEUROSCI BIOBEHAV R, V34, P947, DOI 10.1016/j.neubiorev.2009.12.005; Olivers CNL, 2005, PSYCHOL SCI, V16, P265, DOI 10.1111/j.0956-7976.2005.01526.x; Perfetti CA, 1998, J EXP PSYCHOL LEARN, V24, P101, DOI 10.1037/0278-7393.24.1.101; Potter MC, 2005, PSYCHON B REV, V12, P460, DOI 10.3758/BF03193788; Potter MC, 1998, J EXP PSYCHOL LEARN, V24, P979, DOI 10.1037/0278-7393.24.4.979; RAYMOND JE, 1992, J EXP PSYCHOL HUMAN, V18, P849, DOI 10.1037/0096-1523.18.3.849; Seiffert AE, 1997, J EXP PSYCHOL HUMAN, V23, P1061, DOI 10.1037/0096-1523.23.4.1061; Stein T, 2010, EXP PSYCHOL, V57, P301, DOI 10.1027/1618-3169/a000035; Stein T, 2010, EMOTION, V10, P136, DOI 10.1037/a0017814; Taatgen NA, 2009, COGNITIVE PSYCHOL, V59, P1, DOI 10.1016/j.cogpsych.2008.12.002; Tan LH, 1999, J EXP PSYCHOL LEARN, V25, P382, DOI 10.1037/0278-7393.25.2.382; Tsai JL, 2012, ACTA PSYCHOL, V141, P17, DOI 10.1016/j.actpsy.2012.06.004; Visser TAW, 2007, Q J EXP PSYCHOL, V60, P936, DOI 10.1080/17470210600847727; Visser TAW, 2007, J EXP PSYCHOL HUMAN, V33, P285, DOI 10.1037/0096-1523.33.2.285; Zhou XL, 2000, J EXP PSYCHOL LEARN, V26, P1245, DOI 10.1037//0278-7393.26.5.1245	35	6	6	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e104626	10.1371/journal.pone.0104626	http://dx.doi.org/10.1371/journal.pone.0104626			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM6SB	25101959	Green Submitted, Green Published, gold			2022-12-27	WOS:000339993900081
J	Mu, XW; Pan, C; Zheng, SY; Alhamdi, Y; Sun, BW; Shi, QK; Wang, X; Sun, ZW; Toh, C; Wang, GZ				Mu, Xinwei; Pan, Chen; Zheng, Shuyun; Alhamdi, Yasir; Sun, Bingwei; Shi, Qiankun; Wang, Xiang; Sun, Zhiwei; Toh, Chenghock; Wang, Guozheng			Protective Effects of Carbon Monoxide-Releasing Molecule-2 on the Barrier Function of Intestinal Epithelial Cells	PLOS ONE			English	Article							TIGHT JUNCTION PERMEABILITY; HEME OXYGENASE; KAPPA-B; RAT; SEPSIS; MICE; INDUCTION; INCREASE; SYSTEM; TRANSLOCATION	Objective: To investigate the protective effects and mechanisms of carbon monoxide-releasing molecule-2 (CORM-2) on barrier function of intestinal epithelial cells. Materials and Methods: After pre-incubation with CORM-2 for 1 hour, cultured intestinal epithelial IEC-6 cells were stimulated with 50 mg/ml lipopolysaccharides (LPS). Cytokines levels in culture medium were detected using ELISA kits. Trans-epithelial electrical resistance (TER) of IEC-6 cell monolayers in Transwells were measured with a Millipore electric resistance system (ERS-2; Millipore) and calculated as Omega/cm(2) at different time points after LPS treatment. The permeability changes were also measured using FITC-dextran. The levels of tight junction (TJ) proteins (occludin and ZO-1) and myosin light chain (MLC) phosphorylation were detected using Western blotting with specific antibodies. The subsequent structural changes of TJ were visualized using transmission electron microscopy (TEM). Results: CORM-2 significantly reduced LPS-induced secretion of TNF-alpha and IL-1 beta. The LPS-induced decrease of TER and increase of permeability to FITC-dextran were inhibited by CORM-2 in a concentration dependent manner (P < 0.05). LPS-induced reduction of tight junction proteins and increase of MLC phosphorylation were also attenuated. In LPS-treated cells, TEM showed diminished electron-dense material and interruption of TJ and desmosomes between the apical lateral margins of adjoining cells, which were prevented by CORM-2 treatment. Conclusions: The present study demonstrates that CORM-2, as a novel CO-releasing molecule, has ability to protect the barrier function of LPS-stimulated intestinal epithelial cells. Inhibition of inflammatory cytokines release, restoration of TJ proteins and suppression of MLC phosphorylation are among the protective effects of CORM-2.	[Mu, Xinwei; Zheng, Shuyun; Shi, Qiankun; Wang, Xiang] Nanjing Med Univ, Nanjing Hosp 1, Dept Crit Care Med, Nanjiang, Jiangsu, Peoples R China; [Pan, Chen] Nanjing Med Univ, Nanjing Childrens Hosp, Dept Crit Care Med, Nanjiang, Jiangsu, Peoples R China; [Alhamdi, Yasir; Toh, Chenghock; Wang, Guozheng] Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 3BX, Merseyside, England; [Sun, Bingwei] Jiangsu Univ, Affiliated Hosp, Dept Burn & Plast Surg, Zhenjiang, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; University of Liverpool; Jiangsu University	Zheng, SY (corresponding author), Nanjing Med Univ, Nanjing Hosp 1, Dept Crit Care Med, Nanjiang, Jiangsu, Peoples R China.	syzheng915@163.com			National Natural Science Foundation of China [81171786, 81272148, 81071546]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (http://www.nsfc.gov.cn/publish/portal0/default.htm), No. 81171786, 81272148 and No. 81071546. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Sadi R, 2008, J IMMUNOL, V180, P5653, DOI 10.4049/jimmunol.180.8.5653; Al-Sadi RM, 2007, J IMMUNOL, V178, P4641, DOI 10.4049/jimmunol.178.7.4641; ALEXANDER JW, 1990, ANN SURG, V212, P496, DOI 10.1097/00000658-199010000-00012; Becker JC, 2003, BIOCHEM BIOPH RES CO, V312, P507, DOI 10.1016/j.bbrc.2003.10.146; Berg Rodney D., 1995, Trends in Microbiology, V3, P149, DOI 10.1016/S0966-842X(00)88906-4; Bogatcheva NV, 2011, J CELL PHYSIOL, V226, P3132, DOI 10.1002/jcp.22669; Cepinskas G, 2008, AM J PHYSIOL-GASTR L, V294, pG184, DOI 10.1152/ajpgi.00348.2007; de Plaen IG, 2002, IMMUNOLOGY, V106, P577, DOI 10.1046/j.1365-2567.2002.01453.x; Donato RP, 2011, METHODS MOL BIOL, V763, P115, DOI 10.1007/978-1-61779-191-8_8; Fei DS, 2012, TRANSL RES, V159, P99, DOI 10.1016/j.trsl.2011.10.009; Foresti R, 2004, BRIT J PHARMACOL, V142, P453, DOI 10.1038/sj.bjp.0705825; Garcia-Arnandis I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024591; GOSCHE JR, 1990, ARCH SURG-CHICAGO, V125, P1573; Guo Y, 2007, PHARM RES-DORDR, V24, P1824, DOI 10.1007/s11095-007-9309-1; Hervera A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043693; HIDALGO IJ, 1989, GASTROENTEROLOGY, V96, P736; Ince C, 2004, CRIT CARE MED, V32, P1963, DOI 10.1097/01.CCM.0000139617.88704.B9; Ivanov AI, 2008, FRONT BIOSCI-LANDMRK, V13, P6662, DOI 10.2741/3180; Katada K, 2010, INFLAMMATION, V33, P92, DOI 10.1007/s10753-009-9162-y; Kimura H, 1997, J CELL PHYSIOL, V171, P284, DOI 10.1002/(SICI)1097-4652(199706)171:3<284::AID-JCP6>3.0.CO;2-K; Lancel S, 2009, J PHARMACOL EXP THER, V329, P641, DOI 10.1124/jpet.108.148049; Lee TS, 2003, J BIOL CHEM, V278, P19325, DOI 10.1074/jbc.M300498200; Ma TY, 2004, AM J PHYSIOL-GASTR L, V286, pG367, DOI 10.1152/ajpgi.00173.2003; MADARA JL, 1987, AM J PHYSIOL, V253, pC171, DOI 10.1152/ajpcell.1987.253.1.C171; Maines MD, 1997, ANNU REV PHARMACOL, V37, P517, DOI 10.1146/annurev.pharmtox.37.1.517; Megias J, 2007, BRIT J PHARMACOL, V150, P977, DOI 10.1038/sj.bjp.0707184; Otterbein LE, 2000, NAT MED, V6, P422, DOI 10.1038/74680; QUARONI A, 1979, J CELL BIOL, V80, P248, DOI 10.1083/jcb.80.2.248; Scharte M, 2000, BIOCHEM BIOPH RES CO, V267, P423, DOI 10.1006/bbrc.1999.1936; Schneeberger EE, 2004, AM J PHYSIOL-CELL PH, V286, pC1213, DOI 10.1152/ajpcell.00558.2003; Steidle J, 2011, AM J PHYSIOL-GASTR L, V300, pG207, DOI 10.1152/ajpgi.00407.2010; Sun BW, 2008, INT J BIOL SCI, V4, P270; Sun BW, 2008, INT J BIOL SCI, V4, P176; Takasuka H, 2011, J PHARMACOL EXP THER, V337, P293, DOI 10.1124/jpet.110.175216; TENHUNEN R, 1969, J BIOL CHEM, V244, P6388; Tsoyi K, 2009, MOL PHARMACOL, V76, P173, DOI 10.1124/mol.109.055137; Wang N, 2012, DIGEST DIS SCI, V57, P1792, DOI 10.1007/s10620-012-2094-7; Wei YW, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-42; Willis D, 2000, J PATHOL, V190, P627; Xiao WD, 2011, MOL CELL NEUROSCI, V46, P527, DOI 10.1016/j.mcn.2010.12.007; Yuhan R, 1997, GASTROENTEROLOGY, V113, P1873, DOI 10.1016/S0016-5085(97)70006-4	41	13	16	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e104032	10.1371/journal.pone.0104032	http://dx.doi.org/10.1371/journal.pone.0104032			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25101775	Green Published, Green Submitted, gold			2022-12-27	WOS:000339993900031
J	Zhao, YH; Ye, XR; Su, YT; Sun, LF; She, FF; Wu, YK				Zhao, Yanhe; Ye, Xianren; Su, Yintao; Sun, Lifang; She, Feifei; Wu, Yunkun			Crystal Structure Confirmation of JHP933 as a Nucleotidyltransferase Superfamily Protein from Helicobacter pylori Strain J99	PLOS ONE			English	Article							PLASTICITY REGION; GENE; CLASSIFICATION; IDENTIFICATION; VIRULENCE; FAMILIES; GENOME; ISLAND	Helicobacter pylori is a well-known pathogen involved in the development of peptic ulcer, gastric adenocarcinoma and other forms of gastric cancer. Recently, there has been more considerable interest in strain-specific genes located in plasticity regions with great genetic variability. However, little is known about many of these genes. Studies suggested that certain genes in this region may play key roles in the pathogenesis of H. pylori-associated gastroduodenal diseases. JHP933, a conserved putative protein of unknown function, is encoded by the gene in plasticity region of H. pylori strain J99. Here we have determined the structure of JHP933. Our work demonstrates that JHP933 is a nucleotidyltransferase superfamily protein with a characteristic alpha beta alpha beta alpha beta alpha topology. A superposition demonstrates overall structural homology of the JHP933 N-terminal fragment with lincosamide antibiotic adenylyltransferase LinA and identifies a possible substrate-binding cleft of JHP933. Furthermore, through structural comparison with LinA and LinB, we pinpoint conservative active site residues which may contribute to divalent ion coordination and substrate binding.	[Zhao, Yanhe; Su, Yintao; Sun, Lifang; Wu, Yunkun] Chinese Acad Sci, Fujian Inst Res Struct Matter, State Key Lab Struct Chem, Fuzhou 350002, Fujian, Peoples R China; [Ye, Xianren; She, Feifei] Fujian Med Univ, Sch Basic Med Sci, Minist Educ Gastrointestinal Canc, Key Lab, Fuzhou, Fujian, Peoples R China	Chinese Academy of Sciences; Fujian Institute of Research on the Structure of Matter, CAS; Fujian Medical University	She, FF (corresponding author), Fujian Med Univ, Sch Basic Med Sci, Minist Educ Gastrointestinal Canc, Key Lab, Fuzhou, Fujian, Peoples R China.	shefeifei@yeah.net; wuyk@fjirsm.ac.cn			National Nature Science Foundation of China [31270790, 81271784]; Fujian Province [2012Y0070]; Nature Science Foundation of Fujian Province [2013J01151, 2012J01130]; Fujian Medical University [09ZD018]; National Thousand Talents Program of China; Scientific Research Starting Foundation for Returned Overseas Chinese Scholars of State Human Resource Ministry of China	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fujian Province; Nature Science Foundation of Fujian Province(Natural Science Foundation of Fujian Province); Fujian Medical University; National Thousand Talents Program of China; Scientific Research Starting Foundation for Returned Overseas Chinese Scholars of State Human Resource Ministry of China	The National Nature Science Foundation of China (31270790, 81271784), Key Project of Fujian Province (2012Y0070), the Nature Science Foundation of Fujian Province (2013J01151, 2012J01130), Key Project of Science Research in Fujian Medical University (09ZD018), National Thousand Talents Program of China, and Scientific Research Starting Foundation for Returned Overseas Chinese Scholars of State Human Resource Ministry of China for support on this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Alm RA, 1999, NATURE, V397, P176, DOI 10.1038/16495; Alm RA, 1999, J MOL MED, V77, P834, DOI 10.1007/s001099900067; Aravind L, 1999, NUCLEIC ACIDS RES, V27, P1609, DOI 10.1093/nar/27.7.1609; Atherton JC, 1997, GASTROENTEROLOGY, V112, P92, DOI 10.1016/S0016-5085(97)70223-3; Blaser MJ, 1997, LANCET, V349, P1020, DOI 10.1016/S0140-6736(96)09133-7; Covacci A, 1999, SCIENCE, V284, P1328, DOI 10.1126/science.284.5418.1328; de Jonge R, 2004, FEMS IMMUNOL MED MIC, V41, P161, DOI 10.1016/j.femsim.2004.03.003; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fernandez-Gonzalez E, 2014, J GASTROENTEROL, V49, P594, DOI 10.1007/s00535-014-0938-y; Fischer W, 2010, NUCLEIC ACIDS RES, V38, P6089, DOI 10.1093/nar/gkq378; Franco AT, 2008, CANCER RES, V68, P379, DOI 10.1158/0008-5472.CAN-07-0824; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Kersulyte D, 2003, J BACTERIOL, V185, P3764, DOI 10.1128/JB.185.13.3764-3772.2003; Kuchta K, 2009, NUCLEIC ACIDS RES, V37, P7701, DOI 10.1093/nar/gkp854; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lu H, 2005, GASTROENTEROLOGY, V128, P833, DOI 10.1053/j.gastro.2005.01.009; Morar M, 2009, STRUCTURE, V17, P1649, DOI 10.1016/j.str.2009.10.013; Occhialini A, 2000, INFECT IMMUN, V68, P6240, DOI 10.1128/IAI.68.11.6240-6249.2000; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rogozin IB, 2003, J MOL BIOL, V326, P1449, DOI 10.1016/S0022-2836(03)00055-X; Salih BA, 2007, INFECT GENET EVOL, V7, P509, DOI 10.1016/j.meegid.2007.03.002; Santos A, 2003, J CLIN MICROBIOL, V41, P1651, DOI 10.1128/JCM.41.4.1651-1655.2003; Toro C, 2001, Rev Esp Quimioter, V14, P172; Wand G, 1998, ANTIMICROB AGENTS CH, V42, P1952, DOI 10.1128/AAC.42.8.1952; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yamaoka Y, 2008, J MED MICROBIOL, V57, P545, DOI 10.1099/jmm.0.2008/000570-0	27	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e104609	10.1371/journal.pone.0104609	http://dx.doi.org/10.1371/journal.pone.0104609			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25101777	gold, Green Submitted, Green Published			2022-12-27	WOS:000339993900079
J	Claes, JM; Partridge, JC; Hart, NS; Garza-Gisholt, E; Ho, HC; Mallefet, J; Collin, SP				Claes, Julien M.; Partridge, Julian C.; Hart, Nathan S.; Garza-Gisholt, Eduardo; Ho, Hsuan-Ching; Mallefet, Jerome; Collin, Shaun P.			Photon Hunting in the Twilight Zone: Visual Features of Mesopelagic Bioluminescent Sharks	PLOS ONE			English	Article							GANGLION-CELL TOPOGRAPHY; SPATIAL RESOLVING POWER; RETINAL SPECIALIZATIONS; EYES; PIGMENTS; PHOTORECEPTOR; LUMINESCENCE; FISHES; VISION; LAYER	The mesopelagic zone is a visual scene continuum in which organisms have developed various strategies to optimize photon capture. Here, we used light microscopy, stereology-assisted retinal topographic mapping, spectrophotometry and microspectrophotometry to investigate the visual ecology of deep-sea bioluminescent sharks [four etmopterid species (Etmopterus lucifer, E. splendidus, E. spinax and Trigonognathus kabeyai) and one dalatiid species (Squaliolus aliae)]. We highlighted a novel structure, a translucent area present in the upper eye orbit of Etmopteridae, which might be part of a reference system for counterillumination adjustment or acts as a spectral filter for camouflage breaking, as well as several ocular specialisations such as aphakic gaps and semicircular tapeta previously unknown in elasmobranchs. All species showed pure rod hexagonal mosaics with a high topographic diversity. Retinal specialisations, formed by shallow cell density gradients, may aid in prey detection and reflect lifestyle differences; pelagic species display areae centrales while benthopelagic and benthic species display wide and narrow horizontal streaks, respectively. One species (E. lucifer) displays two areae within its horizontal streak that likely allows detection of conspecifics' elongated bioluminescent flank markings. Ganglion cell topography reveals less variation with all species showing a temporal area for acute frontal binocular vision. This area is dorsally extended in T. kabeyai, allowing this species to adjust the strike of its peculiar jaws in the ventro-frontal visual field. Etmopterus lucifer showed an additional nasal area matching a high rod density area. Peak spectral sensitivities of the rod visual pigments (lambda(max)) fall within the range 484-491 nm, allowing these sharks to detect a high proportion of photons present in their habitat. Comparisons with previously published data reveal ocular differences between bioluminescent and non-bioluminescent deep-sea sharks. In particular, bioluminescent sharks possess higher rod densities, which might provide them with improved temporal resolution particularly useful for bioluminescent communication during social interactions.	[Claes, Julien M.; Mallefet, Jerome] Catholic Univ Louvain, Earth & Life Inst, Marine Biol Lab, Louvain La Neuve, Belgium; [Partridge, Julian C.] Univ Bristol, Sch Biol Sci, Bristol, Avon, England; [Partridge, Julian C.; Hart, Nathan S.; Garza-Gisholt, Eduardo; Collin, Shaun P.] Univ Western Australia, Sch Anim Biol, Neuroecol Grp, Crawley, WA, Australia; [Partridge, Julian C.; Hart, Nathan S.; Garza-Gisholt, Eduardo; Collin, Shaun P.] Univ Western Australia, UWA Oceans Inst, Crawley, WA, Australia; [Ho, Hsuan-Ching] Natl Museum Marine Biol, Checheng, Taiwan; [Ho, Hsuan-Ching] Aquarium, Checheng, Taiwan; [Ho, Hsuan-Ching] Natl Dong Hwa Univ, Inst Marine Biodivers & Evolutionary Biol, Shoufeng, Taiwan	Universite Catholique Louvain; University of Bristol; University of Western Australia; University of Western Australia; National Museum of Marine Biology & Aquarium; National Dong Hwa University	Claes, JM (corresponding author), Catholic Univ Louvain, Earth & Life Inst, Marine Biol Lab, Louvain La Neuve, Belgium.	julien.m.claes@uclouvain.be	Hart, Nathan S/B-8564-2011; Partridge, Julian C/F-2097-2014; Collin, Shaun/K-8827-2012	Hart, Nathan S/0000-0002-7289-9399; Partridge, Julian C/0000-0003-3788-2900; Collin, Shaun/0000-0001-6236-0771; mallefet, jerome/0000-0003-0918-3491; Garza-Gisholt, Eduardo/0000-0002-2353-6612	Fonds National de la Recherche Scientifique (FNRS, Belgium) through a Fonds de la Recherche Fondamentale Collective grant [FRFC - 2.4525.12]; Australian Research Council [DP110103294]; Western Australian State Government; National Museum of Marine Biology and Aquarium	Fonds National de la Recherche Scientifique (FNRS, Belgium) through a Fonds de la Recherche Fondamentale Collective grant(Fonds de la Recherche Scientifique - FNRS); Australian Research Council(Australian Research Council); Western Australian State Government; National Museum of Marine Biology and Aquarium	Financial support (specimen collection, open access fee) was provided by the Fonds National de la Recherche Scientifique (FNRS, Belgium) (http://www.fnrs.be) through a Fonds de la Recherche Fondamentale Collective grant (FRFC - 2.4525.12) and travel grants to JMC (postdoctoral researcher at FNRS) and JM (research associate at FNRS). Part of the research (data collection and analysis) was supported by an Australian Research Council (http://www.arc.gov.au) grant (DP110103294) to SPC, NSH and others, the Western Australian State Government (http://wa.gov.au) to SPC, and the National Museum of Marine Biology and Aquarium (http://www.nmmba.gov.tw/english/index.aspx) to HCH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1977, VISUAL SYSTEM VERTEB, DOI [DOI 10.1007/978-3-642-66468-7, 10.1007/978-3-642-66468-7_11, DOI 10.1007/978-3-642-66468-7_11]; Bernal D, 2005, NATURE, V437, P1349, DOI 10.1038/nature04007; Bozzano A, 2000, BRAIN BEHAV EVOLUT, V55, P191, DOI 10.1159/000006652; Bozzano A, 2001, J FISH BIOL, V59, P1258, DOI 10.1006/jfbi.2001.1737; Claes JM, 2014, SCI REP-UK, V4, DOI 10.1038/srep04328; Claes JM, 2013, SCI REP-UK, V3, DOI 10.1038/srep01308; Claes JM, 2012, J EXP BIOL, V215, P1691, DOI 10.1242/jeb.066704; Claes JM, 2011, J EXP MAR BIOL ECOL, V406, P1, DOI 10.1016/j.jembe.2011.05.033; Claes JM, 2010, J EXP MAR BIOL ECOL, V388, P28, DOI 10.1016/j.jembe.2010.03.009; Claes JM, 2010, J EXP BIOL, V213, P1852, DOI 10.1242/jeb.041947; Claes JM, 2009, ZOOLOGY, V112, P433, DOI 10.1016/j.zool.2009.02.003; Claes JM, 2009, J EXP BIOL, V212, P3684, DOI 10.1242/jeb.034363; Coimbra JP, 2006, BRAIN BEHAV EVOLUT, V68, P15, DOI 10.1159/000092310; Coimbra JP, 2013, J COMP NEUROL, V521, P2042, DOI 10.1002/cne.23271; Collin S.P., 1999, P509; Collin SP, 2008, CLIN EXP OPTOM, V91, P85, DOI 10.1111/j.1444-0938.2007.00228.x; COLLIN SP, 1988, BRAIN BEHAV EVOLUT, V31, P269, DOI 10.1159/000116594; Collin SP, 1996, J FISH BIOL, V49, P157, DOI 10.1111/j.1095-8649.1996.tb06073.x; CORNWALL MC, 1989, J GEN PHYSIOL, V94, P633, DOI 10.1085/jgp.94.4.633; Crescitelli F, 1991, J EXP ZOOL         S, V5, P66, DOI DOI 10.1002/JEZ.1402560510; CURCIO CA, 1987, VISION RES, V27, P9, DOI 10.1016/0042-6989(87)90137-4; DEGRIP WJ, 1982, METHOD ENZYMOL, V81, P256; DENTON EJ, 1957, J MAR BIOL ASSOC UK, V36, P651, DOI 10.1017/S0025315400025911; DOUGLAS RH, 1995, J COMP PHYSIOL A, V177, P111; DOUGLAS RH, 1992, J MAR BIOL ASSOC UK, V72, P93, DOI 10.1017/S0025315400048815; Douglas RH, 1998, PROG RETIN EYE RES, V17, P597, DOI 10.1016/S1350-9462(98)00002-0; Douglas Ronald H., 2003, P323, DOI 10.1007/978-0-387-22628-6_17; Dun W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078087; Ebert DA, 2013, SHARKS WORLD, P256; Fritsches KA, 2005, CURR BIOL, V15, P55, DOI 10.1016/j.cub.2004.12.064; Fritsches KA, 2003, MAR FRESHWATER RES, V54, P333, DOI 10.1071/MF02126; Garza-Gisholt E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093485; Glaser EM, 1998, J MICROSC-OXFORD, V192, P163, DOI 10.1046/j.1365-2818.1998.00417.x; Govardovskii VI, 2000, VISUAL NEUROSCI, V17, P509, DOI 10.1017/S0952523800174036; GRUBER SH, 1975, COPEIA, P378; Hart Nathan S., 2006, P337; Hart NS, 2012, J COMP NEUROL, V520, P1246, DOI 10.1002/cne.22784; Hart NS, 2011, NATURWISSENSCHAFTEN, V98, P193, DOI 10.1007/s00114-010-0758-8; Heidler S, 2006, ELASMOKOP, V10, P2; HERRING PJ, 1983, PROC R SOC SER B-BIO, V220, P183, DOI 10.1098/rspb.1983.0095; HERRING PJ, 1982, OCEANOGR MAR BIOL, V20, P415; Johnsen S. N., 2012, OPTICS LIFE BIOL GUI; Johnsen S, 2014, ANNU REV MAR SCI, V6, P369, DOI 10.1146/annurev-marine-010213-135018; Lamb TD, 2006, INVEST OPHTH VIS SCI, V47, P5138, DOI 10.1167/iovs.06-0849; Land M.F., 1981, HDB SENSORY PHYSL; Land MF, 2002, ANIMAL EYES; Landgren E, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0039; Lisney TJ, 2008, BRAIN BEHAV EVOLUT, V72, P59, DOI 10.1159/000146082; Lisney TJ, 2007, BRAIN BEHAV EVOLUT, V69, P266, DOI 10.1159/000100036; Litherland L, 2008, VISUAL NEUROSCI, V25, P549, DOI 10.1017/S0952523808080693; Litherland L, 2009, VISUAL NEUROSCI, V26, P397, DOI 10.1017/S0952523809990150; LOCKET NA, 1985, PROC R SOC SER B-BIO, V224, P7, DOI 10.1098/rspb.1985.0018; MACNICHOL EF, 1986, VISION RES, V26, P1543, DOI 10.1016/0042-6989(86)90174-4; Marshall N. B., 1954, ASPECTS DEEP SEA BIO; MCNULTY JA, 1976, J MORPHOL, V150, P579; MOCHIZUKI K, 1990, JPN J ICHTHYOL, V36, P385, DOI 10.1007/BF02905456; Munk O., 1980, HVIRVELDYROJET BYGNI; MUNTZ WRA, 1976, J MAR BIOL ASSOC UK, V56, P963, DOI 10.1017/S0025315400021019; MUNZ FW, 1958, J GEN PHYSIOL, V42, P445, DOI 10.1085/jgp.42.2.445; Musick JA, 2004, CRC MAR BIOL SER, P33; Naylor GJP, 2012, CRC MAR BIOL SER, P31; Neiva J, 2006, J MAR BIOL ASSOC UK, V86, P835, DOI 10.1017/S0025315406013762; Newman AS, 2013, BRAIN BEHAV EVOLUT, V82, P237, DOI 10.1159/000355370; PARTRIDGE JC, 1989, J COMP PHYSIOL A, V164, P513, DOI 10.1007/BF00610445; Coimbra JP, 2009, J COMP NEUROL, V514, P66, DOI 10.1002/cne.21992; Pugh E.N., 2000, HDB BIOL PHYS, V3, P183, DOI DOI 10.1016/S1383-8121(00)80008-1; REIF WE, 1985, ACTA ZOOL-STOCKHOLM, V66, P111, DOI 10.1111/j.1463-6395.1985.tb00829.x; Renwart M, 2013, J EXP MAR BIOL ECOL, V448, P214, DOI 10.1016/j.jembe.2013.07.010; Schieber NL, 2012, J MORPHOL, V273, P423, DOI 10.1002/jmor.11033; SEIGEL JA, 1978, COPEIA, P602; Shimomura O, 2012, BIOLUMINESCENCE CHEM; Slomianka L, 2005, NEUROSCIENCE, V136, P757, DOI 10.1016/j.neuroscience.2005.06.086; Stone J, 1981, WHOLE MOUNT HDB GUID; Straube N, 2010, MOL PHYLOGENET EVOL, V56, P905, DOI 10.1016/j.ympev.2010.04.042; Tong D, 2009, P NATL ACAD SCI USA, V106, P9836, DOI 10.1073/pnas.0904571106; Turner JR, 2009, DEEP-SEA RES PT I, V56, P1003, DOI 10.1016/j.dsr.2009.01.007; Ullmann JFP, 2012, BRAIN BEHAV EVOLUT, V79, P26, DOI 10.1159/000332802; Wagner HJ, 1998, PROG RETIN EYE RES, V17, P637, DOI 10.1016/S1350-9462(98)00003-2; Warrant E, 2000, PHILOS T ROY SOC B, V355, P1155, DOI 10.1098/rstb.2000.0658; Warrant E, 1992, NONLINEAR VISION, P391; Warrant EJ, 2004, BIOL REV, V79, P671, DOI 10.1017/S1464793103006420; Warrant Eric J., 2003, P303, DOI 10.1007/978-0-387-22628-6_16; Wetherbee Bradley M., 2000, Pacific Science, V54, P389; Yano K, 2003, ICHTHYOL RES, V50, P251, DOI 10.1007/s10228-003-0165-7; Yano K, 2007, ICHTHYOL RES, V54, P388, DOI 10.1007/s10228-007-0414-2; YOUNG RE, 1979, MAR BIOL, V51, P371, DOI 10.1007/BF00389215; YOUNG RE, 1980, DEEP-SEA RES, V27, P671, DOI 10.1016/0198-0149(80)90022-9; YOUNG RE, 1973, PAC SCI, V27, P1	88	16	16	1	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e104213	10.1371/journal.pone.0104213	http://dx.doi.org/10.1371/journal.pone.0104213			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25099504	Green Published, gold, Green Submitted			2022-12-27	WOS:000339995100052
J	Dimuccio, V; Ranghino, A; Barbato, LP; Fop, F; Biancone, L; Camussi, G; Bussolati, B				Dimuccio, Veronica; Ranghino, Andrea; Barbato, Loredana Pratico; Fop, Fabrizio; Biancone, Luigi; Camussi, Giovanni; Bussolati, Benedetta			Urinary CD133(+) Extracellular Vesicles Are Decreased in Kidney Transplanted Patients with Slow Graft Function and Vascular Damage	PLOS ONE			English	Article							RENAL PROGENITOR CELLS; MEMBRANE-PARTICLES; CURRENT KNOWLEDGE; PROMININ-1 CD133; EXOSOMES; MARKER; RELEASE; PROTEIN; PLASMA	Extracellular vesicles (EVs) present in the urine are mainly released from cells of the nephron and can therefore provide information on kidney function We here evaluated the presence of vesicles expressing the progenitor marker CD133 in the urine of normal subjects and of patients undergoing renal transplant. We found that EV expressing CD133 were present in the urine of normal subjects, but not of patients with end stage renal disease. The first day after transplant, urinary CD133(+) EVs were present at low levels, to increase thereafter (at day 7). Urinary CD133(+) EVs significantly increased in patients with slow graft function in respect to those with early graft function. In patients with a severe pre-transplant vascular damage of the graft, CD133(+) EVs did not increase at day 7. At variance, the levels of EVs expressing the renal exosomal marker CD24 did not vary in the urine of patients with end stage renal disease or in transplanted patients in respect to controls. Sorted CD133(+) EVs were found to express glomerular and proximal tubular markers. These data indicate that urinary CD133(+) EVs are continuously released dLlring the homeostatic turnover of the nephron and may provide information on its function or regenerative potential.	[Dimuccio, Veronica; Bussolati, Benedetta] Univ Turin, Dept Mol Biotechnol & Hlth Sci, Turin, Italy; [Ranghino, Andrea; Biancone, Luigi; Camussi, Giovanni] Univ Turin, Dept Med Sci, Turin, Italy; [Barbato, Loredana Pratico] Citta Salute & Sci Hosp, Immunogenet & Transplant Biol Serv, Turin, Italy; [Fop, Fabrizio] Citta Salute & Sci Hosp, Dept Mol Biotechnol & Hlth Sci, Turin, Italy	University of Turin; University of Turin; A.O.U. Citta della Salute e della Scienza di Torino; A.O.U. Citta della Salute e della Scienza di Torino	Bussolati, B (corresponding author), Univ Turin, Dept Mol Biotechnol & Hlth Sci, Turin, Italy.	benedetta.bussolati@unito.it	Camussi, Giovanni/J-7624-2016; Bussolati, Benedetta/AAA-9058-2022	Camussi, Giovanni/0000-0003-2795-232X; Bussolati, Benedetta/0000-0002-3663-5134; BIANCONE, Luigi/0000-0002-7700-6350	Regione Piemonte; ERA-EDTA	Regione Piemonte(Regione Piemonte); ERA-EDTA	This work was supported by Regione Piemonte, PISTEM project. Dr. Dimuccio was recipient of a long term Fellowship from the ERA-EDTA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2013, STEM CELL TRANSL MED, V2, P1011, DOI 10.5966/sctm.2013-0097; Bauer N, 2011, EMBO MOL MED, V3, P398, DOI 10.1002/emmm.201100147; Bussolati B, 2005, AM J PATHOL, V166, P545, DOI 10.1016/S0002-9440(10)62276-6; Bussolati B, 2012, AM J PHYSIOL-RENAL, V302, pF116, DOI 10.1152/ajprenal.00184.2011; Corbeil D, 2010, FEBS LETT, V584, P1659, DOI 10.1016/j.febslet.2010.01.050; DAVIS BB, 1993, CLIN LAB MED, V13, P131, DOI 10.1016/S0272-2712(18)30465-7; Hogan MC, 2014, KIDNEY INT, V85, P1225, DOI 10.1038/ki.2013.422; Hogan MC, 2009, J AM SOC NEPHROL, V20, P278, DOI 10.1681/ASN.2008060564; Huttner HB, 2008, STEM CELLS, V26, P698, DOI 10.1634/stemcells.2007-0639; Huttner HB, 2012, EPILEPSY RES, V99, P101, DOI 10.1016/j.eplepsyres.2011.10.029; Jenni F, 2013, KIDNEY BLOOD PRESS R, V37, P116, DOI 10.1159/000350065; Keller S, 2007, KIDNEY INT, V72, P1095, DOI 10.1038/sj.ki.5002486; Kim K, 2011, HISTOL HISTOPATHOL, V26, P223, DOI 10.14670/HH-26.223; Logozzi M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005219; Loverre A, 2008, TRANSPLANTATION, V85, P1112, DOI 10.1097/TP.0b013e31816a8891; Marimpietri D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075054; Marsden PA, 2003, NEW ENGL J MED, V349, P182, DOI 10.1056/NEJMe030096; Martinez-Flores JA, 2014, J IMMUNOL METHODS, V403, P62, DOI 10.1016/j.jim.2013.11.019; Marzesco AM, 2005, J CELL SCI, V118, P2849, DOI 10.1242/jcs.02439; Perico N, 2004, LANCET, V364, P1814, DOI 10.1016/S0140-6736(04)17406-0; Pisitkun T, 2004, P NATL ACAD SCI USA, V101, P13368, DOI 10.1073/pnas.0403453101; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Record M, 2011, BIOCHEM PHARMACOL, V81, P1171, DOI 10.1016/j.bcp.2011.02.011; Remuzzi G, 1999, J AM SOC NEPHROL, V10, P2591; Rosengard BR, 2002, AM J TRANSPLANT, V2, P701, DOI 10.1034/j.1600-6143.2002.20804.x; Sagrinati C, 2006, J AM SOC NEPHROL, V17, P2443, DOI 10.1681/ASN.2006010089; Smeets B, 2013, J PATHOL, V229, P645, DOI 10.1002/path.4125; Sonoda H, 2009, AM J PHYSIOL-RENAL, V297, pF1006, DOI 10.1152/ajprenal.00200.2009; van Balkom BWM, 2011, KIDNEY INT, V80, P1138, DOI 10.1038/ki.2011.292; Vlassov AV, 2012, BBA-GEN SUBJECTS, V1820, P940, DOI 10.1016/j.bbagen.2012.03.017; Webber J, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.19861; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Ye YX, 2011, HUM PATHOL, V42, P1132, DOI 10.1016/j.humpath.2010.11.005; Zhou H, 2006, KIDNEY INT, V70, P1847, DOI 10.1038/sj.ki.5001874; Zhou H, 2008, KIDNEY INT, V74, P613, DOI 10.1038/ki.2008.206	35	55	64	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e104490	10.1371/journal.pone.0104490	http://dx.doi.org/10.1371/journal.pone.0104490			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25100147	Green Published, gold, Green Submitted			2022-12-27	WOS:000339995100077
J	Arnold, WH; Heidt, BA; Kuntz, S; Naumova, EA				Arnold, Wolfgang H.; Heidt, Bastian A.; Kuntz, Sebastian; Naumova, Ella A.			Effects of Fluoridated Milk on Root Dentin Remineralization	PLOS ONE			English	Article							CARIES; ENAMEL; BIOFILM	Background: The prevalence of root caries is increasing with greater life expectancy and number of retained teeth. Therefore, new preventive strategies should be developed to reduce the prevalence of root caries. The aim of this study was to investigate the effects of fluoridated milk on the remineralization of root dentin and to compare these effects to those of sodium fluoride (NaF) application without milk. Methods: Thirty extracted human molars were divided into 6 groups, and the root cementum was removed from each tooth. The dentin surface was demineralized and then incubated with one of the following six solutions: Sodium chloride NaCl, artificial saliva, milk, milk+2.5 ppm fluoride, milk+10 ppm fluoride and artificial saliva+10 ppm fluoride. Serial sections were cut through the lesions and investigated with polarized light microscopy and quantitative morphometry, scanning electron microscopy (SEM) and energy-dispersive X-ray spectroscopy (EDS). The data were statistically evaluated using a one-way ANOVA for multiple comparisons. Results: The depth of the lesion decreased with increasing fluoride concentration and was the smallest after incubation with artificial saliva+10 ppm fluoride. SEM analysis revealed a clearly demarcated superficial remineralized zone after incubation with milk+2.5 ppm fluoride, milk+10 ppm fluoride and artificial saliva+10 ppm fluoride. Ca content in this zone increased with increasing fluoride content and was highest after artificial saliva+10 ppm fluoride incubation. In the artificial saliva+10 ppm fluoride group, an additional crystalline layer was present on top of the lesion that contained elevated levels of F and Ca. Conclusion: Incubation of root dentin with fluoridated milk showed a clear effect on root dentin remineralization, and incubation with NaF dissolved in artificial saliva demonstrated a stronger effect.	[Arnold, Wolfgang H.; Heidt, Bastian A.; Kuntz, Sebastian; Naumova, Ella A.] Univ Witten Herdecke, Sch Dent, Fac Hlth, Dept Biol & Mat Sci Dent, Witten, Germany	Witten Herdecke University	Arnold, WH (corresponding author), Univ Witten Herdecke, Sch Dent, Fac Hlth, Dept Biol & Mat Sci Dent, Witten, Germany.	wolfgang.arnold@uni-wh.de			Witten/Herdecke University	Witten/Herdecke University	This study was funded by Witten/Herdecke University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold WH, 2003, ANN ANAT, V185, P419, DOI 10.1016/S0940-9602(03)80099-7; Arnold WH, 2003, ARCH ORAL BIOL, V48, P467, DOI 10.1016/S0003-9969(03)00087-6; Arnold Wolfgang H, 2007, J Prosthodont, V16, P445, DOI 10.1111/j.1532-849X.2007.00220.x; Arnold WH, 2007, ARCH ORAL BIOL, V52, P591, DOI 10.1016/j.archoralbio.2006.11.008; Arnold Wolfgang H., 2006, Biomedical Papers (Olomouc), V150, P63; BANOCZY J, 1985, J ROY SOC HEALTH, V105, P99, DOI 10.1177/146642408510500304; Darling A. I., 1956, BRIT DENT J, V101, P289; Engstrom K, 2006, CLIN ORAL INVEST, V10, P249, DOI 10.1007/s00784-006-0053-4; Espelid I, 2009, EUR ARCH PAEDIATR DE, V10, P149, DOI 10.1007/BF03262676; Fejerskov O, 1997, COMMUNITY DENT ORAL, V25, P5, DOI 10.1111/j.1600-0528.1997.tb00894.x; Giacaman RA, 2012, CARIES RES, V46, P460, DOI 10.1159/000339428; Gokalp S, 2012, COMMUNITY DENT HLTH, V29, P233, DOI 10.1922/CDH_2733Gokalp06; Itthagarun A, 2011, J DENT, V39, P817, DOI 10.1016/j.jdent.2011.08.016; Ivancakova R, 2005, SPEC CARE DENT, V25, P118, DOI 10.1111/j.1754-4505.2005.tb01421.x; Ivanova K, 1995, Adv Dent Res, V9, P120; Marinho VCC, 2009, EUR ARCH PAEDIATR DE, V10, P183, DOI 10.1007/BF03262681; Maslak EE, 2005, CARIES RES, V38, P377; Naumova EA, 2012, J DENT, V40, P750, DOI 10.1016/j.jdent.2012.05.006; Naumova EA, 2012, ARCH ORAL BIOL, V57, P870, DOI 10.1016/j.archoralbio.2012.01.011; Naumova EA, 2010, CENT EUR J MED, V5, P375, DOI 10.2478/s11536-010-0002-0; Neuhaus Klaus, 2005, Schweiz Monatsschr Zahnmed, V115, P1019; NYVAD B, 1982, INT DENT J, V32, P312; Pakhomov G N, 1995, Adv Dent Res, V9, P110; Ravald N, 2012, J CLIN PERIODONTOL, V39, P73, DOI 10.1111/j.1600-051X.2011.01811.x; Riley JC, 2005, COMMUNITY DENT HLTH, V22, P141; Ritter AV, 2010, COMMUNITY DENT ORAL, V38, P383, DOI 10.1111/j.1600-0528.2010.00551.x; Sanchez-Garcia S, 2011, COMMUNITY DENT ORAL, V39, P44, DOI 10.1111/j.1600-0528.2010.00569.x; Silverstone L M, 1968, Br Dent J, V125, P145; Silverstone L M, 1967, Caries Res, V1, P260; Silverstone L M, 1973, Oral Sci Rev, V3, P100; STEPHEN KW, 1984, COMMUNITY DENT ORAL, V12, P223, DOI 10.1111/j.1600-0528.1984.tb01444.x; Sugihara Naoki, 2010, Bull Tokyo Dent Coll, V51, P23; Walls A W G, 2012, Adv Dent Res, V24, P36, DOI 10.1177/0022034512453590; Yeung CA, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003876.pub2; Zimmer Stefan, 2003, Oral Health Prev Dent, V1, P45	35	12	12	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e104327	10.1371/journal.pone.0104327	http://dx.doi.org/10.1371/journal.pone.0104327			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093506	Green Submitted, gold, Green Published			2022-12-27	WOS:000341357200095
J	Hershkovitz, I; Spigelman, M; Sarig, R; Lim, DS; Lee, IS; Oh, CS; May, H; Boaretto, E; Kim, YS; Lee, SD; Peled, N; Kim, MJ; Toledano, T; Bar-Gal, GK; Shin, DH				Hershkovitz, Israel; Spigelman, Mark; Sarig, Rachel; Lim, Do-Sun; Lee, In Sun; Oh, Chang Seok; May, Hila; Boaretto, Elisabetta; Kim, Yi-Suk; Lee, Soong Deok; Peled, Nathan; Kim, Myeung Ju; Toledano, Talya; Bar-Gal, Gila Kahila; Shin, Dong Hoon			A Possible Case of Cherubism in a 17th-Century Korean Mummy	PLOS ONE			English	Article							FIBROUS DYSPLASIA; GENE; SH3BP2; MUTATIONS; PURIFICATION; FEATURES; LESIONS; BONES; MAPS; AGE	Cherubism is a benign fibro-osseous disease of childhood limited specifically to the maxilla and mandible. The progressive replacement of the jaw bones with expansile multilocular cystic lesions causes eventual prominence of the lower face, and hence the classic "cherubic" phenotype reflecting variable extents of jaw hypertrophy. Histologically, this condition has been characterized as replacement of the normal bone matrix with multicystic pockets of fibrous stroma and osteoclastic giant cells. Because of radiographic features common to both, primarily the presence of multiloculated lucencies with heterogeneous "ground-glass" sclerosis on CT imaging, cherubism was long mistaken for a craniofacial subtype of fibrous dysplasia. In 1999, however, the distinct genetic basis for cherubism was mapped to chromosome 4p16.3 and the SH-3 binding protein SH3BP2. But while there are already three suspected cases of fibrous dysplasia amongst archaeological populations, no definitive cases of cherubism have yet been reported in historical populations. In the current study we describe micro-and macro-structural changes in the face of a 17th century Joseon Dynasty Korean mummy which may coincide with the clinic-pathologic and radiologic features of cherubism.	[Hershkovitz, Israel; Spigelman, Mark; Sarig, Rachel; May, Hila] Tel Aviv Univ, Sackler Fac Med, Dept Anat & Anthropol, IL-69978 Tel Aviv, Israel; [Lim, Do-Sun] Eulji Univ, Dept Dent Hyg, Songnam, Gyeonggi Do, South Korea; [Lee, In Sun] Seoul Natl Univ, Coll Med, Dept Diagnost Radiol, Seoul, South Korea; [Oh, Chang Seok; Shin, Dong Hoon] Seoul Natl Univ, Coll Med, Dept Anat, Seoul, South Korea; [Oh, Chang Seok; Lee, Soong Deok; Shin, Dong Hoon] Seoul Natl Univ, Coll Med, Inst Forens Med, Seoul, South Korea; [Lee, Soong Deok] Seoul Natl Univ, Coll Med, Dept Forens Sci, Seoul, South Korea; [Boaretto, Elisabetta] Weizmann Inst Sci, D REAMS Radiocarbon Dating Lab, IL-76100 Rehovot, Israel; [Kim, Yi-Suk] Ewha Womans Univ, Sch Med, Dept Anat, Seoul, South Korea; [Peled, Nathan] Carmel Hosp, Dept Radiol, Haifa, Israel; [Kim, Myeung Ju] Dankook Univ, Coll Med, Dept Anat, Yongin, Gyeonggi Do, South Korea; [Toledano, Talya] Maimonides Hosp, Dept Radiol, Brooklyn, NY 11219 USA; [Bar-Gal, Gila Kahila] Hebrew Univ Jerusalem, Dept Virol, Koret Sch Vet Med, IL-76100 Rehovot, Israel	Tel Aviv University; Sackler Faculty of Medicine; Eulji University; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Weizmann Institute of Science; Ewha Womans University; Clalit Health Services; Carmel Medical Center; Dankook University; Maimonides Medical Center; Hebrew University of Jerusalem	Hershkovitz, I (corresponding author), Tel Aviv Univ, Sackler Fac Med, Dept Anat & Anthropol, IL-69978 Tel Aviv, Israel.	anatom2@post.tau.ac.il; cuteminjae@gmail.com	Hershkovitz, Israel/ABH-4511-2020	Hershkovitz, Israel/0000-0001-5841-6090; Peled, Nir/0000-0003-3714-4377; Sarig, Rachel/0000-0002-9323-5014	Dan David Foundation, The Tassia; Dr. Joseph Meychan Chair for the History and Philosophy of Medicine; Tel Aviv University; Basic Science Research Program through National Research Foundation of Korea (NRF) - Ministry of Education [2013R1A1A2009688]; Conservation Technology Research and Development project (National Research Institute of Cultural Heritage of Cultural Heritage Administration) [10D015Y-00110-2010]	Dan David Foundation, The Tassia; Dr. Joseph Meychan Chair for the History and Philosophy of Medicine; Tel Aviv University; Basic Science Research Program through National Research Foundation of Korea (NRF) - Ministry of Education; Conservation Technology Research and Development project (National Research Institute of Cultural Heritage of Cultural Heritage Administration)	This study was supported by the Dan David Foundation, The Tassia and Dr. Joseph Meychan Chair for the History and Philosophy of Medicine, Tel Aviv University, the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2013R1A1A2009688), and by the Conservation Technology Research and Development project (National Research Institute of Cultural Heritage of Cultural Heritage Administration 10D015Y-00110-2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNOTT DG, 1978, BRIT J ORAL SURG, V16, P38, DOI 10.1016/S0007-117X(78)80054-7; Atalar MH, 2008, J HK COLL RADIOL, V11, P76; AYOUB AF, 1993, J ORAL MAXIL SURG, V51, P702, DOI 10.1016/S0278-2391(10)80276-9; Bancroft G.D., 1996, THEORY PRACTICE PATH, V4th ed.; Bass W.M., 1987, HUMAN OSTEOLOGY LAB, Vthird; Beaman FD, 2004, AM J ROENTGENOL, V182, P1051, DOI 10.2214/ajr.182.4.1821051; BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; Buikstra J.E., 1994, STANDARDS DATA COLLE, DOI 10.1002/ajhb.1310070519; de Lange J, 2005, ORAL SURG ORAL MED O, V99, P464, DOI 10.1016/j.tripleo.2004.11.015; Denninger HS, 1931, ARCH PATHOL, V11, P939; DiCaprio MR, 2005, J BONE JOINT SURG AM, V87A, P1848, DOI 10.2106/JBJS.D.02942; Eller R, 2006, OTOLARYNG CLIN N AM, V39, P585, DOI 10.1016/j.otc.2006.01.013; Faerman M, 2000, AM J PHYS ANTHROPOL, V111, P153; Fitzpatrick KA, 2004, AM J ROENTGENOL, V182, P1389, DOI 10.2214/ajr.182.6.1821389; Goossens M, 1981, Methods Enzymol, V76, P805; HOSS M, 1993, NUCLEIC ACIDS RES, V21, P3913, DOI 10.1093/nar/21.16.3913; Hyckel P, 2005, J CRANIO MAXILL SURG, V33, P61, DOI 10.1016/j.jcms.2004.07.006; Idowu BD, 2008, BRIT J ORAL MAX SURG, V46, P229, DOI 10.1016/j.bjoms.2007.04.014; Jain V, 2006, PEDIATR RADIOL, V36, P1099, DOI 10.1007/s00247-006-0261-8; Jones WA., 1933, AM J CANC, V17, P946, DOI [10.1158/ajc.1933.946, DOI 10.1158/AJC.1933.946]; Kozakiewicz M, 2001, ORAL DIS, V7, P123, DOI 10.1034/j.1601-0825.2001.0070211.x; Lee JY, 2008, ACTA MED OKAYAMA, V62, P209; Lessa Marcus M, 2005, Ear Nose Throat J, V84, P432; Lietman SA, 2006, HUM MUTAT, V27, DOI 10.1002/humu.9433; Lim DS, 2008, J ANAT, V213, P482, DOI 10.1111/j.1469-7580.2008.00955.x; Lo B, 2003, AM J MED GENET A, V121A, P37, DOI 10.1002/ajmg.a.20226; Mangion J, 1999, AM J HUM GENET, V65, P151, DOI 10.1086/302454; Mangion J, 2000, J Med Genet, V37, pE37, DOI 10.1136/jmg.37.11.e37; Nah KS, 1997, J KOREAN ACAD ORAL M, V27, P251; Oh CS, 2013, ANTHR ANZ IN PRESS; Ortner D. J., 1985, IDENTIFICATION PATHO, V28; Ozkan Y, 2003, INT J PEDIATR OTORHI, V67, P1005, DOI 10.1016/S0165-5876(03)00179-4; Petkovska L, 2004, Australas Radiol, V48, P408, DOI 10.1111/j.0004-8461.2004.01329.x; Ramsey CB, 2001, RADIOCARBON, V43, P355; Ramsey CB, 1995, RADIOCARBON, V37, P425, DOI 10.1017/S0033822200030903; Reimer PJ, 2009, RADIOCARBON, V51, P1111, DOI 10.1017/S0033822200034202; Shah S, 2012, SKELETAL RADIOL, V41, P341, DOI 10.1007/s00256-011-1245-9; Shin DH, 2012, J ARCHAEOL SCI, V39, P1103, DOI 10.1016/j.jas.2011.12.011; Shin M.H., 2008, MUMMIES SCI WORLD MU, P105; Sholapurkar Amar A, 2008, Indian J Dent Res, V19, P78; Tartaglia M, 2002, AM J HUM GENET, V70, P1555, DOI 10.1086/340847; Tiziani V, 1999, AM J HUM GENET, V65, P158, DOI 10.1086/302456; Tsai TL, 2003, J CHIN MED ASSOC, V66, P192; Tsai Tung-Lung, 2003, J Chin Med Assoc, V66, P131; Ueki Y, 2001, NAT GENET, V28, P125, DOI 10.1038/88832; von Wowern N, 2000, ORAL SURG ORAL MED O, V90, P765, DOI 10.1067/moe.2000.108438; WALKER RA, 1985, AM J PHYS ANTHROPOL, V68, P67, DOI 10.1002/ajpa.1330680107; WELLS C, 1963, BRIT J RADIOL, V36, P925, DOI 10.1259/0007-1285-36-432-925; Yamaguchi T, 1999, SKELETAL RADIOL, V28, P350, DOI 10.1007/s002560050530; Yizhaq M, 2005, RADIOCARBON, V47, P193, DOI 10.1017/S003382220001969X; ZACHARIADES N, 1985, INT J ORAL MAXILLOF, V14, P138, DOI 10.1016/S0300-9785(85)80085-5; Zenn MR, 2001, J CRANIOFAC SURG, V12, P259, DOI 10.1097/00001665-200105000-00012	52	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e102441	10.1371/journal.pone.0102441	http://dx.doi.org/10.1371/journal.pone.0102441			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093864	Green Published, gold, Green Submitted			2022-12-27	WOS:000341357200011
J	Petri, RM; Mapiye, C; Dugan, MER; McAllister, TA				Petri, Renee M.; Mapiye, Cletos; Dugan, Mike E. R.; McAllister, Tim A.			Subcutaneous Adipose Fatty Acid Profiles and Related Rumen Bacterial Populations of Steers Fed Red Clover or Grass Hay Diets Containing Flax or Sunflower-Seed	PLOS ONE			English	Article							CONJUGATED LINOLEIC-ACID; FORAGE CONSERVATION METHOD; LIPID-METABOLISM; FEEDING FLAXSEED; VACCENIC ACID; LINSEED OIL; RUMINAL BIOHYDROGENATION; EXTRUDED SEEDS; ROLLED SEEDS; CANCER-CELLS	Steers were fed 70:30 forage:concentrate diets for 205 days, with either grass hay (GH) or red clover silage (RC), and either sunflower-seed (SS) or flaxseed (FS), providing 5.4% oil in the diets. Compared to diets containing SS, FS diets had elevated (P<0.05) subcutaneous trans (t)-18:1 isomers, conjugated linoleic acids and n-6 polyunsaturated fatty acid (PUFA). Forage and oilseed type influenced total n-3 PUFA, especially alpha-linolenic acid (ALA) and total non-conjugated diene biohydrogenation (BH) in subcutaneous fat with proportions being greater (P<0.05) for FS or GH as compared to SS or RC. Of the 25 bacterial genera impacted by diet, 19 correlated with fatty acids (FA) profile. Clostridium were most abundant when levels of conjugated linolenic acids, and n-3 PUFA's were found to be the lowest in subcutaneous fat, suggestive of their role in BH. Anerophaga, Fibrobacter, Guggenheimella, Paludibacter and Pseudozobellia were more abundant in the rumen when the levels of VA in subcutaneous fat were low. This study clearly shows the impact of oilseeds and forage source on the deposition of subcutaneous FA in beef cattle. Significant correlations between rumen bacterial genera and the levels of specific FA in subcutaneous fat maybe indicative of their role in determining the FA profile of adipose tissue. However, despite numerous correlations, the dynamics of rumen bacteria in the BH of unsaturated fatty acid and synthesis of PUFA and FA tissue profiles require further experimentation to determine if these correlations are consistent over a range of diets of differing composition. Present results demonstrate that in order to achieve targeted FA profiles in beef, a multifactorial approach will be required that takes into consideration not only the PUFA profile of the diet, but also the non-oil fraction of the diet, type and level of feed processing, and the role of rumen microbes in the BH of unsaturated fatty acid.	[Petri, Renee M.; McAllister, Tim A.] Agr & Agri Food Canada, Lethbridge Res Ctr, Lethbridge, AB, Canada; [Mapiye, Cletos; Dugan, Mike E. R.] Agr & Agri Food Canada, Lacombe Res Ctr, Lacombe, AB, Canada; [Mapiye, Cletos] Univ Stellenbosch, Fac AgriSci, Dept Anim Sci, Matieland, Western Cape, South Africa	Agriculture & Agri Food Canada; Agriculture & Agri Food Canada; Stellenbosch University	McAllister, TA (corresponding author), Agr & Agri Food Canada, Lethbridge Res Ctr, Lethbridge, AB, Canada.	tim.mcallister@agr.gc.ca	Petri, Renee Maxine/J-6102-2019; Mapiye, Cletos/K-9309-2016; McAllister, Tim A./R-9201-2017	Petri, Renee Maxine/0000-0002-8209-8261; Mapiye, Cletos/0000-0002-1474-8648; McAllister, Tim A./0000-0002-8266-6513	Alberta Meat and Livestock Agency (ALMA); NSERC through ALMA	Alberta Meat and Livestock Agency (ALMA); NSERC through ALMA	This work was financed by the Alberta Meat and Livestock Agency (ALMA). Dr. C. Mapiye acknowledges the receipt of NSERC Fellowships funded through ALMA (alma.alberta.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbuGhazaleh AA, 2007, ANIM FEED SCI TECH, V136, P11, DOI 10.1016/j.anifeedsci.2006.08.020; AbuGhazaleh AA, 2002, J DAIRY SCI, V85, P2266, DOI 10.3168/jds.S0022-0302(02)74306-3; Aldai N, 2009, CAN J ANIM SCI, V89, P315, DOI 10.4141/CJAS08126; [Anonymous], 1993, GUIDE CARE USE EXPT; Basarab JA, 2007, CAN J ANIM SCI, V87, P71, DOI 10.4141/A06-048; Bernard L, 2009, J DAIRY SCI, V92, P6083, DOI 10.3168/jds.2009-2048; Bessa RJB, 2007, EUR J LIPID SCI TECH, V109, P868, DOI 10.1002/ejlt.200600311; BRETHOUR JR, 1992, J ANIM SCI, V70, P1039, DOI 10.2527/1992.7041039x; Chow TT, 2004, ANIM FEED SCI TECH, V117, P1, DOI 10.1016/j.anifeedsci.2004.08.008; Crumb D. J., 2011, International Journal of Applied Research in Natural Products, V4, P12; Cruz-Hernandez C, 2004, J AOAC INT, V87, P545; Dilzer Allison, 2012, Crit Rev Food Sci Nutr, V52, P488, DOI 10.1080/10408398.2010.501409; Doreau M, 2009, ANIM FEED SCI TECH, V150, P187, DOI 10.1016/j.anifeedsci.2008.09.004; DOREAU M, 1994, ANIM FEED SCI TECH, V45, P379, DOI 10.1016/0377-8401(94)90039-6; Doreau M, 2009, LIPIDS, V44, P53, DOI 10.1007/s11745-008-3250-x; Dowd SE, 2008, BMC MICROBIOL, V8, DOI [10.1186/1471-2180-8-125, 10.1186/1471-2180-8-43]; Dugan MER, 2008, CAN J ANIM SCI, V88, P591, DOI 10.4141/CJAS08024; Field CJ, 2009, APPL PHYSIOL NUTR ME, V34, P979, DOI 10.1139/H09-079; Geay Y, 2001, REPROD NUTR DEV, V41, P1, DOI 10.1051/rnd:2001108; Gomez-Cortes P, 2009, J DAIRY SCI, V92, P4122, DOI 10.3168/jds.2008-1909; Gunstone F. D., 1994, LIPID HDB, P101; Halmemies-Beauchet-Filleau A, 2013, J DAIRY SCI, V96, P2428, DOI 10.3168/jds.2012-6043; HARFOOT CG, 1973, J SCI FOOD AGR, V24, P961, DOI 10.1002/jsfa.2740240814; He ML, 2012, J ANIM SCI, V90, P592, DOI 10.2527/jas.2011-4281; Hegarty RS, 2004, AUST J EXP AGR, V44, P458, DOI 10.1071/EA02148; Hennessy AA, 2011, LIPIDS, V46, P105, DOI 10.1007/s11745-010-3501-5; HOBSON PN, 1965, J GEN MICROBIOL, V38, P167, DOI 10.1099/00221287-38-2-167; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Huws SA, 2011, ENVIRON MICROBIOL, V13, P1500, DOI 10.1111/j.1462-2920.2011.02452.x; Jacobs AAA, 2011, J DAIRY SCI, V94, P874, DOI 10.3168/jds.2010-3511; Jaudszus A, 2012, BBA-MOL CELL BIOL L, V1821, P1316, DOI 10.1016/j.bbalip.2012.06.010; Jenkins TC, 2008, J ANIM SCI, V86, P397, DOI 10.2527/jas.2007-0588; JENKINS TC, 1993, J DAIRY SCI, V76, P3851, DOI 10.3168/jds.S0022-0302(93)77727-9; Jeronimo E, 2011, EUR J LIPID SCI TECH, V113, P924, DOI 10.1002/ejlt.201000398; Juarez M, 2011, MEAT SCI, V88, P434, DOI 10.1016/j.meatsci.2011.01.023; Khan NA, 2009, ANIM FEED SCI TECH, V154, P183, DOI 10.1016/j.anifeedsci.2009.09.005; Kim CM, 2009, ASIAN AUSTRAL J ANIM, V22, P1151, DOI 10.5713/ajas.2009.90096; Kong YH, 2010, APPL ENVIRON MICROB, V76, P6933, DOI 10.1128/AEM.00217-10; Kramer JKG, 2008, LIPIDS, V43, P259, DOI 10.1007/s11745-007-3143-4; Lee MRF, 2009, MEAT SCI, V81, P738, DOI 10.1016/j.meatsci.2008.11.016; Lee MRF, 2003, ANIM SCI, V76, P491, DOI 10.1017/S1357729800058719; Lee YJ, 2011, J NUTR, V141, P1445, DOI 10.3945/jn.111.138396; Lock AL, 2002, ANIM SCI, V74, P163, DOI 10.1017/S1357729800052334; Maia MRG, 2007, ANTON LEEUW INT J G, V91, P303, DOI 10.1007/s10482-006-9118-2; Mapiye C, 2013, MEAT SCI, V95, P98, DOI 10.1016/j.meatsci.2013.03.033; Mapiye C, 2013, LIVEST SCI, V151, P11, DOI 10.1016/j.livsci.2012.10.021; Mapiye C, 2013, CANADIAN J ANIMAL SC, V93, P1; Marin ALM, 2012, J DAIRY SCI, V95, P1942, DOI 10.3168/jds.2011-4303; McKain N, 2010, MICROBIOL-SGM, V156, P579, DOI 10.1099/mic.0.036442-0; McNeill S, 2012, MEAT SCI, V92, P166, DOI 10.1016/j.meatsci.2012.03.014; Narvaez N, 2013, J SCI FOOD AGR, V93, P45, DOI 10.1002/jsfa.5725; Nassu RT, 2011, MEAT SCI, V89, P469, DOI 10.1016/j.meatsci.2011.05.016; Noci F, 2007, J ANIM SCI, V85, P1062, DOI 10.2527/jas.2006-105; Petri RM, 2013, APPL ENVIRON MICROB, V79, P3744, DOI 10.1128/AEM.03983-12; Petri RM, 2012, J APPL MICROBIOL, V112, P1152, DOI 10.1111/j.1365-2672.2012.05295.x; Petri RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083424; Raes K, 2004, ANIM FEED SCI TECH, V113, P199, DOI 10.1016/j.anifeedsci.2003.09.001; Raes K, 2003, REPROD NUTR DEV, V43, P331, DOI 10.1051/rnd:2003029; Ran-Ressler RR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029032; RUSSELL JB, 1979, APPL ENVIRON MICROB, V37, P531, DOI 10.1128/AEM.37.3.531-536.1979; Salter AM, 2014, ANIMAL IN PRESS, DOI [10.1017/S1751731111002023, DOI 10.1017/S1751731111002023]; Sarnklong C, 2010, ASIAN AUSTRAL J ANIM, V23, P680, DOI 10.5713/ajas.2010.80619; SAS, 2009, US GUID, VVersion 9.2 ed.; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Scollan ND, 2005, EAAP PUBLIC, P151; Shingfield K. J., 2008, ADV EXPT MED BIOL; Shingfield KJ, 2005, J DAIRY RES, V72, P349, DOI 10.1017/S0022029905000919; Sofi F, 2010, NUTR METAB CARDIOVAS, V20, P117, DOI 10.1016/j.numecd.2009.03.004; Van Ranst G, 2011, ANIMAL, V5, P512, DOI 10.1017/S1751731110002028; Vlaeminck B, 2006, ANIM FEED SCI TECH, V131, P389, DOI 10.1016/j.anifeedsci.2006.06.017; Wongtangtintharn S, 2004, J NUTR SCI VITAMINOL, V50, P137, DOI 10.3177/jnsv.50.137; Yang ZH, 2000, CANCER RES, V60, P505; Yutin N, 2013, ENVIRON MICROBIOL, V15, P2631, DOI 10.1111/1462-2920.12173	74	29	33	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e104167	10.1371/journal.pone.0104167	http://dx.doi.org/10.1371/journal.pone.0104167			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093808	Green Published, Green Submitted, gold			2022-12-27	WOS:000341357200081
J	Zvielli, A; Bernstein, A; Koster, EHW				Zvielli, Ariel; Bernstein, Amit; Koster, Ernst H. W.			Dynamics of Attentional Bias to Threat in Anxious Adults: Bias towards and/or Away?	PLOS ONE			English	Article							SEROTONIN TRANSPORTER GENE; IMPAIRMENT SCALE OASIS; EMOTIONAL DISORDERS; SELECTIVE ATTENTION; ANGRY FACES; TIME-COURSE; ANXIETY SEVERITY; VALIDATION; DISENGAGEMENT; INDIVIDUALS	The aim of the present study was to question untested assumptions about the nature of the expression of Attentional Bias (AB) towards and away from threat stimuli. We tested the idea that high trait anxious individuals (N= 106; M(SD)(age) = 23.9(3.2) years; 68% women) show a stable AB towards multiple categories of threatening information using the emotional visual dot probe task. AB with respect to five categories of threat stimuli (i.e., angry faces, attacking dogs, attacking snakes, pointed weapons, violent scenes) was evaluated. In contrast with current theories, we found that 34% of participants expressed AB towards threat stimuli, 20.8% AB away from threat stimuli, and 34% AB towards some categories of threat stimuli and away from others. The multiple observed expressions of AB were not an artifact of a specific criterion AB score cut-off; not specific to certain categories of threat stimuli; not an artifact of differences in within-subject variability in reaction time; nor accounted for by individual differences in anxiety-related variables. Findings are conceptualized as reflecting the understudied dynamics of AB expression, with implications for AB measurement and quantification, etiology, relations, and intervention research.	[Zvielli, Ariel; Bernstein, Amit] Univ Haifa, Dept Psychol, IL-31999 Haifa, Israel; [Koster, Ernst H. W.] Univ Ghent, Dept Psychol, B-9000 Ghent, Belgium	University of Haifa; Ghent University	Bernstein, A (corresponding author), Univ Haifa, Dept Psychol, IL-31999 Haifa, Israel.	abernstein@psy.haifa.ac.il	Koster, Ernst H.W./AFS-7487-2022	Koster, Ernst H.W./0000-0003-0792-476X	Israeli Council for Higher Education Yigal Alon Fellowship; European Union FP-7 Marie Curie Fellowship International Reintegration Grant; Psychology Beyond Borders Mission Award; Israel Science Foundation; University of Haifa Research Authority Exploratory Grant; Rothschild-Caesarea Foundation's Returning Scientists Project at the University of Haifa; University of Haifa President's Doctoral Fellowship Program	Israeli Council for Higher Education Yigal Alon Fellowship; European Union FP-7 Marie Curie Fellowship International Reintegration Grant; Psychology Beyond Borders Mission Award; Israel Science Foundation(Israel Science Foundation); University of Haifa Research Authority Exploratory Grant; Rothschild-Caesarea Foundation's Returning Scientists Project at the University of Haifa; University of Haifa President's Doctoral Fellowship Program	Dr. Bernstein recognizes the funding support from the Israeli Council for Higher Education Yigal Alon Fellowship, the European Union FP-7 Marie Curie Fellowship International Reintegration Grant, Psychology Beyond Borders Mission Award, Israel Science Foundation, the University of Haifa Research Authority Exploratory Grant, and the Rothschild-Caesarea Foundation's Returning Scientists Project at the University of Haifa. Mr. Zvielli recognizes the support from the University of Haifa President's Doctoral Fellowship Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar-Haim Y, 2007, PSYCHOL BULL, V133, P1, DOI 10.1037/0033-2909.133.1.1; Bar-Haim Y, 2010, AM J PSYCHIAT, V167, P694, DOI 10.1176/appi.ajp.2009.09070956; Bardeen JR, 2011, J ANXIETY DISORD, V25, P1008, DOI 10.1016/j.janxdis.2011.06.009; Beard C, 2012, BEHAV THER, V43, P724, DOI 10.1016/j.beth.2012.01.002; Beevers CG, 2009, J ABNORM PSYCHOL, V118, P670, DOI 10.1037/a0016198; Bernstein A, 2014, BEHAV RES THER, V55, P18, DOI 10.1016/j.brat.2014.01.003; Bishop SJ, 2009, NAT NEUROSCI, V12, P92, DOI 10.1038/nn.2242; Bogels SM, 2004, CLIN PSYCHOL REV, V24, P827, DOI 10.1016/j.cpr.2004.06.005; Bradley BP, 2003, PSYCHOL ADDICT BEHAV, V17, P66, DOI 10.1037/0893-164X.17.1.66; BRISLIN RW, 1970, J CROSS CULT PSYCHOL, V1, P185, DOI 10.1177/135910457000100301; Britton JC, 2011, DEPRESS ANXIETY, V28, P5, DOI 10.1002/da.20733; Browning M, 2010, COGN AFFECT BEHAV NE, V10, P8, DOI 10.3758/CABN.10.1.8; Browning M, 2010, BIOL PSYCHIAT, V67, P919, DOI 10.1016/j.biopsych.2009.10.031; Calvo MG, 2005, COGNITION EMOTION, V19, P433, DOI 10.1080/02699930441000157; Campbell-Sills L, 2009, J AFFECT DISORDERS, V112, P92, DOI 10.1016/j.jad.2008.03.014; Cisler JM, 2010, CLIN PSYCHOL REV, V30, P203, DOI 10.1016/j.cpr.2009.11.003; Coan J. A., 2007, HDB EMOTION ELICITAT; Derakshan N, 2009, EXP PSYCHOL, V56, P48, DOI 10.1027/1618-3169.56.1.48; Eitam B, 2010, SOC PERSONAL PSYCHOL, V4, P951, DOI 10.1111/j.1751-9004.2010.00309.x; Eldar S, 2010, BIOL PSYCHOL, V85, P252, DOI 10.1016/j.biopsycho.2010.07.010; Etkin A, 2011, TRENDS COGN SCI, V15, P85, DOI 10.1016/j.tics.2010.11.004; EYSENCK HJ, 1992, PERS INDIV DIFFER, V13, P867, DOI 10.1016/0191-8869(92)90003-8; Field M, 2009, PSYCHOL BULL, V135, P589, DOI 10.1037/a0015843; Fox E, 2011, BIOL PSYCHIAT, V70, P1049, DOI 10.1016/j.biopsych.2011.07.004; Geisinger K., 1994, PSYCHOL ASSESSMENT, V6, P304, DOI [10.1037/1040-3590.6.4.304, DOI 10.1037/1040-3590.6.4.304]; Gilboa-Schechtman E, 2002, PSYCHIAT RES, V113, P279, DOI 10.1016/S0165-1781(02)00266-4; Hakamata Y, 2010, BIOL PSYCHIAT, V68, P982, DOI 10.1016/j.biopsych.2010.07.021; Hallion LS, 2011, PSYCHOL BULL, V137, P940, DOI 10.1037/a0024355; Hertel PT, 2011, PERSPECT PSYCHOL SCI, V6, P521, DOI 10.1177/1745691611421205; Koster EHW, 2006, BEHAV RES THER, V44, P1757, DOI 10.1016/j.brat.2005.12.011; Lang P. J., 1999, INT AFFECTIVE PICTUR; Luijten M, 2012, NEUROPSYCHOPHARMACOL, V37, P2772, DOI 10.1038/npp.2012.143; MACLEOD C, 1986, J ABNORM PSYCHOL, V95, P15, DOI 10.1037/0021-843X.95.1.15; Massar SAA, 2011, COGNITION EMOTION, V25, P805, DOI 10.1080/02699931.2010.515065; Mathews A, 1998, COGNITIVE THER RES, V22, P539, DOI 10.1023/A:1018738019346; Mathews A, 2005, ANNU REV CLIN PSYCHO, V1, P167, DOI 10.1146/annurev.clinpsy.1.102803.143916; Mikels JA, 2005, BEHAV RES METHODS, V37, P626, DOI 10.3758/BF03192732; Mineka S, 2008, ACTA PSYCHOL, V127, P567, DOI 10.1016/j.actpsy.2007.11.007; Mogg K, 1997, BEHAV RES THER, V35, P297, DOI 10.1016/S0005-7967(96)00109-X; Mogg K, 2004, COGNITION EMOTION, V18, P689, DOI 10.1080/02699930341000158; Mogg K, 1998, BEHAV RES THER, V36, P809, DOI 10.1016/S0005-7967(98)00063-1; Mogg K, 2000, COGNITION EMOTION, V14, P375, DOI 10.1080/026999300378888; Mogg K, 2008, BEHAV RES THER, V46, P656, DOI 10.1016/j.brat.2008.02.011; Monk CS, 2006, AM J PSYCHIAT, V163, P1091, DOI 10.1176/appi.ajp.163.6.1091; Norman SB, 2006, DEPRESS ANXIETY, V23, P245, DOI 10.1002/da.20182; Olsson A, 2007, NAT NEUROSCI, V10, P1095, DOI 10.1038/nn1968; Osinsky R, 2012, EMOTION, V12, P460, DOI 10.1037/a0026674; Peckham AD, 2010, DEPRESS ANXIETY, V27, P1135, DOI 10.1002/da.20755; Perez-Edgar K, 2010, BIOL PSYCHOL, V83, P269, DOI 10.1016/j.biopsycho.2009.08.009; Robinson OJ, 2012, NEUROIMAGE, V60, P523, DOI 10.1016/j.neuroimage.2011.11.096; Rueda M. R., 2011, HDB SELF REGULATION, P284; Schneider W., 2002, E PRIME USERS GUIDE; Shechner T, 2013, DEPRESS ANXIETY, V30, P14, DOI 10.1002/da.21986; Shechner T, 2012, DEPRESS ANXIETY, V29, P282, DOI 10.1002/da.20914; Spielberger C, 1983, STAIC STATETRAIT ANX; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Taylor S, 2007, PSYCHOL ASSESSMENT, V19, P176, DOI 10.1037/1040-3590.19.2.176; Terburg D, 2012, PSYCHOL SCI, V23, P459, DOI 10.1177/0956797611433336; Tran US, 2013, J RES PERS, V47, P390, DOI 10.1016/j.jrp.2013.03.007; Vuilleumier P, 2005, TRENDS COGN SCI, V9, P585, DOI 10.1016/j.tics.2005.10.011; Watson D, 2007, PSYCHOL ASSESSMENT, V19, P253, DOI 10.1037/1040-3590.19.3.253; Williams JMG, 1996, PSYCHOL BULL, V120, P3, DOI 10.1037/0033-2909.120.1.3; Wilson E, 2003, J ABNORM PSYCHOL, V112, P212, DOI 10.1037/0021-843X.112.2.212	63	64	64	2	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e104025	10.1371/journal.pone.0104025	http://dx.doi.org/10.1371/journal.pone.0104025			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO5BW	25093664	Green Submitted, Green Published, gold			2022-12-27	WOS:000341357200061
J	Horsak, M; Chytry, M				Horsak, Michal; Chytry, Milan			Unimodal Latitudinal Pattern of Land-Snail Species Richness across Northern Eurasian Lowlands	PLOS ONE			English	Article							PLANT DIVERSITY; GLOBAL PATTERNS; GRADIENT; CLIMATE; ENERGY; SCALE; WATER; HABITAT; PRODUCTIVITY; NESTEDNESS	Large-scale patterns of species richness and their causes are still poorly understood for most terrestrial invertebrates, although invertebrates can add important insights into the mechanisms that generate regional and global biodiversity patterns. Here we explore the general plausibility of the climate-based "water-energy dynamics'' hypothesis using the latitudinal pattern of land-snail species richness across extensive topographically homogeneous lowlands of northern Eurasia. We established a 1480-km long latitudinal transect across the Western Siberian Plain (Russia) from the Russia-Kazakhstan border (54.5 degrees N) to the Arctic Ocean (67.5 degrees N), crossing eight latitudinal vegetation zones: steppe, forest-steppe, subtaiga, southern, middle and northern taiga, forest-tundra, and tundra. We sampled snails in forests and open habitats each half-degree of latitude and used generalized linear models to relate snail species richness to climatic variables and soil calcium content measured in situ. Contrary to the classical prediction of latitudinal biodiversity decrease, we found a striking unimodal pattern of snail species richness peaking in the subtaiga and southern-taiga zones between 57 and 59 degrees N. The main south-to-north interchange of the two principal diversity constraints, i.e. drought stress vs. cold stress, explained most of the variance in the latitudinal diversity pattern. Water balance, calculated as annual precipitation minus potential evapotranspiration, was a single variable that could explain 81.7% of the variance in species richness. Our data suggest that the "water-energy dynamics'' hypothesis can apply not only at the global scale but also at subcontinental scales of higher latitudes, as water availability was found to be the primary limiting factor also in this extratropical region with summer-warm and dry climate. A narrow zone with a sharp south-to-north switch in the two main diversity constraints seems to constitute the dominant and general pattern of terrestrial diversity across a large part of northern Eurasia, resulting in a subcontinental diversity hotspot of various taxa in this zone.	[Horsak, Michal; Chytry, Milan] Masaryk Univ, Dept Bot & Zool, Brno, Czech Republic	Masaryk University Brno	Horsak, M (corresponding author), Masaryk Univ, Dept Bot & Zool, Brno, Czech Republic.	horsak@sci.muni.cz	Chytrý, Milan/J-4954-2012	Chytrý, Milan/0000-0002-8122-3075; Horsak, Michal/0000-0003-2742-2740	Czech Science Foundation [P504/11/0454]	Czech Science Foundation(Grant Agency of the Czech Republic)	This study was funded by the Czech Science Foundation (P504/11/0454). The funders oversaw the collection of data and preparation of the manuscript, but had no role in the study design, data analysis, or decision to publish.	Ansart A, 2003, ACTA OECOL, V24, P95, DOI 10.1016/S1146-609X(03)00045-6; Bannister JR, 2012, AUSTRAL ECOL, V37, P500, DOI 10.1111/j.1442-9993.2011.02312.x; Bromham L, 2003, J EVOLUTION BIOL, V16, P200, DOI 10.1046/j.1420-9101.2003.00526.x; Buckley LB, 2007, P ROY SOC B-BIOL SCI, V274, P1167, DOI 10.1098/rspb.2006.0436; Cameron RAD, 1991, P 10 INT MAL C, P437; Cameron RAD, 2010, MALACOLOGIA, V53, P77, DOI 10.4002/040.053.0105; Cardillo M, 2005, ECOLOGY, V86, P2278, DOI 10.1890/05-0112; Chown SL, 1998, ECOGRAPHY, V21, P342, DOI 10.1111/j.1600-0587.1998.tb00399.x; Churkina G, 1999, GLOBAL CHANGE BIOL, V5, P46, DOI 10.1046/j.1365-2486.1999.00006.x; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; COOK RD, 1977, TECHNOMETRICS, V19, P15, DOI 10.2307/1268249; CURRIE DJ, 1991, AM NAT, V137, P27, DOI 10.1086/285144; Davidowitz G, 1998, J BIOGEOGR, V25, P553, DOI 10.1046/j.1365-2699.1998.2530553.x; Del Grosso S, 2008, ECOLOGY, V89, P2117, DOI 10.1890/07-0850.1; Ehlers J, 2004, QUATERNARY GLACIAT 3; Field R, 2005, ECOLOGY, V86, P2263, DOI 10.1890/04-1910; Field R, 2009, J BIOGEOGR, V36, P132, DOI 10.1111/j.1365-2699.2008.01963.x; Francis AP, 2003, AM NAT, V161, P523, DOI 10.1086/368223; Hausdorf B, 2003, OECOLOGIA, V135, P102, DOI 10.1007/s00442-002-1142-y; Hawkins BA, 2003, ECOLOGY, V84, P3105, DOI 10.1890/03-8006; Hawkins BA, 2003, ECOLOGY, V84, P1608, DOI 10.1890/0012-9658(2003)084[1608:PAHAPO]2.0.CO;2; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hillebrand H, 2004, AM NAT, V163, P192, DOI 10.1086/381004; Horsak M, 2006, J BIOGEOGR, V33, P98, DOI 10.1111/j.1365-2699.2005.01359.x; Horsak M., 2013, MOLLUSCS CZECH SLOVA, DOI DOI 10.1016/j.yqres.2014.01.015; Horsak M, 2008, J BIOGEOGR, V35, P1215, DOI 10.1111/j.1365-2699.2007.01856.x; Horsak M, 2013, POLAR BIOL, V36, P185, DOI 10.1007/s00300-012-1249-5; Horsak Michal, 2003, Malacologica Bohemoslovaca, V2, P11; Hylander K, 2005, OIKOS, V108, P351, DOI 10.1111/j.0030-1299.2005.13400.x; JANZEN DH, 1981, ECOLOGY, V62, P532, DOI 10.2307/1937717; Jurickova L, 2008, EUR J SOIL BIOL, V44, P172, DOI 10.1016/j.ejsobi.2007.07.001; Kerney MP, 1983, LANDSCHNECKEN NORDUN; Lennon JJ, 2000, J ANIM ECOL, V69, P581, DOI 10.1046/j.1365-2656.2000.00418.x; Lozek V., 1964, QUARTARMOLLUSKEN TSC; Malyshev LI, 1993, FRAGM FLOR GEOBOT S, V2, P331; Martin K, 2004, J BIOGEOGR, V31, P531, DOI 10.1046/j.1365-2699.2003.01005.x; Mittelbach GG, 2001, ECOLOGY, V82, P2381, DOI 10.1890/0012-9658(2001)082[2381:WITORB]2.0.CO;2; Nekola J. C., 2009, TENTACLE, V17, P26; Nekola Jeffrey C., 2005, Records of the Western Australian Museum Supplement, V68, P39; O'Brien EM, 2006, J BIOGEOGR, V33, P1868, DOI 10.1111/j.1365-2699.2006.01534.x; O'Brien EM, 1998, J BIOGEOGR, V25, P379, DOI 10.1046/j.1365-2699.1998.252166.x; O'Brien EM, 1998, ECOGRAPHY, V21, P495, DOI 10.1111/j.1600-0587.1998.tb00441.x; Pilsbry H. A., 1948, LAND MOLLUSCA N AM 2, V2; Pimm SL, 2004, SCIENCE, V304, P831, DOI 10.1126/science.1095332; R Core Team, 2021, R LANGUAGE ENV STAT; Riddle WA, 1983, MOLLUSCA, V6, P431; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; ROSENZWEIG ML, 1992, J MAMMAL, V73, P715, DOI 10.2307/1382191; Schamp B, 2010, J ANIM ECOL, V79, P803, DOI 10.1111/j.1365-2656.2010.01685.x; Skillen EL, 2000, ENVIRON ENTOMOL, V29, P460, DOI 10.1603/0046-225X-29.3.460; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Sysoev A., 2009, LAND SNAILS RUSSIA A; Trabucco A, 2008, AGR ECOSYST ENVIRON, V126, P81, DOI 10.1016/j.agee.2008.01.015; von Humboldt A, 1808, ANSICHTEN NATUR WISS; Walter H, 1974, VEGETATION OSTEUROPA; WAREBORN I, 1969, OIKOS, V20, P461, DOI 10.2307/3543209; Willig MR, 2003, ANNU REV ECOL EVOL S, V34, P273, DOI 10.1146/annurev.ecolsys.34.012103.144032; Willis KJ, 2002, SCIENCE, V295, P1245, DOI 10.1126/science.1067335; Zbiral J, 1995, ANAL PLANT MAT UNIFI	59	9	11	3	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e104035	10.1371/journal.pone.0104035	http://dx.doi.org/10.1371/journal.pone.0104035			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25090628	Green Submitted, Green Published, gold			2022-12-27	WOS:000339812700086
J	Liu, T; Choi, H; Zhou, R; Chen, IW				Liu, Ting; Choi, Hoon; Zhou, Rong; Chen, I-Wei			Quantitative Evaluation of the Reticuloendothelial System Function with Dynamic MRI	PLOS ONE			English	Article							SUPERPARAMAGNETIC IRON-OXIDE; HEPATOCELLULAR-CARCINOMA; BACTERIAL-INFECTIONS; LIVER; MACROPHAGES; DEPLETION; BLOOD; RELAXIVITY; SEVERITY; BLOCKADE	Purpose: To evaluate the reticuloendothelial system (RES) function by real-time imaging blood clearance as well as hepatic uptake of superparamagnetic iron oxide nanoparticle (SPIO) using dynamic magnetic resonance imaging (MRI) with two-compartment pharmacokinetic modeling. Materials and Methods: Kinetics of blood clearance and hepatic accumulation were recorded in young adult male 01b74 athymic nude mice by dynamic T2* weighted MRI after the injection of different doses of SPIO nanoparticles (0.5, 3 or 10 mg Fe/kg). Association parameter, K-in, dissociation parameter, K-out, and elimination constant, K-e, derived from dynamic data with two-compartment model, were used to describe active binding to Kupffer cells and extrahepatic clearance. The clodrosome and liposome were utilized to deplete macrophages and block the RES function to evaluate the capability of the kinetic parameters for investigation of macrophage function and density. Results: The two-compartment model provided a good description for all data and showed a low sum squared residual for all mice (0.27 +/- 0.03). A lower K-in, a lower K-out and a lower K-e were found after clodrosome treatment, whereas a lower K-in, a higher K-out and a lower K-e were observed after liposome treatment in comparison to saline treatment (P<0.005). Conclusion: Dynamic SPIO-enhanced MR imaging with two-compartment modeling can provide information on RES function on both a cell number and receptor function level.	[Liu, Ting; Zhou, Rong] Univ Penn, Dept Radiol, Philadelphia, PA 19104 USA; [Choi, Hoon; Chen, I-Wei] Univ Penn, Dept Mat Sci & Engn, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Liu, T (corresponding author), Univ Penn, Dept Radiol, Philadelphia, PA 19104 USA.	tingliu20072008@yahoo.com		Chen, I-Wei/0000-0002-4045-4467	NCATS NIH HHS [UL1TR000003] Funding Source: Medline; NCI NIH HHS [R21 CA198563, R01 CA211337] Funding Source: Medline; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000003] Funding Source: NIH RePORTER	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))		Asanuma T, 2010, GUT, V59, P258, DOI 10.1136/gut.2009.176651; BAAS J, 1995, EUR SURG RES, V27, P137, DOI 10.1159/000129392; BIOZZI G, 1958, J LAB CLIN MED, V51, P230; BOLOGNESI M, 1987, EUR J NUCL MED, V13, P254; Bowen CV, 2002, MAGNET RESON MED, V48, P52, DOI 10.1002/mrm.10192; Bruns OT, 2009, NAT NANOTECHNOL, V4, P193, DOI [10.1038/nnano.2008.405, 10.1038/NNANO.2008.405]; CAPRONLAUDEREAU M, 1987, EUR SURG RES, V19, P388, DOI 10.1159/000128727; FRASER CC, 1995, BLOOD, V86, P183, DOI 10.1182/blood.V86.1.183.bloodjournal861183; GOMEZ F, 1994, NEW ENGL J MED, V331, P1122, DOI 10.1056/NEJM199410273311704; HAMAZAKI K, 1994, RES EXP MED, V194, P237, DOI 10.1007/BF02576385; HOEFS J, 1995, DIGEST DIS SCI, V40, P552, DOI 10.1007/BF02064368; HOEFS JC, 1995, HEPATOLOGY, V22, P1113, DOI 10.1016/0270-9139(95)90617-7; HUET PM, 1976, GASTROENTEROLOGY, V70, P74; Imai Y, 2000, HEPATOLOGY, V32, P205, DOI 10.1053/jhep.2000.9113; Jamagin WR, 2002, ANN SURG, V236, P397, DOI 10.1097/01.SLA.0000029003.66466.B3; MANIFOLD IH, 1983, LANCET, V2, P431; Medzhitov R, 2000, NEW ENGL J MED, V343, P338, DOI 10.1056/NEJM200008033430506; Mulder WJM, 2006, NMR BIOMED, V19, P142, DOI 10.1002/nbm.1011; Navasa M, 2004, LIVER INT, V24, P277, DOI 10.1111/j.1478-3231.2004.0934.x; Nishie A, 2012, J MAGN RESON IMAGING, V36, P664, DOI 10.1002/jmri.23691; PAIN JA, 1987, BRIT J SURG, V74, P1091, DOI 10.1002/bjs.1800741207; PROFFITT RT, 1983, SCIENCE, V220, P502, DOI 10.1126/science.6836294; Rogers Michael J., 2000, Cancer, V88, P2961, DOI 10.1002/1097-0142(20000615)88:12+<2961::AID-CNCR12>3.3.CO;2-C; ROSEN BR, 1990, MAGNET RESON MED, V14, P249, DOI 10.1002/mrm.1910140211; Ross J R, 2004, Health Technol Assess, V8, P1; Schindl MJ, 2006, ANN SURG, V243, P507, DOI 10.1097/01.sla.0000205826.62911.a7; Simon GH, 2006, EUR RADIOL, V16, P738, DOI 10.1007/s00330-005-0031-2; SOUHAMI RL, 1981, BIOCHIM BIOPHYS ACTA, V674, P354, DOI 10.1016/0304-4165(81)90366-4; Tacke F, 2014, J HEPATOL, V60, P1090, DOI 10.1016/j.jhep.2013.12.025; Tanimoto A, 2002, RADIOLOGY, V222, P661, DOI 10.1148/radiol.2223010690; Tromsdorf UI, 2007, NANO LETT, V7, P2422, DOI 10.1021/nl071099b; VANROOIJEN N, 1990, CELL TISSUE RES, V260, P215, DOI 10.1007/BF00318625; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; Wade J, 2003, J HOSP INFECT, V53, P144, DOI 10.1053/jhin.2002.1363; Ward J, 2000, RADIOLOGY, V216, P154, DOI 10.1148/radiology.216.1.r00jl24154; WAXMAN AD, 1982, SEMIN NUCL MED, V12, P75, DOI 10.1016/S0001-2998(82)80030-5; Wynn TA, 2010, SEMIN LIVER DIS, V30, P245, DOI 10.1055/s-0030-1255354	37	22	23	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103576	10.1371/journal.pone.0103576	http://dx.doi.org/10.1371/journal.pone.0103576			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25090653	Green Submitted, gold, Green Published			2022-12-27	WOS:000339812700032
J	Devanna, NB; Vijayan, J; Sharma, TR				Devanna, Navadagi B.; Vijayan, Joshitha; Sharma, Tilak R.			The Blast Resistance Gene Pi54of Cloned from Oryza officinalis Interacts with Avr-Pi54 through Its Novel Non-LRR Domains	PLOS ONE			English	Article							DISEASE RESISTANCE; NUCLEOTIDE-BINDING; MAGNAPORTHE-GRISEA; RICE; PROTEIN; RESPONSES; COMPLEX; IDENTIFICATION; EXPRESSION; RECEPTOR	The dominant rice blast resistance gene Pi54 cloned by map-based cloning approach from indica rice cultivar Tetep confers broad spectrum resistance to Magnaporthe oryzae. In this investigation, an orthologue of Pi54 designated as Pi54of was cloned from Oryza officinalis conferring high degree of resistance to M. oryzae and is functionally validated. We have also characterized the Pi54of protein and demonstrate its interaction with AVR-Pi54 protein. The Pi54of encoded similar to 43 kDa small and unique cytoplasmic LRR family of disease resistance protein having unique Zinc finger domain overlapped with the leucine rich repeat regions. Pi54of showed Magnaporthe-induced expression. The phylogenetic and western blot analysis confirmed orthologous nature of Pi54 and Pi54of genes, whereas the identity of protein was confirmed through MALDI-TOF analysis. The in silico analysis showed that Pi54of is structurally more stable than other cloned Pi54 proteins. The molecular docking revealed that Pi54of protein interacts with AVR-Pi54 through novel non-LRR domains such as STI1 and RhoGEF. The STI1 and GEF domains which interact with AVR-Pi54 are also components of rice defensome complex. The Pi54of protein showed differential domain specificity while interacting with the AVR protein. Functional complementation revealed that Pi54of transferred in two rice lines belonging to indica and japonica background imparts enhanced resistance against three highly virulent strains of M. oryzae. In this study, for the first time, we demonstrated that a rice blast resistance gene Pi54of cloned from wild species of rice provides high degree of resistance to M. oryzae and might display different molecular mechanism involved in AVRPi54-Pi54of interaction.	[Devanna, Navadagi B.; Vijayan, Joshitha; Sharma, Tilak R.] Indian Agr Res Inst, Natl Res Ctr Plant Biotechnol, New Delhi 110012, India	Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; ICAR - National Institute For Plant Biotechnology (NIPB)	Sharma, TR (corresponding author), Indian Agr Res Inst, Natl Res Ctr Plant Biotechnol, New Delhi 110012, India.	trsharma@nrcpb.org		BN, Devanna/0000-0002-7404-6111	Department of Biotechnology, Govt. of India [BT/AB/FG-2 (PHII)/2009-3A, BT/HRD/34/04/2008]; Council of Scientific and Industrial Research, Govt. of India	Department of Biotechnology, Govt. of India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research, Govt. of India(Council of Scientific & Industrial Research (CSIR) - India)	T. R. Sharma is thankful to the Department of Biotechnology, Govt. of India (projects: BT/AB/FG-2 (PHII)/2009-3A and BT/HRD/34/04/2008) for financial assistance. BND is thankful to the Council of Scientific and Industrial Research, Govt. of India for senior research fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramovitch RB, 2006, NAT REV MOL CELL BIO, V7, P601, DOI 10.1038/nrm1984; Bai SW, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002752; Bhattacharjee S, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00364; Bonman JM, 1986, ANNU REV PHYTOPATHOL, V30, P508; Brar DS, 1997, PLANT MOL BIOL, V35, P35, DOI 10.1023/A:1005825519998; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Cesari S, 2013, PLANT CELL, V25, P1463, DOI 10.1105/tpc.112.107201; Chen LT, 2010, CELL HOST MICROBE, V7, P185, DOI 10.1016/j.chom.2010.02.008; Chen XW, 2006, PLANT J, V46, P794, DOI 10.1111/j.1365-313X.2006.02739.x; Chuio T, 2007, BBA-GENE STRUCT EXPR, V1769, P497, DOI 10.1016/j.bbaexp.2007.04.006; Condina MR, 2009, PROTEOMICS, V9, P3047, DOI 10.1002/pmic.200701179; Dai YT, 2010, FUNGAL GENET BIOL, V47, P973, DOI 10.1016/j.fgb.2010.08.003; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; Das A, 2012, FUNCT INTEGR GENOMIC, V12, P215, DOI 10.1007/s10142-012-0284-1; Dehury B, 2013, J MOL GRAPH MODEL, V45, P50, DOI 10.1016/j.jmgm.2013.08.011; DILL KA, 1990, BIOCHEMISTRY-US, V29, P7133, DOI 10.1021/bi00483a001; Enkhbayar P, 2004, PROTEINS, V54, P394, DOI 10.1002/prot.10605; Eulgem T, 1999, EMBO J, V18, P4689, DOI 10.1093/emboj/18.17.4689; FLOR HH, 1971, ANNU REV PHYTOPATHOL, V9, P275, DOI 10.1146/annurev.py.09.090171.001423; Gupta SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042578; Gupta SK, 2012, J EXP BOT, V63, P757, DOI 10.1093/jxb/err297; HammondKosack KE, 1996, PLANT CELL, V8, P1773, DOI 10.1105/tpc.8.10.1773; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Hwang CF, 2003, PLANT J, V34, P585, DOI 10.1046/j.1365-313X.2003.01749.x; Inoue H, 2013, P NATL ACAD SCI USA, V110, P9577, DOI 10.1073/pnas.1222155110; Jia Y, 2003, PLANT DIS, V87, P129, DOI 10.1094/PDIS.2003.87.2.129; Jia Y, 2000, EMBO J, V19, P4004, DOI 10.1093/emboj/19.15.4004; Jia Y, 2008, MOL PLANT MICROBE IN, V21, P396, DOI 10.1094/MPMI-21-4-0396; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kankanala P, 2007, PLANT CELL, V19, P706, DOI 10.1105/tpc.106.046300; Kato M, 2013, ACTA CRYSTALLOGR F, V69, P1411, DOI 10.1107/S1744309113030819; Kim ST, 2009, PROTEOMICS, V9, P1302, DOI 10.1002/pmic.200800589; Kumari A, 2013, EUR J PLANT PATHOL, V137, P55, DOI 10.1007/s10658-013-0216-5; LEE FN, 1994, RICE BLAST DISEASE, P489; Lehmann Przemyslaw, 2002, Journal of Applied Genetics, V43, P403; Li W, 2011, CELL RES, V21, P835, DOI 10.1038/cr.2011.4; Lieberherr D, 2005, PLANT PHYSIOL, V138, P1644, DOI 10.1104/pp.104.057414; Lin F, 2007, GENETICS, V177, P1871, DOI 10.1534/genetics.107.080648; Liu XQ, 2007, GENETICS, V176, P2541, DOI 10.1534/genetics.107.075465; Luo H, 2005, PLANT BIOLOGY, V7, P459, DOI 10.1055/s-2005-865851; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Lv QM, 2013, PHYTOPATHOLOGY, V103, P594, DOI 10.1094/PHYTO-10-12-0260-R; Marone D, 2013, INT J MOL SCI, V14, P7302, DOI 10.3390/ijms14047302; Martin GB, 2003, ANNU REV PLANT BIOL, V54, P23, DOI 10.1146/annurev.arplant.54.031902.135035; Mattos C, 2002, TRENDS BIOCHEM SCI, V27, P203, DOI 10.1016/S0968-0004(02)02067-4; Meier I, 2011, CURR OPIN PLANT BIOL, V14, P538, DOI 10.1016/j.pbi.2011.06.005; Nakashima A, 2008, PLANT CELL, V20, P2265, DOI 10.1105/tpc.107.054395; OCHMAN H, 1988, GENETICS, V120, P621; Pack SP, 2004, J BIOTECHNOL, V111, P269, DOI 10.1016/j.jbiotec.2004.01.018; PADMANABHAN S. Y., 1965, P203; Parker D, 2008, NAT PROTOC, V3, P435, DOI 10.1038/nprot.2007.499; Prasad BD, 2010, PROTEIN EXPRES PURIF, V72, P169, DOI 10.1016/j.pep.2010.03.018; Rai AK, 2011, J PLANT BIOCHEM BIOT, V20, P55, DOI 10.1007/s13562-010-0026-1; Sambrook J, 2007, MOL CLONING LAB MANU, V3 rd; Sharma TR, 2012, AGR RES, V1, P37, DOI 10.1007/s40003-011-0003-5; Sharma TR, 2005, MOL GENET GENOMICS, V274, P569, DOI 10.1007/s00438-005-0035-2; Sharma TR, 2002, J PHYTOPATHOL, V150, P649, DOI 10.1046/j.1439-0434.2002.00812.x; SILUE D, 1992, PHYTOPATHOLOGY, V82, P577, DOI 10.1094/Phyto-82-577; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thao NP, 2007, PLANT CELL, V19, P4035, DOI 10.1105/tpc.107.055517; Wang JC, 2010, P 5 INT RIC BLAST C, P90; Wang ZX, 1999, PLANT J, V19, P55, DOI 10.1046/j.1365-313X.1999.00498.x; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; Xu J, 2001, PROTEIN SCI, V10, P1067, DOI 10.1110/ps.02101; Yang Ming-Zhi, 2007, Zhiwu Shengli yu Fenzi Shengwuxue Xuebao, V33, P589; Yokotani N, 2013, J EXP BOT, V64, P5085, DOI 10.1093/jxb/ert298; Yoshimura S, 1998, P NATL ACAD SCI USA, V95, P1663, DOI 10.1073/pnas.95.4.1663; Yu H, 2009, APPL MICROBIOL BIOT, V82, P279, DOI 10.1007/s00253-008-1748-z	70	54	61	5	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2014	9	8							e104840	10.1371/journal.pone.0104840	http://dx.doi.org/10.1371/journal.pone.0104840			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WB	25111047	Green Published, gold, Green Submitted			2022-12-27	WOS:000341105100105
J	Khor, VK; Ahrends, R; Lin, Y; Shen, WJ; Adams, CM; Roseman, AN; Cortez, Y; Teruel, MN; Azhar, S; Kraemer, FB				Khor, Victor K.; Ahrends, Robert; Lin, Ye; Shen, Wen-Jun; Adams, Christopher M.; Roseman, Ann Nomoto; Cortez, Yuan; Teruel, Mary N.; Azhar, Salman; Kraemer, Fredric B.			The Proteome of Cholesteryl-Ester-Enriched Versus Triacylglycerol-Enriched Lipid Droplets	PLOS ONE			English	Article							DIFFERENTIATION-RELATED PROTEIN; INTRACELLULAR EVENTS; MASS-SPECTROMETRY; PERILIPIN FAMILY; GRANULOSA-CELLS; ISOBARIC TAGS; ADIPOCYTES; STEROIDOGENESIS; MITOCHONDRIA; EXPRESSION	Within cells, lipids are stored in the form of lipid droplets (LDs), consisting of a neutral lipid core, surrounded by a phospholipid monolayer and an outer layer of protein. LDs typically accumulate either triacylglycerol (TAG) and diacylglycerol or cholesteryl ester (CE), depending on the type of tissue. Recently, there has been an increased interest in the proteins that surround LDs. LD proteins have been found to be quite diverse, from structural proteins to metabolic enzymes, proteins involved in vesicular transport, and proteins that may play a role in LD formation. Previous proteomics analyses have focused on TAG-enriched LDs, whereas CE-enriched LDs have been largely ignored. Our study has compared the LD proteins from CE-enriched LDs to TAG-enriched LDs in steroidogenic cells. In primary rat granulosa cells loaded with either HDL to produce CE-enriched LDs or fatty acids to produce TAG-enriched LDs, 61 proteins were found to be elevated in CE-enriched LDs and 40 proteins elevated in TAG-enriched LDs with 278 proteins in similar amounts. Protein expression was further validated by selected reaction monitoring (SRM) mass spectrometry (MS). SRM verified expression of 25 of 27 peptides that were previously detected by tandem mass tagging MS. Several proteins were confirmed to be elevated in CE-enriched LDs by SRM including the intermediate filament vimentin. This study is the first to compare the proteins found on CE-enriched LDs with TAG-enriched LDs and constitutes the first step in creating a better understanding of the proteins found on CE-enriched LDs in steroidogenic cells.	[Khor, Victor K.; Lin, Ye; Shen, Wen-Jun; Kraemer, Fredric B.] Stanford Univ, Div Endocrinol Gerontol & Metab, Stanford, CA 94305 USA; [Azhar, Salman] Stanford Univ, Dept Med, Div Gastroenterol & Hepatol, Stanford, CA 94305 USA; [Ahrends, Robert; Teruel, Mary N.] Stanford Univ, Dept Chem & Syst Biol, Stanford, CA 94305 USA; [Adams, Christopher M.] Stanford Univ, Mass Spectrometry Ctr, Stanford, CA 94305 USA; [Khor, Victor K.; Lin, Ye; Shen, Wen-Jun; Roseman, Ann Nomoto; Cortez, Yuan; Azhar, Salman; Kraemer, Fredric B.] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA	Stanford University; Stanford University; Stanford University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Kraemer, FB (corresponding author), Stanford Univ, Div Endocrinol Gerontol & Metab, Stanford, CA 94305 USA.	fbk@stanford.edu	Kraemer, Fredric/AAC-3633-2019	Teruel, Mary/0000-0002-2854-3598; Ahrends, Robert/0000-0003-0232-3375; Kraemer, Fredric/0000-0003-2468-7807; Shen, Wen-Jun/0000-0001-5150-1698	office of Research and Development, Medical Service, Department of Veterans Affairs; National Institutes of Health, NIHLBI Grant [2R01HL33881]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL033881] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM107615] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000398] Funding Source: NIH RePORTER	office of Research and Development, Medical Service, Department of Veterans Affairs(US Department of Veterans Affairs); National Institutes of Health, NIHLBI Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported in part or in whole by the office of Research and Development, Medical Service, Department of Veterans Affairs, and National Institutes of Health, NIHLBI Grant 2R01HL33881. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abell E, 2011, P NATL ACAD SCI USA, V108, P14485, DOI 10.1073/pnas.1018266108; Aggarwal K, 2005, PROTEOMICS, V5, P2297, DOI 10.1002/pmic.200401231; Aggarwal Kunal, 2006, Briefings in Functional Genomics & Proteomics, V5, P112, DOI 10.1093/bfgp/ell018; ALMAHBOBI G, 1990, J CELL SCI, V97, P679; AZHAR S, 1988, BIOCHIM BIOPHYS ACTA, V963, P139, DOI 10.1016/0005-2760(88)90275-5; Azhar S, 1999, J CELL PHYSIOL, V180, P190, DOI 10.1002/(SICI)1097-4652(199908)180:2<190::AID-JCP7>3.0.CO;2-Z; Bartzt R, 2007, J PROTEOME RES, V6, P3256, DOI 10.1021/pr070158j; Becker L, 2010, CELL METAB, V11, P125, DOI 10.1016/j.cmet.2010.01.003; Beller M, 2008, PLOS BIOL, V6, P2530, DOI 10.1371/journal.pbio.0060292; Bickel PE, 2009, BBA-MOL CELL BIOL L, V1791, P419, DOI 10.1016/j.bbalip.2009.04.002; BLANCHETTEMACKIE EJ, 1995, J LIPID RES, V36, P1211; Bose M, 2008, J BIOL CHEM, V283, P8837, DOI 10.1074/jbc.M709221200; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; Brasaemle DL, 2004, J BIOL CHEM, V279, P46835, DOI 10.1074/jbc.M409340200; Brasaemle DL, 1997, J LIPID RES, V38, P2249; Cong YS, 2006, MECH AGEING DEV, V127, P332, DOI 10.1016/j.mad.2005.12.005; Conway JP, 2005, MOL CELL PROTEOMICS, V4, P1522, DOI 10.1074/mcp.M500111-MCP200; Dalen KT, 2007, BBA-MOL CELL BIOL L, V1771, P210, DOI 10.1016/j.bbalip.2006.11.011; Ding YB, 2012, ACTA BIOCH BIOPH SIN, V44, P394, DOI 10.1093/abbs/gms008; Farese RV, 2009, CELL, V139, P855, DOI 10.1016/j.cell.2009.11.005; GREENBERG AS, 1993, P NATL ACAD SCI USA, V90, P12035, DOI 10.1073/pnas.90.24.12035; Guo Y, 2008, NATURE, V453, P657, DOI 10.1038/nature06928; Hsieh K, 2012, J CELL SCI, V125, P4067, DOI 10.1242/jcs.104943; Hulce JJ, 2013, NAT METHODS, V10, P259, DOI [10.1038/NMETH.2368, 10.1038/nmeth.2368]; Kimmel AR, 2010, J LIPID RES, V51, P468, DOI 10.1194/jlr.R000034; Kraemer FB, 2007, MOL CELL ENDOCRINOL, V265, P42, DOI 10.1016/j.mce.2006.12.001; Kumar C, 2009, FEBS LETT, V583, P1703, DOI 10.1016/j.febslet.2009.03.035; Liu PS, 2007, BBA-MOL CELL RES, V1773, P784, DOI 10.1016/j.bbamcr.2007.02.004; Liu PS, 2004, J BIOL CHEM, V279, P3787, DOI 10.1074/jbc.M311945200; Lu YJ, 2009, MOL CELLS, V28, P175, DOI 10.1007/s10059-009-0120-1; Malmstrom J, 2009, NATURE, V460, P762, DOI 10.1038/nature08184; Martin S, 2008, METHOD ENZYMOL, V438, P109, DOI 10.1016/S0076-6879(07)38008-7; Picotti P, 2009, CELL, V138, P795, DOI 10.1016/j.cell.2009.05.051; REAVEN E, 1995, J LIPID RES, V36, P1602; Reaven E, 1996, J BIOL CHEM, V271, P16208, DOI 10.1074/jbc.271.27.16208; REAVEN E, 1990, J BIOL CHEM, V265, P19100; Rostovtseva TK, 2008, J BIOENERG BIOMEMBR, V40, P163, DOI 10.1007/s10863-008-9145-y; Seachord CL, 2005, BIOL REPROD, V72, P1305, DOI 10.1095/biolreprod.104.037523; SERVETNICK DA, 1995, J BIOL CHEM, V270, P16970, DOI 10.1074/jbc.270.28.16970; Shen WJ, 2012, ENDOCRINOLOGY, V153, P3249, DOI 10.1210/en.2012-1048; Shoshan-Barmatz V, 2010, MOL ASPECTS MED, V31, P227, DOI 10.1016/j.mam.2010.03.002; Suzuki J, 2001, AM J PHYSIOL-ENDOC M, V281, pE857, DOI 10.1152/ajpendo.2001.281.4.E857; Wang H, 2011, J LIPID RES, V52, P2159, DOI 10.1194/jlr.M017939; Welte MA, 2005, CURR BIOL, V15, P1266, DOI 10.1016/j.cub.2005.06.062; Wolins NE, 2006, DIABETES, V55, P3418, DOI 10.2337/db06-0399; Wolins NE, 2003, J BIOL CHEM, V278, P37713, DOI 10.1074/jbc.M304025200; Wolinski H, 2011, J CELL SCI, V124, P3894, DOI 10.1242/jcs.091454; Wu CC, 2000, ELECTROPHORESIS, V21, P3470, DOI 10.1002/1522-2683(20001001)21:16<3470::AID-ELPS3470>3.3.CO;2-7; Xu NY, 2012, J CELL BIOL, V198, P895, DOI 10.1083/jcb.201201139; Yang L, 2012, J LIPID RES, V53, P1245, DOI 10.1194/jlr.R024117; Zhang HN, 2011, J PROTEOME RES, V10, P4757, DOI 10.1021/pr200553c	51	49	52	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2014	9	8							e105047	10.1371/journal.pone.0105047	http://dx.doi.org/10.1371/journal.pone.0105047			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WB	25111084	Green Published, Green Submitted, gold			2022-12-27	WOS:000341105100119
J	Pawlowski, M; Saraswathi, S; Motawea, HKB; Chotani, MA; Kloczkowski, A				Pawlowski, Marcin; Saraswathi, Saras; Motawea, Hanaa K. B.; Chotani, Maqsood A.; Kloczkowski, Andrzej			In Silico Modeling of Human alpha(2C)-Adrenoreceptor Interaction with Filamin-2	PLOS ONE			English	Article							PROTEIN-STRUCTURE PREDICTION; COLD-INDUCED CONSTRICTION; QUALITY ASSESSMENT; MUSCLE; RECEPTORS; MEMBRANE; DATABASE; SERVER; PATHOGENESIS; GENERATION	Vascular smooth muscle alpha(2C)-adrenoceptors (alpha(2C)-ARs) mediate vasoconstriction of small blood vessels, especially arterioles. Studies of endogenous receptors in human arteriolar smooth muscle cells (referred to as microVSM) and transiently transfected receptors in heterologous HEK293 cells show that the alpha(2C)-ARs are perinuclear receptors that translocate to the cell surface under cellular stress and elicit a biological response. Recent studies in microVSM unraveled a crucial role of Rap1A-Rho-ROCK-F-actin pathways in receptor translocation, and identified protein-protein interaction of alpha(2C)-ARs with the actin binding protein filamin-2 as an essential step in the process. To better understand the molecular nature and specificity of this interaction, in this study, we constructed comparative models of human alpha(2C)-AR and human filamin-2 proteins. Finally, we performed in silico protein-protein docking to provide a structural platform for the investigation of human alpha(2C)-AR and filamin-2 interactions. We found that electrostatic interactions seem to play a key role in this complex formation which manifests in interactions between the C-terminal arginines of alpha(2C)-ARs (particularly R454 and R456) and negatively charged residues from filamin-2 region between residues 1979 and 2206. Phylogenetic and sequence analysis showed that these interactions have evolved in warm-blooded animals.	[Pawlowski, Marcin; Saraswathi, Saras; Kloczkowski, Andrzej] Nationwide Childrens Hosp, Res Inst, Battelle Ctr Math Med, Columbus, OH 43205 USA; [Motawea, Hanaa K. B.; Chotani, Maqsood A.] Nationwide Childrens Hosp, Res Inst, Ctr Cardiovasc & Pulm Res, Columbus, OH USA; [Motawea, Hanaa K. B.] Helwan Univ, Dept Pharmacol & Toxicol, Helwan, Egypt; [Chotani, Maqsood A.; Kloczkowski, Andrzej] Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; Egyptian Knowledge Bank (EKB); Helwan University; University System of Ohio; Ohio State University	Pawlowski, M (corresponding author), Nationwide Childrens Hosp, Res Inst, Battelle Ctr Math Med, Columbus, OH 43205 USA.	Marcin.Pawlowski@nationwidechildrens.org	Kloczkowski, Andrzej/M-2655-2019	Kloczkowski, Andrzej/0000-0003-1002-5095	Research Institute at Nationwide Children's Hospital; National Institutes of Health [2R01GM072014-05A1]; National Science Foundation [MCB 1021785]; Ohio State University Davis Heart & Lung Research Institute; American Heart Association; Great Rivers Affiliate [0765204B]; National Heart, Lung and Blood Institute, National Institutes of Health [R21HL088087]; Egyptian Cultural and Educational Bureau, Washington DC; Egyptian Cultural and Educational Sector, Cairo, Egypt; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL088087] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072014] Funding Source: NIH RePORTER	Research Institute at Nationwide Children's Hospital(Ohio State University); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Ohio State University Davis Heart & Lung Research Institute; American Heart Association(American Heart Association); Great Rivers Affiliate(American Heart Association); National Heart, Lung and Blood Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Egyptian Cultural and Educational Bureau, Washington DC(Egyptian Cultural & Educational Bureau); Egyptian Cultural and Educational Sector, Cairo, Egypt(Egyptian Cultural & Educational Bureau); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The in silico modeling studies were supported by the start-up funds from The Research Institute at Nationwide Children's Hospital (url:http://www. nationwidechildrens.org/) to A Kloczkowski, and the grants from the National Institutes of Health (2R01GM072014-05A1, http://www.nih.gov/), and the National Science Foundation (MCB 1021785, url:http://www.nsf.gov/). The experimental studies on alpha<INF>2C</INF>-adrenoceptors were supported by the Ohio State University Davis Heart & Lung Research Institute (url:https://heartlung.osu.edu/Pages/index.html) and The Research Institute at Nationwide Children's Hospital (url:http://www. nationwidechildrens.org/) (Institutional support to MA Chotani), the American Heart Association (url:http://www.heart.org/), Great Rivers Affiliate (Beginning Grant-in-Aid 0765204B, to MA Chotani), the National Heart, Lung and Blood Institute, National Institutes of Health (R21HL088087 to MA Chotani), a graduate training Joint Supervision Program supported by The Egyptian Cultural and Educational Bureau (url:http://www.eecous.net/), Washington DC, and Egyptian Cultural and Educational Sector, Cairo, Egypt (awarded to HKB Motawea). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bailey SR, 2005, AM J PHYSIOL-HEART C, V289, pH243, DOI 10.1152/ajpheart.01305.2004; Bailey SR, 2004, CIRC RES, V94, P1367, DOI 10.1161/01.RES.0000128407.45014.58; Barth P, 2009, P NATL ACAD SCI USA, V106, P1409, DOI 10.1073/pnas.0808323106; Block JA, 2001, LANCET, V357, P2042, DOI 10.1016/S0140-6736(00)05118-7; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; Chotani MA, 2004, AM J PHYSIOL-HEART C, V286, pH59, DOI 10.1152/ajpheart.00268.2003; Chotani MA, 2000, AM J PHYSIOL-HEART C, V278, pH1075, DOI 10.1152/ajpheart.2000.278.4.H1075; Chotani MA, 2011, BBA-MOL CELL RES, V1813, P1495, DOI 10.1016/j.bbamcr.2011.05.006; Congreve M, 2011, J MED CHEM, V54, P4283, DOI 10.1021/jm200371q; Congreve M, 2010, BRIT J PHARMACOL, V159, P986, DOI 10.1111/j.1476-5381.2009.00476.x; Cooke JP, 2005, VASC MED, V10, P293, DOI 10.1191/1358863x05vm639ra; de Vries SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017695; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eid AH, 2008, AM J PHYSIOL-HEART C, V295, pH266, DOI 10.1152/ajpheart.00084.2008; Empfield JR, 2010, IDRUGS, V13, P869; Enyedy IJ, 2001, J MED CHEM, V44, P4313, DOI 10.1021/jm010016f; Flavahan NA, 2003, RHEUM DIS CLIN N AM, V29, P275, DOI 10.1016/S0889-857X(03)00021-8; Flower DR, 1999, BBA-REV BIOMEMBRANES, V1422, P207, DOI 10.1016/S0304-4157(99)00006-4; Frickey T, 2004, BIOINFORMATICS, V20, P3702, DOI 10.1093/bioinformatics/bth444; Fry DC, 2005, J MOL MED, V83, P955, DOI 10.1007/s00109-005-0705-x; Guimaraes S, 2001, PHARMACOL REV, V53, P319; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hein L, 1999, NATURE, V402, P181, DOI 10.1038/46040; Herrick AL, 2005, RHEUMATOLOGY, V44, P587, DOI 10.1093/rheumatology/keh552; Herrick AL, 2012, NAT REV RHEUMATOL, V8, P469, DOI 10.1038/nrrheum.2012.96; Jeyaraj SC, 2001, MOL PHARMACOL, V60, P1195, DOI 10.1124/mol.60.6.1195; Jeyaraj SC, 2012, AM J PHYSIOL-CELL PH, V303, pC499, DOI 10.1152/ajpcell.00461.2011; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Kurowski MA, 2003, NUCLEIC ACIDS RES, V31, P3305, DOI 10.1093/nar/gkg557; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Latek D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056742; Leeson PD, 2007, NAT REV DRUG DISCOV, V6, P881, DOI 10.1038/nrd2445; Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1; MacDonald E, 1997, TRENDS PHARMACOL SCI, V18, P211; Mariani V, 2011, PROTEINS, V79, P37, DOI 10.1002/prot.23177; MIYAZAWA S, 1985, MACROMOLECULES, V18, P534, DOI 10.1021/ma00145a039; Mosca R, 2014, NUCLEIC ACIDS RES, V42, pD374, DOI 10.1093/nar/gkt887; Motawea HK, 2013, AM J PHYSL CELL PHYS; Nakamura F, 2011, CELL ADHES MIGR, V5, P160, DOI 10.4161/cam.5.2.14401; Pawlowski M., 2013, NUCL ACIDS RES; Pawlowski M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-403; Ray A, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-224; Ray A, 2010, BIOINFORMATICS, V26, P3067, DOI 10.1093/bioinformatics/btq581; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Ruuskanen JO, 2005, BRIT J PHARMACOL, V144, P165, DOI 10.1038/sj.bjp.0706057; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Valdar WSJ, 2001, PROTEINS, V42, P108; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wang Z, 2010, BIOINFORMATICS, V26, P882, DOI 10.1093/bioinformatics/btq058; Worth CL, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-185; Zhang J, 2010, BIOINFORMATICS, V26, P3004, DOI 10.1093/bioinformatics/btq563; Zhou HY, 2011, BIOPHYS J, V101, P2043, DOI 10.1016/j.bpj.2011.09.012; Zhou HY, 2002, PROTEIN SCI, V11, P2714, DOI 10.1110/ps.0217002	59	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2014	9	8							e103099	10.1371/journal.pone.0103099	http://dx.doi.org/10.1371/journal.pone.0103099			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WB	25110951	Green Published, Green Submitted, gold			2022-12-27	WOS:000341105100013
J	Heydt, C; Fassunke, J; Kunstlinger, H; Ihle, MA; Konig, K; Heukamp, LC; Schildhaus, HU; Odenthal, M; Buttner, R; Merkelbach-Bruse, S				Heydt, Carina; Fassunke, Jana; Kuenstlinger, Helen; Ihle, Michaela Angelika; Koenig, Katharina; Heukamp, Lukas Carl; Schildhaus, Hans-Ulrich; Odenthal, Margarete; Buettner, Reinhard; Merkelbach-Bruse, Sabine			Comparison of Pre-Analytical FFPE Sample Preparation Methods and Their Impact on Massively Parallel Sequencing in Routine Diagnostics	PLOS ONE			English	Article							DNA EXTRACTION METHODS; REAL-TIME PCR; NUCLEIC-ACIDS; CLINICAL-SAMPLES; BRAF MUTATIONS; FORMALIN; TISSUE; SPECIMENS; BIOPSIES; AMPLIFICATION	Over the last years, massively parallel sequencing has rapidly evolved and has now transitioned into molecular pathology routine laboratories. It is an attractive platform for analysing multiple genes at the same time with very little input material. Therefore, the need for high quality DNA obtained from automated DNA extraction systems has increased, especially to those laboratories which are dealing with formalin-fixed paraffin-embedded (FFPE) material and high sample throughput. This study evaluated five automated FFPE DNA extraction systems as well as five DNA quantification systems using the three most common techniques, UV spectrophotometry, fluorescent dye-based quantification and quantitative PCR, on 26 FFPE tissue samples. Additionally, the effects on downstream applications were analysed to find the most suitable pre-analytical methods for massively parallel sequencing in routine diagnostics. The results revealed that the Maxwell 16 from Promega (Mannheim, Germany) seems to be the superior system for DNA extraction from FFPE material. The extracts had a 1.3-24.6-fold higher DNA concentration in comparison to the other extraction systems, a higher quality and were most suitable for downstream applications. The comparison of the five quantification methods showed intermethod variations but all methods could be used to estimate the right amount for PCR amplification and for massively parallel sequencing. Interestingly, the best results in massively parallel sequencing were obtained with a DNA input of 15 ng determined by the NanoDrop 2000c spectrophotometer (Thermo Fisher Scientific, Waltham, MA, USA). No difference could be detected in mutation analysis based on the results of the quantification methods. These findings emphasise, that it is particularly important to choose the most reliable and constant DNA extraction system, especially when using small biopsies and low elution volumes, and that all common DNA quantification techniques can be used for downstream applications like massively parallel sequencing.	[Heydt, Carina; Fassunke, Jana; Kuenstlinger, Helen; Ihle, Michaela Angelika; Koenig, Katharina; Heukamp, Lukas Carl; Odenthal, Margarete; Buettner, Reinhard; Merkelbach-Bruse, Sabine] Univ Hosp Cologne, Inst Pathol, Cologne, Germany; [Schildhaus, Hans-Ulrich] Univ Hosp Gottingen, Inst Pathol, Gottingen, Germany	University of Cologne; University of Gottingen	Heydt, C (corresponding author), Univ Hosp Cologne, Inst Pathol, Cologne, Germany.	carina.heydt@uk-koeln.de	Heukamp, Lukas/G-9967-2012	Heukamp, Lukas/0000-0002-3388-3482				Akbari M, 2005, J MOL DIAGN, V7, P36, DOI 10.1016/S1525-1578(10)60006-2; Bonin S, 2010, VIRCHOWS ARCH, V457, P309, DOI 10.1007/s00428-010-0917-5; Corless CL, 2012, CANCER DISCOV, V2, P23, DOI 10.1158/2159-8290.CD-11-0319; De Roock W, 2010, LANCET ONCOL, V11, P753, DOI 10.1016/S1470-2045(10)70130-3; Didelot A, 2013, CLIN CHEM, V59, P815, DOI 10.1373/clinchem.2012.193409; Do HD, 2013, CLIN CHEM, V59, P1376, DOI 10.1373/clinchem.2012.202390; Do H, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-82; Fernandez-Jimenez N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028910; Frampton GM, 2013, NAT BIOTECHNOL, V31, P1023, DOI 10.1038/nbt.2696; Gilbert MTP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000537; Hadd AG, 2013, J MOL DIAGN, V15, P234, DOI 10.1016/j.jmoldx.2012.11.006; Huijsmans Cornelis Jj, 2010, BMC Res Notes, V3, P239, DOI 10.1186/1756-0500-3-239; Ihle MA, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-13; Illumina, 2014, MISEQ DESKT SEQ SPEC; Kerick M, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-68; Khokhar SK, 2012, CLIN CHEM LAB MED, V50, P267, DOI 10.1515/CCLM.2011.763; Lehmann U, 2001, METHODS, V25, P409, DOI 10.1006/meth.2001.1263; MRC-Holland, 2010, QIAG BIOR EZ1 GEN M6; Rabelo-Goncalves E, 2014, PATHOL RES PRACT, V210, P142, DOI 10.1016/j.prp.2013.11.003; Sah S, 2013, GENOME MED, V5, DOI 10.1186/gm481; Sato Y, 2001, DIAGN MOL PATHOL, V10, P265, DOI 10.1097/00019606-200112000-00009; Sedlackova T, 2013, BIOL PROCED ONLINE, V15, DOI 10.1186/1480-9222-15-5; Simbolo M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062692; Spencer DH, 2013, J MOL DIAGN, V15, P623, DOI 10.1016/j.jmoldx.2013.05.004; Srinivasan M, 2002, AM J PATHOL, V161, P1961, DOI 10.1016/S0002-9440(10)64472-0; Thermo Scientific, 2013, T042 TECHN B NANODRO; Tuononen K, 2013, GENE CHROMOSOME CANC, V52, P503, DOI 10.1002/gcc.22047; Turashvili G, 2012, EXP MOL PATHOL, V92, P33, DOI 10.1016/j.yexmp.2011.09.013; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang FF, 2007, J MOL DIAGN, V9, P441, DOI 10.2353/jmoldx.2007.070004; Williams C, 1999, AM J PATHOL, V155, P1467, DOI 10.1016/S0002-9440(10)65461-2	31	31	31	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2014	9	8							e104566	10.1371/journal.pone.0104566	http://dx.doi.org/10.1371/journal.pone.0104566			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR0CG	25105902	Green Published, Green Submitted, gold			2022-12-27	WOS:000343231900073
J	Jacob, AG; Singh, RK; Comiskey, DF; Rouhier, MF; Mohammad, F; Bebee, TW; Chandler, DS				Jacob, Aishwarya G.; Singh, Ravi K.; Comiskey, Daniel F., Jr.; Rouhier, Matthew F.; Mohammad, Fuad; Bebee, Thomas W.; Chandler, Dawn S.			Stress-Induced Alternative Splice Forms of MDM2 and MDMX Modulate the p53-Pathway in Distinct Ways	PLOS ONE			English	Article							MESSENGER-RNA STABILIZATION; TUMOR-SUPPRESSOR P53; PROTEASOMAL TURNOVER; P53-INDEPENDENT ROLE; GENE AMPLIFICATION; ONCOPROTEIN MDM2; CELL-GROWTH; EXPRESSION; PROTEIN; PROMOTES	MDM2 and MDMX are the chief negative regulators of the tumor-suppressor protein p53 and are essential for maintaining homeostasis within the cell. In response to genotoxic stress and also in several cancer types, MDM2 and MDMX are alternatively spliced. The splice variants MDM2-ALT1 and MDMX-ALT2 lack the p53-binding domain and are incapable of negatively regulating p53. However, they retain the RING domain that facilitates dimerization of the full-length MDM proteins. Concordantly, MDM2-ALT1 has been shown to lead to the stabilization of p53 through its interaction with and inactivation of full-length MDM2. The impact of MDM2-ALT1 expression on the p53 pathway and the nature of its interaction with MDMX remain unclear. Also, the role of the architecturally similar MDMX-ALT2 and its influence of the MDM2-MDMX-p53 axis are yet to be elucidated. We show here that MDM2-ALT1 is capable of binding full-length MDMX as well as full-length MDM2. Additionally, we demonstrate that MDMX-ALT2 is able to dimerize with both full-length MDMX and MDM2 and that the expression of MDM2-ALT1 and MDMX-ALT2 leads to the upregulation of p53 protein, and also of its downstream target p21. Moreover, MDM2-ALT1 expression causes cell cycle arrest in the G1 phase in a p53 and p21 dependent manner, which is consistent with the increased levels of p21. Finally we present evidence that MDM2-ALT1 and MDMX-ALT2 expression can activate subtly distinct subsets of p53-transcriptional targets implying that these splice variants can modulate the p53 tumor suppressor pathway in unique ways. In summary, our study shows that the stress-inducible alternative splice forms MDM2-ALT1 and MDMX-ALT2 are important modifiers of the p53 pathway and present a potential mechanism to tailor the p53-mediated cellular stress response.	[Jacob, Aishwarya G.; Singh, Ravi K.; Comiskey, Daniel F., Jr.; Rouhier, Matthew F.; Mohammad, Fuad; Bebee, Thomas W.; Chandler, Dawn S.] Nationwide Childrens Hosp, Res Inst, Ctr Childhood Canc, Columbus, OH 43085 USA; [Jacob, Aishwarya G.; Singh, Ravi K.; Comiskey, Daniel F., Jr.; Bebee, Thomas W.; Chandler, Dawn S.] Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA; [Jacob, Aishwarya G.; Singh, Ravi K.; Comiskey, Daniel F., Jr.; Bebee, Thomas W.; Chandler, Dawn S.] Ohio State Univ, Mol Cellular & Dev Biol Program, Columbus, OH 43210 USA; [Jacob, Aishwarya G.; Comiskey, Daniel F., Jr.; Mohammad, Fuad; Chandler, Dawn S.] Ohio State Univ, Ctr RNA Biol, Wexner Med Ctr, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Chandler, DS (corresponding author), Nationwide Childrens Hosp, Res Inst, Ctr Childhood Canc, Columbus, OH 43085 USA.	Dawn.Chandler@nationwidechildrens.org		Singh, Ravi/0000-0002-2524-6109; Mohammad, Fuad/0000-0002-0589-5216	NIH [1R01CA133571]; NATIONAL CANCER INSTITUTE [R01CA133571] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by NIH grant 1R01CA133571 to DSC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amundson SA, 1998, ONCOGENE, V17, P3287, DOI 10.1038/sj.onc.1202576; Bartel F, 2005, INT J CANCER, V117, P469, DOI 10.1002/ijc.21206; Bartel F, 2001, ONCOL RES, V12, P451, DOI 10.3727/096504001108747459; Bartel F, 2001, INT J CANCER, V95, P168, DOI 10.1002/1097-0215(20010520)95:3<168::AID-IJC1029>3.0.CO;2-A; Bouska A, 2008, MOL CELL BIOL, V28, P4862, DOI 10.1128/MCB.01584-07; Braun CJ, 2008, CANCER RES, V68, P10094, DOI 10.1158/0008-5472.CAN-08-1569; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; CARRIER F, 1994, J BIOL CHEM, V269, P32672; Chandler DS, 2006, CANCER RES, V66, P9502, DOI 10.1158/0008-5472.CAN-05-4271; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Chen Jiandong, 2012, Genes Cancer, V3, P274, DOI 10.1177/1947601912454733; D'Amico M, 2004, CANCER RES, V64, P4122, DOI 10.1158/0008-5472.CAN-03-2519; Danovi D, 2004, MOL CELL BIOL, V24, P5835, DOI 10.1128/MCB.24.13.5835-5843.2004; de Graaf P, 2003, J BIOL CHEM, V278, P38315, DOI 10.1074/jbc.M213034200; Dias CS, 2006, CANCER RES, V66, P9467, DOI 10.1158/0008-5472.CAN-05-3013; Dutertre M, 2010, NAT STRUCT MOL BIOL, V17, P1358, DOI 10.1038/nsmb.1912; Eischen CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046148; Eischen CM, 1999, GENE DEV, V13, P2658, DOI 10.1101/gad.13.20.2658; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Evans SC, 2001, ONCOGENE, V20, P4041, DOI 10.1038/sj.onc.1204533; Evdokiou A, 2001, INT J ONCOL, V19, P625; FAKHARZADEH SS, 1991, EMBO J, V10, P1565, DOI 10.1002/j.1460-2075.1991.tb07676.x; Fang SY, 2000, J BIOL CHEM, V275, P8945, DOI 10.1074/jbc.275.12.8945; Feng ZH, 2011, J MOL CELL BIOL, V3, P44, DOI 10.1093/jmcb/mjq040; Fiscella M, 1997, P NATL ACAD SCI USA, V94, P6048, DOI 10.1073/pnas.94.12.6048; Francoz S, 2006, P NATL ACAD SCI USA, V103, P3232, DOI 10.1073/pnas.0508476103; Fridman JS, 2003, CANCER RES, V63, P5703; Fu W, 2009, J BIOL CHEM, V284, P13987, DOI 10.1074/jbc.M901758200; Gu B, 2012, INT J BIOL SCI, V8, P672, DOI 10.7150/ijbs.4283; Gu L, 2012, ONCOGENE, V31, P1342, DOI 10.1038/onc.2011.343; Gu LB, 2002, BLOOD, V99, P3367, DOI 10.1182/blood.V99.9.3367; Gu LB, 2009, CANCER CELL, V15, P363, DOI 10.1016/j.ccr.2009.03.002; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Hermeking H, 1997, MOL CELL, V1, P3, DOI 10.1016/S1097-2765(00)80002-7; Hermeking H, 2012, NAT REV CANCER, V12, P613, DOI 10.1038/nrc3318; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Hori M, 2000, PATHOL INT, V50, P786, DOI 10.1046/j.1440-1827.2000.01119.x; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang L, 2011, P NATL ACAD SCI USA, V108, P12001, DOI 10.1073/pnas.1102309108; Jacob AG, 2013, NEOPLASIA, V15, P1049, DOI 10.1593/neo.13286; Jeyaraj SC, 2009, FRONT BIOSCI-LANDMRK, V14, P2647, DOI 10.2741/3402; Jin Y, 2008, MOL CELL BIOL, V28, P1218, DOI 10.1128/MCB.01198-07; Jin YT, 2003, EMBO J, V22, P6365, DOI 10.1093/emboj/cdg600; Jones SN, 1998, P NATL ACAD SCI USA, V95, P15608, DOI 10.1073/pnas.95.26.15608; Kadakia M, 2002, ONCOGENE, V21, P8776, DOI 10.1038/sj.onc.1205993; KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; Kawai H, 2003, J BIOL CHEM, V278, P45946, DOI 10.1074/jbc.M308295200; Kraus A, 1999, INT J CANCER, V80, P930, DOI 10.1002/(SICI)1097-0215(19990315)80:6<930::AID-IJC20>3.3.CO;2-D; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; Laptenko O, 2006, CELL DEATH DIFFER, V13, P951, DOI 10.1038/sj.cdd.4401916; Lenos K, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/876173; Lenos K, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-111; Lin HK, 2002, EMBO J, V21, P4037, DOI 10.1093/emboj/cdf406; Linares LK, 2003, P NATL ACAD SCI USA, V100, P12009, DOI 10.1073/pnas.2030930100; Lukas J, 2001, CANCER RES, V61, P3212; Lundgren K, 1997, GENE DEV, V11, P714, DOI 10.1101/gad.11.6.714; MACLEOD KF, 1995, GENE DEV, V9, P935, DOI 10.1101/gad.9.8.935; Markey M, 2008, ONCOGENE, V27, P6657, DOI 10.1038/onc.2008.266; Matsumoto R, 1998, CANCER RES, V58, P609; McDonnell TJ, 1999, J PATHOL, V188, P322, DOI 10.1002/(SICI)1096-9896(199907)188:3<322::AID-PATH372>3.0.CO;2-F; MIYASHITA T, 1995, CELL, V80, P293; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; Murray-Zmijewski F, 2008, NAT REV MOL CELL BIO, V9, P702, DOI 10.1038/nrm2451; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Okamoto K, 2009, FEBS LETT, V583, P2710, DOI 10.1016/j.febslet.2009.07.021; Okoro DR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077643; OLINER JD, 1993, NATURE, V362, P857, DOI 10.1038/362857a0; OWENSCHAUB LB, 1995, MOL CELL BIOL, V15, P3032; Pan Y, 2003, MOL CELL BIOL, V23, P5113, DOI 10.1128/MCB.23.15.5113-5121.2003; Park SY, 2009, NAT STRUCT MOL BIOL, V16, P23, DOI 10.1038/nsmb.1533; Prodosmo A, 2008, J MOL MED-JMM, V86, P585, DOI 10.1007/s00109-008-0322-6; Rallapalli R, 2003, J CELL BIOCHEM, V89, P563, DOI 10.1002/jcb.10535; Rallapalli R, 1999, J BIOL CHEM, V274, P8299, DOI 10.1074/jbc.274.12.8299; Raver-Shapira N, 2007, MOL CELL, V26, P731, DOI 10.1016/j.molcel.2007.05.017; Sanchez-Aguilera A, 2006, ONCOGENE, V25, P2565, DOI 10.1038/sj.onc.1209282; Sharp DA, 1999, J BIOL CHEM, V274, P38189, DOI 10.1074/jbc.274.53.38189; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Shvarts A, 1996, EMBO J, V15, P5349, DOI 10.1002/j.1460-2075.1996.tb00919.x; Sigalas I, 1996, NAT MED, V2, P912, DOI 10.1038/nm0896-912; Steinman HA, 2004, J BIOL CHEM, V279, P4877, DOI 10.1074/jbc.M305966200; Taira N, 2012, HISTOL HISTOPATHOL, V27, P437, DOI 10.14670/HH-27.437; Tamborini E, 2001, INT J CANCER, V92, P790, DOI 10.1002/ijc.1271; Tang J, 2006, NAT CELL BIOL, V8, P855, DOI 10.1038/ncb1442; Tang YA, 2012, CLIN CANCER RES, V18, P4325, DOI 10.1158/1078-0432.CCR-11-2617; Tang Y, 2008, CELL, V133, P612, DOI 10.1016/j.cell.2008.03.025; Tanimura S, 1999, FEBS LETT, V447, P5, DOI 10.1016/S0014-5793(99)00254-9; Tarasov V, 2007, CELL CYCLE, V6, P1586, DOI 10.4161/cc.6.13.4436; Tokino T, 2000, CRIT REV ONCOL HEMAT, V33, P1, DOI 10.1016/S1040-8428(99)00051-7; Ugalde AP, 2011, EMBO J, V30, P2219, DOI 10.1038/emboj.2011.124; Volk EL, 2009, DIS MODEL MECH, V2, P47, DOI 10.1242/dmm.000992; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wade M, 2013, NAT REV CANCER, V13, P83, DOI 10.1038/nrc3430; Wade M, 2010, TRENDS CELL BIOL, V20, P299, DOI 10.1016/j.tcb.2010.01.009; Wunderlich M, 2004, CELL CYCLE, V3, P472; XIAO ZX, 1995, NATURE, V375, P694, DOI 10.1038/375694a0; Xiong SB, 2010, CANCER RES, V70, P7148, DOI 10.1158/0008-5472.CAN-10-1457; Xu J, 1999, MOL CELL BIOL, V19, P12; Yang JY, 2008, NAT CELL BIOL, V10, P138, DOI 10.1038/ncb1676; Yang JY, 2006, MOL CELL BIOL, V26, P7269, DOI 10.1128/MCB.00172-06; Zhang Z, 2004, J BIOL CHEM, V279, P16000, DOI 10.1074/jbc.M312264200; Zheng TS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3996; Zhou S, 2011, MOL CELL BIOL, V31, P4928, DOI 10.1128/MCB.06085-11	105	17	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2014	9	8							e104444	10.1371/journal.pone.0104444	http://dx.doi.org/10.1371/journal.pone.0104444			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR0CG	25105592	gold, Green Published			2022-12-27	WOS:000343231900057
J	Lee, JY; Park, JS; Jun, JK; Shin, SH; Ko, YJ; Park, SM				Lee, Jung-Yun; Park, Joong Shin; Jun, Jong Kwan; Shin, Seung Han; Ko, Young-Jin; Park, Sang Min			The Associations between Bridal Pregnancy and Obstetric Outcomes among Live Births in Korea: Population-Based Study	PLOS ONE			English	Article							MATERNAL MARITAL-STATUS; PRETERM BIRTH; RISK; COHABITATION; DISPARITIES; DURATION; MARRIAGE; STRESS; WOMEN	Objective: In East Asia the recently increased number of marriages in response to pregnancy is an important social issue. This study evaluated the association of marriage preceded by pregnancy (bridal pregnancy) with obstetric outcomes among live births in Korea. Methods: In this population-based study, 1,152,593 first singleton births were evaluated from data registered in the national birth registration database from 2004 to 2008 in Korea. In the study population, the pregnancy outcomes among live births from the bridal pregnancy group (N = 62,590) were compared with the outcomes of the post-marital pregnancy group (N = 564,749), composed of women who gave birth after 10 months but before 24 months of marriage. The variables preterm birth (PTB; <37 weeks gestation) and low birth weight (LBW; <2.5 kg) were used to determine the primary outcome. The adjusted odds ratios (aORs) and 95% confidence intervals (CIs) were calculated after controlling for socio-demographic factors. Results: The socio-demographic factors among the bridal pregnancy group were associated with a social disadvantage and particular risk factors. In the subgroup analyses of maternal age, differences in adverse pregnancy outcomes from bridal pregnancy were identified between women in the following age group: (i) <= 19, (ii) 20-39, and (iii) >= 40 years. After the multivariate analysis, the aORs for each age group were 1.47 (95% CI: 1.15-1.89), 1.76 (1.70-1.83), and 1.13 (0.77-1.66), respectively, for PTB and 0.92 (0.70-1.21), 1.60 (1.53-1.66), and 1.11 (0.71-1.74), respectively, for LBW. In the adjusted logistic regression models, bridal pregnancy was associated with PTB (1.76, 1.69-1.82) and LBW (1.53, 1.48-1.59). Conclusion: Pregnancy outcomes among live births from bridal pregnancies are associated with higher risks for PTB and LBW in Korea.	[Lee, Jung-Yun; Park, Joong Shin; Jun, Jong Kwan] Seoul Natl Univ, Coll Med, Dept Obstet & Gynecol, Seoul, South Korea; [Shin, Seung Han] Seoul Natl Univ, Coll Med, Dept Pediat, Seoul, South Korea; [Ko, Young-Jin; Park, Sang Min] Seoul Natl Univ, Coll Med, Dept Family Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Shin, SH (corresponding author), Seoul Natl Univ, Coll Med, Dept Obstet & Gynecol, Seoul, South Korea.	revival421@snu.ac.kr	Park, Joong Shin/D-5741-2012; Jun, Jong Kwan/D-5776-2012; Park, Sang Min/V-9194-2019	Park, Joong Shin/0000-0002-5246-0477; Jun, Jong Kwan/0000-0002-0242-1736; 				Austin MP, 2000, AUST NZ J OBSTET GYN, V40, P331, DOI 10.1111/j.1479-828X.2000.tb03344.x; Bird ST, 2000, FAM PLANN PERSPECT, V32, P281, DOI 10.2307/2648196; Delbaere I, 2007, EUR J OBSTET GYN R B, V135, P41, DOI 10.1016/j.ejogrb.2006.10.030; Goffinet F, 2005, BJOG-INT J OBSTET GY, V112, P38, DOI 10.1111/j.1471-0528.2005.00583.x; Hedegaard M, 1996, EPIDEMIOLOGY, V7, P339, DOI 10.1097/00001648-199607000-00001; HEDEGAARD M, 1993, BMJ-BRIT MED J, V307, P234, DOI 10.1136/bmj.307.6898.234; Hertog Ekaterina, 2009, TOUGH CHOICES BEARIN; Holt VL, 1997, PAEDIATR PERINAT EP, V11, P31, DOI 10.1046/j.1365-3016.11.s1.6.x; Jolly M, 2000, HUM REPROD, V15, P2433, DOI 10.1093/humrep/15.11.2433; Kalinka J, 2003, FETAL DIAGN THER, V18, P345, DOI 10.1159/000071979; Kiernan K, 1999, Popul Trends, P11; Kramer MS, 2000, PAEDIATR PERINAT EP, V14, P194, DOI 10.1046/j.1365-3016.2000.00266.x; Luo ZC, 2004, OBSTET GYNECOL, V103, P1300, DOI 10.1097/01.AOG.0000128070.44805.1f; Martin Joyce A, 2007, Natl Vital Stat Rep, V56, P1; McDonald SD, 2005, J OBSTET GYNAECOL CA, V27, P449, DOI 10.1016/S1701-2163(16)30527-8; McDonald SD, 2009, EUR J OBSTET GYN R B, V146, P138, DOI 10.1016/j.ejogrb.2009.05.035; Mohllajee AP, 2007, OBSTET GYNECOL, V109, P678, DOI 10.1097/01.AOG.0000255666.78427.c5; O'Leary Louise, 2010, Popul Trends, P5, DOI 10.1057/pt.2010.10; Perelli-Harris B, 2010, POPUL DEV REV, V36, P775, DOI 10.1111/j.1728-4457.2010.00357.x; Raatikainen K, 2005, BJOG-INT J OBSTET GY, V112, P1411, DOI 10.1111/j.1471-0528.2005.00667.x; Raymo JM, 2008, J MARRIAGE FAM, V70, P847, DOI 10.1111/j.1741-3737.2008.00531.x; Shah PS, 2011, MATERN CHILD HLTH J, V15, P1097, DOI 10.1007/s10995-010-0654-z; Shah PS, 2011, MATERN CHILD HLTH J, V15, P205, DOI 10.1007/s10995-009-0546-2; Shin SH, 2012, INT J PUBLIC HEALTH, V57, P253, DOI 10.1007/s00038-011-0318-9; Wisborg K, 2008, BJOG-INT J OBSTET GY, V115, P882, DOI 10.1111/j.1471-0528.2008.01734.x; Zeitlin JA, 2002, PAEDIATR PERINAT EP, V16, P124, DOI 10.1046/j.1365-3016.2002.00396.x	26	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2014	9	8							e103178	10.1371/journal.pone.0103178	http://dx.doi.org/10.1371/journal.pone.0103178			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR0CG	25105842	Green Published, Green Submitted, gold			2022-12-27	WOS:000343231900009
J	Serwatowska, J; Roque, E; Gomez-Mena, C; Constantin, GD; Wen, JQ; Mysore, KS; Lund, OS; Johansen, E; Beltran, JP; Canas, LA				Serwatowska, Joanna; Roque, Edelin; Gomez-Mena, Concepcion; Constantin, Gabriela D.; Wen, Jiangqi; Mysore, Kirankumar S.; Lund, Ole S.; Johansen, Elisabeth; Pio Beltran, Jose; Canas, Luis A.			Two euAGAMOUS Genes Control C-Function in Medicago truncatula	PLOS ONE			English	Article							MADS-BOX GENES; FLORAL HOMEOTIC GENE; AGAMOUS SUBFAMILY; REVERSE GENETICS; INSERTIONAL MUTAGENESIS; REGULATORY INTERACTIONS; ARABIDOPSIS GYNOECIUM; SHATTERPROOF GENES; BALANCE HYPOTHESIS; ECTOPIC EXPRESSION	C-function MADS-box transcription factors belong to the AGAMOUS (AG) lineage and specify both stamen and carpel identity and floral meristem determinacy. In core eudicots, the AG lineage is further divided into two branches, the euAG and PLE lineages. Functional analyses across flowering plants strongly support the idea that duplicated AG lineage genes have different degrees of subfunctionalization of the C-function. The legume Medicago truncatula contains three C-lineage genes in its genome: two euAG genes (MtAGa and MtAGb) and one PLENA-like gene (MtSHP). This species is therefore a good experimental system to study the effects of gene duplication within the AG subfamily. We have studied the respective functions of each euAG genes in M. truncatula employing expression analyses and reverse genetic approaches. Our results show that the M. truncatula euAG- and PLENA-like genes are an example of subfunctionalization as a result of a change in expression pattern. MtAGa and MtAGb are the only genes showing a full C-function activity, concomitant with their ancestral expression profile, early in the floral meristem, and in the third and fourth floral whorls during floral development. In contrast, MtSHP expression appears late during floral development suggesting it does not contribute significantly to the C-function. Furthermore, the redundant MtAGa and MtAGb paralogs have been retained which provides the overall dosage required to specify the C-function in M. truncatula.	[Serwatowska, Joanna; Roque, Edelin; Gomez-Mena, Concepcion; Pio Beltran, Jose; Canas, Luis A.] CSIC UPV, Inst Biol Mol & Celular Plantas, Valencia, Spain; [Wen, Jiangqi; Mysore, Kirankumar S.] Samuel Roberts Noble Fdn Inc, Div Plant Biol, Ardmore, OK 73402 USA; [Constantin, Gabriela D.; Lund, Ole S.; Johansen, Elisabeth] Danish Inst Agr Sci, Dept Plant Biol, Frederiksberg C, Denmark	Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Biologia Molecular y Celular de Plantas (IBMCP); Noble Research Institute; Aarhus University	Canas, LA (corresponding author), CSIC UPV, Inst Biol Mol & Celular Plantas, Valencia, Spain.	lcanas@ibmcp.upv.es	Gomez-Mena, Concha/D-9918-2017; Gómez-Mena, Concepción/AAE-4916-2020; Cañas, Luis A./F-7147-2015; Mysore, Kirankumar/AAG-7112-2020; Roque, Edelin/K-7576-2015	Gomez-Mena, Concha/0000-0002-1272-3631; Gómez-Mena, Concepción/0000-0002-1272-3631; Mysore, Kirankumar/0000-0002-9805-5741; Roque, Edelin/0000-0002-2422-8128; Wen, Jiangqi/0000-0001-5113-7750; Canas, Luis/0000-0003-4177-4777; Serwatowska, Joanna/0000-0001-9256-0053	Spanish Ministry of Economy and Competitiveness [BIO2009-08134, BIO2012-39849-C02-01]; Ramon y Cajal Program [RYC-2007-00627]	Spanish Ministry of Economy and Competitiveness(Spanish Government); Ramon y Cajal Program(Spanish Government)	This work was funded by grants BIO2009-08134 and BIO2012-39849-C02-01 from the Spanish Ministry of Economy and Competitiveness and the Ramon y Cajal Program (RYC-2007-00627 to CGM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airoldi CA, 2012, J GENET GENOMICS, V39, P157, DOI 10.1016/j.jgg.2012.02.008; Airoldi CA, 2010, P NATL ACAD SCI USA, V107, P18898, DOI 10.1073/pnas.1009050107; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Becker A, 2003, MOL PHYLOGENET EVOL, V29, P464, DOI 10.1016/S1055-7903(03)00207-0; Benlloch R, 2006, PLANT PHYSIOL, V142, P972, DOI 10.1104/pp.106.083543; Benlloch R, 2009, PLANT J, V60, P102, DOI 10.1111/j.1365-313X.2009.03939.x; Benloch R, 2003, SEX PLANT REPROD, V15, P231, DOI 10.1007/s00497-002-0157-1; Birchler JA, 2007, PLANT CELL, V19, P395, DOI 10.1105/tpc.106.049338; Birchler JA, 2010, NEW PHYTOL, V186, P54, DOI 10.1111/j.1469-8137.2009.03087.x; BOWMAN JL, 1991, DEVELOPMENT, V112, P1; BOWMAN JL, 1989, PLANT CELL, V1, P37, DOI 10.1105/tpc.1.1.37; BRADLEY D, 1993, CELL, V72, P85, DOI 10.1016/0092-8674(93)90052-R; Brunner AM, 2000, PLANT MOL BIOL, V44, P619, DOI 10.1023/A:1026550205851; Busch MA, 1999, SCIENCE, V285, P585, DOI 10.1126/science.285.5427.585; Cannon SB, 2006, P NATL ACAD SCI USA, V103, P14959, DOI 10.1073/pnas.0603228103; Causier B, 2005, CURR BIOL, V15, P1508, DOI 10.1016/j.cub.2005.07.063; Causier B, 2010, SEMIN CELL DEV BIOL, V21, P73, DOI 10.1016/j.semcdb.2009.10.005; Causier B, 2009, PLANT J, V58, P41, DOI 10.1111/j.1365-313X.2008.03759.x; Cheng XF, 2014, NEW PHYTOL, V201, P1065, DOI 10.1111/nph.12575; Cheng XF, 2011, METHODS MOL BIOL, V678, P179, DOI 10.1007/978-1-60761-682-5_13; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Colombo M, 2010, DEV BIOL, V337, P294, DOI 10.1016/j.ydbio.2009.10.043; Constantin GD, 2004, PLANT J, V40, P622, DOI 10.1111/j.1365-313X.2004.02233.x; d'Erfurth I, 2003, PLANT J, V34, P95, DOI 10.1046/j.1365-313X.2003.01701.x; Davies B, 1999, EMBO J, V18, P4023, DOI 10.1093/emboj/18.14.4023; Dellaporta SL, 1983, PLANT MOL BIOL REP, V1, P19, DOI DOI 10.1007/BF02712670; Dong ZC, 2005, PLANT PHYSIOL, V137, P1272, DOI 10.1104/pp.104.054288; Dreni L, 2014, NEW PHYTOL, V201, P717, DOI 10.1111/nph.12555; Edger PP, 2009, CHROMOSOME RES, V17, P699, DOI 10.1007/s10577-009-9055-9; Ferrandiz C, 2000, SCIENCE, V289, P436, DOI 10.1126/science.289.5478.436; Flanagan CA, 1996, PLANT J, V10, P343, DOI 10.1046/j.1365-313X.1996.10020343.x; Fourquin C, 2013, PLANT PHYSIOL, V162, P907, DOI 10.1104/pp.113.217570; Fourquin C, 2012, PLANT J, V71, P990, DOI 10.1111/j.1365-313X.2012.05046.x; Freeling M, 2006, GENOME RES, V16, P805, DOI 10.1101/gr.3681406; Gimenez E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014427; Gronlund M, 2008, VIRUS RES, V135, P345, DOI 10.1016/j.virusres.2008.04.005; Guerineau F., 1993, Plant molecular biology labfax., P121; Hartweck LM, 2002, GENETICS, V161, P1279; Heijmans K, 2012, J EXP BOT, V63, P5397, DOI 10.1093/jxb/ers233; HEWITT E. J., 1952; Hofer JMI, 2014, CURR OPIN PLANT BIOL, V17, P153, DOI 10.1016/j.pbi.2013.11.014; Irish VF, 2003, BIOESSAYS, V25, P637, DOI 10.1002/bies.10292; Irish VF, 2010, PLANT J, V61, P1014, DOI 10.1111/j.1365-313X.2009.04065.x; Jager M, 2003, MOL BIOL EVOL, V20, P842, DOI 10.1093/molbev/msg089; Johansen B, 2002, MOL PHYLOGENET EVOL, V23, P458, DOI 10.1016/S1055-7903(02)00032-5; Kapoor M, 2002, PLANT J, V32, P115, DOI 10.1046/j.1365-313X.2002.01402.x; Kater MM, 1998, PLANT CELL, V10, P171, DOI 10.1105/tpc.10.2.171; Kramer EM, 2004, GENETICS, V166, P1011, DOI 10.1534/genetics.166.2.1011; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Liljegren SJ, 2000, NATURE, V404, P766, DOI 10.1038/35008089; MA H, 1991, GENE DEV, V5, P484, DOI 10.1101/gad.5.3.484; MANDEL MA, 1992, CELL, V71, P133, DOI 10.1016/0092-8674(92)90272-E; MIZUKAMI Y, 1992, CELL, V71, P119, DOI 10.1016/0092-8674(92)90271-D; Moyroud E, 2011, PLANT CELL, V23, P1293, DOI 10.1105/tpc.111.083329; Pan IL, 2010, J EXP BOT, V61, P1795, DOI 10.1093/jxb/erq046; Parcy F, 1998, NATURE, V395, P561, DOI 10.1038/26903; Perl-Treves R, 1998, PLANT CELL PHYSIOL, V39, P701, DOI 10.1093/oxfordjournals.pcp.a029424; Pinyopich A, 2003, NATURE, V424, P85, DOI 10.1038/nature01741; PNUELI L, 1994, PLANT CELL, V6, P163, DOI 10.1105/tpc.6.2.163; Prunet Nathanael, 2014, Methods Mol Biol, V1110, P3, DOI 10.1007/978-1-4614-9408-9_1; Roque E, 2013, PLANT J, V73, P663, DOI 10.1111/tpj.12068; Rutledge R, 1998, PLANT J, V15, P625, DOI 10.1046/j.1365-313x.1998.00250.x; SAVIDGE B, 1995, PLANT CELL, V7, P721, DOI 10.1105/tpc.7.6.721; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sieburth LE, 1997, PLANT CELL, V9, P355, DOI 10.1105/tpc.9.3.355; Tadege M, 2005, TRENDS PLANT SCI, V10, P229, DOI 10.1016/j.tplants.2005.03.009; Tadege M, 2008, PLANT J, V54, P335, DOI 10.1111/j.1365-313X.2008.03418.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TSUCHIMOTO S, 1993, PLANT CELL, V5, P843, DOI 10.1105/tpc.5.8.843; Wesley SV, 2001, PLANT J, V27, P581, DOI 10.1046/j.1365-313X.2001.01105.x; YANOFSKY MF, 1990, NATURE, V346, P35, DOI 10.1038/346035a0; Young ND, 2012, ANNU REV PLANT BIOL, V63, P283, DOI 10.1146/annurev-arplant-042110-103754; Yu DY, 1999, PLANT J, V17, P51, DOI 10.1046/j.1365-313X.1999.00351.x; Zahn LM, 2006, EVOL DEV, V8, P30, DOI 10.1111/j.1525-142X.2006.05073.x	74	17	17	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2014	9	8							e103770	10.1371/journal.pone.0103770	http://dx.doi.org/10.1371/journal.pone.0103770			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR0CG	25105497	Green Published, gold			2022-12-27	WOS:000343231900021
J	Gong, XC; Chen, HL; Chen, T; Qu, HB				Gong, Xingchu; Chen, Huali; Chen, Teng; Qu, Haibin			Unit Operation Optimization for the Manufacturing of Botanical Injections Using a Design Space Approach: A Case Study of Water Precipitation	PLOS ONE			English	Article							MICROWAVE-ASSISTED EXTRACTION; PANAX-GINSENG; QUALITY; GINSENOSIDES; FORMULATION; CHROMATOGRAPHY; FLAVONOIDS; SEPARATION; STRATEGY; PRODUCT	Quality by design (QbD) concept is a paradigm for the improvement of botanical injection quality control. In this work, water precipitation process for the manufacturing of Xueshuantong injection, a botanical injection made from Notoginseng Radix et Rhizoma, was optimized using a design space approach as a sample. Saponin recovery and total saponin purity (TSP) in supernatant were identified as the critical quality attributes (CQAs) of water precipitation using a risk assessment for all the processes of Xueshuantong injection. An Ishikawa diagram and experiments of fractional factorial design were applied to determine critical process parameters (CPPs). Dry matter content of concentrated extract (DMCC), amount of water added (AWA), and stirring speed (SS) were identified as CPPs. Box-Behnken designed experiments were carried out to develop models between CPPs and process CQAs. Determination coefficients were higher than 0.86 for all the models. High TSP in supernatant can be obtained when DMCC is low and SS is high. Saponin recoveries decreased as DMCC increased. Incomplete collection of supernatant was the main reason for the loss of saponins. Design space was calculated using a Monte-Carlo simulation method with acceptable probability of 0.90. Recommended normal operation region are located in DMCC of 0.38-0.41 g/g, AWA of 3.7-4.9 g/g, and SS of 280-350 rpm, with a probability more than 0.919 to attain CQA criteria. Verification experiment results showed that operating DMCC, SS, and AWA within design space can attain CQA criteria with high probability.	[Gong, Xingchu; Chen, Huali; Chen, Teng; Qu, Haibin] Zhejiang Univ, Coll Pharmaceut Sci, Pharmaceut Informat Inst, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Qu, HB (corresponding author), Zhejiang Univ, Coll Pharmaceut Sci, Pharmaceut Informat Inst, Hangzhou 310003, Zhejiang, Peoples R China.	quhb@zju.edu.cn			National S&T Major Project of China [2012ZX09101201-003]; Research Fund for the Doctoral Program of Higher Education of China [20110101120149]	National S&T Major Project of China; Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by the National S&T Major Project of China (2012ZX09101201-003) and Research Fund for the Doctoral Program of Higher Education of China (20110101120149). Haibin Qu received the first fund. The website is http://www.most.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Xingchu Gong received the second fund. The website is http://www.cutech.edu.cn/cn/kyjj/gdxxbsdkyjj/A010301index_1.htm. Fund were used to buy materials, chemicals, and pay labor costs.	Bhambure R, 2013, BIOTECHNOL PROGR, V29, P403, DOI 10.1002/btpr.1705; Charoo NA, 2012, INT J PHARMACEUT, V423, P167, DOI 10.1016/j.ijpharm.2011.12.024; Chen X, 2007, CHINA PHARM, V18, P41; Chinese Pharmacopoeia Commission, 2011, ZHUSH XUESH DONGG; Debrus B, 2011, ANAL CHIM ACTA, V691, P33, DOI 10.1016/j.aca.2011.02.035; Duan MH, 2013, SEP PURIF TECHNOL, V107, P26, DOI 10.1016/j.seppur.2013.01.003; Gong XC, 2013, SEP PURIF TECHNOL, V107, P273, DOI 10.1016/j.seppur.2013.01.029; Gui QF, 2013, NEURAL REGEN RES, V8, P792, DOI 10.3969/j.issn.1673-5374.2013.09.003; HAN BH, 1982, PLANTA MED, V44, P146, DOI 10.1055/s-2007-971425; Ingvarsson PT, 2013, PHARM RES; Kim SJ, 2007, SEP PURIF TECHNOL, V56, P401, DOI 10.1016/j.seppur.2007.06.014; Korakianiti E, 2011, PHARM RES-DORDR, V28, P1465, DOI 10.1007/s11095-010-0315-3; Li RY, 2012, IND ENG CHEM RES, V51, P8141, DOI 10.1021/ie300945p; [李晓海 Li Xiaohai], 2012, [中国新药杂志, Chinese Journal New Drugs], V21, P1362; Looby M, 2011, BIOTECHNOL PROGR, V27, P1718, DOI 10.1002/btpr.672; Lourenco V, 2012, EUR J PHARM BIOPHARM, V81, P438, DOI 10.1016/j.ejpb.2012.03.003; Martins PF, 2012, SEP PURIF TECHNOL, V98, P464, DOI 10.1016/j.seppur.2012.08.009; Mbinze JK, 2012, J CHROMATOGR A, V1263, P113, DOI 10.1016/j.chroma.2012.09.038; Mockus LN, 2011, PHARM DEV TECHNOL, V16, P549, DOI 10.3109/10837450.2011.611138; Nistor I, 2011, J PHARMACEUT BIOMED, V56, P30, DOI 10.1016/j.jpba.2011.04.027; Nistor I, 2013, J PHARMACEUT BIOMED, V74, P273, DOI 10.1016/j.jpba.2012.10.015; Popovich DG, 2004, PHYTOCHEMISTRY, V65, P337, DOI 10.1016/j.phytochem.2003.11.020; Rozet E, 2013, TRAC-TREND ANAL CHEM, V42, P157, DOI 10.1016/j.trac.2012.09.007; Rozet E, 2012, ANAL CHEM, V84, P106, DOI 10.1021/ac202664s; Wang YT, 2008, FOOD CHEM, V110, P161, DOI 10.1016/j.foodchem.2008.01.028; Xiao WH, 2008, SEP PURIF TECHNOL, V62, P614, DOI 10.1016/j.seppur.2008.03.025; Xiao XH, 2009, SEP PURIF TECHNOL, V68, P250, DOI 10.1016/j.seppur.2009.05.011; Xu XM, 2012, INT J PHARMACEUT, V434, P349, DOI 10.1016/j.ijpharm.2012.06.002; Yu LX, 2008, PHARM RES, V25, P781, DOI 10.1007/s11095-007-9511-1; Zhang L, 2013, AAPS PHARMSCITECH, V14, P277, DOI 10.1208/s12249-012-9919-8; Zheng XZ, 2009, SEP PURIF TECHNOL, V70, P34, DOI 10.1016/j.seppur.2009.08.008	31	12	23	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e104493	10.1371/journal.pone.0104493	http://dx.doi.org/10.1371/journal.pone.0104493			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25101624	Green Published, gold, Green Submitted			2022-12-27	WOS:000339993900069
J	Hudson, CD; Huxley, JN; Green, MJ				Hudson, Christopher D.; Huxley, Jonathan N.; Green, Martin J.			Using Simulation to Interpret a Discrete Time Survival Model in a Complex Biological System: Fertility and Lameness in Dairy Cows	PLOS ONE			English	Article							TO-CONCEPTION INTERVAL; REPRODUCTIVE-PERFORMANCE; BODY CONDITION; ODDS RATIO; MILK; CLAW; LESIONS; HEALTH; IMPACT; CATTLE	The ever-growing volume of data routinely collected and stored in everyday life presents researchers with a number of opportunities to gain insight and make predictions. This study aimed to demonstrate the usefulness in a specific clinical context of a simulation-based technique called probabilistic sensitivity analysis (PSA) in interpreting the results of a discrete time survival model based on a large dataset of routinely collected dairy herd management data. Data from 12,515 dairy cows (from 39 herds) were used to construct a multilevel discrete time survival model in which the outcome was the probability of a cow becoming pregnant during a given two day period of risk, and presence or absence of a recorded lameness event during various time frames relative to the risk period amongst the potential explanatory variables. A separate simulation model was then constructed to evaluate the wider clinical implications of the model results (i.e. the potential for a herd's incidence rate of lameness to influence its overall reproductive performance) using PSA. Although the discrete time survival analysis revealed some relatively large associations between lameness events and risk of pregnancy (for example, occurrence of a lameness case within 14 days of a risk period was associated with a 25% reduction in the risk of the cow becoming pregnant during that risk period), PSA revealed that, when viewed in the context of a realistic clinical situation, a herd's lameness incidence rate is highly unlikely to influence its overall reproductive performance to a meaningful extent in the vast majority of situations. Construction of a simulation model within a PSA framework proved to be a very useful additional step to aid contextualisation of the results from a discrete time survival model, especially where the research is designed to guide on-farm management decisions at population (i.e. herd) rather than individual level.	[Hudson, Christopher D.; Huxley, Jonathan N.; Green, Martin J.] Univ Nottingham, Sch Vet Med & Sci, Loughborough, Leics, England	University of Nottingham	Hudson, CD (corresponding author), Univ Nottingham, Sch Vet Med & Sci, Sutton Bonington Campus, Loughborough, Leics, England.	chris.hudson@nottingham.ac.uk	Huxley, Jonathan N/B-7406-2011; Green, Martin/F-7066-2011; Hudson, Chris/G-5561-2011	Huxley, Jonathan N/0000-0002-1149-2480; Green, Martin/0000-0002-6408-6443; Hudson, Chris/0000-0003-4777-062X				Alawneh JI, 2011, J DAIRY SCI, V94, P5487, DOI 10.3168/jds.2011-4395; Anderson K, 2006, ANN INTERN MED, V144, P397, DOI 10.7326/0003-4819-144-6-200603210-00006; Andronis L, 2009, HEALTH TECHNOL ASSES, V13, P1; Bahonar AR, 2009, J ANIM VET ADV, V8, P747; Barker ZE, 2010, J DAIRY SCI, V93, P932, DOI 10.3168/jds.2009-2309; Bellera CA, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-20; Bicalho RC, 2007, J DAIRY SCI, V90, P4586, DOI 10.3168/jds.2007-0297; Bland JM, 2000, BRIT MED J, V320, P1468, DOI 10.1136/bmj.320.7247.1468; Browne W., 2009, MCMC ESTIMATION MLWI; Davies HTO, 1998, BRIT MED J, V316, P989, DOI 10.1136/bmj.316.7136.989; Esslemont RJ, 2002, 5 DAISY U READ; Evans GE, 2009, 2009 WRI WORLD C COM, V4, P379; Garbarino EJ, 2004, J DAIRY SCI, V87, P4123, DOI 10.3168/jds.S0022-0302(04)73555-9; Hernandez J, 2001, J AM VET MED ASSOC, V218, P1611, DOI 10.2460/javma.2001.218.1611; Hernandez JA, 2005, JAVMA-J AM VET MED A, V227, P1284, DOI 10.2460/javma.2005.227.1284; Hudson CD, 2012, J DAIRY SCI, V95, P3683, DOI 10.3168/jds.2011-4629; Huxley JN, 2013, LIVEST SCI, V156, P64, DOI 10.1016/j.livsci.2013.06.012; LeBlanc S, 2007, ADV DAIRY TECHNOL, V19, P201; Loeffler SH, 1999, J DAIRY SCI, V82, P2589, DOI 10.3168/jds.S0022-0302(99)75514-1; Machado VS, 2010, J DAIRY SCI, V93, P4071, DOI 10.3168/jds.2010-3177; Melendez P, 2003, THERIOGENOLOGY, V59, P927, DOI 10.1016/S0093-691X(02)01152-4; Peake KA, 2011, VET REC, V168, DOI 10.1136/vr.c6180; R Core Development Team, 2010, R LANG ENV STAT COMP; Rasbash J, 2009, USERS GUIDE MLWIN V2, V2, P10; Rasbash J, 2010, MLWIN VERSION 2 2; SINGER JD, 1993, J EDUC STAT, V18, P155, DOI 10.2307/1165085; Sogstad AM, 2006, J DAIRY SCI, V89, P2519, DOI 10.3168/jds.S0022-0302(06)72327-X; Steele F, 2003, LIFETIME DATA ANAL, V9, P155, DOI 10.1023/A:1022930918859; Steinfeld H., 2006, LIVESTOCKS LONG SHAD, DOI [10.1890/1540-9295(2007)5[4:D]2.0.CO;2, DOI 10.1890/1540-9295(2007)5[4:D]2.0.CO;2]; Yang M., 2003, MODELLING SURVIVAL D; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	31	7	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e103426	10.1371/journal.pone.0103426	http://dx.doi.org/10.1371/journal.pone.0103426			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25101997	Green Published, Green Submitted, gold			2022-12-27	WOS:000339993900018
J	Rundell, EA; Banta, LM; Ward, DV; Watts, CD; Birren, B; Esteban, DJ				Rundell, Ethan A.; Banta, Lois M.; Ward, Doyle V.; Watts, Corey D.; Birren, Bruce; Esteban, David J.			16S rRNA Gene Survey of Microbial Communities in Winogradsky Columns	PLOS ONE			English	Article							RARE BIOSPHERE; SP-NOV; BODY HABITATS; DIVERSITY; BACTERIAL; SEDIMENT; METAGENOMICS; SEQUENCES; ARCHAEAL; DEPTH	A Winogradsky column is a clear glass or plastic column filled with enriched sediment. Over time, microbial communities in the sediment grow in a stratified ecosystem with an oxic top layer and anoxic sub-surface layers. Winogradsky columns have been used extensively to demonstrate microbial nutrient cycling and metabolic diversity in undergraduate microbiology labs. In this study, we used high-throughput 16s rRNA gene sequencing to investigate the microbial diversity of Winogradsky columns. Specifically, we tested the impact of sediment source, supplemental cellulose source, and depth within the column, on microbial community structure. We found that the Winogradsky columns were highly diverse communities but are dominated by three phyla: Proteobacteria, Bacteroidetes, and Firmicutes. The community is structured by a founding population dependent on the source of sediment used to prepare the columns and is differentiated by depth within the column. Numerous biomarkers were identified distinguishing sample depth, including Cyanobacteria, Alphaproteobacteria, and Betaproteobacteria as biomarkers of the soil-water interface, and Clostridia as a biomarker of the deepest depth. Supplemental cellulose source impacted community structure but less strongly than depth and sediment source. In columns dominated by Firmicutes, the family Peptococcaceae was the most abundant sulfate reducer, while in columns abundant in Proteobacteria, several Deltaproteobacteria families, including Desulfobacteraceae, were found, showing that different taxonomic groups carry out sulfur cycling in different columns. This study brings this historical method for enrichment culture of chemolithotrophs and other soil bacteria into the modern era of microbiology and demonstrates the potential of the Winogradsky column as a model system for investigating the effect of environmental variables on soil microbial communities.	[Rundell, Ethan A.; Esteban, David J.] Vassar Coll, Dept Biol, Poughkeepsie, NY 12601 USA; [Banta, Lois M.; Watts, Corey D.] Williams Coll, Dept Biol, Williamstown, MA 01267 USA; [Ward, Doyle V.; Birren, Bruce] Broad Inst, Genome Sequencing Ctr, Cambridge, MA USA	Vassar College; Williams College; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Esteban, DJ (corresponding author), Vassar Coll, Dept Biol, Poughkeepsie, NY 12601 USA.	daesteban@vassar.edu			Vassar College; Williams College; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007640] Funding Source: NIH RePORTER	Vassar College; Williams College; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Vassar College start-up funds to DJE and Williams College divisional research funds to CDW and LMB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banta LM, 2012, CBE-LIFE SCI EDUC, V11, P203, DOI 10.1187/cbe.11-12-0105; Bayer EA, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 2, THIRD EDITION, P578, DOI 10.1007/0-387-30742-7_19; Bowen JL, 2012, ISME J, V6, P2014, DOI 10.1038/ismej.2012.47; Bowen JL, 2011, ISME J, V5, P1540, DOI 10.1038/ismej.2011.22; Bowen JL, 2009, ISME J, V3, P924, DOI 10.1038/ismej.2009.44; Briee C, 2007, RES MICROBIOL, V158, P213, DOI 10.1016/j.resmic.2006.12.012; Butler J, 2008, GENOME RES, V18, P810, DOI 10.1101/gr.7337908; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Charlton PJ, 1997, J MICROBIOL METH, V30, P161, DOI 10.1016/S0167-7012(97)00051-1; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Daniel R, 2005, NAT REV MICROBIOL, V3, P470, DOI 10.1038/nrmicro1160; de Sousa ML, 2012, ENVIRON ENG SCI, V29, P180, DOI 10.1089/ees.2010.0259; Dickie IA, 2010, NEW PHYTOL, V188, P916, DOI 10.1111/j.1469-8137.2010.03473.x; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Dworkin M, 2012, FEMS MICROBIOL REV, V36, P364, DOI 10.1111/j.1574-6976.2011.00299.x; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Fierer N, 2003, SOIL BIOL BIOCHEM, V35, P167, DOI 10.1016/S0038-0717(02)00251-1; Gobet A, 2012, ISME J, V6, P542, DOI 10.1038/ismej.2011.132; Guhathakurta H, 2007, ISME J, V1, P545, DOI 10.1038/ismej.2007.61; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hansel CM, 2008, APPL ENVIRON MICROB, V74, P1620, DOI 10.1128/AEM.01787-07; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; JANSSEN PH, 1991, INT J SYST BACTERIOL, V41, P26, DOI 10.1099/00207713-41-1-26; Jurkowski Anne, 2007, CBE Life Sci Educ, V6, P260, DOI 10.1187/cbe.07-09-0075; Kuczynski J, 2010, NAT METHODS, V7, P813, DOI [10.1038/NMETH.1499, 10.1038/nmeth.1499]; Lee CK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044224; Llobet-Brossa E, 2002, AQUAT MICROB ECOL, V29, P211, DOI 10.3354/ame029211; Loss RA, 2013, RENEW ENERG, V50, P648, DOI 10.1016/j.renene.2012.07.011; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone CA, 2007, APPL ENVIRON MICROB, V73, P1576, DOI 10.1128/AEM.01996-06; Ludemann H, 2000, APPL ENVIRON MICROB, V66, P754, DOI 10.1128/AEM.66.2.754-762.2000; MCINERNEY MJ, 1981, APPL ENVIRON MICROB, V41, P1029, DOI 10.1128/AEM.41.4.1029-1039.1981; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Mussmann M, 2005, ENVIRON MICROBIOL, V7, P405, DOI 10.1111/j.1462-2920.2005.00708.x; Neufeld JD, 2005, APPL ENVIRON MICROB, V71, P5710, DOI 10.1128/AEM.71.10.5710-5718.2005; NEUTZLING O, 1984, ARCH MICROBIOL, V137, P256, DOI 10.1007/BF00414554; Noll M, 2005, ENVIRON MICROBIOL, V7, P382, DOI 10.1111/j.1462-2920.2005.00700.x; Pester M, 2010, ISME J, V4, P1591, DOI 10.1038/ismej.2010.75; Postgate J.R., 1959, J SCI FOOD AGR, V10, P669; Rabus R, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 2, THIRD EDITION, P659, DOI 10.1007/0-387-30742-7_22; Rogan B, 2005, AM BIOL TEACH, V67, P348, DOI 10.1662/0002-7685(2005)067[0348:ETSNCU]2.0.CO;2; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Shade A, 2012, ENVIRON MICROBIOL, V14, P2247, DOI 10.1111/j.1462-2920.2012.02817.x; Shivaji S, 2011, RES MICROBIOL, V162, P191, DOI 10.1016/j.resmic.2010.09.020; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Teske A, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 6, THIRD EDITION, P784, DOI 10.1007/0-387-30746-x_27; van Niel C.B, 1971, METHODS ENZYMOLOGY A, P3, DOI DOI 10.1016/S0076-6879(71)23077-9; Walters WA, 2011, BIOINFORMATICS, V27, P1159, DOI 10.1093/bioinformatics/btr087; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Winogradsky S, 1888, BEITRAGE MORPHOLOGIE, V1; Winogradsky S.N., 1887, BOT ZEITUNG, V45, P489; Wu JY, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-255; Xiong JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050507; Youssef NH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012414; Zhou JZ, 2004, APPL ENVIRON MICROB, V70, P1723, DOI 10.1128/AEM.70.3.1723-1734.2004	57	21	21	11	168	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e104134	10.1371/journal.pone.0104134	http://dx.doi.org/10.1371/journal.pone.0104134			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25101630	Green Published, gold, Green Submitted			2022-12-27	WOS:000339993900045
J	Yusuf, I; Stern, J; McCaughtry, TM; Gallagher, S; Sun, H; Gao, C; Tedder, T; Carlesso, G; Carter, L; Herbst, R; Wang, Y				Yusuf, Isharat; Stern, Jessica; McCaughtry, Tom M.; Gallagher, Sandra; Sun, Hong; Gao, Changshou; Tedder, Thomas; Carlesso, Gianluca; Carter, Laura; Herbst, Ronald; Wang, Yue			Germinal Center B Cell Depletion Diminishes CD4(+) Follicular T Helper Cells in Autoimmune Mice	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; PRIMARY IMMUNE-RESPONSE; NZB/W F-1 MICE; MURINE LUPUS; MYASTHENIA-GRAVIS; SJOGRENS-SYNDROME; CHEMOKINE CXCL13; DENDRITIC CELLS; FH CELLS; IN-SITU	Background: Continuous support from follicular CD4(+) T helper (Tfh) cells drives germinal center (GC) responses, which last for several weeks to produce high affinity memory B cells and plasma cells. In autoimmune Sle1 and NZB/W F1 mice, elevated numbers of Tfh cells persist, promoting the expansion of self-reactive B cells. Expansion of circulating Tfh like cells have also been described in several autoimmune diseases. Although, the signals required for Tfh differentiation have now been well described, the mechanisms that sustain the maintenance of fully differentiated Tfh are less understood. Recent data demonstrate a role for GC B cells for Tfh maintenance after protein immunization. Methods and Finding: Given the pathogenic role Tfh play in autoimmune disease, we explored whether B cells are required for maintenance of autoreactive Tfh. Our data suggest that the number of mature autoreactive Tfh cells is controlled by GC B cells. Depletion of B cells in Sle1 autoimmune mice leads to a dramatic reduction in Tfh cells. In NZB/W F1 autoimmune mice, similar to the SRBC immunization model, GC B cells support the maintenance of mature Tfh, which is dependent mainly on ICOS. The CD28-associated pathway is dispensable for Tfh maintenance in SRBC immunized mice, but is required in the spontaneous NZB/W F1 model. Conclusion: These data suggest that mature Tfh cells require signals from GC B cells to sustain their optimal numbers and function in both autoimmune and immunization models. Thus, immunotherapies targeting B cells in autoimmune disease may affect pathogenic Tfh cells.	[Yusuf, Isharat; Stern, Jessica; McCaughtry, Tom M.; Gallagher, Sandra; Sun, Hong; Carlesso, Gianluca; Carter, Laura; Herbst, Ronald; Wang, Yue] Medimmune LLC, Dept Resp Inflammat & Autoimmun Res, Gaithersburg, MD 20878 USA; [Gao, Changshou] Medimmune LLC, Dept Antibody Discovery & Prot Engn, Gaithersburg, MD USA; [Tedder, Thomas] Duke Univ, Med Ctr, Dept Immunol, Durham, NC USA	AstraZeneca; Medimmune; AstraZeneca; Medimmune; Duke University	Wang, Y (corresponding author), Medimmune LLC, Dept Resp Inflammat & Autoimmun Res, Gaithersburg, MD 20878 USA.	wangy@medimmune.com			MedImmune	MedImmune(AstraZenecaMedimmune)	MedImmune is the funder of this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja A, 2007, J IMMUNOL, V179, P3351, DOI 10.4049/jimmunol.179.5.3351; Baumjohann D, 2013, IMMUNITY, V38, P596, DOI 10.1016/j.immuni.2012.11.020; Bekar KW, 2010, ARTHRITIS RHEUM-US, V62, P2443, DOI 10.1002/art.27515; Bluml S, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar3906; Boulianne B, 2013, J IMMUNOL, V191, P4521, DOI 10.4049/jimmunol.1300769; Browning JL, 1997, J IMMUNOL, V159, P3288; Bubier JA, 2009, P NATL ACAD SCI USA, V106, P1518, DOI 10.1073/pnas.0807309106; Cannons JL, 2010, IMMUNITY, V32, P253, DOI 10.1016/j.immuni.2010.01.010; Cappione A, 2005, J CLIN INVEST, V115, P3205, DOI 10.1172/JCI24179; Chakera A, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/948218; Choi YS, 2011, IMMUNITY, V34, P932, DOI 10.1016/j.immuni.2011.03.023; Chung Y, 2011, NAT MED, V17, P983, DOI 10.1038/nm.2426; Coyle AJ, 2000, IMMUNITY, V13, P95, DOI 10.1016/S1074-7613(00)00011-X; Craft JE, 2012, NAT REV RHEUMATOL, V8, P337, DOI 10.1038/nrrheum.2012.58; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Ding YN, 2013, J IMMUNOL, V191, P1614, DOI 10.4049/jimmunol.1300479; Fahey LM, 2011, J EXP MED, V208, P987, DOI 10.1084/jem.20101773; Gilliland LK, 1996, TISSUE ANTIGENS, V47, P1, DOI 10.1111/j.1399-0039.1996.tb02509.x; Goenka R, 2011, J IMMUNOL, V187, P1091, DOI 10.4049/jimmunol.1100853; Good-Jacobson KL, 2010, J IMMUNOL, V185, P3117, DOI 10.4049/jimmunol.1001155; Grammer AC, 2003, ARTHRITIS RES THER, V5, pS22, DOI 10.1186/ar1009; Grammer AC, 2003, J CLIN INVEST, V112, P1506, DOI 10.1172/JCI200319301; Haas KM, 2010, J IMMUNOL, V184, P4789, DOI 10.4049/jimmunol.0902391; Hamaguchi Y, 2006, J EXP MED, V203, P743, DOI 10.1084/jem.20052283; HAN SH, 1995, J EXP MED, V182, P1635, DOI 10.1084/jem.182.6.1635; HAN SH, 1995, J IMMUNOL, V155, P556; Haynes NM, 2007, J IMMUNOL, V179, P5099, DOI 10.4049/jimmunol.179.8.5099; He J, 2013, IMMUNITY, V39, P770, DOI 10.1016/j.immuni.2013.09.007; Herbst R, 2010, J PHARMACOL EXP THER, V335, P213, DOI 10.1124/jpet.110.168062; Hu YL, 2009, J IMMUNOL, V182, P1421, DOI 10.4049/jimmunol.182.3.1421; Hutloff A, 2004, ARTHRITIS RHEUM-US, V50, P3211, DOI 10.1002/art.20519; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; King C, 2008, ANNU REV IMMUNOL, V26, P741, DOI 10.1146/annurev.immunol.26.021607.090344; King C, 2012, TRENDS IMMUNOL, V33, P59, DOI 10.1016/j.it.2011.11.006; Lee SK, 2012, IMMUNITY, V37, P880, DOI 10.1016/j.immuni.2012.10.010; Li XY, 2012, BIOCHEM BIOPH RES CO, V422, P238, DOI 10.1016/j.bbrc.2012.04.133; Linterman MA, 2012, IMMUNOL REV, V247, P143, DOI 10.1111/j.1600-065X.2012.01121.x; Linterman MA, 2011, NAT MED, V17, P975, DOI 10.1038/nm.2425; Linterman MA, 2009, J EXP MED, V206, P561, DOI 10.1084/jem.20081886; Linton PJ, 2000, J IMMUNOL, V165, P5558, DOI 10.4049/jimmunol.165.10.5558; Liu R, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4100; Liu XD, 2013, IMMUNOL REV, V252, P139, DOI 10.1111/imr.12040; Luzina IG, 2001, J LEUKOCYTE BIOL, V70, P578; Ma CS, 2012, J EXP MED, V209, P1241, DOI 10.1084/jem.20120994; Ma J, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/827480; Mohan C, 1998, J CLIN INVEST, V101, P1362; MOHAN C, 1995, J IMMUNOL, V154, P1470; Monk NJ, 2003, NAT MED, V9, P1275, DOI 10.1038/nm931; Morel L, 1997, J IMMUNOL, V158, P6019; Morita R, 2011, IMMUNITY, V34, P108, DOI 10.1016/j.immuni.2010.12.012; Murphy G, 2013, LANCET, V382, P809, DOI 10.1016/S0140-6736(13)60889-2; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; Oganesyan V, 2008, ACTA CRYSTALLOGR D, V64, P700, DOI 10.1107/S0907444908007877; Pepper M, 2011, IMMUNITY, V35, P583, DOI 10.1016/j.immuni.2011.09.009; Perry D, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/271694; Qi H, 2008, NATURE, V455, P764, DOI 10.1038/nature07345; Ramiscal RR, 2013, IMMUNOL REV, V252, P146, DOI 10.1111/imr.12031; Rosenblum MD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003504; Saito R, 2005, J NEUROIMMUNOL, V170, P172, DOI 10.1016/j.jneuroim.2005.09.001; Salomonsson S, 2002, SCAND J IMMUNOL, V55, P336, DOI 10.1046/j.1365-3083.2002.01058.x; Schiffer L, 2003, J IMMUNOL, V171, P489, DOI 10.4049/jimmunol.171.1.489; Shi XY, 2007, ARTHRITIS RHEUM-US, V56, P3057, DOI 10.1002/art.22825; Shinall SM, 2000, J IMMUNOL, V164, P5729, DOI 10.4049/jimmunol.164.11.5729; Simpson N, 2010, ARTHRITIS RHEUM-US, V62, P234, DOI 10.1002/art.25032; STEURER W, 1995, J IMMUNOL, V155, P1165; Subramanian S, 2006, P NATL ACAD SCI USA, V103, P9970, DOI 10.1073/pnas.0603912103; Tackenberg B, 2007, EUR J IMMUNOL, V37, P849, DOI 10.1002/eji.200636449; Takahashi Y, 1998, J EXP MED, V187, P885, DOI 10.1084/jem.187.6.885; Tangye SG, 2013, NAT REV IMMUNOL, V13, P412, DOI 10.1038/nri3447; Terrier B, 2012, J RHEUMATOL, V39, P1819, DOI 10.3899/jrheum.120468; Tobon GJ, 2013, AUTOIMMUN DIS, V2013, DOI 10.1155/2013/827254; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032; Vinuesa CG, 2011, IMMUNITY, V35, P671, DOI 10.1016/j.immuni.2011.11.001; Vinuesa CG, 2009, NAT REV IMMUNOL, V9, P845, DOI 10.1038/nri2637; Vinuesa CG, 2005, NATURE, V435, P452, DOI 10.1038/nature03555; Vuyyuru R, 2009, J IMMUNOL, V183, P5716, DOI 10.4049/jimmunol.0804215; Walker LSK, 2003, J IMMUNOL, V170, P91, DOI 10.4049/jimmunol.170.1.91; Wang XB, 2003, ARTHRITIS RHEUM, V48, P495, DOI 10.1002/art.10929; Wang XM, 2011, J EXP MED, V208, P2497, DOI 10.1084/jem.20111449; Whitmire JK, 2009, J IMMUNOL, V182, P1868, DOI 10.4049/jimmunol.0802501; Wong CK, 2010, J CLIN IMMUNOL, V30, P45, DOI 10.1007/s10875-009-9325-5; Xu XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079858; Yao YH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002737; Yazawa N, 2005, P NATL ACAD SCI USA, V102, P15178, DOI 10.1073/pnas.0505539102; Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002; Yusuf I, 2010, J IMMUNOL, V185, P190, DOI 10.4049/jimmunol.0903505; Zhu CL, 2012, J CLIN ENDOCR METAB, V97, P943, DOI 10.1210/jc.2011-2003	88	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e102791	10.1371/journal.pone.0102791	http://dx.doi.org/10.1371/journal.pone.0102791			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25101629	Green Submitted, Green Published, gold			2022-12-27	WOS:000339993900005
J	Ashfaq, M; Hebert, PDN; Mirza, MS; Khan, AM; Mansoor, S; Shah, GS; Zafar, Y				Ashfaq, Muhammad; Hebert, Paul D. N.; Mirza, M. Sajjad; Khan, Arif M.; Mansoor, Shahid; Shah, Ghulam S.; Zafar, Yusuf			DNA Barcoding of Bemisia tabaci Complex (Hemiptera: Aleyrodidae) Reveals Southerly Expansion of the Dominant Whitefly Species on Cotton in Pakistan	PLOS ONE			English	Article							LEAF CURL DISEASE; GENETIC DIFFERENTIATION; GENNADIUS HEMIPTERA; DIVERSITY; POPULATION; STERNORRHYNCHA; BIOTYPES; VIRUS; CHINA; IDENTIFICATION	Background: Although whiteflies (Bemisia tabaci complex) are an important pest of cotton in Pakistan, its taxonomic diversity is poorly understood. As DNA barcoding is an effective tool for resolving species complexes and analyzing species distributions, we used this approach to analyze genetic diversity in the B. tabaci complex and map the distribution of B. tabaci lineages in cotton growing areas of Pakistan. Methods/Principal Findings:Sequence diversity in the DNA barcode region (mtCOI-5') was examined in 593 whiteflies from Pakistan to determine the number of whitefly species and their distributions in the cotton-growing areas of Punjab and Sindh provinces. These new records were integrated with another 173 barcode sequences for B. tabaci, most from India, to better understand regional whitefly diversity. The Barcode Index Number (BIN) System assigned the 766 sequences to 15 BINs, including nine from Pakistan. Representative specimens of each Pakistan BIN were analyzed for mtCOI-3' to allow their assignment to one of the putative species in the B. tabaci complex recognized on the basis of sequence variation in this gene region. This analysis revealed the presence of Asia II 1, Middle East-Asia Minor 1, Asia 1, Asia II 5, Asia II 7, and a new lineage "Pakistan". The first two taxa were found in both Punjab and Sindh, but Asia 1 was only detected in Sindh, while Asia II 5, Asia II 7 and "Pakistan" were only present in Punjab. The haplotype networks showed that most haplotypes of Asia II 1, a species implicated in transmission of the cotton leaf curl virus, occurred in both India and Pakistan. Conclusions: DNA barcodes successfully discriminated cryptic species in B. tabaci complex. The dominant haplotypes in the B. tabaci complex were shared by India and Pakistan. Asia II 1 was previously restricted to Punjab, but is now the dominant lineage in southern Sindh; its southward spread may have serious implications for cotton plantations in this region.	[Ashfaq, Muhammad; Hebert, Paul D. N.] Univ Guelph, Biodivers Inst Ontario, Guelph, ON N1G 2W1, Canada; [Mirza, M. Sajjad; Khan, Arif M.; Mansoor, Shahid] Natl Inst Biotechnol & Genet Engn, Faisalabad, Pakistan; [Shah, Ghulam S.] Agr Res Inst, Entomol Sect, Tandojam, Pakistan; [Zafar, Yusuf] Pakistan Atom Energy Commiss, Agri & Biotech Div, Islamabad, Pakistan	University of Guelph; Pakistan Institute of Engineering & Applied Science; Pakistan Atomic Energy Commission	Ashfaq, M (corresponding author), Univ Guelph, Biodivers Inst Ontario, Guelph, ON N1G 2W1, Canada.	mashfaq@uoguelph.ca	zafar, YUSUF/F-5154-2015; Hebert, Paul DN/C-4161-2013; Ashfaq, Muhammad/J-4723-2019	Hebert, Paul DN/0000-0002-3081-6700; Ashfaq, Muhammad/0000-0003-1351-4126; Mansoor, Shahid/0000-0001-7418-1826	Higher Education Commission of Pakistan [20-1403/R D/09]; IDRC [106106-001]; Government of Canada through Genome Canada; Ontario Genomics Institute in support of the International Barcode of Life (iBOL) project	Higher Education Commission of Pakistan(Higher Education Commission of Pakistan); IDRC; Government of Canada through Genome Canada(Genome Canada); Ontario Genomics Institute in support of the International Barcode of Life (iBOL) project	This research was enabled by grant HEC No. 20-1403/R& D/09, Sequencing DNA Barcodes of Economically Important Insect Species from Pakistan, from the Higher Education Commission of Pakistan. It was also supported by grant 106106-001, Engaging Developing Nations in iBOL, from IDRC. Sequence analysis was made possible by a grant from the Government of Canada through Genome Canada and the Ontario Genomics Institute in support of the International Barcode of Life (iBOL) project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed MZ, 2012, J APPL ENTOMOL, V136, P510, DOI 10.1111/j.1439-0418.2011.01673.x; Ahmed MZ, 2011, PEST MANAG SCI, V67, P307, DOI 10.1002/ps.2067; Ahmed MZ, 2010, J PEST SCI, V83, P135, DOI 10.1007/s10340-009-0279-4; Alemandri V, 2012, J ECON ENTOMOL, V105, P48, DOI 10.1603/EC11161; Amrao L, 2010, VIRUS RES, V153, P161, DOI 10.1016/j.virusres.2010.07.003; [Anonymous], 2012, EVOL BIOINFORM, V8, P1, DOI 10.4137/EBO.S8532; Armstrong KF, 2005, PHILOS T R SOC B, V360, P1813, DOI 10.1098/rstb.2005.1713; Ashfaq M, 2013, MOL ECOL RESOUR, V13, P832, DOI 10.1111/1755-0998.12131; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Baker R, 2013, EFSA J, V11, DOI 10.2903/j.efsa.2013.3162; Blaxter M, 2004, P ROY SOC B-BIOL SCI, V271, pS189, DOI 10.1098/rsbl.2003.0130; Boykin LM, 2007, MOL PHYLOGENET EVOL, V44, P1306, DOI 10.1016/j.ympev.2007.04.020; Boykin LM, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-228; Boykin LM, 2012, INVERTEBR SYST, V26, P506, DOI 10.1071/IS12025; Briski E, 2011, BIOL INVASIONS, V13, P1325, DOI 10.1007/s10530-010-9892-7; Brown JK, 2005, ANN ENTOMOL SOC AM, V98, P827, DOI 10.1603/0013-8746(2005)098[0827:GDOWBT]2.0.CO;2; Chowda-Reddy RV, 2012, J INTEGR AGR, V11, P235, DOI 10.1016/S2095-3119(12)60008-2; Chu D, 2012, J ECON ENTOMOL, V105, P930, DOI 10.1603/EC10373; Chu D, 2010, ENVIRON ENTOMOL, V39, P1028, DOI 10.1603/EN09161; Crowder DW, 2010, J ANIM ECOL, V79, P563, DOI 10.1111/j.1365-2656.2010.01666.x; De Barro P, 2013, GLOBAL BEMISIA DATAS, DOI [10.4225/08/50EB54B6F1042, DOI 10.4225/08/50EB54B6F1042]; De Barro P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025579; De Barro PJ, 2012, J INTEGR AGR, V11, P187, DOI 10.1016/S2095-3119(12)60003-3; De Barro PJ, 2011, ANNU REV ENTOMOL, V56, P1, DOI 10.1146/annurev-ento-112408-085504; De Barro PJ, 2000, MOL PHYLOGENET EVOL, V16, P29, DOI 10.1006/mpev.1999.0768; Dejean T, 2012, J APPL ECOL, V49, P953, DOI 10.1111/j.1365-2664.2012.02171.x; Dewaard JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018290; Dinsdale A, 2010, ANN ENTOMOL SOC AM, V103, P196, DOI 10.1603/AN09061; Ekrem T, 2007, MOL PHYLOGENET EVOL, V43, P530, DOI 10.1016/j.ympev.2006.11.021; Erlandson M, 2003, CAN ENTOMOL, V135, P71; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Farooq J, 2014, CAN J PLANT PROT, V2, P9; Frohlich DR, 1999, MOL ECOL, V8, P1683, DOI 10.1046/j.1365-294x.1999.00754.x; Fu YX, 1997, GENETICS, V147, P915; Gao YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036622; Goloboff PA, 2004, CLADISTICS, V20, P84; Goloboff PA, 1999, CLADISTICS, V15, P415, DOI 10.1111/j.1096-0031.1999.tb00278.x; Guo XJ, 2012, J INTEGR AGR, V11, P206, DOI 10.1016/S2095-3119(12)60005-7; Hameed S, 2012, ELECTRON J BIOTECHN, V15, DOI 10.2225/vol15-issue6-fulltext-5; Hausmann A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084518; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hu J, 2011, PLOS ONE, V6; Janzen DH, 2005, PHILOS T R SOC B, V360, P1835, DOI 10.1098/rstb.2005.1715; Jiu M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000182; Jones YL, 2013, J FOOD PROTECT, V76, P144, DOI 10.4315/0362-028X.JFP-12-168; Kauserud H, 2008, BOTANY, V86, P1326, DOI 10.1139/B08-102; Krishnamurthy PK, 2012, BIODIVERS CONSERV, V21, P1901, DOI 10.1007/s10531-012-0306-2; Landry JF, 2013, ZOOKEYS, P43, DOI 10.3897/zookeys.327.5831; Lee W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063817; Legg JP, 2002, MOL ECOL, V11, P1219, DOI 10.1046/j.1365-294X.2002.01514.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lisha VS, 2003, J ECON ENTOMOL, V96, P322, DOI 10.1603/0022-0493-96.2.322; Liu SS, 2007, SCIENCE, V318, P1769, DOI 10.1126/science.1149887; Liu SS, 2012, J INTEGR AGR, V11, P176, DOI 10.1016/S2095-3119(12)60002-1; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Mugerwa H, 2012, ECOL EVOL, V2, P2749, DOI 10.1002/ece3.379; Muniz Y, 2011, ENVIRON ENTOMOL, V40, P989, DOI 10.1603/EN11129; Mutanen M, 2013, SCI REP-UK, V3, DOI 10.1038/srep02901; Panhwar GR, 2011, PAKISTAN COTTON, V55, P1; Porco D, 2010, MOL ECOL RESOUR, V10, P942, DOI 10.1111/j.1755-0998.2010.2839.x; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Rabello AR, 2008, GENET MOL BIOL, V31, P585, DOI 10.1590/S1415-47572008000300029; Rana VS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042168; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Ratnasingham S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066213; Reitz SR, 2007, SCIENCE, V318, P1733, DOI 10.1126/science.1152124; Rekha AR, 2005, ENTOMOL EXP APPL, V117, P221, DOI 10.1111/j.1570-7458.2005.00352.x; Sattar MN, 2013, J GEN VIROL, V94, P695, DOI 10.1099/vir.0.049627-0; Schloss Patrick D, 2011, Appl Environ Microbiol, V77, P3219, DOI 10.1128/AEM.02810-10; Simon B, 2003, PHYTOPATHOLOGY, V93, P1422, DOI 10.1094/PHYTO.2003.93.11.1422; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; STACKEBRANDT E, 1994, INT J SYST BACTERIOL, V44, P846, DOI 10.1099/00207713-44-4-846; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tautz D, 2003, TRENDS ECOL EVOL, V18, P70, DOI 10.1016/S0169-5347(02)00041-1; Tay WT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050550; Teacher AGF, 2011, MOL ECOL RESOUR, V11, P151, DOI 10.1111/j.1755-0998.2010.02890.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wang P, 2010, INSECT SCI, V17, P508, DOI 10.1111/j.1744-7917.2010.01353.x; Webb JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038063; Xu J, 2010, B ENTOMOL RES, V100, P359, DOI 10.1017/S0007485310000015; Zhang PJ, 2009, P NATL ACAD SCI USA, V106, P21202, DOI 10.1073/pnas.0907890106; Zhou X, 2011, J N AM BENTHOL SOC, V30, P131, DOI 10.1899/10-010.1	84	54	56	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e104485	10.1371/journal.pone.0104485	http://dx.doi.org/10.1371/journal.pone.0104485			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25099936	Green Published, Green Submitted, gold			2022-12-27	WOS:000339995100075
J	Zhu, WJ; Xu, BH				Zhu, Wenjie; Xu, Binghe			MicroRNA-21 Identified as Predictor of Cancer Outcome: A Meta-Analysis	PLOS ONE			English	Article							TUMOR-SUPPRESSOR GENE; HUMAN BREAST-CANCER; CELL LUNG-CANCER; IN-VIVO; CLINICAL-SIGNIFICANCE; PANCREATIC-CANCER; SOLID TUMORS; EXPRESSION; MIR-21; SERUM	Background: Growing evidence from recent studies has revealed the association of microRNA-21 (mir-21) with outcomes in multiple cancers, but inconsistent findings have been reported, which rationalized a summary and analysis of available data to investigate the prognostic role of mir-21. Materials and Methods: Eligible studies were identified through several search strategies and assessed for quality. Data was extracted from studies in terms of baseline characteristics and key statistics such as hazard ratio (HR), 95% confidence interval (CI) and P value, which were utilized to calculate pooled effect size. Results: 25 studies were included in the meta-analysis to evaluate the prognostic role of mir-21 in malignant tumors. Elevated mir-21 level was demonstrated to moderately predict poor overall survival (OS) (HR = 1.903, 95% CI: 1.713-2.113, P = 0.000) and disease-free survival (DFS) (HR = 1.574, 95% CI: 1.139-2.175, P = 0.006) by the fixed and random effect model respectively. Importantly, subgroup analysis disclosed significant association between increased mir-21 level in cancerous tissue and worse survival status. Furthermore, over-expression of mir-21 was an independent prognostic factor for nonsmall cell lung cancer (NSCLC) and pancreatic cancer patients, with the pooled HR being 2.153 (95% CI: 1.693-2.739, P = 0.000) and 1.976 (95% CI: 1.639-2.384, P = 0.000). Conclusions: Over-expression of mir-21, especially in cancerous tissue, was effectively predictive of worse prognosis in various carcinomas. Non-invasive circulating mir-21, however, exhibited modest ability to discriminate outcomes. Major concerns about mir-21 assay standardization and selection of specimen need to be fully addressed before its practical implementation in management of cancer.	[Xu, Binghe] Chinese Acad Med Sci, Canc Hosp & Inst, Dept Med Oncol, Beijing 100730, Peoples R China; Peking Union Med Coll, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Xu, BH (corresponding author), Chinese Acad Med Sci, Canc Hosp & Inst, Dept Med Oncol, Beijing 100730, Peoples R China.	bhxu@hotmail.com			National Natural Science Foundation [81372830]; Beijing Hope Run Special Fund [LC2013L09]; Capital Clinical Feature Applied Research Fund [Z141107002514010]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Beijing Hope Run Special Fund; Capital Clinical Feature Applied Research Fund	This work was supported by National Natural Science Foundation grant [81372830], Beijing Hope Run Special Fund [LC2013L09] and Capital Clinical Feature Applied Research Fund [Z141107002514010]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 2011, MICRORNA EXPRESSION, P59; Asaga S, 2011, CLIN CHEM, V57, P84, DOI 10.1373/clinchem.2010.151845; Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Barh D, 2010, CURR ONCOL, V17, P70; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Childs G, 2009, AM J PATHOL, V174, P736, DOI 10.2353/ajpath.2009.080731; Croce CM, 2005, CELL, V122, P6, DOI 10.1016/j.cell.2005.06.036; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fabian MR, 2012, NAT STRUCT MOL BIOL, V19, P586, DOI 10.1038/nsmb.2296; Frankel LB, 2008, J BIOL CHEM, V283, P1026, DOI 10.1074/jbc.M707224200; Frezzetti D, 2011, ONCOGENE, V30, P275, DOI 10.1038/onc.2010.416; Fu XN, 2011, EUR J CLIN INVEST, V41, P1245, DOI 10.1111/j.1365-2362.2011.02535.x; Gao W, 2012, CANCER BIOL THER, V13, P330, DOI 10.4161/cbt.19073; Garzon R, 2006, TRENDS MOL MED, V12, P580, DOI 10.1016/j.molmed.2006.10.006; Hatley ME, 2010, CANCER CELL, V18, P282, DOI 10.1016/j.ccr.2010.08.013; Heneghan HM, 2010, ONCOLOGIST, V15, P673, DOI 10.1634/theoncologist.2010-0103; Hirata K, 2013, BRIT J CANCER, V109, P379, DOI 10.1038/bjc.2013.314; Hwang JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010630; Jiang L, 2012, ACTA HISTOCHEM, V114, P582, DOI 10.1016/j.acthis.2011.11.001; Krichevsky AM, 2009, J CELL MOL MED, V13, px, DOI 10.1111/j.1582-4934.2008.00556.x; Lawrie CH, 2007, INT J CANCER, V121, P1156, DOI 10.1002/ijc.22800; Lee EJ, 2007, INT J CANCER, V120, P1046, DOI 10.1002/ijc.22394; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Liu R, 2012, CLIN CHEM, V58, P610, DOI 10.1373/clinchem.2011.172767; Lu Z, 2008, ONCOGENE, V27, P4373, DOI 10.1038/onc.2008.72; Manikandan J, 2008, BIOINFORMATION, V2, P330, DOI 10.6026/97320630002330; Markou A, 2008, CLIN CHEM, V54, P1696, DOI 10.1373/clinchem.2007.101741; Medina PP, 2010, NATURE, V467, P86, DOI 10.1038/nature09284; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Nielsen BS, 2011, CLIN EXP METASTAS, V28, P27, DOI 10.1007/s10585-010-9355-7; Papagiannakopoulos T, 2008, CANCER RES, V68, P8164, DOI 10.1158/0008-5472.CAN-08-1305; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Qian BY, 2009, BREAST CANCER RES TR, V117, P131, DOI 10.1007/s10549-008-0219-7; Schetter AJ, 2008, JAMA-J AM MED ASSOC, V299, P425, DOI 10.1001/jama.299.4.425; Shen J, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-374; Si ML, 2007, ONCOGENE, V26, P2799, DOI 10.1038/sj.onc.1210083; Song B, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-29; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang B, 2012, J CANCER RES CLIN, V138, P1659, DOI 10.1007/s00432-012-1244-9; Wang Y, 2014, GENE, V533, P389, DOI 10.1016/j.gene.2013.09.038; Wickramasinghe NS, 2009, NUCLEIC ACIDS RES, V37, P2584, DOI 10.1093/nar/gkp117; Xia XC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080426; Xu YZ, 2013, ASIAN PAC J CANCER P, V14, P1057, DOI 10.7314/APJCP.2013.14.2.1057; Yan LX, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2803; Yan LX, 2008, RNA, V14, P2348, DOI 10.1261/rna.1034808; Yang Y, 2009, PROTEOMICS, V9, P1374, DOI 10.1002/pmic.200800551; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028; Zhao YQ, 2013, INT J CANCER, V132, P2901, DOI 10.1002/ijc.27954; Zhu SM, 2007, J BIOL CHEM, V282, P14328, DOI 10.1074/jbc.M611393200	54	54	58	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e103373	10.1371/journal.pone.0103373	http://dx.doi.org/10.1371/journal.pone.0103373			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25098165	Green Submitted, Green Published, gold			2022-12-27	WOS:000339995100020
J	Dai, DW; Lu, Q; Huang, QH; Yang, PF; Hong, B; Xu, Y; Zhao, WY; Liu, JM; Li, Q				Dai, Dongwei; Lu, Qiong; Huang, Qinghai; Yang, Pengfei; Hong, Bo; Xu, Yi; Zhao, Wenyuan; Liu, Jianmin; Li, Qiang			Serum miRNA Signature in Moyamoya Disease	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; CIRCULATING MICRORNA; FUTURE PERSPECTIVES; DOWN-REGULATION; IVY SIGN; CANCER; GENE; RNF213; CELLS; ANGIOGENESIS	Moyamoya disease (MMD) is a cerebrovascular disease characterized by progressive stenosis of the intracranial internal carotid arteries and their proximal branches. However, the etiology of this rare disease remains unknown. Serum microRNA (miRNA) profiles have been screened to identify novel biomarkers of prognostic values. Here, we identified serum miRNAs that might play an important role in the pathogenesis of MMD. A genome-wide miRNA array analysis of two pooled serum samples from patients with MMD and controls revealed 94 differentially expressed serum miRNAs, including 50 upregulated and 44 downregulated miRNAs. In an independent MMD cohort, real-time PCR confirmed that miR-106b, miR-130a and miR-126 were significantly upregulated while miR-125a-3p was significantly downregulated in serum. GO analysis showed that the differentially expressed serum miRNAs were enriched in metabolic processes, transcription and signal transduction. Pathway analysis showed that the most enriched pathway was mTOR signaling pathway with 16 potential, functional targets. Finally, we found that 16 and 13 aberrant serum miRNAs coordinately inhibited RNF213 and BRCC3 protein expression at the posttranscriptional level, respectively, resulting in defective angiogenesis and MMD pathogenesis. To our knowledge, this is the first study to identify a serum miRNA signature in MMD. Modulation of the mechanism underlying the role of serum miRNAs in MMD is a potential therapeutic strategy and warrants further investigations.	[Dai, Dongwei; Huang, Qinghai; Yang, Pengfei; Hong, Bo; Xu, Yi; Zhao, Wenyuan; Liu, Jianmin; Li, Qiang] Second Mil Med Univ, Changhai Hosp, Dept Neurosurg, Shanghai, Peoples R China; [Lu, Qiong] Second Mil Med Univ, Changhai Hosp, Dept Lab Med, Shanghai, Peoples R China	Naval Medical University; Naval Medical University	Zhao, WY (corresponding author), Second Mil Med Univ, Changhai Hosp, Dept Neurosurg, Shanghai, Peoples R China.	chstroke@126.com; chstroke@163.com; lqeimm@126.com	Li, Qiang/T-3538-2019		National Science Foundation of China [ISIS : 81271271, 81171093, 81101906]; "1255" Discipline Construction Project of Changhai Hospital [CH125520105]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); "1255" Discipline Construction Project of Changhai Hospital	This paper was financially supported by National Science Foundation of China (ISIS : 81271271, 81171093 and 81101906) and "1255" Discipline Construction Project of Changhai Hospital (CH125520105). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aqeilan RI, 2010, CELL DEATH DIFFER, V17, P215, DOI 10.1038/cdd.2009.69; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bai J, 2012, ONCOTARGETS THER, V5, P213, DOI 10.2147/OTT.S36017; Bi Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040169; Boeri M, 2011, P NATL ACAD SCI USA, V108, P3713, DOI 10.1073/pnas.1100048108; Brase JC, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-306; Chen J, 2013, CNS NEUROSCI THER, V19, P638, DOI 10.1111/cns.12130; Concepcion CP, 2012, CANCER J, V18, P262, DOI 10.1097/PPO.0b013e318258b60a; Dai DW, 2013, NEURORADIOLOGY, V55, P1431, DOI 10.1007/s00234-013-1291-1; Dai DW, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-478; Duan L, 2012, STROKE, V43, P56, DOI 10.1161/STROKEAHA.111.621300; Guo DC, 2009, AM J HUM GENET, V84, P617, DOI 10.1016/j.ajhg.2009.04.007; Hitomi T, 2013, BIOCHEM BIOPH RES CO, V438, P13, DOI 10.1016/j.bbrc.2013.07.004; Ho AS, 2010, TRANSL ONCOL, V3, P109, DOI 10.1593/tlo.09256; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kamada F, 2011, J HUM GENET, V56, P34, DOI 10.1038/jhg.2010.132; Kanehisa Minoru, 2013, Methods Mol Biol, V939, P263, DOI 10.1007/978-1-62703-107-3_17; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kang HS, 2010, J NEUROL NEUROSUR PS, V81, P673, DOI 10.1136/jnnp.2009.191817; Kim YJ, 2013, EUR J NEUROL, V20, P1311, DOI 10.1111/ene.12202; Kong YW, 2012, LANCET ONCOL, V13, pE249, DOI 10.1016/S1470-2045(12)70073-6; Kosaka N, 2010, J BIOL CHEM, V285, P17442, DOI 10.1074/jbc.M110.107821; Kossorotoff M, 2012, CEREBROVASC DIS, V33, P76, DOI 10.1159/000333424; Kraemer M, 2008, STROKE, V39, P3193, DOI 10.1161/STROKEAHA.107.513408; Kroh EM, 2010, METHODS, V50, P298, DOI 10.1016/j.ymeth.2010.01.032; Kuroda S, 2008, LANCET NEUROL, V7, P1056, DOI 10.1016/S1474-4422(08)70240-0; Li H, 2010, CEREBROVASC DIS, V30, P618, DOI 10.1159/000319893; Lia D, 2010, J HYPERTENS, V28, P1646, DOI 10.1097/HJH.0b013e32833a4922; Liu WY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022542; Liu Wanyang, 2010, Environmental Health and Preventive Medicine, V15, P94, DOI 10.1007/s12199-009-0116-7; Liu ZH, 2012, CELL PHYSIOL BIOCHEM, V29, P851, DOI 10.1159/000258197; Long GW, 2012, INT J BIOL SCI, V8, P811, DOI 10.7150/ijbs.4439; Lu CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068986; Maeda M, 1999, AM J NEURORADIOL, V20, P1836; Miskinyte S, 2011, AM J HUM GENET, V88, P718, DOI 10.1016/j.ajhg.2011.04.017; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Miyatake S, 2012, NEUROLOGY, V78, P803, DOI 10.1212/WNL.0b013e318249f71f; Mori N, 2009, AM J NEURORADIOL, V30, P930, DOI 10.3174/ajnr.A1504; Roder C, 2010, ACTA NEUROCHIR, P1; Sakurai K, 2004, J HUM GENET, V49, P278, DOI 10.1007/s10038-004-0143-6; Sasahira T, 2012, BRIT J CANCER, V107, P700, DOI 10.1038/bjc.2012.330; Scholer N, 2010, EXP HEMATOL, V38, P1126, DOI 10.1016/j.exphem.2010.10.004; Shi L, 2008, BRAIN RES, V1236, P185, DOI 10.1016/j.brainres.2008.07.085; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Taurino C, 2010, CLIN SCI, V119, P335, DOI 10.1042/CS20100043; Wang GK, 2010, EUR HEART J, V31, P659, DOI 10.1093/eurheartj/ehq013; Wang J, 2009, CANCER PREV RES, V2, P807, DOI 10.1158/1940-6207.CAPR-09-0094; Wang XM, 2013, GENE, V526, P437, DOI 10.1016/j.gene.2013.05.083; Wang XR, 2012, ONCOL LETT, V3, P955, DOI 10.3892/ol.2012.609; Wang YY, 2012, J NEURO-ONCOL, V106, P217, DOI 10.1007/s11060-011-0679-1; Weinberg DG, 2011, NEUROSURG FOCUS, V30, DOI 10.3171/2011.3.FOCUS1151; Wu WH, 2011, AM J HYPERTENS, V24, P1087, DOI 10.1038/ajh.2011.116; Wu ZY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048179; Yamauchi T, 2000, STROKE, V31, P930, DOI 10.1161/01.STR.31.4.930; Yun TJ, 2013, INVEST RADIOL, V48, P795, DOI 10.1097/RLI.0b013e3182981137; Zhao CJ, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0021768, 10.1371/journal.pone.0023925]	56	38	40	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e102382	10.1371/journal.pone.0102382	http://dx.doi.org/10.1371/journal.pone.0102382			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093848	Green Published, Green Submitted, gold			2022-12-27	WOS:000341357200010
J	Davidson, AE; Cheong, SS; Hysi, PG; Venturini, C; Plagnol, V; Ruddle, JB; Ali, H; Carnt, N; Gardner, JC; Hassan, H; Gade, E; Kearns, L; Jelsig, AM; Restori, M; Webb, TR; Laws, D; Cosgrove, M; Hertz, JM; Russell-Eggitt, I; Pilz, DT; Hammond, CJ; Tuft, SJ; Hardcastle, AJ				Davidson, Alice E.; Cheong, Sek-Shir; Hysi, Pirro G.; Venturini, Cristina; Plagnol, Vincent; Ruddle, Jonathan B.; Ali, Hala; Carnt, Nicole; Gardner, Jessica C.; Hassan, Hala; Gade, Else; Kearns, Lisa; Jelsig, Anne Marie; Restori, Marie; Webb, Tom R.; Laws, David; Cosgrove, Michael; Hertz, Jens M.; Russell-Eggitt, Isabelle; Pilz, Daniela T.; Hammond, Christopher J.; Tuft, Stephen J.; Hardcastle, Alison J.			Association of CHRDL1 Mutations and Variants with X-linked Megalocornea, Neuhauser Syndrome and Central Corneal Thickness	PLOS ONE			English	Article							PRIMARY CONGENITAL GLAUCOMA; GENOME-WIDE ASSOCIATION; MENTAL-RETARDATION SYNDROME; CUL4B GENE; CHROMOSOME; LTBP2; DIFFERENTIATION; HYPOGONADISM; BUPHTHALMOS; POPULATION	We describe novel CHRDL1 mutations in ten families with X-linked megalocornea (MGC1). Our mutation-positive cohort enabled us to establish ultrasonography as a reliable clinical diagnostic tool to distinguish between MGC1 and primary congenital glaucoma (PCG). Megalocornea is also a feature of Neuhauser or megalocornea-mental retardation (MMR) syndrome, a rare condition of unknown etiology. In a male patient diagnosed with MMR, we performed targeted and whole exome sequencing (WES) and identified a novel missense mutation in CHRDL1 that accounts for his MGC1 phenotype but not his non-ocular features. This finding suggests that MMR syndrome, in some cases, may be di- or multigenic. MGC1 patients have reduced central corneal thickness (CCT); however no X-linked loci have been associated with CCT, possibly because the majority of genome-wide association studies (GWAS) overlook the X-chromosome. We therefore explored whether variants on the X-chromosome are associated with CCT. We found rs149956316, in intron 6 of CHRDL1, to be the most significantly associated single nucleotide polymorphism (SNP) (p=6.81x10(-6)) on the X-chromosome. However, this association was not replicated in a smaller subset of whole genome sequenced samples. This study highlights the importance of including X-chromosome SNP data in GWAS to identify potential loci associated with quantitative traits or disease risk.	[Davidson, Alice E.; Cheong, Sek-Shir; Ali, Hala; Carnt, Nicole; Gardner, Jessica C.; Hassan, Hala; Webb, Tom R.; Tuft, Stephen J.; Hardcastle, Alison J.] UCL Inst Ophthalmol, London, England; [Hysi, Pirro G.; Venturini, Cristina; Hammond, Christopher J.] Kings Coll London, St Thomas Hosp, Dept Twin Res & Genet Epidemiol, London WC2R 2LS, England; [Plagnol, Vincent] UCL Genet Inst, London, England; [Ruddle, Jonathan B.; Kearns, Lisa] Univ Melbourne, Ctr Eye Res, Dept Ophthalmol, Melbourne, Vic, Australia; [Carnt, Nicole; Hassan, Hala; Restori, Marie; Tuft, Stephen J.] Moorfields Eye Hosp, London, England; [Gade, Else] Odense Univ Hosp, Dept Ophthalmol, DK-5000 Odense, Denmark; [Jelsig, Anne Marie; Hertz, Jens M.] Odense Univ Hosp, Dept Clin Genet, DK-5000 Odense, Denmark; [Laws, David] Singleton Hosp, Dept Ophthalmol, Swansea SA2 8QA, W Glam, Wales; [Cosgrove, Michael] Singleton Hosp, Dept Women & Child Hlth, Swansea SA2 8QA, W Glam, Wales; [Russell-Eggitt, Isabelle] Great Ormond St Hosp Sick Children, London WC1N 3JH, England; [Pilz, Daniela T.] Univ Wales Hosp, Inst Med Genet, Cardiff CF4 4XN, S Glam, Wales	University of London; University College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of London; University College London; University of Melbourne; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital; Singleton Hospital; Singleton Hospital; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Cardiff University	Hardcastle, AJ (corresponding author), UCL Inst Ophthalmol, London, England.	a.hardcastle@ucl.ac.uk	Webb, Tom/GMW-5311-2022; Hertz, Jens Michael/H-6269-2014; Jelsig, Anne Marie/AAR-2372-2020; Carnt, Nicole/T-1585-2017; Webb, Tom/C-6237-2011	Hertz, Jens Michael/0000-0003-0087-4739; Carnt, Nicole/0000-0002-5376-0885; Webb, Tom/0000-0001-5998-8226; Venturini, Cristina/0000-0002-4769-7912; Hammond, Christopher/0000-0002-3227-2620; Hardcastle, Alison/0000-0002-0038-6770; Plagnol, Vincent/0000-0002-5597-9215; Cheong, Sek-Shir/0000-0002-2218-7852; Hysi, Pirro/0000-0001-5752-2510	National Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital; UCL Institute of Ophthalmology; Moorfields Special Trustees; Moorfields Eye Charity; Lanvern foundation; Rosetrees Trust; Australian National Health and Medical Research Council (NHMRC) Centres of Research Excellence Grant [1023911]; National Institute for Health Research [SRF/01/010] Funding Source: researchfish; Rosetrees Trust [M311] Funding Source: researchfish	National Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital; UCL Institute of Ophthalmology; Moorfields Special Trustees; Moorfields Eye Charity; Lanvern foundation; Rosetrees Trust(Rosetrees Trust); Australian National Health and Medical Research Council (NHMRC) Centres of Research Excellence Grant(National Health and Medical Research Council (NHMRC) of Australia); National Institute for Health Research(National Institute for Health Research (NIHR)); Rosetrees Trust(Rosetrees Trust)	This work was supported by the National Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital and UCL Institute of Ophthalmology; Moorfields Special Trustees; Moorfields Eye Charity; the Lanvern foundation; and Rosetrees Trust. CERA receives Operational Infrastructure Support from the Victorian Government. Funding support was provided by an Australian National Health and Medical Research Council (NHMRC) Centres of Research Excellence Grant 1023911 (2012-2016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu A, 2008, AM J HUM GENET, V82, P1217, DOI 10.1016/j.ajhg.2008.04.001; Abu-Amero KK, 2011, MOL VIS, V17, P2911; Akarsu AN, 1996, HUM MOL GENET, V5, P1199, DOI 10.1093/hmg/5.8.1199; Ali M, 2009, AM J HUM GENET, V84, P664, DOI 10.1016/j.ajhg.2009.03.017; Badura-Stronka M, 2010, CLIN GENET, V77, P141, DOI 10.1111/j.1399-0004.2009.01331.x; Bakrania P, 2008, AM J HUM GENET, V82, P304, DOI 10.1016/j.ajhg.2007.09.023; CAMERON JA, 1993, CORNEA, V12, P54, DOI 10.1097/00003226-199301000-00009; CHEN JD, 1989, HUM GENET, V83, P292, DOI 10.1007/BF00285176; Cossette P, 2002, NAT GENET, V31, P184, DOI 10.1038/ng885; Desir J, 2010, EUR J HUM GENET, V18, P761, DOI 10.1038/ejhg.2010.11; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Dimasi DP, 2010, BRIT J OPHTHALMOL, V94, P971, DOI 10.1136/bjo.2009.162735; Doughty MJ, 2000, SURV OPHTHALMOL, V44, P367, DOI 10.1016/S0039-6257(00)00110-7; Fingert JH, 1999, HUM MOL GENET, V8, P899, DOI 10.1093/hmg/8.5.899; Gao WL, 2013, MOL MED REP, V7, P1143, DOI 10.3892/mmr.2013.1310; Gao XY, 2013, INVEST OPHTH VIS SCI, V54, P2435, DOI 10.1167/iovs.13-11692; Gutierrez-Amavizca BE, 2013, GENET COUNSEL, V24, P185; Han J, 2013, OPHTHALMIC GENETICS; Hebsgaard SM, 1996, NUCLEIC ACIDS RES, V24, P3439, DOI 10.1093/nar/24.17.3439; Hoehn R, 2012, HUM GENET, V131, P1783, DOI 10.1007/s00439-012-1201-3; Isidor B, 2010, AM J MED GENET A, V152A, P175, DOI 10.1002/ajmg.a.33152; Kaur K, 2005, CLIN GENET, V67, P335, DOI 10.1111/j.1399-0004.2005.00411.x; Konig IR, 2014, GENET EPIDEMIOL, V38, P97, DOI 10.1002/gepi.21782; KUPFER C, 1979, AM J OPHTHALMOL, V88, P424, DOI 10.1016/0002-9394(79)90643-3; Lee KE, 2009, ARCH OPHTHALMOL-CHIC, V127, P88, DOI 10.1001/archophthalmol.2008.521; Lu Y, 2013, NAT GENET, V45, P155, DOI 10.1038/ng.2506; Lu Y, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000947; MEIRE FM, 1991, OPHTHALMIC PAED GEN, V12, P153, DOI 10.3109/13816819109029398; MEIRE FM, 1994, DOC OPHTHALMOL, V87, P6; Moayyeri A, 2013, TWIN RES HUM GENET, V16, P144, DOI 10.1017/thg.2012.89; Narooie-Nejad M, 2009, HUM MOL GENET, V18, P3969, DOI 10.1093/hmg/ddp338; NEUHAUSER G, 1975, Z KINDERHEILKD, V120, P1, DOI 10.1007/BF00443795; Ojaimi E, 2005, INVEST OPHTH VIS SCI, V46, P2748, DOI 10.1167/iovs.04-1324; Piton A, 2013, AM J HUMAN GENETICS; Piva F, 2009, BIOINFORMATICS, V25, P1211, DOI 10.1093/bioinformatics/btp124; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; Rider CC, 2010, BIOCHEM J, V429, P1, DOI 10.1042/BJ20100305; RUD ERIK, 1960, ACTA OPHTHALMOL, V38, P606; SARFARAZI M, 1995, GENOMICS, V30, P171, DOI 10.1006/geno.1995.9888; Sharafieh R, 2013, OPHTHALMIC GENET, V34, P14, DOI 10.3109/13816810.2012.716486; Stoilov IR, 2002, INVEST OPHTHALMOL VI, V2002; Tarpey PS, 2007, AM J HUM GENET, V80, P345, DOI 10.1086/511134; Vitart V, 2010, HUM MOL GENET, V19, P4304, DOI 10.1093/hmg/ddq349; Vithana EN, 2011, HUM MOL GENET, V20, P649, DOI 10.1093/hmg/ddq511; Webb TR, 2012, AM J HUM GENET, V90, P247, DOI 10.1016/j.ajhg.2011.12.019; Whibley AC, 2010, AM J HUM GENET, V87, P173, DOI 10.1016/j.ajhg.2010.06.017; Winnepenninckx B, 2007, AM J HUM GENET, V80, P221, DOI 10.1086/510800; Wise AL, 2013, AM J HUM GENET, V92, P643, DOI 10.1016/j.ajhg.2013.03.017; Wordinger RJ, 2007, EXP BIOL MED, V232, P979, DOI 10.3181/0510-MR-345; Zou YX, 2007, AM J HUM GENET, V80, P561, DOI 10.1086/512489	50	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e104163	10.1371/journal.pone.0104163	http://dx.doi.org/10.1371/journal.pone.0104163			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093588	Green Published, gold			2022-12-27	WOS:000341357200078
J	Dillon, S; McEvoy, R; Baldwin, DS; Rees, GN; Parsons, Y; Southerton, S				Dillon, Shannon; McEvoy, Rachel; Baldwin, Darren S.; Rees, Gavin N.; Parsons, Yvonne; Southerton, Simon			Characterisation of Adaptive Genetic Diversity in Environmentally Contrasted Populations of Eucalyptus camaldulensis Dehnh. (River Red Gum)	PLOS ONE			English	Article							SECONDARY CELL-WALL; PINE PINUS-TAEDA; CLIMATE-CHANGE; LOCAL ADAPTATION; EVOLUTIONARY RESPONSES; ASSOCIATION GENETICS; CANDIDATE GENES; ABSCISIC-ACID; SELECTION; FOREST	As an increasing number of ecosystems face departures from long standing environmental conditions under climate change, our understanding of the capacity of species to adapt will become important for directing conservation and management of biodiversity. Insights into the potential for genetic adaptation might be gained by assessing genomic signatures of adaptation to historic or prevailing environmental conditions. The river red gum (Eucalyptus camaldulensis Dehnh.) is a widespread Australian eucalypt inhabiting riverine and floodplain habitats which spans strong environmental gradients. We investigated the effects of adaptation to environment on population level genetic diversity of E. camaldulensis, examining SNP variation in candidate gene loci sampled across 20 climatically diverse populations approximating the species natural distribution. Genetic differentiation among populations was high (F-ST = 17%), exceeding previous estimates based on neutral markers. Complementary statistical approaches identified 6 SNP loci in four genes (COMT, Dehydrin, ERECTA and PIP2) which, after accounting for demographic effects, exhibited higher than expected levels of genetic differentiation among populations and whose allelic variation was associated with local environment. While this study employs but a small proportion of available diversity in the eucalyptus genome, it draws our attention to the potential for application of wide spread eucalypt species to test adaptive hypotheses.	[Dillon, Shannon; Southerton, Simon] CSIRO Agr Flagship, Canberra, ACT, Australia; [McEvoy, Rachel; Parsons, Yvonne] La Trobe Univ, Dept Genet, Bundoora, Vic, Australia; [Baldwin, Darren S.; Rees, Gavin N.] Murray Darling Freshwater Res Ctr, Wodonga, Vic, Australia; [Baldwin, Darren S.; Rees, Gavin N.] CSIRO Land & Water Flagship, Wodonga, Vic, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); La Trobe University; Murray Darling Basin Authority; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Dillon, S (corresponding author), CSIRO Agr Flagship, Canberra, ACT, Australia.	Shannon.Dillon@csiro.au	Rees, Gavin/U-5653-2019; Rees, Gavin/E-6869-2011; Baldwin, Darren S/H-2257-2011	Rees, Gavin/0000-0002-5270-8559; Rees, Gavin/0000-0002-5270-8559; Dillon, shannon/0000-0003-2277-9724	Department of Environment, Water, Heritage and the Arts Commonwealth Environmental Research Facilities Significant Project [13282]; CSIRO's Transformational Biology Catalytic Platform	Department of Environment, Water, Heritage and the Arts Commonwealth Environmental Research Facilities Significant Project; CSIRO's Transformational Biology Catalytic Platform	This project was funded by the Department of Environment, Water, Heritage and the Arts Commonwealth Environmental Research Facilities Significant Project funding (http://www.environment.gov.au/node/13282), and CSIRO's Transformational Biology Catalytic Platform (http://www.csiro.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken SN, 2008, EVOL APPL, V1, P95, DOI 10.1111/j.1752-4571.2007.00013.x; Aitken SN, 2013, ANNU REV ECOL EVOL S, V44, P367, DOI 10.1146/annurev-ecolsys-110512-135747; Alberto FJ, 2013, GLOBAL CHANGE BIOL, V19, P1645, DOI 10.1111/gcb.12181; Allen C. D., 2009, Unasylva (English ed.), V60, P43; Allen RJ, 1985, AUSTRALASIAN SUMMER; Audigeos D, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-202; Awe J. O., 1976, Australian Forestry, V39, P201; Baima S, 2001, PLANT PHYSIOL, V126, P643, DOI 10.1104/pp.126.2.643; Barrett RDH, 2008, TRENDS ECOL EVOL, V23, P38, DOI 10.1016/j.tree.2007.09.008; Beaumont MA, 1996, P ROY SOC B-BIOL SCI, V263, P1619, DOI 10.1098/rspb.1996.0237; Beck EH, 2007, J BIOSCIENCES, V32, P501, DOI 10.1007/s12038-007-0049-5; Borevitz JO, 2000, PLANT CELL, V12, P2383, DOI 10.1105/tpc.12.12.2383; Bradbury D, 2013, MOL ECOL, V22, P5112, DOI 10.1111/mec.12463; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Bragg JG, 2014, NEW PHYTOL; Brooker M. I. H., 1999, FILED GUIDE EUCALYPT; Brown DM, 2005, PLANT CELL, V17, P2281, DOI 10.1105/tpc.105.031542; Butcher PA, 2009, TREE GENET GENOMES, V5, P189, DOI 10.1007/s11295-008-0169-6; Carnicer J, 2011, P NATL ACAD SCI USA, V108, P1474, DOI 10.1073/pnas.1010070108; Chen ZZ, 2005, PLANT J, V43, P273, DOI 10.1111/j.1365-313X.2005.02452.x; Coop G, 2010, GENETICS, V185, P1411, DOI 10.1534/genetics.110.114819; Cunningham SC, 2009, ECOSYSTEMS, V12, P207, DOI 10.1007/s10021-008-9218-0; Cunningham SC, 2010, AUSTRAL ECOL, V35, P348, DOI 10.1111/j.1442-9993.2009.02043.x; DAVIDSON NJ, 1989, AUST J ECOL, V14, P139, DOI 10.1111/j.1442-9993.1989.tb01423.x; De Mita S, 2013, MOL ECOL, V22, P1383, DOI 10.1111/mec.12182; Dillon SK, 2013, TREE GENET GENOMES, V9, P1447, DOI 10.1007/s11295-013-0650-8; Dillon SK, 2012, NEW PHYTOL, V195, P596, DOI 10.1111/j.1469-8137.2012.04200.x; Doblin MS, 2002, PLANT CELL PHYSIOL, V43, P1407, DOI 10.1093/pcp/pcf164; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Eckert AJ, 2010, GENETICS, V185, P969, DOI 10.1534/genetics.110.115543; Eckert AJ, 2010, MOL ECOL, V19, P3789, DOI 10.1111/j.1365-294X.2010.04698.x; Eckert AJ, 2009, GENETICS, V183, P289, DOI 10.1534/genetics.109.103895; Eckert AJ, 2009, GENETICS, V182, P1289, DOI 10.1534/genetics.109.102350; El-Lakany MH, 1980, ALEXANDRIA J AGR RES, V28, P309; Eveno E, 2008, MOL BIOL EVOL, V25, P417, DOI 10.1093/molbev/msm272; Excoffier L, 2009, HEREDITY, V103, P285, DOI 10.1038/hdy.2009.74; Excoffier L, 2005, EVOLUTIONARY BIOINFO, V1; Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221; GIBSON A, 1995, AUST J PLANT PHYSIOL, V22, P453, DOI 10.1071/PP9950453; GIBSON A, 1991, AUST J PLANT PHYSIOL, V18, P153, DOI 10.1071/PP9910153; Gibson A, 1994, RELATIONSHIPS SITE C; Gonzalez-Martinez SC, 2008, HEREDITY, V101, P19, DOI 10.1038/hdy.2008.21; Goslee SC, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i07; GRUNWALD C, 1983, SILVAE GENET, V32, P165; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hanna P, 2012, FOREST ECOL MANAG, V274, P91, DOI 10.1016/j.foreco.2012.02.009; Hansen MM, 2012, MOL ECOL, V21, P1311, DOI 10.1111/j.1365-294X.2011.05463.x; Hao GP, 2009, J INTEGR PLANT BIOL, V51, P175, DOI 10.1111/j.1744-7909.2008.00786.x; HENDERSON CR, 1975, BIOMETRICS, V31, P423, DOI 10.2307/2529430; Hoffmann AA, 2008, NAT REV GENET, V9, P421, DOI 10.1038/nrg2339; Hoffmann AA, 2011, NATURE, V470, P479, DOI 10.1038/nature09670; Holliday JA, 2010, NEW PHYTOL, V188, P501, DOI 10.1111/j.1469-8137.2010.03380.x; Hubick K. T., 1993, Stable isotopes and plant carbon-water relations., P311; Ingvarsson PK, 2005, GENETICS, V169, P945, DOI 10.1534/genetics.104.034959; Ioannidis JPA, 2008, EPIDEMIOLOGY, V19, P640, DOI 10.1097/EDE.0b013e31818131e7; JAMES SA, 1995, AUST J BOT, V43, P415, DOI 10.1071/BT9950415; Jeffreys H., 1961, THEORY PROBABILITY; Joost S, 2007, MOL ECOL, V16, P3955, DOI 10.1111/j.1365-294X.2007.03442.x; Kaldenhoff R, 2006, ACTA PHYSIOL, V187, P169, DOI 10.1111/j.1748-1716.2006.01563.x; Kremer A, 2012, ECOL LETT, V15, P378, DOI 10.1111/j.1461-0248.2012.01746.x; Kulheim C, 2011, NEW PHYTOL, V191, P1041, DOI 10.1111/j.1469-8137.2011.03769.x; Kulheim C, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-452; Lemcoff JH, 2002, FLORA, V197, P134, DOI 10.1078/0367-2530-00023; Li LG, 2006, CRIT REV PLANT SCI, V25, P215, DOI 10.1080/07352680600611519; Lindner M, 2010, FOREST ECOL MANAG, V259, P698, DOI 10.1016/j.foreco.2009.09.023; Luikart G, 2003, NAT REV GENET, V4, P981, DOI 10.1038/nrg1226; Lynch M, 2007, P NATL ACAD SCI USA, V104, P8597, DOI 10.1073/pnas.0702207104; Masle J, 2005, NATURE, V436, P866, DOI 10.1038/nature03835; Maurel C, 2008, ANNU REV PLANT BIOL, V59, P595, DOI 10.1146/annurev.arplant.59.032607.092734; McDonald MW, 2009, AUST SYST BOT, V22, P257, DOI 10.1071/SB09005; Millar CI, 2012, CAN J FOREST RES, V42, P749, DOI [10.1139/X2012-031, 10.1139/x2012-031]; MORESHET S, 1981, AUST J BOT, V29, P97, DOI 10.1071/BT9810097; Mosca E, 2014, NEW PHYTOL, V201, P180, DOI 10.1111/nph.12476; Namroud MC, 2008, MOL ECOL, V17, P3599, DOI 10.1111/j.1365-294X.2008.03840.x; Neale DB, 2011, NAT REV GENET, V12, P111, DOI 10.1038/nrg2931; OTEGBEYE GO, 1985, SILVAE GENET, V34, P121; Paccard A, 2013, J EVOLUTION BIOL, V26, P2331, DOI 10.1111/jeb.12220; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Petherick L, 2013, QUATERNARY SCI REV, V74, P58, DOI 10.1016/j.quascirev.2012.12.012; Philippe R, 2010, THEOR APPL GENET, V121, P769, DOI 10.1007/s00122-010-1348-z; Prunier J, 2011, MOL ECOL, V20, P1702, DOI 10.1111/j.1365-294X.2011.05045.x; Reusch TBH, 2005, P NATL ACAD SCI USA, V102, P2826, DOI 10.1073/pnas.0500008102; Rorat T, 2007, CELL MOL BIOL LETT, V12, P148, DOI 10.2478/s11658-006-0044-0; Salvi S, 2007, P NATL ACAD SCI USA, V104, P11376, DOI 10.1073/pnas.0704145104; Savolainen O, 2007, ANNU REV ECOL EVOL S, V38, P595, DOI 10.1146/annurev.ecolsys.38.091206.095646; Schaberg PG, 2008, FOREST ECOL MANAG, V256, P855, DOI 10.1016/j.foreco.2008.06.038; Schueler S, 2013, BIODIVERS CONSERV, V22, P1151, DOI 10.1007/s10531-012-0313-3; SESBOU A, 1978, ANN SCI FOREST, V35, P237, DOI 10.1051/forest/19780401; Sgro CM, 2011, EVOL APPL, V4, P326, DOI 10.1111/j.1752-4571.2010.00157.x; Sork VL, 2013, TREE GENET GENOMES, V9, P901, DOI 10.1007/s11295-013-0596-x; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Szyjanowicz PMJ, 2004, PLANT J, V37, P730, DOI 10.1111/j.1365-313X.2003.02000.x; Thumma BR, 2009, GENETICS, V183, P1153, DOI 10.1534/genetics.109.106591; Thumma BR, 2012, BMC GENOMIC IN PRESS; van Zonneveld M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029845; Wachowiak W, 2009, TREE GENET GENOMES, V5, P117, DOI 10.1007/s11295-008-0188-3; Ward D, 2012, ANN BOT-LONDON, V109, P247, DOI 10.1093/aob/mcr276; Wen L, 2009, ECOHYDROLOGY, V2, P143, DOI 10.1002/eco.46; Xia H, 2010, MOL ECOL, V19, P4144, DOI 10.1111/j.1365-294X.2010.04762.x	101	33	34	2	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e103515	10.1371/journal.pone.0103515	http://dx.doi.org/10.1371/journal.pone.0103515			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093589	Green Published, Green Submitted, gold			2022-12-27	WOS:000341357200024
J	Ido, N; Lee, K; Iwabuchi, K; Izumiya, H; Uchida, I; Kusumoto, M; Iwata, T; Ohnishi, M; Akiba, M				Ido, Noriko; Lee, Ken-ichi; Iwabuchi, Kaori; Izumiya, Hidemasa; Uchida, Ikuo; Kusumoto, Masahiro; Iwata, Taketoshi; Ohnishi, Makoto; Akiba, Masato			Characteristics of Salmonella enterica Serovar 4,[5], 12: i:- as a Monophasic Variant of Serovar Typhimurium	PLOS ONE			English	Article							FLAGELLAR PHASE VARIATION; MOLECULAR CHARACTERIZATION; PHENOTYPIC CHARACTERISTICS; SEROTYPE TYPHIMURIUM; DNA; PLASMID; STRAIN	Salmonella enterica subspecies enterica serovar 4,[5], 12: i:-(S. 4,[5] 12: i:-) is believed to be a monophasic variant of S. enterica serovar Typhimurium (S. Typhimurium). This study was conducted to corroborate this hypothesis and to identify the molecular and phenotypic characteristics of the S. 4,[5] 12: i:-isolates in Japan. A total of 51 S. 4,[5] 12: i:-isolates derived from humans, cattle, swine, chickens, birds, meat (pork), and river water in 15 prefectures in Japan between 2000 and 2010 were analyzed. All the S. 4,[5], 12: i:-isolates were identified as S. Typhimurium by two different polymerase chain reactions (PCR) for identification of S. Typhimurium. Of the 51 S. 4,[5], 12: i:-isolates, 39 (76.5%) harbored a 94-kb virulence plasmid, which is known to be specific for S. Typhimurium. These data suggest that the S. 4,[5], 12: i:-isolates are monophasic variants of S. Typhimurium. The flagellar phase variation is induced by three adjacent genes (fljA, fljB, and hin) in the chromosome. The results of PCR mapping of this region and comparative genomic hybridization analysis suggested that the deletion of the fljAB operon and its flanking region was the major genetic basis of the monophasic phenotype of S. 4,[5], 12: i:-. The fljAB operon and hin gene were detectable in eight of the S. 4,[5], 12: i:-isolates with common amino acid substitutions of A46T in FljA and R140L in Hin. The introduction of these mutations into S. Typhimurium isolates led to the loss of selectability of isolates expressing the phase 2 H antigen. These data suggested that a point mutation was the genetic basis, at least in part, of the S. 4,[5], 12: i:-isolates. The results of phenotypic analysis suggested that the S. 4,[5], 12: i:-isolates in Japan consist of multiple distinct clones. This is the first detailed characterization of the S. 4,[5], 12: i:-isolates derived from various sources across Japan.	[Ido, Noriko] Iwate Prefecture Cent Livestock Hyg Serv Ctr, Takizawa, Iwate, Japan; [Lee, Ken-ichi; Kusumoto, Masahiro; Iwata, Taketoshi; Akiba, Masato] Natl Agr & Food Res Org, Bacterial & Parasit Dis Res Div, Natl Inst Anim Hlth, Ibaraki, Japan; [Iwabuchi, Kaori] Res Inst Environm Sci & Publ Hlth Iwate Prefectur, Takizawa, Iwate, Japan; [Izumiya, Hidemasa; Ohnishi, Makoto] Natl Inst Infect Dis, Dept Bacteriol, Tokyo, Japan; [Uchida, Ikuo] Natl Agr & Food Res Org, Natl Inst Anim Hlth, Hokkaido Res Stn, Sapporo, Hokkaido, Japan; [Akiba, Masato] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Osaka, Japan	National Agriculture & Food Research Organization - Japan; National Institute of Animal Health - Japan; National Institute of Infectious Diseases (NIID); National Agriculture & Food Research Organization - Japan; National Institute of Animal Health - Japan; Osaka Metropolitan University	Akiba, M (corresponding author), Natl Agr & Food Res Org, Bacterial & Parasit Dis Res Div, Natl Inst Anim Hlth, Ibaraki, Japan.	akiba@affrc.go.jp	Lee, Ken-ichi/E-9423-2010	Lee, Ken-ichi/0000-0002-4765-0989	Ministry of Agriculture, Forestry and Fisheries of Japan [24-7304]; Ministry of Health, Labour, and Welfare of Japan [H24-Shokuhin-Ippan-008]	Ministry of Agriculture, Forestry and Fisheries of Japan(Ministry of Agriculture Forestry & Fisheries - Japan); Ministry of Health, Labour, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by grants-in-aid from the Ministry of Agriculture, Forestry and Fisheries of Japan (Research project for ensuring food safety from farm to table 24-7304), and the Ministry of Health, Labour, and Welfare of Japan (H24-Shokuhin-Ippan-008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiba M, 2011, J MICROBIOL METH, V85, P9, DOI 10.1016/j.mimet.2011.02.002; ANDERSON ES, 1977, J HYG-CAMBRIDGE, V78, P297, DOI 10.1017/S0022172400056187; Burnens AP, 1997, MICROBIOL-UK, V143, P1539, DOI 10.1099/00221287-143-5-1539; Centers for Disease Control and Prevention, 2008, SALM SURV ANN SUMM; Clinical and Laboratory Standards Institute, 2008, M31A3 CLIN LAB STAND; de la Torre E, 2003, J CLIN MICROBIOL, V41, P2395, DOI 10.1128/JCM.41.6.2395-2400.2003; Dionisi AM, 2009, FOODBORNE PATHOG DIS, V6, P711, DOI 10.1089/fpd.2008.0240; Echeita MA, 2001, J CLIN MICROBIOL, V39, P2981, DOI 10.1128/JCM.39.8.2981-2983.2001; Edwards PR, 1986, EDWARDS WINGS IDENTI; EFSA, 2008, EFSA J, V6, DOI 10.2903/j.efsa.2008.135r; FENG JA, 1994, SCIENCE, V263, P348, DOI 10.1126/science.8278807; Gallati C, 2013, FOODBORNE PATHOG DIS, V10, P549, DOI 10.1089/fpd.2012.1407; Garaizar J, 2002, J CLIN MICROBIOL, V40, P2074, DOI 10.1128/JCM.40.6.2074-2078.2002; Grimont P. A. D., 2000, Salmonella in domestic animals., P1, DOI 10.1079/9780851992617.0001; Grimont P. A. D., 2007, ANTIGENIC FORMULAE S; GULIG PA, 1993, MOL MICROBIOL, V7, P825, DOI 10.1111/j.1365-2958.1993.tb01172.x; Hashimoto-Gotoh T, 2000, GENE, V241, P185, DOI 10.1016/S0378-1119(99)00434-5; Hauser E, 2010, APPL ENVIRON MICROB, V76, P4601, DOI 10.1128/AEM.02991-09; Ido N, 2011, J VET MED SCI, V73, P241, DOI 10.1292/jvms.10-0140; IINO T, 1969, BACTERIOL REV, V33, P454, DOI 10.1128/MMBR.33.4.454-475.1969; KADO CI, 1981, J BACTERIOL, V145, P1365, DOI 10.1128/JB.145.3.1365-1373.1981; Kutsukake K, 2006, J BACTERIOL, V188, P950, DOI 10.1128/JB.188.3.950-957.2006; Majowicz SE, 2010, CLIN INFECT DIS, V50, P882, DOI 10.1086/650733; Majtan V, 2011, CURR MICROBIOL, V63, P491, DOI 10.1007/s00284-011-0010-6; McClelland M, 2001, NATURE, V413, P852, DOI 10.1038/35101614; Mossong J, 2007, Euro Surveill, V12, pE11; Namimatsu T, 2006, J VET MED SCI, V68, P187, DOI 10.1292/jvms.68.187; National Institute of Infectious Diseases, 2014, INFECT AGENTS SURVEI; Selzer RR, 2005, GENE CHROMOSOME CANC, V44, P305, DOI 10.1002/gcc.20243; SIMON M, 1980, SCIENCE, V209, P1370, DOI 10.1126/science.6251543; STOCKER BAD, 1949, J HYG-CAMBRIDGE, V47, P398, DOI 10.1017/S002217240001473X; Switt AIM, 2009, FOODBORNE PATHOG DIS, V6, P407, DOI 10.1089/fpd.2008.0213; Takahashi Toshio, 2006, Kansenshogaku Zasshi, V80, P185; Yamamoto S, 2006, J BACTERIOL, V188, P958, DOI 10.1128/JB.188.3.958-967.2006; Zamperini K, 2007, AVIAN DIS, V51, P958, DOI 10.1637/7944-021507-REGR.1	35	34	35	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e104380	10.1371/journal.pone.0104380	http://dx.doi.org/10.1371/journal.pone.0104380			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093666	Green Published, gold, Green Submitted			2022-12-27	WOS:000341357200106
J	Kiuchi, K; Kitamura, S; Taoka, T; Yasuno, F; Tanimura, M; Matsuoka, K; Ikawa, D; Toritsuka, M; Hashimoto, K; Makinodan, M; Kosaka, J; Morikawa, M; Kichikawa, K; Kishimoto, T				Kiuchi, Kuniaki; Kitamura, Soichiro; Taoka, Toshiaki; Yasuno, Fumihiko; Tanimura, Masami; Matsuoka, Kiwamu; Ikawa, Daisuke; Toritsuka, Michihiro; Hashimoto, Kazumichi; Makinodan, Manabu; Kosaka, Jun; Morikawa, Masayuki; Kichikawa, Kimihiko; Kishimoto, Toshifumi			Gray and White Matter Changes in Subjective Cognitive Impairment, Amnestic Mild Cognitive Impairment and Alzheimer's Disease: A Voxel-Based Analysis Study	PLOS ONE			English	Article							GLOBAL DETERIORATION SCALE; MEMORY IMPAIRMENT; HYPOTHETICAL MODEL; DYNAMIC BIOMARKERS; DEMENTIA; DECLINE; SCHIZOPHRENIA; ABNORMALITIES; ASSOCIATION; MARKERS	Subjective cognitive impairment may be a very early at-risk period of the continuum of dementia. However, it is difficult to discriminate at-risk states from normal aging. Thus, detection of the early pathological changes in the subjective cognitive impairment period is needed. To elucidate these changes, we employed diffusion tensor imaging and volumetry analysis, and compared subjective cognitive impairment with normal, mild cognitive impairment and Alzheimer's disease. The subjects in this study were 39 Alzheimer's disease, 43 mild cognitive impairment, 28 subjective cognitive impairment and 41 normal controls. There were no statistically significant differences between the normal control and subjective cognitive impairment groups in all measures. Alzheimer's disease and mild cognitive impairment had the same extent of brain atrophy and diffusion changes. These results are consistent with the hypothetical model of the dynamic biomarkers of Alzheimer's disease.	[Kiuchi, Kuniaki; Kitamura, Soichiro; Yasuno, Fumihiko; Matsuoka, Kiwamu; Ikawa, Daisuke; Toritsuka, Michihiro; Hashimoto, Kazumichi; Makinodan, Manabu; Kosaka, Jun; Morikawa, Masayuki; Kishimoto, Toshifumi] Nara Med Univ, Dept Psychiat, Kashihara, Nara 634, Japan; [Kiuchi, Kuniaki; Kitamura, Soichiro; Yasuno, Fumihiko; Matsuoka, Kiwamu; Kishimoto, Toshifumi] Nara Med Univ, Med Ctr Dementia, Kashihara, Nara 634, Japan; [Kiuchi, Kuniaki] Sakai City Mental Hlth Ctr, Sakai, Osaka, Japan; [Kitamura, Soichiro] Natl Inst Radiol Sci, Mol Imaging Ctr, Chiba 260, Japan; [Taoka, Toshiaki; Kichikawa, Kimihiko] Nara Med Univ, Dept Radiol, Kashihara, Nara 634, Japan; [Tanimura, Masami] Doshisha Univ, Fac Psychol, Kyoto 602, Japan; [Morikawa, Masayuki] Mie Prefectural Mental Care Ctr, Tsu, Mie, Japan	Nara Medical University; Nara Medical University; National Institutes for Quantum Science & Technology; Nara Medical University; Doshisha University	Kiuchi, K (corresponding author), Nara Med Univ, Dept Psychiat, Kashihara, Nara 634, Japan.	kuniaki@naramed-u.ac.jp	Taoka, Toshiaki/A-1637-2016	Taoka, Toshiaki/0000-0001-9227-0240; Kiuchi, Kuniaki/0000-0003-3305-5270	JSPS KAKENHI [22791138]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was financially supported by JSPS KAKENHI Grant Number 22791138. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Bateman RJ, 2012, NEW ENGL J MED, V367, P795, DOI 10.1056/NEJMoa1202753; Cummings JL, 2007, NEUROLOGY, V69, P1622, DOI 10.1212/01.wnl.0000295996.54210.69; Dekosky ST, 2003, SCIENCE, V302, P830, DOI 10.1126/science.1090349; FAZEKAS F, 1987, AM J ROENTGENOL, V149, P351, DOI 10.2214/ajr.149.2.351; Galeone F, 2011, INT J GERIATR PSYCH, V26, P695, DOI 10.1002/gps.2583; Ganguli M, 2004, NEUROLOGY, V63, P115, DOI 10.1212/01.WNL.0000132523.27540.81; Gauthier S, 2006, LANCET, V367, P1262, DOI 10.1016/S0140-6736(06)68542-5; Gomar JJ, 2011, ARCH GEN PSYCHIAT, V68, P961, DOI 10.1001/archgenpsychiatry.2011.96; Grambaite R, 2010, J INT NEUROPSYCH SOC, V16, P58, DOI 10.1017/S1355617709990932; Grundman M, 2004, ARCH NEUROL-CHICAGO, V61, P59, DOI 10.1001/archneur.61.1.59; Harwood DG, 2000, NEUROPSY NEUROPSY BE, V13, P83; Jack CR, 2013, LANCET NEUROL, V12, P207, DOI 10.1016/S1474-4422(12)70291-0; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Jessen F, 2010, ARCH GEN PSYCHIAT, V67, P414, DOI 10.1001/archgenpsychiatry.2010.30; Kamagata K, 2013, MAGN RESON IMAGING, V31, P1501, DOI 10.1016/j.mri.2013.06.009; Kennedy KM, 2009, NEUROBIOL AGING, V30, P1657, DOI 10.1016/j.neurobiolaging.2007.12.020; Kiuchi K, 2009, BRAIN RES, V1287, P184, DOI 10.1016/j.brainres.2009.06.052; Kubicki M, 2002, NEUROIMAGE, V17, P1711, DOI 10.1006/nimg.2002.1296; Lopez OL, 2003, ARCH NEUROL-CHICAGO, V60, P1385, DOI 10.1001/archneur.60.10.1385; Luis CA, 2003, NEUROLOGY, V61, P438, DOI 10.1212/01.WNL.0000080366.90234.7F; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Moonis M, 2005, NEUROLOGY, V65, P323, DOI 10.1212/01.wnl.0000171397.32851.bc; Petersen RC, 2010, NEUROLOGY, V74, P201, DOI 10.1212/WNL.0b013e3181cb3e25; Petersen RC, 2001, NEUROLOGY, V56, P1133, DOI 10.1212/WNL.56.9.1133; Petersen RC, 2001, ARCH NEUROL-CHICAGO, V58, P1985, DOI 10.1001/archneur.58.12.1985; Petersen RC, 2005, NEW ENGL J MED, V352, P2379, DOI 10.1056/NEJMoa050151; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; REISBERG B, 1982, AM J PSYCHIAT, V139, P1136; REISBERG B, 1988, PSYCHOPHARMACOL BULL, V24, P661; Reisberg B, 2008, INT PSYCHOGERIATR, V20, P1, DOI 10.1017/S1041610207006412; Reisberg B, 2008, ALZHEIMERS DEMENT, V4, pS98, DOI 10.1016/j.jalz.2007.11.017; Ringman JM, 2008, NEUROLOGY, V71, P85, DOI 10.1212/01.wnl.0000303973.71803.81; Selnes P, 2013, J ALZHEIMERS DIS, V33, P723, DOI 10.3233/JAD-2012-121603; Selnes Per, 2012, Alzheimers Dement, V8, pS112, DOI 10.1016/j.jalz.2011.07.001; Snitz BE, 2013, NEUROLOGY, V80, P1378, DOI 10.1212/WNL.0b013e31828c2fc8; Stenset V, 2011, NEUROBIOL AGING, V32, P581, DOI 10.1016/j.neurobiolaging.2009.04.014; Stewart R, 2011, BRIT J PSYCHIAT, V198, P199, DOI 10.1192/bjp.bp.110.078683; Striepens N, 2010, DEMENT GERIATR COGN, V29, P75, DOI 10.1159/000264630; van Norden AGW, 2008, NEUROLOGY, V71, P1152, DOI 10.1212/01.wnl.0000327564.44819.49; Vogel A, 2005, INT J GERIATR PSYCH, V20, P238, DOI 10.1002/gps.1272; Wang Y, 2012, BBA-MOL BASIS DIS, V1822, P423, DOI 10.1016/j.bbadis.2011.08.002; Wilson RS, 2011, ARCH NEUROL-CHICAGO, V68, P351, DOI 10.1001/archneurol.2011.31; Wolkin A, 1998, AM J PSYCHIAT, V155, P1064, DOI 10.1176/ajp.155.8.1064	44	24	25	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e104007	10.1371/journal.pone.0104007	http://dx.doi.org/10.1371/journal.pone.0104007			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093415	Green Submitted, Green Published, gold			2022-12-27	WOS:000341357200058
J	Pfortmueller, CA; Schankath, AC; Mordasini, P; Koetter, J; Wiest, R; Exadaktylos, AK; Puig, S				Pfortmueller, Carmen A.; Schankath, Adrian C.; Mordasini, Pasquale; Koetter, Jana; Wiest, Roland; Exadaktylos, Aristomenis K.; Puig, Stefan			Radiological Findings of Sexual Intercourse Related Emergency Department Admissions: A First Overview	PLOS ONE			English	Article							URINARY-TRACT-INFECTIONS; SUBARACHNOID HEMORRHAGE; MEDICOLEGAL POSTMORTEM; HEADACHE; AMNESIA; RISK	Objectives: Sexuality is an essential aspect of human function, well-being and quality of life. Many people have sex without complications. However, there are some people who need to seek emergency medical help for related health problems. The aim of this study was to present a first overview of patients who received a radiological examination related to sexual intercourse based emergency department admission. Methods: Our centralized electronic patient record database was reviewed for patients who had been admitted to our emergency department with an emergency after sexual intercourse between 2000 and 2011. The database was scanned for the standardized key words 'sexual intercourse' or 'coitus' retrospectively. For all patients identified in the electronic patient record database the radiological examinations were searched for manually in our Radiology Information System, and reviewed by three independent radiologists. Results: One hundred and twenty nine out of 445 (29,0%) patients received a radiological examination after immediate emergency department admission related to sexual intercourse. Fifty two out of 129 (40.3%) patients had positive radiological findings while 77 (59.7%) did not. Eighty point seven percent (n=42) of the radiological findings were a sexual intercourse-associated pathology and 19.2% (n=10) were considered to be incidental findings. Age and male sex positively correlated with radiological imaging workup (p<0.001, respectively p<0.037). The most common sexual intercourse-associated pathology was headache attributed to cerebrovascular insult (n=21, 40.3%) followed by epididymitis (n=7, 16.6%) and obstructive uropathy (n=5, 11.6%). Of the patients with headache attributed to non-traumatic intracranial hemorrhage, subarachnoid hemorrhage (n=14, 66.6%) was the most common, followed by intracerebral bleeding (n=4, 19.0%) and one subdural hemorrhage. Conclusions: Pathological findings are manifold. Cerebral imaging is the most common type of radiological imaging performed. Further prospective and standardized studies should be performed to better evaluate the significance of radiological imaging in this patient collective with the aim to gain better knowledge on what patients profit from what type of radiological imaging when presenting with a sexual intercourse related emergency. Advances in Knowledge: The present study provides a first overview on radiological findings of sexual intercourse related emergency department admissions.	[Pfortmueller, Carmen A.] Med Univ Vienna, Dept Gen Anaesthesiol Intens Care & Pain Manageme, Vienna, Austria; [Schankath, Adrian C.; Puig, Stefan] Univ Hosp Bern, Univ Inst Diagnost Intervent & Pediat Radiol, CH-3010 Bern, Switzerland; [Pfortmueller, Carmen A.; Schankath, Adrian C.; Mordasini, Pasquale; Koetter, Jana; Wiest, Roland; Exadaktylos, Aristomenis K.; Puig, Stefan] Univ Bern, Bern, Switzerland; [Mordasini, Pasquale; Wiest, Roland] Univ Hosp Bern, Univ Inst Diagnost & Intervent Neuroradiol, CH-3010 Bern, Switzerland; [Pfortmueller, Carmen A.; Koetter, Jana; Exadaktylos, Aristomenis K.] Univ Hosp Bern, Univ Dept Emergency Med, CH-3010 Bern, Switzerland	Medical University of Vienna; University of Bern; University Hospital of Bern; University of Bern; University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern	Pfortmueller, CA (corresponding author), Med Univ Vienna, Dept Gen Anaesthesiol Intens Care & Pain Manageme, Vienna, Austria.	cpfortmueller@gmail.com	Mordasini, Pasquale/H-8321-2015	Pfortmueller, Carmen/0000-0003-0326-2770				Backes D, 2012, STROKE, V43, P2115, DOI 10.1161/STROKEAHA.112.658880; Banerjee A, 1996, POSTGRAD MED J, V72, P653, DOI 10.1136/pgmj.72.853.653; Becker K, 2004, ARCH NEUROL-CHICAGO, V61, P1114, DOI 10.1001/archneur.61.7.1114; Brazzelli M, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007424.pub2; Chen XJ, 2009, INDIAN J MED RES, V130, P681; DINNING TAR, 1953, LANCET, V265, P799; Drory Y, 2002, EUR HEART J SUPPL, V4, pH13, DOI 10.1016/S1520-765X(02)90047-7; Eke N, 2002, BJU INT, V89, P273, DOI 10.1046/j.1464-4096.2001.01458.x; Evans RW, 2001, HEADACHE, V41, P512, DOI 10.1046/j.1526-4610.2001.01091.x; Fann JR, 2000, J NEUROL NEUROSUR PS, V69, P768, DOI 10.1136/jnnp.69.6.768; Hu CM, 2010, J CLIN NEUROSCI, V17, P1349, DOI 10.1016/j.jocn.2010.01.052; Ifergan J, 2012, Diagn Interv Imaging, V93, P509, DOI 10.1016/j.diii.2012.03.010; Johansen TEB, 2004, WORLD J UROL, V22, P392, DOI 10.1007/s00345-004-0414-z; Kriz K, 1970, Cesk Neurol, V33, P162; Larner AJ, 2008, J SEX MED, V5, P284, DOI 10.1111/j.1743-6109.2007.00654.x; Lee J, 2000, J TRAUMA, V49, P351, DOI 10.1097/00005373-200008000-00029; Lee SJ, 2008, EUR J NEUROL, V15, pE101, DOI 10.1111/j.1468-1331.2008.02322.x; Lee S, 2006, J KOREAN MED SCI, V21, P995, DOI 10.3346/jkms.2006.21.6.995; Maloy K, 2011, J EMERG MED, V41, P257, DOI 10.1016/j.jemermed.2008.02.048; Masters WH., 1966, HUMAN SEXUAL RESPONS; Morris-Stiff Gareth, 2008, J Med Case Rep, V2, P6, DOI 10.1186/1752-1947-2-6; Parzeller M, 1999, Z KARDIOL, V88, P44, DOI 10.1007/s003920050262; Pfortmueller Carmen A, 2012, EMERGENCY MED J; PORTER M, 1981, ARCH NEUROL-CHICAGO, V38, P710, DOI 10.1001/archneur.1981.00510110070011; Portunato, 2012, AM J FOREN MED PATH, V33, P90; Provenzale JM, 2010, EMERG RADIOL, V17, P403, DOI 10.1007/s10140-010-0882-y; Reynolds MR, 2011, J NEUROSURG, V114, P969, DOI 10.3171/2010.4.JNS09975; Scholes D, 2005, ANN INTERN MED, V142, P20, DOI 10.7326/0003-4819-142-1-200501040-00008; Stuckey SL, 2007, AM J ROENTGENOL, V189, P913, DOI 10.2214/AJR.07.2424; Valenca MM, 2004, HEADACHE, V44, P244, DOI 10.1111/j.1526-4610.2004.04054.x; Wagenlehner FME, 2011, UROLOGE, V50, P1248, DOI 10.1007/s00120-011-2616-5; Wilson L, 2006, UROL RES, V34, P225, DOI 10.1007/s00240-006-0039-3	32	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e104170	10.1371/journal.pone.0104170	http://dx.doi.org/10.1371/journal.pone.0104170			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093844	Green Published, gold			2022-12-27	WOS:000341357200082
J	Klinker, H; Haas, C; Harrer, N; Becker, PB; Mueller-Planitz, F				Klinker, Henrike; Haas, Caroline; Harrer, Nadine; Becker, Peter B.; Mueller-Planitz, Felix			Rapid Purification of Recombinant Histones	PLOS ONE			English	Article							CHROMATIN REMODELING COMPLEX; NUCLEOSOME CORE PARTICLES; ISWI; RECONSTITUTION; PROTEINS; DNA	The development of methods to assemble nucleosomes from recombinant histones decades ago has transformed chromatin research. Nevertheless, nucleosome reconstitution remains time consuming to this day, not least because the four individual histones must be purified first. Here, we present a streamlined purification protocol of recombinant histones from bacteria. We termed this method "rapid histone purification'' (RHP) as it circumvents isolation of inclusion bodies and thereby cuts out the most time-consuming step of traditional purification protocols. Instead of inclusion body isolation, whole cell extracts are prepared under strongly denaturing conditions that directly solubilize inclusion bodies. By ion exchange chromatography, the histones are purified from the extracts. The protocol has been successfully applied to all four canonical Drosophila and human histones. RHP histones and histones that were purified from isolated inclusion bodies had similar purities. The different purification strategies also did not impact the quality of octamers reconstituted from these histones. We expect that the RHP protocol can be readily applied to the purification of canonical histones from other species as well as the numerous histone variants.	[Klinker, Henrike; Harrer, Nadine; Becker, Peter B.; Mueller-Planitz, Felix] Univ Munich, Adolf Butenandt Inst, Mol Biol Unit, Munich, Germany; [Klinker, Henrike; Becker, Peter B.] Ctr Integrated Prot Sci, Munich, Germany; [Haas, Caroline] Univ Munich, Dept Biochem, Munich, Germany; [Haas, Caroline] Univ Munich, Gene Ctr, Munich, Germany	University of Munich; University of Munich; University of Munich; University of Munich	Mueller-Planitz, F (corresponding author), Univ Munich, Adolf Butenandt Inst, Mol Biol Unit, Marchioninistr 15, Munich, Germany.	Felix.Mueller-Planitz@med.uni-muenchen.de	Mueller-Planitz, Felix/P-8461-2014	Mueller-Planitz, Felix/0000-0001-8273-6473; Becker, Peter/0000-0001-7186-0372	Deutsche Forschungsgemeinschaft [MU3613/1-1, SFB 1064 TP A7, SFB594 TP A6]; Ernst Schering Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ernst Schering Foundation	This work was supported by the Deutsche Forschungsgemeinschaft [MU3613/1-1 and SFB 1064 TP A7 to FMP; SFB594 TP A6 to PBB]. CH was supported by the Ernst Schering Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artimo P, 2012, NUCLEIC ACIDS RES, V40, pW597, DOI 10.1093/nar/gks400; Clapier CR, 2001, MOL CELL BIOL, V21, P875, DOI 10.1128/MCB.21.3.875-883.2001; Dyer PN, 2004, METHOD ENZYMOL, V375, P23; Faye G, 2005, J BIOL CHEM, V280, P33701, DOI 10.1074/jbc.M507048200; Gelbart ME, 2001, MOL CELL BIOL, V21, P2098, DOI 10.1128/MCB.21.6.2098-2106.2001; GLASEL JA, 1995, BIOTECHNIQUES, V18, P62; Klinker H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088411; Luger K, 1999, METHOD ENZYMOL, V304, P3; Luger K, 1997, J MOL BIOL, V272, P301, DOI 10.1006/jmbi.1997.1235; Luger K, 1999, METH MOL B, V119, P1; Morales V, 2004, EMBO J, V23, P2258, DOI 10.1038/sj.emboj.7600235; Mueller-Planitz F, 2013, NAT STRUCT MOL BIOL, V20, P82, DOI 10.1038/nsmb.2457; Shim Y, 2012, ANAL BIOCHEM, V427, P190, DOI 10.1016/j.ab.2012.05.006; STARK GR, 1960, J BIOL CHEM, V235, P3177; Tosi A, 2013, CELL, V154, P1207, DOI 10.1016/j.cell.2013.08.016; Vary JC, 2004, METHOD ENZYMOL, V375, P88; Wittmeyer J, 2004, METHOD ENZYMOL, V377, P322	17	27	28	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e104029	10.1371/journal.pone.0104029	http://dx.doi.org/10.1371/journal.pone.0104029			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25090252	Green Published, gold, Green Submitted			2022-12-27	WOS:000339812700084
J	Mao, R; Kumar, PKR; Guo, C; Zhang, Y; Liang, C				Mao, Rui; Kumar, Praveen Kumar Raj; Guo, Cheng; Zhang, Yang; Liang, Chun			Comparative Analyses between Retained Introns and Constitutively Spliced Introns in Arabidopsis thaliana Using Random Forest and Support Vector Machine	PLOS ONE			English	Article							PARTICLE SWARM OPTIMIZATION; RNA SECONDARY STRUCTURE; FEATURE-SELECTION; REGULATORY ELEMENTS; MESSENGER-RNAS; IDENTIFICATION; CLASSIFICATION; MICROARRAY; RETENTION; COMPLEXITY	One of the important modes of pre-mRNA post-transcriptional modification is alternative splicing. Alternative splicing allows creation of many distinct mature mRNA transcripts from a single gene by utilizing different splice sites. In plants like Arabidopsis thaliana, the most common type of alternative splicing is intron retention. Many studies in the past focus on positional distribution of retained introns (RIs) among different genic regions and their expression regulations, while little systematic classification of RIs from constitutively spliced introns (CSIs) has been conducted using machine learning approaches. We used random forest and support vector machine (SVM) with radial basis kernel function (RBF) to differentiate these two types of introns in Arabidopsis. By comparing coordinates of introns of all annotated mRNAs from TAIR10, we obtained our high-quality experimental data. To distinguish RIs from CSIs, We investigated the unique characteristics of RIs in comparison with CSIs and finally extracted 37 quantitative features: local and global nucleotide sequence features of introns, frequent motifs, the signal strength of splice sites, and the similarity between sequences of introns and their flanking regions. We demonstrated that our proposed feature extraction approach was more accurate in effectively classifying RIs from CSIs in comparison with other four approaches. The optimal penalty parameter C and the RBF kernel parameter gamma in SVM were set based on particle swarm optimization algorithm (PSOSVM). Our classification performance showed F-Measure of 80.8% (random forest) and 77.4% (PSOSVM). Not only the basic sequence features and positional distribution characteristics of RIs were obtained, but also putative regulatory motifs in intron splicing were predicted based on our feature extraction approach. Clearly, our study will facilitate a better understanding of underlying mechanisms involved in intron retention.	[Mao, Rui; Zhang, Yang] Northwest A&F Univ, Coll Mech & Elect Engn, Yangling, Shaanxi, Peoples R China; [Mao, Rui; Zhang, Yang] Northwest A&F Univ, Coll Informat Engn, Yangling, Shaanxi, Peoples R China; [Mao, Rui; Kumar, Praveen Kumar Raj; Guo, Cheng; Liang, Chun] Miami Univ, Dept Biol, Oxford, OH 45056 USA; [Liang, Chun] Miami Univ, Dept Comp Sci & Software Engn, Oxford, OH 45056 USA	Northwest A&F University - China; Northwest A&F University - China; University System of Ohio; Miami University; University System of Ohio; Miami University	Zhang, Y (corresponding author), Northwest A&F Univ, Coll Mech & Elect Engn, Yangling, Shaanxi, Peoples R China.	zhangyang@nwsuaf.edu.cn; liangc@miamioh.edu	Kumar, Praveen Kumar Raj/A-1718-2018	Kumar, Praveen Kumar Raj/0000-0001-6596-9283	China Scholarship Council [201206305024]; Biology Department and Office for the Advancement of Research and Scholarship (OARS) of Miami University in Ohio; NIGMS [1R15GM094732-01A1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM094732] Funding Source: NIH RePORTER	China Scholarship Council(China Scholarship Council); Biology Department and Office for the Advancement of Research and Scholarship (OARS) of Miami University in Ohio; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was partially supported by China Scholarship Council (Award #201206305024 to RM), Biology Department and Office for the Advancement of Research and Scholarship (OARS) of Miami University in Ohio, and NIGMS (1R15GM094732-01A1 to CL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi MJ, 2012, COMPUT MATH METHOD M, V2012, DOI 10.1155/2012/320698; Barbazuk WB, 2008, GENOME RES, V18, P1381, DOI 10.1101/gr.053678.106; Boulesteix AL, 2012, WIRES DATA MIN KNOWL, V2, P493, DOI 10.1002/widm.1072; Bradley AP, 1997, PATTERN RECOGN, V30, P1145, DOI 10.1016/S0031-3203(96)00142-2; Byvatov Evgeny, 2003, Appl Bioinformatics, V2, P67; Campbell MA, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-327; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Coyle JH, 2011, RNA, V17, P1344, DOI 10.1261/rna.2616111; Diaz-Uriarte R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-3; Ding YL, 2014, NATURE, V505, P696, DOI 10.1038/nature12756; Eichner J, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-55; Fairbrother WG, 2002, SCIENCE, V297, P1007, DOI 10.1126/science.1073774; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Filichkin SA, 2010, GENOME RES, V20, P45, DOI 10.1101/gr.093302.109; Florea L, 2006, BRIEF BIOINFORM, V7, P55, DOI 10.1093/bib/bbk005; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; Hsu W C, 2003, PRACTICAL GUIDE SUPP; Hua SJ, 2001, BIOINFORMATICS, V17, P721, DOI 10.1093/bioinformatics/17.8.721; Huang CL, 2008, APPL SOFT COMPUT, V8, P1381, DOI 10.1016/j.asoc.2007.10.007; Huang CL, 2006, EXPERT SYST APPL, V31, P231, DOI 10.1016/j.eswa.2005.09.024; Jin YF, 2011, RNA BIOL, V8, P450, DOI 10.4161/rna.8.3.15388; Keren H, 2010, NAT REV GENET, V11, P345, DOI 10.1038/nrg2776; Kim E, 2007, NUCLEIC ACIDS RES, V35, P125, DOI 10.1093/nar/gkl924; Kim N, 2007, NUCLEIC ACIDS RES, V35, pD93, DOI 10.1093/nar/gkl884; Kornblihtt AR, 2013, NAT REV MOL CELL BIO, V14, P153, DOI 10.1038/nrm3525; Larranaga P, 2006, BRIEF BIOINFORM, V7, P86, DOI 10.1093/bib/bbk007; Lin HT, 2003, STUDY SIGMOID KERNEL, V3, P1, DOI DOI 10.1111/J.1945-1474.2005.TB00541.X; Lin SW, 2008, EXPERT SYST APPL, V35, P1817, DOI 10.1016/j.eswa.2007.08.088; Liu JF, 2006, PLOS GENET, V2, P529, DOI 10.1371/journal.pgen.0020029; Loraine AE, 2013, PLANT PHYSIOL, V162, P1092, DOI 10.1104/pp.112.211441; Marquez Y, 2012, GENOME RES, V22, P1184, DOI 10.1101/gr.134106.111; Masso M, 2010, J THEOR BIOL, V266, P560, DOI 10.1016/j.jtbi.2010.07.026; Mastrangelo AM, 2005, PLANTA, V221, P705, DOI 10.1007/s00425-004-1475-3; Mendoza MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070153; Min JH, 2005, EXPERT SYST APPL, V28, P603, DOI 10.1016/j.eswa.2004.12.008; Mollet IG, 2010, NUCLEIC ACIDS RES, V38, P4740, DOI 10.1093/nar/gkq197; Nagasaki H, 2005, GENE, V364, P53, DOI 10.1016/j.gene.2005.07.027; Naidoo L, 2012, ISPRS J PHOTOGRAMM, V69, P167, DOI 10.1016/j.isprsjprs.2012.03.005; Nair V, 2013, BIOINFORMATION, V9, P481, DOI 10.6026/97320630009481; Nakano S, 2010, ELECTR ENG JPN, V172, P31, DOI 10.1002/eej.20966; Ner-Gaon H, 2004, PLANT J, V39, P877, DOI 10.1111/j.1365-313X.2004.02172.x; Ner-Gaon H, 2006, DNA RES, V13, P111, DOI 10.1093/dnares/dsl003; Nimrod G, 2009, J MOL BIOL, V387, P1040, DOI 10.1016/j.jmb.2009.02.023; O'Fallon BD, 2013, BIOINFORMATICS, V29, P1361, DOI 10.1093/bioinformatics/btt172; Palusa SG, 2007, PLANT J, V49, P1091, DOI 10.1111/j.1365-313X.2006.03020.x; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Pertea M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-159; Rodriguez-Galiano VF, 2012, REMOTE SENS ENVIRON, V121, P93, DOI 10.1016/j.rse.2011.12.003; Sakabe NJ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-59; Sakharkar Meena Kishore, 2004, In Silico Biology, V4, P387; Sammeth M, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000147; Scholkopf B, 1997, IEEE T SIGNAL PROCES, V45, P2758, DOI 10.1109/78.650102; Shi YH, 1998, IEEE C EVOL COMPUTAT, P69, DOI 10.1109/ICEC.1998.699146; SOLNICK D, 1985, CELL, V43, P667, DOI 10.1016/0092-8674(85)90239-9; Statnikov A, 2005, BIOINFORMATICS, V21, P631, DOI 10.1093/bioinformatics/bti033; Statnikov Alexander, 2007, AMIA Annu Symp Proc, P686; Statnikov A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-319; Syed NH, 2012, TRENDS PLANT SCI, V17, P616, DOI 10.1016/j.tplants.2012.06.001; Torrado M, 2009, GENE, V440, P28, DOI 10.1016/j.gene.2009.03.017; Verikas A, 2011, PATTERN RECOGN, V44, P330, DOI 10.1016/j.patcog.2010.08.011; Wang BB, 2006, P NATL ACAD SCI USA, V103, P7175, DOI 10.1073/pnas.0602039103; Wang Fangping, 2011, Wuhan University Journal of Natural Sciences, V16, P260, DOI 10.1007/s11859-011-0747-6; Wang JP, 2004, LECT NOTES COMPUT SC, V3173, P512; Wang ZF, 2004, CELL, V119, P831, DOI 10.1016/j.cell.2004.11.010; Wei LY, 2005, IEEE T MED IMAGING, V24, P371, DOI 10.1109/TMI.2004.842457; Wittkopp PJ, 2012, NAT REV GENET, V13, P59, DOI 10.1038/nrg3095; Wu RH, 2012, MATCH-COMMUN MATH CO, V67, P269; Wu TD, 2005, BIOINFORMATICS, V21, P1859, DOI 10.1093/bioinformatics/bti310; Xueying Zhang, 2009, Proceedings of the 2009 Fifth International Conference on Natural Computation (ICNC 2009), P536, DOI 10.1109/ICNC.2009.257; Yang W, 2008, BIOCHEM BIOPH RES CO, V368, P379, DOI 10.1016/j.bbrc.2008.01.089; Yen SJ, 2009, EXPERT SYST APPL, V36, P5718, DOI 10.1016/j.eswa.2008.06.108; Yeo G, 2004, P NATL ACAD SCI USA, V101, P15700, DOI 10.1073/pnas.0404901101; Yeo GW, 2007, PLOS GENET, V3, P814, DOI 10.1371/journal.pgen.0030085; Zernov VV, 2003, J CHEM INF COMP SCI, V43, P2048, DOI 10.1021/ci0340916	74	20	21	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2014	9	8							e104049	10.1371/journal.pone.0104049	http://dx.doi.org/10.1371/journal.pone.0104049			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WB	25110928	gold, Green Published			2022-12-27	WOS:000341105100026
J	Palmateer, NE; Taylor, A; Goldberg, DJ; Munro, A; Aitken, C; Shepherd, SJ; McAllister, G; Gunson, R; Hutchinson, SJ				Palmateer, Norah E.; Taylor, Avril; Goldberg, David J.; Munro, Alison; Aitken, Celia; Shepherd, Samantha J.; McAllister, Georgina; Gunson, Rory; Hutchinson, Sharon J.			Rapid Decline in HCV Incidence among People Who Inject Drugs Associated with National Scale-Up in Coverage of a Combination of Harm Reduction Interventions	PLOS ONE			English	Article							HEPATITIS-C-VIRUS; HUMAN-IMMUNODEFICIENCY-VIRUS; OPIATE SUBSTITUTION THERAPY; SYRINGE PROGRAMS; EQUIPMENT PROVISION; PUBLIC-HEALTH; 2 DECADES; USERS; INFECTION; NEEDLE	Background: Government policy has precipitated recent changes in the provision of harm reduction interventions injecting equipment provision (IEP) and opiate substitution therapy (OST) - for people who inject drugs (PWID) in Scotland. We sought to examine the potential impact of these changes on hepatitis C virus (HCV) transmission among PWID. Methods and Findings: We used a framework to triangulate different types of evidence: 'group-level/ecological' and 'individual-level'. Evidence was primarily generated from bio-behavioural cross-sectional surveys of PWID, undertaken during 2008-2012. Individuals in the window period (1-2 months) where the virus is present, but antibodies have not yet been formed, were considered to have recent infection. The survey data were supplemented with service data on the provision of injecting equipment and OST. Ecological analyses examined changes in intervention provision, self-reported intervention uptake, self-reported risk behaviour and HCV incidence; individual-level analyses investigated relationships within the pooled survey data. Nearly 8,000 PWID were recruited in the surveys. We observed a decline in HCV incidence, per 100 person-years, from 13.6 (95% CI: 8.1-20.1) in 2008-09 to 7.3 (3.0-12.9) in 2011-12; a period during which increases in the coverage of OST and IEP, and decreases in the frequency of injecting and sharing of injecting equipment, were observed. Individual-level evidence demonstrated that combined high coverage of needles/syringes and OST were associated with reduced risk of recent HCV in analyses that were unweighted (AOR 0.29, 95% CI 0.11-0.74) and weighted for frequency of injecting (AOR(w) 0.05, 95% CI 0.01-0.18). We estimate the combination of harm reduction interventions may have averted 1400 new HCV infections during 2008-2012. Conclusions: This is the first study to demonstrate that impressive reductions in HCV incidence can be achieved among PWID over a relatively short time period through high coverage of a combination of interventions.	[Palmateer, Norah E.; Goldberg, David J.; Hutchinson, Sharon J.] Hlth Protect Scotland, Blood Borne Viruses & Sexually Transmitted Infect, Glasgow, Lanark, Scotland; [Taylor, Avril; Munro, Alison] Univ West Scotland, Inst Appl Social & Hlth Res, Paisley, Renfrew, Scotland; [Aitken, Celia; Shepherd, Samantha J.; McAllister, Georgina; Gunson, Rory] Glasgow Royal Infirm, West Scotland Specialist Virol Ctr, Glasgow G4 0SF, Lanark, Scotland; [Goldberg, David J.; Hutchinson, Sharon J.] Glasgow Caledonian Univ, Sch Hlth & Life Sci, Glasgow G4 0BA, Lanark, Scotland	University of West Scotland; University of Glasgow; Glasgow Caledonian University	Palmateer, NE (corresponding author), Hlth Protect Scotland, Blood Borne Viruses & Sexually Transmitted Infect, Glasgow, Lanark, Scotland.	norah.palmateer@nhs.net	Shepherd, Samantha/HHN-5424-2022; Palmateer, Norah/GPC-8825-2022; Palmateer, Norah/AAX-3803-2021; Hutchinson, Sharon/Y-3949-2019	Palmateer, Norah/0000-0003-4493-0173; Hutchinson, Sharon/0000-0002-6891-6758; Munro, Alison/0000-0002-2350-8128	Scottish Government	Scottish Government	This work was funded by the Scottish Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen EJ, 2012, INT J DRUG POLICY, V23, P346, DOI 10.1016/j.drugpo.2012.07.006; Aspinall E, 2012, DRUG ALCOHOL DEPEN, V126, P340, DOI 10.1016/j.drugalcdep.2012.05.041; Bennett S, 2012, J CLIN VIROL, V54, P106, DOI 10.1016/j.jcv.2012.02.004; CHAMOT E, 1990, AIDS, V4, P1275, DOI 10.1097/00002030-199012000-00016; Craig P, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1655; Craine N, 2009, EPIDEMIOL INFECT, V137, P1255, DOI 10.1017/S095026880900212X; de Vos AS, 2013, ADDICTION, V108, P1070, DOI 10.1111/add.12125; Gillies M, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-721; Health Protection Scotland University of the West of Scotland, 2008, NEEDL EXCH SURV IN N; Hope VD, 2011, J VIRAL HEPATITIS, V18, P262, DOI 10.1111/j.1365-2893.2010.01297.x; ISD, 2012, DRUG MIS STAT SCOTL; ISD, 2013, INJ EQ PROV SCOTL SU; Iversen J, 2013, AM J PUBLIC HEALTH, V103, P1436, DOI 10.2105/AJPH.2012.301206; Judd A, 2005, BMJ-BRIT MED J, V330, P24, DOI 10.1136/bmj.38286.841227.7C; Judd A, 2003, J MED VIROL, V71, P49, DOI 10.1002/jmv.10463; Kirkwood B, 2004, BRIT MED J, V328, P966, DOI 10.1136/bmj.328.7446.966; Kirkwood BR, 1997, TROP MED INT HEALTH, V2, P1022, DOI 10.1046/j.1365-3156.1997.d01-188.x; MacArthur GJ, 2014, INT J DRUG POLICY, V25, P34, DOI 10.1016/j.drugpo.2013.07.001; Martin NK, 2013, CLIN INFECT DIS, V57, pS39, DOI 10.1093/cid/cit296; Martin NK, 2011, J HEPATOL, V54, P1137, DOI 10.1016/j.jhep.2010.08.029; Medical Research Council, 2009, DEV EVALUATING COMPL; Micallef JM, 2006, J VIRAL HEPATITIS, V13, P34, DOI 10.1111/j.1365-2893.2005.00651.x; Overstall A, 2013, STAT MED IN PRESS; Page-Shafer K, 2008, J CLIN MICROBIOL, V46, P499, DOI 10.1128/JCM.01229-07; Palmateer N, 2014, J VIRAL HEPATITIS, V21, P25, DOI 10.1111/jvh.12117; Palmateer N, 2010, ADDICTION, V105, P844, DOI 10.1111/j.1360-0443.2009.02888.x; Pouget ER, 2012, ADDICTION, V107, P1057, DOI 10.1111/j.1360-0443.2011.03765.x; Scottish Government, 2008, ROAD REC NEW APPR TA; Scottish Government, 2010, GUID SERV INJ EQ BES; Smith-Spangler CM, 2012, ADDICTION, V107, P1996, DOI 10.1111/j.1360-0443.2012.04011.x; Takaki A, 2000, NAT MED, V6, P578, DOI 10.1038/75063; Turner KME, 2011, ADDICTION, V106, P1978, DOI 10.1111/j.1360-0443.2011.03515.x; Van den Berg C, 2007, ADDICTION, V102, P1454, DOI 10.1111/j.1360-0443.2007.01912.x; van den Berg CHSB, 2007, EUR J EPIDEMIOL, V22, P183, DOI 10.1007/s10654-006-9089-7; Vickerman P, 2012, ADDICTION, V107, P1984, DOI 10.1111/j.1360-0443.2012.03932.x; Victora CG, 2004, AM J PUBLIC HEALTH, V94, P400, DOI 10.2105/AJPH.94.3.400	36	62	63	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2014	9	8							e104515	10.1371/journal.pone.0104515	http://dx.doi.org/10.1371/journal.pone.0104515			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO1WB	25110927	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000341105100065
J	Chitrala, KN; Yeguvapalli, S				Chitrala, Kumaraswamy Naidu; Yeguvapalli, Suneetha			Computational Screening and Molecular Dynamic Simulation of Breast Cancer Associated Deleterious Non-Synonymous Single Nucleotide Polymorphisms in TP53 Gene	PLOS ONE			English	Article							PROTEIN FUNCTION; CORE DOMAIN; P53; MUTATIONS; DNA; VARIANTS; GROMACS; SERVER; MUTDB; SIFT	Breast cancer is one of the most common cancers among the women around the world. Several genes are known to be responsible for conferring the susceptibility to breast cancer. Among them, TP53 is one of the major genetic risk factor which is known to be mutated in many of the breast tumor types. TP53 mutations in breast cancer are known to be related to a poor prognosis and chemo resistance. This renders them as a promising molecular target for the treatment of breast cancer. In this study, we present a computational based screening and molecular dynamic simulation of breast cancer associated deleterious non-synonymous single nucleotide polymorphisms in TP53. We have predicted three deleterious coding non-synonymous single nucleotide polymorphisms rs11540654 (R110P), rs17849781 (P278A) and rs28934874 (P151T) in TP53 with a phenotype in breast tumors using computational tools SIFT, Polyphen-2 and MutDB. We have performed molecular dynamics simulations to study the structural and dynamic effects of these TP53 mutations in comparison to the wild-type protein. Results from our simulations revealed a detailed consequence of the mutations on the p53 DNA-binding core domain that may provide insight for therapeutic approaches in breast cancer.	[Chitrala, Kumaraswamy Naidu; Yeguvapalli, Suneetha] Sri Venkateswara Univ, Dept Zool, Tirupati 517502, Andhra Pradesh, India	Sri Venkateswara University	Yeguvapalli, S (corresponding author), Sri Venkateswara Univ, Dept Zool, Tirupati 517502, Andhra Pradesh, India.	ysuneethareddy4@gmail.com	Chitrala, Kumara Swamy Naidu/U-1617-2019; Yeguvapalli, Suneetha/ADT-5493-2022	Chitrala, Kumaraswamy naidu/0000-0003-0663-9529; YEGUVAPALLI, SUNEETHA/0000-0002-3035-7196				Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; Berendsen H. J. C., 1981, INTERMOLECULAR FORCE, P331, DOI [10.1007/978-94-015-7658-1_21, DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658, DOI 10.1007/978-94-015-7658]; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bhoo-Pathy N, 2013, EUR J CANCER, V49, P703, DOI 10.1016/j.ejca.2012.09.014; BrandtRauf PW, 1996, J PROTEIN CHEM, V15, P367, DOI 10.1007/BF01886863; Butler JS, 2003, BIOCHEMISTRY-US, V42, P2396, DOI 10.1021/bi026635n; Calhoun S, 2011, BIOCHEMISTRY-US, V50, P5345, DOI 10.1021/bi200192j; Choudhrya N, 2012, APOLLO MED, V9, p133e137; Dantzer J, 2005, NUCLEIC ACIDS RES, V33, pW311, DOI 10.1093/nar/gki404; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Durham E, 2009, J MOL MODEL, V15, P1093, DOI 10.1007/s00894-009-0454-9; Ferrone M, 2006, MOL CANCER THER, V5, P1467, DOI 10.1158/1535-7163.MCT-06-0012; Guimaraes DP, 2002, BIOCHIMIE, V84, P83, DOI 10.1016/S0300-9084(01)01356-6; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kumar A, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003318; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Levy CB, 2011, INT J BIOCHEM CELL B, V43, P60, DOI 10.1016/j.biocel.2010.10.017; Li J, 2014, HUM MUTAT, V35, P575, DOI 10.1002/humu.22528; Lobanov MY, 2008, MOL BIOL+, V42, P623, DOI 10.1134/S0026893308040195; Mavaddat N, 2010, MOL ONCOL, V4, P174, DOI 10.1016/j.molonc.2010.04.011; Ng PC, 2006, ANNU REV GENOM HUM G, V7, P61, DOI 10.1146/annurev.genom.7.080505.115630; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Pirolli D, 2011, INT J MOL SCI, V12, P128, DOI 10.3390/ijms12010128; PyMol, 2006, VERS 0 99; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Singh A, 2008, NUCLEIC ACIDS RES, V36, pD815, DOI 10.1093/nar/gkm659; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Varna M, 2011, J BIOMED BIOTECHNOL, P1, DOI 10.1155/2011/284584; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wang Y, 2007, ACTA CRYSTALLOGR D, V63, P276, DOI 10.1107/S0907444906048499; Zhang B, 2011, LANCET ONCOL, V12, P477, DOI 10.1016/S1470-2045(11)70076-6	36	33	33	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2014	9	8							e104242	10.1371/journal.pone.0104242	http://dx.doi.org/10.1371/journal.pone.0104242			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR0CG	25105660	Green Submitted, gold, Green Published			2022-12-27	WOS:000343231900043
J	Cooper, SE; Driesslein, KG; Noecker, AM; McIntyre, CC; Machado, AM; Butson, CR				Cooper, Scott E.; Driesslein, Klaus G.; Noecker, Angela M.; McIntyre, Cameron C.; Machado, Andre M.; Butson, Christopher R.			Anatomical Targets Associated with Abrupt versus Gradual Washout of Subthalamic Deep Brain Stimulation Effects on Bradykinesia	PLOS ONE			English	Article							HIGH-FREQUENCY STIMULATION; CAUDAL ZONA INCERTA; NUCLEUS STIMULATION; PARKINSONS-DISEASE; LOCALIZATION; CONTACTS; VOLUME; TREMOR; ATLAS; RATS	The subthalamic nucleus (STN) is a common anatomical target for deep brain stimulation (DBS) for the treatment of Parkinson's disease. However, the effects of stimulation may spread beyond the STN. Ongoing research aims to identify nearby anatomical structures where DBS-induced effects could be associated with therapeutic improvement or side effects. We previously found that DBS lead location determines the rate - abrupt vs. gradual - with which therapeutic effect washes out after stimulation is stopped. Those results suggested that electrical current spreads from the electrodes to two spatially distinct stimulation targets associated with different washout rates. In order to identify these targets we used computational models to predict the volumes of tissue activated during DBS in 14 Parkinson's patients from that study. We then coregistered each patient with a stereotaxic atlas and generated a probabilistic stimulation atlas to obtain a 3-dimensional representation of regions where stimulation was associated with abrupt vs. gradual washout. We found that the therapeutic effect which washed out gradually was associated with stimulation of the zona incerta and fields of Forel, whereas abruptly-disappearing therapeutic effect was associated with stimulation of STN itself. This supports the idea that multiple DBS targets exist and that current spread from one electrode may activate more than one of them in a given patient, producing a combination of effects which vary according to electrode location and stimulation settings.	[Cooper, Scott E.; Machado, Andre M.] Cleveland Clin, Ctr Neurol Restorat, Cleveland, OH 44106 USA; [Driesslein, Klaus G.; Butson, Christopher R.] Med Coll Wisconsin, Dept Neurol, Milwaukee, WI 53226 USA; [Driesslein, Klaus G.; Butson, Christopher R.] Med Coll Wisconsin, Dept Neurosurg, Biotechnol & Bioengn Ctr, Milwaukee, WI 53226 USA; [Noecker, Angela M.; McIntyre, Cameron C.] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Medical College of Wisconsin; Medical College of Wisconsin; Case Western Reserve University	Cooper, SE (corresponding author), Cleveland Clin, Ctr Neurol Restorat, Cleveland, OH 44106 USA.	coopers2@ccf.org			 [K23NS052523]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103545] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K23NS052523] Funding Source: NIH RePORTER	; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by K23NS052523 from www.nimh.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anheim M, 2008, ARCH NEUROL-CHICAGO, V65, P612, DOI 10.1001/archneur.65.5.612; Bardinet E, 2009, J NEUROSURG, V110, P208, DOI 10.3171/2008.3.17469; Butson CR, 2007, NEUROIMAGE, V34, P661, DOI 10.1016/j.neuroimage.2006.09.034; Butson CR, 2011, NEUROIMAGE, V54, P2096, DOI 10.1016/j.neuroimage.2010.10.059; Cooper SE, 2011, EXP NEUROL, V231, P207, DOI 10.1016/j.expneurol.2011.06.010; Deuschl G, 2006, NEW ENGL J MED, V355, P896, DOI 10.1056/NEJMoa060281; Follett KA, 2010, NEW ENGL J MED, V362, P2077, DOI 10.1056/NEJMoa0907083; Frankemolle AMM, 2010, BRAIN, V133, P746, DOI 10.1093/brain/awp315; Godinho F, 2006, J NEUROL, V253, P1347, DOI 10.1007/s00415-006-0222-z; Goetz CG, 2008, MOVEMENT DISORD, V23, P2129, DOI 10.1002/mds.22340; Gradinaru V, 2009, SCIENCE, V324, P354, DOI 10.1126/science.1167093; Guehl D, 2008, NEUROLOGY, V70, P1489, DOI 10.1212/01.wnl.0000310426.18409.11; Hamel W, 2003, STEREOT FUNCT NEUROS, V80, P37, DOI 10.1159/000075158; Hashimoto T, 2003, J NEUROSCI, V23, P1916; Henderson JM, 2002, MOVEMENT DISORD, V17, P133, DOI 10.1002/mds.1261; Hilliard JD, 2011, STEREOT FUNCT NEUROS, V89, P357, DOI 10.1159/000331269; Jenkinson N, 2011, TRENDS NEUROSCI, V34, P611, DOI 10.1016/j.tins.2011.09.003; Jones E., 2001, SCIPY OPEN SOURCE SC; Lee KH, 2007, BRAIN RES, V1162, P121, DOI 10.1016/j.brainres.2007.06.021; Lee KH, 2011, IEEE ENG MED BIO, P677, DOI 10.1109/IEMBS.2011.6090152; Li Q, 2012, NEURON, V76, P1030, DOI 10.1016/j.neuron.2012.09.032; Lind G, 2008, STEREOT FUNCT NEUROS, V86, P253, DOI 10.1159/000138769; Lozano AM, 2013, NEURON, V77, P406, DOI 10.1016/j.neuron.2013.01.020; Lujan JL, 2012, HUM BRAIN MAPP, V33, P958, DOI 10.1002/hbm.21262; Mai JK., 2007, ATLAS HUMAN BRAIN; Mallet L, 2008, NEW ENGL J MED, V359, P2121, DOI 10.1056/NEJMoa0708514; McIntyre CC, 2004, CLIN NEUROPHYSIOL, V115, P589, DOI 10.1016/j.clinph.2003.10.033; McNeely ME, 2011, J NEUROL NEUROSUR PS, V82, P1250, DOI 10.1136/jnnp.2010.232900; Mikos A, 2011, NEUROIMAGE, V54, pS238, DOI 10.1016/j.neuroimage.2010.03.068; Miocinovic S, 2007, ACTA NEUROCHIR SUPPL, V97, P561; Mitrofanis J, 2005, NEUROSCIENCE, V130, P1, DOI 10.1016/j.neuroscience.2004.08.017; Nambu A, 2002, NEUROSCI RES, V43, P111, DOI 10.1016/S0168-0102(02)00027-5; Nowinski WL, 2005, NEUROSURGERY, V57, P319, DOI 10.1227/01.NEU.0000180960.75347.11; Ostrem JL, 2011, NEUROLOGY, V76, P870, DOI 10.1212/WNL.0b013e31820f2e4f; Parent M, 2004, PARKINSONISM RELAT D, V10, P203, DOI 10.1016/j.parkreldis.2004.02.007; Plaha P, 2008, J NEUROL NEUROSUR PS, V79, P504, DOI 10.1136/jnnp.2006.112334; Plaha P, 2006, BRAIN, V129, P1732, DOI 10.1093/brain/awl127; Saint-Cyr JA, 2002, J NEUROSURG, V97, P1152, DOI 10.3171/jns.2002.97.5.1152; Videen TO, 2008, J NEUROSCI METH, V168, P275, DOI 10.1016/j.jneumeth.2007.10.007; Viola P, 1997, INT J COMPUT VISION, V24, P137, DOI 10.1023/A:1007958904918; Voges J, 2002, J NEUROSURG, V96, P269, DOI 10.3171/jns.2002.96.2.0269; Zhang JY, 2012, EXP NEUROL, V233, P575, DOI 10.1016/j.expneurol.2011.07.007	42	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e99663	10.1371/journal.pone.0099663	http://dx.doi.org/10.1371/journal.pone.0099663			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25098453	Green Published, gold, Green Submitted			2022-12-27	WOS:000339995100003
J	Szalay, B; Cseh, A; Meszaros, G; Kovacs, L; Balog, A; Vasarhelyi, B				Szalay, Balazs; Cseh, Aron; Meszaros, Gergo; Kovacs, Laszlo; Balog, Attila; Vasarhelyi, Barna			The Impact of DMARD and Anti-TNF Therapy on Functional Characterization of Short-Term T-Cell Activation in Patients with Rheumatoid Arthritis - A Follow-Up Study	PLOS ONE			English	Article							REACTIVE OXYGEN; NITRIC-OXIDE; CHRONIC INFLAMMATION; CALCIUM-FLUX; METHOTREXATE; LYMPHOCYTES; GENERATION; CYTOMETRY; ALPHA	Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by a systemic dysfunction of T-cells. In this study we tested the impact of DMARD and anti-TNF agents on short-term activation characteristics of T-cells. We enrolled 12 patients with newly diagnosed RA (naive RA) who were treated with methothrexate (MTX) and glucocorticsteroid (GCS) and 22 patients with established RA non responding to conventional DMARD therapy who were treated with different anti-TNF agents. Nine healthy volunteers served as controls. Blood samples were taken at baseline, then at 4th and 8th week of therapy. The characteristics of several intracellular activation processes during short-term activation of T-cells including cytoplasmic Ca2+ level, mitochondrial Ca2+ level, reactive oxygen species (ROS) and nitric oxide (NO) generation were determined by a novel flow-cytometry technique. At baseline, the tested processes were comparable to controls in naive RA. During GCS therapy, cytoplasmic Ca2+ level and ROS generation decreased. After the addition of MTX to GCS cytoplasmic Ca2+ level became comparable to controls, while ROS generation decreased further. In DMARD non responders, cytoplasmic Ca2+ level was higher than controls at baseline. The cytoplasmic Ca2+ level became comparable to controls and ROS generation decreased during each of the three anti-TNF-alpha agent therapies. Mitochondrial Ca2+ level and NO generation were unaltered in all of the patient groups. These results indicate that intracelluar machinery is affected in T-cells of RA patients. This may alter the behavior of T-cells during activation. Different therapeutic approaches may modulate the abnormal T-cell functions	[Szalay, Balazs; Vasarhelyi, Barna] Semmelweis Univ, Dept Lab Med, Fac Med, H-1085 Budapest, Hungary; [Cseh, Aron; Meszaros, Gergo] Semmelweis Univ, Dept Pediat 1, Fac Med, H-1085 Budapest, Hungary; [Kovacs, Laszlo; Balog, Attila] Univ Szeged, Dept Rheumatol, Fac Med, Albert Szent Gyorgyi Hlth Ctr, Szeged, Hungary; [Vasarhelyi, Barna] MTA SE, Pediat & Nephrol Res Grp, Budapest, Hungary	Semmelweis University; Semmelweis University; Szeged University	Balog, A (corresponding author), Univ Szeged, Dept Rheumatol, Fac Med, Albert Szent Gyorgyi Hlth Ctr, Szeged, Hungary.	balog.attila@med.u-szeged.hu	Szalay, Balazs/X-6698-2019	Meszaros, Gergo/0000-0003-2808-2135	Hungarian Scientific Research Fund (OTKA) [101661]; Social Renewal Operational Programme [TAMOP-4.2.2.-08/1/KMR-2008-0004]; Abbott Laboratories; Pfizer; Zoltan Magyary Scholarship [TAMOP-4.2.4. A/2-11-1-2012-001]	Hungarian Scientific Research Fund (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Social Renewal Operational Programme; Abbott Laboratories(Abbott Laboratories); Pfizer(Pfizer); Zoltan Magyary Scholarship	The study was supported by Hungarian Scientific Research Fund (OTKA) (Grant no. 101661), Social Renewal Operational Programme (Grant no. TAMOP-4.2.2.-08/1/KMR-2008-0004) and research grants from Abbott Laboratories and Pfizer. Attila Balog was supported by the Zoltan Magyary Scholarship (grant no. TAMOP-4.2.4. A/2-11-1-2012-001). Abbott and Pfizer have provided an unrestricted research grant to facilitate the purchase of laboratory materials. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN ME, 1995, EUR J IMMUNOL, V25, P1547, DOI 10.1002/eji.1830250612; Baus E, 1996, J IMMUNOL, V156, P4555; Capsoni F, 2005, ARTHRITIS RES THER, V7, pR250, DOI 10.1186/ar1477; Carruthers DM, 1996, CLIN EXP IMMUNOL, V105, P291, DOI 10.1046/j.1365-2249.1996.d01-768.x; den Broeder AA, 2003, J RHEUMATOL, V30, P232; Griffiths HR, 2011, BIOCHEM SOC T, V39, P1273, DOI 10.1042/BST0391273; Harr MW, 2009, J BIOL CHEM, V284, P31860, DOI 10.1074/jbc.M109.005579; Hassan SZ, 2011, INT J RHEUM DIS, V14, P325, DOI 10.1111/j.1756-185X.2011.01630.x; Hitchon CA, 2004, ARTHRITIS RES THER, V6, P265, DOI 10.1186/ar1447; Inman RD, 2009, CLIN EXP RHEUMATOL, V27, pS26; Kaposi AS, 2008, CYTOM PART A, V73A, P246, DOI 10.1002/cyto.a.20518; LAM M, 1993, MOL ENDOCRINOL, V7, P686, DOI 10.1210/me.7.5.686; Marumo T, 1998, HYPERTENSION, V32, P1083, DOI 10.1161/01.HYP.32.6.1083; McInnes IB, 2010, ANN RHEUM DIS, V69, P1898, DOI 10.1136/ard.2010.134684; Meszaros G, 2012, ASSAY DRUG DEV TECHN, V10, P97, DOI 10.1089/adt.2011.0368; Nagy G, 2008, IMMUNOL LETT, V118, P55, DOI 10.1016/j.imlet.2008.02.009; Nagy G, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3045; Nagy G, 2007, IMMUNOL LETT, V111, P1, DOI 10.1016/j.imlet.2007.04.013; Pagadigorria CLS, 2006, COMP BIOCHEM PHYS C, V143, P340, DOI 10.1016/j.cbpc.2006.03.007; Pay S, 2005, IMMUNOPHARM IMMUNOT, V27, P187, DOI 10.1081/IPH-200067702; Phillips DC, 2010, ANTIOXID REDOX SIGN, V12, P743, DOI 10.1089/ars.2009.2607; Scott DL, 2010, LANCET, V376, P1094, DOI 10.1016/S0140-6736(10)60826-4; Smolen JS, 2010, ANN RHEUM DIS, V69, P964, DOI 10.1136/ard.2009.126532; Sung JY, 2000, IMMUNOPHARMACOLOGY, V47, P35, DOI 10.1016/S0162-3109(99)00185-X; SZALAY B, 2013, CLIN RHEUMATOL; Szalay B, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/808724; Van Laethem F, 2001, J EXP MED, V193, P803, DOI 10.1084/jem.193.7.803; Vital EM, 2008, J AUTOIMMUN, V31, P219, DOI 10.1016/j.jaut.2008.04.006	28	3	3	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e104298	10.1371/journal.pone.0104298	http://dx.doi.org/10.1371/journal.pone.0104298			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25098248	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000339995100061
J	Thorne, MAS; Kagoshima, H; Clark, MS; Marshall, CJ; Wharton, DA				Thorne, Michael A. S.; Kagoshima, Hiroshi; Clark, Melody S.; Marshall, Craig J.; Wharton, David A.			Molecular Analysis of the Cold Tolerant Antarctic Nematode, Panagrolaimus davidi	PLOS ONE			English	Article							EMBRYOGENESIS ABUNDANT PROTEINS; RIBONUCLEIC-ACID POPULATIONS; CRYOPROTECTIVE DEHYDRATION; DEVELOPMENTAL BIOCHEMISTRY; COTTONSEED EMBRYOGENESIS; CAENORHABDITIS-ELEGANS; LEA PROTEIN; C-ELEGANS; SURVIVAL; TREHALOSE	Isolated and established in culture from the Antarctic in 1988, the nematode Panagrolaimus davidi has proven to be an idel model for the study of adaptation to the cold. Not only is it the best-documented example of an organism surviving intracellular freezing but it is also able to undergo cryoprotective dehydration. As part of an ongoing effort to develop a molecular understanding of this remarkable organism, we have assembled both a transcriptome and a set of genomic scaffolds. We provide an overview of the transcriptome and a survey of genes involved in temperature stress. We also explore, in silico, the possibility that P. davidi will be susceptible to an environmental RNAi response, important for further functional studies.	[Thorne, Michael A. S.; Clark, Melody S.] British Antarctic Survey, Nat Environm Res Council, Cambridge CB3 0ET, England; [Kagoshima, Hiroshi] Res Org Informat & Syst, Transdisciplinary Res Intergrat Ctr, Tokyo, Japan; [Kagoshima, Hiroshi] Natl Inst Genet, Mishima, Shizuoka 411, Japan; [Marshall, Craig J.] Univ Otago, Dept Biochem, Dunedin, New Zealand; [Wharton, David A.] Univ Otago, Dept Zool, Dunedin, New Zealand	UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; Research Organization of Information & Systems (ROIS); Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; University of Otago; University of Otago	Thorne, MAS (corresponding author), British Antarctic Survey, Nat Environm Res Council, Cambridge CB3 0ET, England.	mior@bas.ac.uk	Clark, Melody S/D-7371-2014; Marshall, Craig J./C-6668-2009	Clark, Melody S/0000-0002-3442-3824; Marshall, Craig J./0000-0003-4186-0368; Wharton, David/0000-0001-6369-4984; Thorne, Michael/0000-0001-7759-612X	NERC core funding; Japan Society [23510239]; Transdisciplinary Research Integration Center (TRIC); Research Organisation of Information and Systems (ROIS); Departments of Zoology and Biochemistry at the University of Otago; NERC [bas0100025] Funding Source: UKRI; Natural Environment Research Council [bas0100025] Funding Source: researchfish	NERC core funding; Japan Society(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Transdisciplinary Research Integration Center (TRIC); Research Organisation of Information and Systems (ROIS); Departments of Zoology and Biochemistry at the University of Otago; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	MAST and MSC were supported by NERC core funding to the British Antarctic Survey. HK was supported by grant-in-aid for scientific research (No. 23510239) from the Japan Society for the Promotion of Science. Further support came from the Transdisciplinary Research Integration Center (TRIC), the Research Organisation of Information and Systems (ROIS), and the Departments of Zoology and Biochemistry at the University of Otago. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari BN, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-69; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bahrndorff S, 2009, J INSECT PHYSIOL, V55, P210, DOI 10.1016/j.jinsphys.2008.11.010; Boutros M, 2008, NAT REV GENET, V9, P554, DOI 10.1038/nrg2364; BRENNER S, 1974, GENETICS, V77, P71; Chakrabortee S, 2012, MOL BIOSYST, V8, P210, DOI 10.1039/c1mb05263b; Clark MS, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-328; Clark MS, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-475; CROWE JH, 1984, SCIENCE, V223, P701, DOI 10.1126/science.223.4637.701; Dalzell JJ, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001176; Denekamp NY, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-108; DURE L, 1981, BIOCHEMISTRY-US, V20, P4162, DOI 10.1021/bi00517a033; Gal TZ, 2004, FEBS LETT, V577, P21, DOI 10.1016/j.febslet.2004.09.049; GALAU GA, 1981, BIOCHEMISTRY-US, V20, P4169, DOI 10.1021/bi00517a034; Goldstein Paul, 1996, Cytobios, V85, P81; Hand SC, 2011, ANNU REV PHYSIOL, V73, P115, DOI 10.1146/annurev-physiol-012110-142203; Hengherr S, 2008, FEBS J, V275, P281, DOI 10.1111/j.1742-4658.2007.06198.x; HIGGINS DG, 1988, GENE, V73, P237, DOI 10.1016/0378-1119(88)90330-7; Hooper D. J., 1986, Laboratory methods for work with plant and soil nematodes., P5; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Hunault G, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-221; Jaspard E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036968; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kayukawa T, 2007, INSECT BIOCHEM MOLEC, V37, P1160, DOI 10.1016/j.ibmb.2007.07.007; Kruse E, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-206; Lewis SC, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-15; Li S, 2012, P NATL ACAD SCI USA, V109, P20859, DOI 10.1073/pnas.1214893109; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; MADIN KAC, 1975, J EXP ZOOL, V193, P335, DOI 10.1002/jez.1401930309; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Pellerone FI, 2003, INT J PARASITOL, V33, P1195, DOI 10.1016/S0020-7519(03)00173-5; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; Raymond MR, 2014, ANTARCT SCI, V26, P15, DOI 10.1017/S0954102013000230; Raymond MR, 2013, J COMP PHYSIOL B, V183, P181, DOI 10.1007/s00360-012-0697-0; Ring RA, 1998, CRYOLETTERS, V19, P275; SALT R. W., 1957, CANADIAN ENT, V89, P491; SALT RW, 1962, NATURE, V193, P1207, DOI 10.1038/1931207a0; SALT RW, 1959, NATURE, V184, P1426, DOI 10.1038/1841426a0; Shannon AJ, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-58; Sharon MA, 2009, BIOCHEM CELL BIOL, V87, P415, DOI [10.1139/o09-001, 10.1139/O09-001]; Spieth J, 2006, OVERVIEW GENE STRUCT; Stein LD, 2003, PLOS BIOL, V1, P166, DOI 10.1371/journal.pbio.0000045; Tabara H, 1998, SCIENCE, V282, P430, DOI 10.1126/science.282.5388.430; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Thorne MAS, 2011, INSECT MOL BIOL, V20, P303, DOI 10.1111/j.1365-2583.2010.01062.x; TIMM RW, 1971, P HELM SOC WASH, V38, P42; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Tunnacliffe A, 2005, HYDROBIOLOGIA, V546, P315, DOI 10.1007/s10750-005-4239-6; Tunnacliffe A, 2003, PHILOS T ROY SOC B, V358, P1755, DOI 10.1098/rstb.2002.1214; Tunnacliffe A, 2007, NATURWISSENSCHAFTEN, V94, P791, DOI 10.1007/s00114-007-0254-y; Tyson Trevor, 2012, BMC Research Notes, V5, P68, DOI 10.1186/1756-0500-5-68; Walters KR, 2009, P NATL ACAD SCI USA, V106, P20210, DOI 10.1073/pnas.0909872106; WHARTON DA, 1995, J EXP BIOL, V198, P1381; WHARTON DA, 1989, NEW ZEAL J ZOOL, V16, P467, DOI 10.1080/03014223.1989.10422914; Wharton DA, 2005, CRYOBIOLOGY, V51, P198, DOI 10.1016/j.cryobiol.2005.07.001; Wharton DA, 2005, CRYOBIOLOGY, V50, P21, DOI 10.1016/j.cryobiol.2004.09.004; Wharton DA, 2003, J EXP BIOL, V206, P215, DOI 10.1242/jeb.00083; Wharton DA, 2011, MOLECULAR AND PHYSIOLOGICAL BASIS OF NEMATODE SURVIVAL, P182, DOI 10.1079/9781845936877.0182; Winston WM, 2007, P NATL ACAD SCI USA, V104, P10565, DOI 10.1073/pnas.0611282104; Wise Michael J, 2002, Bioinformatics, V18 Suppl 1, pS38; Wise MJ, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-52; Wolkers WF, 2001, BBA-PROTEIN STRUCT M, V1544, P196, DOI 10.1016/S0167-4838(00)00220-X; Yancey PH, 2005, J EXP BIOL, V208, P2819, DOI 10.1242/jeb.01730	63	14	15	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e104526	10.1371/journal.pone.0104526	http://dx.doi.org/10.1371/journal.pone.0104526			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25098249	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000339995100081
J	Yew, SM; Chan, CL; Lee, KW; Na, SL; Tan, RX; Hoh, CC; Yee, WY; Ngeow, YF; Ng, KP				Yew, Su Mei; Chan, Chai Ling; Lee, Kok Wei; Na, Shiang Ling; Tan, Ruixin; Hoh, Chee-Choong; Yee, Wai-Yan; Ngeow, Yun Fong; Ng, Kee Peng			A Five-Year Survey of Dematiaceous Fungi in a Tropical Hospital Reveals Potential Opportunistic Species	PLOS ONE			English	Article							INTERNAL TRANSCRIBED SPACER; CENTRAL-NERVOUS-SYSTEM; OF-THE-LITERATURE; EXSEROHILUM-ROSTRATUM; AMPHOTERICIN-B; CEREBRAL PHEOHYPHOMYCOSIS; MOLECULAR-IDENTIFICATION; EXOPHIALA-SPINIFERA; FILAMENTOUS FUNGI; MELANIZED FUNGI	Dematiaceous fungi (black fungi) are a heterogeneous group of fungi present in diverse environments worldwide. Many species in this group are known to cause allergic reactions and potentially fatal diseases in humans and animals, especially in tropical and subtropical climates. This study represents the first survey of dematiaceous fungi in Malaysia and provides observations on their diversity as well as in vitro response to antifungal drugs. Seventy-five strains isolated from various clinical specimens were identified by morphology as well as an internal transcribed spacer (ITS)-based phylogenetic analysis. The combined molecular and conventional approach enabled the identification of three classes of the Ascomycota phylum and 16 genera, the most common being Cladosporium, Cochliobolus and Neascytalidium. Several of the species identified have not been associated before with human infections. Among 8 antifungal agents tested, the azoles posaconazole (96%), voriconazole (90.7%), ketoconazole (86.7%) and itraconazole (85.3%) showed in vitro activity (MIC <= 1 mu g/mL) to the largest number of strains, followed by anidulafungin (89.3%), caspofungin (74.7%) and amphotericin B (70.7%). Fluconazole appeared to be the least effective with only 10.7% of isolates showing in vitro susceptibility. Overall, almost half (45.3%) of the isolates showed reduced susceptibility (MIC > 1 mu g/mL) to at least one antifungal agent, and three strains (one Pyrenochaeta unguis-hominis and two Nigrospora oryzae) showed potential multidrug resistance.	[Yew, Su Mei; Chan, Chai Ling; Na, Shiang Ling; Tan, Ruixin; Ngeow, Yun Fong; Ng, Kee Peng] Univ Malaya, Dept Med Microbiol, Fac Med, Kuala Lumpur, Malaysia; [Lee, Kok Wei; Hoh, Chee-Choong; Yee, Wai-Yan] Codon Genom SB, Pusat Bandar Puchong, Selangor Darul, Malaysia	Universiti Malaya	Ng, KP (corresponding author), Univ Malaya, Dept Med Microbiol, Fac Med, Kuala Lumpur, Malaysia.	kpng@ummc.edu.my	NGEOW, YUN FONG/B-9237-2010	Ngeow, Yun Fong/0000-0002-1011-762X	High Impact Research Chancellory from the University of Malaya [UM.C/625/1/HIR/004]; Ministry of Education Malaysia [UM.C/625/1/HIR/MOHE/MED/31]; University of Malaya, Malaysia [PV051/2012A]	High Impact Research Chancellory from the University of Malaya; Ministry of Education Malaysia; University of Malaya, Malaysia(Universiti Malaya)	The study was supported by High Impact Research Chancellory Grant UM.C/625/1/HIR/004 (Account no. J-00000-73551) from the University of Malaya, High Impact Research MoE Grant UM.C/625/1/HIR/MOHE/MED/31 (Account no. H-20001-00-E000070) from the Ministry of Education Malaysia and Postgraduate Research Grant (PPP) PV051/2012A (awarded to Ms. Su Mei Yew) from the University of Malaya, Malaysia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afroz N, 2010, J CYTOL, V27, P133, DOI 10.4103/0970-9371.73297; Al-Tawfiq JA, 2009, MED MYCOL, V47, P648, DOI 10.1080/13693780802669194; Andes D, 2013, FUNGAL GENET BIOL, V61, P143, DOI 10.1016/j.fgb.2013.08.014; Aoyama Y, 2009, MED MYCOL, V47, P95, DOI 10.1080/13693780802526857; Arzanlou M, 2007, STUD MYCOL, P57, DOI 10.3114/sim.2007.58.03; Brandt ME, 2003, J CHEMOTHERAPY, V15, P36, DOI 10.1179/joc.2003.15.Supplement-2.36; Carter E, 2004, J CLIN MICROBIOL, V42, P5419, DOI 10.1128/JCM.42.11.5419-5423.2004; Chou HH, 2001, BIOINFORMATICS, V17, P1093, DOI 10.1093/bioinformatics/17.12.1093; Chowdhary A, 2014, CLIN MICROBIOL INFEC, V20, P47, DOI 10.1111/1469-0691.12515; Clinical and Laboratory Standards Institute, 2008, M38A2 CLSI, V3rd; Clinical and Laboratory Standards Institute CSLI, 2010, M51A CLSI; da Cunha KC, 2012, J CLIN MICROBIOL, V50, P4061, DOI 10.1128/JCM.01965-12; de Gruyter J, 2013, STUD MYCOL, P1, DOI 10.3114/sim0004; de Gruyter J, 2010, MYCOLOGIA, V102, P1066, DOI 10.3852/09-240; de Hoog GS, 2011, PERSOONIA, V27, P46, DOI 10.3767/003158511X614258; De Hoog G. S., 2000, ATLAS CLIN FUNGI; de Hoog GS, 2013, MYCOPATHOLOGIA, V175, P365, DOI 10.1007/s11046-013-9666-8; DELPALACIOHERNANZ A, 1989, J MED VET MYCOL, V27, P127; Denisov GA, 2004, US Patent, Patent No. 6681186; Derber C, 2010, INT J INFECT DIS, V14, pE329, DOI 10.1016/j.ijid.2010.04.003; Desnos-Ollivier M, 2006, J CLIN MICROBIOL, V44, P3517, DOI 10.1128/JCM.00862-06; Diekema DJ, 2003, J CLIN MICROBIOL, V41, P3623, DOI 10.1128/JCM.41.8.3623-3626.2003; Ellis D., 2007, DESCRIPTIONS MED FUN, V2nd, P9; ENGLISH MP, 1980, BRIT J DERMATOL, V103, P91, DOI 10.1111/j.1365-2133.1980.tb15843.x; Espinel-Ingroff A, 2007, J CLIN MICROBIOL, V45, P1811, DOI 10.1128/JCM.00134-07; Guarro J, 1999, J CLIN MICROBIOL, V37, P4170, DOI 10.1128/JCM.37.12.4170-4173.1999; Guinea J, 2010, J CLIN MICROBIOL, V48, P2205, DOI 10.1128/JCM.02321-09; Hinrikson HP, 2005, J CLIN MICROBIOL, V43, P2092, DOI 10.1128/JCM.43.5.2092-2103.2005; HSU MML, 1993, J AM ACAD DERMATOL, V28, P340, DOI 10.1016/0190-9622(93)70050-4; Hubka V, 2011, MED MYCOL, V49, P724, DOI 10.3109/13693786.2011.572299; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jang JH, 2012, ANN LAB MED, V32, P126, DOI 10.3343/alm.2012.32.2.126; Jenks P, 2008, J ANTIMICROB CHEMOTH, V62, pII1, DOI 10.1093/jac/dkn419; Johnson LB, 2003, CLIN INFECT DIS, V36, P630, DOI 10.1086/367933; Ju YM, 1997, MYCOTAXON, V61, P243; Kantarcioglu AS, 2004, MYCOSES, V47, P4, DOI 10.1046/j.1439-0507.2003.00956.x; Karsten E, 2012, OPEN OPHTHALMOL J, V6, P110, DOI 10.2174/1874364101206010110; Khan ZU, 2009, J MYCOL MED, V19, P138, DOI 10.1016/j.mycmed.2009.02.005; Kiran KK, 2008, INDIAN J PATHOL MICR, V51, P556; Kubak BM, 2009, AM J TRANSPLANT, V9, pS208, DOI 10.1111/j.1600-6143.2009.02913.x; Levin TP, 2004, J CLIN MICROBIOL, V42, P4374, DOI 10.1128/JCM.42.9.4374-4378.2004; Malani P N, 2001, Transpl Infect Dis, V3, P40, DOI 10.1034/j.1399-3062.2001.003001040.x; Manamgoda DS, 2012, FUNGAL DIVERS, V56, P131, DOI 10.1007/s13225-012-0189-2; Manamgoda DS, 2011, FUNGAL DIVERS, V51, P3, DOI 10.1007/s13225-011-0139-4; Mani RS, 2008, MED MYCOL, V46, P705, DOI 10.1080/13693780802172017; Martinez RL, 2007, CLIN DERMATOL, V25, P188, DOI 10.1016/j.clindermatol.2006.05.007; Martos AI, 2010, MED MYCOL, V48, P858, DOI 10.3109/13693781003586943; Mikosz CA, 2014, EMERG INFECT DIS, V20, P248, DOI 10.3201/eid2002.131257; Moretti S, 2007, NUCLEIC ACIDS RES, V35, pW645, DOI 10.1093/nar/gkm333; Morio F, 2012, MED MYCOL, V50, P513, DOI 10.3109/13693786.2011.648218; Muralidhar S, 1997, Indian J Pathol Microbiol, V40, P549; Oztas E, 2009, J MED MICROBIOL, V58, P1243, DOI 10.1099/jmm.0.008706-0; Pappas PG, 2013, ANTIMICROB AGENTS CH, V57, P1573, DOI 10.1128/AAC.00205-13; Rajendran C, 2003, MED MYCOL, V41, P437, DOI 10.1080/1369378031000153820; Rajput DK, 2011, PAN ARAB J NEUROSURG, V15, P87; Rakeman JL, 2005, J CLIN MICROBIOL, V43, P3324, DOI 10.1128/JCM.43.7.3324-3333.2005; Revankar SG, 2007, MYCOSES, V50, P91, DOI 10.1111/j.1439-0507.2006.01331.x; Revankar SG, 2010, CLIN MICROBIOL REV, V23, P884, DOI 10.1128/CMR.00019-10; Revankar SG, 2004, CLIN INFECT DIS, V38, P206, DOI 10.1086/380635; Rossmann SN, 1996, CLIN INFECT DIS, V22, P73, DOI 10.1093/clinids/22.1.73; Ryberg M, 2009, NEW PHYTOL, V181, P471, DOI 10.1111/j.1469-8137.2008.02667.x; Sabatelli F, 2006, ANTIMICROB AGENTS CH, V50, P2009, DOI 10.1128/AAC.00163-06; Saint-Jean M, 2007, CAN J INFECT DIS MED, V18, P200, DOI 10.1155/2007/384743; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Schubert MS, 2009, MED MYCOL, V47, pS324, DOI 10.1080/13693780802314809; Shahid Sukhbir K, 2012, ISRN Otolaryngol, V2012, P851831, DOI 10.5402/2012/851831; Singh SM., 1990, INDIAN J DERMATOL VE, V56, P289; Thomas PA, 2003, CLIN MICROBIOL REV, V16, P730, DOI 10.1128/CMR.16.4.730-797.2003; Tokarzewski S, 2012, POL J VET SCI, V15, P125, DOI 10.2478/v10181-011-0123-7; Vermeire SEM, 2010, DIAGN MICR INFEC DIS, V68, P177, DOI 10.1016/j.diagmicrobio.2010.06.002; Viola GM, 2010, INT J INFECT DIS, V14, pE299, DOI 10.1016/j.ijid.2010.02.2239; Wang L, 2013, MYCOPATHOLOGIA, V175, P331, DOI 10.1007/s11046-012-9611-2; White TJ., 1990, PCR PROTOCOLS GUIDE, P315	73	37	39	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e104352	10.1371/journal.pone.0104352	http://dx.doi.org/10.1371/journal.pone.0104352			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25098697	gold, Green Published, Green Submitted			2022-12-27	WOS:000339995100065
J	Lo Sciuto, A; Fernandez-Pinar, R; Bertuccini, L; Iosi, F; Superti, F; Imperi, F				Lo Sciuto, Alessandra; Fernandez-Pinar, Regina; Bertuccini, Lucia; Iosi, Francesca; Superti, Fabiana; Imperi, Francesco			The Periplasmic Protein TolB as a Potential Drug Target in Pseudomonas aeruginosa	PLOS ONE			English	Article							ESCHERICHIA-COLI; CELL-ENVELOPE; PAL PROTEINS; RESISTANCE; INFECTION; VIRULENCE; PATHOGENESIS; ORGANIZATION; LIPOPROTEIN; INVOLVEMENT	The Gram-negative bacterium Pseudomonas aeruginosa is one of the most dreaded pathogens in the hospital setting, and represents a prototype of multi-drug resistant "superbug'' for which effective therapeutic options are very limited. The identification and characterization of new cellular functions that are essential for P. aeruginosa viability and/or virulence could drive the development of anti-Pseudomonas compounds with novel mechanisms of action. In this study we investigated whether TolB, the periplasmic component of the Tol-Pal trans-envelope protein complex of Gram-negative bacteria, represents a potential drug target in P. aeruginosa. By combining conditional mutagenesis with the analysis of specific pathogenicity-related phenotypes, we demonstrated that TolB is essential for P. aeruginosa growth, both in laboratory and clinical strains, and that TolB-depleted P. aeruginosa cells are strongly defective in cell-envelope integrity, resistance to human serum and several antibiotics, as well as in the ability to cause infection and persist in an insect model of P. aeruginosa infection. The essentiality of TolB for P. aeruginosa growth, resistance and pathogenicity highlights the potential of TolB as a novel molecular target for anti-P. aeruginosa drug discovery.	[Lo Sciuto, Alessandra; Fernandez-Pinar, Regina; Imperi, Francesco] Univ Roma La Sapienza, Dept Biol & Biotechnol Charles Darwin, I-00185 Rome, Italy; [Bertuccini, Lucia; Iosi, Francesca; Superti, Fabiana] Natl Inst Hlth, Dept Technol & Hlth, Ultrastruct Infect Pathol Sect, Rome, Italy; [Imperi, Francesco] Univ Roma La Sapienza, Inst Pasteur, Cenci Bolognetti Fdn, I-00185 Rome, Italy	Sapienza University Rome; Istituto Superiore di Sanita (ISS); Fondazione Cenci Bolognetti; Sapienza University Rome	Imperi, F (corresponding author), Univ Roma La Sapienza, Dept Biol & Biotechnol Charles Darwin, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	francesco.imperi@uniroma1.it	Imperi, Francesco/AAA-3671-2021; BERTUCCINI, LUCIA/F-2102-2015; Bertuccini, Lucia/AAI-6683-2021; Superti, Fabiana/F-2100-2015; IOSI, FRANCESCA/F-2106-2015	Bertuccini, Lucia/0000-0002-4278-2376; Superti, Fabiana/0000-0003-4909-7598; IOSI, FRANCESCA/0000-0002-5929-6833	Fundacion Alfonso Martin Escudero (Spain); Pasteur Institute-Cenci Bolognetti Foundation	Fundacion Alfonso Martin Escudero (Spain); Pasteur Institute-Cenci Bolognetti Foundation(Istituto Pasteur Italia Fondazione Cenci Bolognetti)	Regina Fernandez-Pinar is supported by a Post-doc fellowship from the Fundacion Alfonso Martin Escudero (Spain). The work on essential periplasmic proteins in Francesco Imperi's laboratory is supported by a grant from the Pasteur Institute-Cenci Bolognetti Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antunes LCS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022674; BERNSTEIN A, 1972, J BACTERIOL, V112, P74, DOI 10.1128/JB.112.1.74-83.1972; Bertuccini L, 2014, DIGEST LIVER DIS, V46, P496, DOI 10.1016/j.dld.2014.02.009; Bowe F, 1998, INFECT IMMUN, V66, P3372, DOI 10.1128/IAI.66.7.3372-3377.1998; Bragonzi A, 2009, AM J RESP CRIT CARE, V180, P138, DOI 10.1164/rccm.200812-1943OC; Bulitta JB, 2010, ANTIMICROB AGENTS CH, V54, P2051, DOI 10.1128/AAC.00881-09; Cascales E, 2002, J BACTERIOL, V184, P754, DOI 10.1128/JB.184.3.754-759.2002; Dennis JJ, 1996, J BACTERIOL, V178, P7059, DOI 10.1128/jb.178.24.7059-7068.1996; Dubuisson JF, 2005, MICROBIOL-SGM, V151, P3337, DOI 10.1099/mic.0.28237-0; Egan AJF, 2013, ANN NY ACAD SCI, V1277, P8, DOI 10.1111/j.1749-6632.2012.06818.x; Gellatly SL, 2013, PATHOG DIS, V67, P159, DOI 10.1111/2049-632X.12033; Gerding MA, 2007, MOL MICROBIOL, V63, P1008, DOI 10.1111/j.1365-2958.2006.05571.x; Godlewska R, 2009, FEMS MICROBIOL LETT, V298, P1, DOI 10.1111/j.1574-6968.2009.01659.x; Heilpern AJ, 2000, J BACTERIOL, V182, P1739, DOI 10.1128/JB.182.6.1739-1747.2000; Hoang TT, 2000, PLASMID, V43, P59, DOI 10.1006/plas.1999.1441; Imperi F, 2009, PROTEOMICS, V9, P1901, DOI 10.1002/pmic.200800618; Jacobs MA, 2003, P NATL ACAD SCI USA, V100, P14339, DOI 10.1073/pnas.2036282100; Jander G, 2000, J BACTERIOL, V182, P3843, DOI 10.1128/JB.182.13.3843-3845.2000; Lazzaroni JC, 1999, FEMS MICROBIOL LETT, V177, P191, DOI 10.1016/S0378-1097(99)00293-1; Lazzaroni JC, 2002, BIOCHIMIE, V84, P391, DOI 10.1016/S0300-9084(02)01419-0; Liberati NT, 2006, P NATL ACAD SCI USA, V103, P2833, DOI 10.1073/pnas.0511100103; Liss L, 1987, FOCUS, V9, P13; Livermore DM, 2002, CLIN INFECT DIS, V34, P634, DOI 10.1086/338782; Llamas MA, 2000, J BACTERIOL, V182, P4764, DOI 10.1128/JB.182.17.4764-4772.2000; Lloubes R, 2001, RES MICROBIOL, V152, P523, DOI 10.1016/S0923-2508(01)01226-8; Massai F, 2011, BIOSENS BIOELECTRON, V26, P3444, DOI 10.1016/j.bios.2011.01.022; Mdluli KE, 2006, ANTIMICROB AGENTS CH, V50, P2178, DOI 10.1128/AAC.00140-06; Mesaros N, 2007, CLIN MICROBIOL INFEC, V13, P560, DOI 10.1111/j.1469-0691.2007.01681.x; Milton DL, 1996, J BACTERIOL, V178, P1310, DOI 10.1128/jb.178.5.1310-1319.1996; Poole K, 2004, CLIN MICROBIOL INFEC, V10, P12, DOI 10.1111/j.1469-0691.2004.00763.x; Poole K, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00065; RAHME LG, 1995, SCIENCE, V268, P1899, DOI 10.1126/science.7604262; Rossolini GM, 2005, CLIN MICROBIOL INFEC, V11, P17, DOI 10.1111/j.1469-0691.2005.01161.x; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Skurnik D, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003582; Spoering AL, 2001, J BACTERIOL, V183, P6746, DOI 10.1128/JB.183.23.6746-6751.2001; Sturgis JN, 2001, J MOL MICROB BIOTECH, V3, P113; Vaara M, 2013, J ANTIMICROB CHEMOTH, V68, P1213, DOI 10.1093/jac/dkt039; WEBSTER RE, 1991, MOL MICROBIOL, V5, P1005, DOI 10.1111/j.1365-2958.1991.tb01873.x; Yeh YC, 2010, J BACTERIOL, V192, P4847, DOI 10.1128/JB.00607-10	41	37	37	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e103784	10.1371/journal.pone.0103784	http://dx.doi.org/10.1371/journal.pone.0103784			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093328	Green Published, Green Submitted, gold			2022-12-27	WOS:000341357200030
J	Alsheikh-Ali, AA; Omar, MI; Raal, FJ; Rashed, W; Hamoui, O; Kane, A; Alami, M; Abreu, P; Mashhoud, WM				Alsheikh-Ali, Alawi A.; Omar, Mohamed I.; Raal, Frederick J.; Rashed, Wafa; Hamoui, Omar; Kane, Abdoul; Alami, Mohamed; Abreu, Paula; Mashhoud, Walid M.			Cardiovascular Risk Factor Burden in Africa and the Middle East: The Africa Middle East Cardiovascular Epidemiological (ACE) Study	PLOS ONE			English	Article							ACUTE CORONARY SYNDROMES; DISEASE PREVENTION; GULF REGISTRY; MYOCARDIAL-INFARCTION; LOW-INCOME; HEALTH; OBESITY; INTERVENTION; DETERMINANTS; INTERHEART	Background: Increased urbanization in the developing world parallels a rising burden of chronic diseases. Developing countries account for similar to 80% of global cardiovascular (CV) deaths, but contribute a paucity of systematic epidemiological data on CV risk factors. Objective: To estimate the prevalence of CV risk factors in rural and urban cohorts attending general practice clinics in the Africa and Middle East (AfME) region. Methods: In a cross-sectional epidemiological study, the presence of CV risk factors (hypertension, diabetes mellitus (diabetes), dyslipidemia, obesity, smoking and abdominal obesity) were evaluated in stable adult outpatients attending general practice primary care clinics. A rural population was defined as isolated (>50 km or lack of easy access to commuter transportation) from urban centers. Results: 4,378 outpatients were systematically recruited from 94 clinics across 14 AfME countries. Mean age was 46 +/- 14 years and 52% of outpatients were female. A high prevalence of dyslipidemia (70%) and abdominal obesity (68%) were observed, followed by hypertension (43%) and diabetes (25%). The vast majority of outpatients (92%) had at least one modifiable CV risk factor, many (74%) had more than one, and half (53%) had 3 or more. These findings were observed in both genders and across urban and rural centers. Among outpatients with pre-existing hypertension or dyslipidemia, many were not at their target blood pressure or LDL-cholesterol goals. Conclusion: Cardiovascular risk factors are highly prevalent among relatively young, stable outpatients attending general practice clinics across AfME. The findings support opportunistic screening for CV risk factors whenever outpatients visit a general practitioner and provide an opportunity for early identification and management of CV risk factors, including lifestyle interventions.	[Alsheikh-Ali, Alawi A.] Sheikh Khalifa Med City, Inst Cardiac Sci, Abu Dhabi, U Arab Emirates; [Omar, Mohamed I.] Pfizer AfME, Dubai Media City, Dubai, U Arab Emirates; [Raal, Frederick J.] Johannesburg Hosp, Fac Hlth Sci, Dept Med, Johannesburg, South Africa; [Rashed, Wafa] Mubarak Kabeer Hosp, Al Jabriya, Kuwait; [Hamoui, Omar] Clemenceau Med Ctr, Beirut, Lebanon; [Kane, Abdoul] Hop Gen Grand Yoff, Dakar, Senegal; [Alami, Mohamed] Mohammed V Univ, Rabat, Morocco; [Abreu, Paula] Pfizer Inc, New York, NY USA; [Mashhoud, Walid M.] Pfizer Saudi Arabia, Jeddah, Saudi Arabia	Pfizer; University of Witwatersrand; Mohammed V University in Rabat; Pfizer; Pfizer; Pfizer - Saudi Arabia	Alsheikh-Ali, AA (corresponding author), Sheikh Khalifa Med City, Inst Cardiac Sci, Abu Dhabi, U Arab Emirates.	aalsheikhali@alum.mit.edu	Raal, FJ/ABD-5111-2021	Raal, FJ/0000-0002-9170-7938; ALAMI, MOHAMED/0000-0003-1960-6769	Pfizer	Pfizer(Pfizer)	This study was sponsored by Pfizer. Additional editorial support was provided by Steph Milsom at PHASE II International, Esher, Surrey, UK, and funded by Pfizer. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials. Although Pfizer does not deposit clinical trial data into a publicly available resource, Pfizer makes every effort to provide access to clinical data via a data transfer agreement for researchers and investigators who wish to utilize the data to address medically relevant hypotheses. The authors, three of whom are employees at Pfizer, were involved in all aspects of the study design and implementation and we have stated the roles of each of the authors in the 'Additional Information - Author Contributions' section of the online form. All authors have contributed significantly to this work, and meet requirements for authorship in compliance with the International Committee of Medical Journal Editors guidelines. All listed authors have seen and approved the revised version submitted.	Abegunde DO, 2007, LANCET, V370, P1929, DOI 10.1016/S0140-6736(07)61696-1; Agarwal DP, 2001, IJHG, V1, P233; Ajlouni K, 1998, INT J OBESITY, V22, P624, DOI 10.1038/sj.ijo.0800637; Al-Kaabba A., 2012, OJEMD, V2, P89, DOI [10.4236/ojemd.2012.24014, DOI 10.4236/OJEMD.2012.24014]; Alarouj M, 2013, INT J CLIN PRACT, V67, P89, DOI 10.1111/ijcp.12064; Alsheikh-Ali AA, 2009, EUR J HEART FAIL, V11, P1135, DOI 10.1093/eurjhf/hfp151; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; Awad HH, 2011, AM J CARDIOL, V108, P1252, DOI 10.1016/j.amjcard.2011.06.040; Belue R, 2009, GLOBALIZATION HEALTH, V5, DOI 10.1186/1744-8603-5-10; Brockerhoff MP, 2000, POPUL BULL, V55, P3; Celermajer DS, 2012, J AM COLL CARDIOL, V60, P1207, DOI 10.1016/j.jacc.2012.03.074; Chadha SL, 1998, CURR SCI INDIA, V74, P1069; Del Brutto OH, 2013, ENVIRON HEALTH PREV, V18, P422, DOI 10.1007/s12199-013-0344-8; Fuster V, 2007, CIRCULATION, V116, P1966, DOI 10.1161/CIRCULATIONAHA.107.733444; Gaziano TA, 2005, CIRCULATION, V112, P3547, DOI 10.1161/CIRCULATIONAHA.105.591792; Gaziano TA, 2007, LANCET, V370, P1939, DOI 10.1016/S0140-6736(07)61697-3; Gehani AA, 2012, EUR J PREV CARD 1102; Graham I, 2007, EUR HEART J, V28, P2375, DOI 10.1093/eurheartj/ehm316; Grundy SM, 2001, NIH PUBLICATION, V01-3670; Health of Populations in Transition (HoPiT), 2004, CAM BURD DIAB CAMBOD; Hollar D, 2010, AM J PUBLIC HEALTH, V100, P646, DOI 10.2105/AJPH.2009.165746; International Diabetes Federation, 2013, IDF DIABETES ATLAS; International Diabetes Federation, 2005, IDF CONS WORLDW DEF; Levenson James W, 2002, Prev Cardiol, V5, P188, DOI 10.1111/j.1520-037X.2002.00564.x; Okello E, 2013, CARDIOVASC J AFR, V24, P80, DOI [10.5830/CVJA-2013-004, 10.5830/cvja-2013-004]; Opie LH, 2005, CIRCULATION, V112, P3536, DOI 10.1161/CIRCULATIONAHA.105.597765; Perk Joep, 2012, Int J Behav Med, V19, P403, DOI [10.1016/j.atherosclerosis.2012.05.007, 10.1093/eurheartj/ehs092, 10.1007/s12529-012-9242-5]; Reddy KS, 2002, PUBLIC HEALTH NUTR, V5, P231, DOI 10.1079/PHN2001298; Schernthaner G, 2008, DIABETES CARE, V31, pS297, DOI 10.2337/dc08-s270; Selvarajah S, 2013, BMC CARDIOVASC DISOR, V13, DOI 10.1186/1471-2261-13-10; Stern R, 2010, PREV CHRONIC DIS, V7; Steyn K, 2005, CIRCULATION, V112, P3554, DOI 10.1161/CIRCULATIONAHA.105.563452; Strasser R, 2003, FAM PRACT, V20, P457, DOI 10.1093/fampra/cmg422; van Drenth BB, 2000, INT J QUAL HEALTH C, V12, P319, DOI 10.1093/intqhc/12.4.319; World Health Organization, 2006, COUNTR COOP STRAT WH; Yusuf S, 2001, CIRCULATION, V104, P2746, DOI 10.1161/hc4601.099487; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9; Zubaid M, 2011, CIRC-CARDIOVASC QUAL, V4, P477, DOI 10.1161/CIRCOUTCOMES.110.959700; Zubaid M, 2009, ACTA CARDIOL, V64, P439, DOI 10.2143/AC.64.4.2041607	39	77	77	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e102830	10.1371/journal.pone.0102830	http://dx.doi.org/10.1371/journal.pone.0102830			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25090638	gold, Green Published, Green Submitted			2022-12-27	WOS:000339812700010
J	Dong, YF; Tian, H; Wang, W; Zhang, XN; Liu, JX; Ru, SG				Dong, Yifei; Tian, Hua; Wang, Wei; Zhang, Xiaona; Liu, Jinxiang; Ru, Shaoguo			Disruption of the Thyroid System by the Thyroid-Disrupting Compound Aroclor 1254 in Juvenile Japanese Flounder (Paralichthys olivaceus)	PLOS ONE			English	Article							TILAPIA OREOCHROMIS-NILOTICUS; I IODOTHYRONINE DEIODINASE; POLYCHLORINATED-BIPHENYLS; HORMONE LEVELS; ONCORHYNCHUS-KISUTCH; FISH DEVELOPMENT; TELEOST FISH; COHO SALMON; PERCHLORATE; METAMORPHOSIS	Polychlorinated biphenyls (PCBs) are a group of persistent organochlorine compounds that have the potential to disrupt the homeostasis of thyroid hormones (THs) in fish, particularly juveniles. In this study, thyroid histology, plasma TH levels, and iodothyronine deiodinase (IDs, including ID1, ID2, and ID3) gene expression patterns were examined in juvenile Japanese flounder (Paralichthys olivaceus) following 25- and 50-day waterborne exposure to environmentally relevant concentrations of a commercial PCB mixture, Aroclor 1254 (10, 100, and 1000 ng/L) with two-thirds of the test solutions renewed daily. The results showed that exposure to Aroclor 1254 for 50 d increased follicular cell height, colloid depletion, and hyperplasia. In particular, hypothyroidism, which was induced by the administration of 1000 ng/L Aroclor 1254, significantly decreased plasma TT4, TT3, and FT3 levels. Profiles of the changes in mRNA expression levels of IDs were observed in the liver and kidney after 25 and 50 d PCB exposure, which might be associated with a reduction in plasma THs levels. The expression level of ID2 mRNA in the liver exhibited a dose-dependent increase, indicating that this ID isotype might serve as sensitive and stable indicator for thyroid-disrupting chemical (TDC) exposure. Overall, our study confirmed that environmentally relevant concentrations of Aroclor 1254 cause significant thyroid disruption, with juvenile Japanese flounder being suitable candidates for use in TDC studies.	[Dong, Yifei; Tian, Hua; Wang, Wei; Zhang, Xiaona; Liu, Jinxiang; Ru, Shaoguo] Ocean Univ China, Marine Life Sci Coll, Qingdao, Shandong, Peoples R China	Ocean University of China	Ru, SG (corresponding author), Ocean Univ China, Marine Life Sci Coll, Qingdao, Shandong, Peoples R China.	rusg@ouc.edu.cn	Tian, Hua/GPP-4477-2022		National Natural Science Foundation of China [31202001]; Natural Science Foundation of Shandong Province [ZR2012CQ010]; Marine Public Scientific Research Funding Project [2012418012]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Marine Public Scientific Research Funding Project	This work was supported by the National Natural Science Foundation of China (31202001) www.nsfc.gov.cn, Natural Science Foundation of Shandong Province (ZR2012CQ010) www.sdnsf.gov.cn, and Marine Public Scientific Research Funding Project (2012418012) www.soa.gov.cn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams BA, 2000, COMP BIOCHEM PHYS C, V127, P367, DOI 10.1016/S0742-8413(00)00164-X; Besselink HT, 1996, ENVIRON POLLUT, V92, P267, DOI 10.1016/0269-7491(95)00116-6; Blanton ML, 2007, CRIT REV TOXICOL, V37, P97, DOI 10.1080/10408440601123529; Bradford CM, 2005, ENVIRON SCI TECHNOL, V39, P5190, DOI 10.1021/es0484505; Brown SB, 2004, ENVIRON TOXICOL CHEM, V23, P1680, DOI 10.1897/03-242; Brown SB, 2004, AQUAT TOXICOL, V67, P75, DOI 10.1016/j.aquatox.2003.12.002; Brown SB, 2002, AQUAT TOXICOL, V59, P139, DOI 10.1016/S0166-445X(01)00246-6; Castells P, 2008, CHEMOSPHERE, V70, P1552, DOI 10.1016/j.chemosphere.2007.08.034; Coimbra AM, 2005, COMP BIOCHEM PHYS C, V141, P8, DOI 10.1016/j.cca.2005.04.006; Crane HM, 2005, ENVIRON HEALTH PERSP, V113, P396, DOI 10.1289/ehp.7333; Cyr DG, 1996, REV FISH BIOL FISHER, V6, P165, DOI 10.1007/BF00182342; Drezner Z, 2010, COMMUN STAT-SIMUL C, V39, P693, DOI 10.1080/03610911003615816; Eales JG, 1999, AM SOC TEST MATER, V1364, P136, DOI 10.1520/STP15801S; EALES JG, 1993, REV FISH BIOL FISHER, V3, P299, DOI 10.1007/BF00043383; FOK P, 1990, FISH PHYSIOL BIOCHEM, V8, P281, DOI 10.1007/BF00003423; FOLMAR LC, 1982, AQUAT TOXICOL, V2, P291, DOI 10.1016/0166-445X(82)90017-0; Hansen LG, 1998, ENVIRON HEALTH PERSP, V106, P171, DOI 10.2307/3433919; HIGGS DA, 1977, GEN COMP ENDOCR, V32, P29, DOI 10.1016/0016-6480(77)90080-6; INUI Y, 1989, GEN COMP ENDOCR, V74, P406, DOI 10.1016/S0016-6480(89)80038-3; INUI Y, 1985, GEN COMP ENDOCR, V60, P450, DOI 10.1016/0016-6480(85)90080-2; Iwanowicz LR, 2009, AQUAT TOXICOL, V93, P70, DOI 10.1016/j.aquatox.2009.03.008; Jugan ML, 2010, BIOCHEM PHARMACOL, V79, P939, DOI 10.1016/j.bcp.2009.11.006; Kohrle J, 1999, MOL CELL ENDOCRINOL, V151, P103, DOI 10.1016/S0303-7207(99)00040-4; LEATHERLAND JF, 1978, J FISH RES BOARD CAN, V35, P1285, DOI 10.1139/f78-202; Leroy KD, 2006, COMP BIOCHEM PHYS C, V144, P263, DOI 10.1016/j.cbpc.2006.09.005; Leung AM, 2010, BEST PRACT RES CL EN, V24, P133, DOI 10.1016/j.beem.2009.08.009; Li W, 2009, AQUAT TOXICOL, V94, P87, DOI 10.1016/j.aquatox.2009.06.002; Liu FJ, 2006, ENVIRON SCI TECHNOL, V40, P3429, DOI 10.1021/es052538g; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MIWA S, 1992, J EXP ZOOL, V261, P424, DOI 10.1002/jez.1402610409; MIWA S, 1991, J EXP ZOOL, V259, P222, DOI 10.1002/jez.1402590211; MORENO M, 1994, FEBS LETT, V344, P143, DOI 10.1016/0014-5793(94)00365-3; Mukhi S, 2007, TOXICOL SCI, V96, P246, DOI 10.1093/toxsci/kfm001; Okada N, 2005, FISHERIES SCI, V71, P107, DOI 10.1111/j.1444-2906.2005.00937.x; Orozco A, 2005, THYROID, V15, P799, DOI 10.1089/thy.2005.15.799; Palace VP, 2001, CHEMOSPHERE, V45, P185, DOI 10.1016/S0045-6535(00)00577-4; Picard-Aitken M, 2007, AQUAT TOXICOL, V83, P200, DOI 10.1016/j.aquatox.2007.04.004; Power DM, 2001, COMP BIOCHEM PHYS C, V130, P447, DOI 10.1016/S1532-0456(01)00271-X; SAFE SH, 1994, CRIT REV TOXICOL, V24, P87, DOI 10.3109/10408449409049308; Schmidt F, 2012, AQUAT TOXICOL, V109, P47, DOI 10.1016/j.aquatox.2011.11.004; Schnitzler JG, 2011, AQUAT TOXICOL, V105, P438, DOI 10.1016/j.aquatox.2011.07.019; Sprovieri M, 2007, CHEMOSPHERE, V67, P998, DOI 10.1016/j.chemosphere.2006.10.055; Tian H, 2010, AQUAT TOXICOL, V98, P67, DOI 10.1016/j.aquatox.2010.01.011; Van der Geyten S, 1998, FISH PHYSIOL BIOCHEM, V19, P135, DOI 10.1023/A:1007790527748; Van der Geyten S, 2005, J ENDOCRINOL, V184, P467, DOI 10.1677/joe.1.05986; Van der Geyten S, 2001, GEN COMP ENDOCR, V124, P333, DOI 10.1006/gcen.2001.7722; Yamano K, 2005, JARQ-JPN AGR RES Q, V39, P161, DOI 10.6090/jarq.39.161; YAMANO K, 1991, GEN COMP ENDOCR, V81, P464, DOI 10.1016/0016-6480(91)90174-5; Zhang XN, 2013, GEN COMP ENDOCR, V193, P158, DOI 10.1016/j.ygcen.2013.08.003; Zhang ZL, 2003, CHEMOSPHERE, V52, P1423, DOI 10.1016/S0045-6535(03)00478-8	50	23	24	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e104196	10.1371/journal.pone.0104196	http://dx.doi.org/10.1371/journal.pone.0104196			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25090620	Green Published, gold, Green Submitted			2022-12-27	WOS:000339812700108
J	Ghimire, R; Norton, JB; Stahl, PD; Norton, U				Ghimire, Rajan; Norton, Jay B.; Stahl, Peter D.; Norton, Urszula			Soil Microbial Substrate Properties and Microbial Community Responses under Irrigated Organic and Reduced-Tillage Crop and Forage Production Systems	PLOS ONE			English	Article							ARBUSCULAR MYCORRHIZAL FUNGI; ENZYME-ACTIVITIES; CARBON; NITROGEN; BIOMASS; AGROECOSYSTEMS; MANAGEMENT; BACTERIAL; TURNOVER; IMPACT	Changes in soil microbiotic properties such as microbial biomass and community structure in response to alternative management systems are driven by microbial substrate quality and substrate utilization. We evaluated irrigated crop and forage production in two separate four-year experiments for differences in microbial substrate quality, microbial biomass and community structure, and microbial substrate utilization under conventional, organic, and reduced-tillage management systems. The six different management systems were imposed on fields previously under long-term, intensively tilled maize production. Soils under crop and forage production responded to conversion from monocropping to crop rotation, as well as to the three different management systems, but in different ways. Under crop production, four years of organic management resulted in the highest soil organic C (SOC) and microbial biomass concentrations, while under forage production, reduced-tillage management most effectively increased SOC and microbial biomass. There were significant increases in relative abundance of bacteria, fungi, and protozoa, with two-to 36-fold increases in biomarker phospholipid fatty acids (PLFAs). Under crop production, dissolved organic C (DOC) content was higher under organic management than under reduced-tillage and conventional management. Perennial legume crops and organic soil amendments in the organic crop rotation system apparently favored greater soil microbial substrate availability, as well as more microbial biomass compared with other management systems that had fewer legume crops in rotation and synthetic fertilizer applications. Among the forage production management systems with equivalent crop rotations, reduced-tillage management had higher microbial substrate availability and greater microbial biomass than other management systems. Combined crop rotation, tillage management, soil amendments, and legume crops in rotations considerably influenced soil microbiotic properties. More research will expand our understanding of combined effects of these alternatives on feedbacks between soil microbiotic properties and SOC accrual.	[Ghimire, Rajan; Norton, Jay B.; Stahl, Peter D.] Univ Wyoming, Dept Ecosyst Sci & Management, Laramie, WY 82071 USA; [Norton, Urszula] Univ Wyoming, Dept Plant Sci, Laramie, WY 82071 USA	University of Wyoming; University of Wyoming	Norton, JB (corresponding author), Univ Wyoming, Dept Ecosyst Sci & Management, Laramie, WY 82071 USA.	jnorton4@uwyo.edu	Norton, Urszula/AAX-6303-2021; Ghimire, Rajan/D-6947-2011; Ghimire, Rajan/AAF-6487-2020	Ghimire, Rajan/0000-0002-6962-6066	USDA National Institute of Food and Agriculture [2009-55618-05097]	USDA National Institute of Food and Agriculture(United States Department of Agriculture (USDA))	Agricultural Prosperity for Small and Medium-Sized Farms Competitive Grant no. 2009-55618-05097 from the USDA National Institute of Food and Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Martinez V., 2010, Diversity, V2, P910; Acosta-Martinez V, 2007, APPL SOIL ECOL, V37, P41, DOI 10.1016/j.apsoil.2007.03.009; Bailey VL, 2002, SOIL BIOL BIOCHEM, V34, P997, DOI 10.1016/S0038-0717(02)00033-0; Berthrong ST, 2013, MICROB ECOL, V66, P158, DOI 10.1007/s00248-013-0225-0; Blake G. R., 1986, Methods of soil analysis. Part 1. Physical and mineralogical methods, P377; Blanco-Canqui H, 2007, SOIL SCI SOC AM J, V71, P1770, DOI 10.2136/sssaj2007.0048; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Buyer JS, 2002, CAN J MICROBIOL, V48, P955, DOI [10.1139/w02-095, 10.1139/W02-095]; Carpenter-Boggs L, 2003, SOIL TILL RES, V71, P15, DOI 10.1016/S0167-1987(02)00158-7; Delate K, 2004, AGRON J, V96, P1288, DOI 10.2134/agronj2004.1288; DEVOS P, 1985, INT J SYST BACTERIOL, V35, P169, DOI 10.1099/00207713-35-2-169; DRINKWATER LE, 1995, ECOL APPL, V5, P1098, DOI 10.2307/2269357; Fierer N, 2003, SOIL BIOL BIOCHEM, V35, P167, DOI 10.1016/S0038-0717(02)00251-1; Fliessbach A, 2007, AGR ECOSYST ENVIRON, V118, P273, DOI 10.1016/j.agee.2006.05.022; Frey SD, 1999, SOIL BIOL BIOCHEM, V31, P573, DOI 10.1016/S0038-0717(98)00161-8; FROSTEGARD A, 1991, J MICROBIOL METH, V14, P151, DOI 10.1016/0167-7012(91)90018-L; Gardner W. H., 1986, Methods of soil analysis. Part 1. Physical and mineralogical methods, P493; Gee G.W., 1986, METHODS SOIL ANAL PA, P383; Ghimire R, 2014, PLANT SOIL, V374, P173, DOI 10.1007/s11104-013-1854-2; Ghimire R, 2013, RENEW AGR FOOD SYST, V28, P183, DOI 10.1017/S1742170512000208; Halvorson AD, 2002, SOIL SCI SOC AM J, V66, P906, DOI 10.2136/sssaj2002.0906; Jastrow JD, 2007, CLIMATIC CHANGE, V80, P5, DOI 10.1007/s10584-006-9178-3; JENKINSON DS, 1989, SOIL BIOL BIOCHEM, V21, P535, DOI 10.1016/0038-0717(89)90127-2; Kandeler E, 1999, BIOL FERT SOILS, V28, P343, DOI 10.1007/s003740050502; KRALL J M, 1991, Journal of Agronomic Education, V20, P120; Liebig M, 2006, RENEW AGR FOOD SYST, V21, P36, DOI 10.1079/RAF2005124; LINN DM, 1984, SOIL SCI SOC AM J, V48, P1267, DOI 10.2136/sssaj1984.03615995004800060013x; Minoshima H, 2007, SOIL SCI SOC AM J, V71, P952, DOI 10.2136/sssaj2006.0174; Ngosong C, 2010, APPL SOIL ECOL, V46, P134, DOI 10.1016/j.apsoil.2010.07.004; Nie M, 2013, ECOL LETT, V16, P234, DOI 10.1111/ele.12034; Norton JB, 2012, SOIL SCI SOC AM J, V76, P505, DOI 10.2136/sssaj2011.0284; Oehl F, 2003, APPL ENVIRON MICROB, V69, P2816, DOI 10.1128/AEM.69.5.2816-2824.2003; Reganold JP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012346; Schaad N. W., 2001, LAB GUIDE IDENTIFICA, V3rd, P1; Shannon C.E, 1949, MATH THEORY COMMUNIC, V1st; Sherrod LA, 2002, SOIL SCI SOC AM J, V66, P299, DOI 10.2136/sssaj2002.0299; Shi YC, 2012, APPL SOIL ECOL, V62, P14, DOI 10.1016/j.apsoil.2012.07.004; Six J, 2002, AGRONOMIE, V22, P755, DOI 10.1051/agro:2002043; Soil Survey Staff, 2013, WEB SOIL SURV; Stahl PD, 1999, BIOL FERT SOILS, V29, P92, DOI 10.1007/s003740050530; Stout J.D., 1980, Advances in Microbial Ecology, V4, P1; Strickland MS, 2010, SOIL BIOL BIOCHEM, V42, P1385, DOI 10.1016/j.soilbio.2010.05.007; Thomas G. W., 1996, Methods of soil analysis. Part 3 - chemical methods., P475; Western Regional Climate Center, 2013, HIST CLIM INF	44	52	54	6	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103901	10.1371/journal.pone.0103901	http://dx.doi.org/10.1371/journal.pone.0103901			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25090235	Green Published, gold, Green Submitted			2022-12-27	WOS:000339812700062
J	Nassif, C; Gomes, AR; Peixoto, GHC; Chagas, MH; Soares, DD; Silami-Garcia, E; Drinkwater, EJ; Cannon, J; Marino, FE				Nassif, Camila; Gomes, Aline Regina; Peixoto, Gustavo H. C.; Chagas, Mauro Heleno; Soares, Danusa Dias; Silami-Garcia, Emerson; Drinkwater, Eric J.; Cannon, Jack; Marino, Frank E.			The Effect of Double - Blind Carbohydrate Ingestion during 60 km of Self-Paced Exercise in Warm Ambient Conditions	PLOS ONE			English	Article							CYCLING TIME TRIAL; ENDURANCE PERFORMANCE; PERCEIVED EXERTION; PROLONGED EXERCISE; HUMID CONDITIONS; AMINO-ACIDS; FATIGUE; INTENSITY; PLACEBO; HEAT	This study evaluated double blind ingestions of placebo (PLA) versus 6% carbohydrate (CHO) either as capsules (c) or beverage (b) during 60 km self-paced cycling in the heat (32 degrees C and 50% relative humidity). Ten well-trained males (mean +/- SD: 26 +/- 3 years; 64.5 +/- 7.7 kg and 70.7 +/- 8.8 ml.kg(-1).min(-1) maximal oxygen consumption) completed four separate 60 km time trials (TT) punctuated by 1 km sprints (14, 29, 44, 59 km) whilst ingesting either PLA(b) or PLA(c) or CHOb or CHOc. The TT was not different among treatments (PLA(b) 130.2 +/- 11.2 min, CHOb 140.5 +/- 18.1 min, PLA(c) 143.1 +/- 29.2 min, CHOc 137.3 +/- 20.1 min; P>0.05). Effect size (Cohen's d) for time was only moderate when comparing CHOb - PLA(b) (d = 0.68) and PLA(b) - PLA(c) (d = 0.57) whereas all other ES were 'trivial' to 'small'. Mean speed throughout the trial was significantly higher for PLA(b) only (P<0.05). Power output was only different (P<0.05) between the sprints and low intensity efforts within and across conditions. Core and mean skin temperatures were similar among trials. We conclude that CHO ingestion is of little or no benefit as a beverage compared with placebo during 60 km TT in the heat.	[Nassif, Camila; Drinkwater, Eric J.; Cannon, Jack; Marino, Frank E.] Charles Sturt Univ, Sch Human Movement Studies, Bathurst, NSW 2795, Australia; [Gomes, Aline Regina; Peixoto, Gustavo H. C.; Chagas, Mauro Heleno; Soares, Danusa Dias; Silami-Garcia, Emerson] Univ Fed Minas Gerais, Sch Phys Educ Physiotherapy & Occupat Therapy, Belo Horizonte, MG, Brazil	Charles Sturt University; Universidade Federal de Minas Gerais	Marino, FE (corresponding author), Charles Sturt Univ, Sch Human Movement Studies, Bathurst, NSW 2795, Australia.	fmarino@csu.edu.au	Soares, Danusa/H-1385-2012; Soares, Danusa/AAW-1915-2021; Chagas, Mauro Heleno/AAU-4932-2020; Garcia, Emerson S/C-6147-2013; Marino, Frank/AAD-2546-2020; Chagas, Mauro/E-6008-2015; Drinkwater, Eric/B-8313-2019	Soares, Danusa/0000-0002-5705-8890; Chagas, Mauro Heleno/0000-0002-1955-8990; Garcia, Emerson S/0000-0003-0793-2727; Chagas, Mauro/0000-0002-1955-8990; Drinkwater, Eric/0000-0002-9594-9360; Cannon, Jack/0000-0002-1540-8856	Federal University of Minas Gerais	Federal University of Minas Gerais	Funding from Charles Sturt University & Federal University of Minas Gerais. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARIEL G, 1972, MED SCI SPORT EXER, V4, P124; BELOW PR, 1995, MED SCI SPORT EXER, V27, P200; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Burke LM, 2001, COMP BIOCHEM PHYS A, V128, P735, DOI 10.1016/S1095-6433(01)00279-3; Burke LM, 2000, J APPL PHYSIOL, V88, P1284, DOI 10.1152/jappl.2000.88.4.1284; Carter JM, 2004, MED SCI SPORT EXER, V36, P2107, DOI 10.1249/01.MSS.0000147585.65709.6F; Chambers ES, 2009, J PHYSIOL-LONDON, V587, P1779, DOI 10.1113/jphysiol.2008.164285; Clark VR, 2000, MED SCI SPORT EXER, V32, P1642; Desbrow B, 2004, INT J SPORT NUTR EXE, V14, P541, DOI 10.1123/ijsnem.14.5.541; ElSayed MS, 1997, J SPORT SCI, V15, P223, DOI 10.1080/026404197367506; Galloway SDR, 2000, J SPORT SCI, V18, P339, DOI 10.1080/026404100402403; Gant N, 2010, BRAIN RES, V1350, P151, DOI 10.1016/j.brainres.2010.04.004; Jentjens RLPG, 2003, EUR J APPL PHYSIOL, V88, P444, DOI 10.1007/s00421-002-0727-9; Jeukendrup A, 1996, MED SCI SPORT EXER, V28, P266, DOI 10.1097/00005768-199602000-00017; Jeukendrup AE, 2008, EUR J APPL PHYSIOL, V104, P831, DOI 10.1007/s00421-008-0838-z; Kay D, 2001, EUR J APPL PHYSIOL, V84, P115, DOI 10.1007/s004210000340; Lacerda ACR, 2009, J STRENGTH COND RES, V23, P1276, DOI 10.1519/JSC.0b013e3181965ddc; Madsen K, 1996, J APPL PHYSIOL, V81, P2644, DOI 10.1152/jappl.1996.81.6.2644; Marino FE, 2012, COMP EXERC PHYSIOL, V8, P3, DOI 10.3920/CEP11012; Marino FE, 2010, BRIT J SPORT MED, V44, P961, DOI 10.1136/bjsm.2009.054973; Marino FE, 2004, J APPL PHYSIOL, V96, P124, DOI 10.1152/japplphysiol.00582.2003; MCLELLAN TM, 1995, CAN J APPL PHYSIOL, V20, P39, DOI 10.1139/h95-003; MILLARDSTAFFORD ML, 1992, MED SCI SPORT EXER, V24, P934; Nassif C, 2008, J SCI MED SPORT, V11, P72, DOI 10.1016/j.jsams.2007.08.015; Newsholme EA, 1996, EXPERIENTIA, V52, P413, DOI 10.1007/BF01919308; Noakes TD, 2004, J APPL PHYSIOL, V96, P1571, DOI 10.1152/japplphysiol.01124.2003; Nybo L, 2001, J APPL PHYSIOL, V91, P1055, DOI 10.1152/jappl.2001.91.3.1055; Phillips SM, 2014, J SPORT SCI MED, V13, P252; Ramanathan LN, 1964, J APPL PHYSIOL, V19, P531; Tucker R, 2006, J PHYSIOL-LONDON, V574, P905, DOI 10.1113/jphysiol.2005.101733; Watson P, 2012, MED SCI SPORT EXER, V44, P336, DOI 10.1249/MSS.0b013e31822dc5ed	31	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2014	9	8							e104710	10.1371/journal.pone.0104710	http://dx.doi.org/10.1371/journal.pone.0104710			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WB	25110952	Green Published, gold			2022-12-27	WOS:000341105100091
J	Castro, RAO; Silva-Barcellos, NM; Licio, CSA; Souza, JB; Souza-Testasicca, MC; Ferreira, FM; Batista, MA; Silveira-Lemos, D; Moura, SL; Frezard, F; Rezende, SA				Castro, Renata A. O.; Silva-Barcellos, Neila M.; Licio, Carolina S. A.; Souza, Janine B.; Souza-Testasicca, Miriam C.; Ferreira, Flavia M.; Batista, Mauricio A.; Silveira-Lemos, Denise; Moura, Sandra L.; Frezard, Frederic; Rezende, Simone A.			Association of Liposome-Encapsulated Trivalent Antimonial with Ascorbic Acid: An Effective and Safe Strategy in the Treatment of Experimental Visceral Leishmaniasis	PLOS ONE			English	Article							MEGLUMINE ANTIMONIATE; ARSENIC TRIOXIDE; IMMUNE-RESPONSE; BONE-MARROW; GLUTATHIONE; DONOVANI; SIZE; METABOLISM; SYSTEMS; LIVER	Background:: Visceral leishmaniasis (VL) is a chronic debilitating disease endemic in tropical and subtropical areas, caused by protozoan parasites of the genus Leishmania. Annually, it is estimated the occurrence of 0.2 to 0.4 million new cases of the disease worldwide. Considering the lack of an effective vaccine the afflicted population must rely on both, an accurate diagnosis and successful treatment to combat the disease. Here we propose to evaluate the efficacy of trivalent antimonial encapsulated in conventional liposomes, in association with ascorbic acid, by monitoring its toxicity and efficacy in BALB/c mice infected with Leishmania infantum. Methodology/Principal Findings:: Infected mice were subjected to single-dose treatments consisting in the administration of either free or liposome-encapsulated trivalent antimony (SbIII), in association or not with ascorbic acid. Parasite burden was assessed in the liver, spleen and bone marrow using the serial limiting dilution technique. After treatment, tissue alterations were examined by histopathology of liver, heart and kidney and confirmed by serum levels of classic biomarkers. The phenotypic profile of splenocytes was also investigated by flow cytometry. Treatment with liposome-encapsulated SbIII significantly reduced the parasite burden in the liver, spleen and bone marrow. Co-administration of ascorbic acid, with either free SbIII or its liposomal form, did not interfere with its leishmanicidal activity and promoted reduced toxicity particularly to the kidney and liver tissues. Conclusions/Significance:: Among the evaluated posological regimens treatment of L. infantum-infected mice with liposomal SbIII, in association with ascorbic acid, represented the best alternative as judged by its high leishmanicidal activity and absence of detectable toxic effects. Of particular importance, reduction of parasite burden in the bone marrow attested to the ability of SbIII-carrying liposomes to efficiently reach this body compartment.	[Castro, Renata A. O.; Silva-Barcellos, Neila M.; Licio, Carolina S. A.; Souza, Janine B.; Ferreira, Flavia M.; Rezende, Simone A.] Univ Fed Ouro Preto, Programa Posgrad Ciencias Farmaceut Cipharma, Ouro Preto, MG, Brazil; [Souza-Testasicca, Miriam C.] Inst Fed Minas Gerais, Coordenadoria Area Ciencias Biol, Ouro Preto, MG, Brazil; [Batista, Mauricio A.; Silveira-Lemos, Denise; Moura, Sandra L.] Univ Fed Ouro Preto, Programa Posgrad Ciencias Biol NUPEB, Ouro Preto, MG, Brazil; [Frezard, Frederic] Univ Fed Minas Gerais, Dept Fisiol & Biofis, Belo Horizonte, MG, Brazil	Universidade Federal de Ouro Preto; Instituto Federal de Educacao, Ciencia e Tecnologia de Minas Gerais (IFMG); Universidade Federal de Ouro Preto; Universidade Federal de Minas Gerais	Rezende, SA (corresponding author), Univ Fed Ouro Preto, Programa Posgrad Ciencias Farmaceut Cipharma, Ouro Preto, MG, Brazil.	rezende@ef.ufop.br	de Moura, Sandra Aparecida Lima/AAW-3214-2021; Frezard, Frederic/Q-7714-2019; Souza-Testasicca, Miriam Conceição/ABG-6651-2021	Frezard, Frederic/0000-0003-3783-5717; Souza-Testasicca, Miriam Conceição/0000-0001-7010-3118; Silveira Lemos, Denise/0000-0003-0955-458X	"Fundacao de Amparo a Pesquisa de Minas Gerais" (FAPEMIG) [REDE-40/11, APQ-01327-09, APQ-00780-12, 297491]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	"Fundacao de Amparo a Pesquisa de Minas Gerais" (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by "Fundacao de Amparo a Pesquisa de Minas Gerais" at http://www.fapemig.br (FAPEMIG, grant numbers REDE-40/11, APQ-01327-09, APQ-00780-12, and 297491). FF is a recipient of a research fellowship from the "Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq).'' The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Andersen EM, 2005, AM J TROP MED HYG, V72, P133, DOI 10.4269/ajtmh.2005.72.133; Awasthi A, 2004, INDIAN J MED RES, V119, P238; Bachleitner-Hofmann T, 2001, BRIT J HAEMATOL, V112, P783, DOI 10.1046/j.1365-2141.2001.02608.x; Bahlis NJ, 2002, CLIN CANCER RES, V8, P3658; Bajaj G, 2010, PHARM RES-DORDR, V27, P735, DOI 10.1007/s11095-009-0031-z; Biyani N, 2011, MOL BIOCHEM PARASIT, V180, P76, DOI 10.1016/j.molbiopara.2011.08.005; Carrion J, 2006, PARASITE IMMUNOL, V28, P173, DOI 10.1111/j.1365-3024.2006.00817.x; CARTER KC, 1989, J PHARM PHARMACOL, V41, P87, DOI 10.1111/j.2042-7158.1989.tb06399.x; Chappuis F, 2007, NAT REV MICROBIOL, V5, P873, DOI 10.1038/nrmicro1748; Croft SL, 2001, TROP MED INT HEALTH, V6, P899, DOI 10.1046/j.1365-3156.2001.00754.x; CUNNINGHAM ML, 1995, EUR J BIOCHEM, V230, P460, DOI 10.1111/j.1432-1033.1995.tb20583.x; Demicheli C, 2008, CHEM COMMUN, P4828, DOI 10.1039/b809186b; DERKSEN JTP, 1988, BIOCHIM BIOPHYS ACTA, V971, P127, DOI 10.1016/S0005-2728(88)80099-9; Frezard F, 2005, QUIM NOVA, V28, P511, DOI 10.1590/S0100-40422005000300025; Frezard F, 2001, ANTIMICROB AGENTS CH, V45, P913, DOI 10.1128/AAC.45.3.913-916.2001; Frezard F, 2010, EXPERT OPIN DRUG DEL, V7, P1343, DOI 10.1517/17425247.2010.529897; Frezard F, 2009, MOLECULES, V14, P2317, DOI 10.3390/molecules14072317; Gebel T, 1997, CHEM-BIOL INTERACT, V107, P131, DOI 10.1016/S0009-2797(97)00087-2; GREGORIADIS G, 1972, BIOCHEM J, V129, P123, DOI 10.1042/bj1290123; Hantson P, 2000, PHARMACOTHERAPY, V20, P1141, DOI 10.1592/phco.20.13.1141.35032; HARASHIMA H, 1992, BIOPHARM DRUG DISPOS, V13, P549, DOI 10.1002/bdd.2510130708; Herwaldt BL, 1999, LANCET, V354, P1191, DOI 10.1016/S0140-6736(98)10178-2; HIRANO K, 1985, J PHARM SCI, V74, P915, DOI 10.1002/jps.2600740902; Hunter DG, 1998, BIOPHYS J, V74, P2996, DOI 10.1016/S0006-3495(98)78006-3; Kato KC, 2014, ANTIMICROB AGENTS CH, V58, P481, DOI 10.1128/AAC.01499-13; Lambertz U, 2012, J LEUKOCYTE BIOL, V91, P887, DOI 10.1189/jlb.0611326; Marques-da-Silva EA, 2005, PARASITOL RES, V98, P67, DOI 10.1007/s00436-005-0008-8; MAYER LD, 1985, BIOCHIM BIOPHYS ACTA, V817, P193, DOI 10.1016/0005-2736(85)90084-7; McConville MJ, 2007, TRENDS PARASITOL, V23, P368, DOI 10.1016/j.pt.2007.06.009; Moghimi SM, 2012, J INNATE IMMUN, V4, P509, DOI 10.1159/000339153; NAYAR R, 1989, BIOCHIM BIOPHYS ACTA, V986, P200, DOI 10.1016/0005-2736(89)90468-9; NEW RRC, 1978, NATURE, V272, P55, DOI 10.1038/272055a0; Ribeiro RR, 2008, ANTIMICROB AGENTS CH, V52, P2564, DOI 10.1128/AAC.00223-08; Salaun P, 2013, ANAL BIOANAL CHEM, V405, P5201, DOI 10.1007/s00216-013-6947-5; Schettini DA, 2006, INT J PHARMACEUT, V315, P140, DOI 10.1016/j.ijpharm.2006.01.048; Serafim TD, 2010, MEM I OSWALDO CRUZ, V105, P811, DOI 10.1590/S0074-02762010000600014; Shio MT, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/819512; Singh S, 2007, J ENVIRON BIOL, V28, P377; Sohini, 2007, INDIAN J EXP BIOL, V45, P371; Sun HZ, 2000, EUR J BIOCHEM, V267, P5450, DOI 10.1046/j.1432-1327.2000.01605.x; Sundar S, 2010, NEW ENGL J MED, V362, P504, DOI 10.1056/NEJMoa0903627; Therien HM, 1996, BBA-BIOMEMBRANES, V1280, P91, DOI 10.1016/0005-2736(95)00282-0; TITUS RG, 1985, PARASITE IMMUNOL, V7, P545, DOI 10.1111/j.1365-3024.1985.tb00098.x; Wortmann G, 2002, CLIN INFECT DIS, V35, P261, DOI 10.1086/341406; Wyllie S, 2004, J BIOL CHEM, V279, P39925, DOI 10.1074/jbc.M405635200	46	16	16	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2014	9	8							e104055	10.1371/journal.pone.0104055	http://dx.doi.org/10.1371/journal.pone.0104055			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR0CG	25105501	Green Published, gold			2022-12-27	WOS:000343231900035
J	Faulk, C; Barks, A; Sanchez, BN; Zhang, ZZ; Anderson, OS; Peterson, KE; Dolinoy, DC				Faulk, Christopher; Barks, Amanda; Sanchez, Brisa N.; Zhang, Zhenzhen; Anderson, Olivia S.; Peterson, Karen E.; Dolinoy, Dana C.			Perinatal Lead (Pb) Exposure Results in Sex-Specific Effects on Food Intake, Fat, Weight, and Insulin Response across the Murine Life-Course	PLOS ONE			English	Article							EPIGENETIC GENE-REGULATION; MATERNAL BONE-LEAD; DIETARY LEAD; FEMALE MICE; CHILDREN; HEALTH; ASSOCIATION; OBESITY; ONSET; TOXICITY	Developmental lead (Pb) exposure has been associated with lower body weight in human infants and late onset obesity in mice. We determined the association of perinatal Pb exposure in mice with changes in obesity-related phenotypes into adulthood. Mice underwent exposure via maternal drinking water supplemented with 0 (control), 2.1 (low), 16 (medium), or 32 (high) ppm Pb-acetate two weeks prior to mating through lactation. Offspring were phenotyped at ages 3, 6, and 9 months for energy expenditure, spontaneous activity, food intake, body weight, body composition, and at age 10 months for glucose tolerance. Data analyses were stratified by sex and adjusted for litter effects. Exposed females and males exhibited increased energy expenditure as compared to controls (p<0.0001 for both). In females, horizontal activity differed significantly from controls (p = 0.02) over the life-course. Overall, food intake increased in exposed females and males (p<0.0008 and p<0.0001, respectively) with significant linear trends at 9 months in females (p = 0.01) and 6 months in males (p<0.01). Body weight was significantly increased in males at the medium and high exposures (p = 0.001 and p = 0.006). Total body fat differed among exposed females and males (p<0.0001 and p<0.0001, respectively). Insulin response was significantly increased in medium exposure males (p<0.05). Perinatal Pb exposure at blood lead levels between 4.1 mg/dL and 32 mg/dL is associated with increased food intake, body weight, total body fat, energy expenditure, activity, and insulin response in mice. Physiological effects of developmental Pb exposure persist and vary according to sex and age.	[Faulk, Christopher; Barks, Amanda; Anderson, Olivia S.; Peterson, Karen E.; Dolinoy, Dana C.] Univ Michigan, Sch Publ Hlth, Dept Environm Hlth Sci, Ann Arbor, MI 48109 USA; [Sanchez, Brisa N.; Zhang, Zhenzhen] Univ Michigan, Sch Publ Hlth, Dept Biostat, Ann Arbor, MI 48109 USA; [Peterson, Karen E.] Univ Michigan, Ctr Human Growth & Dev, Ann Arbor, MI 48109 USA; [Peterson, Karen E.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Harvard University; Harvard T.H. Chan School of Public Health	Dolinoy, DC (corresponding author), Univ Michigan, Sch Publ Hlth, Dept Environm Hlth Sci, Ann Arbor, MI 48109 USA.	ddolinoy@umich.edu		Barks, Amanda/0000-0002-4807-2818; Faulk, Christopher/0000-0002-9749-9658	University of Michigan, National Institute of Environmental Health Sciences (NIEHS); US Environmental Protection Agency as a Children's Environmental Health Formative Center [P20: ES018171/RD834800]; Michigan Nutrition and Obesity Research Center (MNORC) [P30 DK089503]; UM NIEHS Core Center [P30 ES017885]; UM NIEHS Institutional Training Grant [T32 ES007062]; NIEHS [K99 ES022221]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK089503] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [K99ES022221, T32ES007062, P30ES017885, R00ES022221, P20ES018171] Funding Source: NIH RePORTER	University of Michigan, National Institute of Environmental Health Sciences (NIEHS); US Environmental Protection Agency as a Children's Environmental Health Formative Center; Michigan Nutrition and Obesity Research Center (MNORC); UM NIEHS Core Center; UM NIEHS Institutional Training Grant; NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the University of Michigan's joint grant from the National Institute of Environmental Health Sciences (NIEHS) and US Environmental Protection Agency as a Children's Environmental Health Formative Center P20: ES018171/RD834800 (authors BS, KEP and DD). https://www.niehs.nih.gov and http://www.epa.gov. This work was also supported by the Michigan Nutrition and Obesity Research Center (MNORC) P30 DK089503 (authors KEP and DD) as well as the UM NIEHS Core Center P30 ES017885 (authors BS, KEP and DD), the UM NIEHS Institutional Training Grant T32 ES007062 (author CF), and NIEHS Grant K99 ES022221 (author CF). http://mmoc.med.umich.edu and http://niehs.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afeiche M, 2012, J PEDIATR-US, V160, P1044, DOI 10.1016/j.jpeds.2011.12.022; Afeiche M, 2011, ENVIRON HEALTH PERSP, V119, P1436, DOI 10.1289/ehp.1003184; Anderson OS, 2013, FASEB J, V27, P1784, DOI 10.1096/fj.12-223545; Barker DJP, 2004, J AM COLL NUTR, V23, p588S, DOI 10.1080/07315724.2004.10719428; Bateson P, 2004, NATURE, V430, P419, DOI 10.1038/nature02725; Betts KS, 2012, ENVIRON HEALTH PERSP, V120, pA268, DOI 10.1289/ehp.120-a268; Bihaqi SW, 2011, J ALZHEIMERS DIS, V27, P819, DOI 10.3233/JAD-2011-111013; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Bridbord K, 2009, ENVIRON HEALTH PERSP, V117, P1195, DOI 10.1289/ehp.0800534; Cederroth CR, 2007, ENVIRON HEALTH PERSP, V115, P1467, DOI 10.1289/ehp.10413; Faulk C, 2013, EPIGENOMICS-UK, V5, P487, DOI 10.2217/epi.13.49; Flora Gagan, 2012, Interdiscip Toxicol, V5, P47, DOI 10.2478/v10102-012-0009-2; Gilbert SG, 2006, NEUROTOXICOLOGY, V27, P693, DOI 10.1016/j.neuro.2006.06.008; Gollenberg AL, 2010, ENVIRON HEALTH PERSP, V118, P1782, DOI 10.1289/ehp.1001943; GonzalezCossio T, 1997, PEDIATRICS, V100, P856, DOI 10.1542/peds.100.5.856; Goodell S, 1998, MECH AGEING DEV, V101, P245, DOI 10.1016/S0047-6374(97)00182-6; Gulson BL, 2003, SCI TOTAL ENVIRON, V303, P79, DOI 10.1016/S0048-9697(02)00355-8; Guo J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005370; Haider S, 2013, METAB BRAIN DIS, V28, P85, DOI 10.1007/s11011-012-9374-y; Hernandez-Avila M, 2002, ARCH ENVIRON HEALTH, V57, P482, DOI 10.1080/00039890209601441; Hu H, 1998, ENVIRON HEALTH PERSP, V106, P1, DOI 10.2307/3433626; Huzior-Balajewicz A, 2001, Przegl Lek, V58, P315; Iavicoli I, 2006, REPROD TOXICOL, V22, P586, DOI 10.1016/j.reprotox.2006.03.016; Iavicoli I, 2004, REPROD TOXICOL, V19, P35, DOI 10.1016/j.reprotox.2004.06.013; Jacobs DE, 2002, ENVIRON HEALTH PERSP, V110, pA599, DOI 10.1289/ehp.021100599; KIM R, 1995, ENVIRON HEALTH PERSP, V103, P952, DOI 10.2307/3432741; Leasure JL, 2008, ENVIRON HEALTH PERSP, V116, P355, DOI 10.1289/ehp.10862; Li G, 2013, DIABETES; Little BB, 2009, ANN HUM BIOL, V36, P331, DOI 10.1080/03014460902806615; Meyer PA, 2008, MUTAT RES-REV MUTAT, V659, P166, DOI 10.1016/j.mrrev.2008.03.003; Morgan HD, 1999, NAT GENET, V23, P314, DOI 10.1038/15490; Muntner P, 2005, ARCH INTERN MED, V165, P2155, DOI 10.1001/archinte.165.18.2155; Padilla MA, 2010, INT J ENV RES PUB HE, V7, P3332, DOI 10.3390/ijerph7093332; Pinn VW, 2010, J WOMENS HEALTH, V19, P1603, DOI 10.1089/jwh.2010.2386; Research IfLA, 1966, GUIDE CARE USE LAB A; Ronco AM, 2010, BIOL TRACE ELEM RES, V136, P269, DOI 10.1007/s12011-009-8546-z; Schneider JS, 2013, TOXICOL LETT, V217, P75, DOI 10.1016/j.toxlet.2012.12.004; Snyder JE, 2000, TOXICOL SCI, V57, P87, DOI 10.1093/toxsci/57.1.87; Stewart PW, 1998, PHARMACOL BIOCHEM BE, V59, P183, DOI 10.1016/S0091-3057(97)00412-7; Struzynska L, 1997, ACTA NEUROBIOL EXP, V57, P275; TURNER RC, 1979, METABOLISM, V28, P1086, DOI 10.1016/0026-0495(79)90146-X; Waterland RA, 2003, MOL CELL BIOL, V23, P5293, DOI 10.1128/MCB.23.15.5293-5300.2003; Weinhouse C, 2014, ENV HLTH PERSPECT; Zhang AM, 2012, ENVIRON HEALTH PERSP, V120, P445, DOI 10.1289/ehp.1103736	44	51	52	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2014	9	8							e104273	10.1371/journal.pone.0104273	http://dx.doi.org/10.1371/journal.pone.0104273			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR0CG	25105421	Green Published, gold, Green Submitted			2022-12-27	WOS:000343231900048
J	Hu, J; Hardy, C; Chen, CM; Yang, S; Voloshin, AS; Liu, YL				Hu, Jia; Hardy, Camille; Chen, Chi-Mon; Yang, Shu; Voloshin, Arkady S.; Liu, Yaling			Enhanced Cell Adhesion and Alignment on Micro-Wavy Patterned Surfaces	PLOS ONE			English	Article							MAMMALIAN-CELLS; FIBROBLASTS; MIGRATION; GUIDANCE; BEHAVIOR	Various micropatterns have been fabricated and used to regulate cell adhesion, morphology and function. Micropatterns created by standard photolithography process are usually rectangular channels with sharp corners (microgrooves) which provide limited control over cells and are not favorable for cell-cell interaction and communication. This paper proposes a new micropattern with smooth wavy surfaces (micro-waves) to control the position and orientation of cells. To characterize cell growth and responses on the micro-patterned substrates, bovine aortic endothelial cells were seeded onto surfaces with micro-grooves and micro-waves for 24 h. As a result, the cells on the micro-wavy pattern appeared to have a lower death rate and better alignment compared to those on the micro-grooved pattern. In addition, flow-induced shear stress was applied to examine the adhesion strength of cells on the micro-wavy pattern. Results showed that cells adhered to the wavy surface displayed both improved alignment and adhesion strength compared to those on the flat surface. The combination of increased alignment, lower death rate and enhanced adhesion strength of cells on the micro-wavy patterns will offer advantages in potential applications for cell phenotype, proliferation and tissue engineering.	[Hu, Jia; Voloshin, Arkady S.; Liu, Yaling] Lehigh Univ, Dept Mech Engn & Mech, Bethlehem, PA 18015 USA; [Hardy, Camille; Voloshin, Arkady S.; Liu, Yaling] Lehigh Univ, Bioengn Program, Bethlehem, PA 18015 USA; [Chen, Chi-Mon; Yang, Shu] Univ Penn, Dept Mat Sci, Philadelphia, PA 19104 USA	Lehigh University; Lehigh University; University of Pennsylvania	Liu, YL (corresponding author), Lehigh Univ, Dept Mech Engn & Mech, Bethlehem, PA 18015 USA.	yal310@lehigh.edu	Voloshin, Arkady/AGF-8884-2022; Liu, Yaling/F-5790-2010; Yang, Shu/D-9758-2011	Yang, Shu/0000-0001-8834-3320; Voloshin, Arkady/0000-0003-1448-3229; Liu, Yaling/0000-0002-4519-3358	National Science Foundation (NSF) CAREER [CBET-1113040]; NSF [CBET-1264808]; National Institute of Health (NIH) [EB015105]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R15EB015105] Funding Source: NIH RePORTER; Directorate For Engineering [1263940] Funding Source: National Science Foundation	National Science Foundation (NSF) CAREER(National Science Foundation (NSF)NSF - Office of the Director (OD)); NSF(National Science Foundation (NSF)); National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	The supports of this work are from National Science Foundation (NSF) CAREER grant CBET-1113040, NSF CBET-1264808, and National Institute of Health (NIH) grant EB015105. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DEJ, 2011, ANN BIOMED ENG, V39, P2329, DOI 10.1007/s10439-011-0352-z; Baker BM, 2012, J CELL SCI, V125, P3015, DOI 10.1242/jcs.079509; Baumann K, 2010, NAT REV MOL CELL BIO, V11, P465, DOI 10.1038/nrm2925; BHATIA SN, 1994, ANN NY ACAD SCI, V745, P187; Bowden N, 1999, APPL PHYS LETT, V75, P2557, DOI 10.1063/1.125076; Chang S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088089; Charest JL, 2005, J VAC SCI TECHNOL B, V23, P3011, DOI 10.1116/1.2127951; Chaw KC, 2007, BIOMED MICRODEVICES, V9, P597, DOI 10.1007/s10544-007-9071-5; Choudhury D, 2011, BIOMICROFLUIDICS, V5, DOI 10.1063/1.3593407; CLARK P, 1987, DEVELOPMENT, V99, P439; CURTIS ASG, 1964, J NATL CANCER I, V33, P15; De Silva MN, 2006, BIOTECHNOL BIOENG, V93, P919, DOI 10.1002/bit.20787; Doyle AD, 2009, J CELL BIOL, V184, P481, DOI 10.1083/jcb.200810041; Eddings MA, 2008, J MICROMECH MICROENG, V18, DOI 10.1088/0960-1317/18/6/067001; Feinberg AW, 2008, J BIOMED MATER RES A, V86A, P522, DOI 10.1002/jbm.a.31626; Fu G, 2009, MAT SCI ENG C-MATER, V29, P2011, DOI 10.1016/j.msec.2009.03.017; Hakkinen KM, 2011, TISSUE ENG PT A, V17, P713, DOI 10.1089/ten.TEA.2010.0273; HAMMARBACK JA, 1985, J NEUROSCI RES, V13, P213, DOI 10.1002/jnr.490130115; Harrison RG, 1911, SCIENCE, V34, P279, DOI 10.1126/science.34.870.279; HEALY KE, 1994, BIOTECHNOL BIOENG, V43, P792, DOI 10.1002/bit.260430814; Ho CT, 2006, LAB CHIP, V6, P724, DOI 10.1039/b602036d; Hsiao AY, 2009, BIOMATERIALS, V30, P3020, DOI 10.1016/j.biomaterials.2009.02.047; Hu W, 2005, J VAC SCI TECHNOL B, V23, P2984, DOI 10.1116/1.2121729; Huang ZY, 2005, J MECH PHYS SOLIDS, V53, P2101, DOI 10.1016/j.jmps.2005.03.007; James CD, 1998, LANGMUIR, V14, P741, DOI 10.1021/la9710482; Khare K, 2009, LANGMUIR, V25, P12794, DOI 10.1021/la901736n; Kim DH, 2010, P NATL ACAD SCI USA, V107, P565, DOI 10.1073/pnas.0906504107; Lam MT, 2008, BIOMATERIALS, V29, P1705, DOI 10.1016/j.biomaterials.2007.12.010; Lee PJ, 2007, BIOTECHNOL BIOENG, V97, P1340, DOI 10.1002/bit.21360; LHEUREUX N, 1993, J VASC SURG, V17, P499, DOI 10.1016/0741-5214(93)90150-K; Lin PC, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2743939; Martinez E, 2009, ANN ANAT, V191, P126, DOI 10.1016/j.aanat.2008.05.006; NIELSEN DH, 1984, PHYS THER, V64, P126; Nigro P, 2011, ANTIOXID REDOX SIGN, V15, P1405, DOI 10.1089/ars.2010.3679; Nilsson J, 2009, ANAL CHIM ACTA, V649, P141, DOI 10.1016/j.aca.2009.07.017; Pawlowski KJ, 2004, FRONT BIOSCI-LANDMRK, V9, P1412, DOI 10.2741/1302; Peterbauer T, 2010, MACROMOL SYMP, V296, P272, DOI 10.1002/masy.201051038; Salber J, 2007, SMALL, V3, P1023, DOI 10.1002/smll.200600596; Satyanarayana S, 2005, J MICROELECTROMECH S, V14, P392, DOI 10.1109/JMEMS.2004.839334; Shein M, 2009, BIOMED MICRODEVICES, V11, P495, DOI 10.1007/s10544-008-9255-7; Stafford CM, 2004, NAT MATER, V3, P545, DOI 10.1038/nmat1175; Su WT, 2007, MICRON, V38, P278, DOI 10.1016/j.micron.2006.04.008; VANKOOTEN TG, 1992, BIOMATERIALS, V13, P897, DOI 10.1016/0142-9612(92)90112-2; Vunjak-Novakovic G, 1998, BIOTECHNOL PROGR, V14, P193, DOI 10.1021/bp970120j; Wang PY, 2010, BIOTECHNOL BIOENG, V106, P285, DOI 10.1002/bit.22697; Weiss P, 1934, J EXP ZOOL, V68, P393, DOI 10.1002/jez.1400680304; Wozniak MA, 2004, BBA-MOL CELL RES, V1692, P103, DOI 10.1016/j.bbamcr.2004.04.007; Yang J, 2003, J BIOMED MATER RES A, V67A, P1139, DOI 10.1002/jbm.a.10034; Young EWK, 2007, LAB CHIP, V7, P1759, DOI 10.1039/b712486d; Yuen PK, 2010, LAB CHIP, V10, P384, DOI 10.1039/b918089c; Zhu BS, 2004, BIOMATERIALS, V25, P4215, DOI 10.1016/j.biomaterials.2003.11.020	51	42	42	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2014	9	8							e104502	10.1371/journal.pone.0104502	http://dx.doi.org/10.1371/journal.pone.0104502			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR0CG	25105589	Green Submitted, gold, Green Published			2022-12-27	WOS:000343231900064
J	Zhao, F; Guo, XL; Wang, YJ; Liu, J; Lee, WH; Zhang, Y				Zhao, Feng; Guo, Xiaolong; Wang, Yanjie; Liu, Jie; Lee, Wen-hui; Zhang, Yun			Drug Target Mining and Analysis of the Chinese Tree Shrew for Pharmacological Testing	PLOS ONE			English	Article							MODEL; SYSTEM; QUANTIFICATION; INFECTION; VIRUS	The discovery of new drugs requires the development of improved animal models for drug testing. The Chinese tree shrew is considered to be a realistic candidate model. To assess the potential of the Chinese tree shrew for pharmacological testing, we performed drug target prediction and analysis on genomic and transcriptomic scales. Using our pipeline, 3,482 proteins were predicted to be drug targets. Of these predicted targets, 446 and 1,049 proteins with the highest rank and total scores, respectively, included homologs of targets for cancer chemotherapy, depression, age-related decline and cardiovascular disease. Based on comparative analyses, more than half of drug target proteins identified from the tree shrew genome were shown to be higher similarity to human targets than in the mouse. Target validation also demonstrated that the constitutive expression of the proteinase-activated receptors of tree shrew platelets is similar to that of human platelets but differs from that of mouse platelets. We developed an effective pipeline and search strategy for drug target prediction and the evaluation of model-based target identification for drug testing. This work provides useful information for future studies of the Chinese tree shrew as a source of novel targets for drug discovery research.	[Zhao, Feng; Guo, Xiaolong; Wang, Yanjie; Liu, Jie; Lee, Wen-hui; Zhang, Yun] Chinese Acad Sci, Kunming Inst Zool, Chinese Acad Sci & Yunnan Prov, Key Lab Anim Models & Human Dis Mech, Kunming, Yunnan, Peoples R China; [Zhao, Feng; Guo, Xiaolong; Liu, Jie] Univ Chinese Acad Sci, Kunming Coll Life Sci, Kunming, Yunnan, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhang, Y (corresponding author), Chinese Acad Sci, Kunming Inst Zool, Chinese Acad Sci & Yunnan Prov, Key Lab Anim Models & Human Dis Mech, Kunming, Yunnan, Peoples R China.	zhangy@mail.kiz.ac.cn		Zhang, Yun/0000-0002-8636-183X; Zhao, Feng/0000-0002-8309-0536	Chinese Academy of Sciences [KSCX2-EW-R-11, KSCX2-EW-J-23, KJZD-EW-L03]; National 863 project of China [2012AA021801, 2012AA022402]	Chinese Academy of Sciences(Chinese Academy of Sciences); National 863 project of China(National High Technology Research and Development Program of China)	This work was supported by grants from the Chinese Academy of Sciences (KSCX2-EW-R-11 and KSCX2-EW-J-23), the National 863 project of China (No. 2012AA021801, 2012AA022402), and the Key Research Program of the Chinese Academy of Sciences (KJZD-EW-L03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cheng AC, 2007, NAT BIOTECHNOL, V25, P71, DOI 10.1038/nbt1273; Chu XY, 2013, EXPERT OPIN DRUG MET, V9, P237, DOI 10.1517/17425255.2013.741589; Chua HN, 2011, J BIOL CHEM, V286, P23653, DOI 10.1074/jbc.R110.174797; Coppe A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-635; Fan Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2416; Fuchs E, 2005, CNS SPECTRUMS, V10, P182, DOI 10.1017/S1092852900010038; Horn F, 2001, NUCLEIC ACIDS RES, V29, P346, DOI 10.1093/nar/29.1.346; Kahn ML, 1998, NATURE, V394, P690, DOI 10.1038/29325; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kim DD, 2008, BLOOD, V112, P1109, DOI 10.1182/blood-2008-01-134304; Kim Y, 2011, BIOINFORMATICS, V27, P2772, DOI 10.1093/bioinformatics/btr445; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Li Sheng-An, 2012, Zoological Research, V33, P1, DOI 10.3724/SP.J.1141.2012.01001; Michelson AD, 2010, NAT REV DRUG DISCOV, V9, P154, DOI 10.1038/nrd2957; Norton TT, 2006, INVEST OPHTH VIS SCI, V47, P4700, DOI 10.1167/iovs.05-1641; Ortutay C, 2007, IMMUNOGENETICS, V59, P333, DOI 10.1007/s00251-007-0191-0; Peng YZ, 1991, BIOL CHINESE TREE SH; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ramachandran R, 2012, NAT REV DRUG DISCOV, V11, P69, DOI 10.1038/nrd3615; Rawlings ND, 2006, NUCLEIC ACIDS RES, V34, pD270, DOI 10.1093/nar/gkj089; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tsai IJ, 2013, NATURE, V496, P57, DOI 10.1038/nature12031; Turgeon VL, 1999, J NEUROPATH EXP NEUR, V58, P499, DOI 10.1097/00005072-199905000-00009; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Ward SG, 2003, CURR OPIN PHARMACOL, V3, P391, DOI 10.1016/S1471-4892(03)00085-7; Yamanishi Y, 2008, BIOINFORMATICS, V24, pI232, DOI 10.1093/bioinformatics/btn162; Yan H, 2012, ELIFE, V1, DOI 10.7554/eLife.00049; Yan RQ, 1996, J CANCER RES CLIN, V122, P283, DOI 10.1007/BF01261404; Zhang A, 2012, BMC SYST BIOL, V6, P1752; Zhang Y, 2012, J THROMB HAEMOST, V10, P411, DOI 10.1111/j.1538-7836.2011.04607.x; Zhao F, 2014, DNA RES, V21, P1, DOI 10.1093/dnares/dst035; Zhao SW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011764; Zhao XP, 2002, J CLIN INVEST, V109, P221, DOI 10.1172/JCI13011	36	15	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2014	9	8							e104191	10.1371/journal.pone.0104191	http://dx.doi.org/10.1371/journal.pone.0104191			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR0CG	25105297	Green Published, Green Submitted, gold			2022-12-27	WOS:000343231900040
J	Kanazawa, T; Nakagami, G; Minematsu, T; Yamane, T; Huang, LJ; Mugita, Y; Noguchi, H; Mori, T; Sanada, H				Kanazawa, Toshiki; Nakagami, Gojiro; Minematsu, Takeo; Yamane, Takumi; Huang, Lijuan; Mugita, Yuko; Noguchi, Hiroshi; Mori, Taketoshi; Sanada, Hiromi			Biological Responses of Three-Dimensional Cultured Fibroblasts by Sustained Compressive Loading Include Apoptosis and Survival Activity	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; MOLECULAR-CLONING; HYALURONIC-ACID; STRESS; STRAIN; CELLS; PROTEOGLYCANS; ACTIVATION; EXPRESSION; PREVENTS	Pressure ulcers are characterized by chronicity, which results in delayed wound healing due to pressure. Early intervention for preventing delayed healing due to pressure requires a prediction method. However, no study has reported the prediction of delayed healing due to pressure. Therefore, this study focused on biological response-based molecular markers for the establishment of an assessment technology to predict delayed healing due to pressure. We tested the hypothesis that sustained compressive loading applied to three dimensional cultured fibroblasts leads to upregulation of heat shock proteins (HSPs), CD44, hyaluronan synthase 2 (HAS2), and cyclooxygenase 2 (COX2) along with apoptosis via disruption of adhesion. First, sustained compressive loading was applied to fibroblast-seeded collagen sponges. Following this, collagen sponge samples and culture supernatants were collected for apoptosis and proliferation assays, gene expression analysis, immunocytochemistry, and quantification of secreted substances induced by upregulation of mRNA and protein level. Compared to the control, the compressed samples demonstrated that apoptosis was induced in a time- and load-dependent manner; vinculin and stress fiber were scarce; HSP90 alpha, CD44, HAS2, and COX2 expression was upregulated; and the concentrations of HSP90 alpha, hyaluronan (HA), and prostaglandin E-2 (PGE(2)) were increased. In addition, the gene expression of antiapoptotic Bcl2 was significantly increased in the compressed samples compared to the control. These results suggest that compressive loading induces not only apoptosis but also survival activity. These observations support that HSP90 alpha, HA, and, PGE(2) could be potential molecular markers for prediction of delayed wound healing due to pressure.	[Kanazawa, Toshiki; Nakagami, Gojiro; Minematsu, Takeo; Yamane, Takumi; Huang, Lijuan; Mugita, Yuko; Sanada, Hiromi] Univ Tokyo, Grad Sch Med, Dept Gerontol Nursing Wound Care Management, Tokyo, Japan; [Yamane, Takumi] Tokyo Univ Agr, Fac Appl Biosci, Dept Nutr Sci, Tokyo, Japan; [Noguchi, Hiroshi; Mori, Taketoshi] Univ Tokyo, Grad Sch Med, Dept Life Support Technol, Tokyo, Japan	University of Tokyo; Tokyo University of Agriculture; University of Tokyo	Sanada, H (corresponding author), Univ Tokyo, Grad Sch Med, Dept Gerontol Nursing Wound Care Management, Tokyo, Japan.	hsanada-tky@umin.ac.jp	Yamane, Takumi/N-7442-2019; Nakagami, Gojiro/V-9093-2019; Noguchi, Hiroshi/GQI-0676-2022; Mori, Taketoshi/E-3849-2016	Nakagami, Gojiro/0000-0002-9650-2464; Noguchi, Hiroshi/0000-0002-5303-5210; Mori, Taketoshi/0000-0002-7208-6435; Minematsu, Takeo/0000-0001-5859-7290; Mugita, Yuko/0000-0003-4964-7107	JSPS (Japan Society for the Promotion of Science) [23249088]	JSPS (Japan Society for the Promotion of Science)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a Grant-in-Aid for Scientific Research (A) from JSPS (Japan Society for the Promotion of Science) (No. 23249088). JSPS had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartling B, 2000, BIOCHEM BIOPH RES CO, V278, P740, DOI 10.1006/bbrc.2000.3873; Bunek J, 2011, ORAL DIS, V17, P355, DOI 10.1111/j.1601-0825.2010.01763.x; Cheng TL, 2004, EXP CELL RES, V295, P497, DOI 10.1016/j.yexcr.2004.02.002; Coleman PJ, 1998, J PHYSIOL-LONDON, V509, P695, DOI 10.1111/j.1469-7793.1998.695bm.x; Crockett RJ, 2010, MOL BIOL REP, V37, P2629, DOI 10.1007/s11033-009-9788-8; Darby IA, 1997, INT J BIOCHEM CELL B, V29, P191, DOI 10.1016/S1357-2725(96)00131-8; de Araujo RMS, 2007, J PERIODONTAL RES, V42, P15, DOI 10.1111/j.1600-0765.2006.00906.x; Demiot C, 2011, J INVEST DERMATOL, V131, P2316, DOI 10.1038/jid.2011.211; European Pressure Ulcer Advisory Panel and National Pressure Ulcer Advisory Panel, 2009, PREV TREATM PRESS UL; Evanko SP, 2007, ADV DRUG DELIVER REV, V59, P1351, DOI 10.1016/j.addr.2007.08.008; Fadeel B, 1999, FASEB J, V13, P1647, DOI 10.1096/fasebj.13.13.1647; Falcone SJ, 2006, J BIOMED MATER RES A, V76A, P721, DOI 10.1002/jbm.a.30623; Gerdin B, 1997, J INTERN MED, V242, P49, DOI 10.1046/j.1365-2796.1997.00173.x; Gilmore AP, 2009, CURR OPIN CELL BIOL, V21, P654, DOI 10.1016/j.ceb.2009.05.009; Gilmore AP, 2005, CELL DEATH DIFFER, V12, P1473, DOI 10.1038/sj.cdd.4401723; Gorman AM, 1999, FEBS LETT, V445, P98, DOI 10.1016/S0014-5793(99)00094-0; Gottlieb E, 2000, MOL CELL BIOL, V20, P5680, DOI 10.1128/MCB.20.15.5680-5689.2000; HARDINGHAM TE, 1972, BIOCHIM BIOPHYS ACTA, V279, P401, DOI 10.1016/0304-4165(72)90160-2; HARDINGHAM TE, 1992, FASEB J, V6, P861, DOI 10.1096/fasebj.6.3.1740236; Harper LJ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-166; Henke C, 1996, AM J PATHOL, V149, P1639; Hsieh MH, 2005, INT REV CYTOL, V245, P45, DOI 10.1016/S0074-7696(05)45003-2; Inoue H, 2008, J BIOMED OPT, V13, DOI 10.1117/1.3042266; Itano N, 1999, J BIOL CHEM, V274, P25085, DOI 10.1074/jbc.274.35.25085; Itano N, 1996, BIOCHEM BIOPH RES CO, V222, P816, DOI 10.1006/bbrc.1996.0827; Kreger ST, 2009, MATRIX BIOL, V28, P336, DOI 10.1016/j.matbio.2009.05.001; Lee RT, 2001, J BIOL CHEM, V276, P13847, DOI 10.1074/jbc.M010556200; Maines MD, 1997, ANNU REV PHARMACOL, V37, P517, DOI 10.1146/annurev.pharmtox.37.1.517; Martel H, 2001, CONNECT TISSUE RES, V42, P235, DOI 10.3109/03008200109016838; Mascarenhas MM, 2004, AM J RESP CELL MOL, V30, P51, DOI 10.1165/rcmb.2002-0167OC; Minematsu T, 2013, WOUND REPAIR REGEN, V21, P329, DOI 10.1111/wrr.12017; Misra S, 2008, J BIOL CHEM, V283, P14335, DOI 10.1074/jbc.M703811200; Mitsuhashi M, 2011, INFLAMM RES, V60, P187, DOI 10.1007/s00011-010-0253-x; Moseley R, 2004, BRIT J DERMATOL, V150, P401, DOI 10.1111/j.1365-2133.2004.05845.x; NAKAI A, 1992, J CELL BIOL, V117, P903, DOI 10.1083/jcb.117.4.903; O'Loughlin A, 2013, DIABETES, V62, P2588, DOI 10.2337/db12-1822; Odashima M, 2007, DIGEST DIS SCI, V52, P3087, DOI 10.1007/s10620-007-9795-3; Okuwa Mayumi, 2005, J Tissue Viability, V15, P3; Reno F, 2003, WOUND REPAIR REGEN, V11, P331, DOI 10.1046/j.1524-475X.2003.11504.x; Rigano R, 2007, ANN NY ACAD SCI, V1107, P1, DOI 10.1196/annals.1381.001; Roehlecke C, 2000, HISTOCHEM CELL BIOL, V114, P283; Sae-Sia W, 2007, ARCH PHYS MED REHAB, V88, P1673, DOI 10.1016/j.apmr.2007.07.037; Sato Miwa, 2006, Int Wound J, V3, P355, DOI 10.1111/j.1742-481X.2006.00267.x; Schnaider T, 1999, LIFE SCI, V65, P2417, DOI 10.1016/S0024-3205(99)00508-1; Silver JT, 2012, CELL STRESS CHAPERON, V17, P1, DOI 10.1007/s12192-011-0290-6; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; Spicer AP, 1996, J BIOL CHEM, V271, P23400, DOI 10.1074/jbc.271.38.23400; Spicer AP, 1997, J BIOL CHEM, V272, P8957; Sreedhar AS, 2004, PHARMACOL THERAPEUT, V101, P227, DOI 10.1016/j.pharmthera.2003.11.004; Sugama Junko, 2002, J Tissue Viability, V12, P148; Swain I, 2005, PRESSURE ULCER RESEARCH: CURRENT AND FUTURE PERSPECTIVES, P51, DOI 10.1007/3-540-28804-X_5; Takemura M, 2005, MOL HUM REPROD, V11, P659, DOI 10.1093/molehr/gah229; Tong M, 2013, WOUND REPAIR REGEN, V21, P329; Tsutsumi S, 2007, CANCER SCI, V98, P1536, DOI 10.1111/j.1349-7006.2007.00561.x; UCHIYAMA H, 1990, J BIOL CHEM, V265, P7753; VanGilder C, 2009, J NURS CARE QUAL, V24, P127, DOI 10.1097/01.NCQ.0000347449.83052.1a; Verzijl N, 2000, J BIOL CHEM, V275, P39027, DOI 10.1074/jbc.M006700200; Wang JHC, 2008, INT REV CEL MOL BIO, V271, P301, DOI 10.1016/S1937-6448(08)01207-0; Wild T, 2010, NUTRITION, V26, P862, DOI 10.1016/j.nut.2010.05.008; Xin XJ, 2004, J BIOMAT SCI-POLYM E, V15, P1223, DOI 10.1163/1568562041753025; Yip CP, 2007, BIO-MED MATER ENG, V17, P109	62	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e104676	10.1371/journal.pone.0104676	http://dx.doi.org/10.1371/journal.pone.0104676			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25102054	gold, Green Published, Green Submitted			2022-12-27	WOS:000339993900083
J	Renaud, HJ; Cui, YJ; Lu, H; Zhong, XB; Klaassen, CD				Renaud, Helen J.; Cui, Yue Julia; Lu, Hong; Zhong, Xiao-bo; Klaassen, Curtis D.			Ontogeny of Hepatic Energy Metabolism Genes in Mice as Revealed by RNA-Sequencing	PLOS ONE			English	Article							CARNITINE PALMITOYLTRANSFERASE-I; FATTY-ACID OXIDATION; MULTISTAGE ANALYSIS; LIVER; EXPRESSION; INSULIN; ELOVL3; RESISTANCE; INDUCTION; PGC-1	The liver plays a central role in metabolic homeostasis by coordinating synthesis, storage, breakdown, and redistribution of nutrients. Hepatic energy metabolism is dynamically regulated throughout different life stages due to different demands for energy during growth and development. However, changes in gene expression patterns throughout ontogeny for factors important in hepatic energy metabolism are not well understood. We performed detailed transcript analysis of energy metabolism genes during various stages of liver development in mice. Livers from male C57BL/6J mice were collected at twelve ages, including perinatal and postnatal time points (n = 3/age). The mRNA was quantified by RNA-Sequencing, with transcript abundance estimated by Cufflinks. One thousand sixty energy metabolism genes were examined; 794 were above detection, of which 627 were significantly changed during at least one developmental age compared to adult liver. Two-way hierarchical clustering revealed three major clusters dependent on age: GD17.5-Day 5 (perinatal-enriched), Day 10-Day 20 (pre-weaning-enriched), and Day 25-Day 60 (adolescence/adulthood-enriched). Clustering analysis of cumulative mRNA expression values for individual pathways of energy metabolism revealed three patterns of enrichment: glycolysis, ketogenesis, and glycogenesis were all perinatally-enriched; glycogenolysis was the only pathway enriched during pre-weaning ages; whereas lipid droplet metabolism, cholesterol and bile acid metabolism, gluconeogenesis, and lipid metabolism were all enriched in adolescence/adulthood. This study reveals novel findings such as the divergent expression of the fatty acid beta-oxidation enzymes Acyl-CoA oxidase 1 and Carnitine palmitoyltransferase 1a, indicating a switch from mitochondrial to peroxisomal beta-oxidation after weaning; as well as the dynamic ontogeny of genes implicated in obesity such as Stearoyl-CoA desaturase 1 and Elongation of very long chain fatty acids-like 3. These data shed new light on the ontogeny of homeostatic regulation of hepatic energy metabolism, which could ultimately provide new therapeutic targets for metabolic diseases.	[Renaud, Helen J.; Cui, Yue Julia] Univ Kansas, Med Ctr, Dept Internal Med, Kansas City, KS 66103 USA; [Lu, Hong] SUNY Upstate Med Univ, Dept Pharmacol, Syracuse, NY 13210 USA; [Zhong, Xiao-bo] Univ Connecticut, Sch Pharm, Dept Pharmaceut Sci, Storrs, CT USA; [Klaassen, Curtis D.] Univ Kansas, Coll Med, Kansas City, KS 66160 USA	University of Kansas; University of Kansas Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; University of Connecticut; University of Kansas	Klaassen, CD (corresponding author), Univ Kansas, Coll Med, Kansas City, KS 66160 USA.	curtisklaassenphd@gmail.com			NIH [R01 ES019487]; Canadian Institutes of Health Research; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES019487] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was funded by NIH R01 ES019487 awarded to CDK, HL, and XZ. HJR is supported by a Canadian Institutes of Health Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anzulovich A, 2006, J LIPID RES, V47, P2690, DOI 10.1194/jlr.M600230-JLR200; Bell M, 2008, DIABETES, V57, P2037, DOI 10.2337/db07-1383; Brown JM, 2010, CURR OPIN LIPIDOL, V21, P192, DOI 10.1097/MOL.0b013e32833854ac; Casteels K, 2003, REV ENDOCR METAB DIS, V4, P159, DOI 10.1023/A:1022942120000; CAVENDER CP, 1995, AM J PHYSIOL-ENDOC M, V269, pE331, DOI 10.1152/ajpendo.1995.269.2.E331; DECAUX JF, 1988, J BIOL CHEM, V263, P3284; GIRARD J, 1992, PHYSIOL REV, V72, P507, DOI 10.1152/physrev.1992.72.2.507; Goedeke L, 2012, CELL MOL LIFE SCI, V69, P915, DOI 10.1007/s00018-011-0857-5; Gualdi R, 1996, GENE DEV, V10, P1670, DOI 10.1101/gad.10.13.1670; Herrera E, 2000, DIABETES-METAB RES, V16, P202, DOI 10.1002/1520-7560(200005/06)16:3<202::AID-DMRR116>3.3.CO;2-R; Hirschey MD, 2011, MOL CELL, V44, P177, DOI 10.1016/j.molcel.2011.07.019; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Huyghe S, 2001, BIOCHEM J, V353, P673, DOI 10.1042/0264-6021:3530673; Jakobsson A, 2005, AM J PHYSIOL-ENDOC M, V289, pE517, DOI 10.1152/ajpendo.00045.2005; Jing EX, 2011, P NATL ACAD SCI USA, V108, P14608, DOI 10.1073/pnas.1111308108; Jochheim A, 2003, DIFFERENTIATION, V71, P62, DOI 10.1046/j.1432-0436.2003.700606.x; Jorgensen JA, 2007, AM J PHYSIOL-ENDOC M, V293, pE1159, DOI 10.1152/ajpendo.00213.2007; Koo SH, 2004, NAT MED, V10, P530, DOI 10.1038/nm1044; LEE SST, 1995, MOL CELL BIOL, V15, P3012; Li TT, 2009, GENOMICS, V93, P235, DOI 10.1016/j.ygeno.2008.10.006; Louet JF, 2001, BIOCHEM SOC T, V29, P310, DOI 10.1042/0300-5127:0290310; Lustig Y, 2011, GENE DEV, V25, P1232, DOI 10.1101/gad.2054711; Mauvoisin D, 2011, BIOCHIMIE, V93, P78, DOI 10.1016/j.biochi.2010.08.001; McManaman JL, 2013, J LIPID RES, V54, P1346, DOI 10.1194/jlr.M035063; Miyazaki M, 2005, P NATL ACAD SCI USA, V102, P12501, DOI 10.1073/pnas.0503132102; Neuschwander-Tetri BA, 2007, CURR OPIN GASTROEN, V23, P193, DOI 10.1097/MOG.0b013e32801421a9; Panadero M, 2000, BIOCHIMIE, V82, P723, DOI 10.1016/S0300-9084(00)01147-0; Renaud HJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088584; Rhee J, 2003, P NATL ACAD SCI USA, V100, P4012, DOI 10.1073/pnas.0730870100; Saadeh S, 2007, NUTR CLIN PRACT, V22, P1, DOI 10.1177/011542650702200101; SERRA D, 1993, ARCH BIOCHEM BIOPHYS, V301, P445, DOI 10.1006/abbi.1993.1169; Shimazu T, 2010, CELL METAB, V12, P654, DOI 10.1016/j.cmet.2010.11.003; Sommerfeld A, 2011, MOL CELL ENDOCRINOL, V332, P21, DOI 10.1016/j.mce.2010.11.020; THUMELIN S, 1994, BIOCHEM J, V300, P583, DOI 10.1042/bj3000583; Yubero P, 2004, ENDOCRINOLOGY, V145, P4268, DOI 10.1210/en.2004-0099; Zadravec D, 2010, FASEB J, V24, P4366, DOI 10.1096/fj.09-152298; ZAMMIT VA, 1994, TRENDS BIOCHEM SCI, V19, P313, DOI 10.1016/0968-0004(94)90068-X; Zammit VA, 1996, BIOCHEM J, V314, P1, DOI 10.1042/bj3140001; Zhang X, 2013, J DIABETES	39	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e104560	10.1371/journal.pone.0104560	http://dx.doi.org/10.1371/journal.pone.0104560			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25102070	Green Published, Green Submitted, gold			2022-12-27	WOS:000339993900075
J	Brenner, P; Alexanderson, K; Bjorkenstam, C; Hillert, J; Jokinen, J; Mittendorfer-Rutz, E; Tinghog, P				Brenner, Philip; Alexanderson, Kristina; Bjorkenstam, Charlotte; Hillert, Jan; Jokinen, Jussi; Mittendorfer-Rutz, Ellenor; Tinghog, Petter			Psychiatric Diagnoses, Medication and Risk for Disability Pension in Multiple Sclerosis Patients; a Population-Based Register Study	PLOS ONE			English	Article							QUALITY-OF-LIFE; MENTAL COMORBIDITY; MOOD DISORDER; DEPRESSION; MS; PERSONALITY; SYMPTOMS; ILLNESS; COSTS	Background: Psychiatric comorbidity is common among multiple sclerosis (MS) patients. The majority of MS patients of working ages are on disability pension. The aims of this study were to chart the prevalences of psychiatric diagnoses and medications among MS patients of working ages, and to investigate their association with the risk for future disability pension. Methods: This nationwide, population-based prospective cohort study includes 10,750 MS patients and 5,553,141 non-MS individuals who in 2005 were aged 17-64 years. Psychiatric diagnoses and medications were identified using nationwide registers. Odds ratios (ORs) with 95% confidence intervals (CIs) were calculated adjusting for socio-demographics. Furthermore, a survival analysis with five-year follow-up was performed among the 4,571 MS patients not on disability pension in 2005, with psychiatric diagnoses and medication as risk factors, and disability pension as the outcome. Results: Among MS patients, 35% had been prescribed psychiatric medication compared to 10% of non-MS individuals, adjusted OR 3.72 (95% CI 3.57 to 3.88). Ten percent of MS patients had received a psychiatric diagnosis, compared to 5.7% of non-MS individuals, OR 1.82 (95% CI 1.71 to 1.94). Serotonin reuptake inhibitors (SSRIs), were the most commonly prescribed drugs (17%) among MS patients, while depression (4.8%) was the most common psychiatric diagnosis. In the survival analysis, MS patients with any psychiatric diagnosis had a hazard ratio (HR) of 1.83 (95% CI 1.53 to 2.18) for disability pension compared to other MS patients. MS patients with any psychiatric drug prescription had a HR for disability pension of 2.09 (95% CI 1.84 to 2.33). Conclusion: Psychiatric diagnoses and medications are common among MS patients and adversely affect risk for disability pension. This highlights the importance of correct diagnosis and management of psychiatric comorbidity, in a clinical as well as in a societal perspective.	[Brenner, Philip; Jokinen, Jussi] Karolinska Inst, Karolinska Univ Hosp, Dept Clin Neurosci, Div Psychiat, Stockholm, Sweden; [Alexanderson, Kristina; Bjorkenstam, Charlotte; Mittendorfer-Rutz, Ellenor; Tinghog, Petter] Karolinska Inst, Div Insurance Med, Dept Clin Neurosci, Stockholm, Sweden; [Hillert, Jan] Karolinska Inst, Karolinska Univ Hosp, Dept Clin Neurosci, Div Neuro, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Brenner, P (corresponding author), Karolinska Inst, Karolinska Univ Hosp, Dept Clin Neurosci, Div Psychiat, Stockholm, Sweden.	philip.brenner@ki.se	Brenner, Philip/AAL-6328-2020	Brenner, Philip/0000-0001-5266-6144	Biogen Idec; Swedish Council for Working Life and Social Research [2007-1762]	Biogen Idec(Biogen); Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte))	This study was financially supported by Biogen Idec and the Swedish Council for Working Life and Social Research (grant number 2007-1762). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso A, 2008, NEUROLOGY, V71, P129, DOI 10.1212/01.wnl.0000316802.35974.34; Amato MP, 2002, J NEUROL, V249, P152, DOI 10.1007/PL00007858; Benedict RHB, 2001, J NEUROPSYCH CLIN N, V13, P70, DOI 10.1176/appi.neuropsych.13.1.70; Benedict RHB, 2005, J NEUROL SCI, V231, P29, DOI 10.1016/j.jns.2004.12.009; Bombardier CH, 2004, MULT SCLER, V10, P35, DOI 10.1191/1352458504ms989oa; Bronnum-Hansen H, 2005, J NEUROL NEUROSUR PS, V76, P1457, DOI 10.1136/jnnp.2004.056747; Campbell-Sills L, 2006, BEHAV RES THER, V44, P585, DOI 10.1016/j.brat.2005.05.001; Chwastiak L, 2002, AM J PSYCHIAT, V159, P1862, DOI 10.1176/appi.ajp.159.11.1862; Edwards LJ, 2004, MULT SCLER, V10, P575, DOI 10.1191/1352458504ms1087oa; Fruehwald S, 2001, ACTA NEUROL SCAND, V104, P257, DOI 10.1034/j.1600-0404.2001.00022.x; Ghaffar O, 2007, CURR OPIN PSYCHIATR, V20, P278; Greenblatt DJ, 2012, EXPERT OPIN PHARMACO, V13, P879, DOI 10.1517/14656566.2012.667074; HOLM S, 1979, SCAND J STAT, V6, P65; JOFFE RT, 1987, ARCH NEUROL-CHICAGO, V44, P376, DOI 10.1001/archneur.1987.00520160018007; Kennedy J, 2006, NEUROEPIDEMIOLOGY, V26, P162, DOI 10.1159/000091658; Kobelt G, 2006, J NEUROL NEUROSUR PS, V77, P918, DOI 10.1136/jnnp.2006.090365; Korostil M, 2007, MULT SCLER, V13, P67, DOI 10.1177/1352458506071161; Lunde HMB, 2013, ACTA NEUROL SCAND, V127, P24, DOI 10.1111/ane.12046; Lynch SG, 2001, MULT SCLER J, V7, P411, DOI 10.1191/135245801701566998; Marrie RA, 2009, MULT SCLER, V15, P385, DOI 10.1177/1352458508099477; Marrie RA, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-16; Mohr DC, 2006, MULT SCLER J, V12, P204, DOI 10.1191/135248506ms1265oa; Morin CM, 2012, LANCET, V379, P1129, DOI 10.1016/S0140-6736(11)60750-2; Morrie RA, 2010, LANCET NEUROL, V9, P820, DOI 10.1016/S1474-4422(10)70135-6; National Institute for Health and Care Excellence, 2011, GEN ANX DIS PAN DIS; Patten SB, 2005, NEUROLOGY, V65, P1123, DOI 10.1212/01.wnl.0000178998.95293.29; Patten SB, 2003, NEUROLOGY, V61, P1524, DOI 10.1212/01.WNL.0000095964.34294.B4; Patten SB, 2012, INT J PSYCHIAT MED, V43, P51, DOI 10.2190/PM.43.1.d; Pfleger CCH, 2010, MULT SCLER, V16, P121, DOI 10.1177/1352458509352196; Riise T, 2011, MULT SCLER J, V17, P780, DOI 10.1177/1352458510397686; Sadovnick AD, 1996, NEUROLOGY, V46, P628, DOI 10.1212/WNL.46.3.628; Shakespeare D T, 2001, Cochrane Database Syst Rev, pCD001332, DOI 10.1002/14651858.CD001332; Social Insurance Agency, 2012, SOC INS FIG; Statistics Sweden, 2003, RIK IND ARSB REG IND; Tinghog P, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-117; Tinghog P, 2013, MULT SCLER J, V19, P1923, DOI 10.1177/1352458513488234; WHO, 2011, WORLD REPORT ON DISABILITY, P1; WHO, 2004, INT STAT CLASS DIS R, V1; World Health Organization Collaborating Centre for Drug Statistics Methodology, 2013, ATC CLASS IND DDDS	39	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e104165	10.1371/journal.pone.0104165	http://dx.doi.org/10.1371/journal.pone.0104165			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO5BW	25093730	Green Submitted, gold, Green Published			2022-12-27	WOS:000341357200080
J	Enomoto, Y; Hagiwara, E; Komatsu, S; Nishihira, R; Baba, T; Kitamura, H; Sekine, A; Nakazawa, A; Ogura, T				Enomoto, Yasunori; Hagiwara, Eri; Komatsu, Shigeru; Nishihira, Ryuichi; Baba, Tomohisa; Kitamura, Hideya; Sekine, Akimasa; Nakazawa, Atsuhito; Ogura, Takashi			Pilot Quasi-Randomized Controlled Study of Herbal Medicine Hochuekkito as an Adjunct to Conventional Treatment for Progressed Pulmonary Mycobacterium avium Complex Disease	PLOS ONE			English	Article							YI-QI-TANG; ELDERLY-PATIENTS; NECROSIS-FACTOR; MICE; CLARITHROMYCIN; RIKKUNSHITO; GHRELIN	Introduction: Hochuekkito, a traditional herbal medicine, is occasionally prescribed in Japan to treat patients with a poor general condition. We aimed to examine whether this medicine was beneficial and tolerable for patients with progressed pulmonary Mycobacterium avium complex (MAC) disease. Methods: This pilot open-label quasi-randomized controlled trial enrolled 18 patients with progressed pulmonary MAC disease who had initiated antimycobacterial treatment over one year ago but were persistently culture-positive or intolerant. All patients continued their baseline treatment regimens with (n = 9) or without (n = 9) oral Hochuekkito for 24 weeks. Results: Baseline characteristics were generally similar between the groups. Most patients were elderly (median age 70 years), female, had a low body mass index (<20 kg/m(2)), and a long-term disease duration (median approximately 8 years). After the 24-week treatment period, no patient achieved sputum conversion. Although the number of colonies in sputum tended to increase in the control group, it generally remained stable in the Hochuekkito group. Radiological disease control was frequently observed in the Hochuekkito group than the control group (8/9 vs. 3/9; p = 0.05). Patients in the Hochuekkito group tended to experience increase in body weight and serum albumin level compared with those in the control group (median body weight change: + 0.4 kg vs. 20.8 kg; median albumin change: + 0.2 g/dl vs. +/- 0.0 g/dl). No severe adverse events occurred. Conclusions: Hochuekkito could be an effective, feasible adjunct to conventional therapy for patients with progressed pulmonary MAC disease. Future study is needed to explore this possibility.	[Enomoto, Yasunori; Hagiwara, Eri; Komatsu, Shigeru; Nishihira, Ryuichi; Baba, Tomohisa; Kitamura, Hideya; Sekine, Akimasa; Nakazawa, Atsuhito; Ogura, Takashi] Kanagawa Cardiovasc & Resp Ctr, Dept Resp Med, Yokohama, Kanagawa, Japan	Kanagawa Cardiovascular & Respiratory Center	Enomoto, Y (corresponding author), Kanagawa Cardiovasc & Resp Ctr, Dept Resp Med, Yokohama, Kanagawa, Japan.	yasuyasuyasu29@yahoo.co.jp		Nakazawa, Atsuhito/0000-0002-1326-8343				Chen R, 2009, IMMUNOPHARM IMMUNOT, V31, P238, DOI 10.1080/08923970802391525; CORPE RF, 1981, REV INFECT DIS, V3, P1064; Fujitsuka Naoki, 2012, Critical Reviews in Oncogenesis, V17, P277; Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST; Hasegawa N, 2009, CHEST, V136, P1569, DOI 10.1378/chest.08-2567; Hayashi M, 2012, AM J RESP CRIT CARE, V185, P575, DOI 10.1164/rccm.201107-1203OC; Ishimitsu R, 2001, INT IMMUNOPHARMACOL, V1, P857, DOI 10.1016/S1567-5769(01)00022-4; Jones PW, 2009, EUR RESPIR J, V34, P648, DOI 10.1183/09031936.00102509; Kobashi Y, 2007, RESP MED, V101, P130, DOI 10.1016/j.rmed.2006.04.002; Kobashi Yoshihiro, 2008, Kekkaku, V83, P779; Kuroiwa A, 2004, INT IMMUNOPHARMACOL, V4, P317, DOI 10.1016/j.intimp.2003.12.004; Matsumoto T, 2010, EVID-BASED COMPL ALT, V7, P69, DOI 10.1093/ecam/nem166; Nakayama M, 2012, INFLAMMATION, V35, P1294, DOI 10.1007/s10753-012-9441-x; Nakayama Masayuki, 2011, Nihon Kokyuki Gakkai Zasshi, V49, P232; Satoh N, 2005, PHYTOMEDICINE, V12, P549, DOI 10.1016/j.phymed.2004.06.014; SUZUKI K, 1994, CLIN EXP IMMUNOL, V98, P169; Takeda H, 2012, CURR PHARM DESIGN, V18, P4827, DOI 10.2174/138161212803216933; Tatsumi K, 2009, J AM GERIATR SOC, V57, P169, DOI 10.1111/j.1532-5415.2009.02034.x; Wallace RJ, 1996, AM J RESP CRIT CARE, V153, P1766, DOI 10.1164/ajrccm.153.6.8665032; Winthrop KL, 2008, CLIN INFECT DIS, V46, P1738, DOI 10.1086/587989	20	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e104411	10.1371/journal.pone.0104411	http://dx.doi.org/10.1371/journal.pone.0104411			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093868	Green Published, Green Submitted, gold			2022-12-27	WOS:000341357200110
J	Li, ZL; Zhang, YT; Yu, DF; Zhang, N; Lin, JX; Zhang, JW; Tang, JH; Wang, JF; Mu, CS				Li, Zhuolin; Zhang, Yuting; Yu, Dafu; Zhang, Na; Lin, Jixiang; Zhang, Jinwei; Tang, Jiahong; Wang, Junfeng; Mu, Chunsheng			The Influence of Precipitation Regimes and Elevated CO2 on Photosynthesis and Biomass Accumulation and Partitioning in Seedlings of the Rhizomatous Perennial Grass Leymus chinensis	PLOS ONE			English	Article							ATMOSPHERIC CARBON-DIOXIDE; USE EFFICIENCY; WATER-STRESS; C-4 GRASSES; GROWTH; TEMPERATURE; RESPONSES; DROUGHT; PRODUCTIVITY; PLANTS	Leymus chinensis is a dominant, rhizomatous perennial C-3 species in the grasslands of Songnen Plain of Northern China, and its productivity has decreased year by year. To determine how productivity of this species responds to different precipitation regimes, elevated CO2 and their interaction in future, we measured photosynthetic parameters, along with the accumulation and partitioning of biomass. Plants were subjected to combinations of three precipitation gradients (normal precipitation, versus normal +/- 40%) and two CO2 levels (380 +/- 20 mu mol mol(-1),760 +/- 20 mu mol mol(-1)) in controlled-environment chambers. The net photosynthetic rate, and above-ground and total biomass increased due to both elevated CO2 and increasing precipitation, but not significantly so when precipitation increased from the normal to high level under CO2 enrichment. Water use efficiency and the ratio of root: total biomass increased significantly when precipitation was low, but decreased when it was high under CO2 enrichment. Moreover, high precipitation at the elevated level of CO2 increased the ratio between stem biomass and total biomass. The effect of elevated CO2 on photosynthesis and biomass accumulation was higher at the low level of precipitation than with normal or high precipitation. The results suggest that at ambient CO2 levels, the net photosynthetic rate and biomass of L. chinensis increase with precipitation, but those measures are not further affected by additional precipitation when CO2 is elevated. Furthermore, CO2 may partly compensate for the negative effect of low precipitation on the growth and development of L. chinensis.	[Li, Zhuolin; Zhang, Yuting; Yu, Dafu; Zhang, Na; Zhang, Jinwei; Tang, Jiahong; Wang, Junfeng; Mu, Chunsheng] NE Normal Univ, Inst Grassland Sci, Minist Educ, Key Lab Vegetat Ecol, Changchun, Peoples R China; [Lin, Jixiang] Northeast Forestry Univ, Key Lab Saline Alkali Vegetat Ecol Restorat Oil F, Minist Educ, Alkali Soil Nat Environm Sci Ctr, Harbin, Peoples R China	Northeast Normal University - China; Northeast Forestry University - China	Mu, CS (corresponding author), NE Normal Univ, Inst Grassland Sci, Minist Educ, Key Lab Vegetat Ecol, Changchun, Peoples R China.	mucs821@gmail.com			National Natural Science Foundation of China [31172259, 31370432, 31270464]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The paper was supported by the National Natural Science Foundation of China (grant No. 31172259 and 31370432). Moreover, this paper was supported by the National Natural Science Foundation of China (grant No. 31270464). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth EA, 2005, NEW PHYTOL, V165, P351, DOI 10.1111/j.1469-8137.2004.01224.x; Ainsworth EA, 2007, PLANT CELL ENVIRON, V30, P258, DOI 10.1111/j.1365-3040.2007.01641.x; Arnone JA, 2000, NEW PHYTOL, V147, P73, DOI 10.1046/j.1469-8137.2000.00685.x; Atwell BJ, 2007, FUNCT PLANT BIOL, V34, P1137, DOI 10.1071/FP06338; Baez S, 2013, OECOLOGIA, V172, P1117, DOI 10.1007/s00442-012-2552-0; Bhattacharya N, 2006, PLANT CELL ENVIRON, V13, P933; Cheng WG, 2009, AGR FOREST METEOROL, V149, P51, DOI 10.1016/j.agrformet.2008.07.006; Drake BG, 1997, ANNU REV PLANT PHYS, V48, P609, DOI 10.1146/annurev.arplant.48.1.609; Erice G, 2007, PLANT SCI, V172, P903, DOI 10.1016/j.plantsci.2006.12.013; Fay PA, 2012, J PLANT ECOL, V5, P366, DOI 10.1093/jpe/rts007; Field C.B., 2014, SPEC REP GLOB WARM 1, DOI 10.1017/cbo9780511976988.002; Flexas J, 2002, ANN BOT-LONDON, V89, P183, DOI 10.1093/aob/mcf027; Gao SuHua, 2004, Pratacultural Science, V21, P23; Gavito ME, 2001, J EXP BOT, V52, P1913, DOI 10.1093/jexbot/52.362.1913; Hill PW, 2007, NEW PHYTOL, V173, P766, DOI 10.1111/j.1469-8137.2007.01966.x; Hirel B, 2011, SUSTAINABILITY-BASEL, V3, P1452, DOI 10.3390/su3091452; [马红媛 Hongyuan Ma], 2007, [植物学通报, Chinese Bulletin of Botany], V24, P181; Huang ZeHao, 2002, Grassland of China, V24, P55; Jackson RB, 1995, J BIOGEOGR, V22, P221, DOI 10.2307/2845914; Jia B, 2006, J ARID ENVIRON, V67, P60, DOI 10.1016/j.jaridenv.2006.02.002; Kakani VG, 2007, ENVIRON EXP BOT, V61, P281, DOI 10.1016/j.envexpbot.2007.06.002; Kinmonth-Schultz H, 2011, FUNCT PLANT BIOL, V38, P797, DOI 10.1071/FP11060; Korner C, 2000, ECOL APPL, V10, P1590, DOI 10.2307/2641226; Li XinZhou, 2004, Ganhanqu Yanjiu (Arid Zone Research), V21, P97; Meinshausen M, 2011, CLIMATIC CHANGE, V109, P213, DOI 10.1007/s10584-011-0156-z; Milchunas DG, 2005, GLOBAL CHANGE BIOL, V11, P1837, DOI 10.1111/j.1365-2486.2005.001009.x; Mishra RS, 1999, J AGRON CROP SCI, V182, P223, DOI 10.1046/j.1439-037x.1999.00294.x; Morgan JA, 2001, GLOBAL CHANGE BIOL, V7, P451, DOI 10.1046/j.1365-2486.2001.00415.x; Morgan JA, 2001, PROCEEDINGS OF THE XIX INTERNATIONAL GRASSLAND CONGRESS, P973; Morgan JA, 2011, NATURE, V476, P202, DOI 10.1038/nature10274; Niu SL, 2011, GLOBAL CHANGE BIOL, V17, P1073, DOI 10.1111/j.1365-2486.2010.02280.x; Nowak RS, 2004, NEW PHYTOL, V162, P253, DOI 10.1111/j.1469-8137.2004.01033.x; Ottman MJ, 2001, NEW PHYTOL, V150, P261, DOI 10.1046/j.1469-8137.2001.00110.x; Peters GP, 2012, NAT CLIM CHANGE, V2, P2, DOI 10.1038/nclimate1332; Ping Xiao-Yan, 2010, Chinese Journal of Plant Ecology, V34, P100, DOI 10.3773/j.issn.1005-264x.2010.01.013; Poorter H, 2000, AUST J PLANT PHYSIOL, V27, P595, DOI 10.1071/PP99173; Poorter H, 2001, OECOLOGIA, V129, P1, DOI 10.1007/s004420100736; Poorter H, 2012, NEW PHYTOL, V193, P30, DOI 10.1111/j.1469-8137.2011.03952.x; Rao LE, 2010, OECOLOGIA, V162, P1035, DOI 10.1007/s00442-009-1516-5; Shaw MR, 2002, SCIENCE, V298, P1987, DOI 10.1126/science.1075312; Shipley B, 2002, FUNCT ECOL, V16, P326, DOI 10.1046/j.1365-2435.2002.00626.x; Smith SD, 2000, NATURE, V408, P79, DOI 10.1038/35040544; TOLLEY LC, 1984, CAN J BOT, V62, P2135, DOI 10.1139/b84-291; Volder A, 2004, NEW PHYTOL, V162, P397, DOI 10.1111/j.1469-8137.2004.01025.x; Wand SJE, 1999, GLOB CHANGE BIOL, V5, P723, DOI 10.1046/j.1365-2486.1999.00265.x; Wang Hui, 2012, Chinese Journal of Plant Ecology, V36, P597, DOI 10.3724/SP.J.1258.2012.00597; Wang YH, 2007, CLIMATIC CHANGE, V82, P437, DOI 10.1007/s10584-006-9145-z; Wang ZW, 2004, ACTA OECOL, V26, P255, DOI 10.1016/j.actao.2004.08.007; Xu ZZ, 2007, PLANT SOIL, V301, P87, DOI 10.1007/s11104-007-9424-0; Xu ZZ, 2013, J PLANT GROWTH REGUL, V32, P692, DOI 10.1007/s00344-013-9337-5; Xu ZZ, 2005, PLANT SOIL, V269, P131, DOI 10.1007/s11104-004-0397-y; Zhou G, 2002, J VEG SCI, V13, P361, DOI 10.1111/j.1654-1103.2002.tb02060.x; Ziska LH, 2007, WEED SCI, V55, P288, DOI 10.1614/WS-06-190	53	21	25	1	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e103633	10.1371/journal.pone.0103633	http://dx.doi.org/10.1371/journal.pone.0103633			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093814	gold, Green Submitted, Green Published			2022-12-27	WOS:000341357200027
J	Lin, JL; Wheeldon, I				Lin, Jyun-Liang; Wheeldon, Ian			Dual N- and C-Terminal Helices Are Required for Endoplasmic Reticulum and Lipid Droplet Association of Alcohol Acetyltransferases in Saccharomyces cerevisiae	PLOS ONE			English	Article							ESCHERICHIA-COLI; ISOAMYL ACETATE; TRIACYLGLYCEROL SYNTHESIS; ESTER PRODUCTION; FLAVOR PROFILES; ETHYL-ACETATE; YEAST; PROTEIN; EXPRESSION; SEQUENCE	In the yeast Saccharomyces cerevisiae two alcohol acetyltransferases (AATases), Atf1 and Atf2, condense short chain alcohols with acetyl-CoA to produce volatile acetate esters. Such esters are, in large part, responsible for the distinctive flavors and aromas of fermented beverages including beer, wine, and sake. Atf1 and Atf2 localize to the endoplasmic reticulum (ER) and Atf1 is known to localize to lipid droplets (LDs). The mechanism and function of these localizations are unknown. Here, we investigate potential mechanisms of Atf1 and Atf2 membrane association. Segments of the N- and C-terminal domains of Atf1 (residues 24-41 and 508-525, respectively) are predicted to be amphipathic helices. Truncations of these helices revealed that the terminal domains are essential for ER and LD association. Moreover, mutations of the basic or hydrophobic residues in the N-terminal helix and hydrophobic residues in the C-terminal helix disrupted ER association and subsequent sorting from the ER to LDs. Similar amphipathic helices are found at both ends of Atf2, enabling ER and LD association. As was the case with Atf1, mutations to the N- and C-terminal helices of Atf2 prevented membrane association. Sequence comparison of the AATases from Saccharomyces, non-Saccharomyces yeast (K. lactis and P. anomala) and fruits species (C. melo and S. lycopersicum) showed that only AATases from Saccharomyces evolved terminal amphipathic helices. Heterologous expression of these orthologs in S. cerevisiae revealed that the absence of terminal amphipathic helices eliminates LD association. Combined, the results of this study suggest a common mechanism of membrane association for AATases via dual N- and C-terminal amphipathic helices.	[Lin, Jyun-Liang; Wheeldon, Ian] Univ Calif Riverside, Dept Chem & Environm Engn, Riverside, CA 92521 USA	University of California System; University of California Riverside	Wheeldon, I (corresponding author), Univ Calif Riverside, Dept Chem & Environm Engn, Riverside, CA 92521 USA.	iwheeldon@engr.ucr.edu		Wheeldon, Ian/0000-0002-3492-7539	Bourns College of Engineering at the University of California, Riverside	Bourns College of Engineering at the University of California, Riverside	This study was supported by the Bourns College of Engineering at the University of California, Riverside. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abell BM, 1997, PLANT CELL, V9, P1481, DOI 10.1105/tpc.9.8.1481; Aharoni A, 2000, PLANT CELL, V12, P647, DOI 10.1105/tpc.12.5.647; Athenstaedt K, 1999, J BACTERIOL, V181, P6441, DOI 10.1128/JB.181.20.6441-6448.1999; Binns D, 2006, J CELL BIOL, V173, P719, DOI 10.1083/jcb.200511125; Boulant S, 2006, J BIOL CHEM, V281, P22236, DOI 10.1074/jbc.M601031200; Bouvet S, 2013, J CELL SCI, V126, P4794, DOI 10.1242/jcs.134254; Cauet G, 1999, EUR J BIOCHEM, V261, P317, DOI 10.1046/j.1432-1327.1999.00282.x; Chapman KD, 2012, J LIPID RES, V53, P215, DOI 10.1194/jlr.R021436; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; Connerth M, 2009, METHODS MOL BIOL, V579, P359, DOI 10.1007/978-1-60761-322-0_18; Czabany T, 2008, J BIOL CHEM, V283, P17065, DOI 10.1074/jbc.M800401200; Drin G, 2010, FEBS LETT, V584, P1840, DOI 10.1016/j.febslet.2009.10.022; ERDMANN R, 1995, J CELL BIOL, V128, P509, DOI 10.1083/jcb.128.4.509; Fujii T, 1997, APPL ENVIRON MICROB, V63, P910, DOI 10.1128/AEM.63.3.910-915.1997; FUJII T, 1994, APPL ENVIRON MICROB, V60, P2786, DOI 10.1128/AEM.60.8.2786-2792.1994; Fujiwara D, 1999, YEAST, V15, P1183, DOI 10.1002/(SICI)1097-0061(19990915)15:12<1183::AID-YEA444>3.0.CO;2-J; Galaz S, 2013, FEBS J, V280, P1344, DOI 10.1111/febs.12127; Gautier R, 2008, BIOINFORMATICS, V24, P2101, DOI 10.1093/bioinformatics/btn392; Goodman JM, 2008, J BIOL CHEM, V283, P28005, DOI 10.1074/jbc.R800042200; Grillitsch K, 2011, BBA-MOL CELL BIOL L, V1811, P1165, DOI 10.1016/j.bbalip.2011.07.015; Hinson ER, 2009, P NATL ACAD SCI USA, V106, P20452, DOI 10.1073/pnas.0911679106; Hoover DM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e43; Horton CE, 2006, ENZYME MICROB TECH, V38, P937, DOI 10.1016/j.enzmictec.2005.08.025; Horton CE, 2003, J IND MICROBIOL BIOT, V30, P427, DOI 10.1007/s10295-003-0070-0; HOWARD D, 1976, J I BREWING, V82, P70, DOI 10.1002/j.2050-0416.1976.tb03728.x; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Koffel R, 2005, MOL CELL BIOL, V25, P1655, DOI 10.1128/MCB.25.5.1655-1668.2005; Krahmer N, 2011, CELL METAB, V14, P504, DOI 10.1016/j.cmet.2011.07.013; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; LEBER R, 1994, YEAST, V10, P1421, DOI 10.1002/yea.320101105; Lilly M, 2000, APPL ENVIRON MICROB, V66, P744, DOI 10.1128/AEM.66.2.744-753.2000; Lilly M, 2006, YEAST, V23, P641, DOI 10.1002/yea.1382; MALCORPS P, 1992, EUR J BIOCHEM, V210, P1015, DOI 10.1111/j.1432-1033.1992.tb17507.x; Martin S, 2005, J BIOL CHEM, V280, P42325, DOI 10.1074/jbc.M506651200; Mason AB, 2000, YEAST, V16, P1287, DOI 10.1002/1097-0061(200010)16:14<1287::AID-YEA613>3.0.CO;2-I; McFie PJ, 2011, J BIOL CHEM, V286, P28235, DOI 10.1074/jbc.M111.256008; Nagasawa N, 1998, BIOSCI BIOTECH BIOCH, V62, P1852, DOI 10.1271/bbb.62.1852; Ohsaki Y, 2014, CHEM BIOL, V21, P86, DOI 10.1016/j.chembiol.2013.08.009; Ozeki S, 2005, J CELL SCI, V118, P2601, DOI 10.1242/jcs.02401; Plata C, 2005, WORLD J MICROB BIOT, V21, P115, DOI 10.1007/s11274-004-2780-5; Rodriguez GM, 2014, NAT CHEM BIOL, V10, P259, DOI 10.1038/nchembio.1476; Saerens SMG, 2008, APPL ENVIRON MICROB, V74, P454, DOI 10.1128/AEM.01616-07; Saerens SMG, 2010, MICROB BIOTECHNOL, V3, P165, DOI 10.1111/j.1751-7915.2009.00106.x; Singh R, 2008, BIOPROC BIOSYST ENG, V31, P299, DOI 10.1007/s00449-007-0159-3; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; THURSTON PA, 1982, J I BREWING, V88, P90, DOI 10.1002/j.2050-0416.1982.tb04078.x; Tiwari R, 2007, EMBO J, V26, P5109, DOI 10.1038/sj.emboj.7601924; Vadali RV, 2004, METAB ENG, V6, P294, DOI 10.1016/j.ymben.2004.02.006; Van Laere SDM, 2008, APPL MICROBIOL BIOT, V78, P783, DOI 10.1007/s00253-008-1366-9; Verstrepen KJ, 2004, YEAST, V21, P367, DOI 10.1002/yea.1100; Verstrepen KJ, 2003, APPL ENVIRON MICROB, V69, P5228, DOI 10.1128/AEM.69.9.5228-5237.2003; Walther TC, 2012, ANNU REV BIOCHEM, V81, P687, DOI 10.1146/annurev-biochem-061009-102430; Wilfling F, 2013, DEV CELL, V24, P384, DOI 10.1016/j.devcel.2013.01.013; YOSHIOKA K, 1981, AGR BIOL CHEM TOKYO, V45, P2183, DOI 10.1080/00021369.1981.10864861; ZINSER E, 1995, YEAST, V11, P493, DOI 10.1002/yea.320110602	58	22	23	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e104141	10.1371/journal.pone.0104141	http://dx.doi.org/10.1371/journal.pone.0104141			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093817	gold, Green Published, Green Submitted			2022-12-27	WOS:000341357200072
J	Vensko, SP; Stone, EA				Vensko, Steven P., II; Stone, Eric A.			No Evidence for a Global Male-Specific Lethal Complex-Mediated Dosage Compensation Contribution to the Demasculinization of the Drosophila melanogaster X Chromosome	PLOS ONE			English	Article							BIASED GENE-EXPRESSION; MSL COMPLEX; CHROMATIN-STRUCTURE; TARGET GENES; INACTIVATION; TRANSCRIPTION; SPERMATOGENESIS; ACETYLATION; GERMLINE; REVEALS	In Drosophila melanogaster males, the expression of X-linked genes is regulated by mechanisms that operate on a chromosomal scale. One such mechanism, male-specific lethal complex-dependent X-linked dosage compensation, is thought to broadly enhance the expression of male X-linked genes through two-fold transcriptional upregulation. The evolutionary consequences of this form of dosage compensation are not well understood, particularly with regard to genes more highly expressed in males. It has been observed the X chromosome arrangement of these male-biased genes is non-random, consistent with what one might expect if there is a selective advantage for male-biased genes to avoid dosage compensation. Separately, it has been noted that the male-specific lethal complex and its dosage compensation mechanism appear absent in some male tissues, thus providing a control for the selection hypothesis. Here we utilized publicly available datasets to reassess the arrangement of X-linked male-biased expressed genes after accounting for expression in tissues not dosage compensated by the male-specific lethal complex. Our results do not corroborate previous observations supporting organismal-wide detrimental effects by dosage compensation on X-linked male-biased expressed genes. We instead find no evidence that dosage compensation has played a role in the arrangement of dosage compensated male-biased genes on the X chromosome.	[Vensko, Steven P., II; Stone, Eric A.] N Carolina State Univ, Genet Program, Raleigh, NC 27695 USA; [Stone, Eric A.] N Carolina State Univ, Dept Biol Sci, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	Vensko, SP (corresponding author), N Carolina State Univ, Genet Program, Raleigh, NC 27695 USA.	spvensko@ncsu.edu	Stone, Eric/Q-7840-2016	Stone, Eric/0000-0002-2725-4209	US National Institiutes of Health [RO1-GM70806]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070806] Funding Source: NIH RePORTER	US National Institiutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by RO1-GM70806 from the US National Institiutes of Health - SPV, EAS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alekseyenko AA, 2006, GENE DEV, V20, P848, DOI 10.1101/gad.1400206; Alekseyenko AA, 2008, CELL, V134, P599, DOI 10.1016/j.cell.2008.06.033; Ayroles JF, 2009, NAT GENET, V41, P299, DOI 10.1038/ng.332; BACHILLER D, 1986, DEV BIOL, V118, P379, DOI 10.1016/0012-1606(86)90007-2; Bachtrog D, 2010, CURR BIOL, V20, P1476, DOI 10.1016/j.cub.2010.06.076; Bai YS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r11; Betran E, 2002, GENOME RES, V12, P1854, DOI 10.1101/gr.6049; Chang PL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-364; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Conrad T, 2012, NAT REV GENET, V13, P123, DOI 10.1038/nrg3124; Deng XX, 2006, GENETICS, V174, P1859, DOI 10.1534/genetics.106.064568; Gelbart ME, 2009, NAT STRUCT MOL BIOL, V16, P825, DOI 10.1038/nsmb.1644; Gnad F, 2006, BIOINFORMATICS, V22, P2577, DOI 10.1093/bioinformatics/btl422; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Hamada FN, 2005, GENE DEV, V19, P2289, DOI 10.1101/gad.1343705; Hense W, 2007, PLOS BIOL, V5, P2288, DOI 10.1371/journal.pbio.0050273; Innocenti P, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000335; Kind J, 2007, GENE DEV, V21, P2030, DOI 10.1101/gad.430807; Larschan E, 2011, NATURE, V471, P115, DOI 10.1038/nature09757; Legube G, 2006, GENE DEV, V20, P871, DOI 10.1101/gad.377506; LIFSCHYTZ E, 1972, P NATL ACAD SCI USA, V69, P182, DOI 10.1073/pnas.69.1.182; Marygold SJ, 2013, NUCLEIC ACIDS RES, V41, pD751, DOI 10.1093/nar/gks1024; Meiklejohn CD, 2012, GENOME BIOL EVOL, V4, P895; Meisel RP, 2012, GENOME RES, V22, P1255, DOI 10.1101/gr.132100.111; Meisel RP, 2009, GENOME BIOL EVOL, V1, P176, DOI 10.1093/gbe/evp018; Mikhaylova LM, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-50; Mikhaylova LM, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-29; Parisi M, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-6-r40; Ranz JM, 2003, SCIENCE, V300, P1742, DOI 10.1126/science.1085881; Rastelli L, 1998, MECH DEVELOP, V71, P107, DOI 10.1016/S0925-4773(98)00009-4; Sass GL, 2003, P NATL ACAD SCI USA, V100, P8287, DOI 10.1073/pnas.1332749100; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Straub T, 2005, GENE DEV, V19, P2284, DOI 10.1101/gad.1343105; Straub T, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000302; Sturgill D, 2007, NATURE, V450, P238, DOI 10.1038/nature06330; Vibranovski MD, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-49; Vibranovski MD, 2009, GENOME RES, V19, P897, DOI 10.1101/gr.088609.108; Vicoso B, 2009, J MOL EVOL, V68, P576, DOI 10.1007/s00239-009-9235-4; Yanai I, 2005, BIOINFORMATICS, V21, P650, DOI 10.1093/bioinformatics/bti042	39	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e103659	10.1371/journal.pone.0103659	http://dx.doi.org/10.1371/journal.pone.0103659			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093841	Green Published, gold, Green Submitted			2022-12-27	WOS:000341357200028
J	Xu, ZW; Hu, WB; Zhang, YW; Wang, XF; Tong, SL; Zhou, MG				Xu, Zhiwei; Hu, Wenbiao; Zhang, Yewu; Wang, Xiaofeng; Tong, Shilu; Zhou, Maigeng			Spatiotemporal Pattern of Bacillary Dysentery in China from 1990 to 2009: What Is the Driver Behind?	PLOS ONE			English	Article							CHILDHOOD PNEUMONIA; DISEASE BURDEN; GLOBAL BURDEN; VITAMIN-D; DIARRHEA; SHIGELLOSIS; POPULATION; INFECTIONS; TRENDS	Background: Little is known about the spatiotemporal pattern of bacillary dysentery (BD) in China. This study assessed the geographic distribution and seasonality of BD in China over the past two decades. Methods: Data on monthly BD cases in 31 provinces of China from January 1990 to December 2009 obtained from Chinese Center for Disease Control and Prevention, and data on demographic and geographic factors, as well as climatic factors, were compiled. The spatial distributions of BD in the four periods across different provinces were mapped, and heat maps were created to present the seasonality of BD by geography. A cosinor function combined with Poisson regression was used to quantify the seasonal parameters of BD, and a regression analysis was conducted to identify the potential drivers of morbidity and seasonality of BD. Results: Although most regions of China have experienced considerable declines in BD morbidity over the past two decades, Beijing and Ningxia still had high BD morbidity in 2009. BD morbidity decreased more slowly in North-west China than other regions. BD in China mainly peaked from July to September, with heterogeneity in peak time between regions. Relative humidity was associated with BD morbidity and peak time, and latitude was the major predictor of BD amplitude. Conclusions: The transmission of BD was heterogeneous in China. Improved sanitation and hygiene in North-west China, and better access to clean water and food in the big floating population in some metropolises could be the focus of future preventive interventions against BD. BD control efforts should put more emphasis on those dry areas in summer.	[Xu, Zhiwei; Hu, Wenbiao; Tong, Shilu] Queensland Univ Technol, Sch Publ Hlth & Social Work, Brisbane, Qld 4001, Australia; [Xu, Zhiwei; Hu, Wenbiao; Tong, Shilu] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia; [Zhang, Yewu] Chinese Ctr Dis Control & Prevent, Beijing, Peoples R China; [Wang, Xiaofeng; Zhou, Maigeng] Chinese Ctr Dis Control & Prevent, Natl Ctr Chron & Noncommunicable Dis Control & Pr, Beijing, Peoples R China	Queensland University of Technology (QUT); Queensland University of Technology (QUT); Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; National Center for Chronic & Noncommunicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Tong, SL (corresponding author), Queensland Univ Technol, Sch Publ Hlth & Social Work, Brisbane, Qld 4001, Australia.	s.tong@qut.edu.au; maigengzhou@126.com	Zhou, Maigeng/HCH-7703-2022; PAN, ZEQIANG/X-6341-2018	Hu, Wenbiao/0000-0001-6422-9240; Xu, Zhiwei/0000-0001-7903-2141	National Basic Research Program of China (973 Program) [2012CB955501]	National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This study was funded by the National Basic Research Program of China (973 Program) (Grant No. 2012CB955501). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnett, 2010, ANAL SEASONAL HLTH D; Bhutta ZA, 2013, LANCET, V381, P1417, DOI 10.1016/S0140-6736(13)60648-0; China National Bureau of Statistics, 2012, CHIN STAT YB; Chopra M, 2013, LANCET, V381, P1499, DOI 10.1016/S0140-6736(13)60319-0; Gao Ting, 2007, Zhonghua Yufang Yixue Zazhi, V41, P54; Gill CJ, 2013, LANCET, V381, P1487, DOI 10.1016/S0140-6736(13)60314-1; Gu B, 2013, J BIOMED RES, V27, P103, DOI 10.7555/JBR.27.20120125; Hu WB, 2008, INT J BIOMETEOROL, V52, P689, DOI 10.1007/s00484-008-0161-8; Huang DS, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-130; Kelly-Hope LA, 2008, ENVIRON HEALTH PERSP, V116, P7, DOI 10.1289/ehp.9658; Kim DR, 2008, HEALTH PLACE, V14, P755, DOI 10.1016/j.healthplace.2007.12.003; Kotloff KL, 1999, B WORLD HEALTH ORGAN, V77, P651; Kull M, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-22; Li YongHong, 2009, China Tropical Medicine, V9, P318; Li ZJ, 2013, SCI REP-UK, V3, DOI 10.1038/srep03239; Pei H, 1998, DIS SURVEILLANCE, V13, P408; Sun P, 2008, CAPITAL J PUBLIC HLT, V2, P55; Thornton KA, 2013, PEDIATR INFECT DIS J, V32, P585, DOI 10.1097/INF.0b013e3182868989; von Seidlein L, 2006, PLOS MED, V3, P1556, DOI 10.1371/journal.pmed.0030353; Walker CLF, 2013, LANCET, V381, P1405, DOI 10.1016/S0140-6736(13)60222-6; Wang JF, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002112; Wang X, 1999, CHINESE J EPIDEMIOLO, V20, P62; Wang XY, 2006, B WORLD HEALTH ORGAN, V84, P561, DOI 10.2471/BLT.05.023853; Wang XY, 2005, AM J TROP MED HYG, V73, P416, DOI 10.4269/ajtmh.2005.73.416; Xing WJ, 2014, LANCET INFECT DIS, V14, P308, DOI 10.1016/S1473-3099(13)70342-6; Xu ZW, 2014, J EPIDEMIOL COMMUN H, V68, P304, DOI 10.1136/jech-2013-202725; Yang WZ, 2011, WEST PAC SURVEILL RE, V2, P10, DOI [10.5365/wpsar.2010.1.1.009, 10.5365/WPSAR.2010.1.1.009]; Yu HJ, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001552	28	13	17	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e104329	10.1371/journal.pone.0104329	http://dx.doi.org/10.1371/journal.pone.0104329			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093593	gold, Green Published			2022-12-27	WOS:000341357200096
J	Adamski, MG; Gumann, P; Baird, AE				Adamski, Mateusz G.; Gumann, Patryk; Baird, Alison E.			A Method for Quantitative Analysis of Standard and High-Throughput qPCR Expression Data Based on Input Sample Quantity	PLOS ONE			English	Article							REAL-TIME PCR; NEXT-GENERATION QPCR; GENE-EXPRESSION; HOUSEKEEPING GENES; BETA-ACTIN; RNA EXPRESSION; GAPDH	Over the past decade rapid advances have occurred in the understanding of RNA expression and its regulation. Quantitative polymerase chain reactions (qPCR) have become the gold standard for quantifying gene expression. Microfluidic next generation, high throughput qPCR now permits the detection of transcript copy number in thousands of reactions simultaneously, dramatically increasing the sensitivity over standard qPCR. Here we present a gene expression analysis method applicable to both standard polymerase chain reactions (qPCR) and high throughput qPCR. This technique is adjusted to the input sample quantity (e. g., the number of cells) and is independent of control gene expression. It is efficiency-corrected and with the use of a universal reference sample (commercial complementary DNA (cDNA)) permits the normalization of results between different batches and between different instruments - regardless of potential differences in transcript amplification efficiency. Modifications of the input quantity method include (1) the achievement of absolute quantification and (2) a non-efficiency corrected analysis. When compared to other commonly used algorithms the input quantity method proved to be valid. This method is of particular value for clinical studies of whole blood and circulating leukocytes where cell counts are readily available.	[Adamski, Mateusz G.; Baird, Alison E.] Suny Downstate Med Ctr, Brooklyn, NY 11203 USA; [Adamski, Mateusz G.] UJCM, Krakow, Poland; [Gumann, Patryk] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Gumann, Patryk] Univ Waterloo, Inst Quantum Comp, Dept Phys & Astron, Waterloo, ON N2L 3G1, Canada	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Jagiellonian University; Collegium Medicum Jagiellonian University; Harvard University; University of Waterloo	Baird, AE (corresponding author), Suny Downstate Med Ctr, Brooklyn, NY 11203 USA.	alison.baird@downstate.edu	Adamski, Mateusz G/K-7634-2016; Adamski, Mateusz/F-6274-2015	Adamski, Mateusz/0000-0002-8340-2181	National Institute of Biomedical Imaging and Bioengineering at the National Institutes of Health [R01-EB010087]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB010087] Funding Source: NIH RePORTER	National Institute of Biomedical Imaging and Bioengineering at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by the National Institute of Biomedical Imaging and Bioengineering at the National Institutes of Health [R01-EB010087 to A.E.B.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamski MG, 2013, J BIOMOL SCREEN, V18, P1008, DOI 10.1177/1087057113489882; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chang TJ, 1998, ONCOL REP, V5, P469; Devonshire AS, 2013, METHODS, V59, P89, DOI 10.1016/j.ymeth.2012.07.021; Dheda K, 2004, BIOTECHNIQUES, V37, P112, DOI 10.2144/04371RR03; Feroze-Merzoug F, 2002, BIOTECHNIQUES, V32, P776, DOI 10.2144/02324st03; Li RN, 2013, LIFE SCI, V92, P747, DOI 10.1016/j.lfs.2013.02.014; Lin JT, 2012, DEV GENES EVOL, V222, P369, DOI 10.1007/s00427-012-0420-x; Liu ML, 2011, BIOTECHNOL PROGR, V27, P1407, DOI 10.1002/btpr.666; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Nishimura M, 2008, BIOCHEM BIOPH RES CO, V367, P603, DOI 10.1016/j.bbrc.2008.01.006; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Sikand K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047510; Spurgeon SL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001662; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034	15	31	33	4	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103917	10.1371/journal.pone.0103917	http://dx.doi.org/10.1371/journal.pone.0103917			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25090612	gold, Green Published, Green Submitted			2022-12-27	WOS:000339812700064
J	Lederer, DJ; Philip, N; Rybak, D; Arcasoy, SM; Kawut, SM				Lederer, David J.; Philip, Nisha; Rybak, Debbie; Arcasoy, Selim M.; Kawut, Steven M.			Intravenous Immunoglobulin for Hypogammaglobulinemia after Lung Transplantation: A Randomized Crossover Trial	PLOS ONE			English	Article							RISK-FACTORS; RECIPIENTS; INFECTIONS; OUTCOMES; DISEASE; IMPACT	Background: We aimed to determine the effects of treatment with intravenous immunoglobulin on bacterial infections in patients with hypogammaglobulinemia (HGG) after lung transplantation. Methods: We performed a randomized, double-blind, placebo-controlled two-period crossover trial of immune globulin intravenous (IVIG), 10% Purified (Gamunex, Bayer, Elkhart, IN) monthly in eleven adults who had undergone lung transplantation more than three months previously. We randomized study participants to three doses of IVIG (or 0.1% albumin solution (placebo)) given four weeks apart followed by a twelve week washout and then three doses of placebo (or IVIG). The primary outcome was the number of bacterial infections within each treatment period. Results: IVIG had no effect on the number of bacterial infections during the treatment period (3 during IVIG and 1 during placebo; odds ratio 3.5, 95% confidence interval 0.4 to 27.6, p = 0.24). There were no effects on other infections, use of antibiotics, or lung function. IVIG significantly increased trough IgG levels at all time points (least square means, 765.3 mg/dl during IVIG and 486.3 mg/dl during placebo, p < 0.001). Four serious adverse events (resulting in hospitalization) occurred during the treatment periods (3 during active treatment and 1 during the placebo period, p = 0.37). Chills, flushing, and nausea occurred during one infusion of IVIG. Conclusions: Treatment with IVIG did not reduce the short-term risk of bacterial infection in patients with HGG after lung transplantation. The clinical efficacy of immunoglobulin supplementation in HGG related to lung transplantation over the long term or with recurrent infections is unknown.	[Lederer, David J.; Philip, Nisha; Rybak, Debbie; Arcasoy, Selim M.] Columbia Univ, Coll Physicians & Surgeons, Dept Med, New York, NY USA; [Lederer, David J.] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA; [Kawut, Steven M.] Univ Penn, Perelman Sch Med, Dept Med, Philadelphia, PA 19104 USA; [Kawut, Steven M.] Univ Penn, Perelman Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA	Columbia University; Columbia University; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Kawut, SM (corresponding author), Univ Penn, Perelman Sch Med, Dept Med, Philadelphia, PA 19104 USA.	kawut@upenn.edu	Arcasoy, Selim M/AAR-6637-2020; Lederer, David/W-7957-2018	Lederer, David/0000-0001-5258-0228	Talecris Pharmaceuticals	Talecris Pharmaceuticals	This study was funded by an investigator-initiated grant from Bayer Healthcare (now Talecris Pharmaceuticals). The manuscript was written by the authors, and the decision to submit the manuscript for publication was made solely by the authors. This manuscript was sent to the sponsor before submission for publication, however the sponsor had no right to delay or require any revisions to this manuscript. The sponsor had no role in the design of the study, data collection, analysis, interpretation of the data, or the decision to submit the manuscript.	Aguilar-Guisado M, 2007, AM J TRANSPLANT, V7, P1989, DOI 10.1111/j.1600-6143.2007.01882.x; [Anonymous], 1990, JAMA, V264, P3189; Chambers DC, 2013, J HEART LUNG TRANSPL, V32, P36, DOI 10.1016/j.healun.2012.10.006; de Bruyn G, 2004, AM J TRANSPLANT, V4, P1366, DOI 10.1111/j.1600-6143.2004.00512.x; Doron S, 2006, TRANSPLANTATION, V81, P697, DOI 10.1097/01.tp.0000180531.66518.9e; Fernandez-Ruiz M, 2012, AM J TRANSPLANT, V12, P2763, DOI 10.1111/j.1600-6143.2012.04192.x; Florescu DF, 2013, AM J TRANSPLANT, V13, P2601, DOI 10.1111/ajt.12401; Food and Drug Administration, GUID IND EV CLIN STU; Goldfarb NS, 2001, TRANSPLANTATION, V71, P242, DOI 10.1097/00007890-200101270-00013; Husain S, 2006, AM J TRANSPLANT, V6, P3000, DOI 10.1111/j.1600-6143.2006.01565.x; Kawut SM, 2005, TRANSPLANTATION, V79, P1723, DOI 10.1097/01.TP.0000159136.72693.35; Kotloff RM, 2011, AM J RESP CRIT CARE, V184, P159, DOI 10.1164/rccm.201101-0134CI; Orange JS, 2006, J ALLERGY CLIN IMMUN, V117, pS525, DOI 10.1016/j.jaci.2006.01.015; Remund Kaspar F, 2009, Proc Am Thorac Soc, V6, P94, DOI 10.1513/pats.200809-113GO; Robertson J, 2009, PEDIATR TRANSPLANT, V13, P754, DOI 10.1111/j.1399-3046.2008.01067.x; Yamani MH, 2005, J HEART LUNG TRANSPL, V24, P1766, DOI 10.1016/j.healun.2004.11.016; Yamani MH, 2001, J HEART LUNG TRANSPL, V20, P425, DOI 10.1016/S1053-2498(00)00331-4; Yip NH, 2006, AM J RESP CRIT CARE, V173, P917, DOI 10.1164/rccm.200510-1609OC	18	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103908	10.1371/journal.pone.0103908	http://dx.doi.org/10.1371/journal.pone.0103908			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25090414	gold, Green Published, Green Submitted			2022-12-27	WOS:000339812700063
J	Giacci, MK; Wheeler, L; Lovett, S; Dishington, E; Majda, B; Bartlett, CA; Thornton, E; Harford-Wright, E; Leonard, A; Vink, R; Harvey, AR; Provis, J; Dunlop, SA; Hart, NS; Hodgetts, S; Natoli, R; Van Den Heuvel, C; Fitzgerald, M				Giacci, Marcus K.; Wheeler, Lachlan; Lovett, Sarah; Dishington, Emma; Majda, Bernadette; Bartlett, Carole A.; Thornton, Emma; Harford-Wright, Elizabeth; Leonard, Anna; Vink, Robert; Harvey, Alan R.; Provis, Jan; Dunlop, Sarah A.; Hart, Nathan S.; Hodgetts, Stuart; Natoli, Riccardo; Van Den Heuvel, Corinna; Fitzgerald, Melinda			Differential Effects of 670 and 830 nm Red near Infrared Irradiation Therapy: A Comparative Study of Optic Nerve Injury, Retinal Degeneration, Traumatic Brain and Spinal Cord Injury	PLOS ONE			English	Article							LEVEL LASER THERAPY; CONTROLLED CORTICAL IMPACT; CYTOCHROME-C-OXIDASE; LIGHT THERAPY; SECONDARY DEGENERATION; IN-VIVO; ABSORPTION-MEASUREMENTS; FUNCTIONAL RECOVERY; OXIDATIVE DAMAGE; WHITE-MATTER	Red/near-infrared irradiation therapy (R/NIR-IT) delivered by laser or light-emitting diode (LED) has improved functional outcomes in a range of CNS injuries. However, translation of R/NIR-IT to the clinic for treatment of neurotrauma has been hampered by lack of comparative information regarding the degree of penetration of the delivered irradiation to the injury site and the optimal treatment parameters for different CNS injuries. We compared the treatment efficacy of R/NIR-IT at 670 nm and 830 nm, provided by narrow-band LED arrays adjusted to produce equal irradiance, in four in vivo rat models of CNS injury: partial optic nerve transection, light-induced retinal degeneration, traumatic brain injury (TBI) and spinal cord injury (SCI). The number of photons of 670 nm or 830 nm light reaching the SCI injury site was 6.6% and 11.3% of emitted light respectively. Treatment of rats with 670 nm R/NIR-IT following partial optic nerve transection significantly increased the number of visual responses at 7 days after injury (P <= 0.05); 830 nm R/NIR-IT was partially effective. 670 nm R/NIR-IT also significantly reduced reactive species and both 670 nm and 830 nm R/NIR-IT reduced hydroxynonenal immunoreactivity (P <= 0.05) in this model. Pre-treatment of light-induced retinal degeneration with 670 nm R/NIR-IT significantly reduced the number of Tunel+ cells and 8-hydroxyguanosine immunoreactivity (P <= 0.05); outcomes in 830 nm R/NIR-IT treated animals were not significantly different to controls. Treatment of fluid-percussion TBI with 670 nm or 830 nm R/NIR-IT did not result in improvements in motor or sensory function or lesion size at 7 days (P>0.05). Similarly, treatment of contusive SCI with 670 nm or 830 nm R/NIR-IT did not result in significant improvements in functional recovery or reduced cyst size at 28 days (P>0.05). Outcomes from this comparative study indicate that it will be necessary to optimise delivery devices, wavelength, intensity and duration of R/NIR-IT individually for different CNS injury types.	[Giacci, Marcus K.; Wheeler, Lachlan; Lovett, Sarah; Dishington, Emma; Majda, Bernadette; Bartlett, Carole A.; Harvey, Alan R.; Dunlop, Sarah A.; Hodgetts, Stuart; Fitzgerald, Melinda] Univ Western Australia, Crawley, WA 6009, Australia; [Giacci, Marcus K.; Bartlett, Carole A.; Dunlop, Sarah A.; Hart, Nathan S.; Fitzgerald, Melinda] Univ Western Australia, Sch Anim Biol, Crawley, WA 6009, Australia; [Giacci, Marcus K.; Wheeler, Lachlan; Lovett, Sarah; Dishington, Emma; Majda, Bernadette; Harvey, Alan R.; Hodgetts, Stuart] Univ Western Australia, Sch Anat Physiol & Human Biol, Crawley, WA 6009, Australia; [Thornton, Emma; Harford-Wright, Elizabeth; Leonard, Anna; Vink, Robert; Van Den Heuvel, Corinna] Univ Adelaide, Sch Med Sci, Adelaide, SA, Australia; [Provis, Jan; Natoli, Riccardo] Australian Natl Univ, ANU Med Sch, Canberra, ACT, Australia; [Provis, Jan; Natoli, Riccardo] Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 2601, Australia; [Hart, Nathan S.] Univ Western Australia, Oceans Inst, Neuroecol Grp, Crawley, WA 6009, Australia	University of Western Australia; University of Western Australia; University of Western Australia; University of Adelaide; Australian National University; Australian National University; John Curtin School of Medical Research; University of Western Australia	Fitzgerald, M (corresponding author), Univ Western Australia, Crawley, WA 6009, Australia.	lindy.fitzgerald@uwa.edu.au	Fitzgerald, Melinda/C-4235-2011; Vink, Robert/S-5616-2019; Hart, Nathan S/B-8564-2011; Vink, Robert/J-7351-2012; Provis, Jan/C-9529-2009	Fitzgerald, Melinda/0000-0002-4823-8179; Vink, Robert/0000-0002-4885-0667; Hart, Nathan S/0000-0002-7289-9399; Vink, Robert/0000-0002-4885-0667; Giacci, Marcus/0000-0002-8330-678X; , Corinna/0000-0003-0664-8935; Hodgetts, Stuart/0000-0002-3318-0410; Dunlop, Sarah/0000-0002-1306-3962; , Alan/0000-0002-2590-831X; Natoli, Riccardo/0000-0002-9350-0439; Provis, Jan/0000-0002-6405-2868; Leonard, Anna/0000-0002-9430-3314	Neurotrauma Research Program (Western Australia); Road Trauma Trust Account; University of Western Australia; Western Australian State Government as part of a Western Australian Premiers Fellowship	Neurotrauma Research Program (Western Australia); Road Trauma Trust Account; University of Western Australia; Western Australian State Government as part of a Western Australian Premiers Fellowship	This work was supported by the Neurotrauma Research Program (Western Australia) (http://www.nrp.org.au/). This project is funded through the Road Trauma Trust Account, but does not reflect views or recommendations of the Road Safety Council. NSH was funded by The University of Western Australia and The Western Australian State Government as part of a Western Australian Premiers Fellowship to Prof. Shaun Collin. No individuals employed or contracted by the funders (other than the named authors) played any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abler AS, 1996, RES COMMUN MOL PATH, V92, P177; Albarracin R, 2012, PHOTOCHEM PHOTOBIOL; Albarracin R, 2011, INVEST OPHTH VIS SCI, V52, P3582, DOI 10.1167/iovs.10-6664; Albarracin RS, 2012, ADV EXP MED BIOL, V723, P121, DOI 10.1007/978-1-4614-0631-0_17; Ando T, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.9.098002; Ando T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026212; Aonuma H, 1999, JPN J OPHTHALMOL, V43, P171, DOI 10.1016/S0021-5155(99)00011-8; Back SA, 2005, ANN NEUROL, V58, P108, DOI 10.1002/ana.20530; Back SA, 1998, J NEUROSCI, V18, P6241; Ball KA, 2011, J PHOTOCH PHOTOBIO B, V102, P182, DOI 10.1016/j.jphotobiol.2010.12.002; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Byrnes KR, 2005, LASER SURG MED, V36, P171, DOI 10.1002/lsm.20143; Carrico KM, 2009, J NEUROTRAUM, V26, P1369, DOI [10.1089/neu.2008.0870, 10.1089/neu.2008-0870]; Chung H, 2012, ANN BIOMED ENG, V40, P516, DOI 10.1007/s10439-011-0454-7; Corrigan F, 2012, NEUROSCI LETT, V515, P50, DOI 10.1016/j.neulet.2012.03.017; Cummins N, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-98; Demidova-Rice TN, 2007, LASER SURG MED, V39, P706, DOI 10.1002/lsm.20549; DeTaboada L, 2006, LASER SURG MED, V38, P70, DOI 10.1002/lsm.20256; Eells JT, 2004, MITOCHONDRION, V4, P559, DOI 10.1016/j.mito.2004.07.033; Eells JT, 2003, P NATL ACAD SCI USA, V100, P3439, DOI 10.1073/pnas.0534746100; Fitzgerald M, 2013, REV NEUROSCIENCE, V24, P205, DOI 10.1515/revneuro-2012-0086; Fitzgerald M, 2010, J NEUROTRAUM, V27, P2107, DOI 10.1089/neu.2010.1426; Fitzgerald M, 2010, J NEUROTRAUM, V27, P439, DOI 10.1089/neu.2009.1112; Fitzgerald M, 2009, EXP NEUROL, V216, P219, DOI 10.1016/j.expneurol.2008.11.026; Gkotsi D, 2014, EXP EYE RES, V122, P50, DOI 10.1016/j.exer.2014.02.023; Godinho MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069987; Gupta A, 2014, LASER MED SCI, V29, P257, DOI 10.1007/s10103-013-1319-0; Hacke W, 2013, TRANSCRANIAL LASER T; Hall ED, 2010, NEUROTHERAPEUTICS, V7, P51, DOI 10.1016/j.nurt.2009.10.021; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; HEBEDA KM, 1994, NEUROSURGERY, V35, P720, DOI 10.1227/00006123-199410000-00019; Hodgetts SI, 2013, EXP NEUROL, V248, P343, DOI 10.1016/j.expneurol.2013.06.018; Hodgetts SI, 2013, CELL TRANSPLANT, V22, P393, DOI 10.3727/096368912X656081; Huang YY, 2011, DOSE-RESPONSE, V9, P602, DOI 10.2203/dose-response.11-009.Hamblin; Iwamura A, 2012, NEURORADIOLOGY, V54, P335, DOI 10.1007/s00234-011-0892-9; KARU T, 1989, HEALTH PHYS, V56, P691, DOI 10.1097/00004032-198905000-00015; Karu TI, 2005, J PHOTOCH PHOTOBIO B, V81, P98, DOI 10.1016/j.jphotobiol.2005.07.002; Karu TI, 2008, PHOTOMED LASER SURG, V26, P593, DOI 10.1089/pho.2008.2246; Khuman J, 2012, J NEUROTRAUM, V29, P408, DOI 10.1089/neu.2010.1745; Kokkinopoulos I, 2013, NEUROBIOL AGING, V34, P602, DOI 10.1016/j.neurobiolaging.2012.04.014; Kowaltowski AJ, 2009, FREE RADICAL BIO MED, V47, P333, DOI 10.1016/j.freeradbiomed.2009.05.004; Lampl Y, 2007, STROKE, V38, P1843, DOI 10.1161/STROKEAHA.106.478230; Lapchak PA, 2012, EXPERT REV MED DEVIC, V9, P71, DOI 10.1586/ERD.11.64; Lapchak PA, 2010, BRAIN RES, V1306, P100, DOI 10.1016/j.brainres.2009.10.022; Lenz P, 1999, APPL OPTICS, V38, P3662, DOI 10.1364/AO.38.003662; Liang HL, 2008, NEUROSCIENCE, V153, P963, DOI 10.1016/j.neuroscience.2008.03.042; Lim J, 2010, J PHOTOCH PHOTOBIO B, V99, P105, DOI 10.1016/j.jphotobiol.2010.03.002; Lim J, 2009, J BIOCHEM MOL TOXIC, V23, P1, DOI 10.1002/jbt.20257; Lu JK, 2000, SPINE, V25, P1859, DOI 10.1097/00007632-200007150-00022; Maslim J, 1997, INVEST OPHTH VIS SCI, V38, P1667; Mason MG, 2006, P NATL ACAD SCI USA, V103, P708, DOI 10.1073/pnas.0506562103; McCarthy TJ, 2010, PHOTOMED LASER SURG, V28, P663, DOI 10.1089/pho.2009.2581; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Medalha CC, 2010, PHOTOMED LASER SURG, V28, P669, DOI 10.1089/pho.2009.2691; Metz GA, 2009, J VIS EXP; Modo M, 2000, J NEUROSCI METH, V104, P99, DOI 10.1016/S0165-0270(00)00329-0; Moody DJ, 2005, SPECIFIC EXTINCTION; Moreira MS, 2009, J PHOTOCH PHOTOBIO B, V97, P145, DOI 10.1016/j.jphotobiol.2009.09.002; Naeser MA, 2011, PHOTOMED LASER SURG, V29, P351, DOI 10.1089/pho.2010.2814; Natoli R, 2010, MOL VIS, V16, P1801; Oron A, 2007, J NEUROTRAUM, V24, P651, DOI 10.1089/neu.2006.0198; Oron A, 2006, STROKE, V37, P2620, DOI 10.1161/01.STR.0000242775.14642.b8; Oron U, 2001, LASER SURG MED, V28, P204, DOI 10.1002/lsm.1039; Park E, 2004, J NEUROTRAUM, V21, P754, DOI 10.1089/0897715041269641; Peoples Cassandra, 2012, ISRN Neurol, V2012, P850150, DOI 10.5402/2012/850150; Qu C, 2010, ADV EXP MED BIOL, V664, P365, DOI 10.1007/978-1-4419-1399-9_42; Rojas JC, 2008, J NEUROSCI, V28, P13511, DOI 10.1523/JNEUROSCI.3457-08.2008; Rutar M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-257; Sutherland JC, 2002, PHOTOCHEM PHOTOBIOL, V76, P164, DOI 10.1562/0031-8655(2002)076<0164:BEOPL>2.0.CO;2; Sykova E, 2008, NEUROCHEM INT, V52, P5, DOI 10.1016/j.neuint.2007.04.007; Szymanski CR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066448; TATOR CH, 1991, J NEUROSURG, V75, P15, DOI 10.3171/jns.1991.75.1.0015; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Thornton E, 2006, BRAIN RES, V1094, P38, DOI 10.1016/j.brainres.2006.03.107; Wells J, 2012, J NEUROSCI RES, V90, P606, DOI 10.1002/jnr.22784; Whelan HT, 2001, J CLIN LASER MED SUR, V19, P305, DOI 10.1089/104454701753342758; Wong-Riley MTT, 2005, J BIOL CHEM, V280, P4761, DOI 10.1074/jbc.M409650200; Wu QH, 2012, LASER SURG MED, V44, P218, DOI 10.1002/lsm.22003; Wu XJ, 2009, LASER SURG MED, V41, P36, DOI 10.1002/lsm.20729; Zivin JA, 2009, STROKE, V40, P1359, DOI 10.1161/STROKEAHA.109.547547	80	29	30	4	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2014	9	8							e104565	10.1371/journal.pone.0104565	http://dx.doi.org/10.1371/journal.pone.0104565			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR0CG	25105800	Green Published, gold			2022-12-27	WOS:000343231900072
J	Woodruff, GC; Knauss, CM; Maugel, TK; Haag, ES				Woodruff, Gavin C.; Knauss, Christine M.; Maugel, Timothy K.; Haag, Eric S.			Mating Damages the Cuticle of C-elegans Hermaphrodites	PLOS ONE			English	Article							HISTORY TRADE-OFFS; CAENORHABDITIS; LONGEVITY; MALES; DEATH; COST	Lifespan costs to reproduction are common across multiple species, and such costs could potentially arise through a number of mechanisms. In the nematode Caenorhabditis elegans, it has been suggested that part of the lifespan cost to hermaphrodites from mating results from physical damage owing to the act of copulation itself. Here, we examine whether mating damages the surface of the hermaphrodite cuticle via scanning electron microscopy. It is found that mated hermaphrodites suffered delamination of cuticle layers surrounding the vulva, and that the incidence of such damage depends on genetic background. Unmated hermaphrodites demonstrated almost no such damage, even when cultured in soil with potentially abrasive particles. Thus, a consequence of mating for C. elegans hermaphrodites is physical cuticle damage. These experiments did not assess the consequences of cuticle damage for lifespan, and the biological significance of this damage remains unclear. We further discuss our results within the context of recent studies linking the lifespan cost to mating in C. elegans hermaphrodites to male secretions.	[Woodruff, Gavin C.; Knauss, Christine M.; Haag, Eric S.] Univ Maryland, Dept Biol, College Pk, MD 20742 USA; [Maugel, Timothy K.] Univ Maryland, Lab Biol Ultrastruct, College Pk, MD 20742 USA; [Woodruff, Gavin C.] Forestry & Forest Prod Res Inst, Forest Pathol Lab, Tsukuba, Ibaraki 305, Japan	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; Forestry & Forest Products Research Institute - Japan	Haag, ES (corresponding author), Univ Maryland, Dept Biol, College Pk, MD 20742 USA.	ehaag@umd.edu		Woodruff, Gavin/0000-0003-0919-5660				Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; ALCOCK J, 1977, AM NAT, V111, P145, DOI 10.1086/283145; Anderson JL, 2010, J HERED, V101, pS62, DOI 10.1093/jhered/esq003; Andersson Malte, 1994; [Anonymous], 1990, GENETIC EFFECTS AGIN, P9; Arnqvist Goran, 2005, pUnpaginated; Avila FW, 2011, ANNU REV ENTOMOL, V56, P21, DOI 10.1146/annurev-ento-120709-144823; Barr MM, 2006, MALE MATING BEHAV; Crudgington HS, 2000, NATURE, V407, P855, DOI 10.1038/35038154; Felix MA, 2010, CURR BIOL, V20, pR965, DOI 10.1016/j.cub.2010.09.050; FOWLER K, 1989, NATURE, V338, P760, DOI 10.1038/338760a0; Garcia LR, 2001, CELL, V107, P777, DOI 10.1016/S0092-8674(01)00600-6; Gems D, 1996, NATURE, V379, P723, DOI 10.1038/379723a0; Gems D, 2000, GENETICS, V154, P1597; Kiontke KC, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-339; Kirkwood TBL, 2000, NATURE, V408, P233, DOI 10.1038/35041682; Maures TJ, 2014, SCIENCE, V343, P541, DOI 10.1126/science.1244160; MCKINNEY F, 1983, BEHAVIOUR, V86, P250, DOI 10.1163/156853983X00390; Norman MD, 1997, NATURE, V389, P683, DOI 10.1038/39497; Norris K, 2000, BEHAV ECOL, V11, P19, DOI 10.1093/beheco/11.1.19; Page A. P., 2007, CUTICLE; Palopoli MF, 2008, NATURE, V454, P1019, DOI 10.1038/nature07171; Parker G. A., 1979, SEXUAL SELECTION REP, V123, P166; Pickett CL, 2013, AGING CELL, V12, P544, DOI 10.1111/acel.12079; Rice WR, 1996, NATURE, V381, P232, DOI 10.1038/381232a0; Rolff J, 2003, SCIENCE, V301, P472, DOI 10.1126/science.1080623; Shi C, 2014, SCIENCE, V343, P536, DOI 10.1126/science.1242958; SIH A, 1990, AM NAT, V135, P284, DOI 10.1086/285044; Singer F, 2000, BEHAVIOUR, V137, P93, DOI 10.1163/156853900501890; STEARNS SC, 1989, FUNCT ECOL, V3, P259, DOI 10.2307/2389364; Stutt AD, 2001, P NATL ACAD SCI USA, V98, P5683, DOI 10.1073/pnas.101440698; Valera F, 1997, BEHAV ECOL, V8, P20, DOI 10.1093/beheco/8.1.20; Wegewitz Viktoria, 2008, BMC Ecology, V8, P12, DOI 10.1186/1472-6785-8-12; Westendorp RGJ, 1998, NATURE, V396, P743, DOI 10.1038/25519; Wood WB, 1988, NEMATODE CAENORHABDI; Zera AJ, 2001, ANNU REV ECOL SYST, V32, P95, DOI 10.1146/annurev.ecolsys.32.081501.114006	36	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2014	9	8							e104456	10.1371/journal.pone.0104456	http://dx.doi.org/10.1371/journal.pone.0104456			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR0CG	25105881	gold, Green Published, Green Submitted			2022-12-27	WOS:000343231900059
J	Yuan, T; Yao, WT; Huang, F; Sun, BL; Yang, RG				Yuan, Ting; Yao, Weitong; Huang, Fang; Sun, Binlian; Yang, Rongge			The Human Antiviral Factor TRIM11 Is under the Regulation of HIV-1 Vpr	PLOS ONE			English	Article							URACIL DNA GLYCOSYLASE; E3 LIGASES; PROTEIN; RESTRICTION; TRANSCRIPTION; INFECTION; CELLS; DESTABILIZES; REPLICATION; DEGRADATION	TRIM11 has been reported to be able to restrict HIV-1 replication, but the detailed aspects of the interfering mechanisms remain unclear. In this study, we demonstrated that TRIM11 mainly suppressed the early steps of HIV-1 transduction, resulting in decreased reverse transcripts. Additionally, we found that TRIM11 could inhibit HIV-1 long terminal repeat (LTR) activity, which may be related to its inhibitory effects on NF-kappa B. Deletion mutant experiments showed that the RING domain of TRIM11 was indispensable in inhibiting the early steps of HIV-1 transduction but was dispensable in decreasing NF-kappa B and LTR activities. Moreover, we found that low levels of Vpr decreased TRIM11 protein levels, while high levels increased them, and these regulations were independent of the VprBP-associated proteasome machinery. These results suggest that the antiviral factor TRIM11 is indirectly regulated by HIV-1 Vpr through unknown mechanisms and that the concentration of Vpr is essential to these processes. Thus, our work confirms TRIM11 as a host cellular factor that interferes with the early steps of HIV-1 replication and provides a connection between viral protein and host antiviral factors.	[Yuan, Ting; Yao, Weitong; Huang, Fang; Sun, Binlian; Yang, Rongge] Chinese Acad Sci, Wuhan Inst Virol, Res Grp HIV Mol Epidemiol & Virol, Ctr Emerging Infect Dis,State Key Lab Virol, Wuhan, Hubei, Peoples R China	Chinese Academy of Sciences; Wuhan Institute of Virology, CAS	Sun, BL (corresponding author), Chinese Acad Sci, Wuhan Inst Virol, Res Grp HIV Mol Epidemiol & Virol, Ctr Emerging Infect Dis,State Key Lab Virol, Wuhan, Hubei, Peoples R China.	sunbl@wh.iov.cn; ryang@wh.iov.cn		HUANG, FANG/0000-0002-0511-2568	Key National Science and Technology Program in the twelfth Five-Year Period [2012ZX10001-006]; International Science & Technology Cooperation Program of China [2011DFA31030]; Deutsche Forschungsgemeinschaft (SFB/Transregio TRR60)	Key National Science and Technology Program in the twelfth Five-Year Period; International Science & Technology Cooperation Program of China; Deutsche Forschungsgemeinschaft (SFB/Transregio TRR60)(German Research Foundation (DFG))	This study was supported by the Key National Science and Technology Program in the twelfth Five-Year Period (Grant 2012ZX10001-006) and grants from the International Science & Technology Cooperation Program of China (2011DFA31030) and Deutsche Forschungsgemeinschaft (SFB/Transregio TRR60). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allouch A, 2011, CELL HOST MICROBE, V9, P484, DOI 10.1016/j.chom.2011.05.004; Bachand F, 1999, J BIOL CHEM, V274, P9083, DOI 10.1074/jbc.274.13.9083; Barr SD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000007; Berthoux L, 2005, J VIROL, V79, P7883, DOI 10.1128/JVI.79.12.7883-7888.2005; Brussel A, 2003, J VIROL, V77, P10119, DOI 10.1128/JVI.77.18.10119-10124.2003; Colin L, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-111; de Silva S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035385; Diaz-Griffero F, 2006, VIROLOGY, V349, P300, DOI 10.1016/j.virol.2005.12.040; Gong J, 2011, ARCH VIROL, V156, P1997, DOI 10.1007/s00705-011-1097-6; Guenzel CA, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00127; Guenzel CA, 2012, J VIROL, V86, P2533, DOI 10.1128/JVI.05163-11; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; Ishikawa H, 2006, FEBS LETT, V580, P4784, DOI 10.1016/j.febslet.2006.07.066; Kaiser SM, 2006, J VIROL, V80, P875, DOI 10.1128/JVI.80.2.875-882.2006; Kajaste-Rudnitski A, 2011, J VIROL, V85, P5183, DOI 10.1128/JVI.02302-10; Kogan M, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-25; Li X, 2013, J VIROL, V87, P7234, DOI 10.1128/JVI.00620-13; LUZNIK L, 1995, J CLIN INVEST, V95, P328, DOI 10.1172/JCI117660; Lyonnais S, 2013, VIRUS RES, V171, P287, DOI 10.1016/j.virusres.2012.09.008; Mansky LM, 2000, J VIROL, V74, P7039, DOI 10.1128/JVI.74.15.7039-7047.2000; Maudet C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077320; Ndung'u T, 2011, VIRULENCE, V2, P360, DOI 10.4161/viru.2.4.16372; Nekorchuk MD, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-138; Nermut MV, 2003, J VIROL, V77, P8196, DOI 10.1128/JVI.77.15.8196-8206.2003; Nielsen MH, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-10; Niikura T, 2003, EUR J NEUROSCI, V17, P1150, DOI 10.1046/j.1460-9568.2003.02553.x; Okada H, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-43; Ozato K, 2008, NAT REV IMMUNOL, V8, P849, DOI 10.1038/nri2413; Parodi S, 2012, J MOL MED, V90, P1025, DOI 10.1007/s00109-012-0868-1; Pereira LA, 2000, NUCLEIC ACIDS RES, V28, P663, DOI 10.1093/nar/28.3.663; PERKINS ND, 1993, EMBO J, V12, P3551, DOI 10.1002/j.1460-2075.1993.tb06029.x; Pertel T, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-49; Raposo RAS, 2013, J VIROL, V87, P11924, DOI 10.1128/JVI.02128-13; Rohr O, 2003, J LEUKOCYTE BIOL, V74, P736, DOI 10.1189/jlb.0403180; Schrofelbauer B, 2005, J VIROL, V79, P10978, DOI 10.1128/JVI.79.17.10978-10987.2005; Sharifi HJ, 2012, CURR OPIN HIV AIDS, V7, P187, DOI 10.1097/COH.0b013e32835049e0; Sharifi HJ, 2014, J VIROL, V88, P6944, DOI 10.1128/JVI.00241-14; Song B, 2005, J VIROL, V79, P3930, DOI 10.1128/JVI.79.7.3930-3937.2005; Stremlau M, 2006, P NATL ACAD SCI USA, V103, P5514, DOI 10.1073/pnas.0509996103; Terreni M, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-18; Tuoc TC, 2008, GENE DEV, V22, P1972, DOI 10.1101/gad.471708; Uchil PD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040016; Uchil PD, 2013, J VIROL, V87, P257, DOI 10.1128/JVI.01804-12; Van Damme N, 2008, CELL HOST MICROBE, V3, P245, DOI 10.1016/j.chom.2008.03.001; Wen XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030939; Wiegand HL, 2004, EMBO J, V23, P2451, DOI 10.1038/sj.emboj.7600246; Yan N, 2012, NAT IMMUNOL, V13, P214, DOI 10.1038/ni.2229; Yang B, 2007, J BIOL CHEM, V282, P11667, DOI 10.1074/jbc.M606864200; Zhao RY, 2011, J NEUROIMMUNE PHARM, V6, P216, DOI 10.1007/s11481-011-9261-z; Zimmerman ES, 2004, MOL CELL BIOL, V24, P9286, DOI 10.1128/MCB.24.21.9286-9294.2004	50	11	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2014	9	8							e104269	10.1371/journal.pone.0104269	http://dx.doi.org/10.1371/journal.pone.0104269			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR0CG	25105968	Green Published, gold, Green Submitted			2022-12-27	WOS:000343231900046
J	Daudi, S; Eng, KH; Mhawech-Fauceglia, P; Morrison, C; Miliotto, A; Beck, A; Matsuzaki, J; Tsuji, T; Groman, A; Gnjatic, S; Spagnoli, G; Lele, S; Odunsi, K				Daudi, Sayeema; Eng, Kevin H.; Mhawech-Fauceglia, Paulette; Morrison, Carl; Miliotto, Anthony; Beck, Amy; Matsuzaki, Junko; Tsuji, Takemasa; Groman, Adrienne; Gnjatic, Sacha; Spagnoli, Guillo; Lele, Shashikant; Odunsi, Kunle			Expression and Immune Responses to MAGE Antigens Predict Survival in Epithelial Ovarian Cancer	PLOS ONE			English	Article							CYTOLYTIC T-LYMPHOCYTES; TESTIS ANTIGENS; CANCER/TESTIS ANTIGENS; GENE-EXPRESSION; PHASE-II; MELANOMA; NY-ESO-1; GAUGE; BAGE; IMMUNOTHERAPY	The MAGE cancer-testis antigens (CTA) are attractive candidates for immunotherapy. The aim of this study was to determine the frequency of expression, humoral immunity and prognostic significance of MAGE CTA in human epithelial ovarian cancer (EOC). mRNA or protein expression frequencies were determined for MAGE-A1, -A3, -A4, -A10 and -C1 (CT7) in tissue samples obtained from 400 patients with EOC. The presence of autologous antibodies against the MAGE antigens was determined from 285 serum samples. The relationships between MAGE expression, humoral immunity to MAGE antigens, and clinico-pathologic characteristics were studied. The individual frequencies of expression were as follows: A1: 15% (42/281), A3: 36% (131/390), A4: 47% (186/399), A10: 52% (204/395), C1: 16% (42/267). Strong concordant expression was noted with MAGE-A1:-A4, MAGE-A1:-C1 and MAGE-A4:-A10 (p<0.0005). Expression of MAGE-A1 or -A10 antigens resulted in poor progression free survival (PFS) (OR 1.44, CI 1.01-2.04, p = 0.044 and OR 1.3, CI 1.03-1.64, p = 0.03, respectively); whereas, MAGE-C1 expression was associated with improved PFS (OR 0.62, CI 0.42-0.92, p = 0.016). The improved PFS observed for MAGE-C1 expression, was diminished by co-expression of MAGE-A1 or -A10. Spontaneous humoral immunity to the MAGE antigens was present in 9% (27/285) of patients, and this predicted poor overall survival (log-rank test p = 0.0137). These findings indicate that MAGE-A1, MAGE-A4, MAGE-A3, and MAGE-A10 are priority attractive targets for polyvalent immunotherapy in ovarian cancer patients.	[Daudi, Sayeema; Miliotto, Anthony; Lele, Shashikant; Odunsi, Kunle] Roswell Pk Canc Inst, Dept Gynecol Oncol, Buffalo, NY 14263 USA; [Eng, Kevin H.; Groman, Adrienne] Roswell Pk Canc Inst, Dept Biostatisticsm, Buffalo, NY 14263 USA; [Mhawech-Fauceglia, Paulette] Univ So Calif, Dept Pathol, Los Angeles, CA 90089 USA; [Morrison, Carl] Roswell Pk Canc Inst, Dept Pathol, Buffalo, NY 14263 USA; [Miliotto, Anthony; Beck, Amy; Matsuzaki, Junko; Tsuji, Takemasa; Odunsi, Kunle] Roswell Pk Canc Inst, Ctr Immunotherapy, Buffalo, NY 14263 USA; [Matsuzaki, Junko; Tsuji, Takemasa; Odunsi, Kunle] Roswell Pk Canc Inst, Dept Immunol, Buffalo, NY 14263 USA; [Gnjatic, Sacha] Mt Sinai Hosp, Dept Med, New York, NY 10029 USA; [Spagnoli, Guillo] Univ Basel Hosp, Dept Biomed, CH-4031 Basel, Switzerland	Roswell Park Cancer Institute; Roswell Park Cancer Institute; University of Southern California; Roswell Park Cancer Institute; Roswell Park Cancer Institute; Roswell Park Cancer Institute; Icahn School of Medicine at Mount Sinai; University of Basel	Odunsi, K (corresponding author), Roswell Pk Canc Inst, Dept Gynecol Oncol, Buffalo, NY 14263 USA.	kunle.odunsi@roswellpark.org		Matsuzaki, Junko/0000-0002-2555-1234; Gnjatic, Sacha/0000-0001-5643-9520; Tsuji, Takemasa/0000-0001-7563-2211; Eng, Kevin/0000-0001-5636-0812	Cancer Research Institute Ovarian Cancer Working Group Grant; Cancer Vaccine Collaborative Grant of the Cancer Research Institute; Ludwig Institute for Cancer Research; Anna-Maria Kellen Clinical Investigator Award of the Cancer Research Institute; National Institutes of Health [5T32 CA 108456, R01CA158318-01A1]; Roswell Park Cancer Institute-University of Pittsburg Cancer Institute [P50CA159981-01A1]; NATIONAL CANCER INSTITUTE [R01CA158318, P50CA159981, T32CA108456, P30CA016056] Funding Source: NIH RePORTER	Cancer Research Institute Ovarian Cancer Working Group Grant; Cancer Vaccine Collaborative Grant of the Cancer Research Institute; Ludwig Institute for Cancer Research; Anna-Maria Kellen Clinical Investigator Award of the Cancer Research Institute; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Roswell Park Cancer Institute-University of Pittsburg Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by the Cancer Research Institute Ovarian Cancer Working Group Grant, Cancer Vaccine Collaborative Grant of the Cancer Research Institute and Ludwig Institute for Cancer Research, Anna-Maria Kellen Clinical Investigator Award of the Cancer Research Institute (to Kunle Odunsi), National Institutes of Health 5T32 CA 108456, National Institutes of Health R01CA158318-01A1 and Roswell Park Cancer Institute-University of Pittsburg Cancer Institute Ovarian Cancer Specialized Program of Research Excellence National Institutes of Health P50CA159981-01A1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade Valeria C C, 2008, Cancer Immun, V8, P2; [Anonymous], 1971, INT FEDERATION GYNEC, P1; BRASSEUR F, 1995, INT J CANCER, V63, P375, DOI 10.1002/ijc.2910630313; Bullock TNJ, 2003, J IMMUNOL, V170, P1822, DOI 10.4049/jimmunol.170.4.1822; Caballero OL, 2009, CANCER SCI, V100, P2014, DOI 10.1111/j.1349-7006.2009.01303.x; Chen YT, 1998, P NATL ACAD SCI USA, V95, P6919, DOI 10.1073/pnas.95.12.6919; COX DR, 1972, J R STAT SOC B, V34, P187; CREASMAN WT, 1989, GYNECOL ONCOL, V35, P129, DOI 10.1016/0090-8258(89)90028-0; Gillespie AM, 1998, BRIT J CANCER, V78, P816, DOI 10.1038/bjc.1998.585; Gjerstorff M, 2009, AM J PATHOL, V175, P314, DOI 10.2353/ajpath.2009.080893; Gnjatic Sacha, 2009, V520, P11, DOI 10.1007/978-1-60327-811-9_2; Gure AO, 2005, CLIN CANCER RES, V11, P8055, DOI 10.1158/1078-0432.CCR-05-1203; Jang SJ, 2001, CANCER RES, V61, P7959; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jungbluth AA, 2005, BLOOD, V106, P167, DOI 10.1182/blood-2004-12-4931; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kim J, 2006, INT J CANCER, V118, P2269, DOI 10.1002/ijc.21656; Kondo T, 2007, CLIN CANCER RES, V13, P4713, DOI 10.1158/1078-0432.CCR-07-0618; Kruit WHJ, 2013, J CLIN ONCOL, V31, P2413, DOI 10.1200/JCO.2012.43.7111; Landry C, 2000, INT J CANCER, V86, P835, DOI 10.1002/(SICI)1097-0215(20000615)86:6<835::AID-IJC12>3.0.CO;2-N; Liu W, 2008, CANCER RES, V68, P8104, DOI 10.1158/0008-5472.CAN-08-2132; Monte M, 2006, P NATL ACAD SCI USA, V103, P11160, DOI 10.1073/pnas.0510834103; Odunsi K, 2003, CANCER RES, V63, P6076; Odunsi K, 2007, P NATL ACAD SCI USA, V104, P12837, DOI 10.1073/pnas.0703342104; Odunsi K, 2014, CANCER IMMUNOL RES, V2, P37, DOI 10.1158/2326-6066.CIR-13-0126; Odunsi K, 2012, P NATL ACAD SCI USA, V109, P5797, DOI 10.1073/pnas.1117208109; Okabayashi K, 2012, CANCER SCI, V103, P1617, DOI 10.1111/j.1349-7006.2012.02355.x; Otte M, 2001, CANCER RES, V61, P6682; Ozols RF, 2003, J CLIN ONCOL, V21, P3194, DOI 10.1200/JCO.2003.02.153; PATARD JJ, 1995, INT J CANCER, V64, P60, DOI 10.1002/ijc.2910640112; Picard V, 2007, INT J CANCER, V120, P2170, DOI 10.1002/ijc.22282; Russo V, 1996, INT J CANCER, V67, P457, DOI 10.1002/(SICI)1097-0215(19960729)67:3<457::AID-IJC24>3.0.CO;2-3; SAHIN U, 1995, P NATL ACAD SCI USA, V92, P11810, DOI 10.1073/pnas.92.25.11810; Schultz-Thater E, 2011, INT J CANCER, V129, P1137, DOI 10.1002/ijc.25777; Serov S, 1973, INT HISTOLOGICAL CLA, P51; Shimizu Y, 1998, CANCER-AM CANCER SOC, V82, P893, DOI 10.1002/(SICI)1097-0142(19980301)82:5<893::AID-CNCR14>3.0.CO;2-W; Simpson AJG, 2005, NAT REV CANCER, V5, P615, DOI 10.1038/nrc1669; Stockert E, 1998, J EXP MED, V187, P1349, DOI 10.1084/jem.187.8.1349; VANDENEYNDE B, 1995, J EXP MED, V182, P689, DOI 10.1084/jem.182.3.689; VANDERBRUGGEN P, 1991, SCIENCE, V254, P1643, DOI 10.1126/science.1840703; Vansteenkiste J, 2013, J CLIN ONCOL, V31, P2396, DOI 10.1200/JCO.2012.43.7103; Yakirevich E, 2003, CLIN CANCER RES, V9, P6453; Zhang SQ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-163	43	52	57	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e104099	10.1371/journal.pone.0104099	http://dx.doi.org/10.1371/journal.pone.0104099			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25101620	Green Submitted, Green Published, gold			2022-12-27	WOS:000339993900037
J	Kust, N; Rybalkina, E; Mertsalov, I; Savchenko, E; Revishchin, A; Pavlova, G				Kust, Nadezda; Rybalkina, Ekaterina; Mertsalov, Ilya; Savchenko, Ekaterina; Revishchin, Alexander; Pavlova, Gali			Functional Analysis of Drosophila HSP70 Promoter with Different HSE Numbers in Human Cells	PLOS ONE			English	Article							HEAT-SHOCK GENE; EMBRYONIC STEM-CELLS; TRANSGENE EXPRESSION; IMMUNE-RESPONSE; TRANSCRIPTION; VIRUS; TRANSACTIVATOR; PROTEINS; VECTORS; BRAIN	The activation of genetic constructs including the Drosophila hsp70 promoter with four and eight HSE sequences in the regulatory region has been described in human cells. The promoter was shown to be induced at lower temperatures compared to the human hsp70 promoter. The promoter activity increased after a 60-min heat shock already at 38 degrees C in human cells. The promoter activation was observed 24 h after heat shock for the constructs with eight HSEs, while those with four HSEs required 48 h. After transplantation of in vitro heat-shocked transfected cells, the promoter activity could be maintained for 3 days with a gradual decline. The promoter activation was confirmed in vivo without preliminary heat shock in mouse ischemic brain foci. Controlled expression of the Gdnf gene under a Drosophila hsp70 promoter was demonstrated. This promoter with four and eight HSE sequences in the regulatory region can be proposed as a regulated promoter in genetic therapeutic systems.	[Kust, Nadezda; Mertsalov, Ilya; Revishchin, Alexander; Pavlova, Gali] Russian Acad Sci, Inst Gene Biol, Moscow, Russia; [Savchenko, Ekaterina; Revishchin, Alexander; Pavlova, Gali] Inst Med & Cell Transplantat, Moscow, Russia; [Kust, Nadezda; Rybalkina, Ekaterina; Savchenko, Ekaterina; Revishchin, Alexander; Pavlova, Gali] Ltd Apto Pharm, Moscow, Russia	Russian Academy of Sciences; Institute of Gene Biology (IGB) of Russian Academy of Sciences	Pavlova, G (corresponding author), Russian Acad Sci, Inst Gene Biol, Moscow, Russia.	lkorochkin@mail.ru	Rybalkina, Ekaterina/B-6860-2019; Revishchin, Alexander/AAO-4863-2020; Pavlova, Galina/AAO-4691-2020	Pavlova, Galina/0000-0002-6885-6601; Mertsalov, Ilya/0000-0001-9175-0592; Revishchin, Alexandr/0000-0002-6007-6440	Russian Foundation for Basic Research [13-04-40200H, 13-00-40200K]; Program "Molecular and Cell Biology"; Ministry of Science and Education of the Russian Federation [16.552.11.7067]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Program "Molecular and Cell Biology"; Ministry of Science and Education of the Russian Federation(Ministry of Education and Science, Russian Federation)	This work was supported by Russian Foundation for Basic Research (project nos. 13-04-40200H, 13-00-40200K) and Program "Molecular and Cell Biology". Experiments were performed using the equipment of the IGB RAS facilities supported by the Ministry of Science and Education of the Russian Federation (grants 16.552.11.7067). The authors express appreciation to Vladimir E. Babiy for administration and funding. Authors N. Kust, E. Rybalkina, A. Revishchin, E. Savchenko and G. Pavlova are employed by Ltd Apto-pharm who provided support in the form of salaries for these authors but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "Author Contributions" section.	ABRAVAYA K, 1991, MOL CELL BIOL, V11, P586, DOI 10.1128/MCB.11.1.586; AMIN J, 1988, MOL CELL BIOL, V8, P3761, DOI 10.1128/MCB.8.9.3761; Andreeva L E, 2008, Genetika, V44, P992; BIENZ M, 1987, ADV GENET, V24, P31, DOI 10.1016/S0065-2660(08)60006-1; CORCES V, 1984, J BIOL CHEM, V259, P4812; CORCES V, 1981, P NATL ACAD SCI-BIOL, V78, P7038, DOI 10.1073/pnas.78.11.7038; DIENEL GA, 1986, J CEREBR BLOOD F MET, V6, P505, DOI 10.1038/jcbfm.1986.86; Favre D, 2002, J VIROL, V76, P11605, DOI 10.1128/JVI.76.22.11605-11611.2002; Fernandes M., 1994, BIOL HEAT SHOCK PROT, P375; Hong S, 2007, MOL THER, V15, P1630, DOI 10.1038/sj.mt.6300251; KENNEDY PGE, 1985, NEUROSCI LETT, V61, P321, DOI 10.1016/0304-3940(85)90484-7; Korochkin L. I., 2000, Genetika, V36, P1436; Latta-Mahieu M, 2002, HUM GENE THER, V13, P1611, DOI 10.1089/10430340260201707; Pavlova GV, 2005, B EXP BIOL MED+, V139, P514, DOI 10.1007/s10517-005-0333-z; PELHAM HRB, 1982, EMBO J, V1, P1473, DOI 10.1002/j.1460-2075.1982.tb01340.x; Qin JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010611; SCHLESINGER MJ, 1986, J CELL BIOL, V103, P321, DOI 10.1083/jcb.103.2.321; SCHWEINFEST CW, 1988, GENE, V71, P207, DOI 10.1016/0378-1119(88)90093-5; Stieger K, 2009, ADV DRUG DELIVER REV, V61, P527, DOI 10.1016/j.addr.2008.12.016; WEI R, 1986, NUCLEIC ACIDS RES, V14, P8183, DOI 10.1093/nar/14.20.8183; Wilkerson DC, 2007, CELL STRESS CHAPERON, V12, P283, DOI 10.1379/CSC-250.1; Wu C, 1995, ANNU REV CELL DEV BI, V11, P441, DOI 10.1146/annurev.cellbio.11.1.441; XIAO H, 1988, SCIENCE, V239, P1139, DOI 10.1126/science.3125608; XIAO H, 1991, CELL, V64, P585, DOI 10.1016/0092-8674(91)90242-Q; XIAO H, 1989, MOL CELL BIOL, V9, P1746, DOI 10.1128/MCB.9.4.1746; Xiong WD, 2006, J VIROL, V80, P27, DOI 10.1128/JVI.80.1.27-37.2006	26	6	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e101994	10.1371/journal.pone.0101994	http://dx.doi.org/10.1371/journal.pone.0101994			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25101947	Green Submitted, Green Published, gold			2022-12-27	WOS:000339993900001
J	Daigle, CL; Banerjee, D; Montgomery, RA; Biswas, S; Siegford, JM				Daigle, Courtney L.; Banerjee, Debasmit; Montgomery, Robert A.; Biswas, Subir; Siegford, Janice M.			Moving GIS Research Indoors: Spatiotemporal Analysis of Agricultural Animals	PLOS ONE			English	Article							LAYING HENS; BEHAVIOR; WELFARE; PREDICT	A proof of concept applying wildlife ecology techniques to animal welfare science in intensive agricultural environments was conducted using non-cage laying hens. Studies of wildlife ecology regularly use Geographic Information Systems (GIS) to assess wild animal movement and behavior within environments with relatively unlimited space and finite resources. However, rather than depicting landscapes, a GIS could be developed in animal production environments to provide insight into animal behavior as an indicator of animal welfare. We developed a GIS-based approach for studying agricultural animal behavior in an environment with finite space and unlimited resources. Concurrent data from wireless body-worn location tracking sensor and video-recording systems, which depicted spatially-explicit behavior of hens (135 hens/room) in two identical indoor enclosures, were collected. The spatial configuration of specific hen behaviors, variation in home range patterns, and variation in home range overlap show that individual hens respond to the same environment differently. Such information could catalyze management practice adjustments (e.g., modifying feeder design and/or location). Genetically similar hens exhibited diverse behavioral and spatial patterns via a proof of concept approach enabling detailed examinations of individual non-cage laying hen behavior and welfare.	[Daigle, Courtney L.; Siegford, Janice M.] Michigan State Univ, Dept Anim Sci, E Lansing, MI 48824 USA; [Banerjee, Debasmit; Biswas, Subir] Michigan State Univ, Dept Elect & Comp Engn, E Lansing, MI 48824 USA; [Montgomery, Robert A.] Michigan State Univ, Dept Fisheries & Wildlife, E Lansing, MI 48824 USA	Michigan State University; Michigan State University; Michigan State University	Siegford, JM (corresponding author), Michigan State Univ, Dept Anim Sci, E Lansing, MI 48824 USA.	siegford@msu.edu	, Janice/ABA-3975-2020; Siegford, Janice/AAH-1838-2020; Montgomery, Robert A./C-5541-2019	, Janice/0000-0002-1000-3147; Siegford, Janice/0000-0002-1000-3147; Montgomery, Robert A./0000-0001-5894-0589	United States Department of Agriculture; Agricultural and Food Research Initiative Award [2009-65120-05752]	United States Department of Agriculture(United States Department of Agriculture (USDA)); Agricultural and Food Research Initiative Award	Funding came from the United States Department of Agriculture, Agricultural and Food Research Initiative Award #2009-65120-05752 to Dr. Janice Siegford. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee D, 2012, BODY SENSOR NETWORKS, P107; Boddugari K, 2001, J DAIRY SCI, V84, P873, DOI 10.3168/jds.S0022-0302(01)70210-X; Browne WJ, 2011, APPL ANIM BEHAV SCI, V134, P152, DOI 10.1016/j.applanim.2011.07.004; Buckley NJ, 1997, AM NAT, V149, P1091, DOI 10.1086/286040; Cloutier S, 2000, BEHAVIOUR, V137, P705, DOI 10.1163/156853900502303; Daigle CL, 2012, POULTRY SCI, V91, P2415, DOI 10.3382/ps.2012-02300; Daigle CL, 2014, BEHAV PROCESS, V103, P58, DOI 10.1016/j.beproc.2013.11.002; Dawkins MS, 2003, ZOOLOGY, V106, P383, DOI 10.1078/0944-2006-00122; DUNCAN IJH, 1972, ANIM BEHAV, V20, P444, DOI 10.1016/S0003-3472(72)80007-1; DUNCAN IJH, 1972, ANIM BEHAV, V20, P68, DOI 10.1016/S0003-3472(72)80174-X; Duncan IJH, 1993, ALTERNATIVE HOUSING, V7, P69; Farris CA, 2010, ECOL APPL, V20, P1598, DOI 10.1890/09-1535.1; FASS, 2010, GUID CAR US AGR AN R, V3rd; Fraser D, 2008, ACTA VET SCAND, V50, DOI 10.1186/1751-0147-50-S1-S1; GENTLE MJ, 1990, APPL ANIM BEHAV SCI, V27, P149, DOI 10.1016/0168-1591(90)90014-5; Gitzen RA, 2003, WILDLIFE SOC B, V31, P823; Gitzen RA, 2006, J WILDLIFE MANAGE, V70, P1334, DOI 10.2193/0022-541X(2006)70[1334:BSFFAO]2.0.CO;2; HESTER PY, 1994, POULTRY SCI, V73, P904, DOI 10.3382/ps.0730904; Johnson DS, 2008, ECOLOGY, V89, P1208, DOI 10.1890/07-1032.1; Kernohan B, 2001, RADIOTRACKING ANIMAL; Kristensen HH, 2000, APPL ANIM BEHAV SCI, V68, P307, DOI 10.1016/S0168-1591(00)00110-6; Kuenzel WJ, 2007, POULTRY SCI, V86, P1273, DOI 10.1093/ps/86.6.1273; Lee HJ, 2011, J R SOC INTERFACE, V8, P489, DOI 10.1098/rsif.2010.0268; Mishra A, 2005, POULTRY SCI, V84, P979, DOI 10.1093/ps/84.7.979; Nicol CJ, 2011, ANIM BEHAV, V82, P255, DOI 10.1016/j.anbehav.2011.04.022; NICOL CJ, 1989, APPL ANIM BEHAV SCI, V22, P75, DOI 10.1016/0168-1591(89)90081-6; O'Connor EA, 2011, APPL ANIM BEHAV SCI, V135, P293, DOI 10.1016/j.applanim.2011.09.011; Sih A, 2004, Q REV BIOL, V79, P241, DOI 10.1086/422893; Weary DM, 2009, J ANIM SCI, V87, P770, DOI 10.2527/jas.2008-1297; Weeks CA, 2000, APPL ANIM BEHAV SCI, V67, P111, DOI 10.1016/S0168-1591(99)00102-1; WILLIAMS NS, 1984, PHARMACOL BIOCHEM BE, V20, P681, DOI 10.1016/0091-3057(84)90184-9; Zimmerman PH, 2000, APPL ANIM BEHAV SCI, V69, P265, DOI 10.1016/S0168-1591(00)00136-2	32	18	18	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e104002	10.1371/journal.pone.0104002	http://dx.doi.org/10.1371/journal.pone.0104002			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25098421	Green Published, Green Submitted, gold			2022-12-27	WOS:000339995100043
J	Lee, SM; Yang, S; Cha, RH; Kim, M; An, JN; Paik, JH; Kim, DK; Kang, SW; Lim, CS; Kim, YS; Lee, JP				Lee, Su Mi; Yang, SeungHee; Cha, Ran-Hui; Kim, Myounghee; An, Jung Nam; Paik, Jin Ho; Kim, Dong Ki; Kang, Shin-Wook; Lim, Chun Soo; Kim, Yon Su; Lee, Jung Pyo			Circulating TNF Receptors Are Significant Prognostic Biomarkers for Idiopathic Membranous Nephropathy	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; KIDNEY; EXPRESSION; ALPHA; PREDICT; DAMAGE; RISK; INFLAMMATION; PROGRESSION; DISEASE	Idiopathic membranous nephropathy (iMN) is a common cause of nephrotic syndrome in adults. A biomarker to accurately indicate the severity of iMN and predict long-term prognosis is insufficient. Here, we evaluated the clinical significance of circulating tumor necrosis factor receptors (cTNFRs) as prognostic biomarkers of iMN with nephrotic syndrome. A total of 113 patients with biopsy-proven iMN and 43 healthy volunteers were enrolled in this study. Ninety patients with iMN had nephrotic range proteinuria. Levels of cTNFRs were measured by using serum samples collected at the time of initial diagnosis. Levels of cTNFRs were higher in the patients with nephrotic syndrome than in those with subnephrotic range proteinuria or in the healthy volunteers (P for trend <0.001). Estimated glomerular filtration rate and proteinuria tended to worsen as the cTNFRs levels increased. Having a cTNFR1 level within the highest tertile was a significant risk factor for renal progression after adjustment, in comparison with the other tertiles (hazard ratio [HR], 3.39, 95% confidence interval [95% CI], 48-7.78; P=0.004). The cTNFR2 level within the highest tertile also significantly increased the risk of renal progression (HR, 3.29; 95% CI, 1.43-7.54- P=0.005) Renal tubular TNFRs expression was associated with cTNFRs level. However, the cTNFRs levels were not associated with autoantibody against phospholipase A(2) receptor reactivity/levels or treatment response. This study demonstrated that cTNFRs levels at he time of initial diagnosis could predict renal progression in patients with	[Lee, Su Mi; Yang, SeungHee; An, Jung Nam; Kim, Dong Ki; Kim, Yon Su] Seoul Natl Univ Hosp, Dept Internal Med, Seoul 110744, South Korea; [Lee, Su Mi] Dong A Univ, Dept Internal Med, Pusan, South Korea; [Yang, SeungHee; Kim, Dong Ki; Kim, Yon Su] Seoul Natl Univ, Kidney Res Inst, Seoul, South Korea; [Cha, Ran-Hui] Natl Med Ctr, Dept Internal Med, Seoul, South Korea; [Kim, Myounghee] Eulji Univ, Coll Hlth Sci, Dept Dent Hyg, Songnam, South Korea; [An, Jung Nam; Lee, Jung Pyo] Seoul Natl Univ, Dept Internal Med, Boramae Med Ctr, Seoul, South Korea; [Paik, Jin Ho] Seoul Natl Univ, Bundang Hosp, Dept Pathol, Songnam, South Korea; [Kang, Shin-Wook] Yonsei Univ, Severance Biomed Sci Inst, Brain Korea 21, Seoul 120749, South Korea; [Kang, Shin-Wook] Yonsei Univ, Dept Internal Med, Seoul 120749, South Korea	Seoul National University (SNU); Seoul National University Hospital; Dong A University; Seoul National University (SNU); National Medical Center - Korea; Eulji University; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Yonsei University; Yonsei University	Lee, JP (corresponding author), Seoul Natl Univ, Dept Internal Med, Boramae Med Ctr, Seoul, South Korea.	nephrolee@gmail.com	Kim, Dong Ki/J-5389-2012	Kim, Dong Ki/0000-0002-5195-7852	Korea Healthcare Technology R&D Project, Ministry for Health, Welfare and Family Affairs, Republic of Korea [A070001]	Korea Healthcare Technology R&D Project, Ministry for Health, Welfare and Family Affairs, Republic of Korea	This study was funded by the Korea Healthcare Technology R&D Project, Ministry for Health, Welfare and Family Affairs, Republic of Korea (A070001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Lamki RS, 2001, LAB INVEST, V81, P1503, DOI 10.1038/labinvest.3780364; BAUD L, 1995, MINER ELECTROL METAB, V21, P336; Beck LH, 2009, NEW ENGL J MED, V361, P11, DOI 10.1056/NEJMoa0810457; BERTANI T, 1989, AM J PATHOL, V134, P419; Cattran D, 2005, J AM SOC NEPHROL, V16, P1188, DOI 10.1681/ASN.2005010028; Cattran DC, 2001, KIDNEY INT, V59, P1983, DOI 10.1046/j.1523-1755.2001.0590051983.x; DAMICO G, 1995, AM J KIDNEY DIS, V26, P124, DOI 10.1016/0272-6386(95)90165-5; Eddy AA, 2004, NEPHROL DIAL TRANSPL, V19, P277, DOI 10.1093/ndt/gfg533; EHRENREICH T, 1976, NEW ENGL J MED, V295, P741, DOI 10.1056/NEJM197609302951401; Ernandez T, 2009, KIDNEY INT, V76, P262, DOI 10.1038/ki.2009.142; FATTORI E, 1994, BLOOD, V83, P2570; Gohda T, 2012, J AM SOC NEPHROL, V23, P516, DOI 10.1681/ASN.2011060628; Harris RC, 2006, ANNU REV MED, V57, P365, DOI 10.1146/annurev.med.57.121304.131342; HASEGAWA G, 1991, KIDNEY INT, V40, P1007, DOI 10.1038/ki.1991.308; Hasegawa M, 2009, NEPHRON CLIN PRACT, V113, pC222, DOI 10.1159/000235242; Hehlgans T, 2005, IMMUNOLOGY, V115, P1, DOI 10.1111/j.1365-2567.2005.02143.x; Hofstra JM, 2012, J AM SOC NEPHROL, V23, P1735, DOI 10.1681/ASN.2012030242; HONKANEN E, 1992, NEPHROL DIAL TRANSPL, V7, P35; Idasiak-Piechocka I, 2010, NEPHROL DIAL TRANSPL, V25, P3948, DOI 10.1093/ndt/gfq310; Jha V, 2007, J AM SOC NEPHROL, V18, P1899, DOI 10.1681/ASN.2007020166; Lai KN, 2008, AM J PHYSIOL-RENAL, V294, pF945, DOI 10.1152/ajprenal.00423.2007; Lan HY, 1998, NEPHROL DIAL TRANSPL, V13, P7, DOI 10.1093/ndt/13.1.7; Lee CS, 2010, J KOREAN MED SCI, V25, P1616, DOI 10.3346/jkms.2010.25.11.1616; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lorenzen I, 2011, BIOCHEM BIOPH RES CO, V415, P330, DOI 10.1016/j.bbrc.2011.10.056; MAGIL AB, 1995, AM J KIDNEY DIS, V25, P375, DOI 10.1016/0272-6386(95)90097-7; Nangaku M, 2006, J AM SOC NEPHROL, V17, P17, DOI 10.1681/ASN.2005070757; Navarro JF, 2006, CYTOKINE GROWTH F R, V17, P441, DOI 10.1016/j.cytogfr.2006.09.011; Niewczas MA, 2012, J AM SOC NEPHROL, V23, P507, DOI 10.1681/ASN.2011060627; Oh YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062151; PEI Y, 1992, KIDNEY INT, V42, P960, DOI 10.1038/ki.1992.374; Reichert LJM, 1998, AM J KIDNEY DIS, V31, P1, DOI 10.1053/ajkd.1998.v31.pm9428445; Remuzzi G, 1998, NEW ENGL J MED, V339, P1448, DOI 10.1056/NEJM199811123392007; Rivera F, 2004, KIDNEY INT, V66, P898, DOI 10.1111/j.1523-1755.2004.00833.x; Sean Eardley K, 2005, KIDNEY INT, V68, P437, DOI 10.1111/j.1523-1755.2005.00422.x; Shankar A, 2011, KIDNEY INT, V80, P1231, DOI 10.1038/ki.2011.283; Sprangers B, 2012, AM J NEPHROL, V36, P78, DOI 10.1159/000339628; Takahashi K, 1998, J IMMUNOL, V161, P2629; Timoshanko JR, 2003, J AM SOC NEPHROL, V14, P1785, DOI 10.1097/01.ASN.0000073902.38428.33; Tonelli M, 2005, KIDNEY INT, V68, P237, DOI 10.1111/j.1523-1755.2005.00398.x; Waldman M, 2009, NAT REV NEPHROL, V5, P469, DOI 10.1038/nrneph.2009.101; Wu TF, 2007, ARTHRITIS RHEUM-US, V56, P949, DOI 10.1002/art.22556; Yokoyama H, 2012, CLIN EXP NEPHROL, V16, P557, DOI 10.1007/s10157-012-0593-7; Zhu L, 2009, LUPUS, V18, P116, DOI 10.1177/0961203308094764	44	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e104354	10.1371/journal.pone.0104354	http://dx.doi.org/10.1371/journal.pone.0104354			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25098821	Green Published, gold, Green Submitted			2022-12-27	WOS:000339995100066
J	Okinami, T; Imamura, M; Nishikawa, N; Negoro, H; Sugino, Y; Yoshimura, K; Kanematsu, A; Hashitani, H; Ogawa, O				Okinami, Takeshi; Imamura, Masaaki; Nishikawa, Nobuyuki; Negoro, Hiromitsu; Sugino, Yoshio; Yoshimura, Koji; Kanematsu, Akihiro; Hashitani, Hikaru; Ogawa, Osamu			Altered Detrusor Gap Junction Communications Induce Storage Symptoms in Bladder Inflammation: A Mouse Cyclophosphamide-Induced Model of Cystitis	PLOS ONE			English	Article							URINARY-TRACT SYMPTOMS; OVERACTIVE BLADDER; SMOOTH-MUSCLE; CONNEXIN EXPRESSION; INCONTINENCE; INVOLVEMENT; GENERATION; CELLS; MEN	Lower urinary tract symptoms (LUTS) include storage, voiding and post-micturition symptoms, featuring many urological diseases. Storage symptoms are the most frequent among these and associated with overactive bladder and non-bacterial bladder inflammation such as interstitial cystitis/bladder pain syndrome (IC/BPS). Gap junction, a key regulator of hyperactive conditions in the bladder, has been reported to be involved in pathological bladder inflammation. Here we report involvement of gap junction in the etiology of storage symptoms in bladder inflammation. In this study, cyclophosphamide-induced cystitis was adapted as a model of bladder inflammation. Cyclophosphamide-treated mice showed typical storage symptoms including increased urinary frequency and reduced bladder capacity, with concurrent up-regulation of connexin 43 (GJA1), one of the major gap junction proteins in the bladder. In isometric tension study, bladder smooth muscle strips taken from the treated mice showed more pronounced spontaneous contraction than controls, which was attenuated by carbenoxolone, a gap junction inhibitor. In voiding behavior studies, the storage symptoms in the treated mice characterized by frequent voiding were alleviated by 18 alpha-glycyrrhetinic acid, another gap junction inhibitor. These results demonstrate that cyclophosphamide-induced mouse model of cystitis shows clinical storage symptoms related with bladder inflammation and that gap junction in the bladder may be a key molecule of these storage symptoms. Therefore, gap junction in the bladder might be an alternative therapeutic target for storage symptoms in bladder inflammation.	[Okinami, Takeshi; Imamura, Masaaki; Nishikawa, Nobuyuki; Negoro, Hiromitsu; Sugino, Yoshio; Yoshimura, Koji; Ogawa, Osamu] Kyoto Univ, Grad Sch Med, Dept Urol, Kyoto, Japan; [Kanematsu, Akihiro] Hyogo Coll Med, Dept Urol, Nishinomiya, Hyogo 6638501, Japan; [Nishikawa, Nobuyuki; Hashitani, Hikaru] Nagoya City Univ, Grad Sch Med Sci, Dept Cell Physiol, Nagoya, Aichi, Japan	Kyoto University; Hyogo College of Medicine; Nagoya City University	Ogawa, O (corresponding author), Kyoto Univ, Grad Sch Med, Dept Urol, Kyoto, Japan.	ogawao@kuhp.kyoto-u.ac.jp	Hashitani, Hikaru/AAI-3350-2020; Negoro, Hiromitsu/AAW-3261-2021	Negoro, Hiromitsu/0000-0003-1144-2755	Suzuki Urological Foundation;  [25462511];  [23-4448]	Suzuki Urological Foundation; ; 	This work was supported by Grant-in-Aid for Scientific Research (KAKENHI) No. 25462511 (YK), Grant-in-Aid for JSPS Fellows No. 23-4448 (TO) (http://www.jsps.go.jp/index.html), and Suzuki Urological Foundation (HN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams P, 2003, UROLOGY, V61, P37, DOI 10.1016/S0090-4295(02)02243-4; Andersson KE, 2004, LANCET NEUROL, V3, P46, DOI 10.1016/S1474-4422(03)00622-7; Andersson KE, 1999, BJU INT, V84, P923; Apostolidis A, 2008, EUR UROL, V53, P1245, DOI 10.1016/j.eururo.2008.02.037; Chapple CR, 2006, EUR UROL, V49, P651, DOI 10.1016/j.eururo.2006.02.018; Charrua A, 2007, J UROLOGY, V177, P1537, DOI 10.1016/j.juro.2006.11.046; Comperat E, 2006, EUR UROL, V50, P1058, DOI 10.1016/j.eururo.2006.01.025; Coyne KS, 2008, BJU INT, V101, P1388, DOI 10.1111/j.1464-410X.2008.07601.x; Coyne KS, 2013, NEUROUROL URODYNAM, V32, P230, DOI 10.1002/nau.22295; Dupont E, 2001, J MOL CELL CARDIOL, V33, P359, DOI 10.1006/jmcc.2000.1308; Efimov IR, 2004, ANAT REC PART A, V280A, P952, DOI 10.1002/ar.a.20108; Everaerts W, 2010, P NATL ACAD SCI USA, V107, P19084, DOI 10.1073/pnas.1005333107; Fall M, 2010, EUR UROL, V57, P35, DOI 10.1016/j.eururo.2009.08.020; Fry CH, 2007, NEUROUROL URODYNAM, V26, P914, DOI 10.1002/nau.20483; Ganz ML, 2010, UROLOGY, V75, P533, DOI [10.1016/j.urology.2009.06.096, 10.1016/j.urology.2009.08.003]; Hanno PM, 2011, J UROLOGY, V185, P2162, DOI 10.1016/j.juro.2011.03.064; Hashitani H, 2004, J PHYSIOL-LONDON, V559, P567, DOI 10.1113/jphysiol.2004.065136; Hashitani H, 2004, BRIT J PHARMACOL, V141, P183, DOI 10.1038/sj.bjp.0705602; Hayase M, 2009, J UROLOGY, V181, P2355, DOI 10.1016/j.juro.2009.01.013; Heinrich M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020792; Hu TW, 2000, AM J MANAG CARE, V6, pS591; Ikeda Y, 2007, AM J PHYSIOL-RENAL, V293, pF1018, DOI 10.1152/ajprenal.00183.2007; Imamura M, 2013, J CELL PHYSIOL, V228, P1819, DOI 10.1002/jcp.24333; Imamura M, 2009, AM J PHYSIOL-RENAL, V297, pF46, DOI 10.1152/ajprenal.90207.2008; Irwin DE, 2006, EUR UROL, V50, P1306, DOI 10.1016/j.eururo.2006.09.019; Johnson MH, 2013, J UROLOGY, V189, P1268, DOI 10.1016/j.juro.2012.10.070; Kumar NM, 1996, CELL, V84, P381, DOI 10.1016/S0092-8674(00)81282-9; Li K, 2011, J BIOL CHEM, V286, P41552, DOI 10.1074/jbc.M111.274449; Li LK, 2007, AM J PHYSIOL-CELL PH, V293, pC1627, DOI 10.1152/ajpcell.00122.2007; McCarthy CJ, 2009, J UROLOGY, V181, P1459, DOI 10.1016/j.juro.2008.10.139; Negoro H, 2013, SCI REP-UK, V3, DOI 10.1038/srep02152; Negoro H, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1812; Neuhaus J, 2009, EUR UROL, V55, P491, DOI 10.1016/j.eururo.2008.03.090; Ouslander JG, 2004, NEW ENGL J MED, V350, P786, DOI 10.1056/NEJMra032662; Petkov GV, 2001, J PHYSIOL-LONDON, V537, P443, DOI 10.1111/j.1469-7793.2001.00443.x; Saban Marcia R., 2011, BMC Physiology, V11, P16, DOI 10.1186/1472-6793-11-16; Sui G, 2013, AM J PHYSL RENAL PHY; Sui GP, 2002, BJU INT, V90, P118, DOI 10.1046/j.1464-410X.2002.02834.x; Takeda Y, 2005, AM J PHYSIOL-GASTR L, V288, pG832, DOI 10.1152/ajpgi.00389.2004; Tincello DG, 2005, EUR J OBSTET GYN R B, V118, P91, DOI 10.1016/j.ejogrb.2004.06.012	40	19	19	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e104216	10.1371/journal.pone.0104216	http://dx.doi.org/10.1371/journal.pone.0104216			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25099633	gold, Green Published, Green Submitted			2022-12-27	WOS:000339995100053
J	Singh, P; Jayaramaiah, RH; Sarate, P; Thulasiram, HV; Kulkarni, MJ; Giri, AP				Singh, Priyanka; Jayaramaiah, Ramesha H.; Sarate, Priya; Thulasiram, Hirekodathakallu V.; Kulkarni, Mahesh J.; Giri, Ashok P.			Insecticidal Potential of Defense Metabolites from Ocimum kilimandscharicum against Helicoverpa armigera	PLOS ONE			English	Article							PLANT; AMYLASES; PEST	Genus Ocimum contains a reservoir of diverse secondary metabolites, which are known for their defense and medicinal value. However, the defense-related metabolites from this genus have not been studied in depth. To gain deeper insight into inducible defense metabolites, we examined the overall biochemical and metabolic changes in Ocimum kilimandscharicum that occurred in response to the feeding of Helicoverpa armigera larvae. Metabolic analysis revealed that the primary and secondary metabolism of local and systemic tissues in O. kilimandscharicum was severely affected following larval infestation. Moreover, levels of specific secondary metabolites like camphor, limonene and beta-caryophyllene (known to be involved in defense) significantly increased in leaves upon insect attack. Choice assays conducted by exposing H. armigera larvae on O. kilimandscharicum and tomato leaves, demonstrated that O. kilimandscharicum significantly deters larval feeding. Further, when larvae were fed on O. kilimandscharicum leaves, average body weight decreased and mortality the larvae increased. Larvae fed on artificial diet supplemented with O. kilimandscharicum leaf extract, camphor, limonene and beta-caryophyllene showed growth retardation, increased mortality rates and pupal deformities. Digestive enzymes of H. armigera - namely, amylase, protease and lipase- showed variable patterns after feeding on O. kilimandscharicum, which implies striving of the larvae to attain required nutrition for growth, development and metamorphosis. Evidently, selected metabolites from O. kilimandscharicum possess significant insecticidal activity.	[Singh, Priyanka; Jayaramaiah, Ramesha H.; Sarate, Priya; Giri, Ashok P.] CSIR, Natl Chem Lab, Div Biochem Sci, Plant Mol Biol Unit, Pune, Maharashtra, India; [Singh, Priyanka; Thulasiram, Hirekodathakallu V.] CSIR, Natl Chem Lab, Div Organ Chem, Chem Biol Unit, Pune, Maharashtra, India; [Thulasiram, Hirekodathakallu V.] CSIR, Inst Genom & Integrat Biol, New Delhi 110001, India; [Kulkarni, Mahesh J.] CSIR, Natl Chem Lab, Div Biochem Sci, Prote Facil, Pune, Maharashtra, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Chemical Laboratory (NCL); Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Chemical Laboratory (NCL); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Chemical Laboratory (NCL)	Giri, AP (corresponding author), CSIR, Natl Chem Lab, Div Biochem Sci, Plant Mol Biol Unit, Pune, Maharashtra, India.	ap.giri@ncl.res.in	Jayaramaiah, Ramesha H./AAR-7246-2020; Kulkarni, Mahesh J/G-1473-2010	Jayaramaiah, Ramesha H./0000-0003-4237-9664; 	CSIR, New Delhi [BSC0124]	CSIR, New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	This work is financially supported by CSIR, New Delhi sponsored network project (BSC0124). The funders had no role in study design, data and analysis, decision to publish, or preparation of the manuscript.	Bekele J, 2001, PHYTOCHEMISTRY, V57, P385, DOI 10.1016/S0031-9422(01)00067-X; BENNETT RN, 1994, NEW PHYTOL, V127, P617, DOI 10.1111/j.1469-8137.1994.tb02968.x; BERNFELD P, 1955, METHOD ENZYMOL, V1, P149, DOI 10.1016/0076-6879(55)01021-5; BHARGAVA KP, 1981, INDIAN J MED RES, V73, P443; BROCK FM, 1982, APPL ENVIRON MICROB, V44, P561, DOI 10.1128/AEM.44.3.561-569.1982; Chen H, 2005, P NATL ACAD SCI USA, V102, P19237, DOI 10.1073/pnas.0509026102; Devi PU, 2000, RADIAT RES, V154, P455, DOI 10.1667/0033-7587(2000)154[0455:RPBTOF]2.0.CO;2; Dinant S, 2012, SIGNALING COMMUNICAT, V6, P89; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; FITT GP, 1989, ANNU REV ENTOMOL, V34, P17, DOI 10.1146/annurev.en.34.010189.000313; Furch ACU, 2008, PLANT SIGNAL BEHAV, V3, P858, DOI 10.4161/psb.3.10.6040; Gendo JO, 2008, J STORED PROD RES, V44, P328, DOI 10.1016/j.jspr.2008.02.009; Hakkim FL, 2008, J MED PLANTS RES, V2, P250; Hao PY, 2008, PLANT PHYSIOL, V146, P1810, DOI 10.1104/pp.107.111484; Harborne JB, 2001, SECONDARY METABOLITE; Holopainen JK, 2004, TRENDS PLANT SCI, V9, P529, DOI 10.1016/j.tplants.2004.09.006; Isman MB, 2000, CROP PROT, V19, P603, DOI 10.1016/S0261-2194(00)00079-X; JEMBERE B, 1995, B ENTOMOL RES, V85, P361, DOI 10.1017/S0007485300036099; Kachroo A, 2007, PLANT MOL BIOL, V63, P257, DOI 10.1007/s11103-006-9086-y; Kamaraj C, 2008, PARASITOL RES, V103, P1361, DOI 10.1007/s00436-008-1142-x; Karthikeyan K, 1999, PHARM BIOL, V37, P285, DOI 10.1076/phbi.37.4.285.5801; Khan A, 2010, NAT PROD COMMUN, V5, P345; Khan M.R., 2010, J SCI RES, V2, P158, DOI DOI 10.3329/JSR.V2IL.2769; Kjeldahl Johan Z., 1883, ANAL CHEM, V22, P366, DOI DOI 10.1007/BF01338151; Kotkar HM, 2009, J INSECT PHYSIOL, V55, P663, DOI 10.1016/j.jinsphys.2009.05.004; Leon J, 2001, J EXP BOT, V52, P1, DOI 10.1093/jexbot/52.354.1; Liska A., 2010, 10 INT WORK C STOR P, P716, DOI DOI 10.5073/JKA.2010.425.093; Maor R, 2005, CURR OPIN MICROBIOL, V8, P399, DOI 10.1016/j.mib.2005.06.008; Nagarkatti S, 1974, COMMONWEALTH I BIOL, V17, P169; Prakash P, 2005, Indian J Physiol Pharmacol, V49, P125; Qiantai L, 1998, P 7 INT C STOR PROD, V1, P836; Rajapakse CNK, 2007, ARTHROPOD-PLANT INTE, V1, P17, DOI 10.1007/s11829-007-9003-6; Roitsch T, 2004, TRENDS PLANT SCI, V9, P606, DOI 10.1016/j.tplants.2004.10.009; Rolland F, 2006, ANNU REV PLANT BIOL, V57, P675, DOI 10.1146/annurev.arplant.57.032905.105441; Rozman V, 2007, J STORED PROD RES, V43, P349, DOI 10.1016/j.jspr.2006.09.001; Sarate PJ, 2012, J INSECT SCI, V12, DOI 10.1673/031.012.4201; Schwachtje J, 2006, P NATL ACAD SCI USA, V103, P12935, DOI 10.1073/pnas.0602316103; Tamhane VA, 2005, BBA-GEN SUBJECTS, V1722, P156, DOI 10.1016/j.bbagen.2004.12.017; WINKLER UK, 1979, J BACTERIOL, V138, P663, DOI 10.1128/JB.138.3.663-670.1979; Zavala JA, 2004, PLANT PHYSIOL, V134, P1181, DOI 10.1104/pp.103.035634; ZOLLNER N., 1962, ZEIT GES EXPTL MED, V135, P545, DOI 10.1007/BF02045455	41	22	24	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e104377	10.1371/journal.pone.0104377	http://dx.doi.org/10.1371/journal.pone.0104377			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25098951	Green Submitted, Green Published, gold			2022-12-27	WOS:000339995100067
J	Wright, MJ; Jackson, RC				Wright, Michael J.; Jackson, Robin C.			Deceptive Body Movements Reverse Spatial Cueing in Soccer	PLOS ONE			English	Article							ANTICIPATION SKILL; ATTENTION; CUES; PERCEPTION; EXPERTISE; NOVICE; EYES	The purpose of the experiments was to analyse the spatial cueing effects of the movements of soccer players executing normal and deceptive (step-over) turns with the ball. Stimuli comprised normal resolution or point-light video clips of soccer players dribbling a football towards the observer then turning right or left with the ball. Clips were curtailed before or on the turn (-160, -80, 0 or +80 ms) to examine the time course of direction prediction and spatial cueing effects. Participants were divided into higher-skilled (HS) and lower-skilled (LS) groups according to soccer experience. In experiment 1, accuracy on full video clips was higher than on point-light but results followed the same overall pattern. Both HS and LS groups correctly identified direction on normal moves at all occlusion levels. For deceptive moves, LS participants were significantly worse than chance and HS participants were somewhat more accurate but nevertheless substantially impaired. In experiment 2, point-light clips were used to cue a lateral target. HS and LS groups showed faster reaction times to targets that were congruent with the direction of normal turns, and to targets incongruent with the direction of deceptive turns. The reversed cueing by deceptive moves coincided with earlier kinematic events than cueing by normal moves. It is concluded that the body kinematics of soccer players generate spatial cueing effects when viewed from an opponent's perspective. This could create a reaction time advantage when anticipating the direction of a normal move. A deceptive move is designed to turn this cueing advantage into a disadvantage. Acting on the basis of advance information, the presence of deceptive moves primes responses in the wrong direction, which may be only partly mitigated by delaying a response until veridical cues emerge.	[Wright, Michael J.] Brunel Univ London, Dept Psychol, Ctr Cognit & Neuroimaging, Uxbridge, Middx, England; [Jackson, Robin C.] Brunel Univ London, Dept Sport & Exercise Sci, Ctr Sports Med & Human Performance, Uxbridge, Middx, England	Brunel University; Brunel University	Wright, MJ (corresponding author), Brunel Univ London, Dept Psychol, Ctr Cognit & Neuroimaging, Uxbridge, Middx, England.	michael.wright@brunel.ac.uk	Jackson, Robin/AAJ-9164-2021	Jackson, Robin/0000-0001-7983-3870; Wright, Michael/0000-0001-8969-6830	Departmental research funds	Departmental research funds	The research was supported solely by Departmental research funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERNETHY B, 1987, J SPORT EXERCISE PSY, V9, P326, DOI 10.1123/jsp.9.4.326; Abernethy B, 2001, PERCEPTION, V30, P233, DOI 10.1068/p2872; Abernethy B, 1984, AUSTR J SCI MED SPOR, V16, P2; Abernethy B, 2008, PERCEPTION, V37, P931, DOI 10.1068/p5340; Aglioti SM, 2008, NAT NEUROSCI, V11, P1109, DOI 10.1038/nn.2182; Birmingham E, 2008, Q J EXP PSYCHOL, V61, P986, DOI 10.1080/17470210701410375; Bishop DT, 2013, J SPORT EXERCISE PSY, V35, P98, DOI 10.1123/jsep.35.1.98; Brault S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037494; Canal-Bruland R, 2010, EXP PSYCHOL, V57, P320, DOI 10.1027/1618-3169/a000038; Chica AB, 2014, NEUROSCI BIOBEHAV R, V40, P35, DOI 10.1016/j.neubiorev.2014.01.002; Dicks M, 2011, INT J SPORTS SCI COA, V6, P515, DOI 10.1260/1747-9541.6.4.515; Driver J, 1999, VIS COGN, V6, P509, DOI 10.1080/135062899394920; Farrow D, 2005, MOTOR CONTROL, V9, P332; Friesen CK, 1998, PSYCHON B REV, V5, P490, DOI 10.3758/BF03208827; Itier RJ, 2007, NEUROPSYCHOLOGIA, V45, P1019, DOI 10.1016/j.neuropsychologia.2006.09.004; Jackson RC, 2006, ACTA PSYCHOL, V123, P355, DOI 10.1016/j.actpsy.2006.02.002; Kibele A, 2006, PSYCHOL SPORT EXERC, V7, P591, DOI 10.1016/j.psychsport.2006.05.001; Kuhn G, 2009, VIS COGN, V17, P925, DOI 10.1080/13506280902826775; Kunde W, 2011, J EXP PSYCHOL-APPL, V17, P110, DOI 10.1037/a0023756; Langton SRH, 2000, J EXP PSYCHOL HUMAN, V26, P747, DOI 10.1037//0096-1523.26.2.747; Mann D, 2013, I-PERCEPTION, V4, P78, DOI 10.1068/i0569ic; Mori S, 2013, ATTEN PERCEPT PSYCHO, V75, P751, DOI 10.3758/s13414-013-0435-z; POSNER MI, 1980, J EXP PSYCHOL GEN, V109, P160, DOI 10.1037/0096-3445.109.2.160; Renshaw I, 2000, J SPORT SCI, V18, P951, DOI 10.1080/026404100446757; Richardson JTE, 2011, EDUC RES REV-NETH, V6, P135, DOI 10.1016/j.edurev.2010.12.001; Rowe R, 2009, J APPL SPORT PSYCHOL, V21, P178, DOI 10.1080/10413200902785811; Savelsbergh GJP, 2005, ERGONOMICS, V48, P1686, DOI 10.1080/00140130500101346; Shi JF, 2010, COGNITION, V117, P348, DOI 10.1016/j.cognition.2010.09.001; Sinnett S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013148; Tomeo E, 2013, CEREB CORTEX, V23, P2765, DOI 10.1093/cercor/bhs279; Walter RM, 2003, J EXP BIOL, V206, P1739, DOI 10.1242/jeb.00349; Williams AM, 2009, HUM MOVEMENT SCI, V28, P362, DOI 10.1016/j.humov.2008.10.006; Wright MJ, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00851; Yarbus A.L., 1967, EYE MOVEMENTS VISION, DOI 10.1007/978-1-4899-5379-7	34	14	14	5	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e104290	10.1371/journal.pone.0104290	http://dx.doi.org/10.1371/journal.pone.0104290			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM6SM	25100444	Green Published, Green Submitted, gold			2022-12-27	WOS:000339995100059
J	Zhang, LZ; Liu, RH; Niu, W				Zhang, Lizhen; Liu, Ruihai; Niu, Wei			Phytochemical and Antiproliferative Activity of Proso Millet	PLOS ONE			English	Article							CELLULAR ANTIOXIDANT ACTIVITY; ANTI PROLIFERATIVE ACTIVITIES; PROTEIN; CAROTENOIDS; PHENOLICS; PROFILES; MAIZE; FOODS; ASSAY	The phytochemical content, antioxidant activity and antiproliferative properties of three diverse varieties of proso millet are reported. The free phenolic content ranged from 27.48 (Gumi 20) to 151.14 (Mi2504-6) mg gallic acid equiv/100 g DW. The bound phenolic content ranged from 55.95 (Gumi20) to 305.81 (Mi2504-6) mg gallic acid equiv/100 g DW. The percentage contribution of bound phenolic to the total phenolic content of genotype samples analyzed ranged between 62.08% and 67.05%. Ferulic acid and chlorogenic acid are the predominant phenolic acid found in bound fraction. Caffeic acid and p-coumaric acid were also detected. Syringic acid was detected only in the free fraction. The antioxidant activity was assessed using the hydrophilic peroxyl radical scavenging capacity (PSC) assay. The PSC antioxidant activity of the free fraction ranged from 57.68 (Mi2504-6) to 147.32 (Gumi20) mu mol of vitamin C equiv/100 g DW. The PSC antioxidant activity of the bound fraction ranged from 95.38 (Mizao 52) to 136.48 (Gumi 20) mu mol of vitamin C equiv/100 g DW. The cellular antioxidant activity (CAA) of the extract was assessed using the HepG2 model. CAA value ranged from 2.51 to 6.10 mu mol equiv quercetin/100 g DW. Antiproliferative activities were also studied in vitro against MDA human breast cancer and HepG2 human liver cancer cells. Results exhibited a differential and possible selective antiproliferative property of the proso millet. These results may be used to direct the consumption of proso millet with improved health properties.	[Zhang, Lizhen] Shanxi Univ, Coll Life Sci, Taiyuan, Peoples R China; [Liu, Ruihai] Cornell Univ, Dept Food Sci, Ithaca, NY 14853 USA; [Niu, Wei] Shanxi Acad Agr Sci, Taiyuan, Peoples R China	Shanxi University; Cornell University; Shanxi Agricultural University	Liu, RH (corresponding author), Cornell Univ, Dept Food Sci, Ithaca, NY 14853 USA.	RL23@cornell.edu	Liu, Rui Hai/AAE-4865-2019; Liu, Rui Hai/C-2865-2008	Liu, Rui Hai/0000-0002-7018-7929; 				Adom KK, 2005, J AGR FOOD CHEM, V53, P6572, DOI 10.1021/jf048318o; Adom KK, 2003, J AGR FOOD CHEM, V51, P7825, DOI 10.1021/jf030404l; Adom KK, 2002, J AGR FOOD CHEM, V50, P6182, DOI 10.1021/jf0205099; Asharani VT, 2010, INT J FOOD PROP, V13, P41, DOI 10.1080/10942910802163105; Birgit J, 2011, NUTR CANC, V63, P611; Chandrasekara A, 2011, J AGR FOOD CHEM, V59, P428, DOI 10.1021/jf103896z; Chandrasekara A, 2010, J AGR FOOD CHEM, V58, P6706, DOI 10.1021/jf100868b; Denery-Papini S, 1999, J CEREAL SCI, V30, P121, DOI 10.1006/jcrs.1999.0268; Eberhardt MV, 2000, NATURE, V405, P903, DOI 10.1038/35016148; Hentschel V, 2002, J AGR FOOD CHEM, V50, P6663, DOI 10.1021/jf025701p; Hu XY, 2009, J GENET GENOMICS, V36, P491, DOI 10.1016/S1673-8527(08)60139-3; Hulshof PJM, 2007, J FOOD COMPOS ANAL, V20, P655, DOI 10.1016/j.jfca.2006.04.014; Kalinova J, 2006, PLANT FOOD HUM NUTR, V61, P45, DOI 10.1007/s11130-006-0013-9; Kampa M, 2004, BREAST CANCER RES, V6, pR63, DOI 10.1186/bcr752; Kean EG, 2011, J CEREAL SCI, V54, P450, DOI 10.1016/j.jcs.2011.08.010; Kimura M, 2007, FOOD CHEM, V100, P1734, DOI 10.1016/j.foodchem.2005.10.020; Kumari SK, 1998, PLANT FOOD HUM NUTR, V53, P47, DOI 10.1023/A:1008083020810; Liu CS, 2004, J AGR FOOD CHEM, V52, P4330, DOI 10.1021/jf040028k; Liu M, 2002, J AGR FOOD CHEM, V50, P2926, DOI 10.1021/jf0111209; MCDONOUGH CM, 1985, CEREAL FOOD WORLD, V30, P550; Neelam Chaturvedi, 2011, Journal of Applied Pharmaceutical Science, V1, P6; Nishizawa N, 2002, BIOSCI BIOTECH BIOCH, V66, P92, DOI 10.1271/bbb.66.92; NISHIZAWA N, 1995, BIOSCI BIOTECH BIOCH, V59, P333, DOI 10.1271/bbb.59.333; Okarter N, 2010, FOOD CHEM, V119, P249, DOI 10.1016/j.foodchem.2009.06.021; Singleton VL, 1999, METHOD ENZYMOL, V299, P152; Song W, 2010, J AGR FOOD CHEM, V58, P6621, DOI 10.1021/jf9035832; Sun J, 2008, J AGR FOOD CHEM, V56, P11661, DOI 10.1021/jf8021223; Wang L., 2005, J PLANT GENET RESOUR, V6, P471; Wolfe KL, 2008, J AGR FOOD CHEM, V56, P8418, DOI 10.1021/jf801381y; Wolfe KL, 2007, J AGR FOOD CHEM, V55, P8896, DOI 10.1021/jf0715166; Xu BJ, 2012, FOOD CHEM, V134, P1287, DOI 10.1016/j.foodchem.2012.02.212; YANEZ GA, 1991, J CEREAL SCI, V13, P299, DOI 10.1016/S0733-5210(09)80008-8; Yang J, 2004, J AGR FOOD CHEM, V52, P6787, DOI 10.1021/jf0307144; Yang J, 2009, FOOD CHEM, V116, P332, DOI 10.1016/j.foodchem.2009.02.021	34	57	58	2	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e104058	10.1371/journal.pone.0104058	http://dx.doi.org/10.1371/journal.pone.0104058			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25098952	Green Published, Green Submitted, gold			2022-12-27	WOS:000339995100047
J	Bockor, VV; Barisic, D; Horvat, T; Maglica, Z; Vojta, A; Zoldos, V				Bockor, Vedrana Vicic; Barisic, Darko; Horvat, Tomislav; Maglica, Zeljka; Vojta, Aleksandar; Zoldos, Vlatka			Inhibition of DNA Methylation Alters Chromatin Organization, Nuclear Positioning and Activity of 45S rDNA Loci in Cycling Cells of Q. robur	PLOS ONE			English	Article							POLYMERASE-I TRANSCRIPTION; RIBOSOMAL-RNA GENES; NUCLEOLAR DOMINANCE; WHEAT; RYE; HETEROCHROMATIN; EXPRESSION; PROTEINS; NORS; ARABIDOPSIS	Around 2200 copies of genes encoding ribosomal RNA (rRNA) in pedunculate oak, Quercus robur, are organized into two rDNA loci, the major (NOR-1) and the minor (NOR-2) locus. We present the first cytogenetic evidence indicating that the NOR-1 represents the active nucleolar organizer responsible for rRNA synthesis, while the NOR-2 probably stays transcriptionally silent and does not participate in the formation of the nucleolus in Q. robur, which is a situation resembling the well-known phenomenon of nucleolar dominance. rDNA chromatin topology analyses in cycling root tip cells by light and electron microscopy revealed the minor locus to be highly condensed and located away from the nucleolus, while the major locus was consistently associated with the nucleolus and often exhibited different levels of condensation. In addition, silver precipitation was confined exclusively to the NOR-1 locus. Also, NOR-2 was highly methylated at cytosines and rDNA chromatin was marked with histone modifications characteristic for repressive state. After treatment of the root cells with the methylation inhibitor 5-aza-2'-deoxycytidine, we observed an increase in the total level of rRNA transcripts and a decrease in DNA methylation level at the NOR-2 locus. Also, NOR-2 sites relocalized with respect to the nuclear periphery/nucleolus, however, the relocation did not affect the contribution of this locus to nucleolar formation, nor did it affect rDNA chromatin decondensation, strongly suggesting that NOR-2 has lost the function of rRNA synthesis and nucleolar organization.	[Bockor, Vedrana Vicic; Horvat, Tomislav; Vojta, Aleksandar; Zoldos, Vlatka] Univ Zagreb, Fac Sci, Dept Mol Biol, Zagreb 41000, Croatia; [Barisic, Darko] Friedrich Miescher Inst Biomed Res, Basel, Switzerland; [Maglica, Zeljka] Ecole Polytech Fed Lausanne, Lausanne, Switzerland	University of Zagreb; Friedrich Miescher Institute for Biomedical Research; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Zoldos, V (corresponding author), Univ Zagreb, Fac Sci, Dept Mol Biol, Zagreb 41000, Croatia.	vzoldos@biol.pmf.hr	Maglica, Željka/S-7423-2018; Vojta, Aleksandar/S-2086-2017	Maglica, Željka/0000-0002-6438-861X; Vojta, Aleksandar/0000-0002-4627-1821	Croatian Ministry of Science, Education and Sport [119-1191196-1224]; AUF PCSI Grant; FP7 RegPot Integra-Life grant [315997]	Croatian Ministry of Science, Education and Sport(Ministry of Science, Education and Sports, Republic of Croatia); AUF PCSI Grant; FP7 RegPot Integra-Life grant	The work was supported by the Croatian Ministry of Science, Education and Sport Grant (grant no. 119-1191196-1224), AUF PCSI Grant, and FP7 RegPot Integra-Life grant (grant no. 315997). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amado L, 1997, CHROMOSOME RES, V5, P445, DOI 10.1023/A:1018460828720; Bauer N, 2009, MOL GENET GENOMICS, V281, P207, DOI 10.1007/s00438-008-0404-8; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Canty A RB, 2013, BOOTSTRAP R S PLUS F; Caperta AD, 2002, J CELL SCI, V115, P2839; Caperta AD, 2007, PROTOPLASMA, V232, P55, DOI 10.1007/s00709-007-0277-4; Carmo-Fonseca M, 2000, NAT CELL BIOL, V2, pE107, DOI 10.1038/35014078; Chen ZJ, 1997, GENE DEV, V11, P2124, DOI 10.1101/gad.11.16.2124; Chen ZJ, 1998, P NATL ACAD SCI USA, V95, P14891, DOI 10.1073/pnas.95.25.14891; CLSI guideline EP28, 2010, DEFINING ESTABLISHIN, V3rd Ed; Davison AC, 1997, BOOTSTRAP METHODS TH; Dousset T, 2000, MOL BIOL CELL, V11, P2705, DOI 10.1091/mbc.11.8.2705; Frigola J, 2006, NAT GENET, V38, P540, DOI 10.1038/ng1781; GERLACH WL, 1980, NUCLEIC ACIDS RES, V8, P4851, DOI 10.1093/nar/8.21.4851; Gonzalez IL, 1997, CHROMOSOMA, V105, P431, DOI 10.1007/s004120050204; Grummt I, 2003, NAT REV MOL CELL BIO, V4, P641, DOI 10.1038/nrm1171; Habu Y, 2006, EMBO REP, V7, P1279, DOI 10.1038/sj.embor.7400835; Harrell FE., 2021, HMISC HARRELL MISCEL; Harrell FE DC, 1982, BIOMETRIKA, V69; Heitz E., 1931, PLANTA, V15, P495, DOI [10.1007/BF01909065, DOI 10.1007/BF01909065]; Hernandez-Verdun D, 2006, HISTOCHEM CELL BIOL, V125, P127, DOI 10.1007/s00418-005-0046-4; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kalmarova M, 2007, J STRUCT BIOL, V160, P49, DOI 10.1016/j.jsb.2007.06.012; Lawrence RJ, 2004, MOL CELL, V13, P599, DOI 10.1016/S1097-2765(04)00064-4; LEITCH AR, 1992, J CELL SCI, V101, P751; Manickavelu A, 2007, COLLOID SURFACE B, V54, P254, DOI 10.1016/j.colsurfb.2006.10.024; Matyasek R, 2007, GENETICS, V176, P2509, DOI 10.1534/genetics.107.072751; McCLINTOCK BARBARA, 1934, ZEITSCHR ZELLJORSCH U MIKROSK ANAT, V21, P294, DOI 10.1007/BF00374060; McKeown PC, 2009, CHROMOSOMA, V118, P11, DOI 10.1007/s00412-008-0184-2; MELESE T, 1995, CURR OPIN CELL BIOL, V7, P319, DOI 10.1016/0955-0674(95)80085-9; Modrich P, 1996, ANNU REV BIOCHEM, V65, P101, DOI 10.1146/annurev.bi.65.070196.000533; Muir G, 2001, MOL BIOL EVOL, V18, P112, DOI 10.1093/oxfordjournals.molbev.a003785; Pikaard C, 2007, NAT CELL BIOL, V9, P19, DOI 10.1038/ncb0107-19; Pontes O, 2003, P NATL ACAD SCI USA, V100, P11418, DOI 10.1073/pnas.1932522100; Pontvianne F, 2013, GENE DEV, V27, P1545, DOI 10.1101/gad.221648.113; Preuss S, 2007, BBA-GENE STRUCT EXPR, V1769, P383, DOI 10.1016/j.bbaexp.2007.02.005; Preuss SB, 2008, MOL CELL, V32, P673, DOI 10.1016/j.molcel.2008.11.009; Probst AV, 2004, PLANT CELL, V16, P1021, DOI 10.1105/tpc.018754; R Core t, 2013, LANG ENV STAT COMP; Raska I, 2004, PROG MOL SUBCELL BIO, V35, P23; Raska I, 2004, BIOL CELL, V96, P579, DOI 10.1016/j.biolcel.2004.04.015; RAWLINS DJ, 1990, J MICROSC-OXFORD, V157, P83, DOI 10.1111/j.1365-2818.1990.tb02949.x; ROUSSEL P, 1994, EXP CELL RES, V214, P465, DOI 10.1006/excr.1994.1283; Roussel P, 1996, J CELL BIOL, V133, P235, DOI 10.1083/jcb.133.2.235; Santos AP, 2011, OMICS, V15, P839, DOI 10.1089/omi.2011.0095; Scheer U, 1999, CURR OPIN CELL BIOL, V11, P385, DOI 10.1016/S0955-0674(99)80054-4; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shaw PJ, 2011, PROTEIN REV, V15, P43, DOI 10.1007/978-1-4614-0514-6_3; Silva M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003824; Sirri V, 2000, MICRON, V31, P121, DOI 10.1016/S0968-4328(99)00068-2; TORRESRUIZ RA, 1994, PLANT MOL BIOL, V26, P1167, DOI 10.1007/BF00040697; Tucker S, 2010, CURR OPIN CELL BIOL, V22, P351, DOI 10.1016/j.ceb.2010.03.009; Veiseth SV, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001325; Vicic V, 2013, TREE GENET GENOMES, V9, P1247, DOI 10.1007/s11295-013-0632-x; VIEIRA R, 1990, GENOME, V33, P707, DOI 10.1139/g90-106; WALLACE H, 1971, HEREDITY, V27, P1, DOI 10.1038/hdy.1971.66; Zoldos V, 1999, THEOR APPL GENET, V99, P969, DOI 10.1007/s001220051404	57	8	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e103954	10.1371/journal.pone.0103954	http://dx.doi.org/10.1371/journal.pone.0103954			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093501	gold, Green Published, Green Submitted			2022-12-27	WOS:000341357200050
J	Sinha, A; Rae, R				Sinha, Amit; Rae, Robbie			A Functional Genomic Screen for Evolutionarily Conserved Genes Required for Lifespan and Immunity in Germline-Deficient C. elegans	PLOS ONE			English	Article							LAMPREYS LAMPETRA-FLUVIATILIS; CAENORHABDITIS-ELEGANS; PRISTIONCHUS-PACIFICUS; TRANSCRIPTION FACTOR; LONGEVITY; METABOLISM; EXPRESSION; PATHWAY; SYSTEM; SEX	The reproductive system regulates lifespan in insects, nematodes and vertebrates. In Caenorhabditis elegans removal of germline increases lifespan by 60% which is dependent upon insulin signaling, nuclear hormone signaling, autophagy and fat metabolism and their microRNA-regulators. Germline-deficient C. elegans are also more resistant to various bacterial pathogens but the underlying molecular mechanisms are largely unknown. Firstly, we demonstrate that previously identified genes that regulate the extended lifespan of germline-deficient C. elegans (daf-2, daf-16, daf-12, tcer-1, mir-7.1 and nhr-80) are also essential for resistance to the pathogenic bacterium Xenorhabdus nematophila. We then use a novel unbiased approach combining laser cell ablation, whole genome microarrays, RNAi screening and exposure to X. nematophila to generate a comprehensive genome-wide catalog of genes potentially required for increased lifespan and innate immunity in germline-deficient C. elegans. We find 3,440 genes to be upregulated in C. elegans germline-deficient animals in a gonad dependent manner, which are significantly enriched for genes involved in insulin signaling, fatty acid desaturation, translation elongation and proteasome complex function. Using RNAi against a subset of 150 candidate genes selected from the microarray results, we show that the upregulated genes such as transcription factor DAF-16/FOXO, the PTEN homolog lipid phosphatase DAF-18 and several components of the proteasome complex (rpn-6.1, rpn-7, rpn-9, rpn-10, rpt-6, pbs-3 and pbs-6) are essential for both lifespan and immunity of germline deficient animals. We also identify a novel role for genes including par-5 and T12G3.6 in both lifespan-extension and increased survival on X. nematophila. From an evolutionary perspective, most of the genes differentially expressed in germline deficient C. elegans also show a conserved expression pattern in germline deficient Pristionchus pacificus, a nematode species that diverged from C. elegans 250-400 MYA.	[Sinha, Amit; Rae, Robbie] Max Planck Inst Dev Biol, Dept Evolutionary Biol, Tubingen, Germany	Max Planck Society	Rae, R (corresponding author), Liverpool John Moores Univ, Sch Nat Sci & Psychol, Liverpool L3 5UX, Merseyside, England.	r.g.rae@ljmu.ac.uk	Sinha, Amit/H-5116-2019	Sinha, Amit/0000-0003-1849-710X	Max Planck Society; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	Max Planck Society(Max Planck SocietyFoundation CELLEX); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was funded by the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript and the authors declare that no conflict of interest exists.	Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; Alper S, 2010, J BIOL CHEM, V285, P1822, DOI 10.1074/jbc.M109.057323; Berman JR, 2006, CELL, V124, P1055, DOI 10.1016/j.cell.2006.01.039; Boulias K, 2012, CELL METAB, V15, P439, DOI 10.1016/j.cmet.2012.02.014; Brisbin S, 2009, DEV CELL, V17, P459, DOI 10.1016/j.devcel.2009.08.009; Byrne Alexandra B, 2007, J Biol, V6, P8, DOI 10.1186/jbiol58; Couillault C, 2002, INFECT IMMUN, V70, P4705, DOI 10.1128/IAI.70.8.4705-4707.2002; Dieterich C, 2008, NAT GENET, V40, P1193, DOI 10.1038/ng.227; Drace K, 2008, APPL ENVIRON MICROB, V74, P4509, DOI 10.1128/AEM.00336-08; DRORI D, 1976, EXP GERONTOL, V11, P25, DOI 10.1016/0531-5565(76)90007-3; Engelmann I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019055; Estes KA, 2010, P NATL ACAD SCI USA, V107, P2153, DOI 10.1073/pnas.0914643107; Evans EA, 2008, AGING CELL, V7, P879, DOI 10.1111/j.1474-9726.2008.00435.x; Flatt T, 2008, P NATL ACAD SCI USA, V105, P6368, DOI 10.1073/pnas.0709128105; Forst S, 1997, ANNU REV MICROBIOL, V51, P47, DOI 10.1146/annurev.micro.51.1.47; Garsin DA, 2003, SCIENCE, V300, P1921, DOI 10.1126/science.1080147; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gerisch B, 2001, DEV CELL, V1, P841, DOI 10.1016/S1534-5807(01)00085-5; Ghazi A, 2007, P NATL ACAD SCI USA, V104, P5947, DOI 10.1073/pnas.0700638104; Ghazi A, 2013, GENESIS, V51, P1, DOI 10.1002/dvg.22345; Ghazi A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000639; Goudeau J, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000599; HAMILTON JB, 1965, J GERONTOL, V20, P96, DOI 10.1093/geronj/20.1.96; HAMILTON JB, 1969, J GERONTOL, V24, P395, DOI 10.1093/geronj/24.4.395; Hatle JD, 2008, EXP GERONTOL, V43, P900, DOI 10.1016/j.exger.2008.08.005; Hsin H, 1999, NATURE, V399, P362, DOI 10.1038/20694; Huffman DL, 2004, P NATL ACAD SCI USA, V101, P10995, DOI 10.1073/pnas.0404073101; Irazoqui JE, 2008, P NATL ACAD SCI USA, V105, P17469, DOI 10.1073/pnas.0809527105; Jia KL, 2002, DEVELOPMENT, V129, P221; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kim DH, 2002, SCIENCE, V297, P623, DOI 10.1126/science.1073759; Kim KW, 2010, P NATL ACAD SCI USA, V107, P17445, DOI 10.1073/pnas.1012611107; KIMBLE JE, 1981, DEV BIOL, V81, P208, DOI 10.1016/0012-1606(81)90284-0; KIME DE, 1987, GEN COMP ENDOCR, V68, P189, DOI 10.1016/0016-6480(87)90028-1; Lapierre LR, 2011, CURR BIOL, V21, P1507, DOI 10.1016/j.cub.2011.07.042; LARSEN LO, 1974, GEN COMP ENDOCR, V24, P305, DOI 10.1016/0016-6480(74)90184-1; Mallo GV, 2002, CURR BIOL, V12, P1209, DOI 10.1016/S0960-9822(02)00928-4; McCormick M, 2012, AGING CELL, V11, P192, DOI 10.1111/j.1474-9726.2011.00768.x; Michell AR, 1999, VET REC, V145, P625, DOI 10.1136/vr.145.22.625; Min KJ, 2012, CURR BIOL, V22, pR792, DOI 10.1016/j.cub.2012.06.036; Miyata S, 2008, GENETICS, V178, P903, DOI 10.1534/genetics.107.083923; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Nicholas HR, 2004, CURR BIOL, V14, P1256, DOI 10.1016/j.cub.2004.07.022; Ogg S, 1998, MOL CELL, V2, P887, DOI 10.1016/S1097-2765(00)80303-2; Powell JR, 2009, P NATL ACAD SCI USA, V106, P2782, DOI 10.1073/pnas.0813048106; PRIESS JR, 1987, CELL, V51, P601, DOI 10.1016/0092-8674(87)90129-2; Pujol N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000105; Rae R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002864; Reinke V, 2004, DEVELOPMENT, V131, P311, DOI 10.1242/dev.00914; ROBERTSON OH, 1961, FED PROC, V20, P29; Shapira M, 2006, P NATL ACAD SCI USA, V103, P14086, DOI 10.1073/pnas.0603424103; Shen YD, 2012, SCIENCE, V338, P1472, DOI 10.1126/science.1228967; Sinha A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044255; Sinha A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-254; SMITH JM, 1958, J EXP BIOL, V35, P832; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Sommer RJ, 2013, MOL ECOL, V22, P2380, DOI 10.1111/mec.12286; TeKippe M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011777; Troemel ER, 2006, PLOS GENET, V2, P1725, DOI 10.1371/journal.pgen.0020183; Vilchez D, 2012, NATURE, V489, P263, DOI 10.1038/nature11315; Wang MC, 2008, SCIENCE, V322, P957, DOI 10.1126/science.1162011; Wang Y, 2006, MECH AGEING DEV, V127, P741, DOI 10.1016/j.mad.2006.05.005; Wong D, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r194; Yang JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023525	64	16	19	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e101970	10.1371/journal.pone.0101970	http://dx.doi.org/10.1371/journal.pone.0101970			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093668	gold, Green Published, Green Submitted			2022-12-27	WOS:000341357200007
J	Cao, Y; Rathmell, JC; Macintyre, AN				Cao, Yilin; Rathmell, Jeffrey C.; Macintyre, Andrew N.			Metabolic Reprogramming towards Aerobic Glycolysis Correlates with Greater Proliferative Ability and Resistance to Metabolic Inhibition in CD8 versus CD4 T Cells	PLOS ONE			English	Article							EFFECTOR FUNCTION; PYRUVATE-KINASE; CONCANAVALIN-A; GLUCOSE; LYMPHOCYTES; ACTIVATION; INTERLEUKIN-2; REQUIREMENTS; MECHANISMS; EXPRESSION	T lymphocytes (T cells) undergo metabolic reprogramming after activation to provide energy and biosynthetic materials for growth, proliferation and differentiation. Distinct T cell subsets, however, adopt metabolic programs specific to support their needs. As CD4 T cells coordinate adaptive immune responses while CD8 T cells become cytotoxic effectors, we compared activation-induced proliferation and metabolic reprogramming of these subsets. Resting CD4 and CD8 T cells were metabolically similar and used a predominantly oxidative metabolism. Following activation CD8 T cells proliferated more rapidly. Stimulation led both CD4 and CD8 T cells to sharply increase glucose metabolism and adopt aerobic glycolysis as a primary metabolic program. Activated CD4 T cells, however, remained more oxidative and had greater maximal respiratory capacity than activated CD8 T cells. CD4 T cells were also associated with greater levels of ROS and increased mitochondrial content, irrespective of the activation context. CD8 cells were better able, however, to oxidize glutamine as an alternative fuel source. The more glycolytic metabolism of activated CD8 T cells correlated with increased capacity for growth and proliferation, along with reduced sensitivity of cell growth to metabolic inhibition. These specific metabolic programs may promote greater growth and proliferation of CD8 T cells and enhance survival in diverse nutrient conditions.	[Cao, Yilin; Rathmell, Jeffrey C.; Macintyre, Andrew N.] Duke Univ, Sarah W Stedman Ctr Nutr & Metab, Dept Pharmacol & Canc Biol, Dept Immunol, Durham, NC 27708 USA	Duke University	Rathmell, JC (corresponding author), Duke Univ, Sarah W Stedman Ctr Nutr & Metab, Dept Pharmacol & Canc Biol, Dept Immunol, Durham, NC 27708 USA.	jeff.rathmell@duke.edu; a.n.macintyre@duke.edu		Macintyre, Andrew/0000-0002-5297-0207	American Asthma Foundation; Leukemia Lymphoma Society; Colitis Foundation of America [284879]; American Asthma Foundation [R01AI063345, R01HL108006, R56AI102074]; NATIONAL CANCER INSTITUTE [P30CA014236] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL108006] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI102074, R01AI063345] Funding Source: NIH RePORTER	American Asthma Foundation; Leukemia Lymphoma Society(Leukemia and Lymphoma Society); Colitis Foundation of America; American Asthma Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the American Asthma Foundation (JCR), the Leukemia Lymphoma Society (JCR), the Crohn's and Colitis Foundation of America (284879, ANM), and the American Asthma Foundation (JCR), R01AI063345 (JCR), R01HL108006 (JCR), R56AI102074 (JCR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Campbell SB, 2000, IMMUNOLOGY, V99, P394, DOI 10.1046/j.1365-2567.2000.00971.x; CHAKRABARTI R, 1994, J IMMUNOL, V152, P2660; Cham CM, 2005, J IMMUNOL, V174, P4670, DOI 10.4049/jimmunol.174.8.4670; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; Chen LP, 2013, NAT REV IMMUNOL, V13, P227, DOI 10.1038/nri3405; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Croft M, 2009, IMMUNOL REV, V229, P173, DOI 10.1111/j.1600-065X.2009.00766.x; De Boer RJ, 2003, J IMMUNOL, V171, P3928, DOI 10.4049/jimmunol.171.8.3928; Dreau D, 1998, IMMUNOPHARMACOLOGY, V39, P201, DOI 10.1016/S0162-3109(98)00016-2; Foulds KE, 2002, J IMMUNOL, V168, P1528, DOI 10.4049/jimmunol.168.4.1528; Frauwirth KA, 2002, IMMUNITY, V16, P769, DOI 10.1016/S1074-7613(02)00323-0; Gatza E, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001975; Gubser PM, 2013, NAT IMMUNOL, V14, P1064, DOI 10.1038/ni.2687; He S, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0028291, 10.1371/journal.pone.0020107]; Jacobs SR, 2008, J IMMUNOL, V180, P4476, DOI 10.4049/jimmunol.180.7.4476; KEAST D, 1991, INT J BIOCHEM, V23, P823, DOI 10.1016/0020-711X(91)90066-V; Lee HW, 2002, J IMMUNOL, V169, P4882, DOI 10.4049/jimmunol.169.9.4882; Lunt SY, 2011, ANNU REV CELL DEV BI, V27, P441, DOI 10.1146/annurev-cellbio-092910-154237; Macintyre AN, 2014, CELL METAB IN PRESS; Macintyre AN, 2013, CANCER METAB, V1, DOI 10.1186/2049-3002-1-5; MacIver NJ, 2013, ANNU REV IMMUNOL, V31, P259, DOI 10.1146/annurev-immunol-032712-095956; MARJANOVIC S, 1988, BIOCHIM BIOPHYS ACTA, V970, P1, DOI 10.1016/0167-4889(88)90215-7; MARJANOVIC S, 1990, BIOCHIM BIOPHYS ACTA, V1087, P1, DOI 10.1016/0167-4781(90)90113-G; Michalek RD, 2011, P NATL ACAD SCI USA, V108, P18348, DOI 10.1073/pnas.1108856108; Michalek RD, 2011, J IMMUNOL, V186, P3299, DOI 10.4049/jimmunol.1003613; MILLER ES, 1994, J NEUROIMMUNOL, V52, P165, DOI 10.1016/0165-5728(94)90110-4; Nakaya M, 2014, IMMUNITY, V40, P692, DOI 10.1016/j.immuni.2014.04.007; OROURKE AM, 1989, BIOCHIM BIOPHYS ACTA, V1010, P342, DOI 10.1016/0167-4889(89)90059-1; Ostroukhova M, 2012, AM J PHYSIOL-LUNG C, V302, pL300, DOI 10.1152/ajplung.00221.2011; Rathmell JC, 2000, MOL CELL, V6, P683, DOI 10.1016/S1097-2765(00)00066-6; ROBB RJ, 1987, P NATL ACAD SCI USA, V84, P2002, DOI 10.1073/pnas.84.7.2002; Rochman Y, 2009, NAT REV IMMUNOL, V9, P480, DOI 10.1038/nri2580; Roederer M, 2011, CYTOM PART A, V79A, P95, DOI 10.1002/cyto.a.21010; Shi LZ, 2011, J EXP MED, V208, P1367, DOI 10.1084/jem.20110278; Shuford WW, 1997, J EXP MED, V186, P47, DOI 10.1084/jem.186.1.47; Sinclair LV, 2013, NAT IMMUNOL, V14, P500, DOI 10.1038/ni.2556; Stauber DJ, 2006, P NATL ACAD SCI USA, V103, P2788, DOI 10.1073/pnas.0511161103; Tamada M, 2012, CLIN CANCER RES, V18, P5554, DOI 10.1158/1078-0432.CCR-12-0859; van der Windt GJW, 2013, P NATL ACAD SCI USA, V110, P14336, DOI 10.1073/pnas.1221740110; van der Windt GJW, 2012, IMMUNITY, V36, P68, DOI 10.1016/j.immuni.2011.12.007; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; Wang XQ, 2005, SCIENCE, V310, P1159, DOI 10.1126/science.1117893; Whitmire JK, 2000, CURR OPIN IMMUNOL, V12, P448, DOI 10.1016/S0952-7915(00)00119-9; Wong Nicholas, 2013, Int J Cell Biol, V2013, P242513, DOI 10.1155/2013/242513; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Xu XJ, 2012, SEMIN IMMUNOL, V24, P429, DOI 10.1016/j.smim.2012.12.005; Zhao YX, 2008, METHOD ENZYMOL, V442, P439, DOI [10.1016/S0076-0879(08)01422-5, 10.1016/S0076-6879(08)01422-5]	47	84	88	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e104104	10.1371/journal.pone.0104104	http://dx.doi.org/10.1371/journal.pone.0104104			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25090630	Green Published, gold, Green Submitted			2022-12-27	WOS:000339812700097
J	Bernabe, E; Sheiham, A				Bernabe, Eduardo; Sheiham, Aubrey			Tooth Loss in the United Kingdom - Trends in Social Inequalities: An Age-Period-and-Cohort Analysis	PLOS ONE			English	Article							ORAL-HEALTH; SOCIOECONOMIC INEQUALITIES; LIFE-COURSE; PART 2; DISPARITIES; CARIES	This study assessed trends in social inequalities in tooth loss in the United Kingdom between 1988 and 2009. Data from 20,126 adults who participated in the latest three national Adult Dental Health Surveys in England, Wales and Northern Ireland were used. Social class was determined using the 6-point Registrar General's Social Class. Three indicators of tooth loss were analysed; the proportion of edentate people among all adults and the number of teeth and the proportion with functional dentition (defined as having 20+ teeth) among dentate adults. Trends were modelled within an age, period and cohort framework using partial least squares regression (PLSR). Confidence intervals for PLSR estimates were obtained using non-parametric bootstrapping. The Slope and Relative Index of Inequality (SII and RII) were used to quantify social inequalities in tooth loss. Between 1988 and 2009, absolute inequalities in total tooth loss narrowed (SII changed from - 28.4% to -15.3%) while relative inequalities widened (RII from 6.21 to 20.9) in the whole population. On the other hand, absolute and relative social inequality in tooth loss remained fairly stable over time among dentate adults. There was an absolute difference of 2.5-2.9 in number of teeth and 22-26% in the proportion with functional dentition between the lowest and highest social classes. In relative terms, the highest social class had 10-11% more teeth and 25-28% higher probability of having functional dentition than the lowest social class. The findings show pervasive inequalities in tooth loss by social class among British adults despite marked improvements in tooth retention in recent years and generations. In the whole adult population, absolute inequalities in tooth loss have narrowed while relative inequalities have increased steadily. Among dentate adults, absolute and relative inequalities in number of teeth and proportion of people with functional dentition have remained significant but unchanged over time.	[Bernabe, Eduardo] Kings Coll London Dent Inst Guys Kings Coll & St, Div Populat & Patient Hlth, London, England; [Sheiham, Aubrey] UCL, Dept Epidemiol & Publ Hlth, London, England	University of London; University College London	Sheiham, A (corresponding author), UCL, Dept Epidemiol & Publ Hlth, London, England.	a.sheiham@ucl.ac.uk	Bernabe, Eduardo/R-3441-2017	Bernabe, Eduardo/0000-0002-1858-3713				Baelum V, 2007, J ORAL REHABIL, V34, P872, DOI 10.1111/j.1365-2842.2007.01799.x; Beck AN, 2014, SOC SCI MED, V104, P163, DOI 10.1016/j.socscimed.2013.11.021; Celeste RK, 2011, COMMUNITY DENT ORAL, V39, P204, DOI 10.1111/j.1600-0528.2010.00585.x; Chen FN, 2010, AM SOCIOL REV, V75, P126, DOI 10.1177/0003122409359165; Cheng NF, 2008, AM J EPIDEMIOL, V168, P906, DOI 10.1093/aje/kwn207; CSDH, 2008, CLOS GAP GEN HLTH EQ; Cunha-Cruz J, 2007, J DENT RES, V86, P131, DOI 10.1177/154405910708600205; Dye BA, 2010, PUBLIC HEALTH REP, V125, P817, DOI 10.1177/003335491012500609; Elani HW, 2012, J DENT RES, V91, P865, DOI 10.1177/0022034512455062; Fejerskov O, 2013, J ORAL REHABIL, V40, P707, DOI 10.1111/joor.12082; Galobardes B, 2006, J EPIDEMIOL COMMUN H, V60, P95, DOI 10.1136/jech.2004.028092; Glenn ND., 1977, COHORT ANAL; Guarnizo-Herreno CC, 2013, J EPIDEMIOL COMMUN H, V67, P728, DOI 10.1136/jech-2013-202714; Harper S, 2010, MILBANK Q, V88, P4, DOI 10.1111/j.1468-0009.2010.00587.x; Hayes LJ, 2002, J EPIDEMIOL COMMUN H, V56, P762, DOI 10.1136/jech.56.10.762; Holst D, 2008, COMMUNITY DENT ORAL, V36, P326, DOI 10.1111/j.1600-0528.2008.00433.x; Kassebaum NJ, 2014, J DENT RES, V93, P20, DOI 10.1177/0022034514537828; Kelly M, 2001, ADULT DENT HLTH SURV; Kelly MP, 2007, SOCIAL DETERMINANTS; Krieger N, 1997, ANNU REV PUBL HEALTH, V18, P341, DOI 10.1146/annurev.publhealth.18.1.341; Lynch SM, 2003, DEMOGRAPHY, V40, P309, DOI 10.2307/3180803; Mackenbach JP, 1997, SOC SCI MED, V44, P757, DOI 10.1016/S0277-9536(96)00073-1; MASON KO, 1973, AM SOCIOL REV, V38, P242, DOI 10.2307/2094398; O'Sullivan I, 2011, FDN REPORT ADULT DEN; Pitts NB, 2006, BRIT DENT J, V200, P313, DOI 10.1038/sj.bdj.4813377; Regidor E, 2004, J EPIDEMIOL COMMUN H, V58, P900, DOI 10.1136/jech.2004.023036; Rose D., 2005, NATL STAT SOCIO EC C, P1; Sanders AE, 2006, COMMUNITY DENT ORAL, V34, P310, DOI 10.1111/j.1600-0528.2006.00286.x; Shen J, 2013, COMMUNITY DENT ORAL, V41, P481, DOI 10.1111/cdoe.12071; Steele JG, 2012, BRIT DENT J, V213, P523, DOI 10.1038/sj.bdj.2012.1067; Thomson WM, 2012, COMMUNITY DENT ORAL, V40, P28, DOI 10.1111/j.1600-0528.2012.00716.x; Todd JE, 1991, ADULT DENT HLTH 1988; Tsakos G, 2011, AM J PUBLIC HEALTH, V101, P1892, DOI 10.2105/AJPH.2011.300215; Tu YK, 2012, EPIDEMIOLOGY, V23, P583, DOI 10.1097/EDE.0b013e31824d57a9; Vinzi V.E., 2010, SPRINGER HDB COMPUTA; WAGSTAFF A, 1991, SOC SCI MED, V33, P545, DOI 10.1016/0277-9536(91)90212-U; WHO, 2013, HANDBOOK ON HEALTH INEQUALITY MONITORING: WITH A SPECIAL FOCUS ON LOW- AND MIDDLE-INCOME COUNTRIES, P1; Yang Y, 2013, AGE PERIOD COHORT AN	38	45	49	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2014	9	8							e104808	10.1371/journal.pone.0104808	http://dx.doi.org/10.1371/journal.pone.0104808			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR0CG	25105665	Green Published, gold, Green Submitted			2022-12-27	WOS:000343231900085
J	Conchou, L; Cabioch, L; Rodriguez, LJV; Kjellberg, F				Conchou, Lucie; Cabioch, Lea; Rodriguez, Lillian J. V.; Kjellberg, Finn			Daily Rhythm of Mutualistic Pollinator Activity and Scent Emission in Ficus septica: Ecological Differentiation between Co-Occurring Pollinators and Potential Consequences for Chemical Communication and Facilitation of Host Speciation	PLOS ONE			English	Article							FIG-WASP; MONOTERPENE EMISSIONS; SPECIFICITY; EVOLUTION; DISTRIBUTIONS; AGAONIDAE; VOLATILES; MELANISM; PATTERNS; SIGNALS	The mutualistic interaction between Ficus and their pollinating agaonid wasps constitutes an extreme example of plant-insect co-diversification. Most Ficus species are locally associated with a single specific agaonid wasp species. Specificity is ensured by each fig species emitting a distinctive attractive scent. However, cases of widespread coexistence of two agaonid wasp species on the same Ficus species are documented. Here we document the coexistence of two agaonid wasp species in Ficus septica: one yellow-colored and one black-colored. Our results suggest that their coexistence is facilitated by divergent ecological traits. The black species is longer-lived (a few more hours) and is hence active until later in the afternoon. Some traits of the yellow species must compensate for this advantage for their coexistence to be stable. In addition, we show that the composition of the scent emitted by receptive figs changes between sunrise and noon. The two species may therefore be exposed to somewhat different ranges of receptive fig scent composition and may consequently diverge in the way they perceive and/or respond to scents. Whether such situations may lead to host plant speciation is an open question.	[Conchou, Lucie; Cabioch, Lea; Rodriguez, Lillian J. V.; Kjellberg, Finn] Univ Montpellier 3, CNRS, CEFE UMR 5175, EPHE, F-34032 Montpellier, France; [Rodriguez, Lillian J. V.] Univ Philippines Diliman, Inst Biol, Quezon City, Philippines	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Universite de Montpellier; Universite Paul-Valery; University of the Philippines System; University of the Philippines Diliman	Conchou, L (corresponding author), Univ Montpellier 3, CNRS, CEFE UMR 5175, EPHE, F-34032 Montpellier, France.	lucie.conchou@gmail.com	Conchou, Lucie/M-8289-2016; Kjellberg, Finn/S-3281-2019	Conchou, Lucie/0000-0002-7562-1333; Kjellberg, Finn/0000-0001-6708-9538	Bio-Asie grant FigOdours from the french Ministere des Affaires Etrangeres et Europeennes	Bio-Asie grant FigOdours from the french Ministere des Affaires Etrangeres et Europeennes	Funding was provided by Bio-Asie grant FigOdours from the french Ministere des Affaires Etrangeres et Europeennes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams R.P., 2007, IDENTIFICATION ESSEN, V4th; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Bain A, 2014, ACTA OECOL, V57, P124, DOI 10.1016/j.actao.2013.10.004; Chen C, 2008, J CHEM ECOL, V34, P1536, DOI 10.1007/s10886-008-9558-4; Chen C, 2009, FUNCT ECOL, V23, P941, DOI 10.1111/j.1365-2435.2009.01622.x; Chen Y, 2012, MOL ECOL, V21, P1687, DOI 10.1111/j.1365-294X.2012.05491.x; Compton SG, 2009, AFR ENTOMOL, V17, P215, DOI 10.4001/003.017.0212; Copolovici LO, 2005, PLANT PHYSIOL, V139, P485, DOI 10.1104/pp.105.065995; Cornille A, 2012, P ROY SOC B-BIOL SCI, V279, P1731, DOI 10.1098/rspb.2011.1972; Cruaud A, 2012, SYST BIOL, V61, P1029, DOI 10.1093/sysbio/sys068; Delle-Vedove R, 2011, PHYTOCHEMISTRY, V72, P735, DOI 10.1016/j.phytochem.2011.02.005; ELSAYED AM, 2009, PHEROBASE DATABASE I; Forister ML, 2012, ECOLOGY, V93, P981, DOI 10.1890/11-0650.1; Ghara M, 2010, ECOL ENTOMOL, V35, P139, DOI 10.1111/j.1365-2311.2010.01176.x; GRANDI GUIDO, 1928, BOLL LAB ENT R ISTIT SUP AGR BOLOGNA, V1, P107; GRANDI GUIDO, 1927, PHILIPPINE JOUR SCI, V33, P309; Grison L, 1999, PHYTOCHEMISTRY, V52, P1293, DOI 10.1016/S0031-9422(99)00411-2; Haine ER, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-83; Harrison RD, 2006, J TROP ECOL, V22, P631, DOI 10.1017/S0266467406003488; Helsper JPFG, 1998, PLANTA, V207, P88, DOI 10.1007/s004250050459; Herre EA, 2008, ANNU REV ECOL EVOL S, V39, P439, DOI 10.1146/annurev.ecolsys.37.091305.110232; Jousselin E, 2003, OECOLOGIA, V134, P381, DOI 10.1007/s00442-002-1116-0; Jousselin E, 2001, OIKOS, V94, P287, DOI 10.1034/j.1600-0706.2001.940209.x; Kerdelhue C, 1999, MOL PHYLOGENET EVOL, V11, P401, DOI 10.1006/mpev.1998.0590; KJELLBERG F, 1988, P K NED AKAD C BIOL, V91, P117; Lin RC, 2011, BIOTROPICA, V43, P200, DOI 10.1111/j.1744-7429.2010.00686.x; Linstrom PJ, 69 NIST; Loivamaki M, 2007, PLANT PHYSIOL, V143, P540, DOI 10.1104/pp.106.092759; Lopez-Vaamonde C, 2002, ZOOL J LINN SOC-LOND, V136, P637, DOI 10.1046/j.1096-3642.2002.00040.x; Loreto F, 2004, TREE PHYSIOL, V24, P361, DOI 10.1093/treephys/24.4.361; Loreto F, 2010, TRENDS PLANT SCI, V15, P154, DOI 10.1016/j.tplants.2009.12.006; Martinson EO, 2014, ACTA OECOL, V57, P58, DOI 10.1016/j.actao.2013.07.009; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Parkash R, 2009, J INSECT SCI, V9, DOI 10.1673/031.009.4901; Proffit M, 2009, S AFR J BOT, V75, P771, DOI 10.1016/j.sajb.2009.08.006; Proffit M, 2009, ENTOMOL EXP APPL, V131, P46, DOI 10.1111/j.1570-7458.2009.00823.x; R Core Team, 2021, R LANGUAGE ENV STAT; Ramirez B, 1970, Kans. Univ. Sci. Bull., V49, P1; RAMIREZ W, 1970, Evolution, V24, P680; Roff DA, 2013, J EVOLUTION BIOL, V26, P1406, DOI 10.1111/jeb.12150; Soler CCL, 2012, ECOL LETT, V15, P978, DOI 10.1111/j.1461-0248.2012.01818.x; Song QS, 2001, J CHEM ECOL, V27, P1929, DOI 10.1023/A:1012226400586; Staudt M, 1997, ATMOS ENVIRON, V31, P145, DOI 10.1016/S1352-2310(97)00081-2; Stone GN, 2012, CURR BIOL, V22, P532, DOI 10.1016/j.cub.2012.01.059; Sun XJ, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-86; True JR, 2003, TRENDS ECOL EVOL, V18, P640, DOI 10.1016/j.tree.2003.09.006; vanNoort S, 1996, J BIOGEOGR, V23, P415, DOI 10.1111/j.1365-2699.1996.tb00003.x; Wang G, 2013, ANN BOT-LONDON, V111, P173, DOI 10.1093/aob/mcs250; Wang ZJ, 2010, ECOL ENTOMOL, V35, P691, DOI 10.1111/j.1365-2311.2010.01228.x; Warren M, 2010, ECOGRAPHY, V33, P148, DOI 10.1111/j.1600-0587.2009.06041.x; Warton DI, 2012, METHODS ECOL EVOL, V3, P89, DOI 10.1111/j.2041-210X.2011.00127.x	51	16	16	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2014	9	8							e103581	10.1371/journal.pone.0103581	http://dx.doi.org/10.1371/journal.pone.0103581			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR0CG	25105796	Green Submitted, Green Published, gold			2022-12-27	WOS:000343231900016
J	Shen, LL; Li, Y; Jiang, LH; Wang, XY				Shen, Lulu; Li, Ye; Jiang, Linghuo; Wang, Xiaoyuan			Response of Saccharomyces cerevisiae to the Stimulation of Lipopolysaccharide	PLOS ONE			English	Article							CELL-DEATH; PROTEIN-PHOSPHORYLATION; YEAST-CELLS; APOPTOSIS; AUTOPHAGY; MITOCHONDRIA; COMPLEXES; CYTOSCAPE; OXIDATION; STRESS	Lipopolysaccharide, known as endotoxin, can stimulate potent host immune responses through the complex of Toll-like-receptor 4 and myeloid differentiation protein 2; but its influence on Saccharomyces cerevisiae, a model organism for studying eukaryotes, is not clear. In this study, we found that lipopolysaccharide-treated S. cerevisiae cells could be stained by methylene blue, but did not die. Transcriptional profiling of the lipopolysaccharide-treated S. cerevisiae cells showed that 5745 genes were modulated: 2491 genes up-regulated and 3254 genes down-regulated. Significantly regulated genes (460 up-regulated genes and 135 down-regulated genes) in lipopolysaccharide-treated S. cerevisiae cells were analyzed on Gene Ontology, and used to establish physical protein-protein interaction network and protein phosphorylation network. Based on these analyses, most of the regulated genes in lipopolysaccharide-treated S. cerevisiae cells were related to cell wall, membrane, peroxisome and mitochondrion. Further experiments demonstrated that lipopolysaccharide stimulation caused the exposure of phosphatidylserine and the increase of mitochondrial membrane potential in S. cerevisiae cells, but levels of intracellular reactive oxygen species and metacaspase activation were not increased. This study demonstrated that lipopolysaccharide stimulation causes significant changes in S. cerevisiae cells, and the results would contribute to understand the response of eukaryotic cells to lipopolysaccharide stimulation.	[Shen, Lulu; Wang, Xiaoyuan] Jiangnan Univ, State Key Lab Food Sci & Technol, Wuxi, Peoples R China; [Shen, Lulu; Li, Ye; Jiang, Linghuo] Jiangnan Univ, Sch Biotechnol, Wuxi, Peoples R China; [Wang, Xiaoyuan] Jiangnan Univ, Synerget Innovat Ctr Food Safety & Nutr, Wuxi, Peoples R China	Jiangnan University; Jiangnan University; Jiangnan University	Wang, XY (corresponding author), Jiangnan Univ, State Key Lab Food Sci & Technol, Wuxi, Peoples R China.	xiaoyuanwang@hotmail.com			National Key Basic Research Program of China [2012CB725202]; National Natural Science Foundation of China [31170069]	National Key Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Key Basic Research Program of China (2012CB725202) and the National Natural Science Foundation of China (31170069). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeliovich H, 2001, MICROBIOL MOL BIOL R, V65, P463, DOI 10.1128/MMBR.65.3.463-479.2001; Almeida B, 2007, FEMS YEAST RES, V7, P404, DOI 10.1111/j.1567-1364.2006.00188.x; Alvers AL, 2009, AUTOPHAGY, V5, P847, DOI 10.4161/auto.8824; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Balzan R, 2004, MICROBIOL-SGM, V150, P109, DOI 10.1099/mic.0.26578-0; Benjamini Y, 2001, ANN STAT, V29, P1165; Beutler B, 2003, NAT REV IMMUNOL, V3, P169, DOI 10.1038/nri1004; Buttner S, 2006, J CELL BIOL, V175, P521, DOI 10.1083/jcb.200608098; Buts JP, 2006, PEDIATR RES, V60, P24, DOI 10.1203/01.pdr.0000220322.31940.29; Cai LP, 2013, MAR DRUGS, V11, P377, DOI 10.3390/md11020377; Carmona-Gutierrez D, 2010, CELL DEATH DIFFER, V17, P763, DOI 10.1038/cdd.2009.219; de Castro PA, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-194; de Gannes FMP, 1998, CYTOMETRY, V33, P333; Du L, 2008, FEMS YEAST RES, V8, P531, DOI 10.1111/j.1567-1364.2008.00375.x; Dziedzic SA, 2012, AUTOPHAGY, V8, P731, DOI 10.4161/auto.19314; Galluzzi L, 2012, CELL DEATH DIFFER, V19, P107, DOI 10.1038/cdd.2011.96; Gao J, 2009, BIOINFORMATICS, V25, P137, DOI 10.1093/bioinformatics/btn501; Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220; Jakubowski W, 2000, CELL BIOL INT, V24, P757, DOI 10.1006/cbir.2000.0556; Karima R, 1999, MOL MED TODAY, V5, P123, DOI 10.1016/S1357-4310(98)01430-0; Kissova I, 2006, FREE RADICAL BIO MED, V41, P1655, DOI 10.1016/j.freeradbiomed.2006.08.012; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Ludovico P, 2001, MICROBIOL-SGM, V147, P3335, DOI 10.1099/00221287-147-12-3335; Madeo F, 2004, CURR OPIN MICROBIOL, V7, P655, DOI 10.1016/j.mib.2004.10.012; Madeo F, 2002, MOL CELL, V9, P911, DOI 10.1016/S1097-2765(02)00501-4; Madeo F, 1997, J CELL BIOL, V139, P729, DOI 10.1083/jcb.139.3.729; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Marques JM, 2006, J BIOL CHEM, V281, P24687, DOI 10.1074/jbc.M603753200; MISRA V, 1994, J GASTROEN HEPATOL, V9, P512, DOI 10.1111/j.1440-1746.1994.tb01283.x; Morano KA, 2012, GENETICS, V190, P1157, DOI 10.1534/genetics.111.128033; Narasimhan ML, 2001, MOL CELL, V8, P921, DOI 10.1016/S1097-2765(01)00365-3; NICOLET CM, 1991, METHOD ENZYMOL, V194, P710; PAINTING K, 1990, WORLD J MICROB BIOT, V6, P346, DOI 10.1007/BF01201311; Park MS, 2007, J MICROBIOL BIOTECHN, V17, P1120; Pozniakovsky AI, 2005, J CELL BIOL, V168, P257, DOI 10.1083/jcb.200408145; Ptacek J, 2005, NATURE, V438, P679, DOI 10.1038/nature04187; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; SAMI M, 1994, J FERMENT BIOENG, V78, P212, DOI 10.1016/0922-338X(94)90292-5; Scardoni G, 2009, BIOINFORMATICS, V25, P2857, DOI 10.1093/bioinformatics/btp517; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shi F, 2014, WORLD J MICROB BIOT, V30, P125, DOI 10.1007/s11274-013-1428-8; Silva RD, 2005, MOL MICROBIOL, V58, P824, DOI 10.1111/j.1365-2958.2005.04868.x; VAIRO ML, 1961, STAIN TECHNOL, V36, P329, DOI 10.3109/10520296109113303; Wang XY, 2010, SUBCELL BIOCHEM, V53, P3, DOI 10.1007/978-90-481-9078-2_1; Wang XY, 2010, PROG LIPID RES, V49, P97, DOI 10.1016/j.plipres.2009.06.002; Wang XY, 2009, BIOCHEMISTRY-US, V48, P1162, DOI 10.1021/bi802211k; Wloch-Salamon DM, 2013, J APPL MICROBIOL, V114, P287, DOI 10.1111/jam.12024; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; Yu HY, 2007, PLOS COMPUT BIOL, V3, P713, DOI 10.1371/journal.pcbi.0030059; Zhu ZW, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2112	50	8	9	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2014	9	8							e104428	10.1371/journal.pone.0104428	http://dx.doi.org/10.1371/journal.pone.0104428			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR0CG	25105496	Green Published, gold, Green Submitted			2022-12-27	WOS:000343231900056
J	Choi, Y; Lee, K; Ryu, J; Kim, HG; Jeong, AY; Woo, RS; Lee, JH; Hyun, JW; Hahn, S; Kim, JH; Kim, HS				Choi, Yoori; Lee, Kihwan; Ryu, Junghwa; Kim, Hyoun Geun; Jeong, A. Young; Woo, Ran-Sook; Lee, Jun-Ho; Hyun, Jin Won; Hahn, Seokyung; Kim, Joung-Hun; Kim, Hye-Sun			Neuritin Attenuates Cognitive Function Impairments in Tg2576 Mouse Model of Alzheimer's Disease	PLOS ONE			English	Article							AMYLOID-BETA; HIPPOCAMPAL NEUROGENESIS; ADULT NEUROGENESIS; SYNAPTIC FAILURE; NEURONS BORN; IN-VIVO; CPG15; GROWTH; MICE; MEMORY	Neuritin, also known as CPG15, is a neurotrophic factor that was initially discovered in a screen to identify genes involved in activity-dependent synaptic plasticity. Neuritin plays multiple roles in the process of neural development and synaptic plasticity, although its binding receptor(s) and downstream signaling effectors remain unclear. In this study, we found that the cortical and hippocampal expression of neuritin is reduced in the brains of Alzheimer's disease (AD) patients and demonstrated that viral-mediated expression of neuritin in the dentate gyrus of 13-month-old Tg2576 mice, an AD animal model, attenuated a deficit in learning and memory as assessed by a Morris water maze test. We also found that neuritin restored the reduction in dendritic spine density and the maturity of individual spines in primary hippocampal neuron cultures prepared from Tg2576 mice. It was also shown that viral-mediated expression of neuritin in the dentate gyrus of 7-week-old Sprague-Dawley rats increased neurogenesis in the hippocampus. Taken together, our results demonstrate that neuritin restores the reduction in dendritic spine density and the maturity of individual spines in primary hippocampal neurons from Tg2576 neurons, and also attenuates cognitive function deficits in Tg2576 mouse model of AD, suggesting that neuritin possesses a therapeutic potential for AD.	[Choi, Yoori; Lee, Kihwan; Ryu, Junghwa; Kim, Hye-Sun] Seoul Natl Univ, Coll Med, Neurosci Res Inst, Dept Pharmacol & Biomed Sci, Seoul, South Korea; [Lee, Kihwan] Seoul Natl Univ, Dent Res Inst, Natl Res Lab Pain, Seoul, South Korea; [Lee, Kihwan] Seoul Natl Univ, Sch Dent, Dept Neurobiol & Physiol, Seoul, South Korea; [Kim, Hyoun Geun; Jeong, A. Young; Kim, Joung-Hun] Pohang Univ Sci & Technol POSTECH, Dept Life Sci, Pohang, South Korea; [Woo, Ran-Sook] Eulji Univ, Sch Med, Dept Anat & Neurosci, Taejon, South Korea; [Lee, Jun-Ho] Daejeon Univ, Dept Emergency Med Technol, Taejon, South Korea; [Hyun, Jin Won] Jeju Natl Univ, Sch Med, Dept Biochem, Cheju, South Korea; [Hahn, Seokyung] Seoul Natl Univ Hosp, Med Res Collaborating Ctr, Seoul 110744, South Korea; [Kim, Hye-Sun] Seoul Natl Univ, Coll Med, Bundang Hosp, Songnam, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Pohang University of Science & Technology (POSTECH); Eulji University; Daejeon University; Jeju National University; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU)	Kim, JH (corresponding author), Pohang Univ Sci & Technol POSTECH, Dept Life Sci, Pohang, South Korea.	joungkim@postech.ac.kr; hyisun@snu.ac.kr	Ryu, Junghwa/K-4034-2015	Hahn, Seokyung/0000-0002-4684-4917	Korea Healthcare Technology R&D Project of Ministry for Health, Welfare and Family Affairs of the Republic of Korea [A111230, A111284]; National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2011-0021866]; Seoul National University Bundang Hospital Research Fund [02-2009-025]	Korea Healthcare Technology R&D Project of Ministry for Health, Welfare and Family Affairs of the Republic of Korea; National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of Korea); Seoul National University Bundang Hospital Research Fund	This study was financially supported by grants from the Korea Healthcare Technology R&D Project (A111230) of Ministry for Health, Welfare and Family Affairs of the Republic of Korea (A111284), by the National Research Foundation of Korea (NRF)funded by the Ministry of Education, Science and Technology, grant number 2011-0021866, and in part by Seoul National University Bundang Hospital Research Fund (02-2009-025). Thank you again for the opportunity to resubmit our manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrous DN, 2005, PHYSIOL REV, V85, P523, DOI 10.1152/physrev.00055.2003; ANTONINI A, 1993, SCIENCE, V260, P1819, DOI 10.1126/science.8511592; Arendt T, 2009, ACTA NEUROPATHOL, V118, P167, DOI 10.1007/s00401-009-0536-x; Cantallops I, 2000, NAT NEUROSCI, V3, P1004, DOI 10.1038/79823; Chandler D, 2010, AM J MED GENET B, V153B, P428, DOI 10.1002/ajmg.b.30996; Corriveau RA, 1999, J NEUROSCI, V19, P7999, DOI 10.1523/jneurosci.19-18-07999.1999; Dong H, 2004, NEUROSCIENCE, V127, P601, DOI 10.1016/j.neuroscience.2004.05.040; Donovan MH, 2006, J COMP NEUROL, V495, P70, DOI 10.1002/cne.20840; Feng RB, 2001, NEURON, V32, P911, DOI 10.1016/S0896-6273(01)00523-2; Fujino T, 2003, MOL CELL NEUROSCI, V24, P538, DOI 10.1016/S1044-7431(03)00230-6; Fujino T, 2008, J COMP NEUROL, V507, P1831, DOI 10.1002/cne.21649; Gan L, 2008, NEUROBIOL DIS, V29, P71, DOI 10.1016/j.nbd.2007.08.002; Han Y, 2007, J NEUROTRAUM, V24, P722, DOI 10.1089/neu.2006.0174; Hering H, 2001, NAT REV NEUROSCI, V2, P880, DOI 10.1038/35104061; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Javaherian A, 2005, NEURON, V45, P505, DOI 10.1016/j.neuron.2004.12.051; Jin KL, 2004, P NATL ACAD SCI USA, V101, P13363, DOI 10.1073/pnas.0403678101; Jurgensen S, 2010, J MOL NEUROSCI, V40, P221, DOI 10.1007/s12031-009-9237-0; Karamoysoyli E, 2008, DIABETES, V57, P181, DOI 10.2337/db07-0895; Kim Y, 2006, NATURE, V442, P814, DOI 10.1038/nature04976; Kolecki R, 2008, ACTA NEUROPATHOL, V116, P419, DOI 10.1007/s00401-008-0380-4; Lee KW, 2006, P NATL ACAD SCI USA, V103, P3399, DOI 10.1073/pnas.0511244103; Mainen ZF, 1996, NATURE, V382, P363, DOI 10.1038/382363a0; Marron TU, 2005, J NEUROCHEM, V92, P10, DOI 10.1111/j.1471-4159.2004.02836.x; Maruszak A, 2014, J ALZHEIMERS DIS, V38, P11, DOI 10.3233/JAD-131004; Masliah E, 2001, NEUROLOGY, V56, P127, DOI 10.1212/WNL.56.1.127; Masliah E, 2006, ALZHEIMER'S DISEASE: A CENTURY OF SCIENTIFIC AND CLINICAL RESEARCH, P91; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; Naeve GS, 1997, P NATL ACAD SCI USA, V94, P2648, DOI 10.1073/pnas.94.6.2648; Nedivi E, 1998, SCIENCE, V281, P1863, DOI 10.1126/science.281.5384.1863; NEDIVI E, 1993, NATURE, V363, P718, DOI 10.1038/363718a0; Nedivi E, 2001, J COMP NEUROL, V435, P464, DOI 10.1002/cne.1044; Nedivi E, 1996, P NATL ACAD SCI USA, V93, P2048, DOI 10.1073/pnas.93.5.2048; Putz U, 2005, NAT NEUROSCI, V8, P322, DOI 10.1038/nn1407; SAMUEL W, 1994, NEUROLOGY, V44, P2081, DOI 10.1212/WNL.44.11.2081; Scheff SW, 2007, NEUROLOGY, V68, P1501, DOI 10.1212/01.wnl.0000260698.46517.8f; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Son H, 2012, P NATL ACAD SCI USA, V109, P11378, DOI 10.1073/pnas.1201191109; Stuchlik A, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00106; Tatebayashi Y, 2003, ACTA NEUROPATHOL, V105, P225, DOI 10.1007/s00401-002-0636-3; Toni N, 2008, NAT NEUROSCI, V11, P901, DOI 10.1038/nn.2156; Toni N, 2007, NAT NEUROSCI, V10, P727, DOI 10.1038/nn1908; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Wang R, 2004, NEUROSCIENCE, V126, P305, DOI 10.1016/j.neuroscience.2004.03.048; Wu HY, 2010, J NEUROSCI, V30, P2636, DOI 10.1523/JNEUROSCI.4456-09.2010	45	19	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e104121	10.1371/journal.pone.0104121	http://dx.doi.org/10.1371/journal.pone.0104121			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25101829	Green Submitted, gold, Green Published			2022-12-27	WOS:000339993900040
J	Trajman, A; Pinto, M; de Souza, R; Freitas, M; Torrens, A; Lima, J; Barreira, D; Perkins, MD; Boehme, CC; Ginnard, J; Jefferson, C; Pantoja, A; Kik, SV; Chedore, P; Denkinger, CM; Pai, M				Trajman, Anete; Pinto, Marcia; de Souza Junior, Ruy; Freitas, Marianna; Torrens, Ana; Lima, Josue; Barreira, Draurio; Perkins, Mark D.; Boehme, Catharina C.; Ginnard, Janet; Jefferson, Carole; Pantoja, Andrea; Kik, Sandra V.; Chedore, Pamela; Denkinger, Claudia M.; Pai, Madhukar		TB Diagnostics Market Anal Consort	Market Assessment of Tuberculosis Diagnostics in Brazil in 2012	PLOS ONE			English	Article								Background: Improved diagnostics for the diagnosis of tuberculosis (TB) are urgently needed. However, test developers and investors require market size data to support new product development. This study assessed the served available market for TB diagnostics in Brazil in 2012 and the market segmentation in the public and private sectors. Methods: Data were collected on test volumes done in the public and private sectors for the diagnosis of latent and active TB, drug susceptibility testing and treatment follow-up. Tests included were tuberculin skin tests, interferon-gamma releases assays, smear microscopy, solid and liquid cultures, nucleic acid amplification tests and phenotypic drug susceptibility tests. The data were collected by means of an electronic survey via the Brazilian State laboratories and from sales information provided by manufacturers. Test costs for the public sector were calculated using a components approach, while costs for the private sector were based on prices paid by patients. The overall market value (expenditure) for the entire country was calculated using the public sector test costs. Results: During 2012, an estimated total of 2.4 million TB diagnostic tests were done in Brazil, resulting in an estimated overall market value of USD 17.2 million. The public sector accounted for 91% of the test volumes and 88% of the market value. Smear microscopy was the most commonly test (n = 1.3 million; 55% of total) at an estimated value of USD 3.7 million. Culture overall (n = 302,761) represented 13% of test volumes and 40% (USD 6.9 million) of the market value. On average, USD 208 was spent on TB diagnostics for every notified TB patient in Brazil, in 2012. Conclusion: The TB diagnostics market value in Brazil in 2012 was over USD 17 million. These study results will help test developers to understand the current and potential market for replacement or add-on diagnostic technologies.	[Trajman, Anete] Univ Fed Rio de Janeiro, Internal Med Grad Program, Rio De Janeiro, Brazil; [Trajman, Anete] McGill Univ, Montreal, PQ, Canada; [Pinto, Marcia] Fundacao Oswaldo Cruz, Rio De Janeiro, Brazil; [de Souza Junior, Ruy; Freitas, Marianna; Torrens, Ana; Lima, Josue; Barreira, Draurio] Natl TB Program, Brasilia, DF, Brazil; [Perkins, Mark D.; Boehme, Catharina C.] Fdn Innovat New Diagnost, Geneva, Switzerland; [Ginnard, Janet] UNITAID, Geneva, Switzerland; [Kik, Sandra V.; Chedore, Pamela; Denkinger, Claudia M.; Pai, Madhukar] McGill Int TB Ctr, Montreal, PQ, Canada; [Kik, Sandra V.; Denkinger, Claudia M.; Pai, Madhukar] McGill Univ, Dept Epidemiol & Biostat, Montreal, PQ, Canada	Universidade Federal do Rio de Janeiro; McGill University; Fundacao Oswaldo Cruz; Foundation For Innovative New Diagnostics; McGill University	Kik, SV (corresponding author), McGill Int TB Ctr, Montreal, PQ, Canada.	sandra.kik@mail.mcgill.ca	Pai, Madhukar/AAX-9901-2021; PAL, MRINAL/ABG-9676-2020	Pai, Madhukar/0000-0003-3667-4536; PAL, MRINAL/0000-0002-1032-272X	Bill and Melinda Gates Foundation [OPP1061487]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This study was funded by the Bill and Melinda Gates Foundation (grant OPP1061487). No writing assistance was used. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, MAN REC CONTR TUB BR; Brazilian Ministry of Health, 2013, DATASUS SIST INF AMB; Cobelens F, 2012, J INFECT DIS, V205, pS191, DOI 10.1093/infdis/jis188; Telles MAD, 2012, J BRAS PNEUMOL, V38, P766, DOI 10.1590/S1806-37132012000600013; Drummond MF., 2005, METHODS EC EVALUATIO, V3 rd ed, P1; Pai M, 2013, EXPERT REV MOL DIAGN, V13, P311, DOI [10.1586/erm.13.16, 10.1586/ERM.13.16]; Pai NP, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001306; UNITAID, 2013, TUB DIAGN TECHN MARK, P1; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, 2013, GLOB TUB REP 2013 WH; WHO, 2013, STATE SCI ENDOCRINE, p[1, 5]; World Bank, 2012, WORLD BANK DAT OFF E; World Health Organization, 2006, DEF DIAGN DIAB MELL, P1	13	0	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e104105	10.1371/journal.pone.0104105	http://dx.doi.org/10.1371/journal.pone.0104105			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25099237	Green Published, gold			2022-12-27	WOS:000339995100050
J	Hong, CS; Muller, L; Boyiadzis, M; Whiteside, TL				Hong, Chang Sook; Muller, Laurent; Boyiadzis, Michael; Whiteside, Theresa L.			Isolation and Characterization of CD34+Blast-Derived Exosomes in Acute Myeloid Leukemia	PLOS ONE			English	Article							CELL-LINE; PROGENITOR CELLS; T-CELL; MICROVESICLES; PHENOTYPE; APOPTOSIS; KASUMI-1; PLASMA	Exosomes are membrane-bound vesicles found in all biological fluids. AML patients' plasma collected at diagnosis contains elevated exosome levels relative to normal donor (ND) plasma. The molecular profile of AML exosomes changes in the course of therapy and may serve as a measure of disease progression or response to therapy. However, plasma contains a mix of exosomes derived from various cell types. To be able to utilize blast-derived exosomes as biomarkers for AML, we have developed an immunoaffinity-based capture method utilizing magnetic microbeads coated with anti-CD34 antibody (Ab). This Ab is specific for CD34, a unique marker of AML blasts. The capture procedure was developed using CD34+ exosomes derived from Kasumi-1 AML cell culture supernatants. The capture capacity of CD34microbeads was shown to linearly correlate with the input exosomes. A 10 uL aliquot of CD34 microbeads was able to capture all of CD34+ exosomes present in 100-1,000 uL of AML plasma. The levels of immunocaptured CD34+ exosomes correlated with the percentages of CD34+ blasts in the AML patients' peripheral blood. The immunocaptured exosomes had a typical cup-shaped morphology by transmission electron microscopy, and their molecular cargo was similar to that of parental blasts. These exosomes were biologically-active. Upon co-incubation with natural killer (NK) cells, captured blast-derived exosomes down-regulated surface NKG2D expression, while non-captured exosomes reduced expression levels of NKp46. Our data provide a proof-of-principle that blast-derived exosomes can be quantitatively recovered from AML patients' plasma, their molecular profile recapitulates that of autologous blasts and they retain the ability to mediate immune suppression. These data suggest that immunocaptured blast-derived exosomes might be useful in diagnosis and/or prognosis of AML in the future.	[Hong, Chang Sook; Muller, Laurent; Boyiadzis, Michael; Whiteside, Theresa L.] Univ Pittsburgh, Inst Canc, Pittsburgh, PA 15260 USA; [Muller, Laurent] Univ Hosp, Dept Otolaryngol & Head & Neck Surg, Basel, Switzerland; [Boyiadzis, Michael] Univ Pittsburgh, Sch Med, Div Hematol Oncol, Pittsburgh, PA USA; [Whiteside, Theresa L.] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA USA; [Whiteside, Theresa L.] Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA USA; [Whiteside, Theresa L.] Univ Pittsburgh, Sch Med, Dept Otolaryngol, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Whiteside, TL (corresponding author), Univ Pittsburgh, Inst Canc, Pittsburgh, PA 15260 USA.	whitesidetl@upmc.edu			National Institutes of Health, USA [PO1-CA109688, R01-CA168628]; NATIONAL CANCER INSTITUTE [R01CA168628] Funding Source: NIH RePORTER	National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	National Institutes of Health, USA grants PO1-CA109688 and R01-CA168628 to TLW (www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aatonen M, 2012, SEMIN THROMB HEMOST, V38, P102, DOI 10.1055/s-0031-1300956; Andreola G, 2002, J EXP MED, V195, P1303, DOI 10.1084/jem.20011624; ASOU H, 1991, BLOOD, V77, P2031; Blair A, 1998, BLOOD, V92, P4325, DOI 10.1182/blood.V92.11.4325; Burnett A, 2011, J CLIN ONCOL, V29, P487, DOI 10.1200/JCO.2010.30.1820; EL Andaloussi S, 2013, NAT REV DRUG DISCOV, V12, P348, DOI 10.1038/nrd3978; Filipazzi P, 2012, SEMIN CANCER BIOL, V22, P342, DOI 10.1016/j.semcancer.2012.02.005; Hong CS, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00160; Horton SJ, 2012, HAEMATOL-HEMATOL J, V97, P966, DOI 10.3324/haematol.2011.054734; Ishikawa F, 2007, NAT BIOTECHNOL, V25, P1315, DOI 10.1038/nbt1350; Larizza L, 2005, LEUKEMIA LYMPHOMA, V46, P247, DOI 10.1080/10428190400007565; Logozzi M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005219; Martinez-Lorenzo MJ, 2004, EXP CELL RES, V295, P315, DOI 10.1016/j.yexcr.2003.12.024; Mathivanan S, 2010, MOL CELL PROTEOMICS, V9, P197, DOI 10.1074/mcp.M900152-MCP200; Muller L, 2014, UNPUB; Oyan AM, 2005, CYTOM PART B-CLIN CY, V64B, P18, DOI 10.1002/cyto.b.20044; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Szczepanski MJ, 2011, HAEMATOL-HEMATOL J, V96, P1302, DOI 10.3324/haematol.2010.039743; Tauro BJ, 2013, MOL CELL PROTEOMICS, V12, P587, DOI 10.1074/mcp.M112.021303; Taylor DD, 2011, SEMIN IMMUNOPATHOL, V33, P441, DOI 10.1007/s00281-010-0234-8; Teague RM, 2013, J IMMUNOTHER CANCER, V1, DOI 10.1186/2051-1426-1-13; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Valenti R, 2006, CANCER RES, V66, P9290, DOI 10.1158/0008-5472.CAN-06-1819; van Stijn A, 2003, HAEMATOLOGICA, V88, P497; Whiteside TL, 2014, CANCER IMMUNOL IMMUN, V63, P67, DOI 10.1007/s00262-013-1490-y; Whiteside TL, 2013, BIOCHEM SOC T, V41, P245, DOI 10.1042/BST20120265; Zhang HG, 2012, BIOTECH HISTOCHEM, V87, P161, DOI 10.3109/10520291003659042	27	125	135	4	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e103310	10.1371/journal.pone.0103310	http://dx.doi.org/10.1371/journal.pone.0103310			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093329	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000341357200021
J	Kim, AJ; Lim, HJ; Ro, H; Ko, KP; Han, SY; Chang, JH; Lee, HH; Chung, W; Jung, JY				Kim, Ae Jin; Lim, Hye Jin; Ro, Han; Ko, Kwang-Pil; Han, Song Yi; Chang, Jae Hyun; Lee, Hyun Hee; Chung, Wookyung; Jung, Ji Yong			Low-Dose Aspirin for Prevention of Cardiovascular Disease in Patients with Chronic Kidney Disease	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; ANTIPLATELET THERAPY; BENEFITS; OUTCOMES; PREVALENCE; ACTIVATION; IMPACT; HEART; RISK	Background: Chronic kidney disease (CKD) is a major risk factor for the development of cardiovascular disease (CVD). Previous trials have investigated the effects of low-dose aspirin on CVD prevention in patients with diabetes; however, patients with CKD were not examined. The role of aspirin in diabetics is controversial, and the available literature is contradictory. Therefore, we studied whether low-dose aspirin would be beneficial for patients with CKD, a group that is at high risk for CVD. Method: From a total of 25340 patients with CKD, 1884 recipients of low-dose aspirin (100 mg/day) were paired 1: 1 with non-recipients for analysis using propensity score matching. The primary endpoint was the development of atherosclerotic CVD, including coronary arterial disease, stroke, and peripheral arterial disease. Secondary endpoints included death from any cause, bleeding events, doubling of serum creatinine, and renal death. Results: The incidence of a primary endpoint of any atherosclerotic CVD was significantly higher in the aspirin users than in the non-users (P<0.001). Secondary endpoints, including all-cause mortality and composite bleeding events, were not significantly different between the aspirin users and the non-users. However, the doubling of serum creatinine levels (P=0.001) and renal death (P=0.042) were significantly associated with the use of aspirin. Conclusion: These results suggest that the use of low-dose aspirin in patients with CKD may have harmful consequences related to the development of CVD and renal progression.	[Kim, Ae Jin; Lim, Hye Jin; Ro, Han; Han, Song Yi; Chang, Jae Hyun; Lee, Hyun Hee; Chung, Wookyung; Jung, Ji Yong] Gachon Univ, Gil Med Ctr, Dept Internal Med, Div Nephrol, Inchon, South Korea; [Ro, Han; Chang, Jae Hyun; Lee, Hyun Hee; Chung, Wookyung; Jung, Ji Yong] Gachon Univ, Sch Med, Inchon, South Korea; [Ko, Kwang-Pil] Gachon Univ, Sch Med, Dept Prevent Med, Inchon, South Korea	Gachon University; Gachon University; Gachon University	Jung, JY (corresponding author), Gachon Univ, Gil Med Ctr, Dept Internal Med, Div Nephrol, Inchon, South Korea.	jyjung@gachon.ac.kr			Chong Kun Dang Pharmaceutical Corp. in Korea	Chong Kun Dang Pharmaceutical Corp. in Korea	This study was supported by Chong Kun Dang Pharmaceutical Corp. in Korea. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeseun GA, 2012, AM J NEPHROL, V36, P342, DOI 10.1159/000342794; Angiolillo DJ, 2010, J AM COLL CARDIOL, V55, P1139, DOI 10.1016/j.jacc.2009.10.043; Baigent C, 2005, AM J KIDNEY DIS, V45, P473, DOI 10.1053/j.ajkd.2004.11.015; Boccardo P, 2004, SEMIN THROMB HEMOST, V30, P579, DOI 10.1055/s-2004-835678; Briasoulis A, 2013, CURR CARDIOL REP, V15, DOI 10.1007/s11886-012-0340-4; Calonge N, 2009, ANN INTERN MED, V150, P396; Charytan D, 2006, KIDNEY INT, V70, P2021, DOI 10.1038/sj.ki.5001934; Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Debella YT, 2011, CLIN J AM SOC NEPHRO, V6, P1385, DOI 10.2215/CJN.10271110; Dreisbach AW, 2009, CLIN PHARMACOL THER, V86, P553, DOI 10.1038/clpt.2009.163; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Ethier J, 2007, AM J KIDNEY DIS, V50, P602, DOI 10.1053/j.ajkd.2007.07.007; Gremmel T, 2013, NEPHROL DIAL TRANSPL, V28, P2116, DOI 10.1093/ndt/gft103; Jardine MJ, 2010, J AM COLL CARDIOL, V56, P956, DOI 10.1016/j.jacc.2010.02.068; Mann JFE, 2001, ANN INTERN MED, V134, P629, DOI 10.7326/0003-4819-134-8-200104170-00007; McCullough PA, 2002, AM HEART J, V144, P226, DOI 10.1067/mhj.2002.125513; Mezzano D, 1996, THROMB HAEMOSTASIS, V76, P312; Ninomiya T, 2013, BMJ-BRIT MED J, V347, pf5680, DOI DOI 10.1136/BMJ.F5680; Nolin TD, 2009, J AM SOC NEPHROL, V20, P2269, DOI 10.1681/ASN.2009010082; Oberg BP, 2004, KIDNEY INT, V65, P1009, DOI 10.1111/j.1523-1755.2004.00465.x; Palmer SC, 2012, ANN INTERN MED, V157, P263, DOI 10.7326/0003-4819-157-4-201208210-00007; Palmer SC, 2012, ANN INTERN MED, V156, P445, DOI 10.7326/0003-4819-156-6-201203200-00007; Pignone M, 2010, CIRCULATION, V121, P2694, DOI 10.1161/CIR.0b013e3181e3b133; Sciahbasi Alessandro, 2010, Prev Cardiol, V13, P18, DOI 10.1111/j.1751-7141.2009.00050.x; Shen L, 2012, EXP THER MED, V3, P530, DOI 10.3892/etm.2011.432; Spiel AO, 2008, CIRCULATION, V117, P1449, DOI 10.1161/CIRCULATIONAHA.107.722827; Washam JB, 2008, ADV CHRONIC KIDNEY D, V15, P370, DOI 10.1053/j.ackd.2008.07.006; Wattanakit K, 2008, J AM SOC NEPHROL, V19, P135, DOI 10.1681/ASN.2007030308; Weigert AL, 1998, AM J MED SCI, V316, P94, DOI 10.1097/00000441-199808000-00005	30	42	43	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e104179	10.1371/journal.pone.0104179	http://dx.doi.org/10.1371/journal.pone.0104179			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093403	gold, Green Submitted, Green Published			2022-12-27	WOS:000341357200085
J	Martinez, AA; Zaldivar, YY; De Castillo, Z; Ortiz, AY; Mendoza, Y; Cristina, J; Pascale, JM				Martinez, Alexander A.; Zaldivar, Yamitzel Y.; De Castillo, Zoila; Ortiz, Alma Y.; Mendoza, Yaxelis; Cristina, Juan; Pascale, Juan M.		CSS-NAT Grp	High Diversity of Hepatitis B Virus Genotypes in Panamanian Blood Donors: A Molecular Analysis of New Variants	PLOS ONE			English	Article							MAXIMUM-LIKELIHOOD; CENTRAL-AMERICA; HBV; EPIDEMIOLOGY; RECOMBINANT; TIME	Hepatitis B Virus (HBV) is an infectious agent that causes more than half of the cases of liver disease and cancer in the world. Globally there are around 250 million people chronically infected with this virus. Despite 16% of the cases of liver disease in Central America are caused by HBV, the information regarding its genetic diversity, genotypes and circulation is scarce. The purpose of this study was to evaluate the genetic variability of the HBV genotypes from HBV-DNA positive samples obtained from screening blood donors at the Social Security System of Panama and to estimate its possible origin. From 59,696 blood donors tested for HBV infection during 2010-2012, there were 74 HBV-DNA positive subjects. Analysis of the partial PreS2-S region of 27 sequences shows that 21% of the infections were caused by genotype A, 3% by genotype D and 76% by genotype F. In addition, we were able to confirm circulation of six sub-genotypes A1, A2, A3, D4, F3, F1 and a proposed new sub-genotype denominated F5pan. We found a confinement of sub-genotypes F1 and F5pan to the western area of Panama. The tMRCA analysis suggests a simultaneous circulation of previously described sub-genotypes rather than recent introductions of the Panamanian sub-genotypes in the country. Moreover, these results highlight the need of more intensive research of the HBV strains circulating in the region at the molecular level. In conclusion, Panama has a high HBV genotype diversity that includes a new proposed sub-genotype, an elevated number of PreCore-Core mutations, and confinement of these variants in a specific geographical location.	[Martinez, Alexander A.; Zaldivar, Yamitzel Y.; Ortiz, Alma Y.; Mendoza, Yaxelis; Pascale, Juan M.] Gorgas Mem Inst Hlth Studies, Panama City, Panama; [Martinez, Alexander A.; Mendoza, Yaxelis] Acharya Nagarjuna Univ, Dept Biotechnol, Guntur, AP, India; [Martinez, Alexander A.; Mendoza, Yaxelis] INDICASAT AIP Clayton, City Of Knowledge, Panama; [De Castillo, Zoila; CSS-NAT Grp] Complejo Hosp Dr Arnulfo Arias Madrid, Panama City, Panama; [Cristina, Juan] Univ Republica, Fac Ciencias, Ctr Invest Nucl, Lab Virol Mol, Montevideo, Uruguay	Instituto Conmemorativo Gorgas de Estudios de la Salud; Acharya Nagarjuna University; Universidad de la Republica, Uruguay	Pascale, JM (corresponding author), Gorgas Mem Inst Hlth Studies, Panama City, Panama.	jpascale@gorgas.gob.pa	Martinez, Alexander A/F-9601-2012; Martínez, Alexander/HHC-2101-2022	Martinez, Alexander A/0000-0002-7816-3040; 	Secretaria Nacional de Ciencia y Tecnologia (SENACYT)PANAMA [FID09-050]; Instituto Panameno para formacion de recursos Humanos (IFARHU) PANAMA	Secretaria Nacional de Ciencia y Tecnologia (SENACYT)PANAMA; Instituto Panameno para formacion de recursos Humanos (IFARHU) PANAMA	This study was supported by the Secretaria Nacional de Ciencia y Tecnologia (SENACYT)PANAMA, grant FID09-050. AAM was supported by a fellowship of the Instituto Panameno para formacion de recursos Humanos (IFARHU) PANAMA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarado-Mora MV, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-244; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; ArauzRuiz P, 1997, J INFECT DIS, V176, P851, DOI 10.1086/516507; ArauzRuiz P, 1997, J MED VIROL, V51, P305, DOI 10.1002/(SICI)1096-9071(199704)51:4&lt;305::AID-JMV8&gt;3.0.CO;2-9; Martinez AA, 2013, MEM I OSWALDO CRUZ, V108, P541, DOI 10.1590/S0074-02762013000500002; Baele G, 2012, MOL BIOL EVOL, V29, P2157, DOI 10.1093/molbev/mss084; Bouckaert R, 2013, ANTIVIR THER, V18, P497, DOI 10.3851/IMP2656; Conte E, 2013, ACTUALIZACION INFORM; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fassio E, 2010, ETIOLOGY HEPATOCELLU; Fujisaki S, 2011, J CLIN MICROBIOL, V49, P1017, DOI 10.1128/JCM.02149-10; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; GUNTHER S, 1995, J VIROL, V69, P5437; Hayer J, 2013, NUCLEIC ACIDS RES, V41, pD566, DOI 10.1093/nar/gks1022; Huy TTT, 2006, ARCH VIROL, V151, P589, DOI 10.1007/s00705-005-0671-1; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kato H, 2005, WORLD J GASTROENTERO, V11, P6295, DOI 10.3748/wjg.v11.i40.6295; Kramvis A, 2005, VACCINE, V23, P2409, DOI 10.1016/j.vaccine.2004.10.045; Kramvis A, 2013, ANTIVIR THER, V18, P513, DOI 10.3851/IMP2657; Laufer N, 2010, SEX TRANSM DIS, V37, P342, DOI 10.1097/OLQ.0b013e3181d73c0d; Leon B, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-60; Liu Y, 2007, J CLIN MICROBIOL, V45, P553, DOI 10.1128/JCM.00709-06; Martin D, 2000, BIOINFORMATICS, V16, P562, DOI 10.1093/bioinformatics/16.6.562; Motta-Castro A, 2008, ARCH VIROL, V153, P2197, DOI 10.1007/s00705-008-0237-0; Ott JJ, 2012, VACCINE, V30, P2212, DOI 10.1016/j.vaccine.2011.12.116; Pinho JRR, 2013, ANTIVIR THER, V18, P425, DOI 10.3851/IMP2590; Sa MS, 2007, BRAZ J INFECT DIS, V11, P395, DOI 10.1590/S1413-86702007000400004; Santos AO, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-315; Shi WF, 2013, INFECT GENET EVOL, V16, P355, DOI 10.1016/j.meegid.2013.03.021; Shi YH, 2012, JPN J INFECT DIS, V65, P476, DOI 10.7883/yoken.65.476; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Torres C, 2011, MOL PHYLOGENET EVOL, V59, P114, DOI 10.1016/j.ympev.2011.01.010; Trinks J, 2008, J VIRAL HEPATITIS, V15, P827, DOI 10.1111/j.1365-2893.2008.00997.x	36	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e103545	10.1371/journal.pone.0103545	http://dx.doi.org/10.1371/journal.pone.0103545			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093674	gold, Green Submitted, Green Published			2022-12-27	WOS:000341357200025
J	Wilflingseder, J; Sunzenauer, J; Toronyi, E; Heinzel, A; Kainz, A; Mayer, B; Perco, P; Telkes, G; Langer, RM; Oberbauer, R				Wilflingseder, Julia; Sunzenauer, Judith; Toronyi, Eva; Heinzel, Andreas; Kainz, Alexander; Mayer, Bernd; Perco, Paul; Telkes, Gabor; Langer, Robert M.; Oberbauer, Rainer			Molecular Pathogenesis of Post-Transplant Acute Kidney Injury: Assessment of Whole-Genome mRNA and MiRNA Profiles	PLOS ONE			English	Article							DELAYED GRAFT FUNCTION; ISCHEMIA-REPERFUSION INJURY; GENE-EXPRESSION PATTERNS; ALLOGRAFT; HYPOXIA; TRANSPLANTATION; IDENTIFICATION; PERMEABILITY; ASSOCIATION; MECHANISMS	Acute kidney injury (AKI) affects roughly 25% of all recipients of deceased donor organs. The prevention of post-transplant AKI is still an unmet clinical need. We prospectively collected zero-hour, indication as well as protocol kidney biopsies from 166 allografts between 2011 and 2013. In this cohort eight cases with AKI and ten matched allografts without pathology serving as control group were identified with a follow-up biopsy within the first twelve days after engraftment. For this set the zero-hour and follow-up biopsies were subjected to genome wide microRNA and mRNA profiling and analysis, followed by validation in independent expression profiles of 42 AKI and 21 protocol biopsies for strictly controlling the false discovery rate. Follow-up biopsies of AKI allografts compared to time-matched protocol biopsies, further baseline adjustment for zero-hour biopsy expression level and validation in independent datasets, revealed a molecular AKI signature holding 20 mRNAs and two miRNAs (miR-182-5p and miR-21-3p). Next to several established biomarkers such as lipocalin-2 also novel candidates of interest were identified in the signature. In further experimental evaluation the elevated transcript expression level of the secretory leukocyte peptidase inhibitor (SLPI) in AKI allografts was confirmed in plasma and urine on the protein level (p<0.001 and p=0.003, respectively). miR-182-5p was identified as a molecular regulator of post-transplant AKI, strongly correlated with global gene expression changes during AKI. In summary, we identified an AKI-specific molecular signature providing the ground for novel biomarkers and target candidates such as SLPI and miR-182-5p in addressing AKI.	[Wilflingseder, Julia; Kainz, Alexander; Oberbauer, Rainer] Med Univ Vienna, Dept Nephrol & Dialysis, Vienna, Austria; [Wilflingseder, Julia; Sunzenauer, Judith; Kainz, Alexander; Oberbauer, Rainer] KH Elisabethinen, Dept Nephrol & Transplantat, Linz, Austria; [Toronyi, Eva; Telkes, Gabor; Langer, Robert M.] Semmelweis Univ, Dept Transplantat & Surg, H-1085 Budapest, Hungary; [Heinzel, Andreas; Mayer, Bernd; Perco, Paul] Emergentec Biodev GmbH, Vienna, Austria	Medical University of Vienna; Ordensklinikum Linz Elisabethinen; Semmelweis University; Emergentec Biodevelopment GmbH	Oberbauer, R (corresponding author), Med Univ Vienna, Dept Nephrol & Dialysis, Vienna, Austria.	rainer.oberbauer@meduniwien.ac.at	Perco, Paul/U-2489-2019; Kainz, Alexander/AAM-7296-2021	Perco, Paul/0000-0003-2087-5691; Telkes Dr., Gabor/0000-0002-1551-5029; Wilflingseder, Julia/0000-0002-0230-9349	Austrian Science Fund [FWF P-21436, P-25726]; European Union, grant MC-IOF [328613]; Austrian Science Fund (FWF) [P 25726] Funding Source: researchfish	Austrian Science Fund(Austrian Science Fund (FWF)); European Union, grant MC-IOF; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This study was supported by grants from the Austrian Science Fund (FWF P-21436 and P-25726) and the European Union, grant MC-IOF#328613. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecassis M, 2012, AM J TRANSPLANT, V12, P2608, DOI 10.1111/j.1600-6143.2012.04245.x; [Anonymous], 2011, SRTR ANN REPORT 2011; Bolstad B, 2005, BIOINFORMATICS COMPU; Cavaille-Coll M, 2013, AM J TRANSPLANT, V13, P1134, DOI 10.1111/ajt.12210; Chatterjee PK, 2007, N-S ARCH PHARMACOL, V376, P1, DOI 10.1007/s00210-007-0183-5; Chen CZ, 2013, IMMUNOL REV, V253, P112, DOI 10.1111/imr.12060; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Cohen B, 2005, NEPHROL DIAL TRANSPL, V20, P34, DOI 10.1093/ndt/gfh506; Eltzschig HK, 2011, NEW ENGL J MED, V364, P656, DOI 10.1056/NEJMra0910283; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Famulski KS, 2012, J AM SOC NEPHROL, V23, P948, DOI 10.1681/ASN.2011090887; Godwin JG, 2010, P NATL ACAD SCI USA, V107, P14339, DOI 10.1073/pnas.0912701107; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hall IE, 2010, J AM SOC NEPHROL, V21, P189, DOI 10.1681/ASN.2009030264; Hariharan S, 2002, KIDNEY INT, V62, P311, DOI 10.1046/j.1523-1755.2002.00424.x; Hauser P, 2004, LAB INVEST, V84, P353, DOI 10.1038/labinvest.3700037; HE L, 2004, NAT REV GENET, V5, P522; Hotchkiss RS, 2009, NEW ENGL J MED, V361, P1570, DOI 10.1056/NEJMra0901217; Hsu SD, 2011, NUCLEIC ACIDS RES, V39, pD163, DOI 10.1093/nar/gkq1107; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Irish WD, 2010, AM J TRANSPLANT, V10, P2279, DOI 10.1111/j.1600-6143.2010.03179.x; Jayaram D, 2012, CLIN TRANSPLANT, V26, pE536, DOI 10.1111/ctr.12029; Kerdiles YM, 2010, IMMUNITY, V33, P890, DOI 10.1016/j.immuni.2010.12.002; Legendre C, 2013, TRANSPL INT; Maragkakis M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-295; McDonald R, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S1-S6; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Mueller TF, 2008, AM J TRANSPLANT, V8, P78, DOI 10.1111/j.1600-6143.2007.02032.x; OGAWA S, 1992, AM J PHYSIOL, V262, pC546, DOI 10.1152/ajpcell.1992.262.3.C546; OGAWA S, 1990, J CLIN INVEST, V85, P1090, DOI 10.1172/JCI114540; Ohlsson S, 2001, MEDIAT INFLAMM, V10, P347, DOI 10.1080/09629350120102389; Peng SL, 2008, ONCOGENE, V27, P2337, DOI 10.1038/onc.2008.26; Peng XJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070442; Perco P, 2009, TRANSPLANTATION, V87, P290, DOI 10.1097/TP.0b013e318191b4c0; Perico N, 2004, LANCET, V364, P1814, DOI 10.1016/S0140-6736(04)17406-0; Quiroga I, 2006, NEPHROL DIAL TRANSPL, V21, P1689, DOI 10.1093/ndt/gfl042; Rosin DL, 2011, J AM SOC NEPHROL, V22, P416, DOI 10.1681/ASN.2010040430; Shao XH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084131; Shapiro MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023011; Sharif A, 2013, AM J KIDNEY DIS, V62, P150, DOI 10.1053/j.ajkd.2012.11.050; Siedlecki A, 2011, AM J TRANSPLANT, V11, P2279, DOI 10.1111/j.1600-6143.2011.03754.x; Solez K, 2008, AM J TRANSPLANT, V8, P753, DOI 10.1111/j.1600-6143.2008.02159.x; Stittrich AB, 2010, NAT IMMUNOL, V11, P1057, DOI 10.1038/ni.1945; Szeto CC, 2010, CLIN J AM SOC NEPHRO, V5, P2329, DOI 10.2215/CJN.01910310; Tso PL, 2012, AM J TRANSPLANT, V12, P1091, DOI 10.1111/j.1600-6143.2011.03956.x; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van Rooij E, 2011, CIRC RES, V108, P219, DOI 10.1161/CIRCRESAHA.110.227496; Wilflingseder J, 2013, TRANSPLANTATION, V95, P835, DOI 10.1097/TP.0b013e318280b385; Yan DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040967; Yarlagadda SG, 2009, NEPHROL DIAL TRANSPL, V24, P1039, DOI 10.1093/ndt/gfn667	50	55	57	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e104164	10.1371/journal.pone.0104164	http://dx.doi.org/10.1371/journal.pone.0104164			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093671	Green Published, gold, Green Submitted			2022-12-27	WOS:000341357200079
J	Silva, JN; Godoy, MG; Gutarra, MLE; Freire, DMG				Silva, Jaqueline N.; Godoy, Mateus G.; Gutarra, Melissa L. E.; Freire, Denise M. G.			Impact of Extraction Parameters on the Recovery of Lipolytic Activity from Fermented Babassu Cake	PLOS ONE			English	Article							SOLID-STATE FERMENTATION; PENICILLIUM-SIMPLICISSIMUM; LIPASE PRODUCTION; STRAIN; PURIFICATION; CULTIVATION; BIODIESEL; ENZYMES	Enzyme extraction from solid matrix is as important step in solid-state fermentation to obtain soluble enzymes for further immobilization and application in biocatalysis. A method for the recovery of a pool of lipases from Penicillium simplicissimum produced by solid-state fermentation was developed. For lipase recovery different extraction solution was used and phosphate buffer containing Tween 80 and NaCl showed the best results, yielding lipase activity of 85.7 U/g and 65.7 U/g, respectively. The parameters with great impacts on enzyme extraction detected by the Plackett-Burman analysis were studied by Central Composite Rotatable experimental designs where a quadratic model was built showing maximum predicted lipase activity (160 U/g) at 25 degrees C, Tween 80 0.5% (w/v), pH 8.0 and extraction solution 7 mL/g, maintaining constant buffer molarity of 0.1 M and 200 rpm. After the optimization process a 2.5 fold increase in lipase activity in the crude extract was obtained, comparing the intial value (64 U/g) with the experimental design (160 U/g), thus improving the overall productivity of the process.	[Godoy, Mateus G.; Freire, Denise M. G.] Univ Fed Rio de Janeiro, Inst Quim, Dept Engn Bioquim, BR-20001 Rio De Janeiro, Brazil; [Silva, Jaqueline N.; Gutarra, Melissa L. E.] Univ Fed Rio de Janeiro, Escola Quim, Dept Engn Bioquim, BR-20001 Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Gutarra, MLE (corresponding author), Univ Fed Rio de Janeiro, Escola Quim, Dept Engn Bioquim, BR-20001 Rio De Janeiro, Brazil.	gutarra@gmail.com	de Godoy, Mateus Gomes/D-9977-2015; FREIRE, Denise Maria/D-8699-2014; Gutarra, Melissa/J-5706-2015	de Godoy, Mateus Gomes/0000-0003-2209-7993; FREIRE, Denise Maria/0000-0002-8298-5936; Gutarra, Melissa/0000-0003-2480-7223	PETROBRAS; CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico); FAPERJ (Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro)	PETROBRAS(Fundacao de Amparo a Pesquisa do Amapa (FAPEAP)Petrobras); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ (Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was financially supported by the PETROBRAS and the Brazilian governmental funding agencies CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) and FAPERJ (Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikat K, 2000, PROCESS BIOCHEM, V35, P907, DOI 10.1016/S0032-9592(99)00148-X; Castilho LR, 2000, BIORESOURCE TECHNOL, V71, P45, DOI 10.1016/S0960-8524(99)00058-9; Salum TFC, 2010, PROCESS BIOCHEM, V45, P1348, DOI 10.1016/j.procbio.2010.05.004; Cunha AG, 2009, APPL BIOCHEM BIOTECH, V156, P563, DOI 10.1007/s12010-008-8425-7; De Oliveira D, 2004, APPL BIOCHEM BIOTECH, V113, P771, DOI 10.1385/ABAB:115:1-3:0771; Diaz AB, 2007, ENZYME MICROB TECH, V41, P302, DOI 10.1016/j.enzmictec.2007.02.006; Estrada Gutarra Melissa Limoeiro, 2009, Biotechnology Journal, V4, P1450, DOI 10.1002/biot.200800298; GEKKO K, 1981, BIOCHEMISTRY-US, V20, P4667, DOI 10.1021/bi00519a023; Godoy MG, 2011, J IND MICROBIOL BIOT, V38, P945, DOI 10.1007/s10295-010-0865-8; Godoy MG, 2009, ENZYME MICROB TECH, V44, P317, DOI 10.1016/j.enzmictec.2009.01.002; Gutarra MLE, 2009, BIORESOURCE TECHNOL, V100, P5249, DOI 10.1016/j.biortech.2008.08.050; Gutarra MLE, 2005, APPL BIOCHEM BIOTECH, V121, P105, DOI 10.1385/ABAB:121:1-3:0105; Heck JX, 2005, PROCESS BIOCHEM, V40, P2891, DOI 10.1016/j.procbio.2005.01.006; Jaeger KE, 1999, ANNU REV MICROBIOL, V53, P315, DOI 10.1146/annurev.micro.53.1.315; Johri S, 2001, BIOORGAN MED CHEM, V9, P269, DOI 10.1016/S0968-0896(00)00240-6; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li N, 2010, J MOL CATAL B-ENZYM, V66, P43, DOI 10.1016/j.molcatb.2010.05.004; Mahadik ND, 2002, PROCESS BIOCHEM, V38, P715, DOI 10.1016/S0032-9592(02)00194-2; Mateo C, 2007, ENZYME MICROB TECH, V40, P1451, DOI 10.1016/j.enzmictec.2007.01.018; Mitchell David A, 2002, Biotechnol Annu Rev, V8, P183, DOI 10.1016/S1387-2656(02)08009-2; Palomo JM, 2003, BIOMACROMOLECULES, V4, P204, DOI 10.1021/bm020071l; Sharma R, 2001, BIOTECHNOL ADV, V19, P627, DOI 10.1016/S0734-9750(01)00086-6; Valente AM, 2010, CIENCIA TECNOL ALIME, V30, P483, DOI 10.1590/S0101-20612010000200028; Vardanega R, 2010, FOOD BIOPROCESS TECH, V3, P461, DOI 10.1007/s11947-009-0224-9; Viniegra-Gonzalez G, 2003, BIOCHEM ENG J, V13, P157, DOI 10.1016/S1369-703X(02)00128-6; Zeng GM, 2006, ENZYME MICROB TECH, V39, P1451, DOI 10.1016/j.enzmictec.2006.03.035	26	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103176	10.1371/journal.pone.0103176	http://dx.doi.org/10.1371/journal.pone.0103176			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25090644	gold, Green Submitted, Green Published			2022-12-27	WOS:000339812700021
J	Zhang, Y; Hu, YF; Li, HW; Jin, CW				Zhang, Yi; Hu, Yunfei; Li, Hongwei; Jin, Changwen			Structural Basis for TatA Oligomerization: An NMR Study of Escherichia coli TatA Dimeric Structure	PLOS ONE			English	Article							PROTEIN-TRANSPORT SYSTEM; TWIN-ARGININE TRANSLOCASE; BACILLUS-SUBTILIS; DIPOLAR COUPLINGS; CHEMICAL-SHIFT; COMPONENT; MEMBRANE; COMPLEX; FORM; IDENTIFICATION	Many proteins are transported across lipid membranes by protein translocation systems in living cells. The twin-arginine transport (Tat) system identified in bacteria and plant chloroplasts is a unique system that transports proteins across membranes in their fully-folded states. Up to date, the detailed molecular mechanism of this process remains largely unclear. The Escherichia coli Tat system consists of three essential transmembrane proteins: TatA, TatB and TatC. Among them, TatB and TatC form a tight complex and function in substrate recognition. The major component TatA contains a single transmembrane helix followed by an amphipathic helix, and is suggested to form the translocation pore via self-oligomerization. Since the TatA oligomer has to accommodate substrate proteins of various sizes and shapes, the process of its assembly stands essential for understanding the translocation mechanism. A structure model of TatA oligomer was recently proposed based on NMR and EPR observations, revealing contacts between the transmembrane helices from adjacent subunits. Herein we report the construction and stabilization of a dimeric TatA, as well as the structure determination by solution NMR spectroscopy. In addition to more extensive inter-subunit contacts between the transmembrane helices, we were also able to observe interactions between neighbouring amphipathic helices. The side-by-side packing of the amphipathic helices extends the solvent-exposed hydrophilic surface of the protein, which might be favourable for interactions with substrate proteins. The dimeric TatA structure offers more detailed information of TatA oligomeric interface and provides new insights on Tat translocation mechanism.	[Zhang, Yi; Hu, Yunfei; Li, Hongwei; Jin, Changwen] Peking Univ, Beijing Nucl Magnet Resonance Ctr, Beijing 100871, Peoples R China; [Zhang, Yi; Hu, Yunfei; Jin, Changwen] Peking Univ, Coll Life Sci, Beijing 100871, Peoples R China; [Hu, Yunfei; Li, Hongwei; Jin, Changwen] Peking Univ, Coll Chem & Mol Engn, Beijing 100871, Peoples R China; [Jin, Changwen] Peking Univ, Beijing Natl Lab Mol Sci, Beijing 100871, Peoples R China	Peking University; Peking University; Peking University; Chinese Academy of Sciences; Peking University	Hu, YF (corresponding author), Peking Univ, Beijing Nucl Magnet Resonance Ctr, Beijing 100871, Peoples R China.	yunfei@pku.edu.cn; changwen@pku.edu.cn	Zhang, Yi/J-7181-2019	Zhang, Yi/0000-0001-8170-9983	National Natural Science Foundation of China [31070649]; China Ministry of Science and Technology [2010IM030700]; China Postdoctoral Foundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Ministry of Science and Technology(Ministry of Science and Technology, China); China Postdoctoral Foundation(China Postdoctoral Science Foundation)	This work is supported by National Natural Science Foundation of China Grant 31070649 and the Grant for Innovative Methods 2010IM030700 from China Ministry of Science and Technology (to C.J.). Y.H. acknowledges a special support from China Postdoctoral Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett CML, 2005, J MOL BIOL, V347, P453, DOI 10.1016/j.jmb.2005.01.026; Barrett CML, 2003, FEBS LETT, V537, P42, DOI 10.1016/S0014-5793(03)00068-1; Battiste JL, 2000, BIOCHEMISTRY-US, V39, P5355, DOI 10.1021/bi000060h; Bolhuis A, 2001, J BIOL CHEM, V276, P20213, DOI 10.1074/jbc.M100682200; Bruser T, 2003, MICROBIOL RES, V158, P7, DOI 10.1078/0944-5013-00176; Chan CS, 2011, BBA-BIOMEMBRANES, V1808, P2289, DOI 10.1016/j.bbamem.2011.05.024; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Dabney-Smith C, 2006, J BIOL CHEM, V281, P5476, DOI 10.1074/jbc.M512453200; Dosset P, 2001, J BIOMOL NMR, V20, P223, DOI 10.1023/A:1011206132740; Frobel J, 2011, J BIOL CHEM, V286, P43679, DOI 10.1074/jbc.M111.292565; Fushman D, 1997, J MOL BIOL, V266, P173, DOI 10.1006/jmbi.1996.0771; Gohlke U, 2005, P NATL ACAD SCI USA, V102, P10482, DOI 10.1073/pnas.0503558102; Gouffi K, 2004, J BIOL CHEM, V279, P11608, DOI 10.1074/jbc.M313187200; Greene NP, 2007, J BIOL CHEM, V282, P23937, DOI 10.1074/jbc.M702972200; Hicks MG, 2005, J BACTERIOL, V187, P2920, DOI 10.1128/JB.187.8.2920-2925.2005; Hu YF, 2010, J AM CHEM SOC, V132, P15942, DOI 10.1021/ja1053785; Leake MC, 2008, P NATL ACAD SCI USA, V105, P15376, DOI 10.1073/pnas.0806338105; Lee PA, 2002, J BACTERIOL, V184, P5871, DOI 10.1128/JB.184.21.5871-5879.2002; Lorieau J, 2008, J AM CHEM SOC, V130, P7536, DOI 10.1021/ja801729f; Natale P, 2008, BBA-BIOMEMBRANES, V1778, P1735, DOI 10.1016/j.bbamem.2007.07.015; Orriss GL, 2007, FEBS LETT, V581, P4091, DOI 10.1016/j.febslet.2007.07.044; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; Palmer T, 2012, NAT REV MICROBIOL, V10, P483, DOI 10.1038/nrmicro2814; Patel R, 2014, BIOCH BIOPH IN PRESS; Rodriguez F, 2013, P NATL ACAD SCI USA, V110, pE1092, DOI 10.1073/pnas.1219486110; Sargent F, 2007, BIOCHEM SOC T, V35, P835, DOI 10.1042/BST0350835; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Schwarzinger S, 2001, J AM CHEM SOC, V123, P2970, DOI 10.1021/ja003760i; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Stanley NR, 2001, J BACTERIOL, V183, P139, DOI 10.1128/JB.183.1.139-144.2001; Tarry MJ, 2009, P NATL ACAD SCI USA, V106, P13284, DOI 10.1073/pnas.0901566106; Walther TH, 2013, CELL, V152, P316, DOI 10.1016/j.cell.2012.12.017; Walther TH, 2010, J AM CHEM SOC, V132, P15945, DOI 10.1021/ja106963s; Warren G, 2009, J MOL BIOL, V388, P122, DOI 10.1016/j.jmb.2009.02.060; White GF, 2010, J BIOL CHEM, V285, P2294, DOI 10.1074/jbc.M109.065458; WISHART DS, 1994, J BIOMOL NMR, V4, P171; Zweckstetter M, 2008, NAT PROTOC, V3, P679, DOI 10.1038/nprot.2008.36	38	17	18	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103157	10.1371/journal.pone.0103157	http://dx.doi.org/10.1371/journal.pone.0103157			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25090434	Green Submitted, Green Published, gold			2022-12-27	WOS:000339812700019
J	Feng, Q; Zhang, QL; Du, Y; Ye, YL; He, QQ				Feng, Qi; Zhang, Qing-le; Du, Yue; Ye, Yong-ling; He, Qi-qiang			Associations of Physical Activity, Screen Time with Depression, Anxiety and Sleep Quality among Chinese College Freshmen	PLOS ONE			English	Article							MENTAL-HEALTH; SEDENTARY BEHAVIOR; EXERCISE; ADOLESCENTS; CHILDREN; STUDENTS; TELEVISION; INSTRUMENT; DISORDERS; AVENA	Objectives: To investigate the independent and interactive associations of physical activity (PA) and screen time (ST) with depression, anxiety and sleep quality among Chinese college students. Methods: A cross-sectional study was conducted in Wuhan University, China from November to December 2011. The students reported their PA, ST and socio-economic characteristics using self-administered questionnaires. Sleep quality was measured by the Pittsburgh Sleep Quality Index (PSQI). Depression and anxiety were assessed using the Self-rating Depression Scale (SDS) and Self-rating Anxiety Scale (SAS), respectively. Multivariate logistic regression models were used to estimate the odds ratios (ORs) and 95% confidence intervals (CIs) of the independent and interactive relationships of PA and ST with depression, anxiety and sleep quality. Results: A total of 1106 freshmen (471 females and 635 males) aged 18.9 +/- 0.9 years were included in the study. After adjustment for potential confounders, high PA and low ST were independently associated with significantly lower risks for poor sleep quality (OR: 0.48, 95% CI: 0.30-0.78) and depression (OR: 0.67, 95% CI: 0.44-0.89), respectively. An interactive inverse association was observed for combined effects of PA and low ST on depression (OR: 0.62, 95% CI: 0.40-0.92) and sleep quality (OR: 0.51, 95% CI: 0.27-0.91). No statistically significant associations were found between PA, ST and anxiety among the participants. Conclusions: These findings suggest an independent and interactive relationship of high PA and low ST with significantly reduced prevalence of depressive problems and favorable sleep quality among Chinese college freshmen.	[Feng, Qi; Zhang, Qing-le; Du, Yue; Ye, Yong-ling; He, Qi-qiang] Wuhan Univ, Sch Publ Hlth, Wuhan 430072, Peoples R China; [He, Qi-qiang] Wuhan Univ, Global Hlth Inst, Wuhan 430072, Peoples R China	Wuhan University; Wuhan University	He, QQ (corresponding author), Wuhan Univ, Sch Publ Hlth, Wuhan 430072, Peoples R China.	heqiqiang@gmail.com	He, Qiqiang/A-7990-2012	FENG, QI/0000-0001-9323-9421	Fundamental Research Funds for the Central Universities [2012GSP101]; National Undergraduate Innovative Research Training Program of Wuhan University [201310486083]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Undergraduate Innovative Research Training Program of Wuhan University	This study is a social science research project at Wuhan University, supported by the Fundamental Research Funds for the Central Universities (No. 2012GSP101) and National Undergraduate Innovative Research Training Program of Wuhan University (No. 201310486083). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar-on ME, 2001, PEDIATRICS, V107, P423, DOI 10.1542/peds.107.2.423; Bayram N, 2008, SOC PSYCH PSYCH EPID, V43, P667, DOI 10.1007/s00127-008-0345-x; Brand S, 2010, J ADOLESCENT HEALTH, V46, P133, DOI 10.1016/j.jadohealth.2009.06.018; Buckworth J, 2004, J AM COLL HEALTH, V53, P28, DOI 10.3200/JACH.53.1.28-34; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Cao H, 2011, PREV MED, V53, P316, DOI 10.1016/j.ypmed.2011.09.002; Carney CE, 2006, CHRONOBIOL INT, V23, P623, DOI 10.1080/07420520600650695; Chung KF, 2008, SLEEP, V31, P185, DOI 10.1093/sleep/31.2.185; De Moor MHM, 2008, ARCH GEN PSYCHIAT, V65, P897, DOI 10.1001/archpsyc.65.8.897; Drake C, 2013, J CLIN SLEEP MED, V9, P1195, DOI 10.5664/jcsm.3170; Driver HS, 2000, SLEEP MED REV, V4, P387, DOI 10.1053/smrv.2000.0110; Dworak M, 2008, SLEEP MED, V9, P266, DOI 10.1016/j.sleep.2007.04.017; Fletcher GF, 1996, CIRCULATION, V94, P857, DOI 10.1161/01.CIR.94.4.857; Halson SL, 2014, SPORTS MED, V44, P13, DOI 10.1007/s40279-014-0147-0; Kalak N, 2012, J ADOLESCENT HEALTH, V51, P615, DOI 10.1016/j.jadohealth.2012.02.020; Larun L, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004691.pub2; Lemma S, 2012, SLEEP DISORD, V2012; Li XZ, 2005, ZHONGGUO LINCHUANG K, V8, P20; Liu XC, 1995, CHINESE J PSYCHIAT, p[2, 102]; Martinez-Gomez D, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-274; Oginska H, 2006, CHRONOBIOL INT, V23, P1317, DOI 10.1080/07420520601089349; Pearsall R, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-117; Peng H, 2013, SHANGHAI MED PHARM J, V14, P20, DOI [10.3969/j.issn.1006-1533.2013.14.011, DOI 10.3969/J.ISSN.1006-1533.2013.14.011]; Sharif I, 2006, PEDIATRICS, V118, pE1061, DOI 10.1542/peds.2005-2854; Sloan RA, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-885; Stein C, 2007, J ADOLESCENT HEALTH, V40; Strohle A, 2009, J NEURAL TRANSM, V116, P777, DOI 10.1007/s00702-008-0092-x; Tao M., 1994, CHIN J NERV MENT DIS, V5, P301; Torsheim T, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-324; van Berkel J, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-558; Velez Juan Carlos, 2013, Sleep Disord, V2013, P910104, DOI 10.1155/2013/910104; Vicente-Rodriguez G, 2008, NUTRITION, V24, P654, DOI 10.1016/j.nut.2008.03.011; Xie CJ, 2007, CHINESE J PUBLIC HLT, V5, P42; Xu JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079045; Youngstedt SD, 2003, PHYSIOL BEHAV, V78, P395, DOI 10.1016/S0031-9384(03)00004-0; Youngstedt SD, 1997, SLEEP, V20, P203, DOI 10.1093/sleep/20.3.203; Zivin K, 2009, J AFFECT DISORDERS, V117, P180, DOI 10.1016/j.jad.2009.01.001; ZUNG WWK, 1971, PSYCHOSOMATICS, V12, P371; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V13, P508, DOI 10.1001/archpsyc.1965.01730060026004	39	121	128	10	100	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100914	10.1371/journal.pone.0100914	http://dx.doi.org/10.1371/journal.pone.0100914			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK8WO	25093337	gold, Green Published, Green Submitted			2022-12-27	WOS:000338709500098
J	Yu, HG; Wang, QY; Wang, ZW; Sahinkaya, E; Li, YL; Ma, JX; Wu, ZC				Yu, Hongguang; Wang, Qiaoying; Wang, Zhiwei; Sahinkaya, Erkan; Li, Yongli; Ma, Jinxing; Wu, Zhichao			Start-Up of an Anaerobic Dynamic Membrane Digester for Waste Activated Sludge Digestion: Temporal Variations in Microbial Communities	PLOS ONE			English	Article							METHANOGENIC ACTIVITY; BIOREACTOR; BACTERIAL; DIVERSITY; ARCHAEAL	An anaerobic dynamic membrane digester (ADMD) was developed to digest waste sludge, and pyrosequencing was used to analyze the variations of the bacterial and archaeal communities during the start-up. Results showed that bacterial community richness decreased and then increased over time, while bacterial diversity remained almost the same during the start-up. Proteobacteria and Bacteroidetes were the major phyla. At the class level, Betaproteobacteria was the most abundant at the end of start-up, followed by Sphingobacteria. In the archaeal community, richness and diversity peaked at the end of the start-up stage. Principle component and cluster analyses demonstrated that archaeal consortia experienced a distinct shift and became stable after day 38. Methanomicrobiales and Methanosarcinales were the two predominant orders. Further investigations indicated that Methanolinea and Methanosaeta were responsible for methane production in the ADMD system. Hydrogenotrophic pathways might prevail over acetoclastic means for methanogenesis during the start-up, supported by specific methanogenic activity tests.	[Yu, Hongguang; Wang, Qiaoying; Wang, Zhiwei; Ma, Jinxing; Wu, Zhichao] Tongji Univ, Sch Environm Sci & Engn, State Key Lab Pollut Control & Resource Reuse, Shanghai 200092, Peoples R China; [Sahinkaya, Erkan] Istanbul Medeniyet Univ, Dept Bioengn, Istanbul, Turkey; [Li, Yongli] Univ Rouen, CNRS INSA, Lab Polymeres Biopolymeres & Surfaces, UMR 6270, Mont St Aignan, France	Tongji University; Istanbul Medeniyet University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Universite de Rouen Normandie	Wang, QY (corresponding author), Tongji Univ, Sch Environm Sci & Engn, State Key Lab Pollut Control & Resource Reuse, Shanghai 200092, Peoples R China.	qywang@tongji.edu.cn; zwwang@tongji.edu.cn	Wang, Zhiwei/F-5666-2012; Ma, Jinxing/D-9981-2013; Sahinkaya, Erkan/A-5227-2018; Wang, Qiaoying/AAN-6945-2020	Wang, Zhiwei/0000-0001-6729-2237; Ma, Jinxing/0000-0002-5087-3972; SAHINKAYA, ERKAN/0000-0002-9898-9173	Key Special Program on the S&T for the Pollution Control and Treatment of Water Bodies [2011ZX07303-001]; Science and Technology Commission of Shanghai Municipality [12230707000]	Key Special Program on the S&T for the Pollution Control and Treatment of Water Bodies; Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work is partially supported by the Key Special Program on the S&T for the Pollution Control and Treatment of Water Bodies (2011ZX07303-001) and by the Science and Technology Commission of Shanghai Municipality research project (12230707000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Public Health Association, 2012, HIDROL ME, V22nd; An Y, 2009, CHEM ENG J, V155, P709, DOI 10.1016/j.cej.2009.09.003; Appels L, 2008, PROG ENERG COMBUST, V34, P755, DOI 10.1016/j.pecs.2008.06.002; Ariesyady HD, 2007, WATER RES, V41, P1554, DOI 10.1016/j.watres.2006.12.036; Chouari R, 2005, ENVIRON MICROBIOL, V7, P1104, DOI 10.1111/j.1462-2920.2005.00795.x; Coates JD, 1996, J MICROBIOL METH, V26, P237, DOI 10.1016/0167-7012(96)00915-3; Connaughton S, 2006, WATER RES, V40, P1009, DOI 10.1016/j.watres.2005.12.026; Dagnew M, 2010, WATER SCI TECHNOL, V61, P1451, DOI 10.2166/wst.2010.028; DONLON BA, 1995, APPL ENVIRON MICROB, V61, P3889, DOI 10.1128/AEM.61.11.3889-3893.1995; Fan B, 2002, ENVIRON SCI TECHNOL, V36, P5245, DOI 10.1021/es025789n; Gao WJ, 2012, J MEMBRANE SCI, V421, P131, DOI 10.1016/j.memsci.2012.07.003; Garcia JL, 2000, ANAEROBE, V6, P205, DOI 10.1006/anae.2000.0345; Hatziconstantinou GJ, 1996, WATER SCI TECHNOL, V34, P417, DOI 10.1016/0273-1223(96)00545-8; Kapdan IK, 2006, ENZYME MICROB TECH, V38, P569, DOI 10.1016/j.enzmictec.2005.09.015; Kirchman DL, 2002, FEMS MICROBIOL ECOL, V39, P91, DOI 10.1111/j.1574-6941.2002.tb00910.x; Krause L, 2008, J BIOTECHNOL, V136, P91, DOI 10.1016/j.jbiotec.2008.06.003; Krober M, 2009, J BIOTECHNOL, V142, P38, DOI 10.1016/j.jbiotec.2009.02.010; Liao BQ, 2006, CRIT REV ENV SCI TEC, V36, P489, DOI 10.1080/10643380600678146; Ma JX, 2013, PROCESS BIOCHEM, V48, P510, DOI 10.1016/j.procbio.2013.02.003; Ma JX, 2013, WATER RES, V47, P859, DOI 10.1016/j.watres.2012.11.013; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Nelson MC, 2011, BIORESOURCE TECHNOL, V102, P3730, DOI 10.1016/j.biortech.2010.11.119; Padmasiri SI, 2007, WATER RES, V41, P134, DOI 10.1016/j.watres.2006.09.021; Riviere D, 2009, ISME J, V3, P700, DOI 10.1038/ismej.2009.2; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Wang ZW, 2013, BIOTECHNOL ADV, V31, P1187, DOI 10.1016/j.biotechadv.2013.02.004; Xu ML, 2011, BIORESOURCE TECHNOL, V102, P5617, DOI 10.1016/j.biortech.2011.02.038; Yu HG, 2013, CHEM ENG J, V231, P206, DOI 10.1016/j.cej.2013.07.012; Yukselen MA, 1997, J ENVIRON SCI HEAL A, V32, P2069; Zhang T, 2012, ISME J, V6, P1137, DOI 10.1038/ismej.2011.188; Zhang XY, 2010, CHEM ENG J, V165, P175, DOI 10.1016/j.cej.2010.09.013; Zheng D, 2000, MICROBIAL ECOL, V39, P246	34	53	53	3	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93710	10.1371/journal.pone.0093710	http://dx.doi.org/10.1371/journal.pone.0093710			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24695488	Green Submitted, Green Published, gold			2022-12-27	WOS:000334103000109
J	Zhao, Y; Zhou, W; Xue, LY; Zhang, WM; Zhan, QM				Zhao, Yue; Zhou, Wei; Xue, Liyan; Zhang, Weimin; Zhan, Qimin			Nicotine Activates YAP1 through nAChRs Mediated Signaling in Esophageal Squamous Cell Cancer (ESCC)	PLOS ONE			English	Article							YES-ASSOCIATED PROTEIN; DUCT EPITHELIAL-CELLS; ACETYLCHOLINE-RECEPTOR; CANDIDATE ONCOGENE; STEM-LIKE; KINASE-C; POPULATION; CARCINOMA; PATHWAY; CATENIN	Cigarette smoking is an established risk factor for esophageal cancers. Yes-associated protein 1 (YAP1), the key transcription factor of the mammalian Hippo pathway, has been reported to be an oncogenic factor for many cancers. In this study, we find nicotine administration can induce nuclear translocation and activation of YAP1 in ESCC. Consistently, we observed nuclear translocation and activation of YAP1 by knockdown of CHRNA3, which is a negative regulator of nicotine signaling in bronchial and esophageal cancer cells. Nicotine administration or CHRNA3 depletion substantially increased proliferation and migration in esophageal cancer cells. Interestingly, we find that YAP1 physically interacts with nAChRs, and nAChRs-signaling dissociates YAP1 from its negative regulatory complex composed with alpha-catenin, beta-catenin and 14-3-3 in the cytoplasm, leading to upregulation and nuclear translocation of YAP1. This process likely requires PKC activation, as PKC specific inhibitor Enzastaurin can block nicotine induced YAP1 activation. In addition, we find nicotine signaling also inhibits the interaction of YAP1 with P63, which contributes to the inhibitory effect of nicotine on apoptosis. Using immunohistochemistry analysis we observed upregulation of YAP1 in a significant portion of esophageal cancer samples. Consistently, we have found a significant association between YAP1 upregulation and cigarette smoking in the clinical esophageal cancer samples. Together, these findings suggest that the nicotine activated nAChRs signaling pathway which further activates YAP1 plays an important role in the development of esophageal cancer, and this mechanism may be of a general significance for the carcinogenesis of smoking related cancers.	[Zhao, Yue; Zhou, Wei; Zhang, Weimin; Zhan, Qimin] Chinese Acad Med Sci, Canc Inst & Hosp, State Key Lab Mol Oncol, Beijing 100730, Peoples R China; [Zhao, Yue; Zhou, Wei; Xue, Liyan; Zhang, Weimin; Zhan, Qimin] Peking Union Med Coll, Beijing 100021, Peoples R China; [Xue, Liyan] Chinese Acad Med Sci, Canc Inst & Hosp, Dept Pathol, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS	Zhan, QM (corresponding author), Chinese Acad Med Sci, Canc Inst & Hosp, State Key Lab Mol Oncol, Beijing 100730, Peoples R China.	zhanqimin@pumc.edu.cn			973 National Key Fundamental Research Program of China [2009CB521801]; National Natural Science Foundation of China [81021061]	973 National Key Fundamental Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study has been supported by the funds from the 973 National Key Fundamental Research Program of China (2009CB521801) and the National Natural Science Foundation of China (81021061). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Wadei HAN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029915; Al-Wadei MH, 2012, CARCINOGENESIS, V33, P1745, DOI 10.1093/carcin/bgs229; Al-Wadei MH, 2012, MOL CANCER RES, V10, P239, DOI 10.1158/1541-7786.MCR-11-0332; An Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047919; Bezakova G, 2003, NAT REV MOL CELL BIO, V4, P295, DOI 10.1038/nrm1074; Brown EN, 2003, AM J PHYSIOL-GASTR L, V285, pG37, DOI 10.1152/ajpgi.00053.2003; Brown LM, 2001, AM J EPIDEMIOL, V153, P114, DOI 10.1093/aje/153.2.114; Chen CL, 2013, J CLIN INVEST, V123, P2832, DOI 10.1172/JCI65859; Chernyavsky AI, 2007, EXP CELL RES, V313, P3542, DOI 10.1016/j.yexcr.2007.07.011; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Cordenonsi M, 2011, CELL, V147, P759, DOI 10.1016/j.cell.2011.09.048; Dasgupta P, 2006, P NATL ACAD SCI USA, V103, P6332, DOI 10.1073/pnas.0509313103; Densham RM, 2009, MOL CELL BIOL, V29, P6380, DOI 10.1128/MCB.00116-09; Enzinger PC, 2003, NEW ENGL J MED, V349, P2241, DOI 10.1056/NEJMra035010; Greka A, 2012, SEMIN NEPHROL, V32, P319, DOI 10.1016/j.semnephrol.2012.06.003; He JQ, 2000, J PHYSIOL-LONDON, V524, P807, DOI 10.1111/j.1469-7793.2000.00807.x; Hirata N, 2010, BIOCHEM BIOPH RES CO, V403, P138, DOI 10.1016/j.bbrc.2010.10.134; Kabbani N, 2007, P NATL ACAD SCI USA, V104, P20570, DOI 10.1073/pnas.0710314104; Krais AM, 2011, CARCINOGENESIS, V32, P1388, DOI 10.1093/carcin/bgr090; Muramatsu T, 2011, CARCINOGENESIS, V32, P389, DOI 10.1093/carcin/bgq254; Nakamura T, 2010, J BIOL CHEM, V285, P16145, DOI 10.1074/jbc.M109.081315; Nallet-Staub F, 2013, J INVEST DERMATOL; Onoda N, 2001, HEAD NECK-J SCI SPEC, V23, P860, DOI 10.1002/hed.1125; Overholtzer M, 2006, P NATL ACAD SCI USA, V103, P12405, DOI 10.1073/pnas.0605579103; Ramarao MK, 1998, P NATL ACAD SCI USA, V95, P4007, DOI 10.1073/pnas.95.7.4007; Rosenberg MM, 2008, MOL CELL NEUROSCI, V38, P138, DOI 10.1016/j.mcn.2008.02.006; Rosenbluh J, 2012, CELL, V151, P1457, DOI 10.1016/j.cell.2012.11.026; Schlegelmilch K, 2011, CELL, V144, P782, DOI 10.1016/j.cell.2011.02.031; Schuller HM, 2009, NAT REV CANCER, V9, P195, DOI 10.1038/nrc2590; Takeuchi H, 2010, J DENT RES, V89, P34, DOI 10.1177/0022034509353403; Tomlinson V, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.7; Wu AH, 2001, CANCER CAUSE CONTROL, V12, P721, DOI 10.1023/A:1011290704728; Xu MZ, 2009, CANCER-AM CANCER SOC, V115, P4576, DOI 10.1002/cncr.24495; Yamada K, 2010, CELL PHYSIOL BIOCHEM, V26, P247, DOI 10.1159/000320524; Yeo MK, 2012, ANTICANCER RES, V32, P3835; Yu CC, 2013, TOXICOL APPL PHARM, V266, P459, DOI 10.1016/j.taap.2012.11.023; Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037; Yu MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051967; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zhang B, 2007, J NEUROSCI, V27, P3968, DOI 10.1523/JNEUROSCI.4691-06.2007; Zhao B, 2010, GENE DEV, V24, P862, DOI 10.1101/gad.1909210	41	56	56	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e90836	10.1371/journal.pone.0090836	http://dx.doi.org/10.1371/journal.pone.0090836			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	25093675	Green Published, gold, Green Submitted			2022-12-27	WOS:000332845300031
J	Ser, G; Robertson, A; Sheikh, A				Ser, Gloria; Robertson, Ann; Sheikh, Aziz			A Qualitative Exploration of Workarounds Related to the Implementation of National Electronic Health Records in Early Adopter Mental Health Hospitals	PLOS ONE			English	Article							UNINTENDED CONSEQUENCES; INFORMATION-TECHNOLOGY; MEDICAL-RECORDS; SECONDARY CARE; ORDER ENTRY; COMMUNICATION; INTEGRATION; PHYSICIANS; SYSTEMS; ERRORS	Aims: To investigate the perceptions and reported practices of mental health hospital staff using national hospital electronic health records (EHRs) in order to inform future implementations, particularly in acute mental health settings. Methods: Thematic analysis of interviews with a wide range of clinical, information technology (IT), managerial and other staff at two early adopter mental health National Health Service (NHS) hospitals in London, UK, implementing national EHRs. Results: We analysed 33 interviews. We first sought out examples of workarounds, such as delayed data entry, entering data in wrong places and individuals using the EHR while logged in as a colleague, then identified possible reasons for the reported workarounds. Our analysis identified four main categories of factors contributing to workarounds (i.e., operational, cultural, organisational and technical). Operational factors included poor system integration with existing workflows and the system not meeting users' perceived needs. Cultural factors involved users' competence with IT and resistance to change. Organisational factors referred to insufficient organisational resources and training, while technical factors included inadequate local technical infrastructure. Many of these factors, such as integrating the EHR system with day-to-day operational processes, staff training and adequate local IT infrastructure, were likely to apply to system implementations in various settings, but we also identified factors that related particularly to implementing EHRs in mental health hospitals, for example: EHR system incompatibility with IT systems used by mental health-related sectors, notably social services; the EHR system lacking specific, mental health functionalities and options; and clinicians feeling unable to use computers while attending to distressed psychiatric patients. Conclusions: A better conceptual model of reasons for workarounds should help with designing, and supporting the implementation and adoption of, EHRs for use in hospital mental health settings.	[Ser, Gloria; Robertson, Ann; Sheikh, Aziz] Univ Edinburgh, Ctr Populat Hlth Sci, EHlth Res Grp, Edinburgh, Midlothian, Scotland; [Sheikh, Aziz] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Gen Internal Med & Primary Care, Boston, MA 02115 USA	University of Edinburgh; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Sheikh, A (corresponding author), Univ Edinburgh, Ctr Populat Hlth Sci, EHlth Res Grp, Edinburgh, Midlothian, Scotland.	aziz.sheikh@ed.ac.uk	Sheikh, Aziz/D-2818-2009; Otegui, Javier/B-3973-2012	Sheikh, Aziz/0000-0001-7022-3056; Braak, Kyle/0000-0002-3696-3496; Russell, Laura/0000-0002-1920-5298; Otegui, Javier/0000-0002-8997-3559; Bloom, David/0000-0003-1273-1807; Doring, Markus/0000-0001-7757-1889; Desmet, Peter/0000-0002-8442-8025	NHS CFH Evaluation Programme [NHS CFHEP 005]; Commonwealth Fund; private independent foundation based in New York City	NHS CFH Evaluation Programme; Commonwealth Fund; private independent foundation based in New York City	This study involved the secondary analysis of a sub-set of data previously collected in an independent research programme commissioned by NHS. This report draws on a sub-set of data that were gathered in independent research commissioned by the NHS CFH Evaluation Programme (NHS CFHEP 005). It was undertaken as a post-graduate dissertation research project. Aziz Sheikh has a Harkness Fellowship in Health Policy and Practice and is supported by The Commonwealth Fund, a private independent foundation based in New York City. The funders of the initial, commissioned study and The Commonwealth Fund had no role in study design, data collection and analysis, decision to publish, or preparation of this manuscript.	[Anonymous], 2004, INT J EDUC MANAG, DOI DOI 10.1108/09513540410522234; Ash JS, 2004, J AM MED INFORM ASSN, V11, P104, DOI 10.1197/jamia.M1471; Bates DW, 1998, JAMA-J AM MED ASSOC, V280, P1311, DOI 10.1001/jama.280.15.1311; Black AD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000387; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Burt CW, 2005, HEALTH AFFAIR, V24, P1334, DOI 10.1377/hlthaff.24.5.1334; Campbell EM, 2006, J AM MED INFORM ASSN, V13, P547, DOI 10.1197/jamia.M2042; Campbell EM, 2009, J GEN INTERN MED, V24, P21, DOI 10.1007/s11606-008-0857-9; Cresswell KM, 2012, BMC MED INFORM DECIS, V12, DOI 10.1186/1472-6947-12-15; Crowe S, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-100; Department of Health, 2007, MENT HLTH ACT; Detmer DE, 2009, QUAL HEALTH CARE, V9, P181; Ferneley EH, 2006, EUR J INFORM SYST, V15, P345, DOI 10.1057/palgrave.ejis.3000629; Forum: Qualitative Social Research, 2005, SEC AN QUAL DAT; GASSER L, 1986, ACM T INFORM SYST, V4, P205, DOI 10.1145/214427.214429; Harrison MI, 2007, J AM MED INFORM ASSN, V14, P542, DOI 10.1197/jamia.M2384; Hayes N., 2000, Computer Supported Cooperative Work: The Journal of Collaborative Computing, V9, P435, DOI 10.1023/A:1008795025075; Heaton J, 2004, REWORKING QUALITATIV; Huckvale C, 2010, QUAL SAF HEALTH CARE, V19, DOI 10.1136/qshc.2009.038497; Kobayashi M, 2005, CHI LATE BREAKING RE, P1561, DOI DOI 10.1145/1056808.1056966; Koppel R, 2008, J AM MED INFORM ASSN, V15, P408, DOI 10.1197/jamia.M2616; Linder Jeffrey A, 2006, AMIA Annu Symp Proc, P499; Makoul G, 2001, J AM MED INFORM ASSN, V8, P610, DOI 10.1136/jamia.2001.0080610; Murray SA, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2581; Patton M. Q., 1990, QUALITATIVE EVALUATI; Poelmans S., 1999, SIGGROUP Bulletin, V20, P11; Robertson A, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4564; Robertson A, 2011, J ROY SOC MED, V104, P434, DOI 10.1258/jrsm.2011.11k039; Rouf E, 2008, BMC MED EDUC, V8, DOI 10.1186/1472-6920-8-13; Safadi H, 2010, INT C INF SYS P; Saleem JJ, 2009, INT J MED INFORM, V78, P618, DOI 10.1016/j.ijmedinf.2009.04.001; Salomon RM, 2010, J AM MED INFORM ASSN, V17, P54, DOI 10.1197/jamia.M3341; Sartorius N, 2007, LANCET, V370, P810, DOI 10.1016/S0140-6736(07)61245-8; Sheikh A, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6054; Sobreperez P, 2008, INT FED INFO PROC, V287, P179; Stewart RF, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-3; Stockdale SE, 2011, BMJ QUAL SAF, V20, P941, DOI 10.1136/bmjqs.2010.050450; Strauss A., 1998, BASICS QUALITATIVE R; Ventres W, 2006, ANN FAM MED, V4, P124, DOI 10.1370/afm.425; Vestal K, 2008, NURSE LEAD, V6, P8, DOI 10.1016/j.mnl.2008.06.008; Wachter R., 2008, UNDERSTANDING PATIEN	41	102	104	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2014	9	1							e77669	10.1371/journal.pone.0077669	http://dx.doi.org/10.1371/journal.pone.0077669			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	297DQ	25099149	Green Submitted, gold, Green Published			2022-12-27	WOS:000330236000001
J	Lopez, DC; Zhu-Salzman, K; Ek-Ramos, MJ; Sword, GA				Castillo Lopez, Diana; Zhu-Salzman, Keyan; Julissa Ek-Ramos, Maria; Sword, Gregory A.			The Entomopathogenic Fungal Endophytes Purpureocillium lilacinum (Formerly Paecilomyces lilacinus) and Beauveria bassiana Negatively Affect Cotton Aphid Reproduction under Both Greenhouse and Field Conditions	PLOS ONE			English	Article							VERTICILLIUM-LECANII; PERENNIAL RYEGRASS; THOM SAMSON; SEED; PLANT; ASCOMYCOTA; RESISTANCE; GRASSES; DISEASE; COLONIZATION	The effects of two entomopathogenic fungal endophytes, Beauveria bassiana and Purpureocillium lilacinum (formerly Paecilomyces lilacinus), were assessed on the reproduction of cotton aphid, Aphis gossypii Glover (Homoptera:Aphididae), through in planta feeding trials. In replicate greenhouse and field trials, cotton plants (Gossypium hirsutum) were inoculated as seed treatments with two concentrations of B. bassiana or P. lilacinum conidia. Positive colonization of cotton by the endophytes was confirmed through potato dextrose agar (PDA) media plating and PCR analysis. Inoculation and colonization of cotton by either B. bassiana or P. lilacinum negatively affected aphid reproduction over periods of seven and 14 days in a series of greenhouse trials. Field trials were conducted in the summers of 2012 and 2013 in which cotton plants inoculated as seed treatments with B. bassiana and P. lilacinum were exposed to cotton aphids for 14 days. There was a significant overall effect of endophyte treatment on the number of cotton aphids per plant. Plants inoculated with B. bassiana had significantly lower numbers of aphids across both years. The number of aphids on plants inoculated with P. lilacinum exhibited a similar, but non-significant, reduction in numbers relative to control plants. We also tested the pathogenicity of both P. lilacinum and B. bassiana strains used in the experiments against cotton aphids in a survival experiment where 60% and 57% of treated aphids, respectively, died from infection over seven days versus 10% mortality among control insects. Our results demonstrate (i) the successful establishment of P. lilacinum and B. bassiana as endophytes in cotton via seed inoculation, (ii) subsequent negative effects of the presence of both target endophytes on cotton aphid reproduction using whole plant assays, and (iii) that the P. lilacinum strain used is both endophytic and pathogenic to cotton aphids. Our results illustrate the potential of using these endophytes for the biological control of aphids and other herbivores under greenhouse and field conditions.	[Castillo Lopez, Diana; Zhu-Salzman, Keyan; Sword, Gregory A.] Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA; [Julissa Ek-Ramos, Maria] Autonomous Univ Nuevo Leon, Dept Immunol & Microbiol, San Nicolas De Los Garza, Nuevo Leon, Mexico	Texas A&M University System; Texas A&M University College Station; Universidad Autonoma de Nuevo Leon	Lopez, DC (corresponding author), Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA.	dianacastillo8@tamu.edu	Ramos, Maria Julissa Ek/W-1017-2018; Potts, Brad M/C-6489-2013	Ramos, Maria Julissa Ek/0000-0002-1556-0823; Potts, Brad M/0000-0001-6244-289X; Costa e Silva, Joao/0000-0003-1422-9554	Cotton Incorporated Grant; Good Neighbor Scholarship	Cotton Incorporated Grant; Good Neighbor Scholarship	The work was supported by Cotton Incorporated Grant and Good Neighbor Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akello J, 2008, CROP PROT, V27, P1437, DOI 10.1016/j.cropro.2008.07.003; Akello J, 2012, BIOL CONTROL, V61, P215, DOI 10.1016/j.biocontrol.2012.02.007; Atkins SD, 2005, FEMS MICROBIOL ECOL, V51, P257, DOI 10.1016/j.femsec.2004.09.002; Ball OJP, 1997, J CHEM ECOL, V23, P1419, DOI 10.1023/B:JOEC.0000006473.26175.19; Ball OJP, 1997, J ECON ENTOMOL, V90, P1382, DOI 10.1093/jee/90.5.1382; BING LA, 1991, ENVIRON ENTOMOL, V20, P1207, DOI 10.1093/ee/20.4.1207; Biswas C, 2012, BIOCONTROL, V57, P565, DOI 10.1007/s10526-011-9424-0; Brownbridge M, 2012, BIOL CONTROL, V61, P194, DOI 10.1016/j.biocontrol.2012.01.002; Bush LP, 1997, PLANT PHYSIOL, V114, P1, DOI 10.1104/pp.114.1.1; Carriere Y, 1998, J ECON ENTOMOL, V91, P324, DOI 10.1093/jee/91.1.324; Carrión Gloria, 2012, Rev. mex. fitopatol, V30, P86; Chaudhary KK, 2012, S ASIAN J EXP BIOL, V1, P36; CLAY K, 1993, ECOLOGY, V74, P1767, DOI 10.2307/1939935; Clay K, 1996, RES POPUL ECOL, V38, P191, DOI 10.1007/BF02515727; Doyle J. J., 1987, PHYTOCHEM B, P11; Dugassa-Gobena D., 1996, MITTEILUNGEN BIOL BU, V321, P299; Ek-Ramos MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066049; Fiedler Z, 2007, BIOCONTROL, V52, P547, DOI 10.1007/s10526-006-9052-2; Gange AC, 2012, OECOLOGIA, V168, P1023, DOI 10.1007/s00442-011-2151-5; Gassmann AJ, 2009, PEST MANAG SCI, V65, P1174, DOI 10.1002/ps.1844; GINDIN G, 1994, PHYTOPARASITICA, V22, P189, DOI 10.1007/BF02980318; Godfrey L. D., 1997, 1997 Proceedings Beltwide Cotton Conferences, New Orleans, LA, USA, January 6-10, 1997: Volume 2., P1048; Godfrey L.D., 2000, CALIF AGR, V54, P32, DOI [10.3733/ca.v054n06p26, DOI 10.3733/CA.V054N06P26]; Gould F, 1995, WEED TECHNOL, V9, P830, DOI 10.1017/S0890037X00024301; GRAFTONCARDWELL EE, 1991, J ECON ENTOMOL, V84, P741, DOI 10.1093/jee/84.3.741; Gurulingappa P, 2011, CROP PROT, V30, P349, DOI 10.1016/j.cropro.2010.11.017; Gurulingappa P, 2010, BIOL CONTROL, V55, P34, DOI 10.1016/j.biocontrol.2010.06.011; Hartley SE, 2009, ANNU REV ENTOMOL, V54, P323, DOI 10.1146/annurev.ento.54.110807.090614; Imoulan A, 2011, WORLD J MICROB BIOT, V27, P2619, DOI 10.1007/s11274-011-0735-1; Jaber LR, 2010, ECOL ENTOMOL, V35, P25, DOI 10.1111/j.1365-2311.2009.01152.x; Jung H.S., 2006, KOREAN J MYCOL, V34, P112; KERNS DL, 1992, J ECON ENTOMOL, V85, P1, DOI 10.1093/jee/85.1.1; Khan MR, 2012, TURK J BIOL, V36, P161, DOI 10.3906/biy-1008-72; Kiewnick S, 2011, PHYTOPATHOLOGY, V101, P105, DOI 10.1094/PHYTO-03-10-0090; King EG, 1987, 40 ANN C REP COTT IN; LATCH GCM, 1993, AGR ECOSYST ENVIRON, V44, P143, DOI 10.1016/0167-8809(93)90043-O; Luangsa-Ard J, 2011, FEMS MICROBIOL LETT, V321, P141, DOI 10.1111/j.1574-6968.2011.02322.x; Marti GA, 2006, MYCOPATHOLOGIA, V162, P369, DOI 10.1007/s11046-006-0072-3; Martinuz A, 2012, BIOL CONTROL, V62, DOI 10.1016/j.biocontrol.2012.05.006; McGee PA, 2002, AUST J EXP AGR, V42, P995, DOI 10.1071/EA01124; Munawar Fazal, 2011, Annals of Plant Protection Sciences, V19, P168; O'Brien PJ, 1990, INSECT ACAR TESTS, V15, P254; Omacini M, 2001, NATURE, V409, P78, DOI 10.1038/35051070; Ownley BH, 2008, J INVERTEBR PATHOL, V98, P267, DOI 10.1016/j.jip.2008.01.010; Ownley BH, 2010, BIOCONTROL, V55, P113, DOI 10.1007/s10526-009-9241-x; Porras-Alfaro A, 2011, ANNU REV PHYTOPATHOL, V49, P291, DOI 10.1146/annurev-phyto-080508-081831; Posada FJ, 2005, MYCOLOGIA, V97, P1208; Posada F, 2007, MYCOL RES, V111, P748, DOI 10.1016/j.mycres.2007.03.006; Powell WA, 2009, J ENTOMOL SCI, V44, P391, DOI 10.18474/0749-8004-44.4.391; Price PW, 2011, INSECT ECOLOGY, P121; Raja Kannan, 2012, Journal of Agricultural Science (Toronto), V4, P119; Rao N. B. V. C., 2012, Insect Environment, V17, P151; Raps A, 1998, OECOLOGIA, V114, P541, DOI 10.1007/s004420050478; Rasmussen S, 2008, PLANT PHYSIOL, V146, P1440, DOI 10.1104/pp.107.111898; Reddy Narasimha P., 2009, Journal of Asia-Pacific Entomology, V12, P221, DOI 10.1016/j.aspen.2009.06.001; Rodriguez RJ, 2009, NEW PHYTOL, V182, P314, DOI 10.1111/j.1469-8137.2009.02773.x; Saari S, 2010, MICROB ECOL, V60, P928, DOI 10.1007/s00248-010-9749-8; Saikkonen K, 2006, TRENDS PLANT SCI, V11, P428, DOI 10.1016/j.tplants.2006.07.001; Saikkonen K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011395; Schardl CL, 2004, ANNU REV PLANT BIOL, V55, P315, DOI 10.1146/annurev.arplant.55.031903.141735; Schulz B, 2005, MYCOL RES, V109, P661, DOI 10.1017/S095375620500273X; Silva AX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036810; Swati Sharma, 2012, Indian Journal of Nematology, V42, P1; Vega FE, 2008, BIOL CONTROL, V46, P72, DOI 10.1016/j.biocontrol.2008.01.008; Vega FE, 2010, FUNGAL ECOL, V3, P122, DOI [10.1016/j.funeco.2009.05.001, 10.1016/j.funeco.2009.07.002]; Vicari M, 2002, ECOLOGY, V83, P2452, DOI 10.1890/0012-9658(2002)083[2452:CEOFAM]2.0.CO;2; Wang LD, 2007, PEST MANAG SCI, V63, P381, DOI 10.1002/ps.1359; Waqas Wakil, 2012, African Journal of Biotechnology, V11, P821; Young C, 2010, CELLULAR AND MOLECULAR BIOLOGY OF FILAMENTOUS FUNGI, P660	69	130	135	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e103891	10.1371/journal.pone.0103891	http://dx.doi.org/10.1371/journal.pone.0103891			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093505	gold, Green Published, Green Submitted			2022-12-27	WOS:000341357200041
J	Silva, JCE; Potts, BM; Lopez, GA				Costa e Silva, Joao; Potts, Brad M.; Lopez, Gustavo A.			Heterosis May Result in Selection Favouring the Products of Long-Distance Pollen Dispersal in Eucalyptus	PLOS ONE			English	Article							GLOBULUS SSP GLOBULUS; SPATIAL GENETIC-STRUCTURE; OUTBREEDING DEPRESSION; INBREEDING DEPRESSION; LOCAL ADAPTATION; POPULATION DIFFERENTIATION; ENVIRONMENT INTERACTION; RECIPROCAL HYBRIDS; SEED DISPERSAL; WOOD DENSITY	Using native trees from near the northern and southern extremities of the relatively continuous eastern distribution of Eucalyptus globulus in Tasmania, we compared the progenies derived from natural open-pollination (OP) with those generated from within-region and long-distance outcrossing. Controlled outcrossing amongst eight parents - with four parents from each of the northern and southern regions - was undertaken using a diallel mating scheme. The progeny were planted in two field trials located within the species native range in southern Tasmania, and their survival and diameter growth were monitored over a 13-year-period. The survival and growth performances of all controlled cross types exceeded those of the OP progenies, consistent with inbreeding depression due to a combination of selfing and bi-parental inbreeding. The poorer survival of the northern regional (female(N)male(N)) outcrosses compared with the local southern regional outcrosses (female(S)male(S)) indicated differential selection against the former. Despite this mal-adaptation of the non-local female(N)male(N) crosses at both southern sites, the survival of the inter-regional hybrids (male(N)male(S) and female(S)male(N)) was never significantly different from that of the local female(S)male(S) crosses. Significant site-dependent heterosis was detected for the growth of the surviving long-distance hybrids. This was expressed as mid-parent heterosis, particularly at the more northern planting site. Heterosis increased with age, while the difference between the regional female(N)male(N) and female(S)male(S) crosses remained insignificant at any age at either site. Nevertheless, the results for growth suggest that the fitness of individuals derived from long-distance crossing may be better at the more northern of the planting sites. Our results demonstrate the potential for early-age assessments of pollen dispersal to underestimate realised gene flow, with local inbreeding under natural open-pollination resulting in selection favouring the products of longer-distance pollinations. Indeed, heterosis derived from long-distance pollinations may be sufficient to counter local mal-adaptation, at least in the first generation.	[Costa e Silva, Joao] Univ Lisbon, Inst Super Agron, Ctr Estudos Florestais, P-1699 Lisbon, Portugal; [Potts, Brad M.; Lopez, Gustavo A.] Univ Tasmania, Sch Biol Sci, Hobart, Tas, Australia; [Potts, Brad M.; Lopez, Gustavo A.] Univ Tasmania, Natl Ctr Future Forest Ind, Hobart, Tas, Australia	Universidade de Lisboa; University of Tasmania; University of Tasmania	Silva, JCE (corresponding author), Univ Lisbon, Inst Super Agron, Ctr Estudos Florestais, P-1699 Lisbon, Portugal.	jces@isa.utl.pt	Ramos, Maria Julissa Ek/W-1017-2018; Potts, Brad M/C-6489-2013	Ramos, Maria Julissa Ek/0000-0002-1556-0823; Potts, Brad M/0000-0001-6244-289X; Costa e Silva, Joao/0000-0003-1422-9554	University of Tasmania; Instituto Nacional de Tecnologia Agropecuaria; Argentina Government; Australian Research Council Linkage [LP0884001]; Joao Costa e Silva by Fundacao para a Ciencia e Tecnologia (Lisboa, Portugal) through the Ciencia initiative	University of Tasmania; Instituto Nacional de Tecnologia Agropecuaria; Argentina Government; Australian Research Council Linkage(Australian Research Council); Joao Costa e Silva by Fundacao para a Ciencia e Tecnologia (Lisboa, Portugal) through the Ciencia initiative	The trials studied were established as part of the genetic research undertaken by the CRC for Sustainable Production Forestry, and as part of the PhD studies of Gustavo Lopez. This PhD was supported by the University of Tasmania, the Instituto Nacional de Tecnologia Agropecuaria, and the Argentina Government. Trial measurements and data collation were supported by the CRC for Sustainable Production Forestry, as well as an Australian Research Council Linkage grant (LP0884001) partnered by the Southern Tree Breeding Association Inc. and SeedEnergy Pty. Ltd. The financial support given to Joao Costa e Silva by Fundacao para a Ciencia e Tecnologia (Lisboa, Portugal), through the Ciencia 2007 initiative, is gratefully acknowledged and provided the opportunity to complete this long-term study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A, 2002, CATEGORICAL DATA ANA; Aitken SN, 2008, EVOL APPL, V1, P95, DOI 10.1111/j.1752-4571.2007.00013.x; Aitken SN, 2013, ANNU REV ECOL EVOL S, V44, P367, DOI 10.1146/annurev-ecolsys-110512-135747; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Alberto FJ, 2013, GLOBAL CHANGE BIOL, V19, P1645, DOI 10.1111/gcb.12181; Ashley MV, 2010, CRIT REV PLANT SCI, V29, P148, DOI 10.1080/07352689.2010.481167; Bacles CFE, 2008, HEREDITY, V101, P368, DOI 10.1038/hdy.2008.66; Barbour RC, 2003, AUST J BOT, V51, P429, DOI 10.1071/BT03016; Barlow R., 1981, Animal Breeding Abstracts, V49, P715; Barton NH, 2004, EVOLUTION, V58, P2111; Berens DG, 2013, OIKOS, V122, P1616, DOI 10.1111/j.1600-0706.2013.00515.x; Brautigam K, 2013, ECOL EVOL, V3, P399, DOI 10.1002/ece3.461; Breslow N, 2004, LECT NOTES STAT, V179, P1; Broadhurst LM, 2008, EVOL APPL, V1, P587, DOI 10.1111/j.1752-4571.2008.00045.x; Buschbom J, 2011, J HERED, V102, P464, DOI 10.1093/jhered/esr023; Byrne M., 2008, PLANT GENOME BIODI E, V1, P303; Calvino-Cancela M, 2013, FOREST ECOL MANAG, V305, P129, DOI 10.1016/j.foreco.2013.05.037; Campbell DR, 2010, AM J BOT, V97, P925, DOI 10.3732/ajb.0900387; Campbell DR, 2001, EVOLUTION, V55, P669, DOI 10.1554/0014-3820(2001)055[0669:GBEIAT]2.0.CO;2; Chybicki IJ, 2010, MOL ECOL, V19, P2137, DOI 10.1111/j.1365-294X.2010.04632.x; Silva JCE, 2011, HEREDITY, V107, P50, DOI 10.1038/hdy.2010.154; Silva JCE, 2006, TREE GENET GENOMES, V2, P61, DOI 10.1007/s11295-005-0025-x; Silva JCE, 2012, TREE GENET GENOMES, V8, P249, DOI 10.1007/s11295-011-0437-8; Silva JCE, 2009, TREE GENET GENOMES, V5, P291, DOI 10.1007/s11295-008-0174-9; Cox D.R., 1970, ANAL BINARY DATA, V2; Dungey HS, 2001, FOREST ECOL MANAG, V148, P243, DOI 10.1016/S0378-1127(00)00539-9; Dutkowski GW, 2012, TREE GENET GENOMES, V8, P757, DOI 10.1007/s11295-011-0461-8; Dutkowski GW, 1999, AUST J BOT, V47, P237, DOI 10.1071/BT97114; Dutkowski GW, 2002, CAN J FOREST RES, V32, P2201, DOI 10.1139/X02-111; Edmands S, 2007, MOL ECOL, V16, P463, DOI 10.1111/j.1365-294X.2006.03148.x; ELLSTRAND NC, 1992, OIKOS, V63, P77, DOI 10.2307/3545517; Epperson B. K., 1992, New Forests, V6, P257, DOI 10.1007/BF00120648; Eyles A, 2013, FOREST ECOL MANAG, V304, P49, DOI 10.1016/j.foreco.2013.04.033; Fenster CB, 2000, EVOLUTION, V54, P1157, DOI 10.1111/j.0014-3820.2000.tb00551.x; FIRTH D, 1993, BIOMETRIKA, V80, P27, DOI 10.2307/2336755; Fishman L, 2001, EVOLUTION, V55, P1932, DOI 10.1111/j.0014-3820.2001.tb01311.x; Forrest CN, 2011, ANN BOT-LONDON, V108, P185, DOI 10.1093/aob/mcr100; Freeman JS, 2007, ANN FOREST SCI, V64, P639, DOI 10.1051/forest:2007042; Fritz RS, 2006, EVOLUTION, V60, P1215, DOI 10.1111/j.0014-3820.2006.tb01200.x; Gilmour A. R., 1997, Journal of Agricultural, Biological, and Environmental Statistics, V2, P269, DOI 10.2307/1400446; Gilmour A.R., 2009, ASREML USER GUIDE RE; Gilmour AR, 1995, BIOMETRICS, V51, P1440, DOI 10.2307/2533274; Goto S, 2011, RESTOR ECOL, V19, P243, DOI 10.1111/j.1526-100X.2009.00568.x; GOVINDARAJU DR, 1989, BIOL J LINN SOC, V37, P345, DOI 10.1111/j.1095-8312.1989.tb01910.x; Greiner S, 2013, BIOESSAYS, V35, P354, DOI 10.1002/bies.201200137; HAASE P, 1993, J BIOGEOGR, V20, P79, DOI 10.2307/2845741; Hamilton MG, 2013, HEREDITY, V110, P372, DOI 10.1038/hdy.2012.106; Hamilton MG, 2011, AUST J BOT, V59, P170, DOI 10.1071/BT10313; Hampe A., 2013, P ROYAL SOC B, V280, P1764; Hamrick J. L., 2000, Forest conservation genetics: principles and practice, P81, DOI 10.1079/9780851995045.0081; Hansen TF, 2013, EVOLUTION, V67, P3501, DOI 10.1111/evo.12214; Hardner CM, 1997, EVOLUTION, V51, P103, DOI 10.1111/j.1558-5646.1997.tb02392.x; HARDNER CM, 1995, SILVAE GENET, V44, P46; Hardner CM, 1998, EVOLUTION, V52, P614, DOI [10.2307/2411096, 10.1111/j.1558-5646.1998.tb01660.x]; Harfouche A, 2000, CAN J FOREST RES, V30, P10, DOI 10.1139/cjfr-30-1-10; Heinze G, 2002, STAT MED, V21, P2409, DOI 10.1002/sim.1047; Hingston A. B., 1998, Tasforests, V10, P125; Hingston AB, 2005, AUSTRAL ECOL, V30, P319, DOI 10.1111/j.1442-9993.2005.01476.x; Hingston AB, 2004, AUSTRAL ECOL, V29, P624, DOI 10.1111/j.1442-9993.2004.01397.x; Hingston AB, 2004, AUST J BOT, V52, P371, DOI 10.1071/BT03018; Hingston AB, 2004, AUST J BOT, V52, P353, DOI 10.1071/BT03002; Hirao AS, 2010, ANN BOT-LONDON, V105, P637, DOI 10.1093/aob/mcq018; HIRJI KF, 1989, AM STAT, V43, P7, DOI 10.2307/2685158; Hufford KM, 2003, TRENDS ECOL EVOL, V18, P147, DOI 10.1016/S0169-5347(03)00002-8; Igic B, 2006, EVOLUTION, V60, P1098, DOI 10.1111/j.0014-3820.2006.tb01186.x; Isagi Y, 2007, J ECOL, V95, P983, DOI 10.1111/j.1365-2745.2007.01272.x; Jones RC, 2013, ECOL EVOL, V3, P1, DOI 10.1002/ece3.421; Jones RC, 2011, TREE GENET GENOMES, V7, P1209, DOI 10.1007/s11295-011-0407-1; Jones TH, 2007, MOL ECOL, V16, P697, DOI 10.1111/j.1365-294X.2006.03180.x; Robledo-Arnuncio JJ, 2011, NEW PHYTOL, V190, P222, DOI 10.1111/j.1469-8137.2010.03588.x; Kenward MG, 1997, BIOMETRICS, V53, P983, DOI 10.2307/2533558; Kimball S, 2008, J ECOL, V96, P1306, DOI 10.1111/j.1365-2745.2008.01432.x; KOMENDER P, 1989, LIVEST PROD SCI, V21, P101, DOI 10.1016/0301-6226(89)90042-0; Kremer A, 2012, HEREDITY, V108, P375, DOI 10.1038/hdy.2011.81; Kremer A, 2012, ECOL LETT, V15, P378, DOI 10.1111/j.1461-0248.2012.01746.x; Larcombe MJ, 2013, BIOL INVASIONS, V15, P2763, DOI 10.1007/s10530-013-0492-1; Leimu R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004010; Levin D. A., 1974, EVOL BIOL, V7, P139, DOI DOI 10.1007/978-1-4615-6944-2_5; LEVIN DA, 1981, ANN MO BOT GARD, V68, P233, DOI 10.2307/2398797; Lippman ZB, 2007, TRENDS GENET, V23, P60, DOI 10.1016/j.tig.2006.12.006; Lopez GA, 2000, HEREDITY, V85, P242, DOI 10.1046/j.1365-2540.2000.00739.x; Lopez GA, 2003, CAN J FOREST RES, V33, P2108, DOI [10.1139/x03-132, 10.1139/X03-132]; Lynch Michael, 1998; Martin B, 1989, P IUFRO C BREED TROP, P79; McKinnon GE, 2001, GENOME, V44, P831, DOI 10.1139/gen-44-5-831; Mehta CR, 1992, J COMPUTATIONAL GRAP, V1, P21, DOI DOI 10.2307/1390598; Mimura M, 2009, MOL ECOL, V18, P4180, DOI 10.1111/j.1365-294X.2009.04350.x; Nikles DG, 1992, ACIAR P, P101; O'Reilly-Wapstra JM, 2005, J CHEM ECOL, V31, P357, DOI 10.1007/s10886-005-1346-9; O'Reilly-Wapstra JM, 2002, OECOLOGIA, V130, P289, DOI 10.1007/s004420100797; O'Reilly-Wapstra JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058416; O'Reilly-Wapstra JM, 2011, TREE GENET GENOMES, V7, P485, DOI 10.1007/s11295-010-0350-6; Ozawa H, 2013, J HERED, V104, P465, DOI 10.1093/jhered/est022; POTTS BM, 1988, EVOLUTION, V42, P1245, DOI 10.1111/j.1558-5646.1988.tb04184.x; Rhode JM, 2005, AM NAT, V166, pE124, DOI 10.1086/491798; Rieseberg LH, 2007, SCIENCE, V317, P910, DOI 10.1126/science.1137729; Robertson AW, 2011, INT J PLANT SCI, V172, P191, DOI 10.1086/657678; SAS Institute Inc, 2011, SAS STAT 9 3 US GUID; Savolainen O, 2007, ANNU REV ECOL EVOL S, V38, P595, DOI 10.1146/annurev.ecolsys.38.091206.095646; Silva JCE, 2004, THEOR APPL GENET, V108, P1113, DOI 10.1007/s00122-003-1524-5; Silva JCE, 2001, CAN J FOREST RES, V31, P1887, DOI 10.1139/cjfr-31-11-1887; Silva JCE, 2010, ANN FOREST SCI, V67, DOI 10.1051/forest/2010018; Silva JCE, 2010, ANN FOREST SCI, V67, DOI 10.1051/forest/2010019; Skabo S, 1998, AUST J BOT, V46, P583, DOI 10.1071/BT97056; Slavov GT, 2002, ECOLOGICAL AGRONOMIC, P106; Stackpole DJ, 2011, G3-GENES GENOM GENET, V1, P151, DOI 10.1534/g3.111.000372; Stackpole DJ, 2010, TREE GENET GENOMES, V6, P179, DOI 10.1007/s11295-009-0239-4; Steane DA, 2006, TREE GENET GENOMES, V2, P30, DOI 10.1007/s11295-005-0028-7; Steinitz O, 2011, MOL ECOL, V20, P4152, DOI 10.1111/j.1365-294X.2011.05203.x; Stringer JK, 2006, THESIS U QUEENSLAND; Stringer JK, 2011, J AGR BIOL ENVIR ST, V16, P269, DOI 10.1007/s13253-010-0051-5; Su G, 2009, J DAIRY SCI, V92, P2204, DOI 10.3168/jds.2008-1499; Taylor SJ, 2009, EVOLUTION, V63, P2581, DOI 10.1111/j.1558-5646.2009.00742.x; Vaillancourt R. E., 1995, Forest Genetics, V2, P11; Volker PW, 2008, TREE GENET GENOMES, V4, P445, DOI 10.1007/s11295-007-0122-0; Volker PW, 2002, THEISI U TASMANIA; WADDINGTON KD, 1983, AM NAT, V122, P147, DOI 10.1086/284124; Wallis IR, 2011, PERSPECT PLANT ECOL, V13, P305, DOI 10.1016/j.ppees.2011.05.005; Waser N.M., 1983, P341; Weeks AR, 2011, EVOL APPL, V4, P709, DOI 10.1111/j.1752-4571.2011.00192.x; White T. L., 2007, FOREST GENETICS; Wolfinger RD, 1996, J AGR BIOL ENVIR ST, V1, P205, DOI [10.2307/1400366, DOI 10.2307/1400366]; Yeoh SH, 2012, TREE GENET GENOMES, V8, P695, DOI 10.1007/s11295-011-0457-4; Yu H, 2010, MOL ECOL, V19, P4441, DOI 10.1111/j.1365-294X.2010.04777.x	124	130	135	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e93811	10.1371/journal.pone.0093811	http://dx.doi.org/10.1371/journal.pone.0093811			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	25093505	Green Published, Green Submitted, gold			2022-12-27	WOS:000335227400008
J	Liu, N; Lin, ZF; Guan, LL; Gaughan, G; Lin, GZ				Liu, Nan; Lin, Zhifang; Guan, Lanlan; Gaughan, Gerald; Lin, Guizhu			Antioxidant Enzymes Regulate Reactive Oxygen Species during Pod Elongation in Pisum sativum and Brassica chinensis	PLOS ONE			English	Article							HYDROXYL RADICALS; HYDROGEN-PEROXIDE; CELL-WALL; ROOT; SUPEROXIDE; GROWTH; LEAVES; H2O2	Previous research has focused on the involvement of reactive oxygen species (ROS) in cell wall loosening and cell extension in plant vegetative growth, but few studies have investigated ROS functions specifically in plant reproductive organs. In this study, ROS levels and antioxidant enzyme activities were assessed in Pisum sativum and Brassica chinensis pods at five developmental stages. In juvenile pods, the high levels of O-2(-) and OH indicates that they had functions in cell wall loosening and cell elongation. In later developmental stages, high levels of. OH were also related to increases in cell wall thickness in lignified tissues. Throughout pod development, most of the O-2(-) was detected on plasma membranes of parenchyma cells and outer epidermis cells of the mesocarp, while most of the H2O2 was detected on plasma membranes of most cells throughout the mesocarp. This suggests that these sites are presumably the locations of ROS generation. The antioxidant enzymes superoxide dismutase (SOD), peroxidase (POD), and catalase (CAT) apparently contributed to ROS accumulation in pod wall tissues. Furthermore, specifically SOD and POD were found to be associated with pod growth through the regulation of ROS generation and transformation. Throughout pod development, O-2(-) decreases were associated with increased SOD activity, while changes in H2O2 accumulation were associated with changes in CAT and POD activities. Additionally, high POD activity may contribute to the generation of. OH in the early development of pods. It is concluded that the ROS are produced in different sites of plasma membranes with the regulation of antioxidant enzymes, and that substantial ROS generation and accumulation are evident in cell elongation and cell wall loosening in pod wall cells.	[Liu, Nan; Lin, Zhifang; Guan, Lanlan; Lin, Guizhu] Chinese Acad Sci, South China Bot Garden, Key Lab Vegetat Restorat & Management Degraded Ec, Guangzhou, Guangdong, Peoples R China; [Gaughan, Gerald] Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA	Chinese Academy of Sciences; South China Botanical Garden, CAS; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Lin, ZF (corresponding author), Chinese Acad Sci, South China Bot Garden, Key Lab Vegetat Restorat & Management Degraded Ec, Guangzhou, Guangdong, Peoples R China.	linzhif@scbg.ac.cn	刘, 芳延/AAO-8535-2021; Strugnell, Jan M/P-9921-2016; Moltschaniwskyj, Natalie/AAB-7236-2019; Pecl, Gretta/D-7267-2011; Bertin, Aline/T-5005-2017; van den Bosch, Frank C./ABH-3801-2020; Malausa, Thibaut/X-1614-2018; León, Rafael I/N-6510-2014; Botton, Marcos/I-1731-2016; Deary, Ian/C-6297-2009; Aidar, Marcos Pereira Marinho/B-2212-2013; Inskip, Hazel/L-5467-2018; Persinoti, Gabriela/C-5933-2016; Silva-Rocha, Rafael/H-4929-2012; Sujii, Edison Ryoiti/H-7715-2015; Benzeval, Michaela/J-3163-2015; Apparecida Desiderio, Janete/F-5848-2012; Leimar, Olof/L-3781-2014; Guazzaroni, Maria-Eugenia/E-2599-2013; Dodds, Richard/D-7772-2016; Sujii, Edison/H-7715-2015	刘, 芳延/0000-0002-5155-1916; Pecl, Gretta/0000-0003-0192-4339; Bertin, Aline/0000-0003-4232-4241; van den Bosch, Frank C./0000-0003-3236-2068; Malausa, Thibaut/0000-0003-1681-7958; León, Rafael I/0000-0003-3197-4185; Botton, Marcos/0000-0002-0554-3157; Deary, Ian/0000-0002-1733-263X; Favati, Anna/0000-0002-6435-011X; Aidar, Marcos Pereira Marinho/0000-0001-5728-6749; Fernandes, Odair/0000-0003-3489-4754; Aihie Sayer, Avan/0000-0003-1283-6457; Der, Geoff/0000-0002-8677-073X; Choo, Robin/0000-0002-3240-3029; Dennison, Elaine/0000-0002-3048-4961; Strugnell, Jan/0000-0003-2994-637X; Germain, Jean-Francois/0000-0001-7927-6031; Inskip, Hazel/0000-0001-8897-1749; Persinoti, Gabriela/0000-0002-0975-7283; Silva-Rocha, Rafael/0000-0001-6319-631X; Moltschaniwskyj, Natalie/0000-0001-9709-9876; Sujii, Edison Ryoiti/0000-0001-7602-8999; Benzeval, Michaela/0000-0002-0372-2098; Teixeira da Silva, Jaime A./0000-0003-3299-2772; Apparecida Desiderio, Janete/0000-0001-7723-3070; Souza, Silvia/0000-0001-6293-7665; Semmens, Jayson/0000-0003-1742-6692; Ramos, Jorge E/0000-0002-8690-761X; Wong, Joshua/0000-0001-8268-5610; timbo, renata/0000-0003-1989-7412; Gale, Catharine/0000-0002-3361-8638; Jagger, Carol/0000-0002-6377-9926; Paveley, Neil/0000-0002-1709-4563; Leimar, Olof/0000-0001-8621-6977; Wong, Jason/0000-0002-8167-540X; Cooper, Cyrus/0000-0003-3510-0709; Guazzaroni, Maria-Eugenia/0000-0002-4657-3731; Pacheco da Silva, Vitor/0000-0002-8420-1779; Gan, Victor/0000-0002-6966-2729; Tilling, Kate/0000-0002-1010-8926; R. Silva, Rogerio/0000-0002-0599-2155; Lawlor, Debbie A/0000-0002-6793-2262; Vucicevic, Katarina/0000-0001-9676-5785; Robinson, Sian/0000-0003-1766-7269; Dodds, Richard/0000-0003-4968-7678; Lye, David/0000-0003-0324-0205; Sujii, Edison/0000-0002-0702-0181; N. Silva, Roberto/0000-0002-8992-7130; De Vivo, Immaculata/0000-0002-7185-7402; Cooper, Rachel/0000-0003-3370-5720	China Scholarship Council [201204910138]; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005198] Funding Source: researchfish	China Scholarship Council(China Scholarship Council); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The current study was supported by China Scholarship Council (No. 201204910138, http://www.csc.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alscher RG, 1997, PHYSIOL PLANTARUM, V100, P224, DOI 10.1034/j.1399-3054.1997.1000203.x; BARRETO JC, 1994, LIFE SCI, V56, pPL89, DOI 10.1016/0024-3205(94)00925-2; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carol RJ, 2006, J EXP BOT, V57, P1829, DOI 10.1093/jxb/erj201; Derbyshire P, 2007, J EXP BOT, V58, P2079, DOI 10.1093/jxb/erm074; Dunand C, 2007, NEW PHYTOL, V174, P332, DOI 10.1111/j.1469-8137.2007.01995.x; Foreman J, 2003, NATURE, V422, P442, DOI 10.1038/nature01485; Fry SC, 2001, BIOCHEM J, V357, P729, DOI 10.1042/0264-6021:3570729; Gapper C, 2006, PLANT PHYSIOL, V141, P341, DOI 10.1104/pp.106.079079; GIANNOPOLITIS CN, 1977, PLANT PHYSIOL, V59, P315, DOI 10.1104/pp.59.2.309; GILBERT DL, 1981, OXYGEN LIVING PROCES; Hernandez JA, 2001, PLANT PHYSIOL, V127, P817, DOI 10.1104/pp.010188; Ivakov A, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00439; Ivanchenko MG, 2013, ANN BOT, DOI [10.1093/aob/mct181, DOI 10.1093/A0B/MCT181]; Johnansen DA, 1940, PLANT MICROTECHNIQUE; Kranner I, 2010, J PLANT PHYSIOL, V167, P805, DOI 10.1016/j.jplph.2010.01.019; Kukavica B, 2009, PLANT CELL PHYSIOL, V50, P304, DOI 10.1093/pcp/pcn199; Li SW, 2009, ENVIRON EXP BOT, V65, P63, DOI 10.1016/j.envexpbot.2008.06.004; Liszkay A, 2004, PLANT PHYSIOL, V136, P3114, DOI 10.1104/pp.104.044784; Liu N, 2013, J PLANT GROWTH REGUL, V32, P83, DOI 10.1007/s00344-012-9278-4; Liu N, 2010, ECOTOX ENVIRON SAFE, V73, P1238, DOI 10.1016/j.ecoenv.2010.06.017; Muller K, 2009, PLANT PHYSIOL, V150, P1855, DOI 10.1104/pp.109.139204; Perl RT., 2002, OXIDATIVE STRESS PLA, P1; Romero-Puertas MC, 2004, PLANT CELL ENVIRON, V27, P1122, DOI 10.1111/j.1365-3040.2004.01217.x; Barcelo AR, 2009, SIGNAL COMMUN PLANTS, P73, DOI 10.1007/978-3-642-00390-5_5; Schopfer P, 2006, BIOFACTORS, V28, P73, DOI 10.1002/biof.5520280202; Schopfer P, 2002, PLANTA, V214, P821, DOI 10.1007/s00425-001-0699-8; Schopfer P, 2001, PLANT PHYSIOL, V125, P1591, DOI 10.1104/pp.125.4.1591; Sugimoto-Shirasu K, 2003, CURR OPIN PLANT BIOL, V6, P544, DOI 10.1016/j.pbi.2003.09.009; Yang XF, 2001, ANALYST, V126, P928, DOI 10.1039/b100085n; ZENG S-X, 1991, Acta Phytophysiologica Sinica, V17, P177; [张玲玲 ZHANG LingLing], 2006, [生态学报, Acta Ecologica Sinica], V26, P1330, DOI 10.1016/S1872-2032(06)60025-5	32	446	498	61	151	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e87588	10.1371/journal.pone.0087588	http://dx.doi.org/10.1371/journal.pone.0087588			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302VA	24671213	Green Published, gold, Green Submitted			2022-12-27	WOS:000330631800048
J	Hobbelen, PHF; Paveley, ND; van den Bosch, F				Hobbelen, Peter H. F.; Paveley, Neil D.; van den Bosch, Frank			The Emergence of Resistance to Fungicides	PLOS ONE			English	Article							STRESS-INDUCED MUTAGENESIS; MYCOSPHAERELLA-GRAMINICOLA; PESTICIDE RESISTANCE; SPRAY HETEROGENEITY; SEPTORIA-TRITICI; SELECTION; MIXTURES; PATHOGEN; MODEL; POPULATIONS	Many studies exist about the selection phase of fungicide resistance evolution, where a resistant strain is present in a pathogen population and is differentially selected for by the application of fungicides. The emergence phase of the evolution of fungicide resistance - where the resistant strain is not present in the population and has to arise through mutation and subsequently invade the population - has not been studied to date. Here, we derive a model which describes the emergence of resistance in pathogen populations of crops. There are several important examples where a single mutation, affecting binding of a fungicide with the target protein, shifts the sensitivity phenotype of the resistant strain to such an extent that it cannot be controlled effectively('qualitative' or 'single-step' resistance). The model was parameterized for this scenario for Mycosphaerella graminicola on winter wheat and used to evaluate the effect of fungicide dose rate on the time to emergence of resistance for a range of mutation probabilities, fitness costs of resistance and sensitivity levels of the resistant strain. We also evaluated the usefulness of mixing two fungicides of differing modes of action for delaying the emergence of resistance. The results suggest that it is unlikely that a resistant strain will already have emerged when a fungicide with a new mode of action is introduced. Hence, 'anti-emergence' strategies should be identified and implemented. For all simulated scenarios, the median emergence time of a resistant strain was affected little by changing the dose rate applied, within the range of doses typically used on commercial crops. Mixing a single-site acting fungicide with a multi-site acting fungicide delayed the emergence of resistance to the single-site component. Combining the findings with previous work on the selection phase will enable us to develop more efficient anti-resistance strategies.	[Hobbelen, Peter H. F.; van den Bosch, Frank] Rothamsted Res, Harpenden, Herts, England; [Paveley, Neil D.] ADAS UK Ltd, Malton, N Yorkshire, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research	van den Bosch, F (corresponding author), Rothamsted Res, Harpenden, Herts, England.	frank.vandenbosch@rothamsted.ac.uk	刘, 芳延/AAO-8535-2021; Strugnell, Jan M/P-9921-2016; Moltschaniwskyj, Natalie/AAB-7236-2019; Pecl, Gretta/D-7267-2011; Bertin, Aline/T-5005-2017; van den Bosch, Frank C./ABH-3801-2020; Malausa, Thibaut/X-1614-2018; León, Rafael I/N-6510-2014; Botton, Marcos/I-1731-2016; Deary, Ian/C-6297-2009; Aidar, Marcos Pereira Marinho/B-2212-2013; Inskip, Hazel/L-5467-2018; Persinoti, Gabriela/C-5933-2016; Silva-Rocha, Rafael/H-4929-2012; Sujii, Edison Ryoiti/H-7715-2015; Benzeval, Michaela/J-3163-2015; Apparecida Desiderio, Janete/F-5848-2012; Leimar, Olof/L-3781-2014; Guazzaroni, Maria-Eugenia/E-2599-2013; Dodds, Richard/D-7772-2016; Sujii, Edison/H-7715-2015	刘, 芳延/0000-0002-5155-1916; Pecl, Gretta/0000-0003-0192-4339; Bertin, Aline/0000-0003-4232-4241; van den Bosch, Frank C./0000-0003-3236-2068; Malausa, Thibaut/0000-0003-1681-7958; León, Rafael I/0000-0003-3197-4185; Botton, Marcos/0000-0002-0554-3157; Deary, Ian/0000-0002-1733-263X; Favati, Anna/0000-0002-6435-011X; Aidar, Marcos Pereira Marinho/0000-0001-5728-6749; Fernandes, Odair/0000-0003-3489-4754; Aihie Sayer, Avan/0000-0003-1283-6457; Der, Geoff/0000-0002-8677-073X; Choo, Robin/0000-0002-3240-3029; Dennison, Elaine/0000-0002-3048-4961; Strugnell, Jan/0000-0003-2994-637X; Germain, Jean-Francois/0000-0001-7927-6031; Inskip, Hazel/0000-0001-8897-1749; Persinoti, Gabriela/0000-0002-0975-7283; Silva-Rocha, Rafael/0000-0001-6319-631X; Moltschaniwskyj, Natalie/0000-0001-9709-9876; Sujii, Edison Ryoiti/0000-0001-7602-8999; Benzeval, Michaela/0000-0002-0372-2098; Teixeira da Silva, Jaime A./0000-0003-3299-2772; Apparecida Desiderio, Janete/0000-0001-7723-3070; Souza, Silvia/0000-0001-6293-7665; Semmens, Jayson/0000-0003-1742-6692; Ramos, Jorge E/0000-0002-8690-761X; Wong, Joshua/0000-0001-8268-5610; timbo, renata/0000-0003-1989-7412; Gale, Catharine/0000-0002-3361-8638; Jagger, Carol/0000-0002-6377-9926; Paveley, Neil/0000-0002-1709-4563; Leimar, Olof/0000-0001-8621-6977; Wong, Jason/0000-0002-8167-540X; Cooper, Cyrus/0000-0003-3510-0709; Guazzaroni, Maria-Eugenia/0000-0002-4657-3731; Pacheco da Silva, Vitor/0000-0002-8420-1779; Gan, Victor/0000-0002-6966-2729; Tilling, Kate/0000-0002-1010-8926; R. Silva, Rogerio/0000-0002-0599-2155; Lawlor, Debbie A/0000-0002-6793-2262; Vucicevic, Katarina/0000-0001-9676-5785; Robinson, Sian/0000-0003-1766-7269; Dodds, Richard/0000-0003-4968-7678; Lye, David/0000-0003-0324-0205; Sujii, Edison/0000-0002-0702-0181; N. Silva, Roberto/0000-0002-8992-7130; De Vivo, Immaculata/0000-0002-7185-7402; Cooper, Rachel/0000-0003-3370-5720	Biological and Biotechnological Research Council of the United Kingdom; Department for Environment, Food and Rural Affairs of the United Kingdom [PS2712]; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005198] Funding Source: researchfish	Biological and Biotechnological Research Council of the United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Department for Environment, Food and Rural Affairs of the United Kingdom(Department for Environment, Food & Rural Affairs (DEFRA)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Rothamsted Research receives support from the Biological and Biotechnological Research Council of the United Kingdom. Part of this research was funded by the Department for Environment, Food and Rural Affairs of the United Kingdom (project number PS2712). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birch CPD, 1997, J APPL ECOL, V34, P1032, DOI 10.2307/2405292; Bjedov I, 2003, SCIENCE, V300, P1404, DOI 10.1126/science.1082240; Cao Y, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2159468; Carnegie SF, 2008, POTATO RES, V51, P113, DOI 10.1007/s11540-008-9094-1; DOSTER MA, 1990, PHYTOPATHOLOGY, V80, P1190, DOI 10.1094/Phyto-80-1190; Eyal Z, 1999, EUR J PLANT PATHOL, V105, P629, DOI 10.1023/A:1008716812259; Fraaije BA, 2005, PHYTOPATHOLOGY, V95, P933, DOI 10.1094/PHYTO-95-0933; Fraaije BA, 2012, MOL PLANT PATHOL, V13, P263, DOI 10.1111/j.1364-3703.2011.00746.x; Galhardo RS, 2007, CRIT REV BIOCHEM MOL, V42, P399, DOI 10.1080/10409230701648502; Genet JL, 2006, PEST MANAG SCI, V62, P188, DOI 10.1002/ps.1146; Grabski C., 1985, BRIT CROP PROT C MON, V31, P315; Grimmer M, 2011, RESISTANCE 2011, P94; Gubbins S, 1999, P ROY SOC B-BIOL SCI, V266, P2539, DOI 10.1098/rspb.1999.0957; Hall RJ, 2007, B MATH BIOL, V69, P525, DOI 10.1007/s11538-006-9139-z; Hall RJ, 2004, B MATH BIOL, V66, P825, DOI 10.1016/j.bulm.2003.11.006; HOARE FA, 1986, PLANT PATHOL, V35, P506, DOI 10.1111/j.1365-3059.1986.tb02048.x; Hobbelen PHF, 2013, PHYTOPATHOLOGY, V103, P690, DOI 10.1094/PHYTO-06-12-0142-R; Hobbelen PHF, 2011, PHYTOPATHOLOGY, V101, P1224, DOI 10.1094/PHYTO-10-10-0290; Hobbelen PHF, 2011, PLANT PATHOL, V60, P304, DOI 10.1111/j.1365-3059.2010.02380.x; Horsten JAHM, 1979, THESIS WAGENINGEN U; HUNTER T, 1987, ANN APPL BIOL, V110, P515, DOI 10.1111/j.1744-7348.1987.tb04169.x; Iwasa Y, 2004, J THEOR BIOL, V226, P205, DOI 10.1016/j.jtbi.2003.08.014; JOSEPOVITS G, 1989, CROP PROT, V8, P106, DOI 10.1016/0261-2194(89)90084-7; Kang JM, 2006, FASEB J, V20, P2476, DOI 10.1096/fj.06-6209com; LaMondia J. A., 2001, Journal of Environmental Horticulture, V19, P51; Mavroeidi VI, 2006, PLANT PATHOL, V55, P715, DOI 10.1111/j.1365-3059.2006.01441.x; McCartney C, 2007, CROP PROT, V26, P1272, DOI 10.1016/j.cropro.2006.10.027; Metcalfe RJ, 2000, PLANT PATHOL, V49, P546, DOI 10.1046/j.1365-3059.2000.00486.x; MILGROOM MG, 1990, PHYTOPATHOLOGY, V80, P410, DOI 10.1094/Phyto-80-410; Parnell S, 2006, PHYTOPATHOLOGY, V96, P549, DOI 10.1094/PHYTO-96-0549; Parnell S, 2005, PHYTOPATHOLOGY, V95, P632, DOI 10.1094/PHYTO-95-0632; Paveley ND, 2011, HGCA WHEAT DIS MANAG; Robert C, 2008, FUNCT PLANT BIOL, V35, P997, DOI 10.1071/FP08066; SANDERS PL, 1985, PLANT DIS, V69, P939; SANOAMUANG N, 1995, MYCOL RES, V99, P677, DOI 10.1016/S0953-7562(09)80527-3; Serra MC, 2007, THEOR POPUL BIOL, V72, P167, DOI 10.1016/j.tpb.2007.01.005; Serra MC, 2006, J APPL PROBAB, V43, P296, DOI 10.1239/jap/1143936262; Shaw MW, 2000, PHYTOPATHOLOGY, V90, P333, DOI 10.1094/PHYTO.2000.90.4.333; SHAW MW, 1993, CROP PROT, V12, P120, DOI 10.1016/0261-2194(93)90138-9; Tenaillon O, 2004, TRENDS MICROBIOL, V12, P264, DOI 10.1016/j.tim.2004.04.002; Thornley JHM., 1990, PLANT CROP MODELLING; Thygesen K, 2009, EUR J PLANT PATHOL, V123, P435, DOI 10.1007/s10658-008-9381-3; Turechek WW, 2004, PLANT HLTH PROG; VALI RJ, 1992, PLANT DIS, V76, P919, DOI 10.1094/PD-76-0919; van den Bosch F, 2011, PLANT PATHOL, V60, P597, DOI 10.1111/j.1365-3059.2011.02439.x; van den Bosch F, 2008, ANNU REV PHYTOPATHOL, V46, P123, DOI 10.1146/annurev.phyto.011108.135838; WAGGONER PE, 1987, PHYTOPATHOLOGY, V77, P393; Zhang CQ, 2008, ANN APPL BIOL, V153, P205, DOI 10.1111/j.1744-7348.2008.00248.x	48	446	498	61	151	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e91910	10.1371/journal.pone.0091910	http://dx.doi.org/10.1371/journal.pone.0091910			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24671213	Green Published, Green Submitted, gold			2022-12-27	WOS:000333355300044
J	da Silva, VCP; Bertin, A; Blin, A; Germain, JF; Bernardi, D; Rignol, G; Botton, M; Malausa, T				Pacheco da Silva, Vitor C.; Bertin, Aline; Blin, Aurelie; Germain, Jean-Francois; Bernardi, Daniel; Rignol, Guylene; Botton, Marcos; Malausa, Thibaut			Molecular and Morphological Identification of Mealybug Species (Hemiptera: Pseudococcidae) in Brazilian Vineyards	PLOS ONE			English	Article							FERRISIA FULLAWAY HEMIPTERA; SCALE INSECTS HEMIPTERA; EXPORT GRAPE PRODUCTION; MULTIPLEX PCR; PEST; PHYLOGENY; MARKERS	Mealybugs (Hemiptera: Pseudococcidae) are pests constraining the international trade of Brazilian table grapes. They damage grapes by transmitting viruses and toxins, causing defoliation, chlorosis, and vigor losses and favoring the development of sooty mold. Difficulties in mealybug identification remain an obstacle to the adequate management of these pests. In this study, our primary aim was to identify the principal mealybug species infesting the major table grape-producing regions in Brazil, by morphological and molecular characterization. Our secondary aim was to develop a rapid identification kit based on species-specific Polymerase Chain Reactions, to facilitate the routine identification of the most common pest species. We surveyed 40 sites infested with mealybugs and identified 17 species: Dysmicoccus brevipes (Cockerell), Dysmicoccus sylvarum Williams and Granara de Willink, Dysmicoccus texensis (Tinsley), Ferrisia cristinae Kaydan and Gullan, Ferrisia meridionalis Williams, Ferrisia terani Williams and Granara de Willink, Phenacoccus baccharidis Williams, Phenacoccus parvus Morrison, Phenacoccus solenopsis Tinsley, Planococcus citri (Risso), Pseudococcus viburni (Signoret), Pseudococcus cryptus Hempel, four taxa closely related each of to Pseudococcus viburni, Pseudococcus sociabilis Hambleton, Pseudococcus maritimus (Ehrhorn) and Pseudococcus meridionalis Prado, and one specimen from the genus Pseudococcus Westwood. The PCR method developed effectively identified five mealybug species of economic interest on grape in Brazil: D. brevipes, Pl. citri, Ps. viburni, Ph. solenopsis and Planococcus ficus (Signoret). Nevertheless, it is not possible to assure that this procedure is reliable for taxa that have not been sampled already and might be very closely related to the target species.	[Pacheco da Silva, Vitor C.; Botton, Marcos] Embrapa Uva & Vinho, Bento Goncalves, Brazil; [Bertin, Aline; Bernardi, Daniel] Univ Sao Paulo, Escola Super Agr Luiz de Queiroz, Piracicaba, Brazil; [Blin, Aurelie; Rignol, Guylene; Malausa, Thibaut] INRA, Inst Sophia Agrobiotech, UMR INRA UNSA CNRS, F-06903 Sophia Antipolis, France; [Germain, Jean-Francois] ANSES, Lab Sante Vegetaux, Unite Entomol & Plantes Invas, Montferrier Sur Lez, France	Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade de Sao Paulo; INRAE; UDICE-French Research Universities; Universite Cote d'Azur; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Laboratoire de la Sante des Vegetaux	Malausa, T (corresponding author), INRA, Inst Sophia Agrobiotech, UMR INRA UNSA CNRS, BP 167, F-06903 Sophia Antipolis, France.	tmalausa@sophia.inra.fr	刘, 芳延/AAO-8535-2021; Strugnell, Jan M/P-9921-2016; Moltschaniwskyj, Natalie/AAB-7236-2019; Pecl, Gretta/D-7267-2011; Bertin, Aline/T-5005-2017; van den Bosch, Frank C./ABH-3801-2020; Malausa, Thibaut/X-1614-2018; León, Rafael I/N-6510-2014; Botton, Marcos/I-1731-2016; Deary, Ian/C-6297-2009; Aidar, Marcos Pereira Marinho/B-2212-2013; Inskip, Hazel/L-5467-2018; Persinoti, Gabriela/C-5933-2016; Silva-Rocha, Rafael/H-4929-2012; Sujii, Edison Ryoiti/H-7715-2015; Benzeval, Michaela/J-3163-2015; Apparecida Desiderio, Janete/F-5848-2012; Leimar, Olof/L-3781-2014; Guazzaroni, Maria-Eugenia/E-2599-2013; Dodds, Richard/D-7772-2016; Sujii, Edison/H-7715-2015	刘, 芳延/0000-0002-5155-1916; Pecl, Gretta/0000-0003-0192-4339; Bertin, Aline/0000-0003-4232-4241; van den Bosch, Frank C./0000-0003-3236-2068; Malausa, Thibaut/0000-0003-1681-7958; León, Rafael I/0000-0003-3197-4185; Botton, Marcos/0000-0002-0554-3157; Deary, Ian/0000-0002-1733-263X; Favati, Anna/0000-0002-6435-011X; Aidar, Marcos Pereira Marinho/0000-0001-5728-6749; Fernandes, Odair/0000-0003-3489-4754; Aihie Sayer, Avan/0000-0003-1283-6457; Der, Geoff/0000-0002-8677-073X; Choo, Robin/0000-0002-3240-3029; Dennison, Elaine/0000-0002-3048-4961; Strugnell, Jan/0000-0003-2994-637X; Germain, Jean-Francois/0000-0001-7927-6031; Inskip, Hazel/0000-0001-8897-1749; Persinoti, Gabriela/0000-0002-0975-7283; Silva-Rocha, Rafael/0000-0001-6319-631X; Moltschaniwskyj, Natalie/0000-0001-9709-9876; Sujii, Edison Ryoiti/0000-0001-7602-8999; Benzeval, Michaela/0000-0002-0372-2098; Teixeira da Silva, Jaime A./0000-0003-3299-2772; Apparecida Desiderio, Janete/0000-0001-7723-3070; Souza, Silvia/0000-0001-6293-7665; Semmens, Jayson/0000-0003-1742-6692; Ramos, Jorge E/0000-0002-8690-761X; Wong, Joshua/0000-0001-8268-5610; timbo, renata/0000-0003-1989-7412; Gale, Catharine/0000-0002-3361-8638; Jagger, Carol/0000-0002-6377-9926; Paveley, Neil/0000-0002-1709-4563; Leimar, Olof/0000-0001-8621-6977; Wong, Jason/0000-0002-8167-540X; Cooper, Cyrus/0000-0003-3510-0709; Guazzaroni, Maria-Eugenia/0000-0002-4657-3731; Pacheco da Silva, Vitor/0000-0002-8420-1779; Gan, Victor/0000-0002-6966-2729; Tilling, Kate/0000-0002-1010-8926; R. Silva, Rogerio/0000-0002-0599-2155; Lawlor, Debbie A/0000-0002-6793-2262; Vucicevic, Katarina/0000-0001-9676-5785; Robinson, Sian/0000-0003-1766-7269; Dodds, Richard/0000-0003-4968-7678; Lye, David/0000-0003-0324-0205; Sujii, Edison/0000-0002-0702-0181; N. Silva, Roberto/0000-0002-8992-7130; De Vivo, Immaculata/0000-0002-7185-7402; Cooper, Rachel/0000-0003-3370-5720	European Union [265865, 269196, 324475]; French grants Agropolis Fondation (RTRA - Montpellier, BIOFIS) [1001001]; Bibliotheque du Vivant; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005198] Funding Source: researchfish	European Union(European Commission); French grants Agropolis Fondation (RTRA - Montpellier, BIOFIS); Bibliotheque du Vivant; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the European Union Seventh Framework Programme FP7-KBBE #265865 "PURE'', FP7-IRSES #269196 "IPRABIO'' and FP7-IAPP #324475 "COLBICS'' and by the French grants Agropolis Fondation (http://www.agropolis-fondation.fr/) (RTRA - Montpellier, BIOFIS project number 1001001) and 'Bibliotheque du Vivant'. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd-Rabou S, 2012, B ENTOMOL RES, V102, P515, DOI 10.1017/S0007485312000041; Beltra A, 2012, B ENTOMOL RES, V102, P165, DOI 10.1017/S0007485311000514; Ben-Dov Y, 2012, SCALENET DATABASE SC; Bertin S, 2010, PHYTOPARASITICA, V38, P401, DOI 10.1007/s12600-010-0109-5; Beuning LL, 1999, J ECON ENTOMOL, V92, P463, DOI 10.1093/jee/92.2.463; Camargo UA, 2011, REV BRAS FRUTIC, V33, P144, DOI 10.1590/S0100-29452011000500017; Cavalieri V, 2008, ZOOTAXA, P65, DOI 10.11646/zootaxa.1816.1.6; Charles J. G., 2006, New Zealand Plant Protection, V59, P330; Charles JG, 2011, BIOCONTROL, V56, P155, DOI 10.1007/s10526-010-9322-x; Correa L. R. B., 2005, Laranja, V26, P265; Correa MCG, 2012, B ENTOMOL RES, V102, P524, DOI 10.1017/S0007485312000053; Correa M, 2011, ZOOTAXA, P46, DOI 10.11646/zootaxa.2926.1.2; Santa-Cecilia LVC, 2009, ACTA SCI-AGRON, V31, P13, DOI 10.4025/actasciagron.v31i1.6603; Culik Mark Paul, 2007, Biota Neotrop., V7, P61, DOI 10.1590/S1676-06032007000300006; Culik MP, 2005, ZOOTAXA, P1; Daane KM, 2008, CALIF AGR, V62, P167, DOI 10.3733/ca.v062n04p167; Daane Kent M., 2012, P271; Daane KM, 2011, ENVIRON ENTOMOL, V40, P1595, DOI 10.1603/EN11075; Granara De Willink María Cristina, 2007, Rev. Soc. Entomol. Argent., V66, P29; Demontis MA, 2007, J APPL ENTOMOL, V131, P59, DOI 10.1111/j.1439-0418.2006.01126.x; Foldi Imre, 2005, Nouvelle Revue d'Entomologie, V22, P305; GARAU R, 1995, VITIS, V34, P67; Gimpel William F. Jr, 1996, Contributions on Entomology International, V2, P1; Golino D. A., 2002, California Agriculture, V56, P196, DOI 10.3733/ca.v056n06p196; Gonzalez R. H., 2004, Revista Fruticola, V25, P41; Gullan PJ, 2010, SYST ENTOMOL, V35, P329, DOI 10.1111/j.1365-3113.2009.00513.x; Gullan PJ, 2003, ANN ENTOMOL SOC AM, V96, P723, DOI 10.1603/0013-8746(2003)096[0723:ANPSOT]2.0.CO;2; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Kaydan MB, 2012, ZOOTAXA, P1; Kuniyuki Hugo, 2006, Summa phytopathol., V32, P151, DOI 10.1590/S0100-54052006000200009; Malausa T, 2011, J APPL ENTOMOL, V135, P142, DOI 10.1111/j.1439-0418.2009.01495.x; Martelli G P, 2002, Arch Virol, V147, P2039, DOI 10.1007/s007050200048; Mello LMR, 2013, VITICULTURA BRASILEI; Miller DR, 2002, P ENTOMOL SOC WASH, V104, P825; Morandi Filho WJ, 2008, ARQ I BIOL-SAO PAULO, V76, P427; Morse GE, 2006, SYST ENTOMOL, V31, P338, DOI 10.1111/j.1365-3113.2005.00316.x; Park DS, 2011, B ENTOMOL RES, V101, P429, DOI 10.1017/S0007485310000714; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Saccaggi DL, 2008, B ENTOMOL RES, V98, P27, DOI 10.1017/S000748530700538X; SANTA-CECÍLIA LENIRA V.C., 2002, Neotrop. entomol., V31, P333, DOI 10.1590/S1519-566X2002000200024; Selwyn B, 2007, J AGRAR CHANGE, V7, P526, DOI 10.1111/j.1471-0366.2007.00155.x; Selwyn B, 2010, J AGRAR CHANGE, V10, P537, DOI 10.1111/j.1471-0366.2009.00245.x; Souza B., 2008, Coffee Science, V3, P104; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Villard P, 2013, MOL ECOL RESOUR, V13, P755, DOI 10.1111/1755-0998.12116; Walton V. M., 2004, South African Journal of Enology and Viticulture, V25, P54; Walton VM, 2009, J INSECT SCI, V9, DOI 10.1673/031.009.4701; Willians DJ, 1992, MEALYBUGS CENTRAL S; Yokogawa T, 2009, GENES GENET SYST, V84, P57, DOI 10.1266/ggs.84.57	50	446	498	61	151	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2014	9	7							e103267	10.1371/journal.pone.0103267	http://dx.doi.org/10.1371/journal.pone.0103267			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RP	24671213	Green Submitted, Green Published, gold			2022-12-27	WOS:000339992600050
J	Ramos, JE; Pecl, GT; Moltschaniwskyj, NA; Strugnell, JM; Leon, RI; Semmens, JM				Ramos, Jorge E.; Pecl, Gretta T.; Moltschaniwskyj, Natalie A.; Strugnell, Jan M.; Leon, Rafael I.; Semmens, Jayson M.			Body Size, Growth and Life Span: Implications for the Polewards Range Shift of Octopus tetricus in South-Eastern Australia	PLOS ONE			English	Article							CLIMATE-CHANGE; COMMON OCTOPUS; REPRODUCTIVE-CYCLE; UPWELLING SYSTEM; VULGARIS; SQUID; EVOLUTIONARY; ECOLOGY; AGE; TEMPERATURE	Understanding the response of any species to climate change can be challenging. However, in short-lived species the faster turnover of generations may facilitate the examination of responses associated with longer-term environmental change. Octopus tetricus, a commercially important species, has undergone a recent polewards range shift in the coastal waters of south-eastern Australia, thought to be associated with the southerly extension of the warm East Australian Current. At the cooler temperatures of a polewards distribution limit, growth of a species could be slower, potentially leading to a bigger body size and resulting in a slower population turnover, affecting population viability at the extreme of the distribution. Growth rates, body size, and life span of O. tetricus were examined at the leading edge of a polewards range shift in Tasmanian waters (40 degrees S and 147 degrees E) throughout 2011. Octopus tetricus had a relatively small body size and short lifespan of approximately 11 months that, despite cooler temperatures, would allow a high rate of population turnover and may facilitate the population increase necessary for successful establishment in the new extended area of the range. Temperature, food availability and gender appear to influence growth rate. Individuals that hatched during cooler and more productive conditions, but grew during warming conditions, exhibited faster growth rates and reached smaller body sizes than individuals that hatched into warmer waters but grew during cooling conditions. This study suggests that fast growth, small body size and associated rapid population turnover may facilitate the range shift of O. tetricus into Tasmanian waters.	[Ramos, Jorge E.; Pecl, Gretta T.; Leon, Rafael I.; Semmens, Jayson M.] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia; [Moltschaniwskyj, Natalie A.] Univ Newcastle, Sch Environm & Life Sci, Ourimbah, NSW, Australia; [Strugnell, Jan M.] La Trobe Univ, Dept Genet, La Trobe Inst Mol Sci, Bundoora, Vic, Australia	University of Tasmania; University of Newcastle; La Trobe University	Ramos, JE (corresponding author), Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia.	jeramos@utas.edu.au	刘, 芳延/AAO-8535-2021; Strugnell, Jan M/P-9921-2016; Moltschaniwskyj, Natalie/AAB-7236-2019; Pecl, Gretta/D-7267-2011; Bertin, Aline/T-5005-2017; van den Bosch, Frank C./ABH-3801-2020; Malausa, Thibaut/X-1614-2018; León, Rafael I/N-6510-2014; Botton, Marcos/I-1731-2016; Deary, Ian/C-6297-2009; Aidar, Marcos Pereira Marinho/B-2212-2013; Inskip, Hazel/L-5467-2018; Persinoti, Gabriela/C-5933-2016; Silva-Rocha, Rafael/H-4929-2012; Sujii, Edison Ryoiti/H-7715-2015; Benzeval, Michaela/J-3163-2015; Apparecida Desiderio, Janete/F-5848-2012; Leimar, Olof/L-3781-2014; Guazzaroni, Maria-Eugenia/E-2599-2013; Dodds, Richard/D-7772-2016; Sujii, Edison/H-7715-2015	刘, 芳延/0000-0002-5155-1916; Pecl, Gretta/0000-0003-0192-4339; Bertin, Aline/0000-0003-4232-4241; van den Bosch, Frank C./0000-0003-3236-2068; Malausa, Thibaut/0000-0003-1681-7958; León, Rafael I/0000-0003-3197-4185; Botton, Marcos/0000-0002-0554-3157; Deary, Ian/0000-0002-1733-263X; Favati, Anna/0000-0002-6435-011X; Aidar, Marcos Pereira Marinho/0000-0001-5728-6749; Fernandes, Odair/0000-0003-3489-4754; Aihie Sayer, Avan/0000-0003-1283-6457; Der, Geoff/0000-0002-8677-073X; Choo, Robin/0000-0002-3240-3029; Dennison, Elaine/0000-0002-3048-4961; Strugnell, Jan/0000-0003-2994-637X; Germain, Jean-Francois/0000-0001-7927-6031; Inskip, Hazel/0000-0001-8897-1749; Persinoti, Gabriela/0000-0002-0975-7283; Silva-Rocha, Rafael/0000-0001-6319-631X; Moltschaniwskyj, Natalie/0000-0001-9709-9876; Sujii, Edison Ryoiti/0000-0001-7602-8999; Benzeval, Michaela/0000-0002-0372-2098; Teixeira da Silva, Jaime A./0000-0003-3299-2772; Apparecida Desiderio, Janete/0000-0001-7723-3070; Souza, Silvia/0000-0001-6293-7665; Semmens, Jayson/0000-0003-1742-6692; Ramos, Jorge E/0000-0002-8690-761X; Wong, Joshua/0000-0001-8268-5610; timbo, renata/0000-0003-1989-7412; Gale, Catharine/0000-0002-3361-8638; Jagger, Carol/0000-0002-6377-9926; Paveley, Neil/0000-0002-1709-4563; Leimar, Olof/0000-0001-8621-6977; Wong, Jason/0000-0002-8167-540X; Cooper, Cyrus/0000-0003-3510-0709; Guazzaroni, Maria-Eugenia/0000-0002-4657-3731; Pacheco da Silva, Vitor/0000-0002-8420-1779; Gan, Victor/0000-0002-6966-2729; Tilling, Kate/0000-0002-1010-8926; R. Silva, Rogerio/0000-0002-0599-2155; Lawlor, Debbie A/0000-0002-6793-2262; Vucicevic, Katarina/0000-0001-9676-5785; Robinson, Sian/0000-0003-1766-7269; Dodds, Richard/0000-0003-4968-7678; Lye, David/0000-0003-0324-0205; Sujii, Edison/0000-0002-0702-0181; N. Silva, Roberto/0000-0002-8992-7130; De Vivo, Immaculata/0000-0002-7185-7402; Cooper, Rachel/0000-0003-3370-5720	Consejo Nacional de Ciencia y Tecnologia of Mexico [308672]; University of Tasmania; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005198] Funding Source: researchfish	Consejo Nacional de Ciencia y Tecnologia of Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); University of Tasmania; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	J. Ramos was awarded the scholarship 308672 by Consejo Nacional de Ciencia y Tecnologia of Mexico, a Tasmania Graduate Research scholarship from the University of Tasmania and a Bookend Lynchpin Ocean Scholarship 2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Amundsen PA, 2012, BIOL INVASIONS, V14, P1501, DOI 10.1007/s10530-012-0175-3; Anderson RC, 2008, MAR ECOL PROG SER, V371, P199, DOI 10.3354/meps07649; Arenas M, 2012, MOL BIOL EVOL, V29, P207, DOI 10.1093/molbev/msr187; Arkhipkin AI, 2005, MAR FRESHWATER RES, V56, P371, DOI 10.1071/MF04274; Barratt IM, 2010, ICES J MAR SCI, V67, P1452, DOI 10.1093/icesjms/fsq047; Berteaux D, 2004, INTEGR COMP BIOL, V44, P140, DOI 10.1093/icb/44.2.140; Blois JL, 2013, SCIENCE, V341, P499, DOI 10.1126/science.1237184; Calosi P, 2013, INTEGR COMP BIOL, V53, P660, DOI 10.1093/icb/ict041; Calosi P, 2010, J ANIM ECOL, V79, P194, DOI 10.1111/j.1365-2656.2009.01611.x; Canali E, 2011, MAR ECOL PROG SER, V441, P141, DOI 10.3354/meps09399; Carrasco JF, 2006, AQUAC RES, V37, P1601, DOI 10.1111/j.1365-2109.2006.01594.x; CHEN Y, 1992, CAN J FISH AQUAT SCI, V49, P1228, DOI 10.1139/f92-138; Clarke MR, 1996, PHILOS T ROY SOC B, V351, P1105, DOI 10.1098/rstb.1996.0096; Colautti RI, 2006, BIOL INVASIONS, V8, P1023, DOI 10.1007/s10530-005-3735-y; Cowen RK, 2009, ANNU REV MAR SCI, V1, P443, DOI 10.1146/annurev.marine.010908.163757; Dia M.A., 1988, THESIS U W BRITTANY THESIS U W BRITTANY; Domain F, 2000, J MAR BIOL ASSOC UK, V80, P699, DOI 10.1017/S0025315400002526; Doubleday Z, 2006, J EXP MAR BIOL ECOL, V338, P35, DOI 10.1016/j.jembe.2006.06.027; Edgar G, 2000, AUSTR MARINE LIFE PL; Engel Katharina, 2011, Communicative & Integrative Biology, V4, P247, DOI 10.4161/cib.4.3.14885; Forsythe J.W., 1987, P135; FORSYTHE JW, 1988, MAR BIOL, V98, P369, DOI 10.1007/BF00391113; Forsythe JW, 2004, MAR FRESHWATER RES, V55, P331, DOI 10.1071/MF03146; Fox J., 2019, R COMPANION APPL REG, V.; Fulton EA, 2011, ICES J MAR SCI, V68, P1329, DOI 10.1093/icesjms/fsr032; Guzik MT, 2005, MOL PHYLOGENET EVOL, V37, P235, DOI 10.1016/j.ympev.2005.05.009; Hanlon RT, 1996, CEPHALOPOD BEHAV; Harrington JJ, 2006, FISH RES, V77, P10, DOI 10.1016/j.fishres.2005.09.003; Hermosilla CA, 2010, ICES J MAR SCI, V67, P1458, DOI 10.1093/icesjms/fsq054; Herwig JN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043679; Hill KL, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032912; Hoffmann AA, 2008, NAT REV GENET, V9, P421, DOI 10.1038/nrg2339; Holt RD, 2003, EVOL ECOL RES, V5, P159; Hoving HJT, 2013, GLOBAL CHANGE BIOL, V19, P2089, DOI 10.1111/gcb.12198; Jackson GD, 2004, MAR FRESHWATER RES, V55, P357, DOI 10.1071/MF03152; Jackson GD, 2003, MAR BIOL, V142, P925, DOI 10.1007/s00227-002-1005-4; Jackson GD, 2001, MAR ECOL PROG SER, V218, P167, DOI 10.3354/meps218167; Johnson CR, 2011, J EXP MAR BIOL ECOL, V400, P17, DOI 10.1016/j.jembe.2011.02.032; Katsanevakis S, 2006, ICES J MAR SCI, V63, P151, DOI 10.1016/j.icesjms.2005.07.004; Last PR, 2011, GLOBAL ECOL BIOGEOGR, V20, P58, DOI 10.1111/j.1466-8238.2010.00575.x; Lee CE, 2002, TRENDS ECOL EVOL, V17, P386, DOI 10.1016/S0169-5347(02)02554-5; Leporati SC, 2008, MAR ECOL PROG SER, V367, P213, DOI 10.3354/meps07558; Leporati SC, 2008, MAR BIOL, V155, P375, DOI 10.1007/s00227-008-1033-9; Leporati SC, 2007, MAR BIOL, V151, P1375, DOI 10.1007/s00227-006-0575-y; Lourenco S, 2012, FISH RES, V127, P116, DOI 10.1016/j.fishres.2012.04.006; Mangold K., 1983, P335; Mangold K., 1987, P157; Mather JA, 2012, CURR ZOOL, V58, P597, DOI 10.1093/czoolo/58.4.597; McMahon RF, 2002, CAN J FISH AQUAT SCI, V59, P1235, DOI 10.1139/F02-105; Moreno A, 2012, J MAR BIOL ASSOC UK, V92, P1619, DOI 10.1017/S0025315411002141; Norman M.D., 2000, GUIDE SQUID CUTTLEFI; Okei N, 1999, STOCK ENHANCEMENT AND SEA RANCHING, P468; Oosthuizen A, 2003, J MAR BIOL ASSOC UK, V83, P535, DOI 10.1017/S0025315403007458h; Otero J, 2008, MAR ECOL PROG SER, V362, P181, DOI 10.3354/meps07437; Otero J, 2007, FISH RES, V85, P122, DOI 10.1016/j.fishres.2007.01.007; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pecl GT, 2008, REV FISH BIOL FISHER, V18, P373, DOI 10.1007/s11160-007-9077-3; Pecl GT, 2004, MAR FRESHWATER RES, V55, P387, DOI 10.1071/MF03153; Pinsky ML, 2013, SCIENCE, V341, P1239, DOI 10.1126/science.1239352; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Poloczanska ES, 2007, OCEANOGR MAR BIOL, V45, P407; Poloczanska ES, 2013, NAT CLIM CHANGE, V3, P919, DOI [10.1038/nclimate1958, 10.1038/NCLIMATE1958]; R Core Team, 2021, R LANGUAGE ENV STAT; Ridgway KR, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030392; Ridgway KR, 2003, PROG OCEANOGR, V56, P189, DOI 10.1016/S0079-6611(03)00004-1; Rosa R, 2008, P NATL ACAD SCI USA, V105, P20776, DOI 10.1073/pnas.0806886105; Rosas C, 2008, AQUACULTURE, V275, P291, DOI 10.1016/j.aquaculture.2008.01.015; Sandery PA, 2007, ESTUAR COAST SHELF S, V74, P684, DOI 10.1016/j.ecss.2007.05.011; Scandol J, 2008, STATUS FISHERIES RES, P193; Schwarz R, 2010, FISH RES, V106, P177, DOI 10.1016/j.fishres.2010.06.008; Semmens J, 2011, J EXP BIOL, V214, P2799, DOI 10.1242/jeb.051631; Semmens JM, 2004, MAR FRESHWATER RES, V55, P367, DOI 10.1071/MF03155; Shea K, 2002, TRENDS ECOL EVOL, V17, P170, DOI 10.1016/S0169-5347(02)02495-3; Spiess A, 2013, QPCR MODELLING ANAL; Sunday JM, 2012, NAT CLIM CHANGE, V2, P686, DOI 10.1038/NCLIMATE1539; Tasmania Wild Fisheries Management Branch Tasmania Department of Primary Industries and Water, 2009, SACL FISH MAN PLAN R; Travis JMJ, 2013, OIKOS, V122, P1532, DOI 10.1111/j.1600-0706.2013.00399.x; Villanueva R, 1995, CAN J FISH AQUAT SCI, V52, P2639, DOI 10.1139/f95-853; VILLANUEVA R, 1992, J EXP MAR BIOL ECOL, V159, P157, DOI 10.1016/0022-0981(92)90034-8; Villanueva R, 2008, OCEANOGR MAR BIOL, V46, P105; Wagenmakers EJ, 2004, PSYCHON B REV, V11, P192, DOI 10.3758/BF03206482; Ware DM, 2005, SCIENCE, V308, P1280, DOI 10.1126/science.1109049; Wolf BM, 1997, J SHELLFISH RES, V16, P533	85	446	498	61	151	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103480	10.1371/journal.pone.0103480	http://dx.doi.org/10.1371/journal.pone.0103480			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	24671213	Green Accepted, Green Published, gold			2022-12-27	WOS:000339812700029
J	Wu, KL; Zeng, SJ; Lin, DI; da Silva, JAT; Bu, ZY; Zhang, JX; Duan, J				Wu, Kunlin; Zeng, Songjun; Lin, Danni; da Silva, Jaime A. Teixeira; Bu, Zhaoyang; Zhang, Jianxia; Duan, Ju			In Vitro Propagation and Reintroduction of the Endangered Renanthera imschootiana Rolfe	PLOS ONE			English	Article							ASYMBIOTIC SEED-GERMINATION; CALCIUM HYPOCHLORITE; ESTABLISHMENT; REGENERATION; GROWTH; ORCHID	Renanthera imschootiana Rolfe is an endangered tropical epiphytic orchid that is threatened with extinction due to over-collection and the loss of suitable habitats. In vitro propagation is a useful way to mass produce plants for re-establishment in the wild and for commercial propagation. Seeds collected 150 days after pollination (DAP) were the optimum stage for in vitro culture. Seed germination reached 93.1% on quarter-strength MS (i.e., MS containing a quarter of macro-and micronutrients) medium containing 0.5 mg l(-1) a-naphthaleneacetic acid (NAA), 20% coconut water (CW), 1.0 g l(-1) peptone, 10 g l(-1) sucrose and 1.0 g l(-1) activated charcoal (AC). Quarter-strength MS medium supplemented with 1.0 mg l(-1) BA, 0.5 mg l(-1) NAA, 1.0 g l(-1) peptone, 10 g l(-1) sucrose and 20% CW was suitable for the sub-culture of protocorm-like bodies (PLBs) in which the PLB proliferation ratio was 2.88. Quarter-strength MS medium containing 1.0 mg l(-1) NAA, 1.0 g l(-1) peptone, 100 g l(-1) banana homogenate (BH), and 1.0 g l(-1) AC was suitable for plantlet formation and 95.67% of plantlets developed from PLBs within 60 days of culture. Hyponex N016 medium supplemented with 0.5 mg l(-1) NAA, 1.0 g l(-1) peptone, 20 g l(-1) sucrose, 150 g l(-1) BH, and 1.0 g l(-1) AC was suitable for the in vitro growth of plantlets about 2-cm in height. Plantlets 3-cm in height or taller were transplanted to Chilean sphagnum moss, and 95% of plantlets survived after 60 days in a greenhouse. Three hundred transplanted of seedlings 360-days old were reintroduced into three natural habitats. Highest percentage survival (79.67%) was observed in Yuanjiang Nature Reserve two years after reintroduction, followed by Huolu Mountain forest park (71.33%). This protocol is an efficient means for the large-scale propagation and in vitro and in vivo germplasm conservation of R. imschootiana.	[Wu, Kunlin; Zeng, Songjun; Lin, Danni; Zhang, Jianxia] Chinese Acad Sci, South China Bot Garden, Key Lab Plant Resources Conservat & Sustainable U, Guangzhou, Guangdong, Peoples R China; [Duan, Ju] Chinese Acad Sci, South China Bot Garden, Key Lab S China Agr Plant Mol Anal & Gene Improve, Guangzhou, Guangdong, Peoples R China; [da Silva, Jaime A. Teixeira] Kagawa Ken, Takamatsu, Kagawa, Japan; [Bu, Zhaoyang] Guangxi Acad Agr Sci, Flower Res Inst, Nanning 150931, Peoples R China	Chinese Academy of Sciences; South China Botanical Garden, CAS; Chinese Academy of Sciences; South China Botanical Garden, CAS; Guangxi Academy of Agricultural Sciences	Zeng, SJ (corresponding author), Chinese Acad Sci, South China Bot Garden, Key Lab Plant Resources Conservat & Sustainable U, Guangzhou, Guangdong, Peoples R China.	zengsongjun@scib.ac.cn; yangnv@126.com	刘, 芳延/AAO-8535-2021; Strugnell, Jan M/P-9921-2016; Moltschaniwskyj, Natalie/AAB-7236-2019; Pecl, Gretta/D-7267-2011; Bertin, Aline/T-5005-2017; van den Bosch, Frank C./ABH-3801-2020; Malausa, Thibaut/X-1614-2018; León, Rafael I/N-6510-2014; Botton, Marcos/I-1731-2016; Deary, Ian/C-6297-2009; Aidar, Marcos Pereira Marinho/B-2212-2013; Inskip, Hazel/L-5467-2018; Persinoti, Gabriela/C-5933-2016; Silva-Rocha, Rafael/H-4929-2012; Sujii, Edison Ryoiti/H-7715-2015; Benzeval, Michaela/J-3163-2015; Apparecida Desiderio, Janete/F-5848-2012; Leimar, Olof/L-3781-2014; Guazzaroni, Maria-Eugenia/E-2599-2013; Dodds, Richard/D-7772-2016; Sujii, Edison/H-7715-2015	刘, 芳延/0000-0002-5155-1916; Pecl, Gretta/0000-0003-0192-4339; Bertin, Aline/0000-0003-4232-4241; van den Bosch, Frank C./0000-0003-3236-2068; Malausa, Thibaut/0000-0003-1681-7958; León, Rafael I/0000-0003-3197-4185; Botton, Marcos/0000-0002-0554-3157; Deary, Ian/0000-0002-1733-263X; Favati, Anna/0000-0002-6435-011X; Aidar, Marcos Pereira Marinho/0000-0001-5728-6749; Fernandes, Odair/0000-0003-3489-4754; Aihie Sayer, Avan/0000-0003-1283-6457; Der, Geoff/0000-0002-8677-073X; Choo, Robin/0000-0002-3240-3029; Dennison, Elaine/0000-0002-3048-4961; Strugnell, Jan/0000-0003-2994-637X; Germain, Jean-Francois/0000-0001-7927-6031; Inskip, Hazel/0000-0001-8897-1749; Persinoti, Gabriela/0000-0002-0975-7283; Silva-Rocha, Rafael/0000-0001-6319-631X; Moltschaniwskyj, Natalie/0000-0001-9709-9876; Sujii, Edison Ryoiti/0000-0001-7602-8999; Benzeval, Michaela/0000-0002-0372-2098; Teixeira da Silva, Jaime A./0000-0003-3299-2772; Apparecida Desiderio, Janete/0000-0001-7723-3070; Souza, Silvia/0000-0001-6293-7665; Semmens, Jayson/0000-0003-1742-6692; Ramos, Jorge E/0000-0002-8690-761X; Wong, Joshua/0000-0001-8268-5610; timbo, renata/0000-0003-1989-7412; Gale, Catharine/0000-0002-3361-8638; Jagger, Carol/0000-0002-6377-9926; Paveley, Neil/0000-0002-1709-4563; Leimar, Olof/0000-0001-8621-6977; Wong, Jason/0000-0002-8167-540X; Cooper, Cyrus/0000-0003-3510-0709; Guazzaroni, Maria-Eugenia/0000-0002-4657-3731; Pacheco da Silva, Vitor/0000-0002-8420-1779; Gan, Victor/0000-0002-6966-2729; Tilling, Kate/0000-0002-1010-8926; R. Silva, Rogerio/0000-0002-0599-2155; Lawlor, Debbie A/0000-0002-6793-2262; Vucicevic, Katarina/0000-0001-9676-5785; Robinson, Sian/0000-0003-1766-7269; Dodds, Richard/0000-0003-4968-7678; Lye, David/0000-0003-0324-0205; Sujii, Edison/0000-0002-0702-0181; N. Silva, Roberto/0000-0002-8992-7130; De Vivo, Immaculata/0000-0002-7185-7402; Cooper, Rachel/0000-0003-3370-5720	Key Laboratory of Plant Resources Conservation and Sustainable Utilization, South China Botanical Garden, Chinese Academy of Sciences [211026]; Guangzhou Key Technology Research and Development Program [Y233051001]; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005198] Funding Source: researchfish	Key Laboratory of Plant Resources Conservation and Sustainable Utilization, South China Botanical Garden, Chinese Academy of Sciences; Guangzhou Key Technology Research and Development Program; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was supported by a fund of the Key Laboratory of Plant Resources Conservation and Sustainable Utilization, South China Botanical Garden, Chinese Academy of Sciences (No. 211026), and the Guangzhou Key Technology Research and Development Program (Y233051001). Songjun Zeng received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akeroyd J., 1995, HDB BOT GARDENS REIN; [Anonymous], 2014, WORLD CHECKLIST SELE; Arditti J., 1993, MICROPROPAGATION ORC; Arditti J, 1982, ORCHID BIOL REV PERS, P352; Chu Chin-Chang, 1994, Lindleyana, V9, P153; Chugh S, 2009, SCI HORTIC-AMSTERDAM, V122, P507, DOI 10.1016/j.scienta.2009.07.016; da Silva JAT, 2006, PLANT CELL TISS ORG, V84, P135, DOI 10.1007/s11240-005-9003-0; da Silva JAT, 2005, PROPAG ORNAM PLANTS, V5, P129; DASILVA JAT, 2012, ASIAN AUSTRALASIAN J, V6, P121; DeMarie E., 1991, HORTSCIENCE, V26, P272; Dix L., 1982, PLANT CELL TISSUE OR, V12, P39; Ernst R., 1975, American Orchid Society Bulletin, V44, P12; Ernst R., 1974, American Orchid Society Bulletin, V43, P35; Goh C. J., 1982, Orchid Review, V90, P295; GOH CJ, 1990, SCI HORTIC-AMSTERDAM, V44, P315, DOI 10.1016/0304-4238(90)90132-X; HARVAIS G, 1973, CAN J BOT, V51, P327, DOI 10.1139/b73-040; Hossain MM, 2013, CRIT REV PLANT SCI, V32, P69, DOI 10.1080/07352689.2012.715984; Kauth P.J., 2008, FLORICULTURE ORNAMEN, P375; Kishor R, 2009, EUPHYTICA, V165, P247, DOI 10.1007/s10681-008-9755-9; Knudson Lewis, 1946, AMER ORCHID SOC BULL, V15, P214; Lee YI, 2006, ANN BOT-LONDON, V98, P1311, DOI 10.1093/aob/mcl222; Lin DL, 2008, J FOOD DRUG ANAL, V16, P1; Lo SF, 2004, IN VITRO CELL DEV-PL, V40, P528, DOI 10.1079/IVP2004571; McNaughton S.J., 1989, P109; Miyoshi K, 1998, PHYSIOL PLANTARUM, V102, P481, DOI 10.1034/j.1399-3054.1998.1020401.x; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Mweetwa AM, 2008, SCI HORTIC-AMSTERDAM, V117, P257, DOI 10.1016/j.scienta.2008.03.035; NAGASHIMA T, 1982, J JPN SOC HORTIC SCI, V51, P94, DOI 10.2503/jjshs.51.94; PIERIK RLM, 1988, SCI HORTIC-AMSTERDAM, V34, P139, DOI 10.1016/0304-4238(88)90084-2; Raghavan V., 1977, CRC HDB SERIES NUTR, P361; Ren H, 2012, ORYX, V46, P391, DOI 10.1017/S0030605311000615; Rout TM, 2009, ECOL APPL, V19, P515, DOI 10.1890/07-1989.1; SEENI S, 1992, PLANT CELL TISS ORG, V29, P167, DOI 10.1007/BF00034349; Seeni S, 2000, PLANT CELL TISS ORG, V61, P1, DOI 10.1023/A:1006444614657; Teixeira da Silva J., 2013, FLORIC ORNAM BIOTECH, V7, P1, DOI DOI 10.1016/0168-1656(90)90117-T; Thomale H., 1954, ORCHIDEEN, P62; Thomas TD, 2008, BIOTECHNOL ADV, V26, P618, DOI 10.1016/j.biotechadv.2008.08.003; Tsi Z. H., 1999, FLORA REIPUBLICAE PO, V19, P291; VACIN EF, 1949, BOT GAZ, V110, P605, DOI 10.1086/335561; van der Kinderen G., 1987, LINDLEYANA, V2, P84; VANWAES JM, 1986, PHYSIOL PLANTARUM, V66, P435, DOI 10.1111/j.1399-3054.1986.tb05947.x; Vyas S, 2009, SCI HORTIC-AMSTERDAM, V121, P32, DOI 10.1016/j.scienta.2009.01.012; Wu KL, 2012, SCI HORTIC-AMSTERDAM, V135, P194, DOI 10.1016/j.scienta.2011.11.028; Wu KunLin, 2010, Acta Horticulturae Sinica, V37, P685; Wu Z.Y., 2009, FLORA CHINA, V25; YAM T W, 1990, Lindleyana, V5, P256; Yong JWH, 2009, MOLECULES, V14, P5144, DOI 10.3390/molecules14125144; Zeng SJ, 2015, CRIT REV BIOTECHNOL, V35, P279; Zeng SJ, 2011, HORTSCIENCE, V46, P460, DOI 10.21273/HORTSCI.46.3.460; Zeng SJ, 2012, SCI HORTIC-AMSTERDAM, V138, P198, DOI 10.1016/j.scienta.2012.02.026	51	446	498	61	151	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e110033	10.1371/journal.pone.0110033	http://dx.doi.org/10.1371/journal.pone.0110033			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	24671213	Green Published, Green Submitted, gold			2022-12-27	WOS:000343943100017
